PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Chao, KC; Chang, CC; Chiou, HY; Chang, JS				Chao, Kuo-Ching; Chang, Chun-Chao; Chiou, Hung-Yi; Chang, Jung-Su			Serum Ferritin Is Inversely Correlated with Testosterone in Boys and Young Male Adolescents: A Cross-Sectional Study in Taiwan	PLOS ONE			English	Article							METABOLIC SYNDROME; IRON-METABOLISM; HEPCIDIN; MEN; ASSOCIATION; ANDROGENS; ERYTHROPOIESIS; HYPOGONADISM; CYTOKINE; OBESITY	Objective The transition from childhood to teenaged years is associated with increased testosterone and a decreased iron status. It is not clear whether higher testosterone levels cause the decreased iron status, and to what extent, obesity-related inflammation influences the iron-testosterone relationship. The aim of the present study was to examine relationships of testosterone, iron status, and anti-/proinflammatory cytokines in relation to nutritional status in boys and young adolescent Taiwanese males. Methods In total, 137 boys aged 7 similar to 13 yr were included. Parameters for obesity, the iron status, testosterone, and inflammatory markers were evaluated. Results Overweight and obese (ow/obese) boys had higher mean serum testosterone, interleukin (IL)-1 beta, and nitric oxide (NO) levels compared to their normal-weight counterparts (all p<0.05). Mean serum ferritin was slightly higher in ow/obese boys compared to normal-weight boys, but this did not reach statistical significance. A multiple linear regression showed that serum ferritin (beta = -0.7470, p = 0.003) was inversely correlated with testosterone, while serum IL-10 (beta = 0.3475, p = 0.009) was positively associated with testosterone after adjusting for covariates. When normal-weight boys were separately assessed from ow/obesity boys, the association between testosterone and serum ferritin became stronger (beta = -0.9628, p<0.0001), but the association between testosterone and IL-10 became nonsignificant (beta = 0.1140, p = 0.4065) after adjusting for covariates. In ow/obese boys, only IL-10 was weakly associated with serum testosterone (beta = 0.6444, p = 0.051) after adjusting for age. Conclusions Testosterone and serum ferritin are intrinsically interrelated but this relationship is weaker in ow/obese boys after adjusting for age.	[Chao, Kuo-Ching; Chang, Chun-Chao] Taipei Med Univ Hosp, Div Gastroenterol & Hepatol, Dept Internal Med, Taipei, Taiwan; [Chao, Kuo-Ching; Chang, Chun-Chao] Taipei Med Univ, Div Gastroenterol & Hepatol, Dept Internal Med, Sch Med,Coll Med, Taipei, Taiwan; [Chiou, Hung-Yi] Taipei Med Univ, Sch Publ Hlth, Coll Publ Hlth & Nutr, Taipei, Taiwan; [Chang, Jung-Su] Taipei Med Univ, Sch Nutr & Hlth Sci, Coll Publ Hlth & Nutr, Taipei, Taiwan	Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University	Chang, JS (corresponding author), Taipei Med Univ, Sch Nutr & Hlth Sci, Coll Publ Hlth & Nutr, Taipei, Taiwan.	susanchang@tmu.edu.tw		Chiou, Hung Yi/0000-0002-4545-9697	Taipei Medical University Hospital [103TMU-TMUH-11, 104TMU-TMUH-18]; Ministry of Science and Technology, Taiwan [MOST 103-2320-B-038-015, MOST 104-2311-B-038-005]	Taipei Medical University Hospital; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	Dr. Jung-Su Chang was supported by grants from Taipei Medical University Hospital (103TMU-TMUH-11 and 104TMU-TMUH-18) and the Ministry of Science and Technology, Taiwan (MOST 103-2320-B-038-015 and MOST 104-2311-B-038-005).	Ahmed SA, 2010, SEX HORMONES AND IMMUNITY TO INFECTION, P19, DOI 10.1007/978-3-642-02155-8_2; Bachman E, 2014, J GERONTOL A-BIOL, V69, P725, DOI 10.1093/gerona/glt154; Bachman E, 2010, J CLIN ENDOCR METAB, V95, P4743, DOI 10.1210/jc.2010-0864; Barbosa Maritza Cavalcante, 2013, Rev. Bras. Hematol. Hemoter., V35, P29, DOI 10.5581/1516-8484.20130011; Beggs LA, 2014, AM J PHYSIOL-ENDOC M, V307, pE456, DOI 10.1152/ajpendo.00184.2014; Chang JS, 2013, PEDIAT NEON IN PRESS, P1; Chang JS, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-123; Chang JS, 2013, ASIA PAC J CLIN NUTR, V22, P400, DOI 10.6133/apjcn.2013.22.3.07; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Coviello AD, 2008, J CLIN ENDOCR METAB, V93, P914, DOI 10.1210/jc.2007-1692; Ferrucci L, 2006, ARCH INTERN MED, V166, P1380, DOI 10.1001/archinte.166.13.1380; Galesloot TE, 2011, BLOOD, V117, pE218, DOI 10.1182/blood-2011-02-337907; Ganz T, 2008, BLOOD, V112, P4292, DOI 10.1182/blood-2008-02-139915; Gautier A, 2011, EUR J ENDOCRINOL, V165, P339, DOI 10.1530/EJE-11-0215; Gillum RF, 2001, INT J OBESITY, V25, P639, DOI 10.1038/sj.ijo.0801561; Gray CP, 2001, INT J CANCER, V92, P843, DOI 10.1002/ijc.1269; Guo W, 2013, AGING CELL, V12, P280, DOI 10.1111/acel.12052; HAWKINS WW, 1954, BLOOD, V9, P999, DOI 10.1182/blood.V9.10.999.999; Kroot JJC, 2011, CLIN CHEM, V57, P1650, DOI 10.1373/clinchem.2009.140053; Kroot JJC, 2009, HAEMATOL-HEMATOL J, V94, P1748, DOI 10.3324/haematol.2009.010322; Laarakkers CMM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075518; Liu ZF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075908; Macdougall IC, 2010, CLIN J AM SOC NEPHRO, V5, P1681, DOI 10.2215/CJN.05990809; Mogri M, 2013, CLIN ENDOCRINOL, V78, P593, DOI 10.1111/cen.12018; Noetzli LJ, 2012, AM J HEMATOL, V87, P167, DOI 10.1002/ajh.22247; Price EA, 2008, BLOOD CELL MOL DIS, V41, P158, DOI 10.1016/j.bcmd.2008.04.005; Reinehr T, 2005, J CLIN ENDOCR METAB, V90, P5588, DOI 10.1210/jc.2005-0438; Ruddell RG, 2009, HEPATOLOGY, V49, P887, DOI 10.1002/hep.22716; Soderberg S, 2001, INT J OBESITY, V25, P98, DOI 10.1038/sj.ijo.0801467; Soliman Ashraf, 2014, Indian J Endocrinol Metab, V18, P310, DOI 10.4103/2230-8210.131158; Tan CE, 2004, DIABETES CARE, V27, P1182, DOI 10.2337/diacare.27.5.1182; Tilg H, 2002, J IMMUNOL, V169, P2204, DOI 10.4049/jimmunol.169.4.2204; Uljterschout L, 2014, PEDIATR RES, V76, P409, DOI 10.1038/pr.2014.109; Vandewalle S, 2015, CURR OPIN ENDOCRINOL, V22, P230, DOI 10.1097/MED.0000000000000160; Vyoral D, 2005, INT J BIOCHEM CELL B, V37, P1768, DOI 10.1016/j.biocel.2005.02.023; Wabitsch M, 1997, J CLIN INVEST, V100, P808, DOI 10.1172/JCI119595; Wang CM, 2014, ASIAN PAC J CANCER P, V15, P605, DOI 10.7314/APJCP.2014.15.2.605; Wittert GA, 2003, J GERONTOL A-BIOL, V58, P618; Wu H, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008570, 10.1371/journal.pone.0013316]; Zhang YZ, 2007, CELL PHYSIOL BIOCHEM, V20, P847, DOI 10.1159/000110444	40	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0144238	10.1371/journal.pone.0144238	http://dx.doi.org/10.1371/journal.pone.0144238			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YV	26646112	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903100015
J	El-Ashram, S; Yin, Q; Liu, HB; Al Nasr, I; Liu, XY; Suo, X; Barta, J				El-Ashram, Saeed; Yin, Qing; Liu, Hongbin; Al Nasr, Ibrahim; Liu, Xianyong; Suo, Xun; Barta, John			From the Macro to the Micro: Gel Mapping to Differentiate between Sporozoites of Two Immunologically Distinct Strains of Eimeria maxima (Strains M6 and Guelph)	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; RHOPTRY PROTEINS; FAMILY; EMTFP250	Two immunologically distinct strains of E. maxima were examined in this study: the M6 strain and the Guelph strain. The differential expression between the sporozoites of the two strains of E. maxima was determined by image analysis of 100 mu g of protein from each strain separated by standard one-and conventional two-dimensional polyacrylamide gel electrophoresis. In addition to differences in both molecular weight and the electrophoretic mobility, differences in the intensity of polypeptide bands for example, GS 136.4 and M6 169 were explored. Pooled gels were prepared from each strain. A representative 2D-PAGE gel spanning a non-linear pH range of 3-10 of E. maxima strain M6 consisted of approximately 694 polypeptide spots with about 67 (9.6%) of the polypeptide spots being unique relative to the other strain. E. maxima strain GS had about 696 discernable polypeptide spots with 69 spots (9.9%) that differed from those of the M6 strain. In-depth characterization of the variable polypeptide spots; unique polypeptide spots (absence or presence) and shared polypeptide spots with modifications may lead to novel vaccine target in the form of multicomponent, multi-stage, multi-immunovariant strains, multi-species subunit vaccine, and diagnostic probe for E. maxima.	[El-Ashram, Saeed; Yin, Qing; Liu, Xianyong; Suo, Xun] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China; [El-Ashram, Saeed; Yin, Qing; Liu, Xianyong; Suo, Xun] China Agr Univ, Natl Anim Protozoa Lab, Beijing 100094, Peoples R China; [El-Ashram, Saeed; Yin, Qing; Liu, Xianyong; Suo, Xun] China Agr Univ, Coll Vet Med, Beijing 100094, Peoples R China; [El-Ashram, Saeed] Kafr El Sheikh Univ, Fac Sci, Kafr Al Sheikh, Egypt; [El-Ashram, Saeed; Barta, John] Univ Guelph, Guelph, ON N1G 2W1, Canada; [Liu, Hongbin] Hebei North Univ, Dept Pharmacol, Zhangjiakou, Hebei, Peoples R China; [Al Nasr, Ibrahim] Qassim Univ, Coll Appl Hlth Sci arras, Buraydah, Saudi Arabia	China Agricultural University; China Agricultural University; China Agricultural University; Egyptian Knowledge Bank (EKB); Kafrelsheikh University; University of Guelph; Hebei North University; Qassim University	Suo, X (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China.	suoxun@cau.edu.cn; jbarta@uoguelph.ca	Nasr, Ibrahim Al/AFP-8105-2022; El-Ashram, Saeed/AAC-6060-2021; Barta, John/L-7508-2019; sulaiman, ibrahim/GQZ-6901-2022	El-Ashram, Saeed/0000-0003-0389-1980; AL NASR, IBRAHIM/0000-0003-4690-1050; LIU, XIANYONG/0000-0001-9425-6784	National Basic Science Research Program (973 program) of China [2015CB150300]; Special Fund for Agroscientific Research in the Public Interest [201303042]; National Natural Science Foundation of China [31172309]; Open Project of the State Key Laboratory of Veterinary Etiological Biology [SKLVEB2011KFKT001]	National Basic Science Research Program (973 program) of China(National Basic Research Program of China); Special Fund for Agroscientific Research in the Public Interest; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Project of the State Key Laboratory of Veterinary Etiological Biology	This research was supported by the National Basic Science Research Program (973 program) of China (2015CB150300), the Special Fund for Agroscientific Research in the Public Interest (201303042), the National Natural Science Foundation of China (31172309), and the Open Project of the State Key Laboratory of Veterinary Etiological Biology (SKLVEB2011KFKT001). Additionally, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AQUADRO CF, 1981, P NATL ACAD SCI-BIOL, V78, P3784, DOI 10.1073/pnas.78.6.3784; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Bottje W, 2011, Compositions and methods of enhancing immune responses to Eimeria, Patent No. 61K39002; Choi SH, 2010, KOREAN J PARASITOL, V48, P195, DOI 10.3347/kjp.2010.48.3.195; de Venevelles P, 2004, INT J PARASITOL, V34, P1321, DOI 10.1016/j.ijpara.2004.08.002; Dlugonska Henryka, 2003, Wiadomosci Parazytologiczne, V49, P3; El Hajj H, 2006, PROTEOMICS, V6, P5773, DOI 10.1002/pmic.200600187; El-Ashram S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121647; Feng ZP, 2006, MOL BIOCHEM PARASIT, V150, P256, DOI 10.1016/j.molbiopara.2006.08.011; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; KOGUT MH, 1984, Z PARASITENKD, V70, P287, DOI 10.1007/BF00927814; Kurien BT, 2012, HUMANA, V869, P465; Lal K, 2009, PROTEOMICS, V9, P4566, DOI 10.1002/pmic.200900305; Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111; Martin AG, 1997, INT J PARASITOL, V27, P527, DOI 10.1016/S0020-7519(97)00027-1; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Snelling WJ, 2007, MOL CELL PROTEOMICS, V6, P346, DOI 10.1074/mcp.M600372-MCP200; SUTTON CA, 1989, PARASITOLOGY, V99, P175, DOI 10.1017/S0031182000058613; Thiede B, 2005, METHODS, V35, P237, DOI 10.1016/j.ymeth.2004.08.015; TOMLEY FM, 1994, INFECT IMMUN, V62, P4656, DOI 10.1128/IAI.62.10.4656-4658.1994; Westermeier R, 2005, BIOSCIENCE REP, V25, P19, DOI 10.1007/s10540-005-2845-1; Witcombe DA, 2003, INT J PARASITOL, V33, P691, DOI 10.1016/S0020-7519(03)00086-9; Witcombe DM, 2004, INT J PARASITOL, V34, P861, DOI 10.1016/j.ijpara.2004.03.006	23	6	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0143232	10.1371/journal.pone.0143232	http://dx.doi.org/10.1371/journal.pone.0143232			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641262	Green Published, Green Submitted, gold			2022-12-27	WOS:000366902700013
J	Han, Q; Hong, Y; Fu, ZQ; Zhang, M; Cao, XD; Liu, YT; Ma, S; Guo, YT; Lu, K; Zhu, CG; Lin, JJ				Han, Qian; Hong, Yang; Fu, Zhiqiang; Zhang, Min; Cao, Xiaodan; Liu, Yantao; Ma, Shuai; Guo, Yuntao; Lu, Ke; Zhu, Chuangang; Lin, Jiaojiao			Characterization of VAMP2 in Schistosoma japonicum and the Evaluation of Protective Efficacy Induced by Recombinant SjVAMP2 in Mice	PLOS ONE			English	Article							MEMBRANE-FUSION EVENTS; SNARE COMPLEX; TEGUMENT; MANSONI; PROTEINS; TRANSPORT; RELEASE; INSULIN; VACCINE; SURFACE	Background The outer-tegument membrane covering the schistosome is believed to maintain via the fusion of membranous vesicles. Fusion of biological membranes is a fundamental process in all eukaryotic cells driven by formation of trans-SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) complexes through pairing of vesicle associated v-SNAREs (VAMP) with complementary t-SNAREs on target membranes. The purpose of this study was to characterize Schistosoma japonicum vesicle-associated membrane protein 2 (SjVAMP2) and to investigate its potential as a candidate vaccine against schistosomiasis. Methodology/Principal Findings The sequence of SjVAMP2 was analyzed, cloned, expressed and characterized. SjVAMP2 is a member of the synaptobrevin superfamily harboring the v-SNARE coiled-coil homology domain. RT-PCR analysis revealed that significantly higher SjVAMP2 levels were observed in 14-, 28-and 42-day-old worms, and SjVAMP2 expression was much higher in 42-day-old female worms than in those male worms. Additionally, the expression of SjVAMP2 was associated with membrane recovery in PZQ-treated worms. Immunostaining assay showed that SjVAMP2 was mainly distributed in the sub-tegument of the worms. Western blotting revealed that rSjVAMP2 showed strong immunogenicity. Purified rSjVAMP2 emulsified with ISA206 adjuvant induced 41.5% and 27.3% reductions in worm burden, and 36.8% and 23.3% reductions in hepatic eggs in two independent trials. Besides, significantly higher rSjVAMP2-specific IgG, IgG1, IgG2a levels were detected in rSjVAMP2-vaccinated mice. Conclusion Our study indicated that SjVAMP2 is a potential vaccine candidate against S. japonicum and provided the basis for further investigations into the biological function of SjVAMP2.	[Han, Qian; Hong, Yang; Fu, Zhiqiang; Zhang, Min; Cao, Xiaodan; Liu, Yantao; Ma, Shuai; Lu, Ke; Zhu, Chuangang; Lin, Jiaojiao] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Natl Lab Anim Schistosomiasis Control, Key Lab Anim Parasitol,Minist Agr, Shanghai, Peoples R China; [Zhang, Min] Henan Univ Sci & Technol, Coll Anim Sci & Technol, Luoyang, Peoples R China; [Guo, Yuntao] Chinese Acad Agr Sci, Inst Anim Sci, Beijing 100193, Peoples R China; [Lin, Jiaojiao] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Henan University of Science & Technology; Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS	Lin, JJ (corresponding author), Chinese Acad Agr Sci, Shanghai Vet Res Inst, Natl Lab Anim Schistosomiasis Control, Key Lab Anim Parasitol,Minist Agr, Shanghai, Peoples R China.	jjlin@shvri.ac.cn			National Natural Science Foundation of China [31172315, 81271871, 31472188]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (No. 31172315, 81271871) for J. Lin and National Natural Science Foundation of China (No. 31472188) for Z. Fu.	Aragon AD, 2009, MOL BIOCHEM PARASIT, V164, P57, DOI 10.1016/j.molbiopara.2008.11.007; Burri L, 2003, P NATL ACAD SCI USA, V100, P9873, DOI 10.1073/pnas.1734000100; Cardoso FC, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000308; Castro-Borges W, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000993; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; Collins C, 2012, INFECT DIS POVERTY, V1, DOI 10.1186/2049-9957-1-8; De Blas GA, 2005, PLOS BIOL, V3, P1801, DOI 10.1371/journal.pbio.0030323; Engels D, 2002, ACTA TROP, V82, P139, DOI 10.1016/S0001-706X(02)00045-1; Fix M, 2004, P NATL ACAD SCI USA, V101, P7311, DOI 10.1073/pnas.0401779101; Fonseca Cristina Toscano, 2012, J Parasitol Res, V2012, P541268, DOI 10.1155/2012/541268; Gao Y, 2012, SCIENCE, V337, P1340, DOI 10.1126/science.1224492; Gillon AD, 2012, BBA-MOL CELL BIOL L, V1821, P1040, DOI 10.1016/j.bbalip.2012.01.005; Gobert GN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-128; Gobert GN, 2003, INT J PARASITOL, V33, P1561, DOI 10.1016/S0020-7519(03)00255-8; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Halkic N, 2002, NEW ENGL J MED, V347, P767; Hines-Kay J, 2012, MOL BIOCHEM PARASIT, V186, P87, DOI 10.1016/j.molbiopara.2012.09.006; HOCKLEY D J, 1973, International Journal for Parasitology, V3, P13, DOI 10.1016/0020-7519(73)90004-0; Hurley JH, 2010, CELL, V143, P875, DOI 10.1016/j.cell.2010.11.030; Jiang JW, 1996, EXP PARASITOL, V82, P201, DOI 10.1006/expr.1996.0025; Jiang YY, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-190; Karatekin E, 2010, P NATL ACAD SCI USA, V107, P3517, DOI 10.1073/pnas.0914723107; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Klinovska K, 2014, INT J MOL SCI, V15, P10652, DOI 10.3390/ijms150610652; Li F, 2014, J AM CHEM SOC, V136, P3456, DOI 10.1021/ja410690m; Lin Y, 2011, J CELL PHYSIOL, V226, P2625, DOI 10.1002/jcp.22613; Lundy SK, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00039; Matveeva EA, 2012, NEUROSCIENCE, V202, P77, DOI 10.1016/j.neuroscience.2011.11.055; Mendez M, 2011, J BIOL CHEM, V286, P28608, DOI 10.1074/jbc.M111.225839; MORRIS GP, 1968, J PARASITOL, V54, P15, DOI 10.2307/3276867; Mulvenna J, 2010, INT J PARASITOL, V40, P543, DOI 10.1016/j.ijpara.2009.10.002; Nogi T, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000464; Patz JA, 2000, INT J PARASITOL, V30, P1395, DOI 10.1016/S0020-7519(00)00141-7; Paumet F, 2004, P NATL ACAD SCI USA, V101, P3376, DOI 10.1073/pnas.0400271101; Pearce EJ, 2002, NAT REV IMMUNOL, V2, P499, DOI 10.1038/nri843; Ramakrishnan NA, 2012, MOL CELL NEUROSCI, V50, P58, DOI 10.1016/j.mcn.2012.03.009; Randhawa VK, 2004, MOL BIOL CELL, V15, P5565, DOI 10.1091/mbc.E04-03-0266; Reid AT, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.392803; Rofatto HK, 2013, PEERJ, V1, DOI 10.7717/peerj.58; Ross AGP, 2002, NEW ENGL J MED, V346, P1212, DOI 10.1056/NEJMra012396; Shi L, 2013, NAT PROTOC, V8, P935, DOI 10.1038/nprot.2013.048; Siddiqui AA, 2008, PARASITOL RES, V102, P825, DOI 10.1007/s00436-008-0887-6; Skelly PJ, 2006, ADV PARASIT, V63, P185, DOI 10.1016/S0065-308X(06)63003-0; Skelly PJ, 2001, PARASITOLOGY, V122, P67, DOI 10.1017/S0031182000007071; SMITHERS SR, 1969, PROC R SOC SER B-BIO, V171, P483, DOI 10.1098/rspb.1969.0007; Tajika Y, 2010, ACTA HISTOCHEM CYTOC, V43, P107, DOI 10.1267/ahc.10010; UGLEM GL, 1975, J PARASITOL, V61, P390, DOI 10.2307/3279309; Van Hellemond JJ, 2006, INT J PARASITOL, V36, P691, DOI 10.1016/j.ijpara.2006.01.007; Wan ZhongYuan, 1999, Chinese Journal of Parasitic Disease Control, V12, P45; Wang Shi-Ping, 2009, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V27, P402; Williams D, 2009, MOL BIOL CELL, V20, P4910, DOI 10.1091/mbc.E09-04-0284; Xiong Y, 2013, PLOS ONE, V8; Yang Y, 2010, P NATL ACAD SCI USA, V107, P22145, DOI 10.1073/pnas.1006899108; Zhou XN, 2007, EMERG INFECT DIS, V13, P1470, DOI 10.3201/eid1310.061423	54	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144584	10.1371/journal.pone.0144584	http://dx.doi.org/10.1371/journal.pone.0144584			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641090	Green Published, gold			2022-12-27	WOS:000366902700147
J	Mooney, S; Tracy, R; Osler, T; Grace, C				Mooney, Sarah; Tracy, Russell; Osler, Turner; Grace, Christopher			Elevated Biomarkers of Inflammation and Coagulation in Patients with HIV Are Associated with Higher Framingham and VACS Risk Index Scores	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; INFECTED PATIENTS; MONOCYTE ACTIVATION; AIDS; POPULATION; MARKERS; INDIVIDUALS; INITIATION; MORTALITY	Background Biomarkers of inflammation and altered coagulation are of increasing interest as predictors of chronic disease and mortality in HIV patients, as well as the use of risk stratification scores such as the Framingham index and the Veterans Aging Cohort Study (VACS) score. Methods Demographic and laboratory data for 252 HIV patients were assessed for their relationship with 5 biomarkers: hsCRP, D-dimer, Cystatin C, IL-6 and TNF-alpha. Analysis of variance was used to model the association between the number of elevated biomarkers patients had and their Framingham 10 year cardiovascular risk and VACS scores. Results 87% of patients were male and 75.7% were virally suppressed (HIV RNA < 48 copies/ml). The median and interquartile ranges for each biomarker were: hsCRP 1.65 ug/mL (0.73, 3.89), D-dimer 0.17 ug/mL (0.09, 0.31), Cystatin C 0.87 mg/L (0.78, 1.01), IL-6 2.13 pg/mL (1.3, 3.59), TNF-alpha 4.65 pg/mL (3.5, 5.97). 62.6% of patients had more than one biomarker > 75th percentile, while 18.6% had three or more elevated biomarkers. Increased age, cigarette smoking, CD4 counts of < 200 cells/mm(3), Framingham scores and VACS scores were most strongly associated with elevations in biomarkers. When biomarkers were used to predict the Framingham and VACS scores, those with a higher number of elevated biomarkers had higher mean VACS scores, with a similar but less robust finding for Framingham scores. Conclusions Despite viral suppression and immunological stability, biomarkers of inflammation and coagulation remain elevated in a significant number of patients with HIV and are associated with higher scores on risk stratification indices.	[Mooney, Sarah; Grace, Christopher] Univ Vermont, Coll Med, Dept Med, Infect Dis Unit, Burlington, VT 05405 USA; [Tracy, Russell] Univ Vermont, Coll Med, Dept Pathol & Biochem, Burlington, VT USA; [Osler, Turner] Univ Vermont, Coll Med, Dept Surg, Burlington, VT USA	University of Vermont; University of Vermont; University of Vermont	Grace, C (corresponding author), Univ Vermont, Coll Med, Dept Med, Infect Dis Unit, Burlington, VT 05405 USA.	Christopher.grace@uvmhealth.org						Armah KA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-399; Armah KA, 2012, CLIN INFECT DIS, V55, P126, DOI 10.1093/cid/cis406; Baker JV, 2011, JAIDS-J ACQ IMM DEF, V56, P36, DOI 10.1097/QAI.0b013e3181f7f61a; Boulware DR, 2011, J INFECT DIS, V203, P1637, DOI 10.1093/infdis/jir134; Chen SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060008; Currier JS, 2003, JAIDS-J ACQ IMM DEF, V33, P506, DOI 10.1097/00126334-200308010-00012; D'Agostino RB, 2012, J INFECT DIS, V205, pS362, DOI 10.1093/infdis/jis196; Deeks SG, 2013, IMMUNITY, V39, P633, DOI 10.1016/j.immuni.2013.10.001; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Desquilbet L, 2007, J GERONTOL A-BIOL, V62, P1279, DOI 10.1093/gerona/62.11.1279; Eckard AR, 2014, J INFECT DIS, V209, P1156, DOI 10.1093/infdis/jiu012; Effros RB, 2008, CLIN INFECT DIS, V47, P542, DOI 10.1086/590150; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Guaraldi G, 2011, CLIN INFECT DIS, V53, P1120, DOI 10.1093/cid/cir627; Guzman-Fulgencio M, 2011, J INFECTION, V63, P382, DOI 10.1016/j.jinf.2011.08.006; Justice AC, 2010, HIV MED, V11, P143, DOI 10.1111/j.1468-1293.2009.00757.x; Justice AC, 2013, JAIDS-J ACQ IMM DEF, V62, P149, DOI 10.1097/QAI.0b013e31827df36c; Justice AC, 2012, CLIN INFECT DIS, V54, P984, DOI 10.1093/cid/cir989; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; McComsey GA, 2014, JAIDS-J ACQ IMM DEF, V65, P167, DOI 10.1097/01.qai.0000437171.00504.41; Miller CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095061; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; Nixon DE, 2010, CURR OPIN HIV AIDS, V5, P498, DOI 10.1097/COH.0b013e32833ed6f4; Palella FJ, 2010, AIDS, V24, P1657, DOI 10.1097/QAD.0b013e3283389dfa; Phillips AN, 2008, AIDS, V22, P2409, DOI 10.1097/QAD.0b013e3283174636; Salmon-Ceron D, 2009, J HEPATOL, V50, P736, DOI 10.1016/j.jhep.2008.11.018; Samji H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081355; Shiels MS, 2011, J NATL CANCER I, V103, P753, DOI 10.1093/jnci/djr076; Shirley DK, 2013, CLIN INFECT DIS, V57, P275, DOI 10.1093/cid/cit207; Silver SA, 2011, TRANSPLANTATION, V92, P183, DOI 10.1097/TP.0b013e31821f303f; Triant VA, 2008, J CLIN ENDOCR METAB, V93, P3499, DOI 10.1210/jc.2008-0828	32	37	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144312	10.1371/journal.pone.0144312	http://dx.doi.org/10.1371/journal.pone.0144312			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641655	Green Submitted, gold, Green Published			2022-12-27	WOS:000366902700096
J	Pandey, S; Patel, MK; Mishra, A; Jha, B				Pandey, Sonika; Patel, Manish Kumar; Mishra, Avinash; Jha, Bhavanath			Physio-Biochemical Composition and Untargeted Metabolomics of Cumin (Cuminum cyminum L.) Make It Promising Functional Food and Help in Mitigating Salinity Stress	PLOS ONE			English	Article							ESSENTIAL OIL COMPOSITION; ANTIOXIDANT ACTIVITIES; FATTY-ACID; EXTINCTION COEFFICIENTS; SCAVENGING ACTIVITY; LIPID-PEROXIDATION; CHLOROPHYLL-A; SALT STRESS; TOLERANCE; WATER	Cumin is an annual, aromatic, herbaceous, medicinal, spice plant, most widely used as a food additive and flavoring agent in different cuisines. The study is intended to comprehensively analyse physiological parameters, biochemical composition and metabolites under salinity stress. Seed germination index, rate of seed emergence, rate of seed germination, mean germination time, plant biomass, total chlorophyll and carotenoid contents decreased concomitantly with salinity. In contrast, total antioxidant activity, H2O2, proline and MDA contents increased concurrently with stress treatments. Total phenolic and flavonoid contents were decreased initially about 1.4-fold at 50 mM, and thereafter increased about 1.2-fold at 100 mM NaCl stress. Relative water content remained unchanged up to 50 mM NaCl stress, and thereafter decreased significantly. About 2.8-fold electrolyte leakage was found in 50 mM, which increases further 4-fold at 100 mM NaCl stress. Saturated fatty acids (FAs) increased gradually with salinity, whereas unsaturation index and degree of unsaturation change arbitrarily along with the percent quantity of unsaturated FAs. Total lipid and fatty acid composition were significantly influenced by salinity stress. A total of 45 differentially expressed metabolites were identified, including luteolin, salvianolic acid, kaempferol and quercetin, which are phenolic, flavonoid or alkaloids in nature and contain antioxidant activities. Additionally, metabolites with bioactivity such as anticancerous ( docetaxel) and antimicrobial ( megalomicin) properties were also identified. The study evidenced that plant shoots are a rich source of metabolites, essential amino acids, phenolic compounds and fatty acids, which unveil the medicinal potential of this plant, and also provide useful insight about metabolic responses under salinity stress.	[Pandey, Sonika; Patel, Manish Kumar; Mishra, Avinash; Jha, Bhavanath] CSIR Cent Salt & Marine Chem Res Inst, Div Marine Biotechnol & Ecol, Bhavnagar, Gujarat, India; [Pandey, Sonika; Mishra, Avinash; Jha, Bhavanath] CSIR, Acad Sci & Innovat Res, New Delhi 110001, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Salt & Marine Chemical Research Institute (CSMCRI); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India	Mishra, A (corresponding author), CSIR Cent Salt & Marine Chem Res Inst, Div Marine Biotechnol & Ecol, G B Marg, Bhavnagar, Gujarat, India.	avinash@csmcri.org; bjha@csmcri.org	Patel, Manish Kumar/I-6335-2017; Mishra, Avinash/AAG-2961-2019; Mishra, Avinash/C-3210-2009	Patel, Manish Kumar/0000-0001-5250-1008; Mishra, Avinash/0000-0003-0342-010X; Mishra, Avinash/0000-0003-0342-010X	Council of Scientific and Industrial Research (CSIR), Government of India, New Delhi [BSC0107-PlaGen]	Council of Scientific and Industrial Research (CSIR), Government of India, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This study was supported by the Council of Scientific and Industrial Research (CSIR; www.csir.res.in), Government of India, New Delhi [BSC0107-PlaGen]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1993, ANALYST, V118, P1089; ARUNA K, 1992, FOOD CHEM TOXICOL, V30, P953, DOI 10.1016/0278-6915(92)90180-S; Ashraf M, 2004, PLANT SCI, V166, P3, DOI 10.1016/j.plantsci.2003.10.024; Bajji M, 2002, PLANT GROWTH REGUL, V36, P61, DOI 10.1023/A:1014732714549; BARRS HD, 1962, AUST J BIOL SCI, V15, P413, DOI 10.1071/BI9620413; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Bettaieb I, 2011, J AGR FOOD CHEM, V59, P328, DOI 10.1021/jf1037618; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chaturvedi AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111379; CHEN GX, 1990, J BIOL CHEM, V265, P2775; D'Souza MR, 2010, ACTA PHYSIOL PLANT, V32, P341, DOI 10.1007/s11738-009-0412-2; De Lorenzo A, 2001, DIABETES NUTR METAB, V14, P181; De Vos RCH, 2007, NAT PROTOC, V2, P778, DOI 10.1038/nprot.2007.95; Deepak, 2013, INDIAN J TRADIT KNOW, V12, P300; Dhanalakshmi GS, 2003, NUTR CANCER, V47, P171, DOI 10.1207/s15327914nc4702_10; Ellis R. H., 1980, Seed production., P605; Epstein E, 2005, MINERAL NUTR PLANTS, P342; FAO, 2008, 91 FAO; FERGUSON IB, 1983, PLANT PHYSIOL, V71, P182, DOI 10.1104/pp.71.1.182; Gachkar L, 2007, FOOD CHEM, V102, P898, DOI 10.1016/j.foodchem.2006.06.035; Hajlaoui H, 2010, FOOD CHEM TOXICOL, V48, P2186, DOI 10.1016/j.fct.2010.05.044; Hare PD, 1997, PLANT GROWTH REGUL, V21, P79, DOI 10.1023/A:1005703923347; Hassanzadehdelouei M., 2013, Cercetari Agronomice in Moldova, V46, P89; Hazra B, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-63; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Huang XS, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-230; Iacobellis NS, 2005, J AGR FOOD CHEM, V53, P57, DOI 10.1021/jf0487351; INSKEEP WP, 1985, PLANT PHYSIOL, V77, P483, DOI 10.1104/pp.77.2.483; Isaacson T, 2006, NAT PROTOC, V1, P769, DOI 10.1038/nprot.2006.102; Jha B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071136; Jha B, 2011, MOL BIOL REP, V38, P4823, DOI 10.1007/s11033-010-0625-x; Johri R K, 2011, Pharmacogn Rev, V5, P63, DOI 10.4103/0973-7847.79101; Kaewseejan N, 2015, J FUNCT FOODS, V12, P120, DOI 10.1016/j.jff.2014.11.001; Katembe WJ, 1998, ANN BOT-LONDON, V82, P167, DOI 10.1006/anbo.1998.0663; Khan MSA, 1997, J AGRON CROP SCI, V179, P163, DOI 10.1111/j.1439-037X.1997.tb00512.x; Kholova J, 2009, BIOL PLANTARUM, V53, P249, DOI 10.1007/s10535-009-0047-6; Kitajima J, 2003, PHYTOCHEMISTRY, V62, P115, DOI 10.1016/S0031-9422(02)00438-7; Kwanyuen P, 2010, J AM OIL CHEM SOC, V87, P127, DOI 10.1007/s11746-009-1484-2; Li XM, 2012, PLANT SOIL, V352, P377, DOI 10.1007/s11104-011-1003-8; Lopez-Cobo A, 2015, J FUNCT FOODS, V18, P1167, DOI 10.1016/j.jff.2014.10.023; Lu YR, 2001, TETRAHEDRON LETT, V42, P8223, DOI 10.1016/S0040-4039(01)01738-5; Lutts S, 1996, ANN BOT-LONDON, V78, P389, DOI 10.1006/anbo.1996.0134; MAGUIRE JAMES D., 1962, CROP SCI, V2, P176, DOI 10.2135/cropsci1962.0011183X000200020033x; Matthews S, 2011, SEED SCI TECHNOL, V39, P501, DOI 10.15258/sst.2011.39.2.21; Mishra A, 2015, J FUNCT FOODS, V13, P21, DOI 10.1016/j.jff.2014.12.027; Mishra A, 2009, BIORESOURCE TECHNOL, V100, P3382, DOI 10.1016/j.biortech.2009.02.006; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Mnif S, 2015, CHEM BIODIVERS, V12, P733, DOI 10.1002/cbdv.201400305; Moller IM, 2007, ANNU REV PLANT BIOL, V58, P459, DOI 10.1146/annurev.arplant.58.032806.103946; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Murillo-Amador B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094870; Navarro JM, 2006, FOOD CHEM, V96, P66, DOI 10.1016/j.foodchem.2005.01.057; Neffati M, 2011, FOOD CHEM, V124, P221, DOI 10.1016/j.foodchem.2010.06.022; NIU XM, 1995, PLANT PHYSIOL, V109, P735, DOI 10.1104/pp.109.3.735; Pandey S, 2013, APPL BIOCHEM BIOTECH, V171, P1, DOI 10.1007/s12010-013-0349-1; Panuccio MR, 2014, AOB PLANTS, V6, DOI 10.1093/aobpla/plu047; Patel MK, 2015, PLANT CELL TISS ORG, V122, P477, DOI 10.1007/s11240-015-0785-4; Poerschmann J, 2004, MICROB ECOL, V48, P78, DOI 10.1007/s00248-003-0144-6; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; POWELL AA, 1978, J EXP BOT, V29, P1215, DOI 10.1093/jxb/29.5.1215; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Rebey IB, 2012, IND CROP PROD, V36, P238, DOI 10.1016/j.indcrop.2011.09.013; Saeed N, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-221; Sangwan NS, 2001, PLANT GROWTH REGUL, V34, P3, DOI 10.1023/A:1013386921596; Shahidi F, 2015, J FUNCT FOODS, V18, P820, DOI 10.1016/j.jff.2015.06.018; Shahidi F, 2015, J FUNCT FOODS, V18, P757, DOI 10.1016/j.jff.2015.01.047; Shi J, 2010, TREE PHYSIOL, V30, P914, DOI 10.1093/treephys/tpq030; Shobbar MS, 2012, J PLANT NUTR, V35, P1037, DOI 10.1080/01904167.2012.671407; Shoor M, 2014, RES J AGR ENV MANAGE, V3, P340; Singh N, 2014, GENE, V547, P119, DOI 10.1016/j.gene.2014.06.037; Singh N, 2010, PLANT CELL TISS ORG, V103, P1, DOI 10.1007/s11240-010-9746-0; SMITH IK, 1988, ANAL BIOCHEM, V175, P408, DOI 10.1016/0003-2697(88)90564-7; Sowbhagya HB, 2013, CRIT REV FOOD SCI, V53, P1, DOI 10.1080/10408398.2010.500223; Takayanagi T, 2003, PHYTOCHEMISTRY, V63, P479, DOI 10.1016/S0031-9422(03)00103-1; Tiwari V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131567; Vallverdu-Queralt A, 2014, FOOD CHEM, V154, P299, DOI 10.1016/j.foodchem.2013.12.106; Vasconsuelo A, 2007, PLANT SCI, V172, P861, DOI 10.1016/j.plantsci.2007.01.006; Verpoorte R., 2002, Phytochemistry Reviews, V1, P13, DOI 10.1023/A:1015871916833; Xie ZX, 2008, J PLANT PHYSIOL, V165, P375, DOI 10.1016/j.jplph.2007.06.001; Xu XQ, 1997, PHYTOCHEMISTRY, V45, P655, DOI 10.1016/S0031-9422(96)00868-0; Xue TT, 2009, J EXP BOT, V60, P339, DOI 10.1093/jxb/ern291; Yu XY, 2012, BIORESOURCE TECHNOL, V121, P256, DOI 10.1016/j.biortech.2012.07.002; Zhang W, 2014, J FUNCT FOODS, V10, P427, DOI 10.1016/j.jff.2014.07.015; Zhu ZJ, 2013, NAT PROTOC, V8, P451, DOI 10.1038/nprot.2013.004	86	49	51	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144469	10.1371/journal.pone.0144469	http://dx.doi.org/10.1371/journal.pone.0144469			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641494	Green Submitted, Green Published, gold			2022-12-27	WOS:000366902700131
J	Solari, C; Echegaray, CV; Cosentino, MS; Petrone, MV; Waisman, A; Luzzani, C; Francia, M; Villodre, E; Lenz, G; Miriuka, S; Baranao, L; Guberman, A				Solari, Claudia; Vazquez Echegaray, Camila; Soledad Cosentino, Maria; Victoria Petrone, Maria; Waisman, Ariel; Luzzani, Carlos; Francia, Marcos; Villodre, Emilly; Lenz, Guido; Miriuka, Santiago; Baranao, Lino; Guberman, Alejandra			Manganese Superoxide Dismutase Gene Expression Is Induced by Nanog and Oct4, Essential Pluripotent Stem Cells' Transcription Factors	PLOS ONE			English	Article							STRESS DEFENSE-MECHANISMS; EARLY EMBRYONIC LETHALITY; MUTANT MICE; MOUSE; DIFFERENTIATION; GLUTATHIONE; EMBRYOGENESIS; STAT3	Pluripotent stem cells possess complex systems that protect them from oxidative stress and ensure genomic stability, vital for their role in development. Even though it has been reported that antioxidant activity diminishes along stem cell differentiation, little is known about the transcriptional regulation of the involved genes. The reported modulation of some of these genes led us to hypothesize that some of them could be regulated by the transcription factors critical for self-renewal and pluripotency in embryonic stem cells (ESCs) and in induced pluripotent stem cells (iPSCs). In this work, we studied the expression profile of multiple genes involved in antioxidant defense systems in both ESCs and iPSCs. We found that Manganese superoxide dismutase gene (Mn-Sod/Sod2) was repressed during diverse differentiation protocols showing an expression pattern similar to Nanog gene. Moreover, Sod2 promoter activity was induced by Oct4 and Nanog when we performed a transactivation assay using two different reporter constructions. Finally, we studied Sod2 gene regulation by modulating the expression of Oct4 and Nanog in ESCs by shRNAs and found that downregulation of any of them reduced Sod2 expression. Our results indicate that pluripotency transcription factors positively modulate Sod2 gene transcription.	[Solari, Claudia; Vazquez Echegaray, Camila; Soledad Cosentino, Maria; Victoria Petrone, Maria; Waisman, Ariel; Luzzani, Carlos; Francia, Marcos; Baranao, Lino; Guberman, Alejandra] Univ Buenos Aires, Lab Regulac Genica Celulas Madre, Dept Quim Biol, Fac Ciencias Exactas & Nat, Buenos Aires, DF, Argentina; [Solari, Claudia; Vazquez Echegaray, Camila; Soledad Cosentino, Maria; Victoria Petrone, Maria; Waisman, Ariel; Luzzani, Carlos; Francia, Marcos; Baranao, Lino; Guberman, Alejandra] UBA CONICET, Inst Quim Biol IQUIBICEN, Buenos Aires, DF, Argentina; [Villodre, Emilly; Lenz, Guido] Univ Fed Rio Grande do Sul, Lab Sinalizacao Celular, Dept Biofis, Porto Alegre, RS, Brazil; [Miriuka, Santiago] FLENI, LIAN, Buenos Aires, DF, Argentina; [Miriuka, Santiago; Baranao, Lino; Guberman, Alejandra] Consejo Nacl Invest Cientif & Tecn CONICET, Buenos Aires, DF, Argentina; [Guberman, Alejandra] Univ Buenos Aires, Dept Fisiol & Biol Mol & Celular, Fac Ciencias Exactas & Nat, Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Universidade Federal do Rio Grande do Sul; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Guberman, A (corresponding author), Univ Buenos Aires, Lab Regulac Genica Celulas Madre, Dept Quim Biol, Fac Ciencias Exactas & Nat, Buenos Aires, DF, Argentina.	algub@qb.fcen.uba.ar	Miriuka, Santiago/ABE-9614-2020; Miriuka, Santiago/AAM-4051-2020; Lenz, Guido/A-7618-2008; Villodre, Emilly Schlee/AAF-5786-2021	Miriuka, Santiago/0000-0003-2402-3920; Francia, Marcos Gabriel/0000-0002-9719-8249; Vazquez Echegaray, Camila/0000-0001-8849-6853; Waisman, Ariel/0000-0002-6860-9512	National Scientific and Technical Research Council (CONICET) [PIP 112-200801-03003, PIP112-201101-00243]; National Agency for Science and Technology Promotion (ANPCyT) [PICT 2011-2713]	National Scientific and Technical Research Council (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); National Agency for Science and Technology Promotion (ANPCyT)(ANPCyT)	This work was supported by grants (to AG) from the National Scientific and Technical Research Council (CONICET, PIP 112-200801-03003 and PIP112-201101-00243), National Agency for Science and Technology Promotion (ANPCyT, PICT 2011-2713). CS, MSC, AW and CL are fellows from CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong L, 2010, STEM CELLS, V28, P661, DOI 10.1002/stem.307; Bigarella CL, 2014, DEVELOPMENT, V141, P4206, DOI 10.1242/dev.107086; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cho YM, 2006, BIOCHEM BIOPH RES CO, V348, P1472, DOI 10.1016/j.bbrc.2006.08.020; Glover CH, 2006, PLOS COMPUT BIOL, V2, P1463, DOI 10.1371/journal.pcbi.0020158; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Jakupoglu C, 2005, MOL CELL BIOL, V25, P1980, DOI 10.1128/MCB.25.5.1980-1988.2005; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; Jung JE, 2009, J NEUROSCI, V29, P7003, DOI 10.1523/JNEUROSCI.1110-09.2009; Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Losino N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080681; Losino N, 2011, STEM CELLS DEV, V20, P1439, DOI 10.1089/scd.2010.0336; Luzzani C, 2011, BIOCHEM BIOPH RES CO, V410, P816, DOI 10.1016/j.bbrc.2011.06.070; Matsui M, 1996, DEV BIOL, V178, P179, DOI 10.1006/dbio.1996.0208; Melov S, 1999, P NATL ACAD SCI USA, V96, P846, DOI 10.1073/pnas.96.3.846; Miao L, 2009, FREE RADICAL BIO MED, V47, P344, DOI 10.1016/j.freeradbiomed.2009.05.018; Nonn L, 2003, MOL CELL BIOL, V23, P916, DOI 10.1128/MCB.23.3.916-922.2003; Panopoulos AD, 2012, CELL RES, V22, P168, DOI 10.1038/cr.2011.177; Saretzki G, 2004, STEM CELLS, V22, P962, DOI 10.1634/stemcells.22-6-962; Saretzki G, 2008, STEM CELLS, V26, P455, DOI 10.1634/stemcells.2007-0628; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schmelter M, 2006, FASEB J, V20, P1182, DOI 10.1096/fj.05-4723fje; Sheshadri P, 2015, SCI REP-UK, V5, DOI 10.1038/srep09516; Solari C, 2011, BIOCHEM BIOPH RES CO, V410, P252, DOI 10.1016/j.bbrc.2011.05.126; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; St John JC, 2006, METH MOL B, V331, P347; Stambrook PJ, 2007, MECH AGEING DEV, V128, P31, DOI 10.1016/j.mad.2006.11.007; Tablada, 2014, INFOSTAT STAT SOFTWA; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Trouillas M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-73; Ufer C, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00012; Winkler A, 2011, BIOCHEM BIOPH RES CO, V412, P121, DOI 10.1016/j.bbrc.2011.07.056; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2003, METHOD ENZYMOL, V365, P327	35	14	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144336	10.1371/journal.pone.0144336	http://dx.doi.org/10.1371/journal.pone.0144336			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642061	Green Published, Green Submitted, gold			2022-12-27	WOS:000366902700098
J	Vollsaeter, M; Skromme, K; Satrell, E; Clemm, H; Roksund, O; Oymar, K; Markestad, T; Halvorsen, T				Vollsaeter, Maria; Skromme, Kaia; Satrell, Emma; Clemm, Hege; Roksund, Ola; Oymar, Knut; Markestad, Trond; Halvorsen, Thomas			Children Born Preterm at the Turn of the Millennium Had Better Lung Function Than Children Born Similarly Preterm in the Early 1990s	PLOS ONE			English	Article							RESPIRATORY-FUNCTION; EXTREMELY PREMATURE; BIRTH-WEIGHT; INFANTS; AGE; MORBIDITY; STANDARDIZATION; METHACHOLINE; VICTORIA; CARE	Objective Compare respiratory health in children born extremely preterm (EP) or with extremely low birthweight (ELBW) nearly one decade apart, hypothesizing that better perinatal management has led to better outcome. Design Fifty-seven (93%) of 61 eligible 11-year old children born in Western Norway in 1999-2000 with gestational age (GA) <28 weeks or birthweight <1000 gram (EP1999-2000) and matched term-controls were assessed with comprehensive lung function tests and standardized questionnaires. Outcome was compared with data obtained at 10 years of age from all (n = 35) subjects born at GA <29 weeks or birthweight <1001 gram within a part of the same region in 1991-92 (EP1991-1992) and their matched term-controls. Results EP1999-2000 had significantly reduced forced expiratory flow in 1 second (FEV1), FEV1 to forced vital capacity (FEV1/FVC) and forced expiratory flow between 25-75% of FVC (FEF25-75), with z-scores respectively -0.34, -0.50 and -0.61 below those of the term-control group, and more bronchial hyperresponsiveness to methacholine (dose-response-slope 13.2 vs. 3.5; p<0.001), whereas other outcomes did not differ. Low birthweight z-scores, but not neonatal bronchopulmonary dysplasia (BPD) or low GA, predicted poor outcome. For children with neonatal BPD, important lung-function variables were better in EP1999-2000 compared to EP1991-1992. In regression models, improvements were related to more use of antenatal corticosteroids and surfactant treatment in the EP1999-2000. Conclusions Small airway obstruction and bronchial hyperresponsiveness were still present in children born preterm in 1999-2000, but outcome was better than for children born similarly preterm in 1991-92, particularly after neonatal BPD. The findings suggest that better neonatal management not only improves survival, but also long-term pulmonary outcome.	[Vollsaeter, Maria; Skromme, Kaia; Satrell, Emma; Clemm, Hege; Oymar, Knut; Markestad, Trond; Halvorsen, Thomas] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Vollsaeter, Maria; Clemm, Hege; Roksund, Ola; Markestad, Trond; Halvorsen, Thomas] Haukeland Hosp, Dept Pediat, N-5021 Bergen, Norway; [Roksund, Ola] Bergen Univ Coll, Dept Occupat Therapy Physiotherapy & Radiog, Bergen, Norway; [Oymar, Knut] Stavanger Univ Hosp, Dept Pediat, Stavanger, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; Western Norway University of Applied Sciences; Stavanger University Hospital	Vollsaeter, M (corresponding author), Univ Bergen, Dept Clin Sci, Bergen, Norway.	maria.vollsaeter@helse-bergen.no	Røksund, Ola Drange/AAE-8149-2019; Clemm, Hege/N-7000-2016; Halvorsen, Thomas/P-6741-2015	Clemm, Hege/0000-0002-0096-4032; Halvorsen, Thomas/0000-0003-1471-0225; Skromme, Kaia/0000-0001-9029-5807	University of Bergen; Western Norway Regional Health Authority; Haukeland University Hospital; Pediatric Lung Research Fund, Haukeland University Hospital	University of Bergen; Western Norway Regional Health Authority; Haukeland University Hospital; Pediatric Lung Research Fund, Haukeland University Hospital	Major funding institutions were University of Bergen, Western Norway Regional Health Authority and Haukeland University Hospital. Minor support was provided by Pediatric Lung Research Fund, Haukeland University Hospital.	American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; Baraldi E, 2007, NEW ENGL J MED, V357, P1946, DOI 10.1056/NEJMra067279; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Broughton S, 2005, THORAX, V60, P1039, DOI 10.1136/thx.2004.037853; Coalson JJ, 2006, SEMIN PERINATOL, V30, P179, DOI 10.1053/j.semperi.2006.05.004; Crapo RO, 2000, AM J RESP CRIT CARE, V161, P309; Doyle LW, 2006, PEDIATR PULM, V41, P570, DOI 10.1002/ppul.20412; Fanaroff Avroy A, 2007, Am J Obstet Gynecol, V196, DOI 10.1016/j.ajog.2006.09.014; Fawke J, 2010, AM J RESP CRIT CARE, V182, P237, DOI 10.1164/rccm.200912-1806OC; Filippone M, 2009, JAMA-J AM MED ASSOC, V302, P1418, DOI 10.1001/jama.2009.1419; Gibson AM, 2015, PEDIATR PULM, V50, P987, DOI 10.1002/ppul.23093; Hacking DF, 2013, PEDIATR PULM, V48, P449, DOI 10.1002/ppul.22619; Halvorsen T, 2005, PEDIAT ALLERG IMM-UK, V16, P487, DOI 10.1111/j.1399-3038.2005.00314.x; Halvorsen T, 2006, ACTA PAEDIATR, V95, P547, DOI 10.1080/08035250500477529; Hogman M, 2012, J BREATH RES, V6, DOI 10.1088/1752-7155/6/4/047103; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Juliusson PB, 2013, ANN HUM BIOL, V40, P220, DOI 10.3109/03014460.2012.759276; Kaplan E, 2012, CHEST, V142, P725, DOI 10.1378/chest.11-1562; Korhonen P, 2004, ACTA PAEDIATR, V93, P316, DOI 10.1080/08035250410023593; Kotecha SJ, 2013, THORAX, V68, P760, DOI 10.1136/thoraxjnl-2012-203079; Krauss-Etschmann S, 2013, THORAX, V68, P380, DOI 10.1136/thoraxjnl-2012-201902; Lamarche-Vadel A, 2004, ACTA PAEDIATR, V93, P1340, DOI 10.1080/08035250410032926; Lum S, 2011, EUR RESPIR J, V37, P1199, DOI 10.1183/09031936.00071110; Lydersen S, 2009, STAT MED, V28, P1159, DOI 10.1002/sim.3531; Markestad T, 2005, PEDIATRICS, V115, P1289, DOI 10.1542/peds.2004-1482; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; NIEMINEN MM, 1988, THORAX, V43, P896, DOI 10.1136/thx.43.11.896; OCONNOR G, 1987, AM REV RESPIR DIS, V136, P1412, DOI 10.1164/ajrccm/136.6.1412; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; ROSENTHAL M, 1993, THORAX, V48, P803, DOI 10.1136/thx.48.8.803; Serenius F, 2014, ACTA PAEDIATR, V103, P27, DOI 10.1111/apa.12421; Skjaerven R, 2000, ACTA OBSTET GYN SCAN, V79, P440, DOI 10.1034/j.1600-0412.2000.079006440.x; Skromme K, 2015, ACTA PAEDIATR, V104, P1189, DOI 10.1111/apa.13165; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Vollsaeter M, 2013, THORAX, V68, P767, DOI 10.1136/thoraxjnl-2012-202980; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005	37	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144243	10.1371/journal.pone.0144243	http://dx.doi.org/10.1371/journal.pone.0144243			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641080	Green Published, Green Submitted, gold			2022-12-27	WOS:000366902700084
J	Bockhorst, T; Homberg, U				Bockhorst, Tobias; Homberg, Uwe			Compass Cells in the Brain of an Insect Are Sensitive to Novel Events in the Visual World	PLOS ONE			English	Article							CENTRAL COMPLEX; NEURONS; POLARIZATION; MEMORY; ORIENTATION; NAVIGATION; DYNAMICS; NEUROARCHITECTURE; INFORMATION; INTEGRATION	The central complex of the insect brain comprises a group of neuropils involved in spatial orientation and memory. In fruit flies it mediates place learning based on visual landmarks and houses neurons that encode the orientation for goal-directed locomotion, based on landmarks and self-motion cues for angular path-integration. In desert locusts, the central complex holds a compass-like representation of head directions, based on the polarization pattern of skylight. Through intracellular recordings from immobilized locusts, we investigated whether sky compass neurons of the central complex also represent the position or any salient feature of possible landmarks, in analogy to the observations in flies. Neurons showed strongest responses to the novel appearance of a small moving square, but we found no evidence for a topographic representation of object positions. Responses to an individual square were independent of direction of motion and trajectory, but showed rapid adaptation to successive stimulation, unaffected by changing the direction of motion. Responses reappeared, however, if the moving object changed its trajectory or if it suddenly reversed moving direction against the movement of similar objects that make up a coherent background-flow as induced by ego-motion. Response amplitudes co-varied with the precedent state of dynamic background activity, a phenomenon that has been related to attention-dependent saliency coding in neurons of the mammalian primary visual cortex. The data show that neurons of the central complex of the locust brain are visually bimodal, signaling sky compass direction and the novelty character of moving objects. These response properties might serve to attune compass-aided locomotor control to unexpected events in the environment. The difference to data obtained in fruit flies might relate to differences in the lifestyle of landmark learners (fly) and compass navigators (locust), point to the existence of parallel networks for the two orientation strategies, or reflect differences in experimental conditions.	[Bockhorst, Tobias; Homberg, Uwe] Univ Marburg, Fac Biol, Anim Physiol, Marburg, Germany	Philipps University Marburg	Homberg, U (corresponding author), Univ Marburg, Fac Biol, Anim Physiol, Marburg, Germany.	homberg@biologie.uni-marburg.de	Homberg, Uwe/AFH-8214-2022	Homberg, Uwe/0000-0002-8229-7236	Deutssche Forschungsgemeinschaft [HO 950/21-1, HO 950/23-1]	Deutssche Forschungsgemeinschaft	Deutssche Forschungsgemeinschaft (http://www.dfg.de/) grant numbers HO 950/21-1 and HO 950/23-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Bech M, 2014, CURR BIOL, V24, P2124, DOI 10.1016/j.cub.2014.07.045; Bockhorst T, 2015, J NEUROPHYSIOL, V113, P3291, DOI 10.1152/jn.00742.2014; Boly M, 2007, P NATL ACAD SCI USA, V104, P12187, DOI 10.1073/pnas.0611404104; Chapman JW, 2015, ECOL LETT, V18, P287, DOI 10.1111/ele.12407; Cheng K, 2012, J EXP BIOL, V215, P3169, DOI 10.1242/jeb.070417; CLEMENTS AN, 1974, J EXP BIOL, V60, P673; Collett M, 2013, CURR BIOL, V23, pR789, DOI 10.1016/j.cub.2013.07.020; COYNE JA, 1982, AM NAT, V119, P589, DOI 10.1086/283936; el Jundi B, 2014, J COMP PHYSIOL A, V200, P575, DOI 10.1007/s00359-014-0890-6; Fotowat H, 2011, NEURON, V69, P147, DOI 10.1016/j.neuron.2010.12.007; Foucaud J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015231; GEWECKE M, 1990, BIOL CYBERN, V63, P411, DOI 10.1007/BF00199573; Gewecke M., 1993, SENSORY SYSTEMS ARTH, P119; Gray JR, 2005, J EXP BIOL, V208, P2515, DOI 10.1242/jeb.01640; Gutfreund Y, 2012, BIOL CYBERN, V106, P657, DOI 10.1007/s00422-012-0497-3; Heinze S, 2008, J COMP NEUROL, V511, P454, DOI 10.1002/cne.21842; Heinze S, 2007, SCIENCE, V315, P995, DOI 10.1126/science.1135531; Heinze S, 2011, NEURON, V69, P345, DOI 10.1016/j.neuron.2010.12.025; Heinze S, 2009, J NEUROSCI, V29, P11783, DOI 10.1523/JNEUROSCI.1870-09.2009; Hesselmann G, 2008, P NATL ACAD SCI USA, V105, P10984, DOI 10.1073/pnas.0712043105; HOMBERG U, 1994, J COMP PHYSIOL A, V175, P597, DOI 10.1007/BF00199481; Homberg U, 2011, PHILOS T R SOC B, V366, P680, DOI 10.1098/rstb.2010.0199; Kreuz T, 2011, J NEUROSCI METH, V195, P92, DOI 10.1016/j.jneumeth.2010.11.020; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; Mappes M, 2004, J COMP PHYSIOL A, V190, P61, DOI 10.1007/s00359-003-0473-4; Merlin C, 2011, CURR OPIN NEUROBIOL, V22, P1; Muller M, 1997, CELL TISSUE RES, V288, P159, DOI 10.1007/s004410050803; Netser S, 2011, J NEUROSCI, V31, P17811, DOI 10.1523/JNEUROSCI.4790-11.2011; Neuser K, 2008, NATURE, V453, P1244, DOI 10.1038/nature07003; OCARROLL D, 1993, NATURE, V362, P541, DOI 10.1038/362541a0; Ofstad TA, 2011, NATURE, V474, P204, DOI 10.1038/nature10131; OSHEA M, 1975, NATURE, V254, P53, DOI 10.1038/254053a0; Pan YF, 2009, LEARN MEMORY, V16, P289, DOI 10.1101/lm.1331809; Pfeiffer K, 2014, ANNU REV ENTOMOL, V59, P165, DOI 10.1146/annurev-ento-011613-162031; Ritzmann RE, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00097; Rosner R, 2013, J NEUROSCI, V33, P8122, DOI 10.1523/JNEUROSCI.5390-12.2013; ROWELL CHF, 1977, J EXP BIOL, V68, P157; Sakura M, 2008, J NEUROPHYSIOL, V99, P667, DOI 10.1152/jn.00784.2007; Seelig JD, 2015, NATURE, V521, P186, DOI 10.1038/nature14446; Seelig JD, 2013, NATURE, V503, P262, DOI 10.1038/nature12601; Srinivasan MV, 2011, PHYSIOL REV, V91, P413, DOI 10.1152/physrev.00005.2010; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; Super H, 2003, J NEUROSCI, V23, P3407; Weir PT, 2012, CURR BIOL, V22, P21, DOI 10.1016/j.cub.2011.11.026; Wessnitzer J, 2008, P ROY SOC B-BIOL SCI, V275, P915, DOI 10.1098/rspb.2007.1647; Wiederman SD, 2011, J NEUROSCI, V31, P7141, DOI 10.1523/JNEUROSCI.0970-11.2011	47	4	4	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144501	10.1371/journal.pone.0144501	http://dx.doi.org/10.1371/journal.pone.0144501			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636334	Green Submitted, Green Published, gold			2022-12-27	WOS:000366143800094
J	Womack, RP				Womack, Ryan P.			Research Data in Core Journals in Biology, Chemistry, Mathematics, and Physics	PLOS ONE			English	Article							SCIENTIFIC-DATA; SCIENCE	This study takes a stratified random sample of articles published in 2014 from the top 10 journals in the disciplines of biology, chemistry, mathematics, and physics, as ranked by impact factor. Sampled articles were examined for their reporting of original data or reuse of prior data, and were coded for whether the data was publicly shared or otherwise made available to readers. Other characteristics such as the sharing of software code used for analysis and use of data citation and DOIs for data were examined. The study finds that data sharing practices are still relatively rare in these disciplines' top journals, but that the disciplines have markedly different practices. Biology top journals share original data at the highest rate, and physics top journals share at the lowest rate. Overall, the study finds that within the top journals, only 13% of articles with original data published in 2014 make the data available to others.	[Womack, Ryan P.] Rutgers State Univ, Rutgers Univ Libraries, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick	Womack, RP (corresponding author), Rutgers State Univ, Rutgers Univ Libraries, New Brunswick, NJ 08903 USA.	rwomack@rutgers.edu	Womack, Ryan/K-4224-2019	Womack, Ryan/0000-0003-4873-4268				AKERS K, 2012, IASSIST Q SUMMER, V2012, P16; Alsheikh-Ali AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024357; Altman M., 2009, AM ARCHIVIST, V72, P170, DOI [10.17723/aarc.72.1.eu7252lhnrp7h188, DOI 10.17723/AARC.72.1.EU7252LHNRP7H188, DOI 10.17723/AARC.72.1]; Altman M., 2014, IASSIST Q, V37, P62, DOI 10.29173/iq504; [Anonymous], INCITES J CIT REP; Borgman CL, 2012, J AM SOC INF SCI TEC, V63, P1059, DOI 10.1002/asi.22634; Douglass K, 2014, J ASSOC INF SCI TECH, V65, P251, DOI 10.1002/asi.22988; Fecher B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118053; Fienberg S.E., 1985, SHARING RES DATA; Ganley E, 2014, COLL RES LIB NEWS, V75, P305; Hayden EC, 2015, NATURE, V520, P276, DOI 10.1038/520276a; Hourcle Joseph A., 2012, Bulletin of the American Society for Information Science and Technology, V38, P20, DOI 10.1002/bult.2012.1720380507; Kim Y, 2016, J ASSOC INF SCI TECH, V67, P776, DOI 10.1002/asi.23424; Kratz JE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117619; Light RP, 2014, SCIENTOMETRICS, V101, P1535, DOI 10.1007/s11192-014-1238-2; Lohr S.L., 2010, SAMPLING DESIGN ANAL, Vsecond; MacMillan D, 2014, J ACAD LIBR, V40, P541, DOI 10.1016/j.acalib.2014.06.011; Moles N., 2015, DATA SCI J, V13, P192, DOI [10.2481/dsj.14-047, DOI 10.2481/DSJ.14-047, 10.2481/dsj.14-047.]; Mons B, 2011, NAT GENET, V43, P281, DOI 10.1038/ng0411-281; Mooney H., 2014, IASSIST Q, P71, DOI [10.29173/iq240, DOI 10.29173/IQ240]; Murray-Rust P, 2008, SERIALS REV, V34, P52, DOI 10.1016/j.serrev.2008.01.001; Nicholson SW, 2011, PORTAL-LIBR ACAD, V11, P505; Peng G., 2015, DATA SCI J, V13, P231, DOI [10.2481/dsj.14-049, DOI 10.2481/DSJ.14-049, DOI 10.2481/dsj.14-049]; Piwowar HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018657; ROCKWELL RC, 1994, SOC SCI COMPUT REV, V12, P202, DOI 10.1177/089443939401200205; Sayogo DS, 2013, GOV INFORM Q, V30, pS19, DOI 10.1016/j.giq.2012.06.011; Sedransk N, 2010, STAT SCI, V25, P41, DOI 10.1214/10-STS320; Varin C, J ROYAL STAT SOC A, V179, P1; Vines TH, 2014, CURR BIOL, V24, P94, DOI 10.1016/j.cub.2013.11.014; Vines TH, 2013, FASEB J, V27, P1304, DOI 10.1096/fj.12-218164; Wicherts JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026828; Williams A, 2014, J COMPUT AID MOL DES, V28, P1023, DOI 10.1007/s10822-014-9784-5; Zenk-Moltgen W, 2014, ONLINE INFORM REV, V38, P709, DOI 10.1108/OIR-05-2014-0119	33	23	23	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143460	10.1371/journal.pone.0143460	http://dx.doi.org/10.1371/journal.pone.0143460			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636676	gold, Green Published, Green Submitted			2022-12-27	WOS:000366143800012
J	Xu, YT; Yu, S; Zou, JW; Hu, GX; Rahman, NABD; Othman, RB; Tao, X; Huang, ML				Xu, Yongtao; Yu, Shui; Zou, Jian-Wei; Hu, Guixiang; Rahman, Noorsaadah A. B. D.; Othman, Rozana Binti; Tao, Xia; Huang, Meilan			Identification of Peptide Inhibitors of Enveloped Viruses Using Support Vector Machine	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; MEMBRANE-FUSION PROTEINS; TYPE-1 GLYCOPROTEIN-H; ANTIMICROBIAL PEPTIDES; ANTIBACTERIAL PEPTIDES; SYNTHETIC PEPTIDES; HIV-1 GP41; ENTRY; PREDICTION; DESIGN	The peptides derived from envelope proteins have been shown to inhibit the protein-protein interactions in the virus membrane fusion process and thus have a great potential to be developed into effective antiviral therapies. There are three types of envelope proteins each exhibiting distinct structure folds. Although the exact fusion mechanism remains elusive, it was suggested that the three classes of viral fusion proteins share a similar mechanism of membrane fusion. The common mechanism of action makes it possible to correlate the properties of self-derived peptide inhibitors with their activities. Here we developed a support vector machine model using sequence-based statistical scores of self-derived peptide inhibitors as input features to correlate with their activities. The model displayed 92% prediction accuracy with the Matthew's correlation coefficient of 0.84, obviously superior to those using physicochemical properties and amino acid decomposition as input. The predictive support vector machine model for self-derived peptides of envelope proteins would be useful in development of antiviral peptide inhibitors targeting the virus fusion process.	[Xu, Yongtao; Yu, Shui; Huang, Meilan] Queens Univ Belfast, Sch Chem & Chem Engn, Belfast, Antrim, North Ireland; [Xu, Yongtao] Xinxiang Med Univ, Sch Basic Med Sci, Xinxiang, Henan, Peoples R China; [Zou, Jian-Wei; Hu, Guixiang] Zhejiang Univ, Ningbo Inst Technol, Sch Biotechnol & Chem Engn, Ningbo, Zhejiang, Peoples R China; [Rahman, Noorsaadah A. B. D.; Othman, Rozana Binti] Univ Malaya, Fac Sci, Dept Chem, Kuala Lumpur, Malaysia; [Rahman, Noorsaadah A. B. D.; Othman, Rozana Binti] Univ Malaya, Drug Design & Dev Res Grp, Kuala Lumpur, Malaysia; [Othman, Rozana Binti] Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia; [Tao, Xia] Beijing Univ Chem Technol, State Key Lab Organ Inorgan Composites, Beijing 100029, Peoples R China	Queens University Belfast; Xinxiang Medical University; Zhejiang University; Universiti Malaya; Universiti Malaya; Universiti Malaya; Beijing University of Chemical Technology	Huang, ML (corresponding author), Queens Univ Belfast, Sch Chem & Chem Engn, David Keir Bldg,Stranmillis Rd, Belfast, Antrim, North Ireland.	m.huang@qub.ac.uk	Rahman, Noorsaadah Abd./B-9291-2010; Othman, Rozana/B-9628-2010	Rahman, Noorsaadah Abd./0000-0001-5847-8961; Othman, Rozana/0000-0002-8260-9252				Akkarawongsa R, 2009, ANTIMICROB AGENTS CH, V53, P987, DOI 10.1128/AAC.00793-08; Alhoot MA, 2013, INT J MED SCI, V10, P719, DOI 10.7150/ijms.5037; Backovic M, 2009, CURR OPIN STRUC BIOL, V19, P189, DOI 10.1016/j.sbi.2009.02.012; Badani H, 2014, BBA-BIOMEMBRANES, V1838, P2180, DOI 10.1016/j.bbamem.2014.04.015; Bahadur RP, 2008, CELL MOL LIFE SCI, V65, P1059, DOI 10.1007/s00018-007-7451-x; Bahadur RP, 2004, J MOL BIOL, V336, P943, DOI 10.1016/j.jmb.2003.12.073; Bai FW, 2007, J VIROL, V81, P2047, DOI 10.1128/JVI.01840-06; Cantisani M, 2013, J MED CHEM, V56, P8366, DOI 10.1021/jm400771k; Chakrabarti P, 2002, PROTEINS, V47, P334, DOI 10.1002/prot.10085; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Cherkasov A, 2004, MOLECULES, V9, P1034, DOI 10.3390/91201034; Corinna C, 1995, MACH LEARN, V20, P1, DOI DOI 10.1007/BF00994018; Costin JM, 2010, PLOS NEGLECT TROP D, V4, P1; Egelhofer M, 2004, J VIROL, V78, P568, DOI 10.1128/JVI.78.2.568-575.2004; Fan RE, 2005, J MACH LEARN RES, V6, P1889; Fjell CD, 2011, CHEM BIOL DRUG DES, V77, P48, DOI 10.1111/j.1747-0285.2010.01044.x; Fjell CD, 2009, J MED CHEM, V52, P2006, DOI 10.1021/jm8015365; Frecer V, 2004, ANTIMICROB AGENTS CH, V48, P3349, DOI 10.1128/AAC.48.9.3349-3357.2004; Frecer V, 2006, BIOORGAN MED CHEM, V14, P6065, DOI 10.1016/j.bmc.2006.05.005; Gadkari RA, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-17; Galdiero S, 2006, J GEN VIROL, V87, P1085, DOI 10.1099/vir.0.81794-0; Galdiero S, 2008, PEPTIDES, V29, P1461, DOI 10.1016/j.peptides.2008.04.022; Galdiero S, 2008, CHEMBIOCHEM, V9, P758, DOI 10.1002/cbic.200700457; Galdiero S, 2007, CHEMBIOCHEM, V8, P885, DOI 10.1002/cbic.200700044; Galdiero S, 2013, J PEPT SCI, V19, P148, DOI 10.1002/psc.2489; Glaser F, 2001, PROTEINS, V43, P89, DOI 10.1002/1097-0134(20010501)43:2<89::AID-PROT1021>3.3.CO;2-8; Hrobowski YM, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-49; HSU CW, 2010, PRACTICAL GUIDE SUPP, V1, P1; Janin J, 2003, CURR OPIN STRUC BIOL, V13, P383, DOI 10.1016/S0959-440X(03)00064-2; Jenssen H, 2008, J PEPT SCI, V14, P110, DOI 10.1002/psc.908; Jenssen H, 2007, CHEM BIOL DRUG DES, V70, P134, DOI 10.1111/j.1747-0285.2007.00543.x; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; Koedel Y, 2011, J VIROL, V85, P7037, DOI 10.1128/JVI.02366-10; Koehler J, 2013, PLOS NEGLECT TROP D, V7, P1, DOI DOI 10.1371/JOURNAL.PNTD.0002430; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lata S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S19; Li C, 2012, ANTIVIR RES, V94, P179, DOI 10.1016/j.antiviral.2012.03.002; Liu R, 2010, ANTIVIR RES, V86, P172, DOI 10.1016/j.antiviral.2010.02.316; Liu SW, 2007, J BIOL CHEM, V282, P9612, DOI 10.1074/jbc.M609148200; Lo Conte L, 1999, J MOL BIOL, V285, P2177; London N, 2010, PROTEINS, V78, P3140, DOI 10.1002/prot.22785; Lu H, 2001, PROTEINS, V44, P223, DOI 10.1002/prot.1087; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Melnik LI, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-76; Moult J, 1997, CURR OPIN STRUC BIOL, V7, P194, DOI 10.1016/S0959-440X(97)80025-5; Ngan Shing-Chung, 2008, V413, P243; Pelay-Gimeno M, 2015, ANGEW CHEM INT EDIT, V54, P8896, DOI 10.1002/anie.201412070; QURESHI NM, 1990, AIDS, V4, P553, DOI 10.1097/00002030-199006000-00009; Sabahi A, 2008, THESIS; Sainz B, 2006, VIRUS RES, V120, P146, DOI 10.1016/j.virusres.2006.03.001; Samudrala R, 1998, J MOL BIOL, V275, P895, DOI 10.1006/jmbi.1997.1479; Schmidt AG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000851; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Si YH, 2012, HEPATOLOGY, V56, P507, DOI 10.1002/hep.25685; Spence J, 2013, THESIS; Suntoke TR, 2005, J BIOL CHEM, V280, P19852, DOI 10.1074/jbc.M502196200; Taboureau O, 2006, CHEM BIOL DRUG DES, V68, P48, DOI 10.1111/j.1747-0285.2006.00405.x; Teissier E, 2011, MOLECULES, V16, P221, DOI 10.3390/molecules16010221; Thakur N, 2012, NUCLEIC ACIDS RES, V40, pW199, DOI 10.1093/nar/gks450; Torrent M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-373; Tsai CJ, 1997, PROTEIN SCI, V6, P53; Vigant F, 2015, NAT REV MICROBIOL, V13, P426, DOI 10.1038/nrmicro3475; Vondrasek J, 2009, J PHYS CHEM B, V113, P9041, DOI 10.1021/jp902377q; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; WILD C, 1993, AIDS RES HUM RETROV, V9, P1051, DOI 10.1089/aid.1993.9.1051; WILD C, 1994, P NATL ACAD SCI USA, V91, P12676, DOI 10.1073/pnas.91.26.12676; Xu YT, 2012, PROTEINS, V80, P2154, DOI 10.1002/prot.24105; Yuan KH, 2004, BIOCHEM BIOPH RES CO, V319, P746, DOI 10.1016/j.bbrc.2004.05.046; Zheng BJ, 2005, ANTIVIR THER, V10, P393; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002	71	1	2	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144171	10.1371/journal.pone.0144171	http://dx.doi.org/10.1371/journal.pone.0144171			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636321	gold, Green Submitted, Green Published			2022-12-27	WOS:000366143800052
J	Sweeney, LA; Molloy, GJ; Byrne, M; Murphy, AW; Morgan, K; Hughes, CM; Ingham, R				Sweeney, Leigh-Ann; Molloy, Gerard J.; Byrne, Molly; Murphy, Andrew W.; Morgan, Karen; Hughes, Carmel M.; Ingham, Roger			A Qualitative Study of Prescription Contraception Use: The Perspectives of Users, General Practitioners and Pharmacists	PLOS ONE			English	Article							ACTING REVERSIBLE CONTRACEPTION; EMERGENCY CONTRACEPTION; UNINTENDED PREGNANCY; ATTITUDES; ADHERENCE; HEALTH; WOMEN	Background The oral contraceptive pill (OCP) remains the most popular form of prescription contraception in many countries, despite adherence difficulties for many. Uptake of long acting reversible contraceptives (LARCs), which are less reliant on user adherence, remains low. The aim of this study was to explore the experiences of, and attitudes towards, prescription contraception amongst samples of contraception users, general practitioners (GPs) and pharmacists. Methodology and Findings We conducted a qualitative study using semi-structured interviews with 18 contraception users, 18 GPs and 9 pharmacists. The study took place in Galway, Republic of Ireland between June and September 2014. Thematic analysis was used to analyse the data. Overall, contraception users were more familiar with the OCP, and all the women interviewed began their prescription contraception journey using this method. All participants identified episodes of poor adherence throughout the reproductive life course. The identified barriers for use of LARCs were lack of information, misconceptions, lack of access and high cost. In contrast, GPs believed that adherence to the OCP was good and stated they were more likely to prescribe the OCP than other methods, as they were most familiar with this option. Barriers to prescribing LARCSs were time, cost to practice, training and deskilling. Pharmacists also believed that adherence to the OCP was generally good and that their role was limited to dispensing medication and providing information when asked. Discussion and Conclusion There are contrasting perspectives between contraception service providers and contraceptive users. Training for healthcare providers is required to support informed contraceptive choice and adherence. It is necessary to address the practice barriers of cost and lack of time, to promote better communication around adherence issues and prescription contraception options. There is a need for more easily-accessible public health information to promote awareness on all methods of prescription contraception.	[Sweeney, Leigh-Ann; Molloy, Gerard J.; Byrne, Molly] Natl Univ Ireland, Sch Psychol, Galway, Ireland; [Sweeney, Leigh-Ann; Molloy, Gerard J.; Byrne, Molly] Natl Univ Ireland, Whitaker Inst Innovat & Societal Change, Galway, Ireland; [Murphy, Andrew W.] Natl Univ Ireland, Sch Med, Discipline Gen Practice, Galway, Ireland; [Morgan, Karen] Royal Coll Surgeons Ireland, Dept Psychol, Dublin 2, Ireland; [Morgan, Karen] Perdana Univ, Royal Coll Surg Ireland, Sch Med, Kuala Lumpur, Malaysia; [Hughes, Carmel M.] Queens Univ Belfast, Sch Pharm, Belfast, Antrim, North Ireland; [Ingham, Roger] Univ Southampton, Ctr Sexual Hlth Res, Southampton, Hants, England	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Royal College of Surgeons - Ireland; University College Dublin; Perdana University; Royal College of Surgeons - Ireland; Queens University Belfast; University of Southampton	Molloy, GJ (corresponding author), Natl Univ Ireland, Sch Psychol, Galway, Ireland.	gerry.molloy@nuigalway.ie	morgan, karen/C-3846-2012; Molloy, Gerard J/AAV-2634-2021; Molloy, Gerard J/C-5721-2008	morgan, karen/0000-0001-6193-1747; Molloy, Gerard J/0000-0002-7718-9898; Molloy, Gerard J/0000-0002-7718-9898; Murphy, Andrew/0000-0001-5549-8246; Byrne, Molly/0000-0001-8900-4320	Health Service Executive Crisis Pregnancy Programme [RPG2013-5]	Health Service Executive Crisis Pregnancy Programme	This study was funded by a project grant (Reference: RPG2013-5) awarded by the Health Service Executive Crisis Pregnancy Programme and administered by the Irish Research Council in December 2013 to Dr Gerry Molloy (Principal Investigator), Dr Karen Morgan, Dr Molly Byrne and Dr Andrew Murphy (Co-Investigators). Professor Carmel Hughes, Professor Roger Ingham and Professor Richard Layte were members of the steering committee for this study. Funder website: http://www.crisispregnancy.ie. Funding administered by: http://research.ie/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, CLOS GAP GEN HLTH EQ; [Anonymous], 2013, WORLD CONTR PATT 201; Arrowsmith ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092205; Bazeley P., 2013, QUALITATIVE DATA ANA, V2nd; Biggs MA, 2014, OBSTET GYNECOL, V123, P593, DOI 10.1097/AOG.0000000000000137; Bracken J, 2014, EUR J CONTRACEP REPR, V19, P276, DOI 10.3109/13625187.2014.917623; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Buhling KJ, 2014, CONTRACEPTION, V89, P162, DOI 10.1016/j.contraception.2013.11.011; Cane J, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-37; Castano PM, 2013, CONTRACEPTION, V88, P475, DOI 10.1016/j.contraception.2013.08.002; Corden A., 2006, USING VERBATIM QUOTA; Dombrowski SU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039852; El-Ibiary SY, 2007, EUR J CONTRACEP REPR, V12, P58, DOI 10.1080/13625180601092537; Gipson JD, 2008, STUD FAMILY PLANN, V39, P18, DOI 10.1111/j.1728-4465.2008.00148.x; Glasier A, 2008, J FAM PLAN REPROD H, V34, P213, DOI 10.1783/147118908786000497; Halpern V, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004317.pub4; Hennink MM, 2007, INTERNATIONAL FOCUS GROUP RESEARCH: A HANDBOOK FOR THE HEALTH AND SOCIAL SCIENCES, P1, DOI 10.1017/CBO9780511619458; McBride O, 2012, IRISH CONTRACEPTION; Michie L, 2014, CONTRACEPTION, V90, P447, DOI 10.1016/j.contraception.2014.05.004; Michie L, 2013, Minerva Ginecol, V65, P241; Molloy GJ, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007794; Molloy GJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-838; Moos MK, 2003, CONTRACEPTION, V67, P115, DOI 10.1016/S0010-7824(02)00472-9; O'Donoghue C, 2011, CAMB J ECON, V35, P59, DOI 10.1093/cje/beq010; Okpo E, 2014, PUBLIC HEALTH, V128, P934, DOI 10.1016/j.puhe.2014.08.012; Potter L, 1996, FAM PLANN PERSPECT, V28, P154, DOI 10.2307/2136191; Secura GM, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.04.017; Trussell J, 2011, CONTRACEPTION, V83, P397, DOI 10.1016/j.contraception.2011.01.021; Weedle PB, 2011, PHARM MED LAW IRELAN; Wellings K, 2007, CONTRACEPTION, V76, P208, DOI 10.1016/j.contraception.2007.05.085; Wellings K, 2013, LANCET, V382, P1807, DOI 10.1016/S0140-6736(13)62071-1	31	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144074	10.1371/journal.pone.0144074	http://dx.doi.org/10.1371/journal.pone.0144074			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633191	Green Accepted, gold, Green Published			2022-12-27	WOS:000366040000051
J	Weller, SA; Stokes, MGM; Lukaszewski, RA				Weller, Simon A.; Stokes, Margaret G. M.; Lukaszewski, Roman A.			Observations on the Inactivation Efficacy of a MALDI-TOF MS Chemical Extraction Method on Bacillus anthracis Vegetative Cells and Spores	PLOS ONE			English	Article							MASS-SPECTROMETRY; IDENTIFICATION; MICROBIOLOGY; BACTERIA; TIME	A chemical (ethanol; formic acid; acetonitrile) protein extraction method for the preparation of bacterial samples for matrix assisted laser desorption ionisation time-of-flight mass spectrometry (MALDI-TOF MS) identification was evaluated for its ability to inactivate bacterial species. Initial viability tests (with and without double filtration of the extract through 0.2 mu M filters), indicated that the method could inactivate Escherichia coli MRE 162 and Klebsiella pneumoniae ATCC 35657, with or without filtration, but that filtration was required to exclude viable, avirulent, Bacillus anthracis UM23CL2 from extracts. Multiple, high stringency, viability experiments were then carried out on entire filtered extracts prepared from virulent B. anthracis Vollum vegetative cells and spores ranging in concentration from 10(6)-10(8)cfu per extract. B. anthracis was recovered in 3/18 vegetative cell extracts and 10/18 spore extracts. From vegetative cell extracts B. anthracis was only recovered from extracts that had undergone prolonged Luria (L)-broth (7 day) and L-agar plate (a further 7 days) incubations. We hypothesise that the recovery of B. anthracis in vegetative cell extracts is due to the escape of individual sub-lethally injured cells. We discuss our results in view of working practises in clinical laboratories and in the context of recent inadvertent releases of viable B. anthracis.	[Weller, Simon A.; Stokes, Margaret G. M.; Lukaszewski, Roman A.] Minist Def, CBR Div, Def Sci & Technol Lab, Salisbury, Wilts, England	Defence Science & Technology Laboratory	Weller, SA (corresponding author), Minist Def, CBR Div, Def Sci & Technol Lab, Salisbury, Wilts, England.	sweller@dstl.gov.uk		Weller, Simon/0000-0001-9286-2991	Headquarters Surgeon General, UK Ministry of Defence	Headquarters Surgeon General, UK Ministry of Defence	This study was funded by Headquarters Surgeon General, UK Ministry of Defence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed in this paper may not reflect those of the UK Ministry of Defence.	Bourbeau PP, 2013, J CLIN MICROBIOL, V51, P1658, DOI 10.1128/JCM.00301-13; Carrera M, 2007, J APPL MICROBIOL, V102, P303, DOI 10.1111/j.1365-2672.2006.03111.x; Centers for Disease Control and Prevention, 2014, REP POT EXP ANTHR; Corning Inc, 2013, CORN FILTR GUID; Croxatto A, 2012, FEMS MICROBIOL REV, V36, P380, DOI 10.1111/j.1574-6976.2011.00298.x; Cunningham SA, 2013, J CLIN MICROBIOL, V51, P1639, DOI 10.1128/JCM.00267-13; Daltonics B., 2011, REVISION, V2, P157; Department of Defense, 2015, REV COMM REP IN SHIP; Drevinek M, 2012, LETT APPL MICROBIOL, V55, P40, DOI 10.1111/j.1472-765X.2012.03255.x; Lasch P, 2008, ANAL CHEM, V80, P2026, DOI 10.1021/ac701822j; Oliver JD, 2010, FEMS MICROBIOL REV, V34, P415, DOI 10.1111/j.1574-6976.2009.00200.x; Parsons TM., 2013, J BIOTERR BIODEF, VS3, P009, DOI [10.4172/2157-2526.S3-009, DOI 10.4172/2157-2526.S3-009]; Redmond C, 2004, MICROBIOL-SGM, V150, P355, DOI 10.1099/mic.0.26681-0; Russell AD, 1999, J HOSP INFECT, V43, pS57, DOI 10.1016/S0195-6701(99)90066-X; Schulthess B, 2013, J CLIN MICROBIOL, V51, P1834, DOI 10.1128/JCM.02654-12; Smither SJ, 2015, J CLIN MICROBIOL, V53, P3148, DOI 10.1128/JCM.01449-15; Varughese EA, 2007, J MICROBIOL METH, V71, P66, DOI 10.1016/j.mimet.2007.07.011	17	4	4	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143870	10.1371/journal.pone.0143870	http://dx.doi.org/10.1371/journal.pone.0143870			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633884	gold, Green Published, Green Submitted			2022-12-27	WOS:000366040000027
J	Yang, Y; Pang, DL; Hu, CH; Lv, YJ; He, T; An, YL; Tang, ZG; Deng, ZH				Yang, Yi; Pang, Danlin; Hu, Chenghu; Lv, Yajie; He, Tao; An, Yulin; Tang, Zhangui; Deng, Zhihong			Nestin Positive Bone Marrow Derived Cells Responded to Injury Mobilize into Peripheral Circulation and Participate in Skin Defect Healing	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM; PROGENITOR CELLS; STROMAL CELLS; MOUSE MODEL; BLOOD; RECRUITMENT; EXPRESSION; MIGRATION	Exogenously infused mesenchymal stem cells (MSCs) are thought to migrate to injury site through peripheral blood stream and participate in tissue repair. However, whether and how endogenous bone marrow MSCs mobilized to circulating and targeted to tissue injury has raised some controversy, and related studies were restricted by the difficulty of MSCs identifying in vivo. Nestin, a kind of intermediate filament protein initially identified in neuroepithelial stem cells, was recently reported as a credible criteria for MSCs in bone marrow. In this study, we used a green fluorescent protein (GFP) labeled bone marrow replacement model to trace the nestin positive bone marrow derived cells (BMDCs) of skin defected-mice. We found that after skin injured, numbers of nestin(+) cells in peripheral blood and bone marrow both increased. A remarkable concentration of nestin(+) BMDCs around skin wound was detected, while few of these cells could be observed in uninjured skin or other organs. This recruitment effect could not be promoted by granulocyte colony-stimulating factor (G-CSF), suggests a different mobilization mechanism from ones G-CSF takes effect on hematopoietic cells. Our results proposed nestin(+) BMDCs as mobilized candidates in skin injury repair, which provide a new insight of endogenous MSCs therapy.	[Yang, Yi; Pang, Danlin; Hu, Chenghu; He, Tao; An, Yulin; Deng, Zhihong] Fourth Mil Med Univ, Sch Stomatol, Ctr Tissue Engn, State Key Lab Mil Stomatol, Xian 710032, Shaanxi, Peoples R China; [Pang, Danlin; Tang, Zhangui] Cent S Univ, Xiangya Stomatol Hosp, Changsha, Hunan, Peoples R China; [Deng, Zhihong] Fourth Mil Med Univ, Xijing Hosp, Dept Otolaryngol, Xian 710032, Shaanxi, Peoples R China; [Hu, Chenghu] Xian Inst Tissue Engn & Regenerat Med, Xian, Shaanxi, Peoples R China; [Lv, Yajie] Fourth Mil Med Univ, Tangdu Hosp, Dept Dermatol, Xian 710032, Shannxi, Peoples R China; [Yang, Yi] Fourth Mil Med Univ, Sch Stomatol, Dept Oral Prosthodont, Xian 710032, Shannxi, Peoples R China	Air Force Military Medical University; Central South University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Tang, ZG (corresponding author), Cent S Univ, Xiangya Stomatol Hosp, Changsha, Hunan, Peoples R China.	tangzhanguixiangya@163.com; dengzh@fmmu.edu.cn	Hu, Cheng-Hu/I-4210-2013	Hu, Cheng-Hu/0000-0003-2443-6485	Nature Science Foundation of China [81271065, 81470679]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Nature Science Foundation of China (81271065, 81470679; http://www.nsfc.gov.cn/). The funder was the main designer of the study.; This study was supported by the funding support from the Nature Science Foundation of China (81271065, 81470679). The authors are thankful to Mrs. Congye Li, Cardiac Department of Internal Medicine, Xijing Hospital, Fourth Military Medical University, for the technical assistance of in vivo imaging.	Assis ACM, 2010, CELL TRANSPLANT, V19, P219, DOI 10.3727/096368909X479677; Barbash IM, 2003, CIRCULATION, V108, P863, DOI 10.1161/01.CIR.0000084828.50310.6A; Bian ZY, 2009, ARCH MED RES, V40, P163, DOI 10.1016/j.arcmed.2009.01.002; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Chavakis E, 2008, J MOL CELL CARDIOL, V45, P514, DOI 10.1016/j.yjmcc.2008.01.004; Chen Y, 2010, J CELL MOL MED, V14, P1494, DOI 10.1111/j.1582-4934.2009.00912.x; Deng J, 2011, NEUROL SCI, V32, P641, DOI 10.1007/s10072-011-0608-2; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Epstein RJ, 2004, NAT REV CANCER, V4, P901, DOI 10.1038/nrc1473; Fernandez M, 1997, BONE MARROW TRANSPL, V20, P265, DOI 10.1038/sj.bmt.1700890; Fiorina P, 2010, CELL TRANSPLANT, V19, P1369, DOI 10.3727/096368910X514288; Fiorina P, 2011, J IMMUNOL, V186, P121, DOI 10.4049/jimmunol.1000799; Goldberg ED, 2007, B EXP BIOL MED+, V144, P802, DOI 10.1007/s10517-007-0435-x; Griffin MD, 2013, STEM CELLS, V31, P2033, DOI 10.1002/stem.1452; Hannoush EJ, 2011, J TRAUMA, V71, P283, DOI 10.1097/TA.0b013e318222f380; He QL, 2007, STEM CELLS, V25, P69, DOI 10.1634/stemcells.2006-0335; Herrera MB, 2007, KIDNEY INT, V72, P430, DOI 10.1038/sj.ki.5002334; Hoogduijn MJ, 2014, STEM CELLS DEV, V23, P2328, DOI 10.1089/scd.2014.0269; Huss R, 2000, STEM CELLS, V18, P252, DOI 10.1634/stemcells.18-4-252; Jin SZ, 2012, HEPATOB PANCREAT DIS, V11, P66, DOI 10.1016/S1499-3872(11)60127-6; Kang SK, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/342968; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Kuznetsov SA, 2001, J CELL BIOL, V153, P1133, DOI 10.1083/jcb.153.5.1133; Lazarus HM, 1997, J HEMATOTHER, V6, P447, DOI 10.1089/scd.1.1997.6.447; Li N, 2013, BIOL CELL, V105, P261, DOI 10.1111/boc.201200064; Lv FJ, 2014, STEM CELLS, V32, P1408, DOI 10.1002/stem.1681; Marquez-Curtis LA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/561098; Mazo IB, 2011, TRENDS IMMUNOL, V32, P493, DOI 10.1016/j.it.2011.06.011; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122; Mendez-Ferrer S, 2007, ANN NY ACAD SCI, V1116, P392, DOI 10.1196/annals.1402.086; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Oyama M, 1999, GENE THER, V6, P321, DOI 10.1038/sj.gt.3300839; Pacini S, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00020; Ripa RS, 2007, CIRCULATION, V116, pI24, DOI 10.1161/CIRCULATIONAHA.106.678649; Rochefort GY, 2006, STEM CELLS, V24, P2202, DOI 10.1634/stemcells.2006-0164; Roufosse CA, 2004, INT J BIOCHEM CELL B, V36, P585, DOI 10.1016/j.biocel.2003.10.007; Shirley D, 2005, J ORTHOP RES, V23, P1013, DOI 10.1016/j.orthres.2005.01.013; Stich S, 2009, CELL TISSUE RES, V336, P225, DOI 10.1007/s00441-009-0768-z; Tatsumi K, 2008, CIRC J, V72, P1351, DOI 10.1253/circj.72.1351; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Vanden Berg-Foels WS, 2014, TISSUE ENG PART B-RE, V20, P28, DOI 10.1089/ten.TEB.2013.0100; Wang CH, 2008, ARTERIOSCL THROM VAS, V28, P54, DOI 10.1161/ATVBAHA.107.147256; Wexler SA, 2003, BRIT J HAEMATOL, V121, P368, DOI 10.1046/j.1365-2141.2003.04284.x; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; Zhou J, 2011, J CELL PHYSIOL, V226, P2081, DOI 10.1002/jcp.22538; Zvaifler NJ, 2000, ARTHRITIS RES, V2, P477, DOI 10.1186/ar130	47	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143368	10.1371/journal.pone.0143368	http://dx.doi.org/10.1371/journal.pone.0143368			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633897	Green Submitted, gold, Green Published			2022-12-27	WOS:000366040000013
J	Kim, MG; Kim, SC; Ko, YS; Lee, HY; Jo, SK; Cho, W				Kim, Myung-Gyu; Kim, Sun Chul; Ko, Yoon Sook; Lee, Hee Young; Jo, Sang-Kyung; Cho, Wonyong			The Role of M2 Macrophages in the Progression of Chronic Kidney Disease following Acute Kidney Injury	PLOS ONE			English	Article							RENAL FIBROSIS; CELLS; INFLAMMATION; CONTRIBUTE; RECOVERY	Introduction Acute kidney injury (AKI) is a major risk factor in the development of chronic kidney disease (CKD). However, the mechanisms linking AKI to CKD remain unclear. We examined the alteration of macrophage phenotypes during an extended recovery period following ischemia/reperfusion injury (IRI) and determine their roles in the development of fibrosis. Methods The left renal pedicle of mice was clamped for 40 min. To deplete monocyte/macrophage, liposome clodronate was injected or CD11b-DTR and CD11c-DTR transgenic mice were used. Results Throughout the phase of IRI recovery, M2-phenotype macrophages made up the predominant macrophage subset. On day 28, renal fibrosis was clearly shown with increased type IV collagen and TGF-beta. The depletion of macrophages induced by the liposome clodronate injection improved renal fibrosis with a reduction of kidney IL-6, type IV collagen, and TGF-beta levels. Additionally, the adoptive transfer of the M2c macrophages partially reversed the beneficial effect of macrophage depletion, whereas the adoptive transfer of the M1 macrophages did not. M2 macrophages isolated from the kidneys during the recovery phase expressed 2.5 fold higher levels of TGF-beta than the M1 macrophages. The injection of the diphtheria toxin into CD11b or CD11c-DTR transgenic mice resulted in lesser depletion or no change in M2 macrophages and had little impact on renal fibrosis. Conclusion Although M2 macrophages are known to be indispensible for short-term recovery, they are thought to be main culprit in the development of renal fibrosis following IRI.	[Kim, Myung-Gyu; Kim, Sun Chul; Ko, Yoon Sook; Lee, Hee Young; Jo, Sang-Kyung; Cho, Wonyong] Korea Univ, Coll Med, Dept Internal Med, Seoul 136705, South Korea	Korea University; Korea University Medicine (KU Medicine)	Jo, SK (corresponding author), Korea Univ, Coll Med, Dept Internal Med, Seoul 136705, South Korea.	sang-kyung@korea.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [NRF-2013R1A1A1062586]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (NRF-2013R1A1A1062586). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonventre JV, 2004, KIDNEY INT, V66, P480, DOI 10.1111/j.1523-1755.2004.761_2.x; Bottinger EP, 2007, SEMIN NEPHROL, V27, P309, DOI 10.1016/j.semnephrol.2007.02.009; Braga TT, 2012, MOL MED, V18, P1231, DOI 10.2119/molmed.2012.00131; Canaud G, 2015, NEPHROL DIAL TRANSPL, V30, P575, DOI 10.1093/ndt/gfu230; Chawla LS, 2012, KIDNEY INT, V82, P516, DOI 10.1038/ki.2012.208; Gharib SA, 2014, J LEUKOCYTE BIOL, V95, P9, DOI 10.1189/jlb.1112587; Hanke ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042476; Hsu CY, 2009, CLIN J AM SOC NEPHRO, V4, P891, DOI 10.2215/CJN.05571008; Kim MG, 2010, NEPHROL DIAL TRANSPL, V25, P2908, DOI 10.1093/ndt/gfq183; Kinsey GR, 2008, NEPHRON EXP NEPHROL, V109, pE102, DOI 10.1159/000142934; Ko GJ, 2008, NEPHROL DIAL TRANSPL, V23, P842; Lee S, 2011, J AM SOC NEPHROL, V22, P317, DOI 10.1681/ASN.2009060615; Lu JY, 2013, KIDNEY INT, V84, P745, DOI 10.1038/ki.2013.135; Sedrakyan S, 2012, J AM SOC NEPHROL, V23, P661, DOI 10.1681/ASN.2011030243; Stahl M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081382; Wang Y, 2007, KIDNEY INT, V72, P290, DOI 10.1038/sj.ki.5002275; Wonnacott A, 2014, CLIN J AM SOC NEPHRO, V9, P1007, DOI 10.2215/CJN.07920713; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Yang T, 2007, TRANSL RES, V150, P40, DOI 10.1016/j.trsl.2007.01.006; Zager RA, 2011, AM J PHYSIOL-RENAL, V301, pF1334, DOI 10.1152/ajprenal.00431.2011; Zhang MZ, 2012, J CLIN INVEST, V122, P4519, DOI 10.1172/JCI60363	21	84	85	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143961	10.1371/journal.pone.0143961	http://dx.doi.org/10.1371/journal.pone.0143961			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630505	gold, Green Published, Green Submitted			2022-12-27	WOS:000365926300130
J	Wang, J; Wu, CP; Peng, J; Patel, N; Huang, YY; Gao, XX; Aljarallah, S; Eubanks, JH; McDonald, R; Zhang, L				Wang, Justin; Wu, Chiping; Peng, Jessie; Patel, Nisarg; Huang, Yayi; Gao, Xiaoxing; Aljarallah, Salman; Eubanks, James H.; McDonald, Robert; Zhang, Liang			Early-Onset Convulsive Seizures Induced by Brain Hypoxia-Ischemia in Aging Mice: Effects of Anticonvulsive Treatments	PLOS ONE			English	Article							ACUTE NONCONVULSIVE SEIZURES; CEREBRAL-ARTERY OCCLUSION; TERM VIDEO-EEG; STATUS EPILEPTICUS; THERAPEUTIC HYPOTHERMIA; INTRALUMINAL FILAMENT; POSTISCHEMIC SEIZURES; PERIAQUEDUCTAL GRAY; ACUTE-PHASE; STROKE	Aging is associated with an increased risk of seizures/epilepsy. Stroke (ischemic or hemorrhagic) and cardiac arrest related brain injury are two major causative factors for seizure development in this patient population. With either etiology, seizures are a poor prognostic factor. In spite of this, the underlying pathophysiology of seizure development is not well understood. In addition, a standardized treatment regimen with anticonvulsants and outcome assessments following treatment has yet to be established for these post-ischemic seizures. Previous studies have modeled post-ischemic seizures in adult rodents, but similar studies in aging/aged animals, a group that mirrors a higher risk elderly population, remain sparse. Our study therefore aimed to investigate early-onset seizures in aging animals using a hypoxia-ischemia (HI) model. Male C57 black mice 18-20-month-old underwent a unilateral occlusion of the common carotid artery followed by a systemic hypoxic episode (8% O-2 for 30 min). Early-onset seizures were detected using combined behavioral and electroencephalographic (EEG) monitoring. Brain injury was assessed histologically at different times post HI. Convulsive seizures were observed in 65% of aging mice post-HI but not in control aging mice following either sham surgery or hypoxia alone. These seizures typically occurred within hours of HI and behaviorally consisted of jumping, fast running, barrel-rolling, and/or falling (loss of the righting reflex) with limb spasms. No evident discharges during any convulsive seizures were seen on cortical-hippocampal EEG recordings. Seizure development was closely associated with acute mortality and severe brain injury on brain histological analysis. Intra-peritoneal injections of lorazepam and fosphenytoin suppressed seizures and improved survival but only when applied prior to seizure onset and not after. These findings together suggest that seizures are a major contributing factor to acute mortality in aging mice following severe brain ischemia and that early anticonvulsive treatment may prevent seizure genesis and improve overall outcomes.	[Wang, Justin; Wu, Chiping; Peng, Jessie; Patel, Nisarg; Huang, Yayi; Gao, Xiaoxing; Aljarallah, Salman; Eubanks, James H.; Zhang, Liang] Univ Hlth Network, Toronto Western Res Inst, Toronto, ON, Canada; [Zhang, Liang] Univ Toronto, Dept Med Neurol, Toronto, ON, Canada; [Eubanks, James H.] Univ Toronto, Dept Surg Neurosurg, Toronto, ON, Canada; [McDonald, Robert] Univ Lethbridge, Dept Neurosci, Lethbridge, AB T1K 3M4, Canada; [Aljarallah, Salman] King Saud Univ, Dept Med, Neurol Unit, Riyadh, Saudi Arabia	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Lethbridge; King Saud University	Zhang, L (corresponding author), Univ Hlth Network, Toronto Western Res Inst, Toronto, ON, Canada.	liangz@uhnres.utoronto.ca		Aljarallah, Salman/0000-0003-0138-7924; Zhang, Liang/0000-0002-7888-5043; Eubanks, James/0000-0001-8595-2024	Canadian Institute of Health Research [219171]; Ontario Brain Institute Eplink Program; Natural Science and Engineering Research Council of Canada [RGPIN-2015-04153]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Brain Institute Eplink Program; Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by grants from the Canadian Institute of Health Research to LZ and RM (Grant # 219171); from Ontario Brain Institute Eplink Program to JE and LZ; and from Natural Science and Engineering Research Council of Canada to LZ (RGPIN-2015-04153). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhami F, 2006, AM J PATHOL, V169, P566, DOI 10.2353/ajpath.2006.051066; Bakker A, 2015, NEUROIMAGE-CLIN, V7, P688, DOI 10.1016/j.nicl.2015.02.009; Bakker A, 2012, NEURON, V74, P467, DOI 10.1016/j.neuron.2012.03.023; Balami JS, 2011, LANCET NEUROL, V10, P357, DOI 10.1016/S1474-4422(10)70313-6; Balami JS, NEUROLOGICAL COMPLIC; Bierbower SM, 2015, J NEUROSCI, V35, P2101, DOI 10.1523/JNEUROSCI.3805-14.2015; Bladin Christopher F, 2009, Handb Clin Neurol, V93, P613, DOI 10.1016/S0072-9752(08)93030-X; Boller Manuel, 2011, Resuscitation, V82 Suppl 2, pS27, DOI 10.1016/S0300-9572(11)70148-4; Brodie MJ, 2009, LANCET NEUROL, V8, P1019, DOI 10.1016/S1474-4422(09)70240-6; Burneo JG, 2010, EUR J NEUROL, V17, P52, DOI 10.1111/j.1468-1331.2009.02739.x; Chen RL, 2010, NAT REV NEUROL, V6, P256, DOI 10.1038/nrneurol.2010.36; Chung JM, 2014, NEUROL RES, V36, P403, DOI 10.1179/1743132814Y.0000000352; Claassen J, 2007, NEUROLOGY, V69, P1356, DOI 10.1212/01.wnl.0000281664.02615.6c; Crepeau AZ, 2013, NEUROLOGY, V80, P339, DOI 10.1212/WNL.0b013e31827f089d; Cuaycong M, 2011, DEV NEUROSCI-BASEL, V33, P241, DOI 10.1159/000331646; Cuomo O, 2013, PLOS ONE, V13, DOI [10.1371/journal.pone.0080852, DOI 10.1371/J0URNAL.P0NE.0080852]; DeSalvo MN, 2010, NEUROIMAGE, V50, P902, DOI 10.1016/j.neuroimage.2010.01.006; Devi L, 2013, NEUROBIOL LEARN MEM, V102, P7, DOI 10.1016/j.nlm.2013.02.001; Dudek FE, 2006, MODELS OF SEIZURES AND EPILEPSY, P415, DOI 10.1016/B978-012088554-1/50036-0; El-Hayek YH, 2011, CEREB CORTEX, V21, P2863, DOI 10.1093/cercor/bhr080; El-Hayek YH, 2011, EXP NEUROL, V231, P295, DOI 10.1016/j.expneurol.2011.07.003; FAUGHT E, 1993, STROKE, V24, P609, DOI 10.1161/01.STR.24.4.609; Flurkey KM, 2007, MOUSE BIOMEDICAL RES, V2nd, P637; Foreman B, 2012, CRIT CARE, V16, DOI 10.1186/cc11230; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Fujii M, 1997, STROKE, V28, P1805, DOI 10.1161/01.STR.28.9.1805; GALE K, 1992, J CLIN NEUROPHYSIOL, V9, P264, DOI 10.1097/00004691-199204010-00007; GARCIA JH, 1993, AM J PATHOL, V142, P623; Gooshe M, 2015, EUR J PHARMACOL, V746, P6, DOI 10.1016/j.ejphar.2014.11.005; Guekht A., 2012, HDB CLIN NEUROLOGY, V108, P570; Gursoy-Ozdemir Y, 1999, BRAIN RES, V822, P260, DOI 10.1016/S0006-8993(99)01175-0; Guth JC, 2014, J STROKE CEREBROVASC, V23, P2809, DOI 10.1016/j.jstrokecerebrovasdis.2014.07.023; Han F, 2010, RESUSCITATION, V81, P93, DOI 10.1016/j.resuscitation.2009.09.018; Hartings JA, 2003, EXP NEUROL, V179, P139, DOI 10.1016/S0014-4886(02)00013-4; Hofmeijer J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00039; Hossmann KA, 2008, NEUROPHARMACOLOGY, V55, P257, DOI 10.1016/j.neuropharm.2007.12.004; Howells DW, 2010, J CEREBR BLOOD F MET, V30, P1412, DOI 10.1038/jcbfm.2010.66; Huang CW, 2014, NEUROLOGY, V82, P768, DOI 10.1212/WNL.0000000000000166; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Jeffrey M, 2014, NEUROSCIENCE, V257, P65, DOI 10.1016/j.neuroscience.2013.10.074; Jetter GM, 2008, SEMIN NEUROL, V28, P336, DOI 10.1055/s-2008-1079338; Jordan KG, 2004, J CLIN NEUROPHYSIOL, V21, P341; Kadam SD, 2010, J NEUROSCI, V30, P404, DOI 10.1523/JNEUROSCI.4093-09.2010; Kanthasamy AG, 2000, MOVEMENT DISORD, V15, P31, DOI 10.1002/mds.870150707; Karhunen H, 2007, NEUROSCIENCE, V148, P314, DOI 10.1016/j.neuroscience.2007.05.047; Karhunen H, 2006, EPILEPSY RES, V72, P25, DOI 10.1016/j.eplepsyres.2006.07.003; Kelly KM, 2006, EXP NEUROL, V201, P495, DOI 10.1016/j.expneurol.2006.05.006; Kelly KM, 2011, EXP NEUROL, V232, P15, DOI 10.1016/j.expneurol.2011.07.004; Kelly KM, 2001, EPILEPSY RES, V47, P189, DOI 10.1016/S0920-1211(01)00294-7; Kitagawa K, 1998, J CEREBR BLOOD F MET, V18, P570, DOI 10.1097/00004647-199805000-00012; Klahr AC, 2015, TRANSL STROKE RES, V6, P29, DOI 10.1007/s12975-014-0361-y; Knight WA, 2013, EPILEPSY RES, V106, P396, DOI 10.1016/j.eplepsyres.2013.06.018; Lam A, 2010, EPILEPSIA, V51, P1736, DOI 10.1111/j.1528-1167.2010.02551.x; LEVINE S, 1960, AM J PATHOL, V36, P1; Liu FD, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/464701; Lu XCM, 2009, J CEREBR BLOOD F MET, V29, P1924, DOI 10.1038/jcbfm.2009.109; Lu XCM, 2013, J NEUROTRAUM, V30, P580, DOI 10.1089/neu.2012.2641; Majid A, 2000, STROKE, V31, P2707, DOI 10.1161/01.STR.31.11.2707; Mani R, 2012, RESUSCITATION, V83, P840, DOI 10.1016/j.resuscitation.2012.02.015; Mazarati AM, 2006, MODELS OF SEIZURES AND EPILEPSY, P449, DOI 10.1016/B978-012088554-1/50038-4; McColl BW, 2004, BRAIN RES, V997, P15, DOI 10.1016/j.brainres.2003.10.028; Mecarelli O, 2011, CEREBROVASC DIS, V31, P191, DOI 10.1159/000321872; Meierkord H, 2010, EUR J NEUROL, V17, P348, DOI 10.1111/j.1468-1331.2009.02917.x; Menon B, 2009, EPILEPSY RES, V87, P1, DOI 10.1016/j.eplepsyres.2009.08.007; MILLER JW, 1992, PROG NEUROBIOL, V39, P155, DOI 10.1016/0301-0082(92)90009-4; Olson EE, 2004, J NEUROL SCI, V227, P7, DOI 10.1016/j.jns.2004.07.021; Omori N, 2001, BRAIN RES, V903, P162, DOI 10.1016/S0006-8993(01)02436-2; Paz JT, 2013, NAT NEUROSCI, V16, P64, DOI 10.1038/nn.3269; Peng J, 2015, EPILEPSY RES, V111, P142, DOI 10.1016/j.eplepsyres.2015.01.009; Popa-Wagner A, 2011, AGEING RES REV, V10, P71, DOI 10.1016/j.arr.2009.10.008; Procaccianti G, 2012, NEUROEPIDEMIOLOGY, V39, P45, DOI 10.1159/000338374; Rakhade SN, 2011, EPILEPSIA, V52, P753, DOI 10.1111/j.1528-1167.2011.02992.x; Reddy DS, 2013, INT J MOL SCI, V14, P18284, DOI 10.3390/ijms140918284; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Rittenberger JC, 2012, NEUROCRIT CARE, V16, P114, DOI 10.1007/s12028-011-9565-0; Robitsek J, 2015, HIPPOCAMPUS IN PRESS; Rowe AS, 2014, PHARMACOTHERAPY, V34, P396, DOI 10.1002/phar.1374; Sampath D, 2014, EPILEPSIA, V55, P985, DOI 10.1111/epi.12646; Schmid-Elsaesser R, 1998, STROKE, V29, P2162, DOI 10.1161/01.STR.29.10.2162; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Shabanzadeh AP, 2005, BRAIN RES, V1042, P1, DOI 10.1016/j.brainres.2005.01.105; Shetty AK, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00172; Shorvon S, 2011, CURR OPIN NEUROL, V24, P165, DOI 10.1097/WCO.0b013e3283446f31; Sicard Kenneth M, 2009, Exp Transl Stroke Med, V1, P7, DOI 10.1186/2040-7378-1-7; Silverman IE, 2002, ARCH NEUROL-CHICAGO, V59, P195, DOI 10.1001/archneur.59.2.195; Spiegel AM, 2013, J COMP NEUROL, V521, P3508, DOI 10.1002/cne.23367; Sykes L, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005398.pub3; Szaflarski JP, 2008, EPILEPSIA, V49, P974, DOI 10.1111/j.1528-1167.2007.01513.x; Vannucci SJ, 2001, J CEREBR BLOOD F MET, V21, P52, DOI 10.1097/00004647-200101000-00007; Veliskova J, 2006, MODELS OF SEIZURES AND EPILEPSY, P601, DOI 10.1016/B978-012088554-1/50050-5; Wais M, 2009, NEUROSCIENCE, V161, P599, DOI 10.1016/j.neuroscience.2009.03.036; Waterhouse EJ, 2001, DRUG AGING, V18, P133, DOI 10.2165/00002512-200118020-00006; Williams AJ, 2004, J PHARMACOL EXP THER, V311, P220, DOI 10.1124/jpet.104.069146; Williams AJ, 2006, J PHARMACOL EXP THER, V318, P947, DOI 10.1124/jpet.106.105999; Wither RG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035396; Wu C, 2008, J NEUROSCI METH, V171, P126, DOI 10.1016/j.jneumeth.2008.03.001; Wu CP, 2015, EXP NEUROL, V271, P1, DOI 10.1016/j.expneurol.2015.04.018; Yang L, 2003, NEUROPHARMACOLOGY, V44, P275, DOI 10.1016/S0028-3908(02)00367-2; Zille M, 2012, J CEREBR BLOOD F MET, V32, P213, DOI 10.1038/jcbfm.2011.150	99	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144113	10.1371/journal.pone.0144113	http://dx.doi.org/10.1371/journal.pone.0144113			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630670	Green Submitted, gold, Green Published			2022-12-27	WOS:000365926300161
J	Li, J; Shang, J; Zhou, Y; Li, CQ; Liu, H				Li, Jie; Shang, Jin; Zhou, Yue; Li, Changqing; Liu, Huan			Finite Element Analysis of a New Pedicle Screw-Plate System for Minimally Invasive Transforaminal Lumbar Interbody Fusion	PLOS ONE			English	Article							INTERNAL-FIXATION; SPINE; METAANALYSIS; DISC; BIOMECHANICS; RIGIDITY; LOAD	Purpose Minimally invasive transforaminal lumbar interbody fusion (MI-TLIF) is increasingly popular for the surgical treatment of degenerative lumbar disc diseases. The constructs intended for segmental stability are varied in MI-TLIF. We adopted finite element (FE) analysis to compare the stability after different construct fixations using interbody cage with posterior pedicle screw-rod or pedicle screw-plate instrumentation system. Methods A L3-S1 FE model was modified to simulate decompression and fusion at L4-L5 segment. Fixation modes included unilateral plate (UP), unilateral rod (UR), bilateral plate (BP), bilateral rod (BR) and UP+UR fixation. The inferior surface of the S1 vertebra remained immobilized throughout the load simulation, and a bending moment of 7.5 Nm with 400N pre-load was applied on the L3 vertebra to recreate flexion, extension, lateral bending, and axial rotation. Range of motion (ROM) and Von Mises stress were evaluated for intact and instrumentation models in all loading planes. Results All reconstructive conditions displayed decreased motion at L4-L5. The pedicle screw-plate system offered equal ROM to pedicle screw-rod system in unilateral or bilateral fixation modes respectively. Pedicle screw stresses for plate system were 2.2 times greater than those for rod system in left lateral bending under unilateral fixation. Stresses for plate were 3.1 times greater than those for rod in right axial rotation under bilateral fixation. Stresses on intervertebral graft for plate system were similar to rod system in unilateral and bilateral fixation modes respectively. Increased ROM and posterior instrumentation stresses were observed in all loading modes with unilateral fixation compared with bilateral fixation in both systems. Conclusions Transforaminal lumbar interbody fusion augmentation with pedicle screw-plate system fixation increases fusion construct stability equally to the pedicle screw-rod system. Increased posterior instrumentation stresses are observed in all loading modes with plate fixation, and bilateral fixation could reduce stress concentration.	[Li, Jie; Shang, Jin; Zhou, Yue; Li, Changqing; Liu, Huan] Third Mil Med Univ, Xinqiao Hosp, Dept Orthoped, Chongqing, Peoples R China	Army Medical University	Zhou, Y (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Orthoped, Chongqing, Peoples R China.	xqzhouyue@163.com	Liu, Huan/AGD-0339-2022	Liu, Huan/0000-0002-5519-7336	Chinese National Science and Technology Support Program [2012BAI14B02]; Major Project of Chongqing Municipal Science and Technology Commission [cstc2012gg-yyjsB10012]	Chinese National Science and Technology Support Program; Major Project of Chongqing Municipal Science and Technology Commission	This work was supported by fund of the Chinese National Science and Technology Support Program (2012BAI14B02) and the Major Project of Chongqing Municipal Science and Technology Commission (cstc2012gg-yyjsB10012).	Ambati DV, 2015, SPINE J, V15, P1812, DOI 10.1016/j.spinee.2014.06.015; Ao Jun, 2009, Nan Fang Yi Ke Da Xue Xue Bao, V29, P959; Chen SH, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-72; Crawford Neil R, 2010, Neurosurgery, V66, pE404, DOI 10.1227/01.NEU.0000363701.76835.BF; Dahl MC, 2013, SPINE J, V13, P175, DOI 10.1016/j.spinee.2012.11.045; Denoziere G, 2006, J BIOMECH, V39, P766, DOI 10.1016/j.jbiomech.2004.07.039; Fogel GR, 2003, SPINE, V28, P470, DOI 10.1097/00007632-200303010-00011; Foley Kevin T, 2002, Clin Neurosurg, V49, P499; Foley KT, 2003, SPINE, V28, pS26, DOI 10.1097/00007632-200308011-00006; Gaines RW, 2000, J BONE JOINT SURG AM, V82A, P1458, DOI 10.2106/00004623-200010000-00013; GOEL VK, 1991, SPINE, V16, pS155, DOI 10.1097/00007632-199103001-00023; [黄紫房 Huang Zifang], 2011, [中国脊柱脊髓杂志, Chinese Journal of Spine and Spinal Cord], V21, P325; Jagannathan J, 2009, NEUROSURGERY, V64, P955, DOI 10.1227/01.NEU.0000343544.77456.46; Karikari IO, 2010, SPINE, V35, pS294, DOI 10.1097/BRS.0b013e3182022ddc; Kim HJ, 2013, SPINE J, V13, P1301, DOI 10.1016/j.spinee.2013.06.025; Kim MC, 2013, J SPINAL DISORD TECH, V26, P87, DOI 10.1097/BSD.0b013e318237b9b1; Kim TY, 2012, SPINE, V37, P1456, DOI 10.1097/BRS.0b013e31824da81d; Kuklo TR, 2005, SPINE, V30, P2113, DOI 10.1097/01.brs.0000179260.73267.f4; Li CQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099156; Liu Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111979; MCCORMACK T, 1994, SPINE, V19, P1741, DOI 10.1097/00007632-199408000-00014; Mo ZJ, 2014, EUR SPINE J, V23, P613, DOI 10.1007/s00586-013-3070-4; Mo ZJ, 2015, SPINE, V40, pE469, DOI 10.1097/BRS.0000000000000818; Shen XL, 2014, J CLIN NEUROSCI, V21, P1612, DOI 10.1016/j.jocn.2013.11.055; Shepard MF, 2002, J SPINAL DISORD TECH, V15, P233, DOI 10.1097/00024720-200206000-00012; Slucky Andrew V, 2006, Spine J, V6, P78, DOI 10.1016/j.spinee.2005.08.003; Soriano-Baron H, 2015, NEUROSURGERY; Stanford RE, 2004, SPINE, V29, P367, DOI 10.1097/01.BRS.0000092369.50397.85; Tian NF, 2013, EUR SPINE J, V22, P1741, DOI 10.1007/s00586-013-2747-z; Tsahtsarlis A, 2012, EUR SPINE J, V21, P2300, DOI 10.1007/s00586-012-2376-y; Vadapalli S, 2006, SPINE, V31, P2189, DOI 10.1097/01.brs.0000232720.23748.ce; Wang L, 2014, BMC SURG, V14, DOI 10.1186/1471-2482-14-87; Wilke HJ, 2009, SPINE, V34, P255, DOI 10.1097/BRS.0b013e3181920e9c; Womack Wesley, 2011, Spine (Phila Pa 1976), V36, pE1126, DOI 10.1097/BRS.0b013e31820e3dd1; Wu RH, 2010, SPINE, V35, P2273, DOI 10.1097/BRS.0b013e3181cd42cc	35	13	15	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144637	10.1371/journal.pone.0144637	http://dx.doi.org/10.1371/journal.pone.0144637			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26649749	Green Submitted, Green Published, gold			2022-12-27	WOS:000366903300064
J	Gardas, B; Luczka, J; Ptok, A; Dajka, J				Gardas, B.; Luczka, J.; Ptok, A.; Dajka, J.			Energetics of an rf SQUID Coupled to Two Thermal Reservoirs	PLOS ONE			English	Article							JOSEPHSON-JUNCTIONS; HEAT-FLOW; TRANSPORT	We study energetics of a Josephson tunnel junction connecting a superconducting loop pierced by an external magnetic flux (an rf SQUID) and coupled to two independent thermal reservoirs of different temperature. In the framework of the theory of quantum dissipative systems, we analyze energy currents in stationary states. The stationary energy flow can be periodically modulated by the external magnetic flux exemplifying the rf SQUID as a quantum heat interferometer. We also consider the transient regime and identify three distinct regimes: monotonic decay, damped oscillations and pulse-type behavior of energy currents. The first two regimes can be controlled by the external magnetic flux while the last regime is robust against its variation.	[Gardas, B.; Luczka, J.; Dajka, J.] Univ Silesia, PL-40007 Katowice, Poland; [Gardas, B.] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA; [Luczka, J.; Dajka, J.] Univ Silesia, Silesian Ctr Educ & Interdisciplinary Res, PL-41500 Chorzow, Poland; [Ptok, A.] Polish Acad Sci, Inst Nucl Phys, PL-31342 Krakow, Poland	University of Silesia in Katowice; United States Department of Energy (DOE); Los Alamos National Laboratory; University of Silesia in Katowice; Polish Academy of Sciences; Institute of Nuclear Physics - Polish Academy of Sciences	Dajka, J (corresponding author), Univ Silesia, PL-40007 Katowice, Poland.	jerzy.dajka@us.edu.pl	Ptok, Andrzej/F-1792-2013	Ptok, Andrzej/0000-0002-5566-2656; Gardas, Bartlomiej/0000-0002-1454-1591; Luczka, Jerzy/0000-0003-2296-4532; Dajka, Jerzy/0000-0003-4912-4859	National Center for Science (NCN, Poland) [UMO-2011/01/N/ST3/02473, N202 052940, DEC-2013/09/B/ST3/01659]; NCN (Poland) [UMO-2011/01/N/ST3/02473, N202 052940, DEC-2013/09/B/ST3/01659, 1060/MOB/2013/0]	National Center for Science (NCN, Poland); NCN (Poland)	This work was supported by the National Center for Science (NCN, Poland) under grants UMO-2011/01/N/ST3/02473 (BG), N202 052940 (JL) and DEC-2013/09/B/ST3/01659 (JD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the NCN (Poland) under grants UMO-2011/01/N/ST3/02473 (B.G) and Mobility Plus 1060/MOB/2013/0 (B.G), N202 052940 (J.L.) and DEC-2013/09/B/ST3/01659 (J.D.)	ALICKI R, 1979, J PHYS A-MATH GEN, V12, pL103, DOI 10.1088/0305-4470/12/5/007; Armour AD, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.184508; Barone A., 1982, PHYS APPL JOSEPHSON; Ben-Abdallah P, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.044301; Breuer H.-P., 2002, THEORY OPEN QUANTUM; Butcher J.C., 2008, NUMERICAL METHODS OR, DOI DOI 10.1002/9780470753767; CALDEIRA AO, 1983, PHYSICA A, V121, P587, DOI 10.1016/0378-4371(83)90013-4; Chang CW, 2006, SCIENCE, V314, P1121, DOI 10.1126/science.1132898; Dambach S, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.054508; DAVIES EB, 1974, COMMUN MATH PHYS, V39, P91, DOI 10.1007/BF01608389; Dubi Y, 2011, REV MOD PHYS, V83, P131, DOI 10.1103/RevModPhys.83.131; Elouard C, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/5/055018; Everitt MJ, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.043804; Giazotto F, 2012, NATURE, V492, P401, DOI 10.1038/nature11702; Golubev D, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.094522; Guttman GD, 1998, PHYS REV B, V57, P2717, DOI 10.1103/PhysRevB.57.2717; Guttman GD, 1997, PHYS REV B, V55, P3849, DOI 10.1103/PhysRevB.55.3849; Guttman GD, 1997, PHYS REV B, V55, P12691, DOI 10.1103/PhysRevB.55.12691; Kafanov S, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.120801; Lee KH, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.123604; Leggio B, 2015, PHYS REV A, V91, DOI 10.1103/PhysRevA.91.012117; Li BW, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.184301; Li NB, 2012, REV MOD PHYS, V84, P1045, DOI 10.1103/RevModPhys.84.1045; Makhlin Y, 2001, REV MOD PHYS, V73, P357, DOI 10.1103/RevModPhys.73.357; MAKI K, 1965, PHYS REV LETT, V15, P921, DOI 10.1103/PhysRevLett.15.921; Park JJ, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.230402; Saira OP, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.027203; Volz S., 2007, TOPICS APPL PHYS, V107; Wang L, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.177208; Wang L, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.267203	30	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0143912	10.1371/journal.pone.0143912	http://dx.doi.org/10.1371/journal.pone.0143912			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641890	Green Published, Green Submitted, gold			2022-12-27	WOS:000366902700034
J	Hogarth, LW; Burkett, BJ; McKean, MR				Hogarth, Luke W.; Burkett, Brendan J.; McKean, Mark R.			Activity Profiles and Physiological Responses of Representative Tag Football Players in Relation to Playing Position and Physical Fitness	PLOS ONE			English	Article							RUGBY LEAGUE PLAYERS; 10 HZ GPS; AUSTRALIAN-FOOTBALL; RUNNING PERFORMANCE; MATCH PERFORMANCE; MOTION ANALYSIS; SEVENS PLAYERS; TEAM SPORTS; ELITE; INTENSITY	This study determined the physical fitness, match-activity profiles and physiological responses of representative tag football players and examined the relationship between physical fitness and the match-activity profile. Microtechnology devices and heart rate (HR) chest straps were used to determine the match-activity profiles of sixteen tag football players for five matches during the 2014 Australian National Championships. The relationships between lower body muscular power, straight line running speed and Yo-Yo intermittent recovery test level 2 (Yo-Yo IR2) and the match-activity profile were examined using Pearson's correlation coefficients. Outside players had greater lower body muscular power (ES = 0.98) and straight line running speed (ES = 1.03-1.18) than inside players, and also covered greater very high-speed running (VHSR) distance/min (ES = 0.67) and reached higher peak running speeds (ES = 0.95) during matches. Inside and outside players performed a similar number of repeated high-intensity effort (RHIE) bouts and reported similar mean and maximum efforts per RHIE bout. However, there were differences between playing positions for mean and maximal RHIE effort durations (ES = 0.69-1.15) and mean RHIE bout recovery (ES = 0.56). Inside and outside players also reported small to moderate differences (ES = 0.43-0.80) for times spent in each HR zone. There were a number of moderate to very large correlations between physical fitness measures and match-activity profile variables. This study found lower body muscular power, straight line running speed and Yo-Yo IR2 to be related to the match-activities of representative tag football players, although differences between inside and outside players suggest that athlete testing and training practices should be modified for different playing positions.	[Hogarth, Luke W.; Burkett, Brendan J.; McKean, Mark R.] Univ Sunshine Coast, Sch Hlth & Sport Sci, Fac Sci Hlth Educ & Engn, Maroochydore, Qld, Australia	University of the Sunshine Coast	Hogarth, LW (corresponding author), Univ Sunshine Coast, Sch Hlth & Sport Sci, Fac Sci Hlth Educ & Engn, Maroochydore, Qld, Australia.	luke.hogarth@research.usc.edu.au	Hogarth, Luke/L-4975-2016	Hogarth, Luke/0000-0001-7085-4501	Queensland Oztag; University of the Sunshine Coast [1.043.05662]	Queensland Oztag; University of the Sunshine Coast	This study was conducted as part of a PhD research project funded by Queensland Oztag (www.queenslandoztag.com.au). Further, this study was supported by a research grant from the University of the Sunshine Coast (1.043.05662). The funding organisations had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akenhead R, 2014, J SCI MED SPORT, V17, P562, DOI 10.1016/j.jsams.2013.08.005; Ashton REM, 2015, J STRENGTH COND RES, V29, P2731, DOI 10.1519/JSC.0000000000000933; Aughey RJ, 2011, INT J SPORT PHYSIOL, V6, P295, DOI 10.1123/ijspp.6.3.295; Bangsbo J, 2008, SPORTS MED, V38, P37, DOI 10.2165/00007256-200838010-00004; Batterham AM, 2006, INT J SPORT PHYSIOL, V1, P50, DOI 10.1123/ijspp.1.1.50; Black GM, 2015, INT J SPORT PHYSIOL, V10, P711, DOI 10.1123/ijspp.2014-0081; Buchheit M, 2013, J SCI MED SPORT, V16, P550, DOI 10.1016/j.jsams.2012.12.003; Cummins C, 2013, SPORTS MED, V43, P1025, DOI 10.1007/s40279-013-0069-2; Darral-Jones JD, 2015, J STRENGTH IN PRESS; de Lacey J, 2014, J STRENGTH COND RES, V28, P2372, DOI 10.1519/JSC.0000000000000397; Deutsch MU, 2007, J SPORT SCI, V25, P461, DOI 10.1080/02640410600631298; Foster C, 2001, J STRENGTH COND RES, V15, P109, DOI 10.1519/00124278-200102000-00019; Furlan N, 2015, INT J SPORT PHYSIOL, V10, P802, DOI 10.1123/ijspp.2014-0315; Gabbett TJ, 2013, J STRENGTH COND RES, V27, P2319, DOI 10.1519/JSC.0b013e318277fd21; Gabbett TJ, 2013, J STRENGTH COND RES, V27, P1539, DOI 10.1519/JSC.0b013e318274f236; Gabbett TJ, 2013, INT J SPORT PHYSIOL, V8, P130, DOI 10.1123/ijspp.8.2.130; Gabbett TJ, 2012, J STRENGTH COND RES, V26, P953, DOI 10.1519/JSC.0b013e3182302023; Gabbett TJ, 2012, J SCI MED SPORT, V15, P80, DOI 10.1016/j.jsams.2011.07.004; Gabbett TJ, 2012, J STRENGTH COND RES, V26, P121, DOI 10.1519/JSC.0b013e31821e4c60; Gabbett TJ, 2006, J STRENGTH COND RES, V20, P215; Granatelli G, 2014, J STRENGTH COND RES, V28, P728, DOI 10.1519/JSC.0b013e31829d23c3; Higham DG, 2013, INT J SPORT PHYSIOL, V8, P19, DOI 10.1123/ijspp.8.1.19; Hogarth LW, 2015, INT J PERF ANAL SPOR, V15, P147; Hogarth LW, 2015, INT J PERF ANAL SPOR, V15, P203; Hogarth LW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140547; Hogarth LW, 2015, INT J SPORT PHYSIOL, V10, P559, DOI 10.1123/ijspp.2014-0355; Hogarth LW, 2014, INT J PERF ANAL SPOR, V14, P367; Hogarth LW, 2015, IN J SPORTS IN PRESS; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Johnston RJ, 2013, INT J PERF ANAL SPOR, V13, P262, DOI 10.1080/24748668.2013.11868646; Le Rossignol P, 2014, INT J SPORT PHYSIOL, V9, P161, DOI [10.1123/ijspp.2013-0005, 10.1123/IJSPP.2013-0005]; Mooney MG, 2013, J STRENGTH COND RES, V27, P166, DOI 10.1519/JSC.0b013e3182514683; Rampinini E, 2015, INT J SPORTS MED, V36, P49, DOI 10.1055/s-0034-1385866; Rebelo A, 2014, EUR J SPORT SCI, V14, pS148, DOI 10.1080/17461391.2012.664171; Ross A, 2015, EUR J SPORT SCI, V15, P565, DOI 10.1080/17461391.2015.1029983; Ross A, 2015, INT J SPORT PHYSIOL, V10, P780, DOI 10.1123/ijspp.2014-0331; Spencer M, 2005, SPORTS MED, V35, P1025, DOI 10.2165/00007256-200535120-00003; Spencer M, 2004, J SPORT SCI, V22, P843, DOI 10.1080/02640410410001716715; Stein JG, 2015, J SCI MED SPORT, V18, P742, DOI 10.1016/j.jsams.2014.10.008; Stone NM, 2009, SPORTS MED, V39, P615, DOI 10.2165/00007256-200939080-00002; Suarez-Arrones L, 2014, INT J SPORT PHYSIOL, V9, P316, DOI [10.1123/ijspp.2013-0069, 10.1123/IJSPP.2013-0069]; Suarez-Arrones LJ, 2012, J STRENGTH COND RES, V26, P3155, DOI 10.1519/JSC.0b013e318243fff7; Varley MC, 2012, J SPORT SCI, V30, P121, DOI 10.1080/02640414.2011.627941	43	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144554	10.1371/journal.pone.0144554	http://dx.doi.org/10.1371/journal.pone.0144554			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642320	Green Published, gold, Green Submitted			2022-12-27	WOS:000366902700145
J	Lai, BQ; Qiu, XC; Zhang, K; Zhang, RY; Jin, H; Li, G; Shen, HY; Wu, JL; Ling, EA; Zeng, YS				Lai, Bi-Qin; Qiu, Xue-Chen; Zhang, Ke; Zhang, Rong-Yi; Jin, Hui; Li, Ge; Shen, Hui-Yong; Wu, Jin-Lang; Ling, Eng-Ang; Zeng, Yuan-Shan			Cholera Toxin B Subunit Shows Transneuronal Tracing after Injection in an Injured Sciatic Nerve	PLOS ONE			English	Article							SPINAL-CORD TRANSECTION; LEUKOAGGLUTININ PHA-L; HORSERADISH-PEROXIDASE; ENDOPLASMIC-RETICULUM; PSEUDORABIES VIRUS; TRANSPORT; RAT; NEURONS; LOCALIZATION; MORPHOLOGY	Cholera toxin B subunit (CTB) has been extensively used in the past for monosynaptic mapping. For decades, it was thought to lack the ability of transneuronal tracing. In order to investigate whether biotin conjugates of CTB (b-CTB) would pass through transneurons in the rat spinal cord, it was injected into the crushed left sciatic nerve. For experimental control, the first order afferent neuronal projections were defined by retrograde transport of fluorogold (FG, a non-transneuronal labeling marker as an experimental control) injected into the crushed right sciatic nerve in the same rat. Neurons containing b-CTB or FG were observed in the dorsal root ganglia (DRG) at the L4-L6 levels ipsilateral to the tracer injection. In the spinal cord, b-CTB labeled neurons were distributed in all laminae ipsilaterally between C7 and S1 segments, but labeling of neurons at the cervical segment was abolished when the T10 segment was transected completely. The interneurons, distributed in the intermediate gray matter and identified as gamma-aminobutyric acid-ergic (GABAergic), were labeled by b-CTB. In contrast, FG labeling was confined to the ventral horn neurons at L4-L6 spinal segments ipsilateral to the injection. b-CTB immunoreactivity remained to be restricted to the soma of neurons and often appeared as irregular patches detected by light and electron microscopy. Detection of monosialoganglioside (GM1) in b-CTB labeled neurons suggests that GM1 ganglioside may specifically enhance the uptake and transneuronal passage of b-CTB, thus supporting the notion that it may be used as a novel transneuronal tracer.	[Lai, Bi-Qin; Qiu, Xue-Chen; Jin, Hui; Li, Ge; Zeng, Yuan-Shan] Sun Yat Sen Univ, Minist Educ, Key Lab Stem Cells & Tissue Engn, Guangzhou 510080, Guangdong, Peoples R China; [Zhang, Ke; Zhang, Rong-Yi; Zeng, Yuan-Shan] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Histol & Embryol, Guangzhou 510080, Guangdong, Peoples R China; [Shen, Hui-Yong; Zeng, Yuan-Shan] Sun Yat Sen Univ, Inst Spinal Cord Injury, Guangzhou 510120, Guangdong, Peoples R China; [Zeng, Yuan-Shan] Nantong Univ, Coinnovat Ctr Neuroregenerat, Nantong 226001, Peoples R China; [Shen, Hui-Yong] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Orthoped, Guangzhou 510120, Guangdong, Peoples R China; [Wu, Jin-Lang] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Electron Microscope, Guangzhou 510080, Guangdong, Peoples R China; [Ling, Eng-Ang] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore 117597, Singapore; [Zeng, Yuan-Shan] Sun Yat Sen Univ, Zhongshan Sch Med, Guangdong Prov Key Lab Brain Funct & Dis, Guangzhou 510080, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Nantong University; Sun Yat Sen University; Sun Yat Sen University; National University of Singapore; Sun Yat Sen University	Zeng, YS (corresponding author), Sun Yat Sen Univ, Minist Educ, Key Lab Stem Cells & Tissue Engn, Guangzhou 510080, Guangdong, Peoples R China.	zengysh@mail.sysu.edu.cn		Qiu, Xuecheng/0000-0001-9540-5104; Li, Ge/0000-0001-9030-884X	Chinese National Natural Science Foundation [81330028, U1301223]; National 863 Project [2013AA020106]; Foundation of the Education Ministry of China [201300193035]; Foundation of Guangzhou City [201508020215]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National 863 Project(National High Technology Research and Development Program of China); Foundation of the Education Ministry of China(Ministry of Education, China); Foundation of Guangzhou City	This research was supported by grants from the Chinese National Natural Science Foundation (No. 81330028; U1301223), National 863 Project (No. 2013AA020106), the Foundation of the Education Ministry of China (No. 201300193035) and the Foundation of Guangzhou City (No. 201508020215) to YSZ.	Alioto OE, 2008, AUTON NEUROSCI-BASIC, V140, P80, DOI 10.1016/j.autneu.2008.04.006; Angelucci A, 1996, J NEUROSCI METH, V65, P101, DOI 10.1016/0165-0270(95)00155-7; Aston-Jones G, 2000, J NEUROSCI METH, V103, P51, DOI 10.1016/S0165-0270(00)00295-8; Billig I, 2000, J NEUROSCI, V20, P7446; CHEN LL, 1995, ANAL BIOCHEM, V227, P168, DOI 10.1006/abio.1995.1267; CHEN S, 1995, BRAIN RES, V674, P107, DOI 10.1016/0006-8993(95)00020-Q; Conte WL, 2009, BRAIN STRUCT FUNCT, V213, P367, DOI 10.1007/s00429-009-0212-x; Conte WL, 2009, NAT PROTOC, V4, P1157, DOI 10.1038/nprot.2009.93; Feng Y, 2004, EMBO REP, V5, P596, DOI 10.1038/sj.embor.7400152; GERFEN CR, 1984, BRAIN RES, V290, P219, DOI 10.1016/0006-8993(84)90940-5; Iglesias-Bartolome R, 2009, BBA-BIOMEMBRANES, V1788, P2526, DOI 10.1016/j.bbamem.2009.09.018; Kobbert C, 2000, PROG NEUROBIOL, V62, P327, DOI 10.1016/S0301-0082(00)00019-8; KRISTENSSON K, 1971, BRAIN RES, V29, P363, DOI 10.1016/0006-8993(71)90044-8; Lai BQ, 2014, STEM CELLS DEV, V23, P910, DOI 10.1089/scd.2013.0426; Lai BQ, 2013, BIOMATERIALS, V34, P2888, DOI 10.1016/j.biomaterials.2012.12.046; Lancaster KZ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000791; Lencer WI, 2003, TRENDS BIOCHEM SCI, V28, P639, DOI 10.1016/j.tibs.2003.10.002; Li YC, 2013, J COMP NEUROL, V521, P203, DOI 10.1002/cne.23171; MCBRIDE RL, 1988, EXP NEUROL, V102, P236, DOI 10.1016/0014-4886(88)90099-4; MESULAM MM, 1979, NEUROSCIENCE, V4, P1107, DOI 10.1016/0306-4522(79)90192-1; Miana-Mena FJ, 2003, ACTA NEUROBIOL EXP, V63, P211; Robinson DR, 2004, NEUROGASTROENT MOTIL, V16, P113, DOI 10.1046/j.1365-2982.2003.00456.x; Rodighiero C, 2002, EMBO REP, V3, P1222, DOI 10.1093/embo-reports/kvf239; Schnaar RL, 2014, PHYSIOL REV, V94, P461, DOI 10.1152/physrev.00033.2013; SCHOFIELD BR, 1990, J NEUROSCI METH, V35, P47, DOI 10.1016/0165-0270(90)90093-U; Shehab SAS, 2003, BRAIN RES, V964, P218, DOI 10.1016/S0006-8993(02)04001-5; STREIT WJ, 1987, J NEUROCYTOL, V16, P249, DOI 10.1007/BF01795308; Sugimoto Y, 2001, P NATL ACAD SCI USA, V98, P12391, DOI 10.1073/pnas.221181998; Tong YG, 1999, J COMP NEUROL, V404, P143; Ullah M, 2007, J ANAT, V210, P428, DOI 10.1111/j.1469-7580.2007.00709.x; Wernick NLB, 2010, TOXINS, V2, P310, DOI 10.3390/toxins2030310; Wu CC, 1999, NEUROSCIENCE, V92, P665, DOI 10.1016/S0306-4522(99)00018-4	32	16	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144030	10.1371/journal.pone.0144030	http://dx.doi.org/10.1371/journal.pone.0144030			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26640949	Green Published, Green Submitted, gold			2022-12-27	WOS:000366902700047
J	Li, YH; Zhang, M; Xiao, HT; Fu, HB; Ho, A; Lin, CY; Huang, Y; Lin, G; Bian, ZX				Li, Yan-hong; Zhang, Man; Xiao, Hai-tao; Fu, Hai-bo; Ho, Alan; Lin, Cheng-yuan; Huang, Yu; Lin, Ge; Bian, Zhao-xiang			Addition of Berberine to 5-Aminosalicylic Acid for Treatment of Dextran Sulfate Sodium-Induced Chronic Colitis in C57BL/6 Mice	PLOS ONE			English	Article							NF-KAPPA-B; INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; ACETYLTRANSFERASE ACTIVITY; ADJUNCT THERAPY; IN-VITRO; ACTIVATION; INHIBITION; MUCINS; GROWTH	Ulcerative colitis (UC) is a common chronic remitting disease but without satisfactory treatment. Alternative medicine berberine has received massive attention for its potential in UC treatment. Conventional therapies with the addition of berberine are becoming attractive as novel therapies in UC. In the present study, we investigated the preclinical activity of a conventional oral 5-aminosalicylic acid (5-ASA) therapy plus berberine in experimental colitis. A subclinical dose of 5-ASA (200 mg/kg/day) alone or 5-ASA plus berberine (20 mg/kg/day) was orally administered for 30 days to C57BL/6 mice with colitis induced by three cycles of 2% dextran sulfate sodium (DSS). The disease severity, inflammatory responses, drug accumulation and potential toxicity of colitis mice were examined. The results showed that comparing to 5-ASA alone, 5-ASA plus berberine more potently ameliorated DSS-induced disease severity, colon shortening, and colon histological injury. Further, the up-regulation in mRNA level of colonic TNF-alpha as well as NF kappa B and JAK2 phosphorylation caused by DSS were more pronouncedly reversed in animals treated with the combination therapy than those treated with 5-ASA alone. Moreover, the addition of berberine to 5-ASA more significantly inhibited lymphocyte TNF-alpha secretion of DSS mice than 5-ASA alone. In the meanwhile, no extra drug accumulation or potential toxicity to major organs of colitis mice was observed with this combination treatment. In summary, our studies provide preclinical rationale for the addition of berberine to 5-ASA as a promising therapeutic strategy in clinic by reducing dose of standard therapy.	[Li, Yan-hong; Zhang, Man; Xiao, Hai-tao; Fu, Hai-bo; Ho, Alan; Lin, Cheng-yuan; Bian, Zhao-xiang] Hong Kong Baptist Univ, Lab Brain & Gut Res, Hong Kong Chinese Med Res Ctr, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China; [Huang, Yu; Lin, Ge] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China	Hong Kong Baptist University; Chinese University of Hong Kong	Bian, ZX (corresponding author), Hong Kong Baptist Univ, Lab Brain & Gut Res, Hong Kong Chinese Med Res Ctr, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China.	bzxiang@hkbu.edu.hk	Lin, Ge/R-4200-2018; Huang, Yu/K-2866-2017	Lin, Ge/0000-0002-4586-2603; Huang, Yu/0000-0002-1277-6784; LIN, Chengyuan/0000-0001-7929-0212	Food and Health Bureau of The Government of Hong Kong Special Administration Region [Health and Medical Research Fund] [HMRF10111971]	Food and Health Bureau of The Government of Hong Kong Special Administration Region [Health and Medical Research Fund]	This work was supported by grant from the Food and Health Bureau of The Government of Hong Kong Special Administration Region [Health and Medical Research Fund (HMRF10111971)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen L, 2005, GUT, V54, P503, DOI 10.1136/gut.2003.034165; Ardite E, 1998, BRIT J PHARMACOL, V124, P431, DOI 10.1038/sj.bjp.0701887; Bantel H, 2000, AM J GASTROENTEROL, V95, P3452; Chen CQ, 2014, AM J CHINESE MED, V42, P1053, DOI 10.1142/S0192415X14500669; Chung JG, 1999, FOOD CHEM TOXICOL, V37, P319, DOI 10.1016/S0278-6915(99)00016-2; Coskun M, 2013, PHARMACOL RES, V76, P1, DOI 10.1016/j.phrs.2013.06.007; Cottone M, 2011, CURR DRUG TARGETS, V12, P1396, DOI 10.2174/138945011796818126; Cui GL, 2009, J BIOL CHEM, V284, P28420, DOI 10.1074/jbc.M109.012674; Derosa G, 2014, CURR TOP MED CHEM, V14, P200, DOI 10.2174/1568026613666131213155252; Einerhand AWC, 2002, EUR J GASTROEN HEPAT, V14, P757, DOI 10.1097/00042737-200207000-00008; Fu KQ, 2015, INT IMMUNOPHARMACOL, V24, P128, DOI 10.1016/j.intimp.2014.11.002; Gao MY, 2014, PHARMACOL REP, V66, P480, DOI 10.1016/j.pharep.2013.12.004; Gu GZ, 2011, J CHROMATOGR B, V879, P449, DOI 10.1016/j.jchromb.2010.12.034; Hong T, 2012, IMMUNOPHARM IMMUNOT, V34, P391, DOI 10.3109/08923973.2011.609887; Kaiser GC, 1999, GASTROENTEROLOGY, V116, P602, DOI 10.1016/S0016-5085(99)70182-4; Katz Seymour, 2010, Gastroenterol Hepatol (N Y), V6, P1; Kheir MM, 2010, FOOD CHEM TOXICOL, V48, P1105, DOI 10.1016/j.fct.2010.01.033; Kuo CL, 2004, CANCER LETT, V203, P127, DOI 10.1016/j.canlet.2003.09.002; Lan JR, 2015, J ETHNOPHARMACOL, V161, P69, DOI 10.1016/j.jep.2014.09.049; LAURSEN LS, 1990, GUT, V31, P1271, DOI 10.1136/gut.31.11.1271; Lee IA, 2010, EUR J PHARMACOL, V648, P162, DOI 10.1016/j.ejphar.2010.08.046; Li J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087810; Lin JG, 1999, AM J CHINESE MED, V27, P265, DOI 10.1142/S0192415X99000306; Liptay S, 1999, BRIT J PHARMACOL, V128, P1361, DOI 10.1038/sj.bjp.0702937; Liu L, 2013, INT IMMUNOPHARMACOL, V17, P314, DOI 10.1016/j.intimp.2013.06.020; Mbodji K, 2013, J NUTR BIOCHEM, V24, P700, DOI 10.1016/j.jnutbio.2012.03.022; Mehta SJ, 2013, ALIMENT PHARM THER, V38, P77, DOI 10.1111/apt.12345; Panes J, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0239-9; Pastorini E, 2008, J CHROMATOGR B, V872, P99, DOI 10.1016/j.jchromb.2008.07.026; Qin X, 2010, J IMMUNOL, V185, P1855, DOI 10.4049/jimmunol.0903853; Rhodes JM, 1997, QJM-MON J ASSOC PHYS, V90, P79, DOI 10.1093/qjmed/90.2.79; Sandborn WJ, 2004, ALIMENT PHARM THER, V19, P1089, DOI 10.1111/j.1365-2036.2004.01964.x; Sayer B, 2002, BRIT J PHARMACOL, V135, P1794, DOI 10.1038/sj.bjp.0704633; Shah YM, 2007, AM J PHYSIOL-GASTR L, V292, pG1114, DOI 10.1152/ajpgi.00528.2006; SHARON P, 1978, GASTROENTEROLOGY, V75, P638; Shirazi T, 2000, POSTGRAD MED J, V76, P473, DOI 10.1136/pmj.76.898.473; Tao FF, 2013, BIOCHEM PHARMACOL, V85, P798, DOI 10.1016/j.bcp.2012.12.002; Tillhon M, 2012, BIOCHEM PHARMACOL, V84, P1260, DOI 10.1016/j.bcp.2012.07.018; Toumi R, 2014, INT J IMMUNOPATH PH, V27, P615, DOI 10.1177/039463201402700418; Toumi R, 2013, IMMUNOPHARM IMMUNOT, V35, P403, DOI 10.3109/08923973.2013.790413; Tsang CM, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-619; Tzivras M, 1997, EUR J GASTROEN HEPAT, V9, P729, DOI 10.1097/00042737-199707000-00016; Viennois Emilie, 2013, BMC Res Notes, V6, P360, DOI 10.1186/1756-0500-6-360; Wahl C, 1998, J CLIN INVEST, V101, P1163, DOI 10.1172/JCI992; Wang Y, 2013, PHARM BIOL; Warner TD, 1999, P NATL ACAD SCI USA, V96, P7563, DOI 10.1073/pnas.96.13.7563; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Yan F, 1999, J BIOL CHEM, V274, P36631, DOI 10.1074/jbc.274.51.36631; Yan F, 2012, AM J PHYSIOL-GASTR L, V302, pG504, DOI 10.1152/ajpgi.00312.2011; Yin J, 2008, METABOLISM, V57, P712, DOI 10.1016/j.metabol.2008.01.013; Zhang C, 2013, CLIN REV ALLERG IMMU, V44, P274, DOI 10.1007/s12016-012-8328-9; Zhao LN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094208; Zhou HY, 2000, J PHARMACOL EXP THER, V294, P822	53	35	37	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144101	10.1371/journal.pone.0144101	http://dx.doi.org/10.1371/journal.pone.0144101			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642326	Green Submitted, gold, Green Published			2022-12-27	WOS:000366902700055
J	Wubuli, A; Xue, F; Jiang, DB; Yao, XM; Upur, H; Wushouer, Q				Wubuli, Atikaimu; Xue, Feng; Jiang, Daobin; Yao, Xuemei; Upur, Halmurat; Wushouer, Qimanguli			Socio-Demographic Predictors and Distribution of Pulmonary Tuberculosis (TB) in Xinjiang, China: A Spatial Analysis	PLOS ONE			English	Article								Objectives Xinjiang is one of the high TB burden provinces of China. A spatial analysis was conducted using geographical information system (GIS) technology to improve the understanding of geographic variation of the pulmonary TB occurrence in Xinjiang, its predictors, and to search for targeted interventions. Methods Numbers of reported pulmonary TB cases were collected at county/district level from TB surveillance system database. Population data were extracted from Xinjiang Statistical Yearbook (2006 similar to 2014). Spatial autocorrelation (or dependency) was assessed using global Moran's I statistic. Anselin's local Moran's I and local Getis-Ord statistics were used to detect local spatial clusters. Ordinary least squares (OLS) regression, spatial lag model (SLM) and geographically-weighted regression (GWR) models were used to explore the socio-demographic predictors of pulmonary TB incidence from global and local perspectives. SPSS17.0, ArcGIS10.2.2, and GeoDA software were used for data analysis. Results Incidence of sputum smear positive (SS+) TB and new SS+TB showed a declining trend from 2005 to 2013. Pulmonary TB incidence showed a declining trend from 2005 to 2010 and a rising trend since 2011 mainly caused by the rising trend of sputum smear negative (SS-) TB incidence (p<0.0001). Spatial autocorrelation analysis showed the presence of positive spatial autocorrelation for pulmonary TB incidence, SS+TB incidence and SS-TB incidence from 2005 to 2013 (P<0.0001). The Anselin's Local Moran's I identified the "hotspots" which were consistently located in the southwest regions composed of 20 to 28 districts, and the "coldspots" which were consistently located in the north central regions consisting of 21 to 27 districts. Analysis with the Getis-Ord Gi* statistic expanded the scope of "hotspots" and "coldspots" with different intensity; 30 county/districts clustered as "hotspots", while 47 county/districts clustered as "coldspots". OLS regression model included the "proportion of minorities" and the "per capita GDP" as explanatory variables that explained 64% the variation in pulmonary TB incidence (adjR(2) = 0.64). The SLM model improved the fit of the OLS model with a decrease in AIC value from 883 to 864, suggesting "proportion of minorities" to be the only statistically significant predictor. GWR model also improved the fitness of regression (adj R-2 = 0.68, AIC = 871), which revealed that "proportion of minorities" was a strong predictor in the south central regions while "per capita GDP" was a strong predictor for the southwest regions. Conclusion The SS+TB incidence of Xinjiang had a decreasing trend during 2005-2013, but it still remained higher than the national average in China. Spatial analysis showed significant spatial autocorrelation in pulmonary TB incidence. Cluster analysis detected two clusters-the "hotspots", which were consistently located in the southwest regions, and the "coldspots", which were consistently located in the north central regions. The exploration of socio-demographic predictors identified the "proportion of minorities" and the "per capita GDP" as predictors and may help to guide TB control programs and targeting intervention.	[Wubuli, Atikaimu; Yao, Xuemei] Xinjiang Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Urumqi, Xinjiang, Peoples R China; [Xue, Feng] Xinjiang Uygur Autonomous Reg Ctr Dis Control & P, Ctr TB Control & Prevent, Urumqi, Xinjiang, Peoples R China; [Jiang, Daobin; Wushouer, Qimanguli] Xinjiang Med Univ, Affiliated Hosp 1, Dept Resp Med, Urumqi, Xinjiang, Peoples R China; [Upur, Halmurat] Xinjiang Med Univ, Dept Tradit Uygur Med, Urumqi, Xinjiang, Peoples R China; [Wubuli, Atikaimu] Xinjiang Med Univ, Res Inst Hlth Affairs Dev & Reform, Urumqi, Xinjiang, Peoples R China	Xinjiang Medical University; Xinjiang Medical University; Xinjiang Medical University; Xinjiang Medical University	Upur, H (corresponding author), Xinjiang Med Univ, Dept Tradit Uygur Med, Urumqi, Xinjiang, Peoples R China.	halmurat@263.net; 1634035430@qq.com			National Natural Science Foundation of China [81160004]; Research Foundation of Health Affairs Development and Reform, Xinjiang Medical University [HADR201506]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Foundation of Health Affairs Development and Reform, Xinjiang Medical University	This study was funded by National Natural Science Foundation of China (NO: 81160004) and the Research Foundation of Health Affairs Development and Reform, Xinjiang Medical University, Grant number HADR201506. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; ANSELIN L, 1992, ANN REGIONAL SCI, V26, P19, DOI 10.1007/BF01581478; Anselin L, 2005, EXPLORING SPATIAL DA; Anselin L, 2007, SOC INDIC RES, V82, P287, DOI 10.1007/s11205-006-9034-x; Ben-Shlomo Y, 2005, INT J EPIDEMIOL, V34, P1181, DOI 10.1093/ije/dyi242; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Caprarelli G, 2014, PARASITOLOGY, V141, P581, DOI 10.1017/S0031182013001972; Chan TC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098170; Chan Ta-Chien, 2010, INFECT DIS INFORM BI, P208; Chan-Yeung M, 2005, INT J TUBERC LUNG D, V9, P1320; Cliff A, 1973, SPATIAL AUTOCORRELAT; Esri, 2011, COMM REGR PROBL CONS; Fotheringham A. S., 2002, GEOGRAPHICALLY WEIGH; Goodchild MF., 1986, CATMOG CONCEPTS TECH, V47; Gu XM, 2003, ENDEMIC DIB, V18, P71; Haque U, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-63; Harling G, 2014, HEALTH PLACE, V25, P56, DOI 10.1016/j.healthplace.2013.10.008; Korzeniewska-Kosela M., 2014, PRZEGL EPIDEMIOL, V68, P389; Korzeniewska-Kosela Maria, 2014, Przegl Epidemiol, V68, P295; Li XX, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.23620; Li XQ, 2013, REV INST MED TROP SP, V55, P366, DOI 10.1590/S0036-46652013000500013; Liu YX, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-50; Merza M, 2009, BRAZ J INFECT DIS, V13, P252, DOI 10.1590/S1413-86702009000400002; Myers WP, 2006, AM J PUBLIC HEALTH, V96, P685, DOI 10.2105/AJPH.2004.048132; Poole MA, T I BRIT GEOGRAPHERS, P145; Ribeiro SCM, 2014, J CLIN MICROBIOL, V52, P2615, DOI 10.1128/JCM.00498-14; Statistic Bureau of Xinjiang Uygur Autonomous Region, 2013, MINJ STAT YB 2013; Subramanian SV, 2009, INT J EPIDEMIOL, V38, P342, DOI 10.1093/ije/dyn359; Technical Guidance Group of the Fifth National TB Epidemiological Survey, 2012, CHINESE J ANTITUBERC, V34, P485; Wang T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-885; Wang X, 2011, CHINESES J ANTITUBER, V33, P197; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wu F, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/484535; Xiao He-ping, 2005, Zhonghua Jie He He Hu Xi Za Zhi, V28, P665; Yang J., 2013, CHIN J ANTITUBERC, V35, P960; Zhao F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083605; Zulu LC, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-285	37	45	49	6	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144010	10.1371/journal.pone.0144010	http://dx.doi.org/10.1371/journal.pone.0144010			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1YS	26641642	Green Published, Green Submitted, gold			2022-12-27	WOS:000366902700042
J	Celestino-Soper, PBS; Doytchinova, A; Steiner, HA; Uradu, A; Lynnes, TC; Groh, WJ; Miller, JM; Lin, H; Gao, HY; Wang, ZP; Liu, YL; Chen, PS; Vatta, M				Celestino-Soper, Patricia B. S.; Doytchinova, Anisiia; Steiner, Hillel A.; Uradu, Andrea; Lynnes, Ty C.; Groh, William J.; Miller, John M.; Lin, Hai; Gao, Hongyu; Wang, Zhiping; Liu, Yunlong; Chen, Peng-Sheng; Vatta, Matteo			Evaluation of the Genetic Basis of Familial Aggregation of Pacemaker Implantation by a Large Next Generation Sequencing Panel	PLOS ONE			English	Article							CARDIAC CONDUCTION DISEASE; SICK SINUS SYNDROME; LONG QT SYNDROME; COMPLETE ATRIOVENTRICULAR-BLOCK; MYOCARDIAL-INFARCTION; ATRIAL-FIBRILLATION; MUTATIONS; SCN5A; ABCC9; SUSCEPTIBILITY	Background The etiology of conduction disturbances necessitating permanent pacemaker (PPM) implantation is often unknown, although familial aggregation of PPM (faPPM) suggests a possible genetic basis. We developed a pan-cardiovascular next generation sequencing (NGS) panel to genetically characterize a selected cohort of faPPM. Materials and Methods We designed and validated a custom NGS panel targeting the coding and splicing regions of 246 genes with involvement in cardiac pathogenicity. We enrolled 112 PPM patients and selected nine (8%) with faPPM to be analyzed by NGS. Results Our NGS panel covers 95% of the intended target with an average of 229x read depth at a minimum of 15-fold depth, reaching a SNP true positive rate of 98%. The faPPM patients presented with isolated cardiac conduction disease (ICCD) or sick sinus syndrome (SSS) without overt structural heart disease or identifiable secondary etiology. Three patients (33.3%) had heterozygous deleterious variants previously reported in autosomal dominant cardiac diseases including CCD: LDB3 (p.D117N) and TRPM4 (p.G844D) variants in patient 4; TRPM4 (p.G844D) and ABCC9 (p.V734I) variants in patient 6; and SCN5A (p.T220I) and APOB (p.R3527Q) variants in patient 7. Conclusion FaPPM occurred in 8% of our PPM clinic population. The employment of massive parallel sequencing for a large selected panel of cardiovascular genes identified a high percentage (33.3%) of the faPPM patients with deleterious variants previously reported in autosomal dominant cardiac diseases, suggesting that genetic variants may play a role in faPPM.	[Celestino-Soper, Patricia B. S.; Lynnes, Ty C.; Lin, Hai; Gao, Hongyu; Liu, Yunlong; Vatta, Matteo] Indiana Univ, Dept Med & Mol Genet, Sch Med, Indianapolis, IN 46204 USA; [Doytchinova, Anisiia; Steiner, Hillel A.; Uradu, Andrea; Groh, William J.; Miller, John M.; Chen, Peng-Sheng; Vatta, Matteo] Indiana Univ, Krannert Inst Cardiol, Div Cardiol, Dept Med,Sch Med, Indianapolis, IN 46204 USA; [Lin, Hai; Wang, Zhiping; Liu, Yunlong] Indiana Univ Purdue Univ, Ctr Computat Biol & Bioinformat, Indianapolis, IN 46202 USA; [Steiner, Hillel A.] Poriya MP Lower Galilee, Baruch Padeh Med Ctr, Safed, Israel; [Steiner, Hillel A.] Bar Ilan Univ, Fac Med Galilee, Safed, Israel	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Bar Ilan University	Vatta, M (corresponding author), Indiana Univ, Dept Med & Mol Genet, Sch Med, Indianapolis, IN 46204 USA.	mvatta@iu.edu	Sander-Effron, Samuel/AAX-2231-2020; Resource Center, NINDS Human Genetics/AGF-2474-2022; Lin, Hai/N-3860-2016	Lin, Hai/0000-0002-2094-758X	American Physicians Fellowship for Medicine in Israel; Mark and Anna Ruth Hasten Family Foundation; National Institute of Health (NIH)/NHLBI [P01 HL78931, R01 HL71140]; Medtronic-Zipes Endowment of Indiana University; Indiana University Health/Indiana University School of Medicine Strategic Research Initiative; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002529, UL1TR001108, UL1TR000006] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071140, P01HL078931] Funding Source: NIH RePORTER	American Physicians Fellowship for Medicine in Israel; Mark and Anna Ruth Hasten Family Foundation; National Institute of Health (NIH)/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Medtronic-Zipes Endowment of Indiana University; Indiana University Health/Indiana University School of Medicine Strategic Research Initiative; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr. Steiner is a recipient of a Fellowship Grant from The American Physicians Fellowship for Medicine in Israel and the Mark and Anna Ruth Hasten Family Foundation. This study was supported in part by National Institute of Health (NIH)/NHLBI research grants P01 HL78931 and R01 HL71140 (PSC), the Medtronic-Zipes Endowment of Indiana University (PSC), and the Indiana University Health/Indiana University School of Medicine Strategic Research Initiative (PCS, TCL, PSC, and MV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman MJ, 2011, HEART RHYTHM, V8, P1308, DOI [10.1016/j.hrthm.2011.05.020, 10.1093/europace/eur245]; [Anonymous], HUM GEN MUT DAT HGMD; Balmer C, 2002, EUROPACE, V4, P345, DOI 10.1053/eupc.2002.0266; Baskar S, 2014, J PEDIATR-US, V165, P1050, DOI 10.1016/j.jpeds.2014.07.036; Benson DW, 2003, J CLIN INVEST, V112, P1019, DOI 10.1172/JCI200318062; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Chow GV, 2012, CLIN GERIATR MED, V28, P539, DOI 10.1016/j.cger.2012.07.003; Dobrzynski H, 2007, CIRCULATION, V115, P1921, DOI 10.1161/CIRCULATIONAHA.106.616011; Frey N, 2002, J BIOL CHEM, V277, P13998, DOI 10.1074/jbc.M200712200; Gourraud JB, 2012, HEART, V98, P1305, DOI 10.1136/heartjnl-2012-301872; Gui JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010985; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hu D, 2014, INT J CARDIOL, V171, P431, DOI 10.1016/j.ijcard.2013.12.084; Itoh H, 2010, HEART RHYTHM, V7, P1411, DOI 10.1016/j.hrthm.2010.06.013; Lee KT, 2012, PACE, V35, P544, DOI 10.1111/j.1540-8159.2012.03355.x; Lin XY, 2014, J BIOL CHEM, V289, P13615, DOI 10.1074/jbc.M114.550418; Liu H, 2010, CIRC-CARDIOVASC GENE, V3, P374, DOI 10.1161/CIRCGENETICS.109.930867; MICHAELSSON M, 1995, CIRCULATION, V92, P442, DOI 10.1161/01.CIR.92.3.442; Minoretti P, 2006, CLIN CHIM ACTA, V370, P124, DOI 10.1016/j.cca.2006.02.007; Olesen MS, 2012, CIRC-CARDIOVASC GENE, V5, P450, DOI 10.1161/CIRCGENETICS.111.962597; Olson TM, 2005, JAMA-J AM MED ASSOC, V293, P447, DOI 10.1001/jama.293.4.447; Rehm HL, 2013, GENET MED, V15, P733, DOI 10.1038/gim.2013.92; Rehm HL, 2013, NAT REV GENET, V14, P295, DOI 10.1038/nrg3463; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Schott JJ, 1999, NAT GENET, V23, P20, DOI 10.1038/12618; SENGES J, 1981, J MOL CELL CARDIOL, V13, P253, DOI 10.1016/0022-2828(81)90314-X; Smith KJ, 2013, INT J CARDIOL, V168, P3506, DOI 10.1016/j.ijcard.2013.04.210; Smits JPP, 2005, EUROPACE, V7, P122, DOI 10.1016/j.eupc.2004.11.004; Stallmeyer B, 2012, HUM MUTAT, V33, P109, DOI 10.1002/humu.21599; Tan BH, 2007, CARDIOVASC RES, V76, P409, DOI 10.1016/j.cardiores.2007.08.006; Tan HL, 2001, NATURE, V409, P1043, DOI 10.1038/35059090; Vatta M, 2003, J AM COLL CARDIOL, V42, P2014, DOI 10.1016/j.jacc.2003.10.021; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Xi YT, 2012, CIRC-ARRHYTHMIA ELEC, V5, P1017, DOI 10.1161/CIRCEP.111.969220; Xu XZS, 2001, P NATL ACAD SCI USA, V98, P10692, DOI 10.1073/pnas.191360198	35	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143588	10.1371/journal.pone.0143588	http://dx.doi.org/10.1371/journal.pone.0143588			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636822	gold, Green Published			2022-12-27	WOS:000366143800020
J	Verdone, L; La Fortezza, M; Ciccarone, F; Caiafa, P; Zampieri, M; Caserta, M				Verdone, Loredana; La Fortezza, Marco; Ciccarone, Fabio; Caiafa, Paola; Zampieri, Michele; Caserta, Micaela			Poly(ADP-Ribosyl)ation Affects Histone Acetylation and Transcription	PLOS ONE			English	Article							POLY(ADENOSINE DIPHOSPHATE RIBOSYLATION); POSTTRANSLATIONAL MODIFICATIONS; CHROMATIN-STRUCTURE; GENE-EXPRESSION; PARP-1; MODULATION; ACTIVATION; COACTIVATION; RECRUITMENT; INTERPLAY	Poly(ADP-ribosyl) ation (PARylation) is a posttranslational protein modification catalyzed by members of the poly(ADP-ribose) polymerase (PARP) enzyme family. PARylation regulates a wide variety of biological processes in most eukaryotic cells including energy metabolism and cell death, maintenance of genomic stability, chromatin structure and transcription. Inside the nucleus, cross-talk between PARylation and other epigenetic modifications, such as DNA and histone methylation, was already described. In the present work, using PJ34 or ABT888 to inhibit PARP activity or over-expressing poly(ADP-ribose) glycohydrolase (PARG), we show decrease of global histone H3 and H4 acetylation. This effect is accompanied by a reduction of the steady state mRNA level of p300, Pcaf, and Tnf alpha, but not of Dnmt1. Chromatin immunoprecipitation (ChIP) analyses, performed at the level of the Transcription Start Site (TSS) of these four genes, reveal that changes in histone acetylation are specific for each promoter. Finally, we demonstrate an increase of global deacetylase activity in nuclear extracts from cells treated with PJ34, whereas global acetyltransferase activity is not affected, suggesting a role for PARP in the inhibition of histone deacetylases. Taken together, these results show an important link between PARylation and histone acetylation regulated transcription.	[Verdone, Loredana; Caserta, Micaela] Univ Roma La Sapienza, CNR, Ist Biol & Patol Mol, Dipartimento Biol & Biotecnol, I-00185 Rome, Italy; [La Fortezza, Marco] Univ Munich, Planegg Martinsried, Germany; [Ciccarone, Fabio; Caiafa, Paola; Zampieri, Michele] Univ Roma La Sapienza, Dipartimento Biotecnol Cellulari & Ematol, I-00185 Rome, Italy; [Ciccarone, Fabio; Caiafa, Paola; Zampieri, Michele] Fdn Cenci Bolognetti, Ist Pasteur, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome; University of Munich; Sapienza University Rome; Fondazione Cenci Bolognetti	Zampieri, M (corresponding author), Univ Roma La Sapienza, Dipartimento Biotecnol Cellulari & Ematol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	zampieri@bce.uniroma1.it; micaela.caserta@uniroma1.it	La Fortezza, Marco/AGY-1631-2022; Verdone, Loredana/AGG-5450-2022; Ciccarone, Fabio/AAR-9128-2021; Zampieri, Michele/AGF-5460-2022; Zampieri, Michele/F-7099-2013; CICCARONE, FABIO/K-4225-2016	La Fortezza, Marco/0000-0002-4485-9840; Ciccarone, Fabio/0000-0002-2425-2240; Zampieri, Michele/0000-0002-6799-2492; Zampieri, Michele/0000-0002-6799-2492; Verdone, Loredana/0000-0002-8854-1068	FIRB, Fondo per gli Investimenti della Ricerca di Base [RBIN06E9Z8]	FIRB, Fondo per gli Investimenti della Ricerca di Base(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB))	This work was supported by FIRB, Fondo per gli Investimenti della Ricerca di Base (Grant RBIN06E9Z8).	Agricola E, 2006, MOL MICROBIOL, V62, P1433, DOI 10.1111/j.1365-2958.2006.05451.x; Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Altmeyer M, 2009, AGING-US, V1, P458, DOI 10.18632/aging.100052; Bartke T, 2011, CELL CYCLE, V10, P182, DOI 10.4161/cc.10.2.14477; BOULIKAS T, 1990, J BIOL CHEM, V265, P14638; Burkle A, 2013, MOL ASPECTS MED, V34, P1046, DOI 10.1016/j.mam.2012.12.010; Caiafa P, 2009, FASEB J, V23, P672, DOI 10.1096/fj.08-123265; Clayton AL, 2006, MOL CELL, V23, P289, DOI 10.1016/j.molcel.2006.06.017; Cohen-Armon M, 2007, MOL CELL, V25, P297, DOI 10.1016/j.molcel.2006.12.012; DEMURCIA G, 1986, J BIOL CHEM, V261, P7011; Du JM, 2014, BBA-GENE REGUL MECH, V1839, P719, DOI 10.1016/j.bbagrm.2014.04.011; Frizzell KM, 2009, J BIOL CHEM, V284, P33926, DOI 10.1074/jbc.M109.023879; Gerace E, 2015, NEUROPHARMACOLOGY, V92, P125, DOI 10.1016/j.neuropharm.2015.01.008; Gottschalk AJ, 2009, P NATL ACAD SCI USA, V106, P13770, DOI 10.1073/pnas.0906920106; Guastafierro T, 2008, J BIOL CHEM, V283, P21873, DOI 10.1074/jbc.M801170200; Guastafierro T, 2013, BIOCHEM J, V449, P623, DOI 10.1042/BJ20121429; Hassa PO, 2008, FRONT BIOSCI-LANDMRK, V13, P3046, DOI 10.2741/2909; Hassa PO, 2005, J BIOL CHEM, V280, P40450, DOI 10.1074/jbc.M507553200; Hassa PO, 2003, J BIOL CHEM, V278, P45145, DOI 10.1074/jbc.M307957200; Hazzalin CA, 2005, PLOS BIOL, V3, P2111, DOI 10.1371/journal.pbio.0030393; Hottiger MO, 2011, FEBS LETT, V585, P1595, DOI 10.1016/j.febslet.2011.03.031; Hottiger MO, 2010, TRENDS BIOCHEM SCI, V35, P208, DOI 10.1016/j.tibs.2009.12.003; Ji YBA, 2010, CURR OPIN GENET DEV, V20, P512, DOI 10.1016/j.gde.2010.06.001; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Kraus WL, 2013, MOL ASPECTS MED, V34, P1109, DOI 10.1016/j.mam.2013.01.005; Kraus WL, 2009, NAT STRUCT MOL BIOL, V16, P904, DOI 10.1038/nsmb0909-904; Krishnakumar R, 2010, MOL CELL, V39, P736, DOI 10.1016/j.molcel.2010.08.014; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Luo X, 2012, GENE DEV, V26, P417, DOI 10.1101/gad.183509.111; Malanga M, 2005, BIOCHEM CELL BIOL, V83, P354, DOI 10.1139/o05-038; MALIK N, 1984, BIOCHEMISTRY-US, V23, P3721, DOI 10.1021/bi00311a023; Martinez-Zamudio R, 2012, MOL CELL BIOL, V32, P2490, DOI 10.1128/MCB.06667-11; Mehrotra P, 2011, J BIOL CHEM, V286, P1767, DOI 10.1074/jbc.M110.157768; Messner S, 2010, NUCLEIC ACIDS RES, V38, P6350, DOI 10.1093/nar/gkq463; Murr R, 2010, ADV GENET, V70, P101, DOI [10.1016/B978-0-12-380866-0.60005-8, 10.1016/S0065-2660(10)70005-5]; Reale A, 2005, ONCOGENE, V24, P13, DOI 10.1038/sj.onc.1208005; Rothbart SB, 2014, BBA-GENE REGUL MECH, V1839, P627, DOI 10.1016/j.bbagrm.2014.03.001; Sala A, 2008, PLOS BIOL, V6, P2329, DOI 10.1371/journal.pbio.0060252; Scobie KN, 2014, P NATL ACAD SCI USA, V111, P2005, DOI 10.1073/pnas.1319703111; Tulin A, 2003, SCIENCE, V299, P560, DOI 10.1126/science.1078764; Verdone L, 2005, BIOCHEM CELL BIOL, V83, P344, DOI 10.1139/o05-041; WONG M, 1984, BIOCHEMISTRY-US, V23, P3726, DOI 10.1021/bi00311a024; Yang ZY, 2014, J IMMUNOL, V193, P6114, DOI 10.4049/jimmunol.1400359; Zampieri M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004717; Zardo G, 2002, FASEB J, V16, P1319, DOI 10.1096/fj.01-0827fje; Zhang T, 2012, J BIOL CHEM, V287, P12405, DOI 10.1074/jbc.M111.304469	46	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144287	10.1371/journal.pone.0144287	http://dx.doi.org/10.1371/journal.pone.0144287			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636673	Green Published, gold, Green Submitted			2022-12-27	WOS:000366143800068
J	Yue, Y; Yu, HH; Li, RF; Xing, RG; Liu, S; Li, PC				Yue, Yang; Yu, Huahua; Li, Rongfeng; Xing, Ronge; Liu, Song; Li, Pengcheng			Exploring the Antibacterial and Antifungal Potential of Jellyfish-Associated Marine Fungi by Cultivation-Dependent Approaches	PLOS ONE			English	Article							SEA-DERIVED FUNGUS; STOMOLOPHUS-MELEAGRIS; ASPERGILLUS-FUMIGATUS; CHEMICAL DEFENSE; CULTURABLE FUNGI; A-E; METABOLITES; DIVERSITY; COCULTURE; ALKALOIDS	Fungi isolated from marine invertebrates are of considerable importance as new promising sources of unique secondary metabolites with significant biomedical potential. However, the cultivable fungal community harbored in jellyfish was less investigated. In this work, we seek to recover symbiotic fungi from different tissues of jellyfish Nemopilema nomurai. A total of seven morphotypes were isolated, which were assigned into four genera (Aspergillus, Cladosporium, Purpureocillium, and Tilletiopsis) from two phyla (Ascomycota and Basidiomycota) by comparing the rDNA-ITS sequences with the reference sequences in GenBank. The most fungi were found in the inner tissues of subumbrella. Two of the cultivation- independent procedures, changing media type and co-cultivation, were employed to maximize the complexity of metabolites. Thus, thirteen EtOAc gum were obtained and fingerprinted by High Performance Liquid Chromatography (HPLC) equipped with a photodiode array (PDA) detector. Antibacterial and antifungal activities of these complex mixtures were tested against a panel of bacterial and fungal pathogens. The antimicrobial results showed that all of the 13 EtOAc extracts displayed different levels of antibacterial activity, three of which exhibited strong to significant antibacterial activity to the bacterial pathogens Staphylococcus aureus and Salmonella entrica. Antifungal activity indicated that the EtOAc extracts from pure culture of Aspergillus versicolor and co-culture of A. versicolor and Tilletiopsis sp. in rice media were promising for searching new compounds, with the maximal mycelial growth inhibition of 82.32% +/- 0.61% for Rhizoctonia solani and 48.41% +/- 11.02% for Botrytis cinerea at 200 mu g/ml, respectively. This study is the first report on the antibacterial and antifungal activity of jellyfish-associated fungi and allows the first sight into cultivable fungal community residing in jellyfish. Induced metabolites by cultivation-dependent approaches provides a new reservoir for drug discovery from jellyfish-derived fungi.	[Yue, Yang; Yu, Huahua; Li, Rongfeng; Xing, Ronge; Liu, Song; Li, Pengcheng] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Yue, Yang] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yu, HH (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.	yuhuahua@qdio.ac.cn; pcli@qdio.ac.cn			National Key Technologies RD Program [2011BAE06B04]; National Natural Science Foundation of China [41376004, 41406152]; Public Science and Technology Research Funds Projects of Ocean [201305016-2]	National Key Technologies RD Program(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Public Science and Technology Research Funds Projects of Ocean	The authors gratefully acknowledge financial grants: the National Key Technologies R&D Program (2011BAE06B04), the National Natural Science Foundation of China (41376004, 41406152), and the Public Science and Technology Research Funds Projects of Ocean (201305016-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amend AS, 2012, ISME J, V6, P1291, DOI 10.1038/ismej.2011.193; Bertrand S, 2013, J NAT PROD, V76, P1157, DOI 10.1021/np400258f; Bruce A. J., 1995, Beagle, V12, P61; CLSI, 2012, M02A11 CLSI; Denker E, 2008, CURR BIOL, V18, pR858, DOI 10.1016/j.cub.2008.07.031; Doepke H, 2012, HELGOLAND MAR RES, V66, P43, DOI 10.1007/s10152-011-0245-4; Guo WQ, 2013, J NAT PROD, V76, P2106, DOI 10.1021/np4006647; Hanif N, 2010, J NAT PROD, V73, P1318, DOI 10.1021/np100221k; Jacqueline A., 1994, J AM CHEM SOC, V116, P757, DOI DOI 10.1021/ja00081a042; Alvarez-Tello FJ, 2013, HIDROBIOLOGICA, V23, P138; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kjer J, 2010, NAT PROTOC, V5, P479, DOI 10.1038/nprot.2009.233; La Kim E, 2012, CHEM PHARM BULL, V60, P1590; La Kim E, 2012, BIOORG MED CHEM LETT, V22, P3126, DOI 10.1016/j.bmcl.2012.03.058; Lampert KP, 2012, MAR ECOL-EVOL PERSP, V33, P364, DOI 10.1111/j.1439-0485.2011.00488.x; Li RF, 2014, J PROTEOMICS, V106, P17, DOI 10.1016/j.jprot.2014.04.011; Li RF, 2013, TOXICOL IN VITRO, V27, P1620, DOI 10.1016/j.tiv.2013.04.004; Li RF, 2012, INT J BIOL MACROMOL, V51, P274, DOI 10.1016/j.ijbiomac.2012.05.015; Liu J, 2014, ORGANIC LETT, DOI [10.1021/ol500243k, DOI 10.1021/0L500243K]; Liu J, 2011, J NAT PROD, V74, P1826, DOI 10.1021/np200350b; Luangsa-Ard J, 2011, FEMS MICROBIOL LETT, V321, P141, DOI 10.1111/j.1574-6968.2011.02322.x; Mellas RE, 2014, J EXP MAR BIOL ECOL, V459, P38, DOI 10.1016/j.jembe.2014.04.026; Moore BS, 1999, J ORG CHEM, V64, P1145, DOI 10.1021/jo9814391; Nonaka K, 2011, J ANTIBIOT, V64, P769, DOI 10.1038/ja.2011.91; PALINCSAR EE, 1989, BIOL BULL, V177, P130, DOI 10.2307/1541840; Peng JX, 2014, J ORG CHEM, V79, P7895, DOI 10.1021/jo5010179; Peng JX, 2013, J NAT PROD, V76, P1133, DOI 10.1021/np400200k; Peraud O, 2006, THESIS; Piel J, 2006, CURR MED CHEM, V13, P39, DOI 10.2174/092986706775197971; Piel J, 2004, NAT PROD REP, V21, P519, DOI 10.1039/b310175b; Piel J, 2009, NAT PROD REP, V26, P338, DOI 10.1039/b703499g; Rateb ME, 2013, RSC ADV, V3, P14444, DOI 10.1039/c3ra42378f; Moyano MPS, 2012, MAR BIOL, V159, P1933, DOI 10.1007/s00227-012-1980-z; Schuett C, 2007, HELGOLAND MAR RES, V61, P211, DOI 10.1007/s10152-007-0069-4; Schuett C, 2010, HELGOLAND MAR RES, V64, P205, DOI 10.1007/s10152-009-0179-2; Singh P, 2010, FUNGAL DIVERS, V40, P89, DOI 10.1007/s13225-009-0009-5; Song FH, 2012, ORG LETT, V14, P4770, DOI 10.1021/ol302051x; STIERLE AC, 1988, EXPERIENTIA, V44, P1021, DOI 10.1007/BF01939910; Takahashi JA, 2013, PHYTOCHEM REV, V12, P773, DOI 10.1007/s11101-013-9305-5; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tsukamoto S, 2009, J AM CHEM SOC, V131, P3834, DOI 10.1021/ja810029b; Turk T, 2009, TOXICON, V54, P1031, DOI 10.1016/j.toxicon.2009.06.031; Vervoort HC, 1998, MAR ECOL PROG SER, V164, P221, DOI 10.3354/meps164221; Wang YN, 2011, MAR DRUGS, V9, P1379, DOI 10.3390/md9081379; Wilson DM, 1999, J CHEM ECOL, V25, P2811, DOI 10.1023/A:1020811810223; Wright AD, 2003, ORG BIOMOL CHEM, V1, P507, DOI 10.1039/b208588g; Wu GW, 2014, J NAT PROD, V77, P270, DOI 10.1021/np400833x; Yu Huahua, 2014, Biomed Res Int, V2014, P315853, DOI 10.1155/2014/315853; Zhang F., 2008, THESIS; Zhang XY, 2012, MICROB ECOL, V64, P617, DOI 10.1007/s00248-012-0050-x; Zhang YL, 2013, J AGR FOOD CHEM, V61, P1521, DOI 10.1021/jf305210u; Zuck KM, 2011, J NAT PROD, V74, P1653, DOI 10.1021/np200255f	52	17	19	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144394	10.1371/journal.pone.0144394	http://dx.doi.org/10.1371/journal.pone.0144394			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26637162	Green Submitted, Green Published, gold			2022-12-27	WOS:000366143800085
J	Bashir, A; Gropler, R; Ackerman, J				Bashir, Adil; Gropler, Robert; Ackerman, Joseph			Absolute Quantification of Human Liver Phosphorus-Containing Metabolites In Vivo Using an Inhomogeneous Spoiling Magnetic Field Gradient	PLOS ONE			English	Article							P-31 MR SPECTROSCOPY; RESONANCE-SPECTROSCOPY; NMR-SPECTROSCOPY; SURFACE-COIL; CIRRHOSIS; DISEASE; QUANTITATION; HOMEOSTASIS	Purpose Absolute concentrations of high-energy phosphorus (P-31) metabolites in liver provide more important insight into physiologic status of liver disease compared to resonance integral ratios. A simple method for measuring absolute concentrations of P-31 metabolites in human liver is described. The approach uses surface spoiling inhomogeneous magnetic field gradient to select signal from liver tissue. The technique avoids issues caused by respiratory motion, chemical shift dispersion associated with linear magnetic field gradients, and increased tissue heat deposition due to radiofrequency absorption, especially at high field strength. Methods A method to localize signal from liver was demonstrated using superficial and highly non-uniform magnetic field gradients, which eliminate signal(s) from surface tissue(s) located between the liver and RF coil. A double standard method was implemented to determine absolute P-31 metabolite concentrations in vivo. 8 healthy individuals were examined in a 3 T MR scanner. Results Concentrations of metabolites measured in eight healthy individuals are: gamma-adenosine triphosphate (ATP) = 2.44 +/- 0.21 (mean +/- sd) mmol/l of wet tissue volume, alpha-ATP = 3.2 +/- 0.63 mmol/l, beta-ATP = 2.98 +/- 0.45 mmol/l, inorganic phosphates (Pi) = 1.87 +/- 0.25 mmol/l, phosphodiesters (PDE) = 10.62 +/- 2.20 mmol/l and phosphomonoesters (PME) = 2.12 +/- 0.51 mmol/l. All are in good agreement with literature values. Conclusions The technique offers robust and fast means to localize signal from liver tissue, allows absolute metabolite concentration determination, and avoids problems associated with constant field gradient (linear field variation) localization methods.	[Bashir, Adil; Gropler, Robert; Ackerman, Joseph] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO 63130 USA; [Ackerman, Joseph] Washington Univ, Dept Chem, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL)	Ackerman, J (corresponding author), Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO 63130 USA.	bashir.adil@gmail.com			National Institutes of Health, National Institute of Biomedical Imaging and Bioengineering [K01 EB010171]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [K01EB010171] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was funded by grant # K01 EB010171, National Institutes of Health, National Institute of Biomedical Imaging and Bioengineering (http://www.nibib.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmalek MF, 2012, HEPATOLOGY, V56, P952, DOI 10.1002/hep.25741; Boer VO, 2015, MAGN RESON MED, V73, P2062, DOI 10.1002/mrm.25331; BROWN TR, 1982, P NATL ACAD SCI-BIOL, V79, P3523, DOI 10.1073/pnas.79.11.3523; BUCHLI R, 1994, MAGN RESON MED, V32, P453, DOI 10.1002/mrm.1910320405; BUESS ML, 1991, J MAGN RESON, V92, P348, DOI 10.1016/0022-2364(91)90276-Y; Chen W, 1990, NMR Biomed, V3, P147, DOI 10.1002/nbm.1940030402; Chen W, 1990, NMR Biomed, V3, P158, DOI 10.1002/nbm.1940030403; Chmelik M, 2008, MAGN RESON MED, V60, P796, DOI 10.1002/mrm.21762; Corbin IR, 2004, AM J PHYSIOL-GASTR L, V287, pG379, DOI 10.1152/ajpgi.00418.2003; CROWLEY MG, 1985, J MAGN RESON, V65, P522, DOI 10.1016/0022-2364(85)90140-4; DEBISSCHOP E, 1992, NMR BIOMED, V5, P341, DOI 10.1002/nbm.1940050604; Dezortova M, 2005, WORLD J GASTROENTERO, V11, P6926, DOI 10.3748/wjg.v11.i44.6926; Hashemi R. H., 2004, MRI BASICS, P141; Jalan R, 1996, GUT, V39, P141, DOI 10.1136/gut.39.1.141; JEHENSON P, 1991, J MAGN RESON, V94, P59, DOI 10.1016/0022-2364(91)90294-4; Laufs A, 2014, MAGN RESON MED, V71, P1670, DOI 10.1002/mrm.24835; Li CW, 1996, NMR BIOMED, V9, P141, DOI 10.1002/(SICI)1099-1492(199606)9:4<141::AID-NBM403>3.0.CO;2-P; Lim AKP, 2003, HEPATOLOGY, V37, P788, DOI 10.1053/jhep.2003.50149; MENON DK, 1995, GASTROENTEROLOGY, V108, P776, DOI 10.1016/0016-5085(95)90451-4; Meyerhoff D J, 1990, NMR Biomed, V3, P17, DOI 10.1002/nbm.1940030103; Naressi A, 2001, MAGN RESON MATER PHY, V12, P141, DOI 10.1016/S1352-8661(01)00111-9; Noren B, 2005, EUR RADIOL, V15, P148, DOI 10.1007/s00330-004-2434-x; OBERHAENSLI R, 1990, GUT, V31, P463, DOI 10.1136/gut.31.4.463; ORDIDGE RJ, 1986, J MAGN RESON, V66, P283, DOI 10.1016/0022-2364(86)90031-4; Schaller B, 2015, SUPRESSION SKELETAL, DOI [10.1002/mrm.25755, DOI 10.1002/MRM.25755]; Schmid AI, 2008, NMR BIOMED, V21, P437, DOI 10.1002/nbm.1207; Schmid AI, 2011, DIABETES CARE, V34, P448, DOI 10.2337/dc10-1076; Sevastianova K, 2010, RADIOLOGY, V256, P466, DOI 10.1148/radiol.10091351; Sijens PE, 1998, MAGN RESON IMAGING, V16, P205, DOI 10.1016/S0730-725X(97)00246-4; Szendroedi J, 2009, HEPATOLOGY, V50, P1079, DOI 10.1002/hep.23093; TaylorRobinson SD, 1997, LIVER, V17, P198; Tosner Z, 2001, MAGN RESON MATER PHY, V13, P40, DOI 10.1007/BF02668649; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; Wiesler DG, 1998, JMRI-J MAGN RESON IM, V8, P981, DOI 10.1002/jmri.1880080429; YAMANE Y, 1994, DIGEST DIS SCI, V39, P33, DOI 10.1007/BF02090057	35	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143239	10.1371/journal.pone.0143239	http://dx.doi.org/10.1371/journal.pone.0143239			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633549	Green Published, gold, Green Submitted			2022-12-27	WOS:000366040000010
J	Cluny, NL; Keenan, CM; Reimer, RA; Le Foll, B; Sharkey, KA				Cluny, Nina L.; Keenan, Catherine M.; Reimer, Raylene A.; Le Foll, Bernard; Sharkey, Keith A.			Prevention of Diet-Induced Obesity Effects on Body Weight and Gut Microbiota in Mice Treated Chronically with Delta(9)-Tetrahydrocannabinol	PLOS ONE			English	Article							RECEPTOR ANTAGONIST; GASTROINTESTINAL TRANSIT; AKKERMANSIA-MUCINIPHILA; ENDOCANNABINOID SYSTEM; FOOD-INTAKE; MOTILITY; OLIGOFRUCTOSE; CANNABIS; AGONISTS; NAUSEA	Objective Acute administration of cannabinoid CB1 receptor agonists, or the ingestion of cannabis, induces short-term hyperphagia. However, the incidence of obesity is lower in frequent cannabis users compared to non-users. Gut microbiota affects host metabolism and altered microbial profiles are observed in obese states. Gut microbiota modifies adipogenesis through actions on the endocannabinoid system. This study investigated the effect of chronic THC administration on body weight and gut microbiota in diet-induced obese (DIO) and lean mice. Methods Adult male DIO and lean mice were treated daily with vehicle or THC (2mg/kg for 3 weeks and 4 mg/kg for 1 additional week). Body weight, fat mass, energy intake, locomotor activity, whole gut transit and gut microbiota were measured longitudinally. Results THC reduced weight gain, fat mass gain and energy intake in DIO but not lean mice. DIO-induced changes in select gut microbiota were prevented in mice chronically administered THC. THC had no effect on locomotor activity or whole gut transit in either lean or DIO mice. Conclusions Chronic THC treatment reduced energy intake and prevented high fat diet-induced increases in body weight and adiposity; effects that were unlikely to be a result of sedation or altered gastrointestinal transit. Changes in gut microbiota potentially contribute to chronic THC-induced actions on body weight in obesity.	[Cluny, Nina L.; Keenan, Catherine M.; Sharkey, Keith A.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Cluny, Nina L.; Keenan, Catherine M.; Sharkey, Keith A.] Univ Calgary, Snyder Inst Chron Dis, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Reimer, Raylene A.] Univ Calgary, Fac Kinesiol, Calgary, AB, Canada; [Reimer, Raylene A.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Le Foll, Bernard] CAMH, Campbell Family Mental Hlth Res Inst, Translat Addict Res Lab, Toronto, ON, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada	Sharkey, KA (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada.	ksharkey@ucalgary.ca	; Le Foll, Bernard/K-2952-2014	Reimer, Raylene/0000-0001-5088-7947; Sharkey, Keith/0000-0001-9560-1711; Le Foll, Bernard/0000-0002-6406-4973	Canadian Institutes of Health Research [MOP38185]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was funded by a grant from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html), grant number MOP38185. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Barte JCM, 2010, OBES REV, V11, P899, DOI 10.1111/j.1467-789X.2010.00740.x; Bomhof MR, 2014, OBESITY, V22, P763, DOI 10.1002/oby.20632; Chambers AP, 2007, AM J PHYSIOL-REG I, V293, pR2185, DOI 10.1152/ajpregu.00663.2007; Cluny NL, 2010, BRIT J PHARMACOL, V161, P629, DOI 10.1111/j.1476-5381.2010.00908.x; Cluny NL, 2009, NEUROGASTROENT MOTIL, V21, P420, DOI 10.1111/j.1365-2982.2008.01248.x; Colombo G, 1998, LIFE SCI, V63, pPL113, DOI 10.1016/S0024-3205(98)00322-1; Delzenne NM, 2005, BRIT J NUTR, V93, pS157, DOI 10.1079/BJN20041342; Derrien M, 2004, INT J SYST EVOL MICR, V54, P1469, DOI 10.1099/ijs.0.02873-0; Di Marzo V, 2008, BRIT J PHARMACOL, V153, P1272, DOI 10.1038/sj.bjp.0707682; Esfandyari T, 2006, NEUROGASTROENT MOTIL, V18, P831, DOI 10.1111/j.1365-2982.2006.00834.x; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Izzo AA, 1999, N-S ARCH PHARMACOL, V360, P221, DOI 10.1007/s002109900054; Izzo AA, 2001, BRIT J PHARMACOL, V134, P563, DOI 10.1038/sj.bjp.0704293; Izzo AA, 1999, N-S ARCH PHARMACOL, V359, P65, DOI 10.1007/PL00005325; Izzo AA, 2009, BRIT J PHARMACOL, V158, P451, DOI 10.1111/j.1476-5381.2009.00183.x; Jarbe TUC, 2005, BEHAV PHARMACOL, V16, P373; Klein C, 2011, PSYCHOPHARMACOLOGY, V218, P443, DOI 10.1007/s00213-011-2342-0; Krowicki ZK, 2012, J PHYSIOL PHARMACOL, V63, P581; Krowicki ZK, 1999, EUR J PHARMACOL, V371, P187, DOI 10.1016/S0014-2999(99)00165-X; Landi M, 2002, EUR J PHARMACOL, V450, P77, DOI 10.1016/S0014-2999(02)02053-8; Le Foll B, 2013, MED HYPOTHESES, V80, P564, DOI 10.1016/j.mehy.2013.01.019; Le Strat Y, 2011, AM J EPIDEMIOL, V174, P929, DOI 10.1093/aje/kwr200; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; LUTHRA YK, 1975, TOXICOL APPL PHARM, V32, P418, DOI 10.1016/0041-008X(75)90232-X; MANNING FJ, 1971, SCIENCE, V174, P424, DOI 10.1126/science.174.4007.424; Matias I, 2007, TRENDS ENDOCRIN MET, V18, P27, DOI 10.1016/j.tem.2006.11.006; McLaughlin PJ, 2005, PSYCHOPHARMACOLOGY, V180, P286, DOI 10.1007/s00213-005-2171-0; Monory Krisztina, 2007, PLoS Biol, V5, pe269, DOI 10.1371/journal.pbio.0050269; Muccioli GG, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.46; National Toxicology Program, 1996, Natl Toxicol Program Tech Rep Ser, V446, P1; Osei-Hyiaman D, 2005, J CLIN INVEST, V115, P1298, DOI 10.1172/JCI200523057; Parnell JA, 2012, BRIT J NUTR, V107, P601, DOI 10.1017/S0007114511003163; Pertwee RG, 2012, PHILOS T R SOC B, V367, P3353, DOI 10.1098/rstb.2011.0381; Sink KS, 2008, NEUROPSYCHOPHARMACOL, V33, P946, DOI 10.1038/sj.npp.1301476; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Timofeeva E, 2009, J NEUROENDOCRINOL, V21, P982, DOI 10.1111/j.1365-2826.2009.01921.x; Tremaroli V, 2015, CELL METAB, V22, P228, DOI 10.1016/j.cmet.2015.07.009; Trillou CR, 2004, INT J OBESITY, V28, P640, DOI 10.1038/sj.ijo.0802583	40	74	74	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144270	10.1371/journal.pone.0144270	http://dx.doi.org/10.1371/journal.pone.0144270			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633823	gold, Green Published, Green Submitted			2022-12-27	WOS:000366040000075
J	Li, X; Wang, RJ; Xun, XG; Jiao, WQ; Zhang, MR; Wang, SY; Wang, S; Zhang, LL; Huang, XT; Hu, XL; Bao, ZM				Li, Xue; Wang, Ruijia; Xun, Xiaogang; Jiao, Wenqian; Zhang, Mengran; Wang, Shuyue; Wang, Shi; Zhang, Lingling; Huang, Xiaoting; Hu, Xiaoli; Bao, Zhenmin			The Rho GTPase Family Genes in Bivalvia Genomes: Sequence, Evolution and Expression Analysis	PLOS ONE			English	Article							CELL-MIGRATION; NADPH OXIDASE; AXON GUIDANCE; RAC; DUPLICATIONS; EXPANSION; PROTEINS; ORGANIZATION; SUPERFAMILY; DIVERGENCE	Background Rho GTPases are important members of the Ras superfamily, which represents the largest signaling protein family in eukaryotes, and function as key molecular switches in converting and amplifying external signals into cellular responses. Although numerous analyses of Rho family genes have been reported, including their functions and evolution, a systematic analysis of this family has not been performed in Mollusca or in Bivalvia, one of the most important classes of Mollusca. Results In this study, we systematically identified and characterized a total set (Rho, Rac, Mig, Cdc42, Tc10, Rnd, RhoU, RhoBTB and Miro) of thirty Rho GTPase genes in three bivalve species, including nine in the Yesso scallop Patinopecten yessoensis, nine in the Zhikong scallop Chlamys farreri, and twelve in the Pacific oyster Crassostrea gigas. Phylogenetic analysis and interspecies comparison indicated that bivalves might possess the most complete types of Rho genes in invertebrates. A multiple RNA-seq dataset was used to investigate the expression profiles of bivalve Rho genes, revealing that the examined scallops share more similar Rho expression patterns than the oyster, whereas more Rho mRNAs are expressed in C. farreri and C. gigas than in P. yessoensis. Additionally, Rho, Rac and Cdc42 were found to be duplicated in the oyster but not in the scallops. Among the expanded Rho genes of C. gigas, duplication pairs with high synonymous substitution rates (Ks) displayed greater differences in expression. Conclusion A comprehensive analysis of bivalve Rho GTPase family genes was performed in scallop and oyster species, and Rho genes in bivalves exhibit greater conservation than those in any other invertebrate. This is the first study focusing on a genome-wide characterization of Rho GTPase genes in bivalves, and the findings will provide a valuable resource for a better understanding of Rho evolution and Rho GTPase function in Bivalvia.	[Li, Xue; Wang, Ruijia; Xun, Xiaogang; Jiao, Wenqian; Zhang, Mengran; Wang, Shuyue; Wang, Shi; Zhang, Lingling; Huang, Xiaoting; Hu, Xiaoli; Bao, Zhenmin] Ocean Univ China, Coll Marine Life Sci, Key Lab Marine Genet & Breeding, Minist Educ, Qingdao 266003, Peoples R China	Ocean University of China	Wang, RJ (corresponding author), Ocean Univ China, Coll Marine Life Sci, Key Lab Marine Genet & Breeding, Minist Educ, Qingdao 266003, Peoples R China.	rjwang@ouc.edu.cn; hxl707@ouc.edu.cn	zhang, lingling/HDM-2189-2022	Wang, Ruijia/0000-0002-4211-5207; Li, Xue/0000-0002-7501-4445	National High-Tech R&D Program (863 Program) [2012AA10A405]; Doctoral Fund of Ministry of Education of China [20120132130002]	National High-Tech R&D Program (863 Program); Doctoral Fund of Ministry of Education of China(Ministry of Education, China)	This project was supported by the National High-Tech R&D Program (863 Program, 2012AA10A405, www.863.gov.cn) and Doctoral Fund of Ministry of Education of China (20120132130002, http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/A010301index_1.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was supported by the National High-Tech R&D Program (863 Program, 2012AA10A405) and Doctoral Fund of Ministry of Education of China (20120132130002).	Abascal F, 2015, GENOME BIOL EVOL; Aguirre-Armenta B, 2011, DEV GROWTH DIFFER, V53, P704, DOI 10.1111/j.1440-169X.2011.01280.x; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Aspenstrom P, 2004, BIOCHEM J, V377, P327, DOI 10.1042/BJ20031041; Aspenstrom P, 2007, EXP CELL RES, V313, P3673, DOI 10.1016/j.yexcr.2007.07.022; Babic M, 2015, J NEUROSCI, V35, P5754, DOI 10.1523/JNEUROSCI.1035-14.2015; Bieler R, 2006, ZOOL J LINN SOC-LOND, V148, P223, DOI 10.1111/j.1096-3642.2006.00255.x; Boureux A, 2007, MOL BIOL EVOL, V24, P203, DOI 10.1093/molbev/msl145; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Bradnam KR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003093; Brockman W, 2008, GENOME RES, V18, P763, DOI 10.1101/gr.070227.107; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Fransson A, 2003, J BIOL CHEM, V278, P6495, DOI 10.1074/jbc.M208609200; Freeman JL, 1996, J BIOL CHEM, V271, P19794, DOI 10.1074/jbc.271.33.19794; Gerdol M, 2015, DEV COMP IMMUNOL, V49, P59, DOI 10.1016/j.dci.2014.11.007; Guo X, 2015, FISH SHELLFISH IMMUN; Hakeda-Suzuki S, 2002, NATURE, V416, P438, DOI 10.1038/416438a; Herpin A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000844; Huminiecki L, 2004, GENOME RES, V14, P1870, DOI 10.1101/gr.2705204; Kawano Y, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00522; Kocot KM, 2011, NATURE, V477, P452, DOI 10.1038/nature10382; Koonin EV, 2010, NAT REV GENET, V11, P487, DOI 10.1038/nrg2810; Lacoste A, 2002, J CELL SCI, V115, P761; Lei L, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-51; Li WH, 2005, TRENDS GENET, V21, P602, DOI 10.1016/j.tig.2005.08.006; Lu JG, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-246; Lundquist EA, 2001, DEVELOPMENT, V128, P4475; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch VJ, 2011, NAT GENET, V43, P1154, DOI 10.1038/ng.917; Mackay DJG, 1998, J BIOL CHEM, V273, P20685, DOI 10.1074/jbc.273.33.20685; MADAULE P, 1985, CELL, V41, P31, DOI 10.1016/0092-8674(85)90058-3; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Rojas AM, 2012, J CELL BIOL, V196, P189, DOI 10.1083/jcb.201103008; Paduch M, 2001, ACTA BIOCHIM POL, V48, P829; Panopoulou G, 2005, TRENDS GENET, V21, P559, DOI 10.1016/j.tig.2005.08.004; Peng T, 2015, AQUAT TOXICOL, V163, P89, DOI 10.1016/j.aquatox.2015.03.023; Ponder WF, 2008, PHYLOGENY EVOLUTION; Pruitt K, 2001, CANCER LETT, V171, P1, DOI 10.1016/S0304-3835(01)00528-6; Ramos S, 2002, GENE, V298, P147, DOI 10.1016/S0378-1119(02)00980-0; Reis K, 2009, FEBS LETT, V583, P1391, DOI 10.1016/j.febslet.2009.04.015; Ridley AJ, 2001, J CELL SCI, V114, P2713; Schwartz M, 2004, J CELL SCI, V117, P5457, DOI 10.1242/jcs.01582; SHARP PA, 1981, CELL, V23, P643, DOI 10.1016/0092-8674(81)90425-6; Swope D, 2014, DEV BIOL, V392, P221, DOI 10.1016/j.ydbio.2014.05.024; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Talakhun W, 2014, COMP BIOCHEM PHYS D, V11, P9, DOI 10.1016/j.cbd.2014.05.002; Thibaud-Nissen F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-317; Todd AE, 2001, J MOL BIOL, V307, P1113, DOI 10.1006/jmbi.2001.4513; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; VALENCIA A, 1991, BIOCHEMISTRY-US, V30, P4637, DOI 10.1021/bi00233a001; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Wherlock M, 2002, J CELL SCI, V115, P239; Yamauchi A, 2005, J BIOL CHEM, V280, P953, DOI 10.1074/jbc.M408820200; Yang TJ, 2006, PLANT CELL, V18, P1339, DOI 10.1105/tpc.105.040535; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2; Zipkin ID, 1997, CELL, V90, P883, DOI 10.1016/S0092-8674(00)80353-0	59	8	10	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143932	10.1371/journal.pone.0143932	http://dx.doi.org/10.1371/journal.pone.0143932			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633655	gold, Green Submitted, Green Published			2022-12-27	WOS:000366040000032
J	Patil, KS; Basak, I; Pal, R; Ho, HP; Alves, G; Chang, EJ; Larsen, JP; Moller, SG				Patil, Ketan S.; Basak, Indranil; Pal, Ramavati; Ho, Hsin-Pin; Alves, Guido; Chang, Emmanuel J.; Larsen, Jan Petter; Moller, Simon Geir			A Proteomics Approach to Investigate miR-153-3p and miR-205-5p Targets in Neuroblastoma Cells	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; EARLY-ONSET PARKINSONISM; OXIDATIVE STRESS; DOWN-REGULATION; GLUCOCORTICOID-RECEPTOR; ALZHEIMERS-DISEASE; DIPHOSPHATE KINASE; STRUCTURAL BASIS; ALPHA-ENOLASE; EXPRESSION	MicroRNAs are key regulators associated with numerous diseases. In HEK293 cells, miR-153-3p and miR-205-5p down-regulate alpha-synuclein (SNCA) and Leucine-rich repeat kinase 2 (LRRK2), two key proteins involved in Parkinson's disease (PD). We have used two-dimensional gel electrophoresis (2D-PAGE) coupled to mass spectrometry (MS) to identify a spectrum of miR-153-3p and miR-205-5p targets in neuronal SH-SY5Y cells. We overexpressed and inhibited both microRNAs in SH-SY5Y cells and through comparative proteomics profiling we quantified similar to 240 protein spots from each analysis. Combined, thirty-three protein spots were identified showing significant (p-value < 0.05) changes in abundance. Modulation of miR-153-3p resulted in seven up-regulated proteins and eight down-regulated proteins. miR-205 modulation resulted in twelve up-regulated proteins and six down-regulated proteins. Several of the proteins are associated with neuronal processes, including peroxiredoxin-2 and -4, cofilin-1, prefoldin 2, alpha-enolase, human nucleoside diphosphate kinase B (Nm23) and 14-3-3 protein epsilon. Many of the differentially expressed proteins are involved in diverse pathways including metabolism, neurotrophin signaling, actin cytoskeletal regulation, HIF-1 signaling and the proteasome indicating that miR-153-3p and miR-205-5p are involved in the regulation of a wide variety of biological processes in neuroblastoma cells.	[Patil, Ketan S.; Basak, Indranil; Pal, Ramavati; Moller, Simon Geir] St Johns Univ, Dept Biol Sci, Jamaica, NY 11439 USA; [Ho, Hsin-Pin; Chang, Emmanuel J.] CUNY York Coll, Dept Chem, New York, NY 11451 USA; [Ho, Hsin-Pin; Chang, Emmanuel J.] CUNY, Grad Ctr, New York, NY 11451 USA; [Alves, Guido; Larsen, Jan Petter; Moller, Simon Geir] Stavanger Univ Hosp, Norwegian Ctr Movement Disorders, N-4068 Stavanger, Norway	Saint John's University; City University of New York (CUNY) System; City University of New York (CUNY) System; Stavanger University Hospital	Moller, SG (corresponding author), St Johns Univ, Dept Biol Sci, Jamaica, NY 11439 USA.	mollers@stjohns.edu	Alves, Guido/AAB-4015-2020; Basak, Indranil/P-9279-2016; Basak, Indranil/AAH-2593-2020	Basak, Indranil/0000-0001-5009-2845; Moller, Simon/0000-0002-0460-3592; Alves, Guido/0000-0003-0630-2870	Norwegian Research Council; Western Norway Health Authority; Norwegian Center for Movement Disorders	Norwegian Research Council(Research Council of NorwayEuropean Commission); Western Norway Health Authority; Norwegian Center for Movement Disorders	This work was funded by grants from The Norwegian Research Council, The Western Norway Health Authority and The Norwegian Center for Movement Disorders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by grants from The Norwegian Research Council, The Western Norway Health Authority and The Norwegian Center for Movement Disorders. We thank Dr. Katja Becker, Dr. Christina Fernandez-Valle and Dr. Suzanne Hradetkzy for antibodies. The authors declare that they have no competing interests.	Abdullah R, 2015, EXP GERONTOL, V68, P33, DOI 10.1016/j.exger.2014.09.014; Ardekani Ali M., 2010, Avicenna Journal of Medical Biotechnology, V2, P161; Basak I, 2014, J BIOL CHEM, V289, P14458, DOI 10.1074/jbc.M114.548156; Basso M, 2004, PROTEOMICS, V4, P3943, DOI 10.1002/pmic.200400848; Berg D, 2003, NAT REV NEUROSCI, V4, P752, DOI 10.1038/nrn1197; Bergamaschi A, 2012, ONCOGENE, V31, P39, DOI 10.1038/onc.2011.223; Bonifati V, 2003, NEUROL SCI, V24, P159, DOI 10.1007/s10072-003-0108-0; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Bushati N, 2008, CURR OPIN NEUROBIOL, V18, P292, DOI 10.1016/j.conb.2008.07.001; Calogero S, 1999, NAT GENET, V22, P276, DOI 10.1038/10338; Campanella ME, 2005, P NATL ACAD SCI USA, V102, P2402, DOI 10.1073/pnas.0409741102; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Cervoni N, 2002, J BIOL CHEM, V277, P25026, DOI 10.1074/jbc.M202256200; Cho HJ, 2013, HUM MOL GENET, V22, P608, DOI 10.1093/hmg/dds470; Choudhuri T, 2010, CANCER BIOL THER, V9, P1065, DOI 10.4161/cbt.9.12.11995; Doxakis E, 2010, J BIOL CHEM, V285, P12726, DOI 10.1074/jbc.M109.086827; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Gehrke S, 2010, NATURE, V466, P637, DOI 10.1038/nature09191; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hashimoto Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062589; He JL, 2004, J BIOL CHEM, V279, P4705, DOI 10.1074/jbc.M311183200; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; Hu XM, 2011, J NEUROSCI, V31, P247, DOI 10.1523/JNEUROSCI.4589-10.2011; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Kato M, 2008, STRUCTURE, V16, P1849, DOI 10.1016/j.str.2008.10.010; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kim TH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042818; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Klune JR, 2008, MOL MED, V14, P476, DOI 10.2119/2008-00034.Klune; KOHTZ JD, 1994, NATURE, V368, P119, DOI 10.1038/368119a0; Kwon JH, 2012, J IMMUNOL, V188, P5665, DOI 10.4049/jimmunol.1102306; Maloney MT, 2007, MOL NEUROBIOL, V35, P21, DOI 10.1007/BF02700622; Mandemakers W, 2013, DIABETOLOGIA, V56, P1547, DOI 10.1007/s00125-013-2901-5; Minones-Moyano E, 2011, HUM MOL GENET, V20, P3067, DOI 10.1093/hmg/ddr210; Moller I, 1998, FEBS LETT, V441, P1, DOI 10.1016/S0014-5793(98)01440-9; Moon JC, 2005, J BIOL CHEM, V280, P28775, DOI 10.1074/jbc.M505362200; Obermajer N, 2009, INT J BIOCHEM CELL B, V41, P1685, DOI 10.1016/j.biocel.2009.02.019; Patil KS, 2014, J NEUROSCI RES, V92, P1167, DOI 10.1002/jnr.23396; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; POSTEL EH, 1993, SCIENCE, V261, P478, DOI 10.1126/science.8392752; Postel EH, 2000, J BIOENERG BIOMEMBR, V32, P277, DOI 10.1023/A:1005541114029; Quelo I, 2004, J BIOL CHEM, V279, P43893, DOI 10.1074/jbc.M406310200; Rege Shraddha D, 2013, ISRN Neurol, V2013, P375852, DOI 10.1155/2013/375852; Ruegg J, 2004, MOL CELL BIOL, V24, P9371, DOI 10.1128/MCB.24.21.9371-9382.2004; Silverstein AM, 1997, J BIOL CHEM, V272, P16224, DOI 10.1074/jbc.272.26.16224; Skaper SD, 2011, CNS NEUROL DISORD-DR, V10, P44; Song Y, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-65; Subramanian A, 2000, J BIOL CHEM, V275, P5958, DOI 10.1074/jbc.275.8.5958; Vainberg IE, 1998, CELL, V93, P863, DOI 10.1016/S0092-8674(00)81446-4; Valente EM, 2004, ANN NEUROL, V56, P336, DOI 10.1002/ana.20256; von Blume J, 2009, J CELL BIOL, V187, P1055, DOI 10.1083/jcb.200908040; Vural B, 2011, J NEUROIMMUNOL, V239, P91, DOI 10.1016/j.jneuroim.2011.08.008; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103; Yotov WV, 1998, MOL CELL BIOL, V18, P1303, DOI 10.1128/MCB.18.3.1303; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	57	34	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143969	10.1371/journal.pone.0143969	http://dx.doi.org/10.1371/journal.pone.0143969			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633009	Green Published, gold			2022-12-27	WOS:000366040000036
J	Vainik, U; Dube, L; Lu, J; Fellows, LK				Vainik, Uku; Dube, Laurette; Lu, Ji; Fellows, Lesley K.			Personality and Situation Predictors of Consistent Eating Patterns	PLOS ONE			English	Article							WITHIN-SUBJECT VARIATION; FOOD-INTAKE; NUTRIENT INTAKE; EXTERNAL CUES; OBESITY; ENERGY; BEHAVIOR; SELF; VARIABILITY; WEIGHT	Introduction A consistent eating style might be beneficial to avoid overeating in a food-rich environment. Eating consistency entails maintaining a similar dietary pattern across different eating situations. This construct is relatively under-studied, but the available evidence suggests that eating consistency supports successful weight maintenance and decreases risk for metabolic syndrome and cardiovascular disease. Yet, personality and situation predictors of consistency have not been studied. Methods A community-based sample of 164 women completed various personality tests, and 139 of them also reported their eating behaviour 6 times/day over 10 observational days. We focused on observations with meals (breakfast, lunch, or dinner). The participants indicated if their momentary eating patterns were consistent with their own baseline eating patterns in terms of healthiness or size of the meal. Further, participants described various characteristics of each eating situation. Results Eating consistency was positively predicted by trait self-control. Eating consistency was undermined by eating in the evening, eating with others, eating away from home, having consumed alcohol and having undertaken physical exercise. Interactions emerged between personality traits and situations, including punishment sensitivity, restraint, physical activity and alcohol consumption. Conclusion Trait self-control and several eating situation variables were related to eating consistency. These findings provide a starting point for targeting interventions to improve consistency, suggesting that a focus on self-control skills, together with addressing contextual factors such as social situations and time of day, may be most promising. This work is a first step to provide people with the tools they need to maintain a consistently healthy lifestyle in a food-rich environment.	[Vainik, Uku; Fellows, Lesley K.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; [Vainik, Uku] Univ Tartu, Inst Psychol, EE-50090 Tartu, Estonia; [Dube, Laurette] McGill Univ, Desautels Fac Management, Montreal, PQ, Canada; [Lu, Ji] Dalhousie Univ, Fac Agr, Truro, NS, Canada	McGill University; University of Tartu; McGill University; Dalhousie University	Vainik, U (corresponding author), McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada.	uku.vainik@gmail.com	Vainik, Uku/H-8888-2019; Fellows, Lesley K/B-1778-2018; Lu, Ji/AAR-2726-2021	Vainik, Uku/0000-0002-9375-9520; Fellows, Lesley/0000-0002-9144-092X; Lu, Ji/0000-0003-1048-235X	Social Sciences and Humanities Research Council [410-2003-1362, 410-2010-2258, 435-2014-1964]; Fond de Recherche du Quebec - Societe et Culture Team Grant [2015-SE-179342]; National Institutes for Health [U01 HD061973-03]; Estonian Ministry of Education and Science [IUT2-13]; Canadian Institutes of Health Research [MOP 97821]; Fonds de Recherche en Sante du Quebec Chercheur-Boursier; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD061973] Funding Source: NIH RePORTER	Social Sciences and Humanities Research Council(Social Sciences and Humanities Research Council of Canada (SSHRC)); Fond de Recherche du Quebec - Societe et Culture Team Grant; National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Estonian Ministry of Education and Science(Ministry of Education and Research, Estonia); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche en Sante du Quebec Chercheur-Boursier(Fonds de la Recherche en Sante du Quebec); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Laurette Dube has been supported by Social Sciences and Humanities Research Council Grant dossier no. 410-2003-1362, 410-2010-2258 and 435-2014-1964, as well as Fond de Recherche du Quebec - Societe et Culture Team Grant #: 2015-SE-179342. Laurette Dube and Uku Vainik have been supported by National Institutes for Health grant no. U01 HD061973-03. Uku Vainik has also been supported by an institutional research funding (IUT2-13) from the Estonian Ministry of Education and Science. Lesley K Fellows has been supported by Canadian Institutes of Health Research grant no. MOP 97821, and a Fonds de Recherche en Sante du Quebec Chercheur-Boursier salary award.	ACHESON KJ, 1980, AM J CLIN NUTR, V33, P1147, DOI 10.1093/ajcn/33.5.1147; Akbaraly TN, 2011, AM J CLIN NUTR, V94, P247, DOI 10.3945/ajcn.111.013128; [Anonymous], SJPLOT DATA VISUALIZ; Auguie B, 2012, GRIDEXTRA FUNCTIONS; Bandura A, 1996, PSYCHOL INQ, V7, P20, DOI 10.1207/s15327965pli0701_3; Barr L., 2005, REV EVALUATION EMERG; Bates D.M., 2010, LME4 MIXED EFFECTS M; Baumeister RF, 1996, PSYCHOL INQ, V7, P1, DOI 10.1207/s15327965pli0701_1; Baumeister RF, 2007, CURR DIR PSYCHOL SCI, V16, P351, DOI 10.1111/j.1467-8721.2007.00534.x; BEATON GH, 1979, AM J CLIN NUTR, V32, P2546, DOI 10.1093/ajcn/32.12.2546; Beeken RJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-667; BEM DJ, 1974, PSYCHOL REV, V81, P506, DOI 10.1037/h0037130; BLOCK J, 1961, J CONSULT PSYCHOL, V25, P392, DOI 10.1037/h0042979; Blundell JE, 2011, NUTR BULL, V36, P356, DOI 10.1111/j.1467-3010.2011.01911.x; Bogg T, 2004, PSYCHOL BULL, V130, P887, DOI 10.1037/0033-2909.130.6.887; Carriquiry AL, 2003, J NUTR, V133, p601S, DOI 10.1093/jn/133.2.601S; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; CELLIER KM, 1963, AM J CLIN NUTR, V13, P55, DOI 10.1093/ajcn/13.1.55; Chandon P, 2007, J MARKETING RES, V44, P84, DOI 10.1509/jmkr.44.1.84; Chandon P, 2010, FOUND TRENDS MARKET, V5, P113, DOI 10.1561/1700000016; Christensen T. C., 2003, J HAPPINESS STUD, V4, P53, DOI [10.1023/A:1023609306024, DOI 10.1023/A:1023609306024]; Chun OK., 2012, J NUTR DISORD THER; Cohen Deborah, 2008, Prev Chronic Dis, V5, pA23; Conner T., 2013, EXPERIENCE SAMPLING; Costa PT, 2007, REVISED NEO PERSONAL; DaCoTA, 2012, TRAFF SAF BAS FACTS; de Castro JM, 2000, NUTRITION, V16, P800, DOI 10.1016/S0899-9007(00)00414-7; de Castro JM, 2012, APPETITE, V59, P204, DOI 10.1016/j.appet.2012.04.020; DONAHUE EM, 1993, J PERS SOC PSYCHOL, V64, P834, DOI 10.1037/0022-3514.64.5.834; Drewnowski A, 2009, NUTR REV, V67, pS36, DOI 10.1111/j.1753-4887.2009.00157.x; Dube L, 2005, PHYSIOL BEHAV, V86, P559, DOI 10.1016/j.physbeh.2005.08.023; EDHOLM OG, 1970, BRIT J NUTR, V24, P1091, DOI 10.1079/BJN19700112; Eidehall A, 2012, Method and system for collision avoidance, Patent No. [US 8112225 B2, 8112225]; Eidehall A, 2007, IEEE T INTELL TRANSP, V8, P84, DOI 10.1109/TITS.2006.888606; Eknoyan G, 2008, NEPHROL DIAL TRANSPL, V23, P47, DOI 10.1093/ndt/gfm517; Elder SJ, 2007, NUTR REV, V65, P1, DOI 10.1111/j.1753-4887.2007.tb00263.x; Ello-Martin JA, 2005, AM J CLIN NUTR, V82, p236S, DOI 10.1093/ajcn/82.1.236S; Fox John, 2003, J STAT SOFTW, V8, P1, DOI [10.18637/jss.v008.i15, DOI 10.18637/JSS.V008.I15]; Gelman A., 2014, ARM DATA ANAL USING; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Genne-Bacon Elizabeth A., 2014, Yale Journal of Biology and Medicine, V87, P99; Gerlach G, 2015, OBES REV, V16, P32, DOI 10.1111/obr.12235; Gorin AA, 2004, INT J OBESITY, V28, P278, DOI 10.1038/sj.ijo.0802550; Government of Canada SC, 2003, CAN COMM HLTH SURV C; Grano N, 2004, PERS INDIV DIFFER, V37, P1693, DOI 10.1016/j.paid.2004.03.004; Gray J. A, 1987, COGNITIVE NEUROCHEMI, P171; Guenther PM, 2013, J ACAD NUTR DIET, V113, P569, DOI 10.1016/j.jand.2012.12.016; Guerrieri R., 2008, PSIHOLOGIJSKE TEME, V17, P265; Hall KD, 2011, LANCET, V378, P826, DOI 10.1016/S0140-6736(11)60812-X; HANKIN JH, 1967, AM J CLIN NUTR, V20, P935, DOI 10.1093/ajcn/20.9.935; Herman CP, 2008, PHYSIOL BEHAV, V94, P722, DOI 10.1016/j.physbeh.2008.04.014; Hofmann W, 2012, J PERS SOC PSYCHOL, V102, P1318, DOI 10.1037/a0026545; HUNT WC, 1983, NUTR RES, V3, P433, DOI 10.1016/S0271-5317(83)80005-0; HUNTER DJ, 1988, AM J EPIDEMIOL, V127, P1240, DOI 10.1093/oxfordjournals.aje.a114916; Jackson JJ, 2009, J PERS SOC PSYCHOL, V96, P446, DOI 10.1037/a0014156; John O. P., 2008, HDB PERSONALITY THEO, P114, DOI DOI 10.1016/S0191-8869(97)81000-8; Johnson F, 2012, INT J OBESITY, V36, P665, DOI 10.1038/ijo.2011.156; Johnson F, 2014, ADV NUTR, V5, P851, DOI 10.3945/an.114.007120; Jokela M, 2012, OBES REV; Jokela M, 2013, AM J EPIDEMIOL, V178, P667, DOI 10.1093/aje/kwt170; Jones NRV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109343; Judge TA, 2002, J PERS SOC PSYCHOL, V83, P693, DOI 10.1037//0022-3514.83.3.693; Khare A, 2006, J CONSUM RES, V32, P567, DOI 10.1086/500487; Kouchaki M, 2014, PSYCHOL SCI, V25, P95, DOI 10.1177/0956797613498099; Lakdawalla D., 2002, NBER WORKING PAPERS, V8946; Leikas S, 2012, J PERS SOC PSYCHOL, V103, P1007, DOI 10.1037/a0030385; Levitsky DA, 2005, PHYSIOL BEHAV, V86, P623, DOI 10.1016/j.physbeh.2005.08.053; Lewin K., 1936, PRINCIPLES TOPOLOGIC, DOI [https://doi.org/10.1037/10019-000, DOI 10.1037/10019-000]; Liu C., 2009, FACTORS RELATED FATA; Lu J, 2011, AM J CLIN NUTR, V94, P254, DOI 10.3945/ajcn.110.006361; Lunn TE, 2014, NUTRITION, V30, P403, DOI 10.1016/j.nut.2013.08.012; Macht M, 2008, APPETITE, V50, P1, DOI 10.1016/j.appet.2007.07.002; MacKenzie A., 2014, GIZMAG          0725; Martins C, 2008, INT J OBESITY, V32, P1337, DOI 10.1038/ijo.2008.98; MAYER J, 1956, AM J CLIN NUTR, V4, P169, DOI 10.1093/ajcn/4.2.169; Mela DJ, 2001, OBES RES, V9, p249S, DOI 10.1038/oby.2001.127; NEEL JV, 1962, AM J HUM GENET, V14, P353; NELSON M, 1989, AM J CLIN NUTR, V50, P155, DOI 10.1093/ajcn/50.1.155; NEUHAUS JM, 1991, EPIDEMIOLOGY, V2, P447, DOI 10.1097/00001648-199111000-00011; NHTSA, 2012, FARS ENCY STAT CRASH; Ozer DJ, 2006, ANNU REV PSYCHOL, V57, P401, DOI 10.1146/annurev.psych.57.102904.190127; Pachucki MA, 2012, INT J OBESITY, V36, P686, DOI 10.1038/ijo.2011.133; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; POLIVY J, 1978, J ABNORM PSYCHOL, V87, P497, DOI 10.1037/0021-843X.87.5.497; POLIVY J, 1976, ADDICT BEHAV, V1, P121, DOI 10.1016/0306-4603(76)90004-6; POLIVY J, 1976, J ABNORM PSYCHOL, V85, P601, DOI 10.1037/0021-843X.85.6.601; Prentice AM, 2008, INT J OBESITY, V32, P1607, DOI 10.1038/ijo.2008.147; Price M, SELF REPORT IN PRESS; Quetelet L.A.J, 1842, HIST PSYCHOL SERIESA, DOI DOI 10.1037/11993-000; R Core Team, 2021, R LANGUAGE ENV STAT; Rao M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-004277; Rauthmann JF, 2014, J PERS SOC PSYCHOL, V107, P677, DOI 10.1037/a0037250; Revelle W., 2014, PSYCH PROCEDURES PSY; Roberts BW, 2007, PERSPECT PSYCHOL SCI, V2, P313, DOI 10.1111/j.1745-6916.2007.00047.x; Robinson E, 2014, J ACAD NUTR DIET, V114, P414, DOI 10.1016/j.jand.2013.11.009; ROLLS BJ, 1986, NUTR REV, V44, P93, DOI 10.1111/j.1753-4887.1986.tb07593.x; Rudis B, 2015, INTRO STREAMGRAPH HT; SCHACHTER S, 1968, SCIENCE, V161, P751, DOI 10.1126/science.161.3843.751; Seacat JD, 2016, J HEALTH PSYCHOL, V21, P228, DOI 10.1177/1359105314525067; SEMPOS CT, 1985, AM J EPIDEMIOL, V121, P120, DOI 10.1093/oxfordjournals.aje.a113974; Sherman RA, 2010, J PERS SOC PSYCHOL, V99, P330, DOI 10.1037/a0019796; Sierra-Johnson J, 2008, OBESITY, V16, P1302, DOI 10.1038/oby.2008.203; Story M, 2008, ANNU REV PUBL HEALTH, V29, P253, DOI 10.1146/annurev.publhealth.29.020907.090926; STUFF JE, 1983, AM J CLIN NUTR, V37, P300, DOI 10.1093/ajcn/37.2.300; TARASUK V, 1991, AM J CLIN NUTR, V54, P464, DOI 10.1093/ajcn/54.3.464; TARASUK V, 1992, APPETITE, V18, P43, DOI 10.1016/0195-6663(92)90209-O; Torrubia R, 2001, PERS INDIV DIFFER, V31, P837, DOI 10.1016/S0191-8869(00)00183-5; Tucker LA, 2000, OBES RES, p86S; Vainik U, 2015, EUR J PERSONALITY, V29, P622, DOI 10.1002/per.2009; Vainik U, 2015, APPETITE, V90, P229, DOI 10.1016/j.appet.2015.03.004; Vainik U, 2013, NEUROSCI BIOBEHAV R, V37, P279, DOI 10.1016/j.neubiorev.2012.11.008; van der Laan LN, 2015, CURR OPIN FOOD SCI, V3, P11, DOI 10.1016/j.cofs.2014.11.001; van Strien T, 2002, PERS INDIV DIFFER, V33, P791, DOI 10.1016/S0191-8869(01)00192-1; VANSTRIEN T, 1986, INT J EAT DISORDER, V5, P295, DOI 10.1002/1098-108X(198602)5:2<295::AID-EAT2260050209>3.0.CO;2-T; Victor T., 2005, US Patent, Patent No. [6,974,414, 6974414, 6974414 B2]; Wagerman SA, 2009, CAMBRIDGE HANDBOOK OF PERSONALITY PSYCHOLOGY, P27; Wansink B, 2004, ANNU REV NUTR, V24, P455, DOI 10.1146/annurev.nutr.24.012003.132140; Whiteside SP, 2001, PERS INDIV DIFFER, V30, P669, DOI 10.1016/S0191-8869(00)00064-7; Wickham H, 2011, J STAT SOFTW, V40; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Williamson A, 2005, NSW INJ RISK MANAG R; Wing RR, 2005, AM J CLIN NUTR, V82, p222S, DOI 10.1093/ajcn/82.1.222S	122	15	15	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144134	10.1371/journal.pone.0144134	http://dx.doi.org/10.1371/journal.pone.0144134			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX9QI	26633707	Green Submitted, Green Published, gold			2022-12-27	WOS:000366040000060
J	Kurita, H; Takahashi, S; Asada, A; Matsuo, M; Kishikawa, K; Mizuno, A; Numano, R				Kurita, Hirofumi; Takahashi, Shota; Asada, Atsushi; Matsuo, Minako; Kishikawa, Kenta; Mizuno, Akira; Numano, Rika			Novel Parallelized Electroporation by Electrostatic Manipulation of a Water-in-Oil Droplet as a Microreactor	PLOS ONE			English	Article							AQUEOUS DROPLETS; CELLS; TRANSFECTION; DELIVERY; VOLTAGE	Electroporation is the most widely used transfection method for delivery of cell-impermeable molecules into cells. We developed a novel gene transfection method, water-in-oil (W/O) droplet electroporation, using dielectric oil and an aqueous droplet containing mammalian cells and transgene DNA. When a liquid droplet suspended between a pair of electrodes in dielectric oil is exposed to a DC electric field, the droplet moves between the pair of electrodes periodically and droplet deformation occurs under the intense DC electric field. During electrostatic manipulation of the droplet, the local intense electric field and instantaneous short circuit via the droplet due to droplet deformation facilitate gene transfection. This method has several advantages over conventional transfection techniques, including co-transfection of multiple transgene DNAs into even as few as 103 cells, transfection into differentiated neural cells, and the capable establishment of stable cell lines. In addition, there have been improvements in W/O droplet electroporation electrodes for disposable 96-well plates making them suitable for concurrent performance without thermal loading by a DC electric field. This technique will lead to the development of cell transfection methods for novel regenerative medicine and gene therapy.	[Kurita, Hirofumi; Takahashi, Shota; Asada, Atsushi; Matsuo, Minako; Kishikawa, Kenta; Mizuno, Akira; Numano, Rika] Toyohashi Univ Technol, Dept Environm & Life Sci, Toyohashi, Aichi, Japan; [Numano, Rika] Toyohashi Univ Technol, Elect Inspired Interdisciplinary Res Inst EIIRIS, Toyohashi, Aichi, Japan	Toyohashi University of Technology; Toyohashi University of Technology	Mizuno, A (corresponding author), Toyohashi Univ Technol, Dept Environm & Life Sci, Toyohashi, Aichi, Japan.	mizuno@ens.tut.ac.jp; numano@ens.tut.ac.jp	Kurita, Hirofumi/K-6757-2012	Kurita, Hirofumi/0000-0002-2538-6590	Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Science and Technology Agency (JST); Japan Society for the Promotion of Science (JSPS) [24590350]; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [24108005]; Takeda Science Foundation; Tatematsu Foundation; Grants-in-Aid for Scientific Research [26390096] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Tatematsu Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT)'s Program to Foster Young Researchers Cutting-Edge Interdisciplinary Research and Human Resource Development Program for Science and Technology to R.N., the Japan Science and Technology Agency (JST) (to R.N.), and by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS) (24590350 to R.N.), and by a Grant-in-Aid for Scientific Research in Innovative Areas "Plasma Medical Innovation" (24108005 to A. M.) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, and a Grant-in-Aid for Young Scientists (B) (24760648 to H. K.) and a Grant-in-Aid for Scientific Research (C) (26390096 to H. K) from the Japan Society for the Promotion of Science (JSPS). R.N. was also supported in part by Takeda Science Foundation and The Tatematsu Foundation.	Adamo A, 2013, ANAL CHEM, V85, P1637, DOI 10.1021/ac302887a; Asada A, 2013, IEEE T IND APPL, V49, P311, DOI 10.1109/TIA.2012.2229452; Chang D.C., 1992, GUIDE ELECTROPORATIO; Chen FY, 2011, ANAL CHEM, V83, P8816, DOI 10.1021/ac2022794; Fox MB, 2006, ANAL BIOANAL CHEM, V385, P474, DOI 10.1007/s00216-006-0327-3; Gehl J, 2003, ACTA PHYSIOL SCAND, V177, P437, DOI 10.1046/j.1365-201X.2003.01093.x; Geng T, 2010, J CONTROL RELEASE, V144, P91, DOI 10.1016/j.jconrel.2010.01.030; Gianulis EC, 2015, SCI REP-UK, V5, DOI 10.1038/srep13818; Hamlin BS, 2012, PHYS FLUIDS, V24, DOI 10.1063/1.3674301; Hase M, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.046301; Im DJ, 2012, LANGMUIR, V28, P11656, DOI 10.1021/la3014392; Im DJ, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3665222; Jung YM, 2008, J COLLOID INTERF SCI, V322, P617, DOI 10.1016/j.jcis.2008.04.019; Kawaguchi S, 2007, BIOCHEM BIOPH RES CO, V355, P555, DOI 10.1016/j.bbrc.2007.02.009; Khorshidi B, 2010, J COLLOID INTERF SCI, V352, P211, DOI 10.1016/j.jcis.2010.08.026; Kim SK, 2007, ANAL CHEM, V79, P7761, DOI 10.1021/ac071197h; Knight JS, 2004, J VIROL, V78, P12857, DOI 10.1128/JVI.78.23.12857-12867.2004; Lee DW, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4723633; Lin YC, 2001, J MICROMECH MICROENG, V11, P542, DOI 10.1088/0960-1317/11/5/315; Lu H, 2005, LAB CHIP; Luo CX, 2006, ELECTROPHORESIS, V27, P1977, DOI 10.1002/elps.200500665; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Pakhomov AG, 2015, BBA-BIOMEMBRANES, V1848, P958, DOI 10.1016/j.bbamem.2014.12.026; Pucihar G, 2008, BIOPHYS J, V95, P2837, DOI 10.1529/biophysj.108.135541; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takinoue M, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3358385; Wang QM, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2178; Wang SN, 2013, BIOMICROFLUIDICS, V7, DOI 10.1063/1.4774071; Xiao K, 2010, ELECTROPHORESIS, V31, P3175, DOI 10.1002/elps.201000155; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Zhan YH, 2009, ANAL CHEM, V81, P2027, DOI 10.1021/ac9001172	32	14	14	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144254	10.1371/journal.pone.0144254	http://dx.doi.org/10.1371/journal.pone.0144254			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26649904	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903300041
J	Bernhard, G; Knibbe, RA; von Wolff, A; Dingoyan, D; Schulz, H; Mosko, M				Bernhard, Gerda; Knibbe, Ronald A.; von Wolff, Alessa; Dingoyan, Demet; Schulz, Holger; Moesko, Mike			Development and Psychometric Evaluation of an Instrument to Assess Cross-Cultural Competence of Healthcare Professionals (CCCHP)	PLOS ONE			English	Article							MULTICULTURAL COMPETENCE; COUNSELING INVENTORY; VALIDITY; AWARENESS; REVISION; STRESS; IMPACT; INDEX	Background Cultural competence of healthcare professionals (HCPs) is recognized as a strategy to reduce cultural disparities in healthcare. However, standardised, valid and reliable instruments to assess HCPs' cultural competence are notably lacking. The present study aims to 1) identify the core components of cultural competence from a healthcare perspective, 2) to develop a self-report instrument to assess cultural competence of HCPs and 3) to evaluate the psychometric properties of the new instrument. Methods The conceptual model and initial item pool, which were applied to the cross-cultural competence instrument for the healthcare profession (CCCHP), were derived from an expert survey (n = 23), interviews with HCPs (n = 12), and a broad narrative review on assessment instruments and conceptual models of cultural competence. The item pool was reduced systematically, which resulted in a 59-item instrument. A sample of 336 psychologists, in advanced psychotherapeutic training, and 409 medical students participated, in order to evaluate the construct validity and reliability of the CCCHP. Results Construct validity was supported by principal component analysis, which led to a 32-item six-component solution with 50% of the total variance explained. The different dimensions of HCPs' cultural competence are: Cross-Cultural Motivation/Curiosity, Cross-Cultural Attitudes, Cross-Cultural Skills, Cross-Cultural Knowledge/Awareness and Cross-Cultural Emotions/Empathy. For the total instrument, the internal consistency reliability was .87 and the dimension's Cronbach's alpha ranged from .54 to .84. The discriminating power of the CCCHP was indicated by statistically significant mean differences in CCCHP subscale scores between predefined groups. Conclusions The 32-item CCCHP exhibits acceptable psychometric properties, particularly content and construct validity to examine HCPs' cultural competence. The CCCHP with its five dimensions offers a comprehensive assessment of HCPs' cultural competence, and has the ability to distinguish between groups that are expected to differ in cultural competence. This instrument can foster professional development through systematic self-assessment and thus contributes to improve the quality of patient care.	[Bernhard, Gerda; von Wolff, Alessa; Dingoyan, Demet; Schulz, Holger; Moesko, Mike] Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany; [Knibbe, Ronald A.] Maastricht Univ, Dept Hlth Promot, NL-6200 MD Maastricht, Netherlands	University of Hamburg; University Medical Center Hamburg-Eppendorf; Maastricht University	Bernhard, G (corresponding author), Univ Heidelberg Hosp, Dept Gen Practice, Heidelberg, Germany.	Gerda.Laengst@gmx.de			Volkswagen Foundation (a German non-profit organisation) [II/84 336]; Volkswagen Foundation	Volkswagen Foundation (a German non-profit organisation); Volkswagen Foundation(Volkswagen)	This study is part of the international research project on 'Mental health of people with an immigration background and on cross-cultural openness within the mental healthcare system' (www.segemi.de), supported by a grant from the Volkswagen Foundation (a German non-profit organisation, funding code II/84 336, http://www.volkswagenstiftung.de/). This study was fully conducted by the Study Group on Psychosocial Migration Research at the Department of Medical Psychology at the University Medical Center Hamburg-Eppendorf (UKE). The contract between the sponsor and the UKE leaves the full responsibility for the scientific work, for the management of data, and for analysis and publication to the investigators. The views expressed in this article are those of the authors and not necessarily those of the UKE or the Volkswagen Foundation. The authors are grateful to the Volkswagen Foundation for funding this study.	Abreu JM, 1999, J CONSULT CLIN PSYCH, V67, P387, DOI 10.1037/0022-006X.67.3.387; Agius RM, 1996, OCCUP ENVIRON MED, V53, P217, DOI 10.1136/oem.53.4.217; BARTLETT MS, 1954, J ROY STAT SOC B, V16, P296; Beach MC, 2005, MED CARE, V43, P356, DOI 10.1097/01.mlr.0000156861.58905.96; Beck, 2004, NURSING RES PRINCIPL; Bennegadi R, 2009, CULTURAL COMPETENCE; Berk R A, 1990, West J Nurs Res, V12, P659, DOI 10.1177/019394599001200507; Black RM, 2007, CULTURE OCCUPATION M; Boyle D. P., 2001, J ETHNIC CULTURAL DI, V9, P53, DOI DOI 10.1300/J051V09N03_03; Burns N., 2005, PRACTICE NURSING RES; Byars-Winston AM, 2006, CAREER DEV Q, V54, P187, DOI 10.1002/j.2161-0045.2006.tb00151.x; Campinha-Bacote J., 2020, PROCESS CULTURAL COM; Campinha-Bacote Josepha, 2002, J Transcult Nurs, V13, P181, DOI 10.1177/10459602013003003; Canto JG, 2000, NEW ENGL J MED, V342, P1094, DOI 10.1056/NEJM200004133421505; Cattell R.B., 1978, SCI USE FACTOR ANAL, DOI [DOI 10.1007/978-1-4684-2262-7_5, 10.1007/978-1-4684-2262-7_5]; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Clark LA, 1995, PSYCHOL ASSESSMENT, V7, P309, DOI 10.1037/1040-3590.7.3.309; Collins NM, 2007, J COUNS DEV, V85, P14, DOI 10.1002/j.1556-6678.2007.tb00439.x; Constantine M.G., 2001, HDB MULTICULTURAL CO, P482; Constantine MG, 2000, J COUNS PSYCHOL, V47, P155, DOI 10.1037//0022-0167.47.2.155; CRONBACH LJ, 1955, PSYCHOL BULL, V52, P281, DOI 10.1037/h0040957; DANDREA M, 1991, J COUNS DEV, V70, P143, DOI 10.1002/j.1556-6676.1991.tb01576.x; Deardorff DK, 2006, J STUD INT EDUC, V10, P241, DOI [DOI 10.1177/1028315306287002, 10.1177/1028315306287002]; DeVellis R., 2017, SCALE DEV THEORY APP, V4; Doorenbos Ardith Z, 2004, Am J Hosp Palliat Care, V21, P28, DOI 10.1177/104990910402100108; Doorenbos AZ, 2005, NURS RES, V54, P324, DOI 10.1097/00006199-200509000-00006; Dunn TW, 2006, J COUNS DEV, V84, P471, DOI 10.1002/j.1556-6678.2006.tb00431.x; Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037/1082-989X.4.3.272; Ferguson E, 1993, INT J SEL ASSESS, V1, P84, DOI DOI 10.1111/J.1468-2389.1993.TB00092.X; Fuertes JN, 2001, J MULTICULT COUNS D, V29, P3, DOI 10.1002/j.2161-1912.2001.tb00499.x; Geiger HJ, 2001, CAN MED ASSOC J, V164, P1699; Geron SM, 2002, CULTURAL COMPETENCY; Gerrish K, 1996, NURSING MULTIETHNIC; Goodwin LD, 2002, J NURS EDUC, V41, P100; Gorsuch R., 1983, FACTOR ANAL; Gozu A, 2007, TEACH LEARN MED, V19, P180, DOI 10.1080/10401330701333654; Grant JS, 1997, RES NURS HEALTH, V20, P269, DOI 10.1002/(SICI)1098-240X(199706)20:3<269::AID-NUR9>3.3.CO;2-3; Harkness JA., 2008, INT HDB SURVEY METHO, P56, DOI DOI 10.4324/9780203843123.CH4; Hays DG, 2008, J COUNS DEV, V86, P95, DOI 10.1002/j.1556-6678.2008.tb00630.x; Helms J. E., 1999, USING RACE CULTURE C; Jirwe M, 2006, J MULTICULT NURS HLT, V12, P6; Jirwe M, 2009, J CLIN NURS, V18, P2622, DOI 10.1111/j.1365-2702.2008.02734.x; Jones MC, 1999, WORK STRESS, V13, P162, DOI 10.1080/026783799296129; KAISER HF, 1970, PSYCHOMETRIKA, V35, P401, DOI 10.1007/BF02291817; KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575; Kim BSK, 2003, MEAS EVAL COUNS DEV, V36, P161, DOI 10.1080/07481756.2003.11909740; Kline P., 1986, HDB TEST CONSTRUCTIO; Kline P., 1994, EASY GUIDE FACTOR AN; Kline R.B., 2011, PRINCIPLES PRACTICE; LAFROMBOISE TD, 1991, PROF PSYCHOL-RES PR, V22, P380, DOI 10.1037/0735-7028.22.5.380; Lamping DL, 2002, CHEST, V122, P920, DOI 10.1378/chest.122.3.920; Liu M, 2007, INT J NURS STUD, V44, P805, DOI 10.1016/j.ijnurstu.2006.01.010; Lum D, 2011, CULTURALLY COMPETENT, P123; LYNN MR, 1986, NURS RES, V35, P382; Mason J.L., 1995, CULTURAL COMPETENCE; Mayring P, 1994, QUALITATIVE CONTENT; Nunnally J., 1978, PSYCHOMETRIC THEORY; PONTEROTTO JG, 1995, EDUC PSYCHOL MEAS, V55, P1016, DOI 10.1177/0013164495055006011; Ponterotto JG, 2002, J MULTICULT COUNS D, V30, P153, DOI 10.1002/j.2161-1912.2002.tb00489.x; Ponterotto JG, 1996, HDB MULTICULTURAL AS, P651; Pope-Davis D B, 2001, Cultur Divers Ethnic Minor Psychol, V7, P121, DOI 10.1037/1099-9809.7.2.121; Priest J, 1995, NURSE RES, V2, P69, DOI DOI 10.7748/nr.2.4.69.s8; QURESHI A, 2005, DIVERSITY HLTH SOCIA, V2, P307; Razum O., 2008, MIGRATION GESUNDHEIT; Schenk L, 2007, BUNDESGESUNDHEITSBLA, V50, P590, DOI 10.1007/s00103-007-0220-z; Schim SM, 2007, J TRANSCULT NURS, V18, P103, DOI 10.1177/1043659606298613; Shen ZW, 2015, J TRANSCULT NURS, V26, P308, DOI 10.1177/1043659614524790; SODOWSKY GR, 1994, J COUNS PSYCHOL, V41, P137, DOI 10.1037/0022-0167.41.2.137; Sodowsky GR, 1996, MULTICULTURAL ASSESS, P283; Statistisches Bundesamt, 2010, STAT BUND REIH; Stober J, 2001, EUR J PSYCHOL ASSESS, V17, P222, DOI 10.1027//1015-5759.17.3.222; Stone JH, 2005, CULTURE AND DISABILI; Strauss B., 2009, FORSCHUNGSGUTACHTEN; SUE DW, 1992, J COUNS DEV, V70, P477, DOI 10.1002/j.1556-6676.1992.tb01642.x; SUE DW, 1982, COUNS PSYCHOL, V10, P45, DOI 10.1177/0011000082102008; Sue S, 2006, J COMMUNITY PSYCHOL, V34, P237, DOI 10.1002/jcop.20095; SUE S, 1987, AM PSYCHOL, V42, P37, DOI 10.1037/0003-066X.42.1.37; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; WHO Regional Office for Europe, 2010, HLTH SYST CAN ADDR H; Worthington RL, 2006, COUNS PSYCHOL, V34, P806, DOI 10.1177/0011000006288127; Yeo SA, 2004, ANNU REV NURS RES, V22, P59	81	20	21	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144049	10.1371/journal.pone.0144049	http://dx.doi.org/10.1371/journal.pone.0144049			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1YS	26641876	Green Published, Green Submitted, gold			2022-12-27	WOS:000366902700052
J	Boeve, AJ; Meijer, RR; Albers, CJ; Beetsma, Y; Bosker, RJ				Boeve, Anja J.; Meijer, Rob R.; Albers, Casper J.; Beetsma, Yta; Bosker, Roel J.			Introducing Computer-Based Testing in High-Stakes Exams in Higher Education: Results of a Field Experiment	PLOS ONE			English	Article								The introduction of computer-based testing in high-stakes examining in higher education is developing rather slowly due to institutional barriers (the need of extra facilities, ensuring test security) and teacher and student acceptance. From the existing literature it is unclear whether computer-based exams will result in similar results as paper-based exams and whether student acceptance can change as a result of administering computer-based exams. In this study, we compared results from a computer-based and paper-based exam in a sample of psychology students and found no differences in total scores across the two modes. Furthermore, we investigated student acceptance and change in acceptance of computer-based examining. After taking the computer-based exam, fifty percent of the students preferred paper-and-pencil exams over computer-based exams and about a quarter preferred a computer-based exam. We conclude that computer-based exam total scores are similar as paper-based exam scores, but that for the acceptance of high-stakes computer-based exams it is important that students practice and get familiar with this new mode of test administration.	[Boeve, Anja J.; Meijer, Rob R.; Albers, Casper J.] Univ Groningen, Heymans Inst, Dept Psychometr & Stat, Groningen, Netherlands; [Beetsma, Yta] Univ Groningen, Donald Smits Ctr Informat Technol Educ Support &, Groningen, Netherlands; [Bosker, Roel J.] Univ Groningen, Dept Educ Sci, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Boeve, AJ (corresponding author), Univ Groningen, Heymans Inst, Dept Psychometr & Stat, Groningen, Netherlands.	a.j.boeve@rug.nl	Albers, Casper/H-7942-2019	Albers, Casper/0000-0002-9213-6743; Bosker, Roel/0000-0002-1495-7298				Anakwe B, 2008, J ED BUSINESS, V84; Bayazit A, 2012, ASIA PACIFIC ED REV, V13; Cagiltay N, 2013, COMPUTER APPL ENG ED, V21; Cantillon P, 2004, BMJ, V329; Clariana R., 2002, BRIT J ED TECHNOLOGY, V33; Csapo B, 2012, ASSESSMENT AND TEACHING OF 21ST CENTURY SKILLS, P143, DOI 10.1007/978-94-007-2324-5_4; Deutsch T., 2012, COMPUTERS ED, V58; El Shallaly Gamal E H A, 2012, Educ Health (Abingdon), V25, P148, DOI 10.4103/1357-6283.109789; Frein S, 2011, TEACHING PSYCHOL, V38; Hochlehnert A, 2011, BMC MED EDUC, V11, DOI 10.1186/1472-6920-11-89; Huff K, 2001, ED MEASUREMENT ISSUE, V20; Kalogeropoulos N, 2013, COMPUTER APPL ENG ED, V21; Kim YH, 1993, LEARNING INDIVIDUAL, V5; Lee G, 2001, PSYCHOL B, V23; Lievens F, 2013, MED EDUC, V47, P182, DOI 10.1111/medu.12089; McDonald AS, 2002, COMPUTERS ED, V39; McNulty JA, 2007, J INT ASS MED SCI ED, V17; Mead AD, 1993, PSYCHOL B, V114; Nikou S, 2013, STUDENT ACHIEVEMENT; Norman  G., 2010, ADV HLTH SCI ED, V15, P5; Noyes J, 2004, BRIT J ED TECHNOLOGY, V35; Ricketts C, 2002, ASSESSMENT EVALUATIO, V27; Sinharay S, 2015, J ED MEASUREMENT, V52; Sinharay S, 2014, J ED MEASUREMENT, V51; Terzis V, 2011, COMPUTERS ED, V56; Towns MH, 1993, J RES SCI TEACHING, V30; Wang S, 2008, ED PSYCHOL MEASUREME, V68	27	27	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0143616	10.1371/journal.pone.0143616	http://dx.doi.org/10.1371/journal.pone.0143616			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1YS	26641632	Green Published, Green Submitted, gold			2022-12-27	WOS:000366902700024
J	Brocherie, F; Millet, GP; Hauser, A; Steiner, T; Wehrlin, JP; Rysman, J; Girard, O				Brocherie, Franck; Millet, Gregoire P.; Hauser, Anna; Steiner, Thomas; Wehrlin, Jon P.; Rysman, Julien; Girard, Olivier			Association of Hematological Variables with Team-Sport Specific Fitness Performance	PLOS ONE			English	Article							REPEATED-SPRINT ABILITY; TOTAL HEMOGLOBIN MASS; EXPLORATORY FACTOR-ANALYSIS; BLOOD-VOLUME; IRON STATUS; ALTITUDE; EXERCISE; HEMORHEOLOGY; HEMATOCRIT; PLASMA	Purpose We investigated association of hematological variables with specific fitness performance in elite team-sport players. Methods Hemoglobin mass (Hb(mass)) was measured in 25 elite field hockey players using the optimized (2 min) CO-rebreathing method. Hemoglobin concentration ([Hb]), hematocrit and mean corpuscular hemoglobin concentration (MCHC) were analyzed in venous blood. Fitness performance evaluation included a repeated-sprint ability (RSA) test (8 x 20 m sprints, 20 s of rest) and the Yo-Yo intermittent recovery level 2 (YYIR2). Results Hb(mass) was largely correlated (r = 0.62, P<0.01) with YYIR2 total distance covered (YYIR2TD) but not with any RSA-derived parameters (r ranging from -0.06 to -0.32; all P>0.05). [Hb] and MCHC displayed moderate correlations with both YYIR2TD (r = 0.44 and 0.41; both P<0.01) and RSA sprint decrement score (r = -0.41 and -0.44; both P<0.05). YYIR2TD correlated with RSA best and total sprint times (r = -0.46, P<0.05 and -0.60, P<0.01; respectively), but not with RSA sprint decrement score (r = -0.19, P>0.05). Conclusion Hb(mass) is positively correlated with specific aerobic fitness, but not with RSA, in elite teamsport players. Additionally, the negative relationships between YYIR2 and RSA tests performance imply that different hematological mechanisms may be at play. Overall, these results indicate that these two fitness tests should not be used interchangeably as they reflect different hematological mechanisms.	[Brocherie, Franck; Millet, Gregoire P.; Hauser, Anna; Girard, Olivier] Univ Lausanne, ISSUL, Inst Sports Sci, Lausanne, Switzerland; [Brocherie, Franck; Millet, Gregoire P.; Hauser, Anna; Girard, Olivier] Univ Lausanne, Dept Physiol, Fac Biol & Med, Lausanne, Switzerland; [Hauser, Anna; Steiner, Thomas; Wehrlin, Jon P.] Sect Elite Sport, Swiss Fed Inst Sport, Magglingen, Switzerland; [Rysman, Julien] Univ Libre Bruxelles, Fac Motor Sci, Brussels, Belgium; [Girard, Olivier] Athlete Hlth & Performance Res Ctr, ASPETAR, Orthopaed & Sports Med Hosp, Doha, Qatar	University of Lausanne; University of Lausanne; Universite Libre de Bruxelles; Aspetar Orthopaedic & Sports Medicine Hospital	Brocherie, F (corresponding author), Univ Lausanne, ISSUL, Inst Sports Sci, Lausanne, Switzerland.	franck.brocherie@unil.ch	Millet, Gregoire P/F-4104-2012; Wehrlin, Jon Peter/P-1984-2019; Wehrlin, Jon Peter/G-5101-2011; Millet, Grégoire/M-3220-2019	Millet, Gregoire P/0000-0001-8081-4423; Wehrlin, Jon Peter/0000-0002-8854-7937; Wehrlin, Jon Peter/0000-0002-8854-7937; Millet, Grégoire/0000-0001-8081-4423; Steiner, Thomas/0000-0002-3809-1230; Brocherie, Franck/0000-0002-0808-7986; girard, olivier/0000-0002-4797-182X	Aspetar (Qatar Orthopedic and Sports Medicine Hospital) at the Aspire Zone Foundation, Qatar [AF/C/ASP1905/11]	Aspetar (Qatar Orthopedic and Sports Medicine Hospital) at the Aspire Zone Foundation, Qatar	This research was funded by a Grant awarded by Aspetar (Qatar Orthopedic and Sports Medicine Hospital) at the Aspire Zone Foundation, Qatar (AF/C/ASP1905/11). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alis R, 2014, J SPORTS MED PHYS FI, V2014; Bangsbo J, 2008, SPORTS MED, V38, P37, DOI 10.2165/00007256-200838010-00004; Bishop D, 2004, J SPORT MED PHYS FIT, V44, P1; Bishop D, 2011, SPORTS MED, V41, P741, DOI 10.2165/11590560-000000000-00000; Bodary PF, 1999, MED SCI SPORT EXER, V31, P543, DOI 10.1097/00005768-199904000-00008; Boning D, 2008, EUR J APPL PHYSIOL, V103, P127, DOI 10.1007/s00421-008-0675-0; Boning D, 2004, INT J SPORTS MED, V25, P561, DOI 10.1055/s-2004-820963; Brun JF, 2000, CLIN HEMORHEOL MICRO, V22, P287; Bruna JF, 2013, CLIN HEMORHEOL MICRO, V55, P15, DOI 10.3233/CH-131686; Connes P, 2013, CLIN HEMORHEOL MICRO, V53, P187, DOI 10.3233/CH-2012-1643; CROWELL JW, 1967, J APPL PHYSIOL, V22, P501, DOI 10.1152/jappl.1967.22.3.501; de Winter JCF, 2009, MULTIVAR BEHAV RES, V44, P147, DOI 10.1080/00273170902794206; DILL DB, 1974, J APPL PHYSIOL, V37, P247, DOI 10.1152/jappl.1974.37.2.247; El-Sayed MS, 2005, SPORTS MED, V35, P649, DOI 10.2165/00007256-200535080-00001; Gaudard A, 2003, CLIN HEMORHEOL MICRO, V28, P161; Girard O, 2011, SPORTS MED, V41, P673, DOI 10.2165/11590550-000000000-00000; Gore CJ, 2013, BRIT J SPORT MED, V47, P80; Gore CJ, 1997, INT J SPORTS MED, V18, P477; Heinicke K, 2001, INT J SPORTS MED, V22, P504, DOI 10.1055/s-2001-17613; Hinrichs T, 2010, J STRENGTH COND RES, V24, P629, DOI 10.1519/JSC.0b013e3181a5bc59; Ingebrigtsen J, 2014, J STRENGTH COND RES, V28, P942, DOI 10.1519/JSC.0b013e3182a1f861; KANSTRUP IL, 1984, MED SCI SPORT EXER, V16, P256; Levine BD, 2008, J PHYSIOL-LONDON, V586, P25, DOI 10.1113/jphysiol.2007.147629; Liu HY, 2013, INT J PERF ANAL SPOR, V13, P340, DOI 10.1080/24748668.2013.11868652; Lythe J, 2011, INT J SPORTS MED, V32, P523, DOI 10.1055/s-0031-1273710; MacCallum RC, 2001, MULTIVAR BEHAV RES, V36, P611, DOI 10.1207/S15327906MBR3604_06; McLean BD, 2013, BRIT J SPORT MED, V47, P51; Meister S, 2014, J SPORT SCI, V32, P1328, DOI 10.1080/02640414.2014.927070; Preacher KJ, 2002, BEHAV GENET, V32, P153, DOI 10.1023/A:1015210025234; Prommer N, 2007, EUR J APPL PHYSIOL, V100, P383, DOI 10.1007/s00421-007-0439-2; Pyne DB, 2008, J STRENGTH COND RES, V22, P1633, DOI 10.1519/JSC.0b013e318181fe7a; Rietjens GJWM, 2005, INT J SPORTS MED, V26, P16, DOI 10.1055/s-2004-817914; Rusko HK, 2004, J SPORT SCI, V22, P928, DOI 10.1080/02640410400005933; SCHMIDT W, 1989, EUR J APPL PHYSIOL O, V58, P453, DOI 10.1007/BF02330696; Schmidt W, 2005, EUR J APPL PHYSIOL, V95, P486, DOI 10.1007/s00421-005-0050-3; Schmidt W, 1999, MED SCI SPORTS EXERC, V31, P50; Schmidt W, 2010, EXERC SPORT SCI REV, V38, P68, DOI 10.1097/JES.0b013e3181d4957a; Schumacher YO, 2000, INT J SPORTS MED, V21, P380, DOI 10.1055/s-2000-3785; Schumacher YO, 2002, MED SCI SPORT EXER, V34, P869; Schuster S, 2014, BBA-GEN SUBJECTS, V1840, P271, DOI 10.1016/j.bbagen.2013.08.026; Stark H, 2012, J APPL PHYSIOL, V113, P355, DOI 10.1152/japplphysiol.00369.2012; Steiner T, 2011, SCAND J CLIN LAB INV, V71, P19, DOI 10.3109/00365513.2010.534174; Takeno Y, 2001, J APPL PHYSIOL, V91, P1520, DOI 10.1152/jappl.2001.91.4.1520; Wachsmuth N, 2013, BRIT J SPORT MED, V47, P93, DOI 10.1136/bjsports-2013-092761	44	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144446	10.1371/journal.pone.0144446	http://dx.doi.org/10.1371/journal.pone.0144446			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641647	Green Published, gold			2022-12-27	WOS:000366902700123
J	Chawki, S; Ploussard, G; Montlahuc, C; Verine, J; Mongiat-Artus, P; Desgrandchamps, F; Molina, JM				Chawki, Sylvain; Ploussard, Guillaume; Montlahuc, Claire; Verine, Jerome; Mongiat-Artus, Pierre; Desgrandchamps, Francois; Molina, Jean-Michel			Bladder Cancer in HIV-infected Adults: An Emerging Issue? Case-Reports and Systematic Review	PLOS ONE			English	Review							CELL CARCINOMA; LYMPHOMA; RISK; PATIENT	Objectives Non-AIDS-related malignancies now represent a frequent cause of death among HIV-infected patients. Albeit bladder cancer is one of the most common malignancies worldwide, it has been rarely reported among HIV-infected patients. We wished to assess the prevalence and characteristics of bladder cancer in HIV-infected patients. Methods We conducted a single center retrospective study from 1998 to 2013 in a university hospital in Paris. Cases of bladder cancer among HIV-infected patients were identified using the electronic records of the hospital database and of the HIV-infected cohort. Patient characteristics and outcomes were retrieved from patients charts. A systematic review of published cases of bladder cancers in patients with HIV-infection was also performed. Results During the study period we identified 15 HIV-infected patients (0.2% of the cohort) with a bladder cancer. Patients were mostly men (73%) and smokers (67%), with a median age of 56 years at cancer diagnosis. Bladder cancer was diagnosed a median of 14 years after HIV-infection. Most patients were on ART (86%) with median current and nadir CD4 cell counts of 506 and 195 cells/mm(3), respectively. Haematuria (73%) was the most frequent presenting symptom and HPV-associated lesions were seen in 6/10 (60%) patients. Histopathology showed transitional cell carcinoma in 80% and a high proportion of tumors with muscle invasion (47%) and high histologic grade (73%). One-year survival rate was 74.6%. The systematic review identified 13 additional cases of urothelial bladder cancers which shared similar features. Conclusions Bladder cancers in HIV-infected patients remain rare but may occur in relatively young patients with a low nadir CD4 cell count, have aggressive pathological features and can be fatal.	[Chawki, Sylvain; Molina, Jean-Michel] Univ Paris 07, Univ Paris Diderot, Sorbonne Paris Cite, St Louis Hosp,AP HP,Dept Infect Dis, Paris, France; [Ploussard, Guillaume; Mongiat-Artus, Pierre; Desgrandchamps, Francois] Univ Paris 07, Univ Paris Diderot, Sorbonne Paris Cite, St Louis Hosp,AP HP,Dept Urol, Paris, France; [Montlahuc, Claire] Univ Paris 07, Univ Paris Diderot, Sorbonne Paris Cite, St Louis Hosp,AP HP,Dept Biostat & Med Informat, Paris, France; [Verine, Jerome] Univ Paris 07, Univ Paris Diderot, Sorbonne Paris Cite, St Louis Hosp,AP HP,Dept Pathol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Molina, JM (corresponding author), Univ Paris 07, Univ Paris Diderot, Sorbonne Paris Cite, St Louis Hosp,AP HP,Dept Infect Dis, Paris, France.	jean-michel.molina@aphp.fr	Ploussard, Guillaume/AAY-4767-2021	Chawki, Sylvain/0000-0003-1656-8007				AlSoub H, 1996, POSTGRAD MED J, V72, P302, DOI 10.1136/pgmj.72.847.302; Bartel P, 2013, UROLOGE, V52, P1248, DOI 10.1007/s00120-013-3300-8; Benabdallah JO, 2011, J SPINAL CORD MED, V34, P248, DOI 10.1179/107902610X12883422813705; Couris Chantal Marie, 2006, J Med Syst, V30, P459, DOI 10.1007/s10916-006-9028-x; Gaughan Elizabeth M, 2009, BMC Urol, V9, P10, DOI 10.1186/1471-2490-9-10; Guiguet M, 2009, LANCET ONCOL, V10, P1152, DOI 10.1016/S1470-2045(09)70282-7; Helleberg M, 2014, AIDS, V28, P1499, DOI 10.1097/QAD.0000000000000283; Institut National du Cancer, 2008, PREV NAT CANC PREV P; Lanoy E, 2011, INT J CANCER, V129, P467, DOI 10.1002/ijc.25903; Layman AB, 2008, JAIDS-J ACQ IMM DEF, V48, P365, DOI 10.1097/QAI.0b013e31817ae5da; Li N, 2011, J INFECT DIS, V204, P217, DOI 10.1093/infdis/jir248; Manfredi R, 2006, SCAND J INFECT DIS, V38, P566, DOI 10.1080/00365540500434653; Mearini E, 2002, J UROLOGY, V167, P1397, DOI 10.1016/S0022-5347(05)65316-5; Morlat P, 2014, AIDS, V28, P1181, DOI 10.1097/QAD.0000000000000222; Pai S, 2004, LEUKEMIA LYMPHOMA, V45, P841, DOI 10.1080/10428190310001615927; Ploeg M, 2009, WORLD J UROL, V27, P289, DOI 10.1007/s00345-009-0383-3; Pugliese P, 2009, HIV MED, V10, P504, DOI 10.1111/j.1468-1293.2009.00719.x; Ramos LMC, 1998, BRIT J UROL, V82, P132; Santos J, 2002, INT J STD AIDS, V13, P674, DOI 10.1258/095646202760326417; Silverberg MJ, 2009, AIDS, V23, P2337, DOI 10.1097/QAD.0b013e3283319184; Wolf K., 2001, PRAXIS BERN 1994, V90, P1159; ZAHAR JR, 1995, PRESSE MED, V24, P869	22	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144237	10.1371/journal.pone.0144237	http://dx.doi.org/10.1371/journal.pone.0144237			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642314	Green Published, gold			2022-12-27	WOS:000366902700082
J	Homayounfar, M; Zomorodian, M; Martinez, CJ; Lai, SH				Homayounfar, Mehran; Zomorodian, Mehdi; Martinez, Christopher J.; Lai, Sai Hin			Two Monthly Continuous Dynamic Model Based on Nash Bargaining Theory for Conflict Resolution in Reservoir System	PLOS ONE			English	Article							GAME-THEORY; MULTIOBJECTIVE RESERVOIR; QUALITY MANAGEMENT; WATER ALLOCATION; DECISION-MAKING; OPERATING RULES; NEWTON METHOD; OPTIMIZATION; GROUNDWATER; POLICIES	So far many optimization models based on Nash Bargaining Theory associated with reservoir operation have been developed. Most of them have aimed to provide practical and efficient solutions for water allocation in order to alleviate conflicts among water users. These models can be discussed from two viewpoints: (i) having a discrete nature; and (ii) working on an annual basis. Although discrete dynamic game models provide appropriate reservoir operator policies, their discretization of variables increases the run time and causes dimensionality problems. In this study, two monthly based non-discrete optimization models based on the Nash Bargaining Solution are developed for a reservoir system. In the first model, based on constrained state formulation, the first and second moments (mean and variance) of the state variable (water level in the reservoir) is calculated. Using moment equations as the constraint, the long-term utility of the reservoir manager and water users are optimized. The second model is a dynamic approach structured based on continuous state Markov decision models. The corresponding solution based on the collocation method is structured for a reservoir system. In this model, the reward function is defined based on the Nash Bargaining Solution. Indeed, it is used to yield equilibrium in every proper sub-game, thereby satisfying the Markov perfect equilibrium. Both approaches are applicable for water allocation in arid and semi-arid regions. A case study was carried out at the Zayandeh-Rud river basin located in central Iran to identify the effectiveness of the presented methods. The results are compared with the results of an annual form of dynamic game, a classical stochastic dynamic programming model (e.g. Bayesian Stochastic Dynamic Programming model, BSDP), and a discrete stochastic dynamic game model (PSDNG). By comparing the results of alternative methods, it is shown that both models are capable of tackling conflict issues in water allocation in situations of water scarcity properly. Also, comparing the annual dynamic game models, the presented models result in superior results in practice. Furthermore, unlike discrete dynamic game models, the presented models can significantly reduce the runtime thereby avoiding dimensionality problems.	[Homayounfar, Mehran; Zomorodian, Mehdi; Lai, Sai Hin] Univ Malaya, Dept Civil Engn, Fac Engn Bldg, Kuala Lumpur, Malaysia; [Martinez, Christopher J.] Univ Florida, Dept Agr & Biol Engn, Gainesville, FL USA	Universiti Malaya; State University System of Florida; University of Florida	Lai, SH (corresponding author), Univ Malaya, Dept Civil Engn, Fac Engn Bldg, Kuala Lumpur, Malaysia.	laish@um.edu.my	Homayounfar, Mehran/AAH-2141-2020; Lai, Sai Hin/H-3164-2018	Lai, Sai Hin/0000-0002-7143-4805; Zomorodian, Mehdi/0000-0002-6855-534X	Government of Malaysia; University of Malaya (UM)	Government of Malaysia; University of Malaya (UM)(Universiti Malaya)	The first author is grateful to the Government of Malaysia and the University of Malaya (UM) for financial support of the first author through the Bright Spark Fellowship Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrishamchi A, 2005, J WATER RES PLAN MAN, V131, P326, DOI 10.1061/(ASCE)0733-9496(2005)131:4(326); Behzadian M, 2010, EUR J OPER RES, V200, P198, DOI 10.1016/j.ejor.2009.01.021; Carraro C, 2006, APPL NEGOTIATION THE; Chang NB, 1997, EUR J OPER RES, V99, P289, DOI 10.1016/S0377-2217(96)00019-7; De Steiguer J., 2003, 1 INT C RES WAT; Dong C, 2012, ENERGY, V37, P673, DOI 10.1016/j.energy.2011.10.030; Dreyfus S. E., 1962, APPL DYNAMIC PROGRAM; DUNN JC, 1989, J OPTIMIZ THEORY APP, V63, P23, DOI 10.1007/BF00940728; Fletcher SG, 1996, STOCH HYDROL HYDRAUL, V10, P167, DOI 10.1007/BF01581462; Foued BA, 2001, EUR J OPER RES, V133, P352, DOI 10.1016/S0377-2217(00)00303-9; Ganji A, 2008, WATER RESOUR MANAG, V22, P51, DOI 10.1007/s11269-006-9143-y; Ganji A, 2007, ADV WATER RESOUR, V30, P528, DOI 10.1016/j.advwatres.2006.04.004; Ganji A, 2007, ADV WATER RESOUR, V30, P157, DOI 10.1016/j.advwatres.2006.03.008; Grafton RQ, 2005, B MATH BIOL, V67, P957, DOI 10.1016/j.bulm.2004.11.006; Hajiabadi R, 2014, WATER RESOUR MANAG, V28, P5357, DOI 10.1007/s11269-014-0806-9; Hajkowicz S, 2008, EUR J OPER RES, V184, P255, DOI 10.1016/j.ejor.2006.10.045; Harsanyi J.C., 1982, PAPERS GAME THEORY, P44; Homayoun-Far M, 2010, ADV WATER RESOUR, V33, P752, DOI 10.1016/j.advwatres.2010.04.001; Homayounfar M, 2015, WATER RESOUR MANAG, V29, P2599, DOI 10.1007/s11269-015-0959-1; Homayounfar M, 2014, WATER RESOUR MANAG, V28, P3207, DOI 10.1007/s11269-014-0669-0; Homayounfar M, 2011, WATER RESOUR MANAG, V25, P3427, DOI 10.1007/s11269-011-9863-5; Judd K. L., 1998, NUMERICAL METHODS EC; Kampas A, 2003, ECOL ECON, V47, P135, DOI 10.1016/S0921-8009(03)00195-2; KARAMOUZ M, 1992, WATER RESOUR RES, V28, P1221, DOI 10.1029/92WR00103; KARAMOUZ M, 1982, WATER RESOUR RES, V18, P1337, DOI 10.1029/WR018i005p01337; Kaviani S, 2015, WATER RESOUR MANAG, V29, P1003, DOI 10.1007/s11269-014-0856-z; Kerachian R, 2007, ADV WATER RESOUR, V30, P866, DOI 10.1016/j.advwatres.2006.07.005; Kerachian R, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004575; LAFRANCE JT, 1991, J ECON DYN CONTROL, V15, P355, DOI 10.1016/0165-1889(91)90018-V; Lee CS, 2012, CHEMOSPHERE, V87, P608, DOI 10.1016/j.chemosphere.2012.01.014; Lee CS, 2005, WATER RES, V39, P221, DOI 10.1016/j.watres.2004.09.013; Loaiciga HA, 2004, J HYDROL, V297, P22, DOI 10.1016/j.jhydrol.2004.04.006; LOGANATHAN GV, 1990, J WATER RES PL-ASCE, V116, P820, DOI 10.1061/(ASCE)0733-9496(1990)116:6(820); Madani K, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR010849; Madani K, 2011, WATER RESOUR MANAG, V25, P1949, DOI 10.1007/s11269-011-9783-4; Madani K, 2011, ADV WATER RESOUR, V34, P174, DOI 10.1016/j.advwatres.2010.10.003; Madani K, 2010, J HYDROL, V381, P225, DOI 10.1016/j.jhydrol.2009.11.045; Madani K, 2009, WATER RESOUR MANAG, V23, P2163, DOI 10.1007/s11269-008-9376-z; Mahjouri N, 2011, ENVIRON MONIT ASSESS, V172, P157, DOI 10.1007/s10661-010-1324-8; MARTIN WE, 1993, J ENVIRON ECON MANAG, V25, P1, DOI 10.1006/jeem.1993.1022; Miranda M. J., 2002, APPL COMPUTATIONAL E; Mousavi H, 2000, ADV WATER RESOUR, V23, P613, DOI 10.1016/S0309-1708(99)00053-6; MURRAY DM, 1984, J OPTIMIZ THEORY APP, V43, P395, DOI 10.1007/BF00934463; Nash J, 1953, ECONOMETRICA, V21, P128, DOI 10.2307/1906951; Nikoo MR, 2014, ENVIRON EARTH SCI, V71, P4127, DOI 10.1007/s12665-013-2801-5; Parrachino I, 2006, WORLD BANK POLICY RE; Rafipour-Langeroudi M, 2014, KSCE J CIV ENG, V18, P454, DOI 10.1007/s12205-014-1193-8; Srdjevic B, 2007, DECIS SUPPORT SYST, V42, P2261, DOI 10.1016/j.dss.2006.08.001; SUZUKI M, 1976, MANAGE SCI, V22, P1081, DOI 10.1287/mnsc.22.10.1081; Thomson W, 2001, SOC CHOICE WELFARE, V18, P327, DOI 10.1007/s003550100106; Tolwinski B., 1989, NEWTON TYPE METHODS, P128; YEH WWG, 1985, WATER RESOUR RES, V21, P1797, DOI 10.1029/WR021i012p01797; Zahraie B, 2009, EXPERT SYST APPL, V36, P4980, DOI 10.1016/j.eswa.2008.06.135; Zara S., 2006, WORLD BANK POLICY RE	54	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0143198	10.1371/journal.pone.0143198	http://dx.doi.org/10.1371/journal.pone.0143198			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641095	gold, Green Published, Green Submitted			2022-12-27	WOS:000366902700012
J	Mei, H; Guo, BB; Yin, BM; Liang, X; Adair, L; Thompson, A; Zhang, JD				Mei, Hong; Guo, Bingbing; Yin, Baomin; Liang, Xiong; Adair, Linda; Thompson, Amanda; Zhang, Jianduan			Interactive Effects of Early Exclusive Breastfeeding and Pre-Pregnancy Maternal Weight Status on Young Children's BMI - A Chinese Birth Cohort	PLOS ONE			English	Article							BODY-MASS INDEX; SELF-REPORTED HEIGHT; FED INFANTS; GROWTH; OBESITY; OVERWEIGHT; CHILDHOOD; ADULTS; DURATION; FORMULA	Objectives To assess if the maternal pre-pregnancy weight status (MPWS) alters the association of early infant feeding pattern (at one and third months) with infant body mass index (BMI) in the first two years of life. Methods A cohort of 2,220 neonates were recruited in a community-based study conducted in China. Body weight and length were measured at birth, at age one and two, with BMI calculated accordingly. The BMI z-scores (BMI-Z) were computed according to the World Health Organization Growth Standard (2006). Feeding patterns were classified as exclusive breast-feeding (EBF), mixed feeding (MF), and formula feeding (FF). General linear models (GLM) were employed to estimate main and interaction effects of EBF and MPWS on children's BMI-Z. Results No main effect of MPWS was found on child BMI-Z at ages one and two, nor the feeding patterns. An interaction between MPWS and feeding patterns was detected (p<0.05). For children who were formula fed during the first month, those who were born to overweight/obesity (OW/OB) mothers had a significantly greater BMI-Z at ages one and two, compared with those with underweight/normal weight (UW/NW) mothers. FF children had greater BMI-Z at ages one and two compared with their EBF and MF counterparts, when they were born to OW/OB mothers. Conclusions Maternal pre-pregnancy weight control and early initiation of EBF for children are essential for healthy development in children's BMI, hence the prevention of early life obesity.	[Mei, Hong; Guo, Bingbing; Zhang, Jianduan] Huazhong Univ Sci & Technol, Sch Publ Hlth, Dept Maternal & Child Hlth, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China; [Yin, Baomin] Maternal & Child Hlth Hosp Zhuhai City, Zhuhai, Guangdong, Peoples R China; [Liang, Xiong] Peoples Hosp Zhuhai City, Zhuhai, Guangdong, Peoples R China; [Adair, Linda] Univ N Carolina, Dept Nutr, Chapel Hill, NC USA; [Thompson, Amanda] Univ N Carolina, Dept Anthropol, Chapel Hill, NC USA	Huazhong University of Science & Technology; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Zhang, JD (corresponding author), Huazhong Univ Sci & Technol, Sch Publ Hlth, Dept Maternal & Child Hlth, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China.	jd_zh@hust.edu.cn			National Natural Science Foundation of China (NSFC) [30800917, 81373017]; Special Fund for Basic Scientific Research of Central Colleges [2013T009]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Special Fund for Basic Scientific Research of Central Colleges	This work was supported by 1: National Natural Science Foundation of China (NSFC) (Contract grant number: 30800917); 2: The Special Fund for Basic Scientific Research of Central Colleges (Contract grant number: 2013T009); 3: National Natural Science Foundation of China (NSFC) (Contract grant number: 81373017).	Amir Lisa H, 2007, BMC Pregnancy Childbirth, V7, P9, DOI 10.1186/1471-2393-7-9; [Anonymous], 1986, PEDIATRICS, V78, P521; Baird J, 2005, BMJ-BRIT MED J, V331, P929, DOI 10.1136/bmj.38586.411273.E0; Baker JL, 2008, AM J CLIN NUTR, V88, P1543, DOI 10.3945/ajcn.2008.26379; Bolton-Smith C, 2000, J EPIDEMIOL COMMUN H, V54, P143, DOI 10.1136/jech.54.2.143; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Butte NF, 2000, PEDIATRICS, V106, P1355, DOI 10.1542/peds.106.6.1355; Cai L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098744; Chen CM, 2008, OBES REV, V9, P14, DOI 10.1111/j.1467-789X.2007.00433.x; Chomtho S, 2008, AM J CLIN NUTR, V87, P1776, DOI 10.1093/ajcn/87.6.1776; Chu LS, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/293821; Council S, 2009, NAT PROGR ACT CHILD; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; Dearth-Wesley T, 2008, EUR J CLIN NUTR, V62, P1302, DOI 10.1038/sj.ejcn.1602853; DEWEY KG, 1992, PEDIATRICS, V89, P1035; Freeman DJ, 2010, SEMIN FETAL NEONAT M, V15, P113, DOI 10.1016/j.siny.2009.09.001; Gartner LM, 1997, PEDIATRICS, V100, P1035, DOI 10.1542/peds.100.6.1035; Gillman MW, 2010, NESTLE NUTR WORKS SE, V65, P13, DOI 10.1159/000281141; Gunther ALB, 2007, AM J CLIN NUTR, V86, P1765, DOI 10.1093/ajcn/86.6.1765; Harder T, 2005, AM J EPIDEMIOL, V162, P397, DOI 10.1093/aje/kwi222; Hawkins SS, 2009, J EPIDEMIOL COMMUN H, V63, P147, DOI 10.1136/jech.2008.077917; Hediger ML, 2000, AM J CLIN NUTR, V72, P159; HITCHCOCK NE, 1985, ACTA PAEDIATR SCAND, V74, P240, DOI 10.1111/j.1651-2227.1985.tb10957.x; Jones AD, 2014, MATERN CHILD NUTR, V10, P1, DOI 10.1111/mcn.12070; Jones-Smith JC, 2012, INT J OBESITY, V36, P866, DOI 10.1038/ijo.2011.134; Kabir Z, 2005, INT J EPIDEMIOL, V34, P481, DOI 10.1093/ije/dyi017; Kamudoni P, 2015, EUR J CLIN NUTR, V69, P96, DOI 10.1038/ejcn.2014.148; Kitsantas P, 2015, J MATERN-FETAL NEO M, P1; Krause KM, 2011, MATERN CHILD HLTH J, V15, P367, DOI 10.1007/s10995-010-0667-7; Kuchenbecker J, 2015, PAEDIATR INT CHILD H, V35, P14, DOI 10.1179/2046905514Y.0000000134; Lawlor DA, 2006, INT J EPIDEMIOL, V35, P3, DOI 10.1093/ije/dyi309; Le Huerou-Luron I, 2010, NUTR RES REV, V23, P23, DOI 10.1017/S0954422410000065; Li CY, 2005, OBES RES, V13, P362, DOI 10.1038/oby.2005.48; Li N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077809; Makela J, 2014, EUR J CLIN NUTR, V68, P43, DOI 10.1038/ejcn.2013.229; Martin FPJ, 2014, PEDIATR RES, V75, P535, DOI 10.1038/pr.2013.250; Oddy Wendy H, 2012, Breastfeed Rev, V20, P7; Oken E, 2003, OBES RES, V11, P496, DOI 10.1038/oby.2003.69; Ong KK, 2006, ACTA PAEDIATR, V95, P904, DOI 10.1080/08035250600719754; PERSSON LA, 1985, ANN HUM BIOL, V12, P41, DOI 10.1080/03014468500007551; Poston WSC, 2014, OCCUP MED-OXFORD, V64, P246, DOI 10.1093/occmed/kqu040; Sachdev HS, 2005, AM J CLIN NUTR, V82, P456, DOI 10.1093/ajcn/82.2.456; SALMENPERA L, 1985, PEDIATR RES, V19, P307, DOI 10.1203/00006450-198503000-00011; Savino F, 2009, INT J PEDIATR ENDOCR, DOI 10.1155/2009/327505; Singhal A, 2004, LANCET, V363, P1642, DOI 10.1016/S0140-6736(04)16210-7; Song Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053069; Stettler N, 2005, CIRCULATION, V111, P1897, DOI 10.1161/01.CIR.0000161797.67671.A7; UNICEF, 2013, STAT WORLDS CHILDR 2; Wada K, 2005, INT J OBESITY, V29, P1093, DOI 10.1038/sj.ijo.0803012; WHO, 2011, WHO ANTHRO VERSION 3; Wojcicki JM, 2011, J WOMENS HEALTH, V20, P341, DOI 10.1089/jwh.2010.2248; Xi B, 2012, OBES REV, V13, P287, DOI 10.1111/j.1467-789X.2011.00944.x; Yu ZB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061627; Zhang JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064542	54	6	7	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144357	10.1371/journal.pone.0144357	http://dx.doi.org/10.1371/journal.pone.0144357			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641272	Green Published, gold, Green Submitted			2022-12-27	WOS:000366902700103
J	Stice, E; Yokum, S; Waters, A				Stice, Eric; Yokum, Sonja; Waters, Allison			Dissonance-Based Eating Disorder Prevention Program Reduces Reward Region Response to Thin Models; How Actions Shape Valuation	PLOS ONE			English	Article							COGNITIVE-BEHAVIORAL THERAPY; BODY-IMAGE CONCERNS; ANOREXIA-NERVOSA; RISK-FACTORS; PREVALENCE; ADOLESCENTS; REDUCTION; WOMEN; TRIAL; IDEAL	Research supports the effectiveness of a dissonance-based eating disorder prevention program wherein high-risk young women with body dissatisfaction critique the thin ideal, which reduces pursuit of this ideal, and the theory that dissonance induction contributes to these effects. Based on evidence that dissonance produces attitudinal change by altering neural representation of valuation, we tested whether completing the Body Project would reduce response of brain regions implicated in reward valuation to thin models. Young women with body dissatisfaction were randomized to this intervention or an educational control condition, completing assessments and fMRI scans while viewing images of thin versus average-weight female models at pre and post. Whole brain analyses indicated that, compared to controls, Body Project participants showed greater reductions in caudate response to images of thin versus average-weight models, though participants in the two conditions showed pretest differences in responsivity of other brain regions that might have contributed to this effect. Greater pre-post reductions in caudate and putamen response to thin models correlated with greater reductions in body dissatisfaction. The finding that the Body Project reduces caudate response to thin models provides novel preliminary evidence that this intervention reduces valuation of media images thought to contribute to body dissatisfaction and eating disorders, providing support for the intervention theory by documenting that this intervention alters an objective biological outcome.	[Stice, Eric; Yokum, Sonja] Oregon Res Inst, Eugene, OR 97403 USA; [Waters, Allison] Univ Oregon, Eugene, OR 97403 USA	Oregon Research Institute; University of Oregon	Stice, E (corresponding author), Oregon Res Inst, Eugene, OR 97403 USA.	estice@ori.org		Stice, Eric/0000-0002-9073-4942	NIH [MH86582]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086582, R01MH097720] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by MH86582, http://www.nih.gov/. The National Institutes of Health had no role in the study design, collection, interpretation of the data, writing the manuscript, or the decision to submit the paper for publication.; Address correspondence to Eric Stice, Oregon Research Institute, 1776 Millrace Drive, Eugene, Oregon, 97403. Email: estice@ori.org. This study was supported by NIH grant MH86582. Scanning was conducted at the Lewis Center for Neuroimaging at the University of Oregon. We thank Dove for disseminating a variant of this prevention program, Free Being Me, in 116 countries. The authors report no conflict of interest.	Agras WS, 2000, ARCH GEN PSYCHIAT, V57, P459, DOI 10.1001/archpsyc.57.5.459; [Anonymous], 1962, EXPLORATIONS COGNITI; Arcelus J, 2011, ARCH GEN PSYCHIAT, V68, P724, DOI 10.1001/archgenpsychiatry.2011.74; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Becker CB, 2005, BEHAV THER, V36, P245, DOI 10.1016/S0005-7894(05)80073-5; BERSCHEID E, 1973, PSYCHOL TODAY, V7, P119; BREHM JW, 1956, J ABNORM SOC PSYCH, V52, P384, DOI 10.1037/h0041006; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Crow SJ, 2010, OXFORD HDB EATING DI, P480; Egan LC, 2007, PSYCHOL SCI, V18, P978, DOI 10.1111/j.1467-9280.2007.02012.x; Everitt BJ, 2003, ANN NY ACAD SCI, V985, P233; Festinger L., 1957, THEORY COGNITIVE DIS, V2; Fladung AK, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.88; Fladung AK, 2010, AM J PSYCHIAT, V167, P206, DOI 10.1176/appi.ajp.2009.09010071; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Grabe S, 2008, PSYCHOL BULL, V134, P460, DOI 10.1037/0033-2909.134.3.460; Green Melinda, 2005, Eat Disord, V13, P157, DOI 10.1080/10640260590918955; Grilo CM, 2011, J CONSULT CLIN PSYCH, V79, P675, DOI 10.1037/a0025049; Halliwell E, 2014, HEALTH PSYCHOL, V33, P201, DOI 10.1037/a0032585; Hikosaka O, 2014, ANNU REV NEUROSCI, V37, P289, DOI 10.1146/annurev-neuro-071013-013924; Hudson JI, 2007, BIOL PSYCHIAT, V61, P348, DOI 10.1016/j.biopsych.2006.03.040; Jarcho JM, 2011, SOC COGN AFFECT NEUR, V6, P460, DOI 10.1093/scan/nsq054; Lawrence N., 2014, J PSYCHOPHARMACOLO S, V28, pA130; Lieberman MD, 2001, PSYCHOL SCI, V12, P135, DOI 10.1111/1467-9280.00323; Lock J, 2010, ARCH GEN PSYCHIAT, V67, P1025, DOI 10.1001/archgenpsychiatry.2010.128; Matusek JA, 2004, INT J EAT DISORDER, V36, P376, DOI 10.1002/eat.20059; McMillan W, 2011, J CONSULT CLIN PSYCH, V79, P129, DOI 10.1037/a0022143; Mitchell KS, 2007, INT J EAT DISORDER, V40, P120, DOI 10.1002/eat.20282; Noonan MP, 2012, EUR J NEUROSCI, V35, P997, DOI 10.1111/j.1460-9568.2012.08023.x; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; Orvaschel H., 1994, SCHEDULE AFFECTIVE D; Schonberg T, 2014, NAT NEUROSCI, V17, P625, DOI 10.1038/nn.3673; Seidel A, 2009, BEHAV RES THER, V47, P645, DOI 10.1016/j.brat.2009.04.007; Sharot T, 2009, J NEUROSCI, V29, P3760, DOI 10.1523/JNEUROSCI.4972-08.2009; Stice E, 2008, J CONSULT CLIN PSYCH, V76, P329, DOI 10.1037/0022-006X.76.2.329; Stice E, 2007, J CONSULT CLIN PSYCH, V75, P20, DOI 10.1037/0022-006X.75.1.20; Stice E, 2006, J CONSULT CLIN PSYCH, V74, P263, DOI 10.1037/0022-006X.74.2.263; Stice E, 2013, J ABNORM PSYCHOL, V122, P445, DOI 10.1037/a0030679; Stice E, 2011, BEHAV RES THER, V49, P622, DOI 10.1016/j.brat.2011.06.009; Stice E, 2011, J CONSULT CLIN PSYCH, V79, P500, DOI 10.1037/a0024351; Swanson SA, 2011, ARCH GEN PSYCHIAT, V68, P714, DOI 10.1001/archgenpsychiatry.2011.22; Taylor CB, 2003, AM J PSYCHIAT, V160, P248, DOI 10.1176/appi.ajp.160.2.248; Thesen S, 2000, MAGNET RESON MED, V44, P457, DOI 10.1002/1522-2594(200009)44:3<457::AID-MRM17>3.0.CO;2-R; Thompson JK, 2001, CURR DIR PSYCHOL SCI, V10, P181, DOI 10.1111/1467-8721.00144; Veling H, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00875	45	25	25	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144530	10.1371/journal.pone.0144530	http://dx.doi.org/10.1371/journal.pone.0144530			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1YS	26641854	Green Submitted, Green Published, gold			2022-12-27	WOS:000366902700142
J	Dizier, S; Forel, JM; Ayzac, L; Richard, JC; Hraiech, S; Lehingue, S; Loundou, A; Roch, A; Guerin, C; Papazian, L				Dizier, Stephanie; Forel, Jean-Marie; Ayzac, Louis; Richard, Jean-Christophe; Hraiech, Sami; Lehingue, Samuel; Loundou, Anderson; Roch, Antoine; Guerin, Claude; Papazian, Laurent		ACURASYS Study Investigators; PROSEVA Study Grp	Early Hepatic Dysfunction Is Associated with a Worse Outcome in Patients Presenting with Acute Respiratory Distress Syndrome: A Post-Hoc Analysis of the ACURASYS and PROSEVA Studies	PLOS ONE			English	Article							MORTALITY; SEPSIS; LIVER; BILIRUBIN; LUNG; ARDS; MECHANISMS; PROGNOSIS; INJURY; SCORE	Introduction Bilirubin is well-recognized marker of hepatic dysfunction in intensive care unit (ICU) patients. Multiple organ failure often complicates acute respiratory distress syndrome (ARDS) evolution and is associated with high mortality. The effect of early hepatic dysfunction on ARDS mortality has been poorly investigated. We evaluated the incidence and the prognostic significance of increased serum bilirubin levels in the initial phase of ARDS. Methods The data of 805 patients with ARDS were retrospectively analysed. This population was extracted from two recent multicenter, prospective and randomised trials. Patients presenting with ARDS with a ratio of the partial pressure of arterial oxygen to the fraction of inspired oxygen < 150 mmHg measured with a PEEP >= 5 cm of water were included. The total serum bilirubin was measured at inclusion and at days 2, 4, 7 and 14. The primary objective was to analyse the bilirubin at inclusion according to the 90-day mortality rate. Results The 90-day mortality rate was 33.8% (n = 272). The non-survivors were older, had higher Sepsis-related Organ Failure Assessment (SOFA) score and were more likely to have a medical diagnosis on admission than the survivors. At inclusion, the SOFA score without the liver score (10.3 +/- 2.9 vs. 9.0 +/- 3.0, p<0.0001) and the serum bilirubin levels (36.1 +/- 57.0 vs. 20.5 +/- 31.5 mu mol/L, p<0.0001) were significantly higher in the non-survivors than in the survivors. Age, the hepatic SOFA score, the coagulation SOFA score, the arterial pH level, and the plateau pressure were independently associated with 90-day mortality in patients with ARDS. Conclusion Bilirubin used as a surrogate marker of hepatic dysfunction and measured early in the course of ARDS was associated with the 90-day mortality rate.	[Dizier, Stephanie; Forel, Jean-Marie; Hraiech, Sami; Lehingue, Samuel; Roch, Antoine; Papazian, Laurent] Hop Nord Marseille, AP HP, Reanimat Detresses Resp & Infect Severes, F-13015 Marseille, France; [Dizier, Stephanie; Forel, Jean-Marie; Hraiech, Sami; Lehingue, Samuel; Roch, Antoine; Papazian, Laurent] Aix Marseille Univ, Fac Med, UMR CNRS 7278, URMITE, F-13005 Marseille, France; [Ayzac, Louis] Hop Henri Gabrielle, Hosp Civils Lyon, CClin Sud Est, F-69230 St Genis Aval, France; [Richard, Jean-Christophe; Guerin, Claude] Hop Croix Rousse, Hosp Civils Lyon, Reanimat Med & Surveillance Continue, F-69004 Lyon, France; [Loundou, Anderson] DRRC AP HM, Fac Med, Unite Aide Methodol Rech Clin, Lab Sante Publ, F-13005 Marseille, France	Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); CHU Lyon; CHU Lyon; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Papazian, L (corresponding author), Hop Nord Marseille, AP HP, Reanimat Detresses Resp & Infect Severes, F-13015 Marseille, France.	laurent.papazian@ap-hm.fr	guerin, claude/H-5692-2014; RICHARD, Jean-Christophe/A-4097-2009; Leone, Marc/P-4835-2016	guerin, claude/0000-0003-4700-6672; RICHARD, Jean-Christophe/0000-0003-1503-3035; Leone, Marc/0000-0002-3097-758X; Guervilly, Christophe/0000-0001-9066-6591	Assistance Publique Hopitaux de Marseille; Ministere de la sante [2004-26]	Assistance Publique Hopitaux de Marseille; Ministere de la sante	Financial support: ACURASYS was funded by the Assistance Publique Hopitaux de Marseille and supported by a grant from the Ministere de la sante (Programme Hospitalier de Recherche Clinique regional 2004-26). Glaxo-SmithKline France provided cisatracurium and placebo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer M, 2013, CURR OPIN CRIT CARE, V19, P123, DOI 10.1097/MCC.0b013e32835eba6d; Brienza N, 2006, INTENS CARE MED, V32, P267, DOI 10.1007/s00134-005-0023-3; Brito MA, 2006, CLIN CHIM ACTA, V374, P46, DOI 10.1016/j.cca.2006.06.012; Chopra M, 2009, EXP BIOL MED, V234, P361, DOI 10.3181/0811-MR-318; Cooke CR, 2009, CRIT CARE MED, V37, P1913, DOI 10.1097/CCM.0b013e3181a009b4; Ferguson ND, 2012, INTENS CARE MED, V38, P1573, DOI 10.1007/s00134-012-2682-1; Fernandes A, 2006, J NEUROCHEM, V96, P1667, DOI 10.1111/j.1471-4159.2006.03680.x; FOWLER AA, 1985, AM REV RESPIR DIS, V132, P472; Fuchs M, 2008, CLIN LIVER DIS, V12, P151, DOI 10.1016/j.cld.2007.11.002; Fuhrmann V, 2011, INTENS CARE MED, V37, P1302, DOI 10.1007/s00134-011-2248-7; Guerin C, 2013, NEW ENGL J MED, V368, P2159, DOI 10.1056/NEJMoa1214103; HIRSCH LJ, 1976, AM J PHYSIOL, V230, P1394, DOI 10.1152/ajplegacy.1976.230.5.1394; Kortgen A, 2009, SHOCK, V32, P358, DOI 10.1097/SHK.0b013e31819d8204; Kramer L, 2007, CRIT CARE MED, V35, P1099, DOI 10.1097/01.CCM.0000259462.97164.A0; Krejci V, 2006, CRIT CARE MED, V34, P1456, DOI 10.1097/01.CCM.0000215834.48023.57; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Lescot T, 2012, ANESTHESIOLOGY, V117, P898, DOI 10.1097/ALN.0b013e318266c6df; Matejovic M, 2002, INTENS CARE MED, V28, P1750, DOI 10.1007/s00134-002-1524-y; Matuschak GM, 2001, AM J RESP CRIT CARE, V163, P1002, DOI 10.1164/ajrccm.163.4.2003020; MONTGOMERY AB, 1985, AM REV RESPIR DIS, V132, P485; Noriega GO, 2003, BBA-MOL BASIS DIS, V1638, P173, DOI 10.1016/S0925-4439(03)00081-4; Papazian L, 2010, NEW ENGL J MED, V363, P1107, DOI 10.1056/NEJMoa1005372; Pappalardo F, 2013, INTENS CARE MED, V39, P275, DOI 10.1007/s00134-012-2747-1; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Recknagel P, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001338; REILLY FD, 1981, MICROVASC RES, V21, P103, DOI 10.1016/0026-2862(81)90008-X; Rodrigues CMP, 2002, J HEPATOL, V36, P335, DOI 10.1016/S0168-8278(01)00279-3; SCHLAG G, 1985, CRIT CARE MED, V13, P1045; SCHWARTZ DB, 1989, CHEST, V95, P871, DOI 10.1378/chest.95.4.871; Sheu CC, 2010, CHEST, V138, P559, DOI 10.1378/chest.09-2933; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wang CY, 2014, INTENS CARE MED, V40, P388, DOI 10.1007/s00134-013-3186-3; Zhai R, 2009, THORAX, V64, P784, DOI 10.1136/thx.2009.113464	33	36	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144278	10.1371/journal.pone.0144278	http://dx.doi.org/10.1371/journal.pone.0144278			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636318	Green Published, gold, Green Submitted			2022-12-27	WOS:000366143800066
J	Free, CL; Baxter, GS; Dickman, CR; Lisle, A; Leung, LKP				Free, C. L.; Baxter, G. S.; Dickman, C. R.; Lisle, A.; Leung, L. K. -P.			Diversity and Community Composition of Vertebrates in Desert River Habitats	PLOS ONE			English	Article							POPULATION-DYNAMICS; SMALL MAMMALS; SPATIAL ECOLOGY; ARID AUSTRALIA; AGAMID LIZARDS; RAINFALL; MOVEMENTS; SELECTION; ASSEMBLAGES; IRRUPTIONS	Animal species are seldom distributed evenly at either local or larger spatial scales, and instead tend to aggregate in sites that meet their resource requirements and maximise fitness. This tendency is likely to be especially marked in arid regions where species could be expected to concentrate at resource-rich oases. In this study, we first test the hypothesis that productive riparian sites in arid Australia support higher vertebrate diversity than other desert habitats, and then elucidate the habitats selected by different species. We addressed the first aim by examining the diversity and composition of vertebrate assemblages inhabiting the Field River and adjacent sand dunes in the Simpson Desert, western Queensland, over a period of two and a half years. The second aim was addressed by examining species composition in riparian and sand dune habitats in dry and wet years. Vertebrate species richness was estimated to be highest (54 species) in the riverine habitats and lowest on the surrounding dune habitats (45 species). The riverine habitats had different species pools compared to the dune habitats. Several species, including the agamid Gowidon longirostris and tree frog Litoria rubella, inhabited the riverine habitats exclusively, while others such as the skinks Ctenotus ariadnae and C. dux were captured only in the dune habitats. The results suggest that, on a local scale, diversity is higher along riparian corridors and that riparian woodland is important for tree-dependent species. Further, the distribution of some species, such as Mus musculus, may be governed by environmental variables (e.g. soil moisture) associated with riparian corridors that are not available in the surrounding desert environment. We conclude that inland river systems may be often of high conservation value, and that management should be initiated where possible to alleviate threats to their continued functioning.	[Free, C. L.; Leung, L. K. -P.] Univ Queensland, Sch Agr & Food Sci, Gatton, Qld 4343, Australia; [Baxter, G. S.; Lisle, A.] Univ Queensland, Sch Geog Planning & Environm Management, St Lucia, Qld 4072, Australia; [Dickman, C. R.] Univ Sydney, Sch Biol Sci, Desert Ecol Res Grp, Sydney, NSW 2006, Australia	University of Queensland; University of Queensland; University of Sydney	Free, CL (corresponding author), Univ Queensland, Sch Agr & Food Sci, Gatton, Qld 4343, Australia.	carissa.free@uqconnect.edu.au	Baxter, Greg/AAQ-5364-2021; Dickman, Christopher/Q-4662-2019	Baxter, Greg/0000-0003-1816-4970; Dickman, Christopher/0000-0002-1067-3730; Leung, Luke/0000-0002-8829-4925				[Anonymous], 2007, PRIMER E PRIMER 6 6; BOMFORD M, 1987, AUST WILDLIFE RES, V14, P183; Breed WG, 1995, MAMMALS AUSTR; Byrne M, 2008, MOL ECOL, V17, P4398, DOI 10.1111/j.1365-294X.2008.03899.x; Catterall CP, 2001, AUSTRAL ECOL, V26, P56, DOI 10.1111/j.1442-9993.2001.01074.pp.x; Cogger H., 2014, REPTILES AMPHIBIANS; Cogger H, 2000, REPTILES AMPHIBIANS; Cowell R. K., 2005, ESTIMATES STAT ESTIM; Daly BG, 2008, ECOLOGY, V89, P65, DOI 10.1890/06-1991.1; Daly BG, 2007, AUSTRAL ECOL, V32, P825, DOI 10.1111/j.1442-9993.2007.01768.x; DAVIES SJJF, 1984, J ARID ENVIRON, V7, P183; Denny MJS, 1982, CARNIVOROUS MARSUPIA, V1, P131; Department of Environment and Water Resources, 2007, AUSTR BIOG REG COMM; Dickman CR, 2010, J MAMMAL, V91, P798, DOI 10.1644/09-MAMM-S-205.1; Dickman CR, 1999, WILDLIFE RES, V26, P389, DOI 10.1071/WR97057; Dickman CR, 1995, J ARID ENVIRON, V31, P441, DOI 10.1016/S0140-1963(05)80127-2; DICKMAN CR, 1993, BIOL CONSERV, V65, P219, DOI 10.1016/0006-3207(93)90056-7; Dickman CR, 2001, WILDLIFE RES, V28, P493, DOI 10.1071/WR00023; Duguid A, 2002, WETLANDS ARID NO TER; Fennessy J, 2009, AFR J ECOL, V47, P318, DOI 10.1111/j.1365-2028.2008.00963.x; Free CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072690; FRIEND GR, 1989, AUST WILDLIFE RES, V16, P1; Graf W. L., 1988, FLUVIAL PROCESSES DR; Greenville AC, 2013, AUSTRAL ECOL, V38, P754, DOI 10.1111/aec.12033; Greenville AC, 2009, BIOL J LINN SOC, V97, P531, DOI 10.1111/j.1095-8312.2009.01241.x; Jones H. A., 2007, P132; KAVANAGH RP, 1995, WILDLIFE RES, V22, P359, DOI 10.1071/WR9950359; Kingsford R, 2006, ECOLOGY OF DESERT RIVERS, pXI; Letnic M, 2010, BIOL REV, V85, P501, DOI 10.1111/j.1469-185X.2009.00113.x; Letnic M, 2006, BIODIVERS CONSERV, V15, P3847, DOI 10.1007/s10531-005-0601-2; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; MASTERS P, 1993, WILDLIFE RES, V20, P803, DOI 10.1071/WR9930803; MCGARIGAL K, 1992, J WILDLIFE MANAGE, V56, P10, DOI 10.2307/3808786; McIntyre RES, 2009, J ARID ENVIRON, V73, P48, DOI 10.1016/j.jaridenv.2008.09.011; Milstead WB, 2007, J MAMMAL, V88, P1532, DOI 10.1644/16-MAMM-A-407R.1; Morton S.R., 1990, Proceedings of the Ecological Society of Australia, V16, P201; MORTON SR, 1988, AUST WILDLIFE RES, V15, P571; Munks SA, 1996, WILDLIFE RES, V23, P185, DOI 10.1071/WR9960185; MURRAY BR, 1994, WILDLIFE RES, V21, P647, DOI 10.1071/WR9940647; MURRAY BR, 1994, OECOLOGIA, V99, P216, DOI 10.1007/BF00627733; NAIMAN RJ, 1993, ECOL APPL, V3, P209, DOI 10.2307/1941822; NSW Department of Primary Industries, 2005, AN ETH INFOLINK; PALMER MW, 1993, ECOLOGY, V74, P2215, DOI 10.2307/1939575; Pastro LA, 2013, OECOLOGIA, V173, P603, DOI 10.1007/s00442-013-2642-7; Pavey CR, 2014, J MAMMAL, V95, P615, DOI 10.1644/13-MAMM-A-183; Pianka E., 1986, ECOLOGY NATURAL HIST; PIANKA ER, 1969, ECOLOGY, V50, P1012, DOI 10.2307/1936893; PREDAVEC M, 1994, WILDLIFE RES, V21, P569, DOI 10.1071/WR9940569; Prinsloo GL, 1990, TRANSVAAL MUSEUM MON, P67; Purdie R., 1984, LAND SYSTEMS SIMPSON; Ricklefs R.E., 1993, J EVOLUTION BIOL, DOI DOI 10.1046/J.1420-9101.1993.6020171.X; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Sabo JL, 2005, ECOLOGY, V86, P56, DOI 10.1890/04-0668; Shephard M., 1992, SIMPSON DESERT NATUR; STAFFORD SMITH DM, 1990, J ARID ENVIRON, V18, P255, DOI 10.1016/S0140-1963(18)30837-1; Thompson GG, 2003, AUSTRAL ECOL, V28, P355, DOI 10.1046/j.1442-9993.2003.01294.x; Tongeren OFR, 1995, DATA ANAL COMMUNITY; Unmack PJ, 2001, J ARID ENVIRON, V49, P653, DOI 10.1006/jare.2001.0813; Williams Amy J., 2004, Australian Mammalogy, V26, P205; Woinarski JCZ, 2000, J BIOGEOGR, V27, P843, DOI 10.1046/j.1365-2699.2000.00439.x	60	7	7	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144258	10.1371/journal.pone.0144258	http://dx.doi.org/10.1371/journal.pone.0144258			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26637127	Green Published, Green Submitted, gold			2022-12-27	WOS:000366143800064
J	Labadorf, A; Hoss, AG; Lagomarsino, V; Latourelle, JC; Hadzi, TC; Bregu, J; MacDonald, ME; Gusella, JF; Chen, JF; Akbarian, S; Weng, ZP; Myers, RH				Labadorf, Adam; Hoss, Andrew G.; Lagomarsino, Valentina; Latourelle, Jeanne C.; Hadzi, Tiffany C.; Bregu, Joli; MacDonald, Marcy E.; Gusella, James F.; Chen, Jiang-Fan; Akbarian, Schahram; Weng, Zhiping; Myers, Richard H.			RNA Sequence Analysis of Human Huntington Disease Brain Reveals an Extensive Increase in Inflammatory and Developmental Gene Expression	PLOS ONE			English	Article							NF-KAPPA-B; TRANSCRIPTION FACTOR; ACTIVATION; CALCIUM; PROTEIN; ONSET; PROGRESSION; MUTATION; PATHWAY; ACCUMULATION	Huntington's Disease (HD) is a devastating neurodegenerative disorder that is caused by an expanded CAG trinucleotide repeat in the Huntingtin (HTT) gene. Transcriptional dysregulation in the human HD brain has been documented but is incompletely understood. Here we present a genome-wide analysis of mRNA expression in human prefrontal cortex from 20 HD and 49 neuropathologically normal controls using next generation high-throughput sequencing. Surprisingly, 19% (5,480) of the 28,087 confidently detected genes are differentially expressed (FDR<0.05) and are predominantly up-regulated. A novel hypothesis-free geneset enrichment method that dissects large gene lists into functionally and transcriptionally related groups discovers that the differentially expressed genes are enriched for immune response, neuroinflammation, and developmental genes. Markers for all major brain cell types are observed, suggesting that HD invokes a systemic response in the brain area studied. Unexpectedly, the most strongly differentially expressed genes are a homeotic gene set (represented by Hox and other homeobox genes), that are almost exclusively expressed in HD, a profile not widely implicated in HD pathogenesis. The significance of transcriptional changes of developmental processes in the HD brain is poorly understood and warrants further investigation. The role of inflammation and the significance of non-neuronal involvement in HD pathogenesis suggest anti-inflammatory therapeutics may offer important opportunities in treating HD.	[Labadorf, Adam; Hoss, Andrew G.; Lagomarsino, Valentina; Latourelle, Jeanne C.; Hadzi, Tiffany C.; Bregu, Joli; Chen, Jiang-Fan; Myers, Richard H.] Boston Univ, Dept Neurol, Sch Med, Boston, MA 02215 USA; [Labadorf, Adam; Myers, Richard H.] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [MacDonald, Marcy E.; Gusella, James F.] Harvard Univ, Ctr Human Genet Res, Massachusetts Gen Hosp, Sch Med, Boston, MA USA; [Akbarian, Schahram] Icahn Sch Med Mt Sinai, Friedman Brain Inst, Dept Psychiat, New York, NY 10029 USA; [Weng, Zhiping] Univ Massachusetts, Program Bioinformat & Integrat Biol, Sch Med, Worcester, MA 01605 USA; [Weng, Zhiping] Univ Massachusetts, Dept Biochem & Mol Pharmacol, Sch Med, Worcester, MA 01605 USA; [Myers, Richard H.] Boston Univ, Genome Sci Inst, Sch Med, Boston, MA 02215 USA	Boston University; Boston University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Icahn School of Medicine at Mount Sinai; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Boston University	Myers, RH (corresponding author), Boston Univ, Dept Neurol, Sch Med, Boston, MA 02215 USA.	rmyers@bu.edu		Labadorf, Adam/0000-0002-0753-8992; Chen, Jiang-Fan/0000-0002-0446-3956	Jerry McDonald HD Research Fund; Public Health Service, National Institutes of Health grants; National Institute of Neurological disorders and stroke [R01-NS073947, R01-NS32765, PHY-1444389]; NSF-EArly-concept Grants for Exploratory Research (EAGER) [PHY-1444389]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH096890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073947, R01NS032765] Funding Source: NIH RePORTER; Division Of Physics [1444389] Funding Source: National Science Foundation	Jerry McDonald HD Research Fund; Public Health Service, National Institutes of Health grants; National Institute of Neurological disorders and stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NSF-EArly-concept Grants for Exploratory Research (EAGER); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by the Jerry McDonald HD Research Fund (RHM) and Public Health Service, National Institutes of Health grants, National Institute of Neurological disorders and stroke, R01-NS073947 (RHM) and R01-NS32765 (MEM) and PHY-1444389 NSF-EArly-concept Grants for Exploratory Research (EAGER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge Ms. Jayalakshmi Mysore for her help with the HD postmortem brains and the HTT CAG genotyping. This work was supported by the Jerry McDonald HD Research Fund (RHM) and Public Health Service, National Institutes of Health grants, National Institute of Neurological disorders and stroke, R01-NS073947 (RHM) and R01NS32765 (MEM) and PHY-1444389 NSF-EArly-concept Grants for Exploratory Research (EAGER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, 2014, TOPGO ENRICHMENT ANA; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Beach TG, 2008, CELL TISSUE BANK, V9, P229, DOI 10.1007/s10561-008-9067-2; Bjorkqvist M, 2008, J EXP MED, V205, P1869, DOI 10.1084/jem.20080178; Blumkin L, 2014, NEUROGENETICS, V15, P107, DOI 10.1007/s10048-014-0392-2; Cha JHJ, 2007, PROG NEUROBIOL, V83, P228, DOI 10.1016/j.pneurobio.2007.03.004; Cha JHJ, 2000, TRENDS NEUROSCI, V23, P387, DOI 10.1016/S0166-2236(00)01609-X; Costa V, 2012, EMBO J, V31, P1853, DOI 10.1038/emboj.2012.65; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Cronberg T, 2011, NEUROLOGY, V77, P623, DOI 10.1212/WNL.0b013e31822a276d; Crotti A, 2014, NAT NEUROSCI, V17, P513, DOI 10.1038/nn.3668; D'Aversa TG, 2013, NEUROPATH APPL NEURO, V39, P270, DOI 10.1111/j.1365-2990.2012.01279.x; Damiano M, 2010, BBA-MOL BASIS DIS, V1802, P52, DOI 10.1016/j.bbadis.2009.07.012; Djousse L, 2004, NEUROGENETICS, V5, P109, DOI 10.1007/s10048-004-0175-2; Ellrichmann G, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/541259; Gafni J, 2004, J BIOL CHEM, V279, P20211, DOI 10.1074/jbc.M401267200; Gafni J, 2002, J NEUROSCI, V22, P4842, DOI 10.1523/JNEUROSCI.22-12-04842.2002; Giacomello M, 2011, BIOFACTORS, V37, P206, DOI 10.1002/biof.162; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Gronski MA, 2009, CELL DEATH DIFFER, V16, P1323, DOI 10.1038/cdd.2009.55; Hadzi TC, 2012, NEUROLOGY, V79, P1708, DOI 10.1212/WNL.0b013e31826e9a5d; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hayashida N, 2010, EMBO J, V29, P3459, DOI 10.1038/emboj.2010.225; Hobbs NZ, 2010, AM J NEURORADIOL, V31, P1036, DOI 10.3174/ajnr.A2018; Hodges A, 2006, HUM MOL GENET, V15, P965, DOI 10.1093/hmg/ddl013; Hoss AG, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004188; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Huntington G., 1872, MED SURG REP, V26, P320; Jackson Brian C., 2010, Human Genomics, V4, P345; Jones SE, 2002, INT J BIOCHEM CELL B, V34, P427, DOI 10.1016/S1357-2725(01)00155-8; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li SH, 2002, MOL CELL BIOL, V22, P1277, DOI 10.1128/MCB.22.5.1277-1287.2002; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Marcora E, 2010, HUM MOL GENET, V19, P4373, DOI 10.1093/hmg/ddq358; Mckinney W., 2010, P PYTH SCI C, P51, DOI DOI 10.25080/MAJORA-92BF1922-00A; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Milacic Marija, 2012, Cancers (Basel), V4, P1180, DOI 10.3390/cancers4041180; Myers RH, 1998, GENETIC INSTABILITIES AND HEREDITARY NEUROLOGICAL DISEASES, P301; Myers Richard H, 2004, NeuroRx, V1, P255, DOI 10.1007/BF03206609; Neef DW, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000291; ONeill LAJ, 1997, TRENDS NEUROSCI, V20, P252, DOI 10.1016/S0166-2236(96)01035-1; Perez F, 2007, COMPUT SCI ENG, V9, P21, DOI 10.1109/MCSE.2007.53; Ponomarev EA, 2006, J IMMUNOL, V176, P1402, DOI 10.4049/jimmunol.176.3.1402; R Core Team, 2018, R LANG ENV STAT COMP; Razzell W, 2013, CURR BIOL, V23, P424, DOI 10.1016/j.cub.2013.01.058; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Schapira AHV, 2014, LANCET, V384, P545, DOI 10.1016/S0140-6736(14)61010-2; Selemon LD, 2004, J COMP NEUROL, V468, P190, DOI 10.1002/cne.10938; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Silvestroni A, 2009, NEUROREPORT, V20, P1098, DOI 10.1097/WNR.0b013e32832e34ee; SOTREL A, 1993, NEUROLOGY, V43, P2088, DOI 10.1212/WNL.43.10.2088; SOTREL A, 1991, NEUROLOGY, V41, P1117, DOI 10.1212/WNL.41.7.1117; Squitieri F, 2009, CNS NEUROSCI THER, V15, P1, DOI 10.1111/j.1755-5949.2008.00068.x; Suarez I, 2002, NEUROCHEM INT, V41, P123, DOI 10.1016/S0197-0186(02)00033-5; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thrane AS, 2011, P NATL ACAD SCI USA, V108, P846, DOI 10.1073/pnas.1015217108; van Roon-Mom WMC, 2002, MOL BRAIN RES, V109, P1, DOI 10.1016/S0169-328X(02)00450-3; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Wojda U, 2008, IUBMB LIFE, V60, P575, DOI 10.1002/iub.91	67	97	99	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143563	10.1371/journal.pone.0143563	http://dx.doi.org/10.1371/journal.pone.0143563			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636579	Green Published, gold			2022-12-27	WOS:000366143800018
J	Bayerlova, M; Klemm, F; Kramer, F; Pukrop, T; Beissbarth, T; Bleckmann, A				Bayerlova, Michaela; Klemm, Florian; Kramer, Frank; Pukrop, Tobias; Beissbarth, Tim; Bleckmann, Annalen			Newly Constructed Network Models of Different WNT Signaling Cascades Applied to Breast Cancer Expression Data	PLOS ONE			English	Article							BETA-CATENIN; CELL-PROLIFERATION; WNT/BETA-CATENIN; MICROARRAY DATA; PATHWAY DATA; IDENTIFICATION; MIGRATION; MECHANISM; RESOURCE; SUBTYPES	Introduction WNT signaling is a complex process comprising multiple pathways: the canonical beta-catenin- dependent pathway and several alternative non-canonical pathways that act in a beta-catenin- independent manner. Representing these intricate signaling mechanisms through bioinformatic approaches is challenging. Nevertheless, a simplified but reliable bioinformatic WNT pathway model is needed, which can be further utilized to decipher specific WNT activation states within e.g. high-throughput data. Results In order to build such a model, we collected, parsed, and curated available WNT signaling knowledge from different pathway databases. The data were assembled to construct computationally suitable models of different WNT signaling cascades in the form of directed signaling graphs. This resulted in four networks representing canonical WNT signaling, non-canonical WNT signaling, the inhibition of canonical WNT signaling and the regulation of WNT signaling pathways, respectively. Furthermore, these networks were integrated with microarray and RNA sequencing data to gain deeper insight into the underlying biology of gene expression differences between MCF-7 and MDA-MB-231 breast cancer cell lines, representing weakly and highly invasive breast carcinomas, respectively. Differential genes up-regulated in the MDA-MB-231 compared to the MCF-7 cell line were found to display enrichment in the gene set originating from the non-canonical network. Moreover, we identified and validated differentially regulated modules representing canonical and non-canonical WNT pathway components specific for the aggressive basal-like breast cancer subtype. Conclusions In conclusion, we demonstrated that these newly constructed WNT networks reliably reflect distinct WNT signaling processes. Using transcriptomic data, we shaped these networks into comprehensive modules of the genes implicated in the aggressive basal-like breast cancer subtype and demonstrated that non-canonical WNT signaling is important in this context. The topology of these networks can be further refined in the future by integration with complementary data such as protein-protein interactions, in order to gain greater insight into signaling processes.	[Bayerlova, Michaela; Kramer, Frank; Beissbarth, Tim; Bleckmann, Annalen] Univ Med Ctr Gottingen, Dept Med Stat, Gottingen, Germany; [Klemm, Florian; Pukrop, Tobias; Bleckmann, Annalen] Univ Med Ctr Gottingen, Dept Hematol & Med Oncol, Gottingen, Germany; [Pukrop, Tobias] Univ Hosp Regensburg, Dept Internal Med 3, Regensburg, Germany	University of Gottingen; University of Gottingen; University of Regensburg	Beissbarth, T (corresponding author), Univ Med Ctr Gottingen, Dept Med Stat, Gottingen, Germany.	Tim.Beissbarth@ams.med.uni-goettingen.de	Kramer, Frank/Q-4645-2019; Kramer, Frank/HGB-6558-2022	Kramer, Frank/0000-0002-2857-7122; Klemm, Florian/0000-0002-8944-9175	German Research Foundation (DFG) research group 942 on WNT signaling [BE 2552/8-2]; DFG clinical research group 179 on rectal cancer; German Ministry of Education and Research (BMBF) e:Bio project MetastaSys [0316173A]; German Ministry of Education and Research (BMBF) e: Med project Genoperspektiv [01GP1402]; Open Access Publication Funds of the University of Gottingen; German Ministry of Education and Research (BMBF) e: Med project HER2LOW [031A429C]	German Research Foundation (DFG) research group 942 on WNT signaling; DFG clinical research group 179 on rectal cancer; German Ministry of Education and Research (BMBF) e:Bio project MetastaSys; German Ministry of Education and Research (BMBF) e: Med project Genoperspektiv; Open Access Publication Funds of the University of Gottingen; German Ministry of Education and Research (BMBF) e: Med project HER2LOW	Members of this project received funding from the German Research Foundation (DFG) research group 942 (BE 2552/8-2) on WNT signaling, the DFG clinical research group 179 on rectal cancer, the German Ministry of Education and Research (BMBF) e:Bio project MetastaSys (0316173A) and e: Med projects Genoperspektiv (01GP1402)and HER2LOW (031A429C). We acknowledge support by the Open Access Publication Funds of the University of Gottingen.	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Bader GD, 2006, NUCLEIC ACIDS RES, V34, pD504, DOI 10.1093/nar/gkj126; Beissbarth T, 2006, METHOD ENZYMOL, V411, P340, DOI 10.1016/S0076-6879(06)11018-6; Bender C, 2010, BIOINFORMATICS, V26, pi596, DOI 10.1093/bioinformatics/btq385; Bhalla K, 2011, CANCER RES, V71, P6888, DOI 10.1158/0008-5472.CAN-11-1011; Bina M, 2006, MINING MICROARRAY DA; Cappellen D, 2007, EMBO REP, V8, P70, DOI 10.1038/sj.embor.7400849; Cerami EG, 2011, NUCLEIC ACIDS RES, V39, pD685, DOI 10.1093/nar/gkq1039; Chen EI, 2007, CANCER RES, V67, P1472, DOI 10.1158/0008-5472.CAN-06-3137; Chen JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100702; Choi HK, 2011, MOL CELL, V43, P203, DOI 10.1016/j.molcel.2011.05.027; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Cowling VH, 2007, MOL CELL BIOL, V27, P5135, DOI 10.1128/MCB.02282-06; Critchley DR, 2008, J CELL SCI, V121, P1345, DOI 10.1242/jcs.018085; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Csardi G, 2006, INTERJOURNAL; De A, 2011, ACTA BIOCH BIOPH SIN, V43, P745, DOI 10.1093/abbs/gmr079; Demir E, 2010, NAT BIOTECHNOL, V28, P935, DOI 10.1038/nbt.1666; Dijksterhuis JP, 2014, BRIT J PHARMACOL, V171, P1195, DOI 10.1111/bph.12364; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Frohlich H, 2008, BIOINFORMATICS, V24, P2650, DOI 10.1093/bioinformatics/btm634; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Grumolato L, 2010, GENE DEV, V24, P2517, DOI 10.1101/gad.1957710; Guo Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071462; He J, 2006, J BIOL CHEM, V281, P35598, DOI 10.1074/jbc.C600200200; Henry C, 2015, J CANCER RES CLIN, V141, P243, DOI 10.1007/s00432-014-1824-y; Holland JD, 2013, CURR OPIN CELL BIOL, V25, P254, DOI 10.1016/j.ceb.2013.01.004; HOMMEL G, 1988, BIOMETRIKA, V75, P383, DOI 10.2307/2336190; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kahn M, 2014, NAT REV DRUG DISCOV, V13, P513, DOI 10.1038/nrd4233; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Khramtsov AI, 2010, AM J PATHOL, V176, P2911, DOI 10.2353/ajpath.2010.091125; Klemm F, 2011, CARCINOGENESIS, V32, P434, DOI 10.1093/carcin/bgq269; Kramer F., 2014, THESIS; Kramer Frank, 2014, Biology (Basel), V3, P85, DOI 10.3390/biology3010085; Kramer F, 2013, BIOINFORMATICS, V29, P520, DOI 10.1093/bioinformatics/bts710; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; Mitra K, 2013, NAT REV GENET, V14, P719, DOI 10.1038/nrg3552; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Nishimura D, 2001, BIOTECH SOFTW INTERN, P117, DOI [10.1089/152791601750294344, DOI 10.1089/152791601750294344]; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sadeghi A, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-144; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Takahashi H, 1980, MATH JPN, V24, P573; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; van Amerongen R, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.135re9; Leeuwen IMM, 2007, J THEOR BIOL, V247, P77, DOI 10.1016/j.jtbi.2007.01.019; Yang L, 2011, ONCOGENE, V30, P4437, DOI 10.1038/onc.2011.145; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Yu KD, 2013, CLIN CANCER RES, V19, P2723, DOI 10.1158/1078-0432.CCR-12-2986; Zhang SP, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031127, 10.1371/journal.pone.0046853]; Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078644	65	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144014	10.1371/journal.pone.0144014	http://dx.doi.org/10.1371/journal.pone.0144014			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26632845	Green Submitted, Green Published, gold			2022-12-27	WOS:000366040000042
J	Carter, JM; Gibbs, M; Breuker, CJ				Carter, Jean-Michel; Gibbs, Melanie; Breuker, Casper J.			Divergent RNA Localisation Patterns of Maternal Genes Regulating Embryonic Patterning in the Butterfly Pararge aegeria	PLOS ONE			English	Article							GERM-CELL SPECIFICATION; MESSENGER-RNA; DROSOPHILA EMBRYO; BEETLE TRIBOLIUM; BICOID PROTEIN; AXIS FORMATION; WASP NASONIA; BOMBYX-MORI; POSTERIOR; SEGMENTATION	The maternal effect genes responsible for patterning the embryo along the antero-posterior (AP) axis are broadly conserved in insects. The precise function of these maternal effect genes is the result of the localisation of their mRNA in the oocyte. The main developmental mechanisms involved have been elucidated in Drosophila melanogaster, but recent studies have shown that other insect orders often diverge in RNA localisation patterns. A recent study has shown that in the butterfly Pararge aegeria the distinction between blastodermal embryonic (i.e. germ band) and extra-embryonic tissue (i.e. serosa) is already specified in the oocyte during oogenesis in the ovariole, long before blastoderm cellularisation. To examine the extent by which a female butterfly specifies and patterns the AP axis within the region fated to be the germ band, and whether she specifies a germ plasm, we performed in situ hybridisation experiments on oocytes in P. aegeria ovarioles and on early embryos. RNA localisation of the following key maternal effect genes were investigated: caudal (cad), orthodenticle (otd), hunchback (hb) and four nanos (nos) paralogs, as well as TDRD7 a gene containing a key functional domain (OST-HTH/LOTUS) shared with oskar. TDRD7 was mainly confined to the follicle cells, whilst hb was exclusively zygotically transcribed. RNA of some of the nos paralogs, otd and cad revealed complex localisation patterns within the cortical region prefiguring the germ band (i.e. germ cortex). Rather interestingly, otd was localised within and outside the anterior of the germ cortex. Transcripts of nos-O formed a distinct granular ring in the middle of the germ cortex possibly prefiguring the region where germline stem cells form. These butterfly RNA localisation patterns are highly divergent with respect to other insects, highlighting the diverse ways in which different insect orders maternally regulate early embryogenesis of their offspring.	[Carter, Jean-Michel; Breuker, Casper J.] Oxford Brookes Univ, Fac Hlth & Life Sci, Dept Biol & Med Sci, Evolutionary Dev Biol Res Grp, Oxford OX3 0BP, England; [Gibbs, Melanie] NERC Ctr Ecol & Hydrol, Wallingford OX10 8BB, Oxon, England	Oxford Brookes University; UK Centre for Ecology & Hydrology (UKCEH)	Breuker, CJ (corresponding author), Oxford Brookes Univ, Fac Hlth & Life Sci, Dept Biol & Med Sci, Evolutionary Dev Biol Res Grp, Gipsy Lane, Oxford OX3 0BP, England.	cbreuker@brookes.ac.uk	Gibbs, Melanie/E-6771-2012; Breuker, Casper/P-8270-2019	Gibbs, Melanie/0000-0002-4091-9789; Breuker, Casper/0000-0001-7909-1950; Carter, Jean-Michel/0000-0001-7932-2368	Oxford Brookes University [Jnl 105595, 103324]; Natural Environment Research Council Studentship; Nigel Groome Studentship (Oxford Brookes University); Oxford Brookes University; NERC [ceh020002] Funding Source: UKRI; Natural Environment Research Council [ceh020002] Funding Source: researchfish	Oxford Brookes University; Natural Environment Research Council Studentship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Nigel Groome Studentship (Oxford Brookes University); Oxford Brookes University; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was funded by Oxford Brookes University (https://www.brookes.ac.uk/homepage/, Jnl 105595 and 103324 to CJB), a Natural Environment Research Council Studentship (http://www.nerc.ac.uk to JMC), and a Nigel Groome Studentship (Oxford Brookes University to JMC). Oxford Brookes University kindly made funds available for Open Access publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja A, 2014, DEV GENES EVOL, V224, P65, DOI 10.1007/s00427-013-0463-7; Anantharaman V, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-13; Callebaut I, 2010, BIOINFORMATICS, V26, P1140, DOI 10.1093/bioinformatics/btq122; Carter JM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-283; Copf T, 2004, P NATL ACAD SCI USA, V101, P17711, DOI 10.1073/pnas.0407327102; Davis GK, 2002, ANNU REV ENTOMOL, V47, P669, DOI 10.1146/annurev.ento.47.091201.145251; de Heredia ML, 2004, CURR OPIN CELL BIOL, V16, P80, DOI 10.1016/j.ceb.2003.11.002; DRIEVER W, 1989, NATURE, V340, P363, DOI 10.1038/340363a0; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; Dubnau J, 1996, NATURE, V379, P694, DOI 10.1038/379694a0; Ewen-Campen B, 2013, BIOL OPEN, V2, P556, DOI 10.1242/bio.20134390; Ewen-Campen B, 2013, CURR BIOL, V23, P835, DOI 10.1016/j.cub.2013.03.063; Ewen-Campen B, 2012, CURR BIOL, V22, P2278, DOI 10.1016/j.cub.2012.10.019; Extavour CGM, 2007, INTEGR COMP BIOL, V47, P770, DOI 10.1093/icb/icm027; Extavour CG, 2003, DEVELOPMENT, V130, P5869, DOI 10.1242/dev.00804; Ferguson L, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004698; FOE VE, 1983, J CELL SCI, V61, P31; Fu JP, 2012, P NATL ACAD SCI USA, V109, P7782, DOI 10.1073/pnas.1116641109; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Heasman J, 2001, DEV BIOL, V240, P377, DOI 10.1006/dbio.2001.0495; JARNOT B, 1988, Molecular Reproduction and Development, V1, P35, DOI 10.1002/mrd.1080010107; Jenny A, 2006, DEVELOPMENT, V133, P2827, DOI 10.1242/dev.02456; KASTERN WH, 1990, DEVELOPMENT, V108, P497; Kimelman D, 2012, WIRES DEV BIOL, V1, P253, DOI 10.1002/wdev.25; King R. C., 1970, OVARIAN DEV DROSOPHI; Klomp J, 2015, SCIENCE, V348, P1040, DOI 10.1126/science.aaa7105; Kobayashi S, 1996, NATURE, V380, P708, DOI 10.1038/380708a0; Kobayashi Y., 2003, LEPIDOPTERA MOTHS BU, V2, P495; Kotkamp K, 2010, DEVELOPMENT, V137, P1853, DOI 10.1242/dev.047043; KRAFT R, 1994, P NATL ACAD SCI USA, V91, P6634, DOI 10.1073/pnas.91.14.6634; Lantz VA, 1999, MECH DEVELOP, V85, P111, DOI 10.1016/S0925-4773(99)00096-9; Lynch JA, 2006, NATURE, V439, P728, DOI 10.1038/nature04445; Lynch JA, 2012, WIRES DEV BIOL, V1, P16, DOI 10.1002/wdev.3; Lynch JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002029; McGregor AP, 2006, BIOESSAYS, V28, P683, DOI 10.1002/bies.20429; MYOHARA M, 1994, DEVELOPMENT, V120, P2869; Nagy LM, 2006, MOL MODEL SYSTEMS LE, P139; Nakao H, 2006, DEV GENES EVOL, V216, P94, DOI 10.1007/s00427-005-0033-8; Nakao H, 2008, EVOL DEV, V10, P546, DOI 10.1111/j.1525-142X.2008.00270.x; Nakao H, 2012, DEV BIOL, V371, P293, DOI 10.1016/j.ydbio.2012.08.029; Nakao H, 2010, J EXP ZOOL PART B, V314B, P224, DOI 10.1002/jez.b.21328; Olesnicky EC, 2006, DEVELOPMENT, V133, P3973, DOI 10.1242/dev.02576; Patel NH, 2001, DEVELOPMENT, V128, P3459; Peel AD, 2010, DEV DYNAM, V239, P2875, DOI 10.1002/dvdy.22423; Pflanz R, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.140161; POKRYWKA NJ, 1994, DEV BIOL, V166, P210, DOI 10.1006/dbio.1994.1308; Quah S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142243; RAFF JW, 1989, CELL, V57, P611, DOI 10.1016/0092-8674(89)90130-X; RiveraPomar R, 1996, NATURE, V379, P746, DOI 10.1038/379746a0; Schoppmeier M, 2009, CURR BIOL, V19, P1811, DOI 10.1016/j.cub.2009.09.026; Schroder R, 2003, NATURE, V422, P621, DOI 10.1038/nature01536; Solana J, 2013, EVODEVO, V4, DOI 10.1186/2041-9139-4-2; Telfer WH, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.5001; Wilson MJ, 2010, DEV BIOL, V339, P200, DOI 10.1016/j.ydbio.2009.12.015; XU X, 1994, DEVELOPMENT, V120, P277	56	9	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144471	10.1371/journal.pone.0144471	http://dx.doi.org/10.1371/journal.pone.0144471			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633019	Green Accepted, gold, Green Published			2022-12-27	WOS:000366040000085
J	Gueuvoghlanian-Silva, BY; Cordeiro, FB; Lobo, TF; Cataldi, TR; Lo Turco, EG; Bertolla, RP; Mattar, R; Torloni, MR; Daher, S				Gueuvoghlanian-Silva, Barbara Yasmin; Cordeiro, Fernanda Bertuccez; Lobo, Thalita Frutuoso; Cataldi, Thais Regiani; Lo Turco, Edson Guimaraes; Bertolla, Ricardo Pimenta; Mattar, Rosiane; Torloni, Maria Regina; Daher, Silvia			Lipid Fingerprinting in Mild versus Severe Forms of Gestational Diabetes Mellitus	PLOS ONE			English	Article							INSULIN-RESISTANCE; LOW-CARBOHYDRATE; BIOLOGICAL SAMPLES; RANDOMIZED-TRIAL; FASTING LIPIDS; PREGNANCY; METABOLISM; NEED; ASSOCIATION; CHOLESTEROL	The blood serum lipid profile of women with Gestational Diabetes Mellitus (GDM) is still under study. There are no data on the serum lipid profile of GDM patients with more severe (insulin treated) compared to milder forms (diet treated) GDM. The aim of our study was to analyze the blood serum lipid profile of patients with milder versus more severe forms of GDM and to compare these findings with those of healthy pregnant women. This cross-sectional analytical study included 30 insulin-treated GDM, 30 diet-only GDM and 30 healthy pregnant women. Serum lipid was extracted from the 90 participants and their lipid profiles were analyzed by lipid fingerprinting using liquid-chromatography-mass spectrometry. A total of 143 parent ions were differentially represented in each of the three groups, belonging to the following classes: Glycerophospholipids, Sterol Lipids, Sphingolipids, Prenol Lipids, Fatty Acyls and Glycerolipids. There were significant differences in the lipid profiles of healthy pregnant women compared to GDM patients and also between milder versus more severe forms of GDM. There are marked differences in lipid fingerprinting between healthy pregnant women compared to those with GDM in the third trimester. Moreover, the lipid profile of women with more severe forms of GDM differs considerably from that of women with milder forms of GDM. These findings may be useful to help clarify the pathogenesis of milder and more severe forms of GDM.	[Gueuvoghlanian-Silva, Barbara Yasmin; Lobo, Thalita Frutuoso; Mattar, Rosiane; Torloni, Maria Regina; Daher, Silvia] Univ Fed Sao Paulo, Dept Obstet, Sao Paulo, SP, Brazil; [Cordeiro, Fernanda Bertuccez; Lo Turco, Edson Guimaraes; Bertolla, Ricardo Pimenta] Univ Fed Sao Paulo, Div Urol, Human Reprod Sect, Dept Surg, Sao Paulo, SP, Brazil; [Cataldi, Thais Regiani] Univ Sao Paulo, Dept Genet ESALQ USP, Piracicaba, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo	Daher, S (corresponding author), Univ Fed Sao Paulo, Dept Obstet, Sao Paulo, SP, Brazil.	daher@unifesp.br	Bertolla, Ricardo Pimenta/D-2316-2009; Turco, Edson Lo/B-8719-2009; DAHER, SILVIA/D-2180-2012; Cataldi, Thais/H-5430-2018	Bertolla, Ricardo Pimenta/0000-0001-6892-9244; Turco, Edson Lo/0000-0002-3509-847X; DAHER, SILVIA/0000-0001-5312-7804; Cataldi, Thais/0000-0002-9827-2017; Cordeiro, Fernanda/0000-0002-5690-9665	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [11/14554-2]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	SD received funding from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - 11/14554-2). BYG-S received funding from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (doctoral scholarship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Baig S, 2013, PLACENTA, V34, P436, DOI 10.1016/j.placenta.2013.02.004; Bakiner Okan, 2013, J Clin Med Res, V5, P381, DOI 10.4021/jocmr1515w; Bayraktar F, 2012, INTERNAL MED, V51, P839, DOI 10.2169/internalmedicine.51.5846; Ben-Haroush A, 2004, DIABETIC MED, V21, P103, DOI 10.1046/j.1464-5491.2003.00985.x; Bhatti HN, 2012, STEROIDS, V77, P1267, DOI 10.1016/j.steroids.2012.07.018; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borggreve SE, 2003, EUR J CLIN INVEST, V33, P1051, DOI 10.1111/j.1365-2362.2003.01263.x; Bravata DM, 2003, JAMA-J AM MED ASSOC, V289, P1837, DOI 10.1001/jama.289.14.1837; Coen PM, 2012, TRENDS ENDOCRIN MET, V23, P391, DOI 10.1016/j.tem.2012.05.009; Cohn JS, 2008, CURR OPIN LIPIDOL, V19, P257, DOI 10.1097/MOL.0b013e3282ffaf96; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Coustan DR, 2013, CLIN CHEM, V59, P1310, DOI 10.1373/clinchem.2013.203331; De Oliveira L, 2012, CLIN BIOCHEM, V45, P852, DOI 10.1016/j.clinbiochem.2012.04.012; Durn JH, 2010, PROSTAG LEUKOTR ESS, V82, P21, DOI 10.1016/j.plefa.2009.11.002; Giuffrida FMA, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-156; Han XL, 2003, J LIPID RES, V44, P1071, DOI 10.1194/jlr.R300004-JLR200; Herrera E, 2010, BEST PRACT RES CL EN, V24, P515, DOI 10.1016/j.beem.2010.05.006; Hla T, 2012, CELL METAB, V16, P420, DOI 10.1016/j.cmet.2012.06.017; Ikeda K, 2009, J CHROMATOGR B, V877, P2639, DOI 10.1016/j.jchromb.2009.03.047; Karkkainen H, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-9; Kaur P, 2013, MOL BIOSYST, V9, P307, DOI 10.1039/c2mb25384d; Khalil MB, 2010, MASS SPECTROM REV, V29, P877, DOI 10.1002/mas.20294; Kullenberg D, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-3; Lahiri S, 2007, CELL MOL LIFE SCI, V64, P2270, DOI 10.1007/s00018-007-7076-0; Landon MB, 2009, NEW ENGL J MED, V361, P1339, DOI 10.1056/NEJMoa0902430; Lau ANC, 2012, CAN MED ASSOC J, V184, P767, DOI 10.1503/cmaj.110779; Lee AJ, 2007, DIABETES CARE, V30, P878, DOI 10.2337/dc06-1816; Markovic TP, 2016, DIABETES CARE, V39, P31, DOI 10.2337/dc15-0572; Mendez-Figueroa H, 2014, AM J PERINAT, V31, P105, DOI 10.1055/s-0033-1338174; Merzouk H, 2000, J LAB CLIN MED, V136, P441, DOI 10.1067/mlc.2000.111004; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; MONTELONGO A, 1992, DIABETES, V41, P1651, DOI 10.2337/diabetes.41.12.1651; Murakami M, 2011, EXP ANIM TOKYO, V60, P7, DOI 10.1538/expanim.60.7; Murphy RC, 2011, BBA-MOL CELL BIOL L, V1811, P776, DOI 10.1016/j.bbalip.2011.06.019; Pertot T, 2011, DIABETES CARE, V34, P2214, DOI 10.2337/dc11-0499; Ponssen HH, 2000, CLIN THER, V22, P709, DOI 10.1016/S0149-2918(00)90005-5; Riemens SC, 2001, SCAND J CLIN LAB INV, V61, P1; Sahebkar A, 2013, BBA-MOL CELL BIOL L, V1831, P887, DOI 10.1016/j.bbalip.2013.01.013; Saisho Y, 2010, ENDOCR J, V57, P973, DOI 10.1507/endocrj.K10E-231; Schroeder N, 2015, J ACAD NUTR DIET, V115, P1083, DOI 10.1016/j.jand.2015.03.023; Sharman MJ, 2004, J NUTR, V134, P880, DOI 10.1093/jn/134.4.880; Sokup A, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-21; Summers SA, 2010, CURR OPIN LIPIDOL, V21, P128, DOI 10.1097/MOL.0b013e3283373b66; Vinter CA, 2014, DIABETIC MED, V31, P1323, DOI 10.1111/dme.12548; Volek JS, 2004, J AM COLL NUTR, V23, P177, DOI 10.1080/07315724.2004.10719359; Zhao C, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-S1-S12	47	6	6	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144027	10.1371/journal.pone.0144027	http://dx.doi.org/10.1371/journal.pone.0144027			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633694	Green Published, Green Submitted, gold			2022-12-27	WOS:000366040000046
J	Mazzacavallo, MG; Kulmatiski, A				Mazzacavallo, Michael G.; Kulmatiski, Andrew			Modelling Water Uptake Provides a New Perspective on Grass and Tree Coexistence	PLOS ONE			English	Article							SOIL-WATER; SEASONAL PATTERNS; SAVANNA; CLIMATE; DEPTH; PRODUCTIVITY; VEGETATION; DIVERSITY; DOMINANCE; RESOURCE	Root biomass distributions have long been used to infer patterns of resource uptake. These patterns are used to understand plant growth, plant coexistence and water budgets. Root biomass, however, may be a poor indicator of resource uptake because large roots typically do not absorb water, fine roots do not absorb water from dry soils and roots of different species can be difficult to differentiate. In a sub-tropical savanna, Kruger Park, South Africa, we used a hydrologic tracer experiment to describe the abundance of active grass and tree roots across the soil profile. We then used this tracer data to parameterize a water movement model (Hydrus 1D). The model accounted for water availability and estimated grass and tree water uptake by depth over a growing season. Most root biomass was found in shallow soils (0-20 cm) and tracer data revealed that, within these shallow depths, half of active grass roots were in the top 12 cm while half of active tree roots were in the top 21 cm. However, because shallow soils provided roots with less water than deep soils (20-90 cm), the water movement model indicated that grass and tree water uptake was twice as deep as would be predicted from root biomass or tracer data alone: half of grass and tree water uptake occurred in the top 23 and 43 cm, respectively. Niche partitioning was also greater when estimated from water uptake rather than tracer uptake. Contrary to long-standing assumptions, shallow grass root distributions absorbed 32% less water than slightly deeper tree root distributions when grasses and trees were assumed to have equal water demands. Quantifying water uptake revealed deeper soil water uptake, greater niche partitioning and greater benefits of deep roots than would be estimated from root biomass or tracer uptake data alone.	[Mazzacavallo, Michael G.] Univ Alaska Anchorage, Dept Biol Sci, Anchorage, AK USA; [Kulmatiski, Andrew] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA; [Kulmatiski, Andrew] Utah State Univ, Ctr Ecol, Logan, UT 84322 USA	University of Alaska System; University of Alaska Anchorage; Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University	Kulmatiski, A (corresponding author), Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA.	andrew.kulmatiski@usu.edu			Andrew W. Mellon Foundation; Alaska EPSCoR NSF award [EPS-0701898]; state of Alaska; Utah Agricultural Experiment Station; Utah State University	Andrew W. Mellon Foundation; Alaska EPSCoR NSF award; state of Alaska; Utah Agricultural Experiment Station; Utah State University	The Andrew W. Mellon Foundation, Alaska EPSCoR NSF award #EPS-0701898 and the state of Alaska funded the research. This research was also supported by the Utah Agricultural Experiment Station and Utah State University and approved as journal paper number 8801. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen R. G., 1998, FAO Irrigation and Drainage Paper; [Anonymous], 1995, ZIMBABWE B FORESTRY; Asbjornsen H, 2008, PLANT SOIL, V308, P69, DOI 10.1007/s11104-008-9607-3; Bhattachan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033996; BISHOP K, 1995, CAN J FOREST RES, V25, P286, DOI 10.1139/x95-033; Bradford JB, 2006, ECOSYSTEMS, V9, P934, DOI 10.1007/s10021-004-0164-1; Buitenwerf R, 2014, KOEDOE, V56; Chen XY, 2004, J TROP ECOL, V20, P221, DOI 10.1017/S0266467403001135; DAWSON TE, 1993, GEOCHIM COSMOCHIM AC, V57, P3487, DOI 10.1016/0016-7037(93)90554-A; Donzelli D, 2013, J THEOR BIOL, V332, P181, DOI 10.1016/j.jtbi.2013.04.003; EHLERINGER JR, 1992, PLANT CELL ENVIRON, V15, P1073, DOI 10.1111/j.1365-3040.1992.tb01657.x; Eldridge DJ, 2011, ECOL LETT, V14, P709, DOI 10.1111/j.1461-0248.2011.01630.x; Entsminger G.L., 2014, ECOSIM PROFESSIONAL; February EC, 2010, S AFR J BOT, V76, P517, DOI 10.1016/j.sajb.2010.04.001; Feddes RA, 2001, B AM METEOROL SOC, V82, P2797, DOI 10.1175/1520-0477(2001)082<2797:MRWUIH>2.3.CO;2; Flint AL, 2002, SOIL SCI SOC AM J, V66, P1439, DOI 10.2136/sssaj2002.1439; FRASER S W, 1987, Koedoe, P19; Gat JR, 1996, ANNU REV EARTH PL SC, V24, P225, DOI 10.1146/annurev.earth.24.1.225; Green SR, 1997, AGR FOREST METEOROL, V83, P1, DOI 10.1016/S0168-1923(96)02362-3; Higgins SI, 2000, J ECOL, V88, P213, DOI 10.1046/j.1365-2745.2000.00435.x; Holdo RM, 2014, J ECOL, V102, P1171, DOI 10.1111/1365-2745.12290; Holdo RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069625; Jackson PC, 1999, TREE PHYSIOL, V19, P717; Knapp AK, 2008, BIOSCIENCE, V58, P811, DOI 10.1641/B580908; Kulmatiski A, 2004, SOIL BIOL BIOCHEM, V36, P383, DOI 10.1016/j.soilbio.2003.10.004; Kulmatiski A, 2013, OECOLOGIA; Kulmatiski A, 2013, NATURE CLIMATE CHANG; Kulmatiski A, 2010, NEW PHYTOL, V188, P199, DOI 10.1111/j.1469-8137.2010.03338.x; LANDSBERG JJ, 1973, AGR METEOROL, V12, P169, DOI 10.1016/0002-1571(73)90017-4; LEROUX X, 1995, OECOLOGIA, V104, P147, DOI 10.1007/BF00328579; McKane RB, 2002, NATURE, V415, P68, DOI 10.1038/415068a; Monteith J L, 1965, Symp Soc Exp Biol, V19, P205; Morillas L, 2013, WATER RESOUR RES, V49, P6572, DOI 10.1002/wrcr.20468; Mueller KE, 2013, ECOLOGY, V94, P787, DOI 10.1890/12-1399.1; Newman BD, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004141; Ogle K, 2004, ECOLOGY, V85, P1967, DOI 10.1890/03-0346; Peek MS, 2005, NEW PHYTOL, V165, P171, DOI 10.1111/j.1469-8137.2004.01186.x; Pereira AR, 2006, AGR WATER MANAGE, V83, P153, DOI 10.1016/j.agwat.2005.11.004; Peters DPC, 2002, ECOL MODEL, V152, P5, DOI 10.1016/S0304-3800(01)00460-4; Planka E.R., 1973, Annual Rev Ecol Syst, V4, P53; Ramoelo A, 2014, REMOTE SENS-BASEL, V6, P7406, DOI 10.3390/rs6087406; Sankaran M, 2004, ECOL LETT, V7, P480, DOI 10.1111/j.1461-0248.2004.00596.x; SAXTON KE, 1986, SOIL SCI SOC AM J, V50, P1031, DOI 10.2136/sssaj1986.03615995005000040039x; Schenk HJ, 2002, ECOL MONOGR, V72, P311, DOI 10.1890/0012-9615(2002)072[0311:TGBOR]2.0.CO;2; Scholes RJ, 1997, ANNU REV ECOL SYST, V28, P517, DOI 10.1146/annurev.ecolsys.28.1.517; Scott RL, 2014, GLOBAL CHANGE BIOL, V20, P2198, DOI 10.1111/gcb.12511; Sillmann J, 2013, J GEOPHYS RES-ATMOS, V118, P2473, DOI 10.1002/jgrd.50188; Simunek J., 2005, U CALIFORNIA RIVERSI, V3, P1, DOI DOI 10.1016/J.CEJ.2013.12.061; Smith NG, 2014, REV GEOPHYS, V52, P412, DOI 10.1002/2014RG000458; Smith PP, 1998, BOTHALIA, V28, P197, DOI 10.4102/abc.v28i2.641; Smithwick EAH, 2014, ECOL MODEL, V291, P193, DOI 10.1016/j.ecolmodel.2014.07.023; THORPE MR, 1980, PLANT CELL ENVIRON, V3, P23, DOI 10.1111/1365-3040.ep11580508; Trenberth KE, 2011, CLIM RES, V47, P123, DOI 10.3354/cr00953; Vendramini PF, 2007, RAPID COMMUN MASS SP, V21, P164, DOI 10.1002/rcm.2826; Venter F.J., 2003, KRUGER EXPERIENCE EC, P83, DOI DOI 10.2989/10220110409485835; Verweij RT, 2009, THESIS; Walter H., 1971, ECOLOGY TROPICAL SUB; Ward D, 2013, OECOLOGIA, V172, P617, DOI 10.1007/s00442-012-2538-y; Warren CP, 2015, J ARID ENVIRON, V121, P67, DOI 10.1016/j.jaridenv.2015.06.001; Wigley BJ, 2013, ACTA OECOL, V51, P17, DOI 10.1016/j.actao.2013.05.007; Wilske B, 2010, J ARID ENVIRON, V74, P1461, DOI 10.1016/j.jaridenv.2010.05.013; WINEMILLER KO, 1990, ECOL MONOGR, V60, P27, DOI 10.2307/1943025	62	32	35	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144300	10.1371/journal.pone.0144300	http://dx.doi.org/10.1371/journal.pone.0144300			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633177	Green Published, Green Submitted, gold			2022-12-27	WOS:000366040000079
J	Duan, HX; Wang, L; Zhang, L; Liu, J; Zhang, K; Wu, JH				Duan, Hongxia; Wang, Li; Zhang, Liang; Liu, Jing; Zhang, Kan; Wu, Jianhui			The Relationship between Cortisol Activity during Cognitive Task and Posttraumatic Stress Symptom Clusters	PLOS ONE			English	Article							RESEARCH DOMAIN CRITERIA; TRAIT ANXIETY INVENTORY; SALIVARY CORTISOL; PTSD SYMPTOMS; PHENOTYPIC HETEROGENEITY; PSYCHOMETRIC PROPERTIES; MOMENTARY ASSESSMENT; EARTHQUAKE VICTIMS; LATENT STRUCTURE; NEGATIVE AFFECT	Background The latest development in the dimensional structure of posttraumatic stress disorder (PTSD) is a novel 6-factor model, which builds on the newly released DSM-5. One notable gap in the literature is that little is known about how distinct symptom clusters of PTSD are related to hypothalamic-pituitary-adrenal (HPA) axis activity when people perform a relatively less stressful cognitive task. The purpose of this study was to investigate the relationship between cortisol activity when individuals perform cognitive tasks in the laboratory and a contemporary phenotypic model of posttraumatic stress symptomatology in earthquake survivors. Methods Salivary cortisol while performing cognitive tasks was collected and analyzed in 89 adult earthquake survivors. The PTSD Checklist for the DSM-5 (PCL-5) was used to assess the severity of total PTSD as well as six distinct symptom clusters. Regression analyses were conducted to examine the associations between the six distinct PTSD symptom clusters and cortisol profiles. Results The results showed that the score of the negative affect symptom cluster, but not anhedonia or other clusters, was positively associated with cortisol levels before and during the cognitive tasks. Conclusion The results showed that higher cortisol levels before and during cognitive tasks might be specifically linked to a distinct symptom cluster of PTSD-negative affect symptomatology. This suggests that a distinction should be made between negative affect and anhedonia symptom clusters, as the 6-factor model proposed.	[Duan, Hongxia; Zhang, Liang; Liu, Jing; Zhang, Kan; Wu, Jianhui] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Duan, Hongxia; Liu, Jing] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wang, Li] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Psychology, CAS	Wu, JH (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	wujh@psych.ac.cn		wang, li/0000-0002-1459-3412	National Key Technology Research and Development Program of China [2013BAI08B02]; Chinese Academy of Sciences [KJZD-EW-L04]; National Natural Science Foundation of China [91124003, 81371203, 31271099]	National Key Technology Research and Development Program of China(National Key Technology R&D ProgramNational High Technology Research and Development Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key Technology Research and Development Program of China (No. 2013BAI08B02), the Key Research Program of the Chinese Academy of Sciences (No. KJZD-EW-L04), and the National Natural Science Foundation of China (91124003, 81371203, and 31271099).	Almela M, 2012, PSYCHONEUROENDOCRINO, V37, P1929, DOI 10.1016/j.psyneuen.2012.04.009; American Psychiatric Association (APA), 2013, DIAGN STAT MAN MENT; Asmundson GJG, 2004, J TRAUMA STRESS, V17, P467, DOI 10.1007/s10960-004-5795-7; Asmundson GJG, 2000, BEHAV RES THER, V38, P203, DOI 10.1016/S0005-7967(99)00061-3; Blevins C. A., 2012, 28 ANN M INT SOC TRA; Bremner JD, 2003, PSYCHONEUROENDOCRINO, V28, P733, DOI 10.1016/S0306-4530(02)00067-7; Broman-Fulks JJ, 2009, J TRAUMA STRESS, V22, P146, DOI 10.1002/jts.20399; Broman-Fulks JJ, 2006, BEHAV THER, V37, P364, DOI 10.1016/j.beth.2006.02.006; Buchanan TW, 1999, PSYCHONEUROENDOCRINO, V24, P227, DOI 10.1016/S0306-4530(98)00078-X; Craske MG, 2012, DEPRESS ANXIETY, V29, P253, DOI 10.1002/da.21930; Cuthbert BN, 2013, J ABNORM PSYCHOL, V122, P928, DOI 10.1037/a0034028; Cuthbert BN, 2010, SCHIZOPHRENIA BULL, V36, P1061, DOI 10.1093/schbul/sbq108; de Kloet CS, 2006, J PSYCHIATR RES, V40, P550, DOI 10.1016/j.jpsychires.2005.08.002; Dekel S, 2013, J TRAUMA STRESS, V26, P621, DOI 10.1002/jts.21839; Delahanty DL, 2000, BIOL PSYCHIAT, V48, P940, DOI 10.1016/S0006-3223(00)00896-9; Doane LD, 2014, J ADOLESCENT HEALTH, V54, P536, DOI 10.1016/j.jadohealth.2013.10.007; Elzinga BM, 2003, NEUROPSYCHOPHARMACOL, V28, P1656, DOI 10.1038/sj.npp.1300226; Fang CY, 2014, J INT MED RES, V42, P444, DOI 10.1177/0300060513504696; Gotlib I. H., 1989, ANXIETY DEPRESSION D, P131; Hawk LW, 2000, PSYCHOSOM MED, V62, P423, DOI 10.1097/00006842-200005000-00016; Holsboer F, 1996, ENDOCR REV, V17, P187, DOI 10.1210/er.17.2.187; Jacobs N, 2007, BIOL PSYCHOL, V74, P60, DOI 10.1016/j.biopsycho.2006.07.002; Jacobson L, 2014, COMPR PHYSIOL, V4, P715, DOI 10.1002/cphy.c130036; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Kudielka BM, 2004, PSYCHONEUROENDOCRINO, V29, P983, DOI 10.1016/j.psyneuen.2003.08.009; Lee BK, 2007, ARCH GEN PSYCHIAT, V64, P810, DOI 10.1001/archpsyc.64.7.810; Li HH, 2010, PSYCHOL REP, V107, P733, DOI 10.2466/03.15.20.PR0.107.6.733-739; Liberzon I, 1999, NEUROPSYCHOPHARMACOL, V21, P40, DOI 10.1016/S0893-133X(98)00128-6; Liu P, 2014, J ANXIETY DISORD, V28, P345, DOI 10.1016/j.janxdis.2014.03.008; LOVALLO WR, 1990, PSYCHOSOM MED, V52, P17, DOI 10.1097/00006842-199001000-00002; LOVALLO WR, 1985, PSYCHOPHYSIOLOGY, V22, P283, DOI 10.1111/j.1469-8986.1985.tb01602.x; Ma WF, 2013, J PSYCHIATR MENT HLT, V20, P499, DOI 10.1111/j.1365-2850.2012.01945.x; McDonald SD, 2010, CLIN PSYCHOL REV, V30, P976, DOI 10.1016/j.cpr.2010.06.012; McNally RJ, 2006, TRENDS COGN SCI, V10, P271, DOI 10.1016/j.tics.2006.04.007; Pietrzak RH, 2013, MOL PSYCHIATR, V18, P399, DOI 10.1038/mp.2012.60; Pietrzak RH, 2013, JAMA PSYCHIAT, V70, P1199, DOI 10.1001/jamapsychiatry.2013.399; Pruessner JC, 2003, PSYCHONEUROENDOCRINO, V28, P916, DOI 10.1016/S0306-4530(02)00108-7; Putman P, 2011, PSYCHONEUROENDOCRINO, V36, P439, DOI 10.1016/j.psyneuen.2010.12.001; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; RANKIN SH, 1993, PSYCHOL REP, V73, P1291, DOI 10.2466/pr0.1993.73.3f.1291; Ruscio AM, 2002, J ABNORM PSYCHOL, V111, P290, DOI 10.1037//0021-843X.111.2.290; Rutter M., 1990, RISK PROTECTIVE FACT, P181, DOI DOI 10.1017/CBO9780511752872; Schuitevoerder S, 2013, J ANXIETY DISORD, V27, P550, DOI 10.1016/j.janxdis.2013.01.001; SHEK DTL, 1993, J CLIN PSYCHOL, V49, P349, DOI 10.1002/1097-4679(199305)49:3<349::AID-JCLP2270490308>3.0.CO;2-J; Simeon D, 2007, BIOL PSYCHIAT, V61, P966, DOI 10.1016/j.biopsych.2006.07.030; Smyth J, 1998, PSYCHONEUROENDOCRINO, V23, P353, DOI 10.1016/S0306-4530(98)00008-0; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Steptoe A, 2007, PSYCHONEUROENDOCRINO, V32, P56, DOI 10.1016/j.psyneuen.2006.10.001; Stoppelbein L, 2015, ANXIETY STRESS COPIN, V28, P17, DOI 10.1080/10615806.2014.923844; vanEck M, 1996, PSYCHOSOM MED, V58, P447, DOI 10.1097/00006842-199609000-00007; Wang L, 2015, BIOL PSYCHIAT, V77, pE21, DOI 10.1016/j.biopsych.2014.05.026; Wang L, 2011, J ANXIETY DISORD, V25, P771, DOI 10.1016/j.janxdis.2011.03.011; Wang L, 2009, J TRAUMA STRESS, V22, P444, DOI 10.1002/jts.20439; Watson D, 2005, J ABNORM PSYCHOL, V114, P522, DOI 10.1037/0021-843X.114.4.522; Watson D, 2011, INT J CLIN HLTH PSYC, V11, P429; Watson D, 2009, ANNU REV CLIN PSYCHO, V5, P221, DOI 10.1146/annurev.clinpsy.032408.153510; Weathers FW, 2013, THEPTSDCHECKLISTFORD; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; Zhou XB, 2013, COMPR PSYCHIAT, V54, P493, DOI 10.1016/j.comppsych.2012.12.010	59	8	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144315	10.1371/journal.pone.0144315	http://dx.doi.org/10.1371/journal.pone.0144315			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX8BI	26630485	Green Submitted, Green Published, gold			2022-12-27	WOS:000365926300179
J	Ariyo, EO; Booy, EP; Patel, TR; Dzananovic, E; McRae, EK; Meier, M; McEleney, K; Stetefeld, J; McKenna, SA				Ariyo, Emmanuel O.; Booy, Evan P.; Patel, Trushar R.; Dzananovic, Edis; McRae, Ewan K.; Meier, Markus; McEleney, Kevin; Stetefeld, Jorg; McKenna, Sean A.			Biophysical Characterization of G-Quadruplex Recognition in the PITX1 mRNA by the Specificity Domain of the Helicase RHAU	PLOS ONE			English	Article							HOMEOBOX GENE-EXPRESSION; CIRCULAR-DICHROISM; DNA; SEQUENCE; UNWINDS; STABILITY; BINDING; TRANSCRIPTION; RESOLUTION; INSIGHTS	Nucleic acids rich in guanine are able to fold into unique structures known as G-quadruplexes. G-quadruplexes consist of four tracts of guanylates arranged in parallel or antiparallel strands that are aligned in stacked G-quartet planes. The structure is further stabilized by Hoogsteen hydrogen bonds and monovalent cations centered between the planes. RHAU (RNA helicase associated with AU-rich element) is a member of the ATP-dependent DExH/D family of RNA helicases and can bind and resolve G-quadruplexes. RHAU contains a core helicase domain with an N-terminal extension that enables recognition and full binding affinity to RNA and DNA G-quadruplexes. PITX1, a member of the bicoid class of homeobox proteins, is a transcriptional activator active during development of vertebrates, chiefly in the anterior pituitary gland and several other organs. We have previously demonstrated that RHAU regulates PITX1 levels through interaction with G-quadruplexes at the 3'-end of the PITX1 mRNA. To understand the structural basis of G-quadruplex recognition by RHAU, we characterize a purified minimal PITX1 G-quadruplex using a variety of biophysical techniques including electrophoretic mobility shift assays, UV-VIS spectroscopy, circular dichroism, dynamic light scattering, small angle X-ray scattering and nuclear magnetic resonance spectroscopy. Our biophysical analysis provides evidence that the RNA G-quadruplex, but not its DNA counterpart, can adopt a parallel orientation, and that only the RNA can interact with N-terminal domain of RHAU via the tetrad face of the G-quadruplex. This work extends our insight into how the N-terminal region of RHAU recognizes parallel G-quadruplexes.	[Ariyo, Emmanuel O.; Booy, Evan P.; Dzananovic, Edis; McRae, Ewan K.; Meier, Markus; McEleney, Kevin; Stetefeld, Jorg; McKenna, Sean A.] Univ Manitoba, Dept Chem, Winnipeg, MB R3T 2N2, Canada; [Patel, Trushar R.] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; [McEleney, Kevin; Stetefeld, Jorg; McKenna, Sean A.] Univ Manitoba, Manitoba Inst Mat, Winnipeg, MB R3T 2N2, Canada; [Stetefeld, Jorg; McKenna, Sean A.] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB R3T 2N2, Canada	University of Manitoba; University of Birmingham; University of Manitoba; University of Manitoba	McKenna, SA (corresponding author), Univ Manitoba, Dept Chem, 144 Dysart Rd, Winnipeg, MB R3T 2N2, Canada.	sean.mckenna@umanitoba.ca	Meier, Markus/F-2798-2011; Stetefeld, Joerg/H-7630-2017; Patel, Trushar R./AAB-6250-2020; Patel, Trushar R/F-2776-2011	Meier, Markus/0000-0003-1068-746X; Stetefeld, Joerg/0000-0003-1478-3248; Patel, Trushar R./0000-0003-0627-2923; Patel, Trushar R/0000-0003-0627-2923; McKenna, Sean/0000-0002-9407-7257	Cancer Research Society (Canada) [18206]	Cancer Research Society (Canada)	Funded by the Cancer Research Society (Canada) #18206. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrus A, 2006, NUCLEIC ACIDS RES, V34, P2723, DOI 10.1093/nar/gkl348; Arora A, 2008, RNA, V14, P1290, DOI 10.1261/rna.1001708; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Booy EP, 2012, NUCLEIC ACIDS RES, V40, P4110, DOI 10.1093/nar/gkr1306; Booy Evan P, 2015, Methods Mol Biol, V1259, P125, DOI 10.1007/978-1-4939-2214-7_9; Booy EP, 2014, NUCLEIC ACIDS RES, V42, P3346, DOI 10.1093/nar/gkt1340; Booy Evan P, 2012, Methods Mol Biol, V941, P69, DOI 10.1007/978-1-62703-113-4_6; Brazda V, 2014, INT J MOL SCI, V15, P17493, DOI 10.3390/ijms151017493; Brooks TA, 2010, FEBS J, V277, P3459, DOI 10.1111/j.1742-4658.2010.07759.x; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Chen MC, 2015, NUCLEIC ACIDS RES, V43, P2223, DOI 10.1093/nar/gkv051; Chen Y, 2007, LUNG CANCER, V55, P287, DOI 10.1016/j.lungcan.2006.11.001; Collie GW, 2010, NUCLEIC ACIDS RES, V38, P5569, DOI 10.1093/nar/gkq259; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; Creacy SD, 2008, J BIOL CHEM, V283, P34626, DOI 10.1074/jbc.M806277200; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Dzananovic E, 2013, RNA, V19, P333, DOI 10.1261/rna.035931.112; Eddy J, 2008, NUCLEIC ACIDS RES, V36, P1321, DOI 10.1093/nar/gkm1138; Egli M, 1996, BIOCHEMISTRY-US, V35, P8489, DOI 10.1021/bi9607214; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Frees S, 2014, HUM GENOMICS, V8, DOI 10.1186/1479-7364-8-8; Fry M, 2007, FRONT BIOSCI-LANDMRK, V12, P4336, DOI 10.2741/2391; Gao X, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.571; Giri B, 2011, NUCLEIC ACIDS RES, V39, P7161, DOI 10.1093/nar/gkr234; Heddi B, 2015, P NATL ACAD SCI USA, V112, P9608, DOI 10.1073/pnas.1422605112; Hershman SG, 2008, NUCLEIC ACIDS RES, V36, P144, DOI 10.1093/nar/gkm986; HOOGSTEEN K, 1963, ACTA CRYSTALLOGR, V16, P907, DOI 10.1107/S0365110X63002437; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Huppert JL, 2008, NUCLEIC ACIDS RES, V36, P6260, DOI 10.1093/nar/gkn511; Klopocki E, 2012, EUR J HUM GENET, V20, P705, DOI 10.1038/ejhg.2011.264; Knosel T, 2012, INT J COLORECTAL DIS, V27, P1391, DOI 10.1007/s00384-012-1460-4; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026; Lam EYN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2792; Lamonerie T, 1996, GENE DEV, V10, P1284, DOI 10.1101/gad.10.10.1284; Lanctot C, 1997, DEVELOPMENT, V124, P2807; Lattmann S, 2010, NUCLEIC ACIDS RES, V38, P6219, DOI 10.1093/nar/gkq372; Lord RVN, 2005, SURGERY, V138, P924, DOI 10.1016/j.surg.2005.05.007; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Meier M, 2013, J BIOL CHEM, V288, P35014, DOI 10.1074/jbc.M113.512970; Mergny JL, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni134; Nicoludis JM, 2012, J AM CHEM SOC, V134, P20446, DOI 10.1021/ja3088746; Patel TR, 2010, MATRIX BIOL, V29, P565, DOI 10.1016/j.matbio.2010.07.004; Randazzo A, 2013, TOP CURR CHEM, V330, P67, DOI 10.1007/128_2012_331; Rogers GW, 1999, J BIOL CHEM, V274, P12236, DOI 10.1074/jbc.274.18.12236; Sacca B, 2005, NUCLEIC ACIDS RES, V33, P1182, DOI 10.1093/nar/gki257; Sarkies P, 2010, MOL CELL, V40, P703, DOI 10.1016/j.molcel.2010.11.009; Shang J, 1997, GENOMICS, V40, P108, DOI 10.1006/geno.1996.4558; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Szeto DP, 1996, P NATL ACAD SCI USA, V93, P7706, DOI 10.1073/pnas.93.15.7706; Todd AK, 2005, NUCLEIC ACIDS RES, V33, P2901, DOI 10.1093/nar/gki553; Verma A, 2008, J MED CHEM, V51, P5641, DOI 10.1021/jm800448a; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wieland M, 2007, CHEM BIOL, V14, P757, DOI 10.1016/j.chembiol.2007.06.005; Wu YL, 2008, MOL CELL BIOL, V28, P4116, DOI 10.1128/MCB.02210-07; Zhang AYQ, 2011, BIOCHEMISTRY-US, V50, P7251, DOI 10.1021/bi200805j	61	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144510	10.1371/journal.pone.0144510	http://dx.doi.org/10.1371/journal.pone.0144510			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26649896	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903300053
J	Hashiguchi, M; Imai, S; Uehara, K; Maruyama, J; Shimizu, M; Mochizuki, M				Hashiguchi, Masayuki; Imai, Shungo; Uehara, Keiko; Maruyama, Junya; Shimizu, Mikiko; Mochizuki, Mayumi			Factors Affecting the Timing of Signal Detection of Adverse Drug Reactions	PLOS ONE			English	Article							EVENT REPORTING SYSTEM; PHARMACOVIGILANCE; SAFETY	We investigated factors affecting the timing of signal detection by comparing variations in reporting time of known and unknown ADRs after initial drug release in the USA. Data on adverse event reactions (AERs) submitted to U.S. FDA was used. Six ADRs associated with 6 drugs (rosuvastatin, aripiprazole, teriparatide, telithromycin, exenatide, varenicline) were investigated: Changes in the proportional reporting ratio, reporting odds ratio, and information component as indexes of signal detection were followed every 3 months after each drugs release, and the time for detection of signals was investigated. The time for the detection of signal to be detected after drug release in the USA was 2-10 months for known ADRs and 19-44 months for unknown ones. The median lag time for known and unknown ADRs was 99.0-122.5 days and 185.5-306.0 days, respectively. When the FDA released advisory information on rare but potentially serious health risks of an unknown ADR, the time lag to report from the onset of ADRs to the FDA was shorter. This study suggested that one factor affecting signal detection time is whether an ADR was known or unknown at release.	[Hashiguchi, Masayuki; Imai, Shungo; Maruyama, Junya; Mochizuki, Mayumi] Keio Univ, Fac Pharm, Div Evaluat & Anal Drug Informat, Minato Ku, Tokyo, Japan; [Uehara, Keiko] Japan Pharmaceut Informat Ctr JAPIC, Shibuya Ku, Tokyo, Japan; [Shimizu, Mikiko] Keio Univ, Fac Pharm, Dept Hygien Chem, Minato Ku, Tokyo, Japan	Keio University; Keio University	Hashiguchi, M (corresponding author), Keio Univ, Fac Pharm, Div Evaluat & Anal Drug Informat, Minato Ku, Tokyo, Japan.	hashiguchi-ms@pha.keio.ac.jp		Imai, Shungo/0000-0001-5706-613X				Almenoff J, 2005, DRUG SAFETY, V28, P981, DOI 10.2165/00002018-200528110-00002; Almenoff JS, 2007, CLIN PHARMACOL THER, V82, P157, DOI 10.1038/sj.clpt.6100258; [Anonymous], 2006, PUBL HLTH ADV KET TE; Avery AJ, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15200; Bate A, 2002, DRUG SAFETY, V25, P393, DOI 10.2165/00002018-200225060-00002; Bate A, 2009, PHARMACOEPIDEM DR S, V18, P427, DOI 10.1002/pds.1742; Bate A, 1998, EUR J CLIN PHARMACOL, V54, P315, DOI 10.1007/s002280050466; DuMouchel W, 1999, AM STAT, V53, P177, DOI 10.2307/2686093; DuMouchel W., 2001, P 7 ACM SIGKDD INT C, P67, DOI DOI 10.1145/502512.502526; Evans SJ, 2011, PHARMACOEPIDEM DR S, V10, P483; Gould AL, 2003, PHARMACOEPIDEM DR S, V12, P559, DOI 10.1002/pds.771; Hauben M, 2006, PHARMACOEPIDEM DR S, V15, P775, DOI 10.1002/pds.1275; Hoffman KB, 2014, DRUG SAFETY, V37, P971, DOI 10.1007/s40264-014-0225-0; Kubota K, 2011, JPN J PHARMACOEPIDEM, V16, P27; Kubota K, 2003, J PRACT PHARM, V54, P59; Noren GN, 2006, STAT MED, V25, P3740, DOI 10.1002/sim.2473; Pharmaceuticals and Medical Devices Agency, 2007, REP INTR DAT MIN TEC; Sakaeda T, 2013, INT J MED SCI, V10, P796, DOI 10.7150/ijms.6048; Takarabe M, 2012, BIOINFORMATICS, V28, pI611, DOI 10.1093/bioinformatics/bts413; Tatonetti NP, 2012, J AM MED INFORM ASSN, V19, P79, DOI 10.1136/amiajnl-2011-000214; *US FDA, 2007, EARL COMM ONG SAF RE; *US FDA, 2008, INF HEALTHC PROF EX; US Food and Drug Administration, 2008, PUBL HLTH ADV IMP IN; US Food and Drug Administration (FDA), 2007, INF HEALTHC PROF EX; van Puijenbroek EP, 2002, PHARMACOEPIDEM DR S, V11, P3, DOI 10.1002/pds.668	25	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144263	10.1371/journal.pone.0144263	http://dx.doi.org/10.1371/journal.pone.0144263			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641634	Green Published, gold, Green Submitted			2022-12-27	WOS:000366902700087
J	Jorge-Penas, A; Izquierdo-Alvarez, A; Aguilar-Cuenca, R; Vicente-Manzanares, M; Garcia-Aznar, JM; Van Oosterwyck, H; De-Juan-Pardo, EM; Ortiz-De-Solorzano, C; Munoz-Barrutia, A				Jorge-Penas, Alvaro; Izquierdo-Alvarez, Alicia; Aguilar-Cuenca, Rocio; Vicente-Manzanares, Miguel; Garcia-Aznar, Jose Manuel; Van Oosterwyck, Hans; de-Juan-Pardo, Elena M.; Ortiz-de-Solorzano, Carlos; Munoz-Barrutia, Arrate			Free Form Deformation-Based Image Registration Improves Accuracy of Traction Force Microscopy	PLOS ONE			English	Article							CELLS; STIFFNESS; MOMENTS	Traction Force Microscopy (TFM) is a widespread method used to recover cellular tractions from the deformation that they cause in their surrounding substrate. Particle Image Velocimetry (PIV) is commonly used to quantify the substrate's deformations, due to its simplicity and efficiency. However, PIV relies on a block-matching scheme that easily underestimates the deformations. This is especially relevant in the case of large, locally non-uniform deformations as those usually found in the vicinity of a cell's adhesions to the substrate. To overcome these limitations, we formulate the calculation of the deformation of the substrate in TFM as a non-rigid image registration process that warps the image of the unstressed material to match the image of the stressed one. In particular, we propose to use a B-spline -based Free Form Deformation (FFD) algorithm that uses a connected deformable mesh to model a wide range of flexible deformations caused by cellular tractions. Our FFD approach is validated in 3D fields using synthetic (simulated) data as well as with experimental data obtained using isolated endothelial cells lying on a deformable, polyacrylamide substrate. Our results show that FFD outperforms PIV providing a deformation field that allows a better recovery of the magnitude and orientation of tractions. Together, these results demonstrate the added value of the FFD algorithm for improving the accuracy of traction recovery.	[Jorge-Penas, Alvaro; Izquierdo-Alvarez, Alicia; Van Oosterwyck, Hans] Katholieke Univ Leuven, Dept Mech Engn, Biomech Sect, B-3001 Louvain, Belgium; [Aguilar-Cuenca, Rocio; Vicente-Manzanares, Miguel] Univ Autonoma Madrid, Sch Med, Inst Invest Sanitaria Hosp Univ Princesa, Madrid 28006, Spain; [Garcia-Aznar, Jose Manuel] Univ Zaragoza, Dept Mech Engn, Aragon Inst Engn Res I3A, Multiscale Mech & Biol Engn M2BE, Zaragoza 50018, Spain; [Van Oosterwyck, Hans] Katholieke Univ Leuven, Div Skeletal Tissue Engn, Prometheus, Leuven, Belgium; [de-Juan-Pardo, Elena M.] Queensland Univ Technol, Regenerat Med Program, Inst Hlth & Biomed Innovat, Brisbane, Qld 4059, Australia; [Ortiz-de-Solorzano, Carlos] Univ Navarra, Navarras Hlth Res Inst IDISNA, Program Solid Tumors & Biomarkers, Ctr Appl Med Res CIMA,Canc Imaging Lab, Pamplona 31008, Spain; [Munoz-Barrutia, Arrate] Univ Carlos III Madrid, Bioengn & Aerosp Engn Dept, Inst Invest Sanitaria Gregorio Maranon, Madrid 28911, Spain	KU Leuven; Autonomous University of Madrid; University of Zaragoza; KU Leuven; Queensland University of Technology (QUT); University of Navarra; Universidad Carlos III de Madrid	Munoz-Barrutia, A (corresponding author), Univ Carlos III Madrid, Bioengn & Aerosp Engn Dept, Inst Invest Sanitaria Gregorio Maranon, Madrid 28911, Spain.	mamunozb@ing.uc3m.es	Garcia-Aznar, Jose Manuel/F-8256-2010; Bustelo, Xose R./A-9526-2010; De-Juan-Pardo, Elena M./I-5871-2016; Ortiz-de-Solorzano, Carlos/G-3278-2010; Vicente-Manzanares, Miguel/H-1010-2018; Van Oosterwyck, Hans/C-2528-2016; Munoz-Barrutia, Arrate/G-1776-2016	Garcia-Aznar, Jose Manuel/0000-0002-9864-7683; Bustelo, Xose R./0000-0001-9398-6072; De-Juan-Pardo, Elena M./0000-0001-9005-7497; Ortiz-de-Solorzano, Carlos/0000-0001-8720-0205; Vicente-Manzanares, Miguel/0000-0001-5943-3220; Van Oosterwyck, Hans/0000-0002-2142-9717; Munoz-Barrutia, Arrate/0000-0002-1573-1661	Ministerio de Economia y Competividad [RyC2010-06094, SAF2011-24953, DPI2012-38090-C1, DPI2012-38090-C3, TEC2013-48552-C2-1-R]; Fundacion Ramon Areces; European Research Council [306751, 308223]	Ministerio de Economia y Competividad(Spanish Government); Fundacion Ramon Areces; European Research Council(European Research Council (ERC)European Commission)	Funded by Ministerio de Economia y Competividad (ES); url: http://www.mineco.gob.es/; RyC2010-06094, Fundacion Ramon Areces (ES); url: http://www.fundacionareces.es/fundacionareces/, Ministerio de Economia y Competividad (ES); url: http://www.mineco.gob.es/; SAF2011-24953 (MVM); Ministerio de Economia y Competividad (ES); url: http://www.mineco.gob.es/; DPI2012-38090-C1, European Research Council (BE); url: http://erc.europa.eu/; 306751 (JMGA); European Research Council (BE); url: http://erc.europa.eu/; 308223 (HVO); Ministerio de Economia y Competividad (ES); url: http://www.mineco.gob.es/; DPI2012-38090-C3 (COS); and Ministerio de Economia y Competividad (ES); url: http://www.mineco.gob.es/; TEC2013-48552-C2-1-R (AMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Kochba E, 2015, EXP MECH, V55, P261, DOI 10.1007/s11340-014-9874-2; Bozek J, 2011, ELMAR 2011 P, P14; Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001; Califano JP, 2010, CELL MOL BIOENG, V3, P68, DOI 10.1007/s12195-010-0102-6; Delanoe-Ayari H, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.248103; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Fournier MF, 2010, J CELL BIOL, V188, P287, DOI 10.1083/jcb.200906139; Franck C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017833; Gutierrez E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023807; Hall MS, 2013, EXP CELL RES, V319, P2396, DOI 10.1016/j.yexcr.2013.06.009; Holden M, 2008, IEEE T MED IMAGING, V27, P111, DOI 10.1109/TMI.2007.904691; Huang JY, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118767; Hur SS, 2009, CELL MOL BIOENG, V2, P425, DOI 10.1007/s12195-009-0082-6; Jorge-Penas a, 2014, COMPUT METHOD BIOMEC, P37, DOI 10.1080/10255842; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Klein S, 2009, INT J COMPUT VISION, V81, P227, DOI 10.1007/s11263-008-0168-y; Lange JR, 2013, EXP CELL RES, V319, P2418, DOI 10.1016/j.yexcr.2013.04.023; Legant WR, 2013, P NATL ACAD SCI USA, V110, P881, DOI 10.1073/pnas.1207997110; Legant WR, 2010, NAT METHODS, V7, P969, DOI 10.1038/NMETH.1531; Loeckx D, 2004, LECT NOTES COMPUT SC, V3216, P639; Lopez-Fagundo C, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0247; Lu H, 2000, EXP MECH, V40, P393, DOI 10.1007/BF02326485; Maskarinec SA, 2009, P NATL ACAD SCI USA, V106, P22108, DOI 10.1073/pnas.0904565106; Pan B, 2010, EXP MECH, DOI 10.1007/s11340-010-9418-3; Pathak A, 2011, INTEGR BIOL-UK, V3, P267, DOI 10.1039/c0ib00095g; Pham TQ, 2005, PROC SPIE, V5817, P133, DOI 10.1117/12.603304; Reinhart-King CA, 2003, LANGMUIR, V19, P1573, DOI 10.1021/la026142j; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Sabass B, 2008, BIOPHYS J, V94, P207, DOI 10.1529/biophysj.107.113670; Szeliski R, 1996, INT J COMPUT VISION, V18, P171, DOI 10.1007/BF00055001; Tolic-Norrelykke IM, 2005, J BIOMECH, V38, P1405, DOI 10.1016/j.jbiomech.2004.06.027; Tolic-Norrelykke IM, 2002, AM J PHYSIOL-CELL PH, V283, pC1254, DOI 10.1152/ajpcell.00169.2002; Toyjanova J, 2014, SOFT MATTER, V10, P8095, DOI 10.1039/c4sm01271b; Zitova B, 2003, IMAGE VISION COMPUT, V21, P977, DOI 10.1016/S0262-8856(03)00137-9	34	20	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144184	10.1371/journal.pone.0144184	http://dx.doi.org/10.1371/journal.pone.0144184			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641883	Green Published, gold, Green Submitted			2022-12-27	WOS:000366902700070
J	Mussini, C; Lorenzini, P; Puoti, M; Lichtner, M; Lapadula, G; Di Giambenedetto, S; Antinori, A; Madeddu, G; Cozzi-Lepri, A; Monforte, AD; De Luca, A				Mussini, Cristina; Lorenzini, Patrizia; Puoti, Massimo; Lichtner, Miriam; Lapadula, Giuseppe; Di Giambenedetto, Simona; Antinori, Andrea; Madeddu, Giordano; Cozzi-Lepri, Alessandro; Monforte, Antonella d'Arminio; De Luca, Andrea		ICONA Fdn Study Grp	Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus	PLOS ONE			English	Article							LIVER FIBROSIS; COINFECTED INDIVIDUALS; NONINVASIVE INDEX; HIV; COHORT; MORTALITY; MARKERS; COMBINATION; PREDICTION; EVOLUTION	Objective To evaluate the Fibrosis (FIB)-4 index as a predictor of major liver-related events (LRE) and liver-related death (LRD) in human immunodeficiency virus (HIV) type-1 patients initiating combination antiretroviral therapy (cART). Design Retrospective analysis of a prospective cohort study. Setting Italian HIV care centers participating to the ICONA Foundation cohort. Participants Treatment-naive patients enrolled in ICONA were selected who: initiated cART, had hepatitis C virus (HCV) serology results, were HBsAg negative, had an available FIB-4 index at cART start and during follow up. Methods Cox regression models were used to determine the association of FIB4 with the risk of major LRE (gastrointestinal bleeding, ascites, hepatic encephalopathy, hepato-renal syndrome or hepatocellular carcinoma) or LRD. Results Three-thousand four-hundred seventy-five patients were enrolled: 73.3% were males, 27.2% HCV seropositive. At baseline (time of cART initiation) their median age was 39 years, had a median CD4+ T cell count of 260 cells/uL, and median HIV RNA 4.9 log copies/mL, 65.9% had a FIB-4 < 1.45, 26.4% 1.45-3.25 and 7.7% > 3.25. Over a follow up of 18,662 person-years, 41 events were observed: 25 major LRE and 16 LRD (incidence rate, IR, 2.2 per 1,000 PYFU [95% confidence interval, CI 1.6-3.0]). IR was higher in HCV sero-positives as compared to negatives (5.9 vs 0.5 per 1,000 PYFU). Higher baseline FIB-4 category as compared to < 1.45 (FIB-4 1.45-3.25: HR 3.55, 95% CI 1.09-11.58; FIB-4>3.25: HR 4.25, 1.21-14.92) and time-updated FIB-4 (FIB-4 1.45-3.25: HR 3.40, 1.02-11.40; FIB4>3.25: HR 21.24, 6.75-66.84) were independently predictive of major LRE/LRD, after adjusting for HIV- and HCV-related variables, alcohol consumption and type of cART. Conclusions The FIB-4 index at cART initiation, and its modification over time are risk factors for major LRE or LRD, independently of infection with HCV and could be used to monitor patients on cART.	[Mussini, Cristina] Univ Modena & Reggio Emilia, Clin Infect Dis, Modena, Italy; [Lorenzini, Patrizia; Antinori, Andrea] Natl Inst Infect Dis L Spallanzani, Rome, Italy; [Puoti, Massimo] Maggiore Hosp, Clin Infect Dis, Milan, Italy; [Lichtner, Miriam] Univ Roma La Sapienza, Clin Infect Dis, Rome, Italy; [Lapadula, Giuseppe] San Gerardo Hosp, Dept Infect Dis, Monza, Italy; [Di Giambenedetto, Simona] Univ Cattolica Sacro Cuore, Ist Clin Malattie Infett, Rome, Italy; [Madeddu, Giordano] Univ Sassari, Clin Malattie Infett, I-07100 Sassari, Italy; [Cozzi-Lepri, Alessandro] UCL, Dept Infect & Populat Hlth, Div Populat Hlth, London, England; [Monforte, Antonella d'Arminio] San Paolo Hosp, Dept Hlth Sci, Clin Infect Dis, Milan, Italy; [De Luca, Andrea] Univ Siena, Dept Med Biotechnol, Div Infect Dis, I-53100 Siena, Italy; [De Luca, Andrea] Siena Univ Hosp, Siena, Italy	Universita di Modena e Reggio Emilia; IRCCS Lazzaro Spallanzani; IRCCS Ca Granda Ospedale Maggiore Policlinico; Sapienza University Rome; San Gerardo Hospital; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Sassari; University of London; University College London; San Paolo-Polo Universitaria Hospital; University of Siena; University of Siena; University Hospital of Siena	De Luca, A (corresponding author), Univ Siena, Dept Med Biotechnol, Div Infect Dis, Via Laterina 8, I-53100 Siena, Italy.	a.deluca@ao-siena.toscana.it	De Luca, Andrea/G-8810-2011; nicastri, emanuele/K-7780-2016; Rusconi, Stefano/H-9263-2012; Ippolito, Giuseppe/J-7207-2017; Puoti, Massimo/AAA-6580-2020; Castagna, Antonella/K-3280-2018; Baldin, Gianmaria/A-8562-2019; Mussini, Cristina/K-8672-2016; digiambenedetto, simona/AAL-4429-2020; Saracino, Annalisa/F-5084-2017; Ursini, Tamara/AAB-3891-2019; Lapadula, Giuseppe/J-5163-2012; MADEDDU, Giordano/AAP-4342-2020; PELLICANO', GIOVANNI FRANCESCO/W-4077-2019; Antinori, Andrea/K-7125-2016; SANTORO, MARIA/K-3250-2018; perno, carlo federico/O-1544-2016; Di Biagio, Antonio/J-4901-2019; MARCHETTI, GIULIA CARLA/K-4384-2018; Balotta, Claudia/L-7295-2017; GALLI, MASSIMO/L-7282-2017; LAZZARIN, Adriano/K-3607-2018; QUIROS ROLDAN, Maria Eugenia/K-7586-2015	De Luca, Andrea/0000-0002-9561-9193; nicastri, emanuele/0000-0002-5606-8712; Rusconi, Stefano/0000-0002-0375-9990; Castagna, Antonella/0000-0002-8338-9714; Baldin, Gianmaria/0000-0003-4623-9976; Mussini, Cristina/0000-0002-6615-4198; Saracino, Annalisa/0000-0001-9558-208X; Ursini, Tamara/0000-0002-6012-0667; MADEDDU, Giordano/0000-0001-6099-2273; PELLICANO', GIOVANNI FRANCESCO/0000-0002-9640-8742; Antinori, Andrea/0000-0003-2121-4684; SANTORO, MARIA/0000-0002-6228-1114; Di Biagio, Antonio/0000-0003-1436-5089; Ammassari, Adriana/0000-0002-0284-0340; CECCHERINI SILBERSTEIN, FRANCESCA/0000-0002-6024-5101; Girardi, Enrico/0000-0001-8182-5896; Puoti, Massimo/0000-0003-3278-7138; MARCHETTI, GIULIA CARLA/0000-0002-4498-4828; Calcagno, Andrea/0000-0003-2534-8815; Cinque, Paola/0000-0003-2448-5957; LAPADULA, Giuseppe/0000-0002-9976-8102; Nozza, Silvia/0000-0002-2673-2731; MONNO, Laura/0000-0002-2713-4258; COSTANTINI, ANDREA/0000-0003-1588-7030; Segala, Daniela/0000-0001-6133-0386; PERNO, CARLO FEDERICO/0000-0002-0825-5388; Castelli, Francesco/0000-0001-9161-7804; Vanino, Elisa/0000-0003-3510-1429; Bandera, Alessandra/0000-0003-1626-0328; Gianotti, Nicola/0000-0002-7182-5080; Balotta, Claudia/0000-0002-1107-9119; GALLI, MASSIMO/0000-0001-8887-6215; LAZZARIN, Adriano/0000-0003-2551-7754; Guaraldi, Giovanni/0000-0002-5724-3914; BANDERA, ALESSANDRA/0000-0001-9440-4601; PUZZOLANTE, CINZIA/0000-0002-1179-1341; QUIROS ROLDAN, Maria Eugenia/0000-0003-1452-9100; Ippolito, Giuseppe/0000-0002-1076-2979; Bonfanti, Paolo/0000-0001-7289-8823; Capobianchi, Maria Rosaria/0000-0003-3465-0071; CAUDA, Roberto/0000-0002-1498-4229	Abbvie Italy; Bristol-Myers Squibb Italy; Gilead Italy; Janssen Italy; ViiV Healthcare Italy	Abbvie Italy(AbbVie); Bristol-Myers Squibb Italy(Bristol-Myers Squibb); Gilead Italy(Gilead Sciences); Janssen Italy; ViiV Healthcare Italy	The authors received no specific funding for this work. However, the ICONA Foundation Study is sponsored by unrestricted grants from Abbvie Italy, Bristol-Myers Squibb Italy, Gilead Italy, Janssen Italy, ViiV Healthcare Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bambha K, 2012, AIDS, V26, P599, DOI 10.1097/QAD.0b013e32834fa121; Berenguer J, 2014, CLIN INFECT DIS; Blackard JT, 2011, CLIN INFECT DIS, V52, P674, DOI 10.1093/cid/ciq199; Boursier J, 2014, ALIMENT PHARM THER, V40, P178, DOI 10.1111/apt.12813; Bruno R, 2011, DIGEST LIVER DIS, V43, P575, DOI 10.1016/j.dld.2011.03.009; Chinnaratha MA, 2014, LIVER INT, V34, P720, DOI 10.1111/liv.12306; Grint D, 2013, HIV MED, V14, P614, DOI 10.1111/hiv.12068; Holmberg SD, 2013, CLIN INFECT DIS, V57, P240, DOI 10.1093/cid/cit245; Jain MK, 2012, AIDS PATIENT CARE ST, V26, P73, DOI 10.1089/apc.2011.0191; Lim JK, 2014, CLIN INFECT DIS, V58, P1449, DOI 10.1093/cid/ciu097; Lo Re V, 2014, ANN INTERN MED, V160, P369, DOI 10.7326/M13-1829; Mendeni M, 2011, CLIN INFECT DIS, V52, P1164, DOI 10.1093/cid/cir071; Monforte AD, 2009, CLIN INFECT DIS, V49, P612, DOI 10.1086/603557; Park LS, 2011, CANCER EPIDEM BIOMAR, V20, P2512, DOI 10.1158/1055-9965.EPI-11-0582; Resino S, 2012, CURR OPIN INFECT DIS, V25, P564, DOI 10.1097/QCO.0b013e32835635df; Rivero-Juarez A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068953; Rohrbach J, 2014, ANTIVIR THER, V19, P149, DOI 10.3851/IMP2686; Shah AG, 2009, CLIN GASTROENTEROL H, V7, P1104, DOI 10.1016/j.cgh.2009.05.033; Smith CJ, 2014, LANCET, V384, P241, DOI 10.1016/S0140-6736(14)60604-8; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Sumida Y, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-2; Tahiri M, 2013, WORLD J HEPATOL, V5, P584, DOI 10.4254/wjh.v5.i10.584; Tamaki N, 2014, J GASTROENTEROL, V49, P1495, DOI 10.1007/s00535-013-0914-y; Vergniol J, 2014, HEPATOLOGY, V60, P65, DOI 10.1002/hep.27069; WHO, 2014, GUID SCREEN CAR TREA; Zinkernagel AS, 2006, ANTIVIR THER, V11, P131	26	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0140877	10.1371/journal.pone.0140877	http://dx.doi.org/10.1371/journal.pone.0140877			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26640953	Green Published, gold, Green Submitted			2022-12-27	WOS:000366902700002
J	Novak, PK; Smailovic, J; Sluban, B; Mozetic, I				Novak, Petra Kralj; Smailovic, Jasmina; Sluban, Borut; Mozetic, Igor			Sentiment of Emojis	PLOS ONE			English	Article								There is a new generation of emoticons, called emojis, that is increasingly being used in mobile communications and social media. In the past two years, over ten billion emojis were used on Twitter. Emojis are Unicode graphic symbols, used as a shorthand to express concepts and ideas. In contrast to the small number of well-known emoticons that carry clear emotional contents, there are hundreds of emojis. But what are their emotional contents? We provide the first emoji sentiment lexicon, called the Emoji Sentiment Ranking, and draw a sentiment map of the 751 most frequently used emojis. The sentiment of the emojis is computed from the sentiment of the tweets in which they occur. We engaged 83 human annotators to label over 1.6 million tweets in 13 European languages by the sentiment polarity (negative, neutral, or positive). About 4% of the annotated tweets contain emojis. The sentiment analysis of the emojis allows us to draw several interesting conclusions. It turns out that most of the emojis are positive, especially the most popular ones. The sentiment distribution of the tweets with and without emojis is significantly different. The inter-annotator agreement on the tweets with emojis is higher. Emojis tend to occur at the end of the tweets, and their sentiment polarity increases with the distance. We observe no significant differences in the emoji rankings between the 13 languages and the Emoji Sentiment Ranking. Consequently, we propose our Emoji Sentiment Ranking as a European language-independent resource for automated sentiment analysis. Finally, the paper provides a formalization of sentiment and a novel visualization in the form of a sentiment bar.	[Novak, Petra Kralj; Smailovic, Jasmina; Sluban, Borut; Mozetic, Igor] Jozef Stefan Inst, Ljubljana 1000, Slovenia	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Novak, PK (corresponding author), Jozef Stefan Inst, Jamova 39, Ljubljana 1000, Slovenia.	Petra.Kralj.Novak@ijs.si; Igor.Mozetic@ijs.si	Novak, Petra Kralj/AAE-5852-2020	Mozetic, Igor/0000-0002-5466-0608	EC [610704, 317532, 640772]; Slovenian ARRS programme Knowledge Technologies [P2-103]	EC(European CommissionEuropean Commission Joint Research Centre); Slovenian ARRS programme Knowledge Technologies	This work was supported in part by the EC projects SIMPOL (no. 610704), MULTIPLEX (no. 317532) and DOLFINS (no. 640772), and by the Slovenian ARRS programme Knowledge Technologies (no. P2-103).	Allen JD, 2015, UNICODE STANDARD VER; Allen JD, 2014, UNICODE STANDARD VER; Allen JD, 2011, UNICODE STANDARD VER; Amalanathan A, 2015, INDIAN J SCI TECHNOL, V8; Baccianella S, 2010, LREC 2010 - SEVENTH INTERNATIONAL CONFERENCE ON LANGUAGE RESOURCES AND EVALUATION; Boia M, 2013, 2013 ASE/IEEE INTERNATIONAL CONFERENCE ON SOCIAL COMPUTING (SOCIALCOM), P345, DOI 10.1109/SocialCom.2013.54; Coviello L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090315; Davidov D, 2010, P 23 INT C COMP LING, P241; Dimson T, 2015, EMOJINEERING 1; Fagerland MW, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-78; Ganesan KA, 2008, P 17 INT C WORLD WID, P1181; Go A, 2009, CS224N PROJECT REPOR, V1, P12; Good I. J., 1965, ESTIMATION PROBABILI; Gruzd A, 2011, P 44 HAW INT C SYST, p1a??9; Hatfield E., 1994, EMOTIONAL CONTAGION, P7, DOI [DOI 10.1017/CBO9781139174138, 10.1017/CBO9781139174138]; Hogenboom A., 2013, P 28 ANN ACM S APPL, P703, DOI DOI 10.1145/2480362.2480498; Hogenboom A, 2015, J WEB ENG, V14, P22; Kiritchenko S, 2014, J ARTIF INTELL RES, V50, P723, DOI 10.1613/jair.4272; Kramer A.D., 2012, P SIGCHI C HUMAN FAC, P767, DOI DOI 10.1145/2207676.2207787; Krippendorff K, 2018, CONTENT ANAL INTRO I; Liu B., 2012, SYNTHESIS LECT HUMAN, V5, P1, DOI DOI 10.2200/S00416ED1V01Y201204HLT016; Liu B., 2015, SENTIMENT ANAL MININ; Liu K, 2012, 26 AAAI C ART INT 22, P1678; MILLER GA, 1995, COMMUN ACM, V38, P39, DOI 10.1145/219717.219748; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Pak A., 2010, COMPUTER, P1320, DOI DOI 10.1371/JOURNAL.PONE.0026624; Pearson K., 1895, P R SOC LOND, V58, P240, DOI [10.1098/rspl.1895.0041, DOI 10.1098/RSPL.1895.0041]; Ranco G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138441; Read J., 2005, P ACL STUD RES WORKS, P43, DOI DOI 10.3115/1628960.1628969; Sluban B, 2015, COMPUTATIONAL SOCIAL, V2; Smailovic J., 2015, IEEE DSAA 2015, P1; Smailovic J, 2014, INFORM SCIENCES, V285, P181, DOI 10.1016/j.ins.2014.04.034; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; SwiftKey PT, 2015, MOST USED EMOJI REVE; Thelwall M, 2010, J AM SOC INF SCI TEC, V61, P2544, DOI 10.1002/asi.21416; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Zhang W., 2010, P INT AAAI C WEB SOC, P375; Zhao J., 2012, P 18 ACM SIGKDD INT, P1528, DOI DOI 10.1145/2339530.2339772; Zollo F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138740	40	288	293	21	295	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144296	10.1371/journal.pone.0144296	http://dx.doi.org/10.1371/journal.pone.0144296			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641093	Green Published, gold, Green Submitted			2022-12-27	WOS:000366902700093
J	Yao, CX; Behring, JB; Shao, D; Sverdlov, AL; Whelan, SA; Elezaby, A; Yin, XY; Siwik, DA; Seta, F; Costello, CE; Cohen, RA; Matsui, R; Colucci, WS; McComb, ME; Bachschmid, MM				Yao, Chunxiang; Behring, Jessica B.; Shao, Di; Sverdlov, Aaron L.; Whelan, Stephen A.; Elezaby, Aly; Yin, Xiaoyan; Siwik, Deborah A.; Seta, Francesca; Costello, Catherine E.; Cohen, Richard A.; Matsui, Reiko; Colucci, Wilson S.; McComb, Mark E.; Bachschmid, Markus M.			Overexpression of Catalase Diminishes Oxidative Cysteine Modifications of Cardiac Proteins	PLOS ONE			English	Article							HUMAN CARBONYL REDUCTASE; HYDROGEN-PEROXIDE; SERINE/THREONINE PHOSPHATASES; CONTRACTILE DYSFUNCTION; MITOCHONDRIAL-MEMBRANE; TRANSGENIC MICE; CYTOCHROME-C; MOUSE HEART; DNA-DAMAGE; LIM DOMAIN	Reactive protein cysteine thiolates are instrumental in redox regulation. Oxidants, such as hydrogen peroxide (H2O2), react with thiolates to form oxidative post-translational modifications, enabling physiological redox signaling. Cardiac disease and aging are associated with oxidative stress which can impair redox signaling by altering essential cysteine thiolates. We previously found that cardiac-specific overexpression of catalase (Cat), an enzyme that detoxifies excess H2O2, protected from oxidative stress and delayed cardiac aging in mice. Using redox proteomics and systems biology, we sought to identify the cysteines that could play a key role in cardiac disease and aging. With a 'Tandem Mass Tag' (TMT) labeling strategy and mass spectrometry, we investigated differential reversible cysteine oxidation in the cardiac proteome of wild type and Cat transgenic (Tg) mice. Reversible cysteine oxidation was measured as thiol occupancy, the ratio of total available versus reversibly oxidized cysteine thiols. Catalase overexpression globally decreased thiol occupancy by >= 1.3 fold in 82 proteins, including numerous mitochondrial and contractile proteins. Systems biology analysis assigned the majority of proteins with differentially modified thiols in Cat Tg mice to pathways of aging and cardiac disease, including cellular stress response, proteostasis, and apoptosis. In addition, Cat Tg mice exhibited diminished protein glutathione adducts and decreased H2O2 production from mitochondrial complex I and II, suggesting improved function of cardiac mitochondria. In conclusion, our data suggest that catalase may alleviate cardiac disease and aging by moderating global protein cysteine thiol oxidation.	[Yao, Chunxiang; Behring, Jessica B.; Shao, Di; Seta, Francesca; Cohen, Richard A.; Matsui, Reiko; Bachschmid, Markus M.] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Vasc Biol Sect,Dept Med, Boston, MA 02118 USA; [Sverdlov, Aaron L.; Elezaby, Aly; Siwik, Deborah A.; Colucci, Wilson S.] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Myocardial Biol Unit,Dept Med, Boston, MA 02118 USA; [Whelan, Stephen A.; Costello, Catherine E.; McComb, Mark E.] Boston Univ, Sch Med, Ctr Biomed Mass Spectrometry, Cardiovasc Prote Ctr, Boston, MA 02118 USA; [Yin, Xiaoyan] Boston Univ, Framingham, MA USA; [Yin, Xiaoyan] NHLBI, Framingham Heart Study, Framingham, MA USA; [Yin, Xiaoyan] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA	Boston University; Boston University; Boston University; Boston University; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University	McComb, ME (corresponding author), Boston Univ, Sch Med, Ctr Biomed Mass Spectrometry, Cardiovasc Prote Ctr, Boston, MA 02118 USA.	mccomb@bu.edu; bach@bu.edu	Shao, Di/F-9758-2016; Seta, Francesca/ABB-1566-2020; Sverdlov, Aaron/G-1384-2010	/0000-0002-7166-327X; Whelan, Stephen A/0000-0002-5439-6501; Seta, Francesca/0000-0001-7985-5615; Elezaby, Aly/0000-0001-8389-3200; Bachschmid, Markus Michael/0000-0002-0748-5528; /0000-0002-1070-6408; /0000-0002-4249-485X; Sverdlov, Aaron/0000-0003-2539-8038; Costello, Catherine/0000-0003-1594-5122	NHLBI, National Institutes of Health, Department of Health and Human Services [HHSN268201000031C]; NIH [P01 HL 068758, R37 HL104017, R01 HL064750, R01 HL031607, P41 GM104603, R01 DK103750, S10 OD010724]; National Health and Medical Research Council of Australia [APP1037603]; Royal Australasian College of Physicians; AHA Postdoctoral Fellowship [14POST20490003, 15POST21790006]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064750, R01HL031607, R37HL104017, P01HL068758, T32HL007501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM104603] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010724] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health, Department of Health and Human Services; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Royal Australasian College of Physicians(General Electric); AHA Postdoctoral Fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the NHLBI, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN268201000031C, and by NIH grants P01 HL 068758, R37 HL104017, R01 HL064750, R01 HL031607, P41 GM104603, R01 DK103750 and S10 OD010724. ALS is funded by a CJ Martin Fellowship from the National Health and Medical Research Council of Australia (APP1037603), the Marjorie Hooper Overseas Fellowship from the Royal Australasian College of Physicians and AHA Postdoctoral Fellowship 14POST20490003. DS is funded from the AHA Postdoctoral Fellowship 15POST21790006. The contents are solely the responsibility of the authors and do not represent the official views of the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman RL, 2008, J BIOL CHEM, V283, P35756, DOI 10.1074/jbc.M807125200; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Behring JB, 2014, FASEB J, V28, P1975, DOI 10.1096/fj.13-233445; Bhatia VN, 2009, ANAL CHEM, V81, P9819, DOI 10.1021/ac901335x; Breton-Romero R, 2014, REDOX BIOL, V2, P529, DOI 10.1016/j.redox.2014.02.005; Cameron JM, 2011, AM J HUM GENET, V89, P486, DOI 10.1016/j.ajhg.2011.08.011; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Charles RL, 2007, MOL CELL PROTEOMICS, V6, P1473, DOI 10.1074/mcp.M700065-MCP200; CHEN Y, 1994, FREE RADICAL BIO MED, V17, P529, DOI 10.1016/0891-5849(94)90092-2; CHO ES, 1984, J NUTR, V114, P1853, DOI 10.1093/jn/114.10.1853; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Cui ZY, 2014, J MOL CELL CARDIOL, V71, P32, DOI 10.1016/j.yjmcc.2013.10.008; Dai DF, 2009, CIRCULATION, V119, P2789, DOI 10.1161/CIRCULATIONAHA.108.822403; Dohoney KM, 2004, ONCOGENE, V23, P49, DOI 10.1038/sj.onc.1207005; Doorn JA, 2004, BIOCHEMISTRY-US, V43, P13106, DOI 10.1021/bi049136q; DOROSHOW JH, 1980, J CLIN INVEST, V65, P128, DOI 10.1172/JCI109642; Geula S, 2012, J BIOL CHEM, V287, P2179, DOI 10.1074/jbc.M111.268920; Ghosh S, 2006, J IMMUNOL, V176, P5587, DOI 10.4049/jimmunol.176.9.5587; Hartmanova T, 2013, CHEM-BIOL INTERACT, V202, P136, DOI 10.1016/j.cbi.2012.12.011; Hasty P, 2013, PATHOBIOL AGING AGE, V3, DOI 10.3402/pba.v3i0.22702; Hinds TD, 2008, INT J BIOCHEM CELL B, V40, P2358, DOI 10.1016/j.biocel.2007.08.010; Horn HF, 2007, ONCOGENE, V26, P1306, DOI 10.1038/sj.onc.1210263; Hu XL, 2006, CELL TISSUE RES, V325, P67, DOI 10.1007/s00441-005-0137-5; Huynen MA, 2005, FEBS LETT, V579, P591, DOI 10.1016/j.febslet.2004.11.111; Ishikawa T, 1986, TARGET ORGAN TOXICIT, V1; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kang YJ, 1996, J BIOL CHEM, V271, P12610, DOI 10.1074/jbc.271.21.12610; KashibaIwatsuki M, 1997, J BIOCHEM-TOKYO, V122, P1208; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kohr MJ, 2011, AM J PHYSIOL-HEART C, V300, pH1327, DOI 10.1152/ajpheart.00997.2010; Kontaxis G, 1998, BIOCHEMISTRY-US, V37, P7127, DOI 10.1021/bi973055v; Lemasters JJ, 2007, J GASTROEN HEPATOL, V22, pS31, DOI 10.1111/j.1440-1746.2006.04643.x; Li GQ, 1997, AM J PHYSIOL-HEART C, V273, pH1090, DOI 10.1152/ajpheart.1997.273.3.H1090; Liesa M, 2011, CIRCULATION, V124, P806, DOI 10.1161/CIRCULATIONAHA.110.003418; Liu N, 2008, NUCLEIC ACIDS RES, V36, P5335, DOI 10.1093/nar/gkn504; Ma JJ, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-103; Madesh M, 2001, J CELL BIOL, V155, P1003, DOI 10.1083/jcb.200105057; Maurya SR, 2013, J BIOL CHEM, V288, P25584, DOI 10.1074/jbc.M113.493692; Mitchelmore C, 2004, NEUROBIOL DIS, V16, P48, DOI 10.1016/j.nbd.2004.01.003; Nguyen-nhu NT, 2003, FEBS LETT, V544, P148, DOI 10.1016/S0014-5793(03)00493-9; Nilsson R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4128; Oklu R, 2000, BIOCHEM J, V352, P601, DOI 10.1042/0264-6021:3520601; Peng A, 2010, ONCOGENE, V29, P5977, DOI 10.1038/onc.2010.371; Petrosillo G, 2003, FASEB J, V17, P2202, DOI 10.1096/fj.03-0012com; Pimentel D, 2012, ANTIOXID REDOX SIGN, V16, P524, DOI 10.1089/ars.2011.4336; Qin FZ, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000184; Qin FZ, 2010, CIRC-HEART FAIL, V3, P306, DOI 10.1161/CIRCHEARTFAILURE.109.864785; Rhee SG, 2012, J BIOL CHEM, V287, P4403, DOI 10.1074/jbc.R111.283432; Roret T, 2014, J BIOL CHEM, V289, P24588, DOI 10.1074/jbc.M114.572701; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Sandri M, 2014, J MOL CELL CARDIOL, V71, P3, DOI 10.1016/j.yjmcc.2013.12.015; SCHMEICHEL KL, 1994, CELL, V79, P211, DOI 10.1016/0092-8674(94)90191-0; Shoshan-Barmatz V, 2006, CURR PHARM DESIGN, V12, P2249, DOI 10.2174/138161206777585111; Spencer Jean L, 2013, Curr Protoc Bioinformatics, V44, DOI 10.1002/0471250953.bi1322s44; Sverdlov AL, 2015, J MOL CELL CARDIOL, V78, P165, DOI 10.1016/j.yjmcc.2014.07.018; Takahashi K, 2005, NEUROSCI LETT, V388, P157, DOI 10.1016/j.neulet.2005.06.055; Tinguely JN, 1999, EUR J BIOCHEM, V260, P9, DOI 10.1046/j.1432-1327.1999.00089.x; Trifunovic A, 2008, J INTERN MED, V263, P167, DOI 10.1111/j.1365-2796.2007.01905.x; Turdi S, 2012, FREE RADICAL BIO MED, V53, P1327, DOI 10.1016/j.freeradbiomed.2012.07.084; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wakatsuki T, 1998, BIOL PHARM BULL, V21, P905; Wang LF, 2008, CELL PHYSIOL BIOCHEM, V21, P239, DOI 10.1159/000113765; Wang XJ, 2014, J MOL CELL CARDIOL, V71, P16, DOI 10.1016/j.yjmcc.2013.11.006; Wolkart G, 2006, PHARMACOL RES, V54, P50, DOI 10.1016/j.phrs.2006.02.005; Wu S, 2007, CLIN EXP PHARMACOL P, V34, P81, DOI 10.1111/j.1440-1681.2007.04540.x; Xu GQ, 2010, NAT BIOTECHNOL, V28, P868, DOI 10.1038/nbt.1654; Xu X, 1999, J MEMBRANE BIOL, V170, P89, DOI 10.1007/s002329900540; Young MJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-31	68	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144025	10.1371/journal.pone.0144025	http://dx.doi.org/10.1371/journal.pone.0144025			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642319	Green Published, Green Submitted, gold			2022-12-27	WOS:000366902700046
J	Amgad, M; Itoh, A; Tsui, MMK				Amgad, Mohamed; Itoh, Anri; Tsui, Marco Man Kin			Extending Ripley's K-Function to Quantify Aggregation in 2-D Grayscale Images	PLOS ONE			English	Article							MONITORING PROTEIN STABILITY; BACTERIAL INCLUSION-BODIES; IN-VIVO; SUBCELLULAR-LOCALIZATION; FLUORESCENCE MICROSCOPY; PERFORMANCE EVALUATION; CUBITUS-INTERRUPTUS; CELLS; DEGRADATION; HEDGEHOG	In this work, we describe the extension of Ripley's K-function to allow for overlapping events at very high event densities. We show that problematic edge effects introduce significant bias to the function at very high densities and small radii, and propose a simple correction method that successfully restores the function's centralization. Using simulations of homogeneous Poisson distributions of events, as well as simulations of event clustering under different conditions, we investigate various aspects of the function, including its shape-dependence and correspondence between true cluster radius and radius at which the K-function is maximized. Furthermore, we validate the utility of the function in quantifying clustering in 2-D grayscale images using three modalities: (i) Simulations of particle clustering; (ii) Experimental co-expression of soluble and diffuse protein at varying ratios; (iii) Quantifying chromatin clustering in the nuclei of wt and crwn1 crwn2 mutant Arabidopsis plant cells, using a previously-published image dataset. Overall, our work shows that Ripley's K-function is a valid abstract statistical measure whose utility extends beyond the quantification of clustering of non-overlapping events. Potential benefits of this work include the quantification of protein and chromatin aggregation in fluorescent microscopic images. Furthermore, this function has the potential to become one of various abstract texture descriptors that are utilized in computer-assisted diagnostics in anatomic pathology and diagnostic radiology.	[Amgad, Mohamed; Itoh, Anri; Tsui, Marco Man Kin] Grad Univ, Okinawa Inst Sci & Technol, Okinawa, Japan; [Amgad, Mohamed] Cairo Univ, Fac Med, Cairo, Egypt	Okinawa Institute of Science & Technology Graduate University; Egyptian Knowledge Bank (EKB); Cairo University	Amgad, M (corresponding author), Grad Univ, Okinawa Inst Sci & Technol, Okinawa, Japan.	mohamed-amgad1@hotmail.com; marco.tsui@oist.jp	Amgad, Mohamed/I-7440-2019	Amgad, Mohamed/0000-0001-7599-6162	Okinawa Institute of Science and Technology (OIST) Graduate University	Okinawa Institute of Science and Technology (OIST) Graduate University(Okinawa Institute of Science & Technology Graduate University)	The authors would like to acknowledge with gratitude the institutional support provided by the Okinawa Institute of Science and Technology (OIST) Graduate University, as well as the help provided by: Dr Mostafa Amgad (running the simulations); Dr Mohamed Abdelhak and Dr Shareef Nazzal (technical advice on programming); Dr Maha A. Temraz, Dr Ahmed E. Elmanzalawi and Dr Heba Salah (critically reviewing the manuscript and providing excellent insights and comments). The authors are grateful to the critical comments and suggestions provided by the editor and anonymous reviewers on an earlier version of this manuscript, which improved and solidified the methodology, findings and conclusions of this work.	Ami D, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-17; AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; BESAG J, 1977, J ROYAL STAT SOC B, V39, P193, DOI DOI 10.1016/J.FORECO.2009.04.009; Bovik AC, 2000, IMAGE ANAL METHODS A, V2, P38; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; CLARK PJ, 1954, ECOLOGY, V35, P445, DOI 10.2307/1931034; David Della C., 2012, Frontiers in Genetics, V3, P247, DOI 10.3389/fgene.2012.00247; David DC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000450; Dima AA, 2011, CYTOM PART A, V79A, P545, DOI 10.1002/cyto.a.21079; Dougherty ER, 1989, 12 CAN S REM SENS GE, V3, P1220, DOI DOI 10.1109/IGARSS.1989.576052; Eckel S. M., 2008, STAT ANAL SPATIAL PO; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Garcia-Fruitos E, 2011, FEBS J, V278, P2419, DOI 10.1111/j.1742-4658.2011.08165.x; Gatrell AC, 1996, T I BRIT GEOGR, V21, P256, DOI 10.2307/622936; Gatti-Lafranconi P, 2011, FEBS J, V278, P2408, DOI 10.1111/j.1742-4658.2011.08163.x; Hamilton N, 2009, TRAFFIC, V10, P951, DOI 10.1111/j.1600-0854.2009.00938.x; HARALICK RM, 1979, P IEEE, V67, P786, DOI 10.1109/PROC.1979.11328; Ignatova Z, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-23; Ignatova Z, 2004, P NATL ACAD SCI USA, V101, P523, DOI 10.1073/pnas.0304533101; Jafari-Mamaghani M, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fninf.2010.00009; Jones TR, 2009, P NATL ACAD SCI USA, V106, P1826, DOI 10.1073/pnas.0808843106; KAPUR JN, 1985, COMPUT VISION GRAPH, V29, P273, DOI 10.1016/0734-189X(85)90125-2; Kim W, 2008, J MOL BIOL, V377, P565, DOI 10.1016/j.jmb.2007.12.079; Kiskowski MA, 2009, BIOPHYS J, V97, P1095, DOI 10.1016/j.bpj.2009.05.039; Kosarevych R., 2012, 2012 11th International Conference on "Modern Problems of Radio Engineering, Telecommunications and Computer Science"; Lagache T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080914; Lasserre R, 2010, EMBO J, V29, P2301, DOI 10.1038/emboj.2010.127; Liapis E, 2012, J NEUROCHEM, V122, P568, DOI 10.1111/j.1471-4159.2012.07811.x; Minton AP, 2006, J CELL SCI, V119, P2863, DOI 10.1242/jcs.03063; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; PEEL DJ, 1992, ROUX ARCH DEV BIOL, V201, P120, DOI 10.1007/BF00420423; PETERSON CJ, 1995, J ECOL, V83, P847, DOI 10.2307/2261421; Pop S., 2011, 2011 18th IEEE International Conference on Image Processing (ICIP 2011), P2041, DOI 10.1109/ICIP.2011.6115880; Poulet A, 2015, BIOINFORMATICS, V31, P1144, DOI 10.1093/bioinformatics/btu774; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172; Rooms F, 2005, J MICROSC-OXFORD, V218, P22, DOI 10.1111/j.1365-2818.2005.01455.x; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Ruel L, 2003, NAT CELL BIOL, V5, P907, DOI 10.1038/ncb1052; Sato Y, 1998, Med Image Anal, V2, P143, DOI 10.1016/S1361-8415(98)80009-1; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwarz-Romond T, 2005, J CELL SCI, V118, P5269, DOI 10.1242/jcs.02646; Sezgin M, 2004, J ELECTRON IMAGING, V13, P146, DOI 10.1117/1.1631315; Smal I, 2010, IEEE T MED IMAGING, V29, P282, DOI 10.1109/TMI.2009.2025127; STERNBERG SR, 1983, COMPUTER, V16, P22, DOI 10.1109/MC.1983.1654163; Streib K., 2011, 2011 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P2305, DOI 10.1109/CVPR.2011.5995509; Svoboda D, COMPUTER ANAL IMAGES, P309, DOI [10.1007/978-3-540-74272-2_39, DOI 10.1007/978-3-540-74272-2_]; The MathWorks hnc, MATLAB DOC; Wang GL, 2004, DEV BIOL, V268, P493, DOI 10.1016/j.ydbio.2004.01.008; Wang HY, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-200; Waters JC, 2009, J CELL BIOL, V185, P1135, DOI 10.1083/jcb.200903097; Zhang Q, 2009, P NATL ACAD SCI USA, V106, P21191, DOI 10.1073/pnas.0912008106; ZIJDENBOS AP, 1994, IEEE T MED IMAGING, V13, P716, DOI 10.1109/42.363096	53	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144404	10.1371/journal.pone.0144404	http://dx.doi.org/10.1371/journal.pone.0144404			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636680	Green Published, gold, Green Submitted			2022-12-27	WOS:000366143800089
J	Pearson, SF; Giovanini, J; Jones, JE; Kroll, AJ				Pearson, Scott F.; Giovanini, Jack; Jones, Jay E.; Kroll, Andrew J.			Breeding Bird Community Continues to Colonize Riparian Buffers Ten Years after Harvest	PLOS ONE			English	Article							PACIFIC-NORTHWEST; SPECIES RICHNESS; FOREST HARVEST; CONSERVATION STRATEGY; HABITAT SELECTION; MIXTURE-MODELS; WIDTH; FRAGMENTATION; ABUNDANCE; ASSEMBLAGES	Riparian ecosystems integrate aquatic and terrestrial communities and often contain unique assemblages of flora and fauna. Retention of forested buffers along riparian habitats is a commonly employed practice to reduce potential negative effects of land use on aquatic systems. However, very few studies have examined long-term population and community responses to buffers, leading to considerable uncertainty about effectiveness of this practice for achieving conservation and management outcomes. We examined short-(1-2 years) and long-term (similar to 10 years) avian community responses (occupancy and abundance) to riparian buffer prescriptions to clearcut logging silvicultural practices in the Pacific Northwest USA. We used a Before-After-Control-Impact experimental approach and temporally replicated point counts analyzed within a Bayesian framework. Our experimental design consisted of forested control sites with no harvest, sites with relatively narrow (similar to 13m) forested buffers on each side of the stream, and sites with wider (similar to 30m) and more variable width unharvested buffer. Buffer treatments exhibited a 31-44% increase in mean species richness in the post-harvest years, a pattern most evident 10 years post-harvest. Post-harvest, species turnover was much higher on both treatments (63-74%) relative to the controls (29%). We did not find evidence of local extinction for any species but found strong evidence (no overlap in 95% credible intervals) for an increase in site occupancy on both Narrow (short-term: 7%; long-term 29%) and Wide buffers (short-term: 21%; long-term 93%) relative to controls after harvest. We did not find a treatment effect on total avian abundance. When assessing relationships between buffer width and site level abundance of four riparian specialists, we did not find strong evidence of reduced abundance in Narrow or Wide buffers. Silviculture regulations in this region dictate average buffer widths on small and large permanent streams that range from similar to 22-25 m. Guidelines for this region are within the range of buffers included in our study, in which we observed no evidence for avian species loss or for a decline in species abundance (including riparian associated species).	[Pearson, Scott F.] Washington Dept Fish & Wildlife, Wildlife Res Div, Olympia, WA 98501 USA; [Giovanini, Jack; Jones, Jay E.; Kroll, Andrew J.] Weyerhaeuser, Fed Way, DC USA	Washington Department of Fish & Wildlife (WDFW)	Pearson, SF (corresponding author), Washington Dept Fish & Wildlife, Wildlife Res Div, Olympia, WA 98501 USA.	scott.pearson@dfw.wa.gov	Kroll, Andrew/ABB-3724-2020	Kroll, Andrew/0000-0001-7747-830X; Pearson, Scott/0000-0003-4960-3956	Cooperative Monitoring, Evaluation, and Research (CMER) Committee under Washington Department of Natural Resources; Washington Department of Fish and Wildlife; Weyerhaeuser	Cooperative Monitoring, Evaluation, and Research (CMER) Committee under Washington Department of Natural Resources; Washington Department of Fish and Wildlife; Weyerhaeuser	All funding sources: The Cooperative Monitoring, Evaluation, and Research (CMER) Committee under Washington Department of Natural Resources provided the 10 year resample data to the authors and provided funding to Washington Department of Fish and Wildlife to pay for Scott Pearson's salary associated with data analysis, writing and report preparation (Interagency Agreement 12-118). Other funding sources included Washington Department of Fish and Wildlife funding of Scott Pearson's salary associated with manuscript preparation and Weyerhaeuser who funded Jack Giovanini, Jay E. Jones, and Andrew J. Kroll's salaries while they analyzed data and co-authored the manuscript. Revised funders website: http://www.dnr.wa.gov/.	[Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2006, SAS MIXED MODELS; Archaux F, 2012, METHODS ECOL EVOL, V3, P188, DOI 10.1111/j.2041-210X.2011.00142.x; Bennett AF, 2014, J APPL ECOL, V51, P514, DOI 10.1111/1365-2664.12200; Bilby RE, 2003, T AM FISH SOC, V132, P733, DOI 10.1577/T02-089; Blinn CR, 2001, J FOREST, V99, P11; Brosofske KD, 1997, ECOL APPL, V7, P1188, DOI 10.1890/1051-0761(1997)007[1188:HEOMGF]2.0.CO;2; Bull EL, 1978, TECHNICAL REPORT; CAREY AB, 1991, US FOR SERV T R PNW, V285, P123; Chaloner DT, 2002, CAN J FISH AQUAT SCI, V59, P1257, DOI 10.1139/F02-084; CHAMBERLIN TW, 1991, AM FISH SOC SPEC PUB, V19, P181; Chandler RB, 2013, CONSERV BIOL, V27, P785, DOI 10.1111/cobi.12046; Christensen R., 1996, ANAL VARIANCE DESIGN; DARVEAU M, 1995, J WILDLIFE MANAGE, V59, P67, DOI 10.2307/3809117; Davidson AS, 2001, J WILDLIFE MANAGE, V65, P334, DOI 10.2307/3802913; Dorazio RM, 2005, J AM STAT ASSOC, V100, P389, DOI 10.1198/016214505000000015; Evans KO, 2014, CONSERV BIOL, V28, P892, DOI 10.1111/cobi.12311; FETHERSTON KL, 1995, GEOMORPHOLOGY, V13, P133, DOI 10.1016/0169-555X(95)00033-2; Franklin J.F., 1973, GTRPNW8 USDA US FOR; Gelman A., 2007, DATA ANAL USING REGR; Gelman A., 2004, BAYESIAN DATA ANAL; Gelman A, 2007, SOCIOL METHODOL, V37, P23, DOI 10.1111/j.1467-9531.2007.00181.x; Gimenez O, 2008, AM NAT, V172, P441, DOI 10.1086/589520; Giovanini J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059900; Guzy MJ, 1997, BIRDS N AM; Hagar JC, 1999, J WILDLIFE MANAGE, V63, P484, DOI 10.2307/3802633; Hannon SJ, 2002, ECOL APPL, V12, P1457; Hannon SJ, 2002, CAN J FOREST RES, V32, P1784, DOI 10.1139/X02-092; Hanowski J, 2003, FOREST ECOL MANAG, V174, P315, DOI 10.1016/S0378-1127(02)00040-3; Harper KA, 2001, ECOLOGY, V82, P649, DOI 10.1890/0012-9658(2001)082[0649:SACORB]2.0.CO;2; Hawkes VC, 2012, FOREST ECOL MANAG, V274, P67, DOI 10.1016/j.foreco.2012.02.015; Helfield JM, 2002, OECOLOGIA, V133, P573, DOI 10.1007/s00442-002-1070-x; Hepinstall JA, 2008, LANDSCAPE ECOL, V23, P1257, DOI 10.1007/s10980-008-9296-6; Johnson SL, 2000, CAN J FISH AQUAT SCI, V57, P30, DOI 10.1139/cjfas-57-S2-30; Jones JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043290; Kery M, 2005, ECOL APPL, V15, P1450, DOI 10.1890/04-1120; Kery M, 2008, AUK, V125, P336, DOI 10.1525/auk.2008.06185; Kiffney PM, 2004, J N AM BENTHOL SOC, V23, P542, DOI 10.1899/0887-3593(2004)023&lt;0542:ELAACM&gt;2.0.CO;2; Kilgo JC, 1998, J WILDLIFE MANAGE, V62, P72, DOI 10.2307/3802265; KNOPF FL, 1988, WILSON BULL, V100, P272; Kroll AJ, 2014, FOREST ECOL MANAG, V326, P46, DOI 10.1016/j.foreco.2014.04.011; Kroll AJ, 2012, J WILDLIFE MANAGE, V76, P1188, DOI 10.1002/jwmg.353; Kuglerova L, 2014, FOREST ECOL MANAG, V334, P74, DOI 10.1016/j.foreco.2014.08.033; Lee P, 2004, J ENVIRON MANAGE, V70, P165, DOI 10.1016/j.jenvman.2003.11.009; Leu M., 2000, BREEDING TERRITORY S; Leu M, 2008, ECOL APPL, V18, P1119, DOI 10.1890/07-0480.1; Linden DW, 2012, FOREST ECOL MANAG, V284, P174, DOI 10.1016/j.foreco.2012.08.002; Marczak LB, 2010, ECOL APPL, V20, P126, DOI 10.1890/08-2064.1; Martin TG, 2006, BIOL CONSERV, V127, P201, DOI 10.1016/j.biocon.2005.08.014; McDonald TL, 2000, J AGRIC BIOL ENVIR S, V5, P262, DOI 10.2307/1400453; MCGARIGAL K, 1992, J WILDLIFE MANAGE, V56, P10, DOI 10.2307/3808786; MCGARIGAL K, 1995, ECOL MONOGR, V65, P235, DOI 10.2307/2937059; Miller JR, 2003, ECOL APPL, V13, P1041, DOI 10.1890/1051-0761(2003)13[1041:EOHSOB]2.0.CO;2; MORRISON ML, 1981, AUK, V98, P578; Naiman R.J., 1998, RIVER ECOLOGY MANAGE; Naiman RJ, 2005, RIPARIA ECOLOGY CONS; National Research Council, 2002, RIP AR FUNCT STRAT M; Oakley A.L., 1985, MANAGEMENT WILDLIFE; Osmundson DB, 2002, ECOL APPL, V12, P1719, DOI 10.1890/1051-0761(2002)012[1719:FSBRIF]2.0.CO;2; Peak RG, 2006, J WILDLIFE MANAGE, V70, P173, DOI 10.2193/0022-541X(2006)70[173:FAASRA]2.0.CO;2; Pearson SF, 1998, AUK, V115, P739, DOI 10.2307/4089421; Pearson SF, 2001, ECOL APPL, V11, P840, DOI 10.1890/1051-0761(2001)011[0840:BBRTRB]2.0.CO;2; Perry RW, 2011, BIODIVERS CONSERV, V20, P625, DOI 10.1007/s10531-010-9971-1; PlantyTabacchi AM, 1996, CONSERV BIOL, V10, P598, DOI 10.1046/j.1523-1739.1996.10020598.x; Plummer M., 2003, PROC 3 INT WORK DIST, P1; Richardson JS, 2012, FRESHW SCI, V31, P232, DOI 10.1899/11-031.1; Richardson JS, 2009, CONSERV BIOL SER, P244; Richardson JS, 2005, J AM WATER RESOUR AS, V41, P935, DOI 10.1111/j.1752-1688.2005.tb04471.x; ROBINSON SK, 1995, SCIENCE, V267, P1987, DOI 10.1126/science.267.5206.1987; Rodewald AD, 2006, BIOL CONSERV, V128, P193, DOI 10.1016/j.biocon.2005.09.041; Rohwer S, 1998, AUK, V115, P284, DOI 10.2307/4089188; Royle JA, 2004, BIOMETRICS, V60, P108, DOI 10.1111/j.0006-341X.2004.00142.x; Russell RE, 2009, ECOL APPL, V19, P1253, DOI 10.1890/08-0910.1; Sabo JL, 2005, ECOLOGY, V86, P56, DOI 10.1890/04-0668; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; SCHIECK J, 1995, CONSERV BIOL, V9, P1072, DOI [10.1046/j.1523-1739.1995.9051072.x, 10.1046/j.1523-1739.1995.9051059.x-i1]; Schmiegelow FKA, 2002, ECOL APPL, V12, P375; Shirley SM, BIOL CONS, V125, P475; SPACKMAN SC, 1995, BIOL CONSERV, V71, P325, DOI 10.1016/0006-3207(94)00055-U; STAUFFER DF, 1980, J WILDLIFE MANAGE, V44, P1; Steedman RJ, 2000, WATER AIR SOIL POLL, V122, P139, DOI 10.1023/A:1005235604087; Strahler A.N., 1957, EOS T AM GEOPHYS UN, V38, P913, DOI [DOI 10.1029/TR038I006P00913, 10.1029/TR038i006p00913]; Su Y-S, R2JAGS PACKAGE RUNNI; Swanson FJ, 1982, US IBP SYNTH SER, V14, P233; Tewksbury JJ, 1998, ECOLOGY, V79, P2890, DOI 10.1890/0012-9658(1998)079[2890:BPDNDW]2.0.CO;2; THOMAS JW, 1979, USDA FOREST SERVICE, V553, P40; TRIQUET AM, 1990, J SOIL WATER CONSERV, V45, P500; VanderHaegen WM, 1996, J WILDLIFE MANAGE, V60, P542, DOI 10.2307/3802071; Verner J., 1985, Current Ornithology, V2, P247; WESCHE T A, 1987, North American Journal of Fisheries Management, V7, P151, DOI 10.1577/1548-8659(1987)7<151:CORVTT>2.0.CO;2; Whitaker DM, 1999, J WILDLIFE MANAGE, V63, P167, DOI 10.2307/3802498; WILCOX BA, 1985, AM NAT, V125, P879, DOI 10.1086/284386; Yamaura Y, 2012, BIODIVERS CONSERV, V21, P1365, DOI 10.1007/s10531-012-0244-z; Zipkin EF, 2009, J APPL ECOL, V46, P815, DOI 10.1111/j.1365-2664.2009.01664.x; [No title captured]	95	7	7	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143241	10.1371/journal.pone.0143241	http://dx.doi.org/10.1371/journal.pone.0143241			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26637120	Green Published, Green Submitted, gold			2022-12-27	WOS:000366143800008
J	Sehrish, T; Symonds, VV; Soltis, DE; Soltis, PS; Tate, JA				Sehrish, Tina; Symonds, V. Vaughan; Soltis, Douglas E.; Soltis, Pamela S.; Tate, Jennifer A.			Cytonuclear Coordination Is Not Immediate upon Allopolyploid Formation in Tragopogon miscellus (Asteraceae) Allopolyploids	PLOS ONE			English	Article							RBCS MULTIGENE FAMILY; EXPRESSION LEVEL DOMINANCE; DUPLICATED GENES; SMALL-SUBUNIT; FUNCTIONAL DIVERGENCE; SYNTHETIC POLYPLOIDS; NATURAL-POPULATIONS; RECURRENT FORMATION; MIRUS ASTERACEAE; GENOME EVOLUTION	Allopolyploids, formed by hybridization and chromosome doubling, face the immediate challenge of having duplicated nuclear genomes that interact with the haploid and maternally inherited cytoplasmic (plastid and mitochondrial) genomes. Most of our knowledge of the genomic consequences of allopolyploidy has focused on the fate of the duplicated nuclear genes without regard to their potential interactions with cytoplasmic genomes. As a step toward understanding the fates of nuclear-encoded subunits that are plastid-targeted, here we examine the retention and expression of the gene encoding the small subunit of Ribulose-1, 5-bisphosphate carboxylase/oxygenase (Rubisco; rbcS) in multiple populations of allotetraploid Tragopogon miscellus (Asteraceae). These polyploids formed recently (similar to 80 years ago) and repeatedly from T. dubius and T. pratensis in the northwestern United States. Examination of 79 T. miscellus individuals from 10 natural populations, as well as 25 synthetic allotetraploids, including reciprocally formed plants, revealed a low percentage of naturally occurring individuals that show a bias in either gene (homeolog) loss (12%) or expression (16%), usually toward maintaining the maternal nuclear copy of rbcS. For individuals showing loss, seven retained the maternally derived rbcS homeolog only, while three had the paternally derived copy. All of the synthetic polyploid individuals examined (S-0 and S-1 generations) retained and expressed both parental homeologs. These results demonstrate that cytonuclear coordination does not happen immediately upon polyploid formation in Tragopogon miscellus.	[Sehrish, Tina; Symonds, V. Vaughan; Tate, Jennifer A.] Massey Univ, Inst Fundamental Sci, Palmerston North, New Zealand; [Soltis, Douglas E.] Univ Florida, Dept Biol, Gainesville, FL USA; [Soltis, Douglas E.; Soltis, Pamela S.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Soltis, Douglas E.; Soltis, Pamela S.] Univ Florida, Genet Inst, Gainesville, FL USA	Massey University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Tate, JA (corresponding author), Massey Univ, Inst Fundamental Sci, Palmerston North, New Zealand.	j.tate@massey.ac.nz	Soltis, Douglas/L-5957-2015	Sehrish, Tina/0000-0002-1007-4471; Tate, Jennifer A./0000-0001-5138-2115; Symonds, Vaughan/0000-0003-2533-6830	Higher Education Commission of Pakistan; Massey University Research Fund; Higher Education Commission (HEC) of Pakistan	Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); Massey University Research Fund; Higher Education Commission (HEC) of Pakistan(Higher Education Commission of Pakistan)	A PhD scholarship to TS from the Higher Education Commission of Pakistan funded TS. Massey University Research Fund to JT funded the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Muhammad Faisal for assistance in predicting promoter and terminator elements, Afsana Islam for her guidance in genome walking experiments, and Prashant Joshi for technical assistance. This work was supported in part by a Massey University Research Fund grant to JT. The Higher Education Commission (HEC) of Pakistan is gratefully acknowledged for a Ph. D. scholarship to TS.	Adams KL, 2003, P NATL ACAD SCI USA, V100, P4649, DOI 10.1073/pnas.0630618100; Barr CM, 2010, GENETICS, V184, P455, DOI 10.1534/genetics.109.108175; Birchler JA, 2010, NEW PHYTOL, V186, P54, DOI 10.1111/j.1469-8137.2009.03087.x; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Bottley A, 2006, PLANT J, V47, P897, DOI 10.1111/j.1365-313X.2006.02841.x; Buggs RJA, 2009, HEREDITY, V103, P73, DOI 10.1038/hdy.2009.24; Buggs RJA, 2012, AM J BOT, V99, P372, DOI 10.3732/ajb.1100395; Buggs RJA, 2012, CURR BIOL, V22, P248, DOI 10.1016/j.cub.2011.12.027; Buggs RJA, 2011, CURR BIOL, V21, P551, DOI 10.1016/j.cub.2011.02.016; Buggs RJA, 2010, MOL ECOL, V19, P132, DOI 10.1111/j.1365-294X.2009.04469.x; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Chang WC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-561; Chaudhary B, 2009, GENETICS, V182, P503, DOI 10.1534/genetics.109.102608; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Chen ZJ, 1997, P NATL ACAD SCI USA, V94, P3442, DOI 10.1073/pnas.94.7.3442; Chester M, 2012, P NATL ACAD SCI USA, V109, P1176, DOI 10.1073/pnas.1112041109; Comai L, 2000, PLANT CELL, V12, P1551, DOI 10.1105/tpc.12.9.1551; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; DEAN C, 1989, ANNU REV PLANT PHYS, V40, P415, DOI 10.1146/annurev.pp.40.060189.002215; DEAN C, 1987, MOL GEN GENET, V206, P465, DOI 10.1007/BF00428887; Doyle J. J., 1987, PHYTOCHEM B, P11; Doyle JJ, 2008, ANNU REV GENET, V42, P443, DOI 10.1146/annurev.genet.42.110807.091524; Edger PP, 2009, CHROMOSOME RES, V17, P699, DOI 10.1007/s10577-009-9055-9; Feldman M., 2012, POLYPLOIDY GENOME EV, P109, DOI DOI 10.1007/978-3-642-31442-1_7; Fishman L, 2006, EVOLUTION, V60, P1372, DOI 10.1111/j.0014-3820.2006.tb01216.x; Flagel LE, 2010, NEW PHYTOL, V186, P184, DOI 10.1111/j.1469-8137.2009.03107.x; Gaeta RT, 2007, PLANT CELL, V19, P3403, DOI 10.1105/tpc.107.054346; Gong L, 2014, MOL BIOL EVOL, V31, P2624, DOI 10.1093/molbev/msu207; Gong L, 2012, MOL BIOL EVOL, V29, P3023, DOI 10.1093/molbev/mss110; Goumenaki E, 2010, ENVIRON EXP BOT, V69, P259, DOI 10.1016/j.envexpbot.2010.04.011; GRANT V, 1956, ADV GENET, V8, P55, DOI 10.1016/S0065-2660(08)60499-X; Grover CE, 2012, NEW PHYTOL, V196, P966, DOI 10.1111/j.1469-8137.2012.04365.x; Hegarty MJ, 2006, CURR BIOL, V16, P1652, DOI 10.1016/j.cub.2006.06.071; Hillis DM., 1996, MOL SYSTEMATICS, V2nd; Izumi M, 2012, J EXP BOT, V63, P2159, DOI 10.1093/jxb/err434; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Kapralov MV, 2011, MOL BIOL EVOL, V28, P1491, DOI 10.1093/molbev/msq335; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Koh J, 2012, NEW PHYTOL, V196, P292, DOI 10.1111/j.1469-8137.2012.04251.x; Koh J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-97; KREBBERS E, 1988, PLANT MOL BIOL, V11, P745, DOI 10.1007/BF00019515; Levin DA, 2003, SYST BOT, V28, P5; Li BH, 2004, GENOMICS, V83, P311, DOI 10.1016/j.ygeno.2003.08.005; Lim KY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003353; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Ma XF, 2008, ANN BOT-LONDON, V101, P825, DOI 10.1093/aob/mcm331; Malinska H, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-291; Matsushita SC, 2012, GENETICS, V191, P535, DOI 10.1534/genetics.112.139295; MIZIORKO HM, 1983, ANNU REV BIOCHEM, V52, P507, DOI 10.1146/annurev.bi.52.070183.002451; Neff MM, 2002, TRENDS GENET, V18, P613, DOI 10.1016/S0168-9525(02)02820-2; OEHLKERS F, 1964, ADV GENET, V12, P329, DOI 10.1016/S0065-2660(08)60418-6; OLMSTEAD RG, 1992, ANN MO BOT GARD, V79, P249, DOI 10.2307/2399768; Outchkourov NS, 2003, PLANTA, V216, P1003, DOI 10.1007/s00425-002-0953-8; OWNBEY M, 1953, AM J BOT, V40, P788, DOI 10.2307/2438276; OWNBEY M, 1950, AM J BOT, V37, P487, DOI 10.2307/2438023; Panero Jose L., 2003, Lundellia, P1; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; Roulin A, 2013, PLANT J, V73, P143, DOI 10.1111/tpj.12026; ROZEN S, 2002, BIOINFORMATICS METHO, P365; Sasanuma T, 2001, MOL GENET GENOMICS, V265, P161, DOI 10.1007/s004380000404; Sehrish T, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-701; SIEBERT PD, 1995, NUCLEIC ACIDS RES, V23, P1087, DOI 10.1093/nar/23.6.1087; Sloan DB, 2015, NEW PHYTOL, V205, P1040, DOI 10.1111/nph.12835; Soltis DE, 2004, BIOL J LINN SOC, V82, P485, DOI 10.1111/j.1095-8312.2004.00335.x; Soltis DE, 1999, TRENDS ECOL EVOL, V14, P348, DOI 10.1016/S0169-5347(99)01638-9; SOLTIS DE, 1995, P NATL ACAD SCI USA, V92, P8089, DOI 10.1073/pnas.92.18.8089; Soltis DE, 2009, AM J BOT, V96, P336, DOI 10.3732/ajb.0800079; Soltis PS, 2000, P NATL ACAD SCI USA, V97, P7051, DOI 10.1073/pnas.97.13.7051; SOLTIS PS, 1991, SYST BOT, V16, P407, DOI 10.2307/2419333; SOLTIS PS, 1995, AM J BOT, V82, P1329, DOI 10.2307/2446255; SONG KM, 1995, P NATL ACAD SCI USA, V92, P7719, DOI 10.1073/pnas.92.17.7719; Spreitzer RJ, 2003, ARCH BIOCHEM BIOPHYS, V414, P141, DOI 10.1016/S0003-9861(03)00171-1; Spreitzer RJ, 2002, ANNU REV PLANT BIOL, V53, P449, DOI 10.1146/annurev.arplant.53.100301.135233; Stanke M, 2008, BIOINFORMATICS, V24, P637, DOI 10.1093/bioinformatics/btn013; Symonds VV, 2010, EVOLUTION, V64, P1984, DOI [10.1111/j.1558-5646.2010.00978-x, 10.1111/j.1558-5646.2010.00978.x]; Tate JA, 2006, GENETICS, V173, P1599, DOI 10.1534/genetics.106.057646; Tate JA, 2009, AM J BOT, V96, P979, DOI 10.3732/ajb.0800299; Tate JA, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-80; te Beest M, 2012, ANN BOT-LONDON, V109, P19, DOI 10.1093/aob/mcr277; Vincze T, 2003, NUCLEIC ACIDS RES, V31, P3688, DOI 10.1093/nar/gkg526; WAKSMAN G, 1987, NUCLEIC ACIDS RES, V15, P7181, DOI 10.1093/nar/15.17.7181; Wang JL, 2006, GENETICS, V172, P507, DOI 10.1534/genetics.105.047894; Wang XY, 2005, NEW PHYTOL, V165, P937, DOI 10.1111/j.1469-8137.2004.01293.x; Wendel JF, 2000, PLANT MOL BIOL, V42, P225, DOI 10.1023/A:1006392424384; Wendel JF, 2012, POLYPLOIDY GENOME EV; Wolf JB, 2009, EVOLUTION, V63, P1364, DOI 10.1111/j.1558-5646.2009.00632.x; Wolfe KH, 2001, NAT REV GENET, V2, P333, DOI 10.1038/35072009; Xiong ZY, 2011, P NATL ACAD SCI USA, V108, P7908, DOI 10.1073/pnas.1014138108; Yang XH, 2011, PLANT CELL TISS ORG, V104, P387, DOI 10.1007/s11240-010-9826-1; Yoo MJ, 2013, HEREDITY, V110, P171, DOI 10.1038/hdy.2012.94	90	19	20	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0144339	10.1371/journal.pone.0144339	http://dx.doi.org/10.1371/journal.pone.0144339			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YV	26646761	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903100020
J	Luo, P; He, XY; Liu, QT; Hu, CQ				Luo, Peng; He, Xiangyan; Liu, Qiuting; Hu, Chaoqun			Developing Universal Genetic Tools for Rapid and Efficient Deletion Mutation in Vibrio Species Based on Suicide T-Vectors Carrying a Novel Counterselectable Marker, vmi480	PLOS ONE			English	Article							TOXIN-ANTITOXIN SYSTEMS; ESCHERICHIA-COLI; FUNCTIONAL-ANALYSIS; STRUCTURAL BASIS; CHOLERAE; FAMILY; TRANSFORMATION; TEMPERATURE; INFECTIONS; EXPRESSION	Despite that Vibrio spp. have a significant impact on the health of humans and aquatic animals, the molecular basis of their pathogenesis is little known, mainly due to the limited genetic tools for the functional research of genes in Vibrio. In some cases, deletion of target DNAs in Vibrio can be achieved through the use of suicide vectors. However, these strategies are time-consuming and lack universality, and the widely used counterselectable gene sacB does not work well in Vibrio cells. In this study, we developed universal genetic tools for rapid and efficient deletion mutations in Vibrio species based on suicide T-Vectors carrying a novel counterselectable marker, vmi480. We explored two uncharacterized genes, vmi480 and vmi470, in a genomic island from Vibrio mimicus VM573 and confirmed that vmi480 and vmi470 constitute a two-component toxin-antitoxin system through deletion and expression of vmi480 and vmi470. The product of vmi480 exhibited strong toxicity to Escherichia coli cells. Based on vmi480 and the PBAD or PTAC promoter system, we constructed two suicide T-vectors, pLP11 and pLP12, and each of these vectors contained a multiple cloning region with two AhdI sites. Both vectors linearized by AhdI digestion could be stored and directly ligated with purified PCR products without a digestion step. By using pLP11 and pLP12 coupled with a highly efficient conjugation system provided by E. coli beta 2163, six genes from four representative Vibrio species were easily deleted. By using the counterselective marker vmi480, we obtained 3-12 positive colonies (deletion mutants) among no more than 20 colonies randomly selected on counterselection plates. The strategy does not require the digestion of PCR products and suicide vectors every time, and it avoids large-scale screening colonies on counterselective plates. These results demonstrate that we successfully developed universal genetic tools for rapid and efficient gene deletion in Vibrio species.	[Luo, Peng; He, Xiangyan; Liu, Qiuting; Hu, Chaoqun] Chinese Acad Sci, South China Sea Inst Oceanol, Key Lab Trop Marine Bioresources & Ecol, Guangzhou, Guangdong, Peoples R China; [Luo, Peng; Hu, Chaoqun] Chinese Acad Sci, Guangdong Key Lab Appl Marine Biol, Guangzhou, Guangdong, Peoples R China; [Luo, Peng; Hu, Chaoqun] South China Sea Bioresource Exploitat & Utilizat, Guangzhou, Guangdong, Peoples R China; [He, Xiangyan; Liu, Qiuting] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Hu, CQ (corresponding author), Chinese Acad Sci, South China Sea Inst Oceanol, Key Lab Trop Marine Bioresources & Ecol, Guangzhou, Guangdong, Peoples R China.	hucq@scsio.ac.cn			Natural Science Foundation of China [31370149]; Comprehensive Strategic Cooperation Project of Guangdong Province; Chinese Academy of Sciences [2012B091100269]; Knowledge Innovation Program of Chinese Academy of Sciences [KSCX2-EW-G-12B]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Comprehensive Strategic Cooperation Project of Guangdong Province; Chinese Academy of Sciences(Chinese Academy of Sciences); Knowledge Innovation Program of Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences)	Funded by Natural Science Foundation of China (31370149), http://www.nsfc.gov.cn/, Comprehensive Strategic Cooperation Project of Guangdong Province and Chinese Academy of Sciences (2012B091100269), http://gdcas.gdstc.gov.cn/, and Knowledge Innovation Program of Chinese Academy of Sciences (KSCX2-EW-G-12B), http://www.cas.cn/.	Baumann P, 1984, BERGEYS MANUAL SYSTE, V1, P516; BERNARD P, 1991, MOL GEN GENET, V226, P297, DOI 10.1007/BF00273616; Bhunia AK, 2008, FOOD SCI TEXT SER, P241; BLOMFIELD IC, 1991, MOL MICROBIOL, V5, P1447, DOI 10.1111/j.1365-2958.1991.tb00791.x; Bordeleau E, 2010, ENVIRON MICROBIOL, V12, P510, DOI 10.1111/j.1462-2920.2009.02094.x; Budde PP, 2007, J BACTERIOL, V189, P491, DOI 10.1128/JB.00909-06; Carraro N, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004714; Chatterjee S., 2012, J MAR SCI RES DEV, V1, P1, DOI DOI 10.4172/2155-9910.S1-002; Chen C, 2010, BIOFOULING, V26, P595, DOI 10.1080/08927014.2010.499511; Christensen-Dalsgaard M, 2006, MOL MICROBIOL, V62, P397, DOI 10.1111/j.1365-2958.2006.05385.x; Daniels NA, 2000, INFECT MED, V17, P665; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Demarre G, 2005, RES MICROBIOL, V156, P245, DOI 10.1016/j.resmic.2004.09.007; Direkbusarakom S, 1998, J MAR BIOTECHNOL, V6, P266; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; FUKAMI K, 1985, MAR ECOL PROG SER, V21, P7, DOI 10.3354/meps021007; Gulig PA, 2009, APPL ENVIRON MICROB, V75, P4936, DOI 10.1128/AEM.02564-08; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hansen LH, 1998, CURR MICROBIOL, V36, P341, DOI 10.1007/s002849900320; HOWARD RJ, 1993, ANN SURG, V217, P525, DOI 10.1097/00000658-199305010-00013; Iqbal N, 2015, J BACTERIOL, V197, P2150, DOI 10.1128/JB.00108-15; Jin CY, 2013, ANTON LEEUW INT J G, V103, P989, DOI 10.1007/s10482-013-9878-4; Jorgensen MG, 2009, J BACTERIOL, V191, P1191, DOI 10.1128/JB.01013-08; Kampranis SC, 1999, J MOL BIOL, V293, P733, DOI 10.1006/jmbi.1999.3182; Karlsson SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108521; Kasari V, 2010, J BACTERIOL, V192, P2908, DOI 10.1128/JB.01266-09; Lafferty KD, 2015, ANNU REV MAR SCI, V7, P471, DOI 10.1146/annurev-marine-010814-015646; Le Roux F, 2007, APPL ENVIRON MICROB, V73, P777, DOI 10.1128/AEM.02147-06; Leplae R, 2011, NUCLEIC ACIDS RES, V39, P5513, DOI 10.1093/nar/gkr131; Liu CH, 2004, DIS AQUAT ORGAN, V61, P169, DOI 10.3354/dao061169; Lo Scrudato M, 2013, NUCLEIC ACIDS RES, V41, P3644, DOI 10.1093/nar/gkt041; Luo P, 2008, DIS AQUAT ORGAN, V82, P209, DOI 10.3354/dao01984; Madl T, 2006, J MOL BIOL, V364, P170, DOI 10.1016/j.jmb.2006.08.082; Mahbub KR, 2011, J ADV SCI RES, V2, P74; Marbach A, 2012, J BIOTECHNOL, V157, P82, DOI 10.1016/j.jbiotec.2011.10.009; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; Nakashima N, 2014, INT J MOL SCI, V15, P2773, DOI 10.3390/ijms15022773; Oberer M, 2007, PROTEIN SCI, V16, P1676, DOI 10.1110/ps.062680707; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Reilly GD, 2011, EUROSURVEILLANCE, V16, P10; Reyrat JM, 1998, INFECT IMMUN, V66, P4011; STIBITZ S, 1994, METHOD ENZYMOL, V235, P458; Turner JW, 2014, ENVIRON MICROBIOL, V16, P1019, DOI 10.1111/1462-2920.12246; Vandenberghe J, 2003, AQUACULTURE, V219, P9, DOI 10.1016/S0044-8486(02)00312-5; Yamaichi Y, 2007, P NATL ACAD SCI USA, V104, P630, DOI 10.1073/pnas.0608341104; Zhang Y, 2012, APPL ENVIRON MICROB, V78, P5831, DOI 10.1128/AEM.01147-12	48	38	45	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144465	10.1371/journal.pone.0144465	http://dx.doi.org/10.1371/journal.pone.0144465			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641275	gold, Green Published, Green Submitted			2022-12-27	WOS:000366902700130
J	Bourke, L; McCormick, J; Taylor, V; Pericleous, C; Blanchet, B; Costedoat-Chalumeau, N; Stuckey, D; Lythgoe, MF; Stephanou, A; Ioannou, Y				Bourke, Lauren; McCormick, James; Taylor, Valerie; Pericleous, Charis; Blanchet, Benoit; Costedoat-Chalumeau, Nathalie; Stuckey, Daniel; Lythgoe, Mark F.; Stephanou, Anastasis; Ioannou, Yiannis			Hydroxychloroquine Protects against Cardiac Ischaemia/Reperfusion Injury In Vivo via Enhancement of ERK1/2 Phosphorylation	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; THERAPEUTIC TARGET; KINASE; APOPTOSIS; AUTOPHAGY; BAD; CELLS; HEART; SLE	An increasing number of investigations including human studies demonstrate that pharmacological ischaemic preconditioning is a viable way to protect the heart from myocardial ischaemia/reperfusion (I/R) injury. This study investigated the role of hydroxychloroquine (HCQ) in the heart during I/R injury. In vitro and in vivo models of myocardial I/R injury were used to assess the effects of HCQ. It was found that HCQ was protective in neonatal rat cardiomyocytes through inhibition of apoptosis, measured by TUNEL and cleaved caspase-3. This protection in vitro was mediated through enhancement of ERK1/2 phosphorylation mediated by HCQ in a dose-dependent fashion. A decrease in infarct size was observed in an in vivo model of myocardial I/R injury in HCQ treated animals and furthermore this protection was blocked in the presence of the ERK1/2 inhibitor U0126. For the first time, we have shown that HCQ promotes a preconditioning like protection in an in vivo simulated rat myocardial I/R injury model. Moreover, it was shown that HCQ is protective via enhanced phosphorylation of the pro-survival kinase ERK1/2.	[Bourke, Lauren; Pericleous, Charis; Ioannou, Yiannis] UCL, Ctr Rheumatol, Div Med, Rayne Inst, London, England; [Bourke, Lauren; Ioannou, Yiannis] UCL, Arthrit Res UK, Ctr Adolescent Rheumatol, London, England; [McCormick, James] UCL, Biochem Res Grp, Clin & Mol Genet Unit, Inst Child Hlth, London, England; [McCormick, James] UCL, Great Ormond St Hosp, London, England; [Taylor, Valerie; Stuckey, Daniel; Lythgoe, Mark F.] UCL, Ctr Adv Biomed Imaging, Div Med, London, England; [Blanchet, Benoit] Hop Cochin, Assistance Publ Hop Paris, Unite Fonctionnelle Pharmacocinet & Pharmacochimi, F-75674 Paris, France; [Costedoat-Chalumeau, Nathalie] Univ Paris 05, Ctr Reference Malad Autoimmunes & Syst Rares, Serv Med Interne, Pole Med,Hop Cochin,AP HP, Paris, France; [Stephanou, Anastasis] UCL, Med & Mol Biol Unit, London, England	University of London; King's College London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; University of London; University College London	Ioannou, Y (corresponding author), UCL, Ctr Rheumatol, Div Med, Rayne Inst, London, England.	y.ioannou@ucl.ac.uk		Pericleous, Charis/0000-0001-8804-0493; stuckey, daniel/0000-0001-8888-627X; Blanchet, Benoit/0000-0003-3096-4305; , nathalie/0000-0002-1555-9021; Lythgoe, Mark/0000-0002-4945-0171	Grand Challenge PhD Studentship Programme, UCL; National Institute for Health Research University College London Hospitals Biomedical Research Centre; National Institute for Health Research University College London Hospitals Biomedical Research Centre and Arthritis Research UK [20164]; Arthritis Research UK Programme [19423]; Versus Arthritis [19423] Funding Source: researchfish	Grand Challenge PhD Studentship Programme, UCL; National Institute for Health Research University College London Hospitals Biomedical Research Centre(General Electric); National Institute for Health Research University College London Hospitals Biomedical Research Centre and Arthritis Research UK(Versus Arthritis); Arthritis Research UK Programme(Versus Arthritis); Versus Arthritis(Versus Arthritis)	LB is supported by the Grand Challenge PhD Studentship Programme, UCL. YI is supported by the National Institute for Health Research University College London Hospitals Biomedical Research Centre and Arthritis Research UK Grant 20164. CP is supported by Arthritis Research UK Programme Grant 19423.; LB is supported by the Grand Challenge PhD Studentship Programme, UCL. YI is supported by the National Institute for Health Research University College London Hospitals Biomedical Research Centre and Arthritis Research UK Grant 20164. CP is supported by Arthritis Research UK Programme Grant 19423.	Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Ban KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076790; Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; Bolli R, 2004, CIRC RES, V95, P125, DOI 10.1161/01.RES.0000137171.97172.d7; Bourke Lauren T, 2013, JAKSTAT, V2, pe25666, DOI 10.4161/jkst.25666; Bullard AJ, 2005, BASIC RES CARDIOL, V100, P397, DOI 10.1007/s00395-005-0537-4; Carr CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025669; Chiang CW, 2003, MOL CELL BIOL, V23, P6350, DOI 10.1128/MCB.23.18.6350-6362.2003; Cobb MH, 1999, PROG BIOPHYS MOL BIO, V71, P479, DOI 10.1016/S0079-6107(98)00056-X; Costedoat-Chalumeau N, 2006, ARTHRITIS RHEUM, V54, P3284, DOI 10.1002/art.22156; Das A, 2009, ERK PHOSPHORYLATION, pH1236; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fang H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.225; FOX RI, 1993, SEMIN ARTHRITIS RHEU, V23, P82, DOI 10.1016/S0049-0172(10)80012-5; Garg S, 2003, CURR OPIN CARDIOL, V18, P372, DOI 10.1097/00001573-200309000-00009; Hausenloy DJ, 2007, HEART FAIL REV, V12, P217, DOI 10.1007/s10741-007-9026-1; Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874; Hausenloy DJ, 2012, CLIN RES CARDIOL, V101, P339, DOI 10.1007/s00392-011-0397-x; Hausenloy DJ, 2010, BASIC RES CARDIOL, V105, P677, DOI 10.1007/s00395-010-0121-4; Hausenloy DJ, 2004, CARDIOVASC RES, V61, P448, DOI 10.1016/j.cardiores.2003.09.024; Hausenloy DJ, 2004, CARDIOVASC RES, P305; Hayakawa J, 2000, CANCER RES, V60, P5988; Hetz CA, 2002, J CELL SCI, V115, P4671, DOI 10.1242/jcs.00153; Jing Zhou GL, 2013, EXP CLIN CARDIOL, V18, P95; Jung HJ, 2010, ARTHRITIS RHEUM-US, V62, P863, DOI 10.1002/art.27289; Lee SJ, 2011, NAT REV NEPHROL, V7, P718, DOI 10.1038/nrneph.2011.150; Ma S, 2015, BBA-MOL BASIS DIS, V1852, P271, DOI 10.1016/j.bbadis.2014.05.010; Ma XC, 2012, CIRCULATION, V125, P3170, DOI 10.1161/CIRCULATIONAHA.111.041814; Martin ED, 2012, CIRCULATION, V126, P357, DOI 10.1161/CIRCULATIONAHA.111.071886; Martinez-Lopez N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3799; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Morris SJ, 2011, ARTHRIT CARE RES, V63, P530, DOI 10.1002/acr.20393; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Namura S, 2001, P NATL ACAD SCI USA, V98, P11569, DOI 10.1073/pnas.181213498; Le NT, 2014, J IMMUNOL, V193, P3803, DOI 10.4049/jimmunol.1400571; Salloum F, 2003, CIRC RES, V92, P595, DOI 10.1161/01.RES.0000066853.09821.98; Schmajuk G, 2010, ARTHRIT CARE RES, V62, P386, DOI 10.1002/acr.20002; Sui X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.350; Todorovic Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092673; Willis R, 2012, LUPUS, V21, P830, DOI 10.1177/0961203312437270; Yang CW, 2003, TRANSPLANTATION, V75, P20, DOI 10.1097/01.TP.0000040002.12912.65; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yaoita H, 2000, APOPTOSIS RELEVANT C, P630	44	19	19	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143771	10.1371/journal.pone.0143771	http://dx.doi.org/10.1371/journal.pone.0143771			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636577	gold, Green Published, Green Submitted			2022-12-27	WOS:000366143800025
J	Nolting, S; Maurer, J; Spottl, G; Prada, ETA; Reuther, C; Young, K; Korbonits, M; Goke, B; Grossman, A; Auernhammer, CJ				Noelting, Svenja; Maurer, Julian; Spoettl, Gerald; Prada, Elke Tatjana Aristizabal; Reuther, Clemens; Young, Karen; Korbonits, Marta; Goeke, Burkhard; Grossman, Ashley; Auernhammer, Christoph J.			Additive Anti-Tumor Effects of Lovastatin and Everolimus In Vitro through Simultaneous Inhibition of Signaling Pathways	PLOS ONE			English	Article							CELL LUNG-CANCER; GROWTH-FACTOR RECEPTOR; HEPATOCELLULAR-CARCINOMA; STATINS; AGENTS; GLYCOSYLATION; RESISTANCE; SORAFENIB; MODEL; LINES	Background The mTORC1-inhibitor everolimus shows limited efficacy in treating patients with gastro-entero-pancreatic or pulmonary neuroendocrine tumors (NETs), and poor outcome in patients with malignant pheochromocytoma or hepatic carcinoma. We speculated that any effect may be enhanced by antogonising other signaling pathways. Methods Therefore, we tested the effect of lovastatin-known to inhibit both ERK and AKT signaling-and everolimus, separately and in combination, on cell viability and signaling pathways in human midgut (GOT), pancreatic (BON1), and pulmonary (H727) NET, hepatocellular carcinoma (HepG2, Huh7), and mouse pheochromocytoma (MPC, MTT) cell lines. Results Lovastatin and everolimus separately significantly reduced cell viability in H727, HepG2, Huh7, MPC and MTT cells at clinically relevant doses (P <= 0.05). However, high doses of lovastatin were necessary to affect GOT or BON1 cell viability. Clinically relevant doses of both drugs showed additive anti-tumor effects in H727, HepG2, Huh7, MPC and MTT cells (P <= 0.05), but not in BON1 or GOT cells. In all cell lines investigated, lovastatin inhibited EGFR and AKT signaling. Subsequently, combination treatment more strongly inhibited EGFR and AKT signaling than everolimus alone, or at least attenuated everolimus-induced EGFR or AKT activation. Vice versa, everolimus constantly decreased pp70S6K and combination treatment more strongly decreased pp70S6K than lovastatin alone, or attenuated lovastatin-induced p70S6K activation: in BON1 cells lovastatin-induced EGFR inhibition was least pronounced, possibly explaining the low efficacy and consequent absent additive effect. Conclusion In summary, clinically relevant doses of lovastatin and everolimus were effective separately and showed additive effects in 5 out of 7 cell lines. Our findings emphasize the importance of targeting several interacting signaling pathways simultaneously when attempting to attenuate tumor growth. However, the variable reactions of the different cell lines highlight the necessity to understand the unique molecular aberrations in any tumor. Nevertheless, this combination seems worthy of being tested in vivo.	[Noelting, Svenja; Maurer, Julian; Spoettl, Gerald; Prada, Elke Tatjana Aristizabal; Reuther, Clemens; Goeke, Burkhard; Auernhammer, Christoph J.] Univ Munich, Univ Hosp, Dept Internal Med 2, Munich, Germany; [Young, Karen; Korbonits, Marta] Queen Mary Univ London, Barts & London Sch Med, William Harvey Res Inst, Dept Endocrinol, London, England; [Goeke, Burkhard] Univ Hosp Hamburg Eppendorf, Hamburg, Germany; [Grossman, Ashley] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Dept Endocrinol, Oxford, England	University of Munich; University of London; Queen Mary University London; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Oxford	Nolting, S (corresponding author), Univ Munich, Univ Hosp, Dept Internal Med 2, Campus Grosshadern, Munich, Germany.	svenja.noelting@med.uni-muenchen.de		Korbonits, Marta/0000-0002-4101-9432; Nolting, Svenja/0000-0002-7064-590X	Ludwig-Maximilians University of Munich (Forderprogramm fur Forschung und Lehre [FoFoLe] [865/829]	Ludwig-Maximilians University of Munich (Forderprogramm fur Forschung und Lehre [FoFoLe]	This work was supported by a research grant from the Ludwig-Maximilians University of Munich (Forderprogramm fur Forschung und Lehre [FoFoLe], grant number 865/829).; We thank the statistician Dr. Michael Lauseker for assistance with the statistical analysis. This work was funded by a research grant from the Ludwig-Maximilians University of Munich [Forderprogramm fur Forschung und Lehre (FoFoLe), grant number 865/829].	Agarwal B, 1999, CLIN CANCER RES, V5, P2223; Altwairgi AK, 2015, ONCOL REP, V33, P1019, DOI 10.3892/or.2015.3741; Ampuero J, 2015, WORLD J HEPATOL, V7, P1105, DOI 10.4254/wjh.v7.i8.1105; Auernhammer CJ, 2011, GUT, V60, P1009, DOI 10.1136/gut.2009.204453; Bil J, 2010, CANCER LETT, V288, P57, DOI 10.1016/j.canlet.2009.06.022; Cakir M, 2011, EXPERT OPIN THER TAR, V15, P457, DOI 10.1517/14728222.2011.555403; Carlberg M, 1996, J BIOL CHEM, V271, P17453, DOI 10.1074/jbc.271.29.17453; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Cemeus C, 2008, J NEURO-ONCOL, V90, P9, DOI 10.1007/s11060-008-9627-0; Dimitroulakos J, 2006, CLIN CANCER RES, V12, p4426S, DOI 10.1158/1078-0432.CCR-06-0089; Druce MR, 2009, HORM METAB RES, V41, P697, DOI 10.1055/s-0029-1220687; EVERS BM, 1991, GASTROENTEROLOGY, V101, P303, DOI 10.1016/0016-5085(91)90004-5; Fiala O, 2015, TUMOR BIOL, V36, P5801, DOI 10.1007/s13277-015-3249-x; Fliedner SMJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097712; Frilling A, 2012, ENDOCR-RELAT CANCER, V19, pR163, DOI 10.1530/ERC-12-0024; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Gschwind A, 2001, ONCOGENE, V20, P1594, DOI 10.1038/sj.onc.1204192; Holstein SA, 2006, CANCER CHEMOTH PHARM, V57, P155, DOI 10.1007/s00280-005-0013-8; Holstein SA, 2001, MOL CANCER THER, V1, P141; Holstein SA, 2001, LEUKEMIA RES, V25, P651, DOI 10.1016/S0145-2126(00)00162-4; Hwang KE, 2014, EXP CELL RES, V323, P288, DOI 10.1016/j.yexcr.2014.02.026; Kolby L, 2001, AM J PATHOL, V158, P745, DOI 10.1016/S0002-9440(10)64017-5; Mantha AJ, 2005, CLIN CANCER RES, V11, P2398, DOI 10.1158/1078-0432.CCR-04-1951; Martiniova L, 2009, CLIN EXP METASTAS, V26, P239, DOI 10.1007/s10585-009-9236-0; McGlynn KA, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv009; Mohammed AA, 2014, ONCOL REV, V8, P67, DOI 10.4081/oncol.2014.249; Nielsen SF, 2013, NEW ENGL J MED, V368, P576, DOI 10.1056/NEJMc1214827; Nolting S, 2014, ENDOCRINOLOGY, V155, P2377, DOI 10.1210/en.2014-1027; Nolting S, 2012, J MOL ENDOCRINOL, V49, P79, DOI 10.1530/JME-12-0028; Nolting S, 2012, ENDOCR PATHOL, V23, P21, DOI 10.1007/s12022-012-9199-6; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Park IH, 2010, INVEST NEW DRUG, V28, P791, DOI 10.1007/s10637-009-9319-4; Pavel M, 2013, NEUROENDOCRINOLOGY, V97, P99, DOI 10.1159/000336089; Pavel ME, 2011, LANCET, V378, P2005, DOI 10.1016/S0140-6736(11)61742-X; Powers JF, 2000, CELL TISSUE RES, V302, P309, DOI 10.1007/s004410000290; Rozados VR, 2008, ONCOL REP, V19, P1205; SLIEKER LJ, 1986, J BIOL CHEM, V261, P5233; Spampatti M, 2014, WORLD J GASTROENTERO, V20, P10038, DOI 10.3748/wjg.v20.i29.10038; Yao JC, 2011, NEW ENGL J MED, V364, P514, DOI 10.1056/NEJMoa1009290; Zhao TT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012563; Zhu AX, 2014, JAMA-J AM MED ASSOC, V312, P57, DOI 10.1001/jama.2014.7189; Zitzmann K, 2007, NEUROENDOCRINOLOGY, V85, P54, DOI 10.1159/000100057; Zitzmann K, 2010, CANCER LETT, V295, P100, DOI 10.1016/j.canlet.2010.02.018	43	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143830	10.1371/journal.pone.0143830	http://dx.doi.org/10.1371/journal.pone.0143830			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636335	gold, Green Submitted, Green Published			2022-12-27	WOS:000366143800031
J	Pathak, HB; Zhou, Y; Sethi, G; Hirst, J; Schilder, RJ; Golemis, EA; Godwin, AK				Pathak, Harsh B.; Zhou, Yan; Sethi, Geetika; Hirst, Jeff; Schilder, Russell J.; Golemis, Erica A.; Godwin, Andrew K.			A Synthetic Lethality Screen Using a Focused siRNA Library to Identify Sensitizers to Dasatinib Therapy for the Treatment of Epithelial Ovarian Cancer	PLOS ONE			English	Article							PROTEIN-KINASE CK2; SRC FAMILY KINASES; CHRONIC MYELOID-LEUKEMIA; TYROSINE KINASE; FALLOPIAN-TUBE; CELL-LINES; INHIBITOR; RESISTANCE; EXPRESSION; CX-4945	Molecular targeted therapies have been the focus of recent clinical trials for the treatment of patients with recurrent epithelial ovarian cancer (EOC). The majority have not fared well as monotherapies for improving survival of these patients. Poor bioavailability, lack of predictive biomarkers, and the presence of multiple survival pathways can all diminish the success of a targeted agent. Dasatinib is a tyrosine kinase inhibitor of the Src-family kinases (SFK) and in preclinical studies shown to have substantial activity in EOC. However, when evaluated in a phase 2 clinical trial for patients with recurrent or persistent EOC, it was found to have minimal activity. We hypothesized that synthetic lethality screens performed using a cogently designed siRNA library would identify second-site molecular targets that could synergize with SFK inhibition and improve dasatinib efficacy. Using a systematic approach, we performed primary siRNA screening using a library focused on 638 genes corresponding to a network centered on EGFR, HER2, and the SFK-scaffolding proteins BCAR1, NEDD9, and EFS to screen EOC cells in combination with dasatinib. We followed up with validation studies including deconvolution screening, quantitative PCR to confirm effective gene silencing, correlation of gene expression with dasatinib sensitivity, and assessment of the clinical relevance of hits using TCGA ovarian cancer data. A refined list of five candidates (CSNK2A1, DAG1, GRB2, PRKCE, and VAV1) was identified as showing the greatest potential for improving sensitivity to dasatinib in EOC. Of these, CSNK2A1, which codes for the catalytic alpha subunit of protein kinase CK2, was selected for additional evaluation. Synergistic activity of the clinically relevant inhibitor of CK2, CX-4945, with dasatinib in reducing cell proliferation and increasing apoptosis was observed across multiple EOC cell lines. This overall approach to improving drug efficacy can be applied to other targeted agents that have similarly shown poor clinical activity.	[Pathak, Harsh B.; Hirst, Jeff; Godwin, Andrew K.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA; [Zhou, Yan] Fox Chase Canc Ctr, Biostat & Bioinformat Facil, Philadelphia, PA 19111 USA; [Sethi, Geetika] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19104 USA; [Schilder, Russell J.] Thomas Jefferson Univ, Dept Gynecol Med Oncol, Philadelphia, PA 19107 USA; [Golemis, Erica A.] Fox Chase Canc Ctr, Mol Therapeut Program, Philadelphia, PA 19111 USA; [Godwin, Andrew K.] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center; Fox Chase Cancer Center; Drexel University; Jefferson University; Fox Chase Cancer Center; University of Kansas; University of Kansas Medical Center	Pathak, HB (corresponding author), Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA.	hpathak@kumc.edu		Golemis, Erica/0000-0003-3618-3673	National Cancer Institute [CA140323, CA181287]; Kansas Bioscience Authority Eminent Scholar Program; National Institute of Child Health and Human Development [K12 HD052027]; Madison & Lila Self Graduate Fellowship; National Cancer Institute Cancer Center Support grants [P30 CA168524, P30 CA006927]; University of Kansas Cancer Center [P30 CA168524]; Fox Chase Cancer Center [P30 CA006927]; NCI [CA140323]; NICHD [K12 HD052027]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD052027] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA006927, R01CA140323, P30CA168524, R21CA181287] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Kansas Bioscience Authority Eminent Scholar Program; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Madison & Lila Self Graduate Fellowship; National Cancer Institute Cancer Center Support grants; University of Kansas Cancer Center; Fox Chase Cancer Center; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was funded in part by a grant from the National Cancer Institute (http://www.cancer.gov/) (CA140323) and the Kansas Bioscience Authority (http://www.kansasbioauthority.org/) Eminent Scholar Program to AKG. HBP is an Interdisciplinary Women's Health Research Scholar through the BIRCWH K12 Program at the University of Kansas Medical Center sponsored by a grant from the National Institute of Child Health and Human Development (http://www.nichd.nih.gov) (K12 HD052027). JH is a recipient of the Madison & Lila Self Graduate Fellowship (http://selfgraduate.ku.edu/). EAG's work is supported by a grant from the National Cancer Institute (http://www.cancer.gov/) (CA181287). The authors acknowledge support from the National Cancer Institute (http://www.cancer.gov/) Cancer Center Support grants P30 CA168524 (University of Kansas Cancer Center) and P30 CA006927 (Fox Chase Cancer Center). AKG is the Chancellors Distinguished Chair in Biomedical Sciences Endowed Professor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was funded in part by a grant from the NCI (CA140323) and the Kansas Bioscience Authority Eminent Scholar Program to A.K.G. H.B.P. is an Interdisciplinary Women's Health Research Scholar through the BIRCWH K12 Program at the University of Kansas Medical Center sponsored by a grant from the NICHD (K12 HD052027). J.H. is a recipient of the Madison & Lila Self Graduate Fellowship. E.A.G's work is supported by CA181287. The authors would like to thank Lisa Vanderveer for her technical assistance; Dr. Margret Einarson for assistance with the siRNA screenings; Dr. Brooke Fridley for assistance with annotating the ovarian TCGA data. The authors acknowledge support from the University of Kansas Cancer Center (P30 CA168524) and Fox Chase Cancer Center (P30 CA006927). A.K.G. is the Chancellors Distinguished Chair in Biomedical Sciences Endowed Professor.	Abram CL, 2000, EXP CELL RES, V254, P1, DOI 10.1006/excr.1999.4732; Ahmad KA, 2008, ADV ENZYME REGUL, V48, P179, DOI 10.1016/j.advenzreg.2008.04.002; Alper O, 2005, CURR PHARM DESIGN, V11, P1119, DOI 10.2174/1381612053507576; Alvarez RH, 2006, CANCER-AM CANCER SOC, V107, P1918, DOI 10.1002/cncr.22215; Astsaturov I, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001083; Baccarani M, 2015, ANN HEMATOL, V94, pS141, DOI 10.1007/s00277-015-2322-2; Bast R C Jr, 2011, Ann Oncol, V22 Suppl 8, pviii5, DOI 10.1093/annonc/mdr516; Baumann KH, 2012, FUTURE ONCOL, V8, P1135, DOI [10.2217/FON.12.112, 10.2217/fon.12.112]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bookman MA, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju029; Boutros M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r66; Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Buchdunger E, 1996, CANCER RES, V56, P100; BUDDE RJA, 1994, CANCER BIOCHEM BIOPH, V14, P171; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Chang Tai-Tsung, 2000, Acta Paediatrica Taiwanica, V41, P294; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chou TC, 1996, CALCUSYN WINDOWS SOF; Chou TC, 2008, LEUKEMIA LYMPHOMA, V49, P2059, DOI 10.1080/10428190802353591; Cozza G, 2013, CURR MED CHEM, V20, P671, DOI 10.2174/092986713804999312; Dancey J, 2013, ANN ONCOL, V24, P59, DOI 10.1093/annonc/mdt473; Deneka A, 2015, GENE, V570, P25, DOI 10.1016/j.gene.2015.06.062; Donella-Deana A, 2003, BIOCHEM J, V372, P841, DOI 10.1042/BJ20021905; Erfle H, 2007, NAT PROTOC, V2, P392, DOI 10.1038/nprot.2006.483; Erickson BK, 2013, AM J OBSTET GYNECOL, V209, P409, DOI 10.1016/j.ajog.2013.04.019; EVA A, 1982, NATURE, V295, P116, DOI 10.1038/295116a0; Fogh J., 1975, HUMAN TUMOR CELLS IN, P115, DOI 10.1007/978-1-4757-1647-4_5; Fuss H, 2008, BIOPHYS J, V94, P1995, DOI 10.1529/biophysj.107.115022; Gambacorti-Passerini C, 2015, AM J HEMATOL, V90, P156, DOI 10.1002/ajh.23887; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GODWIN AK, 1992, P NATL ACAD SCI USA, V89, P3070, DOI 10.1073/pnas.89.7.3070; Guerra B, 2008, CURR MED CHEM, V15, P1870, DOI 10.2174/092986708785132933; Hamilton T C, 1989, Cancer Treat Res, V48, P151; Heinrich MC, 2000, BLOOD, V96, P925, DOI 10.1182/blood.V96.3.925.015k50_925_932; Hochhaus A, 2015, ANN HEMATOL, V94, pS133, DOI 10.1007/s00277-015-2323-1; Huang YW, 2013, MOL CELL BIOCHEM, V376, P73, DOI 10.1007/s11010-012-1550-1; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Jabbour E, 2015, CL LYMPH MYELOM LEUK, V15, P323, DOI 10.1016/j.clml.2015.03.006; Jelovac D, 2011, CA-CANCER J CLIN, V61, P183, DOI 10.3322/caac.20113; Kessler M, 2013, INT J MOL SCI, V14, P6571, DOI 10.3390/ijms14046571; KITAS EA, 1990, BIOCHEM BIOPH RES CO, V170, P635, DOI 10.1016/0006-291X(90)92139-Q; Le XF, 2011, CANCER BIOL THER, V12, P260, DOI 10.4161/cbt.12.4.16430; Ledermann JA, 2010, GYNECOL ONCOL, V119, P151, DOI 10.1016/j.ygyno.2010.05.008; Lindauer M, 2014, RECENT RESULTS CANC, V201, P27, DOI 10.1007/978-3-642-54490-3_2; Little JL, 2014, ONCOGENE, V33, P411, DOI 10.1038/onc.2012.607; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; Mantia-Smaldone Gina M, 2011, Cancer Manag Res, V3, P25, DOI 10.2147/CMR.S8759; Matsuo K, 2011, CLIN CANCER RES, V17, P5367, DOI 10.1158/1078-0432.CCR-10-3176; McCluggage WG, 2011, PATHOLOGY, V43, P420, DOI 10.1097/PAT.0b013e328348a6e7; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Miyata Y, 2004, MOL CELL BIOL, V24, P4065, DOI 10.1128/MCB.24.9.4065-4074.2004; O'Shannessy DJ, 2013, INT J MOL SCI, V14, P13687, DOI 10.3390/ijms140713687; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Pierre F, 2011, MOL CELL BIOCHEM, V356, P37, DOI 10.1007/s11010-011-0956-5; Pierre F, 2011, J MED CHEM, V54, P635, DOI 10.1021/jm101251q; Pujade-Lauraine E, 2011, Ann Oncol, V22 Suppl 8, pviii61, DOI 10.1093/annonc/mdr518; Reade CJ, 2014, J OBSTET GYNAECOL CA, V36, P133, DOI 10.1016/S1701-2163(15)30659-9; Rizzieri David, 2012, P T, V37, P640; Schilder RJ, 2012, GYNECOL ONCOL, V127, P70, DOI 10.1016/j.ygyno.2012.06.009; Sethi G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047086; Shagisultanova E, 2015, GENE, V567, P1, DOI 10.1016/j.gene.2015.04.086; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Shigetomi H, 2012, ONCOL REP, V28, P395, DOI 10.3892/or.2012.1833; Siddiqui-Jain A, 2012, MOL CANCER THER, V11, P994, DOI 10.1158/1535-7163.MCT-11-0613; Siddiqui-Jain A, 2010, CANCER RES, V70, P10288, DOI 10.1158/0008-5472.CAN-10-1893; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Singh MK, 2010, CANCER RES, V70, P8907, DOI 10.1158/0008-5472.CAN-10-0353; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stordal B, 2013, MOL ONCOL, V7, P567, DOI 10.1016/j.molonc.2012.12.007; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Tawfic S, 2001, HISTOL HISTOPATHOL, V16, P573, DOI 10.14670/HH-16.573; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; TOYOSHIMA K, 1992, CIBA F SYMP, V164, P240; Toyoshima K, 1986, Princess Takamatsu Symp, V17, P11; Trembley JH, 2010, BIOFACTORS, V36, P187, DOI 10.1002/biof.96; Wiener JR, 2003, GYNECOL ONCOL, V88, P73, DOI 10.1006/gyno.2002.6851; Wong AST, 2001, GYNECOL ONCOL, V82, P305, DOI 10.1006/gyno.2001.6280; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Yokoyama T, 2004, BIOL PHARM BULL, V27, P1895, DOI 10.1248/bpb.27.1895	79	21	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144126	10.1371/journal.pone.0144126	http://dx.doi.org/10.1371/journal.pone.0144126			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26637171	Green Published, gold, Green Submitted			2022-12-27	WOS:000366143800044
J	Roder, P; Hille, C				Roder, Phillip; Hille, Carsten			A Multifunctional Frontloading Approach for Repeated Recycling of a Pressure-Controlled AFM Micropipette	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; INTRACELLULAR CA2+; LIQUID ENVIRONMENT; AQUEOUS GLYCEROL; NANOPARTICLES; DEPOSITION; FLUIDFM; CELLS; NA+	Fluid force microscopy combines the positional accuracy and force sensitivity of an atomic force microscope (AFM) with nanofluidics via a microchanneled cantilever. However, adequate loading and cleaning procedures for such AFM micropipettes are required for various application situations. Here, a new frontloading procedure is described for an AFM micropipette functioning as a force-and pressure-controlled microscale liquid dispenser. This frontloading procedure seems especially attractive when using target substances featuring high costs or low available amounts. Here, the AFM micropipette could be filled from the tip side with liquid from a previously applied droplet with a volume of only a few mu L using a short low-pressure pulse. The liquid-loaded AFM micropipettes could be then applied for experiments in air or liquid environments. AFM micropipette frontloading was evaluated with the well-known organic fluorescent dye rhodamine 6G and the AlexaFluor647-labeled antibody goat anti-rat IgG as an example of a larger biological compound. After micropipette usage, specific cleaning procedures were tested. Furthermore, a storage method is described, at which the AFM micropipettes could be stored for a few hours up to several days without drying out or clogging of the microchannel. In summary, the rapid, versatile and cost-efficient frontloading and cleaning procedure for the repeated usage of a single AFM micropipette is beneficial for various application situations from specific surface modifications through to local manipulation of living cells, and provides a simplified and faster handling for already known experiments with fluid force microscopy.	[Roder, Phillip; Hille, Carsten] Univ Potsdam, Inst Chem, Dept Phys Chem, Appl Laser Sensing Complex Biosyst ALS ComBi, Potsdam, Germany	University of Potsdam	Hille, C (corresponding author), Univ Potsdam, Inst Chem, Dept Phys Chem, Appl Laser Sensing Complex Biosyst ALS ComBi, Potsdam, Germany.	hille@uni-potsdam.de		Hille, Carsten/0000-0003-3454-8077	Federal Ministry of Education and Research ("ALSComBi") [03IPT517Y]; German Research Foundation DFG; Open Access Publishing Fund of the University of Potsdam	Federal Ministry of Education and Research ("ALSComBi"); German Research Foundation DFG(German Research Foundation (DFG)); Open Access Publishing Fund of the University of Potsdam	This work was funded by the Federal Ministry of Education and Research ("ALSComBi", grant number 03IPT517Y, www.bmbf.de). The publication of the paper was funded by the German Research Foundation DFG and the Open Access Publishing Fund of the University of Potsdam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcamone J, 2007, J PHYS CHEM B, V111, P13020, DOI 10.1021/jp075714b; Chung BG, 2006, LAB CHIP, V6, P764, DOI 10.1039/b512667c; Dermutz H, 2014, LANGMUIR, V30, P7037, DOI 10.1021/la5012692; Dorig P, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3462979; Fabie L, 2015, NANOSCALE, V7, P4497, DOI 10.1039/c4nr06824f; Fang AP, 2006, NANO LETT, V6, P2368, DOI 10.1021/nl061694y; Gruter RR, 2013, NANOSCALE, V5, P1097, DOI 10.1039/c2nr33214k; Gruter RR, 2015, NANOTECHNOLOGY, V26, DOI 10.1088/0957-4484/26/17/175301; Guillaume-Gentil O, 2014, TRENDS BIOTECHNOL, V32, P381, DOI 10.1016/j.tibtech.2014.04.008; Guillaume-Gentil O, 2014, LAB CHIP, V14, P402, DOI 10.1039/c3lc51174j; Guillaume-Gentil O, 2013, SMALL, V9, P1904, DOI 10.1002/smll.201202276; Hille C, 2006, CELL CALCIUM, V39, P305, DOI 10.1016/j.ceca.2005.11.006; Hille C, 2008, J EXP BIOL, V211, P568, DOI 10.1242/jeb.010207; Lang I, 2001, J INSECT PHYSIOL, V47, P465, DOI 10.1016/S0022-1910(00)00134-7; Lee S, 2003, LAB CHIP, V3, P164, DOI 10.1039/b305692a; Meister A, 2004, APPL PHYS LETT, V85, P6260, DOI 10.1063/1.1842352; Meister A, 2009, MICROELECTRON ENG, V86, P1481, DOI 10.1016/j.mee.2008.10.025; Meister A, 2009, NANO LETT, V9, P2501, DOI 10.1021/nl901384x; Potthoff E, 2015, NANOSCALE, V7, P4070, DOI 10.1039/c4nr06495j; Potthoff E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052712; SEGUR JB, 1951, IND ENG CHEM, V43, P2117, DOI 10.1021/ie50501a040; Stiefel P, 2013, APPL ENVIRON MICROB, V79, P4895, DOI 10.1128/AEM.01087-13; Stiefel P, 2012, NANO LETT, V12, P4219, DOI 10.1021/nl3018109; Suhling K, 2002, BIOPHYS J, V83, P3589, DOI 10.1016/S0006-3495(02)75359-9; Takamura K, 2012, J PETROL SCI ENG, V98-99, P50, DOI 10.1016/j.petrol.2012.09.003; To ECH, 1999, J SOLUTION CHEM, V28, P1137, DOI 10.1023/A:1021703725091	26	1	2	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144157	10.1371/journal.pone.0144157	http://dx.doi.org/10.1371/journal.pone.0144157			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636981	Green Submitted, Green Published, gold			2022-12-27	WOS:000366143800049
J	Hammer, N; Mobius, R; Gries, A; Hossfeld, B; Bechmann, I; Bernhard, M				Hammer, Niels; Moebius, Robert; Gries, Andre; Hossfeld, Bjoern; Bechmann, Ingo; Bernhard, Michael			Comparison of the Fluid Resuscitation Rate with and without External Pressure Using Two Intraosseous Infusion Systems for Adult Emergencies, the CITRIN (Comparison of InTRaosseous infusion systems in emergency medicINe)-Study	PLOS ONE			English	Article							VASCULAR ACCESS; DEVICE; ANATOMY; HUMERUS; FEMUR; BONE	Introduction Intraosseous infusion is recommended if peripheral venous access fails for cardiopulmonary resuscitation or other medical emergencies. The aim of this study, using body donors, was to compare a semi-automatic (EZ-IO (R)) device at two insertion sites and a sternal intraosseous infusion device (FASTR (TM)). Methods Twenty-seven medical students being inexperienced first-time users were randomized into three groups using EZ-IO and FASTR. The following data were evaluated: attempts required for successful placement, insertion time and flow rates with and without external pressure to the infusion. Results The first-pass insertion success of the EZ-IO tibia, EZ-IO humerus and FASTR was 91%, 77%, and 95%, respectively. Insertion times (MW +/- SD) did not show significant differences with 17 +/- 7 (EZ-IO tibia) vs. 29 +/- 42 (EZ-IO humerus) vs. 33 +/- 21 (FASTR), respectively. One-minute flow rates using external pressures between 0 mmHg and 300 mmHg ranged between 27 +/- 5 to 69 +/- 54 ml/min (EZ-IO tibia), 16 +/- 3 to 60 +/- 44 ml/min (EZ-IO humerus) and 53 +/- 2 to 112 +/- 47 ml/min (FASTR), respectively. Concerning pressure-related increases in flow rates, negligible correlations were found for the EZ-IO tibia in all time frames (c = 0.107-0.366; p <= 0.013), moderate positive correlations were found for the EZ-IO humerus after 5 minutes (c = 0.489; p = 0.021) and strong positive correlations were found for the FASTR in all time frames (c = 0.63-0.80; p <= 0.007). Post-hoc statistical power was 0.62 with the given sample size. Conclusions The experiments with first-time users applying EZ-IO and FASTR in body donors indicate that both devices may be effective intraosseous infusion devices, likely suitable for fluid resuscitation using a pressure bag. Variations in flow rate may limit their reliability. Larger sample sizes will prospectively be required to substantiate our findings.	[Hammer, Niels] Univ Otago, Dept Anat, Dunedin, New Zealand; [Hammer, Niels; Moebius, Robert; Bechmann, Ingo] Univ Leipzig, Fac Med, Inst Anat, D-04109 Leipzig, Germany; [Gries, Andre; Bernhard, Michael] Univ Hosp Leipzig, Emergency Dept, Leipzig, Germany; [Hossfeld, Bjoern] Fed Armed Forces Med Hosp, Sect Emergency Med, Dept Anaesthesiol & Intens Care Med, Ulm, Germany	University of Otago; Leipzig University; Leipzig University	Hammer, N (corresponding author), Univ Otago, Dept Anat, Dunedin, New Zealand.	nlshammer@googlemail.com		Hammer, Niels/0000-0001-8230-9383	CITRIN study; German Research Foundation (DFG); Universitat Leipzig within the program of Open Access Publishing	CITRIN study; German Research Foundation (DFG)(German Research Foundation (DFG)); Universitat Leipzig within the program of Open Access Publishing	Departmental resources supported the CITRIN study. The authors acknowledge support from the German Research Foundation (DFG) and Universitat Leipzig within the program of Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anson JA, 2014, ANESTHESIOLOGY, V120, P1015, DOI 10.1097/ALN.0000000000000140; ARNOLD M, 1972, J THORAC CARDIOV SUR, V64, P596; Babinski MA, 2015, SURG RADIOL ANAT, V37, P287, DOI 10.1007/s00276-014-1339-x; Barnard EBG, 2015, EMERG MED J, V32, P449, DOI 10.1136/emermed-2014-203740; Brenner T, 2008, RESUSCITATION, V78, P314, DOI 10.1016/j.resuscitation.2008.04.004; Deakin CD, 2010, RESUSCITATION, V81, P1305, DOI 10.1016/j.resuscitation.2010.08.017; DEJESUS RA, 1995, ANN THORAC SURG, V59, P163, DOI 10.1016/0003-4975(94)00722-J; Dubick MA, 2000, MIL MED, V165, P552; FASTRESPONDER STERNAL IO, 2015, CLIN EV IND STERN RO; Fokin AA, 2005, ANN THORAC SURG, V79, P1352, DOI 10.1016/j.athoracsur.2004.08.012; FRANCEL TJ, 1992, ARCH SURG-CHICAGO, V127, P1107; Hammer N, 2015, ANAT SCI EDUC, V8, P74, DOI 10.1002/ase.1450; Hammer N, 2012, ANAT SCI EDUC, V5, P225, DOI 10.1002/ase.1270; Helm M, 2015, RESUSCITATION, V88, P43, DOI 10.1016/j.resuscitation.2014.12.015; Kleinman ME, 2010, CIRCULATION, V122, P8466, DOI [10.1161/CIRCULATIONAHA.110.971093, 10.1542/peds.2010-2972A]; Kurowski A, 2014, AM J EMERG MED, V32, P1490, DOI 10.1016/j.ajem.2014.09.007; Lairet JR, 2010, ANN EMERG MED, V56, pS26, DOI 10.1016/j.annemergmed.2010.06.122; Lairet J, 2013, PREHOSP EMERG CARE, V17, P280, DOI 10.3109/10903127.2012.755582; Lanz T von, 2013, LANZ WACHSMUTH PRAKT; Levitan RM, 2009, ANN EMERG MED, V54, P692, DOI 10.1016/j.annemergmed.2009.06.012; Lewis P, 2015, EMERG MED J, V32, P463, DOI 10.1136/emermed-2014-203588; Luck RP, 2010, J EMERG MED, V39, P468, DOI 10.1016/j.jemermed.2009.04.054; Miller L, 2010, ANN EMERG MED, V56, pS151, DOI 10.1016/j.annemergmed.2010.06.510; Nishi H, 2011, EUR J CARDIO-THORAC, V40, P240, DOI 10.1016/j.ejcts.2010.10.027; Ong MEH, 2009, AM J EMERG MED, V27, P8, DOI 10.1016/j.ajem.2008.01.025; Pasley J, 2015, J TRAUMA ACUTE CARE, V78, P295, DOI 10.1097/TA.0000000000000516; Philbeck TE, 2010, JEMS, V35, P69, DOI 10.1016/S0197-2510(10)70232-1; Pietrasik K, 1999, CLIN ANAT, V12, P307, DOI 10.1002/(SICI)1098-2353(1999)12:5<307::AID-CA1>3.0.CO;2-6; RHINELANDER FW, 1974, J BIOMED MATER RES, V8, P87, DOI 10.1002/jbm.820080111; RHINELANDER FW, 1974, CLIN ORTHOP RELAT R, P34; Rhinelander FW, 2012, BIOCH PHYSL BONE, V2, P1; Sajja Lokeswara Rao, 2015, Asian Cardiovasc Thorac Ann, V23, P88, DOI 10.1177/0218492314523629; Schwartz D, 2008, J TRAUMA, V64, P650, DOI 10.1097/TA.0b013e31814db2a6; Singh J, 2013, FORENSIC SCI INT, V228, p181e1, DOI 10. 1016/ j. forsciint. 2013.02.002; Tan BKK, 2012, AM J EMERG MED, V30, P1602, DOI 10.1016/j.ajem.2011.10.025; Tarladacalisir T, 2013, EUR J CARDIO-THORAC, V44, P384, DOI 10.1093/ejcts/ezt091; TONDEVOLD E, 1979, ACTA ORTHOP SCAND, V50, P645, DOI 10.3109/17453677908991287; WARREN DW, 1993, ANN EMERG MED, V22, P183, DOI 10.1016/S0196-0644(05)80199-4	38	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143726	10.1371/journal.pone.0143726	http://dx.doi.org/10.1371/journal.pone.0143726			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630579	Green Published, Green Submitted, gold			2022-12-27	WOS:000365926300090
J	Yuan, XM; Zeng, YW; Nie, KY; Luo, DAH; Wang, ZJ				Yuan, Xiumei; Zeng, Yawei; Nie, Kaiying; Luo, Dianhui; Wang, Zhaojing			Extraction Optimization, Characterization and Bioactivities of a Major Polysaccharide from Sargassum thunbergii	PLOS ONE			English	Article							MICROWAVE-ASSISTED EXTRACTION; RESPONSE-SURFACE METHODOLOGY; STRUCTURAL-CHARACTERIZATION; HOLO-TRANSFERRIN; BROWN SEAWEED; IN-VITRO; ANTIOXIDANT; SEPARATION; FUCOIDAN	Sargassum thunbergii is a kind of natural edible algae. STP (S. thunbergii polysaccharides) was considered as the main bioactive compounds in S. thunbergii. To obtain the optimal processing conditions for maximum total sugar yield, single factor investigation and response surface methodology (RSM) were employed. The optimal processing conditions were as follows: liquid to solid ratio 120 mL/g, extraction time 210 min, extraction temperature 97 degrees C. The experimental yield 7.53% under optimized conditions was closely agreed with the predicted yield 7.85% of the model. The major polysaccharide fraction from S. thunbergii (named STP-II) was purified by DEAE-Sepharose CL-6B column chromatography. High-performance size-exclusion chromatography (HPSEC), gas chromatography (GC) and high-performance liquid chromatography (HPLC) were used to identify its characterizations, and in vitro antioxidant assays and cytotoxicity assays were used to research its bioactivities. The purified fraction STP-II (63.75%) was a single peak in HPSEC with Sugar KS-804 column, had a molecular weight of 550KD, and comprised mainly of fucose, xylose, galactose, glucose and glucuronic acid. STP-II had higher scavenging activities on hydroxyl radical (76.72% at 0.7 mg/mL) and superoxide radical (95.17% at 2 mg/mL) than Vitamin C (Vc). STP-II also exhibited the capability of anti-proliferation in Caco-2 cells. STP-II possessed good antioxidant and inhibitory activity against human colon cancer Caco-2 cells in vitro and could be explored as novel natural functional food.	[Yuan, Xiumei; Zeng, Yawei; Nie, Kaiying; Luo, Dianhui; Wang, Zhaojing] Huaqiao Univ, Dept Bioengn & Biotechnol, Xiamen, Fujian, Peoples R China	Huaqiao University	Wang, ZJ (corresponding author), Huaqiao Univ, Dept Bioengn & Biotechnol, Xiamen, Fujian, Peoples R China.	zhaojingwang@hqu.edu.cn			National Nature Science Foundation of China [31201314]; Fundamental Research Funds for the Central Universities [JB-ZR1222]; Promotion Program for Young and Middle-aged Teacher in Science and Technology Research of Huaqiao University [ZQN-PY316]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Promotion Program for Young and Middle-aged Teacher in Science and Technology Research of Huaqiao University	This work was supported by the National Nature Science Foundation of China (31201314), Fundamental Research Funds for the Central Universities (JB-ZR1222), and Promotion Program for Young and Middle-aged Teacher in Science and Technology Research of Huaqiao University (ZQN-PY316). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Nature Science Foundation of China (31201314), Fundamental Research Funds for the Central Universities (JB-ZR1222), and Promotion Program for Young and Middle-aged Teacher in Science and Technology Research of Huaqiao University (ZQN-PY316).	Banerjee A, 2005, FOOD CHEM, V90, P727, DOI 10.1016/j.foodchem.2004.04.033; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen C, 2015, LWT-FOOD SCI TECHNOL, V64, P1263, DOI 10.1016/j.lwt.2015.07.009; Cheng FC, 2002, J CHROMATOGR B, V781, P481, DOI 10.1016/S1570-0232(02)00620-7; Govender S, 2005, INT J PHARMACEUT, V306, P24, DOI 10.1016/j.ijpharm.2005.07.026; Han X.D., 2005, SPECIAL EC ANIMALS P, V1, P1; Hou XJ, 2008, CARBOHYD POLYM, V72, P67, DOI 10.1016/j.carbpol.2007.07.034; Huang Zhi-xuan, 2005, Zhongguo Zhongyao Zazhi, V30, P211; Itoh H, 1995, ANTICANCER RES, V15, P1937; Jing YS, 2015, J AGR FOOD CHEM, V63, P3464, DOI 10.1021/jf505915t; Kuznetsova IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040845; Lee WC, 2006, J FOOD ENG, V75, P473, DOI 10.1016/j.jfoodeng.2005.04.062; Liu ZD, 2006, CARBOHYD POLYM, V64, P548, DOI 10.1016/j.carbpol.2005.11.006; Liyana-Pathirana C, 2005, FOOD CHEM, V93, P47, DOI 10.1016/j.foodchem.2004.08.050; Luo DH, 2008, CARBOHYD POLYM, V72, P376, DOI 10.1016/j.carbpol.2007.09.006; Luo DH, 2012, CARBOHYD POLYM, V90, P284, DOI 10.1016/j.carbpol.2012.05.036; Maran JP, 2015, CARBOHYD POLYM, V123, P67, DOI 10.1016/j.carbpol.2014.11.072; Nguyen NK, 2008, J STAT PLAN INFER, V138, P294, DOI 10.1016/j.jspi.2007.05.002; Samavati V, 2013, CARBOHYD POLYM, V95, P588, DOI 10.1016/j.carbpol.2013.02.041; Sarzehi S, 2010, INT J BIOL MACROMOL, V47, P558, DOI 10.1016/j.ijbiomac.2010.08.002; Sattar Z, 2012, SPECTROCHIM ACTA A, V97, P1089, DOI 10.1016/j.saa.2012.07.034; Wang GY, 2001, CHEM J CHINESE U, V22, P1688; Wang Y, 2016, FOOD CHEM, V194, P257, DOI 10.1016/j.foodchem.2015.08.016; Wang ZY, 2014, INT J BIOL MACROMOL, V64, P139, DOI 10.1016/j.ijbiomac.2013.11.038; Wang ZJ, 2007, CARBOHYD POLYM, V69, P311, DOI 10.1016/j.carbpol.2006.10.013; [王昭晶 Wang Zhaojing], 2005, [分子科学学报, Journal of molecular science], V21, P28; Wang ZJ, 2004, CARBOHYD POLYM, V57, P241, DOI 10.1016/j.carbpol.2004.04.018; [魏玉西 Wei Yuxi], 2006, [中国海洋药物, Chinese Journal of Marine Drugs], V25, P41; Ye CL, 2011, CARBOHYD POLYM, V84, P495, DOI 10.1016/j.carbpol.2010.12.014; You LJ, 2013, FOOD CHEM, V138, P2242, DOI 10.1016/j.foodchem.2012.11.140; Zhang EX, 1997, CHIN J MAR DRUGS, V3, P1; Zheng Y, 1993, J FUJIAN NORM U, V9, P81; Zhu CP, 2013, CARBOHYD POLYM, V92, P1197, DOI 10.1016/j.carbpol.2012.10.073; ZHUANG C, 1995, BIOSCI BIOTECH BIOCH, V59, P563, DOI 10.1271/bbb.59.563	35	41	46	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144773	10.1371/journal.pone.0144773	http://dx.doi.org/10.1371/journal.pone.0144773			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26649576	Green Published, gold			2022-12-27	WOS:000366903300075
J	Li, YW; Yu, DC				Li, Yanwei; Yu, Dongchuan			Development of Emotion Word Comprehension in Chinese Children from 2 to 13 Years Old: Relationships with Valence and Empathy	PLOS ONE			English	Article							MATHEMATICS ACHIEVEMENT; FACIAL EXPRESSION; AMERICAN-CHILDREN; AFFECTIVE NORMS; DOWN-SYNDROME; RECOGNITION; LANGUAGE; BELIEFS; GENDER; AUTISM	Children's emotion word comprehension (EWC) has constantly received a great deal of attention in developmental science. However, since previous reports focused on only English emotion vocabulary, researchers thus far remained unclear as to the developmental trajectories of EWC (to Chinese emotion words) in Chinese children, let alone the cross-cultural difference of EWC in different languages (i.e., English V.S. Chinese). Furthermore, the influence of valence on EWC, as well as the interaction mechanism between EWC and empathy, has not been fully investigated. Finding answers to these research gaps has become the mainmotivation of the current study. For this purpose, a Chinese emotion vocabulary was first constructed to estimate EWC of Chinese children (ages 2-13 years old). Then, the valence of each emotion word was evaluated using the standard 9-point scale approach. After that, the Chinese children's EWC and empathy were measured in terms of parental ratings. Finally, all data collected were statistically analyzed to reveal the influence of the valence of EWC, the relation between EWC and empathy, and the cross-cultural difference of children's EWC between China and UK from the viewpoint of developmental science. The main results of the current study included the following: (i) EWC in general increased with age for Chinese children ages 2-13 years old, however, there was a dramatic increase during ages 6-8 years old; (ii) EWC of positive emotion words in general developed better than that of negative and neutral ones for Chinese children (ages 2-13 years old); and the disadvantage of EWC to negative emotion words over neutral ones was gradually observed with the increase of age, even though there were no significant differences between them from the beginning; (iii) EWC completely mediated the effect of age on empathy; and (iv) EWC of children in UK developed better than Chinese counterparts during the early childhood period (ages 4-6 years old), then Chinese counterparts developed better during the middle childhood period (ages 7-10 years old), however, there was no significant difference of EWC between both groups during the late childhood period (ages 11-12 years old).	[Li, Yanwei; Yu, Dongchuan] Southeast Univ, Minist Educ, Key Lab Child Dev & Learning Sci, Nanjing, Jiangsu, Peoples R China; [Li, Yanwei; Yu, Dongchuan] Southeast Univ, Res Ctr Learning Sci, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China	Yu, DC (corresponding author), Southeast Univ, Minist Educ, Key Lab Child Dev & Learning Sci, Nanjing, Jiangsu, Peoples R China.	dcyu@seu.edu.cn	li, yan/GTI-4638-2022		Natural Science Foundation of China [61273224, 61074126]; Program for New Century Excellent Talents in University; Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning [CNLYB1308]; Fundamental Research Funds for the Central Universities; Priority Academic Program Development of Jiangsu Higher Education Institutions [KYLX0186]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Priority Academic Program Development of Jiangsu Higher Education Institutions	The work was supported by the Natural Science Foundation of China under Grant Nos. 61273224 and 61074126, by the Program for New Century Excellent Talents in University, by the Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning under Grant No. CNLYB1308, by the Fundamental Research Funds for the Central Universities and by the Priority Academic Program Development of Jiangsu Higher Education Institutions under Grand No. KYLX0186. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The work was supported by the Natural Science Foundation of China under Grant Nos. 61273224 and 61074126, by the Program for New Century Excellent Talents in University, by the Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning under Grant No. CNLYB1308, by the Fundamental Research Funds for the Central Universities and by the Priority Academic Program Development of Jiangsu Higher Education Institutions under Grand No. KYLX0186. We would like to thank anonymous reviewers for their valuable and detailed comments that have greatly improved the quality of the manuscript. We also would like to thank Lisa M. Bemis for her kind proofreading.	Auyeung B, 2009, J AUTISM DEV DISORD, V39, P1509, DOI 10.1007/s10803-009-0772-x; Baez S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057664; Baron-Cohen Simon, 2010, Front Evol Neurosci, V2, P109, DOI 10.3389/fnevo.2010.00109; Bergmann HC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052616; Bretherton I, 1981, INFANT SO HILLSDALE; Bretherton L, 1982, DEV PSYCHOL, V19, P906; Brune M, 2005, SCHIZOPHRENIA BULL, V31, P21, DOI 10.1093/schbul/sbi002; Carlo G, 2012, J SOC PERS RELAT, V29, P337, DOI 10.1177/0265407511431181; Carmona-Perera M, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00050; CHEN CS, 1988, HUM DEV, V31, P351, DOI 10.1159/000276334; Christensen JF, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00757; de Hooge IE, 2014, J BEHAV DECIS MAKING, V27, P246, DOI 10.1002/bdm.1801; Decety J, 2008, DEV PSYCHOPATHOL, V20, P1053, DOI 10.1017/S0954579408000503; DENHAM SA, 1986, CHILD DEV, V57, P194, DOI 10.1111/j.1467-8624.1986.tb00020.x; Eisenberg N, 2006, HANDBOOK OF MORAL DEVELOPMENT, P517; EKMAN P, 1971, J PERS SOC PSYCHOL, V17, P124, DOI 10.1037/h0030377; EKMAN P, 1993, AM PSYCHOL, V48, P384, DOI 10.1037/0003-066X.48.4.384; Eyben F, 2010, J MULTIMODAL USER IN, V3, P7, DOI 10.1007/s12193-009-0032-6; Falck-Ytter T, 2006, NAT NEUROSCI, V9, P878, DOI 10.1038/nn1729; Gallese V, 2001, J CONSCIOUSNESS STUD, V8, P33; Golan O, 2008, J AUTISM DEV DISORD, V38, P1534, DOI 10.1007/s10803-007-0533-7; Harle KM, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00508; Herba C, 2004, J CHILD PSYCHOL PSYC, V45, P1185, DOI 10.1111/j.1469-7610.2004.00316.x; HESS RD, 1987, J EDUC PSYCHOL, V79, P179, DOI 10.1037/0022-0663.79.2.179; Hoffman M. L., 2001, EMPATHY MORAL DEV IM; Jansari A, 2011, BRAIN COGNITION, V76, P415, DOI 10.1016/j.bandc.2011.03.009; Kang JI, 2012, J AFFECT DISORDERS, V141, P286, DOI 10.1016/j.jad.2012.04.001; Kayyal MH, 2013, J LANG SOC PSYCHOL, V32, P261, DOI 10.1177/0261927X12461004; Kayyal MH, 2013, J LANG SOC PSYCHOL; Kuperman V, 2014, J EXP PSYCHOL GEN, V143, P1065, DOI 10.1037/a0035669; Lockwood PL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096555; LOVELAND KA, 1995, DEV PSYCHOPATHOL, V7, P409, DOI 10.1017/S095457940000660X; Marian V, 2008, MENT LEX, V3, P72, DOI 10.1075/ml.3.1.06mar; Montefinese M, 2014, BEHAV RES METHODS, V46, P887, DOI 10.3758/s13428-013-0405-3; Morris JA, 2013, J COGNITIVE NEUROSCI, P182; Parkin T, 2014, PATIENT EDUC COUNS, V96, P144, DOI 10.1016/j.pec.2014.04.019; Pasalich DS, 2014, PSYCHIAT RES, V219, P625, DOI 10.1016/j.psychres.2014.06.025; Pijnenborg GHM, 2013, EUR ARCH PSY CLIN N, V263, P299, DOI 10.1007/s00406-012-0373-0; Pochon R, 2013, J INTELLECT DEV DIS, V38, P332, DOI 10.3109/13668250.2013.826346; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; RIDGEWAY D, 1985, DEV PSYCHOL, V21, P901, DOI 10.1037/0012-1649.21.5.901; Rueda P, 2015, EUR J DEV PSYCHOL, V12, P85, DOI 10.1080/17405629.2014.950221; RUSSELL JA, 1991, PSYCHOL BULL, V110, P426, DOI 10.1037/0033-2909.110.3.426; Salovey P., 1990, IMAGINATION COGNITIO, V9, P185, DOI [https://doi.org/10.2190/DUGG-P24E-52WK-6CDG, 10.2190/DUGG-P24E-52WK-6CDG, DOI 10.2190/DUGG-P24E-52WK-6CDG]; Schrauf R.W., 2004, J MULTILING MULTICUL, V25, P266, DOI [DOI 10.1080/01434630408666532, 10.1080/01434630408666532]; Soares AP, 2012, BEHAV RES METHODS, V44, P256, DOI 10.3758/s13428-011-0131-7; STEVENSON HW, 1986, SCIENCE, V231, P693, DOI 10.1126/science.3945803; STEVENSON HW, 1993, SCIENCE, V259, P53, DOI 10.1126/science.8418494; Tibshirani R.J., 1993, MONOGRAPHS STAT APPL, VVolume 57, P1; Topcu C, 2012, SCHOOL PSYCHOL INT, V33, P550, DOI 10.1177/0143034312446882; Vrticka P, 2011, NEUROPSYCHOLOGIA, V49, P1067, DOI 10.1016/j.neuropsychologia.2011.02.020; Widen SC, 2003, DEV PSYCHOL, V39, P114, DOI 10.1037//0012-1649.39.1.114; Widen S, 2008, COGNITION EMOTION, V22, P1513, DOI 10.1080/02699930801906744; Wierzbicka A, 2012, EMOT REV, V4, P307, DOI 10.1177/1754073912439761; Wierzbicka A, 2009, EMOT REV, V1, P3, DOI 10.1177/1754073908097175; Zajdel RT, 2013, J GENET PSYCHOL, V174, P582, DOI 10.1080/00221325.2012.732125; Zaki J, 2012, NAT NEUROSCI, V15, P675, DOI 10.1038/nn.3085	57	20	20	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0143712	10.1371/journal.pone.0143712	http://dx.doi.org/10.1371/journal.pone.0143712			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1YV	26647060	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903100006
J	Hanna, EM; Zaki, N; Amin, A				Hanna, Eileen Marie; Zaki, Nazar; Amin, Amr			Detecting Protein Complexes in Protein Interaction Networks Modeled as Gene Expression Biclusters	PLOS ONE			English	Article							MODULES; ALGORITHMS; ONTOLOGY; LOGIC; TOOL	Developing suitable methods for the detection of protein complexes in protein interaction networks continues to be an intriguing area of research. The importance of this objective originates from the fact that protein complexes are key players in most cellular processes. The more complexes we identify, the better we can understand normal as well as abnormal molecular events. Up till now, various computational methods were designed for this purpose. However, despite their notable performance, questions arise regarding potential ways to improve them, in addition to ameliorative guidelines to introduce novel approaches. A close interpretation leads to the assent that the way in which protein interaction networks are initially viewed should be adjusted. These networks are dynamic in reality and it is necessary to consider this fact to enhance the detection of protein complexes. In this paper, we present "DyCluster", a framework to model the dynamic aspect of protein interaction networks by incorporating gene expression data, through biclustering techniques, prior to applying complex-detection algorithms. The experimental results show that DyCluster leads to higher numbers of correctly-detected complexes with better evaluation scores. The high accuracy achieved by DyCluster in detecting protein complexes is a valid argument in favor of the proposed method. DyCluster is also able to detect biologically meaningful protein groups. The code and datasets used in the study are downloadable from https://github.com/emhanna/DyCluster.	[Hanna, Eileen Marie; Zaki, Nazar] UAEU, Coll Info Tech, Intelligent Syst, Al Ain 15551, U Arab Emirates; [Amin, Amr] UAEU, Coll Sci, Dept Biol, Al Ain 15551, U Arab Emirates; [Amin, Amr] Cairo Univ, Fac Sci, Cairo, Egypt	United Arab Emirates University; United Arab Emirates University; Egyptian Knowledge Bank (EKB); Cairo University	Hanna, EM (corresponding author), UAEU, Coll Info Tech, Intelligent Syst, Al Ain 15551, U Arab Emirates.	eileen.hanna@uaeu.ac.ae	Zaki, Nazar/ABC-1680-2020; Zaki, Nazar M/F-1972-2013; Amin, Amr/I-2137-2019	Zaki, Nazar M/0000-0002-6259-9843; Amin, Amr/0000-0001-8888-1102; Hanna, Eileen Marie/0000-0002-2093-4586	United Arab Emirates University Program for Advance Research (UPAR) [31T052, 31S118]; Terry Fox Foundation, United Arab Emirates [21S088]	United Arab Emirates University Program for Advance Research (UPAR); Terry Fox Foundation, United Arab Emirates	This work was partially supported by grants ref. no. 31T052 and 31S118 from United Arab Emirates University Program for Advance Research (UPAR) and 21S088-Terry Fox Foundation, United Arab Emirates.; The work is partially supported by grants ref. no. 31T052 and 31S118 from United Arab Emirates University Program for Advance Research (UPAR) and 21S088-Terry Fox Foundation, United Arab Emirates.	Adamcsek B, 2006, BIOINFORMATICS, V22, P1021, DOI 10.1093/bioinformatics/btl039; Adelmant G, 2009, EXPERT REV PROTEOMIC, V6, P5, DOI 10.1586/14789450.6.1.5; Amin A, 2011, HEPATOLOGY, V54, P857, DOI 10.1002/hep.24433; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Asyali MH, 2006, CURR BIOINFORM, V1, P55, DOI 10.2174/157489306775330615; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Baldi P, 2002, DNA MICROARRAYS GENE; Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Barkow S, 2006, BIOINFORMATICS, V22, P1282, DOI 10.1093/bioinformatics/btl099; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Ben-Dor A, 2003, J COMPUT BIOL, V10, P373, DOI 10.1089/10665270360688075; Bergmann S, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.031902; Bozdag D, 2010, 1 ACM INT C BIOINFOR, P265, DOI [DOI 10.1145/1854776.1854814, 10.1145/1854776.1854814]; Busygin S, 2008, COMPUT OPER RES, V35, P2964, DOI 10.1016/j.cor.2007.01.005; Cheng Y, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P93; Chua Hon Nian, 2008, Journal of Bioinformatics and Computational Biology, V6, P435, DOI 10.1142/S0219720008003497; Chua HN, 2006, BIOINFORMATICS, V22, P1623, DOI 10.1093/bioinformatics/btl145; Collins MO, 2008, CURR OPIN BIOTECH, V19, P324, DOI 10.1016/j.copbio.2008.06.002; de Lichtenberg U, 2005, SCIENCE, V307, P724, DOI 10.1126/science.1105103; Dongen S.v, 2000, GRAPH CLUSTERING FLO; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Hanna EM, 2014, BIOINFORMATICS 2014: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON BIOINFORMATICS MODELS, METHODS AND ALGORITHMS, P239; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hodgkin J, 1998, INT J DEV BIOL, V42, P501; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jiang DX, 2004, IEEE T KNOWL DATA EN, V16, P1370, DOI 10.1109/TKDE.2004.68; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kim TH, 2006, ANNU REV GENOM HUM G, V7, P81, DOI 10.1146/annurev.genom.7.080505.115634; Kim Y, 2014, BRIEF BIOINFORM, V15, P212, DOI 10.1093/bib/bbt028; King AD, 2004, BIOINFORMATICS, V20, P3013, DOI 10.1093/bioinformatics/bth351; Lee YH, 2010, PROTEOMICS, V10, P3935, DOI 10.1002/pmic.201000289; Levy ED, 2008, CURR OPIN STRUC BIOL, V18, P349, DOI 10.1016/j.sbi.2008.03.003; Li M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/375262; Liu GM, 2009, BIOINFORMATICS, V25, P1891, DOI 10.1093/bioinformatics/btp311; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; Lubovac Z, 2006, PROTEINS, V64, P948, DOI 10.1002/prot.21071; Madeira SC, 2004, IEEE ACM T COMPUT BI, V1, P24, DOI 10.1109/TCBB.2004.2; Morris MK, 2010, BIOCHEMISTRY-US, V49, P3216, DOI 10.1021/bi902202q; Mukhopadhyay Anirban, 2009, Journal of Bioinformatics and Computational Biology, V7, P853, DOI 10.1142/S0219720009004370; Nepusz T, 2012, NAT METHODS, V9, P471, DOI [10.1038/nmeth.1938, 10.1038/NMETH.1938]; Oghabian A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090801; Przulj N, 2004, BIOINFORMATICS, V20, P340, DOI 10.1093/bioinformatics/btg415; Przytycka TM, 2010, BRIEF BIOINFORM, V11, P15, DOI 10.1093/bib/bbp057; Pu SY, 2009, NUCLEIC ACIDS RES, V37, P825, DOI 10.1093/nar/gkn1005; Remondini D, 2005, P NATL ACAD SCI USA, V102, P6902, DOI 10.1073/pnas.0502081102; Song L, 2009, BIOINFORMATICS, V25, pI128, DOI 10.1093/bioinformatics/btp192; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; Wang JX, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-28; Wang JX, 2011, IEEE INT C BIOINFORM, P37, DOI 10.1109/BIBM.2011.45; Watson James D., 2003, DNA SECRET LIFE; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303; Xu B, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-S1-S7; Zaki N, 2014, SCI REP-UK, V4, DOI 10.1038/srep04262; Zaki N, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-163; Zaki N, 2012, PROCEEDINGS OF THE FOURTEENTH INTERNATIONAL CONFERENCE ON GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P209, DOI 10.1145/2330163.2330193; Zaki N, 2012, PROTEINS, V80, P2459, DOI 10.1002/prot.24130	60	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144163	10.1371/journal.pone.0144163	http://dx.doi.org/10.1371/journal.pone.0144163			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641660	gold, Green Submitted, Green Published			2022-12-27	WOS:000366902700069
J	Wu, K; Hoy, MA				Wu, Ke; Hoy, Marjorie A.			Cloning and Functional Characterization of Two BTB Genes in the Predatory Mite Metaseiulus occidentalis	PLOS ONE			English	Article							DROSOPHILA OVARY MORPHOGENESIS; GENETICALLY-IMPROVED STRAINS; BTB/POZ DOMAIN PROTEINS; ZINC-FINGER PROTEINS; BRIC-A-BRAC; UBIQUITIN LIGASES; TETRAMERIZATION DOMAIN; ACARI PHYTOSEIIDAE; SEXUAL ORIENTATION; POTASSIUM CHANNELS	Proteins containing the BTB (Bric-a-brac, tramtrack, and Broad Complex) domain typically share low sequence similarities and are involved in a wide range of cellular functions. We previously identified two putative and closely related BTB genes, BTB1 and BTB2, in the genome of the predatory mite Metaseiulus occidentalis. In the current study, full-length BTB1 and BTB2 cDNAs were cloned and sequenced. BTB1 and BTB2 encode proteins of 380 and 401 amino acids, respectively. BTB1 and BTB2 proteins each contain an N-terminal BTB domain and no other identifiable domains. Thus, they belong to a large category of BTB-domain proteins that are widely distributed in eukaryotes, yet with largely unknown function(s). BTB1 and BTB2 gene knockdowns in M. occidentalis females using RNAi reduced their fecundity by approximately 40% and 73%, respectively, whereas knockdown had no impact on their survival or the development of their offspring. These findings suggest these two proteins may be involved in processes related to egg production in this predatory mite, expanding the list of functions attributed to these diverse proteins.	[Wu, Ke; Hoy, Marjorie A.] Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Wu, K (corresponding author), Univ Florida, Dept Entomol & Nematol, POB 11620, Gainesville, FL 32611 USA.	kewu@ufl.edu			Davies; Fischer; Eckes Endowment in Biological Control	Davies; Fischer; Eckes Endowment in Biological Control	This research was supported in part by the Davies, Fischer and Eckes Endowment in Biological Control to MAH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Godfrey Maina for assistance in rearing the colonies. This research was supported in part by the Davies, Fischer and Eckes Endowment in Biological Control to MAH.	Ahmad KF, 1998, P NATL ACAD SCI USA, V95, P12123, DOI 10.1073/pnas.95.21.12123; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Bomont P, 2000, NAT GENET, V26, P370, DOI 10.1038/81701; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Couderc JL, 2002, DEVELOPMENT, V129, P2419; Cushman SJ, 2000, NAT STRUCT BIOL, V7, P403; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; FIELD RP, 1985, ENTOMOL EXP APPL, V38, P113, DOI 10.1007/BF00361921; FIELD RP, 1986, HILGARDIA, V54, P1; Field RP, 1978, AUSTR J ZOOL, V26, P519; Furukawa M, 2003, NAT CELL BIOL, V5, P1001, DOI 10.1038/ncb1056; Geyer R, 2003, MOL CELL, V12, P783, DOI 10.1016/S1097-2765(03)00341-1; GODT D, 1995, DEVELOPMENT, V121, P173; HEADLEY JC, 1987, J ECON ENTOMOL, V80, P555, DOI 10.1093/jee/80.3.555; HOY MA, 1985, ANNU REV ENTOMOL, V30, P345, DOI 10.1146/annurev.en.30.010185.002021; HOY MA, 1982, ENTOMOL EXP APPL, V31, P316, DOI 10.1111/j.1570-7458.1982.tb03151.x; HOYT SC, 1969, J ECON ENTOMOL, V62, P74, DOI 10.1093/jee/62.1.74; Ito H, 1996, P NATL ACAD SCI USA, V93, P9687, DOI 10.1073/pnas.93.18.9687; Kang MI, 2004, P NATL ACAD SCI USA, V101, P2046, DOI 10.1073/pnas.0308347100; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; KOONIN EV, 1992, TRENDS BIOCHEM SCI, V17, P213, DOI 10.1016/0968-0004(92)90379-N; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kreusch A, 1998, NATURE, V392, P945, DOI 10.1038/31978; Liu HL, 2005, J BIOMOL STRUCT DYN, V22, P387, DOI 10.1080/07391102.2005.10507011; Liu XS, 2014, GENE DEV, V28, P1917, DOI 10.1101/gad.245910.114; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lours C, 2003, NUCLEIC ACIDS RES, V31, P5389, DOI 10.1093/nar/gkg724; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; MCMURTRY JA, 1970, HILGARDIA, V40, P331, DOI 10.3733/hilg.v40n11p331; Minor DL, 2000, CELL, V102, P657, DOI 10.1016/S0092-8674(00)00088-X; NUMOTO M, 1993, NUCLEIC ACIDS RES, V21, P3767, DOI 10.1093/nar/21.16.3767; Penalva-Arana DC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-79; Perez-Torrado R, 2006, BIOESSAYS, V28, P1194, DOI 10.1002/bies.20500; Pomerantz AF, 2015, EXP APPL ACAROL, V65, P1, DOI 10.1007/s10493-014-9855-2; ROUSH RT, 1981, J ECON ENTOMOL, V74, P142, DOI 10.1093/jee/74.2.142; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; SAHUTBARNOLA I, 1995, DEV BIOL, V170, P127, DOI 10.1006/dbio.1995.1201; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stogios PJ, 2010, J MOL BIOL, V400, P983, DOI 10.1016/j.jmb.2010.05.028; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Wu K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110874; Wu K, 2014, BIOL CONTROL, V77, P59, DOI 10.1016/j.biocontrol.2014.06.008; Wu K, 2014, EXP APPL ACAROL, V63, P171, DOI 10.1007/s10493-014-9772-4; Wu K, 2012, J INVERTEBR PATHOL, V109, P20, DOI 10.1016/j.jip.2011.09.005; Yamamoto D, 2013, NAT REV NEUROSCI, V14, P681, DOI 10.1038/nrn3567; Yandell M, 2012, NAT REV GENET, V13, P329, DOI 10.1038/nrg3174; Ziegelbauer J, 2001, MOL CELL, V8, P339, DOI 10.1016/S1097-2765(01)00313-6; Zipper LM, 2002, J BIOL CHEM, V277, P36544, DOI 10.1074/jbc.M206530200; ZOLLMAN S, 1994, P NATL ACAD SCI USA, V91, P10717, DOI 10.1073/pnas.91.22.10717	51	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144291	10.1371/journal.pone.0144291	http://dx.doi.org/10.1371/journal.pone.0144291			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26640898	Green Submitted, Green Published, gold			2022-12-27	WOS:000366902700092
J	Hyvarinen, S; Jokiranta, TS				Hyvarinen, Satu; Jokiranta, T. Sakari			Minor Role of Plasminogen in Complement Activation on Cell Surfaces	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; FACTOR-H; PLATELET ACTIVATION; CLASSICAL PATHWAY; ENDOTHELIAL-CELLS; BLOOD-PLATELETS; FACTOR-B; FIBRINOLYSIS; MECHANISMS; MUTATIONS	Atypical hemolytic uremic syndrome (aHUS) is a rare, but severe thrombotic microangiopathy. In roughly two thirds of the patients, mutations in complement genes lead to uncontrolled activation of the complement system against self cells. Recently, aHUS patients were described with deficiency of the fibrinolytic protein plasminogen. This zymogen and its protease form plasmin have both been shown to interact with complement proteins in the fluid phase. In this work we studied the potential of plasminogen to restrict complement propagation. In hemolytic assays, plasminogen inhibited complement activation, but only when it had been exogenously activated to plasmin and when it was used at disproportionately high concentrations compared to serum. Addition of only the zymogen plasminogen into serum did not hinder complement-mediated lysis of erythrocytes. Plasminogen could not restrict deposition of complement activation products on endothelial cells either, as was shown with flow cytometry. With platelets, a very weak inhibitory effect on deposition of C3 fragments was observed, but it was considered too weak to be significant for disease pathogenesis. Thus it was concluded that plasminogen is not an important regulator of complement on self cells. Instead, addition of plasminogen was shown to clearly hinder platelet aggregation in serum. This was attributed to plasmin causing disintegration of formed platelet aggregates. We propose that reduced proteolytic activity of plasmin on structures of growing thrombi, rather than on complement activation fragments, explains the association of plasminogen deficiency with aHUS. This adds to the emerging view that factors unrelated to the complement system can also be central to aHUS pathogenesis and suggests that future research on the mechanism of the disease should expand beyond complement dysregulation.	[Hyvarinen, Satu] Univ Helsinki, Dept Bacteriol & Immunol, Helsinki, Finland; Univ Helsinki, Res Programs Unit, Immunobiol, Helsinki, Finland	University of Helsinki; University of Helsinki	Hyvarinen, S (corresponding author), Univ Helsinki, Dept Bacteriol & Immunol, Helsinki, Finland.	satu.hyvarinen@helsinki.fi			Sigrid Juselius Foundation [128646]; Academy of Finland [259793]	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland)	This work was supported by research grants from the Sigrid Juselius Foundation (grant 128646 to TSJ; http://www.sigridjuselius.fi/foundation) and the Academy of Finland (grant 259793 to TSJ; http://www.aka.fi/eng). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara U, 2010, J IMMUNOL, V185, P5628, DOI 10.4049/jimmunol.0903678; Barthel D, 2012, J BIOL CHEM, V287, P18831, DOI 10.1074/jbc.M111.323287; Bruneau S, 2015, BLOOD, V125, P1038, DOI 10.1182/blood-2014-06-579953; Bu FX, 2014, J AM SOC NEPHROL, V25, P55, DOI 10.1681/ASN.2013050453; Cesarman-Maus G, 2005, BRIT J HAEMATOL, V129, P307, DOI 10.1111/j.1365-2141.2005.05444.x; Chung MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018119; del Conde I, 2005, J EXP MED, V201, P871, DOI 10.1084/jem.20041497; Delvaeye M, 2009, NEW ENGL J MED, V361, P345, DOI 10.1056/NEJMoa0810739; Deryugina EI, 2012, J BIOMED BIOTECHNOL, V2012, DOI [10.1155/2012/564259, DOI 10.1155/2012/564259]; Drew AF, 1998, BLOOD, V91, P1616, DOI 10.1182/blood.V91.5.1616.1616_1616_1624; Endo Y, 2010, J INNATE IMMUN, V2, P33, DOI 10.1159/000227805; Foley JH, 2015, J THROMB HAEMOST, V13, P610, DOI 10.1111/jth.12837; GHEBREHIWET B, 1983, J CLIN INVEST, V71, P1450, DOI 10.1172/JCI110898; Gushiken FC, 2009, J THROMB HAEMOST, V7, P865, DOI 10.1111/j.1538-7836.2009.03334.x; HOFFMANN JJML, 1992, THROMB RES, V67, P711, DOI 10.1016/0049-3848(92)90075-L; IKARI N, 1981, FEBS LETT, V131, P143, DOI 10.1016/0014-5793(81)80906-4; Karnchanaphanurach P, 2009, J CLIN INVEST, V119, P788, DOI 10.1172/JCI36088; Kavanagh D, 2010, PEDIATR NEPHROL, V25, P2431, DOI 10.1007/s00467-010-1555-5; KOISTINEN V, 1989, COMPLEMENT INFLAMMAT, V6, P270, DOI 10.1159/000463102; Lahteenmaki K, 2001, FEMS MICROBIOL REV, V25, P531, DOI 10.1111/j.1574-6976.2001.tb00590.x; Lehtinen MJ, 2009, J BIOL CHEM, V284, P15650, DOI 10.1074/jbc.M900814200; Lemaire M, 2013, NAT GENET, V45, P531, DOI 10.1038/ng.2590; Licht C, 2009, BLOOD, V114, P4538, DOI 10.1182/blood-2009-03-205096; Loirat C, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-60; LOSCALZO J, 1995, THROMB HAEMOSTASIS, V74, P291; LOSCALZO J, 1987, J CLIN INVEST, V79, P1749, DOI 10.1172/JCI113015; Madureira PA, 2011, BLOOD, V118, P4789, DOI 10.1182/blood-2011-06-334672; Manuelian T, 2003, J CLIN INVEST, V111, P1181, DOI 10.1172/JCI200316651; Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006; Matsukuma E, 2011, CLIN EXP NEPHROL, V15, P269, DOI 10.1007/s10157-010-0375-z; Mehta R, 2008, HAEMOPHILIA, V14, P1261, DOI 10.1111/j.1365-2516.2008.01825.x; MILES LA, 1985, J BIOL CHEM, V260, P4303; MILES LA, 1986, J CLIN INVEST, V77, P2001, DOI 10.1172/JCI112529; Modde F, 2013, VIRCHOWS ARCH, V462, P455, DOI 10.1007/s00428-013-1386-4; MULLEREBERHARD HJ, 1960, J EXP MED, V111, P201, DOI 10.1084/jem.111.2.201; Noris M, 2014, BLOOD, V124, P1715, DOI 10.1182/blood-2014-02-558296; Noris M, 2009, NEW ENGL J MED, V361, P1676, DOI 10.1056/NEJMra0902814; NUNN DL, 1987, BIOCHEM J, V243, P809, DOI 10.1042/bj2430809; Oikonomopoulou K, 2012, SEMIN IMMUNOPATHOL, V34, P151, DOI 10.1007/s00281-011-0280-x; Peerschke EIB, 2006, J THROMB HAEMOST, V4, P2035, DOI 10.1111/j.1538-7836.2006.02065.x; Peerschke EIB, 2003, THROMB HAEMOSTASIS, V89, P331; PILLEMER L, 1953, J EXP MED, V97, P573, DOI 10.1084/jem.97.4.573; POLLEY MJ, 1983, J EXP MED, V158, P603, DOI 10.1084/jem.158.2.603; POLLEY MJ, 1978, J EXP MED, V147, P1713, DOI 10.1084/jem.147.6.1713; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rooijakkers SHM, 2005, MICROBES INFECT, V7, P476, DOI 10.1016/j.micinf.2004.12.014; Saggu G, 2013, J IMMUNOL, V190, P6457, DOI 10.4049/jimmunol.1300610; SAKATA Y, 1980, J CLIN INVEST, V65, P290, DOI 10.1172/JCI109671; Schaller J, 2011, CELL MOL LIFE SCI, V68, P785, DOI 10.1007/s00018-010-0566-5; SCHREIBER RD, 1974, J EXP MED, V140, P1324, DOI 10.1084/jem.140.5.1324; SEYA T, 1985, Complement, V2, P165; SHATSTSEYTLINA EA, 1994, BLOOD COAGUL FIBRIN, V5, P529; Stahl AL, 2008, BLOOD, V111, P5307, DOI 10.1182/blood-2007-08-106153; TAUBMAN SB, 1971, IMMUNOCHEMISTRY, V8, P951, DOI 10.1016/0019-2791(71)90433-2; Vieira ML, 2011, MICROB PATHOGENESIS, V51, P360, DOI 10.1016/j.micpath.2011.06.008; WARD PA, 1967, J EXP MED, V126, P189, DOI 10.1084/jem.126.2.189; Weisel J. W., 2008, Cardiovascular & Hematological Agents in Medicinal Chemistry, V6, P161, DOI 10.2174/187152508784871963; Yegutkin GG, 2001, FASEB J, V15, P251, DOI 10.1096/fj.00-0268com	58	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143707	10.1371/journal.pone.0143707	http://dx.doi.org/10.1371/journal.pone.0143707			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26637181	Green Published, gold, Green Submitted			2022-12-27	WOS:000366143800023
J	Suzuki, K; Kobayashi, T; Moriyama, K; Kaga, M; Hiratani, M; Watanabe, K; Yamashita, Y; Inagaki, M				Suzuki, Kota; Kobayashi, Tomoka; Moriyama, Karin; Kaga, Makiko; Hiratani, Michio; Watanabe, Kyota; Yamashita, Yushiro; Inagaki, Masumi			Development and Evaluation of a Parenting Resilience Elements Questionnaire (PREQ) Measuring Resiliency in Rearing Children with Developmental Disorders	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDERS; POSITIVE PERCEPTIONS; SOCIAL SUPPORT; MOTHERS; STRESS; DISABILITIES; METAANALYSIS; POPULATION; STRENGTHS; VALIDITY	We developed a parenting resilience elements questionnaire (PREQ) measuring the degree to which mothers possess elements that aid in adapting to challenges and difficulties related to children with developmental disorders (DD). A total of 424 parents of children with DD were recruited from five medical institutes. Psychometric properties of PREQ were evaluated using data of 363 mothers of children with DD. Furthermore, multiple regression analysis was performed, predicting depressive symptoms and parenting behavior with PREQ subscales, a general health questionnaire, and the total difficulties score of a strength and difficulties questionnaire. Factor analysis revealed three reliable factors: "knowledge of the child's characteristics," "perceived social supports," and "positive perceptions of parenting." Moreover, multiple regression analysis showed that "knowledge of the child's characteristics" was associated with parenting behavior, whereas "perceived social supports" predicted depressive symptoms; "positive perceptions of parenting" influenced both parenting behavior and depressive symptoms. These findings indicated that the PREQ may be used as a scale measuring resiliency in mothers of children with DD and is useful for evaluating their parenting ability in clinical interventions.	[Suzuki, Kota; Kobayashi, Tomoka; Moriyama, Karin; Kaga, Makiko; Inagaki, Masumi] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Dev Disorders, Tokyo, Japan; [Kobayashi, Tomoka] NTT Med Ctr Tokyo, Dept Pediat, Shinagawa Ku, Tokyo, Japan; [Kaga, Makiko] Tokyo Metropolitan Med Ctr EAST Children Adults D, Koto Ku, Tokyo, Japan; [Hiratani, Michio] Hiratani Child Dev Clin, Fukui, Fukui, Japan; [Watanabe, Kyota] Kohnodai Hosp, Natl Ctr Global Hlth & Med, Dept Child & Adolescent Psychiat, Ichikawa, Chiba, Japan; [Yamashita, Yushiro] Kurume Univ, Sch Med, Dept Pediat & Child Hlth, Kurume, Fukuoka 830, Japan	National Center for Neurology & Psychiatry - Japan; Kanto Medical Center NTT EC; National Center for Global Health & Medicine - Japan; Kurume University	Suzuki, K (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Dev Disorders, Tokyo, Japan.	kt.suzuki@ncnp.go.jp	Suzuki, Kota/L-2562-2019		Health and Labour Sciences Research Grant for Comprehensive Research on Disability Health and Welfare from the Japanese Ministry of Health, Labour and Welfare [H24 - SHINTAI/CHITEKI - IPPAN - 007]; Ministry of Education, Culture, Sports, Science and Technology of Japan [15K20756]	Health and Labour Sciences Research Grant for Comprehensive Research on Disability Health and Welfare from the Japanese Ministry of Health, Labour and Welfare; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Health and Labour Sciences Research Grant for Comprehensive Research on Disability Health and Welfare (H24 - SHINTAI/CHITEKI - IPPAN - 007) from the Japanese Ministry of Health, Labour and Welfare, and Grant-in Aids for Young Scientists (15K20756) by the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold D.S., 1993, PSYCHOL ASSESSMENT, V9, P137, DOI [10.1037/1040-3590.5.2.137, DOI 10.1037/1040-3590.5.2.137]; Bayat M, 2007, J INTELL DISABIL RES, V51, P702, DOI 10.1111/j.1365-2788.2007.00960.x; BEBKO JM, 1987, J AUTISM DEV DISORD, V17, P565, DOI 10.1007/BF01486971; Boyd BA., 2002, FOCUS AUTISM OTHER D, V17, P208, DOI [10.1177/10883576020170040301, DOI 10.1177/10883576020170040301]; BREEN MJ, 1988, J PEDIATR PSYCHOL, V13, P265, DOI 10.1093/jpepsy/13.2.265; Doi Y, 2003, PSYCHIAT CLIN NEUROS, V57, P379, DOI 10.1046/j.1440-1819.2003.01135.x; Ekas NV, 2010, J AUTISM DEV DISORD, V40, P1274, DOI 10.1007/s10803-010-0986-y; Gardner J., 2002, AUSTR SOCIAL WORK, V55, P60, DOI [10.1080/03124070208411672, DOI 10.1080/03124070208411672]; Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242; Goodman R, 2000, BRIT J PSYCHIAT, V177, P534, DOI 10.1192/bjp.177.6.534; Harrison C, 2002, J AM ACAD CHILD PSY, V41, DOI 10.1097/00004583-200206000-00010; Harvey E, 2001, BEHAV RES THER, V39, P731, DOI 10.1016/S0005-7967(00)00052-8; Hastings RP, 2005, AUTISM, V9, P377, DOI 10.1177/1362361305056078; Hastings RP, 2002, J APPL RES INTELLECT, V15, P269, DOI 10.1046/j.1468-3148.2002.00104.x; Hastings RP, 2002, AM J MENT RETARD, V107, P116, DOI 10.1352/0895-8017(2002)107<0116:PPIFOC>2.0.CO;2; Heine SJ, 1999, PSYCHOL REV, V106, P766, DOI 10.1037/0033-295X.106.4.766; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Ingersoll B, 2011, RES AUTISM SPECT DIS, V5, P337, DOI 10.1016/j.rasd.2010.04.017; Itani Tomomi, 2010, Shinrigaku Kenkyu, V81, P446; Kinoshita Y., 2003, GROUNDED THEORY APPR; KOEGEL RL, 1992, J AUTISM DEV DISORD, V22, P205, DOI 10.1007/BF01058151; Luthar SS, 2000, CHILD DEV, V71, P543, DOI 10.1111/1467-8624.00164; Matsuishi T, 2008, BRAIN DEV-JPN, V30, P410, DOI 10.1016/j.braindev.2007.12.003; Muthen L. K., 1998, MPLUS STAT ANAL LATE, V3; R Development Core Team, 2012, R LANG ENV STAT COMP; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Schieve LA, 2007, PEDIATRICS, V119, pS114, DOI 10.1542/peds.2006-2089Q; Shima S., 1985, PSYCHIATRY, V27, P717, DOI DOI 10.11477/MF.1405203967; Singer GHS, 2007, MENT RETARD DEV D R, V13, P357, DOI 10.1002/mrdd.20175; Singer GHS, 2006, AM J MENT RETARD, V111, P155, DOI 10.1352/0895-8017(2006)111[155:MOCSOD]2.0.CO;2; Skinner D, 1999, EXCEPT CHILDREN, V65, P481, DOI 10.1177/001440299906500404; Smith LE, 2012, J AUTISM DEV DISORD, V42, P1818, DOI 10.1007/s10803-011-1420-9; Suzuki K., 2013, ASIAN J HUMAN SERVIC, V5, P104, DOI [10.14391/ajhs.5.104, DOI 10.14391/AJHS.5.104, 10.14391/ajhs.5.104.]; Suzuki Kota, 2015, No To Hattatsu, V47, P283; Tusaie Kathleen, 2004, Holist Nurs Pract, V18, P3; Whittingham K, 2008, BEHAV CHANGE, V25, P201, DOI 10.1375/bech.25.4.201; Windle G, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-8	37	16	16	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143946	10.1371/journal.pone.0143946	http://dx.doi.org/10.1371/journal.pone.0143946			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX9QI	26633810	Green Published, Green Submitted, gold			2022-12-27	WOS:000366040000033
J	Agrebi, B; Tkatchuk, V; Hlila, N; Mouelhi, E; Belhani, A				Agrebi, Brahim; Tkatchuk, Vladimir; Hlila, Nawel; Mouelhi, Emna; Belhani, Ali			Impact of specific training and competition on myocardial structure and function in different age ranges of male handball players	PLOS ONE			English	Article							LEFT-VENTRICULAR FUNCTION; PHYSIOLOGICAL CARDIAC-HYPERTROPHY; ATHLETES HEART; DIASTOLIC FUNCTION; SOCCER PLAYERS; UPPER LIMIT; ELITE; BOYS; ECHOCARDIOGRAPHY; ADAPTATION	Handball activity involves cardiac changes and demands a mixture of both eccentric and concentric remodeling within the heart. This study seeks to explore heart performance and cardiac remodeling likely to define cardiac parameters which influence specific performance in male handball players across different age ranges. Forty three players, with a regular training and competitive background in handball separated into three groups aged on average 11.78 +/- 0.41 for youth players aka "schools", "elite juniors" 15.99 +/- 0.81 and "elite adults" 24.46 +/- 2.63 years, underwent echocardiography and ECG examinations. Incremental ergo-cycle and specific field (SFT) tests have also been conducted. With age and regular training and competition, myocardial remodeling in different age ranges exhibit significant differences in dilatation's parameters between "schools" and "juniors" players, such as the end-diastolic diameter (LVEDD) and the end-systolic diameter of the left ventricle (LVESD), the root of aorta (Ao) and left atrial (LA), while significant increase is observed between "juniors" and "adults" players in the interventricular septum (IVS), the posterior wall thicknesses (PWT) and LV mass index. ECG changes are also noted but NS differences were observed in studied parameters. For incremental maximal test, players demonstrate a significant increase in duration and total work between "schools" and "juniors" and, in total work only, between "juniors" and "seniors". The SFT shows improvement in performance which ranged between 26.17 +/- 1.83 sec to 31.23 +/- 2.34 sec respectively from "seniors" to "schools". The cross-sectional approach used to compare groups with prior hypothesis that there would be differences in exercise performance and cardiac parameters depending on duration of prior handball practice, leads to point out the early cardiac remodeling within the heart as adaptive change. Prevalence of cardiac chamber dilation with less hypertrophy remodeling was found from "schools" to "juniors" while a prevalence of cardiac hypertrophy with less pronounced chamber dilation remodeling was noted later.	[Agrebi, Brahim] Inst Sports & Phys Educ, Dept Team Sports, Tunis, Tunisia; [Tkatchuk, Vladimir] Natl Univ Pedag Dragomanov MP, Dept Biol Bases Phys Training & Sport Disciplines, Kiev, Ukraine; [Hlila, Nawel; Mouelhi, Emna; Belhani, Ali] Charles Nicolle Hosp, Tunis, Tunisia	Ministry of Education & Science of Ukraine; National Pedagogical Dragomanov University; Universite de Tunis-El-Manar; Hopital Charles Nicolle	Agrebi, B (corresponding author), Inst Sports & Phys Educ, Dept Team Sports, Tunis, Tunisia.	agrebi_brahim@yahoo.fr						Agrebi B, 1997, THESIS; Akova B, 2005, J SPORT SCI MED, V4, P185; Baggish AL, 2008, J APPL PHYSIOL, V104, P1121, DOI 10.1152/japplphysiol.01170.2007; Baker JS, 2009, J EXERC SCI FIT, V7, pS51, DOI 10.1016/S1728-869X(09)60023-X; Beneke R, 2005, J APPL PHYSIOL, V99, P499, DOI 10.1152/japplphysiol.00062.2005; Chaitman BR, 2007, CIRCULATION, V116, P2610, DOI 10.1161/CIRCULATIONAHA.107.711465; Chevalier L, 2004, SCI SPORT, V19, P69, DOI 10.1016/j.scispo.2003.08.005; Corrado D, 2009, BRIT J SPORT MED, V43, P669, DOI 10.1136/bjsm.2008.054759; Cubero GI, 2000, INT J CARDIOL, V75, P261; CUNNINGHAM DA, 1984, J APPL PHYSIOL, V56, P302, DOI 10.1152/jappl.1984.56.2.302; D'Andrea A, 2010, AM J CARDIOL, V105, P1629, DOI 10.1016/j.amjcard.2010.01.028; De Luca A, 2011, CARDIOVASC ULTRASOUN, V9, DOI 10.1186/1476-7120-9-27; DEVEREUX RB, 1987, HYPERTENSION, V9, P19; DEVEREUX RB, 1983, CIRCULATION, V67, P907, DOI 10.1161/01.CIR.67.4.907; Dickhuth HH, 2004, HERZ, V29, P373, DOI 10.1007/s00059-004-2582-4; Dzudie A, 2007, EUR J ECHOCARDIOGR, V8, P122, DOI 10.1016/j.euje.2006.02.006; Granados C, 2007, INT J SPORTS MED, V28, P860, DOI 10.1055/s-2007-964989; Griffet V, 2013, ANN CARDIOL ANGEIOL, V62, P116, DOI 10.1016/j.ancard.2013.02.003; Kaczor JJ, 2005, PEDIATR RES, V57, P331, DOI 10.1203/01.PDR.0000150799.77094.DE; Kororos P., 2009, OPEN SPORTS SCI J, V2, P22, DOI [10.2174/1875399X00902010022, DOI 10.2174/1875399X00902010022]; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Makan J, 2005, HEART, V91, P495, DOI 10.1136/hrt.2004.035121; Manolas MV, 2002, THESIS; Maron BJ, 2006, CIRCULATION, V114, P1633, DOI 10.1161/CIRCULATIONAHA.106.613562; MARON BJ, 1986, J AM COLL CARDIOL, V7, P190, DOI 10.1016/S0735-1097(86)80282-0; Mason JW, 2007, J ELECTROCARDIOL, V40, P228, DOI 10.1016/j.jelectrocard.2006.09.003; Mitchell JH, 2005, J AM COLL CARDIOL, V45, P1364, DOI 10.1016/j.jacc.2005.02.015; Naylor LH, 2008, SPORTS MED, V38, P69, DOI 10.2165/00007256-200838010-00006; Nottin S, 2004, MED SCI SPORT EXER, V36, P1507, DOI 10.1249/01.MSS.0000139900.67704.07; Obert P, 2001, INT J SPORTS MED, V22, P90, DOI 10.1055/s-2001-11343; Obert P, 1998, INT J SPORTS MED, V19, P149, DOI 10.1055/s-2007-971897; Pavlik G, 2001, BRIT J SPORT MED, V35, P95, DOI 10.1136/bjsm.35.2.95; Pelliccia A, 2005, J AM COLL CARDIOL, V46, P690, DOI 10.1016/j.jacc.2005.04.052; PELLICCIA A, 1991, NEW ENGL J MED, V324, P295, DOI 10.1056/NEJM199101313240504; Pelliccia A, 2010, CIRCULATION, V122, P698, DOI 10.1161/CIRCULATIONAHA.109.901074; Pluim BM, 2000, CIRCULATION, V101, P336, DOI 10.1161/01.CIR.101.3.336; Rannou F, 2001, J SPORT MED PHYS FIT, V41, P349; Ratel S, 2002, J APPL PHYSIOL, V92, P479, DOI 10.1152/japplphysiol.00495.2001; Rizzo M, 2003, MED SCI SPORT EXER, V35, P1986, DOI 10.1249/01.MSS.0000098993.51693.0B; Rowland T, 1997, MED SCI SPORT EXER, V29, P1146, DOI 10.1097/00005768-199709000-00005; Sharma S, 1999, BRIT J SPORT MED, V33, P319, DOI 10.1136/bjsm.33.5.319; Sharma S, 2002, J AM COLL CARDIOL, V40, P1431, DOI 10.1016/S0735-1097(02)02270-2; Somauroo JD, 2001, HEART, V85, P649, DOI 10.1136/heart.85.6.649; SPIRITO P, 1994, AM J CARDIOL, V74, P802, DOI 10.1016/0002-9149(94)90439-1; Stein R, 2002, J AM COLL CARDIOL, V39, P1033, DOI 10.1016/S0735-1097(02)01722-9; Triposkiadis F, 2002, EUR J CLIN INVEST, V32, P16, DOI 10.1046/j.0014-2972.2001.00939.x; Urhausen A, 1996, INT J SPORTS MED, V17, pS145, DOI 10.1055/s-2007-972916; van Buuren F, 2013, INT J SPORTS MED, V34, P200, DOI 10.1055/s-0032-1316313; Vasiliauskas D, 2006, EUR J CARDIOV PREV R, V13, P985, DOI 10.1097/01.hjr.0000238394.04600.fc; Whyte GP, 2004, EUR J APPL PHYSIOL, V92, P592, DOI 10.1007/s00421-004-1052-2; Woo EJ, 1992, KOREAN CIRC J, V22, P939; Zdravkovic M, 2010, J SCI MED SPORT, V13, P602, DOI 10.1016/j.jsams.2010.03.005	52	4	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143609	10.1371/journal.pone.0143609	http://dx.doi.org/10.1371/journal.pone.0143609			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630561	Green Published, gold, Green Submitted			2022-12-27	WOS:000365926300070
J	Laughinghouse, HD; Muller, KM; Adey, WH; Lara, Y; Young, R; Johnson, G				Laughinghouse, Haywood Dail; Mueller, Kirsten M.; Adey, Walter H.; Lara, Yannick; Young, Robert; Johnson, Gabriel			Evolution of the Northern Rockweed, Fucus distichus, in a Regime of Glacial Cycling: Implications for Benthic Algal Phylogenetics	PLOS ONE			English	Article							MORPHOLOGICAL VARIATION; BIOGEOGRAPHY; MODEL; PHYLOGEOGRAPHY; PHAEOPHYCEAE; SEAWEEDS; RANGE; TIME; DNA	Northern hemisphere rockweeds (Fucus) are thought to have evolved in the North Pacific and then spread to the North Atlantic following the opening of the Bering Strait. They have dispersed and widely speciated in the North Atlantic and its tributary seas. Fucus distichus is likely near the ancestral member of this genus, and studies have shown that there are several species/subspecies in this complex (i. e. F. evanescens and F. gardneri). We used phylogenetic and haplotype analyses to test the phylogenetic relationships and biogeography of F. distichus. Our data and subsequent analyses demonstrate that, unlike previous studies that lacked samples from an extensive geographical area of the Arctic and Subarctic, there is a distinct Arctic haplotype that is the source of subspecies in both the North Pacific and North Atlantic. Fucus distichus occupies a low tide zone habitat, and in Arctic/Subarctic regions it is adapted to the severe stress of sea ice coverage and disturbance during many months per year. We hypothesize that the very large geographic area of Arctic and Subarctic rocky shores available to this species during interglacials, supported by large Arctic/Subarctic fringe areas as well as unglaciated refugia during glacial cycles, provided a robust population and gene pool (described by the Thermogeographic Model). This gene pool dilutes that of the more fragmented and area-limited Temperate/Boreal area populations when they are brought together during glacial cycles. We suggest that similar subspecies complexes for a variety of Arctic/Subarctic shore biota should be examined further in this context, rather than arbitrarily being split up into numerous species.	[Laughinghouse, Haywood Dail; Adey, Walter H.] Smithsonian Inst, Natl Museum Nat Hist, Dept Bot, MRC 166, Washington, DC 20013 USA; [Mueller, Kirsten M.; Young, Robert] Univ Waterloo, Dept Biol, Waterloo, ON N2T 2T4, Canada; [Lara, Yannick] Univ Liege, Ctr Prot Engn, B-4000 Liege, Belgium; [Johnson, Gabriel] Smithsonian Inst, Museum Support Ctr, Dept Bot, Suitland, MD 20746 USA; [Johnson, Gabriel] Smithsonian Inst, Museum Support Ctr, Labs Analyt Biol, Suitland, MD 20746 USA	Smithsonian Institution; Smithsonian National Museum of Natural History; University of Waterloo; University of Liege; Smithsonian Institution; Smithsonian National Museum of Natural History; Smithsonian Institution; Smithsonian National Museum of Natural History	Muller, KM (corresponding author), Univ Waterloo, Dept Biol, Waterloo, ON N2T 2T4, Canada.	kirsten.muller@uwaterloo.ca	Laughinghouse, H. Dail/M-5836-2016	Laughinghouse, H. Dail/0000-0003-1018-6948; Adey, Walter/0000-0001-9823-2501	National Science and Engineering Research Council of Canada (NSERC) [RGPin 238619-2012 32709]; Dept. of Botany, Smithsonian Institution; Statoil; FRS-FNRS; NSERC Discovery Grant Program	National Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Dept. of Botany, Smithsonian Institution; Statoil; FRS-FNRS(Fonds de la Recherche Scientifique - FNRS); NSERC Discovery Grant Program(Natural Sciences and Engineering Research Council of Canada (NSERC))	Research by K. Muller was supported by an National Science and Engineering Research Council of Canada (NSERC) Discovery grant: http://www.nserc-crsng.gc.ca/Professors-Professeurs/Grants-Subs/DGIGP-PSIGP_eng.asp, Grant Number -RGPin 238619-2012 32709. W. Adey received internal funding from the Dept. of Botany, Smithsonian Institution for DNA extraction and sequencing and H.D. Laughinghouse IV was funded by grants from Statoil and FRS-FNRS during different parts of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Dr. J Coyer for his exceptional support during this study, from sharing his "Rosetta Stone" to reviewing an earlier version of this manuscript. We would also like to thank Chris MacTaggart for drawing our map, Dr. M Wynne for his view on current taxonomy of Fucus species, to RM Fischer for proofreading our manuscript, and to two anonymous reviewers for their comments. K. Muller received funding from the NSERC Discovery Grant Program, W. Adey received internal funding from the Dept. of Botany, Smithsonian Institution for DNA extraction and sequencing, and H.D. Laughinghouse IV was funded by grants from Statoil and FRS-FNRS during different parts of this study.	ABBOTT I A, 1976, P827; Adey WH, 2011, NORTHEAST NAT, V18, P1; Adey WH, 2008, J PHYCOL, V44, P1384, DOI 10.1111/j.1529-8817.2008.00605.x; Adey WH, 2005, CRYPTOGAMIE ALGOL, V26, P35; Adey WH, 2001, J PHYCOL, V37, P677, DOI 10.1046/j.1529-8817.2001.00176.x; Canovas FG, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-371; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Coyer JA, 2006, MOL PHYLOGENET EVOL, V39, P209, DOI 10.1016/j.ympev.2006.01.019; Coyer JA, 2011, J BIOGEOGR, V38, P756, DOI 10.1111/j.1365-2699.2010.02437.x; Drummond A. J., 2011, GENEIOUS V5 4; DUNTON K, 1992, TRENDS ECOL EVOL, V7, P183, DOI 10.1016/0169-5347(92)90070-R; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; Fenberg PB, 2014, ECOL EVOL, V4, P3244, DOI 10.1002/ece3.1181; Gabrielson P.W., 2006, PHYCOLOGICAL CONTRIB; Gabrielson PW, 2000, PHYCOL CONTRIB, V5, P1; Gladenkov AY, 2002, PALAEOGEOGR PALAEOCL, V183, P321, DOI 10.1016/S0031-0182(02)00249-3; Holden PB, 2010, CLIM PAST, V6, P431, DOI 10.5194/cp-6-431-2010; Huson DH, 2011, GENOME BIOL EVOL, V3, P23, DOI 10.1093/gbe/evq077; Kalvas A, 1998, J MAR BIOL ASSOC UK, V78, P985, DOI 10.1017/S0025315400044921; KONIECZNY A, 1993, PLANT J, V4, P403, DOI 10.1046/j.1365-313X.1993.04020403.x; Lindstrom SC, 2009, J BIOGEOGR, V36, P401, DOI 10.1111/j.1365-2699.2007.01855.x; Lindstrom SC, 2001, J BIOGEOGR, V28, P243, DOI 10.1046/j.1365-2699.2001.00529.x; Luning K., 1990, SEAWEEDS THEIR ENV B; Marincovich L, 1999, NATURE, V397, P149, DOI 10.1038/16446; Miller M.A., 2010, P GAT COMP ENV WORKS; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; RICE EL, 1985, MAR BIOL, V88, P207, DOI 10.1007/BF00397168; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruuskanen AT, 2005, ANN BOT FENN, V42, P27; Scagel RF, 1989, PHYCOL CONTRIB, P3; Scott GW, 2001, EUR J PHYCOL, V36, P43, DOI 10.1017/S0967026201003055; Sears J, 2002, NE ALGAL SOC CONTRIB, V2, P1; Serrao EA, 1999, J PHYCOL, V35, P382, DOI 10.1046/j.1529-8817.1999.3520382.x; Siegenthaler U, 2005, SCIENCE, V310, P1313, DOI 10.1126/science.1120130; Silva PC, 1953, WASMANN J BIOL, V11, P221; Sime LC, 2009, NATURE, V462, P342, DOI 10.1038/nature08564; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor W.R, 1957, MARINE ALGAE NE COAS; VANOPPEN MJH, 1995, MAR BIOL, V123, P179, DOI 10.1007/BF00350338; Villalard-Bohnsack M, 1995, ILLUSTRATED KEY SEAW; Wilce RT, 2014, ARCTIC, V67, P43, DOI 10.14430/arctic4360; Witt JDS, 2011, J BIOGEOGR, V38, P1557, DOI 10.1111/j.1365-2699.2011.02497.x	43	10	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143795	10.1371/journal.pone.0143795	http://dx.doi.org/10.1371/journal.pone.0143795			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630571	Green Published, gold, Green Submitted			2022-12-27	WOS:000365926300100
J	Timm-Davis, LL; DeWitt, TJ; Marshall, CD				Timm-Davis, Lori L.; DeWitt, Thomas J.; Marshall, Christopher D.			Divergent Skull Morphology Supports Two Trophic Specializations in Otters (Lutrinae)	PLOS ONE			English	Article							SEA OTTERS; SEXUAL-DIMORPHISM; SARCOMERE-LENGTH; FEEDING ECOLOGY; BITE FORCE; LUTRA-PERSPICILLATA; FORAGING PATTERNS; PREY SELECTION; CLAWLESS OTTER; FIBER LENGTH	Variation in terrestrial mammalian skull morphology is known to constrain feeding performance, which in turn influences dietary habits and ultimately fitness. Among mustelids, otters have evolved two feeding specializations: underwater raptorial capture of prey (mouth-oriented) and capture of prey by hand (hand-oriented), both of which have likely associations with morphology and bite performance. However, feeding biomechanics and performance data for otters are sparse. The first goal of this study was to investigate the relationships between feeding morphology and bite performance among two mouth-oriented piscivores (Pteronura brasiliensis and Lontra canadensis) and two hand-oriented invertebrate specialists (Enhydra lutris and Aonyx cinerea). Since other vertebrate taxa that are mouth-oriented piscivores tend to possess longer skulls and mandibles, with jaws designed for increased velocity at the expense of biting capability, we hypothesized that mouth-oriented otters would also possess long, narrow skulls indicative of high velocity jaws. Conversely, hand-oriented otters were expected to possess short, blunt skulls with adaptations to increase bite force and crushing capability. Concomitant with these skull shapes we hypothesized that sea otters would possess a greater mandibular bluntness index, providing for a greater mechanical advantage compared to other otter species investigated. A second goal was to examine morphological variation at a finer scale by assessing variation in cranial morphology among three sea otter subspecies. Since diet varies among these subspecies, and their populations are isolated, we hypothesized that the magnitude of mandibular bluntness and concomitant mechanical advantage, as well as occlusal surface area would also vary within species according to their primary food source (fish versus hard invertebrates). Functional expectations were met for comparisons among and within species. Among species the phylogeny suggests a deeply rooted transition to alternative foraging types. Yet within foraging types alternative species were also strongly variable, suggesting either selective differences in the extent or nature of realized foraging mode, or an accumulation of non-adaptive changes during the long independent evolutionary history. At the finest scale, variation among subspecies indicates that trophic adaptation occurred rapidly, making it interesting that we happened to find both deeply and shallowly-rooted transformations associated with diet type in otter species and subspecies.	[Timm-Davis, Lori L.; DeWitt, Thomas J.; Marshall, Christopher D.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA; [Timm-Davis, Lori L.; Marshall, Christopher D.] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System	Timm-Davis, LL (corresponding author), Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA.	lori.timm@sjcd.edu	Marshall, Christopher/AAF-9097-2019	DeWitt, Thomas/0000-0001-7405-3904	W.B. Davis Endowed Scholarship at Texas AM University; Lerner-Gray Fund for Marine Research; Erma Lee and Luke Mooney Graduate Travel Grants; Department of Marine Biology at Texas AM University	W.B. Davis Endowed Scholarship at Texas AM University; Lerner-Gray Fund for Marine Research; Erma Lee and Luke Mooney Graduate Travel Grants; Department of Marine Biology at Texas AM University	This work was supported by: W.B. Davis Endowed Scholarship at Texas A&M University; Lerner-Gray Fund for Marine Research; Erma Lee and Luke Mooney Graduate Travel Grants; Department of Marine Biology at Texas A&M University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We want to extend our gratitude to Dr. Jim Kenagy and Jeff Bradley at the Burk Museum of Natural History (Seattle, Washington), and collection managers at the National Museum of Natural History (Washington, D.C.), and the American Museum of Natural History (New York, New York) for allowing us access to otter specimens. We also want to thank the following for financial support: W.B. Davis Endowed Scholarship at Texas A&M University, Lerner-Gray Fund for Marine Research, Erma Lee and Luke Mooney Graduate Travel Grants, and the Department of Marine Biology at Texas A&M University.	Abramov AV, 2005, ZOOL ANZ, V244, P11, DOI 10.1016/j.jcz.2004.12.002; Aldridge K, 2002, J HUM EVOL, V60, P94; Anton SC, 1999, INT J PRIMATOL, V20, P441, DOI 10.1023/A:1020509006259; BERTA A, 1985, J PALEONTOL, V59, P809; Blundell GM, 2002, BEHAV ECOL, V13, P134, DOI 10.1093/beheco/13.1.134; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L, P59; Carss David N., 1995, Hystrix, V7, P179; Carter SK, 1997, MAMMAL REV, V27, P1, DOI 10.1111/j.1365-2907.1997.tb00370.x; Christiansen P, 2007, ECOLOGY, V88, P347, DOI 10.1890/0012-9658(2007)88[347:BFAEAT]2.0.CO;2; CLOSE RI, 1972, PHYSIOL REV, V52, P129, DOI 10.1152/physrev.1972.52.1.129; CROMPTON A W, 1969, Discovery (New Haven), V5, P23; de Ruiter DJ, 2013, SCIENCE, V340, DOI 10.1126/science.1232997; Dumont ER, 2003, J EXP BIOL, V206, P2117, DOI 10.1242/jeb.00375; Enders C. K., 2010, APPL MISSING DATA AN; ESTES JA, 1995, ECOL MONOGR, V65, P75, DOI 10.2307/2937159; Estes JA, 2003, J ANIM ECOL, V72, P144, DOI 10.1046/j.1365-2656.2003.00690.x; Fairbairn DJ, 2007, SEX SIZE GENDER ROLE; Figueirido B, 2009, J ZOOL, V277, P70, DOI 10.1111/j.1469-7998.2008.00511.x; FREEMAN PW, 1979, J MAMMAL, V60, P467, DOI 10.2307/1380088; GANS C, 1987, J MORPHOL, V192, P63, DOI 10.1002/jmor.1051920106; GARSHELIS DL, 1986, J WILDLIFE MANAGE, V50, P637, DOI 10.2307/3800974; Ginter CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034481; Gittleman JL, 1997, J ZOOL, V242, P97, DOI 10.1111/j.1469-7998.1997.tb02932.x; Goswami A, 2006, EVOLUTION, V60, P169; GREAVES WS, 1985, ZOOL J LINN SOC-LOND, V85, P267, DOI 10.1111/j.1096-3642.1985.tb01506.x; GREAVES WS, 1983, BIOL J LINN SOC, V20, P353, DOI 10.1111/j.1095-8312.1983.tb01596.x; GREEN GA, 1991, MAR MAMMAL SCI, V7, P395, DOI 10.1111/j.1748-7692.1991.tb00114.x; Hattori K, 2003, J VET MED SCI, V65, P439, DOI 10.1292/jvms.65.439; He T, 2002, LAB ANIM-UK, V36, P86, DOI 10.1258/0023677021911795; Herrel A, 2002, J EVOLUTION BIOL, V15, P1083, DOI 10.1046/j.1420-9101.2002.00459.x; Herrel A, 2008, J EXP BIOL, V211, P86, DOI 10.1242/jeb.012211; HERRING SW, 1985, AM ZOOL, V25, P339; HERRING SW, 1979, AM J ANAT, V154, P563, DOI 10.1002/aja.1001540410; HERRING SW, 1984, MUSCLE NERVE, V7, P161, DOI 10.1002/mus.880070213; Herring SW, 2001, COMP BIOCHEM PHYS A, V131, P207, DOI 10.1016/S1095-6433(01)00472-X; HERRING SW, 1974, AM NAT, V108, P561, DOI 10.1086/282934; Hussain SA, 1997, BIOL CONSERV, V80, P199, DOI 10.1016/S0006-3207(96)00033-X; Hylander WL, 1972, THESIS; Jacques H, 2009, AFR ZOOL, V44, P159, DOI 10.3377/004.044.0204; Johnson JB, 2008, EVOLUTION, V62, P1243, DOI 10.1111/j.1558-5646.2008.00343.x; Koepfli K-P, 2002, J ZOOL LOND, V246, P401; Koepfli KP, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-10; KRUUK H, 1994, BIOL CONSERV, V69, P115, DOI 10.1016/0006-3207(94)90334-4; KVITEK RG, 1993, MAR MAMMAL SCI, V9, P168, DOI 10.1111/j.1748-7692.1993.tb00441.x; Laidre KL, 2006, J MAMMAL, V87, P799, DOI 10.1644/05-MAMM-A-244R2.1; Langerhans RB, 2004, AM NAT, V164, P335, DOI 10.1086/422857; Lee S, 2004, J MORPHOL, V260, P57, DOI 10.1002/jmor.10212; Lewis ME, 2008, CR PALEVOL, V7, P607, DOI 10.1016/j.crpv.2008.09.010; LYNCH JM, 1993, BIOL ENVIRON, V93B, P97; Marshall CD, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P406; Medina-Vogel G, 2004, MAR MAMMAL SCI, V20, P134, DOI 10.1111/j.1748-7692.2004.tb01144.x; Meiri S, 2005, FUNCT ECOL, V19, P337, DOI 10.1111/j.1365-2435.2005.00964.x; MOTTA PJ, 1992, NETH J ZOOL, V42, P400; MUHL ZF, 1978, ARCH ORAL BIOL, V23, P1051, DOI 10.1016/0003-9969(78)90108-5; Nogueira MR, 2009, FUNCT ECOL, V23, P715, DOI 10.1111/j.1365-2435.2009.01549.x; OSTFELD RS, 1982, OECOLOGIA, V53, P170, DOI 10.1007/BF00545660; Pfaller JB, 2011, J EXP BIOL, V214, P1655, DOI 10.1242/jeb.048090; Popowics TE, 2003, J MORPHOL, V256, P322, DOI 10.1002/jmor.10091; Preuschoft Holger, 2002, Senckenbergiana Lethaea, V82, P207; RADINSKY LB, 1968, J COMP NEUROL, V134, P495, DOI 10.1002/cne.901340408; RADINSKY LB, 1981, BIOL J LINN SOC, V16, P337, DOI 10.1111/j.1095-8312.1981.tb01657.x; RADINSKY LB, 1981, BIOL J LINN SOC, V15, P369, DOI 10.1111/j.1095-8312.1981.tb00770.x; RADINSKY LB, 1985, ANNU REV ECOL SYST, V16, P1; Rafferty KL, 2003, J MORPHOL, V257, P33, DOI 10.1002/jmor.10104; RALLS K, 1995, CAN J ZOOL, V73, P523, DOI 10.1139/z95-060; RIEDMAN ML, 1988, CAN J ZOOL, V66, P1396, DOI 10.1139/z88-205; RILEY MA, 1985, J MAMMAL, V66, P519, DOI 10.2307/1380927; ROEST AI, 1985, CALIF FISH GAME, V71, P179; Rosas FCW, 1999, BIOTROPICA, V31, P502, DOI 10.1111/j.1744-7429.1999.tb00393.x; Sacco T, 2004, J ZOOL, V263, P41, DOI 10.1017/S0952836904004856; Satoh K, 2006, J MORPHOL, V267, P987, DOI 10.1002/jmor.10443; SIVASOTHI N, 1994, HYDROBIOLOGIA, V285, P151, DOI 10.1007/BF00005663; Slater GJ, 2009, J EVOLUTION BIOL, V22, P2278, DOI 10.1111/j.1420-9101.2009.01845.x; Sokal RR, 1995, BIOMETRY; Somers MJ, 1996, AFR J ECOL, V34, P158, DOI 10.1111/j.1365-2028.1996.tb00609.x; Swanson EM, 2010, P R SOC B, V2512, P1471; Tanner JB, 2010, J MORPHOL, V271, P353, DOI 10.1002/jmor.10802; Taylor AB, 2009, AM J PHYS ANTHROPOL, V139, P353, DOI 10.1002/ajpa.20991; Timm LT, 2013, THESIS TEXAS A M U C, P173; Tinker MT, 2007, DEEP-SEA RES PT II, V54, P330, DOI 10.1016/j.dsr2.2006.11.012; Tinker MT, 2008, P NATL ACAD SCI USA, V105, P560, DOI 10.1073/pnas.0709263105; TOWEILL DE, 1974, J WILDLIFE MANAGE, V38, P107, DOI 10.2307/3800205; Van Valkenburgh B, 2007, INTEGR COMP BIOL, V47, P147, DOI 10.1093/icb/icm016; van Zyll de Jong CG, 1972, SYSTEMATIC REV NEARC; VANEIJDEN TMGJ, 1992, ANAT REC, V232, P78, DOI 10.1002/ar.1092320109; Watt J, 2000, OECOLOGIA, V124, P289, DOI 10.1007/s004420000373; WEIJS WA, 1983, ARCH ORAL BIOL, V28, P307, DOI 10.1016/0003-9969(83)90073-0; Werth AJ, 2006, J MAMMAL, V87, P579, DOI 10.1644/05-MAMM-A-279R1.1; Westneat MW, 2005, P ROY SOC B-BIOL SCI, V272, P993, DOI 10.1098/rspb.2004.3013; WESTNEAT MW, 1994, ZOOMORPHOLOGY, V114, P103, DOI 10.1007/BF00396643; WILLIAMS PE, 1978, J ANAT, V127, P459; WILSON DE, 1991, J MAMMAL, V72, P22, DOI 10.2307/1381977; Wroe S, 2007, EVOLUTION, V61, P1251, DOI 10.1111/j.1558-5646.2007.00101.x; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR	94	30	30	2	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0143236	10.1371/journal.pone.0143236	http://dx.doi.org/10.1371/journal.pone.0143236			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26649575	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903300015
J	Lobo, MR; Kukino, A; Tran, H; Schabel, MC; Springer, CS; Gillespie, GY; Grafe, MR; Woltjer, RL; Pike, MM				Lobo, Merryl R.; Kukino, Ayaka; Tran, Huong; Schabel, Matthias C.; Springer, Charles S., Jr.; Gillespie, G. Yancey; Grafe, Marjorie R.; Woltjer, Randall L.; Pike, Martin M.			Synergistic Antivascular and Antitumor Efficacy with Combined Cediranib and SC6889 in Intracranial Mouse Glioma	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM-STRESS; CONTRAST-ENHANCED MRI; PROTEASOME INHIBITOR BORTEZOMIB; INPUT FUNCTION ESTIMATION; MONTE-CARLO METHOD; IN-VIVO; KAPPA-B; PROLONGS SURVIVAL; KINASE INHIBITOR; TUMOR-GROWTH	Prognosis remains extremely poor for malignant glioma. Targeted therapeutic approaches, including single agent anti-angiogenic and proteasome inhibition strategies, have not resulted in sustained anti-glioma clinical efficacy. We tested the anti-glioma efficacy of the anti-angiogenic receptor tyrosine kinase inhibitor cediranib and the novel proteasome inhibitor SC68896, in combination and as single agents. To assess anti-angiogenic effects and evaluate efficacy we employed 4C8 intracranial mouse glioma and a dual-bolus perfusion MRI approach to measure K-trans, relative cerebral blood flow and volume (rCBF, rCBV), and relative mean transit time (rMTT) in combination with anatomical MRI measurements of tumor growth. While single agent cediranib or SC68896 treatment did not alter tumor growth or survival, combined cediranib/SC68896 significantly delayed tumor growth and increased median survival by 2-fold, compared to untreated. This was accompanied by substantially increased tumor necrosis in the cediranib/SC68896 group (p<0.01), not observed with single agent treatments. Mean vessel density was significantly lower, and mean vessel lumen area was significantly higher, for the combined cediranib/SC68896 group versus untreated. Consistent with our previous findings, cediranib alone did not significantly alter mean tumor rCBF, rCBV, rMTT, or K-trans. In contrast, SC68896 reduced rCBF in comparison to untreated, but without concomitant reductions in rCBV, rMTT, or K-trans. Importantly, combined cediranib/SC68896 substantially reduced rCBF, rCBV. rMTT, and K-trans. A novel analysis of K-trans/rCBV suggests that changes in K-trans with time and/or treatment are related to altered total vascular surface area. The data suggest that combined cediranib/SC68896 induced potent anti-angiogenic effects, resulting in increased vascular efficiency and reduced extravasation, consistent with a process of vascular normalization. The study represents the first demonstration that the combination of cediranib with a proteasome inhibitor substantially increases the anti-angiogenic efficacy produced from either agent alone, and synergistically slows glioma tumor growth and extends survival, suggesting a promising treatment which warrants further investigation.	[Lobo, Merryl R.; Kukino, Ayaka; Schabel, Matthias C.; Springer, Charles S., Jr.; Pike, Martin M.] Oregon Hlth & Sci Univ, Adv Imaging Res Ctr, Portland, OR 97201 USA; [Lobo, Merryl R.; Pike, Martin M.] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA; [Tran, Huong; Grafe, Marjorie R.; Woltjer, Randall L.] Oregon Hlth & Sci Univ, Dept Pathol, Portland, OR 97201 USA; [Gillespie, G. Yancey] Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35294 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; University of Alabama System; University of Alabama Birmingham	Pike, MM (corresponding author), Oregon Hlth & Sci Univ, Adv Imaging Res Ctr, Portland, OR 97201 USA.	pikema@ohsu.edu	Schabel, Matthias C./H-4647-2019	Gillespie, George/0000-0001-6436-9542	National Institutes of Health, National Cancer Institute [1R21 CA114279-01A2, 1R21 CA167302-01]; NATIONAL CANCER INSTITUTE [R21CA114279, R21CA167302] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health, National Cancer Institute grants 1R21 CA114279-01A2 (MMP) and 1R21 CA167302-01 (MMP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almond JB, 2002, LEUKEMIA, V16, P433, DOI 10.1038/sj.leu.2402417; Befani CD, 2012, J MOL MED, V90, P45, DOI 10.1007/s00109-011-0805-8; Belloni D, 2010, EXP CELL RES, V316, P1010, DOI 10.1016/j.yexcr.2009.11.005; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Birle DC, 2007, CANCER RES, V67, P1735, DOI 10.1158/0008-5472.CAN-06-2722; Boccadoro M, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-18; Brignole C, 2006, J NATL CANCER I, V98, P1142, DOI 10.1093/jnci/djj309; Buac D, 2013, CURR PHARM DESIGN, V19, P4025, DOI 10.2174/1381612811319220012; Chen KF, 2008, CANCER RES, V68, P6698, DOI 10.1158/0008-5472.CAN-08-0257; Chen KF, 2009, J BIOL CHEM, V284, P11121, DOI 10.1074/jbc.M806268200; Daniel KG, 2005, CURR CANCER DRUG TAR, V5, P529, DOI 10.2174/156800905774574075; de Wilt LHAM, 2013, CRIT REV ONCOL HEMAT, V85, P363, DOI 10.1016/j.critrevonc.2012.08.001; Drexler HCA, 2000, FASEB J, V14, P65, DOI 10.1096/fasebj.14.1.65; Driscoll JJ, 2012, SEMIN HEMATOL, V49, P277, DOI 10.1053/j.seminhematol.2012.04.002; DYER CA, 1995, J NEUROPATH EXP NEUR, V54, P852, DOI 10.1097/00005072-199511000-00012; Fels DR, 2008, CANCER RES, V68, P9323, DOI 10.1158/0008-5472.CAN-08-2873; Gladson CL, 2010, ANNU REV PATHOL-MECH, V5, P33, DOI 10.1146/annurev-pathol-121808-102109; Goel S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006486; Gotink KJ, 2010, ANGIOGENESIS, V13, P1, DOI 10.1007/s10456-009-9160-6; Hardee ME, 2012, AM J PATHOL, V181, P1126, DOI 10.1016/j.ajpath.2012.06.030; Healy SJM, 2009, EUR J PHARMACOL, V625, P234, DOI 10.1016/j.ejphar.2009.06.064; Inoue T, 2006, ANTI-CANCER DRUG, V17, P261, DOI 10.1097/00001813-200603000-00004; Jiang LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055527; Kaluz S, 2008, J CELL BIOCHEM, V104, P536, DOI 10.1002/jcb.21644; Kamoun WS, 2009, J CLIN ONCOL, V27, P2542, DOI 10.1200/JCO.2008.19.9356; Kardosh A, 2008, CANCER RES, V68, P843, DOI 10.1158/0008-5472.CAN-07-5555; Kaur B, 2005, NEURO-ONCOLOGY, V7, P134, DOI 10.1215/S1152851704001115; Khan T, 2006, J IMMUNOL, V176, P6302, DOI 10.4049/jimmunol.176.10.6302; Labussiere M, 2008, ONCOL REP, V20, P1283, DOI 10.3892/or_00000142; Leban J, 2008, BIOORGAN MED CHEM, V16, P4579, DOI 10.1016/j.bmc.2008.02.042; LeBlanc R, 2002, CANCER RES, V62, P4996; Li X, 2009, NMR BIOMED, V22, P148, DOI 10.1002/nbm.1293; Lobo MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114110; Lobo MR, 2013, NEURO-ONCOLOGY, V15, P1673, DOI 10.1093/neuonc/not119; Martinho O, 2013, TRANSL ONCOL, V6, P187, DOI 10.1593/tlo.12400; Matsuo Y, 2010, DIGEST DIS SCI, V55, P1167, DOI 10.1007/s10620-009-0814-4; McConkey DJ, 2008, DRUG RESIST UPDATE, V11, P164, DOI 10.1016/j.drup.2008.08.002; Milano A, 2009, ONCOTARGETS THER, V2, P171; Nawrocki ST, 2005, CANCER RES, V65, P11658, DOI 10.1158/0008-5472.CAN-05-2370; Nestler U, 2015, ACTA NEUROCHIR, V157, P179, DOI 10.1007/s00701-014-2271-x; Njus JM, 2008, P INT SOC MAGN RESON, V16; Noguchi M, 2014, BBA-REV CANCER, V1846, P342, DOI 10.1016/j.bbcan.2014.07.013; Norden AD, 2009, NAT REV NEUROL, V5, P610, DOI 10.1038/nrneurol.2009.159; O'Connor JPB, 2012, NAT REV CLIN ONCOL, V9, P167, DOI 10.1038/nrclinonc.2012.2; Ostergaard L, 1996, MAGN RESON MED, V36, P715, DOI 10.1002/mrm.1910360510; Peng L, 2013, ONCOL REP, V29, P571, DOI 10.3892/or.2012.2165; Phillips H, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.2001; Pike MM, 2009, MAGN RESON MED, V61, P615, DOI 10.1002/mrm.21931; Rahimi N, 2012, MOL CANCER THER, V11, P538, DOI 10.1158/1535-7163.MCT-11-0555; Rahman R, 2010, J ONCOL, V2010, DOI 10.1155/2010/251231; Roccaro AM, 2006, CANCER RES, V66, P184, DOI 10.1158/0008-5472.CAN-05-1195; Roth P, 2009, CLIN CANCER RES, V15, P6609, DOI 10.1158/1078-0432.CCR-09-0548; Schabel MC, 2010, PHYS MED BIOL, V55, P4783, DOI 10.1088/0031-9155/55/16/011; Schabel MC, 2010, PHYS MED BIOL, V55, P4807, DOI 10.1088/0031-9155/55/16/012; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shin DH, 2008, ONCOGENE, V27, P1939, DOI 10.1038/sj.onc.1210826; Shin DH, 2008, BLOOD, V111, P3131, DOI 10.1182/blood-2007-11-120576; Sorensen AG, 2012, CANCER RES, V72, P402, DOI 10.1158/0008-5472.CAN-11-2464; Sourbron SP, 2012, PHYS MED BIOL, V57, pR1, DOI 10.1088/0031-9155/57/2/R1; Sterz J, 2008, EXPERT OPIN INV DRUG, V17, P879, DOI 10.1517/13543784.17.6.879 ; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sunwoo JB, 2001, CLIN CANCER RES, V7, P1419; Tabatabai G, 2009, CURR OPIN NEUROL, V22, P639, DOI 10.1097/WCO.0b013e328332ba28; Thaker NG, 2009, EXPERT REV NEUROTHER, V9, P1815, DOI 10.1586/ERN.09.116; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Tuominen VJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2615; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Veschini L, 2007, BLOOD, V109, P2565, DOI 10.1182/blood-2006-06-032664; Wedge SR, 2005, CANCER RES, V65, P4389, DOI 10.1158/0008-5472.CAN-04-4409; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/S1535-6108(04)00305-8; Xie TX, 2010, ONCOL REP, V23, P725, DOI 10.3892/or_00000690; Yeramian A, 2012, INT J CANCER, V130, P967, DOI 10.1002/ijc.26096; Yu CR, 2006, MOL CANCER THER, V5, P2378, DOI 10.1158/1535-7163.MCT-06-0235; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200	74	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0144488	10.1371/journal.pone.0144488	http://dx.doi.org/10.1371/journal.pone.0144488			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YV	26645398	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903100026
J	Bartholomew, AJ; Meck, WH; Cirulli, ET				Bartholomew, Alex J.; Meck, Warren H.; Cirulli, Elizabeth T.			Analysis of Genetic and Non-Genetic Factors Influencing Timing and Time Perception	PLOS ONE			English	Article							AGE-RELATED-CHANGES; INTERNAL CLOCK; DURATION JUDGMENTS; SCALAR PROPERTY; ATTENTION; MEMORY; MECHANISMS; REPRODUCTION; PERFORMANCE; ACTIVATION	Performance on different psychophysical tasks measuring the sense of time indicates a large amount of individual variation in the accuracy and precision of timing in the hundredths of milliseconds-to-minutes range. Quantifying factors with an influence on timing is essential to isolating a biological (genetic) contribution to the perception and estimation of time. In the largest timing study to date, 647 participants completed a duration-discrimination task in the sub-second range and a time-production task in the supra-second range. We confirm the stability of a participant's time sense across multiple sessions and substantiate a modest sex difference on time production. Moreover, we demonstrate a strong correlation between performance on a standardized cognitive battery and performance in both duration-discrimination and time-production tasks; we further show that performance is uncorrelated with age after controlling for general intelligence. Additionally, we find an effect of ethnicity on time sense, with African Americans and possibly Hispanics in our cohort differing in accuracy and precision from other ethnic groups. Finally, a preliminary genome-wide association and exome chip study was performed on 148 of the participants, ruling out the possibility for a single common variant or groups of low-frequency coding variants within a single gene to explain more than similar to 18% of the variation in the sense of time.	[Bartholomew, Alex J.; Cirulli, Elizabeth T.] Duke Univ, Sch Med, Ctr Appl Genom & Precis Med, Durham, NC 27708 USA; [Meck, Warren H.] Duke Univ, Dept Psychol & Neurosci, Durham, NC 27708 USA	Duke University; Duke University	Cirulli, ET (corresponding author), Duke Univ, Sch Med, Ctr Appl Genom & Precis Med, Durham, NC 27708 USA.	etc3@duke.edu		Meck, Warren/0000-0002-6120-4790; Cirulli Rogers, Liz/0000-0001-7808-2809	National Institute of Mental Health of the National Institutes of Health [K01MH098126]; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH098126] Funding Source: NIH RePORTER	National Institute of Mental Health of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Research reported in this publication was supported by the National Institute of Mental Health of the National Institutes of Health under award number K01MH098126. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostino PV, 2011, FRONTIERS INTEGRATIV, P5; Allman MJ, 2014, ANNU REV PSYCHOL, V65, P743, DOI 10.1146/annurev-psych-010213-115117; Allman MJ, 2012, BRAIN, V135, P656, DOI 10.1093/brain/awr210; Anderson JW, 2014, INT J AGING HUM DEV, V78, P259, DOI 10.2190/AG.78.3.c; Baharloo S, 1998, AM J HUM GENET, V62, P224, DOI 10.1086/301704; Balci F, 2013, NEUROPSYCHOLOGIA, V51, P293, DOI 10.1016/j.neuropsychologia.2012.08.002; Bartholomew AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091773; Battery AIT, 1944, MAN DIR SCOR; Baudouin A, 2006, ACTA PSYCHOL, V121, P285, DOI 10.1016/j.actpsy.2005.07.004; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Benton AL., 1983, MULTILINGUAL APHASIA; Block RA, 2000, MEM COGNITION, V28, P1333, DOI 10.3758/BF03211834; Block RA, 1998, PSYCHOL AGING, V13, P584, DOI 10.1037/0882-7974.13.4.584; Bonnot O, 2011, J PHYSIOL-PARIS, V105, P164, DOI 10.1016/j.jphysparis.2011.07.006; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Broadway JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025422; Buonomano DV, 2007, NAT CHEM BIOL, V3, P594, DOI 10.1038/nchembio1007-594; Buonomano DV, 2014, ADV EXP MED BIOL, V829, P101, DOI 10.1007/978-1-4939-1782-2_6; Burle B, 2001, J EXP PSYCHOL HUMAN, V27, P195, DOI 10.1037/0096-1523.27.1.195; Cirulli E. T., 2015, SCIENCE; Cirulli ET, 2011, CLIN NEUROPSYCHOL, V25, P778, DOI 10.1080/13854046.2011.578587; Cirulli ET, 2010, EUR J HUM GENET, V18, P815, DOI 10.1038/ejhg.2010.2; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Coelho M, 2004, J INT NEUROPSYCH SOC, V10, P332, DOI 10.1017/S1355617704103019; Coull JT, 2011, NEUROPSYCHOPHARMACOL, V36, P3, DOI 10.1038/npp.2010.113; Espinosa-Fernandez L, 2003, ACTA PSYCHOL, V112, P221, DOI 10.1016/S0001-6918(02)00093-8; Evangelou E, 2013, NAT REV GENET, V14, P379, DOI 10.1038/nrg3472; Feng S, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-12; FORTIN C, 1993, PERCEPT PSYCHOPHYS, V53, P536, DOI 10.3758/BF03205202; FORTIN C, 2003, METH NE FRO NEUROSCI, P235; GIBBON J, 1984, ANN NY ACAD SCI, V423, P52, DOI 10.1111/j.1749-6632.1984.tb23417.x; Gibbon J, 1997, CURR OPIN NEUROBIOL, V7, P170, DOI 10.1016/S0959-4388(97)80005-0; Gilaie-Dotan S, 2011, FRONTIERS INTEGRATIV, P5; GOLDEN CJ, 1975, J PERS ASSESS, V39, P502, DOI 10.1207/s15327752jpa3905_9; Gooch CM, 2009, AGING NEUROPSYCHOL C, V16, P285, DOI 10.1080/13825580802592771; Grassi M, 2009, BEHAV RES METHODS, V41, P20, DOI 10.3758/BRM.41.1.20; GREEN DM, 1990, J ACOUST SOC AM, V87, P2662, DOI 10.1121/1.399058; GREEN DM, 1993, J ACOUST SOC AM, V93, P2096, DOI 10.1121/1.406696; Green P., 2005, STORY RECALL TEST; Grondin S, 2012, J EXP PSYCHOL HUMAN, V38, P880, DOI 10.1037/a0027188; Gu BM, 2011, NEUROSCIENCE, V179, P143, DOI 10.1016/j.neuroscience.2011.01.048; Gu B- M, 2015, BAYESIAN MODELS INTE, P284; Hancock PA, 2010, ACTA PSYCHOL, V133, P170, DOI 10.1016/j.actpsy.2009.11.005; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hass J, 2014, ADV EXP MED BIOL, V829, P49, DOI 10.1007/978-1-4939-1782-2_4; Henley SMD, 2014, NEUROPSYCHOLOGIA, V65, P88, DOI 10.1016/j.neuropsychologia.2014.10.009; Hinton SC, 2004, PSYCHON B REV, V11, P24, DOI 10.3758/BF03206456; KITAMURA T, 1983, ACTA PSYCHIAT SCAND, V68, P15, DOI 10.1111/j.1600-0447.1983.tb06976.x; Lake JI, 2013, NEUROPSYCHOLOGIA, V51, P284, DOI 10.1016/j.neuropsychologia.2012.09.014; Lewis PA, 2009, PHILOS T R SOC B, V364, P1897, DOI 10.1098/rstb.2009.0020; Lewis PA, 2003, NEUROPSYCHOLOGIA, V41, P1583, DOI 10.1016/S0028-3932(03)00118-0; Lewis PA, 2003, CURR OPIN NEUROBIOL, V13, P250, DOI 10.1016/S0959-4388(03)00036-9; Lewis PA, 2012, PSYCHOLOGIST, V25, P594; Lustig C., 2003, METH NE FRO NEUROSCI, P261; Lustig C, 2011, BRAIN COGNITION, V77, P298, DOI 10.1016/j.bandc.2011.07.007; Matell MS, 2000, BIOESSAYS, V22, P94, DOI 10.1002/(SICI)1521-1878(200001)22:1<94::AID-BIES14>3.0.CO;2-E; Matthews WJ, 2014, WIRES COGN SCI, V5, P429, DOI 10.1002/wcs.1298; McAuley JD, 2006, J EXP PSYCHOL GEN, V135, P348, DOI 10.1037/0096-3445.135.3.348; Meck WH, 2012, NEUROPHARMACOLOGY, V62, P1221, DOI 10.1016/j.neuropharm.2011.01.042; Merchant H, 2008, J NEUROPHYSIOL, V99, P939, DOI 10.1152/jn.01225.2007; Merchant H, 2013, ANNU REV NEUROSCI, V36, P313, DOI 10.1146/annurev-neuro-062012-170349; Merchant H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003169; Morita T, 2005, PHYSIOL BEHAV, V85, P93, DOI 10.1016/j.physbeh.2005.02.024; Oberfeld D, 2014, FRONT PSYCHOL, P5; Ottoni GL, 2011, CHRONOBIOL INT, V28, P229, DOI 10.3109/07420528.2011.553696; Penney TB, 2005, BRAIN COGNITION, V58, P109, DOI 10.1016/j.bandc.2004.09.012; Perbal S, 2005, BRAIN COGNITION, V58, P35, DOI 10.1016/j.bandc.2005.02.003; Perbal S, 2002, AGING NEUROPSYCHOL C, V9, P201, DOI 10.1076/anec.9.3.201.9609; Pleil KE, 2011, FRONTIERS INTEGRATIV, P5; Poryazova R, 2013, J SLEEP RES, V22, P625, DOI 10.1111/jsr.12069; Pouthas V, 2004, ACTA NEUROBIOL EXP, V64, P367; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rakitin BC, 1998, J EXP PSYCHOL-ANIM B, V24, P15, DOI 10.1037/0097-7403.24.1.15; Rakitin BC, 2008, BRAIN RES BULL, V75, P23, DOI 10.1016/j.brainresbull.2007.07.014; Rammsayer TH, 1999, Q J EXP PSYCHOL-B, V52, P273; Rammsayer TH, 2002, J RES PERS, V36, P507, DOI 10.1016/S0092-6566(02)00006-5; Rammsayer TH, 2007, INTELLIGENCE, V35, P123, DOI 10.1016/j.intell.2006.04.007; ROSEN W G, 1980, Journal of Clinical Neuropsychology, V2, P135, DOI 10.1080/01688638008403788; Sato T, 2005, J PSYCHOL, V139, P545, DOI 10.3200/JRLP.139.6.545-552; Schulz R, 2014, CEREB CORTEX; Shi ZH, 2013, TRENDS COGN SCI, V17, P556, DOI 10.1016/j.tics.2013.09.009; StataCorp, 2013, STAT STAT SOFTW REL; Sysoeva OV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012650; Teki S, 2011, FRONTIERS INTEGRATIV, P5; Thones S, 2015, J AFFECTIVE DISORDER; Treisman M., 2013, TIMING TIME PERCEPTI, V1, P131, DOI [10.1163/22134468-00002017, DOI 10.1163/22134468-00002017]; Troche SJ, 2009, INTELLIGENCE, V37, P479, DOI 10.1016/j.intell.2009.06.001; Tucci V, 2011, FRONTIERS INTEGRATIV, P5; Tucci V, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2012.0470; Ullen F, 2008, J NEUROSCI, V28, P4238, DOI 10.1523/JNEUROSCI.0825-08.2008; van Rijn H, 2014, ADV EXP MED BIOL, V829, P75, DOI 10.1007/978-1-4939-1782-2_5; Viau-Quesnel C, 2014, TIMING TIME PERCEPTI, V2, P129, DOI [10.1163/22134468-00002019, DOI 10.1163/22134468-00002019]; Wearden JH, 1997, J EXP PSYCHOL HUMAN, V23, P962; Wechsler D, 1997, SCALE WAI WAIS 3 WMS; Wiener M, 2014, NEUROIMAGE, V89, P10, DOI 10.1016/j.neuroimage.2013.11.019; Wittmann M, 2005, PSYCHOL REP, V97, P921, DOI 10.2466/pr0.97.3.921-935	96	30	30	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0143873	10.1371/journal.pone.0143873	http://dx.doi.org/10.1371/journal.pone.0143873			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1YS	26641268	Green Submitted, Green Published, gold			2022-12-27	WOS:000366902700031
J	Hirbo, J; Eidem, H; Rokas, A; Abbot, P				Hirbo, Jibril; Eidem, Haley; Rokas, Antonis; Abbot, Patrick			Integrating Diverse Types of Genomic Data to Identify Genes that Underlie Adverse Pregnancy Phenotypes	PLOS ONE			English	Article							WIDE ASSOCIATION ANALYSIS; RECENT POSITIVE SELECTION; HUMAN-DISEASE GENES; GROWTH-FACTOR; POPULATION DIFFERENTIATION; ACCELERATED EVOLUTION; NONCODING SEQUENCES; NATURAL-SELECTION; GESTATIONAL-AGE; EXPRESSED GENES	Progress in understanding complex genetic diseases has been bolstered by synthetic approaches that overlay diverse data types and analyses to identify functionally important genes. Pre-term birth (PTB), a major complication of pregnancy, is a leading cause of infant mortality worldwide. A major obstacle in addressing PTB is that the mechanisms controlling parturition and birth timing remain poorly understood. Integrative approaches that overlay datasets derived from comparative genomics with function-derived ones have potential to advance our understanding of the genetics of birth timing, and thus provide insights into the genes that may contribute to PTB. We intersected data from fast evolving coding and non-coding gene regions in the human and primate lineage with data from genes expressed in the placenta, from genes that show enriched expression only in the placenta, as well as from genes that are differentially expressed in four distinct PTB clinical subtypes. A large fraction of genes that are expressed in placenta, and differentially expressed in PTB clinical subtypes (23-34%) are fast evolving, and are associated with functions that include adhesion neurodevelopmental and immune processes. Functional categories of genes that express fast evolution in coding regions differ from those linked to fast evolution in non-coding regions. Finally, there is a surprising lack of overlap between fast evolving genes that are differentially expressed in four PTB clinical subtypes. Integrative approaches, especially those that incorporate evolutionary perspectives, can be successful in identifying potential genetic contributions to complex genetic diseases, such as PTB.	[Hirbo, Jibril; Eidem, Haley; Rokas, Antonis; Abbot, Patrick] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	Vanderbilt University	Abbot, P (corresponding author), Vanderbilt Univ, Dept Biol Sci, Box 35164,Stn B, Nashville, TN 37235 USA.	patrick.abbot@vanderbilt.edu	Rokas, Antonis/A-9775-2008	Rokas, Antonis/0000-0002-7248-6551; Hirbo, Jibril/0000-0002-8932-7311	March of Dimes through the March of Dimes Prematurity Research Center Ohio Collaborative	March of Dimes through the March of Dimes Prematurity Research Center Ohio Collaborative	This work was supported by the March of Dimes through the March of Dimes Prematurity Research Center Ohio Collaborative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors gratefully acknowledge thoughtful contributions from the members of the Ohio Collaborative. Research on this project was supported by the March of Dimes through the March of Dimes Prematurity Research Center Ohio Collaborative.	Abdel-Salam G, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-12; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Anum EA, 2009, PEDIATR RES, V65, P1, DOI 10.1203/PDR.0b013e31818912e7; Aulchenko YS, 2009, EUR J HUM GENET, V17, P1070, DOI 10.1038/ejhg.2009.5; Bakewell MA, 2007, P NATL ACAD SCI USA, V104, P7489, DOI 10.1073/pnas.0701705104; Bao SH, 2013, CLIN EXP IMMUNOL, V172, P437, DOI 10.1111/cei.12066; Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; Bednarek AK, 2001, CANCER RES, V61, P8068; Behrman, 2007, PRETERM BIRTH CAUSES; Bird CP, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r118; Boyd HA, 2009, AM J EPIDEMIOL, V170, P1358, DOI 10.1093/aje/kwp324; Brosens I, 2011, AM J OBSTET GYNECOL, V204, P193, DOI 10.1016/j.ajog.2010.08.009; Brown EA, 2013, TRENDS GENET, V29, P585, DOI 10.1016/j.tig.2013.03.001; Browne VA, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0068; Brunetti-Pierri N, 2008, NAT GENET, V40, P1466, DOI 10.1038/ng.279; Burton GJ, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.07.050; Bush EC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-17; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Cai JJ, 2009, GENOME BIOL EVOL, V1, P131, DOI 10.1093/gbe/evp013; Cai Z, 2011, EUR J HUM GENET, V19, P667, DOI 10.1038/ejhg.2010.257; Carlson CS, 2005, GENOME RES, V15, P1553, DOI 10.1101/gr.4326505; Carter AM, 2011, BEST PRACT RES CL OB, V25, P249, DOI 10.1016/j.bpobgyn.2010.10.010; Chang NS, 2001, J BIOL CHEM, V276, P3361, DOI 10.1074/jbc.M007140200; Chen H, 2010, GENOME RES, V20, P393, DOI 10.1101/gr.100545.109; Chen Q, 2009, MOL HUM REPROD, V15, P215, DOI 10.1093/molehr/gap009; Chen R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r170; Chen WV, 2013, DEVELOPMENT, V140, P3297, DOI 10.1242/dev.090621; Chhabra A, 2012, DEV CELL, V22, P651, DOI 10.1016/j.devcel.2011.12.022; Cordeaux Y, 2009, J PHARMACOL EXP THER, V328, P682, DOI 10.1124/jpet.108.143040; Crisci JL, 2011, GENOME BIOL EVOL, V3, P791, DOI 10.1093/gbe/evr075; Crosley EJ, 2013, PLACENTA, V34, P127, DOI 10.1016/j.placenta.2012.12.001; Cross JC, 2006, REPROD FERT DEVELOP, V18, P71, DOI 10.1071/RD05121; Davis JM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004241; Di Rienzo A, 2006, CURR OPIN GENET DEV, V16, P630, DOI 10.1016/j.gde.2006.10.002; Dickerson JE, 2012, MOL BIOL EVOL, V29, P2284, DOI 10.1093/molbev/mss195; Dissanayake VHW, 2007, MOL HUM REPROD, V13, P425, DOI 10.1093/molehr/gam011; Domazet-Loso T, 2008, MOL BIOL EVOL, V25, P2699, DOI 10.1093/molbev/msn214; Dorus S, 2004, CELL, V119, P1027, DOI 10.1016/j.cell.2004.11.040; Dumas LJ, 2012, AM J HUM GENET, V91, P444, DOI 10.1016/j.ajhg.2012.07.016; Dunsworth HM, 2012, P NATL ACAD SCI USA, V109, P15212, DOI 10.1073/pnas.1205282109; Edwards SL, 2013, AM J HUM GENET, V93, P779, DOI 10.1016/j.ajhg.2013.10.012; Eidem HR, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0099-8; Elliot MG, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0069; Enard D, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000840; Fagny M, 2014, MOL BIOL EVOL, V31, P1850, DOI 10.1093/molbev/msu118; Faxen M, AM J PERINATOL, V15, P9; FONDACCI C, 1994, J CLIN INVEST, V93, P1149, DOI 10.1172/JCI117067; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fritz R, 2014, INT J DEV BIOL, V58, P261, DOI 10.1387/ijdb.140011da; Gaya-Vidal M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-599; George RD, 2011, GENOME RES, V21, P1686, DOI 10.1101/gr.121327.111; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Gogat K, 2004, INVEST OPHTH VIS SCI, V45, P7, DOI 10.1167/iovs.02-1096; GOUSTIN AS, 1985, CELL, V41, P301, DOI 10.1016/0092-8674(85)90083-2; Grossman SR, 2013, CELL, V152, P703, DOI 10.1016/j.cell.2013.01.035; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Haasl RJ, 2014, GENOME BIOL EVOL, V6, P1843, DOI 10.1093/gbe/evu134; Hakonen E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093651; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Haygood R, 2007, NAT GENET, V39, P1140, DOI 10.1038/ng2104; Haygood R, 2010, P NATL ACAD SCI USA, V107, P7853, DOI 10.1073/pnas.0911249107; Heuberger J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002915; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hirano S, 2012, PHYSIOL REV, V92, P597, DOI 10.1152/physrev.00014.2011; Hoch RV, 2003, DEVELOPMENT, V130, P4769, DOI 10.1242/dev.00721; Howard S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023899; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Iwaki A, 2008, J MED GENET, V45, P32, DOI 10.1136/jmg.2007.053942; Johansson A, 2008, HEREDITAS, V145, P126, DOI 10.1111/j.0018-0661.2008.02054.x; Johnson MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033666; Jones RL, 2006, REPRODUCTION, V132, P217, DOI 10.1530/rep.1.01076; Jukic AM, 2013, HUM REPROD, V28, P2848, DOI 10.1093/humrep/det297; Jurccoviccova J, PLACENTA, V19, P423; Keeney JG, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00427; Kelly CR, 2006, J PHARMACOL EXP THER, V317, P1254, DOI 10.1124/jpet.105.100172; KIELER H, 1995, ULTRASOUND OBST GYN, V6, P353, DOI 10.1046/j.1469-0705.1995.06050353.x; Kim SY, 2011, CELL ADHES MIGR, V5, P97, DOI 10.4161/cam.5.2.14374; Kimura R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000286; Kitazawa T, 1998, BRIT J PHARMACOL, V123, P173, DOI 10.1038/sj.bjp.0701583; Knoefler Martin, 2013, Frontiers in Genetics, V4, P190, DOI 10.3389/fgene.2013.00190; Large MJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004451; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Levinson DF, 2011, AM J PSYCHIAT, V168, P302, DOI 10.1176/appi.ajp.2010.10060876; Li Q, 2014, ELECTRON J DIFFER EQ; LINDSAY D, 1963, J ENDOCRINOL, V26, P85, DOI 10.1677/joe.0.0260085; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Liu XY, 2013, AM J HUM GENET, V92, P866, DOI 10.1016/j.ajhg.2013.04.021; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lopez-Bigas N, 2004, NUCLEIC ACIDS RES, V32, P3108, DOI 10.1093/nar/gkh605; Lui JLC, 2012, HUM MOL GENET, V21, P5193, DOI 10.1093/hmg/dds347; Lunde A, 2007, AM J EPIDEMIOL, V165, P734, DOI 10.1093/aje/kwk107; Mallaret M, 2014, BRAIN, V137, P411, DOI 10.1093/brain/awt338; Manuck TA, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2015.02.010; Marie PJ, 2013, BONEKEY REP, V2; Matsumoto M, 1996, NATURE, V379, P168, DOI 10.1038/379168a0; Maxwell EK, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0212-1; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; Mignot C, 2015, J MED GENET, V52, P61, DOI 10.1136/jmedgenet-2014-102748; Mitchell KJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-237; Mizuno H, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-27; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Moffett A, 2015, PHILOS T R SOC LON B, V370; Nassar N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056238; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Nilsson UW, 2013, OBSTET GYNECOL, V122, P737, DOI 10.1097/AOG.0b013e3182a1ba56; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Ozcelik T, 2008, P NATL ACAD SCI USA, V105, P4232, DOI 10.1073/pnas.0804078105; Paulson AF, 2014, CELL ADHES MIGR, V8, P19, DOI 10.4161/cam.27839; Phillips Julie Baker, 2015, Evolution Medicine and Public Health, P136, DOI 10.1093/emph/eov010; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Plunkett J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001365; Pollard KS, 2006, PLOS GENET, V2, P1599, DOI 10.1371/journal.pgen.0020168; Popesco MC, 2006, SCIENCE, V313, P1304, DOI 10.1126/science.1127980; Powe CE, 2011, CIRCULATION, V123, P2856, DOI 10.1161/CIRCULATIONAHA.109.853127; Prabhakar S, 2006, SCIENCE, V314, P786, DOI 10.1126/science.1130738; Rafajlovic M, 2014, THEOR POPUL BIOL, V95, P1, DOI 10.1016/j.tpb.2014.05.002; Ramanan VK, 2012, TRENDS GENET, V28, P323, DOI 10.1016/j.tig.2012.03.004; Redies C, 2011, CEREBELLUM, V10, P393, DOI 10.1007/s12311-010-0207-4; Ritchie MD, 2015, NAT REV GENET, V16, P85, DOI 10.1038/nrg3868; Robinson MR, 2014, TRENDS GENET, V30, P124, DOI 10.1016/j.tig.2014.02.003; Rockwell LC, 2003, AM J HUM BIOL, V15, P330, DOI 10.1002/ajhb.10151; Roy PJ, 2002, NATURE, V418, P975, DOI 10.1038/nature01012; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sawamiphak S, 2010, NATURE, V465, P487, DOI 10.1038/nature08995; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Schwenke M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054336; Shi P, 2006, TRENDS GENET, V22, P608, DOI 10.1016/j.tig.2006.09.001; Su MT, 2011, HUM REPROD, V26, P758, DOI 10.1093/humrep/deq401; Svensson AC, 2009, AM J EPIDEMIOL, V170, P1365, DOI 10.1093/aje/kwp328; Swaggart KA, 2015, COLD SPRING HARB PER, V5; Synofzik M, 2011, J MED GENET, V48, P407, DOI 10.1136/jmg.2010.087023; Talwar P, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-199; Tang K, 2007, PLOS BIOL, V5, P1587, DOI 10.1371/journal.pbio.0050171; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Tuteja G, 2012, PLACENTA, V33, P1055, DOI 10.1016/j.placenta.2012.09.016; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Uzun A, 2012, DATABASE-OXFORD, DOI 10.1093/database/bar069; Venny, INTERACTIVE TOOL COM; Wang LL, 2011, GENOMICS, V98, P1, DOI 10.1016/j.ygeno.2011.04.006; Wang YG, 2012, NATURE, V485, P128, DOI 10.1038/nature10988; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Weiner S, 2008, CLIN PERINATOL, V35, P469, DOI 10.1016/j.clp.2008.06.003; Wells JCK, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0067; Wilcox AJ, 2008, AM J EPIDEMIOL, V167, P474, DOI 10.1093/aje/kwm319; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Worley KC, 2014, NAT GENET, V46, P850, DOI 10.1038/ng.3042; Wu W, 2013, F1000RESEARCH, V2; Xiong Q, 2012, GENOME RES, V22, P386, DOI 10.1101/gr.124370.111; York TP, 2013, AM J EPIDEMIOL, V178, P543, DOI 10.1093/aje/kwt005; York TP, 2009, TWIN RES HUM GENET, V12, P333, DOI 10.1375/twin.12.4.333; Zhang YE, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001179; Zhang Z, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-17; Zhong H, 2010, AM J HUM GENET, V86, P581, DOI 10.1016/j.ajhg.2010.02.020	160	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144155	10.1371/journal.pone.0144155	http://dx.doi.org/10.1371/journal.pone.0144155			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641094	Green Submitted, Green Published, gold			2022-12-27	WOS:000366902700066
J	Lindborg, P; Friberg, AK				Lindborg, PerMagnus; Friberg, Anders K.			Colour Association with Music Is Mediated by Emotion: Evidence from an Experiment Using a CIE Lab Interface and Interviews	PLOS ONE			English	Article								Crossmodal associations may arise at neurological, perceptual, cognitive, or emotional levels of brain processing. Higher-level modal correspondences between musical timbre and visual colour have been previously investigated, though with limited sets of colour. We developed a novel response method that employs a tablet interface to navigate the CIE Lab colour space. The method was used in an experiment where 27 film music excerpts were presented to participants (n = 22) who continuously manipulated the colour and size of an on-screen patch to match the music. Analysis of the data replicated and extended earlier research, for example, that happy music was associated with yellow, music expressing anger with large red colour patches, and sad music with smaller patches towards dark blue. Correlation analysis suggested patterns of relationships between audio features and colour patch parameters. Using partial least squares regression, we tested models for predicting colour patch responses from audio features and ratings of perceived emotion in the music. Parsimonious models that included emotion robustly explained between 60% and 75% of the variation in each of the colour patch parameters, as measured by cross-validated R-2. To illuminate the quantitative findings, we performed a content analysis of structured spoken interviews with the participants. This provided further evidence of a significant emotion mediation mechanism, whereby people tended to match colour association with the perceived emotion in the music. The mixed method approach of our study gives strong evidence that emotion can mediate crossmodal association between music and visual colour. The CIE Lab interface promises to be a useful tool in perceptual ratings of music and other sounds.	[Lindborg, PerMagnus] Nanyang Technol Univ, Sch Art Design & Media, Area Interact Media, Singapore 639798, Singapore; [Lindborg, PerMagnus; Friberg, Anders K.] KTH Royal Inst Technol, Dept Speech Mus & Hearing, Stockholm, Sweden	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Royal Institute of Technology	Lindborg, P (corresponding author), Nanyang Technol Univ, Sch Art Design & Media, Area Interact Media, Singapore 639798, Singapore.	permagnus@ntu.edu.sg	Friberg, Anders K/A-2490-2012; Lindborg, PerMagnus/E-8520-2018	Lindborg, PerMagnus/0000-0001-8121-9263	Tier 1 grant, Academic Research Fund, Ministry of Education, Singapore [4010958]	Tier 1 grant, Academic Research Fund, Ministry of Education, Singapore	The work was supported by Tier 1 grant #4010958, Academic Research Fund, Ministry of Education, Singapore.	Asutay E, 2012, J AUDIO ENG SOC, V60, P21; Barbiere J.M., 2007, EMPIR STUD ARTS, V25, P193, DOI [10.2190/A704-5647-5245-R47P, DOI 10.2190/A704-5647-5245-R47P]; Bauer M, 2012, QUALITATIVE RES TEXT; Bresin R., 2005, P INT COMPUTER MUSIC, P367; Cabrera D, 2014, PSYSOUND3; Cabrera D, 2008, ACOUSTICS; Chion Michael, 2003, FILM A SOUND ART; Collignon O, 2010, NEUROPSYCHOLOGIA, V48, P220, DOI 10.1016/j.neuropsychologia.2009.09.007; Cycling ` 74 (), 2015, MAX 7 SOFTW; Datteri DL, 2004, P ICMPC8 AD AUSTR; Eerola T, 2011, PSYCHOL MUSIC, V39, P18, DOI 10.1177/0305735610362821; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Fastl H., 2007, PSYCHOACOUSTICS FACT, V3rd; Flick U, 2012, QUALITATIVE RES TEXT; Fox J., 2015, COMPANION APPL REGRE; Friberg A., 2011, GEMESSENE INTERPRETA, P237; Friberg A, 2014, ARXIV14037923; Gabrielsson A., 2010, HDB MUSIC EMOTION TH, P547; GAVER WW, 1993, ECOL PSYCHOL, V5, P285, DOI 10.1207/s15326969eco0504_2; Giannakis K, 2001, MUSICAL IMAGERY, P161; Hansen T, 2009, J VISION, V9, DOI 10.1167/9.4.26; Hoffmann G, 2003, CIELAB COLOR SPACE; Holm J, 2009, J NEW MUSIC RES, V38, P87, DOI 10.1080/09298210902940094; Huron D.B., 2006, SWEET ANTICIPATION M; Juslin PN, 2008, BEHAV BRAIN SCI, V31, P559, DOI 10.1017/S0140525X08005293; Kabacoff RI., 2011, R ACTION DATA ANAL G, V1; Lartillot O, 2013, MIRTOOLBOX V1 5; Lindborg P, 2015, APPL ACOUST, V92, P47, DOI 10.1016/j.apacoust.2015.01.002; Lindborg PM, 2015, PERSONALITY TR UNPUB; Lipscomb SD, 2008, P ICMPC8 AD AUSTR; Mevik B., 2015, PARTIAL LEAST SQUARE; Nygren P, 2009, THESIS; Palmer SE, 2006, P NATL ACAD SCI; Pierce AH, 1901, STUDIES AUDITORY VIS, P188; Pitteri M, 2015, PSYCHOL RES, P1; Plazak J, 2011, MUSIC SCI, V15, P29, DOI 10.1177/1029864910391455; R Core Team, 2013, R LANG ENV STAT COMP; Regier T, 2007, P NATL ACAD SCI USA, V104, P1436, DOI 10.1073/pnas.0610341104; Regier T, 2009, TRENDS COGN SCI, V13, P439, DOI 10.1016/j.tics.2009.07.001; Rusconi E, 2006, COGNITION, V99, P113, DOI 10.1016/j.cognition.2005.01.004; Spence C., 2012, FLAVOUR, V1, P1, DOI [10.1186/2044-7248-1-12, DOI 10.1186/2044-7248-1-12]; Spence C, 2001, ATTENTIONAL CAPTURE; Spence C, 2011, ATTEN PERCEPT PSYCHO, V73, P971, DOI 10.3758/s13414-010-0073-7; Tuuri K, 2012, J NEW MUSIC RES, V41, P137, DOI 10.1080/09298215.2011.614951; Velasco C, 2015, FOOD QUAL PREFER, V41, P151, DOI 10.1016/j.foodqual.2014.11.010; Vuoskoski JK, 2013, PSYCHOL MUSIC; Whittle P, 2003, COLOUR PERCEPTION MI; Wold H., 1985, PARTIAL LEAST SQUARE, P581; Woods AT, 2015, PEERJ, V3, DOI 10.7717/peerj.1058	49	23	23	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144013	10.1371/journal.pone.0144013	http://dx.doi.org/10.1371/journal.pone.0144013			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642050	Green Submitted, Green Published, gold			2022-12-27	WOS:000366902700044
J	Liu, GS; Wang, JH; Lee, JH; Tsai, PJ; Tsai, HE; Sheu, SJ; Lin, HC; Dusting, GJ; Tai, MH; Bee, YS				Liu, Guei-Sheung; Wang, Jiang-Hui; Lee, Jia Hui; Tsai, Pei-Jhen; Tsai, Han-En; Sheu, Shwu-Jiuan; Lin, Hsiu-Chen; Dusting, Gregory J.; Tai, Ming-Hong; Bee, Youn-Shen			Gene Delivery by Subconjunctival Injection of Adenovirus in Rats: A Study of Local Distribution, Transgene Duration and Safety	PLOS ONE			English	Article							CHOROIDAL NEOVASCULARIZATION; MEDIATED TRANSFER; IMMUNE-RESPONSE; DRUG-DELIVERY; EXPRESSION; MOUSE; THERAPY; VECTORS; CELLS; BIODISTRIBUTION	Subconjunctival injection is a minimally invasive route for gene delivery to ocular tissues, but has traditionally been limited to use in the cornea. The accurate ocular distribution of virus has not, however, been previously investigated. Adenovirus is an attractive gene vector as it can deliver large genes and allow for short-term gene expression, but how safe it is when delivered via subconjunctival injection remains to be established. We have characterized the bio-distribution and safety of subconjunctivally administered adenovirus in Brown Norway rats. The bio-distribution and transgene duration of adenovirus carrying luciferase gene (Ad-Luci) at various time intervals were evaluated via bioluminescence imaging after subconjunctival injection. Adenovirus carrying a reporter gene, beta-galactosidase (Ad-LacZ) or hrGFP (Ad-hrGFP) was administered subconjunctivally and the viral distribution in various ocular tissues was assessed by histological analysis and quantitative PCR (qPCR). Hepatic damage was assessed by biochemical and immunohistological analysis with TUNEL stain. Systemic immunogenicity was assessed by measuring serum level of TNF-alpha via ELISA, 2 hours and 14 days after administration of adenovirus. Retinal function was examined by electroretinography. Subconjunctival injection of Ad-Luci induced luciferase expression in the injected eyes within 24 hours, for at least 64 days. Histological analysis showed adenovirus distributed across anterior and posterior ocular tissues. qPCR demonstrated different amounts of adenovirus in different ocular tissues, with the highest amounts closest to the injection site Unlike the intravenous route, subconjunctivally delivered adenovirus did not elicit any detectable hepatic injury or systemic immunogenicity. Retinal function was unaffected by adenovirus irrespective of administration route. In conclusion, an adeno-viral vector administered subconjunctivally can infiltrate into different ocular tissues and lead to short-term ocular transgene expression, without causing hepatic injury and immune activation. Therefore, subconjunctivally administered adenovirus may be a promising gene delivery approach for managing anterior and posterior segment eye diseases requiring short-term therapy.	[Liu, Guei-Sheung; Wang, Jiang-Hui; Lee, Jia Hui; Dusting, Gregory J.] Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, East Melbourne, Vic, Australia; [Liu, Guei-Sheung; Wang, Jiang-Hui; Dusting, Gregory J.] Univ Melbourne, Dept Surg, Ophthalmol, East Melbourne, Vic, Australia; [Tsai, Pei-Jhen; Sheu, Shwu-Jiuan; Lin, Hsiu-Chen; Bee, Youn-Shen] Kaohsiung Vet Gen Hosp, Dept Ophthalmol, Kaohsiung, Taiwan; [Tsai, Han-En; Tai, Ming-Hong] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung 80424, Taiwan; [Sheu, Shwu-Jiuan] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Bee, Youn-Shen] Natl Def Med Ctr, Taipei, Taiwan; [Bee, Youn-Shen] Yuh Ing Jr Coll Hlth Care & Management, Kaohsiung, Taiwan	Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; Kaohsiung Veterans General Hospital; National Sun Yat Sen University; National Yang Ming Chiao Tung University; National Defense Medical Center	Bee, YS (corresponding author), Kaohsiung Vet Gen Hosp, Dept Ophthalmol, Kaohsiung, Taiwan.	ysbee@vghks.gov.tw	Wang, Jiang-Hui/AAW-4653-2020; Liu, Guei-Sheung/Q-6472-2018	Wang, Jiang-Hui/0000-0002-1551-9660; Liu, Guei-Sheung/0000-0003-3379-724X; Tsai, Pei- Jhen/0000-0003-0005-1476	National Science Council, Taiwan [NSC100-2314-B-075B-006]; Kaohsiung Veterans General Hospital [VGHKS 96-075, 98-062, 99-062, 101-056]; National Health and Medical Research Council of Australia (NHMRC) [1061912]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Kaohsiung Veterans General Hospital; National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from National Science Council, Taiwan (NSC100-2314-B-075B-006), Kaohsiung Veterans General Hospital (VGHKS 96-075, 98-062, 99-062, 101-056) and the National Health and Medical Research Council of Australia (NHMRC #1061912). The Centre for Eye Research Australia receives Operational Infrastructure Support from the Victorian Government.	Ali RR, 1998, GENE THER, V5, P1561, DOI 10.1038/sj.gt.3300761; Solinis MA, 2015, EUR J PHARM BIOPHARM, V95, P331, DOI 10.1016/j.ejpb.2014.12.022; Ashtari M, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa8791; Borras T, 2012, INVEST OPHTH VIS SCI, V53, P2506, DOI 10.1167/iovs.12-9483o; BRODY SL, 1994, HUM GENE THER, V5, P437, DOI 10.1089/hum.1994.5.4-437; Chan HH, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-83; Cheng HC, 2007, MOL VIS, V13, P2344; De Kozak Y, 2002, CLIN EXP IMMUNOL, V130, P212, DOI 10.1046/j.1365-2249.2002.01969.x; Fejer G, 2005, J IMMUNOL, V175, P1498, DOI 10.4049/jimmunol.175.3.1498; Gaudana R, 2010, AAPS J, V12, P348, DOI 10.1208/s12248-010-9183-3; GUZMAN RJ, 1994, P NATL ACAD SCI USA, V91, P10732, DOI 10.1073/pnas.91.22.10732; Hamilton MM, 2006, INVEST OPHTH VIS SCI, V47, P299, DOI 10.1167/iovs.05-0731; Harui A, 1999, J VIROL, V73, P6141, DOI 10.1128/JVI.73.7.6141-6146.1999; Hendrickx R, 2014, HUM GENE THER, V25, P265, DOI 10.1089/hum.2014.001; Ildefonso CJ, 2010, MOL THER, V18, P1885, DOI 10.1038/mt.2010.139; Jiang XD, 2015, DRUG DES DEV THER, V9, P3043, DOI 10.2147/DDDT.S85529; Julien S, 2008, MOL VIS, V14, P1358; Koblin BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024517; Kong FS, 2010, EXP EYE RES, V90, P546, DOI 10.1016/j.exer.2010.01.011; Lam S, 2014, GENES DIS, V1, P227, DOI 10.1016/j.gendis.2014.09.002; Liu GS, 2011, HUM GENE THER, V22, P325, DOI 10.1089/hum.2010.090; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mohan RR, 2013, OCUL SURF, V11, P150, DOI 10.1016/j.jtos.2012.10.004; Rhee EG, 2011, J VIROL, V85, P315, DOI 10.1128/JVI.01597-10; Salako MA, 2011, MOL THER, V19, P490, DOI 10.1038/mt.2010.247; Stevens Sue, 2009, Community Eye Health, V22, P15; Tai MH, 2003, EXP NEUROL, V183, P508, DOI 10.1016/S0014-4886(03)00130-4; Ueyama K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108071; Urtti A, 2006, ADV DRUG DELIVER REV, V58, P1131, DOI 10.1016/j.addr.2006.07.027; Veneziale RW, 2007, CUTAN OCUL TOXICOL, V26, P83, DOI 10.1080/15569520701212167; Wang HP, 2013, INT J MOL MED, V31, P377, DOI 10.3892/ijmm.2012.1197; Wen SF, 2003, EXP EYE RES, V77, P355, DOI 10.1016/S0014-4835(03)00122-2; Yan H, 2013, OPHTHALMIC RES, V49, P81, DOI 10.1159/000342979; Yanagi Y, 2003, INVEST OPHTH VIS SCI, V44, P751, DOI 10.1167/iovs.02-0222; Yanagi Y, 2002, INVEST OPHTH VIS SCI, V43, P3495; Yang JG, 2009, ACTA PHARMACOL SIN, V30, P413, DOI 10.1038/aps.2009.23; YANG YP, 1994, P NATL ACAD SCI USA, V91, P4407, DOI 10.1073/pnas.91.10.4407; Zhou SY, 2010, MOL VIS, V16, P1389	38	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0143956	10.1371/journal.pone.0143956	http://dx.doi.org/10.1371/journal.pone.0143956			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642208	gold, Green Published			2022-12-27	WOS:000366902700036
J	Martinou, AF; Stavrinides, MC				Martinou, Angeliki F.; Stavrinides, Menelaos C.			Effects of Sublethal Concentrations of Insecticides on the Functional Response of Two Mirid Generalist Predators	PLOS ONE			English	Article							TETRANYCHUS-URTICAE ACARI; BIOLOGICAL-CONTROL AGENT; TUTA-ABSOLUTA; BENEFICIAL ARTHROPODS; MACROLOPHUS-PYGMAEUS; TOMATO PINWORM; BEMISIA-TABACI; PEST-CONTROL; HOST-PLANT; BEHAVIOR	The use of agrochemicals particularly pesticides, can hamper the effectiveness of natural enemies, causing disruption in the ecosystem service of biological control. In the current study, the effects of the insecticides thiacloprid and chlorantraniliprole on the functional response curves were assessed for two mirid predator nymphs, Macrolophus pygmaeus Rambur and Nesidiocoris tenuis Reuter. In the absence of insecticides, both predators exhibited a type II functional response when feeding on eggs of the moth Ephestia kuehniella. N. tenuis seems to be a more efficient predator than M. pygmaeus, as model estimated handling time was significantly lower for the former than for the latter. Residual exposure of M. pygmaeus to sublethal concentrations of either insecticide was associated with a change in the asymptote but not the type of the functional response curve. Thiacloprid seems to be the least compatible with M. pygmaeus, as it led to both a significant reduction of the attack rate and an increase in handling time. In contrast, chlorantraniliprole exposure significantly increased the handling time, but not the attack rate of the predator. Residual exposure of N. tenuis to sublethal concentrations of either insecticide did not have a significant effect on the type nor the parameters of the functional response model. The results show that pesticide residues that do not have lethal effects on beneficial arthropods can reduce prey consumption depending on predator species and on likely risks associated with toxicity.	[Martinou, Angeliki F.; Stavrinides, Menelaos C.] Cyprus Univ Technol, Dept Agr Sci Biotechnol & Food Sci, CY-3036 Limassol, Cyprus	Cyprus University of Technology	Stavrinides, MC (corresponding author), Cyprus Univ Technol, Dept Agr Sci Biotechnol & Food Sci, Arch Kyprianos 30, CY-3036 Limassol, Cyprus.	m.stavrinides@cut.ac.cy	Martinou, Kelly/AAN-5691-2020	Martinou, Kelly/0000-0003-2892-8583; Stavrinides, Menelaos/0000-0002-6459-1941	Hydroflies project an INTERREG (Interregional Cooperation) Greece-Cyprus program [C(2008)1131/28-03-2008]	Hydroflies project an INTERREG (Interregional Cooperation) Greece-Cyprus program	Part of the study was funded through the Hydroflies project (C(2008)1131/28-03-2008), an INTERREG (Interregional Cooperation) Greece-Cyprus (2007-2013) program (http://www.greececyprus.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljetlawi AA, 2004, J ANIM ECOL, V73, P239, DOI 10.1111/j.0021-8790.2004.00800.x; Ambrose DP, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.18701; Biondi A, 2012, PEST MANAG SCI, V68, P1523, DOI 10.1002/ps.3396; Cabello T, 2015, ENVIRON ENTOMOL, V44, P12, DOI 10.1093/ee/nvu017; Candolfi M. P., 2001, EUR STAND CHAR REG T; CHESSON J, 1989, ECOLOGY, V70, P1227, DOI 10.2307/1938180; Chong JH, 2006, BIOL CONTROL, V39, P320, DOI 10.1016/j.biocontrol.2006.08.013; Claver MA, 2003, J APPL ENTOMOL, V127, P18, DOI 10.1046/j.1439-0418.2003.00654.x; Cordova D, 2006, PESTIC BIOCHEM PHYS, V84, P196, DOI 10.1016/j.pestbp.2005.07.005; Croft B. A., 1990, ARTHROPOD BIOL CONTR; De Clercq P, 2000, BIOL CONTROL, V18, P65, DOI 10.1006/bcon.1999.0808; Delpuech JM, 2012, ECOTOX ENVIRON SAFE, V84, P32, DOI 10.1016/j.ecoenv.2012.06.007; Deng LL, 2007, ENVIRON TOXICOL CHEM, V26, P478, DOI 10.1897/06-344R.1; Desneux N, 2005, J ECON ENTOMOL, V98, P9, DOI 10.1603/0022-0493-98.1.9; Desneux N, 2004, ENTOMOL EXP APPL, V112, P227, DOI 10.1111/j.0013-8703.2004.00198.x; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Desneux N, 2011, J PEST SCI, V84, P403, DOI 10.1007/s10340-011-0398-6; Desneux N, 2010, J PEST SCI, V83, P197, DOI 10.1007/s10340-010-0321-6; Elbert A, 2008, PEST MANAG SCI, V64, P1099, DOI 10.1002/ps.1616; Fantke P, 2014, ENVIRON SCI TECHNOL, V48, P8588, DOI 10.1021/es500434p; Gardiner MM, 2009, INTEGRATED PEST MANAGEMENT: CONCEPTS, TACTICS, STRATEGIES AND CASE STUDIES, P151; Hassell M.P., 2000, SPATIAL TEMPORAL DYN; HASSELL MP, 1977, J ANIM ECOL, V46, P249, DOI 10.2307/3959; HASSELL MP, 1982, ANN APPL BIOL, V101, P170; He YX, 2012, ECOTOXICOLOGY, V21, P1291, DOI 10.1007/s10646-012-0883-6; Holling C. S., 1959, Canadian Entomologist, V91, P385; Holling C. S., 1965, MEMOIRS ENTOMOLOGICA, V97, P5, DOI DOI 10.4039/ENTM9745FV; Holling C. S., 1966, MEM ENTOMOL SOC CAN, V98, P5, DOI [10.4039/entm9848fv, DOI 10.4039/ENTM9848FV]; JULIANO SA, 1985, EVOLUTION, V39, P212, DOI 10.1111/j.1558-5646.1985.tb04096.x; Juliano SA, 2001, DESIGN ANAL ECOLOGIC, P159; Lampropoulos PD, 2013, BASIC APPL ECOL, V14, P605, DOI 10.1016/j.baae.2013.08.004; Li DX, 2006, J APPL ENTOMOL, V130, P314, DOI 10.1111/j.1439-0418.2006.01056.x; Malaquias JB, 2014, ECOTOXICOLOGY, V23, P192, DOI 10.1007/s10646-013-1162-x; Martinou AF, 2014, CHEMOSPHERE, V96, P167, DOI 10.1016/j.chemosphere.2013.10.024; Martinou AF, 2010, ECOL ENTOMOL, V35, P183, DOI 10.1111/j.1365-2311.2009.01171.x; Maselou DA, 2014, BIOL CONTROL, V79, P92, DOI 10.1016/j.biocontrol.2014.09.002; Messina FJ, 1998, ENVIRON ENTOMOL, V27, P1196, DOI 10.1093/ee/27.5.1196; Mills NJ, 2004, ECOL ENTOMOL, V29, P208, DOI 10.1111/j.0307-6946.2004.00584.x; Milonas PG, 2011, BIOL CONTROL, V59, P141, DOI 10.1016/j.biocontrol.2011.06.016; Molla O, 2014, BIOCONTROL, V59, P175, DOI 10.1007/s10526-013-9553-8; Murdoch W.W., 2003, CONSUMER RESOURCE DY; Murray GPD, 2013, ETHOLOGY, V119, P751, DOI 10.1111/eth.12117; Omirou M, 2009, FOOD CHEM, V116, P499, DOI 10.1016/j.foodchem.2009.03.007; Pekar S, 2012, PEST MANAG SCI, V68, P1438, DOI 10.1002/ps.3397; Perdikis D, 2011, BIOL CONTROL, V59, P13, DOI 10.1016/j.biocontrol.2011.03.014; Poletti M, 2007, BIOL CONTROL, V40, P30, DOI 10.1016/j.biocontrol.2006.09.001; R Core Development Team, 2008, R LANG ENV STAT COMP; Rezac M, 2010, BIOCONTROL, V55, P503, DOI 10.1007/s10526-010-9272-3; Stavrinides MC, 2003, B ENTOMOL RES, V93, P343, DOI 10.1079/BER2003243; TREXLER JC, 1988, OECOLOGIA, V76, P206, DOI 10.1007/BF00379954; Urbaneja A, 2009, J APPL ENTOMOL, V133, P292, DOI 10.1111/j.1439-0418.2008.01319.x; Urbaneja A, 2012, PEST MANAG SCI, V68, P1215, DOI 10.1002/ps.3344; Zappala L, 2013, J PEST SCI, V86, P635, DOI 10.1007/s10340-013-0531-9; Zhang LP, 2011, PEST MANAG SCI, V67, P226, DOI 10.1002/ps.2056	54	21	22	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144413	10.1371/journal.pone.0144413	http://dx.doi.org/10.1371/journal.pone.0144413			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641652	Green Published, Green Submitted, gold			2022-12-27	WOS:000366902700114
J	Cardoso, THS; Freitas, ACO; Andrade, BS; de Sousa, AO; Santiago, AD; Koop, DM; Gramacho, KP; Alvim, FC; Micheli, F; Pirovani, CP				Santana Cardoso, Thyago Hermylly; Oliveira Freitas, Ana Camila; Andrade, Bruno Silva; de Sousa, Aurizangela Oliveira; Santiago, Andre da Silva; Koop, Daniela Martins; Gramacho, Karina Peres; Alvim, Fatima Cerqueira; Micheli, Fabienne; Pirovani, Carlos Priminho			TcCYPR04, a Cacao Papain-Like Cysteine-Protease Detected in Senescent and Necrotic Tissues Interacts with a Cystatin TcCYS4	PLOS ONE			English	Article							WITCHES-BROOM DISEASE; PROGRAMMED CELL-DEATH; THEOBROMA-CACAO; MONILIOPHTHORA-PERNICIOSA; CRINIPELLIS-PERNICIOSA; MEROPS DATABASE; GENE-EXPRESSION; CAUSAL AGENT; SWISS-MODEL; RESISTANCE	The interaction amongst papain-like cysteine-proteases (PLCP) and their substrates and inhibitors, such as cystatins, can be perceived as part of the molecular battlefield in plant-pathogen interaction. In cacao, four cystatins were identified and characterized by our group. We identified 448 proteases in cacao genome, whereof 134 were cysteine-proteases. We expressed in Escherichia coli a PLCP from cacao, named TcCYSPR04. Immunoblottings with anti-TcCYSPR04 exhibited protein increases during leaf development. Additional isoforms of TcCYSPR04 appeared in senescent leaves and cacao tissues infected by Moniliophthora perniciosa during the transition from the biotrophic to the saprophytic phase. TcCYSPR04 was induced in the apoplastic fluid of Catongo and TSH1188 cacao genotypes, susceptible and resistant to M. perniciosa, respectively, but greater intensity and additional isoforms were observed in TSH1188. The fungal protein MpNEP induced PLCP isoform expression in tobacco leaves, according to the cross reaction with anti-TcCYSPR04. Several protein isoforms were detected at 72 hours after treatment with MpNEP. We captured an active PLCP from cacao tissues, using a recombinant cacao cystatin immobilized in CNBr-Sepharose. Mass spectrometry showed that this protein corresponds to TcCYSPR04. A homology modeling was obtained for both proteins. In order to become active, TcCYSPR04 needs to lose its inhibitory domain. Molecular docking showed the physical-chemical complementarities of the interaction between the cacao enzyme and its inhibitor. We propose that TcCYSPR04 and its interactions with cacao cystatins are involved in the senescence and necrosis events related to witches' broom symptoms. This molecular interaction may be the target for future interventions to control witches' broom disease.	[Santana Cardoso, Thyago Hermylly; Oliveira Freitas, Ana Camila; de Sousa, Aurizangela Oliveira; Santiago, Andre da Silva; Koop, Daniela Martins; Alvim, Fatima Cerqueira; Micheli, Fabienne; Pirovani, Carlos Priminho] Univ Estadual Santa Cruz, Ctr Biotecnol & Genet, Ilheus, BA, Brazil; [Andrade, Bruno Silva] UESB, Jequie, BA, Brazil; [Gramacho, Karina Peres] Comissao Execut Plano Lavoura Cacaueira CEPLAC, Ctr Pesquisa Cacau CEPEC, Ilheus, BA, Brazil; [Micheli, Fabienne] CIRAD, UMR AGAP, Montpellier, France	Universidade Estadual de Santa Cruz; Universidade Estadual do Sudoeste da Bahia; CIRAD; Universite de Montpellier	Pirovani, CP (corresponding author), Univ Estadual Santa Cruz, Ctr Biotecnol & Genet, Rodovia Ilheus Itabuna,Km 16, Ilheus, BA, Brazil.	pirovani@uesc.br	GRAMACHO, KARINA PERES/J-3868-2014; Pirovani, Carlos Priminho/N-1153-2019; Pirovani, Carlos P/J-3426-2017; Andrade, Bruno S/C-8170-2013; Micheli, Fabienne/AAL-9895-2021; Andrade, Bruno/AAP-8926-2020; GRAMACHO, KARINA PERES/AAO-8862-2020	GRAMACHO, KARINA PERES/0000-0003-4037-1554; Pirovani, Carlos Priminho/0000-0002-6176-4069; Pirovani, Carlos P/0000-0002-6176-4069; Andrade, Bruno/0000-0002-8031-9454; GRAMACHO, KARINA PERES/0000-0003-4037-1554; Micheli, Fabienne/0000-0002-9031-362X	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [305309/2012-9]; Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB); CNPq (PRONEM) [PNE0005/2011]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil); FAPESB	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)); CNPq (PRONEM)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESB(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB))	THSC was supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). CPP was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [http://www.cnpq.br], process number 305309/2012-9). The authors thank Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB) [http://www.fapesb.ba.gov.br/] and the CNPq (PRONEM, process number PNE0005/2011) for the financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The work of THS Cardoso and DM Koop was supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil) and the FAPESB, respectively. We are thankful to Xavier Sabau (Cirad, France) for granting TcCYSPR04 cDNA clones, Claudia Fortes Ferreira (Embrapa, Cruz das Almas-BA, Brazil) for the critical reading of the manuscript, and Juliano Oliveira Santana for figure edition.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andebrhan T, 1999, EUR J PLANT PATHOL, V105, P167, DOI 10.1023/A:1008716000479; [Anonymous], [No title captured]; Arai S, 2002, J AGR FOOD CHEM, V50, P6612, DOI 10.1021/jf0201935; Argout X, 2011, NAT GENET, V43, P101, DOI 10.1038/ng.736; Argout X, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-512; Barrett AJ, 2001, J STRUCT BIOL, V134, P95, DOI 10.1006/jsbi.2000.4332; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown JS, 2005, J AM SOC HORTIC SCI, V130, P366, DOI 10.21273/JASHS.130.3.366; Cambra I, 2012, J EXP BOT, V63, P4615, DOI 10.1093/jxb/ers137; Cappetta M, 2002, BIOL CHEM, V383, P1215, DOI 10.1515/BC.2002.134; CASE DA, 2004, AMBER 8; Ceita GD, 2007, PLANT SCI, V173, P106, DOI 10.1016/j.plantsci.2007.04.006; Chan YL, 2010, PLANT CELL REP, V29, P231, DOI 10.1007/s00299-009-0815-y; Chu MH, 2011, PLANTA, V234, P243, DOI 10.1007/s00425-011-1398-8; Cygler M, 1996, STRUCTURE, V4, P405, DOI 10.1016/S0969-2126(96)00046-9; Eason JR, 2005, PLANT MOL BIOL, V57, P645, DOI 10.1007/s11103-005-0999-7; Faleiro FG, 2006, EUPHYTICA, V149, P227, DOI 10.1007/s10681-005-9070-7; Freitas AC, 2015, ACTIVITY TCCYS4 MODI, V10, DOI [10.1371/journal.pone.0121519, DOI 10.1371/JOURNAL.PONE.0121519]; Garcia O, 2007, MYCOL RES, V111, P443, DOI 10.1016/j.mycres.2007.01.017; Gesteira AS, 2007, ANN BOT-LONDON, V100, P129, DOI 10.1093/aob/mcm092; Greenberg JT, 2004, CELL MICROBIOL, V6, P201, DOI 10.1111/j.1462-5822.2004.00361.x; Grudkowska M, 2004, ACTA BIOCHIM POL, V51, P609; Grzonka Z, 2001, ACTA BIOCHIM POL, V48, P1; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Hayden DM, 2004, PLANT SCI, V166, P779, DOI 10.1016/j.plantsci.2003.11.019; Hayik SA, 2010, J CHEM THEORY COMPUT, V6, P3079, DOI 10.1021/ct100315g; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jenko S, 2003, J MOL BIOL, V326, P875, DOI 10.1016/S0022-2836(02)01432-8; Kawai-Yamada M, 2001, P NATL ACAD SCI USA, V98, P12295, DOI 10.1073/pnas.211423998; Kiss G, 2010, PROTEIN SCI, V19, P1760, DOI 10.1002/pro.462; Kordis D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-266; Kozakov D, 2010, PROTEINS, V78, P3124, DOI 10.1002/prot.22835; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mans BJ, 2002, INSECT BIOCHEM MOLEC, V32, P821, DOI 10.1016/S0965-1748(01)00169-2; MCINTYRE GF, 1993, P NATL ACAD SCI USA, V90, P10588, DOI 10.1073/pnas.90.22.10588; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Michaud D, 1998, ANAL CHIM ACTA, V372, P173, DOI 10.1016/S0003-2670(98)00349-3; Nandy SK, 2013, J BIOMOL STRUCT DYN, V31, P649, DOI 10.1080/07391102.2012.706403; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Nooden LD, 1997, PHYSIOL PLANTARUM, V101, P746, DOI 10.1111/j.1399-3054.1997.tb01059.x; Orlikowska M, 2011, J STRUCT BIOL, V173, P406, DOI 10.1016/j.jsb.2010.11.009; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Pietra D, 2014, CHEM BIOL DRUG DES, V84, P648, DOI 10.1111/cbdd.12357; Pirovani CP, 2008, ELECTROPHORESIS, V29, P2391, DOI 10.1002/elps.200700743; Pirovani CP, 2010, PLANTA, V232, P1485, DOI 10.1007/s00425-010-1272-0; Pirovani CP, 2002, EUR J BIOCHEM, V269, P3998, DOI 10.1046/j.1432-1033.2002.03089.x; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Rawlings ND, 2010, BIOCHIMIE, V92, P1463, DOI 10.1016/j.biochi.2010.04.013; Ritchie DW, 2010, BIOINFORMATICS, V26, P2398, DOI 10.1093/bioinformatics/btq444; Salas CE, 2008, PHYTOCHEMISTRY, V69, P2263, DOI 10.1016/j.phytochem.2008.05.016; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Santana LS, 2014, GENET MOL RES, V13, P7636, DOI 10.4238/2014.September.26.1; Schafmeister C. E. A. F., 1995, LEAP; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shindo T, 2008, MOL PLANT PATHOL, V9, P119, DOI [10.1111/j.1364-3703.2007.00439.x, 10.1111/J.1364-3703.2007.00439.X]; STASKAWICZ BJ, 1995, SCIENCE, V268, P661, DOI 10.1126/science.7732374; Surujdeo-Maharaj S, 2003, PLANT PATHOL, V52, P464, DOI 10.1046/j.1365-3059.2003.00865.x; Tajima T, 2011, PHYSIOL PLANTARUM, V141, P97, DOI 10.1111/j.1399-3054.2010.01425.x; Vajda S, 2009, CURR OPIN STRUC BIOL, V19, P164, DOI 10.1016/j.sbi.2009.02.008; van der Hoorn RAL, 2004, CURR OPIN PLANT BIOL, V7, P400, DOI 10.1016/j.pbi.2004.04.003; van der Hoorn RAL, 2004, PLANT PHYSIOL, V135, P1170, DOI 10.1104/pp.104.041467; van der Hoorn RAL, 2008, ANNU REV PLANT BIOL, V59, P191, DOI 10.1146/annurev.arplant.59.032607.092835; van der Linde K, 2012, PLANT SIGNAL BEHAV, V7, P1397, DOI 10.4161/psb.21902; van Doorn WG, 2003, PLANT MOL BIOL, V53, P845, DOI 10.1023/B:PLAN.0000023670.61059.1d; VERNET T, 1995, J BIOL CHEM, V270, P10838, DOI 10.1074/jbc.270.18.10838; WEINER SJ, 1986, J COMPUT CHEM, V7, P230, DOI 10.1002/jcc.540070216; Wiederanders B, 2003, ACTA BIOCHIM POL, V50, P691	70	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144440	10.1371/journal.pone.0144440	http://dx.doi.org/10.1371/journal.pone.0144440			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641247	Green Published, gold, Green Submitted			2022-12-27	WOS:000366902700121
J	Shen, XJ; Huang, TC; Wang, GY; Li, GL				Shen, Xiaojuan; Huang, Tongcheng; Wang, Guanyu; Li, Guanglin			How the Sequence of a Gene Specifies Structural Symmetry in Proteins	PLOS ONE			English	Article							RNA SECONDARY STRUCTURE; BETA-TREFOIL FAMILY; CODON USAGE; ESCHERICHIA-COLI; DNA-SEQUENCES; IN-VIVO; EVOLUTION; TRANSLATION; REPEATS; DUPLICATION	Internal symmetry is commonly observed in the majority of fundamental protein folds. Meanwhile, sufficient evidence suggests that nascent polypeptide chains of proteins have the potential to start the co-translational folding process and this process allows mRNA to contain additional information on protein structure. In this paper, we study the relationship between gene sequences and protein structures from the viewpoint of symmetry to explore how gene sequences code for structural symmetry in proteins. We found that, for a set of two-fold symmetric proteins from left-handed beta-helix fold, intragenic symmetry always exists in their corresponding gene sequences. Meanwhile, codon usage bias and local mRNA structure might be involved in modulating translation speed for the formation of structural symmetry: a major decrease of local codon usage bias in the middle of the codon sequence can be identified as a common feature; and major or consecutive decreases in local mRNA folding energy near the boundaries of the symmetric substructures can also be observed. The results suggest that gene duplication and fusion may be an evolutionarily conserved process for this protein fold. In addition, the usage of rare codons and the formation of higher order of secondary structure near the boundaries of symmetric substructures might have coevolved as conserved mechanisms to slow down translation elongation and to facilitate effective folding of symmetric substructures. These findings provide valuable insights into our understanding of the mechanisms of translation and its evolution, as well as the design of proteins via symmetric modules.	[Shen, Xiaojuan; Huang, Tongcheng] Shaoyang Univ, Dept Informat Engn, Shaoyang, Hunan, Peoples R China; [Shen, Xiaojuan; Li, Guanglin] Chinese Acad Sci, Shenzhen Inst Adv Technol, Key Lab Human Machine Intelligence Synergy Syst, Shenzhen, Peoples R China; [Shen, Xiaojuan; Wang, Guanyu] South Univ Sci & Technol China, Dept Biol, Shenzhen, Peoples R China	Shaoyang University; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Southern University of Science & Technology	Wang, GY (corresponding author), South Univ Sci & Technol China, Dept Biol, Shenzhen, Peoples R China.	wanggy@sustc.edu.cn; gl.li@siat.ac.cn		Li, Guanglin/0000-0001-9016-2617	National Natural Science Foundation of China [61135004, 61471186]; Hunan Provincial Natural Science Foundation of China [14JJ7075]; key Scientific Research fund of Hunan Provincial Education Department [13A091]; key Scientific Research fund of Provincial Key Laboratory of Informational Service for Rural Area of Southwestern Hunan; Aid program for Science and Technology Innovative Research Team in Higher Educational Institutions of Hunan Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province); key Scientific Research fund of Hunan Provincial Education Department(Hunan Provincial Education Department); key Scientific Research fund of Provincial Key Laboratory of Informational Service for Rural Area of Southwestern Hunan; Aid program for Science and Technology Innovative Research Team in Higher Educational Institutions of Hunan Province	GLL received funding from the National Natural Science Foundation of China (61135004): http://www.nsfc.gov.cn/. He conceived and designed the experiments, and contributed to the writing of the manuscript. GYW received funding from the National Natural Science Foundation of China (61471186): http://www.nsfc.gov.cn/. He conceived and designed the experiments, and contributed to the writing of the manuscript. TCH received funding from the Hunan Provincial Natural Science Foundation of China (14JJ7075): http://www.hnst.gov.cn/zxgz/zkjj/. He contributed to the writing of the manuscript. TCH received funding from the key Scientific Research fund of Hunan Provincial Education Department (13A091): http://gov.hnedu.cn/zwgk.jsp. TCH received funding from the key Scientific Research fund of Provincial Key Laboratory of Informational Service for Rural Area of Southwestern Hunan: http://www.hnst.gov.cn/zxgz/zkjj/. He contributed to the writing of the manuscript. TCH received funding from the Aid program for Science and Technology Innovative Research Team in Higher Educational Institutions of Hunan Province: http: http://gov.hnedu.cn/zwgk.jsp. He contributed to the writing of the manuscript.	Abraham AL, 2008, BIOINFORMATICS, V24, P1536, DOI 10.1093/bioinformatics/btn234; Achaz G, 2007, BIOINFORMATICS, V23, P119, DOI 10.1093/bioinformatics/btl519; Andrade MA, 2001, J STRUCT BIOL, V134, P117, DOI 10.1006/jsbi.2001.4392; Apic G, 2001, J MOL BIOL, V310, P311, DOI 10.1006/jmbi.2001.4776; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Blaber M, 2012, CURRENT OPINION STRU; Blaber M, 2012, CELLULAR MOL LIFE SC, P1; Broom A, 2012, STRUCTURE, V20, P161, DOI 10.1016/j.str.2011.10.021; Cannarrozzi G, 2010, CELL, V141, P355, DOI 10.1016/j.cell.2010.02.036; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; CROMBIE T, 1992, J MOL BIOL, V228, P7, DOI 10.1016/0022-2836(92)90486-4; De Winter R, 1995, CELL BIOL, V15, P3023; ECKMANN JP, 1987, EUROPHYS LETT, V4, P973, DOI 10.1209/0295-5075/4/9/004; Forrest L, 2015, ANN REV BIOPHYSICS, V44; Fredrick K, 2010, CELL, V141, P227, DOI 10.1016/j.cell.2010.03.033; Gershenson A, 2011, CURR OPIN STRUC BIOL, V21, P32, DOI 10.1016/j.sbi.2010.11.001; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Gu WJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000664; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Heger A, 2000, PROTEINS, V41, P224, DOI 10.1002/1097-0134(20001101)41:2<224::AID-PROT70>3.0.CO;2-Z; Henn-Sax M, 2001, BIOL CHEM, V382, P1315, DOI 10.1515/BC.2001.163; Huang YZ, 2007, PROTEINS, V68, P267, DOI 10.1002/prot.21330; Iengar P, 2006, STRUCTURE, V14, P529, DOI 10.1016/j.str.2005.11.021; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Ji HF, 2010, TRENDS BIOCHEM SCI, V35, P129, DOI 10.1016/j.tibs.2009.12.002; Ji XF, 2007, COMPUT BIOL CHEM, V31, P61, DOI 10.1016/j.compbiolchem.2007.01.002; Katz L, 2003, GENOME RES, V13, P2042, DOI 10.1101/gr.1257503; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Komar AA, 2009, TRENDS BIOCHEM SCI, V34, P16, DOI 10.1016/j.tibs.2008.10.002; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Lang D, 2000, SCIENCE, V289, P1546, DOI 10.1126/science.289.5484.1546; Li MF, 2005, CHAOS SOLITON FRACT, V25, P491, DOI 10.1016/j.chaos.2004.11.049; Marsh JA, 2015, ANNU REV BIOCHEM, V84, P551, DOI 10.1146/annurev-biochem-060614-034142; MCLACHLAN AD, 1977, NATURE, V267, P465, DOI 10.1038/267465a0; MCLACHLAN AD, 1972, J MOL BIOL, V64, P417, DOI 10.1016/0022-2836(72)90508-6; MEDIGUE C, 1991, J MOL BIOL, V222, P851, DOI 10.1016/0022-2836(91)90575-Q; MEDIGUE C, 1991, MOL MICROBIOL, V5, P2629, DOI 10.1111/j.1365-2958.1991.tb01972.x; Mount D. W., 2004, BIOINFORMATICS, V2; Parisi G, 2000, MOL PHYLOGENET EVOL, V14, P323, DOI 10.1006/mpev.1999.0734; Pechmann S, 2014, NAT STRUCT MOL BIOL, V21, P1100, DOI 10.1038/nsmb.2919; Salem GM, 1999, J MOL BIOL, V287, P969, DOI 10.1006/jmbi.1999.2642; SHARP PM, 1986, NUCLEIC ACIDS RES, V14, P5125, DOI 10.1093/nar/14.13.5125; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Shen XJ, 2011, J THEOR BIOL, V285, P77, DOI 10.1016/j.jtbi.2011.06.011; SWEET RM, 1983, J MOL BIOL, V171, P479, DOI 10.1016/0022-2836(83)90041-4; Szklarczyk R, 2004, BIOINFORMATICS, V20, P311, DOI 10.1093/bioinformatics/bth911; Taylor WR, 2002, PROTEIN ENG, V15, P79, DOI 10.1093/protein/15.2.79; Thanaraj TA, 1996, PROTEIN SCI, V5, P1594, DOI 10.1002/pro.5560050814; Tsai CJ, 2008, J MOL BIOL, V383, P281, DOI 10.1016/j.jmb.2008.08.012; Tuller T, 2015, NUCLEIC ACIDS RES, V43, P13, DOI 10.1093/nar/gku1313; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; VARENNE S, 1984, J MOL BIOL, V180, P549, DOI 10.1016/0022-2836(84)90027-5; Venkatakrishnan AJ, 2010, BIOCHEM SOC T, V38, P879, DOI 10.1042/BST0380879; Vogel C, 2006, BIOESSAYS, V28, P973, DOI 10.1002/bies.20474; Wang XC, 2008, J MOL GRAPH MODEL, V26, P829, DOI 10.1016/j.jmgm.2007.04.014; Wolynes PG, 1996, P NATL ACAD SCI USA, V93, P14249, DOI 10.1073/pnas.93.25.14249; Xu RZ, 2005, COMPUT BIOL CHEM, V29, P79, DOI 10.1016/j.compbiolchem.2004.12.003; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang G, 2009, NAT STRUCT MOL BIOL, V16, P274, DOI 10.1038/nsmb.1554; Zhou M, 2013, NATURE, V495, P111, DOI 10.1038/nature11833	62	3	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144473	10.1371/journal.pone.0144473	http://dx.doi.org/10.1371/journal.pone.0144473			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641668	Green Published, gold, Green Submitted			2022-12-27	WOS:000366902700132
J	Slunge, D				Slunge, Daniel			The Willingness to Pay for Vaccination against Tick-Borne Encephalitis and Implications for Public Health Policy: Evidence from Sweden	PLOS ONE			English	Article							CONTINGENT VALUATION; FOLLOW-UP; DEMAND	The increasing incidence of tick-borne encephalitis (TBE) in Sweden and several other European countries has sparked a discussion about the need for a public vaccination strategy. However, TBE vaccination coverage is incomplete and there is little knowledge about the factors influencing vaccination behavior. Based on a survey of 1,500 randomly selected respondents in Sweden, we estimate vaccination coverage in areas with different TBE risk levels and analyze the role of vaccine price and other factors influencing the demand for vaccination. First, we find that the average rate of TBE vaccination in Sweden is 33% in TBE risk areas and 18% elsewhere. Income, age and risk-related factors such as incidence of TBE in the area of residence, frequency of visits to areas with TBE risk, and experience with tick bites are positively associated with demand for TBE vaccine. Next, using contingent valuation methodology, we estimate the willingness to pay for TBE vaccination among the unvaccinated respondents and the effect of a possible subsidy. Among the unvaccinated respondents in TBE risk areas, we estimate the mean willingness to pay for the recommended three doses of TBE vaccine to be 465 SEK (approximately 46 euros or 40% of the current market price). We project that a subsidy making TBE vaccines free of charge could increase the vaccination rate in TBE risk areas to around 78%, with a larger effect on low-income households, whose current vaccination rate is only 15% in risk areas. However, price is not the only factor affecting demand. We find significant effects on vaccination behavior associated with trust in vaccine recommendations, perceptions about tick bite-related health risks and knowledge about ticks and tick-borne diseases. Hence, increasing knowledge and trust, as well as ease of access to vaccinations, can also be important measures for public health agencies that want to increase the vaccination rate.	[Slunge, Daniel] Univ Gothenburg, Dept Econ, Gothenburg, Sweden	University of Gothenburg	Slunge, D (corresponding author), Univ Gothenburg, Dept Econ, Gothenburg, Sweden.	daniel.slunge@economics.gu.se		Slunge, Daniel/0000-0002-6219-3376	University of Gothenburg, Centre for Environment and Sustainability; Region Vastra Gotaland	University of Gothenburg, Centre for Environment and Sustainability; Region Vastra Gotaland	Support was provided by the University of Gothenburg, Centre for Environment and Sustainability [http://gmv.gu.se/] and Region Vastra Gotaland [http://www.vgregion.se/en]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askling HH, 2015, VACCINE, V33, P4962, DOI 10.1016/j.vaccine.2015.07.030; Blomquist GC, 2009, ENVIRON RESOUR ECON, V43, P473, DOI 10.1007/s10640-008-9242-8; Carson RT, 2012, J ECON PERSPECT, V26, P27, DOI 10.1257/jep.26.4.27; Cropper ML, 2004, J DEV ECON, V75, P303, DOI 10.1016/j.jdeveco.2003.02.006; Cummings RG, 1999, AM ECON REV, V89, P649, DOI 10.1257/aer.89.3.649; Desjeux G, 2005, PHARMACOECONOMICS, V23, P913, DOI 10.2165/00019053-200523090-00004; Engman ML, 2012, PEDIATR INFECT DIS J, V31, P570, DOI 10.1097/INF.0b013e31824f23c0; European Centre for Disease Prevention and Control, 2014, ANN EP REP 2014 EM V; European Centre for Disease Prevention and Control, 2012, DALNEVOSTOCHNYJ ZH I, DOI 10.2900/62311; Finnish Institute of Public Health, 2013, REPORT TICK BORNE EN, V44, P1; Freeman A.M., 2014, MEASUREMENT ENV RESO; GROSSMAN M, 1972, J POLIT ECON, V80, P223, DOI 10.1086/259880; Haab T. C., 2002, VALUING ENV NATURAL; Haglund M, 2003, VACCINE, V21, pS11, DOI 10.1016/S0264-410X(02)00811-3; Haglund M, 1996, SCAND J INFECT DIS, V28, P217, DOI 10.3109/00365549609027160; HANEMANN WM, 1984, AM J AGR ECON, V66, P332, DOI 10.2307/1240800; Heinz FX, 2007, VACCINE, V25, P7559, DOI 10.1016/j.vaccine.2007.08.024; Heinz FX, 2013, EMERG INFECT DIS, V19, P69, DOI 10.3201/eid1901.120458; Jaenson TGT, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-8; Kosnik IG, 2013, VACCINE, V31, P732, DOI 10.1016/j.vaccine.2012.12.005; Kunz C, 2003, VACCINE, V21, pS50, DOI 10.1016/S0264-410X(02)00813-7; List JA, 2001, ENVIRON RESOUR ECON, V20, P241, DOI 10.1023/A:1012791822804; Morrison M, 2009, ENVIRON RESOUR ECON, V44, P307, DOI 10.1007/s10640-009-9287-3; Palanca-Tan R, 2008, VACCINE, V26, P914, DOI 10.1016/j.vaccine.2007.12.011; Rapola S, 2007, NATL IMMUNIZATION PR, V2007, P66, DOI [10.3402/ijch.v66i5.18310, DOI 10.3402/IJCH.V66I5.18310]; Schwarz B, 1993, Wien Med Wochenschr, V143, P551; Smit R, 2012, VACCINE, V30, P6301, DOI 10.1016/j.vaccine.2012.07.083; Streefland P, 1999, SOC SCI MED, V49, P1705, DOI 10.1016/S0277-9536(99)00239-7; Suraratdecha C, 2005, HEALTH POLICY, V73, P272, DOI [10.1016/j.healthpol.2004.11.019, 10.1016/j.healthpol.2004.05.005]; Whittington D, 2009, WORLD DEV, V37, P399, DOI 10.1016/j.worlddev.2008.04.002; Who Publication, 2011, Vaccine, V29, P8769, DOI 10.1016/j.vaccine.2011.07.024; Zavadska D, 2013, HUM VACC IMMUNOTHER, V9, P362, DOI 10.4161/hv.22766	32	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0143875	10.1371/journal.pone.0143875	http://dx.doi.org/10.1371/journal.pone.0143875			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1YS	26641491	gold, Green Published, Green Submitted			2022-12-27	WOS:000366902700032
J	White, JS; Null, SE; Tarboton, DG				White, James S.; Null, Sarah E.; Tarboton, David G.			How Do Changes to the Railroad Causeway in Utah's Great Salt Lake Affect Water and Salt Flow?	PLOS ONE			English	Article							MODEL; BIOACCUMULATION; MERCURY	Managing terminal lake elevation and salinity are emerging problems worldwide. We contribute to terminal lake management research by quantitatively assessing water and salt flow for Utah's Great Salt Lake. In 1959, Union Pacific Railroad constructed a rock-filled causeway across the Great Salt Lake, separating the lake into a north and south arm. Flow between the two arms was limited to two 4.6 meter wide rectangular culverts installed during construction, an 88 meter opening (referred to locally as a breach) installed in 1984, and the semi porous material of the causeway. A salinity gradient developed between the two arms of the lake over time because the south arm receives approximately 95% of the incoming streamflow entering Great Salt Lake. The north arm is often at, or near, salinity saturation, averaging 317 g/L since 1966, while the south is considerably less saline, averaging 142 g/L since 1966. Ecological and industrial uses of the lake are dependent on long-term salinity remaining within physiological and economic thresholds, although optimal salinity varies for the ecosystem and between diverse stakeholders. In 2013, Union Pacific Railroad closed causeway culverts amid structural safety concerns and proposed to replace them with a bridge, offering four different bridge designs. As of summer 2015, no bridge design has been decided upon. We investigated the effect that each of the proposed bridge designs would have on north and south arm Great Salt Lake elevation and salinity by updating and applying US Geological Survey's Great Salt Lake Fortran Model. Overall, we found that salinity is sensitive to bridge size and depth, with larger designs increasing salinity in the south arm and decreasing salinity in the north arm. This research illustrates that flow modifications within terminal lakes cannot be separated from lake salinity, ecology, management, and economic uses.	[White, James S.; Null, Sarah E.] Utah State Univ, Dept Watershed Sci, Logan, UT 84322 USA; [Tarboton, David G.] Utah State Univ, Dept Civil & Environm Engn, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University	White, JS (corresponding author), Utah State Univ, Dept Watershed Sci, Logan, UT 84322 USA.	whitej33@gmail.com	Ioda, Julia/P-1722-2015; Null, Sarah/E-4422-2011; Tarboton, David/G-8972-2011	Ioda, Julia/0000-0002-7320-0666; Null, Sarah/0000-0001-7451-7908; Tarboton, David/0000-0002-1998-3479; White, James/0000-0002-7255-3785	Utah Department of Natural Resource's Great Salt Lake Technical Advisory Council; Utah Division of Forestry, Fire State Lands; Office Of The Director [1208732] Funding Source: National Science Foundation	Utah Department of Natural Resource's Great Salt Lake Technical Advisory Council; Utah Division of Forestry, Fire State Lands; Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	This research was supported by a research grant from the Utah Department of Natural Resource's Great Salt Lake Technical Advisory Council. A summary of the authors' grant can be found at: http://ffsl.utah.gov/images/statelands/greatsaltlake/techteam/RFP/2014/Coversheets/Null-USU-Cover-dnd.pdf. This research was also funded by the Utah Division of Forestry, Fire & State Lands. As per grant requirements, a report to the state was submitted, and published on their website: http://ffsl.utah.gov/images/statelands/greatsaltlake/techteam/RFP/2014/FinalReports/Null_Final_Report_GSL_Causeway_Modeling_UDNR-dnd.pdf. The scope of this report is smaller than the one the authors present here, and no figure, table, or text has been reused. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded by the Utah Division of Forestry, Fire & State Lands. We thank Wayne Wurtsbaugh for providing a wealth of knowledge about the Great Salt Lake ecosystem and history. We also thank Taiye Sangoyomi and two anonymous reviewers for providing feedback to improve our paper.	Aldrich T.W., 2002, GREAT SALT LAKE OVER, P343; Arnow T., 1990, US GEOLOGICAL SURVEY, V2332, P32; Barnes BD, 2015, CAN J FISH AQUAT SCI, V72, P807, DOI 10.1139/cjfas-2014-0396; Beisner K, 2009, SCI TOTAL ENVIRON, V407, P5263, DOI 10.1016/j.scitotenv.2009.06.005; Benduhn F, 2004, J MARINE SYST, V47, P35, DOI 10.1016/j.jmarsys.2003.12.007; Bioeconomics Inc, 2012, SIGN GREAT SALT LAK; FFSL (Utah Division of Natural Resources Division of Forestry Fire & State Lands), 2013, FIN GREAT SALT LAK C; Garfin G, 2013, NCA REGION INPUT REP, P1, DOI 10.5822/978-1-61091-484-0; Hahl DC, 1964, TECHNICAL REPORT; HOLLEY ER, 1976, J HYDR ENG DIV-ASCE, V102, P969; Jones EF, 2014, LIMNOL OCEANOGR, V59, P141, DOI 10.4319/lo.2014.59.1.0141; Kebede S, 2006, J HYDROL, V316, P233, DOI 10.1016/j.jhydrol.2005.05.011; Legates DR, 1999, WATER RESOUR RES, V35, P233, DOI 10.1029/1998WR900018; Loving BL, 2000, 004221 US DEP INT US; Mohammed IN, 2012, WATER RESOUR RES, V48, DOI 10.1029/2012WR011908; Moriasi DN, 2007, T ASABE, V50, P885, DOI 10.13031/2013.23153; Nash J.E., 1970, J HYDROL, V370, P139, DOI [10.1016/0022-1694(70)90255-6, DOI 10.1016/0022-1694(70)90255-6]; Null S., 2013, FRIENDS GREAT SALT L, V19, P14; PENMAN HL, 1948, PROC R SOC LON SER-A, V193, P120, DOI 10.1098/rspa.1948.0037; POST FJ, 1977, MICROB ECOL, V3, P143, DOI 10.1007/BF02010403; Price D., 1985, 2232 US GEOL SURV; R Core Team, 2021, R LANGUAGE ENV STAT; Roberts Anthony J., 2013, Human-Wildlife Interactions, V7, P158; STEPHENS DW, 1990, HYDROBIOLOGIA, V197, P139, DOI 10.1007/BF00026946; Troin M, 2010, J HYDROL, V393, P233, DOI 10.1016/j.jhydrol.2010.08.019; Vorster P., 1985, THESIS; Waddell KM, 1973, EFFECTS RESTRICTED C; Waddell KM, 2014, BRIDGE EVALUATION RE; White JS., 2014, MODELED CHANGES GREA; Williams W. D., 1999, Lakes Reservoirs Research and Management, V4, P85, DOI 10.1046/j.1440-1770.1999.00089.x; Wold SR, 1997, US GEOLOGICAL SURVEY, P1; WURTSBAUGH WA, 1990, CAN J FISH AQUAT SCI, V47, P100, DOI 10.1139/f90-010; Wurtsbaugh WA, 2011, SCI TOTAL ENVIRON, V409, P4425, DOI 10.1016/j.scitotenv.2011.07.027	33	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144111	10.1371/journal.pone.0144111	http://dx.doi.org/10.1371/journal.pone.0144111			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641101	Green Published, Green Submitted, gold			2022-12-27	WOS:000366902700057
J	Jing, W; Zhu, H; Guo, HB; Zhang, Y; Shi, F; Han, AQ; Li, MH; Kong, L; Yu, JM				Jing, Wang; Zhu, Hui; Guo, Hongbo; Zhang, Yan; Shi, Fang; Han, Anqin; Li, Minghuan; Kong, Li; Yu, Jinming			Feasibility of Elective Nodal Irradiation (ENI) and Involved Field Irradiation (IFI) in Radiotherapy for the Elderly Patients (Aged >= 70 Years) with Esophageal Squamous Cell Cancer: A Retrospective Analysis from a Single Institute	PLOS ONE			English	Article							DEFINITIVE CHEMORADIOTHERAPY; RADIATION-THERAPY; CARCINOMA; PATTERNS; TRIAL	Purpose We conducted a retrospective analysis to assess the feasibility of involved field irradiation (IFI) in elderly patients with esophageal squamous cell cancer (ESCC). Materials and Methods We performed a retrospective review of the records of elderly patients (>= 70 years) with unresectable ESCC and no distant metastases who received treatment with radiotherapy between January 2009 and March 2013. According to the irradiation volume, patients were allocated into either the elective nodal irradiation (ENI) group or the IFI group. Overall survival (OS), progression-free survival (PFS) and treatment-related toxicities were compared between the two groups. Results A total of 137 patients were enrolled. Fifty-four patients (39.4%) were allocated to the ENI group and 83 patients (60.6%) to the IFI group, the median doses in the two groups were 60 Gy and 59.4 Gy, respectively. For the entire group, the median survival time (MST) and PFS were 16 months and 12 months, respectively. The median PFS and 3-year PFS rate in the ENI group were 13 months and 20.6%, compared to 11 months and 21.0% in the IFI groups (p = 0.61). The MST and 3-year OS rate in the ENI and IFI groups were 17 months and 26.4% and 15.5 months and 21.7%, respectively (p = 0.25). The rate of grade >= 3 acute irradiation esophagitis in the ENI group was significantly higher than that in the IFI group (18.5% vs. 6.0%; p = 0.027). Other grade >= 3 treatment-related toxicities did not significantly differ between the two groups. Conclusions IFI resulted in decreased irradiation toxicities without sacrificing OS in elderly patients with ESCC.	[Jing, Wang] Weifang Med Univ, Weifang, Shandong, Peoples R China; [Zhu, Hui; Zhang, Yan; Shi, Fang; Han, Anqin; Li, Minghuan; Kong, Li; Yu, Jinming] Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Shandong, Peoples R China; [Guo, Hongbo] Shandong Canc Hosp & Inst, Dept Thorac Surg, Jinan, Shandong, Peoples R China	Weifang Medical University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences	Kong, L (corresponding author), Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Shandong, Peoples R China.	kongli7@sina.com; sdyujinming@126.com			Natural Science Foundation of Shandong Province [ZR2011HL029]	Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This study was supported by Grant NO. ZR2011HL029 from the Natural Science Foundation of Shandong Province to Hongbo Guo.	Button MR, 2009, INT J RADIAT ONCOL, V73, P818, DOI 10.1016/j.ijrobp.2008.04.062; Cooper JS, 1999, JAMA-J AM MED ASSOC, V281, P1623, DOI 10.1001/jama.281.17.1623; Fernandes AT, 2010, RADIOTHER ONCOL, V95, P178, DOI 10.1016/j.radonc.2010.02.007; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kato K, 2013, JPN J CLIN ONCOL, V43, P608, DOI 10.1093/jjco/hyt048; Kawaguchi Y, 2011, JPN J CLIN ONCOL, V41, P1007, DOI 10.1093/jjco/hyr069; Li Xue, 2015, Asian Pac J Cancer Prev, V16, P1463; Liu MN, 2014, RADIAT ONCOL, V9, DOI 10.1186/s13014-014-0232-4; Ma JB, 2011, ONKOLOGIE, V34, P599, DOI 10.1159/000334194; Minsky BD, 2002, J CLIN ONCOL, V20, P1167, DOI 10.1200/JCO.20.5.1167; Onozawa M, 2009, RADIOTHER ONCOL, V92, P266, DOI 10.1016/j.radonc.2008.09.025; Rizk NP, 2007, J CLIN ONCOL, V25, P507, DOI 10.1200/JCO.2006.08.0101; Rochigneux P, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00100; Semrau R, 2012, STRAHLENTHER ONKOL, V188, P226, DOI 10.1007/s00066-011-0039-2; Servagi-Vernat S, 2009, DRUG AGING, V26, P255, DOI 10.2165/00002512-200926030-00006; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Smith BD, 2009, J CLIN ONCOL, V27, P2758, DOI 10.1200/JCO.2008.20.8983; Takeuchi S, 2007, AM J CLIN ONCOL-CANC, V30, P607, DOI 10.1097/COC.0b013e3180ca7c84; Tougeron D, 2008, BRIT J CANCER, V99, P1586, DOI 10.1038/sj.bjc.6604749; Uno T, 2004, ANTICANCER RES, V24, P2483; Yamashita H, 2014, RADIOTHER ONCOL, V113, P182, DOI 10.1016/j.radonc.2014.11.004; Yamashita H, 2011, RADIOTHER ONCOL, V98, P255, DOI 10.1016/j.radonc.2010.10.021; Zhang P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105270; Zhang XJ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085007, 10.1186/1748-717X-9-64]; Zhao KL, 2010, INT J RADIAT ONCOL, V76, P446, DOI 10.1016/j.ijrobp.2009.02.078	25	16	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143007	10.1371/journal.pone.0143007	http://dx.doi.org/10.1371/journal.pone.0143007			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636574	Green Submitted, Green Published, gold			2022-12-27	WOS:000366143800004
J	Devleesschauwer, B; Haagsma, JA; Angulo, FJ; Bellinger, DC; Cole, D; Dopfer, D; Fazil, A; Fevre, EM; Gibb, HJ; Hald, T; Kirk, MD; Lake, RJ; de Noordhout, CM; Mathers, CD; McDonald, SA; Pires, SM; Speybroeck, N; Thomas, MK; Torgerson, PR; Wu, F; Havelaar, AH; Praet, N				Devleesschauwer, Brecht; Haagsma, Juanita A.; Angulo, Frederick J.; Bellinger, David C.; Cole, Dana; Doepfer, Doerte; Fazil, Aamir; Fevre, Eric M.; Gibb, Herman J.; Hald, Tine; Kirk, Martyn D.; Lake, Robin J.; de Noordhout, Charline Maertens; Mathers, Colin D.; McDonald, Scott A.; Pires, Sara M.; Speybroeck, Niko; Thomas, M. Kate; Torgerson, Paul R.; Wu, Felicia; Havelaar, Arie H.; Praet, Nicolas			Methodological Framework for World Health Organization Estimates of the Global Burden of Foodborne Disease	PLOS ONE			English	Article							SYSTEMATIC ANALYSIS; DISABILITY WEIGHTS	Background The Foodborne Disease Burden Epidemiology Reference Group (FERG) was established in 2007 by the World Health Organization to estimate the global burden of foodborne diseases (FBDs). This paper describes the methodological framework developed by FERG's Computational Task Force to transform epidemiological information into FBD burden estimates. Methods and Findings The global and regional burden of 31 FBDs was quantified, along with limited estimates for 5 other FBDs, using Disability-Adjusted Life Years in a hazard-and incidence-based approach. To accomplish this task, the following workflow was defined: outline of disease models and collection of epidemiological data; design and completion of a database template; development of an imputation model; identification of disability weights; probabilistic burden assessment; and estimating the proportion of the disease burden by each hazard that is attributable to exposure by food (i.e., source attribution). All computations were performed in R and the different functions were compiled in the R package 'FERG'. Traceability and transparency were ensured by sharing results and methods in an interactive way with all FERG members throughout the process. Conclusions We developed a comprehensive framework for estimating the global burden of FBDs, in which methodological simplicity and transparency were key elements. All the tools developed have been made available and can be translated into a user-friendly national toolkit for studying and monitoring food safety at the local level.	[Devleesschauwer, Brecht] Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, Merelbeke, Belgium; [Devleesschauwer, Brecht; de Noordhout, Charline Maertens; Speybroeck, Niko] Catholic Univ Louvain, Insitute Hlth & Soc IRSS, B-1200 Brussels, Belgium; [Devleesschauwer, Brecht; Praet, Nicolas] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Devleesschauwer, Brecht; Havelaar, Arie H.] Univ Florida, Dept Anim Sci, Gainesville, FL 32611 USA; [Devleesschauwer, Brecht; Havelaar, Arie H.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Haagsma, Juanita A.] Erasmus Univ, Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [Angulo, Frederick J.; Cole, Dana] Ctr Dis Control & Prevent, Atlanta, GA USA; [Bellinger, David C.] Harvard Univ, Sch Med, Dept Neurol, Boston Childrens Hosp, Boston, MA 02115 USA; [Bellinger, David C.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Doepfer, Doerte] Univ Wisconsin, Sch Vet Med, Dept Med Sci, Madison, WI 53706 USA; [Fazil, Aamir; Thomas, M. Kate] Publ Hlth Agcy Canada, Guelph, ON, Canada; [Fevre, Eric M.] Univ Liverpool, Inst Infect & Global Hlth, Neston, England; [Fevre, Eric M.] Int Livestock Res Inst, Nairobi, Kenya; [Gibb, Herman J.] Gibb Epidemiol Consulting, Arlington, VA USA; [Hald, Tine; Pires, Sara M.] Danish Tech Univ, Natl Food Inst, Lyngby, Denmark; [Kirk, Martyn D.] Australian Natl Univ, Res Sch Populat Hlth, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Lake, Robin J.] Inst Environm Sci & Res, Christchurch, New Zealand; [Mathers, Colin D.] WHO, Dept Hlth Stat & Informat Syst, CH-1211 Geneva, Switzerland; [McDonald, Scott A.] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands; [Torgerson, Paul R.] Univ Zurich, Vetsuisse Fac, Epidemiol Sect, Zurich, Switzerland; [Wu, Felicia] Michigan State Univ, Dept Agr Food & Resource Econ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA; [Havelaar, Arie H.] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Havelaar, Arie H.] Univ Utrecht, Utrecht, Netherlands	Ghent University; Universite Catholique Louvain; Institute of Tropical Medicine (ITM); State University System of Florida; University of Florida; State University System of Florida; University of Florida; Erasmus University Rotterdam; Erasmus MC; Centers for Disease Control & Prevention - USA; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of Wisconsin System; University of Wisconsin Madison; Public Health Agency of Canada; University of Liverpool; CGIAR; International Livestock Research Institute (ILRI); Technical University of Denmark; Australian National University; Institute of Environmental Science & Research (ESR) - New Zealand; World Health Organization; Netherlands National Institute for Public Health & the Environment; University of Zurich; Michigan State University; Netherlands National Institute for Public Health & the Environment; Utrecht University	Devleesschauwer, B (corresponding author), Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, Merelbeke, Belgium.	brechtdv@gmail.com	Havelaar, Arie H./P-8495-2014; Torgerson, Paul R/M-4447-2013; Pires, Sara/M-2506-2019; Hald, Tine/B-5477-2016; Devleesschauwer, Brecht/G-9895-2018; Torgerson, Paul R/A-7510-2010	Havelaar, Arie H./0000-0002-6456-5460; Torgerson, Paul R/0000-0003-4277-9983; Pires, Sara/0000-0002-7751-1509; Hald, Tine/0000-0002-1115-9792; Devleesschauwer, Brecht/0000-0002-2867-6892; Torgerson, Paul R/0000-0003-4277-9983; Kirk, Martyn/0000-0001-5432-5984; Fevre, Eric/0000-0001-8931-4986; Mathers, Colin/0000-0002-0617-6731; Speybroeck, Niko/0000-0003-3322-3502	World Health Organization (WHO); Gibb Epidemiology Consulting, LLC; European Centre for Disease Control and Prevention (Solna, Sweden); Medical Research Council [G1100783] Funding Source: researchfish; MRC [G1100783] Funding Source: UKRI	World Health Organization (WHO)(World Health Organization); Gibb Epidemiology Consulting, LLC; European Centre for Disease Control and Prevention (Solna, Sweden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was commissioned and paid for by the World Health Organization (WHO). Copyright in the original work on which this article is based belongs to WHO. The authors have been given permission to publish this article. Gibb Epidemiology Consulting, LLC, provided support in the form of salaries for author [HJG], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.; We would like to acknowledge the assistance of the WHO Secretariat over the life of the FERG initiative, particularly Claudia Stein, Tanja Kuchenmuller, Amy Cawthorne, Yuki Minato, Tim Corrigan, Kurt Straif (IARC), Philippe Verger, Arve Lee Willingham and Danilo Lo Fo Wong. We acknowledge the Institute for Health Metrics and Evaluation (Seattle, WA, USA) for providing data on the global burden of selected diseases. The European Centre for Disease Control and Prevention (Solna, Sweden) supported the work by providing their outcome trees and sponsoring a study on disability weights. The findings and conclusions of this report are those of the authors and do not necessarily represent the official views, decisions or policies of the World Health Organization, US Centers for Disease Control and Prevention, the US Government or other institutions listed. FJA and DC are employees of the US Government. This work was part of their official duties.	[Anonymous], 2010, WHO IN EST GLOB BURD; [Anonymous], 2011, WHO IN EST GLOB BURD; [Anonymous], 2013, 5 FORM M FOOD BORN D; Bhaskaran K, 2014, INT J EPIDEMIOL, V43, P1336, DOI 10.1093/ije/dyu080; Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711; de Noordhout CM, 2014, LANCET INFECT DIS, V14, P1073, DOI 10.1016/S1473-3099(14)70870-9; Devleesschauwer B, 2015, INT J PARASITOL, V45, P95, DOI 10.1016/j.ijpara.2014.05.006; Devleesschauwer B, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1196; Devleesschauwer B, 2014, INT J PUBLIC HEALTH, V59, P565, DOI 10.1007/s00038-014-0552-z; Devleesschauwer B, 2014, INT J PUBLIC HEALTH, V59, P571, DOI 10.1007/s00038-014-0553-y; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; Gibb HJ, 2010, WHO ESTIMATES UNPUB; Haagsma JA, 2010, EPIDEMIOL INFECT, V138, P1650, DOI 10.1017/S0950268810000531; Haagsma JA, 2014, POPUL HEALTH METR, V12, DOI 10.1186/s12963-014-0020-2; Haagsma JA, 2013, INT J FOOD MICROBIOL, V166, P34, DOI 10.1016/j.ijfoodmicro.2013.05.029; Hald T, ESTIMATES RELA UNPUB; Havelaar AH, 2010, WHO ESTIMATES UNPUB; Havelaar AH, 2012, INT J FOOD MICROBIOL, V156, P231, DOI 10.1016/j.ijfoodmicro.2012.03.029; Kirk MD, 2010, WHO ESTIMAT IN PRESS; Knopp S, 2012, INFECT DIS CLIN N AM, V26, P341, DOI 10.1016/j.idc.2012.02.006; Kretzschmar M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001205; Kuchenmuller T, 2009, EUROSURVEILLANCE, V14, P19; Kuchenmulller T, 2013, REV SCI TECH OIE, V32, P459; Lanata CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072788; Mangen MJJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079740; McDonald SA, 2015, B WORLD HEALTH ORGAN, V93, P228, DOI 10.2471/BLT.14.139972; Murray CJL, 2007, LANCET, V369, P862, DOI 10.1016/S0140-6736(07)60415-2; Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Murray CJL, 2000, B WORLD HEALTH ORGAN, V78, P981; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; Pires SM, AETIOLOGY SPEC UNPUB; Plummer M., 2003, JAGS PROGRAM ANAL BA, DOI DOI 10.1.1.13.3406; Plummer M, 2014, R PACKAGE VERSION 3; Polinder S, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-21; Pruss-Ustun A., 2003, WHO ENV BURDEN DIS S; R Core Team, 2013, R LANG ENV STAT COMP; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; Salomon JA, 2015, LANCET GLOB HEALTH, V3, pE712, DOI 10.1016/S2214-109X(15)00069-8; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Schroeder SA, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-19; Torgerson P, 2010, WHO ESTIMAT IN PRESS; United Nations Population Division, 2013, WORLD POP PROSP 2012; Viergever RF, 2010, HEALTH RES POLICY SY, V8, DOI 10.1186/1478-4505-8-36; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wang HD, 2014, LANCET, V384, P957, DOI 10.1016/S0140-6736(14)60497-9; World Health Organization, 2017, WHO METHODS DATA SOU; World Health Organization, 2014, WHOHTMTB201311	49	66	67	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0142498	10.1371/journal.pone.0142498	http://dx.doi.org/10.1371/journal.pone.0142498			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633883	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000366040000006
J	Liu, YP; Xu, HQ; Li, M; Yang, X; Yu, S; Fu, WL; Huang, Q				Liu, Yue-Ping; Xu, Han-Qing; Li, Ming; Yang, Xiang; Yu, Shu; Fu, Wei-Ling; Huang, Qing			Association between Thiopurine S-Methyltransferase Polymorphisms and Azathioprine-Induced Adverse Drug Reactions in Patients with Autoimmune Diseases: A Meta-Analysis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; SYSTEMIC-LUPUS-ERYTHEMATOSUS; IMPLEMENTATION CONSORTIUM GUIDELINES; ETHNIC-DIFFERENCES; JAPANESE PATIENTS; PHARMACOGENETICS; GENOTYPE; TPMT; TOXICITY; PHENOTYPE	Purpose Azathioprine (AZA) is widely used as an immunosuppressive drug in autoimmune diseases, but its use is limited by significant adverse drug reactions (ADRs). Thiopurine S-methyltransferase (TPMT) is an important enzyme involved in AZA metabolism. Several clinical guidelines recommend determining TPMT genotype or phenotype before initiating AZA therapy. Although several studies have investigated the association between TPMT polymorphisms and AZA-induced ADRs, the results are inconsistent. The purpose of this study is to evaluate whether there is an association between TPMT polymorphisms and AZA-induced ADRs using meta-analysis. Methods We explored PubMed, Web of Science and Embase for articles on TPMT polymorphisms and AZA-induced ADRs. Studies that compared TPMT polymorphisms with-ADRs and with-out-ADRs in patients with autoimmune diseases were included. Relevant outcome data from all the included articles were extracted and the pooled odds ratios (ORs) with corresponding 95% confidence intervals (CIs) were calculated using Revman 5.3 software. Results Eleven published studies, with a total of 651 patients with autoimmune diseases, investigated associations between TPMT polymorphisms and AZA-induced ADRs, were included in this meta-analysis. Our meta-analysis demonstrated that TPMT polymorphisms were significantly associated with AZA-induced overall ADRs, bone marrow toxicity and gastric intolerance; pooled ORs were 3.12 (1.48-6.56), 3.76 (1.97-7.17) and 6.43 (2.04-20.25), respectively. TPMT polymorphisms were not associated with the development of hepatotoxicity; the corresponding pooled OR was 2.86 (95% CI: 0.32-25.86). However, the association in GI subset could be driven by one single study. After this study was excluded, the OR was 2.11 (95% CI: 0.36-12.42); namely, the association became negative. Conclusions Our meta-analysis demonstrated an association of TPMT polymorphisms with overall AZA-induced ADRs, bone marrow toxicity and gastric intolerance, but not with hepatotoxicity. The presence of the normal TPMT genotypes cannot preclude the development of ADRs during AZA treatment, TPMT genotyping prior to commencing AZA therapy cannot replace, may augment, the current practice of regular monitoring of the white blood cell. Because of small sample sizes, large and extensive exploration was required to validate our findings.	[Liu, Yue-Ping; Xu, Han-Qing; Yang, Xiang; Yu, Shu; Fu, Wei-Ling; Huang, Qing] Third Mil Med Univ, Southwest Hosp, Dept Lab Med, Chongqing, Peoples R China; [Liu, Yue-Ping; Li, Ming] 477th Hosp PLA, Dept Lab Med, Xiangyang City, Hubei Province, Peoples R China	Army Medical University	Fu, WL (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Lab Med, Chongqing, Peoples R China.	weiling_fu@163.com; Dr.Q.Huang@gmail.com	fu, weiling/AAX-3286-2021; Yang, Xiang/ADF-3825-2022; Huang, Qing/E-1872-2017	fu, weiling/0000-0002-5768-6563; Huang, Qing/0000-0002-0140-8978	National Natural Science Foundation of China [31370853]; Transformation Foundation on Scientific and Technological Achievements of The Third Military Medical University [2012XZH03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Transformation Foundation on Scientific and Technological Achievements of The Third Military Medical University	This work was supported by grants from National Natural Science Foundation of China (General Program, No. 31370853), and the Transformation Foundation on Scientific and Technological Achievements of The Third Military Medical University (2012XZH03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from National Natural Science Foundation of China(General Program, No. 31370853); the Transformation Foundation on Scientific and Technological Achievements of The Third Military Medical University (2012XZH03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstey AV, 2004, BRIT J DERMATOL, V151, P1123, DOI 10.1111/j.1365-2133.2004.06323.x; Appell ML, 2013, PHARMACOGENET GENOM, V23, P242, DOI 10.1097/FPC.0b013e32835f1cc0; Bezier M, 2008, EUR J DERMATOL, V18, P512, DOI 10.1684/ejd.2008.0473; Booth RA, 2011, ANN INTERN MED, V154, P814, DOI 10.7326/0003-4819-154-12-201106210-00009; Chen DY, 2014, CLIN RHEUMATOL, V33, P499, DOI 10.1007/s10067-013-2441-x; Collie-Duguid ESR, 1999, PHARMACOGENETICS, V9, P37, DOI 10.1097/00008571-199902000-00006; Corominas H, 2003, RHEUMATOLOGY, V42, P40, DOI 10.1093/rheumatology/keg028; Das Pranab K, 2011, Immunotherapy, V3, P147, DOI 10.2217/imt.10.102; de Jong DJ, 2003, SCAND J GASTROENTERO, V38, P69, DOI 10.1080/00855920310002726; Dong XW, 2010, WORLD J GASTROENTERO, V16, P3187, DOI 10.3748/wjg.v16.i25.3187; Egan LJ, 2006, CLIN GASTROENTEROL H, V4, P21, DOI 10.1016/j.cgh.2005.10.003; Engen RM, 2006, CURR DRUG TARGETS, V7, P1641, DOI 10.2174/138945006779025446; Gisbert JP, 2008, AM J GASTROENTEROL, V103, P1783, DOI 10.1111/j.1572-0241.2008.01848.x; Goding JW, 2001, NEW ENGL J MED, V345, P1707; Heap GA, 2014, NAT GENET, V46, P1131, DOI 10.1038/ng.3093; Heneghan MA, 2006, J HEPATOL, V45, P584, DOI 10.1016/j.jhep.2006.05.011; Higgs JE, 2010, PHARMACOGENOMICS, V11, P177, DOI 10.2217/PGS.09.155; Ishioka S, 1999, INTERNAL MED, V38, P944, DOI 10.2169/internalmedicine.38.944; Jun JB, 2005, CLIN EXP RHEUMATOL, V23, P873; Langley PG, 2002, J HEPATOL, V37, P441, DOI 10.1016/S0168-8278(02)00214-3; LENNARD L, 1992, EUR J CLIN PHARMACOL, V43, P329, DOI 10.1007/BF02220605; Lennard L, 2002, GUT, V51, P143, DOI 10.1136/gut.51.2.143; Lennard L, 2014, BRIT J CLIN PHARMACO, V77, P704, DOI 10.1111/bcp.12226; Lennard L, 2013, BRIT J CLIN PHARMACO, V76, P125, DOI 10.1111/bcp.12066; Liu YP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121745; McLeod HL, 1999, PHARMACOGENETICS, V9, P773, DOI 10.1097/01213011-199912000-00012; Naughton MA, 1999, RHEUMATOLOGY, V38, P640, DOI 10.1093/rheumatology/38.7.640; Okada Y, 2005, BIOL PHARM BULL, V28, P2117, DOI 10.1248/bpb.28.2117; Otterness D, 1997, CLIN PHARMACOL THER, V62, P60, DOI 10.1016/S0009-9236(97)90152-1; Relling MV, 2013, CLIN PHARMACOL THER, V93, P324, DOI 10.1038/clpt.2013.4; Relling MV, 2011, CLIN PHARMACOL THER, V89, P387, DOI 10.1038/clpt.2010.320; SINHA AA, 1990, SCIENCE, V248, P1380, DOI 10.1126/science.1972595; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Tamori A, 2007, LIVER INT, V27, P95, DOI 10.1111/j.1478-3231.2006.01392.x; Tani C, 2009, CLIN EXP RHEUMATOL, V27, P321; Van Dieren JM, 2007, ALIMENT PHARM THERAP, V26, P643, DOI 10.1111/j.1365-2036.2007.03412.x; Wang LW, 2010, PHARMACOGENET GENOM, V20, P401, DOI 10.1097/FPC.0b013e3283352860; WEINSHILBOUM RM, 1980, AM J HUM GENET, V32, P651; Zabala W, 2013, PHARMACOGENOMICS, V14, P631, DOI [10.2217/PGS.13.38, 10.2217/pgs.13.38]; Zabala-Fernandez W, 2011, J GASTROINTEST LIVER, V20, P247	40	28	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144234	10.1371/journal.pone.0144234	http://dx.doi.org/10.1371/journal.pone.0144234			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633017	Green Published, gold, Green Submitted			2022-12-27	WOS:000366040000071
J	Zheng, JY; Liu, Y; Hao, ZX				Zheng, Jingyun; Liu, Yang; Hao, Zhixin			Annual Temperature Reconstruction by Signal Decomposition and Synthesis from Multi-Proxies in Xinjiang, China, from 1850 to 2001	PLOS ONE			English	Article							SURFACE AIR-TEMPERATURE	We reconstructed the annual temperature anomaly series in Xinjiang during 1850-2001 based on three kinds of proxies, including 17 tree-ring width chronologies, one tree-ring delta C-13 series and two delta O-18 series of ice cores, and instrumental observation data. The low- and high-frequency signal decomposition for the raw temperature proxy data was obtained by a fast Fourier transform filter with a window size of 20 years, which was used to build a good relationship that explained the high variance between the temperature and the proxy data used for the reconstruction. The results showed that for 1850-2001, the temperature during most periods prior to the 1920s was lower than the mean temperature in the 20th century. Remarkable warming occurred in the 20th century at a rate of 0.85 degrees C/100a, which was higher than that during the past 150 years. Two cold periods occurred before the 1870s and around the 1910s, and a relatively warm interval occurred around the 1940s. In addition, the temperature series showed a warming hiatus of approximately 20 years around the 1970s, and a rapid increase since the 1980s.	[Zheng, Jingyun; Liu, Yang; Hao, Zhixin] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Land Surface Pattern & Simulat, Beijing 100101, Peoples R China; [Liu, Yang] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Hao, ZX (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Land Surface Pattern & Simulat, Beijing 100101, Peoples R China.	haozx@igsnrr.ac.cn	Zheng, Jingyun/M-5789-2015	LIU, Yang/0000-0001-9683-9123	Strategic Priority Research Program of the Chinese Academy of Sciences [XDA05090104, KJZD-EW-TZ-G10]; National Natural Science Foundation of China [41430528]; Basic Research Project of the Ministry of Science and Technology [2011FY120300]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Research Project of the Ministry of Science and Technology	Funding provided by XDA05090104, KJZD-EW-TZ-G10, the Strategic Priority Research Program of the Chinese Academy of Sciences, http://www.cas.cn/; 41430528, National Natural Science Foundation of China, http://www.nsfc.gov.cn/; 2011FY120300, Basic Research Project of the Ministry of Science and Technology, http://www.most.cn/.	[Anonymous], 2011, 2 CHIN NAT ASS REP C, P79; Cao LJ, 2013, J GEOPHYS RES-ATMOS, V118, P8197, DOI 10.1002/jgrd.50615; [陈峰 CHEN Feng], 2009, [中国沙漠, Journal of Desert Research], V29, P162; Chen J, 2009, CHINESE SCI BULL, V54, P2300, DOI 10.1007/s11434-009-0051-4; CHEN JY, 1989, SCI CHINA SER B, V32, P1487; Cook ER, 2013, CLIM DYNAM, V41, P2957, DOI 10.1007/s00382-012-1611-x; Draper NR., 1998, APPL REGRESSION ANAL, DOI [10.1002/9781118625590, DOI 10.1002/9781118625590]; [段建平 DUAN Jianping], 2009, [地理科学进展, Progress in Geography], V28, P231; Esper J, 2002, SCIENCE, V295, P2250, DOI 10.1126/science.1066208; [范敏杰 FAN Minjie], 2008, [干旱区研究, Arid Zone Research], V25, P75, DOI 10.3724/SP.J.1148.2008.00075; [郭允允 Guo Yunyun], 2007, [第四纪研究, Quaternary Sciences], V27, P322; Hansen J, 2010, REV GEOPHYS, V48, DOI 10.1029/2010RG000345; [胡义成 Hu Yicheng], 2012, [中国沙漠, Journal of Desert Research], V32, P1003; Jiayinaguli W, 2013, PLATEAU MOUNTAIN MET, V33, P48; Jones PD, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017139; Jones PD, 1999, REV GEOPHYS, V37, P173, DOI 10.1029/1999RG900002; Lawrence JF, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB007836; Li QX, 2010, CHINESE SCI BULL, V55, P1974, DOI 10.1007/s11434-010-3209-1; Lin X. C., 1995, SCI ATMOS SIN, V19, P525, DOI DOI 10.3878/J.ISSN.1006-9895.1995.05.02.(IN; McCarroll D, 2004, QUATERNARY SCI REV, V23, P771, DOI 10.1016/j.quascirev.2003.06.017; Michaelsen J., 1981, J CLIM APPL METEOROL, V26, P1589; Moberg A, 2005, NATURE, V433, P613, DOI 10.1038/nature03265; PAGES, 2009, 57 IGBP SECR; [潘娅婷 PAN Yating], 2007, [中国沙漠, Journal of Desert Research], V27, P159; Rohde R., 2013, GEOINFOR GEOSTAT OVE, V1, P1, DOI [10.4172/2327-4581.1000101, 10.4172/gigs.1000101]; Shang HM, 2013, DESERT OASIS METEORO, V7, P7; [尚华明 Shang Huaming], 2010, [干旱区资源与环境, Journal of Arid Land Resources and Environment], V24, P116; Shi F, 2015, CLIMATIC CHANGE, V131, P663, DOI 10.1007/s10584-015-1413-3; Shi F, 2012, SCI CHINA EARTH SCI, V55, P2058, DOI 10.1007/s11430-012-4374-7; Tang G. L., 1992, METEOROL MONOGR, V18, P3; Tang G. L, 2005, ENVIRON RES, V10, P791, DOI DOI 10.3969/J.ISSN.1006-9585.2005.04.010.(IN; [唐国利 Tang Guoli], 2009, [气候变化研究进展, Advances in Climate Change Research], V5, P71; Tao S., 1991, ORNLCDIAC47; Wang CY, 1990, BIMONTHLY XINJIANG M, V13, P19; Wang CY, 1996, ARID LAND GEOGRAPHY, V19, P37; Wang NL, 1997, J GLACIOL GEOCRYOL, V19, P17; Wang SW, 1998, Q J APPL METEOROLOGY, V9, P9; Wu ZH, 2009, ADV DATA SCI ADAPT, V1, P1, DOI 10.1142/S1793536909000047; Xu YF, 2009, ADV ATMOS SCI, V26, P265, DOI 10.1007/s00376-009-0265-z; Yan HM, 2004, CHINESE ASTRON ASTR, V28, P120, DOI 10.1016/j.chinastron.2004.01.014; Yang B, 2011, THEOR APPL CLIMATOL, V106, P489, DOI 10.1007/s00704-011-0451-7; Yao TD, 1996, SCI CHINA SER D, V39, P587; [喻树龙 YU Shulong], 2007, [冰川冻土, Journal of Glaciology and Geocryology], V29, P374; Yuan YJ, 1999, J GLACIOLOGY GEOCRYO, V21, P64; [张同文 Zhang Tongwen], 2011, [第四纪研究, Quaternary Sciences], V31, P1011; Zhang Xian-gong, 1982, Acta Meteorologica Sinica, V40, P198; Zhang Z.H., 1998, ACTA METEOROL SIN, V56, P77, DOI [10.11676/qxxb1998.007, DOI 10.11676/QXXB1998.007]; Zhao HB, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD015735	48	5	5	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144210	10.1371/journal.pone.0144210	http://dx.doi.org/10.1371/journal.pone.0144210			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26632814	Green Published, gold, Green Submitted			2022-12-27	WOS:000366040000070
J	Hernandez, JA; Hernandez-Sanchez, M; Rodriguez-Vicente, AE; Grossmann, V; Collado, R; Heras, C; Puiggros, A; Martin, AA; Puig, N; Benito, R; Robledo, C; Delgado, J; Gonzalez, T; Queizan, JA; Galende, J; de la Fuente, I; Martin-Nunez, G; Alonso, JM; Abrisqueta, P; Luno, E; Marugan, I; Gonzalez-Gason, I; Bosch, F; Kohlmann, A; Gonzalez, M; Espinet, B; Hernandez-Rivas, JM				Angel Hernandez, Jose; Hernandez-Sanchez, Maria; Eugenia Rodriguez-Vicente, Ana; Grossmann, Vera; Collado, Rosa; Heras, Cecilia; Puiggros, Anna; Africa Martin, Ana; Puig, Noemi; Benito, Rocio; Robledo, Cristina; Delgado, Julio; Gonzalez, Teresa; Antonio Queizan, Jose; Galende, Josefina; de la Fuente, Ignacio; Martin-Nunez, Guillermo; Maria Alonso, Jose; Abrisqueta, Pau; Luno, Elisa; Marugan, Isabel; Gonzalez-Gason, Isabel; Bosch, Francesc; Kohlmann, Alexander; Gonzalez, Marcos; Espinet, Blanca; Maria Hernandez-Rivas, Jesus		Grp Cooperativo Espanol; GELLC	A Low Frequency of Losses in 11q Chromosome Is Associated with Better Outcome and Lower Rate of Genomic Mutations in Patients with Chronic Lymphocytic Leukemia	PLOS ONE			English	Article							LRF CLL4 TRIAL; IN-SITU HYBRIDIZATION; SF3B1 MUTATIONS; ATM MUTATIONS; PROGNOSTIC-SIGNIFICANCE; INDEPENDENT PREDICTOR; TP53 MUTATIONS; DELETION; SURVIVAL; NOTCH1	To analyze the impact of the 11q deleted (11q-) cells in CLL patients on the time to first therapy (TFT) and overall survival (OS), 2,493 patients with CLL were studied. 242 patients (9.7%) had 11q-. Fluorescence in situ hybridization (FISH) studies showed a threshold of 40% of deleted cells to be optimal for showing that clinical differences in terms of TFT and OS within 11q-CLLs. In patients with >= 40% of losses in 11q (11q-H) (74%), the median TFT was 19 months compared with 44 months in CLL patients with <40% del(11q) (11q-L) (P<0.0001). In the multivariate analysis, only the presence of 11q-L, mutated IGHV status, early Binet stage and absence of extended lymphadenopathy were associated with longer TFT. Patients with 11q-H had an OS of 90 months, while in the 11q-L group the OS was not reached (P = 0.008). The absence of splenomegaly (P = 0.02), low LDH (P = 0.018) or beta 2M (P = 0.006), and the presence of 11q-L (P = 0.003) were associated with a longer OS. In addition, to detect the presence of mutations in the ATM, TP53, NOTCH1, SF3B1, MYD88, FBXW7, XPO1 and BIRC3 genes, a select cohort of CLL patients with losses in 11q was sequenced by next-generation sequencing of amplicons. Eighty % of CLLs with 11q-showed mutations and fewer patients with low frequencies of 11q-had mutations among genes examined (50% vs 94.1%, P = 0.023). In summary, CLL patients with <40% of 11q-had a long TFT and OS that could be associated with the presence of fewer mutated genes.	[Angel Hernandez, Jose; Heras, Cecilia; Gonzalez-Gason, Isabel] Univ Complutense Madrid, Dept Hematol, Hosp Univ Infanta Leonor, Madrid, Spain; [Hernandez-Sanchez, Maria; Eugenia Rodriguez-Vicente, Ana; Benito, Rocio; Robledo, Cristina; Gonzalez, Marcos; Maria Hernandez-Rivas, Jesus] Univ Salamanca, Hosp Univ Salamanca, CSIC, IBSAL,IBMCC,Ctr Invest Canc, E-37008 Salamanca, Spain; [Grossmann, Vera; Kohlmann, Alexander] MLL Munich, Munich, Germany; [Collado, Rosa] Gen Hosp, Dept Hematol, Valencia, Spain; [Puiggros, Anna] Hosp del Mar, Dept Pathol, Barcelona, Spain; [Africa Martin, Ana; Puig, Noemi; Gonzalez, Marcos; Maria Hernandez-Rivas, Jesus] Univ Hosp, Dept Hematol, Salamanca, Spain; [Delgado, Julio] Hosp Clin Barcelona, Dept Hematol, Barcelona, Spain; [Gonzalez, Teresa] Fdn Publ Galega Med Xenom, Santiago De Compostela, Spain; [Antonio Queizan, Jose] Gen Hosp, Dept Hematol, Segovia, Spain; [Galende, Josefina] Hosp Bierzo, Dept Hematol, Leon, Spain; [de la Fuente, Ignacio] Hosp Univ Rio Hortega, Dept Hematol, Valladolid, Spain; [Martin-Nunez, Guillermo] Hosp Virgen del Puerto, Dept Hematol, Plasencia, Caceres, Spain; [Maria Alonso, Jose] Hosp Rio Carrion, Dept Hematol, Palencia, Spain; [Abrisqueta, Pau; Bosch, Francesc] Hosp Valle De Hebron, Dept Hematol, Barcelona, Spain; [Luno, Elisa] Univ Oviedo, Hosp Cent Asturias, Dept Hematol, E-33080 Oviedo, Spain; [Marugan, Isabel] Hosp Clin, Dept Hematol, Valencia, Spain; [Kohlmann, Alexander] AstraZeneca, Personalized Healthcare & Biomarkers, Innovat Med, Macclesfield, Cheshire, England	Complutense University of Madrid; Hospital Universitario Infanta Leonor; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; MLL Munich Leukemia Laboratory; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; University of Barcelona; Hospital Clinic de Barcelona; Hospital del Rio Hortega; Hospital Universitari Vall d'Hebron; Central University Hospital Asturias; University of Oviedo; AstraZeneca	Hernandez, JA (corresponding author), Univ Complutense Madrid, Dept Hematol, Hosp Univ Infanta Leonor, Madrid, Spain.	fbosch@vhebron.net; BEspinet@parcdesalutmar.cat; jmhr@usal.es	Bosch, Francesc/AAE-7052-2019; Hernández, Jesus M/B-5459-2017; Hernández-Sánchez, María/I-9045-2016; BENITO, ROCIO/B-4271-2017; Collado Nieto, Rosa María/GZK-9557-2022; Rodriguez, Ana E/B-5462-2017; Rodríguez-Vicente, Ana E/AAP-5504-2021; Delgado, Julio/D-4891-2013; Robledo Montero, Cristina/B-4495-2017; Hernandez-Rivas, Jose-Angel/ADF-6441-2022	Bosch, Francesc/0000-0001-9241-2886; Hernández, Jesus M/0000-0002-9661-9371; Hernández-Sánchez, María/0000-0001-9968-2782; BENITO, ROCIO/0000-0001-9781-4198; Rodriguez, Ana E/0000-0001-6516-2172; Rodríguez-Vicente, Ana E/0000-0001-6516-2172; Delgado, Julio/0000-0002-5157-4376; Robledo Montero, Cristina/0000-0003-0445-3210; Hernandez-Rivas, Jose-Angel/0000-0003-4550-757X; Abrisqueta, Pau/0000-0001-9625-7422; Collado, Rosa/0000-0002-8205-6192; Gonzalez-Gascon y Marin, Isabel/0000-0001-6329-1704; Galende del Canto, Josefina/0000-0001-6542-4961; Gonzalez Diaz, Marcos/0000-0001-6637-1072; Espinet, Blanca/0000-0002-4294-8145; Puiggros, Anna/0000-0001-9627-4978; DE LA FUENTE GRACIANI, IGNACIO/0000-0001-5381-820X	Spanish Fondo de Investigaciones Sanitarias FIS [09/01543, PI12/00281, PI15/01471]; Instituto de Salud Carlos III (ISCIII); European Regional Development Fund (ERDF) "Una manera de hacer Europa"; Proyectos de Investigacion del SACYL [355/A/09, GRS/1172/A15]; COST Action EuGESMA [BM0801]; Fundacion Manuel Solorzano; Obra Social Banca Civica; Fundacion Espanola de Hematologia y Hemoterapia (FEHH); Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Instituto de Salud Carlos III (ISCIII), Spanish Ministry of Economy and Competitiveness [RD12/0036/0069, RD12/0036/0044]; Instituto de Salud Carlos III (ISCIII), Spanish Ministry of Economy and Competitiveness; European Regional Development Fund (ERDF) "Una manera de hacer Europa" [CEI 2010-1-0010]; European Union [306242-NGS-PTL]; Ayuda Predoctoral de la Junta de Castilla y Leon from the Fondo Social Europeo [JCYL-EDU/346/2013]; MLL Munich; AstraZeneca	Spanish Fondo de Investigaciones Sanitarias FIS(Instituto de Salud Carlos III); Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); European Regional Development Fund (ERDF) "Una manera de hacer Europa"(European Commission); Proyectos de Investigacion del SACYL; COST Action EuGESMA(European Cooperation in Science and Technology (COST)); Fundacion Manuel Solorzano; Obra Social Banca Civica; Fundacion Espanola de Hematologia y Hemoterapia (FEHH); Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Instituto de Salud Carlos III (ISCIII), Spanish Ministry of Economy and Competitiveness; Instituto de Salud Carlos III (ISCIII), Spanish Ministry of Economy and Competitiveness; European Regional Development Fund (ERDF) "Una manera de hacer Europa"(European Commission); European Union(European Commission); Ayuda Predoctoral de la Junta de Castilla y Leon from the Fondo Social Europeo; MLL Munich; AstraZeneca(AstraZeneca)	This work was supported by grants from the Spanish Fondo de Investigaciones Sanitarias FIS 09/01543, PI12/00281 and PI15/01471, Instituto de Salud Carlos III (ISCIII), European Regional Development Fund (ERDF) "Una manera de hacer Europa", Proyectos de Investigacion del SACYL 355/A/09, GRS/1172/A15, COST Action EuGESMA (BM0801), Fundacion Manuel Solorzano, Obra Social Banca Civica (Caja Burgos), Fundacion Espanola de Hematologia y Hemoterapia (FEHH), and by grants (RD12/0036/0069 and RD12/0036/0044) from Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Instituto de Salud Carlos III (ISCIII), Spanish Ministry of Economy and Competitiveness and European Regional Development Fund (ERDF) "Una manera de hacer Europa" (CEI 2010-1-0010). The research leading to these results has received funding from the European Union Seventh Framework Programme [FP7/2007-2013] under Grant Agreement no 306242-NGS-PTL. Mutation analyses were performed using oligonucleotide primer plates designed as part of the IRON-II collaborative network of hematological laboratories applying 454 amplicon next-generation deep-sequencing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Maria Hernandez-Sanchez is fully supported by an Ayuda Predoctoral de la Junta de Castilla y Leon from the Fondo Social Europeo (JCYL-EDU/346/2013 Ph.D. scholarship). Vera Grossmann was supported by MLL Munich and Alexander Kohlmann was supported by MLL Munich and AstraZeneca in terms of salary. These funders provided support in the form of salaries for these authors but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Austen B, 2007, J CLIN ONCOL, V25, P5448, DOI 10.1200/JCO.2007.11.2649; Bullrich F, 1999, CANCER RES, V59, P24; Catovsky D, 2007, LANCET, V370, P230, DOI 10.1016/S0140-6736(07)61125-8; Dal Bo M, 2011, GENE CHROMOSOME CANC, V50, P633, DOI 10.1002/gcc.20885; Dicker F, 2009, LEUKEMIA, V23, P117, DOI 10.1038/leu.2008.274; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Dohner H, 1997, BLOOD, V89, P2516, DOI 10.1182/blood.V89.7.2516; Fabbri G, 2011, J EXP MED, V208, P1389, DOI 10.1084/jem.20110921; Gonzalez MB, 2004, HAEMATOLOGICA, V89, P1213; Gonzalez-Gascon YMI, 2015, HEMATOL ONCOL, DOI [10.1002/hon.2196, DOI 10.1002/HON.2196]; Greipp PT, 2013, BRIT J HAEMATOL, V163, P326, DOI 10.1111/bjh.12534; Grossmann V, 2013, J MOL DIAGN, V15, P473, DOI 10.1016/j.jmoldx.2013.03.003; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Hernandez JA, 2009, HAEMATOL-HEMATOL J, V94, P364, DOI 10.3324/haematol.13862; Jain P, 2015, AM J HEMATOL, V90, P471, DOI 10.1002/ajh.23978; Jeromin S, 2014, LEUKEMIA, V28, P108, DOI 10.1038/leu.2013.263; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Mansouri L, 2013, LEUKEMIA, V27, P512, DOI 10.1038/leu.2012.307; Marasca R, 2013, HEMATOL ONCOL, V31, P348, DOI 10.1002/hon.2028; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Navrkalova V, 2013, HAEMATOLOGICA, V98, P1124, DOI 10.3324/haematol.2012.081620; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Oscier DG, 2013, BLOOD, V121, P468, DOI 10.1182/blood-2012-05-429282; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Puiggros A, 2013, BRIT J HAEMATOL, V163, P47, DOI 10.1111/bjh.12479; Quesada V, 2012, NAT GENET, V44, P47, DOI 10.1038/ng.1032; Rodriguez-Vicente AE, 2013, CANCER GENET-NY, V206, P49, DOI 10.1016/j.cancergen.2013.01.003; Rose-Zerilli MJJ, 2014, HAEMATOLOGICA, V99, P736, DOI 10.3324/haematol.2013.098574; Rossi D, 2013, BLOOD, V121, P1403, DOI 10.1182/blood-2012-09-458265; Rossi D, 2012, BLOOD, V119, P2854, DOI 10.1182/blood-2011-12-395673; Rossi D, 2012, BLOOD, V119, P521, DOI 10.1182/blood-2011-09-379966; Rossi D, 2009, CLIN CANCER RES, V15, P995, DOI 10.1158/1078-0432.CCR-08-1630; Schaffner C, 1999, BLOOD, V94, P748, DOI 10.1182/blood.V94.2.748.414k02_748_753; Skowronska A, 2012, J CLIN ONCOL, V30, P4524, DOI 10.1200/JCO.2011.41.0852; Stilgenbauer S, 1996, P NATL ACAD SCI USA, V93, P11837, DOI 10.1073/pnas.93.21.11837; Tam CS, 2009, BLOOD, V114, P957, DOI 10.1182/blood-2009-03-210591; Tsimberidou AM, 2009, CANCER-AM CANCER SOC, V115, P373, DOI 10.1002/cncr.23993; Van Dyke DL, 2010, BRIT J HAEMATOL, V148, P544, DOI 10.1111/j.1365-2141.2009.07982.x; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Weissmann S, 2013, LEUKEMIA, V27, P2393, DOI 10.1038/leu.2013.218	41	21	21	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143073	10.1371/journal.pone.0143073	http://dx.doi.org/10.1371/journal.pone.0143073			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630574	gold, Green Published, Green Submitted			2022-12-27	WOS:000365926300030
J	Kjartansdottir, KR; Reda, A; Panula, S; Day, K; Hultenby, K; Soder, O; Hovatta, O; Stukenborg, JB				Kjartansdottir, Kristin Ros; Reda, Ahmed; Panula, Sarita; Day, Kelly; Hultenby, Kjell; Soder, Olle; Hovatta, Outi; Stukenborg, Jan-Bernd			A Combination of Culture Conditions and Gene Expression Analysis Can Be Used to Investigate and Predict hES Cell Differentiation Potential towards Male Gonadal Cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELL; PRIMORDIAL GERM-CELLS; TESTIS DEVELOPMENT; SERTOLI-CELLS; FEEDER CELLS; HUMAN FIBROBLASTS; DERIVATION; LINES; FETAL; GENERATION	Human embryonic stem cell differentiation towards various cell types belonging to ecto-, endo-and mesodermal cell lineages has been demonstrated, with high efficiency rates using standardized differentiation protocols. However, germ cell differentiation from human embryonic stem cells has been very inefficient so far. Even though the influence of various growth factors has been evaluated, the gene expression of different cell lines in relation to their differentiation potential has not yet been extensively examined. In this study, the potential of three male human embryonic stem cell lines to differentiate towards male gonadal cells was explored by analysing their gene expression profiles. The human embryonic stem cell lines were cultured for 14 days as monolayers on supporting human foreskin fibroblasts or as spheres in suspension, and were differentiated using BMP7, or spontaneous differentiation by omitting exogenous FGF2. TLDA analysis revealed that in the undifferentiated state, these cell lines have diverse mRNA profiles and exhibit significantly different potentials for differentiation towards the cell types present in the male gonads. This potential was associated with important factors directing the fate of the male primordial germ cells in vivo to form gonocytes, such as SOX17 or genes involved in the NODAL/ACTIVIN pathway, for example. Stimulation with BMP7 in suspension culture resulted in up-regulation of cytoplasmic SOX9 protein expression in all three lines. The observation that human embryonic stem cells differentiate towards germ and somatic cells after spontaneous and BMP7-induced stimulation in suspension emphasizes the important role of somatic cells in germ cell differentiation in vitro.	[Kjartansdottir, Kristin Ros; Reda, Ahmed; Soder, Olle; Stukenborg, Jan-Bernd] Karolinska Inst, Dept Womens & Childrens Hlth, Pediat Endocrinol Unit, SE-17176 Stockholm, Sweden; [Kjartansdottir, Kristin Ros; Reda, Ahmed; Soder, Olle; Stukenborg, Jan-Bernd] Univ Hosp, SE-17176 Stockholm, Sweden; [Kjartansdottir, Kristin Ros; Panula, Sarita; Day, Kelly; Hovatta, Outi] Karolinska Inst, Div Obstet & Gynecol, Dept Clin Sci Intervent & Technol, SE-14186 Huddinge, Sweden; [Kjartansdottir, Kristin Ros] Horsens Hosp, Sci Unit, Reprod Biol Lab, DK-8700 Horsens, Denmark; [Hultenby, Kjell] Karolinska Inst, Dept Lab Med, Div Clin Res Ctr, SE-14186 Huddinge, Sweden	Karolinska Institutet; Karolinska Institutet; Aarhus University; Karolinska Institutet	Stukenborg, JB (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, Pediat Endocrinol Unit, Q2 08, SE-17176 Stockholm, Sweden.	jan-bernd.stukenborg@ki.se		Reda, Ahmed/0000-0001-7053-7979; Stukenborg, Jan-bernd/0000-0002-2839-1870	Stiftelsen Frimurare Barnhuset in Stockholm; Paediatric Research Foundation; Sallskapet Barnavard in Stockholm; Stiftelsen Sigurd och Elsa Goljes Minne, Barnforskningen vid ALB; Swedish Research Council/Finnish Academy of Science; Tore Nilsons Stiftelse for Medical Research, Stiftelsen for Barnendokrinologkisk Forskning Laboratory; Emil och Wera Cornells Stiftelse; German Research Foundation (DFG) [STU 506/3-1]	Stiftelsen Frimurare Barnhuset in Stockholm; Paediatric Research Foundation; Sallskapet Barnavard in Stockholm; Stiftelsen Sigurd och Elsa Goljes Minne, Barnforskningen vid ALB; Swedish Research Council/Finnish Academy of Science; Tore Nilsons Stiftelse for Medical Research, Stiftelsen for Barnendokrinologkisk Forskning Laboratory; Emil och Wera Cornells Stiftelse; German Research Foundation (DFG)(German Research Foundation (DFG))	Financial support was received from Stiftelsen Frimurare Barnhuset in Stockholm; the Paediatric Research Foundation; Sallskapet Barnavard in Stockholm; Stiftelsen Sigurd och Elsa Goljes Minne, Barnforskningen vid ALB; the Swedish Research Council/Finnish Academy of Science; Tore Nilsons Stiftelse for Medical Research, Stiftelsen for Barnendokrinologkisk Forskning Laboratory; and Emil och Wera Cornells Stiftelse. JBS was supported by the German Research Foundation (DFG-Grant No.: STU 506/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Allegrucci C, 2007, HUM REPROD UPDATE, V13, P103, DOI 10.1093/humupd/dml041; AMLANI S, 1988, ANAT REC, V220, P143, DOI 10.1002/ar.1092200206; Annab LA, 2012, DIFFERENTIATION, V84, P330, DOI 10.1016/j.diff.2012.07.006; Bucay N, 2009, STEM CELLS, V27, P68, DOI 10.1634/stemcells.2007-1018; Clark AT, 2004, HUM MOL GENET, V13, P727, DOI 10.1093/hmg/ddh088; de Jong J, 2008, J PATHOL, V215, P21, DOI 10.1002/path.2332; de Santa Barbara P, 2000, DEV DYNAM, V217, P293, DOI 10.1002/(SICI)1097-0177(200003)217:3<293::AID-DVDY7>3.0.CO;2-P; Eguizabal C, 2011, STEM CELLS, V29, P1186, DOI 10.1002/stem.672; Eguizabal C, 2009, DIFFERENTIATION, V78, P116, DOI 10.1016/j.diff.2009.07.001; Eiselleova L, 2008, INT J DEV BIOL, V52, P353, DOI 10.1387/ijdb.082590le; Ezeh UI, 2005, CANCER-AM CANCER SOC, V104, P2255, DOI 10.1002/cncr.21432; FRANKE WW, 1979, EXP CELL RES, V123, P25, DOI 10.1016/0014-4827(79)90418-X; FUJIMOTO T, 1977, ANAT REC, V188, P315, DOI 10.1002/ar.1091880305; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; Gkountela S, 2013, NAT CELL BIOL, V15, P113, DOI 10.1038/ncb2638; Gunesdogan U, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0543; Hovatta O, 2003, HUM REPROD, V18, P1404, DOI 10.1093/humrep/deg290; Inzunza J, 2005, STEM CELLS, V23, P544, DOI 10.1634/stemcells.2004-0201; Irie N, 2015, CELL, V160, P253, DOI 10.1016/j.cell.2014.12.013; Kee K, 2008, CSH PROTOC, DOI [10.1101/pdb.prot5048, DOI 10.1101/PDB.PR0T5048]; Kee K, 2006, STEM CELLS DEV, V15, P831, DOI 10.1089/scd.2006.15.831; Kee K, 2009, NATURE, V462, P222, DOI 10.1038/nature08562; Kjartansdottir KR, 2012, SYST BIOL REPROD MED, V58, P330, DOI 10.3109/19396368.2012.694009; Krentz AD, 2013, DEV BIOL, V377, P67, DOI 10.1016/j.ydbio.2013.02.014; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Liu CX, 2014, MOL REPROD DEV, V81, P470, DOI 10.1002/mrd.22312; Lonardo E, 2011, CELL STEM CELL, V9, P433, DOI 10.1016/j.stem.2011.10.001; Lopes SMCD, 2004, GENE DEV, V18, P1838, DOI 10.1101/gad.294004; Malki S, 2005, EXP CELL RES, V309, P468, DOI 10.1016/j.yexcr.2005.07.005; Melichar H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019854; Miles DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054606; Panula S, 2011, HUM MOL GENET, V20, P752, DOI 10.1093/hmg/ddq520; Park Y, 2011, STEM CELLS DEV, V20, P1901, DOI 10.1089/scd.2010.0496; Perrett RM, 2008, BIOL REPROD, V78, P852, DOI 10.1095/biolreprod.107.066175; Qin YJ, 2005, HUM MOL GENET, V14, P1221, DOI 10.1093/hmg/ddi133; Rao M, 2008, GENE THER, V15, P82, DOI 10.1038/sj.gt.3303061; Russel L. D., 1990, HISTOLOGICAL HISTOPA; Ruzzenente B, 2012, EMBO J, V31, P443, DOI 10.1038/emboj.2011.392; Sathananthan Henry, 2002, Reprod Biomed Online, V4, P56; Sharpe RM, 2003, REPRODUCTION, V125, P769, DOI 10.1530/rep.0.1250769; Simard J, 2000, ENDOCR RES, V26, P761, DOI 10.3109/07435800009048597; Sonne SB, 2010, INT J DEV BIOL, V54, P755, DOI 10.1387/ijdb.082668ss; Souquet B, 2012, ENDOCRINOLOGY, V153, P2466, DOI 10.1210/en.2011-2056; Spiller CM, 2013, INT J DEV BIOL, V57, P211, DOI 10.1387/ijdb.130028pk; Spiller CM, 2012, DEVELOPMENT, V139, P4123, DOI 10.1242/dev.083006; Steiner D, 2010, NAT BIOTECHNOL, V28, P361, DOI 10.1038/nbt.1616; Strom S, 2010, IN VITRO CELL DEV-AN, V46, P337, DOI 10.1007/s11626-010-9308-0; Stukenborg JB, 2010, SEX DEV, V4, P199, DOI 10.1159/000317090; Stukenborg JB, 2014, HORM RES PAEDIAT, V81, P2, DOI 10.1159/000355599; Stukenborg JB, 2009, MOL HUM REPROD, V15, P521, DOI 10.1093/molehr/gap052; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Toyooka Y, 2003, P NATL ACAD SCI USA, V100, P11457, DOI 10.1073/pnas.1932826100; Vidal VPI, 2001, NAT GENET, V28, P216, DOI 10.1038/90046; Viger RS, 2005, VITAM HORM, V70, P387, DOI 10.1016/S0083-6729(05)70013-3; Vo BT, 2011, PROSTATE, V71, P1084, DOI 10.1002/pros.21326; West FD, 2010, HUM REPROD, V25, P168, DOI 10.1093/humrep/dep338; West FD, 2011, STEM CELLS DEV, V20, P1079, DOI 10.1089/scd.2010.0255; West FD, 2008, STEM CELLS, V26, P2768, DOI 10.1634/stemcells.2008-0124; Wu Q, 2013, DEVELOPMENT, V140, P291, DOI 10.1242/dev.087882; Ying Y, 2000, MOL ENDOCRINOL, V14, P1053, DOI 10.1210/me.14.7.1053; Ying Y, 2001, P NATL ACAD SCI USA, V98, P7858, DOI 10.1073/pnas.151242798	63	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144029	10.1371/journal.pone.0144029	http://dx.doi.org/10.1371/journal.pone.0144029			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630562	gold, Green Published, Green Submitted			2022-12-27	WOS:000365926300140
J	Nakagawa, Y; Nagasawa, M; Medina, J; Kojima, I				Nakagawa, Yuko; Nagasawa, Masahiro; Medina, Johan; Kojima, Itaru			Glucose Evokes Rapid Ca2+ and Cyclic AMP Signals by Activating the Cell-Surface Glucose-Sensing Receptor in Pancreatic beta-Cells	PLOS ONE			English	Article							SWEET TASTE RECEPTOR; PROTEIN-KINASE-C; INSULIN-SECRETION; ENDOPLASMIC-RETICULUM; ADENYLYL-CYCLASE; PHOSPHOLIPASE-C; ISLETS; EXPRESSION; CAMP; COINCIDENCE	Glucose is a primary stimulator of insulin secretion in pancreatic beta-cells. High concentration of glucose has been thought to exert its action solely through its metabolism. In this regard, we have recently reported that glucose also activates a cell-surface glucose-sensing receptor and facilitates its own metabolism. In the present study, we investigated whether glucose activates the glucose-sensing receptor and elicits receptor-mediated rapid actions. In MIN6 cells and isolated mouse beta-cells, glucose induced triphasic changes in cytoplasmic Ca2+ concentration ([Ca2+](c)); glucose evoked an immediate elevation of [Ca2+](c), which was followed by a decrease in [Ca2+](c), and after a certain lag period it induced large oscillatory elevations of [Ca2+](c). Initial rapid peak and subsequent reduction of [Ca2+](c) were independent of glucose metabolism and reproduced by a nonmetabolizable glucose analogue. These signals were also blocked by an inhibitor of T1R3, a subunit of the glucose-sensing receptor, and by deletion of the T1R3 gene. Besides Ca2+, glucose also induced an immediate and sustained elevation of intracellular cAMP ([cAMP](c)). The elevation of [cAMP](c) was blocked by transduction of the dominant-negative G(s), and deletion of the T1R3 gene. These results indicate that glucose induces rapid changes in [Ca2+](c) and [cAMP](c) by activating the cell-surface glucose-sensing receptor. Hence, glucose generates rapid intracellular signals by activating the cell-surface receptor.	[Nakagawa, Yuko; Nagasawa, Masahiro; Medina, Johan; Kojima, Itaru] Gunma Univ, Inst Mol & Cellular Regulat, Dept Cell Biol, Maebashi, Gunma 371, Japan	Gunma University	Kojima, I (corresponding author), Gunma Univ, Inst Mol & Cellular Regulat, Dept Cell Biol, Maebashi, Gunma 371, Japan.	ikojima@gunma-u.ac.jp			Ministry of Education, Science, Sports and Culture of Japan [25670431]; Japan Society for the Promotion of Science	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by the Grant-in-Aid for Exploratory Research from the Ministry of Education, Science, Sports and Culture of Japan and #25670431, Japan Society for the Promotion of Science (https://www.jsps.go.jp) to IK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi E, 2009, PFLUG ARCH EUR J PHY, V459, P227, DOI 10.1007/s00424-009-0705-8; ASHCROFT FM, 1989, PROG BIOPHYS MOL BIO, V54, P87, DOI 10.1016/0079-6107(89)90013-8; BLEASDALE JE, 1990, J PHARMACOL EXP THER, V255, P756; Cerasi E, 1973, FEBS LETT, V33, P311; CHARLES MA, 1973, SCIENCE, V179, P569, DOI 10.1126/science.179.4073.569; CHOW RH, 1995, J PHYSIOL-LONDON, V485, P607, DOI 10.1113/jphysiol.1995.sp020756; COOK DL, 1984, NATURE, V311, P271, DOI 10.1038/311271a0; DEAN PM, 1968, NATURE, V219, P389, DOI 10.1038/219389a0; Delmeire D, 2003, DIABETOLOGIA, V46, P1383, DOI 10.1007/s00125-003-1203-8; Fridlyand LE, 2007, AM J PHYSIOL-CELL PH, V293, pC1924, DOI 10.1152/ajpcell.00555.2006; Furman B, 2010, ADV EXP MED BIOL, V654, P281, DOI 10.1007/978-90-481-3271-3_13; GANESAN S, 1992, J CELL BIOL, V119, P313, DOI 10.1083/jcb.119.2.313; Geraedts MCP, 2012, AM J PHYSIOL-ENDOC M, V303, pE464, DOI 10.1152/ajpendo.00163.2012; GRAPENGIESSER E, 1988, BIOCHEM BIOPH RES CO, V151, P1299, DOI 10.1016/S0006-291X(88)80503-5; Hamano K, 2015, J ENDOCRINOL, V226, P57, DOI 10.1530/JOE-15-0102; Hellman B, 2014, ACTA PHYSIOL, V210, P479, DOI 10.1111/apha.12217; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; HENQUIN JC, 1984, EXPERIENTIA, V40, P1043, DOI 10.1007/BF01971450; Horikawa K, 2010, NAT METHODS, V7, P729, DOI 10.1038/nmeth.1488; Kim JW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002127; Kojima I, 2015, J DIABETES INVEST, V6, P256, DOI 10.1111/jdi.12304; Kyriazis GA, 2014, ENDOCRINOLOGY, V155, P2112, DOI 10.1210/en.2013-2015; Kyriazis GA, 2012, P NATL ACAD SCI USA, V109, pE524, DOI 10.1073/pnas.1115183109; Landa LR, 2005, J BIOL CHEM, V280, P31294, DOI 10.1074/jbc.M505657200; Leech CA, 1999, BIOCHEM BIOPH RES CO, V254, P703, DOI 10.1006/bbrc.1998.9906; MATSCHINSKY FM, 1990, DIABETES, V39, P647, DOI 10.2337/diabetes.39.6.647; Medina A, 2014, ENDOCR J, V61, P797, DOI 10.1507/endocrj.EJ14-0221; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Mogami H, 2003, J BIOL CHEM, V278, P9896, DOI 10.1074/jbc.M210653200; Murovets VO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130997; Nagasawa M, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12296; Nakagawa Y, 2014, ENDOCR J, V61, P119, DOI 10.1507/endocrj.EJ13-0431; Nakagawa Y, 2013, ENDOCR J, V60, P1191, DOI 10.1507/endocrj.EJ13-0282; Nakagawa Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005106; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Ohtsu Y, 2014, MOL CELL ENDOCRINOL, V394, P70, DOI 10.1016/j.mce.2014.07.004; RASMUSSEN H, 1990, DIABETES CARE, V13, P655, DOI 10.2337/diacare.13.6.655; Ravier MA, 2011, DIABETES, V60, P2533, DOI 10.2337/db10-1543; ROE MW, 1994, AM J PHYSIOL, V266, pE852, DOI 10.1152/ajpendo.1994.266.6.E852; Rorsman P, 1997, DIABETOLOGIA, V40, P487, DOI 10.1007/s001250050706; RORSMAN P, 1985, PFLUG ARCH EUR J PHY, V405, P305, DOI 10.1007/BF00595682; RORSMAN P, 1984, FEBS LETT, V170, P196, DOI 10.1016/0014-5793(84)81398-8; Suzuki Y, 2006, J BIOL CHEM, V281, P28499, DOI 10.1074/jbc.M604291200; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Tengholm A, 2001, J PHYSIOL-LONDON, V530, P533, DOI 10.1111/j.1469-7793.2001.0533k.x; WOLF BA, 1990, J CLIN INVEST, V85, P482, DOI 10.1172/JCI114463; YADA T, 1992, CELL CALCIUM, V13, P69, DOI 10.1016/0143-4160(92)90031-M; Yaekura K, 1998, AM J PHYSIOL-CELL PH, V274, pC513, DOI 10.1152/ajpcell.1998.274.2.C513	49	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144053	10.1371/journal.pone.0144053	http://dx.doi.org/10.1371/journal.pone.0144053			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630567	Green Published, Green Submitted, gold			2022-12-27	WOS:000365926300150
J	Jenny, L; Dobo, J; Gal, P; Schroeder, V				Jenny, Lorenz; Dobo, Jozsef; Gal, Peter; Schroeder, Verena			MASP-1 Induced Clotting - The First Model of Prothrombin Activation by MASP-1	PLOS ONE			English	Article							COMPLEMENT LECTIN PATHWAY; THROMBIN; MEIZOTHROMBIN; COAGULATION; BINDING; FIBRINOGEN; INTERFACE; PROCEEDS; SYSTEM	Mannan-binding lectin-associated serine protease-1 (MASP-1), a protein of the complement lectin pathway, resembles thrombin in terms of structural features and substrate specificity. Due to its interplay with several coagulation factors, it has the ability to induce fibrin clot formation independent of the usual coagulation activation pathways. We have recently shown that MASP-1 activates prothrombin and identified arginine (R) 155, R271, and R393 as potential cleavage sites. FXa cleaves R320 instead of R393, and thrombin cleaves R155 and R284 in prothrombin. Here we have used three arginine-to-glutamine mutants of prothrombin, R271Q, R320Q, R393Q and the serine-to-alanine active site mutant S525A to investigate in detail the mechanism of MASP-1 mediated prothrombin activation. Prothrombin wildtype and mutants were digested with MASP-1 and the cleavage products were analysed by SDS-PAGE and N-terminal sequencing. A functional clotting assay was performed by thrombelastography. We have found that MASP-1 activates prothrombin via two simultaneous pathways, either cleaving at R271 or R393 first. Both pathways result in the formation of several active alternative thrombin species. Functional studies confirmed that both R393 and R320 are required for prothrombin activation by MASP-1, whereas R155 is not considered to be an important cleavage site in this process. In conclusion, we have described for the first time a detailed model of prothrombin activation by MASP-1.	[Jenny, Lorenz; Schroeder, Verena] Univ Hosp Bern, Haemostasis Res Lab, Univ Clin Haematol, CH-3010 Bern, Switzerland; [Jenny, Lorenz; Schroeder, Verena] Univ Bern, Dept Clin Res, Bern, Switzerland; [Dobo, Jozsef; Gal, Peter] Hungarian Acad Sci, Inst Enzymol, Res Ctr Nat Sci, Budapest, Hungary	University of Bern; University Hospital of Bern; University of Bern; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Schroeder, V (corresponding author), Univ Hosp Bern, Haemostasis Res Lab, Univ Clin Haematol, CH-3010 Bern, Switzerland.	verena.schroeder@dkf.unibe.ch	Gal, Peter/B-5886-2011	Dobo, Jozsef/0000-0001-9187-8502; Schroeder, Verena/0000-0001-6508-3271	Swiss National Science Foundation [310030_140925]; OPO Foundation (Zurich, Switzerland); Hungarian Scientific Research Fund (OTKA) [NK100834]; Janos Bolyai Research Fellowship of the Hungarian Academy of Sciences	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); OPO Foundation (Zurich, Switzerland); Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Janos Bolyai Research Fellowship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work was supported by grants from the Swiss National Science Foundation (grant 310030_140925) to VS, OPO Foundation (Zurich, Switzerland) to VS, Hungarian Scientific Research Fund (OTKA grant NK100834) to JD and PG, and the Janos Bolyai Research Fellowship of the Hungarian Academy of Sciences to JD and PG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara U, 2010, J IMMUNOL, V185, P5628, DOI 10.4049/jimmunol.0903678; BOVILL EG, 1995, ARTERIOSCL THROM VAS, V15, P754, DOI 10.1161/01.ATV.15.6.754; Bradford HN, 2012, J BIOL CHEM, V287, P30414, DOI 10.1074/jbc.M112.394809; Dobo J, 2014, MOL IMMUNOL, V61, P69, DOI 10.1016/j.molimm.2014.05.013; Dobo J, 2009, J IMMUNOL, V183, P1207, DOI 10.4049/jimmunol.0901141; Gal P, 2009, MOL IMMUNOL, V46, P2745, DOI 10.1016/j.molimm.2009.04.026; Haynes LM, 2012, J BIOL CHEM, V287, P38647, DOI 10.1074/jbc.M112.407791; Hess K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035690; HIGGINS DL, 1983, J BIOL CHEM, V258, P9276; Huntington JA, 2005, J THROMB HAEMOST, V3, P1861, DOI 10.1111/j.1538-7836.2005.01363.x; Jenny L, 2015, CLIN EXP IMMUNOL, V180, P227, DOI 10.1111/cei.12574; Jenny L, 2015, MOL IMMUNOL, V65, P398, DOI 10.1016/j.molimm.2015.02.014; Krarup A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000623; Krarup A, 2008, BBA-PROTEINS PROTEOM, V1784, P1294, DOI 10.1016/j.bbapap.2008.03.020; Krishnaswamy S, 2013, J THROMB HAEMOST, V11, P265, DOI 10.1111/jth.12217; KRISHNASWAMY S, 1986, J BIOL CHEM, V261, P8977; La Bonte LR, 2012, J IMMUNOL, V188, P885, DOI 10.4049/jimmunol.1102916; MANN KG, 1990, BLOOD, V76, P1; Megyeri M, 2013, J BIOL CHEM, V288, P8922, DOI 10.1074/jbc.M112.446500; Myles T, 2001, J BIOL CHEM, V276, P25143, DOI 10.1074/jbc.M011324200; Orcutt SJ, 2004, J BIOL CHEM, V279, P54927, DOI 10.1074/jbc.M410866200; Parej K, 2013, MOL IMMUNOL, V54, P415, DOI 10.1016/j.molimm.2013.01.009; Petrovan RJ, 1998, BIOCHEMISTRY-US, V37, P1185, DOI 10.1021/bi971948h; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; ROSING J, 1980, J BIOL CHEM, V255, P274; Takahashi K, 2011, IMMUNOBIOLOGY, V216, P96, DOI 10.1016/j.imbio.2010.02.005; Tang YQ, 2012, BBA-PROTEINS PROTEOM, V1824, P253, DOI 10.1016/j.bbapap.2011.05.021	27	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0144633	10.1371/journal.pone.0144633	http://dx.doi.org/10.1371/journal.pone.0144633			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YV	26645987	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903100030
J	Castelnuovo, B; Kiragga, A; Musaazi, J; Sempa, J; Mubiru, F; Wanyama, J; Wandera, B; Kamya, MR; Kambugu, A				Castelnuovo, Barbara; Kiragga, Agnes; Musaazi, Joseph; Sempa, Joseph; Mubiru, Frank; Wanyama, Jane; Wandera, Bonnie; Kamya, Moses Robert; Kambugu, Andrew			Outcomes in a Cohort of Patients Started on Antiretroviral Treatment and Followed up for a Decade in an Urban Clinic in Uganda	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; TREATMENT PROGRAMS; ADULT PATIENTS; THERAPY; TOXICITY; FAILURE; CARE; 1ST	Background Short-medium term studies from sub-Saharan Africa show that, despite high early mortality, substantial loss to program, and high rates toxicity, patients on antiretroviral treatment have achieved outcomes comparable to those in developed settings. However, these studies were unable to account for long term outcomes of patients as they stayed longer on treatment. Objectives We aim to describe ten years outcomes of one of the first cohort of HIV positive patients started on antiretroviral treatment (ART) in Sub-Saharan Africa. Methods We report 10-years outcomes including mortality, retention, CD4-count response, virological outcomes, ART regimens change from a prospective cohort of 559 patients initiating ART and followed up for 10 years Uganda. Results Of 559 patients, 69.1% were female, median age (IQR) was 38 (33-44) years, median CD4-count (IQR) 98 (21-163) cell/mu L; 74% were started on stavudine, lamivudine and nevi-rapine, 26% on zidovudine, lamivudine and efavirenz. After 10 years 361 (65%) patients were still in the study; 127 (22.7%) had died; 30 (5%) were lost to follow-up; 27 (5%) transferred; 18 (3%) withdrew consent. The probability of death was high in the first year (0.15, 95%, CI 0.12-0.18). The median CD4 count increased from 98 to 589 cell/mu L (IQR: 450739 cell/mu L) with a median increase of 357 cells/mu L (IQR: 128-600 cells/mu L); 7.4% never attained initial viral suppression and of those who did 31.7% experienced viral failure. Three hundred and two patients had at least one drug substitution while on first line after a median of 40 months; 66 (11.9%) of the patients were switched to a second line PI-based regimen due to confirmed treatment failure. Conclusions Despite the high rate of early mortality due to advanced disease at presentation the outcomes from this cohort are encouraging, particularly the remarkable and incremental immune-recovery and a satisfactory rate of virologic suppression.	[Castelnuovo, Barbara; Kiragga, Agnes; Musaazi, Joseph; Sempa, Joseph; Mubiru, Frank; Wanyama, Jane; Wandera, Bonnie; Kambugu, Andrew] Makerere Univ, Mulago Hosp, Infect Dis Inst, Kampala, Uganda; [Kamya, Moses Robert] Makerere Univ, Mulago Hosp, Sch Med, Kampala, Uganda	Makerere University; Mulago National Referral Hospital; Makerere University; Mulago National Referral Hospital	Castelnuovo, B (corresponding author), Makerere Univ, Mulago Hosp, Infect Dis Inst, Kampala, Uganda.	bcastelnuovo@idi.co.ug	Wanyama, Jane Namukasa/J-5481-2019	Bukulu Sempa, Joseph/0000-0003-1062-0417				Bannister WP, 2006, JAIDS-J ACQ IMM DEF, V42, P229, DOI 10.1097/01.qai.0000214815.95786.31; Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; Boulle A, 2007, ANTIVIR THER, V12, P753; Bussmann H, 2008, AIDS, V22, P2303, DOI 10.1097/QAD.0b013e3283129db0; Castelnuovo B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051631; Castelnuovo B, 2011, JAIDS-J ACQ IMM DEF, V56, P59, DOI 10.1097/QAI.0b013e3181f5bd03; Center for Disease Control and Prevention, GLOC HIV AIDS UG; De Beaudrap P, 2013, JAIDS-J ACQ IMM DEF, V62, P381, DOI 10.1097/QAI.0b013e31827a2a7a; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Kamya MR, 2007, JAIDS-J ACQ IMM DEF, V46, P187, DOI 10.1097/QAI.0b013e31814278c0; Kiragga AN, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-3; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Makerere University John Hopkins (MUJHU) Laboratory, 2009, UG REF RANG FLOW CYT; Mermin J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6792; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Nwaka S, 2012, BMC INT HEALTH HUM R, V12, DOI 10.1186/1472-698X-12-11; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Sanne IM, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-38; Uganda Ministry of Health, 2013, NAT ANT TREATM CAR G; UNAIDS Access to antoretrovira treatment in Africa, 2013, UNAIDS ACCESS ANTORE; World Health Organization, 2003, SCAL ANT THER RES LT; World Health Organization HIV/AIDS, ANT THER COV SUBS AF	23	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0142722	10.1371/journal.pone.0142722	http://dx.doi.org/10.1371/journal.pone.0142722			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642214	Green Published, gold, Green Submitted			2022-12-27	WOS:000366902700009
J	Gaytan, F; Morales, C; Leon, S; Garcia-Galiano, D; Roa, J; Tena-Sempere, M				Gaytan, Francisco; Morales, Concepcion; Leon, Silvia; Garcia-Galiano, David; Roa, Juan; Tena-Sempere, Manuel			Crowding and Follicular Fate: Spatial Determinants of Follicular Reserve and Activation of Follicular Growth in the Mammalian Ovary	PLOS ONE			English	Article							PRIMORDIAL FOLLICLES; GROWING FOLLICLES; HYPOGONADAL HPG; OOCYTE GROWTH; SHORT-TERM; HORMONE; DYNAMICS; KISSPEPTIN; RECEPTOR; NUMBER	Initiation of growth of resting ovarian follicles is a key phenomenon for providing an adequate number of mature oocytes in each ovulation, while preventing premature exhaustion of primordial follicle reserve during the reproductive lifespan. Resting follicle dynamics strongly suggest that primordial follicles are under constant inhibitory influences, by mechanisms and factors whose nature remains ill defined. In this work, we aimed to assess the influence of spatial determinants, with special attention to clustering patterns and crowding, on the fate of early follicles in the adult mouse and human ovary. To this end, detailed histological and morphometric analyses, targeting resting and early growing follicles, were conducted in ovaries from mice, either wild type (WT) or genetically modified to lack kisspeptin receptor expression (Kiss1r KO), and healthy adult women. Kiss1r KO mice were studied as model of persistent hypogonadotropism and anovulation. Different qualitative and quantitative indices of the patterns of spatial distribution of resting and early growing follicles in the mouse and human ovary, including the Morisita's index of clustering, were obtained. Our results show that resting primordial follicles display a clear-cut clustered pattern of spatial distribution in adult mouse and human ovaries, and that resting follicle aggrupation is inversely correlated with the proportion of follicles initiating growth and entering into the growing pool. As a whole, our data suggest that resting follicle crowding, defined by changes in density and clustered pattern of distribution, is a major determinant of follicular activation and the fate of ovarian reserve. Uneven follicle crowding would constitute the structural counterpart of the major humoral regulators of early follicular growth, with potential implications in ovarian ageing and pathophysiology.	[Gaytan, Francisco; Leon, Silvia; Garcia-Galiano, David; Roa, Juan; Tena-Sempere, Manuel] Univ Cordoba, Dept Cell Biol Physiol & Immunol, Cordoba 14004, Spain; [Gaytan, Francisco; Roa, Juan; Tena-Sempere, Manuel] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr, Cordoba 14004, Spain; [Gaytan, Francisco; Leon, Silvia; Roa, Juan; Tena-Sempere, Manuel] Hosp Univ Reina Sofia, Inst Maimonides Invest Biomed IMIBIC, Cordoba 14004, Spain; [Morales, Concepcion] Univ Cordoba, Dept Pathol, Cordoba 14004, Spain; [Tena-Sempere, Manuel] Univ Turku, FiDiPro Program, Dept Physiol, FIN-20520 Turku, Finland	Universidad de Cordoba; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Universidad de Cordoba; University of Turku	Gaytan, F (corresponding author), Univ Cordoba, Dept Cell Biol Physiol & Immunol, Cordoba 14004, Spain.	bc1galuf@uco.es; fi1tesem@uco.es	Tena-Sempere, Manuel/AAX-3602-2021; Rivas, Juan Roa/L-3689-2014; Garcia Galiano, David/GSE-3416-2022; Garcia-Galiano, David/Q-8089-2019	Tena-Sempere, Manuel/0000-0002-4741-5567; Rivas, Juan Roa/0000-0002-8970-421X; Garcia-Galiano, David/0000-0001-9506-8785	Ministerio de Economia y Competitividad, Spain [BFU2011-025021, BFU2014-57581]; EU funds from FEDER Program; Junta de Andalucia, Spain [P12-FQM-01943]	Ministerio de Economia y Competitividad, Spain; EU funds from FEDER Program; Junta de Andalucia, Spain(Junta de AndaluciaEuropean Commission)	This work was supported by grants BFU2011-025021 and BFU2014-57581 (Ministerio de Economia y Competitividad, Spain; co-funded with EU funds from FEDER Program), and project P12-FQM-01943 (Junta de Andalucia, Spain) (to MT-S). CIBER Fisiopatologia de la Obesidad y Nutricion is an initiative of the Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari D, 2009, ENDOCR REV, V30, P438, DOI 10.1210/er.2008-0048; Allan CM, 2006, J ENDOCRINOL, V188, P549, DOI 10.1677/joe.1.06614; Anderson RA, 2014, HUM REPROD, V29, P97, DOI 10.1093/humrep/det388; Armstrong RA, 2006, J MICROSC-OXFORD, V221, P153, DOI 10.1111/j.1365-2818.2006.01559.x; Bristol-Gould SK, 2006, DEV BIOL, V298, P132, DOI 10.1016/j.ydbio.2006.06.025; Byskov AG, 1997, MOL HUM REPROD, V3, P795, DOI 10.1093/molehr/3.9.795; Castellano JM, 2006, ENDOCRINOLOGY, V147, P4852, DOI 10.1210/en.2006-0117; Charleston JS, 2007, HUM REPROD, V22, P2103, DOI 10.1093/humrep/dem137; Da Silva-Buttkus P, 2009, P NATL ACAD SCI USA, V106, P456, DOI 10.1073/pnas.0810012106; Dierich A, 1998, P NATL ACAD SCI USA, V95, P13612, DOI 10.1073/pnas.95.23.13612; Dorfman MD, 2014, ENDOCRINOLOGY, V155, P3098, DOI 10.1210/en.2014-1111; Durlinger ALL, 1999, ENDOCRINOLOGY, V140, P5789, DOI 10.1210/en.140.12.5789; Edson MA, 2009, ENDOCR REV, V30, P624, DOI 10.1210/er.2009-0012; Faire M, 2015, DEV BIOL, V403, P69, DOI 10.1016/j.ydbio.2015.04.006; Franks S, 2008, HUM REPROD UPDATE, V14, P367, DOI 10.1093/humupd/dmn015; Garcia-Galiano D, 2012, ENDOCRINOLOGY, V153, P316, DOI 10.1210/en.2011-1260; Gaytan F, 2003, J CLIN ENDOCR METAB, V88, P879, DOI 10.1210/jc.2002-021196; Gaytan F, 2009, AM J PHYSIOL-ENDOC M, V296, pE520, DOI 10.1152/ajpendo.90895.2008; Gaytan F, 2014, ENDOCRINOLOGY, V155, P3088, DOI 10.1210/en.2014-1110; Gomez R, 2011, J CLIN ENDOCR METAB, V96, P2484, DOI 10.1210/jc.2011-0075; GOUGEON A, 1994, BIOL REPROD, V50, P653, DOI 10.1095/biolreprod50.3.653; GOUGEON A, 1987, J REPROD FERTIL, V81, P433; Gougeon A., 2004, OVARY, V2nd ed., P25, DOI [DOI 10.1016/B978-012444562-8/50003-3, 10.1016/B978-012444562-8/50003-3]; HALPIN DMG, 1986, J REPROD FERTIL, V77, P287, DOI 10.1530/jrf.0.0770287; HALPIN DMG, 1988, J REPROD FERTIL, V82, P393, DOI 10.1530/jrf.0.0820393; Hansen KR, 2008, HUM REPROD, V23, P699, DOI 10.1093/humrep/dem408; HIRSHFIELD AN, 1995, BIOL REPROD, V53, P1208, DOI 10.1095/biolreprod53.5.1208; HIRSHFIELD AN, 1992, BIOL REPROD, V47, P466, DOI 10.1095/biolreprod47.3.466; HIRSHFIELD AN, 1994, BIOL REPROD, V50, P421, DOI 10.1095/biolreprod50.2.421; Hutcheson K, 1989, ESTIMATION ANAL INSE, P335; Jonard S, 2005, HUM REPROD, V20, P2893, DOI 10.1093/humrep/dei159; KRARUP T, 1969, NATURE, V224, P187, DOI 10.1038/224187a0; Laoharatchatathanin T, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.127902; Matzuk MM, 2002, SCIENCE, V296, P2178, DOI 10.1126/science.1071965; McGee EA, 2000, ENDOCR REV, V21, P200, DOI 10.1210/er.21.2.200; MEIJSROELOFS HMA, 1990, J ENDOCRINOL, V124, P247, DOI 10.1677/joe.0.1240247; Meredith S, 2000, J REPROD FERTIL, V119, P43, DOI 10.1530/reprod/119.1.43; MEREDITH S, 1986, BIOL REPROD, V35, P68, DOI 10.1095/biolreprod35.1.68; Monget P, 2012, MOL CELL ENDOCRINOL, V356, P2, DOI 10.1016/j.mce.2011.07.046; Monniaux D, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.117077; Morisita M., 1962, RES POPUL ECOL, V4, P1, DOI [10.1007/BF02533903, DOI 10.1007/BF02533903]; Pangas SA, 2006, P NATL ACAD SCI USA, V103, P8090, DOI 10.1073/pnas.0601083103; PEDERSEN T, 1968, J REPROD FERTIL, V17, P555, DOI 10.1530/jrf.0.0170555; PETERS H, 1978, CLIN ENDOCRINOL META, V7, P469, DOI 10.1016/S0300-595X(78)80005-X; Pinilla L, 2012, PHYSIOL REV, V92, P1235, DOI 10.1152/physrev.00037.2010; Rajkovic A, 2004, SCIENCE, V305, P1157, DOI 10.1126/science.1099755; Ren Y, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0151-3; Schmidt KLT, 2003, HUM REPROD, V18, P1158, DOI 10.1093/humrep/deg246; Tingen CM, 2009, BIOL REPROD, V81, P16, DOI 10.1095/biolreprod.108.074898; Uda M, 2004, HUM MOL GENET, V13, P1171, DOI 10.1093/hmg/ddh124; vanWezel IL, 1996, BIOL REPROD, V55, P1003, DOI 10.1095/biolreprod55.5.1003; Wang XX, 2014, J CELL BIOL, V206, P923, DOI 10.1083/jcb.201403084; Wang Y, 2005, BIOL REPROD, V73, P610, DOI 10.1095/biolreprod.105.039602; Zhang H, 2014, CURR BIOL, V24, P2501, DOI 10.1016/j.cub.2014.09.023; Zheng WJ, 2014, MOL HUM REPROD, V20, P286, DOI 10.1093/molehr/gau007; Zheng WJ, 2014, HUM MOL GENET, V23, P920, DOI 10.1093/hmg/ddt486	56	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144099	10.1371/journal.pone.0144099	http://dx.doi.org/10.1371/journal.pone.0144099			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642206	Green Published, Green Submitted, gold			2022-12-27	WOS:000366902700054
J	Vargas-Angel, B; Richards, CL; Vroom, PS; Price, NN; Schils, T; Young, CW; Smith, J; Johnson, MD; Brainard, RE				Vargas-Angel, Bernardo; Richards, Cristi L.; Vroom, Peter S.; Price, Nichole N.; Schils, Tom; Young, Charles W.; Smith, Jennifer; Johnson, Maggie D.; Brainard, Russell E.			Baseline Assessment of Net Calcium Carbonate Accretion Rates on US Pacific Reefs	PLOS ONE			English	Article							CRUSTOSE CORALLINE ALGAE; OCEAN ACIDIFICATION; CLIMATE-CHANGE; COMMUNITY; ECOSYSTEM; SURVIVAL; DIOXIDE; CONSEQUENCES; PRODUCTIVITY; METABOLISM	This paper presents a comprehensive quantitative baseline assessment of in situ net calcium carbonate accretion rates (g CaCO3 cm(-2) yr(-1)) of early successional recruitment communities on Calcification Accretion Unit (CAU) plates deployed on coral reefs at 78 discrete sites, across 11 islands in the central and south Pacific Oceans. Accretion rates varied substantially within and between islands, reef zones, levels of wave exposure, and island geomorphology. For forereef sites, mean accretion rates were the highest at Rose Atoll, Jarvis, and Swains Islands, and the lowest at Johnston Atoll and Tutuila. A comparison between reef zones showed higher accretion rates on forereefs compared to lagoon sites; mean accretion rates were also higher on windward than leeward sites but only for a subset of islands. High levels of spatial variability in net carbonate accretion rates reported herein draw attention to the heterogeneity of the community assemblages. Percent cover of key early successional taxa on CAU plates did not reflect that of the mature communities present on surrounding benthos, possibly due to the short deployment period (2 years) of the experimental units. Yet, net CaCO3 accretion rates were positively correlated with crustose coralline algae (CCA) percent cover on the surrounding benthos and on the CAU plates, which on average represented >70% of the accreted material. For foreeefs and lagoon sites combined CaCO3 accretion rates were statistically correlated with total alkalinity and Chlorophyll-a; a GAM analysis indicated that SiOH and Halimeda were the best predictor variables of accretion rates on lagoon sites, and total alkalinity and Chlorophyll-a for forereef sites, demonstrating the utility of CAUs as a tool to monitor changes in reef accretion rates as they relate to ocean acidification. This study underscores the pivotal role CCA play as a key benthic component and supporting actively calcifying reefs; high Mg-calcite exoskeletons makes CCA extremely susceptible changes in ocean water pH, emphasizing the far-reaching threat that ocean acidification poses to the ecological function and persistence of coral reefs worldwide.	[Vargas-Angel, Bernardo; Young, Charles W.] Univ Hawaii, Joint Inst Marine & Atmospher Res, Honolulu, HI 96818 USA; [Vroom, Peter S.] Ocean Associates, Honolulu, HI 96818 USA; [Price, Nichole N.] Bigelow Lab Ocean Sci, East Boothbay, ME 04544 USA; [Schils, Tom] Univ Guam, Marine Lab, Mangilao, GU 96913 USA; [Smith, Jennifer; Johnson, Maggie D.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Brainard, Russell E.] NOAA, Pacific Isl Fisheries Sci Ctr, Coral Reef Ecosyst Div, Honolulu, HI 96818 USA	University of Hawaii System; Bigelow Laboratory for Ocean Sciences; University of Guam; University of California System; University of California San Diego; Scripps Institution of Oceanography; National Oceanic Atmospheric Admin (NOAA) - USA	Vargas-Angel, B (corresponding author), Univ Hawaii, Joint Inst Marine & Atmospher Res, Honolulu, HI 96818 USA.	Bernado.VargasAngel@noaa.gov	Johnson, Maggie D/C-6469-2013; Schils, Tom/A-7087-2008	Johnson, Maggie D/0000-0002-1319-2545; Schils, Tom/0000-0002-1516-9082; Price, Nichole/0000-0001-6773-3215	NOAA Coral Reef Conservation Program; NOAA NMFS Office of Science and Technology; NOAA Ocean Acidification Program; NOAA Pacific Islands Fisheries Science Center's Coral Reef Ecosystem Division (CRED); Scripps Institution of Oceanography; American Samoa Department of Marine and Wildlife Resources; National Park of American Samoa; National Marine Sanctuary of American Samoa; U.S. Fish and Wildlife Service; NOAA Ship Hi'ialakai	NOAA Coral Reef Conservation Program(National Oceanic Atmospheric Admin (NOAA) - USA); NOAA NMFS Office of Science and Technology; NOAA Ocean Acidification Program; NOAA Pacific Islands Fisheries Science Center's Coral Reef Ecosystem Division (CRED); Scripps Institution of Oceanography(University of California System); American Samoa Department of Marine and Wildlife Resources; National Park of American Samoa; National Marine Sanctuary of American Samoa; U.S. Fish and Wildlife Service(US Fish & Wildlife Service); NOAA Ship Hi'ialakai	This work was supported by the NOAA Coral Reef Conservation Program, the NOAA NMFS Office of Science and Technology, and NOAA Ocean Acidification Program. Institutional, logistic, and financial support was also provided by NOAA Pacific Islands Fisheries Science Center's Coral Reef Ecosystem Division (CRED) and Scripps Institution of Oceanography. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Ocean Associates provided support in the form of a salary for author PSV, but did not have any additional role in the study.; This work was supported by the NOAA Ocean Acidification Program and the NOAA NMFS Office of Science and Technology. Institutional, logistic, and financial support was also provided by NOAA Pacific Islands Fisheries Science Center's Coral Reef Ecosystem Division (CRED) and Scripps Institution of Oceanography. Permission to work in American Samoa and the Pacific Island National Marine Monument was granted by the American Samoa Department of Marine and Wildlife Resources, the National Park of American Samoa, the National Marine Sanctuary of American Samoa, and by the U.S. Fish and Wildlife Service. Thanks are due to the officers and crew of the NOAA Ship Hi'ialakai for support with dive and small boat operations. A number of CRED staff assisted with construction, deployment, and recovery of the CAU assemblies. E Penland, E Looney, P Misa-Lozada, B Richards, and H, Bailey assisted with CAU lab processing; staff from J Smith Lab at Scripps helped with the CAU plate image analysis, and T Acoba, J Ehses, and A Dillon assisted with figure preparation and formatting. The authors also want to thank B Schumacher, J Samson, P Misa-Lozada, and T Oliver, as well as to anonymous reviewers, whose comments greatly improved this manuscript. The manuscript contents are solely the opinion of the authors and do not constitute a statement of policy, decision, or position on behalf of NOAA or the U.S. Government.	Adey WH, 1998, J PHYCOL, V34, P393, DOI 10.1046/j.1529-8817.1998.340393.x; Albright R, 2011, GLOBAL CHANGE BIOL, V17, P2478, DOI 10.1111/j.1365-2486.2011.02404.x; Andersson AJ, 2008, MAR ECOL PROG SER, V373, P265, DOI 10.3354/meps07639; [Anonymous], 2007, SYSTAT SYSTAT 12 STA; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Anthony KRN, 2011, GLOBAL CHANGE BIOL, V17, P3655, DOI 10.1111/j.1365-2486.2011.02510.x; Arrow Kenneth J., 1996, CLIMATE CHANGE 1995; ATKINSON MJ, 1984, CORAL REEFS, V3, P13, DOI 10.1007/BF00306136; Barnes D.J., 1990, P109; Borowitza M.A., 1982, Progress phycol. Res., V1, P137; BOSENCE DWJ, 1983, J GEOL SOC LONDON, V140, P365, DOI 10.1144/gsjgs.140.3.0365; Brinkman TJ, 2015, MAR FRESHWATER RES, V66, P360, DOI 10.1071/MF14077; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Comeau S, 2013, LIMNOL OCEANOGR, V58, P388, DOI 10.4319/lo.2013.58.1.0388; Cooley SR, 2009, OCEANOGRAPHY, V22, P172, DOI 10.5670/oceanog.2009.106; Cooley SR, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/2/024007; Craig P, 2005, 11 NOS NCCOS NOAA CT, P312; Crawley A, 2010, GLOBAL CHANGE BIOL, V16, P851, DOI 10.1111/j.1365-2486.2009.01943.x; Diaz-Pulido G., 2007, CLIMATE CHANGE GREAT, P151; Diaz-Pulido G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4310; Dickson A., 2007, PICES SPECIAL PUBLIC, V3, DOI 10.25607/OBP-1342; Dufault AM, 2012, P ROY SOC B-BIOL SCI, V279, P2951, DOI 10.1098/rspb.2011.2545; Erez J, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P151, DOI 10.1007/978-94-007-0114-4_10; Fabricius K, 2001, CORAL REEFS, V19, P303, DOI 10.1007/s003380000120; Fabricius K, 2013, P R SOC B, V282; Fabricius KE, 2015, SCI REP-UK, V5, DOI 10.1038/srep09537; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Fearnside PM, 2000, CLIMATIC CHANGE, V46, P115, DOI 10.1023/A:1005569915357; Feely RA, 2009, OCEANOGRAPHY, V22, P36, DOI 10.5670/oceanog.2009.95; Goldberg W, 2013, BIOL REEF ORGANISMS; Goodenough AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034338; Gorley C.K., 2006, GETTING STARTED PRIM; Gove JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061974; Hallock P, 1997, NATL GEOGR RES EXPLO, V9, P358; Hamylton SM, 2013, CORAL REEFS, V32, P1025, DOI 10.1007/s00338-013-1074-5; Harrington L, 2004, ECOLOGY, V85, P3428, DOI 10.1890/04-0298; Heyward AJ, 1999, CORAL REEFS, V18, P273, DOI 10.1007/s003380050193; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Hofmann GE, 2010, ANNU REV ECOL EVOL S, V41, P127, DOI 10.1146/annurev.ecolsys.110308.120227; Jokiel PL, 2008, CORAL REEFS, V27, P473, DOI 10.1007/s00338-008-0380-9; Jokiel PL, 2011, B MAR SCI, V87, P639, DOI 10.5343/bms.2010.1107; Kamenos NA, 2013, GLOBAL CHANGE BIOL, V19, P3621, DOI 10.1111/gcb.12351; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; KLUMPP DW, 1992, MAR ECOL PROG SER, V86, P77, DOI 10.3354/meps086077; Kroeker KJ, 2011, P NATL ACAD SCI USA, V108, P14515, DOI 10.1073/pnas.1107789108; Kurihara H, 2008, J EXP MAR BIOL ECOL, V367, P41, DOI 10.1016/j.jembe.2008.08.016; Lee D, 2001, CHEM GEOL, V172, P307, DOI 10.1016/S0009-2541(00)00258-8; Littler MM, 1984, PHYCOLOG RES, V3, P324; Maragos James, 2008, V1, P595, DOI 10.1007/978-1-4020-6847-8_15; Martin S, 2009, GLOBAL CHANGE BIOL, V15, P2089, DOI 10.1111/j.1365-2486.2009.01874.x; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Miller J, 2008, 73 NOS NCCOS NOAA CT, P353; Morse JW, 2006, GEOCHIM COSMOCHIM AC, V70, P5814, DOI 10.1016/j.gca.2006.08.017; Nelson WA, 2009, MAR FRESHWATER RES, V60, P787, DOI 10.1071/MF08335; Noisette F, 2013, J PHYCOL, V49, P746, DOI 10.1111/jpy.12085; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Portner HO, 2005, J GEOPHYS RES, V110; Preskitt Linda B., 2004, Pacific Science, V58, P201, DOI 10.1353/psc.2004.0021; Price N, 2010, OECOLOGIA, V163, P747, DOI 10.1007/s00442-010-1578-4; Price NN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043843; Price NN, 2011, MAR ECOL PROG SER, V440, P67, DOI 10.3354/meps09309; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Semesi IS, 2009, ESTUAR COAST SHELF S, V84, P337, DOI 10.1016/j.ecss.2009.03.038; Silbiger NJ, 2014, MAR ECOL PROG SER, V515, P33, DOI 10.3354/meps10999; Smith AM, 2012, PHYTOCHEMISTRY, V81, P97, DOI 10.1016/j.phytochem.2012.06.003; Smith JB, 2009, P NATL ACAD SCI USA, V106, P4133, DOI 10.1073/pnas.0812355106; SMITH SV, 1975, LIMNOL OCEANOGR, V20, P493, DOI 10.4319/lo.1975.20.3.0493; Solomon S., 2007, PHYS SCI BASIS WORKI; Stocker T.F., 2013, PHYS SCI BASIS, P1535, DOI [10.1017/CBO9781107415324, DOI 10.1017/CB09781107415324, DOI 10.1017/CBO9781107415324]; Tanhua T, 2013, INT GEOPHYS SERIES, V103, P787, DOI DOI 10.1016/B978-0-12-391851-2.00030-1; Tucker M., 1990, CARBONATE SEDIMENTOL; Ulfsbo A, 2014, THESIS; US. Census Bureau, 2010, AM SAM DEM PROF DAT; Vecsei A, 2004, GLOBAL PLANET CHANGE, V43, P1, DOI 10.1016/j.gloplacha.2003.12.002; Vroom P. S., 2003, BIOLOGIST, V50, P222; Vroom PS, 2010, BIODIVERS CONSERV, V19, P797, DOI 10.1007/s10531-009-9735-y; Vroom PS, 2001, AM SCI, V89, P524, DOI 10.1511/2001.40.748	78	12	12	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0142196	10.1371/journal.pone.0142196	http://dx.doi.org/10.1371/journal.pone.0142196			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641885	Green Published, gold, Green Submitted			2022-12-27	WOS:000366902700007
J	Gosak, M; Markovic, R; Fajmut, A; Marhl, M; Hawlina, M; Andjelic, S				Gosak, Marko; Markovic, Rene; Fajmut, Ales; Marhl, Marko; Hawlina, Marko; Andjelic, Sofija			The Analysis of Intracellular and Intercellular Calcium Signaling in Human Anterior Lens Capsule Epithelial Cells with Regard to Different Types and Stages of the Cataract	PLOS ONE			English	Article							GAP-JUNCTION PROTEIN; NETWORK MEDICINE; COMMUNICATION; MOBILIZATION; MEMBRANE; CONNECTIVITY; STIMULATION; PHYSIOLOGY; CALMODULIN; EXPRESSION	In this work we investigated how modifications of the Ca2+ homeostasis in anterior lens epithelial cells (LECs) are associated with different types of cataract (cortical or nuclear) and how the progression of the cataract (mild or moderate) affects the Ca2+ signaling. We systematically analyzed different aspects of intra-and inter-cellular Ca2+ signaling in the human LECs, which are attached to surgically isolated lens capsule (LC), obtained during cataract surgery. We monitored the temporal and spatial changes in intracellular Ca2+ concentration after stimulation with acetylcholine by means of Fura-2 fluorescence captured with an inverted microscope. In our analysis we compared the features of Ca2+ signals in individual cells, synchronized activations, spatio-temporal grouping and the nature of intercellular communication between LECs. The latter was assessed by using the methodologies of the complex network theory. Our results point out that at the level of individual cells there are no significant differences when comparing the features of the signals with regard either to the type or the stage of the cataract. On the other hand, noticeable differences are observed at the multicellular level, despite inter-capsule variability. LCs associated with more developed cataracts were found to exhibit a slower collective response to stimulation, a less pronounced spatio-temporal clustering of LECs with similar signaling characteristics. The reconstructed intercellular networks were found to be sparser and more segregated than in LCs associated with mild cataracts. Moreover, we show that spontaneously active LECs often operate in localized groups with quite well aligned Ca2+ activity. The presence of spontaneous activity was also found to affect the stimulated Ca2+ responses of individual cells. Our findings indicate that the cataract progression entails the impairment of intercellular signaling thereby suggesting the functional importance of altered Ca2+ signaling of LECs in cataractogenesis.	[Gosak, Marko] Univ Maribor, Fac Med, Inst Physiol, Maribor, Slovenia; [Gosak, Marko; Markovic, Rene; Fajmut, Ales; Marhl, Marko] Univ Maribor, Fac Nat Sci & Math, SLO-2000 Maribor, Slovenia; [Markovic, Rene; Marhl, Marko] Univ Maribor, Fac Educ, SLO-2000 Maribor, Slovenia; [Fajmut, Ales] Univ Maribor, Fac Hlth Sci, SLO-2000 Maribor, Slovenia; [Hawlina, Marko; Andjelic, Sofija] Hosp Eye, Univ Med Ctr, Ljubljana, Slovenia	University of Maribor; University of Maribor; University of Maribor; University of Maribor; University Medical Centre Ljubljana	Andjelic, S (corresponding author), Hosp Eye, Univ Med Ctr, Ljubljana, Slovenia.	sofija.andjelic@kclj.si	Hawlina, Marko/AAZ-8084-2020; Markovič, Rene/M-3148-2019	Markovič, Rene/0000-0001-9068-6373; Gosak, Marko/0000-0001-9735-0485	Slovenian Research Agency [P3-0333, I0-0029, P3-0396]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by the Slovenian Research Agency (Programs P3-0333, I0-0029 and P3-0396). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the support from the Slovenian Research Agency (Programs P30333, I0-0029 and P3-0396).	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Andjelic S, 2011, J CLIN EXPT OPHTHA S, VS1, P002, DOI [10.4172/2155-9570.S1-002, DOI 10.4172/2155-9570.S1-002]; Andjelic S, 2014, CURR EYE RES, V39, P1020, DOI 10.3109/02713683.2014.894077; Andjelic S, 2012, ZDR VESTN, V81, pI122; Andjelic S, 2011, ACTA OPHTHALMOL, V89, pe645, DOI 10.1111/j.1755-3768.2011.02199.x; Andjelic S, 2010, ZDR VESTN, V79, P123; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 2007, NEW ENGL J MED, V357, P404, DOI 10.1056/NEJMe078114; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Barberan A, 2012, ISME J, V6, P343, DOI 10.1038/ismej.2011.119; Bashan A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1705; Benninger RKP, 2014, TRENDS ENDOCRIN MET, V25, P399, DOI 10.1016/j.tem.2014.02.005; Berthoud VM, 2014, FEBS LETT, V588, P1297, DOI 10.1016/j.febslet.2013.12.024; Berthoud VM, 2009, ANTIOXID REDOX SIGN, V11, P339, DOI 10.1089/ars.2008.2119; Beyer EC, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00043; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Boscia F, INVEST OPHTHALMOL VI, V41, P2461; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Churchill GC, 1996, J CELL SCI, V109, P355; Churchill GC, 2001, AM J PHYSIOL-CELL PH, V281, pC972, DOI 10.1152/ajpcell.2001.281.3.C972; Collison DJ, 2000, INVEST OPHTH VIS SCI, V41, P2633; Collison DJ, 2001, INVEST OPHTH VIS SCI, V42, P2355; Das Gupta P, 2004, ACTA PHARMACOL SIN, V25, P1250; Delamere NA, 2004, PROG RETIN EYE RES, V23, P593, DOI 10.1016/j.preteyeres.2004.06.003; DeRosa AM, 2009, EXP CELL RES, V315, P1063, DOI 10.1016/j.yexcr.2009.01.017; DUNCAN G, 1975, EXP EYE RES, V20, P223, DOI 10.1016/0014-4835(75)90136-0; DUNCAN G, 1994, PROG RETIN EYE RES, V13, P623, DOI 10.1016/1350-9462(94)90025-6; Gong XH, 1997, CELL, V91, P833, DOI 10.1016/S0092-8674(00)80471-7; Gosak M, 2015, CHAOS SOLITON FRACT, V80, P76, DOI 10.1016/j.chaos.2015.06.009; Harris AL, 2007, PROG BIOPHYS MOL BIO, V94, P120, DOI 10.1016/j.pbiomolbio.2007.03.011; HIGHTOWER KR, 1989, INVEST OPHTH VIS SCI, V30, P569; HIGHTOWER KR, 1994, EXP EYE RES, V59, P557, DOI 10.1006/exer.1994.1141; Hodson DJ, 2010, J NEUROENDOCRINOL, V22, P1217, DOI 10.1111/j.1365-2826.2010.02052.x; Hodson DJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1612; Johar SRK, 2003, PHOTOCHEM PHOTOBIOL, V78, P306, DOI 10.1562/0031-8655(2003)078<0306:SEOURO>2.0.CO;2; Klein BEK, 2002, OPHTHALMOLOGY, V109, P2052, DOI 10.1016/S0161-6420(02)01249-6; KONNERTH A, 1987, J PHYSIOL-LONDON, V393, P681, DOI 10.1113/jphysiol.1987.sp016848; Le ACN, 1998, DEV BIOL, V204, P80, DOI 10.1006/dbio.1998.9030; LI WC, 1995, J CELL BIOL, V130, P169, DOI 10.1083/jcb.130.1.169; Lurtz MM, 2003, AM J PHYSIOL-CELL PH, V285, pC1475, DOI 10.1152/ajpcell.00361.2002; Markovic R, 2015, SCI REP-UK, V5, DOI 10.1038/srep07845; Mathias RT, 2004, EXP EYE RES, V78, P689, DOI 10.1016/j.exer.2003.07.001; Michael Ralph, 2000, Ophthalmic Research, V32, P1, DOI 10.1159/000055633; MUSIL LS, 1990, J MEMBRANE BIOL, V116, P163, DOI 10.1007/BF01868674; Oyster CW., 1999, HUMAN EYE STRUCTURE; PAUL DL, 1991, J CELL BIOL, V115, P1077, DOI 10.1083/jcb.115.4.1077; PERACCHIA C, 1978, NATURE, V271, P669, DOI 10.1038/271669a0; Pires M, 2014, J THEOR BIOL, V356, P201, DOI 10.1016/j.jtbi.2014.04.024; RAFFERTY NS, 1994, EXP EYE RES, V59, P191, DOI 10.1006/exer.1994.1097; Rhodes JD, 2009, EXP EYE RES, V88, P226, DOI 10.1016/j.exer.2008.10.025; Rutter GA, 2015, CELL MOL LIFE SCI, V72, P453, DOI 10.1007/s00018-014-1755-4; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stozer A, 2013, PLOS COMPUT BIOL, P9; Tang DX, 2003, INVEST OPHTH VIS SCI, V44, P2059, DOI 10.1167/iovs.02-0345; Vrensen GFJM, 2009, ACTA OPHTHALMOL, V87, P602, DOI 10.1111/j.1755-3768.2009.01674.x; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WHITE TW, 1992, MOL BIOL CELL, V3, P711, DOI 10.1091/mbc.3.7.711; White TW, 2000, BRAIN RES REV, V32, P130, DOI 10.1016/S0165-0173(99)00072-7; WILLIAMS MR, 1993, EXP EYE RES, V57, P381, DOI 10.1006/exer.1993.1138; Xu Q, 2012, AM J PHYSIOL-CELL PH, V302, pC1548, DOI 10.1152/ajpcell.00319.2011; Yan Q, 2006, DIFFERENTIATION, V74, P195, DOI 10.1111/j.1432-0436.2006.00068.x; Yawata K, 2001, JPN J PHYSIOL, V51, P81, DOI 10.2170/jjphysiol.51.81	62	13	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143781	10.1371/journal.pone.0143781	http://dx.doi.org/10.1371/journal.pone.0143781			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636768	Green Published, Green Submitted, gold			2022-12-27	WOS:000366143800027
J	Wang, JL; Zeng, YX; Luo, WZ; Xie, XH; Li, SY				Wang, Jinlin; Zeng, Yunxiang; Luo, Weizhan; Xie, Xiaohong; Li, Shiyue			The Role of Cryptococcus in the Immune System of Pulmonary Cryptococcosis Patients	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELL RESPONSE; CEREBROSPINAL-FLUID; NEOFORMANS; IMMUNOCOMPETENT; INFECTION; INTERLEUKIN-12; MECHANISMS; EXPRESSION; MONOCYTES	Objectives To investigate the role of Cryptococcus in the immune system of immunocompetent patients with pulmonary cryptococcosis (PC) by analysing the dynamic changes of patients' immune status before and after antifungal therapy. Methods The level of the serum interferon-gamma (IFN-gamma) and interleukin (IL)-2, -4, -10 and -12 was measured before and after 6-months of treatment. Peripheral blood samples were obtained from 30 immunocompetent PC patients and 30 age-and gender-matched healthy controls. Peripheral blood mononuclear cells (PBMCs) were isolated and incubated with recombinant human IL-12 (rhIL-12) for 48 h. Then the concentrations of IFN-gamma and IL-4 in the supernatant were analysed. Results Baseline serum IFN-gamma level was significantly lower in the PC patients as compared with the control group (P < 0.001). The serum IL-2 and IFN-gamma of PC patients were significantly increased after appropriate treatments (P < 0.05 and P < 0.001 when compared to their baseline levels). The productions of IFN-gamma in the culture supernatant of PBMCs showed no significant difference between the control and PC patients both before and after antifungal treatments. RhIL-12 is a potent stimulus for IFN-gamma production. Culture PBMCs collected from PC patients before treatments had a smaller increase of IFN-gamma production in the present of rhIL-12 than the control (P < 0.01); PBMCs from PC patients completing 6-months of treatment showed a comparable increase of IFN-gamma production by rhIL-12 stimulation to the control group. Conclusions In apparently immunocompetent patients with PC, a normalization of serum IFN-gamma was achieved after recovery from infection. This suggests that Cryptococcus infection per se can suppress the immune system and its elimination contributes to the reestablishment of an immune equilibrium.	[Wang, Jinlin; Zeng, Yunxiang; Luo, Weizhan; Xie, Xiaohong; Li, Shiyue] Guangzhou Inst Resp Dis, China Clin Res Ctr Resp Dis, Dept Resp, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China	State Key Laboratory of Respiratory Disease	Li, SY (corresponding author), Guangzhou Inst Resp Dis, Dept Resp, Guangzhou, Guangdong, Peoples R China.	2289219440@qq.com			Foundation of Guangzhou Health Development Planning Commission [20131A011139]	Foundation of Guangzhou Health Development Planning Commission	The study was supported by grants from the Foundation of Guangzhou Health Development Planning Commission (No: 20131A011139). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angkasekwinai P, 2014, INFECT IMMUN, V82, P3880, DOI 10.1128/IAI.01773-14; Baddley JW, 2008, EUR J CLIN MICROBIOL, V27, P937, DOI 10.1007/s10096-008-0529-z; BLACKSTOCK R, 1984, MYCOPATHOLOGIA, V86, P35, DOI 10.1007/BF00437227; Chaka W, 1997, J INFECT DIS, V176, P1633, DOI 10.1086/517344; Chang WC, 2006, CHEST, V129, P333, DOI 10.1378/chest.129.2.333; Cheng PY, 2009, INFECT IMMUN, V77, P4284, DOI 10.1128/IAI.00628-09; D'Elios MM, 2011, J INFECT DEV COUNTR, V5, P640, DOI 10.3855/jidc.2019; Edwards L, 2005, EUR J IMMUNOL, V35, P273, DOI 10.1002/eji.200425640; Garro AP, 2011, IMMUNOLOGY, V134, P198, DOI 10.1111/j.1365-2567.2011.03479.x; Harrison TS, 1997, J INFECT DIS, V176, P537, DOI 10.1086/517284; Huston SM, 2013, J IMMUNOL, V191, P249, DOI 10.4049/jimmunol.1202707; Idnurm A, 2005, NAT REV MICROBIOL, V3, P753, DOI 10.1038/nrmicro1245; Kawakami K, 1999, CELL IMMUNOL, V197, P55, DOI 10.1006/cimm.1999.1557; Kobayashi M, 2004, ACTA DERM-VENEREOL, V84, P320, DOI 10.1080/00015550410025868; Koguchi Yoshinobu, 2002, Int Rev Immunol, V21, P423, DOI 10.1080/08830180213274; Lehtonen A, 2003, CYTOKINE, V24, P81, DOI 10.1016/j.cyto.2003.07.001; Lindell RM, 2005, RADIOLOGY, V236, P326, DOI 10.1148/radiol.2361040460; Lortholary O, 2005, CLIN MICROBIOL INFEC, V11, P296, DOI 10.1111/j.1469-0691.2005.01074.x; Lortholary O, 2001, J INFECT DIS, V183, P294, DOI 10.1086/317937; Milam JE, 2007, INFECT IMMUN, V75, P4951, DOI 10.1128/IAI.00176-07; Mora DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120297; Murdock BJ, 2014, J IMMUNOL, V193, P4107, DOI 10.4049/jimmunol.1400650; Olszewski MA, 2010, FUTURE MICROBIOL, V5, P1269, DOI [10.2217/fmb.10.93, 10.2217/FMB.10.93]; Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858; Pietrella D, 2004, CELL MICROBIOL, V6, P883, DOI 10.1111/j.1462-5822.2004.00411.x; Pitzurra L, 2000, INFECT IMMUN, V68, P558, DOI 10.1128/IAI.68.2.558-563.2000; Qu YJ, 2012, ACTA RADIOL, V53, P668, DOI 10.1258/ar.2012.110612; SPITZER ED, 1993, LANCET, V341, P595, DOI 10.1016/0140-6736(93)90354-J; Velagapudi R, 2009, INFECT IMMUN, V77, P4345, DOI 10.1128/IAI.00542-09; Wang JL, 2013, GENET MOL RES, V12, P5733, DOI 10.4238/2013.November.18.22; Wormley FL, 2007, INFECT IMMUN, V75, P1453, DOI 10.1128/IAI.00274-06; Ye F, 2012, LUNG, V190, P339, DOI 10.1007/s00408-011-9362-8; Yu JQ, 2012, BRAZ J INFECT DIS, V16, P531, DOI 10.1016/j.bjid.2012.07.004; Zhang Y, 2012, EUR RESPIR J, V40, P1191, DOI 10.1183/09031936.00168011; Zheng CF, 2007, BLOOD, V109, P2049, DOI 10.1182/blood-2006-03-009720	35	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144427	10.1371/journal.pone.0144427	http://dx.doi.org/10.1371/journal.pone.0144427			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26637129	gold, Green Published, Green Submitted			2022-12-27	WOS:000366143800092
J	Wu, B; Zheng, JX; Zhou, M; Xi, XH; Wang, Q; Hua, J; Hu, XF; Liu, JQ				Wu, Bin; Zheng, Jinxia; Zhou, Ming; Xi, Xiaohong; Wang, Qin; Hua, Jing; Hu, Xuefeng; Liu, Jiang-Qin			Improvement of Expressed Breast Milk in Mothers of Preterm Infants by Recording Breast Milk Pumping Diaries in a Neonatal Center in China	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; TRIAL	Objectives Because inadequate expression of human milk (EBM) in mothers of hospitalized infants were noticed in a neonatal center of our hospital, family education program was carried out to increase the EBM. Methods A breast milk pumping diary was introduced to the mothers with preterm infant(s) admitted in the NICU. The ratios of EBM (days of EBM to NICU/hospitalized days), breast milk feeding (BMF) (days of infants fed with exclusive human milk/hospitalized days), mixed feeding (MF) (days of infants fed with partial breast milk and partial formula/hospitalized days), and formula feeding (FF) (days of infants fed with preterm formula/hospitalized days) were evaluated. Results During January to April, 2014, the ratios of EBM to the NICU, BMF, MF and FF were 28.11%, 6.6%, 32.8% and 60.6%, respectively. After the introduction of breast milk pumping diary to the mothers from May 2014, the ratio of EBM to the NICU increased significantly to 53.3% (p<0.01) within the following eight months. Both the ratios of BMF and MF also rose to 23.8% and MF 55.3%, respectively. Consequently, the ratio of FF was reduced to 20.9%. Exclusive breast milk feeding also significantly reduce the duration of nil per oral (NPO) of the very low birth weight infants during hospital stay as compared to those fed with mixed feeding and formula feeding. Conclusion The introduction of a breast milk pumping diary was associated with a significant increase in the intake of EBM of the hospitalized preterm newborns.	[Wu, Bin; Zheng, Jinxia; Zhou, Ming; Xi, Xiaohong; Wang, Qin; Hu, Xuefeng; Liu, Jiang-Qin] Tongji Univ, Sch Med, Shanghai Matern & Infant Hosp 1, Dept Neonatol, Shanghai 200092, Peoples R China; [Hua, Jing] Tongji Univ, Sch Med, Shanghai Matern & Infant Hosp 1, Dept Maternal & Child Hlth, Shanghai 200092, Peoples R China	Tongji University; Tongji University	Liu, JQ (corresponding author), Tongji Univ, Sch Med, Shanghai Matern & Infant Hosp 1, Dept Neonatol, Shanghai 200092, Peoples R China.	jiangqinliu@yahoo.com						Acuna-Muga J, 2014, J HUM LACT, V30, P41, DOI 10.1177/0890334413509140; Arslanoglu S, 2013, J PERINAT MED, V41, P129, DOI 10.1515/jpm-2012-0196; Boucher CA, 2011, NEONATAL NETW, V30, P21, DOI 10.1891/0730-0832.30.1.21; Cristofalo EA, 2013, J PEDIATR-US, V163, P1592, DOI 10.1016/j.jpeds.2013.07.011; Dougherty D, 2008, NEONATAL NETW, V27, P371, DOI 10.1891/0730-0832.27.6.371; Flacking R, 2006, SOC SCI MED, V62, P70, DOI 10.1016/j.socscimed.2005.05.026; Flaherman VJ, 2013, PEDIATR CLIN N AM, V60, P227, DOI 10.1016/j.pcl.2012.10.003; Furman L, 2003, ARCH PEDIAT ADOL MED, V157, P66, DOI 10.1001/archpedi.157.1.66; Hill P D, 2001, J Hum Lact, V17, P9, DOI 10.1177/089033440101700103; Hill PD, 2005, J HUM LACT, V21, P22, DOI 10.1177/0890334404272407; Hylander M A, 2001, J Perinatol, V21, P356, DOI 10.1038/sj.jp.7210548; Jones E, 2001, ARCH DIS CHILD-FETAL, V85, pF91, DOI 10.1136/fn.85.2.F91; Jones E, 2007, ARCH DIS CHILD-FETAL, V92, P236, DOI 10.1136/adc.2006.100941; Josephson CD, 2014, JAMA PEDIATR, V168, P1054, DOI 10.1001/jamapediatrics.2014.1360; Kavanaugh K, 1997, J Hum Lact, V13, P15, DOI 10.1177/089033449701300111; LUCAS A, 1992, LANCET, V339, P261, DOI 10.1016/0140-6736(92)91329-7; Meier PP, 2007, NEOREVIEWS, V8, P467, DOI DOI 10.1542/NEO.8-11-E467; Patel AL, 2013, J PERINATOL, V33, P514, DOI 10.1038/jp.2013.2; Ronnestad A, 2005, PEDIATRICS, V115, pE269, DOI 10.1542/peds.2004-1833; Sullivan S, 2010, J PEDIATR-US, V156, P562, DOI 10.1016/j.jpeds.2009.10.040; Sweet L, 2008, INT BREASTFEED J, V3, DOI 10.1186/1746-4358-3-30; Vohr BR, 2006, PEDIATRICS, V118, pE115, DOI 10.1542/peds.2005-2382	22	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144123	10.1371/journal.pone.0144123	http://dx.doi.org/10.1371/journal.pone.0144123			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26637118	gold, Green Submitted, Green Published			2022-12-27	WOS:000366143800043
J	Chu, YW; Liu, ST; Cheng, HC; Huang, SM; Chang, YL; Chiang, CP; Liu, YC; Wang, WM				Chu, Yu-Wen; Liu, Shu-Ting; Cheng, Hsiao-Chun; Huang, Shih-Ming; Chang, Yung-Lung; Chiang, Chien-Ping; Liu, Ying-Chun; Wang, Wei-Ming			Opposing Effects of Zac1 and Curcumin on AP-1-Regulated Expressions of S100A7	PLOS ONE			English	Article							NF-KAPPA-B; PSORIASIN S100A7; GENE-EXPRESSION; EPIDERMAL DIFFERENTIATION; ATOPIC-DERMATITIS; PROTEIN PSORIASIN; PHORBOL ESTER; AP-1; SKIN; TRANSCRIPTION	ZAC, an encoding gene mapped at chromosome 6q24-q25 within PSORS1, was previously found over-expressed in the lower compartment of the hyperplastic epidermis in psoriatic lesions. Cytokines produced in the inflammatory dermatoses may drive AP-1 transcription factor to induce responsive gene expressions. We demonstrated that mZac1 can enhance AP-1-responsive S100A7 expression of which the encoding gene was located in PSORS4 with HaCaT keratinocytes. However, the mZac1-enhanced AP-1 transcriptional activity was suppressed by curcumin, indicating the anti-inflammatory property of this botanical agent and is exhibited by blocking the AP-1-mediated cross-talk between PSORS1 and PSORS4. Two putative AP-1-binding sites were found and demonstrated to be functionally important in the regulation of S100A7 promoter activity. Moreover, we found curcumin reduced the DNA-binding activity of AP-1 to the recognition element located in the S100A7 promoter. The S100A7 expression was found to be upregulated in the lesioned epidermis of atopic dermatitis and psoriasis, which is where this keratinocyte-derived chemoattractant engaged in the pro-inflammatory feedback loop. Understanding the regulatory mechanism of S100A7 expression will be helpful to develop therapeutic strategies for chronic inflammatory dermatoses via blocking the reciprocal stimuli between the inflammatory cells and keratinocytes.	[Chu, Yu-Wen; Wang, Wei-Ming] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Chu, Yu-Wen] Taichung Vet Gen Hosp, Dept Pharm, Taichung, Taiwan; [Liu, Shu-Ting; Cheng, Hsiao-Chun; Huang, Shih-Ming; Chang, Yung-Lung; Chiang, Chien-Ping; Wang, Wei-Ming] Natl Def Med Ctr, Dept Biochem, Taipei, Taiwan; [Liu, Ying-Chun] Natl Def Med Ctr, Sch Nursing, Taipei, Taiwan; [Liu, Ying-Chun] Natl Yang Ming Univ, Sch Nursing, Taipei 112, Taiwan; [Chiang, Chien-Ping; Wang, Wei-Ming] Triserv Gen Hosp, Dept Dermatol, Natl Def Med Ctr, Taipei, Taiwan	National Defense Medical Center; Taichung Veterans General Hospital; National Defense Medical Center; National Defense Medical Center; National Yang Ming Chiao Tung University; National Defense Medical Center; Tri-Service General Hospital	Huang, SM (corresponding author), Natl Def Med Ctr, Dept Biochem, Taipei, Taiwan.	shihming@ndmctsgh.edu.tw; ades0431@ms38.hinet.net			National Science Council [NSC 99-2314-B-016-005-MY3, NSC 102-2314-B-016-011-MY2, MOST 104-2314-B-016-031-MY3]; Tri-Service General Hospital, Taiwan, ROC [TSGH-C103-040]	National Science Council(Ministry of Science and Technology, Taiwan); Tri-Service General Hospital, Taiwan, ROC	This work was supported by grants from the National Science Council [NSC 99-2314-B-016-005-MY3, NSC 102-2314-B-016-011-MY2 and MOST 104-2314-B-016-031-MY3 to W-M Wang] and the Tri-Service General Hospital [TSGH-C103-040 to W-M Wang], Taiwan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript in this revision version.	Aggarwal BB, 2009, INT J BIOCHEM CELL B, V41, P40, DOI 10.1016/j.biocel.2008.06.010; Albanesi C, 2010, CURR OPIN ALLERGY CL, V10, P452, DOI 10.1097/ACI.0b013e32833e08ae; Angel P, 2001, ONCOGENE, V20, P2413, DOI 10.1038/sj.onc.1204380; Bangert C, 2011, CLIN DERMATOL, V29, P360, DOI 10.1016/j.clindermatol.2011.01.006; Basyuk E, 2005, MOL CANCER RES, V3, P483, DOI 10.1158/1541-7786.MCR-05-0019; Buchau AS, 2007, CLIN DERMATOL, V25, P616, DOI 10.1016/j.clindermatol.2007.08.016; CELIS JE, 1990, ELECTROPHORESIS, V11, P242, DOI 10.1002/elps.1150110308; Chand S, 2012, CURR PHARM DESIGN, V18, P4725, DOI 10.2174/138161212802651625; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Eckert RL, 2006, J INVEST DERMATOL, V126, P1442, DOI 10.1038/sj.jid.5700265; Eckert RL, 2004, J INVEST DERMATOL, V123, P23, DOI 10.1111/j.0022-202X.2004.22719.x; Eckert RL, 1996, MOL BIOL REP, V23, P59, DOI 10.1007/BF00357073; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Elder JT, 2010, J INVEST DERMATOL, V130, P1213, DOI 10.1038/jid.2009.319; Foletta VC, 1998, J LEUKOCYTE BIOL, V63, P139, DOI 10.1002/jlb.63.2.139; Gittler JK, 2012, J ALLERGY CLIN IMMUN, V130, P1344, DOI 10.1016/j.jaci.2012.07.012; Glaser R, 2011, J DTSCH DERMATOL GES, V9, P897, DOI [10.1111/j.1610-0387.2011.07683.x, 10.1111/j.1610-0387.2011.07718_suppl.x]; Glaser R, 2009, J INVEST DERMATOL, V129, P641, DOI 10.1038/jid.2008.268; Glaser R, 2005, NAT IMMUNOL, V6, P57, DOI 10.1038/ni1142; Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016; Gross SR, 2014, CELL MOL LIFE SCI, V71, P1551, DOI 10.1007/s00018-013-1400-7; Guilloteau K, 2010, J IMMUNOL; Han SS, 2002, J BIOCHEM MOL BIOL, V35, P337; Hegyi Z, 2012, J INVEST DERMATOL, V132, P1416, DOI 10.1038/jid.2011.486; Hsu L, 2014, BRIT J DERMATOL, V170, P261, DOI 10.1111/bjd.12654; Jullien D, 2006, J EUR ACAD DERMATOL, V20, P42, DOI 10.1111/j.1468-3083.2006.01772.x; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kaur J, 2014, INT J CANCER, V134, P1379, DOI 10.1002/ijc.28473; Kurd SK, 2008, J AM ACAD DERMATOL, V58, P625, DOI 10.1016/j.jaad.2007.12.035; Liang Y, 2014, EUR J IMMUNOL, V44, P1265, DOI 10.1002/eji.201344369; Liu PY, 2011, EXP CELL RES, V317, P2925, DOI 10.1016/j.yexcr.2011.09.018; Liu WC, 2009, J BIOL CHEM, V284, P24006, DOI 10.1074/jbc.M109.025528; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Lowes MA, 2013, TRENDS IMMUNOL, V34, P174, DOI 10.1016/j.it.2012.11.005; Lynch M, 2014, EXPERT REV CLIN IMMU, V10, P269, DOI 10.1586/1744666X.2014.873701; Ma H, 1999, MOL CELL BIOL, V19, P6164; MADSEN P, 1991, J INVEST DERMATOL, V97, P701, DOI 10.1111/1523-1747.ep12484041; Michalek M, 2009, DEV COMP IMMUNOL, V33, P740, DOI 10.1016/j.dci.2008.12.005; Nakatsuji T, 2012, J INVEST DERMATOL, V132, P887, DOI 10.1038/jid.2011.387; Nickoloff BJ, 2006, TRENDS MOL MED, V12, P102, DOI 10.1016/j.molmed.2006.01.001; Oh IY, 2014, J INVEST DERMATOL, V134, P2371, DOI 10.1038/jid.2014.44; Ryan C, 2014, J AM ACAD DERMATOL, V70, P146, DOI 10.1016/j.jaad.2013.08.042; Semprini S, 1999, HUM GENET, V104, P130, DOI 10.1007/s004390050925; Sun WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092927; Surh YJ, 2000, BIOFACTORS, V12, P107, DOI 10.1002/biof.5520120117; Tsuchisaka A, 2014, J INVEST DERMATOL, V134, P1194, DOI 10.1038/jid.2014.15; Wang WM, 2008, PROTEIN EXPRES PURIF, V59, P144, DOI 10.1016/j.pep.2008.01.016; Wang WM, 2011, DERMATOL SIN, V29, P115, DOI 10.1016/j.dsi.2011.09.001; Wang WM, 2011, J BIOL CHEM, V286, P40974, DOI 10.1074/jbc.M111.290874; Wang WM, 2011, BBA-MOL CELL RES, V1813, P2050, DOI 10.1016/j.bbamcr.2011.08.005; Watson PH, 1998, INT J BIOCHEM CELL B, V30, P567, DOI 10.1016/S1357-2725(97)00066-6; West NR, 2010, ONCOGENE, V29, P2083, DOI 10.1038/onc.2009.488; Wolf R, 2006, J INVEST DERMATOL, V126, P1600, DOI 10.1038/sj.jid.5700210; Wu MH, 2007, INT J BIOCHEM CELL B, V39, P413, DOI 10.1016/j.biocel.2006.09.008; Zhao W, 1997, J VIROL, V71, P8832, DOI 10.1128/JVI.71.11.8832-8840.1997; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	56	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144175	10.1371/journal.pone.0144175	http://dx.doi.org/10.1371/journal.pone.0144175			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633653	Green Submitted, gold, Green Published			2022-12-27	WOS:000366040000067
J	Silva, DN; Duplessis, S; Talhinhas, P; Azinheira, H; Paulo, OS; Batista, D				Silva, Diogo N.; Duplessis, Sebastien; Talhinhas, Pedro; Azinheira, Helena; Paulo, Octavio S.; Batista, Dora			Genomic Patterns of Positive Selection at the Origin of Rust Fungi	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; PATHOGENIC FUNGUS; NATURAL-SELECTION; MODEL; EVOLUTION; ADAPTATION; ALIGNMENT; VIRULENCE; OBLIGATE; SEQUENCE	Understanding the origin and evolution of pathogenicity and biotrophic life-style of rust fungi has remained a conundrum for decades. Research on the molecular mechanisms responsible for rust fungi evolution has been hampered by their biotrophic life-style until the sequencing of some rust fungi genomes. With the availability of multiple whole genomes and EST data for this group, it is now possible to employ genome-wide surveys and investigate how natural selection shaped their evolution. In this work, we employed a phylogenomics approach to search for positive selection and genes undergoing accelerated evolution at the origin of rust fungi on an assembly of single copy genes conserved across a broad range of basidiomycetes. Up to 985 genes were screened for positive selection on the phylogenetic branch leading to rusts, revealing a pervasive signal of positive selection throughout the data set with the proportion of positively selected genes ranging between 19.6-33.3%. Additionally, 30 genes were found to be under accelerated evolution at the origin of rust fungi, probably due to a mixture of positive selection and relaxation of purifying selection. Functional annotation of the positively selected genes revealed an enrichment in genes involved in the biosynthesis of secondary metabolites and several metabolism and transporter classes.	[Silva, Diogo N.; Talhinhas, Pedro; Azinheira, Helena; Batista, Dora] Univ Lisbon, Inst Super Agron, Ctr Invest Ferrugens Cafeeiro, Oeiras, Portugal; [Silva, Diogo N.; Paulo, Octavio S.; Batista, Dora] Univ Lisbon, Fac Ciencias, Computat Biol & Populat Genom Grp, CE3c Ctr Ctr Ecol Evolut & Environm Changes, Lisbon, Portugal; [Silva, Diogo N.] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Silva, Diogo N.] Univ Aveiro, CESAM Centro Estudos Ambiente & Mar, P-3800 Aveiro, Portugal; [Duplessis, Sebastien] Univ Lorraine Interact Arbres Microorganismes, INRA, UMR 1136, Champenoux, France; [Duplessis, Sebastien] Univ Lorraine Interact Arbres Microorganismes, INRA, Univ Lorraine, UMR 1136, Vandoeuvre Les Nancy, France; [Talhinhas, Pedro; Azinheira, Helena] Univ Lisbon, Inst Super Agron, Linking Landscape Environm Agr & Food, LEAF, P-1699 Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa; Universidade de Aveiro; Universidade de Aveiro; INRAE; Universite de Lorraine; INRAE; Universite de Lorraine; Universidade de Lisboa	Silva, DN (corresponding author), Univ Lisbon, Inst Super Agron, Ctr Invest Ferrugens Cafeeiro, Oeiras, Portugal.	o.diogosilva@gmail.com	Paulo, Octávio/D-9921-2011; , DUPLESSIS/G-4150-2011; Azinheira, Helena/ADX-1184-2022; Batista, Dora/N-7385-2013	Paulo, Octávio/0000-0001-5408-5212; , DUPLESSIS/0000-0002-2072-2989; Azinheira, Helena/0000-0002-9007-0082; Batista, Dora/0000-0003-4031-8999; Silva, Diogo/0000-0002-6827-2673	Fundacao para a Ciencia e Tecnologia (FCT) [PTDC/AGR-GPL/119943/2010]; FCT [UID/BIA/00329/2013, SFRH/BD/86736/2012, SFRH/BPD/88994/2012, SFRH/BPD/104629/2014]; Agence Nationele de la Recherche (France) "Investissements d'Avenir" program (Lab of Excellence ARBRE) [ANR-11-LABX-0002-01]	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Agence Nationele de la Recherche (France) "Investissements d'Avenir" program (Lab of Excellence ARBRE)(French National Research Agency (ANR))	The project was funded by project grant PTDC/AGR-GPL/119943/2010 from the Fundacao para a Ciencia e Tecnologia (FCT) (http://www.fct.pt/) and by FCT Unit funding UID/BIA/00329/2013. DNS acknowledges the FCT grant SFRH/BD/86736/2012. SD acknowledges the Agence Nationele de la Recherche (France) "Investissements d'Avenir" program (ANR-11-LABX-0002-01, Lab of Excellence ARBRE). PT acknowledges the FCT grant SFRH/BPD/88994/2012. DB acknowledges the FCT grant SFRH/BPD/104629/2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Aguileta G, 2010, MOL ECOL, V19, P292, DOI 10.1111/j.1365-294X.2009.04454.x; Aguileta G, 2012, INFECT GENET EVOL, V12, P987, DOI 10.1016/j.meegid.2012.02.012; Aguileta G, 2009, INFECT GENET EVOL, V9, P656, DOI 10.1016/j.meegid.2009.03.010; Aime MC, 2006, MYCOLOGIA, V98, P896, DOI 10.3852/mycologia.98.6.896; Aime M. Catherine, 2006, Mycoscience, V47, P112, DOI 10.1007/s10267-006-0281-0; Anisimova M, 2007, HEREDITY, V99, P567, DOI 10.1038/sj.hdy.6801052; Bailey A, 2000, J BIOL CHEM, V275, P14242, DOI 10.1074/jbc.275.19.14242; Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; Barrett RDH, 2011, NAT REV GENET, V12, P767, DOI 10.1038/nrg3015; Benner Steven A., 2007, V75, P1; Cantu Dario, 2013, BMC Genomics, V14, P270, DOI 10.1186/1471-2164-14-270; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Chen YA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-416; Duplessis S, 2011, P NATL ACAD SCI USA, V108, P9166, DOI 10.1073/pnas.1019315108; Ebersberger I, 2012, MOL BIOL EVOL, V29, P1319, DOI 10.1093/molbev/msr285; Ebersberger I, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-157; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Fernandez D, 2013, MYCOTA; Goldstein AL, 2001, GENETICS, V159, P499; Griffith CL, 2004, J BIOL CHEM, V279, P51669, DOI 10.1074/jbc.M408889200; Hunt BG, 2011, P NATL ACAD SCI USA, V108, P15936, DOI 10.1073/pnas.1104825108; Jordan G, 2012, MOL BIOL EVOL, V29, P1125, DOI 10.1093/molbev/msr272; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Lee CM, 2004, MOL MICROBIOL, V51, P691, DOI 10.1111/j.1365-2958.2003.03879.x; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liebmann B, 2004, ARCH MICROBIOL, V181, P378, DOI 10.1007/s00203-004-0667-3; Link T, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00587; Ma T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3797; MacColl ADC, 2011, TRENDS ECOL EVOL, V26, P514, DOI 10.1016/j.tree.2011.06.009; Maier W, 2007, MYCOL RES, V111, P176, DOI 10.1016/j.mycres.2006.11.005; Maor BP, 2004, BIOCHEM J, V381, P131, DOI 10.1042/BJ20031075; Miller M.A., 2010, P GAT COMP ENV WORKS; Nemri A, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00098; Nery MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065491; Pendleton AL, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00299; Perpetua NS, 1996, MOL PLANT MICROBE IN, V9, P323, DOI 10.1094/MPMI-9-0323; Powell S, 2014, NUCLEIC ACIDS RES, V42, pD231, DOI 10.1093/nar/gkt1253; Roux J, 2014, MOL BIOL EVOL, V31, P1661, DOI 10.1093/molbev/msu141; RUIZHERRERA J, 1994, CRIT REV MICROBIOL, V20, P143, DOI 10.3109/10408419409113553; Sela I, 2015, NUCLEIC ACIDS RES, V43, pW7, DOI 10.1093/nar/gkv318; Shaffer HB, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r28; Spanu PD, 2012, ANNU REV PHYTOPATHOL, V50, P91, DOI 10.1146/annurev-phyto-081211-173024; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Staples RC, 2000, ANNU REV PHYTOPATHOL, V38, P49, DOI 10.1146/annurev.phyto.38.1.49; Stukenbrock EH, 2007, MOL PLANT PATHOL, V8, P321, DOI 10.1111/J.1364-3703.2007.00396.X; Sun CB, 2006, PLANT CELL, V18, P3686, DOI 10.1105/tpc.105.037861; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Talhinhas P, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00088; Tellier A, 2014, EVOLUTION, V68, P2211, DOI 10.1111/evo.12427; Valdes-Santiago Laura, 2012, J Amino Acids, V2012, P837932, DOI 10.1155/2012/837932; Valdes-Santiago L, 2012, MICROBIOL-SGM, V158, P674, DOI 10.1099/mic.0.055954-0; Valle M, 2014, BIOINFORMATICS, V30, P1129, DOI 10.1093/bioinformatics/btt760; Vamathevan JJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-273; Van der Merwe MM, 2009, P ROY SOC B-BIOL SCI, V276, P2913, DOI 10.1098/rspb.2009.0328; Van Dongen S.M., 2000, THESIS UTRECHT U; Vitti JJ, 2013, ANNU REV GENET, V47, P97, DOI 10.1146/annurev-genet-111212-133526; Wang XX, 2004, HUM MOL GENET, V13, P2671, DOI 10.1093/hmg/ddh289; Wang Y, 2013, PLANT J, V76, P557, DOI 10.1111/tpj.12313; Wei RX, 2011, J INTEGR PLANT BIOL, V53, P682, DOI 10.1111/j.1744-7909.2011.01058.x; Wilson RA, 2007, EMBO J, V26, P3673, DOI 10.1038/sj.emboj.7601795; Win J, 2007, PLANT CELL, V19, P2349, DOI 10.1105/tpc.107.051037; Winnenburg R, 2006, NUCLEIC ACIDS RES, V34, pD459, DOI 10.1093/nar/gkj047; Wu MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030288; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064; Xiao JH, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r141; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yang ZH, 2011, MOL BIOL EVOL, V28, P1217, DOI 10.1093/molbev/msq303; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhao L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064642	74	9	8	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143959	10.1371/journal.pone.0143959	http://dx.doi.org/10.1371/journal.pone.0143959			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26632820	Green Published, Green Submitted, gold			2022-12-27	WOS:000366040000035
J	Stockley, J; Nisar, SP; Leo, VC; Sabi, E; Cunningham, MR; Eikenboom, JC; Lethagen, S; Schneppenheim, R; Goodeve, AC; Watson, SP; Mundell, SJ; Daly, ME				Stockley, Jacqueline; Nisar, Shaista P.; Leo, Vincenzo C.; Sabi, Essa; Cunningham, Margaret R.; Eikenboom, Jeroen C.; Lethagen, Stefan; Schneppenheim, Reinhard; Goodeve, Anne C.; Watson, Steve P.; Mundell, Stuart J.; Daly, Martina E.		GAPP Study; MCMDM-1VWD Study Gp	Identification and Characterization of Novel Variations in Platelet G-Protein Coupled Receptor (GPCR) Genes in Patients Historically Diagnosed with Type 1 von Willebrand Disease	PLOS ONE			English	Article							THROMBOXANE A(2) RECEPTOR; VARIANT; MUTATION; DYSFUNCTION; HEMOSTASIS; ACTIVATION; MCMDM-1VWD; GENOTYPE; FAMILIES; DENSITY	The clinical expression of type 1 von Willebrand disease may be modified by co-inheritance of other mild bleeding diatheses. We previously showed that mutations in the platelet P2Y12 ADP receptor gene (P2RY12) could contribute to the bleeding phenotype in patients with type 1 von Willebrand disease. Here we investigated whether variations in platelet G protein-coupled receptor genes other than P2RY12 also contributed to the bleeding phenotype. Platelet G protein-coupled receptor genes P2RY1, F2R, F2RL3, TBXA2R and PTGIR were sequenced in 146 index cases with type 1 von Willebrand disease and the potential effects of identified single nucleotide variations were assessed using in silico methods and heterologous expression analysis. Seven heterozygous single nucleotide variations were identified in 8 index cases. Two single nucleotide variations were detected in F2R; a novel c.-67G> C transversion which reduced F2R transcriptional activity and a rare c. 1063C> T transition predicting a p. L355F substitution which did not interfere with PAR1 expression or signalling. Two synonymous single nucleotide variations were identified in F2RL3 (c. 402C> G, p. A134 =; c. 1029 G> C p. V343 =), both of which introduced less commonly used codons and were predicted to be deleterious, though neither of them affected PAR4 receptor expression. A third single nucleotide variation in F2RL3 (c. 65 C> A; p. T22N) was co-inherited with a synonymous single nucleotide variation in TBXA2R (c. 6680 C> T, p. S218 =). Expression and signalling of the p. T22N PAR4 variant was similar to wild-type, while the TBXA2R variation introduced a cryptic splice site that was predicted to cause premature termination of protein translation. The enrichment of single nucleotide variations in G protein-coupled receptor genes among type 1 von Willebrand disease patients supports the view of type 1 von Willebrand disease as a polygenic disorder.	[Stockley, Jacqueline; Leo, Vincenzo C.; Sabi, Essa; Goodeve, Anne C.; Daly, Martina E.] Univ Sheffield, Dept Cardiovasc Sci, Sheffield, S Yorkshire, England; [Nisar, Shaista P.; Cunningham, Margaret R.; Mundell, Stuart J.] Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England; [Eikenboom, Jeroen C.] Leiden Univ, Med Ctr, Dept Thrombosis & Hemostasis, Leiden, Netherlands; [Lethagen, Stefan] Rigshosp, Univ Hosp, Natl Haemophilia Ctr, DK-2100 Copenhagen, Denmark; [Schneppenheim, Reinhard] Univ Med Ctr Hamburg Eppendorf, Dept Pediat Hematol & Oncol, Hamburg, Germany; [Watson, Steve P.] Univ Birmingham, Coll Med & Dent Sci, Ctr Cardiovasc Sci, Birmingham, W Midlands, England	University of Sheffield; University of Bristol; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Rigshospitalet; University of Copenhagen; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Birmingham	Daly, ME (corresponding author), Univ Sheffield, Dept Cardiovasc Sci, Sheffield, S Yorkshire, England.	m.daly@sheffield.ac.uk	Eikenboom, Jeroen/F-9156-2018; Tosetto, Alberto/AAM-3200-2020; Watson, Stephen P/Q-6292-2016	Eikenboom, Jeroen/0000-0002-3268-5759; Tosetto, Alberto/0000-0002-0119-5204; Watson, Stephen P/0000-0002-7846-7423; Stockley, Jacqueline/0000-0001-6601-5107; Cunningham, Margaret/0000-0001-6454-8671	British Heart Foundation [RG/09/007/27917]; European Community under the Fifth Framework Programme [QLG1-CT-2000-00387]; British Heart Foundation [FS/11/49/28751] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); European Community under the Fifth Framework Programme; British Heart Foundation(British Heart Foundation)	This work was funded by the British Heart Foundation, www.bhf.org.uk/ (RG/09/007/27917). SPW holds a BHF Chair. The MCMDM-1VWD study was supported by the European Community under the Fifth Framework Programme (QLG1-CT-2000-00387).	Broos K, 2011, BLOOD REV, V25, P155, DOI 10.1016/j.blre.2011.03.002; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Cumming A, 2006, THROMB HAEMOSTASIS, V96, P630, DOI 10.1160/TH06-07-0383; Cunningham MR, 2012, J BIOL CHEM, V287, P16656, DOI 10.1074/jbc.M111.315911; Daly ME, 2009, BLOOD, V113, P4110, DOI 10.1182/blood-2008-11-190850; Dupont A, 2003, BLOOD, V101, P1833, DOI 10.1182/blood-2002-07-2149; Getz TM, 2010, J THROMB HAEMOST, V8, P2283, DOI 10.1111/j.1538-7836.2010.04000.x; Gilissen C, 2012, EUR J HUM GENET, V20, P490, DOI 10.1038/ejhg.2011.258; GILL JC, 1987, BLOOD, V69, P1691; Goodeve A, 2007, BLOOD, V109, P112, DOI 10.1182/blood-2006-05-020784; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Hirata T, 1996, J CLIN INVEST, V97, P949, DOI 10.1172/JCI118518; James PD, 2007, BLOOD, V109, P145, DOI 10.1182/blood-2006-05-021105; Kamae T, 2011, J THROMB HAEMOST, V9, P1040, DOI 10.1111/j.1538-7836.2011.04245.x; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Knobe KE, 2008, HAEMOPHILIA, V14, P723, DOI 10.1111/j.1365-2516.2008.01753.x; Lillicrap D, 2013, BLOOD, V122, P3735, DOI 10.1182/blood-2013-06-498303; Mumford AD, 2013, J THROMB HAEMOST, V11, P547, DOI 10.1111/jth.12117; Mumford AD, 2010, BLOOD, V115, P363, DOI 10.1182/blood-2009-08-236976; Nisar S, 2011, BLOOD, V118, P5641, DOI 10.1182/blood-2011-02-336826; Nisar SP, 2014, THROMB HAEMOSTASIS, V111, P923, DOI 10.1160/TH13-08-0672; Offermanns S, 2006, CIRC RES, V99, P1293, DOI 10.1161/01.RES.0000251742.71301.16; Ramstrom S, 2008, THROMB RES, V121, P681, DOI 10.1016/j.thromres.2007.06.010; Smith NL, 2010, CIRCULATION, V121, P1382, DOI 10.1161/CIRCULATIONAHA.109.869156; Tosetto A, 2006, J THROMB HAEMOST, V4, P766, DOI 10.1111/j.1538-7836.2006.01847.x; Tricoci P, 2012, NEW ENGL J MED, V366, P20, DOI 10.1056/NEJMoa1109719; Xu WF, 1998, P NATL ACAD SCI USA, V95, P6642, DOI 10.1073/pnas.95.12.6642; Zhang C, 2012, NATURE, V492, P387, DOI 10.1038/nature11701	28	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143913	10.1371/journal.pone.0143913	http://dx.doi.org/10.1371/journal.pone.0143913			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630678	Green Published, gold, Green Accepted			2022-12-27	WOS:000365926300121
J	Tan, SH; Sapari, NS; Miao, H; Hartman, M; Loh, M; Chng, WJ; Iau, P; Buhari, SA; Soong, R; Lee, SC				Tan, Sing-Huang; Sapari, Nur Sabrina; Miao, Hui; Hartman, Mikael; Loh, Marie; Chng, Wee-Joo; Iau, Philip; Buhari, Shaik Ahmad; Soong, Richie; Lee, Soo-Chin			High-Throughput Mutation Profiling Changes before and 3 Weeks after Chemotherapy in Newly Diagnosed Breast Cancer Patients	PLOS ONE			English	Article							GENE-EXPRESSION CHANGES; PIK3CA MUTATIONS; NEOADJUVANT CHEMOTHERAPY; GROWTH; HETEROGENEITY; EVOLUTION; ONCOGENE; THERAPY	Background Changes in tumor DNA mutation status during chemotherapy can provide insights into tumor biology and drug resistance. The purpose of this study is to analyse the presence or absence of mutations in cancer-related genes using baseline breast tumor samples and those obtained after exposure to one cycle of chemotherapy to determine if any differences exist, and to correlate these differences with clinical and pathological features. Methods Paired breast tumor core biopsies obtained pre- and post-first cycle doxorubicin (n = 18) or docetaxel (n = 22) in treatment-naive breast cancer patients were analysed for 238 mutations in 19 cancer-related genes by the Sequenom Oncocarta assay. Results Median age of patients was 48 years (range 32-64); 55% had estrogen receptor-positive tumors, and 60% had tumor reduction >= 25% after cycle 1. Mutations were detected in 10/40 (25%) pre-treatment and 11/40 (28%) post-treatment samples. Four mutation pattern categories were identified based on tumor mutation status pre- -> post-treatment: wildtype (WT)-> WT, n = 24; mutant (MT)-> MT, n = 5; MT -> WT, n = 5; WT -> MT, n = 6. Overall, the majority of tumors were WT at baseline (30/40, 75%), of which 6/30 (20%) acquired new mutations after chemotherapy. Pre-treatment mutations were predominantly in PIK3CA (8/10, 80%), while post-treatment mutations were distributed in PIK3CA, EGFR, PDGFRA, ABL1 and MET. All 6WT -> MT cases were treated with docetaxel. Higher mutant allele frequency in baseline MT tumors (n = 10; PIK3CA mutations n = 8) correlated with less tumor reduction after cycle 1 chemotherapy (R = -0.667, p = 0.035). No other associations were observed between mutation pattern category with treatment, clinicopathological features, and tumor response or survival. Conclusion Tumor mutational profiles can change as quickly as after one cycle of chemotherapy in breast cancer. Understanding of these changes can provide insights on potential therapeutic options in residual resistant tumors.	[Tan, Sing-Huang; Chng, Wee-Joo; Lee, Soo-Chin] Natl Univ Hlth Syst, Natl Univ Canc Inst Singapore, Dept Haematol Oncol, Singapore, Singapore; [Sapari, Nur Sabrina; Loh, Marie; Chng, Wee-Joo; Soong, Richie; Lee, Soo-Chin] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Miao, Hui] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Hartman, Mikael; Iau, Philip; Buhari, Shaik Ahmad] Natl Univ Hlth Syst, Natl Univ Canc Inst Singapore, Dept Surg, Singapore, Singapore; [Soong, Richie] Natl Univ Singapore, Dept Pathol, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore	Lee, SC (corresponding author), Natl Univ Hlth Syst, Natl Univ Canc Inst Singapore, Dept Haematol Oncol, Singapore, Singapore.	csilsc@nus.edu.sg	Iau, Philip/B-4641-2011; Lee, Soo Chin/S-9111-2016; Buhari, Shaik Ahmad/C-7597-2011; Hartman, Mikael/B-4324-2011	Lee, Soo Chin/0000-0002-5835-6419; Loh, Marie/0000-0003-3626-8466; Hartman, Mikael/0000-0001-5726-9965	National Medical Research Council (NMRC), Singapore [NMRC/CG/NCIS/2010, NPRC10/NM16O, NMRC/CSI/0015/2009]	National Medical Research Council (NMRC), Singapore(National Medical Research Council, Singapore)	This work was supported by grants from the National Medical Research Council (NMRC), Singapore [grant numbers NMRC/CG/NCIS/2010 [NPRC10/NM16O]; NMRC/CSI/0015/2009].	Buchholz TA, 2002, CANCER J, V8, P461, DOI 10.1097/00130404-200211000-00010; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; Ehrich M, 2008, 12112008 SEQ; Fumagalli D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-101; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gordon MS, 2011, ASCO MEETING ABSTRAC, V29, P3010; Jiang YZ, 2014, CANCER RES, V74, P3399, DOI 10.1158/0008-5472.CAN-14-0092; Kancha RK, 2009, CLIN CANCER RES, V15, P460, DOI 10.1158/1078-0432.CCR-08-1757; Karakas B, 2006, BRIT J CANCER, V94, P455, DOI 10.1038/sj.bjc.6602970; Lee SC, 2009, PHARMACOGENET GENOM, V19, P833, DOI 10.1097/FPC.0b013e328330a39f; Lee SC, 2009, PHARMACOGENET GENOM, V19, P181, DOI 10.1097/FPC.0b013e32831ebb5d; Loibl S, 2014, J CLIN ONCOL, V32, P3212, DOI 10.1200/JCO.2014.55.7876; Majewski IJ, 2015, J CLIN ONCOL, V33, P1334, DOI 10.1200/JCO.2014.55.2158; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Ng CKY, 2012, EXPERT REV ANTICANC, V12, P1021, DOI [10.1586/ERA.12.85, 10.1586/era.12.85]; Osborne C, 2004, ONCOLOGIST, V9, P361, DOI 10.1634/theoncologist.9-4-361; Santarpia L, 2012, BREAST CANCER RES TR, V134, P333, DOI 10.1007/s10549-012-2035-3; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Teng YHF, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2857; Walerych D, 2012, CARCINOGENESIS, V33, P2007, DOI 10.1093/carcin/bgs232; Wang SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051021; Wang Y, 2014, NATURE, V512, P155, DOI 10.1038/nature13600; Winer EP, 2012, J CLIN ONCOL S, V30; Yakes FM, 2011, MOL CANCER THER, V10, P2298, DOI 10.1158/1535-7163.MCT-11-0264	26	16	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0142466	10.1371/journal.pone.0142466	http://dx.doi.org/10.1371/journal.pone.0142466			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630576	Green Submitted, Green Published, gold			2022-12-27	WOS:000365926300010
J	Uys, P; Brand, H; Warren, R; van der Spuy, G; Hoal, EG; van Helden, PD				Uys, Pieter; Brand, Hilmarie; Warren, Robin; van der Spuy, Gian; Hoal, Eileen G.; van Helden, Paul D.			The Risk of Tuberculosis Reinfection Soon after Cure of a First Disease Episode Is Extremely High in a Hyperendemic Community	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; SUSCEPTIBILITY; TRANSMISSION; INFECTION	Elevated rates of reinfection tuberculosis in various hyperendemic regions have been reported and, in particular, it has been shown that in a high-incidence setting near Cape Town, South Africa, the rate of reinfection tuberculosis (TB) disease after cure of a previous TB disease episode is about four times greater than the rate of first-time TB disease. It is not known whether this elevated rate is caused by a high reinfection rate due, for instance, to living circumstances, or a high rate of progress to disease specific to the patients, or both. In order to address that question we analysed an extensive data set from clinics attended by TB patients in the high-incidence setting near Cape Town, South Africa and found that, in fact, the (average) rate of reinfection (as opposed to the rate of reinfection disease) after cure of a previous TB disease episode is initially about 0.85 per annum. This rate diminishes rapidly over time and after about ten years this rate is similar to the rate of infection in the general population. Also, the rate of progress to disease after reinfection is initially high but declines in subsequent years down to the figure typical for the general population. These findings suggest that the first few months after cure of a TB disease episode form a critical period for controlling reinfection disease in a hyperendemic setting and that monitoring such cured patients could pre-empt a reinfection progressing to active disease.	[Uys, Pieter; Brand, Hilmarie] Univ Stellenbosch, DST NRF Ctr Excellence Epidemiol Modelling & Anal, SACEMA, ZA-7600 Stellenbosch, Western Cape, South Africa; [Uys, Pieter; Warren, Robin; van der Spuy, Gian; Hoal, Eileen G.; van Helden, Paul D.] Univ Stellenbosch, Fac Hlth Sci, Div Mol Biol & Human Genet, DST NRF Ctr Excellence Biomed TB Res,MRC Ctr Mol, ZA-7600 Stellenbosch, Western Cape, South Africa	National Research Foundation - South Africa; Stellenbosch University; National Research Foundation - South Africa; Stellenbosch University	Uys, P (corresponding author), Univ Stellenbosch, DST NRF Ctr Excellence Epidemiol Modelling & Anal, SACEMA, ZA-7600 Stellenbosch, Western Cape, South Africa.	pieter@edserve.co.za	van der Spuy, Gian/AAY-7701-2020	van der Spuy, Gian/0000-0002-9067-5903; Warren, Robin/0000-0001-5741-7358				Andrews JR, 2012, CLIN INFECT DIS, V54, P784, DOI 10.1093/cid/cir951; Chiang CY, 2005, LANCET INFECT DIS, V5, P629, DOI 10.1016/S1473-3099(05)70240-1; Chimusa ER, 2014, HUM MOL GENET, V23, P796, DOI 10.1093/hmg/ddt462; Cobat A, 2015, J INFECT DIS, V211, P317, DOI 10.1093/infdis/jiu446; Cobat A, 2010, J INFECT DIS, V201, P15, DOI 10.1086/648611; Cobat A, 2009, J EXP MED, V206, P2583, DOI 10.1084/jem.20090892; COMSTOCK GW, 1978, AM REV RESPIR DIS, V117, P621; Daya M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1021; Daya M, 2014, TUBERCULOSIS, V94, P413, DOI 10.1016/j.tube.2014.03.012; Gomes MGM, 2012, P ROY SOC B-BIOL SCI, V279, P2473, DOI 10.1098/rspb.2011.2712; Hirsch CS, 1999, J INFECT DIS, V180, P2069, DOI 10.1086/315114; Kalbfleisch J.D., 1980, STAT ANAL FAILURE TI, DOI [10.1002/9781118032985, DOI 10.1002/9781118032985]; Klein JP, 2003, SURVIVAL ANAL; Kumar D, 2011, MICROBES INFECT, V13, P121, DOI 10.1016/j.micinf.2010.10.009; Marx FM, 2014, CLIN INFECT DIS, V58, P1676, DOI 10.1093/cid/ciu186; Moller M, 2010, TUBERCULOSIS, V90, P71, DOI 10.1016/j.tube.2010.02.002; Rodrigues P, 2009, J THEOR BIOL, V259, P280, DOI 10.1016/j.jtbi.2009.03.013; Sahiratmadja E, 2007, INFECT IMMUN, V75, P820, DOI 10.1128/IAI.00602-06; Salie M, 2015, TUBERCULOSIS, V95, P817, DOI 10.1016/j.tube.2015.09.003; Salie M, 2014, J INFECT DIS, V209, P216, DOI 10.1093/infdis/jit443; Schurz H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139711; Shen G, 2006, EMERG INFECT DIS; STEAD WW, 1992, ANN INTERN MED, V116, P937, DOI 10.7326/0003-4819-116-11-937; Uys P, 2011, CLIN INFECT DIS, V52, P1399, DOI 10.1093/cid/cir229; Verver S, 2005, AM J RESP CRIT CARE, V171, P1430, DOI 10.1164/rccm.200409-1200OC; Wang JY, 2007, J INFECT DIS, V196, P281, DOI 10.1086/518898; Wood R, 2010, CLIN INFECT DIS, V51, P401, DOI 10.1086/655129	27	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144487	10.1371/journal.pone.0144487	http://dx.doi.org/10.1371/journal.pone.0144487			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26649422	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903300050
J	Yadesa, TM; Gudina, EK; Angamo, MT				Yadesa, Tadele Mekuriya; Gudina, Esayas Kebede; Angamo, Mulugeta Tarekegn			Antimicrobial Use-Related Problems and Predictors among Hospitalized Medical In-Patients in Southwest Ethiopia: Prospective Observational Study	PLOS ONE			English	Article							ICU	Background The spread of antimicrobial resistance in developing countries is associated with complex and interconnected factors, such as excessive and unnecessary prescribing of antimicrobials, increased self-prescribing by the people and poor quality of available antimicrobials. Moreover, the failure to implement infection control practices and the dearth of routine susceptibility testing and surveillance magnify the problems. This may spread the inappropriateness of prescribing, ending up with the spread of antimicrobial resistance. Objective The aim of this study was to assess antimicrobial use related problems and associated factors among patients admitted at Jimma University specialized hospital. Methods A hospital based prospective observational study design was employed at medical wards of Jimma University specialized hospital, Ethiopia. Data collected from patient medication charts and from the patients was analyzed using SPSS, version 16.0. Logistic regression was used to determine the associations between variables. Statistical significance was considered at p-value <0.05. Results Out of 152 study participants, at least one antimicrobial use problem was identified among 115(75.7%). Accordingly, additional antimicrobials were needed by 45(29.6%) of the patients, whereas they were unnecessary among 44(28.9%). Similarly, 17% of the patients were noncompliant to at least one antimicrobial therapy, while 8.6% experienced at least one type of adverse drug reaction. On the other hand, the coverage of the infectious medical condition in the national guidelines (AOR = 4.888) and the duration of hospital stay (AOR = 3.086) were the determinants of the antimicrobial use problems. Conclusion Most of the antimicrobial use problems identified were related to delay of initiation of effective antimicrobials and excessive use; use without indication or using duplicates of broad spectrum antimicrobials or use for longer duration than recommended. The coverage of the infectious medical condition in the national treatment guidelines and the duration of hospital stay were the determinants of the antimicrobial use problems.	[Yadesa, Tadele Mekuriya; Angamo, Mulugeta Tarekegn] Jimma Univ, Dept Pharm, Coll Publ Hlth & Med Sci, Jimma, Ethiopia; [Gudina, Esayas Kebede] Jimma Univ, Dept Internal Med, Coll Publ Hlth & Med Sci, Jimma, Ethiopia	Jimma University; Jimma University	Yadesa, TM (corresponding author), Jimma Univ, Dept Pharm, Coll Publ Hlth & Med Sci, Jimma, Ethiopia.	maatiikoo4@gmail.com	Mekuriya Yadesa, Tadele/GWQ-3954-2022; Gudina, Esayas Kebede/U-9370-2019; Angamo, Mulugeta/O-9568-2014; Gudina, Esayas Kebede/AAX-2374-2020	Gudina, Esayas Kebede/0000-0002-6264-9695; Angamo, Mulugeta/0000-0002-8604-6258; Gudina, Esayas Kebede/0000-0002-6264-9695; YADESA, TADELE/0000-0001-5151-2610	Jimma University	Jimma University	Jimma University funded the research as staff research.	Agalu A, 2011, J MULTIDISCIP HEALTH, V4, P377, DOI 10.2147/JMDH.S24671; Aryanti R, 2002, CHILD HLTH RES PROJE, V4, P5; Azza MH, 2011, INT J INFECT CONTROL, V7; Baktygul K, 2011, NAGOYA J MED SCI, V73, P157; Banja WD, 2007, ANTIBIOTIC USE 2 HOS, P33; Bergmans DCJJ, 1997, J ANTIMICROB CHEMOTH, V39, P527, DOI 10.1093/jac/39.4.527; Canton R, 2013, ENFERM INFEC MICR CL, V31, P1, DOI [10.1016/j.eimc.2012.08.007, 10.1016/S0213-005X(13)70126-5]; Ceyhan M, 2010, INT J INFECT DIS, V14, pE55, DOI 10.1016/j.ijid.2009.03.013; Cipolle RJ, 2007, PHARM CARE PRACTICES; Dagnew Mulat, 2013, BMC Res Notes, V6, P283, DOI 10.1186/1756-0500-6-283; Estela L, 2007, REV SAUDE PUBLICA, V41; Haq E, 2010, JUMDC, V1, P1; Hecker MT, 2003, ARCH INTERN MED, V163, P972, DOI 10.1001/archinte.163.8.972; Imai-Kamata S, 2011, INT J QUAL HEALTH C, V23, P167, DOI 10.1093/intqhc/mzq080; John PB, 2001, CLIN INFECT DIS   S2, V33, pS78; Martin C, 2011, IMPLEMENTING ANTIMIC, P2; Singh N, 2000, CHEST, V117, P1496, DOI 10.1378/chest.117.5.1496; Suttajit Siritree, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P489; Toubes E, 2003, CLIN INFECT DIS, V36, P724, DOI 10.1086/368081; van der Velden LBJ, 2012, EUR J CLIN MICROBIOL, V31, P1561, DOI 10.1007/s10096-011-1478-5; Vlahovic-Palcevski V, 2007, CLIN MICROBIOL INFEC, V13, P277, DOI 10.1111/j.1469-0691.2006.01613.x; Werner NL, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-187	22	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0138385	10.1371/journal.pone.0138385	http://dx.doi.org/10.1371/journal.pone.0138385			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26649431	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903300002
J	Kuo, YT; Shih, PH; Kao, SH; Yeh, GC; Lee, HM				Kuo, Yung-Ting; Shih, Ping-Hsiao; Kao, Shu-Huei; Yeh, Geng-Chang; Lee, Horng-Mo			Pyrroloquinoline Quinone Resists Denervation-Induced Skeletal Muscle Atrophy by Activating PGC-1 alpha and Integrating Mitochondrial Electron Transport Chain Complexes	PLOS ONE			English	Article							TIME-COURSE; FIBER TYPES; APOPTOSIS; RECEPTOR; METABOLISM; MECHANISMS; EXPRESSION; SOLEUS; DISUSE	Denervation-mediated skeletal muscle atrophy results from the loss of electric stimulation and leads to protein degradation, which is critically regulated by the well-confirmed transcriptional co-activator peroxisome proliferator co-activator 1 alpha (PGC-1 alpha). No adequate treatments of muscle wasting are available. Pyrroloquinoline quinone (PQQ), a naturally occurring antioxidant component with multiple functions including mitochondrial modulation, demonstrates the ability to protect against muscle dysfunction. However, it remains unclear whether PQQ enhances PGC-1 alpha activation and resists skeletal muscle atrophy in mice subjected to a denervation operation. This work investigates the expression of PGC-1 alpha and mitochondrial function in the skeletal muscle of denervated mice administered PQQ. The C57BL6/J mouse was subjected to a hindlimb sciatic axotomy. A PQQ-containing ALZET (R) osmotic pump (equivalent to 4.5 mg/day/kg b.w.) was implanted subcutaneously into the right lower abdomen of the mouse. In the time course study, the mouse was sacrificed and the gastrocnemius muscle was prepared for further myopathological staining, energy metabolism analysis, western blotting, and real-time quantitative PCR studies. We observed that PQQ administration abolished the denervation-induced decrease in muscle mass and reduced mitochondrial activities, as evidenced by the reduced fiber size and the decreased expression of cytochrome c oxidase and NADH-tetrazolium reductase. Bioenergetic analysis demonstrated that PQQ reprogrammed the denervation-induced increase in the mitochondrial oxygen consumption rate (OCR) and led to an increase in the extracellular acidification rate (ECAR), a measurement of the glycolytic metabolism. The protein levels of PGC-1 alpha and the electron transport chain (ETC) complexes were also increased by treatment with PQQ. Furthermore, PQQ administration highly enhanced the expression of oxidative fibers and maintained the type II glycolytic fibers. This pre-clinical in vivo study suggests that PQQ may provide a potent therapeutic benefit for the treatment of denervation-induced atrophy by activating PGC-1 alpha and maintaining the mitochondrial ETC complex in skeletal muscles.	[Kuo, Yung-Ting; Yeh, Geng-Chang] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Kuo, Yung-Ting; Shih, Ping-Hsiao; Yeh, Geng-Chang] Taipei Med Univ, Coll Med, Sch Med, Dept Pediat, Taipei, Taiwan; [Kuo, Yung-Ting] Taipei Med Univ, Shuang Ho Hosp, Dept Pediat, Taipei, Taiwan; [Kao, Shu-Huei; Lee, Horng-Mo] Taipei Med Univ, Coll Med Sci & Technol, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University	Lee, HM (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan.	leehorng@tmu.edu.tw	Shih, Ping-Hsiao/GPG-2472-2022	Shih, Ping-Hsiao/0000-0002-8387-105X; KUO, Yung-Ting/0000-0002-4579-9421; Kao, Shu-Huei/0000-0003-4618-0898	Taipei Medical University [TMU101-AE3-Y08]	Taipei Medical University	The authors received funding from Taipei Medical University (TMU101-AE3-Y08).	ADAMS L, 1995, J CELL BIOL, V131, P1341, DOI 10.1083/jcb.131.5.1341; Adhihetty PJ, 2007, J APPL PHYSIOL, V102, P1143, DOI 10.1152/japplphysiol.00768.2006; Amuthan G, 2001, EMBO J, V20, P1910, DOI 10.1093/emboj/20.8.1910; Ashley Z, 2007, AM J PHYSIOL-CELL PH, V292, pC440, DOI 10.1152/ajpcell.00085.2006; Bauerly K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021779; Borisov AB, 2000, ANAT RECORD, V258, P305; Borisov AB, 2000, ANAT REC, V258, P292; Callahan ZJ, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12359; Carraro U, 2015, EUR J TRANSL MYOL, V25, P77, DOI 10.4081/ejtm.2015.4832; Chen CN, 2015, AM J PHYSIOL-ENDOC M, V308, pE942, DOI 10.1152/ajpendo.00508.2014; Chowanadisai W, 2010, J BIOL CHEM, V285, P142, DOI 10.1074/jbc.M109.030130; Czubryt MP, 2003, P NATL ACAD SCI USA, V100, P1711, DOI 10.1073/pnas.0337639100; dAlbis A, 1995, BIOL CELL, V85, P9, DOI 10.1016/0248-4900(96)89123-4; Danon MJ, 2007, CLIN BIOCHEM, V40, P46, DOI 10.1016/j.clinbiochem.2006.09.002; Degens H, 2008, APPL PHYSIOL NUTR ME, V33, P299, DOI 10.1139/H07-189; Dott W, 2014, REDOX BIOL, V2, P224, DOI 10.1016/j.redox.2013.12.028; Dubowitz V, 2006, NEUROMUSCULAR DISORD, V16, P865, DOI 10.1016/j.nmd.2006.09.003; Dutt V, 2015, PHARMACOL RES, V99, P86, DOI 10.1016/j.phrs.2015.05.010; Gong DZ, 2012, EUR J PHARMACOL, V697, P53, DOI 10.1016/j.ejphar.2012.09.052; Guerfali I, 2007, PFLUG ARCH EUR J PHY, V454, P297, DOI 10.1007/s00424-007-0206-6; Gullapalli R, 2012, DRUG DELIV, V19, P239, DOI 10.3109/10717544.2012.691121; Hara H, 2007, NEUROCHEM RES, V32, P489, DOI 10.1007/s11064-006-9257-x; Harris CB, 2013, J NUTR BIOCHEM, V24, P2076, DOI 10.1016/j.jnutbio.2013.07.008; Hawkins JL, 2015, NEUROSCIENCE, V290, P115, DOI 10.1016/j.neuroscience.2015.01.034; Hepple RT, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00211; Li L, 2011, DIABETES, V60, P157, DOI 10.2337/db10-0331; Midrio M, 2006, EUR J APPL PHYSIOL, V98, P1, DOI 10.1007/s00421-006-0256-z; Min ZH, 2014, J CANCER, V5, P609, DOI 10.7150/jca.9002; Misra HS, 2004, FEBS LETT, V578, P26, DOI 10.1016/j.febslet.2004.10.061; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; Sakuma K, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/721219; Sandona D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033232; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Singh K, 2011, AM J PHYSIOL-CELL PH, V300, pC138, DOI 10.1152/ajpcell.00181.2010; Siu PM, 2005, J PHYSIOL-LONDON, V565, P309, DOI 10.1113/jphysiol.2004.081083; Vainshtein A, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0033-y; Wang YC, 2013, CURR OPIN CLIN NUTR, V16, P243, DOI 10.1097/MCO.0b013e328360272d; Yang LJ, 2015, EUR SPINE J, V24, P1702, DOI 10.1007/s00586-014-3630-2	39	28	28	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0143600	10.1371/journal.pone.0143600	http://dx.doi.org/10.1371/journal.pone.0143600			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YV	26646764	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903100004
J	Li, L; Li, CY; Pan, P; Chen, XL; Wu, XK; Ng, EHY; Yang, DZ				Li, Lin; Li, Chengyan; Pan, Ping; Chen, Xiaoli; Wu, Xiaoke; Ng, Ernest Hung Yu; Yang, Dongzi			A Single Arm Pilot Study of Effects of Berberine on the Menstrual Pattern, Ovulation Rate, Hormonal and Metabolic Profiles in Anovulatory Chinese Women with Polycystic Ovary Syndrome	PLOS ONE			English	Article							GLUCOSE-METABOLISM; METFORMIN; CLOMIPHENE; INDUCTION; TRIAL	Objective To evaluate the effects of berberine on the menstrual pattern, ovulation rate, hormonal and metabolic profiles in anovulatory Chinese women with polycystic ovary syndrome. Methods Berberine 0.4 g three times per day was given for four months to 102 anovulatory Chinese women with polycystic ovary syndrome. The menstrual pattern, ovulation rate, hormonal and metabolic profiles were compared before and after the berberine treatment. Ovulation was confirmed by serum progesterone level >= 10ng/ml. Results A total of 98 of 102 subjects (96.1%) completed the four month treatment, including 69 (70.4%, 69/98) normal weight and 29 (29.6%, 29/98) overweight/obese. Fourteen women (14.3%, 14/98) had regained regular menses after berberine treatment and there was no significant difference between normal weight and overweight/obese groups. The ovulation rate was 25.0% over four months in the whole group, 22.5% in the normal weight group and 31.0% in the overweight/obese group. Sex hormone binding globulin, insulin resistance, total cholesterol, total triglyceride and low-density lipoprotein cholesterol decreased after berberine treatment in the normal weight group only. Conclusions Our study found that administration of berberine alone may improve the menstrual pattern and ovulation rate in anovulatory Chinese women with polycystic ovary syndrome. Berberine can also decrease sex hormone binding globulin, insulin resistance, total cholesterol, triglycerides and low-density lipoprotein cholesterol in normal weight polycystic ovary syndrome women.	[Li, Lin; Li, Chengyan; Pan, Ping; Chen, Xiaoli; Yang, Dongzi] Sun Yat Sen Mem Hosp, Dept Obstet & Gynecol, Guangzhou, Guangdong, Peoples R China; [Li, Chengyan] Guangdong Med Coll, Dept Obstetr & Gynecol, Affiliated Hosp, Zhanjiang, Peoples R China; [Wu, Xiaoke] Heilongjiang Univ Chinese Med, Dept Obstet & Gynecol, Affiliated Hosp 1, Harbin, Peoples R China; [Ng, Ernest Hung Yu] Univ Hong Kong, Dept Obstet & Gynecol, Hong Kong, Hong Kong, Peoples R China	Sun Yat Sen University; Guangdong Medical University; Heilongjiang University of Chinese Medicine; University of Hong Kong	Yang, DZ (corresponding author), Sun Yat Sen Mem Hosp, Dept Obstet & Gynecol, Guangzhou, Guangdong, Peoples R China.	yangdz@mail.sysu.edu.cn	Li, Chengyan/AAS-4540-2021	Ng, Ernest/0000-0002-7688-4557	Natural Science Foundation of Research Project of Guangdong Province [2014A030313011]; National Natural Science Foundation of China [81370680]; specialized National Natural Science Foundation of China (popular science) [81320004]; specialized research fund for the doctoral program of Chinese Ministry of Education [20130171130009]; Natural Science Foundation of Key Research Project of Guangdong Province [2013020012660]	Natural Science Foundation of Research Project of Guangdong Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); specialized National Natural Science Foundation of China (popular science)(National Natural Science Foundation of China (NSFC)); specialized research fund for the doctoral program of Chinese Ministry of Education; Natural Science Foundation of Key Research Project of Guangdong Province	This study was supported by the Natural Science Foundation of Research Project of Guangdong Province, No. 2014A030313011. The grant receipt is Lin Li. This study was also supported by Grant No. 81370680 from the National Natural Science Foundation of China, Grant No. 81320004 from the specialized National Natural Science Foundation of China (popular science), Grant No. 20130171130009 from the specialized research fund for the doctoral program of Chinese Ministry of Education, Grant No. 2013020012660 from the Natural Science Foundation of Key Research Project of Guangdong Province. All fundings are contributed to Dongzi Yang.	An Y, 2014, CLIN ENDOCRINOL, V80, P425, DOI 10.1111/cen.12294; Angioni S, 2008, OBSTET GYNECOL SURV, V63, P796, DOI 10.1097/OGX.0b013e3181895a06; Azziz R, 2004, J CLIN ENDOCR METAB, V89, P2745, DOI 10.1210/jc.2003-032046; Bridger T, 2006, ARCH PEDIAT ADOL MED, V160, P241, DOI 10.1001/archpedi.160.3.241; Chen XL, 2006, HUM REPROD, V21, P2027, DOI 10.1093/humrep/del142; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; Gu Y, 2010, TALANTA, V81, P766, DOI 10.1016/j.talanta.2010.01.015; Ko BS, 2005, BIOL PHARM BULL, V28, P1431, DOI 10.1248/bpb.28.1431; Ladson G, 2011, FERTIL STERIL, V95, P1059, DOI 10.1016/j.fertnstert.2010.12.002; Legro RS, 2007, NEW ENGL J MED, V356, P551, DOI 10.1056/NEJMoa063971; Li Y, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003934; MATHUR RS, 1981, FERTIL STERIL, V35, P29; Mohiyiddeen L, 2013, J OBSTET GYNAECOL, V33, P165, DOI 10.3109/01443615.2012.745839; Ni YX, 1998, ZHONG XI YI JIE HE Z, V8, P711; Palomba S, 2005, J CLIN ENDOCR METAB, V90, P4068, DOI 10.1210/jc.2005-0110; Pan GY, 2003, PLANTA MED, V69, P632, DOI 10.1055/s-2003-41121; Tang T, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003053.pub5; Wei W, 2012, EUR J ENDOCRINOL, V166, P99, DOI 10.1530/EJE-11-0616; World Health Organization, 2000, RIGH HLTH IND AIR ST, P15; Xie P., 2005, CHINESE J CLIN HEALT, V8, P402; Yin J, 2002, METABOLISM, V51, P1439, DOI 10.1053/meta.2002.34715; Yin J, 2008, AM J PHYSIOL-ENDOC M, V294, pE148, DOI 10.1152/ajpendo.00211.2007; Zain MM, 2009, FERTIL STERIL, V91, P514, DOI 10.1016/j.fertnstert.2007.12.002; Zhang YF, 2008, J CLIN ENDOCR METAB, V93, P2559, DOI 10.1210/jc.2007-2404; Zhao XM, 2011, FERTIL STERIL, V96, P792, DOI 10.1016/j.fertnstert.2011.06.040; Zhou LB, 2007, METABOLISM, V56, P405, DOI 10.1016/j.metabol.2006.10.025	26	16	20	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0144072	10.1371/journal.pone.0144072	http://dx.doi.org/10.1371/journal.pone.0144072			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YV	26645811	gold, Green Published, Green Submitted			2022-12-27	WOS:000366903100013
J	Jansson, F; Eriksson, K				Jansson, Fredrik; Eriksson, Kimmo			Cooperation and Shared Beliefs about Trust in the Assurance Game	PLOS ONE			English	Article							MODERATING ROLE; GROUP IDENTITY; INCENTIVES; STRANGERS; EXCHANGE	Determinants of cooperation include ingroup vs. outgroup membership, and individual traits, such as prosociality and trust. We investigated whether these factors can be overridden by beliefs about people's trust. We manipulated the information players received about each other's level of general trust, "high" or "low". These levels were either measured (Experiment 1) or just arbitrarily assigned labels (Experiment 2). Players' choices whether to cooperate or defect in a stag hunt (or an assurance game)-where it is mutually beneficial to cooperate, but costly if the partner should fail to do so-were strongly predicted by what they were told about the other player's trust label, as well as by what they were told that the other player was told about their own label. Our findings demonstrate the importance for cooperation in a risky coordination game of both first-and second-order beliefs about how much people trust each other. This supports the idea that institutions can influence cooperation simply by influencing beliefs.	[Jansson, Fredrik] Linkoping Univ, Inst Analyt Sociol, SE-60174 Norrkoping, Sweden; [Eriksson, Kimmo] Stockholm Univ, Ctr Study Cultural Evolut, SE-10691 Stockholm, Sweden; [Eriksson, Kimmo] Malardalen Univ, Sch Educ Culture & Commun, SE-72123 Vasteras, Sweden	Linkoping University; Stockholm University; Malardalen University	Jansson, F (corresponding author), Linkoping Univ, Inst Analyt Sociol, SE-60174 Norrkoping, Sweden.	fredrik.jansson@liu.se; kimmo.eriksson@mdh.se	Jansson, Fredrik/B-7616-2011; Eriksson, Kimmo/F-6253-2013	Jansson, Fredrik/0000-0001-8357-0276; Eriksson, Kimmo/0000-0002-7164-0924	Swedish Research Council [2009-2390]; European Research Council under the European Union's Seventh Framework Programme (FP7)/ERC Grant [324233]	Swedish Research Council(Swedish Research CouncilEuropean Commission); European Research Council under the European Union's Seventh Framework Programme (FP7)/ERC Grant(European Research Council (ERC))	This work was supported by Swedish Research Council grant number 2009-2390 (http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html) and European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement no. 324233 (http://ec.europa.eu/research/fp7/index_en.cfm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AM, 2007, J ECON PSYCHOL, V28, P324, DOI 10.1016/j.joep.2007.01.007; Argyle M., 1991, COOPERATION BASIS SO; Balliet D, 2013, PSYCHOL BULL, V139, P1090, DOI 10.1037/a0030939; Boone C, 2010, J CONFLICT RESOLUT, V54, P799, DOI 10.1177/0022002710372329; BRECHNER KC, 1977, J EXP SOC PSYCHOL, V13, P552, DOI 10.1016/0022-1031(77)90054-3; BREWER MB, 1979, PSYCHOL BULL, V86, P307, DOI 10.1037/0033-2909.86.2.307; Charness G, 2006, ECONOMETRICA, V74, P1579, DOI 10.1111/j.1468-0262.2006.00719.x; Clark K, 2000, INT J GAME THEORY, V29, P495; COLEMAN JS, 1986, AM J SOCIOL, V91, P1309, DOI 10.1086/228423; Cooper R., 1999, COORDINATION GAMES C; Cooper R., 1994, PROBLEMS COORDINATIO, P129; DAWES RM, 1988, ACTA PSYCHOL, V68, P83, DOI 10.1016/0001-6918(88)90047-9; De Kwaadsteniet EW, 2012, GROUP PROCESS INTERG, V15, P257, DOI 10.1177/1368430211410235; DIEKMANN A, 1993, INT J GAME THEORY, V22, P75, DOI 10.1007/BF01245571; Diekmann A, 2015, SCI REP-UK, V5, DOI 10.1038/srep10321; Dufwenberg M, 2011, GAME ECON BEHAV, V73, P459, DOI 10.1016/j.geb.2011.02.003; Eriksson K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040325; Foddy M, 2009, PSYCHOL SCI, V20, P419, DOI 10.1111/j.1467-9280.2009.02312.x; Gambetta D., 1988, TRUST MAKING BREAKIN, P213; Glaeser EL, 2000, Q J ECON, V115, P811, DOI 10.1162/003355300554926; He JZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103931; Jansson F, 2015, J THEOR BIOL, V373, P100, DOI 10.1016/j.jtbi.2015.03.008; Kiyonari T, 2000, EVOL HUM BEHAV, V21, P411, DOI 10.1016/S1090-5138(00)00055-6; Kollock P, 1998, ANNU REV SOCIOL, V24, P183, DOI 10.1146/annurev.soc.24.1.183; Kramer Roderick, 1995, TRUST ORG, P357; North D. C., 1998, EC VALUES ORG, P491; Ostrom E, 1998, AM POLIT SCI REV, V92, P1, DOI 10.2307/2585925; Platow MJ, 2012, EUR J SOC PSYCHOL, V42, P30, DOI 10.1002/ejsp.852; Rothstein B, 2009, RATION SOC, V21, P81, DOI 10.1177/1043463108099349; Rothstein Bo, 2005, SOCIAL TRAPS PROBLEM; Schelling T., 1957, CONFLICT RESOLUTION, V1, P19, DOI [10.1177/002200275700100104, DOI 10.1177/002200275700100104]; Schelling T.C., 1960, STRATEGY CONFLICT; SEN AK, 1967, Q J ECON, V81, P112, DOI 10.2307/1879675; Simpson B, 2008, SOC NETWORKS, V30, P1, DOI 10.1016/j.socnet.2007.04.004; Skyrms B, 2003, STAG HUNT EVOLUTION; Vanberg C, 2008, ECONOMETRICA, V76, P1467, DOI 10.3982/ECTA7673; YAMAGISHI T, 1993, SOC PSYCHOL QUART, V56, P235, DOI 10.2307/2786661; YAMAGISHI T, 1986, J PERS SOC PSYCHOL, V51, P110, DOI 10.1037/0022-3514.51.1.110	38	7	7	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144191	10.1371/journal.pone.0144191	http://dx.doi.org/10.1371/journal.pone.0144191			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1YS	26640892	Green Submitted, Green Published, gold			2022-12-27	WOS:000366902700074
J	Petrova, A; Smith, CM				Petrova, Adelina; Smith, Charles Michael			Application of Brown Planthopper Salivary Gland Extract to Rice Plants Induces Systemic Host mRNA Patterns Associated with Nutrient Remobilization	PLOS ONE			English	Article							SENESCENCE-ASSOCIATED GENES; LEAF SENESCENCE; AMINO-ACID; GLUTAMINE-SYNTHETASE; SIGNALING PATHWAYS; GLYOXALASE PATHWAY; CALCIUM; DEFENSE; EXPRESSION; APHIDS	Insect saliva plays an important role in modulation of plant-insect interactions. Although this area of research has generated much attention in recent years, mechanisms of how saliva affects plant responses remain poorly understood. To address this void, the present study investigated the impact of the brown planthopper (Nilaparvata lugens, Stal; hereafter BPH) salivary gland extract (SGE) on rice (Oryza sativa) systemic responses at the mRNA level. Differentially expressed rice mRNAs were generated through suppression subtractive hybridization (SSH) and classified into six functional groups. Those with the most representatives were from the primary metabolism (28%), signaling-defense (22%) and transcription-translation-regulation group (16%). To validate SSH library results, six genes were further analyzed by One-Step Real-Time Reverse Transcriptase-PCR. Five of these genes exhibited up-regulation levels of more than 150% of those in the control group in at least one post-application time point. Results of this study allow assignment of at least two putative roles of BPH saliva: First, application of SGE induces immediate systemic responses at the mRNA level, suggesting that altering of the rice transcriptome at sites distant to hoppers feeding locations may play an important role in BPH-rice interactions. Second, 58% of SGE-responsive up-regulated genes have a secondary function associated with senescence, a process characterized by remobilization of nutrients. This suggests that BPH salivary secretions may reprogram the rice transcriptome for nutritional enhancement. When these findings are translated onto 'whole plant' scale, they indicate that BPH saliva may play the 'wise investment' role of 'minimum input today, maximum output tomorrow'.	[Petrova, Adelina] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA; [Smith, Charles Michael] Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA	Washington State University; Kansas State University	Petrova, A (corresponding author), Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA.	adelina.petrova@wsu.edu	Petrova, Adelina/H-4976-2019		RB Cooke scholarship, Newcastle University, UK; Yorkshire Agricultural Society, UK; Adelina Petrova, Washington State University, US	RB Cooke scholarship, Newcastle University, UK; Yorkshire Agricultural Society, UK; Adelina Petrova, Washington State University, US	This work has been sponsored by RB Cooke scholarship, Newcastle University, UK, Yorkshire Agricultural Society, UK, and Adelina Petrova, Washington State University, US.	Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Bissoli G, 2012, PLANT J, V70, P704, DOI 10.1111/j.1365-313X.2012.04921.x; Breeze E, 2011, PLANT CELL, V23, P873, DOI 10.1105/tpc.111.083345; Buchanan-Wollaston V, 2005, PLANT J, V42, P567, DOI 10.1111/j.1365-313X.2005.02399.x; BuchananWollaston V, 1997, J EXP BOT, V48, P181, DOI 10.1093/jxb/48.2.181; Burd JD, 2002, J ECON ENTOMOL, V95, P463, DOI 10.1603/0022-0493-95.2.463; Cheng XY, 2013, MOL PLANT, V6, P621, DOI 10.1093/mp/sst030; Cherqui A, 2000, J INSECT PHYSIOL, V46, P1177, DOI 10.1016/S0022-1910(00)00037-8; De Vos M, 2009, PLANT CELL ENVIRON, V32, P1548, DOI 10.1111/j.1365-3040.2009.02019.x; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; DORSCHNER KW, 1987, ENVIRON ENTOMOL, V16, P1007, DOI 10.1093/ee/16.4.1007; Espinoza C, 2007, J EXP BOT, V58, P3197, DOI 10.1093/jxb/erm165; FUKUMORITA T, 1983, SOIL SCI PLANT NUTR, V29, P185, DOI 10.1080/00380768.1983.10432419; FUKUMORITA T, 1982, PLANT CELL PHYSIOL, V23, P273; HAYASHI H, 1990, PLANT CELL PHYSIOL, V31, P247; Heinrichs EA, 1999, GLOBAL PLANT GENETIC RESOURCES FOR INSECT-RESISTANT CROPS, P3; Huang WH, 2013, MOL PLANT, V6, P1673, DOI 10.1093/mp/sst069; Inoue Y, 1995, Adv Microb Physiol, V37, P177, DOI 10.1016/S0065-2911(08)60146-0; Jimenez A, 1998, PLANT PHYSIOL, V118, P1327, DOI 10.1104/pp.118.4.1327; KAMACHI K, 1992, PLANT PHYSIOL, V98, P1323, DOI 10.1104/pp.98.4.1323; KAMACHI K, 1991, PLANT PHYSIOL, V96, P411, DOI 10.1104/pp.96.2.411; KEYS AJ, 1978, NATURE, V275, P741, DOI 10.1038/275741a0; Klusener B, 2002, PLANT PHYSIOL, V130, P2152, DOI 10.1104/pp.012187; Knight H, 2000, INT REV CYTOL, V195, P269; Knoblauch M, 2004, CELL MOTIL CYTOSKEL, V58, P137, DOI 10.1002/cm.20006; Knoblauch M, 1998, PLANT CELL, V10, P35, DOI 10.1105/tpc.10.1.35; Koch W, 2003, PLANT J, V33, P211, DOI 10.1046/j.1365-313X.2003.01618.x; Koyama Y, 2004, ENTOMOL EXP APPL, V113, P35, DOI 10.1111/j.0013-8703.2004.00207.x; LARSON KC, 1991, OECOLOGIA, V88, P15, DOI 10.1007/BF00328398; Lecourieux D, 2006, NEW PHYTOL, V171, P249, DOI 10.1111/j.1469-8137.2006.01777.x; Levine A, 1996, CURR BIOL, V6, P427, DOI 10.1016/S0960-9822(02)00510-9; Liu CX, 2010, J PROTEOME RES, V9, P6774, DOI 10.1021/pr100970q; Liu L, 2008, PLANT MOL BIOL, V67, P37, DOI 10.1007/s11103-008-9300-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Miles PW, 1999, BIOL REV, V74, P41, DOI 10.1017/S0006323198005271; MILES PW, 1989, J INSECT PHYSIOL, V35, P865, DOI 10.1016/0022-1910(89)90102-9; MILES PW, 1991, ENTOMOL EXP APPL, V59, P123, DOI 10.1007/BF00351957; Miranda M, 2001, PLANT J, V28, P61, DOI 10.1046/j.1365-313X.2001.01129.x; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Ortiz-Lopez A, 2000, BBA-BIOMEMBRANES, V1465, P275, DOI 10.1016/S0005-2736(00)00144-9; Park SJ, 2006, PLANTA, V223, P932, DOI 10.1007/s00425-005-0148-1; Pegadaraju V, 2005, PLANT PHYSIOL, V139, P1927, DOI 10.1104/pp.105.070433; Petrova A, 2014, INSECT MOL BIOL, V23, P13, DOI 10.1111/imb.12058; Petrova A, 2000, THESIS; Petrova A, 2009, THESIS; Plaxton WC, 1996, ANNU REV PLANT PHYS, V47, P185, DOI 10.1146/annurev.arplant.47.1.185; Quirino BF, 1999, PLANT MOL BIOL, V40, P267, DOI 10.1023/A:1006199932265; Sanders D, 2002, PLANT CELL, V14, pS401, DOI 10.1105/tpc.002899; Sandstrom J, 2000, J INSECT PHYSIOL, V46, P33, DOI 10.1016/S0022-1910(99)00098-0; Singla-Pareek SL, 2006, PLANT PHYSIOL, V140, P613, DOI 10.1104/pp.105.073734; Singla-Pareek SL, 2003, P NATL ACAD SCI USA, V100, P14672, DOI 10.1073/pnas.2034667100; Singla-Pareek SL, 2008, TRANSGENIC RES, V17, P171, DOI 10.1007/s11248-007-9082-2; Sogawa K., 1979, International Rice Research Institute: Brown planthopper: threat to rice production in Asia., P125; SOGAWA K, 1982, ANNU REV ENTOMOL, V27, P49, DOI 10.1146/annurev.en.27.010182.000405; Steinhorst L, 2013, PLANT PHYSIOL, V163, P471, DOI 10.1104/pp.113.222950; Telang A, 1999, ENTOMOL EXP APPL, V91, P403, DOI 10.1023/A:1003617523820; THORNALLEY PJ, 1990, BIOCHEM J, V269, P1; Urbanska A, 1998, ENTOMOL EXP APPL, V86, P197, DOI 10.1023/A:1003119900578; Vreden G. van, 1986, Pests of rice and their natural enemies in Peninsular Malaysia.; WALLSGROVE RM, 1987, PLANT PHYSIOL, V83, P155, DOI 10.1104/pp.83.1.155; Wang YC, 2008, ENTOMOL EXP APPL, V129, P295, DOI 10.1111/j.1570-7458.2008.00785.x; White PJ, 2000, BBA-BIOMEMBRANES, V1465, P171, DOI 10.1016/S0005-2736(00)00137-1; White PJ, 2003, ANN BOT-LONDON, V92, P487, DOI 10.1093/aob/mcg164; Will T, 2007, P NATL ACAD SCI USA, V104, P10536, DOI 10.1073/pnas.0703535104; Yuan HY, 2005, PLANTA, V221, P105, DOI 10.1007/s00425-004-1422-3; Zhu-Salzman K, 2004, PLANT PHYSIOL, V134, P420, DOI 10.1104/pp.103.028324	66	11	11	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0141769	10.1371/journal.pone.0141769	http://dx.doi.org/10.1371/journal.pone.0141769			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641488	Green Submitted, Green Published, gold			2022-12-27	WOS:000366902700005
J	Shang, XS; Ding, YH; Wang, YH; Yang, LF				Shang, Xiaosen; Ding, Yunhong; Wang, Yonghui; Yang, Lifeng			Rheological and Performance Research on a Regenerable Polyvinyl Alcohol Fracturing Fluid	PLOS ONE			English	Article							GUM	A regenerable polyvinyl alcohol/organic boron fracturing fluid system with 1.6 wt% polyvinyl alcohol (PVOH) and 1.2 wt% organic boron (OBT) was studied, and its main regeneration mechanism is the reversible cross-linking reaction between B(OH)(4)(-) and hydroxyl groups of PVOH as the change of pH. Results of rheology evaluations show that both the apparent viscosity and the thermal stability of the fracturing fluid decreased with the regeneration number of times increasing. In addition, the apparent viscosity of the fluid which was without regeneration was more sensitive to the shear action compared with that of the fluid with regeneration once or twice. When the fracturing fluid was without regeneration, the elasticity was dominating due to the three-dimensional network structure of the formed gel; the viscosity gradually occupied the advantage when the fracturing fluid was regenerated once or twice. The settling velocity of proppant was accelerated by both the regeneration process and the increasing temperature, but it was decelerated when the proppant ratio increased. Results of core damage tests indicate that less permeability damage was caused by the PVOH/OBT fracturing fluid compared with that caused by the guar gum fracturing fluid after gel breaking.	[Shang, Xiaosen; Ding, Yunhong; Wang, Yonghui; Yang, Lifeng] PetroChina Res Inst Petr Explorat & Dev Langfang, Langfang 065007, Hebei, Peoples R China; [Shang, Xiaosen] PetroChina Res Inst Petr Explorat & Dev, Beijing 100083, Peoples R China	China National Petroleum Corporation; China National Petroleum Corporation	Shang, XS (corresponding author), PetroChina Res Inst Petr Explorat & Dev Langfang, Langfang 065007, Hebei, Peoples R China.	shangxs2015@163.com			National Science and Technology Major Project of China [2011ZX05013-003]; Key Laboratory of Reservoir Simulation of China National Petroleum Corporation (CNPC)	National Science and Technology Major Project of China; Key Laboratory of Reservoir Simulation of China National Petroleum Corporation (CNPC)	This work was supported by the National Science and Technology Major Project of China (Grant No. 2011ZX05013-003) and The Key Laboratory of Reservoir Simulation of China National Petroleum Corporation (CNPC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brannon HD, 1996, P SPE ANN TECHN C EX; Carlos B, 2010, FOOD HYDROCOLLOID, V24, P783; Chindam C, 2014, MATER LETT, V116, P296, DOI 10.1016/j.matlet.2013.11.054; Dantas TNC, 2005, J DISPER SCI TECHNOL, V26, P1, DOI 10.1081/DIS-200040161; Ganguly S, 2002, SPE J, V7, P309, DOI 10.2118/79402-PA; [郭建春 Guo Jianchun], 2012, [石油学报, Acta Petrolei Sinica], V33, P1018; Hou XQ, 2013, PETROL EXPLOR DEV+, V40, P646, DOI 10.1016/S1876-3804(13)60085-3; Johannes K, 2012, PETROLEUM ENG GUIDE; Khair EMM, 2011, J PETROL SCI ENG, V78, P131, DOI 10.1016/j.petrol.2011.05.011; Li A, 2014, P SPE LAT AM CAR PET; Li L, 2015, CHINA ADHESIVE, V24, P19; Li ZM, 2005, POLYMER, V46, P5358, DOI 10.1016/j.polymer.2005.04.016; [刘平礼 Liu Pingli], 2014, [油田化学, Oilfield Chemistry], V31, P334; Lu H, 2014, PETROL SCI TECHNOL, V32, P1233, DOI 10.1080/10916466.2011.649098; Lu Y, 1999, P SPE INT S OILF CHE; Lukocs B., 2007, US Patent Application, Patent No. 20070173413; Luo XR, 2014, J PETROL SCI ENG, V120, P154, DOI 10.1016/j.petrol.2014.06.009; Luyster MR, 2000, P SPE INT S FORM DAM; Maitland GC, 2000, CURR OPIN COLLOID IN, V5, P301, DOI 10.1016/S1359-0294(00)00069-8; Maleki MR, 2012, J PETROL SCI ENG, V92-93, P158, DOI 10.1016/j.petrol.2012.06.011; Medina-Torres L, 2000, FOOD HYDROCOLLOID, V14, P417, DOI 10.1016/S0268-005X(00)00015-1; Peressini D, 2015, FOOD HYDROCOLLOID, V43, P73, DOI 10.1016/j.foodhyd.2014.04.036; Samuel M., 2000, P SPE ROCK MOUNT REG; Sun H., 2011, P SPE INT S OILF CHE; Tang HB, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.40489; Vargas-Vasquez SM, 2009, PETROL SCI TECHNOL, V27, P1727, DOI 10.1080/10916460802611564; Wang L, 2013, J POLYM RES, V20, DOI 10.1007/s10965-013-0088-6; Williams NJ, 2012, P INT PETR TECHN C F; [薛小佳 Xue XiaoJia], 2012, [油田化学, Oilfield Chemistry], V29, P415; Zhao G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082651	30	3	3	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144449	10.1371/journal.pone.0144449	http://dx.doi.org/10.1371/journal.pone.0144449			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641857	Green Published, Green Submitted, gold			2022-12-27	WOS:000366902700124
J	Jung, JH; Kim, CY; Son, SH; Kim, DH; Jeong, SY; Lee, SW; Lee, J; Ahn, BC				Jung, Ji-hoon; Kim, Choon-Young; Son, Seung Hyun; Kim, Do-Hoon; Jeong, Shin Young; Lee, Sang-Woo; Lee, Jaetae; Ahn, Byeong-Cheol			Preoperative Prediction of Cervical Lymph Node Metastasis Using Primary Tumor SUVmax on F-18-FDG PET/CT in Patients with Papillary Thyroid Carcinoma	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; FDG-PET; CLINICAL-SIGNIFICANCE; THYROGLOBULIN LEVELS; COMPUTED-TOMOGRAPHY; NECK-CANCER; DISSECTION; MICROCARCINOMA; ULTRASOUND; MANAGEMENT	Objectives The aim of the current study was to evaluate the value of preoperative F-18-FDG (FDG) PET/CT in predicting cervical lymph node (LN) metastasis in patients with papillary thyroid carcinoma (PTC). Methods One hundred and ninety-three newly diagnosed PTC patients (M: F = 25: 168, age = 46.8 +/- 12.2) who had undergone pretreatment FDG PET/CT and had neck node dissection were included in this study. The FDG avidity of the primary tumor and the SUVmax of the primary tumor (pSUVmax) were analyzed for prediction of LN metastasis. Detectability by ultrasonography (US) and FDG PET/CT for cervical LN metastasis were also assessed and compared with the pSUVmax. Results The FDG avidity of the primary tumor was identified in 118 patients (FDG avid group: 61.0%, M: F = 16: 102, age 47.0 +/- 12.7 years) and pSUVmax ranged from 1.3 to 35.6 (median 4.6) in the FDG avid group. The tumor size in the FDG avid group was bigger and there was a higher incidence of LN metastasis compared to the FDG non-avid group (0.93 vs. 0.59 cm, p < 0.001 and 49.2 vs. 33.3%, p < 0.05). In the FDG avid group, patients with LN metastasis had higher pSUVmax than patients without LN metastasis (8.7 +/- 8.3 vs. 5.7 +/- 5.1, p < 0.001). The incidence of central LN metastasis in patients with a pSUVmax > 4.6 was 54%; however, the detectability of central LN metastasis by US and FDG PET/CT were 10.3% and 3.6%, respectively. Conclusion A high FDG avidity of the primary tumor was related to LN metastasis in PTC patients. Therefore, patients with a high pSUVmax should be cautiously assessed for LN metastasis and might need a more comprehensive surgical approach.	[Jung, Ji-hoon; Kim, Choon-Young; Son, Seung Hyun; Kim, Do-Hoon; Jeong, Shin Young; Lee, Sang-Woo; Lee, Jaetae; Ahn, Byeong-Cheol] Kyungpook Natl Univ, Sch Med & Hosp, Dept Nucl Med, Daegu, South Korea	Kyungpook National University	Ahn, BC (corresponding author), Kyungpook Natl Univ, Sch Med & Hosp, Dept Nucl Med, Daegu, South Korea.	abc2000@knu.ac.kr	Lee, Jaetae/AAR-3317-2021; Lee, Jaetae/ABF-3980-2020	Jung, Ji-hoon/0000-0002-1173-3942	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2012M2A2A7014020]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI15C0001]	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea); Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by National Nuclear R&D Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (No. 2012M2A2A7014020) and a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI15C0001).	Alnafisi NS, 2000, J NUCL MED, V41, P1010; Are C, 2007, ANN SURG ONCOL, V14, P239, DOI 10.1245/s10434-006-9181-y; Blokhuis GJ, 2014, EUR J NUCL MED MOL I, V41, P1916, DOI 10.1007/s00259-014-2801-z; Bohuslavizki KH, 2000, J NUCL MED, V41, P816; Byun BH, 2012, ANN NUCL MED, V26, P471, DOI 10.1007/s12149-012-0594-3; Choi JY, 2006, J NUCL MED, V47, P609; Choi WH, 2011, J ULTRAS MED, V30, P1267; Crivellaro C, 2012, GYNECOL ONCOL, V127, P131, DOI 10.1016/j.ygyno.2012.06.041; Edge SB, 2010, AJCC CANC STAGING MA; Hoetjes NJ, 2010, EUR J NUCL MED MOL I, V37, P1679, DOI 10.1007/s00259-010-1472-7; Hughes DT, 2010, SURGERY, V148, P1100, DOI 10.1016/j.surg.2010.09.019; Hwang HS, 2011, LARYNGOSCOPE, V121, P487, DOI 10.1002/lary.21227; Ito Y, 2006, WORLD J SURG, V30, P91, DOI 10.1007/s00268-005-0113-y; Jeong HS, 2006, CLIN ENDOCRINOL, V65, P402, DOI 10.1111/j.1365-2265.2006.02612.x; Kao J, 2009, CANCER-AM CANCER SOC, V115, P4586, DOI 10.1002/cncr.24493; Keam B, 2013, BREAST CANCER-TOKYO, V20, P167, DOI 10.1007/s12282-011-0323-0; Kim DH, 2014, EUR J NUCL MED MOL I, V41, P2051, DOI 10.1007/s00259-014-2831-6; Kim DH, 2014, NUCL MED MOLEC IMAG, V48, P55, DOI 10.1007/s13139-013-0239-z; Kim E, 2008, THYROID, V18, P411, DOI 10.1089/thy.2007.0269; Kim S, 2014, NUCL MED MOLEC IMAG, V48, P91, DOI 10.1007/s13139-013-0249-x; Kresnik E, 2001, EUR J NUCL MED, V28, P816, DOI 10.1007/s002590100554; Lee BJ, 2007, ARCH OTOLARYNGOL, V133, P1028, DOI 10.1001/archotol.133.10.1028; Lee JW, 2015, NUCL MED MOLEC IMAG, V49, P127, DOI 10.1007/s13139-015-0324-6; Lee S, 2014, NUCL MED MOLEC IMAG, V48, P121, DOI 10.1007/s13139-013-0247-z; Lundgren CI, 2006, CANCER, V106, P524, DOI 10.1002/cncr.21653; Machens A, 2002, WORLD J SURG, V26, P22; Mazzaferri EL, 2001, J CLIN ENDOCR METAB, V86, P1447, DOI 10.1210/jc.86.4.1447; Morita S, 2010, WORLD J SURG, V34, P2564, DOI 10.1007/s00268-010-0733-8; Nilsson IL, 2011, WORLD J SURG, V35, P2691, DOI 10.1007/s00268-011-1291-4; Oh HH, 2011, J SURG ONCOL, V104, P530, DOI 10.1002/jso.21985; Palmedo H, 2006, J NUCL MED, V47, P616; Park HL, 2013, NUCL MED MOLEC IMAG, V47, P242, DOI 10.1007/s13139-013-0222-8; Pieterman RM, 2000, NEW ENGL J MED, V343, P254, DOI 10.1056/NEJM200007273430404; Rousset OG, 1998, J NUCL MED, V39, P904; Smith BR, 2006, THYROID, V16, P109, DOI 10.1089/thy.2006.16.109; Wang TS, 2004, ARCH OTOLARYNGOL, V130, P110, DOI 10.1001/archotol.130.1.110; Wang WP, 1999, J CLIN ENDOCR METAB, V84, P2291, DOI 10.1210/jc.84.7.2291; White ML, 2007, WORLD J SURG, V31, P895, DOI 10.1007/s00268-006-0907-6	38	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144152	10.1371/journal.pone.0144152	http://dx.doi.org/10.1371/journal.pone.0144152			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636824	Green Published, gold, Green Submitted			2022-12-27	WOS:000366143800048
J	Lee, SE; West, KP; Cole, RN; Schulze, KJ; Christian, P; Wu, LSF; Yager, JD; Groopman, J; Ruczinski, I				Lee, Sun Eun; West, Keith P., Jr.; Cole, Robert N.; Schulze, Kerry J.; Christian, Parul; Wu, Lee Shu-Fune; Yager, James D.; Groopman, John; Ruczinski, Ingo			Plasma Proteome Biomarkers of Inflammation in School Aged Children in Nepal	PLOS ONE			English	Article							6-TO 8-YEAR-OLD CHILDREN; HORMONE-BINDING GLOBULIN; ACUTE-PHASE PROTEINS; EXTRACELLULAR-MATRIX; MULTIPLE ROLES; RURAL NEPAL; EXPRESSION; GROWTH; GENE; SUPPLEMENTATION	Inflammation is a condition stemming from complex host defense and tissue repair mechanisms, often simply characterized by plasma levels of a single acute reactant. We attempted to identify candidate biomarkers of systemic inflammation within the plasma proteome. We applied quantitative proteomics using isobaric mass tags (iTRAQ) tandem mass spectrometry to quantify proteins in plasma of 500 Nepalese children 6-8 years of age. We evaluated those that co-vary with inflammation, indexed by alpha-1-acid glycoprotein (AGP), a conventional biomarker of inflammation in population studies. Among 982 proteins quantified in > 10% of samples, 99 were strongly associated with AGP at a family-wise error rate of 0.1%. Magnitude and significance of association varied more among proteins positively (n = 41) than negatively associated (n = 58) with AGP. The former included known positive acute phase proteins including C-reactive protein, serum amyloid A, complement components, protease inhibitors, transport proteins with anti-oxidative activity, and numerous unexpected intracellular signaling molecules. Negatively associated proteins exhibited distinct differences in abundance between secretory hepatic proteins involved in transporting or binding lipids, micronutrients (vitamin A and calcium), growth factors and sex hormones, and proteins of largely extra-hepatic origin involved in the formation and metabolic regulation of extracellular matrix. With the same analytical approach and the significance threshold, seventy-two out of the 99 proteins were commonly associated with CRP, an established biomarker of inflammation, suggesting the validity of the identified proteins. Our findings have revealed a vast plasma proteome within a free-living population of children that comprise functional biomarkers of homeostatic and induced host defense, nutrient metabolism and tissue repair, representing a set of plasma proteins that may be used to assess dynamics and extent of inflammation for future clinical and public health application.	[Lee, Sun Eun; West, Keith P., Jr.; Schulze, Kerry J.; Christian, Parul; Wu, Lee Shu-Fune] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Human Nutr, Dept Int Hlth, Baltimore, MD 21205 USA; [Cole, Robert N.] Johns Hopkins Sch Med, Dept Biol Chem, Mass Spectrometry & Prote Facil, Baltimore, MD USA; [Yager, James D.; Groopman, John] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA; [Ruczinski, Ingo] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Lee, SE (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Human Nutr, Dept Int Hlth, Baltimore, MD 21205 USA.	slee278@jhu.edu	/X-4205-2019	/0000-0003-4690-2133	Bill and Melinda Gates Foundation, Seattle, WA, USA [OPP5241, OPP614]; Office of Health, Infectious Diseases and Nutrition, US Agency for International Development, Washington, DC [HRN-A-00-97-00015-00]; Sight and Life Global Nutrition Research Institute, Baltimore, MD, USA	Bill and Melinda Gates Foundation, Seattle, WA, USA(Bill & Melinda Gates Foundation); Office of Health, Infectious Diseases and Nutrition, US Agency for International Development, Washington, DC(United States Agency for International Development (USAID)); Sight and Life Global Nutrition Research Institute, Baltimore, MD, USA	This work was supported by: 1. The Bill and Melinda Gates Foundation, Seattle, WA, USA. Grants OPP5241 (Yiwu He, Senior Program Officer) and OPP614 (Ellen Piwoz, Senior Program Officer), http://www.gatesfoundation.org/. 2. The Office of Health, Infectious Diseases and Nutrition, US Agency for International Development, Washington, DC. Grant number (HRN-A-00-97-00015-00), http://www.usaid.gov/who-we-are/organization/bureaus/bureauglobal-health. 3. The Sight and Life Global Nutrition Research Institute, Baltimore, MD, USA, http://www.sightandlife.org/ and http://www.jhsph.edu/departments/international-health/news/dsm-sightand-life.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta AM, 2014, CLIN INFECT DIS, V59, pS193, DOI 10.1093/cid/ciu653; Ademowo OS, 2013, GENES AUTOIMMUNITY I, P237; Ahmed S, 2014, TOXICOL SCI, V141, P166, DOI 10.1093/toxsci/kfu113; Aldred A.R., 1993, ACUTE PHASE PROTEINS, V1st ed., P21; ALDRED AR, 1993, ACUTE PHASE PROTEINS, P21; AmiGO2, 2014, AC PHAS RESP GO 0006, P214; ANDERSON DC, 1974, CLIN ENDOCRINOL, V3, P69, DOI 10.1111/j.1365-2265.1974.tb03298.x; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Arora PD, 2004, MOL BIOL CELL, V15, P588, DOI 10.1091/mbc.E03-07-0468; BAXTER RC, 1994, HORM RES, V42, P140, DOI 10.1159/000184186; Bell SE, 2001, J CELL SCI, V114, P2755; Binder JX, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau012; Byron A, 2013, INT J EXP PATHOL, V94, P75, DOI 10.1111/iep.12011; Calder PC, 2013, BRIT J NUTR, V109, pS1, DOI 10.1017/S0007114512005119; Ceciliani F, 2002, PROTEIN PEPTIDE LETT, V9, P211, DOI 10.2174/0929866023408779; Ceciliani F, 2007, CURR PROTEIN PEPT SC, V8, P91, DOI 10.2174/138920307779941497; Chowdhury R, 2011, ANN TROP MED PARASIT, V105, P31, DOI 10.1179/136485911X12899838683124; Christian P, 2003, BMJ-BRIT MED J, V326, P571, DOI 10.1136/bmj.326.7389.571; Cole RN, 2013, J NUTR, V143, P1540, DOI 10.3945/jn.113.175018; Coles CL, 2009, TROP MED INT HEALTH, V14, P1025, DOI 10.1111/j.1365-3156.2009.02331.x; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Delano Matthew J, 2006, Nutr Clin Pract, V21, P68, DOI 10.1177/011542650602100168; Fey G H, 1990, Prog Liver Dis, V9, P89; Fukasawa K, 2006, CANCER LETT, V243, P135, DOI 10.1016/j.canlet.2005.11.051; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Geer LY, 2010, NUCLEIC ACIDS RES, V38, pD492, DOI 10.1093/nar/gkp858; Gower J., 2011, UNDERSTANDING BIPLOT; Gray KA, 2015, NUCLEIC ACIDS RES, V43, pD1079, DOI 10.1093/nar/gku1071; Groopman JD, 2014, FOOD CHEM TOXICOL, V74, P184, DOI 10.1016/j.fct.2014.09.016; HARVILLE DA, 1977, J AM STAT ASSOC, V72, P320, DOI 10.2307/2286796; Herbrich SM, 2013, J PROTEOME RES, V12, P594, DOI 10.1021/pr300624g; Hochepied T, 2003, CYTOKINE GROWTH F R, V14, P25, DOI 10.1016/S1359-6101(02)00054-0; Hotchkiss KA, 2005, EXP CELL RES, V305, P133, DOI 10.1016/j.yexcr.2004.12.025; Huntley RP, 2015, NUCLEIC ACIDS RES, V43, pD1057, DOI 10.1093/nar/gku1113; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Jahnen-Dechent W, 2011, CIRC RES, V108, P1494, DOI 10.1161/CIRCRESAHA.110.234260; KALMOVARIN N, 1991, INFLAMMATION, V15, P369, DOI 10.1007/BF00917353; Kelly-Spratt KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019721; Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08; Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200; Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377; Korpos E, 2009, CURR PHARM DESIGN, V15, P1349, DOI 10.2174/138161209787846685; Kumar V, 2012, ROBBINS BASIC PATHOL; KUSHNER I, 1982, ANN NY ACAD SCI, V389, P39, DOI 10.1111/j.1749-6632.1982.tb22124.x; KUSHNER I, 1987, DIS MARKERS, V5, P1; Le Roith D, 2001, ENDOCR REV, V22, P53, DOI 10.1210/er.22.1.53; Liao CH, 2012, CLIN CHIM ACTA, V413, P803, DOI 10.1016/j.cca.2012.01.021; Luo RY, 2012, STAT INTERFACE, V5, P99; Man XY, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3877; MOODY BJ, 1982, CLIN CHIM ACTA, V118, P87, DOI 10.1016/0009-8981(82)90229-7; Nakamura H, 2000, BIOCHEM BIOPH RES CO, V276, P779, DOI 10.1006/bbrc.2000.3522; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Navitsky RC, 1998, J PARASITOL, V84, P647, DOI 10.2307/3284746; O'Brien P, 2008, BBA-PROTEINS PROTEOM, V1784, P1130, DOI 10.1016/j.bbapap.2008.01.006; O'Donnell LC, 2002, J LEUKOCYTE BIOL, V72, P478; Petrilli V, 2005, CURR BIOL, V15, pR581, DOI 10.1016/j.cub.2005.07.049; Pinkney J, 2014, J CLIN ENDOCR METAB, V99, P3224, DOI 10.1210/jc.2013-3902; Prendergast AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086928; Qian WJ, 2005, PROTEOMICS, V5, P572, DOI 10.1002/pmic.200400942; Raiten DJ, 2015, J NUTR, V145, p1039S, DOI 10.3945/jn.114.194571; Ramirez VP, 2012, CYTOKINE GROWTH F R, V23, P109, DOI 10.1016/j.cytogfr.2012.04.002; Redlich K, 2012, NAT REV DRUG DISCOV, V11, P234, DOI 10.1038/nrd3669; Robinson G.K., 1991, STAT SCI, P15, DOI DOI 10.1214/SS/1177011926; Rodriguez L, 2011, INT J ENV RES PUB HE, V8, P1174, DOI 10.3390/ijerph8041174; Rosales FJ, 1998, J NUTR, V128, P960, DOI 10.1093/jn/128.6.960; Saha S, 2009, PROTEOMICS, V9, P470, DOI 10.1002/pmic.200800507; Samols D, 2002, ACUTE PHASE PROTEINS; Schreiber G, 1983, PLASMA PROTEIN SECRE; Schulze KJ, 2014, J NUTR, V144, P979, DOI 10.3945/jn.114.192336; Stewart CP, 2009, J NUTR, V139, P1575, DOI 10.3945/jn.109.106666; Stewart CP, 2009, AM J CLIN NUTR, V90, P132, DOI 10.3945/ajcn.2008.27368; Thakur JK, 2011, WATER-SUI, V3, P1, DOI 10.3390/w3010001; Thurnham DI, 2005, P NUTR SOC, V64, P502, DOI 10.1079/PNS2005468; Thurnham DI, 2012, REPORT PRIORITIES AS; Tseng S, 2009, BIOMARK INSIGHTS, V4, P33; Tsilidis KK, 2013, ANDROLOGY-US, V1, P919, DOI 10.1111/j.2047-2927.2013.00129.x; Turner PC, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/152879; Urciuolo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2964; Wang XM, 2013, NATURE, V499, P306, DOI 10.1038/nature12345; WEWER UM, 1994, J CELL BIOL, V127, P1767, DOI 10.1083/jcb.127.6.1767; WHICHER T, 1991, PURE APPL CHEM, V63, P1111, DOI 10.1351/pac199163081111; Wilson R, 2010, EXPERT REV PROTEOMIC, V7, P803, DOI 10.1586/EPR.10.93; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yoo JY, 2003, P NATL ACAD SCI USA, V100, P1157, DOI 10.1073/pnas.0336385100; YUASA I, 1986, HUM GENET, V74, P160, DOI 10.1007/BF00282080; Yucel G, 2011, CELL, V144, P319, DOI 10.1016/j.cell.2011.01.023	87	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144279	10.1371/journal.pone.0144279	http://dx.doi.org/10.1371/journal.pone.0144279			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636573	gold, Green Published, Green Submitted			2022-12-27	WOS:000366143800067
J	Sanna, D; Barbato, M; Hadjisterkotis, E; Cossu, P; Decandia, L; Trova, S; Pirastru, M; Leoni, GG; Naitana, S; Francalacci, P; Masala, B; Manca, L; Mereu, P				Sanna, Daria; Barbato, Mario; Hadjisterkotis, Eleftherios; Cossu, Piero; Decandia, Luca; Trova, Sandro; Pirastru, Monica; Leoni, Giovanni Giuseppe; Naitana, Salvatore; Francalacci, Paolo; Masala, Bruno; Manca, Laura; Mereu, Paolo			The First Mitogenome of the Cyprus Mouflon (Ovis gmelini ophion): New Insights into the Phylogeny of the Genus Ovis	PLOS ONE			English	Article							SHEEP AMMOTRAGUS-LERVIA; MITOCHONDRIAL-DNA; CONTROL REGION; COMPREHENSIVE ANALYSIS; Y-CHROMOSOME; CLUSTAL-W; DOMESTICATION; EVOLUTION; SEQUENCE; WILD	Sheep are thought to have been one of the first livestock to be domesticated in the Near East, thus playing an important role in human history. The current whole mitochondrial genome phylogeny for the genus Ovis is based on: the five main domestic haplogroups occurring among sheep (O. aries), along with molecular data from two wild European mouflons, three urials, and one argali. With the aim to shed some further light on the phylogenetic relationship within this genus, the first complete mitochondrial genome sequence of a Cypriot mouflon (O. gmelini ophion) is here reported. Phylogenetic analyses were performed using a dataset of whole Ovis mitogenomes as well as D-loop sequences. The concatenated sequence of 28 mitochondrial genes of one Cypriot mouflon, and the D-loop sequence of three Cypriot mouflons were compared to sequences obtained from samples representatives of the five domestic sheep haplogroups along with samples of the extant wild and feral sheep. The sample included also individuals from the Mediterranean islands of Sardinia and Corsica hosting remnants of the first wave of domestication that likely went then back to feral life. The divergence time between branches in the phylogenetic tree has been calculated using seven different calibration points by means of Bayesian and Maximum Likelihood inferences. Results suggest that urial (O. vignei) and argali (O. ammon) diverged from domestic sheep about 0.89 and 1.11 million years ago (MYA), respectively; and dates the earliest radiation of domestic sheep common ancestor at around 0.3 MYA. Additionally, our data suggest that the rise of the modern sheep haplogroups happened in the span of time between six and 32 thousand years ago (KYA). A close phylogenetic relationship between the Cypriot and the Anatolian mouflon carrying the X haplotype was detected. The genetic distance between this group and the other ovine haplogroups supports the hypothesis that it may be a new haplogroup never described before. Furthermore, the updated phylogenetic tree presented in this study determines a finer classification of ovine species and may help to classify more accurately new mitogenomes within the established haplogroups so far identified.	[Sanna, Daria; Cossu, Piero; Francalacci, Paolo] Univ Sassari, Dipartimento Sci Nat & Terr, I-07100 Sassari, Italy; [Barbato, Mario] Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Hadjisterkotis, Eleftherios] Minist Interior, Nicosia, Cyprus; [Decandia, Luca; Trova, Sandro; Pirastru, Monica; Masala, Bruno; Manca, Laura; Mereu, Paolo] Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy; [Leoni, Giovanni Giuseppe; Naitana, Salvatore] Univ Sassari, Dept Vet Med, I-07100 Sassari, Italy; [Decandia, Luca; Trova, Sandro; Pirastru, Monica; Leoni, Giovanni Giuseppe; Naitana, Salvatore; Masala, Bruno; Manca, Laura; Mereu, Paolo] Univ Sassari, Ctr Excellence Biotechnol Dev & Res Biodivers, I-07100 Sassari, Italy	University of Sassari; Cardiff University; University of Sassari; University of Sassari; University of Sassari	Mereu, P (corresponding author), Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy.	pmereu@uniss.it	BARBATO, Mario/AAG-5854-2019; Mereu, Paolo/AAE-7100-2019; Cossu, Piero/B-8528-2019	BARBATO, Mario/0000-0002-7203-1549; Mereu, Paolo/0000-0001-6615-4828; Cossu, Piero/0000-0002-8946-8261; Trova, Sandro/0000-0002-0367-5463	Fondazione Banco di Sardegna [2013.1313]	Fondazione Banco di Sardegna(Fondazione Banco di Sardegna)	This work was supported by 2013.1313 http://www.fondazionebancodisardegna.it/ Fondazione Banco di Sardegna to MP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, TRACER V1 6; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barbanera F, 2012, FORENSIC SCI INT-GEN, V6, P671, DOI 10.1016/j.fsigen.2011.12.001; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bibi F, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-166; Bruford MW, 2006, DOCUMENTING DOMESTICATION: NEW GENETIC AND ARCHAEOLOGICAL PARADIGMS, P306; Bunch TD, 2006, J HERED, V97, P21, DOI 10.1093/jhered/esi127; Bunch TD, 1998, J HERED, V89, P266, DOI 10.1093/jhered/89.3.266; Cetti F, 1774, QUADRUPEDI SARDEGNA; Chessa B, 2009, SCIENCE, V324, P532, DOI 10.1126/science.1170587; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cooper A, 2015, SCIENCE, V349, P602, DOI 10.1126/science.aac4315; Corander J, 2007, MATH BIOSCI, V205, P19, DOI 10.1016/j.mbs.2006.09.015; Davidson A, 2006, OXFORD COMPANION FOO; Demirci S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081952; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Excoffier L, 1999, MOL BIOL EVOL, V16, P1357, DOI 10.1093/oxfordjournals.molbev.a026046; Francalacci P, 2008, J ANTHROPOL SCI, V86, P59; Frisina M.R., 2013, Taprobanica, V5, P157; Gemmell NJ, 1996, MOL BIOL EVOL, V13, P798, DOI 10.1093/oxfordjournals.molbev.a025640; Hadjinicolaou P, 2011, REG ENVIRON CHANGE, V11, P441, DOI 10.1007/s10113-010-0153-1; Hadjisterkotis E., 1997, P89; Hadjisterkotis E, 1996, Z JAGDWISS, V42, P104, DOI 10.1007/BF02240505; Hadjisterkotis E, 2008, EUR J WILDLIFE RES, V54, P122, DOI 10.1007/s10344-007-0121-3; Hadjisterkotis Eleftherios, 2012, P49; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hassanin A, 2012, CR BIOL, V335, P32, DOI 10.1016/j.crvi.2011.11.002; Hassanin A, 2009, J MOL EVOL, V68, P293, DOI 10.1007/s00239-009-9208-7; Helmer Daniel, 2005, P86; Hiendleder S, 1998, J MOL EVOL, V47, P441, DOI 10.1007/PL00006401; Hiendleder S, 2002, P ROY SOC B-BIOL SCI, V269, P893, DOI 10.1098/rspb.2002.1975; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; IUCN/SSC Caprine Specialist Group, 2000, WORKSH CAPR TAX MAY; Kijas JW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001258; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kivisild T, 2004, AM J HUM GENET, V75, P752, DOI 10.1086/425161; Kivisild T, 2006, NUCL ACID M, V18, P149; Lancioni H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073712; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lohse M, 2013, NUCLEIC ACIDS RES, V41, pW575, DOI 10.1093/nar/gkt289; MADDISON DR, 1992, SYST BIOL, V41, P111, DOI 10.2307/2992510; Manca L, 2006, COMP BIOCHEM PHYS B, V145, P214, DOI 10.1016/j.cbpb.2006.07.010; Meadows JRS, 2011, HEREDITY, V106, P700, DOI 10.1038/hdy.2010.122; Meadows JRS, 2007, GENETICS, V175, P1371, DOI 10.1534/genetics.106.068353; Mereu P, 2008, DNA SEQUENCE, V19, P241, DOI 10.1080/10425170701550599; Meyer S, 1999, GENETICS, V152, P1103; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; NADLER C F, 1973, Zeitschrift fuer Saeugetierkunde, V38, P109; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paradis E, 2013, MOL PHYLOGENET EVOL, V67, P436, DOI 10.1016/j.ympev.2013.02.008; Parma P, 2004, DNA SEQUENCE, V15, P369, DOI 10.1080/10425170400019318; Pedrosa S, 2005, P ROY SOC B-BIOL SCI, V272, P2211, DOI 10.1098/rspb.2005.3204; Peters Joris, 2005, P96; Pirastru M, 2009, COMP BIOCHEM PHYS D, V4, P168, DOI 10.1016/j.cbd.2009.02.002; Renaudeau D, 2012, ANIMAL, V6, P707, DOI 10.1017/S1751731111002448; Rezaei HR, 2010, MOL PHYLOGENET EVOL, V54, P315, DOI 10.1016/j.ympev.2009.10.037; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Ryder M.L., 1983, SHEEP AND MAN; Ryder ML, 1984, EVOLUTION DOMESTICAT, P63; Salas A, 2004, AM J HUM GENET, V74, P454, DOI 10.1086/382194; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Shackleton D.M., 1997, P9; SIMPSON GG, 1945, B AM MUS NAT HIST, V85, P1; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tapio M, 2006, MOL BIOL EVOL, V23, P1776, DOI 10.1093/molbev/msl043; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Valdez R, 1982, WILD SHEEP WORLD; Vigne J. D., 2014, EURASIAN PREHISTORY, V10, P157; Vigne JD, 2011, CURR ANTHROPOL, V52, pS255, DOI 10.1086/659306; Vigne JD, 2011, CR BIOL, V334, P171, DOI 10.1016/j.crvi.2010.12.009; Wilkens Barbara, 2003, Sardinia Corsica et Baleares Antiquae, V1, P181; Xu Shu-Qing, 2005, Genomics Proteomics & Bioinformatics, V3, P5; Zeder MA, 2008, P NATL ACAD SCI USA, V105, P11597, DOI 10.1073/pnas.0801317105; Zeuner MA, 1963, HIST DOMESTICATED AN	82	23	23	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144257	10.1371/journal.pone.0144257	http://dx.doi.org/10.1371/journal.pone.0144257			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636977	Green Published, Green Submitted, gold			2022-12-27	WOS:000366143800063
J	Gage, BK; Asadi, A; Baker, RK; Webber, TD; Wang, R; Itoh, M; Hayashi, M; Miyata, R; Akashi, T; Kieffer, TJ				Gage, Blair K.; Asadi, Ali; Baker, Robert K.; Webber, Travis D.; Wang, Rennian; Itoh, Masayuki; Hayashi, Masaharu; Miyata, Rie; Akashi, Takumi; Kieffer, Timothy J.			The Role of ARX in Human Pancreatic Endocrine Specification	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; INSULIN-PRODUCING CELLS; BETA-CELLS; HOMEOBOX GENE; MICE LACKING; ABNORMAL GENITALIA; PROGENITOR CELLS; MOUSE PANCREAS; ALPHA-CELL; IN-VITRO	The in vitro differentiation of human embryonic stem cells (hESCs) offers a model system to explore human development. Humans with mutations in the transcription factor Aristaless Related Homeobox (ARX) often suffer from the syndrome X-linked lissencephaly with ambiguous genitalia (XLAG), affecting many cell types including those of the pancreas. Indeed, XLAG pancreatic islets lack glucagon and pancreatic polypeptide-positive cells but retain somatostatin, insulin, and ghrelin-positive cells. To further examine the role of ARX in human pancreatic endocrine development, we utilized genomic editing in hESCs to generate deletions in ARX. ARX knockout hESCs retained pancreatic differentiation capacity and ARX knockout endocrine cells were biased toward somatostatin-positive cells (94% of endocrine cells) with reduced pancreatic polypeptide (rarely detected), glucagon (90% reduced) and insulin-positive (65% reduced) lineages. ARX knockout somatostatin-positive cells shared expression patterns with human fetal and adult delta-cells. Differentiated ARX knockout cells upregulated PAX4, NKX2.2, ISL1, HHEX, PCSK1, PCSK2 expression while downregulating PAX6 and IRX2. Re-expression of ARX in ARX knockout pancreatic progenitors reduced HHEX and increased PAX6 and insulin expression following differentiation. Taken together these data suggest that ARX plays a key role in pancreatic endocrine fate specification of pancreatic polypeptide, somatostatin, glucagon and insulin positive cells from hESCs.	[Gage, Blair K.; Asadi, Ali; Baker, Robert K.; Webber, Travis D.; Kieffer, Timothy J.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada; [Wang, Rennian] Univ Western Ontario, Dept Physiol, Child Hlth Res Inst, London, ON, Canada; [Wang, Rennian] Univ Western Ontario, Dept Pharmacol, Child Hlth Res Inst, London, ON, Canada; [Wang, Rennian] Univ Western Ontario, Dept Med, Child Hlth Res Inst, London, ON, Canada; [Itoh, Masayuki] Natl Ctr Neurol & Psychiat, Tokyo, Japan; [Hayashi, Masaharu; Miyata, Rie] Tokyo Metropolitan Inst Med Sci, Tokyo 113, Japan; [Akashi, Takumi] Tokyo Med & Dent Univ, Tokyo, Japan; [Kieffer, Timothy J.] Univ British Columbia, Dept Surg, Vancouver, BC V6T 1W5, Canada	University of British Columbia; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); National Center for Neurology & Psychiatry - Japan; Tokyo Metropolitan Institute of Medical Science; Tokyo Medical & Dental University (TMDU); University of British Columbia	Kieffer, TJ (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada.	tim.kieffer@ubc.ca			Stem Cell Network (SCN); STEMCELL Technologies; Juvenile Diabetes Research Foundation (JDRF); Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council; Michael Smith Foundation for Health Research; University of British Columbia; JDRF; Canadian Institutes of Health Research (CIHR) Regenerative Medicine and Nanomedicine Initiative; STEMCELL Technologies Inc.	Stem Cell Network (SCN); STEMCELL Technologies; Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); University of British Columbia; JDRF(Juvenile Diabetes Research Foundation); Canadian Institutes of Health Research (CIHR) Regenerative Medicine and Nanomedicine Initiative(Canadian Institutes of Health Research (CIHR)); STEMCELL Technologies Inc.	This work was funded by the Stem Cell Network (SCN), STEMCELL Technologies, Juvenile Diabetes Research Foundation (JDRF) and Canadian Institutes of Health Research (CIHR). BKG has received PhD funding from the Natural Sciences and Engineering Research Council, the Michael Smith Foundation for Health Research, and the University of British Columbia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by the Stem Cell Network (SCN), JDRF and the Canadian Institutes of Health Research (CIHR) Regenerative Medicine and Nanomedicine Initiative. BKG received Ph.D. funding from the Natural Sciences and Engineering Research Council, the Michael Smith Foundation for Health Research and the University of British Columbia. We thank Dr. Jenny Bruin for critical suggestions on this manuscript and Dr. P. Collombat, Dr. J. Habener, Dr. A. Rezania, Dr. L. Devi, the Beta Cell Biology Consortium, and the Developmental Studies Hybridoma Bank for the contribution of antibodies used in this study and STEMCELL Technologies Inc. for financial support.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Basford CL, 2012, DIABETOLOGIA, V55, P358, DOI 10.1007/s00125-011-2335-x; BERSANI M, 1989, J BIOL CHEM, V264, P10633; Blyszczuk P, 2003, P NATL ACAD SCI USA, V100, P998, DOI 10.1073/pnas.0237371100; BRAKCH N, 1995, FEBS LETT, V362, P143, DOI 10.1016/0014-5793(95)00229-3; Bruin JE, 2014, STEM CELL RES, V12, P194, DOI 10.1016/j.scr.2013.10.003; Caron NJ, 2013, BIOTECHNOL BIOENG, V110, P2706, DOI 10.1002/bit.24936; Cho G, 2012, NEUROGENETICS, V13, P23, DOI 10.1007/s10048-011-0304-7; Collombat P, 2005, DEVELOPMENT, V132, P2969, DOI 10.1242/dev.01870; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; Collombat P, 2007, J CLIN INVEST, V117, P961, DOI 10.1172/JCI29115; Collombat P, 2009, CELL, V138, P449, DOI 10.1016/j.cell.2009.05.035; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Du AP, 2012, DEV BIOL, V365, P175, DOI 10.1016/j.ydbio.2012.02.024; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Fujita Y, 2010, AM J PHYSIOL-GASTR L, V298, pG608, DOI 10.1152/ajpgi.00024.2010; Furuta M, 1997, P NATL ACAD SCI USA, V94, P6646, DOI 10.1073/pnas.94.13.6646; Gage BK, 2014, ISLETS OF LANGERHANS, P1; Gage BK, 2014, ISLETS, V6, DOI 10.4161/isl.29236; Gage BK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082076; Goudet G, 1999, J BIOL CHEM, V274, P4067, DOI 10.1074/jbc.274.7.4067; Harrison KA, 1999, NAT GENET, V23, P71, DOI 10.1038/12674; Itoh M, 2010, DIFFERENTIATION, V80, P118, DOI 10.1016/j.diff.2010.05.003; Jiang JJ, 2007, STEM CELLS, V25, P1940, DOI 10.1634/stemcells.2006-0761; Kitamura K, 2002, NAT GENET, V32, P359, DOI 10.1038/ng1009; Li H, 1999, NAT GENET, V23, P67; Liew CG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001783; Lyttle BM, 2008, DIABETOLOGIA, V51, P1169, DOI 10.1007/s00125-008-1006-z; Mastracci TL, 2011, DEV BIOL, V359, P1, DOI 10.1016/j.ydbio.2011.08.001; McKenzie O, 2007, NEUROSCIENCE, V146, P236, DOI 10.1016/j.neuroscience.2007.01.038; Metzger DE, 2014, DIABETES, V63, P1804, DOI 10.2337/db13-0867; Miura H, 1997, MECH DEVELOP, V65, P99, DOI 10.1016/S0925-4773(97)00062-2; Miyata R, 2009, BRAIN DEV-JPN, V31, P456, DOI 10.1016/j.braindev.2008.08.008; Nostro MC, 2011, DEVELOPMENT, V138, P861, DOI 10.1242/dev.055236; Ohira R, 2002, MOL GENET METAB, V77, P179, DOI 10.1016/S1096-7192(02)00126-9; Pan FC, 2015, DEVELOPMENT, V142, P3637, DOI 10.1242/dev.126011; Prado CL, 2004, P NATL ACAD SCI USA, V101, P2924, DOI 10.1073/pnas.0308604100; Rezania A, 2014, NAT BIOTECHNOL, V32, P1121, DOI 10.1038/nbt.3033; Rezania A, 2013, STEM CELLS, V31, P2432, DOI 10.1002/stem.1489; Rezania A, 2011, DIABETES, V60, P239, DOI 10.2337/db10-0573; Riedel MJ, 2012, DIABETOLOGIA, V55, P372, DOI 10.1007/s00125-011-2344-9; Sander M, 1997, GENE DEV, V11, P1662, DOI 10.1101/gad.11.13.1662; Sarkar SA, 2008, DIABETOLOGIA, V51, P285, DOI 10.1007/s00125-007-0880-0; Segev H, 2004, STEM CELLS, V22, P265, DOI 10.1634/stemcells.22-3-265; Shoubridge C, 2010, HUM MUTAT, V31, P889, DOI 10.1002/humu.21288; Shoubridge Cheryl, 2010, Pathogenetics, V3, P1, DOI 10.1186/1755-8417-3-1; Sosa-Pineda B, 2004, MOL CELLS, V18, P289; SosaPineda B, 1997, NATURE, V386, P399, DOI 10.1038/386399a0; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; Stromme P, 2002, NAT GENET, V30, P441, DOI 10.1038/ng862; Sussel L, 1998, DEVELOPMENT, V125, P2213; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; Wilcox CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078741; Zhang J, 2014, GENE DEV, V28, P829, DOI 10.1101/gad.235499.113	54	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144100	10.1371/journal.pone.0144100	http://dx.doi.org/10.1371/journal.pone.0144100			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633894	Green Published, gold, Green Submitted			2022-12-27	WOS:000366040000055
J	Kelly, P; Thomas, E; Doherty, A; Harms, T; Burke, O; Gershuny, J; Foster, C				Kelly, Paul; Thomas, Emma; Doherty, Aiden; Harms, Teresa; Burke, Orlaith; Gershuny, Jonathan; Foster, Charlie			Developing a Method to Test the Validity of 24 Hour Time Use Diaries Using Wearable Cameras: A Feasibility Pilot	PLOS ONE			English	Article							SENSECAM; BEHAVIOR; HEALTH; TRAVEL; ERROR	Self-report time use diaries collect a continuous sequenced record of daily activities but the validity of the data they produce is uncertain. This study tests the feasibility of using wearable cameras to generate, through image prompted interview, reconstructed 'near-objective' data to assess their validity. 16 volunteers completed the Harmonised European Time Use Survey (HETUS) diary and used an Autographer wearable camera (recording images at approximately 15 second intervals) for the waking hours of the same 24-hour period. Participants then completed an interview in which visual images were used as prompts to reconstruct a record of activities for comparison with the diary record. 14 participants complied with the full collection protocol. We compared time use and number of discrete activities from the diary and camera records (using 10 classifications of activity). In terms of aggregate totals of daily time use we found no significant difference between the diary and camera data. In terms of number of discrete activities, participants reported a mean of 19.2 activities per day in the diaries, while image prompted interviews revealed 41.1 activities per day. The visualisations of the individual activity sequences reveal some potentially important differences between the two record types, which will be explored at the next project stage. This study demonstrates the feasibility of using wearable cameras to reconstruct time use through image prompted interview in order to test the concurrent validity of 24-hour activity time-use budgets. In future we need a suitably powered study to assess the validity and reliability of 24-hour time use diaries.	[Kelly, Paul] Univ Edinburgh, Inst Sport Phys Educ & Hlth Sci, Phys Act Hlth Res Ctr, Edinburgh, Midlothian, Scotland; [Kelly, Paul; Thomas, Emma; Doherty, Aiden; Foster, Charlie] Univ Oxford, Nuffield Dept Populat Hlth, British Heart Fdn Ctr Populat Approaches Noncommu, Oxford, Oxon, England; [Harms, Teresa; Gershuny, Jonathan] Univ Oxford, Dept Sociol, Ctr Time Use Res, Oxford, Oxon, England; [Burke, Orlaith] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, Oxon, England	University of Edinburgh; University of Oxford; University of Oxford; University of Oxford	Kelly, P (corresponding author), Univ Edinburgh, Inst Sport Phys Educ & Hlth Sci, Phys Act Hlth Res Ctr, Edinburgh, Midlothian, Scotland.	p.kelly@ed.ac.uk	Thomas, Emma/AAJ-6492-2020	Thomas, Emma/0000-0001-8415-0521; Gershuny, Jonathan/0000-0001-5011-0257; Doherty, Aiden/0000-0003-1840-0451	Wellcome Trust Small Grants Fund; John Fell Fund; British Heart Foundation; UK Economic and Social Research Council; Economic and Social Research Council [ES/F037937/1, RES-000-23-0704-A, ES/L011662/1, RES-000-23-0704] Funding Source: researchfish; ESRC [ES/L011662/1, ES/F037937/1] Funding Source: UKRI	Wellcome Trust Small Grants Fund(Wellcome Trust); John Fell Fund; British Heart Foundation(British Heart Foundation); UK Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was funded by: the Wellcome Trust Small Grants Fund http://www.wellcome.ac.uk/Funding/Medical-humanities/Funding-schemes/Small-grants/index.htm, the John Fell Fund https://www.admin.ox.ac.uk/pras/jff/, The British Heart Foundation https://www.bhf.org.uk/, and the UK Economic and Social Research Council http://www.esrc.ac.uk/. The funders provided salary support for the research team.	Bin YS, 2013, AM J EPIDEMIOL, V177, P826, DOI 10.1093/aje/kws308; CAPRANI N, 2010, CHI 10 HUM FACT COMP, P4291, DOI DOI 10.1145/1753846.1754141; Chenu A, 2006, ARCH EUR SOCIOL, V47, P335, DOI 10.1017/S0003975606000117; Cowburn G, 2015, PUBLIC HLTH NUTR FIR, P1; Doherty AR, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-22; Doherty AR, 2013, AM J PREV MED, V44, P320, DOI 10.1016/j.amepre.2012.11.008; Doherty AR, 2011, MEMORY, V19, P785, DOI 10.1080/09658211.2010.509732; Ellis K, 2014, PROCEEDINGS OF THE 2014 ACM INTERNATIONAL JOINT CONFERENCE ON PERVASIVE AND UBIQUITOUS COMPUTING (UBICOMP'14 ADJUNCT), P431, DOI 10.1145/2638728.2641673; Esliger DW, 2011, MED SCI SPORT EXER, V43, P1085, DOI 10.1249/MSS.0b013e31820513be; Eurostat, 2008, HARM EUR TIM US SURV; Fisher K, TIME USE TIME DIARY; Gemming L, 2013, EUR J CLIN NUTR, V67, P1095, DOI 10.1038/ejcn.2013.156; Gemming L, 2015, BRIT J NUTR, V113, P284, DOI 10.1017/S0007114514003602; Gershuny J., 2000, CHANGING TIMES WORK; Hodges S, 2011, MEMORY, V19, P685, DOI 10.1080/09658211.2011.605591; Kan MY, 2008, SOCIOL METHODOL, V38, P101, DOI 10.1111/j.1467-9531.2008.00197.x; Kelly P, 2014, J TRANSP HEALTH, V1, P190, DOI 10.1016/j.jth.2014.04.003; Kelly P, 2013, ASSESSING UTILITY WE; Kelly P, 2011, INT J BEHAV NUTR PHY, V8; Kelly P, 2013, AM J PREV MED, V44, P314, DOI 10.1016/j.amepre.2012.11.006; Kelly P, 2012, AM J PREV MED, V43, P546, DOI 10.1016/j.amepre.2012.07.027; Kerr J, 2013, AM J PREV MED, V44, P290, DOI 10.1016/j.amepre.2012.11.004; Krizek KJ, 2009, ENVIRON PLANN B, V36, P725, DOI 10.1068/b34023; Ng SW, 2012, OBES REV, V13, P659, DOI 10.1111/j.1467-789X.2011.00982.x; Robinson JP, 1977, AM US TIM SOC PSYCH	25	34	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0142198	10.1371/journal.pone.0142198	http://dx.doi.org/10.1371/journal.pone.0142198			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX9QI	26633807	Green Published, gold			2022-12-27	WOS:000366040000005
J	Minami, U; Nishi, M; Fukaya, T; Hasebe, M; Nonaka, K; Koike, T; Suzuki, H; Murayama, Y; Uchida, H; Fujiwara, Y				Minami, Ushio; Nishi, Mariko; Fukaya, Taro; Hasebe, Masami; Nonaka, Kumiko; Koike, Takashi; Suzuki, Hiroyuki; Murayama, Yoh; Uchida, Hayato; Fujiwara, Yoshinori			Effects of the Change in Working Status on the Health of Older People in Japan	PLOS ONE			English	Article							MENTAL-HEALTH; RETIREMENT; EMPLOYMENT; ADULTS	Background Working at old ages is regarded as a good way to keep one's health according to the idea of productive aging. However, there is not enough evidence yet whether retirement is good or bad, or the kind of effects it has on the health of older adults aged 65 and over. We examined it by using a recent data of Wako city, a suburb area near Tokyo in Japan. Methods One thousand seven hundred sixty-eight participants answered to 3 waves of survey questionnaires: 2008, 2010, and 2012, successively. We considered 3 indicators of health; self-rated health, mental health (GDS15) and HLFC (Higher-Level Functional Capacity: TMIG-IC). In cross-sectional analysis, we compared these 3 indicators by three groups: full-time worker, part-time worker, and non-worker. In longitudinal analysis, we compared these three indicators by two groups: subjects who successively worked in 2008, 2010, 2012, and subjects who worked in 2008 but retired before 2010. We used one-way and two way repeated measures ANCOVA for these analyses, respectively. Results It was significantly clear that retirement worsened both mental health and HLFC in people aged 65 years and over; especially, mental health worsened rapidly and HLFC gradually. However, these indicators didn't worsen in subjects who changed from full-time jobs to part-time jobs. Quitting from part-time jobs deteriorated mental health gradually and HLFC moderately compared to full-time jobs. Conclusion The results support the activity theory that older adults who quit from full-time jobs deteriorated both mental health and HLFC, though at different speeds. If they make a transit to part-time jobs, the deterioration would be moderate. It shows that working is an effective way of social participation for older people aged 65 years and over in Japan.	[Minami, Ushio; Nishi, Mariko; Hasebe, Masami; Nonaka, Kumiko; Koike, Takashi; Suzuki, Hiroyuki; Murayama, Yoh; Fujiwara, Yoshinori] Tokyo Metropolitan Inst Gerontol, Res Team Social Participat & Community Hlth, Tokyo, Japan; [Minami, Ushio; Uchida, Hayato] Univ Hyogo, Grad Sch Human Sci & Environm, Kobe, Hyogo 6500044, Japan; [Fukaya, Taro] Tokyo Metropolitan Inst Gerontol, Dept Translat Res Promot, Tokyo, Japan; [Hasebe, Masami] Seigakuin Univ, Fac Human Welf, Saitama, Japan; [Koike, Takashi] Nihon Univ, Coll Humanities & Sci, Tokyo, Japan	Tokyo Metropolitan Institute of Gerontology; University of Hyogo; Tokyo Metropolitan Institute of Gerontology; Nihon University	Minami, U (corresponding author), Tokyo Metropolitan Inst Gerontol, Res Team Social Participat & Community Hlth, Tokyo, Japan.	minami@tmig.or.jp	Minami, Ushio/O-5071-2019; Minami, Ushio/ABF-9488-2020	MINAMI, USHIO/0000-0002-5754-7440	Health Labour Sciences Research Grant from the Ministry of Health, Labour and Welfare, Japan [2008-Research on Policy Planning and Evaluation-012]; JSPS KAKENHI [23790719]; Grants-in-Aid for Scientific Research [26310112] Funding Source: KAKEN	Health Labour Sciences Research Grant from the Ministry of Health, Labour and Welfare, Japan; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Health Labour Sciences Research Grant (2008-Research on Policy Planning and Evaluation-012, to YF) from the Ministry of Health, Labour and Welfare, Japan, and JSPS KAKENHI Grant-in-Aid for Young Scientists (B) (grant number 23790719, to MN). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], LAB FORC STAT; BOSSE R, 1987, PSYCHOL AGING, V2, P383, DOI 10.1037/0882-7974.2.4.383; Cabinet Office, 2013, GOV JAP PROV AG SOC, P55; Cabinet Office, 2014, GOV JAP EC SIT OLD P, P11; Christ SL, 2007, J GERONTOL B-PSYCHOL, V62, pS399, DOI 10.1093/geronb/62.6.S399; Cumming Elaine, 1961, GROWING OLD PROCESS; EKERDT DJ, 1983, AM J PUBLIC HEALTH, V73, P779, DOI 10.2105/AJPH.73.7.779; Fujiwara Y, 2014, J JPN SOC INTERGENER, V4, P17; Fujiwara Y, 2016, GERIATR GERONTOL INT, V16, P126, DOI 10.1111/ggi.12441; Genda Y., 2001, NAGGING SENSE JOB IN, P97; Hammerman-Rozenberg R, 2005, AGING CLIN EXP RES, V17, P508, DOI 10.1007/BF03327419; Harada K., 2009, JAPANESE J GERONTOLO, V31, P350; Harigane M., 2009, JAPANESE J GERONTOLO, V31, P32; Havighurst RJ., 1963, PROCESSES AGING SOCI, P299, DOI 10.1093/geront/1.1.8; Hotta T., 2003, JPN J GERIATR PSYCHI, V14, P853; KOYANO W, 1991, ARCH GERONTOL GERIAT, V13, P103, DOI 10.1016/0167-4943(91)90053-S; Li YW, 2014, GERONTOLOGIST, V54, P784, DOI 10.1093/geront/gnt106; Matz-Costa C, 2014, GERONTOLOGIST, V54, P277, DOI 10.1093/geront/gns148; Mein G, 2003, J EPIDEMIOL COMMUN H, V57, P46, DOI 10.1136/jech.57.1.46; MIDANIK LT, 1995, J GERONTOL B-PSYCHOL, V50, pS59, DOI 10.1093/geronb/50B.1.S59; Minami Ushio, 2015, Nihon Koshu Eisei Zasshi, V62, P281, DOI 10.11236/jph.62.6_281; Osada H, 1998, JOB STRESS RES, V5, P106; Reitzes DC, 1996, GERONTOLOGIST, V36, P649, DOI 10.1093/geront/36.5.649; Schwingel A, 2009, AGE AGEING, V38, P531, DOI 10.1093/ageing/afp089; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Sugihara Y, 2008, J GERONTOL B-PSYCHOL, V63, pP227, DOI 10.1093/geronb/63.4.P227; Sugisawa A, 1997, Nihon Koshu Eisei Zasshi, V44, P123; Suzuki M, 2010, BRIT J SOCIOL, V61, P513, DOI 10.1111/j.1468-4446.2010.01324.x	28	29	29	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144069	10.1371/journal.pone.0144069	http://dx.doi.org/10.1371/journal.pone.0144069			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX9QI	26633033	gold, Green Published, Green Submitted			2022-12-27	WOS:000366040000050
J	Wang, JY; Sun, HY; Wang, JT; Hung, CC; Yu, MC; Lee, CH; Lee, LN				Wang, Jann-Yuan; Sun, Hsin-Yun; Wang, Jann-Tay; Hung, Chien-Ching; Yu, Ming-Chih; Lee, Chih-Hsin; Lee, Li-Na			Nine- to Twelve-Month Anti-Tuberculosis Treatment Is Associated with a Lower Recurrence Rate than 6-9-Month Treatment in Human Immunodeficiency Virus-Infected Patients: A Retrospective Population-Based Cohort Study in Taiwan	PLOS ONE			English	Article							ACQUIRED RIFAMYCIN RESISTANCE; TUBERCULOSIS; HIV; MOXIFLOXACIN; ETHAMBUTOL; RIFABUTIN; RELAPSE	Background Human immunodeficiency virus (HIV)-infected patients are at an increased risk of tuberculosis (TB) and its recurrence following completion of anti-TB treatment. We investigated whether extending anti-TB treatment to 9 months or longer reduces TB recurrence. Methods HIV-infected patients who were diagnosed with pulmonary TB between 1997 and 2009 and who received anti-TB treatment for a duration between 5.5 and 12.5 months were identified from the National Health Insurance Research Database in Taiwan. Those who received any non-fluoroquinolone second-line anti-TB drug for >28 days were excluded. Factors associated with TB recurrence within 2 years after completion of anti-TB treatment were explored using Cox regression analysis. Sensitivity analysis was performed for a subpopulation fulfilling strict diagnostic criteria for HIV infection. Results TB recurrence was observed in 18 (3.5%) of 508 HIV-infected patients. The recurrence rate declined from 5.4% to 1.0% after the implementation of directly observed therapy, short course (DOTS) in 2006 (p = 0.014). The recurrence rate was 5.9%, 5.2%, and 1.6% in patients who received anti-TB treatment for < 195, 195-270, and > 270 days, respectively (p = 0.066). Cox regression analysis revealed that TB diagnosed in the DOTS era (hazard ratio [HR]: 0.18 [0.04-0.77]) and anti-TB treatment for > 270 days (HR: 0.24 [0.06-0.89]) were associated with a reduced risk of TB recurrence. Sensitivity analysis of 449 selected patients revealed that anti-TB treatment for > 270 days was a significant factor. Conclusion In Taiwan, the 2-year TB recurrence rate in HIV-infected patients declined after implementation of DOTS. The risk of TB recurrence in HIV-infected patients can be further reduced by extending anti-TB treatment to 9-12.5 months.	[Wang, Jann-Yuan; Sun, Hsin-Yun; Wang, Jann-Tay; Hung, Chien-Ching] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Wang, Jann-Yuan; Sun, Hsin-Yun; Wang, Jann-Tay; Hung, Chien-Ching; Lee, Li-Na] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Yu, Ming-Chih; Lee, Chih-Hsin] Taipei Med Univ, Wan Fang Hosp, Div Pulm Med, Dept Internal Med, Taipei, Taiwan; [Lee, Li-Na] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan; [Lee, Chih-Hsin] Taipei Med Univ, Coll Med, Sch Med, Taipei, Taiwan; [Yu, Ming-Chih] Taipei Med Univ, Sch Resp Therapy, Coll Med, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; Taipei Medical University; Taipei Municipal WanFang Hospital; National Taiwan University; National Taiwan University Hospital; Taipei Medical University; Taipei Medical University	Lee, CH (corresponding author), Taipei Med Univ, Wan Fang Hosp, Div Pulm Med, Dept Internal Med, Taipei, Taiwan.	chlee.tw@gmail.com	; Lee, Chih-Hsin/D-2697-2014	WANG, JANN-YUAN/0000-0003-3406-366X; LEE, LI-NA/0000-0002-7654-2450; Lee, Chih-Hsin/0000-0003-1492-3044; WANG, JANN-TAY/0000-0002-0924-3469; SUN, HSIN-YUN/0000-0003-0074-7721; Hung, Chien-Ching/0000-0001-7345-0836	National Science Council, Taiwan [NSC 99-2314-B-002-088-MY2, NSC 101-3114-Y-002-003]; Centers for Disease Control, Taiwan [DOH-101-DC-1101, DOH-102-DC-1301, MOHW-103-CDC-C-114-112302]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Centers for Disease Control, Taiwan	This study was supported by the National Science Council, Taiwan (grant NSC 99-2314-B-002-088-MY2; NSC 101-3114-Y-002-003; http://web1.nsc.gov.tw/) and the Centers for Disease Control, Taiwan (grant DOH-101-DC-1101; DOH-102-DC-1301; MOHW-103-CDC-C-114-112302). The funders had no role in the study design, conduct, data collection and analysis, preparation of the manuscript, or decision of submission.	[Anonymous], 1986, Tubercle, V67, P5; [Anonymous], 1982, Am Rev Respir Dis, V126, P460; [Anonymous], 2011, GLOB TUB CONTR; [Anonymous], GUID US ANT AG HIV 1; Bureau of National Health Insurance, 2011, NAT HLTH INS STAT 20; Burman WJ, 2006, AM J RESP CRIT CARE, V174, P331, DOI 10.1164/rccm.200603-360OC; Centers for Disease Control Taiwan, 2012, TAIW TUB CONTR REP 2; Centers for Disease Control Taiwan, 2010, GUID DIAGN TREATM HI; Chan PC, 2014, J FORMOS MED ASSOC, V113, P775, DOI 10.1016/j.jfma.2014.03.003; Conde MB, 2009, LANCET, V373, P1183, DOI 10.1016/S0140-6736(09)60333-0; Dorman SE, 2009, AM J RESP CRIT CARE, V180, P273, DOI 10.1164/rccm.200901-0078OC; Driver CR, 2001, CLIN INFECT DIS, V33, P1762, DOI 10.1086/323784; Harries AD, 2009, INT J TUBERC LUNG D, V13, P6; Huang SK, 2014, J FORMOS MED ASSOC, V113, P1, DOI 10.1016/j.jfma.2013.08.010; Hung CC, 2003, JAIDS-J ACQ IMM DEF, V34, P437, DOI 10.1097/00126334-200312010-00012; Khan FA, 2010, CLIN INFECT DIS, V50, P1288, DOI 10.1086/651686; Korenromp EL, 2003, CLIN INFECT DIS, V37, P101, DOI 10.1086/375220; Lee CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037978; Lien YC, 2013, BRIT J CANCER, V109, P2933, DOI 10.1038/bjc.2013.538; Luh KT, 2013, TAIWAN GUIDELINES TB; Nahid P, 2007, AM J RESP CRIT CARE, V175, P1199, DOI 10.1164/rccm.200509-1529OC; Nettles RE, 2004, CLIN INFECT DIS, V38, P731, DOI 10.1086/381675; PERRIENS JH, 1995, NEW ENGL J MED, V332, P779, DOI 10.1056/NEJM199503233321204; Swaminathan S, 2010, AM J RESP CRIT CARE, V181, P743, DOI 10.1164/rccm.200903-0439OC; Wang JY, 2015, CHEST, V147, P520, DOI 10.1378/chest.14-0918; Weiner M, 2005, CLIN INFECT DIS, V41, P1343, DOI 10.1086/496980; Weiner M, 2005, CLIN INFECT DIS, V40, P1481, DOI 10.1086/429321; WHO, 2009, TREATM TUB GUID; World Health Organisation Collaborating Center for Drug Statistics Methodology, 2011, GUID ATC CLASS DDD A	29	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144136	10.1371/journal.pone.0144136	http://dx.doi.org/10.1371/journal.pone.0144136			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633835	gold, Green Published			2022-12-27	WOS:000366040000061
J	Qin, Z; Wang, YP; Wang, QM; Li, AX; Hou, FY; Zhang, LM				Qin, Zhen; Wang, Yanping; Wang, Qingmei; Li, Aixian; Hou, Fuyun; Zhang, Liming			Evolution Analysis of Simple Sequence Repeats in Plant Genome	PLOS ONE			English	Article							TANDEM REPEATS; MUTATION-RATES; WIDE ANALYSIS; MICROSATELLITES; DUPLICATION; DIVERGENCE; GENES; MAIZE; DNA; CHLAMYDOMONAS	Simple sequence repeats (SSRs) are widespread units on genome sequences, and play many important roles in plants. In order to reveal the evolution of plant genomes, we investigated the evolutionary regularities of SSRs during the evolution of plant species and the plant kingdom by analysis of twelve sequenced plant genome sequences. First, in the twelve studied plant genomes, the main SSRs were those which contain repeats of 1-3 nucleotides combination. Second, in mononucleotide SSRs, the A/T percentage gradually increased along with the evolution of plants (except for P. patens). With the increase of SSRs repeat number the percentage of A/T in C. reinhardtii had no significant change, while the percentage of A/T in terrestrial plants species gradually declined. Third, in dinucleotide SSRs, the percentage of AT/TA increased along with the evolution of plant kingdom and the repeat number increased in terrestrial plants species. This trend was more obvious in dicotyledon than monocotyledon. The percentage of CG/GC showed the opposite pattern to the AT/TA. Forth, in trinucleotide SSRs, the percentages of combinations including two or three A/T were in a rising trend along with the evolution of plant kingdom; meanwhile with the increase of SSRs repeat number in plants species, different species chose different combinations as dominant SSRs. SSRs in C. reinhardtii, P. patens, Z. mays and A. thaliana showed their specific patterns related to evolutionary position or specific changes of genome sequences. The results showed that, SSRs not only had the general pattern in the evolution of plant kingdom, but also were associated with the evolution of the specific genome sequence. The study of the evolutionary regularities of SSRs provided new insights for the analysis of the plant genome evolution.	[Qin, Zhen; Wang, Qingmei; Li, Aixian; Hou, Fuyun; Zhang, Liming] Shandong Acad Agr Sci, Crop Res Inst, Jinan, Peoples R China; [Wang, Yanping] Shandong Acad Agr Sci, Inst Anim Sci & Vet Med, Shandong Key Lab Anim Dis Control & Breeding, Jinan, Peoples R China	Shandong Academy of Agricultural Sciences; Shandong Academy of Agricultural Sciences	Zhang, LM (corresponding author), Shandong Acad Agr Sci, Crop Res Inst, Jinan, Peoples R China.	zhanglm11@sina.com			National Nature Science Foundation of China [31401460]; China Agriculture Research System of Sweetpotato [CARS-11-B-06, CARS-11-B-11]; Nature Science Foundation of Shandong province [ZR2014YL015]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System of Sweetpotato; Nature Science Foundation of Shandong province(Natural Science Foundation of Shandong Province)	This work was supported by the National Nature Science Foundation of China (31401460; http://isisn.nsfc.gov.cn/egrantweb/), the China Agriculture Research System of Sweetpotato (CARS-11-B-06 and CARS-11-B-11) and the Nature Science Foundation of Shandong province (ZR2014YL015).	Akagi H, 2001, MOL GENET GENOMICS, V266, P471, DOI 10.1007/s004380100563; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Chakraborty R, 1997, P NATL ACAD SCI USA, V94, P1041, DOI 10.1073/pnas.94.3.1041; Chaw SM, 2004, J MOL EVOL, V58, P424, DOI 10.1007/s00239-003-2564-9; Coates BS, 2010, J MOL EVOL, V70, P275, DOI 10.1007/s00239-010-9330-6; CRANE PR, 1989, SCIENCE, V246, P675, DOI 10.1126/science.246.4930.675; De Bodt S, 2005, TRENDS ECOL EVOL, V20, P591, DOI 10.1016/j.tree.2005.07.008; Freeling M, 2006, GENOME RES, V16, P805, DOI 10.1101/gr.3681406; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Grossman AR, 2007, CURR OPIN PLANT BIOL, V10, P190, DOI 10.1016/j.pbi.2007.01.012; Haasl RJ, 2013, MOL BIOL EVOL, V30, P285, DOI 10.1093/molbev/mss247; Harr B, 2002, MOL CELL, V10, P199, DOI 10.1016/S1097-2765(02)00575-0; HENDERSON ST, 1992, MOL CELL BIOL, V12, P2749, DOI 10.1128/MCB.12.6.2749; Hou L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126794; Katti MV, 2001, MOL BIOL EVOL, V18, P1161, DOI 10.1093/oxfordjournals.molbev.a003903; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Lawson MJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r14; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Li YC, 2002, MOL ECOL, V11, P2453, DOI 10.1046/j.1365-294X.2002.01643.x; Loire E, 2013, GENOME BIOL EVOL, V5, P283, DOI 10.1093/gbe/evt003; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Matsuoka Y, 2002, P NATL ACAD SCI USA, V99, P6080, DOI 10.1073/pnas.052125199; Matsuoka Y, 2002, THEOR APPL GENET, V104, P436, DOI 10.1007/s001220100694; Mayer C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-277; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Proost S, 2011, PLANT J, V66, P58, DOI 10.1111/j.1365-313X.2011.04521.x; Pumpernik D, 2008, MOL GENET GENOMICS, V279, P53, DOI 10.1007/s00438-007-0294-1; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Rensing SA, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-130; SanMiguel P, 1998, NAT GENET, V20, P43, DOI 10.1038/1695; SCHLOTTERER C, 1992, NUCLEIC ACIDS RES, V20, P211, DOI 10.1093/nar/20.2.211; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Schug MD, 1998, MOL BIOL EVOL, V15, P1751, DOI 10.1093/oxfordjournals.molbev.a025901; Seoighe C, 2004, TRENDS GENET, V20, P461, DOI 10.1016/j.tig.2004.07.008; Shankar R, 2007, MOL GENET GENOMICS, V277, P441, DOI 10.1007/s00438-007-0210-8; Shi JQ, 2014, DNA RES, V21, P53, DOI 10.1093/dnares/dst040; Shi JQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059988; Siddle KJ, 2011, BIOINFORMATICS, V27, P895, DOI 10.1093/bioinformatics/btr067; Simillion C, 2002, P NATL ACAD SCI USA, V99, P13627, DOI 10.1073/pnas.212522399; TAUTZ D, 1984, NUCLEIC ACIDS RES, V12, P4127, DOI 10.1093/nar/12.10.4127; TAUTZ D, 1994, CURR OPIN GENET DEV, V4, P832, DOI 10.1016/0959-437X(94)90067-1; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Van de Peer Y, 2009, NAT REV GENET, V10, P725, DOI 10.1038/nrg2600; Victoria FC, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-15; Vigouroux Y, 2003, MOL BIOL EVOL, V20, P1480, DOI 10.1093/molbev/msg156; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Xie Chuanxiao, 2007, Journal of Genetics and Genomics, V34, P738, DOI 10.1016/S1673-8527(07)60083-6; Yu J, 2005, PLOS BIOL, V3, P266, DOI 10.1371/journal.pbio.0030038; Zhang P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111508; Zhao ZX, 2014, G3-GENES GENOM GENET, V4, P67, DOI 10.1534/g3.113.008524	59	28	28	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144108	10.1371/journal.pone.0144108	http://dx.doi.org/10.1371/journal.pone.0144108			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630570	Green Submitted, Green Published, gold			2022-12-27	WOS:000365926300160
J	Shin, SY; Lee, S; Yun, ID; Jung, HY; Heo, YS; Kim, SM; Lee, KM				Shin, Seung Yeon; Lee, Soochahn; Yun, Il Dong; Jung, Ho Yub; Heo, Yong Seok; Kim, Sun Mi; Lee, Kyoung Mu			A Novel Cascade Classifier for Automatic Microcalcification Detection	PLOS ONE			English	Article							CLUSTER DETECTION; VECTOR MACHINE	In this paper, we present a novel cascaded classification framework for automatic detection of individual and clusters of microcalcifications (mu C). Our framework comprises three classification stages: i) a random forest (RF) classifier for simple features capturing the second order local structure of individual mu Cs, where non-mu C pixels in the target mammogram are efficiently eliminated; ii) a more complex discriminative restricted Boltzmann machine (DRBM) classifier for mu C candidates determined in the RF stage, which automatically learns the detailed morphology of mu C appearances for improved discriminative power; and iii) a detector to detect clusters of mu Cs from the individual mu C detection results, using two different criteria. From the two-stage RF-DRBM classifier, we are able to distinguish mu Cs using explicitly computed features, as well as learn implicit features that are able to further discriminate between confusing cases. Experimental evaluation is conducted on the original Mammographic Image Analysis Society (MIAS) and mini-MIAS databases, as well as our own Seoul National University Bundang Hospital digital mammographic database. It is shown that the proposed method outperforms comparable methods in terms of receiver operating characteristic (ROC) and precision-recall curves for detection of individual mu Cs and free-response receiver operating characteristic (FROC) curve for detection of clustered mu Cs.	[Shin, Seung Yeon; Lee, Kyoung Mu] Seoul Natl Univ, Dept Elect & Comp Engn, ASRI, Seoul, South Korea; [Lee, Soochahn] Soonchunhyang Univ, Dept Elect Engn, Asan, South Korea; [Yun, Il Dong; Jung, Ho Yub] Hankuk Univ Foreign Studies, Div Comp & Elect Syst Engn, Yongin, South Korea; [Heo, Yong Seok] Ajou Univ, Dept Elect & Comp Engn, Suwon 441749, South Korea; [Kim, Sun Mi] Seoul Natl Univ, Bundang Hosp, Dept Radiol, Seongnam, South Korea	Seoul National University (SNU); Soonchunhyang University; Hankuk University Foreign Studies; Ajou University; Seoul National University (SNU)	Lee, S (corresponding author), Soonchunhyang Univ, Dept Elect Engn, Asan, South Korea.	sclsch@sch.ac.kr; yun@hufs.ac.kr	Heo, Yong Seok/AAD-8816-2021; Lee, Kyoung Mu/AAC-4063-2020; Lee, Soochahn/AAE-8471-2020	Lee, Kyoung Mu/0000-0001-7210-1036; Lee, Soochahn/0000-0002-2975-2519	Soonchunhyang university; Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2013R1A1A2A10004550, 2015R1A5A7036384]; Hankuk University of Foreign Studies Research Fund; Korea Science and Engineering Foundation (KOSEF) - Korean government (MEST) [2012R1A1A3008621]	Soonchunhyang university; Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Hankuk University of Foreign Studies Research Fund; Korea Science and Engineering Foundation (KOSEF) - Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorea Science and Engineering FoundationKorean Government)	SL has been funded by the Soonchunhyang university (http://home.sch.ac.kr/english/index.jsp) research fund. IDY was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF, http://www.nrf.re.kr/nrf_eng_cms/), funded by the Ministry of Education, Science and Technology (2013R1A1A2A10004550, 2015R1A5A7036384). HYJ was supported by Hankuk University of Foreign Studies Research Fund of 2015. SMK was supported by the Korea Science and Engineering Foundation (KOSEF) grant funded by the Korean government (MEST, http://english.msip.go.kr/english/main/main.do) (grant code: 2012R1A1A3008621). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2015, WHAT AR KEY STAT BRE; Bornefalk H, 2005, MED PHYS, V32, P412, DOI 10.1118/1.1844433; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bria A, 2014, MED IMAGE ANAL, V18, P241, DOI 10.1016/j.media.2013.10.014; BUNCH PC, 1978, AM J ROENTGENOL, V130, P382; Criminisi A., 2013, DECISION FORESTCOM; de Paredes ES, 2003, APPL RADIOL, V32, P29; Diaz-Huerta CC, 2014, EXPERT SYST APPL, V41, P7361, DOI 10.1016/j.eswa.2014.05.051; Eddaoudi F, 2011, APPL MATH SCI, V5, P381; El-Naqa I, 2002, IEEE T MED IMAGING, V21, P1552, DOI 10.1109/TMI.2002.806569; Frangi AF, 1998, LECT NOTES COMPUT SC, V1496, P130, DOI 10.1007/BFb0056195; Hinton G.E., 2012, NEURAL NETWORKS TRIC, VVolume 7700, P599, DOI [10.1007/978-3-642-35289-8_32, DOI 10.1007/978-3-642-35289-8_32]; Hinton GE, 2002, NEURAL COMPUT, V14, P1771, DOI 10.1162/089976602760128018; Jiang YZ, 2015, IEEE T CYBERNETICS, V45, P548, DOI 10.1109/TCYB.2014.2330844; Jiebo Huang, 2011, 2011 International Conference on Multimedia Technology, P4768; Kallergi M, 1999, MED PHYS, V26, P267, DOI 10.1118/1.598514; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Larochelle Hugo, 2008, P 25 INT C MACHINE L, P536, DOI DOI 10.1145/1390156.1390224; Lee H., 2009, P 26 ANN INT C MACH, P609, DOI [DOI 10.1145/1553374.1553453, 10.1145/1553374.1553453]; Oliver A, 2012, KNOWL-BASED SYST, V28, P68, DOI 10.1016/j.knosys.2011.11.021; Oporto-Diaz S, 2005, P INT C IM AN REC IC, P998, DOI [http://dx.doi.org/10.1007/11559573_121, DOI 10.1007/11559573_121]; Papadopoulos A, 2008, COMPUT BIOL MED, V38, P1045, DOI 10.1016/j.compbiomed.2008.07.006; Papadopoulos A, 2005, ARTIF INTELL MED, V34, P141, DOI 10.1016/j.artmed.2004.10.001; Papadopoulos A, 2002, ARTIF INTELL MED, V25, P149, DOI 10.1016/S0933-3657(02)00013-1; Quintanilla-Dominguez J, 2010, WORLD AUT C, P1; Salvado J, 2005, 2005 IEEE INTERNATIONAL WORKSHOP ON INTELLIGENT SIGNAL PROCESSING (WISP), P200; Sankar D, 2010, J DIGIT IMAGING, V23, P538, DOI 10.1007/s10278-009-9224-6; Sharp T, 2008, LECT NOTES COMPUT SC, V5305, P595, DOI 10.1007/978-3-540-88693-8_44; Shin S, P SPIE MED IMAGING; Smolensky P., 1986, PARALLEL DISTRIBUTED, V1, P194; SUCKLING J, 1994, INT CONGR SER, V1069, P375; Wei LY, 2005, IEEE T MED IMAGING, V24, P1278, DOI 10.1109/TMI.2005.855435; World Cancer Research Fund International, 2013, BREAST CANC STAT; Zhang Xiaoyong, 2013, J Med Eng, V2013, P615254, DOI 10.1155/2013/615254	34	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143725	10.1371/journal.pone.0143725	http://dx.doi.org/10.1371/journal.pone.0143725			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630496	gold, Green Published, Green Submitted			2022-12-27	WOS:000365926300089
J	Bu, RY; Lu, JW; Ren, T; Liu, B; Li, XK; Cong, RH				Bu, Rongyan; Lu, Jianwei; Ren, Tao; Liu, Bo; Li, Xiaokun; Cong, Rihuan			Particulate Organic Matter Affects Soil Nitrogen Mineralization under Two Crop Rotation Systems	PLOS ONE			English	Article							N-MINERALIZATION; LAND-USE; CARBON SEQUESTRATION; MICROBIAL BIOMASS; HUMIC FRACTIONS; PADDY; DECOMPOSITION; AVAILABILITY; PRODUCTIVITY; MANAGEMENT	Changes in the quantity and/or quality of soil labile organic matter between and after different types of cultivation system could play a dominant role in soil nitrogen (N) mineralization. The quantity and quality of particulate organic matter (POM) and potentially mineralizable-N (PMN) contents were measured in soils from 16 paired rice-rapeseed (RR)/cotton-rapeseed (CR) rotations sites in Hubei province, central China. Then four paired soils encompassing low (10th percentile), intermediate (25th and 75th percentiles), and high (90th percentile) levels of soil PMN were selected to further study the effects of POM on soil N mineralization by quantifying the net N mineralization in original soils and soils from which POM was removed. Both soil POM carbon (POM-C) and N (POM-N) contents were 45.8% and 55.8% higher under the RR rotation compared to the CR rotation, respectively. The PMN contents were highly correlated with the POM contents. The PMN and microbial biomass N (MBN) contents concurrently and significantly decreased when POM was removed. The reduction rate of PMN was positively correlated with changes in MBN after the removal of POM. The reduction rates of PMN and MBN after POM removal are lower under RR rotations (38.0% and 16.3%, respectively) than CR rotations (45.6% and 19.5%, respectively). Furthermore, infrared spectroscopy indicated that compounds with low-bioavailability accumulated (e.g., aromatic recalcitrant materials) in the soil POM fraction under the RR rotation but not under the CR rotation. The results of the present study demonstrated that POM plays a vital role in soil N mineralization under different rotation systems. The discrepancy between POM content and composition resulting from different crop rotation systems caused differences in N mineralization in soils.	[Bu, Rongyan; Lu, Jianwei; Ren, Tao; Liu, Bo; Li, Xiaokun; Cong, Rihuan] Huazhong Agr Univ, Coll Resources & Environm, Wuhan, Peoples R China; [Bu, Rongyan; Lu, Jianwei; Ren, Tao; Liu, Bo; Li, Xiaokun; Cong, Rihuan] Minist Agr, Key Lab Arable Land Conservat,Middle & Lower Reac, Wuhan, Peoples R China	Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs	Ren, T (corresponding author), Huazhong Agr Univ, Coll Resources & Environm, Wuhan, Peoples R China.	rentao@mail.hzau.edu.cn		Ren, Tao/0000-0002-7147-3775	National Natural Science Foundation of China [41401324]; Specialize Research Fund for the Doctoral Program of Higher Education [20120146120021]; earmarked fund for China Agriculture Research System [CARS-13]; Fundamental Research Funds for the Central Universities [2013QC045]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialize Research Fund for the Doctoral Program of Higher Education; earmarked fund for China Agriculture Research System; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (41401324), the Specialize Research Fund for the Doctoral Program of Higher Education (20120146120021), the earmarked fund for China Agriculture Research System (CARS-13), and the Fundamental Research Funds for the Central Universities (2013QC045).	Baldock JA, 2000, ORG GEOCHEM, V31, P697, DOI 10.1016/S0146-6380(00)00049-8; Besnard E, 1996, EUR J SOIL SCI, V47, P495, DOI 10.1111/j.1365-2389.1996.tb01849.x; CAMBARDELLA CA, 1994, SOIL SCI SOC AM J, V58, P123, DOI 10.2136/sssaj1994.03615995005800010017x; Carpenter-Boggs L, 2000, SOIL SCI SOC AM J, V64, P2038, DOI 10.2136/sssaj2000.6462038x; Chang RY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085426; Chen XN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103720; Cookson WR, 2005, SOIL BIOL BIOCHEM, V37, P1726, DOI 10.1016/j.soilbio.2005.02.007; Cookson WR, 2004, SOIL BIOL BIOCHEM, V36, P2097, DOI 10.1016/j.soilbio.2004.05.013; [戴传云 Dai Chuanyun], 2003, [重庆大学学报. 自然科学版, Journal of Chongqing University(Natural Science Edition)], V26, P15; Doane TA, 2003, GEODERMA, V114, P319, DOI 10.1016/S0016-7061(03)00047-8; GOLCHIN A, 1994, AUST J SOIL RES, V32, P285, DOI 10.1071/SR9940285; Gosling P, 2013, BIOL FERT SOILS, V49, P1001, DOI 10.1007/s00374-013-0791-9; Han ChengWei, 2007, Scientia Agricultura Sinica, V40, P107; Huang Shan, 2009, Huanjing Kexue, V30, P1146; Kuzyakov Y, 2006, SOIL BIOL BIOCHEM, V38, P747, DOI 10.1016/j.soilbio.2005.06.025; Lehmann J, 2001, GEODERMA, V99, P147, DOI 10.1016/S0016-7061(00)00070-7; Leifeld J, 2005, GEODERMA, V124, P143, DOI 10.1016/j.geoderma.2004.04.009; Li ZP, 2010, GEODERMA, V157, P206, DOI 10.1016/j.geoderma.2010.04.015; Liu XL, 2010, PEDOSPHERE, V20, P666, DOI 10.1016/S1002-0160(10)60056-2; Marriott EE, 2006, SOIL BIOL BIOCHEM, V38, P1527, DOI 10.1016/j.soilbio.2005.11.009; McCarty GW, 2002, SOIL SCI SOC AM J, V66, P640, DOI 10.2136/sssaj2002.0640; MEELU OP, 1979, PLANT SOIL, V51, P51, DOI 10.1007/BF02205926; Mendham DS, 2004, SOIL BIOL BIOCHEM, V36, P1067, DOI 10.1016/j.soilbio.2004.02.018; Olk DC, 2007, EUR J SOIL SCI, V58, P270, DOI 10.1111/j.1365-2389.2006.00836.x; Olk DC, 1996, EUR J SOIL SCI, V47, P293, DOI 10.1111/j.1365-2389.1996.tb01403.x; Preger AC, 2010, EUR J SOIL SCI, V61, P551, DOI 10.1111/j.1365-2389.2010.01248.x; Rahn CR, 2003, SOIL USE MANAGE, V19, P193, DOI [10.1079/SUM2003188, 10.1111/j.1475-2743.2003.tb00304.x]; Rahn CR, 2002, J SCI FOOD AGR, V82, P19, DOI 10.1002/jsfa.1003; Ros GH, 2012, SOIL BIOL BIOCHEM, V45, P132, DOI 10.1016/j.soilbio.2011.10.015; Ros GH, 2011, SOIL BIOL BIOCHEM, V43, P1714, DOI 10.1016/j.soilbio.2011.04.017; Roth PJ, 2011, GLOBAL CHANGE BIOL, V17, P3405, DOI 10.1111/j.1365-2486.2011.02500.x; Rui YC, 2011, J SOIL SEDIMENT, V11, P903, DOI 10.1007/s11368-011-0388-6; Sano S, 2006, SOIL SCI PLANT NUTR, V52, P49, DOI 10.1111/j.1747-0765.2006.00003.x; Sequeira CH, 2011, SOIL BIOL BIOCHEM, V43, P438, DOI 10.1016/j.soilbio.2010.11.014; [申小冉 SHEN Xiaoran], 2011, [干旱地区农业研究, Agricultural Research in the Arid Areas], V29, P121; SKJEMSTAD JO, 1990, AUST J SOIL RES, V28, P267, DOI 10.1071/SR9900267; Sparks D.L., 1996, SOIL SCI SOC AM BOOK; SPARLING G, 1993, SOIL BIOL BIOCHEM, V25, P1793, DOI 10.1016/0038-0717(93)90185-E; Stelzer RS, 2014, BIOGEOCHEMISTRY, V119, P387, DOI 10.1007/s10533-014-9975-0; Wang WN, 2012, FIELD CROP RES, V137, P37, DOI 10.1016/j.fcr.2012.08.010; Wang WJ, 2003, SOIL BIOL BIOCHEM, V35, P273, DOI 10.1016/S0038-0717(02)00274-2; Whalen JK, 2000, SOIL BIOL BIOCHEM, V32, P1345, DOI 10.1016/S0038-0717(00)00040-7; Witt C, 2000, PLANT SOIL, V225, P263, DOI 10.1023/A:1026594118145; Xiang SR, 2008, SOIL BIOL BIOCHEM, V40, P2281, DOI 10.1016/j.soilbio.2008.05.004; Xiao KC, 2013, SOIL BIOL BIOCHEM, V67, P70, DOI 10.1016/j.soilbio.2013.08.012; Yamada T, 2010, JARQ-JPN AGR RES Q, V44, P269, DOI 10.6090/jarq.44.269; Yin F, 2007, J SOIL SEDIMENT, V7, P136, DOI 10.1065/jss2007.04.218; Zeller B, 2011, SOIL BIOL BIOCHEM, V43, P542, DOI 10.1016/j.soilbio.2010.11.019	48	22	24	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0143835	10.1371/journal.pone.0143835	http://dx.doi.org/10.1371/journal.pone.0143835			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YV	26647157	Green Submitted, Green Published, gold			2022-12-27	WOS:000366903100007
J	Moon, CM; Jung, SA; Kim, SE; Song, HJ; Jung, Y; Ye, BD; Cheon, JH; Kim, YS; Kim, YH; Kim, JS; Han, DS				Moon, Chang Mo; Jung, Sung-Ae; Kim, Seong-Eun; Song, Hyun Joo; Jung, Yunho; Ye, Byong Duk; Cheon, Jae Hee; Kim, You Sun; Kim, Young-Ho; Kim, Joo Sung; Han, Dong Soo		CONNECT Study Grp	Clinical Factors and Disease Course Related to Diagnostic Delay in Korean Crohn's Disease Patients: Results from the CONNECT Study	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; HELICOBACTER-PYLORI; ULCERATIVE-COLITIS; RISK-FACTORS; FEATURES; CLASSIFICATION; EPIDEMIOLOGY; PREDICTORS; REMISSION; SURGERY	Diagnostic delay frequently occurs in Crohn's disease (CD) patients because of diagnostic limitations. However, diagnostic delay and its related factors remain poorly defined. Therefore, we aimed to identify the predictors associated with diagnostic delay and to evaluate the impact of diagnostic delay on clinical course in a Korean CD patient cohort. We performed a multicenter retrospective analysis of 1,047 CD patients registered in the Crohn's Disease Clinical Network and Cohort study in Korea. The mean interval of diagnostic delay was 16.0 +/- 33.1 months. Multivariate analysis showed that older age at diagnosis (>= 40 years) (p = 0.014), concomitant upper gastrointestinal (UGI) disease (p = 0.012) and penetrating disease behavior at diagnosis (p = 0.001) were positively associated with long diagnostic delay (>= 18 months). During the longitudinal follow-up, long diagnostic delay was independently predictive of further development of intestinal stenosis (hazard ratio [HR], 1.43; 95% confidence interval [CI], 1.07-1.93; p = 0.017), internal fistulas (HR, 1.62; 95% CI, 1.12-2.33; p = 0.011), and perianal fistulas (HR, 1.38; 95% CI, 1.06-1.80; p = 0.016). However, as for the risk of abscess formation, bowel perforation, and CD-related abdominal surgery, no significant association with diagnostic delay was observed. Older age at diagnosis, UGI involvement, and penetrating behavior are associated with long diagnostic delay in Korean CD patients. Moreover, diagnostic delay is associated with an increased risk of CD-related complications such as intestinal stenosis, internal fistulas, and perianal fistulas.	[Moon, Chang Mo; Jung, Sung-Ae; Kim, Seong-Eun] Ewha Womans Univ, Sch Med, Dept Internal Med, Seoul, South Korea; [Song, Hyun Joo] Jeju Natl Univ, Sch Med, Dept Internal Med, Jeju, South Korea; [Jung, Yunho] Soonchunhyang Univ, Coll Med, Cheonan Hosp, Dept Internal Med, Cheonan, South Korea; [Ye, Byong Duk] Univ Ulsan, Coll Med, Dept Internal Med, Seoul, South Korea; [Cheon, Jae Hee] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, You Sun] Inje Univ, Coll Med, Seoul Paik Hosp, Dept Internal Med, Seoul, South Korea; [Kim, Young-Ho] Sungkyunkwan Univ, Sch Med, Dept Internal Med, Seoul, South Korea; [Kim, Joo Sung] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Han, Dong Soo] Hanyang Univ, Coll Med, Guri Hosp, Dept Internal Med, Guri, South Korea	Ewha Womans University; Jeju National University; Soonchunhyang University; University of Ulsan; Yonsei University; Yonsei University Health System; Inje University; Sungkyunkwan University (SKKU); Seoul National University (SNU); Hanyang University	Jung, SA (corresponding author), Ewha Womans Univ, Sch Med, Dept Internal Med, Seoul, South Korea.	jassa@ewha.ac.kr	Han, Dong Soo/P-1753-2015; Ye, Byong Duk/AAF-4955-2020; Han, Dong Soo/AHD-6285-2022; Song, hyunjoo/GWC-1292-2022; Kim, You Sun/AFR-0428-2022; Cheon, Jae Hee/B-4523-2015	Ye, Byong Duk/0000-0001-6647-6325; Han, Dong Soo/0000-0001-7103-3318; Kim, You Sun/0000-0002-5156-3458; Cheon, Jae Hee/0000-0002-2282-8904; Jung, Seok Won/0000-0001-7001-0341; /0000-0002-7760-0050	Korea Centers for Disease Control and Prevention [2013-E63004-01]	Korea Centers for Disease Control and Prevention	This work was supported by the Research Program, funded by the Korea Centers for Disease Control and Prevention (2013-E63004-01).	Beaugerie L, 2006, GASTROENTEROLOGY, V130, P650, DOI 10.1053/j.gastro.2005.12.019; BROE PJ, 1982, SURGERY, V91, P249; Cheon JH, 2013, J GASTROEN HEPATOL, V28, P220, DOI 10.1111/jgh.12053; Cosnes J, 2002, INFLAMM BOWEL DIS, V8, P244, DOI 10.1097/00054725-200207000-00002; D'Haens G, 2008, LANCET, V371, P660, DOI 10.1016/S0140-6736(08)60304-9; Hall B, 2015, DIGEST DIS, V33, P42, DOI 10.1159/000366047; Kane SV, 2005, J CLIN GASTROENTEROL, V39, P32; Kim ES, 2010, GUT LIVER, V4, P1, DOI 10.5009/gnl.2010.4.1.1; Lakatos PL, 2007, WORLD J GASTROENTERO, V13, P6134, DOI 10.3748/wjg.13.6134; Levine A, 2011, INFLAMM BOWEL DIS, V17, P1314, DOI 10.1002/ibd.21493; Li Y, 2015, DIGEST LIVER DIS, V47, P544, DOI 10.1016/j.dld.2015.03.004; Loly C, 2008, SCAND J GASTROENTERO, V43, P948, DOI 10.1080/00365520801957149; Louis E, 2001, GUT, V49, P777, DOI 10.1136/gut.49.6.777; MARSHALL BJ, 1984, LANCET, V1, P1311; Moayyedi P, 2003, AM J GASTROENTEROL, V98, P2621, DOI [10.1016/j.amjgastroenterol.2003.07.003, 10.1111/j.1572-0241.2003.08724.x]; Moon CM, 2014, J GASTROEN HEPATOL, V29, P74, DOI 10.1111/jgh.12369; Nahon S, 2014, J CROHNS COLITIS, V8, P964, DOI 10.1016/j.crohns.2014.01.023; Ng SC, 2014, BEST PRACT RES CL GA, V28, P363, DOI 10.1016/j.bpg.2014.04.003; Ng SC, 2013, GASTROENTEROLOGY, V145, P158, DOI 10.1053/j.gastro.2013.04.007; Oberhuber G, 2000, VIRCHOWS ARCH, V437, P293, DOI 10.1007/s004280000226; Park SH, 2007, INFLAMM BOWEL DIS, V13, P278, DOI 10.1002/ibd.20015; Perminow G, 2009, SCAND J GASTROENTERO, V44, P446, DOI 10.1080/00365520802647434; Peyrin-Biroulet L, 2012, AM J GASTROENTEROL, V107, P1770, DOI 10.1038/ajg.2012.117; Pimentel M, 2000, AM J GASTROENTEROL, V95, P3458; Raghunath A, 2003, BMJ-BRIT MED J, V326, P737, DOI 10.1136/bmj.326.7392.737; Rutgeerts P, 2006, GASTROINTEST ENDOSC, V63, P433, DOI 10.1016/j.gie.2005.08.011; Ryan WR, 2004, AM J SURG, V187, P219, DOI 10.1016/j.amjsurg.2003.11.007; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Schoepfer AM, 2013, AM J GASTROENTEROL, V108, P1744, DOI 10.1038/ajg.2013.248; Schoepfer AM, 2012, DIGESTION, V86, P23, DOI 10.1159/000341961; Schreiber S, 2010, AM J GASTROENTEROL, V105, P1574, DOI 10.1038/ajg.2010.78; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Simren M, 2002, AM J GASTROENTEROL, V97, P389; Solberg IC, 2007, CLIN GASTROENTEROL H, V5, P1430, DOI 10.1016/j.cgh.2007.09.002; Song XM, 2011, DIS COLON RECTUM, V54, P1147, DOI 10.1097/DCR.0b013e318222ddc3; Thienpont C, 2014, DIGEST DIS, V32, P35, DOI 10.1159/000367824; Vavricka SR, 2012, INFLAMM BOWEL DIS, V18, P496, DOI 10.1002/ibd.21719; Yang SK, 2008, INFLAMM BOWEL DIS, V14, P542, DOI 10.1002/ibd.20310; Ye BD, 2014, INTEST RES, V12, P263, DOI 10.5217/ir.2014.12.4.263; Ye Byong Duk, 2009, Korean J Gastroenterol, V53, P161; Ye BD, 2010, SCAND J GASTROENTERO, V45, P1178, DOI 10.3109/00365521.2010.497936; Yim JY, 2007, HELICOBACTER, V12, P333, DOI 10.1111/j.1523-5378.2007.00504.x; Yoon JY, 2014, INTEST RES, V12, P80, DOI [10.5217/ir.2014.12.1.80, 10.5217/ir.2014.12.3.173]	43	28	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0144390	10.1371/journal.pone.0144390	http://dx.doi.org/10.1371/journal.pone.0144390			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YV	26647084	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903100023
J	Ali, TB; Schleret, TR; Reilly, BM; Chen, WY; Abagyan, R				Ali, Thibault B.; Schleret, Thomas R.; Reilly, Brian M.; Chen, Winston Yuchen; Abagyan, Ruben			Adverse Effects of Cholinesterase Inhibitors in Dementia, According to the Pharmacovigilance Databases of the United-States and Canada	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; RIVASTIGMINE; EFFICACY; SAFETY; PATCH	This survey analyzes two national pharmacovigilance databases in order to determine the major adverse reactions observed with the use of cholinesterase inhibitors in dementia. We conducted a statistical analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS) and the Canada Vigilance Adverse Reaction Database (CVARD) concerning the side effects of cholinesterase inhibitors. The statistics calculated for each adverse event were the frequency and the reporting odds ratios (ROR). A total of 9877 and 2247 reports were extracted from the FAERS and CVARD databases, respectively. A disproportionately higher frequency of reports of death as an adverse event for rivastigmine, compared to the other acetylcholinesterase inhibiting drugs, was observed in both the FAERS (ROR = 3.42; CI95% = 2.94-3.98; P<0.0001) and CVARD (ROR = 3.67; CI95% = 1.92-7.00; P = 0.001) databases. While cholinesterase inhibitors remain to be an important therapeutic tool against Alzheimer's disease, the disproportionate prevalence of fatal outcomes with rivastigmine compared with alternatives should be taken into consideration.	[Ali, Thibault B.; Schleret, Thomas R.; Reilly, Brian M.; Chen, Winston Yuchen; Abagyan, Ruben] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Abagyan, R (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.	ruben@ucsd.edu		reilly, brian/0000-0001-7418-1359	NIGMS NIH HHS [R01 GM071872] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071872] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aly HAA, 2015, WHO TECH REP SER, V994, P1; Bar-On P, 2002, BIOCHEMISTRY-US, V41, P3555, DOI 10.1021/bi020016x; Chen M, 2013, OVERVIEW POSTMARKETI; Chen Y., 2008, PHARM MED, V22, P359, DOI 10.1007/bf03256733; Emre M, 2010, CNS NEUROSCI THER, V16, P246, DOI 10.1111/j.1755-5949.2010.00141.x; Gruber T, 2007, NOVARTIS PHARM IMPOR; Guerchet M., 2013, POLICY BRIEF HEADS G; Han HJ, 2011, J CLIN NEUROL, V7, P137, DOI 10.3988/jcn.2011.7.3.137; Health Canada, 2013, INSTR CAN VIG ADV RE; Health Canada, 2014, CAN VIG ADV REACT ON; Health Canada, 2014, SEARCH CAN VIG ADV R; HOFFMAN KB, 2012, PLOS ONE, V7, DOI DOI 10.1371/J0URNAL.P0NE.0042866; Huang FL, 2010, CURR CLIN PHARMACOL, V5, P115, DOI 10.2174/157488410791110805; Jann MW, 2000, PHARMACOTHERAPY, V20, P1, DOI 10.1592/phco.20.1.1.34664; Lovborg H, 2012, CURR DRUG SAF, V7, P30, DOI 10.2174/157488612800492717; Pirker C, 2002, CONTACT DERMATITIS, V47, P135, DOI 10.1034/j.1600-0536.2002.470302.x; Prince M, 2013, WORLD ALZHEIMER REP; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Qiu Chengxuan, 2009, Dialogues Clin Neurosci, V11, P111; Reitz C, 2011, NAT REV NEUROL, V7, P137, DOI [10.1038/nrneurol.2011.2, 10.1101/cshperspect.a006239]; Rosler M, 1999, BMJ-BRIT MED J, V318, P633, DOI 10.1136/bmj.318.7184.633; Sahin OZ, 2014, CASE REPORT RARE CAS, V2014, P14; Sakaeda T, 2013, INT J MED SCI, V10, P796, DOI 10.7150/ijms.6048; Szumilas M, 2010, J CAN ACAD CHILD ADO, V19, P227; US Food and Drug Administration, 2014, FDA ADV EV REP SYST; Wilkinson D G, 1999, Expert Opin Pharmacother, V1, P121, DOI 10.1517/14656566.1.1.121; Wilkinson DG, 2004, DRUG AGING, V21, P453, DOI 10.2165/00002512-200421070-00004; Winblad B, 2007, NEUROLOGY, V69, pS14, DOI 10.1212/01.wnl.0000281847.17519.e0; Winston C, 2014, EARLY DRUG ALERT	29	85	87	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144337	10.1371/journal.pone.0144337	http://dx.doi.org/10.1371/journal.pone.0144337			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642212	Green Published, gold, Green Submitted			2022-12-27	WOS:000366902700099
J	De Fanti, S; Barbieri, C; Sarno, S; Sevini, F; Vianello, D; Tamm, E; Metspalu, E; van Oven, M; Hubner, A; Sazzini, M; Franceschi, C; Pettener, D; Luiselli, D				De Fanti, Sara; Barbieri, Chiara; Sarno, Stefania; Sevini, Federica; Vianello, Dario; Tamm, Erika; Metspalu, Ene; van Oven, Mannis; Huebner, Alexander; Sazzini, Marco; Franceschi, Claudio; Pettener, Davide; Luiselli, Donata			Fine Dissection of Human Mitochondrial DNA Haplogroup HV Lineages Reveals Paleolithic Signatures from European Glacial Refugia	PLOS ONE			English	Article							NEAR-EASTERN; HUMAN MTDNA; POPULATION EXPANSIONS; PHYLOGEOGRAPHY; EVOLUTION; SELECTION; SOUTH; ASIA; RECOLONIZATION; SETTLEMENT	Genetic signatures from the Paleolithic inhabitants of Eurasia can be traced from the early divergent mitochondrial DNA lineages still present in contemporary human populations. Previous studies already suggested a pre-Neolithic diffusion of mitochondrial haplogroup HV*(xH, V) lineages, a relatively rare class of mtDNA types that includes parallel branches mainly distributed across Europe and West Asia with a certain degree of structure. Up till now, variation within haplogroup HV was addressed mainly by analyzing sequence data from the mtDNA control region, except for specific sub-branches, such as HV4 or the widely distributed haplogroups H and V. In this study, we present a revised HV topology based on full mtDNA genome data, and we include a comprehensive dataset consisting of 316 complete mtDNA sequences including 60 new samples from the Italian peninsula, a previously underrepresented geographic area. We highlight points of instability in the particular topology of this haplogroup, reconstructed with BEAST-generated trees and networks. We also confirm a major lineage expansion that probably followed the Late Glacial Maximum and preceded Neolithic population movements. We finally observe that Italy harbors a reservoir of mtDNA diversity, with deep-rooting HV lineages often related to sequences present in the Caucasus and the Middle East. The resulting hypothesis of a glacial refugium in Southern Italy has implications for the understanding of late Paleolithic population movements and is discussed within the archaeological cultural shifts occurred over the entire continent.	[De Fanti, Sara; Barbieri, Chiara; Sarno, Stefania; Sazzini, Marco; Pettener, Davide; Luiselli, Donata] Univ Bologna, Dept Biol Geol & Environm Sci, Bologna, Italy; [Sevini, Federica; Vianello, Dario; Franceschi, Claudio] Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy; [Sevini, Federica; Vianello, Dario; Franceschi, Claudio] Univ Bologna, CIG Interdepartmental Ctr L Galvani Integrated St, Bologna, Italy; [Tamm, Erika; Metspalu, Ene; van Oven, Mannis] Evolutionary Biol Grp, Estonian Bioctr, Tartu, Estonia; [Tamm, Erika; Metspalu, Ene] Univ Tartu, Dept Evolutionary Biol, EE-50090 Tartu, Estonia; [van Oven, Mannis] Erasmus MC Univ Med Ctr Rotterdam, Dept Forens Mol Biol, Rotterdam, Netherlands; [Huebner, Alexander] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, Leipzig, Germany; [Franceschi, Claudio] Osped Bellaria, Inst Neurol Sci Bologna, IRCCS, Bologna, Italy; [Franceschi, Claudio] CNR, Inst Organ Synth & Photoreact ISOF, Bologna, Italy	University of Bologna; University of Bologna; University of Bologna; Estonian Biocentre; University of Tartu; Erasmus University Rotterdam; Erasmus MC; Max Planck Society; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); Consiglio Nazionale delle Ricerche (CNR); Istituto per la Sintesi Organica e la Fotoreattivita (ISOF-CNR)	Barbieri, C (corresponding author), Max Planck Inst Sci Human Hist, Dept Linguist & Cultural Evolut, Jena, Germany.	barbieri.chiara@gmail.com; donata.luiselli@unibo.it	Tamm, Erika/G-2818-2017; Pettener, Davide/E-1576-2017; Franceschi, Claudio/L-4484-2017	Tamm, Erika/0000-0003-0694-3598; Franceschi, Claudio/0000-0001-9841-6386; Hubner, Alexander/0000-0003-3572-9996; van Oven, Mannis/0000-0003-0026-7998; Barbieri, Chiara/0000-0001-8827-5655; SAZZINI, MARCO/0000-0001-5382-7827; Vianello, Dario/0000-0003-1350-7284	PRIN Progetti di Ricerca di Interesse Nazionale [2010EL8TXP_006]; European Research Council [ERC-2011-AdG 295733]; Estonian Research Council [IUT24-1]; European Regional Development Fund (European Union) through the Centre of Excellence in Genomics to Estonian Biocentre; European Regional Development Fund (European Union) through University of Tartu; Estonian Biocentre EBC ECOGENE student fellowship	PRIN Progetti di Ricerca di Interesse Nazionale(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); European Research Council(European Research Council (ERC)European Commission); Estonian Research Council(Estonian Research Council); European Regional Development Fund (European Union) through the Centre of Excellence in Genomics to Estonian Biocentre; European Regional Development Fund (European Union) through University of Tartu; Estonian Biocentre EBC ECOGENE student fellowship	This work was supported by the PRIN Progetti di Ricerca di Interesse Nazionale 2010EL8TXP_006 grant to DL, http://prin.miur.it/; the European Research Council ERC-2011-AdG 295733 (Langelin) to DP and CB, http://erc.europa.eu/; the Institutional Research Funding from the Estonian Research Council [IUT24-1], http://www.etag.ee/en/estonian-research-council/; and by the European Regional Development Fund (European Union), http://ec.europa.eu/regional_policy/index.cfm/en/funding/erdf/, through the Centre of Excellence in Genomics to Estonian Biocentre and University of Tartu, http://genomics.ebc.ee/. MvO was supported in part by an Estonian Biocentre EBC ECOGENE student fellowship, https://edukad.etag.ee/project/3010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Achilli A, 2013, P NATL ACAD SCI USA, V110, P14308, DOI 10.1073/pnas.1306290110; Allentoft ME, 2015, NATURE, V522, P167, DOI 10.1038/nature14507; Baele G, 2013, MOL BIOL EVOL, V30, P239, DOI 10.1093/molbev/mss243; Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bandelt HJ, 2002, AM J HUM GENET, V71, P1150, DOI 10.1086/344397; Barbieri C, 2013, AM J HUM GENET, V92, P285, DOI 10.1016/j.ajhg.2012.12.010; Batini C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8152; Batini C, 2011, MOL BIOL EVOL, V28, P1099, DOI 10.1093/molbev/msq294; Behar DM, 2012, AM J HUM GENET, V90, P486, DOI 10.1016/j.ajhg.2012.01.002; Behar DM, 2012, AM J HUM GENET, V90, P675, DOI 10.1016/j.ajhg.2012.03.002; Benazzi S, 2015, SCIENCE, V348, P793, DOI 10.1126/science.aaa2773; Boattini A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065441; Bodner M, 2012, GENOME RES, V22, P811, DOI 10.1101/gr.131722.111; Brandon MC, 2009, HUM MUTAT, V30, P1, DOI 10.1002/humu.20801; Brandt G, 2015, J HUM EVOL, V79, P73, DOI 10.1016/j.jhevol.2014.06.017; Brandt G, 2013, SCIENCE, V342, P257, DOI 10.1126/science.1241844; Brotherton P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2656; Canestrelli D, 2007, MOL ECOL, V16, P4808, DOI 10.1111/j.1365-294X.2007.03534.x; Caramelli D, 2003, P NATL ACAD SCI USA, V100, P6593, DOI 10.1073/pnas.1130343100; Cerezo M, 2012, GENOME RES, V22, P821, DOI 10.1101/gr.134452.111; Darriba D, 2012, MOL BIOL EVOL, V9, P239; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Duggan AT, 2013, AM J HUM GENET, V92, P279, DOI 10.1016/j.ajhg.2012.12.004; Farjadian S, 2011, HUM HERED, V72, P73, DOI 10.1159/000330166; Fontanesi F, 2006, AM J PHYSIOL-CELL PH, V291, pC1129, DOI 10.1152/ajpcell.00233.2006; Forster P, 1996, AM J HUM GENET, V59, P935; Fu QM, 2013, CURR BIOL, V23, P553, DOI 10.1016/j.cub.2013.02.044; Gamble C, 2004, PHILOS T R SOC B, V359, P243, DOI 10.1098/rstb.2003.1396; Gomez-Carballa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032851; Gvozdik V, 2013, MOL PHYLOGENET EVOL, V69, P1077, DOI 10.1016/j.ympev.2013.05.004; Haak W, 2015, NATURE, V522, P207, DOI 10.1038/nature14317; Henn BM, 2009, MOL BIOL EVOL, V26, P217, DOI 10.1093/molbev/msn244; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Jochim M., 1987, PLEISTOCENE OLD WORL, P317, DOI DOI 10.1007/978-1-4613-1817-020; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Kloss-Brandstatter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382; Krause J, 2010, CURR BIOL, V20, P231, DOI 10.1016/j.cub.2009.11.068; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lippold Sebastian, 2014, Investig Genet, V5, P13, DOI 10.1186/2041-2223-5-13; Loogvali EL, 2004, MOL BIOL EVOL, V21, P2012, DOI 10.1093/molbev/msh209; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Malyarchuk B, 2008, MOL BIOL EVOL, V25, P1651, DOI 10.1093/molbev/msn114; Malyarchuk BA, 2002, HUM GENET, V111, P46, DOI 10.1007/s00439-002-0740-4; Mannino MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049802; Metspalu M, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-26; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Mussi M., 1992, POPOLI CIVILTA ITALI; Nenadic O, 2007, J STAT SOFTW, V20; Feliner GN, 2011, TAXON, V60, P365, DOI 10.1002/tax.602007; Ottoni C, 2011, EUR J HUM GENET, V19, P571, DOI 10.1038/ejhg.2010.230; Pala M, 2012, AM J HUM GENET, V90, P915, DOI 10.1016/j.ajhg.2012.04.003; Pala M, 2009, AM J HUM GENET, V84, P814, DOI 10.1016/j.ajhg.2009.05.004; Pereira L, 2005, GENOME RES, V15, P19, DOI 10.1101/gr.3182305; Pinhasi R, 2012, TRENDS GENET, V28, P496, DOI 10.1016/j.tig.2012.06.006; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Raule N, 2014, AGING CELL, V13, P401, DOI 10.1111/acel.12186; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x; Rieux A, 2014, MOL BIOL EVOL, V31, P2780, DOI 10.1093/molbev/msu222; Roostalu U, 2007, MOL BIOL EVOL, V24, P436, DOI 10.1093/molbev/msl173; Sazzini M, 2014, MEDITERRANEAN SEA: ITS HISTORY AND PRESENT CHALLENGES, P529, DOI 10.1007/978-94-007-6704-1_31; Schonberg A, 2011, EUR J HUM GENET, V19, P988, DOI 10.1038/ejhg.2011.62; Skoglund P, 2012, SCIENCE, V336, P466, DOI 10.1126/science.1216304; Soares P, 2010, CURR BIOL, V20, pR174, DOI 10.1016/j.cub.2009.11.054; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; Torroni A, 2001, AM J HUM GENET, V69, P844, DOI 10.1086/323485; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Underhill PA, 2007, ANNU REV GENET, V41, P539, DOI 10.1146/annurev.genet.41.110306.130407; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Vianello D, 2013, HUM MUTAT, V34, P1189, DOI 10.1002/humu.22356; Zheng HX, 2012, SCI REP-UK, V2, DOI 10.1038/srep00745	76	19	19	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144391	10.1371/journal.pone.0144391	http://dx.doi.org/10.1371/journal.pone.0144391			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26640946	Green Submitted, Green Published, gold			2022-12-27	WOS:000366902700110
J	Desoti, VC; Lazarin-Bidoia, D; Ribeiro, FM; Martins, SC; Rodrigues, JHD; Ueda-Nakamura, T; Nakamura, CV; Ximenes, VF; Silva, SD				Desoti, Vania Cristina; Lazarin-Bidoia, Danielle; Ribeiro, Fabianne Martins; Martins, Solange Cardoso; da Silva Rodrigues, Jean Henrique; Ueda-Nakamura, Tania; Nakamura, Celso Vataru; Ximenes, Valdecir Farias; Silva, Sueli de Oliveira			The Combination of Vitamin K-3 and Vitamin C Has Synergic Activity against Forms of Trypanosoma cruzi through a Redox Imbalance Process	PLOS ONE			English	Article							KILLS CANCER-CELLS; OXIDATIVE STRESS; CHAGAS-DISEASE; TRYPANOCIDAL ACTION; CARCINOMA-CELLS; TRYPANOTHIONE REDUCTASE; ANTITUMOR-ACTIVITY; CYCLE ARREST; IN-VITRO; DEATH	Chagas' disease is an infection that is caused by the protozoan Trypanosoma cruzi, affecting millions of people worldwide. Because of severe side effects and variable efficacy, the current treatments for Chagas' disease are unsatisfactory, making the search for new chemotherapeutic agents essential. Previous studies have reported various biological activities of naphthoquinones, such as the trypanocidal and antitumor activity of vitamin K-3. The combination of this vitamin with vitamin C exerted better effects against various cancer cells than when used alone. These effects have been attributed to an increase in reactive oxygen species generation. In the present study, we evaluated the activity of vitamin K-3 and vitamin C, alone and in combination, against T. cruzi. The vitamin K-3 + vitamin C combination exerted synergistic effects against three forms of T. cruzi, leading to morphological, ultrastructural, and functional changes by producing reactive species, decreasing reduced thiol groups, altering the cell cycle, causing lipid peroxidation, and forming autophagic vacuoles. Our hypothesis is that the vitamin K-3 + vitamin C combination induces oxidative imbalance in T. cruzi, probably started by a redox cycling process that leads to parasite cell death.	[Desoti, Vania Cristina; Lazarin-Bidoia, Danielle; Ribeiro, Fabianne Martins; Ueda-Nakamura, Tania; Nakamura, Celso Vataru; Silva, Sueli de Oliveira] Univ Estadual Maringa, Programa Pos Grad Ciencias Farmaceut, Maringa, PR, Brazil; [Martins, Solange Cardoso; da Silva Rodrigues, Jean Henrique; Nakamura, Celso Vataru] Univ Estadual Maringa, Programa Pos Grad Ciencias Biol Biol Celular & Mo, Maringa, PR, Brazil; [Ximenes, Valdecir Farias] Univ Estadual Paulista, Dept Quim, Fac Ciencias, Bauru, SP, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa; Universidade Estadual Paulista	Silva, SD (corresponding author), Univ Estadual Maringa, Programa Pos Grad Ciencias Farmaceut, Maringa, PR, Brazil.	lautenschlager@uem.br	Rodrigues, Jean Henrique/G-6277-2017; Desoti, Vania/AAC-6414-2020; Ueda-Nakamura, Tania/P-8250-2015; Ximenes, Valdecir/A-5323-2008; Nakamura, Celso Vataru/AAA-5620-2019; Lautenschlager, Sueli OS/P-2164-2017; Bidoia, Danielle Lazarin/AAQ-2024-2020	Rodrigues, Jean Henrique/0000-0003-2902-4578; Ueda-Nakamura, Tania/0000-0001-5057-3518; Ximenes, Valdecir/0000-0003-2636-3080; Lautenschlager, Sueli OS/0000-0001-9303-0804; DESOTI, VANIA/0000-0002-2087-5248	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Capacitacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Financiadora de Estudos e Projetos (FINEP); Programa de Nucleos de Excelencia (PRONEX/Fundacao Araucaria); Programa de Pos-Graduacao em Ciencias Farmaceuticas da Universidade Estadual de Maringa; Complexo de Centrais de Apoio a Pesquisa (COMCAP-UEM)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Capacitacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Programa de Nucleos de Excelencia (PRONEX/Fundacao Araucaria)(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FA); Programa de Pos-Graduacao em Ciencias Farmaceuticas da Universidade Estadual de Maringa; Complexo de Centrais de Apoio a Pesquisa (COMCAP-UEM)	This study was supported by grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Capacitacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Financiadora de Estudos e Projetos (FINEP), Programa de Nucleos de Excelencia (PRONEX/Fundacao Araucaria), Programa de Pos-Graduacao em Ciencias Farmaceuticas da Universidade Estadual de Maringa, and Complexo de Centrais de Apoio a Pesquisa (COMCAP-UEM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyoshi T, 2009, CANCER CHEMOTH PHARM, V65, P143, DOI 10.1007/s00280-009-1016-7; Ariyanayagam MR, 2003, J BIOL CHEM, V278, P27612, DOI 10.1074/jbc.M302750200; Beck R, 2011, INVEST NEW DRUG, V29, P891, DOI 10.1007/s10637-010-9441-3; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Bothiraja C, 2013, THER DELIV, V4, P1247, DOI [10.4155/TDE.13.92, 10.4155/tde.13.92]; BOVERIS A, 1978, COMP BIOCHEM PHYS C, V61, P327, DOI 10.1016/0306-4492(78)90063-1; BRENER Z., 1962, REV INST MED TROP SAO PAULO, V4, P389; Caballero AB, 2011, J INORG BIOCHEM, V105, P770, DOI 10.1016/j.jinorgbio.2011.03.015; CamargO E. P., 1964, Revista do Instituto de Medicina Tropical de Sao Paulo, V6, P93; Chagas C, 1909, MEM I O CRUZ, V1, P159, DOI DOI 10.1590/S0074-02761909000200008; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Ciccarelli AB, 2012, ANTIMICROB AGENTS CH, V56, P5315, DOI 10.1128/AAC.00481-12; Coura JR, 2002, MEM I OSWALDO CRUZ, V97, P3, DOI 10.1590/S0074-02762002000100001; CROFT SL, 1992, J ANTIMICROB CHEMOTH, V30, P827, DOI 10.1093/jac/30.6.827; da Silva AO, 2013, EUR J MED CHEM, V60, P51, DOI 10.1016/j.ejmech.2012.11.034; Rodrigues JHD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085706; DAHL C, 1987, P NATL ACAD SCI USA, V84, P4012, DOI 10.1073/pnas.84.12.4012; Desoti VC, 2012, MAR DRUGS, V10, P1631, DOI 10.3390/md10081631; Faundez M, 2005, ANTIMICROB AGENTS CH, V49, P126, DOI 10.1128/AAC.49.1.126-130.2005; Fleury C, 2002, BIOCHIMIE, V84, P131, DOI 10.1016/S0300-9084(02)01369-X; Gilloteaux J, 2005, ULTRASTRUCT PATHOL, V29, P221, DOI 10.1080/01913120590951239; Gilloteaux J, 2004, TISSUE CELL, V36, P197, DOI 10.1016/j.tice.2004.01.006; Gilloteaux J, 1998, SCANNING, V20, P564; Gilloteaux J, 2010, ULTRASTRUCT PATHOL, V34, P140, DOI 10.3109/01913121003662304; Graciani FS, 2012, BRAZ J MED BIOL RES, V45, P701, DOI 10.1590/S0100-879X2012007500078; Haberzettl P, 2013, REDOX BIOL, V1, P56, DOI 10.1016/j.redox.2012.10.003; Uc-Cachon AH, 2014, PULM PHARMACOL THER, V27, P114, DOI 10.1016/j.pupt.2013.08.001; Irigoin F, 2008, FREE RADICAL BIO MED, V45, P733, DOI 10.1016/j.freeradbiomed.2008.05.028; Izumi E, 2011, NAT PROD REP, V28, P809, DOI 10.1039/c0np00069h; Jamison JM, 2004, BIOCHEM PHARMACOL, V67, P337, DOI 10.1016/j.bcp.2003.08.040; Jamison JM, 2001, J NUTR, V131, p158S, DOI 10.1093/jn/131.1.158S; Lamson Davis W, 2003, Altern Med Rev, V8, P303; Lazarin-Bidoia D, 2013, FREE RADICAL BIO MED, V60, P17, DOI 10.1016/j.freeradbiomed.2013.01.008; Macao LB, 2007, INT J CARDIOL, V123, P43, DOI 10.1016/j.ijcard.2006.11.118; Maguire JH, 2006, NEW ENGL J MED, V355, P760, DOI 10.1056/NEJMp068130; Marquez VE, 2014, BIOCHIMIE, V106, P56, DOI 10.1016/j.biochi.2014.07.027; Maya JD, 2007, COMP BIOCHEM PHYS A, V146, P601, DOI 10.1016/j.cbpa.2006.03.004; Menna-Barreto RFS, 2009, FREE RADICAL BIO MED, V47, P644, DOI 10.1016/j.freeradbiomed.2009.06.004; Munafo DB, 2001, J CELL SCI, V114, P3619; NOTO V, 1989, CANCER, V63, P901, DOI 10.1002/1097-0142(19890301)63:5<901::AID-CNCR2820630518>3.0.CO;2-G; Orrenius S, 2007, ANNU REV PHARMACOL, V47, P143, DOI 10.1146/annurev.pharmtox.47.120505.105122; Pelizzaro-Rocha KJ, 2010, PHYTOMEDICINE, V18, P36, DOI 10.1016/j.phymed.2010.09.005; Pereira-da Silva L. H., 1953, Folia Clinica et Biologica Sao Paulo, V20, P191; Piacenza L, 2009, INT J PARASITOL, V39, P1455, DOI 10.1016/j.ijpara.2009.05.010; Pinto AV, 2009, MOLECULES, V14, P4570, DOI 10.3390/molecules14114570; Polanco-Hernandez G, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/435398; POMPELLA A, 1987, LIPIDS, V22, P206, DOI 10.1007/BF02537304; Salmon-Chemin L, 2001, J MED CHEM, V44, P548, DOI 10.1021/jm001079l; Salomao K, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-196; Shukla AK, 2012, EUR J MED CHEM, V54, P49, DOI 10.1016/j.ejmech.2012.04.034; Taper HS, 2001, J HISTOCHEM CYTOCHEM, V49, P109, DOI 10.1177/002215540104900111; Tareen Basir, 2008, Int J Med Sci, V5, P62; Tarleton RL, 2007, PLOS MED, V4, P1852, DOI 10.1371/journal.pmed.0040332; Venugopal M, 1996, CELL BIOL INT, V20, P787, DOI 10.1006/cbir.1996.0102; Verrax J, 2004, APOPTOSIS, V9, P223, DOI 10.1023/B:APPT.0000018804.26026.1a; Verrax J, 2003, EUR J MED CHEM, V38, P451, DOI 10.1016/S0223-5234(03)00082-5; Verrax J, 2006, BIOCHEM PHARMACOL, V72, P671, DOI 10.1016/j.bcp.2006.05.025; Wilkinson SR, 2000, J BIOL CHEM, V275, P8220, DOI 10.1074/jbc.275.11.8220; Wilkinson SR, 2005, P NATL ACAD SCI USA, V102, P11645, DOI 10.1073/pnas.0504251102; World Health Organization, 2015, CHAG DIS AM TRYP; Wu FYH, 1999, EUR J CANCER, V35, P1388, DOI 10.1016/S0959-8049(99)00156-2; Wymann MP, 1996, MOL CELL BIOL, V16, P1722; Zhao Liang, 2010, Front Biosci (Elite Ed), V2, P241, DOI 10.2741/e86	63	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144033	10.1371/journal.pone.0144033	http://dx.doi.org/10.1371/journal.pone.0144033			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641473	Green Submitted, gold, Green Published			2022-12-27	WOS:000366902700050
J	Peng, H; Zhao, DD; Liu, XM; Gao, JX				Peng, Hao; Zhao, Dandan; Liu, Xueming; Gao, Jianxi			Collective Motion in a Network of Self-Propelled Agent Systems	PLOS ONE			English	Article							DYNAMICS	Collective motions of animals that move towards the same direction is a conspicuous feature in nature. Such groups of animals are called a self-propelled agent (SPA) systems. Many studies have been focused on the synchronization of isolated SPA systems. In real scenarios, different SPA systems are coupled with each other forming a network of SPA systems. For example, a flock of birds and a school of fish show predator-prey relationships and different groups of birds may compete for food. In this work, we propose a general framework to study the collective motion of coupled self-propelled agent systems. Especially, we study how three different connections between SPA systems: symbiosis, predator-prey, and competition influence the synchronization of the network of SPA systems. We find that a network of SPA systems coupled with symbiosis relationship arrive at a complete synchronization as all its subsystems showing a complete synchronization; a network of SPA systems coupled by predator-prey relationship can not reach a complete synchronization and its subsystems converges to different synchronized directions; and the competitive relationship between SPA systems could increase the synchronization of each SPA systems, while the network of SPA systems coupled by competitive relationships shows an optimal synchronization for small coupling strength, indicating that small competition promotes the synchronization of the entire system.	[Peng, Hao; Zhao, Dandan] Zhejiang Normal Univ, Dept Comp Sci & Engn, Jinhua 321004, Zhejiang, Peoples R China; [Liu, Xueming] Huazhong Univ Sci & Technol, Sch Automat, Key Lab Image Informat Proc & Intelligent Control, Wuhan 430074, Hubei, Peoples R China; [Liu, Xueming] Boston Univ, Ctr Polymer Studies, Boston, MA 02215 USA; [Liu, Xueming] Boston Univ, Dept Phys, Boston, MA 02215 USA; [Gao, Jianxi] Northeastern Univ, Ctr Complex Network Res, Boston, MA 02115 USA; [Gao, Jianxi] Northeastern Univ, Dept Phys, Boston, MA 02115 USA	Zhejiang Normal University; Huazhong University of Science & Technology; Boston University; Boston University; Northeastern University; Northeastern University	Gao, JX (corresponding author), Northeastern Univ, Ctr Complex Network Res, Boston, MA 02115 USA.	jianxi.gao@gmail.com	Gao, Jianxi/C-8494-2015; Gao, Jianxi/I-1300-2013	Gao, Jianxi/0000-0002-3952-208X; Gao, Jianxi/0000-0002-3952-208X; Liu, Xueming/0000-0003-0676-9745	US Army Research Laboratory and the US Army Research Office under Cooperative Agreement [W911NF-09-2-0053]; John Templeton Foundation [51977]; Defense Threat Reduction Agency Basic Research [HDTRA1-10-1-0100]; Zhejiang Provincial Natural Science Foundation of China [LQ13F020007, LQ16F020002]; MOE (Ministry of Education in China) Project of Humanity and Social Science [15YJCZH125]; National Natural Science Foundation of China [61374160, 61170108]; Key Lab of Information Network Security, Ministry of Public Security [C15610]; Shanghai Information Security Key Laboratory of Integrated Management of Technology [AGK2013003]	US Army Research Laboratory and the US Army Research Office under Cooperative Agreement; John Templeton Foundation; Defense Threat Reduction Agency Basic Research(United States Department of DefenseDefense Threat Reduction Agency); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); MOE (Ministry of Education in China) Project of Humanity and Social Science; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Lab of Information Network Security, Ministry of Public Security; Shanghai Information Security Key Laboratory of Integrated Management of Technology	The authors gratefully acknowledge support from the US Army Research Laboratory and the US Army Research Office under Cooperative Agreement W911NF-09-2-0053, The John Templeton Foundation (Grant No.51977), as well as the Defense Threat Reduction Agency Basic Research (Grant No. HDTRA1-10-1-0100). Besides, this work was partly supported by Zhejiang Provincial Natural Science Foundation of China (Grant No.LQ13F020007 and No.LQ16F020002), MOE (Ministry of Education in China) Project of Humanity and Social Science (Grant No. 15YJCZH125), National Natural Science Foundation of China (Grant NO.61374160 and No.61170108), Key Lab of Information Network Security, Ministry of Public Security (Grant No. C15610) and Shanghai Information Security Key Laboratory of Integrated Management of Technology (Grant No.AGK2013003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge support from the US Army Research Laboratory and the US Army Research Office under Cooperative Agreement W911NF-09-2-0053, The John Templeton Foundation (Grant No.51977), as well as the Defense Threat Reduction Agency Basic Research (Grant No. HDTRA1-10-1-0100). Besides, this work was partly supported by Zhejiang Provincial Natural Science Foundation of China (Grant No.LQ13F020007 and No.LQ16F020002), MOE (Ministry of Education in China) Project of Humanity and Social Science (Grant No.15YJCZH125), National Natural Science Foundation of China (Grant NO.61374160 and No.61170108), Key Lab of Information Network Security, Ministry of Public Security (Grant No. C15610) and Shanghai Information Security Key Laboratory of Integrated Management of Technology (Grant No.AGK2013003).	Aguirre J, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.248701; Akyildiz IF, 2002, COMPUT NETW, V38, P393, DOI 10.1016/S1389-1286(01)00302-4; Aldana M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.095702; Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; Barthelemy Marc, 2011, Physics Reports, V499, P1, DOI 10.1016/j.physrep.2010.11.002; Bialek W, 2012, P NATL ACAD SCI USA, V109, P4786, DOI 10.1073/pnas.1118633109; Bonabeau E, 1999, P NATL ACAD SCI USA, V96, P4472, DOI 10.1073/pnas.96.8.4472; Bricard A, 2013, NATURE, V503, P95, DOI 10.1038/nature12673; Brummitt CD, 2012, P NATL ACAD SCI USA, V109, pE680, DOI 10.1073/pnas.1110586109; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Burt R. S, 1992, STRUCTURAL HOLES; Czirok A, 1997, J PHYS A-MATH GEN, V30, P1375, DOI 10.1088/0305-4470/30/5/009; De Angelis D., 1992, INDIVIDUAL BASED MOD, DOI 10.1201/9781351073462; Gao JX, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.062816; Gao JX, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.066134; Gao JX, 2012, NAT PHYS, V8, P40, DOI 10.1038/nphys2180; Gao JX, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.046115; Gao JX, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.041918; Gao J, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.092002; Gregoire G, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.025702; Herbert-Read JE, 2011, P NATL ACAD SCI USA, V108, P18726, DOI 10.1073/pnas.1109355108; Kang W, 2000, P AMER CONTR CONF, P379, DOI 10.1109/ACC.2000.878924; Nagy M, 2007, PHYSICA A, V373, P445, DOI 10.1016/j.physa.2006.05.035; Nagy M, 2010, NATURE, V464, P890, DOI 10.1038/nature08891; Parshani R, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.048701; Qin H, 2014, SCI CHINA PHYS MECH, V57, P1918, DOI 10.1007/s11433-014-5466-5; Qin HX, 2014, SCI CHINA TECHNOL SC, V57, P936, DOI 10.1007/s11431-014-5534-0; Ravussin E, 1999, SCIENCE, V283, P184, DOI 10.1126/science.283.5399.184; Shores T. S., 2007, APPL LINEAR ALGEBRA; Stilwell DJ, 2000, IEEE CONTR SYST MAG, V20, P45, DOI 10.1109/37.887448; Stipanovic DM, 2004, AUTOMATICA, V40, P1285, DOI 10.1016/j.automatica.2004.02.017; Szell M, 2010, P NATL ACAD SCI USA, V107, P13636, DOI 10.1073/pnas.1004008107; Tang CB, 2014, SCI REP-UK, V4, DOI 10.1038/srep04590; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Vicsek T, 2012, PHYS REP, V517, P71, DOI 10.1016/j.physrep.2012.03.004; Wang YW, 2015, IEEE T NEUR NET LEAR, V26, P2487, DOI 10.1109/TNNLS.2014.2387443	37	6	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144153	10.1371/journal.pone.0144153	http://dx.doi.org/10.1371/journal.pone.0144153			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26640954	Green Published, Green Submitted, gold			2022-12-27	WOS:000366902700065
J	Sano, I; Tanito, M; Uchida, K; Katsube, T; Kitagaki, H; Ohira, A				Sano, Ichiya; Tanito, Masaki; Uchida, Koji; Katsube, Takashi; Kitagaki, Hajime; Ohira, Akihiro			Assessment of Filtration Bleb and Endplate Positioning Using Magnetic Resonance Imaging in Eyes Implanted with Long-Tube Glaucoma Drainage Devices	PLOS ONE			English	Article							RANDOMIZED CLINICAL-TRIAL; BAERVELDT GLAUCOMA; COMBINED TRABECULOTOMY; INTRAOCULAR-PRESSURE; REFRACTORY GLAUCOMA; ANTERIOR-CHAMBER; AHMED VALVE; SEGMENT; SHUNT; OUTCOMES	Background To evaluate ocular fluid filtration and endplate positioning in glaucomatous eyes with long-tube glaucoma drainage devices (GDDs) using magnetic resonance imaging (MRI) and the effects of various factors on postoperative intraocular pressure (IOP). Methods This observational case series included 27 consecutive glaucomatous eyes (18 men, 7 women; mean age +/- standard error, 63.0 +/- 2.0 years) who underwent GDD implantation (n = 8 Ahmed Glaucoma Valves [AGV] and n = 19 Baerveldt Glaucoma Implants [BGI]). Tubes were inserted into the pars plana in 23 eyes and anterior chamber in 4 eyes. Six months postoperatively, high-resolution orbital images were obtained using 3-Tesla MRI with head-array coils, and the filtering bleb volume, bleb height, and distances between the anterior endplate edge and corneal center or limbus or between the endplate and orbital wall were measured. Results In MR images obtained by three-dimensional fast imaging employing steady-state acquisition (3D-FIESTA) sequences, the shunt endplate was identified as low-intensity signal, and the filtering bleb was identified as high-intensity signals above and below the endplate in all eyes. The 6-month-postoperative IOP level was correlated negatively with bleb volume (r = -0.4510, P = 0.0182) and bleb height (r = -0.3954, P = 0.0412). The postoperative IOP was significantly (P = 0.0026) lower in BGI-implanted eyes (12.2 +/- 0.7 mmHg) than AGV-implanted eyes (16.7 +/- 1.2 mmHg); bleb volume was significantly (P = 0.0093) larger in BGI-implanted eyes (478.8 +/- 84.2 mm(3)) than AGV-implanted eyes (161.1 +/- 52.3 mm3). Other parameters did not differ. Conclusions The presence of intraorbital/periocular accumulation of ocular fluid affects postoperative IOP levels in eyes implanted with long-tube GDDs. Larger filtering blebs after BGI than AGI implantations explain lower postoperative IOP levels achieved with BGI than AGV. The findings will contribute to better understanding of IOP reducing mechanism of long-tube GDDs.	[Sano, Ichiya; Tanito, Masaki] Matsue Red Cross Hosp, Div Ophthalmol, Matsue, Shimane, Japan; [Sano, Ichiya; Tanito, Masaki; Ohira, Akihiro] Shimane Univ, Dept Ophthalmol, Fac Med, Izumo, Shimane, Japan; [Uchida, Koji; Katsube, Takashi; Kitagaki, Hajime] Shimane Univ, Fac Med, Dept Radiol, Izumo, Shimane, Japan	Shimane University; Shimane University	Tanito, M (corresponding author), Matsue Red Cross Hosp, Div Ophthalmol, Matsue, Shimane, Japan.	tanito-oph@umin.ac.jp	ohira, akihiro/G-8352-2017	ohira, akihiro/0000-0002-1307-5592				Britt MT, 1999, OPHTHALMOLOGY, V106, P2312, DOI 10.1016/S0161-6420(99)90532-8; Budenz DL, 2011, OPHTHALMOLOGY, V118, P443, DOI 10.1016/j.ophtha.2010.07.016; Ceballos EM, 2002, AM J NEURORADIOL, V23, P935; Chihara E, 2012, JPN J OPHTHALMOL, V56, P119, DOI 10.1007/s10384-011-0108-1; Chmarra MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064180; Christakis PG, 2011, OPHTHALMOLOGY, V118, P2180, DOI 10.1016/j.ophtha.2011.05.004; Coleman AL, 2008, SURV OPHTHALMOL, V53, pS3, DOI 10.1016/j.survophthal.2008.08.006; Danesh-Meyer HV, 2002, ARCH OPHTHALMOL-CHIC, V120, P846; De Leon-Ortega Julio E, 2002, Ophthalmol Clin North Am, V15, P215, DOI 10.1016/S0896-1549(02)00011-1; De Moura CR, 2005, AM J OPHTHALMOL, V139, P847, DOI 10.1016/j.ajo.2004.12.028; Desai Manishi A, 2011, Ophthalmic Surg Lasers Imaging, V42, P202, DOI [10.3928/15428877-20110224-94, 10.3928/15428877-20110224-04]; Detorakis ET, 2009, J GLAUCOMA, V18, P453, DOI 10.1097/IJG.0b013e3181895e42; Garcia-Feijoo J, 2001, AM J OPHTHALMOL, V132, P571, DOI 10.1016/S0002-9394(01)01057-1; Gedde SJ, 2012, CURR OPIN OPHTHALMOL, V23, P118, DOI 10.1097/ICU.0b013e32834ff2d1; Hatipoglu HG, 2007, DIAGN INTERV RADIOL, V13, P56; HEUER DK, 1992, OPHTHALMOLOGY, V99, P1512; Hitchings R, 2001, J GLAUCOMA, V10, P436, DOI 10.1097/00061198-200110000-00014; Ho LC, 2014, INVEST OPHTH VIS SCI, V55, P5662, DOI 10.1167/iovs.14-14561; Ho LC, 2014, INVEST OPHTH VIS SCI, V55, P3747, DOI 10.1167/iovs.14-14263; Jeon TY, 2007, AM J NEURORADIOL, V28, P1565, DOI 10.3174/ajnr.A0610; Kawana K, 2009, OPHTHALMOLOGY, V116, P848, DOI 10.1016/j.ophtha.2008.11.019; LLOYD MA, 1994, OPHTHALMOLOGY, V101, P1456; Maris PJG, 2013, J GLAUCOMA, V22, P183, DOI 10.1097/IJG.0b013e318237c115; Minckler DS, 2008, OPHTHALMOLOGY, V115, P1089, DOI 10.1016/j.ophtha.2008.03.031; Miura M, 2008, J GLAUCOMA, V17, P193, DOI 10.1097/IJG.0b013e31815a34cd; MUNOZ M, 1993, ARCH OPHTHALMOL-CHIC, V111, P1096, DOI 10.1001/archopht.1993.01090080092023; Nouri-Mahdavi K, 2003, AM J OPHTHALMOL, V136, P1001, DOI 10.1016/S0002-9394(03)00630-5; Pakravan M, 2009, OPHTHALMOLOGY, V116, P208, DOI 10.1016/j.ophtha.2008.09.003; Park HYL, 2012, EYE, V26, P1256, DOI 10.1038/eye.2012.131; Pirouzian A, 2006, J AAPOS, V10, P340, DOI 10.1016/j.jaapos.2006.03.001; PRATA JA, 1995, OPHTHALMOLOGY, V102, P894, DOI 10.1016/S0161-6420(95)30937-2; Prata Jr JA, 1995, GLAUCOMA, V4, P274; QUIGLEY HA, 1989, AM J OPHTHALMOL, V107, P453, DOI 10.1016/0002-9394(89)90488-1; Ramulu PY, 2007, OPHTHALMOLOGY, V114, P2265, DOI 10.1016/j.ophtha.2007.02.005; Reiter M, 2012, J COMPUT ASSIST TOMO, V36, P277, DOI 10.1097/RCT.0b013e31824afda8; Rososinski A, 2015, J GLAUCOMA, V24, P95, DOI 10.1097/IJG.0b013e31829d9be2; SooHoo JR, 2014, CAN J OPHTHALMOL, V49, P528, DOI 10.1016/j.jcjo.2014.09.002; Syed HM, 2004, J GLAUCOMA, V13, P38, DOI 10.1097/00061198-200402000-00008; Tanito M, 2002, J GLAUCOMA, V11, P3, DOI 10.1097/00061198-200202000-00002; Tanito M, 2001, J GLAUCOMA, V10, P302, DOI 10.1097/00061198-200108000-00010; Tanito M, 2015, ACTA OPHTHALMOL, V93, pe237, DOI 10.1111/aos.12561; Tanito M, 2015, BMC OPHTHALMOL, V15, DOI 10.1186/1471-2415-15-2; Tsai JC, 2006, OPHTHALMOLOGY, V113, P913, DOI 10.1016/j.ophtha.2006.02.029; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Yunker BE, 2013, MED PHYS, V40, DOI 10.1118/1.4802083	45	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144595	10.1371/journal.pone.0144595	http://dx.doi.org/10.1371/journal.pone.0144595			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641251	Green Submitted, Green Published, gold			2022-12-27	WOS:000366902700148
J	Sotiriadis, G; Dodagatta-Marri, E; Kouser, L; Alhamlan, FS; Kishore, U; Karteris, E				Sotiriadis, Georgios; Dodagatta-Marri, Eswari; Kouser, Lubna; Alhamlan, Fatimah S.; Kishore, Uday; Karteris, Emmanouil			Surfactant Proteins SP-A and SP-D Modulate Uterine Contractile Events in ULTR Myometrial Cell Line	PLOS ONE			English	Article							POOLED AMNIOTIC-FLUID; TRANSCRIPTION FACTOR; FETAL MEMBRANES; PRETERM BIRTH; EXPRESSION; PREGNANCY; PURIFICATION; CHEMOKINES; RECEPTORS; SUPPRESS	Pulmonary surfactant proteins SP-A and SP-D are pattern recognition innate immune molecules. However, there is extrapulmonary existence, especially in the amniotic fluid and at the feto-maternal interface. There is sufficient evidence to suggest that SP-A and SP-D are involved in the initiation of labour. This is of great importance given that preterm birth is associated with increased mortality and morbidity. In this study, we investigated the effects of recombinant forms of SP-A and SP-D (rhSP-A and rhSP-D, the comprising of trimeric lectin domain) on contractile events in vitro, using a human myometrial cell line (ULTR) as an experimental model. Treatment with rhSP-A or rhSP-D increased the cell velocity, distance travelled and displacement by ULTR cells. rhSP-A and rhSP-D also affected the contractile response of ULTRs when grown on collagen matrices showing reduced surface area. We investigated this effect further by measuring contractility-associated protein (CAP) genes. Treatment with rhSP-A and rhSP-D induced expression of oxytocin receptor (OXTR) and connexin 43 (CX43). In addition, rhSP-A and rhSP-D were able to induce secretion of GROa and IL-8. rhSP-D also induced the expression of IL-6 and IL-6 Ra. We provide evidence that SP-A and SP-D play a key role in modulating events prior to labour by reconditioning the human myometrium and in inducing CAP genes and pro-inflammatory cytokines thus shifting the uterus from a quiescent state to a contractile one.	[Sotiriadis, Georgios; Dodagatta-Marri, Eswari; Kouser, Lubna; Kishore, Uday; Karteris, Emmanouil] Brunel Univ London, Coll Hlth & Life Sci, Ctr Infect Immun & Dis Mech, Uxbridge UB8 3PH, Middx, England; [Alhamlan, Fatimah S.] King Faisal Specialist Hosp & Res Ctr, Dept Infect & Immun, Riyadh 11211, Saudi Arabia; [Karteris, Emmanouil] Brunel Univ London, Inst Environm Heath & Soc, Uxbridge UB8 3PH, Middx, England	Brunel University; King Faisal Specialist Hospital & Research Center; Brunel University	Karteris, E (corresponding author), Brunel Univ London, Coll Hlth & Life Sci, Ctr Infect Immun & Dis Mech, Uxbridge UB8 3PH, Middx, England.	Emmanouil.karteris@brunel.ac.uk	Karteris, Emmanouil/AAC-6821-2022; Kishore, Uday/Y-7976-2018	Kishore, Uday/0000-0002-6033-6759				Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Belt AR, 1999, AM J OBSTET GYNECOL, V181, P359, DOI 10.1016/S0002-9378(99)70562-4; Borron PJ, 2002, J IMMUNOL, V169, P5844, DOI 10.4049/jimmunol.169.10.5844; Breuiller-Fouche M, 2010, AM J PHYSIOL-ENDOC M, V298, pE1188, DOI 10.1152/ajpendo.00746.2009; Clemens SL, J APPL THEORY, p[1, 3]; Condon JC, 2004, P NATL ACAD SCI USA, V101, P4978, DOI 10.1073/pnas.0401124101; Devost D, 2007, AM J PHYSIOL-ENDOC M, V292, pE1, DOI 10.1152/ajpendo.00529.2005; Dimitriadis E, 2005, HUM REPROD UPDATE, V11, P613, DOI 10.1093/humupd/dmi023; Dodagatta-Marri E, 2014, METHODS MOL BIOL, V1100, P273, DOI 10.1007/978-1-62703-724-2_22; Foster HA, 2014, J STEROID BIOCHEM, V139, P166, DOI 10.1016/j.jsbmb.2013.02.017; Garcia-Verdugo I, 2008, BIOL REPROD, V79, P348, DOI 10.1095/biolreprod.108.068338; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; HAAGSMAN HP, 1991, ANNU REV PHYSIOL, V53, P441, DOI 10.1146/annurev.physiol.53.1.441; Jaffer S, 2009, ENDOCRINOLOGY, V150, P4672, DOI 10.1210/en.2009-0419; Karbani N, 2014, METHODS MOL BIOL, V1100, P257, DOI 10.1007/978-1-62703-724-2_21; Karteris E, 2001, MOL GENET METAB, V72, P287, DOI 10.1006/mgme.2001.3159; Karteris E, 2001, J CLIN ENDOCR METAB, V86, P4512, DOI 10.1210/jc.86.9.4512; Kishore U, 2006, MOL IMMUNOL, V43, P1293, DOI 10.1016/j.molimm.2005.08.004; Krolak-Olejnik B, 2006, PEDIATR INT, V48, P586, DOI 10.1111/j.1442-200X.2006.02289.x; MacNeill C, 2004, IMMUNOLOGY, V111, P91, DOI 10.1111/j.1365-2567.2004.01782.x; Madan T, 1997, INFECT IMMUN, V65, P3171, DOI 10.1128/IAI.65.8.3171-3179.1997; Madhukaran SP, 2015, MOL IMMUNOL, V66, P197, DOI 10.1016/j.molimm.2015.03.001; Mendelson CR, 2009, MOL ENDOCRINOL, V23, P947, DOI 10.1210/me.2009-0016; MIYAMURA K, 1994, BBA-LIPID LIPID MET, V1210, P303, DOI 10.1016/0005-2760(94)90233-X; Montalbano AP, 2013, ENDOCRINOLOGY, V154, P483, DOI 10.1210/en.2012-1797; Mosher AA, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-S1-S7; Nadesalingam J, 2003, J BIOL CHEM, V278, P25678, DOI 10.1074/jbc.M210186200; Nayak A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00131; Oberley RE, 2004, MOL HUM REPROD, V10, P861, DOI 10.1093/molehr/gah117; OHMERSCHROCK D, 1995, J CELL SCI, V108, P3695; PEREZREYES N, 1992, P NATL ACAD SCI USA, V89, P1224, DOI 10.1073/pnas.89.4.1224; Rajagopal SP, 2015, MOL HUM REPROD; Reynolds LP, 1998, J ANIM SCI, V76, P1671; Romero R, 2014, SCIENCE, V345, P760, DOI 10.1126/science.1251816; Schaub B, 2004, CLIN EXP ALLERGY, V34, P1819, DOI 10.1111/j.1365-2222.2004.02068.x; Shynlova O, 2009, EUR J OBSTET GYN R B, V144, pS2, DOI 10.1016/j.ejogrb.2009.02.044; Sykes L, 2014, REPRODUCTION, V148, pR29, DOI 10.1530/REP-13-0587; Vassiliadis S, 2005, Clin Dev Immunol, V12, P125, DOI 10.1080/17402520500125484; Yadav AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108815; Zaragoza DB, 2006, BIOL REPROD, V75, P697, DOI 10.1095/biolreprod.106.053439	41	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0143379	10.1371/journal.pone.0143379	http://dx.doi.org/10.1371/journal.pone.0143379			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641881	gold, Green Published, Green Submitted			2022-12-27	WOS:000366902700016
J	Tennstaedt, A; Mastropietro, A; Nelles, M; Beyrau, A; Hoehn, M				Tennstaedt, Annette; Mastropietro, Alfonso; Nelles, Melanie; Beyrau, Andreas; Hoehn, Mathias			In Vivo Fate Imaging of Intracerebral Stem Cell Grafts in Mouse Brain	PLOS ONE			English	Article							VITRO DIFFERENTIATION; AXONAL-TRANSPORT; SURVIVAL; MRI; STROKE; NANOPARTICLES; MIGRATION; RAT; PROTEIN; CNS	We generated transgenic human neural stem cells (hNSCs) stably expressing the reporter genes Luciferase for bioluminescence imaging (BLI) and GFP for fluorescence imaging, for multimodal imaging investigations. These transgenic hNSCs were further labeled with a clinically approved perfluoropolyether to perform parallel F-19 MRI studies. In vitro validation demonstrated normal cell proliferation and differentiation of the transgenic and additionally labeled hNSCs, closely the same as the wild type cell line, making them suitable for in vivo application. Labeled and unlabeled transgenic hNSCs were implanted into the striatum of mouse brain. The time profile of their cell fate after intracerebral grafting was monitored during nine days following implantation with our multimodal imaging approach, assessing both functional and anatomical condition. The F-19 MRI demarcated the graft location and permitted to estimate the cell number in the graft. BLI showed a pronounce cell loss during this monitoring period, indicated by the decrease of the viability signal. The in vivo obtained cell fate results were further validated and confirmed by immunohistochemistry. We could show that the surviving cells of the graft continued to differentiate into early neurons, while the severe cell loss could be explained by an inflammatory reaction to the graft, showing the graft being surrounded by activated microglia and macrophages. These results are different from earlier cell survival studies of our group where we had implanted the identical cells into the same mouse strain but in the cortex and not in the striatum. The cortical transplanted cells did not show any loss in viability but only pronounced and continuous neuronal differentiation.	[Tennstaedt, Annette; Mastropietro, Alfonso; Nelles, Melanie; Beyrau, Andreas; Hoehn, Mathias] Max Planck Inst Metab Res, In Vivo NMR Lab, Cologne, Germany; [Mastropietro, Alfonso] IRCCS Fdn Neurol Inst C Besta, Sci Direct Unit, Milan, Italy; [Mastropietro, Alfonso] Politecn Milan, Dept Elect Informat & Bioengn, I-20133 Milan, Italy; [Hoehn, Mathias] Leiden Univ, Leiden Univ Med Ctr, Dept Radiol, Leiden, Netherlands	Polytechnic University of Milan; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Hoehn, M (corresponding author), Max Planck Inst Metab Res, In Vivo NMR Lab, Cologne, Germany.	mathias@sf.mpg.de	Mastropietro, Alfonso/AAY-7271-2020	Mastropietro, Alfonso/0000-0003-3358-7111	European Union [PIAPP-GA-2013-612360, HEALTH-F2-2012-279017]; Deutsche Forschungsgemeinschaft [AS-464/1-1]; MIUR [RBAP1183B5]	European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); MIUR(Ministry of Education, Universities and Research (MIUR))	This study was supported by European Union PIAPP-GA-2013-612360 and HEALTH-F2-2012-279017; Deutsche Forschungsgemeinschaft AS-464/1-1; MIUR RBAP1183B5.	Ahrens ET, 2013, NMR BIOMED, V26, P860, DOI 10.1002/nbm.2948; Almad AA, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt128; Andres RH, 2011, BRAIN, V134, P1777, DOI 10.1093/brain/awr094; Aswendt M, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00226; Aswendt M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055662; Badr CE, 2011, TRENDS BIOTECHNOL, V29, P624, DOI 10.1016/j.tibtech.2011.06.010; Baydyuk M, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00254; Berman SMC, 2013, MAGN RESON MED, V69, P255, DOI 10.1002/mrm.24216; Boehm-Sturm P, 2014, BIOMATERIALS, V35, P2218, DOI 10.1016/j.biomaterials.2013.11.085; Boehm-Sturm P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029040; De Vocht N, 2013, IMMUNOBIOLOGY, V218, P696, DOI 10.1016/j.imbio.2012.08.266; Dhara SK, 2008, DIFFERENTIATION, V76, P454, DOI 10.1111/j.1432-0436.2007.00256.x; Gaudet JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118544; GUDBJARTSSON H, 1995, MAGNET RESON MED, V34, P910, DOI 10.1002/mrm.1910340618; Guzman R, 2007, P NATL ACAD SCI USA, V104, P10211, DOI 10.1073/pnas.0608519104; Himmelreich U, 2005, MOL IMAGING, V4, P1; Hoehn M, 2002, P NATL ACAD SCI USA, V99, P16267, DOI 10.1073/pnas.242435499; Hong S, 2007, MOL THER, V15, P1630, DOI 10.1038/sj.mt.6300251; Janowski M, 2014, CELL TRANSPLANT, V23, P253, DOI 10.3727/096368912X661328; Kokaia Z, 1998, EXP NEUROL, V154, P289, DOI 10.1006/exnr.1998.6888; McNeish J, 2010, J BIOL CHEM, V285, P17209, DOI 10.1074/jbc.M109.098814; Modo M, 2004, NEUROIMAGE, V21, P311, DOI 10.1016/j.neuroimage.2003.08.030; Muhammad G, 2015, ACTA NEUROBIOL EXP, V75, P144; Praet J, 2012, CELL TRANSPLANT, V21, P1867, DOI 10.3727/096368912X636920; Ramos-Cabrer P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012779; Reekmans K, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt147; Reinhardt P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059252; Ruiz-Cabello J, 2008, MAGN RESON MED, V60, P1506, DOI 10.1002/mrm.21783; Sher F, 2009, STEM CELLS, V27, P1582, DOI 10.1002/stem.76; Sijbers J, 2007, PHYS MED BIOL, V52, P1335, DOI 10.1088/0031-9155/52/5/009; Soenen SJH, 2011, BIOMATERIALS, V32, P195, DOI 10.1016/j.biomaterials.2010.08.075; Srinivas M, 2012, BIOMATERIALS, V33, P8830, DOI 10.1016/j.biomaterials.2012.08.048; Srinivas M, 2010, TRENDS BIOTECHNOL, V28, P363, DOI 10.1016/j.tibtech.2010.04.002; Takahashi Y, 2011, CELL TRANSPLANT, V20, P727, DOI 10.3727/096368910X536554; Tennstaedt A, 2015, BIOMATERIALS, V44, P143, DOI 10.1016/j.biomaterials.2014.12.038; Wang JH, 2005, MAGN RESON MED, V53, P408, DOI 10.1002/mrm.20354; Yan Q, 1997, NEUROSCIENCE, V78, P431, DOI 10.1016/S0306-4522(96)00613-6; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	38	14	14	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144262	10.1371/journal.pone.0144262	http://dx.doi.org/10.1371/journal.pone.0144262			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641453	Green Submitted, gold, Green Published			2022-12-27	WOS:000366902700086
J	de Man-van Ginkel, JM; Hafsteinsdottir, TB; Lindeman, E; Geerlings, MI; Grobbee, DE; Schuurmans, MJ				de Man-van Ginkel, Janneke M.; Hafsteinsdottir, Thora B.; Lindeman, Eline; Geerlings, Mirjam I.; Grobbee, Diederick E.; Schuurmans, Marieke J.			Clinical Manifestation of Depression after Stroke: Is It Different from Depression in Other Patient Populations?	PLOS ONE			English	Article							INTEGRATED CARE PATHWAY; POSTSTROKE DEPRESSION; HEALTH QUESTIONNAIRE; EVIDENCE BASE; SYMPTOMS; METAANALYSIS; FREQUENCY; DISEASE; PHENOMENOLOGY; PROGRESSION	Background Despite ample research on depression after stroke, the debate continues regarding whether symptoms such as sleep disturbances, loss of energy, changes in appetite and diminished concentration should be considered to be consequences of stroke or general symptoms of depression. By comparing symptoms in depressed and non-depressed stroke patients with patients in general practice and patients with symptomatic atherosclerotic diseases, we aim to further clarify similarities and distinctions of depression after stroke and depression in other patient populations. Based on this, it is possible to determine if somatic symptoms should be evaluated in stroke patients in diagnosing depression after stroke. Methods An observational multicenter study is conducted in three hospitals and seven general practices including 382 stroke patients admitted to hospital with a clinical diagnosis of intracerebral hemorrhage or ischemic infarction, 1160 patients in general practice (PREDICT-NL), and 530 patients with symptomatic atherosclerotic diseases (SMART-Medea). Results The prevalence of major depressive disorder according to DSM-IV criteria was 14.1% (95% CI 11.0%-18.0%) in the stroke cohort, 5.4% (95% CI 3.8%-7.9%) in the symptomatic atherosclerotic diseases cohort and 12.9% (95% CI 11.1%-15.0%) in the general practice cohorts. Comparing depressed patients of the three cohorts demonstrated broadly similar symptom profiles, as well as comparable levels of individual symptom prevalence. However, the stroke patients suffered more severely from these symptoms than patients in the other populations. Conclusions The findings suggest that depression after stroke is not a different type of depression. This finding indicates that all depressive symptoms should be evaluated in stroke patients, including somatic symptoms.	[de Man-van Ginkel, Janneke M.; Hafsteinsdottir, Thora B.; Lindeman, Eline; Schuurmans, Marieke J.] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Rehabil Nursing Sci & Sports, Utrecht, Netherlands; [de Man-van Ginkel, Janneke M.; Hafsteinsdottir, Thora B.; Schuurmans, Marieke J.] Univ Med Ctr Utrecht, Nursing Sci Program Clin Hlth Sci, Utrecht, Netherlands; [Hafsteinsdottir, Thora B.; Schuurmans, Marieke J.] Univ Profess Educ Utrecht, Dept Healthcare, Utrecht, Netherlands; [Hafsteinsdottir, Thora B.] Univ Iceland, Fac Nursing, Reykjavik, Iceland; [Lindeman, Eline] Rehabil Ctr De Hoogstraat, Ctr Excellence Rehabil Med, Utrecht, Netherlands; [Geerlings, Mirjam I.; Grobbee, Diederick E.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; University of Iceland; Utrecht University; Utrecht University Medical Center	de Man-van Ginkel, JM (corresponding author), Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Rehabil Nursing Sci & Sports, Utrecht, Netherlands.	J.M.deMan@umcutrecht.nl	Geerlings, Mirjam I/F-4087-2015	Geerlings, Mirjam I/0000-0002-4037-036X				Aben I, 2006, PANMINERVA MED, V48, P49; American Psychiatric Association, 2000, AM PSYCH ASS DIAGN S; Ayerbe L, 2013, BRIT J PSYCHIAT, V202, P14, DOI 10.1192/bjp.bp.111.107664; Bartoli F, 2014, NEUROLOGY, V83, P1998, DOI 10.1212/WNL.0000000000001040; Bartoli F, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/862978; Beblo T, 2002, J GERIATR PSYCH NEUR, V15, P44, DOI 10.1177/089198870201500109; Bour A, 2009, INT J GERIATR PSYCH, V24, P1134, DOI 10.1002/gps.2236; Cumming TB, 2010, ACTA PSYCHIAT SCAND, V121, P424, DOI 10.1111/j.1600-0447.2010.01558.x; Silva CEDE, 2013, CEREBROVASC DIS, V35, P385, DOI 10.1159/000348852; de Coster L, 2005, INT J GERIATR PSYCH, V20, P358, DOI 10.1002/gps.1290; de Man-van Ginkel JM, 2012, STROKE, V43, P854, DOI 10.1161/STROKEAHA.111.640276; Enderby P, 2006, FRENCHAY APHASIA SCR; FEDOROFF JP, 1991, AM J PSYCHIAT, V148, P1172; FEDOROFF JP, 1991, J AFFECT DISORDERS, V22, P83, DOI 10.1016/0165-0327(91)90088-A; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gainotti G, 1999, BRIT J PSYCHIAT, V175, P163, DOI 10.1192/bjp.175.2.163; Gilbody S, 2007, J GEN INTERN MED, V22, P1596, DOI 10.1007/s11606-007-0333-y; Grool AM, 2012, PSYCHOL MED, V42, P359, DOI 10.1017/S0033291711001383; Hackett ML, 2014, INT J STROKE, V9, P1017, DOI 10.1111/ijs.12357; Hackett ML, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003689.pub3; Hackett ML, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003437.pub3; Kauhanen ML, 2000, CEREBROVASC DIS, V10, P455, DOI 10.1159/000016107; King M, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-6; Koenig HG, 1997, AM J PSYCHIAT, V154, P1376; Kutlubaev MA, 2014, INT J STROKE, V9, P1026, DOI 10.1111/ijs.12356; LIPSEY JR, 1986, AM J PSYCHIAT, V143, P527; Mast BT, 2004, AM J GERIAT PSYCHIAT, V12, P315; Mortensen JK, 2015, EXPERT OPIN DRUG SAF, V14, P911, DOI 10.1517/14740338.2015.1033396; Nannetti L, 2005, DISABIL REHABIL, V27, P170, DOI 10.1080/09638280400009378; Paradiso S, 1997, INT J PSYCHIAT MED, V27, P137, DOI 10.2190/BWJA-KQP3-7VUY-D06T; Popa-Wagner A, 2014, BIOGERONTOLOGY, V15, P439, DOI 10.1007/s10522-014-9516-1; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; Robinson RG, 2003, BIOL PSYCHIAT, V54, P376, DOI 10.1016/S0006-3223(03)00423-2; Robinson RG, 2010, CAN J PSYCHIAT, V55, P341, DOI 10.1177/070674371005500602; Salter K, 2007, TOP STROKE REHABIL, V14, P1, DOI 10.1310/tsr1403-1; Spalletta G, 2005, AM J GERIAT PSYCHIAT, V13, P108; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Ter Smitten R, 2008, COMPOSITE INT DIAGNO; Turner-Stokes L, 2002, CLIN REHABIL, V16, P231, DOI 10.1191/0269215502cr487oa; Turner-Stokes L, 2002, CLIN REHABIL, V16, P248, DOI 10.1191/0269215502cr488oa; Zuithoff NPA, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-98; Zuithoff NPA, 2009, FAM PRACT, V26, P241, DOI 10.1093/fampra/cmp036	42	17	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144450	10.1371/journal.pone.0144450	http://dx.doi.org/10.1371/journal.pone.0144450			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26637178	Green Submitted, Green Published, gold			2022-12-27	WOS:000366143800093
J	Foisy, A; Gaertner, C; Matheron, E; Kapoula, Z				Foisy, A.; Gaertner, C.; Matheron, E.; Kapoula, Z.			Controlling Posture and Vergence Eye Movements in Quiet Stance: Effects of Thin Plantar Inserts	PLOS ONE			English	Article							FOOT POSTURE; PRESSURE; BALANCE; STIMULATION; ACTIVATION; SACCADES; SOLE; ACCOMMODATION; COORDINATION; STABILITY	The purpose of this study was to assess properties of vergence and saccade eye movements as well as posture in quiet stance, and the effects of thin plantar inserts upon postural and oculomotor control. The performances of 36 young healthy subjects were recorded by a force platform and an eye tracker in three testing conditions: without plantar stimulation, with a 3 millimetre-thick plantar insert, either a Medial or a Lateral Arch Support (MAS / LAS). The results showed a decrease of the Surface and Variance of Speed and a more posterior position of the CoP with either stimulation compared with the control condition. The fractal analysis showed a decrease with MAS. Wavelet analysis in the time-frequency domain revealed an increase in the Cancelling Time of the low frequency band with MAS. These results suggest a better stability for a lower energy cost. Concerning eye movements, the inserts influenced only vergence (not saccades): MAS caused an increase of the phasic amplitude of divergence, and conversely a decrease of the tonic amplitude. In contrast, LAS caused an increase of the tonic amplitude of convergence. Thus, MAS renders divergence less visually driven, while LAS renders convergence more visually driven. We conclude that the CNS uses the podal signal for both postural and vergence control via specific mechanisms. Plantar inserts have an influence upon posture and vergence movements in a different way according to the part of the foot sole being stimulated. These results can be useful to clinicians interested in foot or eye.	[Foisy, A.; Gaertner, C.; Matheron, E.; Kapoula, Z.] FR3636 Neurosci CNRS, IRIS Team, Physiopathol Vis & Motricite Binoculaire, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Foisy, A (corresponding author), FR3636 Neurosci CNRS, IRIS Team, Physiopathol Vis & Motricite Binoculaire, Paris, France.	arnaud.foisy@gmail.com; zoi.kapoula@parisdescartes.fr			COE (College Osteopathique Europeen); API (Association de Posturologie Internationale); Institut d'Assas	COE (College Osteopathique Europeen); API (Association de Posturologie Internationale); Institut d'Assas(Centre National de la Recherche Scientifique (CNRS))	A. Foisy was financially supported by the COE (College Osteopathique Europeen, 2000(sic) http://www.osteo-coe.fr/), the API (Association de Posturologie Internationale, 750(sic) http://www.posturologie.asso.fr/API/Accueil.html) and the Institut d'Assas (250(sic) http://www.ecoledassas.com/). None of these sponsors played a role in any part of the study.	Aminian G, 2013, PROSTHET ORTHOT INT, V37, P227, DOI 10.1177/0309364612461167; Andersen OK, 2007, ACTA PHYSIOL, V189, P1, DOI 10.1111/j.1748-1716.2007.01706.x; ANDERSSON GBJ, 1977, CLIN ORTHOP RELAT R, P156; Angin S, 2013, EKLEM HAST CERRAHISI, V24, P144, DOI 10.5606/ehc.2013.32; BARON J, 1953, Rev Otoneuroophtalmol, V25, P1; Bernard-Demanze L, 2009, Curr Aging Sci, V2, P139; Blaszczyk JW, 2001, ACTA NEUROBIOL EXP, V61, P105; Buldt AK, 2013, GAIT POSTURE, V38, P363, DOI 10.1016/j.gaitpost.2013.01.010; Chiang JH, 1997, GAIT POSTURE, V5, P239, DOI 10.1016/S0966-6362(96)01091-0; Clarke AH, 2002, BEHAV RES METH INS C, V34, P549, DOI 10.3758/BF03195484; Cohen J.E., 1988, STAT POWER ANAL BEHA; Collewijn H, 1997, VISION RES, V37, P1049, DOI 10.1016/S0042-6989(96)00245-3; Crowdy KA, 2000, EXP BRAIN RES, V135, P437, DOI 10.1007/s002210000539; Crowdy KA, 2002, EXP BRAIN RES, V146, P244, DOI 10.1007/s00221-002-1171-0; Doyle TL, 2005, ARCH PHYS MED REHAB, V86, P2034, DOI 10.1016/j.apmr.2005.05.014; Duane A, 1912, J AMER MED ASSOC, V59, P1010; Erkelens CJ, 2011, J VISION, V11, DOI 10.1167/11.10.21; ERKELENS CJ, 1989, PROC R SOC SER B-BIO, V236, P417, DOI 10.1098/rspb.1989.0030; Fallon JB, 2005, J NEUROPHYSIOL, V94, P3795, DOI 10.1152/jn.00359.2005; Feise Ronald J, 2002, BMC Med Res Methodol, V2, P8, DOI 10.1186/1471-2288-2-8; Forth KE, 2008, AVIAT SPACE ENVIR MD, V79, P844, DOI 10.3357/ASEM.2176.2008; Forth KE, 2007, AM J PHYS MED REHAB, V86, P50, DOI 10.1097/PHM.0b013e31802b8da4; Fransson PA, 2007, J VESTIBUL RES-EQUIL, V17, P47; Gaertner C, 2013, INVEST OPHTH VIS SCI, V54, P529, DOI 10.1167/iovs.12-10586; Gagey PM, 2004, POSTUROLOGIE REGULAT; Gamlin PD, 2000, NATURE, V407, P1003, DOI 10.1038/35039506; Garrigues B., 2007, POSTUROLOGIE CLIN DY, P70; Giacomini PG, 2004, EUR J PAIN, V8, P579, DOI 10.1016/j.ejpain.2004.02.004; Han Y, 1998, ACTA OPHTHALMOL SCAN, V76, P283, DOI 10.1034/j.1600-0420.1998.760306.x; HAN Y, 1995, ACTA OPHTHALMOL SCAN, V73, P414; Hirata RP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071253; Hirata RP, 2012, EUR J APPL PHYSIOL, V112, P2511, DOI 10.1007/s00421-011-2226-3; Hollands MA, 2001, J MOTOR BEHAV, V33, P205, DOI 10.1080/00222890109603151; Hollands MA, 2004, EXP BRAIN RES, V154, P261, DOI 10.1007/s00221-003-1718-8; HOLLANDS MA, 1995, J MOTOR BEHAV, V27, P155, DOI 10.1080/00222895.1995.9941707; Hollands MA, 1996, EXP BRAIN RES, V109, P343; Janin M, 2009, NEUROSCI LETT, V461, P245, DOI 10.1016/j.neulet.2009.06.043; Janin M, 2005, GAIT POSTURE, V21, P879; Kapoula Z, 2007, J NEUROL, V254, P1174, DOI 10.1007/s00415-006-0460-0; Kapoula Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066652; Kapoula Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019272; Kavounoudias A, 2001, J PHYSIOL-LONDON, V532, P869, DOI 10.1111/j.1469-7793.2001.0869e.x; Kavounoudias A, 2008, NEUROPSYCHOLOGIA, V46, P567, DOI 10.1016/j.neuropsychologia.2007.10.002; Kavounoudias A, 1999, NEUROSCI LETT, V266, P181, DOI 10.1016/S0304-3940(99)00302-X; Kavounoudias A, 1998, NEUROREPORT, V9, P3247, DOI 10.1097/00001756-199810050-00021; Kennedy PM, 2002, J PHYSIOL-LONDON, V538, P995, DOI 10.1113/jphysiol.2001.013087; Kuriyama Naoyuki, 2005, Journal of Nippon Medical School, V72, P165, DOI 10.1272/jnms.72.165; Lacour M, 2008, NEUROPHYSIOL CLIN, V38, P411, DOI 10.1016/j.neucli.2008.09.005; Leigh RJ, 2006, NEUROLOGY EYE MOVEME, p[111, 124, 355, 400, 401]; Lennerstrand G, 1996, GRAEF ARCH CLIN EXP, V234, P703, DOI 10.1007/BF00292357; Christovao TCL, 2013, J PHYS THER SCI, V25, P1353, DOI 10.1589/jpts.25.1353; Manabe Y, 2001, NEUROL RES, V23, P397, DOI 10.1179/016164101101198613; MARENDAZ C, 1989, PERCEPTION, V18, P739, DOI 10.1068/p180739; Matheron E, 2007, NEUROSCI LETT, V423, P236, DOI 10.1016/j.neulet.2007.07.016; Matheron E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018110; Missaoui B, 2008, NEUROPHYSIOL CLIN, V38, P447, DOI 10.1016/j.neucli.2008.09.004; Nashner L M, 1979, Prog Brain Res, V50, P177; Neycenssas C., 2013, MEMOIRE PATA U BOURG; Oie KS, 2001, NEUROSCI LETT, V315, P113, DOI 10.1016/S0304-3940(01)02348-5; Paillard T, 2002, BRIT J SPORT MED, V36, P304, DOI 10.1136/bjsm.36.4.304; Perennou D, 2006, EFFICIENCE DEFICIENC, P65; Perry SD, 2008, J GERONTOL A-BIOL, V63, P595, DOI 10.1093/gerona/63.6.595; Popov KE, 1999, EXP BRAIN RES, V128, P343, DOI 10.1007/s002210050854; Radebold A, 2001, SPINE, V26, P724, DOI 10.1097/00007632-200104010-00004; Rey F, 2008, AURIS NASUS LARYNX, V35, P185, DOI 10.1016/j.anl.2007.07.001; Roll J. P., 1987, EYE MOVEMENTS PHYSL, P57; ROLL JP, 1988, INT CONGR SER, V812, P155; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; RUTSTEIN RP, 1993, OPTOMETRY VISION SCI, V70, P496, DOI 10.1097/00006324-199306000-00008; SEMMLOW JL, 1993, OPHTHAL PHYSL OPT, V13, P48, DOI 10.1111/j.1475-1313.1993.tb00426.x; SEMMLOW JL, 1994, VISION RES, V34, P1335, DOI 10.1016/0042-6989(94)90208-9; Silva AG, 2013, PHYSIOTHER THEOR PR, V29, P1, DOI 10.3109/09593985.2012.677111; Sparks DL, 1999, CURR OPIN NEUROBIOL, V9, P698, DOI 10.1016/S0959-4388(99)00039-2; Stacoff A, 2007, FOOT, V17, P143, DOI DOI 10.1016/J.FOOT.2007.02.004; Streiner DL, 2011, CHEST, V140, P16, DOI 10.1378/chest.11-0523; TAKAGI M, 1995, VISION RES, V35, P3373, DOI 10.1016/0042-6989(95)00073-N; Tropp H, 2002, J ATHL TRAINING, V37, P512; Tyler CW, 2012, J VISION, V12, DOI 10.1167/12.11.21; Tzelepi A, 2004, EXP BRAIN RES, V155, P439, DOI 10.1007/s00221-003-1741-9; Villeneuve P, 2011, PLANTAR ORTHOTICS PA; Wright WG, 2012, J NEUROPHYSIOL, V107, P1513, DOI 10.1152/jn.00256.2011; Yang Q, 2002, INVEST OPHTH VIS SCI, V43, P2939	82	13	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143693	10.1371/journal.pone.0143693	http://dx.doi.org/10.1371/journal.pone.0143693			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26637132	Green Published, Green Submitted, gold			2022-12-27	WOS:000366143800022
J	Manuel, DG; Tuna, M; Perez, R; Tanuseputro, P; Hennessy, D; Bennett, C; Rosella, L; Sanmartin, C; van Walraven, C; Tu, JV				Manuel, Douglas G.; Tuna, Meltem; Perez, Richard; Tanuseputro, Peter; Hennessy, Deirdre; Bennett, Carol; Rosella, Laura; Sanmartin, Claudia; van Walraven, Carl; Tu, Jack V.			Predicting Stroke Risk Based on Health Behaviours: Development of the Stroke Population Risk Tool (SPoRT)	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; ADMINISTRATIVE DATA; COMPETING RISKS; GUIDELINES; MODELS; PREVENTION; COUNTRIES; VALIDITY	Background Health behaviours, important factors in cardiovascular disease, are increasingly a focus of prevention. We appraised whether stroke risk can be accurately assessed using self-reported information focused on health behaviours. Methods Behavioural, sociodemographic and other risk factors were assessed in a population-based survey of 82 259 Ontarians who were followed for a median of 8.6 years (688 000 person-years follow-up) starting in 2001. Predictive algorithms for 5-year incident stroke resulting in hospitalization were created and then validated in a similar 2007 survey of 28 605 respondents (median 4.2 years follow-up). Results We observed 3 236 incident stroke events (1 551 resulting in hospitalization; 1 685 in the community setting without hospital admission). The final algorithms were discriminating (C-stat: 0.85, men; 0.87, women) and well-calibrated (in 65 of 67 subgroups for men; 61 of 65 for women). An index was developed to summarize cumulative relative risk of incident stroke from health behaviours and stress. For men, each point on the index corresponded to a 12% relative risk increase (180% risk difference, lowest (0) to highest (9) scores). For women, each point corresponded to a 14% relative risk increase (340% difference, lowest (0) to highest (11) scores). Algorithms for secondary stroke outcomes (stroke resulting in death; classified as ischemic; excluding transient ischemic attack; and in the community setting) had similar health behaviour risk hazards. Conclusion Incident stroke can be accurately predicted using self-reported information focused on health behaviours. Risk assessment can be performed with population health surveys to support population health planning or outside of clinical settings to support patient-focused prevention.	[Manuel, Douglas G.; Tuna, Meltem; Perez, Richard; Hennessy, Deirdre; Bennett, Carol; van Walraven, Carl] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Manuel, Douglas G.; Tuna, Meltem; Perez, Richard; Tanuseputro, Peter; Bennett, Carol; Rosella, Laura; van Walraven, Carl; Tu, Jack V.] Inst Clin Evaluat Sci, Ottawa, ON, Canada; [Manuel, Douglas G.; Tuna, Meltem; Perez, Richard; Tanuseputro, Peter; Bennett, Carol; Rosella, Laura; van Walraven, Carl; Tu, Jack V.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Manuel, Douglas G.; Hennessy, Deirdre; Sanmartin, Claudia] STAT Canada, Ottawa, ON, Canada; [Manuel, Douglas G.] Univ Ottawa, Dept Family Med, Ottawa, ON, Canada; [Manuel, Douglas G.; Tanuseputro, Peter; van Walraven, Carl] Univ Ottawa, Epidemiol & Community Med, Ottawa, ON, Canada; [Manuel, Douglas G.] Bruyere Res Inst, Ottawa, ON, Canada; [Rosella, Laura] Publ Hlth Ontario, Toronto, ON, Canada; [Rosella, Laura] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [van Walraven, Carl] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Tu, Jack V.] Univ Toronto, Sunnybrook Schulich Heart Ctr, Toronto, ON, Canada; [Tu, Jack V.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Toronto; Statistics Canada; University of Ottawa; University of Ottawa; University of Ottawa; University of Toronto; University of Ottawa; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Manuel, DG (corresponding author), Ottawa Hosp Res Inst, Ottawa, ON, Canada.	dmanuel@ohri.ca	; Manuel, Doug/D-7100-2014	Bennett, Carol/0000-0002-3033-9860; Tanuseputro, Peter/0000-0002-4409-0795; Manuel, Doug/0000-0003-0912-0845	Public Health Agency of Canada; Population Health Improvement Research Program of the Ontario Ministry of Health and Long-term Care; Cardiovascular Health in Ambulatory Research Team (CANHEART) from the Canadian Institutes of Health Research [TCA 118349]; Heart and Stroke Foundation; Institute for Clinical Evaluative Sciences (ICES) - Ontario Ministry of Health and Long-Term Care (MOHLTC)	Public Health Agency of Canada; Population Health Improvement Research Program of the Ontario Ministry of Health and Long-term Care; Cardiovascular Health in Ambulatory Research Team (CANHEART) from the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation(Heart & Stroke Foundation of Canada); Institute for Clinical Evaluative Sciences (ICES) - Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario)	The study was supported by funding from the Public Health Agency of Canada, the Population Health Improvement Research Program of the Ontario Ministry of Health and Long-term Care and the Cardiovascular Health in Ambulatory Research Team (CANHEART) from the Canadian Institutes of Health Research (TCA 118349). At the time of this research, DGM held a Chair in Applied Population Health from the Canadian Institutes of Health Research and the Public Health Agency of Canada. JVT holds a Tier 1 Canada Research Council Chair in Health Services Research and A Career Investigator award from the Heart and Stroke Foundation. This study was also supported by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal A, 2013, STAT MED, V32, P1877, DOI 10.1002/sim.5736; Beland Yves, 2002, Health Rep, V13, P9; Bouwmeester W, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001221; Cecchini M, 2010, LANCET, V376, P1775, DOI 10.1016/S0140-6736(10)61514-0; Chiuve SE, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000954; Collins GS, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7594; CSS Information & Evaluation Working Group, 2010, CAN STROK STRAT COR, P1; Dalton Andrew R H, 2011, Inform Prim Care, V19, P225; DIAMOND GA, 1989, J AM COLL CARDIOL, V14, pA12, DOI 10.1016/0735-1097(89)90157-5; Ferket BS, 2010, ARCH INTERN MED, V170, P27, DOI 10.1001/archinternmed.2009.434; Garriguet D, 2014, HEALTH REP, V25, P3; Garriguet Didier, 2009, Health Rep, V20, P41; Gaziano TA, 2008, LANCET, V371, P923, DOI 10.1016/S0140-6736(08)60418-3; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.3.CO;2-F; Kokotailo RA, 2005, STROKE, V36, P1776, DOI 10.1161/01.STR.0000174293.17959.a1; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Manuel D, 2008, ICES INVESTIGATIVE R; Manuel DG, 2012, AN ICES PHO REPORT; Manuel DG, 2014, 900 000 DAYS HOSP AN; Manuel DG, 2012, J EPIDEMIOL COMMUN H, V66, P859, DOI 10.1136/jech-2012-200971; Manuel DG, 2010, CURR OPIN LIPIDOL, V21, P359, DOI 10.1097/MOL.0b013e32833c1f2b; MOZAFFARIAN D, 2011, CIRCULATION, V123, P2870, DOI [DOI 10.1161/CIRCULATI0NAHA.110.968735, 10.1161/circulationaha.110.968735]; Muggah E, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-16; Nardo M., 2005, HDB CONSTRUCTING COM, P17, DOI [10.1787/533411815016, DOI 10.1787/533411815016]; Noble D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7163; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Pencina MJ, 2009, CIRCULATION, V119, P3078, DOI 10.1161/CIRCULATIONAHA.108.816694; Pintilie M, 2002, STAT MED, V21, P3317, DOI 10.1002/sim.1271; Qiao Q, 2012, INT J STROKE, V7, P662, DOI 10.1111/j.1747-4949.2011.00692.x; Rabar S, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4356; Reynolds K, 2003, JAMA-J AM MED ASSOC, V289, P579, DOI 10.1001/jama.289.5.579; Rose GA, 2008, ROSES STRATEGY OF PR; Rosella LC, 2011, J EPIDEMIOL COMMUN H, V65, P613, DOI 10.1136/jech.2009.102244; Schisterman EF, 2009, EPIDEMIOLOGY, V20, P488, DOI 10.1097/EDE.0b013e3181a819a1; Schulte JM, 2014, NEW ENGL J MED, V371, DOI 10.1056/NEJMclde1407177; Sheridan SL, 2010, ARCH INTERN MED, V170, P230, DOI 10.1001/archinternmed.2009.516; Shields Margot, 2008, Health Rep, V19, P61; Steyerberg E., 2009, CLIN PREDICTION MODE; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Taljaard M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006701; Tripepi G, 2010, NEPHROL DIAL TRANSPL, V25; Tu K, 2013, CAN J CARDIOL, V29, P1388, DOI 10.1016/j.cjca.2013.07.676; Veerman L., 2010, ASSESSING COST EFFEC; Wong SL, 2012, HEALTH REP, V23, P47; World Health Organization, 2007, PREV CARD DIS GUID A	49	14	14	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143342	10.1371/journal.pone.0143342	http://dx.doi.org/10.1371/journal.pone.0143342			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26637172	Green Published, Green Submitted, gold			2022-12-27	WOS:000366143800009
J	de la Pena, P				de la Pena, Paloma			Refining Our Understanding of Howiesons Poort Lithic Technology: The Evidence from Grey Rocky Layer in Sibudu Cave (KwaZulu-Natal, South Africa)	PLOS ONE			English	Article							MIDDLE-STONE-AGE; ROSE COTTAGE CAVE; WESTERN-CAPE; BONE TECHNOLOGY; HUMAN-BEHAVIOR; KLASIES RIVER; SHELTER; VARIABILITY; SEQUENCE	The detailed technological analysis of the youngest Howiesons Poort occupation in Sibudu Cave, layer Grey Rocky, has shown the importance of blade production (with different knapping methods involved), but also of flaking methods in coarse grained rock types. Moreover, new strategies of bifacial production and microlithism were important. Grey Rocky lithic technology shows a really versatile example of reduction strategies that were highly influenced by the characteristics of the rock types. This lithic assemblage is another example of the technological variability linked to the Howiesons Poort technocomplex. The reasons for this variability are still difficult to elucidate. Discrepancies between sites might be for different reasons: diachronic variations, functional variations, organizational variations or maybe different regional variations within what has been recognized traditionally and typologically as Howiesons Poort. The technological comparison of the Grey Rocky assemblage with assemblages from other Howiesons Poort sites demonstrates that there are common technological trends during the late Pleistocene, but they still need to be properly circumscribed chronologically. On the one hand, Howiesons Poort characteristics such as the bifacial production in quartz are reminiscent of production in some Still Bay or pre-Still Bay industries and the flake production or the prismatic blade production described here could be a point in common with pre-Still Bay and post-Howiesons Poort industries. On the other hand, the detailed analysis of the Grey Rocky lithics reinforces the particular character of this Howiesons Poort technocomplex, yet it also shows clear technological links with other Middle Stone Age assemblages.	[de la Pena, Paloma] Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, South Africa	University of Witwatersrand	de la Pena, P (corresponding author), Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, South Africa.	paloma.delapenya@gmail.com	de la Peña, Paloma/AAA-6605-2021; de la Peña, Paloma/ABB-3086-2021	de la Peña, Paloma/0000-0001-9731-7001	DST-NRF Centre of Excellence in Paleosciences, Evolutionary Studies Institute (University of the Witwatersrand)	DST-NRF Centre of Excellence in Paleosciences, Evolutionary Studies Institute (University of the Witwatersrand)	Funded by a postdoctoral scholarship of the DST-NRF Centre of Excellence in Paleosciences, Evolutionary Studies Institute (University of the Witwatersrand).	Alonso P., 2012, COMPLUTUM, V23, P41; Ambrose SH, EMERGENCE MODERN HUM, P3; [Anonymous], 2003, BAR INT SERIES; [Anonymous], J ARCHAEOLOGICAL MET, DOI DOI 10.1007/BF02229424; Beaumont PB, 1978, THESIS; Boeda E., 1993, BULL SOC PREHIST FR, V90, P392, DOI [10.3406/bspf.1993.9669, DOI 10.3406/BSPF.1993.9669]; Boeda E., 1990, PALEO, V2, P43, DOI [DOI 10.3406/PAL.1990.988, DOI 10.3406/PAL.1990.988)]; Bordes F., 1961, OUTILS LEVALLOIS TYP; BOUSMAN C. B., 1993, LITHIC TECHNOL, V18, P59, DOI DOI 10.1080/01977261.1993.11720897; Brown KS, 2012, NATURE, V491, P590, DOI 10.1038/nature11660; CALLAHAN E, 1991, PLAINS ANTHROPOL, V36, P367; Callahan E., 1985, EVALUATION LITHIC TE; Clark J D, 1955, P 3 PAN AFR C PREH L, P412; Clark JL, 2008, J HUM EVOL, V54, P886, DOI 10.1016/j.jhevol.2007.12.004; Clarke B.M., 2007, GEOLOGY VERULAM AREA; Clarke D.L., 1968, ANAL ARCHAEOLOGY; Clarkson C, 2010, NEW PERSPECTIVES ON OLD STONES: ANALYTICAL APPROACHES TO PALEOLITHIC TECHNOLOGIES, P43, DOI 10.1007/978-1-4419-6861-6_3; Cochrane G.W.G., 2006, SOUTH AFR HUMANIT, V18, P69; Cochrane G.W.G., 2008, S AFRICAN ARCHAEOLOG, V10, P157; d'Errico F, 2007, J HUM EVOL, V52, P142, DOI 10.1016/j.jhevol.2006.08.003; d'Errico F, 2012, J ARCHAEOL SCI, V39, P2479, DOI 10.1016/j.jas.2012.01.040; de la Pena P., 2013, S AFRICAN ARCHAEOLOG, V68, P136; de la Pena P., 2015, CURRENT ANT IN PRESS; de la Pena P, 2015, LITHIC TECH IN PRESS; de la Pena P, 2014, QUATERN INT, V350, P26, DOI 10.1016/j.quaint.2014.03.043; de la Pena P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101534; de Lombera-Hermida A, 2008, ANN U STUDI FERRARA, P101; Deacon H.J., 1995, S AFR ARCHAEOL B, V50, P121, DOI [10.2307/3889061, DOI 10.2307/3889061]; DEACON HJ, 1989, HUMAN REVOLUTION, P547; Delagnes A., 2006, SO AFRICAN HUMANITIE, V18, P43; Dibble E., 1995, DEFINITION INTERPRET, P41; Dibble H.L., 1995, INTERPRETATION DEFIN, P93; Dibble Harold L., 1984, PAL ORIENT, V10, P23, DOI DOI 10.3406/PALEO.1984.937; Diez-Martin F, 2009, J ANTHROPOL ARCHAEOL, V28, P274, DOI 10.1016/j.jaa.2009.03.001; Driscoll K, 2014, J ARCHAEOL SCI, V47, P134, DOI 10.1016/j.jas.2014.04.008; Feathers J., 2015, J ARCHAEOLO IN PRESS; Goldberg P, 2009, ARCHAEOL ANTHROP SCI, V1, P95, DOI 10.1007/s12520-009-0008-1; Goren-Inbar N., 1988, LITHIC TECHNOL, V17, P37, DOI [10.1080/01977261.1988.11754524, DOI 10.1080/01977261.1988.11754524]; Harper PT, 1994, THESIS; Harper PTN, 1997, S AFR J SCI, V93, P470; Henshilwood CS, 2014, J ARCHAEOL SCI, V45, P284, DOI 10.1016/j.jas.2014.01.033; Henshilwood CS, 2012, J WORLD PREHIST, V25, P205, DOI 10.1007/s10963-012-9060-3; Hensilwood C., 2003, INDOPACIFIC PREHISTO, V44, P627, DOI DOI 10.7152/BIPPA.V15I0.11544; Hiscock P, 2015, WORLD ARCHAEOL, V47, P158, DOI 10.1080/00438243.2014.991808; Hivernel-Guerre F, 1974, B SOC PREHISTORIQUE, V71, P119; Igreja M, 2013, J ARCHAEOL SCI, V40, P3475, DOI 10.1016/j.jas.2013.02.026; Jacobs Z, 2015, J ARCHAEOLO IN PRESS; Jacobs Z, 2008, S AFRICAN ARCHAEOLOG, V10, P9; Jacobs Z, 2008, SCIENCE, V322, P733, DOI 10.1126/science.1162219; Kaplan J, 1990, NATAL MUSEUM J HUMAN, V2, P1; Karlin C., 1991, OBSERVER LACTION TEC, P101; Klaric L., 2003, THESIS; Le Brun-Ricalens F, 2006, S 6 7 15 C UISPP 2 8; Lemonnier P, 1976, TECHNIQUES CULTURE, V1, P101; Lennox SJ, 2015, S AFRICAN J SCI, V111; Lombard M., 2007, THESIS; Lombard M, 2011, ANTIQUITY, V85, P1433, DOI 10.1017/S0003598X00062153; Mackay A., 2009, THESIS; Mackay A, 2008, J ARCHAEOL SCI, V35, P1521, DOI 10.1016/j.jas.2007.10.015; Mackay A, 2014, J HUM EVOL, V72, P26, DOI 10.1016/j.jhevol.2014.03.003; Martinez Cortizas A, 1996, NONFLINT STONE TOOLS, V649, P49; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; Minichillo T., 2005, MIDDLE STONE AGE LIT; Mourre V, 1996, PALEO, V8, P205, DOI DOI 10.3406/PAL.1996.1160; Nishiaki Y., 1985, U TOKYO B, V4, P215; Pargeter J, 2007, S AFR ARCHAEOL BULL, V62, P147, DOI 10.2307/20474970; Pelegrin J., 1995, CAHIERS QUATERNAIRE, V20, P297; Porraz G, 2013, J ARCHAEOL SCI, V40, P3376, DOI 10.1016/j.jas.2013.02.012; Rios J, 2012, EKOB, V5, P79; Shimelmitz R., 2013, PALEOANTHROPOLOGY, P1, DOI [10.4207/PA.2013.ART77, DOI 10.4207/PA.2013.ART77]; Shott Michael J., 2003, LITHIC TECHNOL, V28, P95, DOI DOI 10.1080/01977261.2003.11721005; Singer R., 1982, MIDDLE STONE AGE KLA; Solecki L, 1970, B MUSEE BEYRUTH, VXXIII, P138; Soriano S, 2007, J ARCHAEOL SCI, V34, P681, DOI 10.1016/j.jas.2006.06.017; Soriano S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131127; Soto Sebastian A., 2014, PRODUCCION GESTION I; Stapleton P., 1927, S AFR J SCI, V24, P574; Stapleton P., 1928, S AFR J SCI, V25, P399; Texier PJ, 2010, P NATL ACAD SCI USA, V107, P6180, DOI 10.1073/pnas.0913047107; THACKERAY AI, 1992, J WORLD PREHIST, V6, P385, DOI 10.1007/BF00975633; Tostevin G., 2012, SEEING LITHICS MIDDL, DOI [10.2218/jls.v3i1.1336, DOI 10.2218/JLS.V3I1.1336]; Tribolo C, 2013, J ARCHAEOL SCI, V40, P3401, DOI 10.1016/j.jas.2012.12.001; VANPEER P, 1991, J ANTHROPOL ARCHAEOL, V10, P107, DOI 10.1016/0278-4165(91)90017-R; Villa P, 2010, J ARCHAEOL SCI, V37, P630, DOI 10.1016/j.jas.2009.10.028; Villa P, 2012, P NATL ACAD SCI USA, V109, P13208, DOI 10.1073/pnas.1202629109; Wadley L, 2015, DELAGNES AEDITORS SE, VIV, P11; Wadley L, 1987, CAMBRIDGE MONOGRAPHS, V25; Wadley L, 2006, SOUTH AFR HUMANIT, V18, P1; Wadley L., 1989, S AFR ARCHAEOL BULL, V44, P23, DOI DOI 10.2307/3888316; Wadley L, 2008, S AFRICAN ARCHAEOLOG, V1, P122; Wadley L, 2008, J ARCHAEOL SCI, V35, P2594, DOI 10.1016/j.jas.2008.04.017; Wadley L, 2015, AZANIA, V50, P155, DOI 10.1080/0067270X.2015.1039236; Wadley L, 2011, SOUTH AFR HUMANIT, V23, P87; Wadley L, 2011, SCIENCE, V334, P1388, DOI 10.1126/science.1213317; Wadley L, 2012, QUATERN INT, V247, P341, DOI 10.1016/j.quaint.2010.10.026; Wadley L, 2009, P NATL ACAD SCI USA, V106, P9590, DOI 10.1073/pnas.0900957106; Wendt W. E., 1976, S AFR ARCHAEOL BULL, V31, P5, DOI DOI 10.2307/3888265; WIESSNER P, 1983, AM ANTIQUITY, V48, P253, DOI 10.2307/280450; Will M, PLOS ONE, V9, DOI [10.1371/journal.pone.0098359, DOI 10.1371/JOURNAL.PONE.0098359]; Wurz S, 1999, S AFR ARCHAEOL BULL, V54, P38, DOI 10.2307/3889138; Wurz S., 2000, MIDDLE STONE AGE KLA; Wurz S, 2013, CURR ANTHROPOL, V54, pS305, DOI 10.1086/673283	102	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143451	10.1371/journal.pone.0143451	http://dx.doi.org/10.1371/journal.pone.0143451			52	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CX9QI	26633008	Green Published, gold			2022-12-27	WOS:000366040000015
J	Li, ZF; Liu, YJ; Feng, ZL; Feng, HJ; Klosterman, SJ; Zhou, FF; Zhao, LH; Shi, YQ; Zhu, HQ				Li, Zhi-Fang; Liu, Yi-Jie; Feng, Zi-Li; Feng, Hong-Jie; Klosterman, Steven J.; Zhou, Fang-Fang; Zhao, Li-Hong; Shi, Yong-Qiang; Zhu, He-Qin			VdCYC8, Encoding CYC8 Glucose Repression Mediator Protein, Is Required for Microsclerotia Formation and Full Virulence in Verticillium dahliae	PLOS ONE			English	Article							GENE-EXPRESSION; TRANSCRIPTIONAL REPRESSION; HYDROPHOBIN GENE; CROP-ROTATION; KINASE GENE; WILT; GROWTH; PATHOGENICITY; SSN6; BIOSYNTHESIS	Verticillium dahliae is the primary causal agent for Verticillium wilt disease on a diverse array of economically important crops, including cotton. In previous research, we obtained the low-pathogenicity mutant T286 from the T-DNA insertional mutant library of the highly virulent isolate Vd080 derived from cotton. In this study, the target disrupted gene VdCYC8 was identified by TAIL-PCR, encoding a homolog of CYC8 proteins involved in glucose repression. The deletion mutant Delta CYC8 exhibited several developmental deficiencies, including reduced microsclerotia formation, reduced sporulation, and slower growth. Moreover, compared with the wild type strain Vd080, the pathogenicity of strain Delta CYC8 was significantly decreased on cotton seedlings. However, the complementary mutants Delta CYC8-C led to restoration of the wild type phenotype or near wild type levels of virulence on cotton. Interestingly, pathogenicity of the strains was correlated with VdCYC8 gene expression levels in complemented mutants. Gene expression analyses in the wild type strain Vd080, the Delta CYC8-45 strain, and complemented strain Delta CYC8-C26 indicated that VdCYC8 regulates the transcription levels of several genes in V. dahliae that have roles in melanin and production.	[Li, Zhi-Fang; Liu, Yi-Jie; Feng, Zi-Li; Feng, Hong-Jie; Zhou, Fang-Fang; Zhao, Li-Hong; Shi, Yong-Qiang; Zhu, He-Qin] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang 455000, Henan, Peoples R China; [Klosterman, Steven J.] ARS, USDA, Salinas, CA 93905 USA	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; United States Department of Agriculture (USDA)	Zhu, HQ (corresponding author), Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang 455000, Henan, Peoples R China.	zhuheqin2012@163.com			National Natural Science Foundation of China [31201466]; National High-Tech Program [2013AA102601]; ARS [ARS-0426096] Funding Source: Federal RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech Program; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was financially supported by the National Natural Science Foundation of China (No. 31201466) and the National High-Tech Program (No. 2013AA102601).; This work was financially supported by the National Natural Science Foundation of China (No. 31201466) and the National High-tech program (No. 2013AA102601). We thank Prof. Dai Xiaofeng for providing A. tumefaciens strain AGL1 and plasmid pCTHyg.	BELL AA, 1986, ANNU REV PHYTOPATHOL, V24, P411, DOI 10.1146/annurev.py.24.090186.002211; Chen Y, 2015, MOL PLANT PATHOL, V16, P799, DOI 10.1111/mpp.12235; CHET I, 1975, ANNU REV PHYTOPATHOL, V13, P169, DOI 10.1146/annurev.py.13.090175.001125; COLEYSMI.JR, 1971, ANNU REV PHYTOPATHOL, V9, P65, DOI 10.1146/annurev.py.09.090171.000433; Debode J, 2007, J APPL MICROBIOL, V103, P1184, DOI 10.1111/j.1365-2672.2007.03348.x; Duressa D, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-607; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gao F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015319; Hoppenau CE, 2014, ENVIRON EXP BOT, V108, P14, DOI 10.1016/j.envexpbot.2013.12.015; Hu DF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100046; Hwang CS, 2003, MOL MICROBIOL, V47, P1029, DOI 10.1046/j.1365-2958.2003.03353.x; Ikeda K, 2015, J GEN PLANT PATHOL, V81, P77, DOI 10.1007/s10327-014-0559-6; Johnson DA, 2015, PLANT DIS, V99, P257, DOI 10.1094/PDIS-03-14-0271-RE; Khang CH, 2005, FUNGAL GENET BIOL, V42, P483, DOI 10.1016/j.fgb.2005.03.004; Klimes A, 2006, FUNGAL GENET BIOL, V43, P283, DOI 10.1016/j.fgb.2005.12.006; Klimes A, 2006, THESIS; Klimes A, 2008, FUNGAL GENET BIOL, V45, P1525, DOI 10.1016/j.fgb.2008.09.014; Klosterman SJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002137; Klosterman SJ, 2009, ANNU REV PHYTOPATHOL, V47, P39, DOI 10.1146/annurev-phyto-080508-081748; Lee JE, 2015, FEBS LETT, V589, P513, DOI 10.1016/j.febslet.2015.01.011; Lengeler KB, 2000, MICROBIOL MOL BIOL R, V64, P746, DOI 10.1128/MMBR.64.4.746-785.2000; Lin X, 2014, MICROB CELL FACT, V13, DOI 10.1186/s12934-014-0093-4; Liu SY, 2013, GENE, V529, P307, DOI 10.1016/j.gene.2013.06.089; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; [刘义杰 Liu Yijie], 2015, [植物病理学报, Acta Phytopathologica Sinica], V45, P258; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malave TM, 2006, BIOCHEM CELL BIOL, V84, P437, DOI 10.1139/O06-073; Neumann MJ, 2003, FUNGAL GENET BIOL, V38, P54, DOI 10.1016/S1087-1845(02)00507-8; Pegg GF, 2002, VERTICILLUM WILTS, DOI [DOI 10.1079/9780851995298.0000, 10.1079/9780851995298.0000]; Pegg GF, 1989, VASCULAR WILT DIS PL, P51; Puhalla J. E., 1981, FUNGAL WILT DIS PLAN, P146; Rauyaree P, 2005, CURR GENET, V48, P109, DOI 10.1007/s00294-005-0586-0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Santhanam P, 2013, MOL PLANT MICROBE IN, V26, P249, DOI 10.1094/MPMI-08-12-0198-R; Schnathorst WC, 1981, FUNGAL WILT DIS PLAN, P81, DOI DOI 10.1016/B978-0-12-464450-2.50009-7; Short DPG, 2015, PHYTOPATHOLOGY, V105, P80, DOI 10.1094/PHYTO-02-14-0046-R; Smith RL, 2000, TRENDS BIOCHEM SCI, V25, P325, DOI 10.1016/S0968-0004(00)01592-9; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tjamos EC, 1989, VASCULAR WILT DIS PL, P51; TRUMBLY RJ, 1988, GENE, V73, P97, DOI 10.1016/0378-1119(88)90316-2; Tzima AK, 2012, FUNGAL GENET BIOL, V49, P271, DOI 10.1016/j.fgb.2012.02.005; Tzima AK, 2011, MOL PLANT MICROBE IN, V24, P129, DOI 10.1094/MPMI-09-09-0217; Vallad GE, 2008, PHYTOPATHOLOGY, V98, P871, DOI 10.1094/PHYTO-98-8-0871; Wong KH, 2011, GENE DEV, V25, P2525, DOI 10.1101/gad.179275.111; Woo PCY, 2010, FEBS J, V277, P3750, DOI 10.1111/j.1742-4658.2010.07776.x; Xia ZJ, 1998, EUR J PLANT PATHOL, V104, P871, DOI 10.1023/A:1008628209867; Xiao CL, 1998, PHYTOPATHOLOGY, V88, P1046, DOI 10.1094/PHYTO.1998.88.10.1046; Xiong DG, 2015, GENE, V562, P169, DOI 10.1016/j.gene.2015.02.063; Yamashiro CT, 1996, MOL CELL BIOL, V16, P6218; Yu Zhang, 2015, 2015 IEEE MTT-S International Microwave Symposium (IMS2015), P1, DOI 10.1109/MWSYM.2015.7166999; Zhang Y., 2015, CRIM JUSTICE REV, V40, P340, DOI DOI 10.1177/0734016815573309; Zhu HQ, 2013, J PHYTOPATHOL, V161, P70, DOI 10.1111/jph.12027	52	9	17	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144020	10.1371/journal.pone.0144020	http://dx.doi.org/10.1371/journal.pone.0144020			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633180	Green Submitted, gold, Green Published			2022-12-27	WOS:000366040000044
J	Anjomshoaa, I; Briseno-Ruiz, J; Deeley, K; Poletta, FA; Mereb, JC; Leite, AL; Barreta, PATM; Silva, TL; Dizak, P; Ruff, T; Patir, A; Koruyucu, M; Abbasoglu, Z; Casado, PL; Brown, A; Zaky, SH; Bayram, M; Kuchler, EC; Cooper, ME; Liu, K; Marazita, ML; Tanboga, I; Granjeiro, JM; Seymen, F; Castilla, EE; Orioli, IM; Sfeir, C; Owyang, H; Buzalaf, MAR; Vieira, AR				Anjomshoaa, Ida; Briseno-Ruiz, Jessica; Deeley, Kathleen; Poletta, Fernardo A.; Mereb, Juan C.; Leite, Aline L.; Barreta, Priscila A. T. M.; Silva, Thelma L.; Dizak, Piper; Ruff, Timothy; Patir, Asli; Koruyucu, Mine; Abbasoglu, Zerrin; Casado, Priscila L.; Brown, Andrew; Zaky, Samer H.; Bayram, Merve; Kuechler, Erika C.; Cooper, Margaret E.; Liu, Kai; Marazita, Mary L.; Tanboga, Ilknur; Granjeiro, Jose M.; Seymen, Figen; Castilla, Eduardo E.; Orioli, Ieda M.; Sfeir, Charles; Owyang, Hongjiao; Buzalaf, Marilia A. R.; Vieira, Alexandre R.			Aquaporin 5 Interacts with Fluoride and Possibly Protects against Caries	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DENTAL-CARIES; SALIVARY-GLANDS; EXPRESSION; POLYMORPHISM; GENES; SCAN; LOCALIZATION; EXPERIENCE; SECRETION	Aquaporins (AQP) are water channel proteins and the genes coding for AQP2, AQP5, and AQP6 are clustered in 12q13. Since AQP5 is expressed in serous acinar cells of salivary glands, we investigated its involvement in caries. DNA samples from 1,383 individuals from six groups were studied. Genotypes of eight single nucleotide polymorphisms covering the aquaporin locus were tested for association with caries experience. Interaction with genes involved in enamel formation was tested. The association between enamel microhardness at baseline, after creation of artificial caries lesion, and after exposure to fluoride and the genetic markers in AQP5 was tested. Finally, AQP5 expression in human whole saliva, after exposure to fluoride in a mammary gland cell line, which is known to express AQP5, and in Wistar rats was also verified. Nominal associations were found between caries experience and markers in the AQP5 locus. Since these associations suggested that AQP5 may be inhibited by levels of fluoride in the drinking water that cause fluorosis, we showed that fluoride levels above optimal levels change AQP5 expression in humans, cell lines, and rats. We have shown that AQP5 is involved in the pathogenesis of caries and likely interacts with fluoride.	[Anjomshoaa, Ida; Briseno-Ruiz, Jessica; Deeley, Kathleen; Dizak, Piper; Ruff, Timothy; Brown, Andrew; Zaky, Samer H.; Kuechler, Erika C.; Cooper, Margaret E.; Marazita, Mary L.; Sfeir, Charles; Vieira, Alexandre R.] Univ Pittsburgh, Sch Dent Med, Dept Oral Biol, Pittsburgh, PA 15260 USA; [Poletta, Fernardo A.; Castilla, Eduardo E.] CEMIC Ctr Med Educ & Clin Res, ECLAMC Latin Amer Collaborat Study Congenital Mal, Buenos Aires, DF, Argentina; [Mereb, Juan C.] Hosp Area El Bolson, ECLAMC, El Bolson, RN, Argentina; [Leite, Aline L.; Barreta, Priscila A. T. M.; Silva, Thelma L.; Buzalaf, Marilia A. R.] Univ Sao Paulo, Bauru Sch Dent, Bauru, SP, Brazil; [Patir, Asli; Bayram, Merve] Medipol Istanbul Univ, Dept Pedodont, Istanbul, Turkey; [Koruyucu, Mine; Seymen, Figen] Istanbul Univ, Dept Pedodont, Istanbul, Turkey; [Abbasoglu, Zerrin] Yeditepe Univ, Dept Pediat Dent, Fac Dent, Istanbul, Turkey; [Casado, Priscila L.; Granjeiro, Jose M.] Univ Fed Fluminense, Sch Dent, Clin Res Unit, Niteroi, RJ, Brazil; [Casado, Priscila L.] Univ Fed Fluminense, Inst Biol, Niteroi, RJ, Brazil; [Liu, Kai] Univ Pittsburgh, Sch Dent Med, Dept Endodont, Pittsburgh, PA USA; [Tanboga, Ilknur; Owyang, Hongjiao] Marmara Univ, Dept Pediat Dent, Fac Dent, Istanbul, Turkey; [Granjeiro, Jose M.] Natl Inst Metrol INMETRO, Niteroi, RJ, Brazil; [Castilla, Eduardo E.] Fundacao Oswaldo Cruz, Natl Inst Populat Med Genet, Dept Genet, ECLAMC,INAGEMP,CNPq, Rio De Janeiro, Brazil; [Orioli, Ieda M.] Univ Fed Rio de Janeiro, Natl Inst Populat Med Genet, Dept Genet, ECLAMC,INAGEMP,CNPq Inst Biol,Ctr Hlth Sci, Rio De Janeiro, Brazil	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Centro de Educacion Medica e Investigaciones Clinicas (CEMIC); Universidade de Sao Paulo; Medipol Hospital; Istanbul University; Yeditepe University; Universidade Federal Fluminense; Universidade Federal Fluminense; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Marmara University; Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO); Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro	Vieira, AR (corresponding author), Univ Pittsburgh, Sch Dent Med, Dept Oral Biol, Pittsburgh, PA 15260 USA.	arv11@pitt.edu	Leite, Aline/J-9748-2012; Koruyucu, M/AAC-6713-2020; Seymen, Figen/AAC-6736-2020; Buzalaf, Marilia Afonso Rabelo/AAU-2554-2021; Buzalaf, Marilia Afonso Rabelo/C-5228-2012; Küchler, Erika C/B-4669-2014; Bayram, Merve/B-1230-2018; casado, priscila ladeira/E-6401-2014; Granjeiro, Jose/D-8289-2012	Leite, Aline/0000-0002-2112-1309; Koruyucu, M/0000-0002-2077-5095; Seymen, Figen/0000-0001-7010-2035; Buzalaf, Marilia Afonso Rabelo/0000-0002-5985-3951; Buzalaf, Marilia Afonso Rabelo/0000-0002-5985-3951; Bayram, Merve/0000-0002-8440-367X; casado, priscila ladeira/0000-0002-7551-0190; Kuchler, Erika/0000-0001-5351-2526; Zaky, Samer/0000-0001-5550-5450; Granjeiro, Jose/0000-0002-8027-8293; Abbasoglu, Zerrin/0000-0002-0077-5581; Poletta, Fernando/0000-0002-6102-8416	NIH/NIDCR [R01-DE18914]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018914] Funding Source: NIH RePORTER	NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by NIH/NIDCR grant R01-DE18914. The NIH had no role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Abbasoglu Z, 2014, CARIES RES IN PRESS; Amerongen AVN, 2002, ORAL DIS, V8, P12, DOI 10.1034/j.1601-0825.2002.1o816.x; [Anonymous], EUR J DENT; Azevedo LF, 2010, J APPL ORAL SCI, V18, P166, DOI 10.1590/S1678-77572010000200011; Baum BJ, 2012, P NATL ACAD SCI USA, V109, P19403, DOI 10.1073/pnas.1210662109; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Culp DJ, 2005, CARIES RES, V39, P448, DOI 10.1159/000088179; Deeley K, 2008, CARIES RES, V42, P8, DOI 10.1159/000111744; Felszeghy S, 2004, ARCH ORAL BIOL, V49, P247, DOI 10.1016/j.archoralbio.2003.09.011; Flueck WT, 2013, J WILDLIFE DIS, V49, P355, DOI 10.7589/2012-11-272; Funaki H, 1998, AM J PHYSIOL-CELL PH, V275, pC1151, DOI 10.1152/ajpcell.1998.275.4.C1151; Hamann S, 1998, AM J PHYSIOL-CELL PH, V274, pC1332, DOI 10.1152/ajpcell.1998.274.5.C1332; Hamilton IR, 1977, CARIES RES S1, V11, P321; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Ishida N, 1997, BIOCHEM BIOPH RES CO, V238, P891, DOI 10.1006/bbrc.1997.7396; Kang SW, 2011, ORAL DIS, V17, P399, DOI 10.1111/j.1601-0825.2010.01766.x; Kato MT, 2014, J DENT RES, V93, P74, DOI 10.1177/0022034513511820; King LS, 1996, ANNU REV PHYSIOL, V58, P619, DOI 10.1146/annurev.ph.58.030196.003155; Kuchler EC, 2012, J APPL ORAL SCI, V20, P467, DOI 10.1590/S1678-77572012000400013; Kulkarni GV, 2013, CARIES RES, V47, P219, DOI 10.1159/000345652; Kumari SS, 2012, MOL VIS, V18, P957; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma TH, 1996, GENOMICS, V35, P543, DOI 10.1006/geno.1996.0396; Ma TH, 1999, J BIOL CHEM, V274, P20071, DOI 10.1074/jbc.274.29.20071; Menezes-Silva R, 2012, J ENDODONT, V38, P604, DOI 10.1016/j.joen.2012.02.009; Nielsen S, 1997, AM J PHYSIOL-CELL PH, V273, pC1549, DOI 10.1152/ajpcell.1997.273.5.C1549; Ozturk A, 2010, J DENT RES, V89, P631, DOI 10.1177/0022034510364491; Pan Y, 2009, BBA-GEN SUBJECTS, V1790, P49, DOI 10.1016/j.bbagen.2008.08.009; Patir A, 2008, CARIES RES, V42, P394, DOI 10.1159/000154785; Perez Carrera A., 2004, InVet - Investigacion Veterinaria, V6, P51; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ranade K, 2001, GENOME RES, V11, P1262; SCANNAPIECO FA, 1994, CRIT REV ORAL BIOL M, V5, P203, DOI 10.1177/10454411940050030201; Shaffer JR, 2013, J DENT RES, V92, P38, DOI 10.1177/0022034512463579; Shaffer JR, 2011, J DENT RES, V90, P1457, DOI 10.1177/0022034511422910; Shimizu T, 2013, CARIES RES, V47, P273, DOI 10.1159/000346278; Shimizu T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045022; Slayton RL, 2005, J DENT RES, V84, P711, DOI 10.1177/154405910508400805; Spring KR, 1998, ANNU REV PHYSIOL, V60, P105, DOI 10.1146/annurev.physiol.60.1.105; Sugimoto N, 2013, SCI REP-UK, V3, DOI 10.1038/srep01763; Tannure PN, 2012, CARIES RES, V46, P401, DOI 10.1159/000339379; Tannure PN, 2012, J DENT, V40, P381, DOI 10.1016/j.jdent.2012.01.015; Valarini N, 2012, CARIES RES, V46, P530, DOI 10.1159/000341188; Vieira AR, 2008, J DENT RES, V87, P435, DOI 10.1177/154405910808700506; Wang D, 2009, J MED INVESTIG, V56, P350, DOI 10.2152/jmi.56.350; Wang X, 2012, CARIES RES, V46, P177, DOI 10.1159/000337282; Wang XJ, 2012, BMC ORAL HEALTH, V12, DOI 10.1186/1472-6831-12-57; Wendell S, 2010, J DENT RES, V89, P1198, DOI 10.1177/0022034510381502; World Health Organization, 1997, ORAL HEALTH SURVEYS; Zeng Z, 2013, J DENT RES, V92, P432, DOI 10.1177/0022034513481976	52	19	19	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143068	10.1371/journal.pone.0143068	http://dx.doi.org/10.1371/journal.pone.0143068			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630491	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000365926300029
J	Qian, GF; Fan, W; Ahlemeyer, B; Karnati, S; Baumgart-Vogt, E				Qian, Guofeng; Fan, Wei; Ahlemeyer, Barbara; Karnati, Srikanth; Baumgart-Vogt, Eveline			Peroxisomes in Different Skeletal Cell Types during Intramembranous and Endochondral Ossification and Their Regulation during Osteoblast Differentiation by Distinct Peroxisome Proliferator-Activated Receptors	PLOS ONE			English	Article							RHIZOMELIC CHONDRODYSPLASIA PUNCTATA; BETA-OXIDATION ENZYMES; IN-SITU HYBRIDIZATION; NEURONAL MIGRATION; ZELLWEGER-SYNDROME; PPAR-ALPHA; RESPONSE ELEMENT; BONE-MARROW; MOUSE MODEL; PROTEINS	Ossification defects leading to craniofacial dysmorphism or rhizomelia are typical phenotypes in patients and corresponding knockout mouse models with distinct peroxisomal disorders. Despite these obvious skeletal pathologies, to date no careful analysis exists on the distribution and function of peroxisomes in skeletal tissues and their alterations during ossification. Therefore, we analyzed the peroxisomal compartment in different cell types of mouse cartilage and bone as well as in primary cultures of calvarial osteoblasts. The peroxisome number and metabolism strongly increased in chondrocytes during endochondral ossification from the reserve to the hypertrophic zone, whereas in bone, metabolically active osteoblasts contained a higher numerical abundance of this organelle than osteocytes. The high abundance of peroxisomes in these skeletal cell types is reflected by high levels of Pex11 beta gene expression. During culture, calvarial pre-osteoblasts differentiated into secretory osteoblasts accompanied by peroxisome proliferation and increased levels of peroxisomal genes and proteins. Since many peroxisomal genes contain a PPAR-responsive element, we analyzed the gene expression of PPAR alpha/beta/gamma in calvarial osteoblasts and MC3T3-E1 cells, revealing higher levels for PPAR beta than for PPAR. and PPAR.. Treatment with different PPAR agonists and antagonists not only changed the peroxisomal compartment and associated gene expression, but also induced complex alterations of the gene expression patterns of the other PPAR family members. Studies in M3CT3-E1 cells showed that the PPAR beta agonist GW0742 activated the PPRE-mediated luciferase expression and up-regulated peroxisomal gene transcription (Pex11, Pex13, Pex14, Acox1 and Cat), whereas the PPAR beta antagonist GSK0660 led to repression of the PPRE and a decrease of the corresponding mRNA levels. In the same way, treatment of calvarial osteoblasts with GW0742 increased in peroxisome number and related gene expression and accelerated osteoblast differentiation. Taken together, our results suggest that PPAR beta regulates the numerical abundance and metabolic function of peroxisomes via Pex11 beta in parallel to osteoblast differentiation.	[Qian, Guofeng; Fan, Wei; Ahlemeyer, Barbara; Karnati, Srikanth; Baumgart-Vogt, Eveline] Univ Giessen, Med Cell Biol, Inst Anat & Cell Biol, D-35385 Giessen, Germany	Justus Liebig University Giessen	Baumgart-Vogt, E (corresponding author), Univ Giessen, Med Cell Biol, Inst Anat & Cell Biol, Aulweg 123, D-35385 Giessen, Germany.	Eveline.Baumgart-Vogt@anatomie.med.uni-giessen.de	Baumgart-Vogt, Eveline/I-5945-2013; Karnati, Srikanth/AAP-9038-2021	Baumgart-Vogt, Eveline/0000-0002-8265-3763; Karnati, Srikanth/0000-0001-9083-2916	Leistungsorientierte Mittel der Justus-Liebig University Giessen	Leistungsorientierte Mittel der Justus-Liebig University Giessen	The work was supported by Leistungsorientierte Mittel der Justus-Liebig University Giessen.	AGAMANOLIS DP, 1995, PEDIATR PATHOL LAB M, V15, P503, DOI 10.3109/15513819509026986; Ahlemeyer B, 2007, J COMP NEUROL, V505, P1, DOI 10.1002/cne.21448; Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; Aleshin S, 2013, NEUROCHEM INT, V63, P322, DOI 10.1016/j.neuint.2013.06.012; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1652, DOI 10.1111/bph.12448; Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; Babiychuk EB, 2000, J CELL BIOL, V150, P1113, DOI 10.1083/jcb.150.5.1113; Baes M, 1997, NAT GENET, V17, P49, DOI 10.1038/ng0997-49; Baumgart E, 1997, HISTOCHEM CELL BIOL, V108, P371, DOI 10.1007/s004180050178; Baumgart E, 1997, HISTOCHEM CELL BIOL, V108, P185, DOI 10.1007/s004180050160; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braverman N, 1997, NAT GENET, V15, P369, DOI 10.1038/ng0497-369; Braverman N, 2002, HUM MUTAT, V20, P284, DOI 10.1002/humu.10124; Braverman N, 2010, MOL GENET METAB, V99, P408, DOI 10.1016/j.ymgme.2009.12.005; Brites P, 2003, HUM MOL GENET, V12, P2255, DOI 10.1093/hmg/ddg236; Brosius U, 2002, CELL MOL LIFE SCI, V59, P1058, DOI 10.1007/s00018-002-8486-7; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Colasante C, 2015, THROMB HAEMOSTASIS, V113, P452, DOI 10.1160/TH14-06-0497; Cook WS, 2000, BIOCHEM BIOPH RES CO, V278, P250, DOI 10.1006/bbrc.2000.3739; DEAHL ST, 1992, J BONE MINER RES, V7, P187; DeLuca JG, 2000, MOL PHARMACOL, V58, P470, DOI 10.1124/mol.58.3.470; Eaton SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072457; En-Nosse M, 2009, CELL TISSUE RES, V338, P203, DOI 10.1007/s00441-009-0871-1; Faust PL, 1997, J CELL BIOL, V139, P1293, DOI 10.1083/jcb.139.5.1293; Fox MA, 2014, IN VITRO CELL DEV-AN, V50, P340, DOI 10.1007/s11626-013-9710-5; Fox MA, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-24; Fransen M, 1999, BIOCHEM J, V340, P561, DOI 10.1042/0264-6021:3400561; GENGE BR, 1990, J BIOL CHEM, V265, P4703; Gillette JM, 2004, J CELL SCI, V117, P441, DOI 10.1242/jcs.00909; Girnun GD, 2002, MOL ENDOCRINOL, V16, P2793, DOI 10.1210/me.2002-0020; Grabenbauer M, 2000, CELL BIOCHEM BIOPHYS, V32, P37, DOI 10.1385/CBB:32:1-3:37; Grant P, 2013, HISTOCHEM CELL BIOL, V140, P423, DOI 10.1007/s00418-013-1133-6; Hah YS, 2014, INT J MED SCI, V11, P1116, DOI 10.7150/ijms.9611; HEYMANS HSA, 1985, NEW ENGL J MED, V313, P187; Huang Yen-Hua, 2014, Biomed Res Int, V2014, P195162, DOI 10.1155/2014/195162; Imai Y, 2013, PHYSIOL REV, V93, P481, DOI 10.1152/physrev.00008.2012; Jackson SM, 2000, FEBS LETT, V471, P119, DOI 10.1016/S0014-5793(00)01372-7; James AW, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/684736; Kajarabille N, 2013, SCI WORLD J, DOI 10.1155/2013/589641; Kang S, 2007, J BIOL CHEM, V282, P14515, DOI 10.1074/jbc.M700030200; Karnati S, 2008, HISTOCHEM CELL BIOL, V130, P719, DOI 10.1007/s00418-008-0462-3; Kirsch T, 2005, FRONT BIOSCI-LANDMRK, V10, P576, DOI 10.2741/1553; Kruger MC, 2010, PROG LIPID RES, V49, P438, DOI 10.1016/j.plipres.2010.06.002; Lanyon-Hogg T, 2010, BIOL CELL, V102, P245, DOI 10.1042/BC20090159; Latruffe N, 1997, BIOCHIMIE, V79, P81, DOI 10.1016/S0300-9084(97)81496-4; Lawrence JW, 2001, J BIOL CHEM, V276, P31521, DOI 10.1074/jbc.M103306200; Lecka-Czernik B, 1999, J CELL BIOCHEM, V74, P357, DOI 10.1002/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7; Li XL, 2002, MOL CELL BIOL, V22, P4358, DOI 10.1128/MCB.22.12.4358-4365.2002; Li XL, 2002, MOL CELL BIOL, V22, P8226, DOI 10.1128/MCB.22.23.8226-8240.2002; Lin S, 2015, MOL GENETICS PEDIAT, P56; Maxwell M, 2003, MOL CELL BIOL, V23, P5947, DOI 10.1128/MCB.23.16.5947-5957.2003; Michalik L, 2006, PHARMACOL REV, V58, P726, DOI 10.1124/pr.58.4.5; Nardacci R, 2004, J HISTOCHEM CYTOCHEM, V52, P423, DOI 10.1177/002215540405200401; Nenicu A, 2007, BIOL REPROD, V77, P1060, DOI 10.1095/biolreprod.107.061242; Nuttall ME, 1998, J BONE MINER RES, V13, P371, DOI 10.1359/jbmr.1998.13.3.371; Okuno Y, 2008, BIOCHEM BIOPH RES CO, V366, P698, DOI 10.1016/j.bbrc.2007.12.001; OSUMI T, 1990, J BIOCHEM-TOKYO, V108, P614, DOI 10.1093/oxfordjournals.jbchem.a123252; Park J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085045; Peters JM, 2000, MOL CELL BIOL, V20, P5119, DOI 10.1128/MCB.20.14.5119-5128.2000; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poll-The BT, 2004, AM J MED GENET A, V126A, P333, DOI 10.1002/ajmg.a.20664; Purdue PE, 1999, NEUROCHEM RES, V24, P581, DOI 10.1023/A:1023957110171; ROBISON WG, 1977, INVEST OPHTH VIS SCI, V16, P1110; SCHEPERS L, 1988, J BIOL CHEM, V263, P2724; Scholtysek C, 2013, NAT MED, V19, P608, DOI 10.1038/nm.3146; Schrader M, 2012, BBA-MOL BASIS DIS, V1822, P1343, DOI 10.1016/j.bbadis.2011.12.014; Schrader M, 1998, J BIOL CHEM, V273, P29607, DOI 10.1074/jbc.273.45.29607; STEIN GS, 1989, CONNECT TISSUE RES, V20, P3, DOI 10.3109/03008208909049996; Stelzig I, 2013, HISTOCHEM CELL BIOL, V140, P443, DOI 10.1007/s00418-013-1131-8; Still K, 2008, CALCIFIED TISSUE INT, V83, P285, DOI 10.1007/s00223-008-9175-9; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; Syversen U, 2009, BMC ENDOCR DISORD, V9, DOI 10.1186/1472-6823-9-10; Tugwood J D, 1998, Arch Toxicol Suppl, V20, P377; Van Veldhoven P P, 1998, Verh K Acad Geneeskd Belg, V60, P195; Vijayan V, 2011, J IMMUNOL, V187, P817, DOI 10.4049/jimmunol.1003631; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Wanders RJA, 2004, MOL GENET METAB, V83, P16, DOI 10.1016/j.ymgme.2004.08.016; Wang W, 2002, J CELL BIOL, V157, P1061, DOI 10.1083/jcb.200203014; Watkins BA, 2003, PROSTAG LEUKOTR ESS, V68, P387, DOI 10.1016/S0952-3278(03)00063-2; Woodyatt NJ, 1999, CARCINOGENESIS, V20, P369, DOI 10.1093/carcin/20.3.369; Wu X, 2000, BONE, V26, P21, DOI 10.1016/S8756-3282(99)00238-0; Wuthier RE, 2011, FRONT BIOSCI-LANDMRK, V16, P2812, DOI 10.2741/3887; Yamashita A, 2006, FEBS LETT, V580, P4121, DOI 10.1016/j.febslet.2006.06.057; Yoshida K, 2002, P NATL ACAD SCI USA, V99, P4580, DOI 10.1073/pnas.062053399; Zhang XP, 2002, J CLIN INVEST, V109, P1405, DOI 10.1172/JCI200215681	85	15	16	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143439	10.1371/journal.pone.0143439	http://dx.doi.org/10.1371/journal.pone.0143439			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630504	Green Published, gold			2022-12-27	WOS:000365926300050
J	Robinson, S; Guyon, L; Nevalainen, J; Toriseva, M; Aring;kerfelt, M; Nees, M				Robinson, Sean; Guyon, Laurent; Nevalainen, Jaakko; Toriseva, Mervi; Akerfelt, Malin; Nees, Matthias			Segmentation of Image Data from Complex Organotypic 3D Models of Cancer Tissues with Markov Random Fields	PLOS ONE			English	Article							MICROSCOPY IMAGES; ENERGY MINIMIZATION; COMPUTER VISION; BREAST-CANCER; TUMOR-STROMA; CELL-NUCLEI; GRAPH CUTS; EXPRESSION; CARCINOMA; TRACKING	Organotypic, three dimensional (3D) cell culture models of epithelial tumour types such as prostate cancer recapitulate key aspects of the architecture and histology of solid cancers. Morphometric analysis of multicellular 3D organoids is particularly important when additional components such as the extracellular matrix and tumour microenvironment are included in the model. The complexity of such models has so far limited their successful implementation. There is a great need for automatic, accurate and robust image segmentation tools to facilitate the analysis of such biologically relevant 3D cell culture models. We present a segmentation method based on Markov random fields (MRFs) and illustrate our method using 3D stack image data from an organotypic 3D model of prostate cancer cells co-cultured with cancer-associated fibroblasts (CAFs). The 3D segmentation output suggests that these cell types are in physical contact with each other within the model, which has important implications for tumour biology. Segmentation performance is quantified using ground truth labels and we show how each step of our method increases segmentation accuracy. We provide the ground truth labels along with the image data and code. Using independent image data we show that our segmentation method is also more generally applicable to other types of cellular microscopy and not only limited to fluorescence microscopy.	[Robinson, Sean; Nevalainen, Jaakko] Univ Turku, Dept Math & Stat, Turku, Finland; [Robinson, Sean; Toriseva, Mervi; Akerfelt, Malin; Nees, Matthias] VTT Tech Res Ctr Finland, Ind Biotechnol, Turku, Finland; [Robinson, Sean; Guyon, Laurent] Univ Grenoble Alpes, F-38000 Grenoble, France; [Robinson, Sean; Guyon, Laurent] CEA Grenoble, iRTSV, Biol Grande Echelle, F-38054 Grenoble, France; [Robinson, Sean; Guyon, Laurent] INSERM, U1038, F-38054 Grenoble, France; [Nevalainen, Jaakko] Univ Tampere, Sch Hlth Sci, FIN-33101 Tampere, Finland; [Toriseva, Mervi; Akerfelt, Malin; Nees, Matthias] Univ Turku, Inst Biomed, Turku, Finland; [Toriseva, Mervi; Akerfelt, Malin; Nees, Matthias] Univ Turku, Turku Ctr Biotechnol, Turku, Finland	University of Turku; VTT Technical Research Center Finland; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); Tampere University; University of Turku; University of Turku	Robinson, S (corresponding author), Univ Turku, Dept Math & Stat, Turku, Finland.	sean.j.robinson@utu.fi	Nevalainen, Jaakko/X-1828-2019; Nees, Matthias/AAT-5577-2020; Nees, Matthias/W-6596-2018	Nevalainen, Jaakko/0000-0001-6295-0245; Nees, Matthias/0000-0002-9034-301X; Akerfelt, Malin/0000-0003-4810-7862; Toriseva, Mervi/0000-0003-3024-6282; Guyon, Laurent/0000-0002-7674-2348; Robinson, Sean/0000-0003-3957-1735	Academy of Finland [284619, 267326]; VTT	Academy of Finland(Academy of Finland); VTT	VTT Oy is a non-profit, fully government-owned research institution that officially succeeds the previous organization, founded in 1942, formerly known as Valtion Teknillinen Tutkimuskeskus or VTT (The National Technical Research Centre of Finland). VTT Oy was incorporated in 01.01.2015 and maintains the structure of a large-scale research institution. The research described here is of exclusively academic nature, not related in any way to commercial products, services or ongoing contract research with third parties conducted at VTT Oy. This work was supported by the Academy of Finland, grant numbers 284619 (MA) and 267326 (MN). SR is the beneficiary of a CEA-Industry thesis contract and a VTT thesis contract. VTT provided support in the form of salaries for authors SR, MA, and MN, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. MT has worked as an external researcher affiliated to VTT through the research group (led by MN). The specific roles of these authors are articulated in the author contributions section.	Akerfelt M, 2015, ONCOTARGET, V6, P30035, DOI 10.18632/oncotarget.5046; Amat F, 2013, BIOINFORMATICS, V29, P373, DOI 10.1093/bioinformatics/bts706; Boykov Y, 2001, IEEE T PATTERN ANAL, V23, P1222, DOI 10.1109/34.969114; Boykov Y, 2004, IEEE T PATTERN ANAL, V26, P1124, DOI 10.1109/TPAMI.2004.60; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Danek O, 2009, LECT NOTES COMPUT SC, V5575, P410, DOI 10.1007/978-3-642-02230-2_42; Danuser G, 2011, CELL, V147, P973, DOI 10.1016/j.cell.2011.11.001; Dimopoulos S, 2014, BIOINFORMATICS, V30, P2644, DOI 10.1093/bioinformatics/btu302; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Gelasca ED, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-368; Gonzalez R. C., 2013, DIGITAL IMAGE PROCES, V2nd; Harma V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096426; Harma V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010431; Hoque MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079865; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Karagiannis GS, 2012, MOL CANCER RES, V10, P1403, DOI 10.1158/1541-7786.MCR-12-0307; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Keuper M, 2011, I S BIOMED IMAGING, P973, DOI 10.1109/ISBI.2011.5872565; Kolmogorov V, 2004, IEEE T PATTERN ANAL, V26, P147, DOI 10.1109/TPAMI.2004.1262177; Liang LC, 2007, 2007 IEEE/NIH LIFE SCIENCE SYSTEMS AND APPLICATIONS WORKSHOP, P9, DOI 10.1109/LSSA.2007.4400872; Liu AA, 2012, IEEE T MED IMAGING, V31, P359, DOI 10.1109/TMI.2011.2169495; Ljosa V, 2012, NAT METHODS, V9, P637, DOI 10.1038/nmeth.2083; Lou XH, 2012, PROC CVPR IEEE, P1012; Luck BL, 2005, IEEE T IMAGE PROCESS, V14, P1265, DOI 10.1109/TIP.2005.852460; Madar S, 2009, CARCINOGENESIS, V30, P20, DOI 10.1093/carcin/bgn232; Meas-Yedid V, 2002, INT C PATT RECOG, P796, DOI 10.1109/ICPR.2002.1044879; Mondal PP, 2007, J APPL PHYS, V102, DOI 10.1063/1.2770961; Otsu N, 1975, AUTOMATICA, V1, P62; Peng B, 2013, PATTERN RECOGN, V46, P1020, DOI 10.1016/j.patcog.2012.09.015; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Rajapakse JC, 2011, IEEE ENG MED BIO, P5128, DOI 10.1109/IEMBS.2011.6091270; Roberts TJ, 2010, MACH VISION APPL, V21, P921, DOI 10.1007/s00138-009-0207-x; Rother C, 2011, MARKOV RANDOM FIELDS FOR VISION AND IMAGE PROCESSING, P111; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sokolova M, 2009, INFORM PROCESS MANAG, V45, P427, DOI 10.1016/j.ipm.2009.03.002; Subramanian B, 2010, TISSUE ENG PT A, V16, P2821, DOI [10.1089/ten.tea.2009.0595, 10.1089/ten.TEA.2009.0595]; Szummer M, 2011, MARKOV RANDOM FIELDS FOR VISION AND IMAGE PROCESSING, P233; Tokunaga T, 2014, BIOINFORMATICS, V30, P43, DOI 10.1093/bioinformatics/btu271; Vicidomini G, 2009, J MICROSC-OXFORD, V234, P47, DOI 10.1111/j.1365-2818.2009.03150.x; Wang CH, 2013, COMPUT VIS IMAGE UND, V117, P1610, DOI 10.1016/j.cviu.2013.07.004; Warger WC, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2937468; Weigelt B, 2014, ADV DRUG DELIVER REV, V69, P42, DOI 10.1016/j.addr.2014.01.001; Zaritsky A, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-319; Zhu YQ, 2011, IEEE INT C BIOINFORM, P352, DOI 10.1109/BIBM.2011.104	45	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143798	10.1371/journal.pone.0143798	http://dx.doi.org/10.1371/journal.pone.0143798			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630674	Green Published, Green Submitted, gold			2022-12-27	WOS:000365926300101
J	Senger, S; Sapone, A; Fiorentino, MR; Mazzarella, G; Lauwers, GY; Fasano, A				Senger, Stefania; Sapone, Anna; Fiorentino, Maria Rosaria; Mazzarella, Giuseppe; Lauwers, Gregory Y.; Fasano, Alessio			Celiac Disease Histopathology Recapitulates Hedgehog Downregulation, Consistent with Wound Healing Processes Activation	PLOS ONE			English	Article							RESTRICTED T-CELLS; STEM-CELLS; SMALL-INTESTINE; SMOOTH-MUSCLE; INTERFERON-GAMMA; GENE-EXPRESSION; MOUSE INTESTINE; SONIC HEDGEHOG; IN-VITRO; CRYPT	Background In celiac disease (CD), intestinal epithelium damage occurs secondary to an immune insult and is characterized by blunting of the villi and crypt hyperplasia. Similarities between Hedgehog (Hh)/BMP4 downregulation, as reported in a mouse model, and CD histopathology, suggest mechanistic involvement of Hh/BMP4/WNT pathways in proliferation and differentiation of immature epithelial cells in the context of human intestinal homeostasis and regeneration after damage. Herein we examined the nature of intestinal crypt hyperplasia and involvement of Hh/BMP4 in CD histopathology. Methods and Findings Immunohistochemistry, qPCR and in situ hybridization were used to study a cohort of 24 healthy controls (HC) and 24 patients with diagnosed acute celiac disease (A-CD) intestinal biopsies. In A-CD we observed an increase in cells positive for Leucin-rich repeat-containing G protein-coupled receptor 5 (LGR5), an epithelial stem cell specific marker and expansion of WNT responding compartment. Further, we observed alteration in number and distribution of mesenchymal cells, predicted to be part of the intestinal stem cells niche. At the molecular level we found downregulation of indian hedgehog (IHH) and other components of the Hh pathway, but we did not observe a concurrent downregulation of BMP4. However, we observed upregulation of BMPs antagonists, gremlin 1 and gremlin 2. Conclusions Our data suggest that acute CD histopathology partially recapitulates the phenotype reported in Hh knockdown models. Specifically, Hh/BMP4 paradigm appears to be decoupled in CD, as the expansion of the immature cell population does not occur consequent to downregulation of BMP4. Instead, we provide evidence that upregulation of BMP antagonists play a key role in intestinal crypt hyperplasia. This study sheds light on the molecular mechanisms underlying CD histopathology and the limitations in the use of mouse models for celiac disease.	[Senger, Stefania; Sapone, Anna; Fiorentino, Maria Rosaria; Fasano, Alessio] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Mucosal Immunol & Biol Res,Children & Celiac, Charlestown, MA 02129 USA; [Sapone, Anna] Beth Israel Deaconess Med Ctr, Celiac Ctr, Div Gastroenterol, Dept Med, Boston, MA 02215 USA; [Sapone, Anna] Harvard Univ, Sch Med, Boston, MA USA; [Mazzarella, Giuseppe] CNR, Inst Food Sci, I-83100 Avellino, Italy; [Lauwers, Gregory Y.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR); Harvard University; Massachusetts General Hospital	Fasano, A (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Mucosal Immunol & Biol Res,Children & Celiac, Charlestown, MA 02129 USA.	afasano@mgh.harvard.edu	Fasano, Alessio/K-5486-2016; Fiorentino, Maria/AAV-9514-2020; Mazzarella, Giuseppe/GSO-3318-2022	Fasano, Alessio/0000-0002-2134-0261; Fiorentino, Maria R/0000-0001-5318-7313; Mazzarella, Giuseppe/0000-0002-7294-8277	NIH grant [R01DK048373]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048373] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors declare that the study entitled: "Celiac Disease Histopathology Recapitulates Hedgehog Downregulation, Consistent with Wound Healing Processes Activation" was funded exclusively by NIH grant, R01DK048373 to AF and there was no additional external funding received for this study.	Bajaj-Elliott M, 1998, J CLIN INVEST, V102, P1473, DOI 10.1172/JCI2792; Bardella MT, 2007, HISTOPATHOLOGY, V50, P465, DOI 10.1111/j.1365-2559.2007.02621.x; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2012, CELL STEM CELL, V11, P452, DOI 10.1016/j.stem.2012.09.009; Blache P, 2004, J CELL BIOL, V166, P37, DOI 10.1083/jcb.200311021; Buller NVJA, 2012, PHYSIOLOGY, V27, P148, DOI 10.1152/physiol.00003.2012; Capuano M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029094; Ciccocioppo R, 2005, LAB INVEST, V85, P397, DOI 10.1038/labinvest.3700225; Gentile Nicole M, 2012, Curr Gastroenterol Rep, V14, P380, DOI 10.1007/s11894-012-0276-2; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Korpe PS, 2012, TRENDS MOL MED, V18, P328, DOI 10.1016/j.molmed.2012.04.007; Kosinski C, 2007, P NATL ACAD SCI USA, V104, P15418, DOI 10.1073/pnas.0707210104; Kosinski C, 2010, GASTROENTEROLOGY, V139, P893, DOI 10.1053/j.gastro.2010.06.014; Lanzini A, 2009, ALIMENT PHARM THER, V29, P1299, DOI 10.1111/j.1365-2036.2009.03992.x; Liang R, 2013, CANADIAN J GASTROENT, V27, pe5; LUNDIN KEA, 1993, J EXP MED, V178, P187, DOI 10.1084/jem.178.1.187; Madison BB, 2005, DEVELOPMENT, V132, P279, DOI 10.1242/dev.01576; Malamut G, 2015, BEST PRACT RES CL GA, V29, P451, DOI 10.1016/j.bpg.2015.05.005; MARSH MN, 1992, GASTROENTEROLOGY, V102, P330, DOI 10.1016/0016-5085(92)91819-P; Mifflin RC, 2011, AM J PHYSIOL-GASTR L, V300, pG684, DOI 10.1152/ajpgi.00474.2010; NILSEN EM, 1995, GUT, V37, P766, DOI 10.1136/gut.37.6.766; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Powell DW, 2005, AM J PHYSIOL-GASTR L, V289, pG2, DOI 10.1152/ajpgi.00075.2005; Roberts DJ, 1998, DEVELOPMENT, V125, P2791; ROBERTS DJ, 1995, DEVELOPMENT, V121, P3163; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Savidge TC, 1996, GUT, V39, P185, DOI 10.1136/gut.39.2.185; SAVIDGE TC, 1995, GUT, V36, P321, DOI 10.1136/gut.36.3.321; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SELBY WS, 1983, CLIN EXP IMMUNOL, V52, P219; Shi ZD, 2010, J BIOL CHEM, V285, P32415, DOI 10.1074/jbc.M110.164863; Simmons JG, 2002, AM J PHYSIOL-GASTR L, V283, pG809, DOI 10.1152/ajpgi.00057.2002; Snippert HJ, 2009, GASTROENTEROLOGY, V136, P2187, DOI 10.1053/j.gastro.2009.03.002; Sukegawa A, 2000, DEVELOPMENT, V127, P1971; van Dop WA, 2010, GASTROENTEROLOGY, V139, P1665, DOI 10.1053/j.gastro.2010.07.045; Vanuytsel T, 2013, BBA-GEN SUBJECTS, V1830, P2410, DOI 10.1016/j.bbagen.2012.08.006; Verbeke S, 2002, J CLIN PATHOL, V55, P440, DOI 10.1136/jcp.55.6.440; Zacharias WJ, 2011, DEV BIOL, V355, P152, DOI 10.1016/j.ydbio.2011.04.025; Zacharias WJ, 2010, GASTROENTEROLOGY, V138, P2368, DOI 10.1053/j.gastro.2010.02.057; Zuniga A, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-23	42	19	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144634	10.1371/journal.pone.0144634	http://dx.doi.org/10.1371/journal.pone.0144634			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26649570	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903300063
J	Zheng, YL; Sun, YP; Zhang, H; Liu, WJ; Jiang, R; Li, WY; Zheng, YH; Zhang, ZG				Zheng, Yu-Liang; Sun, Yang-Peng; Zhang, Hong; Liu, Wen-Jing; Jiang, Rui; Li, Wen-Yu; Zheng, You-Hua; Zhang, Zhi-Guang			Mesenchymal Stem Cells Obtained from Synovial Fluid Mesenchymal Stem Cell-Derived Induced Pluripotent Stem Cells on a Matrigel Coating Exhibited Enhanced Proliferation and Differentiation Potential	PLOS ONE			English	Article							STROMAL CELLS; BONE-MARROW; DERIVATION; PRECURSORS; INDUCTION; CULTURES; TISSUES	Induced pluripotent stem cell-derived mesenchymal stem cells (iPSC-MSCs) serve as a promising source for cell-based therapies in regenerative medicine. However, optimal methods for transforming iPSCs into MSCs and the characteristics of iPSC-MSCs obtained from different methods remain poorly understood. In this study, we developed a one-step method for obtaining iPSC-MSCs (CD146+STRO-1+MSCs) from human synovial fluid MSC-derived induced iPSCs (SFMSC-iPSCs). CD146-STRO-1-SFMSCs were reprogrammed into iPSCs by transduction with lentivirus-mediated Sox2, Oct-3/4, klf4, and c-Myc. SFMSC-iPSCs were maintained with mTeSR1 medium in Matrigel-coated culture plates. Single dissociated cells were obtained by digesting the SFMSC-iPSCs with trypsin. The dissociated cells were then plated into Matrigel-coated culture plate with alpha minimum essential medium supplemented with 10% fetal bovine serum, 1x Glutamax, and the ROCK inhibitor Y-27632. Cells were then passaged in standard cell culture plates with alpha minimum essential medium supplemented with 10% fetal bovine serum and 1x Glutamax. After passaging in vitro, the cells showed a homogenous spindle-shape similar to their ancestor cells (SFMSCs), but with more robust proliferative activity. Flow cytometric analysis revealed typical MSC surface markers, including expression of CD73, CD90, CD105, and CD44 and lack of CD45, CD34, CD11b, CD19, and HLA-DR. However, these cells were positive for CD146 and stro-1, which the ancestor cells were not. Moreover, the cells could also be induced to differentiate in osteogenic, chondrogenic, and adipogenic lineages in vitro. The differentiation potential was improved compared with the ancestor cells in vitro. The cells were not found to exhibit oncogenicity in vivo. Therefore, the method presented herein facilitated the generation of STRO-1+CD146+MSCs from SFMSC-iPSCs exhibiting enhanced proliferation and differentiation potential.	[Zheng, Yu-Liang; Sun, Yang-Peng; Zhang, Hong; Liu, Wen-Jing; Zheng, You-Hua; Zhang, Zhi-Guang] Sun Yat Sen Univ, Guanghua Sch Stomatol, Hosp Stomatol, Guangdong Prov Key Lab Stomatol, Guangzhou 510275, Guangdong, Peoples R China; [Jiang, Rui; Li, Wen-Yu] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Wen-Jing] Sun Yat Sen Univ, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Zheng, Yu-Liang] Guangdong Second Tradit Chinese Med Hosp, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Sun, YP (corresponding author), Sun Yat Sen Univ, Guanghua Sch Stomatol, Hosp Stomatol, Guangdong Prov Key Lab Stomatol, Guangzhou 510275, Guangdong, Peoples R China.	sunyp@mail2.sysu.edu.cn; kouqiangzzg@hotmail.com			National Science Foundation of China [81271115]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Science Foundation of China (81271115), http://isisn.nsfc.gov.cn/egrantweb/.	Bakopoulou A, 2013, ARCH ORAL BIOL, V58, P1556, DOI 10.1016/j.archoralbio.2013.06.018; Barberi T, 2005, PLOS MED, V2, P554, DOI 10.1371/journal.pmed.0020161; Barbosa I, 2003, GLYCOBIOLOGY, V13, P647, DOI 10.1093/glycob/cwg082; Bensidhoum M, 2004, BLOOD, V103, P3313, DOI 10.1182/blood-2003-04-1121; Brown SE, 2009, CELLS TISSUES ORGANS, V189, P256, DOI 10.1159/000151746; Chen YS, 2012, STEM CELL TRANSL MED, V1, P83, DOI 10.5966/sctm.2011-0022; Choo A, 2011, METHODS MOL BIOL, V690, P175, DOI 10.1007/978-1-60761-962-8_12; de Bruin T, 2005, AM J VET RES, V66, P1903, DOI 10.2460/ajvr.2005.66.1903; Devine SM, 2003, BLOOD, V101, P2999, DOI 10.1182/blood-2002-06-1830; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Gadkari R, 2014, REGEN MED, V9, P453, DOI [10.2217/RME.14.13, 10.2217/rme.14.13]; Harvanova D, 2011, FOLIA BIOL-PRAGUE, V57, P119; Hynes K, 2016, METHODS MOL BIOL, V1357, P353, DOI 10.1007/7651_2014_142; Hynes K, 2014, STEM CELLS DEV, V23, P1084, DOI 10.1089/scd.2013.0111; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Keung AJ, 2010, ANNU REV CELL DEV BI, V26, P533, DOI 10.1146/annurev-cellbio-100109-104042; Kim YK, 2012, J CRANIO MAXILL SURG, V40, pE337, DOI 10.1016/j.jcms.2012.02.002; Koyama N, 2011, LIFE SCI, V89, P741, DOI 10.1016/j.lfs.2011.09.005; Lee EJ, 2010, TISSUE ENG PT A, V16, P705, DOI 10.1089/ten.tea.2008.0596; Lei M, 2014, BIOMATERIALS, V35, P6332, DOI 10.1016/j.biomaterials.2014.04.071; Li Y, 2014, CELL TRANSPLANT, V23, P776; Lian QZ, 2007, STEM CELLS, V25, P425, DOI 10.1634/stemcells.2006-0420; Lian QZ, 2010, CIRCULATION, V121, P1113, DOI 10.1161/CIRCULATIONAHA.109.898312; Liu YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033225; Mahmood A, 2012, STEM CELLS DEV, V21, P3114, DOI 10.1089/scd.2012.0035; Mundra V, 2013, MOL PHARMACEUT, V10, P77, DOI 10.1021/mp3005148; Nasef A, 2009, INT J LAB HEMATOL, V31, P9, DOI 10.1111/j.1751-553X.2007.00997.x; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Olivier EN, 2006, STEM CELLS, V24, P1914, DOI 10.1634/stemcells.2005-0648; Papadopoulou A, 2012, ANN RHEUM DIS, V71, P1733, DOI 10.1136/annrheumdis-2011-200985; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Russell KC, 2013, TISSUE ENG PT A, V19, P2253, DOI [10.1089/ten.tea.2012.0649, 10.1089/ten.TEA.2012.0649]; Sakaguchi Y, 2005, ARTHRITIS RHEUM-US, V52, P2521, DOI 10.1002/art.21212; SIMMONS PJ, 1991, BLOOD, V78, P55; Stewart K, 1999, J BONE MINER RES, V14, P1345, DOI 10.1359/jbmr.1999.14.8.1345; Sun Y, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/214841; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Trivedi P, 2008, EXP HEMATOL, V36, P350, DOI 10.1016/j.exphem.2007.10.007; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wei HM, 2012, STEM CELL RES, V9, P87, DOI 10.1016/j.scr.2012.04.003; Wu RR, 2013, HUM CELL, V26, P19, DOI 10.1007/s13577-011-0022-3; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	45	13	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144226	10.1371/journal.pone.0144226	http://dx.doi.org/10.1371/journal.pone.0144226			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26649753	gold, Green Submitted, Green Published			2022-12-27	WOS:000366903300040
J	Berrou, E; Kauskot, A; Adam, F; Harel, A; Legendre, P; Bombled, CL; Rothschild, C; Prevost, N; Christophe, OD; Lenting, PJ; Denis, CV; Rosa, JP; Bryckaert, M				Berrou, Eliane; Kauskot, Alexandre; Adam, Frederic; Harel, Amelie; Legendre, Paulette; Bombled, Cecile Lavenu; Rothschild, Chantal; Prevost, Nicolas; Christophe, Olivier D.; Lenting, Peter J.; Denis, Cecile V.; Rosa, Jean-Philippe; Bryckaert, Marijke			Apoptotic Platelet Events Are Not Observed in Severe von Willebrand Disease-Type 2B Mutation p.V1316M	PLOS ONE			English	Article							VONWILLEBRAND DISEASE; THROMBOCYTOPENIA	Thrombocytopenia and increased platelet clearance observed in von Willebrand diseasetype 2B (VWD-2B) may be explained by platelet apoptosis triggered by the constitutive binding of VWF to its receptor, glycoprotein Ib (GPIb). Apoptosis was assessed in platelets from two patients with a severe VWD-2B mutation VWF/p.V1316M and from mice transiently expressing VWF/p.V1316M. We now report that the VWD-2B mutation VWF/p. V1316M which binds spontaneously to its receptor GPIba does not induce apoptosis. In 2 unrelated patients (P1 and P2) exhibiting different VWF plasma levels (70% and 36%, respectively, compared with normal pooled human plasma given as 100%), inner transmembrane depolarization of mitochondria, characteristic of apoptotic events was undetectable in platelets, whether washed or in whole blood. No or a moderate phosphatidyl serine (PS) exposure as measured by annexin-V staining was observed for P1 and P2, respectively. Expression of pro-apoptotic proteins Bak and Bax, and caspase-3 activity were similar to control platelets. In the VWD-2B mouse model expressing high levels of mVWF/p.V1316M (423%), similar to what is found in inflammatory pathologies, no significant difference was observed between mice expressing mVWF/WT and mVWF/p.V1316M. These results strongly argue against apoptosis as a mechanism for the thrombocytopenia of severe VWD-2B exhibiting the VWF/p.V1316M mutation.	[Berrou, Eliane; Kauskot, Alexandre; Adam, Frederic; Harel, Amelie; Legendre, Paulette; Bombled, Cecile Lavenu; Christophe, Olivier D.; Lenting, Peter J.; Denis, Cecile V.; Rosa, Jean-Philippe; Bryckaert, Marijke] Univ Paris Saclay, Univ Paris 11, INSERM, UMR S 1176, F-94276 Le Kremlin Bicetre, France; [Bombled, Cecile Lavenu] AP HP, Serv Hematol Biol, Le Kremlin Bicetre, France; [Rothschild, Chantal] Hop Necker Enfants Malad, Ctr Hemophilie, Paris, France; [Prevost, Nicolas] Kyoto Gakuen Univ, Kameoka, Japan	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Bryckaert, M (corresponding author), Univ Paris Saclay, Univ Paris 11, INSERM, UMR S 1176, F-94276 Le Kremlin Bicetre, France.	marijke.bryckaert@inserm.fr	christophe, olivier/W-4268-2017; ROSA, JEAN-PHILIPPE/B-6245-2018; Denis, Cecile/A-7649-2011; Lenting, Peter/AAH-5663-2019; Kauskot, Alexandre/J-6794-2015; Lenting, Peter/F-8269-2013	christophe, olivier/0000-0002-9080-6336; ROSA, JEAN-PHILIPPE/0000-0001-7342-0389; Denis, Cecile/0000-0001-5152-9156; Lenting, Peter/0000-0002-7937-3429; Kauskot, Alexandre/0000-0002-4064-8114; Lenting, Peter/0000-0002-7937-3429; ADAM, Frederic/0000-0001-6603-2687; Bryckaert, Marijke/0000-0003-3398-0976	INSERM; Agence Nationale de la Recherche [ANR 11 BSV101001]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR))	This study was financially supported by grants from INSERM and Agence Nationale de la Recherche (ANR 11 BSV101001 to C.V Denis).	Baumgartner R, 2013, J PROTEOMICS, V94, P540, DOI 10.1016/j.jprot.2013.10.015; Bryckaert M, 2015, CELL MOL LIFE SCI, V72, P307, DOI 10.1007/s00018-014-1743-8; Casari C, 2013, J CLIN INVEST, V123, P5071, DOI 10.1172/JCI69458; Casari C, 2013, BLOOD, V122, P2893, DOI 10.1182/blood-2013-03-493312; Federici AB, 2009, BLOOD, V113, P526, DOI 10.1182/blood-2008-04-152280; GINSBURG D, 1992, BLOOD, V79, P2507; Li S, 2010, THROMB HAEMOSTASIS, V8, P341, DOI [10.1111/j.1538-7836.2009.03653.x, DOI 10.1111/J.1538-7836.2009.03653.X]; Nurden P, 2000, BRIT J HAEMATOL, V110, P704, DOI 10.1046/j.1365-2141.2000.02246.x; Nurden P, 2010, BLOOD, V115, P2649, DOI 10.1182/blood-2009-07-231886; OKITA JR, 1989, BLOOD, V74, P715; Rand ML, 2010, AM J HEMATOL, V85, P584, DOI 10.1002/ajh.21768; Rayes J, 2010, BLOOD, V115, P4870, DOI 10.1182/blood-2009-11-254193; Ruggeri ZM, 2007, THROMB HAEMOSTASIS, V98, P55, DOI 10.1160/TH07-04-0279; van der Wal DE, 2010, J THROMB HAEMOST, V8, P2554, DOI 10.1111/j.1538-7836.2010.04043.x	14	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0143896	10.1371/journal.pone.0143896	http://dx.doi.org/10.1371/journal.pone.0143896			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YV	26645283	gold, Green Submitted, Green Published			2022-12-27	WOS:000366903100009
J	Yuan, HJ; Houck, KL; Tian, Y; Bharadwaj, U; Hull, K; Zhou, Z; Zhou, MZ; Wu, XP; Tweardy, DJ; Romo, D; Fu, XY; Zhang, YJ; Zhang, JN; Dong, JF				Yuan, Hengjie; Houck, Katie L.; Tian, Ye; Bharadwaj, Uddalak; Hull, Ken; Zhou, Zhou; Zhou, Mingzhao; Wu, Xiaoping; Tweardy, David J.; Romo, Daniel; Fu, Xiaoyun; Zhang, Yanjun; Zhang, Jianning; Dong, Jing-fei			Piperlongumine Blocks JAK2-STAT3 to Inhibit Collagen-Induced Platelet Reactivity Independent of Reactive Oxygen Species	PLOS ONE			English	Article							SIGNAL TRANSDUCER; TRANSCRIPTION; ACTIVATION; STAT3; INTERLEUKIN-6; CONSTITUENTS; AGGREGATION; TYROSINE; FRUIT	Background Piperlongumine (PL) is a compound isolated from the piper longum plant. It possesses anti-cancer activities through blocking the transcription factor STAT3 and by inducing reactive oxygen species (ROS) in cancer, but not normal cells. It also inhibits platelet aggregation induced by collagen, but the underlying mechanism is not known. Objective We conducted in vitro experiments to test the hypothesis that PL regulates a non-transcriptional activity of STAT3 to specifically reduce the reactivity of human platelets to collagen. Results PL dose-dependently blocked collagen-induced platelet aggregation, calcium influx, CD62p expression and thrombus formation on collagen with a maximal inhibition at 100 mu M. It reduced platelet microvesiculation induced by collagen. PL blocked the activation of JAK2 and STAT3 in collagen-stimulated platelets. This inhibitory effect was significantly reduced in platelets pretreated with a STAT3 inhibitor. Although PL induced ROS production in platelets; quenching ROS using excessive reducing agents: 20 mu M GSH and 0.5 mM L-Cysteine, did not block the inhibitory effects. The NADPH oxidase inhibitor Apocynin also had no effect. Conclusions PL inhibited collagen-induced platelet reactivity by targeting the JAK2-STAT3 pathway. We also provide experimental evidence that PL and collagen induce different oxidants that have differential effects on platelets. Studying these differential effects may uncover new mechanisms of regulating platelet functions by oxidants in redox signals.	[Yuan, Hengjie; Houck, Katie L.; Tian, Ye; Zhou, Zhou; Wu, Xiaoping; Fu, Xiaoyun; Dong, Jing-fei] Bloodworks Northwest Res Inst, Seattle, WA USA; [Yuan, Hengjie; Tian, Ye; Zhang, Jianning] Tianjin Med Univ, Tianjin Neurol Inst, Gen Hosp, Tianjin, Peoples R China; [Bharadwaj, Uddalak; Tweardy, David J.] Baylor Coll Med, Div Infect Dis, Dept Med, Houston, TX 77030 USA; [Hull, Ken; Zhou, Mingzhao; Romo, Daniel] Texas A&M Univ, Nat Prod LINCHPIN Lab, College Stn, TX USA; [Hull, Ken; Zhou, Mingzhao; Romo, Daniel] Texas A&M Univ, Dept Chem, College Stn, TX USA; [Zhang, Yanjun] Univ London Imperial Coll Sci Technol & Med, Div Med, London, England; [Fu, Xiaoyun; Dong, Jing-fei] Univ Washington, Sch Med, Div Hematol, Dept Med, Seattle, WA 98195 USA	Tianjin Medical University; Baylor College of Medicine; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Imperial College London; University of Washington; University of Washington Seattle	Zhang, JN (corresponding author), Tianjin Med Univ, Tianjin Neurol Inst, Gen Hosp, Tianjin, Peoples R China.	jfdong@BloodworksNW.org; jianningzhang@hotmail.com	Tweardy, David/L-3929-2019; zhang, yanjun/S-5114-2019	Zhang, Yanjun/0000-0002-3123-1405; Romo, Daniel/0000-0003-3805-092X; Yuan, Hengjie/0000-0001-7132-5572	National Heart, Lung, and Blood Institute [HL71895, HL085769]; National Cancer Institute [CA149783]; Cancer Prevention and Research Institute of Texas [RP100421]; Tianjin Science and Technology Support Program of China [14ZCZDSY00020]; Natural Science Foundation of China [13JCYBJC21900, 12JCYBJC31500]; John S. Dunn Gulf Coast Consortium for Chemical Genomics Discovery Project; Tianjin Natural Science Foundation of China [13JCYBJC21900]; Tianjin Municipal Science and Technology Project [14ZCZDSY00020]; Vice President for Research, College of Science, and Department of Chemistry at Texas AM University; NATIONAL CANCER INSTITUTE [R21CA149783] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085769, R01HL071895] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Prevention and Research Institute of Texas; Tianjin Science and Technology Support Program of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); John S. Dunn Gulf Coast Consortium for Chemical Genomics Discovery Project; Tianjin Natural Science Foundation of China; Tianjin Municipal Science and Technology Project; Vice President for Research, College of Science, and Department of Chemistry at Texas AM University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by 1) grants HL71895 and HL085769 from the National Heart, Lung, and Blood Institute and CA149783 from the National Cancer Institute; 2) the Cancer Prevention and Research Institute of Texas (RP100421); 3) the Tianjin Science and Technology Support Program of China (No. 14ZCZDSY00020); 4) the Natural Science Foundation of China (No. 13JCYBJC21900 and 12JCYBJC31500); 5) the John S. Dunn Gulf Coast Consortium for Chemical Genomics Discovery Project; and 6) Tianjin Natural Science Foundation of China (No. 13JCYBJC21900) and Tianjin Municipal Science and Technology Project (No. 14ZCZDSY00020).; We thank the Vice President for Research, College of Science, and Department of Chemistry at Texas A&M University for seed funding to the Natural Products LINCHPIN Laboratory.	Adams DJ, 2012, P NATL ACAD SCI USA, V109, P15115, DOI 10.1073/pnas.1212802109; Arthur JF, 2012, J THROMB HAEMOST, V10, P1133, DOI 10.1111/j.1538-7836.2012.04734.x; Arthur JF, 2008, PLATELETS, V19, P1, DOI 10.1080/09537100701817224; Begonja AJ, 2005, BLOOD, V106, P2757, DOI 10.1182/blood-2005-03-1047; Bezerra DP, 2013, EUR J PHARM SCI, V48, P453, DOI 10.1016/j.ejps.2012.12.003; Bharadwaj U, 2014, ONCOGENE IN PRESS; BOSIN TR, 1991, BIOCHEM PHARMACOL, V41, P967, DOI 10.1016/0006-2952(91)90203-H; Essex DW, 2003, BIOCHEMISTRY-US, V42, P129, DOI 10.1021/bi0205045; Gkaliagkousi E, 2007, CIRC RES, V101, P654, DOI 10.1161/CIRCRESAHA.107.158410; Hu H, 2005, THROMB RES, V116, P241, DOI 10.1016/j.thromres.2004.12.015; Iwashita M, 2007, EUR J PHARMACOL, V570, P38, DOI 10.1016/j.ejphar.2007.05.073; Jarvius M, 2013, BIOCHEM BIOPH RES CO, V431, P117, DOI 10.1016/j.bbrc.2013.01.017; Jin Z, 2009, PHYTOTHER RES, V23, P1194, DOI 10.1002/ptr.2630; Kim KS, 2006, PIGM CELL RES, V19, P90, DOI 10.1111/j.1600-0749.2005.00281.x; Kumar S, 2011, J ACUPUNCT MERIDIAN, V4, P134, DOI 10.1016/S2005-2901(11)60020-4; Lee SE, 2007, FOOD ADDIT CONTAM A, V24, P391, DOI 10.1080/02652030601053147; LUTTICKEN C, 1994, SCIENCE, V263, P89, DOI 10.1126/science.8272872; Mieyal JJ, 2012, ANTIOXID REDOX SIGN, V16, P471, DOI 10.1089/ars.2011.4454; MILSOM JP, 1979, METABOLISM, V28, P313, DOI 10.1016/0026-0495(79)90101-X; Morikawa T, 2004, PLANTA MED, V70, P152, DOI 10.1055/s-2004-815493; Park BS, 2007, PHYTOMEDICINE, V14, P853, DOI 10.1016/j.phymed.2007.06.011; Park BS, 2008, PHYTOTHER RES, V22, P1195, DOI 10.1002/ptr.2432; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Reich NC, 2006, NAT REV IMMUNOL, V6, P602, DOI 10.1038/nri1885; Silva DR, 2009, MOLECULES, V14, P1171, DOI 10.3390/molecules14031171; Son DJ, 2012, BIOCHEM BIOPH RES CO, V427, P349, DOI 10.1016/j.bbrc.2012.09.061; WEGENKA UM, 1993, MOL CELL BIOL, V13, P276, DOI 10.1128/MCB.13.1.276; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Zhang HL, 2008, BIOORG MED CHEM LETT, V18, P3272, DOI 10.1016/j.bmcl.2008.04.052; Zhang YJ, 2013, THROMB HAEMOSTASIS, V110, P331, DOI 10.1160/TH12-11-0853; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422; Zhou Z, 2013, CIRCULATION, V127, P476, DOI 10.1161/CIRCULATIONAHA.112.132126	32	13	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0143964	10.1371/journal.pone.0143964	http://dx.doi.org/10.1371/journal.pone.0143964			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YV	26645674	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903100012
J	Chechenova, MB; Maes, S; Cripps, RM				Chechenova, Maria B.; Maes, Sara; Cripps, Richard M.			Expression of the Troponin C at 41C Gene in Adult Drosophila Tubular Muscles Depends upon Both Positive and Negative Regulatory Inputs	PLOS ONE			English	Article							MYOCYTE ENHANCER FACTOR-2; TROPONIN-C; FLIGHT-MUSCLE; MEF2; TRANSCRIPTION; MELANOGASTER; TARGET; ISOFORMS; MYOSIN; IDENTIFICATION	Most animals express multiple isoforms of structural muscle proteins to produce tissues with different physiological properties. In Drosophila, the adult muscles include tubular-type muscles and the fibrillar indirect flight muscles. Regulatory processes specifying tubular muscle fate remain incompletely understood, therefore we chose to analyze the transcriptional regulation of TpnC41C, a Troponin C gene expressed in the tubular jump muscles, but not in the fibrillar flight muscles. We identified a 300-bp promoter fragment of TpnC41C sufficient for the fiber-specific reporter expression. Through an analysis of this regulatory element, we identified two sites necessary for the activation of the enhancer. Mutations in each of these sites resulted in 70% reduction of enhancer activity. One site was characterized as a binding site for Myocyte Enhancer Factor-2. In addition, we identified a repressive element that prevents activation of the enhancer in other muscle fiber types. Mutation of this site increased jump muscle-specific expression of the reporter, but more importantly reporter expression expanded into the indirect flight muscles. Our findings demonstrate that expression of the TpnC41C gene in jump muscles requires integration of multiple positive and negative transcriptional inputs. Identification of the transcriptional regulators binding the cis-elements that we identified will reveal the regulatory pathways controlling muscle fiber differentiation.	[Chechenova, Maria B.; Maes, Sara; Cripps, Richard M.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA	University of New Mexico	Cripps, RM (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.	rcripps@unm.edu			NIH/NIGMS (National Institutes of Health /Italian Association for Cancer Research) [GM061738]; NIH/NIGMS [GM061738, T34 GM008751]; Stephanie Ruby Undergraduate Fellowship; NIH (National Institutes of Health) grant from the Institute Development Award (IDeA) Program of NIGMS [P20 GM103452]; NIEHS (National Institute of Environmental Health Sciences) [ES06694]; NIH/NCI (National Institutes of Health/National Cancer Institute) [CA023074]; BIO5 Institute of the University of Arizona; NIH grant from the Institute Development Award (IDeA) Program of NIGMS [P20 GM103452]; NIEHS grant [ES06694]; NIH/NCI grant [CA023074]; NATIONAL CANCER INSTITUTE [P30CA023074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103452, R01GM061738, P30GM110907, T34GM008751] Funding Source: NIH RePORTER; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	NIH/NIGMS (National Institutes of Health /Italian Association for Cancer Research); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Stephanie Ruby Undergraduate Fellowship; NIH (National Institutes of Health) grant from the Institute Development Award (IDeA) Program of NIGMS; NIEHS (National Institute of Environmental Health Sciences)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH/NCI (National Institutes of Health/National Cancer Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); BIO5 Institute of the University of Arizona; NIH grant from the Institute Development Award (IDeA) Program of NIGMS; NIEHS grant; NIH/NCI grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This work was supported by GM061738 awarded by the NIH/NIGMS (National Institutes of Health /Italian Association for Cancer Research) to RMC. SM was supported by T34 GM008751 awarded by the NIH/NIGMS and by a Stephanie Ruby Undergraduate Fellowship. The authors acknowledge technical support from the Molecular Biology Facility at the Department of Biology, UNM, supported by NIH (National Institutes of Health) grant P20 GM103452 from the Institute Development Award (IDeA) Program of NIGMS. Mass spectrometry and proteomics data were acquired by the Arizona Proteomics Consortium supported by NIEHS (National Institute of Environmental Health Sciences) grant ES06694 to the SWEHSC (Southwest Environmental Health Sciences Center (University of Arizona)), NIH/NCI (National Institutes of Health/National Cancer Institute) grant CA023074 to the UA Cancer Center and by the BIO5 Institute of the University of Arizona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Kyle Belozerov for advice on the pull-down assays. This work was supported by GM061738 awarded by the NIH/NIGMS to RMC. SM was supported by T34 GM008751 awarded by the NIH/NIGMS and by a Stephanie Ruby Undergraduate Fellowship. We acknowledge technical support from the Molecular Biology Facility at the Department of Biology, UNM, supported by NIH grant P20 GM103452 from the Institute Development Award (IDeA) Program of NIGMS. Mass spectrometry and proteomics data were acquired by the Arizona Proteomics Consortium supported by NIEHS grant ES06694 to the SWEHSC, NIH/NCI grant CA023074 to the UA Cancer Center and by the BIO5 Institute of the University of Arizona. The funders had no role in study design, data collection and analysis, decision to publish, nor preparation of the manuscript.	Allen DL, 2001, DEV BIOL, V229, P383, DOI 10.1006/dbio.2000.9974; ANDRES V, 1995, J BIOL CHEM, V270, P23246, DOI 10.1074/jbc.270.40.23246; Arredondo JJ, 2001, J BIOL CHEM, V276, P8278, DOI 10.1074/jbc.M009302200; Baker PW, 2005, GENETICS, V170, P1747, DOI 10.1534/genetics.105.041749; Barrio R, 1996, DEV GENES EVOL, V206, P315, DOI 10.1007/s004270050058; Belozerov VE, 2012, MOL CELL BIOL, V32, P3695, DOI 10.1128/MCB.00232-12; BERNSTEIN SI, 1993, INT REV CYTOL, V143, P63; Bessarab DA, 2008, DEV BIOL, V323, P216, DOI 10.1016/j.ydbio.2008.08.015; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Brunetti TM, 2015, DEV BIOL, V401, P299, DOI 10.1016/j.ydbio.2015.02.026; Bryantsev AL, 2012, DEV CELL, V23, P664, DOI 10.1016/j.devcel.2012.08.004; Bryantsev AL, 2012, DEV BIOL, V361, P191, DOI 10.1016/j.ydbio.2011.09.031; Cripps RM, 2004, DEV BIOL, V267, P536, DOI 10.1016/j.ydbio.2003.12.004; Cripps RM, 1998, GENE DEV, V12, P422, DOI 10.1101/gad.12.3.422; Cuomo A, 2014, METHODS MOL BIOL, V1188, P293, DOI 10.1007/978-1-4939-1142-4_21; Eldred CC, 2014, J MUSCLE RES CELL M, V35, P211, DOI 10.1007/s10974-014-9387-8; GOSSETT LA, 1989, MOL CELL BIOL, V9, P5022, DOI 10.1128/MCB.9.11.5022; Herranz R, 2004, GENE EXPR PATTERNS, V4, P183, DOI 10.1016/j.modgep.2003.09.008; HORTON RM, 1995, MOL BIOTECHNOL, V3, P93, DOI 10.1007/BF02789105; Huang Audrey M, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5198; Kawasaki H, 2005, CYTOTECHNOLOGY, V49, P67, DOI 10.1007/s10616-005-5414-3; Kelly KK, 2002, MECH DEVELOP, V110, P39, DOI 10.1016/S0925-4773(01)00586-X; Lania L, 1997, INT J BIOCHEM CELL B, V29, P1313, DOI 10.1016/S1357-2725(97)00094-0; Lieber RL, 2010, SKELETAL MUSCLE STRU; Lin MH, 1996, P NATL ACAD SCI USA, V93, P4623, DOI 10.1073/pnas.93.10.4623; Marin MC, 2004, MOL BIOL CELL, V15, P1185, DOI 10.1091/mbc.E03-09-0663; Mas JA, 2004, MOL BIOL CELL, V15, P1931, DOI 10.1091/mbc.e03-10-0729; Maves L, 2007, DEVELOPMENT, V134, P3371, DOI 10.1242/dev.003905; Mittler G, 2009, GENOME RES, V19, P284, DOI 10.1101/gr.081711.108; Morin S, 2000, EMBO J, V19, P2046, DOI 10.1093/emboj/19.9.2046; Morriss GR, 2011, MYOGENESIS METHODS P; PECKHAM M, 1990, J MUSCLE RES CELL M, V11, P203, DOI 10.1007/BF01843574; Qiu F, 2003, BIOCHEM J, V371, P811, DOI 10.1042/BJ20021814; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Sandmann T, 2006, DEV CELL, V10, P797, DOI 10.1016/j.devcel.2006.04.009; Sartorius CA, 1998, J CELL BIOL, V141, P943, DOI 10.1083/jcb.141.4.943; Schonbauer C, 2011, NATURE, V479, P406, DOI 10.1038/nature10559; Soler C, 2012, DEVELOPMENT, V139, P1270, DOI 10.1242/dev.077875; Tanaka KKK, 2008, MOL CELL BIOL, V28, P1616, DOI 10.1128/MCB.01169-07; Thummel CS, 1992, DROS INF SERV, V71, P150; Von Hosfstren J, 2008, DEVELOPMENT, V138, P4399; Wells L, 1996, EMBO J, V15, P4454, DOI 10.1002/j.1460-2075.1996.tb00822.x; Yao ZZ, 2013, BIOL OPEN, V2, P546, DOI 10.1242/bio.20133921; Zinzen RP, 2009, NATURE, V462, P65, DOI 10.1038/nature08531	44	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144615	10.1371/journal.pone.0144615	http://dx.doi.org/10.1371/journal.pone.0144615			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641463	Green Submitted, gold, Green Published			2022-12-27	WOS:000366902700149
J	Incio, J; Suboj, P; Chin, SM; Vardam-Kaur, T; Liu, H; Hato, T; Babykutty, S; Chen, I; Deshpande, V; Jain, RK; Fukumura, D				Incio, Joao; Suboj, Priya; Chin, Shan M.; Vardam-Kaur, Trupti; Liu, Hao; Hato, Tai; Babykutty, Suboj; Chen, Ivy; Deshpande, Vikram; Jain, Rakesh K.; Fukumura, Dai			Metformin Reduces Desmoplasia in Pancreatic Cancer by Reprogramming Stellate Cells and Tumor-Associated Macrophages	PLOS ONE			English	Article							HIGH-ENERGY DIET; ANTIDIABETIC DRUG METFORMIN; SP TRANSCRIPTION-FACTORS; IN-VIVO; DUCTAL ADENOCARCINOMA; MESENCHYMAL TRANSITION; CHRONIC INFLAMMATION; INSULIN-RESISTANCE; DIABETES-MELLITUS; CARCINOMA GROWTH	Background Pancreatic ductal adenocarcinoma (PDAC) is a highly desmoplastic tumor with a dismal prognosis for most patients. Fibrosis and inflammation are hallmarks of tumor desmoplasia. We have previously demonstrated that preventing the activation of pancreatic stellate cells (PSCs) and alleviating desmoplasia are beneficial strategies in treating PDAC. Metformin is a widely used glucose-lowering drug. It is also frequently prescribed to diabetic pancreatic cancer patients and has been shown to associate with a better outcome. However, the underlying mechanisms of this benefit remain unclear. Metformin has been found to modulate the activity of stellate cells in other disease settings. In this study, we examine the effect of metformin on PSC activity, fibrosis and inflammation in PDACs. Methods/Results In overweight, diabetic PDAC patients and pre-clinical mouse models, treatment with metformin reduced levels of tumor extracellular matrix (ECM) components, in particular hyaluronan (HA). In vitro, we found that metformin reduced TGF-beta signaling and the production of HA and collagen-I in cultured PSCs. Furthermore, we found that metformin alleviates tumor inflammation by reducing the expression of inflammatory cytokines including IL-1 beta as well as infiltration and M2 polarization of tumor-associated macrophages (TAMs) in vitro and in vivo. These effects on macrophages in vitro appear to be associated with a modulation of the AMPK/STAT3 pathway by metformin. Finally, we found in our preclinical models that the alleviation of desmoplasia by metformin was associated with a reduction in ECM remodeling, epithelial-to-mesenchymal transition (EMT) and ultimately systemic metastasis. Conclusion Metformin alleviates the fibro-inflammatory microenvironment in obese/diabetic individuals with pancreatic cancer by reprogramming PSCs and TAMs, which correlates with reduced disease progression. Metformin should be tested/explored as part of the treatment strategy in overweight diabetic PDAC patients.	[Incio, Joao; Suboj, Priya; Chin, Shan M.; Vardam-Kaur, Trupti; Liu, Hao; Hato, Tai; Babykutty, Suboj; Chen, Ivy; Jain, Rakesh K.; Fukumura, Dai] Harvard Univ, Sch Med, Massachusetts Gen Hosp,Res Inst, Edwin L Steele Labs,Dept Radiat Oncol, Boston, MA 02115 USA; [Incio, Joao] Hosp Sao Joao, Dept Internal Med, Oporto, Portugal; [Incio, Joao] Univ Porto, Fac Med, Inst Innovat & Res Heath,I3S, Metab Nutr & Endocrinol Grp,Dept Biochem, P-4100 Oporto, Portugal; [Suboj, Priya] St Xaviers Coll, Dept Bot & Biotechnol, Trivandrum, Kerala, India; [Liu, Hao] Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA 02115 USA; [Hato, Tai] Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan; [Babykutty, Suboj] Mar Ivanios Coll, Dept Zool, Trivandrum, Kerala, India; [Chen, Ivy] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Deshpande, Vikram] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Sao Joao Hospital; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Harvard University; Harvard Medical School; Keio University; Harvard University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Jain, RK (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp,Res Inst, Edwin L Steele Labs,Dept Radiat Oncol, Boston, MA 02115 USA.	jain@steele.mgh.harvard.edu; dai@steele.mgh.harvard.edu	Incio, Joao/A-1550-2017; Chen, Ivy/N-8231-2019; Hato, Tai/AAN-2940-2020; BABYKUTTY, SUBOJ/R-3723-2017; Liu, Hao/GVS-9284-2022; Jain, Rakesh K/I-1384-2017	Incio, Joao/0000-0002-0259-1356; Hato, Tai/0000-0002-1319-505X; Jain, Rakesh K/0000-0001-7571-3548; Liu, Hao/0000-0002-9262-5774; Babykutty, Suboj/0000-0002-1376-6959	National Institutes of Health [R35-CA197743, CA80124, CA85140, CA96915, CA115767, CA126642]; Lustgarten Foundation; Foundation for Science and Technology (Portugal); NATIONAL CANCER INSTITUTE [R01CA096915, P01CA080124, R01CA085140, R01CA126642, R24CA085140, R01CA115767, R35CA197743] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lustgarten Foundation; Foundation for Science and Technology (Portugal)(Portuguese Foundation for Science and Technology); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (http://nih.gov/; R35-CA197743, CA80124, CA85140, CA96915, CA115767, and CA126642 to RKJ and DF), the Lustgarten Foundation (http://www.lustgarten.org/; research grant to RKJ) and the Foundation for Science and Technology (http://www.fct.pt/; Portugal, POPH/FSE funding program, fellowship and research grant to JI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algire C, 2011, ONCOGENE, V30, P1174, DOI 10.1038/onc.2010.483; Algire C, 2008, ENDOCR-RELAT CANCER, V15, P833, DOI 10.1677/ERC-08-0038; Algire C, 2010, ENDOCR-RELAT CANCER, V17, P351, DOI 10.1677/ERC-09-0252; American Cancer Society, 2015, CANC FACTS FIG; Bao B, 2011, BBA-REV CANCER, V1815, P135, DOI 10.1016/j.bbcan.2010.11.003; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Bartosch-Harlid A, 2010, PANCREATOLOGY, V10, P423, DOI 10.1159/000264676; Calle EE, 2004, ONCOGENE, V23, P6365, DOI 10.1038/sj.onc.1207751; Chauhan VP, 2014, CANCER CELL, V26, P14, DOI 10.1016/j.ccr.2014.06.003; Chauhan VP, 2013, NAT MATER, V12, P958, DOI 10.1038/nmat3792; Chauhan VP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3516; Chen SJ, 2015, CURR ONCOL, V22, pE11, DOI 10.3747/co.22.2150; Choi YK, 2013, MOL CELLS, V36, P279, DOI 10.1007/s10059-013-0169-8; CHOW WH, 1995, J NATL CANCER I, V87, P930, DOI 10.1093/jnci/87.12.930; Cifarelli V, 2015, DIABETES, V64, P1632, DOI 10.2337/db14-1132; Cirri P, 2011, AM J CANCER RES, V1, P482; Costa Carla, 2007, Angiogenesis, V10, P149, DOI 10.1007/s10456-007-9074-0; Cufi S, 2010, CELL CYCLE, V9, P4461, DOI 10.4161/cc.9.22.14048; Franco CCD, 2014, CELL PHYSIOL BIOCHEM, V34, P1920, DOI 10.1159/000366390; Diop-Frimpong B, 2011, P NATL ACAD SCI USA, V108, P2909, DOI 10.1073/pnas.1018892108; Dowling RJO, 2012, J MOL ENDOCRINOL, V48, pR31, DOI 10.1530/JME-12-0007; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Feig C, 2012, CLIN CANCER RES, V18, P4266, DOI 10.1158/1078-0432.CCR-11-3114; Foretz M, 2014, CELL METAB, V20, P953, DOI 10.1016/j.cmet.2014.09.018; Fukumura D, 2003, CIRC RES, V93, pE88, DOI 10.1161/01.RES.0000099243.20096.FA; Furstenberger G, 2002, LANCET ONCOL, V3, P298, DOI 10.1016/S1470-2045(02)00731-3; Genkinger JM, 2011, INT J CANCER, V129, P1708, DOI 10.1002/ijc.25794; Gilkes DM, 2014, NAT REV CANCER, V14, P430, DOI 10.1038/nrc3726; Godsland IF, 2010, CLIN SCI, V118, P315, DOI 10.1042/CS20090399; Gong J, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00426; Goodwin PJ, 2015, ANNU REV MED, V66, P281, DOI 10.1146/annurev-med-051613-012328; Goodwin PJ, 2011, BREAST, V20, pS31, DOI 10.1016/S0960-9776(11)70291-0; Gutschalk CM, 2013, CANCER MED-US, V2, P117, DOI 10.1002/cam4.20; Hirsch HA, 2013, P NATL ACAD SCI USA, V110, P972, DOI 10.1073/pnas.1221055110; Hori M, 2014, CLIN TRANSL GASTROEN, V5, DOI 10.1038/ctg.2014.5; Hursting SD, 2012, ANN NY ACAD SCI, V1271, P82, DOI 10.1111/j.1749-6632.2012.06737.x; Ijichi H, 2012, ONCOIMMUNOLOGY, V1, DOI 10.4161/onci.19402; Incio J, 2013, TUMOR ANGIOGENESIS REGULATORS, P411; Inman KS, 2014, WORLD J GASTROENTERO, V20, P11160, DOI 10.3748/wjg.v20.i32.11160; Isoda K, 2006, ARTERIOSCL THROM VAS, V26, P611, DOI 10.1161/01.ATV.0000201938.78044.75; Jain RK, 2014, ANNU REV BIOMED ENG, V16, P321, DOI 10.1146/annurev-bioeng-071813-105259; Jain RK, 2014, SCI AM, V310, P46, DOI 10.1038/scientificamerican0214-46; Jain RK, 2013, J CLIN ONCOL, V31, P2205, DOI 10.1200/JCO.2012.46.3653; Joost HG, 2014, DIABETES VASC DIS RE, V11, P390, DOI 10.1177/1479164114550813; Karnevi E, 2014, IMMUNOL CELL BIOL, V92, P543, DOI 10.1038/icb.2014.22; Kasenda B, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-728; Kisfalvi K, 2013, PANCREAS, V42, P781, DOI 10.1097/MPA.0b013e31827aec40; Kordes S, 2015, LANCET ONCOL, V16, P839, DOI 10.1016/S1470-2045(15)00027-3; Leone A, 2014, CANCER TREAT RES, V159, P355, DOI 10.1007/978-3-642-38007-5_21; Li DH, 2012, MOL CARCINOGEN, V51, P64, DOI 10.1002/mc.20771; Li DH, 2009, GASTROENTEROLOGY, V137, P482, DOI 10.1053/j.gastro.2009.04.013; Li DH, 2009, JAMA-J AM MED ASSOC, V301, P2553, DOI 10.1001/jama.2009.886; Li HL, 2014, AM J PHYSIOL-ENDOC M, V306, pE197, DOI 10.1152/ajpendo.00202.2013; Liu CY, 2013, LAB INVEST, V93, P844, DOI 10.1038/labinvest.2013.69; Liu J, 2010, J HUAZHONG U SCI-MED, V30, P222, DOI 10.1007/s11596-010-0218-x; Liu J, 2013, UROL ONCOL-SEMIN ORI, V31, P264, DOI 10.1016/j.urolonc.2011.01.003; Mace TA, 2013, CANCER RES, V73, P3007, DOI 10.1158/0008-5472.CAN-12-4601; Martin TL, 2006, J BIOL CHEM, V281, P18933, DOI 10.1074/jbc.M512831200; Martinez-Outschoorn UE, 2010, CELL CYCLE, V9, P3256, DOI 10.4161/cc.9.16.12553; Mashhedi H, 2011, CELL CYCLE, V10, P2770, DOI 10.4161/cc.10.16.16219; Mathsyaraja H, 2015, ONCOGENE, V34, P3651, DOI 10.1038/onc.2014.294; McCarroll JA, 2014, FRONT PHYSIOL, V5, DOI [10.3389/fphys.2014.00141, 10.3389/fphys.2014.00002]; Metlakunta AS, 2008, ENDOCRINOLOGY, V149, P1121, DOI 10.1210/en.2007-1307; Mohammed A, 2013, TRANSL ONCOL, V6, P649, DOI 10.1593/tlo.13556; Montgomery MK, 2013, DIABETOLOGIA, V56, P1129, DOI 10.1007/s00125-013-2846-8; Moore T, 2008, CANCER PREV RES, V1, P65, DOI 10.1158/1940-6207.CAPR-08-0022; Nair V, 2014, J BIOL CHEM, V289, P27692, DOI 10.1074/jbc.M114.592576; Nair V, 2013, CARCINOGENESIS, V34, P2870, DOI 10.1093/carcin/bgt231; Noto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033411; Pandol S, 2009, CLIN GASTROENTEROL H, V7, pS44, DOI 10.1016/j.cgh.2009.07.039; Pannala R, 2009, LANCET ONCOL, V10, P88, DOI 10.1016/S1470-2045(08)70337-1; Parhar K, 2003, IMMUNOLOGY, V108, P502, DOI 10.1046/j.1365-2567.2003.01603.x; Perdiguero E, 2011, J CELL BIOL, V195, P307, DOI 10.1083/jcb.201104053; Phillips P., 2012, PANCREATIC CANC TUMO; Pischon T, 2008, P NUTR SOC, V67, P128, DOI 10.1017/S0029665108006976; Qu HM, 2015, CELL BIOCHEM BIOPHYS, V71, P931, DOI 10.1007/s12013-014-0287-8; Ramos-Nino Maria E, 2013, ISRN Oncol, V2013, P697521, DOI 10.1155/2013/697521; Rattan R, 2011, NEOPLASIA, V13, P483, DOI 10.1593/neo.11148; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rider P, 2011, J IMMUNOL, V187, P4835, DOI 10.4049/jimmunol.1102048; Roongruedee Chaiteerakij DBZ, 2015, METFORMIN USE DOES N; Sadeghi N, 2012, CLIN CANCER RES, V18, P2905, DOI 10.1158/1078-0432.CCR-11-2994; Shi WY, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.13; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Smyth S, 2006, NAT MED, V12, P75, DOI 10.1038/nm0106-75; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; Tam J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004974; Tan XL, 2015, PANCREAS, V44, P636, DOI 10.1097/MPA.0000000000000308; Vasamsetti SB, 2015, DIABETES, V64, P2028, DOI 10.2337/db14-1225; Wang Y, 2012, CURR MOL MED, V12, P331, DOI 10.2174/156652412799218868; Wu Y, 2008, J IMMUNOL, V181, P6384, DOI 10.4049/jimmunol.181.9.6384; Xu ZH, 2010, AM J PATHOL, V177, P2585, DOI 10.2353/ajpath.2010.090899; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Yu Ji Hoon, 2014, J Cancer Prev, V19, P97, DOI 10.15430/JCP.2014.19.2.97; Zechner D, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1047-x; [No title captured], DOI DOI 10.1136/BMJ.G3962	97	102	105	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0141392	10.1371/journal.pone.0141392	http://dx.doi.org/10.1371/journal.pone.0141392			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641266	Green Published, Green Submitted, gold			2022-12-27	WOS:000366902700004
J	Kotapalli, SS; Nallam, SSA; Nadella, L; Banerjee, T; Rode, HB; Mainkar, PS; Ummanni, R				Kotapalli, Sudha Sravanti; Nallam, Sri Satya Anila; Nadella, Lavanya; Banerjee, Tanmay; Rode, Haridas B.; Mainkar, Prathama S.; Ummanni, Ramesh			Identification of New Molecular Entities (NMEs) as Potential Leads against Tuberculosis from Open Source Compound Repository	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; DRUG DISCOVERY; BACTERICIDAL ACTIVITIES; MEDICINAL CHEMISTRY; INHIBITORS; COMBINATORIAL; SMEGMATIS; EXPOSURE; GENOMICS; LIBRARY	The purpose of this study was to provide a number of diverse and promising early-lead compounds that will feed into the drug discovery pipeline for developing new antitubercular agents. The results from the phenotypic screening of the open-source compound library against Mycobacterium smegmatis and Mycobacterium bovis (BCG) with hit validation against M. tuberculosis (H37Rv) have identified novel potent hit compounds. To determine their druglikeness, a systematic analysis of physicochemical properties of the hit compounds has been performed using cheminformatics tools. The hit molecules were analysed by clustering based on their chemical finger prints and structural similarity determining their chemical diversity. The hit compound library is also filtered for druglikeness based on the physicochemical descriptors following Lipinski filters. The robust filtration of hits followed by secondary screening against BCG, H37Rv and cytotoxicity evaluation has identified 12 compounds with potential against H37Rv (MIC range 0.4 to 12.5 mu M). Furthermore in cytotoxicity assays, 12 compounds displayed low cytotoxicity against liver and lung cells providing high therapeutic index > 50. To avoid any variations in activity due to the route of chemical synthesis, the hit compounds were re synthesized independently and confirmed for their potential against H37Rv. Taken together, the hits reported here provides copious potential starting points for generation of new leads eventually adds to drug discovery pipeline against tuberculosis.	[Kotapalli, Sudha Sravanti; Nallam, Sri Satya Anila; Ummanni, Ramesh] CSIR Indian Inst Chem Technol, Ctr Chem Biol, Hyderabad 500007, Andhra Pradesh, India; [Nadella, Lavanya; Rode, Haridas B.; Mainkar, Prathama S.] CSIR Indian Inst Chem Technol, Div Nat Prod Chem, Hyderabad 500007, Andhra Pradesh, India; [Banerjee, Tanmay] Syngene Int Ltd, Bangalore 560099, Karnataka, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Syngene International Limited	Mainkar, PS (corresponding author), CSIR Indian Inst Chem Technol, Div Nat Prod Chem, Hyderabad 500007, Andhra Pradesh, India.	prathama@iict.res.in; ummanni@iict.res.in			Open Source Drug Discovery (OSDD)-Council for Scientific and Industrial Research (CSIR), India [HCP-0001]; Syngene International Ltd.	Open Source Drug Discovery (OSDD)-Council for Scientific and Industrial Research (CSIR), India; Syngene International Ltd.	The authors thank Open Source Drug Discovery (OSDD)-Council for Scientific and Industrial Research (CSIR), India for financial support under project code HCP-0001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Syngene International Ltd. provided support in the form of salaries for authors [TB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahmad Z, 2005, FEMS MICROBIOL LETT, V251, P19, DOI 10.1016/j.femsle.2005.07.022; Altaf M, 2010, TUBERCULOSIS, V90, P333, DOI 10.1016/j.tube.2010.09.002; Ananthan S, 2009, TUBERCULOSIS, V89, P334, DOI 10.1016/j.tube.2009.05.008; Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; [Anonymous], 2008, TB SCI FACTS DRUG RE; Backman TWH, 2011, NUCLEIC ACIDS RES, V39, pW486, DOI 10.1093/nar/gkr320; Bakker-Woudenberg IAJM, 2005, ANTIMICROB AGENTS CH, V49, P2387, DOI 10.1128/AAC.49.6.2387-2398.2005; Ballell L, 2013, CHEMMEDCHEM, V8, P313, DOI 10.1002/cmdc.201200428; Barile FA, 2010, CLINICAL TOXICOLOGY: PRINCIPLES AND MECHANISMS, 2ND EDITION, P1, DOI 10.3109/9781420092264; Barry CE, 2000, BIOCHEM PHARMACOL, V59, P221, DOI 10.1016/S0006-2952(99)00253-1; Berry M, 2009, EUR RESPIR REV, V18, P195, DOI 10.1183/09059180.00005209; Blower SM, 1998, J MOL MED, V76, P624, DOI 10.1007/s001090050260; Butina D, 1999, J CHEM INF COMP SCI, V39, P747, DOI 10.1021/ci9803381; Castro A, 2006, BIOORGAN MED CHEM, V14, P1644, DOI 10.1016/j.bmc.2005.10.012; Cordone A, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-231; Forbes L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129234; Ghose AK, 1999, J COMB CHEM, V1, P55, DOI 10.1021/cc9800071; Grant SS, 2013, ACS CHEM BIOL, V8, P2224, DOI 10.1021/cb4004817; Greendyke R, 2008, ANTIMICROB AGENTS CH, V52, P2019, DOI 10.1128/AAC.00986-07; Haggarty SJ, 2005, CURR OPIN CHEM BIOL, V9, P296, DOI 10.1016/j.cbpa.2005.04.006; Hitchcock SA, 2006, J MED CHEM, V49, P7559, DOI 10.1021/jm060642i; Jao CW, 2008, J NAT PROD, V71, P1275, DOI 10.1021/np800064w; Khan A, 2008, J MICROBIOL METH, V73, P62, DOI 10.1016/j.mimet.2008.01.015; King GM, 2003, APPL ENVIRON MICROB, V69, P7266, DOI 10.1128/AEM.69.12.7266-7272.2003; Leeson PD, 2007, NAT REV DRUG DISCOV, V6, P881, DOI 10.1038/nrd2445; Liofilchem, 2015, LIST BACT BACT ANT A; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lipinski Christopher A, 2004, Drug Discov Today Technol, V1, P337, DOI 10.1016/j.ddtec.2004.11.007; Lu T, 2003, J ANTIMICROB CHEMOTH, V52, P61, DOI 10.1093/jac/dkg268; Monge A, 2006, MOL DIVERS, V10, P389, DOI 10.1007/s11030-006-9033-5; Muller PY, 2012, NAT REV DRUG DISCOV, V11, P751, DOI 10.1038/nrd3801; MURDOCK KC, 1978, J MED CHEM, V21, P403, DOI 10.1021/jm00202a020; Oprea TI, 2007, NAT CHEM BIOL, V3, P447, DOI 10.1038/nchembio0807-447; Pankey GA, 2004, CLIN INFECT DIS, V38, P864, DOI 10.1086/381972; Savjani KT, 2012, ISRN PHARM, V2012, DOI DOI 10.5402/2012/195727; Shahbazi Y, 2015, J PATHOG, V2015, DOI DOI 10.1155/2015/916305; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sood R., 2006, Infectious Disorders - Drug Targets, V6, P343, DOI 10.2174/187152606779025860; Steinbeck C, 2003, J CHEM INF COMP SCI, V43, P493, DOI 10.1021/ci025584y; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; Strausberg RL, 2003, SCIENCE, V300, P294, DOI 10.1126/science.1083395; VANHOOF R, 1980, ANTIMICROB AGENTS CH, V18, P118, DOI 10.1128/AAC.18.1.118; Veber DF, 2002, J MED CHEM, V45, P2615, DOI 10.1021/jm020017n; World Health Organisation, 2011, WHOHTMTB201116; World Health Organization website, 2014, FACTSH; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7; YAMORI S, 1992, MICROBIOL IMMUNOL, V36, P361, DOI 10.1111/j.1348-0421.1992.tb02035.x; Zuo X, 2010, J AGR FOOD CHEM, V58, P2755, DOI 10.1021/jf902863z	49	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144018	10.1371/journal.pone.0144018	http://dx.doi.org/10.1371/journal.pone.0144018			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642200	Green Published, Green Submitted, gold			2022-12-27	WOS:000366902700045
J	Rahmani, H; Rietveld, T; Gussenhoven, C				Rahmani, Hamed; Rietveld, Toni; Gussenhoven, Carlos			Stress "Deafness" Reveals Absence of Lexical Marking of Stress or Tone in the Adult Grammar	PLOS ONE			English	Article							SPOKEN-WORD RECOGNITION; PITCH ACCENT; INFANTS; PERCEPTION; ROBUST	A Sequence Recall Task with disyllabic stimuli contrasting either for the location of prosodic prominence or for the medial consonant was administered to 150 subjects equally divided over five language groups. Scores showed a significant interaction between type of contrast and language group, such that groups did not differ on their performance on the consonant contrast, while two language groups, Dutch and Japanese, significantly outperformed the three other language groups (French, Indonesian and Persian) on the prosodic contrast. Since only Dutch and Japanese words have unpredictable stress or accent locations, the results are interpreted to mean that stress "deafness" is a property of speakers of languages without lexical stress or tone markings, as opposed to the presence of stress or accent contrasts in phrasal (post-lexical) constructions. Moreover, the degree of transparency between the locations of stress/tone and word boundaries did not appear to affect our results, despite earlier claims that this should have an effect. This finding is of significance for speech processing, language acquisition and phonological theory.	[Rahmani, Hamed; Rietveld, Toni; Gussenhoven, Carlos] Radboud Univ Nijmegen, Dept Linguist, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Gussenhoven, C (corresponding author), Radboud Univ Nijmegen, Dept Linguist, NL-6525 ED Nijmegen, Netherlands.	c.gussenhoven@let.ru.nl	Gussenhoven, Carlos/D-1904-2010		Centre for Language Studies, Radboud University Nijmegen	Centre for Language Studies, Radboud University Nijmegen	Support for this research was provided by the Centre for Language Studies, Radboud University Nijmegen (http://www.ru.nl/cls/), through a travel grant to HR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abolhasanizadeh V, 2012, LINGUA, V122, P1380, DOI 10.1016/j.lingua.2012.06.002; Beckman Mary E., 1986, STRESS NONSTRESS ACC; Bermudez-Otero Ricardo, 2014, OXFORD HDB HIST PHON; Boersma P., 2013, PRAAT DOING PHONETIC; Cooper N, 2002, LANG SPEECH, V45, P207, DOI 10.1177/00238309020450030101; Correia S, 2015, LANG SPEECH, V58, P48, DOI 10.1177/0023830914565193; Cutler A, 1999, J ACOUST SOC AM, V105, P1877, DOI 10.1121/1.426724; CUTLER A, 1986, LANG SPEECH, V29, P201, DOI 10.1177/002383098602900302; Cutler Anne, 2012, NATIVE LISTENING LAN; Dupoux E, 2001, J ACOUST SOC AM, V110, P1606, DOI 10.1121/1.1380437; Dupoux E, 1997, DESTRESSING DEAFNESS, V36, P406, DOI [10.1006/jmla.1996.2500, DOI 10.1006/JMLA.1996.2500]; Dupoux E, 2008, COGNITION, V106, P682, DOI 10.1016/j.cognition.2007.04.001; FERGUSON CA, 1957, LANGUAGE, V33, P123, DOI 10.2307/410724; Friedrich CK, 2004, COGNITIVE BRAIN RES, V20, P300, DOI 10.1016/j.cogbrainres.2004.03.007; Ghomeshi Jila, 1996, THESIS; Goedemans R., 2007, PROSODY INDONESIAN L, P35; Gussenhoven C, 2014, OXFORD HDB WORLD ENG, DOI [10.1093/oxfordhb/9780199777716.013.29, DOI 10.1093/OXFORDHB/9780199777716.013.29]; Hanique I, 2013, MENT LEX, V8, P269, DOI 10.1075/ml.8.3.01han; Himmelmann NP, 2014, LANGUAGE, V90, P927, DOI 10.1353/lan.2014.0105; Hyman Larry M., 2006, PHONOLOGY, V23, P225, DOI [10.1017/S0952675706000893, DOI 10.1017/S0952675706000893]; Jun SA, 2000, TEXT SPEECH LANG TEC, V15, P209; Kiparsky P, 2000, LINGUIST REV, V17, P351, DOI 10.1515/tlir.2000.17.2-4.351; Kiparsky P., 1982, LINGUISTICS MORNING, P4; Kiparsky Paul., 1985, PHONOLOGY YB, V2, P85, DOI DOI 10.1017/S0952675700000397; Kolinsky R, 2009, MUSIC PERCEPT, V26, P235, DOI 10.1525/MP.2009.26.3.235; KUBOZONO H., 1993, ORG JAPANESE PROSODY; KUHL PK, 1992, SCIENCE, V255, P606, DOI 10.1126/science.1736364; Ladd DR, 2008, CAMB STUD LINGUIST, V79, P1; Lazard Gilbert., 1992, GRAMMAR CONT PERSIAN; Liu LQ, 2014, COGNITION, V133, P385, DOI 10.1016/j.cognition.2014.06.004; LU ZL, 1992, SCIENCE, V258, P1668, DOI 10.1126/science.1455246; Myers J, 1996, J CHILD LANG, V23, P1, DOI 10.1017/S0305000900010072; Peperkamp S, 2004, LANGUAGE, V80, P98, DOI 10.1353/lan.2004.0035; Peperkamp S, 2002, PHONOL PHON, V4-1, P203; Peperkamp S, 2010, J PHONETICS, V38, P422, DOI 10.1016/j.wocn.2010.04.001; Pierrehumbert J., 1988, LINGUISTIC INQUIRY M, P1; Post B, 2000, THESIS; Rietveld T., 2005, STAT LANGUAGE RES AN; Schneider W., 2002, E PRIME USERS GUIDE; Selkirk Elisabeth, 1995, HDB PHONOLOGICAL THE, P550; Sluijter AMC, 1997, J ACOUST SOC AM, V101, P503, DOI 10.1121/1.417994; Utsugi A, P 20 INT C AC ICA 20, P3689; Utsugi A, 2011, 17 INT C PHON SCI IC, P2046; van Zanten E., 1994, SEMAIAN, P27; Welby P, 2006, J PHONETICS, V34, P343, DOI 10.1016/j.wocn.2005.09.001; Williams RH, 1996, APPL PSYCH MEAS, V20, P59, DOI 10.1177/014662169602000106; ZWICKY AM, 1983, LANGUAGE, V59, P502, DOI 10.2307/413900	47	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0143968	10.1371/journal.pone.0143968	http://dx.doi.org/10.1371/journal.pone.0143968			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CZ1YS	26642328	Green Published, Green Submitted, gold			2022-12-27	WOS:000366902700037
J	Alnek, K; Kisand, K; Heilman, K; Peet, A; Varik, K; Uibo, R				Alnek, Kristi; Kisand, Kalle; Heilman, Kaire; Peet, Aleksandr; Varik, Karin; Uibo, Raivo			Increased Blood Levels of Growth Factors, Proinflammatory Cytokines, and Th17 Cytokines in Patients with Newly Diagnosed Type 1 Diabetes	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; INFLAMMATORY CYTOKINES; CELLS; PATHOGENESIS; ASSOCIATION; EXPRESSION; CHILDREN; MELLITUS; INTERLEUKIN-27; AUTOIMMUNITY	The production of several cytokines could be dysregulated in type 1 diabetes (T1D). In particular, the activation of T helper (Th) type 1 (Th-1) cells has been proposed to underlie the autoimmune pathogenesis of the disease, although roles for inflammatory processes and the Th-17 pathway have also been shown. Nevertheless, despite evidence for the role of cytokines before and at the onset of T1D, the corresponding findings are inconsistent across studies. Moreover, conflicting data exist regarding the blood cytokine levels in T1D patients. The current study was performed to investigate genetic and autoantibody markers in association with the peripheral blood cytokine profiles by xMap multiplex technology in newly diagnosed young T1D patients and age-matched healthy controls. The onset of young-age T1D was characterized by the upregulation of growth factors, including granulocyte macrophage-colony stimulating factor (GM-CSF) and interleukin (IL)-7, the proinflammatory cytokine IL-1 beta (but not IL-6 or tumor necrosis factor [TNF]-alpha), Th-17 cytokines, and the regulatory cytokines IL-10 and IL-27. Ketoacidosis and autoantibodies (anti-IA-2 and -ZnT8), but not human leukocyte antigen (HLA) genotype, influenced the blood cytokine levels. These findings broaden the current understanding of the dysregulation of systemic levels of several key cytokines at the young-age onset of T1D and provide a further basis for the development of novel immunoregulatory treatments in this disease.	[Alnek, Kristi; Kisand, Kalle; Uibo, Raivo] Univ Tartu, Dept Immunol, Inst Bio & Translat Med, Tartu, Estonia; [Heilman, Kaire] Tallinn Childrens Hosp, Tallinn, Estonia; [Heilman, Kaire; Peet, Aleksandr] Univ Tartu, Dept Pediat, EE-50090 Tartu, Estonia; [Peet, Aleksandr] Tartu Univ Hosp, Childrens Clin, Tartu, Estonia; [Varik, Karin] Tartu Univ Hosp, Surg Clin, Tartu, Estonia	University of Tartu; University of Tartu	Uibo, R (corresponding author), Univ Tartu, Dept Immunol, Inst Bio & Translat Med, Tartu, Estonia.	raivo.uibo@ut.ee	Kisand, Kalle/S-5958-2016; Alnek, Kristi/E-3847-2019; Kisand, Kalle/AAZ-2563-2020; Peet, Aleksandr/H-6114-2018	Kisand, Kalle/0000-0002-7789-5565; Kisand, Kalle/0000-0002-7789-5565; Uibo, Raivo/0000-0002-2298-1300	Estonian Ministry of Education and Research [SF0180035s08, IUT20-43]; European Union Regional Development Fund	Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); European Union Regional Development Fund(European Commission)	This work was supported by Estonian Ministry of Education and Research grant no SF0180035s08, IUT20-43 and by European Union Regional Development Fund.; We would like to thank all participants for donating their blood for the present study. We are also grateful to the hospital nurses for their kind help in collecting the study material. We would like to thank Prof. Jorma Ilonen (University of Turku, Finland) for HLA determinations, Dr. Ulle Einberg for collection patient's data and Mrs Kaja Metskula d Dr. Koit Reimand for islet cell autoantibodies assays performance and standardization by IASP2012. This work was supported by Estonian Ministry of Education and Research grant no SF0180035s08, IUT20- 43 and by European Union Regional Development Fund.	Calzascia T, 2008, P NATL ACAD SCI USA, V105, P2999, DOI 10.1073/pnas.0712135105; CAVALLO MG, 1991, CLIN EXP IMMUNOL, V86, P256; Chatzigeorgiou A, 2010, ANN MED, V42, P426, DOI 10.3109/07853890.2010.495951; Cheatem DM University of Illinois at Chicago HSC, 2007, IMMUNOMODULATION DEN; Devaraj S, 2006, DIABETES, V55, P774, DOI 10.2337/diabetes.55.03.06.db05-1417; Di Caro V, 2011, CLIN EXP IMMUNOL, V165, P60, DOI 10.1111/j.1365-2249.2011.04334.x; Dogan Y, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/59206; Enzler T, 2007, BLOOD, V110, P954, DOI 10.1182/blood-2006-08-043786; Foss NT, 2007, DIABETES METAB, V33, P439, DOI 10.1016/j.diabet.2007.10.001; Fujimoto H, 2011, AM J PATHOL, V179, P2327, DOI 10.1016/j.ajpath.2011.08.001; Garrigan E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076919; Gaudreau S, 2007, J IMMUNOL, V179, P3638, DOI 10.4049/jimmunol.179.6.3638; Gavin JR, 1999, DIABETES CARE, V22, pS5; Haller MJ, 2008, PEDIATR DIABETES, V9, P1, DOI 10.1111/j.1399-5448.2007.00364.x; Hanifi-Moghaddam P, 2003, DIABETES, V52, P1137, DOI 10.2337/diabetes.52.5.1137; Hartgring SAY, 2006, ANN RHEUM DIS, V65, P69, DOI 10.1136/ard.2006.058479; He JS, 2014, ASIAN PAC J TROP MED, V7, P823, DOI 10.1016/S1995-7645(14)60144-9; Hekkala A, 2011, EUR J ENDOCRINOL, V165, P813, DOI 10.1530/EJE-11-0376; Honkanen J, 2010, J IMMUNOL, V185, P1959, DOI 10.4049/jimmunol.1000788; Kaas A, 2012, DIABETIC MED, V29, P734, DOI 10.1111/j.1464-5491.2011.03544.x; KARJALAINEN J, 1989, NEW ENGL J MED, V320, P881, DOI 10.1056/NEJM198904063201401; Kim SJ, 2004, IMMUNITY, V21, P643, DOI 10.1016/j.immuni.2004.09.009; Kisand K, 2011, CLIN CHEM LAB MED, V49, P229, DOI 10.1515/CCLM.2011.049; Larousserie F, 2004, J PATHOL, V202, P164, DOI 10.1002/path.1508; Li CR, 2014, J IMMUNOL, V192, P1425, DOI 10.4049/jimmunol.1301742; Lohmann T, 2002, DIABETES, V51, P2474, DOI 10.2337/diabetes.51.8.2474; Lundmark F, 2007, NAT GENET, V39, P1108, DOI 10.1038/ng2106; Meyers AJ, 2010, J MOL MED, V88, P1221, DOI 10.1007/s00109-010-0666-6; Moran A, 2013, LANCET, V381, P1905, DOI 10.1016/S0140-6736(13)60023-9; NERUP J, 1994, DIABETOLOGIA, V37, pS82, DOI 10.1007/BF00400830; Pot C, 2011, SEMIN IMMUNOL, V23, P438, DOI 10.1016/j.smim.2011.08.003; Quintana FJ, 2003, J AUTOIMMUN, V21, P65, DOI 10.1016/S0896-8411(03)00064-7; Rabinovitch A, 1998, DIABETES METAB REV, V14, P129, DOI 10.1002/(SICI)1099-0895(199806)14:2<129::AID-DMR208>3.3.CO;2-M; Reddy MVPL, 2011, GENES IMMUN, V12, P208, DOI 10.1038/gene.2010.70; Reimers JI, 1998, DAN MED BULL, V45, P157; Rowe PA, 2011, SEMIN IMMUNOPATHOL, V33, P29, DOI 10.1007/s00281-010-0208-x; Rumore-Maton B, 2008, CLIN DEV IMMUNOL, DOI 10.1155/2008/769795; Ryden A, 2014, PEDIATR RES, V75, P45, DOI 10.1038/pr.2013.167; Ryden A, 2009, DIABETES-METAB RES, V25, P335, DOI 10.1002/dmrr.958; Santos AS, 2013, CYTOKINE, V61, P349, DOI 10.1016/j.cyto.2012.12.003; Schmidt C, 2005, INFLAMM BOWEL DIS, V11, P16, DOI 10.1097/00054725-200501000-00003; Stechova K, 2007, DIABETES-METAB RES, V23, P462, DOI 10.1002/dmrr.718; Stumhofer JS, 2008, IMMUNOL LETT, V117, P123, DOI 10.1016/j.imlet.2008.01.011; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Svensson J, 2012, HUM IMMUNOL, V73, P1116, DOI 10.1016/j.humimm.2012.07.337; Uibo R, 2008, ADV IMMUNOL, V100, P39, DOI 10.1016/S0065-2776(08)00803-1; Ustinova J, 2014, J IMMUNOL METHODS, V405, P67, DOI 10.1016/j.jim.2014.01.009; Wang R, 2008, CELL MOL LIFE SCI, V65, P3851, DOI 10.1007/s00018-008-8540-1; Watanabe M, 1999, IMMUNOL RES, V20, P251, DOI 10.1007/BF02790408; Yeung WCG, 2012, DIABETES, V61, P1500, DOI 10.2337/db11-0264	50	52	53	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0142976	10.1371/journal.pone.0142976	http://dx.doi.org/10.1371/journal.pone.0142976			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636339	Green Published, gold, Green Submitted			2022-12-27	WOS:000366143800003
J	Reneaux, M; Gupta, R; Karmeshu				Reneaux, Melissa; Gupta, Rahul; Karmeshu			Stochastic Mesocortical Dynamics and Robustness of Working Memory during Delay-Period	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; D-1 DOPAMINE-RECEPTORS; AGE-RELATED-CHANGES; CEREBRAL-CORTEX; RHESUS-MONKEYS; NETWORK MODEL; IN-VIVO; SCHIZOPHRENIA; MODULATION; NEURONS	The role of prefronto-mesoprefrontal system in the dopaminergic modulation of working memory during delayed response tasks is well-known. Recently, a dynamical model of the closed-loop mesocortical circuit has been proposed which employs a deterministic framework to elucidate the system's behavior in a qualitative manner. Under natural conditions, noise emanating from various sources affects the circuit's functioning to a great extent. Accordingly in the present study, we reformulate the model into a stochastic framework and investigate its steady state properties in the presence of constant background noise during delay-period. From the steady state distribution, global potential landscape and signal-to-noise ratio are obtained which help in defining robustness of the circuit dynamics. This provides insight into the robustness of working memory during delay-period against its disruption due to background noise. The findings reveal that the global profile of circuit's robustness is predominantly governed by the level of D1 receptor activity and high D1 receptor stimulation favors the working memory-associated sustained-firing state over the spontaneous-activity state of the system. Moreover, the circuit's robustness is further fine-tuned by the levels of excitatory and inhibitory activities in a way such that the robustness of sustained-firing state exhibits an inverted-U shaped profile with respect to D1 receptor stimulation. It is predicted that the most robust working memory is formed possibly at a subtle ratio of the excitatory and inhibitory activities achieved at a critical level of D1 receptor stimulation. The study also paves a way to understand various cognitive deficits observed in old-age, acute stress and schizophrenia and suggests possible mechanistic routes to the working memory impairments based on the circuit's robustness profile.	[Reneaux, Melissa; Gupta, Rahul; Karmeshu] Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi 110067, India; [Karmeshu] Jawaharlal Nehru Univ, Sch Comp & Syst Sci, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi	Karmeshu (corresponding author), Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi 110067, India.	karmeshu@mail.jnu.ac.in			Council of Scientific and Industrial Research, India [09/263(0991)/2013-EMR-I]; Council of Scientific and Industrial Research (CSIR), India [09/263(0991)/2013-EMR-I]	Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	MR received funding from Council of Scientific and Industrial Research, India (grant no. 09/263(0991)/2013-EMR-I, www.csirhrdg.res.in) for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors sincerely thank the referees for their critical review of the research paper. MR would like to gratefully acknowledge the financial support from Council of Scientific and Industrial Research (CSIR), India (grant no. 09/263(0991)/2013-EMR-I) to carry out this research work.	Abi-Dargham A, 2002, J NEUROSCI, V22, P3708, DOI 10.1523/jneurosci.22-09-03708.2002; Abi-Dargham A, 2003, NEUROSCIENTIST, V9, P404, DOI 10.1177/1073858403252674; Abi-Dargham A, 2012, J PSYCHOPHARMACOL, V26, P794, DOI 10.1177/0269881111409265; AKIL M, 1995, SCHIZOPHR RES, V15, P25, DOI 10.1016/0920-9964(95)95089-R; Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; Arnsten AFT, 1998, ARCH GEN PSYCHIAT, V55, P362, DOI 10.1001/archpsyc.55.4.362; Arnsten AFT, 1997, J PSYCHOPHARMACOL, V11, P151, DOI 10.1177/026988119701100208; Arnsten AFT, 2012, NEURON, V76, P223, DOI 10.1016/j.neuron.2012.08.038; Arnsten AFT, 2011, INT J DEV NEUROSCI, V29, P215, DOI 10.1016/j.ijdevneu.2011.02.006; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Ballard IC, 2011, J NEUROSCI, V31, P10340, DOI 10.1523/JNEUROSCI.0895-11.2011; BARTUS RT, 1979, EXP AGING RES, V5, P385, DOI 10.1080/03610737908257214; BARTUS RT, 1978, J GERONTOL, V33, P858, DOI 10.1093/geronj/33.6.858; BARTUS RT, 1977, BRAIN RES, V119, P233, DOI 10.1016/0006-8993(77)90103-2; Bertolino A, 2000, NEUROPSYCHOPHARMACOL, V22, P125, DOI 10.1016/S0893-133X(99)00096-2; Bjorklund A., 1984, CLASSICAL NEUROTRA 1, V2, P55; BROZOSKI TJ, 1979, SCIENCE, V205, P929, DOI 10.1126/science.112679; Brunel N, 1998, J THEOR BIOL, V195, P87, DOI 10.1006/jtbi.1998.0782; Brunel N, 2001, J COMPUT NEUROSCI, V11, P63, DOI 10.1023/A:1011204814320; Cai JX, 1997, J PHARMACOL EXP THER, V283, P183; Castner SA, 2004, J NEUROSCI, V24, P1446, DOI 10.1523/JNEUROSCI.3987-03.2004; DANIEL DG, 1991, J NEUROSCI, V11, P1907; DAVIS HP, 1990, BEHAV NEUROSCI, V104, P288, DOI 10.1037/0735-7044.104.2.288; Deco G, 2003, EUR J NEUROSCI, V18, P2374, DOI 10.1046/j.1460-9568.2003.02956.x; DEKEYSER J, 1990, BRAIN RES, V528, P308, DOI 10.1016/0006-8993(90)91672-4; del Arco A, 2005, J NEURAL TRANSM, V112, P97, DOI 10.1007/s00702-004-0172-5; Driesen NR, 2008, BIOL PSYCHIAT, V64, P1026, DOI 10.1016/j.biopsych.2008.07.029; Durstewitz D, 2000, J NEUROPHYSIOL, V83, P1733, DOI 10.1152/jn.2000.83.3.1733; Durstewitz D, 1999, J NEUROSCI, V19, P2807; Durstewitz D, 2002, NEURAL NETWORKS, V15, P561, DOI 10.1016/S0893-6080(02)00049-7; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Finlay JM, 1997, NEUROCHEM RES, V22, P1387, DOI 10.1023/A:1022075324164; Finlay JM, 2001, SCHIZOPHRENIA BULL, V27, P431, DOI 10.1093/oxfordjournals.schbul.a006885; Gazzaley A, 2005, NAT NEUROSCI, V8, P1298, DOI 10.1038/nn1543; Gold JM, 1997, ARCH GEN PSYCHIAT, V54, P159; Goldman-Rakic PS, 2000, BRAIN RES REV, V31, P295, DOI 10.1016/S0165-0173(99)00045-4; GOLDMANRAKIC PS, 1994, J NEUROPSYCH CLIN N, V6, P348; GOLDMANRAKIC PS, 1981, NEUROSCIENCE, V6, P177, DOI 10.1016/0306-4522(81)90053-1; Gooding DC, 2004, SCHIZOPHR RES, V68, P189, DOI 10.1016/j.schres.2003.07.007; Gorelova N, 2002, J NEUROPHYSIOL, V88, P3150, DOI 10.1152/jn.00335.2002; Henze DA, 2000, J NEUROPHYSIOL, V84, P2799, DOI 10.1152/jn.2000.84.6.2799; Howes OD, 2009, SCHIZOPHRENIA BULL, V35, P549, DOI 10.1093/schbul/sbp006; Kloeden P. E., 1995, NUMERICAL SOLUTION S; KORNHUBER J, 1984, BRAIN RES, V322, P124, DOI 10.1016/0006-8993(84)91189-2; Lachowicz JE, 1997, PHARMACOL TOXICOL, V81, P105, DOI 10.1111/j.1600-0773.1997.tb00039.x; Leung HC, 2002, J COGNITIVE NEUROSCI, V14, P659, DOI 10.1162/08989290260045882; LIDOW MS, 1991, NEUROSCIENCE, V40, P657, DOI 10.1016/0306-4522(91)90003-7; Loh M, 2007, PHARMACOPSYCHIATRY, V40, pS78, DOI 10.1055/s-2007-990304; Loh M, 2007, PLOS COMPUT BIOL, V3, P2255, DOI 10.1371/journal.pcbi.0030228; LUINE V, 1990, BRAIN RES, V537, P271, DOI 10.1016/0006-8993(90)90368-L; Murphy BL, 1996, P NATL ACAD SCI USA, V93, P1325, DOI 10.1073/pnas.93.3.1325; Okimura T, 2015, NEUROSCIENCE, V295, P80, DOI 10.1016/j.neuroscience.2015.03.039; PARK S, 1992, ARCH GEN PSYCHIAT, V49, P975; Perlstein WM, 2001, AM J PSYCHIAT, V158, P1105, DOI 10.1176/appi.ajp.158.7.1105; Postle BR, 2006, NEUROSCIENCE, V139, P23, DOI 10.1016/j.neuroscience.2005.06.005; Qin SZ, 2009, BIOL PSYCHIAT, V66, P25, DOI 10.1016/j.biopsych.2009.03.006; RAPP PR, 1989, J NEUROSCI, V9, P3568; Rolls ET, 2008, NAT REV NEUROSCI, V9, P696, DOI 10.1038/nrn2462; Rolls ET, 2015, NEUROBIOL LEARN MEM, V118, P150, DOI 10.1016/j.nlm.2014.12.003; Rolls ET, 2010, THE NOISY BRAIN STOC; Rowe JB, 2000, SCIENCE, V288, P1656, DOI 10.1126/science.288.5471.1656; SAWAGUCHI T, 1991, SCIENCE, V251, P947, DOI 10.1126/science.1825731; Sawaguchi T, 2001, NEUROSCI RES, V41, P115, DOI 10.1016/S0168-0102(01)00270-X; SAWAGUCHI T, 1994, J NEUROPHYSIOL, V71, P515, DOI 10.1152/jn.1994.71.2.515; SCHULTZ W, 1993, J NEUROSCI, V13, P900; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Seamans JK, 2003, CEREB CORTEX, V13, P1242, DOI 10.1093/cercor/bhg094; Seamans JK, 2001, P NATL ACAD SCI USA, V98, P301, DOI 10.1073/pnas.011518798; Seamans JK, 2001, J NEUROSCI, V21, P3628, DOI 10.1523/JNEUROSCI.21-10-03628.2001; Sesack SR, 2002, PHYSIOL BEHAV, V77, P513, DOI 10.1016/S0031-9384(02)00931-9; SMILEY JF, 1994, P NATL ACAD SCI USA, V91, P5720, DOI 10.1073/pnas.91.12.5720; SUHARA T, 1991, PSYCHOPHARMACOLOGY, V103, P41, DOI 10.1007/BF02244071; Tabuchi Y, 2003, NEUROCOMPUTING, V52-4, P403, DOI 10.1016/S0925-2312(02)00849-4; Tanaka S, 2006, NEUROSCIENCE, V139, P153, DOI 10.1016/j.neuroscience.2005.08.070; Tanaka S, 2002, NEUROCOMPUTING, V44, P1001, DOI 10.1016/S0925-2312(02)00503-9; Tanaka S, 2002, NEURAL NETWORKS, V15, P573, DOI 10.1016/S0893-6080(02)00050-3; Tritsch NX, 2012, NEURON, V76, P33, DOI 10.1016/j.neuron.2012.09.023; Van Kampen NG, 1992, STOCHASTIC PROCESSES; Wang J, 2001, CEREB CORTEX, V11, P452, DOI 10.1093/cercor/11.5.452; Wang M, 2013, NEURON, V77, P736, DOI 10.1016/j.neuron.2012.12.032; WEINBERGER DR, 1988, ARCH GEN PSYCHIAT, V45, P609; WENK GL, 1989, NEUROBIOL AGING, V10, P11, DOI 10.1016/S0197-4580(89)80005-3; Williams GV, 2006, NEUROSCIENCE, V139, P263, DOI 10.1016/j.neuroscience.2005.09.028; Williams SM, 1998, CEREB CORTEX, V8, P321, DOI 10.1093/cercor/8.4.321; Yang CR, 1999, NEUROPSYCHOPHARMACOL, V21, P161, DOI 10.1016/S0893-133X(98)00112-2; Zahrt J, 1997, J NEUROSCI, V17, P8528	86	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144378	10.1371/journal.pone.0144378	http://dx.doi.org/10.1371/journal.pone.0144378			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636712	Green Published, gold, Green Submitted			2022-12-27	WOS:000366143800082
J	Ruwandeepika, HAD; Karunasagar, I; Bossier, P; Defoirdt, T				Ruwandeepika, H. A. Darshanee; Karunasagar, Indrani; Bossier, Peter; Defoirdt, Tom			Expression and Quorum Sensing Regulation of Type III Secretion System Genes of Vibrio harveyi during Infection of Gnotobiotic Brine Shrimp	PLOS ONE			English	Article							AEROMONAS-HYDROPHILA; PROTEIN SECRETION; VIRULENCE; LUMINESCENCE; ANGUILLARUM; REGULON; IMPACT	Type III secretion systems enable pathogens to inject their virulence factors directly into the cytoplasm of the host cells. The type III secretion system of Vibrio harveyi, a major pathogen of aquatic organisms and a model species in quorum sensing studies, is repressed by the quorum sensing master regulator LuxR. In this study, we found that during infection of gnotobiotic brine shrimp larvae, the expression levels of three type III secretion operons in V. harveyi increased within the first 12h after challenge and decreased again thereafter. The in vivo expression levels were highest in a mutant with a quorum sensing system that is locked in low cell density configuration (minimal LuxR levels) and lowest in a mutant with a quorum sensing system that is locked in the high cell density configuration (maximal LuxR levels), which is consistent with repression of type III secretion by LuxR. Remarkably, in vivo expression levels of the type III secretion system genes were much (> 1000 fold) higher than the in vitro expression levels, indicating that (currently unknown) host factors significantly induce the type III secretion system. Given the fact that type III secretion is energy-consuming, repression by the quorum sensing master regulators might be a mechanism to save energy under conditions where it does not provide an advantage to the cells.	[Ruwandeepika, H. A. Darshanee] Sabaragamuwa Univ Sri Lanka, Fac Agr Sci, Dept Livestock Prod, Belihuloya, Sri Lanka; [Ruwandeepika, H. A. Darshanee; Karunasagar, Indrani] Nitte Univ, UNESCO MIRCEN Med & Marine Biotechnol, Ctr Sci Educ & Res, Mangalore, India; [Bossier, Peter; Defoirdt, Tom] Univ Ghent, Lab Aquaculture, B-9000 Ghent, Belgium; [Bossier, Peter; Defoirdt, Tom] Univ Ghent, Artemia Reference Ctr, B-9000 Ghent, Belgium	Sabaragamuwa University of Sri Lanka; NITTE (Deemed to be University); Nitte University Center for Science Education & Research (NUCSER); Ghent University; Ghent University	Defoirdt, T (corresponding author), Univ Ghent, Lab Aquaculture, B-9000 Ghent, Belgium.	Tom.Defoirdt@UGent.be	Bossier, Peter GM/A-8118-2008; Ruwandeepika, Darshanee/E-5288-2015; Ruwandeepika, Darshanee/ABE-7303-2020; Defoirdt, Tom/A-5120-2009	Bossier, Peter GM/0000-0002-6165-9111; Ruwandeepika, Darshanee/0000-0001-8851-5698; Defoirdt, Tom/0000-0002-7446-2246	Flemish Interuniversity Council-University Development Cooperation (VLIR); Indo-Belgian Research and Technology Cooperation (project AQUAS-TRESS)	Flemish Interuniversity Council-University Development Cooperation (VLIR); Indo-Belgian Research and Technology Cooperation (project AQUAS-TRESS)	The financial support by the Flemish Interuniversity Council-University Development Cooperation (VLIR) to the study is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The financial support by the Flemish Interuniversity Council-University Development Cooperation (VLIR) and the Indo-Belgian Research and Technology Cooperation (project AQUAS-TRESS) to the study is gratefully acknowledged. The guidance and assistance of the staff of the Laboratory of Aquaculture & Artemia Reference Center (Ghent University, Belgium) and UNESCO MIRCEN for Marine Biotechnology, Nitte University, Mangalore is highly appreciated. The authors declare that there is no conflict of interest.	Atkinson S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001250; Bassler BL, 1997, J BACTERIOL, V179, P4043, DOI 10.1128/jb.179.12.4043-4045.1997; Bleves S, 2005, J BACTERIOL, V187, P3898, DOI 10.1128/JB.187.11.3898-3902.2005; Defoirdt T, 2005, ENVIRON MICROBIOL, V7, P1239, DOI 10.1111/j.1462-2920.2005.00807.x; Defoirdt T, 2008, ISME J, V2, P19, DOI 10.1038/ismej.2007.92; Defoirdt T, 2007, TRENDS BIOTECHNOL, V25, P472, DOI 10.1016/j.tibtech.2007.08.001; Defoirdt T, 2007, ENVIRON MICROBIOL, V9, P2486, DOI 10.1111/j.1462-2920.2007.01367.x; Defoirdt T, 2014, REV AQUACULT, V6, P100, DOI 10.1111/raq.12030; Defoirdt T, 2012, ISME J, V6, P2314, DOI 10.1038/ismej.2012.58; Fan FX, 2014, INFECT IMMUN, V82, P1676, DOI 10.1128/IAI.01377-13; Freeman JA, 1999, MOL MICROBIOL, V31, P665, DOI 10.1046/j.1365-2958.1999.01208.x; Gerlach RG, 2007, INT J MED MICROBIOL, V297, P401, DOI 10.1016/j.ijmm.2007.03.017; Henke JM, 2004, J BACTERIOL, V186, P6902, DOI 10.1128/JB.186.20.6902-6914.2004; Henke JM, 2004, J BACTERIOL, V186, P3794, DOI 10.1128/JB.186.12.3794-3805.2004; Kosarewicz A, 2012, PHILOS T R SOC B, V367, P1140, DOI 10.1098/rstb.2011.0205; Lamarche MG, 2008, FEMS MICROBIOL REV, V32, P461, DOI 10.1111/j.1574-6976.2008.00101.x; Li X, 2015, VET MICROBIOL, V175, P44, DOI 10.1016/j.vetmic.2014.10.033; Lin BC, 2010, ENV MICROBIOL REP, V2, P81, DOI 10.1111/j.1758-2229.2009.00100.x; Merrell DS, 2004, NATURE, V430, P250, DOI 10.1038/nature02760; Milton DL, 2006, INT J MED MICROBIOL, V296, P61, DOI 10.1016/j.ijmm.2006.01.044; Ruwandeepika HAD, 2011, ENV MICROBIOL REP, V3, P597, DOI 10.1111/j.1758-2229.2011.00268.x; Ruwandeepika HAD, 2011, ENVIRON MICROBIOL, V13, P506, DOI 10.1111/j.1462-2920.2010.02354.x; Ruwandeepika HAD, 2012, REV AQUACULT, V4, P59, DOI 10.1111/j.1753-5131.2012.01061.x; Septer AN, 2013, APPL ENVIRON MICROB, V79, P1826, DOI 10.1128/AEM.03079-12; Smith H, 2000, PHILOS T R SOC B, V355, P551, DOI 10.1098/rstb.2000.0597; Sperandio V, 1999, P NATL ACAD SCI USA, V96, P15196, DOI 10.1073/pnas.96.26.15196; Tu KC, 2007, GENE DEV, V21, P221, DOI 10.1101/gad.1502407; van Kessel JC, 2013, J BACTERIOL, V195, P436, DOI 10.1128/JB.01998-12; Virgin HW, 2007, NAT IMMUNOL, V8, P1143, DOI 10.1038/ni1529; Waters CM, 2010, APPL ENVIRON MICROB, V76, P4996, DOI 10.1128/AEM.00886-10; Yang MH, 2013, P NATL ACAD SCI USA, V110, P2348, DOI 10.1073/pnas.1218039110; Yang Q, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00584; Zhou WG, 2007, PROG BIOCHEM BIOPHYS, V34, P647	33	21	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143935	10.1371/journal.pone.0143935	http://dx.doi.org/10.1371/journal.pone.0143935			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636765	Green Submitted, gold, Green Published			2022-12-27	WOS:000366143800034
J	McDaniel, PA; Cadman, B; Offen, N; Malone, RE				McDaniel, Patricia A.; Cadman, Brie; Offen, Naphtali; Malone, Ruth E.			Smoking or My Job? US Media Coverage of Nonsmoker-Only Hiring Policies	PLOS ONE			English	Article							INTERRATER RELIABILITY; NEWSPAPER COVERAGE; TOBACCO ISSUES; ADVOCACY; SMOKERS; KAPPA; NEWS	Objectives Media advocacy plays a critical role in tobacco control, shaping the content of news in ways that generate public support for tobacco control. We examined US media coverage of non-smoker- only hiring policies, which have little US public support, exploring the extent to which tobacco control advocates and experts have engaged the media on this controversial issue. Methods We searched online media databases (Lexis Nexis, Access World News, and Proquest) for articles published from 1995-2013, coding retrieved items through a collaborative, iterative process. We analyzed the volume, type, provenance, prominence, content and slant of coverage. Results We found 1,159 media items on nonsmoker-only hiring policies, most published in local newspapers in regions where such policies were enacted. The most common reason given for implementing such policies was to reduce healthcare costs. Most news items offered reasons both to support and oppose such policies; thus, the slant of the majority of news items was neutral or mixed. Tobacco control advocates or experts were infrequently cited or quoted in news items, and rarely authored opinion pieces. Those who expressed opinions were more likely to support than oppose nonsmoker-only hiring policies, for economic and health reasons. Ethical concerns about the policies were seldom raised. Conclusions As presented in the media, nonsmoker-only hiring policies were primarily framed in terms of business cost savings and had little connection to health initiatives. Tobacco control advocates were rarely quoted and their positions were not consistent. Given their intrusiveness and the lack of strong evidence that such business policies actually do improve worker health, tobacco control advocates may feel that the status quo is preferable to engaging on a policy that the majority of Americans dislike.	[McDaniel, Patricia A.; Cadman, Brie; Offen, Naphtali; Malone, Ruth E.] Univ Calif San Francisco, Sch Nursing, Dept Social & Behav Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	McDaniel, PA (corresponding author), Univ Calif San Francisco, Sch Nursing, Dept Social & Behav Sci, San Francisco, CA 94143 USA.	patricia.mcdaniel@ucsf.edu		McDaniel, Patricia A/0000-0002-2750-4124	National Cancer Institute [R01 CA143076]; NATIONAL CANCER INSTITUTE [R01CA143076] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by the National Cancer Institute, grant number R01 CA143076. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Z, 2008, SARASOTA HERA A 0521; [Anonymous], 2012, MOR WORKPL BANN SMOK; [Anonymous], 1985, PALM BEACH POST 0201; [Anonymous], 2012, COLUMBIA EXAMIN 0106; [Anonymous], 2008, NAPLES DAILY NE 0525; [Anonymous], 2005, PHILADELPHIA IN 0311; [Anonymous], 2011, DALLAS MORNING NEWS; [Anonymous], 1983, EUGENE REGISTER 0616; [Anonymous], 2012, STATES NEWS SER 0109; [Anonymous], 1988, TIMES UNION     1008; [Anonymous], 2012, READING EAGLE   0107; Asbridge M, 2004, SOC SCI MED, V58, P13, DOI 10.1016/S0277-9536(03)00154-0; Asch DA, 2013, NEW ENGL J MED, V368, P1371, DOI 10.1056/NEJMp1303632; Baethge C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061401; Banzhaf III J, 1999, CHRISTIAN SCI M 0128; Banzhaf III J., 2005, AUSTIN AM STATE 1230; Berman H, 2007, COLUMBUS DISPATCH; BOOTH A, 1970, PUBLIC OPIN QUART, V34, P604, DOI 10.1086/267845; Bregel E., 2010, CHATTANOOGA TIM 0118; Burden M., 2011, DETROIT NEWS A  0314; Chapman S, 2005, TOB CONTROL, V14, P144, DOI 10.1136/tc.2004.010348; Chapman S, 2007, PUBLIC HEALTH ADVOCACY AND TOBACCO CONTROL: MAKING SMOKING HISTORY, P1, DOI 10.1002/9780470692479; Chapman S, 2001, HEALTH EDUC BEHAV, V28, P274, DOI 10.1177/109019810102800303; Connors D, 2002, DAYTONA BEACH N 0407; Correction, 2002, ASS PRESS STAT LOC W; Costello D, 2005, LOS ANGELES TIMES; Dorfman L, 2005, HEALTH EDUC BEHAV, V32, P320, DOI 10.1177/1090198105275046; Ebeling A, 2013, MORE EMPLOYERS SHUN; Eisner J, 2005, PHILADELPHIA A  0210; ENTMAN RM, 1993, J COMMUN, V43, P51, DOI 10.1111/j.1460-2466.1993.tb01304.x; Fahs J, 1996, CIGARETTE CONFIDENTI; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L; Gallup, 2014, HIR DISCR SMOK OB RE; Garner DW, 1992, SETON HALL L REV, V23, P417; Gemskie J, 2002, ORLANDO SENTINE 0331; Glantz SA, 2011, PRIMER BIOSTATISTICS; Gray NJ, 2005, TOB CONTROL, V14, P143, DOI 10.1136/tc.2004.010215; Gwet KL, 2008, BRIT J MATH STAT PSY, V61, P29, DOI 10.1348/000711006X126600; Hay T, 2004, SAN MATEO COUNT 0707; Healton CG, 2010, EL PASO TIMES   0725; Hilts PJ, 1993, NY TIMES; Hoffman B, 2005, KING COUNTY J   0228; Hoffman KB, 2005, FORT WAYNE J B  0209; Hoffman KB, 2005, WORKERS TOLD NO SMOK; Hoffman KB, 2005, VANCOUVER COL E 0209; Holt S, 2004, SEATTLE TIMES; Howie A, 2002, ORLANDO SENTI G 0331; Huddle TS, 2014, ACAD MED, V89, P843, DOI 10.1097/ACM.0000000000000247; Hunt A, 2002, ORLANDO SENTINE 0327; Karash J., 2006, KANSAS CITY S A 0303; Karr A, 2010, DOYLESTOWN INTE 0405; King BA, 2013, NICOTINE TOB RES, V15, P1464, DOI 10.1093/ntr/nts342; Kozelle CR, 2010, CNN WIRE        0708; Kristofic C, 2012, DOYLESTOWN IN A 0511; Lionetti D, 2002, ORLANDO SENTI A 0405; Lionetti DM, 2002, ORLANDO SENTINEL; McCullough M, 2012, PHILADELPHIA INQUIRE; McDaniel PA, 2014, AM J PUBLIC HEALTH, V104, P562, DOI 10.2105/AJPH.2013.301564; Mckenzie MN, 1996, SEATTLE POSTI B 1230; Menashe CL, 1998, J HEALTH COMMUN, V3, P307, DOI 10.1080/108107398127139; Nauert H, 2008, FOX NEWS; Not hiring smokers would do more harm than good, 2008, U WIRE          0313; Oliver M, 2012, PRESS REGISTE A 1116; Palmer K, 2013, CLEVELAND CLIN ANNOU; Pellegrini M, 1995, PITTSBURGH PO A 0402; Pletten B, 2005, DETROIT NEWS A  0225; Raybum RL, 2010, COMMUNICATION; Reed SG, 1998, SARASOTA HERALD 1130; Reid A, 2009, FT LAUDERDALE B 1001; Retsinas G., 1998, SARASOTA HERA A 1024; Roan S, 2009, LOS ANGELES T A 0123; Sapatkin D, 2013, PHILADELPHIA INQUIRE; Schmidt H, 2013, NEW ENGL J MED, V368, P1369, DOI 10.1056/NEJMp1301951; Smith KC, 2008, TOB CONTROL, V17, P17, DOI 10.1136/tc.2007.020495; Smith KC, 2006, J PUBLIC HEALTH POL, V27, P166, DOI 10.1057/palgrave.jphp.3200079; Smith KC, 2005, QUAL HEALTH RES, V15, P1180, DOI 10.1177/1049732305279145; Smith KC, 2005, NICOTINE TOB RES, V7, P289, DOI 10.1080/14622200500056291; Smoking policy will save taxpayers in long run, 2008, ENGLEWOOD SUN   0605; Sulzberger AG, 2011, NY TIMES; Taylor WC, 2010, ALLENTOWN MOR A 0414; Terpeluk P, 2012, US TODAY; Ullmann CY, 1999, TACOMA NEWS T A 0107; Wallack L, 1996, HEALTH EDUC QUART, V23, P293, DOI 10.1177/109019819602300303; Wallack Lawrence., 1993, MEDIA ADVOCACY PUBLI; Walters P, 2005, WANTED MONTGOMERY CO; Wartenberg S, 2012, COLUMBUS DISP D 1125; Wellness Councils of America, 2007, THER SMOK YOUR FIR C; Wenner D, 2011, GEISINGER HLTH SYSTE; Wongpakaran N, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-61; Young D, 2007, AUST NZ J PUBL HEAL, V31, P164, DOI 10.1111/j.1753-6405.2007.00035.x	90	1	1	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144281	10.1371/journal.pone.0144281	http://dx.doi.org/10.1371/journal.pone.0144281			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX9QI	26632824	Green Published, gold			2022-12-27	WOS:000366040000077
J	Avramenko, RW; Redman, EM; Lewis, R; Yazwinski, TA; Wasmuth, JD; Gilleard, JS				Avramenko, Russell W.; Redman, Elizabeth M.; Lewis, Roy; Yazwinski, Thomas A.; Wasmuth, James D.; Gilleard, John S.			Exploring the Gastrointestinal "Nemabiome": Deep Amplicon Sequencing to Quantify the Species Composition of Parasitic Nematode Communities	PLOS ONE			English	Article							RIBOSOMAL-RNA; CATTLE; IDENTIFICATION; INFECTIONS; AMPLIFICATION; HELMINTHS; LIVESTOCK; CULTURE; FECES; EGGS	Parasitic helminth infections have a considerable impact on global human health as well as animal welfare and production. Although co-infection with multiple parasite species within a host is common, there is a dearth of tools with which to study the composition of these complex parasite communities. Helminth species vary in their pathogenicity, epidemiology and drug sensitivity and the interactions that occur between co-infecting species and their hosts are poorly understood. We describe the first application of deep amplicon sequencing to study parasitic nematode communities as well as introduce the concept of the gastro-intestinal "nemabiome". The approach is analogous to 16S rDNA deep sequencing used to explore microbial communities, but utilizes the nematode ITS-2 rDNA locus instead. Gastro-intestinal parasites of cattle were used to develop the concept, as this host has many well-defined gastro-intestinal nematode species that commonly occur as complex co-infections. Further, the availability of pure mono-parasite populations from experimentally infected cattle allowed us to prepare mock parasite communities to determine, and correct for, species representation biases in the sequence data. We demonstrate that, once these biases have been corrected, accurate relative quantitation of gastro-intestinal parasitic nematode communities in cattle fecal samples can be achieved. We have validated the accuracy of the method applied to field-samples by comparing the results of detailed morphological examination of L3 larvae populations with those of the sequencing assay. The results illustrate the insights that can be gained into the species composition of parasite communities, using grazing cattle in the mid-west USA as an example. However, both the technical approach and the concept of the 'nemabiome' have a wide range of potential applications in human and veterinary medicine. These include investigations of host-parasite and parasite-parasite interactions during co-infection, parasite epidemiology, parasite ecology and the response of parasite populations to both drug treatments and control programs.	[Avramenko, Russell W.; Redman, Elizabeth M.; Gilleard, John S.] Univ Calgary, Fac Vet Med, Dept Comparat Biol & Expt Med, Calgary, AB, Canada; [Lewis, Roy] Merck Anim Hlth, Calgary, AB, Canada; [Yazwinski, Thomas A.] Univ Arkansas, Dept Anim Sci, Fayetteville, AR 72701 USA; [Wasmuth, James D.] Univ Calgary, Fac Vet Med, Dept Ecosyst & Publ Hlth, Calgary, AB, Canada	University of Calgary; University of Arkansas System; University of Arkansas Fayetteville; University of Calgary	Gilleard, JS (corresponding author), Univ Calgary, Fac Vet Med, Dept Comparat Biol & Expt Med, Calgary, AB, Canada.	jsgillea@ucalgary.ca		Gilleard, John/0000-0002-6787-4699; Wasmuth, James/0000-0002-9516-212X	Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN/371529-2209]; University of Calgary NSERC-CREATE Host Parasite Interactions (HPI); Alberta Livestock and Meat Agency (ALMA) [2011R024R]; Merck Animal Health	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Calgary NSERC-CREATE Host Parasite Interactions (HPI); Alberta Livestock and Meat Agency (ALMA); Merck Animal Health(Merck & Company)	Funding support from Natural Sciences and Engineering Research Council of Canada (NSERC) (Grant number RGPIN/371529-2209), the University of Calgary NSERC-CREATE Host Parasite Interactions (HPI) graduate training program and the Alberta Livestock and Meat Agency (ALMA) (Grant number 2011R024R). The funders provided support in the form of salaries for RWA, EMR, and JSG and research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Roy Lewis is employed with Merck Animal Health as a Technical Services Veterinarian part-time. Dr Lewis provided fecal samples for the study but the project was not funded by Merck Animal Health. Merck Animal Health provided support in the form of salary for RL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Agneessens J, 1997, VET PARASITOL, V69, P65, DOI 10.1016/S0304-4017(96)01116-8; Bik HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078230; Brooks JP, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0351-6; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chilton NB, 1998, INT J PARASITOL, V28, P1765, DOI 10.1016/S0020-7519(98)00129-5; Darby BJ, 2013, MOL ECOL, V22, P5456, DOI 10.1111/mec.12480; DOBSON RJ, 1992, INT J PARASITOL, V22, P1005, DOI 10.1016/0020-7519(92)90060-X; Durette-Desset MC, 1999, INT J PARASITOL, V29, P1065, DOI 10.1016/S0020-7519(99)00028-4; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Gasbarre LC, 2014, VET PARASITOL, V204, P3, DOI 10.1016/j.vetpar.2014.03.017; GASSER RB, 1993, NUCLEIC ACIDS RES, V21, P2525, DOI 10.1093/nar/21.10.2525; Gasser RB, 2008, BIOTECHNOL ADV, V26, P325, DOI 10.1016/j.biotechadv.2008.03.003; Gloor GB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015406; Hoglund J, 2013, VET PARASITOL, V197, P251, DOI 10.1016/j.vetpar.2013.04.044; Hotez P, 2011, VACCINE, V29, pD104, DOI 10.1016/j.vaccine.2011.06.024; Ito S., 1980, Journal of the Japan Veterinary Medical Association, V33, P424; Lee CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044224; Lello J, 2004, NATURE, V428, P840, DOI 10.1038/nature02490; Lichtenfels JR, 2008, VET PARASITOL, V156, P4, DOI 10.1016/j.vetpar.2008.04.026; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Mamedov TG, 2008, COMPUT BIOL CHEM, V32, P452, DOI 10.1016/j.compbiolchem.2008.07.021; Mochizuki R, 2006, J VET MED SCI, V68, P345, DOI 10.1292/jvms.68.345; Parkins J J, 1989, Nutr Res Rev, V2, P227, DOI 10.1079/NRR19890016; Powers TO, 1997, RDNA INTERNAL TRANSC; ROBERTS FHS, 1950, AUST J AGR RES, V1, P99, DOI 10.1071/AR9500099; Roeber F, 2014, VET PARASITOL, V205, P619, DOI 10.1016/j.vetpar.2014.08.005; Roeber F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037327; Roeber F, 2011, INFECT GENET EVOL, V11, P849, DOI 10.1016/j.meegid.2011.01.013; Rogers GB, 2010, MOL DIAGN THER, V14, P343, DOI 10.2165/11587680-000000000-00000; Sargison ND, 2010, VET REC, V167, P752, DOI 10.1136/vr.c5428; Serrano E, 2014, EPIDEMIOL INFECT, V142, P1533, DOI 10.1017/S0950268813002100; Stromberg BE, 2006, VET CLIN N AM-FOOD A, V22, P543, DOI 10.1016/j.cvfa.2006.08.003; Supali T, 2010, INT J PARASITOL, V40, P1171, DOI 10.1016/j.ijpara.2010.05.003; Sutherland IA, 2011, TRENDS PARASITOL, V27, P176, DOI 10.1016/j.pt.2010.11.008; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; van Wyk JA, 2004, VET PARASITOL, V119, P277, DOI 10.1016/j.vetpar.2003.11.012; van Wyk JA, 2013, ONDERSTEPOORT J VET, V80, DOI 10.4102/ojvr.v80i1.539; von Samson-Himmestjerna G, 2002, INT J PARASITOL, V32, P1529, DOI 10.1016/S0020-7519(02)00163-7	38	93	94	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143559	10.1371/journal.pone.0143559	http://dx.doi.org/10.1371/journal.pone.0143559			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630572	Green Published, Green Submitted, gold			2022-12-27	WOS:000365926300060
J	Biner, O; Trachsel, C; Moser, A; Kopp, L; Langenegger, N; Kampfer, U; von Ballmoos, C; Nentwig, W; Schurch, S; Schaller, J; Kuhn-Nentwig, L				Biner, Olivier; Trachsel, Christian; Moser, Aline; Kopp, Lukas; Langenegger, Nicolas; Kaempfer, Urs; von Ballmoos, Christoph; Nentwig, Wolfgang; Schuerch, Stefan; Schaller, Johann; Kuhn-Nentwig, Lucia			Isolation, N-glycosylations and Function of a Hyaluronidase-Like Enzyme from the Venom of the Spider Cupiennius salei	PLOS ONE			English	Article							HEPARAN-SULFATE; CAENORHABDITIS-ELEGANS; MULTICOMPONENT VENOM; CHONDROITIN SULFATE; SPREADING FACTOR; SCORPION-VENOM; CDNA CLONING; PURIFICATION; GLYCOSAMINOGLYCANS; ACID	Structure of Cupiennius salei venom hyaluronidase Hyaluronidases are important venom components acting as spreading factor of toxic compounds. In several studies this spreading effect was tested on vertebrate tissue. However, data about the spreading activity on invertebrates, the main prey organisms of spiders, are lacking. Here, a hyaluronidase-like enzyme was isolated from the venom of the spider Cupiennius salei. The amino acid sequence of the enzyme was determined by cDNA analysis of the venom gland transcriptome and confirmed by protein analysis. Two complex N-linked glycans akin to honey bee hyaluronidase glycosylations, were identified by tandem mass spectrometry. A C-terminal EGF-like domain was identified in spider hyaluronidase using InterPro. The spider hyaluronidase-like enzyme showed maximal activity at acidic pH, between 40-60 degrees C, and 0.2 M KCl. Divalent ions did not enhance HA degradation activity, indicating that they are not recruited for catalysis. Function of venom hyaluronidases Besides hyaluronan, the enzyme degrades chondroitin sulfate A, whereas heparan sulfate and dermatan sulfate are not affected. The end products of hyaluronan degradation are tetramers, whereas chondroitin sulfate A is mainly degraded to hexamers. Identification of terminal N-acetylglucosamine or N-acetylgalactosamine at the reducing end of the oligomers identified the enzyme as an endo-a-N-acetyl-D-hexosaminidase hydrolase. The spreading effect of the hyaluronidase-like enzyme on invertebrate tissue was studied by coinjection of the enzyme with the Cupiennius salei main neurotoxin CsTx-1 into Drosophila flies. The enzyme significantly enhances the neurotoxic activity of CsTx-1. Comparative substrate degradation tests with hyaluronan, chondroitin sulfate A, dermatan sulfate, and heparan sulfate with venoms from 39 spider species from 21 families identified some spider families (Atypidae, Eresidae, Araneidae and Nephilidae) without activity of hyaluronidase-like enzymes. This is interpreted as a loss of this enzyme and fits quite well the current phylogenetic idea on a more isolated position of these families and can perhaps be explained by specialized prey catching techniques.	[Biner, Olivier; Kopp, Lukas; Langenegger, Nicolas; Kaempfer, Urs; von Ballmoos, Christoph; Schuerch, Stefan; Schaller, Johann] Univ Bern, Dept Chem & Biochem, Bern, Switzerland; [Trachsel, Christian] Univ Zurich, Funct Genom Ctr Zurich, ETH Zurich, Zurich, Switzerland; [Moser, Aline; Nentwig, Wolfgang; Kuhn-Nentwig, Lucia] Univ Bern, Inst Ecol & Evolut, Bern, Switzerland	University of Bern; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Bern	Kuhn-Nentwig, L (corresponding author), Univ Bern, Inst Ecol & Evolut, Bern, Switzerland.	lucia.kuhn@iee.unibe.ch	Schürch, Stefan/ABE-4977-2022; Biner, Olivier Felix/AAD-1086-2022	Schürch, Stefan/0000-0001-5109-4623; Biner, Olivier Felix/0000-0001-6935-2475; von Ballmoos, Christoph/0000-0002-4642-6088				Arming S, 1997, EUR J BIOCHEM, V247, P810, DOI 10.1111/j.1432-1033.1997.t01-1-00810.x; BRUCKNER J, 1955, BIOCHEM J, V60, P200; Chao KL, 2007, BIOCHEMISTRY-US, V46, P6911, DOI 10.1021/bi700382g; Chatel A, 2010, MATRIX BIOL, V29, P494, DOI 10.1016/j.matbio.2010.05.005; Cherr GN, 2001, MATRIX BIOL, V20, P515, DOI 10.1016/S0945-053X(01)00171-8; Clement H, 2012, TOXICON, V60, P1223, DOI 10.1016/j.toxicon.2012.08.018; Csoka AB, 2013, GLYCOBIOLOGY, V23, P398, DOI 10.1093/glycob/cws218; da Silveira RB, 2007, TOXICON, V49, P758, DOI 10.1016/j.toxicon.2006.11.024; DeAngelis PL, 2002, ANAT RECORD, V268, P317, DOI 10.1002/ar.10163; DIFERRANTE N, 1956, J BIOL CHEM, V220, P303; dos Santos AVF, 2006, MICRON, V37, P41, DOI 10.1016/j.micron.2005.07.002; Duan ZG, 2013, J PROTEOMICS, V78, P416, DOI 10.1016/j.jprot.2012.10.011; Erickson M, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/893947; Escoubas P, 1995, TOXICON, V33, P1549, DOI 10.1016/0041-0101(95)00107-7; Feng L, 2008, COMP BIOCHEM PHYS C, V148, P250, DOI 10.1016/j.cbpc.2008.06.003; Ferrer VP, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002206; Fry BG, 2009, ANNU REV GENOM HUM G, V10, P483, DOI 10.1146/annurev.genom.9.081307.164356; Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x; Girish KS, 2002, MOL CELL BIOCHEM, V240, P105, DOI 10.1023/A:1020651607164; Gouveia AID, 2005, TOXICON, V45, P403, DOI 10.1016/j.toxicon.2004.11.008; Hofinger ESA, 2007, GLYCOBIOLOGY, V17, P444, DOI 10.1093/glycob/cwm003; Honda T, 2012, BIOMOLECULES, V2, P549, DOI 10.3390/biom2040549; Iacob S, 2006, INT J BIOCHEM CELL B, V38, P123, DOI 10.1016/j.biocel.2005.08.011; Jedrzejas MJ, 2005, PROTEINS, V61, P227, DOI 10.1002/prot.20592; Kakizaki I, 2010, FEBS J, V277, P1776, DOI 10.1111/j.1742-4658.2010.07600.x; Kaneiwa T, 2008, J BIOL CHEM, V283, P14971, DOI 10.1074/jbc.M709236200; Kaneiwa T, 2010, GLYCOBIOLOGY, V20, P300, DOI 10.1093/glycob/cwp174; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kelstrup CD, 2012, J PROTEOME RES, V11, P3487, DOI 10.1021/pr3000249; KEMENY DM, 1984, EUR J BIOCHEM, V139, P217, DOI 10.1111/j.1432-1033.1984.tb07997.x; Kemparaju K, 2006, CELL BIOCHEM FUNCT, V24, P7, DOI 10.1002/cbf.1261; Kolarich D, 2005, FEBS J, V272, P5182, DOI 10.1111/j.1742-4658.2005.04841.x; KUBELKA V, 1995, GLYCOCONJUGATE J, V12, P77, DOI 10.1007/BF00731872; Kuhn-Nentwig L, 2004, TOXICON, V43, P543, DOI 10.1016/j.toxicon.2004.02.009; Kuhn-Nentwig L, 2002, J BIOL CHEM, V277, P11208, DOI 10.1074/jbc.M111099200; Kuhn-Nentwig L, 2012, J BIOL CHEM, V287, P25640, DOI 10.1074/jbc.M112.339051; Kuhn-Nentwig L, 2011, ADV INSECT PHYSIOL, V40, P1, DOI 10.1016/B978-0-12-387668-3.00001-5; Kuhn-Nentwig L, 2011, AMINO ACIDS, V40, P69, DOI 10.1007/s00726-009-0471-0; KUHNNENTWIG L, 1994, TOXICON, V32, P287, DOI 10.1016/0041-0101(94)90082-5; Lawrence R, 2008, J BIOL CHEM, V283, P33674, DOI 10.1074/jbc.M804288200; Li MW, 2002, J ANDROL, V23, P211; LIN Y, 1994, J CELL BIOL, V125, P1157, DOI 10.1083/jcb.125.5.1157; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Madokoro M, 2011, TOXICON, V58, P285, DOI 10.1016/j.toxicon.2011.07.014; Markovic-Housley Z, 2000, STRUCTURE, V8, P1025, DOI 10.1016/S0969-2126(00)00511-6; Medeiros GF, 2000, BBA-GEN SUBJECTS, V1475, P287, DOI 10.1016/S0304-4165(00)00079-9; Menin Marcelo, 2005, Phyllomedusa, V4, P39; Morey SS, 2006, TOXICON, V47, P188, DOI 10.1016/j.toxicon.2005.10.014; Nagaraju S, 2007, TOXICON, V50, P383, DOI 10.1016/j.toxicon.2007.04.007; Nyffeler M, 2001, ECOL ENTOMOL, V26, P617, DOI 10.1046/j.1365-2311.2001.00365.x; Nyffeler M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099459; Nyffeler M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058120; Ospedal KZ, 2002, INT J EXP PATHOL, V83, P287, DOI 10.1046/j.1365-2613.2002.00241.x; Pessini AC, 2001, TOXICON, V39, P1495, DOI 10.1016/S0041-0101(01)00122-2; Horta CCR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002693; REISSIG JL, 1955, J BIOL CHEM, V217, P959; Sanggaard KW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4765; SCHANBAC.FL, 1973, TOXICON, V11, P21, DOI 10.1016/0041-0101(73)90147-5; Schilling B, 2012, MOL CELL PROTEOMICS, V11, P202, DOI 10.1074/mcp.M112.017707; SHIMADA E, 1984, J BIOCHEM-TOKYO, V96, P721, DOI 10.1093/oxfordjournals.jbchem.a134890; Sinnis P, 2007, J BIOL CHEM, V282, P25376, DOI 10.1074/jbc.M704698200; Smithers P, 2005, J ARACHNOL, V33, P243, DOI 10.1636/CT-05-2.1; Souza MLS, 2004, COMP BIOCHEM PHYS B, V139, P631, DOI 10.1016/j.cbpc.2004.08.017; Stern R, 2006, CHEM REV, V106, P818, DOI 10.1021/cr050247k; Stern R, 2007, BIOTECHNOL ADV, V25, P537, DOI 10.1016/j.biotechadv.2007.07.001; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Sutti R, 2014, J VENOM ANIM TOXINS, V20, DOI 10.1186/1678-9199-20-2; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; Trachsel C, 2012, FEBS J, V279, P2683, DOI 10.1111/j.1742-4658.2012.08650.x; TU AT, 1983, COMP BIOCHEM PHYS B, V76, P377, DOI 10.1016/0305-0491(83)90086-X; Veiga SS, 2000, HISTOCHEM J, V32, P397, DOI 10.1023/A:1004031019827; Vercruysse KP, 1999, CARBOHYD RES, V318, P26, DOI 10.1016/S0008-6215(99)00087-7; Violette A, 2012, MAR DRUGS, V10, P258, DOI 10.3390/md10020258; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Volpi N, 2005, BIOMACROMOLECULES, V6, P3174, DOI 10.1021/bm0505033; Volpi N, 2003, BIOCHIMIE, V85, P619, DOI 10.1016/S0300-9084(03)00083-X; Wahby AF, 2012, TOXICON, V60, P1380, DOI 10.1016/j.toxicon.2012.08.016; Yamada Shuhei, 2011, Commun Integr Biol, V4, P150, DOI 10.4161/cib.4.2.14547; Young AR, 2001, TOXICON, V39, P391, DOI 10.1016/S0041-0101(00)00145-8; Zhang L, 2009, J BIOL CHEM, V284, P9433, DOI 10.1074/jbc.M900210200	80	18	20	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143963	10.1371/journal.pone.0143963	http://dx.doi.org/10.1371/journal.pone.0143963			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630650	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000365926300131
J	Zijlema, WL; Klijs, B; Stolk, RP; Rosmalen, JGM				Zijlema, Wilma L.; Klijs, Bart; Stolk, Ronald P.; Rosmalen, Judith G. M.			(Un)Healthy in the City: Respiratory, Cardiometabolic and Mental Health Associated with Urbanity	PLOS ONE			English	Article							RISK-FACTORS; BLOOD-PRESSURE; PHYSICAL-ACTIVITY; BREAST-CANCER; AIR-POLLUTION; OBESITY; NEIGHBORHOODS; URBANIZATION; ENVIRONMENTS; MORTALITY	Background Research has shown that health differences exist between urban and rural areas. Most studies conducted, however, have focused on single health outcomes and have not assessed to what extent the association of urbanity with health is explained by population composition or socioeconomic status of the area. Our aim is to investigate associations of urbanity with four different health outcomes (i. e. lung function, metabolic syndrome, depression and anxiety) and to assess whether these associations are independent of residents' characteristics and area socioeconomic status. Methods Our study population consisted of 74,733 individuals (42% males, mean age 43.8) who were part of the baseline sample of the LifeLines Cohort Study. Health outcomes were objectively measured with spirometry, a physical examination, laboratory blood analyses, and a psychiatric interview. Using multilevel linear and logistic regression models, associations of urbanity with lung function, and prevalence of metabolic syndrome, major depressive disorder and generalized anxiety disorder were assessed. All models were sequentially adjusted for age, sex, highest education, household equivalent income, smoking, physical activity, and mean neighborhood income. Results As compared with individuals living in rural areas, those in semi-urban or urban areas had a poorer lung function (beta-1.62, 95% CI -2.07;-1.16), and higher prevalence of major depressive disorder (OR 1.65, 95% CI 1.35; 2.00), and generalized anxiety disorder (OR 1.58, 95% CI 1.35; 1.84). Prevalence of metabolic syndrome, however, was lower in urban areas (OR 0.51, 95% CI 0.44; 0.59). These associations were only partly explained by differences in residents' demographic, socioeconomic and lifestyle characteristics and socioeconomic status of the areas. Conclusions Our results suggest a differential health impact of urbanity according to type of disease. Living in an urban environment appears to be beneficial for cardiometabolic health but to have a detrimental impact on respiratory function and mental health. Future research should investigate which underlying mechanisms explain the differential health impact of urbanity.	[Zijlema, Wilma L.; Klijs, Bart; Stolk, Ronald P.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Rosmalen, Judith G. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands	University of Groningen; University of Groningen	Zijlema, WL (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands.	w.l.zijlema@umcg.nl	Zijlema, Wilma/AAE-2409-2021; Rosmalen, Judith G.M./F-5375-2011	Rosmalen, Judith G.M./0000-0002-6393-0032; Stolk, Ronald/0000-0002-0518-1205; Zijlema, Wilma/0000-0002-6257-5091	European Union Seventh Framework Programme (FP7) [261433]; Netherlands Organization of Scientific Research NWO [175.010.2007.006]; Economic Structure Enhancing Fund (FES) of the Dutch government; Ministry of Economic Affairs; Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; Northern Netherlands Collaboration of Provinces; Province of Groningen; University Medical Center Groningen; University of Groningen; Dutch Kidney Foundation; Dutch Diabetes Research Foundation; European Union Seventh Framework Programme (FP7) [261433]; Netherlands Organization of Scientific Research NWO [175.010.2007.006]; Economic Structure Enhancing Fund (FES) of the Dutch government; Ministry of Economic Affairs; Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; Northern Netherlands Collaboration of Provinces; Province of Groningen; University Medical Center Groningen; University of Groningen; Dutch Kidney Foundation; Dutch Diabetes Research Foundation	European Union Seventh Framework Programme (FP7); Netherlands Organization of Scientific Research NWO(Netherlands Organization for Scientific Research (NWO)); Economic Structure Enhancing Fund (FES) of the Dutch government; Ministry of Economic Affairs; Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; Northern Netherlands Collaboration of Provinces; Province of Groningen; University Medical Center Groningen; University of Groningen; Dutch Kidney Foundation; Dutch Diabetes Research Foundation; European Union Seventh Framework Programme (FP7); Netherlands Organization of Scientific Research NWO(Netherlands Organization for Scientific Research (NWO)); Economic Structure Enhancing Fund (FES) of the Dutch government; Ministry of Economic Affairs; Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; Northern Netherlands Collaboration of Provinces; Province of Groningen; University Medical Center Groningen; University of Groningen; Dutch Kidney Foundation; Dutch Diabetes Research Foundation	The research leading to these results received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement n<SUP>o</SUP>261433 (Biobank Standardisation and Harmonisation for Research Excellence in the European Union-BioSHaRE-EU). The LifeLines Cohort Study, and generation and management of GWAS genotype data for the LifeLines Cohort Study was supported by the Netherlands Organization of Scientific Research NWO (grant 175.010.2007.006), the Economic Structure Enhancing Fund (FES) of the Dutch government, the Ministry of Economic Affairs, the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the Northern Netherlands Collaboration of Provinces (SNN), the Province of Groningen, University Medical Center Groningen, the University of Groningen, Dutch Kidney Foundation and Dutch Diabetes Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Been JV, 2014, LANCET, V383, P1549, DOI 10.1016/S0140-6736(14)60082-9; Bluhm GL, 2007, OCCUP ENVIRON MED, V64, P122, DOI 10.1136/oem.2005.025866; Broms K, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-303; Bruner M, 2008, INT J PEDIATR OBES, V3, P205, DOI 10.1080/17477160802158477; Buhrman B., 1988, REV INCOME WEALTH, V2, P115; Burgoine T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1464; Chaix B, 2008, J HYPERTENS, V26, P1078, DOI 10.1097/HJH.0b013e3282fd991f; Chaix B, 2010, HYPERTENSION, V55, P769, DOI 10.1161/HYPERTENSIONAHA.109.143206; Chaix B, 2006, INT J EPIDEMIOL, V35, P633, DOI 10.1093/ije/dyl009; Edwards KL, 2010, J EPIDEMIOL COMMUN H, V64, P194, DOI 10.1136/jech.2009.088906; Emaus MJ, 2014, BREAST CANCER RES TR, V148, P655, DOI 10.1007/s10549-014-3205-2; Leal C, 2011, OBES REV, V12, P217, DOI 10.1111/j.1467-789X.2010.00726.x; Lederbogen F, 2011, NATURE, V474, P498, DOI 10.1038/nature10190; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lindroth M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-825; Maio S, 2009, CHEST, V135, P434, DOI 10.1378/chest.08-0252; Mujahid MS, 2008, EPIDEMIOLOGY, V19, P590, DOI 10.1097/EDE.0b013e3181772cb2; Mujahid MS, 2008, AM J EPIDEMIOL, V167, P1349, DOI 10.1093/aje/kwn047; Neovius M, 2008, OBESITY, V16, P671, DOI 10.1038/oby.2007.115; Peen J, 2010, ACTA PSYCHIAT SCAND, V121, P84, DOI 10.1111/j.1600-0447.2009.01438.x; Power MC, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1111; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Raaschou-Nielsen O, 2013, LANCET ONCOL, V14, P813, DOI 10.1016/S1470-2045(13)70279-1; Robert SA, 2004, EPIDEMIOLOGY, V15, P442, DOI 10.1097/01.ede.0000129512.61698.03; ROWLAND ML, 1990, AM J CLIN NUTR, V52, P1125, DOI 10.1093/ajcn/52.6.1125; Saelens BE, 2003, AM J PUBLIC HEALTH, V93, P1552, DOI 10.2105/AJPH.93.9.1552; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Scholtens S, 2015, INT J EPIDEMIOL, V44, P1172, DOI 10.1093/ije/dyu229; Statistics Netherlands, 2013, CBS KERNC WIJK BUURT; Stolk RP, 2008, EUR J EPIDEMIOL, V23, P67, DOI 10.1007/s10654-007-9204-4; UNFPA, 2007, STAT WORLD POP 2007; van Hooijdonk C, 2008, J EPIDEMIOL COMMUN H, V62, P499, DOI 10.1136/jech.2007.060145; Van Hulst A, 2012, J HYPERTENS, V30, P1336, DOI 10.1097/HJH.0b013e3283544863; Verheij RA, 1996, SOC SCI MED, V42, P923, DOI 10.1016/0277-9536(95)00190-5; Wilcox S, 2000, J EPIDEMIOL COMMUN H, V54, P667, DOI 10.1136/jech.54.9.667; Zijlema WL, 2015, INT J HYG ENVIR HEAL, V218, P543, DOI 10.1016/j.ijheh.2015.05.001	37	28	28	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143910	10.1371/journal.pone.0143910	http://dx.doi.org/10.1371/journal.pone.0143910			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630577	Green Published, gold, Green Submitted			2022-12-27	WOS:000365926300120
J	Chang, LL; Liu, XW; Wang, DD; Ma, J; Zhou, TY; Chen, Y; Sheng, R; Hu, YZ; Du, Y; He, QJ; Yang, B; Zhu, H				Chang, Linlin; Liu, Xiaowen; Wang, Dandan; Ma, Jian; Zhou, Tianyi; Chen, Ying; Sheng, Rong; Hu, Yongzhou; Du, Ying; He, Qiaojun; Yang, Bo; Zhu, Hong			Hypoxia-Targeted Drug Q6 Induces G2-M Arrest and Apoptosis via Poisoning Topoisomerase II under Hypoxia	PLOS ONE			English	Article							DNA TOPOISOMERASE; CANCER-THERAPY; HEPATOCELLULAR-CARCINOMA; ANTITUMOR AGENTS; SOLID TUMORS; IN-VITRO; INHIBITION; CELLS; KINASE; ATM	In spite of the tremendous efforts dedicated to developing hypoxia-activated prodrugs, no agents yet have been approved for clinical therapy. In the present study, the hypoxic selective anti-cancer activity as well as the cellular target of a novel tirapazamine (TPZ) analogue, 7-methyl-3-(3-chlorophenyl)-quinoxaline-2-carbonitrile 1,4-dioxide (Q6) were investigated. Q6 implemented anti-cancer effects via poisoning topoisomerase II (topo II) under hypoxia. Modified trapped in agarose DNA immunostaining (TARDIS) assay showed more topo II-DNA cleavage complexes trapped by Q6 than TPZ at even lower concentration. In addition, by introducing ataxia-telangiectasia-mutated (ATM) kinase inhibitors caffeine and KU-60019, we displayed that Q6-triggered apoptosis was attributed, at least partially, to DNA double-strand breaks generated by the topo II-targeting effect. Collectively, Q6 stood out for its better hypoxia-selectivity and topo II-poisoning than the parental compound TPZ. All these data shed light on the research of Q6 as a promising hypoxia-activated prodrug candidate for human hepatocellular carcinoma therapy.	[Chang, Linlin; Liu, Xiaowen; Wang, Dandan; Ma, Jian; Zhou, Tianyi; Chen, Ying; He, Qiaojun; Yang, Bo; Zhu, Hong] Zhejiang Univ, Coll Pharmaceut Sci, Zhejiang Prov Key Lab Anticanc Drug Res, Hangzhou 310003, Zhejiang, Peoples R China; [Sheng, Rong; Hu, Yongzhou] Zhejiang Univ, Coll Pharmaceut Sci, ZJU ENS Joint Lab Med Chem, Hangzhou 310003, Zhejiang, Peoples R China; [Du, Ying] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Zhu, H (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci, Zhejiang Prov Key Lab Anticanc Drug Res, Hangzhou 310003, Zhejiang, Peoples R China.	hongzhu@zju.edu.cn		Zhu, Hong/0000-0002-2575-4031	National Natural Science Foundation of China [81473228, 81473226]; Zhejiang Provincial Program for The Cultivation of HighLevel Innovative Health Talents, Zhejiang Science and Technology Department [2013C33158]; Zhejiang Provincial Nature Science Foundation of China [LQ12H16010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Program for The Cultivation of HighLevel Innovative Health Talents, Zhejiang Science and Technology Department; Zhejiang Provincial Nature Science Foundation of China	The authors gratefully acknowledge financial support from the National Natural Science Foundation of China (81473228, 81473226, http://www.nsfc.gov.cn/), Zhejiang Provincial Program for The Cultivation of HighLevel Innovative Health Talents, Zhejiang Science and Technology Department (2013C33158, http://www.zjkjt.gov.cn/), and Zhejiang Provincial Nature Science Foundation of China (LQ12H16010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbattista MR, 2015, CANCER BIOL THER, V16, P610, DOI 10.1080/15384047.2015.1017171; Ahn GO, 2007, FRONT BIOSCI-LANDMRK, V12, P3483, DOI 10.2741/2329; Biddlestone-Thorpe L, 2013, CLIN CANCER RES, V19, P3189, DOI 10.1158/1078-0432.CCR-12-3408; Cartron PF, 2002, HUM MOL GENET, V11, P675, DOI 10.1093/hmg/11.6.675; Chang Q, 2011, CANCER RES, V71, P3110, DOI 10.1158/0008-5472.CAN-10-4049; CHEN AY, 1994, ANNU REV PHARMACOL, V34, P191, DOI 10.1146/annurev.pa.34.040194.001203; Creighton-Gutteridge M, 2007, CLIN CANCER RES, V13, P1010, DOI 10.1158/1078-0432.CCR-06-2301; Dai M, 2010, J CELL MOL MED, V14, P2281, DOI 10.1111/j.1582-4934.2009.00822.x; Gammon L, 2015, J ORAL PATHOL MED; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; Hicks KO, 2010, CLIN CANCER RES, V16, P4946, DOI 10.1158/1078-0432.CCR-10-1439; Hill RP, 2009, SEMIN RADIAT ONCOL, V19, P106, DOI 10.1016/j.semradonc.2008.12.002; Hsieh T, 1994, Adv Pharmacol, V29A, P191; Hu YZ, 2012, MOLECULES, V17, P9683, DOI 10.3390/molecules17089683; Kawatani M, 2011, CHEM BIOL, V18, P743, DOI 10.1016/j.chembiol.2011.03.012; KLEIN F, 1992, J CELL BIOL, V117, P935, DOI 10.1083/jcb.117.5.935; Liao D, 2007, CANCER METAST REV, V26, P281, DOI 10.1007/s10555-007-9066-y; LIU LF, 1989, ANNU REV BIOCHEM, V58, P351, DOI 10.1146/annurev.bi.58.070189.002031; Liu XW, 2014, AUTOPHAGY, V10, P111, DOI 10.4161/auto.26838; Magdolenova Z, 2015, NANOTOXICOLOGY, V9, P44, DOI 10.3109/17435390.2013.847505; Marcu L, 2006, CURR CLIN PHARMACOL, V1, P71, DOI 10.2174/157488406775268192; Melillo G, 2007, CANCER METAST REV, V26, P341, DOI 10.1007/s10555-007-9059-x; Papadopoulou MV, 2003, CLIN CANCER RES, V9, P5714; Patterson AV, 2007, CLIN CANCER RES, V13, P3922, DOI 10.1158/1078-0432.CCR-07-0478; Patterson LH, 2000, BRIT J CANCER, V83, P1589, DOI 10.1054/bjoc.2000.1564; Peters KB, 2002, CANCER RES, V62, P5248; Raleigh SM, 1998, INT J RADIAT ONCOL, V42, P763, DOI 10.1016/S0360-3016(98)00308-3; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Saggar JK, 2014, INT J CANCER, V134, P2726, DOI 10.1002/ijc.28595; Semenza GL, 2004, CANCER CELL, V5, P405, DOI 10.1016/S1535-6108(04)00118-7; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shiloh Y, 2001, CURR OPIN GENET DEV, V11, P71, DOI 10.1016/S0959-437X(00)00159-3; Smart DJ, 2008, MUTAT RES-FUND MOL M, V641, P43, DOI 10.1016/j.mrfmmm.2008.03.005; Sudan S, 2014, NUTR CANCER, V66, P1237, DOI 10.1080/01635581.2014.951733; Sun JD, 2015, CANCER BIOL THER, V16, P438, DOI 10.1080/15384047.2014.1003005; TANABE K, 1991, CANCER RES, V51, P4903; Tang YZ, 2014, MOL CANCER THER, V13, P1526, DOI 10.1158/1535-7163.MCT-13-0981; Toh YM, 2011, CLIN CANCER RES, V17, P5026, DOI 10.1158/1078-0432.CCR-11-0235; Wang QZ, 1996, J NATL CANCER I, V88, P956, DOI 10.1093/jnci/88.14.956; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Yao SL, 1996, NAT MED, V2, P1140, DOI 10.1038/nm1096-1140; Zheng L, 2014, INT J CANCER, V135, P1721, DOI 10.1002/ijc.28810; Zheng L, 2011, CANCER LETT, V309, P27, DOI 10.1016/j.canlet.2011.05.011; Zhu H, 2007, MOL CANCER THER, V6, P484, DOI 10.1158/1535-7163.MCT-06-0584; Zirkin S, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.458851	45	9	10	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144506	10.1371/journal.pone.0144506	http://dx.doi.org/10.1371/journal.pone.0144506			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26649750	gold, Green Published, Green Submitted			2022-12-27	WOS:000366903300052
J	Chen, F; Long, ZH; Yin, JB; Zuo, ZY; Li, H				Chen, Feng; Long, Zonghong; Yin, Jinbo; Zuo, Zhiyi; Li, Hong			Isoflurane Post-Treatment Improves Outcome after an Embolic Stroke in Rabbits	PLOS ONE			English	Article							ISCHEMIA; INJURY; RATS; NEUROPROTECTION; EPIDEMIOLOGY; PREVALENCE; MICE	Application of commonly used volatile anesthetics after brain ischemia onset (post-treatment) provides neuroprotection in rodents. To further test its translational potential, this study was designed to determine whether isoflurane post-treatment induced neuroprotection in rabbits after embolic stroke. White male New Zealand rabbits received intra-carotid injection of clots when they were awake. Some rabbits were exposed to 2.5% isoflurane for 1 h at 5 min after the injection. Isoflurane post-treatment increased the tolerance of rabbits to the amount of clots. Isoflurane post-treatment also reduced brain infarct volumes and plasma S100B 3 days after the injection of 5 mg clots and improved neurological deficit scores after the stroke. Isoflurane post-treatment improves neurological outcome in rabbits after embolic stroke.	[Chen, Feng; Long, Zonghong; Zuo, Zhiyi; Li, Hong] Third Mil Med Univ, Dept Anesthesiol, Xinqiao Hosp, Chongqing, Peoples R China; [Yin, Jinbo] Third Mil Med Univ, Dept Neurosurg, Xinqiao Hosp, Chongqing, Peoples R China; [Zuo, Zhiyi] Univ Virginia, Dept Anesthesiol, Charlottesville, VA USA	Army Medical University; Army Medical University; University of Virginia	Zuo, ZY (corresponding author), Third Mil Med Univ, Dept Anesthesiol, Xinqiao Hosp, Chongqing, Peoples R China.	zz3c@virginia.edu; Lh78553@126.com	Zuo, Zhiyi/F-3950-2010	Zuo, Zhiyi/0000-0002-3542-5047	Natural Science Foundation Project of CQ CSTC of China [CSTC2013C292]; National Natural Science Foundation of China, Beijing, China [81070094, 81471192]; Robert M. Epstein Professorship, University of Virginia, Charlottesville, VA, USA	Natural Science Foundation Project of CQ CSTC of China(Natural Science Foundation Project of CQ CSTC); National Natural Science Foundation of China, Beijing, China(National Natural Science Foundation of China (NSFC)); Robert M. Epstein Professorship, University of Virginia, Charlottesville, VA, USA	This study was supported by grants from Natural Science Foundation Project of CQ CSTC (CSTC2013C292) of China, the National Natural Science Foundation of China (grant numbers: 81070094 and 81471192), Beijing, China, and Robert M. Epstein Professorship, University of Virginia, Charlottesville, VA, USA.	Altay O, 2012, STROKE, V43, P2513, DOI 10.1161/STROKEAHA.112.661728; An SA, 2013, CLIN BIOCHEM, V46, P710, DOI 10.1016/j.clinbiochem.2013.02.005; DRUMMOND JC, 1985, ANESTHESIOLOGY, V62, P336, DOI 10.1097/00000542-198503000-00020; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; GARCIA JH, 1993, AM J PATHOL, V142, P623; Gonzalez-Garcia S, 2012, CLIN BIOCHEM, V45, P1302, DOI 10.1016/j.clinbiochem.2012.07.094; Grysiewicz RA, 2008, NEUROL CLIN, V26, P871, DOI 10.1016/j.ncl.2008.07.003; Lapchak PA, 2010, BRAIN RES, V1309, P136, DOI 10.1016/j.brainres.2009.10.067; Lapchak PA, 2009, BRAIN RES, V1294, P211, DOI 10.1016/j.brainres.2009.07.058; Lee JJ, 2008, ANESTHESIOLOGY, V108, P1055, DOI 10.1097/ALN.0b013e3181730257; Li H, 2013, NEUROBIOL DIS, V54, P216, DOI 10.1016/j.nbd.2012.12.014; Ren XY, 2014, NEUROL SCI, V35, P1401, DOI 10.1007/s10072-014-1726-4; Wang DD, 2008, PROG NEUROBIOL, V86, P342, DOI 10.1016/j.pneurobio.2008.09.015; Wang JK, 2010, BRAIN RES, V1357, P142, DOI 10.1016/j.brainres.2010.08.009; ZIVIN JA, 1985, SCIENCE, V230, P1289, DOI 10.1126/science.3934754; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027	16	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0143931	10.1371/journal.pone.0143931	http://dx.doi.org/10.1371/journal.pone.0143931			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YV	26645542	Green Submitted, Green Published, gold			2022-12-27	WOS:000366903100011
J	Chang, YL; Sheng, JY; Ohashi, K; Beguer-Pon, M; Miyazawa, Y				Chang, Yu-Lin; Sheng, Jinyu; Ohashi, Kyoko; Beguer-Pon, Melanie; Miyazawa, Yasumasa			Impacts of Interannual Ocean Circulation Variability on Japanese Eel Larval Migration in the Western North Pacific Ocean	PLOS ONE			English	Article							EQUATORIAL CURRENT; EUROPEAN EEL; GLASS EELS; EL-NINO; ANGUILLA; TRANSPORT; WATER; LEPTOCEPHALI; RECRUITMENT; MORTALITY	The Japanese eel larvae hatch near the West Mariana Ridge seamount chain and travel through the North Equatorial Current (NEC), the Kuroshio, and the Subtropical Countercurrent (STCC) region during their shoreward migration toward East Asia. The interannual variability of circulation over the subtropical and tropical regions of the western North Pacific Ocean is affected by the Philippines-Taiwan Oscillation (PTO). This study examines the effect of the PTO on the Japanese eel larval migration routes using a three-dimensional (3D) particle tracking method, including vertical and horizontal swimming behavior. The 3D circulation and hydrography used for particle tracking are from the ocean circulation reanalysis produced by the Japan Coastal Ocean Predictability Experiment 2 (JCOPE2). Our results demonstrate that bifurcation of the NEC and the strength and spatial variation of the Kuroshio affect the distribution and migration of eel larvae. During the positive phase of PTO, more virtual eels ("v-eels") can enter the Kuroshio to reach the south coast of Japan and more v-eels reach the South China Sea through the Luzon Strait; the stronger and more offshore swing of the Kuroshio in the East China Sea leads to fewer eels entering the East China Sea and the onshore movement of the Kuroshio to the south of Japan brings the eels closer to the Japanese coast. Significant differences in eel migration routes and distributions regulated by ocean circulation in different PTO phases can also affect the otolith increment. The estimated otolith increment suggests that eel age tends to be underestimated after six months of simulation due to the cooler lower layer temperature. Underestimation is more significant in the positive PTO years due to the wide distribution in higher latitudes than in the negative PTO years.	[Chang, Yu-Lin] Natl Taiwan Normal Univ, Inst Marine Environm Sci & Technol, Taipei, Taiwan; [Chang, Yu-Lin; Sheng, Jinyu; Ohashi, Kyoko; Beguer-Pon, Melanie] Dalhousie Univ, Dept Oceanog, Halifax, NS, Canada; [Miyazawa, Yasumasa] Japan Agcy Marine Earth Sci & Technol, Applicat Lab, Yokohama, Kanagawa, Japan	National Taiwan Normal University; Dalhousie University; Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Chang, YL (corresponding author), Natl Taiwan Normal Univ, Inst Marine Environm Sci & Technol, Taipei, Taiwan.	ychang@ntnu.edu.tw	Miyazawa, Yasumasa/J-3196-2014	Miyazawa, Yasumasa/0000-0002-0107-6272	Ministry of Science and Technology of Taiwan [102-2611-M-003-003-MY3]; research abroad grant [104-2918-I-003-001]; Lloyd's Register Foundation; JSPS KAKENHI [26287116]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); research abroad grant; Lloyd's Register Foundation; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	YLC is supported by the Ministry of Science and Technology of Taiwan under grant 102-2611- M-003-003-MY3, and the research abroad grant (104-2918-I-003-001). JS is supported by Lloyd's Register Foundation. YM is supported by JSPS KAKENHI (26287116). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The observed drifter data are obtained from the Global Drifter Program. YLC is supported by the Ministry of Science and Technology of Taiwan under grant 102-2611-M-003-003-MY3, and the research abroad grant (104-2918-I-003-001). JS is supported by Lloyd's Register Foundation, which helps to protect life and property by supporting engineering-related education, public engagement, and the application of research. YM is supported by JSPS KAKENHI (26287116).	Aida K., 2003, EEL BIOL; Aoyama J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088759; Balmaseda MA, 2013, Q J ROY METEOR SOC, V139, P1132, DOI 10.1002/qj.2063; Baltazar-Soares M, 2014, CURRENT BIOL; Blanke B, 2012, DYNAM ATMOS OCEANS, V55-56, P22, DOI 10.1016/j.dynatmoce.2012.04.003; Bonhommeau S, 2009, J FISH BIOL, V74, P1891, DOI 10.1111/j.1095-8649.2009.02298.x; Bonhommeau S, 2008, MAR ECOL PROG SER, V373, P71, DOI 10.3354/meps07696; Campana SE, 2005, MAR FRESHWATER RES, V56, P485, DOI 10.1071/MF04147; CASTONGUAY M, 1987, J PLANKTON RES, V9, P195, DOI 10.1093/plankt/9.1.195; Chang YL, 2012, J CLIMATE, V25, P1597, DOI 10.1175/JCLI-D-11-00158.1; Chang YL, 2015, PROG OCEANOGR, V135, P64, DOI 10.1016/j.pocean.2015.04.006; Dekker W, 2003, FISHERIES MANAG ECOL, V10, P365, DOI 10.1111/j.1365-2400.2003.00352.x; FLIERL GR, 1981, GEOPHYS ASTRO FLUID, V18, P39, DOI 10.1080/03091928108208773; Friedland KD, 2007, ICES J MAR SCI, V64, P519, DOI 10.1093/icesjms/fsm022; Fukuda N, 2009, J FISH BIOL, V74, P1915, DOI 10.1111/j.1095-8649.2009.02287.x; Gentleman W, 2002, HYDROBIOLOGIA, V480, P69, DOI 10.1023/A:1021289119442; Han YS, 2009, ZOOL STUD, V48, P632; ICES (2006) (International Council for the Exploration of the Sea), 2006, REP EIF ICES WORK GR; Jacoby D, 2014, ANGUILLA JAPONICA IU; Kim H, 2007, ICES J MAR SCI, V64, P1387, DOI 10.1093/icesjms/fsm091; Kimura S, 2001, FISH OCEANOGR, V10, P51, DOI 10.1046/j.1365-2419.2001.00159.x; Knights B, 2003, SCI TOTAL ENVIRON, V310, P237, DOI 10.1016/S0048-9697(02)00644-7; Kuroki Mari, 2010, Coastal Marine Science, V34, P31; Mellor G, 2002, OCEAN FORECASTING CO, P55, DOI DOI 10.1007/978-3-662-22648-3_4; Miller Michael J., 2009, Aqua-Bioscience Monographs, V2, P1; Miyazawa Y, 2009, J OCEANOGR, V65, P737, DOI 10.1007/s10872-009-0063-3; Ohashi K, 2015, ATMOSPHERE OCEAN; Press W., 1992, NUMERICAL RECIPES FO; Qiu B, 2010, J PHYS OCEANOGR, V40, P2525, DOI 10.1175/2010JPO4462.1; Qiu B, 2010, J PHYS OCEANOGR, V40, P213, DOI 10.1175/2009JPO4285.1; Rypina II, 2014, LIMNOL OCEANOGR, V59, P1704, DOI 10.4319/lo.2014.59.5.1704; Shan SL, 2014, OCEAN DYNAM, V64, P117, DOI 10.1007/s10236-013-0672-7; Sheng JY, 2009, J MARINE SYST, V77, P350, DOI 10.1016/j.jmarsys.2008.01.013; Shinoda A, 2011, REV FISH BIOL FISHER, V21, P591, DOI 10.1007/s11160-010-9195-1; Tesch F.-W., 2003, THE EEL; Tsukamoto K, 2009, J FISH BIOL, V74, P1833, DOI 10.1111/j.1095-8649.2009.02242.x; Tsukamoto K, 2006, NATURE, V439, P929, DOI 10.1038/439929a; TSUKAMOTO K, 1992, NATURE, V356, P789, DOI 10.1038/356789a0; Tzeng WN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030805; Wang J, 2014, GEOPHYS RES LETT, V41, P8538, DOI 10.1002/2014GL062118; Wuenschel MJ, 2008, MAR BIOL, V154, P775, DOI 10.1007/s00227-008-0970-7; Yamada Y, 2009, MAR ECOL PROG SER, V379, P241, DOI 10.3354/meps07912; Zenimoto K, 2009, J FISH BIOL, V74, P1878, DOI 10.1111/j.1095-8649.2009.02295.x; Zenimoto K, 2011, MAR ECOL PROG SER, V438, P219, DOI 10.3354/meps09255	44	26	27	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144423	10.1371/journal.pone.0144423	http://dx.doi.org/10.1371/journal.pone.0144423			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642318	Green Published, Green Submitted, gold			2022-12-27	WOS:000366902700118
J	Dovana, F; Mucciarelli, M; Mascarello, M; Fusconi, A				Dovana, Francesco; Mucciarelli, Marco; Mascarello, Maurizio; Fusconi, Anna			In Vitro Morphogenesis of Arabidopsis to Search for Novel Endophytic Fungi Modulating Plant Growth	PLOS ONE			English	Article							MODEL SYSTEM; THALIANA; DIVERSITY; BACTERIA; IDENTIFICATION; ARCHITECTURE; MYCORRHIZAE; PATHOGENS; PHOSPHATE; RESPONSES	Fungal endophytes have shown to affect plant growth and to confer stress tolerance to the host; however, effects of endophytes isolated from water plants have been poorly investigated. In this study, fungi isolated from stems (stem-E) and roots (root-E) of Mentha aquatica L. (water mint) were identified, and their morphogenetic properties analysed on in vitro cultured Arabidopsis (L.) Heynh., 14 and 21 days after inoculation (DAI). Nineteen fungi were analysed and, based on ITS analysis, 17 isolates showed to be genetically distinct. The overall effect of water mint endophytes on Arabidopsis fresh (FW) and dry weight (DW) was neutral and positive, respectively, and the increased DW, mainly occurring 14 DAI, was possibly related to plant defence mechanism. Only three fungi increased both FW and DW of Arabidopsis at 14 and 21 DAI, thus behaving as plant growth promoting (PGP) fungi. E-treatment caused a reduction of root depth and primary root length in most cases and inhibition-to-promotion of root area and lateral root length, from 14 DAI. Only Phoma macrostoma, among the water mint PGP fungi, increased both root area and depth, 21 DAI. Root depth and area 14 DAI were shown to influence DWs, indicating that the extension of the root system, and thus nutrient uptake, was an important determinant of plant dry biomass. Reduction of Arabidopsis root depth occurred to a great extent when plants where treated with stem-E while root area decreased or increased under the effects of stem-E and root-E, respectively, pointing to an influence of the endophyte origin on root extension. M. aquatica and many other perennial hydrophytes have growing worldwide application in water pollution remediation. The present study provided a model for directed screening of endophytes able to modulate plant growth in the perspective of future field applications of these fungi.	[Dovana, Francesco] Univ Piemonte Orientale, Dept Sci & Innovat Technol, Alessandria, Italy; [Mucciarelli, Marco; Mascarello, Maurizio; Fusconi, Anna] Univ Turin, Dept Life Sci & Syst Biol, Turin, Italy	University of Eastern Piedmont Amedeo Avogadro; University of Turin	Mucciarelli, M (corresponding author), Univ Turin, Dept Life Sci & Syst Biol, Turin, Italy.	marco.mucciarelli@unito.it	Mucciarelli, Marco/D-6054-2011; dovana, francesco/AAA-4431-2020	dovana, francesco/0000-0002-8556-7692	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	A. Fusconi and M. Mucciarelli were supported by Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Contreras-Cornejo HA, 2015, J PLANT GROWTH REGUL, V34, P425, DOI 10.1007/s00344-014-9471-8; Contreras-Cornejo HA, 2009, PLANT PHYSIOL, V149, P1579, DOI 10.1104/pp.108.130369; Avelar FF, 2014, ENVIRON TECHNOL, V35, P2095, DOI 10.1080/09593330.2014.893025; Bailey KL, 2011, BIOL CONTROL, V59, P268, DOI 10.1016/j.biocontrol.2011.06.019; Botella L, 2011, FUNGAL DIVERS, V47, P9, DOI 10.1007/s13225-010-0061-1; Brankovic S, 2015, BIOTECHNOL BIOTECHNO, V26, P2731; Brundrett M, 2004, BIOL REV, V79, P473, DOI 10.1017/S1464793103006316; Dolatabadi HK, 2011, SYMBIOSIS, V53, P29, DOI 10.1007/s13199-010-0104-0; Fouda A. H., 2015, Annals of Agricultural Science (Cairo), V60, P95; Fusconi A, 2014, ANN BOT-LONDON, V113, P19, DOI 10.1093/aob/mct258; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Goh CH, 2013, J CHEM ECOL, V39, P826, DOI 10.1007/s10886-013-0326-8; Gramaje D, 2011, PLANT DIS, V95, P1040, DOI 10.1094/PDIS-01-11-0025; Gravel V, 2007, SOIL BIOL BIOCHEM, V39, P1968, DOI 10.1016/j.soilbio.2007.02.015; Haichar FE, 2014, SOIL BIOL BIOCHEM, V77, P69, DOI 10.1016/j.soilbio.2014.06.017; Hamann E, 2013, ANN BOT-LONDON, V112, P1869, DOI 10.1093/aob/mct221; Hodge A, 2009, PLANT SOIL, V321, P153, DOI 10.1007/s11104-009-9929-9; Hung R, 2013, FUNGAL ECOL, V6, P19, DOI 10.1016/j.funeco.2012.09.005; Jaber LR, 2010, ECOL ENTOMOL, V35, P25, DOI 10.1111/j.1365-2311.2009.01152.x; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Khan AL, 2015, CRIT REV BIOTECHNOL, V35, P62, DOI 10.3109/07388551.2013.800018; Khan AL, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-51; Long HH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002702; Lopez-Bucio J, 2002, PLANT PHYSIOL, V129, P244, DOI 10.1104/pp.010934; Ludwig-Muller J, 2015, J PLANT PHYSIOL, V172, P4, DOI 10.1016/j.jplph.2014.01.002; Mandyam KG, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00776; Mandyam KG, 2013, FUNGAL BIOL-UK, V117, P250, DOI 10.1016/j.funbio.2013.02.001; Martinuz A, 2015, PLANTA, V241, P1015, DOI 10.1007/s00425-014-2237-5; Mayerhofer MS, 2013, MYCORRHIZA, V23, P119, DOI 10.1007/s00572-012-0456-9; Mucciarelli M, 2003, NEW PHYTOL, V158, P579, DOI 10.1046/j.1469-8137.2003.00762.x; Mucciarelli M, 2002, MYCOLOGIA, V94, P28, DOI 10.2307/3761843; Mucciarelli M, 2007, MICROB ECOL, V54, P685, DOI 10.1007/s00248-007-9227-0; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Murphy BR, 2015, SYMBIOSIS, V65, P1, DOI 10.1007/s13199-015-0314-6; Newsham KK, 2011, NEW PHYTOL, V190, P783, DOI 10.1111/j.1469-8137.2010.03611.x; Okane I, 2015, CURR SC, V108, P1; Okubara PA, 2005, PLANT SOIL, V274, P215, DOI 10.1007/s11104-004-7328-9; Peskan-Berghofer T, 2004, PHYSIOL PLANTARUM, V122, P465, DOI 10.1111/j.1399-3054.2004.00424.x; PITT JI, 1991, PHYTOPATHOLOGY, V81, P1108, DOI 10.1094/Phyto-81-1108; Rai M, 2014, SYMBIOSIS, V62, P63, DOI 10.1007/s13199-014-0273-3; Remans T, 2012, ANN BOT-LONDON, V110, P239, DOI 10.1093/aob/mcs105; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Rosa LH, 2010, FEMS MICROBIOL ECOL, V73, P178, DOI 10.1111/j.1574-6941.2010.00872.x; Salas-Marina MA, 2011, J MICROBIOL BIOTECHN, V21, P686, DOI 10.4014/jmb.1101.01012; Sandberg DC, 2014, MICROB ECOL, V67, P735, DOI 10.1007/s00248-013-0324-y; Sati SC, 2010, SYMBIOSIS, V50, P143, DOI 10.1007/s13199-010-0054-6; Sherameti I, 2008, MOL PLANT MICROBE IN, V21, P799, DOI 10.1094/MPMI-21-6-0799; Skouboe P, INTEGRATION MODERN T, P179; Su H, 2014, CHIANG MAI J SCI, V41, P1; Sukumar P, 2013, PLANT CELL ENVIRON, V36, P909, DOI 10.1111/pce.12036; Vadassery J, 2008, MOL PLANT MICROBE IN, V21, P1371, DOI 10.1094/MPMI-21-10-1371; Vandenkoornhuyse P, 2015, NEW PHYTOL, V206, P1196, DOI 10.1111/nph.13312; Vaz ABM, 2012, APPL SOIL ECOL, V61, P288, DOI 10.1016/j.apsoil.2011.10.017; Wachowska U, 2014, BIOCONTROL, V59, P635, DOI 10.1007/s10526-014-9596-5; Wang XM, 2015, J BASIC MICROB, V55, P659, DOI 10.1002/jobm.201300601; Wani ZA, 2015, APPL MICROBIOL BIOT, V99, P2955, DOI 10.1007/s00253-015-6487-3; Waqas M, 2015, MOLECULES, V9, P10754; Waqas M, 2014, J PLANT INTERACT, V9, P478, DOI 10.1080/17429145.2013.860562; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Zalar P, 2007, STUD MYCOL, P157, DOI 10.3114/sim.2007.58.06; Zurayk R, 2002, WATER AIR SOIL POLL, V139, P355, DOI 10.1023/A:1015840601761	61	12	13	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0143353	10.1371/journal.pone.0143353	http://dx.doi.org/10.1371/journal.pone.0143353			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641657	Green Published, Green Submitted, gold			2022-12-27	WOS:000366902700015
J	Garbarino, S; Magnavita, N				Garbarino, Sergio; Magnavita, Nicola			Work Stress and Metabolic Syndrome in Police Officers. A Prospective Study	PLOS ONE			English	Article							EFFORT-REWARD IMBALANCE; CORONARY-HEART-DISEASE; JOB DEMAND-CONTROL; CARDIOVASCULAR-DISEASE; PSYCHOMETRIC PROPERTIES; OCCUPATIONAL STRESS; DECISION LATITUDE; PERCEIVED STRESS; OXIDATIVE STRESS; LIFE-STYLE	Objective The aim of this longitudinal study was to evaluate the association between occupational stress and metabolic syndrome (MetS) in a rapid response police unit. Method Work-related stress was continuously monitored during the 5-year period with both the Demand-Control-Support (DCS) and the Effort-Reward Imbalance (ERI) models. Blood pressure, body mass index (BMI), waist circumference, triglycerides, HDL-cholesterol, and fasting blood glucose were measured at baseline in January 2009, and in January 2014. 234 out of 290 police officers (81%) completed the follow-up. Results The majority of police officers had high stress levels. At follow-up, police officers in the highest quartile of stress had significantly higher mean levels of triglycerides, and lower levels of HDL-cholesterol than their colleagues in the lowest quartile. Police officers with high stress had an increased adjusted risk of developing MetS (aOR = 2.68; CI95%= 1.08-6.70), and hypertriglyceridemia (aOR = 7.86; CI95 = 1.29-48.04). Demand and Effort were significant predictors of MetS. Conclusion Our study supports the hypothesis that work-related stress induces MetS, particularly through its effects on blood lipids. Future longitudinal studies with continuous monitoring of stress levels will definitively confirm this hypothesis.	[Garbarino, Sergio] Minist Interior, State Police Hlth Serv Dept, Genoa, Italy; [Garbarino, Sergio] Univ Genoa, Dept Hlth Sci, Genoa, Italy; [Garbarino, Sergio] Dept Neurosci Rehabil Ophthalmol Genet & Maternal, Genoa, Italy; [Magnavita, Nicola] Univ Cattolica Sacro Cuore, Dept Publ Hlth, Rome, Italy	University of Genoa; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Magnavita, N (corresponding author), Univ Cattolica Sacro Cuore, Dept Publ Hlth, Rome, Italy.	nicolamagnavita@gmail.com	Magnavita, Nicola/J-6074-2014; Garbarino, Sergio/AAV-4629-2021; Garbarino, Sergio/X-5368-2018	Magnavita, Nicola/0000-0002-0988-7344; Garbarino, Sergio/0000-0002-8508-552X; Garbarino, Sergio/0000-0002-8508-552X				Allard KO, 2011, J OCCUP ENVIRON MED, V53, P1364, DOI 10.1097/JOM.0b013e3182363bda; Almadi T, 2013, PSYCHOPHYSIOLOGY, V50, P821, DOI 10.1111/psyp.12069; Aschbacher K, 2014, PSYCHONEUROENDOCRINO, V46, P14, DOI 10.1016/j.psyneuen.2014.04.003; Bartoli F, 2013, METAB SYNDR RELAT D, V11, P301, DOI 10.1089/met.2013.0010; Baughman P, 2016, AM J HUM BIOL, V28, P138, DOI 10.1002/ajhb.22748; Beck-Nielsen H., 2013, METABOLIC SYNDROME, DOI [10.1007/978-3-7091-1331-8_2, DOI 10.1007/978-3-7091-1331-8_]; Bergmann N, 2014, ENDOCR CONNECT, V3, pR55, DOI 10.1530/EC-14-0031; Berset M, 2011, SCAND J WORK ENV HEA, V37, P45, DOI 10.5271/sjweh.3089; Bhandari R, 2014, INT J BREAST CANCER, V2014, DOI 10.1155/2014/189384; Bo S, 2007, DIABETES RES CLIN PR, V75, P362, DOI 10.1016/j.diabres.2006.06.031; Braga RT, 2014, AM J MENS HEALTH, V8, P503, DOI 10.1177/1557988314526750; Chandola T, 2006, BMJ-BRIT MED J, V332, P521, DOI 10.1136/bmj.38693.435301.80; Chandola T, 2008, EUR HEART J, V29, P640, DOI 10.1093/eurheartj/ehm584; Chen X, 2015, J OCCUP ENVIRON MED, V57, P400, DOI 10.1097/JOM.0000000000000372; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Copertaro A, 2009, EPIDEMIOL PREV, V33, P227; Dashti HS, 2015, AM J HYPERTENS; Djindjic N, 2012, ANN OCCUP HYG, V56, P1051, DOI 10.1093/annhyg/mes059; Edwards EM, 2012, J OCCUP ENVIRON MED, V54, P1447, DOI 10.1097/JOM.0b013e3182783f27; Esposito K, 2012, DIABETES CARE, V35, P2402, DOI 10.2337/dc12-0336; Falkner B, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0449-5; Federation ID, 2006, IDF CONS WORLDW DEF; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Fujishiro K, 2011, J IMMIGR MINOR HEALT, V13, P533, DOI 10.1007/s10903-010-9364-2; Garbarino S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097188; Garbarino S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002791; Gimeno D, 2010, OCCUP ENVIRON MED, V67, P256, DOI 10.1136/oem.2009.047324; Griep RH, 2009, INT ARCH OCC ENV HEA, V82, P1163, DOI 10.1007/s00420-009-0460-3; Hartley Tara A, 2011, Int J Emerg Ment Health, V13, P243; Hartley TA, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/861219; Hermida RC, 2007, CHRONOBIOL INT, V24, P749, DOI 10.1080/07420520701535837; Hermida RC, 2010, CHRONOBIOL INT, V27, P1629, DOI 10.3109/07420528.2010.510230; Janczura M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133750; Joseph PN, 2009, J OCCUP ENVIRON MED, V51, P700, DOI 10.1097/JOM.0b013e3181a02252; Kang MG, 2004, YONSEI MED J, V45, P838, DOI 10.3349/ymj.2004.45.5.838; KARASEK RA, 1979, ADMIN SCI QUART, V24, P285, DOI 10.2307/2392498; Kawada T, 2013, INT ARCH OCC ENV HEA, V86, P725, DOI 10.1007/s00420-013-0870-0; Kivimaki M, 2012, LANCET, V380, P1491, DOI 10.1016/S0140-6736(12)60994-5; Kivimaki M, 2002, BRIT MED J, V325, P857, DOI 10.1136/bmj.325.7369.857; Kumar Pranav, 2013, Indian J Public Health, V57, P24, DOI 10.4103/0019-557X.111364; Maggi S, 2006, J GERONTOL A-BIOL, V61, P505, DOI 10.1093/gerona/61.5.505; Magnavita N, 2008, RADIOL MED, V113, P329, DOI 10.1007/s11547-008-0259-4; Magnavita N, 2007, G Ital Med Lav Ergon, V29, P667; Magnavita Nicola, 2013, Psychiatry J, V2013, P701872, DOI 10.1155/2013/701872; Magnavita N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130944; Magnavita N, 2014, J NURS SCHOLARSHIP, V46, P366, DOI 10.1111/jnu.12088; Magnavita N, 2014, RADIOL MED, V119, P142, DOI 10.1007/s11547-013-0329-0; Magnavita N, 2013, AM J IND MED, V56, P765, DOI 10.1002/ajim.22155; Magnavital Nicola, 2014, G Ital Med Lav Ergon, V36, P400; Maia DB, 2008, J AFFECT DISORDERS, V107, P259, DOI 10.1016/j.jad.2007.08.013; da Silva MEM, 2012, J MED ETHICS, V38, P639, DOI 10.1136/medethics-2011-100208; McCanlies EC, 2012, WORK, V43, P133, DOI 10.3233/WOR-2012-1399; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; Niedhammer I, 2002, INT ARCH OCC ENV HEA, V75, P129, DOI 10.1007/s004200100270; Nieuwenhuijsen K, 2010, OCCUP MED-OXFORD, V60, P277, DOI 10.1093/occmed/kqq081; Nomura K, 2010, AM J IND MED, V53, P1128, DOI 10.1002/ajim.20859; Novelletto BF, 2012, METAB SYNDR RELAT D, V10, P56, DOI 10.1089/met.2011.0065; Pelfrene E, 2001, WORK STRESS, V15, P297, DOI 10.1080/02678370110086399; Pickering T G, 2001, Curr Hypertens Rep, V3, P249, DOI 10.1007/s11906-001-0047-1; Puustinen PJ, 2011, PSYCHOSOM MED, V73, P158, DOI 10.1097/PSY.0b013e3182037315; Rosenbaum S, 2015, METABOLISM, V64, P926, DOI [10.1016/j.metabol.2015.04.009, 10.1016/j.metabol.2015.01.016]; Sale JEM, 2002, INT ARCH OCC ENV HEA, V75, P145, DOI 10.1007/s004200100289; Sanne B, 2005, SCAND J PUBLIC HEALT, V33, P166, DOI 10.1080/14034940410019217; Scheen A J, 2003, Rev Med Liege, V58, P479; Schmidt B, 2015, INT J CARDIOL, V178, P24, DOI 10.1016/j.ijcard.2014.10.115; Siegrist J, 1996, J Occup Health Psychol, V1, P27, DOI 10.1037/1076-8998.1.1.27; Siervo M, 2014, J ALZHEIMERS DIS, V41, P151, DOI 10.3233/JAD-132279; Soderberg M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1102; Song Fu-jun, 2013, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V31, P834; Steptoe A, 2013, ANNU REV PUBL HEALTH, V34, P337, DOI 10.1146/annurev-publhealth-031912-114452; Tangvarasittichai S, 2015, WORLD J DIABETES, V6, P456, DOI 10.4239/wjd.v6.i3.456; Thayyil J, 2012, N AM J MED SCI, V4, P630, DOI 10.4103/1947-2714.104313; Tsimakouridze Elena V, 2015, Front Pharmacol, V6, P77, DOI 10.3389/fphar.2015.00077; van Vliet-Ostaptchouk JV, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-9; Vidigal FD, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1198; Violanti JM, 2009, ARCH ENVIRON OCCUP H, V64, P194, DOI 10.1080/19338240903241259; Walvekar SS, 2015, J CLIN DIAGN RES, V9, pBC10, DOI 10.7860/JCDR/2015/12015.5576; Wilson MG, 2012, J SCI MED SPORT, V15, P266, DOI 10.1016/j.jsams.2011.10.007; Wirth MD, 2014, J OCCUP ENVIRON MED, V56, P986, DOI 10.1097/JOM.0000000000000213; Yamamoto K, 2011, J PHYSIOL ANTHROPOL, V30, P15, DOI 10.2114/jpa2.30.15; Yoo HL, 2009, J OCCUP ENVIRON MED, V51, P46, DOI 10.1097/JOM.0b013e31817f9e43; Yoo H, 2013, J OCCUP ENVIRON MED, V55, P111, DOI 10.1097/JOM.0b013e31826e294c; Zhou L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027481	83	86	89	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144318	10.1371/journal.pone.0144318	http://dx.doi.org/10.1371/journal.pone.0144318			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641879	gold, Green Published, Green Submitted			2022-12-27	WOS:000366902700097
J	He, B; Tao, X; Gu, YH; Wei, CH; Cheng, XJ; Xiao, SQ; Cheng, ZQ; Zhang, YZ				He, Bin; Tao, Xiang; Gu, Yinghong; Wei, Changhe; Cheng, Xiaojie; Xiao, Suqin; Cheng, Zaiquan; Zhang, Yizheng			Transcriptomic Analysis and the Expression of Disease-Resistant Genes in Oryza meyeriana under Native Condition	PLOS ONE			English	Article							CULTIVATED RICE; SATIVA L.; GENOME; SEQUENCE; ARABIDOPSIS; GENERATION; EVOLUTION; PATHWAYS; DEFENSE; POACEAE	Oryza meyeriana (O. meyeriana), with a GG genome type (2n = 24), accumulated plentiful excellent characteristics with respect to resistance to many diseases such as rice shade and blast, even immunity to bacterial blight. It is very important to know if the diseases-resistant genes exist and express in this wild rice under native conditions. However, limited genomic or transcriptomic data of O. meyeriana are currently available. In this study, we present the first comprehensive characterization of the O. meyeriana transcriptome using RNA-seq and obtained 185,323 contigs with an average length of 1,692 bp and an N50 of 2,391 bp. Through differential expression analysis, it was found that there were most tissue-specifically expressed genes in roots, and next to stems and leaves. By similarity search against protein databases, 146,450 had at least a significant alignment to existed gene models. Comparison with the Oryza sativa (japonica-type Nipponbare and indica-type 93-11) genomes revealed that 13% of the O. meyeriana contigs had not been detected in O. sativa. Many diseases-resistant genes, such as bacterial blight resistant, blast resistant, rust resistant, fusarium resistant, cyst nematode resistant and downy mildew gene, were mined from the transcriptomic database. There are two kinds of rice bacterial blight-resistant genes (Xa1 and Xa26) differentially or specifically expressed in O. meyeriana. The 4 Xa1 contigs were all only expressed in root, while three of Xa26 contigs have the highest expression level in leaves, two of Xa26 contigs have the highest expression profile in stems and one of Xa26 contigs was expressed dominantly in roots. The transcriptomic database of O. meyeriana has been constructed and many diseases-resistant genes were found to express under native condition, which provides a foundation for future discovery of a number of novel genes and provides a basis for studying the molecular mechanisms associated with disease resistance in O. meyeriana.	[He, Bin; Tao, Xiang; Gu, Yinghong; Wei, Changhe; Cheng, Xiaojie; Zhang, Yizheng] Sichuan Univ, Coll Life Sci, Sichuan Key Lab Mol Biol & Biotechnol, Minist Educ,Key Lab Bio Resources & Ecoenvironm, Chengdu 610064, Peoples R China; [Xiao, Suqin; Cheng, Zaiquan] Yunnan Acad Agr Sci, Biotechnol & Genet Resources Inst, Kunming 650223, Peoples R China	Sichuan University; Yunnan Academy of Agricultural Sciences	Cheng, ZQ (corresponding author), Yunnan Acad Agr Sci, Biotechnol & Genet Resources Inst, Kunming 650223, Peoples R China.	czquan-99@163.com; yizzhang@scu.edu.cn	GU, Yinghong/D-2433-2010	GU, Yinghong/0000-0002-9364-1389	National Natural Science Foundation of China [3160067, U1302265]; scientific projects of Yunnan Province [2012FA005, 2012HA002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); scientific projects of Yunnan Province	This work was supported by National Natural Science Foundation of China (3160067 and U1302265) and the scientific projects of Yunnan Province (2012FA005 and 2012HA002) in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov NN, 2006, PLANT MOL BIOL, V60, P69, DOI 10.1007/s11103-005-2564-9; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andrews S., 2010, FASTQC QUALITY CONTR; Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Berger S, 2007, J EXP BOT, V58, P4019, DOI 10.1093/jxb/erm298; Bon SG, 2011, PHILIPP J CROP SCI, V36, P28; Brar D, 2002, TRANSFERRING GENES W; Brar DS., 1991, RICE GENET NEWSL, V8, P91; Carels N, 2000, GENETICS, V154, P1819; Cheng Z, 2010, PLANT BREEDING, V129, P393, DOI 10.1111/j.1439-0523.2009.01701.x; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Cho SK, 2004, PLANT CELL REP, V22, P839, DOI 10.1007/s00299-004-0764-4; Fuller DQ, 2010, ARCHAEOL ANTHROP SCI, V2, P115, DOI 10.1007/s12520-010-0035-y; Ge S, 1999, P NATL ACAD SCI USA, V96, P14400, DOI 10.1073/pnas.96.25.14400; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Glowacki S, 2011, CELL MOL BIOL LETT, V16, P1, DOI 10.2478/s11658-010-0024-2; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; He B, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-014-1192-7; Herbers K, 1996, PLANT CELL, V8, P793, DOI 10.1105/tpc.8.5.793; Hernandez D, 2013, BIOINFORMATICS; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Hulbert SH, 2001, ANNU REV PHYTOPATHOL, V39, P285, DOI 10.1146/annurev.phyto.39.1.285; Jena KK, 2010, BREEDING SCI, V60, P518, DOI 10.1270/jsbbs.60.518; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li CB, 2001, THEOR APPL GENET, V103, P197, DOI 10.1007/s001220100562; Lu TT, 2008, DNA RES, V15, P285, DOI 10.1093/dnares/dsn018; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Moghaddam M. R. B., 2012, J EXP BOT; Mullins IM, 2002, THEOR APPL GENET, V105, P841, DOI 10.1007/s00122-002-1056-4; Nakagami H, 2005, TRENDS PLANT SCI, V10, P339, DOI 10.1016/j.tplants.2005.05.009; Piegu B, 2006, GENOME RES, V16, P1262, DOI 10.1101/gr.5290206; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Rahman ML, 2009, THEOR APPL GENET, V119, P1237, DOI 10.1007/s00122-009-1125-z; Ram T, 2007, CURR SCI INDIA, V92, P225; Rausher MD, 2001, NATURE, V411, P857, DOI 10.1038/35081193; Robatzek S, 2007, PLANT MOL BIOL, V64, P539, DOI 10.1007/s11103-007-9173-8; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Spoel SH, 2012, NAT REV IMMUNOL, V12, P89, DOI 10.1038/nri3141; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Torbica A, 2010, FOOD HYDROCOLLOID, V24, P626, DOI 10.1016/j.foodhyd.2010.03.004; Wang XM, 2013, J PHYTOPATHOL, V161, P324, DOI 10.1111/jph.12066; Yan CQ, 2004, PLANT CELL REP, V22, P569, DOI 10.1007/s00299-003-0732-4; Yang HY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-705; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485; Zou XH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r49	53	7	10	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144518	10.1371/journal.pone.0144518	http://dx.doi.org/10.1371/journal.pone.0144518			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26640944	Green Submitted, Green Published, gold			2022-12-27	WOS:000366902700137
J	Jiang, SW; Fei, AH; Peng, Y; Zhang, J; Lu, YR; Wang, HR; Chen, M; Pan, SM				Jiang, Shaowei; Fei, Aihua; Peng, Ya; Zhang, Jun; Lu, You-ran; Wang, Hai-rong; Chen, Miao; Pan, Shuming			Predictors of Outcome and Hemorrhage in Patients Undergoing Endovascular Therapy with Solitaire Stent for Acute Ischemic Stroke	PLOS ONE			English	Article							ANTERIOR CIRCULATION STROKE; IMPAIRED GLUCOSE-TOLERANCE; MECHANICAL THROMBECTOMY; PROGNOSTIC-FACTORS; INTRAVENOUS THROMBOLYSIS; DIABETES-MELLITUS; HYPERGLYCEMIA; REVASCULARIZATION; PREVALENCE; MANAGEMENT	Background Endovascular mechanical thrombectomy is emerging as a promising therapeutic approach for acute ischemic stroke and show some advantages. However, the data of predicting clinical outcome after thrombectomy with Solitaire retriever were limited. We attempt to identify prognostic factors of clinical outcome in patients with acute ischemic stroke undergoing thrombectomy with Solitaire retriever. Methods We conducted a retrospective analysis of consecutive acute ischemic strokes cases treated between December 2010 and December2013 where the Solitaire stent retriever was used for acute ischemic stroke. We assessed the effect of selected demographic characteristics, clinical factors on poor outcome at 3 months (modified Rankin score 3-6), mortality at 3 months, and hemorrhage within 24 h (symptomatic and asymptomatic). Clinical, imaging and logistic variables were analyzed. A multivariate logistic regression analysis was used to identify variables influencing clinical outcome, based on discharge NIHSS score change and mRS at 3 months. Results Eighty nine consecutive patients with acute ischemic stroke underwent mechanical thrombectomy. Multivariate analysis revealed that admission NIHSS score, Serum glucose and endovascular procedure duration were independently associated with clinical outcome. Sex, NIHSS score at admission, diabetes and time of operation were associated with sICH in 1 day. NIHSS score >= 20 (OR 9.38; 95% CI 2.41-36.50), onset to reperfusion >5 hours (OR 5.23; 95% CI1.34,20.41) and symptomatic intracranial hemorrhage (OR 10.19; 95% CI1.80,57.83) were potential predictive factors of mortality at 3 months. Conclusion Multiple pre- and intra-procedural factors can be used to predict clinical outcome, symptomatic intracranial hemorrhage and mortality in acute ischemic stroke patients undergoing endovascular therapy. This knowledge is helpful for patients selection for endovascular mechanical thrombectomy.	[Jiang, Shaowei; Fei, Aihua; Wang, Hai-rong; Chen, Miao; Pan, Shuming] Shanghai Jiao Tong Univ, Sch Med, Emergency Dept, Xinhua Hosp, Shanghai 200092, Peoples R China; [Peng, Ya] Soochow Univ, Cerebral Vasc Dis Ctr, Peoples Hosp Changzhou 1, Changzhou 213003, Peoples R China; [Zhang, Jun; Lu, You-ran] Soochow Univ, Dept Med Imaging, Peoples Hosp Changzhou 1, Changzhou 213003, Peoples R China	Shanghai Jiao Tong University; Soochow University - China; Soochow University - China	Pan, SM (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Emergency Dept, Xinhua Hosp, Shanghai 200092, Peoples R China.	shumingpan@163.com	Wang, Hairong/HGF-1825-2022		Science and Technology Commission of Shanghai Municipality grants [13ZR1426500]	Science and Technology Commission of Shanghai Municipality grants	This study is supported by 2013-2014 National clinical key specialty construction project and Science and Technology Commission of Shanghai Municipality grants 13ZR1426500.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Baird TA, 2003, STROKE, V34, P2208, DOI 10.1161/01.STR.0000085087.41330.FF; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Broderick JP, 2013, NEW ENGL J MED, V368, P893, DOI 10.1056/NEJMoa1214300; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Chindaprasirt Jarin, 2013, ISRN Neurol, V2013, P710681, DOI 10.1155/2013/710681; Christensen H, 2002, EUR J NEUROL, V9, P297, DOI 10.1046/j.1468-1331.2002.00409.x; Costalat V, 2012, EUR J RADIOL, V81, P4075, DOI 10.1016/j.ejrad.2012.07.012; Covel CL, 2014, THROMB HAEMOSTASIS, V111, P385, DOI 10.1160/TH13-04-0347; Davalos A, 2012, STROKE, V43, P2699, DOI 10.1161/STROKEAHA.112.663328; Desilles JP, 2013, STROKE, V44, P1915, DOI 10.1161/STROKEAHA.111.000813; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Gratz PP, 2014, STROKE, V45, P152, DOI 10.1161/STROKEAHA.113.002591; Gray CS, 2004, AGE AGEING, V33, P71, DOI 10.1093/ageing/afh026; Grunwald IQ, 2011, AM J NEURORADIOL, V32, P238, DOI 10.3174/ajnr.A2346; Hacke W, 1998, LANCET, V352, P1245, DOI 10.1016/S0140-6736(98)08020-9; HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017; Hametner C, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0262-z; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; Hill Michael D, 2014, Handb Clin Neurol, V126, P167, DOI 10.1016/B978-0-444-53480-4.00012-6; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Khatri P, 2014, LANCET NEUROL, V13, P567, DOI 10.1016/S1474-4422(14)70066-3; Koh Jun Seok, 2012, Neurointervention, V7, P1, DOI 10.5469/neuroint.2012.7.1.1; Kruyt ND, 2010, NAT REV NEUROL, V6, P145, DOI 10.1038/nrneurol.2009.231; Lefevre PH, 2014, J NEURORADIOLOGY, V41, P80, DOI 10.1016/j.neurad.2013.10.002; Leigh R, 2004, STROKE, V35, P1903, DOI 10.1161/01.STR.0000132571.77987.4c; Lewandowski CA, 1999, STROKE, V30, P2598, DOI 10.1161/01.STR.30.12.2598; Lorenzano S, 2013, STROKE, V44, P3401, DOI 10.1161/STROKEAHA.113.002908; Luitse MJA, 2012, LANCET NEUROL, V11, P261, DOI 10.1016/S1474-4422(12)70005-4; Mishra SM, 2014, AM J NEURORADIOL, V35, P2265, DOI 10.3174/ajnr.A4048; Nogueira RG, 2012, LANCET, V380, P1231, DOI 10.1016/S0140-6736(12)61299-9; Pereira VM, 2013, STROKE, V44, P2802, DOI 10.1161/STROKEAHA.113.001232; PESSIN MS, 1991, AM J NEURORADIOL, V12, P1123; Powers WJ, 2015, STROKE, DOI DOI 10.1161/STR.0000000000000074; Raoult H, 2013, J NEURORADIOLOGY, V40, P252, DOI 10.1016/j.neurad.2013.04.001; Roth DL, 2011, STROKE, V42, P626, DOI 10.1161/STROKEAHA.110.595322; Saver JL, 2012, LANCET, V380, P1241, DOI 10.1016/S0140-6736(12)61384-1; Scott JF, 1999, LANCET, V353, P376, DOI 10.1016/S0140-6736(05)74948-5; Shi ZS, 2014, STROKE, V45, P1977, DOI 10.1161/STROKEAHA.114.005603; Skagen K, 2015, J STROKE CEREBROVASC; Smit EJ, 2013, STROKE, V44, P2194, DOI 10.1161/STROKEAHA.111.000675; Smith WS, 2008, STROKE, V39, P1205, DOI 10.1161/STROKEAHA.107.497115; Smith WS, 2005, STROKE, V36, P1432, DOI 10.1161/01.STR.0000171066.25248.1d; Soize S, 2013, NEURORADIOLOGY, V55, P977, DOI 10.1007/s00234-013-1191-4; Strbian D, 2011, NEUROLOGY, V77, P341, DOI 10.1212/WNL.0b013e3182267b8c; Yang Y, 2015, INT J SURG, V16, P36, DOI 10.1016/j.ijsu.2015.02.013	46	51	60	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144452	10.1371/journal.pone.0144452	http://dx.doi.org/10.1371/journal.pone.0144452			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642052	gold, Green Published, Green Submitted			2022-12-27	WOS:000366902700125
J	Rebollo-Lopez, MJ; Lelievre, J; Alvarez-Gomez, D; Castro-Pichel, J; Martinez-Jimenez, F; Papadatos, G; Kumar, V; Colmenarejo, G; Mugumbate, G; Hurle, M; Barroso, V; Young, RJ; Martinez-Hoyos, M; del Rio, RG; Bates, RH; Lopez-Roman, EM; Mendoza-Losana, A; Brown, JR; Alvarez-Ruiz, E; Marti-Renom, MA; Overington, JP; Cammack, N; Ballell, L; Barros-Aguire, D				Jose Rebollo-Lopez, Maria; Lelievre, Joel; Alvarez-Gomez, Daniel; Castro-Pichel, Julia; Martinez-Jimenez, Francisco; Papadatos, George; Kumar, Vinod; Colmenarejo, Gonzalo; Mugumbate, Grace; Hurle, Mark; Barroso, Vanessa; Young, Rob J.; Martinez-Hoyos, Maria; Gonzalez del Rio, Ruben; Bates, Robert H.; Maria Lopez-Roman, Eva; Mendoza-Losana, Alfonso; Brown, James R.; Alvarez-Ruiz, Emilio; Marti-Renom, Marc A.; Overington, John P.; Cammack, Nicholas; Ballell, Lluis; Barros-Aguire, David			Release of 50 new, drug-like compounds and their computational target predictions for open source anti-tubercular drug discovery	PLOS ONE			English	Article							PROTEIN; DATABASE	As a follow up to the antimycobacterial screening exercise and the release of GSK's first Tres Cantos Antimycobacterial Set (TCAMS-TB), this paper presents the results of a second antitubercular screening effort of two hundred and fifty thousand compounds recently added to the GSK collection. The compounds were further prioritized based on not only antitubercular potency but also on physicochemical characteristics. The 50 most attractive compounds were then progressed for evaluation in three different predictive computational biology algorithms based on structural similarity or GSK historical biological assay data in order to determine their possible mechanisms of action. This effort has resulted in the identification of novel compounds and their hypothesized targets that will hopefully fuel future TB drug discovery and target validation programs alike.	[Jose Rebollo-Lopez, Maria; Lelievre, Joel; Alvarez-Gomez, Daniel; Castro-Pichel, Julia; Martinez-Hoyos, Maria; Gonzalez del Rio, Ruben; Bates, Robert H.; Maria Lopez-Roman, Eva; Mendoza-Losana, Alfonso; Cammack, Nicholas; Ballell, Lluis; Barros-Aguire, David] GlaxoSmithKline, Dis Developing World, Madrid, Spain; [Martinez-Jimenez, Francisco; Marti-Renom, Marc A.] CNAG, Genome Biol Grp, Barcelona, Spain; [Martinez-Jimenez, Francisco; Marti-Renom, Marc A.] CRG, Gene Regulat Stem Cells & Canc Program, Barcelona, Spain; [Papadatos, George; Mugumbate, Grace; Overington, John P.] EMBL EBI, Cambridge, England; [Kumar, Vinod; Hurle, Mark; Brown, James R.] GlaxoSmithKline, Computat Biol, Quantitat Sci, Collegeville, PA USA; [Colmenarejo, Gonzalo] GlaxoSmithKline, Ctr Invest Basica, CSci Computat Chem, Madrid, Spain; [Young, Rob J.] GlaxoSmithKline, Med Res Ctr, CSC Med Chem, Stevenage, Herts, England; [Marti-Renom, Marc A.] ICREA, Barcelona, Spain; [Barroso, Vanessa; Alvarez-Ruiz, Emilio] GlaxoSmithKline, Ctr Invest Basica Platform Technol & Sci, Madrid, Spain	GlaxoSmithKline; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); European Molecular Biology Laboratory (EMBL); GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; ICREA; GlaxoSmithKline	Lelievre, J (corresponding author), GlaxoSmithKline, Dis Developing World, Madrid, Spain.	joel.l.lelievre@gsk.com; mmarti@pcb.ub.cat	Marti-Renom, Marc A./Y-8803-2019; Young, Robert/AAM-7439-2020; Colmenarejo, Gonzalo/Q-6535-2018; Mendoza-Losana, Alfonso/AAF-4383-2021; Overington, John/G-8607-2015	Marti-Renom, Marc A./0000-0002-0151-4279; Young, Robert/0000-0002-7763-0575; Colmenarejo, Gonzalo/0000-0002-8249-4547; Mendoza-Losana, Alfonso/0000-0003-2493-4118; Martinez-Jimenez, Francisco/0000-0001-7804-1134; Papadatos, George/0000-0002-8314-7061; Overington, John/0000-0002-5859-1064; Mugumbate, Grace/0000-0002-2829-9425; Brown, James/0000-0002-9368-627X; Ballell, Lluis/0000-0002-3029-1860	TB Alliance; European Union [261378]; ERA-NET Pathogenomics Project GeMoA [PIM2010EPA-00719]; GlaxoSmithKline; ICREA Funding Source: Custom	TB Alliance; European Union(European Commission); ERA-NET Pathogenomics Project GeMoA; GlaxoSmithKline(GlaxoSmithKline); ICREA(ICREA)	The research behind these results received funding from the TB Alliance, the European Union's 7th framework programme (FP7-2007-2013) under grant agreement ORCHID no. 261378 and the ERA-NET Pathogenomics Project GeMoA (PIM2010EPA-00719). Those funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder GlaxoSmithKline provided support in the form of salaries for authors [MJR, JL, DAG, JCP, GC, VB, RJY, MMH, RGR, RHB, EMLR, AML, JRB, EAR, NC. LB and DBA], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; The research behind these results received funding from the TB Alliance, the European Union's 7th framework programme (FP7-2007-2013) under grant agreement ORCHID no. 261378 and the ERA-NET Pathogenomics Project GeMoA (PIM2010EPA-00719). Marc A. MartiRenom (mmarti@pcb.ub.cat) is the Corresponding Author for computational analysis.	Abrahams KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052951; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Analytical Methods Committee, 1989, ANALYST, V114, P1693, DOI 10.1039/AN9891401693; Andries K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102135; Ballell L, 2013, CHEMMEDCHEM, V8, P313, DOI 10.1002/cmdc.201200428; Bento AP, 2014, NUCLEIC ACIDS RES, V42, pD1083, DOI 10.1093/nar/gkt1031; Berman H, 2007, NUCLEIC ACIDS RES, V35, pD301, DOI 10.1093/nar/gkl971; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Coma I, 2009, METHODS MOL BIOL, V565, P69, DOI 10.1007/978-1-60327-258-2_4; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Hill AP, 2010, DRUG DISCOV TODAY, V15, P648, DOI 10.1016/j.drudis.2010.05.016; Ioerger TR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075245; Kalinina OV, 2012, NUCLEIC ACIDS RES, V40, pD549, DOI 10.1093/nar/gkr1049; Kalinina OV, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002043; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; KANEHISA M., 2002, NOVART FDN SYMP, V247, P3; Konc J, 2010, NUCLEIC ACIDS RES, V38, pW436, DOI 10.1093/nar/gkq479; Lee J, 2009, YONSEI MED J, V50, P1, DOI 10.3349/ymj.2009.50.1.1; Marti-Renom MA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S4-S4; Martinez-Jimenez F, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004157; Martinez-Jimenez F, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003253; Nathan C, 2015, IMMUNOL REV, V264, P308, DOI 10.1111/imr.12275; Pethe K, 2013, NAT MED, V19, P1157, DOI 10.1038/nm.3262; Remuinan MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060933; Rogers D, 2010, J CHEM INF MODEL, V50, P742, DOI 10.1021/ci100050t; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Trefzer C, 2012, J AM CHEM SOC, V134, P912, DOI 10.1021/ja211042r; Valko K, 1997, ANAL CHEM, V69, P2022, DOI 10.1021/ac961242d; Warrier T, 2015, IDENTIFICATION NOVEL; WHO, 2014, GLOB TUB REP 2014; Young RJ, 2011, DRUG DISCOV TODAY, V16, P822, DOI 10.1016/j.drudis.2011.06.001	33	31	32	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0142293	10.1371/journal.pone.0142293	http://dx.doi.org/10.1371/journal.pone.0142293			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642067	Green Submitted, Green Published, gold			2022-12-27	WOS:000366902700008
J	Mora, AL; Detalle, L; Van Geelen, A; Davis, MS; Stohr, T; Gallup, JM; Ackermann, MR				Mora, Alejandro Larios; Detalle, Laurent; Van Geelen, Albert; Davis, Michael S.; Stohr, Thomas; Gallup, Jack M.; Ackermann, Mark R.			Kinetics of Respiratory Syncytial Virus (RSV) Memphis Strain 37 (M37) Infection in the Respiratory Tract of Newborn Lambs as an RSV Infection Model for Human Infants	PLOS ONE			English	Article							MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA; EPITHELIAL-CELLS; DISEASE SEVERITY; VIRAL LOAD; RESPONSES; CHILDREN; INTERLEUKIN-8; PATHOGENESIS; SECRETIONS; PREVENTION	Rationale Respiratory syncytial virus (RSV) infection in preterm and newborn infants can result in severe bronchiolitis and hospitalization. The lamb lung has several key features conducive to modeling RSV infection in human infants, including susceptibility to human strains of RSV such as the A2, Long, and Memphis Strain 37 (M37). In this study, the kinetics of M37 infection was investigated in newborn lambs in order to better define clinical, viral, physiological, and immunological parameters as well as the pathology and lesions. Methods Newborn lambs were nebulized with M37 hRSV (6 mL of 1.27 x 10(7) FFU/mL), monitored daily for clinical responses, and respiratory tissues were collected from groups of lambs at days 1, 3, 4, 6, and 8 post-inoculation for the assessment of viral replication parameters, lesions and also cellular, immunologic and inflammatory responses. Results Lambs had increased expiratory effort (forced expiration) at days 4, 6, and 8 post-inoculation. Nasal wash lacked RSV titers at day 1, but titers were present at low levels at days 3 (peak), 4, and 8. Viral titers in bronchoalveolar lavage fluid (BALF) reached a plateau at day 3 (4.6 Log(10) FFU/mL), which was maintained until day 6 (4.83 Log(10) FFU/mL), and were markedly reduced or absent at day 8. Viral RNA levels (detected by RT-qPCR) in BALF were indistinguishable at days 3 (6.22 +/- 0.08 Log(10) M37 RNA copies/mL; mean +/- se) and 4 (6.20 +/- 0.16 Log(10) M37 RNA copies/mL; mean +/- se) and increased slightly on day 6 (7.15 +/- 0.2 Log(10) M37 RNA copies/mL; mean +/- se). Viral antigen in lung tissue as detected by immunohistochemistry was not seen at day 1, was present at days 3 and 4 before reaching a peak by day 6, and was markedly reduced by day 8. Viral antigen was mainly present in airways (bronchi, bronchioles) at day 3 and was increasingly present in alveolar cells at days 4 and 6, with reduction at day 8. Histopathologic lesions such as bronchitis/bronchiolitis, epithelial necrosis and hyperplasia, peribronchial lymphocyte infiltration, and syncytial cells, were consistent with those described previously for lambs and infants. Conclusion This work demonstrates that M37 hRSV replication in the lower airways of newborn lambs is robust with peak replication on day 3 and sustained until day 6. These findings, along with the similarities of lamb lung to those of infants in terms of alveolar development, airway branching and epithelium, susceptibility to human RSV strains, lesion characteristics (bronchiolitis), lung size, clinical parameters, and immunity, further establish the neonatal lamb as a model with key features that mimic RSV infection in infants.	[Mora, Alejandro Larios; Van Geelen, Albert; Gallup, Jack M.; Ackermann, Mark R.] Iowa State Univ, Dept Vet Pathol, Ames, IA 50011 USA; [Detalle, Laurent; Stohr, Thomas] Ablynx NV, Zwijnaarde, Belgium; [Davis, Michael S.] Oklahoma State Univ, Ctr Vet Hlth Sci, Stillwater, OK 74078 USA	Iowa State University; Oklahoma State University System; Oklahoma State University - Stillwater	Mora, AL (corresponding author), Iowa State Univ, Dept Vet Pathol, Ames, IA 50011 USA.	alarios@iastate.edu		Detalle, Laurent/0000-0001-8481-7736	Ablynx, NV; "Agentschap voor Innovatie door Wetenschap en Techniek (IWT)"- Belgium [130562]	Ablynx, NV; "Agentschap voor Innovatie door Wetenschap en Techniek (IWT)"- Belgium	This work was funded by Ablynx, NV and by the "Agentschap voor Innovatie door Wetenschap en Techniek (IWT)"- Belgium - grant No 130562. Ablynx had a role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.; We thank Diane Gerjets, Toni Christofferson, and Jennifer Groeltz-Thrush for their technical histology assistance and expertise, as well as Diane McDonald, Kathleen Mullin, and Dale Hinderaker of the Laboratory Animal Resources (LAR) and the Livestock Infectious Disease Isolation Facility (LIDIF). The work was funded by Ablynx, NV and by the "Agentschap voor Innovatie door Wetenschap en Techniek (IWT)"-Belgium-grant No 130562.	Abu-Harb M, 1999, EUR RESPIR J, V14, P139, DOI 10.1034/j.1399-3003.1999.14a23.x; AHERNE W, 1970, J CLIN PATHOL, V23, P7, DOI 10.1136/jcp.23.1.7; Bont L, 1999, EUR RESPIR J, V14, P144, DOI 10.1034/j.1399-3003.1999.14a24.x; Bonville CA, 1999, PEDIATR ALLERGY IMMU, V10, P39, DOI 10.1034/j.1399-3038.1999.101005.x; Collins PL, 2008, J VIROL, V82, P2040, DOI 10.1128/JVI.01625-07; Crowe JE, 1999, CURR TOP MICROBIOL, V236, P191; CUTLIP RC, 1979, AM J VET RES, V40, P1479; Derscheid RJ, 2013, VET PATHOL, V50, P827, DOI 10.1177/0300985813480216; Derscheid RJ, 2014, BIORESEARCH OPEN ACC, V3, P60, DOI 10.1089/biores.2013.0044; Derscheid RJ, 2014, AM J RESP CELL MOL, V50, P389, DOI 10.1165/rcmb.2012-0529OC; Derscheid RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081472; Derscheid RJ, 2013, VIRUSES-BASEL, V5, P2881, DOI 10.3390/v5112881; Derscheid RJ, 2012, VIRUSES-BASEL, V4, P2359, DOI 10.3390/v4102359; DeVincenzo J, 2010, P NATL ACAD SCI USA, V107, P8800, DOI 10.1073/pnas.0912186107; DeVincenzo JP, 2014, NEW ENGL J MED, V371, P711, DOI 10.1056/NEJMoa1401184; DeVincenzo JP, 2010, AM J RESP CRIT CARE, V182, P1305, DOI 10.1164/rccm.201002-0221OC; Dudas RA, 1998, CLIN MICROBIOL REV, V11, P430, DOI 10.1128/CMR.11.3.430; Eiland Lea S, 2009, J Pediatr Pharmacol Ther, V14, P75, DOI 10.5863/1551-6776-14.2.75; Empey KM, 2010, CLIN INFECT DIS, V50, P1258, DOI 10.1086/651603; EVERARD ML, 1994, ARCH DIS CHILD, V71, P428, DOI 10.1136/adc.71.5.428; Friedman JN, 2014, PAED CHILD HEALT-CAN, V19, P484, DOI 10.1093/pch/19.9.485; Gallup JM, 2006, BIOL PROCED ONLINE, V8, P87, DOI 10.1251/bpo122; Gallup Jack M, 2008, Int J Biomed Sci, V4, P273; Garofalo RP, 2001, J INFECT DIS, V184, P393, DOI 10.1086/322788; Gern JE, 2002, PEDIAT ALLERG IMM-UK, V13, P386, DOI 10.1034/j.1399-3038.2002.01093.x; Goldmann DA, 2001, EMERG INFECT DIS, V7, P249, DOI 10.3201/eid0702.010220; GRAHAM BS, 1995, AM J RESP CRIT CARE, V152, pS63, DOI 10.1164/ajrccm/152.4_Pt_2.S63; GRAHAM BS, 1991, J CLIN INVEST, V88, P1026, DOI 10.1172/JCI115362; Grosz Drew D, 2014, BMC Res Notes, V7, P158, DOI 10.1186/1756-0500-7-158; HALL CB, 1986, NEW ENGL J MED, V315, P77, DOI 10.1056/NEJM198607103150201; Hsia CCW, 2004, AM J RESP CRIT CARE, V170, P319, DOI 10.1164/rccm.200209-1062ST; Johnson JE, 2007, MODERN PATHOL, V20, P108, DOI 10.1038/modpathol.3800725; KAPIKIAN AZ, 1969, AM J EPIDEMIOL, V89, P405, DOI 10.1093/oxfordjournals.aje.a120954; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; Kim YI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113100; LEHMKUHL HD, 1979, AM J VET RES, V40, P1729; Lukens MV, 2010, J VIROL, V84, P2374, DOI 10.1128/JVI.01807-09; McNamara PS, 2005, J INFECT DIS, V191, P1225, DOI 10.1086/428855; McNamara PS, 2003, ARCH DIS CHILD, V88, P922, DOI 10.1136/adc.88.10.922; McNamara PS, 2002, BRIT MED BULL, V61, P13, DOI 10.1093/bmb/61.1.13; Meeusen EN, 2009, DRUG DISCOV TODAY DI, V6, P101, DOI [DOI 10.1016/J.DDM0D.2009.12.002, 10.1016/j.ddmod.2009.12.002]; Mellow TE, 2004, EXP LUNG RES, V30, P43, DOI 10.1080/01902140490252812; Murai Hiroki, 2007, Allergol Int, V56, P157, DOI 10.2332/allergolint.O-06-454; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Olivier A, 2009, INT J EXP PATHOL, V90, P431, DOI 10.1111/j.1365-2613.2009.00643.x; Olivier AK, 2011, EXP LUNG RES, V37, P131, DOI 10.3109/01902148.2010.484518; Peebles R Stokes Jr, 2005, Proc Am Thorac Soc, V2, P110, DOI 10.1513/pats.200501-002AW; Pickles RJ, 2015, J PATHOL, V235, P266, DOI 10.1002/path.4462; Prevention CfDCa, 2014, RESP SYNC VIR INF RS; Sacco RE, 2012, VIRUSES-BASEL, V4, P3731, DOI 10.3390/v4123731; Scheerlinck JPY, 2008, TRENDS BIOTECHNOL, V26, P259, DOI 10.1016/j.tibtech.2008.02.002; Sheeran P, 1999, PEDIATR INFECT DIS J, V18, P115, DOI 10.1097/00006454-199902000-00007; Smyth RL, 2002, PEDIATR PULM, V33, P339, DOI 10.1002/ppul.10080; Sow FB, 2011, AM J PHYSIOL-LUNG C, V300, pL12, DOI 10.1152/ajplung.00169.2010; TYRRELL DAJ, 1979, INFECT IMMUN, V26, P621, DOI 10.1128/IAI.26.2.621-629.1979; van Woensel JBM, 2003, PEDIATR INFECT DIS J, V22, P721, DOI 10.1097/01.inf.0000078165.62923.15; Villenave R, 2012, P NATL ACAD SCI USA, V109, P5040, DOI 10.1073/pnas.1110203109; Wang SZ, 1998, EUR RESPIR J, V12, P612, DOI 10.1183/09031936.98.12030612; Welliver TP, 2007, J INFECT DIS, V195, P1126, DOI 10.1086/512615; Zhang LQ, 2002, J VIROL, V76, P5654, DOI 10.1128/JVI.76.11.5654-5666.2002	60	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0143580	10.1371/journal.pone.0143580	http://dx.doi.org/10.1371/journal.pone.0143580			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641081	Green Published, gold, Green Submitted			2022-12-27	WOS:000366902700021
J	Ohmayer, U; Gil-Hernandez, A; Sauert, M; Martin-Marcos, P; Tamame, M; Tschochner, H; Griesenbeck, J; Milkereit, P				Ohmayer, Uli; Gil-Hernandez, Alvaro; Sauert, Martina; Martin-Marcos, Pilar; Tamame, Mercedes; Tschochner, Herbert; Griesenbeck, Joachim; Milkereit, Philipp			Studies on the Coordination of Ribosomal Protein Assembly Events Involved in Processing and Stabilization of Yeast Early Large Ribosomal Subunit Precursors	PLOS ONE			English	Article							PUTATIVE RNA HELICASE; SACCHAROMYCES-CEREVISIAE; EUKARYOTIC RIBOSOME; ANGSTROM RESOLUTION; IN-VIVO; NUCLEAR EXPORT; PRE-RIBOSOME; BIOGENESIS; MATURATION; DYNAMICS	Cellular production of ribosomes involves the formation of highly defined interactions between ribosomal proteins (r-proteins) and ribosomal RNAs (rRNAs). Moreover in eukaryotic cells, efficient ribosome maturation requires the transient association of a large number of ribosome biogenesis factors (RBFs) with newly forming ribosomal subunits. Here, we investigated how r-protein assembly events in the large ribosomal subunit (LSU) rRNA domain II are coordinated with each other and with the association of RBFs in early LSU precursors of the yeast Saccharomyces cerevisiae. Specific effects on the pre-ribosomal association of RBFs could be observed in yeast mutants blocked in LSU rRNA domain II assembly. Moreover, formation of a cluster of r-proteins was identified as a downstream event in LSU rRNA domain II assembly. We analyzed in more detail the functional relevance of eukaryote specific bridges established by this r-protein cluster between LSU rRNA domain II and VI and discuss how they can support the stabilization and efficient processing of yeast early LSU precursor RNAs.	[Ohmayer, Uli; Sauert, Martina; Tschochner, Herbert; Griesenbeck, Joachim; Milkereit, Philipp] Univ Regensburg, Lehrstuhl Biochem 3, D-93053 Regensburg, Germany; [Gil-Hernandez, Alvaro; Martin-Marcos, Pilar; Tamame, Mercedes] Univ Salamanca, CSIC, Inst Biol Func & Genom, E-37008 Salamanca, Spain	University of Regensburg; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca	Tamame, M (corresponding author), Univ Salamanca, CSIC, Inst Biol Func & Genom, E-37008 Salamanca, Spain.	tamame@usal.es; Herbert.Tschochner@vkl.uni-regensburg.de; Joachim.Griesenbeck@vkl.uni-regensburg.de; Philipp.Milkereit@vkl.uni-regensburg.de		Tamame, Mercedes/0000-0002-6484-0346; Sauert, Martina/0000-0002-2179-9515; Griesenbeck, Joachim/0000-0002-7817-6095	collaborative research center from "Deutsche Forschungsgemeinschaft" [SFB 960]; CSIC JAE Predoc Fellowship from Spanish Research Council CSIC; EMBO Short Term Fellowship [ASTF 266-2013]; Spanish Ministry of Economy and Competitiveness (MINECO) [IPT-2012-1321-06000]	collaborative research center from "Deutsche Forschungsgemeinschaft"(German Research Foundation (DFG)); CSIC JAE Predoc Fellowship from Spanish Research Council CSIC; EMBO Short Term Fellowship(European Molecular Biology Organization (EMBO)); Spanish Ministry of Economy and Competitiveness (MINECO)	This work was supported by a grant which was given in the collaborative research center SFB 960, from the "Deutsche Forschungsgemeinschaft" (www.dfg.de) to JG, HT and PM. AGH acknowledges support through a CSIC JAE Predoc Fellowship from the Spanish Research Council CSIC and an EMBO Short Term Fellowship (ASTF 266-2013). PMM and MT were supported in part by project IPT-2012-1321-06000, granted by the Spanish Ministry of Economy and Competitiveness (MINECO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armache JP, 2013, NUCLEIC ACIDS RES, V41, P1284, DOI 10.1093/nar/gks1259; Babiano R, 2013, NUCLEIC ACIDS RES, V41, P9461, DOI 10.1093/nar/gkt726; Ban N, 2014, CURR OPIN STRUC BIOL, V24, P165, DOI 10.1016/j.sbi.2014.01.002; Bassler J, 2001, MOL CELL, V8, P517, DOI 10.1016/S1097-2765(01)00342-2; Bassler J, 2014, J CELL BIOL, V207, P481, DOI 10.1083/jcb.201408111; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Chaudhuri S, 2007, RNA, V13, P2224, DOI 10.1261/rna.694007; de la Cruz J, 1998, RNA, V4, P1268, DOI 10.1017/S1355838298981158; de la Cruz J, 2015, ANNU REV BIOCHEM, V84, P93, DOI 10.1146/annurev-biochem-060614-033917; Dembowski JA, 2013, RNA, V19, P1639, DOI 10.1261/rna.041194.113; Dembowski JA, 2013, NUCLEIC ACIDS RES, V41, P7889, DOI 10.1093/nar/gkt545; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fernandez-Pevida A, 2015, WIRES RNA, V6, P191, DOI 10.1002/wrna.1267; Ferreira-Cerca S, 2007, MOL CELL, V28, P446, DOI 10.1016/j.molcel.2007.09.029; Gamalinda M, 2014, RNA, V20, P1725, DOI 10.1261/rna.046649.114; Gamalinda M, 2014, GENE DEV, V28, P198, DOI 10.1101/gad.228825.113; Gamalinda M, 2013, NUCLEIC ACIDS RES, V41, P1965, DOI 10.1093/nar/gks1272; Gerhardy S, 2014, CHROMOSOMA, V123, P327, DOI 10.1007/s00412-014-0463-z; Graifer D, 2015, BIOCHIMIE, V109, P1, DOI 10.1016/j.biochi.2014.11.016; Granneman S, 2011, EMBO J, V30, P4006, DOI 10.1038/emboj.2011.256; Hector RD, 2014, NUCLEIC ACIDS RES, V42, P12138, DOI 10.1093/nar/gku815; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Henras AK, 2015, WIRES RNA, V6, P225, DOI 10.1002/wrna.1269; Hierlmeier T, 2013, NUCLEIC ACIDS RES, V41, P1191, DOI 10.1093/nar/gks1056; Horsey EW, 2004, RNA, V10, P813, DOI 10.1261/rna.5255804; Jakob S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032552; Jakovljevic J, 2012, RNA, V18, P1805, DOI 10.1261/rna.032540.112; Jeeninga RE, 1997, RNA, V3, P476; Johnson AW, 2001, METHOD ENZYMOL, V342, P260, DOI 10.1016/S0076-6879(01)42550-X; Garcia-Gomez JJ, 2011, MOL CELL BIOL, V31, P4156, DOI 10.1128/MCB.05436-11; Kaser A, 2001, BIOL CHEM, V382, P1637, DOI 10.1515/BC.2001.199; Klinge S, 2012, TRENDS BIOCHEM SCI, V37, P189, DOI 10.1016/j.tibs.2012.02.007; Klinge S, 2011, SCIENCE, V334, P941, DOI 10.1126/science.1211204; Kressler D, 1999, NUCLEIC ACIDS RES, V27, P4598, DOI 10.1093/nar/27.23.4598; Lapeyre B, 2004, MOL CELL, V16, P663, DOI 10.1016/j.molcel.2004.10.022; Lebreton A, 2008, NUCLEIC ACIDS RES, V36, P4988, DOI 10.1093/nar/gkn469; Lebreton A, 2006, J BIOL CHEM, V281, P27099, DOI 10.1074/jbc.M602199200; Mager WH, 1997, NUCLEIC ACIDS RES, V25, P4872, DOI 10.1093/nar/25.24.4872; Martin-Marcos P, 2007, MOL CELL BIOL, V27, P5968, DOI 10.1128/MCB.00019-07; McCann KL, 2015, GENE DEV, V29, P862, DOI 10.1101/gad.256370.114; Milkereit P, 2001, CELL, V105, P499, DOI 10.1016/S0092-8674(01)00358-0; Neueder A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010194; Ohmayer U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068412; Phipps KR, 2011, WIRES RNA, V2, P1, DOI 10.1002/wrna.57; Pillet B, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005565; Pintard L, 2000, MOL CELL BIOL, V20, P1370, DOI 10.1128/MCB.20.4.1370-1381.2000; Poll G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008249; Polikanov YS, 2014, NAT STRUCT MOL BIOL, V21, P787, DOI 10.1038/nsmb.2871; Pratte D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082741; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Robledo S, 2008, RNA, V14, P1918, DOI 10.1261/rna.1132008; Rosado IV, 2007, NUCLEIC ACIDS RES, V35, P4203, DOI 10.1093/nar/gkm388; Sahasranaman A, 2011, EMBO J, V30, P4020, DOI 10.1038/emboj.2011.338; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Sentenac A, 2013, BBA-GENE REGUL MECH, V1829, P251, DOI 10.1016/j.bbagrm.2012.10.012; Stelter P, 2015, MOL CELL, V58, P854, DOI 10.1016/j.molcel.2015.03.029; Talkish J, 2014, MOL CELL BIOL, V34, P1863, DOI 10.1128/MCB.01322-13; VANNUES RW, 1995, J MOL BIOL, V250, P24, DOI 10.1006/jmbi.1995.0355; Venema J, 1998, METH MOL B, V77, P257; Voorhees RM, 2014, CELL, V157, P1632, DOI 10.1016/j.cell.2014.05.024; Voorhees RM, 2013, ANNU REV BIOCHEM, V82, P203, DOI 10.1146/annurev-biochem-113009-092313; Wan K, 2015, CURR GENET, V61, P31, DOI 10.1007/s00294-014-0442-1; Wang MS, 2015, RNA, V21, P1240, DOI 10.1261/rna.051169.115; Woolford JL, 2013, GENETICS, V195, P643, DOI 10.1534/genetics.113.153197; Xiang S, 2009, NATURE, V458, P784, DOI 10.1038/nature07731; Yusupova G, 2014, ANNU REV BIOCHEM, V83, P467, DOI 10.1146/annurev-biochem-060713-035445	67	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0143768	10.1371/journal.pone.0143768	http://dx.doi.org/10.1371/journal.pone.0143768			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642313	Green Submitted, gold, Green Published			2022-12-27	WOS:000366902700028
J	Pietralik, Z; Kolodziejska, Z; Weiss, M; Kozak, M				Pietralik, Zuzanna; Kolodziejska, Zaneta; Weiss, Marek; Kozak, Maciej			Gemini Surfactants Based on Bis-Imidazolium Alkoxy Derivatives as Effective Agents for Delivery of Nucleic Acids: A Structural and Spectroscopic Study	PLOS ONE			English	Article							GENE-THERAPY; BROMIDE) SURFACTANTS; AQUEOUS-SOLUTION; CATIONIC LIPIDS; PLASMID DNA; SPACER; LIPOPLEXES; COMPLEXES; BEHAVIOR; CONDENSATION	The success rate of gene therapy depends on the efficient transfection of genetic material into cells. The golden mean between harmlessness and high effectiveness can be provided by synthetic lipid-like molecules that are similar to the components of biological membranes. Cationic gemini surfactants are one such moiety and because of their favourable physicochemical properties (double positive electric charge, reduced toxicity, low values of critical micelle concentration), they show great potential as delivery system components for genetic material in gene therapy. The aim of this study was to investigate the process of the complexation of cationic gemini surfactants with nucleic acids: double-stranded DNA of different sizes (21 bp, similar to 185 bp, similar to 20 kbp) and siRNA (21 bp). The tested series of dicationic surfactants consists of bis-imidazolium quaternary salts with varying lengths of hydrophobic side chains (m = 5, 6, 7, 8, 9, 11, 12, 14, 16). On the basis of the data obtained by circular dichroism spectroscopy and electrophoresis, we concluded that the studied gemini surfactants with long side chains effectively bind nucleic acids at low concentrations, which leads to the formation of stable lipoplexes. Images obtained by atomic force microscopy also confirmed the formation of vesicular structures, i.e., complexes between DNA and surfactants. The cytotoxicity of selected surfactants was also tested on HeLa cells. The surfactant toxicity significantly depends on surfactant geometry (the length of hydrophobic chain).	[Pietralik, Zuzanna; Kolodziejska, Zaneta; Kozak, Maciej] Adam Mickiewicz Univ, Fac Phys, Dept Macromol Phys, PL-61614 Poznan, Poland; [Weiss, Marek] Poznan Univ Tech, Inst Phys, PL-60965 Poznan, Poland; [Kozak, Maciej] Adam Mickiewicz Univ, Fac Phys, Joint Lab SAXS Studies, PL-61614 Poznan, Poland	Adam Mickiewicz University; Poznan University of Technology; Adam Mickiewicz University	Kozak, M (corresponding author), Adam Mickiewicz Univ, Fac Phys, Dept Macromol Phys, Umultowska 85, PL-61614 Poznan, Poland.	mkozak@amu.edu.pl	Pietralik-Molińska, Zuzanna/AAE-8265-2021; Weiss, Marek/M-8296-2014	Weiss, Marek/0000-0001-9539-138X; Kozak, Maciej/0000-0003-3312-6518	National Science Centre (Poland) [DEC-2011/01/B/ST5/00846]; Ministry of Science and Higher Education in Poland [06/62/DSPB/0215]	National Science Centre (Poland); Ministry of Science and Higher Education in Poland(Ministry of Science and Higher Education, Poland)	This research has been financed by the National Science Centre (Poland) with funds granted pursuant to decision no. DEC-2011/01/B/ST5/00846. M.W. thanks the Ministry of Science and Higher Education in Poland for financial support within Project No. 06/62/DSPB/0215. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamcik J, 2006, FEBS LETT, V580, P5671, DOI 10.1016/j.febslet.2006.09.017; [Anonymous], OPT PROT HELA CELLS; Badea I, 2005, J GENE MED, V7, P1200, DOI 10.1002/jgm.763; Bajaj A, 2007, BIOCONJUGATE CHEM, V18, P1537, DOI 10.1021/bc070010q; Barran-Berdon AL, 2014, J MATER CHEM B, V2, P4640, DOI 10.1039/c4tb00389f; Behlke MA, 2006, MOL THER, V13, P644, DOI 10.1016/j.ymthe.2006.01.001; Belletti D, 2013, COLLOID SURFACE A, V436, P459, DOI 10.1016/j.colsurfa.2013.07.021; Bello-Roufai M, 2007, NUCLEIC ACIDS RES, V35, P728, DOI 10.1093/nar/gkl860; Bombelli C, 2005, LANGMUIR, V21, P10271, DOI 10.1021/la051324+; Braun CS, 2001, ULTRAVIOLET ABSORPTI, P253; Chen GX, 2014, ONCOTARGETS THER, V7, P1901, DOI 10.2147/OTT.S50483; Dan N, 2014, ADV COLLOID INTERFAC, V205, P230, DOI 10.1016/j.cis.2014.01.013; Donkuru M, 2010, NANOMEDICINE-UK, V5, P1103, DOI [10.2217/nnm.10.80, 10.2217/NNM.10.80]; Emery DE, 2004, CLIN APPL IMMUNOL RE, V4, P411; Falsini S, 2014, SOFT MATTER, V10, P2226, DOI 10.1039/c3sm52429a; Gandhi NS, 2014, J CONTROL RELEASE, V194, P238, DOI 10.1016/j.jconrel.2014.09.001; Giacca M, 2012, J CONTROL RELEASE, V161, P377, DOI 10.1016/j.jconrel.2012.04.008; Ibraheem D, 2014, INT J PHARMACEUT, V459, P70, DOI 10.1016/j.ijpharm.2013.11.041; Ilies MA, 2006, J MED CHEM, V49, P3872, DOI 10.1021/jm0601755; In M, 2007, J DISPER SCI TECHNOL, V28, P143, DOI 10.1080/01932690600991888; Janssens ACJW, 2008, HUM MOL GENET, V17, pR166, DOI 10.1093/hmg/ddn250; Kamboj R, 2012, LANGMUIR, V28, P11969, DOI 10.1021/la300920p; Karlsson L, 2002, J COLLOID INTERF SCI, V252, P290, DOI 10.1006/jcis.2002.8477; Khatri N, 2012, J PHARM BIOALLIED SC, V4, pS1, DOI 10.4103/0975-7406.94115; Kirby AJ, 2003, ANGEW CHEM INT EDIT, V42, P1448, DOI 10.1002/anie.200201597; Kumar K, 2015, J MATER CHEM B, V3, P1495, DOI 10.1039/c4tb01948b; Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026; LeWitt PA, 2011, LANCET NEUROL, V10, P309, DOI 10.1016/S1474-4422(11)70039-4; Li S, 2000, GENE THER, V7, P31, DOI 10.1038/sj.gt.3301110; Luciani P, 2007, BIOMACROMOLECULES, V8, P1999, DOI 10.1021/bm070202o; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Munoz-Ubeda M, 2012, BIOMACROMOLECULES; Munoz-Ubeda M, 2012, BIOMACROMOLECULES, V13, P3926, DOI 10.1021/bm301066w; Munoz-Ubeda M, 2011, J AM CHEM SOC, V133, P18014, DOI 10.1021/ja204693f; Necas D, 2012, CENT EUR J PHYS, V10, P181, DOI 10.2478/s11534-011-0096-2; O'Mahony AM, 2014, J PHARM SCI-US, V103, P1346, DOI 10.1002/jps.23922; Pietralik Z, 2010, ACTA PHYS POL A, V117, P311, DOI 10.12693/APhysPolA.117.311; Pietralik Z, 2015, COLLOID SURFACE B, V131, P83, DOI 10.1016/j.colsurfb.2015.04.042; Pietralik Z, 2013, INT J MOL SCI, V14, P7642, DOI 10.3390/ijms14047642; Ristori S, 2012, SOFT MATTER, V8, P749, DOI 10.1039/c1sm06470c; Rosenzweig HS, 2001, BIOCONJUGATE CHEM, V12, P258, DOI 10.1021/bc000099z; Sharma VD, 2014, MED RES REV, V34, P1, DOI 10.1002/med.21272; Verma M, 2012, J PERS MED, V2, P1, DOI 10.3390/jpm2010001; Wang CZ, 2007, PHYS CHEM CHEM PHYS, V9, P1616, DOI 10.1039/b618579g; Wettig SD, 2007, J GENE MED, V9, P649, DOI 10.1002/jgm.1060; Zana R, 2002, ADV COLLOID INTERFAC, V97, P205, DOI 10.1016/S0001-8686(01)00069-0; Zana R, 2002, J COLLOID INTERF SCI, V246, P182, DOI 10.1006/jcis.2001.7921; ZANA R, 1991, LANGMUIR, V7, P1072, DOI 10.1021/la00054a008; Zhao XF, 2008, CHINESE J CHEM ENG, V16, P923, DOI 10.1016/S1004-9541(09)60017-3; Zhou T, 2012, COLLOID SURFACE A, V414, P33, DOI 10.1016/j.colsurfa.2012.08.060	51	16	16	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144373	10.1371/journal.pone.0144373	http://dx.doi.org/10.1371/journal.pone.0144373			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641889	Green Published, Green Submitted, gold			2022-12-27	WOS:000366902700106
J	Schill, SR; Raber, GT; Roberts, JJ; Treml, EA; Brenner, J; Halpin, PN				Schill, Steven R.; Raber, George T.; Roberts, Jason J.; Treml, Eric A.; Brenner, Jorge; Halpin, Patrick N.			No Reef Is an Island: Integrating Coral Reef Connectivity Data into the Design of Regional-Scale Marine Protected Area Networks	PLOS ONE			English	Article							CARIBBEAN CORAL; POPULATION CONNECTIVITY; LARVAL DISPERSAL; OCEAN CURRENTS; CONSERVATION; RESILIENCE; MANAGEMENT; EVOLUTION; DECLINES; COASTAL	We integrated coral reef connectivity data for the Caribbean and Gulf of Mexico into a conservation decision-making framework for designing a regional scale marine protected area (MPA) network that provides insight into ecological and political contexts. We used an ocean circulation model and regional coral reef data to simulate eight spawning events from 2008-2011, applying a maximum 30-day pelagic larval duration and 20% mortality rate. Coral larval dispersal patterns were analyzed between coral reefs across jurisdictional marine zones to identify spatial relationships between larval sources and destinations within countries and territories across the region. We applied our results in Marxan, a conservation planning software tool, to identify a regional coral reef MPA network design that meets conservation goals, minimizes underlying threats, and maintains coral reef connectivity. Our results suggest that approximately 77% of coral reefs identified as having a high regional connectivity value are not included in the existing MPA network. This research is unique because we quantify and report coral larval connectivity data by marine ecoregions and Exclusive Economic Zones (EZZ) and use this information to identify gaps in the current Caribbean-wide MPA network by integrating asymmetric connectivity information in Marxan to design a regional MPA network that includes important reef network connections. The identification of important reef connectivity metrics guides the selection of priority conservation areas and supports resilience at the whole system level into the future.	[Schill, Steven R.] Nature Conservancy, Caribbean Program, Coral Gables, FL USA; [Raber, George T.] Univ So Mississippi, Dept Geog & Geol, Hattiesburg, MS 39406 USA; [Roberts, Jason J.; Halpin, Patrick N.] Duke Univ, Nicholas Sch Environm, Marine Geospatial Ecol Lab, Durham, NC 27708 USA; [Treml, Eric A.] Univ Melbourne, Sch Biosci, Melbourne, Vic, Australia; [Brenner, Jorge] Nature Conservancy, Texas Chapter, Houston, TX USA	Nature Conservancy; University of Southern Mississippi; Duke University; University of Melbourne; Nature Conservancy	Raber, GT (corresponding author), Univ So Mississippi, Dept Geog & Geol, Hattiesburg, MS 39406 USA.	george.raber@usm.edu	Treml, Eric A/C-7580-2013	Treml, Eric A/0000-0003-4844-4420; Schill, Steven R/0000-0002-9066-434X; Brenner, Jorge/0000-0002-4962-4784	John D. and Catherine T. MacArthur Foundation;  [1715173007]	John D. and Catherine T. MacArthur Foundation; 	This project was funded by a grant from the John D. and Catherine T. MacArthur Foundation. The title of the grant was "A Vision for Protecting Shared Marine Resources across the Caribbean Biological Corridor." The URL for the funder is http://www.macfound.org/. The grant number is 1715173007. The author who received the funding was Steven R. Schill. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no current funding sources for this study (The Nature Conservancy has agreed to cover the cost of the PLOS ONE publication fee from their own funds. The University of Southern Mississippi has agreed to host any data sharing requirements through existing computing resources).; This work was made possible by a grant from the John D. and Catherine T. MacArthur Foundation Program on Global Security and Sustainability to develop a tri-national, Haiti-Dominican Republic-Cuba marine action plan for the Caribbean Biological Corridor.	Agardy TS, 2010, MAR POLICY, V35, P226; Agostini V.N., 2010, MARINE ZONING SAINT; Almany GR, 2009, CORAL REEFS, V28, P339, DOI 10.1007/s00338-009-0484-x; Andrefouet S, 2004, P 10 INT COR REEF S, P1732; Ardron J. A., 2010, MARXAN GOOD PRACTICE; Ball I. R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; Bastidas C, 2005, HYDROBIOLOGIA, V541, P101, DOI 10.1007/s10750-004-4672-y; Baums IB, 2005, MOL ECOL, V14, P1377, DOI 10.1111/j.1365-294X.2005.02489.x; Beger M, 2010, CONSERV LETT, V3, P359, DOI 10.1111/j.1755-263X.2010.00123.x; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Berglund M, 2012, ECOL MODEL, V240, P105, DOI 10.1016/j.ecolmodel.2012.04.011; Bleck R, 2002, OCEAN MODEL, V4, P55, DOI 10.1016/S1463-5003(01)00012-9; Botsford LW, 2009, CORAL REEFS, V28, P327, DOI 10.1007/s00338-009-0466-z; Burgess SC, 2014, ECOL APPL, V24, P257, DOI 10.1890/13-0710.1; Burke L., 2011, REEFS RISK REVISITED; Buston PM, 2012, P ROY SOC B-BIOL SCI, V279, P1883, DOI 10.1098/rspb.2011.2041; Connolly SR, 2010, ECOLOGY, V91, P3572, DOI 10.1890/10-0143.1; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Cowen RK, 2007, OCEANOGRAPHY, V20, P14, DOI 10.5670/oceanog.2007.26; Cvitanovic C, 2013, J ENVIRON MANAGE, V114, P84, DOI 10.1016/j.jenvman.2012.10.051; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; Arias-Gonzalez JE, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P373, DOI 10.1007/978-94-007-0114-4_21; Fischer DT, 2011, PROF GEOGR, V63, P489, DOI 10.1080/00330124.2011.585079; Foster NL, 2012, MOL ECOL, V21, P1143, DOI 10.1111/j.1365-294X.2012.05455.x; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Golbuu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050998; Graham EM, 2008, CORAL REEFS, V27, P529, DOI 10.1007/s00338-008-0361-z; Green AL, 2015, BIOL REV, V90, P1215, DOI 10.1111/brv.12155; Guarderas AP, 2008, CONSERV BIOL, V22, P1630, DOI 10.1111/j.1523-1739.2008.01023.x; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hoegh-Guldberg O, 2011, REG ENVIRON CHANGE, V11, pS215, DOI 10.1007/s10113-010-0189-2; Hogan JD, 2012, OECOLOGIA, V168, P61, DOI 10.1007/s00442-011-2058-1; Holstein DM, 2014, MAR ECOL PROG SER, V499, P1, DOI 10.3354/meps10647; Huggins AE, 2007, TECHNICAL REPORT; IUCN & UNEP-WCMC, 2014, WORLD DAT PROT AR WD; Jackson JBC, 2008, P NATL ACAD SCI USA, V105, P11458, DOI 10.1073/pnas.0802812105; Jones GP, 2009, CORAL REEFS, V28, P303, DOI 10.1007/s00338-008-0440-1; Jones GP, 2009, CORAL REEFS, V28, P307, DOI 10.1007/s00338-009-0469-9; Kennedy EV, 2013, CURR BIOL, V23, P912, DOI 10.1016/j.cub.2013.04.020; Klein CJ, 2010, FRONT ECOL ENVIRON, V8, P349, DOI 10.1890/090047; Knowles JE, 2015, MAR POLICY, V60, P84, DOI 10.1016/j.marpol.2015.05.005; Lagabrielle E, 2014, AQUAT CONSERV, V24, P94, DOI 10.1002/aqc.2500; Magris RA, 2015, ECOGRAPHY IN PRESS; Makino A, 2013, BIOL CONSERV, V165, P35, DOI 10.1016/j.biocon.2013.05.027; McCook LJ, 2009, CORAL REEFS, V28, P353, DOI 10.1007/s00338-008-0463-7; Mehra A, 2010, TERR ATMOS OCEAN SCI, V21, P211, DOI 10.3319/TAO.2009.04.16.01(IWNOP); Mendes JM, 2002, MAR ECOL PROG SER, V227, P241, DOI 10.3354/meps227241; Micheli F, 2014, BIOL CONSERV, V171, P186, DOI 10.1016/j.biocon.2013.12.029; Mora C, 2006, SCIENCE, V314, P758; Mora C, 2012, ECOGRAPHY, V35, P89, DOI 10.1111/j.1600-0587.2011.06874.x; Nishikawa A, 2005, ZOOL SCI, V22, P391, DOI 10.2108/zsj.22.391; North EW, 2009, ICES INT COUNC EXPLO; Palumbi SR, 2003, FRONT ECOL ENVIRON, V1, P73, DOI 10.2307/3868033; Paris CB, 2007, MAR ECOL PROG SER, V347, P285, DOI 10.3354/meps06985; Roberts CM, 1997, SCIENCE, V278, P1454, DOI 10.1126/science.278.5342.1454; Roberts JJ, 2010, ENVIRON MODELL SOFTW, V25, P1197, DOI 10.1016/j.envsoft.2010.03.029; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Sandin SA, 2008, GLOBAL ECOL BIOGEOGR, V17, P770, DOI 10.1111/j.1466-8238.2008.00418.x; Schill SR, 2012, MACARTHUR FDN PROGRA; Severance EG, 2006, MAR BIOL, V150, P57, DOI 10.1007/s00227-006-0332-2; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Steneck RS, 2009, CORAL REEFS, V28, P367, DOI 10.1007/s00338-009-0470-3; Strathmann RR, 2002, B MAR SCI, V70, P377; Taylor MS, 2006, MOL ECOL, V15, P695, DOI 10.1111/j.1365-294X.2006.02820.x; Treml EA, 2008, LANDSCAPE ECOL, V23, P19, DOI 10.1007/s10980-007-9138-y; Treml EA, 2015, GLOBAL ENVIRON CHANG, V31, P263, DOI 10.1016/j.gloenvcha.2015.01.012; Treml EA, 2012, CONSERV LETT, V5, P441, DOI 10.1111/j.1755-263X.2012.00260.x; Treml EA, 2012, INTEGR COMP BIOL, V52, P525, DOI 10.1093/icb/ics101; van Woesik R, 2006, ECOL LETT, V9, P390, DOI 10.1111/j.1461-0248.2006.00886.x; Vollmer SV, 2007, J HERED, V98, P40, DOI 10.1093/jhered/esl057; Watts ME, 2009, ENVIRON MODELL SOFTW, V24, P1513, DOI 10.1016/j.envsoft.2009.06.005; White C, 2010, P ROY SOC B-BIOL SCI, V277, P1685, DOI 10.1098/rspb.2009.2214; White JW, 2014, CONSERVATION LETT; Willis TJ, 2003, ENVIRON CONSERV, V30, P97, DOI 10.1017/S0376892903000092	75	45	45	3	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144199	10.1371/journal.pone.0144199	http://dx.doi.org/10.1371/journal.pone.0144199			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641083	Green Published, gold			2022-12-27	WOS:000366902700075
J	Upperman, CR; Parker, J; Jiang, CS; He, X; Murtugudde, R; Sapkota, A				Upperman, Crystal Romeo; Parker, Jennifer; Jiang, Chengsheng; He, Xin; Murtugudde, Raghuram; Sapkota, Amir			Frequency of Extreme Heat Event as a Surrogate Exposure Metric for Examining the Human Health Effects of Climate Change	PLOS ONE			English	Article							NEW-YORK-STATE; DISEASE MORTALITY; UNITED-STATES; EL-NINO; URBANIZATION; US; EPIDEMIOLOGY; IMPACT; ENSO; RISK	Epidemiological investigation of the impact of climate change on human health, particularly chronic diseases, is hindered by the lack of exposure metrics that can be used as a marker of climate change that are compatible with health data. Here, we present a surrogate exposure metric created using a 30-year baseline (1960-1989) that allows users to quantify long-term changes in exposure to frequency of extreme heat events with near unabridged spatial coverage in a scale that is compatible with national/state health outcome data. We evaluate the exposure metric by decade, seasonality, area of the country, and its ability to capture long-term changes in weather (climate), including natural climate modes. Our findings show that this generic exposure metric is potentially useful to monitor trends in the frequency of extreme heat events across varying regions because it captures long-term changes; is sensitive to the natural climate modes (ENSO events); responds well to spatial variability, and; is amenable to spatial/temporal aggregation, making it useful for epidemiological studies.	[Upperman, Crystal Romeo; Sapkota, Amir] Univ Maryland, Maryland Inst Appl Environm Hlth, Sch Publ Hlth, College Pk, MD 20742 USA; [Upperman, Crystal Romeo; Jiang, Chengsheng] Univ Maryland, Marine Estuarine Environm Sci Program, College Pk, MD 20742 USA; [Parker, Jennifer] Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA; [He, Xin] Univ Maryland, Sch Publ Hlth, Dept Epidemiol & Biostat, College Pk, MD 20742 USA; [Murtugudde, Raghuram] Univ Maryland, Dept Atmospher & Ocean Sci, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS); University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Sapkota, A (corresponding author), Univ Maryland, Maryland Inst Appl Environm Hlth, Sch Publ Hlth, College Pk, MD 20742 USA.	amirsap@umd.edu	Sapkota, Amir/A-5968-2011; He, Xin/N-6742-2016		Centers for Disease Control and Prevention (CDC); National Institute of Environmental Health Sciences [NIEHS: 1R21ES021422-01A1]; Centers for Disease Control and Prevention; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD041041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES021422] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The funding for this work was provided by the Centers for Disease Control and Prevention (CDC) and the National Institute of Environmental Health Sciences (NIEHS: 1R21ES021422-01A1).; The findings and conclusions in this paper are those of the authors and do not necessarily represent the views of the National Center for Health Statistics or the Centers for Disease Control and Prevention. The funding for this work was provided by the Centers for Disease Control and Prevention and the National Institute of Environmental Health Sciences (NIEHS: 1R21ES021422-01A1)	Abdi H., 2010, ENCY RES DESIGN, V3, P1, DOI DOI 10.4135/9781412961288.N178; Akinbami LJ, 2010, ENVIRON RES, V110, P294, DOI 10.1016/j.envres.2010.01.001; Alexander LV, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006290; [Anonymous], EL NIN SO OSC COLD W; Barnett E, 1996, J EPIDEMIOL COMMUN H, V50, P252, DOI 10.1136/jech.50.3.252; Beniston M, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL037119; Byers AL, 2003, J CLIN EPIDEMIOL, V56, P559, DOI 10.1016/S0895-4356(03)00028-3; Cayan DR, 2001, B AM METEOROL SOC, V82, P399, DOI 10.1175/1520-0477(2001)082<0399:CITOOS>2.3.CO;2; Corti S, 1999, NATURE, V398, P799, DOI 10.1038/19745; Costello A, 2009, LANCET, V373, P1693, DOI [10.1016/S0140-6736(09)60935-1, 10.1016/S0140-6736(09)60929-6]; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Frumkin H, 2008, AM J PUBLIC HEALTH, V98, P435, DOI 10.2105/AJPH.2007.119362; Ganeshan M, 2013, URBAN CLIM, V6, P1, DOI 10.1016/j.uclim.2013.09.004; Greene W.H, 1994, ACCOUNTING EXCESS ZE; Gutowski WJ, 2008, REPORT US CLIMATE CH; Haines A, 1997, BRIT MED J, V315, P870, DOI 10.1136/bmj.315.7112.870; Hales S., 2014, QUANTITATIVE RISK AS; Hao ZC, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/034014; INGRAM DD, 1989, J CLIN EPIDEMIOL, V42, P857, DOI 10.1016/0895-4356(89)90099-1; Ingram Deborah D, 2012, Vital Health Stat 2, P1; Jiang CS, 2015, ENVIRON INT, V83, P58, DOI 10.1016/j.envint.2015.06.006; Kalnay E, 2003, NATURE, V423, P528, DOI 10.1038/nature01675; Knobeloch Lynda, 2007, WMJ, V106, P137; Larkin NK, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022860; Leung LR, 2005, GEOPHYS RES LETT, P32; Luber G, 2014, CLIMATE CHANGE IMPAC, P220, DOI DOI 10.7930/J0PN93H5; Luber G, 2008, AM J PREV MED, V35, P429, DOI 10.1016/j.amepre.2008.08.021; McMichael AJ, 2001, AM J PUBLIC HEALTH, V91, P1172, DOI 10.2105/AJPH.91.8.1172; McPhaden MJ, 2006, SCIENCE, V314, P1740, DOI 10.1126/science.1132588; Menzel A, 1999, NATURE, V397, P659, DOI 10.1038/17709; Murtugudde R, 2009, CURR OPIN ENV SUST, V1, P37, DOI 10.1016/j.cosust.2009.07.004; Parker Jennifer D, 2008, Vital Health Stat 2, P1; Parker JD, 2009, ENVIRON HEALTH PERSP, V117, P140, DOI 10.1289/ehp.11497; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Perkins SE, 2013, J CLIMATE, V26, P4500, DOI 10.1175/JCLI-D-12-00383.1; Ramesh N, 2012, NAT CLIM CHANGE, V2, DOI 10.1038/NCLIMATE1600; Rossen LM, 2013, AM J PREV MED, V45, pE19, DOI 10.1016/j.amepre.2013.07.012; Savitz DA, 2014, MATERN CHILD HLTH J, V18, P829, DOI 10.1007/s10995-013-1307-9; Savitz DA, 2011, ANN EPIDEMIOL, V21, P399, DOI 10.1016/j.annepidem.2011.03.003; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stenseth NC, 2003, P ROY SOC B-BIOL SCI, V270, P2087, DOI 10.1098/rspb.2003.2415; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Watson RT, 2001, CLIMATE CHANGE 2001: IMPACTS, ADAPTATION, AND VULNERABILITY, pIX; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Wolff C, 2011, SCIENCE, V333, P743, DOI 10.1126/science.1203724; Wolter K, 1999, J CLIMATE, V12, P3255, DOI 10.1175/1520-0442(1999)012<3255:STCEOT>2.0.CO;2; Zhai P, 2003, ACTA GEOGR SIN, P58; Zhou LM, 2004, P NATL ACAD SCI USA, V101, P9540, DOI 10.1073/pnas.0400357101; Ziska LH, 2012, J ALLERGY CLIN IMMUN, V129, P27, DOI 10.1016/j.jaci.2011.10.032	49	15	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144202	10.1371/journal.pone.0144202	http://dx.doi.org/10.1371/journal.pone.0144202			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641244	Green Published, gold, Green Submitted			2022-12-27	WOS:000366902700076
J	Zhang, Y; Xu, H; Wang, T; He, JG; Qiao, YF; Wei, J; Dong, JS				Zhang, Yi; Xu, Hua; Wang, Tao; He, Jinguang; Qiao, Yufei; Wei, Jiao; Dong, Jiasheng			Psychosocial Predictors and Outcomes of Delayed Breast Reconstruction in Mastectomized Women in Mainland China: An Observational Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; BODY-IMAGE; GLYCEMIC CONTROL; BLOOD-GLUCOSE; SOCIODEMOGRAPHIC FACTORS; PSYCHOLOGICAL DISTRESS; PATIENT SATISFACTION; DIABETES-MELLITUS; SURGERY PATIENTS; DECISION-MAKING	Background The aim of the present study was to evaluate potential psychosocial factors that impact Chinese female breast cancer patients to select breast reconstruction (BR), and potential connection of psychosocial outcomes with their satisfaction with BR. Methods A total of 264 female breast cancer patients with mastectomy were recruited from 2012 to 2014. All patients were informed with BR options at their first visit. Personal and medical profiles were collected. Body image, self-esteem, depression and anxiety were assessed using validated scales. Patients who were selected to undergo BR after the first visit were followed up for six months. The same assessment was performed at 6 months post BR, and their satisfaction with BR was evaluated using the Alderman scale. Multivariate linear and logistic regressions were performed. Results Forty-seven percent of the patients (126/264) opted to undergo BR within six months after the initial visit. Multivariate logistic regression analysis revealed that self-esteem (P < 0.05), body image (P < 0.01), education level (P < 0.05), and their husband's recommendation (P < 0.05) were highly related to the patients' decision to undergo BR. In addition, multivariate linear regression analysis showed that patient satisfaction with BR was significantly associated with preoperative body image (P < 0.01), postoperative improvement in self-esteem (P < 0.01), improvement in body image (P < 0.01), reduction in depression (P < 0.05), pain (P < 0.05), and scarring (P < 0.01). Conclusions The psychosocial factors including self-esteem and body image are highly related to selecting the BR option and post-BR satisfaction in Chinese female breast cancer patients.	[Zhang, Yi; Xu, Hua; Wang, Tao; He, Jinguang; Qiao, Yufei; Wei, Jiao; Dong, Jiasheng] Shanghai Jiao Tong Univ, Sch Med, Dept Plast & Reconstruct Surg, Shanghai Peoples Hosp 9, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Dong, JS (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Plast & Reconstruct Surg, Shanghai Peoples Hosp 9, Shanghai 200030, Peoples R China.	dongjiasheng_9y@163.com						Agarwal S, 2010, BREAST J, V16, P503, DOI 10.1111/j.1524-4741.2010.00958.x; Albornoz CR, 2012, PLAST RECONSTR SURG, V129, P1071, DOI 10.1097/PRS.0b013e31824a29c5; Alderman AK, 2000, PLAST RECONSTR SURG, V106, P769, DOI 10.1097/00006534-200009040-00003; Alderman AK, 2003, PLAST RECONSTR SURG, V111, P695, DOI 10.1097/01.PRS.0000041438.50018.02; Azin A, 2014, PLAST RECONSTR SURG, V133, p776E, DOI 10.1097/PRS.0000000000000227; Begum S, 2011, PATIENT EDUC COUNS, V84, P105, DOI 10.1016/j.pec.2010.07.004; Bell RJ, 2012, BREAST, V21, P394, DOI 10.1016/j.breast.2012.04.006; Brandberg Y, 2008, J CLIN ONCOL, V26, P3943, DOI 10.1200/JCO.2007.13.9568; Chen JJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001399; Christian CK, 2006, ANN SURG, V243, P241, DOI 10.1097/01.sla.0000197738.63512.23; Clark L, 2011, ANN ROY COLL SURG, V93, P106, DOI 10.1308/003588411X12851639107593; Craft RO, 2011, PLAST RECONSTR SURG, V127, P1417, DOI 10.1097/PRS.0b013e318208d12a; Dawson J, 2010, J SHOULDER ELB SURG, V19, P635, DOI 10.1016/j.jse.2010.02.003; Didie ER, 2003, J WOMEN HEALTH GEN-B, V12, P241, DOI 10.1089/154099903321667582; Duggal CS, 2013, ANN PLAS SURG, V70, P506, DOI [10.1097/SAP.0b013e3182851052, 10.1097/SAP.0b013e318263f1f8]; Evans JMM, 1999, BMJ-BRIT MED J, V319, P83, DOI 10.1136/bmj.319.7202.83; Ferlay J, 2010, GLOBOCAN 2008 CANC I; Fobair P, 2006, PSYCHO-ONCOL, V15, P579, DOI 10.1002/pon.991; GOLDBERG P, 1984, ANN PLAS SURG, V13, P38, DOI 10.1097/00000637-198407000-00008; Gopie JP, 2014, PSYCHO-ONCOLOGY, V23, P100, DOI 10.1002/pon.3377; Guo XH, 2012, CHINESE MED J-PEKING, V125, P4175, DOI 10.3760/cma.j.issn.0366-6999.2012.23.003; Guyomard V, 2009, J PLAST RECONSTR AES, V62, P782, DOI 10.1016/j.bjps.2007.09.054; He J, 2015, MICROSURGERY; Hegel MT, 2008, PSYCHO-ONCOL, V17, P556, DOI 10.1002/pon.1289; Jabor MA, 2002, PLAST RECONSTR SURG, V110, P457, DOI 10.1097/00006534-200208000-00013; Keith DJW, 2003, PLAST RECONSTR SURG, V111, P1051, DOI 10.1097/01.PRS.0000046247.56810.40; Lang JE, 2013, J SURG ONCOL, V108, P163, DOI 10.1002/jso.23365; Martin S, 2006, DIABETOLOGIA, V49, P271, DOI 10.1007/s00125-005-0083-5; Matrai Z, 2014, MED SCI MONITOR, V20, P2633, DOI 10.12659/MSM.891072; MOCK V, 1993, NURS RES, V42, P153; Moolenburgh SE, 2009, PSYCHO-ONCOLOGY, V18, P747, DOI 10.1002/pon.1459; Morrow M, 2005, CANCER-AM CANCER SOC, V104, P2340, DOI 10.1002/cncr.21444; Nilsson MI, 2013, PSYCHO-ONCOLOGY, V22, P1639, DOI 10.1002/pon.3192; Parsa Parisa, 2006, Asian Pac J Cancer Prev, V7, P509; Pyszel A, 2006, LYMPHOLOGY, V39, P185; Reuben BC, 2009, AM J SURG, V198, P237, DOI 10.1016/j.amjsurg.2008.11.034; Roblin DW, 2007, J AMBUL CARE MANAG, V30, P64, DOI 10.1097/00004479-200701000-00009; Silva DDR, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/1758-5996-7-2; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Sarwer DB, 1998, ANN PLAS SURG, V40, P403, DOI 10.1097/00000637-199804000-00014; Shaikh-Naidu N, 2004, ANN PLAS SURG, V52, P465, DOI 10.1097/01.sap.0000123901.06133.b7; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sheehan J, 2007, PSYCHO-ONCOLOGY, V16, P342, DOI 10.1002/pon.1067; Shridharani SM, 2010, PLAST RECONSTR SURG, V126, P2243, DOI 10.1097/PRS.0b013e3181f445ae; Tseng WH, 2010, PLAST RECONSTR SURG, V126, P1815, DOI 10.1097/PRS.0b013e3181f444bc; Veiga DF, 2010, PLAST RECONSTR SURG, V125, P811, DOI 10.1097/PRS.0b013e3181ccdac5; Versnel SL, 2010, J PLAST RECONSTR AES, V63, P1642, DOI 10.1016/j.bjps.2009.10.018; Wang T, 2014, AESTHETIC PLAST SURG; White CA, 2000, PSYCHO-ONCOL, V9, P183; Xu H, 2009, PLAST RECONSTR SURG, V124, P1797, DOI 10.1097/PRS.0b013e3181bf81cf; Yang XH, 2014, PSYCHIAT RES, V220, P874, DOI 10.1016/j.psychres.2014.08.056; Yong J, 2011, DIABETES, V60, P1383, DOI 10.2337/db10-0907; Yu DD, 2013, J CRANIOFAC SURG, V24, P743, DOI 10.1097/SCS.0b013e318285d5a4; Zhang BN, 2013, BREAST, V22, P676, DOI 10.1016/j.breast.2013.01.004; Zycinska J, 2014, QUAL LIFE RES, V23, P1803, DOI 10.1007/s11136-013-0612-5	55	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144410	10.1371/journal.pone.0144410	http://dx.doi.org/10.1371/journal.pone.0144410			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1YS	26641252	Green Published, Green Submitted, gold			2022-12-27	WOS:000366902700112
J	Fan, YL; Kress, WJ; Li, QJ				Fan, Yong-Li; Kress, W. John; Li, Qing-Jun			A New Secondary Pollen Presentation Mechanism from a Wild Ginger (Zingiber densissimum) and Its Functional Roles in Pollination Process	PLOS ONE			English	Article							FLOWERING PLANTS; SELF-POLLINATION; SEXUAL SELECTION; FLORAL NECTAR; EVOLUTION; COST; CAMPANULACEAE; MARANTACEAE; ANGIOSPERMS; DISPERSAL	Background and Aims Secondary pollen presentation (SPP), a floral mechanism of reproductive adaptation, has been described for more than 200 years, with nine types SPP recorded. However, few studies have been done experimentally to link the floral mechanism of SPP to its functional roles in pollination process. This study aims to describe a new SPP mechanism from a wild ginger (Zingiber densissimum, Zingiberaceae) and explore how the pollen arrangement of SPP affects pollen removal during the interaction with different pollinators. Methodology/Principal Findings Field observations and experiments revealed that flowers lasted for less than one day. The breeding system was partially self-incompatible. Two bee species, Macropis hedini (which carried pollen dorsally) and Amegilla zonata (which carried pollen ventrally) were the primary pollinators. About a third of pollen grains were relocated from the anther to the labellum staminode of flowers through the adherence of aggregated pollen chains, while other grains were presented on the anther. In a single visit, each bee species removed pollen grains from both the labellum staminode and the anther. Macropis hedini was more effective than Amegilla zonata. Conclusions/Significance Our study describes a new SPP mechanism in angiosperms. The new SPP mode enables pollen grains presented on the anther and the labellum staminode simultaneously via the adherence of aggregated pollen chains, thus promoting pollen to be taken away by different pollinators. This SPP mechanism plays a key role during pollen removal and may have evolved under the pressure to improve male fitness.	[Fan, Yong-Li; Li, Qing-Jun] Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Mengla, Yunnan, Peoples R China; [Fan, Yong-Li] Univ Chinese Acad Sci, Beijing, Peoples R China; [Fan, Yong-Li] China Forest Explorat & Design Inst Kunming, Kunming, Peoples R China; [Fan, Yong-Li; Kress, W. John] Smithsonian Inst, Natl Museum Nat Hist, Dept Bot, Washington, DC 20560 USA	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Smithsonian Institution; Smithsonian National Museum of Natural History	Li, QJ (corresponding author), Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Mengla, Yunnan, Peoples R China.	qjli@xtbg.ac.cn	Fan, Yongli/M-8841-2019	Fan, Yongli/0000-0002-2186-3011	Natural Science Foundation of China [U1202261, 31070340]; Chinese Scholarship Council [201304910290]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Scholarship Council(China Scholarship Council)	This work was supported by the Natural Science Foundation of China (U1202261 and 31070340) granted to Q-JL and a scholarship from the Chinese Scholarship Council (201304910290). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashman TL, 1997, EVOL ECOL, V11, P289, DOI 10.1023/A:1018416403530; ASHMAN TL, 1994, NATURE, V371, P788, DOI 10.1038/371788a0; BELL G, 1985, PROC R SOC SER B-BIO, V224, P223, DOI 10.1098/rspb.1985.0031; BRANTJES NBM, 1983, ACTA BOT NEERL, V32, P213, DOI 10.1111/j.1438-8677.1983.tb01702.x; Castellanos MC, 2006, AM NAT, V167, P288, DOI 10.1086/498854; Castro S, 2008, AM J BOT, V95, P706, DOI 10.3732/ajb.2007329; CRUDEN RW, 1977, EVOLUTION, V31, P32, DOI 10.1111/j.1558-5646.1977.tb00979.x; Duan YA, 2008, J SYST EVOL, V46, P545, DOI 10.3724/SP.J.1002.2008.08009; Faegri K., 1966, PRINCIPLES POLLINATI; Fan YL, 2012, ANN BOT-LONDON, V110, P969, DOI 10.1093/aob/mcs169; Glinos E, 2011, PLANT SYST EVOL, V291, P49, DOI 10.1007/s00606-010-0379-x; Harder L., 2006, ECOLOGY EVOLUTION FL; Harder LD, 2008, INT J PLANT SCI, V169, P59, DOI 10.1086/523364; HARDER LD, 1994, EVOL ECOL, V8, P542, DOI 10.1007/BF01238257; HARDER LD, 1989, AM NAT, V133, P323, DOI 10.1086/284922; HOWELL GJ, 1993, AUST J BOT, V41, P417, DOI 10.1071/BT9930417; Javorek SK, 2002, ANN ENTOMOL SOC AM, V95, P345, DOI 10.1603/0013-8746(2002)095[0345:CPEABH]2.0.CO;2; Kennedy H., 1978, University of California Publications in Botany, V71; Kress WJ, 2001, SYST BIOL, V50, P926, DOI 10.1080/106351501753462885; LADD PG, 1994, BOT J LINN SOC, V115, P165, DOI 10.1006/bojl.1994.1040; Larson BMH, 1999, J ECOL, V87, P371, DOI 10.1046/j.1365-2745.1999.00362.x; Ley AC, 2009, ANN BOT-LONDON, V104, P41, DOI 10.1093/aob/mcp106; Li QJ, 2001, NATURE, V410, P432, DOI 10.1038/35068635; LI YQ, 1994, SEX PLANT REPROD, V7, P145; Liang YH, 1988, ACTA PHYTOTAXONOMICA, V26, P265; Lin H, 2012, FLORA, V207, P895, DOI 10.1016/j.flora.2012.10.001; Lloyd D.G., 1984, PERSPECTIVES PLANT P, P277; LLOYD DG, 1982, EVOLUTION, V36, P903, DOI 10.1111/j.1558-5646.1982.tb05462.x; MCCONCHIE CA, 1986, ANN BOT-LONDON, V57, P155, DOI 10.1093/oxfordjournals.aob.a087102; Ordano M, 2005, J TROP ECOL, V21, P541, DOI 10.1017/S026646740500266X; PERCIVAL M. S., 1955, NEW PHYTOL, V54, P353, DOI 10.1111/j.1469-8137.1955.tb06192.x; PYKE GH, 1991, NATURE, V350, P58, DOI 10.1038/350058a0; Sakai S, 1999, AM J BOT, V86, P56, DOI 10.2307/2656954; SEDGLEY M, 1982, AUST J BOT, V30, P601, DOI 10.1071/BT9820601; Seymour RS, 2003, NATURE, V426, P243, DOI 10.1038/426243a; SLATER AT, 1991, AUST J BOT, V39, P229, DOI 10.1071/BT9910229; Specht CD, 2012, BOT REV, V78, P440, DOI 10.1007/s12229-012-9111-6; THEILADE I, 1993, GRANA, V32, P338, DOI 10.1080/00173139309428961; THOMSON JD, 1986, J ECOL, V74, P329, DOI 10.2307/2260258; Wang YQ, 2005, INT J PLANT SCI, V166, P753, DOI 10.1086/431803; Wang YQ, 2004, NATURE, V431, P39, DOI 10.1038/431039b; Waser NM, 1996, ECOLOGY, V77, P1043, DOI 10.2307/2265575; WILLSON MF, 1979, AM NAT, V113, P777, DOI 10.1086/283437; WILSON P, 1994, AM NAT, V143, P283, DOI 10.1086/285604; Wu D.L, 2000, FLORA CHINA, V24, P362; Yatomi R, 2002, GRANA, V41, P21, DOI 10.1080/00173130260045468; Yeo P. F., 1993, SECONDARY POLLEN PRE; Zhang ZQ, 2008, ANN BOT-LONDON, V102, P531, DOI 10.1093/aob/mcn136	48	5	7	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143812	10.1371/journal.pone.0143812	http://dx.doi.org/10.1371/journal.pone.0143812			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26637125	gold, Green Submitted, Green Published			2022-12-27	WOS:000366143800029
J	Yamakoshi, T; Lee, JY; Matsumura, K; Yamakoshi, Y; Rolfe, P; Kiyohara, D; Yamakoshi, KI				Yamakoshi, Takehiro; Lee, Jihyoung; Matsumura, Kenta; Yamakoshi, Yasuhiro; Rolfe, Peter; Kiyohara, Daiki; Yamakoshi, Ken-ichi			Integrating Sphere Finger-Photoplethysmography: Preliminary Investigation towards Practical Non-Invasive Measurement of Blood Constituents	PLOS ONE			English	Article							NORMALIZED PULSE VOLUME; MEAN ARTERIAL-PRESSURE; OSCILLOMETRIC METHOD; HEART-RATE; GLUCOSE; SPECTROSCOPY; SKIN; REFLECTANCE; TISSUE; MODEL	The aim of this study was to compare conventional photoplethysmography (PPG) in a finger with PPG using an integrating sphere ((IS)PPG) to enhance scattered light collection. Two representative wavelengths were used; 1160 nm, a window through the absorption spectra of water and alcohol, and 1600 nm around where water absorption is high and there is an absorption peak of blood glucose. Simultaneous transmission-type measurements were made with conventional PPG and with (IS)PPG for each wavelength in the tips of index fingers of both hands in a total of 10 healthy young male and female volunteers (21.7 +/- 1.6 years old). During a 5 min period in which subjects were in a relaxed state we determined the signal-to-noise ratio, SNR, and the PPG detectability (or sensitivity) by the two techniques. SNR during the test period was significantly higher with (IS)PPG as compared with conventional PPG, especially for the 1600 nm wavelength. PPG signals with 1600 nm could scarcely be detected by conventional PPG, while they could be detected with good sensitively by (IS)PPG. We conclude that under controlled conditions (IS)PPG has better SNR and higher sensitivity than conventional transmission PPG, especially in wavelength regions where water absorption is high but where there is potential for practical measurement of blood constituents including glucose.	[Yamakoshi, Takehiro; Lee, Jihyoung] Fukuoka Inst Technol, Fac Informat Engn, Dept Informat & Syst Engn, Higashi Ku, Fukuoka, Fukuoka 8110295, Japan; [Matsumura, Kenta; Yamakoshi, Yasuhiro] Hokkaido Univ, Grad Sch Informat Sci & Technol, Div Bioengn & Bioinformat, Kita Ku, Sapporo, Hokkaido 0600814, Japan; [Rolfe, Peter] Harbin Inst Technol, Dept Automat Measurement & Control, Harbin 150001, Peoples R China; [Kiyohara, Daiki] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan; [Yamakoshi, Ken-ichi] Showa Univ, Sch Med, Shinagawa Ku, Tokyo, Japan	Fukuoka Institute of Technology; Hokkaido University; Harbin Institute of Technology; Kanazawa University; Showa University	Yamakoshi, T (corresponding author), Fukuoka Inst Technol, Fac Informat Engn, Dept Informat & Syst Engn, Higashi Ku, 3-30-1 Wajiro Higashi, Fukuoka, Fukuoka 8110295, Japan.	yamakoshi@fit.ac.jp	Matsumura, Kenta/ABH-9288-2020	Matsumura, Kenta/0000-0002-4271-1543	Ministry of Education, Science, Sports and Culture [26242044, 23650349, 24680063]; Grants-in-Aid for Scientific Research [26242044] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Scientific Research (A) (Grant No. 26242044): J.L. T.Y.K.Y., https://kaken.nii.ac.jp/d/p/26242044.en.html. Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Challenging Exploratory Research (Grant No. 23650349): T.Y.K.Y., https://kaken.nii.ac.jp/d/p/23650349.en.html. Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Young Scientists (A) (Grant No. 24680063): T.Y., https://kaken.nii.ac.jp/d/p/24680063.en.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to give their sincere thanks to Mr. Naoto Tanaka, NPO Research Institute of Life Benefit, for his technical assistance in developing the laser instrument, and Mr. Takashi Nagai, Kanazawa University, for his experimental assistance. Financial support for this work was partially provided by the Ministry of Education, Science, Sports and Culture, Grantin- Aid for Scientific Research (A) (Grant No. 26242044), Challenging Exploratory Research (Grant No. 23650349), and Young Scientists (A) (Grant No. 24680063), Japan. The authors declare that they have no conflict of interest.	Allen J, 2000, PHYSIOL MEAS, V21, P369, DOI 10.1088/0967-3334/21/3/303; Allen J, 2004, COMPUT CARDIOL, V31, P485, DOI 10.1109/CIC.2004.1442980; Allen J, 2007, PHYSIOL MEAS, V28, pR1, DOI 10.1088/0967-3334/28/3/R01; ANDERSON RR, 1981, J INVEST DERMATOL, V77, P13, DOI 10.1111/1523-1747.ep12479191; Aoyagi T, 1974, 13TH MEETING OF THE; Berger AJ, 1999, APPL OPTICS, V38, P2916, DOI 10.1364/AO.38.002916; BONNER R, 1981, APPL OPTICS, V20, P2097, DOI 10.1364/AO.20.002097; Cameron BD, 1997, IEEE T BIO-MED ENG, V44, P1221, DOI 10.1109/10.649993; Cao Q, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.10.101318; CUI W, 1990, IEEE T BIO-MED ENG, V37, P632, DOI 10.1109/10.55667; Fiala J, 2013, BIOMED MICRODEVICES, V15, P73, DOI 10.1007/s10544-012-9689-9; KAMAL AAR, 1989, COMPUT METH PROG BIO, V28, P257, DOI 10.1016/0169-2607(89)90159-4; KRUSEJARRES JD, 1990, CLIN CHEM, V36, P401; Lee J, 2013, IEEE ENG MED BIO, P1724, DOI 10.1109/EMBC.2013.6609852; Lee J, 2013, PHYSIOL MEAS, V34, P359, DOI 10.1088/0967-3334/34/3/359; MacKenzie HA, 1999, CLIN CHEM, V45, P1587; Maeda Y, 2011, J MED SYST, V35, P829, DOI 10.1007/s10916-010-9506-z; Maruo K, 2003, APPL SPECTROSC, V57, P1236, DOI 10.1366/000370203769699090; Matsumura Kenta, 2015, Methods Mol Biol, V1256, P305, DOI 10.1007/978-1-4939-2172-0_21; Matsumura K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091205; Matsumura K, 2013, BEHAV RES METHODS, V45, P1272, DOI 10.3758/s13428-012-0312-z; Millasseau SC, 2006, J HYPERTENS, V24, P1449, DOI 10.1097/01.hjh.0000239277.05068.87; Nilsson LM, 2013, ANESTH ANALG, V117, P859, DOI 10.1213/ANE.0b013e31828098b2; OBEID AN, 1988, MED BIOL ENG COMPUT, V26, P415, DOI 10.1007/BF02442302; Patterson JAC, 2009, SIXTH INTERNATIONAL WORKSHOP ON WEARABLE AND IMPLANTABLE BODY SENSOR NETWORKS, PROCEEDINGS, P286, DOI 10.1109/P3644.15; Sawada Y, 2001, INT J PSYCHOPHYSIOL, V41, P1, DOI 10.1016/S0167-8760(00)00162-8; Shih WC, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.5.051036; Silva SML, 2003, J BIOMED OPT, V8, P525, DOI 10.1117/1.1578495; Tanaka G, 2011, PHYSIOL MEAS, V32, P1869, DOI 10.1088/0967-3334/32/11/003; Yamakoshi K, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2360919; YAMAKOSHI K, 1982, MED BIOL ENG COMPUT, V20, P314, DOI 10.1007/BF02442798; YAMAKOSHI K, 1982, MED BIOL ENG COMPUT, V20, P307, DOI 10.1007/BF02442797; YAMAKOSHI K, 1980, IEEE T BIO-MED ENG, V27, P150, DOI 10.1109/TBME.1980.326616; Yamakoshi K., 2004, SENSORS APPL, V3, P107, DOI DOI 10.1002/3527601414.CH5; Yamakoshi T., 2012, T JPN SOC MED BIOL E, V50, P237; Yamakoshi T., 2012, IEEJ T ELECT INF SYS, V132, P2059, DOI DOI 10.1541/IEEJEISS.132.2059; Yamakoshi T, 2014, IEEE J BIOMED HEALTH, V18, P28, DOI 10.1109/JBHI.2013.2274460	37	4	4	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143506	10.1371/journal.pone.0143506	http://dx.doi.org/10.1371/journal.pone.0143506			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636974	Green Published, Green Submitted, gold			2022-12-27	WOS:000366143800014
J	Dave, JA; Cohen, K; Micklesfield, LK; Maartens, G; Levitt, NS				Dave, Joel A.; Cohen, Karen; Micklesfield, Lisa K.; Maartens, Gary; Levitt, Naomi S.			Antiretroviral Therapy, Especially Efavirenz, Is Associated with Low Bone Mineral Density in HIV-Infected South Africans	PLOS ONE			English	Article							VITAMIN-D STATUS; BODY-COMPOSITION; OSTEOPOROSIS; PREVALENCE; INITIATION; DISEASE; WOMEN	Purpose We determined the prevalence and correlates of low bone mineral density (BMD) in HIV-infected South Africans as there is a paucity of such data from Africa. Methods BMD and serum 25-hydroxyvitamin D were measured in HIV-positive participants on antiretroviral therapy (ART) and in those not yet on ART (ART-naive). Results We enrolled 444 participants [median age 35(IQR: 30, 40) years; 77% women]. BMD was low (z score <-2SD) in 17% and 5% of participants at the lumbar spine and total hip, respectively. Total hip [0.909 (SD 0.123) vs 0.956 (SD 0.124) g/cm(2), p = 0.0001] and neck of femur BMD [0.796 (SD 0.130) vs 0.844 (SD 0.120) g/cm(2), p = 0.0001] were lower in the ART, compared to the ART-naive group. Vitamin D deficiency was present in 15% of participants and was associated with efavirenz use [adjusted OR 2.04 (95% CI 1.01 to 4.13)]. In a multivariate linear regression, exposure to efavirenz or lopinavir-based ART was associated with lower total hip BMD, whereas higher weight, being male and higher vitamin D concentration were associated with higher total hip BMD (adjusted R-2 = 0.28). Age, weight, sex, and the use of efavirenz-based ART were independently associated with lumbar spine BMD (adjusted R-2 = 0.13). Conclusions Vitamin D status, use of efavirenz or lopinavir/ritonavir, weight, age and sex are significantly associated with lower BMD in this young cohort of HIV-infected South Africans.	[Dave, Joel A.; Levitt, Naomi S.] Univ Cape Town, Dept Med, Div Diabet Med & Endocrinol, ZA-7925 Cape Town, South Africa; [Cohen, Karen; Maartens, Gary] Univ Cape Town, Dept Med, Div Clin Pharmacol, ZA-7925 Cape Town, South Africa; [Micklesfield, Lisa K.] Univ Cape Town, UCT MRC Res Unit Exercise Sci & Sports Med, Dept Human Biol, ZA-7925 Cape Town, South Africa; [Micklesfield, Lisa K.] Univ Witwatersrand, MRC Wits Dev Pathways Hlth Res Unit, Dept Paediat, Fac Hlth Sci, Johannesburg, South Africa	University of Cape Town; University of Cape Town; University of Cape Town; University of Witwatersrand	Dave, JA (corresponding author), Univ Cape Town, Dept Med, Div Diabet Med & Endocrinol, ZA-7925 Cape Town, South Africa.	joel.dave@uct.ac.za	Cohen, Karen/D-4036-2017; Micklesfield, Lisa/AAR-8262-2021; Maartens, Gary/S-2788-2019; Maartens, Gary/F-3836-2014	Micklesfield, Lisa/0000-0002-4994-0779; Maartens, Gary/0000-0003-3080-6606; Maartens, Gary/0000-0003-3080-6606; Levitt, Naomi/0000-0001-6480-8066; Cohen, Karen/0000-0002-1892-4207; Dave, joel/0000-0003-3084-7408	World Diabetes Foundation; South African Department of Health; National Research Foundation of South Africa; Medical Research Council/Department for International Development (DFID) African Research Leader Scheme	World Diabetes Foundation; South African Department of Health; National Research Foundation of South Africa(National Research Foundation - South Africa); Medical Research Council/Department for International Development (DFID) African Research Leader Scheme	JAD and NSL received grants from the World Diabetes Foundation and the South African Department of Health. GM acknowledges partial support by the National Research Foundation of South Africa. LKM would like to acknowledge funding from the Medical Research Council/Department for International Development (DFID) African Research Leader Scheme.	[Anonymous], 2013, UNAIDS REP GLOB AIDS; Anostos K, 2007, ANTIVIR THER, V12, P1049; Bedimo R, 2012, AIDS, V26, P825, DOI 10.1097/QAD.0b013e32835192ae; Bolland MJ, 2006, CLIN ENDOCRINOL, V65, P191, DOI 10.1111/j.1365-2265.2006.02572.x; Borderi M, 2009, AIDS, V23, P1297, DOI 10.1097/QAD.0b013e32832ce85a; Brown TT, 2006, AIDS, V20, P2165, DOI 10.1097/QAD.0b013e32801022eb; Brown TT, 2010, ANTIVIR THER, V15, P425, DOI [10.3851/IMP1502, 10.3851/IMP15021]; Brown TT, 2009, JAIDS-J ACQ IMM DEF, V51, P554, DOI 10.1097/QAI.0b013e3181adce44; Calmy A, 2013, OSTEOPOROSIS INT, V24, P1843, DOI 10.1007/s00198-012-2189-1; Calmy A, 2009, J INFECT DIS, V200, P1746, DOI 10.1086/644785; Casado JL, 2014, OSTEOPOROSIS INT, V25, P1071, DOI 10.1007/s00198-013-2506-3; Castronuovo D, 2013, EUR REV MED PHARMACO, V17, P2413; Cervero M, 2012, AIDS RES HUM RETROV, V28, P763, DOI [10.1089/AID.2011.0244, 10.1089/aid.2011.0244]; Cournil A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031726; Dave JA, 2011, JAIDS-J ACQ IMM DEF, V57, P284, DOI 10.1097/QAI.0b013e318221863f; Friedenreich CM, 1998, MED SCI SPORT EXER, V30, P266, DOI 10.1097/00005768-199802000-00015; Hamill MM, 2013, OSTEOPOROSIS INT, V24, P2855, DOI 10.1007/s00198-013-2373-y; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Martineaua AR, 2011, P NATL ACAD SCI USA, V108, P19013, DOI 10.1073/pnas.1111825108; McComsey GA, 2008, CLIN INFECT DIS, V46, P1290, DOI 10.1086/529384; Ofotokun I, 2012, CURR HIV-AIDS REP, V9, P16, DOI 10.1007/s11904-011-0099-z; Panayiotopoulos A, 2013, REV ENDOCR METAB DIS, V14, P119, DOI 10.1007/s11154-013-9246-8; Rothman MS, 2012, CURR OSTEOPOROS REP, V10, P270, DOI 10.1007/s11914-012-0125-0; Shiau S, 2013, AIDS, V27, P1949, DOI 10.1097/QAD.0b013e328361d241; Welz T, 2010, AIDS, V24, P1923, DOI 10.1097/QAD.0b013e32833c3281; Yin MT, 2012, J CLIN ENDOCR METAB, V97, P554, DOI 10.1210/jc.2011-2197	26	27	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144286	10.1371/journal.pone.0144286	http://dx.doi.org/10.1371/journal.pone.0144286			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633015	gold, Green Published, Green Submitted			2022-12-27	WOS:000366040000078
J	Emer, C; Vaughan, IP; Hiscock, S; Memmott, J				Emer, Carine; Vaughan, Ian P.; Hiscock, Simon; Memmott, Jane			The Impact of the Invasive Alien Plant, Impatiens glandulifera, on Pollen Transfer Networks	PLOS ONE			English	Article							POLLINATOR NETWORKS; DEPOSITION; VISITATION; ASTERACEAE; TOLERANCE; RECEIPT; SUCCESS; SYSTEMS; SURFACE	Biological invasions are a threat to the maintenance of ecological processes, including pollination. Plant-flower visitor networks are traditionally used as a surrogated for pollination at the community level, despite they do not represent the pollination process, which takes place at the stigma of plants where pollen grains are deposited. Here we investigated whether the invasion of the alien plant Impatiens glandulifera (Balsaminaceae) affects pollen transfer at the community level. We asked whether more alien pollen is deposited on the stigmas of plants on invaded sites, whether deposition is affected by stigma type (dry, semidry and wet) and whether the invasion of I. glandulifera changes the structure of the resulting pollen transfer networks. We sampled stigmas of plants on 10 sites invaded by I. glandulifera (hereafter, balsam) and 10 non-invaded control sites. All 20 networks had interactions with balsam pollen, although significantly more balsam pollen was found on plants with dry stigmas in invaded areas. Balsam pollen deposition was restricted to a small subset of plant species, which is surprising because pollinators are known to carry high loads of balsam pollen. Balsam invasion did not affect the loading of native pollen, nor did it affect pollen transfer network properties; networks were modular and poorly nested, both of which are likely to be related to the specificity of pollen transfer interactions. Our results indicate that pollination networks become more specialized when moving from the flower visitation to the level of pollen transfer networks. Therefore, caution is needed when inferring pollination from patterns of insect visitation or insect pollen loads as the relationship between these and pollen deposition is not straightforward.	[Emer, Carine; Hiscock, Simon; Memmott, Jane] Univ Bristol, Bristol, Avon, England; [Emer, Carine] Univ Estadual Paulista UNESP, Dept Ecol, Rio Claro, Brazil; [Vaughan, Ian P.] Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Hiscock, Simon] Univ Oxford, Bot Garden, Oxford, England	University of Bristol; Universidade Estadual Paulista; Cardiff University; University of Oxford	Emer, C (corresponding author), Univ Bristol, Bristol Life Sci Bldg, Bristol, Avon, England.	carine.emer@rc.unesp.br	Emer, Carine/I-4741-2015; Vaughan, Ian/A-4782-2010; Emer, Carine/AAB-6912-2020	Emer, Carine/0000-0002-1258-2816; Vaughan, Ian/0000-0002-7263-3822; Emer, Carine/0000-0002-1258-2816; Hiscock, Simon/0000-0003-0954-0540	Coordination for the Improvement of Higher Education Personnel (CAPES, Brazil) [BEX 5706/10-5]	Coordination for the Improvement of Higher Education Personnel (CAPES, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	CE was funded by a studentship from the Coordination for the Improvement of Higher Education Personnel (CAPES, Brazil), BEX 5706/10-5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2008, PLOS BIOL, V6, P396, DOI 10.1371/journal.pbio.0060031; Alberdi A, 2019, MOL ECOL RESOUR, V19, P327, DOI 10.1111/1755-0998.12960; Allen AM, 2011, ANN BOT-LONDON, V108, P687, DOI 10.1093/aob/mcr147; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], [No title captured]; [Anonymous], [No title captured]; Ashman TL, 2013, AM J BOT, V100, P1061, DOI 10.3732/ajb.1200496; Bartomeus I, 2008, ANN BOT-LONDON, V102, P417, DOI 10.1093/aob/mcn109; Bartomeus I, 2008, OECOLOGIA, V155, P761, DOI 10.1007/s00442-007-0946-1; Bartomeus I, 2010, J ECOL, V98, P440, DOI 10.1111/j.1365-2745.2009.01629.x; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bersier LF, 2002, ECOLOGY, V83, P2394, DOI 10.2307/3071801; Bjerknes AL, 2007, BIOL CONSERV, V138, P1, DOI 10.1016/j.biocon.2007.04.015; Bluethgen Nico, 2006, BMC Ecology, V6, P9, DOI 10.1186/1472-6785-6-9; Cawoy Valerie, 2012, Journal of Pollination Ecology, V10, P130; Chittka L, 2001, NATURE, V411, P653, DOI 10.1038/35079676; Clarke D, 2013, SCIENCE, V340, P66, DOI 10.1126/science.1230883; Da Silva EM, 2011, BOTANY, V89, P141, DOI 10.1139/B11-001; Dormann CF, 2014, METHODS ECOL EVOL, V5, P90, DOI 10.1111/2041-210X.12139; Edlund AF, 2004, PLANT CELL, V16, pS84, DOI 10.1105/tpc.015800; Fang Q, 2013, ECOLOGY, V94, P1176, DOI 10.1890/12-1634.1; Forup ML, 2008, J APPL ECOL, V45, P742, DOI 10.1111/j.1365-2664.2007.01390.x; Gegear RJ, 2004, ETHOLOGY, V110, P793, DOI 10.1111/j.1439-0310.2004.01010.x; Gelman A., 2007, DATA ANAL USING REGR; Goldstein H, 1995, MULTILEVEL STAT MODE, V2nd; Harder LD, 2010, PHILOS T R SOC B, V365, P529, DOI 10.1098/rstb.2009.0226; HESLOPHARRISON Y, 1977, ANN BOT-LONDON, V41, P1233, DOI 10.1093/oxfordjournals.aob.a085414; Hiscock SJ, 2002, INT J PLANT SCI, V163, P1, DOI 10.1086/324530; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Huang ZH, 2015, J PLANT ECOL, V8, P109, DOI 10.1093/jpe/rtv015; Jakobsson A, 2008, BIOL CONSERV, V141, P136, DOI 10.1016/j.biocon.2007.09.005; Kaiser-Bunbury CN, 2011, J ECOL, V99, P202, DOI 10.1111/j.1365-2745.2010.01732.x; Kearns C. A., 1993, TECHNIQUES POLLINATI; Larson DL, 2006, BIOL CONSERV, V130, P148, DOI 10.1016/j.biocon.2005.12.009; Lopezaraiza-Mikel ME, 2007, ECOL LETT, V10, P539, DOI 10.1111/j.1461-0248.2007.01055.x; Matsumoto T, 2010, BIOL INVASIONS, V12, P1617, DOI 10.1007/s10530-009-9574-5; Memmott J, 1999, ECOL LETT, V2, P276, DOI 10.1046/j.1461-0248.1999.00087.x; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Memmott J, 2002, P ROY SOC B-BIOL SCI, V269, P2395, DOI 10.1098/rspb.2002.2174; Molina-Montenegro MA, 2008, OIKOS, V117, P1833, DOI 10.1111/j.0030-1299.2008.16896.x; Montgomery BR, 2012, OECOLOGIA, V168, P449, DOI 10.1007/s00442-011-2094-x; Morales CL, 2008, CRIT REV PLANT SCI, V27, P221, DOI 10.1080/07352680802205631; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Petanidou T, 2008, ECOL LETT, V11, P564, DOI 10.1111/j.1461-0248.2008.01170.x; Raine NE, 2007, ENTOMOL GEN, V30, P191; Sax D. F., 2005, SPECIES INVASIONS IN; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Titze A, 2000, NORD J BOT, V20, P33, DOI 10.1111/j.1756-1051.2000.tb00729.x; Traveset A, 2006, TRENDS ECOL EVOL, V21, P208, DOI 10.1016/j.tree.2006.01.006; Traveset A, 2014, ANNU REV ECOL EVOL S, V45, P89, DOI 10.1146/annurev-ecolsys-120213-091857; Tur C, 2014, J ANIM ECOL, V83, P306, DOI 10.1111/1365-2656.12130; Tylianakis JM, 2007, NATURE, V445, P202, DOI 10.1038/nature05429; Waser NM, 1996, ECOLOGY, V77, P1043, DOI 10.2307/2265575; Zuur Alain F., 2009, P1	56	35	37	10	124	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143532	10.1371/journal.pone.0143532	http://dx.doi.org/10.1371/journal.pone.0143532			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633170	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000366040000016
J	Lyssimachou, A; Santos, JG; Andre, A; Soares, J; Lima, D; Guimaraes, L; Almeida, CMR; Teixeira, C; Castro, LFC; Santos, MM				Lyssimachou, Angeliki; Santos, Joana G.; Andre, Ana; Soares, Joana; Lima, Daniela; Guimaraes, Laura; Almeida, C. Marisa R.; Teixeira, Catarina; Castro, L. Filipe C.; Santos, Miguel M.			The Mammalian "Obesogen" Tributyltin Targets Hepatic Triglyceride Accumulation and the Transcriptional Regulation of Lipid Metabolism in the Liver and Brain of Zebrafish	PLOS ONE			English	Article							ENDOCRINE-DISRUPTING CHEMICALS; RETINOID-X-RECEPTOR; ORGANOTIN COMPOUNDS; ADIPOCYTE DIFFERENTIATION; GENE-EXPRESSION; ENVIRONMENTAL LEVELS; PRENATAL EXPOSURE; PROTEIN; LIPOTOXICITY; STEATOSIS	Recent findings indicate that different Endocrine Disrupting Chemicals (EDCs) interfere with lipid metabolic pathways in mammals and promote fat accumulation, a previously unknown site of action for these compounds. The antifoulant and environmental pollutant tributyltin (TBT), which causes imposex in gastropod snails, induces an "obesogenic" phenotype in mammals, through the activation of the nuclear receptors retinoid X receptor (RXR) and peroxisome proliferator-activated receptor gamma (PPAR.). In teleosts, the effects of TBT on the lipid metabolism are poorly understood, particularly following exposure to low, environmental concentrations. In this context, the present work shows that exposure of zebrafish to 10 and 50 ng/L of TBT (as Sn) from pre-hatch to 9 months of age alters the body weight, condition factor, hepatosomatic index and hepatic triglycerides in a gender and dose related manner. Furthermore, TBT modulated the transcription of key lipid regulating factors and enzymes involved in adipogenesis, lipogenesis, glucocorticoid metabolism, growth and development in the brain and liver of exposed fish, revealing sexual dimorphic effects in the latter. Overall, the present study shows that the model mammalian obesogen TBT interferes with triglyceride accumulation and the transcriptional regulation of lipid metabolism in zebrafish and indentifies the brain lipogenic transcription profile of fish as a new target of this compound.	[Lyssimachou, Angeliki; Santos, Joana G.; Andre, Ana; Soares, Joana; Lima, Daniela; Guimaraes, Laura; Almeida, C. Marisa R.; Teixeira, Catarina; Castro, L. Filipe C.; Santos, Miguel M.] Interdisciplinary Ctr Marine & Environm Res, CIMAR CIIMAR AL, P-4050123 Oporto, Portugal; [Santos, Miguel M.] Univ Porto, Fac Sci, FCUP Dept Biol, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto	Lyssimachou, A (corresponding author), Interdisciplinary Ctr Marine & Environm Res, CIMAR CIIMAR AL, Rua Bragas 289, P-4050123 Oporto, Portugal.	angeliki@ciimar.up.pt; filipe.castro@ciimar.up.pt; santos@ciimar.up.pt	Guimaraes, Laura/A-6759-2011; Almeida, C. Marisa/O-8210-2019; Almeida, C. Marisa R./J-6375-2012; Santos, Miguel M./AAD-9267-2021; Soares, Joana/F-5812-2014; Teixeira, Catarina/B-1182-2013; Quality, Aquaculture Seafood/AAD-7718-2019; Castro, Filipe/AAA-2197-2022	Guimaraes, Laura/0000-0003-3360-3783; Almeida, C. Marisa/0000-0002-6836-0331; Almeida, C. Marisa R./0000-0002-6836-0331; Soares, Joana/0000-0002-7105-2815; Teixeira, Catarina/0000-0003-3842-7133; Castro, Filipe/0000-0001-7697-386X; Andre, Ana/0000-0002-0638-8304; Santos, Miguel/0000-0001-7347-0546; Lyssimachou, Angeliki/0000-0003-1438-1222	FCT-Fundacao para a Ciencia e a Tecnologia (Portugal) [PTDC/MAR/115199/2009]; European Regional Development Fund (ERDF) through the COMPETE-Operational Competitiveness Programme; FCT-Fundacao para a Ciencia e a Tecnologia [PEst-C/MAR/LA0015/2013, SFRH/BPD/74231/2010]; Fundacao para a Ciencia e a Tecnologia (Portugal) [PTDC/MAR/115199/2009]	FCT-Fundacao para a Ciencia e a Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); European Regional Development Fund (ERDF) through the COMPETE-Operational Competitiveness Programme; FCT-Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology); Fundacao para a Ciencia e a Tecnologia (Portugal)(Portuguese Foundation for Science and Technology)	This work was supported by FCT-Fundacao para a Ciencia e a Tecnologia (Portugal), through project PTDC/MAR/115199/2009, the European Regional Development Fund (ERDF) through the COMPETE-Operational Competitiveness Programme and national funds through FCT-Fundacao para a Ciencia e a Tecnologia, under the project "PEst-C/MAR/LA0015/2013" and pos-doctoral fellowship SFRH/BPD/74231/2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Fundacao para a Ciencia e a Tecnologia (Portugal), through project PTDC/MAR/115199/2009, the European Regional Development Fund (ERDF) through the COMPETE-Operational Competitiveness Programme and national funds through FCT-Fundacao para a Ciencia e a Tecnologia, under the project "PEst-C/MAR/LA0015/2013" and posdoctoral fellowship SFRH/BPD/74231/2010. The authors declare they have no actual or potential competing financial interests.	Alsop D, 2008, AM J PHYSIOL-REG I, V294, pR711, DOI 10.1152/ajpregu.00671.2007; Amali AA, 2006, J BIOMED SCI, V13, P225, DOI 10.1007/s11373-005-9055-5; Antizar-Ladislao B, 2008, ENVIRON INT, V34, P292, DOI 10.1016/j.envint.2007.09.005; Balazs Z, 2008, J AM SOC NEPHROL, V19, P92, DOI 10.1681/ASN.2007030263; Briant N, 2013, MAR POLLUT BULL, V73, P78, DOI 10.1016/j.marpolbul.2013.05.038; Calabrese EJ, 2005, TOXICOL APPL PHARM, V204, P1, DOI 10.1016/j.taap.2004.11.015; Carmona-Antonanzas G, 2014, GENE, V534, P1, DOI 10.1016/j.gene.2013.10.040; Carvalho AP, 2006, AQUAC RES, V37, P1107, DOI 10.1111/j.1365-2109.2006.01534.x; Carvalho PN, 2007, MICROCHEM J, V87, P147, DOI 10.1016/j.microc.2007.07.003; Castro LF, AQUAT TOXICOL; Chamorro-Garcia R, 2013, ENVIRON HEALTH PERSP, V121, P359, DOI 10.1289/ehp.1205701; Clement L, PFLUG ARCH EUR J PHY; Cooke GM, 2008, J TOXICOL ENV HEAL A, V71, P384, DOI 10.1080/15287390701801653; Cruz SA, 2010, COMP BIOCHEM PHYS A, V156, P190, DOI 10.1016/j.cbpa.2010.01.019; Dentin R, 2005, BIOCHIMIE, V87, P81, DOI 10.1016/j.biochi.2004.11.008; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Enes P, 2008, COMP BIOCHEM PHYS A, V149, P80, DOI 10.1016/j.cbpa.2007.10.012; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Fent K, 1996, CRIT REV TOXICOL, V26, P3, DOI 10.3109/10408449609089891; FENT K, 1993, AQUAT TOXICOL, V24, P219, DOI 10.1016/0166-445X(93)90073-A; Frayn KN, 2006, ESSAYS BIOCHEM, V42, P89, DOI 10.1042/bse0420089; Gao S, 2003, P NATL ACAD SCI USA, V100, P5628, DOI 10.1073/pnas.1031698100; Gao S, 2007, P NATL ACAD SCI USA, V104, P17358, DOI 10.1073/pnas.0708385104; Grun F, 2009, MOL CELL ENDOCRINOL, V304, P19, DOI 10.1016/j.mce.2009.02.018; Grun F, 2006, MOL ENDOCRINOL, V20, P2141, DOI 10.1210/me.2005-0367; Gumy C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003545; Hanson AM, 2012, AQUACULTURE, V362, P241, DOI 10.1016/j.aquaculture.2010.09.015; Her GM, 2013, BBA-MOL CELL BIOL L, V1831, P1037, DOI 10.1016/j.bbalip.2013.02.002; HOLM G, 1991, J FISH BIOL, V38, P373, DOI 10.1111/j.1095-8649.1991.tb03127.x; Ibabe A, 2005, HISTOCHEM CELL BIOL, V123, P75, DOI 10.1007/s00418-004-0737-2; Janesick A, 2011, BIRTH DEFECTS RES C, V93, P34, DOI 10.1002/bdrc.20197; JOBLING S, 1995, ENVIRON HEALTH PERSP, V103, P582, DOI 10.2307/3432434; Kanayama T, 2005, MOL PHARMACOL, V67, P766, DOI 10.1124/mol.104.008409; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; Kirchner S, 2010, MOL ENDOCRINOL, V24, P526, DOI 10.1210/me.2009-0261; le Maire A, 2009, EMBO REP, V10, P367, DOI 10.1038/embor.2009.8; Lima D, 2011, AQUAT TOXICOL, V101, P221, DOI 10.1016/j.aquatox.2010.09.022; Liu Q, 2010, GEN COMP ENDOCR, V166, P346, DOI 10.1016/j.ygcen.2009.11.015; Lo JH, 2010, ENDOCRINOLOGY, V151, P2128, DOI 10.1210/en.2009-0960; Luquet Serge, 2009, Front Biosci (Schol Ed), V1, P448; Lyssimachou A, 2006, TOXICOL SCI, V91, P82, DOI 10.1093/toxsci/kfj136; Malhi H, 2008, SEMIN LIVER DIS, V28, P360, DOI 10.1055/s-0028-1091980; Matthiessen P, 1998, ENVIRON TOXICOL CHEM, V17, P37, DOI 10.1002/etc.5620170106; McAllister BG, 2003, AQUAT TOXICOL, V65, P309, DOI 10.1016/S0166-445X(03)00154-1; McGinnis CL, 2011, AQUAT TOXICOL, V103, P25, DOI 10.1016/j.aquatox.2011.01.005; Meador JP, 2011, ENVIRON RES, V111, P50, DOI 10.1016/j.envres.2010.11.012; Morcillo Y, 1998, TRAC-TREND ANAL CHEM, V17, P109, DOI 10.1016/S0165-9936(97)00115-5; Moreno-Navarrete J. M., 2012, ADIPOSE TISSUE BIOL, P17, DOI [10.1007/978-1-4614-0965-6_2, DOI 10.1007/978-1-4614-0965-6]; Newbold RR, 2008, INT J ANDROL, V31, P201, DOI 10.1111/j.1365-2605.2007.00858.x; Nishikawa J, 2004, ENVIRON SCI TECHNOL, V38, P6271, DOI 10.1021/es049593u; Nogueiras R, 2008, REGUL PEPTIDES, V149, P26, DOI 10.1016/j.regpep.2007.09.034; Oberemm A, 2000, LAB ANIMAL, V29, P32; Oka Takehiko, 2010, BMC Physiol, V10, P21, DOI 10.1186/1472-6793-10-21; Pai WY, 2013, TRANSGENIC RES, V22, P823, DOI 10.1007/s11248-012-9685-0; Passeri MJ, 2009, HEPATOLOGY, V49, P443, DOI 10.1002/hep.22667; Pavlikova N, 2010, AQUAT TOXICOL, V99, P176, DOI 10.1016/j.aquatox.2010.04.014; Payne VA, 2007, J BIOL CHEM, V282, P21005, DOI 10.1074/jbc.M702871200; Pfaffl M.W., 2004, A Z QUANT PCR, P87; Porchas MM, 2009, PAN AM JAQ SCI, V4, P58; Radke B, 2013, SOIL SEDIMENT CONTAM, V22, P614, DOI 10.1080/15320383.2013.756448; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; Ribeiro CAO, 2002, ECOTOX ENVIRON SAFE, V51, P161, DOI 10.1006/eesa.2001.2121; Ribeiro C, 2012, TOXICOL MECH METHOD, V22, P47, DOI 10.3109/15376516.2011.593053; Riu A, HALOGENATED BISPHENO; Rochette-Egly C, 2003, CELL SIGNAL, V15, P355, DOI 10.1016/S0898-6568(02)00115-8; Santos MM, 2012, BIOCHEMICAL AND BIOLOGICAL EFFECTS OF ORGANOTINS, P83; Santos MM, 2006, COMP BIOCHEM PHYS C, V142, P151, DOI 10.1016/j.cbpc.2005.11.014; Schwartz DM, 2007, J LIPID RES, V48, P2514, DOI 10.1194/jlr.D700017-JLR200; Shieh YS, 2010, BBA-MOL CELL BIOL L, V1801, P721, DOI 10.1016/j.bbalip.2010.04.008; Shimasaki Y, 2003, ENVIRON TOXICOL CHEM, V22, P141, DOI 10.1002/etc.5620220118; Shimasaki Y, 2008, J FAC AGR KYUSHU U, V53, P67; Si JL, 2011, ENVIRON TOXICOL, V26, P307, DOI 10.1002/tox.20560; SMITH B S, 1971, Proceedings of the Malacological Society of London, V39, P377; Soengas JL, 2002, COMP BIOCHEM PHYS B, V131, P271, DOI 10.1016/S1096-4959(02)00022-2; Sousa A, 2009, CHEMOSPHERE, V77, P566, DOI 10.1016/j.chemosphere.2009.06.049; Tallafuss A, 2006, GENE EXPR PATTERNS, V6, P556, DOI 10.1016/j.modgep.2005.10.005; Tingaud-Sequeira A, 2011, J LIPID RES, V52, P1765, DOI 10.1194/jlr.D017012; Titley-O'Neal CP, 2011, J ENVIRON MONITOR, V13, P2360, DOI 10.1039/c1em10011d; Tocher DR, 2003, REV FISH SCI, V11, P107, DOI 10.1080/713610925; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050; Weger BD, 2012, ACS CHEM BIOL, V7, P1178, DOI 10.1021/cb3000474; Welshons WV, 2006, ENDOCRINOLOGY, V147, pS56, DOI 10.1210/en.2005-1159; Wood AW, 2005, INT REV CYTOL, V243, P215, DOI 10.1016/S0074-7696(05)43004-1; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Yanik SC, 2011, TOXICOL SCI, V122, P476, DOI 10.1093/toxsci/kfr140; Zhang JL, 2013, MAR ENVIRON RES, V90, P113, DOI 10.1016/j.marenvres.2013.06.004; Zhang JL, 2013, CHEMOSPHERE, V90, P1294, DOI 10.1016/j.chemosphere.2012.10.078; Zhang JL, 2009, ENVIRON TOXICOL CHEM, V28, P1528, DOI 10.1897/08-347.1; Zhang W, 2012, ENVIRON SCI TECHNOL, V46, P5175, DOI 10.1021/es300147w; Zheng WL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053562; Zuo Z, 2009, ENVIRON TOXICOL, V26, P79, DOI DOI 10.1002/TOX.20531	92	66	69	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143911	10.1371/journal.pone.0143911	http://dx.doi.org/10.1371/journal.pone.0143911			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633012	Green Published, Green Submitted, gold			2022-12-27	WOS:000366040000029
J	Aubrey, W; Riley, MC; Young, M; King, RD; Oliver, SG; Clare, A				Aubrey, Wayne; Riley, Michael C.; Young, Michael; King, Ross D.; Oliver, Stephen G.; Clare, Amanda			A Tool for Multiple Targeted Genome Deletions that Is Precise, Scar-Free, and Suitable for Automation	PLOS ONE			English	Article							SITE-SPECIFIC RECOMBINATION; MINIMAL-GENE-SET; SACCHAROMYCES-CEREVISIAE; YEAST; DNA; SYSTEM; REARRANGEMENTS; MANIPULATION; REPLACEMENT; TRANSPORTER	Many advances in synthetic biology require the removal of a large number of genomic elements from a genome. Most existing deletion methods leave behind markers, and as there are a limited number of markers, such methods can only be applied a fixed number of times. Deletion methods that recycle markers generally are either imprecise (remove untargeted sequences), or leave scar sequences which can cause genome instability and rearrangements. No existing marker recycling method is automation-friendly. We have developed a novel openly available deletion tool that consists of: 1) a method for deleting genomic elements that can be repeatedly used without limit, is precise, scar-free, and suitable for automation; and 2) software to design the method's primers. Our tool is sequence agnostic and could be used to delete large numbers of coding sequences, promoter regions, transcription factor binding sites, terminators, etc in a single genome. We have validated our tool on the deletion of non-essential open reading frames (ORFs) from S. cerevisiae. The tool is applicable to arbitrary genomes, and we provide primer sequences for the deletion of: 90% of the ORFs from the S. cerevisiae genome, 88% of the ORFs from S. pombe genome, and 85% of the ORFs from the L. lactis genome.	[Aubrey, Wayne; Clare, Amanda] Aberystwyth Univ, Dept Comp Sci, Aberystwyth SY23 3DB, Dyfed, Wales; [Riley, Michael C.; Young, Michael] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth SY23 3DD, Dyfed, Wales; [King, Ross D.] Univ Manchester, Manchester Inst Biotechnol, Manchester M1 7DN, Lancs, England; [King, Ross D.] Univ Manchester, Sch Comp Sci, Manchester M1 7DN, Lancs, England; [Oliver, Stephen G.] Univ Cambridge, Cambridge Syst Biol Ctr, Cambridge CB2 1GA, England; [Oliver, Stephen G.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England	Aberystwyth University; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); University of Manchester; University of Manchester; University of Cambridge; University of Cambridge	Aubrey, W (corresponding author), Aberystwyth Univ, Dept Comp Sci, Aberystwyth SY23 3DB, Dyfed, Wales.	waa2@aber.ac.uk	Aubrey, Wayne/AAE-7321-2021; Oliver, Stephen/AAQ-5992-2021	Oliver, Stephen/0000-0003-3410-6439; King, Ross/0000-0001-7208-4387; Clare, Amanda/0000-0001-8315-3659	Biotechnology and Biological Sciences Research Council [BB/G024782/1]; BBSRC [BB/F008228/1, BB/G024782/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F008228/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk), project reference BB/G024782/1 awarded to AC and a PhD funded by Biotechnology and Biological Sciences Research Council to WA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akada R, 2006, YEAST, V23, P399, DOI 10.1002/yea.1365; Amberg DC., 2005, METHODS YEAST GENETI; BACH ML, 1987, CURR GENET, V12, P527, DOI 10.1007/BF00419562; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Campo N, 2002, APPL ENVIRON MICROB, V68, P2359, DOI 10.1128/AEM.68.5.2359-2367.2002; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Colson I, 2004, EMBO REP, V5, P392, DOI 10.1038/sj.embor.7400123; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Cross FR, 2011, YEAST, V28, P167, DOI 10.1002/yea.1822; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; David L, 2011, METHODS MOL BIOL, V759, P107, DOI 10.1007/978-1-61779-173-4_7; Delneri D, 2003, NATURE, V422, P68, DOI 10.1038/nature01418; Delneri D, 2001, CURR OPIN BIOTECH, V12, P87, DOI 10.1016/S0958-1669(00)00179-8; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Gietz RD, 2007, NAT PROTOC, V2, P5, DOI 10.1038/nprot.2007.16; GRIMM C, 1988, MOL GEN GENET, V215, P81, DOI 10.1007/BF00331307; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Isaacs FJ, 2011, SCIENCE, V333, P348, DOI 10.1126/science.1205822; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Koonin EV, 2000, ANNU REV GENOM HUM G, V1, P99, DOI 10.1146/annurev.genom.1.1.99; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Liu HP, 1996, GENETICS, V144, P967; Mans R, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov004; Mudge DK, 2012, CURR GENET, V58, P59, DOI 10.1007/s00294-011-0360-4; Mushegian AR, 1996, P NATL ACAD SCI USA, V93, P10268, DOI 10.1073/pnas.93.19.10268; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Riley MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080156; SAUER B, 1993, METHOD ENZYMOL, V225, P890; SAUER B, 1987, MOL CELL BIOL, V7, P2087, DOI 10.1128/MCB.7.6.2087; Schneider BL, 1996, YEAST, V12, P129, DOI 10.1002/(SICI)1097-0061(199602)12:2<129::AID-YEA891>3.0.CO;2-O; Sivakumar S, 2004, METHODS, V33, P213, DOI 10.1016/j.ymeth.2003.11.016; Solem C, 2008, APPL ENVIRON MICROB, V74, P4772, DOI 10.1128/AEM.00134-08; Storici F, 2006, METHOD ENZYMOL, V409, P329, DOI 10.1016/S0076-6879(05)09019-1; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; Waghmare SK, 2003, BIOTECHNIQUES, V34, P1024, DOI 10.2144/03345rr02; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Wang LL, 2004, METHODS, V33, P199, DOI 10.1016/j.ymeth.2003.11.014; Wieczorke R, 1999, FEBS LETT, V464, P123, DOI 10.1016/S0014-5793(99)01698-1; Xu T, 2011, METHODS MOL BIOL, V765, P207, DOI 10.1007/978-1-61779-197-0_13	45	1	1	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0142494	10.1371/journal.pone.0142494	http://dx.doi.org/10.1371/journal.pone.0142494			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630677	Green Published, gold, Green Submitted			2022-12-27	WOS:000365926300011
J	Jiao, HH; Natoll, R; Valter, K; Provis, JM; Rutar, M				Jiao, Haihan; Natoll, Riccardo; Valter, Krisztina; Provis, Jan M.; Rutar, Matt			Spatiotemporal Cadence of Macrophage Polarisation in a Model of Light-Induced Retinal Degeneration	PLOS ONE			English	Article							BONE-MARROW; PHOTORECEPTOR DEGENERATION; MICROGLIAL ACTIVATION; CASPASE-3 ACTIVATION; MACULAR DEGENERATION; MOUSE MODEL; CELLS; INFLAMMATION; RECRUITMENT; EXPRESSION	Background The recruitment of macrophages accompanies almost every pathogenic state of the retina, and their excessive activation in the subretinal space is thought to contribute to the progression of diseases including age-related macular degeneration. Previously, we have shown that macrophages aggregate in the outer retina following damage elicited by photo-oxidative stress, and that inhibition of their recruitment reduces photoreceptor death. Here, we look for functional insight into macrophage activity in this model through the spatiotemporal interplay of macrophage polarisation over the course of degeneration. Methods Rats were exposed to 1000 lux light damage (LD) for 24hrs, with some left to recover for 3 and 7 days post-exposure. Expression and localisation of M1-and M2-macrophage markers was investigated in light-damaged retinas using qPCR, ELISA, flow cytometry, and immunohistochemistry. Results Expression of M1- (Ccl3, Il-6, Il-12, Il-1 beta, TNF alpha) and M2- (CD206, Arg1, Igf1, Lyve1, Clec7a) related markers followed discrete profiles following light damage; up-regulation of M1 genes peaked at the early phase of cell death, while M2 genes generally exhibited more prolonged increases during the chronic phase. Moreover, Il-1 beta and CD206 labelled accumulations of microglia/macrophages which differed in their morphological, temporal, and spatial characteristics following light damage. Conclusions The data illustrate a dynamic shift in macrophage polarisation following light damage through a broad swathe of M1 and M2 markers. Pro-inflammatory M1 activation appears to dominate the early phase of degeneration while M2 responses appear to more heavily mark the chronic post-exposure period. While M1/M2 polarisation represents two extremes amongst a spectrum of macrophage activity, knowledge of their predominance offers insight into functional consequences of macrophage activity over the course of damage, which may inform the spatiotemporal employment of therapeutics in retinal disease.	[Jiao, Haihan; Natoll, Riccardo; Valter, Krisztina; Provis, Jan M.; Rutar, Matt] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia; [Natoll, Riccardo; Valter, Krisztina; Provis, Jan M.] Australian Natl Univ, ANU Med Sch, Canberra, ACT 2601, Australia	Australian National University; John Curtin School of Medical Research; Australian National University	Rutar, M (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia.	matt.rutar@anu.edu.au	Valter, Krisztina/L-3015-2016; Provis, Jan/C-9529-2009	Valter, Krisztina/0000-0002-2033-0408; Rutar, Matthew/0000-0002-8893-5120; Jiao, Haihan/0000-0002-5404-9307; Natoli, Riccardo/0000-0002-9350-0439; Provis, Jan/0000-0002-6405-2868	National Health and Medical Research Council (NHMRC) Project Grant; Ophthalmic Research Institute of Australia (ORIA)	National Health and Medical Research Council (NHMRC) Project Grant(National Health and Medical Research Council (NHMRC) of Australia); Ophthalmic Research Institute of Australia (ORIA)	This work was supported by National Health and Medical Research Council (NHMRC) Project Grant, Chief Investigators: Dr. Krisztina Valter and Prof. Jan Provis, and the Ophthalmic Research Institute of Australia (ORIA), Chief Investigators: Dr. Matt Rutar.	Apte RS, 2006, PLOS MED, V3, P1371, DOI 10.1371/journal.pmed.0030310; Berger S, 2008, INVEST OPHTH VIS SCI, V49, P3605, DOI 10.1167/iovs.07-0817; Bosco A, 2008, INVEST OPHTH VIS SCI, V49, P1437, DOI 10.1167/iovs.07-1337; Cao XG, 2011, PATHOL INT, V61, P528, DOI 10.1111/j.1440-1827.2011.02695.x; Chang CJ, 2005, OPHTHALMIC RES, V37, P202, DOI 10.1159/000086610; Chen L, 2004, EXP EYE RES, V79, P239, DOI 10.1016/j.exer.2004.05.002; Chen M, 2012, GLIA, V60, P833, DOI 10.1002/glia.22315; Cherepanoff S, 2010, BRIT J OPHTHALMOL, V94, P918, DOI 10.1136/bjo.2009.165563; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Cruz-Guilloty F, 2013, INT J INFLAMM, V2013, DOI 10.1155/2013/503725; Cruz-Guilloty F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088201; Ezzat MK, 2008, BRIT J OPHTHALMOL, V92, P976, DOI 10.1136/bjo.2007.129742; Gupta N, 2003, EXP EYE RES, V76, P463, DOI 10.1016/S0014-4835(02)00332-9; HOPPELER T, 1988, CURR EYE RES, V7, P849, DOI 10.3109/02713688808997242; Hu SJ, 2015, J NEUROSCI, V35, P6987, DOI 10.1523/JNEUROSCI.3955-14.2015; Hu XM, 2015, NAT REV NEUROL, V11, P56, DOI 10.1038/nrneurol.2014.207; Ibrahim AS, 2010, MOL VIS, V16, P2033; Joly S, 2009, AM J PATHOL, V174, P2310, DOI 10.2353/ajpath.2009.090023; Kaneko H, 2008, INVEST OPHTH VIS SCI, V49, P4162, DOI 10.1167/iovs.08-1738; Karlstetter M, 2015, PROG RETIN EYE RES, V45, P30, DOI 10.1016/j.preteyeres.2014.11.004; Kataoka K, 2010, INVEST OPHTHALMOL VI; Kelly J, 2007, J CLIN INVEST, V117, P3421, DOI 10.1172/JCI32430; Kohno H, 2014, J IMMUNOL, V192, P3816, DOI 10.4049/jimmunol.1301738; Krady JK, 2005, DIABETES, V54, P1559, DOI 10.2337/diabetes.54.5.1559; Labonte AC, 2014, MOL CELLS, V37, P275, DOI 10.14348/molcells.2014.2374; Levy O, 2015, EMBO MOL MED; Levy O, 2015, EMBO MOL MED, V7, P211, DOI 10.15252/emmm.201404524; Lewis GP, 2005, MOL VIS, V11, P491; London A, 2013, J IMMUNOL, V190, P3570, DOI 10.4049/jimmunol.1202076; London A, 2011, J EXP MED, V208, P23, DOI 10.1084/jem.20101202; Luhmann UFO, 2009, INVEST OPHTH VIS SCI, V50, P5934, DOI 10.1167/iovs.09-3462; Ma WX, 2013, NEUROBIOL AGING, V34, P2310, DOI 10.1016/j.neurobiolaging.2013.03.022; Maslim J, 1997, INVEST OPHTH VIS SCI, V38, P1667; Nakazawa T, 2007, P NATL ACAD SCI USA, V104, P2425, DOI 10.1073/pnas.0608167104; Neufeld AH, 2004, BRAIN RES BULL, V62, P455, DOI 10.1016/j.brainresbull.2003.07.005; Neufeld AH, 1999, ARCH OPHTHALMOL-CHIC, V117, P1050; Ni YQ, 2008, INVEST OPHTH VIS SCI, V49, P2589, DOI 10.1167/iovs.07-1173; Patel C, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00173; PENFOLD PL, 1986, INVEST OPHTH VIS SCI, V27, P364; Rohrer B, 2007, INVEST OPHTH VIS SCI, V48, P5282, DOI 10.1167/iovs.07-0282; Rutar M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-221; Rutar M, 2011, INVEST OPHTH VIS SCI, V52, P5347, DOI 10.1167/iovs.10-7119; Rutar M, 2011, INVEST OPHTH VIS SCI, V52, P2379, DOI 10.1167/iovs.10-6010; Rutar M, 2010, CURR EYE RES, V35, P631, DOI 10.3109/02713681003682925; Sennlaub F, 2013, EMBO MOL MED, V5, P1775, DOI 10.1002/emmm.201302692; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; VRABEC F, 1975, A GRAEF ARCH KLIN EX, V196, P49, DOI 10.1007/BF00410026; Wong JG, 2001, INVEST OPHTH VIS SCI, V42, pS227; Yang LP, 2007, MOL VIS, V13, P2048; Yuan LY, 2001, J NEUROSCI RES, V64, P523, DOI 10.1002/jnr.1104; Zeng HY, 2008, ARCH OPHTHALMOL-CHIC, V126, P227, DOI 10.1001/archophthalmol.2007.65	51	30	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143952	10.1371/journal.pone.0143952	http://dx.doi.org/10.1371/journal.pone.0143952			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630454	Green Published, gold			2022-12-27	WOS:000365926300129
J	Pedersen, CET; Frandsen, P; Wekesa, SN; Heller, R; Sangula, AK; Wadsworth, J; Knowles, NJ; Muwanika, VB; Siegismund, HR				Pedersen, Casper-Emil T.; Frandsen, Peter; Wekesa, Sabenzia N.; Heller, Rasmus; Sangula, Abraham K.; Wadsworth, Jemma; Knowles, Nick J.; Muwanika, Vincent B.; Siegismund, Hans R.			Time Clustered Sampling Can Inflate the Inferred Substitution Rate in Foot-And-Mouth Disease Virus Analyses	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; MOSAIC STRUCTURE; RECOMBINATION; SEROTYPE; SEQUENCES; LINEAGES	With the emergence of analytical software for the inference of viral evolution, a number of studies have focused on estimating important parameters such as the substitution rate and the time to the most recent common ancestor (tMRCA) for rapidly evolving viruses. Coupled with an increasing abundance of sequence data sampled under widely different schemes, an effort to keep results consistent and comparable is needed. This study emphasizes commonly disregarded problems in the inference of evolutionary rates in viral sequence data when sampling is unevenly distributed on a temporal scale through a study of the foot-and-mouth (FMD) disease virus serotypes SAT 1 and SAT 2. Our study shows that clustered temporal sampling in phylogenetic analyses of FMD viruses will strongly bias the inferences of substitution rates and tMRCA because the inferred rates in such data sets reflect a rate closer to the mutation rate rather than the substitution rate. Estimating evolutionary parameters from viral sequences should be performed with due consideration of the differences in short-term and longer-term evolutionary processes occurring within sets of temporally sampled viruses, and studies should carefully consider how samples are combined.	[Pedersen, Casper-Emil T.; Frandsen, Peter; Heller, Rasmus; Siegismund, Hans R.] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Wekesa, Sabenzia N.; Sangula, Abraham K.] Foot & Mouth Dis Lab, Nairobi, Kenya; [Wadsworth, Jemma; Knowles, Nick J.] Pirbright Inst, Pirbright, England; [Muwanika, Vincent B.] Makerere Univ, Dept Environm Management, Coll Agr & Environm Sci, Kampala, Uganda	University of Copenhagen; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; Makerere University	Pedersen, CET (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	capedersen@bio.ku.dk	Ibrahim, Essam Hassan/G-1960-2018; Heller, Rasmus/M-2580-2014; Muwanika, Vincent/AGP-2612-2022; Muwanika, Vincent/GQH-5983-2022; Frandsen, Peter/O-3698-2019; Pedersen, Casper-Emil Tingskov/M-5135-2014	Ibrahim, Essam Hassan/0000-0003-0130-2257; Heller, Rasmus/0000-0001-6583-6923; Frandsen, Peter/0000-0001-7131-0944; Pedersen, Casper-Emil Tingskov/0000-0003-2540-5373	Danish International Development Agency (DANIDA) under the Transboundary Animal Diseases in East Africa (TADEA) project, DFC [10-006KU]; Department for Environment, Food and Rural Affairs (Defra), UK [SE2939, SE2940]; Villum Fonden [00007371] Funding Source: researchfish	Danish International Development Agency (DANIDA) under the Transboundary Animal Diseases in East Africa (TADEA) project, DFC; Department for Environment, Food and Rural Affairs (Defra), UK(Department for Environment, Food & Rural Affairs (DEFRA)); Villum Fonden(Villum Fonden)	This work was supported by the Danish International Development Agency (DANIDA) under the Transboundary Animal Diseases in East Africa (TADEA) project, DFC no. 10-006KU. NJK and JW were partially funded by the Department for Environment, Food and Rural Affairs (Defra), UK (contract numbers SE2939 and SE2940). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandersen S, 2005, CURR TOP MICROBIOL, V288, P9; Bari FD, 2014, VACCINE, V32, P5794, DOI 10.1016/j.vaccine.2014.08.033; Bastos ADS, 2001, ARCH VIROL, V146, P1537, DOI 10.1007/s007050170077; Binder H, 2005, SCHWEIZ ARCH TIERH, V147, P0143, DOI [10.1024/0036-7281.147.3.143a, DOI 10.1024/0036-7281.147.3.143A]; BITTLE JL, 1982, NATURE, V298, P30, DOI 10.1038/298030a0; Cottam EM, 2006, J VIROL, V80, P11274, DOI 10.1128/JVI.01236-06; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Di Nardo A, 2014, VET RES, V45, DOI 10.1186/s13567-014-0090-y; Drummond A, 2007, TRACER V1 5; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Duchene S, 2015, MOL BIOL EVOL, V32, P1895, DOI 10.1093/molbev/msv056; Duchene S, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0732; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Firth C, 2010, MOL BIOL EVOL, V27, P2038, DOI 10.1093/molbev/msq088; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Heller R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062992; Ho SYW, 2007, BIOL LETTERS, V3, P702, DOI 10.1098/rsbl.2007.0377; Ho SYW, 2011, MOL ECOL, V20, P3087, DOI 10.1111/j.1365-294X.2011.05178.x; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Jackson AL, 2007, J GEN VIROL, V88, P487, DOI 10.1099/vir.0.82555-0; Knowles NJ, 2003, VIRUS RES, V91, P65, DOI 10.1016/S0168-1702(02)00260-5; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Murray GGR, 2015, METHODS ECOL EVOL; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Ramsden C, 2009, MOL BIOL EVOL, V26, P143, DOI 10.1093/molbev/msn234; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Roeder P, 2009, GLOB CONTROL FMD TOO; Samuel AR, 2001, J GEN VIROL, V82, P609, DOI 10.1099/0022-1317-82-3-609; Sangula AK, 2011, EPIDEMIOL INFECT, V139, P189, DOI 10.1017/S0950268810000580; Sangula AK, 2010, ARCH VIROL, V155, P1625, DOI 10.1007/s00705-010-0742-9; Schierup MH, 2000, GENETICS, V156, P879; SMITH JM, 1992, J MOL EVOL, V34, P126; Valdazo-Gonzalez B, 2012, J VIROL, V86, P8901, DOI 10.1128/JVI.01231-12; Vosloo W, 1996, J GEN VIROL, V77, P1457, DOI 10.1099/0022-1317-77-7-1457; Vosloo W, 2002, REV SCI TECH OIE, V21, P437, DOI 10.20506/rst.21.3.1349; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wekesa SN, 2014, INFECT GENET EVOL, V21, P408, DOI 10.1016/j.meegid.2013.12.006	42	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143605	10.1371/journal.pone.0143605	http://dx.doi.org/10.1371/journal.pone.0143605			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630483	Green Published, Green Submitted, gold			2022-12-27	WOS:000365926300069
J	Poly, F; Serichantalergs, O; Kuroiwa, J; Pootong, P; Mason, C; Guerry, P; Parker, CT				Poly, Frederic; Serichantalergs, Oralak; Kuroiwa, Janelle; Pootong, Piyarat; Mason, Carl; Guerry, Patricia; Parker, Craig T.			Updated Campylobacter jejuni Capsule PCR Multiplex Typing System and Its Application to Clinical Isolates from South and Southeast Asia	PLOS ONE			English	Article							POLYSACCHARIDE CONJUGATE VACCINE; IRRITABLE-BOWEL-SYNDROME; GENOME SEQUENCE; DIVERSITY; SEROTYPE; IDENTIFICATION; OUTBREAK; CHILDREN; THAILAND; STRAIN	Campylobacter jejuni produces a polysaccharide capsule that is the major determinant of the Penner serotyping scheme. This passive slide agglutination typing system was developed in the early 1980's and was recognized for over two decades as the gold standard for C. jejuni typing. A preliminary multiplex PCR technique covering 17 serotypes was previously developed in order to replace this classic serotyping scheme. Here we report the completion of the multiplex PCR technology that is able to identify all the 47 Penner serotypes types known for C. jejuni. The number of capsule types represented within the 47 serotypes is 35. We have applied this method to a collection of 996 clinical isolates from Thailand, Cambodia and Nepal and were able to successfully determine capsule types of 98% of these.	[Poly, Frederic; Kuroiwa, Janelle; Guerry, Patricia] Naval Med Res Ctr, Enter Dis Dept, Silver Spring, MD 20910 USA; [Serichantalergs, Oralak; Pootong, Piyarat; Mason, Carl] Armed Forces Res Inst Med Sci, Bangkok 10400, Thailand; [Parker, Craig T.] ARS, USDA, Albany, CA USA	Naval Medical Research Center (NMRC); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); United States Department of Agriculture (USDA)	Poly, F (corresponding author), Naval Med Res Ctr, Enter Dis Dept, Silver Spring, MD 20910 USA.	frederic.m.poly.ctr@mail.mil	Mason, Carl J/F-3538-2010; Mason, Carl/ABH-3298-2021	Mason, Carl J/0000-0002-3676-2811; Mason, Carl/0000-0002-3676-2811; Parker, Craig/0000-0002-7719-8882	U.S. Naval Medical Research and Development Command Work Unit [6000.RAD1.DA3.A0308]; US department of agriculture-Agricultural Research Service [CRIS 5325-42000-047]; Military Infectious Diseases Research Program, Walter Reed Army Institute of Research, Washington, DC	U.S. Naval Medical Research and Development Command Work Unit; US department of agriculture-Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Military Infectious Diseases Research Program, Walter Reed Army Institute of Research, Washington, DC	This work was supported by U.S. Naval Medical Research and Development Command Work Unit 6000.RAD1.DA3.A0308 (FP JK PP PG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. US department of agriculture-Agricultural Research Service, CRIS 5325-42000-047 (CTP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Military Infectious Diseases Research Program, Walter Reed Army Institute of Research, Washington, DC (OS PP CM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang CW, 2004, TRENDS IMMUNOL, V25, P61, DOI 10.1016/j.it.2003.12.004; Bacon DJ, 2001, MOL MICROBIOL, V40, P769, DOI 10.1046/j.1365-2958.2001.02431.x; Bertolo L, 2013, CARBOHYD RES, V366, P45, DOI 10.1016/j.carres.2012.11.017; Chen YH, 2008, CARBOHYD RES, V343, P1034, DOI 10.1016/j.carres.2008.02.024; Coker AO, 2002, EMERG INFECT DIS, V8, P237, DOI 10.3201/eid0803.010233; Dorrell N, 2001, GENOME RES, V11, P1706, DOI 10.1101/gr.185801; Fouts DE, 2005, PLOS BIOL, V3, P72, DOI 10.1371/journal.pbio.0030015; Grant AJ, 2005, APPL ENVIRON MICROB, V71, P8031, DOI 10.1128/AEM.71.12.8031-8041.2005; Guerry P, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00007; Hofreuter D, 2006, INFECT IMMUN, V74, P4694, DOI 10.1128/IAI.00210-06; Karlyshev AV, 2005, MOL MICROBIOL, V55, P90, DOI 10.1111/j.1365-2958.2004.04374.x; Karlyshev AV, 2000, MOL MICROBIOL, V35, P529, DOI 10.1046/j.1365-2958.2000.01717.x; Keo T, 2011, VIRULENCE, V2, P30, DOI 10.4161/viru.2.1.14752; Klena JD, 2004, J CLIN MICROBIOL, V42, P5549, DOI 10.1128/JCM.42.12.5549-5557.2004; KORLATH JA, 1985, J INFECT DIS, V152, P592, DOI 10.1093/infdis/152.3.592; Lee G, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002036; Lesinski Gregory B., 2001, Current Drug Targets - Infectious Disorders, V1, P325, DOI 10.2174/1568005014605964; Maue AC, 2014, HUM VACC IMMUNOTHER, V10, P1499, DOI 10.4161/hv.27985; Maue AC, 2013, INFECT IMMUN, V81, P665, DOI 10.1128/IAI.01008-12; Miller WG, 2000, APPL ENVIRON MICROB, V66, P5426, DOI 10.1128/AEM.66.12.5426-5436.2000; Monteiro MA, 2009, INFECT IMMUN, V77, P1128, DOI 10.1128/IAI.01056-08; PALMER SR, 1983, LANCET, V1, P287, DOI 10.1016/S0140-6736(83)91698-7; Parker CT, 2006, J CLIN MICROBIOL, V44, P4125, DOI 10.1128/JCM.01231-06; Parker CT, 2005, J CLIN MICROBIOL, V43, P2771, DOI 10.1128/JCM.43.6.2771-2781.2005; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Pearson BM, 2007, J BACTERIOL, V189, P8402, DOI 10.1128/JB.01404-07; PENNER JL, 1983, EUR J CLIN MICROBIOL, V2, P378, DOI 10.1007/BF02019474; PENNER JL, 1980, J CLIN MICROBIOL, V12, P732, DOI 10.1128/JCM.12.6.732-737.1980; Pike BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067375; Pimentel M, 2008, DIGEST DIS SCI, V53, P982, DOI 10.1007/s10620-007-9977-z; Poly F, 2005, J CLIN MICROBIOL, V43, P2330, DOI 10.1128/JCM.43.5.2330-2338.2005; Poly F, 2004, J BACTERIOL, V186, P4781, DOI 10.1128/JB.186.14.4781-4795.2004; Poly F, 2008, INFECT IMMUN, V76, P5655, DOI 10.1128/IAI.00780-08; Poly F, 2007, INFECT IMMUN, V75, P3425, DOI 10.1128/IAI.00050-07; Poly F, 2011, J CLIN MICROBIOL, V49, P1750, DOI 10.1128/JCM.02348-10; Pope JE, 2007, SEMIN ARTHRITIS RHEU; PRESTON MA, 1989, CAN J MICROBIOL, V35, P265, DOI 10.1139/m89-040; Rao MR, 2001, AM J EPIDEMIOL, V154, P166, DOI 10.1093/aje/154.2.166; Serichantalergs O, 2010, GUT PATHOG, V2, DOI 10.1186/1757-4749-2-15; STEELE TW, 1984, PATHOLOGY, V16, P263, DOI 10.3109/00313028409068535; TAYLOR DN, 1988, J CLIN MICROBIOL, V26, P863, DOI 10.1128/JCM.26.5.863-868.1988; Thabane M, 2010, AM J GASTROENTEROL, V105, P933, DOI 10.1038/ajg.2010.74; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; van Alphen LB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087051; Vugia D., 2007, Morbidity and Mortality Weekly Report, V56, P336	45	33	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144349	10.1371/journal.pone.0144349	http://dx.doi.org/10.1371/journal.pone.0144349			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630669	gold, Green Published, Green Submitted			2022-12-27	WOS:000365926300181
J	Rubenstein, R; Chang, BG; Petersen, R; Chiu, A; Davies, P				Rubenstein, Richard; Chang, Binggong; Petersen, Robert; Chiu, Allen; Davies, Peter			T-Tau and P-Tau in Brain and Blood from Natural and Experimental Prion Diseases	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; SCRAPIE-INFECTED MICE; CEREBROSPINAL-FLUID; PHOSPHORYLATED-TAU; DIFFERENT STRAINS; ME7 MODEL; PROTEIN; AGENT; PRP; DEGENERATION	Synaptic abnormalities are prominent in prion disease pathogenesis and are responsible for functional deficits. The microtubule associated protein, Tau, binds to and stabilizes microtubules in axons ensuring axonal transport of synaptic components. Tau phosphorylation reduces its affinity for microtubules leading to their instability and resulting in disrupted axonal transport and synaptic dysfunction. We report on the levels of total Tau (T-Tau) and phosphorylated Tau (P-Tau), measured by highly sensitive laser-based immunoassays, in the central nervous system and biofluids from experimentally transmitted prion disease in mice and natural cases of sporadic Creutzfeldt-Jakob Disease (sCJD) in humans. We found that, in contrast to sCJD where only the levels of T-Tau in brain are increased, both T-Tau and P-Tau are increased in the brains of symptomatic mice experimentally infected with the ME7, 139A and 22L mouse-adapted scrapie strains. The increased levels of T-Tau in sCJD brain, compared to control samples, were also observed in patient plasma. In contrast, there was no detectable increase in T-Tau and P-Tau in plasma from symptomatic experimentally infected mice. Furthermore, our data suggests that in mice showing clinical signs of prion disease the levels and/or ratios of T-Tau and P-Tau are only a useful parameter for differentiating the mouse-adapted scrapie strains that differ in the extent of disease. We conclude that the neuropathogenesis associated with P-Tau and synaptic dysfunction is similar for at least two of the mouse-adapted scrapie strains tested but may differ between sporadic and experimentally transmitted prion diseases.	[Rubenstein, Richard; Chang, Binggong; Chiu, Allen] Suny Downstate Med Ctr, Dept Neurol, Brooklyn, NY 11203 USA; [Petersen, Robert] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Davies, Peter] Feinstein Inst Med Res, Litwin Zucker Ctr Res Alzheimers Dis, Manhasset, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Case Western Reserve University; Northwell Health	Rubenstein, R (corresponding author), Suny Downstate Med Ctr, Dept Neurol, Brooklyn, NY 11203 USA.	richard.rubenstein@downstate.edu	Petersen, Robert/B-5075-2011	Petersen, Robert/0000-0002-3154-0072	State University of New York Downstate Medical Center; Los Alamos National Laboratories; NATIONAL INSTITUTE ON AGING [R01AG022102, R37AG022102] Funding Source: NIH RePORTER	State University of New York Downstate Medical Center; Los Alamos National Laboratories(United States Department of Energy (DOE)Los Alamos National Laboratory); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Support was provided by the State University of New York Downstate Medical Center (RR) and Los Alamos National Laboratories (RR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker CM, 2013, NEUROBIOL AGING, V34, P338, DOI 10.1016/j.neurobiolaging.2012.05.010; Asuni AA, 2010, BIOCHEM SOC T, V38, P545, DOI 10.1042/BST0380545; Bautista MJ, 2006, VET MICROBIOL, V115, P293, DOI 10.1016/j.vetmic.2006.02.017; Belichenko PV, 2000, NEUROPATH APPL NEURO, V26, P143, DOI 10.1046/j.1365-2990.2000.026002143.x; Blennow K, 2005, INT J MOL MED, V16, P1147; Brown D, 2001, NEUROREPORT, V12, P179, DOI 10.1097/00001756-200101220-00043; BRUCE ME, 1993, BRIT MED BULL, V49, P822, DOI 10.1093/oxfordjournals.bmb.a072649; BRUCE ME, 1987, J GEN VIROL, V68, P79, DOI 10.1099/0022-1317-68-1-79; BRUCE ME, 1991, J GEN VIROL, V72, P595, DOI 10.1099/0022-1317-72-3-595; Carp R I, 1989, Prog Clin Biol Res, V317, P567; CARP RI, 1984, INTERVIROLOGY, V21, P61, DOI 10.1159/000149503; Chang BG, 2009, J VIROL METHODS, V159, P15, DOI 10.1016/j.jviromet.2009.02.019; Cunningham C, 2003, EUR J NEUROSCI, V17, P2147, DOI 10.1046/j.1460-9568.2003.02662.x; DICKINSON AG, 1971, MOL GEN GENET, V112, P73, DOI 10.1007/BF00266934; DICKINSON AG, 1988, CIBA F SYMP, V135, P63; DICKINSON AG, 1977, SLOW VIRUS INFECTION, P3; FRASER H, 1968, J COMP PATHOL, V78, P301, DOI 10.1016/0021-9975(68)90006-6; Giaccone G, 2008, NEUROBIOL AGING, V29, P1864, DOI 10.1016/j.neurobiolaging.2007.04.026; Gray BC, 2009, NEUROBIOL DIS, V35, P63, DOI 10.1016/j.nbd.2009.04.001; Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008; Ishizawa K, 2002, ACTA NEUROPATHOL, V104, P342, DOI 10.1007/s00401-002-0547-3; Jeffrey M, 2000, NEUROPATH APPL NEURO, V26, P41, DOI 10.1046/j.1365-2990.2000.00216.x; Kascsak R J, 1991, Curr Top Microbiol Immunol, V172, P139; KASCSAK RJ, 1986, J VIROL, V59, P676, DOI 10.1128/JVI.59.3.676-683.1986; KIM YS, 1987, J GEN VIROL, V68, P695, DOI 10.1099/0022-1317-68-3-695; KIM YS, 1988, P SOC EXP BIOL MED, V189, P21; KIMBERLIN RH, 1983, J NEUROL SCI, V59, P355, DOI 10.1016/0022-510X(83)90021-7; Kunzi V, 2002, J NEUROSCI, V22, P7471; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Noguchi-Shinohara M, 2011, J NEUROL, V258, P1464, DOI 10.1007/s00415-011-5960-x; Riemenschneider M, 2003, MOL PSYCHIATR, V8, P343, DOI 10.1038/sj.mp.4001220; Rubenstein R, 2015, J NEUROTRAUM, V32, P342, DOI 10.1089/neu.2014.3548; Sarac H, 2008, COLLEGIUM ANTROPOL, V32, P199; Skillback T, 2014, JAMA NEUROL, V71, P476, DOI 10.1001/jamaneurol.2013.6455; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Van Everbroeck B, 2002, J NEUROL NEUROSUR PS, V73, P79, DOI 10.1136/jnnp.73.1.79; Wang XF, 2008, MOL CELL BIOCHEM, V310, P49, DOI 10.1007/s11010-007-9664-6; WISNIEWSKI HM, 1983, J NEUROPATH EXP NEUR, V42, P615, DOI 10.1097/00005072-198311000-00002	38	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143103	10.1371/journal.pone.0143103	http://dx.doi.org/10.1371/journal.pone.0143103			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630676	gold, Green Submitted, Green Published			2022-12-27	WOS:000365926300031
J	Yao, Y; Zeng, QX; Deng, XQ; Tang, GN; Guo, JB; Sun, YQ; Ru, K; Rizzo, AN; Shi, JB; Fu, QL				Yao, Yin; Zeng, Qing-Xiang; Deng, Xue-Quan; Tang, Guan-Nan; Guo, Jie-Bo; Sun, Yue-Qi; Ru, Kun; Rizzo, Alicia N.; Shi, Jian-Bo; Fu, Qing-Ling			Connexin 43 Upregulation in Mouse Lungs during Ovalbumin-Induced Asthma	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; INNATE LYMPHOID-CELLS; AIRWAY INFLAMMATION; GAP-JUNCTIONS; CHANNELS; EXPRESSION; EPITHELIUM; DISEASE; CANCER	Background Connexin (Cx)-based gap junction channels play important roles in the inflammatory response. Cx43 is involved in the pathogenesis of some lung diseases such as acute lung injury. However, the Cx43 expression in asthma is unclear. In the present study, we used a murine model of ovalbumin (OVA)-induced allergic airway disease to examine the levels of Cx43 and analyze the relationship between Cx43 and airway inflammation in allergic airway disease. Methods Asthma was induced in mice via sensitization and challenge with OVA. Cx43 mRNA and protein expression levels were investigated via QT-PCR, western blot, and immunohistochemistry 0 h, 8 h, 1 d, 2 d and 4 d after the first challenge. The relationship between Cx43 protein levels and inflammatory cell infiltration, cytokine levels was analyzed. Results The OVA-induced mice exhibited typical pathological features of asthma, including airway hyper-responsiveness; strong inflammatory cell infiltration surrounding the bronchia and vessels; many inflammatory cells in the bronchoalveolar lavage fluid (BALF); higher IL-4, IL5 and IL-13 levels; and high OVA specific IgE levels. Low Cx43 expression was detected in the lungs of control (PBS) mice. A dramatic increase in the Cx43 mRNA and protein levels was found in the asthmatic mice. Cx43 mRNA and protein expression levels increased in a time-dependent manner in asthma mice, and Cx43 was mostly localized in the alveolar and bronchial epithelial layers. Moreover, lung Cx43 protein levels showed a significant positive correlation with inflammatory cell infiltration in the airway and IL-4 and IL-5 levels in the BALF at different time points after challenge. Interestingly, the increase in Cx43 mRNA and protein levels occurred prior to the appearance of the inflammatory cell infiltration. Conclusion Our data suggest that there is a strong upregulation of Cx43 mRNA and protein levels in the lungs in asthma. Cx43 levels also exhibited a positive correlation with allergic airway inflammation. Cx43 may represent a target to treat allergic airway diseases in the future.	[Yao, Yin; Zeng, Qing-Xiang; Deng, Xue-Quan; Tang, Guan-Nan; Guo, Jie-Bo; Sun, Yue-Qi; Ru, Kun; Shi, Jian-Bo; Fu, Qing-Ling] Sun Yat Sen Univ, Affiliated Hosp 1, Otorhinolaryngol Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Yao, Yin; Zeng, Qing-Xiang; Deng, Xue-Quan; Tang, Guan-Nan; Guo, Jie-Bo; Sun, Yue-Qi; Ru, Kun; Shi, Jian-Bo; Fu, Qing-Ling] Sun Yat Sen Univ, Otorhinolaryngol Inst, Guangzhou 510275, Guangdong, Peoples R China; [Rizzo, Alicia N.] Univ Illinois, Div Pulm Crit Care Sleep & Allergy, Chicago, IL USA	Sun Yat Sen University; Sun Yat Sen University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Fu, QL (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Otorhinolaryngol Hosp, Guangzhou 510275, Guangdong, Peoples R China.	fuqingl@mail.sysu.edu.cn	Sun, Yueqi/N-4528-2018	Sun, Yueqi/0000-0002-2382-0429; Yin, Yao/0000-0002-5833-5263; Rizzo, Alicia/0000-0001-9289-4635	NSFC [81322012, NCET-13-0608, 81373174, 81170896, 81272062, 81273212, 81471832]; Science and Technology Foundation of Guangdong Province, China [2011B031800243, 2012B031800045, 2015B020226002]; Fundamental Research Funds for the Central Universities [13ykzd07]; Industry Foundation of the Ministry of Health of China [201202005]	NSFC(National Natural Science Foundation of China (NSFC)); Science and Technology Foundation of Guangdong Province, China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Industry Foundation of the Ministry of Health of China	This study was supported by grants from the NSFC for Excellent Young Scholars (81322012 to Prof. QL Fu), NCET-13-0608 for Prof. QL Fu, NSFC (81373174, 81170896, 81272062, 81273212 and 81471832), the Science and Technology Foundation of Guangdong Province, China (2011B031800243, 2012B031800045 and 2015B020226002), the Fundamental Research Funds for the Central Universities (13ykzd07) and the Industry Foundation of the Ministry of Health of China (201202005).	Ahmad T, 2014, EMBO J, V33, P994, DOI 10.1002/embj.201386030; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Chen ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051268; Cruciani V, 2007, BIOL CHEM, V388, P253, DOI 10.1515/BC.2007.028; Deckers J, 2013, TRENDS IMMUNOL, V34, P540, DOI 10.1016/j.it.2013.08.004; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Elzarrad MK, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-20; Goodenough DA, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002576; Gras D, 2013, PHARMACOL THERAPEUT, V140, P290, DOI 10.1016/j.pharmthera.2013.07.008; Harris AL, 2007, PROG BIOPHYS MOL BIO, V94, P120, DOI 10.1016/j.pbiomolbio.2007.03.011; Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736; Jinn Y, 1998, CANCER LETT, V127, P161, DOI 10.1016/S0304-3835(98)00032-9; Kar R, 2012, ARCH BIOCHEM BIOPHYS, V524, P2, DOI 10.1016/j.abb.2012.03.008; Koval M, 2013, ANNU REV PHYSIOL, V75, P551, DOI 10.1146/annurev-physiol-030212-183809; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Licona-Limon P, 2013, NAT IMMUNOL, V14, P536, DOI 10.1038/ni.2617; Losa D, 2011, EXPERT OPIN THER TAR, V15, P989, DOI 10.1517/14728222.2011.584875; Ma KT, 2014, HYPERTENS RES, V37, P110, DOI 10.1038/hr.2013.120; Marquez-Rosado L, 2012, BBA-BIOMEMBRANES, V1818, P1985, DOI 10.1016/j.bbamem.2011.07.028; Martin FJ, 2008, J IMMUNOL, V180, P4986, DOI 10.4049/jimmunol.180.7.4986; Mese G, 2007, J INVEST DERMATOL, V127, P2516, DOI 10.1038/sj.jid.5700770; Naus CC, 2010, NAT REV CANCER, V10, P435, DOI 10.1038/nrc2841; Ogawa K, 2012, CANCER SCI, V103, P860, DOI 10.1111/j.1349-7006.2012.02228.x; Otsu K, 2009, BLOOD, V113, P4197, DOI 10.1182/blood-2008-09-176198; Park SJ, 2007, EXP MOL MED, V39, P629, DOI 10.1038/emm.2007.69; Parthasarathi K, 2006, J CLIN INVEST, V116, P2193, DOI 10.1172/JCI26605; Saab JB, 2014, FEBS LETT, V588, P1288, DOI 10.1016/j.febslet.2014.02.059; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Sarieddine MZR, 2009, J CELL MOL MED, V13, P4560, DOI 10.1111/j.1582-4934.2008.00654.x; Scheckenbach KEL, 2011, J VASC RES, V48, P91, DOI 10.1159/000316942; Sun YQ, 2012, STEM CELLS, V30, P2692, DOI 10.1002/stem.1241; Vinken M, 2006, CELL SIGNAL, V18, P592, DOI 10.1016/j.cellsig.2005.08.012; Yeh TH, 2005, AM J RHINOL, V19, P59, DOI 10.1177/194589240501900110; Yu S, 2014, J ALLERGY CLIN IMMUN, V133, P943, DOI 10.1016/j.jaci.2014.02.015	34	10	10	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144106	10.1371/journal.pone.0144106	http://dx.doi.org/10.1371/journal.pone.0144106			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630490	Green Published, Green Submitted, gold			2022-12-27	WOS:000365926300159
J	Nagashima, JB; Sylvester, SR; Nelson, JL; Cheong, SH; Mukai, C; Lambo, C; Flanders, JA; Meyers-Wallen, VN; Songsasen, N; Travis, AJ				Nagashima, Jennifer B.; Sylvester, Skylar R.; Nelson, Jacquelyn L.; Cheong, Soon Hon; Mukai, Chinatsu; Lambo, Colleen; Flanders, James A.; Meyers-Wallen, Vicki N.; Songsasen, Nucharin; Travis, Alexander J.			Live Births from Domestic Dog (Canis familiaris) Embryos Produced by In Vitro Fertilization	PLOS ONE			English	Article							PROGESTERONE-RECEPTORS; NUCLEAR MATURATION; ACROSOME REACTION; CALCIUM INFLUX; OOCYTES; SPERMATOZOA; BITCH; IMMUNOLOCALIZATION; CAPACITATION; EXOCYTOSIS	Development of assisted reproductive technologies (ART) in the dog has resisted progress for decades, due to their unique reproductive physiology. This lack of progress is remarkable given the critical role ART could play in conserving endangered canid species or eradicating heritable disease through gene-editing technologies-an approach that would also advance the dog as a biomedicalmodel. Over 350 heritable disorders/traits in dogs are homologous with human conditions, almost twice the number of any other species. Here we report the first live births from in vitro fertilized embryos in the dog. Adding to the practical significance, these embryos had also been cryopreserved. Changes in handling of both gametes enabled this progress. The medium previously used to capacitate sperm excludedmagnesium because it delayed spontaneous acrosome exocytosis. We found that magnesium significantly enhanced sperm hyperactivation and ability to undergo physiologically-induced acrosome exocytosis, two functions essential to fertilize an egg. Unlike other mammals, dogs ovulate a primary oocyte, which reaches metaphase II on Days 4-5 after the luteinizing hormone (LH) surge. We found that only on Day 6 are oocytes consistently able to be fertilized. In vitro fertilization of Day 6 oocytes with sperm capacitated inmediumsupplemented with magnesium resulted in high rates of embryo development (78.8%, n = 146). Intra-oviductal transfer of nineteen cryopreserved, in vitro fertilization (IVF)-derived embryos resulted in seven live, healthy puppies. Development of IVF enables modern genetic approaches to be applied more efficiently in dogs, and for gamete rescue to conserve endangered canid species.	[Nagashima, Jennifer B.; Sylvester, Skylar R.; Nelson, Jacquelyn L.; Mukai, Chinatsu; Lambo, Colleen; Meyers-Wallen, Vicki N.; Travis, Alexander J.] Cornell Univ, Coll Vet Med, Baker Inst Anim Hlth, Ithaca, NY 14853 USA; [Nagashima, Jennifer B.; Travis, Alexander J.] Cornell Univ, Atkinson Ctr Sustainable Future, Ithaca, NY USA; [Nagashima, Jennifer B.; Songsasen, Nucharin] Natl Zool Pk, Smithsonian Conservat Biol Inst, Front Royal, VA USA; [Cheong, Soon Hon; Flanders, James A.] Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Cornell University	Travis, AJ (corresponding author), Cornell Univ, Coll Vet Med, Baker Inst Anim Hlth, Ithaca, NY 14853 USA.	ajt32@cornell.edu		Mukai, Chinatsu/0000-0003-0080-9371; Nagashima, Jennifer/0000-0001-6189-0914; , Nucharin/0000-0003-2800-1163; Cheong, Soon Hon/0000-0001-9002-7589	National Institutes of Health [DP-EB016541]; Cornell University's Baker Institute for Animal Health; Atkinson Center for a Sustainable Future; Smithsonian Institution Predoctoral Fellowship; NIH [DP-EB016541]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [DP1EB016541] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cornell University's Baker Institute for Animal Health; Atkinson Center for a Sustainable Future; Smithsonian Institution Predoctoral Fellowship(Smithsonian Institution); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This research was supported by the National Institutes of Health DP-EB016541 (A.J.T.), Cornell University's Baker Institute for Animal Health (A.J.T.), the Atkinson Center for a Sustainable Future (A.J.T.), and the Smithsonian Institution Predoctoral Fellowship (J.B.N.).; This research was supported by NIH DP-EB016541 (A.J.T.), Cornell University's Baker Institute for Animal Health (A.J.T.), the Atkinson Center for a Sustainable Future (A.J.T.), and the Smithsonian Institution Predoctoral Fellowship (J.B.N.).	Abe Y, 2008, J REPROD DEVELOP, V54, P135, DOI 10.1262/jrd.19139; Abe Y, 2011, BIOL REPROD, V84, P363, DOI 10.1095/biolreprod.110.087312; Aitken RJ, 2013, MOL HUM REPROD, V19, P785, DOI 10.1093/molehr/gat067; Brewis IA, 2001, MOL REPROD DEV, V60, P491, DOI 10.1002/mrd.1114; Bysted B. V., 2000, Theriogenology, V53, P269; Chastant-Maillard S, 2010, REPROD FERT DEVELOP, V22, P1049, DOI 10.1071/RD09270; Choi J, 2014, BEHAV GENET, V44, P68, DOI 10.1007/s10519-013-9620-z; Cohen R, 2014, DEV CELL, V28, P310, DOI 10.1016/j.devcel.2014.01.005; Concannon PW, 2011, ANIM REPROD SCI, V124, P200, DOI 10.1016/j.anireprosci.2010.08.028; Davis BW, 2014, ILAR J, V55, P59, DOI 10.1093/ilar/ilu017; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Dragileva E, 1999, BIOL REPROD, V61, P1226, DOI 10.1095/biolreprod61.5.1226; England GCW, 2001, VET REC, V148, P20, DOI 10.1136/vr.148.1.20; Evecen M, 2010, KAFKAS UNIV VET FAK, V16, P897; Hatoya S, 2006, THERIOGENOLOGY, V66, P1083, DOI 10.1016/j.theriogenology.2005.12.015; HOLST PA, 1971, BIOL REPROD, V5, P194, DOI 10.1093/biolreprod/5.2.194; Hong SG, 2009, GENESIS, V47, P314, DOI 10.1002/dvg.20504; Kim MJ, 2011, GENESIS, V49, P472, DOI 10.1002/dvg.20737; Kim Y, 2007, THERIOGENOLOGY, V68, P1177, DOI 10.1016/j.theriogenology.2007.08.018; Kutzler MA, 2003, THERIOGENOLOGY, V60, P1187, DOI 10.1016/S0093-691X(03)00109-2; Kuwayama M, 2005, REPROD BIOMED ONLINE, V11, P608, DOI 10.1016/S1472-6483(10)61169-8; MAHI CA, 1978, GAMETE RES, V1, P101, DOI 10.1002/mrd.1120010203; Nicholas FW, 2003, NUCLEIC ACIDS RES, V31, P275, DOI 10.1093/nar/gkg074; OLSON PN, 1982, BIOL REPROD, V27, P1196, DOI 10.1095/biolreprod27.5.1196; Otoi T, 2004, REPROD NUTR DEV, V44, P631, DOI 10.1051/rnd:2004065; Otoi T, 2000, VET REC, V146, P52, DOI 10.1136/vr.146.2.52; PETTERS RM, 1993, J REPROD FERTIL, P61; RENTON JP, 1991, J REPROD FERTIL, V93, P221, DOI 10.1530/jrf.0.0930221; Reynaud K, 2005, REPRODUCTION, V130, P193, DOI 10.1530/rep.1.00500; Reynaud K, 2012, INT S CAN FEL REPR W; Rodrigues BD, 2004, MOL REPROD DEV, V67, P215, DOI 10.1002/mrd.10394; Saikhun J, 2008, THERIOGENOLOGY, V69, P1104, DOI 10.1016/j.theriogenology.2008.01.024; Songsasen N, 2005, MOL REPROD DEV, V72, P113, DOI 10.1002/mrd.20330; Songsasen N, 2002, MOL REPROD DEV, V62, P407, DOI 10.1002/mrd.10130; Suarez SS, 2008, HUM REPROD UPDATE, V14, P647, DOI 10.1093/humupd/dmn029; Switonski M, 2014, REPROD BIOL, V14, P44, DOI 10.1016/j.repbio.2013.12.007; Tahir MZ, 2013, REPROD FERT DEVELOP, V25, P1065, DOI 10.1071/RD12108; Tahir MZ, 2012, REPROD DOMEST ANIM, V47, P35, DOI 10.1111/rda.12070; Tsutsui T, 2009, REPROD DOMEST ANIM, V44, P230, DOI 10.1111/j.1439-0531.2009.01450.x; Tsutsui T, 2001, J VET MED SCI, V63, P401, DOI 10.1292/jvms.63.401; Tsutsui T, 2006, THERIOGENOLOGY, V66, P1703, DOI 10.1016/j.theriogenology.2006.01.009; Vermeirsch H, 2001, REPRODUCTION, V122, P73, DOI 10.1530/reprod/122.1.73; Visconti PE, 1999, J BIOL CHEM, V274, P3235, DOI 10.1074/jbc.274.5.3235; WHITTINGHAM DG, 1974, GENETICS, V78, P395	44	40	41	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0143930	10.1371/journal.pone.0143930	http://dx.doi.org/10.1371/journal.pone.0143930			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650234	Green Submitted, gold, Green Published			2022-12-27	WOS:000366903300031
J	Scanu, B; Linaldeddu, BT; Deidda, A; Jung, T				Scanu, Bruno; Linaldeddu, Benedetto T.; Deidda, Antonio; Jung, Thomas			Diversity of Phytophthora Species from Declining Mediterranean Maquis Vegetation, including Two New Species, Phytophthora crassamura and P. ornamentata sp nov.	PLOS ONE			English	Article							EUCALYPTUS-MARGINATA; NATURAL ECOSYSTEMS; OAK FORESTS; CINNAMOMI; PATHOGEN; MULTIPLE; CONSERVATION; BIODIVERSITY; PHOSPHITE; BANKSIA	The Mediterranean basin is recognized as a global biodiversity hotspot accounting for more than 25,000 plant species that represent almost 10% of the world's vascular flora. In particular, the maquis vegetation on Mediterranean islands and archipelagos constitutes an important resource of the Mediterranean plant diversity due to its high rate of endemism. Since 2009, a severe and widespread dieback and mortality of Quercus ilex trees and several other plant species of the Mediterranean maquis has been observed in the National Park of La Maddalena archipelago (northeast Sardinia, Italy). Infected plants showed severe decline symptoms and a significant reduction of natural regeneration. First studies revealed the involvement of the highly invasive wide-host range pathogen Phytophthora cinnamomi and several fungal pathogens. Subsequent detailed research led to a better understanding of these epidemics showing that multiple Phytophthora spp. were involved, some of them unknown to science. In total, nine Phytophthora species were isolated from rhizosphere soil samples collected from around symptomatic trees and shrubs including Asparagus albus, Cistus sp., Juniperus phoenicea, J. oxycedrus, Pistacia lentiscus and Rhamnus alaternus. Based on morphological characters, growth-temperature relations and sequence analysis of the ITS and cox1 gene regions, the isolates were identified as Phytophthora asparagi, P. bilorbang, P. cinnamomi, P. cryptogea, P. gonapodyides, P. melonis, P. syringae and two new Clade 6 taxa which are here described as P. crassamura sp. nov. and P. ornamentata sp. nov. Pathogenicity tests supported their possible involvement in the severe decline that is currently threatening the Mediterranean maquis vegetation in the La Maddalena archipelago.	[Scanu, Bruno; Linaldeddu, Benedetto T.; Deidda, Antonio] Univ Sassari, Sez Patol Vegetale Entomol SPaVE, Dipartimento Agr, I-07100 Sassari, Italy; [Jung, Thomas] Phytophthora Res & Consultancy, D-83131 Nussdorf, Germany; [Jung, Thomas] Univ Algarve, Lab Mol Biotechnol & Phytopathol, Ctr Mediterranean Bioresources & Food MeditBio, P-8005139 Faro, Portugal	University of Sassari; Universidade do Algarve	Scanu, B (corresponding author), Univ Sassari, Sez Patol Vegetale Entomol SPaVE, Dipartimento Agr, Viale Italia 39, I-07100 Sassari, Italy.	bscanu@uniss.it	Linaldeddu, Benedetto/V-1349-2019; Jung, Thomas/F-1665-2013; Linaldeddu, Benedetto/J-4646-2015; Deidda, Antonio/AAA-6343-2022; Scanu, Bruno/AAQ-1671-2020	Linaldeddu, Benedetto/0000-0003-2428-9905; Jung, Thomas/0000-0003-2034-0718; Linaldeddu, Benedetto/0000-0003-2428-9905; Deidda, Antonio/0000-0003-1672-2721; Scanu, Bruno/0000-0002-0690-580X	National Park of the La Maddalena archipelago; Sardinian Regional Government; Autonomous Region of Sardinia, Visiting Professor Programme at the University of Sassari, Italy	National Park of the La Maddalena archipelago; Sardinian Regional Government(Regione Sardegna); Autonomous Region of Sardinia, Visiting Professor Programme at the University of Sassari, Italy	This research was supported by grants from the National Park of the La Maddalena archipelago and from the Sardinian Regional Government (P.O.R. Sardegna F.S.E. Operational Programme of the Autonomous Region of Sardinia, European Social Fund 2007-2013 - Axis IV Human Resources, Objective l.3, Line of Activity l.3.1.). TJ acknowledges support by the Autonomous Region of Sardinia, Visiting Professor Programme at the University of Sassari, Italy.; The authors would like to thank Paola Brundu who provided help and support with logistic and field work in the National Park of La Maddalena archipelago, and Emma Dempsey for English language editing. TJ acknowledges support by the Autonomous Region of Sardinia, Visiting Professor Programme at the University of Sassari, Italy.	Aghighi S, 2012, EUR J PLANT PATHOL, V133, P841, DOI 10.1007/s10658-012-0006-5; Biondi E., 2005, FITOSOCIOLOGIA S1, V42, P1; Bocchieri E., 1992, FLORA MEDITERRANEA, V2, P33; Brasier CM, 2008, PLANT PATHOL, V57, P792, DOI 10.1111/j.1365-3059.2008.01886.x; BRASIER CM, 1993, PLANT PATHOL, V42, P140, DOI 10.1111/j.1365-3059.1993.tb01482.x; Brasier CM, 2003, MYCOL RES, V107, P277, DOI 10.1017/S095375620300738X; Brasier CM, 1967, THESIS; Burgess TI, 2009, PLANT DIS, V93, P215, DOI 10.1094/PDIS-93-3-0215; Cacciola SO, 1996, INFORM FITOPATOLOGIC, V7-8, P33; Cacciola SO, 2006, J PLANT PATHOL, V88, pS34; Cooke DEL, 2000, FUNGAL GENET BIOL, V30, P17, DOI 10.1006/fgbi.2000.1202; Cunnington JH, 2005, AUSTRALAS PLANT PATH, V34, P413, DOI 10.1071/AP05034; Dick M.W, 1990, KEYS TO PYTHIUM; ELLIOTT CG, 1966, J GEN MICROBIOL, V42, P425, DOI 10.1099/00221287-42-3-425; Erwin C. D., 1996, PHYTOPHTHORA DIS WOR; Franceschini A., 2012, IOBC/WPRS Bulletin, V76, P101; Granke LL, 2012, PERSOONIA, V28, P146; Guharoy S, 2006, J PHYTOPATHOL, V154, P612, DOI 10.1111/j.1439-0434.2006.01155.x; Hall T., 2001, BIOEDIT VERSION 5 0; Hansen E, 1999, ANN FOR SCI, V56, P539, DOI 10.1051/forest:19990702; Hansen E, 2015, P 7 M IUFRO WORK PAR; Hardham AR, 2005, MOL PLANT PATHOL, V6, P589, DOI 10.1111/J.1364-3703.2005.00308.X; Hardy GES, 2001, AUSTRALAS PLANT PATH, V30, P133, DOI 10.1071/AP01012; Henricot B, 2014, PLANT PATHOL, V63, P1095, DOI 10.1111/ppa.12194; Ho HH, 2007, MYCOTAXON, V102, P339; Huberli D, 2013, AUSTRALAS PLANT PATH, V42, P251, DOI 10.1007/s13313-012-0195-6; Jung T, 2016, FOREST PATHOL, V46, P134, DOI 10.1111/efp.12239; Jung T, 2013, FOREST PATHOL, V43, P266, DOI 10.1111/efp.12025; Jung T, 1996, EUR J FOREST PATHOL, V26, P253; Jung T, 2011, PERSOONIA, V26, P13, DOI 10.3767/003158511X557577; Jung T, 2013, CABI PLANT PROT SER, P146, DOI 10.1079/9781780640938.0146; Linaldeddu BT, 2014, FOREST PATHOL, V44, P191, DOI 10.1111/efp.12081; Linaldeddu BT, 2013, MYCOLOGIA, V105, P1266, DOI 10.3852/12-370; Martin FN, 2003, MYCOLOGIA, V95, P269, DOI 10.2307/3762038; Medail F, 1997, ANN MO BOT GARD, V84, P112, DOI 10.2307/2399957; Mirabolfathy M, 2001, MYCOL RES, V105, P1166, DOI 10.1016/S0953-7562(08)61987-5; Mohaghegh P, 2011, PLANT DIS, V95, P455, DOI 10.1094/PDIS-05-10-0379; Moralejo E, 2009, PLANT PATHOL, V58, P100, DOI 10.1111/j.1365-3059.2008.01930.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Perez-Sierra A, 2013, FOREST PATHOL, V43, P331, DOI 10.1111/efp.12037; Rea AJ, 2010, AUSTRALAS PLANT PATH, V39, P477, DOI 10.1071/AP10014; Reeser PW, 2011, MYCOLOGIA, V103, P22, DOI 10.3852/10-013; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Saude C, 2008, PHYTOPATHOLOGY, V98, P1075, DOI 10.1094/PHYTO-98-10-1075; Scanu B, 2014, FOREST PATHOL, V44, P1, DOI 10.1111/efp.12064; Scanu B, 2013, FOREST PATHOL, V43, P340, DOI 10.1111/efp.12039; Scanu B, 2015, P 7 M IUFRO WORK PAR; Scanu B, 2014, PHYTOPATHOL MEDITERR, V53, P480; Scott PM, 2009, PERSOONIA, V22, P1, DOI 10.3767/003158509X415450; Shearer BL, 2007, AUSTRALAS PLANT PATH, V36, P78, DOI 10.1071/AP06085; Shearer BL, 1989, JARRAH DIEBACK DYNAM; Smith RS, 2003, PHYTOPHTHORA FORESTS, P194; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Thompson JD, 2005, TAXON, V54, P967, DOI 10.2307/25065481; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vettraino AM, 2002, FOREST PATHOL, V32, P19, DOI 10.1046/j.1439-0329.2002.00264.x; Yang X., 2013, J PLANT PATHOL, V4, P5, DOI [10.4172/2157-7471.1000180, DOI 10.4172/2157-7471.1000180]	57	42	42	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0143234	10.1371/journal.pone.0143234	http://dx.doi.org/10.1371/journal.pone.0143234			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26649428	Green Submitted, Green Published, gold			2022-12-27	WOS:000366903300014
J	Ali, SA; Chew, YW; Omar, TC; Azman, N				Ali, Syed A.; Chew, Yik Wei; Omar, Tasyriq Che; Azman, Nizuwan			Use of FabV-Triclosan Plasmid Selection System for Efficient Expression and Production of Recombinant Proteins in Escherichia coli	PLOS ONE			English	Article							ANTIBIOTIC-FREE SELECTION; ESSENTIAL GENE MARKER; PERSPECTIVES; MAINTENANCE; AUXOTROPHY; MECHANISMS; ACID	Maintenance of recombinant plasmid vectors in host bacteria relies on the presence of selection antibiotics in the growth media to suppress plasmid -free segregants. However, presence of antibiotic resistance genes and antibiotics themselves is not acceptable in several applications of biotechnology. Previously, we have shown that FabV-Triclosan selection system can be used to select high and medium copy number plasmid vectors in E. coli. Here, we have extended our previous work and demonstrated that expression vectors containing FabV can be used efficiently to express heterologous recombinant proteins in similar or better amounts in E. coli host when compared with expression vectors containing beta-lactamase. Use of small amount of non-antibiotic Triclosan as selection agent in growth medium, enhanced plasmid stability, applicability in various culture media, and compatibility with other selection systems for multiple plasmid maintenance are noteworthy features of FabV-Triclosan selection system.	[Ali, Syed A.; Chew, Yik Wei; Omar, Tasyriq Che] Univ Sains Malaysia, Adv Med & Dent Inst, Oncol & Radiol Sci, Kepala Batas 13200, Pulau Pinang, Malaysia; [Azman, Nizuwan] Univ Sains Malaysia, Adv Med & Dent Inst, Div Res Publicat & Innovat, Kepala Batas 13200, Pulau Pinang, Malaysia	Universiti Sains Malaysia; Universiti Sains Malaysia	Ali, SA (corresponding author), Univ Sains Malaysia, Adv Med & Dent Inst, Oncol & Radiol Sci, Kepala Batas 13200, Pulau Pinang, Malaysia.	alilabwork@gmail.com	Omar, Mohammad Tasyriq Che/L-3839-2017; Azman, Nizuwan/Y-5331-2019; Chew, Yik Wei/M-9669-2017; Omar, Mohammad Tasyriq Che/AFP-0240-2022	Omar, Mohammad Tasyriq Che/0000-0002-1294-7520; Chew, Yik Wei/0000-0003-4772-0702; Omar, Mohammad Tasyriq Che/0000-0002-1294-7520	ERGS grant from the Ministry of Higher Education (MOHE), Government of Malaysia [203/CIPPT/6730104]; Ministry of Higher Education (MOHE), Government of Malaysia [KPM (B) 860208015480]	ERGS grant from the Ministry of Higher Education (MOHE), Government of Malaysia; Ministry of Higher Education (MOHE), Government of Malaysia	This work was supported by the ERGS grant (203/CIPPT/6730104) from the Ministry of Higher Education (MOHE), Government of Malaysia, to SAA. YWC is a recipient of MyMaster scholarship (KPM (B) 860208015480) under MyBrain15 program of Ministry of Higher Education (MOHE), Government of Malaysia.	Ali SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129547; Carnes AE, 2009, BIOTECHNOL BIOENG, V104, P505, DOI 10.1002/bit.22415; Cranenburgh RM, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.5.e26; Dann AB, 2011, J APPL TOXICOL, V31, P285, DOI 10.1002/jat.1660; Dong WR, 2010, APPL ENVIRON MICROB, V76, P2295, DOI 10.1128/AEM.02462-09; Dryselius R, 2003, BIOTECHNIQUES, V35, P1060; El-Attar LMR, 2012, VACCINE, V30, P1702, DOI 10.1016/j.vaccine.2011.12.078; Friehs K, 2004, ADV BIOCHEM ENG BIOT, V86, P47; Goh S, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-61; Hagg P, 2004, J BIOTECHNOL, V111, P17, DOI 10.1016/j.jbiotec.2004.03.010; Heath RJ, 1999, J BIOL CHEM, V274, P11110, DOI 10.1074/jbc.274.16.11110; Jang CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057075; Kroll J, 2010, MICROB BIOTECHNOL, V3, P634, DOI 10.1111/j.1751-7915.2010.00170.x; Mualif SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130446; Oliveira PH, 2013, TRENDS BIOTECHNOL, V31, P539, DOI 10.1016/j.tibtech.2013.06.001; Peubez I, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-65; Rodricks JV, 2010, CRIT REV TOXICOL, V40, P422, DOI 10.3109/10408441003667514; Rosano GL, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00172; Schnappinger D, 1996, ARCH MICROBIOL, V165, P359, DOI 10.1007/s002030050339; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Selvamani RSV, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-58; Teow SY, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-107; Vandermeulen G, 2011, MOL THER, V19, P1942, DOI 10.1038/mt.2011.182; Vidal L, 2008, J BIOTECHNOL, V134, P127, DOI 10.1016/j.jbiotec.2008.01.011	24	3	3	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144189	10.1371/journal.pone.0144189	http://dx.doi.org/10.1371/journal.pone.0144189			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642325	Green Published, gold, Green Submitted			2022-12-27	WOS:000366902700073
J	Carrella, S; Barbato, S; D'Agostino, Y; Salierno, FG; Manfredi, A; Banfi, S; Conte, I				Carrella, Sabrina; Barbato, Sara; D'Agostino, Ylenia; Salierno, Francesco Giuseppe; Manfredi, Anna; Banfi, Sandro; Conte, Ivan			TGF-beta Controls miR-181/ERK Regulatory Network during Retinal Axon Specification and Growth	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; CHEMOTROPIC RESPONSES; ORYZIAS-LATIPES; IN-VIVO; EXPRESSION; NEURONS; MECHANISMS; PROMOTE; MEDAKA; CONES	Retinal axon specification and growth are critically sensitive to the dosage of numerous signaling molecules and transcription factors. Subtle variations in the expression levels of key molecules may result in a variety of axonal growth anomalies. miR-181a and miR-181b are two eye-enriched microRNAs whose inactivation in medaka fish leads to alterations of the proper establishment of connectivity and function in the visual system. miR-181a/b are fundamental regulators of MAPK signaling and their role in retinal axon growth and specification is just beginning to be elucidated. Here we demonstrate that miR-181a/b are key nodes in the interplay between TGF-beta and MAPK/ERK within the functional pathways that control retinal axon specification and growth. Using a variety of in vivo and in vitro approaches in medaka fish, we demonstrate that TGF-beta signaling controls the miR-181/ERK regulatory network, which in turn strengthens the TGF-beta-mediated regulation of RhoA degradation. Significantly, these data uncover the role of TGF-beta signaling in vivo, for the first time, in defining the correct wiring and assembly of functional retina neural circuits and further highlight miR-181a/b as key factors in axon specification and growth.	[Carrella, Sabrina; Barbato, Sara; D'Agostino, Ylenia; Salierno, Francesco Giuseppe; Manfredi, Anna; Banfi, Sandro; Conte, Ivan] Telethon Inst Genet & Med, I-80078 Naples, Italy; [Banfi, Sandro] Univ Naples 2, Med Genet, Dipartimento Biochim Biofis & Patol Generale, I-80138 Naples, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Universita della Campania Vanvitelli	Banfi, S (corresponding author), Telethon Inst Genet & Med, Via Campi Flegrei 34, I-80078 Naples, Italy.	banfi@tigem.it; conte@tigem.it	Manfredi, Anna/ABC-8588-2021; Banfi, Sandro/K-3963-2018; Carrella, Sabrina/AAD-3103-2020	Banfi, Sandro/0000-0002-6541-8833; D'Agostino, Ylenia/0000-0002-1890-6682; Conte, Ivan/0000-0002-8968-9021; Carrella, Sabrina/0000-0002-3302-1698	Italian Telethon Foundation [TGM11SB2]	Italian Telethon Foundation(Fondazione Telethon)	This study was supported by the Italian Telethon Foundation (GRANT TGM11SB2 to SB), www.telethon.it. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avellino R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061099; Baudet ML, 2013, SEMIN CELL DEV BIOL, V24, P146, DOI 10.1016/j.semcdb.2012.11.004; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; Braunger BM, 2013, J NEUROSCI, V33, P14246, DOI 10.1523/JNEUROSCI.0991-13.2013; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Campbell DS, 2003, NEURON, V37, P939, DOI 10.1016/S0896-6273(03)00158-2; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Carrella S, 2015, DEV NEUROBIOL, V75, P1252, DOI 10.1002/dneu.22282; Choi WY, 2007, SCIENCE, V318, P271, DOI 10.1126/science.1147535; Close JL, 2005, DEVELOPMENT, V132, P3015, DOI 10.1242/dev.01882; Conte I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r137; Conte I, 2014, NUCLEIC ACIDS RES, V42, P7793, DOI 10.1093/nar/gku498; Conte I, 2010, P NATL ACAD SCI USA, V107, P15491, DOI 10.1073/pnas.0914785107; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Del Bene F, 2007, PLOS GENET, V3, P1661, DOI 10.1371/journal.pgen.0030159; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Duenker N, 2005, INT REV CYTOL, V245, P17, DOI 10.1016/S0074-7696(05)45002-0; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Glinka Y, 2008, J LEUKOCYTE BIOL, V84, P302, DOI 10.1189/jlb.0208090; Harada T, 2007, GENE DEV, V21, P367, DOI 10.1101/gad.1504307; Hata A, 2009, CYTOKINE GROWTH F R, V20, P517, DOI 10.1016/j.cytogfr.2009.10.004; He QT, 2013, BBA-GEN SUBJECTS, V1830, P5258, DOI 10.1016/j.bbagen.2013.07.028; Hocking JC, 2008, MOL CELL NEUROSCI, V37, P247, DOI 10.1016/j.mcn.2007.09.011; Holt CE, 2013, NEURON, V80, P648, DOI 10.1016/j.neuron.2013.10.036; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Iwamatsu T, 2004, MECH DEVELOP, V121, P605, DOI 10.1016/j.mod.2004.03.012; Kazenwadel J, 2010, BLOOD, V116, P2395, DOI 10.1182/blood-2009-12-256297; Kerrison JB, 2005, MOL VIS, V11, P208; Kim IJ, 2004, J NEUROSCI, V24, P3304, DOI 10.1523/JNEUROSCI.3286-03.2004; Kita EM, 2013, DEVELOPMENT, V140, P2933, DOI 10.1242/dev.088286; Kitambi SS, 2008, DEV DYNAM, V237, P3870, DOI 10.1002/dvdy.21797; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Murali D, 2011, INVEST OPHTH VIS SCI, V52, P2930, DOI 10.1167/iovs.10-5940; Neel JC, 2013, CELL SIGNAL, V25, P1556, DOI 10.1016/j.cellsig.2013.03.013; Neiffer DL, 2009, ILAR J, V50, P343, DOI 10.1093/ilar.50.4.343; Ng J, 2008, DEVELOPMENT, V135, P4025, DOI 10.1242/dev.028209; Piper M, 2006, NEURON, V49, P215, DOI 10.1016/j.neuron.2005.12.008; Reinhardt P, 2013, CELL STEM CELL, V12, P354, DOI 10.1016/j.stem.2013.01.008; Ross S, 2008, INT J BIOCHEM CELL B, V40, P383, DOI 10.1016/j.biocel.2007.09.006; Sanchez-Camacho C, 2009, BIOESSAYS, V31, P1013, DOI 10.1002/bies.200900063; Tesseur I, 2006, J CLIN INVEST, V116, P3060, DOI 10.1172/JCI27341; Trousse F, 2001, J NEUROSCI, V21, P1292; Walshe TE, 2011, NEUROSCIENCE, V189, P123, DOI 10.1016/j.neuroscience.2011.05.020; Wang B, 2010, ONCOGENE, V29, P1787, DOI 10.1038/onc.2009.468; Wang Y, 2011, ONCOGENE, V30, P1470, DOI 10.1038/onc.2010.531; Yi JJ, 2010, CELL, V142, P144, DOI 10.1016/j.cell.2010.06.010	48	24	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144129	10.1371/journal.pone.0144129	http://dx.doi.org/10.1371/journal.pone.0144129			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641497	Green Submitted, gold, Green Published			2022-12-27	WOS:000366902700059
J	Enkhbaatar, P; Nelson, C; Salsbury, JR; Carmical, JR; Torres, KEO; Herndon, D; Prough, DS; Luan, LM; Sherwood, ER				Enkhbaatar, Perenlei; Nelson, Christina; Salsbury, John R.; Carmical, Joseph R.; Torres, Karen E. O.; Herndon, David; Prough, Donald S.; Luan, Liming; Sherwood, Edward R.			Comparison of Gene Expression by Sheep and Human Blood Stimulated with the TLR4 Agonists Lipopolysaccharide and Monophosphoryl Lipid A	PLOS ONE			English	Article							LONG PENTRAXIN; SEVERE SEPSIS; PLASMA-LEVELS; ANIMAL-MODEL; ENDOTOXIN; MOUSE; REPRODUCIBILITY; EPIDEMIOLOGY; INFLAMMATION; PNEUMONIA	Background Animal models that mimic human biology are important for successful translation of basic science discoveries into the clinical practice. Recent studies in rodents have demonstrated the efficacy of TLR4 agonists as immunomodulators in models of infection. However, rodent models have been criticized for not mimicking important characteristics of the human immune response to microbial products. The goal of this study was to compare genomic responses of human and sheep blood to the TLR4 agonists lipopolysaccharide (LPS) and monophosphoryl lipid A (MPLA). Methods Venous blood, withdrawn from six healthy human adult volunteers (similar to 28 years old) and six healthy adult female sheep (similar to 3 years old), was mixed with 30 mu L of PBS, LPS (1 mu g/mL) or MPLA (10 mu g/mL) and incubated at room temperature for 90 minutes on a rolling rocker. After incubation, 2.5 mL of blood was transferred to Paxgene Blood RNA tubes. Gene expression analysis was performed using an Agilent Bioanalyzer with the RNA6000 Nano Lab Chip. Agilent gene expression microarrays were scanned with a G2565 Microarray Scanner. Differentially expressed genes were identified. Results 11,431 human and 4,992 sheep probes were detected above background. Among them 1,029 human and 175 sheep genes were differentially expressed at a stringency of 1.5-fold change (p<0.05). Of the 175 sheep genes, 54 had a known human orthologue. Among those genes, 22 had > 1.5-fold changes in human samples. Genes of major inflammatory mediators, such as IL-1, IL-6 and IL-8, TNF alpha, NF-kappaB, ETS2, PTGS2, PTX3, CXCL16, KYNU, and CLEC4E were similarly (> 2-fold) upregulated by LPS and MPLA in both species. Conclusion The genomic responses of peripheral blood to LPS and MPLA in sheep are quite similar to those observed in humans, supporting the use of the ovine model for translational studies that mimic human inflammatory diseases and the study of TLR-based immunomodulators.	[Enkhbaatar, Perenlei; Nelson, Christina; Salsbury, John R.; Prough, Donald S.] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA; [Carmical, Joseph R.] Baylor Coll Med, Alkek Ctr Metagen & Microbiome Res, Mol Virol & Microbiol Core, Houston, TX 77030 USA; [Torres, Karen E. O.] GenUs BioSyst, Northbrook, IL USA; [Herndon, David] Shriners Hosp Children, Galveston, TX 77550 USA; [Luan, Liming; Sherwood, Edward R.] Vanderbilt Univ, Med Ctr, Dept Anesthesiol, Nashville, TN USA	University of Texas System; University of Texas Medical Branch Galveston; Baylor College of Medicine; Vanderbilt University	Enkhbaatar, P (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA.	peenkhba@utmb.edu	Prough, Donald S/G-5793-2013; Herndon, David/AAC-3354-2020	Prough, Donald S/0000-0001-7994-532X; 	NIH [GM097480, GM104306]; Shriners hospital of North America [SHC84050]; GenUs Biosystems; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097480, R01GM104306] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners hospital of North America; GenUs Biosystems; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by NIH GM097480 and GM104306 and Shriners hospital of North America SHC84050. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. GenUs Biosystems provided support in the form of salaries for author [KT], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ABRAHAM WM, 1983, AM REV RESPIR DIS, V128, P839; Angus DC, 2001, CRIT CARE MED, V29, pS109, DOI 10.1097/00003246-200107001-00035; Azzurri A, 2005, MICROBES INFECT, V7, P1, DOI 10.1016/j.micinf.2004.09.004; Bohannon JK, 2013, SHOCK, V40, P451, DOI 10.1097/SHK.0000000000000042; BOHS CT, 1979, CIRC SHOCK, V6, P13; CRAIG I, 1987, AM J PATHOL, V128, P241; Delano M. L., 2002, Laboratory animal medicine, P519, DOI 10.1016/B978-012263951-7/50017-X; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Efron PA, 2015, J LEUKOC BIOL; Enkhbaatar P, 2008, SHOCK, V29, P642, DOI 10.1097/SHK.0b013e318158125b; Ertmer C, 2007, SHOCK, V27, P281, DOI 10.1097/01.shk.0000235140.97903.90; GAJEWSKI J, 1971, AM J VET RES, V32, P405; Garlanda C, 2002, NATURE, V420, P182, DOI 10.1038/nature01195; GODSOE A, 1988, CIRC SHOCK, V25, P61; Hotchkiss RS, 2010, NEW ENGL J MED, V363, P87, DOI 10.1056/NEJMcibr1004371; Hotchkiss RS, 2009, NAT MED, V15, P496, DOI 10.1038/nm0509-496; Hu XB, 2013, IMMUNOBIOLOGY, V218, P1524, DOI 10.1016/j.imbio.2013.05.006; Iannuzzi L, 1999, MAMM GENOME, V10, P719, DOI 10.1007/s003359901078; John-Aryankalayil M, 2009, MOL CANCER THER, V8, P261, DOI 10.1158/1535-7163.MCT-08-0928; JOHNSON AG, 1987, REV INFECT DIS, V9, pS512; Kaisho T, 2000, CRIT REV IMMUNOL, V20, P393; Lange M, 2007, SHOCK, V27, P701, DOI 10.1097/01.shk.0000246902.58068.73; Lange M, 2012, BURNS, V38, P1072, DOI 10.1016/j.burns.2012.02.019; Lehrke M, 2007, J AM COLL CARDIOL, V49, P442, DOI 10.1016/j.jacc.2006.09.034; Mairuhu ATA, 2005, J MED VIROL, V76, P547, DOI 10.1002/jmv.20397; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Mayr FB, 2014, VIRULENCE, V5, P4, DOI 10.4161/viru.27372; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Mitka M, 2011, JAMA-J AM MED ASSOC, V306, P2439, DOI 10.1001/jama.2011.1755; Monie A., 2008, BIOLOGICS, V2, P97; Murakami K, 2002, CRIT CARE MED, V30, P2083, DOI 10.1097/00003246-200209000-00022; NOSHIMA S, 1993, J APPL PHYSIOL, V74, P1528, DOI 10.1152/jappl.1993.74.4.1528; Osuchowski MF, 2014, SHOCK, V41, P463, DOI 10.1097/SHK.0000000000000153; Rabuel C, 2004, ANESTHESIOLOGY, V101, P583, DOI 10.1097/00000542-200409000-00006; RIBI E, 1984, REV INFECT DIS, V6, P567; Rojo DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023111; Romero CD, 2011, INFECT IMMUN, V79, P3576, DOI 10.1128/IAI.00022-11; Scheerlinck JPY, 2008, TRENDS BIOTECHNOL, V26, P259, DOI 10.1016/j.tibtech.2008.02.002; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shi LM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S9-S10; Sprong T, 2009, SHOCK, V31, P28, DOI 10.1097/SHK.0b013e31817fd543; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; TRABER DL, 1988, AM J PHYSIOL, V254, pH833, DOI 10.1152/ajpheart.1988.254.5.H833; van Rijssel J, 2013, BIOL OPEN, V2, P569, DOI 10.1242/bio.20134382; Wagenaar JFP, 2009, J INFECTION, V58, P425, DOI 10.1016/j.jinf.2009.04.004; Wheeler AP, 1999, NEW ENGL J MED, V340, P207, DOI 10.1056/NEJM199901213400307; Widdicombe JH, 2001, J ANAT, V198, P207, DOI 10.1046/j.1469-7580.2001.19820207.x; Wiersinga WJ, 2011, CURR OPIN CRIT CARE, V17, P480, DOI 10.1097/MCC.0b013e32834a4aeb; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992	51	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144345	10.1371/journal.pone.0144345	http://dx.doi.org/10.1371/journal.pone.0144345			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26640957	Green Published, gold, Green Submitted			2022-12-27	WOS:000366902700101
J	Liu, Y; Kimura, K; Orita, T; Sonoda, KH				Liu, Yang; Kimura, Kazuhiro; Orita, Tomoko; Sonoda, Koh-Hei			Necrosis-Induced Sterile Inflammation Mediated by Interleukin-1 alpha in Retinal Pigment Epithelial Cells	PLOS ONE			English	Article							MOLECULAR-PATTERNS; GENE-EXPRESSION; IL-1-ALPHA; FIBROBLASTS; ACTIVATION; MECHANISMS	Endogenous danger signals released from necrotic cells contribute to retinal inflammation. We have now investigated the effects of necrotic cell extracts prepared from ARPE-19 human retinal pigment epithelial cells (ANCE) on the release of proinflammatory cytokines and chemokines by healthy ARPE-19 cells. ANCE were prepared by subjection of ARPE-19 cells to freeze-thaw cycles. The release of various cytokines and chemokines from ARPE-19 cells was measured with a multiplex assay system or enzyme-linked immunosorbent assays. The expression of interleukin (IL)-1 alpha and the phosphorylation and degradation of the endogenous nuclear factor-kappa B (NF-kappa B) inhibitor I kappa B-alpha were examined by immunoblot analysis. Among the various cytokines and chemokines examined, we found that ANCE markedly stimulated the release of the proinflammatory cytokine IL-6 and the chemokines IL-8 and monocyte chemoattractant protein (MCP)-1 by ARPE-19 cells. ANCE-induced IL-6, IL-8, and MCP-1 release was inhibited by IL-1 receptor antagonist and by an IKK2 inhibitor (a blocker of NF-kappa B signaling) in a concentration-dependent manner, but was not affected by a pan-caspase inhibitor (Z-VAD-FMK). Recombinant IL-1 alpha also induced the secretion of IL-6, IL-8, and MCP-1 from ARPE-19 cells, and IL-1 alpha was detected in ANCE. Furthermore, ANCE induced the phosphorylation and degradation of I kappa B-alpha in ARPE-19 cells. Our findings thus suggest that IL-1 alpha is an important danger signal that is released from necrotic retinal pigment epithelial cells and triggers proinflammatory cytokine and chemokine secretion from intact cells in a manner dependent on NF-kappa B signaling. IL-1 alpha is therefore a potential therapeutic target for amelioration of sterile inflammation in the retina.	[Liu, Yang; Kimura, Kazuhiro; Orita, Tomoko; Sonoda, Koh-Hei] Yamaguchi Univ, Grad Sch Med, Dept Ophthalmol, Ube, Yamaguchi 755, Japan; [Liu, Yang] Jilin Univ, Hosp 1, Dept Ophthalmol, Jilin, Peoples R China	Yamaguchi University; Jilin University	Kimura, K (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Ophthalmol, Ube, Yamaguchi 755, Japan.	k.kimura@yamaguchi-u.ac.jp			Japan Society for the Promotion of Science (JSPS); JSPS; National Science Foundation of China [81100635]; Grants-in-Aid for Scientific Research [26861453, 26462663] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-Aid from the Japan Society for the Promotion of Science (JSPS, to K.S. and Y.L.), by a JSPS postdoctoral fellowship for foreign researchers (Y.L.), and by a grant (no. 81100635) from the National Science Foundation of China (Y.L.).	Abe T, 1999, TOHOKU J EXP MED, V189, P179, DOI 10.1620/tjem.189.179; Arimura N, 2009, LAB INVEST, V89, P278, DOI 10.1038/labinvest.2008.165; Cascella R, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/582842; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Dinarello CA, 2000, NEW ENGL J MED, V343, P732, DOI 10.1056/NEJM200009073431011; Eigenbrod T, 2008, J IMMUNOL, V181, P8194, DOI 10.4049/jimmunol.181.12.8194; Feenstra Derrick J, 2013, J Clin Exp Ophthalmol, V4, P298; Gao JY, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/690243; Horn F, 2000, IMMUNOBIOLOGY, V202, P151, DOI 10.1016/S0171-2985(00)80061-3; Juel HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064619; Kawano H, 2014, LAB INVEST, V94, P569, DOI 10.1038/labinvest.2014.46; Kimura K, 2008, INVEST OPHTH VIS SCI, V49, P565, DOI 10.1167/iovs.07-0419; Kimura K, 2012, EXP EYE RES, V96, P157, DOI 10.1016/j.exer.2011.10.015; Land Walter G, 2015, Sultan Qaboos Univ Med J, V15, pe9; Latz E, 2010, CURR OPIN IMMUNOL, V22, P28, DOI 10.1016/j.coi.2009.12.004; Luo Y, 2006, INVEST OPHTH VIS SCI, V47, P3644, DOI 10.1167/iovs.06-0166; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; McBee JK, 2001, PROG RETIN EYE RES, V20, P469, DOI 10.1016/S1350-9462(01)00002-7; McCarthy CG, 2014, AM J PHYSIOL-HEART C, V306, pH184, DOI 10.1152/ajpheart.00328.2013; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Monteleone M, 2015, CYTOKINE, V74, P213, DOI 10.1016/j.cyto.2015.03.022; Murakami Y, 2014, CELL DEATH DIFFER, V21, P270, DOI 10.1038/cdd.2013.109; Nace G, 2012, J INNATE IMMUN, V4, P6, DOI 10.1159/000334245; Owen LA, 2013, CURR DIABETES REP, V13, P476, DOI 10.1007/s11892-013-0382-z; Qin SF, 2011, EXP EYE RES, V93, P889, DOI 10.1016/j.exer.2011.10.002; Qiu YG, 2015, SCI REP-UK, V5, DOI 10.1038/srep14362; Rao DA, 2007, J IMMUNOL, V179, P6536, DOI 10.4049/jimmunol.179.10.6536; Rubartelli A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00398; Scarpa M, 2015, AM J PATHOL, V185, P1624, DOI 10.1016/j.ajpath.2015.02.018; SHYY YJ, 1993, BIOCHEM BIOPH RES CO, V192, P693, DOI 10.1006/bbrc.1993.1470; Skeie JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127567; Srivastava SK, 2009, EXP EYE RES, V88, P2, DOI 10.1016/j.exer.2008.03.012; Tian J, 2005, BRIT J OPHTHALMOL, V89, P1510, DOI 10.1136/bjo.2005.072108; Tseng WA, 2013, INVEST OPHTH VIS SCI, V54, P110, DOI 10.1167/iovs.12-10655; Zheng Y, 2013, IMMUNITY, V38, P285, DOI 10.1016/j.immuni.2013.01.008	35	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144460	10.1371/journal.pone.0144460	http://dx.doi.org/10.1371/journal.pone.0144460			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641100	Green Published, Green Submitted, gold			2022-12-27	WOS:000366902700129
J	Moriarty, ME; Vickers, TW; Clifford, DL; Garcelon, DK; Gaffney, PM; Lee, KW; King, JL; Duncan, CL; Boyce, WM				Moriarty, Megan E.; Vickers, T. Winston; Clifford, Deana L.; Garcelon, David K.; Gaffney, Patricia M.; Lee, Kenneth W.; King, Julie L.; Duncan, Calvin L.; Boyce, Walter M.			Ear Mite Removal in the Santa Catalina Island Fox (Urocyon littoralis catalinae): Controlling Risk Factors for Cancer Development	PLOS ONE			English	Article							ALLERGEN-SPECIFIC IGE; COCKTAIL-BASED ELISA; NOTOEDRIC MANGE; DOGS; EXPOSURE; RECEPTOR; TUMORS; LIONS	Ear mites (Otodectes cynotis) and ear canal tumors are highly prevalent among federally endangered Island foxes (Urocyon littoralis catalinae) living on Santa Catalina Island off the coast of Southern California. Since studies began in the 1990s, nearly all foxes examined were found to be infected with ear mites, and ceruminous gland tumors (carcinomas and adenomas) were detected in approximately half of all foxes >= 4 years of age. We hypothesized that reduction of ear mite infection would reduce otitis externa and ceruminous gland hyperplasia, a risk factor for tumor development. In this study, we conducted a randomized field trial to assess the impact of acaricide treatment on ear mite prevalence and intensity of infection, otitis externa, ceruminous gland hyperplasia, and mite-specific IgG and IgE antibody levels. Treatment was highly effective at eliminating mites and reducing otitis externa and ceruminous gland hyperplasia, and mite-specific IgG antibody levels were significantly lower among uninfected foxes. Ceruminous gland hyperplasia increased in the chronically infected, untreated foxes during the six month study. Our results provide compelling evidence that acaricide treatment is an effective means of reducing ear mites, and that mite removal in turn reduces ear lesions and mite-specific IgG antibody levels in Santa Catalina Island foxes. This study has advanced our understanding of the underlying pathogenesis which results in ceruminous gland tumors, and has helped inform management decisions that impact species conservation.	[Moriarty, Megan E.; Vickers, T. Winston; Clifford, Deana L.; Boyce, Walter M.] Univ Calif Davis, Sch Vet Med, Karen C Drayer Wildlife Hlth Ctr, Davis, CA 95616 USA; [Vickers, T. Winston; Garcelon, David K.] Inst Wildlife Studies, Arcata, CA USA; [Clifford, Deana L.] Calif Dept Fish & Wildlife, Wildlife Invest Lab, Rancho Cordova, CA USA; [Gaffney, Patricia M.; Boyce, Walter M.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Gaffney, Patricia M.] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA; [Gaffney, Patricia M.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Lee, Kenneth W.] Greer Lab, Lenoir, NC USA; [King, Julie L.; Duncan, Calvin L.] Catalina Isl Conservancy, Avalon, CA USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California San Diego; University of California System; University of California San Diego	Vickers, TW (corresponding author), Univ Calif Davis, Sch Vet Med, Karen C Drayer Wildlife Hlth Ctr, Davis, CA 95616 USA.	twvickers@ucdavis.edu; wmboyce@ucdavis.edu		King, Julie/0000-0001-7900-8109	Morris Animal Foundation [D08ZO-043]; Institute for Wildlife Studies; Catalina Island Conservancy; Greer Laboratories, Inc.; Students Training in Advanced Research, UC Davis School of Veterinary Medicine; Greer Laboratories, Inc; Nature Conservancy; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T32OD017863] Funding Source: NIH RePORTER	Morris Animal Foundation; Institute for Wildlife Studies; Catalina Island Conservancy; Greer Laboratories, Inc.; Students Training in Advanced Research, UC Davis School of Veterinary Medicine; Greer Laboratories, Inc; Nature Conservancy; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by Morris Animal Foundation (TWV; grant number D08ZO-043; http://www.morrisanimalfoundation.org), Institute for Wildlife Studies (TWV, MEM; http://www.iws.org), Catalina Island Conservancy (JLK, CLD ; https://www.catalinaconservancy.org), Greer Laboratories, Inc. (KWL, MEM; http://www.greerlabs.com), Students Training in Advanced Research, UC Davis School of Veterinary Medicine (MEM; http://www.vetmed.ucdavis.edu/research/grad_education/star). The funders had no role in study design, data collection. Greer Laboratories, Inc provided support in the form of salaries for authors [KWL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; The authors thank M. Puzzo, R. Shea, L. Campbell, and C. Boser for field assistance; J. Rudd, K. Blankenship, Z. McCurry, B. McKinney, G. Lee, and M. Plancarte for laboratory assistance; M. Christopher and J. Mazet for manuscript review; A. Kent for help creating the map for this manuscript; J. Sanchez for help with image formatting. We also acknowledge the cooperation and support of the Catalina Island Conservancy, the Institute for Wildlife Studies, and The Nature Conservancy. Laboratory support, equipment, and space were provided by Greer Laboratories, Inc. and the Boyce laboratory at the University of California, Davis.	Aguilar A, 2004, P NATL ACAD SCI USA, V101, P3490, DOI 10.1073/pnas.0306582101; Aguirre AA., 2004, ECOHEALTH, V1, P275, DOI [10.1007/s10393-004-0097-3, DOI 10.1007/S10393-004-0097-3]; BERNSTEIN JM, 1984, INT J PEDIATR OTORHI, V8, P125, DOI 10.1016/S0165-5876(84)80061-0; Burgess STG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-624; Clifford DL, 2006, BIOL CONSERV, V131, P230, DOI 10.1016/j.biocon.2006.04.029; Colegrove KM, 2009, VET PATHOL, V46, P642, DOI 10.1354/vp.08-VP-0214-C-FL; Collins P W, 1982, THESIS; Collins Paul W., 1993, P351; Coonan TJ., 2010, DECLINE RECOVERY ISL; Daniel W., 2009, BIOSTATISTICS FDN AN, V9; DAVIDSON WR, 1992, J WILDLIFE DIS, V28, P581, DOI 10.7589/0090-3558-28.4.581; Degiorgis MP, 2001, J WILDLIFE DIS, V37, P626, DOI 10.7589/0090-3558-37.3.626; Dela Cruz FN, 2013, EMERG INFECT DIS, V19, P77, DOI 10.3201/eid1901.121078; GUNNARSSON E, 1991, J WILDLIFE DIS, V27, P105, DOI 10.7589/0090-3558-27.1.105; HITES MJ, 1989, VET IMMUNOL IMMUNOP, V22, P39, DOI 10.1016/0165-2427(89)90162-1; KING JL, 2014, MONOGR WEST NORTH AM, V7, P382, DOI DOI 10.3398/042.007.0129; Lafferty KD, 2002, CONSERV BIOL, V16, P593, DOI 10.1046/j.1523-1739.2002.00446.x; Lee KW, 2012, VET IMMUNOL IMMUNOP, V148, P267, DOI 10.1016/j.vetimm.2012.05.011; Lee KW, 2009, VET DERMATOL, V20, P157, DOI 10.1111/j.1365-3164.2009.00740.x; MAEHR DS, 1995, J WILDLIFE DIS, V31, P251, DOI 10.7589/0090-3558-31.2.251; Martineau D, 2002, ENVIRON HEALTH PERSP, V110, P285, DOI 10.1289/ehp.02110285; McCallum H, 2007, ECOHEALTH, V4, P318, DOI 10.1007/s10393-007-0118-0; McGavin MD, 2007, PATHOLOGIC BASIS VET; Moisan PG, 1996, J AM ANIM HOSP ASSOC, V32, P448, DOI 10.5326/15473317-32-5-448; National Oceanic and Atmospheric Administration, CLIM DAT ONL; PENCE DB, 1982, J WILDLIFE DIS, V18, P47, DOI 10.7589/0090-3558-18.1.47; Rampton M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065354; Riley SPD, 2007, J WILDLIFE MANAGE, V71, P1874, DOI 10.2193/2005-615; Scott DW, 1980, J AM ANIM HOSP ASSOC, V16, P426; Scott DW, 1995, SMALL ANIMAL DERMATO, P392; Service USFW, 2015, REC PLAN 4 SUBSP ISL; Sula MJM, 2012, VET CLIN N AM-SMALL, V42, P1161, DOI 10.1016/j.cvsm.2012.08.004; SWEATMAN GORDON K., 1958, CANADIAN JOUR ZOOL, V36, P849, DOI 10.1139/z58-072; Timm SF, 2009, J WILDLIFE DIS, V45, P333, DOI 10.7589/0090-3558-45.2.333; U.S. Fish and Wildlife Service, 2004, FED REGISTER, V69, P10335; VANDERGAAG I, 1986, VET QUART, V8, P307, DOI 10.1080/01652176.1986.9694061; Vickers TW, 2015, PLOSONE IN PRESS; WAYNE RK, 1991, EVOLUTION, V45, P1849, DOI 10.1111/j.1558-5646.1991.tb02692.x; Wood J. E., 1958, Journal of Mammalogy, V39, P74, DOI 10.2307/1376612	39	11	11	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144271	10.1371/journal.pone.0144271	http://dx.doi.org/10.1371/journal.pone.0144271			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641820	Green Submitted, Green Published, gold			2022-12-27	WOS:000366902700088
J	Oh, YS; Bae, SS; Park, JB; Ha, SH; Ryu, SH; Suh, PG				Oh, Yong-Seok; Bae, Sun Sik; Park, Jong Bae; Ha, Sang Hoon; Ryu, Sung Ho; Suh, Pann-Ghill			Mouse Sphingosine Kinase 1a Is Negatively Regulated through Conventional PKC-Dependent Phosphorylation at S373 Residue	PLOS ONE			English	Article							FACTOR-INDUCED ACTIVATION; CALCIUM MOBILIZATION; MOLECULAR-CLONING; FUNCTIONAL-CHARACTERIZATION; CELLULAR-REGULATION; DISTINCT ROLES; SPHINGOSINE-1-PHOSPHATE; 1-PHOSPHATE; RECEPTOR; PATHWAY	Sphingosine kinase is a lipid kinase that converts sphingosine into sphingosine-1-phosphate, an important signaling molecule with intracellular and extracellular functions. Although diverse extracellular stimuli influence cellular sphingosine kinase activity, the molecular mechanisms underlying its regulation remain to be clarified. In this study, we investigated the phosphorylation-dependent regulation of mouse sphingosine kinase (mSK) isoforms 1 and 2. mSK1a was robustly phosphorylated in response to extracellular stimuli such as phorbol ester, whereas mSK2 exhibited a high basal level of phosphorylation in quiescent cells regardless of agonist stimulation. Interestingly, phorbol ester-induced phosphorylation of mSK1a correlated with suppression of its activity. Chemical inhibition of conventional PKCs (cPKCs) abolished mSK1a phosphorylation, while overexpression of PKC alpha, a cPKC isoform, potentiated the phosphorylation, in response to phorbol ester. Furthermore, an in vitro kinase assay showed that PKC alpha directly phosphorylated mSK1a. In addition, phosphopeptide mapping analysis determined that the S373 residue of mSK1a was the only site phosphorylated by cPKC. Interestingly, alanine substitution of S373 made mSK1a refractory to the inhibitory effect of phorbol esters, whereas glutamate substitution of the same residue resulted in a significant reduction in mSK1a activity, suggesting the significant role of this phosphorylation event. Taken together, we propose that mSK1a is negatively regulated through cPKC-dependent phosphorylation at S373 residue.	[Oh, Yong-Seok] DGIST, Dept Brain Cognit Sci, Taegu, South Korea; [Park, Jong Bae; Ha, Sang Hoon; Ryu, Sung Ho] Pohang Univ Sci & Technol, Div Mol & Life Sci, Dept Life Sci, Pohang, South Korea; [Bae, Sun Sik; Suh, Pann-Ghill] UNIST, Dept Biol Sci, Ulsan, South Korea	Daegu Gyeongbuk Institute of Science & Technology (DGIST); Pohang University of Science & Technology (POSTECH); Ulsan National Institute of Science & Technology (UNIST)	Oh, YS (corresponding author), DGIST, Dept Brain Cognit Sci, Taegu, South Korea.	ysoh2040@dgist.ac.kr; pgsuh@unist.ac.kr	Suh, Pann-Ghill/F-3610-2010	Oh, Yong-Seok/0000-0002-9039-2014; Ryu, Sung Ho/0000-0003-0913-3048	Daegu Gyeongbuk Institute of Science & Technology (DGIST) MIREBraiN program [14-01-HRLA-01]; Daegu Gyeongbuk Institute of Science & Technology (DGIST) RD program [15-BD-0402]; Basic Science Research Program through the ministry of science, ICT & future planning of Korea [2015010015, 2014R1A1A1003159]; National Research Foundation of Korea (NRF) grant - Korean government (MSIP) [2010-0028684]	Daegu Gyeongbuk Institute of Science & Technology (DGIST) MIREBraiN program; Daegu Gyeongbuk Institute of Science & Technology (DGIST) RD program; Basic Science Research Program through the ministry of science, ICT & future planning of Korea; National Research Foundation of Korea (NRF) grant - Korean government (MSIP)	This work was supported by Daegu Gyeongbuk Institute of Science & Technology (DGIST) MIREBraiN program (14-01-HRLA-01), R&D program (15-BD-0402) to YSO, Basic Science Research Program through the ministry of science, ICT & future planning of Korea (2015010015, 2014R1A1A1003159) to YSO. In addition, the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (No. 2010-0028684) to PGS has supported this work.	Ader I, 2009, CANCER RES, V69, P3723, DOI 10.1158/0008-5472.CAN-09-0389; Alemany R, 1999, J BIOL CHEM, V274, P3994, DOI 10.1074/jbc.274.7.3994; Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Ancellin N, 2002, J BIOL CHEM, V277, P6667, DOI 10.1074/jbc.M102841200; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Buehrer BM, 1996, BBA-LIPID LIPID MET, V1303, P233, DOI 10.1016/0005-2760(96)00092-6; Choi OH, 1996, NATURE, V380, P634; DEKKER LV, 1994, TRENDS BIOCHEM SCI, V19, P73, DOI 10.1016/0968-0004(94)90038-8; Goel G, 2007, INT J TOXICOL, V26, P279, DOI 10.1080/10915810701464641; Hait NC, 2007, J BIOL CHEM, V282, P12058, DOI 10.1074/jbc.M609559200; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Heringdorf DMZ, 1998, EMBO J, V17, P2830, DOI 10.1093/emboj/17.10.2830; Jensen ON, 1996, ELECTROPHORESIS, V17, P938, DOI 10.1002/elps.1150170516; Jo SK, 2009, KIDNEY INT, V75, P167, DOI 10.1038/ki.2008.400; Karliner JS, 2013, BBA-MOL CELL BIOL L, V1831, P203, DOI 10.1016/j.bbalip.2012.06.006; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Lai WQ, 2009, J IMMUNOL, V183, P2097, DOI 10.4049/jimmunol.0804376; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Machwate M, 1998, MOL PHARMACOL, V54, P70, DOI 10.1124/mol.54.1.70; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Medkova M, 1998, J BIOL CHEM, V273, P17544, DOI 10.1074/jbc.273.28.17544; Melendez A, 1998, J BIOL CHEM, V273, P9393, DOI 10.1074/jbc.273.16.9393; Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005; Mochly-Rosen D, 2012, NAT REV DRUG DISCOV, V11, P937, DOI 10.1038/nrd3871; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; NIXON JS, 1991, DRUG EXP CLIN RES, V17, P389; OLIVERA A, 1993, NATURE, V365, P557, DOI 10.1038/365557a0; OLIVERA A, 1994, J BIOL CHEM, V269, P17924; Olivera A, 1999, FASEB J, V13, P1593, DOI 10.1096/fasebj.13.12.1593; OLIVERA A, 1994, ANAL BIOCHEM, V223, P306, DOI 10.1006/abio.1994.1589; Oskeritzian CA, 2008, BLOOD, V111, P4193, DOI 10.1182/blood-2007-09-115451; Pitson SM, 2000, BIOCHEM J, V350, P429, DOI 10.1042/0264-6021:3500429; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Pitson SM, 2011, TRENDS BIOCHEM SCI, V36, P97, DOI 10.1016/j.tibs.2010.08.001; Pyne Nigel J, 2012, Adv Biol Regul, V52, P31; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Pyne S, 1996, EUR J BIOCHEM, V237, P819, DOI 10.1111/j.1432-1033.1996.0819p.x; Rigogliuso S, 2010, J ONCOL, V2010, DOI 10.1155/2010/509329; Rius RA, 1997, FEBS LETT, V417, P173, DOI 10.1016/S0014-5793(97)01277-5; Shen HY, 2014, NAT CELL BIOL, V16, P652, DOI 10.1038/ncb2987; Shu XD, 2002, MOL CELL BIOL, V22, P7758, DOI 10.1128/MCB.22.22.7758-7768.2002; Spiegel S, 2007, J BIOL CHEM, V282, P2125, DOI 10.1074/jbc.R600028200; Taha TA, 2006, J BIOCHEM MOL BIOL, V39, P113; van Koppen CJ, 2001, LIFE SCI, V68, P2535, DOI 10.1016/S0024-3205(01)01049-9; Wadgaonkar R, 2009, AM J PHYSIOL-LUNG C, V296, pL603, DOI 10.1152/ajplung.90357.2008; Wang Z, 2013, STRUCTURE, V21, P798, DOI 10.1016/j.str.2013.02.025; Xia P, 1998, P NATL ACAD SCI USA, V95, P14196, DOI 10.1073/pnas.95.24.14196; Xia P, 1999, J BIOL CHEM, V274, P33143, DOI 10.1074/jbc.274.46.33143; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737	52	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0143695	10.1371/journal.pone.0143695	http://dx.doi.org/10.1371/journal.pone.0143695			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642194	Green Published, gold, Green Submitted			2022-12-27	WOS:000366902700027
J	Sokol, S; Portais, JC				Sokol, Serguei; Portais, Jean-Charles			Theoretical Basis for Dynamic Label Propagation in Stationary Metabolic Networks under Step and Periodic Inputs	PLOS ONE			English	Article							BIDIRECTIONAL REACTION STEPS; FLUX ANALYSIS; FRAMEWORK; PATHWAY	The dynamics of label propagation in a stationary metabolic network during an isotope labeling experiment can provide highly valuable information on the network topology, metabolic fluxes, and on the size of metabolite pools. However, major issues, both in the experimental set-up and in the accompanying numerical methods currently limit the application of this approach. Here, we propose a method to apply novel types of label inputs, sinusoidal or more generally periodic label inputs, to address both the practical and numerical challenges of dynamic labeling experiments. By considering a simple metabolic system, i.e. a linear, non-reversible pathway of arbitrary length, we develop mathematical descriptions of label propagation for both classical and novel label inputs. Theoretical developments and computer simulations show that the application of rectangular periodic pulses has both numerical and practical advantages over other approaches. We applied the strategy to estimate fluxes in a simulated experiment performed on a complex metabolic network ( the central carbon metabolism of Escherichia coli), to further demonstrate its value in conditions which are close to those in real experiments. This study provides a theoretical basis for the rational interpretation of label propagation curves in real experiments, and will help identify the strengths, pitfalls and limitations of such experiments. The cases described here can also be used as test cases for more general numerical methods aimed at identifying network topology, analyzing metabolic fluxes or measuring concentrations of metabolites.	[Sokol, Serguei; Portais, Jean-Charles] Univ Toulouse, LISBP, INSA, UPS,INP, Toulouse, France; [Sokol, Serguei; Portais, Jean-Charles] INRA, Lab Ingn Syst Biol & Proc, UMR792, F-31931 Toulouse, France; [Sokol, Serguei; Portais, Jean-Charles] CNRS, UMR5504, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse	Sokol, S (corresponding author), Univ Toulouse, LISBP, INSA, UPS,INP, Toulouse, France.	sokol@insa-toulouse.fr	Sokol, Serguei/Z-3029-2019	Sokol, Serguei/0000-0002-5674-3327; Portais, Jean-Charles/0000-0002-3480-0933	Agence Nationale de la Recherche ('METABOHUB' ANR-11-INBS-0010-01) Region Midi-Pyrenees; European Regional Development Fund; French Ministry for Higher Education and Research; SICOVAL; Institut National de la Recherche Agronomique; IBiSa	Agence Nationale de la Recherche ('METABOHUB' ANR-11-INBS-0010-01) Region Midi-Pyrenees(French National Research Agency (ANR)); European Regional Development Fund(European Commission); French Ministry for Higher Education and Research; SICOVAL; Institut National de la Recherche Agronomique; IBiSa	This work was supported by Agence Nationale de la Recherche ('METABOHUB' ANR-11-INBS-0010-01) Region Midi-Pyrenees, the European Regional Development Fund, the French Ministry for Higher Education and Research, the SICOVAL, the Institut National de la Recherche Agronomique, and IBiSa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniewicz MR, 2007, METAB ENG, V9, P68, DOI 10.1016/j.ymben.2006.09.001; Kajihata S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/627014; MARKUS M, 1985, ARCH BIOL MED EXP, V18, P261; Millard P, 2012, BIOINFORMATICS, V28, P1294, DOI 10.1093/bioinformatics/bts127; Mollney M, 1999, BIOTECHNOL BIOENG, V66, P86, DOI 10.1002/(SICI)1097-0290(1999)66:2<86::AID-BIT2>3.0.CO;2-A; Noack S, 2011, J BIOTECHNOL, V154, P179, DOI 10.1016/j.jbiotec.2010.07.008; Noh K, 2007, J BIOTECHNOL, V129, P249, DOI 10.1016/j.jbiotec.2006.11.015; Noh K, 2011, APPL MICROBIOL BIOT, V91, P1247, DOI 10.1007/s00253-011-3390-4; Peyraud R, 2009, P NATL ACAD SCI USA, V106, P4846, DOI 10.1073/pnas.0810932106; Schaub J, 2008, BIOTECHNOL BIOENG, V99, P1170, DOI 10.1002/bit.21675; Sokol S, 2012, BIOINFORMATICS, V28, P687, DOI 10.1093/bioinformatics/btr716; SUNDSTROM DW, 1976, BIOTECHNOL BIOENG, V18, P1, DOI 10.1002/bit.260180102; Tang YJ, 2009, MASS SPECTROM REV, V28, P362, DOI 10.1002/mas.20191; Weitzel M, 2013, BIOINFORMATICS, V29, P143, DOI 10.1093/bioinformatics/bts646; Wiechert W, 1999, BIOTECHNOL BIOENG, V66, P69; Wiechert W, 2005, ADV BIOCHEM ENG BIOT, V92, P145, DOI 10.1007/b98921; Wiechert W, 2001, METAB ENG, V3, P265, DOI 10.1006/mben.2001.0188; Wiechert W, 2001, MATH BIOSCI, V169, P173, DOI 10.1016/S0025-5564(00)00059-6; Wittmann C., 2013, METABOLOMICS PRACTIC, P285; Young JD, 2014, BIOINFORMATICS, V30, P1333, DOI 10.1093/bioinformatics/btu015; Young JD, 2011, METAB ENG, V13, P656, DOI 10.1016/j.ymben.2011.08.002; Zamboni N, 2009, NAT PROTOC, V4, P878, DOI 10.1038/nprot.2009.58; Zhao Z, 2008, METAB ENG, V10, P178, DOI 10.1016/j.ymben.2008.04.003	23	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144652	10.1371/journal.pone.0144652	http://dx.doi.org/10.1371/journal.pone.0144652			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641860	Green Published, gold, Green Submitted			2022-12-27	WOS:000366902700151
J	Liu, YM; Jia, LY; Liu, BB; Meng, XF; Yang, J; Li, JZ; Zhou, YH; Jiao, LQ; Hua, Y				Liu, Yumei; Jia, Lingyun; Liu, Beibei; Meng, Xiufeng; Yang, Jie; Li, Jingzhi; Zhou, Yinghua; Jiao, Liqun; Hua, Yang			Evaluation of Endarterectomy Recanalization under Ultrasound Guidance in Symptomatic Patients with Carotid Artery Occlusion	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; IMAGING-BASED SELECTION; PLASMINOGEN-ACTIVATOR; THROMBUS; THROMBOENDARTERECTOMY; THROMBOLYSIS	Rigorous screening and good imaging would help perform surgery on carotid artery occlusion CAO safely and effectively. The purpose of this study was to retrospectively evaluate carotid endarterectomy (CEA) recanalization in patients with common carotid artery occlusion (CCAO) or internal carotid artery occlusion (ICAO) with color Doppler flow imaging (CDFI). A total of 59 patients undergoing CEA were enrolled. According to the results of CEA, the patients were divided into successful recanalization (group A) and unsuccessful recanalization (group B) groups. The original diameter, lesion length, proximal-to-distal diameter ratio and echo characteristics of the lesion within the lumen of the carotid artery were recorded before CEA and compared between the two groups. In regards to the achievement of repatency by CEA, the overall success rate was 74.6% (44/59), the success rate in CCAO patients was 75.9% (22/29) and the success rate in ICAO patients was 73.3% (22/30). There was no significant difference in the success rates between the CCAO and ICAO patients (chi(2) = 0.050, P = 0.824). The overall rate of stroke and death within 30 postoperative days was 5.1% (3/59). For the CCAO patients, the lesion length in group A was shorter than that in group B (t = 3.221, P = 0.004). For the ICAO patients, the original diameter of the distal ICA was broader (t = 6.254, P = 0.000) and the proximal-to-distal ICA diameter ratio was smaller (t = 8.036, P = 0.000) in group A than in group B. The rate of recanalization for lumens with a homogeneous echo pattern (hypoecho or isoecho) was significantly higher than that for lumens with echo heterogeneity for both the CCAO and ICAO patients (chi(2) = 14.477, P = 0.001; chi(2) = 10.519, P = 0.003). However, for both the CCAO and ICAO patients, there was no difference in the rate of recanalization between patients with hypoecho and isoecho lesions (chi(2) = 0.109, P = 0.742; chi(2) = 0.836, P = 0.429). The original diameter, proximal-to-distal ICA diameter ratio, lesion length and echo characteristics may affect the success of CEA recanalization in patients with CCAO and ICAO. CDFI is helpful in screening patients with carotid artery occlusion and may improve the success rate of CEA.	[Liu, Yumei; Jia, Lingyun; Liu, Beibei; Meng, Xiufeng; Yang, Jie; Li, Jingzhi; Zhou, Yinghua; Hua, Yang] Capital Med Univ, Xuanwu Hosp, Dept Vasc Ultrasonog, Beijing, Peoples R China; [Jiao, Liqun] Capital Med Univ, Xuanwu Hosp, Dept Neurosurg, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Hua, Y (corresponding author), Capital Med Univ, Xuanwu Hosp, Dept Vasc Ultrasonog, Beijing, Peoples R China.	dryanghua99@163.com	hua, yang/GSE-0594-2022; Jiao, Liqun/T-5944-2017; Jiao, Liqun/AAF-9351-2020	Liu, Yumei/0000-0001-8372-0537				ARCHIE JP, 1994, J VASC SURG, V19, P23, DOI 10.1016/S0741-5214(94)70117-2; Brott TG, 2011, CIRCULATION, V124, pE54, DOI [10.1161/CIR.0b013e31820d8c98, 10.1161/CIR.0b0113e31820d8c98]; Bryan DS, 2013, ANN VASC SURG, V27, P186, DOI 10.1016/j.avsg.2012.03.010; Demchuk AM, 2012, ANN NY ACAD SCI, V1268, P63, DOI 10.1111/j.1749-6632.2012.06732.x; Duijsens HM, 2015, J NEUROINTERV SURG, V7, P709, DOI 10.1136/neurintsurg-2014-011297; Furie B, 2008, NEW ENGL J MED, V359, P938, DOI 10.1056/NEJMra0801082; HUGENHOLTZ H, 1980, J NEUROSURG, V53, P776, DOI 10.3171/jns.1980.53.6.0776; Kappelhof M, 2015, J NEUROINTERV SURG, V7, P8, DOI 10.1136/neurintsurg-2013-011004; Kirchhof K, 2004, ROFO-FORTSCHR RONTG, V176, P98; Kniemeyer HW, 2007, CHIRURG, V78, P236, DOI 10.1007/s00104-006-1287-z; Kwak HS, 2013, AM J NEURORADIOL, V34, P841, DOI 10.3174/ajnr.A3304; Lee Tsong-Hai, 1992, Journal of the Formosan Medical Association, V91, P575; Li Q, 2015, J STROKE CEREBROVASC, V24, P1591, DOI 10.1016/j.jstrokecerebrovasdis.2015.03.028; Liebeskind DS, 2011, STROKE, V42, P1237, DOI 10.1161/STROKEAHA.110.605576; Marder VJ, 2006, STROKE, V37, P2086, DOI 10.1161/01.STR.0000230307.03438.94; Marquering HA, 2013, CLIN NEUROL NEUROSUR, V115, P1591, DOI 10.1016/j.clineuro.2013.02.008; Mazur S H, 2012, Klin Khir, P20; MEYER FB, 1986, ANN SURG, V203, P82, DOI 10.1097/00000658-198601000-00014; Morais LT, 2013, J NEUROINTERV SURG, V5, P13, DOI 10.1136/neurintsurg-2013-010733; Morgenstern LB, 1997, NEUROLOGY, V48, P911, DOI 10.1212/WNL.48.4.911; Nielubowiczowa H, 1982, Neurol Neurochir Pol, V16, P153; Puig J, 2012, AM J NEURORADIOL, V33, P90, DOI 10.3174/ajnr.A2878; Riedel CH, 2010, STROKE, V41, P1659, DOI 10.1161/STROKEAHA.110.580662; SHUCART WA, 1976, J NEUROSURG, V45, P442, DOI 10.3171/jns.1976.45.4.0442; Weis-Muller BT, 2013, ANN VASC SURG, V27, P424, DOI 10.1016/j.avsg.2012.05.023	25	3	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144381	10.1371/journal.pone.0144381	http://dx.doi.org/10.1371/journal.pone.0144381			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636827	Green Published, Green Submitted, gold			2022-12-27	WOS:000366143800083
J	Tay, SH; Ho, CS; Ho, RCM; Mak, A				Tay, Sen Hee; Ho, Chung Shun; Ho, Roger Chun-Man; Mak, Anselm			25-Hydroxyvitamin D-3 Deficiency Independently Predicts Cognitive Impairment in Patients with Systemic Lupus Erythematosus	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; DISEASE-ACTIVITY; CHINESE PATIENTS; D-RECEPTOR; DYSFUNCTION; ABNORMALITIES; PATHOGENESIS; VALIDATION; DEMENTIA; CRITERIA	Objectives Cognitive dysfunction has been reported in 20-80% of SLE patients. Converging evidence has indicated the importance of vitamin D as a neuroimmunomodulator for cognitive function. In this study, we evaluated the relationship between vitamin D and cognitive dysfunction. Methods Consecutive age-and gender-matched SLE patients and healthy controls (HCs) were administered Automated Neuropsychological Assessment Metrics in this cross-sectional study. The primary outcome was the total throughput score (TTS). Anxiety and depression were measured using the Hospital Anxiety and Depression Scale (HADS). Levels of 25hydroxyvitamin D [25(OH)D-3 and total 25(OH)D] were measured using Liquid Chromatography-Tandem Mass Spectrometry. Results In total, 61 SLE patients and 61 HCs were studied. SLE patients scored significantly lower than HCs in the TTS (p = 0.004). There were no statistically significant differences in 25 (OH)D-3 levels, total 25(OH)D levels and total 25(OH) D deficiency between SLE patients and HCs. However, more SLE patients had 25(OH)D-3 deficiency compared to HCs [12 (19.7%) versus 2 (3.3%), p = 0.003]. Deficiency of 25(OH)D-3 (beta = -63.667, SE = 27.456, p = 0.025), but not other vitamin D variables, independently predicted worse TTS after adjusting for age, education, gender, ethnicity, HADS-Total, duration of SLE, SELENA-SLEDAI, SLICC/ACR Damage Index and cumulative steroid dose in SLE patients. Age (beta = -4.261, SE = 0.866, p < 0.001) was the only predictor of TTS after adjusting for education, gender, ethnicity, HADS-Total, vitamin D levels or status in HCs. Conclusions Deficiency of 25(OH)D-3, a potentially modifiable risk factor, independently predicted cognitive impairment in SLE patients.	[Tay, Sen Hee; Mak, Anselm] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore; [Tay, Sen Hee; Mak, Anselm] Natl Univ Hlth Syst, Natl Univ Hosp, Dept Med, Div Rheumatol, Singapore, Singapore; [Ho, Chung Shun] Chinese Univ Hong Kong, Dept Chem Pathol, Biomed Mass Spectrometry Unit, Prince Wales Hosp, Hong Kong, Hong Kong, Peoples R China; [Ho, Roger Chun-Man] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Psychol Med, Singapore 117595, Singapore	National University of Singapore; National University of Singapore; Chinese University of Hong Kong; Prince of Wales Hospital; National University of Singapore	Tay, SH (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore.	sen_hee_tay@nuhs.edu.sg	Ho, Roger C./ABD-9061-2021; Ho, Roger/ABD-8859-2021	Ho, Roger C./0000-0001-9629-4493; Tay, Sen Hee/0000-0002-7907-5288				Amital H, 2010, ANN RHEUM DIS, V69, P1155, DOI 10.1136/ard.2009.120329; Annweiler C, 2014, EUR J NEUROL, V21, P1436, DOI 10.1111/ene.12511; Annweiler C, 2009, EUR J NEUROL, V16, P1083, DOI 10.1111/j.1468-1331.2009.02755.x; Annweiler C, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-230; Annweiler C, 2010, NEUROPSYCHOBIOLOGY, V62, P139, DOI 10.1159/000318570; Antonchak MA, 2011, J RHEUMATOL, V38, P1020, DOI 10.3899/jrheum.100560; Aranow C, 2015, ARTHRITIS RHEUMATOL, V67, P1848, DOI 10.1002/art.39108; Balion C, 2012, NEUROLOGY, V79, P1397, DOI 10.1212/WNL.0b013e31826c197f; Brunner HI, 2013, ARTHRIT CARE RES, V65, P372, DOI 10.1002/acr.21835; Buell JS, 2009, J GERONTOL A-BIOL, V64, P888, DOI 10.1093/gerona/glp032; Buell JS, 2008, MOL ASPECTS MED, V29, P415, DOI 10.1016/j.mam.2008.05.001; Burne THJ, 2004, BEHAV BRAIN RES, V154, P549, DOI 10.1016/j.bbr.2004.03.023; Etgen T, 2012, DEMENT GERIATR COGN, V33, P297, DOI 10.1159/000339702; Eyles DW, 2005, J CHEM NEUROANAT, V29, P21, DOI 10.1016/j.jchemneu.2004.08.006; Gauzzi MC, 2005, J IMMUNOL, V174, P270, DOI 10.4049/jimmunol.174.1.270; Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303; Hanly JG, 2015, ARTHRITIS RHEUMATOL, V67, P1837, DOI 10.1002/art.39111; Hanly JG, 2014, NAT REV RHEUMATOL, V10, P338, DOI 10.1038/nrrheum.2014.15; Hanly JG, 2012, J RHEUMATOL, V39, P1371, DOI 10.3899/jrheum.111504; Hanly JG, 2010, ARTHRITIS RHEUM-US, V62, P1478, DOI 10.1002/art.27404; Haroon M, 2012, CLIN RHEUMATOL, V31, P199, DOI 10.1007/s10067-011-1880-5; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Holliday SL, 2003, LUPUS, V12, P697, DOI 10.1191/0961203303lu442oa; Houghton LA, 2006, AM J CLIN NUTR, V84, P694, DOI 10.1093/ajcn/84.4.694; Jeltsch-David H, 2014, NAT REV NEUROL, V10, P579, DOI 10.1038/nrneurol.2014.148; Johansson P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081989; Kozora E, 2008, ARTHRITIS RHEUM-US, V58, P3286, DOI 10.1002/art.23991; Liang MH, 1999, ARTHRITIS RHEUM-US, V42, P599; Linker-Israeli M, 2001, CLIN IMMUNOL, V99, P82, DOI 10.1006/clim.2000.4998; McGrath J, 2001, TRENDS NEUROSCI, V24, P570, DOI 10.1016/S0166-2236(00)01949-4; Meng JE, 2012, CANCER EPIDEM BIOMAR, V21, P916, DOI 10.1158/1055-9965.EPI-12-0026; Mikdashi J, 2007, LUPUS, V16, P418, DOI 10.1177/0961203307079044; Mok CC, 2012, LUPUS, V21, P36, DOI 10.1177/0961203311422094; Mok CC, 2012, RHEUMATOLOGY, V51, P644, DOI 10.1093/rheumatology/ker212; Ong L, 2012, CLIN CHIM ACTA, V413, P1127, DOI 10.1016/j.cca.2012.03.009; Panopalis P, 2007, ARTHRIT RHEUM-ARTHR, V57, P1453, DOI 10.1002/art.23090; PARDRIDGE WM, 1985, J NEUROCHEM, V44, P1138, DOI 10.1111/j.1471-4159.1985.tb08735.x; Petri M, 2005, NEW ENGL J MED, V353, P2550, DOI 10.1056/NEJMoa051135; Petri M, 2008, J RHEUMATOL, V35, P1776; Petri M, 2013, ARTHRITIS RHEUM-US, V65, P1865, DOI 10.1002/art.37953; Przybelski R, 2008, OSTEOPOROSIS INT, V19, P1621, DOI 10.1007/s00198-008-0619-x; Ramage AE, 2011, ARTHRITIS RHEUM-US, V63, P3048, DOI 10.1002/art.30458; Ramagopalan SV, 2010, GENOME RES, V20, P1352, DOI 10.1101/gr.107920.110; Ritterhouse LL, 2011, ANN RHEUM DIS, V70, P1569, DOI 10.1136/ard.2010.148494; Robien K, 2013, BRIT J NUTR, V109, P493, DOI 10.1017/S0007114512001675; Robinson AB, 2012, J PEDIATR-US, V160, P297, DOI 10.1016/j.jpeds.2011.08.011; Roebuck-Spencer TM, 2006, ARTHRIT RHEUM-ARTHR, V55, P434, DOI 10.1002/art.21992; Ross AC, 2011, DIETARY REFERENCE INTAKES FOR CALCIUM AND VITAMIN D, P35; Sarbu N, 2015, AUTOIMMUN REV, V14, P153, DOI 10.1016/j.autrev.2014.11.001; Stewart A, 2010, BEHAV PHARMACOL, V21, P420, DOI 10.1097/FBP.0b013e32833c850f; Tam LS, 2008, J RHEUMATOL, V35, P1038; Tay SH, 2015, LUPUS, V24, P1392, DOI 10.1177/0961203315591026; Tay SH, 2015, INT J MOL SCI, V16, P10281, DOI 10.3390/ijms160510281; Yap KS, 2015, INT J RHEUM DIS, V18, P242, DOI 10.1111/1756-185X.12489	54	18	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144149	10.1371/journal.pone.0144149	http://dx.doi.org/10.1371/journal.pone.0144149			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636681	Green Published, Green Submitted, gold			2022-12-27	WOS:000366143800047
J	Zhong, R; Liu, H; Wang, H; Li, XJ; He, Z; Gangla, MD; Zhang, JD; Han, DD; Liu, JX				Zhong, Rui; Liu, Hua; Wang, Hong; Li, Xiaojuan; He, Zeng; Gangla, Meiduo; Zhang, Jingdan; Han, Dingding; Liu, Jiaxin			Adaption to High Altitude: An Evaluation of the Storage Quality of Suspended Red Blood Cells Prepared from the Whole Blood of Tibetan Plateau Migrants	PLOS ONE			English	Article							HEMOGLOBIN; OXYGEN; TRANSFUSION; ADAPTATION; SURVIVAL; AFFINITY; SHAPE	Hypoxia has been reported to cause the significant enhancement of hemoglobin (Hb) and hematocrit (Hct), which stabilizes at relatively high levels after an individual ascends to a high altitude. However, the quality of the suspended red blood cells (SRBCs) obtained from individuals at high altitudes such as Tibetan plateau migrants after storage has not been studied. In this study, we compared the storage quality of SRBCs prepared from Tibetan plateau and Deyang lowland populations by adding a normal volume of mannitol-adenine-phosphate (MAP), which is a common additive solution used in blood storage in Asian countries. The storage cell characteristics were examined on days1, 7, 14 and 35. We found higher Hct and Hb levels and viscosity in the high altitude samples. The metabolic rates, including those for electrolytes and lactate, were higher in plateau SRBCs than in lowland SRBCs; these findings were consistent with the higher osmotic fragility and hemolysis of plateau SRBCs throughout the entire storage period. In addition, the reduction rates of 2,3-diphosphoglycerate (2,3-DPG) and oxygen tension to attain 50% oxygen saturation of Hb (P50) in plateau SRBCs were higher than those in lowland SRBCs, and the oxygen delivering capacity in plateau SRBCs was weaker than that in lowland SRBCs. We concluded that the storage quality of plateau SRBCs was inferior to that of lowland SRBCs when using the same concentration of MAP. We suggested that the optimal formula, including the MAP concentration or even a new additive solution, to store the plateau SRBCs must be assessed and regulated.	[Zhong, Rui; Wang, Hong; He, Zeng; Zhang, Jingdan; Han, Dingding; Liu, Jiaxin] Chinese Acad Med Sci, Inst Blood Transfus, Chengdu, Sichuan, Peoples R China; [Zhong, Rui; Wang, Hong; He, Zeng; Zhang, Jingdan; Han, Dingding; Liu, Jiaxin] Peking Union Med Coll, Chengdu, Sichuan, Peoples R China; [Liu, Hua; Li, Xiaojuan; Gangla, Meiduo] Tibet Autonomous Reg Blood Ctr, Lhasa, Tibet, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Blood Transfusion - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Liu, JX (corresponding author), Chinese Acad Med Sci, Inst Blood Transfus, Chengdu, Sichuan, Peoples R China.	jxliu8122@vip.sina.com			National Natural Science Fundation of China [51403238]	National Natural Science Fundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Fundation of China, grant number: 51403238, URL: http://www.nsfc.gov.cn/.	[Anonymous], 2013, PLOS ONE, V8, P1; Aste-Salazar H, 1944, AM J PHYSIOL, V142, P0733, DOI 10.1152/ajplegacy.1944.142.5.733; Baskurt OK, 2003, SEMIN THROMB HEMOST, V29, P435; Berezina TL, 2002, J SURG RES, V102, P6, DOI 10.1006/jsre.2001.6306; BEUTLER E, 1979, BLOOD, V54, P1; Blasi B, 2012, TRANSFUSION MED, V22, P90, DOI 10.1111/j.1365-3148.2012.01139.x; Boas Franz, 1912, CHANGES BODILY FORM; BRECHER G, 1972, BLOOD-J HEMATOL, V40, P333, DOI 10.1182/blood.V40.3.333.333; GREULICH WW, 1957, AM J PHYS ANTHROPOL, V15, P489, DOI 10.1002/ajpa.1330150403; HEBBEL RP, 1978, J CLIN INVEST, V62, P593, DOI 10.1172/JCI109165; Hess JR, 2006, VOX SANG, V91, P13, DOI 10.1111/j.1423-0410.2006.00778.x; Hess JR, 2002, TRANSFUS MED REV, V16, P283, DOI 10.1053/tmrv.2002.35212; Hogman CF, 1999, TRANSFUS MED REV, V13, P275, DOI 10.1016/S0887-7963(99)80058-3; Hogman CF, 1998, VOX SANG, V74, P177; Hovav T, 1999, TRANSFUSION, V39, P277, DOI 10.1046/j.1537-2995.1999.39399219284.x; HUANG SY, 1984, HIGH ALTITUDE MAN, P173; HULSE FREDERICK S., 1960, HUMAN BIOL, V32, P63; HURTADO ALBERTO, 1964, HANDBOOK PHYSIOL, V4, P843; Korte D, 2008, TRANSFUSION, V48, P1081, DOI [10.1111/j.1537-2995.2008.01689.x, DOI 10.1111/J.1537-2995.2008.01689.X]; LENFANT C, 1971, NEW ENGL J MED, V284, P1298, DOI 10.1056/NEJM197106102842305; LENFANT C, 1968, J CLIN INVEST, V47, P2652, DOI 10.1172/JCI105948; MERINO CF, 1950, BLOOD, V5, P1; Niinisto K, 2008, VET J, V176, P227, DOI 10.1016/j.tvjl.2007.02.015; REINHART WH, 1992, EUR J CLIN INVEST, V22, P38, DOI 10.1111/j.1365-2362.1992.tb01933.x; REYNAFARJE C, 1964, P SOC EXP BIOL MED, V116, P649; Rui Z, 2014, J CHINESE TRANSFUSIO, V27, P702; Sollberger T, 2002, VOX SANG, V82, P191, DOI 10.1046/j.1423-0410.2002.00167.x; Sowemimo-Coker SO, 2002, TRANSFUS MED REV, V16, P46, DOI 10.1053/tmrv.2002.29404; Sullivan MT, 2007, TRANSFUSION, V47, P385, DOI 10.1111/j.1537-2995.2007.01128.x; Tianyi W, 2006, HIGH ALT MED BIOL, V7, P193; Tianyi W, 2005, J APPL PHYSIOL, V98, P598; Veale MF, 2011, TRANSFUSION, V51, p25S, DOI 10.1111/j.1537-2995.2010.02960.x; WINSLOW RM, 1989, J APPL PHYSIOL, V66, P1561, DOI 10.1152/jappl.1989.66.4.1561; Zehnder L, 2008, VOX SANG, V95, P280, DOI 10.1111/j.1423-0410.2008.01097.x; ZUCK TF, 1977, TRANSFUSION, V17, P374, DOI 10.1046/j.1537-2995.1977.17477216866.x	35	18	18	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144201	10.1371/journal.pone.0144201	http://dx.doi.org/10.1371/journal.pone.0144201			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26637115	gold, Green Published, Green Submitted			2022-12-27	WOS:000366143800057
J	Albuquerque, CP; Yeung, E; Ma, S; Fu, T; Corbett, KD; Zhou, HL				Albuquerque, Claudio P.; Yeung, Eyan; Ma, Shawn; Fu, Ting; Corbett, Kevin D.; Zhou, Huilin			A Chemical and Enzymatic Approach to Study Site-Specific Sumoylation	PLOS ONE			English	Article							PROTEIN SUMOYLATION; CONJUGATING ENZYME; SUMO CONJUGATION; DNA-REPAIR; UBIQUITIN; UBC9; IDENTIFICATION; CONTRIBUTES; ATTACHMENT; INSIGHTS	A variety of cellular pathways are regulated by protein modifications with ubiquitin-family proteins. SUMO, the Small Ubiquitin-like MOdifier, is covalently attached to lysine on target proteins via a cascade reaction catalyzed by E1, E2, and E3 enzymes. A major barrier to understanding the diverse regulatory roles of SUMO has been a lack of suitable methods to identify protein sumoylation sites. Here we developed a mass-spectrometry (MS) based approach combining chemical and enzymatic modifications to identify sumoylation sites. We applied this method to analyze the auto-sumoylation of the E1 enzyme in vitro and compared it to the GG-remnant method using Smt3-I96R as a substrate. We further examined the effect of smt3-I96R mutation in vivo and performed a proteome-wide analysis of protein sumoylation sites in Saccharomyces cerevisiae. To validate these findings, we confirmed several sumoylation sites of Aos1 and Uba2 in vivo. Together, these results demonstrate that our chemical and enzymatic method for identifying protein sumoylation sites provides a useful tool and that a combination of methods allows a detailed analysis of protein sumoylation sites.	[Albuquerque, Claudio P.; Yeung, Eyan; Ma, Shawn; Fu, Ting; Corbett, Kevin D.; Zhou, Huilin] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Corbett, Kevin D.; Zhou, Huilin] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Zhou, Huilin] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Zhou, HL (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.	huzhou@ucsd.edu		Corbett, Kevin/0000-0001-5854-2388; Fu, Ting/0000-0003-0936-732X; Ma, Shawn/0000-0002-6286-1194; Zhou, Huilin/0000-0002-1350-4430	Ludwig Institute for Cancer Research [GM116897, GM104141]; Sidney Kimmel Foundation Kimmel Scholars Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM116897, R01GM104141] Funding Source: NIH RePORTER	Ludwig Institute for Cancer Research; Sidney Kimmel Foundation Kimmel Scholars Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	HZ is supported by the Ludwig Institute for Cancer Research and GM116897. KDC acknowledges support from the Ludwig Institute for Cancer Research, GM104141 and the Sidney Kimmel Foundation Kimmel Scholars Program.	Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Albuquerque CP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003670; Bachant J, 2002, MOL CELL, V9, P1169, DOI 10.1016/S1097-2765(02)00543-9; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Chicooree N, 2013, RAPID COMMUN MASS SP, V27, P2108, DOI 10.1002/rcm.6670; Chicooree N, 2013, RAPID COMMUN MASS SP, V27, P127, DOI 10.1002/rcm.6425; Cremona CA, 2012, MOL CELL, V45, P422, DOI 10.1016/j.molcel.2011.11.028; Denison C, 2005, MOL CELL PROTEOMICS, V4, P246, DOI 10.1074/mcp.M400154-MCP200; Felberbaum R, 2012, MOL CELL BIOL, V32, P64, DOI 10.1128/MCB.05878-11; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Hang LE, 2014, J BIOL CHEM, V289, P10308, DOI 10.1074/jbc.M113.526178; Hang LE, 2011, NAT STRUCT MOL BIOL, V18, P920, DOI 10.1038/nsmb.2100; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Hardeland U, 2002, EMBO J, V21, P1456, DOI 10.1093/emboj/21.6.1456; Ho CW, 2011, J BIOL CHEM, V286, P21826, DOI 10.1074/jbc.M111.234914; Hochstrasser M, 2000, SCIENCE, V289, P563, DOI 10.1126/science.289.5479.563; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Johnson ES, 1997, J BIOL CHEM, V272, P26799, DOI 10.1074/jbc.272.43.26799; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Truong K, 2012, J BIOL CHEM, V287, P42611, DOI 10.1074/jbc.M112.420877; Truong K, 2012, J BIOL CHEM, V287, P15154, DOI 10.1074/jbc.M112.353789; Klug H, 2013, MOL CELL, V50, P625, DOI 10.1016/j.molcel.2013.03.027; Knipscheer P, 2008, MOL CELL, V31, P371, DOI 10.1016/j.molcel.2008.05.022; Li SJ, 2000, MOL CELL BIOL, V20, P2367, DOI 10.1128/MCB.20.7.2367-2377.2000; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Lin DH, 2002, J BIOL CHEM, V277, P21740, DOI 10.1074/jbc.M108418200; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; Matic I, 2010, MOL CELL, V39, P641, DOI 10.1016/j.molcel.2010.07.026; Montpetit B, 2006, J CELL BIOL, V174, P653, DOI 10.1083/jcb.200605019; Olsen SK, 2010, NATURE, V463, P906, DOI 10.1038/nature08765; Panse VG, 2004, J BIOL CHEM, V279, P41346, DOI 10.1074/jbc.M407950200; Psakhye I, 2012, CELL, V151, P807, DOI 10.1016/j.cell.2012.10.021; Putnam C. D., 2010, COLD SPRING HARB PRO, V2010; Reindle A, 2006, J CELL SCI, V119, P4749, DOI 10.1242/jcs.03243; Rosonina E, 2012, GENE DEV, V26, P350, DOI 10.1101/gad.184689.111; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Sarangi P, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004899; Sarangi P, 2014, CELL REP, V9, P143, DOI 10.1016/j.celrep.2014.08.054; Sterner DE, 2006, BIOCHEMISTRY-US, V45, P1035, DOI 10.1021/bi051624q; Tammsalu T, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005146; Vigasova D, 2013, NUCLEIC ACIDS RES, V41, P5341, DOI 10.1093/nar/gkt236; Wang JG, 2010, 2010 INTERNATIONAL CONFERENCE ON INFORMATION, ELECTRONIC AND COMPUTER SCIENCE, VOLS 1-3, P5; Wang YB, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000253; Wang YQ, 2006, J BIOL CHEM, V281, P1964, DOI 10.1074/jbc.M508985200; Wohlschlegel JA, 2006, J PROTEOME RES, V5, P761, DOI 10.1021/pr050451o; Wohlschlegel JA, 2004, J BIOL CHEM, V279, P45662, DOI 10.1074/jbc.M409203200; Yunus Ali A., 2009, V497, P167, DOI 10.1007/978-1-59745-566-4_11; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102; Zhou WD, 2004, J BIOL CHEM, V279, P32262, DOI 10.1074/jbc.M404173200	52	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143810	10.1371/journal.pone.0143810	http://dx.doi.org/10.1371/journal.pone.0143810			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633173	Green Published, Green Submitted, gold			2022-12-27	WOS:000366040000023
J	Dehnhard, M; Kumar, V; Chandrasekhar, M; Jewgenow, K; Umapathy, G				Dehnhard, Martin; Kumar, Vinod; Chandrasekhar, Mithileshwari; Jewgenow, Katarina; Umapathy, Govindhaswamy			Non-Invasive Pregnancy Diagnosis in Big Cats using the PGFM (13,14-dihydro-15-keto-PGF(2 alpha)) Assay	PLOS ONE			English	Article							OVARIAN ACTIVITY; REPRODUCTIVE STATUS; ENZYME-IMMUNOASSAY; NONDOMESTIC FELIDS; METABOLISM; URINARY; RELAXIN; WILD; RADIOIMMUNOASSAY; PROGESTERONE	Non-invasive monitoring of hormones using feces has become a vital tool for reproductive management and reliable pregnancy diagnosis in big cats. Previous studies described the PGF(2 alpha) metabolite (PGFM) as an indicator of pregnancy in various feline species. The present study aimed to standardize pregnancy detection in big cats like the tiger (Panthera tigris), jaguar (Panthera onca) and lion (Panthera leo) using fecal samples. High-performance liquid chromatography (HPLC) and liquid chromatography-mass spectrometry (LCMS) were performed to identify PGFM in feces. An EIA developed against 9 alpha, 11 alpha-dihydroxy-15-oxo-prost-5-en-1-oic acid-BSA was used to assay PGFM in fecal samples of the Bengal tiger, Asiatic lion and jaguar. The PGFM levels increased after 9 weeks of pregnancy and remained elevated until parturition. All animals showed elevated levels of PGFM in the last trimester of pregnancy, thus making PGFM a reliable tool for pregnancy diagnosis during this period that can be useful in captive breeding programs in these species.	[Dehnhard, Martin; Jewgenow, Katarina] Leibniz Inst Zoo & Wildlife Res IZW, Dept Reprod Biol, D-10315 Berlin, Germany; [Kumar, Vinod; Chandrasekhar, Mithileshwari; Umapathy, Govindhaswamy] Ctr Cellular & Mol Biol, CSIR Lab Conservat Endangered Species, Hyderabad 500007, Andhra Pradesh, India	Leibniz Institut fur Zoo und Wildtierforschung; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Umapathy, G (corresponding author), Ctr Cellular & Mol Biol, CSIR Lab Conservat Endangered Species, Uppal Rd, Hyderabad 500007, Andhra Pradesh, India.	guma@ccmb.res.in		Kumar, Vinod/0000-0002-1409-770X; Jewgenow, Katarina/0000-0002-6173-840X; Umapathy, Govindhaswamy/0000-0003-4086-7445	Department of Science and Technology; Central Zoo Authority of India, Government of India	Department of Science and Technology(Department of Science & Technology (India)); Central Zoo Authority of India, Government of India	This study was funded by the Department of Science and Technology and Central Zoo Authority of India, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by the Department of Science and Technology and Central Zoo Authority of India, Government of India. We thank the chief wildlife warden of Andhra Pradesh Government and the curator of Nehru Zoological Park, Hyderabad for granting permission for sample collection. Manuscript editing was performed by Barry Bavister.	Baan M, 2008, THERIOGENOLOGY, V69, P399, DOI 10.1016/j.theriogenology.2007.10.008; BARONE MA, 1994, J REPROD FERTIL, V101, P103, DOI 10.1530/jrf.0.1010103; Basu S, 1998, FEBS LETT, V428, P32, DOI 10.1016/S0014-5793(98)00481-5; Bergfelt DR, 2014, THERIOGENOLOGY, V82, P1187, DOI 10.1016/j.theriogenology.2014.07.030; Braun BC, 2009, THERIOGENOLOGY, V71, P754, DOI 10.1016/j.theriogenology.2008.09.054; Brown JL, 2006, THERIOGENOLOGY, V66, P25, DOI 10.1016/j.theriogenology.2006.03.011; Brown JL, 2011, ANIM REPROD SCI, V124, P155, DOI 10.1016/j.anireprosci.2010.08.024; BROWN JL, 1994, BIOL REPROD, V51, P776, DOI 10.1095/biolreprod51.4.776; DASHMAN T, 1987, PROSTAGLANDINS, V33, P419, DOI 10.1016/0090-6980(87)90023-2; Dehnhard M, 2008, REPROD DOMEST ANIM, V43, P74, DOI 10.1111/j.1439-0531.2008.01145.x; Dehnhard M, 2014, THERIOGENOLOGY, V81, P733, DOI 10.1016/j.theriogenology.2013.12.007; Dehnhard M, 2012, THERIOGENOLOGY, V77, P1088, DOI 10.1016/j.theriogenology.2011.10.011; Dehnhard M, 2003, J STEROID BIOCHEM, V84, P383, DOI 10.1016/S0960-0760(03)00056-6; DIMOV V, 1990, DRUG METAB DISPOS, V18, P107; Fanson KV, 2010, GEN COMP ENDOCR, V169, P217, DOI 10.1016/j.ygcen.2010.09.003; Finkenwirth C, 2010, THERIOGENOLOGY, V73, P530, DOI 10.1016/j.theriogenology.2009.10.008; Ginther OJ, 2007, BIOL REPROD, V76, P506, DOI 10.1095/biolreprod.106.057653; Graham LH, 2006, GEN COMP ENDOCR, V147, P362, DOI 10.1016/j.ygcen.2006.02.008; Harris LA, 2008, J ZOO WILDLIFE MED, V39, P170, DOI 10.1638/2007-0093R.1; Kumar V, 2014, GEN COMP ENDOCR, V201, P37, DOI 10.1016/j.ygcen.2014.03.024; LASLEY BL, 1991, J ZOO WILDLIFE MED, V22, P23; Lawson DM., 1985, HDB PHARM METHODOLOG, P385; Lee J, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100438; Li HW, 1999, P NATL ACAD SCI USA, V96, P13381, DOI 10.1073/pnas.96.23.13381; Luz MR, 2006, THERIOGENOLOGY, V66, P1436, DOI 10.1016/j.theriogenology.2006.01.036; McCracken JA, 1999, PHYSIOL REV, V79, P263, DOI 10.1152/physrev.1999.79.2.263; MUNRO CJ, 1991, CLIN CHEM, V37, P838; Palme R, 1996, ANIM REPROD SCI, V43, P43, DOI 10.1016/0378-4320(95)01458-6; PIPER PJ, 1970, NATURE, V225, P600, DOI 10.1038/225600a0; RAMESHA CS, 1985, PROSTAGLANDINS, V29, P991, DOI 10.1016/0090-6980(85)90223-0; Roberts LJ, 1996, J BIOL CHEM, V271, P20617, DOI 10.1074/jbc.271.34.20617; SCHLEGEL W, 1982, ACTA ENDOCRINOL-COP, V100, P98, DOI 10.1530/acta.0.1000098; SCHRICK FN, 1993, BIOL REPROD, V49, P617, DOI 10.1095/biolreprod49.3.617; Schwarzenberger F., 2007, International Zoo Yearbook, V41, P52, DOI 10.1111/j.1748-1090.2007.00017.x; Schwarzenberger F, 1996, ANIM REPROD SCI, V42, P515, DOI 10.1016/0378-4320(96)01561-8; Steinetz B, 2009, ANN NY ACAD SCI, V1160, P179, DOI 10.1111/j.1749-6632.2008.03824.x; SVANBORG K, 1972, EUR J BIOCHEM, V28, P127, DOI 10.1111/j.1432-1033.1972.tb01893.x; Swanson WF, 2004, ANIM REPROD SCI, V82-3, P21, DOI 10.1016/j.anireprosci.2004.05.008; Touma C, 2005, ANN NY ACAD SCI, V1046, P54, DOI 10.1196/annals.1343.006; Umapathy G, 2013, GEN COMP ENDOCR, V180, P33, DOI 10.1016/j.ygcen.2012.10.009; van Dorsser FJD, 2006, BIOL REPROD, V74, P1090, DOI [10.1095/biolreprd.105.050146, 10.1095/biolreprod.105.050146]; VELEZ JS, 1993, THERIOGENOLOGY, V39, P1377, DOI 10.1016/0093-691X(93)90239-2; Verstegen J, 1992, J REPROD FERTIL S, V47, P411; Weems CW, 2006, VET J, V171, P206, DOI 10.1016/j.tvjl.2004.11.014	44	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143958	10.1371/journal.pone.0143958	http://dx.doi.org/10.1371/journal.pone.0143958			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633886	Green Submitted, Green Published, gold			2022-12-27	WOS:000366040000034
J	Garziera, M; Bidoli, E; Cecchin, E; Mini, E; Nobili, S; Lonardi, S; Buonadonna, A; Errante, D; Pella, N; D'Andrea, M; De Marchi, F; De Paoli, A; Zanusso, C; De Mattia, E; Tassi, R; Toffoli, G				Garziera, Marica; Bidoli, Ettore; Cecchin, Erika; Mini, Enrico; Nobili, Stefania; Lonardi, Sara; Buonadonna, Angela; Errante, Domenico; Pella, Nicoletta; D'Andrea, Mario; De Marchi, Francesco; De Paoli, Antonino; Zanusso, Chiara; De Mattia, Elena; Tassi, Renato; Toffoli, Giuseppe			HLA-G 3 ' UTR Polymorphisms Impact the Prognosis of Stage II-III CRC Patients in Fluoropyrimidine-Based Treatment	PLOS ONE			English	Article							LEUKOCYTE-ANTIGEN-G; COLORECTAL-CANCER PATIENTS; 3' UNTRANSLATED REGION; G MESSENGER-RNA; IMMUNE-RESPONSE; GENE; EXPRESSION; SUPPRESSION; PREDICTOR; INDICATOR	An important hallmark of CRC is the evasion of immune surveillance. HLA-G is a negative regulator of host's immune response. Overexpression of HLA-G protein in primary tumour CRC tissues has already been associated to worse prognosis; however a definition of the role of immunogenetic host background is still lacking. Germline polymorphisms in the 3'UTR region of HLA-G influence the magnitude of the protein by modulating HLA-G mRNA stability. Soluble HLA-G has been associated to 3'UTR +2960 Ins/Ins and +3035 C/T (lower levels) and +3187 G/G (high levels) genotypes. HLA-G 3'UTR SNPs have never been explored in CRC outcome. The purpose of this study was to investigate if common HLA-G 3'UTR polymorphisms have an impact on DFS and OS of 253 stage II-III CRC patients, after primary surgery and ADJ-CT based on FL. The 3'UTR was sequenced and SNPs were analyzed for their association with survival by Kaplan-Meier and multivariate Cox models; results underwent internal validation using a resampling method (bootstrap analysis). In a multivariate analysis, we estimated an association with improved DFS in Ins allele (Ins/Del +Ins/Ins) carriers (HR 0.60, 95% CI 0.38-0.93, P = 0.023) and in patients with +3035 C/T genotype (HR 0.51, 95% CI 0.26-0.99, P = 0.045). The +3187 G/G mutated carriers (G/G vs A/A+A/G) were associated to a worst prognosis in both DFS (HR 2.46, 95% CI 1.19-5.05, P = 0.015) and OS (HR 2.71, 95% CI 1.16-6.63, P = 0.022). Our study shows a prognostic and independent role of 3 HLA-G 3'UTR SNPs, +2960 14-bp INDEL, +3035 C>T, and +3187 A>G.	[Garziera, Marica; Cecchin, Erika; Zanusso, Chiara; De Mattia, Elena; Toffoli, Giuseppe] Aviano Natl Canc Inst, IRCCS, Expt & Clin Pharmacol Unit, CRO, I-33081 Aviano, Italy; [Bidoli, Ettore] Aviano Natl Canc Inst, IRCCS, Epidemiol & Biostat Unit, CRO, I-33081 Aviano, Italy; [Mini, Enrico; Tassi, Renato] Univ Florence, Dept Expt & Clin Med, Sect Internal Med, Florence, Italy; [Nobili, Stefania] Univ Florence, Dept Hlth Sci, Sect Clin Pharmacol & Oncol, Florence, Italy; [Lonardi, Sara] IRCCS, Ist Oncol Veneto, Med Oncol Unit 1, Padua, Italy; [Buonadonna, Angela] Aviano Natl Canc Inst, IRCCS, Div Med Oncol B, I-33081 Aviano, Italy; [Buonadonna, Angela] Aviano Natl Canc Inst, IRCCS, CRO, I-33081 Aviano, Italy; [Errante, Domenico] Osped Civile Vittorio Veneto, Med Oncol Unit, Vittorio Veneto, TV, Italy; [Pella, Nicoletta] Univ Hosp, Med Oncol Unit, Udine, Italy; [D'Andrea, Mario] San Filippo Neri Hosp, Med Oncol Unit, Rome, Italy; [De Marchi, Francesco] Aviano Natl Canc Inst, IRCCS, CRO, Dept Surg Oncol, I-33081 Aviano, Italy; [De Paoli, Antonino] Aviano Natl Canc Inst, IRCCS, CRO, Dept Radiotherapy, I-33081 Aviano, Italy	IRCCS Aviano (CRO); IRCCS Aviano (CRO); University of Florence; University of Florence; IRCCS Istituto Oncologico Veneto (IOV); IRCCS Aviano (CRO); ULSS 2 Marca TV; Ospedale Vittorio Veneto; San Filippo Neri Hospital; IRCCS Aviano (CRO); IRCCS Aviano (CRO)	Garziera, M (corresponding author), Aviano Natl Canc Inst, IRCCS, Expt & Clin Pharmacol Unit, CRO, Via F Gallini 2, I-33081 Aviano, Italy.	mgarziera@cro.it	Bidoli, Ettore/AAC-1762-2020; Toffoli, Giuseppe/F-6642-2018; Mini, Enrico/AAA-5908-2019; Buonadonna, Angela/ABE-2374-2020; Cecchin, Erika/K-2448-2018; De Mattia, Elena/F-6593-2018; Nobili, Stefania/AAA-5917-2019; Lonardi, Sara/F-4228-2014; Garziera, Marica/S-8383-2019	Bidoli, Ettore/0000-0001-8273-9084; Toffoli, Giuseppe/0000-0002-5323-4762; Buonadonna, Angela/0000-0002-1930-0308; Cecchin, Erika/0000-0001-7517-7490; De Mattia, Elena/0000-0003-4948-8767; Lonardi, Sara/0000-0002-7593-8138; De Paoli, Antonino/0000-0002-9512-8108; Garziera, Marica/0000-0001-6902-210X	"Application of advanced nanotechnology in the development of innovative cancer diagnostic tools", AIRCx1000 Special Program Molecular Oncology [12214]	"Application of advanced nanotechnology in the development of innovative cancer diagnostic tools", AIRCx1000 Special Program Molecular Oncology	This work was supported by grant "Application of advanced nanotechnology in the development of innovative cancer diagnostic tools", AIRCx1000 Special Program Molecular Oncology (Grant number 12214).	Amodio G, 2014, TISSUE ANTIGENS, V84, P255, DOI 10.1111/tan.12427; Angelova M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0620-6; Broadbridge VT, 2013, BRIT J CANCER, V109, P1338, DOI 10.1038/bjc.2013.388; Bukur J, 2012, SEMIN CANCER BIOL, V22, P350, DOI 10.1016/j.semcancer.2012.03.003; Cai MY, 2009, CLIN CANCER RES, V15, P4686, DOI 10.1158/1078-0432.CCR-09-0463; Cao M, 2011, TISSUE ANTIGENS, V78, P120, DOI 10.1111/j.1399-0039.2011.01716.x; Carlini F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082517; Carosella ED, 2008, BLOOD, V111, P4862, DOI 10.1182/blood-2007-12-127662; Carosella ED, 2008, TRENDS IMMUNOL, V29, P125, DOI 10.1016/j.it.2007.11.005; Castelli EC, 2010, GENES IMMUN, V11, P134, DOI 10.1038/gene.2009.74; Castelli EC, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/734068; Castelli EC, 2011, MOL BIOL EVOL, V28, P3069, DOI 10.1093/molbev/msr138; Cecchin E, 2015, PHARMACOGENOMICS J, V15, P219, DOI 10.1038/tpj.2014.64; Cecchin E, 2013, PHARMACOGENOMICS J, V13, P403, DOI 10.1038/tpj.2012.31; Curigliano G, 2013, CLIN CANCER RES, V19, P5564, DOI 10.1158/1078-0432.CCR-12-3697; Dahl M, 2014, AM J REPROD IMMUNOL, V72, P89, DOI 10.1111/aji.12251; Donadi EA, 2011, CELL MOL LIFE SCI, V68, P369, DOI 10.1007/s00018-010-0580-7; Fehlker M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-64; Ferguson R, 2012, INT J CANCER, V131, pE312, DOI 10.1002/ijc.27356; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Fukushima Y, 1998, INT J MOL MED, V2, P349; Garziera M, 2014, WORLD J GASTROENTERO, V20, P3778, DOI 10.3748/wjg.v20.i14.3778; Gimenes F, 2014, BBA-REV CANCER, V1846, P576, DOI 10.1016/j.bbcan.2014.10.004; Goel Gaurav, 2014, J Gastrointest Cancer, V45, P399, DOI 10.1007/s12029-014-9634-7; Guo ZY, 2015, CELL IMMUNOL, V293, P10, DOI 10.1016/j.cellimm.2014.10.003; Hansel Donna E, 2005, Int J Gastrointest Cancer, V35, P15, DOI 10.1385/IJGC:35:1:015; Hviid TVF, 2003, IMMUNOGENETICS, V55, P63, DOI 10.1007/s00251-003-0547-z; Jeong S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098284; Johnston PG, 2014, ONCOLOGIST, V19, P568, DOI 10.1634/theoncologist.2014-038; Kopetz S, 2015, ONCOLOGIST, V20, P127, DOI 10.1634/theoncologist.2014-0325; Larsen MH, 2013, J INFECT DIS, V207, P903, DOI 10.1093/infdis/jis924; Larsen MH, 2009, HUM IMMUNOL, V70, P1026, DOI 10.1016/j.humimm.2009.07.015; Mariaselvam CM, 2015, TISSUE ANTIGENS, V85, P182, DOI 10.1111/tan.12521; Martelli-Palomino G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071742; Ong CW, 2015, ONCOTARGET, V6, P12763; Porto IOP, 2015, MOL IMMUNOL, V65, P230, DOI 10.1016/j.molimm.2015.01.030; Reissfelder C, 2015, J CLIN INVEST, V125, P739, DOI 10.1172/JCI74894; Rizzo R, 2014, HAEMATOLOGICA, V99, P888, DOI 10.3324/haematol.2013.095281; Rouas-Freiss N, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/359748; Roxburgh CS, 2013, BRIT J CANCER, V109, P2207, DOI 10.1038/bjc.2013.556; Sabbagh A, 2014, GENES IMMUN, V15, P95, DOI 10.1038/gene.2013.67; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stremitzer S, 2015, PHARMACOGENOMICS J, V15, P521, DOI 10.1038/tpj.2015.14; Toffoli G, 2015, INT J CANCER, V137, P2971, DOI 10.1002/ijc.29654; Ye SR, 2007, MODERN PATHOL, V20, P375, DOI 10.1038/modpathol.3800751; Yie SM, 2008, MOL HUM REPROD, V14, P649, DOI 10.1093/molehr/gan059; Zeestraten ECM, 2014, BRIT J CANCER, V110, P459, DOI 10.1038/bjc.2013.696; Zhu CB, 2011, INT J CANCER, V128, P617, DOI 10.1002/ijc.25372; Zitvogel L, 2015, NATURE, V521, P35, DOI 10.1038/nature14388	51	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144000	10.1371/journal.pone.0144000	http://dx.doi.org/10.1371/journal.pone.0144000			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633805	Green Published, Green Submitted, gold			2022-12-27	WOS:000366040000040
J	Yang, JJ; Song, M; Yoon, HS; Lee, HW; Lee, Y; Lee, SA; Choi, JY; Lee, JK; Kang, D				Yang, Jae Jeong; Song, Minkyo; Yoon, Hyung-Suk; Lee, Hwi-Won; Lee, Yunhee; Lee, Sang-Ah; Choi, Ji-Yeob; Lee, Jong-Koo; Kang, Daehee			What Are the Major Determinants in the Success of Smoking Cessation: Results from the Health Examinees Study	PLOS ONE			English	Article							NATIONAL EPIDEMIOLOGIC SURVEY; UNITED-STATES; SOCIOECONOMIC-STATUS; CIGARETTE-SMOKING; PREDICTORS; SMOKERS; INITIATION; NICOTINE; POPULATION; DISORDERS	Understanding mechanisms underlying smoking-related factors should be prioritized in establishing smoking prevention and cessation policy. The aim of this study was to identify factors significantly associated with smoking initiation and/or smoking cessation as well as the most important determinants of successful smoking cessation in a developed non-Western setting. Based on multiple logistic regression models, the odds ratios (ORs) for smoking initiation and cessation were estimated among males (N = 24,490) who had participated in the Health Examinees (HEXA) study. The Cox proportional hazards regression model was used to assess the association between selected predictors of smoking cessation and the likelihood of reaching this goal. Finally, Kaplan-Meier curves were constructed to illustrate the distribution of time from age at smoking initiation to age at smoking cessation. We found that the ORs for successfully quitting smoking increased with age, married status, educational achievement, having a non-manual job, drinking cessation and disease morbidity. Those exposed to secondhand smoking showed less likelihood of quitting smoking. A continual decrease in the ORs for successfully quitting smoking was observed according to increased smoking duration, smoking dose per day and lifetime tobacco exposure (ptrend <0.001). Among the selected predictors, lifetime tobacco exposure, educational attainment, alcohol drinking status and birth cohort were the major determinants in the success of smoking cessation. Our findings suggest that lifetime tobacco exposure, educational attainment, alcohol drinking status and birth cohort can determine success in smoking cessation. Public interventions promoting a smoke-free environment are needed to reinforce discouraging the initiation of, reducing, and quitting cigarette smoking.	[Yang, Jae Jeong; Song, Minkyo; Yoon, Hyung-Suk; Lee, Hwi-Won; Lee, Yunhee; Choi, Ji-Yeob; Kang, Daehee] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Yang, Jae Jeong; Song, Minkyo; Yoon, Hyung-Suk; Kang, Daehee] Seoul Natl Univ, Med Res Ctr, Inst Environm Med, Seoul, South Korea; [Song, Minkyo; Yoon, Hyung-Suk; Lee, Hwi-Won; Lee, Yunhee; Choi, Ji-Yeob; Kang, Daehee] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea; [Lee, Sang-Ah] Kangwon Natl Univ, Dept Prevent Med, Kangwon Do, South Korea; [Choi, Ji-Yeob; Kang, Daehee] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea; [Lee, Jong-Koo] Seoul Natl Univ, Coll Med, JW Lee Ctr Global Med, Seoul, South Korea; [Lee, Jong-Koo] Seoul Natl Univ, Coll Med, Dept Family Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Kangwon National University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kang, D (corresponding author), Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea.	dhkang@snu.ac.kr	Song, Minkyo/AAE-9095-2020; Yoon, Alex/ADQ-5328-2022	Song, Minkyo/0000-0002-9412-2871; Yoon, Alex/0000-0001-6368-2684; Kang, Daehee/0000-0003-4031-5878				Augustson EM, 2008, AM J PUBLIC HEALTH, V98, P549, DOI 10.2105/AJPH.2005.084137; Borland R, 2010, NICOTINE TOB RES, V12, pS45, DOI 10.1093/ntr/ntq038; Broms U, 2004, NICOTINE TOB RES, V6, P447, DOI 10.1080/14622200410001696637; Brook JS, 2009, DRUG ALCOHOL DEPEN, V101, P62, DOI 10.1016/j.drugalcdep.2008.11.003; CORRIGALL WA, 1991, BRIT J ADDICT, V86, P507; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; ESCOBEDO LG, 1990, JAMA-J AM MED ASSOC, V264, P1550, DOI 10.1001/jama.264.12.1550; Falk DE, 2006, ALCOHOL RES HEALTH, V29, P162; Federico B, 2009, TOB CONTROL, V18, P393, DOI 10.1136/tc.2008.029280; Freedman Kit S, 2012, Prev Chronic Dis, V9, pE05; FREUND KM, 1992, AM J EPIDEMIOL, V135, P957, DOI 10.1093/oxfordjournals.aje.a116407; Geckova A, 2002, Cent Eur J Public Health, V10, P79; Giovino GA, 2012, LANCET, V380, P668, DOI 10.1016/S0140-6736(12)61085-X; Grant BF, 2004, ARCH GEN PSYCHIAT, V61, P1107, DOI 10.1001/archpsyc.61.11.1107; Hagimoto A, 2010, ADDICTION, V105, P164, DOI 10.1111/j.1360-0443.2009.02735.x; Health Examinees Study Group, 2015, Asian Pac J Cancer Prev, V16, P1591; Helmert Uwe, 1999, Reviews on Environmental Health, V14, P239; Hiscock R, 2012, ANN NY ACAD SCI, V1248, P107, DOI 10.1111/j.1749-6632.2011.06202.x; Honjo K, 2010, NICOTINE TOB RES, V12, P1050, DOI 10.1093/ntr/ntq143; Hyland Andrew, 2004, Nicotine Tob Res, V6 Suppl 3, pS363; Kobus K, 2003, ADDICTION, V98, P37, DOI 10.1046/j.1360-0443.98.s1.4.x; Lee CW, 2007, AM J PUBLIC HEALTH, V97, P1503, DOI 10.2105/AJPH.2005.083527; Leonardi-Bee J, 2011, THORAX, V66, P847, DOI 10.1136/thx.2010.153379; Lynch JW., 2000, SOCIAL EPIDEMIOLOGY, P13; Maarcher Ann, 2011, Morbidity and Mortality Weekly Report, V60, P1513; Ministry of Health and Welfare Korean Centers for Disease Control and Prevention, 2012, KOR HLTH STAT 2010 K; Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534; Nagelhout GE, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-303; Osler M, 1999, PREV MED, V29, P57, DOI 10.1006/pmed.1999.0510; Osler M, 2008, INT J EPIDEMIOL, V37, P1367, DOI 10.1093/ije/dyn115; Peto R, 2000, BRIT MED J, V321, P323, DOI 10.1136/bmj.321.7257.323; PIERCE JP, 1989, JAMA-J AM MED ASSOC, V261, P56, DOI 10.1001/jama.261.1.56; Pirie K, 2013, LANCET, V381, P133, DOI 10.1016/S0140-6736(12)61720-6; Poland B, 2006, TOB CONTROL, V15, P59, DOI 10.1136/tc.2004.009886; Rafful C, 2013, ADDICT BEHAV, V38, P1920, DOI 10.1016/j.addbeh.2012.12.019; Siahpush M, 2003, NICOTINE TOB RES, V5, P597, DOI 10.1080/1462220031000118711; Siahpush M, 2009, ADDICTION, V104, P1382, DOI 10.1111/j.1360-0443.2009.02599.x; Sofuoglu M, 2012, DRUG ALCOHOL DEPEN, V125, P1, DOI 10.1016/j.drugalcdep.2012.04.023; Tsai ACH, 2012, ARCH GERONTOL GERIAT, V55, P295, DOI 10.1016/j.archger.2011.08.004; Unger JB, 1999, ADDICT BEHAV, V24, P371, DOI 10.1016/S0306-4603(98)00102-6; WILCOX NS, 1985, ADDICT BEHAV, V10, P407, DOI 10.1016/0306-4603(85)90037-1; World Health Organization, 2019, WHO REP GLOB TOB EP; World Health Organization-WHO, 2013, WHO REP GLOB TOB EP; Zheng W, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001631	44	38	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143303	10.1371/journal.pone.0143303	http://dx.doi.org/10.1371/journal.pone.0143303			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX9QI	26633704	Green Published, gold, Green Submitted			2022-12-27	WOS:000366040000011
J	Cramer, MD; Hoffman, MT				Cramer, Michael D.; Hoffman, M. Timm			The Consequences of Precipitation Seasonality for Mediterranean-Ecosystem Vegetation of South Africa	PLOS ONE			English	Article							PLANT-SPECIES RICHNESS; PHOSPHORUS LIMITATION; NUTRIENT DYNAMICS; CANOPY STRUCTURE; CLIMATE; DIVERSITY; WATER; RAINFALL; GROWTH; FOREST	Globally, mediterranean-climate ecosystem vegetation has converged on an evergreen, sclerophyllous and shrubby growth form. The particular aspects of mediterranean-climate regions that contribute to this convergence include summer droughts and relatively nutrient-poor soils. We hypothesised that winter-precipitation implies stressful summer droughts and leaches soils due to greater water availability (i.e. balance between precipitation and potential evapotranspiration; P-PET) during cold periods. We conducted a comparative analysis of normalised difference vegetation indices (NDVI) and edaphic and climate properties across the biomes of South Africa. NDVI was strongly correlated with both precipitation and P-PET (r(2) = 0.8). There was no evidence, however, that winter-precipitation reduces NDVI in comparison to similar amounts of summer-precipitation. Base saturation (BS), a measure of soil leaching was, however, negatively related to P-PET (r(2) = 0.64). This led to an interaction between P-PET and BS in determining NDVI, indicating the existence of a trade-off between water availability and soil nutrients that enables NDVI to increase with precipitation, despite negative consequences for soil nutrient availability. The mechanism of this trade-off is suggested to be that water increases nutrient accessibility. This implies that along with nutrient-depauperate geologies and long periods of time since glaciation, the winter-precipitation may have contributed to the highly leached status of the soils. Since many of the ecophysiological characteristics of mediterranean-ecosystem flora are associated with low nutrient availabilities (e.g. evergreen foliage, sclerophylly, cluster roots), we conclude that mediterranean-climates promote convergence of growth-forms in these regions through high leaching capacity.	[Cramer, Michael D.; Hoffman, M. Timm] Univ Cape Town, Dept Biol Sci, ZA-7925 Cape Town, South Africa	University of Cape Town	Cramer, MD (corresponding author), Univ Cape Town, Dept Biol Sci, ZA-7925 Cape Town, South Africa.	Michael.cramer@uct.ac.za	Hoffman, Timm/K-4937-2016; Cramer, Michael D/A-3213-2013	Hoffman, Timm/0000-0002-5843-2397; Cramer, Michael D/0000-0003-0989-3266				ALBRECHT WA, 1957, GEOGR REV, V47, P86, DOI 10.2307/212191; [Anonymous], 2014, QGIS GEOGR INF SYST; Archibald S, 2010, INT J WILDLAND FIRE, V19, P774, DOI [10.1071/WF08207, 10.1071/WF10008]; Batjes N. H., 2012, Report - ISRIC World Soil Information; BEERY M, 1971, Ohio Journal of Science, V71, P43; Belda M, 2014, CLIM RES, V59, P1, DOI 10.3354/cr01204; Bergh NG, 2014, FYNBOS: ECOLOGY, EVOLUTION, AND CONSERVATION OF A MEGADIVERSE REGION, P1; Born J, 2007, J BIOGEOGR, V34, P147, DOI 10.1111/j.1365-2699.2006.01595.x; Cowling RM, 2009, MOL PHYLOGENET EVOL, V51, P64, DOI 10.1016/j.ympev.2008.05.034; Cowling RM, 1996, TRENDS ECOL EVOL, V11, P362, DOI 10.1016/0169-5347(96)10044-6; Cowling RM, 2005, GLOBAL ECOL BIOGEOGR, V14, P509, DOI 10.1111/j.1466-822x.2005.00166.x; Cowling RM, 2002, DIVERS DISTRIB, V8, P163, DOI 10.1046/j.1472-4642.2002.00143.x; Cramer MD, 2014, FYNBOS: ECOLOGY, EVOLUTION, AND CONSERVATION OF A MEGADIVERSE REGION, P248; Cramer MD, 2012, OECOLOGIA, V169, P61, DOI 10.1007/s00442-011-2177-8; Cramer MD, 2009, OECOLOGIA, V161, P15, DOI 10.1007/s00442-009-1364-3; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; CURRIE DJ, 1993, OIKOS, V67, P56, DOI 10.2307/3545095; Daget P, 1988, MEDITERRANEAN TYPE E, P139; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; FAO/IIASA/ISRIC/ISSCAS/JRC, 2012, HARM WORLD SOIL DAT; GAMON JA, 1995, ECOL APPL, V5, P28, DOI 10.2307/1942049; Good SP, 2011, P NATL ACAD SCI USA, V108, P4902, DOI 10.1073/pnas.1013100108; HARGREAVES GL, 1985, J IRRIG DRAIN ENG, V111, P265, DOI 10.1061/(ASCE)0733-9437(1985)111:3(265); Hawkins HJ, 2009, FUNCT PLANT BIOL, V36, P752, DOI 10.1071/FP09046; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2014, PACKAGE DISMO; Hopper SD, 2009, PLANT SOIL, V322, P49, DOI 10.1007/s11104-009-0068-0; Huston MA, 2012, ECOL MONOGR, V82, P277, DOI 10.1890/11-1927.1; Jenny H., 1941, FACTORS SOIL FORMATI, DOI 10.1097/00010694-194111000-00009; KAUFMAN YJ, 1992, IEEE T GEOSCI REMOTE, V30, P261, DOI 10.1109/36.134076; Koenker R., 2013, QUANTREG QUANTILE RE; Lamont B. B, 1995, ECOLOGY BIOGEOGRAPHY, P211, DOI DOI 10.1007/978-1-4612-2490-7_9; Lamont BB, 2002, FUNCT ECOL, V16, P403, DOI 10.1046/j.1365-2435.2002.00631.x; Leith H., 1975, PRIMARY PRODUCTIVITY, DOI [10.1007/978-3-642-80913-2_12, DOI 10.1007/978-3-642-80913-2_12]; Linder HP, 2010, CURR OPIN ENV SUST, V2, P109, DOI 10.1016/j.cosust.2010.02.001; Linder HP, 2005, TRENDS PLANT SCI, V10, P536, DOI 10.1016/j.tplants.2005.09.006; MILLER PC, 1983, ECOL STUD, V43, P133; Montenegro G., 1995, ECOLOGY BIOGEOGRAPHY, P160; MUCINA L., 2006, VEGETATION S AFRICA, V19; O'Brien EM, 1998, J BIOGEOGR, V25, P379, DOI 10.1046/j.1365-2699.1998.252166.x; O'Brien EM, 1998, ECOGRAPHY, V21, P495, DOI 10.1111/j.1600-0587.1998.tb00441.x; OBRIEN EM, 1993, J BIOGEOGR, V20, P181, DOI 10.2307/2845670; ORSHAN G, 1983, ECOL STUD, V43, P86; Pate JS, 2001, AUST J BOT, V49, P529, DOI 10.1071/BT00086; Penuelas J, 1998, TRENDS PLANT SCI, V3, P151, DOI 10.1016/S1360-1385(98)01213-8; POST WM, 1982, NATURE, V298, P156, DOI 10.1038/298156a0; R Development Core Team, 2014, R LANG ENV STAT COMP; Richard Y, 1998, INT J REMOTE SENS, V19, P2907, DOI 10.1080/014311698214343; Richards MB, 1997, PLANT ECOL, V130, P143, DOI 10.1023/A:1009742225383; Richardson SJ, 2005, ECOLOGY, V86, P20, DOI 10.1890/04-0524; Richardson SJ, 2004, OECOLOGIA, V139, P267, DOI 10.1007/s00442-004-1501-y; Ripley BS, 2013, J EXP BOT, V64, P5485, DOI 10.1093/jxb/ert314; Rosseel Y, 2014, PACKAGE LAVAAN LATEN; Schoenholtz SH, 2000, FOREST ECOL MANAG, V138, P335, DOI 10.1016/S0378-1127(00)00423-0; SCHULTZ PA, 1993, ADV SPACE RES-SERIES, V13, P277, DOI 10.1016/0273-1177(93)90559-T; Schulze R.E., 1997, S AFRICAN ATLAS AGRO; Schuur EAG, 2003, ECOLOGY, V84, P1165, DOI 10.1890/0012-9658(2003)084[1165:PAGCRT]2.0.CO;2; Soderberg K, 2007, ECOSYSTEMS, V10, P550, DOI 10.1007/s10021-007-9032-0; SPECHT RL, 1983, ECOL STUD, V43, P120; Specht RL, 1988, MEDITERRANEAN TYPE E, P149; STOCK WD, 1986, J ECOL, V74, P317, DOI 10.2307/2260257; Stock WD, 2012, GLOBAL ECOL BIOGEOGR, V21, P1147, DOI 10.1111/j.1466-8238.2011.00752.x; SWAIN P.H., 1973, P AM SOC PHOT REM SE, P536; Trabucco A., 2009, GLOBAL ARIDITY INDEX; Turner BL, 2013, PLANT SOIL, V367, P225, DOI 10.1007/s11104-012-1493-z; Vitousek PM, 2010, ECOL APPL, V20, P5, DOI 10.1890/08-0127.1; WALKER TW, 1976, GEODERMA, V15, P1, DOI 10.1016/0016-7061(76)90066-5; Wardle DA, 2004, SCIENCE, V305, P509, DOI 10.1126/science.1098778; Wessels K, 2011, APPL VEG SCI, V14, P49, DOI 10.1111/j.1654-109X.2010.01100.x; West AG, 2012, NEW PHYTOL, V195, P396, DOI 10.1111/j.1469-8137.2012.04170.x; WITKOWSKI ETF, 1990, ACTA OECOL, V11, P311; Xu C, 2012, ENVIRON MONIT ASSESS, V184, P1275, DOI 10.1007/s10661-011-2039-1; Yates MJ, 2010, FUNCT ECOL, V24, P485, DOI 10.1111/j.1365-2435.2009.01678.x	74	15	15	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144512	10.1371/journal.pone.0144512	http://dx.doi.org/10.1371/journal.pone.0144512			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650081	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903300054
J	Czaplicki, A; Jarocka, M; Walawski, J				Czaplicki, Adam; Jarocka, Marta; Walawski, Jacek			Isokinetic Identification of Knee Joint Torques before and after Anterior Cruciate Ligament Reconstruction	PLOS ONE			English	Article							PATELLAR TENDON; ACCELERATED REHABILITATION; QUADRICEPS STRENGTH; HAMSTRING TENDON; MUSCLE STRENGTH; SEMITENDINOSUS; RETURN; STABILITY; AUTOGRAFT; FIXATION	The aim of this study was to evaluate the serial change of isokinetic muscle strength of the knees before and after anterior cruciate ligament reconstruction (ACLR) in physically active males and to estimate the time of return to full physical fitness. Extension and flexion torques were measured for the injured and healthy limbs at two angular velocities approximately 1.5 months before the surgery and 3, 6, and 12 months after ACLR. Significant differences (p <= 0.05) in peak knee extension and flexion torques, hamstring/quadriceps (H/Q) strength ratios, uninvolved/involved limb peak torque ratios, and the normalized work of these muscles between the four stages of rehabilitation were identified. Significant differences between extension peak torques for the injured and healthy limbs were also detected at all stages. The obtained results showed that 12 months of rehabilitation were insufficient for the involved knee joint to recover its strength to the level of strength of the uninvolved knee joint. The results helped to evaluate the progress of the rehabilitation and to implement necessary modifications optimizing the rehabilitation training program. The results of the study may also be used as referential data for physically active males of similar age.	[Czaplicki, Adam] Josef Pilsudski Univ Phys Educ, Fac Phys Educ & Sport, Dept Biomech & Comp Sci, Biala Podlaska, Poland; [Jarocka, Marta] Josef Pilsudski Univ Phys Educ, Fac Tourism & Hlth, Dept Physiotherapy, Biala Podlaska, Poland; [Walawski, Jacek] Josef Pilsudski Univ Phys Educ, Fac Tourism & Hlth, Dept Rehabil Med, Biala Podlaska, Poland; [Walawski, Jacek] MSW Hosp, Orthopaed Surg Unit, Dept Gen Surg, Lublin, Poland	Jozef Pilsudski University Physical Education in Warsaw; Jozef Pilsudski University Physical Education in Warsaw; Jozef Pilsudski University Physical Education in Warsaw	Czaplicki, A (corresponding author), Josef Pilsudski Univ Phys Educ, Fac Phys Educ & Sport, Dept Biomech & Comp Sci, Biala Podlaska, Poland.	adam.czaplicki@awf-bp.edu.pl	Czaplicki, Adam/E-2719-2019	Czaplicki, Adam/0000-0003-2816-099X				Alkjaer T, 2011, KNEE SURG SPORT TR A, V19, P615, DOI 10.1007/s00167-010-1302-2; [Anonymous], 1999, BIOD SYST 3 ADV SOFT; Arampatzis A, 2004, CLIN BIOMECH, V19, P277, DOI 10.1016/j.clinbiomech.2003.11.011; Ardern CL, 2011, AM J SPORT MED, V39, P538, DOI 10.1177/0363546510384798; Aune AK, 2001, AM J SPORT MED, V29, P722, DOI 10.1177/03635465010290060901; Cascio BM, 2004, CLIN SPORT MED, V23, P395, DOI 10.1016/j.csm.2004.03.004; Coombs Rosalind, 2002, J Sports Sci Med, V1, P56; DANIEL DM, 1985, J BONE JOINT SURG AM, V67A, P720, DOI 10.2106/00004623-198567050-00006; Deneweth JM, 2010, AM J SPORT MED, V38, P1820, DOI 10.1177/0363546510365531; Ejerhed L, 2003, AM J SPORT MED, V31, P19, DOI 10.1177/03635465030310011401; FEIRING D C, 1990, Journal of Orthopaedic and Sports Physical Therapy, V11, P298; Hartigan EH, 2012, J APPL BIOMECH, V28, P366, DOI 10.1123/jab.28.4.366; Herzog W, 1988, J BIOMECH, V21, P124; Hislop H J, 1967, Phys Ther, V47, P114; Jarocka M, 2013, POL J SPORT TOURISM, V20, P13; KANNUS P, 1988, PHYS THER, V68, P961, DOI 10.1093/ptj/68.6.961; Karanikas K, 2009, EUR J PHYS REHAB MED, V45, P37; KAUFMAN KR, 1995, J BIOMECH, V28, P1243, DOI 10.1016/0021-9290(94)00176-5; Keays SL, 2003, J ORTHOPAED RES, V21, P231, DOI 10.1016/S0736-0266(02)00160-2; Keays SL, 2001, KNEE, V8, P229, DOI 10.1016/S0968-0160(01)00099-0; Kellis E, 1996, MED SCI SPORT EXER, V28, P900, DOI 10.1097/00005768-199607000-00018; Konishi Y, 2012, SCAND J MED SCI SPOR, V22, P791, DOI 10.1111/j.1600-0838.2011.01332.x; Kvist J, 2004, SPORTS MED, V34, P269, DOI 10.2165/00007256-200434040-00006; Lewek M, 2002, CLIN BIOMECH, V17, P56, DOI 10.1016/S0268-0033(01)00097-3; LYSHOLM J, 1982, AM J SPORT MED, V10, P150, DOI 10.1177/036354658201000306; MACDONALD PB, 1995, AM J SPORT MED, V23, P588, DOI 10.1177/036354659502300512; Oberlander KD, 2013, MED SCI SPORT EXER, V45, P506, DOI 10.1249/MSS.0b013e3182752ae3; Roewer BD, 2011, J BIOMECH, V44, P1948, DOI 10.1016/j.jbiomech.2011.04.037; Rudolph KS, 2001, KNEE SURG SPORT TR A, V9, P62, DOI 10.1007/s001670000166; SACHS RA, 1989, AM J SPORT MED, V17, P760, DOI 10.1177/036354658901700606; SAPEGA AA, 1990, J BONE JOINT SURG AM, V72A, P1562, DOI 10.2106/00004623-199072100-00023; Scanlan SF, 2013, J BIOMECH, V46, P849, DOI 10.1016/j.jbiomech.2012.12.026; Scanlan SF, 2010, J BIOMECH, V43, P1817, DOI 10.1016/j.jbiomech.2010.02.010; Scranton PE, 1998, ARTHROSCOPY, V14, P702, DOI 10.1016/S0749-8063(98)70097-0; SHELBOURNE KD, 1990, AM J SPORT MED, V18, P292, DOI 10.1177/036354659001800313; SnyderMackler L, 1997, AM J SPORT MED, V25, P191, DOI 10.1177/036354659702500209; STROYAN M, 1993, J ORTHOP SPORT PHYS, V17, P279, DOI 10.2519/jospt.1993.17.6.279; TEGNER Y, 1985, CLIN ORTHOP RELAT R, P43; Torry MR, 2011, CLIN BIOMECH, V26, P1019, DOI 10.1016/j.clinbiomech.2011.06.010; Urabe Y, 2002, J SPORT REHABIL, V11, P252, DOI 10.1123/jsr.11.4.252; van Grinsven S, 2010, KNEE SURG SPORT TR A, V18, P1128, DOI 10.1007/s00167-009-1027-2; Wagner M, 2005, AM J SPORT MED, V33, P1327, DOI 10.1177/0363546504273488; Witvrouw E, 2001, INT ORTHOP, V25, P308, DOI 10.1007/s002640100268; YASUDA K, 1995, AM J SPORT MED, V23, P706, DOI 10.1177/036354659502300613; Zabala ME, 2013, J BIOMECH, V46, P515, DOI 10.1016/j.jbiomech.2012.10.010; Zysk SP, 2000, ACTA ORTHOP SCAND, V71, P381, DOI 10.1080/000164700317393385	46	15	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0144283	10.1371/journal.pone.0144283	http://dx.doi.org/10.1371/journal.pone.0144283			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YV	26646385	Green Submitted, Green Published, gold			2022-12-27	WOS:000366903100017
J	Jalal, B; Krishnakumar, D; Ramachandran, VS				Jalal, Baland; Krishnakumar, Divya; Ramachandran, Vilayanur S.			"I Feel Contaminated in My Fake Hand": Obsessive-Compulsive-Disorder like Disgust Sensations Arise from Dummy during Rubber Hand Illusion	PLOS ONE			English	Article							BODILY SELF; PAIN; SENSITIVITY; OWNERSHIP	Despite its theoretical and clinical interest, there are no experimental studies exploring obsessive-compulsive disorder (OCD)-like disgust sensations through using somatosensory illusions. Such illusions provide important clues to the nature and limits of multisensory integration and how the brain constructs body image; and may potentially inform novel therapies. One such effect is the rubber hand illusion (RHI) in which tactile sensations are referred to a rubber hand; if the experimenter simultaneously strokes a subject's occluded hand together with a visible fake hand, the subject starts experiencing the touch sensations as arising from the dummy. In this study, we explore whether OCD-like disgust may result from contamination of a dummy hand during the RHI; suggesting a possible integration of somatosensory and limbic inputs in the construction of body image. We predicted that participants would experience sensations of disgust, when placing a disgust stimulus (fake feces, vomit or blood) on the dummy hand after establishing the RHI. We found that 9 out of 11 participants experienced greater disgust during the synchronous condition (real hidden hand and fake hand are stroked in synchrony) compared to the asynchronous control condition (real hidden hand and fake hand are stroked in asynchrony); and on average such disgust was significantly greater during the synchronous condition compared to the asynchronous control condition, Z = 2.7, p = .008. These results argue against a strictly hierarchical modular approach to brain function and suggest that a four-way multisensory interaction occurs between vision, touch, proprioception on the one hand and primal emotions like disgust on the other. These findings may inform novel clinical approaches for OCD; that is, contaminating a dummy during the RHI could possibly be used as part of an in-vivo exposure-intervention for OCD.	[Jalal, Baland; Krishnakumar, Divya; Ramachandran, Vilayanur S.] Univ Calif San Diego, Ctr Brain & Cognit, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Jalal, B (corresponding author), Univ Calif San Diego, Ctr Brain & Cognit, La Jolla, CA 92093 USA.	bjalal@ucsd.edu						Abramowitz JS, 1996, BEHAV THER, V27, P583, DOI 10.1016/S0005-7894(96)80045-1; Altman SE, 2009, CLIN PSYCHOL REV, V29, P638, DOI 10.1016/j.cpr.2009.08.001; Armel KC, 2003, P ROY SOC B-BIOL SCI, V270, P1499, DOI 10.1098/rspb.2003.2364; Avery JA, 2015, HUM BRAIN MAPP, V36, P2996, DOI 10.1002/hbm.22823; Berlucchi G, 2010, EXP BRAIN RES, V200, P25, DOI 10.1007/s00221-009-1970-7; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Breiter HC, 1996, ARCH GEN PSYCHIAT, V53, P595; Breiter HC, 1996, NEUROIMAGE, V4, pS127, DOI 10.1006/nimg.1996.0063; Capelari EDP, 2009, PERCEPTION, V38, P92, DOI 10.1068/p5892; Costantini M, 2007, CONSCIOUS COGN, V16, P229, DOI 10.1016/j.concog.2007.01.001; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Del Casale A, 2011, NEUROPSYCHOBIOLOGY, V64, P61, DOI 10.1159/000325223; Ehrsson HH, 2007, P NATL ACAD SCI USA, V104, P9828, DOI 10.1073/pnas.0610011104; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Eshkevari E, 2012, PSYCHOL MED, V42, P819, DOI 10.1017/S0033291711002091; HAMILTON JG, 1995, J FAM PRACTICE, V41, P169; Jalal B, 2013, SOC NEUROSCIENCE, V732, pEE6; Jalal B, FRONT PSYCH IN PRESS; Kammers MPM, 2009, NEUROPSYCHOLOGIA, V47, P204, DOI 10.1016/j.neuropsychologia.2008.07.028; Kilteni K, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00141; Limanowski J, 2014, NEUROIMAGE, V86, P514, DOI 10.1016/j.neuroimage.2013.10.035; Martini M, 2014, EUR J PAIN, V18, P1040, DOI 10.1002/j.1532-2149.2014.00451.x; Martini M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00438; Mohan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052400; Phillips ML, 2000, PSYCHOL MED, V30, P1037, DOI 10.1017/S0033291799002652; Ramachandran VS, 2009, BRAIN, V132, P1693, DOI 10.1093/brain/awp135; Ramachandran VS, 2011, PERCEPTION, V40, P367, DOI 10.1068/p6754; RAMACHANDRAN VS, 1995, NATURE, V377, P489, DOI 10.1038/377489a0; Samad M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117178; Shapira NA, 2003, BIOL PSYCHIAT, V54, P751, DOI 10.1016/S0006-3223(03)00003-9; Thakkar KN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027089; Tsakiris M, 2007, CEREB CORTEX, V17, P2235, DOI 10.1093/cercor/bhl131; Tsakiris M, 2011, P ROY SOC B-BIOL SCI, V278, P2470, DOI 10.1098/rspb.2010.2547	33	11	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0139159	10.1371/journal.pone.0139159	http://dx.doi.org/10.1371/journal.pone.0139159			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1YS	26642323	Green Published, gold, Green Submitted			2022-12-27	WOS:000366902700001
J	Lin, HH; Liao, YC				Lin, Hsin-Hung; Liao, Yu-Chieh			Evaluation and Validation of Assembling Corrected PacBio Long Reads for Microbial Genome Completion via Hybrid Approaches	PLOS ONE			English	Article							BACTERIAL GENOMES; SEQUENCE DATA; EFFICIENT; ACCURATE; TOOL	Despite the ever-increasing output of next-generation sequencing data along with developing assemblers, dozens to hundreds of gaps still exist in de novo microbial assemblies due to uneven coverage and large genomic repeats. Third-generation single-molecule, realtime (SMRT) sequencing technology avoids amplification artifacts and generates kilobase-long reads with the potential to complete microbial genome assembly. However, due to the low accuracy (similar to 85%) of third-generation sequences, a considerable amount of long reads (>50X) are required for self-correction and for subsequent de novo assembly. Recently-developed hybrid approaches, using next-generation sequencing data and as few as 5X long reads, have been proposed to improve the completeness of microbial assembly. In this study we have evaluated the contemporary hybrid approaches and demonstrated that assembling corrected long reads (by runCA) produced the best assembly compared to long-read scaffolding (e.g., AHA, Cerulean and SSPACE-LongRead) and gap-filling (SPAdes). For generating corrected long reads, we further examined long-read correction tools, such as ECTools, LSC, LoRDEC, PBcR pipeline and proovread. We have demonstrated that three microbial genomes including Escherichia coli K12 MG1655, Meiothermus ruber DSM1279 and Pdeobacter heparinus DSM2366 were successfully hybrid assembled by runCA into near-perfect assemblies using ECTools-corrected long reads. In addition, we developed a tool, Patch, which implements corrected long reads and pre-assembled contigs as inputs, to enhance microbial genome assemblies. With the additional 20X long reads, short reads of S. cerevisiae W303 were hybrid assembled into 115 contigs using the verified strategy, ECTools + runCA. Patch was subsequently applied to upgrade the assembly to a 35-contig draft genome. Our evaluation of the hybrid approaches shows that assembling the ECTools-corrected long reads via runCA generates near complete microbial genomes, suggesting that genome assembly could benefit from re-analyzing the available hybrid datasets that were not assembled in an optimal fashion.	[Lin, Hsin-Hung; Liao, Yu-Chieh] Natl Hlth Res Inst, Inst Populat Hlth Sci, Taipei, Miaoli County, Taiwan	National Health Research Institutes - Taiwan	Liao, YC (corresponding author), Natl Hlth Res Inst, Inst Populat Hlth Sci, Taipei, Miaoli County, Taiwan.	jade@nhri.org.tw	Liao, Yu-Chieh/L-5113-2019	Liao, Yu-Chieh/0000-0002-4360-7932	National Health Research Institutes [PH-104-PP-05, PH-104-SP-03]; Ministry of Science and Technology, Taiwan [103-2320-B-400-001]	National Health Research Institutes(National Health Research Institutes, Japan); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the intramural funding of National Health Research Institutes (PH-104-PP-05 and PH-104-SP-03) and the Ministry of Science and Technology, Taiwan (103-2320-B-400-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au KF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046679; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bashir A, 2012, NAT BIOTECHNOL, V30, P701, DOI 10.1038/nbt.2288; Berlin K, 2015, NAT BIOTECHNOL, V33, P623, DOI 10.1038/nbt.3238; Boetzer M, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-211; Brown SD, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-40; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Deshpande Viraj, 2013, Algorithms in Bioinformatics. 13th International Workshop, WABI 2013. Proceedings: LNCS 8126, P349, DOI 10.1007/978-3-642-40453-5_27; English AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041444; Ferrarini M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-670; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Hackl T, 2014, BIOINFORMATICS, V30, P3004, DOI 10.1093/bioinformatics/btu392; Huddleston J, 2014, GENOME RES, V24, P688, DOI 10.1101/gr.168450.113; Junemann S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107014; Junemann S, 2013, NAT BIOTECHNOL, V31, P294, DOI 10.1038/nbt.2522; Koren S, 2015, CURR OPIN MICROBIOL, V23, P110, DOI 10.1016/j.mib.2014.11.014; Koren S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r101; Koren S, 2012, NAT BIOTECHNOL, V30, P692, DOI 10.1038/nbt.2280; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lee H., 2014, ERROR CORRECTION ASS, DOI [10.1101/006395, DOI 10.1101/006395]; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liao YC, 2015, SCI REP-UK, V5, DOI 10.1038/srep08747; Nagarajan N, 2013, NAT REV GENET, V14, P157, DOI 10.1038/nrg3367; Powers JG, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-675; Prjibelski AD, 2014, BIOINFORMATICS, V30, P293, DOI 10.1093/bioinformatics/btu266; Ribeiro FJ, 2012, GENOME RES, V22, P2270, DOI 10.1101/gr.141515.112; Salmela L, 2014, BIOINFORMATICS, V30, P3506, DOI 10.1093/bioinformatics/btu538; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Utturkar SM, 2014, BIOINFORMATICS, V30, P2709, DOI 10.1093/bioinformatics/btu391	29	20	21	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144305	10.1371/journal.pone.0144305	http://dx.doi.org/10.1371/journal.pone.0144305			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641475	Green Submitted, Green Published, gold			2022-12-27	WOS:000366902700095
J	Martinez-Zamora, A; Meseguer, S; Esteve, JM; Villarroya, M; Aguado, C; Enriquez, JA; Knecht, E; Armengod, ME				Martinez-Zamora, Ana; Meseguer, Salvador; Esteve, Juan M.; Villarroya, Magda; Aguado, Carmen; Enriquez, J. Antonio; Knecht, Erwin; Armengod, M. -Eugenia			Defective Expression of the Mitochondrial-tRNA Modifying Enzyme GTPBP3 Triggers AMPK-Mediated Adaptive Responses Involving Complex I Assembly Factors, Uncoupling Protein 2, and the Mitochondrial Pyruvate Carrier	PLOS ONE			English	Article							FATTY-ACID OXIDATION; RESPIRATORY-CHAIN DEFICIENCY; HYPERTROPHIC CARDIOMYOPATHY; LACTIC-ACIDOSIS; ROS PRODUCTION; CELL-SURVIVAL; WOBBLE BASE; STRESS; TRANSLATION; KINASE	GTPBP3 is an evolutionary conserved protein presumably involved in mitochondrial tRNA (mt-tRNA) modification. In humans, GTPBP3 mutations cause hypertrophic cardiomyopathy with lactic acidosis, and have been associated with a defect in mitochondrial translation, yet the pathomechanism remains unclear. Here we use a GTPBP3 stable-silencing model (shGTPBP3 cells) for a further characterization of the phenotype conferred by the GTPBP3 defect. We experimentally show for the first time that GTPBP3 depletion is associated with an mt-tRNA hypomodification status, as mt-tRNAs from shGTPBP3 cells were more sensitive to digestion by angiogenin than tRNAs from control cells. Despite the effect of stable silencing of GTPBP3 on global mitochondrial translation being rather mild, the steady-state levels and activity of Complex I, and cellular ATP levels were 50% of those found in the controls. Notably, the ATPase activity of Complex V increased by about 40% in GTPBP3 depleted cells suggesting that mitochondria consume ATP to maintain the membrane potential. Moreover, shGTPBP3 cells exhibited enhanced antioxidant capacity and a nearly 2-fold increase in the uncoupling protein UCP2 levels. Our data indicate that stable silencing of GTPBP3 triggers an AMPK-dependent retrograde signaling pathway that down-regulates the expression of the NDUFAF3 and NDUFAF4 Complex I assembly factors and the mitochondrial pyruvate carrier (MPC), while up-regulating the expression of UCP2. We also found that genes involved in glycolysis and oxidation of fatty acids are up-regulated. These data are compatible with a model in which high UCP2 levels, together with a reduction in pyruvate transport due to the down-regulation of MPC, promote a shift from pyruvate to fatty acid oxidation, and to an uncoupling of glycolysis and oxidative phosphorylation. These metabolic alterations, and the low ATP levels, may negatively affect heart function.	[Martinez-Zamora, Ana; Meseguer, Salvador; Villarroya, Magda; Armengod, M. -Eugenia] Ctr Invest Principe Felipe, Lab RNA Modificat & Mitochondrial Dis, Valencia, Spain; [Esteve, Juan M.; Aguado, Carmen; Knecht, Erwin] Ctr Invest Principe Felipe, Lab Intracellular Prot Degradat & Rare Dis, Valencia, Spain; [Aguado, Carmen; Knecht, Erwin; Armengod, M. -Eugenia] CIBERER, Node U721, Valencia, Spain; [Enriquez, J. Antonio] Ctr Nacl Invest Cardiovasc Carl III, Dept Desarrollo & Reparac Cardiovasc, Madrid, Spain; [Enriquez, J. Antonio] Univ Zaragoza, Fac Ciencias, Dept Bioquim & Biol Mol & Celular, E-50009 Zaragoza, Spain	Prince Felipe Research Center; Prince Felipe Research Center; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Centro Nacional de Investigaciones Cardiovasculares (CNIC); University of Zaragoza	Armengod, ME (corresponding author), Ctr Invest Principe Felipe, Lab RNA Modificat & Mitochondrial Dis, Valencia, Spain.	marmengod@cipf.es	Enríquez, J.A./M-8468-2016; Knecht, Erwin/K-2432-2014; Villarroya, M Magdalena/K-7621-2014; Knecht, Erwin/A-9366-2014; Aguado, Carmen/K-4354-2014; Meseguer, Salvador/K-7137-2014	Enríquez, J.A./0000-0002-3671-2961; Knecht, Erwin/0000-0002-7208-3832; Villarroya, M Magdalena/0000-0003-4542-7430; Aguado, Carmen/0000-0002-3113-4269; Meseguer, Salvador/0000-0002-2718-4351	Spanish Ministry of Economy and Competitiveness [BFU2010-19737, BFU2014-58673-P, BFU2011-22630, SAF2014-54604-C3-2-R]; Generalitat Valenciana [ACOMP/2012/065, PROMETEO/2012/061]; Instituto de Salud Carlos III	Spanish Ministry of Economy and Competitiveness(Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work has been supported by grants from the Spanish Ministry of Economy and Competitiveness (http://www.mineco.gob.es/portal/site/mineco/) (grant numbers BFU2010-19737 and BFU2014-58673-P to M.-E. A., BFU2011-22630 and SAF2014-54604-C3-2-R to E.K.) and the Generalitat Valenciana (http://www.gva.es/va/inicio/presentacion) (grant numbers ACOMP/2012/065 to M.-E. A., and PROMETEO/2012/061 to M.-E. A. and E.K.), and a PhD fellowship from the Instituto de Salud Carlos III (http://www.isciii.es/) to A.M.-Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin-Perez R, 2014, BBA-BIOENERGETICS, V1837, P444, DOI 10.1016/j.bbabio.2013.12.009; Aebi H, 1984, Methods Enzymol, V105, P121; Armengod ME, 2012, BIOCHIMIE, V94, P1510, DOI 10.1016/j.biochi.2012.02.019; Barnes K, 2002, J CELL SCI, V115, P2433; Bartlett K, 2004, EUR J BIOCHEM, V271, P462, DOI 10.1046/j.1432-1033.2003.03947.x; Baruffini E, 2013, HUM MUTAT, V34, P1501, DOI 10.1002/humu.22393; Blanco S, 2014, EMBO J, V33, P2020, DOI 10.15252/embj.201489282; Boczonadi V, 2014, INT J BIOCHEM CELL B, V48, P77, DOI 10.1016/j.biocel.2013.12.011; Boczonadi V, 2013, HUM MOL GENET, V22, P4602, DOI 10.1093/hmg/ddt309; Bouillaud F, 2009, BBA-BIOENERGETICS, V1787, P377, DOI 10.1016/j.bbabio.2009.01.003; Bregeon D, 2001, GENE DEV, V15, P2295, DOI 10.1101/gad.207701; Burroughs AM, 2011, RNA BIOL, V8, P158, DOI 10.4161/rna.8.1.14300; Calegari VC, 2011, J ENDOCRINOL, V208, P257, DOI 10.1530/JOE-10-0450; Canto C, 2010, CELL MOL LIFE SCI, V67, P3407, DOI 10.1007/s00018-010-0454-z; Capella MAM, 2007, CELL BIOL TOXICOL, V23, P413, DOI 10.1007/s10565-007-9003-4; Chae S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003266; Chinopoulos C, 2010, BBA-MOL BASIS DIS, V1802, P221, DOI 10.1016/j.bbadis.2009.08.008; Chomyn A, 1996, Methods Enzymol, V264, P197, DOI 10.1016/S0076-6879(96)64020-8; Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Cotan D, 2011, FASEB J, V25, P2669, DOI 10.1096/fj.10-165340; Cox AG, 2010, BIOCHEM J, V425, P313, DOI 10.1042/BJ20091541; del Hoyo P, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-95; DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302; Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119; Dodson M, 2013, FREE RADICAL BIO MED, V63, P207, DOI 10.1016/j.freeradbiomed.2013.05.014; Dominy JE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a015008; ELSEVIERS D, 1984, NUCLEIC ACIDS RES, V12, P3521, DOI 10.1093/nar/12.8.3521; ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47; Enriquez JA, 2014, MOL SYNDROMOL, V5, P119, DOI 10.1159/000363364; Armengod ME, 2014, RNA BIOL, V11, P1495, DOI 10.4161/15476286.2014.992269; Fillmore N, 2013, BBA-MOL CELL RES, V1833, P857, DOI 10.1016/j.bbamcr.2012.08.014; Finsterer J, 2009, EUR J NEUROL, V16, P1255, DOI 10.1111/j.1468-1331.2009.02811.x; Foretz M, 2005, DIABETES, V54, P1331, DOI 10.2337/diabetes.54.5.1331; Fu HJ, 2009, FEBS LETT, V583, P437, DOI 10.1016/j.febslet.2008.12.043; Gaignard P, 2013, JIMD REP, V11, P117, DOI 10.1007/8904_2013_230; Gao AW, 2014, EMBO MOL MED, V6, P580, DOI 10.1002/emmm.201303782; GEHRKE CW, 1989, J CHROMATOGR, V471, P3, DOI 10.1016/S0021-9673(00)94152-9; Ghezzi D, 2012, ADV EXP MED BIOL, V748, P65, DOI 10.1007/978-1-4614-3573-0_4; Ghezzi D, 2012, AM J HUM GENET, V90, P1079, DOI 10.1016/j.ajhg.2012.04.011; Gray LR, 2014, CELL MOL LIFE SCI, V71, P2577, DOI 10.1007/s00018-013-1539-2; Hamalainen RH, 2013, P NATL ACAD SCI USA, V110, pE3622, DOI 10.1073/pnas.1311660110; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Islam MM, 2007, J BIOL CHEM, V282, P11893, DOI 10.1074/jbc.M700198200; Jager G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060246; Jaswal JS, 2011, BBA-MOL CELL RES, V1813, P1333, DOI 10.1016/j.bbamcr.2011.01.015; Jezek P, 2014, PHYSIOL RES, V63, pS73, DOI 10.33549/physiolres.932633; Kemp JP, 2011, BRAIN, V134, P183, DOI 10.1093/brain/awq320; Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X; KNECHT E, 1984, HISTOCHEMISTRY, V80, P359, DOI 10.1007/BF00495417; Kopajtich R, 2014, AM J HUM GENET, V95, P708, DOI 10.1016/j.ajhg.2014.10.017; Kramer EB, 2007, RNA, V13, P87, DOI 10.1261/rna.294907; Kruger MK, 1998, J MOL BIOL, V284, P621, DOI 10.1006/jmbi.1998.2196; Kukat A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004385; LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6; Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010; Li N, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/740849; Li SP, 2012, J CELL PHYSIOL, V227, P2822, DOI 10.1002/jcp.23051; Lopez-Armada MJ, 2006, OSTEOARTHR CARTILAGE, V14, P1011, DOI 10.1016/j.joca.2006.03.008; Lowes DA, 2011, BIOCHEM J, V436, P123, DOI 10.1042/BJ20102135; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maniataki E, 2005, RNA, V11, P849, DOI 10.1261/rna.2210805; Marsin AS, 2000, CURR BIOL, V10, P1247, DOI 10.1016/S0960-9822(00)00742-9; Martin D, 2002, J BIOL CHEM, V277, P42943, DOI 10.1074/jbc.M201070200; Martinez-Vicente M, 2005, J BIOL CHEM, V280, P30660, DOI 10.1074/jbc.M503223200; MCCORD JM, 1969, J BIOL CHEM, V244, P6056; Mesegueri S, 2015, HUM MOL GENET, V24, P167, DOI 10.1093/hmg/ddu427; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Mimaki M, 2012, BBA-BIOENERGETICS, V1817, P851, DOI 10.1016/j.bbabio.2011.08.010; Moran M, 2010, BBA-MOL BASIS DIS, V1802, P443, DOI 10.1016/j.bbadis.2010.02.001; Moreno-Loshuertos R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001379; Moukadiri I, 2014, NUCLEIC ACIDS RES, V42, P2602, DOI 10.1093/nar/gkt1228; Moukadiri I, 2009, NUCLEIC ACIDS RES, V37, P7177, DOI 10.1093/nar/gkp762; Murphy FV, 2004, NAT STRUCT MOL BIOL, V11, P1186, DOI 10.1038/nsmb861; Nunez C, 2005, CIRC RES, V97, P1063, DOI 10.1161/01.RES.0000190588.84680.34; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Pecqueur C, 2008, FASEB J, V22, P9, DOI 10.1096/fj.07-8945com; Pecqueur C, 2009, IUBMB LIFE, V61, P762, DOI 10.1002/iub.188; Rendon OZ, 2012, HUM MOL GENET, V21, P3815, DOI 10.1093/hmg/dds209; Saada A, 2009, AM J HUM GENET, V84, P718, DOI 10.1016/j.ajhg.2009.04.020; Sasarman F, 2011, HUM MOL GENET, V20, P4634, DOI 10.1093/hmg/ddr397; SAXENA SK, 1992, J BIOL CHEM, V267, P21982; Scarpulla RC, 2012, TRENDS ENDOCRIN MET, V23, P459, DOI 10.1016/j.tem.2012.06.006; Schaefer M, 2010, GENE DEV, V24, P1590, DOI 10.1101/gad.586710; Schara U, 2011, J INHERIT METAB DIS, V34, P197, DOI 10.1007/s10545-010-9250-z; Schonfeld P, 2010, BBA-BIOENERGETICS, V1797, P929, DOI 10.1016/j.bbabio.2010.01.010; Shabalina IG, 2011, BIOCHEM SOC T, V39, P1305, DOI 10.1042/BST0391305; Sies H, 2014, J BIOL CHEM, V289, P8735, DOI 10.1074/jbc.R113.544635; Sissler M, 2008, METHODS, V44, P176, DOI 10.1016/j.ymeth.2007.11.002; Smits P, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/737385; Soper J W, 1979, Methods Enzymol, V55, P328; Suzuki T, 2007, METHOD ENZYMOL, V425, P231, DOI 10.1016/S0076-6879(07)25010-4; Suzuki T, 2014, NUCLEIC ACIDS RES, V42, P7346, DOI 10.1093/nar/gku390; Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531; Suzuki T, 2011, WIRES RNA, V2, P376, DOI 10.1002/wrna.65; Tait SWG, 2012, J CELL SCI, V125, P807, DOI 10.1242/jcs.099234; Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184; Temperley R, 2010, SCIENCE, V327, P301, DOI 10.1126/science.1180674; Tischner C, 2015, HUM MOL GENET, V24, P2247, DOI 10.1093/hmg/ddu743; Twig G, 2011, ANTIOXID REDOX SIGN, V14, P1939, DOI 10.1089/ars.2010.3779; Umeda N, 2005, J BIOL CHEM, V280, P1613, DOI 10.1074/jbc.M409306200; Urbonavicius J, 2001, EMBO J, V20, P4863, DOI 10.1093/emboj/20.17.4863; Uusimaa J, 2011, J MED GENET, V48, P660, DOI 10.1136/jmg.2011.089995; Vacanti NM, 2014, MOL CELL, V56, P425, DOI 10.1016/j.molcel.2014.09.024; Villarroya M, 2008, MOL CELL BIOL, V28, P7514, DOI 10.1128/MCB.00946-08; Viollet B, 2010, CRIT REV BIOCHEM MOL, V45, P276, DOI 10.3109/10409238.2010.488215; Vozza A, 2014, P NATL ACAD SCI USA, V111, P960, DOI 10.1073/pnas.1317400111; Wang YD, 2010, J BIOL CHEM, V285, P29834, DOI 10.1074/jbc.M110.139493; Westhof Eric, 2014, F1000Prime Rep, V6, P19, DOI 10.12703/P6-19; Wu N, 2013, MOL CELL, V49, P1167, DOI 10.1016/j.molcel.2013.01.035; Wu SB, 2014, BBA-GEN SUBJECTS, V1840, P1331, DOI 10.1016/j.bbagen.2013.10.034; Xie ZL, 2008, DIABETES, V57, P3222, DOI 10.2337/db08-0610; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106; Yang CD, 2014, MOL CELL, V56, P414, DOI 10.1016/j.molcel.2014.09.025; Yim L, 2006, NUCLEIC ACIDS RES, V34, P5892, DOI 10.1093/nar/gkl752; Zeharia A, 2009, AM J HUM GENET, V85, P401, DOI 10.1016/j.ajhg.2009.08.004; Zinshteyn B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003675	117	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144273	10.1371/journal.pone.0144273	http://dx.doi.org/10.1371/journal.pone.0144273			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642043	Green Published, gold, Green Submitted			2022-12-27	WOS:000366902700089
J	Raghunayakula, S; Subramonian, D; Dasso, M; Kumar, R; Zhang, XD				Raghunayakula, Sarita; Subramonian, Divya; Dasso, Mary; Kumar, Rita; Zhang, Xiang-Dong			Molecular Characterization and Functional Analysis of Annulate Lamellae Pore Complexes in Nuclear Transport in Mammalian Cells	PLOS ONE			English	Article							ACTIVATING PROTEIN RANGAP1; XENOPUS EGG EXTRACT; ARGININE DEPRIVATION; E3 LIGASE; KB CELLS; IN-VIVO; NUCLEOCYTOPLASMIC TRANSPORT; SUMO-1 MODIFICATION; GTP HYDROLYSIS; RAN	Annulate lamellae are cytoplasmic organelles containing stacked sheets of membranes embedded with pore complexes. These cytoplasmic pore complexes at annulate lamellae are morphologically similar to nuclear pore complexes at the nuclear envelope. Although annulate lamellae has been observed in nearly all types of cells, their biological functions are still largely unknown. Here we show that SUMO1-modification of the Ran GTPase-activating protein RanGAP1 not only target RanGAP1 to its known sites at nuclear pore complexes but also to annulate lamellae pore complexes through interactions with the Ran-binding protein RanBP2 and the SUMO-conjugating enzyme Ubc9 in mammalian cells. Furthermore, upregulation of annulate lamellae, which decreases the number of nuclear pore complexes and concurrently increases that of annulate lamellae pore complexes, causes a redistribution of nuclear transport receptors including importin alpha/beta and the exportin CRM1 from nuclear pore complexes to annulate lamellae pore complexes and also reduces the rates of nuclear import and export. Moreover, our results reveal that importin alpha/beta-mediated import complexes initially accumulate at annulate lamellae pore complexes upon the activation of nuclear import and subsequently disassociate for nuclear import through nuclear pore complexes in cells with upregulation of annulate lamellae. Lastly, CRM1-mediated export complexes are concentrated at both nuclear pore complexes and annulate lamellae pore complexes when the disassembly of these export complexes is inhibited by transient expression of a Ran GTPase mutant arrested in its GTP-bound form, suggesting that RanGAP1/RanBP2-activated RanGTP hydrolysis at these pore complexes is required for the dissociation of the export complexes. Hence, our findings provide a foundation for further investigation of how upregulation of annulate lamellae decreases the rates of nuclear transport and also for elucidation of the biological significance of the interaction between annulate lamellae pore complexes and nuclear transport complexes in mammalian cells.	[Raghunayakula, Sarita; Subramonian, Divya; Zhang, Xiang-Dong] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA; [Dasso, Mary] NICHHD, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA; [Kumar, Rita] Wayne State Univ, Dept Emergency Med, Detroit, MI USA; [Kumar, Rita] Wayne State Univ, Dept Psychol, Detroit, MI 48202 USA	Wayne State University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Wayne State University; Wayne State University	Zhang, XD (corresponding author), Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA.	xzhang@wayne.edu	Subramonian, Divya/AGF-1165-2022	Subramonian, Divya/0000-0002-9849-6512; Kumar, Rita/0000-0002-9573-7667; Zhang, Xiang-Dong/0000-0001-5097-3191; Dasso, Mary/0000-0002-5410-1371	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008954] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Antonin W, 2008, FEBS LETT, V582, P2004, DOI 10.1016/j.febslet.2008.02.067; Askjaer P, 1999, MOL CELL BIOL, V19, P6276; Ayaydin F, 2004, MOL BIOL CELL, V15, P5208, DOI 10.1091/mbc.E04-07-0589; Bernad R, 2004, MOL CELL BIOL, V24, P2373, DOI 10.1128/MCB.24.6.2373-2384.2004; BISCHOFF FR, 1991, NATURE, V354, P80, DOI 10.1038/354080a0; BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; BISCHOFF FR, 1995, P NATL ACAD SCI USA, V92, P1749, DOI 10.1073/pnas.92.5.1749; CHAMBERS VC, 1964, J CELL BIOL, V21, P133, DOI 10.1083/jcb.21.1.133; CHEN TY, 1988, J CELL BIOL, V107, P1299, DOI 10.1083/jcb.107.4.1299; Clever M, 2013, NUCLEUS-PHILA, V4, P105, DOI 10.4161/nucl.23796; Cordes VC, 1997, EXP CELL RES, V237, P419, DOI 10.1006/excr.1997.3806; Cordes VC, 1996, CELL TISSUE RES, V284, P177, DOI 10.1007/s004410050578; Cordes VC, 1997, J CELL BIOL, V136, P515, DOI 10.1083/jcb.136.3.515; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; Cronshaw JM, 2003, P NATL ACAD SCI USA, V100, P5823, DOI 10.1073/pnas.1031047100; Dabauvalle MC, 1999, EUR J CELL BIOL, V78, P749, DOI 10.1016/S0171-9335(99)80043-0; DABAUVALLE MC, 1991, BIOL CELL, V72, P25, DOI 10.1016/0248-4900(91)90074-W; DABAUVALLE MC, 1991, J CELL BIOL, V112, P1073, DOI 10.1083/jcb.112.6.1073; DAVIS LI, 1986, CELL, V45, P699, DOI 10.1016/0092-8674(86)90784-1; DEBRABANDER M, 1975, J CELL SCI, V19, P331; Delphin C, 1997, MOL BIOL CELL, V8, P2379, DOI 10.1091/mbc.8.12.2379; Doucet CM, 2010, CHROMOSOMA, V119, P469, DOI 10.1007/s00412-010-0289-2; Doucet CM, 2010, CELL, V141, P1030, DOI 10.1016/j.cell.2010.04.036; EPSTEIN MA, 1961, J BIOPHYS BIOCHEM CY, V10, P153, DOI 10.1083/jcb.10.2.153; Ewald A, 1996, J CELL SCI, V109, P1813; Ewald A, 2001, EUR J CELL BIOL, V80, P678, DOI 10.1078/0171-9335-00207; Ewald A, 1997, EUR J CELL BIOL, V73, P259; Flotho A, 2012, NUCLEUS-AUSTIN, V3, P429, DOI 10.4161/nucl.21980; Franz C, 2007, EMBO REP, V8, P165, DOI 10.1038/sj.embor.7400889; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Fung HYJ, 2014, SEMIN CANCER BIOL, V27, P52, DOI 10.1016/j.semcancer.2014.03.002; Gillespie PJ, 2007, CURR BIOL, V17, P1657, DOI 10.1016/j.cub.2007.08.041; GOLDBERG MW, 1995, CURR OPIN CELL BIOL, V7, P301, DOI 10.1016/0955-0674(95)80083-2; Guzzo CM, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003485; Hilgenberg Lutz G W, 2007, J Vis Exp, P562, DOI 10.3791/562; Hutten S, 2008, MOL BIOL CELL, V19, P2300, DOI 10.1091/mbc.E07-12-1279; Hutten S, 2007, TRENDS CELL BIOL, V17, P193, DOI 10.1016/j.tcb.2007.02.003; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Joseph J, 2004, CURR BIOL, V14, P611, DOI 10.1016/j.cub.2004.03.031; Kehlenbach RH, 1999, J CELL BIOL, V145, P645, DOI 10.1083/jcb.145.4.645; KESSEL RG, 1992, INT REV CYTOL, V133, P43, DOI 10.1016/S0074-7696(08)61858-6; KESSEL RG, 1984, J MORPHOL, V179, P291, DOI 10.1002/jmor.1051790307; KESSEL RG, 1989, ELECTRON MICROSC REV, V2, P257, DOI 10.1016/0892-0354(89)90003-8; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P639, DOI 10.1021/bi00002a031; LANE NJ, 1965, J CELL BIOL, V27, P603, DOI 10.1083/jcb.27.3.603; Love DC, 1998, P NATL ACAD SCI USA, V95, P10608, DOI 10.1073/pnas.95.18.10608; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Mahajan R, 1998, J CELL BIOL, V140, P259, DOI 10.1083/jcb.140.2.259; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Matunis MJ, 1998, J CELL BIOL, V140, P499, DOI 10.1083/jcb.140.3.499; Maul GG, 1977, INT REV CYTOL S, P75; MCCULLOCH D, 1952, J EXP ZOOL, V119, P47, DOI 10.1002/jez.1401190105; MELCHIOR F, 1995, J CELL BIOL, V131, P571, DOI 10.1083/jcb.131.3.571; MERISKO EM, 1989, TISSUE CELL, V21, P343, DOI 10.1016/0040-8166(89)90049-9; Miller BR, 2000, TRAFFIC, V1, P941, DOI 10.1034/j.1600-0854.2000.011204.x; Murawala P, 2009, J CELL SCI, V122, P3113, DOI 10.1242/jcs.037523; Nikolaev AY, 2003, CELL, V112, P29, DOI 10.1016/S0092-8674(02)01255-2; Onischenko EA, 2004, TRAFFIC, V5, P152, DOI 10.1111/j.1600-0854.2004.0166.x; PALADE GE, 1955, J BIOPHYS BIOCHEM CY, V1, P567, DOI 10.1083/jcb.1.6.567; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Perez-Terzic C, 2003, CIRC RES, V92, P444, DOI 10.1161/01.RES.0000059415.25070.54; Rasala BA, 2008, MOL BIOL CELL, V19, P3982, DOI 10.1091/mbc.E08-01-0012; Rasala BA, 2006, P NATL ACAD SCI USA, V103, P17801, DOI 10.1073/pnas.0608484103; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Saitoh H, 1997, P NATL ACAD SCI USA, V94, P3736, DOI 10.1073/pnas.94.8.3736; SCHEER U, 1969, J CELL BIOL, V42, P519, DOI 10.1083/jcb.42.2.519; SCHULZ HERIBERT, 1957, ONCOLOGIA, V10, P307; Singh BB, 1999, J BIOL CHEM, V274, P37370, DOI 10.1074/jbc.274.52.37370; SWIFT HEWSON, 1956, JOUR BIOPHYS AND BIOCHEM CYTOL, V2, P415, DOI 10.1083/jcb.2.4.415; Tirard M, 2012, P NATL ACAD SCI USA, V109, P21122, DOI 10.1073/pnas.1215366110; Walther TC, 2003, NATURE, V424, P689, DOI 10.1038/nature01898; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; WEISSFELD AS, 1977, J CELL BIOL, V75, P889, DOI 10.1083/jcb.75.3.889; WEISSFELD AS, 1977, J CELL BIOL, V75, P881, DOI 10.1083/jcb.75.3.881; Werner A, 2012, MOL CELL, V46, P287, DOI 10.1016/j.molcel.2012.02.017; WU J, 1995, J BIOL CHEM, V270, P14209, DOI 10.1074/jbc.270.23.14209; Wu XS, 2001, P NATL ACAD SCI USA, V98, P3191, DOI 10.1073/pnas.051631598; Yaseen NR, 1999, J BIOL CHEM, V274, P26493, DOI 10.1074/jbc.274.37.26493; YOKOYAMA N, 1995, NATURE, V376, P184, DOI 10.1038/376184a0; Zhang H, 2002, MOL CELL BIOL, V22, P6498, DOI 10.1128/MCB.22.18.6498-6508.2002; Zhang XD, 2008, MOL CELL, V29, P729, DOI 10.1016/j.molcel.2008.01.013; Zhu SS, 2009, MOL CELL, V33, P570, DOI 10.1016/j.molcel.2009.02.008	82	9	9	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144508	10.1371/journal.pone.0144508	http://dx.doi.org/10.1371/journal.pone.0144508			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642330	Green Published, Green Submitted, gold			2022-12-27	WOS:000366902700136
J	Steinach, M; Kohlberg, E; Maggioni, MA; Mendt, S; Opatz, O; Stahn, A; Tiedemann, J; Gunga, HC				Steinach, Mathias; Kohlberg, Eberhard; Maggioni, Martina Anna; Mendt, Stefan; Opatz, Oliver; Stahn, Alexander; Tiedemann, Josefine; Gunga, Hanns-Christian			Changes of 25-OH-Vitamin D during Overwintering at the German Antarctic Stations Neumayer II and III	PLOS ONE			English	Article							VITAMIN-D STATUS; 25-HYDROXYVITAMIN D; DIETARY-INTAKE; D DEFICIENCY; BODY-COMPOSITION; SEASONAL-CHANGES; SERUM-LEVELS; FOOD; WOMEN; SUNLIGHT	Purpose Humans in Antarctica face different environmental challenges, such as low ultra-violet radiation, which is crucial for vitamin D production in humans. Therefore we assessed changes in 25-OH-vitamin D serum concentration during 13 months of overwintering at the German Stations Neumayer II and III (2007-2012). We hypothesized that (i) 25-OH-vitamin D serum concentration would significantly decrease, (ii) changes would be affected by age, gender, baseline (i.e. pre-overwintering) fat mass, baseline 25-OH-vitamin D serum concentration, and station residence, and (iii) our results would not differ from similar previous studies in comparable high latitudes. Materials & Methods 25-OH-vitamin D serum concentrations were determined before, after, and monthly during the campaigns from venous blood samples of n = 43 participants (28 men, 15 women). Baseline fat mass was determined via bio impedance analysis and body plethysmography. Data were analyzed for change over time, dependency on independent parameters, and after categorization for sufficiency (> 50nmol/l), insufficiency (25-50nmol/l), and deficiency (<25nmol/l). Results were compared with data from similar previous studies. Results We found a significant decrease of 25-OH-vitamin D with dependency on month. Age, gender, fat mass, and station residence had no influence. Only baseline 25-OH-vitamin D serum concentrations significantly affected subsequent 25-OH-vitamin D values. Conclusions Overwinterings at the Antarctic German research stations Neumayer II and III are associated with a decrease in 25-OH-vitamin D serum concentrations, unaffected by age, gender, baseline fat mass, and station residence. Higher baseline vitamin D serum concentrations might protect from subsequent deficiencies. Residence at the Neumayer Stations may lead to lower vitamin D serum concentrations than found in other comparable high latitudes.	[Steinach, Mathias; Maggioni, Martina Anna; Mendt, Stefan; Opatz, Oliver; Stahn, Alexander; Tiedemann, Josefine; Gunga, Hanns-Christian] Charite, Ctr Space Med & Extreme Environments Berlin, Inst Physiol, D-13353 Berlin, Germany; [Kohlberg, Eberhard] Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany; [Maggioni, Martina Anna] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Milan	Steinach, M (corresponding author), Charite, Ctr Space Med & Extreme Environments Berlin, Inst Physiol, D-13353 Berlin, Germany.	mathias.steinach@charite.de	Maggioni, Martina Anna A/M-2931-2016; Maggioni, Martina Anna/P-1351-2019	Maggioni, Martina Anna A/0000-0002-6319-8566; Maggioni, Martina Anna/0000-0002-6319-8566; Mendt, Stefan/0000-0001-8227-9655	Federal Ministry for Economic Affairs and Energy (BMWi, Berlin); German Space Administration (Raumfahrtmanagement DLR, Bonn-Oberkassel); German Aerospace Center (Deutsches Zentrum fur Luft- und Raumfahrt DLR, Cologne); Aktenzeichen 50 Forschung unter Weltraumbedingungen 0724 [AZ50WB0724]; Aktenzeichen 50 Forschung unter Weltraumbedingungen 1030 [AZ50WB1030]; Aktenzeichen 50 Forschung unter Weltraumbedingungen 1330 [AZ50WB1330]	Federal Ministry for Economic Affairs and Energy (BMWi, Berlin)(Federal Ministry for Economic Affairs and Energy (BMWi)); German Space Administration (Raumfahrtmanagement DLR, Bonn-Oberkassel); German Aerospace Center (Deutsches Zentrum fur Luft- und Raumfahrt DLR, Cologne); Aktenzeichen 50 Forschung unter Weltraumbedingungen 0724; Aktenzeichen 50 Forschung unter Weltraumbedingungen 1030; Aktenzeichen 50 Forschung unter Weltraumbedingungen 1330	All grants were received by the Federal Ministry for Economic Affairs and Energy (BMWi, Berlin, website:http://www.bmwi.de/en), the German Space Administration (Raumfahrtmanagement DLR, Bonn-Oberkassel, website:http://www.dlr.de/rd/en), and the German Aerospace Center (Deutsches Zentrum fur Luft- und Raumfahrt DLR, Cologne, website:http://www.dlr.de/dlr/en). Grant numbers: "Aktenzeichen 50 Forschung unter Weltraumbedingungen 0724" (AZ50WB0724), "Aktenzeichen 50 Forschung unter Weltraumbedingungen 1030" (AZ50WB1030), "Aktenzeichen 50 Forschung unter Weltraumbedingungen 1330" (AZ50WB1330). Initials of author who received funding: HCG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud M, 2014, J STEROID BIOCHEM, V144, P232, DOI 10.1016/j.jsbmb.2013.10.020; Afzal S, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6330; Andersen R, 2013, EUR J CLIN NUTR, V67, P270, DOI 10.1038/ejcn.2013.3; Andersen S, 2013, BRIT J NUTR, V110, P50, DOI 10.1017/S0007114512004709; Anderson LN, 2010, CAN J PUBLIC HEALTH, V101, P318, DOI 10.1007/BF03405294; Arabi A, 2010, BONE, V47, P408, DOI 10.1016/j.bone.2010.05.002; AWI, 2012, A WEG I POL MAR RES; Baeke F, 2010, CURR OPIN PHARMACOL, V10, P482, DOI 10.1016/j.coph.2010.04.001; Bersamin A, 2008, J AM DIET ASSOC, V108, P266, DOI 10.1016/j.jada.2007.10.046; Bhattacharyya M, 2008, INT J BIOMETEOROL, V52, P869, DOI 10.1007/s00484-008-0183-2; Bikle D, 2009, J CLIN ENDOCR METAB, V94, P26, DOI 10.1210/jc.2008-1454; Brustad M, 2004, PUBLIC HEALTH NUTR, V7, P327, DOI 10.1079/PHN2003536; Brustad M, 2007, PHOTOCH PHOTOBIO SCI, V6, P903, DOI 10.1039/b702947k; Brustad Magritt, 2003, Int J Circumpolar Health, V62, P40; Cattermole TJ, 1999, AVIAT SPACE ENVIR MD, V70, P135; Clark MK, 2011, OBES RES CLIN PRACT, V5, pE85, DOI 10.1016/j.orcp.2010.09.180; Custaud MA, 2004, EUR J APPL PHYSIOL, V91, P508, DOI 10.1007/s00421-003-1027-8; Ebling FJP, 2008, J NEUROENDOCRINOL, V20, P827, DOI 10.1111/j.1365-2826.2008.01721.x; EDHOLM OG, 1966, P NUTR SOC, V25, P113, DOI 10.1079/PNS19660025; FAIRNEY A, 1979, POSTGRAD MED J, V55, P248, DOI 10.1136/pgmj.55.642.248; Fields DA, 2002, AM J CLIN NUTR, V75, P453, DOI 10.1093/ajcn/75.3.453; Gangwisch JE, 2009, OBES REV, V10, P37, DOI 10.1111/j.1467-789X.2009.00663.x; Ganji Vijay, 2010, Int Arch Med, V3, P29, DOI 10.1186/1755-7682-3-29; Garland CF, 2009, ANN EPIDEMIOL, V19, P468, DOI 10.1016/j.annepidem.2009.03.021; Gombart AF, 2009, FUTURE MICROBIOL, V4, P1151, DOI 10.2217/FMB.09.87; Grant WB, 2011, EUR J CLIN NUTR, V65, P1016, DOI 10.1038/ejcn.2011.68; GUENTER CA, 1970, ARCH INTERN MED, V125, P630, DOI 10.1001/archinte.125.4.630; Gulseth HL, 2013, CURR VASC PHARMACOL, V11, P968, DOI 10.2174/15701611113119990169; HARFORD RR, 1993, METABOLISM, V42, P1159, DOI 10.1016/0026-0495(93)90274-R; Heaney RP, 2011, J BONE MINER RES, V26, P455, DOI 10.1002/jbmr.328; HOLICK MF, 1989, LANCET, V2, P1104; Holick MF, 1999, BIOLOGIC EFFECTS OF LIGHT 1998, P11; Holick MF, 2008, AM J CLIN NUTR, V87, p1080S; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2009, ANN EPIDEMIOL, V19, P73, DOI 10.1016/j.annepidem.2007.12.001; Hollis BW, 2005, J NUTR, V135, P317, DOI 10.1093/jn/135.2.317; Hollis BW, 1996, CALCIFIED TISSUE INT, V58, P4, DOI 10.1007/s002239900002; Huotari A, 2008, INT J CIRCUMPOL HEAL, V67, P164, DOI 10.3402/ijch.v67i2-3.18258; KENNAWAY DJ, 1991, AM J PHYSIOL, V260, pR1137, DOI 10.1152/ajpregu.1991.260.6.R1137; Kim SH, 2014, PUBLIC HEALTH NUTR, V17, P122, DOI 10.1017/S1368980012004703; Kulie T, 2009, J AM BOARD FAM MED, V22, P698, DOI 10.3122/jabfm.2009.06.090037; Kull M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-22; Laaksi IT, 2006, EUR J CLIN NUTR, V60, P1035, DOI 10.1038/sj.ejcn.1602414; Lehmann B, 2012, VITAMIN D UPDATE 201, P1; Looker AC, 2008, AM J CLIN NUTR, V88, P1519, DOI 10.3945/ajcn.2008.26182; Luick B, 2014, INT J CIRCUMPOL HEAL, V73, DOI 10.3402/ijch.v73.22732; LUND B, 1979, SCAND J CLIN LAB INV, V39, P23, DOI 10.3109/00365517909104935; Maalouf NM, 2008, CURR OPIN NEPHROL HY, V17, P408, DOI 10.1097/MNH.0b013e3283040c99; Macdonald HM, 2008, BONE, V42, P996, DOI 10.1016/j.bone.2008.01.011; MACLAUGHLIN J, 1985, J CLIN INVEST, V76, P1536, DOI 10.1172/JCI112134; Maillet A, 1995, J GRAVIT PHYSL, V2, P25; Malabanan A, 1998, LANCET, V351, P805, DOI 10.1016/S0140-6736(05)78933-9; Mattila PH, 2011, J AGR FOOD CHEM, V59, P8298, DOI 10.1021/jf2012634; MCLAUGHLIN M, 1974, LANCET, V1, P536; OLIVERI MB, 1994, EUR J CLIN NUTR, V48, P397; Ovesen L, 2003, ANN NUTR METAB, V47, P107, DOI 10.1159/000070031; Palinkas LA, 2000, AVIAT SPACE ENVIR MD, V71, P619; Palinkas LA, 2008, LANCET, V371, P153, DOI 10.1016/S0140-6736(07)61056-3; PARKER RH, 1985, EUR J APPL PHYSIOL, V54, P363, DOI 10.1007/BF02337179; Pearce SHS, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5664; Persson K, 2013, ACTA PAEDIATR, V102, P644, DOI 10.1111/apa.12172; Piirainen T, 2007, EUR J CLIN NUTR, V61, P123, DOI 10.1038/sj.ejcn.1602506; Premkumar M, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0129-0; REED HL, 1990, J CLIN ENDOCR METAB, V70, P965, DOI 10.1210/jcem-70-4-965; Rejnmark L, 2004, CALCIFIED TISSUE INT, V74, P255, DOI 10.1007/s00223-003-0110-9; Rodriguez-Rodriguez E, 2009, OBESITY, V17, P778, DOI 10.1038/oby.2008.649; ROTHBLUM ED, 1990, J PSYCHOL, V124, P253, DOI 10.1080/00223980.1990.10543221; Sharma S, 2011, NUTR REV, V69, P468, DOI 10.1111/j.1753-4887.2011.00406.x; Shearer WT, 2002, J ALLERGY CLIN IMMUN, V109, P854, DOI 10.1067/mai.2002.123873; Smith SM, 2009, AM J CLIN NUTR, V89, P1092, DOI 10.3945/ajcn.2008.27189; Sohl E, 2013, OSTEOPOROSIS INT, V24, P187, DOI 10.1007/s00198-012-2124-5; Soni M, 2012, SCAND J CLIN LAB INV, V72, P79, DOI 10.3109/00365513.2012.681969; Stahn A, 2014, HUMAN PHYSL EXTREME; Stahn A, 2013, HDB ANTHROPOMETRY PH; Strassl H, 1951, POLARFORSCHUNG, V21, P40; Sun SS, 2003, AM J CLIN NUTR, V77, P331, DOI 10.1093/ajcn/77.2.331; Taylor CL, 2014, J NUTR, V144, P654, DOI 10.3945/jn.113.189811; Valtuena J, 2013, QJM-INT J MED, V106, P809, DOI 10.1093/qjmed/hct089; Vats P, 2005, NUTR NEUROSCI, V8, P233, DOI 10.1080/10284150500193726; Vieth R, 2005, ANN MED, V37, P278, DOI 10.1080/07853890510007313; Vieth R, 2007, AM J CLIN NUTR, V85, P649, DOI 10.1093/ajcn/85.3.649; Wacker M, 2013, DERM-ENDOCRINOL, V5, DOI [10.4161/derm.24476, 10.4161/derm.24494]; Wacker M, 2013, NUTRIENTS, V5, P111, DOI 10.3390/nu5010111; Webb AR, 2006, PROG BIOPHYS MOL BIO, V92, P17, DOI 10.1016/j.pbiomolbio.2006.02.004; WEBB AR, 1988, J CLIN ENDOCR METAB, V67, P373, DOI 10.1210/jcem-67-2-373; Whiting SJ, 2005, J NUTR, V135, P304, DOI 10.1093/jn/135.2.304; Wolff AE, 2008, NAT CLIN PRACT RHEUM, V4, P580, DOI 10.1038/ncprheum0921; Zerath E, 1999, EUR J APPL PHYSIOL, V79, P141, DOI 10.1007/s004210050487	89	7	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144130	10.1371/journal.pone.0144130	http://dx.doi.org/10.1371/journal.pone.0144130			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641669	Green Published, gold, Green Submitted			2022-12-27	WOS:000366902700060
J	Whisenant, TC; Peralta, ER; Aarreberg, LD; Gao, NJ; Head, SR; Ordoukhanian, P; Williamson, JR; Salomon, DR				Whisenant, Thomas C.; Peralta, Eigen R.; Aarreberg, Lauren D.; Gao, Nina J.; Head, Steven R.; Ordoukhanian, Phillip; Williamson, Jamie R.; Salomon, Daniel R.			The Activation-Induced Assembly of an RNA/Protein Interactome Centered on the Splicing Factor U2AF2 Regulates Gene Expression in Human CD4 T Cells	PLOS ONE			English	Article							PRE-MESSENGER-RNA; HNRNP-L; SITE RECOGNITION; PROTEIN; EXON; BINDING; MECHANISMS; NETWORKS; PHOSPHORYLATION; DIFFERENTIATION	Activation of CD4 T cells is a reaction to challenges such as microbial pathogens, cancer and toxins that defines adaptive immune responses. The roles of T cell receptor crosslinking, intracellular signaling, and transcription factor activation are well described, but the importance of post-transcriptional regulation by RNA-binding proteins (RBPs) has not been considered in depth. We describe a new model expanding and activating primary human CD4 T cells and applied this to characterizing activation-induced assembly of splicing factors centered on U2AF2. We immunoprecipitated U2AF2 to identify what mRNA transcripts were bound as a function of activation by TCR crosslinking and costimulation. In parallel, mass spectrometry revealed the proteins incorporated into the U2AF2-centered RNA/protein interactome. Molecules that retained interaction with the U2AF2 complex after RNAse treatment were designated as "central" interactome members (CIMs). Mass spectrometry also identified a second class of activation-induced proteins, "peripheral" interacto memembers (PIMs), that bound to the same transcripts but were not in physical association with U2AF2 or its partners. siRNA knockdown of two CIMs and two PIMs caused changes in activation marker expression, cytokine secretion, and gene expression that were unique to each protein and mapped to pathways associated with key aspects of T cell activation. While knocking down the PIM, SYNCRIP, impacts a limited but immunologically important set of U2AF2-bound transcripts, knockdown of U2AF1 significantly impairs assembly of the majority of protein and mRNA components in the activation-induced interactome. These results demonstrated that CIMs and PIMs, either directly or indirectly through RNA, assembled into activation-induced U2AF2 complexes and play roles in post-transcriptional regulation of genes related to cytokine secretion. These data suggest an additional layer of regulation mediated by the activation-induced assembly of RNA splicing interactomes that is important for understanding T cell activation.	[Whisenant, Thomas C.; Peralta, Eigen R.; Aarreberg, Lauren D.; Gao, Nina J.; Salomon, Daniel R.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Williamson, Jamie R.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Head, Steven R.; Ordoukhanian, Phillip] Scripps Res Inst, NGS & Microarray Core Facil, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Salomon, DR (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA.	dsalomon@scripps.edu	Williamson, James/AAL-2104-2021; Williamson, James R/B-2891-2009	Williamson, James/0000-0002-8772-468X; Williamson, James R/0000-0002-8772-468X; Gao, Nina/0000-0003-4314-3805; Hatfield, Lauren D/0000-0003-0095-9863	National Institute of Health [U01 GM094653, U19 A1063603]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI063603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM094653] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of Health (www.nih.gov)-U01 GM094653 to TCW, ERP, LDA, NJG, JRW, and DRS, with additional funding from National Institute of Health (www.nih.gov)-U19 A1063603 to SRH, PO, and DRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubol BE, 2013, J MOL BIOL, V425, P2894, DOI 10.1016/j.jmb.2013.05.013; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Brooks AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087361; Chen SS, 2013, J MOL BIOL, V425, P767, DOI 10.1016/j.jmb.2012.11.040; Chiou NT, 2013, MOL CELL, V49, P972, DOI 10.1016/j.molcel.2012.12.025; Cho SY, 2011, P NATL ACAD SCI USA, V108, P8233, DOI 10.1073/pnas.1017700108; Cho V, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r26; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Corrionero A, 2011, RNA, V17, P401, DOI 10.1261/rna.2444811; Di Fusco D, 2014, EXPERT OPIN THER TAR, V18, P1329, DOI 10.1517/14728222.2014.945426; Emig D, 2010, NUCLEIC ACIDS RES, V38, pW755, DOI 10.1093/nar/gkq405; Faye MD, 2013, MOL CELL BIOL, V33, P307, DOI 10.1128/MCB.00546-12; Fu Y, 2011, NUCLEIC ACIDS RES, V39, P4396, DOI 10.1093/nar/gkr026; Gama-Carvalho M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r113; Ghosh G, 2011, FEBS J, V278, P587, DOI 10.1111/j.1742-4658.2010.07992.x; Graber TE, 2010, CELL DEATH DIFFER, V17, P719, DOI 10.1038/cdd.2009.164; Grigoryev YA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007906; Hart T, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-778; Heiner M, 2010, RNA BIOL, V7, P56, DOI 10.4161/rna.7.1.10402; Ip JY, 2007, RNA, V13, P563, DOI 10.1261/rna.457207; JANEWAY CA, 1992, ANNU REV IMMUNOL, V10, P645, DOI 10.1146/annurev.immunol.10.1.645; Jin WX, 2012, FEBS LETT, V586, P3852, DOI 10.1016/j.febslet.2012.09.006; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kielkopf CL, 2001, CELL, V106, P595, DOI 10.1016/S0092-8674(01)00480-9; Kralovicova J, 2015, NUCLEIC ACIDS RES, V43, P3747, DOI 10.1093/nar/gkv194; LEDBETTER JA, 1993, CURR OPIN IMMUNOL, V5, P334, DOI 10.1016/0952-7915(93)90050-3; Mallory MJ, 2015, P NATL ACAD SCI USA, V112, pE2139, DOI 10.1073/pnas.1423695112; Martinez NM, 2013, IMMUNOL REV, V253, P216, DOI 10.1111/imr.12047; Martinez NM, 2012, RNA, V18, P1029, DOI 10.1261/rna.032243.112; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Melton AA, 2007, MOL CELL BIOL, V27, P6972, DOI 10.1128/MCB.00419-07; Soares LMM, 2006, SCIENCE, V312, P1961, DOI 10.1126/science.1128659; Millevoi S, 2006, EMBO J, V25, P4854, DOI 10.1038/sj.emboj.7601331; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Naito T, 2011, INT IMMUNOL, V23, P661, DOI 10.1093/intimm/dxr078; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Okunola HL, 2009, MOL CELL BIOL, V29, P5620, DOI 10.1128/MCB.01678-08; Pacheco TR, 2006, MOL CELL BIOL, V26, P8183, DOI 10.1128/MCB.00350-06; Parrish-Novak J, 2002, J LEUKOCYTE BIOL, V72, P856; Tavanez JP, 2012, MOL CELL, V45, P314, DOI 10.1016/j.molcel.2011.11.033; Podshivalova K, 2013, CRIT REV IMMUNOL, V33, P435, DOI 10.1615/CritRevImmunol.2013006858; Popova AM, 2014, J AM CHEM SOC, V136, P2058, DOI 10.1021/ja412084b; Preussner M, 2012, NUCLEIC ACIDS RES, V40, P5666, DOI 10.1093/nar/gks221; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; RUSKIN B, 1988, CELL, V52, P207, DOI 10.1016/0092-8674(88)90509-0; SCHNEIDER U, 1977, INT J CANCER, V19, P621, DOI 10.1002/ijc.2910190505; Shao CW, 2014, NAT STRUCT MOL BIOL, V21, P997, DOI 10.1038/nsmb.2906; Singh G, 2015, ANNU REV BIOCHEM, V84, P325, DOI 10.1146/annurev-biochem-080111-092106; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Tisserant A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001418; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wang M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-225; Warf MB, 2010, TRENDS BIOCHEM SCI, V35, P169, DOI 10.1016/j.tibs.2009.10.004; Whistler T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-496; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I; Wu SP, 1999, NATURE, V402, P832, DOI 10.1038/45590; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Xie Aini, 2012, J Clin Cell Immunol, VSuppl 9, P1; Yamane H, 2013, IMMUNOL REV, V252, P12, DOI 10.1111/imr.12032; Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078644; Zhou ZH, 2013, CHROMOSOMA, V122, P191, DOI 10.1007/s00412-013-0407-z; Zhu JF, 2010, IMMUNOL REV, V238, P247, DOI 10.1111/j.1600-065X.2010.00951.x; Zuo P, 1996, GENE DEV, V10, P1356, DOI 10.1101/gad.10.11.1356	65	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144409	10.1371/journal.pone.0144409	http://dx.doi.org/10.1371/journal.pone.0144409			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641092	Green Published, gold, Green Submitted			2022-12-27	WOS:000366902700111
J	Zughaier, SM; Kandler, JL; Balthazar, JT; Shafer, WM				Zughaier, Susu M.; Kandler, Justin L.; Balthazar, Jacqueline T.; Shafer, William M.			Phosphoethanolamine Modification of Neisseria gonorrhoeae Lipid A Reduces Autophagy Flux in Macrophages	PLOS ONE			English	Article							CATIONIC ANTIMICROBIAL PEPTIDES; NORMAL HUMAN SERUM; GONOCOCCAL-INFECTION; IN-VIVO; MYCOBACTERIUM-TUBERCULOSIS; HELICOBACTER-PYLORI; INNATE IMMUNITY; PROTECTIVE ROLE; RESISTANCE; INDUCTION	Autophagy, an ancient homeostasis mechanism for macromolecule degradation, performs an important role in host defense by facilitating pathogen elimination. To counteract this host defense strategy, bacterial pathogens have evolved a variety of mechanisms to avoid or otherwise dysregulate autophagy by phagocytic cells so as to enhance their survival during infection. Neisseria gonorrhoeae is a strictly human pathogen that causes the sexually transmitted infection, gonorrhea. Phosphoethanolamine (PEA) addition to the 4' position of the lipid A (PEA-lipid A) moiety of the lipooligosaccharide (LOS) produced by gonococci performs a critical role in this pathogen's ability to evade innate defenses by conferring decreased susceptibility to cationic antimicrobial (or host-defense) peptides, complement-mediated killing by human serum and intraleukocytic killing by human neutrophils compared to strains lacking this PEA decoration. Heretofore, however, it was not known if gonococci can evade autophagy and if so, whether PEA-lipid A contributes to this ability. Accordingly, by using murine macrophages and human macrophage-like phagocytic cell lines we investigated if PEA decoration of gonococcal lipid A modulates autophagy formation. We report that infection with PEA-lipid A-producing gonococci significantly reduced autophagy flux in murine and human macrophages and enhanced gonococcal survival during their association with macrophages compared to a PEA-deficient lipid A mutant. Our results provide further evidence that PEA-lipid A produced by gonococci is a critical component in the ability of this human pathogen to evade host defenses.	[Zughaier, Susu M.; Shafer, William M.] Dept Vet Affairs Med Ctr Decatur, Lab Bacterial Pathogenesis, Atlanta, GA 30033 USA; [Zughaier, Susu M.; Kandler, Justin L.; Balthazar, Jacqueline T.; Shafer, William M.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Shafer, William M.] Emory Univ, Sch Med, Emory Antibiot Resistance Ctr, Atlanta, GA USA	Emory University; Emory University	Zughaier, SM (corresponding author), Dept Vet Affairs Med Ctr Decatur, Lab Bacterial Pathogenesis, Atlanta, GA 30033 USA.	szughai@emory.edu	Zughaier, Susu/GLQ-9288-2022; Zughaier, Susu/N-3185-2019	Zughaier, Susu/0000-0001-7487-8770	VA Merit Award from the Biomedical Laboratory Research and Development Service of the Department of Veterans Affairs [510 1BX000112-07]; Development Research Program grant from the Henry M. Jackson Foundation through NIH grant [1U19AI113170-01]; Senior Research Career Award from the Biomedical Laboratory Research and Development Service of the Department of Veterans Affairs; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI113170] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000112] Funding Source: NIH RePORTER	VA Merit Award from the Biomedical Laboratory Research and Development Service of the Department of Veterans Affairs; Development Research Program grant from the Henry M. Jackson Foundation through NIH grant; Senior Research Career Award from the Biomedical Laboratory Research and Development Service of the Department of Veterans Affairs; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by a VA Merit Award grant (510 1BX000112-07) to WMS. from the Biomedical Laboratory Research and Development Service of the Department of Veterans Affairs. SMZ was supported by a Development Research Program grant from the Henry M. Jackson Foundation through NIH grant 1U19AI113170-01 (Ann E. Jerse, PI, Uniformed Services University, Bethesda, MD). WMS was supported by a Senior Research Career Award from the Biomedical Laboratory Research and Development Service of the Department of Veterans Affairs. The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Department of Veterans Affairs or the United States Government.	Ahuja SK, 1996, J BIOL CHEM, V271, P20545, DOI 10.1074/jbc.271.34.20545; Al-Younes HM, 2004, INFECT IMMUN, V72, P4751, DOI 10.1128/IAI.72.8.4751-4762.2004; Amer AO, 2005, CELL MICROBIOL, V7, P765, DOI 10.1111/j.1462-5822.2005.00509.x; Bergman P, 2005, CELL MICROBIOL, V7, P1009, DOI 10.1111/j.1462-5822.2005.00530.x; Bolan GA, 2012, NEW ENGL J MED, V366, P485, DOI 10.1056/NEJMp1112456; Burman C, 2010, SEMIN IMMUNOPATHOL, V32, P397, DOI 10.1007/s00281-010-0222-z; Lerena MC, 2011, CELL MICROBIOL, V13, P814, DOI 10.1111/j.1462-5822.2011.01581.x; Chong A, 2012, AUTOPHAGY, V8, P1342, DOI 10.4161/auto.20808; Choy A, 2012, SCIENCE, V338, P1072, DOI 10.1126/science.1227026; Czeslick E, 2006, INFLAMM RES, V55, P511, DOI 10.1007/s00011-006-6057-3; Deuretzbacher A, 2009, J IMMUNOL, V183, P5847, DOI 10.4049/jimmunol.0804242; Dong N, 2012, CELL, V150, P1029, DOI 10.1016/j.cell.2012.06.050; Dortet L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002168; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Duncan JA, 2009, J IMMUNOL, V182, P6460, DOI 10.4049/jimmunol.0802696; Fine KL, 2012, CELL MICROBIOL, V14, P1402, DOI 10.1111/j.1462-5822.2012.01804.x; Fritz T, 2011, GUT, V60, P1580, DOI 10.1136/gut.2009.206466; Guo F, 2012, CELL MOL BIOL LETT, V17, P249, DOI 10.2478/s11658-012-0009-4; Gutierrez MG, 2005, CELL MICROBIOL, V7, P981, DOI 10.1111/j.1462-5822.2005.00527.x; Handing JW, 2015, CELL MICROBIOL, V17, P910, DOI 10.1111/cmi.12411; Harris J, 2011, J BIOL CHEM, V286, P9587, DOI 10.1074/jbc.M110.202911; Hisamatsu T, 2013, PHARMACOL THERAPEUT, V137, P283, DOI 10.1016/j.pharmthera.2012.10.008; Hobbs MM, 2013, MBIO, V4, DOI 10.1128/mBio.00892-13; Huang J, 2014, NAT REV MICROBIOL, V12, P101, DOI 10.1038/nrmicro3160; Huang J, 2009, P NATL ACAD SCI USA, V106, P6226, DOI 10.1073/pnas.0811045106; Jia KL, 2007, AUTOPHAGY, V3, P21, DOI 10.4161/auto.3528; John CM, 2009, J LIPID RES, V50, P424, DOI 10.1194/jlr.M800184-JLR200; Johnson MB, 2013, CELL MICROBIOL, V15, P1323, DOI 10.1111/cmi.12117; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kandler JL, 2014, ANTIMICROB AGENTS CH, V58, P4230, DOI 10.1128/AAC.03108-14; Klose J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095970; Lee EH, 1999, MOL MICROBIOL, V33, P839, DOI 10.1046/j.1365-2958.1999.01530.x; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Lewis LA, 2013, INFECT IMMUN, V81, P33, DOI 10.1128/IAI.00751-12; Lewis LA, 2009, INFECT IMMUN, V77, P1112, DOI 10.1128/IAI.01280-08; Luciani A, 2012, AUTOPHAGY, V8, P1657, DOI 10.4161/auto.21483; Luciani A, 2010, NAT CELL BIOL, V12, P863, DOI 10.1038/ncb2090; LUSTER AD, 1985, NATURE, V315, P672, DOI 10.1038/315672a0; Mostowy S, 2011, J BIOL CHEM, V286, P26987, DOI 10.1074/jbc.M111.223610; Niu H, 2008, CELL MICROBIOL, V10, P593, DOI 10.1111/j.1462-5822.2007.01068.x; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Ogawa M, 2009, METHOD ENZYMOL, V452, P363, DOI 10.1016/S0076-6879(08)03622-7; Packiam M, 2012, MUCOSAL IMMUNOL, V5, P19, DOI 10.1038/mi.2011.38; Packiam M, 2014, INFECT IMMUN, V82, P2170, DOI 10.1128/IAI.01504-14; Packiam M, 2010, INFECT IMMUN, V78, P433, DOI 10.1128/IAI.00711-09; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Pujol C, 2009, INFECT IMMUN, V77, P2251, DOI 10.1128/IAI.00068-09; Raju D, 2012, AUTOPHAGY, V8, P1387, DOI 10.4161/auto.21007; Raju D, 2012, GASTROENTEROLOGY, V142, P1160, DOI 10.1053/j.gastro.2012.01.043; Romagnoli A, 2012, AUTOPHAGY, V8, P1357, DOI 10.4161/auto.20881; Rossignol DP, 2002, J ENDOTOXIN RES, V8, P483, DOI 10.1179/096805102125001127; Sato E, 2013, J DERMATOL SCI, V70, P166, DOI 10.1016/j.jdermsci.2013.01.011; Schnaith A, 2007, J BIOL CHEM, V282, P2695, DOI 10.1074/jbc.M609784200; SHAFER WM, 1986, INFECT IMMUN, V54, P184, DOI 10.1128/IAI.54.1.184-188.1986; Shafer WM, 1998, P NATL ACAD SCI USA, V95, P1829, DOI 10.1073/pnas.95.4.1829; Shafer WM, 2002, J ENDOTOXIN RES, V8, P47, DOI 10.1179/096805102125000083; SHAFER WM, 1984, J INFECT DIS, V149, P175, DOI 10.1093/infdis/149.2.175; Shahnazari S, 2011, AUTOPHAGY, V7, P957, DOI 10.4161/auto.7.9.16435; Shin DM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001230; Shultz TR, 2001, ANTIMICROB AGENTS CH, V45, P734, DOI 10.1128/AAC.45.3.734-738.2001; Sims K, 2010, J BIOL CHEM, V285, P38568, DOI 10.1074/jbc.M110.170621; Stankowski RV, 2012, SEX TRANSM DIS, V39, P238, DOI 10.1097/OLQ.0b013e3182471974; Tattoli I, 2012, AUTOPHAGY, V8, P1848, DOI 10.4161/auto.21863; Tattoli I, 2012, CELL HOST MICROBE, V11, P563, DOI 10.1016/j.chom.2012.04.012; Tzeng YL, 2005, J BACTERIOL, V187, P5387, DOI 10.1128/JB.187.15.5387-5396.2005; Ubale RV, 2013, J MICROENCAPSUL, V30, P28, DOI 10.3109/02652048.2012.692402; Uchiyama Y, 2008, HISTOCHEM CELL BIOL, V129, P407, DOI 10.1007/s00418-008-0406-y; Unemo M, 2014, CLIN MICROBIOL REV, V27, P587, DOI 10.1128/CMR.00010-14; Vidal R, 2011, CURR MOL MED, V11, P1, DOI 10.2174/156652411794474419; Wang CH, 2012, P NATL ACAD SCI USA, V109, P11008, DOI 10.1073/pnas.1203952109; Warner DM, 2008, MOL MICROBIOL, V70, P462, DOI 10.1111/j.1365-2958.2008.06424.x; Weis SN, 2014, NEUROSCIENCE, V256, P201, DOI 10.1016/j.neuroscience.2013.10.046; Weiss G, 2015, IMMUNOL REV, V264, P182, DOI 10.1111/imr.12266; World Health Organization, 2011, EM MULT RES NEISS GO; Xu Y, 2008, AUTOPHAGY, V4, P110, DOI 10.4161/auto.5225; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yoshikawa Y, 2009, NAT CELL BIOL, V11, P1233, DOI 10.1038/ncb1967; Zughaier SM, 2005, INFECT IMMUN, V73, P2940, DOI 10.1128/IAI.73.5.2940-2950.2005; Zughaier S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009165; Zughaier SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087688; Zughaier SM, 2011, J LEUKOCYTE BIOL, V89, P469, DOI 10.1189/jlb.0610369	82	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144347	10.1371/journal.pone.0144347	http://dx.doi.org/10.1371/journal.pone.0144347			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641098	Green Published, Green Submitted, gold			2022-12-27	WOS:000366902700102
J	Birget, PLG; Koella, JC				Birget, Philip L. G.; Koella, Jacob C.			An Epidemiological Model of the Effects of Insecticide-Treated Bed Nets on Malaria Transmission	PLOS ONE			English	Article							WESTERN KENYA; VECTOR CONTROL; IMPREGNATED BEDNETS; MATHEMATICAL-MODEL; MOSQUITOS DIPTERA; FIELD-EVALUATION; CHILD-MORTALITY; IMPACT; REPELLENTS; AREA	Insecticide-treated bed nets (ITNs) have become a central tool for malaria control because they provide personal and community-wide protection through their repellent and insecticidal properties. Here we propose a model that allows to assess the relative importance of those two effects in different epidemiological contexts and we show that these two levels of protection may oppose each other. On the one hand, repellency offers personal protection to the users of ITNs. The repellent action, however, is a two-edged sword, for it diverts infectious mosquitoes to non-users, thereby increasing their risk. Furthermore, with increasing ITN coverage, the personal protection effect of repellency decreases as mosquitoes are forced to perform multiple feeding attempts even on ITN users. On the other hand, the insecticidal property, which offers community-wide protection by killing mosquitoes, requires that mosquitoes contact the insecticide on the ITN and is thus counteracted by the repellency. Our model confirms that ITNs are an effective intervention method by reducing total malaria prevalence in the population, but that there is a conflict between personal protection, offered by repellency, and community-wide protection, which relies on the ITN's insecticidal properties. Crucially, the model suggests that weak repellency allows disease elimination at lower ITN coverage levels.	[Birget, Philip L. G.] Univ London Imperial Coll Sci Technol & Med, Silwood Pk, Ascot, Berks, England; [Koella, Jacob C.] Univ Neuchatel, Inst Biol, CH-2000 Neuchatel, Switzerland	Imperial College London; University of Neuchatel	Birget, PLG (corresponding author), Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland.	p.l.g.birget@sms.ed.ac.uk						ALONSO PL, 1991, LANCET, V337, P1499, DOI 10.1016/0140-6736(91)93194-E; Aponte JJ, 2007, PLOS MED, V4, P1259, DOI 10.1371/journal.pmed.0040242; Aron J.L., 1982, P139; Atieli HE, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-113; Bayoh MN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-62; Bejon P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008321; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Binka FN, 1998, AM J TROP MED HYG, V59, P80, DOI 10.4269/ajtmh.1998.59.80; Birget Philip L. G., 2015, Evolution Medicine and Public Health, P205, DOI 10.1093/emph/eov019; Bousema T, 2014, NAT REV MICROBIOL, V12, P833, DOI 10.1038/nrmicro3364; Chen-Hussey V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070664; Chitnis N, 2008, B MATH BIOL, V70, P1272, DOI 10.1007/s11538-008-9299-0; Chitnis Nakul, 2008, Journal of Biological Dynamics, V2, P259, DOI 10.1080/17513750701769857; Clarke SE, 2001, T ROY SOC TROP MED H, V95, P457, DOI 10.1016/S0035-9203(01)90001-X; Debboun M, 2013, MED VET ENTOMOL, V27, P1, DOI 10.1111/j.1365-2915.2012.01020.x; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Gimnig JE, 2003, AM J TROP MED HYG, V68, P16, DOI 10.4269/ajtmh.2003.68.16; Gu WD, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-256; GUPTA RK, 1994, AM J TROP MED HYG, V50, P82, DOI 10.4269/ajtmh.1994.50.82; Gupta S, 1999, NAT MED, V5, P340, DOI 10.1038/6560; Hawley WA, 2003, AM J TROP MED HYG, V68, P121, DOI 10.4269/ajtmh.2003.68.121; Hay SI, 2008, LANCET INFECT DIS, V8, P369, DOI 10.1016/S1473-3099(08)70069-0; Hewitt S, 1997, B ENTOMOL RES, V87, P455, DOI 10.1017/S0007485300041316; Howard SC, 2000, T ROY SOC TROP MED H, V94, P357, DOI 10.1016/S0035-9203(00)90103-2; Iwashita H, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-52; Jagannathan P, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-435; Kawada H, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-208; Killeen GF, 2007, PLOS MED, V4, P1246, DOI 10.1371/journal.pmed.0040229; Killeen GF, 2007, T ROY SOC TROP MED H, V101, P867, DOI 10.1016/j.trstmh.2007.04.022; Killeen GF, 2006, AM J TROP MED HYG, V75, P38, DOI 10.4269/ajtmh.2006.75.2_suppl.0750038; Killeen GF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-146; Killeen GF, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-207; Killeen GF, 2001, T ROY SOC TROP MED H, V95, P469, DOI 10.1016/S0035-9203(01)90005-7; Killeen GF, 2000, AM J TROP MED HYG, V62, P535, DOI 10.4269/ajtmh.2000.62.535; Kiszewski AE, 2010, J VECTOR DIS, V47, P217; Kiware SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037661; Klepac P, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0137; KOELLA JC, 1991, ACTA TROP, V49, P1, DOI 10.1016/0001-706X(91)90026-G; Kweka EJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-59; Le Menach A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-10; Lindblade KA, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0554-1; LINDSAY SW, 1992, B ENTOMOL RES, V82, P49, DOI 10.1017/S0007485300051488; Macdonald G., 1952, Tropical Diseases Bulletin, V49, P569; MAGESA SM, 1991, ACTA TROP, V49, P97, DOI 10.1016/0001-706X(91)90057-Q; Mathenge EM, 2001, J MED ENTOMOL, V38, P531, DOI 10.1603/0022-2585-38.4.531; Menger DJ, 2014, MED VET ENTOMOL, V28, P407, DOI 10.1111/mve.12061; Moore SJ, 2007, J MED ENTOMOL, V44, P624, DOI 10.1603/0022-2585(2007)44[624:FEOTUP]2.0.CO;2; Mutuku FM, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-356; Ngwa GA, 2000, MATH COMPUT MODEL, V32, P747, DOI 10.1016/S0895-7177(00)00169-2; Padonou GG, 2012, PARASITE VECTOR, V5, P1; Ross R., 1910, PREVENTION MALARIA; Russell TL, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-187; SAUL AJ, 1990, J APPL ECOL, V27, P123, DOI 10.2307/2403572; Smith DL, 2014, T ROY SOC TROP MED H, V108, P185, DOI 10.1093/trstmh/tru026; Smith DL, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0145; Smith DL, 2009, TRENDS PARASITOL, V25, P511, DOI 10.1016/j.pt.2009.08.002; Soetaert K, 2009, ROOTSOLVE NONLINEAR; ter Kuile FO, 2003, AM J TROP MED HYG, V68, P50, DOI 10.4269/ajtmh.2003.68.50; Wagman JM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0692-5	59	14	14	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144173	10.1371/journal.pone.0144173	http://dx.doi.org/10.1371/journal.pone.0144173			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636568	Green Published, Green Submitted, gold			2022-12-27	WOS:000366143800053
J	Grugni, V; Battaglia, V; Perego, UA; Raveane, A; Lancioni, H; Olivieri, A; Ferretti, L; Woodward, SR; Pascale, JM; Cooke, R; Myres, N; Motta, J; Torroni, A; Achilli, A; Semino, O				Grugni, Viola; Battaglia, Vincenza; Perego, Ugo Alessandro; Raveane, Alessandro; Lancioni, Hovirag; Olivieri, Anna; Ferretti, Luca; Woodward, Scott R.; Miguel Pascale, Juan; Cooke, Richard; Myres, Natalie; Motta, Jorge; Torroni, Antonio; Achilli, Alessandro; Semino, Ornella			Exploring the Y Chromosomal Ancestry of Modern Panamanians	PLOS ONE			English	Article							NATIVE-AMERICAN POPULATIONS; EARLY HUMAN SETTLEMENT; MIGRATORY EVENTS; MTDNA VARIATION; DNA DIVERSITY; HAPLOGROUP-E; COSTA-RICA; MITOCHONDRIAL; EUROPE; STRS	Geologically, Panama belongs to the Central American land-bridge between North and South America crossed by Homo sapiens > 14 ka ago. Archaeologically, it belongs to a wider Isthmo-Colombian Area. Today, seven indigenous ethnic groups account for 12.3% of Panama's population. Five speak Chibchan languages and are characterized by low genetic diversity and a high level of differentiation. In addition, no evidence of differential structuring between maternally and paternally inherited genes has been reported in isthmian Chibchan cultural groups. Recent data have shown that 83% of the Panamanian general population harbour mitochondrial DNAs (mtDNAs) of Native American ancestry. Considering differential male/female mortality at European contact and multiple degrees of geographical and genetic isolation over the subsequent five centuries, the Y-chromosome Native American component is expected to vary across different geographic regions and communities in Panama. To address this issue, we investigated Y-chromosome variation in 408 modern males from the nine provinces of Panama and one indigenous territory (the comarca of Kuna Yala). In contrast to mtDNA data, the Y-chromosome Native American component (haplogroup Q) exceeds 50% only in three populations facing the Caribbean Sea: the comarca of Kuna Yala and Bocas del Toro province where Chibchan languages are spoken by the majority, and the province of Colon where many Kuna and people of mixed indigenous-African-and-European descent live. Elsewhere the Old World component is dominant and mostly represented by western Eurasian haplogroups, which signal the strong male genetic impact of invaders. Sub-Saharan African input accounts for 5.9% of male haplotypes. This reflects the consequences of the colonial Atlantic slave trade and more recent influxes of West Indians of African heritage. Overall, our findings reveal a local evolution of the male Native American ancestral gene pool, and a strong but geographically differentiated unidirectional sex bias in the formation of local modern Panamanian populations.	[Grugni, Viola; Battaglia, Vincenza; Raveane, Alessandro; Olivieri, Anna; Ferretti, Luca; Torroni, Antonio; Achilli, Alessandro; Semino, Ornella] Univ Pavia, Dept Biol & Biotechnol, I-27100 Pavia, Italy; [Perego, Ugo Alessandro; Woodward, Scott R.; Myres, Natalie] Sorenson Mol Geneal Fdn, Salt Lake City, UT USA; [Perego, Ugo Alessandro; Lancioni, Hovirag; Achilli, Alessandro] Univ Perugia, Dept Chem Biol & Biotechnol, I-06100 Perugia, Italy; [Miguel Pascale, Juan] Inst Conmemorat Gorgas Estudios Salud, Panama City, Panama; [Cooke, Richard] Smithsonian Trop Res Inst, Panama City, Panama; [Myres, Natalie] Ancestry, Provo, UT USA	University of Pavia; University of Perugia; Instituto Conmemorativo Gorgas de Estudios de la Salud; Smithsonian Institution; Smithsonian Tropical Research Institute	Semino, O (corresponding author), Univ Pavia, Dept Biol & Biotechnol, Via Palestro 3, I-27100 Pavia, Italy.	ornella.semino@unipv.it	Motta, Jorge Alejandro/ABI-6006-2020; Battaglia, Vincenza/F-6950-2017; Perego, Ugo/AAG-9327-2019; Raveane, Alessandro/AAA-1650-2021; Torroni, Antonio/E-1557-2011; Achilli, Alessandro/I-9236-2012; OLIVIERI, ANNA/I-9235-2012; Lancioni, Hovirag/F-9067-2014	Raveane, Alessandro/0000-0002-8322-5461; Torroni, Antonio/0000-0002-4163-4478; Achilli, Alessandro/0000-0001-6871-3451; OLIVIERI, ANNA/0000-0002-3941-8098; Lancioni, Hovirag/0000-0001-5514-1853; Ferretti, Luca/0000-0001-5044-8442	Instituto Conmemorativo Gorgas de Estudios de la Salud; Sorenson Molecular Genealogy Foundation; Italian Ministry of the University: Progetti di Ricerca Interesse Nazionale; Progetti Futuro in Ricerca [RBFR126B8I]	Instituto Conmemorativo Gorgas de Estudios de la Salud; Sorenson Molecular Genealogy Foundation; Italian Ministry of the University: Progetti di Ricerca Interesse Nazionale; Progetti Futuro in Ricerca	This research is part of the University of Pavia strategic theme "Towards a governance model for international migration: an interdisciplinary and diachronic perspective" (MIGRAT-IN-G) and received support from the Instituto Conmemorativo Gorgas de Estudios de la Salud (to JM, JMP), the Sorenson Molecular Genealogy Foundation (to UAP, NM, SRW), the Italian Ministry of the University: Progetti di Ricerca Interesse Nazionale 2012 (to AA, AT and OS) and Progetti Futuro in Ricerca 2012 (RBFR126B8I) (to AO, AA). Ancestry.com provided support in the form of salaries for author [NM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceituno FJ, 2013, QUATERN INT, V301, P23, DOI 10.1016/j.quaint.2012.05.017; Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Aikhenvald A.Y., 2007, VANISHING LANGUAGES, P183; Al-Zahery N, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-288; Ascunce MS, 2008, HUM BIOL, V80, P287, DOI 10.3378/1534-6617-80.3.287; Athey T. W., 2005, J GENET GENEAL, V1, P1; ATHEY TW, 2006, J GENET, V2, P34; Athey W, 2011, INT J LEGAL MED, V125, P901, DOI 10.1007/s00414-010-0459-z; BANDELT HJ, 1995, GENETICS, V141, P743; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BARRANTES R, 1990, AM J HUM GENET, V46, P63; BATISTA O, 1995, HUM MOL GENET, V4, P921, DOI 10.1093/hmg/4.5.921; Battaglia V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071390; Battaglia V, 2009, EUR J HUM GENET, V17, P820, DOI 10.1038/ejhg.2008.249; Bieber H, 1996, HUM BIOL, V68, P929; Borjas Lisbeth, 2008, Legal Medicine, V10, P107, DOI 10.1016/j.legalmed.2007.08.005; Bouckaert R, 2012, SCIENCE, V337, P957, DOI 10.1126/science.1219669; Bray W., 1984, ARCHAEOLOGY LOWER CE, P305; Cadenas AM, 2008, EUR J HUM GENET, V16, P374, DOI 10.1038/sj.ejhg.5201934; Monterrosa JC, 2010, LEGAL MED-TOKYO, V12, P46, DOI 10.1016/j.legalmed.2009.10.003; Chiaroni J, 2010, EUR J HUM GENET, V18, P348, DOI 10.1038/ejhg.2009.166; Constenla Umana A., 1991, LENGUAS AREA INTERME; Constenla Umana A., 2012, INDIGENOUS LANGUAGES, P391, DOI 10.1515/9783110258035.391; Constenla Umana Adolfo, 2008, ESTUDIOS LINGUISTICA, V27, P117; Cooke R, 2005, J ARCHAEOL RES, V13, P129, DOI 10.1007/s10804-005-2486-4; Cooke R., 2003, MESOAMERICA, V45, P1; Cooke R, 2013, QUATERN INT, V301, P3, DOI 10.1016/j.quaint.2013.02.032; Cruciani F, 2004, AM J HUM GENET, V74, P1014, DOI 10.1086/386294; Cruciani F, 2007, MOL BIOL EVOL, V24, P1300, DOI 10.1093/molbev/msm049; De Perez A, 1994, PANAMA SUS USOS COST, P107; Di Giacomo F, 2004, HUM GENET, V115, P357, DOI 10.1007/s00439-004-1168-9; Ellis N, 2002, GENOME RES, V12, P339; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gaya-Vidal M, 2011, AM J PHYS ANTHROPOL, V145, P215, DOI 10.1002/ajpa.21487; Gonzalez-Andrade F, 2009, FORENSIC SCI INT-GEN, V3, pE83, DOI 10.1016/j.fsigen.2008.08.003; Grugni V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041252; Herlihy PH, 1985, YB C LAT AM GEOGR LO; Hoopes J., 2003, GOLD POWER ANCIENT C, P49; Hoopes John W., 1995, EMERGENCE POTTERY TE, P185; Aceituno FJ, 2015, QUATERN INT, V363, P20, DOI 10.1016/j.quaint.2014.06.027; Avila SJ, 2009, J FORENSIC LEG MED, V16, P204, DOI 10.1016/j.jflm.2008.12.002; Karachanak S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056779; King RJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-69; KOLMAN CJ, 1995, GENETICS, V140, P275; Kolman CJ, 1997, GENETICS, V147, P1289; LOEWEN JA, 1963, INT J AM LINGUIST, V29, P239, DOI 10.1086/464740; Lovo-Gomez J, 2007, FORENSIC SCI INT, V171, P198, DOI 10.1016/j.forsciint.2006.07.005; Martin Juan Guillermo, 2002, ARQUEOLOGIA PANAMA V, V2, P230; Martinez Mauri Monica, 2011, AUTONOMIA INDIGENA P; Martinez-Gonzalez LJ, 2012, FORENSIC SCI INT-GEN, V6, P136, DOI 10.1016/j.fsigen.2011.04.003; Matamoros Mireya, 2009, Legal Medicine, V11, P251, DOI 10.1016/j.legalmed.2009.06.001; Melton PE, 2007, AM J PHYS ANTHROPOL, V133, P753, DOI 10.1002/ajpa.20581; Melton PE, 2013, AM J HUM BIOL, V25, P480, DOI 10.1002/ajhb.22382; Mendez FL, 2011, HUM BIOL, V83, P39, DOI 10.3378/027.083.0103; Mon RA, 1994, PANAMA SUS USOS COST, P53; Myres NM, 2007, CROAT MED J, V48, P450; Myres NM, 2011, EUR J HUM GENET, V19, P95, DOI 10.1038/ejhg.2010.146; Nunez C, 2012, FORENSIC SCI INT-GEN, V6, pE192, DOI 10.1016/j.fsigen.2012.06.011; Nunez C, 2010, AM J PHYS ANTHROPOL, V143, P591, DOI 10.1002/ajpa.21355; Pagan-Jimenez JR, 2015, QUATERNARY SCI REV, V123, P231, DOI 10.1016/j.quascirev.2015.07.005; Pala M, 2012, AM J HUM GENET, V90, P915, DOI 10.1016/j.ajhg.2012.04.003; Pardo-Rojas M., 1987, B MUSEO ORO, V18, P46; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perego UA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038337; Petrejcikova E, 2014, ANTHROPOL ANZ, V71, P275, DOI 10.1127/0003-5548/2014/0368; Piperno DR, 2011, S-P B ENVIRON SCI, P185; Piperno DR, 2011, CURR ANTHROPOL, V52, pS453, DOI 10.1086/659998; Ranere A., 2007, INT J S AM ARCHAEOLO, V1, P25; Regueiro M, 2015, GENE, V564, P141, DOI 10.1016/j.gene.2015.02.042; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Reid Carlos, 1980, MEMORIAS CRIOLLO BOC; Romoli K, 1975, REV COLOMB ANTROPOL, V19, P9; Romoli Kathleen, 1987, LENGUA CUEVA; Rootsi S, 2012, EUR J HUM GENET, V20, P1275, DOI 10.1038/ejhg.2012.86; Ruiz-Narvaez EA, 2005, HUM BIOL, V77, P71, DOI 10.1353/hub.2005.0032; Sandoval K, 2012, AM J PHYS ANTHROPOL, V148, P395, DOI 10.1002/ajpa.22062; SANTOS M, 1994, HUM BIOL, V66, P963; Scoullar WT, 1916, BLUE BOOK PANAMA; Semino O, 2004, AM J HUM GENET, V74, P1023, DOI 10.1086/386295; Semino O, 2002, AM J HUM GENET, V70, P265, DOI 10.1086/338306; Sengupta S, 2006, AM J HUM GENET, V78, P202, DOI 10.1086/499411; Siu, 2005, MEMORIES FUTURE HOME; Suarez O.J., 1998, POBLACION ISTMO PANA POBLACION ISTMO PANA; TORRONI A, 1994, AM J HUM GENET, V54, P303; TORRONI A, 1994, P NATL ACAD SCI USA, V91, P1158, DOI 10.1073/pnas.91.3.1158; Toscanini U, 2011, AM J PHYS ANTHROPOL, V146, P188, DOI 10.1002/ajpa.21562; Trombetta B, 2015, GENOME BIOL EVOL, V7, P1940, DOI 10.1093/gbe/evv118; Underhill PA, 2007, ANNU REV GENET, V41, P539, DOI 10.1146/annurev.genet.41.110306.130407; Underhill PA, 2015, EUR J HUM GENET, V23, P124, DOI 10.1038/ejhg.2014.50; Underhill PA, 2010, EUR J HUM GENET, V18, P479, DOI 10.1038/ejhg.2009.194; van Oven M, 2014, HUM MUTAT, V35, P187, DOI 10.1002/humu.22468; van Oven M, 2012, J HUM GENET, V57, P65, DOI 10.1038/jhg.2011.120; Vargas Sarmiento Patricia, 1993, EMBERA CUNA IMPACTO; Wang CC, 2013, J SYST EVOL, V51, P280, DOI 10.1111/j.1759-6831.2012.00244.x; Ward Christopher, 1993, IMPERIAL PANAMA COMM; Willuweit S, 2015, FORENSIC SCI INT-GEN, V15, P43, DOI 10.1016/j.fsigen.2014.11.024; Zhivotovsky LA, 2004, AM J HUM GENET, V74, P50, DOI 10.1086/380911; [No title captured]; [No title captured]	99	16	16	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144223	10.1371/journal.pone.0144223	http://dx.doi.org/10.1371/journal.pone.0144223			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636572	Green Published, Green Submitted, gold			2022-12-27	WOS:000366143800060
J	Karhson, DS; Mock, JR; Golob, EJ				Karhson, Debra S.; Mock, Jeffrey R.; Golob, Edward J.			The Role of Right Inferior Parietal Cortex in Auditory Spatial Attention: A Repetitive Transcranial Magnetic Stimulation Study	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; SOUND LOCALIZATION; UNILATERAL NEGLECT; VISUAL-ATTENTION; SIGNAL-DETECTION; DETECTION TASK; P300 LATENCY; HUMAN BRAIN; MECHANISMS; REPRESENTATIONS	Behavioral studies support the concept of an auditory spatial attention gradient by demonstrating that attentional benefits progressively diminish as distance increases from an attended location. Damage to the right inferior parietal cortex can induce a rightward attention bias, which implicates this region in the construction of attention gradients. This study used event-related potentials (ERPs) to define attention-related gradients before and after repetitive transcranial magnetic stimulation (rTMS) to the right inferior parietal cortex. Subjects (n = 16) listened to noise bursts at five azimuth locations (left to right: -90 degrees, -45 degrees, 0 degrees midline, +45 degrees, +90 degrees) and responded to stimuli at one target location (-90 degrees, +90 degrees, separate blocks). ERPs as a function of non-target location were examined before (baseline) and after 0.9 Hz rTMS. Results showed that ERP attention gradients were observed in three time windows (frontal 230-340, parietal 400-460, frontal 550-750 ms). Significant transient rTMS effects were seen in the first and third windows. The first window had a voltage decrease at the farthest location when attending to either the left or right side. The third window had on overall increase in positivity, but only when attending to the left side. These findings suggest that rTMS induced a small contraction in spatial attention gradients within the first time window. The asymmetric effect of attended location on gradients in the third time window may relate to neglect of the left hemispace after right parietal injury. Together, these results highlight the role of the right inferior parietal cortex in modulating frontal lobe attention network activity.	[Karhson, Debra S.; Golob, Edward J.] Tulane Univ, Program Neurosci, New Orleans, LA 70118 USA; [Mock, Jeffrey R.; Golob, Edward J.] Tulane Univ, Dept Psychol, New Orleans, LA 70118 USA; [Golob, Edward J.] Tulane Univ, Ctr Aging, New Orleans, LA 70118 USA	Tulane University; Tulane University; Tulane University	Golob, EJ (corresponding author), Tulane Univ, Program Neurosci, New Orleans, LA 70118 USA.	egolob@tulane.edu		Mock, Jeffrey/0000-0003-0446-6687; Karhson, Debra/0000-0002-3850-3119	National Science Foundation [BCS-0844961]; Southern Regional Education Board - Louisiana Board of Regents Doctoral Scholars Program	National Science Foundation(National Science Foundation (NSF)); Southern Regional Education Board - Louisiana Board of Regents Doctoral Scholars Program	This study was supported by funding from National Science Foundation (BCS-0844961) and the Southern Regional Education Board - Louisiana Board of Regents Doctoral Scholars Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank John Holmes, Michael Seay, Kelsey Ward, and Drs. Kate Yurgil and Jeremy Nelson for valuable discussions and help with this study. This work was supported by the National Science Foundation (BCS-0844961).	Adair JC, 2008, ANN NY ACAD SCI, V1142, P21, DOI 10.1196/annals.1444.008; Ahveninen J, 2006, P NATL ACAD SCI USA, V103, P14608, DOI 10.1073/pnas.0510480103; Arnott SR, 2002, PSYCHOPHYSIOLOGY, V39, P625, DOI 10.1017/S0048577202394149; At A, 2011, NEUROPSYCHOLOGIA, V49, P2794, DOI 10.1016/j.neuropsychologia.2011.05.024; Barrett AM, 1998, NEUROLOGY, V51, P972, DOI 10.1212/WNL.51.4.972; Barrick TR, 2007, CEREB CORTEX, V17, P591, DOI 10.1093/cercor/bhk004; Behrmann M, 1997, NEUROPSYCHOLOGIA, V35, P1445, DOI 10.1016/S0028-3932(97)00058-4; Bellmann A, 2001, BRAIN, V124, P676, DOI 10.1093/brain/124.4.676; Berardelli A, 1998, EXP BRAIN RES, V122, P79, DOI 10.1007/s002210050493; Blauert J., 1997, SPATIAL HEARING PSYC; CARLILE S, 1996, VIRTUAL AUDITORY SPA; Caspers S, 2006, NEUROIMAGE, V33, P430, DOI 10.1016/j.neuroimage.2006.06.054; Caspers S, 2011, NEUROIMAGE, V58, P362, DOI 10.1016/j.neuroimage.2011.06.027; Cave KR, 1999, PSYCHON B REV, V6, P204, DOI 10.3758/BF03212327; Chen R, 1997, ELECTROMYOGR MOTOR C, V105, P415, DOI 10.1016/S0924-980X(97)00036-2; Clarke S, 1998, NEUROREPORT, V9, P3433, DOI 10.1097/00001756-199810260-00018; Clarke S, 2004, CORTEX, V40, P291, DOI 10.1016/S0010-9452(08)70124-2; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2011, ANNU REV NEUROSCI, V34, P569, DOI 10.1146/annurev-neuro-061010-113731; COURCHESNE E, 1975, ELECTROEN CLIN NEURO, V39, P131, DOI 10.1016/0013-4694(75)90003-6; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DOWNING CJ, 1988, J EXP PSYCHOL HUMAN, V14, P188, DOI 10.1037/0096-1523.14.2.188; Egeth HE, 1997, ANNU REV PSYCHOL, V48, P269, DOI 10.1146/annurev.psych.48.1.269; Egner T, 2007, COGN AFFECT BEHAV NE, V7, P380, DOI 10.3758/CABN.7.4.380; ERIKSEN CW, 1986, PERCEPT PSYCHOPHYS, V40, P225, DOI 10.3758/BF03211502; Friedman D, 2001, NEUROSCI BIOBEHAV R, V25, P355, DOI 10.1016/S0149-7634(01)00019-7; Golob EJ, 2016, PERCEPTION, V45, P165, DOI 10.1177/0301006615599906; Golob EJ, 2011, BRAIN RES, V1384, P128, DOI 10.1016/j.brainres.2011.01.089; Halgren E, 1998, ELECTROEN CLIN NEURO, V106, P156, DOI 10.1016/S0013-4694(97)00119-3; Hall DA, 2003, AUDIOL NEURO-OTOL, V8, P1, DOI 10.1159/000067894; Hallett M, 2000, NATURE, V406, P147, DOI 10.1038/35018000; HEILMAN KM, 1980, NEUROLOGY, V30, P327, DOI 10.1212/WNL.30.3.327; HEILMAN KM, 1972, ARCH NEUROL-CHICAGO, V26, P32, DOI 10.1001/archneur.1972.00490070050007; Hilgetag CC, 2001, NAT NEUROSCI, V4, P953, DOI 10.1038/nn0901-953; Husain M, 2003, NAT REV NEUROSCI, V4, P26, DOI 10.1038/nrn1005; Karnath HO, 2012, NEUROPSYCHOLOGIA, V50, P1010, DOI 10.1016/j.neuropsychologia.2011.06.027; Kong LQ, 2014, CEREB CORTEX, V24, P773, DOI 10.1093/cercor/bhs359; LABERGE D, 1989, PSYCHOL REV, V96, P101, DOI 10.1037/0033-295X.96.1.101; Lewald J, 2004, NEUROPSYCHOLOGIA, V42, P1598, DOI 10.1016/j.neuropsychologia.2004.04.012; Lewald J, 2004, J COGNITIVE NEUROSCI, V16, P828, DOI 10.1162/089892904970834; Macaluso E, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00685; MAGLIERO A, 1984, PSYCHOPHYSIOLOGY, V21, P171, DOI 10.1111/j.1469-8986.1984.tb00201.x; Mesulam MM, 1999, PHILOS T R SOC B, V354, P1325, DOI 10.1098/rstb.1999.0482; MIDDLEBROOKS JC, 1991, ANNU REV PSYCHOL, V42, P135, DOI 10.1146/annurev.ps.42.020191.001031; Middlebrooks JC, 1981, J NEUROSCI, V1; MILLS AW, 1958, J ACOUST SOC AM, V30, P237, DOI 10.1121/1.1909553; Mock JR, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00179; MONDOR TA, 1995, J EXP PSYCHOL HUMAN, V21, P387, DOI 10.1037/0096-1523.21.2.387; Muggleton NG, 2006, NEUROPSYCHOLOGIA, V44, P1222, DOI 10.1016/j.neuropsychologia.2005.10.004; NASH A, 1994, BIOL PSYCHOL, V37, P219, DOI 10.1016/0301-0511(94)90004-3; Pascual-Leone A, 1998, J CLIN NEUROPHYSIOL, V15, P333, DOI 10.1097/00004691-199807000-00005; POLICH J, 1983, PSYCHOPHYSIOLOGY, V20, P665, DOI 10.1111/j.1469-8986.1983.tb00936.x; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Pouget A, 2000, CURR OPIN NEUROBIOL, V10, P242, DOI 10.1016/S0959-4388(00)00077-5; Price CJ, 2001, J COGNITIVE NEUROSCI, V13, P419, DOI 10.1162/08989290152001853; PRITCHARD WS, 1986, PSYCHOPHYSIOLOGY, V23, P166, DOI 10.1111/j.1469-8986.1986.tb00611.x; Rader SK, 2008, CLIN NEUROPHYSIOL, V119, P1176, DOI 10.1016/j.clinph.2008.01.014; Recanzone GH, 2000, P NATL ACAD SCI USA, V97, P11829, DOI 10.1073/pnas.97.22.11829; ROHRBAUGH JW, 1978, ELECTROEN CLIN NEURO, V45, P551, DOI 10.1016/0013-4694(78)90156-6; Rorden C, 2001, EXP BRAIN RES, V137, P487, DOI 10.1007/s002210100679; Rothwell JC, 1997, J NEUROSCI METH, V74, P113, DOI 10.1016/S0165-0270(97)02242-5; RUCHKIN DS, 1980, ELECTROEN CLIN NEURO, V50, P35, DOI 10.1016/0013-4694(80)90321-1; Rushworth MFS, 2006, NEUROPSYCHOLOGIA, V44, P2700, DOI 10.1016/j.neuropsychologia.2005.12.007; SCHARF B, 1998, ATTENTION, P75; Siebner HR, 2009, BRAIN STIMUL, V2, P58, DOI 10.1016/j.brs.2008.11.002; Spencer KM, 2001, PSYCHOPHYSIOLOGY, V38, P343, DOI 10.1111/1469-8986.3820343; SQUIRES KC, 1975, J EXP PSYCHOL HUMAN, V1, P268, DOI 10.1037/0096-1523.1.3.268; SQUIRES NK, 1975, ELECTROEN CLIN NEURO, V38, P387, DOI 10.1016/0013-4694(75)90263-1; Sur Shravani, 2009, Ind Psychiatry J, V18, P70, DOI 10.4103/0972-6748.57865; Teder-Salejarvi WA, 1998, PERCEPT PSYCHOPHYS, V60, P1228, DOI 10.3758/BF03206172; Teder-Salejarvi WA, 1999, COGNITIVE BRAIN RES, V8, P213, DOI 10.1016/S0926-6410(99)00023-3; Vallar G, 1997, PHILOS T ROY SOC B, V352, P1401, DOI 10.1098/rstb.1997.0126; Vallar G, 2007, CNS SPECTRUMS, V12, P527, DOI 10.1017/S1092852900021271; YUND EW, 1990, BRAIN COGNITION, V12, P42, DOI 10.1016/0278-2626(90)90003-7	75	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144221	10.1371/journal.pone.0144221	http://dx.doi.org/10.1371/journal.pone.0144221			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636333	Green Published, Green Submitted, gold			2022-12-27	WOS:000366143800059
J	Neugebauer, T; Bordeleau, E; Burrus, V; Brzezinski, R				Neugebauer, Tomasz; Bordeleau, Eric; Burrus, Vincent; Brzezinski, Ryszard			DNA Data Visualization (DDV): Software for Generating Web-Based Interfaces Supporting Navigation and Analysis of DNA Sequence Data of Entire Genomes	PLOS ONE			English	Article							TANDEM REPEATS; STREPTOMYCES; REPLICATION; ORGANIZATION; ELEMENTS; MOBILE	Data visualization methods are necessary during the exploration and analysis activities of an increasingly data-intensive scientific process. There are few existing visualization methods for raw nucleotide sequences of a whole genome or chromosome. Software for data visualization should allow the researchers to create accessible data visualization interfaces that can be exported and shared with others on the web. Herein, novel software developed for generating DNA data visualization interfaces is described. The software converts DNA data sets into images that are further processed as multi-scale images to be accessed through a web-based interface that supports zooming, panning and sequence fragment selection. Nucleotide composition frequencies and GC skew of a selected sequence segment can be obtained through the interface. The software was used to generate DNA data visualization of human and bacterial chromosomes. Examples of visually detectable features such as short and long direct repeats, long terminal repeats, mobile genetic elements, heterochromatic segments in microbial and human chromosomes, are presented. The software and its source code are available for download and further development. The visualization interfaces generated with the software allow for the immediate identification and observation of several types of sequence patterns in genomes of various sizes and origins. The visualization interfaces generated with the software are readily accessible through a web browser. This software is a useful research and teaching tool for genetics and structural genomics.	[Neugebauer, Tomasz] Concordia Univ Libraries, Montreal, PQ, Canada; [Bordeleau, Eric; Burrus, Vincent; Brzezinski, Ryszard] Univ Sherbrooke, Dept Biol, Fac Sci, Sherbrooke, PQ J1K 2R1, Canada	Concordia University - Canada; University of Sherbrooke	Neugebauer, T (corresponding author), Concordia Univ Libraries, Montreal, PQ, Canada.	tomasz.neugebauer@concordia.ca	Burrus, Vincent/H-5000-2019	Burrus, Vincent/0000-0001-6318-6904; Neugebauer, Tomasz/0000-0002-9743-5910	Concordia University Libraries; Natural Sciences and Engineering Council of Canada [326810, 412288]; Cystic Fibrosis Canada-Kin Canada Fellowship; Le Fonds de Recherche du Quebec - Sante (FRQS); Le Fonds de Recherche du Quebec-Sante (FRQS);  [2014-05177]	Concordia University Libraries; Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Cystic Fibrosis Canada-Kin Canada Fellowship; Le Fonds de Recherche du Quebec - Sante (FRQS); Le Fonds de Recherche du Quebec-Sante (FRQS); 	Work at Concordia University was supported by Concordia University Libraries. Work at Sherbrooke University was supported by Discovery Grant and Discovery Acceleration Supplement from the Natural Sciences and Engineering Council of Canada [326810 and 412288] to VB and Discovery Grant 2014-05177 to RB. VB holds a Canada Research Chair in Bacterial Molecular Genetics. EB is the recipient of a Cystic Fibrosis Canada-Kin Canada Fellowship and a postdoctoral fellowship from Le Fonds de Recherche du Quebec - Sante (FRQS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Work at Concordia University was supported by Concordia University Libraries. Work at Sherbrooke University was supported by Discovery Grant and Discovery Acceleration Supplement from the Natural Sciences and Engineering Council of Canada [326810 and 412288] to VB and Discovery Grant 2014-05177 to RB. VB holds a Canada Research Chair in Bacterial Molecular Genetics. EB is the recipient of a Cystic Fibrosis Canada-Kin Canada Fellowship and a postdoctoral fellowship from Le Fonds de Recherche du Quebec-Sante (FRQS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Brouwer MSM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023014; Burrus V, 2002, PLASMID, V48, P77, DOI 10.1016/S0147-619X(02)00102-6; Butler JM, 2006, J FORENSIC SCI, V51, P253, DOI 10.1111/j.1556-4029.2006.00046.x; Eichler EE, 2004, NAT REV GENET, V5, P345, DOI 10.1038/nrg1322; Farrow KA, 2001, MICROBIOL-SGM, V147, P2717, DOI 10.1099/00221287-147-10-2717; FRENCH S, 1992, SCIENCE, V258, P1362, DOI 10.1126/science.1455232; Frost LS, 2005, NAT REV MICROBIOL, V3, P722, DOI 10.1038/nrmicro1235; Garber M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r60; Hopwood DA, 2006, ANNU REV GENET, V40, P1, DOI 10.1146/annurev.genet.40.110405.090639; Isenberg P, 2011, INFORM VISUAL, V10, P310, DOI 10.1177/1473871611412817; Jankowitsch F, 2012, J BACTERIOL, V194, P6818, DOI 10.1128/JB.01592-12; Kepes F, 2012, FEBS LETT, V586, P2043, DOI 10.1016/j.febslet.2012.03.051; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Makino S, 1999, P JPN ACAD B-PHYS, V75, P311, DOI 10.2183/pjab.75.311; Martinez K, 2005, IEEE IMAGE PROC, P2485; National Library of Medicine, BAS LOC AL SEARCH TO; Nielsen CB, 2010, NAT METHODS, V7, pS5, DOI [10.1038/NMETH.1422, 10.1038/nmeth.1422]; PERNODET JL, 1989, GENE, V79, P33, DOI 10.1016/0378-1119(89)90090-5; Picardeau M, 1999, MOL MICROBIOL, V32, P437, DOI 10.1046/j.1365-2958.1999.01368.x; Rocha EPC, 1999, MOL MICROBIOL, V32, P11, DOI 10.1046/j.1365-2958.1999.01334.x; Seaman JD, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-452; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Weaver D, 2004, MOL MICROBIOL, V51, P1535, DOI 10.1111/j.1365-2958.2003.03920.x; Wlodarczyk M, 2006, POSTEP MIKROBIOL, V45, P5; WRIGHT F, 1992, GENE, V113, P55, DOI 10.1016/0378-1119(92)90669-G; Yoshida T, 2000, J MOL BIOL, V298, P343, DOI 10.1006/jmbi.2000.3667; ZarkoPostawka M, 1997, GENE, V185, P231	29	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143615	10.1371/journal.pone.0143615	http://dx.doi.org/10.1371/journal.pone.0143615			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636979	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000366143800021
J	Newman, SL; Tumin, R; Andridge, R; Anderson, SE				Newman, Sarah L.; Tumin, Rachel; Andridge, Rebecca; Anderson, Sarah E.			Family Meal Frequency and Association with Household Food Availability in United States Multi-Person Households: National Health and Nutrition Examination Survey 2007-2010	PLOS ONE			English	Article							DIET QUALITY; HISPANIC IMMIGRANTS; US; PATTERNS; WEIGHT; ACCULTURATION; ENVIRONMENT; BEHAVIORS; CHILDREN; MOTHERS	Objective Family meals are associated with a healthier diet among children and adolescents, but how family meal frequency varies in the U.S. population overall by household food availability and sociodemographic characteristics is not well characterized. Design The U.S. National Health and Nutrition Examination Survey 2007-2010 assessed the frequency of family meals eaten at home in the past week and the household availability of fruits, dark green vegetables, salty snacks, and sugar-sweetened beverages. Setting Computer-assisted face-to-face interviews with a selected adult (>= 18 years) who owned or rented the home (i.e., the household reference person). Subjects We analyzed information on family meal frequency for 18,031 participants living in multi-person households in relation to sociodemographic characteristics and food availability. Results Among the U.S. population living in households of two or more individuals, the prevalence (95% confidence interval) of having 0-2, 3-6 and >= 7 family meals/week was 18.0%(16.6-19.3), 32.4% (31.0-33.9), and 49.6% (47.8-51.4), respectively. Greater household availability of fruits and dark green vegetables and less availability of salty snacks and sugar-sweetened beverages was associated with more frequent family meals. Family meals were more prevalent in low-income households and those in which the reference person was >= 65 years, married, or had less than high school education. Conclusions About half of the US population living in households of 2 or more people shares meals frequently with their family at home. Family meal frequency was positively associated with a healthier pattern of household food availability.	[Newman, Sarah L.; Tumin, Rachel; Anderson, Sarah E.] Ohio State Univ, Coll Publ Hlth, Div Epidemiol, Columbus, OH 43210 USA; [Andridge, Rebecca] Ohio State Univ, Coll Publ Hlth, Div Biostat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Anderson, SE (corresponding author), Ohio State Univ, Coll Publ Hlth, Div Epidemiol, Columbus, OH 43210 USA.	sanderson@cph.osu.edu	Andridge, Rebecca Roberts/C-8457-2012	Andridge, Rebecca Roberts/0000-0001-9991-9647				Agresti A., 2012, CATEGORICAL DATA ANA, P293; Akresh IR, 2007, J HEALTH SOC BEHAV, V48, P404, DOI 10.1177/002214650704800405; Berge JM, 2015, J PEDIATR-US, V166, P296, DOI 10.1016/j.jpeds.2014.08.030; Berge JM, 2012, APPETITE, V58, P1128, DOI 10.1016/j.appet.2012.03.008; Boutelle KN, 2003, J NUTR EDUC BEHAV, V35, P24, DOI 10.1016/S1499-4046(06)60323-0; Bowen S, 2014, CONTEXTS, V13, P20, DOI [10.1177/1536504214545755, DOI 10.1177/1536504214545755]; Curtin LR., 2013, VITAL HLTH STAT, V2, P2007; Devine CM, 2005, J NUTR EDUC BEHAV, V37, P121, DOI 10.1016/S1499-4046(06)60266-2; Fiese B.H., 2008, SOCIAL POLICY REP, V22, P3; Fulkerson JA, 2014, J NUTR EDUC BEHAV, V46, P2, DOI 10.1016/j.jneb.2013.07.012; Gordon-Larsen P, 2003, SOC SCI MED, V57, P2023, DOI 10.1016/S0277-9536(03)00072-8; Haines J, 2013, JAMA PEDIATR, V167, P1072, DOI 10.1001/jamapediatrics.2013.2356; Herman CP, 2003, PSYCHOL BULL, V129, P873, DOI 10.1037/0033-2909.129.6.873; Hunt LM, 2004, SOC SCI MED, V59, P973, DOI 10.1016/j.socscimed.2003.12.009; Johnson CL., 2013, ANAL GUIDELINES 1999; Koszewski W, 2011, FAM CONSUM SCI RES J, V39, P431, DOI 10.1111/j.1552-3934.2011.02080.x; Larson N, 2013, J ACAD NUTR DIET, V113, P1601, DOI 10.1016/j.jand.2013.08.011; Larson N, 2013, PUBLIC HEALTH NUTR, V16, P883, DOI 10.1017/S1368980012003539; Larson NI, 2007, J AM DIET ASSOC, V107, P1502, DOI 10.1016/j.jada.2007.06.012; Larson NI, 2009, J AM DIET ASSOC, V109, P72, DOI 10.1016/j.jada.2008.10.017; Malhotra K, 2013, J ACAD NUTR DIET, V113, P1484, DOI 10.1016/j.jand.2013.07.028; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Masters MA, 2014, J ACAD NUTR DIET, V114, P1533, DOI 10.1016/j.jand.2014.04.023; Neumark-Sztainer D, 2003, J AM DIET ASSOC, V103, P317, DOI 10.1053/jada.2003.50048; Reicks M, 2014, J AM COLL NUTR, V33, P315, DOI 10.1080/07315724.2014.887485; Sobal J, 2014, APPETITE, V78, P81, DOI 10.1016/j.appet.2014.03.016; Sobal J, 2011, PUBLIC HEALTH NUTR, V14, P1555, DOI 10.1017/S1368980011000127; Tourangeau R., 2000, PSYCHOL SURVEY RESPO; Tumin R, 2015, PUBLIC HEALTH NUTR, V18, P1474, DOI 10.1017/S1368980014001773; Virudachalam S, 2014, PUBLIC HEALTH NUTR, V17, P1022, DOI 10.1017/S1368980013002589; Winker MA, 2004, JAMA-J AM MED ASSOC, V292, P1612, DOI 10.1001/jama.292.13.1612; Woodruff SJ, 2013, DIET QUALITY EVIDENC, P89; Zipf G, 2013, VITAL HLTH STAT, V1	33	17	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144330	10.1371/journal.pone.0144330	http://dx.doi.org/10.1371/journal.pone.0144330			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636976	Green Published, gold, Green Submitted			2022-12-27	WOS:000366143800077
J	Vegosen, L; Breysse, PN; Agnew, J; Gray, GC; Nachamkin, I; Sheikh, K; Kamel, F; Silbergeld, E				Vegosen, Leora; Breysse, Patrick N.; Agnew, Jacqueline; Gray, Gregory C.; Nachamkin, Irving; Sheikh, Kazim; Kamel, Freya; Silbergeld, Ellen			Occupational Exposure to Swine, Poultry, and Cattle and Antibody Biomarkers of Campylobacter jejuni Exposure and Autoimmune Peripheral Neuropathy	PLOS ONE			English	Article							GUILLAIN-BARRE-SYNDROME; LINKED-IMMUNOSORBENT-ASSAY; MOLECULAR MIMICRY; NEUROLOGIC SYMPTOMS; UNITED-STATES; INFECTION; WORKERS; RISK; GANGLIOSIDE; RESPONSES	Introduction Foodborne Campylobacter jejuni infection has been associated with an increased risk of autoimmune peripheral neuropathy, but risks of occupational exposure to C. jejuni have received less attention. This study compared anti-C. jejuni IgA, IgG, and IgM antibody levels, as well as the likelihood of testing positive for any of five anti-ganglioside autoantibodies, between animal farmers and non-farmers. Anti-C. jejuni antibody levels were also compared between farmers with different animal herd or flock sizes. The relationship between anti-C. jejuni antibody levels and detection of anti-ganglioside autoantibodies was also assessed. Methods Serum samples from 129 Agricultural Health Study swine farmers (some of whom also worked with other animals) and 46 non-farmers, all from Iowa, were analyzed for anti-C. jejuni antibodies and anti-ganglioside autoantibodies using ELISA. Information on animal exposures was assessed using questionnaire data. Anti-C. jejuni antibody levels were compared using Mann-Whitney tests and linear regression on log-transformed outcomes. Fisher's Exact Tests and logistic regression were used to compare likelihood of positivity for anti-ganglioside autoantibodies. Results Farmers had significantly higher levels of anti-C. jejuni IgA (p < 0.0001) and IgG (p = 0.02) antibodies compared to non-farmers. There was no consistent pattern of anti-C. jejuni antibody levels based on animal herd or flock size. A higher percentage of farmers (21%) tested positive for anti-ganglioside autoantibodies compared to non- farmers (9%), but this difference was not statistically significant (p = 0.11). There was no significant association between anti-C. jejuni antibody levels and anti-ganglioside autoantibodies. Conclusions The findings provide evidence that farmers who work with animals may be at increased risk of exposure to C. jejuni. Future research should include longitudinal studies of exposures and outcomes, as well as studies of interventions to reduce exposure. Policies to reduce occupational exposure to C. jejuni should be considered.	[Vegosen, Leora; Breysse, Patrick N.; Agnew, Jacqueline; Silbergeld, Ellen] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA; [Gray, Gregory C.] Duke Univ, Div Infect Dis, Sch Med, Durham, NC USA; [Nachamkin, Irving] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Sheikh, Kazim] Univ Texas Houston, Dept Neurol, Sch Med, Houston, TX USA; [Kamel, Freya] NIEHS, Epidemiol Branch, NIH, Res Triangle Pk, NC 27709 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Duke University; University of Pennsylvania; Pennsylvania Medicine; University of Texas System; University of Texas Health Science Center Houston; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Vegosen, L (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA.	lvegosen@jhsph.edu	Nachamkin, Irving/Q-3673-2019; Gray, Gregory C./ABF-1298-2020	Kamel, Freya/0000-0001-5052-6615; Nachamkin, Irving/0000-0003-4811-9716; Gray, Gregory/0000-0002-4628-5908	intramural research program of the National Institutes of Health; National Institute of Environmental Health Sciences [Z01-ES049030]; National Institute for Occupational Safety and Health (NIOSH) Education and Research Center for Occupational Safety and Health at the Johns Hopkins Bloomberg School of Public Health [T42OH008428, 90035666]; Johns Hopkins Center for a Livable Future Innovation Grant [1602030070]; Hopkins Sommer Scholarship; Dr. C. W. Kruse Memorial Fund Award; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [T42OH008428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES049030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054962, R01NS042888] Funding Source: NIH RePORTER	intramural research program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute for Occupational Safety and Health (NIOSH) Education and Research Center for Occupational Safety and Health at the Johns Hopkins Bloomberg School of Public Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); Johns Hopkins Center for a Livable Future Innovation Grant; Hopkins Sommer Scholarship; Dr. C. W. Kruse Memorial Fund Award; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the intramural research program of the National Institutes of Health, the National Institute of Environmental Health Sciences (Z01-ES049030) (https://www.niehs.nih.gov/ and http://aghealth.nih.gov/), the National Institute for Occupational Safety and Health (NIOSH) Education and Research Center for Occupational Safety and Health at the Johns Hopkins Bloomberg School of Public Health #T42OH008428 Pilot Project Research Training Award 90035666 (http://www.jhsph.edu/research/centers-and-institutes/johns-hopkins-education-and-research-center-for-occupational-safety-and-health/index. html), the Johns Hopkins Center for a Livable Future Innovation Grant 1602030070 (http://www.jhsph.edu/research/centers-and-institutes/johns-hopkins-center-for-a-livable-future/index.html), Hopkins Sommer Scholarship (http://www.jhsph.edu/admissions/scholarships/institutional-scholarships/sommer-scholars/), and the Dr. C. W. Kruse Memorial Fund Award (http://www.jhsph.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavanja MCR, 1996, ENVIRON HEALTH PERSP, V104, P362, DOI 10.2307/3432672; Ang CW, 2004, TRENDS IMMUNOL, V25, P61, DOI 10.1016/j.it.2003.12.004; BLASER MJ, 1984, INFECT IMMUN, V44, P292, DOI 10.1128/IAI.44.2.292-298.1984; BLASER MJ, 1983, J INFECT DIS, V147, P820, DOI 10.1093/infdis/147.5.820; Bragg LA, 2004, J DAIRY SCI, V87, P3092, DOI 10.3168/jds.S0022-0302(04)73444-X; Neyra RC, 2012, SAF HEALTH WORK-KR, V3, P85, DOI 10.5491/SHAW.2012.3.2.85; Caudie C, 2011, J NEUROL, V258, P1958, DOI 10.1007/s00415-011-6042-9; Cawthraw SA, 2000, CLIN EXP IMMUNOL, V122, P55, DOI 10.1046/j.1365-2249.2000.01349.x; Cawthraw SA, 2002, CLIN EXP IMMUNOL, V130, P101, DOI 10.1046/j.1365-2249.2002.01966.x; Davis MF, 2011, J OCCUP ENVIRON MED, V53, P190, DOI 10.1097/JOM.0b013e31820805d5; de Perio MA, 2013, EMERG INFECT DIS, V19, P286, DOI 10.3201/eid1902.121147; Domingues AR, 2012, EPIDEMIOL INFECT, V140, P970, DOI 10.1017/S0950268811002676; Dong FX, 2010, AM J AGR ECON, V92, P667, DOI 10.1093/ajae/aap041; Fairweather D, 2008, AM J PATHOL, V173, P600, DOI 10.2353/ajpath.2008.071008; Frasca D, 2011, AGEING RES REV, V10, P330, DOI 10.1016/j.arr.2010.08.004; Friedman CR, 2004, CLIN INFECT DIS, V38, pS285, DOI 10.1086/381598; Gilbert MJ, 2012, OCCUP ENVIRON MED, V69, P472, DOI 10.1136/oemed-2011-100069; Gray GC, 2007, EMERG INFECT DIS, V13, P1871, DOI 10.3201/eid1312.061323; Gray GC, 2008, INFLUENZA OTHER RESP, V2, P61, DOI 10.1111/j.1750-2659.2008.00041.x; Hardy CG, 2011, INT J FOOD MICROBIOL, V145, P395, DOI 10.1016/j.ijfoodmicro.2010.12.027; Hughes RAC, 1997, J INFECT DIS, V176, pS92, DOI 10.1086/513793; Humphrey T, 2007, INT J FOOD MICROBIOL, V117, P237, DOI 10.1016/j.ijfoodmicro.2007.01.006; Islam Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043976; Jacobs BC, 1998, NEUROLOGY, V51, P1110, DOI 10.1212/WNL.51.4.1110; JONES DM, 1981, LANCET, V1, P440; Kaida K, 2009, GLYCOBIOLOGY, V19, P676, DOI 10.1093/glycob/cwp027; Kapperud G, 2003, AM J EPIDEMIOL, V158, P234, DOI 10.1093/aje/kwg139; KIMURA F, 1995, INTERNAL MED, V34, P1009, DOI 10.2169/internalmedicine.34.1009; Kuwabara S, 2007, CURR NEUROL NEUROSCI, V7, P57, DOI 10.1007/s11910-007-0022-6; Larson KRL, 2012, J AGRIC SAF HEALTH, V18, P5, DOI 10.13031/2013.41229; Marx A, 2000, EPIDEMIOL REV, V22, P298, DOI 10.1093/oxfordjournals.epirev.a018041; MISHU B, 1993, ANN INTERN MED, V118, P947, DOI 10.7326/0003-4819-118-12-199306150-00006; Nachamkin I, 2002, MICROBES INFECT, V4, P399, DOI 10.1016/S1286-4579(02)01553-8; Perera VN, 2007, FEMS IMMUNOL MED MIC, V50, P27, DOI 10.1111/j.1574-695X.2007.00225.x; Price LB, 2007, J OCCUP ENVIRON MED, V49, P748, DOI 10.1097/JOM.0b013e3180d09ec5; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710; Shahrizaila N, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/829129; Sheikh KA, 1998, NEUROLOGY, V51, P371, DOI 10.1212/WNL.51.2.371; Silbergeld EK, 2008, ANNU REV PUBL HEALTH, V29, P151, DOI 10.1146/annurev.publhealth.29.020907.090904; Strid MA, 2001, CLIN DIAGN LAB IMMUN, V8, P314, DOI 10.1128/CDLI.8.2.314-319.2001; SVEDHEM A, 1983, J INFECT DIS, V148, P82, DOI 10.1093/infdis/148.1.82; Tam CC, 2006, J INFECT DIS, V194, P95, DOI 10.1086/504294; U.S. Department of Agriculture, 2007, CENS AGR STAT LEV DA; Vegosen L, 2012, J OCCUP ENVIRON MED, V54, P1253, DOI 10.1097/JOM.0b013e31825a2574; Willison HJ, 2005, J PERIPHER NERV SYST, V10, P94, DOI 10.1111/j.1085-9489.2005.0010202.x; WILLISON HJ, 1993, J NEUROL SCI, V114, P209, DOI 10.1016/0022-510X(93)90300-N; Yu RK, 2006, INFECT IMMUN, V74, P6517, DOI 10.1128/IAI.00967-06	48	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143587	10.1371/journal.pone.0143587	http://dx.doi.org/10.1371/journal.pone.0143587			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636679	gold, Green Published, Green Submitted			2022-12-27	WOS:000366143800019
J	Zhang, YC; Li, WJ; Dou, YJ; Zhang, JX; Jiang, GH; Miao, LX; Han, GF; Liu, YX; Li, H; Zhang, ZH				Zhang, Yuchao; Li, Weijia; Dou, Yujuan; Zhang, Junxiang; Jiang, Guihua; Miao, Lixiang; Han, Guofen; Liu, Yuexue; Li, He; Zhang, Zhihong			Transcript Quantification by RNA-Seq Reveals Differentially Expressed Genes in the Red and Yellow Fruits of Fragaria vesca	PLOS ONE			English	Article							SUPPRESSES ANTHOCYANIN; BIOSYNTHESIS; STRAWBERRY; MYB; PIGMENTATION; ACCUMULATION; IDENTIFICATION; COLORATION; PROTEIN; BLAST	Fragaria vesca (2n = 2x = 14), the woodland strawberry, is a perennial herbaceous plant with a small sequenced genome (240 Mb). It is commonly used as a genetic model plant for the Fragaria genus and the Rosaceae family. Fruit skin color is one of the most important traits for both the commercial and esthetic value of strawberry. Anthocyanins are the most prominent pigments in strawberry that bring red, pink, white, and yellow hues to the fruits in which they accumulate. In this study, we conducted a de novo assembly of the fruit transcriptome of woodland strawberry and compared the gene expression profiles with yellow (Yellow Wonder, YW) and red (Ruegen, RG) fruits. De novo assembly yielded 75,426 unigenes, 21.3% of which were longer than 1,000 bp. Among the high-quality unique sequences, 45,387 (60.2%) had at least one significant match to an existing gene model. A total of 595 genes, representing 0.79% of total unigenes, were differentially expressed in YW and RG. Among them, 224 genes were up-regulated and 371 genes were down-regulated in the fruit of YW. Particularly, some flavonoid biosynthetic pathway genes, including C4H, CHS, CHI, F3H, DFR and ANS, as well as some transcription factors (TFs), including MYB (putative MYB86 and MYB39), WDR and MADS, were down-regulated in YW fruit, concurrent with a reduction in anthocyanin accumulation in the yellow pigment phenotype, whereas a putative transcription repressor MYB1R was up-regulated in YW fruit. The altered expression levels of the genes encoding flavonoid biosynthetic enzymes and TFs were confirmed by quantitative RT-PCR. Our study provides important insights into the molecular mechanisms underlying the yellow pigment phenotype in F. vesca.	[Zhang, Yuchao; Li, Weijia; Dou, Yujuan; Zhang, Junxiang; Han, Guofen; Liu, Yuexue; Li, He; Zhang, Zhihong] Shenyang Agr Univ, Coll Hort, Shenyang 110866, Peoples R China; [Zhang, Yuchao; Jiang, Guihua; Miao, Lixiang] Zhejiang Acad Agr Sci, Inst Hort, Hangzhou 310021, Zhejiang, Peoples R China; [Dou, Yujuan] Inst Soil & Water Conservat Liaoning Prov, Chaoyang 122000, Peoples R China	Shenyang Agricultural University; Zhejiang Academy of Agricultural Sciences; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS	Zhang, ZH (corresponding author), Shenyang Agr Univ, Coll Hort, 120 Dongling Rd, Shenyang 110866, Peoples R China.	zhang_sau@163.com	Zhang, Zhihong/W-1011-2017	Zhang, Zhihong/0000-0001-5935-1567	National Natural Science Foundation of China [31372037]; Science and Technology Program of Liaoning Province [2015204013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Program of Liaoning Province	This research was supported by National Natural Science Foundation of China (Grant No. 31372037) and by Science and Technology Program of Liaoning Province (No. 2015204013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A, 2001, PLANT J, V28, P319, DOI 10.1046/j.1365-313X.2001.01154.x; Allan AC, 2008, TRENDS PLANT SCI, V13, P99, DOI 10.1016/j.tplants.2007.11.012; Almeida JRM, 2007, ARCH BIOCHEM BIOPHYS, V465, P61, DOI 10.1016/j.abb.2007.04.040; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Baudry A, 2004, PLANT J, V39, P366, DOI 10.1111/j.1365-313X.2004.02138.x; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Chang L, 2007, J PHYTOPATHOL, V155, P431, DOI 10.1111/j.1439-0434.2007.01254.x; Chen JX, 2014, ACTA PHYSIOL PLANT, V36, P2441, DOI 10.1007/s11738-014-1617-6; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Deng C, 2001, THEOR APPL GENET, V103, P316, DOI 10.1007/s001220100648; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hichri I, 2011, J EXP BOT, V62, P2465, DOI 10.1093/jxb/erq442; Honda C, 2002, PLANT PHYSIOL BIOCH, V40, P955, DOI 10.1016/S0981-9428(02)01454-7; Jaakola L, 2010, PLANT PHYSIOL, V153, P1619, DOI 10.1104/pp.110.158279; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Jiang F, 2013, J PLANT GROWTH REGUL, V32, P182, DOI 10.1007/s00344-012-9289-1; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Lalusin AG, 2006, MOL GENET GENOMICS, V275, P44, DOI 10.1007/s00438-005-0080-x; Lalusin AG, 2011, PHILIPP J CROP SCI, V36, P30; Lepiniec L, 2006, ANNU REV PLANT BIOL, V57, P405, DOI 10.1146/annurev.arplant.57.032905.105252; Lin-Wang K, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00651; Lin-Wang Kui, 2010, BMC Plant Biol, V10, P50, DOI 10.1186/1471-2229-10-50; Medina-Puche L, 2014, J EXP BOT, V65, P401, DOI 10.1093/jxb/ert377; Miosic S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112707; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakatsuka T, 2013, PLANT CELL REP, V32, P1925, DOI 10.1007/s00299-013-1504-4; Nesi N, 2002, PLANT CELL, V14, P2463, DOI 10.1105/tpc.004127; Ng M, 2001, NAT REV GENET, V2, P186, DOI 10.1038/35056041; Oono Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-77; PIRIE A, 1976, PLANT PHYSIOL, V58, P468, DOI 10.1104/pp.58.4.468; Qiu Q, 2011, TREE PHYSIOL, V31, P452, DOI 10.1093/treephys/tpr015; Riechmann JL, 1997, BIOL CHEM, V378, P1079; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Salvatierra A, 2013, PHYTOCHEMISTRY, V90, P25, DOI 10.1016/j.phytochem.2013.02.016; Schijlen EGW, 2004, PHYTOCHEMISTRY, V65, P2631, DOI 10.1016/j.phytochem.2004.07.028; Schwinn K, 2006, PLANT CELL, V18, P831, DOI 10.1105/tpc.105.039255; Shimada S, 2005, PLANT J, V44, P950, DOI 10.1111/j.1365-313X.2005.02574.x; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Smyth D, 2000, TRENDS PLANT SCI, V5, P315, DOI 10.1016/S1360-1385(00)01690-3; SWAIN T., 1959, Journal of the Science of Food and Agriculture, V10, P63, DOI 10.1002/jsfa.2740100110; Tanaka Y, 2008, PLANT J, V54, P733, DOI 10.1111/j.1365-313X.2008.03447.x; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilhelm BT, 2009, METHODS, V48, P249, DOI 10.1016/j.ymeth.2009.03.016; Wu J, 2013, TREE GENET GENOMES, V9, P75, DOI 10.1007/s11295-012-0534-3; Yuan YW, 2013, GENETICS, V194, P255, DOI 10.1534/genetics.112.146852; Zhao L, 2013, FUNCT INTEGR GENOMIC, V13, P75, DOI 10.1007/s10142-012-0301-4; Zhu HF, 2009, MOL PLANT, V2, P790, DOI 10.1093/mp/ssp030	50	34	37	3	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144356	10.1371/journal.pone.0144356	http://dx.doi.org/10.1371/journal.pone.0144356			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636322	Green Published, Green Submitted, gold			2022-12-27	WOS:000366143800080
J	Jain, V; Chang, W; Byonanebye, DM; Owaraganise, A; Twinomuhwezi, E; Amanyire, G; Black, D; Marseille, E; Kamya, MR; Havlir, DV; Kahn, JG				Jain, Vivek; Chang, Wei; Byonanebye, Dathan M.; Owaraganise, Asiphas; Twinomuhwezi, Ellon; Amanyire, Gideon; Black, Douglas; Marseille, Elliot; Kamya, Moses R.; Havlir, Diane V.; Kahn, James G.			Estimated Costs for Delivery of HIV Antiretroviral Therapy to Individuals with CD4+T-Cell Counts > 350 cells/uL in Rural Uganda	PLOS ONE			English	Article							CLINICAL-OUTCOMES; HEALTH WORKER; SOUTH-AFRICA; RISK-FACTORS; CARE; RETENTION; ADULTS; ELIGIBILITY; PREVENTION; INITIATION	Background Evidence favoring earlier HIV ART initiation at high CD4+ T-cell counts (CD4>350/uL) has grown, and guidelines now recommend earlier HIV treatment. However, the cost of providing ART to individuals with CD4>350 in Sub-Saharan Africa has not been well estimated. This remains a major barrier to optimal global cost projections for accelerating the scale-up of ART. Our objective was to compute costs of ART delivery to high CD4+ count individuals in a typical rural Ugandan health center-based HIV clinic, and use these data to construct scenarios of efficient ART scale-up. Methods Within a clinical study evaluating streamlined ART delivery to 197 individuals with CD4+ cell counts >350 cells/uL (EARLI Study: NCT01479634) in Mbarara, Uganda, we performed a micro-costing analysis of administrative records, ART prices, and time-and-motion analysis of staff work patterns. We computed observed per-person-per-year (ppy) costs, and constructed models estimating costs under several increasingly efficient ART scale-up scenarios using local salaries, lowest drug prices, optimized patient loads, and inclusion of viral load (VL) testing. Findings Among 197 individuals enrolled in the EARLI Study, median pre-ART CD4+ cell count was 569/uL (IQR 451-716). Observed ART delivery cost was $628 ppy at steady state. Models using local salaries and only core laboratory tests estimated costs of $529/$445 ppy (+/-VL testing, respectively). Models with lower salaries, lowest ART prices, and optimized healthcare worker schedules reduced costs by $100-200 ppy. Costs in a maximally efficient scale-up model were $320/$236 ppy (+/-VL testing). This included $39 for personnel, $106 for ART, $130/$46 for laboratory tests, and $46 for administrative/other costs. A key limitation of this study is its derivation and extrapolation of costs from one large rural treatment program of high CD4+ count individuals. Conclusions In a Ugandan HIV clinic, ART delivery costs-including VL testing-for individuals with CD4>350 were similar to estimates from high-efficiency programs. In higher efficiency scale-up models, costs were substantially lower. These favorable costs may be achieved because high CD4+ count patients are often asymptomatic, facilitating more efficient streamlined ART delivery. Our work provides a framework for calculating costs of efficient ART scale-up models using accessible data from specific programs and regions.	[Jain, Vivek; Black, Douglas; Havlir, Diane V.] Univ Calif San Francisco, San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA 94143 USA; [Jain, Vivek; Byonanebye, Dathan M.; Owaraganise, Asiphas; Twinomuhwezi, Ellon; Black, Douglas; Kamya, Moses R.; Havlir, Diane V.] Makerere Univ UCSF MU UCSF Res Collaborat, Kampala, Uganda; [Chang, Wei; Kahn, James G.] Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA; [Amanyire, Gideon] Makerere Univ Joint AIDS Program MJAP, Kampala, Uganda; [Marseille, Elliot] Hlth Strategies Int, Oakland, CA USA; [Kamya, Moses R.] Makerere Univ, Coll Hlth Sci, Dept Med, Kampala, Uganda	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Makerere University	Jain, V (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA 94143 USA.	vivek.jain@ucsf.edu	Byonanebye, Dathan/HDN-5435-2022; Chang, Wei/AAE-3555-2021; Chang, Wei/M-7473-2016	Owaraganise, Asiphas/0000-0002-5594-0310; Byonanebye, Dathan M/0000-0001-9862-4724; Chang, Wei/0000-0002-2949-269X	National Institutes of Health [U01 AI069502, P30 AI027763]; UCSF [R01 DA15612]; UCSF-CTSI [KL2TR000143]; Gilead Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI099959, U01AI069502, P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015612, R37DA015612] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF; UCSF-CTSI; Gilead Sciences(Gilead Sciences); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health U01 AI069502 to DH, P30 AI027763 to Paul Volberding, UCSF, R01 DA15612 to JGK, and UCSF-CTSI KL2TR000143 and an investigator-initiated grant from Gilead Sciences to VJ. An antiretroviral medication (Truvada) was donated to the study by Gilead Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adakun SA, 2013, JAIDS-J ACQ IMM DEF, V62, P317, DOI 10.1097/QAI.0b013e3182800daf; Alistar SS, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-46; [Anonymous], 2011, EARLI STUDY EARLY AN; Asfaw A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122583; Chang LVW, 2009, JAIDS-J ACQ IMM DEF, V50, P276, DOI 10.1097/QAI.0b013e3181988375; Chang Larry William, 2008, J Int Assoc Physicians AIDS Care (Chic), V7, P130, DOI 10.1177/1545109708318525; Crawford KW, 2015, HIV MED, V16, P95, DOI 10.1111/hiv.12177; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Decroo T, 2014, TROP MED INT HEALTH, V19, P514, DOI 10.1111/tmi.12278; Drummond MF, 2015, METHODS EC EVALUATIO; Eaton JW, 2014, LANCET GLOB HEALTH, V2, pE23, DOI 10.1016/S2214-109X(13)70172-4; Fairall L, 2012, LANCET, V380, P889, DOI 10.1016/S0140-6736(12)60730-2; Galarraga O, 2011, PHARMACOECONOMICS, V29, P579, DOI 10.2165/11586120-000000000-00000; Gale HB, 2013, CLIN INFECT DIS, V56, P1340, DOI 10.1093/cid/cit004; Geng EH, 2015, INT J EPIDEMIOL, V44, P251, DOI 10.1093/ije/dyu271; Girard PM, 2013, AIDS, V27, P2759, DOI 10.1097/01.aids.0000432458.98851.c1; Grinsztejn B, 2014, LANCET INFECT DIS, V14, P281, DOI 10.1016/S1473-3099(13)70692-3; Hendrich Ann, 2008, Perm J, V12, P25; Hontelez JAC, 2012, HUM RESOUR HEALTH, V10, DOI 10.1186/1478-4491-10-39; Jain V, 2014, AIDS, V28, P2241, DOI 10.1097/QAD.0000000000000401; Johns B, 2014, JAIDS-J ACQ IMM DEF, V65, pE140, DOI 10.1097/QAI.0000000000000064; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2013, GLOB REP UNAIDS REP, P1; Joint United Nations Programme on HIV/ AIDS (UNAIDS), 2013, ACC ANT THER AFR STA, P1; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Koole O, 2014, TROP MED INT HEALTH, V19, P1397, DOI 10.1111/tmi.12386; Koole Olivier, 2014, J Acquir Immune Defic Syndr, V67, pe27, DOI 10.1097/QAI.0000000000000252; Larson BA, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18026; Matthews LT, 2015, J ACQUIR IMMUNE DEFI; Mbilinyi D, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-266; Medecins Sans Frontieres, UNT WEB ANT PRIC RED; Menzies NA, 2011, AIDS, V25, P1753, DOI 10.1097/QAD.0b013e3283463eec; Mills FP, 2012, JAIDS-J ACQ IMM DEF, V61, P364, DOI 10.1097/QAI.0b013e318265df06; Okulicz JF, 2015, JAMA INTERN MED, V175, P88, DOI 10.1001/jamainternmed.2014.4010; Rich ML, 2012, JAIDS-J ACQ IMM DEF, V59, pE35, DOI 10.1097/QAI.0b013e31824476c4; Sanne I, 2010, LANCET, V376, P33, DOI 10.1016/S0140-6736(10)60894-X; Scott CA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-296; Sempa J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-736; Shafiee H, 2015, ANNU REV MED, V66, P387, DOI 10.1146/annurev-med-092112-143017; Shumbusho F, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000163; Stover J, 2014, AIDS, V28, pS225, DOI 10.1097/QAD.0000000000000235; Tagar E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108304; U.S. Department of Labor Bureau of Labor Statistics, CPI INFL CALC 2015; Uganda Ministry of Health, 2012, UG INT NAT GUID ANT; Were MC, 2008, AIDS CARE, V20, P677, DOI 10.1080/09540120701687067; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2012, WORLD HEAL ORGAN, P1; World Health Organization, 2013, COMPREHENSIVE CERVIC; World Helath Organisation WHO, 2014, 2013 CONS GUID US S, P1	48	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143433	10.1371/journal.pone.0143433	http://dx.doi.org/10.1371/journal.pone.0143433			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26632823	Green Published, Green Submitted, gold			2022-12-27	WOS:000366040000014
J	Klop, C; Welsing, PMJ; Leufkens, HGM; Elders, PJM; Overbeek, JA; van den Bergh, JP; Bijlsma, JWJ; de Vries, F				Klop, Corinne; Welsing, Paco M. J.; Leufkens, Hubert G. M.; Elders, Petra J. M.; Overbeek, Jetty A.; van den Bergh, Joop P.; Bijlsma, Johannes W. J.; de Vries, Frank			The Epidemiology of Hip and Major Osteoporotic Fractures in a Dutch Population of Community-Dwelling Elderly: Implications for the Dutch FRAX (R) Algorithm	PLOS ONE			English	Article							VERTEBRAL FRACTURES; INCIDENCE RATES; HEALTH-CARE; WOMEN; TRENDS; RISK; MEN; ASSOCIATION; NETHERLANDS; CALIBRATION	Background Incidence rates of non-hip major osteoporotic fractures (MOF) remain poorly characterized in the Netherlands. The Dutch FRAX (R) algorithm, which predicts 10-year probabilities of hip fracture and MOF (first of hip, humerus, forearm, clinical vertebral), therefore incorporates imputed MOF rates. Swedish incidence rate ratios for hip fracture to MOF (Malmo 1987-1996) were used to perform this imputation. However, equality of these ratios between countries is uncertain and recent evidence is scarce. Aims were to estimate incidence rates of hip fracture and MOF and to compare observed MOF rates to those predicted by the imputation method for the Netherlands. Methods Using hospitalisation and general practitioner records from the Dutch PHARMO Database Network (2002-2011) we calculated age-and-sex-specific and age-standardized incidence rates (IRs) of hip and other MOFs (humerus, forearm, clinical vertebral) and as used in FRAX (R). Observed MOF rates were compared to those predicted among community-dwelling individuals >= 50 years by the standardized incidence ratio (SIR; 95% CI). Results Age-standardized IRs (per 10,000 person-years) of MOF among men and women >= 50 years were 25.9 and 77.0, respectively. These numbers were 9.3 and 24.0 for hip fracture. Among women 55-84 years, observed MOF rates were significantly higher than predicted (SIR ranged between 1.12-1.50, depending on age). In men, the imputation method performed reasonable. Conclusion Observed MOF incidence was higher than predicted for community-dwelling women over a wide age-range, while it agreed reasonable for men. As miscalibration may influence treatment decisions, there is a need for confirmation of results in another data source. Until then, the Dutch FRAX1output should be interpreted with caution.	[Klop, Corinne; Leufkens, Hubert G. M.; de Vries, Frank] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands; [Welsing, Paco M. J.; Bijlsma, Johannes W. J.] Univ Med Ctr, Dept Rheumatol & Clin Immunol, Utrecht, Netherlands; [Welsing, Paco M. J.] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Elders, Petra J. M.] Vrije Univ Amsterdam, Med Ctr, Dept Gen Practice & Elderly Care, Amsterdam, Netherlands; [Overbeek, Jetty A.] PHARMO Inst Drug Outcomes Res, Utrecht, Netherlands; [van den Bergh, Joop P.] Viecuri Med Ctr, Dept Internal Med, Venlo, Netherlands; [van den Bergh, Joop P.] Maastricht Univ, Med Ctr, Dept Internal Med, NL-6200 MD Maastricht, Netherlands; [van den Bergh, Joop P.] Univ Hasselt, Biomed Res Inst, Hasselt, Belgium; [de Vries, Frank] Maastricht Univ, Med Ctr, Dept Clin Pharm & Toxicol, NL-6200 MD Maastricht, Netherlands; [de Vries, Frank] Southampton Gen Hosp, MRC Lifecourse Epidemiol Unit, Southampton SO9 4XY, Hants, England	Utrecht University; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; VieCuri Medical Center; Maastricht University; Hasselt University; Maastricht University; University of Southampton	de Vries, F (corresponding author), Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands.	f.devries@uu.nl	Overbeek, Jetty/AAG-1770-2019; de Vries, Frank/E-4934-2011	de Vries, Frank/0000-0003-3837-8319; van den Bergh, Joop/0000-0003-3984-2232; Elders, Petra/0000-0002-5907-7219	Netherlands Organization for Health Research and Development [ZonMw] [113101007]	Netherlands Organization for Health Research and Development [ZonMw](Netherlands Organization for Health Research and Development)	Support was provided by the Netherlands Organization for Health Research and Development [ZonMw; http://www.zonmw.nl/nl/; grant 113101007]. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bruin de A, 2009, METHODE BIJSCHATTEN; Cauley JA, 2014, NAT REV ENDOCRINOL, V10, P338, DOI 10.1038/nrendo.2014.51; CBO Kwaliteitsinstituut voor de Gezondheidszorg Nederlandse Vereniging voor Reumatologie, 2011, RICHTL OST FRACT DER; COOPER C, 1992, J BONE MINER RES, V7, P221, DOI 10.1002/jbmr.5650070214; Cooper C, 2011, OSTEOPOROSIS INT, V22, P1277, DOI 10.1007/s00198-011-1601-6; de Putter CE, 2013, INJURY, V44, P421, DOI 10.1016/j.injury.2012.10.025; Felsenberg D, 2002, J BONE MINER RES, V17, P716; Fink HA, 2005, J BONE MINER RES, V20, P1216, DOI 10.1359/JBMR.050314; Finsterwald M, 2014, OSTEOPOROSIS INT, V25, P167, DOI 10.1007/s00198-013-2513-4; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Haentjens P, 2010, ANN INTERN MED, V152, P380, DOI 10.7326/0003-4819-152-6-201003160-00008; Hartholt KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022227; Herings R., 2012, PHARMACOEPIDEM DR S, P270, DOI [10.1002/9781119959946.ch18, DOI 10.1002/9781119959946.CH18]; Herings RMC, 1996, J CLIN EPIDEMIOL, V49, P115, DOI 10.1016/0895-4356(95)00552-8; Jean S, 2013, J BONE MINER RES, V28, P1283, DOI 10.1002/jbmr.1863; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Kanis JA, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0144-1; Kanis JA, 2001, OSTEOPOROSIS INT, V12, P417, DOI 10.1007/s001980170112; Klop C, 2015, OSTEOPOROSIS INT, V26, P1831, DOI 10.1007/s00198-015-3084-3; Lalmohamed A, 2012, OSTEOPOROSIS INT, V23, P861, DOI 10.1007/s00198-011-1852-2; Lam A, 2014, J BONE MINER RES, V29, P1067, DOI 10.1002/jbmr.2146; Leslie WD, 2011, OSTEOPOROSIS INT, V22, P2137, DOI 10.1007/s00198-010-1470-4; Leslie WD, 2011, J CLIN DENSITOM, V14, P272, DOI 10.1016/j.jocd.2011.03.007; Merrill R. M., INTRO EPIDEMIOLOGY, P98; National Institute for Health and Care Excellence, 2012, CG146 OST ASS RISK F; National Osteoporosis Foundation, 2014, CLIN GUID PREV TREAT; National Osteoporosis Guideline Group on behalf of the Bone Research Society British Geriatrics Society British Orthopaedic Association British Orthopaedics Research Society British Society of Rheumatology National Osteoporosis Society Osteoporosis 2000 Osteoporosis Dorset Primary Care Rheumatology Society Royal College of Physicians and Society for Endocrinology, 2014, OST CLIN GUID PREV T; Nilson F, 2013, J PUBLIC HEALTH-UK, V35, P125, DOI 10.1093/pubmed/fds053; Oudshoorn C, 2012, INJURY, V43, P458, DOI 10.1016/j.injury.2011.09.014; Pages-Castella A, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-79; Papaioannou A, 2010, CAN MED ASSOC J, V182, P1864, DOI 10.1503/cmaj.100771; Pfeilschifter J, 2012, OSTEOPOROSIS INT, V23, P2179, DOI 10.1007/s00198-011-1840-6; Rapp K, 2008, J BONE MINER RES, V23, P1825, DOI 10.1359/JBMR.080702; Schuit SCE, 2004, BONE, V34, P195, DOI 10.1016/j.bone.2003.10.001; Siggeirsdottir K, 2014, OSTEOPOROSIS INT, V25, P2445, DOI 10.1007/s00198-014-2777-3; Siggeirsdottir K, 2014, OSTEOPOROSIS INT, V25, P211, DOI 10.1007/s00198-013-2422-6; Van Der Klift M, 2002, J BONE MINER RES, V17, P1051, DOI 10.1359/jbmr.2002.17.6.1051; van Herk-Sukel MPP, 2012, PHARMACOEPIDEM DR S, V21, P94, DOI 10.1002/pds.2205; van Staa TP, 2006, JAMA-J AM MED ASSOC, V295, P2599, DOI 10.1001/jama.295.22.2599-a; Van Staa TP, 2000, PHARMACOEPIDEM DR S, V9, P359, DOI 10.1002/1099-1557(200009/10)9:5<359::AID-PDS507>3.0.CO;2-E; Warriner AH, 2011, J CLIN EPIDEMIOL, V64, P46, DOI 10.1016/j.jclinepi.2010.07.007; Watts NB, 2014, NAT REV ENDOCRINOL, V10, P412, DOI 10.1038/nrendo.2014.55	42	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143800	10.1371/journal.pone.0143800	http://dx.doi.org/10.1371/journal.pone.0143800			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633011	Green Published, gold			2022-12-27	WOS:000366040000022
J	Ridinger, G; McBride, M				Ridinger, Garret; McBride, Michael			Money Affects Theory of Mind Differently by Gender	PLOS ONE			English	Article							SOCIAL VALUE ORIENTATION; COMPLEX EMOTION RECOGNITION; ASPERGER-SYNDROME; DECISION-MAKING; FRONTAL VARIANT; NORMAL ADULTS; COMPETITION; VOICE; PSYCHOLOGY; MOTIVATION	Theory of Mind (ToM) - the ability to understand other's thoughts, intentions, and emotions - is important for navigating interpersonal relationships, avoiding conflict, and empathizing. Prior research has identified many factors that affect one's ToM ability, but little work has examined how different kinds of monetary incentives affect ToM ability. We ask: Does money affect ToM ability? If so, how does the effect depend on the structure of monetary incentives? How do the differences depend on gender? We hypothesize that money will affect ToM ability differently by gender: monetary rewards increase males' motivation to express ToM ability while simultaneously crowding out females' motivation. This prediction is confirmed in an experiment that varies the structure of monetary rewards for correct answers in the Reading the Mind in the Eyes Test (RMET). RMET scores decrease for females and increase for males with individual payments, and this effect is stronger with competitively-structured payments. RMET scores do not significantly change when monetary earnings go to a charity. Whether money improves or hinders ToM ability, and, hence, success in social interactions, thus depends on the interaction of gender and monetary incentive structure.	[Ridinger, Garret; McBride, Michael] Univ Calif Irvine, Dept Econ, Expt Social Sci Lab, Irvine, CA 92717 USA	University of California System; University of California Irvine	McBride, M (corresponding author), Univ Calif Irvine, Dept Econ, Expt Social Sci Lab, Irvine, CA 92717 USA.	mcbride@uci.edu		Ridinger, Garret/0000-0001-6415-9676	Army Research Office [W911NF-11-1-0332]; Air Force Office of Scientific Research Award [FA9550-10-1-0569]	Army Research Office; Air Force Office of Scientific Research Award(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	Financial support for this study was provided by Army Research Office Award No. W911NF-11-1-0332 and Air Force Office of Scientific Research Award No. FA9550-10-1-0569. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RB, 2010, J COGNITIVE NEUROSCI, V22, P97, DOI 10.1162/jocn.2009.21187; Ahmed FS, 2011, J AUTISM DEV DISORD, V41, P667, DOI 10.1007/s10803-010-1087-7; ALLEN JP, 1994, AM J COMMUN PSYCHOL, V22, P617, DOI 10.1007/BF02506896; Amato PR, 1997, J MARRIAGE FAM, V59, P612, DOI 10.2307/353949; Babcock L, 2003, WOMEN DONT ASK: NEGOTIATION AND THE GENDER DIVIDE, P1; Baker CA, 2014, INTELLIGENCE, V44, P78, DOI 10.1016/j.intell.2014.03.001; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; BaronCohen S, 1997, J CHILD PSYCHOL PSYC, V38, P813, DOI 10.1111/j.1469-7610.1997.tb01599.x; Bayard K, 2003, J LABOR ECON, V21, P887, DOI 10.1086/377026; Bekkers R, 2010, SOC SCI RES, V39, P369, DOI 10.1016/j.ssresearch.2009.08.008; Bosman R, 2002, ECON J, V112, P147, DOI 10.1111/1468-0297.0j677; Bowles HR, 2005, J PERS SOC PSYCHOL, V89, P951, DOI 10.1037/0022-3514.89.6.951; Camera G, 2013, P NATL ACAD SCI USA, V110, P14889, DOI 10.1073/pnas.1301888110; Carroll JM, 2006, J AUTISM DEV DISORD, V36, P949, DOI 10.1007/s10803-006-0127-9; Coricelli G, 2010, EXP ECON, V13, P226, DOI 10.1007/s10683-010-9237-5; Cornelissen G, 2011, PERS SOC PSYCHOL B, V37, P1080, DOI 10.1177/0146167211405996; de Waal FBM, 2012, SCIENCE, V336, P874, DOI 10.1126/science.1220999; Declerck CH, 2008, J SOC PSYCHOL, V148, P711, DOI 10.3200/SOCP.148.6.711-726; Dziobek I, 2006, J AUTISM DEV DISORD, V36, P623, DOI 10.1007/s10803-006-0107-0; Eckel CC, 2001, ECON INQ, V39, P171, DOI 10.1093/ei/39.2.171; Frederick S, 2005, J ECON PERSPECT, V19, P25, DOI 10.1257/089533005775196732; Frey BS, 1997, AM ECON REV, V87, P746; Frith U, 2010, PHILOS T R SOC B, V365, P165, DOI 10.1098/rstb.2009.0160; Gneezy U, 2004, AM ECON REV, V94, P377, DOI 10.1257/0002828041301821; Gneezy U, 2003, Q J ECON, V118, P1049, DOI 10.1162/00335530360698496; Gneezy U, 2009, ECONOMETRICA, V77, P1637, DOI 10.3982/ECTA6690; Golan O, 2007, J AUTISM DEV DISORD, V37, P1096, DOI 10.1007/s10803-006-0252-5; Golan O, 2006, J AUTISM DEV DISORD, V36, P169, DOI 10.1007/s10803-005-0057-y; Graham T., 1997, EMPATHIC ACCURACY, P117; Gregory C, 2002, BRAIN, V125, P752, DOI 10.1093/brain/awf079; Grimshaw GM, 2004, BRAIN COGNITION, V54, P248, DOI 10.1016/j.bandc.2004.02.029; Guariglia P, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00292; HAPPE FGE, 1994, J AUTISM DEV DISORD, V24, P129, DOI 10.1007/BF02172093; Hart D, 1998, J SOC ISSUES, V54, P513, DOI 10.1111/0022-4537.801998080; Heyman J, 2004, PSYCHOL SCI, V15, P787, DOI 10.1111/j.0956-7976.2004.00757.x; Hoffmann H, 2010, ACTA PSYCHOL, V135, P278, DOI 10.1016/j.actpsy.2010.07.012; Horgan, 2000, GENDER EMOTION SOCIA, P97, DOI DOI 10.1017/CBO9780511628191.006; Ickes W, 2000, PERS RELATIONSHIP, V7, P95, DOI 10.1111/j.1475-6811.2000.tb00006.x; Jevons W.S., 1875, MONEY MECH EXCHANGE; Kidd DC, 2013, SCIENCE, V342, P377, DOI 10.1126/science.1239918; Kirkland R.A., 2013, N AM J PSYCHOL, V15, P121, DOI DOI 10.3389/fpsyg.2015.01503; Klein KJK, 2001, PERS SOC PSYCHOL B, V27, P720, DOI 10.1177/0146167201276007; Klein RA, 2014, SOC PSYCHOL-GERMANY, V45, P142, DOI 10.1027/1864-9335/a000178; Kleinjans KJ, 2009, J ECON PSYCHOL, V30, P701, DOI 10.1016/j.joep.2009.03.006; Lacetera N, 2010, J ECON PSYCHOL, V31, P738, DOI 10.1016/j.joep.2010.05.007; Lea SEG, 2006, BEHAV BRAIN SCI, V29, P161; Lerner JS, 2004, PSYCHOL SCI, V15, P337, DOI 10.1111/j.0956-7976.2004.00679.x; Ma-Kellams C, 2013, J EXP SOC PSYCHOL, V49, P65, DOI 10.1016/j.jesp.2012.08.014; Mayr U, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P303, DOI 10.1016/B978-0-12-374176-9.00020-8; McCabe K, 2001, P NATL ACAD SCI USA, V98, P11832, DOI 10.1073/pnas.211415698; McCabe KA, 2000, P NATL ACAD SCI USA, V97, P4404, DOI 10.1073/pnas.97.8.4404; MCCLINTOCK CG, 1989, J APPL SOC PSYCHOL, V19, P353, DOI 10.1111/j.1559-1816.1989.tb00060.x; Mellstrom C, 2008, J EUR ECON ASSOC, V6, P845, DOI 10.1162/JEEA.2008.6.4.845; Murayama K, 2010, P NATL ACAD SCI USA, V107, P20911, DOI 10.1073/pnas.1013305107; Nettle D, 2008, EUR J PERSONALITY, V22, P323, DOI 10.1002/per.672; Niederle M, 2011, ANNU REV ECON, V3, P601, DOI 10.1146/annurev-economics-111809-125122; NORTH DC, 1987, ECON INQ, V25, P419, DOI 10.1111/j.1465-7295.1987.tb00750.x; Rohrer D, 2015, J EXP PSYCHOL GEN, V144, pE73, DOI 10.1037/xge0000058; Rutherford MD, 2002, J AUTISM DEV DISORD, V32, P189, DOI 10.1023/A:1015497629971; Saxe R, 2004, ANNU REV PSYCHOL, V55, P87, DOI 10.1146/annurev.psych.55.090902.142044; Shamay-Tsoory SG, 2011, NEUROSCIENTIST, V17, P18, DOI 10.1177/1073858410379268; Sher I, 2014, P NATL ACAD SCI USA, V111, P13307, DOI 10.1073/pnas.1403283111; Sherman GD, 2015, SOC PSYCHOL PERS SCI, V6, P559, DOI 10.1177/1948550614567358; Shurchkov O, 2012, J EUR ECON ASSOC, V10, P1189, DOI 10.1111/j.1542-4774.2012.01084.x; Singer T, 2005, AM ECON REV, V95, P340, DOI 10.1257/000282805774670103; Smith A., 1976, INQUIRY NATURE CAUSE; Smith V.L., 2007, RATIONALITY EC CONST; SMITH VL, 1976, AM ECON REV, V66, P274; Stevenson MT, 2012, EMOTION, V12, P882, DOI 10.1037/a0028628; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Stuhlmacher AF, 1999, PERS PSYCHOL, V52, P653, DOI 10.1111/j.1744-6570.1999.tb00175.x; Toplak ME, 2011, MEM COGNITION, V39, P1275, DOI 10.3758/s13421-011-0104-1; Torralva T, 2007, NEUROPSYCHOLOGIA, V45, P342, DOI 10.1016/j.neuropsychologia.2006.05.031; Uggen C, 1999, SOC FORCES, V78, P331, DOI 10.2307/3005799; Van Lange PAM, 2007, BASIC APPL SOC PSYCH, V29, P375, DOI 10.1080/01973530701665223; Vohs KD, 2008, CURR DIR PSYCHOL SCI, V17, P208, DOI 10.1111/j.1467-8721.2008.00576.x; Vohs KD, 2006, SCIENCE, V314, P1154, DOI 10.1126/science.1132491; Walters AE, 1998, ORGAN BEHAV HUM DEC, V76, P1, DOI 10.1006/obhd.1998.2797	78	8	8	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143973	10.1371/journal.pone.0143973	http://dx.doi.org/10.1371/journal.pone.0143973			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX9QI	26633171	Green Submitted, Green Published, gold			2022-12-27	WOS:000366040000037
J	Tai, AS; Bell, SC; Kidd, TJ; Trembizki, E; Buckley, C; Ramsay, KA; David, M; Wainwright, CE; Grimwood, K; Whiley, DM				Tai, Anna Sze; Bell, Scott Cameron; Kidd, Timothy James; Trembizki, Ella; Buckley, Cameron; Ramsay, Kay Annette; David, Michael; Wainwright, Claire Elizabeth; Grimwood, Keith; Whiley, David Mark			Genotypic Diversity within a Single Pseudomonas aeruginosa Strain Commonly Shared by Australian Patients with Cystic Fibrosis	PLOS ONE			English	Article							TRANSMISSIBLE STRAINS; LUNG INFECTIONS; CROSS-INFECTION; LASR MUTANTS; ADAPTATION; AIRWAYS; IDENTIFICATION; PREVENTION; RESISTANCE; GUIDELINE	In cystic fibrosis (CF), Pseudomonas aeruginosa undergoes intra-strain genotypic and phenotypic diversification while establishing and maintaining chronic lung infections. As the clinical significance of these changes is uncertain, we investigated intra-strain diversity in commonly shared strains from CF patients to determine if specific gene mutations were associated with increased antibiotic resistance and worse clinical outcomes. Two-hundred-and-one P. aeruginosa isolates (163 represented a dominant Australian shared strain, AUST-02) from two Queensland CF centres over two distinct time-periods (2001-2002 and 2007-2009) underwent mexZ and lasR sequencing. Broth microdilution antibiotic susceptibility testing in a subset of isolates was also performed. We identified a novel AUST-02 subtype (M3L7) in adults attending a single Queensland CF centre. This M3L7 subtype was multi-drug resistant and had significantly higher antibiotic minimum inhibitory concentrations than other AUST-02 sub-types. Prospective molecular surveillance using polymerase chain reaction assays determined the prevalence of the 'M3L7' subtype at this centre during 2007-2009 (170 patients) and 2011 (173 patients). Three-year clinical outcomes of patients harbouring different strains and subtypes were compared. MexZ and LasR sequences from AUST-02 isolates were more likely in 2007-2009 than 2001-2002 to exhibit mutations (mexZ: odds ratio (OR) = 3.8; 95% confidence interval (CI): 1.1-13.5 and LasR: OR = 2.5; 95% CI: 1.3-5.0). Surveillance at the adult centre in 2007-2009 identified M3L7 in 28/509 (5.5%) P. aeruginosa isolates from 13/170 (7.6%) patients. A repeat survey in 2011 identified M3L7 in 21/519 (4.0%) P. aeruginosa isolates from 11/173 (6.4%) patients. The M3L7 subtype was associated with greater intravenous antibiotic and hospitalisation requirements, and a higher 3-year risk of death/lung transplantation, than other AUST-02 subtypes (adjusted hazard ratio [HR] = 9.4; 95% CI: 2.2-39.2) and non-AUST-02 strains (adjusted HR = 4.8; 95% CI: 1.4-16.2). This suggests ongoing microevolution of the shared CF strain, AUST-02, was associated with an emerging multi-drug resistant subtype and possibly poorer clinical outcomes.	[Tai, Anna Sze; Kidd, Timothy James; Trembizki, Ella; Buckley, Cameron; Ramsay, Kay Annette; David, Michael; Wainwright, Claire Elizabeth; Grimwood, Keith; Whiley, David Mark] Childrens Hlth Queensland, Queensland Childrens Med Res Inst, South Brisbane, Qld, Australia; [Tai, Anna Sze; Bell, Scott Cameron] Prince Charles Hosp, Dept Thorac Med, Adult Cyst Fibrosis Ctr, Chermside, Qld, Australia; [Tai, Anna Sze; Trembizki, Ella; Ramsay, Kay Annette] Univ Queensland, Sch Med, Herston, Qld, Australia; [Bell, Scott Cameron] QIMR Berghofer Med Res Inst, Herston, Qld, Australia; [Kidd, Timothy James] Queens Univ Belfast, Ctr Infect & Immun, Belfast, Antrim, North Ireland; [David, Michael] Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia; [Wainwright, Claire Elizabeth] Lady Cilento Childrens Hosp, Dept Resp & Sleep Med, South Brisbane, Qld, Australia; [Grimwood, Keith] Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Qld, Australia; [Grimwood, Keith] Gold Coast Univ Hosp, Gold Coast, Qld, Australia; [Whiley, David Mark] Pathol Queensland Cent Lab, Herston, Qld, Australia	Prince Charles Hospital; University of Queensland; QIMR Berghofer Medical Research Institute; Queens University Belfast; University of Queensland; Griffith University; Menzies Health Institute Queensland; Gold Coast University Hospital	Tai, AS (corresponding author), Childrens Hlth Queensland, Queensland Childrens Med Res Inst, South Brisbane, Qld, Australia.	anna.tai@uq.net.au	Trembizki, Ella/AAX-8520-2020; Whiley, David M/E-8955-2011; Bell, Scott/AAJ-4298-2020; Kidd, Timothy/F-2149-2010; Bell, Scott C/A-7241-2011; Wainwright, Claire E/G-4218-2013	Whiley, David M/0000-0001-5969-3161; Bell, Scott/0000-0001-8651-7139; Kidd, Timothy/0000-0002-6135-6364; Bell, Scott C/0000-0001-8651-7139; Wainwright, Claire E/0000-0001-8389-3809; Grimwood, Keith/0000-0003-3174-9834	Children's Hospital Foundation [Queensland Children's Medical Research Institute (QCMRI) Grant] [50024]; Prince Charles Hospital Foundation [MS2013-02]; National Health Medical Research Council [455919]; National Health and Medical Research Early Career Fellowship [APP1054129]; QCMRI Early Career Fellowship [50024]; Queensland Health Office of Health and Medical Research Fellowship [QCOS013795]; ERS-EU RESPIRE2 Marie Sklodowska-Curie Postdoctoral Research Fellowship (MC RESPIRE2 first round) [4571-2013]; Australian Postgraduate Award [2127932]; National Health and Medical Research Council Post-graduate Medical and Dental Scholarship [APP1017517]; Australian Cystic Fibrosis Foundation Postgraduate Scholarship; People Programme of the European Union's Seventh Framework Programme (FP7), under REA grant [600368]	Children's Hospital Foundation [Queensland Children's Medical Research Institute (QCMRI) Grant]; Prince Charles Hospital Foundation; National Health Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Early Career Fellowship; QCMRI Early Career Fellowship; Queensland Health Office of Health and Medical Research Fellowship; ERS-EU RESPIRE2 Marie Sklodowska-Curie Postdoctoral Research Fellowship (MC RESPIRE2 first round); Australian Postgraduate Award(Australian Government); National Health and Medical Research Council Post-graduate Medical and Dental Scholarship(National Health and Medical Research Council (NHMRC) of Australia); Australian Cystic Fibrosis Foundation Postgraduate Scholarship; People Programme of the European Union's Seventh Framework Programme (FP7), under REA grant	This study was funded by the Children's Hospital Foundation [Queensland Children's Medical Research Institute (QCMRI) Grant 50024], a Project Grant from The Prince Charles Hospital Foundation [MS2013-02 to SCB, DMW and TJK] (http://www.tpchfoundation.org.au) and a National Health Medical Research Council Project Grant [455919 to SCB & CEW] (www.nhmrc.gov.au). DMW is a recipient of a National Health and Medical Research Early Career Fellowship [APP1054129] (www.nhmrc.gov.au) and QCMRI Early Career Fellowship [50024] (www.qcmri.org.au). SCB is a recipient of Queensland Health Office of Health and Medical Research Fellowship [QCOS013795] (www.health.qld.gov.au/ohmr/html/funding/funding.asp). TJK is the recipient of an ERS-EU RESPIRE2 Marie Sklodowska-Curie Postdoctoral Research Fellowship (MC RESPIRE2 first round, 4571-2013) (www.ersnet.org/ers-funding/fellowships/post-doc/eu-co-funded-respire-2), which was partly funded by the People Programme of the European Union's Seventh Framework Programme (FP7/2007-2013), under REA grant agreement 600368. KAR is the recipient of an Australian Postgraduate Award Scholarship [2127932] (https://education.gov.au/australian-postgraduate-awards). AST is the recipient of a National Health and Medical Research Council Post-graduate Medical and Dental Scholarship [APP1017517] (www.nhmrc.gov.au) and Australian Cystic Fibrosis Foundation Postgraduate Scholarship (www.cysticfibrosis.org.au/cfwa-scholarship). All aforementioned funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron SD, 2010, JAMA-J AM MED ASSOC, V304, P2145, DOI 10.1001/jama.2010.1665; Al-Aloul M, 2004, THORAX, V59, P334, DOI 10.1136/thx.2003.014258; Ashish Abdul, 2013, JRSM Short Rep, V4, P1, DOI 10.1258/shorts.2012.012018; Ashish A, 2012, J CYST FIBROS, V11, P173, DOI 10.1016/j.jcf.2011.11.004; Burns JL, 2001, J INFECT DIS, V183, P444, DOI 10.1086/318075; Chung JCS, 2012, J BACTERIOL, V194, P4857, DOI 10.1128/JB.01050-12; CLSI, 2013, PERFORMANCE STANDARD; D'Argenio DA, 2007, MOL MICROBIOL, V64, P512, DOI 10.1111/j.1365-2958.2007.05678.x; Fernandez L, 2012, CLIN MICROBIOL REV, V25, P661, DOI 10.1128/CMR.00043-12; Folkesson A, 2012, NAT REV MICROBIOL, V10, P841, DOI 10.1038/nrmicro2907; Fothergill JL, 2012, EUR RESPIR J, V40, P227, DOI 10.1183/09031936.00204411; Foundation CF., 1994, MICR INF DIS CONS C; Foweraker JE, 2005, J ANTIMICROB CHEMOTH, V55, P921, DOI 10.1093/jac/dki146; Griffiths AL, 2005, AM J RESP CRIT CARE, V171, P1020, DOI 10.1164/rccm.200409-1194OC; Hauser AR, 2011, CLIN MICROBIOL REV, V24, P29, DOI 10.1128/CMR.00036-10; Hoffman LR, 2009, J CYST FIBROS, V8, P66, DOI 10.1016/j.jcf.2008.09.006; Hogardt M, 2010, INT J MED MICROBIOL, V300, P557, DOI 10.1016/j.ijmm.2010.08.008; Jeukens J, 2013, GENOME ANNOUNC, V1; Jones AM, 2003, THORAX, V58, P525, DOI 10.1136/thorax.58.6.525; Jones AM, 2010, CHEST, V137, P1405, DOI 10.1378/chest.09-2406; Kidd TJ, 2015, LANCET RESP MED, V3, P640, DOI 10.1016/S2213-2600(15)00228-3; Kidd TJ, 2015, J CYST FIBROS, V14, P361, DOI 10.1016/j.jcf.2014.12.007; Kidd TJ, 2013, EUR RESPIR J, V41, P1091, DOI 10.1183/09031936.00060512; Kidd TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044199; Knibbs LD, 2014, THORAX, V69, P740, DOI 10.1136/thoraxjnl-2014-205213; Ledson MJ, 1998, THORAX, V53, P432, DOI 10.1136/thx.53.5.432; Luna RA, 2013, J CLIN MICROBIOL, V51, P1237, DOI 10.1128/JCM.02157-12; Marvig RL, 2015, NAT GENET, V47, P57, DOI 10.1038/ng.3148; Mogayzel Peter J Jr, 2014, Ann Am Thorac Soc, V11, P1640, DOI 10.1513/AnnalsATS.201404-166OC; Mowat E, 2011, AM J RESP CRIT CARE, V183, P1674, DOI 10.1164/rccm.201009-1430OC; O'Carroll MR, 2004, EUR RESPIR J, V24, P101, DOI 10.1183/09031936.04.00122903; Qin X, 2012, ANTIMICROB AGENTS CH, V56, P5971, DOI 10.1128/AAC.01371-12; Saiman L, 2014, INFECT CONT HOSP EP, V35, pS1, DOI 10.1086/676882; Scott FW, 2004, J MED MICROBIOL, V53, P609, DOI 10.1099/jmm.0.45620-0; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Syrmis MW, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-307; Trust CF, 2011, STANDARDS CLIN CARE; Wainwright CE, 2009, THORAX, V64, P926, DOI 10.1136/thx.2008.112466; Williams D, 2015, AM J RESP CRIT CARE, V191, P775, DOI 10.1164/rccm.201409-1646OC; Workentine ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060225; Yang L, 2011, P NATL ACAD SCI USA, V108, P7481, DOI 10.1073/pnas.1018249108	41	13	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144022	10.1371/journal.pone.0144022	http://dx.doi.org/10.1371/journal.pone.0144022			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633539	Green Published, Green Submitted, gold			2022-12-27	WOS:000366040000045
J	Szczesny, B; Brunyanszki, A; Ahmad, A; Olah, G; Porter, C; Toliver-Kinsky, T; Sidossis, L; Herndon, DN; Szabo, C				Szczesny, Bartosz; Brunyanszki, Attila; Ahmad, Akbar; Olah, Gabor; Porter, Craig; Toliver-Kinsky, Tracy; Sidossis, Labros; Herndon, David N.; Szabo, Csaba			Time-Dependent and Organ-Specific Changes in Mitochondrial Function, Mitochondrial DNA Integrity, Oxidative Stress and Mononuclear Cell Infiltration in a Mouse Model of Burn Injury	PLOS ONE			English	Article							ACUTE LUNG INJURY; POLY(ADP-RIBOSE) POLYMERASE; HYDROGEN-SULFIDE; PLASMA; INHIBITION; DAMAGE; ACTIVATION; RESPONSES; TRAUMA	Severe thermal injury induces a pathophysiological response that affects most of the organs within the body; liver, heart, lung, skeletal muscle among others, with inflammation and hyper-metabolism as a hallmark of the post-burn damage. Oxidative stress has been implicated as a key component in development of inflammatory and metabolic responses induced by burn. The goal of the current study was to evaluate several critical mitochondrial functions in a mouse model of severe burn injury. Mitochondrial bioenergetics, measured by Extracellular Flux Analyzer, showed a time dependent, post-burn decrease in basal respiration and ATP-turnover but enhanced maximal respiratory capacity in mitochondria isolated from the liver and lung of animals subjected to burn injury. Moreover, we detected a tissue-specific degree of DNA damage, particularly of the mitochondrial DNA, with the most profound effect detected in lungs and hearts of mice subjected to burn injury. Increased mitochondrial biogenesis in lung tissue in response to burn injury was also observed. Burn injury also induced time dependent increases in oxidative stress (measured by amount of malondialdehyde) and neutrophil infiltration (measured by myeloperoxidase activity), particularly in lung and heart. Tissue mononuclear cell infiltration was also confirmed by immunohistochemistry. The amount of poly(ADP-ribose) polymers decreased in the liver, but increased in the heart in later time points after burn. All of these biochemical changes were also associated with histological alterations in all three organs studied. Finally, we detected a significant increase in mitochondrial DNA fragments circulating in the blood immediately post-burn. There was no evidence of systemic bacteremia, or the presence of bacterial DNA fragments at any time after burn injury. The majority of the measured parameters demonstrated a sustained elevation even at 20-40 days post injury suggesting a long-lasting effect of thermal injury on organ function. The current data show that there are marked time-dependent and tissue-specific alterations in mitochondrial function induced by thermal injury, and suggest that mitochondria-specific damage is one of the earliest responses to burn injury. Mitochondria may be potential therapeutic targets in the future experimental therapy of burns.	[Szczesny, Bartosz; Brunyanszki, Attila; Ahmad, Akbar; Olah, Gabor; Toliver-Kinsky, Tracy; Szabo, Csaba] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA; [Szczesny, Bartosz; Porter, Craig; Sidossis, Labros; Herndon, David N.; Szabo, Csaba] Shriners Hosp Children, Galveston, TX 77550 USA; [Porter, Craig; Sidossis, Labros; Herndon, David N.] Univ Texas Med Branch, Dept Surg, Galveston, TX 77555 USA; [Toliver-Kinsky, Tracy] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Szabo, C (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA.	szabocsaba@aol.com	Herndon, David/AAC-3354-2020; Toliver-Kinsky, Tracy/ABE-2048-2020; Sidossis, Labros/AAN-9546-2021; Szabo, Csaba/ABG-2644-2021	Sidossis, Labros/0000-0001-8313-7966; Ahmad, Akbar/0000-0003-1841-9670; porter, Craig/0000-0003-3657-6645	US National Institutes of Health [2P50 GM060338]; Shriners of North America [85800]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM060338] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners of North America; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the US National Institutes of Health 2P50 GM060338 and by a grant from the Shriners of North America (#85800) to C.S.	Ahmad A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057208; Asmussen S, 2011, SHOCK, V36, P402, DOI 10.1097/SHK.0b013e318228f614; Ayala-Torres S, 2000, METHODS, V22, P135, DOI 10.1006/meth.2000.1054; Bartha E, 2011, SHOCK, V36, P144, DOI 10.1097/SHK.0b013e318212988c; Brunyanszki A, 2014, MOL PHARMACOL, V86, P450, DOI 10.1124/mol.114.094318; Burkle A, 2013, MOL ASPECTS MED, V34, P1046, DOI 10.1016/j.mam.2012.12.010; Cauwels A, 2013, P NATL ACAD SCI USA, V110, pE3150, DOI 10.1073/pnas.1308333110; Cevik O, 2012, BURNS, V38, P861, DOI 10.1016/j.burns.2012.01.006; Chen XQ, 1999, CLIN CANCER RES, V5, P2297; Chiu TW, 2006, CLIN CHEM LAB MED, V44, P13, DOI 10.1515/CCLM.2006.003; Coletta C, 2015, MOL MED, V21, DOI 10.2119/molmed.2015.00035; Cree MG, 2008, AM J SURG, V196, P234, DOI 10.1016/j.amjsurg.2007.09.048; Csontos C, 2012, BURNS, V38, P428, DOI 10.1016/j.burns.2011.09.011; Cuzzocrea S, 2001, BRIT J PHARMACOL, V132, P19, DOI 10.1038/sj.bjp.0703775; Enkhbaatar P, 2011, BURNS, V37, P638, DOI 10.1016/j.burns.2010.12.011; Esechie A, 2008, CLIN SCI, V115, P91, DOI 10.1042/CS20080021; Herndon DN, 2004, LANCET, V363, P1895, DOI 10.1016/S0140-6736(04)16360-5; Horton JW, 2003, TOXICOLOGY, V189, P75, DOI 10.1016/S0300-483X(03)00154-9; Itagaki K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120549; Jagtap P, 2005, NAT REV DRUG DISCOV, V4, P421, DOI 10.1038/nrd1718; Jeschke MG, 2008, ANN SURG, V248, P387, DOI 10.1097/SLA.0b013e3181856241; Jeschke MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021245; Jeschke MG, 2001, AM J PHYSIOL-GASTR L, V280, pG1314, DOI 10.1152/ajpgi.2001.280.6.G1314; Kathe SD, 2004, J BIOL CHEM, V279, P18511, DOI 10.1074/jbc.M313598200; Keck M, 2009, WIEN MED WOCHENSCHR, V159, P327, DOI 10.1007/s10354-009-0651-2; Kwan JA, 2004, FASEB J, V18, P690, DOI 10.1096/fj.02-1202fje; Lange M, 2012, SHOCK, V37, P468, DOI 10.1097/SHK.0b013e31824b1793; Liang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068786; Liaudet L, 2001, AM J RESP CRIT CARE, V164, P1213, DOI 10.1164/ajrccm.164.7.2101013; Malik AN, 2013, MITOCHONDRION, V13, P481, DOI 10.1016/j.mito.2012.10.011; Maybauer DM, 2011, BURNS, V37, P842, DOI 10.1016/j.burns.2010.12.020; Modis K, 2013, FASEB J, V27, P601, DOI 10.1096/fj.12-216507; Murakami K, 2004, SHOCK, V21, P126, DOI 10.1097/01.shk.0000108397.56565.4a; Olah G, 2011, SHOCK, V36, P18, DOI 10.1097/SHK.0b013e3182168d8f; Osuchowski MF, 2014, SHOCK, V41, P463, DOI 10.1097/SHK.0000000000000153; Porter C, 2015, J BURN CARE RES; Porter C, 2015, SHOCK, V44, P258, DOI 10.1097/SHK.0000000000000410; Porter C, 2014, AM J PHYSIOL-ENDOC M, V307, pE462, DOI 10.1152/ajpendo.00206.2014; Porter C, 2013, BURNS, V39, P1039, DOI 10.1016/j.burns.2013.03.018; Sandre C, 2006, J TRAUMA, V60, P627, DOI 10.1097/01.ta.0000205640.82459.d6; Sarma JV, 2011, COMPR PHYSIOL, V1, P1365, DOI 10.1002/cphy.c100068; Saunders FD, 2010, AM J PHYSIOL-LUNG C, V298, pL427, DOI 10.1152/ajplung.00147.2009; Sehirli O, 2008, PEPTIDES, V29, P1231, DOI 10.1016/j.peptides.2008.02.012; Sener G, 2007, BURNS, V33, P587, DOI 10.1016/j.burns.2006.10.381; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shimoda K, 2003, AM J PHYSIOL-LUNG C, V285, pL240, DOI 10.1152/ajplung.00319.2002; Silveira PCL, 2014, MAT SCI ENG C-MATER, V44, P380, DOI 10.1016/j.msec.2014.08.045; Song JQ, 2009, MOL MED, V15, P316, DOI 10.2119/molmed.2009.00048; Szczesny B, 2014, NUCLEIC ACIDS RES, V42, P13161, DOI 10.1093/nar/gku1089; Takao K, 2015, P NATL ACAD SCI USA, V112, P1167, DOI 10.1073/pnas.1401965111; Ward PA, 2010, ANN NY ACAD SCI, V1203, P53, DOI 10.1111/j.1749-6632.2010.05552.x; Yalcin AD, 2012, INT J BURNS TRAUMA, V2, P110; Yao X, 2014, AM J PHYSIOL-HEART C, V306, pH882, DOI 10.1152/ajpheart.00475.2013; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhong Xiao Yan, 2007, Archives of Gynecology and Obstetrics, V276, P327, DOI 10.1007/s00404-007-0345-1	55	52	55	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143730	10.1371/journal.pone.0143730	http://dx.doi.org/10.1371/journal.pone.0143730			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630679	gold, Green Published, Green Submitted			2022-12-27	WOS:000365926300091
J	Apostolaki, NE; Rayfield, EJ; Barrett, PM				Apostolaki, Naomi E.; Rayfield, Emily J.; Barrett, Paul M.			Osteological and Soft-Tissue Evidence for Pneumatization in the Cervical Column of the Ostrich (Struthio camelus) and Observations on the Vertebral Columns of Non-Volant, Semi-Volant and Semi-Aquatic Birds	PLOS ONE			English	Article							POSTCRANIAL SKELETAL PNEUMATICITY; UNIDIRECTIONAL AIR-FLOW; RESPIRATORY SYSTEM; SAC SYSTEM; EVOLUTION; ORIGIN; LUNG; VENTILATION; MORPHOLOGY; SAUROPODS	Postcranial skeletal pneumaticity (PSP) is a condition most notably found in birds, but that is also present in other saurischian dinosaurs and pterosaurs. In birds, skeletal pneumatization occurs where bones are penetrated by pneumatic diverticula, membranous extensions that originate from air sacs that serve in the ventilation of the lung. Key questions that remain to be addressed include further characterizing (1) the skeletal features that can be used to infer the presence/absence and extent of PSP in birds and non-avian dinosaurs, and (2) the association between vertebral laminae and specific components of the avian respiratory system. Previous work has used vertebral features such as pneumatic foramina, fossae, and laminae to identify/infer the presence of air sacs and diverticula, and to discuss the range of possible functions of such features. Here, we tabulate pneumatic features in the vertebral column of 11 avian taxa, including the flightless ratites and selected members of semi-volant and semi-aquatic Neornithes. We investigate the associations of these osteological features with each other and, in the case of Struthio camelus, with the specific presence of pneumatic diverticula. We find that the mere presence of vertebral laminae does not indicate the presence of skeletal pneumaticity, since laminae are not always associated with pneumatic foramina or fossae. Nevertheless, laminae are more strongly developed when adjacent to foramina or fossae. In addition, membranous air sac extensions and adjacent musculature share the same attachment points on the vertebrae, rendering the use of such features for reconstructing respiratory soft tissue features ambiguous. Finally, pneumatic diverticula attach to the margins of laminae, foramina, and/or fossae prior to their intraosseous course. Similarities in PSP distribution among the examined taxa are concordant with their phylogenetic interrelationships. The possible functions of PSP are discussed in brief, based upon variation in the extent of PSP between taxa with differing ecologies.	[Apostolaki, Naomi E.; Rayfield, Emily J.] Univ Bristol, Dept Earth Sci, Bristol, Avon, England; [Barrett, Paul M.] Nat Hist Museum, Dept Earth Sci, Div Vertebrates Anthropol & Palaeobiol, London SW7 5BD, England	University of Bristol; Natural History Museum London	Apostolaki, NE (corresponding author), Univ Bristol, Dept Earth Sci, Bristol, Avon, England.	Naomi.Apostolaki@bris.ac.uk	Barrett, Paul M/A-2648-2010; Rayfield, Emily/F-5038-2010	Barrett, Paul M/0000-0003-0412-3000; Rayfield, Emily/0000-0002-2618-750X; Apostolaki, Naomi/0000-0002-3083-7675				Baumel J.J, 1993, HDB AVIAN ANATOMY NO; Benson RBJ, 2012, BIOL REV, V87, P168, DOI 10.1111/j.1469-185X.2011.00190.x; Bezuidenhout AJ, 1999, OSTRICH: BIOLOGY, PRODUCTION AND HEALTH, P13; BRACKENBURY J, 1990, J EXP BIOL, V152, P93; BRACKENBURY JH, 1990, EXP PHYSIOL, V75, P391, DOI 10.1113/expphysiol.1990.sp003414; Bremer JL, 1940, ANAT RECORD, V77, P197, DOI 10.1002/ar.1090770209; Britt BB, 1993, THESIS; Brown RE, 1997, ENVIRON HEALTH PERSP, V105, P188, DOI 10.2307/3433242; Butler RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034094; Butler RJ, 2009, BIOL LETTERS, V5, P557, DOI 10.1098/rsbl.2009.0139; Carrier DR, 2000, AM ZOOL, V40, P87, DOI 10.1668/0003-1569(2000)040[0087:TIOVAL]2.0.CO;2; Cieri RL, 2014, P NATL ACAD SCI USA, V111, P17218, DOI 10.1073/pnas.1405088111; Claessens LPAM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004497; Claessens LPAM, 2004, J VERTEBR PALEONTOL, V24, P89, DOI 10.1671/A1116-8; Codd JR, 2008, P ROY SOC B-BIOL SCI, V275, P157, DOI 10.1098/rspb.2007.1233; Duncker H R, 1971, Ergeb Anat Entwicklungsgesch, V45, P7; DUNCKER HR, 1972, RESP PHYSIOL, V14, P44, DOI 10.1016/0034-5687(72)90016-3; Duncker HR, 2004, RESP PHYSIOL NEUROBI, V144, P111, DOI 10.1016/j.resp.2004.07.020; Duncker HR, 1989, STRUCTURAL FUNCTIONA; Evans Howard E., 1996, P79; Fajardo RJ, 2007, J ANAT, V211, P138, DOI 10.1111/j.1469-7580.2007.00749.x; Farmer CG, 2006, RESP PHYSIOL NEUROBI, V154, P89, DOI 10.1016/j.resp.2006.04.014; Farmer CG, 2010, SCIENCE, V327, P338, DOI 10.1126/science.1180219; Ghetie VCS., 1976, ANATOMICAL ATLAS DOM; Gower DJ, 2001, NATURWISSENSCHAFTEN, V88, P119, DOI 10.1007/s001140100206; Gutzwiller SC, 2010, THESIS; Habib M, 2010, BIOL J LINN SOC, V99, P687, DOI 10.1111/j.1095-8312.2010.01372.x; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Harshman J, 2008, P NATL ACAD SCI USA, V105, P13462, DOI 10.1073/pnas.0803242105; Heard DJ, 1997, SEMIN AVIAN EXOT PET, V6, P172, DOI 10.1016/S1055-937X(97)80002-3; HOGG DA, 1984, J ANAT, V139, P105; HOGG DA, 1980, IBIS, V122, P359, DOI 10.1111/j.1474-919X.1980.tb00890.x; King A. S., 1966, International Review of General and Experimental Zoology, V2, P171; King AS, 1993, HDB AVIAN ANATOMY NO, P257; LIEM KF, 1989, AM ZOOL, V29, P333; Livezey BC, 2007, ZOOL J LINN SOC-LOND, V149, P1, DOI 10.1111/j.1096-3642.2006.00293.x; M?ller B., 1908, SMITHSONIAN MISCELLA, V50, P365; MAGNUSSEN H, 1976, RESP PHYSIOL, V26, P129, DOI 10.1016/0034-5687(76)90057-8; Maina JN, 2007, RESP PHYSIOL NEUROBI, V155, P1, DOI 10.1016/j.resp.2006.05.005; Maina J.N., 1989, P307; Maina J.N., 1998, GAS EXCHANGERS STRUC; Maina JN, 2000, J EXP BIOL, V203, P2865; Maina JN, 2001, J EXP BIOL, V204, P2313; Maina JN, 2006, BIOL REV, V81, P545, DOI 10.1017/S1464793106007111; Mayr G, 2014, PALAEONTOLOGY, V57, P231, DOI 10.1111/pala.12103; McLelland J., 1989, P221; MEISTER W, 1962, ANAT REC, V143, P377, DOI 10.1002/ar.1091430408; Nysten M., 1962, ANN MUSEE ROYAL AFRI, V8, P187; O'Connor PM, 2006, J MORPHOL, V267, P1199, DOI 10.1002/jmor.10470; O'Connor PM, 2009, J EXP ZOOL PART A, V311A, P629, DOI 10.1002/jez.548; O'Connor PM, 2004, J MORPHOL, V261, P141, DOI 10.1002/jmor.10190; O'Connor PM, 2005, NATURE, V436, P253, DOI 10.1038/nature03716; Owen, 1859, PHILOS T ROY SOC LON, V149, P161; Perry Steven F., 1998, V19, P1; Powell F.L., 2000, P233, DOI 10.1016/B978-012747605-6/50011-0; Schachner ER, 2014, NATURE, V506, P367, DOI 10.1038/nature12871; Schachner Emma R., 2013, PEERJ, V1, pe60, DOI [10.7717/peerj.60, DOI 10.7717/PEERJ.60]; Schwarz D, 2007, ACTA PALAEONTOL POL, V52, P167; Schwarz D, 2006, ECLOGAE GEOL HELV, V99, P65, DOI 10.1007/s00015-006-1177-x; Schwarz-Wings D, 2010, P ROY SOC B-BIOL SCI, V277, P11, DOI 10.1098/rspb.2009.1275; Seeley HG., 1870, ANN MAG NAT HIST SER, V5, P279, DOI [10.1080/00222937008696155, DOI 10.1080/00222937008696155]; Sereno PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003303; Tickle PG, 2007, J EXP BIOL, V210, P3955, DOI 10.1242/jeb.008953; WAKE DB, 1963, J MORPHOL, V113, P77, DOI 10.1002/jmor.1051130106; Wedel M, 2007, SPEC PAP PALAEONTOL, P207; Wedel MJ, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P201; Wedel MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078213; Wedel MJ, 2009, J EXP ZOOL PART A, V311A, P611, DOI 10.1002/jez.513; Wedel MJ, 2003, J VERTEBR PALEONTOL, V23, P344, DOI 10.1671/0272-4634(2003)023[0344:TEOVPI]2.0.CO;2; Wedel MJ, 2003, PALEOBIOLOGY, V29, P243, DOI 10.1666/0094-8373(2003)029<0243:VPASAT>2.0.CO;2; Welty JC, 1979, LIFE BIRDS; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P639, DOI 10.1080/02724634.1999.10011178; Wilson JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017114; WITMER LM, 1990, ZOOL J LINN SOC-LOND, V100, P327, DOI 10.1111/j.1096-3642.1990.tb01865.x; Yates AM, 2012, ACTA PALAEONTOL POL, V57, P85, DOI 10.4202/app.2010.0075; [No title captured]	76	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0143834	10.1371/journal.pone.0143834	http://dx.doi.org/10.1371/journal.pone.0143834			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26649745	gold, Green Published, Green Submitted			2022-12-27	WOS:000366903300028
J	Han, FL; Forster, CA; Clark, JM; Xu, X				Han, Fenglu; Forster, Catherine A.; Clark, James M.; Xu, Xing			A New Taxon of Basal Ceratopsian from China and the Early Evolution of Ceratopsia	PLOS ONE			English	Article							DINOSAUR CHANGCHUNSAURUS-PARVUS; NEOCERATOPSIAN DINOSAUR; TUCHENGZI FORMATION; JILIN PROVINCE	Ceratopsia is one of the best studied herbivorous ornithischian clades, but the early evolution of Ceratopsia, including the placement of Psittacosaurus, is still controversial and unclear. Here, we report a second basal ceratopsian, Hualianceratops wucaiwanensis gen. et sp. nov., from the Upper Jurassic (Oxfordian) Shishugou Formation of the Junggar Basin, northwestern China. This new taxon is characterized by a prominent caudodorsal process on the subtemporal ramus of the jugal, a robust quadrate with an expansive quadratojugal facet, a prominent notch near the ventral region of the quadrate, a deep and short dentary, and strongly rugose texturing on the lateral surface of the dentary. Hualianceratops shares several derived characters with both Psittacosaurus and the basal ceratopsians Yinlong, Chaoyangsaurus, and Xuanhuaceratops. A new comprehensive phylogeny of ceratopsians weakly supports both Yinlong and Hualianceratops as chaoyangsaurids (along with Chaoyangsaurus and Xuanhuaceratops), as well as the monophyly of Chaoyangosauridae + Psittacosaurus. This analysis also weakly supports the novel hypothesis that Chaoyangsauridae + Psittacosaurus is the sister group to the rest of Neoceratopsia, suggesting a basal split between these clades before the Late Jurassic. This phylogeny and the earliest Late Jurassic age of Yinlong and Hualianceratops imply that at least five ceratopsian lineages (Yinlong, Hualianceratops, Chaoyangsaurus + Xuanhuaceratops, Psittacosaurus, Neoceratopsia) were present at the beginning of the Late Jurassic.	[Han, Fenglu] China Univ Geosci, Sch Earth Sci, Wuhan 430074, Peoples R China; [Han, Fenglu; Xu, Xing] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Evolutionary Systemat Vertebrates, Beijing, Peoples R China; [Forster, Catherine A.; Clark, James M.] George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA	China University of Geosciences; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; George Washington University	Han, FL (corresponding author), China Univ Geosci, Sch Earth Sci, Wuhan 430074, Peoples R China.	hfl0501@163.com		, Fenglu/0000-0003-3399-4008	National Natural Science Foundation of China [41120124002]; National Geographic Society; U.S. National Science Foundation [EAR 0310217, EAR 0228559]; CAF; Fundamental Research Funds for the Central Universities [CUGL140806]; China postdoctoral Science Foundation [2014M552108]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Geographic Society(National Geographic Society); U.S. National Science Foundation(National Science Foundation (NSF)); CAF; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); China postdoctoral Science Foundation(China Postdoctoral Science Foundation)	Collection of the fossils and subsequent research were funded by the National Natural Science Foundation of China (41120124002; http://www.nsfc.gov.cn) to XX, the National Geographic Society to JMC, the U.S. National Science Foundation (EAR 0310217 and EAR 0228559; http://www.nsf.gov) to JMC and CAF, and the Fundamental Research Funds for the Central Universities (CUGL140806; http://www.moe.gov.cn/) and China postdoctoral Science Foundation (2014M552108; http://www.chinapostdoctor.org.cn) to FLH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averianov AO, 2006, J SYST PALAEONTOL, V4, P359, DOI 10.1017/S1477201906001933; BROWN BARNUM, 1940, ANN NEW YORK ACAD SCI, V40, P133; Butler RJ, 2008, J SYST PALAEONTOL, V6, P1, DOI 10.1017/S1477201907002271; Butler RJ, 2011, PALAEONTOLOGY, V54, P667, DOI 10.1111/j.1475-4983.2011.01046.x; Eberth DA, 2010, PALAIOS, V25, P112, DOI 10.2110/palo.2009.p09-028r; Farke AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112055; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1; Han F-L, J VERTEBR P IN PRESS; Han FX., 2009, THESIS; He HY, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025274; Jin LY, 2010, J VERTEBR PALEONTOL, V30, P196, DOI 10.1080/02724630903412372; Lee YN, 2011, NATURWISSENSCHAFTEN, V98, P39, DOI 10.1007/s00114-010-0739-y; Lucas SG, 2006, CRETACEOUS RES, V27, P189, DOI 10.1016/j.cretres.2005.11.011; Makovicky PJ, 2011, J VERTEBR PALEONTOL, V31, P626, DOI 10.1080/02724634.2011.557114; Makovicky Peter J., 2010, P68; Makovicky PJ, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3530[1:YDANPC]2.0.CO;2; Marsh O.C., 1889, AM J SCI, V38, P173, DOI [10.2475/ajs.s3-38.224.173, DOI 10.2475/AJS.S3-38.224.173]; Marsh O.C., 1890, AM J SCI, V39, P418, DOI DOI 10.2475/AJS.S3-39.233.418; Maryanska T, 1974, Palaeontologia Polonica, VNo. 30, P45; Maryanska T, 2004, DINOSAURIA, 2ND EDITION, P464; Morschhauser EM, 2012, AAI3509219; Osborn H. F., 1923, American Museum Novitates, V95, P1; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; Ryan MJ, 2012, CRETACEOUS RES, V35, P69, DOI 10.1016/j.cretres.2011.11.018; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Sereno P.C., 1990, P579; Sereno Paul C., 1998, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V210, P41; Sereno Paul C., 2010, P21; Swisher CC, 2002, CHINESE SCI BULL, V47, P135; Xu Huan, 2012, Palaeoworld, V21, P222, DOI 10.1016/j.palwor.2012.10.003; Xu X, 2002, NATURE, V416, P314, DOI 10.1038/416314a; Xu X, 2006, P ROY SOC B-BIOL SCI, V273, P2135, DOI 10.1098/rspb.2006.3566; Xu X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013835; You Hai-Lu, 2010, P59; You Hailu, 2004, P478; You HL, 2005, ACTA GEOL SIN-ENGL, V79, P593; You HL, 2005, ACTA GEOL SIN-ENGL, V79, P168; You HL, 2003, ACTA PALAEONTOL POL, V48, P261; Zhao XJ, 2006, ACTA GEOL SIN-ENGL, V80, P467; Zhao XJ, 1999, J VERTEBR PALEONTOL, V19, P681; Zhou Chang-Fu, 2006, Palaeoworld, V15, P100, DOI 10.1016/j.palwor.2005.11.001	42	14	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0143369	10.1371/journal.pone.0143369	http://dx.doi.org/10.1371/journal.pone.0143369			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26649770	gold, Green Published, Green Submitted			2022-12-27	WOS:000366903300016
J	Makino, TT; Yokoyama, J				Makino, Takashi T.; Yokoyama, Jun			Nonrandom Composition of Flower Colors in a Plant Community: Mutually Different Co-Flowering Natives and Disturbance by Aliens	PLOS ONE			English	Article							POLLINATION SYSTEMS; BOMBUS-TERRESTRIS; FLORAL COLOR; CHARACTER DISPLACEMENT; INSECT POLLINATORS; VISION; DISCRIMINATION; COMPETITION; HUMMINGBIRD; MIMICRY	When pollinators use flower color to locate food sources, a distinct color can serve as a reproductive barrier against co-flowering species. This anti-interference function of flower color may result in a community assembly of plant species displaying mutually different flower colors. However, such color dispersion is not ubiquitous, suggesting a variable selection across communities and existence of some opposing factors. We conducted a 30-week study in a plant community and measured the floral reflectances of 244 species. The reflectances were evaluated in insect color spaces (bees, swallowtails, and flies), and the dispersion was compared with random expectations. We found that co-existing colors were overdispersed for each analyzed pollinator type, and this overdispersion was statistically significant for bees. Furthermore, we showed that exclusion of 32 aliens from the analysis significantly increased the color dispersion of native flowers in every color space. This result indicated that aliens disturbed a native plant-pollinator network via similarly colored flowers. Our results demonstrate the masking effects of aliens in the detection of color dispersion of native flowers and that variations in pollinator vision yield different outcomes. Our results also support the hypothesis that co-flowering species are one of the drivers of color diversification and affect the community assembly.	[Makino, Takashi T.; Yokoyama, Jun] Yamagata Univ, Fac Sci, Dept Biol, Yamagata 990, Japan; [Yokoyama, Jun] Yamagata Univ, Inst Reg Innovat, Yamagata 990, Japan	Yamagata University; Yamagata University	Makino, TT (corresponding author), Yamagata Univ, Fac Sci, Dept Biol, 1-4-12 Kojirakawa, Yamagata 990, Japan.	mkntkst@gmail.com			Sasakawa Scientific Research [25-503]; JSPS KAKENHI Grant [26840139, 26291076]	Sasakawa Scientific Research; JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by The Sasakawa Scientific Research (No. 25-503) to TTM, http://www.jss.or.jp/ikusei/sasakawa/; a JSPS KAKENHI Grant (No. 26840139) to TTM, http://www.jsps.go.jp/english/index.html; and a JSPS KAKENHI Grant (No. 26291076) to JY, http://www.jsps.go.jp/english/index.html.	ARMBRUSTER WS, 1994, ECOLOGY, V75, P315, DOI 10.2307/1939537; Arnold SEJ, 2009, ARTHROPOD-PLANT INTE, V3, P27, DOI 10.1007/s11829-009-9056-9; Benitez-Vieyra S, 2007, P ROY SOC B-BIOL SCI, V274, P2239, DOI 10.1098/rspb.2007.0588; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blackiston D, 2011, J EXP BIOL, V214, P509, DOI 10.1242/jeb.048728; Brown BJ, 2002, ECOLOGY, V83, P2328, DOI 10.1890/0012-9658(2002)083[2328:CFPBAI]2.0.CO;2; Campbell DR, 2010, ECOLOGY, V91, P2638, DOI 10.1890/09-0941.1; CHITTKA L, 1992, J COMP PHYSIOL A, V171, P171, DOI 10.1007/BF00188925; Chittka L, 2001, NATURE, V411, P653, DOI 10.1038/35079676; CHITTKA L, 1992, J COMP PHYSIOL A, V170, P533; Chittka L, 1997, ISRAEL J PLANT SCI, V45, P115, DOI 10.1080/07929978.1997.10676678; Chittka L., 2001, COGNITIVE ECOLOGY PO, DOI 10.1017/CBO9780511542268; Chittka L., 2005, PRACTICAL POLLINATIO, P157; Cornwell WK, 2009, ECOL MONOGR, V79, P109, DOI 10.1890/07-1134.1; DAFNI A, 1984, ANNU REV ECOL SYST, V15, P259, DOI 10.1146/annurev.es.15.110184.001355; de Jager ML, 2011, OECOLOGIA, V166, P543, DOI 10.1007/s00442-010-1879-7; Dyer AG, 2006, ENTOMOL GEN, V28, P257; Dyer AG, 2004, J COMP PHYSIOL A, V190, P105, DOI 10.1007/s00359-003-0475-2; Eaton DAR, 2012, ECOLOGY, V93, pS182, DOI 10.1890/11-0501.1; Fenster CB, 2004, ANNU REV ECOL EVOL S, V35, P375, DOI 10.1146/annurev.ecolsys.34.011802.132347; FUKUSHI T, 1989, J COMP PHYSIOL A, V166, P57, DOI 10.1007/BF00190210; Glover B.J., 2007, UNDERSTANDING FLOWER; GOLDSMITH TH, 1979, J COMP PHYSIOL, V130, P209, DOI 10.1007/BF00614607; Grotewold E, 2006, ANNU REV PLANT BIOL, V57, P761, DOI 10.1146/annurev.arplant.57.032905.105248; Gumbert A, 1999, P ROY SOC B-BIOL SCI, V266, P1711, DOI 10.1098/rspb.1999.0836; Gumbert A, 2000, BEHAV ECOL SOCIOBIOL, V48, P36, DOI 10.1007/s002650000213; Harder LD, 2006, ECOLOGY EVOLUTION FL; Jersakova J, 2007, FUNCT ECOL, V21, P496, DOI 10.1111/j.1365-2435.2007.01256.x; Johnson SD, 2000, TRENDS ECOL EVOL, V15, P140, DOI 10.1016/S0169-5347(99)01811-X; Kalisz S, 2008, HEREDITY, V100, P171, DOI 10.1038/sj.hdy.6800939; Kelber A, 1999, J COMP PHYSIOL A, V184, P535, DOI 10.1007/s003590050353; King VM, 2012, BIOL INVASIONS, V14, P1809, DOI 10.1007/s10530-012-0191-3; Koshitaka H, 2008, P ROY SOC B-BIOL SCI, V275, P947, DOI 10.1098/rspb.2007.1614; LUNAU K, 1994, J COMP PHYSIOL A, V174, P575, DOI 10.1007/BF00217378; McEwen JR, 2010, P ROY SOC B-BIOL SCI, V277, P2957, DOI 10.1098/rspb.2010.0501; MENZEL R, 1993, BIOL REV, V68, P81, DOI 10.1111/j.1469-185X.1993.tb00732.x; Mitchell RJ, 2009, ANN BOT-LONDON, V103, P1403, DOI 10.1093/aob/mcp062; Morales CL, 2008, CRIT REV PLANT SCI, V27, P221, DOI 10.1080/07352680802205631; Muchhala N, 2007, P ROY SOC B-BIOL SCI, V274, P2731, DOI 10.1098/rspb.2007.0670; Muchhala N, 2014, EVOLUTION, V68, P2275, DOI 10.1111/evo.12441; Muchhala N, 2012, FUNCT ECOL, V26, P476, DOI 10.1111/j.1365-2435.2011.01950.x; Myczko L, 2014, APIDOLOGIE; Newman E, 2012, P ROY SOC B-BIOL SCI, V279, P2309, DOI 10.1098/rspb.2011.2375; Ohashi K, 2015, FUNCT ECOL; Ollerton J, 2009, NATURWISSENSCHAFTEN, V96, P221, DOI 10.1007/s00114-008-0467-8; Papadopulos AST, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0960; Pellissier Loic, 2012, Systematics Association Special Volume Series, V81, P392; Roy BA, 1999, TRENDS PLANT SCI, V4, P325, DOI 10.1016/S1360-1385(99)01445-4; Sargent RD, 2008, TRENDS ECOL EVOL, V23, P123, DOI 10.1016/j.tree.2007.11.003; Schemske DW, 1999, P NATL ACAD SCI USA, V96, P11910, DOI 10.1073/pnas.96.21.11910; Shrestha M, 2013, NEW PHYTOL, V198, P301, DOI 10.1111/nph.12135; Smith SD, 2008, EVOLUTION, V62, P793, DOI 10.1111/j.1558-5646.2008.00327.x; Suzuki MF, 2014, FUNCT ECOL, V28, P549, DOI 10.1111/1365-2435.12209; TROJE N, 1993, Z NATURFORSCH C, V48, P96; Waser NM, 1996, ECOLOGY, V77, P1043, DOI 10.2307/2265575; Weiss MR, 1997, ANIM BEHAV, V53, P1043, DOI 10.1006/anbe.1996.0357; Whitfield M, 2014, BEHAV ECOL, V25, P328, DOI 10.1093/beheco/art115; Willmer P., 2011, POLLINATION FLORAL E	58	15	15	7	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0143443	10.1371/journal.pone.0143443	http://dx.doi.org/10.1371/journal.pone.0143443			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650121	Green Submitted, gold, Green Published			2022-12-27	WOS:000366903300018
J	Moser, DA; Paoloni-Giacobino, A; Stenz, L; Adouan, W; Manini, A; Suardi, F; Cordero, MI; Vital, M; Rossignol, AS; Rusconi-Serpa, S; Ansermet, F; Dayer, AG; Schechter, DS				Moser, Dominik A.; Paoloni-Giacobino, Ariane; Stenz, Ludwig; Adouan, Wafae; Manini, Aurelia; Suardi, Francesca; Cordero, Maria I.; Vital, Marylene; Rossignol, Ana Sancho; Rusconi-Serpa, Sandra; Ansermet, Francois; Dayer, Alexandre G.; Schechter, Daniel S.			BDNF Methylation and Maternal Brain Activity in a Violence-Related Sample	PLOS ONE			English	Article							PROMOTER METHYLATION; POSTTRAUMATIC-STRESS; NEUROTROPHIC FACTOR; SUICIDAL IDEATION; MOTHERS; FEAR; EXPRESSION; CHILD; PTSD; IV	It is known that increased circulating glucocorticoids in the wake of excessive, chronic, repetitive stress increases anxiety and impairs Brain-Derived Neurotrophic Factor (BDNF) signaling. Recent studies of BDNF gene methylation in relation to maternal care have linked high BDNF methylation levels in the blood of adults to lower quality of received maternal care measured via self-report. Yet the specific mechanisms by which these phenomena occur remain to be established. The present study examines the link between methylation of the BDNF gene promoter region and patterns of neural activity that are associated with maternal response to stressful versus non-stressful child stimuli within a sample that includes mothers with interpersonal violence-related PTSD (IPV-PTSD). 46 mothers underwent fMRI. The contrast of neural activity when watching children-including their ownwas then correlated to BDNF methylation. Consistent with the existing literature, the present study found that maternal BDNF methylation was associated with higher levels of maternal anxiety and greater childhood exposure to domestic violence. fMRI results showed a positive correlation of BDNF methylation with maternal brain activity in the anterior cingulate (ACC), and ventromedial prefrontal cortex (vmPFC), regions generally credited with a regulatory function toward brain areas that are generating emotions. Furthermore we found a negative correlation of BDNF methylation with the activity of the right hippocampus. Since our stimuli focus on stressful parenting conditions, these data suggest that the correlation between vmPFC/ACC activity and BDNF methylation may be linked to mothers who are at a disadvantage with respect to emotion regulation when facing stressful parenting situations. Overall, this study provides evidence that epigenetic signatures of stress-related genes can be linked to functional brain regions regulating parenting stress, thus advancing our understanding of mothers at risk for stress-related psychopathology.	[Moser, Dominik A.; Manini, Aurelia; Suardi, Francesca; Vital, Marylene; Rossignol, Ana Sancho; Rusconi-Serpa, Sandra; Ansermet, Francois; Schechter, Daniel S.] Univ Hosp Geneva, Dept Child & Adolescent Psychiat, Geneva, Switzerland; [Moser, Dominik A.] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Paoloni-Giacobino, Ariane; Stenz, Ludwig; Adouan, Wafae] Univ Hosp Geneva, Dept Genet Med & Dev, Fac Med, Geneva, Switzerland; [Cordero, Maria I.; Dayer, Alexandre G.] Manchester Metropolitan Univ, Fac Hlth Psychol & Social Care, Manchester M15 6BH, Lancs, England	University of Geneva; Icahn School of Medicine at Mount Sinai; University of Geneva; Manchester Metropolitan University	Moser, DA (corresponding author), Univ Hosp Geneva, Dept Child & Adolescent Psychiat, Geneva, Switzerland.	domamoser@gmail.com	Cordero, Maria Isabel/A-2532-2013; Giacobino, Ariane/AHC-7144-2022; Cordero, Maria Isabel/AAF-2935-2019; Stenz, L/N-7605-2017; SCHECHTER, Daniel S/ABF-5565-2020; Moser, Dominik Andreas/H-9359-2019	Cordero, Maria Isabel/0000-0003-0692-8064; Cordero, Maria Isabel/0000-0003-0692-8064; Stenz, L/0000-0002-2339-9451; SCHECHTER, Daniel S/0000-0003-1663-6305; Moser, Dominik Andreas/0000-0001-7119-1033; Giacobino, Ariane/0000-0001-9432-1785; Dayer, Alexandre/0000-0002-4490-9780	National Center of Competence in Research (NCCR) "SYNAPSY-The Synaptic Bases of Mental Diseases" - Swiss National Science Foundation [51AU40_125759]; Gertrude von Meissner Foundation; Oak Foundation; la Fondation Prim'Enfance; Center for Biomedical Imaging (CIBM) of the Geneva-Lausanne Universities; EPFL; Geneva-Lausanne University Hospitals	National Center of Competence in Research (NCCR) "SYNAPSY-The Synaptic Bases of Mental Diseases" - Swiss National Science Foundation; Gertrude von Meissner Foundation; Oak Foundation; la Fondation Prim'Enfance; Center for Biomedical Imaging (CIBM) of the Geneva-Lausanne Universities; EPFL; Geneva-Lausanne University Hospitals	This research was supported by the National Center of Competence in Research (NCCR) "SYNAPSY-The Synaptic Bases of Mental Diseases" (nccr-synapsy.ch) financed by the Swiss National Science Foundation (no 51AU40_125759), the Gertrude von Meissner Foundation, the Oak Foundation (http://www.oakfnd.org) and la Fondation Prim'Enfance (http://www.primenfance.ch). This work was further supported in part by the Center for Biomedical Imaging (CIBM) of the Geneva-Lausanne Universities, the EPFL and the Geneva-Lausanne University Hospitals (http://www.cibm.ch). The authors report no conflict of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the National Center of Competence in Research (NCCR) "SYNAPSY-The Synaptic Bases of Mental Diseases" (nccr-synapsy.ch) financed by the Swiss National Science Foundation (no 51AU40_125759), the Gertrude von Meissner Foundation, the Oak Foundation (http://www.oakfnd.org) and la Fondation Prim'Enfance (http://www.primenfance.ch). This work was further supported in part by the Center for Biomedical Imaging (CIBM) of the Geneva-Lausanne Universities, the EPFL and the Geneva-Lausanne University Hospitals (http://www.cibm.ch).	Association WM., 1999, B MED ETHICS NO, V147, P18; Baker-Andresen D, 2013, LEARN MEMORY, V20, P237, DOI 10.1101/lm.029520.112; Beck AT., 1996, MANUAL BECK DEPRESSI; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Boersma GJ, 2014, EPIGENETICS-US, V9, P437, DOI 10.4161/epi.27558; Borelli JL, 2012, INFANT MENT HEALTH J, V33, P506, DOI 10.1002/imhj.21340; Braithwaite EC, 2015, EPIGENETICS-US, V10, P408, DOI 10.1080/15592294.2015.1039221; Branchi I, 2009, NEUROSCI BIOBEHAV R, V33, P551, DOI 10.1016/j.neubiorev.2008.03.011; Cannon EA, 2009, ARCH PEDIAT ADOL MED, V163, P706, DOI 10.1001/archpediatrics.2009.91; Carlberg L, 2014, J AFFECT DISORDERS, V168, P399, DOI 10.1016/j.jad.2014.07.022; Chatterjee D, 2007, BRAIN RES, V1158, P11, DOI 10.1016/j.brainres.2007.04.069; Chiba S, 2012, PROG NEURO-PSYCHOPH, V39, P112, DOI 10.1016/j.pnpbp.2012.05.018; Derogatis LR., 1994, SCL 90 R SYMPTOM CHE; Diekhof EK, 2011, NEUROIMAGE, V58, P275, DOI 10.1016/j.neuroimage.2011.05.073; Doherty TS, 2016, BEHAV BRAIN RES, V298, P55, DOI 10.1016/j.bbr.2015.05.028; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Heldt SA, 2007, MOL PSYCHIATR, V12, P656, DOI 10.1038/sj.mp.4001957; Ho SS, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00152; Jeanneteau FD, 2012, P NATL ACAD SCI USA, V109, P1305, DOI 10.1073/pnas.1114122109; Kang HJ, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2014.12.035; Keller S, 2010, ARCH GEN PSYCHIAT, V67, P258, DOI 10.1001/archgenpsychiatry.2010.9; Kim JM, 2015, INT J PSYCHIAT MED, V49, P75, DOI 10.1177/0091217415574439; Kim JM, 2014, AM J GERIAT PSYCHIAT, V22, P989, DOI 10.1016/j.jagp.2014.02.011; Kleimann A, 2015, J NEURAL TRANSM, V122, P925, DOI 10.1007/s00702-014-1336-6; Kubany ES, 2000, PSYCHOL ASSESSMENT, V12, P210, DOI 10.1037//1040-3590.12.2.210; Laurent HK, 2012, INFANT BEHAV DEV, V35, P761, DOI 10.1016/j.infbeh.2012.07.007; Lenzi D, 2009, CEREB CORTEX, V19, P1124, DOI 10.1093/cercor/bhn153; Lubin FD, 2008, J NEUROSCI, V28, P10576, DOI 10.1523/JNEUROSCI.1786-08.2008; Marshall RD, 1998, J CLIN PSYCHOPHARM, V18, P10, DOI 10.1097/00004714-199802000-00003; Martin SL, 2002, INT J EPIDEMIOL, V31, P560, DOI 10.1093/ije/31.3.560; McAdams TA, 2015, PSYCHOL MED, V45, P2583, DOI 10.1017/S0033291715000501; Moser DA, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01575; Noriuchi M, 2008, BIOL PSYCHIAT, V63, P415, DOI 10.1016/j.biopsych.2007.05.018; Pat-Horenczyk R, 2015, INFANT MENT HEALTH J, V36, P337, DOI 10.1002/imhj.21515; Perroud N, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.140; Rodrigues SM, 2009, ANNU REV NEUROSCI, V32, P289, DOI 10.1146/annurev.neuro.051508.135620; Roth TL, 2011, J PSYCHIATR RES, V45, P919, DOI 10.1016/j.jpsychires.2011.01.013; Schechter DS, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00690; Schechter DS, 2012, SOC COGN AFFECT NEUR, V7, P969, DOI 10.1093/scan/nsr069; Schechter DS, 2005, ATTACH HUM DEV, V7, P313, DOI 10.1080/14616730500246011; Schulz-Klaus B, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00205; St-Cyr S, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00145; Stenz L, 2015, NEUROSCI RES, V91, P1, DOI 10.1016/j.neures.2014.10.003; Strathearn L, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00176; Strathearn L, 2009, NEUROPSYCHOPHARMACOL, V34, P2655, DOI 10.1038/npp.2009.103; Straus Murray A, 2004, Violence Vict, V19, P507; Swain JE, 2008, J CHILD PSYCHOL PSYC, V49, P1042, DOI 10.1111/j.1469-7610.2008.01963.x; Thaler L, 2014, PROG NEURO-PSYCHOPH, V54, P43, DOI 10.1016/j.pnpbp.2014.04.010; Unternaehrer E, 2015, STRESS, V18, P451, DOI 10.3109/10253890.2015.1038992; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Weder N, 2014, J AM ACAD CHILD PSY, V53, P417, DOI 10.1016/j.jaac.2013.12.025; Zeanah C.H., 2000, HDB INFANT MENTAL HL, P222; Zovkic IB, 2013, NEUROPSYCHOPHARMACOL, V38, P77, DOI 10.1038/npp.2012.79	53	32	32	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0143427	10.1371/journal.pone.0143427	http://dx.doi.org/10.1371/journal.pone.0143427			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26649946	Green Published, gold			2022-12-27	WOS:000366903300017
J	Batchelder, CA; Martinez, ML; Tarantal, AF				Batchelder, Cynthia A.; Martinez, Michele L.; Tarantal, Alice F.			Natural Scaffolds for Renal Differentiation of Human Embryonic Stem Cells for Kidney Tissue Engineering	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX SCAFFOLDS; PORCINE KIDNEYS; TRANSPLANTATION; DECELLULARIZATION; REGENERATION; ONTOGENY; PROGENITORS; GENERATION; STRATEGIES; ORGANOIDS	Despite the enthusiasm for bioengineering of functional renal tissues for transplantation, many obstacles remain before the potential of this technology can be realized in a clinical setting. Viable tissue engineering strategies for the kidney require identification of the necessary cell populations, efficient scaffolds, and the 3D culture conditions to develop and support the unique architecture and physiological function of this vital organ. Our studies have previously demonstrated that decellularized sections of rhesus monkey kidneys of all age groups provide a natural extracellular matrix (ECM) with sufficient structural properties with spatial and organizational influences on human embryonic stem cell (hESC) migration and differentiation. To further explore the use of decellularized natural kidney scaffolds for renal tissue engineering, pluripotent hESC were seeded in whole-or on sections of kidney ECM and cell migration and phenotype compared with the established differentiation assays for hESC. Results of qPCR and immunohistochemical analyses demonstrated upregulation of renal lineage markers when hESC were cultured in decellularized scaffolds without cytokine or growth factor stimulation, suggesting a role for the ECM in directing renal lineage differentiation. hESC were also differentiated with growth factors and compared when seeded on renal ECM or a new biologically inert polysaccharide scaffold for further maturation. Renal lineage markers were progressively upregulated over time on both scaffolds and hESC were shown to express signature genes of renal progenitor, proximal tubule, endothelial, and collecting duct populations. These findings suggest that natural scaffolds enhance expression of renal lineage markers particularly when compared to embryoid body culture. The results of these studies show the capabilities of a novel polysaccharide scaffold to aid in defining a protocol for renal progenitor differentiation from hESC, and advance the promise of tissue engineering as a source of functional kidney tissue.	[Batchelder, Cynthia A.; Martinez, Michele L.; Tarantal, Alice F.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Tarantal, Alice F.] Univ Calif Davis, Sch Med, Dept Pediat, Davis, CA 95616 USA; [Tarantal, Alice F.] Univ Calif Davis, Sch Med, Dept Cell Biol & Human Anat, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Tarantal, AF (corresponding author), Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA.	aftarantal@ucdavis.edu			UC Davis Translational Human Embryonic Stem Cell Shared Research Facility [CL1-00504]; base operating grant for the California National Primate Research Center [P51-OD011107]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011107] Funding Source: NIH RePORTER	UC Davis Translational Human Embryonic Stem Cell Shared Research Facility; base operating grant for the California National Primate Research Center; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	These studies were supported by the UC Davis Translational Human Embryonic Stem Cell Shared Research Facility (# CL1-00504) and the base operating grant for the California National Primate Research Center (# P51-OD011107). These entities had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Badylak SF, 2011, ANNU REV BIOMED ENG, V13, P27, DOI 10.1146/annurev-bioeng-071910-124743; Batchelder CA, 2014, ANAT REC, V297, P1392, DOI 10.1002/ar.22943; Batchelder CA, 2013, ANAT REC, V296, P1747, DOI 10.1002/ar.22756; Batchelder CA, 2010, ANAT REC, V293, P1971, DOI 10.1002/ar.21242; Batchelder CA, 2009, DIFFERENTIATION, V78, P45, DOI 10.1016/j.diff.2009.05.001; Bonandrini B, 2014, TISSUE ENG PT A, V20, P1486, DOI [10.1089/ten.tea.2013.0269, 10.1089/ten.TEA.2013.0269]; Bontrop RE, 2001, IMMUNOL REV, V183, P5, DOI 10.1034/j.1600-065x.2001.1830101.x; Caralt M, 2015, AM J TRANSPLANT, V15, P64, DOI 10.1111/ajt.12999; Challen GA, 2006, J AM SOC NEPHROL, V17, P1896, DOI 10.1681/ASN.2005111228; Crowley C, 2015, J TISSUE ENG REGEN M, V9, P357, DOI 10.1002/term.1847; Dekel B, 2003, NAT MED, V9, P53, DOI 10.1038/nm812; Dekel B, 2006, J AM SOC NEPHROL, V17, P3300, DOI 10.1681/ASN.2005020195; Gupta S, 2006, J AM SOC NEPHROL, V17, P3028, DOI 10.1681/ASN.2006030275; Harari-Steinberg O, 2013, EMBO MOL MED, V5, P1556, DOI 10.1002/emmm.201201584; Hiatt MJ, 2010, AM J PATHOL, V176, P630, DOI 10.2353/ajpath.2010.090389; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Katari R, 2014, NEPHRON EXP NEPHROL, V126, P119, DOI 10.1159/000360684; Kim D, 2005, J AM SOC NEPHROL, V16, P3527, DOI 10.1681/ASN.2005050544; Ko IK, 2014, TECHNOLOGY, V2, P243, DOI 10.1142/S2339547814500228; L'Heureux N, 2007, NEW ENGL J MED, V357, P1451, DOI 10.1056/NEJMc071536; Lusis M, 2010, STEM CELL RES, V5, P23, DOI 10.1016/j.scr.2010.03.003; Nakayama KH, 2010, TISSUE ENG PT A, V16, P2207, DOI [10.1089/ten.tea.2009.0602, 10.1089/ten.TEA.2009.0602]; Nakayama KH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064134; Nakayama KH, 2011, TISSUE ENG PT A, V17, P2891, DOI [10.1089/ten.TEA.2010.0714, 10.1089/ten.tea.2010.0714]; Oliver JA, 2004, J CLIN INVEST, V114, P795, DOI 10.1172/JCI200420921; Orlando G, 2013, BIOMATERIALS, V34, P5915, DOI 10.1016/j.biomaterials.2013.04.033; Orlando G, 2012, ANN SURG, V256, P363, DOI 10.1097/SLA.0b013e31825a02ab; Osafune K, 2006, DEVELOPMENT, V133, P151, DOI 10.1242/dev.02174; Park KM, 2012, TRANSPL P, V44, P1146, DOI 10.1016/j.transproceed.2012.03.043; Peloso A, 2015, TRANSPLANTATION, V99, P1807, DOI 10.1097/TP.0000000000000811; Petrosyan A, 2015, CELLR4, V3, pe1401; Rogers SA, 1998, KIDNEY INT, V54, P27, DOI 10.1046/j.1523-1755.1998.00971.x; Ross EA, 2012, ORGANOGENESIS, V8, P49, DOI 10.4161/org.20209; Ross EA, 2009, J AM SOC NEPHROL, V20, P2338, DOI 10.1681/ASN.2008111196; Sagrinati C, 2006, J AM SOC NEPHROL, V17, P2443, DOI 10.1681/ASN.2006010089; Shin'oka T, 2001, NEW ENGL J MED, V344, P532, DOI 10.1056/NEJM200102153440717; Song JJ, 2013, NAT MED, V19, P646, DOI 10.1038/nm.3154; Strome M, 2001, NEW ENGL J MED, V344, P1676, DOI 10.1056/NEJM200105313442204; Sullivan DC, 2012, BIOMATERIALS, V33, P7756, DOI 10.1016/j.biomaterials.2012.07.023; Taguchi A, 2014, CELL STEM CELL, V14, P53, DOI 10.1016/j.stem.2013.11.010; Takasato M, 2014, NAT CELL BIOL, V16, P118, DOI 10.1038/ncb2894; Tarantal AF, 2001, KIDNEY INT, V59, P446, DOI 10.1046/j.1523-1755.2001.059002446.x; Tarantal AF, 2011, STEM CELLS BIOL REG, P393, DOI 10.1007/978-1-61779-322-6_21; Trobridge GD, 2010, GENE THER, V17, P939, DOI 10.1038/gt.2010.47; Uzarski JS, 2014, CURR OPIN NEPHROL HY, V23, P399, DOI 10.1097/01.mnh.0000447019.66970.ea; Wang YJ, 2015, XENOTRANSPLANTATION, V22, P48, DOI 10.1111/xen.12141; Watt FM, 2013, NAT REV MOL CELL BIO, V14, P467, DOI 10.1038/nrm3620; Xia Y, 2014, NAT PROTOC, V9, P2693, DOI 10.1038/nprot.2014.182; Xinaris C, 2012, J AM SOC NEPHROL, V23, P1857, DOI 10.1681/ASN.2012050505; Yu YL, 2014, BIOMATERIALS, V35, P6822, DOI 10.1016/j.biomaterials.2014.04.074	51	41	44	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0143849	10.1371/journal.pone.0143849	http://dx.doi.org/10.1371/journal.pone.0143849			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YV	26645109	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903100008
J	Li, LD; Sun, HF; Liu, XX; Gao, SP; Jiang, HL; Hu, X; Jin, W				Li, Liang-Dong; Sun, He-Fen; Liu, Xue-Xiao; Gao, Shui-Ping; Jiang, Hong-Lin; Hu, Xin; Jin, Wei			Down-Regulation of NDUFB9 Promotes Breast Cancer Cell Proliferation, Metastasis by Mediating Mitochondrial Metabolism	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; COLORECTAL-CANCER; COMPLEX-I; TARGET; GENES; TUMORIGENESIS; ACTIVATION; AUTOPHAGY; MOTILITY; PATHWAY	Despite advances in basic and clinical research, metastasis remains the leading cause of death in breast cancer patients. Genetic abnormalities in mitochondria, including mutations affecting complex I and oxidative phosphorylation, are found in breast cancers and might facilitate metastasis. Genes encoding complex I components have significant breast cancer prognostic value. In this study, we used quantitative proteomic analyses to compare a highly metastatic cancer cell line and a parental breast cancer cell line; and observed that NDUFB9, an accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (complex I), was down-regulated in highly metastatic breast cancer cells. Furthermore, we demonstrated that loss of NDUFB9 promotes MDA-MB-231 cells proliferation, migration, and invasion because of elevated levels of mtROS, disturbance of the NAD(+)/NADH balance, and depletion of mtDNA. We also showed that, the Akt/mTOR/p70S6K signaling pathway and EMT might be involved in this mechanism. Thus, our findings contribute novel data to support the hypothesis that misregulation of mitochondrial complex I NADH dehydrogenase activity can profoundly enhance the aggressiveness of human breast cancer cells, suggesting that complex I deficiency is a potential and important biomarker for further basic research or clinical application.	[Li, Liang-Dong; Sun, He-Fen; Gao, Shui-Ping; Jiang, Hong-Lin; Hu, Xin; Jin, Wei] Fudan Univ, Shanghai Canc Ctr, Dept Breast Surg, Key Lab Breast Canc Shanghai, Shanghai 200030, Peoples R China; [Li, Liang-Dong; Sun, He-Fen; Gao, Shui-Ping; Jiang, Hong-Lin; Jin, Wei] Fudan Univ, Dept Oncol, Shanghai Med Coll, Shanghai 200030, Peoples R China; [Liu, Xue-Xiao] Lishui Cent Hosp, Dept Radiotherapy, Lishui 323000, Zhejiang, Peoples R China	Fudan University; Fudan University	Jin, W (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Breast Surg, Key Lab Breast Canc Shanghai, Shanghai 200030, Peoples R China.	weijin7207@126.com			National Natural Science Foundation of China [81272923]; Program for New Century Excellent Talents in University [NCET-12-0127]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by National Natural Science Foundation of China (81272923), Program for New Century Excellent Talents in University (NCET-12-0127) http://www.nsfc.gov.cn/publish/portal1/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhat TA, 2015, DRUG DISCOV TODAY, V20, P635, DOI 10.1016/j.drudis.2015.03.001; Brieger K, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13659; Cannito S, 2010, ANTIOXID REDOX SIGN, V12, P1383, DOI 10.1089/ars.2009.2737; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Cheon H, 2010, ONCOL REP, V23, P779, DOI 10.3892/or_00000698; Cichon MA, 2014, ONCOTARGET, V5, P2827, DOI 10.18632/oncotarget.1940; Cui HH, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-110; Dong LF, 2014, PROG MOL BIOL TRANSL, V127, P211, DOI 10.1016/B978-0-12-394625-6.00008-8; Fiorini C, 2015, BBA-MOL CELL RES, V1853, P549, DOI 10.1016/j.bbamcr.2014.12.016; Gu JZ, 1996, GENOMICS, V35, P6, DOI 10.1006/geno.1996.0316; Gulhati P, 2011, CANCER RES, V71, P3246, DOI 10.1158/0008-5472.CAN-10-4058; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Haack TB, 2012, J MED GENET, V49, P83, DOI 10.1136/jmedgenet-2011-100577; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Imanishi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023401; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Jiang HL, 2015, ONCOTARGET, V2015; Lamouille S, 2012, J CELL SCI, V125, P1259, DOI 10.1242/jcs.095299; LeBleu VS, 2014, NAT CELL BIOL, V16, P992, DOI 10.1038/ncb3039; Li XY, 2014, ONCOTARGET, V5, P788, DOI 10.18632/oncotarget.1772; Lin HC, 2013, J PROTEOME RES, V12, P3423, DOI 10.1021/pr400273z; Lin X, 1999, HUM HERED, V49, P75, DOI 10.1159/000022848; Moro L, 2009, CELL DEATH DIFFER, V16, P571, DOI 10.1038/cdd.2008.178; Porporato PE, 2014, CELL REP, V8, P754, DOI 10.1016/j.celrep.2014.06.043; Porporato PE, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00049; Ren W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096816; Santidrian AF, 2014, DNA REPAIR, V23, P79, DOI 10.1016/j.dnarep.2014.08.006; Santidrian AF, 2013, J CLIN INVEST, V123, P1068, DOI 10.1172/JCI64264; Schroder K, 2014, ANTIOXID REDOX SIGN, V20, P2043, DOI 10.1089/ars.2013.5633; Sun H, 2013, ANTI-CANCER AGENT ME, V13, P1048, DOI 10.2174/18715206113139990130; Tan AS, 2014, BBA-GEN SUBJECTS, V1840, P1454, DOI 10.1016/j.bbagen.2013.10.016; Tochhawng L, 2013, MITOCHONDRION, V13, P246, DOI 10.1016/j.mito.2012.08.002; Ushio-Fukai M, 2008, CANCER LETT, V266, P37, DOI 10.1016/j.canlet.2008.02.044; van Horssen R, 2013, CELL MOL LIFE SCI, V70, P2175, DOI 10.1007/s00018-012-1249-1; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; Wang F, 2015, DRUG DES DEV THER, V9, P537, DOI 10.2147/DDDT.S73689; Wang L, 2008, CANCER EPIDEM BIOMAR, V17, P3558, DOI 10.1158/1055-9965.EPI-08-0434; Yang J, 2013, NEOPLASMA, V60, P364, DOI 10.4149/neo_2013_048; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Yu M, 2013, TRANSL RES, V161, P165, DOI 10.1016/j.trsl.2012.10.011; Zhou W, 2015, CANCER LETT, V360, P68, DOI 10.1016/j.canlet.2015.02.004	42	49	52	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144441	10.1371/journal.pone.0144441	http://dx.doi.org/10.1371/journal.pone.0144441			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641458	gold, Green Published, Green Submitted			2022-12-27	WOS:000366902700122
J	Martins, RST; Gomez, A; Zanuy, S; Carrillo, M; Canario, AVM				Martins, Rute S. T.; Gomez, Ana; Zanuy, Silvia; Carrillo, Manuel; Canario, Adelino V. M.			Photoperiodic Modulation of Circadian Clock and Reproductive Axis Gene Expression in the Pre-Pubertal European Sea Bass Brain	PLOS ONE			English	Article							DICENTRARCHUS-LABRAX; CONTINUOUS LIGHT; SEXUAL-MATURATION; FISH; PITUITARY; L.; GNRH; HORMONES; SYSTEM; DIFFERENTIATION	The acquisition of reproductive competence requires the activation of the brain-pituitary-gonad (BPG) axis, which in most vertebrates, including fishes, is initiated by changes in photoperiod. In the European sea bass long-term exposure to continuous light (LL) alters the rhythm of reproductive hormones, delays spermatogenesis and reduces the incidence of precocious males. In contrast, an early shift from long to short photoperiod (AP) accelerates spermatogenesis. However, how photoperiod affects key genes in the brain to trigger the onset of puberty is still largely unknown. Here, we investigated if the integration of the light stimulus by clock proteins is sufficient to activate key genes that trigger the BPG axis in the European sea bass. We found that the clock genes clock, npas2, bmal1 and the BPG genes gnrh, kiss and kissr share conserved transcription factor frameworks in their promoters, suggesting co-regulation. Other gene promoters of the BGP axis were also predicted to be co-regulated by the same frameworks. Co-regulation was confirmed through gene expression analysis of brains from males exposed to LL or AP photoperiod compared to natural conditions: LL fish had suppressed gnrh1, kiss2, galr1b and esr1, while AP fish had stimulated npas2, gnrh1, gnrh2, kiss2, kiss1rb and galr1b compared to NP. It is concluded that fish exposed to different photoperiods present significant expression differences in some clock and reproductive axis related genes well before the first detectable endocrine and morphological responses of the BPG axis.	[Martins, Rute S. T.; Canario, Adelino V. M.] Univ Algarve, Ctr Marine Sci CCMAR, Comparat Endocrinol & Integrat Biol Grp, Faro, Portugal; [Gomez, Ana; Zanuy, Silvia; Carrillo, Manuel] CSIC, Inst Acuicultura Torre La Sal, Dept Fish Physiol & Biotechnol, Torre De La Sal, Castellon, Spain	Universidade do Algarve; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Acuicultura de Torre de la Sal (IATS)	Martins, RST (corresponding author), Univ Algarve, Ctr Marine Sci CCMAR, Comparat Endocrinol & Integrat Biol Grp, Campus Gambelas, Faro, Portugal.	rsmartin@ualg.pt	Canario, Adelino/C-7942-2009; Gómez, Ana/K-6998-2014; Martins, Rute Sofia Tavares/AAK-4776-2021	Canario, Adelino/0000-0002-6244-6468; Gómez, Ana/0000-0003-4714-8064; Martins, Rute Sofia Tavares/0000-0001-5804-2981	European Community [222719 - LIFECYCLE]; Foundation for Science and Technology of Portugal (FCT) [SFRH/BPD/66742/2009, PEst-C/MAR/LA0015/2011]; Valencian Regional Goverment [Prometeo II/2014/051]; Spanish Ministry of Science and Innovation (MICINN) [CSD 2007-0002]	European Community(European Commission); Foundation for Science and Technology of Portugal (FCT)(Portuguese Foundation for Science and Technology); Valencian Regional Goverment; Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	The research leading to these results was funded by European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 222719 - LIFECYCLE and by the Foundation for Science and Technology of Portugal (FCT), through project PEst-C/MAR/LA0015/2011 and Prometeo II/2014/051 from the Valencian Regional Goverment and CSD 2007-0002 (AQUAGENOMICS) Spanish Ministry of Science and Innovation (MICINN). RSTM was funded by the Foundation for Science and Technology of Portugal (FCT) under fellowship (SFRH/BPD/66742/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayarri MJ, 2004, GEN COMP ENDOCR, V136, P72, DOI 10.1016/j.ygcen.2003.12.004; Beaver LM, 2002, P NATL ACAD SCI USA, V99, P2134, DOI 10.1073/pnas.032426699; Begtashi I, 2004, AQUACULTURE, V241, P539, DOI 10.1016/j.aquaculture.2004.07.011; Choi JH, 2013, CURR OPIN ENDOCRINOL, V20, P62, DOI 10.1097/MED.0b013e32835b7ec7; Cohen CD, 2006, P NATL ACAD SCI USA, V103, P5682, DOI 10.1073/pnas.0511257103; de la Iglesia HO, 2006, ENDOCRINOLOGY, V147, P1148, DOI 10.1210/en.2005-1311; Escobar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070177; Escobar S, 2013, J COMP NEUROL, V521, P933, DOI 10.1002/cne.23211; Espigares F, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.125138; Felip A, 2008, AQUACULTURE, V275, P347, DOI 10.1016/j.aquaculture.2008.01.020; Felip A, 2009, MOL CELL ENDOCRINOL, V312, P61, DOI 10.1016/j.mce.2008.11.017; Fessele S, 2002, TRENDS GENET, V18, P60, DOI 10.1016/S0168-9525(02)02591-X; Gillespie JMA, 2003, ENDOCRINOLOGY, V144, P5285, DOI 10.1210/en.2003-0802; Gonzalez-Martinez D, 2002, J COMP NEUROL, V446, P95, DOI 10.1002/cne.10190; Gottsch ML, 2004, ENDOCRINOLOGY, V145, P4073, DOI 10.1210/en.2004-0431; Harmer SL, 2001, ANNU REV CELL DEV BI, V17, P215, DOI 10.1146/annurev.cellbio.17.1.215; Bayarri MJ, 2009, CHRONOBIOL INT, V26, P184, DOI 10.1080/07420520902758311; Kennaway DJ, 2005, HUM REPROD UPDATE, V11, P91, DOI 10.1093/humupd/dmh054; Kitahashi T, 2009, ENDOCRINOLOGY, V150, P821, DOI 10.1210/en.2008-0940; Klein SE, 2008, MOL CELL ENDOCRINOL, V286, P148, DOI 10.1016/j.mce.2007.08.010; Kovanen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010007; Martins RST, 2014, GEN COMP ENDOCR, V205, P109, DOI 10.1016/j.ygcen.2014.06.030; Martins RST, 2013, GENE, V530, P66, DOI 10.1016/j.gene.2013.07.052; Miller BH, 2004, CURR BIOL, V14, P1367, DOI 10.1016/j.cub.2004.07.055; Nabi G, 2014, J BIOL LIFE SCI, V6, P1; Nishiguchi Ryo, 2012, Front Endocrinol (Lausanne), V3, P122, DOI 10.3389/fendo.2012.00122; Parhar I, 2012, PROG NEUROBIOL, V98, P176, DOI 10.1016/j.pneurobio.2012.05.011; Prat F, 1999, J FISH BIOL, V54, P125, DOI 10.1111/j.1095-8649.1999.tb00617.x; Rodriguez L, 2004, GEN COMP ENDOCR, V136, P37, DOI 10.1016/j.ygcen.2003.11.010; Rodriguez L, 2001, AQUACULTURE, V202, P235, DOI 10.1016/S0044-8486(01)00774-8; Rodriguez L, 2000, FISH PHYSIOL BIOCHEM, V23, P141, DOI 10.1023/A:1007871604795; Rodriguez L, 2001, AQUACULTURE, V196, P159, DOI 10.1016/S0044-8486(00)00555-X; Rodriguez R, 2012, AQUACULT INT, V20, P1071, DOI 10.1007/s10499-012-9510-z; Saillant E, 2003, J ZOOL, V260, P53, DOI 10.1017/S0952836903003467; Servili A, 2011, ENDOCRINOLOGY, V152, P1527, DOI 10.1210/en.2010-0948; Smarr BL, 2012, ENDOCRINOLOGY, V153, P2839, DOI 10.1210/en.2011-1857; Taranger GL, 2010, GEN COMP ENDOCR, V165, P483, DOI 10.1016/j.ygcen.2009.05.004; Tena-Sempere M, 2012, GEN COMP ENDOCR, V175, P234, DOI 10.1016/j.ygcen.2011.11.015; Volkoff H, 2005, GEN COMP ENDOCR, V142, P3, DOI 10.1016/j.ygcen.2004.11.001; Volkoff H, 2010, GEN COMP ENDOCR, V167, P352, DOI 10.1016/j.ygcen.2009.09.001; Werner T, 2003, TRENDS BIOTECHNOL, V21, P9, DOI 10.1016/S0167-7799(02)00003-3; Williams WP, 2011, ENDOCRINOLOGY, V152, P595, DOI 10.1210/en.2010-0943; Xia W, 2014, SCI REP-UK, V4, DOI 10.1038/srep03676; Zmora N, 2014, ENDOCRINOLOGY, V155, P1874, DOI 10.1210/en.2013-1894	44	17	17	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144158	10.1371/journal.pone.0144158	http://dx.doi.org/10.1371/journal.pone.0144158			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641263	Green Submitted, Green Published, gold			2022-12-27	WOS:000366902700067
J	Sell, R; Goldberg, S; Conron, K				Sell, Randall; Goldberg, Shoshana; Conron, Kerith			The Utility of an Online Convenience Panel for Reaching Rare and Dispersed Populations	PLOS ONE			English	Article							ORIENTATION DATA-COLLECTION; SEXUAL ORIENTATION; PROBABILITY; ATTITUDES; INTERNET; CANCER	Gaps in data collection systems, as well as challenges associated with gathering data from rare and dispersed populations, render current health surveillance systems inadequate to identify and monitor efforts to reduce health disparities. Using sexual and gender minorities we investigated the utility of using a large nonprobability online panel to conduct rapid population assessments of such populations using brief surveys. Surveys of the Google Android Panel (four assessing sexual orientation and one assessing gender identity and sex assigned at birth) were conducted resulting in invitation of 53,739 application users (37,505 of whom viewed the invitation) to generate a total of 34,759 who completed screening questions indicating their sexual orientation, or gender identity and sex at birth. Where possible we make comparisons to similar data from two population-based surveys (NHIS and NESARC). We found that 99.4% to 100.0% of respondents across our Google Android panel samples completed the screening questions and 97.8% to 99.2% of those that consented to participate in our surveys indicated they were "OK" with the content of surveys that assessed sexual orientation and sex/gender. In our Google Android panel samples there was a higher percentage of sexual minority respondents than in either NHIS or NESARC with 7.4% of men and 12.4% of women reporting gay, lesbian or bisexual identities. The proportion sexual minority was 2.8 to 5.6 times higher in the Google Android panel samples than was found in the 2012 NHIS sample, for men and women, respectively. The percentage of "transgender" identified individuals in the Google sample was 0.7%, which is similar to 0.5% transgender identified through the Massachusetts BRFSS, and using a transgender status item we found that 2.0% of the overall sample fit could be classified as transgender. The Google samples sometimes more closely approximated national averages for ethnicity and race than NHIS.	[Sell, Randall] Drexel Univ, Sch Publ Hlth, Dept Community Hlth & Prevent, Philadelphia, PA 19104 USA; [Goldberg, Shoshana] Univ N Carolina, Chapel Hill, NC USA; [Conron, Kerith] Fenway Hlth, Ctr Populat Res LGBT Hlth, Boston, MA USA	Drexel University; University of North Carolina; University of North Carolina Chapel Hill; Fenway Health	Sell, R (corresponding author), Drexel Univ, Sch Publ Hlth, Dept Community Hlth & Prevent, Philadelphia, PA 19104 USA.	Randy@Drexel.edu						[Anonymous], 2008, FIN REP NAT HLTH INT; [Anonymous], ASSESSMENT INNOVATIO; Association AP, 2015, WHAT DOES TRANSG MEA; Baker R, 2013, J SUVERY STATE METHO, V1, P90, DOI [DOI 10.1093/JSSAM/SMT008, 10.1093/jssam/smt008, https:/doi.org/10.1093/jssam/smt008]; Baker R, 2011, USE MISUSES ONLINE P; Baker R, 2010, PUBLIC OPIN QUART, V74, P711, DOI 10.1093/poq/nfq048; Bauer GR, 2013, LANCET INFECT DIS, V13, P832, DOI 10.1016/S1473-3099(13)70242-1; Cho MK, 2015, ANN INTERN MED, V162, P690, DOI 10.7326/M15-0166; Conron K.J., 2014, BEST PRACTICES ASKIN, VCA2014, P9; Conron KJ, 2014, AM J PUBLIC HEALTH, V104, P970, DOI 10.2105/AJPH.2013.301831; Grant BF, INTRO NATL EPIDEMILO; Groves RM, 2011, PUBLIC OPIN QUART, V75, P861, DOI 10.1093/poq/nfr057; Institute of Medicine (U.S.), 2003, FUT PUBL HLTH 21 CEN, Vxxv; Institute of Medicine (U.S.), 2011, HLTH LESB GAY BIS TR, Vxviii; Lavrakas PJ, 2008, ENCY SURVEY RES METH, DOI DOI 10.1371/journal.pone.0073008; McDonald Paul, COMPARING GOOGLE CON; McGinty EE, 2013, AM J PSYCHIAT, V170, P494, DOI 10.1176/appi.ajp.2013.13010014; Ryan JM., 2011, DESIGN DEV TESTING N; Salsman JM, 2014, CANCER-AM CANCER SOC, V120, P2247, DOI 10.1002/cncr.28739; Sell RL, 2007, J HOMOSEXUAL, V53, P163, DOI 10.1080/00918360802103407; Sell RL, 2014, AM J PUBLIC HEALTH, V104, P967, DOI 10.2105/AJPH.2013.301814; Sell Randall L, 2008, J LGBT Health Res, V4, P27, DOI 10.1080/15574090802615703; Sell RL, 1997, AM J PUBLIC HEALTH, V87, P297, DOI 10.2105/AJPH.87.2.297; Sell RL, 2001, AM J PUBLIC HEALTH, V91, P876, DOI 10.2105/AJPH.91.6.876; Statistics NCfH, NAT HLTH INT SURV; U.S. Census Bureau, 2015, QUICK FACTS BET; US Department of Health and Human Services, HLTH PEOPL FDN MEAS; US Department of Health and Human Services, HLTH PEOPL 2020 FRAM; Van den Bruel A, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h980; Yeager DS, 2011, PUBLIC OPIN QUART, V75, P709, DOI 10.1093/poq/nfr020	30	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144011	10.1371/journal.pone.0144011	http://dx.doi.org/10.1371/journal.pone.0144011			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1YS	26641840	Green Published, gold, Green Submitted			2022-12-27	WOS:000366902700043
J	Nakamura, M; Kanda, T; Sasaki, R; Haga, Y; Jiang, X; Wu, S; Nakamoto, S; Yokosuka, O				Nakamura, Masato; Kanda, Tatsuo; Sasaki, Reina; Haga, Yuki; Jiang, Xia; Wu, Shuang; Nakamoto, Shingo; Yokosuka, Osamu			MicroRNA-122 Inhibits the Production of Inflammatory Cytokines by Targeting the PKR Activator PACT in Human Hepatic Stellate Cells	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; NF-KAPPA-B; RECEPTOR 4; NONALCOHOLIC STEATOHEPATITIS; 122 EXPRESSION; LIVER-INJURY; FIBROSIS; MIR-122; DIFFERENTIATION; IDENTIFICATION	MicroRNA-122 (miR-122) is one of the most abundant miRs in the liver. Previous studies have demonstrated that miR-122 plays a role in inflammation in the liver and functions in hepatic stellate cells (HSCs), which reside in the space of Disse. Here, we showed that the transient inhibition of PKR-activating protein (PACT) expression, by miR-122 or siRNA targeting of PACT, suppressed the production of proinflammatory cytokines, such as interleukin (IL)-6, monocyte chemoattractant protein-1 (MCP-1) and IL-1 beta, in human HSC LX-2. Sequence and functional analyses confirmed that miR-122 directly targeted the 30-untranslated region of PACT. Immunofluorescence analysis revealed that miR-122 blocked NF-kappa B-nuclear translocation in LX-2 cells. We also showed that conditioned medium from miR-122-transfected LX-2 cells suppressed human monocyte-derived THP-1 cell migration. Taken together, our study indicates that miR-122 may downregulate cytokine production in HSCs and macrophage chemotaxis and that the targeting of miR-122 may have therapeutic potential for preventing the progression of liver diseases.	[Nakamura, Masato; Kanda, Tatsuo; Sasaki, Reina; Haga, Yuki; Jiang, Xia; Wu, Shuang; Nakamoto, Shingo; Yokosuka, Osamu] Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba 2608677, Japan; [Nakamoto, Shingo] Chiba Univ, Grad Sch Med, Dept Mol Virol, Chiba 2608677, Japan	Chiba University; Chiba University	Kanda, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba 2608677, Japan.	kandat-cib@umin.ac.jp		Kanda, Tatsuo/0000-0002-1654-5385	Ministry of Education, Culture, Sports, Science, and Technology of Japan [20345002]; Chugai [J09KF00234]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Chugai	This work was supported by a KAKEN Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (20345002 to TK) (https://kaken.nii.ac.jp/d/r/20345002.ja.html), and by a grant from Chugai (J09KF00234 to TK and OY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo P, 1999, HEPATOLOGY, V30, P1356, DOI 10.1002/hep.510300604; Baeck C, 2012, GUT, V61, P416, DOI 10.1136/gutjnl-2011-300304; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bartuzi P, 2013, BBA-MOL BASIS DIS, V1832, P2315, DOI 10.1016/j.bbadis.2013.09.014; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Brenner David A, 2009, Trans Am Clin Climatol Assoc, V120, P361; Chen L, 2014, HEPATOLOGY, V59, P1118, DOI 10.1002/hep.26768; Cheung O, 2008, HEPATOLOGY, V48, P1810, DOI 10.1002/hep.22569; Chew V, 2010, J HEPATOL, V52, P370, DOI 10.1016/j.jhep.2009.07.013; Couturier J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-72; Csak T, 2011, AM J PHYSIOL-GASTR L, V300, pG433, DOI 10.1152/ajpgi.00163.2009; D'Acquisto F, 2001, Sci STKE, V2001, pre1, DOI 10.1126/stke.2001.89.re1; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Estko M, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0650-3; Estrabaud E, 2014, J VIROL, V88, P6394, DOI 10.1128/JVI.00016-14; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Girard M, 2008, J HEPATOL, V48, P648, DOI 10.1016/j.jhep.2008.01.019; Guo JS, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-21; Guo JS, 2009, HEPATOLOGY, V49, P960, DOI 10.1002/hep.22697; Hsu SH, 2012, J CLIN INVEST, V122, P2871, DOI 10.1172/JCI63539; Iwamura T, 2001, BIOCHEM BIOPH RES CO, V282, P515, DOI 10.1006/bbrc.2001.4606; Jammi NV, 2003, BIOCHEM BIOPH RES CO, V308, P50, DOI 10.1016/S0006-291X(03)01318-4; Jiao JJ, 2009, CURR OPIN GASTROEN, V25, P223, DOI 10.1097/MOG.0b013e3283279668; KUMAR A, 1994, P NATL ACAD SCI USA, V91, P6288, DOI 10.1073/pnas.91.14.6288; Kusov Y, 2006, J VIROL, V80, P5599, DOI 10.1128/JVI.01773-05; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Li J, 2013, J HEPATOL, V58, P522, DOI 10.1016/j.jhep.2012.11.011; Li J, 2011, MOL PHARMACOL, V80, P191, DOI 10.1124/mol.110.068247; Li SD, 2006, P NATL ACAD SCI USA, V103, P10005, DOI 10.1073/pnas.0602317103; Li S, 2012, NUCLEIC ACIDS RES, V40, P884, DOI 10.1093/nar/gkr715; Mandal P, 2010, J IMMUNOL, V185, P4928, DOI 10.4049/jimmunol.1002060; Mandrekar P, 2011, HEPATOLOGY, V54, P2185, DOI 10.1002/hep.24599; Marra F, 2014, GASTROENTEROLOGY, V147, P577, DOI 10.1053/j.gastro.2014.06.043; Momen-Heravi F, 2015, SCI REP-UK, V5, DOI 10.1038/srep09991; Patel RC, 1998, EMBO J, V17, P4379, DOI 10.1093/emboj/17.15.4379; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Puche JE, 2013, COMPR PHYSIOL, V3, P1473, DOI 10.1002/cphy.c120035; RHOADS RE, 1993, J BIOL CHEM, V268, P3017; Rothwarf D M, 1999, Sci STKE, V1999, pRE1, DOI 10.1126/stke.1999.5.re1; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Seki E, 2009, HEPATOLOGY, V50, P185, DOI 10.1002/hep.22952; Song K, 2013, HEPATOLOGY, V58, P1681, DOI 10.1002/hep.26514; Szabo G, 2013, NAT REV GASTRO HEPAT, V10, P542, DOI 10.1038/nrgastro.2013.87; Tamura R, 2011, J INFECT DIS, V204, P793, DOI 10.1093/infdis/jir381; Tazi KA, 2007, J HEPATOL, V46, P1075, DOI 10.1016/j.jhep.2007.01.034; Trebicka J, 2013, J HEPATOL, V58, P234, DOI 10.1016/j.jhep.2012.10.015; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Wang SF, 2012, HEPATOLOGY, V55, P730, DOI 10.1002/hep.24809; Wu SA, 2010, VIRAL IMMUNOL, V23, P467, DOI 10.1089/vim.2010.0042; Xu H, 2010, HEPATOLOGY, V52, P1431, DOI 10.1002/hep.23818; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Yin CY, 2013, J CLIN INVEST, V123, P1902, DOI 10.1172/JCI66369; Yoshida K, 2012, J CELL BIOCHEM, V113, P165, DOI 10.1002/jcb.23340	56	24	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144295	10.1371/journal.pone.0144295	http://dx.doi.org/10.1371/journal.pone.0144295			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636761	Green Submitted, Green Published, gold			2022-12-27	WOS:000366143800069
J	Salgado, P; Vazquez, JA; Riobo, P; Franco, JM; Figueroa, RI; Kremp, A; Bravo, I				Salgado, Pablo; Vazquez, Jose A.; Riobo, Pilar; Franco, Jose M.; Figueroa, Rosa I.; Kremp, Anke; Bravo, Isabel			A Kinetic and Factorial Approach to Study the Effects of Temperature and Salinity on Growth and Toxin Production by the Dinoflagellate Alexandrium ostenfeldii from the Baltic Sea	PLOS ONE			English	Article							PARALYTIC SHELLFISH TOXINS; LACTIC-ACID BACTERIA; GENUS ALEXANDRIUM; SACCHAROMYCES-CEREVISIAE; SPIROLIDE PRODUCTION; PERUVIANUM BALECH; MENDIOLA BALECH; CYST FORMATION; DINOPHYCEAE; BLOOM	Alexandrium ostenfeldii is present in a wide variety of environments in coastal areas worldwide and is the only dinoflagellate known species that produces paralytic shellfish poisoning (PSP) toxins and two types of cyclic imines, spirolides (SPXs) and gymnodimines (GYMs). The increasing frequency of A. ostenfeldii blooms in the Baltic Sea has been attributed to the warming water in this region. To learn more about the optimal environmental conditions favoring the proliferation of A. ostenfeldii and its complex toxicity, the effects of temperature and salinity on the kinetics of both the growth and the net toxin production of this species were examined using a factorial design and a response-surface analysis (RSA). The results showed that the growth of Baltic A. ostenfeldii occurs over a wide range of temperatures and salinities (12.5-25.5 degrees C and 5-21, respectively), with optimal growth conditions achieved at a temperature of 25.5 degrees C and a salinity of 11.2. Together with the finding that a salinity > 21 was the only growth-limiting factor detected for this strain, this study provides important insights into the autecology and population distribution of this species in the Baltic Sea. The presence of PSP toxins, including gonyautoxin (GTX)-3, GTX-2, and saxitoxin (STX), and GYMs (GYM-A and GYM-B/-C analogues) was detected under all temperature and salinity conditions tested and in the majority of the cases was concomitant with both the exponential growth and stationary phases of the dinoflagellate's growth cycle. Toxin concentrations were maximal at temperatures and salinities of 20.9 degrees C and 17 for the GYM-A analogue and > 19 degrees C and 15 for PSP toxins, respectively. The ecological implications of the optimal conditions for growth and toxin production of A. ostenfeldii in the Baltic Sea are discussed.	[Salgado, Pablo] Inst Fomento Pesquero IFOP, Dept Medio Ambiente, Div Invest Acuicultura, Punta Arenas, Chile; [Vazquez, Jose A.] CSIC, IIM, Grp Reciclado & Valorizac Mat Residuales REVAL, Vigo, Spain; [Riobo, Pilar; Franco, Jose M.] CSIC, IIM, Vigo, Spain; [Salgado, Pablo; Figueroa, Rosa I.; Bravo, Isabel] Ctr Oceanog Vigo, IEO, Vigo, Spain; [Kremp, Anke] Finnish Environm Inst SYKE, Ctr Marine Res, Helsinki, Finland	Instituto de Fomento Pesquero (Valparaiso); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM); Spanish Institute of Oceanography; Finnish Environment Institute	Salgado, P (corresponding author), Inst Fomento Pesquero IFOP, Dept Medio Ambiente, Div Invest Acuicultura, Punta Arenas, Chile.	pablo.salgado@ifop.cl	Figueroa, Rosa Isabel/M-7598-2015; Bravo, Isabel/D-3147-2012; Riobó, Pilar/K-1945-2017; Vazquez Alvarez, Jose Antonio/K-5938-2014	Figueroa, Rosa Isabel/0000-0001-9944-7993; Riobó, Pilar/0000-0002-1921-6229; Salgado, Pablo/0000-0002-4168-3675; Bravo, Isabel/0000-0003-3764-745X; Vazquez Alvarez, Jose Antonio/0000-0002-1122-4726	CCVIEO project; Ministry of Economy and Competitiveness [CICAN-2013-40671-R]	CCVIEO project; Ministry of Economy and Competitiveness	This work is a contribution of the Unidad Asociada "Microalgas Nocivas" (CSIC-IEO) and was financially supported by the CCVIEO project and CICAN-2013-40671-R (Ministry of Economy and Competitiveness). P. Salgado is a researcher at IFOP, which has provided financial support for his doctoral stay.	Aasen J, 2005, CHEM RES TOXICOL, V18, P509, DOI 10.1021/tx049706n; Almandoz GO, 2014, HARMFUL ALGAE, V37, P100, DOI 10.1016/j.hal.2014.05.011; ANDERSON DM, 1990, TOXICON, V28, P885, DOI 10.1016/0041-0101(90)90018-3; Anderson DM, 2012, HARMFUL ALGAE, V14, P10, DOI 10.1016/j.hal.2011.10.012; Avaria Sergio, 2003, Ciencia y Tecnologia del Mar, V26, P79; Balech E., 1977, NEOTROPICA, V23, P49; Borkman DG, 2012, HARMFUL ALGAE, V19, P92, DOI 10.1016/j.hal.2012.06.004; BOX G.E.P., 2005, STAT EXPT DESIGN INN; Bravo I, 2006, EUR J PHYCOL, V41, P293, DOI 10.1080/09670260600810360; Brown L, 2010, EUR J PHYCOL, V45, P375, DOI 10.1080/09670262.2010.495164; Burson A, 2014, HARMFUL ALGAE, V31, P125, DOI 10.1016/j.hal.2013.10.017; Cembella AD, 2000, PHYCOLOGIA, V39, P67, DOI 10.2216/i0031-8884-39-1-67.1; Cembella Allan D., 1998, NATO ASI Series Series G Ecological Sciences, V41, P381; Ciminiello P, 2006, TOXICON, V47, P597, DOI 10.1016/j.toxicon.2006.02.003; Dantigny P, 2007, INT J FOOD MICROBIOL, V114, P17, DOI 10.1016/j.ijfoodmicro.2006.11.002; Etheridge SM, 2005, DEEP-SEA RES PT II, V52, P2491, DOI 10.1016/j.dsr2.2005.06.026; European Union Reference Laboratory for Marine Biotoxins (EURLMB), 2011, EU HARM STAND OP PRO; Figueroa RI, 2008, HARMFUL ALGAE, V7, P653, DOI 10.1016/j.hal.2008.02.005; Franco D, 2012, POULTRY SCI, V91, P487, DOI 10.3382/ps.2011-01546; Franco D, 2013, MEAT SCI, V93, P547, DOI 10.1016/j.meatsci.2012.11.018; Franco J. M., 2006, 12 INT C HARMF ALG C; Graneli E, 2006, ECOL STUD; Gribble KE, 2005, DEEP-SEA RES PT II, V52, P2745, DOI 10.1016/j.dsr2.2005.06.018; Grzebyk D, 2003, J PLANKTON RES, V25, P1185, DOI 10.1093/plankt/fbg088; Gu HF, 2011, J SYST EVOL, V49, P606, DOI 10.1111/j.1759-6831.2011.00160.x; GUILLARD RRL, 1993, PHYCOLOGIA, V32, P234, DOI 10.2216/i0031-8884-32-3-234.1; Guzman L, 2013, PROGRAMA MANEJO MONI, P45; Hakanen P, 2012, HARMFUL ALGAE, V15, P91, DOI 10.1016/j.hal.2011.12.002; HANSEN PJ, 1992, J PHYCOL, V28, P597, DOI 10.1111/j.0022-3646.1992.00597.x; Harju K, 2014, 16 INT C HARMF ALG 2; Haro Daniela, 2013, Anales Instituto Patagonia (Chile), V41, P77; Haywood AJ, 2004, J PHYCOL, V40, P165, DOI 10.1111/j.0022-3646.2004.02-149.x; Wardhani DH, 2009, J AGR FOOD CHEM, V57, P540, DOI 10.1021/jf802492s; Hwang DF, 2000, TOXICON, V38, P1491, DOI 10.1016/S0041-0101(00)00080-5; Figueroa RI, 2011, J PHYCOL, V47, P13, DOI 10.1111/j.1529-8817.2010.00937.x; Jayakar SS, 2013, BIOPROC BIOSYST ENG, V36, P1063, DOI 10.1007/s00449-012-0859-1; Jensen MO, 1997, EUR J PHYCOL, V32, P9, DOI 10.1080/09541449710001719325; Katikou P, 2010, 14 INT C HARMF ALG C; Kebreab E, 2007, J ANIM SCI, V85, P2498, DOI 10.2527/jas.2006-738; Kremp A, 2014, J PHYCOL, V50, P81, DOI 10.1111/jpy.12134; Kremp A, 2012, ECOL EVOL, V2, P1195, DOI 10.1002/ece3.245; Kremp A, 2009, HARMFUL ALGAE, V8, P318, DOI 10.1016/j.hal.2008.07.004; Laabir M, 2011, J PLANKTON RES, P1; Lakeman MB, 2009, HARMFUL ALGAE, V8, P746, DOI 10.1016/j.hal.2008.11.011; Lembeye G., 2006, AVANCES CONOCIMIENTO, P99; Lim PT, 2005, HARMFUL ALGAE, V4, P391, DOI 10.1016/j.hal.2004.07.001; Liu JZ, 2003, BIOCHEM ENG J, V14, P137, DOI 10.1016/S1369-703X(02)00169-9; MacKinnon SL, 2006, J NAT PROD, V69, P983, DOI 10.1021/np050220w; Maclean C, 2003, BOT MAR, V46, P466, DOI 10.1515/BOT.2003.048; Marrouchi R, 2010, ADV NEW TECHNOLOGIES, P79; Medhioub W, 2011, HARMFUL ALGAE, V10, P794, DOI 10.1016/j.hal.2011.06.012; Miles CO, 2003, J AGR FOOD CHEM, V51, P4838, DOI 10.1021/jf030101r; Miles CO, 2000, J AGR FOOD CHEM, V48, P1373, DOI 10.1021/jf991031k; Molgo J., 2014, SEAFOOD FRESHWATER T, P951; Murray SA, 2014, HARMFUL ALGAE, V31, P54, DOI 10.1016/j.hal.2013.09.005; Otero P, 2010, ENVIRON TOXICOL CHEM, V29, P301, DOI 10.1002/etc.41; Paulsen O., 1904, MEDD KOMMN HAVUNDERS, V1, P1; Paz B, 2006, MAR ENVIRON RES, V62, P286, DOI 10.1016/j.marenvres.2006.04.066; Paz B, 2009, HARMFUL ALGAE, V8, P730, DOI 10.1016/j.hal.2009.03.001; Planas M, 2004, AQUACULTURE, V240, P313, DOI 10.1016/j.aquaculture.2004.07.016; Rial D, 2013, J HAZARD MATER, V263, P374, DOI 10.1016/j.jhazmat.2013.07.010; Richard D. J. A., 2000, HARMFUL ALGAL BLOOMS, P383; Rourke WA, 2008, J AOAC INT, V91, P589; Salgado P, 2015, TOXICON, V103, P85, DOI 10.1016/j.toxicon.2015.06.015; Sanchez S, 2004, 11 INT C HARMF ALG B, P227; Senft-Batoh CD, 2015, LIMNOL OCEANOGR, V00, P1; Senft-Batoh CD, 2015, HARMFUL ALGAE, V44, P20, DOI 10.1016/j.hal.2015.02.008; Smayda TJ, 2002, J OCEANOGR, V58, P281, DOI 10.1023/A:1015861725470; Spor A, 2010, INT J FOOD MICROBIOL, V142, P25, DOI 10.1016/j.ijfoodmicro.2010.05.012; Suikkanen S, 2013, HARMFUL ALGAE, V26, P52, DOI 10.1016/j.hal.2013.04.001; Tahvanainen P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053602; Tatters AO, 2012, HARMFUL ALGAE, V19, P160, DOI 10.1016/j.hal.2012.07.002; Tillmann U, 2014, HARMFUL ALGAE, V39, P259, DOI 10.1016/j.hal.2014.08.008; Tomas CR, 2012, HARMFUL ALGAE, V17, P54, DOI 10.1016/j.hal.2012.02.011; Van Wagoner RM, 2011, TETRAHEDRON LETT, V52, P4243, DOI 10.1016/j.tetlet.2011.05.137; Vazquez JA, 2008, BIORESOURCE TECHNOL, V99, P6246, DOI 10.1016/j.biortech.2007.12.006; Vazquez JA, 2008, BIOCHEM ENG J, V39, P276, DOI 10.1016/j.bej.2007.09.012; Vazquez JA, 2004, ENZYME MICROB TECH, V35, P385, DOI 10.1016/j.enzmictec.2004.02.007; Vazquez JA, 2012, J THEOR BIOL, V39, P276; Wang DZ, 2005, HARMFUL ALGAE, V4, P401, DOI 10.1016/j.hal.2004.07.002; Wang H, 2008, AQUACULTURE, V284, P68, DOI 10.1016/j.aquaculture.2008.07.008; Wardhani DH, 2010, FOOD CHEM, V118, P731, DOI 10.1016/j.foodchem.2009.05.057; WOOD AM, 1992, J PHYCOL, V28, P723, DOI 10.1111/j.0022-3646.1992.00723.x	83	7	7	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143021	10.1371/journal.pone.0143021	http://dx.doi.org/10.1371/journal.pone.0143021			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636674	Green Published, gold, Green Submitted			2022-12-27	WOS:000366143800005
J	Tamosiunas, A; Radisauskas, R; Klumbiene, J; Bernotiene, G; Petkeviciene, J; Luksiene, D; Virviciute, D; Malinauskiene, V; Vikhireva, O; Grabauskas, V				Tamosiunas, Abdonas; Radisauskas, Ricardas; Klumbiene, Jurate; Bernotiene, Gailute; Petkeviciene, Janina; Luksiene, Dalia; Virviciute, Dalia; Malinauskiene, Vilija; Vikhireva, Olga; Grabauskas, Vilius			The Prognostic Value of Family History for the Estimation of Cardiovascular Mortality Risk in Men: Results from a Long-Term Cohort Study in Lithuania	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; MYOCARDIAL-INFARCTION; ALCOHOL-CONSUMPTION; POPULATION; PREVALENCE; PREMATURE; DEATH; VALIDATION; SMOKING; STROKE	Aim To evaluate the additional prognostic value of family history for the estimation of cardiovascular (CVD) mortality risk in middle-aged urban Lithuanian men. Methods The association between family history of CVD and the risk of CVD mortality was examined in a population-based cohort of 6,098 men enrolled during 1972-1974 and 1976-1980 in Kaunas, Lithuania. After up to 40 years of follow-up, 2,272 deaths from CVD and 1,482 deaths from coronary heart disease (CHD) were identified. Multivariate Cox proportional hazards models were used to estimate hazard ratios (HR) for CVD and CHD mortality. Results After adjustment for traditional CVD risk factors, the HR for CVD mortality was 1.24 (95% CI 1.09-1.42) and for CHD mortality 1.20 (1.02-1.42) in men with first-degree relatives having a history of myocardial infarction (MI), compared to men without positive family history. A significant effect on the risk of CVD and CHD mortality was also observed for the family history of sudden cardiac death and any CVD. Addition of family history of MI, sudden death, and any CVD to traditional CVD risk factors demonstrated modest improvement in the performance of Cox models for CVD and CHD mortality. Conclusions Family history of CVD is associated with a risk of CVD and CHD mortality significantly and independently of other risk factors in a middle-aged male population. Addition of family history to traditional CVD risk factors improves the prediction of CVD mortality and could be used for identification of high-risk individuals.	[Tamosiunas, Abdonas; Radisauskas, Ricardas; Bernotiene, Gailute; Luksiene, Dalia; Virviciute, Dalia; Malinauskiene, Vilija] Lithuanian Univ Hlth Sci, Inst Cardiol, Med Acad, Kaunas, Lithuania; [Tamosiunas, Abdonas; Radisauskas, Ricardas; Klumbiene, Jurate; Petkeviciene, Janina; Luksiene, Dalia; Malinauskiene, Vilija; Grabauskas, Vilius] Lithuanian Univ Hlth Sci, Med Acad, Fac Publ Hlth, Kaunas, Lithuania; [Vikhireva, Olga] UCL, Dept Epidemiol & Publ Hlth, London, England	Lithuanian University of Health Sciences; Lithuanian University of Health Sciences; University of London; University College London	Tamosiunas, A (corresponding author), Lithuanian Univ Hlth Sci, Inst Cardiol, Med Acad, Kaunas, Lithuania.	abdonas.tamosiunas@lsmuni.lt	Tamosiunas, Abdonas/AAD-4274-2021; Radišauskas, Ričardas/AAT-8920-2021	Radišauskas, Ričardas/0000-0002-1227-2674				Acheson LS, 2010, GENET MED, V12, P212, DOI 10.1097/GIM.0b013e3181d56ae6; Bachmann JM, 2012, CIRCULATION, V125, P3092, DOI 10.1161/CIRCULATIONAHA.111.065490; Chow CK, 2007, BMJ-BRIT MED J, V335, P481, DOI 10.1136/bmj.39253.577859.BE; Chow CK, 2011, J AM COLL CARDIOL, V57, P619, DOI 10.1016/j.jacc.2010.07.054; Germano G, 2012, EUR HEART J, V33, P137; Glasunov IS, 1981, KAUNAS ROTTERDAM INT; Guttmacher AE, 2004, NEW ENGL J MED, V351, P2333, DOI 10.1056/NEJMsb042979; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hintsa T, 2010, OCCUP ENVIRON MED, V67, P330, DOI 10.1136/oem.2009.048470; Hippisley-Cox J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6624; HUANG TC, 1961, ANAL CHEM, V33, P1405, DOI 10.1021/ac60178a040; KEE F, 1993, BRIT MED J, V307, P1528, DOI 10.1136/bmj.307.6918.1528; Kinra S, 2003, HEART, V89, P834, DOI 10.1136/heart.89.8.834; Klemenc-Ketis Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080333; Kuklina EV, 2010, ANN FAM MED, V8, P327, DOI 10.1370/afm.1137; Kuzmickiene I, 2013, CANCER EPIDEMIOL, V37, P133, DOI 10.1016/j.canep.2012.10.001; Long GH, 2015, PREV MED, V71, P121, DOI 10.1016/j.ypmed.2014.12.013; Merry AHH, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-13; Murabito JM, 2004, ANN INTERN MED, V140, P434, DOI 10.7326/0003-4819-140-6-200403160-00010; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Prineas R., 1982, MINNESOTA CODE MANUA; Radisauskas R, 2011, ALCOHOL ALCOHOLISM, V46, P614, DOI 10.1093/alcalc/agr068; Ranthe MF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125896; Ranthe MF, 2012, J AM COLL CARDIOL, V60, P814, DOI 10.1016/j.jacc.2012.06.018; Reibis R, 2012, VASC HEALTH RISK MAN, V8, P473, DOI 10.2147/VHRM.S33305; Reklaitiene R, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-68; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Ridker PM, 2008, CIRCULATION, V118, P2243, DOI 10.1161/CIRCULATIONAHA.108.814251; Rose G, 1982, CARDIOVASCULAR SURVE; Scheuner MT, 2010, CIRC-CARDIOVASC GENE, V3, P97, DOI 10.1161/CIRCGENETICS.109.894527; Seshadri S, 2010, CIRCULATION, V121, P1304, DOI 10.1161/CIRCULATIONAHA.109.854240; Sivapalaratnam S, 2010, HEART, V96, P1985, DOI 10.1136/hrt.2010.210740; Tamosiunas A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114283; Van daele CM, 2013, PLOS ONE, V2, DOI [10.1371/journal.pone.0063185, DOI 10.1371/J0URNAL.P0NE.0063185]; van Dis I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028697; Yanez ND, 2009, ANN EPIDEMIOL, V19, P858, DOI 10.1016/j.annepidem.2009.07.095; Yang ZJ, 2012, EUR HEART J, V33, P213, DOI 10.1093/eurheartj/ehr205	37	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143839	10.1371/journal.pone.0143839	http://dx.doi.org/10.1371/journal.pone.0143839			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630455	gold, Green Published, Green Submitted			2022-12-27	WOS:000365926300109
J	Zhou, YL; Williams, J; Smallwood, PM; Nathans, J				Zhou, Yulian; Williams, John; Smallwood, Philip M.; Nathans, Jeremy			Sox7, Sox17, and Sox18 Cooperatively Regulate Vascular Development in the Mouse Retina	PLOS ONE			English	Article							REDUNDANT ROLES; TRANSCRIPTIONAL REGULATION; PHENOTYPIC HETEROGENEITY; INTRACRANIAL ANEURYSM; TIP CELLS; ANGIOGENESIS; NOTCH; MUTATIONS; DEFECTS; SPECIFICATION	Vascular development and maintenance are controlled by a complex transcriptional program, which integrates both extracellular and intracellular signals in endothelial cells. Here we study the roles of three closely related SoxF family transcription factors-Sox7, Sox17, and Sox18-in the developing and mature mouse vasculature using targeted gene deletion on a mixed C57/129/CD1 genetic background. In the retinal vasculature, each SoxF gene exhibits a distinctive pattern of expression in different classes of blood vessels. On a mixed genetic background, vascular endothelial-specific deletion of individual SoxF genes has little or no effect on vascular architecture or differentiation, a result that can be explained by overlapping function and by reciprocal regulation of gene expression between Sox7 and Sox17. By contrast, combined deletion of Sox7, Sox17, and Sox18 at the onset of retinal angiogenesis leads to a dense capillary plexus with a nearly complete loss of radial arteries and veins, whereas the presence of a single Sox17 allele largely restores arterial identity, as determined by vascular smooth muscle cell coverage. In the developing retina, expression of all three SoxF genes is reduced in the absence of Norrin/Frizzled4-mediated canonical Wnt signaling, but SoxF gene expression is unaffected by reduced VEGF signaling in response to deletion of Neuropilin1 (Npn1). In adulthood, Sox7, Sox17, and Sox18 act in a largely redundant manner to maintain blood vessel function, as adult onset vascular endothelial-specific deletion of all three SoxF genes leads to massive edema despite nearly normal vascular architecture. These data reveal critical and partially redundant roles for Sox7, Sox17 and Sox18 in vascular growth, differentiation, and maintenance.	[Zhou, Yulian; Williams, John; Smallwood, Philip M.; Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Dept Mol Biol, Baltimore, MD 21205 USA; [Zhou, Yulian; Williams, John; Smallwood, Philip M.; Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Dept Genet, Baltimore, MD 21205 USA; [Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Williams, John; Smallwood, Philip M.; Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Nathans, J (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol, Baltimore, MD 21205 USA.	jnathans@jhmi.edu		Nathans, Jeremy/0000-0001-8106-5460	Howard Hughes Medical Institute and the National Eye Institute [R01EY081637]	Howard Hughes Medical Institute and the National Eye Institute	This work was supported by the Howard Hughes Medical Institute and the National Eye Institute (R01EY081637 to JN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae; Alg VS, 2013, NEUROLOGY, V80, P2154, DOI 10.1212/WNL.0b013e318295d751; Badea TC, 2003, J NEUROSCI, V23, P2314; Benedito R, 2012, NATURE, V484, P110, DOI 10.1038/nature10908; Bilguvar K, 2008, NAT GENET, V40, P1472, DOI 10.1038/ng.240; Blanco R, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a006569; Bowles J, 2000, DEV BIOL, V227, P239, DOI 10.1006/dbio.2000.9883; Cermenati S, 2008, BLOOD, V111, P2657, DOI 10.1182/blood-2007-07-100412; Claxton S, 2008, GENESIS, V46, P74, DOI 10.1002/dvg.20367; Corada M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3609; Downes M, 2001, TRENDS CARDIOVAS MED, V11, P318, DOI 10.1016/S1050-1738(01)00131-1; Downes M, 2009, HUM MOL GENET, V18, P2839, DOI 10.1093/hmg/ddp219; Ehling M, 2013, DEVELOPMENT, V140, P3051, DOI 10.1242/dev.093351; Eilken HM, 2010, CURR OPIN CELL BIOL, V22, P617, DOI 10.1016/j.ceb.2010.08.010; Foroud T, 2012, STROKE, V43, P2846, DOI 10.1161/STROKEAHA.112.656397; Francois M, 2008, NATURE, V456, P643, DOI 10.1038/nature07391; Francois M, 2011, PHYSIOLOGY, V26, P146, DOI 10.1152/physiol.00053.2010; Francois M, 2010, INT J BIOCHEM CELL B, V42, P445, DOI 10.1016/j.biocel.2009.08.017; Gelfand MV, 2014, ELIFE, V3, DOI 10.7554/eLife.03720; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hermkens DMA, 2015, DEVELOPMENT, V142, P1695, DOI 10.1242/dev.117275; Herpers R, 2008, CIRC RES, V102, P12, DOI 10.1161/CIRCRESAHA.107.166066; Hosking B, 2009, DEVELOPMENT, V136, P2385, DOI 10.1242/dev.034827; Irrthum A, 2003, AM J HUM GENET, V72, P1470, DOI 10.1086/375614; James K, 2003, GENESIS, V36, P1, DOI 10.1002/gene.10190; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Lal A, 2004, SEMIN HEMATOL, V41, P17, DOI 10.1053/j.seminhematol.2004.08.004; Lee SH, 2014, CIRC RES, V115, P215, DOI 10.1161/CIRCRESAHA.115.303142; Lee S, 2015, CIRCULATION, V131, P995, DOI 10.1161/CIRCULATIONAHA.114.012568; Matsui T, 2006, J CELL SCI, V119, P3513, DOI 10.1242/jcs.03081; Morini MF, 2014, CURR OPIN HEMATOL, V21, P229, DOI 10.1097/MOH.0000000000000043; Pendeville H, 2008, DEV BIOL, V317, P405, DOI 10.1016/j.ydbio.2008.01.028; Pennisi D, 2000, NAT GENET, V24, P434, DOI 10.1038/74301; Radu M, 2013, JOVE-J VIS EXP, DOI 10.3791/50062; RALEIGH JA, 1987, BRIT J CANCER, V56, P395, DOI 10.1038/bjc.1987.213; Rattner A, 2014, INVEST OPHTH VIS SCI, V55, P8614, DOI 10.1167/iovs.14-15693; Rattner A, 2013, P NATL ACAD SCI USA, V110, pE3830, DOI 10.1073/pnas.1315509110; Sacilotto N, 2013, P NATL ACAD SCI USA, V110, P11893, DOI 10.1073/pnas.1300805110; Sakamoto Y, 2007, BIOCHEM BIOPH RES CO, V360, P539, DOI 10.1016/j.bbrc.2007.06.093; Siemerink MJ, 2013, J HISTOCHEM CYTOCHEM, V61, P101, DOI 10.1369/0022155412467635; Stahl A, 2010, INVEST OPHTH VIS SCI, V51, P2813, DOI 10.1167/iovs.10-5176; Vallon M, 2014, CELL MOL LIFE SCI, V71, P3489, DOI 10.1007/s00018-014-1625-0; Wang YS, 2012, CELL, V151, P1332, DOI 10.1016/j.cell.2012.10.042; Wu H, 2014, NEURON, V81, P103, DOI 10.1016/j.neuron.2013.10.051; Yanh H, 2013, J CLIN INVEST, V123, P418, DOI 10.1172/JCI64547; Yasuno K, 2010, NAT GENET, V42, P420, DOI 10.1038/ng.563; Ye X, 2010, TRENDS MOL MED, V16, P417, DOI 10.1016/j.molmed.2010.07.003; Ye X, 2009, CELL, V139, P285, DOI 10.1016/j.cell.2009.07.047; Zhou YL, 2014, DEV CELL, V31, P248, DOI 10.1016/j.devcel.2014.08.018	51	44	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143650	10.1371/journal.pone.0143650	http://dx.doi.org/10.1371/journal.pone.0143650			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630461	gold, Green Published, Green Submitted			2022-12-27	WOS:000365926300079
J	Haley, BM; Paunesku, T; Grdina, DJ; Woloschak, GE				Haley, Benjamin M.; Paunesku, Tatjana; Grdina, David J.; Woloschak, Gayle E.			The Increase in Animal Mortality Risk following Exposure to Sparsely Ionizing Radiation Is Not Linear Quadratic with Dose	PLOS ONE			English	Article							ATOMIC-BOMB SURVIVORS; CANCER-RISKS; PROTECTION; UNCERTAINTY; HUMANS; ISSUES; MODELS; CT	Introduction The US government regulates allowable radiation exposures relying, in large part, on the seventh report from the committee to estimate the Biological Effect of Ionizing Radiation (BEIR VII), which estimated that most contemporary exposures- protracted or low-dose, carry 1.5 fold less risk of carcinogenesis and mortality per Gy than acute exposures of atomic bomb survivors. This correction is known as the dose and dose rate effectiveness factor for the life span study of atomic bomb survivors (DDREFLSS). It was calculated by applying a linear-quadratic dose response model to data from Japanese atomic bomb survivors and a limited number of animal studies. Methods and Results We argue that the linear-quadratic model does not provide appropriate support to estimate the risk of contemporary exposures. In this work, we re-estimated DDREFLSS using 15 animal studies that were not included in BEIR VII's original analysis. Acute exposure data led to a DDREFLSS estimate from 0.9 to 3.0. By contrast, data that included both acute and protracted exposures led to a DDREFLSS estimate from 4.8 to infinity. These two estimates are significantly different, violating the assumptions of the linear-quadratic model, which predicts that DDREFLSS values calculated in either way should be the same. Conclusions Therefore, we propose that future estimates of the risk of protracted exposures should be based on direct comparisons of data from acute and protracted exposures, rather than from extrapolations from a linear-quadratic model. The risk of low dose exposures may be extrapolated from these protracted estimates, though we encourage ongoing debate as to whether this is the most valid approach. We also encourage efforts to enlarge the datasets used to estimate the risk of protracted exposures by including both human and animal data, carcinogenesis outcomes, a wider range of exposures, and by making more radiobiology data publicly accessible. We believe that these steps will contribute to better estimates of the risks of contemporary radiation exposures.	[Haley, Benjamin M.; Paunesku, Tatjana; Woloschak, Gayle E.] Northwestern Univ, Dept Radiat Oncol, Feinberg Sch Med, Chicago, IL 60611 USA; [Grdina, David J.] Univ Chicago, Radiat Dept, Chicago, IL 60637 USA; [Grdina, David J.] Univ Chicago, Dept Cellular Oncol, Chicago, IL 60637 USA; [Woloschak, Gayle E.] Northwestern Univ, Dept Radiol, Feinberg Sch Med, Chicago, IL 60611 USA; [Woloschak, Gayle E.] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; University of Chicago; University of Chicago; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Woloschak, GE (corresponding author), Northwestern Univ, Dept Radiat Oncol, Feinberg Sch Med, Chicago, IL 60611 USA.	g-woloschak@northwestern.edu	Paunesku, Tatjana/A-3488-2017; Paunesku, Tatjana/AAF-8529-2021; Woloschak, Gayle E/A-3799-2017	Paunesku, Tatjana/0000-0001-8698-2938; Paunesku, Tatjana/0000-0001-8698-2938; Woloschak, Gayle E/0000-0001-9209-8954	U.S. Department of Energy Office of Science, Low Dose Radiation Research Program [DE-SC0001271, DEFG02-07ER64342]; European Commission [028275 (FI6R)]	U.S. Department of Energy Office of Science, Low Dose Radiation Research Program(United States Department of Energy (DOE)); European Commission(European CommissionEuropean Commission Joint Research Centre)	Time to conduct the analysis in this paper and Janus Data was supported by Gayle E Woloschak, U.S. Department of Energy Office of Science, Low Dose Radiation Research Program, http://lowdose.energy.gov/, DE-SC0001271, DEFG02-07ER64342. Data was also obtained from the European Radiobiology Archive supported by European Commission, http://ec.europa.eu/index_en.htm, 028275 (FI6R).	[Anonymous], 2014, R LANG ENV STAT COMP; Aypar U, 2011, INT J RADIAT BIOL, V87, P179, DOI 10.3109/09553002.2010.522686; Bates D., 2014, LINEAR MIXED EFFECTS; Board of Radiation Effects Research Division on Earth and Life Sciences National Research Council of the National Academies, 2006, HLTH RISKS EXP LOW L; BREIMER LH, 1988, BRIT J CANCER, V57, P6, DOI 10.1038/bjc.1988.2; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2003, P NATL ACAD SCI USA, V100, P13761, DOI 10.1073/pnas.2235592100; COX DR, 1972, J R STAT SOC B, V34, P187; Dahl DB, 2014, XTABLE EXPORT TABLES; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DUMOUCHEL WH, 1983, J AM STAT ASSOC, V78, P293, DOI 10.2307/2288631; Feinendegen LE, 2005, BRIT J RADIOL, V78, P3, DOI 10.1259/bjr/63353075; FERTIL B, 1984, RADIAT RES, V99, P73, DOI 10.2307/3576448; Gerber G, 1996, INT RADIOBIOLOGY ARC; German Comission on Radiological Protection-SSK, 2006, COMM 2006 DRAFT ICRP; German Commission on Radiological Protection (SSK), 2014, DOS DOS RAT EFF FACT; Gompertz B., 1825, PHILOS T ROYAL SOC L, V115, P515, DOI [DOI 10.1098/RSTL.1825.0026, 10.1098/rstl.1825.0026]; Goodman DM, 2013, JAMA-J AM MED ASSOC, V309, P647, DOI 10.1001/jama.2013.83; Haley B, 2011, HEALTH PHYS, V100, P613, DOI 10.1097/HP.0b013e3181febad3; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hoel DG, 2015, HEALTH PHYS, V108, P351, DOI 10.1097/HP.0000000000000189; International Commission on Radiological Protection, 2005, ANN ICRP, V99; Jacob P, 2009, OCCUP ENVIRON MED, V66, P789, DOI 10.1136/oem.2008.043265; Land CE, 2009, HEALTH PHYS, V97, P407, DOI 10.1097/HP.0b013e3181b1871b; Little MP, 2008, RADIAT RES, V169, P660, DOI 10.1667/RR1091.1; Marples B, 2008, INT J RADIAT ONCOL, V70, P1310, DOI 10.1016/j.ijrobp.2007.11.071; Mettler FA, 2008, RADIOLOGY, V248, P254, DOI 10.1148/radiol.2481071451; Morgan WF, 2013, RADIAT RES, V179, P501, DOI 10.1667/RR3306.1; Mothersill C, 2013, RADIAT ENVIRON BIOPH, V52, P293, DOI 10.1007/s00411-013-0472-y; National Council on Radiation Protection and Measurements, 2009, 160 NAT COUNC RAD PR; National Council on Radiation Protection and Measurements, 1980, INFL DOS ITS DISTR T; Ozasa K, 2012, RADIAT RES, V177, P229, DOI 10.1667/RR2629.1; Pierce DA, 1996, RADIAT RES, V146, P1, DOI 10.2307/3579391; Pierce DA, 2000, RADIAT RES, V154, P178, DOI 10.1667/0033-7587(2000)154[0178:RRCRAL]2.0.CO;2; Prasad KN, 2004, BRIT J RADIOL, V77, P97, DOI 10.1259/bjr/88081058; Preston DL, 2003, RADIAT RES, V160, P381, DOI 10.1667/RR3049; R Core Team, 2014, PANDER R PANDOC WRIT; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Sodickson A, 2009, RADIOLOGY, V251, P175, DOI 10.1148/radiol.2511081296; Tapio S, 2008, INT J RADIAT BIOL, V84, P930, DOI 10.1080/09553000802460214; Therneau T, 2012, COXME MIXED EFFECTS; Therneau TM, 2014, PACKAGE SURVIVAL ANA; Therneau TM., 2014, RADIOACTIVITY HLTH H, DOI DOI 10.2172/6608787; United Nations Scientific Committee on the Effects of Atomic Radiation, 2012, UNC RISK EST RAD IND; United Nations Scientific Committee on the Effects of Atomic Radiation, 2006, EFF ION RAD ANN A EP; VENZON DJ, 1988, J R STAT SOC C-APPL, V37, P87, DOI 10.2307/2347496; Viechtbauer W., 2010, J STAT SOFTW, P36; Wang QO, 2010, RADIAT ENVIRON BIOPH, V49, P317, DOI 10.1007/s00411-010-0270-8; Wickham H, 2014, DPLYR GRAMMAR DATA M; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Wickham H, 2007, J STAT SOFTW, V21, P1	52	25	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0140989	10.1371/journal.pone.0140989	http://dx.doi.org/10.1371/journal.pone.0140989			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26649569	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903300003
J	Lee, JH; Kim, T; Lee, JJ; Lee, KJ; Kim, HK; Yun, B; Jeon, J; Kim, SK; Ma, JY				Lee, Ji-Hye; Kim, Taesoo; Lee, Jung-Jin; Lee, Kwang Jin; Kim, Hyun-Kyu; Yun, Bora; Jeon, Jongwook; Kim, Sang Kyum; Ma, Jin Yeul			The Herbal Medicine KBH-1 Inhibits Fat Accumulation in 3T3-L1 Adipocytes and Reduces High Fat Diet-Induced Obesity through Regulation of the AMPK Pathway	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; PPAR-GAMMA; DIFFERENTIATION; EXPRESSION; ADIPOGENESIS; METABOLISM; RECEPTOR; ENERGY; LIPOLYSIS; EXTRACT	The aim of this study was to investigate whether a novel formulation of an herbal extract, KBH-1, has an inhibitory effect on obesity. To determine its anti-obesity effects and its underlying mechanism, we performed anti-obesity-related experiments in vitro and in vivo. 3T3-L1 preadipocytes were analyzed for lipid accumulation as well as the protein and gene expression of molecular targets involved in fatty acid synthesis. To determine whether KBH-1 oral administration results in a reduction in high-fat diet (HFD)-induced obesity, we examined five groups (n = 9) of C57BL/6 mice as follows: 10% kcal fat diet-fed mice (ND), 60% kcal fat diet-fed mice (HFD), HFD-fed mice treated with orlistat (tetrahydrolipstatin, marketed under the trade name Xenical), HFD-fed mice treated with 150 mg/kg KBH-1 (KBH-1 150) and HFD-fed mice treated with 300 mg/kg KBH-1 (KBH- 1 300). During adipogenesis of 3T3-L1 cells in vitro, KBH- 1 significantly reduced lipid accumulation and downregulated the expression of master adipogenic transcription factors, including CCAAT/ enhancer binding protein (C/EBP) beta, C/EBP a and peroxisome proliferation-activity receptor (PPAR)., which led to the suppression of the expression of several adipocyte-specific genes and proteins. KBH- 1 also markedly phosphorylated the adenosine monophosphate-activated protein kinase ( AMPK) and acetyl-CoA carboxylase (ACC). In addition, KBH-1-induced the inhibition effect on lipid accumulation and AMPK-mediated signal activation were decreased by blocking AMPK phosphorylation using AMPK siRNA. Furthermore, daily oral administration of KBH- 1 resulted in dose-dependent decreases in body weight, fat pad mass and fat tissue size without systemic toxicity. These results suggest that KBH- 1 inhibits lipid accumulation by down-regulating the major transcription factors of the adipogenesis pathway by regulating the AMPK pathway in 3T3-L1 adipocytes and in mice with HFD-induced obesity. These results implicate KBH-1, a safe herbal extract, as a potential anti-obesity therapeutic agent.	[Lee, Ji-Hye; Kim, Taesoo; Lee, Jung-Jin; Lee, Kwang Jin; Jeon, Jongwook; Ma, Jin Yeul] Korea Inst Oriental Med, KM Applicat Ctr, Daejeon 305811, South Korea; [Lee, Ji-Hye; Kim, Sang Kyum] Chungnam Natl Univ, Coll Pharm, Taejon 305764, South Korea; [Kim, Hyun-Kyu; Yun, Bora] Kolmar BNH, Nutraceut Food R&D Ctr, Sejong 339851, South Korea	Korea Institute of Oriental Medicine (KIOM); Chungnam National University	Kim, SK (corresponding author), Chungnam Natl Univ, Coll Pharm, Taejon 305764, South Korea.	sangkim@cnu.ac.kr; jyma@kiom.re.kr		Kim, Sang Kyum/0000-0001-5769-0792	Korea Institute Oriental Medicine (KIOM) [K15280]; Innopolis Foundation [1711008676 (A2013DD103)]	Korea Institute Oriental Medicine (KIOM); Innopolis Foundation	This research was in part supported by the grant K15280 awarded to J.Y. Ma of Korea Institute Oriental Medicine (KIOM) and Innopolis Foundation (Project No. 1711008676 (A2013DD103)) awarded to H.K. Kim of Kolmar BNH from the Ministry of Science, ICT and Future Planning (MISP), Korea. Authors have an additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Arun N, 2002, PLANT FOOD HUM NUTR, V57, P41, DOI 10.1023/A:1013106527829; Berry R, 2014, CELL METAB, V19, P8, DOI 10.1016/j.cmet.2013.10.003; Chen SF, 2011, CAN J PHYSIOL PHARM, V89, P793, DOI 10.1139/Y11-077; Cho SY, 2007, AM J PHYSIOL-ENDOC M, V292, pE1166, DOI 10.1152/ajpendo.00436.2006; Choi KM, 2014, J NUTR BIOCHEM, V25, P201, DOI 10.1016/j.jnutbio.2013.10.007; Choi KM, 2013, J NUTR BIOCHEM, V24, P335, DOI 10.1016/j.jnutbio.2012.06.018; Chung BS, 1990, DICT KOREAN FOLK MED; CORNELIUS P, 1994, ANNU REV NUTR, V14, P99, DOI 10.1146/annurev.nu.14.070194.000531; Corson TW, 2007, CELL, V130, P769, DOI 10.1016/j.cell.2007.08.021; Dagon Y, 2006, BIOCHEM BIOPH RES CO, V340, P43, DOI 10.1016/j.bbrc.2005.11.159; Daval M, 2006, J PHYSIOL-LONDON, V574, P55, DOI 10.1113/jphysiol.2006.111484; Galgani J, 2008, INT J OBESITY, V32, pS109, DOI 10.1038/ijo.2008.246; Giri S, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-31; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Grundy SM, 2004, J CLIN ENDOCR METAB, V89, P2595, DOI 10.1210/jc.2004-0372; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Hardie DG, 1997, BIOCHEM SOC T, V25, P1229, DOI 10.1042/bst0251229; He YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076495; Jeong Mi-Young, 2013, Evid Based Complement Alternat Med, V2013, P475386, DOI 10.1155/2013/475386; Jiang Y, 2005, J NAT PROD, V68, P875, DOI 10.1021/np050026+; Jou PC, 2010, J AGR FOOD CHEM, V58, P12703, DOI 10.1021/jf103121c; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Karamadoukis L, 2009, CLIN NEPHROL, V71, P430; Kim A, 2014, ONCOL REP, V31, P287, DOI 10.3892/or.2013.2822; Kiyohara H, 2004, EVID-BASED COMPL ALT, V1, P83, DOI 10.1093/ecam/neh004; Kwak DH, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/413906; Kwak DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049530; Lefterova MI, 2010, MOL CELL BIOL, V30, P2078, DOI 10.1128/MCB.01651-09; Li CJ, 2008, PLANTA MED, V74, P133, DOI 10.1055/s-2008-1034296; Moon HS, 2007, OBESITY, V15, P2571, DOI 10.1038/oby.2007.309; Pari Leelavinothan, 2008, Archives of Physiology and Biochemistry, V114, P127, DOI [10.1080/13813450802033958, 10.1080/13813450802033958 ]; Park JP, 2011, BIOTECHNOL BIOPROC E, V16, P1065, DOI 10.1007/s12257-011-0215-3; Ramadan G, 2011, INFLAMMATION, V34, P291, DOI 10.1007/s10753-010-9278-0; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Sham TT, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/925302; Shim Ki-Shuk, 2012, Evid Based Complement Alternat Med, V2012, P325791, DOI 10.1155/2012/325791; Steger DJ, 2010, GENE DEV, V24, P1035, DOI 10.1101/gad.1907110; Thi KVL, 2012, BIOL PHARM BULL, V35, P1379, DOI 10.1248/bpb.b12-00426; Thompson GM, 2004, ANAL BIOCHEM, V330, P21, DOI 10.1016/j.ab.2004.03.061; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Xing YF, 2010, BIOCHEM BIOPH RES CO, V396, P691, DOI 10.1016/j.bbrc.2010.04.163; Xu JF, 2004, J BIOL CHEM, V279, P35914, DOI 10.1074/jbc.M402297200; Yiu WF, 2011, J FOOD SCI, V76, pH80, DOI 10.1111/j.1750-3841.2011.02042.x; Yun JW, 2010, PHYTOCHEMISTRY, V71, P1625, DOI 10.1016/j.phytochem.2010.07.011	45	14	15	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0142041	10.1371/journal.pone.0142041	http://dx.doi.org/10.1371/journal.pone.0142041			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26649747	gold, Green Published, Green Submitted			2022-12-27	WOS:000366903300004
J	Parent, M; Boudier, A; Perrin, J; Vigneron, C; Maincent, P; Violle, N; Bisson, JF; Lartaud, I; Dupuis, F				Parent, Marianne; Boudier, Ariane; Perrin, Julien; Vigneron, Claude; Maincent, Philippe; Violle, Nicolas; Bisson, Jean-Francois; Lartaud, Isabelle; Dupuis, Francois			In Situ Microparticles Loaded with S-Nitrosoglutathione Protect from Stroke	PLOS ONE			English	Article							NITRIC-OXIDE; BLOOD-PRESSURE; ISCHEMIC-STROKE; RAT MODEL; NITROSOTHIOLS; IMPLANTS; WISTAR; VITRO; EFFICACY; DELIVERY	Treatment of stroke, especially during the first hours or days, is still lacking. S-nitrosoglutathione (GSNO), a cerebroprotective agent with short life time, may help if administered early with a sustain delivery while avoiding intensive reduction in blood pressure. We developed in situ forming implants (biocompatible biodegradable copolymer) and microparticles (same polymer and solvent emulsified with an external oily phase) of GSNO to lengthen its effects and allow cerebroprotection after a single subcutaneous administration to Wistar rats. Arterial pressure was recorded for 3 days (telemetry, n = 14), whole-blood platelet aggregation up to 13 days (aggregometry, n = 58), and neurological score, cerebral infarct size and edema volume for 2 days after obstruction of the middle cerebral artery by autologous blood clots (n = 30). GSNO-loaded formulations (30 mg/kg) induced a slighter and longer hypotension (-10 vs. -56 +/- 6 mmHg mean arterial pressure, 18 h vs. 40 min) than free GSNO at the same dose. The change in pulse pressure (-50%) lasted even up to 42 h for microparticles. GSNO-loaded formulations (30 mg/kg) prevented the transient 24 h hyperaggregability observed with free GSNO and 7.5 mg/kg-loaded formulations. When injected 2 h after stroke, GSNO-loaded microparticles (30 mg/kg) reduced neurological score at 24 (-62%) and 48 h (-75%) vs. empty microparticles and free GSNO 7.5 mg/kg and, compared to free GSNO, divided infarct size by 10 and edema volume by 8 at 48 h. Corresponding implants reduced infarct size and edema volume by 2.5 to 3 times. The longer (at least 2 days) but slight effects on arterial pressures show sustained delivery of GSNO-loaded formulations (30 mg/kg), which prevent transient platelet hyper-responsiveness and afford cerebroprotection against the consequences of stroke. In conclusion, in situ GSNO-loaded formulations are promising candidates for the treatment of stroke.	[Parent, Marianne; Boudier, Ariane; Vigneron, Claude; Maincent, Philippe; Lartaud, Isabelle; Dupuis, Francois] Univ Lorraine, CITHEFOR EA 3452, Fac Pharm, Nancy, France; [Perrin, Julien] Univ Lorraine, INSERM U1116, Fac Med, Vandoeuvre Les Nancy, France; [Violle, Nicolas; Bisson, Jean-Francois] ETAP Ethol Appl, Res Ctr Pharmacol Nutr & Toxicol, Vandoeuvre Les Nancy, France	Universite de Lorraine; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine	Dupuis, F (corresponding author), Univ Lorraine, CITHEFOR EA 3452, Fac Pharm, Nancy, France.	Francois.Dupuis@univ-lorraine.fr		DUPUIS, Francois/0000-0003-1947-3839; Parent, Marianne/0000-0002-7447-9806; Lartaud, Isabelle/0000-0001-9257-6311	Agence Nationale de la Recherche [ANR NanoSNO project] [EA3452]; French Ministry of Research and Education (Paris, France)	Agence Nationale de la Recherche [ANR NanoSNO project](French National Research Agency (ANR)); French Ministry of Research and Education (Paris, France)	This work was supported by the Agence Nationale de la Recherche [ANR NanoSNO project 2010-2014, managed by P. LEROY, Universite de Lorraine, EA3452 CITHEFOR]; and the French Ministry of Research and Education (Paris, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There is no commercial affiliation between ETAP-Lab and the other laboratory implicated in this work. ETAP-Lab did not provide any financial support to the present project. ETAP-Lab provided salaries only for authors that are members of its staff: Nicolas Violle and Jean-Francois Bisson. ETAP-Lab realized the stroke study in its own facilities on the demand of EA3542. For this study, EA3542 provided GSNO, formulations and consumable materials (Animals, syringe,...). ETAP-Lab provided surgeons, experimenters and laboratory technician, as well as facilities and equipment. ETAP-Lab participated to the study design, data collection and analysis, decision to publish, and preparation of the manuscript relatives to the stroke study.	Ahmed TA, 2014, AAPS PHARMSCITECH, V15, P772, DOI 10.1208/s12249-014-0101-3; Al-Sa'doni H, 2000, CLIN SCI, V98, P507, DOI 10.1042/CS19990267; Ankolekar S, 2013, STROKE, V44, P3120, DOI 10.1161/STROKEAHA.113.001301; Bath PMW, 2015, LANCET, V385, P617, DOI 10.1016/S0140-6736(14)61121-1; Bath PMW, 2014, INT J STROKE, V9, P372, DOI 10.1111/ijs.12235; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Bramanti E, 2010, TALANTA, V81, P1295, DOI 10.1016/j.talanta.2010.02.024; Defontis M, 2013, EXP TOXICOL PATHOL, V65, P637, DOI 10.1016/j.etp.2012.07.003; DERYCK M, 1989, STROKE, V20, P1383, DOI 10.1161/01.STR.20.10.1383; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gaucher C, 2013, CURR PHARM DESIGN, V19, P458, DOI 10.2174/138161213804143635; Geeganage C, 2011, STROKE, V42, P491, DOI 10.1161/STROKEAHA.110.596163; Giustarini D, 2007, J CHROMATOGR B, V851, P124, DOI 10.1016/j.jchromb.2006.09.031; Gordge MP, 2010, BRIT J PHARMACOL, V159, P1572, DOI 10.1111/j.1476-5381.2010.00670.x; He J, 2014, JAMA-J AM MED ASSOC, V311, P479, DOI 10.1001/jama.2013.282543; Jia L, 1996, NATURE, V380, P221, DOI 10.1038/380221a0; Kaposzta Z, 2002, CIRCULATION, V106, P3057, DOI 10.1161/01.CIR.0000041251.07332.28; Khan M, 2005, J CEREBR BLOOD F MET, V25, P177, DOI 10.1038/sj.jcbfm.9600012; Khan M, 2006, NITRIC OXIDE-BIOL CH, V15, P114, DOI 10.1016/j.niox.2006.01.008; Khan M, 2012, J NEUROCHEM, V123, P86, DOI 10.1111/j.1471-4159.2012.07947.x; Kim CW, 2011, THROMB RES, V127, P565, DOI 10.1016/j.thromres.2011.02.004; Kozak W, 2008, J PHARMACOL EXP THER, V326, P773, DOI 10.1124/jpet.108.139618; Kranz H, 2008, EUR J PHARM SCI, V34, P164, DOI 10.1016/j.ejps.2008.03.004; Kranz H, 2001, INT J PHARM, V212, P11, DOI 10.1016/S0378-5173(00)00568-8; LARTAUD I, 1993, AM J PHYSIOL, V264, pH851, DOI 10.1152/ajpheart.1993.264.3.H851; Lee M, 2015, STROKE, V46, P1883, DOI 10.1161/STROKEAHA.115.009552; Li JZ, 2008, CHEM PHARM BULL, V56, P796, DOI 10.1248/cpb.56.796; Marozkina NV, 2012, BBA-GEN SUBJECTS, V1820, P722, DOI 10.1016/j.bbagen.2011.06.017; Munzel T, 2011, CIRCULATION, V123, P2132, DOI 10.1161/CIRCULATIONAHA.110.981407; Nedelmann M, 2007, BRAIN RES, V1130, P188, DOI 10.1016/j.brainres.2006.10.087; Niederhoffer N, 1997, HYPERTENSION, V30, P1169, DOI 10.1161/01.HYP.30.5.1169; Niessen F, 2003, STROKE, V34, P2019, DOI 10.1161/01.STR.0000080941.73934.30; Parent M, 2013, EUR J PHARM BIOPHARM, V85, P640, DOI 10.1016/j.ejpb.2013.08.005; Parent M, 2013, J CONTROL RELEASE, V172, P292, DOI 10.1016/j.jconrel.2013.08.024; Parent M, 2013, CURR PHARM ANAL, V9, P31; RADOMSKI MW, 1992, BRIT J PHARMACOL, V107, P745, DOI 10.1111/j.1476-5381.1992.tb14517.x; Rassaf T, 2002, CIRC RES, V91, P470, DOI 10.1161/01.RES.0000035038.41739.CB; Rassaf T, 2006, EUR HEART J, V27, P1699, DOI 10.1093/eurheartj/ehl096; Sandset EC, 2011, LANCET, V377, P741, DOI 10.1016/S0140-6736(11)60104-9; Sehba FA, 1999, STROKE, V30, P1955, DOI 10.1161/01.STR.30.9.1955; Shatoor AS, 2012, THROMB RES, V130, P75, DOI 10.1016/j.thromres.2012.01.001; Sogo N, 2000, BRIT J PHARMACOL, V131, P1236, DOI 10.1038/sj.bjp.0703700; Solorio L, 2010, J CONTROL RELEASE, V143, P183, DOI 10.1016/j.jconrel.2010.01.001; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Tsikas D, 2001, BBA-PROTEIN STRUCT M, V1546, P422, DOI 10.1016/S0167-4838(01)00166-2; Yoo JW, 2009, BIOMATERIALS, V30, P3978, DOI 10.1016/j.biomaterials.2009.04.004; Zanini GM, 2012, J NEUROIMMUNE PHARM, V7, P477, DOI 10.1007/s11481-012-9343-6; Zhang GY, 2011, BLOOD, V118, P3670, DOI 10.1182/blood-2011-03-341107	48	17	17	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0144659	10.1371/journal.pone.0144659	http://dx.doi.org/10.1371/journal.pone.0144659			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YV	26646285	gold, Green Published, Green Submitted			2022-12-27	WOS:000366903100032
J	Stiglic, G; Brzan, PP; Fijacko, N; Wang, F; Delibasic, B; Kalousis, A; Obradovic, Z				Stiglic, Gregor; Brzan, Petra Povalej; Fijacko, Nino; Wang, Fei; Delibasic, Boris; Kalousis, Alexandros; Obradovic, Zoran			Comprehensible Predictive Modeling Using Regularized Logistic Regression and Comorbidity Based Features	PLOS ONE			English	Article								Different studies have demonstrated the importance of comorbidities to better understand the origin and evolution of medical complications. This study focuses on improvement of the predictive model interpretability based on simple logical features representing comorbidities. We use group lasso based feature interaction discovery followed by a post-processing step, where simple logic terms are added. In the final step, we reduce the feature set by applying lasso logistic regression to obtain a compact set of non-zero coefficients that represent a more comprehensible predictive model. The effectiveness of the proposed approach was demonstrated on a pediatric hospital discharge dataset that was used to build a readmission risk estimation model. The evaluation of the proposed method demonstrates a reduction of the initial set of features in a regression model by 72%, with a slight improvement in the Area Under the ROC Curve metric from 0.763 (95% CI: 0.755-0.771) to 0.769 (95% CI: 0.761-0.777). Additionally, our results show improvement in comprehensibility of the final predictive model using simple comorbidity based terms for logistic regression.	[Stiglic, Gregor; Brzan, Petra Povalej; Fijacko, Nino] Univ Maribor, Fac Hlth Sci, SLO-2000 Maribor, Slovenia; [Stiglic, Gregor] Univ Maribor, Fac Elect Engn & Comp Sci, SLO-2000 Maribor, Slovenia; [Wang, Fei] Univ Connecticut, Dept Comp Sci & Engn, Storrs, CT USA; [Delibasic, Boris] Univ Belgrade, Fac Org Sci, Belgrade, Serbia; [Kalousis, Alexandros] Univ Appl Sci Western Switzerland, Dept Business Informat, Carouge, Switzerland; [Kalousis, Alexandros] Univ Geneva, Dept Comp Sci, Geneva, Switzerland; [Obradovic, Zoran] Temple Univ, Ctr Data Analyt & Biomed Informat, Philadelphia, PA 19122 USA	University of Maribor; University of Maribor; University of Connecticut; University of Belgrade; University of Applied Sciences & Arts Western Switzerland; University of Geneva; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Stiglic, G (corresponding author), Univ Maribor, Fac Hlth Sci, SLO-2000 Maribor, Slovenia.	gregor.stiglic@um.si	Povalej, Petra/R-2277-2017; Fijačko, Nino/ABI-2948-2020; Fijačko, Nino/ABI-2409-2020; Stiglic, Gregor/E-5286-2011	Povalej, Petra/0000-0001-7872-586X; Fijačko, Nino/0000-0003-2722-0049; Stiglic, Gregor/0000-0002-0183-8679; Obradovic, Zoran/0000-0002-2051-0142	U.S. Office of Naval Research [N00014-151-2729]; U.S. Air Force Office of Scientific Research (AFOSR) [FA9550-12-1-0406]; Defense Advanced Research Project Agency (DARPA); Swiss National Science Foundation [SNSF IZ73Z0_152415]; Bilateral research grant [BI-RS/14-15-027]	U.S. Office of Naval Research(Office of Naval Research); U.S. Air Force Office of Scientific Research (AFOSR)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Defense Advanced Research Project Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Bilateral research grant	This research was partially supported by the U.S. Office of Naval Research grant N00014-151-2729 and grant #FA9550-12-1-0406 from the U.S. Air Force Office of Scientific Research (AFOSR) and the Defense Advanced Research Project Agency (DARPA). We also acknowledge partial financial support by the Swiss National Science Foundation through a SCOPES 2013 Joint Research Projects grant SNSF IZ73Z0_152415 and Bilateral research grant BI-RS/14-15-027. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharyya N, 2015, LARYNGOSCOPE, V125, P754, DOI 10.1002/lary.24706; Bien J, 2013, ANN STAT, V41, P1111, DOI 10.1214/13-AOS1096; BLYTH CR, 1972, J AM STAT ASSOC, V67, P364, DOI 10.2307/2284382; Chen ES, 2014, METHODS MOL BIOL, V1159, P269, DOI 10.1007/978-1-4939-0709-0_15; Choi NH, 2010, J AM STAT ASSOC, V105, P354, DOI 10.1198/jasa.2010.tm08281; COX DR, 1984, INT STAT REV, V52, P1, DOI 10.2307/1403235; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Friedman JH, 2012, INT J FORECASTING, V28, P722, DOI 10.1016/j.ijforecast.2012.05.001; Kuhn M., 2015, C5 0 DECISION TREES; Lappenschaar Martijn, 2013, Artificial Intelligence in Medicine. 14th Conference on Artificial Intelligence in Medicine, AIME 2013. Proceedings, P135, DOI 10.1007/978-3-642-38326-7_21; Lim Michael, 2013, ARXIV13082719; Quinlan JR., 1993, C45 PROGRAMS MACHINE; Radchenko P, 2010, J AM STAT ASSOC, V105, P1541, DOI 10.1198/jasa.2010.tm10130; Riano David, 2013, Artificial Intelligence in Medicine. 14th Conference on Artificial Intelligence in Medicine, AIME 2013. Proceedings, P11, DOI 10.1007/978-3-642-38326-7_2; Ruczinski I, 2003, J COMPUT GRAPH STAT, V12, P475, DOI 10.1198/1061860032238; Schapire RE, 1999, MACH LEARN, V37, P297, DOI 10.1023/A:1007614523901; Stiglic G, 2014, P AMIA ANN S 2014 NO, P1072; Stiglic G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033812; Stiglic G, 2006, COMP MED SY, P691, DOI 10.1109/CBMS.2006.169; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Zhang W, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S8-S7; Zhao P, 2006, 703 DEP STAT	22	15	16	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0144439	10.1371/journal.pone.0144439	http://dx.doi.org/10.1371/journal.pone.0144439			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YV	26645087	gold, Green Published, Green Submitted			2022-12-27	WOS:000366903100024
J	Peng, YG; Li, W; Wang, Y; Bo, J; Chen, H				Peng, Yaguang; Li, Wei; Wang, Yang; Bo, Jian; Chen, Hui			The Cut-Off Point and Boundary Values of Waist-to-Height Ratio as an Indicator for Cardiovascular Risk Factors in Chinese Adults from the PURE Study	PLOS ONE			English	Article							BODY-MASS INDEX; HEART-DISEASE RISK; METABOLIC RISK; FAT DISTRIBUTION; OBESITY; CIRCUMFERENCE; MEN; PREDICTORS; OVERWEIGHT; CHILDREN	To explore a scientific boundary of WHtR to evaluate central obesity and CVD risk factors in a Chinese adult population. The data are from the Prospective Urban Rural Epidemiology (PURE) China study that was conducted from 2005-2007. The final study sample consisted of 43 841 participants (18 019 men and 25 822 women) aged 35-70 years. According to the group of CVD risk factors proposed by Joint National Committee 7 version and the clustering of risk factors, some diagnosis parameters, such as sensitivity, specificity and receiver operating characteristic (ROC) curve least distance were calculated for hypertension, diabetes, high serum triglyceride (TG), high serum low density lipoprotein cholesterol (LDL-C), low serum high density lipoprotein cholesterol (HDL-C) and clustering of risk factors (number >= 2) to evaluate the efficacy at each value of the WHtR cut-off point. The upper boundary value for severity was fixed on the point where the specificity was above 90%. The lower boundary value, which indicated above underweight, was determined by the percentile distribution of WHtR, specifically the 5(th) percentile (P-5) for both males and females population. Then, based on convenience and practical use, the optimal boundary values of WHtR for underweight and obvious central obesity were determined. For the whole study population, the optimal WHtR cut-off point for the CVD risk factor cluster was 0.50. The cutoff points for severe central obesity were 0.57 in the whole population. The upper boundary values of WHtR to detect the risk factor cluster with specificity above 90% were 0.55 and 0.58 for men and women, respectively. Additionally, the cut-off points of WHtR for each of four cardiovascular risk factors with specificity above 90% in males ranged from 0.55 to 0.56, whereas in females, it ranged from 0.57 to 0.58. The P5 of WHtR, which represents the lower boundary values of WHtR that indicates above underweight, was 0.40 in the whole population. WHtR 0.50 was an optimal cut-off point for evaluating CVD risks in Chinese adults of both genders. The optimal boundaries of WHtR were 0.40 and 0.57, indicating low body weight and severe risk for CVD, respectively, in Chinese adults.	[Peng, Yaguang; Li, Wei; Wang, Yang; Bo, Jian; Chen, Hui] Chinese Acad Med Sci, State Key Lab Cardiovasc Dis, Fuwai Hosp, Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China; [Peng, Yaguang; Li, Wei; Wang, Yang; Bo, Jian; Chen, Hui] Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Li, W (corresponding author), Chinese Acad Med Sci, State Key Lab Cardiovasc Dis, Fuwai Hosp, Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China.; Li, W (corresponding author), Peking Union Med Coll, Beijing 100021, Peoples R China.	liwei@mrbc-nccd.com		Peng, Yaguang/0000-0002-7987-6464	Canadian Institutes of Health Research; Heart and Stroke Foundation of Ontario; National Center for Cardiovascular Diseases in China	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); National Center for Cardiovascular Diseases in China	The PURE-China study was funded by the Canadian Institutes of Health Research, the Heart and Stroke Foundation of Ontario, and National Center for Cardiovascular Diseases in China.	Ashwell M, 2005, INT J FOOD SCI NUTR, V56, P303, DOI 10.1080/09637480500195066; Ashwell M, 1996, BRIT MED J, V313, P559; Ashwell M, 2011, OBES REV, V10, P1; ASHWELL M, 1997, OBES RES, V5, pS45; Ashwell M, 2011, NUTR TODAY, V46, P85, DOI DOI 10.1097/NT.0B013E3182118779; Ashwell Margaret, 1998, International Journal of Obesity, V22, pS213; Bertsias G, 2003, BMC PUBLIC HEALTH, V3, DOI 10.1186/1471-2458-3-3; Billington CJ, 2000, ARCH INTERN MED, V160, P898, DOI 10.1001/archinte.160.7.898; Bosy-Westphal A, 2006, INT J OBESITY, V30, P475, DOI 10.1038/sj.ijo.0803144; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Corsi DJ, 2013, AM HEART J, V166, P636, DOI 10.1016/j.ahj.2013.04.019; Czernichow S, 2011, OBES REV, V12, P680, DOI 10.1111/j.1467-789X.2011.00879.x; Diaz VA, 2007, DIABETIC MED, V24, P1199, DOI 10.1111/j.1464-5491.2007.02244.x; Han TS, 1997, INT J OBESITY, V21, P83, DOI 10.1038/sj.ijo.0800371; Han TS, 1997, INT J OBESITY, V21, P587, DOI 10.1038/sj.ijo.0800446; Hsieh SD, 2005, PREV MED, V40, P216, DOI 10.1016/j.ypmed.2004.05.025; HSIEH SD, 1995, INT J OBESITY, V19, P585; Hsieh SD, 2003, INT J OBESITY, V27, P610, DOI 10.1038/sj.ijo.0802259; Lee CMY, 2008, J CLIN EPIDEMIOL, V61, P646, DOI 10.1016/j.jclinepi.2007.08.012; Lee J S, 1995, Sangyo Eiseigaku Zasshi, V37, P9; Lee K, 2008, OBESITY, V16, P834, DOI 10.1038/oby.2007.109; Li CY, 2006, PEDIATRICS, V118, pE1390, DOI 10.1542/peds.2006-1062; Lofgren I, 2004, J NUTR, V134, P1071, DOI 10.1093/jn/134.5.1071; Neville KA, 2006, J CLIN ENDOCR METAB, V91, P4401, DOI 10.1210/jc.2006-0128; Noori N, 2009, J RENAL NUTR, V19, P228, DOI 10.1053/j.jrn.2008.11.005; Sargeant LA, 2002, OBES RES, V10, P792, DOI 10.1038/oby.2002.107; Savva SC, 2000, INT J OBESITY, V24, P1453, DOI 10.1038/sj.ijo.0801401; Schneider HJ, 2007, J CLIN ENDOCR METAB, V92, P589, DOI 10.1210/jc.2006-0254; Schneider Harald J, 2011, Diabetes Care, V34, pe7, DOI 10.2337/dc10-1794; Shimajiri T, 2008, J ATHEROSCLER THROMB, V15, P94, DOI 10.5551/jat.E540; Teo K, 2009, AM HEART J, V158, P1, DOI 10.1016/j.ahj.2009.04.019; Tseng CH, 2007, CIRC J, V71, P1749, DOI 10.1253/circj.71.1749; World Health Organisation (WHO), 2000, TECHNICAL REPORT SER; Zhou Beifan, 2002, Zhonghua Liu Xing Bing Xue Za Zhi, V23, P5; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P245	35	22	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144539	10.1371/journal.pone.0144539	http://dx.doi.org/10.1371/journal.pone.0144539			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642201	Green Published, gold, Green Submitted			2022-12-27	WOS:000366902700144
J	Takakura, K; Shibazaki, Y; Yoneyama, H; Fujii, M; Hashiguchi, T; Ito, Z; Kajihara, M; Misawa, T; Homma, S; Ohkusa, T; Koido, S				Takakura, Kazuki; Shibazaki, Yuichiro; Yoneyama, Hiroyuki; Fujii, Masato; Hashiguchi, Taishi; Ito, Zensho; Kajihara, Mikio; Misawa, Takeyuki; Homma, Sadamu; Ohkusa, Toshifumi; Koido, Shigeo			Inhibition of Cell Proliferation and Growth of Pancreatic Cancer by Silencing of Carbohydrate Sulfotransferase 15 In Vitro and in a Xenograft Model	PLOS ONE			English	Article							CHONDROITIN-SULFATE-E; CARCINOMA; BINDING; GLYCOSAMINOGLYCANS; PROTEOGLYCAN; INVOLVEMENT; METASTASIS; MOTILITY; PATHWAY; BIOLOGY	Chondroitin sulfate E (CS-E), a highly sulfated glycosaminoglycan, is known to promote tumor invasion and metastasis. Because the presence of CS-E is detected in both tumor and stromal cells in pancreatic ductal adenocarcinoma (PDAC), multistage involvement of CS-E in the development of PDAC has been considered. However, its involvement in the early stage of PDAC progression is still not fully understood. In this study, to clarify the direct role of CS-E in tumor, but not stromal, cells of PDAC, we focused on carbohydrate sulfotransferase 15 (CHST15), a specific enzyme that biosynthesizes CS-E, and investigated the effects of the CHST15 siRNA on tumor cell proliferation in vitro and growth in vivo. CHST15 mRNA is highly expressed in the human pancreatic cancer cell lines PANC-1, MIA PaCa-2, Capan-1 and Capan-2. CHST15 siRNA significantly inhibited the expression of CHST15 mRNA in these four cells in vitro. Silencing of the CHST15 gene in the cells was associated with significant reduction of proliferation and up-regulation of the cell cycle inhibitor-related gene p21(CIP1/WAF1). In a subcutaneous xenograft tumor model of PANC-1 in nude mice, a single intratumoral injection of CHST15 siRNA almost completely suppressed tumor growth. Reduced CHST15 protein signals associated with tumor necrosis were observed with the treatment with CHST15 siRNA. These results provide evidence of the direct action of CHST15 on the proliferation of pancreatic tumor cells partly through the p21(CIP1/WAF1) pathway. Thus, CHST15-CS-E axis-mediated tumor cell proliferation could be a novel therapeutic target in the early stage of PDAC progression.	[Takakura, Kazuki; Ito, Zensho; Kajihara, Mikio; Ohkusa, Toshifumi; Koido, Shigeo] Jikei Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo, Japan; [Shibazaki, Yuichiro; Yoneyama, Hiroyuki; Fujii, Masato; Hashiguchi, Taishi] Stel Inst & Co Inc, Tokyo, Japan; [Misawa, Takeyuki] Jikei Univ, Sch Med, Dept Surg, Tokyo, Japan; [Homma, Sadamu] Jikei Univ, Sch Med, Dept Oncol, Inst DNA Med, Tokyo, Japan; [Koido, Shigeo] Jikei Univ, Sch Med, Inst Clin Med & Res, Kashiwa, Chiba, Japan	Jikei University; Jikei University; Jikei University; Jikei University	Takakura, K (corresponding author), Jikei Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo, Japan.	ktakakura@jikei.ac.jp	大草, 敏史/HGD-2376-2022		Mitsui Life Social Welfare Foundation; medical office (Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine); Stelic Institute Co., Inc.	Mitsui Life Social Welfare Foundation; medical office (Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine); Stelic Institute Co., Inc.	This work was supported, in part, by the Mitsui Life Social Welfare Foundation, grant number N/A, SK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Besides this, the necessary expenses were paid from the financial resources of our medical office (Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine). Stelic Institute & Co., Inc. provided support in the form of salaries for authors (YS, HY, MF, TH), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Basappa, 2009, GLYCOBIOLOGY, V19, P735, DOI 10.1093/glycob/cwp041; Brune K, 2008, CANCER EPIDEM BIOMAR, V17, P3536, DOI 10.1158/1055-9965.EPI-08-0630; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; Dhir V, 2014, EXPERT REV GASTROENT, V8, P775, DOI 10.1586/17474124.2014.917953; FAASSEN AE, 1992, J CELL BIOL, V116, P521, DOI 10.1083/jcb.116.2.521; Fuccio Lorenzo, 2014, Curr Treat Options Gastroenterol, V12, P183, DOI 10.1007/s11938-014-0015-x; Ito Y, 2007, ACTA HISTOCHEM CYTOC, V40, P53, DOI 10.1267/ahc.07004; Khvalevsky EZ, 2013, P NATL ACAD SCI USA, V110, P20723, DOI 10.1073/pnas.1314307110; Li F, 2008, J BIOL CHEM, V283, P34294, DOI 10.1074/jbc.M806015200; Mazumdar T, 2011, CANCER RES, V71, P5904, DOI 10.1158/0008-5472.CAN-10-4173; Mizumoto S, 2013, GLYCOCONJUGATE J, V30, P619, DOI 10.1007/s10719-012-9463-5; Mizumoto S, 2013, BIOMED RES INT, V2013, DOI [10.1155/2013/56319, 10.1155/2013/656319]; Monzavi-Karbassi B, 2007, INT J CANCER, V120, P1179, DOI 10.1002/ijc.22424; Morton JP, 2010, P NATL ACAD SCI USA, V107, P246, DOI 10.1073/pnas.0908428107; Nakai Yousuke, 2012, Gastrointest Endosc Clin N Am, V22, P315, DOI 10.1016/j.giec.2012.04.014; Ohta M, 2005, CANCER RES, V65, P10822, DOI 10.1158/0008-5472.CAN-05-0777; Shirley LA, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/207129; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Sugahara KN, 2008, CANCER RES, V68, P7191, DOI 10.1158/0008-5472.CAN-07-6198; Takakura K, 2014, ANTICANCER RES, V34, P4849; Tan EH, 2014, ONCOGENE, V33, P3325, DOI 10.1038/onc.2013.287; ten Dam GB, 2007, AM J PATHOL, V171, P1324, DOI 10.2353/ajpath.2007.070111; Thoennissen NH, 2009, CANCER RES, V69, P5876, DOI 10.1158/0008-5472.CAN-09-0536; Vallen MJE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111806; Vogt A, 1997, J BIOL CHEM, V272, P27224, DOI 10.1074/jbc.272.43.27224; Wegrowski Y, 2004, CRIT REV ONCOL HEMAT, V49, P259, DOI 10.1016/j.critrevonc.2003.10.005; Whalen DM, 2013, P NATL ACAD SCI USA, V110, P16420, DOI 10.1073/pnas.1310097110; Zou P, 2003, GLYCOBIOLOGY, V13, P35, DOI 10.1093/glycob/cwg001	29	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0142981	10.1371/journal.pone.0142981	http://dx.doi.org/10.1371/journal.pone.0142981			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642349	Green Published, gold, Green Submitted			2022-12-27	WOS:000366902700010
J	McDonald, KP; Ma, LL				McDonald, Kyla P.; Ma, Lili			Dress Nicer = Know More? Young Children's Knowledge Attribution and Selective Learning Based on How Others Dress	PLOS ONE			English	Article							DEVELOPMENTAL-CHANGE; TRUST; INFORMATION; PERCEPTIONS; TESTIMONY; ATTRACTIVENESS; INSTRUCTORS; EXPERTISE; BEHAVIOR; BEAUTY	This research explored whether children judge the knowledge state of others and selectively learn novel information from them based on how they dress. The results indicated that 4-and 6-year-olds identified a formally dressed individual as more knowledgeable about new things in general than a casually dressed one (Study 1). Moreover, children displayed an overall preference to seek help from a formally dressed individual rather than a casually dressed one when learning about novel objects and animals (Study 2). These findings are discussed in relation to the halo effect, and may have important implications for child educators regarding how instructor dress might influence young students' knowledge attribution and learning preferences.	[McDonald, Kyla P.; Ma, Lili] Ryerson Univ, Dept Psychol, Toronto, ON, Canada	Toronto Metropolitan University	Ma, LL (corresponding author), Ryerson Univ, Dept Psychol, Toronto, ON, Canada.	lilima@psych.ryerson.ca		Ma, Lili/0000-0003-4549-0464				AMBADY N, 1993, J PERS SOC PSYCHOL, V64, P431, DOI 10.1037/0022-3514.64.3.431; [Anonymous], 2014, EL SEC ED SURV ESES; [Anonymous], 2011, TOR CMA PROF; Bascandziev I, 2014, BRIT J DEV PSYCHOL, V32, P94, DOI 10.1111/bjdp.12022; Brosseau-Liard PE, 2010, DEVELOPMENTAL SCI, V13, P772, DOI 10.1111/j.1467-7687.2009.00932.x; Bruner J., 1973, GOING INFORM GIVEN; Burton S, 2003, CHILD DEV, V74, P426, DOI 10.1111/1467-8624.7402007; BUTLER S, 1991, PERCEPT MOTOR SKILL, V73, P943, DOI 10.2466/PMS.73.7.943-951; Cain KM, 1997, SOC DEV, V6, P53, DOI 10.1111/j.1467-9507.1997.tb00094.x; Cialdini R.B., 2008, INFLUENCE SCI PRACTI; DiYanni C, 2008, J EXP CHILD PSYCHOL, V101, P241, DOI 10.1016/j.jecp.2008.05.002; EAGLY AH, 1991, PSYCHOL BULL, V110, P109, DOI 10.1037/0033-2909.110.1.109; Fusaro M, 2008, DEVELOPMENTAL SCI, V11, P771, DOI 10.1111/j.1467-7687.2008.00728.x; Gorham J, 1999, COMMUN Q, V47, P281; Gurung RAR, 2011, TEACH PSYCHOL, V34, P5; HANNOVER B, 2004, EUROPEAN REV SOCIAL, V15, P297, DOI DOI 10.1080/10463280440000053; Harris PL, 2006, CHILD DEV, V77, P505, DOI 10.1111/j.1467-8624.2006.00886.x; Heyman GD, 2013, COGNITIVE SCI, V37, P646, DOI 10.1111/cogs.12020; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Jaffer S, 2015, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01524; KAO G, 1995, AM J EDUC, V103, P121, DOI 10.1086/444094; KERR BA, 1976, J COUNS PSYCHOL, V23, P553, DOI 10.1037/0022-0167.23.6.553; Kinzler KD, 2011, DEVELOPMENTAL SCI, V14, P106, DOI 10.1111/j.1467-7687.2010.00965.x; Koenig MA, 2005, CHILD DEV, V76, P1261, DOI 10.1111/j.1467-8624.2005.00849.x; Koenig MA, 2004, PSYCHOL SCI, V15, P694, DOI 10.1111/j.0956-7976.2004.00742.x; Koenig MA, 2011, CHILD DEV, V82, P1634, DOI 10.1111/j.1467-8624.2011.01618.x; Landrum AR, 2013, DEVELOPMENTAL SCI, V16, P622, DOI 10.1111/desc.12059; Lane JD, 2013, CHILD DEV, V84, P1253, DOI 10.1111/cdev.12029; Langlois JH, 2000, PSYCHOL BULL, V126, P390, DOI 10.1037/0033-2909.126.3.390; Liu J, 2013, J EDUC BUS, V88, P94, DOI 10.1080/08832323.2011.652695; Lucas AJ, 2013, DEV PSYCHOL, V49, P579, DOI 10.1037/a0029864; LUKAVSKY J, 1995, PERCEPT MOTOR SKILL, V81, P231, DOI 10.2466/pms.1995.81.1.231; Lutz DJ, 2013, CHILD DEV, V73, P1078; Ma LL, 2013, J COGN DEV, V14, P100, DOI 10.1080/15248372.2011.638687; Ma LL, 2010, DEVELOPMENTAL SCI, V13, P151, DOI 10.1111/j.1467-7687.2009.00878.x; Mascaro O, 2009, COGNITION, V112, P367, DOI 10.1016/j.cognition.2009.05.012; Mascolo MF, 2014, PEDAGOGY HUMAN SCI, V1, P3; Mehrabian A., 1971, SILENT MESSAGES, V8; Mills CM, 2013, DEV PSYCHOL, V49, P404, DOI 10.1037/a0029500; Morris TL, 1996, COMMUN EDUC, V45, P135, DOI 10.1080/03634529609379043; Naumann LP, 2009, PERS SOC PSYCHOL B, V35, P1661, DOI 10.1177/0146167209346309; NISBETT RE, 1977, J PERS SOC PSYCHOL, V35, P250, DOI 10.1037//0022-3514.35.4.250; Olson KR, 2012, CHILD DEV, V83, P1884, DOI 10.1111/j.1467-8624.2012.01819.x; Pasquini ES, 2007, DEV PSYCHOL, V43, P1216, DOI 10.1037/0012-1649.43.5.1216; Piaget J., 1970, SCI ED PSYCHOL CHILD; RAFAELI A, 1993, ACAD MANAGE REV, V18, P32, DOI 10.2307/258822; Reid A, 1997, PERCEPT MOTOR SKILL, V84, P237; Riniolo TC, 2006, J GEN PSYCHOL, V133, P19, DOI 10.3200/GENP.133.1.19-35; Roach D., 1997, COMMUNICATION Q, V45, P125, DOI DOI 10.1080/01463379709370056; Rocca KA, 1999, COMMUN EDUC, V48, P308, DOI 10.1080/03634529909379181; Rollman SA, 1980, ANN M SO SPEECH COMM; Shih M, 1999, PSYCHOL SCI, V10, P80, DOI 10.1111/1467-9280.00111; Shutts K, 2010, DEVELOPMENTAL SCI, V13, P599, DOI 10.1111/j.1467-7687.2009.00913.x; Sperber D, 2010, MIND LANG, V25, P359, DOI 10.1111/j.1468-0017.2010.01394.x; STIPEK D, 1989, CHILD DEV, V60, P521, DOI 10.1111/j.1467-8624.1989.tb02734.x; TAYLOR M, 1994, CHILD DEV, V65, P1581, DOI 10.2307/1131282; TAYLOR M, 1991, CHILD DEV, V62, P1334, DOI 10.1111/j.1467-8624.1991.tb01609.x; Thorndike EL, 1920, J APPL PSYCHOL, V4, P25, DOI 10.1037/h0071663; Timmons S, 2011, SOCIOL HEALTH ILL, V33, P1035, DOI 10.1111/j.1467-9566.2011.01357.x; Todorov A, 2009, SOC COGNITION, V27, P813, DOI 10.1521/soco.2009.27.6.813	60	9	9	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144424	10.1371/journal.pone.0144424	http://dx.doi.org/10.1371/journal.pone.0144424			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY1CH	26636980	Green Published, gold, Green Submitted			2022-12-27	WOS:000366143800091
J	Vleeshouwer-Neumann, T; Phelps, M; Bammler, TK; MacDonald, JW; Jenkins, I; Chen, EY				Vleeshouwer-Neumann, Terra; Phelps, Michael; Bammler, Theo K.; MacDonald, James W.; Jenkins, Isaac; Chen, Eleanor Y.			Histone Deacetylase Inhibitors Antagonize Distinct Pathways to Suppress Tumorigenesis of Embryonal Rhabdomyosarcoma	PLOS ONE			English	Article							CELL-LINES; HDAC INHIBITORS; MOUSE MODEL; IN-VITRO; DIFFERENTIATION; EXPRESSION; ALVEOLAR; RECEPTOR; THERAPY; GROWTH	Embryonal rhabdomyosarcoma (ERMS) is the most common soft tissue cancer in children. The prognosis of patients with relapsed or metastatic disease remains poor. ERMS genomes show few recurrent mutations, suggesting that other molecular mechanisms such as epigenetic regulation might play a major role in driving ERMS tumor biology. In this study, we have demonstrated the diverse roles of histone deacetylases (HDACs) in the pathogenesis of ERMS by characterizing effects of HDAC inhibitors, trichostatin A (TSA) and suberoylanilide hydroxamic acid (SAHA; also known as vorinostat) in vitro and in vivo. TSA and SAHA suppress ERMS tumor growth and progression by inducing myogenic differentiation as well as reducing the self-renewal and migratory capacity of ERMS cells. Differential expression profiling and pathway analysis revealed downregulation of key oncogenic pathways upon HDAC inhibitor treatment. By gain-of-function, loss-of-function, and chromatin immunoprecipitation (ChIP) studies, we show that Notch1- and EphrinB1-mediated pathways are regulated by HDACs to inhibit differentiation and enhance migratory capacity of ERMS cells, respectively. Our study demonstrates that aberrant HDAC activity plays a major role in ERMS pathogenesis. Druggable targets in the molecular pathways affected by HDAC inhibitors represent novel therapeutic options for ERMS patients.	[Vleeshouwer-Neumann, Terra; Phelps, Michael; Chen, Eleanor Y.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Bammler, Theo K.; MacDonald, James W.] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; [Jenkins, Isaac] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Chen, EY (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	eleanor2@uw.edu	Phelps, Michael/O-6686-2018	Phelps, Michael/0000-0001-8246-0710; Jenkins, Isaac/0000-0002-3774-3823	NIH [K08 AR063165-03]; St. Baldrick's Scholar Award; Sarcoma Foundation of America; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR063165] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); St. Baldrick's Scholar Award; Sarcoma Foundation of America; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	EYC is supported by NIH K08 AR063165-03 and St. Baldrick's Scholar Award. MP and TVN are supported by Sarcoma Foundation of America.	Abraham J, 2014, GENE DEV, V28, P1578, DOI 10.1101/gad.238733.114; Aslam MI, 2014, P NATL ACAD SCI USA, V111, P6383, DOI 10.1073/pnas.1403608111; Azzi S, 2011, J NATL CANCER I, V103, P1884, DOI 10.1093/jnci/djr451; Belyea BC, 2011, CLIN CANCER RES, V17, P7324, DOI 10.1158/1078-0432.CCR-11-1004; Berardi AC, 2008, ANTICANCER RES, V28, P763; Blattmann C, 2010, INT J RADIAT ONCOL, V78, P237, DOI 10.1016/j.ijrobp.2010.03.010; Boyd AW, 2014, NAT REV DRUG DISCOV, V13, P39, DOI 10.1038/nrd4175; Bridge JA, 2002, GENE CHROMOSOME CANC, V33, P310, DOI 10.1002/gcc.10026; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Charytonowicz E, 2012, J CLIN INVEST, V122, P886, DOI 10.1172/JCI60015; Chen EY, 2014, P NATL ACAD SCI USA, V111, P5349, DOI 10.1073/pnas.1317731111; Chen EY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003727; Chen X, 2013, CANCER CELL, V24, P710, DOI 10.1016/j.ccr.2013.11.002; Chen YY, 2006, GENE CHROMOSOME CANC, V45, P583, DOI 10.1002/gcc.20322; Chiappalupi S, 2014, CARCINOGENESIS, V35, P2382, DOI 10.1093/carcin/bgu176; Chien AJ, 2009, P NATL ACAD SCI USA, V106, P1193, DOI 10.1073/pnas.0811902106; Clifford N, 2008, J CELL BIOCHEM, V105, P1250, DOI 10.1002/jcb.21926; Davicioni E, 2009, AM J PATHOL, V174, P550, DOI 10.2353/ajpath.2009.080631; Davy A, 2004, GENE DEV, V18, P572, DOI 10.1101/gad.1171704; De Salvo M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096238; Demetri GD, 1999, P NATL ACAD SCI USA, V96, P3951, DOI 10.1073/pnas.96.7.3951; Egea J, 2007, TRENDS CELL BIOL, V17, P230, DOI 10.1016/j.tcb.2007.03.004; Gao Q, 2014, HUM PATHOL, V45, P372, DOI 10.1016/j.humpath.2013.10.001; Gerber AN, 2007, ONCOGENE, V26, P1122, DOI 10.1038/sj.onc.1209891; Goldstein M, 2006, NEOPLASIA, V8, P332, DOI 10.1593/neo.05829; Gorlin RJ, 2004, GENET MED, V6, P530, DOI 10.1097/01.GIM.0000144188.15902.C4; Hatley ME, 2012, CANCER CELL, V22, P536, DOI 10.1016/j.ccr.2012.09.004; Haydon RC, 2002, CLIN CANCER RES, V8, P1288; Hedrick E, 2015, MOL CANCER THER, V14, P2143, DOI 10.1158/1535-7163.MCT-15-0148; Ignatius MS, 2012, CANCER CELL, V21, P680, DOI 10.1016/j.ccr.2012.03.043; Jain S, 2011, J BLOOD MED, V2, P37, DOI 10.2147/JBM.S9649; Kandouz M, 2012, CANCER METAST REV, V31, P353, DOI 10.1007/s10555-012-9352-1; Khan O, 2012, IMMUNOL CELL BIOL, V90, P85, DOI 10.1038/icb.2011.100; Kutko MC, 2003, CLIN CANCER RES, V9, P5749; Langenau DM, 2007, GENE DEV, V21, P1382, DOI 10.1101/gad.1545007; Lopez-Atalaya JP, 2013, NUCLEIC ACIDS RES, V41, P8072, DOI 10.1093/nar/gkt590; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; Missiaglia E, 2009, GENE CHROMOSOME CANC, V48, P455, DOI 10.1002/gcc.20655; Mizgireuv IV, 2006, CANCER RES, V66, P3120, DOI 10.1158/0008-5472.CAN-05-3800; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Paulson V, 2011, GENE CHROMOSOME CANC, V50, P397, DOI 10.1002/gcc.20864; Petty A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042120; Raimondi L, 2012, CELL DEATH DIFFER, V19, P871, DOI 10.1038/cdd.2011.171; Rephaeli A, 2005, INT J CANCER, V116, P226, DOI 10.1002/ijc.21030; Ritchie ME, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-261; Satheesha S, 2016, ONCOGENE, V35, P2020, DOI 10.1038/onc.2015.267; Shern JF, 2014, CANCER DISCOV, V4, P216, DOI 10.1158/2159-8290.CD-13-0639; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; STONE RM, 1988, BLOOD, V71, P690; TAPSCOTT SJ, 1993, SCIENCE, V259, P1450, DOI 10.1126/science.8383879; Uhmann Anja, 2012, Sarcoma, V2012, P357040, DOI 10.1155/2012/357040; Walter D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019506; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; West AC, 2014, J CLIN INVEST, V124, P30, DOI 10.1172/JCI69738; Williamson D, 2010, J CLIN ONCOL, V28, P2151, DOI 10.1200/JCO.2009.26.3814; Yang ZH, 2009, GENE DEV, V23, P694, DOI 10.1101/gad.1765109	57	31	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144320	10.1371/journal.pone.0144320	http://dx.doi.org/10.1371/journal.pone.0144320			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636678	Green Submitted, Green Published, gold			2022-12-27	WOS:000366143800075
J	Gontikaki, E; Thornton, B; Cornulier, T; Witte, U				Gontikaki, Evangelia; Thornton, Barry; Cornulier, Thomas; Witte, Ursula			Occurrence of Priming in the Degradation of Lignocellulose in Marine Sediments	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; RATIO MASS-SPECTROMETRY; MICROBIAL COMMUNITIES; COASTAL OCEAN; CARBON; TERRESTRIAL; BACTERIA; FUNGI; FATE; BIODEGRADATION	More than 50% of terrestrially-derived organic carbon (terrOC) flux from the continents to the ocean is remineralised in the coastal zone despite its perceived high refractivity. The efficient degradation of terrOC in the marine environment could be fuelled by labile marine-derived material, a phenomenon known as "priming effect", but experimental data to confirm this mechanism are lacking. We tested this hypothesis by treating coastal sediments with C-13-lignocellulose, as a proxy for terrOC, with and without addition of unlabelled diatom detritus that served as the priming inducer. The occurrence of priming was assessed by the difference in lignocellulose mineralisation between diatom-amended treatments and controls in aerobic sediment slurries. Priming of lignocellulose degradation was observed only at the initial stages of the experiment (day 7) and coincided with overall high microbial activity as exemplified by total CO2 production. Lignocellulose mineralisation did not differ consistently between diatom treatments and control for the remaining experimental time (days 14-28). Based on this pattern, we hypothesize that the faster initiation of lignocellulose mineralisation in diatom-amended treatments is attributed to the decomposition of accessible polysaccharide components within the lignocellulose complex by activated diatom degraders. The fact that diatom-degraders contributed to lignocellulose degradation was also supported by the different patterns in C-13-enrichment of phospholipid fatty acids between treatments. Although we did not observe differences between treatments in the total quantity of respired lignocellulose at the end of the experiment, differences in timing could be important in natural ecosystems where the amount of time that a certain compound is subject to aerobic degradation before burial to deeper anoxic sediments may be limited.	[Gontikaki, Evangelia; Witte, Ursula] Univ Aberdeen, Inst Biol & Environm Sci, Oceanlab, Newburgh, Scotland; [Thornton, Barry] James Hutton Inst, Aberdeen, Scotland; [Cornulier, Thomas] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland	University of Aberdeen; James Hutton Institute; University of Aberdeen	Gontikaki, E (corresponding author), Univ Aberdeen, Inst Biol & Environm Sci, Oceanlab, Newburgh, Scotland.	e.gontikaki@abdn.ac.uk	Cornulier, Thomas/G-6841-2014; Cornulier, Thomas/AAC-9753-2022; Gontikaki, Evina/C-5559-2017	Cornulier, Thomas/0000-0003-2738-4801; Gontikaki, Evina/0000-0003-1838-210X	MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland) [HR09011]; Scottish Government's Rural and Environment Science and Analytical Services (RESAS) Division	MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland); Scottish Government's Rural and Environment Science and Analytical Services (RESAS) Division	E.G. was funded by the MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland, grant reference HR09011). B.T. received funding from the Scottish Government's Rural and Environment Science and Analytical Services (RESAS) Division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Niels Jobstvogt and Bruce Clark for their assistance in sampling. E.G. was funded by the MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland, grant reference HR09011). B.T. received funding from the Scottish Government's Rural and Environment Science and Analytical Services (RESAS) Division.	[Anonymous], 2007, BIOGEOCHEMISTRY ESTU; [Anonymous], 2014, R LANG ENV STAT COMP; Arnosti C, 2011, ANNU REV MAR SCI, V3, P401, DOI 10.1146/annurev-marine-120709-142731; BAIRD D, 1981, ESTUAR COAST SHELF S, V13, P455, DOI 10.1016/S0302-3524(81)80041-2; Bauer JE, 2013, NATURE, V504, P61, DOI 10.1038/nature12857; Bengtsson MM, 2014, SCI REP-UK, V4, DOI 10.1038/srep05187; BENNER R, 1984, APPL ENVIRON MICROB, V47, P998, DOI 10.1128/AEM.47.5.998-1004.1984; BENNER R, 1986, MICROBIAL ECOL, V12, P291, DOI 10.1007/BF02011172; Berlemont R, 2013, APPL ENVIRON MICROB, V79, P1545, DOI 10.1128/AEM.03305-12; Bianchi TS, 2011, P NATL ACAD SCI USA, V108, P19473, DOI 10.1073/pnas.1017982108; Blair NE, 2012, ANNU REV MAR SCI, V4, P401, DOI 10.1146/annurev-marine-120709-142717; Bugg TDH, 2011, CURR OPIN BIOTECH, V22, P394, DOI 10.1016/j.copbio.2010.10.009; Burdige DJ, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002368; Cai WJ, 2011, ANNU REV MAR SCI, V3, P123, DOI 10.1146/annurev-marine-120709-142723; CANFIELD DE, 1994, CHEM GEOL, V114, P315, DOI 10.1016/0009-2541(94)90061-2; Craine JM, 2007, ECOLOGY, V88, P2105, DOI 10.1890/06-1847.1; Danger M, 2013, ECOLOGY, V94, P1604, DOI 10.1890/12-0606.1; Darjany LE, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00263; de Boer W, 2005, FEMS MICROBIOL REV, V29, P795, DOI 10.1016/j.femsre.2004.11.005; Edwards JL, 2010, GENES-BASEL, V1, P371, DOI 10.3390/genes1030371; FINDLAY RH, 1990, MAR ECOL PROG SER, V62, P121, DOI 10.3354/meps062121; Fontaine S, 2003, SOIL BIOL BIOCHEM, V35, P837, DOI 10.1016/S0038-0717(03)00123-8; Gihring TM, 2009, LIMNOL OCEANOGR, V54, P1073, DOI 10.4319/lo.2009.54.4.1073; Gontikaki E, 2011, MAR ECOL PROG SER, V421, P39, DOI 10.3354/meps08892; Gontikaki E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067722; Gonzalez JM, 2000, INT J SYST EVOL MICR, V50, P831, DOI 10.1099/00207713-50-2-831; Green CT, 2000, HYDROGEOL J, V8, P126, DOI 10.1007/s100400050013; Guenet B, 2010, ECOLOGY, V91, P2850, DOI 10.1890/09-1968.1; Hedges JI, 1997, ORG GEOCHEM, V27, P195, DOI 10.1016/S0146-6380(97)00066-1; Jiao N, 2010, NAT REV MICROBIOL, V8, P593, DOI 10.1038/nrmicro2386; Joos O, 2008, RAPID COMMUN MASS SP, V22, P4029, DOI 10.1002/rcm.3827; Kim YS, 2000, IAWA J, V21, P135, DOI 10.1163/22941932-90000241; Koch BP, 2014, BIOGEOSCIENCES, V11, P4173, DOI 10.5194/bg-11-4173-2014; Kumar P, 2009, IND ENG CHEM RES, V48, P3713, DOI 10.1021/ie801542g; Li J., 2009, FRONT BIOL CHINA, V4, P29, DOI DOI 10.1007/S11515-008-0097-8; Loh PS, 2008, ESTUAR COAST SHELF S, V76, P566, DOI 10.1016/j.ecss.2007.07.023; Luna GM, 2002, APPL ENVIRON MICROB, V68, P3509, DOI 10.1128/AEM.68.7.3509-3513.2002; Malherbe S., 2002, Re/Views in Environmental Science and Bio/Technology, V1, P105, DOI 10.1023/A:1020858910646; Mayor DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038582; Middelburg JJ, 2000, LIMNOL OCEANOGR, V45, P1224, DOI 10.4319/lo.2000.45.6.1224; Mincer TJ, 2002, APPL ENVIRON MICROB, V68, P5005, DOI 10.1128/AEM.68.10.5005-5011.2002; Moodley L, 2005, J MAR RES, V63, P457, DOI 10.1357/0022240053693662; Mook WG, 2001, IHP 5 TECHNICAL DOCU, VVI; Ogawa H, 2001, SCIENCE, V292, P917, DOI 10.1126/science.1057627; Perez J., 2002, International Microbiology, V5, P53, DOI 10.1007/s10123-002-0062-3; Raghukumar S, 2004, MARINE MICROBIOLOGY, P92; Richards TA, 2012, ANNU REV MAR SCI, V4, P495, DOI 10.1146/annurev-marine-120710-100802; Romani AM, 2006, ECOLOGY, V87, P2559, DOI 10.1890/0012-9658(2006)87[2559:IOBAFO]2.0.CO;2; Sanchez G., 2012, PLSDEPOT PARTIAL LEA; Santhi Velayudhan Satheeja, 2014, Biotechnol Rep (Amst), V1-2, P8, DOI 10.1016/j.btre.2014.05.002; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; Schneckenberger K, 2008, SOIL BIOL BIOCHEM, V40, P1981, DOI 10.1016/j.soilbio.2008.02.020; Sridhar KR, 2012, MAR FRESHW BOTANY, P475; Theuerl S, 2010, BIOL FERT SOILS, V46, P215, DOI 10.1007/s00374-010-0440-5; Thornton B, 2011, RAPID COMMUN MASS SP, V25, P2433, DOI 10.1002/rcm.5148; Turnewitsch R, 2007, J SEA RES, V57, P270, DOI 10.1016/j.seares.2006.08.001; van Nugteren P, 2009, MAR BIOL, V156, P2277, DOI 10.1007/s00227-009-1255-5; Wagner K, 2014, APPL ENVIRON MICROB, V80, P6004, DOI 10.1128/AEM.01128-14; Weiner RM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000087; WHITE DC, 1979, OECOLOGIA, V40, P51, DOI 10.1007/BF00388810	60	23	23	4	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143917	10.1371/journal.pone.0143917	http://dx.doi.org/10.1371/journal.pone.0143917			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633175	Green Submitted, gold, Green Published			2022-12-27	WOS:000366040000030
J	Palacios-Gimenez, OM; Carvalho, CR; Soares, FAF; Cabral-de-Mello, DC				Palacios-Gimenez, Octavio M.; Roberto Carvalho, Carlos; Ferrari Soares, Fernanda Aparecida; Cabral-de-Mello, Diogo C.			Contrasting the Chromosomal Organization of Repetitive DNAs in Two Gryllidae Crickets with Highly Divergent Karyotypes	PLOS ONE			English	Article							NEO-SEX CHROMOSOMES; 5S RIBOSOMAL DNA; HISTONE H3 GENES; EVOLUTIONARY DYNAMICS; MICROSATELLITE DISTRIBUTION; ORTHOPTERA TETTIGONIIDAE; ENEOPTERA-SURINAMENSIS; BISEXUAL RELATIVES; SATELLITE DNA; Y-CHROMOSOME	A large percentage of eukaryotic genomes consist of repetitive DNA that plays an important role in the organization, size and evolution. In the case of crickets, chromosomal variability has been found using classical cytogenetics, but almost no information concerning the organization of their repetitive DNAs is available. To better understand the chromosomal organization and diversification of repetitive DNAs in crickets, we studied the chromosomes of two Gryllidae species with highly divergent karyotypes, i.e., 2n(male) = 29, X0 (Gryllus assimilis) and 2n = 9, neo-X1X2Y (Eneoptera surinamensis). The analyses were performed using classical cytogenetic techniques, repetitive DNA mapping and genome-size estimation. Conserved characteristics were observed, such as the occurrence of a small number of clusters of rDNAs and U snDNAs, in contrast to the multiple clusters/dispersal of the H3 histone genes. The positions of U2 snDNA and 18S rDNA are also conserved, being intermingled within the largest autosome. The distribution and base-pair composition of the heterochromatin and repetitive DNA pools of these organisms differed, suggesting reorganization. Although the microsatellite arrays had a similar distribution pattern, being dispersed along entire chromosomes, as has been observed in some grasshopper species, a band-like pattern was also observed in the E. surinamensis chromosomes, putatively due to their amplification and clustering. In addition to these differences, the genome of E. surinamensis is approximately 2.5 times larger than that of G. assimilis, which we hypothesize is due to the amplification of repetitive DNAs. Finally, we discuss the possible involvement of repetitive DNAs in the differentiation of the neo-sex chromosomes of E. surinamensis, as has been reported in other eukaryotic groups. This study provided an opportunity to explore the evolutionary dynamics of repetitive DNAs in two non-model species and will contribute to the understanding of chromosomal evolution in a group about which little chromosomal and genomic information is known.	[Palacios-Gimenez, Octavio M.; Cabral-de-Mello, Diogo C.] UNESP Univ Estadual Paulista, Inst Biociencias IB, Dept Biol, Rio Claro, SP, Brazil; [Roberto Carvalho, Carlos; Ferrari Soares, Fernanda Aparecida] UFV Univ Fed Vicosa, Ctr Ciencias Biol, Dept Biol Geral, Vicosa, MG, Brazil	Universidade Estadual Paulista	Cabral-de-Mello, DC (corresponding author), UNESP Univ Estadual Paulista, Inst Biociencias IB, Dept Biol, Rio Claro, SP, Brazil.	mellodc@rc.unesp.br	Cabral-de-Mello, Diogo C/F-5328-2010; Cabral-de-Mello, Diogo Cavalcanti/E-7656-2012	Cabral-de-Mello, Diogo Cavalcanti/0000-0002-4721-2655	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2014/11763-8, 2014/02038-8]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq (CNPQ) [304758/2014-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq (CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF))	This study was funded by a scholarship obtained from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, process numbers 2014/11763-8, 2014/02038-8) and a research productivity fellowship from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq (CNPQ, process number 304758/2014-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjos A, 2015, HEREDITY, V114, P207, DOI 10.1038/hdy.2014.87; Baumgartner WJ, 1904, BIOL BULL-US, V8, P1, DOI 10.2307/1535776; Bergero R, 2015, CURR BIOL, V25, P1234, DOI 10.1016/j.cub.2015.03.015; Biemont C, 2006, NATURE, V443, P521, DOI 10.1038/443521a; Bran EJ, 1964, 2 C LAT AM ZOOL S PA, VI, P9; Bueno D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066532; Cabral-de-Mello DC, 2012, CHROMOSOME RES, V20, P279, DOI 10.1007/s10577-011-9271-y; Cabral-de-Mello DC, 2010, HEREDITY, V104, P393, DOI 10.1038/hdy.2009.126; Cabral-de-Mello DC, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-88; Cabral-de-Mello DC, 2011, GENETICA, V139, P921, DOI 10.1007/s10709-011-9596-7; Cabrero J, 2008, CHROMOSOME RES, V16, P595, DOI 10.1007/s10577-008-1214-x; Cabrero J, 2009, CHROMOSOME RES, V17, P397, DOI 10.1007/s10577-009-9030-5; Camacho JPM, 2015, CHROMOSOMA, V124, P263, DOI 10.1007/s00412-014-0499-0; Camacho J. P. M., 2015, PROTOCOLS CYTOGENETI, P381; CHARLESWORTH B, 1994, NATURE, V371, P215, DOI 10.1038/371215a0; Charlesworth B, 1996, CURR BIOL, V6, P149, DOI 10.1016/S0960-9822(02)00448-7; Clark AG, 2014, NATURE, V508, P463, DOI 10.1038/508463a; Cohen S, 2010, MOBILE DNA-UK, V1, DOI 10.1186/1759-8753-1-11; Colgan DJ, 1998, AUST J ZOOL, V46, P419, DOI 10.1071/ZO98048; de Barros AV, 2011, AQUACULTURE, V322, P47, DOI 10.1016/j.aquaculture.2011.10.002; DRETS ME, 1974, CHROMOSOMA, V48, P367, DOI 10.1007/BF00290994; Eades DC, 2015, ORTHOPTERA SPECIES F; Eickbush TH, 2007, GENETICS, V175, P477, DOI 10.1534/genetics.107.071399; Ferreira Amilton, 2006, Chromosome Science, V9, P47; Ferreira A, 2010, NEOTROP ENTOMOL, V39, P590, DOI 10.1590/S1519-566X2010000400019; Gregory T. R., 2011, EVOLUTION GENOME; Gregory TR, 2015, ANIMAL GENOME SIZE D; Grimaldi David, 2005, pi; Grzywacz B, 2014, J ZOOL SYST EVOL RES, V52, P109, DOI 10.1111/jzs.12046; HANDA SM, 1985, CYTOLOGIA, V50, P711, DOI 10.1508/cytologia.50.711; Hanrahan SJ, 2011, CHROMOSOME RES, V19, P809, DOI 10.1007/s10577-011-9231-6; HEWITT GM, 1979, GRASSHOPPERS CRICKET, V3; IJDO JW, 1991, NUCLEIC ACIDS RES, V19, P4780, DOI 10.1093/nar/19.17.4780; JOHN B, 1985, GENETICA, V66, P183, DOI 10.1007/BF00128039; Kejnovsky E, 2009, HEREDITY, V102, P533, DOI 10.1038/hdy.2009.17; Kejnovsky E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0045519; Kidwell MG, 1997, P NATL ACAD SCI USA, V94, P7704, DOI 10.1073/pnas.94.15.7704; Kubat Z, 2008, GENOME, V51, P350, DOI 10.1139/G08-024; LAMBOROT M, 1985, CAN J ZOOL, V63, P2626, DOI 10.1139/z85-392; Lepesant JMJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r14; Lopes DM, 2009, APIDOLOGIE, V40, P517, DOI 10.1051/apido/2009030; Lopez-Flores I, 2012, GENOME DYNAM, V7, P1, DOI 10.1159/000337118; Loureiro J, 2006, ANN BOT-LONDON, V98, P679, DOI 10.1093/aob/mcl141; Loureiro J, 2006, ANN BOT-LONDON, V98, P515, DOI 10.1093/aob/mcl140; Lynch M, 2007, ORIGINS GENOME ARCHI; Manchado M, 2006, GENOME, V49, P79, DOI 10.1139/G05-068; Matsubara K, 2016, CHROMOSOMA, V125, P111, DOI 10.1007/s00412-015-0531-z; Matsubara K, 2013, MOL CYTOGENET, V6, DOI 10.1186/1755-8166-6-60; Matsunaga S, 2009, HEREDITY, V102, P525, DOI 10.1038/hdy.2009.36; MESA A, 1982, ANN SOC ENTOMOL FR, V18, P507; Milani D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097956; Navajas-Perez R, 2005, J MOL EVOL, V60, P391, DOI 10.1007/s00239-004-0199-0; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Nguyen P, 2010, GENETICA, V138, P343, DOI 10.1007/s10709-009-9424-5; ORGEL LE, 1980, NATURE, V284, P604, DOI 10.1038/284604a0; Otto F, 1990, Methods Cell Biol, V33, P105; Palacios-Gimenez OM, 2015, CHROMOSOMA, V124, P353, DOI 10.1007/s00412-015-0505-1; Palacios-Gimenez OM, 2015, MOL GENET GENOMICS, V290, P623, DOI 10.1007/s00438-014-0947-9; Palacios-Gimenez OM, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-167; Panzera Y, 2012, CYTOGENET GENOME RES, V138, P56, DOI 10.1159/000341888; Pelliccia F, 2001, GENOME, V44, P331, DOI 10.1139/gen-44-3-331; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; Pokorna M, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-90; RASCH EM, 1981, J HISTOCHEM CYTOCHEM, V29, P885; Richard GF, 2008, MICROBIOL MOL BIOL R, V72, P686, DOI 10.1128/MMBR.00011-08; Rodrigo Castillo Elio, 2010, Journal of Orthoptera Research, V19, P213, DOI 10.1665/034.019.0207; Ruiz-Ruano FJ, 2015, CHROMOSOMA, V124, P221, DOI 10.1007/s00412-014-0492-7; SAEZ FA, 1957, AM NAT, V91, P259, DOI 10.1086/281984; Sambrook J., 2001, MOL CLONING LAB MANU; SANTOS JL, 1983, GENETICA, V61, P65, DOI 10.1007/BF00563233; Sapienza C, NATURE, V190, p[601, 284]; SCHWEIZER D, 1983, CHROMOSOMA, V88, P227, DOI 10.1007/BF00285625; Shapiro HM, 2003, PRACTICAL FLOW CYTOM; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Song HJ, 2015, CLADISTICS, V31, P621, DOI 10.1111/cla.12116; Steflova P, 2013, GENOME BIOL EVOL, V5, P769, DOI 10.1093/gbe/evt049; Steinemann M, 1997, GENETICS, V145, P261; Steinemann S, 2005, CYTOGENET GENOME RES, V110, P134, DOI 10.1159/000084945; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; Toups M, 2015, CURR BIOL, V25, pR427, DOI 10.1016/j.cub.2015.03.054; Ubeda-Manzanaro M, 2010, GENETICA, V138, P787, DOI 10.1007/s10709-010-9460-1; Utsunomia R, 2014, CYTOGENET GENOME RES, V142, P286, DOI 10.1159/000362258; Vierna J, 2011, HEREDITY, V107, P127, DOI 10.1038/hdy.2010.174; Wang XH, 2014, NAT COMMUN, V5, P1, DOI 10.1038/ncomms3957; Warchalowska-Sliwa E, 1998, FOLIA BIOL-KRAKOW, V46, P143; WEBB GC, 1978, CHROMOSOMA, V67, P309, DOI 10.1007/BF00285964; WESTERMAN M, 1987, HEREDITY, V58, P221, DOI 10.1038/hdy.1987.36; WHITE M J D, 1973, P961; Yoshimura A, 2006, CYTOGENET GENOME RES, V112, P329, DOI 10.1159/000089889; Yoshimura A, 2005, ENTOMOL SCI, V8, P219, DOI 10.1111/j.1479-8298.2005.00118.x; Zefa E, 1999, GENET MOL BIOL, V22, P333, DOI 10.1590/S1415-47571999000300008; Zefa E, 2014, ZOOTAXA, V3860, P396, DOI 10.11646/zootaxa.3860.4.7; Zwick MS, 1997, GENOME, V40, P138, DOI 10.1139/g97-020	93	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143540	10.1371/journal.pone.0143540	http://dx.doi.org/10.1371/journal.pone.0143540			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630487	Green Published, gold, Green Submitted			2022-12-27	WOS:000365926300059
J	Kvistad, L; Ingwersen, D; Pavlova, A; Bull, JK; Sunnucks, P				Kvistad, Lynna; Ingwersen, Dean; Pavlova, Alexandra; Bull, James K.; Sunnucks, Paul			Very Low Population Structure in a Highly Mobile and Wide-Ranging Endangered Bird Species	PLOS ONE			English	Article							HONEYEATER XANTHOMYZA-PHRYGIA; MICROSATELLITE NULL ALLELES; REGENT-HONEYEATER; COMPUTER-PROGRAM; CLIMATE-CHANGE; FRAGMENTED LANDSCAPES; HABITAT FRAGMENTATION; ANTHOCHAERA-PHRYGIA; TELL US; CONSERVATION	The loss of biodiversity following fragmentation and degradation of habitat is a major issue in conservation biology. As competition for resources increases following habitat loss and fragmentation, severe population declines may occur even in common, highly mobile species; such demographic decline may cause changes within the population structure of the species. The regent honeyeater, Anthochaera phrygia, is a highly nomadic woodland bird once common in its native southeast Australia. It has experienced a sharp decline in abundance since the late 1970s, following clearing of large areas of its preferred habitat, boxironbark woodland, within the last 200 years. A captive breeding program has been established as part of efforts to restore this species. This study used genetic data to examine the range-wide population structure of regent honeyeaters, including spatial structure, its change through time, sex differences in philopatry and mobility, and genetic differences between the captive and wild populations. There was low genetic differentiation between birds captured in different geographic areas. Despite the recent demographic decline, low spatial structure appears to have some temporal consistency. Both sexes appear to be highly mobile, and there does not seem to be significant genetic differentiation between the captive and wild populations. We conclude that management efforts for survival of this species, including habitat protection, restoration, and release of captive-bred birds into the wild, can treat the species as effectively a single genetic population.	[Kvistad, Lynna; Pavlova, Alexandra; Bull, James K.; Sunnucks, Paul] Monash Univ, Sch Biol Sci, Melbourne, Vic, Australia; [Ingwersen, Dean] BirdLife Australia, Melbourne, Vic, Australia	Monash University	Kvistad, L (corresponding author), Monash Univ, Sch Biol Sci, Melbourne, Vic, Australia.	lynna.kvistad@monash.edu	Pavlova, Alexandra/H-4749-2014	Pavlova, Alexandra/0000-0001-9455-4124; Bull, James/0000-0002-0274-4359; Sunnucks, Paul/0000-0002-8139-7059	BirdLife Australia's Woodland Birds program; Australian Research Council Linkage Grant [LP0776322]; Victorian Department of Environment and Primary Industries; Museum of Victoria; Parks Victoria; North Central Catchment Management Authority; Goulburn Broken Catchment Management Authority	BirdLife Australia's Woodland Birds program; Australian Research Council Linkage Grant(Australian Research Council); Victorian Department of Environment and Primary Industries; Museum of Victoria; Parks Victoria; North Central Catchment Management Authority; Goulburn Broken Catchment Management Authority	Funding was provided by BirdLife Australia's (http://birdlife.org.au) Woodland Birds program and the Australian Research Council (http://www.arc.gov.au) Linkage Grant (LP0776322), with contributing partner organizations Victorian Department of Environment and Primary Industries (http://www.dse.vic.gov.au), Museum of Victoria (http://museumvictoria.com.au), Parks Victoria (http://parkweb.vic.gov.au), North Central Catchment Management Authority (http://www.nccma.vic.gov.au), and Goulburn Broken Catchment Management Authority (http://www.gbcma.vic.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos JN, 2014, ECOLOGY, V95, P1556, DOI 10.1890/13-1328.1; Balloux F, 2001, J HERED, V92, P301, DOI 10.1093/jhered/92.3.301; Banks SC, 2012, MOL ECOL, V21, P2092, DOI 10.1111/j.1365-294X.2012.05485.x; Barr KR, 2008, MOL ECOL, V17, P3628, DOI 10.1111/j.1365-294X.2008.03868.x; Brookfield JFY, 1996, MOL ECOL, V5, P453, DOI 10.1046/j.1365-294X.1996.00098.x; Carlsson J, 2008, J HERED, V99, P616, DOI 10.1093/jhered/esn048; CAUGHLEY G, 1994, J ANIM ECOL, V63, P215, DOI 10.2307/5542; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Cooke B, 2000, AUST J ZOOL, V48, P379, DOI 10.1071/ZO00005; Cooper CB, 2002, CONSERV BIOL, V16, P471, DOI 10.1046/j.1523-1739.2002.00346.x; Cornuet JM, 1996, GENETICS, V144, P2001; Coulon A, 2010, CONSERV BIOL, V24, P1080, DOI 10.1111/j.1523-1739.2009.01438.x; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; Dale S, 2001, OIKOS, V92, P344, DOI 10.1034/j.1600-0706.2001.920217.x; DINERSTEIN E, 1990, CONSERV BIOL, V4, P417, DOI 10.1111/j.1523-1739.1990.tb00316.x; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Durand E, 2009, MOL BIOL EVOL, V26, P1963, DOI 10.1093/molbev/msp106; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; FitzSimmons NN, 1997, P NATL ACAD SCI USA, V94, P8912, DOI 10.1073/pnas.94.16.8912; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; FORD H, 1993, EMU, V93, P277, DOI 10.1071/MU9930277; Ford HA, 2001, BIOL CONSERV, V97, P71, DOI 10.1016/S0006-3207(00)00101-4; Ford Hugh A., 2011, Pacific Conservation Biology, V17, P303; Ford HA, 2011, EMU, V111, P1, DOI 10.1071/MU09115; Ford HA, 2009, BIOL CONSERV, V142, P3182, DOI 10.1016/j.biocon.2009.08.022; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; FRANKHAM R, 1995, GENET RES, V66, P95, DOI 10.1017/S0016672300034455; Frankham R, 2015, MOL ECOL, V24, P2610, DOI 10.1111/mec.13139; Frankham R, 2014, BIOL CONSERV, V170, P56, DOI 10.1016/j.biocon.2013.12.036; FRANKLIN DC, 1989, EMU, V89, P140, DOI 10.1071/MU9890140; Garnett S. T., 2011, ACTION PLAN AUSTR BI; Geering D, 1998, EMU, V98, P104, DOI 10.1071/MU98011; Geering D, 2008, REGENTS ROAM NEWSLET; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Hansson B, 2004, EVOLUTION, V58, P2546, DOI 10.1111/j.0014-3820.2004.tb00883.x; Harrisson KA, 2014, EVOL APPL, V7, P1008, DOI 10.1111/eva.12149; Harrisson KA, 2014, J ANIM ECOL, V83, P616, DOI 10.1111/1365-2656.12172; Harrisson KA, 2013, J ANIM ECOL, V82, P322, DOI 10.1111/1365-2656.12007; Harrisson KA, 2012, LANDSCAPE ECOL, V27, P813, DOI 10.1007/s10980-012-9743-2; Higgins P. J., 2001, HDB AUSTR NZ ANTARCT, V5; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Hull JM, 2005, MOL ECOL, V14, P159, DOI 10.1111/j.1365-294X.2004.02366.x; Ingwersen Dean, 2014, Australian Birdlife, V3, P20; JORDE PE, 1995, GENETICS, V139, P1077; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Landguth EL, 2010, MOL ECOL, V19, P4179, DOI 10.1111/j.1365-294X.2010.04808.x; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; Mac Nally R, 2009, DIVERS DISTRIB, V15, P720, DOI 10.1111/j.1472-4642.2009.00578.x; NEI M, 1981, GENETICS, V98, P625; Oliver D. L., 2010, Pacific Conservation Biology, V16, P27; Oliver DL, 1998, AUST J ZOOL, V46, P153, DOI 10.1071/ZO97028; Oliver DL, 1998, WILDLIFE RES, V25, P409, DOI 10.1071/WR97078; Oliver DL, 2000, EMU, V100, P12, DOI 10.1071/MU9837; Oliver DL, 1998, EMU, V98, P97, DOI 10.1071/MU98010; Oliver DL, 2001, AUSTR J ZOOLOGY, V49, P659; Oliver DL, 2001, PACIFIC CONSERVATION, V5, P224; Palstra FP, 2008, MOL ECOL, V17, P3428, DOI 10.1111/j.1365-294X.2008.03842.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; Radford JQ, 2005, BIOL CONSERV, V124, P317, DOI 10.1016/j.biocon.2005.01.039; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Roderick M, 2013, SWIFT PARROTS REGENT; Roderick Michael, 2014, Australian Field Ornithology, V31, P113; de Cara MAR, 2013, MOL ECOL, V22, P6091, DOI 10.1111/mec.12560; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Seabloom EW, 2002, P NATL ACAD SCI USA, V99, P11229, DOI 10.1073/pnas.162064899; Smouse PE, 2008, MOL ECOL, V17, P3389, DOI 10.1111/j.1365-294X.2008.03839.x; Sonsthagen S, 2015, CONSERV GENET, V16, P223, DOI 10.1007/s10592-014-0654-4; Spielman D, 2004, P NATL ACAD SCI USA, V101, P15261, DOI 10.1073/pnas.0403809101; Sunnucks P, 2011, EMU, V111, P19, DOI 10.1071/MU10008; Tallmon DA, 2008, MOL ECOL RESOUR, V8, P299, DOI 10.1111/j.1471-8286.2007.01997.x; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WALKER J, 1993, J APPL ECOL, V30, P265, DOI 10.2307/2404628; Waples RS, 2007, GENETICS, V175, P219, DOI 10.1534/genetics.106.065300	80	16	16	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0143746	10.1371/journal.pone.0143746	http://dx.doi.org/10.1371/journal.pone.0143746			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26649426	Green Submitted, Green Published, gold			2022-12-27	WOS:000366903300026
J	Ohashi, A; Ohori, M; Iwai, K; Nambu, T; Miyamoto, M; Kawamoto, T; Okaniwa, M				Ohashi, Akihiro; Ohori, Momoko; Iwai, Kenichi; Nambu, Tadahiro; Miyamoto, Maki; Kawamoto, Tomohiro; Okaniwa, Masanori			A Novel Time-Dependent CENP-E Inhibitor with Potent Antitumor Activity	PLOS ONE			English	Article							ADVANCED SOLID TUMORS; SPINDLE-ASSEMBLY CHECKPOINT; MITOTIC KINESIN KSP; PROTEIN-E; PHASE-II; KINETOCHORE MOTOR; DNA-DAMAGE; CANCER; ISPINESIB; CELLS	Centromere-associated protein E (CENP-E) regulates both chromosome congression and the spindle assembly checkpoint (SAC) during mitosis. The loss of CENP-E function causes chromosome misalignment, leading to SAC activation and apoptosis during prolonged mitotic arrest. Here, we describe the biological and antiproliferative activities of a novel small-molecule inhibitor of CENP-E, Compound-A (Cmpd-A). Cmpd-A inhibits the ATPase activity of the CENP-E motor domain, acting as a time-dependent inhibitor with an ATP-competitive-like behavior. Cmpd-A causes chromosome misalignment on the metaphase plate, leading to prolonged mitotic arrest. Treatment with Cmpd-A induces antiproliferation in multiple cancer cell lines. Furthermore, Cmpd-A exhibits antitumor activity in a nude mouse xenograft model, and this antitumor activity is accompanied by the elevation of phosphohistone H3 levels in tumors. These findings demonstrate the potency of the CENP-E inhibitor Cmpd-A and its potential as an anticancer therapeutic agent.	[Ohashi, Akihiro; Ohori, Momoko; Iwai, Kenichi; Nambu, Tadahiro; Okaniwa, Masanori] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Oncol Drug Discovery Unit, Fujisawa, Kanagawa, Japan; [Miyamoto, Maki] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, DMPK Res Labs, Fujisawa, Kanagawa, Japan; [Kawamoto, Tomohiro] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Biomol Res Labs, Fujisawa, Kanagawa, Japan	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd	Ohashi, A (corresponding author), Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Oncol Drug Discovery Unit, Fujisawa, Kanagawa, Japan.	akihiro.ohashi@takeda.com		Okaniwa, Masanori/0000-0002-6982-9947	Takeda Pharmaceutical Company, Ltd.	Takeda Pharmaceutical Company, Ltd.(Takeda Pharmaceutical Company Ltd)	This research was supported by Takeda Pharmaceutical Company, Ltd. The funder provided support in the form of salaries for authors (AO, MOh, KI, TN, MM, TK, MOk), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Balamuth NJ, 2010, CANCER RES, V70, P2749, DOI 10.1158/0008-5472.CAN-09-3844; Barisic M, 2015, SCIENCE, V348, P799, DOI 10.1126/science.aaa5175; Barisic M, 2014, NAT CELL BIOL, V16, P1249, DOI 10.1038/ncb3060; BEIS I, 1975, BIOCHEM J, V152, P23, DOI 10.1042/bj1520023; Carter BZ, 2009, LEUKEMIA, V23, P1755, DOI 10.1038/leu.2009.101; Chung V, 2012, CANCER CHEMOTH PHARM, V69, P733, DOI 10.1007/s00280-011-1756-z; Hirayama T, 2015, J MED CHEM, V58, P8036, DOI 10.1021/acs.jmedchem.5b00836; Hirayama T, 2013, BIOORGAN MED CHEM, V21, P5488, DOI 10.1016/j.bmc.2013.05.067; Holen K, 2012, INVEST NEW DRUG, V30, P1088, DOI 10.1007/s10637-011-9653-1; Holen KD, 2011, CANCER CHEMOTH PHARM, V67, P447, DOI 10.1007/s00280-010-1346-5; Hollebecque A, 2013, INVEST NEW DRUG, V31, P1530, DOI 10.1007/s10637-013-0026-9; Howell BJ, 2004, CURR BIOL, V14, P953, DOI 10.1016/j.cub.2004.05.053; Jackson JR, 2007, NAT REV CANCER, V7, P107, DOI 10.1038/nrc2049; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kantarjian HM, 2012, INVEST NEW DRUG, V30, P1107, DOI 10.1007/s10637-011-9660-2; Knox JJ, 2008, INVEST NEW DRUG, V26, P265, DOI 10.1007/s10637-007-9103-2; Kung PP, 2014, MOL CANCER THER, V13, P2104, DOI 10.1158/1535-7163.MCT-14-0083-T; Lad L, 2008, BIOCHEMISTRY-US, V47, P3576, DOI 10.1021/bi702061g; Lee CW, 2008, INVEST NEW DRUG, V26, P249, DOI 10.1007/s10637-007-9097-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lock RB, 2012, PEDIATR BLOOD CANCER, V58, P916, DOI 10.1002/pbc.23176; LoRusso PM, 2015, INVEST NEW DRUG, V33, P440, DOI 10.1007/s10637-015-0211-0; Luo L, 2007, NAT CHEM BIOL, V3, P722, DOI 10.1038/nchembio.2007.34; Miki H, 2005, TRENDS CELL BIOL, V15, P467, DOI 10.1016/j.tcb.2005.07.006; Musacchio A, 2002, NAT REV MOL CELL BIO, V3, P731, DOI 10.1038/nrm929; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Ohashi A, 2005, J BIOL CHEM, V280, P14877, DOI 10.1074/jbc.M414669200; Ohashi A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8668; Qian XP, 2010, ACS MED CHEM LETT, V1, P30, DOI 10.1021/ml900018m; Rath O, 2012, NAT REV CANCER, V12, P527, DOI 10.1038/nrc3310; Tang PA, 2008, INVEST NEW DRUG, V26, P257, DOI 10.1007/s10637-007-9098-8; Tao WK, 2005, CANCER CELL, V8, P49, DOI 10.1016/j.ccr.2005.06.003; Tomillero A, 2010, Methods Find Exp Clin Pharmacol, V32, P517, DOI 10.1358/mf.2010.32.7.1549223; Wakui H, 2014, CANCER CHEMOTH PHARM, V74, P15, DOI 10.1007/s00280-014-2467-z; Wassmann K, 2001, CURR OPIN GENET DEV, V11, P83, DOI 10.1016/S0959-437X(00)00161-1; Wood KW, 2010, P NATL ACAD SCI USA, V107, P5839, DOI 10.1073/pnas.0915068107; Wood KW, 1997, CELL, V91, P357, DOI 10.1016/S0092-8674(00)80419-5; Yao XB, 1997, J CELL BIOL, V139, P435, DOI 10.1083/jcb.139.2.435; YEN TJ, 1992, NATURE, V359, P536, DOI 10.1038/359536a0	39	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144675	10.1371/journal.pone.0144675	http://dx.doi.org/10.1371/journal.pone.0144675			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26649895	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903300065
J	Woo, J; Bae, SH; Kim, B; Park, JS; Jung, S; Lee, M; Kim, YH; Choi, D				Woo, Jongsu; Bae, Seong-Ho; Kim, Bokyoung; Park, Jin Sil; Jung, Subin; Lee, Minhyung; Kim, Yong-Hee; Choi, Donghoon			Cardiac Usage of Reducible Poly(oligo-D-arginine) As a Gene Carrier for Vascular Endothelial Growth Factor Expression	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; VEGF PLASMID; THERAPY; ISCHEMIA; GENOME; OXYGEN	Developments of non-viral carriers have headed toward reducing cytotoxicity, which results from the use of conventional gene carriers, and enhancing gene delivery efficiency. Cys(D-R9)-Cys repeated reducible poly(oligo-D-arginine) (rPOA) is one of the most efficient non-viral carriers for gene therapy; however, while its efficiency has been verified in the lung and brain, it is necessary to confirm its activity in each organ or tissue since there are differences of gene carrier susceptibility to among tissue types. We therefore tested the compatibility of rPOA in cardiac tissue by in vitro or in vivo experiments and confirmed its high transfection efficiency and low cytotoxicity. Moreover, substantial regenerative effects were observed following transfection with rPOA/pVEGF expression vector complexes (79% decreased infarct size) compared to polyethyleneimine (PEI) (34% decreased infarct size) in a rat myocardial infarction (MI) model. These findings suggest that rPOA efficiently enables DNA transfection in cardiac tissue and can be used as a useful non-viral therapeutic gene carrier for gene therapy in ischemic heart disease.	[Woo, Jongsu; Kim, Bokyoung; Park, Jin Sil; Jung, Subin; Choi, Donghoon] Yonsei Univ Hlth Syst, Severance Integrat Res Inst Cerebral & Cardiovasc, Seoul, South Korea; [Bae, Seong-Ho] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea; [Lee, Minhyung; Kim, Yong-Hee] Hanyang Univ, Coll Engn, Dept Bioengn, Seoul 133791, South Korea; [Choi, Donghoon] Yonsei Univ, Coll Med, Cardiovasc Res Inst, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Hanyang University; Yonsei University; Yonsei University Health System	Bae, SH (corresponding author), Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea.	bshoooo@yuhs.ac; cdhlyj@yuhs.ac	Lee, Minhyung/W-1245-2018	Choi, Donghoon/0000-0002-2009-9760; Bae, Seong-ho/0000-0002-3624-6649	Korea Healthcare Technology Research & Development Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [A085136, A102064]; Mid-career Researcher Program through NRF - MEST, Republic of Korea [2015R1A2A2A01002731]; Cardiovascular Research Center, Seoul, Korea	Korea Healthcare Technology Research & Development Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea; Mid-career Researcher Program through NRF - MEST, Republic of Korea; Cardiovascular Research Center, Seoul, Korea	This study was supported by a grant from the Korea Healthcare Technology Research & Development Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (Nos. A085136 and A102064), the Mid-career Researcher Program through NRF grant funded by the MEST, Republic of Korea (No. 2015R1A2A2A01002731) and the Cardiovascular Research Center, Seoul, Korea.	Bull DA, 2003, J CONTROL RELEASE, V93, P175, DOI 10.1016/j.jconrel.2003.06.002; Frobert O, 2007, CATHETER CARDIO INTE, V70, P958, DOI 10.1002/ccd.21280; Godbey WT, 2001, BIOMATERIALS, V22, P471, DOI 10.1016/S0142-9612(00)00203-9; Gomez-Vargas A, 2004, SEMIN THROMB HEMOST, V30, P197, DOI 10.1055/s-2004-825633; Hyun H, 2010, BIOMATERIALS, V31, P9128, DOI 10.1016/j.biomaterials.2010.08.038; Kim HA, 2010, PHARM RES-DORDR, V27, P2075, DOI 10.1007/s11095-010-0206-7; Kim SH, 2011, MOL THER, V19, P741, DOI 10.1038/mt.2010.301; Kim Y, 2013, NAT BIOTECHNOL, V31, P251, DOI 10.1038/nbt.2517; Krijnen PAJ, 2002, J CLIN PATHOL, V55, P801, DOI 10.1136/jcp.55.11.801; Losordo DW, 1998, CIRCULATION, V98, P2800, DOI 10.1161/01.CIR.98.25.2800; Moon HH, 2014, BIOMATERIALS, V35, P1744, DOI 10.1016/j.biomaterials.2013.11.019; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Taimeh Z, 2013, NAT REV CARDIOL, V10, P519, DOI 10.1038/nrcardio.2013.94; Wadia JS, 2002, CURR OPIN BIOTECH, V13, P52, DOI 10.1016/S0958-1669(02)00284-7; Wijesinghe M, 2009, HEART, V95, P198, DOI 10.1136/hrt.2008.148742; Willyard C, 2012, NAT MED, V18, P328, DOI 10.1038/nm0312-328; Wolfram JA, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000119; Won YW, 2013, BIOMATERIALS, V34, P6229, DOI 10.1016/j.biomaterials.2013.04.061; Won YW, 2012, J CONTROL RELEASE, V160, P525, DOI 10.1016/j.jconrel.2012.03.010; Won YW, 2011, BIOMATERIALS, V32, P9766, DOI 10.1016/j.biomaterials.2011.08.089; Won YW, 2010, MOL THER, V18, P734, DOI 10.1038/mt.2009.297; Xin M, 2013, NAT REV MOL CELL BIO, V14, P529, DOI 10.1038/nrm3619; Yin H, 2014, NAT REV GENET, V15, P541, DOI 10.1038/nrg3763	23	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144491	10.1371/journal.pone.0144491	http://dx.doi.org/10.1371/journal.pone.0144491			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26649571	gold, Green Published, Green Submitted			2022-12-27	WOS:000366903300051
J	Kim, H; Park, HC; Ryu, H; Kim, K; Kim, HS; Oh, KH; Yu, SJ; Chung, JW; Cho, JY; Kim, SH; Cheong, HI; Lee, K; Park, JH; Pei, Y; Hwang, YH; Ahn, C				Kim, Hyunsuk; Park, Hayne Cho; Ryu, Hyunjin; Kim, Kiwon; Kim, Hyo Sang; Oh, Kook-Hwan; Yu, Su Jong; Chung, Jin Wook; Cho, Jeong Yeon; Kim, Seung Hyup; Cheong, Hae Il; Lee, Kyubeck; Park, Jong Hoon; Pei, York; Hwang, Young-Hwan; Ahn, Curie			Clinical Correlates of Mass Effect in Autosomal Dominant Polycystic Kidney Disease	PLOS ONE			English	Article							LIVER INVOLVEMENT; HEPATIC CYSTS; MANAGEMENT; VOLUME; DIAGNOSIS; THERAPY	Mass effect from polycystic kidney and liver enlargement can result in significant clinical complications and symptoms in autosomal dominant polycystic kidney disease (ADPKD). In this single-center study, we examined the correlation of height-adjusted total liver volume (htTLV) and total kidney volume (htTKV) by CT imaging with hepatic complications (n = 461) and abdominal symptoms (n = 253) in patients with ADPKD. "Mass-effect" complications were assessed by review of medical records and abdominal symptoms, by a standardized research questionnaire. Overall, 91.8% of patients had 4 or more liver cysts on CT scans. Polycystic liver disease (PLD) was classified as none or mild (htTLV < 1,600 mL/m); moderate (1,600 <= htTLV < 3,200 mL/m); and severe (htTLV >= 3,200 mL/m). The prevalence of moderate and severe PLD in our patient cohort was 11.7% (n = 54/461) and 4.8%(n = 22/461), respectively, with a female predominance in both the moderate (61.1%) and severe (95.5%) PLD groups. Pressure-related complications such as leg edema (20.4%), ascites (16.6%), and hernia (3.6%) were common, and patients with moderate to severe PLD exhibited a 6-fold increased risk (compared to no or mild PLD) for these complications in multivariate analysis. Similarly, abdominal symptoms including back pain (58.8%), flank pain (53.1%), abdominal fullness (46.5%), and dyspnea/chest-discomfort (44.3%) were very common, and patients with moderate to severe PLD exhibited a 5-fold increased risk for these symptoms. Moderate to severe PLD is a common and clinically important problem in similar to 16% of patients with ADPKD who may benefit from referral to specialized centers for further management.	[Kim, Hyunsuk; Ryu, Hyunjin; Oh, Kook-Hwan; Ahn, Curie] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea; [Park, Hayne Cho] Armed Forces Capital Hosp, Dept Internal Med, Songnam, Gyeonggi Do, South Korea; [Kim, Kiwon] Natl Canc Ctr, Nephrol Clin, Goyang Si, Gyeonggi Do, South Korea; [Kim, Hyo Sang] Univ Ulsan, Dept Internal Med, Asan Med Ctr, Seoul, South Korea; [Yu, Su Jong] Seoul Natl Univ Hosp, Div Hepatol, Seoul 110744, South Korea; [Chung, Jin Wook; Cho, Jeong Yeon; Kim, Seung Hyup] Seoul Natl Univ Hosp, Dept Radiol, Seoul 110744, South Korea; [Cheong, Hae Il] Seoul Natl Univ, Childrens Hosp, Dept Pediat, Seoul, South Korea; [Cheong, Hae Il; Hwang, Young-Hwan; Ahn, Curie] Seoul Natl Univ Hosp, Res Coordinat Ctr Rare Dis, Seoul 110744, South Korea; [Lee, Kyubeck] Kangbuk Samsung Med Ctr, Dept Internal Med, Seoul, South Korea; [Park, Jong Hoon] Sookmyoung Womens Univ, Dept Biol Sci, Seoul, South Korea; [Pei, York] Univ Hlth Network, Div Nephrol, Dept Internal Med, Toronto, ON, Canada; [Pei, York] Univ Toronto, Toronto, ON M5S 1A1, Canada; [Hwang, Young-Hwan] Eulji Gen Hosp, Dept Internal Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; National Cancer Center - Korea (NCC); University of Ulsan; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Sookmyung Women's University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Eulji University	Ahn, C (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea.	Curie@snu.ac.kr		Kim, Hyunsuk/0000-0003-1889-253X; Yu, Su Jong/0000-0001-8888-7977; Hwang, Young-Hwan/0000-0001-8935-2659	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI12C0014]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI12C0014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI12C0014). A part of this work was presented at Kidney Week 2014 on November 12 in Philadelphia, PA. Authors greatly appreciate Yongho Song, radiological technician for his dedicated efforts in measurement of TLV.	Arnold HL, 2005, AM J GASTROENTEROL, V100, P2569, DOI 10.1111/j.1572-0241.2005.00263.x; Bae KT, 2006, CLIN J AM SOC NEPHRO, V1, P64, DOI 10.2215/CJN.00080605; Bae KT, 2009, CLIN J AM SOC NEPHRO, V4, P719, DOI 10.2215/CJN.03750708; Bae K, 2013, CLIN J AM SOC NEPHRO, V8, P1089, DOI 10.2215/CJN.10561012; Chauveau D, 2000, J AM SOC NEPHROL, V11, P1767, DOI 10.1681/ASN.V1191767; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Everson Gregory T, 2005, Curr Gastroenterol Rep, V7, P19, DOI 10.1007/s11894-005-0061-6; GABOW PA, 1990, HEPATOLOGY, V11, P1033, DOI 10.1002/hep.1840110619; Hogan MC, 2015, CLIN GASTROENTEROL H, V13, P155, DOI 10.1016/j.cgh.2014.07.051; Hogan MC, 2010, J AM SOC NEPHROL, V21, P1052, DOI 10.1681/ASN.2009121291; Irazabal MV, 2015, J AM SOC NEPHROL, V26, P160, DOI 10.1681/ASN.2013101138; Jouret F, 2012, NEPHROL DIAL TRANSPL, V27, P3746, DOI 10.1093/ndt/gfs352; Kistler AD, 2009, KIDNEY INT, V75, P235, DOI 10.1038/ki.2008.558; Onori P, 2013, LIVER INT, V33, P914, DOI 10.1111/liv.12177; Park HC, 2009, J KOREAN MED SCI, V24, P57, DOI 10.3346/jkms.2009.24.1.57; Pei Y, 2009, J AM SOC NEPHROL, V20, P205, DOI 10.1681/ASN.2008050507; Qian Q, 2003, HEPATOLOGY, V37, P164, DOI 10.1053/jhep.2003.50006; Russell RT, 2007, WORLD J GASTROENTERO, V13, P5052, DOI 10.3748/wjg.v13.i38.5052; Sherstha R, 1997, HEPATOLOGY, V26, P1282; Stevens LA, 2010, AM J KIDNEY DIS, V56, P486, DOI 10.1053/j.ajkd.2010.03.026; Suwabe T, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-179; SVEDLUND J, 1988, DIGEST DIS SCI, V33, P129, DOI 10.1007/BF01535722; Temmerman F, 2011, ALIMENT PHARM THER, V34, P702, DOI 10.1111/j.1365-2036.2011.04783.x; Torres VE, 2009, KIDNEY INT, V76, P149, DOI 10.1038/ki.2009.128; Van Keimpema L, 2009, GASTROENTEROLOGY, V137, P1661, DOI 10.1053/j.gastro.2009.07.052; Wijnands TFM, 2014, LIVER INT, V34, P1578, DOI 10.1111/liv.12430; Yu HC, 2004, LIVER TRANSPLANT, V10, P779, DOI 10.1002/lt.20188	27	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144526	10.1371/journal.pone.0144526	http://dx.doi.org/10.1371/journal.pone.0144526			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641645	gold, Green Submitted, Green Published			2022-12-27	WOS:000366902700141
J	Prell, C; Sun, LX; Feng, KS; Myroniuk, TW				Prell, Christina; Sun, Laixiang; Feng, Kuishuang; Myroniuk, Tyler W.			Inequalities in Global Trade: A Cross-Country Comparison of Trade Network Position, Economic Wealth, Pollution and Mortality	PLOS ONE			English	Article							CARBON-DIOXIDE EMISSIONS; ECOLOGICALLY UNEQUAL EXCHANGE; INTERNATIONAL-TRADE; WORLD-SYSTEM; AIR-POLLUTION; EAST-ASIA; GROWTH; GLOBALIZATION; CONSUMPTION; ENVIRONMENT	In this paper we investigate how structural patterns of international trade give rise to emissions inequalities across countries, and how such inequality in turn impact countries' mortality rates. We employ Multi-regional Input-Output analysis to distinguish between sulfurdioxide (SO2) emissions produced within a country's boarders (production-based emissions) and emissions triggered by consumption in other countries (consumption-based emissions). We use social network analysis to capture countries' level of integration within the global trade network. We then apply the Prais-Winsten panel estimation technique to a panel data set across 172 countries over 20 years (1990-2010) to estimate the relationships between countries' level of integration and SO2 emissions, and the impact of trade integration and SO2 emission on mortality rates. Our findings suggest a positive, (log-) linear relationship between a country's level of integration and both kinds of emissions. In addition, although more integrated countries are mainly responsible for both forms of emissions, our findings indicate that they also tend to experience lower mortality rates. Our approach offers a unique combination of social network analysis with multiregional input-output analysis, which better operationalizes intuitive concepts about global trade and trade structure.	[Prell, Christina] Univ Maryland, Dept Sociol, College Pk, MD 20742 USA; [Sun, Laixiang; Feng, Kuishuang] Univ Maryland, Geog Sci Dept, College Pk, MD 20742 USA; [Myroniuk, Tyler W.] Brown Univ, Populat Studies & Training Ctr, Providence, RI 02912 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Brown University	Prell, C (corresponding author), Univ Maryland, Dept Sociol, College Pk, MD 20742 USA.	cprell@umd.edu	Sun, Laixiang/ABB-2622-2021; Feng, Kuishuang/Y-2541-2019	Sun, Laixiang/0000-0002-7784-7942; Myroniuk, Tyler W./0000-0001-6674-7930	College of Behavioral and Social Sciences at the University of Maryland: Dean's Research Initiative; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD041041] Funding Source: NIH RePORTER	College of Behavioral and Social Sciences at the University of Maryland: Dean's Research Initiative; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by the College of Behavioral and Social Sciences at the University of Maryland: Dean's Research Initiative (2011-2014). This was a seed-grant award to encourage collaborative research across two disciplines/departments in the University College.	Anderson E, 2005, WORLD DEV, V33, P1045, DOI 10.1016/j.worlddev.2005.04.003; Appelbaum RP, 1997, INT J URBAN REGIONAL, V21, P202, DOI 10.1111/1468-2427.00069; Arribas I, 2009, WORLD DEV, V37, P127, DOI 10.1016/j.worlddev.2008.03.009; Arrighi Giovanni, 1986, REV FERNAND BRAUDEL, V10, P9; Beck U., 1994, RISK SOC NEW MODERNI; Bell ML, 2007, ENVIRON HEALTH PERSP, V115, P1118, DOI 10.1289/ehp.9759; Bongaarts J, 2008, STUD FAMILY PLANN, V39, P105, DOI 10.1111/j.1728-4465.2008.00157.x; Borgatti SP, 1999, SOC NETWORKS, V21, P375; Breiger RL, 1981, CONTINUITIES STRUCTU; Bunker SG., 2005, GLOBALIZATION RACE R; Caldeira K, 2011, P NATL ACAD SCI USA, V108, P8533, DOI 10.1073/pnas.1106517108; Chase-Dunn C, 2000, AM SOCIOL REV, V65, P77, DOI 10.2307/2657290; Chase-Dunn Christopher K., 1998, GLOBAL FORMATION STR; Clark R, 2010, SOC FORCES, V88, P1123; Clark R, 2009, INT J COMP SOCIOL, V50, P5, DOI 10.1177/0020715208098615; Copeland B., 2003, TRADE ENV THEORY EVI; Copeland BR, 2004, J ECON LIT, V42, P7, DOI 10.1257/002205104773558047; Davis SJ, 2011, P NATL ACAD SCI USA, V108, P18554, DOI 10.1073/pnas.1107409108; Davis SJ, 2010, P NATL ACAD SCI USA, V107, P5687, DOI 10.1073/pnas.0906974107; Dietz T, 2007, FRONT ECOL ENVIRON, V5, P13, DOI 10.1890/1540-9295(2007)5[13:DTHEF]2.0.CO;2; EPA US, 2009, DAT NAT EM INV VERS; Feng KS, 2011, ECON SYST RES, V23, P371, DOI 10.1080/09535314.2011.638276; Halkos GE, 2013, J ENVIRON PLANN MAN, V56, P159, DOI 10.1080/09640568.2012.657756; Hoppe R, 2006, DER SPIEGEL     0131; Hornborg A., 2011, GLOBAL ECOLOGY UNEQU; Huber J, 2004, NEW TECHNOLOGIES ENV, Vx; JAFFE AB, 1995, J ECON LIT, V33, P132; Jevons W. S., 1866, COAL QUESTION ENQUIR; Jorgenson AK., 2004, HUMBOLDT J SOCIAL RE, V28, P47; Jorgenson AK, 2007, SOC PROBL, V54, P371, DOI 10.1525/sp.2007.54.3.371; Jorgenson AK, 2006, RURAL SOCIOL, V71, P685, DOI 10.1526/003601106781262016; Jorgenson AK, 2012, J WORLD SYST RES, V18, P103, DOI 10.5195/JWSR.2012.483; Jorgenson AK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123920; Jorgenson AK, 2012, AM J SOCIOL, V118, P1, DOI 10.1086/665990; Jorgenson AK, 2012, SOC SCI RES, V41, P242, DOI 10.1016/j.ssresearch.2011.11.011; Jorgenson AK, 2011, SOCIOL INQ, V81, P53, DOI 10.1111/j.1475-682X.2010.00354.x; Jorgenson AK, 2011, SOC SCI RES, V40, P226, DOI 10.1016/j.ssresearch.2010.09.004; Kali R, 2010, ECON INQ, V48, P1072, DOI 10.1111/j.1465-7295.2009.00249.x; Kick E., 1997, J WORLD SYSTEMS RES, V3, P432, DOI DOI 10.5195/JWSR.1997.98; Kim S, 2002, SOC FORCES, V81, P445, DOI 10.1353/sof.2003.0014; Kinsella K, 2005, POPUL BULL, V60, P3; Knight KW, 2014, SUSTAINABILITY-BASEL, V6, P3722, DOI 10.3390/su6063722; LAVE LB, 1970, SCIENCE, V169, P723, DOI 10.1126/science.169.3947.723; Lenzen M, 2012, NATURE, V486, P109, DOI 10.1038/nature11145; Lenzen M, 2013, ECON SYST RES, V25, P20, DOI 10.1080/09535314.2013.769938; Leonard H.J., 2006, POLLUTION STRUGGLE W; Lloyd P, 2009, J WORLD SYST RES, V15, P48, DOI 10.5195/JWSR.2009.335; Mahutga MC, 2006, SOC FORCES, V84, P1863, DOI 10.1353/sof.2006.0098; Mahutga MC, 2011, SOC SCI RES, V40, P257, DOI 10.1016/j.ssresearch.2010.08.012; Minx JC, 2009, ECON SYST RES, V21, P187, DOI 10.1080/09535310903541298; Montalbano P, 2011, WORLD DEV, V39, P1489, DOI 10.1016/j.worlddev.2011.02.009; Moran DD, 2013, ECOL ECON, V89, P177, DOI 10.1016/j.ecolecon.2013.02.013; Nissanke M, 2006, WORLD DEV, V34, P1338, DOI 10.1016/j.worlddev.2005.10.008; Peters GP, 2008, ECOL ECON, V65, P13, DOI 10.1016/j.ecolecon.2007.10.014; Peters GP, 2008, CLIMATIC CHANGE, V86, P51, DOI 10.1007/s10584-007-9280-1; Peters GP, 2011, P NATL ACAD SCI USA, V108, P8903, DOI 10.1073/pnas.1006388108; Pope CA, 2006, J AIR WASTE MANAGE, V56, P709, DOI 10.1080/10473289.2006.10464485; Prell C, 2014, SOC FORCES, V93, P405, DOI 10.1093/sf/sou048; Prew P, 2010, J WORLD SYST RES, V16, P162, DOI 10.5195/JWSR.2010.436; Reyes J, 2010, J INT TRADE ECON DEV, V19, P215, DOI 10.1080/09638190802521278; Rice J, 2007, SOC FORCES, V85, P1369, DOI 10.1353/sof.2007.0054; Roberts J.T., 2003, J WORLD SYST RES, V9, P277; Roberts J.Timmons., 2007, CLIMATE INJUSTICE GL; Roberts JT, 1997, WORLD DEV, V25, P191, DOI 10.1016/S0305-750X(96)00104-0; SMITH DA, 1992, SOC FORCES, V70, P857, DOI 10.2307/2580193; SNYDER D, 1979, AM J SOCIOL, V84, P1096, DOI 10.1086/226902; Steinberger JK, 2012, NAT CLIM CHANGE, V2, P81, DOI [10.1038/NCLIMATE1371, 10.1038/nclimate1371]; Stern DI, 2001, J ENVIRON ECON MANAG, V41, P162, DOI 10.1006/jeem.2000.1132; SU TT, 1994, SOCIOL INQ, V64, P415, DOI 10.1111/j.1475-682X.1994.tb00400.x; Thomas AR, 2012, J WORLD SYST RES, V18, P211, DOI 10.5195/JWSR.2012.479; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Wiedmann TO, 2015, P NATL ACAD SCI USA, V112, P6271, DOI 10.1073/pnas.1220362110; Yu Y, 2013, GLOBAL ENVIRON CHANG, V23, P1178, DOI 10.1016/j.gloenvcha.2013.04.006; Yu Y, 2010, ECOL ECON, V69, P1140, DOI 10.1016/j.ecolecon.2009.12.008	74	16	16	5	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144453	10.1371/journal.pone.0144453	http://dx.doi.org/10.1371/journal.pone.0144453			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1YS	26642202	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000366902700126
J	Suarez, P; Nagamachi, CY; Lanzone, C; Malleret, MM; O'Brien, PCM; Ferguson-Smith, MA; Pieczarka, JC				Suarez, Pablo; Nagamachi, Cleusa Yoshiko; Lanzone, Cecilia; Maximiliano Malleret, Matias; O'Brien, Patricia Caroline Mary; Ferguson-Smith, Malcolm Andrew; Pieczarka, Julio Cesar			Clues on Syntenic Relationship among Some Species of Oryzomyini and Akodontini Tribes (Rodentia: Sigmodontinae)	PLOS ONE			English	Article							G-BANDING PATTERNS; CHROMOSOMAL EVOLUTION; WHOLE CHROMOSOME; ZOO-FISH; CRICETIDAE; CURSOR; DNA; DIVERSIFICATION; MUROIDEA; MOUSE	Sigmodontinae rodents represent one of the most diverse and complex components of the mammalian fauna of South America. Among them most species belongs to Oryzomyini and Akodontini tribes. The highly specific diversification observed in both tribes is characterized by diploid complements, which vary from 2n = 10 to 86. Given this diversity, a consistent hypothesis about the origin and evolution of chromosomes depends on the correct establishment of synteny analyzed in a suitable phylogenetic framework. The chromosome painting technique has been particularly useful for identifying chromosomal synteny. In order to extend our knowledge of the homeological relationships between Akodontini and Oryzomyini species, we analyzed the species Akodon montensis (2n = 24) and Thaptomys nigrita (2n = 52) both from the tribe Akodontini, with chromosome probes of Hylaeamys megacephalus (2n = 54) of the tribe Oryzomyini. The results indicate that at least 12 of the 26 autosomes of H. megacephalus show conserved synteny in A. montensis and 14 in T. nigrita. The karyotype of Akodon montensis, as well as some species of the Akodon cursor species group, results from many chromosomal fusions and therefore the syntenic associations observed probably represent synapomorphies. Our finding of a set of such associations revealed by H. megacephalus chromosome probes (6/21; 3/25; 11/16/17; and, 14/19) provides phylogenetic information for both tribes. An extension of these observations to other members of Akodontini and Oryzomyini tribes should improve our knowledge about chromosome evolution in both these groups.	[Suarez, Pablo; Nagamachi, Cleusa Yoshiko; Pieczarka, Julio Cesar] UFPa, ICB, Ctr Estudos Avancados Biodiversidade, Lab Citogenet, Belem, Para, Brazil; [Lanzone, Cecilia; Maximiliano Malleret, Matias] CONICET UNaM, FCEQyN, IBS, Lab Genet Evolut, Posadas, Misiones, Argentina; [O'Brien, Patricia Caroline Mary; Ferguson-Smith, Malcolm Andrew] Univ Cambridge, Dept Vet Med, Cambridge Resource Ctr Comparat Genom, Cambridge, England; [Nagamachi, Cleusa Yoshiko; Pieczarka, Julio Cesar] CNPq Researchers, Brasilia, DF, Brazil	Universidade Federal do Para; University of Cambridge	Pieczarka, JC (corresponding author), UFPa, ICB, Ctr Estudos Avancados Biodiversidade, Lab Citogenet, Belem, Para, Brazil.	juliopieczarka@gmail.com	Nagamachi, Cleusa/AAV-8985-2021; Pieczarka, Julio C/E-7585-2016	Pieczarka, Julio C/0000-0003-2951-8877; Nagamachi, Cleusa Yoshiko/0000-0003-1516-2734; Malleret, Matias Maximiliano/0000-0001-8409-6385	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Para (FAPESPA) [552032/2010-7, ICAAF 007/2011]; Banco Nacional de Desenvolvimento Economico e Social-BNDES [2.318.697.0001]; FAPESPA [2010/110447]; Welcome Trust; CNPq [159537/2011-8]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Para (FAPESPA)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Banco Nacional de Desenvolvimento Economico e Social-BNDES; FAPESPA(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA)); Welcome Trust(Wellcome Trust); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors thank the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and the Fundacao de Amparo a Pesquisa do Estado do Para (FAPESPA) (Edital BIONORTE/CNPq Proc 552032/2010-7 and Edital BIONORTE/FAPESPA, ICAAF 007/2011) and the Banco Nacional de Desenvolvimento Economico e Social-BNDES (Operacao 2.318.697.0001) for financial support on a project coordinated by CY Nagamachi; the FAPESPA for financial support (Edital Vale-Proc 2010/110447) on a project coordinated by JC Pieczarka, and the Welcome Trust for a grant to MA Ferguson-Smith. CL thanks PICT 2010/1095 and CONICET PIP 198. PS thanks CNPq by postdoctoral fellowship (159537/2011-8).	BIANCHI NO, 1971, EVOLUTION, V25, P724, DOI 10.1111/j.1558-5646.1971.tb01929.x; D'Elia G, 2003, CLADISTICS, V19, P307, DOI 10.1016/S0748-3007(03)00071-9; D'Elía Guillermo, 2007, Gayana (Concepc.), V71, P187; Silva MJD, 2006, GENET MOL BIOL, V29, P469, DOI 10.1590/S1415-47572006000300012; Di-Nizo CB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117579; Fagundes V, 1997, CYTOGENET CELL GENET, V78, P224, DOI 10.1159/000134662; Fagundes V, 1997, CHROMOSOME RES, V5, P228, DOI 10.1023/A:1018463401887; FORD CE, 1956, STAIN TECHNOL, V31, P247, DOI 10.3109/10520295609113814; Geise L, 1998, J HERED, V89, P158, DOI 10.1093/jhered/89.2.158; Geise L, 2001, J MAMMAL, V82, P92, DOI 10.1644/1545-1542(2001)082<0092:DITGAR>2.0.CO;2; Hass I, 2011, CYTOGENET GENOME RES, V135, P42, DOI 10.1159/000330259; Hass I, 2008, CHROMOSOME RES, V16, P75, DOI 10.1007/s10577-007-1211-5; Murphy WJ, 1999, GENOME RES, V9, P1223, DOI 10.1101/gr.9.12.1223; Musser GG, 2005, MAMMAL SPECIES WORLD, P1; Nagamachi CY, 2013, CHROMOSOME RES, V21, P107, DOI 10.1007/s10577-013-9341-4; Patton JL, 2000, B AM MUS NAT HIST, P1, DOI 10.1206/0003-0090(2000)244<0001:MOTRJA>2.0.CO;2; Romanenko SA, 2012, HEREDITY, V108, P4, DOI 10.1038/hdy.2011.110; Romanenko SA, 2007, CHROMOSOME RES, V15, P283, DOI 10.1007/s10577-007-1124-3; Romanenko SA, 2006, MAMM GENOME, V17, P1183, DOI 10.1007/s00335-006-0081-z; Sbalqueiro IJ, 1996, BRAZ J GENET, V19, P565, DOI 10.1590/S0100-84551996000400005; SEABRIGH.M, 1971, LANCET, V2, P971; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Sitnikova NA, 2007, CHROMOSOME RES, V15, P447, DOI 10.1007/s10577-007-1137-y; Stanyon R, 2004, CYTOGENET GENOME RES, V105, P406, DOI 10.1159/000078213; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; Swier VJ, 2009, CYTOGENET GENOME RES, V125, P54, DOI 10.1159/000218747; TELENIUS H, 1992, GENOMICS, V13, P718, DOI 10.1016/0888-7543(92)90147-K; Ventura K, 2009, CHROMOSOME RES, V17, P1063, DOI 10.1007/s10577-009-9083-5; Volobouev VT, 2000, CHROMOSOME RES, V8, P295, DOI 10.1023/A:1009223210737; YANG F, 1995, CHROMOSOMA, V103, P642, DOI 10.1007/BF00357691; Yang Fengtang, 2009, P323, DOI 10.1007/978-3-540-70581-9_29	31	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0143482	10.1371/journal.pone.0143482	http://dx.doi.org/10.1371/journal.pone.0143482			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642204	Green Submitted, Green Published, gold			2022-12-27	WOS:000366902700018
J	Marsh, JW; Krauland, MG; Nelson, JS; Schlackman, JL; Brooks, AM; Pasculle, AW; Shutt, KA; Doi, Y; Querry, AM; Muto, CA; Harrison, LH				Marsh, Jane W.; Krauland, Mary G.; Nelson, Jemma S.; Schlackman, Jessica L.; Brooks, Anthony M.; Pasculle, A. William; Shutt, Kathleen A.; Doi, Yohei; Querry, Ashley M.; Muto, Carlene A.; Harrison, Lee H.			Genomic Epidemiology of an Endoscope-Associated Outbreak of Klebsiella pneumoniae Carbapenemase (KPC)-Producing K. pneumoniae	PLOS ONE			English	Article							ESCHERICHIA-COLI; SEQUENCE; SURVEILLANCE; TRANSMISSION; PKPQIL; GENE	Increased incidence of infections due to Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae (KPC-Kp) was noted among patients undergoing endoscopic retrograde cholangiopancreatography (ERCP) at a single hospital. An epidemiologic investigation identified KPC-Kp and non-KPC-producing, extended-spectrum beta-lactamase (ESBL)-producing Kp in cultures from 2 endoscopes. Genotyping was performed on patient and endoscope isolates to characterize the microbial genomics of the outbreak. Genetic similarity of 51 Kp isolates from 37 patients and 3 endoscopes was assessed by pulsed-field gel electrophoresis (PFGE) and multi-locus sequence typing (MLST). Five patient and 2 endoscope isolates underwent whole genome sequencing (WGS). Two KPC-encoding plasmids were characterized by single molecule, real-time sequencing. Plasmid diversity was assessed by endonuclease digestion. Genomic and epidemiologic data were used in conjunction to investigate the outbreak source. Two clusters of Kp patient isolates were genetically related to endoscope isolates by PFGE. A subset of patient isolates were collected post-ERCP, suggesting ERCP endoscopes as a possible source. A phylogeny of 7 Kp genomes from patient and endoscope isolates supported ERCP as a potential source of transmission. Differences in gene content defined 5 ST258 subclades and identified 2 of the subclades as outbreak-associated. A novel KPC-encoding plasmid, pKp28 helped define and track one endoscope-associated ST258 subclade. WGS demonstrated high genetic relatedness of patient and ERCP endoscope isolates suggesting ERCP-associated transmission of ST258 KPC-Kp. Gene and plasmid content discriminated the outbreak from endemic ST258 populations and assisted with the molecular epidemiologic investigation of an extended KPC-Kp outbreak.	[Marsh, Jane W.; Krauland, Mary G.; Nelson, Jemma S.; Schlackman, Jessica L.; Brooks, Anthony M.; Shutt, Kathleen A.; Muto, Carlene A.; Harrison, Lee H.] Univ Pittsburgh, Sch Med, Infect Dis Epidemiol Res Unit, Pittsburgh, PA 15261 USA; [Marsh, Jane W.; Krauland, Mary G.; Nelson, Jemma S.; Schlackman, Jessica L.; Brooks, Anthony M.; Shutt, Kathleen A.; Muto, Carlene A.; Harrison, Lee H.] Grad Sch Publ Hlth, Pittsburgh, PA USA; [Krauland, Mary G.] Univ Pittsburgh, Grad Sch Publ Hlth, Publ Hlth Dynam Lab, Pittsburgh, PA USA; [Pasculle, A. William] Univ Pittsburgh, Med Ctr, Div Microbiol, Pittsburgh, PA USA; [Doi, Yohei] Univ Pittsburgh, Sch Med, Div Infect Dis, Pittsburgh, PA USA; [Querry, Ashley M.; Muto, Carlene A.] Univ Pittsburgh, Med Ctr, Div Hosp Epidemiol & Infect Control, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Marsh, JW (corresponding author), Univ Pittsburgh, Sch Med, Infect Dis Epidemiol Res Unit, Pittsburgh, PA 15261 USA.	jwmarsh@pitt.edu		Krauland, Mary/0000-0002-1548-6221; Doi, Yohei/0000-0002-9620-2525; Nelson, Jemma/0000-0003-2846-2007; Shutt, Kathleen/0000-0003-3376-6152				BARTON BM, 1995, ANAL BIOCHEM, V226, P235, DOI 10.1006/abio.1995.1220; Centers for Disease Control and Prevention, 2015, CDC STAT LOS ANG COU; Chen L, 2014, MBIO, V5, DOI 10.1128/mBio.01355-14; Chen L, 2014, ANTIMICROB AGENTS CH, V58, P2871, DOI 10.1128/AAC.00120-14; Chevreux B, 1999, P GERM C BIOINF HANN; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Conlan S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009845; Deleo FR, 2014, P NATL ACAD SCI USA, V111, P4988, DOI 10.1073/pnas.1321364111; Diancourt L, 2005, J CLIN MICROBIOL, V43, P4178, DOI 10.1128/JCM.43.8.4178-4182.2005; Endimiani A, 2009, J ANTIMICROB CHEMOTH, V63, P427, DOI 10.1093/jac/dkn547; Epstein L, 2014, JAMA-J AM MED ASSOC, V312, P1447, DOI 10.1001/jama.2014.12720; Garcia A, 2005, J ANTIMICROB CHEMOTH, V56, P819, DOI 10.1093/jac/dki345; Gastmeier P, 2014, INFECTION, V42, P15, DOI 10.1007/s15010-013-0544-6; Hudson CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099209; Kaiser RM, 2013, DIAGN MICR INFEC DIS, V76, P356, DOI 10.1016/j.diagmicrobio.2013.03.032; Kitchel B, 2009, ANTIMICROB AGENTS CH, V53, P3365, DOI 10.1128/AAC.00126-09; Kovaleva J, 2013, CLIN MICROBIOL REV, V26, P231, DOI 10.1128/CMR.00085-12; Leavitt A, 2010, ANTIMICROB AGENTS CH, V54, P4493, DOI 10.1128/AAC.00175-10; Lee Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/352862; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Marquez C, 2014, New Microbes New Infect, V2, P58, DOI 10.1002/nmi2.40; Mathers AJ, 2015, ANTIMICROB AGENTS CH, V59, P1661, DOI 10.1128/AAC.04292-14; McCool S, 2013, ID WEEK; McCool S, 2014, ID WEEK; Naas T, 2010, J ANTIMICROB CHEMOTH, V65, P1305, DOI 10.1093/jac/dkq117; Nordmann P, 2009, LANCET INFECT DIS, V9, P228, DOI 10.1016/S1473-3099(09)70054-4; Poirel L, 2010, ANTIMICROB AGENTS CH, V54, P24, DOI 10.1128/AAC.01512-08; Robledo IE, 2011, ANTIMICROB AGENTS CH, V55, P2968, DOI 10.1128/AAC.01633-10; Rodriguez-Zuluet P, 2013, ANTIMICROB AGENTS CH, V57, P4086, DOI 10.1128/AAC.02530-12; Sambrook J., 2001, MOL CLONING LAB MANU; Snitkin ES, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004129; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; US Food and Drug Administration, 2015, END RETR CHOL ERCP D; Vimont S, 2008, J MED MICROBIOL, V57, P1308, DOI 10.1099/jmm.0.2008/003798-0	34	53	58	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144310	10.1371/journal.pone.0144310	http://dx.doi.org/10.1371/journal.pone.0144310			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26637170	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000366143800072
J	Perez-Munoz, ME; Joglekar, P; Shen, YJ; Chang, KY; Peterson, DA				Perez-Munoz, Maria Elisa; Joglekar, Payal; Shen, Yi-Ji; Chang, Kuan Y.; Peterson, Daniel A.			Identification and Phylogeny of the First T Cell Epitope Identified from a Human Gut Bacteroides Species	PLOS ONE			English	Article							MICROBIAL ECOLOGY; INTESTINAL FLORA; BACTERIA; DISEASE; REACTIVITY; ANTIGENS; COLITIS; OBESITY	Host T cell reactivity toward gut bacterial epitopes has been recognized as part of disease pathogenesis. However, the specificity of T cells that recognize this vast number of epitopes has not yet been well described. After colonizing a C57BL/6J germ-free mouse with the human gut symbiotic bacteria Bacteroides thetaiotaomicron, we isolated a T cell that recognized these bacteria in vitro. Using this T cell, we mapped the first known non-carbohydrate T cell epitope within the phylum Bacteroidetes. The T cell also reacted to two other additional Bacteroides species. We identified the peptide that stimulated the T cell by using a genetic approach. Genomic data from the epitope-positive and epitope-negative bacteria explain the cross-reactivity of the T cell to multiple species. This epitope degeneracy should shape our understanding of the T cell repertoire stimulated by the complex microbiome residing in the gastrointestinal tract in both healthy and disease states.	[Perez-Munoz, Maria Elisa; Joglekar, Payal; Peterson, Daniel A.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Joglekar, Payal] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Perez-Munoz, Maria Elisa] Univ Nebraska, Dept Food Sci & Technol, Lincoln, NE 68583 USA; [Shen, Yi-Ji; Chang, Kuan Y.] Natl Taiwan Ocean Univ, Dept Comp Sci & Engn, Keelung, Taiwan	Johns Hopkins University; Stanford University; University of Nebraska System; University of Nebraska Lincoln; National Taiwan Ocean University	Peterson, DA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.	daniel.peterson@jhmi.edu	Chang, Kuan Y./AAB-3639-2020	Chang, Kuan Y./0000-0002-2262-5218	National Institutes of Health [AI097419, AI07660901]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI097419] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the National Institutes of Health (http://www.nih.gov) grants AI097419 and AI07660901 given to DAP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan RK, 2011, CELL STRESS CHAPERON, V16, P353, DOI 10.1007/s12192-010-0248-0; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Duchmann R, 1999, GUT, V44, P812, DOI 10.1136/gut.44.6.812; Ergin A, 2008, MUCOSAL IMMUNOL, V1, pS19, DOI 10.1038/mi.2008.44; Goodman AL, 2009, CELL HOST MICROBE, V6, P279, DOI 10.1016/j.chom.2009.08.003; Hansen JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042645; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lucke K, 2006, J MED MICROBIOL, V55, P617, DOI 10.1099/jmm.0.46198-0; Perez-Munoz ME, 2014, GUT MICROBES, V5, P286, DOI 10.4161/gmic.28622; Peterson DA, 1999, IMMUNITY, V11, P453, DOI 10.1016/S1074-7613(00)80120-X; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; PIRZER U, 1991, LANCET, V338, P1238, DOI 10.1016/0140-6736(91)92104-A; Rath HC, 1996, J CLIN INVEST, V98, P945, DOI 10.1172/JCI118878; Roesch LFW, 2009, ISME J, V3, P536, DOI 10.1038/ismej.2009.5; Saitoh S, 2002, CLIN DIAGN LAB IMMUN, V9, P54, DOI 10.1128/CDLI.9.1.54-59.2002; Sanchez E, 2011, APPL ENVIRON MICROB, V77, P5316, DOI 10.1128/AEM.00365-11; Schloissnig S, 2013, NATURE, V493, P45, DOI 10.1038/nature11711; TerAvest MA, 2014, BIOTECHNOL BIOENG, V111, P165, DOI 10.1002/bit.24994; Vael C, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-68; Vael Carl, 2008, BMC Pulm Med, V8, P19, DOI 10.1186/1471-2466-8-19; Wu N, 2013, MICROB ECOL, V66, P462, DOI 10.1007/s00248-013-0245-9	22	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144382	10.1371/journal.pone.0144382	http://dx.doi.org/10.1371/journal.pone.0144382			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26637014	gold, Green Published			2022-12-27	WOS:000366143800084
J	Hilario, E; Barron, L; Deng, CH; Datson, PM; De Silva, N; Davy, MW; Storey, RD				Hilario, Elena; Barron, Lorna; Deng, Cecilia H.; Datson, Paul M.; De Silva, Nihal; Davy, Marcus W.; Storey, Roy D.			Random Tagging Genotyping by Sequencing (rtGBS), an Unbiased Approach to Locate Restriction Enzyme Sites across the Target Genome	PLOS ONE			English	Article							DNA; AMPLIFICATION; PCR	Genotyping by sequencing (GBS) is a restriction enzyme based targeted approach developed to reduce the genome complexity and discover genetic markers when a priori sequence information is unavailable. Sufficient coverage at each locus is essential to distinguish heterozygous from homozygous sites accurately. The number of GBS samples able to be pooled in one sequencing lane is limited by the number of restriction sites present in the genome and the read depth required at each site per sample for accurate calling of single-nucleotide polymorphisms. Loci bias was observed using a slight modification of the Elshire et al. method: some restriction enzyme sites were represented in higher proportions while others were poorly represented or absent. This bias could be due to the quality of genomic DNA, the endonuclease and ligase reaction efficiency, the distance between restriction sites, the preferential amplification of small library restriction fragments, or bias towards cluster formation of small amplicons during the sequencing process. To overcome these issues, we have developed a GBS method based on randomly tagging genomic DNA (rtGBS). By randomly landing on the genome, we can, with less bias, find restriction sites that are far apart, and undetected by the standard GBS (stdGBS) method. The study comprises two types of biological replicates: six different kiwifruit plants and two independent DNA extractions per plant; and three types of technical replicates: four samples of each DNA extraction, stdGBS vs. rtGBS methods, and two independent library amplifications, each sequenced in separate lanes. A statistically significant unbiased distribution of restriction fragment size by rtGBS showed that this method targeted 49%(39,145) of BamH I sites shared with the reference genome, compared to only 14%(11,513) by stdGBS.	[Hilario, Elena; Barron, Lorna; Deng, Cecilia H.; Datson, Paul M.; De Silva, Nihal] New Zealand Inst Plant & Food Res Ltd, Auckland 1025, New Zealand; [Davy, Marcus W.; Storey, Roy D.] New Zealand Inst Plant & Food Res Ltd, Te Puke 3182, New Zealand	New Zealand Institute for Plant & Food Research Ltd; New Zealand Institute for Plant & Food Research Ltd	Hilario, E (corresponding author), New Zealand Inst Plant & Food Res Ltd, Priv Bag 92-169, Auckland 1025, New Zealand.	elena.hilario@plantandfood.co.nz	Hilario, Elena/ABB-8574-2021; Deng, Cecilia Hong/O-2891-2017	Hilario, Elena/0000-0001-8124-8881; Deng, Cecilia Hong/0000-0002-2954-762X; , Pepe/0000-0002-8794-9985	Centres of Research Excellence/Kiwifruit Royalty Investment project - Kiwifruit Germplasm at Plant Food Research [P/111444/21]	Centres of Research Excellence/Kiwifruit Royalty Investment project - Kiwifruit Germplasm at Plant Food Research	Funding was provided by Centres of Research Excellence/Kiwifruit Royalty Investment project - Kiwifruit Germplasm at Plant & Food Research. Grant number P/111444/21.; We gratefully thank the following scientists at Plant & Food Research: Matthew Templeton for sharing an extra Illumina sequencing lane for an earlier pilot study, Benjamin Warren for bioinformatics support, and Peter Alspach, David Chagne, Zac Hanley, and Richard Newcomb for critically reviewing the manuscript. Anonymous reviewers provided valuable suggestions to improve this manuscript. Funding was provided by Centres of Research Excellence/Kiwifruit Royalty Investment project-Kiwifruit Germplasm at Plant & Food Research. We dedicate this publication to the memory of our dear colleague and friend Dr H. Nihal De Silva.	Ahveninen J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3585; Arneson N., 2008, CSH PROTOC, V2008; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; Eaton D.A.R., 2014, BIOINFORMATICS; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Green MR, 2012, MOL CLONING LAB MANU, V1; GROTHUES D, 1993, NUCLEIC ACIDS RES, V21, P1321, DOI 10.1093/nar/21.5.1321; Heffelfinger C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-979; Hilario E, 2015, PLANT GENOTYPING MET; HOPPING ME, 1994, NEW ZEAL J BOT, V32, P85, DOI 10.1080/0028825X.1994.10410410; JEFFREYS AJ, 1991, NATURE, V354, P204, DOI 10.1038/354204a0; Kasem S, 2008, PLANT GENOTYPING II: SNP TECHNOLOGY, P219, DOI 10.1079/9781845933821.0219; Ko WY, 2003, J MOL EVOL, V57, P562, DOI 10.1007/s00239-003-2510-x; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Sonah H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054603; TAYLOR JM, 1976, BIOCHIM BIOPHYS ACTA, V442, P324, DOI 10.1016/0005-2787(76)90307-5; van Gurp T, 2011, DEENA BIOINFORMATICS; Venables WN., 2002, MODERN APPL STAT S 4; Wong KK, 1996, NUCLEIC ACIDS RES, V24, P3778, DOI 10.1093/nar/24.19.3778; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847	26	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143193	10.1371/journal.pone.0143193	http://dx.doi.org/10.1371/journal.pone.0143193			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633193	Green Submitted, Green Published, gold			2022-12-27	WOS:000366040000009
J	Lima, VD; Rozada, I; Grebely, J; Hull, M; Lourenco, L; Nosyk, B; Krajden, M; Yoshida, E; Wood, E; Montaner, JSG				Lima, Viviane D.; Rozada, Ignacio; Grebely, Jason; Hull, Mark; Lourenco, Lillian; Nosyk, Bohdan; Krajden, Mel; Yoshida, Eric; Wood, Evan; Montaner, Julio S. G.			Are Interferon-Free Direct-Acting Antivirals for the Treatment of HCV Enough to Control the Epidemic among People Who Inject Drugs?	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; OPIATE SUBSTITUTION THERAPY; INFECTION; COHORT; USERS; HIV; COINFECTION; METAANALYSIS; MANAGEMENT; CIRRHOSIS	Background Widely access to interferon-free direct-acting antiviral regimens (IFN-free DAA) is poised to dramatically change the impact of the HCV epidemic among people who inject drugs (PWID). We evaluated the long-term effect of increasing HCV testing, treatment and engagement into harm-reduction activities, focused on active PWID, on the HCV epidemic in British Columbia (BC), Canada. Methods We built a compartmental model of HCV disease transmission stratified by disease progression, transmission risk, and fibrosis level. We explored the effect of: (1) Increasing treatment rates from 8 to 20, 40 and 80 per 1000 infected PWID/year; (2) Increasing treatment eligibility based on fibrosis level; (3) Maximizing the effect of testing by performing it immediately upon ending the acute phase; (4) Increasing access to harm-reduction activities to reduce the risk of re-infection; (5) Different HCV antiviral regimens on the Control Reproduction Number R-c. We assessed the impact of these interventions on incidence, prevalence and mortality from 2016 to 2030. Results Of all HCV antiviral regimens, only IFN-free DAAs offered a high chance of disease elimination (i.e. R-c < 1), but it would be necessary to substantially increase the current low testing and treatment rates. Assuming a treatment rate of 80 per 1000 infected PWID per year, coupled with a high testing rate, the incidence rate, at the end of 2030, could decrease from 92.9 per 1000 susceptible PWID per year (Status Quo) to 82.8 (by treating only PWID with fibrosis level F-2 and higher) or to 65.5 (by treating PWID regardless of fibrosis level). If PWID also had access to increased harm-reduction activities, the incidence rate further decreased to 53.1 per 1000 susceptible PWID per year. We also obtained significant decreases in prevalence and mortality at the end of 2030. Conclusions The combination of increased access to HCV testing, highly efficacious antiviral treatment and harm-reduction programs can substantially decrease the burden of the HCV epidemic among PWID. However, unless we increase the current levels of treatment and testing, the HCV epidemic among PWID in BC, and in other parts of the world with similar epidemiological background, will remain a substantial public health concern for many years.	[Lima, Viviane D.; Rozada, Ignacio; Hull, Mark; Lourenco, Lillian; Nosyk, Bohdan; Wood, Evan; Montaner, Julio S. G.] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Grebely, Jason] Univ New South Wales Australia, Kirby Inst, Sydney, NSW, Australia; [Krajden, Mel] British Columbia Ctr Dis Control, Publ Hlth Microbiol & Reference Lab, Vancouver, BC, Canada; [Yoshida, Eric] Univ British Columbia, Fac Med, Dept Med, Div Gastroenterol, Vancouver, BC, Canada	B.C. Centre for Excellence in HIV/AIDS; University of New South Wales Sydney; Kirby Institute; University of British Columbia	Lima, VD (corresponding author), British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada.	vlima@cfenet.ubc.ca			British Columbia Ministry of Health; US National Institutes of Health [R01DA036307]; US National Institute on Drug Abuse [R03DA033851]; Canadian Institutes of Health Research [MOP-125948]; Michael Institute for Health Research; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA033851, R01DA036307] Funding Source: NIH RePORTER	British Columbia Ministry of Health; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Institute for Health Research; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Dr. Montaner is supported with grants paid to his institution by the British Columbia Ministry of Health and by the US National Institutes of Health (R01DA036307). Dr. Lima was funded by a grant from the US National Institute on Drug Abuse (R03DA033851) during the time this manuscript was first submitted, and she is currently funded by a grant from the Canadian Institutes of Health Research (MOP-125948) and by a Scholar Award from the Michael Institute for Health Research and a New Investigator award from the Canadian Institutes of Health Research.	Alavi M, 2014, LIVER INT, V34, P1198, DOI 10.1111/liv.12370; ANDERSON R M, 1991; Backx M, 2014, J VIRAL HEPATITIS, V21, P208, DOI 10.1111/jvh.12132; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Canada H., SUMMARY BASIS DECISI; Dalgard O, 2005, CLIN INFECT DIS, V40, pS336, DOI 10.1086/427449; De Vos AS, 2013, J THEOR BIOL, V333, P126, DOI 10.1016/j.jtbi.2013.05.017; Deans Gregory D, 2013, CMAJ Open, V1, pE68, DOI 10.9778/cmajo.20130002; Degenhardt L, 2006, SEX TRANSM INFECT, V82, pIII56, DOI 10.1136/sti.2005.019273; Deuffic-Burban S, 2012, GASTROENTEROLOGY, V143, P974, DOI 10.1053/j.gastro.2012.05.054; Deuffic-Burban S, 2012, CLIN INFECT DIS, V54, P1272, DOI 10.1093/cid/cis047; Eckman MH, 2013, CLIN INFECT DIS, V56, P1382, DOI 10.1093/cid/cit069; European Association for The Study of The Liver, EASL REC TREATM HEP; Feld JJ, 2014, SEMIN LIVER DIS, V34, P37, DOI 10.1055/s-0034-1371009; Grebely J, 2011, J VIRAL HEPATITIS, V18, pe104, DOI 10.1111/j.1365-2893.2010.01370.x; Grebely J, 2009, J VIRAL HEPATITIS, V16, P352, DOI 10.1111/j.1365-2893.2009.01080.x; Grebely J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097726; Hagan H, 2011, J INFECT DIS, V204, P74, DOI 10.1093/infdis/jir196; Hajarizadeh B, 2014, J MED VIROL, V86, P1722, DOI 10.1002/jmv.24010; Hernandez MD, 2011, CURR OPIN HIV AIDS, V6, P478, DOI 10.1097/COH.0b013e32834bd365; Hezode C, 2013, J HEPATOL, V59, P434, DOI 10.1016/j.jhep.2013.04.035; Holmberg SD, 2013, NEW ENGL J MED, V368, P1859, DOI 10.1056/NEJMp1302973; Hull M, 2013, CAN J INFECT DIS MED, V24, P217, DOI 10.1155/2013/781410; Jennings CL, 2012, CURR HIV-AIDS REP, V9, P231, DOI 10.1007/s11904-012-0122-z; Kleinman SH, 2009, TRANSFUSION, V49, P2454, DOI 10.1111/j.1537-2995.2009.02322.x; Lai M, 2011, AM J GASTROENTEROL, V106, P2121, DOI 10.1038/ajg.2011.343; Lawitz E, 2013, LANCET INFECT DIS, V13, P401, DOI 10.1016/S1473-3099(13)70033-1; Marcellin P, 2013, LANCET, V381, P468, DOI 10.1016/S0140-6736(12)61425-1; Martin NK, 2013, HEPATOLOGY, V58, P1598, DOI 10.1002/hep.26431; Martin NK, 2011, J HEPATOL, V54, P1137, DOI 10.1016/j.jhep.2010.08.029; Martin NK, 2011, J THEOR BIOL, V274, P58, DOI 10.1016/j.jtbi.2010.12.041; Merkinaite Simona, 2008, Central European Journal of Public Health, V16, P106; Moyer VA, 2013, ANN INTERN MED, V159, P349, DOI 10.7326/0003-4819-159-5-201309030-00672; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; Razavi H, 2014, J VIRAL HEPATITIS, V21, P34, DOI 10.1111/jvh.12248; Rolls DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078286; Rosen HR, 2011, NEW ENGL J MED, V364, P2429, DOI 10.1056/NEJMcp1006613; Shah NG, 2006, DRUG ALCOHOL DEPEN, V83, P147, DOI 10.1016/j.drugalcdep.2005.11.007; Soriano V, 2009, CLIN INFECT DIS, V48, P313, DOI 10.1086/595848; Soriano V, 2007, AIDS, V21, P1073, DOI 10.1097/QAD.0b013e3281084e4d; Swan D, 2010, AIDS PATIENT CARE ST, V24, P753, DOI 10.1089/apc.2010.0142; Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375; Turner KME, 2011, ADDICTION, V106, P1978, DOI 10.1111/j.1360-0443.2011.03515.x; Van den Berg C, 2007, ADDICTION, V102, P1454, DOI 10.1111/j.1360-0443.2007.01912.x; Vickerman P, 2012, ADDICTION, V107, P1984, DOI 10.1111/j.1360-0443.2012.03932.x; Wagner BG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041212; Wendt A, 2014, CLIN PHARMACOL-ADV A, V6, P1, DOI 10.2147/CPAA.S30338	48	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143836	10.1371/journal.pone.0143836	http://dx.doi.org/10.1371/journal.pone.0143836			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX9QI	26633652	gold, Green Published, Green Submitted			2022-12-27	WOS:000366040000025
J	Schaarschmidt, ML; Kromer, C; Herr, R; Schmieder, A; Sonntag, D; Goerdt, S; Peitsch, WK				Schaarschmidt, Marthe-Lisa; Kromer, Christian; Herr, Raphael; Schmieder, Astrid; Sonntag, Diana; Goerdt, Sergij; Peitsch, Wiebke K.			Patient Preferences for Biologicals in Psoriasis: Top Priority of Safety for Cardiovascular Patients	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; RANDOMIZED CONTROLLED-TRIALS; ANTI-TNF-THERAPY; QUALITY-OF-LIFE; IL 12/23 AGENTS; RHEUMATOID-ARTHRITIS; DOUBLE-BLIND; INSULIN SENSITIVITY; PLAQUE PSORIASIS; 2 METAANALYSES	Patients with psoriasis are often affected by comorbidities, which largely influence treatment decisions. Here we performed conjoint analysis to assess the impact of comorbidities on preferences of patients with moderate-to-severe psoriasis for outcome (probability of 50% and 90% improvement, time until response, sustainability of success, probability of mild and severe adverse events (AE), probability of ACR 20 response) and process attributes (treatment location, frequency, duration and delivery method) of biologicals. The influence of comorbidities on Relative Importance Scores (RIS) was determined with analysis of variance and multivariate regression. Among the 200 participants completing the study, 22.5% suffered from psoriatic arthritis, 31.5% from arterial hypertension, 15% from cardiovascular disease (myocardial infarction, stroke, coronary artery disease, and/or arterial occlusive disease), 14.5% from diabetes, 11% from hyperlipidemia, 26% from chronic bronchitis or asthma and 12.5% from depression. Participants with psoriatic arthritis attached greater importance to ACR 20 response (RIS = 10.3 vs. 5.0, p<0.001; beta = 0.278, p<0.001) and sustainability (RIS = 5.8 vs. 5.0, p = 0.032) but less value to time until response (RIS = 3.4 vs. 4.8, p = 0.045) than those without arthritis. Participants with arterial hypertension were particularly interested in a low risk of mild AE (RIS 9.7 vs. 12.1; p = 0.033) and a short treatment duration (RIS = 8.0 vs. 9.6, p = 0.002). Those with cardiovascular disease worried more about mild AE (RIS = 12.8 vs. 10, p = 0.027; beta = 0.170, p = 0.027) and severe AE (RIS = 23.2 vs. 16.2, p = 0.001; beta = 0.203, p = 0.007) but cared less about time until response (beta = -0.189, p = 0.013), treatment location (beta = -0.153, p = 0.049), frequency (beta = -0.20, p = 0.008) and delivery method (beta = -0.175, p = 0.023) than others. Patients' concerns should be addressed in-depth when prescribing biologicals to comorbid patients, keeping in mind that TNF antagonists may favourably influence cardiovascular risk.	[Schaarschmidt, Marthe-Lisa; Kromer, Christian; Schmieder, Astrid; Goerdt, Sergij; Peitsch, Wiebke K.] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Dermatol, Mannheim, Germany; [Herr, Raphael; Sonntag, Diana] Heidelberg Univ, Mannheim Inst Publ Hlth Social & Prevent Med, Med Fac Mannheim, Mannheim, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Peitsch, WK (corresponding author), Heidelberg Univ, Univ Med Ctr Mannheim, Dept Dermatol, Mannheim, Germany.	wiebke.ludwig@umm.de	Herr, Raphael/GYU-5115-2022	Herr, Raphael/0000-0003-0079-2792	German network "Health Services Research Baden-Wurttemberg" of the Ministry of Science, Research and Arts; Ministry of Employment and Social Order, Family, Women and Senior Citizens, Baden-Wurttemberg	German network "Health Services Research Baden-Wurttemberg" of the Ministry of Science, Research and Arts; Ministry of Employment and Social Order, Family, Women and Senior Citizens, Baden-Wurttemberg	The study was funded by the young scientists' program of the German network "Health Services Research Baden-Wurttemberg" of the Ministry of Science, Research and Arts in collaboration with the Ministry of Employment and Social Order, Family, Women and Senior Citizens, Baden-Wurttemberg (grant to Marthe-Lisa Schaarschmidt).	Ahlehoff O, 2015, J EUR ACAD DERMATOL, V29, P1128, DOI 10.1111/jdv.12768; Ahlehoff O, 2013, J INTERN MED, V273, P197, DOI 10.1111/j.1365-2796.2012.02593.x; Angel K, 2010, HYPERTENSION, V55, P333, DOI 10.1161/HYPERTENSIONAHA.109.143982; Armstrong AW, 2014, BRIT J DERMATOL, V170, P304, DOI 10.1111/bjd.12670; Armstrong EJ, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000062; Ash Z, 2012, ANN RHEUM DIS, V71, P319, DOI 10.1136/ard.2011.150995; Augustin M, 2011, DERMATOLOGY, V222, P363, DOI 10.1159/000329026; Benson MM, 2015, CARDIOL REV, V23, P312, DOI 10.1097/CRD.0000000000000048; Boehncke WH, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5666; Candia R, 2015, J EUR ACAD DERMATOL, V29, P656, DOI 10.1111/jdv.12847; Christophers E, 2013, J DERMATOL TREAT, V24, P193, DOI 10.3109/09546634.2012.697112; Chung ES, 2003, CIRCULATION, V107, P3133, DOI 10.1161/01.CIR.0000077913.60364.D2; Dommasch ED, 2014, J AM ACAD DERMATOL, V70, P381, DOI 10.1016/j.jaad.2013.10.053; Dommasch ED, 2013, J AM ACAD DERMATOL, V68, P863, DOI 10.1016/j.jaad.2013.01.011; Dowlatshahi EA, 2014, J INVEST DERMATOL, V134, P1542, DOI 10.1038/jid.2013.508; Duffin KC, 2014, BRIT J DERMATOL, V170, P672, DOI 10.1111/bjd.12745; Gerdes S, 2008, BRIT J DERMATOL, V159, P1116, DOI 10.1111/j.1365-2133.2008.08786.x; Gonzalez-Gay MA, 2006, CLIN EXP RHEUMATOL, V24, P83; Gottlieb A, 2008, J AM ACAD DERMATOL, V58, P851, DOI 10.1016/j.jaad.2008.02.040; Hugh J, 2014, J AM ACAD DERMATOL, V70, P168, DOI 10.1016/j.jaad.2013.09.020; Jokai H, 2013, J AM ACAD DERMATOL, V69, P523, DOI 10.1016/j.jaad.2013.06.019; Kannan S, 2013, J DERMATOL TREAT, V24, P148, DOI 10.3109/09546634.2011.619159; Kimball AB, 2011, J EUR ACAD DERMATOL, V25, P157, DOI 10.1111/j.1468-3083.2010.03730.x; Kimball AB, 2008, J AM ACAD DERMATOL, V58, P1031, DOI 10.1016/j.jaad.2008.01.006; Kromer C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129120; Langley RG, 2010, J AM ACAD DERMATOL, V63, P457, DOI 10.1016/j.jaad.2009.09.014; Marra M, 2007, INT J IMMUNOPATH PH, V20, P731, DOI 10.1177/039463200702000408; McInnes IB, 2013, LANCET, V382, P780, DOI 10.1016/S0140-6736(13)60594-2; Mehta NN, 2011, AM J MED, V124, DOI 10.1016/j.amjmed.2011.03.028; Menter A, 2010, J AM ACAD DERMATOL, V62, P812, DOI 10.1016/j.jaad.2009.07.022; Mrowietz U, 2014, EXP DERMATOL, V23, P705, DOI 10.1111/exd.12437; Nast A, 2013, J INVEST DERMATOL, V133, P1963, DOI 10.1038/jid.2013.78; Nast A, 2012, J DTSCH DERMATOL GES, V10, DOI 10.1111/j.1610-0387.2012.07919.x; Papp KA, 2013, BRIT J DERMATOL, V168, P844, DOI 10.1111/bjd.12214; Picardi A, 2013, CLIN DERMATOL, V31, P47, DOI 10.1016/j.clindermatol.2011.11.006; Pina T, 2016, J EUR ACAD DERMATOL, V30, P92, DOI 10.1111/jdv.13005; Pina T, 2015, J EUR ACAD DERMATOL, V29, P1325, DOI 10.1111/jdv.12814; Reich K, 2012, BRIT J DERMATOL, V166, P179, DOI 10.1111/j.1365-2133.2011.10583.x; Reich K, 2011, BRIT J DERMATOL, V164, P862, DOI 10.1111/j.1365-2133.2011.10257.x; Ryan C, 2011, JAMA-J AM MED ASSOC, V306, P864, DOI 10.1001/jama.2011.1211; Samarasekera EJ, 2013, J INVEST DERMATOL, V133, P2340, DOI 10.1038/jid.2013.149; Schaarschmidt ML, 2013, J EUR ACAD DERMATOL, V27, P187, DOI 10.1111/j.1468-3083.2011.04440.x; Schaarschmidt ML, 2011, ARCH DERMATOL, V147, P1285, DOI 10.1001/archdermatol.2011.309; Schmieder A, 2012, J AM ACAD DERMATOL, V67, P363, DOI 10.1016/j.jaad.2011.08.023; Shlyankevich J, 2014, AM J MED, V127, P1148, DOI 10.1016/j.amjmed.2014.08.008; Solomon DH, 2011, JAMA-J AM MED ASSOC, V305, P2525, DOI 10.1001/jama.2011.878; Strober B, 2008, BRIT J DERMATOL, V159, P322, DOI 10.1111/j.1365-2133.2008.08628.x; Tam LS, 2014, RHEUMATOLOGY, V53, P1108, DOI 10.1093/rheumatology/ket454; Taylor W, 2006, ARTHRITIS RHEUM, V54, P2665, DOI 10.1002/art.21972; Tezel N, 2015, INT J RHEUM DIS, V18, P63, DOI 10.1111/1756-185X.12283; Tzellos T, 2013, J EUR ACAD DERMATOL, V27, P622, DOI 10.1111/j.1468-3083.2012.04500.x; Tzellos T, 2014, J AM ACAD DERMATOL, V70, P380, DOI 10.1016/j.jaad.2013.07.050; Umar N, 2012, ACTA DERM-VENEREOL, V92, P341, DOI 10.2340/00015555-1304; van Cranenburgh OD, 2013, BRIT J DERMATOL, V169, P398, DOI 10.1111/bjd.12372; Westlake SL, 2011, RHEUMATOLOGY, V50, P518, DOI 10.1093/rheumatology/keq316; Wu JJ, 2012, ARCH DERMATOL, V148, P1244, DOI 10.1001/archdermatol.2012.2502	56	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144335	10.1371/journal.pone.0144335	http://dx.doi.org/10.1371/journal.pone.0144335			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633680	Green Published, gold, Green Submitted			2022-12-27	WOS:000366040000081
J	Wakatsuki, Y; Shinojima, A; Kawamura, A; Yuzawa, M				Wakatsuki, Yu; Shinojima, Ari; Kawamura, Akiyuki; Yuzawa, Mitsuko			Correlation of Aging and Segmental Choroidal Thickness Measurement using Swept Source Optical Coherence Tomography in Healthy Eyes	PLOS ONE			English	Article							RETINAL-PIGMENT EPITHELIUM; BRUCHS MEMBRANE; JAPANESE SUBJECTS; CHORIOCAPILLARIS; VOLUME	Purpose To assess and compare choroidal thickness changes related to aging, we determined whether changes are due to thinning of the choriocapillaris plus Sattler's (CS) layer and/or the large vessel layer in healthy eyes using swept-source optical coherence tomography (SS-OCT) at a wavelength of 1,050-nm. Methods We studied 115 normal eyes of 115 healthy volunteers, all with refractive errors of less than -6 diopters. All 115 eyes underwent analysis of choroidal thickness at the fovea, the CS layer and the large choroidal vessel layer. In 68 of the 115 eyes, choroidal thickness was determined at five sites (the fovea, and superior, inferior, nasal, and temporal sites) using SS-OCT with an Early Treatment of Diabetic Retinopathy grid scan. Results Total choroidal thicknesses at each of the five sites were related to subject age (P<0.0001). The choroid was thinnest at the nasal site, followed by the temporal, inferior, superior and finally the subfoveal site itself. The total choroidal thickness at the nasal site was significantly less than those at the other four sites (p<0.05). The CS layer showed thinning which correlated with age (P<0.0001). The thickness of the choroidal large vessel layer also decreased with age (p = 0.02). Subfoveal choroidal thickness was calculated as follows: 443.89-2.98xage (mu m) (P<0.0001). Conclusion Subfoveal choroidal thickness decreases by 2.98 mu m each year. Total choroidal thickness diminishes with age. The CS and large vessel layers of the choroid at the subfovea showed significant decreases, though only the former correlated strongly with age.	[Wakatsuki, Yu; Shinojima, Ari; Kawamura, Akiyuki; Yuzawa, Mitsuko] Nihon Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan	Nihon University	Shinojima, A (corresponding author), Nihon Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan.	shinojima.ari@nihon-u.ac.jp	Shinojima, Ari/AAR-4442-2021	Shinojima, Ari/0000-0003-2322-0332				Agawa T, 2011, GRAEF ARCH CLIN EXP, V249, P1485, DOI 10.1007/s00417-011-1708-7; Bird AC, 2003, EYE, V17, P457, DOI 10.1038/sj.eye.6700562; Blaauwgeers HGT, 1999, AM J PATHOL, V155, P421, DOI 10.1016/S0002-9440(10)65138-3; Branchini LA, 2013, OPHTHALMOLOGY, V120, P1901, DOI 10.1016/j.ophtha.2013.01.066; Chan-Ling T, 2011, EXP EYE RES, V92, P361, DOI 10.1016/j.exer.2011.02.009; Chan-Ling T, 2011, INVEST OPHTH VIS SCI, V52, P399, DOI 10.1167/iovs.10-5403; Chen FK, 2012, INVEST OPHTH VIS SCI, V53, P975, DOI 10.1167/iovs.11-8771; Esmaeelpour M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099690; Fujiwara A, 2012, JPN J OPHTHALMOL, V56, P230, DOI 10.1007/s10384-012-0128-5; Fujiwara T, 2009, AM J OPHTHALMOL, V148, P445, DOI 10.1016/j.ajo.2009.04.029; Hirata M, 2011, INVEST OPHTH VIS SCI, V52, P4971, DOI 10.1167/iovs.11-7729; HOLZ FG, 1994, ARCH OPHTHALMOL-CHIC, V112, P402, DOI 10.1001/archopht.1994.01090150132035; Ikuno Y, 2010, INVEST OPHTH VIS SCI, V51, P2173, DOI 10.1167/iovs.09-4383; Ikuno Y, 2009, INVEST OPHTH VIS SCI, V50, P3876, DOI 10.1167/iovs.08-3325; Koina ME, 2015, INVEST OPHTH VIS SCI, V56, P1310, DOI 10.1167/iovs.14-15705; Manjunath V, 2010, AM J OPHTHALMOL, V150, P325, DOI 10.1016/j.ajo.2010.04.018; Mansouri K, 2013, OPHTHALMOLOGY, V120, P2508, DOI 10.1016/j.ophtha.2013.07.040; Margolis R, 2009, AM J OPHTHALMOL, V147, P811, DOI 10.1016/j.ajo.2008.12.008; Marneros AG, 2005, AM J PATHOL, V167, P1451, DOI 10.1016/S0002-9440(10)61231-X; MOORE DJ, 1995, INVEST OPHTH VIS SCI, V36, P1290; Mwanza JC, 2011, INVEST OPHTH VIS SCI, V52, P3430, DOI 10.1167/iovs.10-6600; Ouyang YL, 2011, INVEST OPHTH VIS SCI, V52, P7019, DOI 10.1167/iovs.11-8046; PAULEIKHOFF D, 1990, OPHTHALMOLOGY, V97, P171; Rahman W, 2011, INVEST OPHTH VIS SCI, V52, P2267, DOI 10.1167/iovs.10-6024; RAMRATTAN RS, 1994, INVEST OPHTH VIS SCI, V35, P2857; Schlingemann RO, 2004, GRAEF ARCH CLIN EXP, V242, P91, DOI 10.1007/s00417-003-0828-0; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Yamashita T, 2012, INVEST OPHTH VIS SCI, V53, P1102, DOI 10.1167/iovs.11-8836	28	79	82	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144156	10.1371/journal.pone.0144156	http://dx.doi.org/10.1371/journal.pone.0144156			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26632821	Green Submitted, gold, Green Published			2022-12-27	WOS:000366040000063
J	Wakisaka, N; Hasegawa, Y; Yoshimoto, S; Miura, K; Shiotani, A; Yokoyama, J; Sugasawa, M; Moriyama-Kita, M; Endo, K; Yoshizaki, T				Wakisaka, Naohiro; Hasegawa, Yasuhisa; Yoshimoto, Seiichi; Miura, Kouki; Shiotani, Akihiro; Yokoyama, Junkichi; Sugasawa, Masashi; Moriyama-Kita, Makiko; Endo, Kazuhira; Yoshizaki, Tomokazu			Primary Tumor-Secreted Lymphangiogenic Factors Induce Pre-Metastatic Lymphvascular Niche Formation at Sentinel Lymph Nodes in Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; VEGF-C; CANCER PROGRESSION; TYROSINE KINASES; NECK DISSECTION; BREAST-CANCER; VESSELS; MIGRATION; VENULES; TONGUE	Objectives The objectives of this study were to evaluate the formation of lymphvascular niches in lymph nodes of patients with oral squamous cell carcinoma (OSCC), and investigate the roles of lymphangiogenic and angiogenic factors, such as vascular endothelial growth factor (VEGF)-A, VEGF-C, and VEGF-D, expressed in the primary tumors. Materials and Methods Forty-four patients with previously untreated clinically late T2 or T3 OSCC of cN0 were evaluated for primary tumors and 166 sentinel lymph nodes (SLNs). Primary tumors were immunohistochemically analyzed for expressions of VEGFs. Densities of lymphatic vessels (LVDpodoplanin) and high endothelial venules (HEVD) in the SLNs were also calculated using antibodies for each marker, podoplanin and MECA-79, respectively. Results In 25 patients, all lymph nodes were metastasis-negative, whereas, in 19 patients, metastasis was positive for at least one lymph node (either at SLN, non-SLN, or nodal recurrence). From the analyses of 140 SLNs without metastasis, LVDpodoplanin in 50 SLNs of metastasis-positive cases was significantly higher than that in 90 SLNs of metastasis-negative cases (p = 0.0025). HEVD was not associated with lymph node metastasis. The patients with VEGF-A-High or VEGF-D-High tumors had significantly higher LVDpodoplanin than patients with their Low counterparts (p = 0.0233 and p = 0.0209, respectively). In cases with lymph node metastasis, the VEGF-D-expression score was significantly higher than in those without lymph node metastasis (p = 0.0006). Conclusions These results suggest that lymph node lymphangiogenesis occurs before metastasis in OSCC. VEGF-A and VEGF-D play critical roles in this process. VEGF-D is a potential predictive marker of positive lymph node metastasis in cN0 patients.	[Wakisaka, Naohiro; Moriyama-Kita, Makiko; Endo, Kazuhira; Yoshizaki, Tomokazu] Kanazawa Univ, Div Otolaryngol & Head & Neck Surg, Kanazawa, Ishikawa, Japan; [Hasegawa, Yasuhisa] Aichi Canc Ctr, Dept Head & Neck Surg, Nagoya, Aichi 464, Japan; [Yoshimoto, Seiichi] Natl Canc Ctr, Dept Head & Neck Oncol, Chuo Ku, Tokyo, Japan; [Miura, Kouki] Int Univ Hlth & Welf, Mita Hosp, Dept Head & Neck Oncol & Surg, Minato Ku, Tokyo, Japan; [Shiotani, Akihiro] Natl Def Med Coll, Dept Otolaryngol Head & Neck Surg, Tokorozawa, Saitama 359, Japan; [Yokoyama, Junkichi] Juntendo Univ, Fac Med, Dept Otorhinolaryngol, Bunkyo Ku, Tokyo, Japan; [Sugasawa, Masashi] Saitama Med Univ, Int Med Ctr, Dept Head & Neck Surg & Otolaryngol, Hidaka, Saitama, Japan	Kanazawa University; Aichi Cancer Center; National Cancer Center - Japan; International University of Health & Welfare; National Defense Medical College - Japan; Juntendo University; Saitama Medical University	Wakisaka, N (corresponding author), Kanazawa Univ, Div Otolaryngol & Head & Neck Surg, Kanazawa, Ishikawa, Japan.	wakisaka@med.kanazawa-u.ac.jp			Ministry of Education, Science, Sports, Culture and Technology of Japan [C21592189]; Astellas Foundation on Metabolic Disorders; Health and Labor Sciences Research Grant for Clinical Cancer Research [H24-Gannrinshou-Japan-006]	Ministry of Education, Science, Sports, Culture and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Astellas Foundation on Metabolic Disorders; Health and Labor Sciences Research Grant for Clinical Cancer Research	This work was supported by a scientific research grant from the Ministry of Education, Science, Sports, Culture and Technology of Japan (C21592189), a research grant from the Astellas Foundation on Metabolic Disorders, and a Health and Labor Sciences Research Grant for Clinical Cancer Research (H24-Gannrinshou-Japan-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achen MG, 1998, P NATL ACAD SCI USA, V95, P548, DOI 10.1073/pnas.95.2.548; Alex JC, 2000, LARYNGOSCOPE, V110, P198, DOI 10.1097/00005537-200002010-00003; Alitalo A, 2012, ONCOGENE, V31, P4499, DOI 10.1038/onc.2011.602; Argiris A, 2008, LANCET, V371, P1695, DOI 10.1016/S0140-6736(08)60728-X; Broglie MA, 2011, ANN SURG ONCOL, V18, P2732, DOI 10.1245/s10434-011-1780-6; Chepeha DB, 2002, HEAD NECK-J SCI SPEC, V24, P432, DOI 10.1002/hed.10067; Chung MK, 2012, ANN SURG ONCOL, V19, P1595, DOI 10.1245/s10434-011-2154-9; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; Dellinger MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074686; Duda DG, 2010, CANCER RES, V70, P5670, DOI 10.1158/0008-5472.CAN-10-0119; Duvvuri U, 2004, LARYNGOSCOPE, V114, P2228, DOI 10.1097/01.mlg.0000149464.73080.20; Ferris RL, 2012, CLIN EXP METASTAS, V29, P729, DOI 10.1007/s10585-012-9520-2; George ML, 2001, NEOPLASIA, V3, P420, DOI 10.1038/sj.neo.7900186; Girard JP, 2012, NAT REV IMMUNOL, V12, P762, DOI 10.1038/nri3298; He YL, 2004, CANCER RES, V64, P3737, DOI 10.1158/0008-5472.CAN-04-0088; Hirakawa S, 2005, J EXP MED, V201, P1089, DOI 10.1084/jem.20041896; Hirakawa S, 2009, CANCER SCI, V100, P983, DOI 10.1111/j.1349-7006.2009.01142.x; Hirota K, 2012, HISTOPATHOLOGY, V61, P1065, DOI 10.1111/j.1365-2559.2012.04341.x; Ishii H, 2010, ORAL ONCOL, V46, P373, DOI 10.1016/j.oraloncology.2010.02.014; Joukov V, 1996, EMBO J, V15, P290; Jurisic G, 2012, CIRC RES, V111, P426, DOI 10.1161/CIRCRESAHA.112.269399; Karaman S, 2014, J CLIN INVEST, V124, P922, DOI 10.1172/JCI71606; Lee SY, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-206; Martinet L, 2011, CANCER RES, V71, P5678, DOI 10.1158/0008-5472.CAN-11-0431; Niki T, 2000, CLIN CANCER RES, V6, P2431; Paget G, 1889, Br Med J, V1, P1; Ruddle NH, 2014, J CLIN INVEST, V124, P953, DOI 10.1172/JCI71611; SACKSTEIN R, 1993, SEMIN ONCOL, V20, P34; Sano D, 2007, CANCER METAST REV, V26, P645, DOI 10.1007/s10555-007-9082-y; Sceneay J, 2013, CANCER METAST REV, V32, P449, DOI 10.1007/s10555-013-9420-1; Shrestha B, 2010, J IMMUNOL, V184, P4819, DOI 10.4049/jimmunol.0903063; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; STREETER PR, 1988, J CELL BIOL, V107, P1853, DOI 10.1083/jcb.107.5.1853; Tanaka M, 2010, CANCER SCI, V101, P2121, DOI 10.1111/j.1349-7006.2010.01649.x; Terada A, 2011, EUR ARCH OTO-RHINO-L, V268, P429, DOI 10.1007/s00405-010-1364-2; von Andrian UH, 1998, CELL ADHES COMMUN, V6, P85	36	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144056	10.1371/journal.pone.0144056	http://dx.doi.org/10.1371/journal.pone.0144056			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630663	gold, Green Submitted, Green Published			2022-12-27	WOS:000365926300151
J	Kogure, A; Kotani, K; Katada, S; Takagi, H; Kamikozuru, M; Isaji, T; Hakata, S				Kogure, Akira; Kotani, Kazuhiko; Katada, Shigehiko; Takagi, Hiroshi; Kamikozuru, Masahiro; Isaji, Takashi; Hakata, Setsuo			A Randomized, Single-Blind, Placebo-Controlled Study on the Efficacy of the Arthrokinematic Approach-Hakata Method in Patients with Chronic Nonspecific Low Back Pain	PLOS ONE			English	Article							MORRIS DISABILITY QUESTIONNAIRE; VISUAL ANALOG SCALE; QUALITY-OF-LIFE; CONTROLLED-TRIAL; PRIMARY-CARE; PHYSICAL-THERAPY; EXERCISE THERAPY; MANAGEMENT; VALIDATION; VALIDITY	Study design cized, single-blind, controlled trial. Objective To investigate the efficacy of the Arthrokinematic approach (AKA)-Hakata (H) method for chronic low back pain. Summary of Background Data The AKA-H method is used to manually treat abnormalities of intra-articular movement. Methods One hundred eighty-six patients with chronic nonspecific low back pain randomly received either the AKA-H method (AKA-H group) or the sham technique (S group) monthly for 6 months. Data were collected at baseline and once a month. Outcome measures were pain intensity (visual analogue scale [VAS]) and quality of life (the Roland-Morris Disability Questionnaire [RDQ] and Short Form SF-36 questionnaire [SF-36]). Results At baseline, the VAS, RDQ, and SF-36 scores showed similar levels between the groups. After 6 months, the AKA-H group had more improvement in the VAS (42.8% improvement) and RDQ score (31.1% improvement) than the sham group (VAS: 10.4% improvement; RDQ: 9.8% improvement; both, P < 0.001). The respective scores for the SF-36 subscales (physical functioning, role physical, bodily pain, social functioning, general health perception, role emotional, and mental health) were also significantly more improved in the AKA-H group than in the sham group (all, P < 0.001). The scores for the physical, psychological, and social aspects of the SF-36 subscales showed similar improvement in the AKA-H group. Conclusion The AKA-H method can be effective in managing chronic low back pain.	[Kogure, Akira] Sakura Orthoped Hosp, Phys Med & Rehabil, Chiba, Japan; [Kotani, Kazuhiko] Jichi Med Univ, Div Community & Family Med, Shimotsuke, Tochigi, Japan; [Kotani, Kazuhiko] Jichi Med Univ, Dept Clin Lab Med, Dept Publ Hlth, Shimotsuke, Tochigi, Japan; [Katada, Shigehiko] Katada Orthoped Clin, Orthoped Div, Shimbashi, Kanagawa, Japan; [Takagi, Hiroshi] Saitama Prefectural Rehabil Ctr, Dept Orthoped, Ageo, Saitama, Japan; [Kamikozuru, Masahiro] Oka Orthoped Hosp, Dept Orthoped, Sagamihara, Kanagawa, Japan; [Isaji, Takashi] Teikyo Univ, Sch Med, Dept Rehabil Med, Tokyo 173, Japan; [Hakata, Setsuo] Japanese Med Soc Arthrokinemat Approach, Phys Med & Rehabil, Yamanashi, Japan	Jichi Medical University; Jichi Medical University; Teikyo University	Kogure, A (corresponding author), Sakura Orthoped Hosp, Phys Med & Rehabil, Chiba, Japan.	anakin_kogure@ybb.ne.jp						Aaronson N K, 1992, Qual Life Res, V1, P349, DOI 10.1007/BF00434949; Airaksinen O, 2006, EUR SPINE J, V15, pS192, DOI 10.1007/s00586-006-1072-1; Andersson GBJ, 1999, LANCET, V354, P581, DOI 10.1016/S0140-6736(99)01312-4; Arnau JM, 2006, EUR SPINE J, V15, P543, DOI 10.1007/s00586-005-1027-y; Aure OF, 2003, SPINE, V28, P525, DOI 10.1097/00007632-200303150-00002; Boonstra AM, 2008, INT J REHABIL RES, V31, P165, DOI 10.1097/MRR.0b013e3282fc0f93; Cherkin DC, 2011, ANN INTERN MED, V155, P1, DOI 10.7326/0003-4819-155-1-201107050-00002; Cherkin DC, 1998, NEW ENGL J MED, V339, P1021, DOI 10.1056/NEJM199810083391502; Chou R., 2009, GUIDELINE EVALUATION; Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; Chou R, 2009, LANCET, V373, P463, DOI 10.1016/S0140-6736(09)60172-0; Clancy CM, 2005, HEALTH AFFAIR, V24, P151, DOI 10.1377/hlthaff.24.1.151; COSTE J, 1995, REV EPIDEMIOL SANTE, V43, P127; Croft PR, 1998, BRIT MED J, V316, P1356, DOI 10.1136/bmj.316.7141.1356; Dworkin RH, 2007, PAIN, V132, P237, DOI 10.1016/j.pain.2007.08.033; Ernst E, 1999, J PAIN SYMPTOM MANAG, V17, P65, DOI 10.1016/S0885-3924(98)00129-8; Fairbank J, 2011, SPINE, V36, P19; Ferreira-Valente MA, 2011, PAIN, V152, P2399, DOI 10.1016/j.pain.2011.07.005; Friedly J, 2010, PHYS MED REH CLIN N, V21, P659, DOI 10.1016/j.pmr.2010.08.002; Fritz JM, 2001, PHYS THER, V81, P776, DOI 10.1093/ptj/81.2.776; Fujiwara A, 2003, SPINE, V28, P1601, DOI 10.1097/00007632-200307150-00023; Fukuhara S, 2002, PHARMACOECONOMICS, V20, P17, DOI 10.2165/00019053-200220002-00003; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1037, DOI 10.1016/S0895-4356(98)00095-X; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1045, DOI 10.1016/S0895-4356(98)00096-1; Furlan AD, 2002, SPINE, V27, P1896, DOI 10.1097/00007632-200209010-00017; GARG A, 1992, OCCUP MED, V7, P593; GARROW JS, 1985, INT J OBESITY, V9, P147; GILBERT JR, 1986, CAN FAM PHYSICIAN, V32, P1855; Goldby LJ, 2006, SPINE, V31, P1083, DOI 10.1097/01.brs.0000216464.37504.64; Hakata S, 2005, MAN MED, V43, P19, DOI 10.1007/s00337-005-0339-7; Hay EM, 2005, LANCET, V365, P2024, DOI 10.1016/S0140-6736(05)66696-2; Hayden JA, 2005, ANN INTERN MED, V142, P776, DOI 10.7326/0003-4819-142-9-200505030-00014; Hayden JA, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000335.pub2; Hendriks H., 2006, KNGF GUIDELINES NONS; Henschke N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002014.pub3; Hestbaek L, 2003, EUR SPINE J, V12, P149, DOI 10.1007/s00586-002-0508-5; HUSKISSON EC, 1974, LANCET, V2, P1127, DOI 10.1016/S0140-6736(74)90884-8; International Academy of Manual/ Musculoskeletal Medicine, FIMM ONL; Kaltenborn FM, 1976, MANUAL THERAPY EXTRE; Kelley JM, 2009, PSYCHOSOM MED, V71, P789, DOI 10.1097/PSY.0b013e3181acee12; Krismer M, 2007, BEST PRACT RES CL RH, V21, P77, DOI 10.1016/j.berh.2006.08.004; Lamb SE, 2010, LANCET, V375, P916, DOI 10.1016/S0140-6736(09)62164-4; Lampe A, 1998, J PSYCHOSOM RES, V44, P555, DOI 10.1016/S0022-3999(97)00231-6; LANGLEY GB, 1985, RHEUMATOL INT, V5, P145, DOI 10.1007/BF00541514; LEAVITT F, 1979, PAIN, V7, P187, DOI 10.1016/0304-3959(79)90010-1; Leboeuf-Yde C, 1997, J Manipulative Physiol Ther, V20, P507; MacConaill MA, 1977, MUSCLES MOVEMENTS BA, P31; McCarney R, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-30; MCMAHON SB, 2005, WALL MELZACKS TXB PA; Mennell J.M, 1964, JOINT PAIN DIAGNOSIS, P1; Nakamura M, 2003, SPINE, V28, P2414, DOI 10.1097/01.BRS.0000085425.90995.09; Nicholas MK, 2011, PHYS THER, V91, P737, DOI 10.2522/ptj.20100224; POLATIN PB, 1993, SPINE, V18, P66, DOI 10.1097/00007632-199301000-00011; PRICE DD, 1983, PAIN, V17, P45, DOI 10.1016/0304-3959(83)90126-4; Ransford AO., 1976, SPINE, V1, P127, DOI DOI 10.1097/00007632-197606000-00007; Roelofs PDDM, 2008, SPINE, V33, P1766, DOI 10.1097/BRS.0b013e31817e69d3; ROLAND M, 1983, SPINE, V8, P141, DOI 10.1097/00007632-198303000-00004; Roland M, 2000, SPINE, V25, P3115, DOI 10.1097/00007632-200012150-00006; ROSE SJ, 1982, PHYS THER, V62, P1754, DOI 10.1093/ptj/62.12.1754; ROSOMOFF HL, 1989, PAIN, V37, P279, DOI 10.1016/0304-3959(89)90192-9; Rubinstein SM, 2011, SPINE, V36, pE825, DOI 10.1097/BRS.0b013e3182197fe1; SHEKELLE PG, 1992, ANN INTERN MED, V117, P590, DOI 10.7326/0003-4819-117-7-590; Shirado O, 2010, SPINE, V35, pE811, DOI 10.1097/BRS.0b013e3181d7a4d2; Statistics and Information Department, 2010, STAT ABSTR HLTH WELF; Suzukamo Yoshimi, 2003, J Orthop Sci, V8, P543, DOI 10.1007/s00776-003-0679-x; Takahashi N., 2004, CLIN ORTHOP SURG, V39, P315; Takeyachi Y, 2003, SPINE, V28, P1461, DOI 10.1097/00007632-200307010-00018; Tavafian SS, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-21; van Middelkoop M, 2011, EUR SPINE J, V20, P19, DOI 10.1007/s00586-010-1518-3; van Tulder MW, 1998, FAM PRACT, V15, P126, DOI 10.1093/fampra/15.2.126; vanTulder MW, 1997, SPINE, V22, P2128, DOI 10.1097/00007632-199709150-00012; Vickers AJ, 2012, ARCH INTERN MED, V172, P1444, DOI 10.1001/archinternmed.2012.3654; VONKORFF M, 1992, PAIN, V50, P133, DOI 10.1016/0304-3959(92)90154-4; WADDELL G, 1980, SPINE, V5, P117, DOI 10.1097/00007632-198003000-00005; Waddell G, 2004, BACK PAIN REVOLUTION; Williams PL, 1989, GRAYS ANATOMY, P482; WMA Medical Ethics Committee, 2001, B WORLD HEALTH ORGAN, V71, P373; WYKE B, 1981, CLIN RHEUM DIS, V7, P223	78	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0144325	10.1371/journal.pone.0144325	http://dx.doi.org/10.1371/journal.pone.0144325			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YV	26646534	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903100018
J	Teraguchi, T; Kugihara, N				Teraguchi, Tsukasa; Kugihara, Naoki			Effects of Labeling and Group Category of Evaluators on Evaluations of Aggression	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; MANAGEMENT; NEGATIVITY; IMPLICIT; HOT	This study investigated whether the effect of labeling on people's evaluation of aggression varies according to the group category of the evaluators (i.e., whether they are ingroup members or third parties). Two labeling strategies-the negative labeling of victims (NL strategy) and the positive labeling of aggressors (PL strategy)-were adopted. We conducted an experiment using the hot sauce paradigm, as a way to assess aggressive intent that includes behavioral measures of evaluations. The results suggested that the NL strategy causes ingroup members to evaluate aggression in a more positive light, while the PL strategy has the same effect but on third parties instead. Thus, labeling strategies may increase the severity of aggressors' reaction and could also be a factor that can escalate a war or conflict.	[Teraguchi, Tsukasa; Kugihara, Naoki] Osaka Univ, Grad Sch Human Sci, Suita, Osaka, Japan; [Teraguchi, Tsukasa] Japan Soc Promot Sci, Tokyo, Japan	Osaka University; Japan Society for the Promotion of Science	Teraguchi, T (corresponding author), Osaka Univ, Grad Sch Human Sci, Suita, Osaka, Japan.	teraguchi@hus.osaka-u.ac.jp			JSPS KAKENHI [13J03530]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI (grant no. 13J03530, https://kaken.nii.ac.jp/d/p/13J03530.en.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, PSYCHOL ORIGINS I TO; Ayduk O, 2008, J EXP SOC PSYCHOL, V44, P775, DOI 10.1016/j.jesp.2007.07.004; Baker Peter, 2011, NY TIMES, pA1; BANDURA A, 1990, J SOC ISSUES, V46, P27, DOI 10.1111/j.1540-4560.1990.tb00270.x; BANDURA A, 1975, J RES PERS, V9, P253, DOI 10.1016/0092-6566(75)90001-X; Becker HS., 1963, OUTSIDERS STUDIES SO; Bernburg JG, 2006, J RES CRIME DELINQ, V43, P67, DOI 10.1177/0022427805280068; Bilali R, 2012, REMEMBERING INTERGRO; BORDEN RJ, 1975, J PERS SOC PSYCHOL, V31, P567, DOI 10.1037/h0076480; Carraro L, 2010, POLIT PSYCHOL, V31, P617, DOI 10.1111/j.1467-9221.2010.00771.x; Crawford MT, 2002, J PERS SOC PSYCHOL, V83, P1076, DOI 10.1037//0022-3514.83.5.1076; Davies PG, 2012, INT J ADV PSYCHOL, V1, P18; FELSON RB, 1982, SOC PSYCHOL QUART, V45, P245, DOI 10.2307/3033920; Foroni F, 2013, J EXP SOC PSYCHOL, V49, P126, DOI 10.1016/j.jesp.2012.08.002; Gourevitch Philip, 1998, WE WISH INFORM YOU T; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Hammack PL, 2010, CULT PSYCHOL, V16, P507, DOI 10.1177/1354067X10380159; Ito TA, 1998, J PERS SOC PSYCHOL, V75, P887, DOI 10.1037/0022-3514.75.4.887; Kanouse D. E., 1971, ATTRIBUTION PERCEIV; Lennings HIB, 2011, J EXP SOC PSYCHOL, V47, P794, DOI 10.1016/j.jesp.2011.02.006; Levine M, 2011, PSYCHOL SCI, V22, P406, DOI 10.1177/0956797611398495; Lieberman JD, 1999, AGGRESSIVE BEHAV, V25, P331, DOI 10.1002/(SICI)1098-2337(1999)25:5<331::AID-AB2>3.0.CO;2-1; Lotz S, 2011, J EXP SOC PSYCHOL, V47, P477, DOI 10.1016/j.jesp.2010.10.004; Marcu A, 2007, BRIT J SOC PSYCHOL, V46, P875, DOI 10.1348/014466607X174356; Matsueda Ross., 2014, LABELING THEORY EMPI, V18, P13; McGregor HA, 1998, J PERS SOC PSYCHOL, V74, P590, DOI 10.1037/0022-3514.74.3.590; Mead G. H., 1934, MIND SELF SOC; Parks MJ, 2013, AGGRESSIVE BEHAV, V39, P257, DOI 10.1002/ab.21475; Peeters G., 1990, EUROPEAN REV SOCIAL, V1, P33, DOI [10.1080/14792779108401856, DOI 10.1080/14792779108401856]; Perugini M, 2004, EUR J SOC PSYCHOL, V34, P69, DOI 10.1002/ejsp.186; Richetin J, 2010, ROLE PREVOLITIONAL P, V35, P1; SKOWRONSKI JJ, 1989, PSYCHOL BULL, V105, P131, DOI 10.1037/0033-2909.105.1.131; Takagi K, 2004, JAPANESE J SOCIAL PS, P124; Tamura T, 2006, JAPANESE J SOCIAL PS, V22, P165; Teraguchi T, 2012, P 53 JAP SOC SOC PSY; Teraguchi T, 2014, P 55 JAP SOC SOC PSY; Teraguchi T, 2013, JAPANESE J INTERPERS, V13, P77; Webster GD, 2006, AGGRESSIVE BEHAV, V32, P17, DOI 10.1002/ab.20102	38	0	0	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0144384	10.1371/journal.pone.0144384	http://dx.doi.org/10.1371/journal.pone.0144384			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1YV	26646836	Green Published, gold			2022-12-27	WOS:000366903100021
J	Kinnunen, S; Valimaki, M; Tolli, M; Wohlfahrt, G; Darwich, R; Komati, H; Nemer, M; Ruskoaho, H				Kinnunen, Sini; Vaelimaeki, Mika; Toelli, Marja; Wohlfahrt, Gerd; Darwich, Rami; Komati, Hiba; Nemer, Mona; Ruskoaho, Heikki			Nuclear Receptor-Like Structure and Interaction of Congenital Heart Disease-Associated Factors GATA4 and NKX2-5	PLOS ONE			English	Article							TRANSCRIPTION FACTOR GATA-4; OF-FUNCTION MUTATION; DNA-BINDING TARGETS; CARDIAC TRANSCRIPTION; GENE-EXPRESSION; VENTRAL MORPHOGENESIS; MUTUAL COFACTORS; DEFINED FACTORS; TUBE FORMATION; ADULT HEART	Aims Transcription factor GATA4 is a dosage sensitive regulator of heart development and alterations in its level or activity lead to congenital heart disease (CHD). GATA4 has also been implicated in cardiac regeneration and repair. GATA4 action involves combinatorial interaction with other cofactors such as NKX2-5, another critical cardiac regulator whose mutations also cause CHD. Despite its critical importance to the heart and its evolutionary conservation across species, the structural basis of the GATA4-NKX2-5 interaction remains incompletely understood. Methods and Results A homology model was constructed and used to identify surface amino acids important for the interaction of GATA4 and NKX2-5. These residues were subjected to site-directed mutagenesis, and the mutant proteins were characterized for their ability to bind DNA and to physically and functionally interact with NKX2-5. The studies identify 5 highly conserved amino acids in the second zinc finger (N272, R283, Q274, K299) and its C-terminal extension (R319) that are critical for physical and functional interaction with the third alpha helix of NKX2-5 homeodomain. Integration of the experimental data with computational modeling suggests that the structural arrangement of the zinc finger-homeodomain resembles the architecture of the conserved DNA binding domain of nuclear receptors. Conclusions The results provide novel insight into the structural basis for protein-protein interactions between two important classes of transcription factors. The model proposed will help to elucidate the molecular basis for disease causing mutations in GATA4 and NKX2-5 and may be relevant to other members of the GATA and NK classes of transcription factors.	[Kinnunen, Sini; Vaelimaeki, Mika; Ruskoaho, Heikki] Univ Helsinki, Div Pharmacol & Pharmacotherapy, Helsinki, Finland; [Kinnunen, Sini; Vaelimaeki, Mika; Toelli, Marja; Ruskoaho, Heikki] Univ Oulu, Dept Pharmacol & Toxicol, Inst Biomed, Oulu, Finland; [Wohlfahrt, Gerd] Comp Aided Drug Design, Orion Pharma, Espoo, Finland; [Darwich, Rami; Komati, Hiba; Nemer, Mona] Univ Ottawa, Dept Biochem Immunol & Microbiol, Lab Cardiac Dev & Differentiat, Ottawa, ON, Canada	University of Helsinki; University of Oulu; Orion Corporation; University of Ottawa	Nemer, M (corresponding author), Univ Ottawa, Dept Biochem Immunol & Microbiol, Lab Cardiac Dev & Differentiat, Ottawa, ON, Canada.	mona.nemer@uottawa.ca; heikki.ruskoaho@helsinki.fi		Valimaki, Mika/0000-0002-9687-8197; Kinnunen, Sini/0000-0003-1592-8306; Wohlfahrt, Gerd/0000-0003-0530-2000	Academy of Finland [266661]; Tekes large strategic research opening [40395/13]; Sigrid Juselius Foundation; Finnish Foundation for Cardiovascular Research; Canadian Institute for Health Research [MOP36382]; Orion Pharma	Academy of Finland(Academy of Finland); Tekes large strategic research opening; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Foundation for Cardiovascular Research; Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Orion Pharma	This work was supported by grants from the Academy of Finland (266661) (HR), the Tekes large strategic research opening (project no. 40395/13) (HR), Sigrid Juselius Foundation (HR), the Finnish Foundation for Cardiovascular Research (HR) (the authors do not have specific grant numbers for these grants), and the Canadian Institute for Health Research (MN) (MOP36382). Funding for open access charge came from the Academy of Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Orion Pharma provided support in the form of salary for GW, but Orion Pharma or the funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of GW is articulated in the 'author contributions' section.	ARCECI RJ, 1993, MOL CELL BIOL, V13, P2235, DOI 10.1128/MCB.13.4.2235; ARGENTIN S, 1994, MOL CELL BIOL, V14, P777, DOI 10.1128/MCB.14.1.777; Aries A, 2004, P NATL ACAD SCI USA, V101, P6975, DOI 10.1073/pnas.0401833101; Bisping E, 2006, P NATL ACAD SCI USA, V103, P14471, DOI 10.1073/pnas.0602543103; Brown CO, 2004, J BIOL CHEM, V279, P10659, DOI 10.1074/jbc.M301648200; Charron F, 2001, GENE DEV, V15, P2702, DOI 10.1101/gad.915701; CHEN CY, 1995, J BIOL CHEM, V270, P15628, DOI 10.1074/jbc.270.26.15628; Crispino JD, 2001, GENE DEV, V15, P839, DOI 10.1101/gad.875201; Dentice M, 2003, MOL ENDOCRINOL, V17, P1508, DOI 10.1210/me.2002-0348; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; Durocher D, 1998, DEV GENET, V22, P250, DOI 10.1002/(SICI)1520-6408(1998)22:3<250::AID-DVG7>3.0.CO;2-5; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Gallagher JM, 2012, MOL CELL BIOL, V32, P2214, DOI 10.1128/MCB.00218-12; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Grepin C, 1997, DEVELOPMENT, V124, P2387; GREPIN C, 1994, MOL CELL BIOL, V14, P3115, DOI 10.1128/MCB.14.5.3115; Gupta V, 2013, CURR BIOL, V23, P1221, DOI 10.1016/j.cub.2013.05.028; Hakkola J, 2003, J PHARMACOL EXP THER, V304, P1048, DOI 10.1124/jpet.102.041582; Hautala N, 2001, CIRCULATION, V103, P730; HEIKINHEIMO M, 1994, DEV BIOL, V164, P361, DOI 10.1006/dbio.1994.1206; Heineke J, 2007, J CLIN INVEST, V117, P3198, DOI 10.1172/JCI32573; Ho CKM, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-10; Hunter CC, 2014, EUKARYOT CELL, V13, P527, DOI 10.1128/EC.00040-14; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Kasahara H, 2004, CARDIOVASC RES, V64, P40, DOI 10.1016/j.cardiores.2004.06.004; Kasahara H, 2001, J BIOL CHEM, V276, P4570, DOI 10.1074/jbc.M004995200; Kerkela R, 2002, J BIOL CHEM, V277, P13752, DOI 10.1074/jbc.M105736200; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; Kuo HC, 1999, DEVELOPMENT, V126, P4223; Labute P, 2008, J COMPUT CHEM, V29, P1693, DOI 10.1002/jcc.20933; Lavallee G, 2006, EMBO J, V25, P5201, DOI 10.1038/sj.emboj.7601379; Lee Y, 1998, MOL CELL BIOL, V18, P3120, DOI 10.1128/MCB.18.6.3120; Li RG, 2013, BIOCHEM BIOPH RES CO, V439, P591, DOI 10.1016/j.bbrc.2013.09.023; Lourenco D, 2011, P NATL ACAD SCI USA, V108, P1597, DOI 10.1073/pnas.1010257108; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; Misra C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002690; Molkentin JD, 2000, J BIOL CHEM, V275, P38949, DOI 10.1074/jbc.R000029200; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Monzen K, 1999, MOL CELL BIOL, V19, P7096; Moreira IS, 2007, PROTEINS, V68, P803, DOI 10.1002/prot.21396; Nemer Georges, 2006, Hum Mutat, V27, P293, DOI 10.1002/humu.9410; Oka T, 2006, CIRC RES, V98, P837, DOI 10.1161/01.RES.0000215985.18538.c4; Patient RK, 2002, CURR OPIN GENET DEV, V12, P416, DOI 10.1016/S0959-437X(02)00319-2; Philips AS, 2007, J BIOL CHEM, V282, P24915, DOI 10.1074/jbc.M701789200; Pikkarainen S, 2004, CARDIOVASC RES, V63, P196, DOI 10.1016/j.cardiores.2004.03.025; Pikkarainen S, 2003, J BIOL CHEM, V278, P23807, DOI 10.1074/jbc.M302719200; Prall OWJ, 2007, CELL, V128, P947, DOI 10.1016/j.cell.2007.01.042; Pu WT, 2004, DEV BIOL, V275, P235, DOI 10.1016/j.ydbio.2004.08.008; Ranganayakulu G, 1998, DEVELOPMENT, V125, P3037; Reamon-Buettner SM, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.025395; Reamon-Buettner SM, 2010, HUM MUTAT, V31, P1185, DOI 10.1002/humu.21345; Rivkees SA, 1999, J BIOL CHEM, V274, P14204, DOI 10.1074/jbc.274.20.14204; Rysa J, 2010, CIRC-HEART FAIL, V3, P440, DOI 10.1161/CIRCHEARTFAILURE.109.889642; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; SCHWABE JWR, 1993, CELL, V75, P567, DOI 10.1016/0092-8674(93)90390-C; Sepulveda JL, 1998, MOL CELL BIOL, V18, P3405, DOI 10.1128/MCB.18.6.3405; Takeuchi JK, 2009, NATURE, V459, P708, DOI 10.1038/nature08039; Tenhunen O, 2004, J BIOL CHEM, V279, P24852, DOI 10.1074/jbc.M314317200; Trainor CD, 1996, MOL CELL BIOL, V16, P2238; Wang E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062138; Wang J, 2005, MOL CELL BIOL, V25, P9829, DOI 10.1128/MCB.25.22.9829-9844.2005; Xiang R, 2014, GENE, V534, P320, DOI 10.1016/j.gene.2013.10.028; Yamak A, 2014, P NATL ACAD SCI USA, V111, P1415, DOI 10.1073/pnas.1312993111; Yang YQ, 2013, HUM MUTAT, V34, P1662, DOI 10.1002/humu.22434	67	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144145	10.1371/journal.pone.0144145	http://dx.doi.org/10.1371/journal.pone.0144145			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642209	gold, Green Published			2022-12-27	WOS:000366902700063
J	Tsivgoulis, G; Katsanos, AH; Grigoriadis, N; Hadjigeorgiou, GM; Heliopoulos, I; Papathanasopoulos, P; Kilidireas, C; Voumvourakis, K; Dardiotis, E				Tsivgoulis, Georgios; Katsanos, Aristeidis H.; Grigoriadis, Nikolaos; Hadjigeorgiou, Georgios M.; Heliopoulos, Ioannis; Papathanasopoulos, Panagiotis; Kilidireas, Constantinos; Voumvourakis, Konstantinos; Dardiotis, Efthimios		HELANI Hellenic Acad	The Effect of Disease Modifying Therapies on Disease Progression in Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							SUBCUTANEOUS INTERFERON BETA-1A; PLACEBO-CONTROLLED PHASE-3; DISABILITY STATUS SCALE; DOUBLE-BLIND; GLATIRAMER ACETATE; INTRAMUSCULAR INTERFERON; ORAL TERIFLUNOMIDE; CONTROLLED TRIAL; NATALIZUMAB; FINGOLIMOD	Importance A number of officially approved disease-modifying drugs (DMD) are currently available for the early intervention in patients with relapsing-remitting multiple sclerosis (RRMS). The aim of the present study was to systematically evaluate the effect of DMDs on disability progression in RRMS Methods We performed a systematic review on MEDLINE and SCOPUS databases to include all available placebo-controlled randomized clinical trials (RCTs) of RRMS patients that reported absolute numbers or percentages of disability progression during each study period. Observational studies, case series, case reports, RCTs without placebo subgroups and studies reporting the use of RRMS therapies that are not still officially approved were excluded. Risk ratios (RRs) were calculated in each study protocol to express the comparison of disability progression in RRMS patients treated with a DMD and those RRMS patients receiving placebo. The mixed-effects model was used to calculate both the pooled point estimate in each subgroup and the overall estimates. Results DMDs for RRMS were found to have a significantly lower risk of disability progression compared to placebo (RR = 0.72, 95% CI: 0.66-0.79; p<0.001), with no evidence of heterogeneity or publication bias. In subsequent subgroup analyses, neither dichotomization of DMDs as "first" and "second" line RRMS therapies [(RR = 0.72, 95% CI = 0.65-0.80) vs. (RR = 0.72, 95% = 0.57-0.91); p = 0.96] nor the route of administration (injectable or oral) [ RR = 0.75 (95% CI = 0.64-0.87) vs. RR = 0.74 (95% CI = 0.66-0.83); p = 0.92] had a differential effect on the risk of disability progression. Either considerable (5-20%) or significant (>20%) rates of loss to follow-up were reported in many study protocols, while financial and/or other support from pharmaceutical industries with a clear conflict of interest on the study outcomes was documented in all included studies. Conclusions Available DMD are effective in reducing disability progression in patients with RRMS, independently of the route of administration and their classification as "first" or "second" line therapies. Attrition bias needs to be taken into account in the interpretation of these findings.	[Tsivgoulis, Georgios; Katsanos, Aristeidis H.; Voumvourakis, Konstantinos] Univ Athens, Sch Med, Dept Neurol 2, Attikon Hosp, GR-11527 Athens, Greece; [Tsivgoulis, Georgios] Univ Tennessee, Ctr Hlth Sci, Dept Neurol, Memphis, TN 38163 USA; [Tsivgoulis, Georgios] St Annes Univ Hosp Brno, Int Clin Res Ctr, Dept Neurol, Brno, Czech Republic; [Katsanos, Aristeidis H.] Univ Ioannina, Dept Neurol, Sch Med, GR-45110 Ioannina, Greece; [Grigoriadis, Nikolaos] Aristotle Univ Thessaloniki, Dept Neurol 2, AHEPA Univ Hosp, GR-54006 Thessaloniki, Macedonia, Greece; [Hadjigeorgiou, Georgios M.; Dardiotis, Efthimios] Univ Thessaly, Dept Neurol, Univ Hosp Larissa, Larisa, Greece; [Heliopoulos, Ioannis] Democritus Univ Thrace, Dept Neurol, Alexandroupolis Univ Hosp, Alexandroupolis, Greece; [Papathanasopoulos, Panagiotis] Univ Patras, Sch Med, Dept Neurol, GR-26110 Patras, Greece; [Kilidireas, Constantinos] Univ Athens, Sch Med, Dept Neurol 1, Eginit Hosp, GR-11527 Athens, Greece	Athens Medical School; National & Kapodistrian University of Athens; University Hospital Attikon; University of Tennessee System; University of Tennessee Health Science Center; St Anne's University Hospital Brno (FNUSA-ICRC); University of Ioannina; Aristotle University of Thessaloniki; Ahepa University Hospital; General University Hospital of Larissa; University of Thessaly; Democritus University of Thrace; University of Patras; Athens Medical School; National & Kapodistrian University of Athens	Tsivgoulis, G (corresponding author), Univ Athens, Sch Med, Dept Neurol 2, Attikon Hosp, GR-11527 Athens, Greece.	tsivgoulisgiorg@yahoo.gr	Tsivgoulis, Georgios/AAD-5360-2020; Katsanos, Aristeidis H/AAD-7458-2019; Heliopoulos, Ioannis/ABH-2614-2021; Tsivgoulis, Georgios/AAD-7467-2019	Tsivgoulis, Georgios/0000-0002-0640-3797; Katsanos, Aristeidis H/0000-0002-6359-0023; Dardiotis, Efthimios/0000-0003-2957-641X	Hellenic Academy of Neuroimmunology (HELANI)	Hellenic Academy of Neuroimmunology (HELANI)	The authors would like to thank the Hellenic Academy of Neuroimmunology (HELANI) for supporting their research with an unrestricted grant for publication fees.	Bero LA, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000075; Brown MG, 2007, NEUROLOGY, V69, P1498, DOI 10.1212/01.wnl.0000271884.11129.f3; Calabresi PA, 2014, LANCET NEUROL, V13, P657, DOI 10.1016/S1474-4422(14)70068-7; Calabresi PA, 2014, LANCET NEUROL, V13, P545, DOI 10.1016/S1474-4422(14)70049-3; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Comi G, 2001, ANN NEUROL, V49, P290, DOI 10.1002/ana.64; Confavreux C, 2014, LANCET NEUROL, V13, P247, DOI 10.1016/S1474-4422(13)70308-9; De Stefano N, 2010, MULT SCLER J, V16, P888, DOI 10.1177/1352458510362442; Deeks JJ, COCHRANE HDB SYSTEMA; DUQUETTE P, 1993, NEUROLOGY, V43, P655, DOI 10.1212/wnl.43.4.655; Ebers GC, 1998, LANCET, V352, P1498, DOI 10.1016/S0140-6736(98)03334-0; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Filippini G, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008933.pub2; Fox EJ, 2012, CURR OPIN NEUROL, V25, pS11, DOI 10.1097/01.wco.0000413320.94715.e9; Fox RJ, 2012, NEW ENGL J MED, V367, P1087, DOI 10.1056/NEJMoa1206328; Freedman MS, 2013, CAN J NEUROL SCI, V40, P307, DOI 10.1017/S0317167100014244; Giovannoni G, 2009, MULT SCLER J, V15, P219, DOI 10.1177/1352458508097299; Gold R, 2012, NEW ENGL J MED, V367, P1098, DOI 10.1056/NEJMoa1114287; Havrdova E, 2010, NEUROLOGY, V74, pS3, DOI 10.1212/WNL.0b013e3181dbb51c; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hofstetter L, 2014, MULT SCLER J, V20, P202, DOI 10.1177/1352458513493034; Izquierdo G, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.337; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; JOHNSON KP, 1995, NEUROLOGY, V45, P1268, DOI 10.1212/WNL.45.7.1268; Kappos L, 2014, MULT SCLER J, V20; Kappos L, 2015, J NEUROL NEUROSUR PS, V86, P1202, DOI 10.1136/jnnp-2014-310024; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Khan O, 2013, ANN NEUROL, V73, P705, DOI 10.1002/ana.23938; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lavery AM, 2014, MULT SCLER INT, V2014, DOI 10.1155/2014/262350; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; Meyniel C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038661; O'Connor P, 2011, NEW ENGL J MED, V365, P1293, DOI 10.1056/NEJMoa1014656; Phillips JT, 2011, MULT SCLER J, V17, P970, DOI 10.1177/1352458511399611; Polman Chris H, 2006, N Engl J Med, V354, P899; Popescu V, 2013, J NEUROL NEUROSUR PS, V84, P1082, DOI 10.1136/jnnp-2012-304094; Rovaris M, 2001, BRAIN, V124, P1803, DOI 10.1093/brain/124.9.1803; Rudick RA, 2006, NEW ENGL J MED, V354, P911, DOI 10.1056/NEJMoa044396; Sacket DL., 1997, EVIDENCE BASED MED P; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Tsivgoulis G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116511; Vermersch P, 2014, MULT SCLER J, V20, P705, DOI 10.1177/1352458513507821	42	28	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144538	10.1371/journal.pone.0144538	http://dx.doi.org/10.1371/journal.pone.0144538			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642051	Green Published, gold			2022-12-27	WOS:000366902700143
J	Chang, SF; Hsieh, RZ; Huang, KC; Chang, CA; Chiu, FY; Kuo, HC; Chen, CN; Su, YP				Chang, Shun-Fu; Hsieh, Rong-Ze; Huang, Kuo-Chin; Chang, Cheng Allen; Chiu, Fang-Yao; Kuo, Hsing-Chun; Chen, Cheng-Nan; Su, Yu-Ping			Upregulation of Bone Morphogenetic Protein-2 Synthesis and Consequent Collagen II Expression in Leptin-stimulated Human Chondrocytes	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; HISTONE DEACETYLASES; ARTICULAR-CARTILAGE; OSTEOARTHRITIC CHONDROCYTES; SERINE PHOSPHORYLATION; OSTEOPHYTE FORMATION; STAT3; ACTIVATION; DEGRADATION; OBESITY	Bone morphogenetic proteins (BMPs) play positive roles in cartilage development, but they can barely be detected in healthy articular cartilage. However, recent evidence has indicated that BMPs could be detected in osteoarthritic and damaged cartilage and their precise roles have not been well defined. Extremely high amounts of leptin have been reported in obese individuals, which can be associated with osteoarthritis (OA) development. The aim of this study was to investigate whether BMPs could be induced in human primary chondrocytes during leptin-stimulated OA development and the underlying mechanism. We found that expression of BMP-2 mRNA, but not BMP-4, BMP-6, or BMP-7 mRNA, could be increased in human primary chondrocytes under leptin stimulation. Moreover, this BMP-2 induction was mediated through transcription factor-signal transducer and activator of transcription (STAT) 3 activation via JAK2-ERK1/2-induced Ser727-phosphorylation. Of note, histone deacetylases (HDACs) 3 and 4 were both involved in modulating leptin-induced BMP-2 mRNA expression through different pathways: HDAC3, but not HDAC4, associated with STAT3 to form a complex. Our results further demonstrated that the role of BMP-2 induction under leptin stimulation is to increase collagen II expression. The findings in this study provide new insights into the regulatory mechanism of BMP-2 induction in leptin-stimulated chondrocytes and suggest that BMP-2 may play a reparative role in regulating leptin-induced OA development.	[Chang, Shun-Fu; Hsieh, Rong-Ze] Chang Gung Mem Hosp, Dept Med Res & Dev, Chiayi Branch, Chiayi, Taiwan; [Huang, Kuo-Chin] Chang Gung Mem Hosp, Dept Orthopaed, Chiayi Branch, Chiayi, Taiwan; [Chang, Cheng Allen] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei, Taiwan; [Chiu, Fang-Yao; Su, Yu-Ping] Taipei Vet Gen Hosp, Dept Orthopaed & Traumatol, Taipei, Taiwan; [Chiu, Fang-Yao; Su, Yu-Ping] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Kuo, Hsing-Chun] Chang Gung Univ Sci & Technol, Dept Nursing, Chiayi, Taiwan; [Chen, Cheng-Nan] Natl Chiayi Univ, Dept Biochem Sci & Technol, Chiayi, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Chang Gung University of Science & Technology; National Chiayi University	Chen, CN (corresponding author), Natl Chiayi Univ, Dept Biochem Sci & Technol, Chiayi, Taiwan.	cnchen@mail.ncyu.edu.tw; ypsu@vghtpe.gov.tw	HUANG, Kuo-Chin/S-7371-2019	HUANG, Kuo-Chin/0000-0002-3225-1504; Su, Yu-Ping/0000-0002-5390-4113	National Science Council of Taiwan [NSC 101-2320-B-010-035, 102-2320-B-010-028, MOST 103-2320-B-182A-021-MY3]; Taipei Veterans General Hospital of Taiwan [V102C-194, V103C-116, V104C-155]; Chang Gung Memorial Hospital-Chiayi Branch of Taiwan [CMRPG6E0231]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital of Taiwan(Taipei Veterans General Hospital); Chang Gung Memorial Hospital-Chiayi Branch of Taiwan	This work was supported by the grants from National Science Council of Taiwan (NSC 101-2320-B-010-035, 102-2320-B-010-028, and MOST 103-2320-B-182A-021-MY3), Taipei Veterans General Hospital of Taiwan (V102C-194, V103C-116, and V104C-155), and Chang Gung Memorial Hospital-Chiayi Branch of Taiwan (CMRPG6E0231). The funders had no role in study design, data collection and analysis, or manuscript preparation.	Aggarwal BB, 2009, ANN NY ACAD SCI, V1171, P59, DOI 10.1111/j.1749-6632.2009.04911.x; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Babaei A, 2011, HORM-INT J ENDOCRINO, V10, P16, DOI 10.14310/horm.2002.1289; Ben-Eliezer M, 2007, ENDOCRINE, V32, P235, DOI 10.1007/s12020-007-9025-y; Chen WP, 2010, MOL BIOL REP, V37, P3967, DOI 10.1007/s11033-010-0055-9; Chubinskaya S, 2007, INT ORTHOP, V31, P773, DOI 10.1007/s00264-007-0423-9; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Coppari R, 2012, NAT REV DRUG DISCOV, V11, P692, DOI 10.1038/nrd3757; Culley KL, 2013, ARTHRITIS RHEUM-US, V65, P1822, DOI 10.1002/art.37965; Davidson ENB, 2007, ARTHRITIS RHEUM, V56, P4065, DOI 10.1002/art.23034; Davidson ENB, 2015, ANN RHEUM DIS, V74, P1257, DOI 10.1136/annrheumdis-2013-204528; Davidson ENB, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2305; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Dell'Accio F, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2029; Fukui N, 2003, J BONE JOINT SURG AM, V85A, P59, DOI 10.2106/00004623-200300003-00011; Gao SM, 2013, EXP HEMATOL, V41, P261, DOI 10.1016/j.exphem.2012.10.012; Griffin TM, 2009, ARTHRITIS RHEUM-US, V60, P2935, DOI 10.1002/art.24854; Gualillo O, 2007, OSTEOARTHR CARTILAGE, V15, P857, DOI 10.1016/j.joca.2007.04.015; Gupta M, 2012, LEUKEMIA, V26, P1356, DOI 10.1038/leu.2011.340; Hayashi M, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2521; Hui W, 2012, ANN RHEUM DIS, V71, P455, DOI 10.1136/annrheumdis-2011-200372; Im GI, 2013, EXPERT OPIN BIOL TH, V13, P713, DOI 10.1517/14712598.2013.764410; Ku JH, 2009, CLIN RHEUMATOL, V28, P1431, DOI 10.1007/s10067-009-1242-8; Leah Emma, 2013, Nat Rev Rheumatol, V9, P321, DOI 10.1038/nrrheum.2013.63; Lee DY, 2012, P NATL ACAD SCI USA, V109, P1967, DOI 10.1073/pnas.1121214109; Miljkovic ND, 2008, OSTEOARTHR CARTILAGE, V16, P1121, DOI 10.1016/j.joca.2008.03.003; Minami J, 2014, LEUKEMIA, V28, P680, DOI 10.1038/leu.2013.231; Nakase T, 2003, OSTEOARTHR CARTILAGE, V11, P278, DOI 10.1016/S1063-4584(03)00004-9; Ohba S, 2010, OSTEOARTHR CARTILAGE, V18, P1620, DOI 10.1016/j.joca.2010.09.006; Otsuki S, 2010, P NATL ACAD SCI USA, V107, P10202, DOI 10.1073/pnas.0913897107; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Sakaguchi M, 2012, J INVEST DERMATOL, V132, P1877, DOI 10.1038/jid.2012.45; Scotece M, 2013, CURR MED CHEM, V20, P3416, DOI 10.2174/0929867311320270006; Scotece M, 2014, DRUG DISCOV TODAY, V19, P241, DOI 10.1016/j.drudis.2013.07.012; Togi S, 2009, BIOCHEM BIOPH RES CO, V379, P616, DOI 10.1016/j.bbrc.2008.12.132; van Beuningen HM, 1998, OSTEOARTHR CARTILAGE, V6, P306, DOI 10.1053/joca.1998.0129; van der Kraan PM, 2010, OSTEOARTHR CARTILAGE, V18, P735, DOI 10.1016/j.joca.2010.03.001; Vuolteenaho K, 2012, ANN RHEUM DIS, V71, P1912, DOI 10.1136/annrheumdis-2011-201242; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Xiong H, 2012, MOL CARCINOGEN, V51, P174, DOI 10.1002/mc.20777; Yang RH, 2007, CIRC RES, V101, P545, DOI 10.1161/CIRCRESAHA.107.156596; Yeh CC, 2009, ARTHRITIS RHEUM-US, V60, P2350, DOI 10.1002/art.24680; Yusuf E, 2010, ANN RHEUM DIS, V69, P761, DOI 10.1136/ard.2008.106930; Zhou BD, 2011, CARDIOVASC RES, V90, P413, DOI 10.1093/cvr/cvr003; Zhou Z, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-109	45	10	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144252	10.1371/journal.pone.0144252	http://dx.doi.org/10.1371/journal.pone.0144252			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636769	Green Published, gold, Green Submitted			2022-12-27	WOS:000366143800062
J	Tosetto, A; Manotti, C; Marongiu, F				Tosetto, Alberto; Manotti, Cesare; Marongiu, Francesco		Italian Federation Anticoagulation	Center-Related Determinants of VKA Anticoagulation Quality: A Prospective, Multicenter Evaluation	PLOS ONE			English	Article							ATRIAL-FIBRILLATION PATIENTS; NORMALIZED RATIO CONTROL; ORAL ANTICOAGULANT; VETERANS AFFAIRS; WARFARIN CONTROL; ADVERSE EVENTS; STROKE; METAANALYSIS; THERAPY; LEVEL	Background Center-specific TTR (c-TTR) is a measure reporting the mean patient TTR within an anticoagulation clinic describing the quality of anticoagulant monitoring offered by that clinic. c-TTR has a considerable between-center variation, but its determinants are poorly understood. Objectives We aimed at evaluating which clinical, procedural or laboratory factors could be associated with c-TTR variability in a multicenter, observational cross-sectional study over a five-year period. Patients/Methods Data from 832,204 individual patients followed for VKA therapy in 292 Centers affiliated with the Italian Federation of Anticoagulation Clinics (FCSA) were analyzed. c-TTR was computed based on the TTR of patients followed at each Center, and a mixed linear regression model was used for a predefined set of explanatory variables. Results The Center next-visit interval ratio (the mean number of days after a visit with an INR outside the therapeutic range, divided by the days after a visit with an INR within the therapeutic range), the Center mean patient INR and the Center laboratory performance at EQA proficiency testing were the only variables that were independently associated with c-TTR (beta-coefficients -17.32, 9.67, and -0.11, respectively; r(2) = 0.635). Conclusions These findings suggest that c-TTR associates with proactive strategies aimed at keeping patients very close to their target INR with a prompt re-evaluation of those patients with under- or over-therapeutic INR.	[Tosetto, Alberto] S Bortolo Hosp, Dept Hematol, Vicenza, Italy; [Manotti, Cesare] Fidenza Vaio Hosp, Hemostasis Ctr, Fidenza, Italy; [Marongiu, Francesco] Univ Cagliari, Dept Internal Med, Cagliari, Italy	ULSS 8 Berica; Ospedale San Bortolo di Vicenza; University of Cagliari	Tosetto, A (corresponding author), S Bortolo Hosp, Dept Hematol, Vicenza, Italy.	alberto.tosetto@ulssvicenza.it	Tosetto, Alberto/AAB-9320-2022; Gaidano, Gianluca/AAW-2773-2021; Tosetto, Alberto/AAM-3200-2020	Gaidano, Gianluca/0000-0002-4681-0151; Tosetto, Alberto/0000-0002-0119-5204; Capalbo, Silvana/0000-0002-6247-5007				Ageno W, 2012, CHEST, V141, pE44S, DOI 10.1378/chest.11-2292; Ansell J, 2008, CHEST, V133, p160S, DOI 10.1378/chest.08-0670; Apostolakis S, 2013, CHEST, V144, P1555, DOI 10.1378/chest.13-0054; Baker WL, 2009, J MANAGE CARE PHARM, V15, P244, DOI 10.18553/jmcp.2009.15.3.244; Cios DA, 2009, AM J HEALTH-SYST PH, V66, P916, DOI 10.2146/ajhp080507; Connolly SJ, 2008, CIRCULATION, V118, P2029, DOI 10.1161/CIRCULATIONAHA.107.750000; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Gallagher AM, 2011, THROMB HAEMOSTASIS, V106, P968, DOI 10.1160/TH11-05-0353; Garcia DA, 2013, AM HEART J, V166, P549, DOI 10.1016/j.ahj.2013.05.016; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Italian Federation of Thrombosis Centers (FCSA), 2003, HAEMATOLOGICA SUPPL, V88, P52; Jones M, 2005, HEART, V91, P472, DOI 10.1136/hrt.2004.042465; Kim YK, 2010, J THROMB HAEMOST, V8, P101, DOI [10.14801/JAITC.2018.8.2.101, 10.1111/j.1538-7836.2009.03652.x]; Mearns ES, 2014, THROMB J, V12, DOI 10.1186/1477-9560-12-14; Nieuwlaat R, 2012, THROMB RES, V129, P715, DOI 10.1016/j.thromres.2011.08.024; Oake N, 2007, CAN MED ASSOC J, V176, P1589, DOI 10.1503/cmaj.061523; Palareti G, 1998, HAEMOSTASIS, V28, P1; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Rabe-Hasketh S, 2009, MULTILEVEL AND LONGI; Rabe-Hesketh S, 2008, STAT METHODS MED RES, V17, P5, DOI 10.1177/0962280207081236; Rose AJ, 2012, J THROMB HAEMOST, V10, P590, DOI 10.1111/j.1538-7836.2012.04649.x; Rose AJ, 2010, J THROMB HAEMOST, V8, P2182, DOI 10.1111/j.1538-7836.2010.03996.x; Rose AJ, 2011, CIRC-CARDIOVASC QUAL, V4, P276, DOI 10.1161/CIRCOUTCOMES.110.960096; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Singer DE, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.000067; StataCorp, 2014, STAT STAT SOFTW REL; Van Spall HGC, 2012, CIRCULATION, V126, P2309, DOI 10.1161/CIRCULATIONAHA.112.101808; Veeger NJGM, 2005, BRIT J HAEMATOL, V128, P513, DOI 10.1111/j.1365-2141.2004.05348.x; Wallentin L, 2010, LANCET, V376, P975, DOI 10.1016/S0140-6736(10)61194-4; Wan Y, 2008, CIRC-CARDIOVASC QUAL, V1, P84, DOI 10.1161/CIRCOUTCOMES.108.796185	31	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144314	10.1371/journal.pone.0144314	http://dx.doi.org/10.1371/journal.pone.0144314			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636337	Green Published, gold, Green Submitted			2022-12-27	WOS:000366143800073
J	Yui, DS; Nishida, Y; Nishina, T; Mogushi, K; Tajiri, M; Ishibashi, S; Ajioka, I; Ishikawa, K; Mizusawa, H; Murayama, S; Yokota, T				Yui, Daishi; Nishida, Yoichiro; Nishina, Tomoko; Mogushi, Kaoru; Tajiri, Mio; Ishibashi, Satoru; Ajioka, Itsuki; Ishikawa, Kinya; Mizusawa, Hidehiro; Murayama, Shigeo; Yokota, Takanori			Enhanced Phospholipase A2 Group 3 Expression by Oxidative Stress Decreases the Insulin-Degrading Enzyme	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; NEURITE OUTGROWTH; MOUSE MODEL; A(2); BRAIN; PROTEIN; DEATH; ACID; DYSFUNCTION; ACTIVATION	Oxidative stress has a ubiquitous role in neurodegenerative diseases and oxidative damage in specific regions of the brain is associated with selective neurodegeneration. We previously reported that Alzheimer disease (AD) model mice showed decreased insulindegrading enzyme (IDE) levels in the cerebrum and accelerated phenotypic features of AD when crossbred with alpha-tocopherol transfer protein knockout (Ttpa(-/-)) mice. To further investigate the role of chronic oxidative stress in AD pathophysiology, we performed DNA microarray analysis using young and aged wild-type mice and aged Ttpa(-/-) mice. Among the genes whose expression changed dramatically was Phospholipase A2 group 3 (Pla2g3); Pla2g3 was identified because of its expression profile of cerebral specific up-regulation by chronic oxidative stress in silico and in aged Ttpa(-/-) mice. Immunohistochemical studies also demonstrated that human astrocytic Pla2g3 expression was significantly increased in human AD brains compared with control brains. Moreover, transfection of HEK293 cells with human Pla2g3 decreased endogenous IDE expression in a dose-dependent manner. Our findings show a key role of Pla2g3 on the reduction of IDE, and suggest that cerebrum specific increase of Pla2g3 is involved in the initiation and/or progression of AD.	[Yui, Daishi; Nishida, Yoichiro; Nishina, Tomoko; Tajiri, Mio; Ishibashi, Satoru; Ishikawa, Kinya; Yokota, Takanori] Tokyo Med & Dent Univ, Grad Sch Med, Dept Neurol & Neurol Sci, Tokyo, Japan; [Mogushi, Kaoru] Tokyo Med & Dent Univ, Med Res Inst, Dept Bioinformat, Tokyo, Japan; [Ajioka, Itsuki] Tokyo Med & Dent Univ, Ctr Brain Integrat Res, Tokyo, Japan; [Mizusawa, Hidehiro] Natl Ctr Neurol & Psychiat, Natl Ctr Hosp, Tokyo, Japan; [Murayama, Shigeo] Tokyo Metropolitan Inst Gerontol, Dept Neuropathol, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); National Center for Neurology & Psychiatry - Japan; Tokyo Metropolitan Institute of Gerontology	Yokota, T (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med, Dept Neurol & Neurol Sci, Tokyo, Japan.	yokonuro@tmd.ac.jp		Yokota, Takanori/0000-0002-6490-3263; Mogushi, Kaoru/0000-0002-2618-8684	Strategic Research Program for Brain Sciences from the Ministry of Education, Culture, Sports, Science and Technology of Japan	Strategic Research Program for Brain Sciences from the Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported by the Strategic Research Program for Brain Sciences from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinho P, 2010, CURR PHARM DESIGN, V16, P2766, DOI 10.2174/138161210793176572; Ajioka I, 2015, TISSUE ENG PT A, V21, P193, DOI [10.1089/ten.tea.2014.0080, 10.1089/ten.TEA.2014.0080]; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Dorfman VB, 2010, NEUROBIOL AGING, V31, P1743, DOI 10.1016/j.neurobiolaging.2008.09.016; Brookmeyer R, 2011, ALZHEIMERS DEMENT, V7, P61, DOI 10.1016/j.jalz.2010.11.007; Butenko O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039959; Butterfield DA, 2002, FREE RADICAL BIO MED, V32, P1050, DOI 10.1016/S0891-5849(02)00794-3; Chiricozzi E, 2010, J NEUROCHEM, V112, P1574, DOI 10.1111/j.1471-4159.2010.06567.x; Cook DG, 2003, AM J PATHOL, V162, P313, DOI 10.1016/S0002-9440(10)63822-9; DeCoster MA, 2003, BRAIN RES, V988, P20, DOI 10.1016/S0006-8993(03)03326-2; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; Dennis EA, 1997, TRENDS BIOCHEM SCI, V22, P1, DOI 10.1016/S0968-0004(96)20031-3; Edbauer D, 2002, J BIOL CHEM, V277, P13389, DOI 10.1074/jbc.M111571200; Feng L, 2013, CELL MOL NEUROBIOL, V33, P759, DOI 10.1007/s10571-013-9943-6; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Ichijo M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138029; Ikeno Y, 2005, J BIOL CHEM, V280, P28044, DOI 10.1074/jbc.M503343200; KATZMAN R, 1991, FASEB J, V5, P278, DOI 10.1096/fasebj.5.3.2001787; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kriem B, 2004, FASEB J, V18, P85, DOI 10.1096/fj.04-1807fje; Li Y, 2012, P NATL ACAD SCI USA, V109, P15491, DOI 10.1073/pnas.1212899109; LOVELL MA, 1995, NEUROLOGY, V45, P1594, DOI 10.1212/WNL.45.8.1594; Martinez-Garcia A, 2010, J ALZHEIMERS DIS, V22, P1181, DOI 10.3233/JAD-2010-101348; Masuda S, 2005, J BIOL CHEM, V280, P23203, DOI 10.1074/jbc.M500985200; Moreira PI, 2005, ANN NY ACAD SCI, V1043, P545, DOI 10.1196/annals.1333.062; Muller WE, 2010, MOL NEUROBIOL, V41, P159, DOI 10.1007/s12035-010-8141-5; Mulder SD, 2012, EXP NEUROL, V233, P373, DOI 10.1016/j.expneurol.2011.11.001; Murakami M, 2015, ALLERGOL INT, V64, P4, DOI 10.1016/j.alit.2014.07.005; Nishida Y, 2006, BIOCHEM BIOPH RES CO, V350, P530, DOI 10.1016/j.bbrc.2006.09.083; Nishida Y, 2009, J BIOL CHEM, V284, P33400, DOI 10.1074/jbc.M109.054056; Perez A, 2000, NEUROCHEM RES, V25, P247, DOI 10.1023/A:1007527721160; Sanchez-Mejia RO, 2008, NAT NEUROSCI, V11, P1311, DOI 10.1038/nn.2213; Sanchez-Ortiz E, 2012, J NEUROSCI, V32, P4065, DOI 10.1523/JNEUROSCI.6314-11.2012; Santos RX, 2010, INT J CLIN EXP PATHO, V3, P570; Sato H, 2010, J CLIN INVEST, V120, P1400, DOI 10.1172/JCI40493; Sato H, 2009, BIOCHEM J, V421, P17, DOI 10.1042/BJ20082429; Sato H, 2008, J BIOL CHEM, V283, P33483, DOI 10.1074/jbc.M804628200; Schaeffer EL, 2010, PROG NEURO-PSYCHOPH, V34, P1381, DOI 10.1016/j.pnpbp.2010.08.019; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Smallheiser NR, 1996, BRAIN RES, V721, P39, DOI 10.1016/0006-8993(96)00134-5; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Taketomi Y, 2013, NAT IMMUNOL, V14, P554, DOI 10.1038/ni.2586; Tetsuka K, 2001, CELL STRUCT FUNCT, V26, P197, DOI 10.1247/csf.26.197; Venkateshappa C, 2012, NEUROCHEM RES, V37, P1601, DOI 10.1007/s11064-012-0755-8; Yagami T, 2003, J NEUROCHEM, V85, P749, DOI 10.1046/j.1471-4159.2003.01712.x; Yagami T, 2002, MOL PHARMACOL, V61, P114, DOI 10.1124/mol.61.1.114; Yokota T, 2001, P NATL ACAD SCI USA, V98, P15185, DOI 10.1073/pnas.261456098; Yui D, 2001, ONCOGENE, V20, P4317, DOI 10.1038/sj.onc.1204576; Zhao Z, 2007, NEUROBIOL AGING, V28, P824, DOI 10.1016/j.neurobiolaging.2006.05.001	51	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143518	10.1371/journal.pone.0143518	http://dx.doi.org/10.1371/journal.pone.0143518			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26637123	Green Submitted, Green Published, gold			2022-12-27	WOS:000366143800015
J	Silva-Herzog, E; McDonald, EM; Crooks, AL; Detweiler, CS				Silva-Herzog, Eugenia; McDonald, Erin M.; Crooks, Amy L.; Detweiler, Corrella S.			Physiologic Stresses Reveal a Salmonella Persister State and TA Family Toxins Modulate Tolerance to These Stresses	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; ESCHERICHIA-COLI; BACTERIAL PERSISTENCE; GENE-EXPRESSION; ANTITOXIN LOCI; CELLS; MACROPHAGES; VIRULENCE; DEPOLARIZATION; REPLICATION	Bacterial persister cells are considered a basis for chronic infections and relapse caused by bacterial pathogens. Persisters are phenotypic variants characterized by low metabolic activity and slow or no replication. This low metabolic state increases pathogen tolerance to antibiotics and host immune defenses that target actively growing cells. In this study we demonstrate that within a population of Salmonella enterica serotype Typhimurium, a small percentage of bacteria are reversibly tolerant to specific stressors that mimic the macrophage host environment. Numerous studies show that Toxin-Antitoxin (TA) systems contribute to persister states, based on toxin inhibition of bacterial metabolism or growth. To identify toxins that may promote a persister state in response to host-associated stressors, we analyzed the six TA loci specific to S. enterica serotypes that cause systemic infection in mammals, including five RelBE family members and one VapBC member. Deletion of TA loci increased or decreased tolerance depending on the stress conditions. Similarly, exogenous expression of toxins had mixed effects on bacterial survival in response to stress. In macrophages, S. Typhimurium induced expression of three of the toxins examined. These observations indicate that distinct toxin family members have protective capabilities for specific stressors but also suggest that TA loci have both positive and negative effects on tolerance.	[Silva-Herzog, Eugenia; McDonald, Erin M.; Crooks, Amy L.; Detweiler, Corrella S.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Detweiler, CS (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	detweile@colorado.edu	Silva-Herzog, Eugenia/AFP-3674-2022; DETWEILER, CORRELLA S/ABG-2625-2021	DETWEILER, CORRELLA S/0000-0002-7783-0876	United States National Institutes of Health [AI095395]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095395, R21AI099593, R56AI095395] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by Grant # AI095395 from the United States National Institutes of Health to CSD (http://projectreporter.nih.gov/reporter.cfm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison KR, 2011, CURR OPIN MICROBIOL, V14, P593, DOI 10.1016/j.mib.2011.09.002; Amato SM, 2013, MOL CELL, V50, P475, DOI 10.1016/j.molcel.2013.04.002; Amatore C, 2006, CHEMBIOCHEM, V7, P653, DOI 10.1002/cbic.200500359; ASHBY MJ, 1994, J ANTIMICROB CHEMOTH, V33, P443, DOI 10.1093/jac/33.3.443; Balaban NQ, 2011, CURR OPIN GENET DEV, V21, P768, DOI 10.1016/j.gde.2011.10.001; Balaban NQ, 2013, NAT REV MICROBIOL, V11, P587, DOI 10.1038/nrmicro3076; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bigger JW, 1944, LANCET, V2, P497; Boyd EF, 1996, APPL ENVIRON MICROB, V62, P804, DOI 10.1128/AEM.62.3.804-808.1996; Boyer E, 2002, INFECT IMMUN, V70, P6032, DOI 10.1128/IAI.70.11.6032-6042.2002; BUCHMEIER NA, 1989, INFECT IMMUN, V57, P1; Cheng HY, 2014, ENVIRON MICROBIOL, V16, P1741, DOI 10.1111/1462-2920.12373; De la Cruz MA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003827; Dey AK, 2013, J BACTERIOL, V195, P2004, DOI 10.1128/JB.02127-12; Dorr T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000317; Drecktrah D, 2006, TRAFFIC, V7, P39, DOI 10.1111/j.1600-0854.2005.00360.x; Georgiades K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017962; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Helaine S, 2014, SCIENCE, V343, P204, DOI 10.1126/science.1244705; Horcajo P, 2013, CAN J VET RES, V77, P158; Kaspy I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms4001; Katribe E, 2009, J BACTERIOL, V191, P2843, DOI 10.1128/JB.01223-08; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5; Kim J, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-84; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Lobato-Marquez D, 2015, SCI REP-UK, V5, DOI 10.1038/srep09374; Maisonneuve E, 2014, CELL, V157, P539, DOI 10.1016/j.cell.2014.02.050; Maisonneuve E, 2013, CELL, V154, P1140, DOI 10.1016/j.cell.2013.07.048; Maisonneuve E, 2011, P NATL ACAD SCI USA, V108, P13206, DOI 10.1073/pnas.1100186108; Markowitz VM, 2014, NUCLEIC ACIDS RES, V42, pD568, DOI 10.1093/nar/gkt919; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Monack DM, 2004, NAT REV MICROBIOL, V2, P747, DOI 10.1038/nrmicro955; Nagy TA, 2013, INFECT IMMUN, V81, P4063, DOI 10.1128/IAI.00412-13; Norton JP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002954; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Pedersen K, 2002, MOL MICROBIOL, V45, P501, DOI 10.1046/j.1365-2958.2002.03027.x; Pilonieta MC, 2009, J BACTERIOL, V191, P7243, DOI 10.1128/JB.00688-09; Rosenberger CM, 2004, P NATL ACAD SCI USA, V101, P2422, DOI 10.1073/pnas.0304455101; Sat B, 2003, J BACTERIOL, V185, P1803, DOI 10.1128/JB.185.6.1803-1807.2003; Shao YC, 2011, NUCLEIC ACIDS RES, V39, pD606, DOI 10.1093/nar/gkq908; Silva-Herzog E, 2010, INFECT IMMUN, V78, P3369, DOI 10.1128/IAI.00292-10; Slattery A, 2013, J BACTERIOL, V195, P647, DOI 10.1128/JB.01397-12; SMITH BP, 1984, AM J VET RES, V45, P59; Tsolis RM, 2011, INFECT IMMUN, V79, P1806, DOI 10.1128/IAI.01369-10; Tsolis RM, 1996, INFECT IMMUN, V64, P4549, DOI 10.1128/IAI.64.11.4549-4556.1996; Van Acker H, 2014, PATHOG DIS, V71, P326, DOI 10.1111/2049-632X.12177; Verstraeten N, 2015, MOL CELL, V59, P9, DOI 10.1016/j.molcel.2015.05.011; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; Yamaguchi Y, 2011, NAT REV MICROBIOL, V9, P779, DOI 10.1038/nrmicro2651	52	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0141343	10.1371/journal.pone.0141343	http://dx.doi.org/10.1371/journal.pone.0141343			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633172	gold, Green Submitted, Green Published			2022-12-27	WOS:000366040000002
J	Tsuruya, K; Yoshida, H; Haruyama, N; Fujisaki, K; Hirakata, H; Kitazono, T				Tsuruya, Kazuhiko; Yoshida, Hisako; Haruyama, Naoki; Fujisaki, Kiichiro; Hirakata, Hideki; Kitazono, Takanari			Clinical Significance of Fronto-Temporal Gray Matter Atrophy in Executive Dysfunction in Patients with Chronic Kidney Disease: The VCOHP Study	PLOS ONE			English	Article							CHRONIC-HEMODIALYSIS PATIENTS; VOXEL-BASED MORPHOMETRY; BRAIN ATROPHY; COGNITIVE IMPAIRMENT; CEREBRAL ATROPHY; MEMORY DYSFUNCTION; OXIDATIVE STRESS; ELDERLY JAPANESE; WORKING-MEMORY; RISK-FACTORS	Background & Objectives It is well known that cognitive impairment in patients with chronic kidney disease (CKD) is characterized by executive dysfunction, rather than memory dysfunction, although the precise mechanism of this remains to be elucidated. The purpose of the present study is to examine the correlation between gray matter volume (GMV) and executive function in CKD patients. Design, Setting, Participants, Measurements This cross-sectional study recruited 95 patients with non-dialysis-dependent CKD (NDD-CKD) with no history of cerebrovascular disease, who underwent brain magnetic resonance imaging (MRI) and Trail Making Test (TMT) in the VCOHP Study. The subjects underwent brain MRI and TMT part A (TMT-A) and part B (TMT-B). The segmentation algorithm from Statistical Parametric Mapping 8 software was applied to every T1-weighted MRI scan to extract tissue maps corresponding to gray matter, white matter, and cerebrospinal fluid. GMV was normalized by dividing by the total intracranial volume, calculated by adding GMV, white matter volume, and cerebrospinal fluid space volume. Then, normalized whole-brain GMV was divided into four categories of brain lobes; frontal, parietal, temporal, and occipital. We assessed the correlation between normalized GMV and TMT using multivariable regression analysis. Results Normalized whole-brain GMV was significantly inversely correlated to the scores of TMT-A, TMT-B, and Delta TMT (TMT-B minus TMT-A). These correlations remained significant even after adjusting for relevant confounding factors. Normalized frontal and temporal GMV, but not parietal and occipital GMV, were significantly inversely correlated with TMT-A, TMT-B, and Delta TMT using multivariable regression analysis. Conclusions The present study demonstrates the correlation between normalized GMV, especially in the frontal and temporal lobes, and executive function, suggesting that fronto-temporal gray matter atrophy might contribute to executive dysfunction in NDD-CKD.	[Tsuruya, Kazuhiko; Yoshida, Hisako] Kyushu Univ, Grad Sch Med Sci, Dept Integrated Therapy Chron Kidney Dis, Fukuoka 812, Japan; [Tsuruya, Kazuhiko; Haruyama, Naoki; Fujisaki, Kiichiro; Kitazono, Takanari] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 812, Japan; [Hirakata, Hideki] Japanese Red Cross Fukuoka Hosp, Div Nephrol, Fukuoka, Japan; [Hirakata, Hideki] Japanese Red Cross Fukuoka Hosp, Dialysis Ctr, Fukuoka, Japan	Kyushu University; Kyushu University	Tsuruya, K (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Integrated Therapy Chron Kidney Dis, Fukuoka 812, Japan.	tsuruya@intmed2.med.kyushu-u.ac.jp						Bassi A, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00182; BOONE KB, 1992, ARCH NEUROL-CHICAGO, V49, P549, DOI 10.1001/archneur.1992.00530290141024; Bowie CR, 2006, NAT PROTOC, V1, P2277, DOI 10.1038/nprot.2006.390; Bugnicourt JM, 2013, J AM SOC NEPHROL, V24, P353, DOI 10.1681/ASN.2012050536; Crowe SF, 1998, J CLIN PSYCHOL, V54, P585, DOI 10.1002/(SICI)1097-4679(199808)54:5<585::AID-JCLP4>3.3.CO;2-M; Fazekas G, 1996, NUCL MED COMMUN, V17, P603, DOI 10.1097/00006231-199607000-00011; Franc DT, 2011, DIABETES, V60, P315, DOI 10.2337/db10-0598; Fujisaki K, 2014, NEPHROL DIAL TRANSPL, V29, P529, DOI 10.1093/ndt/gft327; Fukunishi I, 2002, NEPHRON, V91, P344, DOI 10.1159/000058418; Haruyama N, 2014, LIFE SCI, V113, P55, DOI 10.1016/j.lfs.2014.07.032; Hashimoto R, 2006, PSYCHIAT CLIN NEUROS, V60, P422, DOI 10.1111/j.1440-1819.2006.01526.x; Hayashi K, 2011, DIABETES RES CLIN PR, V94, P180, DOI 10.1016/j.diabres.2011.07.002; HIRAKATA H, 1992, AM J PHYSIOL, V262, pF737, DOI 10.1152/ajprenal.1992.262.5.F737; Hirota C, 2010, GERIATR GERONTOL INT, V10, P40, DOI 10.1111/j.1447-0594.2009.00557.x; Hughes TM, 2013, J DIABETES COMPLICAT, V27, P558, DOI 10.1016/j.jdiacomp.2013.07.001; Jokinen H, 2012, NEUROLOGY, V78, P1785, DOI 10.1212/WNL.0b013e3182583070; Kamata T, 2000, AM J NEPHROL, V20, P27, DOI 10.1159/000013551; Koushik NS, 2010, NEUROPSYCHOL REV, V20, P33, DOI 10.1007/s11065-009-9110-5; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Madero M, 2008, SEMIN DIALYSIS, V21, P29, DOI 10.1111/j.1525-139X.2007.00384.x; MARSH JT, 1991, KIDNEY INT, V39, P155, DOI 10.1038/ki.1991.20; Mizumasa T, 2004, NEPHRON CLIN PRACT, V97, pC23, DOI 10.1159/000077592; Moran C, 2015, DIABETES, V64, P279, DOI 10.2337/db14-0506; Murea M, 2015, NEPHROL DIAL TRANSPL, V30, P1322, DOI 10.1093/ndt/gfv030; Nagano-Saito A, 2005, NEUROLOGY, V64, P224, DOI 10.1212/01.WNL.0000149510.41793.50; O'Brien JT, 2003, LANCET NEUROL, V2, P89, DOI 10.1016/S1474-4422(03)00305-3; Reitan RM, 1985, HALSTEAD REITAN NEUR; Roberts RO, 2014, NEUROLOGY, V82, P1132, DOI 10.1212/WNL.0000000000000269; Sanchez-Cubillo I, 2009, J INT NEUROPSYCH SOC, V15, P438, DOI 10.1017/S1355617709090626; SAVAZZI GM, 1995, NEPHRON, V69, P29, DOI 10.1159/000188356; Savazzi GM, 2001, NEPHRON, V89, P31, DOI 10.1159/000046040; Sluimer JD, 2008, RADIOLOGY, V248, P590, DOI 10.1148/radiol.2482070938; Taki Y, 2004, NEUROBIOL AGING, V25, P455, DOI 10.1016/j.neurobiolaging.2003.09.002; Tamura MK, 2008, AM J KIDNEY DIS, V52, P227, DOI 10.1053/j.ajkd.2008.05.004; Tsuruya K, 2015, AM J KIDNEY DIS, V65, P312, DOI 10.1053/j.ajkd.2014.07.011; Yakushiji Y, 2010, HYPERTENS RES, V33, P1232, DOI 10.1038/hr.2010.171; Yao H, 2011, HYPERTENS RES, V34, P1023, DOI 10.1038/hr.2011.83; Yoshimitsu T, 2000, CLIN NEPHROL, V53, P445; Zhang LJ, 2013, METAB BRAIN DIS, V28, P647, DOI 10.1007/s11011-013-9438-7	39	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143706	10.1371/journal.pone.0143706	http://dx.doi.org/10.1371/journal.pone.0143706			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26632813	Green Published, gold, Green Submitted			2022-12-27	WOS:000366040000021
J	Wojtal-Frankiewicz, A; Kruk, A; Frankiewicz, P; Oleksinska, Z; Izydorczyk, K				Wojtal-Frankiewicz, Adrianna; Kruk, Andrzej; Frankiewicz, Piotr; Oleksinska, Zuzanna; Izydorczyk, Katarzyna			Long-Term Patterns in the Population Dynamics of Daphnia longispina, Leptodora kindtii and Cyanobacteria in a Shallow Reservoir: A Self-Organising Map (SOM) Approach	PLOS ONE			English	Article							CLEAR-WATER PHASE; MICROCYSTIS-AERUGINOSA; PEG-MODEL; ZOOPLANKTON COMMUNITY; SEASONAL SUCCESSION; SULEJOW-RESERVOIR; PRIMARY PRODUCERS; GREEN-ALGA; BLOOMS; PHYTOPLANKTON	The recognition of long-term patterns in the seasonal dynamics of Daphnia longispina, Leptodora kindtii and cyanobacteria is dependent upon their interactions, the water temperature and the hydrological conditions, which were all investigated between 1999 and 2008 in the lowland Sulejow Reservoir. The biomass of cyanobacteria, densities of D. longispina and L. kindtii, concentration of chlorophyll a and water temperature were assessed weekly from April to October at three sampling stations along the longitudinal reservoir axis. The retention time was calculated using data on the actual water inflow and reservoir volume. A self-organising map (SOM) was used due to high interannual variability in the studied parameters and their often non-linear relationships. Classification of the SOM output neurons into three clusters that grouped the sampling terms with similar biotic states allowed identification of the crucial abiotic factors responsible for the seasonal sequence of events: cluster CL-ExSp (extreme/spring) corresponded to hydrologically unstable cold periods (mostly spring) with extreme values and highly variable abiotic factors, which made abiotic control of the biota dominant; cluster CL-StSm (stable/summer) was associated with ordinary late spring and summer and was characterised by stable non-extreme abiotic conditions, which made biotic interactions more important; and the cluster CL-ExSm (extreme/summer), was associated with late spring/summer and characterised by thermal or hydrological extremes, which weakened the role of biotic factors. The significance of the differences between the SOM sub-clusters was verified by Kruskal-Wallis and post-hoc Dunn tests. The importance of the temperature and hydrological regimes as the key plankton-regulating factors in the dam reservoir, as shown by the SOM, was confirmed by the results of canonical correlation analyses (CCA) of each cluster. The demonstrated significance of hydrology in seasonal plankton dynamics complements the widely accepted pattern proposed by the plankton succession model for lakes, the PEG (Plankton Ecology Group), and may be useful for the formulation of management decisions in dam reservoirs.	[Wojtal-Frankiewicz, Adrianna; Frankiewicz, Piotr; Oleksinska, Zuzanna] Univ Lodz, Dept Appl Ecol, Fac Biol & Environm Protect, PL-90131 Lodz, Poland; [Kruk, Andrzej] Univ Lodz, Dept Ecol & Vertebrate Zool, Fac Biol & Environm Protect, PL-90131 Lodz, Poland; [Frankiewicz, Piotr; Izydorczyk, Katarzyna] Polish Acad Sci, European Reg Ctr Ecohydrol, Lodz, Poland	University of Lodz; University of Lodz; Polish Academy of Sciences; European Regional Centre for Ecohydrology of the Polish Academy of Sciences	Wojtal-Frankiewicz, A (corresponding author), Univ Lodz, Dept Appl Ecol, Fac Biol & Environm Protect, PL-90131 Lodz, Poland.	adwoj@biol.uni.lodz.pl		Izydorczyk, Katarzyna/0000-0003-2056-2513; Kruk, Andrzej/0000-0003-1452-7906; Wojtal-Frankiewicz, Adrianna/0000-0003-3509-6076; Frankiewicz, Piotr/0000-0003-1782-9539	Life+EnvEurope Project [LIFE08 ENV/IT/000339]	Life+EnvEurope Project	The Sulejow Reservoir is a part of the Polish National Long-Term Ecosystem Research Network and the European LTER site. It is also a monitoring and research site of the Life+EnvEurope Project LIFE08 ENV/IT/000339. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian R, 2006, GLOBAL CHANGE BIOL, V12, P652, DOI 10.1111/j.1365-2486.2006.01125.x; [Anonymous], 1999, TOXIC CYANOBACTERIA; Bednarska A, 2014, J PLANKTON RES, V36, P838, DOI 10.1093/plankt/fbu009; Benndorf J, 2001, FRESHWATER BIOL, V46, P199, DOI 10.1046/j.1365-2427.2000.00657.x; Benzie J.A., 2005, GUIDES IDENTIFICATIO, V21, P1; BRANSTRATOR DK, 1991, LIMNOL OCEANOGR, V36, P483, DOI 10.4319/lo.1991.36.3.0483; Brosse S, 2001, ECOL MODEL, V146, P159, DOI 10.1016/S0304-3800(01)00303-9; Carlotti F., 2000, P571, DOI 10.1016/B978-012327645-2/50013-X; Cereghino R, 2009, ENVIRON MODELL SOFTW, V24, P945, DOI 10.1016/j.envsoft.2009.01.008; Chen CY, 1996, LIMNOL OCEANOGR, V41, P1077, DOI 10.4319/lo.1996.41.5.1077; Demott WR, 1999, FRESHWATER BIOL, V42, P263, DOI 10.1046/j.1365-2427.1999.444494.x; Droscher I, 2008, INT VER THEOR ANGEW, V30, P186; Ebert D., 2005, ECOLOGY EPIDEMIOLOGY; Elliott JA, 2010, GLOBAL CHANGE BIOL, V16, P864, DOI 10.1111/j.1365-2486.2009.01998.x; Ferrao AS, 2002, LIMNOLOGICA, V32, P295, DOI 10.1016/S0075-9511(02)80021-4; Frankiewicz P, 1999, HYDROBIOLOGIA, V408, P47, DOI 10.1023/A:1017001803791; FULTON RS, 1987, J PLANKTON RES, V9, P837, DOI 10.1093/plankt/9.5.837; Godlewska M, 2003, HYDROBIOLOGIA, V504, P305, DOI 10.1023/B:HYDR.0000008530.31142.81; Harris GP., 1986, PHYTOPLANKTON ECOLOG; HERZIG A, 1990, HYDROBIOLOGIA, V198, P107, DOI 10.1007/BF00048627; Izydorczyk K, 2008, INT REV HYDROBIOL, V93, P257, DOI 10.1002/iroh.200710959; Johnk KD, 2008, GLOBAL CHANGE BIOL, V14, P495, DOI 10.1111/j.1365-2486.2007.01510.x; Jurczak T, 2005, WATER RES, V39, P2394, DOI 10.1016/j.watres.2005.04.031; JURGENS K., 1994, REV MAR MICROB FOOD, V8, P295; Kimmel B.L., 1990, RESERVOIR LIMNOLOGY, P133; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; Kohonen T., 2001, SELF ORG MAPS; Komarkova J, 1995, WATER SCI TECHNOL, V32, P207, DOI 10.1016/0273-1223(95)00700-8; Lampert W, 2011, DAPHNIA DEV MODEL OR; Lampert W, 1997, LIMNOECOLOGY ECOLOGY; Lehman JT, 2007, FRESHWATER BIOL, V52, P1773, DOI 10.1111/j.1365-2427.2007.01808.x; Lek S, 2005, MODELLING COMMUNITY; Lindenmayer DB, 2012, AUSTRAL ECOL, V37, P745, DOI 10.1111/j.1442-9993.2011.02351.x; LUNTE CC, 1990, LIMNOL OCEANOGR, V35, P1091, DOI 10.4319/lo.1990.35.5.1091; Mankiewicz-Boczek J, 2006, ENVIRON TOXICOL, V21, P380, DOI 10.1002/tox.20200; Muller-Navarra DC, 2000, NATURE, V403, P74, DOI 10.1038/47469; Naselli-Flores L, 1997, HYDROBIOLOGIA, V360, P223, DOI 10.1023/A:1003108919638; Paerl H, 2008, ADV EXP MED BIOL, V619, P217, DOI 10.1007/978-0-387-75865-7_10; Paerl Hans W., 2014, Life-Basel, V4, P988, DOI 10.3390/life4040988; Persson J, 2007, OIKOS, V116, P1152, DOI 10.1111/j.2007.0030-1299.15639.x; Quinn GP, 2003, EXPT DESIGN DATA ANA; Reichwaldt ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066674; Rennella AM, 2006, HYDROBIOLOGIA, V556, P181, DOI 10.1007/s10750-005-0318-y; Roelke DL, 2011, J PLANKTON RES, V33, P205, DOI 10.1093/plankt/fbq143; Rohrlack T, 1999, J PLANKTON RES, V21, P1489, DOI 10.1093/plankt/21.8.1489; Schalau K, 2008, OECOLOGIA, V157, P531, DOI 10.1007/s00442-008-1081-3; Sommer F, 2003, FRESHWATER BIOL, V48, P67, DOI 10.1046/j.1365-2427.2003.00971.x; SOMMER U, 1986, ARCH HYDROBIOL, V106, P433; Sommer U, 2012, ANNU REV ECOL EVOL S, V43, P429, DOI 10.1146/annurev-ecolsys-110411-160251; Straile D, 2015, FRESHWATER BIOL, V60, P174, DOI 10.1111/fwb.12484; Straskrabova V., 2005, Limnetica, V24, P9; Talling JF, 2003, FRESHWATER BIOL, V48, P39, DOI 10.1046/j.1365-2427.2003.00968.x; Thomton J., 1996, WATER QUALITY ASSESS, P371; Verbitsky VB, 2011, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2011019; Vesanto J, 2000, IEEE T NEURAL NETWOR, V11, P586, DOI 10.1109/72.846731; Vesanto J., 2000, SOM TOOLBOX MATLAB 5; VOROS L, 1991, HYDROBIOLOGIA, V215, P111, DOI 10.1007/BF00014715; Wagner A, 2007, OECOLOGIA, V151, P351, DOI 10.1007/s00442-006-0554-5; Wagner I., 2009, Ecohydrology and Hydrobiology, V9, P13, DOI 10.2478/V10104-009-0042-8; Wetzel R.G., 2001, LIMNOLOGY LAKE RIVER, DOI DOI 10.1046/J.1529-8817.2001.37602.X; Wojtal A, 2008, ANN LIMNOL-INT J LIM, V44, P7, DOI 10.1051/limn:2008025; Wojtal A, 2004, HYDROBIOLOGIA, V515, P123, DOI 10.1023/B:HYDR.0000027324.44452.9e; Wojtal A, 1999, HYDROBIOLOGIA, V416, P215, DOI 10.1023/A:1003815520751; Wojtal A., 2000, THESIS; Wojtal-Frankiewicz A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112597; Wojtal-Frankiewicz A, 2013, J LIMNOL, V72, P154, DOI 10.4081/jlimnol.2013.e13; Wojtal-Frankiewicz A, 2012, AQUAT ECOL, V46, P37, DOI 10.1007/s10452-011-9380-x; Wolfinbarger WC, 1999, HYDROBIOLOGIA, V400, P13, DOI 10.1023/A:1003738608697; Zalewski M, 2002, HYDROLOG SCI J, V47, P823, DOI 10.1080/02626660209492986; Zalewski M., 1985, P3; Zar J.H., 1999, ZAR KUHR 5 2019, V4th; ZETTLER ER, 1986, CAN J FISH AQUAT SCI, V43, P665, DOI 10.1139/f86-080	72	10	10	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144109	10.1371/journal.pone.0144109	http://dx.doi.org/10.1371/journal.pone.0144109			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633032	Green Submitted, Green Published, gold			2022-12-27	WOS:000366040000057
J	Minor, RL; Koprowski, JL				Minor, Rebecca L.; Koprowski, John L.			Seed Removal Increased by Scramble Competition with an Invasive Species	PLOS ONE			English	Article							GRAHAM RED SQUIRREL; ABERTS SQUIRRELS; INTERSPECIFIC COMPETITION; BIOLOGICAL INVASIONS; POPULATION-DYNAMICS; GREY SQUIRRELS; MIXED-CONIFER; HOME RANGES; FOOD; SELECTION	Competition for seeds has a major influence on the evolution of granivores and the plants on which they rely. The complexity of interactions and coevolutionary relationships vary across forest types. The introduction of non-native granivores has considerable potential to alter seed dispersal dynamics. Non-native species are a major cause of endangerment for native species, but the mechanisms are often unclear. As biological invasions continue to rise, it is important to understand mechanisms to build up strategies to mitigate the threat. Our field experiment quantified the impact of introduced Abert's squirrels (Sciurus aberti) on rates of seed removal within the range of critically endangered Mount Graham red squirrels (Tamiasciurus hudsonicus grahamensis), which consumes similar foods. In the presence of invasive Abert's squirrels, the time cones were removed was faster than when the invasive was excluded, accounting for a median removal time of cones available to red and Abert's squirrels that is 32.8% less than that of cones available only to the rare native red squirrels. Moreover, in the presence of Abert's squirrels, removal rates are higher at great distance from a territorial red squirrel larderhoard and in more open portions of the forest, which suggests differential patterns of seed dispersal. The impact on food availability as a result of cone removal by Abert's squirrels suggests the potential of food competition as a mechanism of endangerment for the Mount Graham red squirrel. Furthermore, the magnitude and differential spatial patterns of seed removal suggest that non-native granivores may have impacts on forest regeneration and structure.	[Minor, Rebecca L.; Koprowski, John L.] Univ Arizona, Sch Nat Resources & Environm, Wildlife & Fisheries Sci, Tucson, AZ 85721 USA	University of Arizona	Minor, RL (corresponding author), Univ Arizona, Sch Nat Resources & Environm, Wildlife & Fisheries Sci, Tucson, AZ 85721 USA.	rlminor@email.arizona.edu		Koprowski, John/0000-0003-1406-9853	University of Arizona; Arizona Agricultural Experiment Station	University of Arizona; Arizona Agricultural Experiment Station	Funding was provided by the University of Arizona and the Arizona Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allred WS, 2010, NATURAL HIST TASSEL; Atkinson IAE, 1996, WILDLIFE BIOL, V2, P135, DOI 10.2981/wlb.1996.011; Benkman CW, 2013, EVOLUTION, V67, P157, DOI 10.1111/j.1558-5646.2012.01736.x; Blount SJ, 2012, SOUTHWEST NAT, V57, P8, DOI 10.1894/0038-4909-57.1.8; BOUTIN S, 1990, CAN J ZOOL, V68, P203, DOI 10.1139/z90-031; BOWERS MA, 1982, ECOLOGY, V63, P391, DOI 10.2307/1938957; BROWN DE, 1984, ARIZONAS TREE SQUIRR; Buck CL, 1999, J MAMMAL, V80, P430, DOI 10.2307/1383291; Choquenot D, 2000, J ANIM ECOL, V69, P1058, DOI 10.1046/j.1365-2656.2000.00462.x; Collar N.J., 1996, COLONIA WATERBIRDS, DOI [10.2307/1521829, DOI 10.2307/1521829]; CONNELL JH, 1961, ECOLOGY, V42, P710, DOI 10.2307/1933500; Connolly BM, 2014, ECOLOGY, V95, P1759, DOI 10.1890/13-1774.1; Courchamp F, 2003, BIOL REV, V78, P347, DOI 10.1017/S1464793102006061; DAYAN T, 1994, AM NAT, V143, P462, DOI 10.1086/285613; deRivera CE, 2005, ECOLOGY, V86, P3364, DOI 10.1890/05-0479; Eccard JA, 2002, OIKOS, V99, P580, DOI 10.1034/j.1600-0706.2002.11833.x; Edelman AJ, 2006, CAN J ZOOL, V84, P404, DOI 10.1139/z06-009; Edelman AJ, 2005, SOUTHWEST NAT, V50, P461, DOI 10.1894/0038-4909(2005)050[0461:DATUOA]2.0.CO;2; Edelman AJ, 2005, J MAMMAL, V86, P1220, DOI 10.1644/04-MAMM-A-029R1.1; Edelman Andrew J., 2005, U S Forest Service Rocky Mountain Research Station Proceedings RMRS-P, V36, P395; Edelman AJ, 2009, J MAMMAL, V90, P167, DOI 10.1644/07-MAMM-A-282.1; GURNELL J, 1984, ANIM BEHAV, V32, P1119, DOI 10.1016/S0003-3472(84)80228-6; GURNELL J, 1983, MAMMAL REV, V13, P133, DOI 10.1111/j.1365-2907.1983.tb00274.x; Gwinn RN, 2011, THESIS; Hatten JR, 2000, 160 AR GAM FISH DEP; Hayssen V, 2008, J MAMMAL, V89, P582, DOI 10.1644/07-MAMM-A-064R2.1; HERBOLD B, 1986, AM NAT, V128, P751, DOI 10.1086/284600; Holway DA, 1999, ECOLOGY, V80, P238, DOI 10.1890/0012-9658(1999)080[0238:CMUTDO]2.0.CO;2; Hulme PE, 2006, J APPL ECOL, V43, P835, DOI 10.1111/j.1365-2664.2006.01227.x; Hutton KA, 2003, SOUTHWEST NAT, V48, P257, DOI 10.1894/0038-4909(2003)048&lt;0257:UOMASF&gt;2.0.CO;2; KEITH JO, 1965, ECOLOGY, V46, P150, DOI 10.2307/1935266; KLENNER W, 1991, J ANIM ECOL, V60, P961, DOI 10.2307/5425; Koprowski JL, 2005, J MAMMAL, V86, P309, DOI 10.1644/BWG-232.1; KOPROWSKI JL, 1991, J MAMMAL, V72, P367, DOI 10.2307/1382108; Koprowski John L., 2008, Endangered Species Research, V4, P227, DOI 10.3354/esr00026; Kuhn KM, 2009, WEST N AM NATURALIST, V69, P309, DOI 10.3398/064.069.0304; Kupferberg SJ, 1997, ECOLOGY, V78, P1736; LANGE KENNETH I, 1960, AMER MIDLAND NAT, V64, P436, DOI 10.2307/2422673; Larson MM, 2005, USDA FOREST SERVICE, VRM-58, P1; Leonard KM, 2009, AM MIDL NAT, V162, P125, DOI 10.1674/0003-0031-162.1.125; Lichti NI, 2014, ECOLOGY, V95, P1746, DOI 10.1890/13-1657.1; MACARTHUR RH, 1964, P NATL ACAD SCI USA, V51, P1207, DOI 10.1073/pnas.51.6.1207; Mendes CP, 2016, ECOGRAPHY, V39, P465, DOI 10.1111/ecog.01592; Posthumus EE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123633; Prather JW, 2006, J WILDLIFE MANAGE, V70, P723, DOI 10.2193/0022-541X(2006)70[723:LMTPTI]2.0.CO;2; Reitz SR, 2002, ANNU REV ENTOMOL, V47, P435, DOI 10.1146/annurev.ento.47.091201.145227; Rushton SP, 2006, BIOL CONSERV, V131, P121, DOI 10.1016/j.biocon.2006.02.010; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Sanderson H.R., 2009, LAST REFUGE MT GRAHA; Sanguinetti J, 2010, BIOL INVASIONS, V12, P689, DOI 10.1007/s10530-009-9474-8; Schmitz DC, 1997, ISSUES SCI TECHNOL, V13, P33; Simberloff Daniel, 1995, Pacific Science, V49, P87; SMITH AA, 1994, J WILDLIFE MANAGE, V58, P437, DOI 10.2307/3809314; Steele MA, 2006, ANIM BEHAV, V71, P155, DOI 10.1016/j.anbehav.2005.05.005; Steele MA, 2008, CURR SCI INDIA, V95, P871; Sundaram M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130942; Talluto MV, 2013, ECOLOGY, V94, P1307, DOI 10.1890/12-2058.1; Traveset A, 2006, TRENDS ECOL EVOL, V21, P208, DOI 10.1016/j.tree.2006.01.006; Vander Wall SB., 1990, FOOD HOARDING ANIMAL; Vander Wall SB, 2012, BOT REV, V78, P10, DOI 10.1007/s12229-011-9093-9; Wauters LA, 2002, BEHAV ECOL SOCIOBIOL, V52, P332, DOI 10.1007/s00265-002-0516-9; Wauters LA, 1995, P ROYAL SOC LOND B, V262, P227; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Wilson DJ, 2007, ECOGRAPHY, V30, P105, DOI [10.1111/j.2006.0906-7590.04771.x, 10.1111/j.0906-7590.2007.04771.x]; WILSON E O, 1992; Wood DJA, 2007, J MAMMAL, V88, P1271, DOI 10.1644/06-MAMM-A-303.1; Young Paul J., 2009, P124; Zugmeyer CA, 2007, SOUTHWEST NAT, V52, P155, DOI 10.1894/0038-4909(2007)52[155:ANPBEM]2.0.CO;2; Zugmeyer CA, 2009, J MAMMAL, V90, P175, DOI 10.1644/07-MAMM-A-399.1	69	2	2	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0143927	10.1371/journal.pone.0143927	http://dx.doi.org/10.1371/journal.pone.0143927			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650073	gold, Green Published, Green Submitted			2022-12-27	WOS:000366903300030
J	Papailiou, AP; Yokum, DV; Robertson, CT				Papailiou, Athan P.; Yokum, David V.; Robertson, Christopher T.			The Novel New Jersey Eyewitness Instruction Induces Skepticism but Not Sensitivity	PLOS ONE			English	Article							ACCURACY; JURORS	In recent decades, social scientists have shown that the reliability of eyewitness identifications is much worse than laypersons tend to believe. Although courts have only recently begun to react to this evidence, the New Jersey judiciary has reformed its jury instructions to notify jurors about the frailties of human memory, the potential for lineup administrators to nudge witnesses towards suspects that they police have already identified, and the advantages of alternative lineup procedures, including blinding of the administrator. This experiment tested the efficacy of New Jersey's jury instruction. In a 2x2 between-subjects design, mock jurors (N = 335) watched a 35-minute murder trial, wherein identification quality was either "weak" or "strong" and either the New Jersey or a "standard" instruction was delivered. Jurors were more than twice as likely to convict when the standard instruction was used (OR = 2.55; 95% CI = 1.37-4.89, p < 0.001). The New Jersey instruction, however, did not improve juror's ability to discern quality; rather, jurors receiving those instructions indiscriminatingly discounted "weak" and "strong" testimony in equal measure.	[Papailiou, Athan P.; Yokum, David V.; Robertson, Christopher T.] Univ Arizona, James E Rogers Coll Law, Tucson, AZ 85721 USA; [Yokum, David V.] Univ Arizona, Dept Psychol, Tucson, AZ 85721 USA	University of Arizona; University of Arizona	Papailiou, AP (corresponding author), Univ Arizona, James E Rogers Coll Law, Tucson, AZ 85721 USA.	athan@email.arizona.edu			University of Arizona, James E. Rogers College of Law; University of Arizona Honor's College	University of Arizona, James E. Rogers College of Law; University of Arizona Honor's College	This work was supported by the University of Arizona, James E. Rogers College of Law and the University of Arizona Honor's College.	Bornstein BH, 2012, COURT REV, V48, P48; CUTLER BL, 1990, J APPL SOC PSYCHOL, V20, P1197, DOI 10.1111/j.1559-1816.1990.tb00400.x; Devine D.J., 2012, JURY DECISION MAKING; GREENE E, 1988, J APPL SOC PSYCHOL, V18, P252, DOI 10.1111/j.1559-1816.1988.tb00016.x; Laudan L, 2012, PERSPECT PSYCHOL SCI, V7, P272, DOI 10.1177/1745691612443065; Nadel Lynn, 2012, OXFORD SERIES NEUROS; Nietzel MT, 1999, PERSPECTIVES LAW PSY, V1, P10; Pawlenko NB, 2013, APPL COGNITIVE PSYCH, V27, P190, DOI 10.1002/acp.2895; Penrod S, 1995, PSYCHOL PUBLIC POL L, V1, P817, DOI 10.1037/1076-8971.1.4.817; Petty R. E., 1986, COMMUN PERSUATION, P1; Ramirez G., 1996, AM J FORENSIC PSYCH, V14, P31; Schacter DL, 2013, NAT NEUROSCI, V16, P119, DOI 10.1038/nn.3294	12	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0142695	10.1371/journal.pone.0142695	http://dx.doi.org/10.1371/journal.pone.0142695			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1YX	26650237	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903300007
J	Carpio, VH; Opata, MM; Montanez, ME; Banerjee, PP; Dent, AL; Stephens, R				Carpio, Victor H.; Opata, Michael M.; Montanez, Marelle E.; Banerjee, Pinaki P.; Dent, Alexander L.; Stephens, Robin			IFN-gamma and IL-21 Double Producing T Cells Are Bcl6-Independent and Survive into the Memory Phase in Plasmodium chabaudi Infection	PLOS ONE			English	Article							FOLLICULAR HELPER; PROTECTIVE IMMUNITY; MALARIA INFECTION; CUTTING EDGE; B-CELLS; TH1; EFFECTOR; INTERLEUKIN-21; BCL6; DIFFERENTIATION	CD4 T cells are required to fight malaria infection by promoting both phagocytic activity and B cell responses for parasite clearance. In Plasmodium chabaudi infection, one specific CD4 T cell subset generates anti-parasitic IFN-gamma and the antibody-promoting cytokine, IL-21. To determine the lineage of these multifunctional T cells, we followed IFN-gamma(+) effector T cells (Teff) into the memory phase using Ifng-reporter mice. While Ifng(+) Teff expanded, the level of the Th1 lineage-determining transcription factor T-bet only peaked briefly. Ifng(+) Teff also co-express ICOS, the B cell area homing molecule CXCR5, and other Tfh lineage-associated molecules including Bcl6, the transcription factor required for germinal center (GC) T follicular helper cells (Tfh) differentiation. Because Bcl6 and T-bet co-localize to the nucleus of Ifng(+) Teff, we hypothesized that Bcl6 controls the Tfh-like phenotype of Ifng(+) Teff cells in P. chabaudi infection. We first transferred Bcl6-deficient T cells into wildtype hosts. Bcl6-deficient T cells did not develop into GC Tfh, but they still generated CXCR5(+)IFN-gamma+IL-21(+)IL-10(+) Teff, suggesting that this predominant population is not of the Tfh-lineage. IL-10 deficient mice, which have increased IFN-gamma and T-bet expression, demonstrated expansion of both IFN-gamma+IL-21(+)CXCR5(+) cells and IFN-gamma(+) GC Tfh cells, suggesting a Th1 lineage for the former. In the memory phase, all Ifng(+) T cells produced IL-21, but only a small percentage of highly proliferative Ifng(+) T cells maintained a T-bethi phenotype. In chronic malaria infection, serum IFN-gamma correlates with increased protection, and our observation suggests Ifng(+) T cells are maintained by cellular division. In summary, we found that Ifng(+) T cells are not strictly Tfh derived during malaria infection. T cells provide the host with a survival advantage when facing this well-equipped pathogen, therefore, understanding the lineage of pivotal T cell players will aid in the rational design of an effective malaria vaccine.	[Carpio, Victor H.; Opata, Michael M.; Montanez, Marelle E.; Stephens, Robin] Univ Texas Med Branch, Dept Internal Med, Div Infect Dis, Galveston, TX 77555 USA; [Carpio, Victor H.; Montanez, Marelle E.; Stephens, Robin] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Banerjee, Pinaki P.] Texas Childrens Hosp, Baylor Coll Med, Ctr Human Immunobiol, Houston, TX 77030 USA; [Dent, Alexander L.] Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Baylor College of Medicine; Indiana University System; Indiana University-Purdue University Indianapolis	Stephens, R (corresponding author), Univ Texas Med Branch, Dept Internal Med, Div Infect Dis, Galveston, TX 77555 USA.	rostephe@utmb.edu	Opata, Michael/X-2751-2019		National Institute of Allergy and Infectious Diseases [R01AI08995304, R01AI08995304S1, T32AI7536-15]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089953, T32AI007536] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institute of Allergy and Infectious Diseases grant numbers R01AI08995304 (to RS and MMO), R01AI08995304S1 (to VHC), and T32AI7536-15 (to MMO).	Achtman AH, 2007, PARASITE IMMUNOL, V29, P435, DOI 10.1111/j.1365-3024.2007.00960.x; Anderson CF, 2007, J EXP MED, V204, P285, DOI 10.1084/jem.20061886; Batten M, 2010, J EXP MED, V207, P2895, DOI 10.1084/jem.20100064; Bouneauld C, 2005, J EXP MED, V201, P579, DOI 10.1084/jem.20040876; Cannons JL, 2013, TRENDS IMMUNOL, V34, P200, DOI 10.1016/j.it.2013.01.001; Chacon-Salinas R, 2011, J IMMUNOL, V186, P25, DOI 10.4049/jimmunol.1001657; Choi YS, 2013, J IMMUNOL, V190, P4014, DOI 10.4049/jimmunol.1202963; Crawford A, 2014, IMMUNITY, V40, P289, DOI 10.1016/j.immuni.2014.01.005; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; Curtis MM, 2010, CELL HOST MICROBE, V8, P163, DOI 10.1016/j.chom.2010.07.006; da Silva HB, 2013, J IMMUNOL, V191, P5160, DOI 10.4049/jimmunol.1300462; DELORON P, 1992, PARASITOL TODAY, V8, P375, DOI 10.1016/0169-4758(92)90174-Z; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; do Rosario APF, 2012, J IMMUNOL, V188, P1178, DOI 10.4049/jimmunol.1102755; Elsaesser H, 2009, SCIENCE, V324, P1569, DOI 10.1126/science.1174182; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Fahey LM, 2011, J EXP MED, V208, P987, DOI 10.1084/jem.20101773; Findlay EG, 2010, J IMMUNOL, V185, P2482, DOI 10.4049/jimmunol.0904019; do Rosario APF, 2008, J IMMUNOL, V181, P8344, DOI 10.4049/jimmunol.181.12.8344; Frohlich A, 2009, SCIENCE, V324, P1576, DOI 10.1126/science.1172815; Gazzinelli RT, 1996, J IMMUNOL, V157, P798; Hale JS, 2013, IMMUNITY, V38, P805, DOI 10.1016/j.immuni.2013.02.020; Harrington LE, 2008, NATURE, V452, P356, DOI 10.1038/nature06672; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Hogan RJ, 2002, J IMMUNOL, V169, P4976, DOI 10.4049/jimmunol.169.9.4976; Hollister K, 2013, J IMMUNOL, V191, P3705, DOI 10.4049/jimmunol.1300378; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Kallies A, 2009, IMMUNITY, V31, P283, DOI 10.1016/j.immuni.2009.06.021; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kroenke MA, 2012, J IMMUNOL, V188, P3734, DOI 10.4049/jimmunol.1103246; Langhorne J, 1989, Int Immunol, V1, P416, DOI 10.1093/intimm/1.4.416; Langhorne J, 1998, P NATL ACAD SCI USA, V95, P1730, DOI 10.1073/pnas.95.4.1730; Li C, 2003, INFECT IMMUN, V71, P4850, DOI 10.1128/IAI.71.9.4850-4856.2003; Li C, 1999, INFECT IMMUN, V67, P4435, DOI 10.1128/IAI.67.9.4435-4442.1999; Luthje K, 2012, NAT IMMUNOL, V13, P491, DOI 10.1038/ni.2261; Luty AJF, 1999, J INFECT DIS, V179, P980, DOI 10.1086/314689; Mascle X, 2003, BIOCHEM BIOPH RES CO, V300, P391, DOI 10.1016/S0006-291X(02)02873-5; McLane LM, 2013, J IMMUNOL, V190, P3207, DOI 10.4049/jimmunol.1201556; MEDING SJ, 1991, EUR J IMMUNOL, V21, P1433, DOI 10.1002/eji.1830210616; Mewono L, 2008, EUR CYTOKINE NETW, V19, P30, DOI 10.1684/ecn.2008.0114; Monteleone G, 2005, GASTROENTEROLOGY, V128, P687, DOI 10.1053/j.gastro.2004.12.042; Nakayamada S, 2011, IMMUNITY, V35, P919, DOI 10.1016/j.immuni.2011.11.012; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Oakley MS, 2014, EUR J IMMUNOL, V44, P2680, DOI 10.1002/eji.201344437; Oakley MS, 2013, J IMMUNOL, V191, P4699, DOI 10.4049/jimmunol.1300396; Obeng-Adjei N, 2015, CELL REP, V13, P425, DOI 10.1016/j.celrep.2015.09.004; Oestreich KJ, 2012, NAT IMMUNOL, V13, P405, DOI 10.1038/ni.2242; Olson JA, 2013, IMMUNITY, V38, P1250, DOI 10.1016/j.immuni.2013.05.009; Park AY, 2000, J IMMUNOL, V165, P896, DOI 10.4049/jimmunol.165.2.896; Perez-Mazliah D, 2015, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00671; Perez-Mazliah D, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004715; Portugal S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004079; Pot C, 2009, J IMMUNOL, V183, P797, DOI 10.4049/jimmunol.0901233; Reiley WW, 2010, P NATL ACAD SCI USA, V107, P19408, DOI 10.1073/pnas.1006298107; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Roetynck S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055195; Sarra M, 2010, INFLAMM BOWEL DIS, V16, P1332, DOI 10.1002/ibd.21238; Scott P, 2004, IMMUNOL REV, V201, P318, DOI 10.1111/j.0105-2896.2004.00198.x; Shah S, 2015, ELIFE, V4, DOI 10.7554/eLife.09017; Sponaas AM, 2006, J EXP MED, V203, P1427, DOI 10.1084/jem.20052450; Stephens R, 2012, TRENDS PARASITOL, V28, P73, DOI 10.1016/j.pt.2011.10.006; Stephens R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001208; Stobie L, 2000, P NATL ACAD SCI USA, V97, P8427, DOI 10.1073/pnas.160197797; Strengeil M, 2002, J IMMUNOL, V169, P3600, DOI 10.4049/jimmunol.169.7.3600; Stumhofer JS, 2008, IMMUNOL LETT, V117, P123, DOI 10.1016/j.imlet.2008.01.011; Su Z, 2002, J IMMUNOL, V168, P1348, DOI 10.4049/jimmunol.168.3.1348; Suto A, 2006, J IMMUNOL, V177, P3721, DOI 10.4049/jimmunol.177.6.3721; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Weinmann AS, 2014, IMMUNOL CELL BIOL, V92, P34, DOI 10.1038/icb.2013.49; Wurster AL, 2002, J EXP MED, V196, P969, DOI 10.1084/jem.20020620; Yap G, 2000, J IMMUNOL, V165, P628, DOI 10.4049/jimmunol.165.2.628; Yi JS, 2009, SCIENCE, V324, P1572, DOI 10.1126/science.1175194; Zaph C, 2006, J IMMUNOL, V177, P511, DOI 10.4049/jimmunol.177.1.511	75	37	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0144654	10.1371/journal.pone.0144654	http://dx.doi.org/10.1371/journal.pone.0144654			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YV	26646149	Green Published, gold			2022-12-27	WOS:000366903100031
J	Pillaud, V; Rigaud, D; Clemence, A				Pillaud, Vincent; Rigaud, David; Clemence, Alain			The Influence of Chronic and Situational Social Status on Stereotype Susceptibility	PLOS ONE			English	Article							CHILDRENS PERCEPTIONS; GENDER STEREOTYPES; MOTOR-PERFORMANCE; THREAT; MATH; IDENTITY; HEIGHT; MATHEMATICS; ACTIVATION; POWER	We tested whether stereotypical situations would affect low-status group members' performance more strongly than high-status group members'. Experiment 1 and 2 tested this hypothesis using gender as a proxy of chronic social status and a gender-neutral task that has been randomly presented to favor boys (men superiority condition), favor girls (women superiority condition), or show no gender preference (control condition). Both experiments found that women's (Experiment 1) and girls' performance (Experiment 2) suffered more from the evoked stereotypes than did men's and boys' ones. This result was replicated in Experiment 3, indicating that short men (low-status group) were more affected compared to tallmen (high-status group). Additionally, men were more affected compared to women when they perceived height as a threat. Hence, individuals are more or less vulnerable to identity threats as a function of the chronic social status at play; enjoying a high status provides protection and endorsing a low one weakens individual performance in stereotypical situations.	[Pillaud, Vincent; Rigaud, David; Clemence, Alain] Univ Lausanne, Inst Psychol, Lausanne, Switzerland	University of Lausanne	Pillaud, V (corresponding author), Univ Lausanne, Inst Psychol, Lausanne, Switzerland.	pillaudv@gmail.com						Adams G, 2006, J EXP SOC PSYCHOL, V42, P602, DOI 10.1016/j.jesp.2005.10.004; Ambady N, 2004, J EXP SOC PSYCHOL, V40, P401, DOI 10.1016/j.jesp.2003.08.003; Ambady N, 2001, PSYCHOL SCI, V12, P385, DOI 10.1111/1467-9280.00371; Aronson J, 2002, ADOLESCENCE EDUC, P299; Aronson J, 2002, J EXP SOC PSYCHOL, V38, P113, DOI 10.1006/jesp.2001.1491; Arthur A.E., 2008, INTERGROUP ATTITUDES, P66; Bagues MF, 2010, REV ECON STUD, V77, P1301, DOI 10.1111/j.1467-937X.2009.00601.x; BERG K, 1989, Physiotherapy Canada, V41, P304; Betz DE, 2012, SOC PSYCHOL PERS SCI, V3, P738, DOI 10.1177/1948550612440735; Brown CS, 2005, CHILD DEV, V76, P533, DOI 10.1111/j.1467-8624.2005.00862.x; Brown CS, 2004, DEV PSYCHOL, V40, P714, DOI 10.1037/0012-1649.40.5.714; Brown RP, 2003, J EXP SOC PSYCHOL, V39, P626, DOI 10.1016/S0022-1031(03)00039-8; Cadinu M, 2005, PSYCHOL SCI, V16, P572, DOI 10.1111/j.0956-7976.2005.01577.x; Case A, 2008, AM ECON REV, V98, P463, DOI 10.1257/aer.98.2.463; Cialdini RB, 1993, INFLUENCE; Cinnirella F, 2011, ECON HUM BIOL, V9, P407, DOI 10.1016/j.ehb.2011.04.006; Cromer J, 2009, PSYCHOL SPORT EXERC, V10, P552, DOI 10.1016/j.psychsport.2009.03.001; Cvencek D, 2011, CHILD DEV, V82, P766, DOI 10.1111/j.1467-8624.2010.01529.x; Duckitt J., 2010, SAGE HDB PREJUDICE S, P29, DOI DOI 10.4135/9781446200919; Duveen G., 1990, SOCIAL REPRESENTATIO; Else-Quest NM, 2010, PSYCHOL BULL, V136, P103, DOI 10.1037/a0018053; Erceg-Hurn DM, 2008, AM PSYCHOL, V63, P591, DOI 10.1037/0003-066X.63.7.591; European Commission, 2005, WOM MEN DEC MAK A QU, V04, P10; European Commission, 2014, GEND BAL CORP BOARDS, P03; FISKE ST, 1993, AM PSYCHOL, V48, P621, DOI 10.1037/0003-066X.48.6.621; Fiske ST, 2010, AM PSYCHOL, V65, P698, DOI 10.1037/0003-066X.65.8.698; Ghosh P, 2011, INT BUSINESS TIMES, V11, P31; Good C, 2003, J APPL DEV PSYCHOL, V24, P645, DOI 10.1016/j.appdev.2003.09.002; Gresky DM, 2005, SEX ROLES, V53, P703, DOI 10.1007/s11199-005-7735-2; Hartley BL, 2013, CHILD DEV, V84, P1716, DOI 10.1111/cdev.12079; Healy A, 2011, ECON J, V121, P1192, DOI 10.1111/j.1468-0297.2010.02409.x; Hutcheson G. D., 1999, MULTIVARIATE SOCIAL; Hyde JS, 2008, SCIENCE, V321, P494, DOI 10.1126/science.1160364; Inzlicht M, 2000, PSYCHOL SCI, V11, P365, DOI 10.1111/1467-9280.00272; Inzlicht M., 2012, STEREOTYPE THREAT TH; Inzlicht Michael, 2009, COPING MINORITY STAT, P13, DOI [DOI 10.1017/CBO9780511804465.002, 10.1017/CBO9780511804465.002]; Josephs RA, 2003, PSYCHOL SCI, V14, P158, DOI 10.1111/1467-9280.t01-1-01435; Jost JT, 2004, POLIT PSYCHOL, V25, P881, DOI 10.1111/j.1467-9221.2004.00402.x; Judd C. M., 2011, DATA ANAL MODEL COMP; Judge TA, 2004, J APPL PSYCHOL, V89, P428, DOI 10.1037/0021-9010.89.3.428; Keaten J, 2009, THE WORLD POST, V09, P08; Koch S, 2014, SEX ROLES, V70, P79, DOI 10.1007/s11199-014-0342-3; LeClair K, 1996, CLIN BIOMECH, V11, P176, DOI 10.1016/0268-0033(95)00027-5; Lee S, 2014, ECON LETT, V124, P474, DOI 10.1016/j.econlet.2014.07.001; Leyens JP, 2000, PERS SOC PSYCHOL B, V26, P1189, DOI 10.1177/0146167200262002; Magnusson PKE, 2006, INT J EPIDEMIOL, V35, P658, DOI 10.1093/ije/dyl011; Martens A, 2006, J EXP SOC PSYCHOL, V42, P236, DOI 10.1016/j.jesp.2005.04.010; Martiny SE, 2012, EUR J SOC PSYCHOL, V42, P65, DOI 10.1002/ejsp.840; Moe A, 2006, LEARN INDIVID DIFFER, V16, P369, DOI 10.1016/j.lindif.2007.01.002; Murphy M.C., 2012, STEREOTYPE THREAT TH, P17; Niederle M, 2007, Q J ECON, V122, P1067, DOI 10.1162/qjec.122.3.1067; Niederle M, 2013, MANAGE SCI, V59, P1, DOI 10.1287/mnsc.1120.1602; Niederle M, 2011, ANNU REV ECON, V3, P601, DOI 10.1146/annurev-economics-111809-125122; Pavlova MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114802; Pratto F., 2006, EUROPEAN REV SOCIAL, V17, P271, DOI [10.1080/10463280601055772, DOI 10.1080/10463280601055772]; PRIETO AG, 1975, PERCEPT MOTOR SKILL, V40, P395, DOI 10.2466/pms.1975.40.2.395; Ridgeway Cecilia L., 2011, FRAMED GENDER GENDER; Rydell RJ, 2010, J PERS SOC PSYCHOL, V99, P883, DOI 10.1037/a0021139; Salska I, 2008, PERS INDIV DIFFER, V44, P203, DOI 10.1016/j.paid.2007.08.008; Scheepers D, 2005, J EXP SOC PSYCHOL, V41, P192, DOI 10.1016/j.jesp.2004.06.002; Schmader T, 2002, J EXP SOC PSYCHOL, V38, P194, DOI 10.1006/jesp.2001.1500; Sekaquaptewa D, 2003, J EXP SOC PSYCHOL, V39, P68, DOI 10.1016/S0022-1031(02)00508-5; Simonton D.K., 1994, GREATNESS WHO MAKES; Sorokowski P, 2010, EUR J SOC PSYCHOL, V40, P1302, DOI 10.1002/ejsp.710; Spencer SJ, 1999, J EXP SOC PSYCHOL, V35, P4, DOI 10.1006/jesp.1998.1373; Stangor C, 1998, J PERS SOC PSYCHOL, V75, P1191, DOI 10.1037/0022-3514.75.5.1191; Steele Claude M., 2010, WHISTLING VIVALDI OT; Steele CM, 1997, AM PSYCHOL, V52, P613, DOI 10.1037/0003-066X.52.6.613; STEELE CM, 1995, J PERS SOC PSYCHOL, V69, P797, DOI 10.1037/0022-3514.69.5.797; Steele CM, 2002, ADV EXP SOC PSYCHOL, V34, P379, DOI 10.1016/S0065-2601(02)80009-0; Steele J, 2003, J APPL SOC PSYCHOL, V33, P2587, DOI 10.1111/j.1559-1816.2003.tb02782.x; Stoet G, 2012, REV GEN PSYCHOL, V16, P93, DOI 10.1037/a0026617; Stone J, 1999, J PERS SOC PSYCHOL, V77, P1213, DOI 10.1037/0022-3514.77.6.1213; Sutter M, 2014, MANAGE SCI, V10, P31; THOMAS JR, 1985, PSYCHOL BULL, V98, P260, DOI 10.1037/0033-2909.98.2.260	75	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0144582	10.1371/journal.pone.0144582	http://dx.doi.org/10.1371/journal.pone.0144582			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1YV	26645829	Green Submitted, gold, Green Published			2022-12-27	WOS:000366903100029
J	Al-Awaidy, S; Hamid, S; Al Obaidani, I; Al Baqlani, S; Al Busaidi, S; Bawikar, S; El-Shoubary, W; Dueger, EL; Said, MM; Elamin, E; Shah, P; Talaat, M				Al-Awaidy, Salah; Hamid, Sarah; Al Obaidani, Idris; Al Baqlani, Said; Al Busaidi, Suleiman; Bawikar, Shyam; El-Shoubary, Waleed; Dueger, Erica L.; Said, Mayar M.; Elamin, Emdeldin; Shah, Parag; Talaat, Maha			The Burden of Influenza-Associated Hospitalizations in Oman, January 2008-June 2013	PLOS ONE			English	Article							OUTPATIENTS; INFECTION	Introduction Acute respiratory infections (ARI), including influenza, comprise a leading cause of morbidity and mortality worldwide. Influenza surveillance provides important information to inform policy on influenza control and vaccination. While the epidemiology of influenza has been well characterized in western countries, few data exist on influenza epidemiology in the Eastern Mediterranean Region. We describe the epidemiology of influenza virus in Oman. Methods Using syndromic case definitions and protocols, patients from four regional hospitals in Oman were enrolled in a descriptive prospective study to characterize the burden of severe acute respiratory infections (SARI) and influenza. Eligible patients provided demographic information as well as oropharyngeal (OP) and nasopharyngeal (NP) swabs. Specimens were tested for influenza A and influenza B; influenza A viruses were subtyped using RT-PCR. Results From January 2008 through June 2013, a total of 5,147 cases were enrolled and tested for influenza. Influenza strains were detected in 8% of cases for whom samples were available. Annual incidence rates ranged from 0.5 to 15.4 cases of influenza-associated SARI per 100,000 population. The median age of influenza patients was 6 years with children 0-2 years accounting for 34% of all influenza-associated hospitalizations. By contrast, the median age of non-influenza SARI cases was 1 year with children 0-2 years comprising 59% of SARI. Compared to non-influenza SARI cases, a greater proportion of influenza cases had pre-existing chronic conditions and underwent ventilation during hospitalization. Conclusions Influenza virus is associated with a substantial proportion of SARI in Oman. Influenza in Oman approximately follows northern hemisphere seasonality, with major peaks in October to December and a lesser peak around April. The burden of influenza was greatest in children and the elderly. Future efforts should examine the burden of influenza in other potential risk groups such as pregnant women to inform interventions including targeted vaccination.	[Al-Awaidy, Salah; Al Obaidani, Idris; Al Baqlani, Said; Al Busaidi, Suleiman; Bawikar, Shyam; Elamin, Emdeldin; Shah, Parag] Minist Hlth, Muscat, Oman; [Hamid, Sarah; El-Shoubary, Waleed; Dueger, Erica L.; Talaat, Maha] US Naval Med Res, Global Dis Detect & Response Program, Unit 3, Cairo, Egypt; [Hamid, Sarah; El-Shoubary, Waleed; Talaat, Maha] Ctr Dis Control & Prevent, Global Dis Detect Ctr, Cairo, Egypt; [Dueger, Erica L.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Said, Mayar M.] US Naval Med Res, Unit 3, Cairo, Egypt	Naval Medical Research Center (NMRC); Naval Medical Research Unit - No. 3 (NAMRU-3); Centers for Disease Control & Prevention - USA; Naval Medical Research Center (NMRC); Naval Medical Research Unit - No. 3 (NAMRU-3)	Hamid, S (corresponding author), US Naval Med Res, Global Dis Detect & Response Program, Unit 3, Cairo, Egypt.	hamids@wpro.who.int	Awaidy, Salah Al/AAF-5884-2020	Awaidy, Salah Al/0000-0001-5112-3893; Hamid, Sarah/0000-0001-8164-0656	Global Emerging Infections Surveillance Program [GEIS847705.821000.25GB.E0018]; Centers of Disease Control (CDC) in Atlanta, Georgia	Global Emerging Infections Surveillance Program; Centers of Disease Control (CDC) in Atlanta, Georgia	This work was supported by the Global Emerging Infections Surveillance Program [GEIS847705.821000.25GB.E0018] and the Centers of Disease Control (CDC) in Atlanta, Georgia.	Ahmad Akhwand Shakeel, 2011, Oman Med J, V26, P329, DOI 10.5001/omj.2011.82; Al-Lawati J, 2010, SULTAN QABOOS U MED, V10, P326; Al-Mahrezi A, 2012, INT J INFECT DIS, V16, pE504, DOI 10.1016/j.ijid.2012.02.015; Al-Muharrmi Zakariya, 2010, Sultan Qaboos Univ Med J, V10, P187; [Anonymous], 2012, BACKGR SUMM NOV COR; Azziz-Baumgartner E, 2012, B WORLD HEALTH ORGAN, V90, P12, DOI 10.2471/BLT.11.090209; Central Intelligence Agency, WORLD FACTBOOK; Emukule GO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105543; International Emerging Infections Program-Thailand, ACT SURV PNEUM REQ H; Karageorgopoulos D. E., 2011, PLoS ONE, pe21690, DOI 10.1371/journal.pone.0021690; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Meerhoff TJ, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-014-0722-x; Pajankar Sumant, 2012, Oman Med J, V27, P201, DOI 10.5001/omj.2012.46; Patrozou E, 2009, PUBLIC HEALTH REP, V124, P193, DOI 10.1177/003335490912400205; Radin JM, 2012, J INFECT DIS, V206, pS14, DOI 10.1093/infdis/jis606; Tallo VL, 2014, INFLUENZA OTHER RESP, V8, P159, DOI 10.1111/irv.12223; Tamfum JJM, 2012, J INFECT DIS, V206, pS36, DOI 10.1093/infdis/jis537; Templeton KE, 2004, J CLIN MICROBIOL, V42, P1564, DOI 10.1128/JCM.42.4.1564-1569.2004; Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053; World Health Organization, 2011, WHO GLOB TECHN CONS; World Health Organization, 2015, FLUNET CHARTS; World Health Organization, 2012, INFL VIR ACT WORLD; World Health Organization, PAHO CDC GEN PROT IN; World Health Organization, 2015, INFL VIR UPD; World Health Organization, 2005, HDB IMCI	25	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144186	10.1371/journal.pone.0144186	http://dx.doi.org/10.1371/journal.pone.0144186			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642055	Green Published, Green Submitted, gold			2022-12-27	WOS:000366902700071
J	Ali, S; Haileamlak, A; Wieser, A; Pritsch, M; Heinrich, N; Loscher, T; Hoelscher, M; Rachow, A				Ali, Solomon; Haileamlak, Abraham; Wieser, Andreas; Pritsch, Michael; Heinrich, Norbert; Loscher, Thomas; Hoelscher, Michael; Rachow, Andrea			Prevalence of Pulmonary Tuberculosis among Prison Inmates in Ethiopia, a Cross-Sectional Study	PLOS ONE			English	Article								Setting Tuberculosis (TB) is one of the major health problems in prisons. Objective This study was done to assess the prevalence and determinants of active tuberculosis in Ethiopian prisons. Design A cross-sectional study was conducted from January 2013 to December 2013 in 13 zonal prisons. All incarcerated inmates underwent TB symptom screening according to WHO criteria. From identified TB-suspects two sputum samples were analyzed using smear microscopy and solid culture. A standardized questionnaire assessing TB risk factors was completed for each TB suspect. Results 765 (4.9%) TB suspects were identified among 15,495 inmates. 51 suspects were already on anti-TB treatment (6.67%) and 20 (2.8%) new culture-confirmed TB cases were identified in the study, resulting in an overall TB prevalence of 458.1/100,000 (95% CI: 350-560/100,000). Risk factors for active TB were alcohol consumption, contact with a TB case before incarceration and no window in prison cell. HIV prevalence was not different between TB suspects and active TB cases. Further, the TB burden in prisons increased with advancing distance from the capital Addis Ababa. Conclusions The overall TB prevalence in Ethiopian prisons was high and extremely variable among different prisons. TB risk factors related to conditions of prison facilities and the impact of implemented TB control measures need to be further studied in order to improve TB control among inmates.	[Ali, Solomon; Haileamlak, Abraham; Wieser, Andreas] Jimma Univ, Coll Hlth Sci, Jimma City, Ethiopia; [Wieser, Andreas; Pritsch, Michael; Heinrich, Norbert; Loscher, Thomas; Hoelscher, Michael; Rachow, Andrea] Univ Munich LMU, Med Ctr, Div Infect Dis & Trop Med, Munich, Germany; [Wieser, Andreas; Pritsch, Michael; Heinrich, Norbert; Hoelscher, Michael; Rachow, Andrea] German Ctr Infect Res DZIF, Berlin, Germany; [Ali, Solomon] Univ Munich, Ctr Int Hlth, Munich, Germany	Jimma University; University of Munich; German Center for Infection Research; University of Munich	Ali, S (corresponding author), Jimma Univ, Coll Hlth Sci, Jimma City, Ethiopia.	solali2005@gmail.com	Pritsch, Michael/AAE-6474-2020; Löscher, Thomas/AAA-8399-2020; Hoelscher, Michael/D-3436-2012; N, Heinrich/B-3750-2014	Pritsch, Michael/0000-0001-7383-8750; N, Heinrich/0000-0001-9252-7106; Ali, Solomon/0000-0001-5641-8797	European and developing countries Clinical trials partnership (EDCTP) [SP.2011.41304.022]; German Academic Exchange Service (DAAD); DAAD-Exceed Program; German Ministry for Economic Cooperation and Development	European and developing countries Clinical trials partnership (EDCTP); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); DAAD-Exceed Program; German Ministry for Economic Cooperation and Development	The study was financially supported by European and developing countries Clinical trials partnership (EDCTP) Grant number SP.2011.41304.022 (http://www.edctp.org/). The funder has no role in study design, data collection, analysis, decision to publish and preparation of this manuscript.; The authors are grateful to prison officials, health workers and inmates of participating prisons and Jimma University for laboratory facility and vehicle support. We forward our sincere thanks to the CIH<SUP>LMU</SUP> Center for International Health, Ludwig-Maximilians-Universitat, Munich, Germany, and its funding agencies, the German Academic Exchange Service (DAAD), the DAAD-Exceed Program, and the German Ministry for Economic Cooperation and Development for scientific support of the first author's (SA) PhD.	Abebe DS, 2011, INT J TUBERC LUNG D, V15, P668, DOI 10.5588/ijtld.10.0363; Aerts A, 2006, INT J TUBERC LUNG D, V10, P1215; Banda HT, 2009, INT J TUBERC LUNG D, V13, P1557; Banu S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010759; Baussano I, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000381; Berile, 2012, STATUS HUMAN RIGHTS; Habeenzu C, 2007, INT J TUBERC LUNG D, V11, P1216; Henostroza G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067338; Kebede AH, 2014, INT J TUBERC LUNG D, V18, P635, DOI 10.5588/ijtld.13.0417; Maher D, 1998, GUIDELINES CONTROL T; Moges B, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-352; Noeske J, 2006, East Afr Med J, V83, P25; O'Grady J, 2011, TUBERCULOSIS, V91, P173, DOI 10.1016/j.tube.2010.12.002; Telisinghe L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087262; WHO, GLOB TUB REP 2014; Winetsky DE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086046; Zerdo Z, 2014, AM J HLTH RES, V2, P291, DOI DOI 10.11648/j.ajhr.20140205.21	17	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144040	10.1371/journal.pone.0144040	http://dx.doi.org/10.1371/journal.pone.0144040			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641654	gold, Green Published, Green Submitted			2022-12-27	WOS:000366902700051
J	Marcus, T; Boch, S; Durka, W; Fischer, M; Gossner, MM; Muller, J; Schoning, I; Weisser, WW; Drees, C; Assmann, T				Marcus, Tamar; Boch, Steffen; Durka, Walter; Fischer, Markus; Gossner, Martin M.; Mueller, Joerg; Schoening, Ingo; Weisser, Wolfgang W.; Drees, Claudia; Assmann, Thorsten			Living in Heterogeneous Woodlands - Are Habitat Continuity or Quality Drivers of Genetic Variability in a Flightless Ground Beetle?	PLOS ONE			English	Article							FOREST MANAGEMENT INTENSITY; LICHEN LOBARIA-PULMONARIA; PAST LAND-USE; CARABID BEETLES; ENVIRONMENTAL-FACTORS; POPULATION-GENETICS; SPECIES COMPOSITION; PLANT DIVERSITY; SOIL PROPERTIES; COLEOPTERA	Although genetic diversity is one of the key components of biodiversity, its drivers are still not fully understood. While it is known that genetic diversity is affected both by environmental parameters as well as habitat history, these factors are not often tested together. Therefore, we analyzed 14 microsatellite loci in Abax parallelepipedus, a flightless, forest dwelling ground beetle, from 88 plots in two study regions in Germany. We modeled the effects of historical and environmental variables on allelic richness, and found for one of the regions, the Schorfheide-Chorin, a significant effect of the depth of the litter layer, which is a main component of habitat quality, and of the sampling effort, which serves as an inverse proxy for local population size. For the other region, the Schwabische Alb, none of the potential drivers showed a significant effect on allelic richness. We conclude that the genetic diversity in our study species is being driven by current local population sizes via environmental variables and not by historical processes in the studied regions. This is also supported by lack of genetic differentiation between local populations sampled from ancient and from recent woodlands. We suggest that the potential effects of former fragmentation and recolonization processes have been mitigated by the large and stable local populations of Abax parallelepipedus in combination with the proximity of the ancient and recent woodlands in the studied landscapes.	[Marcus, Tamar; Assmann, Thorsten] Univ Luneburg, Inst Ecol, Luneburg, Germany; [Boch, Steffen; Fischer, Markus] Univ Bern, Inst Plant Sci & Bot Garden, Bern, Switzerland; [Durka, Walter] UFZ Ctr Environm Res, Dept Community Ecol, Halle, Germany; [Gossner, Martin M.; Weisser, Wolfgang W.] Tech Univ Munich, Dept Ecol & Ecosyst Management, Terr Ecol Res Grp, Freising Weihenstephan, Germany; [Mueller, Joerg] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Schoening, Ingo] Max Planck Inst Biogeochem, D-07745 Jena, Germany; [Drees, Claudia] Univ Hamburg, Inst Zool, Bioctr Grindel, Hamburg, Germany	Leuphana University Luneburg; University of Bern; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Technical University of Munich; University of Potsdam; Max Planck Society; University of Hamburg	Marcus, T (corresponding author), Univ Luneburg, Inst Ecol, Luneburg, Germany.	marcus@leuphana.de	Fischer, Markus/C-6411-2008; Gossner, Martin M./J-2730-2015; Schöning, Ingo/D-3341-2009; Assmann, Thorsten/Q-9304-2017; Drees, Claudia/D-9353-2017; Durka, Walter/E-4667-2010; Weisser, Wolfgang W/B-9718-2014; Boch, Steffen/L-5436-2016	Fischer, Markus/0000-0002-5589-5900; Gossner, Martin M./0000-0003-1516-6364; Schöning, Ingo/0000-0002-9830-5026; Assmann, Thorsten/0000-0002-9203-769X; Drees, Claudia/0000-0003-2743-395X; Durka, Walter/0000-0002-6611-2246; Weisser, Wolfgang W/0000-0002-2757-8959; 	DFG (German Research Foundation) as a part of the PopGeneLand project [AS 309/3-1, 1374]	DFG (German Research Foundation) as a part of the PopGeneLand project(German Research Foundation (DFG))	The work has been funded by the DFG (German Research Foundation; http://www.dfg.de/en/index.jsp) as a part of the PopGeneLand project (AS 309/3-1) in the framework of the Biodiversity Exploratories (SSP Priority Program 1374 "Infrastructure-Biodiversity-Exploratories"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agashe D, 2009, AM NAT, V174, P255, DOI 10.1086/600085; Altermatt F, 2008, ECOL LETT, V11, P918, DOI 10.1111/j.1461-0248.2008.01203.x; Altizer S, 2003, TRENDS ECOL EVOL, V18, P589, DOI 10.1016/j.tree.2003.08.013; Amos W, 1998, PHILOS T ROY SOC B, V353, P177, DOI 10.1098/rstb.1998.0200; Assmann T, 1999, BIODIVERS CONSERV, V8, P1499, DOI 10.1023/A:1008974413376; Bjornstad O. N., 2013, NCF SPATIAL NONPARAM; Brandmayr P, 2009, J INSECT CONSERV, V13, P231, DOI 10.1007/s10841-008-9161-6; Brouat C, 2004, MOL ECOL, V13, P1815, DOI 10.1111/j.1365-294X.2004.02206.x; Brouwers NC, 2009, INSECT CONSERV DIVER, V2, P10, DOI 10.1111/j.1752-4598.2008.00041.x; BUSE A, 1988, HOLARCTIC ECOL, V11, P241; Butterfield J, 1995, FOREST ECOL MANAG, V79, P63, DOI 10.1016/0378-1127(95)03620-2; Cena CJ, 2006, MOL ECOL, V15, P303, DOI 10.1111/j.1365-294X.2005.02637.x; Chaabane K, 1996, ANN ZOOL FENN, V33, P97; COVINGTON WW, 1981, ECOLOGY, V62, P41, DOI 10.2307/1936666; CUENDET G, 1984, PEDOBIOLOGIA, V26, P421; DAY KR, 1993, FORESTRY, V66, P37, DOI 10.1093/forestry/66.1.37; DENBOER PJ, 1981, OECOLOGIA, V50, P39, DOI 10.1007/BF00378792; Desender K., 2002, How to protect or what we know about Carabid Beetles: from knowledge to application, from Wijster (1969) to Tuczno (2001), P227; Desender K., 2002, How to protect or what we know about Carabid Beetles: from knowledge to application, from Wijster (1969) to Tuczno (2001), P237; Desender K, 2004, IUFRO RES SER, V10, P117, DOI 10.1079/9780851998022.0117; Desender K., 2005, DIAS REPORTS, V114, P49; Desender K, 2005, CARABIDOLOGY 2003, P73; Deuschle J, 2008, B INSECTOL, V61, P73; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Doyle J. J., 1991, Molecular techniques in taxonomy., P283; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Engelhardt KAM, 2014, BIOL CONSERV, V179, P6, DOI 10.1016/j.biocon.2014.08.011; ESRI, 2012, ARCGIS REL 10 1; European Environment Agency, 2006, COR LAND COV 2006 DA; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Eyre MD, 2005, J BIOGEOGR, V32, P973, DOI 10.1111/j.1365-2699.2005.01258.x; Fahy O, 1998, FOREST ECOL MANAG, V110, P263, DOI 10.1016/S0378-1127(98)00285-0; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Flinn KM, 2007, ECOL APPL, V17, P452, DOI 10.1890/05-1963; Foll M, 2006, GENETICS, V174, P875, DOI 10.1534/genetics.106.059451; Franceschini G, 1997, EUR J SOIL BIOL, V33, P117; Galhidy L, 2006, PLANT ECOL, V183, P133, DOI 10.1007/s11258-005-9012-4; Gaublomme E, 2013, INSECT CONSERV DIVER, V6, P473, DOI 10.1111/icad.12002; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Gillingham PK, 2012, ECOGRAPHY, V35, P831, DOI 10.1111/j.1600-0587.2011.07434.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Gunther J, 2004, PEDOBIOLOGIA, V48, P159, DOI 10.1016/j.pedobi.2003.11.002; Hawes C, 2002, OECOLOGIA, V131, P612, DOI 10.1007/s00442-002-0916-6; Hermy M, 1999, BIOL CONSERV, V91, P9, DOI 10.1016/S0006-3207(99)00045-2; Hermy M, 2007, ECOL RES, V22, P361, DOI 10.1007/s11284-007-0354-3; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Huber C, 2005, BIODIVERS CONSERV, V14, P1989, DOI 10.1007/s10531-004-2528-4; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Jacquemyn H, 2004, MOL ECOL, V13, P211, DOI 10.1046/j.1365-294X.2003.02033.x; Jopp F, 2005, ECOL MODEL, V186, P389, DOI 10.1016/j.ecolmodel.2005.02.009; Judas M, 2002, J BIOGEOGR, V29, P491, DOI 10.1046/j.1365-2699.2002.00697.x; Juriado I, 2011, BIODIVERS CONSERV, V20, P1803, DOI 10.1007/s10531-011-0062-8; Jukes MR, 2001, FOREST ECOL MANAG, V148, P271, DOI 10.1016/S0378-1127(00)00530-2; Kahl T, 2014, NAT CONSERV-BULGARIA, P15, DOI 10.3897/natureconservation.7.7281; Keller I, 2004, MOL ECOL, V13, P2983, DOI 10.1111/j.1365-294X.2004.02310.x; Keller I, 2003, P ROY SOC B-BIOL SCI, V270, P417, DOI 10.1098/rspb.2002.2247; Koerner W, 1997, J ECOL, V85, P351, DOI 10.2307/2960507; Kohlpaintner M, 2009, PLANT SOIL, V314, P285, DOI 10.1007/s11104-008-9729-7; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Kruck S, 2006, J PLANT NUTR SOIL SC, V169, P651, DOI 10.1002/jpln.200521903; Lange M, 2014, FOREST ECOL MANAG, V329, P166, DOI 10.1016/j.foreco.2014.06.012; Lindroth C.H., 1985, CARABIDAE COLEOPTERA; LOREAU M, 1987, PEDOBIOLOGIA, V30, P173; LOREAU M, 1984, PEDOBIOLOGIA, V27, P269; LOREAU M, 1993, ACTA OECOL, V14, P247; Magura T., 2001, Web Ecology, V2, P7; Magura T, 2000, BIOL CONSERV, V93, P95, DOI 10.1016/S0006-3207(99)00073-7; Magura T, 2002, EUR J SOIL BIOL, V38, P291, DOI 10.1016/S1164-5563(02)01162-7; Marcus T, 2013, CONSERV GENET RESOUR, V5, P1151, DOI 10.1007/s12686-013-9985-6; Martinez A, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2009003; NORDSTRM S, 1974, PEDOBIOLOGIA, V14, P1; Otalora MG, 2011, BIODIVERS CONSERV, V20, P1239, DOI 10.1007/s10531-011-0025-0; Oxbrough A, 2010, FOREST ECOL MANAG, V259, P2111, DOI 10.1016/j.foreco.2010.02.023; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Peterken G. F, 1993, WOODLAND CONSERVATIO; Petit S, 1998, BIODIVERS CONSERV, V7, P1549, DOI 10.1023/A:1008875403868; PHILLIPSON J, 1976, PEDOBIOLOGIA, V16, P258; POTT R, 1991, HUDELANDSCHAFTEN NOR; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2020, R LANG ENV STAT COMP; Rackham O, 2003, ANCIENT WOODLAND ITS; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Reisch C, 2007, NORD J BOT, V25, P366, DOI 10.1111/j.0107-055X.2008.00188.x; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schall P, 2013, EUR J FOREST RES, V132, P379, DOI 10.1007/s10342-013-0681-6; Scheidegger C, 2012, ECOL EVOL, V2, P2223, DOI 10.1002/ece3.341; Scherber C, 2010, NATURE, V468, P553, DOI 10.1038/nature09492; Schmitz MF, 1998, FOREST ECOL MANAG, V109, P137, DOI 10.1016/S0378-1127(98)00241-2; Scribner KT, 2001, BIOL CONSERV, V98, P201, DOI 10.1016/S0006-3207(00)00155-5; SLATKIN M, 1977, THEOR POPUL BIOL, V12, P253, DOI 10.1016/0040-5809(77)90045-4; Thiele H.U., 1977, CARABID BEETLES THEI, P369, DOI [DOI 10.1007/978-3-642-81154-8, 10.1007/978-3-642-81154-8]; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vandepitte K, 2007, MOL ECOL, V16, P4171, DOI 10.1111/j.1365-294X.2007.03473.x; Vellend M, 2004, ECOLOGY, V85, P3043, DOI 10.1890/04-0435; von Oheimb G, 2008, FOREST ECOL MANAG, V255, P1984, DOI 10.1016/j.foreco.2007.12.021; Wahbe TR, 2005, CAN J ZOOL, V83, P1460, DOI 10.1139/Z05-141; Wang ZS, 2006, BIOL CONSERV, V129, P551, DOI 10.1016/j.biocon.2005.11.022	102	7	7	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144217	10.1371/journal.pone.0144217	http://dx.doi.org/10.1371/journal.pone.0144217			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641644	gold, Green Published, Green Submitted			2022-12-27	WOS:000366902700078
J	Sass, LA; Hair, PS; Perkins, AM; Shah, TA; Krishna, NK; Cunnion, KM				Sass, Laura A.; Hair, Pamela S.; Perkins, Amy M.; Shah, Tushar A.; Krishna, Neel K.; Cunnion, Kenji M.			Complement Effectors of Inflammation in Cystic Fibrosis Lung Fluid Correlate with Clinical Measures of Disease	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; PSEUDOMONAS-AERUGINOSA; STAPHYLOCOCCUS-AUREUS; C5A RECEPTOR; FACTOR-H; ACTIVATION; ELASTASE; NEUTROPHILS; BINDING; SPUTUM	In cystic fibrosis (CF), lung damage is mediated by a cycle of obstruction, infection, and inflammation. Here we explored complement inflammatory effectors in CF lung fluid. In this study soluble fractions (sols) from sputum samples of 15 CF patients were assayed for complement effectors and analyzed with clinical measurements. The pro-inflammatory peptide C5a was increased 4.8-fold (P = 0.04) in CF sols compared with controls. Incubation of CF sols with P. aeruginosa or S. aureus increased C5a concentration 2.3-fold (P = 0.02). A peptide inhibitor of complement C1 (PIC1) completely blocked the increase in C5a concentration from P. aeruginosa in CF sol in vitro (P = 0.001). C5a concentration in CF sol correlated inversely with body mass index (BMI) percentile in children (r = -0.77, P = 0.04). C3a, which has anti-inflammatory effects, correlated positively with FEV1% predicted (r(s) = 0.63, P = 0.02). These results suggest that complement effectors may significantly impact inflammation in CF lung fluid.	[Sass, Laura A.; Hair, Pamela S.; Perkins, Amy M.; Shah, Tushar A.; Krishna, Neel K.; Cunnion, Kenji M.] Eastern Virginia Med Sch, Dept Pediat, Norfolk, VA 23501 USA; [Sass, Laura A.; Shah, Tushar A.; Krishna, Neel K.; Cunnion, Kenji M.] Childrens Specialty Grp, Norfolk, VA USA; [Sass, Laura A.; Perkins, Amy M.; Shah, Tushar A.; Cunnion, Kenji M.] Childrens Hosp Kings Daughters, Norfolk, VA USA; [Shah, Tushar A.; Cunnion, Kenji M.] Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Norfolk, VA 23501 USA	Eastern Virginia Medical School; Eastern Virginia Medical School	Cunnion, KM (corresponding author), Eastern Virginia Med Sch, Dept Pediat, 700 West Olney Rd, Norfolk, VA 23501 USA.	cunniokm@EVMS.EDU		Shah, Tushar/0000-0001-5962-1838				Amdahl H, 2013, J IMMUNOL, V191, P1775, DOI 10.4049/jimmunol.1300638; BERGER M, 1989, J CLIN INVEST, V84, P1302, DOI 10.1172/JCI114298; Bosmann M, 2012, ADV EXP MED BIOL, V946, P147, DOI 10.1007/978-1-4614-0106-3_9; Chalmers JD, 2011, GLYCOBIOLOGY, V21, P271, DOI 10.1093/glycob/cwq161; Coulthard LG, 2015, J IMMUNOL, V194, P3542, DOI 10.4049/jimmunol.1403068; Cunnion KM, 2001, INFECT IMMUN, V69, P6796, DOI 10.1128/IAI.69.11.6796-6803.2001; Davies JR, 1999, BIOCHEM J, V344, P321, DOI 10.1042/0264-6021:3440321; Dwyer M, 2014, J INNATE IMMUN; Engel LS, 1998, J BIOL CHEM, V273, P16792, DOI 10.1074/jbc.273.27.16792; FICK RB, 1986, PEDIATR RES, V20, P1258, DOI 10.1203/00006450-198612000-00014; Gharib SA, 2009, J PROTEOME RES, V8, P3020, DOI 10.1021/pr900093j; Gifford AM, 2014, CURR OPIN HEMATOL, V21, P16, DOI 10.1097/MOH.0000000000000009; Hair Pamela S, 2013, Results Immunol, V3, P114, DOI 10.1016/j.rinim.2013.10.004; Hair PS, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-35; Hair PS, 2010, INFECT IMMUN, V78, P1717, DOI 10.1128/IAI.01065-09; HATANO K, 1995, INFECT IMMUN, V63, P21, DOI 10.1128/IAI.63.1.21-26.1995; HODSON ME, 1995, AM J RESP CRIT CARE, V151, pS70, DOI 10.1164/ajrccm/151.3_Pt_2.S70; Kunert A, 2007, J IMMUNOL, V179, P2979, DOI 10.4049/jimmunol.179.5.2979; Laarman AJ, 2012, J IMMUNOL, V188, P386, DOI 10.4049/jimmunol.1102162; LAMBRIS JD, 1998, HUMAN COMPLEMENT SYS, P83; Laursen NS, 2012, CURR MOL MED, V12, P1083; Le Gars M, 2013, AM J RESP CRIT CARE, V187, P170, DOI 10.1164/rccm.201205-0875OC; Mauriello CT, 2013, MOL IMMUNOL, V53, P132, DOI 10.1016/j.molimm.2012.07.012; Mollnes TE, 2002, BLOOD, V100, P1869; PEDERSEN SS, 1990, INFECT IMMUN, V58, P3363, DOI 10.1128/IAI.58.10.3363-3368.1990; Pfeifer PH, 1999, CLIN CHEM, V45, P1190; Pfeifer PH, 2000, IMMUNOPHARMACOLOGY, V46, P163, DOI 10.1016/S0162-3109(99)00167-8; PRESSLER T, 1995, PEDIATR PULM, V20, P71, DOI 10.1002/ppul.1950200204; Ricklin D, 2007, NAT BIOTECHNOL, V25, P1265, DOI 10.1038/nbt1342; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Sagel SD, 2012, AM J RESP CRIT CARE, V186, P857, DOI 10.1164/rccm.201203-0507OC; SCHIOTZ PO, 1979, ACTA PATH MICRO IM C, V87, P1; Schmidtchen A, 2003, MICROB PATHOGENESIS, V34, P47, DOI 10.1016/S0882-4010(02)00197-3; Schmudde I, 2013, MUCOSAL IMMUNOL, V6, P807, DOI 10.1038/mi.2012.119; Shah TA, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-181; Sharp JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132446; Sharp JA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00406; Sharp JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038407; Shinjyo N, 2009, STEM CELLS, V27, P2824, DOI 10.1002/stem.225; Smailhodzic D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112682; TOSI MF, 1990, J CLIN INVEST, V86, P300, DOI 10.1172/JCI114699; Tralau T, 2004, EXP DERMATOL, V13, P316, DOI 10.1111/j.0906-6705.2004.00145.x; Van de Weert-van Leeuwen PB, 2013, AM J RESP CELL MOL, V49, P463, DOI 10.1165/rcmb.2012-0502OC; Zipfel PF, 2014, INT J MED MICROBIOL, V304, P188, DOI 10.1016/j.ijmm.2013.11.004	44	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144723	10.1371/journal.pone.0144723	http://dx.doi.org/10.1371/journal.pone.0144723			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642048	Green Published, gold, Green Submitted			2022-12-27	WOS:000366902700152
J	Sun, S; Henriksen, K; Karsdal, MA; Byrjalsen, I; Rittweger, J; Armbrecht, G; Belavy, DL; Felsenberg, D; Nedergaard, AF				Sun, Shu; Henriksen, Kim; Karsdal, Morten A.; Byrjalsen, Inger; Rittweger, Joern; Armbrecht, Gabriele; Belavy, Daniel L.; Felsenberg, Dieter; Nedergaard, Anders F.			Collagen Type III and VI Turnover in Response to Long-Term Immobilization	PLOS ONE			English	Article							MUSCLE PROTEIN-SYNTHESIS; SEROLOGICAL BIOMARKERS; C5 DOMAIN; ATROPHY; EXPRESSION; EXERCISE; MATRIX; MASS; PROTEOGLYCAN; STRENGTH	Background Muscle mass and function are perturbed by immobilization and remobilization. When muscle mass changes, the quality and quantity of the extracellular matrix protein, particularly the collagens, change with it. In this study, we investigated the temporal profile of three peptide biomarkers derived from turnover of collagen type III and type VI in a long-term immobilization and remobilization study. We also compared individual biomarker levels with Lean body Mass (LBM) and changes therein, hypothesizing that these biomarkers would be biomarkers of the remodeling processes associated with immobilization and/or remobilization. Methods In the Berlin bed rest study, 20 young men were recruited and randomly assigned to 8-week's strict bed rest with or without resistive vibration exercise countermeasure. We measured three neo-epitope ELISA kits in the serum samples of this study: Pro-C3, measured the synthesis of collagen type III; Pro-C6, measured the synthesis of collagen type VI; and C6M measured the degradation of collagen type VI induced by MMP-2 and MMP-9 cleavage. Results Pro-C3 and Pro-C6 biomarkers are up-regulated with both immobilization and remobilization, whereas C6M is hardly affected at all. We found that Pro-C3 and C6M levels are related to LBM at baseline and that high levels of Pro-C6 are associated with smaller changes in muscle mass during both immobilization and remobilization. Conclusion The Pro-C3 and-C6 biomarkers change likely reflect remodeling changes in response to unloading or reloading, whereas C6M does not appear to respond to unloading. Pro-C3 and C6M levels correlate with LBM at baseline, while Pro-C6 is related to the anabolic and catabolic responses to unloading and reloading.	[Sun, Shu; Henriksen, Kim; Karsdal, Morten A.; Byrjalsen, Inger; Nedergaard, Anders F.] Nord Biosci Biomarkers & Res, Herlev, Denmark; [Nedergaard, Anders F.] Bispebjerg Hosp, Inst Sports Med Copenhagen, DK-2400 Copenhagen NW, Denmark; [Rittweger, Joern] German Aerosp Ctr, Inst Aerosp Med, Cologne, Germany; [Armbrecht, Gabriele; Belavy, Daniel L.; Felsenberg, Dieter] Charite Univ Med Berlin, Ctr Muscle & Bone Res, Berlin, Germany; [Armbrecht, Gabriele; Belavy, Daniel L.; Felsenberg, Dieter] Free Univ Berlin, Berlin, Germany; [Armbrecht, Gabriele; Belavy, Daniel L.; Felsenberg, Dieter] Humboldt Univ, D-10099 Berlin, Germany; [Belavy, Daniel L.] Deakin Univ, Ctr Phys Act & Nutr Res, Sch Exercise & Nutr Sci, Burwood, Vic 3125, Australia	Nordic Bioscience; University of Copenhagen; Bispebjerg Hospital; Helmholtz Association; German Aerospace Centre (DLR); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Deakin University	Sun, S (corresponding author), Nord Biosci Biomarkers & Res, Herlev, Denmark.	ssu@nordicbioscience.com	Belavy, Daniel/P-4947-2016; Rittweger, Jörn/A-4308-2009	Belavy, Daniel/0000-0002-9307-832X; Rittweger, Jörn/0000-0002-2223-8963; Karsdal, Morten/0000-0001-5026-8740; Sun, Shu/0000-0002-2477-8904; Armbrecht, Gabriele/0000-0002-6578-338X	Danish Research Foundation; Nordic Bioscience; Department of Sports Medicine Copenhagen; Danish Advanced Technology Foundation	Danish Research Foundation; Nordic Bioscience; Department of Sports Medicine Copenhagen; Danish Advanced Technology Foundation	The biomarker portion of the study was supported by the Danish Research Foundation. AFN is funded in part by Nordic Bioscience through industrial post doc collaboration with the Department of Sports Medicine Copenhagen and the Danish Advanced Technology Foundation. Nordic Bioscience provided support in the form of salaries for authors SS, KH, MAK and IB. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner T, 2002, BIOCHEM BIOPH RES CO, V290, P743, DOI 10.1006/bbrc.2001.6227; Armbrecht G, 2010, OSTEOPOROSIS INT, V21, P597, DOI 10.1007/s00198-009-0985-z; Barascuk N, 2010, CLIN BIOCHEM, V43, P899, DOI 10.1016/j.clinbiochem.2010.03.012; Belavy DL, 2012, J ENDOCRINOL INVEST, V35, P54, DOI 10.3275/7606; Belavy DL, 2009, J MUSCULOSKEL NEURON, V9, P225; Bhasin S, 2009, J CLIN ENDOCR METAB, V94, P4224, DOI 10.1210/jc.2009-1434; BIDANSET DJ, 1992, J BIOL CHEM, V267, P5250; BONALDO P, 1990, BIOCHEMISTRY-US, V29, P1245, DOI 10.1021/bi00457a021; Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389; Caron AZ, 2009, J APPL PHYSIOL, V106, P2049, DOI 10.1152/japplphysiol.91505.2008; Chen F, 2011, J CACHEXIA SARCOPENI, V2, P45, DOI 10.1007/s13539-011-0021-y; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Evans WJ, 2010, AM J CLIN NUTR, V91, p1123S, DOI 10.3945/ajcn.2010.28608A; GEFTER ML, 1977, SOMAT CELL GENET, V3, P231, DOI 10.1007/BF01551818; Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002; Giannelli G, 2005, HISTOL HISTOPATHOL, V20, P99, DOI 10.14670/HH-20.99; Goodpaster BH, 2006, J GERONTOL A-BIOL, V61, P1059, DOI 10.1093/gerona/61.10.1059; GRANZIER HL, 1995, BIOPHYS J, V68, P1027, DOI 10.1016/S0006-3495(95)80278-X; Heinemeier KM, 2009, J APPL PHYSIOL, V106, P178, DOI 10.1152/japplphysiol.91092.2008; Hortobagyi T, 2000, J PHYSIOL-LONDON, V524, P293, DOI 10.1111/j.1469-7793.2000.00293.x; JOZSA L, 1988, EXP MOL PATHOL, V49, P267, DOI 10.1016/0014-4800(88)90039-1; KEENE DR, 1988, J CELL BIOL, V107, P1995, DOI 10.1083/jcb.107.5.1995; Kuo HJ, 1997, J BIOL CHEM, V272, P26522, DOI 10.1074/jbc.272.42.26522; Lamande SR, 2006, J BIOL CHEM, V281, P16607, DOI 10.1074/jbc.M510192200; Lampe AK, 2005, J MED GENET, V42, P673, DOI 10.1136/jmg.2002.002311; Miller BF, 2005, J PHYSIOL-LONDON, V567, P1021, DOI 10.1113/jphysiol.2005.093690; Miller TA, 2001, AM J PHYSIOL-REG I, V281, pR1710, DOI 10.1152/ajpregu.2001.281.5.R1710; Nedergaard A, 2015, J CACHEXIA SARCOPENI, V6, P335, DOI 10.1002/jcsm.12027; Nedergaard A, 2013, J CACHEXIA SARCOPENI, V4, P267, DOI 10.1007/s13539-013-0114-x; Nedergaard A, 2013, J CACHEXIA SARCOPENI, V4, P1, DOI 10.1007/s13539-012-0086-2; Nielsen MJ, 2013, AM J TRANSL RES, V5, P303; NIEMELA O, 1985, BIOCHEM J, V232, P145, DOI 10.1042/bj2320145; Paddon-Jones D, 2006, J CLIN ENDOCR METAB, V91, P4836, DOI 10.1210/jc.2006-0651; Phillips SM, 2009, J APPL PHYSIOL, V107, P645, DOI 10.1152/japplphysiol.00452.2009; Rennie MJ, 2010, SCAND J MED SCI SPOR, V20, P5, DOI 10.1111/j.1600-0838.2009.00967.x; Reznick AZ, 2003, MUSCLE NERVE, V27, P51, DOI 10.1002/mus.10277; Rittweger J, 2006, INT J SPORTS MED, V27, P553, DOI 10.1055/s-2005-872903; Scharf G, 2012, J CACHEXIA SARCOPENI, V3, P145, DOI 10.1007/s13539-012-0081-7; STALLCUP WB, 1990, J CELL BIOL, V111, P3177, DOI 10.1083/jcb.111.6.3177; Symons TB, 2009, J APPL PHYSIOL, V107, P34, DOI 10.1152/japplphysiol.91137.2008; Tapanainen P, 1997, EUR J ENDOCRINOL, V137, P621, DOI 10.1530/eje.0.1370621; Urciuolo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2964; Veidal SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024753; Welle S, 2002, CAN J APPL PHYSIOL, V27, P19, DOI 10.1139/h02-002; WILLIAMS PE, 1981, CELL TISSUE RES, V221, P465, DOI 10.1007/BF00216749	45	53	55	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144525	10.1371/journal.pone.0144525	http://dx.doi.org/10.1371/journal.pone.0144525			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641456	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000366902700140
J	Zhao, XJ; Xu, W; Ma, YJ; Hu, FY				Zhao, Xiujuan; Xu, Wei; Ma, Yunjia; Hu, Fuyu			Scenario-Based Multi-Objective Optimum Allocation Model for Earthquake Emergency Shelters Using a Modified Particle Swarm Optimization Algorithm: A Case Study in Chaoyang District, Beijing, China	PLOS ONE			English	Article							LOCATION; SELECTION; NETWORK	The correct location of earthquake emergency shelters and their allocation to residents can effectively reduce the number of casualties by providing safe havens and efficient evacuation routes during the chaotic period of the unfolding disaster. However, diverse and strict constraints and the discrete feasible domain of the required models make the problem of shelter location and allocation more difficult. A number of models have been developed to solve this problem, but there are still large differences between the models and the actual situation because the characteristics of the evacuees and the construction costs of the shelters have been excessively simplified. We report here the development of a multi-objective model for the allocation of residents to earthquake shelters by considering these factors using the Chaoyang district, Beijing, China as a case study. The two objectives of this model were to minimize the total weighted evacuation time from residential areas to a specified shelter and to minimize the total area of all the shelters. The two constraints were the shelter capacity and the service radius. Three scenarios were considered to estimate the number of people who would need to be evacuated. The particle swarm optimization algorithm was first modified by applying the von Neumann structure in former loops and global structure in later loops, and then used to solve this problem. The results show that increasing the shelter area can result in a large decrease in the total weighted evacuation time from scheme 1 to scheme 9 in scenario A, from scheme 1 to scheme 9 in scenario B, from scheme 1 to scheme 19 in scenario C. If the funding were not a limitation, then the final schemes of each scenario are the best solutions, otherwise the earlier schemes are more reasonable. The modified model proved to be useful for the optimization of shelter allocation, and the result can be used as a scientific reference for planning shelters in the Chaoyang district, Beijing.	[Zhao, Xiujuan; Xu, Wei; Ma, Yunjia; Hu, Fuyu] Beijing Normal Univ, Minist Educ, Key Lab Environm Change & Nat Disaster, Beijing 100875, Peoples R China; [Zhao, Xiujuan; Xu, Wei; Ma, Yunjia; Hu, Fuyu] Beijing Normal Univ, Minist Civil Affairs, Acad Disaster Reduct & Emergency Management, Beijing 100875, Peoples R China; [Zhao, Xiujuan; Xu, Wei; Ma, Yunjia; Hu, Fuyu] Beijing Normal Univ, Minist Educ, Beijing 100875, Peoples R China	Beijing Normal University; Beijing Normal University; Beijing Normal University	Xu, W (corresponding author), Beijing Normal Univ, Minist Educ, Key Lab Environm Change & Nat Disaster, Beijing 100875, Peoples R China.	xuwei@bnu.edu.cn		Zhao, Xiujuan/0000-0002-6650-5728; Ma, Yunjia/0000-0002-7856-9323	National Natural Science Foundation of China [41201547, 41321001]; State Administration of Foreign Experts Affairs P.R. China [B08008]; Ministry of Science and Technology of the People's Republic of China [2013BAK05B02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Administration of Foreign Experts Affairs P.R. China; Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	Support was provided by National Natural Science Foundation of China No. 41201547 [http://www.nsfc.gov.cn/] to WX; the National Natural Science Foundation of China No. 41321001 [http://www.nsfc.gov.cn/] to WX; the State Administration of Foreign Experts Affairs P.R. China No. B08008 [http://www.safea.gov.cn/] to WX; the Ministry of Science and Technology of the People's Republic of China No. 2013BAK05B02 [http://www.most.gov.cn/] to WX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshinmanesh F, 2005, EUROCON 2005: THE INTERNATIONAL CONFERENCE ON COMPUTER AS A TOOL, VOL 1 AND 2 , PROCEEDINGS, P217; Ai TJ, 2009, COMPUT OPER RES, V36, P1693, DOI 10.1016/j.cor.2008.04.003; Alcada-Almeida L, 2009, GEOGR ANAL, V41, P9, DOI 10.1111/j.1538-4632.2009.00745.x; Barzinpour F, 2014, INT J ADV MANUF TECH, V70, P1291, DOI 10.1007/s00170-013-5379-x; Beijing MPCO, 2010, EARTHQ EM SHELT PLAN; Cai Q, 2014, NEURAL NETWORKS, V58, P4, DOI 10.1016/j.neunet.2014.04.006; [陈志宗 Chen Zhizong], 2005, [自然灾害学报, Journal of Natural Disasters], V14, P131; Church R., 1974, PAP REG SCI ASS, V32, P101, DOI DOI 10.1007/BF01942293; Clerc M, 2004, STUD FUZZ SOFT COMP, V141, P219; Clerc M, 2002, IEEE T EVOLUT COMPUT, V6, P58, DOI 10.1109/4235.985692; Dai S., 2010, J CATASTROPHOLOGY, V25, P50, DOI [10.3969/j.issn.1000-811X.2010.z1.011, DOI 10.3969/J.ISSN.1000-811X.2010.Z1.011]; Dalal J, 2007, DISASTER PREV MANAG, DOI [10.1108/09653560710739559, DOI 10.1108/09653560710739559]; Deb K., 2000, Parallel Problem Solving from Nature PPSN VI. 6th International Conference. Proceedings (Lecture Notes in Computer Science Vol.1917), P849; Doerner KF, 2009, OR SPECTRUM, V31, P651, DOI 10.1007/s00291-008-0126-7; Eberhart R., 1995, P 6 INT S MICR MACH, P39; Gates TJ, 2006, P TRB 2006 ANN M; HAKIMI SL, 1965, OPER RES, V13, P462, DOI 10.1287/opre.13.3.462; HAKIMI SL, 1964, OPER RES, V12, P450, DOI 10.1287/opre.12.3.450; Hasan M., 1995, International Transactions in Operational Research, V2, P89, DOI 10.1111/j.1475-3995.1995.tb00007.x; He Q, 2007, APPL MATH COMPUT, V186, P1407, DOI 10.1016/j.amc.2006.07.134; Hu F, 2014, INT J GEOGR INF SYST, V28, P1; Hu FY, 2012, INT J GEOGR INF SCI, V26, P1643, DOI 10.1080/13658816.2011.643802; Jin YX, 2007, ELECTR POW SYST RES, V77, P227, DOI 10.1016/j.epsr.2006.02.016; Kennedy J, 1997, IEEE SYS MAN CYBERN, P4104, DOI 10.1109/ICSMC.1997.637339; Khan M. A. A., 2007, Proceedings. IEEE SoutheastCon 2007 (IEEE Cat. No.07CH37882); Li X, 2009, INT J GEOGR INF SCI, V23, P399, DOI 10.1080/13658810801918491; Pan QK, 2008, COMPUT OPER RES, V35, P2807, DOI 10.1016/j.cor.2006.12.030; Salman A, 2002, MICROPROCESS MICROSY, V26, P363, DOI 10.1016/S0141-9331(02)00053-4; Shen Q, 2007, TALANTA, V71, P1679, DOI 10.1016/j.talanta.2006.07.047; SHERALI HD, 1991, TRANSPORT RES B-METH, V25, P439, DOI 10.1016/0191-2615(91)90037-J; Shi YH, 1998, IEEE C EVOL COMPUTAT, P69, DOI 10.1109/ICEC.1998.699146; Srinivas H, 2008, J ENVIRON MANAGE, V89, P4, DOI 10.1016/j.jenvman.2007.01.054; TOREGAS C, 1971, OPER RES, V19, P1363, DOI 10.1287/opre.19.6.1363; VANLAARHOVEN PJM, 1992, OPER RES, V40, P113, DOI 10.1287/opre.40.1.113; Widener MJ, 2011, J TRANSP GEOGR, V19, P821, DOI 10.1016/j.jtrangeo.2010.10.006; Widener MJ, 2009, MODELLING HURRICANE; Woods C, 2014, INT J QUAL STUD HEAL, V9, DOI 10.3402/qhw.v9.19821; Yaghini M, 2013, 4OR-Q J OPER RES, V11, P229, DOI 10.1007/s10288-012-0223-y; Yin PY, 2007, APPL MATH COMPUT, V184, P407, DOI 10.1016/j.amc.2006.06.071; Zhang Yang, 2009, Acta Seismologica Sinica, V31, P290	40	18	20	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144455	10.1371/journal.pone.0144455	http://dx.doi.org/10.1371/journal.pone.0144455			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642322	Green Published, gold			2022-12-27	WOS:000366902700127
J	Bongio, NJ; Lampe, DJ				Bongio, Nicholas J.; Lampe, David J.			Inhibition of Plasmodium berghei Development in Mosquitoes by Effector Proteins Secreted from Asaia sp. Bacteria Using a Novel Native Secretion Signal	PLOS ONE			English	Article							MALARIA PARASITE DEVELOPMENT; ANOPHELES-GAMBIAE; ALKALINE-PHOSPHATASE; SYMBIOTIC BACTERIA; ESCHERICHIA-COLI; VECTOR MOSQUITOS; GENUS ASAIA; BIOLOGY; TRANSMISSION; INFECTIVITY	Novel interventions are needed to prevent the transmission of the Plasmodium parasites that cause malaria. One possible method is to supply mosquitoes with antiplasmodial effector proteins from bacteria by paratransgenesis. Mosquitoes have a diverse complement of midgut microbiota including the Gram-negative bacteria Asaia bogorensis. This study presents the first use of Asaia sp. bacteria for paratransgenesis against P. berghei. We identified putative secreted proteins from A. bogorensis by a genetic screen using alkaline phosphatase gene fusions. Two were secreted efficiently: a siderophore receptor protein and a YVTN beta-propeller repeat protein. The siderophore receptor gene was fused with antiplasmodial effector genes including the scorpine antimicrobial peptide and an anti-Pbs21 scFv-Shiva1 immunotoxin. Asaia SF2.1 secreting these fusion proteins were fed to mosquitoes and challenged with Plasmodium berghei-infected blood. With each of these effector constructs, significant inhibition of parasite development was observed. These results provide a novel and promising intervention against malaria transmission.	[Bongio, Nicholas J.; Lampe, David J.] Duquesne Univ, Dept Biol Sci, Pittsburgh, PA 15219 USA	Duquesne University	Lampe, DJ (corresponding author), Duquesne Univ, Dept Biol Sci, Pittsburgh, PA 15219 USA.	lampe@duq.edu			National Institute of Allergy and Infectious Diseases [R15AI107735]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI107735] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support was provided by the National Institute of Allergy and Infectious Diseases [http://www.niaid.nih.gov] award number R15AI107735 to DJL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari MT, 2013, MINI-REV MED CHEM, V13, P1879, DOI 10.2174/13895575113136660097; Bagos PG, 2010, BIOINFORMATICS, V26, P2811, DOI 10.1093/bioinformatics/btq530; Boissiere Anne, 2012, PLoS Pathog, V8, pe1002742, DOI 10.1371/journal.ppat.1002742; BROCKMAN RW, 1968, BIOCHEMISTRY-US, V7, P2554, DOI 10.1021/bi00847a016; Chang TLY, 2003, P NATL ACAD SCI USA, V100, P11672, DOI 10.1073/pnas.1934747100; Chiang SL, 2002, GENE, V296, P179, DOI 10.1016/S0378-1119(02)00856-9; Cirimotich CM, 2011, SCIENCE, V332, P855, DOI 10.1126/science.1201618; Conde R, 2000, FEBS LETT, V471, P165, DOI 10.1016/S0014-5793(00)01384-3; Dalbey RE, 2012, MICROBIOL MOL BIOL R, V76, P311, DOI 10.1128/MMBR.05019-11; Damiani C, 2010, MICROB ECOL, V60, P644, DOI 10.1007/s00248-010-9704-8; Damiani C, 2008, CURR BIOL, V18, pR1087, DOI 10.1016/j.cub.2008.10.040; De Vooght L, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-23; Drexler AL, 2008, TRENDS PARASITOL, V24, P333, DOI 10.1016/j.pt.2008.05.005; Durfee T, 2008, J BACTERIOL, V190, P2597, DOI 10.1128/JB.01695-07; Durvasula RV, 2008, EXP PARASITOL, V119, P94, DOI 10.1016/j.exppara.2007.12.020; Durvasula RV, 1997, P NATL ACAD SCI USA, V94, P3274, DOI 10.1073/pnas.94.7.3274; Fang WG, 2011, SCIENCE, V331, P1074, DOI 10.1126/science.1199115; Faraldo-Gomez JD, 2003, NAT REV MOL CELL BIO, V4, P105, DOI 10.1038/nrm1015; Favia G, 1997, INSECT MOL BIOL, V6, P377, DOI 10.1046/j.1365-2583.1997.00189.x; Favia G, 2008, ADV EXP MED BIOL, V627, P49, DOI 10.1007/978-0-387-78225-6_4; Favia G, 2007, P NATL ACAD SCI USA, V104, P9047, DOI 10.1073/pnas.0610451104; Ghosh AK, 2001, P NATL ACAD SCI USA, V98, P13278, DOI 10.1073/pnas.241491198; Gouagna LC, 1998, TROP MED INT HEALTH, V3, P21, DOI 10.1046/j.1365-3156.1998.00156.x; HOFFMAN CS, 1985, P NATL ACAD SCI USA, V82, P5107, DOI 10.1073/pnas.82.15.5107; Jing H, 2002, STRUCTURE, V10, P1453, DOI 10.1016/S0969-2126(02)00840-7; Karunamoorthi K, 2014, INT J PREVENTIVE MED, V5, P529; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; MaAuley A, 2008, PROTEIN SCI, V17, P95, DOI 10.1110/ps.073134408; Manson P., 1897, British Medical Journal, Vii, P1786; McKenzie GJ, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-39; Melen K, 2003, J MOL BIOL, V327, P735, DOI 10.1016/S0022-2836(03)00182-7; Mitraka E, 2013, PATHOG GLOB HEALTH, V107, P305, DOI 10.1179/2047773213Y.0000000106; Moreira LA, 2002, J BIOL CHEM, V277, P40839, DOI 10.1074/jbc.M206647200; Poirot E, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008846.pub2; Raghavendra K, 2011, PARASITOL RES, V108, P757, DOI 10.1007/s00436-010-2232-0; Ren XX, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000135; Shane JL, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01202-13; Sibley CH, 2014, MOL BIOCHEM PARASIT, V195, P107, DOI 10.1016/j.molbiopara.2014.06.001; Sinden RE, 1996, ADV PARASIT, V38, P53, DOI 10.1016/S0065-308X(08)60033-0; Sokhna C, 2013, CLIN MICROBIOL INFEC, V19, P902, DOI 10.1111/1469-0691.12314; Sone M, 1997, J BIOL CHEM, V272, P6174, DOI 10.1074/jbc.272.10.6174; Wang SB, 2013, TRENDS BIOTECHNOL, V31, P185, DOI 10.1016/j.tibtech.2013.01.001; Wang SB, 2012, P NATL ACAD SCI USA, V109, P12734, DOI 10.1073/pnas.1204158109; Whitten MMA, 2006, PARASITE IMMUNOL, V28, P121, DOI 10.1111/j.1365-3024.2006.00804.x; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Yamada Y, 2000, INT J SYST EVOL MICR, V50, P823, DOI 10.1099/00207713-50-2-823; Yoshida S, 2001, MOL BIOCHEM PARASIT, V113, P89, DOI 10.1016/S0166-6851(00)00387-X	47	35	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143541	10.1371/journal.pone.0143541	http://dx.doi.org/10.1371/journal.pone.0143541			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636338	Green Submitted, gold, Green Published			2022-12-27	WOS:000366143800017
J	Tao, Y; Liu, J				Tao, Yong; Liu, Johne			The Majority of Resorptions in Old Mice Are Euploid	PLOS ONE			English	Article							PERI-OVULATORY PUTRESCINE; MOUSE EMBRYOS; MATERNAL AGE; MEIOSIS-I; ANEUPLOIDY; TRISOMY; ORIGIN; IMPLANTATION; SEGREGATION; MATURATION	Chromosomal abnormality is a leading cause of aging-related infertility, spontaneous abortion and congenital birth defects in humans. Karyotype analyses of spontaneously aborted human fetuses reveal high proportions (similar to 50%) being chromosomal abnormal with the majority being trisomies of various chromosomes. As a model organism, mice are widely used for studies of reproduction and reproductive aging. Like older women, older mice exhibit high incidences of early embryo death. However, it is not known if aneuploidy is prevalent amongst resorptions in older mice. We have karyotyped 65 retarded/resorbed fetuses in 10-month-old C57BL/6 mice, and found that 55 (84.6%+/- 8.8%, with 95% confidence) were euploid. Similarly, of 40 such fetuses from 17 month-old C57BL/6 mice, we found 38 (95 +/- 7%, with 95% confidence 95%) being euploid. Therefore, aneuploidy is not a leading cause of embryo death in older mice.	[Tao, Yong; Liu, Johne] Ottawa Hosp, Res Inst, Ottawa, ON K1H 8L6, Canada; [Liu, Johne] Univ Ottawa, Dept Obstet & Gynaecol, Ottawa, ON, Canada; [Liu, Johne] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa	Liu, J (corresponding author), Ottawa Hosp, Res Inst, Gen Campus,501 Smyth Rd,Box 511, Ottawa, ON K1H 8L6, Canada.	jliu@ohri.ca		Liu, X. Johne/0000-0003-3381-5030	March of Dimes Foundation [6-FY13126]	March of Dimes Foundation(March of Dimes)	This work was supported by a research grant from March of Dimes Foundation (#6-FY13126, to XJL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen AMN, 2000, BRIT MED J, V320, P1708, DOI 10.1136/bmj.320.7251.1708; ANGELL RR, 1991, HUM GENET, V86, P383; Baird DT, 2005, HUM REPROD UPDATE, V11, P261, DOI 10.1093/humupd/dmi006; Carp H, 2001, FERTIL STERIL, V75, P678, DOI 10.1016/S0015-0282(00)01801-X; CHARD T, 1991, BAILLIERE CLIN OB GY, V5, P179, DOI 10.1016/S0950-3552(05)80077-X; Chiang T, 2010, CURR BIOL, V20, P1522, DOI 10.1016/j.cub.2010.06.069; Cukurcam S, 2007, HUM REPROD, V22, P815, DOI 10.1093/humrep/del442; Delhanty JDA, 2001, ANN HUM GENET, V65, P331, DOI 10.1017/S0003480001008739; EPPIG JJ, 1994, DEV BIOL, V164, P1, DOI 10.1006/dbio.1994.1175; EPSTEIN CJ, 1977, NATURE, V267, P615, DOI 10.1038/267615a0; EPSTEIN CJ, 1979, NATURE, V280, P144, DOI 10.1038/280144a0; EVANS EP, 1972, STAIN TECHNOL, V47, P229, DOI 10.3109/10520297209116541; FINN C. A., 1962, NATURE, V194, P499, DOI 10.1038/194499a0; Fragouli E, 2013, HUM GENET, V132, P1001, DOI 10.1007/s00439-013-1309-0; Gabriel AS, 2011, J MED GENET, V48, P433, DOI 10.1136/jmg.2010.088070; Geraedts J, 2011, HUM REPROD, V26, P3173, DOI 10.1093/humrep/der294; GOLBUS MS, 1981, CYTOGENET CELL GENET, V31, P84, DOI 10.1159/000131629; GOODLIN ROBERT C., 1965, J REPROD FERTIL, V9, P355, DOI 10.1530/jrf.0.0090355; GROPP A, 1975, CYTOGENET CELL GENET, V14, P42, DOI 10.1159/000130318; GROPP A, 1974, CYTOGENET CELL GENET, V13, P511, DOI 10.1159/000130304; Haadsma ML, 2010, REPROD BIOMED ONLINE, V20, P191, DOI 10.1016/j.rbmo.2009.11.005; HASSOLD T, 1980, ANN HUM GENET, V44, P151, DOI 10.1111/j.1469-1809.1980.tb00955.x; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; KAJII T, 1977, CYTOGENET CELL GENET, V18, P109, DOI 10.1159/000130756; Koehler KE, 2006, CURR BIOL, V16, pR579, DOI 10.1016/j.cub.2006.07.018; Kroon B, 2011, FERTIL STERIL, V95, P1827, DOI 10.1016/j.fertnstert.2010.11.065; Kuliev A, 2011, REPROD BIOMED ONLINE, V22, P2, DOI 10.1016/j.rbmo.2010.08.014; Lightfoot DA, 2006, DEV BIOL, V289, P384, DOI 10.1016/j.ydbio.2005.11.001; Liu XJ, 2016, CELL TISSUE RES, V363, P57, DOI 10.1007/s00441-015-2264-y; Liu XJ, 2012, AGING-US, V4, P723, DOI 10.18632/aging.100500; Liu XJ, 2012, CYTOSKELETON, V69, P670, DOI 10.1002/cm.21041; Massie JAM, 2011, FERTIL STERIL, V95, P970, DOI 10.1016/j.fertnstert.2010.07.1088; MAUDLIN I, 1977, J REPROD FERTIL, V50, P275, DOI 10.1530/jrf.0.0500275; Merriman JA, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095711; Munne Santiago, 2002, Reprod Biomed Online, V4, P223; Pan H, 2008, DEV BIOL, V316, P397, DOI 10.1016/j.ydbio.2008.01.048; Pereira PNG, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-48; Sakakibara Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8550; Schieve LA, 2003, OBSTET GYNECOL, V101, P959, DOI 10.1016/S0029-7844(03)00121-2; Selesniemi K, 2011, P NATL ACAD SCI USA, V108, P12319, DOI 10.1073/pnas.1018793108; Tao Y, 2015, HUM REPROD, V30, P1867, DOI 10.1093/humrep/dev130; Tao Y, 2013, AGING CELL, V12, P42, DOI 10.1111/acel.12016; Theiler K., 1989, HOUSE MOUSE ATLAS EM, P44; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924; Yun Y, 2014, DEVELOPMENT, V141, P199, DOI 10.1242/dev.100206; Zaragoza MV, 2000, AM J HUM GENET, V66, P1807, DOI 10.1086/302951	46	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143360	10.1371/journal.pone.0143360	http://dx.doi.org/10.1371/journal.pone.0143360			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636341	gold, Green Published, Green Submitted			2022-12-27	WOS:000366143800010
J	Bundgaard-Nielsen, RL; Baker, BJ; Kroos, CH; Harvey, M; Best, CT				Bundgaard-Nielsen, Rikke L.; Baker, Brett J.; Kroos, Christian H.; Harvey, Mark; Best, Catherine T.			Discrimination of Multiple Coronal Stop Contrasts in Wubuy (Australia): A Natural Referent Consonant Account	PLOS ONE			English	Article							LANGUAGE; PERCEPTION; ADULTS	Native speech perception is generally assumed to be highly efficient and accurate. Very little research has, however, directly examined the limitations of native perception, especially for contrasts that are only minimally differentiated acoustically and articulatorily. Here, we demonstrate that native speech perception may indeed be more difficult than is often assumed, where phonemes are highly similar, and we address the nature and extremes of consonant perception. We present two studies of native and non-native (English) perception of the acoustically and articulatorily similar four-way coronal stop contrast /tttt(rho)/ (apico-alveolar, apico-retroflex, lamino-dental, lamino-alveopalatal) of Wubuy, an indigenous language of Australia. The results show that all listeners find contrasts involving /t(rho)/ easy to discriminate, but that, for both groups, contrasts involving /ttt/ are much harder. Where the two groups differ, the results largely reflect native language (Wubuy vs English) attunement as predicted by the Perceptual Assimilation Model [1, 2, 3]. We also observe striking perceptual asymmetries in the native listeners' perception of contrasts involving the latter three stops, likely due to the differences in input frequency. Such asymmetries have not previously been observed in adults, and we propose a novel Natural Referent Consonant Hypothesis to account for the results.	[Bundgaard-Nielsen, Rikke L.; Kroos, Christian H.; Best, Catherine T.] Univ Western Sydney, MARCS Inst, Sydney, NSW, Australia; [Bundgaard-Nielsen, Rikke L.; Kroos, Christian H.; Best, Catherine T.] Univ Western Sydney, Sch Humanities & Commun Arts, Sydney, NSW, Australia; [Bundgaard-Nielsen, Rikke L.] La Trobe Univ, Melbourne, Vic, Australia; [Baker, Brett J.] Univ Melbourne, Melbourne, Vic, Australia; [Kroos, Christian H.] Curtin Univ, Perth, WA 6845, Australia; [Harvey, Mark] Univ Newcastle, Newcastle, NSW 2300, Australia; [Best, Catherine T.] Haskins Labs Inc, New Haven, CT USA	Western Sydney University; Western Sydney University; La Trobe University; University of Melbourne; Curtin University; University of Newcastle; Yale University; Haskins Laboratories	Bundgaard-Nielsen, RL (corresponding author), Univ Western Sydney, MARCS Inst, Sydney, NSW, Australia.	rikkelou@gmail.com	Best, Catherine T/M-4547-2019; Harvey, Mark/G-7133-2013	Best, Catherine T/0000-0002-2447-2024; Baker, Brett/0000-0002-7012-4442; Harvey, Mark/0000-0001-9901-9921	Early Career Researcher Grant; University of Melbourne (ECR ) [601103]; University of Melbourne Early Career Researcher grant; University of Melbourne's Human Research Ethics Committee [1035119]	Early Career Researcher Grant; University of Melbourne (ECR )(University of Melbourne); University of Melbourne Early Career Researcher grant(University of Melbourne); University of Melbourne's Human Research Ethics Committee	The research was funded by and Early Career Researcher Grant awarded to Brett Baker by the University of Melbourne (ECR grant 601103 Perception of rich consonant contrasts in Wubuy', awarded 21 October 2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the Wubuy speakers and the Wubuy and Australian English listeners for their participation in this research project. We thank the editor of PLoS, Linda Polka, and an anonymous reviewer for comments which led to significant improvements in this paper. We would also like to thank the audiences at the Australian Languages Workshop 2011, SST 2014, at the Universities of Melbourne and Aarhus ('Biases in Perception' workshop), and at the Australian Linguistics Society Conference 2013, for their comments and insights. This research was funded by a University of Melbourne Early Career Researcher grant to the second author, and approved by the University of Melbourne's Human Research Ethics Committee [1035119].	Anderson V., 1997, P EUR 1997 5 C SPEEC, P389; [Anonymous], 2013, WORLD PHONOTACTICS D; Baker B., 2014, LANGUAGES LINGUISTIC, P139; Baker B, 2014, AUST J LINGUIST, V34, P307, DOI 10.1080/07268602.2014.898222; Baker Brett J., 2008, WORD STRUCTURE NGALA; BALISE RR, 1994, PHONETICA, V51, P99, DOI 10.1159/000261962; Best C., 2007, HONOR JAMES EMIL FLE, V1334, P1, DOI DOI 10.1075/LLLT.17.07BES; Best C. T., 1994, DEV SPEECH PERCEPTIO, P167; Best C. T., 1995, SPEECH PERCEPTION LI, P171; Best CC, 2003, LANG SPEECH, V46, P183, DOI 10.1177/00238309030460020701; Blevins Juliette, 2004, EVOLUTIONARY PHONOLO; Bohn O-S, 2008, INPUT MATTERS SLA, P207; Bohn O-S, 2007, J ACOUST SOC AM, V121, P3187; Bohn OS, 2012, J PHONETICS, V40, P109, DOI 10.1016/j.wocn.2011.08.002; Bonte ML, 2005, CLIN NEUROPHYSIOL, V116, P2765, DOI 10.1016/j.clinph.2005.08.012; Bundgaard-Nielsen R. L., 2014, P 15 AUSTR INT SPEEC, P205; Bundgaard-Nielsen RikkeL., 2012, LAB PHONOL, V3, P133, DOI [10.1515/lp-2012-0009, DOI 10.1515/LP-2012-0009]; Butcher Andrew., 2012, QUANTITATIVE APPROAC, P133; Chomsky Noam, 1968, SOUND PATTERN ENGLIS; Commonwealth of Australia/AIATSIS, 2005, NAT IND LANG SURV RE; Cornell SA, 2013, J EXP PSYCHOL HUMAN, V39, P757, DOI 10.1037/a0030862; Dixon R. M. W., 1980, LANGUAGES AUSTR; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; Evans N., 1992, AUST J LINGUIST, V12, P45, DOI DOI 10.1080/07268609208599471; Evans Nicholas., 1995, HDB PHONOLOGICAL THE, P723; Feldman LB, 2001, J EXP PSYCHOL HUMAN, V27, P680, DOI 10.1037//0096-1523.27.3.680; Flege J.E, 1995, SPEECH PERCEPTION LI, V92, P233, DOI DOI 10.1075/LLLT.17.08STR; Friedman M, 1937, J AM STAT ASSOC, V32, P675, DOI 10.2307/2279372; Goldstein L., 2003, PHONETICS PHONOLOGY, P159; Hamilton P.J., 1996, THESIS U TORONTO; Harvey M., 2003, PACIFIC LINGUISTICS, V552, P205; Heath J., 1980, NUNGGUBUYU MYTHS ETH; Heath Jeffrey., 1978, LINGUISTIC DIFFUSION; HEATH JEFFREY, 1984, FUNCTIONAL GRAMMAR N; Jakobson R., 1961, PRELIMINARIES SPEECH; Kuhl PK, 2008, PHILOS T R SOC B, V363, P979, DOI 10.1098/rstb.2007.2154; Ladefoged P., 2001, VOWELS CONSONANTS IN; Lahiri A, 2002, PHONOL PHONET, V4-1, P637; Laver J, 1994, PRINCIPLES PHONETICS; Maddieson, 1996, SOUNDS WORLDS LANGUA; MAY JG, 1981, LANG SPEECH, V24, P273, DOI 10.1177/002383098102400307; Mellor S., 2004, AUSTR ED REV, V47; MILLER GA, 1955, J ACOUST SOC AM, V27, P338, DOI 10.1121/1.1907526; Mitterer H, 2011, J EXP PSYCHOL HUMAN, V37, P496, DOI 10.1037/a0020989; OHala J.J., 1981, PAPERS PARASESSION L, P178; Ohala J.J., 1974, PAPERS PARASESSION N, P251; OHala J.J., 1993, HIST LINGUISTICS PRO, P237; Polka L, 2003, SPEECH COMMUN, V41, P221, DOI 10.1016/S0167-6393(02)00105-X; Polka L, 2001, J ACOUST SOC AM, V109, P2190, DOI 10.1121/1.1362689; Polka L., 2005, J ACOUST SOC AM, V117, P2398; Polka L, 2011, J PHONETICS, V39, P467, DOI 10.1016/j.wocn.2010.08.007; REPP BH, 1990, J ACOUST SOC AM, V88, P2080, DOI 10.1121/1.400105; Sagey E, 1990, THESIS; Steriade D., 2001, ROLE SPEECH PERCEPTI, P219; Steriade Donca., 1997, UCLA WORKING PAPERS, V3, P25; STEVENS KN, 1989, LANGUAGE, V65, P81, DOI 10.2307/414843; Studdert-Kennedy M, 2003, LANGUAGE EVOLUTION, P219; Sundara M, 2008, COGNITION, V106, P234, DOI 10.1016/j.cognition.2007.01.011; Sundara M, 2006, COGNITION, V100, P369, DOI 10.1016/j.cognition.2005.04.007; Tabain M, 1999, J PHONETICS, V27, P333, DOI 10.1006/jpho.1999.0099; TAFT M, 1975, J VERB LEARN VERB BE, V14, P638, DOI 10.1016/S0022-5371(75)80051-X; TAFT M, 1994, LANG COGNITIVE PROC, V9, P271, DOI 10.1080/01690969408402120; TAFT M, 1979, MEM COGNITION, V7, P263, DOI 10.3758/BF03197599; Tsuji S, 2015, COGNITION, V134, P252, DOI 10.1016/j.cognition.2014.10.009; Tsushima T., 2003, Acoustical Science and Technology, V24, P410, DOI 10.1250/ast.24.410; Tyler MD, 2014, DEV PSYCHOBIOL, V56, P210, DOI 10.1002/dev.21195; West P., 2000, P 5 SEM SPEECH PROD, P105	67	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0142054	10.1371/journal.pone.0142054	http://dx.doi.org/10.1371/journal.pone.0142054			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CX9QI	26633651	Green Published, gold			2022-12-27	WOS:000366040000004
J	Pires, SM; Fischer-Walker, CL; Lanata, CF; Devleesschauwer, B; Hall, AJ; Kirk, MD; Duarte, ASR; Black, RE; Angulo, FJ				Pires, Sara M.; Fischer-Walker, Christa L.; Lanata, Claudio F.; Devleesschauwer, Brecht; Hall, Aron J.; Kirk, Martyn D.; Duarte, Ana S. R.; Black, Robert E.; Angulo, Frederick J.			Aetiology-Specific Estimates of the Global and Regional Incidence and Mortality of Diarrhoeal Diseases Commonly Transmitted through Food	PLOS ONE			English	Article							FOODBORNE ILLNESS; UNSPECIFIED AGENTS; BURDEN; INFECTIONS; PATHOGENS; CHILDREN	Background Diarrhoeal diseases are major contributors to the global burden of disease, particularly in children. However, comprehensive estimates of the incidence and mortality due to specific aetiologies of diarrhoeal diseases are not available. The objective of this study is to provide estimates of the global and regional incidence and mortality of diarrhoeal diseases caused by nine pathogens that are commonly transmitted through foods. Methods and Findings We abstracted data from systematic reviews and, depending on the overall mortality rates of the country, applied either a national incidence estimate approach or a modified Child Health Epidemiology Reference Group (CHERG) approach to estimate the aetiology-specific incidence and mortality of diarrhoeal diseases, by age and region. The nine diarrhoeal diseases assessed caused an estimated 1.8 billion (95% uncertainty interval [UI] 1.1-3.3 billion) cases and 599,000 (95% UI 472,000-802,000) deaths worldwide in 2010. The largest number of cases were caused by norovirus (677 million; 95% UI 468-1,153 million), enterotoxigenic Escherichia coli (ETEC) (233 million; 95% UI 154-380 million), Shigella spp. (188 million; 95% UI 94-379 million) and Giardia lamblia (179 million; 95% UI 125-263); the largest number of deaths were caused by norovirus (213,515; 95% UI 171,783-266,561), enteropathogenic E. coli (121,455; 95% UI 103,657-143,348), ETEC (73,041; 95% UI 55,474-96,984) and Shigella (64,993; 95% UI 48,966-92,357). There were marked regional differences in incidence and mortality for these nine diseases. Nearly 40% of cases and 43% of deaths caused by these nine diarrhoeal diseases occurred in children under five years of age. Conclusions Diarrhoeal diseases caused by these nine pathogens are responsible for a large disease burden, particularly in children. These aetiology-specific burden estimates can inform efforts to reduce diarrhoeal diseases caused by these nine pathogens commonly transmitted through foods.	[Pires, Sara M.; Duarte, Ana S. R.] Danish Tech Univ, Natl Food Inst, Copenhagen, Denmark; [Fischer-Walker, Christa L.; Black, Robert E.] Johns Hopkins Univ, Baltimore, MD USA; [Lanata, Claudio F.] Inst Invest Nutr, Lima, Peru; [Lanata, Claudio F.] US Naval Med Res Unit 6, Callao, Peru; [Devleesschauwer, Brecht] Univ Ghent, Fac Vet Med, Merelbeke, Belgium; [Devleesschauwer, Brecht] Catholic Univ Louvain, Fac Publ Hlth, Inst Hlth & Soc IRSS, B-1200 Brussels, Belgium; [Devleesschauwer, Brecht] Inst Trop Med, B-2000 Antwerp, Belgium; [Hall, Aron J.; Angulo, Frederick J.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Kirk, Martyn D.] Australian Natl Univ, Canberra, ACT, Australia	Technical University of Denmark; Johns Hopkins University; Naval Medical Research Center (NMRC); Naval Medical Research Unit No. 6 (NAMRU-6); Ghent University; Universite Catholique Louvain; Institute of Tropical Medicine (ITM); Centers for Disease Control & Prevention - USA; Australian National University	Pires, SM (corresponding author), Danish Tech Univ, Natl Food Inst, Copenhagen, Denmark.	smpi@food.dtu.dk	Pires, Sara/M-2506-2019; Lanata, Claudio F./N-7997-2018; Devleesschauwer, Brecht/G-9895-2018	Pires, Sara/0000-0002-7751-1509; Lanata, Claudio F./0000-0002-6994-7425; Devleesschauwer, Brecht/0000-0002-2867-6892; Kirk, Martyn/0000-0001-5432-5984; Ribeiro Duarte, Ana Sofia/0000-0002-8794-0542	World Health Organization under the Foodborne Disease Burden Epidemiology Reference Group; Bill and Melinda Gates Foundation through the Child Health Epidemiology Reference Group (CHERG)	World Health Organization under the Foodborne Disease Burden Epidemiology Reference Group; Bill and Melinda Gates Foundation through the Child Health Epidemiology Reference Group (CHERG)	The World Health Organization funded this study under the Foodborne Disease Burden Epidemiology Reference Group through contributions from member states and international agencies. The authors would also like to acknowledge the support from the Bill and Melinda Gates Foundation, who funded Dr. Claudio E. Lanata, Dr. Christa Fisher-Walker and Dr. Robert E. Black through the Child Health Epidemiology Reference Group (CHERG).r The World Health Organization funded this study under the Foodborne Disease Burden Epidemiology Reference Group through contributions from member states and international agencies. We would also like to acknowledge the support from the Bill and Melinda Gates Foundation, who funded Dr. Claudio E. Lanata, Dr. Christa Fisher-Walker and Prof. Robert E. Black through the Child Health Epidemiology Reference Group (CHERG).	Ahmed SM, 2014, LAN INFECT IN PRESS; Ali M, 2012, B WORLD HEALTH ORGAN, V90, P209, DOI 10.2471/BLT.11.093427; Flint JA, 2005, CLIN INFECT DIS, V41, P698, DOI 10.1086/432064; Hald T, WHO FOODBORNE UNPUB; Havelaar AH, 2012, INT J FOOD MICROBIOL, V156, P231, DOI 10.1016/j.ijfoodmicro.2012.03.029; Kirk M, 2014, EMERG INFECT DIS, V20, P1857, DOI 10.3201/eid2011.131315; Kirk MD, 2010, PLOS MED UNPUB; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Lake RJ, 2010, RISK ANAL, V30, P743, DOI 10.1111/j.1539-6924.2009.01269.x; Lanata CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072788; Lopman B, 2014, AM J EPIDEMIOL, V179, P507, DOI 10.1093/aje/kwt287; Majowicz SE, 2014, FOODBORNE PATHOG DIS, V11, P447, DOI 10.1089/fpd.2013.1704; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Pires SM, 2013, FOODBORNE PATHOG DIS, V10, P206, DOI 10.1089/fpd.2012.1134; Platts-Mills JA, 2015, LANCET GLOB HEALTH, V3, pE564, DOI 10.1016/S2214-109X(15)00151-5; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Tam CC, 2012, GUT, V61, P69, DOI 10.1136/gut.2011.238386; Tauxe RV, 2010, INT J FOOD MICROBIOL, V139, pS16, DOI 10.1016/j.ijfoodmicro.2009.10.014; Thomas MK, 2013, FOODBORNE PATHOG DIS, V10, P639, DOI 10.1089/fpd.2012.1389; Vaillant V, 2005, FOODBORNE PATHOG DIS, V2, P221, DOI 10.1089/fpd.2005.2.221; Walker CLF, 2010, EPIDEMIOL INFECT, V138, P1215, DOI 10.1017/S0950268810000592; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Walker CLF, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000768	23	213	221	5	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0142927	10.1371/journal.pone.0142927	http://dx.doi.org/10.1371/journal.pone.0142927			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26632843	Green Published, gold, Green Submitted			2022-12-27	WOS:000366040000007
J	Lubeck, AJA; Bos, JE; Stins, JF				Lubeck, Astrid J. A.; Bos, Jelte E.; Stins, John F.			Interaction between Depth Order and Density Affects Vection and Postural Sway	PLOS ONE			English	Article							CIRCULAR VECTION; ECCENTRICITY; MAGNITUDE; DIRECTION; STIMULUS	Objective Vection, a feeling of self-motion while being physically stationary, and postural sway can be modulated by various visual factors. Moreover, vection and postural sway are often found to be closely related when modulated by such visual factors, suggesting a common neural mechanism. One well-known visual factor is the depth order of the stimulus. The density, i.e. number of objects per unit area, is proposed to interact with the depth order in the modulation of vection and postural sway, which has only been studied to a limited degree. Methods We therefore exposed 17 participants to 18 different stimuli containing a stationary pattern and a pattern rotating around the naso-occipital axis. The density of both patterns was varied between 10 and 90%; the densities combined always added up to 100%. The rotating pattern occluded or was occluded by the stationary pattern, suggesting foreground or background motion, respectively. During pattern rotation participants reported vection by pressing a button, and postural sway was recorded using a force plate. Results Participants always reported more vection and swayed significantly more when rotation was perceived in the background and when the rotating pattern increased in density. As hypothesized, we found that the perceived depth order interacted with pattern density. A pattern rotating in the background with a density between 60 and 80% caused significantly more vection and postural sway than when it was perceived to rotate in the foreground. Conclusions The findings suggest that the ratio between fore-and background pattern densities is an important factor in the interaction with the depth order, and it is not the density of rotating pattern per se. Moreover, the observation that vection and postural sway were modulated in a similar way points towards a common neural origin regulating both variables.	[Lubeck, Astrid J. A.; Bos, Jelte E.; Stins, John F.] Vrije Univ Amsterdam, Fac Behav & Movement Sci, Dept Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands; [Bos, Jelte E.] TNO Perceptual & Cognit Syst, Soesterberg, Netherlands	Vrije Universiteit Amsterdam; Netherlands Organization Applied Science Research	Lubeck, AJA (corresponding author), Vrije Univ Amsterdam, Fac Behav & Movement Sci, Dept Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands.	astrid.lubeck@vu.nl		Bos, Jelte/0000-0002-1494-6804; Stins, John/0000-0001-5251-5610	Netherlands Organisation for Scientific Research [406-11-020]; TNO Perceptual and Cognitive Systems	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); TNO Perceptual and Cognitive Systems	This study is part of the PhD project titled "Standing Well" and is financed by the Netherlands Organisation for Scientific Research (http://www.nwo.nl/en) with grant number 406-11-020. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. TNO Perceptual and Cognitive Systems provided support in the form of salary for author JEB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berthoz A, 1979, Prog Brain Res, V50, P197; Bos JE, 2002, BIOL CYBERN, V86, P191, DOI 10.1007/s00422-001-0289-7; Bos JE, 2008, DISPLAYS, V29, P47, DOI 10.1016/j.displa.2007.09.002; BRANDT T, 1975, PERCEPT PSYCHOPHYS, V17, P497, DOI 10.3758/BF03203301; DICHGANS J, 1972, SCIENCE, V178, P1217, DOI 10.1126/science.178.4066.1217; Dichgans J, 1978, PERCEPTION; Guerraz M, 2008, NEUROSCI LETT, V443, P12, DOI 10.1016/j.neulet.2008.07.053; Hale K.S., 2014, HDB VIRTUAL ENV DESI, VSecond Edition; HOWARD IP, 1994, PERCEPTION, V23, P745, DOI 10.1068/p230745; HOWARD IP, 1989, PERCEPTION, V18, P657, DOI 10.1068/p180657; Ito H, 2005, VISION RES, V45, P397, DOI 10.1016/j.visres.2004.11.009; Kuno S, 1999, JPN J PHYSIOL, V49, P417, DOI 10.2170/jjphysiol.49.417; LESTIENNE F, 1977, EXP BRAIN RES, V28, P363; MITTELSTAEDT H, 1983, NATURWISSENSCHAFTEN, V70, P272, DOI 10.1007/BF00404833; Nakamura S, 2006, VISION RES, V46, P2344, DOI 10.1016/j.visres.2006.01.016; OHMI M, 1987, PERCEPTION, V16, P17, DOI 10.1068/p160017; OHMI M, 1988, PERCEPTION, V17, P5, DOI 10.1068/p170005; Palmisano S, 1998, PERCEPTION, V27, P1067, DOI 10.1068/p271067; Pollock AS, 2000, CLIN REHABIL, V14, P402, DOI 10.1191/0269215500cr342oa; REASON J, 1981, ACTA PSYCHOL, V48, P241, DOI 10.1016/0001-6918(81)90065-2; Riecke BE., 2013, HUMAN WALKING VIRTUA, P27, DOI [10.1007/978-1-4419-8432-6_2, DOI 10.1007/978-1-4419-8432-6_2]; Riecke BE, 2011, VIRTUAL REALITY, P149; Riley MA, 1999, HUM MOVEMENT SCI, V18, P795, DOI 10.1016/S0167-9457(99)00041-X; Seno T, 2009, VISION RES, V49, P2973, DOI 10.1016/j.visres.2009.09.017; Tanahashi S, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-39; TELFORD L, 1993, PERCEPT PSYCHOPHYS, V53, P682, DOI 10.3758/BF03211744; TELFORD L, 1992, PERCEPTION, V21, P337, DOI 10.1068/p210337; Thissen D, 2002, J EDUC BEHAV STAT, V27, P77, DOI 10.3102/10769986027001077; Thurrell AEI, 2002, EXP BRAIN RES, V147, P558, DOI 10.1007/s00221-002-1296-1; VANASTEN WNJC, 1988, J OPT SOC AM A, V5, P1781, DOI 10.1364/JOSAA.5.001781; Zupan LH, 2003, J NEUROPHYSIOL, V89, P390, DOI 10.1152/jn.00513.2001	32	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144034	10.1371/journal.pone.0144034	http://dx.doi.org/10.1371/journal.pone.0144034			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX8BI	26630658	Green Published, gold, Green Submitted			2022-12-27	WOS:000365926300141
J	Wright, N; Hill, J; Pickles, A; Sharp, H				Wright, Nicola; Hill, Jonathan; Pickles, Andrew; Sharp, Helen			The Specific Role of Relationship Life Events in the Onset of Depression during Pregnancy and the Postpartum	PLOS ONE			English	Article							INTERPERSONAL PSYCHOTHERAPY; RISK-FACTORS; MAJOR DEPRESSION; WOMEN; ANXIETY; STRESS; METAANALYSIS; SYMPTOMS; DISORDER; PSYCHOPATHOLOGY	Background The precipitating role of life events in the onset of depression is well-established. The present study sought to examine whether life events hypothesised to be personally salient would be more strongly associated with depression than other life events. In a sample of women making the first transition to parenthood, we hypothesised that negative events related to the partner relationship would be particularly salient and thus more strongly predictive of depression than other events. Methods A community-based sample of 316 first-time mothers stratified by psychosocial risk completed interviews at 32 weeks gestation and 29 weeks postpartum to assess dated occurrence of life events and depression onsets from conception to 29 weeks postpartum. Complete data was available from 273 (86.4%). Cox proportional hazards regression was used to examine risk for onset of depression in the 6 months following a relationship event versus other events, after accounting for past history of depression and other potential confounders. Results 52 women (19.0%) experienced an onset of depression between conception and 6 months postpartum. Both relationship events (Hazard Ratio = 2.1, p =.001) and other life events (Hazard Ratio = 1.3, p =.020) were associated with increased risk for depression onset; however, relationship events showed a significantly greater risk for depression than did other life events (p =.044). Conclusions The results are consistent with the hypothesis that personally salient events are more predictive of depression onset than other events. Further, they indicate the clinical significance of events related to the partner relationship during pregnancy and the postpartum.	[Wright, Nicola; Sharp, Helen] Univ Liverpool, Inst Psychol Hlth & Soc, Liverpool L69 3BX, Merseyside, England; [Hill, Jonathan] Univ Reading, Sch Psychol & Clin Language Sci, Reading, Berks, England; [Pickles, Andrew] Univ London, Kings Coll London, Biostat Dept, Inst Psychiat, London SW3 6LX, England	University of Liverpool; University of Reading; University of London; King's College London	Wright, N (corresponding author), Univ Liverpool, Inst Psychol Hlth & Soc, Liverpool L69 3BX, Merseyside, England.	nwright@liv.ac.uk	Sharp, Helen/G-5754-2016; Pickles, Andrew/A-9625-2011; Sharp, Helen/GOG-8045-2022	Pickles, Andrew/0000-0003-1283-0346; Sharp, Helen/0000-0002-0988-8718; wright, nicola/0000-0002-3285-2051	Medical Research Council [G0400577]; MRC [G0400577] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (grant number G0400577; http://www.mrc.ac.uk/).	American Psychiatric Association, 2017, DIAGN STAT MAN MENT, V5th; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Austin MP, 2014, BEST PRACT RES CL OB, V28, P179, DOI 10.1016/j.bpobgyn.2013.08.016; Beck CT, 2001, NURS RES, V50, P275, DOI 10.1097/00006199-200109000-00004; Belli RF, 2001, PUBLIC OPIN QUART, V65, P45, DOI 10.1086/320037; Brown G., 1978, SOCIAL ORIGINS DEPRE; BROWN GW, 1995, PSYCHOL MED, V25, P7, DOI 10.1017/S003329170002804X; BROWN GW, 1987, BRIT J PSYCHIAT, V150, P30, DOI 10.1192/bjp.150.1.30; Brown GW, 1989, LIFE EVENTS ILLNESS; BRUGHA T, 1985, PSYCHOL MED, V15, P189, DOI 10.1017/S003329170002105X; Caspi A, 1996, INT J METHOD PSYCH, V6, P101, DOI 10.1002/(SICI)1234-988X(199607)6:2<101::AID-MPR156>3.3.CO;2-E; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Cohn J F, 1986, New Dir Child Dev, P31; Connell AM, 2002, PSYCHOL BULL, V128, P746, DOI 10.1037//0033-2909.128.5.746; COX DR, 1972, J R STAT SOC B, V34, P187; Dayan J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012942; FIELD T, 1985, DEV PSYCHOL, V21, P1152, DOI 10.1037/0012-1649.21.6.1152; FINLAYJONES R, 1981, PSYCHOL MED, V11, P803, DOI 10.1017/S0033291700041301; Freedman D, 1988, Sociol Methodol, V18, P37, DOI 10.2307/271044; GOTLIB IH, 1991, J ABNORM PSYCHOL, V100, P122, DOI 10.1037/0021-843X.100.2.122; Gotlib IH, 2002, HANDBOOK OF DEPRESSION, P1; Grace S L, 2003, Arch Womens Ment Health, V6, P263, DOI 10.1007/s00737-003-0024-6; Grote NK, 2010, ARCH GEN PSYCHIAT, V67, P1012, DOI 10.1001/archgenpsychiatry.2010.111; HAMMEN C, 1990, ARCH GEN PSYCHIAT, V47, P1112; Hammen C, 2005, ANNU REV CLIN PSYCHO, V1, P293, DOI 10.1146/annurev.clinpsy.1.102803.143938; HARRINGTON R, 1988, PSYCHOL MED, V18, P487, DOI 10.1017/S0033291700008023; HEDEGAARD M, 1993, BMJ-BRIT MED J, V307, P234, DOI 10.1136/bmj.307.6898.234; Hoffman S, 2000, HEALTH PSYCHOL, V19, P535, DOI 10.1037/0278-6133.19.6.535; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; Kendler KS, 2003, ARCH GEN PSYCHIAT, V60, P789, DOI 10.1001/archpsyc.60.8.789; Kendler KS, 2001, AM J PSYCHIAT, V158, P587, DOI 10.1176/appi.ajp.158.4.587; Kendler KS, 1999, AM J PSYCHIAT, V156, P837, DOI 10.1176/ajp.156.6.837; Kessler RC, 1997, ANNU REV PSYCHOL, V48, P191, DOI 10.1146/annurev.psych.48.1.191; Kurki T, 2000, OBSTET GYNECOL, V95, P487, DOI 10.1016/S0029-7844(99)00602-X; Lancaster CA, 2010, AM J OBSTET GYNECOL, V202, P5, DOI 10.1016/j.ajog.2009.09.007; LEWINSOHN PM, 1985, J CLIN PSYCHOL, V41, P483, DOI 10.1002/1097-4679(198507)41:4<483::AID-JCLP2270410407>3.0.CO;2-0; Liu RT, 2010, CLIN PSYCHOL REV, V30, P582, DOI 10.1016/j.cpr.2010.04.010; Lloyd, 2004, ENGLISH INDICES DEPR; Lovejoy MC, 2000, CLIN PSYCHOL REV, V20, P561, DOI 10.1016/S0272-7358(98)00100-7; Luoma I, 2001, J AM ACAD CHILD PSY, V40, P1367, DOI 10.1097/00004583-200112000-00006; Mazure CM, 1998, CLIN PSYCHOL-SCI PR, V5, P291, DOI 10.1111/j.1468-2850.1998.tb00151.x; Moffitt TE, 1997, PSYCHOL ASSESSMENT, V9, P47, DOI 10.1037/1040-3590.9.1.47; Monroe SM, 1999, J ABNORM PSYCHOL, V108, P606, DOI 10.1037/0021-843X.108.4.606; MURRAY D, 1995, BRIT J PSYCHIAT, V166, P595, DOI 10.1192/bjp.166.5.595; O'Hara MW, 2000, ARCH GEN PSYCHIAT, V57, P1039, DOI 10.1001/archpsyc.57.11.1039; Paykel ES, 2003, ACTA PSYCHIAT SCAND, V108, P61, DOI 10.1034/j.1600-0447.108.s418.13.x; Pilkington PD, 2015, J AFFECT DISORDERS, V178, P165, DOI 10.1016/j.jad.2015.02.023; Robertson E, 2004, GEN HOSP PSYCHIAT, V26, P289, DOI 10.1016/j.genhosppsych.2004.02.006; Schmeelk KH, 1999, BEHAV MED, V25, P88, DOI 10.1080/08964289909595741; Sharp H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045446; Spinelli MG, 2013, J CLIN PSYCHIAT, V74, P393, DOI 10.4088/JCP.12m07909; Spinelli MG, 2003, AM J PSYCHIAT, V160, P555, DOI 10.1176/appi.ajp.160.3.555; SPITZER REJ, 1977, SCHEDULE AFFECTIVE D; StataCorp, 2011, STAT STAT SOFTW REL, P173; Stuart S, 1995, J Psychother Pract Res, V4, P18; SURTEES PG, 1983, SOC PSYCHIATR, V18, P37, DOI 10.1007/BF00583386; Swendsen JD, 2000, CLIN PSYCHOL-SCI PR, V7, P17, DOI 10.1093/clipsy/7.1.17; ZIMMERMANNTANSELLA C, 1991, PSYCHOL MED, V21, P505, DOI 10.1017/S0033291700020614; ZUCKERMAN B, 1989, AM J OBSTET GYNECOL, V160, P1107, DOI 10.1016/0002-9378(89)90170-1	59	10	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0144131	10.1371/journal.pone.0144131	http://dx.doi.org/10.1371/journal.pone.0144131			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1YV	26645963	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000366903100014
J	Watson, DM				Watson, David M.			Disproportionate Declines in Ground-Foraging Insectivorous Birds after Mistletoe Removal	PLOS ONE			English	Article							PARASITIC PLANTS; WOODLAND BIRDS; COMMUNITY STRUCTURE; SOUTHWEST ZIMBABWE; KEYSTONE RESOURCE; SEMIARID SAVANNA; BARTSIA-ALPINA; CLIMATE-CHANGE; FOREST; LITTER	Insectivorous birds have been recognized as disproportionately sensitive to land-use intensification and habitat loss, with those species feeding primarily on the ground exhibiting some of the most dramatic declines. Altered litter inputs and availability of epigeic arthropods have been suggested to underlie reduced abundances and shrinking distributions but direct evidence is lacking. I used a patch-scale removal experiment in southern Australia to evaluate whether ground-feeding insectivores are especially vulnerable to altered litter-fall. Building on work demonstrating the importance of mistletoe litter to nutrient dynamics, litter was reduced by removing mistletoe (Loranthaceae) from one set of eucalypt woodlands, responses of birds three years after mistletoe removal compared with otherwise similar control woodlands containing mistletoe. Despite not feeding on mistletoes directly, insectivores exhibited the greatest response to mistletoe removal. Among woodland residents, ground-foraging insectivores showed the most dramatic response; treatment woodlands losing an average of 37.4% of their pre-treatment species richness. Once these 19 species of ground-foraging insectivores were excluded, remaining woodland species showed no significant effect of mistletoe removal. This response reflects greater initial losses in treatment woodlands during the study (which coincided with a severe drought) and double the number of species returning to control woodlands (where mistletoe numbers and litter were not manipulated) post-drought. These findings support the productivity-based explanation of declining insectivores, suggesting diminished litter-fall reduced habitat quality for these birds via decreased availability of their preferred prey. In addition to altered prey availability, interactions between litter-fall and epigeic arthropods exemplify the importance of below-ground / above-ground linkages driving ecosystem function.	[Watson, David M.] Charles Sturt Univ, Inst Land Water & Soc, Albury, NSW, Australia	Charles Sturt University	Watson, DM (corresponding author), Charles Sturt Univ, Inst Land Water & Soc, Albury, NSW, Australia.	dwatson@csu.edu.au		David, Watson/0000-0003-1821-4632	Australian Research Council [DP034259]; Winnifred Violet Scott Trust; Charles Sturt University	Australian Research Council(Australian Research Council); Winnifred Violet Scott Trust; Charles Sturt University	This research was supported by the Australian Research Council (DP034259), the Winnifred Violet Scott Trust and Charles Sturt University. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; I am grateful to the 18 Billabong Creek catchment landholders for allowing access to their properties and supporting all aspects of fieldwork and data collection. Matthew Herring was instrumental in organizing teams of volunteers for the mistletoe removal phase, and technicians from the Charles Sturt University Ecology Lab provided logistical support throughout. This research was supported by the Australian Research Council (DP034259), the Winnifred Violet Scott Trust and Charles Sturt University. Maggie Watson, Dale Nimmo and Karen Ikin provided constructive feedback on an earlier version of this manuscript and Simon McDonland (CSU SPAN) assisted with the figure.	Ameloot E, 2008, PLANT SOIL, V311, P255, DOI 10.1007/s11104-008-9640-2; [Anonymous], 1996, PRAIRIE CONSERVATION; Bardgett RD, 2006, NATURE, V439, P969, DOI 10.1038/nature04197; Bennett AF, 2011, EMU, V111, pI, DOI 10.1071/MUv111n1_ED; BOM CSIRO, 2014, STAT CLIM 2014 COMM; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Cullings K, 2010, SOIL BIOL BIOCHEM, V42, P1976, DOI 10.1016/j.soilbio.2010.07.018; Donald PF, 2001, P ROY SOC B-BIOL SCI, V268, P25, DOI 10.1098/rspb.2000.1325; Facelli JM, 1991, BOT REV, V53, P12, DOI 10.1007/BF02858763; Fisher JP, 2013, NEW PHYTOL, V198, P222, DOI 10.1111/nph.12144; Fuller RJ, 2007, IBIS, V149, P261, DOI 10.1111/j.1474-919X.2007.00775.x; Hamer KC, 2015, BIOL CONSERV, V188, P82, DOI 10.1016/j.biocon.2014.09.026; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Luck GW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063671; Mac Nally R, 2009, DIVERS DISTRIB, V15, P720, DOI 10.1111/j.1472-4642.2009.00578.x; March WA, 2007, OECOLOGIA, V154, P339, DOI 10.1007/s00442-007-0835-7; Maron M, 2005, AUSTRAL ECOL, V30, P383, DOI 10.1111/j.1442-9993.2005.01480.x; Montague-Drake RM, 2009, BIOL CONSERV, V142, P2896, DOI 10.1016/j.biocon.2009.07.009; Ndagurwa HGT, 2014, PLANT SOIL, V383, P291, DOI 10.1007/s11104-014-2176-8; Ndagurwa HGT, 2014, PLANT ECOL, V215, P15, DOI 10.1007/s11258-013-0275-x; Pennings SC, 1996, ECOLOGY, V77, P1410, DOI 10.2307/2265538; Powell LL, 2015, BIOL CONSERV, V188, P1, DOI 10.1016/j.biocon.2015.03.025; Quested HM, 2008, PLANT SOIL, V311, P269, DOI 10.1007/s11104-008-9646-9; Quested HM, 2003, OECOLOGIA, V135, P606, DOI 10.1007/s00442-003-1225-4; Quested HM, 2002, OECOLOGIA, V130, P88, DOI 10.1007/s004420100780; Razeng E, 2015, J AVIAN BIOL, V46, P89, DOI 10.1111/jav.00475; Razeng E, 2012, EMU, V112, P149, DOI 10.1071/MU11099; Robinson SK, 1998, AUK, V115, P1; Sekercioglu CH, 2002, P NATL ACAD SCI USA, V99, P263, DOI 10.1073/pnas.012616199; Spasojevic MJ, 2011, OECOLOGIA, V165, P193, DOI 10.1007/s00442-010-1726-x; Stevens HC, 2013, EMU, V113, P112, DOI 10.1071/MU12063; Taylor S. C., 2008, VICTORIAN NAT, V125, P19; Totterman Stephen L., 2015, Corella, V39, P1; Usher M.B., 1993, Biodiversity Letters, V1, P54, DOI 10.2307/2999650; Watson D. M., 2010, TEMPERATE WOODLAND C, P159; Watson DM, 2015, BIOL CONSERV, V191, P830, DOI 10.1016/j.biocon.2015.08.035; Watson DM, 2012, P ROY SOC B-BIOL SCI, V279, P3853, DOI 10.1098/rspb.2012.0856; Watson DM, 2011, EMU, V111, P10, DOI 10.1071/MU09109; Watson DM, 2009, J ECOL, V97, P1151, DOI 10.1111/j.1365-2745.2009.01576.x; Watson DM, 2004, WILDLIFE RES, V31, P1, DOI 10.1071/WR03022; Watson DM, 2003, AUSTRAL ECOL, V28, P515, DOI 10.1046/j.1442-9993.2003.01308.x; Watson DM, 2001, ANNU REV ECOL SYST, V32, P219, DOI 10.1146/annurev.ecolsys.32.081501.114024; Yong DL, 2011, J TROP ECOL, V27, P1, DOI 10.1017/S0266467410000520; Zanette L, 2000, ECOLOGY, V81, P1654, DOI 10.1890/0012-9658(2000)081[1654:FSISFE]2.0.CO;2	44	16	17	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0142992	10.1371/journal.pone.0142992	http://dx.doi.org/10.1371/journal.pone.0142992			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26640895	Green Submitted, Green Published, gold			2022-12-27	WOS:000366902700011
J	Whaley, C; Reed, M; Hsu, J; Fung, V				Whaley, Christopher; Reed, Mary; Hsu, John; Fung, Vicki			Functional Limitations, Medication Support, and Responses to Drug Costs among Medicare Beneficiaries	PLOS ONE			English	Article							HEALTH-INSURANCE; PART-D; CLINICAL EVENTS; SOCIAL SUPPORT; COVERAGE GAP; CARE; ADHERENCE; BENEFITS; ADULTS; NEEDS	Objective Standard Medicare Part D prescription drug benefits include substantial and complex cost-sharing. Many beneficiaries also have functional limitations that could affect self-care capabilities, including managing medications, but also have varying levels of social support to help with these activities. We examined the associations between drug cost responses, functional limitations, and social support. Data Sources and Study Setting We conducted telephone interviews in a stratified random sample of community-dwelling Medicare Advantage beneficiaries (N = 1,201, response rate = 70.0%). Participants reported their functional status (i.e., difficulty with activities of daily living) and social support (i.e., receiving help with medications). Drug cost responses included cost-reducing behaviors, cost-related non-adherence, and financial stress. Study Design We used multivariate logistic regression to assess associations among functional status, help with medications, and drug cost responses, adjusting for patient characteristics. Principal Findings Respondents with multiple limitations who did not receive help with their medications were more likely to report cost-related non-adherence (OR = 3.2, 95% CI: 1.2-8.5) and financial stress (OR = 2.4, 95% CI: 1.3-4.5) compared to subjects with fewer limitations and no help; however, those with multiple limitations and with medication help had similar odds of unfavorable cost responses as those with fewer limitations. Conclusion The majority of beneficiaries with functional limitations did not receive help with medications. Support with medication management for beneficiaries who have functional limitations could improve adherence and outcomes.	[Whaley, Christopher] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Whaley, Christopher; Reed, Mary] Kaiser Permanente No Calif, Div Res, Oakland, CA USA; [Hsu, John; Fung, Vicki] Massachusetts Gen Hosp, Mongan Inst Hlth Policy, Boston, MA 02114 USA; [Hsu, John; Fung, Vicki] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Hsu, John] Dept Hlth Care Policy, Boston, MA USA	University of California System; University of California Berkeley; Kaiser Permanente; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Whaley, C (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.	cwhaley@berkeley.edu; mary.e.reed@kp.org			Kaiser Permanente Community Benefits; National Institute of Mental Health [R01MH090284]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090284] Funding Source: NIH RePORTER	Kaiser Permanente Community Benefits; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by Kaiser Permanente Community Benefits, recipient: John Hsu; National Institute of Mental Health, grant # R01MH090284, recipient: Vicki Fung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, HLTH CAR SPEND MED P; Congressional Budget Office, 2013, RIS DEM LONG TERM SE; Desai MM, 2001, GERONTOLOGIST, V41, P82, DOI 10.1093/geront/41.1.82; DiMatteo MR, 2004, HEALTH PSYCHOL, V23, P207, DOI 10.1037/0278-6133.23.2.207; Donelan K, 2002, HEALTH AFFAIR, V21, P222, DOI 10.1377/hlthaff.21.4.222; Drainoni ML., 2006, J DIABIL POLICY STUD, V17, P101, DOI [10.1177/10442073060170020101, DOI 10.1177/10442073060170020101]; Foden-Vencil K, 2013, KAISER HLTH NEW 0710; Fung V, 2013, HLTH SERV RES; Fung V, 2013, MED CARE, V51, P614, DOI 10.1097/MLR.0b013e31829019c5; Fung V, 2010, HEALTH SERV RES, V45, P355, DOI 10.1111/j.1475-6773.2009.01071.x; Goldman DP, 2004, JAMA-J AM MED ASSOC, V291, P2344, DOI 10.1001/jama.291.19.2344; Hsu J, 2006, HEALTH SERV RES, V41, P1801, DOI 10.1111/j.1475-6773.2006.00562.x; Hudson TJ, 2013, J CLIN PSYCHIAT, V65, P211; Jaffe S, 2013, KAISER HLTH NEW 0625; Jaffe S, 2013, NY TIMES; Johnson R.W., 2006, PROFILE FRAIL OLDER; Kaye HS, 2013, HEALTH AFFAIR, V32, P127, DOI 10.1377/hlthaff.2012.0533; Klein D, 2004, GERONTOLOGIST, V44, P779, DOI 10.1093/geront/44.6.779; Kuye IO, 2013, JAMA INTERN MED, V173, P1100, DOI 10.1001/jamainternmed.2013.845; Kuzuya M, 2008, J AM GERIATR SOC, V56, P881, DOI 10.1111/j.1532-5415.2008.01676.x; Lew J, 2013, 2013 ANN REPORT BOAR; Long SK, 2002, HEALTH CARE FINANC R, V23, P159; Madden JM, 2008, JAMA-J AM MED ASSOC, V299, P1922, DOI 10.1001/jama.299.16.1922; Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x; NEWHOUSE JP, 1981, NEW ENGL J MED, V305, P1501, DOI 10.1056/NEJM198112173052504; Newhouse JP, 1993, FREE ALL LESSONS RAN; Peikes D, 2009, JAMA-J AM MED ASSOC, V301, P603, DOI 10.1001/jama.2009.126; Sayers SL, 2008, ANN BEHAV MED, V35, P70, DOI 10.1007/s12160-007-9003-x; Schore J, 2011, 6555440 MATH POL RES; Soumerai SB, 2006, ARCH INTERN MED, V166, P1829, DOI 10.1001/archinte.166.17.1829; Talaga S, 2013, R42998 C RES OFF; Zhang YT, 2013, AM J MANAG CARE, V19, pE214; Zhang YT, 2012, ARCH GEN PSYCHIAT, V69, P672, DOI 10.1001/archgenpsychiatry.2011.1402	33	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144236	10.1371/journal.pone.0144236	http://dx.doi.org/10.1371/journal.pone.0144236			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1YS	26642195	Green Published, Green Submitted, gold			2022-12-27	WOS:000366902700081
J	Chen, K; Ding, AM; Liang, XH; Zhang, LP; Wang, L; Song, XM				Chen, Ke; Ding, Ai-Min; Liang, Xiao-Hua; Zhang, Li-Peng; Wang, Ling; Song, Xue-Mei			Effect of Contrast on Visual Spatial Summation in Different Cell Categories in Cat Primary Visual Cortex	PLOS ONE			English	Article							FAST-SPIKING INTERNEURONS; RAT FRONTAL-CORTEX; NONCLASSICAL RECEPTIVE-FIELD; PUTATIVE PYRAMIDAL NEURONS; STRIATE CORTEX; INHIBITORY NEURONS; CORTICAL-NEURONS; SYNAPTIC CONNECTIONS; PREFRONTAL CORTEX; MORPHOLOGICAL-CHARACTERISTICS	Multiple cell classes have been found in the primary visual cortex, but the relationship between cell types and spatial summation has seldom been studied. Parvalbumin-expressing inhibitory interneurons can be distinguished from pyramidal neurons based on their briefer action potential durations. In this study, we classified V1 cells into fast-spiking units (FSUs) and regular-spiking units (RSUs) and then examined spatial summation at high and low contrast. Our results revealed that the excitatory classical receptive field and the suppressive non-classical receptive field expanded at low contrast for both FSUs and RSUs, but the expansion was more marked for the RSUs than for the FSUs. For most V1 neurons, surround suppression varied as the contrast changed from high to low. However, FSUs exhibited no significant difference in the strength of suppression between high and low contrast, although the overall suppression decreased significantly at low contrast for the RSUs. Our results suggest that the modulation of spatial summation by stimulus contrast differs across populations of neurons in the cat primary visual cortex.	[Chen, Ke; Ding, Ai-Min; Liang, Xiao-Hua; Zhang, Li-Peng; Wang, Ling] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab Neuroinformat, Chengdu 610054, Peoples R China; [Song, Xue-Mei] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China	University of Electronic Science & Technology of China; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Chen, K (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab Neuroinformat, Chengdu 610054, Peoples R China.	chenke0703@163.com		Chen, Ke/0000-0003-2209-1452	Major State Basic Research Program of China [2013CB329401]; Natural Science Foundations of China [31300912, 91420105, 3100492]; China Postdoctoral Science Foundation [2012M521681, 2013T60844]; Fundamental Research Funds for the Central Universities [ZYGX2014J080]	Major State Basic Research Program of China(National Basic Research Program of China); Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	Major State Basic Research Program of China (2013CB329401); Natural Science Foundations of China (31300912, 91420105, 3100492); China Postdoctoral Science Foundation (2012M521681, 2013T60844); Fundamental Research Funds for the Central Universities (ZYGX2014J080). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRECHT DG, 1982, J NEUROPHYSIOL, V48, P217, DOI 10.1152/jn.1982.48.1.217; Andermann ML, 2004, NEURON, V42, P451, DOI 10.1016/S0896-6273(04)00198-9; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Angelucci A, 2002, J NEUROSCI, V22, P8633; Atencio CA, 2008, J NEUROSCI, V28, P3897, DOI 10.1523/JNEUROSCI.5366-07.2008; Azouz R, 1997, CEREB CORTEX, V7, P534, DOI 10.1093/cercor/7.6.534; Burkhalter A, 2008, FRONT NEUROSCI-SWITZ, V2, P155, DOI 10.3389/neuro.01.026.2008; Cardin JA, 2007, J NEUROSCI, V27, P10333, DOI 10.1523/JNEUROSCI.1692-07.2007; Chen K, 2014, VISION RES, V96, P87, DOI 10.1016/j.visres.2014.01.011; Chen K, 2013, CEREB CORTEX, V23, P283, DOI 10.1093/cercor/bhs012; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; Constantinidis C, 2002, J NEUROPHYSIOL, V88, P3487, DOI 10.1152/jn.00188.2002; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; DEANGELIS GC, 1994, J NEUROPHYSIOL, V71, P347, DOI 10.1152/jn.1994.71.1.347; Descaizo VF, 2005, J NEUROPHYSIOL, V8, P1552; DYKES RW, 1988, BRAIN RES, V441, P48, DOI 10.1016/0006-8993(88)91382-0; Gibber M, 2001, NEUROREPORT, V12, P2293, DOI 10.1097/00001756-200107200-00049; Gold C, 2006, J NEUROPHYSIOL, V95, P3113, DOI 10.1152/jn.00979.2005; Gonchar Y, 1997, CEREB CORTEX, V7, P347, DOI 10.1093/cercor/7.4.347; Gonzalez-Burgos G, 2005, J NEUROPHYSIOL, V93, P942, DOI 10.1152/jn.00787.2004; Gray CM, 1996, SCIENCE, V274, P109, DOI 10.1126/science.274.5284.109; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; HIRSCH JA, 1991, J NEUROSCI, V11, P1800; Hofer SB, 2011, NAT NEUROSCI, V14, P1045, DOI 10.1038/nn.2876; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Huang XY, 2014, J NEUROSCI, V34, P4976, DOI 10.1523/JNEUROSCI.4116-13.2014; JONES JP, 1987, J NEUROPHYSIOL, V58, P1212, DOI 10.1152/jn.1987.58.6.1212; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; KAWAGUCHI Y, 1993, J NEUROPHYSIOL, V69, P416, DOI 10.1152/jn.1993.69.2.416; KAWAGUCHI Y, 1995, J NEUROSCI, V15, P2638; KISVARDAY ZF, 1986, EXP BRAIN RES, V64, P541, DOI 10.1007/BF00340492; Kuhlman SJ, 2011, NAT NEUROSCI, V14, P1121, DOI 10.1038/nn.2890; Lampl I, 2001, NEURON, V30, P263, DOI 10.1016/S0896-6273(01)00278-1; Lauritzen TZ, 2003, J NEUROSCI, V23, P10201; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Levitt JB, 2002, VISUAL NEUROSCI, V19, P439, DOI 10.1017/S0952523802194065; LI CY, 1995, J NEUROSCI METH, V57, P217, DOI 10.1016/0165-0270(94)00151-6; LI CY, 1994, VISION RES, V34, P2337, DOI 10.1016/0042-6989(94)90280-1; Marino J, 2005, NAT NEUROSCI, V8, P194, DOI 10.1038/nn1391; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Martina M, 1997, J PHYSIOL-LONDON, V505, P593, DOI 10.1111/j.1469-7793.1997.593ba.x; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; Mruczek REB, 2012, J NEUROPHYSIOL, V108, P2725, DOI 10.1152/jn.00618.2012; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Povysheva NV, 2006, CEREB CORTEX, V16, P541, DOI 10.1093/cercor/bhj002; RIBAUPIERRE FD, 1972, BRAIN RES, V48, P205, DOI 10.1016/0006-8993(72)90179-5; Rose HJ, 2005, J NEUROPHYSIOL, V94, P2019, DOI 10.1152/jn.00860.2004; Sceniak MP, 1999, NAT NEUROSCI, V2, P733, DOI 10.1038/11197; SIMONS DJ, 1978, J NEUROPHYSIOL, V41, P798, DOI 10.1152/jn.1978.41.3.798; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Somers DC, 1998, CEREB CORTEX, V8, P204, DOI 10.1093/cercor/8.3.204; Song XM, 2008, CEREB CORTEX, V18, P331, DOI 10.1093/cercor/bhm057; STEMMLER M, 1995, SCIENCE, V269, P1877, DOI 10.1126/science.7569930; Swadlow HA, 2003, CEREB CORTEX, V13, P25, DOI 10.1093/cercor/13.1.25; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Troyer TW, 1998, J NEUROSCI, V18, P5908; VOLKOV I O, 1989, Neirofiziologiya, V21, P613; West DC, 2006, CEREB CORTEX, V16, P200, DOI 10.1093/cercor/bhi098; Yokoi I, 2010, J NEUROPHYSIOL, V104, P1603, DOI 10.1152/jn.00160.2010; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252	62	1	1	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144403	10.1371/journal.pone.0144403	http://dx.doi.org/10.1371/journal.pone.0144403			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636580	Green Submitted, gold, Green Published			2022-12-27	WOS:000366143800088
J	Spoorenberg, V; Hulscher, MEJL; Geskus, RB; de Reijke, TM; Opmeer, BC; Prins, JM; Geerlings, SE				Spoorenberg, Veroniek; Hulscher, Marlies E. J. L.; Geskus, Ronald B.; de Reijke, Theo M.; Opmeer, Brent C.; Prins, Jan M.; Geerlings, Suzanne E.			A Cluster-Randomized Trial of Two Strategies to Improve Antibiotic Use for Patients with a Complicated Urinary Tract Infection	PLOS ONE			English	Article							QUALITY IMPROVEMENT; ANTIMICROBIAL RESISTANCE; CARE; HOSPITALS; INTERVENTIONS; EPIDEMIOLOGY; GUIDELINES; MORTALITY; LENGTH	Background Up to 50% of hospital antibiotic use is inappropriate and therefore improvement strategies are urgently needed. We compared the effectiveness of two strategies to improve the quality of antibiotic use in patients with a complicated urinary tract infection (UTI). Methods In a multicentre, cluster-randomized trial 19 Dutch hospitals (departments Internal Medicine and Urology) were allocated to either a multi-faceted strategy including feedback, educational sessions, reminders and additional/optional improvement actions, or a competitive feedback strategy, i.e. providing professionals with non-anonymous comparative feedback on the department's appropriateness of antibiotic use. Retrospective baseline-and post-intervention measurements were performed in 2009 and 2012 in 50 patients per department, resulting in 1,964 and 2,027 patients respectively. Principal outcome measures were nine validated guideline-based quality indicators (QIs) that define appropriate antibiotic use in patients with a complicated UTI, and a QI sumscore that summarizes for each patient the appropriateness of antibiotic use. Results Performance scores on several individual QIs showed improvement from baseline to post-intervention measurements, but no significant differences were found between both strategies. The mean patient's QI sum score improved significantly in both strategy groups (multifaceted: 61.7% to 65.0%, P = 0.04 and competitive feedback: 62.8% to 66.7%, P = 0.01). Compliance with the strategies was suboptimal, but better compliance was associated with more improvement. Conclusion The effectiveness of both strategies was comparable and better compliance with the strategies was associated with more improvement. To increase effectiveness, improvement activities should be rigorously applied, preferably by a locally initiated multidisciplinary team.	[Spoorenberg, Veroniek; Prins, Jan M.; Geerlings, Suzanne E.] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Div Infect Dis,Ctr Infect & Immun Amsterdam, NL-1105 AZ Amsterdam, Netherlands; [Hulscher, Marlies E. J. L.] Radboud Univ Nijmegen, Med Ctr, Sci Inst Qual Healthcare, NL-6525 ED Nijmegen, Netherlands; [Geskus, Ronald B.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands; [de Reijke, Theo M.] Univ Amsterdam, Acad Med Ctr, Dept Urol, NL-1105 AZ Amsterdam, Netherlands; [Opmeer, Brent C.] Univ Amsterdam, Acad Med Ctr, Clin Res Unit, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Spoorenberg, V (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Div Infect Dis,Ctr Infect & Immun Amsterdam, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	v.spoorenberg@amc.nl; s.e.geerlings@amc.uva.nl	Prins, Jan M./AAF-4945-2020; Hulscher, Marlies/B-1229-2014; Geskus, Ronald B/H-3684-2019	Hulscher, Marlies/0000-0002-2160-4810; Geskus, Ronald B/0000-0002-2740-3155; Prins, Jan/0000-0002-5415-8933	Netherlands Organisation for Health Research and Development [993002]; ZonMw	Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); ZonMw(Netherlands Organization for Health Research and Development)	The trial was supported by ZonMw, the Netherlands Organisation for Health Research and Development (www.zonmw.nl), project number 993002. The grant recipient is SG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], CYB LAB; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Chassin MR, 2010, NEW ENGL J MED, V363, P683, DOI 10.1056/NEJMsb1002320; Costelloe Ceire, 2010, BMJ, V340, pc2096, DOI 10.1136/bmj.c2096; Davey P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003543.pub3; de Kraker MEA, 2011, J ANTIMICROB CHEMOTH, V66, P398, DOI 10.1093/jac/dkq412; Dellit TH, 2007, CLIN INFECT DIS, V44, P159, DOI 10.1086/510393; Flottorp S, 2003, BMC HEALTH SERV RES, V3, DOI 10.1186/1472-6963-3-3; Foxman B, 2010, NAT REV UROL, V7, P653, DOI 10.1038/nrurol.2010.190; Fraser A, 2006, AM J MED, V119, P970, DOI 10.1016/j.amjmed.2006.03.034; Fung CH, 2008, ANN INTERN MED, V148, P111, DOI 10.7326/0003-4819-148-2-200801150-00006; Geerlings S E, 2006, Ned Tijdschr Geneeskd, V150, P2370; Hermanides HS, 2008, CLIN INFECT DIS, V46, P703, DOI 10.1086/527384; Huis A, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-41; Hulscher MEJL, 2010, LANCET INFECT DIS, V10, P167, DOI 10.1016/S1473-3099(10)70027-X; Hulscher MEJL, 2003, QUAL SAF HEALTH CARE, V12, P40, DOI 10.1136/qhc.12.1.40; Ivers N, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000259.pub3; Ketelaar NABM, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004538.pub2; Lindenauer PK, 2007, NEW ENGL J MED, V356, P486, DOI 10.1056/NEJMsa064964; Majumdar Sumit R, 2004, Jt Comm J Qual Saf, V30, P387; McKibben L, 2005, AM J INFECT CONTROL, V33, P217, DOI 10.1016/j.ajic.2005.04.001; R Core Team, 2021, R LANGUAGE ENV STAT; Ramsay C, 2003, J ANTIMICROB CHEMOTH, V52, P764, DOI 10.1093/jac/dkg460; Rubenstein JN, 2003, INFECT DIS CLIN N AM, V17, P333, DOI 10.1016/S0891-5520(03)00012-6; Schouten JA, 2007, QUAL SAF HEALTH CARE, V16, P143, DOI 10.1136/qshc.2005.017327; Schouten JA, 2007, CLIN INFECT DIS, V44, P931, DOI 10.1086/512193; Septimus EJ, 2011, CLIN INFECT DIS, V53, pS8, DOI 10.1093/cid/cir363; Spoorenberg V, 2014, CLIN INFECT DIS, V58, P164, DOI 10.1093/cid/cit688; Stamm WE, 2001, J INFECT DIS, V183, pS1, DOI 10.1086/318850; Tacconelli E, 2009, CURR OPIN INFECT DIS, V22, P352, DOI 10.1097/QCO.0b013e32832d52e0; Weinberg M, 2001, ARCH INTERN MED, V161, P2357, DOI 10.1001/archinte.161.19.2357; Zarb P, 2011, J ANTIMICROB CHEMOTH, V66, P443, DOI 10.1093/jac/dkq430	33	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0142672	10.1371/journal.pone.0142672	http://dx.doi.org/10.1371/journal.pone.0142672			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26637169	gold, Green Submitted, Green Published			2022-12-27	WOS:000366143800002
J	Tchoubi, S; Sobngwi-Tambekou, J; Noubiap, JJN; Asangbeh, SL; Nkoum, BA; Sobngwi, E				Tchoubi, Sebastien; Sobngwi-Tambekou, Joelle; Noubiap, Jean Jacques N.; Asangbeh, Serra Lem; Nkoum, Benjamin Alexandre; Sobngwi, Eugene			Prevalence and Risk Factors of Overweight and Obesity among Children Aged 6-59 Months in Cameroon: A Multistage, Stratified Cluster Sampling Nationwide Survey	PLOS ONE			English	Article							BODY-MASS INDEX; CHILDHOOD OBESITY; PRESCHOOL-CHILDREN; EARLY DETERMINANTS; UNITED-STATES; BIRTH-WEIGHT; MORTALITY; COUNTRIES	Background Childhood obesity is one of the most serious public health challenges of the 21st century. The prevalence of overweight and obesity among children (<5 years) in Cameroon, based on weight-for-height index, has doubled between 1991 and 2006. This study aimed to determine the prevalence and risk factors of overweight and obesity among children aged 6 months to 5 years in Cameroon in 2011. Methods Four thousand five hundred and eighteen children (2205 boys and 2313 girls) aged between 6 to 59 months were sampled in the 2011 Demographic Health Survey (DHS) database. Body Mass Index (BMI) z-scores based on WHO 2006 reference population was chosen to estimate overweight (BMI z-score >2) and obesity (BMI for age >3). Regression analyses were performed to investigate risk factors of overweight/obesity. Results The prevalence of overweight and obesity was 8% (1.7% for obesity alone). Boys were more affected by overweight than girls with a prevalence of 9.7% and 6.4% respectively. The highest prevalence of overweight was observed in the Grassfield area (including people living in West and North-West regions) (15.3%). Factors that were independently associated with overweight and obesity included: having overweight mother (adjusted odds ratio (aOR) = 1.51; 95% CI 1.15 to 1.97) and obese mother (aOR = 2.19; 95% CI = 155 to 3.07), compared to having normal weight mother; high birth weight (aOR = 1.69; 95% CI 1.24 to 2.28) compared to normal birth weight; male gender (aOR = 1.56; 95% CI 1.24 to 1.95); low birth rank (aOR = 1.35; 95% CI 1.06 to 1.72); being aged between 13-24 months (aOR = 1.81; 95% CI = 1.21 to 2.66) and 25-36 months (aOR = 2.79; 95% CI 1.93 to 4.13) compared to being aged 45 to 49 months; living in the grassfield area (aOR = 2.65; 95% CI = 1.87 to 3.79) compared to living in Forest area. Muslim appeared as a protective factor (aOR = 0.67; 95% CI 0.46 to 0.95). compared to Christian religion. Conclusion This study underlines a high prevalence of early childhood overweight with significant disparities between ecological areas of Cameroon. Risk factors of overweight included high maternal BMI, high birth weight, male gender, low birth rank, aged between 13-36 months, and living in the Grassfield area while being Muslim appeared as a protective factor. Preventive strategies should be strengthened especially in Grassfield areas and should focus on sensitization campaigns to reduce overweight and obesity in mothers and on reinforcement of measures such as surveillance of weight gain during antenatal consultation and clinical follow-up of children with high birth weight. Meanwhile, further studies including nutritional characteristics are of great interest to understand the association with religion, child age and ecological area in this age group, and will help in refining preventive strategies against childhood overweight and obesity in Cameroon.	[Tchoubi, Sebastien; Sobngwi-Tambekou, Joelle] Minist Publ Hlth, Yaounde, Cameroon; [Asangbeh, Serra Lem; Nkoum, Benjamin Alexandre] Catholic Univ Cent Africa, Sch Hlth Sci, Yaounde, Cameroon; [Sobngwi-Tambekou, Joelle] Clinton Hlth Access Initiat, Yaounde, Cameroon; [Noubiap, Jean Jacques N.] Groote Schuur Hosp, Dept Med, ZA-7925 Cape Town, South Africa; [Noubiap, Jean Jacques N.] Univ Cape Town, ZA-7925 Cape Town, South Africa; [Noubiap, Jean Jacques N.] Med Diagnost Ctr, Yaounde, Cameroon; [Sobngwi, Eugene] Univ Yaounde I, Fac Med & Biomed Sci, Dept Internal Med & Specialties, Yaounde, Cameroon; [Sobngwi, Eugene] Univ Yaounde I, Lab Mol Med & Metab, Ctr Biotechnol, Yaounde, Cameroon; [Sobngwi, Eugene] Yaounde Cent Hosp, Natl Obes Ctr, Yaounde, Cameroon	University of Cape Town; University of Cape Town; University of Yaounde I; University of Yaounde I	Sobngwi-Tambekou, J (corresponding author), Minist Publ Hlth, Yaounde, Cameroon.	sobngwijoelle@gmail.com		Noubiap, Jean Jacques/0000-0002-7722-9757				Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X; Atkinson RL, 2005, OBESITY, P406; BROOKS AA, 1995, EARLY HUM DEV, V42, P29, DOI 10.1016/0378-3782(95)01637-I; Daniels SR, 2009, INT J OBESITY, V33, pS60, DOI 10.1038/ijo.2009.20; Onis M, 2006, ACTA PAEDIATR, V95, P7, DOI 10.1080/08035320500495407; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Dubois L, 2006, INT J OBESITY, V30, P610, DOI 10.1038/sj.ijo.0803141; Fatemeh Taheri, 2012, BMC Res Notes, V5, P529, DOI 10.1186/1756-0500-5-529; Flores G, 2013, AM J CLIN NUTR, V97, P1178, DOI 10.3945/ajcn.112.052019; Foster BA, 2015, ACAD PEDIATR, V15, P353, DOI 10.1016/j.acap.2015.04.037; Gupta N, 2012, ENDOCR REV, V33, P48, DOI 10.1210/er.2010-0028; Heppe DHM, 2013, PEDIATR RES, V73, P120, DOI 10.1038/pr.2012.145; Huus K, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-42; Institut National de la Statistique (INS) et ICF International, 2012, ENQ DEM SANT IND MUL; Josse J, 2012, J SFDS, V153, P79; Jouret B, 2007, AM J CLIN NUTR, V85, P1643, DOI 10.1093/ajcn/85.6.1643; Kitsantas P, 2010, EARLY HUM DEV, V86, P563, DOI 10.1016/j.earlhumdev.2010.07.006; Kramoh KE, 2012, ANN CARDIOL ANGEIOL, V61, P145, DOI 10.1016/j.ancard.2012.04.020; Kuhle S, 2010, INT J PEDIATR OBES, V5, P88, DOI 10.3109/17477160903060028; Li L, 2009, AM J CLIN NUTR, V89, P551, DOI 10.3945/ajcn.2008.26759; Link K, 2004, J CLIN ENDOCR METAB, V89, P5003, DOI 10.1210/jc.2004-0126; Lunde A, 2007, AM J EPIDEMIOL, V165, P734, DOI 10.1093/aje/kwk107; Manios Y, 2013, PEDIAT DIABETES; MEASURE DHS/ICF International USAID, 2013, DESCR DEM HLTH SURV; Moraeus L, 2012, INT J OBESITY, V36, P969, DOI 10.1038/ijo.2012.79; Mosli RH, 2015, PEDIAT OBES; Mushtaq MU, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-114; Must A, 1996, AM J CLIN NUTR, V63, P445, DOI 10.1093/ajcn/63.3.445; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; OMS, 2003, 894 OMS; OMS, 2013, GLOB DAT CHILD GROWT; Oreopoulos A, 2009, EUR HEART J, V30, P2584, DOI 10.1093/eurheartj/ehp288; Paciorek CJ, 2013, LANCET GLOB HEALTH, V1, pE300, DOI 10.1016/S2214-109X(13)70109-8; Pulgaron ER, 2013, CLIN THER, V35, pA18, DOI 10.1016/j.clinthera.2012.12.014; RAVELLI GP, 1979, AM J EPIDEMIOL, V109, P66, DOI 10.1093/oxfordjournals.aje.a112660; Reilly JJ, 2011, INT J OBESITY, V35, P891, DOI 10.1038/ijo.2010.222; Reilly JJ, 2005, BMJ-BRIT MED J, V330, P1357, DOI 10.1136/bmj.38470.670903.E0; Rooney BL, 2011, MATERN CHILD HLTH J, V15, P1166, DOI 10.1007/s10995-010-0689-1; Rustein S. O., 2004, 6 ORC MACR; Schellong K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047776; Seth A, 2013, INDIAN J PEDIATR, V80, P309, DOI 10.1007/s12098-012-0931-5; Shawky R.M., 2012, EGYPTIAN J MED HUMAN, V13, P11, DOI DOI 10.1016/J.EJMHG.2011.08.005; Singh GK, 2008, ANN EPIDEMIOL, V18, P682, DOI 10.1016/j.annepidem.2008.05.001; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Tabacchi G, 2007, NUTR RES, V27, P587, DOI 10.1016/j.nutres.2007.06.001; van Stralen MM, 2012, OBES REV, V13, P29, DOI 10.1111/j.1467-789X.2011.00959.x; World Health Organization, GLOB DAT CHILD GROWT; World Health Organization (WHO), 2008, TRAIN COURS CHILD GR	48	33	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143215	10.1371/journal.pone.0143215	http://dx.doi.org/10.1371/journal.pone.0143215			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636970	Green Published, gold, Green Submitted			2022-12-27	WOS:000366143800007
J	Ocelotl, J; Sanchez, J; Arroyo, R; Garcia-Gomez, BI; Gomez, I; Unnithan, GC; Tabashnik, BE; Bravo, A; Soberon, M				Ocelotl, Josue; Sanchez, Jorge; Arroyo, Raquel; Garcia-Gomez, Blanca I.; Gomez, Isabel; Unnithan, Gopalan C.; Tabashnik, Bruce E.; Bravo, Alejandra; Soberon, Mario			Binding and Oligomerization of Modified and Native Bt Toxins in Resistant and Susceptible Pink Bollworm	PLOS ONE			English	Article							BACILLUS-THURINGIENSIS TOXINS; BORDER MEMBRANE-VESICLES; FIELD-EVOLVED RESISTANCE; INSECT RESISTANCE; PORE FORMATION; MANDUCA-SEXTA; CRY1AC TOXIN; MECHANISM; CROPS; LEPIDOPTERA	Insecticidal proteins from Bacillus thuringiensis (Bt) are used extensively in sprays and transgenic crops for pest control, but their efficacy is reduced when pests evolve resistance. Better understanding of the mode of action of Bt toxins and the mechanisms of insect resistance is needed to enhance the durability of these important alternatives to conventional insecticides. Mode of action models agree that binding of Bt toxins to midgut proteins such as cadherin is essential for toxicity, but some details remain unresolved, such as the role of toxin oligomers. In this study, we evaluated how Bt toxin Cry1Ac and its genetically engineered counterpart Cry1AcMod interact with brush border membrane vesicles (BBMV) from resistant and susceptible larvae of Pectinophora gossypiella (pink bollworm), a global pest of cotton. Compared with Cry1Ac, Cry1AcMod lacks 56 amino acids at the amino-terminus including helix alpha-1; previous work showed that Cry1AcMod formed oligomers in vitro without cadherin and killed P. gossypiella larvae harboring cadherin mutations linked with > 1000-fold resistance to Cry1Ac. Here we found that resistance to Cry1Ac was associated with reduced oligomer formation and insertion. In contrast, Cry1AcMod formed oligomers in BBMV from resistant larvae. These results confirm the role of cadherin in oligomerization of Cry1Ac in susceptible larvae and imply that forming oligomers without cadherin promotes toxicity of Cry1AcMod against resistant P. gossypiella larvae that have cadherin mutations.	[Ocelotl, Josue; Sanchez, Jorge; Arroyo, Raquel; Garcia-Gomez, Blanca I.; Gomez, Isabel; Bravo, Alejandra; Soberon, Mario] Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca 62210, Morelos, Mexico; [Unnithan, Gopalan C.; Tabashnik, Bruce E.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA	Universidad Nacional Autonoma de Mexico; University of Arizona	Bravo, A (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Apdo Postal 510-3, Cuernavaca 62210, Morelos, Mexico.	bravo@ibt.unam.mx; mario@ibt.unam.mx	de la Parra, Maria Alejandra Bravo/R-6740-2017	Bravo, Alejandra/0000-0002-7573-7475	Consejo Nacional de Ciencia y Tecnologia MX [179977]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico [IN205411-3]; United States Departament of Agriculture, National Research Initiativ [2008-03980]	Consejo Nacional de Ciencia y Tecnologia MX; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); United States Departament of Agriculture, National Research Initiativ	This work was funded by Consejo Nacional de Ciencia y Tecnologia MX 179977; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico IN205411-3; and United States Departament of Agriculture, National Research Initiative 2008-03980. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adang MJ, 2014, ADV INSECT PHYSIOL, V47, P39, DOI 10.1016/B978-0-12-800197-4.00002-6; Arenas I, 2010, J BIOL CHEM, V285, P12497, DOI 10.1074/jbc.M109.085266; Chen WC, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/462929; Comas C, 2014, TRANSGENIC RES, V23, P135, DOI 10.1007/s11248-013-9737-0; Crickmore N, 2011, BACILLUS THURINGIENS; Farias JR, 2014, CROP PROT, V64, P150, DOI 10.1016/j.cropro.2014.06.019; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; Gahan LJ, 2001, SCIENCE, V293, P857, DOI 10.1126/science.1060949; Gassmann AJ, 2014, P NATL ACAD SCI USA, V111, P5141, DOI 10.1073/pnas.1317179111; Gomez I, 2002, FEBS LETT, V513, P242, DOI 10.1016/S0014-5793(02)02321-9; Gomez I, 2014, BIOCHEM J, V459, P383, DOI 10.1042/BJ20131408; Gonzalez-Cabrera J, 2003, INSECT BIOCHEM MOLEC, V33, P929, DOI 10.1016/S0965-1748(03)00099-7; Ihara H, 2008, J INVERTEBR PATHOL, V98, P177, DOI 10.1016/j.jip.2008.02.007; Janmaat AF, 2003, P ROY SOC B-BIOL SCI, V270, P2263, DOI 10.1098/rspb.2003.2497; Jimenez-Juarez N, 2007, J BIOL CHEM, V282, P21222, DOI 10.1074/jbc.M701314200; Li YP, 2012, J INTEGR AGR, V11, P1845, DOI 10.1016/S2095-3119(12)60189-0; Liu YB, 2001, J ECON ENTOMOL, V94, P1237, DOI 10.1603/0022-0493-94.5.1237; Mendelsohn M, 2003, NAT BIOTECHNOL, V21, P1003, DOI 10.1038/nbt0903-1003; Monnerat R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119544; Morin S, 2003, P NATL ACAD SCI USA, V100, P5004, DOI 10.1073/pnas.0831036100; Nicolia A, 2014, CRIT REV BIOTECHNOL, V34, P77, DOI 10.3109/07388551.2013.823595; Pacheco S, 2009, J BIOL CHEM, V284, P32750, DOI 10.1074/jbc.M109.024968; Peng DH, 2010, APPL MICROBIOL BIOT, V85, P1033, DOI 10.1007/s00253-009-2142-1; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Sanahuja G, 2011, PLANT BIOTECHNOL J, V9, P283, DOI 10.1111/j.1467-7652.2011.00595.x; Soberon M, 2007, SCIENCE, V318, P1640, DOI 10.1126/science.1146453; Tabashnik BE, 2000, P NATL ACAD SCI USA, V97, P12980, DOI 10.1073/pnas.97.24.12980; Tabashnik BE, 2003, J ECON ENTOMOL, V96, P1031, DOI 10.1603/0022-0493-96.4.1031; TABASHNIK BE, 1994, ANNU REV ENTOMOL, V39, P47, DOI 10.1146/annurev.en.39.010194.000403; Tabashnik BE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080496; Tabashnik BE, 2013, NAT BIOTECHNOL, V31, P510, DOI 10.1038/nbt.2597; Tabashnik BE, 2011, NAT BIOTECHNOL, V29, P1128, DOI 10.1038/nbt.1988; Vachon V, 2012, J INVERTEBR PATHOL, V111, P1, DOI 10.1016/j.jip.2012.05.001; WOLFERSBERGER MG, 1993, ARCH INSECT BIOCHEM, V24, P139, DOI 10.1002/arch.940240304; Wu YD, 2014, ADV INSECT PHYSIOL, V47, P297, DOI 10.1016/B978-0-12-800197-4.00006-3; Xiao YT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06184; Xu XJ, 2005, APPL ENVIRON MICROB, V71, P948, DOI 10.1128/AEM.71.2.948-954.2005; Zhang XB, 2006, P NATL ACAD SCI USA, V103, P9897, DOI 10.1073/pnas.0604017103	38	13	14	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144086	10.1371/journal.pone.0144086	http://dx.doi.org/10.1371/journal.pone.0144086			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633693	Green Published, Green Submitted, gold			2022-12-27	WOS:000366040000053
J	Sola-Campoy, PJ; Robles, F; Schwarzacher, T; Rejon, CR; de la Herran, R; Navajas-Perez, R				Sola-Campoy, Pedro J.; Robles, Francisca; Schwarzacher, Trude; Ruiz Rejon, Carmelo; de la Herran, Roberto; Navajas-Perez, Rafael			The Molecular Cytogenetic Characterization of Pistachio (Pistacia vera L.) Suggests the Arrest of Recombination in the Largest Heteropycnotic Pair HC1	PLOS ONE			English	Article							SATELLITE-DNA; SEX-CHROMOSOMES; REPETITIVE DNA; CENTROMERIC SATELLITE; NUCLEOTIDE-SEQUENCE; SILENE-LATIFOLIA; Y-CHROMOSOME; EVOLUTION; IDENTIFICATION; ORGANIZATION	This paper represents the first molecular cytogenetic characterization of the strictly dioecious pistachio tree (Pistacia vera L.). The karyotype was characterized by fluorescent in situ hybridization (FISH) with probes for 5S and 45S rDNAs, and the pistachio specific satellite DNAs PIVE-40, and PIVE-180, together with DAPI-staining. PIVE-180 has a monomeric unit of 176-178 bp and high sequence homology between family members; PIVE-40 has a 43 bp consensus monomeric unit, and is most likely arranged in higher order repeats (HORs) of two units. The P. vera genome is highly heterochromatic, and prominent DAPI positive blocks are detected in most chromosomes. Despite the difficulty in classifying chromosomes according to morphology, 10 out of 15 pairs (2n = 30) could be distinguished by their unique banding patterns using a combination of FISH probes. Significantly, the largest pair, designated HC1, is strongly heteropycnotic, shows differential condensation, and has massive enrichment in PIVE-40 repeats. There are two types of HC1 chromosomes (type-I and type-II) with differing PIVE-40 hybridization signal. Only type-I/II heterozygotes and type-I homozygotes individuals were found. We speculate that the differentiation between the two HC1 chromosomes is due to suppression of homologous recombination at meiosis, reinforced by the presence of PIVE-40 HORs and differences in PIVE-40 abundance. This would be compatible with a ZW sex-determination system in the pistachio tree.	[Sola-Campoy, Pedro J.; Robles, Francisca; Ruiz Rejon, Carmelo; de la Herran, Roberto; Navajas-Perez, Rafael] Univ Granada, Dept Genet, E-18071 Granada, Spain; [Schwarzacher, Trude] Univ Leicester, Dept Biol, Leicester LE1 7RH, Leics, England	University of Granada; University of Leicester	Navajas-Perez, R (corresponding author), Univ Granada, Dept Genet, Campus Fuentenueva S-N, E-18071 Granada, Spain.	rnavajas@ugr.es	Navajas-Pérez, Rafael/F-7122-2012; Rejón, Carmelo Ruiz/AAU-2107-2020; Robles Rodríguez, Francisca/K-3587-2014	Navajas-Pérez, Rafael/0000-0002-6147-3640; Robles Rodríguez, Francisca/0000-0003-1738-5325; De la Herran, Roberto/0000-0002-3772-4374; Schwarzacher, Trude/0000-0001-8310-5489	Ministerio de Ciencia e Innovacion of Spain [RYC-2011-08653, AGL2009-09094]	Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by the project AGL2009-09094. P.J.S.-C. is an FPI scholar and R. N.-P. a Ramon y Cajal senior postdoctoral researcher (RYC-2011-08653), all funded by Ministerio de Ciencia e Innovacion of Spain (http://www.idi.mineco.gob.es/portal/site/MICINN/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Saghir Mohannad G., 2010, Asian Journal of Plant Sciences, V9, P28; ALEXANDROV IA, 1988, CHROMOSOMA, V96, P443, DOI 10.1007/BF00303039; [Anonymous], PLANT TAXONOMY; Ashikawa I, 1994, DNA Res, V1, P67, DOI 10.1093/dnares/1.2.67; Ayaz E, 2009, NAT PROD RES, V23, P866, DOI 10.1080/14786410802263675; Bachtrog D, 2013, NAT REV GENET, V14, P113, DOI 10.1038/nrg3366; Bennett MD, 2012, ANGIOSPERM DNA C VAL; BLANCHETOT A, 1991, NUCLEIC ACIDS RES, V19, P929, DOI 10.1093/nar/19.4.929; Cermak T, 2008, CHROMOSOME RES, V16, P961, DOI 10.1007/s10577-008-1254-2; CHARLESWORTH B, 1978, AM NAT, V112, P975, DOI 10.1086/283342; Charlesworth B, 1996, CURR BIOL, V6, P149, DOI 10.1016/S0960-9822(02)00448-7; Charlesworth D, 2005, HEREDITY, V95, P118, DOI 10.1038/sj.hdy.6800697; Couceiro JF, 2013, CULTIVO PISTACHO; Cunado N, 2007, CHROMOSOME RES, V15, P825, DOI 10.1007/s10577-007-1166-6; Damasceno PC, 2010, CARYOLOGIA, V63, P229; de la Herran R, 2008, CYTOGENET GENOME RES, V121, P271, DOI 10.1159/000138896; De Souza Almeida CC, 2007, BOT J LINN SOC, V155, P541, DOI 10.1111/j.1095-8339.2007.00721.x; DEUMLING B, 1981, P NATL ACAD SCI-BIOL, V78, P338, DOI 10.1073/pnas.78.1.338; Divashuk MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085118; Fasihi Harandi O., 2001, Cahiers Options Mediterraneennes, V56, P35; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; GARRIDORAMOS MA, 1994, CYTOGENET CELL GENET, V65, P233, DOI 10.1159/000133637; GERLACH WL, 1980, NUCLEIC ACIDS RES, V8, P4851, DOI 10.1093/nar/8.21.4851; Ghaffari S. M., 2005, Options Mediterraneennes. Serie A, Seminaires Mediterraneens, P347; Ghaffari SM, 2002, ACTA HORTIC, P389, DOI 10.17660/ActaHortic.2002.591.59; Grabowska-Joachimiak A, 2011, CYTOGENET GENOME RES, V132, P203, DOI 10.1159/000321584; Heslop-Harrison JS, 2013, P NATL ACAD SCI USA, V110, P19974, DOI 10.1073/pnas.1319945110; Hobza R, 2006, CHROMOSOMA, V115, P376, DOI 10.1007/s00412-006-0065-5; Hobza R, 2015, CHROMOSOME RES, V23, P561, DOI 10.1007/s10577-015-9496-2; Hormaza JI, 1996, AM J BOT, V83, P759, DOI 10.2307/2445853; HORZ W, 1981, NUCLEIC ACIDS RES, V9, P683, DOI 10.1093/nar/9.3.683; Huang S. F., 1989, Acta Botanica Austro Sinica, P161; Ila HB, 2003, J HORTIC SCI BIOTECH, V78, P35; Kafkas S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1326-6; Kejnovsky E, 2009, HEREDITY, V102, P533, DOI 10.1038/hdy.2009.17; Kipling D, 1995, THE TELOMERE; Kuhn GCS, 2008, CHROMOSOME RES, V16, P307, DOI 10.1007/s10577-007-1195-1; Kumar S, 2014, J GENET, V93, P241, DOI 10.1007/s12041-014-0326-7; Lan T, 2006, CYTOGENET GENOME RES, V114, P175, DOI 10.1159/000093335; Lopez-Flores I, 2012, GENOME DYNAM, V7, P1, DOI 10.1159/000337118; Macas J, 2002, BIOINFORMATICS, V18, P28, DOI 10.1093/bioinformatics/18.1.28; Mahendran B, 2006, GENE, V370, P51, DOI 10.1016/j.gene.2005.11.010; Ming R, 2014, PLANT GENETICS GENOM, P225; Ming R, 2008, NATURE, V452, P991, DOI 10.1038/nature06856; Ming R, 2011, ANNU REV PLANT BIOL, V62, P485, DOI 10.1146/annurev-arplant-042110-103914; Nakayama S, 2001, CHROMOSOME RES, V9, P469, DOI 10.1023/A:1011676328165; Natarajan G, 1978, TAXON, V27, P519; Navajas-Perez R, 2005, J MOL EVOL, V60, P391, DOI 10.1007/s00239-004-0199-0; Navajas-Perez R, 2009, CYTOGENET GENOME RES, V124, P81, DOI 10.1159/000200091; Navajas-Perez R, 2009, GENETICA, V135, P87, DOI 10.1007/s10709-008-9261-y; Navajas-Perez R, 2007, BIOINFORMATICS, V23, P767, DOI 10.1093/bioinformatics/btm005; Navajas-Perez R, 2009, MOL GENET GENOMICS, V281, P579, DOI 10.1007/s00438-009-0433-y; Novak P, 2013, BIOINFORMATICS, V29, P792, DOI 10.1093/bioinformatics/btt054; Ozbek S, 1957, ANKARA U ZIRAAT FAKU, V3, P203; Pich U, 1996, CHROMOSOME RES, V4, P207, DOI 10.1007/BF02254961; Plohl M, 2012, GENOME DYNAM, V7, P126, DOI 10.1159/000337122; Pons J, 2003, HEREDITAS, V139, P28, DOI 10.1111/j.1601-5223.2003.01760.x; Renner SS, 2014, AM J BOT, V101, P1588, DOI 10.3732/ajb.1400196; Rozen S, 2000, Methods Mol Biol, V132, P365; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sandhu P.S., 1988, J CYTOLOGY GENETICS, V23, P219; Schueler MG, 2001, SCIENCE, V294, P109, DOI 10.1126/science.1065042; SCHWARZACHER T, 1989, ANN BOT-LONDON, V64, P315, DOI 10.1093/oxfordjournals.aob.a087847; Schwarzacher T, 2000, PRACTICAL SITU HYBRI, V2; Sola-Campoy PJ, 2012, NEW INSIGHTS PLANT S, P1; Sousa A, 2013, CYTOGENET GENOME RES, V139, P107, DOI 10.1159/000345370; Steflova P, 2013, GENOME BIOL EVOL, V5, P769, DOI 10.1093/gbe/evt049; Stratikopoulos EE, 2002, CHROMOSOME RES, V10, P287, DOI 10.1023/A:1016567624117; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tilkat EA, 2011, AUST J CROP SCI, V5, P288; Wang JP, 2012, P NATL ACAD SCI USA, V109, P13710, DOI 10.1073/pnas.1207833109; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; WRIGHT JM, 1989, NUCLEIC ACIDS RES, V17, P5071, DOI 10.1093/nar/17.13.5071; Yonemori K., 2010, Acta Horticulturae, P133; Zohary M., 1952, Palestine Journal of Botany (Jerusalem Series), V5, P187	75	8	8	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143861	10.1371/journal.pone.0143861	http://dx.doi.org/10.1371/journal.pone.0143861			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633808	Green Submitted, Green Published, gold			2022-12-27	WOS:000366040000026
J	Xie, YH; Tan, Y; Chongsuvivatwong, V; Wu, XH; Bi, FY; Hadler, SC; Jiraphongsa, C; Sornsrivichai, V; Lin, M; Quan, Y				Xie, Yihong; Tan, Yi; Chongsuvivatwong, Virasakdi; Wu, Xinghua; Bi, Fuyin; Hadler, Stephen C.; Jiraphongsa, Chuleeporn; Sornsrivichai, Vorasith; Lin, Mei; Quan, Yi			A Population-Based Acute Meningitis and Encephalitis Syndromes Surveillance in Guangxi, China, May 2007-June 2012	PLOS ONE			English	Article							BACTERIAL-MENINGITIS; CRYPTOCOCCAL MENINGITIS; CHILDREN; EPIDEMIOLOGY; DISEASE; VACCINATION; ELIMINATION; PROGRESS; ENGLAND; MEASLES	Objectives Acute meningitis and encephalitis (AME) are common diseases with the main pathogens being viruses and bacteria. As specific treatments are different, it is important to develop clinical prediction rules to distinguish aseptic from bacterial or fungal infection. In this study we evaluated the incidence rates, seasonal variety and the main etiologic agents of AME, and identified factors that could be used to predict the etiologic agents. Methods A population-based AME syndrome surveillance system was set up in Guigang City, Guangxi, involving 12 hospitals serving the study communities. All patients meeting the case definition were investigated. Blood and/or cerebrospinal fluid were tested for bacterial pathogens using culture or RT-PCR and serological tests for viruses using enzyme-linked immunosorbent assays. Laboratory testing variables were grouped using factor analysis. Multinomial logistic regression was used to predict the etiology of AME. Results From May 2007 to June 2012, the annual incidence rate of AME syndrome, and disease specifically caused by Japanese encephalitis (JE), other viruses, bacteria and fungi were 12.55, 0.58, 4.57, 0.45 and 0.14 per 100,000 population, respectively. The top three identified viral etiologic agents were enterovirus, mumps virus, and JE virus, and for bacteria/fungi were Streptococcus sp., Cryptococcus neoformans and Staphylococcus sp. The incidence of JE and other viruses affected younger populations and peaked from April to August. Alteration of consciousness and leukocytosis were more likely to be caused by JE, bacteria and fungi whereas CSF inflammation was associated with bacterial/fungal infection. Conclusions With limited predictive validity of symptoms and signs and routine laboratory tests, specific tests for JE virus, mumps virus and enteroviruses are required to evaluate the immunization impact and plan for further intervention. CSF bacterial culture cannot be omitted in guiding clinical decisions regarding patient treatment.	[Xie, Yihong; Tan, Yi; Wu, Xinghua; Bi, Fuyin; Lin, Mei; Quan, Yi] Guangxi Zhuang Autonomous Reg Ctr Dis Prevent & C, Acute Infect Dis Prevent & Control, Nanning, Guangxi, Peoples R China; [Chongsuvivatwong, Virasakdi; Sornsrivichai, Vorasith] Prince Songkla Univ, Epidemiol Unit, Fac Med, Hat Yai, Songkla, Thailand; [Hadler, Stephen C.] Ctr Dis Control & Prevent, Div Bacterial Dis, Atlanta, GA USA; [Jiraphongsa, Chuleeporn] Minist Publ Hlth, Bur Epidemiol, IFETP, Bangkok, Thailand	Prince of Songkla University; Centers for Disease Control & Prevention - USA; Ministry of Public Health - Thailand	Xie, YH (corresponding author), Guangxi Zhuang Autonomous Reg Ctr Dis Prevent & C, Acute Infect Dis Prevent & Control, Nanning, Guangxi, Peoples R China.	wallstreetxie@hotmail.com; cvirasak@gmail.com			AMES Surveillance project, Division of Global Disease Detection and Emergency Response, US CDC; China Ministry of Health and Youth Foundation of Guangxi [011GXNSFB018090]; Guangxi Science and Technology Bureau	AMES Surveillance project, Division of Global Disease Detection and Emergency Response, US CDC; China Ministry of Health and Youth Foundation of Guangxi; Guangxi Science and Technology Bureau	This study was supported by the AMES Surveillance project, Division of Global Disease Detection and Emergency Response, US CDC from 2007 to 2009, and was further supported by the China Ministry of Health and Youth Foundation of Guangxi (project ID: 011GXNSFB018090; http://kjxm.gxsti.net/), grant by Guangxi Science and Technology Bureau since 2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS WG, 1993, JAMA-J AM MED ASSOC, V269, P221, DOI 10.1001/jama.269.2.221; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Connolly K J, 1990, Infect Dis Clin North Am, V4, P599; Davison KL, 2003, ARCH DIS CHILD, V88, P662, DOI 10.1136/adc.88.8.662; Davison KL, 2003, EMERG INFECT DIS, V9, P234; Deng Xingchao, 2007, APPL PREV MED, V13, P33; Fuller DG, 2003, ANN TROP PAEDIATR, V23, P233, DOI 10.1179/027249303225007752; Glaser CA, 2003, CLIN INFECT DIS, V36, P731, DOI 10.1086/367841; Guangxi Zhuang Autonomous Region Statistic Bureau, 2008, GUANGX STAT YB; Guo JH, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-376; Hinson VK, 2001, CURR OPIN NEUROL, V14, P369, DOI 10.1097/00019052-200106000-00017; Jackson Lisa A., 1993, Morbidity and Mortality Weekly Report, V42, P21; Johnson RT, 1996, CLIN INFECT DIS, V23, P219, DOI 10.1093/clinids/23.2.219; Khayhan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072222; Kolski H, 1998, CLIN INFECT DIS, V26, P398, DOI 10.1086/516301; Lee TC, 2003, JPN J INFECT DIS, V56, P193; Li YX, 2014, EMERG INFECT DIS, V20, P61, DOI 10.3201/eid2001.120375; Lin MC, 2013, J MICROBIOL IMMUNOL; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Luksic I, 2013, CROAT MED J, V54, P510, DOI 10.3325/cmj.2013.54.510; Ma C, 2014, B WORLD HEALTH ORGAN, V92, P340, DOI 10.2471/BLT.13.130195; Ma C, 2011, J INFECT DIS, V204, pS447, DOI 10.1093/infdis/jir103; Namani SA, 2014, J INFECT DEV COUNTR, V8, P823, DOI 10.3855/jidc.3553; Novak RT, 2012, LANCET INFECT DIS, V12, P757, DOI 10.1016/S1473-3099(12)70168-8; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Ramakrishna C, 2013, FUTURE VIROL, V8, P259, DOI 10.2217/FVL.12.138; Ray P, 2007, AM J EMERG MED, V25, P179, DOI 10.1016/j.ajem.2006.07.012; Sandhu Hardeep S., 2012, Morbidity and Mortality Weekly Report, V61, P1008; Wall EC, 2014, CLIN INFECT DIS, V58, pE137, DOI 10.1093/cid/ciu057; Wang Meng, 2012, Disease Surveillance, V27, P435; WENGER JD, 1993, INFECT AGENT DIS, V2, P324; White K, 2012, DIAGN MICR INFEC DIS, V73, P27, DOI 10.1016/j.diagmicrobio.2012.02.010; Xiao Ge-xin, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P808; Yin ZD, 2010, AM J TROP MED HYG, V83, P766, DOI 10.4269/ajtmh.2010.09-0748; Zhu Q, 2011, BIOMED ENVIRON SCI, V24, P349, DOI 10.3967/0895-3988.2011.04.005	36	22	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144366	10.1371/journal.pone.0144366	http://dx.doi.org/10.1371/journal.pone.0144366			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633824	Green Published, gold			2022-12-27	WOS:000366040000082
J	Ming, X; Feng, YM; Liu, H; Zhang, Y; Zhou, L; Deng, J				Ming, Xin; Feng, Yuanming; Liu, Huan; Zhang, Ying; Zhou, Li; Deng, Jun			Cardiac Exposure in the Dynamic Conformal Arc Therapy, Intensity-Modulated Radiotherapy and Volumetric Modulated Arc Therapy of Lung Cancer	PLOS ONE			English	Article							BODY RADIATION-THERAPY; EARLY BREAST-CANCER; HEART-DISEASE; LONG-TERM; CARDIOVASCULAR-DISEASE; CHILDHOOD-CANCER; HODGKIN LYMPHOMA; RISK; MORTALITY; TOXICITY	Purpose To retrospectively evaluate the cardiac exposure in three cohorts of lung cancer patients treated with dynamic conformal arc therapy (DCAT), intensity-modulated radiotherapy (IMRT), or volumetric modulated arc therapy (VMAT) at our institution in the past seven years. Methods and Materials A total of 140 lung cancer patients were included in this institutional review board approved study: 25 treated with DCAT, 70 with IMRT and 45 with VMAT. All plans were generated in a same commercial treatment planning system and have been clinically accepted and delivered. The dose distribution to the heart and the effects of tumor laterality, the irradiated heart volume and the beam-to-heart distance on the cardiac exposure were investigated. Results The mean dose to the heart among all 140 plans was 4.5 Gy. Specifically, the heart received on average 2.3, 5.2 and 4.6 Gy in the DCAT, IMRT and VMAT plans, respectively. The mean heart doses for the left and right lung tumors were 4.1 and 4.8 Gy, respectively. No patients died with evidence of cardiac disease. Three patients (2%) with preexisting cardiac condition developed cardiac disease after treatment. Furthermore, the cardiac exposure was found to increase linearly with the irradiated heart volume while decreasing exponentially with the beam-to-heart distance. Conclusions Compared to old technologies for lung cancer treatment, modern radiotherapy treatment modalities demonstrated better heart sparing. But the heart dose in lung cancer radiotherapy is still higher than that in the radiotherapy of breast cancer and Hodgkin's disease where cardiac complications have been extensively studied. With strong correlations of mean heart dose with beam-to-heart distance and irradiated heart volume, cautions should be exercised to avoid long-term cardiac toxicity in the lung cancer patients undergoing radiotherapy.	[Ming, Xin; Feng, Yuanming; Zhang, Ying] Tianjin Univ, Dept Biomed Engn, Tianjin 300072, Peoples R China; [Ming, Xin; Zhang, Ying; Deng, Jun] Yale Univ, Dept Therapeut Radiol, New Haven, CT 06520 USA; [Liu, Huan; Deng, Jun] Yale New Haven Med Ctr, Dept Therapeut Radiol, New Haven, CT 06504 USA; [Zhou, Li] Sichuan Univ, West China Hosp, Ctr Canc, Ctr Radiat Phys & Technol, Chengdu 610064, Peoples R China	Tianjin University; Yale University; Yale University; Sichuan University	Deng, J (corresponding author), Yale Univ, Dept Therapeut Radiol, New Haven, CT 06520 USA.	jun.deng@yale.edu			Fellowship of China Scholarship Council [201206250086]	Fellowship of China Scholarship Council	This work was supported by the Fellowship of China Scholarship Council #201206250086.	Adams MJ, 2003, CRIT REV ONCOL HEMAT, V45, P55, DOI 10.1016/S1040-8428(01)00227-X; Aleman BMP, 2007, BLOOD, V109, P1878, DOI 10.1182/blood-2006-07-034405; American Cancer Society, 2015, CANC FACTS FIG 2015; Andratschke N, 2011, RADIOTHER ONCOL, V100, P160, DOI 10.1016/j.radonc.2010.08.010; Belliere A, 2009, CANCER RADIOTHER, V13, P298, DOI 10.1016/j.canrad.2009.04.004; Bezjak A, 2014, NRG ONCOLOGY RTOG 08; Borger JH, 2007, INT J RADIAT ONCOL, V69, P1131, DOI 10.1016/j.ijrobp.2007.04.042; Bradley J, 2014, RAD THERAPY ONCOLOGY; Brenner DJ, 2014, JAMA INTERN MED, V174, P158, DOI 10.1001/jamainternmed.2013.11790; Carr ZA, 2005, INT J RADIAT ONCOL, V61, P842, DOI 10.1016/j.ijrobp.2004.07.708; Castellino SM, 2011, BLOOD, V117, P1806, DOI 10.1182/blood-2010-04-278796; Chargari Cyrus, 2013, Presse Med, V42, pe342, DOI 10.1016/j.lpm.2013.06.012; Darby S, 2003, BRIT MED J, V326, P256, DOI 10.1136/bmj.326.7383.256; Darby SC, 2013, NEW ENGL J MED, V368, P987, DOI 10.1056/NEJMoa1209825; Darby SC, 2010, INT J RADIAT ONCOL, V76, P656, DOI 10.1016/j.ijrobp.2009.09.064; Darby SC, 2005, LANCET ONCOL, V6, P557, DOI 10.1016/S1470-2045(05)70251-5; Demirci S, 2009, INT J RADIAT ONCOL, V73, P980, DOI 10.1016/j.ijrobp.2008.11.016; Fakiris AJ, 2009, INT J RADIAT ONCOL, V75, P677, DOI 10.1016/j.ijrobp.2008.11.042; Gagliardi G, 2010, INT J RADIAT ONCOL, V76, pS77, DOI 10.1016/j.ijrobp.2009.04.093; Gai J, 2014, MED PHYS, V41, DOI [10.1118/1.4856175, DOI 10.1118/1.4856175]; Gayed I, 2009, INT J CARDIOVAS IMAG, V25, P487, DOI 10.1007/s10554-009-9440-7; Grills IS, 2003, INT J RADIAT ONCOL, V57, P875, DOI 10.1016/S0360-3016(03)00743-0; Hardy D, 2010, ANN ONCOL, V21, P1825, DOI 10.1093/annonc/mdq042; Holt A, 2011, INT J RADIAT ONCOL, V81, P1560, DOI 10.1016/j.ijrobp.2010.09.014; Hooning MJ, 2007, JNCI-J NATL CANCER I, V99, P365, DOI 10.1093/jnci/djk064; Jaworski C, 2013, J AM COLL CARDIOL, V61, P2319, DOI 10.1016/j.jacc.2013.01.090; Lally BE, 2007, CANCER-AM CANCER SOC, V110, P911, DOI 10.1002/cncr.22845; Lilenbaum R, 2008, RAD THERAPY ONCOLOGY; Little MP, 2012, INT J RADIAT ONCOL, V84, P1101, DOI 10.1016/j.ijrobp.2012.01.053; Marks LB, 2010, INT J RADIAT ONCOL, V76, pS10, DOI 10.1016/j.ijrobp.2009.07.1754; Martel MK, 1998, INT J RADIAT ONCOL, V40, P155, DOI 10.1016/S0360-3016(97)00584-1; McGale P, 2011, RADIOTHER ONCOL, V100, P167, DOI 10.1016/j.radonc.2011.06.016; Merrow CE, 2012, J APPL CLIN MED PHYS, V14, P4110; Mulrooney DA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4606; Prosnitz RG, 2005, SEMIN ONCOL, V32, pS71, DOI 10.1053/j.seminoncol.2005.03.013; Schytte T, 2010, ACTA ONCOL, V49, P1058, DOI 10.3109/0284186X.2010.504736; Steingart RM, 2013, SEMIN ONCOL, V40, P690, DOI 10.1053/j.seminoncol.2013.09.010; Swerdlow AJ, 2007, J NATL CANCER I, V99, P206, DOI 10.1093/jnci/djk029; Takeda A, 2009, INT J RADIAT ONCOL, V74, P363, DOI 10.1016/j.ijrobp.2008.08.012; Taylor CW, 2009, INT J RADIAT ONCOL, V73, P1061, DOI 10.1016/j.ijrobp.2008.05.066; Taylor CW, 2008, INT J RADIAT ONCOL, V72, P501, DOI 10.1016/j.ijrobp.2007.12.058; Taylor CW, 2007, INT J RADIAT ONCOL, V69, P1484, DOI 10.1016/j.ijrobp.2007.05.034; Taylor CW, 2011, RADIOTHER ONCOL, V100, P176, DOI 10.1016/j.radonc.2011.01.020; Timmerman R, 2010, JAMA-J AM MED ASSOC, V303, P1070, DOI 10.1001/jama.2010.261; Tukenova M, 2010, J CLIN ONCOL, V28, P1308, DOI 10.1200/JCO.2008.20.2267; Videtic GMM, 2012, NRG ONCOLOGY RTOG 09; Wei X, 2008, INT J RADIAT ONCOL, V70, P707, DOI 10.1016/j.ijrobp.2007.10.056	47	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144211	10.1371/journal.pone.0144211	http://dx.doi.org/10.1371/journal.pone.0144211			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630566	Green Submitted, Green Published, gold			2022-12-27	WOS:000365926300170
J	Loizides, C; Iacovides, D; Hadjiandreou, MM; Rizki, G; Achilleos, A; Strati, K; Mitsis, GD				Loizides, Charalambos; Iacovides, Demetris; Hadjiandreou, Marios M.; Rizki, Gizem; Achilleos, Achilleas; Strati, Katerina; Mitsis, Georgios D.			Model-Based Tumor Growth Dynamics and Therapy Response in a Mouse Model of De Novo Carcinogenesis	PLOS ONE			English	Article							SOLID TUMOR; CANCER; CHEMOTHERAPY; INFLAMMATION; GENE; E6	Tumorigenesis is a complex, multistep process that depends on numerous alterations within the cell and contribution from the surrounding stroma. The ability to model macroscopic tumor evolution with high fidelity may contribute to better predictive tools for designing tumor therapy in the clinic. However, attempts to model tumor growth have mainly been developed and validated using data from xenograft mouse models, which fail to capture important aspects of tumorigenesis including tumor-initiating events and interactions with the immune system. In the present study, we investigate tumor growth and therapy dynamics in a mouse model of de novo carcinogenesis that closely recapitulates tumor initiation, progression and maintenance in vivo. We show that the rate of tumor growth and the effects of therapy are highly variable and mouse specific using a Gompertz model to describe tumor growth and a two-compartment pharmacokinetic/pharmacodynamic model to describe the effects of therapy in mice treated with 5-FU. We show that inter-mouse growth variability is considerably larger than intra-mouse variability and that there is a correlation between tumor growth and drug kill rates. Our results show that in vivo tumor growth and regression in a double transgenic mouse model are highly variable both within and between subjects and that mathematical models can be used to capture the overall characteristics of this variability. In order for these models to become useful tools in the design of optimal therapy strategies and ultimately in clinical practice, a subject-specific modelling strategy is necessary, rather than approaches that are based on the average behavior of a given subject population which could provide erroneous results.	[Loizides, Charalambos; Hadjiandreou, Marios M.; Achilleos, Achilleas; Mitsis, Georgios D.] Univ Cyprus, Dept Elect & Elect Engn, CY-1678 Nicosia, Cyprus; [Loizides, Charalambos; Hadjiandreou, Marios M.; Achilleos, Achilleas; Mitsis, Georgios D.] Univ Cyprus, KIOS Res Ctr Intelligent Syst & Networks, CY-1678 Nicosia, Cyprus; [Iacovides, Demetris; Rizki, Gizem; Strati, Katerina] Univ Cyprus, Dept Biol Sci, CY-1678 Nicosia, Cyprus; [Rizki, Gizem] MIT, Dept Biol, Cambridge, MA USA; [Mitsis, Georgios D.] McGill Univ, Dept Bioengn, Montreal, PQ, Canada	University of Cyprus; University of Cyprus; University of Cyprus; Massachusetts Institute of Technology (MIT); McGill University	Strati, K (corresponding author), Univ Cyprus, Dept Biol Sci, CY-1678 Nicosia, Cyprus.	strati.katerina@ucy.ac.cy; georgios.mitsis@mcgill.ca	Strati, Katerina/GSN-2131-2022; Mitsis, Georgios D/AGY-4548-2022	Strati, Katerina/0000-0002-2332-787X; Mitsis, Georgios/0000-0001-9975-5128	European Territorial Cooperation Programmes; national funds of Greece and Cyprus	European Territorial Cooperation Programmes; national funds of Greece and Cyprus	This work is co-funded by the European Territorial Cooperation Programmes (80%) and by national funds of Greece and Cyprus (20%). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilleos A, 2014, ANN BIOMED ENG, V42, P1095, DOI 10.1007/s10439-014-0975-y; Agliari E, 2014, SCI REP-UK, V4, DOI 10.1038/srep06639; BALMAIN A, 1984, NATURE, V307, P658, DOI 10.1038/307658a0; Barbolosi D, 2001, COMPUT BIOL MED, V31, P157, DOI 10.1016/S0010-4825(00)00032-9; Benzekry S, 2014, ARXIV14061446; Blesch KS, 2003, INVEST NEW DRUG, V21, P195, DOI 10.1023/A:1023525513696; Bresch D, 2010, SIAM J SCI COMPUT, V32, P2321, DOI 10.1137/070708895; CHEN HSG, 1979, CANCER CHEMOTH PHARM, V2, P85; Clairambault J, 2009, MATH MODEL NAT PHENO, V4, P12, DOI 10.1051/mmnp/20094302; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; d'Onofrio A, 2004, MATH BIOSCI, V191, P159, DOI 10.1016/j.mbs.2004.06.003; de Pillis LG, 2001, J THEO MED, V24, P79, DOI [10.1080/10273660108833067, DOI 10.1080/10273660108833067]; DeVita VT, 1997, CANC PRINCIPLES PRAC; Doyle F, 2007, J PROCESS CONTR, V17, P571, DOI 10.1016/j.jprocont.2007.01.012; Dua P, 2008, COMPUT CHEM ENG, V32, P99, DOI 10.1016/j.compchemeng.2007.07.001; Duff G, 1966, AM J PHYS, V34, P1205; Gatenby RA, 2009, CANCER RES, V69, P4894, DOI 10.1158/0008-5472.CAN-08-3658; Glantz S., 1990, PRIMER APPL REGRESSI; Hadjiandreou MM, 2014, IEEE T BIO-MED ENG, V61, P415, DOI 10.1109/TBME.2013.2280189; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harrold JM, 2009, COMPUT CHEM ENG, V33, P2042, DOI 10.1016/j.compchemeng.2009.06.005; Hattori Y, 2009, J CONTROL RELEASE, V136, P30, DOI 10.1016/j.jconrel.2009.01.013; Kosmrlj A, 2008, P NATL ACAD SCI USA, V105, P16671, DOI 10.1073/pnas.0808081105; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Macklin P, 2012, J THEOR BIOL, V301, P122, DOI 10.1016/j.jtbi.2012.02.002; Malet-Martino M., 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P267; Mantovani A, 2005, NATURE, V435, P752, DOI 10.1038/435752a; Martin R. B., 1994, OPTIMAL CONTROL DRUG; MARTIN RB, 1992, AUTOMATICA, V28, P1113, DOI 10.1016/0005-1098(92)90054-J; Michael S, 2013, VIROLOGY, V443, P218, DOI 10.1016/j.virol.2013.04.008; MICHELSON S, 1987, CELL TISSUE KINET, V20, P343, DOI 10.1111/j.1365-2184.1987.tb01316.x; Moreira J, 2002, ADV COMPLEX SYST, V5, P247, DOI [10.1142/s0219525902000572, DOI 10.1142/S0219525902000572]; NORTON L, 1988, CANCER RES, V48, P7067; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Powathil G, 2014, SEMINARS CANC BIOL; Powathil GG, 2012, J THEOR BIOL, V308, P1, DOI 10.1016/j.jtbi.2012.05.015; Sakkalis V, 2014, IEEE J BIOMED HEALTH, V18, P824, DOI 10.1109/JBHI.2013.2297167; Simeoni M, 2004, CANCER RES, V64, P1094, DOI 10.1158/0008-5472.CAN-03-2524; Siolas D, 2013, CANCER RES, V73, P5315, DOI 10.1158/0008-5472.CAN-13-1069; SKIPPER H E, 1964, Cancer Chemother Rep, V35, P1; Song S, 2000, VIROLOGY, V267, P141, DOI 10.1006/viro.1999.0106; Song SY, 1999, J VIROL, V73, P5887, DOI 10.1128/JVI.73.7.5887-5893.1999; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Wang TT, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00358; Yu Sherry H, 2014, Adv Exp Med Biol, V810, P182; Zamboni WC, 2008, CANCER CHEMOTH PHARM, V62, P417, DOI 10.1007/s00280-007-0620-7	46	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0143840	10.1371/journal.pone.0143840	http://dx.doi.org/10.1371/journal.pone.0143840			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26649886	gold, Green Published, Green Submitted			2022-12-27	WOS:000366903300029
J	Gao, Y; Wei, S; Song, B; Qin, J; Fang, H; Ji, Y; Zhang, R; Sun, SL; Xu, YM				Gao, Yuan; Wei, Sen; Song, Bo; Qin, Jie; Fang, Hui; Ji, Yan; Zhang, Rui; Sun, Shilei; Xu, Yuming			Homocysteine Level Is Associated with White Matter Hyperintensity Locations in Patients with Acute Ischemic Stroke	PLOS ONE			English	Article							SIGNAL HYPERINTENSITIES; PLASMA HOMOCYSTEINE; RISK-FACTORS; BRAIN; LEUKOARAIOSIS; AGE; DETERMINANTS; MRI; VULNERABILITY; POPULATION	Background and Purpose The relationship between plasma level of total homocysteine (tHcy) and white matter hyper-intensities (WMHs), especially in patients with acute ischemic stroke (AIS), is controversial. The present study investigated the association between these two as well as WMH locations in a large cohort of patients with AIS. Methods Consecutive patients were reviewed from a prospective ischemic stroke database. Clinical data, including tHcy level and WMHs, were assessed. WMHs were assessed using the Fazekas scale and Age-Related White Matter Changes (ARWMC) visual grading scale. The association between tHcy and WMH locations was investigated by using multivariate logistic regression analyses. Results A total of 923 out of 1,205 patients were examined. The average age was 58.9 +/- 11.9 years; 31.6% were female. Elevated tHcy level was significantly associated with WMHs. For the highest tHcy quartile, the odds ratio (OR) (95% confidence interval; CI) was 1.891 (1.257; 2.843) according to the Fazekas scale and 1.781 (1.185; 2.767) according to the ARWMC scale when compared to the lowest quartile. However, in a subgroup analysis, only WMHs in the periventricular area and left or right frontal areas were found to be independently associated with tHcy level. For the highest tHcy quartile, the OR (95% CI) was 1.761 (1.172; 2.648) for the periventricular WMHs, 1.768 (1.134; 2.756) for the left frontal WMHs, and 1.890 (1.206; 2.960) for the right frontal WMHs. Conclusions In patients with AIS, plasma tHcy level is related to WMHs, especially WMHs distributed within the periventricular and frontal areas.	[Gao, Yuan; Wei, Sen; Song, Bo; Qin, Jie; Fang, Hui; Ji, Yan; Zhang, Rui; Sun, Shilei; Xu, Yuming] Zhengzhou Univ, Affiliated Hosp 1, Dept Neurol, Zhengzhou 450052, Henan, Peoples R China	Zhengzhou University	Xu, YM (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Neurol, Zhengzhou 450052, Henan, Peoples R China.	xuyuming@zzu.edu.cn		Wei, Sen/0000-0002-1831-6818; Gao, Yuan/0000-0003-2596-4773				Chou PS, 2015, INTERN MED J, V45, P390, DOI 10.1111/imj.12704; Eikelboom JW, 2000, STROKE, V31, P1069, DOI 10.1161/01.STR.31.5.1069; Erten-Lyons D, 2013, NEUROLOGY, V81, P977, DOI 10.1212/WNL.0b013e3182a43e45; Evers S, 1997, ARCH NEUROL-CHICAGO, V54, P1276, DOI 10.1001/archneur.1997.00550220074017; FAZEKAS F, 1993, NEUROLOGY, V43, P1683, DOI 10.1212/WNL.43.9.1683; FAZEKAS F, 1988, STROKE, V19, P1285, DOI 10.1161/01.STR.19.10.1285; Gouw AA, 2008, STROKE, V39, P1414, DOI 10.1161/STROKEAHA.107.498535; Hooshmand B, 2013, BRAIN, V136, P2707, DOI 10.1093/brain/awt206; Jacques PF, 2001, AM J CLIN NUTR, V73, P613; Kapeller P, 2003, STROKE, V34, P441, DOI 10.1161/01.STR.0000049766.26453.E9; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; OLSZEWSKI AJ, 1993, FREE RADICAL BIO MED, V14, P683, DOI 10.1016/0891-5849(93)90151-J; Pantoni L, 1997, STROKE, V28, P652, DOI 10.1161/01.STR.28.3.652; Payabvash S, 2011, STROKE, V42, P1255, DOI 10.1161/STROKEAHA.110.600940; Raz N, 2003, BEHAV NEUROSCI, V117, P1169, DOI 10.1037/0735-7044.117.6.1169; Raz N, 2012, BBA-MOL BASIS DIS, V1822, P361, DOI 10.1016/j.bbadis.2011.08.007; Sachdev P, 2004, ARCH NEUROL-CHICAGO, V61, P1369, DOI 10.1001/archneur.61.9.1369; SCHMIDT R, 1992, ARCH NEUROL-CHICAGO, V49, P825, DOI 10.1001/archneur.1992.00530320049011; SELHUB J, 1993, JAMA-J AM MED ASSOC, V270, P2693, DOI 10.1001/jama.270.22.2693; Seshadri S, 2002, NEW ENGL J MED, V346, P476, DOI 10.1056/NEJMoa011613; Seshadri S, 2008, ARCH NEUROL-CHICAGO, V65, P642, DOI 10.1001/archneur.65.5.642; Smith EE, 2011, NEUROLOGY, V76, P1492, DOI 10.1212/WNL.0b013e318217e7c8; Szolnoki Z, 2007, NEUROMOL MED, V9, P21, DOI 10.1385/NMM:9:1:21; Tran T., 2015, J SOUND VIB, V20, P1, DOI [10.1177/1077546315616522, DOI 10.1177/1077546315616522]; TSAI JC, 1994, P NATL ACAD SCI USA, V91, P6369, DOI 10.1073/pnas.91.14.6369; Tseng YL, 2009, J NEUROL SCI, V284, P36, DOI 10.1016/j.jns.2009.03.030; Valdes Hernandez MC, 2014, AM J NEURORADIOL, V35, P55, DOI [10.3174/ajnr.A3612, DOI 10.3174/AJNR.A3612]; Vermeer SE, 2002, ANN NEUROL, V51, P285, DOI 10.1002/ana.10111; Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318; WALDEMAR G, 1994, J NEUROL NEUROSUR PS, V57, P1458, DOI 10.1136/jnnp.57.12.1458; Yoshita M, 2006, NEUROLOGY, V67, P2192, DOI 10.1212/01.wnl.0000249119.95747.1f	31	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144431	10.1371/journal.pone.0144431	http://dx.doi.org/10.1371/journal.pone.0144431			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641086	Green Submitted, gold, Green Published			2022-12-27	WOS:000366902700120
J	Mahmoodian, R; Yahya, R; Dabbagh, A; Hamdi, M; Hassan, MA				Mahmoodian, Reza; Yahya, Rosiyah; Dabbagh, Ali; Hamdi, Mohd; Hassan, Mohsen A.			Investigation of Embedded Si/C System Exposed to a Hybrid Reaction of Centrifugal-Assisted Thermite Method	PLOS ONE			English	Article							HIGH-TEMPERATURE SYNTHESIS; SILICON-CARBIDE; COMBUSTION SYNTHESIS; PHASE; NITRIDE; COMPOSITES; CERAMICS; SHS	A novel method is proposed to study the behavior and phase formation of a Si+C compacted pellet under centrifugal acceleration in a hybrid reaction. Si+C as elemental mixture in the form of a pellet is embedded in a centrifugal tube. The pellet assembly and tube are exposed to the sudden thermal energy of a thermite reaction resulted in a hybrid reaction. The hybrid reaction of thermite and Si+C produced unique phases. X-ray diffraction pattern (XRD) as well as microstructural and elemental analyses are then investigated. XRD pattern showed formation of materials with possible electronic and magnetic properties. The cooling rate and the molten particle viscosity mathematical model of the process are meant to assist in understanding the physical and chemical phenomena took place during and after reaction. The results analysis revealed that up to 85% of materials converted into secondary products as ceramics-matrix composite.	[Mahmoodian, Reza; Dabbagh, Ali; Hamdi, Mohd; Hassan, Mohsen A.] Univ Malaya, Fac Engn, Dept Mech Engn, Ctr Adv Mfg & Mat Proc AMMP, Kuala Lumpur, Malaysia; [Yahya, Rosiyah] Univ Malaya, Dept Chem, Fac Sci, Kuala Lumpur, Malaysia; [Mahmoodian, Reza] Azarin Kar Ind Co, Dept Res & Dev, Kerman, Iran; [Hassan, Mohsen A.] Assiut Univ, Dept Mech Engn, Assiut, Egypt	Universiti Malaya; Universiti Malaya; Egyptian Knowledge Bank (EKB); Assiut University	Mahmoodian, R (corresponding author), Univ Malaya, Fac Engn, Dept Mech Engn, Ctr Adv Mfg & Mat Proc AMMP, Kuala Lumpur, Malaysia.	mahmoodian@um.edu.my	Dabbagh, A/F-9075-2014; yahya, rosiyah/B-9604-2010; Abd Shukor, Mohd Hamdi/B-9093-2010; Hassan, Mohsen A./J-9534-2012; Mahmoodian, Reza/C-7875-2009	Dabbagh, A/0000-0002-5940-8882; Abd Shukor, Mohd Hamdi/0000-0003-2123-3041; Hassan, Mohsen A./0000-0001-8599-7732; Mahmoodian, Reza/0000-0001-5426-7665	Ministry of Higher Education, Malaysia [HIR-MOHE-16001-00-D000001, BK064-2014, RG048/09AET]; Azarin Kar Ind. Co.	Ministry of Higher Education, Malaysia(Ministry of Education, Malaysia); Azarin Kar Ind. Co.	The authors would like to acknowledge the University of Malaya for providing the necessary facilities and resources for this research. This research was fully funded by the Ministry of Higher Education, Malaysia with the high impact research (HIR) grant number of HIR-MOHE-16001-00-D000001, BKP grant (BK064-2014), UMRG (RG048/09AET). The funders have paid for professional services (characterizations, equipment and consumable materials) while had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Author RM was employed by Azarin Kar Ind. Co. Author RM has not received any payment support from Azarin Kar Ind. Co. for this paper. The Azarin Kar Ind. Co. support was in form given space and using its equipment as courtesy. Azarin Kar Ind. Co. did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Balout B, 2012, J MATER ENG PERFORM, V21, P450, DOI 10.1007/s11665-011-9873-8; Brand M, 2008, NAT PROTOC, V3, P398, DOI 10.1038/nprot.2008.8; Burkes DE, 2006, J ENG MATER-T ASME, V128, P445, DOI 10.1115/1.2204950; Fan RH, 2006, THERMOCHIM ACTA, V440, P129, DOI 10.1016/j.tca.2005.10.020; Feng KQ, 2010, J ALLOY COMPD, V504, P277, DOI 10.1016/j.jallcom.2010.05.112; Feng PZ, 2012, ADV POWDER TECHNOL, V23, P133, DOI 10.1016/j.apt.2011.01.003; FERRO AC, 1995, ACTA METALL MATER, V43, P3061, DOI 10.1016/0956-7151(95)00014-M; Greco A, 2009, J MANUF SCI E-T ASME, V131, DOI 10.1115/1.4000418; Greenwood N.N., 1997, CHEM ELEMENTS; Hassan MA, 2015, SURF COAT TECH, V277, P216, DOI 10.1016/j.surfcoat.2015.07.061; Hassan MA, 2014, SCI REP-UK, V4, DOI 10.1038/srep03724; HILL RJ, 1987, J APPL CRYSTALLOGR, V20, P467, DOI 10.1107/S0021889887086199; Ho YH, 1996, ISIJ INT, V36, P1030, DOI 10.2355/isijinternational.36.1030; Jin HB, 2009, POWDER TECHNOL, V196, P229, DOI 10.1016/j.powtec.2009.07.016; Kappe CO, 2012, MOL DIVERS, V16, P5, DOI 10.1007/s11030-011-9346-x; Kim YY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5341; Kostic IG, 2011, HIGH TEMP MATER P-US, V15, P321; Ksandopulo GI, 2011, INT J SELF-PROPAG HI, V20, P220, DOI 10.3103/S1061386211040078; Kumar BVM, 2010, SCI TECHNOL ADV MAT, V11, DOI 10.1088/1468-6996/11/4/044303; Lee WC, 1997, J AM CERAM SOC, V80, P53, DOI 10.1111/j.1151-2916.1997.tb02790.x; Lin J, 2010, INT J REFRACT MET H, V28, P2, DOI 10.1016/j.ijrmhm.2009.07.012; Lu YJ, 2014, MAT SCI ENG A-STRUCT, V590, P368, DOI 10.1016/j.msea.2013.10.039; Mahmoodian R, 2013, JOM-US, V65, P80, DOI 10.1007/s11837-012-0498-7; Mahmoodian R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130836; Mahmoodian R, 2014, COMBUST SCI TECHNOL, V186, P737, DOI 10.1080/00102202.2013.878705; Mahmoodian R, 2014, COMPOS PART B-ENG, V59, P279, DOI 10.1016/j.compositesb.2013.12.016; Mahmoodian R, 2013, COMPOS PART B-ENG, V50, P187, DOI 10.1016/j.compositesb.2013.02.016; Mahmoodian R, 2012, HIGH TEMP MATER P-US, V16, P15, DOI 10.1615/HighTempMatProc.2012004708; Morsi K, 2012, J MATER SCI, V47, P68, DOI 10.1007/s10853-011-5926-5; Niu YR, 2011, CERAM INT, V37, P1675, DOI 10.1016/j.ceramint.2011.01.040; Odkhuu D, 2011, IEEE T MAGN, V47, P2920, DOI 10.1109/TMAG.2011.2154307; Park J, 2012, ELECTROCHEM SOLID ST, V15, pH148, DOI 10.1149/2.014205esl; Persson P, 2002, J MATER PROCESS TECH, V127, P131, DOI 10.1016/S0924-0136(02)00113-9; Rendtel A, 2008, HARDNESS HARDNESS DE; Rubtsov NM, 2010, THEOR FOUND CHEM EN+, V44, P458, DOI 10.1134/S0040579510040159; Ryu ZY, 2001, CARBON, V39, P1929, DOI 10.1016/S0008-6223(01)00153-1; Schubert U., 2005, SYNTHESIS INORGANIC; Schwetz KA, 2010, CERAMIC SCI TECHNOLO, V2, P131; Seo S-H, 2010, United States patent, Patent No. [US7767021 B2, 7767021]; Taylor JA, 2012, PROC MAT SCI, V1, P19, DOI 10.1016/j.mspro.2012.06.004; WASHBURN ME, 1988, AM CERAM SOC BULL, V67, P356; Woo MJ, 2006, J KOREAN PHYS SOC, V48, P1405; Yadhukulakrishnan GB, 2012, MAT SCI ENG A-STRUCT, V552, P125, DOI 10.1016/j.msea.2012.05.020; Yamamura K, 2011, CIRP ANN-MANUF TECHN, V60, P571, DOI 10.1016/j.cirp.2011.03.072; Yang H, 2012, CERAM INT, V38, P2213, DOI 10.1016/j.ceramint.2011.10.069; Yeh CL, 2011, J ALLOY COMPD, V509, P3257, DOI 10.1016/j.jallcom.2010.12.004; Young R.A, 1993, RIETVELD METHOD	47	0	0	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144632	10.1371/journal.pone.0144632	http://dx.doi.org/10.1371/journal.pone.0144632			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641651	gold, Green Published, Green Submitted			2022-12-27	WOS:000366902700150
J	Montrieux, H; Vanderlinde, R; Schellens, T; De Marez, L				Montrieux, Hannelore; Vanderlinde, Ruben; Schellens, Tammy; De Marez, Lieven			Teaching and Learning with Mobile Technology: A Qualitative Explorative Study about the Introduction of Tablet Devices in Secondary Education	PLOS ONE			English	Article							TEACHERS; ICT; ACCEPTANCE; CLASSROOM; STUDENTS; PERCEPTIONS; INTEGRATION; KNOWLEDGE; ATTITUDES; IPADS	This paper investigates teachers' and students' perceptions concerning the impact of using tablet devices for teaching and learning purposes. An explorative focus group study was conducted with teachers (n = 18) and students (n = 39) in a secondary school that has implemented tablet devices since 2012. The general finding of this study shows that the use of tablet devices in the classroom setting has an impact on both teaching and learning practices. The results suggest that teachers can be divided into two categories: the innovative teachers and the instrumental teachers. Innovative teachers attempt to shift from a teacher-centered to a learning-centered approach. They have changed their teaching style by transforming lessons in accordance with the advantages tablet computers can offer. Instrumental teachers seem to use the device as a 'book behind glass'. The distinction between the two groups has consequences for both the way courses are given and how students experience them. In general, the introduction of tablet devices entails a shift in the way students learn, as the devices provide interactive, media-rich, and exciting new environments. The results of this study indicate that policy makers should consider introducing technical and pedagogical support in order to facilitate both teachers' and students' understanding of the full potential of this kind of technology in education.	[Montrieux, Hannelore; Vanderlinde, Ruben; Schellens, Tammy] Univ Ghent, Dept Educ Studies, B-9000 Ghent, Belgium; [De Marez, Lieven] Univ Ghent, iMinds MICT Dept Commun Sci, B-9000 Ghent, Belgium	Ghent University; Ghent University; IMEC	Montrieux, H (corresponding author), Univ Ghent, Dept Educ Studies, B-9000 Ghent, Belgium.	Hannelore.Montrieux@UGent.be		Vanderlinde, Ruben/0000-0002-4912-3410; schellens, tammy/0000-0002-3615-7347; De Marez, Lieven/0000-0001-7716-4079				Albirini A, 2006, COMPUT EDUC, V47, P373, DOI 10.1016/j.compedu.2004.10.013; Becker H. J., 1999, Journal of Research on Computing in Education, V31, P356; Burden K., 2012, IPAD SCOTLAND EVALUA; Chen FH, 2009, J COMPUT ASSIST LEAR, V25, P470, DOI [10.1111/J.1365-2729.2009.00323.x, 10.1111/j.1365-2729.2009.00323.x]; Clark W., 2013, IPADS CLASSROOM; Clarke B, 2014, UPDATE LITERATURE RE; Corrin L., 2010, P 7 INT C NETWORKED, P643; Cumming TM, 2014, ACTION RES-LONDON, V12, P151, DOI 10.1177/1476750314525480; De Smet C, 2012, COMPUT EDUC, V58, P688, DOI 10.1016/j.compedu.2011.09.013; El-Gayar O, 2011, EDUC TECHNOL SOC, V14, P58; Falloon G, 2013, COMPUT EDUC, V68, P505, DOI 10.1016/j.compedu.2013.06.006; Figueiredo A. D., 2005, MANAGING LEARNING VI, P1; Fullan M, 2001, NEW MEANING ED CHANG; Gess-Newsome J, 2003, AM EDUC RES J, V40, P731, DOI 10.3102/00028312040003731; Ghaith G, 1997, TEACH TEACH EDUC, V13, P451, DOI 10.1016/S0742-051X(96)00045-5; Goodison T, 2002, BRIT J EDUC TECHNOL, V33, P215, DOI 10.1111/1467-8535.00255; Groff Jennifer, 2008, AACE Journal, V16, P21; Hattie J., 2013, VISIBLE LEARNING SYN; Hayes DNA, 2007, COMPUT EDUC, V49, P385, DOI 10.1016/j.compedu.2005.09.003; Heinrich P, 2012, IPAD TOOL ED CASE ST; Hermans R, 2008, COMPUT EDUC, V51, P1499, DOI 10.1016/j.compedu.2008.02.001; Hill JR, 2001, ETR&D-EDUC TECH RES, V49, P37, DOI 10.1007/BF02504914; Ifenthaler D, 2013, COMPUT HUM BEHAV, V29, P525, DOI 10.1016/j.chb.2012.11.004; Karsenti T., 2013, IPAD ED USES BENEFIT; Kim P, 2011, ETR&D-EDUC TECH RES, V59, P465, DOI 10.1007/s11423-010-9172-3; Koehler Matthew J., 2009, Contemporary Issues in Technology and Teacher Education, V9, P60; Kozma R., 2005, HUMAN TECHNOLOGY, V1, P117, DOI DOI 10.17011/HT/URN.201506212391; Krueger R.A., 2000, FOCUS GROUP DISCUSSI, V3; Krueger RA, 2009, FOCUS GROUPS PRACTIC; Lai HM, 2011, COMPUT EDUC, V56, P948, DOI 10.1016/j.compedu.2010.11.010; Linn MC, 1998, INT HDB SCI ED; MELHUISH K., 2010, COMPUTERS NZ SCH LEA, V22, P1; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Montrieux H, 2014, INT J MOB BLENDED LE, V6, P26, DOI 10.4018/ijmbl.2014040103; Niederhauser DS, 2001, TEACH TEACH EDUC, V17, P15, DOI 10.1016/S0742-051X(00)00036-6; OECD, 2015, STUD COMP LEARN MAK; Pelgrum WJ, 2001, COMPUT EDUC, V37, P163, DOI 10.1016/S0360-1315(01)00045-8; Puchta C., 2004, FOCUS GROUP PRACTICE; Pynoo B, 2012, COMPUT EDUC, V58, P1308, DOI 10.1016/j.compedu.2011.12.026; Rogers E.M., 1995, DIFFUSION INNOVATION; Rossing J., 2012, J SCHOLARSHIP TEACHI, V12, P1; Sandholtz Judith Haymore, 1997, TEACHING TECHNOLOGY; Stoddart T., 1993, Computers in the Schools, V9, P5, DOI 10.1300/J025v09n02_02; Strudler N, 2008, INT HDB INFORM TECHN, P579, DOI DOI 10.1007/978-0-387-73315-9_34; Tondeur J, 2008, COMPUT EDUC, V51, P212, DOI 10.1016/j.compedu.2007.05.003; Twining P., 2005, TABLET PCS SCH CASE; Vanderlinde R, 2011, THESIS; Vanderlinde R, 2011, EDUC TECHNOL SOC, V14, P124; Vanderlinde R, 2010, COMPUT EDUC, V55, P541, DOI 10.1016/j.compedu.2010.02.016; VANDUSEN LM, 1995, EDUC LEADERSHIP, V53, P28; Vaughn Sharon, 1996, FOCUS GROUP INTERVIE; Vogel D, 2001, J COMPUT ASSIST LEAR, V17, P104, DOI 10.1046/j.1365-2729.2001.00163.x; Welliver P, 1990, INSTRUCTIONAL TRANSF; Yelland N, 2006, EDUC MEDIA INT, V43, P121, DOI 10.1080/09523980500237922	54	70	76	3	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144008	10.1371/journal.pone.0144008	http://dx.doi.org/10.1371/journal.pone.0144008			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1YS	26641454	Green Published, Green Submitted, gold			2022-12-27	WOS:000366902700041
J	Mu, TH; Zhang, M; Raad, L; Sun, HN; Wang, C				Mu, Tai-Hua; Zhang, Miao; Raad, Leyla; Sun, Hong-Nan; Wang, Cheng			Effect of alpha-Amylase Degradation on Physicochemical Properties of Pre-High Hydrostatic Pressure-Treated Potato Starch	PLOS ONE			English	Article							DIFFERENTIAL SCANNING CALORIMETRY; ULTRA-HIGH PRESSURE; RHEOLOGICAL PROPERTIES; NATIVE STARCHES; GELATINIZATION; ACID; NANOPARTICLES; HYDROLYSIS; L.; GRANULES	The effect of high hydrostatic pressure (HHP) on the susceptibility of potato starch (25%, w/v) suspended in water to degradation by exposure to bacterial alpha-amylase (0.02%, 0.04% and 0.06%, w/v) for 40 min at 25 degrees C was investigated. Significant differences (p < 0.05) in the structure, morphology and physicochemical properties were observed. HHP-treated potato starch (PS) exposed to alpha-amylase (0.06%, w/v) showed a significantly greater degree of hydrolysis and amount of reducing sugar released compared to alpha-amylase at a concentration of 0.04% (w/v) or 0.02% (w/v). Native PS (NPS) granules have a spherical and elliptical form with a smooth surface, whereas the hydrolyzed NPS (hNPS) and hydrolyzed HHP-treated PS granules showed irregular and ruptured forms with several cracks and holes on the surface. Hydrolysis of HHP-treated PS by alpha-amylase could decrease the average granule size significantly (p < 0.05) from 29.43 to 20.03 mu m. Swelling power decreased and solubility increased with increasing enzyme concentration and increasing pressure from 200-600 MPa, with the exception of the solubility of HHP-treated PS at 600 MPa (HHP600 PS). Fourier transform infrared spectroscopy (FTIR) showed extensive degradation of the starch in both the ordered and the amorphous structure, especially in hydrolyzed HHP600 PS. The B-type of hydrolyzed HHP600 PS with alpha-amylase at a concentration 0.06% (w/v) changed to a B+V type with an additional peak at 2 theta = 19.36 degrees. The HHP600 starch with 0.06% (w/v) alpha-amylase displayed the lowest value of To (onset temperature), T-c (conclusion temperature) and Delta H-gel (enthalpies of gelatinization). These results indicate the pre-HHP treatment of NPS leads to increased susceptibility of the granules to enzymatic degradation and eventually changes of both the amorphous and the crystalline structures.	[Mu, Tai-Hua; Zhang, Miao; Raad, Leyla; Sun, Hong-Nan] Chinese Acad Agr Sci, Inst Agroprod Proc Sci & Technol, Beijing, Peoples R China; [Mu, Tai-Hua; Zhang, Miao; Raad, Leyla; Sun, Hong-Nan] Minist Agr, Key Lab Agroprod Proc, Beijing, Peoples R China; [Wang, Cheng] Xinjiang Acad Agr Sci, Inst Qual Stand & Testing Technol Agroprod, Xinjiang, Xinjiang Uygur, Peoples R China	Chinese Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Mu, TH (corresponding author), Chinese Acad Agr Sci, Inst Agroprod Proc Sci & Technol, Beijing, Peoples R China.	mutaihuacaas@126.com	ZHANG, MIAO/M-8080-2018	ZHANG, MIAO/0000-0003-3174-7994; Wang, Cheng/0000-0002-2497-3099; GUILBERT, Stephane/0000-0002-8964-670X	earmarked fund for China Agriculture Research System [CARS-11-B-19]	earmarked fund for China Agriculture Research System	This study was funded by the earmarked fund for China Agriculture Research System (CARS-11-B-19). The authors also thank the Fundamental Research budget incremental project of the Chinese Academy of Agricultural Sciences (2014ZL009).	Adzahan NM, 2002, THESIS, P222; [Anonymous], 1982, 3946 ISO EN; AOAC, 2000, OFF METH AN; Atichokudomchai N, 2002, STARCH-STARKE, V54, P343, DOI 10.1002/1521-379X(200208)54:8<343::AID-STAR343>3.0.CO;2-J; BILIADERIS CG, 1991, CAN J PHYSIOL PHARM, V69, P60, DOI 10.1139/y91-011; Biliaderis CG, 1998, POLYSACHARIDE ASS ST; Blaszczak W, 2005, CARBOHYD POLYM, V59, P377, DOI 10.1016/j.carbpol.2004.10.008; Chang YH, 2006, FOOD CHEM, V99, P794, DOI 10.1016/j.foodchem.2005.07.060; Cheftel J. C., 1992, HIGH PRESSURE BIOTEC; CROSBIE GB, 1991, J CEREAL SCI, V13, P145, DOI 10.1016/S0733-5210(09)80031-3; Dura A, 2014, CARBOHYD POLYM, V101, P837, DOI 10.1016/j.carbpol.2013.10.013; Fang JM, 2002, CARBOHYD POLYM, V47, P245, DOI 10.1016/S0144-8617(01)00187-4; FAO (Food and agriculture organization), 2012, FOOD AGR COMM PROD; FRANCO CML, 1992, STARCH-STARKE, V44, P422, DOI 10.1002/star.19920441106; FRENCH D, 1984, ORG STARCH GRANULES, P183; Fukami K., 2010, Journal of Applied Glycoscience, V57, P67, DOI 10.5458/jag.57.67; Gunaratne A, 2002, CARBOHYD POLYM, V49, P425, DOI 10.1016/S0144-8617(01)00354-X; Guo ZB, 2015, FOOD CHEM, V186, P223, DOI 10.1016/j.foodchem.2015.03.069; Hoover R., 2001, CURRENT PROTOCOLS FO, DOI DOI 10.1002/0471142913.FAE0203S00; Jiang QQ, 2011, FOOD HYDROCOLLOID, V25, P521, DOI 10.1016/j.foodhyd.2010.08.003; Kaur B, 2011, FOOD HYDROCOLLOIDS; Kaur L, 2002, FOOD CHEM, V79, P183, DOI 10.1016/S0308-8146(02)00130-9; Kaur M, 2004, FOOD CHEM, V85, P131, DOI 10.1016/j.foodchem.2003.06.013; Kawai K, 2007, CARBOHYD POLYM, V69, P590, DOI 10.1016/j.carbpol.2007.01.015; KRUEGER BR, 1987, J FOOD SCI, V52, P715, DOI 10.1111/j.1365-2621.1987.tb06709.x; Li WH, 2011, J FOOD ENG, V103, P388, DOI 10.1016/j.jfoodeng.2010.11.008; Liu YT, 2008, J FOOD ENG, V88, P126, DOI 10.1016/j.jfoodeng.2008.02.001; Madesn MH, 1996, STARCH, V48, P245; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Molina-Garcia A. D., 2007, MODERN RES ED TOPICS, P719; Oh HE, 2008, CARBOHYD POLYM, V73, P332, DOI 10.1016/j.carbpol.2007.11.038; Peshin A, 2001, J FOOD SCI TECH MYS, V38, P447; Reddy CK, 2014, FOOD CHEM, V155, P38, DOI 10.1016/j.foodchem.2014.01.023; Rubens P, 1999, CARBOHYD POLYM, V39, P231, DOI 10.1016/S0144-8617(99)00005-3; Sevenou O, 2002, INT J BIOL MACROMOL, V31, P79, DOI 10.1016/S0141-8130(02)00067-3; Shi AM, 2012, CARBOHYD POLYM, V88, P1334, DOI 10.1016/j.carbpol.2012.02.013; Srichuwong S, 2005, INT J BIOL MACROMOL, V37, P115, DOI 10.1016/j.ijbiomac.2005.09.006; Sun QJ, 2014, CARBOHYD POLYM, V111, P133, DOI 10.1016/j.carbpol.2014.03.094; Sun QJ, 2014, FOOD CHEM, V162, P223, DOI 10.1016/j.foodchem.2014.04.068; Tester RF, 2006, ANIM FEED SCI TECH, V130, P39, DOI 10.1016/j.anifeedsci.2006.01.016; Uthumporn U, 2012, APPL BIOCHEM BIOTECH, V166, P1167, DOI 10.1007/s12010-011-9502-x; Vallons KJR, 2009, EUR FOOD RES TECHNOL, V230, P343, DOI 10.1007/s00217-009-1172-3; Vasanthan T, 1999, FOOD RES INT, V32, P355, DOI 10.1016/S0963-9969(99)00096-4; Waigh TA, 2000, CARBOHYD RES, V328, P165, DOI 10.1016/S0008-6215(00)00098-7; Yaldagard M, 2008, AFR J BIOTECHNOL, V7, P2739; Yusuph M, 2003, FOOD CHEM, V82, P283, DOI 10.1016/S0308-8146(02)00549-6	46	21	23	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0143620	10.1371/journal.pone.0143620	http://dx.doi.org/10.1371/journal.pone.0143620			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642044	gold, Green Published, Green Submitted			2022-12-27	WOS:000366902700026
J	Ocampo-Penuela, N; Pimm, SL				Ocampo-Penuela, Natalia; Pimm, Stuart L.			Elevational Ranges of Montane Birds and Deforestation in the Western Andes of Colombia	PLOS ONE			English	Article							RAIN-FOREST BIRDS; CLIMATE-CHANGE; CONSERVATION; BIODIVERSITY; RESPONSES; FRAGMENTATION; EXTINCTIONS; SHIFTS; BIOGEOGRAPHY; COMMUNITIES	Deforestation causes habitat loss, fragmentation, degradation, and can ultimately cause extinction of the remnant species. Tropical montane birds face these threats with the added natural vulnerability of narrower elevational ranges and higher specialization than lowland species. Recent studies assess the impact of present and future global climate change on species' ranges, but only a few of these evaluate the potentially confounding effect of lowland deforestation on species elevational distributions. In the Western Andes of Colombia, an important biodiversity hotspot, we evaluated the effects of deforestation on the elevational ranges of montane birds along altitudinal transects. Using point counts and mist-nets, we surveyed six altitudinal transects spanning 2200 to 2800m. Three transects were forested from 2200 to 2800m, and three were partially deforested with forest cover only above 2400m. We compared abundance-weighted mean elevation, minimum elevation, and elevational range width. In addition to analysing the effect of deforestation on 134 species, we tested its impact within trophic guilds and habitat preference groups. Abundance-weighted mean and minimum elevations were not significantly different between forested and partially deforested transects. Range width was marginally different: as expected, ranges were larger in forested transects. Species in different trophic guilds and habitat preference categories showed different trends. These results suggest that deforestation may affect species' elevational ranges, even within the forest that remains. Climate change will likely exacerbate harmful impacts of deforestation on species' elevational distributions. Future conservation strategies need to account for this by protecting connected forest tracts across a wide range of elevations.	[Ocampo-Penuela, Natalia; Pimm, Stuart L.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA	Duke University	Ocampo-Penuela, N (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.	no19@duke.edu	Ocampo-Peñuela, Natalia/X-2458-2019; pimm, stuart/ABF-1082-2020	Ocampo-Peñuela, Natalia/0000-0002-5120-7226; 	National Science Foundation Doctoral Dissertation Improvement Grant [1434281]; Rufford Foundation [14204-1]; Explorer's Club Exploration Fund Grant; Ideawild; Duke University Graduate School Dissertation Research Travel Award: International; Duke Center for Latin American and Caribbean Studies Graduate Student Research Awards for Research in Latin America and the Caribbean	National Science Foundation Doctoral Dissertation Improvement Grant(National Science Foundation (NSF)); Rufford Foundation; Explorer's Club Exploration Fund Grant; Ideawild; Duke University Graduate School Dissertation Research Travel Award: International; Duke Center for Latin American and Caribbean Studies Graduate Student Research Awards for Research in Latin America and the Caribbean	This work was supported by National Science Foundation Doctoral Dissertation Improvement Grant #1434281 (https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5234), the Rufford Foundation Small grants programme #14204-1 (http://www.rufford.org/), the Explorer's Club Exploration Fund Grant (https://explorers.org/expeditions/funding/expedition_grants), Ideawild (http://www.ideawild.org/), Duke University Graduate School Dissertation Research Travel Award: International (https://gradschool.duke.edu/financial-support/find-funding/dissertation-research-travel-award-international), and Duke Center for Latin American and Caribbean Studies Graduate Student Research Awards for Research in Latin America and the Caribbean (http://latinamericancaribbean.duke.edu/funding/graduate-funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DL, 2006, AM NAT, V167, P216, DOI 10.1086/498622; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Becker A, 2007, MT RES DEV, V27, P58, DOI 10.1659/0276-4741(2007)27[58:EALUSA]2.0.CO;2; Bibby C., 1993, BIRD CENSUS TECHNIQU; BirdLife International, 2014, IUCN RED LIST BIRDS; Blackburn TM, 1996, PHILOS T R SOC B, V351, P897, DOI 10.1098/rstb.1996.0083; Bohning-Gaese K, 2004, ADV ECOL RES, V35, P211, DOI 10.1016/S0065-2504(04)35010-5; Bohorquez Clara Isabel, 2003, Ornitologia Neotropical, V14, P67; BRASH AR, 1987, BIOL CONSERV, V39, P97, DOI 10.1016/0006-3207(87)90028-0; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Brooks TM, 1999, CONSERV BIOL, V13, P1140, DOI 10.1046/j.1523-1739.1999.98341.x; Brooks TM, 1999, J ANIM ECOL, V68, P1061, DOI 10.1046/j.1365-2656.1999.00353.x; Buckland S.T., 2001, pi; Canaday C, 1996, BIOL CONSERV, V77, P63, DOI 10.1016/0006-3207(95)00115-8; Channell R, 2000, NATURE, V403, P84, DOI 10.1038/47487; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Cuervo Andres M., 2003, Bulletin of the British Ornithologists' Club, V123, P7; del Hoyo J., 2015, HDB BIRDS WORLD ALIV; Dixo M, 2009, BIOL CONSERV, V142, P1560, DOI 10.1016/j.biocon.2008.11.016; Forero-Medina G, 2011, CONSERV BIOL, V25, P163, DOI 10.1111/j.1523-1739.2010.01572.x; Forero-Medina G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013210; Fundacion Colibri, 2015, INV FAUN FLOR RES NA; Haddad NM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500052; Hadley AS, 2009, BIOL LETTERS, V5, P207, DOI 10.1098/rsbl.2008.0691; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Harris GM, 2005, CONSERV BIOL, V19, P1957, DOI 10.1111/j.1523-1739.2005.00307.x; Hilty SL, 1986, GUIDE BIRDS COLOMBIA; Jankowski JE, 2010, ECOLOGY, V91, P1877, DOI 10.1890/09-2063.1; Jenkins CN, 2013, P NATL ACAD SCI USA, V110, pE2602, DOI 10.1073/pnas.1302251110; Jenkins CN, 2011, NAT CONSERVACAO, V9, P152, DOI 10.4322/natcon.2011.021; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Kattan GH, 2004, J BIOGEOGR, V31, P1829, DOI 10.1111/j.1365-2699.2004.01109.x; KATTAN GH, 1994, CONSERV BIOL, V8, P138, DOI 10.1046/j.1523-1739.1994.08010138.x; Krosby M, 2010, CONSERV BIOL, V24, P1686, DOI 10.1111/j.1523-1739.2010.01585.x; La Sorte Frank A, 2010, Proc Biol Sci, V277, P3401, DOI 10.1098/rspb.2010.0612; Laurance SGW, 2004, ECOL APPL, V14, P1344, DOI 10.1890/03-5194; Laurance WF, 1999, BIOL CONSERV, V91, P109, DOI 10.1016/S0006-3207(99)00088-9; Laurance WF, 2011, BIOL CONSERV, V144, P56, DOI 10.1016/j.biocon.2010.09.021; Laurance WF, 2011, BIOL CONSERV, V144, P548, DOI 10.1016/j.biocon.2010.10.010; Lee TM, 2005, BIOL CONSERV, V122, P193, DOI 10.1016/j.biocon.2004.07.005; LOISELLE BA, 1992, BIOSCIENCE, V42, P838, DOI 10.2307/1312083; Manne LL, 2001, ANIM CONSERV, V4, P221, DOI 10.1017/S1367943001001263; Moore RP, 2008, ECOL LETT, V11, P960, DOI 10.1111/j.1461-0248.2008.01196.x; Moura NG, 2013, BIOL CONSERV, V167, P339, DOI 10.1016/j.biocon.2013.08.023; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; O'Dea N, 2007, BIODIVERS CONSERV, V16, P1131, DOI 10.1007/s10531-006-9095-9; Ocampo-Penuela N, 2014, CONSERV BIOL, V28, P1260, DOI 10.1111/cobi.12312; Orme CDL, 2006, PLOS BIOL, V4, P1276, DOI 10.1371/journal.pbio.0040208; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Peh KSH, 2007, CONDOR, V109, P437, DOI 10.1650/0010-5422(2007)109[437:PEOCCO]2.0.CO;2; Pimm SL, 2005, SCI AM, V293, P66, DOI 10.1038/scientificamerican0905-66; Popy S, 2010, J BIOGEOGR, V37, P57, DOI 10.1111/j.1365-2699.2009.02197.x; Powell George V. N., 1994, Bird Conservation International, V4, P161; Powell GVN, 2004, CONSERV BIOL, V18, P500, DOI 10.1111/j.1523-1739.2004.00044.x; R Core Team, 2015, R LANG ENV STAT COMP; Ralph CJ, 1993, HDB FIELD METHODS MO; Renjifo LM, 2001, ECOL APPL, V11, P14, DOI 10.1890/1051-0761(2001)011[0014:EONAAL]2.0.CO;2; Renjifo Luis Miguel, 1997, Ornithological Monographs, V48, P577; Restrepo C, 1998, ECOL APPL, V8, P170, DOI 10.1890/1051-0761(1998)008[0170:ROUBTA]2.0.CO;2; Ribon R, 2003, CONSERV BIOL, V17, P1827, DOI 10.1111/j.1523-1739.2003.00377.x; Robbins MB, 1999, AUK, V116, P305, DOI 10.2307/4089365; ROBINSON SK, 1995, SCIENCE, V267, P1987, DOI 10.1126/science.267.5206.1987; Rodriguez JP, 2002, ECOL APPL, V12, P238; Rosselli Loreta, 1994, Bird Conservation International, V4, P143; Sekercioglu CH, 2008, CONSERV BIOL, V22, P140, DOI 10.1111/j.1523-1739.2007.00852.x; Sekercioglu CH, 2012, BIOL CONSERV, V148, P1, DOI 10.1016/j.biocon.2011.10.019; Shoo LP, 2005, BIOL CONSERV, V125, P335, DOI 10.1016/j.biocon.2005.04.003; Sodhi NS, 2004, ANNU REV ECOL EVOL S, V35, P323, DOI 10.1146/annurev.ecolsys.35.112202.130209; Stiles FG, 2014, SPECIES LISTS BIRDS; Travis JMJ, 2003, P ROY SOC B-BIOL SCI, V270, P467, DOI 10.1098/rspb.2002.2246; Turner IM, 1996, J APPL ECOL, V33, P200, DOI 10.2307/2404743; Velasquez-Tibata J, 2013, REG ENVIRON CHANGE, V13, P235, DOI 10.1007/s10113-012-0329-y; Villard MA, 1999, CONSERV BIOL, V13, P774, DOI 10.1046/j.1523-1739.1999.98059.x; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054; White RL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121849; WILCOVE DS, 1985, ECOLOGY, V66, P1211, DOI 10.2307/1939174	76	8	11	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0143311	10.1371/journal.pone.0143311	http://dx.doi.org/10.1371/journal.pone.0143311			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641477	Green Submitted, Green Published, gold			2022-12-27	WOS:000366902700014
J	Srivastava, R; Patnaik, R; Shukla, UK; Sahni, A				Srivastava, Rahul; Patnaik, Rajeev; Shukla, U. K.; Sahni, Ashok			Crocodilian Nest in a Late Cretaceous Sauropod Hatchery from the Type Lameta Ghat Locality, Jabalpur, India	PLOS ONE			English	Article							SNOUTED DYROSAURID CROCODYLIFORMES; EGGS; PALEOCENE; EGGSHELLS; EOCENE; BEDS; MESOEUCROCODYLIA; CROCODYLOMORPHA; TRANSITION; MOROCCO	The well-known Late Cretaceous Lameta Ghat locality (Jabalpur, India) provides a window of opportunity to study a large stable, near shore sandy beach, which was widely used by sauropod dinosaurs as a hatchery. In this paper, we revisit the eggs and eggshell fragments previously assigned to lizards from this locality and reassign them to crocodylomorphs. Several features point to a crocodilian affinity, including a subspherical to ellipsoidal shape, smooth, uneven external surface, discrete trapezoid shaped shell units with wide top and narrow base, basal knobs and wedge shaped crystallites showing typical inverted triangular extinction under crossed nicols. The crocodylomorph eggshellmaterial presented in this paper adds to the skeletal data of these most probably Cretaceous-Eocene dryosaurid crocodiles.	[Patnaik, Rajeev; Sahni, Ashok] Panjab Univ, Ctr Adv Study Geol, Chandigarh 160014, India; [Shukla, U. K.] Banaras Hindu Univ, Dept Geol, Varanasi 221006, Uttar Pradesh, India	Panjab University; Banaras Hindu University (BHU)	Srivastava, R (corresponding author), 361-2 Tikait Rai LDA Colony, Lucknow 226017, Uttar Pradesh, India.	rsrivastava@hotmail.com	Shukla, Uma Kant/AAC-2357-2020	Shukla, Uma Kant/0000-0001-5607-0700				Barbosa JA, 2008, P ROY SOC B-BIOL SCI, V275, P1385, DOI 10.1098/rspb.2008.0110; Brochu CA, 2002, J PALEONTOL, V76, P1060, DOI 10.1666/0022-3360(2002)076<1060:ADCBFM>2.0.CO;2; BROOKFIELD M E, 1987, Cretaceous Research, V8, P1, DOI 10.1016/0195-6671(87)90008-5; BUFFETAUT E, 1977, CR ACAD SCI D NAT, V285, P869; Buffetaut E., 1978, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V156, P262; Buffetaut E., 1978, NEUES JB GEOLOGIE PA, V5, P273; Buscalioni Angela D., 2003, Coloquios de Paleontologia Volumen Extraordinario, V1, P77; COURTILLOT V, 1986, EARTH PLANET SC LETT, V80, P361, DOI 10.1016/0012-821X(86)90118-4; FERGUSON M W J, 1982, Transactions of the Zoological Society of London, V36, P99; Fernandez MS, 2015, HIST BIOL, V27, P158, DOI 10.1080/08912963.2013.871718; Garcia G., 2000, GEOBIOS, V33, P114; Grellet-Tinner G, 2006, CAN J EARTH SCI, V43, P705, DOI 10.1139/E06-033; Hastings A, 2007, J VERTEBR PALEONTOL, V27, p87A; Hirsch K.F., 1992, Journal of Vertebrate Paleontology, V12, P59; Hirsch KF, 1996, J VERTEBR PALEONTOL, V16, P752, DOI 10.1080/02724634.1996.10011363; HIRSCH KF, 1985, J PALEONTOL, V59, P531; Jackson FD, 2010, J VERTEBR PALEONTOL, V30, P1142, DOI 10.1080/02724634.2010.483537; Jin XS, 2010, J VERTEBR PALEONTOL, V30, P188, DOI 10.1080/02724630903409279; Jouve S, 2005, PALAEONTOLOGY, V48, P359, DOI 10.1111/j.1475-4983.2005.00442.x; Jouve S, 2008, PALAEONTOLOGY, V51, P281, DOI 10.1111/j.1475-4983.2007.00747.x; Jouve S, 2006, ZOOL J LINN SOC-LOND, V148, P603, DOI 10.1111/j.1096-3642.2006.00241.x; Keller G, 2009, EARTH PLANET SC LETT, V282, P10, DOI 10.1016/j.epsl.2009.02.016; Khosla A, 2003, J ASIAN EARTH SCI, V21, P895, DOI 10.1016/S1367-9120(02)00092-5; Khosla A, 2014, ACTA GEOL POL, V64, P311, DOI 10.2478/agp-2014-0016; Khosla A, 2009, J VERTEBR PALEONTOL, V29, P1321, DOI 10.1671/039.029.0416; Khosla Subhash Chandar, 2011, Revista Espanola de Micropaleontologia, V43, P209; Kohring R, 1996, J VERTEBR PALEONTOL, V16, P67, DOI 10.1080/02724634.1996.10011285; Marzola M, 2015, HIST BIOL, V27, P115, DOI 10.1080/08912963.2013.871009; MIKHAILOV K E, 1991, Acta Palaeontologica Polonica, V36, P193; Mikhailov K.E., 1997, SP PAP PALAEONTOL, V56; Mikhailov KE, 1996, J VERTEBR PALEONTOL, V16, P763, DOI 10.1080/02724634.1996.10011364; Mohabey D.M., 1996, GEOL SOC AM MEM, V37, P363; Mohabey DM, 2005, GONDWANA GEOL MAG SP, V8, P37; Moreno-Azanza M, 2014, HIST BIOL, V26, P195, DOI 10.1080/08912963.2013.786067; Panades I Blas Xavier, 2009, PalArch's Journal of Vertebrate Palaeontology, V6, P1; Patnaik Rajeev, 1993, Mitteilungen der Bayerischen Staatssammlung fuer Palaeontologie und Historische Geologie, V33, P91; Prasad Guntupalli V.R., 2002, Annales de Paleontologie, V88, P19, DOI 10.1016/S0753-3969(02)01036-4; Rana Rajendra Singh, 2000, Journal of the Palaeontological Society of India, V45, P123; RANA RS, 1987, CURR SCI INDIA, V56, P532; Saha O, 2010, J GEOL SOC INDIA, V76, P607, DOI 10.1007/s12594-010-0121-x; Sahni Ashok, 1994, P204; Schleich H. H., 1988, REPTILE EGGSHELLS SE; Schwarz D, 2006, PALAEONTOLOGY, V49, P695, DOI 10.1111/j.1475-4983.2006.00563.x; Shukla UK, 2008, CRETACEOUS RES, V29, P674, DOI 10.1016/j.cretres.2008.02.003; Singh SD, 1998, OFFENTLICHUNGEN FUHL, V4, P307; Fernandez MS, 2013, NATURWISSENSCHAFTEN, V100, P451, DOI 10.1007/s00114-013-1044-3; STORRS G W, 1986, Postilla, P1; Tandon SK, 2001, SEDIMENTOLOGY, V48, P339, DOI 10.1046/j.1365-3091.2001.00367.x; TANDON SK, 1995, PALAEOGEOGR PALAEOCL, V117, P153, DOI 10.1016/0031-0182(94)00128-U; Wilson Jeffrey A., 2001, Contributions from the Museum of Paleontology University of Michigan, V30, P321	50	10	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144369	10.1371/journal.pone.0144369	http://dx.doi.org/10.1371/journal.pone.0144369			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641665	Green Published, gold			2022-12-27	WOS:000366902700105
J	Wang, HZ; Chu, ZZ; Chen, CC; Cao, AC; Tong, X; Ouyang, CB; Yuan, QH; Wang, MN; Wu, ZK; Wang, HH; Wang, SB				Wang, Hua-zhen; Chu, Zhi-zhan; Chen, Chang-chao; Cao, Ao-cheng; Tong, Xin; Ouyang, Can-bin; Yuan, Qi-hang; Wang, Mi-nan; Wu, Zhong-kun; Wang, Hai-hong; Wang, Sheng-bin			Recombinant Passenger Proteins Can Be Conveniently Purified by One-Step Affinity Chromatography	PLOS ONE			English	Article							ETCH VIRUS PROTEASE; ESCHERICHIA-COLI; TEV PROTEASE; FUSION PARTNERS; EXPRESSION; PURIFICATION; VECTORS; TAGS; CONSTRUCTION; SOLUBILITY	Fusion tag is one of the best available tools to date for enhancement of the solubility or improvement of the expression level of recombinant proteins in Escherichia coli. Typically, two consecutive affinity purification steps are often necessitated for the purification of passenger proteins. As a fusion tag, acyl carrier protein (ACP) could greatly increase the soluble expression level of Glucokinase (GlcK), alpha-Amylase (Amy) and GFP. When fusion protein ACP-G2-GlcK-Histag and ACP-G2-Amy-Histag, in which a protease TEV recognition site was inserted between the fusion tag and passenger protein, were coexpressed with protease TEV respectively in E. coli, the efficient intracellular processing of fusion proteins was achieved. The resulting passenger protein GlcK-Histag and Amy-Histag accumulated predominantly in a soluble form, and could be conveniently purified by one-step Nichelating chromatography. However, the fusion protein ACP-GFP-Histag was processed incompletely by the protease TEV coexpressed in vivo, and a large portion of the resulting target protein GFP-Histag aggregated in insoluble form, indicating that the intracellular processing may affect the solubility of cleaved passenger protein. In this context, the soluble fusion protein ACP-GFP-Histag, contained in the supernatant of E. coli cell lysate, was directly subjected to cleavage in vitro by mixing it with the clarified cell lysate of E. coli over-expressing protease TEV. Consequently, the resulting target protein GFP-Histag could accumulate predominantly in a soluble form, and be purified conveniently by one-step Ni-chelating chromatography. The approaches presented here greatly simplify the purification process of passenger proteins, and eliminate the use of large amounts of pure site-specific proteases.	[Wang, Hua-zhen; Chu, Zhi-zhan; Chen, Chang-chao; Tong, Xin; Yuan, Qi-hang; Wang, Mi-nan; Wu, Zhong-kun; Wang, Hai-hong; Wang, Sheng-bin] South China Agr Univ, Coll Life Sci, Guangzhou 541642, Guangdong, Peoples R China; [Wang, Hua-zhen; Chu, Zhi-zhan; Chen, Chang-chao; Tong, Xin; Yuan, Qi-hang; Wang, Mi-nan; Wu, Zhong-kun; Wang, Hai-hong; Wang, Sheng-bin] Guangdong Prov Key Lab Prot Funct & Regulat Agr O, Guangzhou 541642, Guangdong, Peoples R China; [Cao, Ao-cheng; Ouyang, Can-bin] Chinese Acad Agr Sci, Inst Plant Protect, Dept Pesticides, Minist Agr, Beijing 100193, Peoples R China; [Cao, Ao-cheng; Ouyang, Can-bin] State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China	South China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Ministry of Agriculture & Rural Affairs	Wang, SB (corresponding author), South China Agr Univ, Coll Life Sci, Guangzhou 541642, Guangdong, Peoples R China.	swwl@scau.edu.cn		wang, huazhen/0000-0002-4875-1829	Special Nonprofit Agricultural Industrial Research Fund of China [201103027]	Special Nonprofit Agricultural Industrial Research Fund of China	This work was supported by Special Nonprofit Agricultural Industrial Research Fund of China (201103027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Special Nonprofit Agricultural Industrial Research Fund of China (201103027).	BARTOLOME B, 1991, GENE, V102, P75, DOI 10.1016/0378-1119(91)90541-I; Berlec A, 2013, J IND MICROBIOL BIOT, V40, P257, DOI 10.1007/s10295-013-1235-0; Bird LE, 2011, METHODS, V55, P29, DOI 10.1016/j.ymeth.2011.08.002; Blommel PG, 2007, PROTEIN EXPRES PURIF, V55, P53, DOI 10.1016/j.pep.2007.04.013; Rodriguez VB, 2006, BIOTECHNOL PROGR, V22, P718, DOI 10.1021/bp060057a; Costa S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00063; Cronan JE, 2009, METHOD ENZYMOL, V459, P395, DOI 10.1016/S0076-6879(09)04617-5; Demain AL, 2009, BIOTECHNOL ADV, V27, P297, DOI 10.1016/j.biotechadv.2009.01.008; Douette P, 2005, BIOCHEM BIOPH RES CO, V333, P686, DOI 10.1016/j.bbrc.2005.05.164; Eisenmesser EZ, 2000, PROTEIN EXPRES PURIF, V20, P186, DOI 10.1006/prep.2000.1283; Esposito D, 2006, CURR OPIN BIOTECH, V17, P353, DOI 10.1016/j.copbio.2006.06.003; Fernandes Pedro, 2010, Enzyme Res, V2010, P862537, DOI 10.4061/2010/862537; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Kapust RB, 2000, PROTEIN EXPRES PURIF, V19, P312, DOI 10.1006/prep.2000.1251; Kuo WHK, 2011, BIOTECHNOL LETT, V33, P1075, DOI 10.1007/s10529-011-0554-3; Li YF, 2011, PROTEIN EXPRES PURIF, V80, P260, DOI 10.1016/j.pep.2011.08.001; Li YF, 2011, BIOTECHNOL LETT, V33, P869, DOI 10.1007/s10529-011-0533-8; Lucast LJ, 2001, BIOTECHNIQUES, V30, P544, DOI 10.2144/01303st06; Nallamsetty S, 2006, PROTEIN EXPRES PURIF, V45, P175, DOI 10.1016/j.pep.2005.06.012; Pacheco B, 2012, PROTEIN EXPRES PURIF, V81, P33, DOI 10.1016/j.pep.2011.08.030; Pal M, 2009, DRUG DISCOV TODAY, V14, P784, DOI 10.1016/j.drudis.2009.05.013; Phan J, 2002, J BIOL CHEM, V277, P50564, DOI 10.1074/jbc.M207224200; Shih YP, 2005, PROTEIN SCI, V14, P936, DOI 10.1110/ps.041129605; Su Y, 2007, J BIOTECHNOL, V129, P373, DOI 10.1016/j.jbiotec.2007.01.015; Sun CS, 2012, PROTEIN EXPRES PURIF, V82, P226, DOI 10.1016/j.pep.2012.01.005; Tropea Joseph E., 2009, V498, P297, DOI 10.1007/978-1-59745-196-3_19; Waugh DS, 2011, PROTEIN EXPRES PURIF, V80, P283, DOI 10.1016/j.pep.2011.08.005; Young CL, 2012, BIOTECHNOL J, V7, P620, DOI 10.1002/biot.201100155	28	3	3	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0143598	10.1371/journal.pone.0143598	http://dx.doi.org/10.1371/journal.pone.0143598			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641240	Green Submitted, gold, Green Published			2022-12-27	WOS:000366902700022
J	Oruko, K; Nyothach, E; Zielinski-Gutierrez, E; Mason, L; Alexander, K; Vulule, J; Laserson, KF; Phillips-Howard, PA				Oruko, Kelvin; Nyothach, Elizabeth; Zielinski-Gutierrez, Emily; Mason, Linda; Alexander, Kelly; Vulule, John; Laserson, Kayla F.; Phillips-Howard, Penelope A.			'He is the one who is providing you with everything so whatever he says is what you do': A Qualitative Study on Factors Affecting Secondary Schoolgirls' Dropout in Rural Western Kenya	PLOS ONE			English	Article							CASH TRANSFER PROGRAM; GENDER-DIFFERENCES; SEXUAL-BEHAVIOR; PREMARITAL SEX; ADOLESCENTS; HIV; COUNTRIES; ECONOMICS; EDUCATION; PEOPLE	Education is an effective way to improve girls' self-worth, health, and productivity; however there remains a gender gap between girls' and boys' completion of school. The literature around factors influencing girls' decision to stay in school is limited. Seven focus group discussions took place among 79 girls in forms 2 to 4 at secondary schools in rural western Kenya, to examine their views on why girls absent themselves or dropout from school. Data were analysed thematically. Lack of resources, sexual relationships with boyfriends, and menstrual care problems were reported to lead directly to dropout or school absence. These were tied to girls increased vulnerability to pregnancy, poor performance in school, and punishments, which further increase school absence and risk of dropout. Poverty, unmet essential needs, coercive sexual relationships, and an inequitable school environment collude to counter girls' resolve to complete their schooling. Lack of resources drive girls to have sex with boyfriends or men who provide them with essentials their family cannot afford, such as sanitary pads and transport to school. While these improve quality of their school life, this dynamic increases their exposure to sexual risk, pregnancy, punishment, and dropout. Evaluation of interventions to ameliorate these challenges is warranted, including provision of pocket money to address their needs.	[Oruko, Kelvin; Nyothach, Elizabeth; Vulule, John; Phillips-Howard, Penelope A.] Ctr Global Hlth Res, Kenya Med Res Inst KEMRI, Kisumu, Kenya; [Zielinski-Gutierrez, Emily; Laserson, Kayla F.] Ctr Dis Control & Prevent, Ctr Global Hlth, Atlanta, GA USA; [Mason, Linda; Alexander, Kelly; Phillips-Howard, Penelope A.] Univ Liverpool Liverpool Sch Trop Med, Dept Clin Studies, Liverpool, Merseyside, England	Kenya Medical Research Institute; Centers for Disease Control & Prevention - USA; Liverpool School of Tropical Medicine	Phillips-Howard, PA (corresponding author), Ctr Global Hlth Res, Kenya Med Res Inst KEMRI, Kisumu, Kenya.	Penelope.Phillips-Howard@lstmed.ac.uk		Phillips-Howard, Penelope A/0000-0003-1018-116X; Nyothach, Elizabeth/0000-0003-0904-9081	United Kingdom Joint Global Health Trials [G1100677/1]; MRC [G1100677] Funding Source: UKRI; Medical Research Council [G1100677] Funding Source: researchfish	United Kingdom Joint Global Health Trials; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded through the United Kingdom Joint Global Health Trials (grant number G1100677/1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuya B, 2014, DETERMINANTS ED EXCL, V44, P381; Abuya B, 2013, COMPARE, V43, P740, DOI 10.1080/03057925.2012.707458; Alexander KT, 2014, WATER-SUI, V6, P1453, DOI 10.3390/w6051453; Alika IH, 2009, EDO J COUNSELLING, V2; [Anonymous], 2011, ACCESS QUALITY KENYA; Baird S, 2014, J DEV EFFECT, V6, P1, DOI 10.1080/19439342.2014.890362; Baird S, 2010, HEALTH ECON, V19, P55, DOI 10.1002/hec.1569; Baird SJ, 2012, LANCET, V379, P1320, DOI 10.1016/S0140-6736(11)61709-1; Beegle K, 2005, WHY SHOULD WE CARE C; Beguy D, 2013, J BIOSOC SCI, V45, P721, DOI 10.1017/S0021932013000199; Biddlecom A, 2008, STUD FAMILY PLANN, V39, P337, DOI 10.1111/j.1728-4465.2008.00179.x; Bundy D, 2011, RETHINKING SCH HLTH; Chaaban J, 2011, MEASURING EC GAIN IN, P5753; Chemwei B, 2013, J ED PRACTICE, V4, P1; Cohen David William, 1989, SIAYA HISTORICAL ANT; Grant M., 2006, PREGNANCY RELATED SC; Hargreaves JR, 2008, J EPIDEMIOL COMMUN H, V62, P113, DOI 10.1136/jech.2006.053827; Herz Barbara, 2004, WHAT WORKS GIRLS ED; Humphrey KW., 2013, J EMERGING TRENDS EC, V4, P253; Jukes M, 2008, AIDS, V22, pS41, DOI 10.1097/01.aids.0000341776.71253.04; Kaufman CE, 2004, CULT HEALTH SEX, V6, P377, DOI 10.1080/13691050410001680492; Kenya national Bureau of statistics (KNBS) and ICF macro, 2010, KEN DEM HLTH SURV 20; Kirby D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2054; Lees S, 2009, CULT HEALTH SEX, V11, P581, DOI 10.1080/13691050902721846; Lloyd CB, 2008, J RES ADOLESCENCE, V18, P99, DOI 10.1111/j.1532-7795.2008.00552.x; Lloyd CB, 2008, POP STUD-J DEMOG, V62, P1, DOI 10.1080/00324720701810840; Loaiza E., 2013, ADOLESCENT PREGNANCY; Lucas A, 2011, DOES FREE PRIMARY ED; Maganja RK, 2007, AIDS CARE, V19, P974, DOI 10.1080/09540120701294286; Mason L., 2015, Waterlines, V34, P15, DOI 10.3362/1756-3488.2015.003; Mason L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079132; McMahon SA, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-7; Meekers D, 1997, Health Transit Rev, V7 Suppl, P361; Meltzer MI, 2003, AM J TROP MED HYG, V68, P149, DOI 10.4269/ajtmh.2003.68.149; Mensch BS, 1998, STUD FAMILY PLANN, V29, P167, DOI 10.2307/172157; Mensch BS, 2001, STUD FAMILY PLANN, V32, P285, DOI 10.1111/j.1728-4465.2001.00285.x; Moore Ann M, 2007, Afr J Reprod Health, V11, P44, DOI 10.2307/25549731; Moswela B, 2012, INT J BUSINESS SOCIA, V3; Njoroge J, 2012, INT J CURRENT RES, V4, P160; Nobelius AM, 2010, J SEX RES, V47, P490, DOI 10.1080/00224499.2010.494776; Odhiambo FO, 2012, INT J EPIDEMIOL, V41, P977, DOI 10.1093/ije/dys108; One_Girl, 2010, PROJ 8 SIERR LEON GI; Phillips-Howard PA, 2015, J WOMENS HEALTH, V24, P801, DOI 10.1089/jwh.2014.5031; Rihani A, 2006, KEEPING PROMISE 5 BE; Rumberger R.W., 2008, WHY STUDENTS DROP OU; Sekiwunga Richard, 2009, Afr J Reprod Health, V13, P113; Sommer M, 2010, J ADOLESCENCE, V33, P521, DOI 10.1016/j.adolescence.2009.03.008; Uche RD., 2013, J ED PRACTICE, V4, P25; UNESCO, 2005, EFA GLOB MON REP; UNESCO, 2011, REG OV SUBS AFR; UNESCO, 2012, ED 1 IN UN SECR GEN; UNICEF, 2012, GLOB LIF SKILLS ED E; UWESO, 2012, AR OUR CHILDR LEARN; Wamoyi J, 2011, ARCH SEX BEHAV, V40, P5, DOI 10.1007/s10508-010-9646-8	54	30	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144321	10.1371/journal.pone.0144321	http://dx.doi.org/10.1371/journal.pone.0144321			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY1CH	26636771	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000366143800076
J	Escott-Price, V; Kirov, G; Rees, E; Isles, AR; Owen, MJ; O'Donovan, MC				Escott-Price, Valentina; Kirov, George; Rees, Elliott; Isles, Anthony R.; Owen, Michael J.; O'Donovan, Michael C.			No Evidence for Enrichment in Schizophrenia for Common Allelic Associations at Imprinted Loci	PLOS ONE			English	Article							PARENT; GENES; TWIN	Most genetic studies assume that the function of a genetic variant is independent of the parent from which it is inherited, but this is not always true. The best known example of parent-of-origin effects arises with respect to alleles at imprinted loci. In classical imprinting, characteristically, either the maternal or paternal copy is expressed, but not both. Only alleles present in one of the parental copies of the gene, the expressed copy, is likely to contribute to disease. It has been postulated that imprinting is important in central nervous system development, and that consequently, imprinted loci may be involved in schizophrenia. If this is true, allowing for parent-of-origin effects might be important in genetic studies of schizophrenia. Here, we use genome-wide association data from one of the world's largest samples (N = 695) of parent schizophrenia-offspring trios to test for parent-of-origin effects. To maximise power, we restricted our analyses to test two main hypotheses. If imprinting plays a disproportionate role in schizophrenia susceptibility, we postulated a) that alleles showing robust evidence for association to schizophrenia from previous genome-wide association studies should be enriched for parent-of-origin effects and b) that genes at loci imprinted in humans or mice should be enriched both for genome-wide significant associations, and in our sample, for parent-of-origin effects. Neither prediction was supported in the present study. We have shown, that it is unlikely that parent-of-origin effects or imprinting play particularly important roles in schizophrenia, although our findings do not exclude such effects at specific loci nor do they exclude such effects among rare alleles.	[Escott-Price, Valentina; Kirov, George; Rees, Elliott; Isles, Anthony R.; Owen, Michael J.; O'Donovan, Michael C.] Cardiff Univ, MRC Ctr Neuropsychiat Genet & Genom, Cardiff CF10 3AX, S Glam, Wales	Cardiff University	Escott-Price, V (corresponding author), Cardiff Univ, MRC Ctr Neuropsychiat Genet & Genom, Cardiff CF10 3AX, S Glam, Wales.	EscottPriceV@cf.ac.uk	O'Donovan, Michael C/P-7005-2018	O'Donovan, Michael C/0000-0001-7073-2379; Escott-Price, Valentina/0000-0003-1784-5483; Isles, Anthony/0000-0002-7587-5712; Rees, Elliott/0000-0002-6168-9222	Medical Research Council (MRC) [G0800509, G0801418]; Stanley Medical Research Institute; Merck Genome Research Foundation; Herman Foundation; Janssen Research Foundation; Medical Research Council [G0801418, G0800509, MR/L023784/2, MR/L010305/1] Funding Source: researchfish; MRC [MR/L023784/2, G0800509, G0801418] Funding Source: UKRI	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Stanley Medical Research Institute; Merck Genome Research Foundation; Herman Foundation; Janssen Research Foundation(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (MRC) Centre Grant G0800509 and Program Grant G0801418. Genotyping was funded by multiple grants to the Stanley Center for Psychiatric Research at the Broad Institute from the Stanley Medical Research Institute, The Merck Genome Research Foundation and the Herman Foundation. Funding for recruitment was provided by the Janssen Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cardno AG, 2000, AM J MED GENET, V97, P12, DOI 10.1002/(SICI)1096-8628(200021)97:1<12::AID-AJMG3>3.3.CO;2-L; Chamberlain SJ, 2010, NEUROBIOL DIS, V39, P13, DOI 10.1016/j.nbd.2010.03.011; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Guilmatre A, 2012, CLIN GENET, V81, P201, DOI 10.1111/j.1399-0004.2011.01790.x; Ingason A, 2011, AM J PSYCHIAT, V168, P408, DOI 10.1176/appi.ajp.2010.09111660; Kirov G, 2012, MOL PSYCHIATR, V17, P142, DOI 10.1038/mp.2011.154; Lawson HA, 2013, NAT REV GENET, V14, P608, DOI 10.1038/nrg3543; Luedi PP, 2007, GENOME RES, V17, P1723, DOI 10.1101/gr.6584707; MURRAY RM, 1987, BRIT MED J, V295, P681, DOI 10.1136/bmj.295.6600.681; Niemitz E., 2014, NAT GENET, V46, P219; Owen MJ, 2011, BRIT J PSYCHIAT, V198, P173, DOI 10.1192/bjp.bp.110.084384; Rees E, 2014, BRIT J PSYCHIAT, V204, P108, DOI 10.1192/bjp.bp.113.131052; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ruderfer DM, 2011, MOL PSYCHIATR, V16, P887, DOI 10.1038/mp.2011.34; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Weinberg CR, 1998, AM J HUM GENET, V62, P969, DOI 10.1086/301802; Weinberger DR, 1986, NEUROLOGY SCHIZOPHRE, P387; Wilkinson LS, 2007, NAT REV NEUROSCI, V8, P832, DOI 10.1038/nrn2235	20	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144172	10.1371/journal.pone.0144172	http://dx.doi.org/10.1371/journal.pone.0144172			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633303	Green Submitted, Green Published, gold			2022-12-27	WOS:000366040000066
J	Fiset, J; Tessier, N; Millien, V; Lapointe, FJ				Fiset, Jessica; Tessier, Nathalie; Millien, Virginie; Lapointe, Francois-Joseph			Phylogeographic Structure of the White-Footed Mouse and the Deer Mouse, Two Lyme Disease Reservoir Hosts in Quebec	PLOS ONE			English	Article							EREMICUS SPECIES GROUP; BORRELIA-BURGDORFERI; GENETIC-STRUCTURE; PEROMYSCUS-MANICULATUS; POPULATION-GENETICS; DISTANCE MATRICES; LEUCOPUS; PATTERNS; MODEL; MICE	Modification of a species range is one of many consequences of climate change and is driving the emergence of Lyme disease in eastern Canada. The primary reservoir host of the bacteria responsible for Lyme disease, Borrelia burgdorferi, is the white-footed mouse (Peromyscus leucopus), whose range is rapidly shifting north into southern Quebec. The deer mouse, P. maniculatus, is occurring over most Quebec province and is a less competent host for B. burgdorferi. Here, we compared the phylogeographic structure of both Peromyscus species in Quebec. Using a combination of multiple mitochondrial DNA markers and phylogeographic methods, we detected an ongoing and rapid expansion of P. leucopus, while P. maniculatus appears more stable. Haplotype and populations networks indicated that populations of P. maniculatus exhibit more genetic structure than P. leucopus across the study area. Furthermore, significant and consistent genetic divergences between populations of the two species on both sides of the St. Lawrence River suggest that distinct lineages of P. leucopus and P. maniculatus with different ancestral origins colonized Southern Quebec following the Last Glacial Maximum. The phylogeographic structure of pathogens is expected to mirror the structure observed in their reservoir hosts. As different strains of Borrelia burgdorferi may be associated with different levels of pathogenicity and immune responses of their hosts, our results are helpful at better understanding the pattern of spread of Lyme disease in a zone of emergence, and associated risk for human populations.	[Fiset, Jessica; Tessier, Nathalie; Lapointe, Francois-Joseph] Univ Montreal, Dept Sci Biol, Montreal, PQ H3C 3J7, Canada; [Tessier, Nathalie] Minist Forets Faune & Parcs, Longueuil, PQ, Canada; [Millien, Virginie] McGill Univ, Redpath Museum, Montreal, PQ H3A 2K6, Canada	Universite de Montreal; McGill University	Millien, V (corresponding author), McGill Univ, Redpath Museum, 859 Sherbrooke St W, Montreal, PQ H3A 2K6, Canada.	virginie.millien@mcgill.ca	Millien, Virginie/D-6457-2013	Millien, Virginie/0000-0002-1390-766X	Quebec Government (Fonds Vert, PACC26 - Ouranos); QCBS Excellence Award; NSERC	Quebec Government (Fonds Vert, PACC26 - Ouranos); QCBS Excellence Award; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Quebec Government (Fonds Vert, PACC26 - Ouranos) to VM and FJL and a QCBS Excellence Award to JF. VM is supported by the NSERC Discovery Grant Program. URLs: http://www.ouranos.ca/en/scientific-program/impacts-adaptation/ecosystem-biodiversity.php; http://qcbs.ca/resources/student-grants/excellence-awards/; http://www.nserc-crsng.gc.ca/Professors-Professeurs/Grants-Subs/DGIGP-PSIGP_eng.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise J. C., 2000, PHYLOGEOGRAPHY HIST; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Barbour AG, 2010, MBIO, V1, DOI 10.1128/mBio.00153-10; Bell RC, 2012, P ROY SOC B-BIOL SCI, V279, P991, DOI 10.1098/rspb.2011.1229; Bouchard C, 2011, TICKS TICK-BORNE DIS, V2, P183, DOI 10.1016/j.ttbdis.2011.03.005; Bradley RD, 2007, J MAMMAL, V88, P1146, DOI 10.1644/06-MAMM-A-342R.1; Campbell V, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-64; Diffenbaugh NS, 2013, SCIENCE, V341, P486, DOI 10.1126/science.1237123; Ditchfield AD, 2000, MOL ECOL, V9, P1307, DOI 10.1046/j.1365-294x.2000.01013.x; Dooley JL, 1996, OECOLOGIA, V105, P81, DOI 10.1007/BF00328794; Dragoo JW, 2006, J GEN VIROL, V87, P1997, DOI 10.1099/vir.0.81576-0; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Dyer RJ, 2004, MOL ECOL, V13, P1713, DOI 10.1111/j.1365-294X.2004.02177.x; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Excoffier L, 2004, MOL ECOL, V13, P853, DOI 10.1046/j.1365-294X.2003.02004.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; FARRIS JS, 1970, SYST ZOOL, V19, P83, DOI 10.2307/2412028; Felsenstein J, 1996, MOL BIOL EVOL, V13, P93, DOI 10.1093/oxfordjournals.molbev.a025575; Fouquet A, 2012, SYST BIOL, V61, P461, DOI 10.1093/sysbio/syr130; Fu YX, 1997, GENETICS, V147, P915; Graham WR, 2004, FAUNMAP ELECT DATABA; GRANT PR, 1976, CAN J ZOOL, V54, P2156, DOI 10.1139/z76-249; Griekspoor A, 2005, 4PEAKS PROGRAM HELPS; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Hanincova K, 2006, EMERG INFECT DIS, V12, P604; Hibbard C. W., 1968, P6; Hooper E. T., 1968, P27; Houghton J. T., 2001, CLIMATE CHANGE 2001; Humphrey PT, 2010, EVOLUTION, V64, P2653, DOI 10.1111/j.1558-5646.2010.01001.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lapointe FJ, 2010, TRENDS MICROBIOL, V18, P341, DOI 10.1016/j.tim.2010.03.009; Legendre P, 2004, AUST NZ J STAT, V46, P615, DOI 10.1111/j.1467-842X.2004.00357.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MANTEL N, 1967, CANCER RES, V27, P209; Margos G, 2012, APPL ENVIRON MICROB, V78, P6059, DOI 10.1128/AEM.00231-12; Marrotte RR, 2014, MOL ECOL, V23, P3983, DOI 10.1111/mec.12847; McCarty JP, 2001, CONSERV BIOL, V15, P320, DOI 10.1046/j.1523-1739.2001.015002320.x; McKenna MC, 1997, CLASSIFICATION MAMMA; Myers P, 2009, GLOBAL CHANGE BIOL, V15, P1434, DOI 10.1111/j.1365-2486.2009.01846.x; Noel S, 2005, PARASITOLOGY, V131, P237, DOI 10.1017/S0031182005007584; OGDEN NH, 2008, INT J HEALTH GEOGR, V22, P7; Ogden NH, 2010, ENVIRON HEALTH PERSP, V118, P909, DOI 10.1289/ehp.0901766; Olsen JB, 1996, MOL MAR BIOL BIOTECH, V5, P259; Ostfeld R. S., 2011, LYME DIS ECOLOGY COM; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pfeifer B, 2014, MOL BIOL EVOL, V31, P1929, DOI 10.1093/molbev/msu136; Polihronakis M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-195; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; RAND PW, 1993, J MED ENTOMOL, V30, P614, DOI 10.1093/jmedent/30.3.614; Ray N, 2003, MOL BIOL EVOL, V20, P76, DOI 10.1093/molbev/msg009; Riddle BR, 2000, MOL PHYLOGENET EVOL, V17, P145, DOI 10.1006/mpev.2000.0841; Riddle BR, 2000, MOL PHYLOGENET EVOL, V17, P161, DOI 10.1006/mpev.2000.0842; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rogic A, 2013, ECOL EVOL, V3, P2075, DOI 10.1002/ece3.620; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Rowe KC, 2006, MOL ECOL, V15, P4003, DOI 10.1111/j.1365-294X.2006.03063.x; Roy-Dufresne E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080724; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salzburger W, 2011, MOL ECOL, V20, P1952, DOI 10.1111/j.1365-294X.2011.05066.x; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; SCHWAN TG, 1989, INFECT IMMUN, V57, P3445, DOI 10.1128/IAI.57.11.3445-3451.1989; Shipp-Pennock MA, 2005, J MAMMAL, V86, P803, DOI 10.1644/1545-1542(2005)086[0803:SOTWMP]2.0.CO;2; Simon JA, 2014, EVOL APPL, V7, P750, DOI 10.1111/eva.12165; SLATKIN M, 1991, GENETICS, V129, P555; Stanek G, 2009, CURR OPIN INFECT DIS, V22, P450, DOI 10.1097/QCO.0b013e32832ee880; Sullivan J, 2000, AM NAT, V155, P755, DOI 10.1086/303362; Swenson NG, 2005, AM NAT, V166, P581, DOI 10.1086/491688; Swofford DL, 2002, PAUP PHYLOGENETIC AN; TAJIMA F, 1989, GENETICS, V123, P597; Templeton AR, 1998, MOL ECOL, V7, P381, DOI 10.1046/j.1365-294x.1998.00308.x; Tessier N, 2004, CAN J ZOOL, V82, P1832, DOI 10.1139/Z04-173; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wolff JO, 1996, OECOLOGIA, V108, P529, DOI 10.1007/BF00333730; Zheng XG, 2003, MOL ECOL, V12, P711, DOI 10.1046/j.1365-294X.2003.01770.x	79	18	19	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144112	10.1371/journal.pone.0144112	http://dx.doi.org/10.1371/journal.pone.0144112			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633555	gold, Green Submitted, Green Published			2022-12-27	WOS:000366040000059
J	Lu, L; Guo, L; Gauba, E; Tian, J; Wang, L; Tandon, N; Shankar, M; Beck, SJ; Du, YF; Du, H				Lu, Lin; Guo, Lan; Gauba, Esha; Tian, Jing; Wang, Lu; Tandon, Neha; Shankar, Malini; Beck, Simon J.; Du, Yifeng; Du, Heng			Transient Cerebral Ischemia Promotes Brain Mitochondrial Dysfunction and Exacerbates Cognitive Impairments in Young 5xFAD Mice	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; OXIDATIVE STRESS; PERMEABILITY TRANSITION; CYCLOPHILIN-D; AMYLOID-BETA; MOUSE MODEL; CELL-DEATH; DYNAMICS; FISSION; DEMENTIA	Alzheimer's disease (AD) is heterogeneous and multifactorial neurological disorder; and the risk factors of AD still remain elusive. Recent studies have highlighted the role of vascular factors in promoting the progression of AD and have suggested that ischemic events increase the incidence of AD. However, the detailed mechanisms linking ischemic insult to the progression of AD is still largely undetermined. In this study, we have established a transient cerebral ischemia model on young 5xFAD mice and their non-transgenic (nonTg) littermates by the transient occlusion of bilateral common carotid arteries. We have found that transient cerebral ischemia significantly exacerbates brain mitochondrial dysfunction including mitochondrial respiration deficits, oxidative stress as well as suppressed levels of mitochondrial fusion proteins including optic atrophy 1 (OPA1) and mitofusin 2 (MFN2) in young 5xFAD mice resulting in aggravated spatial learning and memory. Intriguingly, transient cerebral ischemia did not induce elevation in the levels of cortical or mitochondrial Amyloid beta (A beta) 1-40 or 1-42 levels in 5xFAD mice. In addition, the glucose-and oxygen-deprivation- induced apoptotic neuronal death in A-treated neurons was significantly mitigated by mitochondria-targeted antioxidant mitotempo which suppresses mitochondrial superoxide levels. Therefore, the simplest interpretation of our results is that young 5xFAD mice with pre-existing AD-like mitochondrial dysfunction are more susceptible to the effects of transient cerebral ischemia; and ischemic events may exacerbate dementia and worsen the outcome of AD patients by exacerbating mitochondrial dysfunction.	[Lu, Lin; Guo, Lan; Gauba, Esha; Tian, Jing; Wang, Lu; Tandon, Neha; Shankar, Malini; Beck, Simon J.; Du, Heng] Univ Texas Dallas, Dept Biol Sci, Richardson, TX 75083 USA; [Lu, Lin; Wang, Lu; Du, Yifeng; Du, Heng] Shandong Univ, Shandong Prov Hosp, Dept Neurol, Jinan 250100, Shandong, Peoples R China	University of Texas System; University of Texas Dallas; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Du, YF (corresponding author), Shandong Univ, Shandong Prov Hosp, Dept Neurol, Jinan 250100, Shandong, Peoples R China.	duyifeng2013@163.com; heng.du@utdallas.edu	Gauba, Esha/AAN-4475-2020	Gauba, Esha/0000-0002-1757-6765	National Institute on Aging [R00AG037716]; Alzheimer's Association [NIRG-12-242803]; National Science Foundation of China [131271145, 1381200847]; National Science Foundation of Shandong [2013JQB14007]; NIH [R00AG037716]; NSFC [131271145, 1381200847]; SDNSF [2013JQB14007]; NATIONAL INSTITUTE ON AGING [R00AG037716] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alzheimer's Association(Alzheimer's Association); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation of Shandong(Natural Science Foundation of Shandong Province); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSFC(National Natural Science Foundation of China (NSFC)); SDNSF; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by National Institute on Aging (R00AG037716), Alzheimer's Association (NIRG-12-242803), National Science Foundation of China (131271145, 1381200847), and National Science Foundation of Shandong (2013JQB14007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This study is supported by research funding from NIH (R00AG037716), Alzheimer's Association (NIRG-12-242803), NSFC (131271145, 1381200847) and SDNSF (2013JQB14007).	Bonda DJ, 2010, DRUG AGING, V27, P181, DOI 10.2165/11532140-000000000-00000; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Cook M, 2015, AGE AGEING, V44, P695, DOI 10.1093/ageing/afv061; Costantini LC, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S16; Dalleau S, 2013, CELL DEATH DIFFER, V20, P1615, DOI 10.1038/cdd.2013.138; Doll DN, 2015, STROKE, V46, P1681, DOI 10.1161/STROKEAHA.115.009099; Du C, 1996, J CEREBR BLOOD F MET, V16, P195, DOI 10.1097/00004647-199603000-00003; Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868; Du H, 2014, BBA-MOL BASIS DIS, V1842, P2517, DOI 10.1016/j.bbadis.2013.03.004; Du H, 2010, P NATL ACAD SCI USA, V107, P18670, DOI 10.1073/pnas.1006586107; Du H, 2011, NEUROBIOL AGING, V32, P398, DOI 10.1016/j.neurobiolaging.2009.03.003; Eimer WA, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-2; Feely SME, 2011, NEUROLOGY, V76, P1690, DOI 10.1212/WNL.0b013e31821a441e; Gage Gregory J, 2012, J Vis Exp, DOI 10.3791/3564; Gan XQ, 2014, BBA-MOL BASIS DIS, V1842, P220, DOI 10.1016/j.bbadis.2013.11.009; Girard SD, 2013, J ALZHEIMERS DIS, V33, P781, DOI 10.3233/JAD-2012-120982; Guerreiro RJ, 2012, NEUROBIOL AGING, V33, P437, DOI 10.1016/j.neurobiolaging.2010.03.025; Guo L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054914; Higgins GC, 2010, J ALZHEIMERS DIS, V20, pS453, DOI 10.3233/JAD-2010-100321; Huang CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087095; Imai Y, 2011, CURR OPIN NEUROBIOL, V21, P935, DOI 10.1016/j.conb.2011.10.016; Jawhar S, 2011, J BIOL CHEM, V286, P4454, DOI 10.1074/jbc.M110.185819; Johnson KA, 1998, NEUROLOGY, V50, P1563, DOI 10.1212/WNL.50.6.1563; Jordan J, 2003, J PHYSIOL BIOCHEM, V59, P129, DOI 10.1007/BF03179878; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; Keating DJ, 2008, J NEUROCHEM, V104, P298, DOI 10.1111/j.1471-4159.2007.04997.x; Kemppainen S, 2014, BEHAV BRAIN RES, V275, P15, DOI 10.1016/j.bbr.2014.08.050; Lim KL, 2012, ANTIOXID REDOX SIGN, V16, P935, DOI 10.1089/ars.2011.4105; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; Manczak M, 2012, HUM MOL GENET, V21, P2538, DOI 10.1093/hmg/dds072; Martorell-Riera A, 2014, EMBO J, V33, P2388, DOI 10.15252/embj.201488327; Mukhopadhyay P, 2007, BIOCHEM BIOPH RES CO, V358, P203, DOI 10.1016/j.bbrc.2007.04.106; NAGY Z, 1995, DEMENTIA, V6, P21, DOI 10.1159/000106918; Nelson PT, 2012, J NEUROPATH EXP NEUR, V71, P362, DOI 10.1097/NEN.0b013e31825018f7; Ni HM, 2015, REDOX BIOL, V4, P6, DOI 10.1016/j.redox.2014.11.006; Pimentel-Coelho PM, 2013, NEUROBIOL AGING, V34, P679, DOI 10.1016/j.neurobiolaging.2012.06.025; Porporato PE, 2014, CELL REP, V8, P754, DOI 10.1016/j.celrep.2014.06.043; Qi JP, 2007, J ALZHEIMERS DIS, V12, P335; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Reddy PH, 2008, TRENDS MOL MED, V14, P45, DOI 10.1016/j.molmed.2007.12.002; Reddy PH, 2014, DRUG DISCOV TODAY, V19, P951, DOI 10.1016/j.drudis.2014.03.020; Rojas S, 2013, NEUROBIOL AGING, V34, P1790, DOI 10.1016/j.neurobiolaging.2012.12.027; Ryu SW, 2015, MOL CELLS, V38, P89, DOI 10.14348/molcells.2015.2285; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Silvestrini M, 2011, J ALZHEIMERS DIS, V25, P719, DOI 10.3233/JAD-2011-101968; Skoog I, 2006, NEUROL RES, V28, P605, DOI 10.1179/016164106X130506; Song WJ, 2011, NAT MED, V17, P377, DOI 10.1038/nm.2313; Sun YY, 2015, STROKE, V46, P1947, DOI 10.1161/STROKEAHA.115.009162; Swerdlow RH, 2010, J ALZHEIMERS DIS, V20, pS265, DOI 10.3233/JAD-2010-100339; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Troncoso JC, 2008, ANN NEUROL, V64, P168, DOI 10.1002/ana.21413; Ugarte-Uribe B, 2014, BIOL CHEM, V395, P297, DOI 10.1515/hsz-2013-0234; Vaseva AV, 2012, CELL, V149, P1536, DOI 10.1016/j.cell.2012.05.014; Venna VR, 2014, STROKE, V45, P3101, DOI 10.1161/STROKEAHA.114.006553; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang XL, 2014, BBA-MOL BASIS DIS, V1842, P1240, DOI 10.1016/j.bbadis.2013.10.015; Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009; Wappler EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063206; White L, 2002, ANN NY ACAD SCI, V977, P9, DOI 10.1111/j.1749-6632.2002.tb04794.x; Winters A, 2012, TRANSL STROKE RES, V3, P279, DOI 10.1007/s12975-012-0148-y; Yates D, 2013, NAT REV NEUROSCI, V14, P156, DOI 10.1038/nrn3463; Yoritaka A, 1996, P NATL ACAD SCI USA, V93, P2696, DOI 10.1073/pnas.93.7.2696; Yoshioka H, 2011, J NEUROTRAUM, V28, P649, DOI 10.1089/neu.2010.1662; Zhang FY, 1997, J NEUROSCI, V17, P7655, DOI 10.1523/jneurosci.17-20-07655.1997; Zhang QN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033722; Zhen G, 2007, J NEUROSCI METH, V166, P73, DOI 10.1016/j.jneumeth.2007.06.029; Zhu XW, 2007, J NEUROL SCI, V257, P240, DOI 10.1016/j.jns.2007.01.039; Zhu XW, 2013, J ALZHEIMERS DIS, V33, pS253, DOI 10.3233/JAD-2012-129005	69	27	28	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144068	10.1371/journal.pone.0144068	http://dx.doi.org/10.1371/journal.pone.0144068			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26632816	Green Submitted, Green Published, gold			2022-12-27	WOS:000366040000049
J	Jacques, CN; Jenks, JA; Grovenburg, TW; Klaver, RW				Jacques, Christopher N.; Jenks, Jonathan A.; Grovenburg, Troy W.; Klaver, Robert W.			Influence of Habitat and Intrinsic Characteristics on Survival of Neonatal Pronghorn	PLOS ONE			English	Article							WHITE-TAILED DEER; FUNCTIONAL-RESPONSES; POPULATION-DYNAMICS; LARGE HERBIVORES; BIRTH SYNCHRONY; SITE SELECTION; CALF SURVIVAL; HOME-RANGE; MORTALITY; FAWNS	Increased understanding of the influence of habitat (e.g., composition, patch size) and intrinsic (e.g., age, birth mass) factors on survival of neonatal pronghorn (Antilocapra americana) is a prerequisite to successful management programs, particularly as they relate to population dynamics and the role of population models in adaptive species management. Nevertheless, few studies have presented empirical data quantifying the influence of habitat variables on survival of neonatal pronghorn. During 2002-2005, we captured and radiocollared 116 neonates across two sites in western South Dakota. We documented 31 deaths during our study, of which coyote (Canis latrans) predation (n = 15) was the leading cause of mortality. We used known fate analysis in Program MARK to investigate the influence of intrinsic and habitat variables on neonatal survival. We generated a priori models that we grouped into habitat and intrinsic effects. The highest-ranking model indicated that neonate mortality was best explained by site, percent grassland, and open water habitat; 90-day survival (0.80; 90% CI = 0.71-0.88) declined 23% when grassland and water increased from 80.1 to 92.3% and 0.36 to 0.40%, respectively, across 50% natal home ranges. Further, our results indicated that grassland patch size and shrub density were important predictors of neonate survival; neonate survival declined 17% when shrub density declined from 5.0 to 2.5 patches per 100 ha. Excluding the site covariates, intrinsic factors (i. e., sex, age, birth mass, year, parturition date) were not important predictors of survival of neonatal pronghorns. Further, neonatal survival may depend on available land cover and interspersion of habitats. We have demonstrated that maintaining minimum and maximum thresholds for habitat factors (e. g., percentages of grassland and open water patches, density of shrub patches) throughout natal home ranges will in turn, ensure relatively high (> 0.50) neonatal survival rates, especially as they relate to coyote predation. Thus, landscape level variables (particularly percentages of open water, grassland habitats, and shrub density) should be incorporated into the development or implementation of pronghorn management plans across sagebrush steppe communities of the western Dakotas, and potentially elsewhere within the geographic range of pronghorn.	[Jacques, Christopher N.; Jenks, Jonathan A.; Grovenburg, Troy W.] S Dakota State Univ, Dept Nat Resource Management, Brookings, SD 57007 USA; [Klaver, Robert W.] Iowa State Univ, US Geol Survey, Iowa Cooperat Fish & Wildlife Res Unit, Ames, IA USA	South Dakota State University; Iowa State University; United States Department of the Interior; United States Geological Survey	Jacques, CN (corresponding author), Western Illinois Univ, Dept Biol Sci, Macomb, IL 61455 USA.	cn-jacques@wiu.edu	Jenks, Jonathan A/B-7321-2009		Federal Aid in Wildlife Restoration [75103]; National Park Service; Pope and Young Club; Safari Club International; South Dakota State University	Federal Aid in Wildlife Restoration; National Park Service; Pope and Young Club; Safari Club International; South Dakota State University	Funding was provided by Federal Aid in Wildlife Restoration administered by South Dakota Department of Game, Fish and Parks, Study No. 75103, the National Park Service administered through the South Dakota Cooperative Fish and Wildlife Research Unit at South Dakota State University, the Pope and Young Club, Safari Club International, and South Dakota State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLDREDGE AW, 1991, J WILDLIFE MANAGE, V55, P222, DOI 10.2307/3809143; Andrew NG, 1997, WILDLIFE SOC B, V25, P823; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Autenrieth, 1982, P PRONGH ANT WORKSH, V10, P112; Autenrieth R.E., 1984, P BIENNIAL PRONGHORN, V11, P49; Autenrieth R. E., 1975, WILDLIFE MONOGR, V42, P3; Barber-Meyer S.M., 2008, Wildlife Biology in Practice, V4, P8; Barber-Meyer SM, 2008, WILDLIFE MONOGR, P1, DOI 10.2193/2008-004; Barbknecht AE, 2011, J WILDLIFE MANAGE, V75, P646, DOI 10.1002/jwmg.100; Barrett M.W., 1978, Proceedings of the Pronghorn Antelope Workshop, V8, P429; BARRETT MW, 1981, J WILDLIFE MANAGE, V45, P120, DOI 10.2307/3807880; BARRETT MW, 1984, J WILDLIFE MANAGE, V48, P542, DOI 10.2307/3801187; Bishop CJ, 2008, J WILDLIFE MANAGE, V72, P1085, DOI 10.2193/2007-423; Bleich VC, 1997, WILDLIFE MONOGR, P1; BLOOD DA, 1970, J WILDLIFE MANAGE, V34, P451, DOI 10.2307/3799032; Bowyer RT, 2006, DIVERS DISTRIB, V12, P244, DOI 10.1111/j.1366-9516.2006.00247.x; Brinkman TJ, 2002, WILDLIFE SOC B, V30, P258; Broyles B, 1995, WILDLIFE SOC B, V23, P663; BURGER LD, 1994, J WILDLIFE MANAGE, V58, P249, DOI 10.2307/3809387; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [10.1007/b97636, DOI 10.1007/B97636]; Byers J.A., 1997, AM PRONGHORN SOCIAL; BYERS JA, 1990, BEHAV ECOL SOCIOBIOL, V26, P157; Canon SK, 1997, J WILDLIFE MANAGE, V61, P1134, DOI 10.2307/3802111; CAUGHLEY G, 1966, ECOLOGY, V47, P906, DOI 10.2307/1935638; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; Cooch EG, 2015, PROGRAM MARK GENTLE, P633; Devries JH, 2003, J WILDLIFE MANAGE, V67, P551, DOI 10.2307/3802713; ESTES R D, 1976, East African Wildlife Journal, V14, P135; FAIRBANKS WS, 1993, J MAMMAL, V74, P129, DOI 10.2307/1381911; Fichter E, 1974, INT UNION CONSERVATI, V1, P352; Gaillard JM, 1998, TRENDS ECOL EVOL, V13, P58, DOI 10.1016/S0169-5347(97)01237-8; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; Godvik IMR, 2009, ECOLOGY, V90, P699, DOI 10.1890/08-0576.1; Gregg MA, 2001, J WILDLIFE MANAGE, V65, P19, DOI 10.2307/3803271; Grovenburg TW, 2014, WILDLIFE SOC B, V38, P89, DOI 10.1002/wsb.366; Grovenburg TW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108797; Grovenburg TW, 2012, J WILDLIFE MANAGE, V76, P944, DOI 10.1002/jwmg.339; Grovenburg TW, 2011, AM MIDL NAT, V166, P147, DOI 10.1674/0003-0031-166.1.147; Grovenburg TW, 2011, J WILDLIFE MANAGE, V75, P213, DOI 10.1002/jwmg.20; Gustine DD, 2006, WILDLIFE MONOGR, P1, DOI 10.2193/0084-0173(2006)165[1:CSOWCI]2.0.CO;2; Herfindal I, 2009, ECOGRAPHY, V32, P849, DOI 10.1111/j.1600-0587.2009.05783.x; Homer C, 2007, PHOTOGRAMM ENG REM S, V73, P337; Jacques CN, 2007, J WILDLIFE MANAGE, V71, P737, DOI 10.2193/2005-685; Jacques CN, 2014, J WILDLIFE MANAGE, V78, P164, DOI 10.1002/jwmg.634; Jacques CN, 2011, J WILDLIFE MANAGE, V75, P221, DOI 10.1002/jwmg.23; Jacques CN, 2009, J WILDLIFE MANAGE, V73, P1282, DOI 10.2193/2009-039; Jacques CN, 2009, J MAMMAL, V90, P433, DOI 10.1644/07-MAMM-A-395.1; Johnson JR, 1999, PLANTS BLACK HILLS B; Johnson W. F., 1988, SOIL SURVEY HARDING; Kalvels J., 1982, SOIL SURVEY FALL RIV; KANTRUD HA, 1993, J SOIL WATER CONSERV, V48, P238; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kie JG, 2002, ECOLOGY, V83, P530, DOI 10.1890/0012-9658(2002)083[0530:LHADSE]2.0.CO;2; Kitchen D.W., 1974, Wildlife Monogr, VNo. 38, P1; Kohlmann SG, 2004, PRONGHORN ECOLOGY MA, P645; KUNKEL KE, 1994, CAN J ZOOL, V72, P1557, DOI 10.1139/z94-207; Larson G.E., 1999, GRASSLAND PLANTS S D; McGarigal K., 2002, FRAGSTATS SPATIAL PA; Moreau G, 2012, J APPL ECOL, V49, P611, DOI 10.1111/j.1365-2664.2012.02134.x; Morellet N, 2007, J APPL ECOL, V44, P634, DOI 10.1111/j.1365-2664.2007.01307.x; Mysterud A, 1998, ECOLOGY, V79, P1435, DOI 10.1890/0012-9658(1998)079[1435:FRIHUA]2.0.CO;2; O'Gara Bart W., 2004, P809; O'Gara Bart W., 2004, P337; Ockenfels RA, 1992, P PRONGHORN ANTELOPE, V15, P78; OGara BW, 2004, PRONGHORN ECOLOGY MA, P675; OWENSMITH N, 1993, J ANIM ECOL, V62, P428, DOI 10.2307/5192; POLLOCK KH, 1989, J WILDLIFE MANAGE, V53, P7, DOI 10.2307/3801296; Poole KG, 2007, J MAMMAL, V88, P139, DOI 10.1644/06-MAMM-A-127R1.1; RILEY SJ, 1984, J WILDLIFE MANAGE, V48, P1302, DOI 10.2307/3801790; ROBBINS CT, 1979, AM NAT, V114, P101, DOI 10.1086/283456; Rohm JH, 2007, J WILDLIFE MANAGE, V71, P851, DOI 10.2193/2006-027; RUTBERG AT, 1987, AM NAT, V130, P692, DOI 10.1086/284739; Saether BE, 1997, TRENDS ECOL EVOL, V12, P143, DOI 10.1016/S0169-5347(96)10068-9; Schroeder M.A., 1999, BIRDS OF THE WORLD; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Smith Joe T., 2004, Prairie Naturalist, V36, P213; Sovada MA, 2000, J WILDLIFE MANAGE, V64, P820, DOI 10.2307/3802752; THORNE ET, 1976, J WILDLIFE MANAGE, V40, P330, DOI 10.2307/3800433; TRAINER C. E., 1983, 12 OR DEP FISH WILDL; TUCKER RD, 1983, J RANGE MANAGE, V36, P110, DOI 10.2307/3897995; Tucker RD, 1980, P ANN C W ASS FISH W, V60, P620; Van Moorter B, 2013, ECOGRAPHY, V36, P323, DOI 10.1111/j.1600-0587.2012.07291.x; Von Gunten BL, 1978, P BIEN PRONG ANTELOP, V8, P349; Webb SL, 2007, J WILDLIFE MANAGE, V71, P555, DOI 10.2193/2006-189; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wissel C, 1988, EVOL ECOL, V2, P102, DOI 10.1007/BF02067271; Yoakum Jim D., 2004, P409	87	10	10	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144026	10.1371/journal.pone.0144026	http://dx.doi.org/10.1371/journal.pone.0144026			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630484	Green Submitted, Green Published, gold			2022-12-27	WOS:000365926300139
J	Kelley, NJ; Schmeichel, BJ				Kelley, Nicholas J.; Schmeichel, Brandon J.			Thinking about Death Reduces Delay Discounting	PLOS ONE			English	Article							TERROR MANAGEMENT THEORY; MORTALITY SALIENCE; SELF-ESTEEM; SYMBOLIC IMMORTALITY; CULTURAL WORLDVIEW; PERSPECTIVE; DEPLETION; THOUGHTS; BEHAVIOR; DEFENSE	The current study tested competing predictions regarding the effect of mortality salience on delay discounting. One prediction, based on evolutionary considerations, was that reminders of death increase the value of the present. Another prediction, based in part on construal level theory, was that reminders of death increase the value of the future. One-hundred eighteen participants thought about personal mortality or a control topic and then completed an inter-temporal choice task pitting the chance to gain $50 now against increasingly attractive rewards three months later. Consistent with the hypothesis inspired by construal theory, participants in the mortality salience condition traded $50 now for $66.67 in three months, whereas participants in the dental pain salience condition required $72.84 in three months in lieu of $50 now. Thus, participants in the mortality salience condition discounted future monetary gains less than other participants, suggesting that thoughts of death may increase the subjective value of the future.	[Kelley, Nicholas J.] Northwestern Univ, Dept Psychol, Evanston, IL 60208 USA; [Schmeichel, Brandon J.] Texas A&M Univ, Dept Psychol, College Stn, TX 77843 USA	Northwestern University; Texas A&M University System; Texas A&M University College Station	Kelley, NJ (corresponding author), Northwestern Univ, Dept Psychol, Evanston, IL 60208 USA.	nicholasjkelley@gmail.com						Arndt J, 1997, PSYCHOL SCI, V8, P379, DOI 10.1111/j.1467-9280.1997.tb00429.x; Bastian B, 2013, SOC PSYCHOL PERS SCI, V4, P215, DOI 10.1177/1948550612451156; Ben-Ari OT, 1999, J PERS SOC PSYCHOL, V76, P35, DOI 10.1037/0022-3514.76.1.35; Burke BL, 2010, PERS SOC PSYCHOL REV, V14, P155, DOI 10.1177/1088868309352321; Carver CS, 2001, PERS SOC PSYCHOL REV, V5, P345, DOI 10.1207/S15327957PSPR0504_4; CHAPMAN GB, 1995, MED DECIS MAKING, V15, P373, DOI 10.1177/0272989X9501500408; Cox CR, 2009, HEALTH PSYCHOL, V28, P746, DOI 10.1037/a0016388; Dechesne M, 2003, J PERS SOC PSYCHOL, V84, P722, DOI 10.1037/0022-3514.84.4.722; Ferraro R, 2005, J CONSUM RES, V32, P65, DOI 10.1086/429601; Florian V, 1998, J PERS SOC PSYCHOL, V74, P725, DOI 10.1037/0022-3514.74.3.725; Fujita K, 2006, J PERS SOC PSYCHOL, V90, P351, DOI 10.1037/0022-3514.90.3.351; Gailliot MT, 2006, J PERS SOC PSYCHOL, V91, P49, DOI 10.1037/0022-3514.91.1.49; Goldenberg JL, 1999, J PERS SOC PSYCHOL, V77, P1173, DOI 10.1037/0022-3514.77.6.1173; Greenberg J, 2000, PERS SOC PSYCHOL B, V26, P91, DOI 10.1177/0146167200261009; GREENBERG J, 1994, J PERS SOC PSYCHOL, V67, P627, DOI 10.1037/0022-3514.67.4.627; GREENBERG J, 1990, J PERS SOC PSYCHOL, V58, P308, DOI 10.1037/0022-3514.58.2.308; Griskevicius V, 2011, J PERS SOC PSYCHOL, V100, P1015, DOI 10.1037/a0022403; Harmon-Jones E, 1997, J PERS SOC PSYCHOL, V72, P24, DOI 10.1037/0022-3514.72.1.24; Hart J, 2010, BRIT J SOC PSYCHOL, V49, P425, DOI 10.1348/014466610X485465; Haselton MG, 2009, SOC COGNITION, V27, P733, DOI 10.1521/soco.2009.27.5.733; Haselton MG, 2006, PERS SOC PSYCHOL REV, V10, P47, DOI 10.1207/s15327957pspr1001_3; Jones BA, 2009, J EXP ANAL BEHAV, V91, P61, DOI 10.1901/jeab.2009.91-61; King LA, 2009, PSYCHOL SCI, V20, P1459, DOI 10.1111/j.1467-9280.2009.02466.x; Landau MJ, 2011, SELF IDENTITY, V10, P64, DOI 10.1080/15298860903557243; Leary MR, 1997, PSYCHOL INQ, V8, P26, DOI 10.1207/s15327965pli0801_4; Litton RJ, 1979, BROKEN CONNECTION DE; MISCHEL W, 1973, J PERS SOC PSYCHOL, V28, P172, DOI 10.1037/h0035716; MISCHEL W, 1989, SCIENCE, V244, P933, DOI 10.1126/science.2658056; Pyszczynski T, 2000, CURR DIR PSYCHOL SCI, V9, P156, DOI 10.1111/1467-8721.00083; Pyszczynski T, 2004, PSYCHOL BULL, V130, P435, DOI 10.1037/0033-2909.130.3.435; Reimers S, 2009, PERS INDIV DIFFER, V47, P973, DOI 10.1016/j.paid.2009.07.026; ROSENBLATT A, 1989, J PERS SOC PSYCHOL, V57, P681, DOI 10.1037/0022-3514.57.4.681; Schmeichel BJ, 2009, J PERS SOC PSYCHOL, V96, P1077, DOI 10.1037/a0015091; Schmeichel BJ, 2009, J PERS SOC PSYCHOL, V96, P770, DOI 10.1037/a0014635; Simon L, 1997, J PERS SOC PSYCHOL, V72, P1132, DOI 10.1037/0022-3514.72.5.1132; Trope Y, 2003, PSYCHOL REV, V110, P403, DOI 10.1037/0033-295X.110.3.403; Vail KE, 2012, PERS SOC PSYCHOL REV, V16, P303, DOI 10.1177/1088868312440046; VALLACHER RR, 1987, PSYCHOL REV, V94, P3, DOI 10.1037/0033-295X.94.1.3; Vess M, 2008, J RES PERS, V42, P1376, DOI 10.1016/j.jrp.2008.04.007; Wade-Benzoni KA, 2012, PSYCHOL SCI, V23, P704, DOI 10.1177/0956797612443967; Weber EU, 2007, PSYCHOL SCI, V18, P516, DOI 10.1111/j.1467-9280.2007.01932.x; Wegner, 2014, THEORY ACTION IDENTI; Weller RE, 2008, APPETITE, V51, P563, DOI 10.1016/j.appet.2008.04.010	43	14	15	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144228	10.1371/journal.pone.0144228	http://dx.doi.org/10.1371/journal.pone.0144228			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX8BI	26630664	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000365926300171
J	Yahalom-Mack, N; Langgut, D; Dvir, O; Tirosh, O; Eliyahu-Behar, A; Erel, Y; Langford, B; Frumkin, A; Ullman, M; Davidovich, U				Yahalom-Mack, Naama; Langgut, Dafna; Dvir, Omri; Tirosh, Ofir; Eliyahu-Behar, Adi; Erel, Yigal; Langford, Boaz; Frumkin, Amos; Ullman, Mika; Davidovich, Uri			The Earliest Lead Object in the Levant	PLOS ONE			English	Article							BRONZE-AGE; ORE SOURCES; ISOTOPE; ARTIFACTS; COPPER; METALLURGY; ANCIENT; SILVER	In the deepest section of a large complex cave in the northern Negev desert, Israel, a bi-conical lead object was found logged onto a wooden shaft. Associated material remains and radiocarbon dating of the shaft place the object within the Late Chalcolithic period, at the late 5th millennium BCE. Based on chemical and lead isotope analysis, we show that this unique object was made of almost pure metallic lead, likely smelted from lead ores originating in the Taurus range in Anatolia. Either the finished object, or the raw material, was brought to the southern Levant, adding another major component to the already-rich Late Chalcolithic metallurgical corpus known to-date. The paper also discusses possible uses of the object, suggesting that it may have been used as a spindle whorl, at least towards its deposition.	[Yahalom-Mack, Naama; Dvir, Omri; Tirosh, Ofir; Erel, Yigal] Hebrew Univ Jerusalem, Fredy & Nadine Herrmann Inst Earth Sci, IL-91904 Jerusalem, Israel; [Yahalom-Mack, Naama; Ullman, Mika; Davidovich, Uri] Hebrew Univ Jerusalem, Inst Archaeol, IL-91904 Jerusalem, Israel; [Langgut, Dafna] Tel Aviv Univ, Sonia & Marco Nadler Inst Archaeol, Lab Archaeobot & Ancient Environm, IL-6997801 Tel Aviv, Israel; [Eliyahu-Behar, Adi] Bar Ilan Univ, Martin Szusz Dept Land Israel Studies & Archaeol, IL-5290002 Ramat Gan, Israel; [Langford, Boaz; Frumkin, Amos; Ullman, Mika; Davidovich, Uri] Hebrew Univ Jerusalem, Dept Geog, Israel Cave Res Ctr, IL-91905 Jerusalem, Israel; [Davidovich, Uri] Univ Cambridge, McDonald Inst Archaeol Res, Cambridge CB2 3ER, England	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Tel Aviv University; Bar Ilan University; Hebrew University of Jerusalem; University of Cambridge	Yahalom-Mack, N (corresponding author), Hebrew Univ Jerusalem, Fredy & Nadine Herrmann Inst Earth Sci, Edmond J Safra Campus, IL-91904 Jerusalem, Israel.	naama.yahalom@mail.huji.ac.il	Eliyahu-Behar, Adi/CAA-9789-2022	Eliyahu-Behar, Adi/0000-0001-8472-4433; Langgut, Dafna/0000-0002-4824-1044; Yahalom-Mack, Naama/0000-0002-9296-8435; Davidovich, Uri/0000-0001-5947-1534				Abdel-Motelib A., 2012, METALLA, V19, P3; [Anonymous], 1993, RIVERS MOUNTAINS; Badalyan R., 2003, ARCHAEOMETALLURGY EU, V24, P597; Bar-Adon P, 1980, CAVE TREASURE FINDS; Cohen R, 1999, 6 ISR ANT AUTH; Davidovich U, 2016, PROFUNDIS C IN PRESS; Frumkin A, 2015, QUATERNARY LEVANT; Gale N.H., 1981, ANNU BRIT SCH ATHENS, V76, P169, DOI [10.1017/S0068245400019523, DOI 10.1017/S0068245400019523]; Gale N. H., 1978, THERA AEGEAN WORLD, VI, P529; GALE NH, 1982, SCIENCE, V216, P11, DOI 10.1126/science.216.4541.11; Golden J., 2014, ARCHAEOMETALLURGY GL, P559, DOI 10.1007/978-1-4614-9017-3_21; Golden J., 2010, DAWN METAL AGE TECHN, P48; GOPHER A, 1990, CURR ANTHROPOL, V31, P436, DOI 10.1086/203868; Goren Y, 2014, NEAR EAST ARCHAEOL, V77, P260, DOI 10.5615/neareastarch.77.4.0260; Gosic M, 2013, METALLURGY MAGIC SOC; Hauptmann A, 2007, NAT SCI ARCHAEOL, P1, DOI 10.1007/978-3-540-72238-0; Hauptmann A., 2002, PALEORIENT, V28, P43, DOI [DOI 10.3406/PALE0.2002.4745, 10.3406/paleo.2002.4745]; Hauptmann A, 1999, BEGINNINGS METALLURG, V9, P107; Hess K., 1998, METALLURGICA ANTIQUA, V8, P57; Hess K., 1999, ANSCHNITT, P141; Hirao Y., 1995, ESSAYS ANCIENT ANATO, P89; Joffe H.A., 2003, NEAR E SW ESSAYS HON, P45; Key C.A., 1980, CAVE TREASURE, P238; Langgut D, EARLIEST NEAR E WOOD; Mallowan MEL, 1935, PREHISTORIC ASSYRIA, P104; MELLAART J, 1967, CATAL HUYUK; Merpert NI, 1977, SUMER, V33, P84; Moorey P. R. S., 1994, ANCIENT MESOPOTAMIAN; Nezafati N, 2008, ANCIENT MINING TURKE, P329; Nezafati N, 2009, TUBA-AR-TURK ACAD SC, V12, P223; PATTERSON CC, 1971, AM ANTIQUITY, V36, P286, DOI 10.2307/277716; PATTERSON CC, 1972, ECON HIST REV, V25, P205; Pemicka E, 2010, EURASIA ANTIQUA; Pemicka E, 2012, IRANIAN ARCHAEOLOGY, V3, P38; Pernicka E., 2004, PERSIAS ANCIENT SPLE, P232; Pernicka E., 1998, METALLURGICA ANTIQUA, P123; Pernicka E, 2011, ARCHAOLOGIE IRAN TUR, P631; Pernicka E., 2013, ARCHAEOMETALLURGY GL, P239, DOI [DOI 10.1007/978-1-4614-9017-3_11, 10.1007/978-1-4614-9017-3_11]; Platzner I, 2001, FRESEN J ANAL CHEM, V370, P624, DOI 10.1007/s002160100875; Prag K., 1978, ARCHAEOLOGY LEVANT E, P36; Radivojevic M, 2010, J ARCHAEOL SCI, V37, P2775, DOI 10.1016/j.jas.2010.06.012; SAYRE EV, 1992, ARCHAEOMETRY, V34, P73, DOI 10.1111/j.1475-4754.1992.tb00479.x; Sayre EV, 2001, ARCHAEOMETRY, V43, P77, DOI 10.1111/1475-4754.00006; Seeliger T. C., 1985, JB ROMISCH GERMANISC, V32, P597; SHALEV S, 1993, ARCHAEOMETRY, V35, P35, DOI 10.1111/j.1475-4754.1993.tb01022.x; SPERL G, 1990, Z METALLKD, V81, P799; Stos-Gale Z.A., 1981, ARCHE OSCIENCES REV, V1, P285, DOI [10.3406/arsci.1981.1158, DOI 10.3406/ARSCI.1981.1158]; Stos-Gale ZA, 2009, ARCHAEOL ANTHROP SCI, V1, P195, DOI 10.1007/s12520-009-0011-6; Sugar AN, 2000, ARCHAEOMETALLURGICAL; Tadmor M., 1995, ATIQOT, V27, P95; Tylecote R. F., 1962, METALLURGY ARCHAEOLO; Vaks A, 2013, EARTH PLANET SC LETT, V368, P88, DOI 10.1016/j.epsl.2013.02.027; Vavelidis M., 1985, SILBER BLEI GOLD SIF, P59; Wagner G.A., 1986, JB R MISCH GERMANISC, V33, P723; Wagner GA, 1985, B MINERAL RES EXPLOR, V101/102, P45; WERTIME TA, 1973, SCIENCE, V182, P875, DOI 10.1126/science.182.4115.875; Yellin J, 1996, J FIELD ARCHAEOL, V23, P361, DOI 10.1179/009346996791973873; YENER KA, 1991, J ARCHAEOL SCI, V18, P541, DOI 10.1016/0305-4403(91)90053-R	58	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0142948	10.1371/journal.pone.0142948	http://dx.doi.org/10.1371/journal.pone.0142948			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CX8BI	26630666	Green Published, gold, Green Submitted			2022-12-27	WOS:000365926300021
J	Gao, HJ; Wong, KK; Zheteyeva, Y; Shi, JR; Uzicanin, A; Rainey, JJ				Gao, Hongjiang; Wong, Karen K.; Zheteyeva, Yenlik; Shi, Jianrong; Uzicanin, Amra; Rainey, Jeanette J.			Comparing Observed with Predicted Weekly Influenza-Like Illness Rates during the Winter Holiday Break, United States, 2004-2013	PLOS ONE			English	Article							SCHOOL CLOSURE; TRANSMISSION; CANADA	In the United States, influenza season typically begins in October or November, peaks in February, and tapers off in April. During the winter holiday break, from the end of December to the beginning of January, changes in social mixing patterns, healthcare-seeking behaviors, and surveillance reporting could affect influenza-like illness (ILI) rates. We compared predicted with observed weekly ILI to examine trends around the winter break period. We examined weekly rates of ILI by region in the United States from influenza season 20032004 to 2012-2013. We compared observed and predicted ILI rates from week 44 to week 8 of each influenza season using the auto-regressive integrated moving average (ARIMA) method. Of 1,530 region, week, and year combinations, 64 observed ILI rates were significantly higher than predicted by the model. Of these, 21 occurred during the typical winter holiday break period (weeks 51-52); 12 occurred during influenza season 2012-2013. There were 46 observed ILI rates that were significantly lower than predicted. Of these, 16 occurred after the typical holiday break during week 1, eight of which occurred during season 2012-2013. Of 90 (10 HHS regions x 9 seasons) predictions during the peak week, 78 predicted ILI rates were lower than observed. Out of 73 predictions for the post-peak week, 62 ILI rates were higher than observed. There were 53 out of 73 models that had lower peak and higher post-peak predicted ILI rates than were actually observed. While most regions had ILI rates higher than predicted during winter holiday break and lower than predicted after the break during the 2012-2013 season, overall there was not a consistent relationship between observed and predicted ILI around the winter holiday break during the other influenza seasons.	[Gao, Hongjiang; Wong, Karen K.; Zheteyeva, Yenlik; Uzicanin, Amra; Rainey, Jeanette J.] Ctr Dis Control & Prevent, Natl Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Atlanta, GA 30329 USA; [Shi, Jianrong] Chenega Time Solut, Chesapeake, VA USA	Centers for Disease Control & Prevention - USA	Gao, HJ (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Atlanta, GA 30329 USA.	hgao@cdc.gov		Wong, Karen/0000-0002-5287-6456	Chenega Time Solutions	Chenega Time Solutions	The authors received no specific funding for this work. Chenega Time Solutions provided support in the form of salaries for author JS, but didn't have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	[Anonymous], 2013, R FDN STAT COMP; Box GE, 1976, TIME SERIES ANAL FOR, V2nd; Brocklebank JC., 2003, SAS FORECASTING TIME, V2nd ed., P317; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; Earn DJD, 2012, ANN INTERN MED, V156, P173, DOI 10.7326/0003-4819-156-3-201202070-00005; Heymann AD, 2009, EPIDEMIOL INFECT, V137, P1369, DOI 10.1017/S0950268809002556; Hyndman R. J., 2013, FORECAST FORECASTING; Kane MJ, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-276; OSBORN DR, 1988, OXFORD B ECON STAT, V50, P361; Soebiyanto RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009450; Upshur REG, 1999, AM J EPIDEMIOL, V149, P85, DOI 10.1093/oxfordjournals.aje.a009731	11	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0143791	10.1371/journal.pone.0143791	http://dx.doi.org/10.1371/journal.pone.0143791			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26649568	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903300027
J	Sereni, L; Einum, S				Sereni, Laura; Einum, Sigurd			No Evidence for Activity Adjustment in Response to Increased Density in Daphnia magna	PLOS ONE			English	Article							SWIMMING BEHAVIOR; DEPENDENT DISPERSAL; METABOLIC-RATES; FOOD; GROWTH; HERITABILITY; COMPETITION; LARVAE; SPEED; PREY	Increased population density may lead to a decrease in energy available for growth and reproduction via effects on the activity level of individuals. Whilst this may be of particular importance for organisms that compete for defendable resources and/or have a high frequency of social interactions, it is less obvious how individual activity should covary with population density when food resources are not defendable or direct interactions among individuals are negligible. Based on observations that there is a general negative relationship between population density and metabolism it has been suggested that organisms actively reduce activity under increased density to accommodate an expected decrease in food availability. However, in the absence of direct activity measurements the validity of this hypothesis is unclear. Here we test for such anticipatory adjustments of activity levels in the planktonic cladoceran Daphnia magna Straus, a filter feeder whose food resources are not defendable, meaning that density responses can be evaluated in the absence of direct interactions. We tested for changes in activity in response to two separate density cues, one being the direct physical and visual stimuli resulting from being in the vicinity of conspecifics ('direct density experiment'), and the other being the detection of olfactory cues in their environment ('olfactory cue experiment'). Ten genetically distinct clones were used to evaluate the potential for genetic variation in these responses. Our measures of activity were highly repeatable, and there was significant variation in activity among clones. Furthermore, this clonal variation was consistent in the 'direct density' and 'olfactory cue' experiments. The estimated evolvability of the trait (1.3-3.2%) was within the range typically observed in behavioural traits. However, there was no indication that the activity level of individuals respond to population density, either directly to actual density or to olfactory cues representing high density. In this case, the energetic influence of density on population dynamics is sufficiently described by effects on per capita resource availability.	[Sereni, Laura; Einum, Sigurd] Norwegian Univ Sci & Technol, Dept Biol, Ctr Biodivers Dynam, NTNU, NO-7491 Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Einum, S (corresponding author), Norwegian Univ Sci & Technol, Dept Biol, Ctr Biodivers Dynam, NTNU, NO-7491 Trondheim, Norway.	sigurd.einum@ntnu.no		Einum, Sigurd/0000-0002-3788-7800	Research Council of Norway [230482, SFF-III 223257/F50]; Norwegian University of Science and Technology (NTNU)	Research Council of Norway(Research Council of Norway); Norwegian University of Science and Technology (NTNU)	The study received funding from The Research Council of Norway (http://www.forskningsradet.no/), projects 230482 and SFF-III 223257/F50, and Norwegian University of Science and Technology (NTNU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auer SK, 2015, J ANIM ECOL, V84, P1405, DOI 10.1111/1365-2656.12384; Bates D., 2015, LME4 LINEAR MIXED EF; Boersma M, 1998, AM NAT, V152, P237, DOI 10.1086/286164; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; DeLong JP, 2014, J ANIM ECOL, V83, P51, DOI 10.1111/1365-2656.12065; DeLong JP, 2009, ISME J, V3, P1396, DOI 10.1038/ismej.2009.81; DINI ML, 1992, J PLANKTON RES, V14, P359, DOI 10.1093/plankt/14.3.359; Dodson SI, 1997, J PLANKTON RES, V19, P1537, DOI 10.1093/plankt/19.10.1537; Edelsparre AH, 2014, ECOL LETT, V17, P333, DOI 10.1111/ele.12234; Einum S, 2006, OIKOS, V113, P489, DOI 10.1111/j.2006.0030-1299.14806.x; Einum S, 2014, AM NAT, V183, P410, DOI 10.1086/674951; Fiksen O, 2011, MAR ECOL PROG SER, V432, P207, DOI 10.3354/meps09148; FORMANOWICZ DR, 1982, J ANIM ECOL, V51, P757, DOI 10.2307/4003; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Gandon Sylvain, 2001, P155; GARLAND T, 1988, EVOLUTION, V42, P335, DOI 10.1111/j.1558-5646.1988.tb04137.x; Hansen TF, 2011, EVOL BIOL, V38, P258, DOI 10.1007/s11692-011-9127-6; Higginson AD, 2012, AM NAT, V180, P589, DOI 10.1086/667885; JOHANSSON F, 1991, HYDROBIOLOGIA, V209, P79, DOI 10.1007/BF00006721; KLUTTGEN B, 1994, WATER RES, V28, P743, DOI 10.1016/0043-1354(94)90157-0; Kuefler D, 2013, FUNCT ECOL, V27, P323, DOI 10.1111/1365-2435.12065; LAMPERT W, 1986, OECOLOGIA, V70, P495, DOI 10.1007/BF00379894; Lena JP, 1998, BEHAV ECOL, V9, P500, DOI 10.1093/beheco/9.5.500; Leonardsson K, 1997, J EVOLUTION BIOL, V10, P703; LI HW, 1977, J FISH BIOL, V11, P329, DOI 10.1111/j.1095-8649.1977.tb04126.x; Matthysen E, 2005, ECOGRAPHY, V28, P403, DOI 10.1111/j.0906-7590.2005.04073.x; Mattila ALK, 2014, J EVOLUTION BIOL, V27, P1733, DOI 10.1111/jeb.12426; Meylan S, 2007, OIKOS, V116, P650, DOI 10.1111/j.2007.0030-1299.15432.x; Nishikawa Jun, 1998, Plankton Biology and Ecology, V45, P55; O'Keefe TC, 1998, J PLANKTON RES, V20, P973; PORTER KG, 1982, LIMNOL OCEANOGR, V27, P935, DOI 10.4319/lo.1982.27.5.0935; R Development Core Team, 2014, R LANG ENV STAT COMP; Roozen F, 2001, J PLANKTON RES, V23, P797, DOI 10.1093/plankt/23.8.797; Sibly RM, 2002, PHILOS T R SOC B, V357, P1153, DOI 10.1098/rstb.2002.1117; Sommer U, 2012, ANNU REV ECOL EVOL S, V43, P429, DOI 10.1146/annurev-ecolsys-110411-160251; WALDE SJ, 1984, CAN J ZOOL, V62, P2221, DOI 10.1139/z84-323; Weber A, 2002, J PLANKTON RES, V24, P1335, DOI 10.1093/plankt/24.12.1335; WERNER EE, 1993, AM NAT, V142, P242, DOI 10.1086/285537; Zuur Alain F., 2009, P1	39	5	5	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144759	10.1371/journal.pone.0144759	http://dx.doi.org/10.1371/journal.pone.0144759			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26649427	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903300074
J	Cohen, S; Benjamini, Y; Golani, I				Cohen, Shay; Benjamini, Yoav; Golani, Ilan			Coping with Space Neophobia in Drosophila melanogaster: The Asymmetric Dynamics of Crossing a Doorway to the Untrodden	PLOS ONE			English	Article							FREE EXPLORATION; CENTRAL COMPLEX; LOW RESPONDERS; MOVEMENT; BEHAVIOR; MEMORY; FLIGHT; DISCRIMINATION; RESPONSES; STRAIGHT	We discover and examine within a wide phylogenetic perspective spatial neophobia, avoidance of untrodden terrain, in fruit flies, in an experimental setup that reduces the gap between the field and the laboratory. In our setup, fruit flies use a natal fruit as their origin, freely exploring for days their surroundings, which consists of a mixture of trodden and untrodden terrain. The interface between trodden and untrodden is, however, reduced in our setup to a wide doorway, opened within a surrounding wall. Crossing this doorway, characterized by a sharp contrast interface between trodden and untrodden, generates a behavior whose dynamics betrays the flies' space neophobia. The moment-by-moment dynamics of crossing is remarkably similar to that reported in mouse models of anxiety. This means that neophobic behavior is either homologous across arthropods and vertebrates or, not less interesting, convergent, whereby the same behavior is mediated in the two phyla by two completely different schemata.	[Cohen, Shay; Golani, Ilan] Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel; [Benjamini, Yoav] Tel Aviv Univ, Dept Stat & OR, IL-69978 Tel Aviv, Israel; [Cohen, Shay; Benjamini, Yoav; Golani, Ilan] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Tel Aviv University	Golani, I (corresponding author), Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel.	ilan99@tau.ac.il			Israel Science Foundation (ISF) [1351]	Israel Science Foundation (ISF)(Israel Science Foundation)	This study was supported by a grant from the Israel Science Foundation (ISF 1351). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a grant from the Israel Science Foundation (ISF 1351). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank Prof. Daniel Segal of the department of Microbiology and Biotechnology, Tel Aviv University, Tel Aviv, Israel, for supplying the experimental animals, and Prof. Segal and Prof. John Ringo of the University of Maine, Orono, ME USA for their advice along the way. Dr. Alex Gomez Marin of Champalimaud Neuroscience Lisbon and Dr. Eyal Gruntman of Janelia Farm HHMI provided useful comments on the manuscript. Ms Naomi Paz edited and proofread the manuscript. We thank Yair Wexler of Tel Aviv University for his help with the Figs.	Baerends GP, 1941, FORTPFLANZUNGSVERHAL; Barrows WM, 1907, J EXP ZOOL, V4, P513; Benjamini Y, 2011, P NATL ACAD SCI USA, V108, P15580, DOI 10.1073/pnas.1014837108; Brembs B, 2006, LEARN MEMORY, V13, P629, DOI 10.1101/lm.319406; Cartwright B, 1982, NATURE; CONNOLLY K, 1967, ANIM BEHAV, V15, P149, DOI 10.1016/S0003-3472(67)80026-5; COOLS AR, 1993, CAN J PHYSIOL PHARM, V71, P335, DOI 10.1139/y93-052; Cools AR, 1998, PHARMACOL BIOCHEM BE, V60, P151, DOI 10.1016/S0091-3057(97)00586-8; DACUNHA AB, 1951, EVOLUTION, V5, P97, DOI 10.1111/j.1558-5646.1951.tb02766.x; Drai D, 2000, J NEUROSCI METH, V96, P119, DOI 10.1016/S0165-0270(99)00194-6; Ernst R, 1999, VISION RES, V39, P3920, DOI 10.1016/S0042-6989(99)00114-5; Fonio E, 2009, P NATL ACAD SCI USA, V106, P21335, DOI 10.1073/pnas.0812513106; Forrest J, 2009, P ROY SOC B-BIOL SCI, V276, P935, DOI 10.1098/rspb.2008.1434; GOLANI I, 1992, BEHAV BRAIN SCI, V15, P249, DOI 10.1017/S0140525X00068539; Golani I, 2012, BEHAV BRAIN RES, V231, P309, DOI 10.1016/j.bbr.2012.01.039; Gordon G, 2014, J COMPUTATIONAL NEUR, P1; Hager T, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00314; Heinze S, 2007, SCIENCE, V315, P995, DOI 10.1126/science.1135531; HOFFMANN AA, 1989, ANIM BEHAV, V38, P23, DOI 10.1016/S0003-3472(89)80062-4; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; Markow TA, 2015, ELIFE, V4, DOI 10.7554/eLife.06793; Mittelstaedt H., 1957, P51; Mizunami M, 1998, J COMP NEUROL, V402, P520; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Ofstad TA, 2011, NATURE, V474, P204, DOI 10.1038/nature10131; Olberg RM, 2012, CURR OPIN NEUROBIOL, V22, P267, DOI 10.1016/j.conb.2011.11.015; Pfeiffer K, 2007, CURR BIOL, V17, P960, DOI 10.1016/j.cub.2007.04.059; QUINN WG, 1974, P NATL ACAD SCI USA, V71, P708, DOI 10.1073/pnas.71.3.708; Reiser MB, 2010, J EXP BIOL, V213, P1771, DOI 10.1242/jeb.035147; Ritzmann RE, 2007, COLD SPRING HARB MON, V49, P229; Seelig JD, 2015, NATURE, V521, P186, DOI 10.1038/nature14446; SIEGEL RW, 1979, P NATL ACAD SCI USA, V76, P3430, DOI 10.1073/pnas.76.7.3430; Stamps J, 2005, ANIM BEHAV, V70, P609, DOI 10.1016/j.anbehav.2004.11.018; Strausfeld NJ, 2013, SCIENCE, V340, P157, DOI 10.1126/science.1231828; STRAUSS R, 1990, J COMP PHYSIOL A, V167, P403, DOI 10.1007/BF00192575; THOMPSON RF, 1966, PSYCHOL REV, V73, P16, DOI 10.1037/h0022681; TINBERGEN N., 1948, LEVENDE NATUUR, V51, P65; Valente D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001083; Vitzthum H, 2002, J NEUROSCI, V22, P1114, DOI 10.1523/JNEUROSCI.22-03-01114.2002; WEHNER R, 1981, J COMP PHYSIOL, V142, P315, DOI 10.1007/BF00605445; Wessnitzer J, 2008, P ROY SOC B-BIOL SCI, V275, P915, DOI 10.1098/rspb.2007.1647	41	3	3	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0140207	10.1371/journal.pone.0140207	http://dx.doi.org/10.1371/journal.pone.0140207			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YV	26646394	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903100001
J	Denisov, S; Bazykin, G; Favorov, A; Mironov, A; Gelfand, M				Denisov, Stepan; Bazykin, Georgii; Favorov, Alexander; Mironov, Andrey; Gelfand, Mikhail			Correlated Evolution of Nucleotide Positions within Splice Sites in Mammals	PLOS ONE			English	Article							PRE-MESSENGER-RNA; COMPENSATORY BASE CHANGE; U1 SNRNA; STATISTICAL-ANALYSIS; IN-VIVO; POLYPYRIMIDINE TRACT; U2 SNRNA; INTRON; EXONS; PROTEINS	Splice sites (SSs)-short nucleotide sequences flanking introns-are under selection for spliceosome binding, and adhere to consensus sequences. However, non-consensus nucleotides, many of which probably reduce SS performance, are frequent. Little is known about the mechanisms maintaining such apparently suboptimal SSs. Here, we study the correlations between strengths of nucleotides occupying different positions of the same SS. Such correlations may arise due to epistatic interactions between positions (i.e., a situation when the fitness effect of a nucleotide in one position depends on the nucleotide in another position), their evolutionary history, or to other reasons. Within both the intronic and the exonic parts of donor SSs, nucleotides that increase (decrease) SS strength tend to co-occur with other nucleotides increasing (respectively, decreasing) it, consistent with positive epistasis. Between the intronic and exonic parts of donor SSs, the correlations of nucleotide strengths tend to be negative, consistent with negative epistasis. In the course of evolution, substitutions at a donor SS tend to decrease the strength of its exonic part, and either increase or do not change the strength of its intronic part. In acceptor SSs, the situation is more complicated; the correlations between adjacent positions appear to be driven mainly by avoidance of the AG dinucleotide which may cause aberrant splicing. In summary, both the content and the evolution of SSs is shaped by a complex network of interdependences between adjacent nucleotides that respond to a range of sometimes conflicting selective constraints.	[Denisov, Stepan; Bazykin, Georgii; Mironov, Andrey; Gelfand, Mikhail] RAS, AA Kharkevich Inst Informat Transmiss Problems, Moscow 117901, Russia; [Bazykin, Georgii; Mironov, Andrey; Gelfand, Mikhail] Moscow MV Lomonosov State Univ, Fac Bioengn & Bioinformat, Moscow, Russia; [Favorov, Alexander] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Div Oncol Biostat, Baltimore, MD USA; [Favorov, Alexander] NI Vavilov Gen Genet Res Inst, Dept Computat Syst Biol, Lab Syst Biol & Computat Genet, Moscow 117809, Russia; [Favorov, Alexander] State Res Inst Genet & Select Ind Microorganism G, Lab Bioinformat, Moscow, Russia	Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences; Lomonosov Moscow State University; Johns Hopkins University; Johns Hopkins Medicine; Russian Academy of Sciences; Vavilov Institute of General Genetics; National Research Centre - Kurchatov Institute; Institute of Genetics & Selection of Industrial Microorganisms	Denisov, S (corresponding author), RAS, AA Kharkevich Inst Informat Transmiss Problems, Moscow 117901, Russia.	stepan@bioinf.fbb.msu.ru	Denisov, Stepan/AAX-4554-2021; Bazykin, Georgii/E-4601-2012; Favorov, Alexander V/K-2699-2018; Gelfand, Mikhail S/F-3425-2012	Denisov, Stepan/0000-0001-6465-3818; Bazykin, Georgii/0000-0003-2334-2751; Favorov, Alexander V/0000-0003-2595-1091; Gelfand, Mikhail/0000-0003-4181-0846	Russian Science Foundation [14-50-00150, 16-24-00155]; National Institutes of Health [P30 CA006973]; Russian Foundation for Basic Research [14-04-01872 A, 14-04-00576 A]; NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER	Russian Science Foundation(Russian Science Foundation (RSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work has been performed in IITP RAS and supported by the Russian Science Foundation (grant 14-50-00150) http://rscf.ru/en/. The work was partially supported by Russian Science Foundation (grant 16-24-00155 to MG, SD) http://rscf.ru/en/; by National Institutes of Health (grant P30 CA006973 to AF) http://www.nih.gov/; Russian Foundation for Basic Research (14-04-01872 A to AF, 14-04-00576 A to AM, AF) http://www.rfbr.ru/rffi/eng. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agirre E, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0141-5; Artamonova II, 2004, J MOL EVOL, V59, P620, DOI 10.1007/s00239-004-2654-3; Ast G, 2004, NAT REV GENET, V5, P773, DOI 10.1038/nrg1451; Baek D, 2005, P NATL ACAD SCI USA, V102, P12813, DOI 10.1073/pnas.0506139102; Barry D., 1987, STAT SCI, V2, P191, DOI DOI 10.1214/SS/1177013353; Bouck J, 1998, NUCLEIC ACIDS RES, V26, P4516, DOI 10.1093/nar/26.19.4516; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Carmel I, 2004, RNA, V10, P828, DOI 10.1261/rna.5196404; Clark F, 2002, HUM MOL GENET, V11, P451, DOI 10.1093/hmg/11.4.451; Collins L, 2005, MOL BIOL EVOL, V22, P1053, DOI 10.1093/molbev/msi091; Coolidge CJ, 1997, NUCLEIC ACIDS RES, V25, P888, DOI 10.1093/nar/25.4.888; Denisov SV, 2014, GENOME BIOL EVOL, V6, P1437, DOI 10.1093/gbe/evu100; DIBB NJ, 1989, EMBO J, V8, P2015, DOI 10.1002/j.1460-2075.1989.tb03609.x; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; GELFAND MS, 1989, NUCLEIC ACIDS RES, V17, P6369, DOI 10.1093/nar/17.15.6369; GELFAND MS, 1992, J MOL EVOL, V35, P239; Gonzalez I, 2015, NAT STRUCT MOL BIOL, V22, P370, DOI 10.1038/nsmb.3005; Irimia M, 2007, TRENDS GENET, V23, P321, DOI 10.1016/j.tig.2007.04.001; Jenkins JL, 2013, NUCLEIC ACIDS RES, V41, P3859, DOI 10.1093/nar/gkt046; Kornblihtt AR, 2004, RNA, V10, P1489, DOI 10.1261/rna.7100104; Kralovicova J, 2015, NUCLEIC ACIDS RES, V43, P3747, DOI 10.1093/nar/gkv194; KRETZNER L, 1987, CELL, V50, P593, DOI 10.1016/0092-8674(87)90032-8; LERNER MR, 1980, NATURE, V283, P220, DOI 10.1038/283220a0; Manceau V, 2006, FEBS J, V273, P577, DOI 10.1111/j.1742-4658.2005.05091.x; Maor GL, 2015, TRENDS GENET, V31, P274, DOI 10.1016/j.tig.2015.03.002; Mercer TR, 2015, GENOME RES, V25, P290, DOI 10.1101/gr.182899.114; MICHAUD S, 1991, GENE DEV, V5, P2534, DOI 10.1101/gad.5.12b.2534; Naftelberg S, 2015, ANNU REV BIOCHEM, V84, P165, DOI 10.1146/annurev-biochem-060614-034242; NELSON KK, 1990, P NATL ACAD SCI USA, V87, P6253, DOI 10.1073/pnas.87.16.6253; Nurtdinov RN, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-249; Nurtdinov RN, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-142; Nurtdinov RN, 2006, BIOPHYSICS-USSR, V51, P523, DOI [10.1134/S0006350906040026, DOI 10.1134/S0006350906040026]; Ohno K, 1999, AM J HUM GENET, V65, P635, DOI 10.1086/302551; Prasad AB, 2008, MOL BIOL EVOL, V25, P1795, DOI 10.1093/molbev/msn104; Ram O, 2007, TRENDS GENET, V23, P5, DOI 10.1016/j.tig.2006.10.002; Roca X, 2005, RNA, V11, P683, DOI 10.1261/rna.2040605; Rogozin IB, 1997, J MOL EVOL, V45, P50, DOI 10.1007/PL00006200; Rogozin IB, 2003, CURR BIOL, V13, P1512, DOI 10.1016/S0960-9822(03)00558-X; Rogozin IB, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-11; Rollins RA, 2006, GENOME RES, V16, P157, DOI 10.1101/gr.4262006; ROSCIGNO RF, 1993, J BIOL CHEM, V268, P11222; Sadusky T, 2004, CURR BIOL, V14, P505, DOI 10.1016/j.cub.2004.02.063; SCARANO E, 1967, P NATL ACAD SCI USA, V57, P1394, DOI 10.1073/pnas.57.5.1394; Schwartz SH, 2008, GENOME RES, V18, P88, DOI 10.1101/gr.6818908; Segault V, 1999, MOL CELL BIOL, V19, P2782; SERAPHIN B, 1989, CELL, V59, P349, DOI 10.1016/0092-8674(89)90296-1; SERAPHIN B, 1988, EMBO J, V7, P2533, DOI 10.1002/j.1460-2075.1988.tb03101.x; Shcherbakova I, 2013, CELL REP, V5, P151, DOI 10.1016/j.celrep.2013.08.026; Sheth N, 2006, NUCLEIC ACIDS RES, V34, P3955, DOI 10.1093/nar/gkl556; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; Sorek R, 2003, GENOME RES, V13, P1631, DOI 10.1101/gr.1208803; Stamm S, 2000, DNA CELL BIOL, V19, P739, DOI 10.1089/104454900750058107; STAMM S, 1994, NUCLEIC ACIDS RES, V22, P1515, DOI 10.1093/nar/22.9.1515; Sverdlov AV, 2004, CURR BIOL, V14, P1505, DOI 10.1016/j.cub.2004.08.027; Sverdlov AV, 2003, CURR BIOL, V13, P2170, DOI 10.1016/j.cub.2003.12.003; Taggart AJ, 2012, NAT STRUCT MOL BIOL, V19, P719, DOI 10.1038/nsmb.2327; Thanaraj T A, 2000, Brief Bioinform, V1, P343, DOI 10.1093/bib/1.4.343; Valcarcel J, 1996, SCIENCE, V273, P1706, DOI 10.1126/science.273.5282.1706; Zheng CL, 2005, RNA, V11, P1777, DOI 10.1261/rna.2660805; Zheng ZM, 2000, J VIROL, V74, P5902, DOI 10.1128/JVI.74.13.5902-5910.2000; ZHUANG Y, 1986, CELL, V46, P827, DOI 10.1016/0092-8674(86)90064-4; ZHUANG Y, 1989, GENE DEV, V3, P1545, DOI 10.1101/gad.3.10.1545	63	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144388	10.1371/journal.pone.0144388	http://dx.doi.org/10.1371/journal.pone.0144388			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642327	Green Published, Green Submitted, gold			2022-12-27	WOS:000366902700109
J	Eyring, KR; Pedersen, BS; Yang, IV; Schwartz, DA				Eyring, Kenneth R.; Pedersen, Brent S.; Yang, Ivana V.; Schwartz, David A.			In Utero Cigarette Smoke Affects Allergic Airway Disease But Does Not Alter the Lung Methylome	PLOS ONE			English	Article							MATERNAL SMOKING; IMMUNE-RESPONSES; TOBACCO-SMOKE; PREGNANCY; ASTHMA; METHYLATION; EXPOSURE; MICE; INFLAMMATION; EXPRESSION	Prenatal and postnatal cigarette smoke exposure enhances the risk of developing asthma. Despite this as well as other smoking related risks, 11% of women still smoke during pregnancy. We hypothesized that cigarette smoke exposure during prenatal development generates long lasting differential methylation altering transcriptional activity that correlates with disease. In a house dust mite (HDM) model of allergic airway disease, we measured airway hyperresponsiveness (AHR) and airway inflammation between mice exposed prenatally to cigarette smoke (CS) or filtered air (FA). DNA methylation and gene expression were then measured in lung tissue. We demonstrate that HDM-treated CS mice develop a more severe allergic airway disease compared to HDM-treated FA mice including increased AHR and airway inflammation. While DNA methylation changes between the two HDM-treated groups failed to reach genome-wide significance, 99 DMRs had an uncorrected p-value < 0.001. 6 of these 99 DMRs were selected for validation, based on the immune function of adjacent genes, and only 2 of the 6 DMRs confirmed the bisulfite sequencing data. Additionally, genes near these 6 DMRs (Lif, Il27ra, Tle4, Ptk7, Nfatc2, and Runx3) are differentially expressed between HDM-treated CS mice and HDM-treated FA mice. Our findings confirm that prenatal exposure to cigarette smoke is sufficient to modify allergic airway disease; however, it is unlikely that specific methylation changes account for the exposure-response relationship. These findings highlight the important role in utero cigarette smoke exposure plays in the development of allergic airway disease.	[Eyring, Kenneth R.; Pedersen, Brent S.; Yang, Ivana V.; Schwartz, David A.] Univ Colorado, Dept Med, Sch Med, Aurora, CO 80045 USA; [Schwartz, David A.] Univ Colorado, Dept Immunol, Sch Med, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Schwartz, DA (corresponding author), Univ Colorado, Dept Med, Sch Med, Aurora, CO 80045 USA.	david.schwartz@ucdenver.edu	Yang, Ivana V/P-3059-2018	Yang, Ivana V/0000-0002-1018-489X; Eyring, Kenneth/0000-0003-4163-5435	National Institute of Health, National Institute of Environmental Health Sciences [PO1-ES18181]; National Institute of Health, National Heart, Lung, and Blood Institute [RO1-HL101251]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL101251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES018181] Funding Source: NIH RePORTER	National Institute of Health, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grants PO1-ES18181 (National Institute of Health, National Institute of Environmental Health Sciences, http://www.niehs.nih.gov/, to DA); and RO1-HL101251 (National Institute of Health, National Heart, Lung, and Blood Institute, http://www.nhlbi.nih.gov/, to DA and IV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbarian S, 2002, J NEUROSCI, V22, P4153, DOI 10.1523/JNEUROSCI.22-10-04153.2002; Akinbami LJ, 2005, NATL HLTH STAT REP, V2011, P1; Blacquiere MJ, 2009, EUR RESPIR J, V33, P1133, DOI 10.1183/09031936.00129608; Bousquet J, 2004, ALLERGY, V59, P138, DOI 10.1046/j.1398-9995.2003.00359.x; Devereux G, 2002, CLIN EXP ALLERGY, V32, P43, DOI 10.1046/j.0022-0477.2001.01267.x; DeWan AT, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-95; Fainaru O, 2005, P NATL ACAD SCI USA, V102, P10598, DOI 10.1073/pnas.0504787102; Hollingsworth JW, 2008, J CLIN INVEST, V118, P3462, DOI 10.1172/JCI34378; Hu FB, 1997, ANN ALLERG ASTHMA IM, V79, P80, DOI 10.1016/S1081-1206(10)63090-6; Jaakkola JJK, 2004, AM J PUBLIC HEALTH, V94, P136, DOI 10.2105/AJPH.94.1.136; Kelada SNP, 2014, AM J RESP CELL MOL, V51, P436, DOI 10.1165/rcmb.2013-0501OC; Kim DH, 2001, CANCER RES, V61, P3419; KLIPPERAURBACH Y, 1995, MED HYPOTHESES, V45, P486, DOI 10.1016/0306-9877(95)90228-7; Launay JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007959; Marwick JA, 2004, AM J RESP CELL MOL, V31, P633, DOI 10.1165/rcmb.2004-0006OC; Murin S, 2011, CLIN CHEST MED, V32, P75, DOI 10.1016/j.ccm.2010.11.004; Noakes PS, 2006, EUR RESPIR J, V28, P721, DOI 10.1183/09031936.06.00050206; Noakes PS, 2003, ALLERGY, V58, P1053, DOI 10.1034/j.1398-9995.2003.00290.x; Pedersen BS, 2014, ARXIV E PRINTS, P1401; Phillips JM, 2009, TOXICOLOGY, V260, P7, DOI 10.1016/j.tox.2009.03.001; Rosas SLB, 2001, CANCER RES, V61, P939; Rouse RL, 2007, ENVIRON HEALTH PERSP, V115, P1757, DOI 10.1289/ehp.10358; Singh SP, 2009, J IMMUNOL, V183, P2115, DOI 10.4049/jimmunol.0900826; Singh SP, 2003, AM J RESP CRIT CARE, V168, P342, DOI 10.1164/rccm.200211-1262OC; Sofer T, 2013, BIOINFORMATICS, V29, P2884, DOI 10.1093/bioinformatics/btt498; Tebow G, 2008, PEDIATRICS, V121, pE1563, DOI 10.1542/peds.2007-2795; Tong V. T., 2013, MMWR-MORBID MORTAL W, V62, P1; WEGMANN TG, 1993, IMMUNOL TODAY, V14, P353, DOI 10.1016/0167-5699(93)90235-D; Wolff EM, 2008, CANCER RES, V68, P6208, DOI 10.1158/0008-5472.CAN-07-6616; Wu ZX, 2009, ENVIRON HEALTH PERSP, V117, P1434, DOI 10.1289/ehp.0800511; Yao HW, 2011, TOXICOL APPL PHARM, V254, P72, DOI 10.1016/j.taap.2009.10.022; Zaghouani H, 2009, TRENDS IMMUNOL, V30, P585, DOI 10.1016/j.it.2009.09.002	32	10	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144087	10.1371/journal.pone.0144087	http://dx.doi.org/10.1371/journal.pone.0144087			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642056	Green Published, Green Submitted, gold			2022-12-27	WOS:000366902700053
J	Jin, Y; Liu, YL; Zhang, J; Huang, W; Jiang, HN; Hou, YY; Xu, C; Zhai, CW; Gao, X; Wang, SY; Wu, Y; Zhu, HG; Lu, SH				Jin, Yi; Liu, Yalan; Zhang, Jin; Huang, Wei; Jiang, Hongni; Hou, Yingyong; Xu, Chen; Zhai, Changwen; Gao, Xue; Wang, Shuyang; Wu, Ying; Zhu, Hongguang; Lu, Shaohua			The Expression of miR-375 Is Associated with Carcinogenesis in Three Subtypes of Lung Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; DOWN-REGULATION; MICRORNA-375; ACTIVATION; TUMOR; HEAD; NECK; METASTASIS; PROFILES; MARKERS	Many studies demonstrated unique microRNA profiles in lung cancer. Nonetheless, the role and related signal pathways of miR-375 in lung cancer are largely unknown. Our study investigated relationships between carcinogenesis and miR-375 in adenocarcinoma, squamous cell carcinoma and small cell lung carcinoma to identify new molecular targets for treatment. We evaluated 723 microRNAs in microdissected cancerous cells and adjacent normal cells from 126 snap-frozen lung specimens using microarrays. We validated the expression profiles of miR-375 and its 22 putative target mRNAs in an independent cohort of 78 snap-frozen lung cancer tissues using quantitative reverse-transcriptase PCR. Moreover, we performed dual luciferase reporter assay and Western blot on 6 targeted genes (FZD8, ITGA10, ITPKB, LRP5, PIAS1 andRUNX1) in small cell lung carcinoma cell line NCI-H82. We also detected the effect of miR-375 on cell proliferation in NCI-H82. We found that miR-375 expression was significantly up-regulated in adenocarcinoma and small cell lung carcinoma but down-regulated in squamous cell carcinoma. Among the 22 putative target genes, 11 showed significantly different expression levels in at least 2 of 3 pair-wise comparisons (adenocarcinoma vs. normal, squamous cell carcinoma vs. normal or small cell lung carcinoma vs. normal). Six targeted genes had strong negative correlation with the expression level of miR-375 in small cell lung carcinoma. Further investigation revealed that miR-375 directly targeted the 3'UTR of ITPKB mRNA and over-expression of miR-375 led to significantly decreased ITPKB protein level and promoted cell growth. Thus, our study demonstrates the differential expression profiles of miR-375 in 3 subtypes of lung carcinomas and finds thatmiR-375 directly targets ITPKB and promoted cell growth in SCLC cell line.	[Jin, Yi; Wang, Shuyang; Wu, Ying; Zhu, Hongguang] Fudan Univ, Sch Basic Med Sci, Dept Pathol, Shanghai 200433, Peoples R China; [Jin, Yi] Wenzhou Med Univ, Affiliated Hosp 1, Dept Pathol, Wenzhou, Peoples R China; [Liu, Yalan; Hou, Yingyong; Xu, Chen; Zhai, Changwen; Lu, Shaohua] Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200433, Peoples R China; [Zhang, Jin] Fudan Univ, Shanghai Med Coll, Inst Med Sci,Dept Biochem & Mol Biol, Key Lab Mol Med,Minist Educ, Shanghai 200433, Peoples R China; [Huang, Wei] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Dept Thorac Surg, Shanghai 200092, Peoples R China; [Jiang, Hongni] Fudan Univ, Zhongshan Hosp, Dept Pulm Med, Shanghai 200433, Peoples R China; [Gao, Xue; Zhu, Hongguang] Fudan Univ, Huashan Hosp, Dept Pathol, Shanghai 200433, Peoples R China	Fudan University; Wenzhou Medical University; Fudan University; Fudan University; Tongji University; Fudan University; Fudan University	Lu, SH (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200433, Peoples R China.	lushaohua2010@126.com			National Natural Science Foundation of China [81472174, 81401879]; Science and Technology Commission of Shanghai Municipality [14411965900, 14ZR1406100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by National Natural Science Foundation of China (No. 81472174 and 81401879), Science and Technology Commission of Shanghai Municipality (No. 14411965900 and 14ZR1406100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avnit-Sagi T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005033; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beasley MB, 2005, SEMIN ROENTGENOL, V40, P90, DOI 10.1053/j.ro.2005.01.001; Chang CW, 2012, NEUROSCI LETT, V531, P204, DOI 10.1016/j.neulet.2012.10.021; Dai XN, 2012, MOL MED REP, V5, P1299, DOI 10.3892/mmr.2012.815; Feng QH, 2008, CANCER EPIDEM BIOMAR, V17, P645, DOI 10.1158/1055-9965.EPI-07-2518; Harris T, 2012, AM J PATHOL, V180, P917, DOI 10.1016/j.ajpath.2011.12.004; He XX, 2012, ONCOGENE, V31, P3357, DOI 10.1038/onc.2011.500; Huang W, 2012, AM J RESP CRIT CARE, V186, P1160, DOI 10.1164/rccm.201203-0534OC; Hui ABY, 2011, CLIN CANCER RES, V17, P7539, DOI 10.1158/1078-0432.CCR-11-2102; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kim S, 2009, COMPUT BIOL CHEM, V33, P94, DOI 10.1016/j.compbiolchem.2008.07.016; Kimura S, 2010, ONCOL REP, V23, P1625, DOI 10.3892/or_00000804; Kloosterman WP, 2007, PLOS BIOL, V5, P1738, DOI 10.1371/journal.pbio.0050203; Kong KL, 2012, GUT, V61, P33, DOI 10.1136/gutjnl-2011-300178; Lee EHL, 2008, CLIN MED INSIGHTS-ON, V2, P169; Leidner RS, 2012, GENE CHROMOSOME CANC, V51, P473, DOI 10.1002/gcc.21934; Li JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053582; Li Y, 2012, J INT MED RES, V40, P1662, DOI 10.1177/030006051204000505; Majid S, 2010, CANCER-AM CANCER SOC, V116, P5637, DOI 10.1002/cncr.25488; Mascaux C, 2009, EUR RESPIR J, V33, P352, DOI 10.1183/09031936.00084108; Megidish T, 2002, J BIOL CHEM, V277, P8255, DOI 10.1074/jbc.C200001200; Miller YE, 2005, AM J RESP CELL MOL, V33, P216, DOI 10.1165/rcmb.2005-0158OE; Nalaskowski MM, 2011, J BIOL CHEM, V286, P4500, DOI 10.1074/jbc.M110.173062; Nishikawa E, 2011, CANCER RES, V71, P6165, DOI 10.1158/0008-5472.CAN-11-1020; Nunez-Iglesias J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008898; Saitoh T, 2001, INT J ONCOL, V18, P991; Simonini PDR, 2010, CANCER RES, V70, P9175, DOI 10.1158/0008-5472.CAN-10-1318; Szczyrba J, 2011, MOL CANCER RES, V9, P791, DOI 10.1158/1541-7786.MCR-10-0573; Tajouri L, 2005, BRAIN RES PROTOC, V15, P79, DOI 10.1016/j.brainresprot.2005.04.003; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Wang SY, 2013, GUT, V62, P280, DOI 10.1136/gutjnl-2011-301554; Wang SY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-163; Wang YP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-218; Wu HL, 2009, CELL RES, V19, P439, DOI 10.1038/cr.2009.18; Yan JW, 2014, INT J CANCER, V135, P1011, DOI 10.1002/ijc.28563; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang Y, 2010, CANCER GENET CYTOGEN, V200, P127, DOI 10.1016/j.cancergencyto.2010.03.014; Zhao HJ, 2012, ACTA BIOCH BIOPH SIN, V44, P177, DOI 10.1093/abbs/gmr110	39	40	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144187	10.1371/journal.pone.0144187	http://dx.doi.org/10.1371/journal.pone.0144187			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642205	gold, Green Published, Green Submitted			2022-12-27	WOS:000366902700072
J	Khorramian, K; Maleki, S; Shariati, M; Sulong, NHR				Khorramian, Koosha; Maleki, Shervin; Shariati, Mahdi; Sulong, N. H. Ramli			Behavior of Tilted Angle Shear Connectors	PLOS ONE			English	Article							CHANNEL; CONCRETE; STRENGTH	According to recent researches, angle shear connectors are appropriate to transfer longitudinal shear forces across the steel-concrete interface. Angle steel profile has been used in different positions as L-shaped or C-shaped shear connectors. The application of angle shear connectors in tilted positions is of interest in this study. This study investigates the behaviour of tilted-shaped angle shear connectors under monotonic loading using experimental push out tests. Eight push-out specimens are tested to investigate the effects of different angle parameters on the ultimate load capacity of connectors. Two different tilted angles of 112.5 and 135 degrees between the angle leg and steel beam are considered. In addition, angle sizes and lengths are varied. Two different failure modes were observed consisting of concrete crushing-splitting and connector fracture. By increasing the size of connector, the maximum load increased for most cases. In general, the 135 degrees tilted angle shear connectors have a higher strength and stiffness than the 112.5 degrees type.	[Khorramian, Koosha; Maleki, Shervin] Sharif Univ Technol, Dept Civil Engn, Tehran, Iran; [Shariati, Mahdi; Sulong, N. H. Ramli] Univ Malaya, Dept Civil Engn, Kuala Lumpur, Malaysia	Sharif University of Technology; Universiti Malaya	Shariati, M (corresponding author), Sharif Univ Technol, Dept Civil Engn, Tehran, Iran.	shariati@um.edu.my	Shariati, Mahdi/C-9626-2019; SULONG, NOR HAFIZAH RAMLI/B-9311-2010	Shariati, Mahdi/0000-0002-0440-7612; SULONG, NOR HAFIZAH RAMLI/0000-0001-8209-313X; maleki, shervin/0000-0002-3574-2106	UM High Impact Research Grant from the Ministry of Higher Education Malaysia [UM.C/625/1/HIR/MOHE/ENG/57]	UM High Impact Research Grant from the Ministry of Higher Education Malaysia	This research was supported by the UM High Impact Research Grant UM.C/625/1/HIR/MOHE/ENG/57 from the Ministry of Higher Education Malaysia.	[Anonymous], 2004, C11 EN EUR COMM STAN; [Anonymous], 2010, MAN ABAQUS VERS 6 10; [Anonymous], 0595 STRUCT DIV SUB; Choi S M, 2011, THESIS; Choi SM, 2008, INT J STEEL STRUCT, V8, P199; Ciutina A L, CYCLIC PERFORMANCES; Fukazawa K., 2002, MITSUI ZOSEN TECHNIC, VI-456, P8; Khalilian M, 2013, THESIS; Maleki S, 2008, J CONSTR STEEL RES, V64, P1333, DOI 10.1016/j.jcsr.2008.01.010; Maleki S, 2008, J CONSTR STEEL RES, V64, P1341, DOI 10.1016/j.jcsr.2008.01.006; Maleki S, 2009, J CONSTR STEEL RES, V65, P1787, DOI 10.1016/j.jcsr.2009.04.008; Osamu K, 1986, STRENGTH PROPERTIES; Rao S N, 1970, J I ENG; Ros S., 2009, 8 S RES APPL HYBR CO, P1; Saidi T., 2008, J MAT CONCR STRUCT P, V64, P122; Shariati A, 2012, MATER DESIGN, V33, P325; Shariati M, 2014, ENG FAIL ANAL, V41, P124, DOI 10.1016/j.engfailanal.2014.02.017; Shariati M, 2013, CONSTR BUILD MATER, V38, P582, DOI 10.1016/j.conbuildmat.2012.07.050; Shariati M, 2012, MATER DESIGN, V41, P67, DOI 10.1016/j.matdes.2012.04.039	19	88	88	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144288	10.1371/journal.pone.0144288	http://dx.doi.org/10.1371/journal.pone.0144288			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642193	Green Published, gold, Green Submitted			2022-12-27	WOS:000366902700090
J	Leong, V; Goswami, U				Leong, Victoria; Goswami, Usha			Acoustic-Emergent Phonology in the Amplitude Envelope of Child-Directed Speech	PLOS ONE			English	Article								When acquiring language, young children may use acoustic spectro-temporal patterns in speech to derive phonological units in spoken language (e.g., prosodic stress patterns, syllables, phonemes). Children appear to learn acoustic-phonological mappings rapidly, without direct instruction, yet the underlying developmental mechanisms remain unclear. Across different languages, a relationship between amplitude envelope sensitivity and phonological development has been found, suggesting that children may make use of amplitude modulation (AM) patterns within the envelope to develop a phonological system. Here we present the Spectral Amplitude Modulation Phase Hierarchy (S-AMPH) model, a set of algorithms for deriving the dominant AM patterns in child-directed speech (CDS). Using Principal Components Analysis, we show that rhythmic CDS contains an AM hierarchy comprising 3 core modulation timescales. These timescales correspond to key phonological units: prosodic stress (Stress AM, similar to 2 Hz), syllables (Syllable AM, similar to 5 Hz) and onset-rime units (Phoneme AM, similar to 20 Hz). We argue that these AM patterns could in principle be used by naive listeners to compute acoustic-phonological mappings without lexical knowledge. We then demonstrate that the modulation statistics within this AM hierarchy indeed parse the speech signal into a primitive hierarchically-organised phonological system comprising stress feet (proto-words), syllables and onset-rime units. We apply the S-AMPH model to two other CDS corpora, one spontaneous and one deliberately-timed. The model accurately identified 72-82% (freely-read CDS) and 90-98% (rhythmically-regular CDS) stress patterns, syllables and onset-rime units. This in-principle demonstration that primitive phonology can be extracted from speech AMs is termed Acoustic-Emergent Phonology (AEP) theory. AEP theory provides a set of methods for examining how early phonological development is shaped by the temporal modulation structure of speech across languages. The S-AMPH model reveals a crucial developmental role for stress feet (AMs similar to 2 Hz). Stress feet underpin different linguistic rhythm typologies, and speech rhythm underpins language acquisition by infants in all languages.	[Leong, Victoria; Goswami, Usha] Univ Cambridge, Ctr Neurosci Educ, Dept Psychol, Cambridge, England	University of Cambridge	Leong, V (corresponding author), Univ Cambridge, Ctr Neurosci Educ, Dept Psychol, Cambridge, England.	vvec2@cam.ac.uk	Leong, Victoria/G-5778-2013	Leong, Victoria/0000-0003-0666-9445; Goswami, Usha/0000-0001-7858-2336	Harold Hyam Wingate Foundation Research Scholarship; Lucy Cavendish College Junior Research Fellowship; Medical Research Council [G0902375]; MRC [G0902375] Funding Source: UKRI	Harold Hyam Wingate Foundation Research Scholarship; Lucy Cavendish College Junior Research Fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was funded by a Harold Hyam Wingate Foundation Research Scholarship and a Lucy Cavendish College Junior Research Fellowship to VL, and by a grant from the Medical Research Council to UG (G0902375). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded by a Harold Hyam Wingate Foundation Research Scholarship and a Lucy Cavendish College Junior Research Fellowship to VL, and by a grant from the Medical Research Council to UG (G0902375). We thank Richard Turner for the use of his PCA scripts, and Michael Stone for the use of his code.		0	59	59	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144411	10.1371/journal.pone.0144411	http://dx.doi.org/10.1371/journal.pone.0144411			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641472	Green Submitted, gold, Green Published			2022-12-27	WOS:000366902700113
J	Macias, J; Lopez-Cortes, LF; Tellez, F; Recio, E; Ojeda-Burgos, G; Rios, MJ; Rivero-Juarez, A; Delgado, M; Rivas-Jeremias; Pineda, JA				Macias, Juan; Lopez-Cortes, Luis F.; Tellez, Francisco; Recio, Eva; Ojeda-Burgos, Guillermo; Jose Rios, Ma; Rivero-Juarez, Antonio; Delgado, Marcial; Rivas-Jeremias; Pineda, Juan A.			Low Efficacy of Pegylated Interferon plus Ribavirin plus Nitazoxanide for HCV Genotype 4 and HIV Coinfection	PLOS ONE			English	Article							HEPATITIS-C VIRUS; INFECTED PATIENTS; EXPERIENCED PATIENTS; TREATMENT-NAIVE; OPEN-LABEL; PEG-IFN; THERAPY; PEGINTERFERON; EPIDEMIOLOGY; SOFOSBUVIR	Background Nitazoxanide (NTZ) plus pegylated interferon and ribavirin (Peg-IFN/RBV) improved the sustained virological response (SVR) achieved with Peg-IFN/RBV in hepatitis C virus genotype 4 (HCV-4)-monoinfected patients. There are no data currently on the efficacy of PegIFN/RBV plus NTZ for human immunodeficiency virus (HIV)/HCV-4 coinfection. Therefore, the objectives of this clinical trial were to assess the efficacy and to evaluate the safety of Peg-IFN/RBV plus NTZ in HIV/HCV-4-coinfected patients. Patients and Methods This was an open-label, single arm, multicenter phase II pilot clinical trial (NCT01529073) enrolling HIV-infected individuals with HCV-4 chronic infection, naive to HCV therapy. Patients were treated with NTZ 500 mg bid for 4 weeks, followed by NTZ 500 mg bid plus Peg-IFN alpha-2b 1.5 mu g/kg/week plus weight-adjusted RBV during 48 weeks. Analyses were done by intention-to-treat (ITT, missing = failure). A historical cohort of HIV/HCV-4-infected patients treated with Peg-IFN alpha-2b and RBV at the same area was used as control. Results Two (9.5%) of 21 patients included in the trial compared with 5 (21.7%) of 23 patients included in the historical cohort achieved SVR (SVR risk difference, -12.2%; 95% confidence interval, -33.2% to 8.8%; p = 0.416). Virological failure was due to lack of response in 13 (62%) individuals recruited in the trial. Two (9.5%) patients included in the trial and two (9.5%) individuals from the historical cohort discontinued permanently due to adverse events. Conclusions No increase in SVR was observed among HIV/HCV-4-coinfected patients receiving Peg-IFN/RBV plus NTZ compared with a historical cohort treated with Peg-IFN/RBV. Interruptions due to adverse events of Peg-IFN/RBV plus NTZ were similar to those of dual therapy.	[Macias, Juan; Recio, Eva; Pineda, Juan A.] Hosp Univ Valme, Unidad Clin Enfermedades Infecciosas & Microbiol, Seville, Spain; [Lopez-Cortes, Luis F.; Rivas-Jeremias] Hosp Univ Virgen Rocia, Inst Biomed Sevilla IBiS, Unidad Clin Enfermedades Infecciosas Microbiol &, Seville, Spain; [Tellez, Francisco] Hosp La Linea Concepc, AGS Campo Gibraltar, Unidad Gest Clin Enfermedades Infecciosas & Micro, Cadiz, Spain; [Ojeda-Burgos, Guillermo] Complejo Hosp Malaga, Hosp Virgen Victoria, Unidad Gest Clin Enfermedades Infecciosas, Malaga, Spain; [Jose Rios, Ma] Hosp Univ Virgen Macarena, Unidad Enfermedades Infecciosas, Seville, Spain; [Rivero-Juarez, Antonio] Hosp Univ Reina Sofia, Inst Maimonides Invest Biomed Cordoba IMIBIC, Unidad Enfermedades Infecciosas, Cordoba, Spain; [Delgado, Marcial] Hosp Reg Malaga, Serv Enfermedades Infecciosas, Malaga, Spain	Hospital Valme; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Hospital Universitario Virgen Macarena	Macias, J (corresponding author), Hosp Univ Valme, Unidad Clin Enfermedades Infecciosas & Microbiol, Seville, Spain.	juan.macias.sanchez@gmail.com	Lopez.Cortes, Luis Fernando/W-8323-2019; IBIS, VIH/O-8856-2015; Macias, Juan/I-9133-2019; Rivero, Antonio/ABE-5294-2020; Pineda, Juan A./AAO-9312-2021; Rivero-Juarez, Antonio/E-4528-2019	Lopez.Cortes, Luis Fernando/0000-0002-3804-3458; Macias, Juan/0000-0002-4778-790X; Pineda, Juan A./0000-0002-3751-0296; Rivero-Juarez, Antonio/0000-0002-5813-6889; Ojeda Burgos, Guillermo/0000-0003-0544-4690; Tellez, Francisco/0000-0002-9997-6761	Servicio Andaluz de Salud de la Junta de Andalucia [B-0037]; Instituto de Salud Carlos III [Programa-I3SNS]; Plan Nacional R + D + I [RD12/0017/0012]; ISCIII-Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER) [RIS-HEP04]; Ministerio de Sanidad, Politica Social e Igualdad [EC10-187, EC11-286]; Fundacion Progreso y Salud (Consejeria de Salud, Innovacion y Ciencia de la Junta de Andalucia) [0028/2013]	Servicio Andaluz de Salud de la Junta de Andalucia(Junta de Andalucia); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Plan Nacional R + D + I; ISCIII-Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER); Ministerio de Sanidad, Politica Social e Igualdad(Spanish Government); Fundacion Progreso y Salud (Consejeria de Salud, Innovacion y Ciencia de la Junta de Andalucia)	JM is the recipient of a grant from the Servicio Andaluz de Salud de la Junta de Andalucia (B-0037). JAP is the recipient of an intensification grant from the Instituto de Salud Carlos III (grant number Programa-I3SNS). Besides, this work has been partially funded by the RD12/0017/0012 project as part of the Plan Nacional R + D + I and cofinanced by ISCIII-Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER) (RIS-HEP04). It has been partly supported by grants from Ministerio de Sanidad, Politica Social e Igualdad (references EC10-187 and EC11-286). A.R-J is the recipient of a Post- Doctoral Research Extension Grant from the Fundacion Progreso y Salud (0028/2013; Consejeria de Salud, Innovacion y Ciencia de la Junta de Andalucia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorosa VK, 2013, HIV CLIN TRIALS, V14, P274, DOI [10.1310/hct1406-274, 10.1310/hct1408-274]; Antaki N, 2013, J VIRAL HEPATITIS, V20, P59, DOI 10.1111/j.1365-2893.2012.01621.x; Cifuentes C, 2015, ENFERM INFEC MICR CL, V33, P110, DOI 10.1016/j.eimc.2014.05.010; Cornberg M, 2011, LIVER INT, V31, P30, DOI 10.1111/j.1478-3231.2011.02539.x; de Bruijne J, 2009, J CLIN MICROBIOL, V47, P3832, DOI 10.1128/JCM.01146-09; Esmat G, 2014, LIVER INT, V34, P24, DOI 10.1111/liv.12397; Hezode C, 2015, LANCET, V385, P2502, DOI 10.1016/S0140-6736(15)60159-3; Hezode C, 2015, GUT, V64, P948, DOI 10.1136/gutjnl-2014-307498; Kamal SM, 2014, AM J GASTROENTEROL, V109, P199, DOI 10.1038/ajg.2013.427; Korba BE, 2008, ANTIVIR RES, V77, P56, DOI 10.1016/j.antiviral.2007.08.005; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Martin-Carbonero L, 2008, J VIRAL HEPATITIS, V15, P710, DOI 10.1111/j.1365-2893.2008.01015.x; Mira JA, 2012, AIDS, V26, P1721, DOI 10.1097/QAD.0b013e3283568884; Molina JM, 2015, LANCET, V385, P1098, DOI 10.1016/S0140-6736(14)62483-1; Moreno C, 2015, J HEPATOL, V62, P1047, DOI 10.1016/j.jhep.2014.12.031; Naggie S, 2015, CROI; Neukam K, 2012, J HEPATOL, V56, P788, DOI 10.1016/j.jhep.2011.11.008; Rossignol JF, 2014, ANTIVIR RES, V110, P94, DOI 10.1016/j.antiviral.2014.07.014; Rossignol JF, 2010, J CLIN GASTROENTEROL, V44, P504, DOI 10.1097/MCG.0b013e3181bf9b15; Rossignol JF, 2009, GASTROENTEROLOGY, V136, P856, DOI 10.1053/j.gastro.2008.11.037; Serpaggi J, 2006, AIDS, V20, P233, DOI 10.1097/01.aids.0000200541.40633.56; Sievert W, 2011, LIVER INT, V31, P61, DOI 10.1111/j.1478-3231.2011.02540.x; Soriano V, 2005, ANTIVIR THER, V10, P167; Wyles D, 2015, CROI	24	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0143492	10.1371/journal.pone.0143492	http://dx.doi.org/10.1371/journal.pone.0143492			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26640956	Green Submitted, Green Published, gold			2022-12-27	WOS:000366902700020
J	Spies, C; Luetz, A; Lachmann, G; Renius, M; von Haefen, C; Wernecke, KD; Bahra, M; Schiemann, A; Paupers, M; Meisel, C				Spies, Claudia; Luetz, Alawi; Lachmann, Gunnar; Renius, Markus; von Haefen, Clarissa; Wernecke, Klaus-Dieter; Bahra, Marcus; Schiemann, Alexander; Paupers, Marco; Meisel, Christian			Influence of Granulocyte-Macrophage Colony-Stimulating Factor or Influenza Vaccination on HLA-DR, Infection and Delirium Days in Immunosuppressed Surgical Patients: Double Blind, Randomised Controlled Trial	PLOS ONE			English	Article							FACTOR GM-CSF; INTENSIVE-CARE; SYSTEMIC INFLAMMATION; 3 SCORES; EXPRESSION; MORTALITY; SEPSIS; VACCINES; SAFETY; PATHOPHYSIOLOGY	Purpose Surgical patients are at high risk for developing infectious complications and postoperative delirium. Prolonged infections and delirium result in worse outcome. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and influenza vaccination are known to increase HLA-DR on monocytes and improve immune reactivity. This study aimed to investigate whether GM-CSF or vaccination reverses monocyte deactivation. Secondary aims were whether it decreases infection and delirium days after esophageal or pancreatic resection over time. Methods In this prospective, randomized, placebo-controlled, double-blind, double dummy trial setting on an interdisciplinary ICU of a university hospital 61 patients with immunosuppression (monocytic HLA-DR [mHLA-DR] < 10,000 monoclonal antibodies [mAb] per cell) on the first day after esophageal or pancreatic resection were treated with either GM-CSF (250 mu g/m2/d), influenza vaccination (Mutagrip 0.5 ml/d) or placebo for a maximum of 3 consecutive days if mHLA-DR remained below 10,000 mAb per cell. HLA-DR on monocytes was measured daily until day 5 after surgery. Infections and delirium were followed up for 9 days after surgery. Primary outcome was HLA-DR on monocytes, and secondary outcomes were duration of infection and delirium. Results mHLA-DR was significantly increased compared to placebo (p < 0.001) and influenza vaccination (p < 0.001) on the second postoperative day. Compared with placebo, GM-CSF-treated patients revealed shorter duration of infection (p < 0.001); the duration of delirium was increased after vaccination (p = 0.003). Conclusion Treatment with GM-CSF in patients with postoperative immune suppression was safe and effective in restoring monocytic immune competence. Furthermore, therapy with GM-CSF reduced duration of infection in immune compromised patients. However, influenza vaccination increased duration of delirium after major surgery.	[Spies, Claudia; Luetz, Alawi; Lachmann, Gunnar; Renius, Markus; von Haefen, Clarissa; Schiemann, Alexander; Paupers, Marco] Charite, Campus Charite Mitte, Dept Anesthesiol & Intens Care Med, D-13353 Berlin, Germany; [Spies, Claudia; Luetz, Alawi; Lachmann, Gunnar; Renius, Markus; von Haefen, Clarissa; Schiemann, Alexander; Paupers, Marco] Charite, Campus Virchow Klinikum, D-13353 Berlin, Germany; [Wernecke, Klaus-Dieter] Sostana GmbH, Berlin, Germany; [Bahra, Marcus] Charite, Dept Gen Abdominal & Transplantat Surg, Campus Virchow Klinikum, D-13353 Berlin, Germany; [Meisel, Christian] Charite, Inst Med Immunol, Campus Virchow Klinikum, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Sostana GmbH; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Spies, C (corresponding author), Charite, Campus Charite Mitte, Dept Anesthesiol & Intens Care Med, D-13353 Berlin, Germany.	claudia.spies@charite.de	Spies, Claudia/AAJ-5412-2020	Spies, Claudia/0000-0002-1062-0495; Meisel, Christian/0000-0003-0222-991X; Lachmann, Gunnar/0000-0003-2330-9839; Luetz, Alawi/0000-0001-8814-1809	Deutsche Forschungsgemeinschaft [DFG SP432-1]; Charite - Universitatsmedizin Berlin; inneruniversitary grants	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Charite - Universitatsmedizin Berlin; inneruniversitary grants	Funding provided by Deutsche Forschungsgemeinschaft (DFG SP432-1), http://www.dfg.de/ and Charite - Universitatsmedizin Berlin (www.charite.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. One of the co-authors, Professor Klaus-Dieter Wernecke, is the owner of the commercial company Sostana GmbH Berlin. However, there are no conflicts of interests in this case. The funders of our study, 'Deutsche Forschungsgemeinschaft' and inneruniversitary grants, provided financial support in form of salaries for authors, but did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Bilgin K, 2001, PEDIATRICS, V107, P36, DOI 10.1542/peds.107.1.36; Blazevic V, 2000, HUM IMMUNOL, V61, P845, DOI 10.1016/S0198-8859(00)00170-1; Bo LL, 2011, CRIT CARE, V15, DOI 10.1186/cc10031; Borgermann J, 2007, THORAC CARDIOV SURG, V55, P24, DOI 10.1055/s-2006-924621; BOUTROS N, 1993, AM J PSYCHIAT, V150, P1899; Cerejeira J, 2012, J AM GERIATR SOC, V60, P669, DOI 10.1111/j.1532-5415.2011.03883.x; Cheron A, 2010, CRIT CARE, V14, DOI 10.1186/cc9331; Clapp BR, 2004, CARDIOVASC RES, V64, P172, DOI 10.1016/j.cardiores.2004.06.020; Dasgupta M, 2006, J AM GERIATR SOC, V54, P1578, DOI 10.1111/j.1532-5415.2006.00893.x; Delgado-Rodriguez M, 1999, J HOSP INFECT, V41, P203, DOI 10.1016/S0195-6701(99)90017-8; Docke WD, 2005, CLIN CHEM, V51, P2341, DOI 10.1373/clinchem.2005.052639; Egli A, 2015, J INFECT DIS, V212, P137, DOI 10.1093/infdis/jiv015; Evans TG, 2002, VACCINE, V21, P322, DOI 10.1016/S0264-410X(02)00454-1; Forrest BD, 2011, VACCINE, V29, P3633, DOI 10.1016/j.vaccine.2011.03.029; Geffers C, 2008, INFECT CONT HOSP EP, V29, P1167, DOI 10.1086/592410; Goldmann A, 2015, EUR J ANAESTH, V32, P584, DOI 10.1097/EJA.0000000000000171; Gorse GJ, 2001, AIDS RES HUM RETROV, V17, P1175, DOI 10.1089/088922201316912781; Greenberg DP, 2013, VACCINE, V31, P770, DOI 10.1016/j.vaccine.2012.11.074; Haining WN, 2004, BRIT J HAEMATOL, V127, P322, DOI 10.1111/j.1365-2141.2004.05204.x; Hala M, 2007, MED HYPOTHESES, V68, P194, DOI 10.1016/j.mehy.2006.07.003; Hall MW, 2011, INTENS CARE MED, V37, P525, DOI 10.1007/s00134-010-2088-x; Harms H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002158; Haupt W, 1998, DIGEST SURG, V15, P102, DOI 10.1159/000018601; Hensler T, 1997, INFECT IMMUN, V65, P2283, DOI 10.1128/IAI.65.6.2283-2291.1997; Heymann A, 2010, J INT MED RES, V38, P1584, DOI 10.1177/147323001003800503; Hingorani AD, 2000, CIRCULATION, V102, P994, DOI 10.1161/01.CIR.102.9.994; HORAN TC, 1992, AM J INFECT CONTROL, V20, P271, DOI 10.1016/S0196-6553(05)80201-9; Hornell TMC, 2003, J IMMUNOL, V171, P2374, DOI 10.4049/jimmunol.171.5.2374; Hughes CG, 2012, CURR OPIN CRIT CARE, V18, P518, DOI 10.1097/MCC.0b013e328357effa; Landelle C, 2010, INTENS CARE MED, V36, P1859, DOI 10.1007/s00134-010-1962-x; Lendemans S, 2007, INFLAMM RES, V56, P38, DOI 10.1007/s00011-007-6069-7; Luetz A, 2010, CRIT CARE MED, V38, P409, DOI 10.1097/CCM.0b013e3181cabb42; Lukaszewicz AC, 2009, CRIT CARE MED, V37, P2746, DOI 10.1097/CCM.0b013e3181ab858a; Meisel C, 2009, AM J RESP CRIT CARE, V180, P640, DOI 10.1164/rccm.200903-0363OC; Murray C, 2012, NEUROBIOL AGING, V33, P603, DOI 10.1016/j.neurobiolaging.2010.04.002; Nierhaus A, 2003, INTENS CARE MED, V29, P646, DOI 10.1007/s00134-003-1666-6; Patel SB, 2014, AM J RESP CRIT CARE, V189, P658, DOI 10.1164/rccm.201310-1815OC; Pisani MA, 2009, AM J RESP CRIT CARE, V180, P1092, DOI 10.1164/rccm.200904-0537OC; Radtke FM, 2008, BRIT J ANAESTH, V101, P338, DOI 10.1093/bja/aen193; Radtke FM, 2010, WORLD J SURG, V34, P487, DOI 10.1007/s00268-009-0376-9; Schinkel C, 1998, J TRAUMA, V44, P743, DOI 10.1097/00005373-199805000-00001; Semenenko T. A., 2005, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P24; Spies C, 2013, SOPS INTENSIVMEDIZIN; Spies CD, 2008, J INT MED RES, V36, P296, DOI 10.1177/147323000803600212; Spies CD, 2002, ANESTH ANALG, V95, P9, DOI 10.1097/00000539-200207000-00002; Spies CD, 2004, ANESTHESIOLOGY, V100, P1088, DOI 10.1097/00000542-200405000-00010; Terrando N, 2011, ANN NEUROL, V70, P986, DOI 10.1002/ana.22664; van Gool WA, 2010, LANCET, V375, P773, DOI 10.1016/S0140-6736(09)61158-2; Vellozzi C, 2009, VACCINE, V27, P2114, DOI 10.1016/j.vaccine.2009.01.125; WAKEFIELD CH, 1993, BRIT J SURG, V80, P205, DOI 10.1002/bjs.1800800224; Weimann K, 2015, J INT MED RES, V43, P435, DOI 10.1177/0300060514557711; Wu JF, 2011, CRIT CARE, V15, DOI 10.1186/cc10457	54	17	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144003	10.1371/journal.pone.0144003	http://dx.doi.org/10.1371/journal.pone.0144003			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641243	Green Published, Green Submitted, gold			2022-12-27	WOS:000366902700040
J	Zheljazkov, VD; Gawde, A; Cantrell, CL; Astatkie, T; Schlegel, V				Zheljazkov, Valtcho D.; Gawde, Archana; Cantrell, Charles L.; Astatkie, Tess; Schlegel, Vicki			Distillation Time as Tool for Improved Antimalarial Activity and Differential Oil Composition of Cumin Seed Oil	PLOS ONE			English	Article							ARTEMISIA-ANNUA L.; ANTIOXIDANT CAPACITY; YIELD; ASSAY	A steam distillation extraction kinetics experiment was conducted to estimate essential oil yield, composition, antimalarial, and antioxidant capacity of cumin (Cuminum cyminum L.) seed (fruits). Furthermore, regression models were developed to predict essential oil yield and composition for a given duration of the steam distillation time (DT). Ten DT durations were tested in this study: 5, 7.5, 15, 30, 60, 120, 240, 360, 480, and 600 min. Oil yields increased with an increase in the DT. Maximum oil yield (content, 2.3 g/100 seed), was achieved at 480 min; longer DT did not increase oil yields. The concentrations of the major oil constituents alpha-pinene (0.14-0.5% concentration range), beta-pinene (3.7-10.3% range),gamma-cymene (5-7.3% range),gamma-terpinene (1.8-7.2% range), cumin aldehyde (50-66% range), alpha-terpinen-7-al (3.8-16% range), and beta-terpinen-7-al (12-20% range) varied as a function of the DT. The concentrations of alpha-pinene, beta-pinene, gamma-cymene, gamma-terpinene in the oil increased with the increase of the duration of the DT; alpha-pinene was highest in the oil obtained at 600 min DT, beta-pinene and alpha-terpinene reached maximum concentrations in the oil at 360 min DT; gamma-cymene reached a maximum in the oil at 60 min DT, cumin aldehyde was high in the oils obtained at 5-60 min DT, and low in the oils obtained at 240-600 min DT, gamma-terpinen-7-al reached maximum in the oils obtained at 480 or 600 min DT, whereas beta-terpinen-7-al reached a maximum concentration in the oil at 60 min DT. The yield of individual oil constituents (calculated from the oil yields and the concentration of a given compound at a particular DT) increased and reached a maximum at 480 or 600 min DT. The antimalarial activity of the cumin seed oil obtained during the 0-5 and at 5-7.5 min DT time-frames was twice higher than the antimalarial activity of the oils obtained at the other DT. This study opens the possibility for distinct marketing and utilization for these improved oils. The antioxidant capacity of the oil was highest in the oil obtained at 30 min DT and lowest in the oil from 360 min DT. The Michaelis-Menton and the Power nonlinear regression models developed in this study can be utilized to predict essential oil yield and composition of cumin seed at any given duration of DT and may also be useful to compare previous reports on cumin oil yield and composition. DT can be utilized to obtain cumin seed oil with improved antimalarial activity, improved antioxidant capacity, and with various compositions.	[Zheljazkov, Valtcho D.] Oregon State Univ, Columbia Basin Agr Res Ctr, Adams, OR 97810 USA; [Gawde, Archana; Cantrell, Charles L.] USDA, Nat Prod Utilizat Res Unit, Agr Res Serv, University, MS 38677 USA; [Astatkie, Tess] Dalhousie Univ, Fac Agr, Truro, NS B2N 5E3, Canada; [Schlegel, Vicki] Univ Nebraska, Dept Food Sci & Technol, Lincoln, NE 68583 USA	Oregon State University; United States Department of Agriculture (USDA); Dalhousie University; University of Nebraska System; University of Nebraska Lincoln	Zheljazkov, VD (corresponding author), Oregon State Univ, Columbia Basin Agr Res Ctr, 48037 Cty 788 Rd, Adams, OR 97810 USA.	Valtcho.jeliazkov@oregonstate.edu	Astatkie, Tessema/J-7231-2012	Astatkie, Tessema/0000-0002-9779-8789; Gawde, Archana/0000-0002-6495-3850	University of Wyoming Outreach School; Department of Plant Science; ARS [ARS-0429247] Funding Source: Federal RePORTER	University of Wyoming Outreach School; Department of Plant Science; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Financial support was provided in part by the University of Wyoming Outreach School and the Department of Plant Science allocations to Valtcho D. Jeliazkov (V.D. Zheljazkov).; The authors thank Jeremiah Vardiman from the University of Wyoming Sheridan Research and Extension Center for their help with the laboratory work, the extraction and measurements of the essential oils, and Rochelle Koltiska for proofreading the manuscript. The authors also thank Solomon Green III for technical assistance at the National Center for Natural Products Research in Oxford, MS and USDA-ARS. Financial support was provided in part by the University of Wyoming Outreach School and the Department of Plant Science allocations to Valtcho D. Jeliazkov (V.D. Zheljazkov).	Alsheik EAMO, 2009, Patent number application, Patent No. [WO 2009139672 A1, 2009139672]; Azeez S, 2008, CHEMISTRY OF SPICES, P211, DOI 10.1079/9781845934057.0211; BADR FH, 1990, FOOD CHEM, V38, P273, DOI 10.1016/0308-8146(90)90184-6; Bameri Z., 2013, International Research Journal of Applied and Basic Sciences, V6, P286; Bates D., 2007, NONLINEAR REGRESSION; Bharate SB, 2007, BIOORGAN MED CHEM, V15, P87, DOI 10.1016/j.bmc.2006.10.006; Cannon JB, 2013, IND CROP PROD, V41, P214, DOI 10.1016/j.indcrop.2012.04.021; Chaubey MK, 2008, J OLEO SCI, V57, P171, DOI 10.5650/jos.57.171; Deepak, 2013, INDIAN J TRADIT KNOW, V12, P300; Dobreva K., 2009, Trakia Journal of Sciences, V7, P191; Ferreira JFS, 2013, IND CROP PROD, V41, P294, DOI 10.1016/j.indcrop.2012.05.005; Ferreira JFS, 2010, MOLECULES, V15, P3135, DOI 10.3390/molecules15053135; Gohari A. R., 2011, Pharmacognosy Journal, V3, P1, DOI 10.5530/pj.2011.25.1; Huang DJ, 2002, J AGR FOOD CHEM, V50, P1815, DOI 10.1021/jf0113732; Huang DJ, 2002, J AGR FOOD CHEM, V50, P4437, DOI 10.1021/jf0201529; Montgomery D.C., 2013, DESIGN ANAL EXPT; SAS Institute Inc, 2010, SAS STAT 9 3 US GUID; Stojanov N, 1973, CUMIN OUR MED PLANTS, P266; Topalo VD, 1962, ITALIAN CUMIN CUMINU, P246; Zheljazkov VD, 2013, HORTSCIENCE, V48, P1393, DOI 10.21273/HORTSCI.48.11.1393; Zheljazkov VD, 2013, HORTSCIENCE, V48, P1288, DOI 10.21273/HORTSCI.48.10.1288; Zheljazkov VD, 2013, J OLEO SCI, V62, P665, DOI 10.5650/jos.62.665; Zheljazkov VD, 2013, J OLEO SCI, V62, P195, DOI 10.5650/jos.62.195; Zheljazkov VD, 2012, J OLEO SCI, V61, P537, DOI 10.5650/jos.61.537	24	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144120	10.1371/journal.pone.0144120	http://dx.doi.org/10.1371/journal.pone.0144120			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641276	Green Published, gold			2022-12-27	WOS:000366902700058
J	Lee, YE; An, J; Lee, KH; Kim, SS; Song, HJ; Pyeon, H; Nam, H; Kang, K; Joo, KM				Lee, Young Eun; An, Jaeyeol; Lee, Kee-Hang; Kim, Sung Su; Song, Hye Jin; Pyeon, Heejang; Nam, Hyun; Kang, Kyeongjin; Joo, Kyeung Min			The Synergistic Local Immunosuppressive Effects of Neural Stem Cells Expressing Indoleamine 2,3-Dioxygenase (IDO) in an Experimental Autoimmune Encephalomyelitis (EAE) Animal Model	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; ISCHEMIC-STROKE; INFLAMMATORY MECHANISMS; TRYPTOPHAN CATABOLISM; DENDRITIC CELLS; PRECURSOR CELLS; BRAIN; TRANSPLANTATION; DISEASE; THERAPY	Neurodegenerative diseases provoke robust immunological reactions in the central nervous system (CNS), which further deteriorate the neural tissue damage. We hypothesized that the expression levels of indoleamine 2,3-dioxygenase (IDO), an enzyme that has potent immune suppressive activities, in neural stem cells (NSCs) would have synergistic therapeutic effects against neurodegenerative diseases, since NSCs themselves have low IDO expression. In this study, the synergistic immune suppressive effects of rat fetal NSCs expressing IDO (rfNSCs-IDO) were validated by mixed leukocyte reaction (MLR) in vitro and an experimental autoimmune encephalomyelitis (EAE) animal model in vivo. rfNSCs-IDO showed significantly more suppressive effects on T cell proliferation in the MLR compared to control rfNSCs (rfNSCs-Cont). Importantly, IDO inhibition using 1-methyl-DL-tryptophan (1-MT), an IDO inhibitor, reversed the synergistic effects, confirming IDO-specific effects in rfNSCs-IDO. In the EAE animal model, systemic rfNSCs-IDO injections resulted in significant local immune suppression in the cervical lymph nodes and CNS, evidenced by a reduction in the number of activated T lymphocytes and an increase in regulatory T cell numbers, which induced significantly fewer clinical symptoms and faster recovery. In contrast, rfNSCs-Cont failed to reduce symptoms in the EAE animal models, although they showed local immune suppression, which was significantly less than that in rfNSCs-IDO. Taken together, IDO expression in NSCs synergistically potentiates the immune suppression activities of NSCs and could be applicable for the development of therapeutic modalities against various neurodegenerative diseases.	[Lee, Young Eun; Lee, Kee-Hang; Kim, Sung Su; Joo, Kyeung Min] Sungkyunkwan Univ, SAIHST, Dept Hlth Sci & Technol, Seoul, South Korea; [Song, Hye Jin; Pyeon, Heejang; Kang, Kyeongjin; Joo, Kyeung Min] Sungkyunkwan Univ, Sch Med, Dept Anat & Cell Biol, Suwon, South Korea; [Joo, Kyeung Min] Samsung Med Ctr, Samsung Biomed Res Inst, Seoul, South Korea; [Lee, Young Eun; An, Jaeyeol; Lee, Kee-Hang; Kim, Sung Su; Song, Hye Jin; Pyeon, Heejang; Nam, Hyun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurosurg, Seoul, South Korea	Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Joo, KM (corresponding author), Sungkyunkwan Univ, SAIHST, Dept Hlth Sci & Technol, Seoul, South Korea.	kangk@skku.edu; kmjoo@skku.edu			Ministry of Food and Drug Safety [14172MFDS974]; Samsung Biomedical Research Institute; Samsung Biomedical Research Institute in Samsung Medical Center	Ministry of Food and Drug Safety(Ministry of Food & Drug Safety (MFDS), Republic of Korea); Samsung Biomedical Research Institute(Samsung); Samsung Biomedical Research Institute in Samsung Medical Center(Samsung)	This research was supported by a grant (14172MFDS974) from Ministry of Food and Drug Safety in 2014 and Samsung Biomedical Research Institute grant. The Samsung Biomedical Research Institute in Samsung Medical Center provided partial financial support for research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn M, 2011, BRAIN RES, V1416, P51, DOI 10.1016/j.brainres.2011.08.009; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Ben-Hur T, 2008, J NEUROL SCI, V265, P102, DOI 10.1016/j.jns.2007.05.007; Bliss T, 2007, STROKE, V38, P817, DOI 10.1161/01.STR.0000247888.25985.62; Blurton-Jones M, 2009, P NATL ACAD SCI USA, V106, P13594, DOI 10.1073/pnas.0901402106; Bonnamain V, 2012, STEM CELLS, V30, P2342, DOI 10.1002/stem.1199; Braun D, 2005, BLOOD, V106, P2375, DOI 10.1182/blood-2005-03-0979; Chen YH, 2009, NAT MED, V15, P1215, DOI 10.1038/nm.2025; Chiarugi A, 2001, J NEUROCHEM, V77, P1310, DOI 10.1046/j.1471-4159.2001.00335.x; Choi SA, 2015, CANCER GENE THER, V22, P302, DOI 10.1038/cgt.2015.25; Chu K, 2004, BRAIN RES, V1023, P213, DOI 10.1016/j.brainres.2004.07.045; Cid MP, 2011, NEUROSCIENCE, V189, P337, DOI 10.1016/j.neuroscience.2011.05.005; Codega P, 2014, NEURON, V82, P545, DOI 10.1016/j.neuron.2014.02.039; DelaRosa O, 2009, TISSUE ENG PT A, V15, P2795, DOI [10.1089/ten.tea.2008.0630, 10.1089/ten.TEA.2008.0630]; Doeppner TR, 2012, STEM CELLS, V30, P1297, DOI 10.1002/stem.1098; Einstein O, 2003, MOL CELL NEUROSCI, V24, P1074, DOI 10.1016/j.mcn.2003.08.009; Einstein O, 2008, ARCH NEUROL-CHICAGO, V65, P452, DOI 10.1001/archneur.65.4.452; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Giachino C, 2014, STEM CELLS, V32, P70, DOI 10.1002/stem.1520; Giusto E, 2014, EXP NEUROL, V260, P19, DOI 10.1016/j.expneurol.2013.03.009; Hermann DM, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00291; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; Hsu YC, 2007, CELL TRANSPLANT, V16, P133; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Jones BJ, 2007, PLACENTA, V28, P1174, DOI 10.1016/j.placenta.2007.07.001; Joo KM, 2013, EXP NEUROL, V240, P168, DOI 10.1016/j.expneurol.2012.11.021; Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101; Kim SU, 2013, NEUROPATHOLOGY, V33, P491, DOI 10.1111/neup.12020; Krause D, 2011, AM J PATHOL, V179, P1360, DOI 10.1016/j.ajpath.2011.05.048; Lakhan SE, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-97; Lanz TV, 2010, STEM CELLS DEV, V19, P657, DOI 10.1089/scd.2009.0385; Lindvall O, 2004, NAT MED, V10, pS42, DOI 10.1038/nm1064; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; Martino G, 2011, BRAIN, V134, P1585, DOI 10.1093/brain/awr115; Matysiak M, 2008, J NEUROIMMUNOL, V193, P12, DOI 10.1016/j.jneuroim.2007.07.025; Meisel R, 2011, LEUKEMIA, V25, P648, DOI 10.1038/leu.2010.310; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Morando S, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt94; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Popov A, 2008, J MOL MED, V86, P145, DOI 10.1007/s00109-007-0262-6; RAINE CS, 1994, J NEUROPATH EXP NEUR, V53, P328, DOI 10.1097/00005072-199407000-00002; Ramirez-Castillejo C, 2006, NAT NEUROSCI, V9, P331, DOI 10.1038/nn1657; Ren GW, 2009, STEM CELLS, V27, P1954, DOI 10.1002/stem.118; Richardson RM, 2005, BRAIN RES, V1032, P11, DOI 10.1016/j.brainres.2004.10.043; Ryu JK, 2004, NEUROBIOL DIS, V16, P68, DOI 10.1016/j.nbd.2004.01.016; Sanai N, 2005, NEW ENGL J MED, V353, P811, DOI 10.1056/NEJMra043666; Schwartz M, 2006, J NEUROIMMUNE PHARM, V1, P4, DOI 10.1007/s11481-005-9010-2; Seger J, 2010, MEM I OSWALDO CRUZ, V105, P263, DOI 10.1590/S0074-02762010000300004; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; SHIN TY, 1995, J NEUROIMMUNOL, V56, P171, DOI 10.1016/0165-5728(94)00144-D; Stone TW, 2003, CLIN CHEM LAB MED, V41, P852, DOI 10.1515/CCLM.2003.129; Taupin P, 2009, CURR ALZHEIMER RES, V6, P461, DOI 10.2174/156720509790147151; TAYLOR MW, 1991, FASEB J, V5, P2516, DOI 10.1096/fasebj.5.11.1907934; van Noort JM, 2009, PROG BRAIN RES, V175, P139, DOI 10.1016/S0079-6123(09)17509-X; Zhang X, 2012, CURR GENE THER, V12, P423, DOI 10.2174/156652312802762590; Zhou D, 2006, P NATL ACAD SCI USA, V103, P19057, DOI 10.1073/pnas.0607242103	56	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144298	10.1371/journal.pone.0144298	http://dx.doi.org/10.1371/journal.pone.0144298			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636969	Green Published, Green Submitted, gold			2022-12-27	WOS:000366143800070
J	Skagseth, O; Slotte, A; Stenevik, EK; Nash, RDM				Skagseth, Oystein; Slotte, Aril; Stenevik, Erling Kare; Nash, Richard D. M.			Characteristics of the Norwegian Coastal Current during Years with High Recruitment of Norwegian Spring Spawning Herring (Clupea harengus L.)	PLOS ONE			English	Article							COD GADUS-MORHUA; NORTH-SEA; LARVAL RETENTION; FISH; POPULATIONS; STOCK; ABUNDANCE; TEMPERATURE; VARIABILITY; ADVECTION	Norwegian Spring Spawning herring (NSSH) Clupea harengus L. spawn on coastal banks along the west coast of Norway. The larvae are generally transported northward in the Norwegian Coastal Current (NCC) with many individuals utilizing nursery grounds in the Barents Sea. The recruitment to this stock is highly variable with a few years having exceptionally good recruitment. The principal causes of recruitment variability of this herring population have been elusive. Here we undertake an event analysis using data between 1948 and 2010 to gain insight into the physical conditions in the NCC that coincide with years of high recruitment. In contrast to a typical year when northerly upwelling winds are prominent during spring, the years with high recruitment coincide with predominantly southwesterly winds and weak upwelling in spring and summer, which lead to an enhanced northward coastal current during the larval drift period. Also in most peak recruitment years, low-salinity anomalies are observed to propagate northward during the spring and summer. It is suggested that consistent southwesterly (downwelling) winds and propagating low-salinity anomalies, both leading to an enhanced northward transport of larvae, are important factors for elevated recruitment. At the same time, these conditions stabilize the coastal waters, possibly leading to enhanced production and improved feeding potential along the drift route to Barents Sea. Further studies on the drivers of early life history mortality can now be undertaken with a better understanding of the physical conditions that prevail during years when elevated recruitment occurs in this herring stock.	[Skagseth, Oystein; Slotte, Aril; Stenevik, Erling Kare; Nash, Richard D. M.] Inst Marine Res, N-5024 Bergen, Norway; [Skagseth, Oystein] Bjerknes Ctr Climate Res, Bergen, Norway	Institute of Marine Research - Norway; Bjerknes Centre for Climate Research	Skagseth, O (corresponding author), Inst Marine Res, POB 1870, N-5024 Bergen, Norway.	oystein.skagseth@imr.no		Nash, Richard/0000-0003-0958-149X	Pelagic and Oceanography and Climate Research Groups of the Institute of Marine Research, Norway; Norwegian Research Council project EPOCASA [229774]	Pelagic and Oceanography and Climate Research Groups of the Institute of Marine Research, Norway; Norwegian Research Council project EPOCASA	This research was partially supported by the Pelagic and Oceanography and Climate Research Groups of the Institute of Marine Research, Norway, and the Norwegian Research Council project EPOCASA grant no. 229774. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful for helpful comments by anonymous reviewers and to Ken Drinkwater for providing useful comments on an earlier version of the manuscript. This research was partially supported by the Pelagic and Oceanography and Climate Research Groups of the Institute of Marine Research, Norway, and the Norwegian Research Council project EPOCASA grant no. 229774.	[Anonymous], 1988, DEV ATMOSPHERIC SCI; Aure J, 1993, FISK HAV, V6, P7; BARTSCH J, 1989, NATURE, V340, P632, DOI 10.1038/340632a0; Churchill JH, 2011, FISH OCEANOGR, V20, P32, DOI 10.1111/j.1365-2419.2010.00563.x; CURY P, 1989, CAN J FISH AQUAT SCI, V46, P670, DOI 10.1139/f89-086; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; Cushing DH, 1966, FISH INVEST 2, V2, P25; Cushing DH, 1975, MARINE ECOLOGY FISHE; de Barros P, 1998, ICES J MAR SCI, V55, P454, DOI 10.1006/jmsc.1997.0347; Dickey-Collas M, 2014, ICES J MAR SCI, V71, P2300, DOI 10.1093/icesjms/fst215; Dickey-Collas M, 2010, ICES J MAR SCI, V67, P1875, DOI 10.1093/icesjms/fsq033; DRAGESUND O, 1970, Fiskeridirektoratets Skrifter Serie Havundersokelser, V15, P381; Dragesund O., 1971, Fiskeridirektoratets Skr (Havundersok), V16, P49; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Fiksen O, 2002, CAN J FISH AQUAT SCI, V59, P211, DOI 10.1139/F02-002; Fossum P, 1996, ICES J MAR SCI, V53, P51, DOI 10.1006/jmsc.1996.0005; Helland-Hansen B., 1909, REP NORWEGIAN FISHER, V2, P1; Hjort J., 1926, Journal du Conseil Copenhague, V1, P5; Hjort J., 1914, RAPP P V REUN CONS I, V20, P1; Holst JC, 1998, ICES J MAR SCI, V55, P987, DOI 10.1006/jmsc.1998.0371; Holst Jens Christian, 2004, P203; Hufnagl M, 2015, PROG OCEANOGR, V138, P486, DOI 10.1016/j.pocean.2014.04.029; Husebo A, 2009, ICES J MAR SCI, V66, P1710, DOI 10.1093/icesjms/fsp150; ICES, 2013, 2012ACOM15 ICES CM; Iden KA, 1997, DEN NORSKE LOS, P129; ILES TD, 1982, SCIENCE, V215, P627, DOI 10.1126/science.215.4533.627; Johansen GO, 2004, CAN J FISH AQUAT SCI, V61, P343, DOI 10.1139/F03-168; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Mantzouni I, 2010, P R SOC B, DOI [10.1098/rspb2009.1906, DOI 10.1098/RSPB2009.1906]; Nash RDM, 2009, FISH RES, V95, P88, DOI 10.1016/j.fishres.2008.08.003; NICHOLS JH, 1989, RAP PROCES, V191, P160; Parada C, 2008, AFR J MAR SCI, V30, P437, DOI 10.2989/AJMS.2008.30.3.1.635; Payne MR, 2010, ICES J MAR SCI, V67, P1939, DOI 10.1093/icesjms/fsq036; Petitgas P., 2009, 2009E25 ICES CM; Petitgas P, 2013, FISH OCEANOGR, V22, P121, DOI 10.1111/fog.12010; Pyper BJ, 1998, CAN J FISH AQUAT SCI, V55, P2127; Rottingen I, 1989, BIOL FISHERIES NORWE, P165; Runge JA, 2010, PROG OCEANOGR, V87, P251, DOI 10.1016/j.pocean.2010.09.016; Saetre R, 2002, SARSIA, V87, P167, DOI 10.1080/003648202320205247; Saetre R, 2002, ICES J MAR SCI, V59, P725, DOI 10.1006/jmsc.2002.1180; SINCLAIR M, 1984, CAN J FISH AQUAT SCI, V41, P1055, DOI 10.1139/f84-123; Sinclair M, 1988, MARINE POPULATIONS E; Sinclair M, 2015, FISH RES, V172, P401, DOI 10.1016/j.fishres.2015.07.026; Skagseth O., 2008, ARCTIC SUBARCTIC OCE, P45, DOI DOI 10.1007/978-1-4020-6774-7_3; Skagseth O, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC006996; Skaret G, 2015, ICES J MAR SCI, V72, P2313, DOI 10.1093/icesjms/fsv087; Slotte A, 2000, J FISH BIOL, V56, P138; Stenevik EK, 2012, FISH OCEANOGR, V21, P363, DOI 10.1111/j.1365-2419.2012.00631.x; Sundby S, 2000, SARSIA, V85, P277, DOI 10.1080/00364827.2000.10414580; TORESEN R, 1991, FISH RES, V10, P317, DOI 10.1016/0165-7836(91)90083-R; Toresen R, 2002, ICES MAR SCI S, V215, P532; Toresen R, 2000, FISH FISH, V1, P231, DOI 10.1111/j.1467-2979.2000.00022.x; Vikebo FB, 2012, ICES J MAR SCI, V69, P1298, DOI 10.1093/icesjms/fss083; Vikebo FB, 2010, ICES J MAR SCI, V67, P1948, DOI 10.1093/icesjms/fsq084	54	34	34	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144117	10.1371/journal.pone.0144117	http://dx.doi.org/10.1371/journal.pone.0144117			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636759	Green Published, gold, Green Submitted			2022-12-27	WOS:000366143800041
J	Teng, RY; Hu, Y; Zhou, JC; Seifer, B; Chen, YX; Shen, JG; Wang, LB				Teng, Rongyue; Hu, Yan; Zhou, Jichun; Seifer, Benjamin; Chen, Yongxia; Shen, Jianguo; Wang, Linbo			Overexpression of Lin28 Decreases the Chemosensitivity of Gastric Cancer Cells to Oxaliplatin, Paclitaxel, Doxorubicin, and Fluorouracil in Part via microRNA-107	PLOS ONE			English	Article							C-MYC; EXPRESSION; CHEMOTHERAPY; INHIBITION; MIR-107; GROWTH; DEATH	Higher Lin28 expression is associated with worse pathologic tumor responses in locally advanced gastric cancer patients undergoing neoadjuvant chemotherapy. However, the characteristics of Lin28 and its mechanism of action in chemotherapy resistance is still unclear. In this study, we found that transfection of Lin28 into gastric cancer cells (MKN45 and MKN28) increased their resistance to the chemo-drugs oxaliplatin (OXA), paclitaxel (PTX), doxorubicin (ADM), and fluorouracil (5-Fu) compared with gastric cancer cells transfected with a control vector. When knockdown Lin28 expression by Lin28 small interfering RNA (siRNA) was evaluated in vitro, we found that the resistance to chemo-drugs was reduced. Furthermore, we found that Lin28 up-regulates C-myc and P-gp and down-regulates Cylin D1. Finally, we found that miR-107 is a target microRNA of Lin28 and that it participates in the mechanism of chemotherapy resistance. Our results suggest that the Lin28/miR-107 pathway could be one of many signaling pathways regulated by Lin28 and associated with gastric cancer chemo-resistance.	[Teng, Rongyue; Hu, Yan; Chen, Yongxia; Shen, Jianguo; Wang, Linbo] Sir Run Run Shaw Hosp, Dept Surg Oncol, Hangzhou, Zhejiang, Peoples R China; [Hu, Yan; Zhou, Jichun] Zhejiang Univ, Hangzhou 310003, Zhejiang, Peoples R China; [Seifer, Benjamin] Yale Univ, Postgrad Res Associate, Sch Med, Dept Ob Gyn & Reprod Sci, New Haven, CT USA	Zhejiang University; Zhejiang University; Yale University	Shen, JG (corresponding author), Sir Run Run Shaw Hosp, Dept Surg Oncol, Hangzhou, Zhejiang, Peoples R China.	drshenjianguo@yahoo.com.cn; wanglinbo@medmail.com.cn	wang, lili/HDL-7210-2022; Zhou, Jichun/Q-8646-2019; wang, lin/HHM-2225-2022; wang, lin/GSE-3040-2022	Zhou, Jichun/0000-0002-0727-4034; 	ZHEJIANG Provincial Natural Science Foundation of CHINA [LQ13H160014]	ZHEJIANG Provincial Natural Science Foundation of CHINA(Natural Science Foundation of Zhejiang Province)	Support was provided by ZHEJIANG Provincial Natural Science Foundation of CHINA: LQ13H160014 [http://www.zjnsf.gov.cn/b/home.aspx].	Calcagno DQ, 2008, WORLD J GASTROENTERO, V14, P5962, DOI 10.3748/wjg.14.5962; Chen HY, 2012, CANCER RES, V72, P3631, DOI 10.1158/0008-5472.CAN-12-0667; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; CORDONCARDO C, 1995, AM J PATHOL, V147, P545; Eda A, 2009, BIOCHEM BIOPH RES CO, V388, P648, DOI 10.1016/j.bbrc.2009.08.040; Feng L, 2012, MED ONCOL, V29, P856, DOI 10.1007/s12032-011-9823-1; Gunaratne PH, 2009, CURR STEM CELL RES T, V4, P168, DOI 10.2174/157488809789057400; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; Kim YJ, 2011, HEAD NECK-J SCI SPEC, V33, P1458, DOI 10.1002/hed.21611; Lee KH, 2009, PANCREATOLOGY, V9, P293, DOI 10.1159/000186051; Lv KZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040008; Nieminen AI, 2007, CELL CYCLE, V6, P2464, DOI 10.4161/cc.6.20.4917; Piao LZ, 2012, MOL THER, V20, P1261, DOI 10.1038/mt.2012.67; Takahashi Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006677; Teng RY, 2013, ONCOTARGETS THER, V6, P1341, DOI 10.2147/OTT.S45705; van Jaarsveld MTM, 2010, INT J BIOCHEM CELL B, V42, P1282, DOI 10.1016/j.biocel.2010.01.014; von Bueren AO, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-10; Wang CG, 2011, CANCER BIOL THER, V11, P615, DOI 10.4161/cbt.11.7.14688; West JA, 2009, NATURE, V460, P909, DOI 10.1038/nature08210; Xu CY, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0382-x; Yang GF, 2004, WORLD J GASTROENTERO, V10, P491, DOI 10.3748/wjg.v10.i4.491	24	37	37	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143716	10.1371/journal.pone.0143716	http://dx.doi.org/10.1371/journal.pone.0143716			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636340	Green Submitted, gold, Green Published			2022-12-27	WOS:000366143800024
J	Yin, XL; Zhang, TW; Su, XY; Ji, Y; Ye, P; Fu, HH; Fan, SQ; Shen, YY; Gavine, PR; Gu, Y				Yin, Xiaolu; Zhang, Tianwei; Su, Xinying; Ji, Yan; Ye, Peng; Fu, Haihua; Fan, Shuqiong; Shen, Yanying; Gavine, Paul R.; Gu, Yi			Relationships between Chromosome 7 Gain, MET Gene Copy Number Increase and MET Protein Overexpression in Chinese Papillary Renal Cell Carcinoma Patients	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; C-MET; CLEAR-CELL; LUNG-CANCER; AMPLIFICATION; EXPRESSION; TARGET; TUMORS; PROTOONCOGENE; MUTATIONS	To investigate the relationships between Chromosome 7 gain, mesenchymal-epithelial transition factor (MET) gene copy number increase and MET protein overexpression in Chinese patients with papillary renal cell carcinoma (PRCC), immunohistochemistry (IHC), immunofluorescence (IF) and fluorescence in situ hybridization (FISH) were performed on 98 formalin-fixed, paraffin-embedded (FFPE) PRCC samples. Correlations between MET gene copy number increase, Chromosome 7 gain and MET protein overexpression were analyzed statistically. A highly significant correlation was observed between the percentage of tumor cells with MET gene copy number >= 3 and CEP7 copy number >= 3 (R-2 = 0.90, p<0.001) across two subtypes of PRCC. In addition, the percentage of tumor cells with MET gene copy number >= 3 was found to increase along with increases in MET IHC score. This correlation was further confirmed in those PRCC tumor cells with average MET gene copy number >5 using combined IF and FISH methodology. Overall, this study provides evidence that Chromosome 7 gain drives MET gene copy number increase in PRCC tumors, and appears to subsequently lead to an increase in MET protein overexpression in these tumor cells. This supports MET activation as a potential therapeutic target in sporadic PRCC.	[Yin, Xiaolu; Zhang, Tianwei; Su, Xinying; Ye, Peng; Fu, Haihua; Fan, Shuqiong; Gavine, Paul R.; Gu, Yi] AstraZeneca R&D, Asia & Emerging Markets iMed, Shanghai, Peoples R China; [Ji, Yan] AstraZeneca R&D, Res & Dev Informat, Shanghai, Peoples R China; [Shen, Yanying] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Pathol, Shanghai 200030, Peoples R China	AstraZeneca; AstraZeneca; Shanghai Jiao Tong University	Yin, XL (corresponding author), AstraZeneca R&D, Asia & Emerging Markets iMed, Shanghai, Peoples R China.	lucy.yin@astrazeneca.com			AstraZeneca	AstraZeneca(AstraZeneca)	Authors affiliated with AstraZeneca are full-time employees and/or stakeholders of AstraZeneca. This study is fully funded by AstraZeneca. The funder provided support in the form of salaries for authors (YX, ZT, SX, JY, YP, FH, FS, GP and GY). The specific roles of these authors are articulated in the "author contributions" section. In addition to the salaries, this study was completed in AstraZeneca's facility and using AstraZeneca's resources.; We thank AstraZeneca for sponsoring this study.	Albiges L, 2014, CLIN CANCER RES, V20, P3411, DOI 10.1158/1078-0432.CCR-13-2173; Arai E, 2011, INT J CLIN EXP PATHO, V4, P58; Balint I, 2009, J CLIN PATHOL, V62, P892, DOI 10.1136/jcp.2009.066423; Beau-Faller M, 2008, J THORAC ONCOL, V3, P331, DOI 10.1097/JTO.0b013e318168d9d4; Brunelli M, 2003, MODERN PATHOL, V16, P1053, DOI 10.1097/01.MP.0000090924.90762.94; Choi JS, 2006, J KOREAN MED SCI, V21, P672, DOI 10.3346/jkms.2006.21.4.672; Choueiri TK, 2013, J CLIN ONCOL, V31, P181, DOI 10.1200/JCO.2012.43.3383; Corless CL, 1996, DIAGN MOL PATHOL, V5, P53, DOI 10.1097/00019606-199603000-00009; Delahunt B, 1997, MODERN PATHOL, V10, P537; Dharmawardana PG, 2004, CURR MOL MED, V4, P855, DOI 10.2174/1566524043359674; Fay AP, 2014, CLIN CANCER RES, V20, P3361, DOI 10.1158/1078-0432.CCR-14-0690; Gibney GT, 2013, ANN ONCOL, V24, P343, DOI 10.1093/annonc/mds463; Henke RP, 2002, VIRCHOWS ARCH, V440, P604, DOI 10.1007/s004280100519; Hughson MD, 1998, CANCER GENET CYTOGEN, V106, P93, DOI 10.1016/S0165-4608(98)00068-5; Kontovinis LF, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-82; Ljungberg B, 2011, EUR UROL, V60, P615, DOI 10.1016/j.eururo.2011.06.049; Lopez-Beltran A, 2006, EUR UROL, V49, P798, DOI 10.1016/j.eururo.2005.11.035; Moch H, 1998, J PATHOL, V184, P424; Motzer RJ, 2002, J CLIN ONCOL, V20, P2376, DOI 10.1200/JCO.2002.11.123; Nakajima M, 1999, CANCER, V85, P1894; Schmidt L, 1997, NAT GENET, V16, P68, DOI 10.1038/ng0597-68; Schmidt L, 1999, ONCOGENE, V18, P2343, DOI 10.1038/sj.onc.1202547; Schuller AG, 2015, CLIN CANC R IN PRESS; Sweeney P, 2002, J UROLOGY, V168, P51, DOI 10.1016/S0022-5347(05)64830-6; Tanizaki J, 2011, J THORAC ONCOL, V6, P1624, DOI 10.1097/JTO.0b013e31822591e9; Tsugawa K, 1998, ONCOLOGY-BASEL, V55, P475, DOI 10.1159/000011898; Wadt KAW, 2012, FAM CANCER, V11, P535, DOI 10.1007/s10689-012-9542-6; Xie L, 2013, CLIN CANCER RES, V19, P2572, DOI 10.1158/1078-0432.CCR-12-3898; Yap TA, 2011, CURR DRUG TARGETS, V12, P2045; Zhuang ZP, 1998, NAT GENET, V20, P66, DOI 10.1038/1727	30	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143468	10.1371/journal.pone.0143468	http://dx.doi.org/10.1371/journal.pone.0143468			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636767	Green Published, Green Submitted, gold			2022-12-27	WOS:000366143800013
J	Zhang, C; Ge, RC; Zhang, JW; Chen, YJ; Wang, HZ; Wei, JH; Li, RF				Zhang, Chao; Ge, Rongchao; Zhang, Junwen; Chen, Yajuan; Wang, Hongzhi; Wei, Jianhua; Li, Ruifen			Identification and Expression Analysis of a Novel HbCIPK2-Interacting Ferredoxin from Halophyte H. brevisubulatum	PLOS ONE			English	Article							INTERACTING PROTEIN-KINASE; PLANT FERREDOXIN; CHLAMYDOMONAS-REINHARDTII; ARABIDOPSIS-THALIANA; ENHANCES TOLERANCE; SULFITE REDUCTASE; ELECTRON-TRANSFER; HEAT-STRESS; PHOSPHORYLATION; ACTIVATION	Ferredoxin is a small iron-sulfer protein involved in various one-eletron transfer pathways. Little is known about how ferredoxin is regulated to distribute electron under abiotic stress. Our previous study has showed that HbCIPK2 conferred salinity and drought tolerance. Thus, we hypothesized that HbCIPK2 could mediate the activities of interacting partners as a signal transducer. In this report, we identified a novel HbCIPK2-interacting ferredoxin (HbFd1) from halophyte Hordeum brevisubulatum by yeast two-hybrid screens, confirmed this interaction by BiFC in vivo and CoIP in vitro, and presented the expression pattern of HbFd1. HbFd1 was down-regulated under salinity and cold stress but up-regulated under PEG stress, its expression showed tissue-specific, mainly in shoot chloroplast, belonging to leaf-type subgroup. Moreover, HbCIPK2 could recruit HbFd1 to the nucleus for their interaction. The C-terminal segment in HbFd1 protein was involved in the interaction with HbCIPK2. These results provided insight into the connection between CBL-CIPK signaling network and Fd-dependent metabolic pathways.	[Zhang, Chao; Chen, Yajuan; Wang, Hongzhi; Wei, Jianhua; Li, Ruifen] Beijing Acad Agr & Forestry Sci, Beijing Agrobiotechnol Res Ctr, Beijing Key Lab Agr Genet Resources & Biotechnol, Beijing, Peoples R China; [Ge, Rongchao] Hebei Normal Univ, Coll Life Sci, Shijiazhuang, Peoples R China; [Zhang, Junwen] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Biochem & Mol Biol, Beijing 100005, Peoples R China; [Zhang, Junwen] Peking Union Med Coll, Beijing 100005, Peoples R China	Beijing Academy of Agriculture & Forestry; Hebei Normal University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Wei, JH (corresponding author), Beijing Acad Agr & Forestry Sci, Beijing Agrobiotechnol Res Ctr, Beijing Key Lab Agr Genet Resources & Biotechnol, Beijing, Peoples R China.	weijianhua@baafs.net.cn; liruifen@aliyun.com			National Natural Science Foundation of China [31271785]; National Transgenic Major Program of China [2014ZX0800917B]; Beijing Natural Science Foundation [5132010]; Beijing Academy of Agriculture and Forestry Sciences [KJCX20140202]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Transgenic Major Program of China; Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Academy of Agriculture and Forestry Sciences	This work was supported by National Natural Science Foundation of China to RL (31271785), http://www.nsfc.gov.cn/, National Transgenic Major Program of China to JW (2014ZX0800917B), http://www.nmp.gov.cn/, Beijing Natural Science Foundation to RL (5132010), http://www.bjnsf.org/, Special Grant for Innovative Ability Improvement from Beijing Academy of Agriculture and Forestry Sciences to JW and RL (KJCX20140202), http://www.baafs.net.cn/ and Grant for Institute Innovation Team from Beijing Academy of Agriculture and Forestry Sciences to RL, http://www.baafs.net.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL S, 1994, PLANT J, V5, P421, DOI 10.1111/j.1365-313X.1994.00421.x; Akashi T, 1999, J BIOL CHEM, V274, P29399, DOI 10.1074/jbc.274.41.29399; Drerup MM, 2013, MOL PLANT, V6, P559, DOI 10.1093/mp/sst009; Eckert C, 2014, PLANT J, V78, P146, DOI 10.1111/tpj.12456; Frohnecke N, 2015, FEBS LETT, V589, P31, DOI 10.1016/j.febslet.2014.11.020; Hanke G, 2013, PLANT CELL ENVIRON, V36, P1071, DOI 10.1111/pce.12046; Hirasawa M, 2009, MOL PLANT, V2, P407, DOI 10.1093/mp/ssn098; Kameda H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021947; Li RF, 2012, PLANT CELL ENVIRON, V35, P1582, DOI 10.1111/j.1365-3040.2012.02511.x; Li RF, 2009, PROG NAT SCI-MATER, V19, P667, DOI 10.1016/j.pnsc.2008.06.030; Lin YH, 2015, NEW BIOTECHNOL, V32, P235, DOI 10.1016/j.nbt.2014.12.001; Lin YH, 2013, INT J MOL SCI, V14, P20913, DOI 10.3390/ijms141020913; Lin YH, 2010, PLANT SCI, V179, P450, DOI 10.1016/j.plantsci.2010.07.006; Luan S, 2009, CURR OPIN PLANT BIOL, V12, P339, DOI 10.1016/j.pbi.2009.05.003; Meena MK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123640; Ogasawara Y, 2008, J BIOL CHEM, V283, P8885, DOI 10.1074/jbc.M708106200; Peden EA, 2013, J BIOL CHEM, V288, P35192, DOI 10.1074/jbc.M113.483727; Quintero FJ, 2011, P NATL ACAD SCI USA, V108, P2611, DOI 10.1073/pnas.1018921108; Romina DC, 2011, PLANT MOL BIOL, V76, P535, DOI [10.1007/s11103-011-9786-9, DOI 10.1007/S11103-011-9786-9]; Saitoh T, 2006, J BIOL CHEM, V281, P10482, DOI 10.1074/jbc.M510530200; Waadt R, 2008, PLANT J, V56, P505, DOI 10.1111/j.1365-313X.2008.03612.x; Xu J, 2006, CELL, V125, P1347, DOI 10.1016/j.cell.2006.06.011	22	8	8	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144132	10.1371/journal.pone.0144132	http://dx.doi.org/10.1371/journal.pone.0144132			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636581	Green Submitted, gold, Green Published			2022-12-27	WOS:000366143800046
J	Hasegawa, Y; Tanino, H; Horiguchi, J; Miura, D; Ishikawa, T; Hayashi, M; Takao, S; Kim, SJ; Yamagami, K; Miyashita, M; Konishi, M; Shigeoka, Y; Suzuki, M; Taguchi, T; Kubota, T; Akazawa, K; Kohno, N				Hasegawa, Yoshie; Tanino, Hirokazu; Horiguchi, Jun; Miura, Daishu; Ishikawa, Takashi; Hayashi, Mitsuhiro; Takao, Shintaro; Kim, Seung Jin; Yamagami, Kazuhiko; Miyashita, Masaru; Konishi, Muneharu; Shigeoka, Yasushi; Suzuki, Masato; Taguchi, Tetsuya; Kubota, Tomoyuki; Akazawa, Kouhei; Kohno, Norio		JONIE Study Grp	Randomized Controlled Trial of Zoledronic Acid plus Chemotherapy versus Chemotherapy Alone as Neoadjuvant Treatment of HER2-Negative Primary Breast Cancer (JONIE Study)	PLOS ONE			English	Article							ANTITUMOR-ACTIVITY; TUMOR RESPONSE; WOMEN; THERAPY; BISPHOSPHONATE; LETROZOLE	Purpose Zoledronic acid (ZOL) is a nitrogen-containing bisphosphonate that induces osteoclast apoptosis and inhibits bone resorption by inhibiting the mevalonate pathway. Its benefit for the prevention of skeletal complications due to bone metastases has been established. However, the antitumor efficacy of ZOL, although suggested by multiple preclinical and clinical studies, has not yet been clinically proven. We performed the present randomized Phase 2 trial to investigate the antitumor effect of ZOL with chemotherapy (CT). Methods Asian patients with HER2-negative invasive breast cancer were randomly assigned to either the CT or CT+ZOL (CTZ) group. One hundred and eighty-eight patients were randomized to either the CT group (n = 95) or the CTZ group (n = 93) from March 2010 to April 2012, and 180 patients were assessed. All patients received four cycles of FEC100 (fluorouracil 500 mg/m(2), epirubicin 100 mg/m(2), and cyclophosphamide 500 mg/m(2)), followed by 12 cycles of paclitaxel at 80 mg/m(2) weekly. ZOL (4 mg) was administered three to four times weekly for 7 weeks to the patients in the CTZ group. The primary endpoint was the pathological complete response (pCR) rate, which was defined as no invasive cancer in the breast tissue specimen. Safety was assessed in all patients who received at least one dose of the study drug. Results This randomized controlled trial indicated that the rates of pCR in CTZ group (14.8%) was doubled to CT group (7.7%), respectively (one-sided chi-square test, p = 0.068), though the additional efficacy of zoledronic acid was not demonstrated statistically. The pCR rate in postmenopausal patients was 18.4% and 5.1% in the CTZ and CT groups, respectively (one-sided Fisher's exact test, p = 0.071), and that in patients with triple-negative breast cancer was 35.3% and 11.8% in the CTZ and CT groups, respectively (one-sided Fisher's exact test, p = 0.112). Thus the addition of ZOL to neoadjuvant CT has potential anticancer benefits in postmenopausal patients and patients with triple-negative breast cancer. Further investigation is warranted.	[Hasegawa, Yoshie] Hirosaki Municipal Hosp, Dept Breast Surg, Aomori, Japan; [Tanino, Hirokazu] Kitasato Univ Hosp, Dept Breast & Thyroid Surg, Sagamihara, Kanagawa, Japan; [Horiguchi, Jun] Gunma Univ Hosp, Dept Breast & Endocrine Surg, Gunma, Japan; [Miura, Daishu] Toranomon Gen Hosp, Dept Breast & Endocrine Surg, Tokyo, Japan; [Ishikawa, Takashi] Yokohama City Univ, Med Ctr, Dept Breast & Thyroid Surg, Yokohama, Kanagawa, Japan; [Hayashi, Mitsuhiro] Tokyo Med Univ, Hachioji Med Ctr, Dept Breast Oncol, Tokyo 1608402, Japan; [Takao, Shintaro] Hyogo Canc Ctr, Dept Breast Surg, Akashi, Hyogo, Japan; [Kim, Seung Jin] Osaka Univ, Grad Sch Med, Dept Breast & Endocrine Surg, Osaka, Japan; [Yamagami, Kazuhiko] Shinko Hosp, Dept Breast Oncol, Kobe, Hyogo, Japan; [Miyashita, Masaru] Konan Hosp, Dept Surg, Kobe, Hyogo, Japan; [Konishi, Muneharu] Hyogo Prefectural Nishinomiya Hosp, Dept Surg, Kobe, Hyogo, Japan; [Shigeoka, Yasushi] Yodogawa Christians Hosp, Dept Med Oncol, Osaka, Japan; [Suzuki, Masato] Teikyo Univ, Chiba Med Ctr, Dept Surg, Chiba, Japan; [Taguchi, Tetsuya] Kyoto Prefectural Univ Med, Dept Endocrine & Breast Surg, Kyoto, Japan; [Kubota, Tomoyuki] Kamiiida Daiichi Gen Hosp, Dept Breast Surg, Nagoya, Aichi, Japan; [Akazawa, Kouhei] Niigata Univ, Med & Dent Hosp, Dept Med Informat, Niigata, Japan; [Kohno, Norio] Kobe Kaisei Hosp, Dept Breast Oncol, Kobe, Hyogo, Japan	Kitasato University; Gunma University; Toranomon Hospital; Yokohama City University; Tokyo Medical University; Hyogo Cancer Center; Osaka University; Teikyo University; Kyoto Prefectural University of Medicine; Niigata University	Hasegawa, Y (corresponding author), Hirosaki Municipal Hosp, Dept Breast Surg, Aomori, Japan.	vo-irene.yoshie@nifty.com	Tanino, Hirokazu/AAN-4455-2021; Kohno, Norio/Q-5594-2019		Novaltis Pharma	Novaltis Pharma	This study was supported by Novaltis Pharma. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aft R, 2010, LANCET ONCOL, V11, P421, DOI 10.1016/S1470-2045(10)70054-1; Almubarak Hussain, 2011, J Carcinog, V10, P2, DOI 10.4103/1477-3163.75723; Charehbili A, 2014, ANN ONCOL, V25, P998, DOI 10.1093/annonc/mdu102; Coleman R, 2013, CANCER RES, V73, DOI 10.1158/0008-5472.SABCS13-S4-07; Coleman R, 2013, ANN ONCOL, V24, P398, DOI 10.1093/annonc/mds277; Coleman R, 2011, BREAST CANCER RES TR, V127, P429, DOI 10.1007/s10549-011-1429-y; Coleman RE, 2010, BRIT J CANCER, V102, P1099, DOI 10.1038/sj.bjc.6605604; Coleman RE, 2011, NEW ENGL J MED, V365, P1396, DOI 10.1056/NEJMoa1105195; Fehm T, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-308; Fleisch H, 2002, BREAST CANCER RES, V4, P30, DOI 10.1186/bcr414; Gnant M, 2011, LANCET ONCOL, V12, P631, DOI 10.1016/S1470-2045(11)70122-X; Gnant M, 2009, NEW ENGL J MED, V360, P679, DOI 10.1056/NEJMoa0806285; Green JR, 2011, CRIT REV ONCOL HEMAT, V77, pS3, DOI 10.1016/S1040-8428(11)70003-8; Kohno N, 2005, J CLIN ONCOL, V23, P3314, DOI 10.1200/JCO.2005.05.116; Neville-Webbe HL, 2010, BRIT J CANCER, V102, P1010, DOI 10.1038/sj.bjc.6605579; Ottewell PD, 2010, INT J CANCER, V126, P522, DOI 10.1002/ijc.24756	16	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143643	10.1371/journal.pone.0143643	http://dx.doi.org/10.1371/journal.pone.0143643			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633806	gold, Green Published, Green Submitted			2022-12-27	WOS:000366040000019
J	Yassine, HN; Trenchevska, O; Ramrakhiani, A; Parekh, A; Koska, J; Walker, RW; Billheimer, D; Reaven, PD; Yen, FT; Nelson, RW; Goran, MI; Nedelkov, D				Yassine, Hussein N.; Trenchevska, Olgica; Ramrakhiani, Ambika; Parekh, Aarushi; Koska, Juraj; Walker, Ryan W.; Billheimer, Dean; Reaven, Peter D.; Yen, Frances T.; Nelson, Randall W.; Goran, Michael I.; Nedelkov, Dobrin			The Association of Human Apolipoprotein C-III Sialylation Proteoforms with Plasma Triglycerides	PLOS ONE			English	Article							APOC-III; RICH LIPOPROTEINS; INSULIN; GENE; CIII; LDL; CARBOHYDRATE; INHIBITION; MUTATIONS; KINETICS	Introduction Apolipoprotein C-III (apoC-III) regulates triglyceride (TG) metabolism. In plasma, apoC-III exists in non-sialylated (apoC-III0a without glycosylation and apoC-III0b with glycosylation), monosialylated (apoC-III1) or disialylated (apoC-III2) proteoforms. Our aim was to clarify the relationship between apoC-III sialylation proteoforms with fasting plasma TG concentrations. Methods In 204 non-diabetic adolescent participants, the relative abundance of apoC-III plasma proteoforms was measured using mass spectrometric immunoassay. Results Compared with the healthy weight subgroup (n = 16), the ratios of apoC-III0a, apoC-III0b, and apoC-III1 to apoC-III2 were significantly greater in overweight (n = 33) and obese participants (n = 155). These ratios were positively correlated with BMI z-scores and negatively correlated with measures of insulin sensitivity (Si). The relationship of apoC-III1 / apoC-III2 with Si persisted after adjusting for BMI (p = 0.02). Fasting TG was correlated with the ratio of apoC-III0a / apoC-III2 (r = 0.47, p<0.001), apoC-III0b / apoC-III2 (r = 0.41, p<0.001), apoC-III1 / apoC-III2 (r = 0.43, p<0.001). By examining apoC-III concentrations, the association of apoC-III proteoforms with TG was driven by apoC-III0a (r = 0.57, p<0.001), apoC-III0b (r = 0.56. p<0.001) and apoC-III1 (r = 0.67, p<0.001), but not apoC-III2 (r = 0.006, p = 0.9) concentrations, indicating that apoC-III relationship with plasma TG differed in apoC-III2 compared with the other proteoforms. Conclusion We conclude that apoC-III0a, apoC-III0b, and apoC-III1, but not apoC-III2 appear to be under metabolic control and associate with fasting plasma TG. Measurement of apoC-III proteoforms can offer insights into the biology of TG metabolism in obesity.	[Yassine, Hussein N.; Ramrakhiani, Ambika; Parekh, Aarushi] Univ So Calif, Dept Med, Los Angeles, CA 90089 USA; [Trenchevska, Olgica; Nelson, Randall W.; Nedelkov, Dobrin] Arizona State Univ, Biodesign Inst, Tempe, AZ USA; [Koska, Juraj; Reaven, Peter D.] Phoenix Vet Affairs Med Ctr, Dept Med, Phoenix, AZ USA; [Walker, Ryan W.] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA; [Goran, Michael I.] Icahn Sch Med Mt Sinai, Dept Prevent Med, New York, NY 10029 USA; [Billheimer, Dean] Univ Arizona, Biostat Consulting Lab, Tucson, AZ USA; [Yen, Frances T.] Univ Lorraine, URAFPA, INSERM, Vandoeuvre Les Nancy, France	University of Southern California; Arizona State University; Arizona State University-Tempe; University of Southern California; Icahn School of Medicine at Mount Sinai; University of Arizona; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine	Yassine, HN (corresponding author), Univ So Calif, Dept Med, Los Angeles, CA 90089 USA.	hyassine@usc.edu	Yen, Frances T/G-9175-2014; Nedelkov, Dobrin/I-3603-2013	Yen, Frances T/0000-0001-8740-4304; 	National Institute of Heart, Lung and Blood [K23HL107389]; American Heart Association [12CRP11750017]; USC CTSI pilot [UL1TR000130]; National Institute of Diabetes And Digestive and Kidney Diseases [R01DK082542, R24DK090958]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000130] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL107389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082542, R24DK090958] Funding Source: NIH RePORTER	National Institute of Heart, Lung and Blood(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); USC CTSI pilot; National Institute of Diabetes And Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr. Yassine was supported by K23HL107389 from National Institute of Heart, Lung and Blood, 12CRP11750017 from the American Heart Association and USC CTSI pilot UL1TR000130. Mass spectrometry work was supported by Awards R01DK082542 and R24DK090958 from the National Institute of Diabetes And Digestive and Kidney Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batal R, 2000, J LIPID RES, V41, P706; Bondarenko PV, 1999, J LIPID RES, V40, P543; BOSELLO O, 1985, ANN NUTR METAB, V29, P33, DOI 10.1159/000176951; BREWER HB, 1974, J BIOL CHEM, V249, P4975; Breyer ED, 1999, J LIPID RES, V40, P1875; Caron S, 2011, ARTERIOSCL THROM VAS, V31, P513, DOI 10.1161/ATVBAHA.110.220723; CATAPANO AL, 1987, CHEM PHYS LIPIDS, V45, P39, DOI 10.1016/0009-3084(87)90038-7; CHEN M, 1994, J LIPID RES, V35, P1918; Crosby J, 2014, NEW ENGL J MED, V371, P22, DOI 10.1056/NEJMoa1307095; Cruz ML, 2002, DIABETES CARE, V25, P1631, DOI 10.2337/diacare.25.9.1631; FALKO JM, 1980, METABOLISM, V29, P654, DOI 10.1016/0026-0495(80)90110-9; Fredenrich A, 1997, J LIPID RES, V38, P1421; Gaudet D, 2015, NEW ENGL J MED, V373, P438, DOI 10.1056/NEJMoa1400283; Graham MJ, 2013, CIRC RES, V112, P1479, DOI 10.1161/CIRCRESAHA.111.300367; Harduin-Lepers A, 2001, BIOCHIMIE, V83, P727, DOI 10.1016/S0300-9084(01)01301-3; Harvey SB, 2009, J PROTEOME RES, V8, P603, DOI 10.1021/pr800751x; Hiukka A, 2009, DIABETES, V58, P2018, DOI 10.2337/db09-0206; HOLDSWORTH G, 1982, J CLIN INVEST, V69, P932, DOI 10.1172/JCI110532; Holleboom AG, 2011, CELL METAB, V14, P811, DOI 10.1016/j.cmet.2011.11.005; ITO Y, 1990, SCIENCE, V249, P790, DOI 10.1126/science.2167514; KASHYAP ML, 1981, J LIPID RES, V22, P800; Katrine T-BS, 2012, P NATL ACAD SCI USA, V109, P9893; Li WW, 1995, J CLIN INVEST, V96, P2601, DOI 10.1172/JCI118324; Lindbohm N, 1999, CLIN CHIM ACTA, V285, P69, DOI 10.1016/S0009-8981(99)00107-2; Mann CJ, 1997, J BIOL CHEM, V272, P31348, DOI 10.1074/jbc.272.50.31348; Marucci A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070159; Mauger JF, 2006, J LIPID RES, V47, P1212, DOI 10.1194/jlr.M500455-JLR200; Millar JS, 2001, ATHEROSCLEROSIS, V154, P1, DOI 10.1016/S0021-9150(00)00697-3; Must A, 2006, INT J OBESITY, V30, P590, DOI 10.1038/sj.ijo.0803300; Nelson RW, 2011, J AM SOC MASS SPECTR, V22, P960, DOI 10.1007/s13361-011-0094-z; NELSON RW, 1995, ANAL CHEM, V67, P1153, DOI 10.1021/ac00103a003; ROGHANI A, 1988, J BIOL CHEM, V263, P17925; Savinova OV, 2015, ATHEROSCLEROSIS, V240, P520, DOI 10.1016/j.atherosclerosis.2015.04.793; Savinova OV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104833; Trenchevska O, 2015, METHODS; VAITH P, 1978, BIOCHIM BIOPHYS ACTA, V541, P234, DOI 10.1016/0304-4165(78)90396-3; Wada Y, 2007, GLYCOBIOLOGY, V17, P411, DOI 10.1093/glycob/cwl086; WANG CS, 1985, J CLIN INVEST, V75, P384, DOI 10.1172/JCI111711; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; WINDLER E, 1985, J LIPID RES, V26, P556; WITZTUM JL, 1978, DIABETES, V27, P1215, DOI 10.2337/diabetes.27.12.1215; Yassine HN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115320; ZANNIS VI, 1985, ADV HUM GENET, V14, P125; Zheng CY, 2007, J LIPID RES, V48, P1190, DOI 10.1194/jlr.P600011-JLR200	44	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144138	10.1371/journal.pone.0144138	http://dx.doi.org/10.1371/journal.pone.0144138			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633899	Green Published, gold, Green Submitted			2022-12-27	WOS:000366040000062
J	O'Quin, KE; Doshi, P; Lyon, A; Hoenemeyer, E; Yoshizawa, M; Jeffery, WR				O'Quin, Kelly E.; Doshi, Pooja; Lyon, Anastasia; Hoenemeyer, Emma; Yoshizawa, Masato; Jeffery, William R.			Complex Evolutionary and Genetic Patterns Characterize the Loss of Scleral Ossification in the Blind Cavefish Astyanax mexicanus	PLOS ONE			English	Article							REGRESSIVE EVOLUTION; SKELETAL ELEMENTS; EYE-SIZE; OSSICLES; POPULATIONS; CHARACIDAE; TELEOSTEI; FISH; CONVERGENCE; ADAPTATIONS	The sclera is the tough outer covering of the eye that provides structural support and helps maintain intraocular pressure. In some fishes, reptiles, and birds, the sclera is reinforced with an additional ring of hyaline cartilage or bone that forms from scleral ossicles. Currently, the evolutionary and genetic basis of scleral ossification is poorly understood, especially in teleost fishes. We assessed scleral ossification among several groups of the Mexican tetra (Astyanax mexicanus), which exhibit both an eyed and eyeless morph. Although eyed Astyanax surface fish have bony sclera similar to other teleosts, the ossicles of blind Astyanax cavefish generally do not form. We first sampled cavefish from multiple independent populations and used ancestral character state reconstructions to determine how many times scleral ossification has been lost. We then confirmed these results by assessing complementation of scleral ossification among the F-1 hybrid progeny of two cavefish populations. Finally, we quantified the number of scleral ossicles present among the F-2 hybrid progeny of a cross between surface fish and cavefish, and used this information to identify quantitative trait loci (QTL) responsible for this trait. Our results indicate that the loss of scleral ossification is common-but not ubiquitous-among Astyanax cavefish, and that this trait has been convergently lost at least three times. The presence of wild-type, ossified sclera among the F1 hybrid progeny of a cross between different cavefish populations confirms the convergent evolution of this trait. However, a strongly skewed distribution of scleral ossicles found among surface fish x cavefish F-2 hybrids suggests that scleral ossification is a threshold trait with a complex genetic basis. Quantitative genetic mapping identified a single QTL for scleral ossification on Astyanax linkage group 1. We estimate that the threshold for this trait is likely determined by at least three genetic factors which may control the severity and onset of lens degeneration in cavefishes. We conclude that complex evolutionary and genetic patterns underlie the loss of scleral ossification in Astyanax cavefish.	[O'Quin, Kelly E.; Lyon, Anastasia; Hoenemeyer, Emma] Ctr Coll Danville, Biol Program, Danville, KY 40422 USA; [Doshi, Pooja; Jeffery, William R.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Yoshizawa, Masato] Univ Hawaii Manoa, Dept Biol, Honolulu, HI 96822 USA	University System of Maryland; University of Maryland College Park; University of Hawaii System; University of Hawaii Manoa	O'Quin, KE (corresponding author), Ctr Coll Danville, Biol Program, Danville, KY 40422 USA.	kelly.oquin@centre.edu	Yoshizawa, Masato/AAE-9415-2022; Yoshizawa, Masato/AFD-8467-2022	Yoshizawa, Masato/0000-0001-8455-8252; Yoshizawa, Masato/0000-0001-8455-8252; Lyon, Anastasia/0000-0002-7365-4035	National Science Foundation [IBN-05384]; National Institutes of Health [R01-EY014619, R01-EY024941]; NATIONAL EYE INSTITUTE [R01EY024941] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants from the National Science Foundation (IBN-05384) and National Institutes of Health (R01-EY014619 and R01-EY024941) to WRJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beale A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3769; Borowsky R, 2002, J HERED, V93, P19, DOI 10.1093/jhered/93.1.19; Borowsky R, 2008, CURR BIOL, V18, pR23, DOI 10.1016/j.cub.2007.11.023; Broman KW, 2009, STAT BIOL HEALTH, P1, DOI 10.1007/978-0-387-92125-9_1; Coghill LM, 2014, MOL PHYLOGENET EVOL, V79, P368, DOI 10.1016/j.ympev.2014.06.029; COULOMBRE J, 1975, DEV BIOL, V45, P291, DOI 10.1016/0012-1606(75)90067-6; Dowling TE, 2002, MOL BIOL EVOL, V19, P446, DOI 10.1093/oxfordjournals.molbev.a004100; Duboue ER, 2011, CURR BIOL, V21, P671, DOI 10.1016/j.cub.2011.03.020; Duench K, 2012, DEV BIOL, V365, P251, DOI 10.1016/j.ydbio.2012.02.016; Dufton M, 2015, DEV DYNAM, V244, P1109, DOI 10.1002/dvdy.24278; Dufton M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050308; EDINGER TILLY, 1929, ZOOL JAHRB ABT ANAT U ONTOGEN TIERE, V51, P163; Elipot Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4647; Espinasa L, 2001, ENVIRON BIOL FISH, V62, P339, DOI 10.1023/A:1011852603162; Franz-Odendaal TA, 2008, ANAT REC, V291, P161, DOI 10.1002/ar.20639; Franz-Odendaal TA, 2007, J EXP ZOOL PART B, V308B, P709, DOI 10.1002/jez.b.21185; Franz-Odendaal TA, 2006, J MORPHOL, V267, P1326, DOI 10.1002/jmor.10479; Franz-Odendaal TA, 2006, DEV DYNAM, V235, P1244, DOI 10.1002/dvdy.20718; Gross JB, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-105; Gross JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000326; Hall B.K., 2015, BONES CARTILAGE DEV; Hanken J., 1981, Functional Photography, V16, P22; Jeffery WR, 2003, INTEGR COMP BIOL, V43, P531, DOI 10.1093/icb/43.4.531; Kague E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047394; Koktekir BE, 2014, J CRANIOFAC SURG, V25, pE562, DOI 10.1097/SCS.0000000000001109; LANGECKER TG, 1993, COPEIA, P976; Lynch M., 1998, GENETICS ANAL QUANTI; Maddison W, 2014, MESQUITE MODUAL SYST, V2, P75; Manichaikul A, 2009, GENETICS, V181, P1077, DOI 10.1534/genetics.108.094565; McBrien NA, 2003, PROG RETIN EYE RES, V22, P307, DOI 10.1016/S1350-9462(02)00063-0; MITCHELL RW, 1977, SPEC PUBL MUS TEXAS, V12, P1; Mok HK, 2012, ZOOL STUD, V51, P1490; MULLANEY J, 1971, BRIT J OPHTHALMOL, V55, P243, DOI 10.1136/bjo.55.4.243; O'Quin KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057281; Pagel M, 1999, SYST BIOL, V48, P612, DOI 10.1080/106351599260184; PALMOSKI MJ, 1970, J EXP ZOOL, V174, P157, DOI 10.1002/jez.1401740205; Pecorella I, 2006, ORBIT, V25, P35, DOI 10.1080/01676830500505962; PINTO CB, 1991, J EXP ZOOL, V259, P92, DOI 10.1002/jez.1402590112; Poulson TL, 2001, ENVIRON BIOL FISH, V62, P345, DOI 10.1023/A:1011893916855; Protas ME, 2006, NAT GENET, V38, P107, DOI 10.1038/ng1700; Protas M, 2008, EVOL DEV, V10, P196, DOI 10.1111/j.1525-142X.2008.00227.x; Protas M, 2007, CURR BIOL, V17, P452, DOI 10.1016/j.cub.2007.01.051; Rasband WS, 2014, IMAGEJ; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schobert CS, 2013, VET OPHTHALMOL, V16, P359, DOI 10.1111/vop.12006; Strecker U, 2003, MOL ECOL, V12, P699, DOI 10.1046/j.1365-294X.2003.01753.x; Thompson H, 2010, DEV BIOL, V347, P40, DOI 10.1016/j.ydbio.2010.08.006; Wilkens H, 2003, BIOL J LINN SOC, V80, P545, DOI 10.1111/j.1095-8312.2003.00230.x; WILKENS H, 1971, EVOLUTION, V25, P530, DOI 10.1111/j.1558-5646.1971.tb01913.x; Wilkens H, 1988, EVOL BIOL, V23, P271, DOI [10.1007/978-1-4613-1043-3_8, DOI 10.1007/978-1-4613-1043-3_]; Wright S, 1934, GENETICS, V19, P0537; Yamamoto Y, 2003, EVOL DEV, V5, P435, DOI 10.1046/j.1525-142X.2003.03050.x; Yoshizawa M, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-108	53	14	14	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0142208	10.1371/journal.pone.0142208	http://dx.doi.org/10.1371/journal.pone.0142208			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26649887	Green Submitted, Green Published, gold			2022-12-27	WOS:000366903300005
J	Oettler, J; Nachtigal, AL; Schrader, L				Oettler, Jan; Nachtigal, Anna-Lena; Schrader, Lukas			Expression of the Foraging Gene Is Associated with Age Polyethism, Not Task Preference, in the Ant Cardiocondyla obscurior	PLOS ONE			English	Article							DIVISION-OF-LABOR; HARVESTER ANT; PLASTICITY; SOCIETIES; BEHAVIORS; COLONIES	One of the fundamental principles of social organization, age polyethism, describes behavioral maturation of workers leading to switches in task preference. Here we present a system that allows for studying division of labor (DOL) by taking advantage of the relative short life of Cardiocondyla obscurior workers and thereby the pace of behavioral transitions. By challenging same-age young and older age cohorts to de novo establish DOL into nurse and foraging tasks and by forcing nurses to precociously become foragers and vice versa we studied expression patterns of one of the best known candidates for social insect worker behavior, the foraging gene. Contrary to our expectations we found that foraging gene expression correlates with age, but not with the task foraging per se. This suggests that this nutrition-related gene, and the pathways it is embedded in, correlates with physiological changes over time and potentially primes, but not determines task preference of individual workers.	[Oettler, Jan; Nachtigal, Anna-Lena; Schrader, Lukas] Univ Regensburg, Inst Zool, D-93053 Regensburg, Germany	University of Regensburg	Oettler, J (corresponding author), Univ Regensburg, Inst Zool, D-93053 Regensburg, Germany.	joettler@gmail.com	Schrader, Lukas/AAU-6061-2021	Schrader, Lukas/0000-0001-9863-0526	Deutsche Forschungsgemeinschaft [He 1623/23]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by Deutsche Forschungsgemeinschaft (www.dfg.de) grant: He 1623/23. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amdam GV, 2003, P NATL ACAD SCI USA, V100, P1799, DOI 10.1073/pnas.0333979100; Ament SA, 2008, P NATL ACAD SCI USA, V105, P4226, DOI 10.1073/pnas.0800630105; Ben-Shahar Y, 2002, SCIENCE, V296, P741, DOI 10.1126/science.1069911; Bressan JMA, 2015, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00166; Dolezal AG, 2012, J EXP BIOL, V215, P454, DOI 10.1242/jeb.060822; Fitzpatrick MJ, 2007, NATURE, V447, P210, DOI 10.1038/nature05764; FRANKS NR, 1994, ANIM BEHAV, V48, P470, DOI 10.1006/anbe.1994.1261; Herb BR, 2012, NAT NEUROSCI, V15, P1371, DOI 10.1038/nn.3218; Holbrook CT, 2014, ANIM BEHAV, V97, P177, DOI 10.1016/j.anbehav.2014.09.015; Ingram KK, 2005, MOL ECOL, V14, P813, DOI 10.1111/j.1365-294X.2005.02450.x; Ingram Krista K., 2011, BMC Ecology, V11, P19, DOI 10.1186/1472-6785-11-19; Julian GE, 2004, ANIM BEHAV, V68, P1, DOI 10.1016/j.anbehav.2003.06.023; Kaun KR, 2009, GENOME, V52, P1, DOI 10.1139/G08-090; Kent CF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000609; Leoncini I, 2004, P NATL ACAD SCI USA, V101, P17559, DOI 10.1073/pnas.0407652101; Lucas C, 2010, ARCH INSECT BIOCHEM, V74, P52, DOI 10.1002/arch.20363; Lucas C, 2009, P NATL ACAD SCI USA, V106, P6351, DOI 10.1073/pnas.0809463106; Modlmeier AP, 2012, P ROY SOC B-BIOL SCI, V279, P2142, DOI 10.1098/rspb.2011.2376; Oettler J, 2009, J INSECT BEHAV, V22, P217, DOI 10.1007/s10905-008-9167-7; PORTER SD, 1981, BEHAV ECOL SOCIOBIOL, V9, P247, DOI 10.1007/BF00299879; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schrader L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6495; Schwander T, 2011, TRENDS ECOL EVOL, V26, P143, DOI 10.1016/j.tree.2010.12.010; Uller T, 2011, TRENDS ECOL EVOL, V26, P435, DOI 10.1016/j.tree.2011.05.013; Waddington SJ, 2010, BEHAV ECOL, V21, P1165, DOI 10.1093/beheco/arq128; West-Eberhard MJ, 2005, P NATL ACAD SCI USA, V102, P6543, DOI 10.1073/pnas.0501844102; Wiernasz DC, 2008, MOL ECOL, V17, P1137, DOI 10.1111/j.1365-294X.2007.03646.x	28	19	19	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144699	10.1371/journal.pone.0144699	http://dx.doi.org/10.1371/journal.pone.0144699			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650238	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903300067
J	Plevock, KM; Galletta, BJ; Slep, KC; Rusan, NM				Plevock, Karen M.; Galletta, Brian J.; Slep, Kevin C.; Rusan, Nasser M.			Newly Characterized Region of CP190 Associates with Microtubules and Mediates Proper Spindle Morphology in Drosophila Stem Cells	PLOS ONE			English	Article							CENTROSOME-ASSOCIATED PROTEIN; ORDER CHROMATIN ORGANIZATION; INSULATOR PROTEINS; BINDING; TUBULIN; COMPLEX; LOCALIZATION; MELANOGASTER; DOMAIN	CP190 is a large, multi-domain protein, first identified as a centrosome protein with oscillatory localization over the course of the cell cycle. During interphase it has a well-established role within the nucleus as a chromatin insulator. Upon nuclear envelope breakdown, there is a striking redistribution of CP190 to centrosomes and the mitotic spindle, in addition to the population at chromosomes. Here, we investigate CP190 in detail by performing domain analysis in cultured Drosophila S2 cells combined with protein structure determination by X-ray crystallography, in vitro biochemical characterization, and in vivo fixed and live imaging of cp190 mutant flies. Our analysis of CP190 identifies a novel N-terminal centrosome and microtubule (MT) targeting region, sufficient for spindle localization. This region consists of a highly conserved BTB domain and a linker region that serves as the MT binding domain. We present the 2.5 resolution structure of the CP190 N-terminal 126 amino acids, which adopts a canonical BTB domain fold and exists as a stable dimer in solution. The ability of the linker region to robustly localize to MTs requires BTB domain-mediated dimerization. Deletion of the linker region using CRISPR significantly alters spindle morphology and leads to DNA segregation errors in the developing Drosophila brain neuroblasts. Collectively, we highlight a multivalent MT-binding architecture in CP190, which confers distinct subcellular cytoskeletal localization and function during mitosis.	[Plevock, Karen M.; Galletta, Brian J.; Rusan, Nasser M.] NIH, Cell Biol & Physiol Ctr, Natl Heart Lung & Blood Inst, Bethesda, MD 20892 USA; [Plevock, Karen M.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Slep, Kevin C.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Slep, KC (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA.	kslep@bio.unc.edu; nasser@nih.gov	Rusan, Nasser/U-2513-2017; Rusan, Nasser/P-3511-2016		National Institutes of Health [R01GM094415, T32GM008570]; Division of Intramural Research, National Heart Lung and Blood Institute [1ZIAHL006104]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008570, R01GM094415] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Intramural Research, National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (grant nos. R01GM094415, T32GM008570), and the Division of Intramural Research, National Heart Lung and Blood Institute (grant no. 1ZIAHL006104). Other than the grants listed above, the authors received no additional funding for this work.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahanger SH, 2013, NUCLEUS-AUSTIN, V4, P115, DOI 10.4161/nucl.23389; Ahmad KF, 1998, P NATL ACAD SCI USA, V95, P12123, DOI 10.1073/pnas.95.21.12123; Bushey AM, 2009, GENE DEV, V23, P1338, DOI 10.1101/gad.1798209; Butcher RDJ, 2004, J CELL SCI, V117, P1191, DOI 10.1242/jcs.00979; Campbell JN, 2011, METHODS MOL BIOL, V777, P87, DOI 10.1007/978-1-61779-252-6_6; Chodagam S, 2005, CURR BIOL, V15, P1308, DOI 10.1016/j.cub.2005.06.024; Dictenberg JB, 1998, J CELL BIOL, V141, P163, DOI 10.1083/jcb.141.1.163; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gopalakrishnan J, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1367; Goshima G, 2008, J CELL BIOL, V181, P421, DOI 10.1083/jcb.200711053; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Huang AM., 2009, COLD SPRING HARB PRO; Jiang K, 2012, CURR BIOL, V22, P1800, DOI 10.1016/j.cub.2012.07.047; KELLOGG DR, 1989, J CELL BIOL, V109, P2977, DOI 10.1083/jcb.109.6.2977; KELLOGG DR, 1992, MOL BIOL CELL, V3, P1, DOI 10.1091/mbc.3.1.1; Korenjak M, 2014, NUCLEIC ACIDS RES, V42, P8939, DOI 10.1093/nar/gku609; LEAHY DJ, 1994, PROTEINS, V19, P48, DOI 10.1002/prot.340190107; Lerit DA, 2014, JOVE-J VIS EXP, DOI 10.3791/51756; Miller PM, 2009, NAT CELL BIOL, V11, P1069, DOI 10.1038/ncb1920; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Mohan M, 2007, EMBO J, V26, P4203, DOI 10.1038/sj.emboj.7601851; Mollinari C, 2002, J CELL BIOL, V157, P1175, DOI 10.1083/jcb.200111052; MORITZ M, 1995, NATURE, V378, P638, DOI 10.1038/378638a0; OEGEMA K, 1995, J CELL BIOL, V131, P1261, DOI 10.1083/jcb.131.5.1261; Oegema K, 1997, J CELL SCI, V110, P1573; Oliver D, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-101; Ong CT, 2013, CELL, V155, P148, DOI 10.1016/j.cell.2013.08.052; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rogers SL, 2008, NAT PROTOC, V3, P606, DOI 10.1038/nprot.2008.18; Vogelmann J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004544; Vogelmann J, 2011, NUCLEUS-PHILA, V2, P358, DOI 10.4161/nucl.2.5.17860; Wallace HA, 2010, CHROMOSOMA, V119, P177, DOI 10.1007/s00412-009-0246-0; WEISENBERG RC, 1972, SCIENCE, V177, P1104, DOI 10.1126/science.177.4054.1104; WHITFIELD WGF, 1995, J CELL SCI, V108, P3377	36	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144174	10.1371/journal.pone.0144174	http://dx.doi.org/10.1371/journal.pone.0144174			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26649574	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903300039
J	Kan, LJ; Smith, A; Chen, M; Ledford, BT; Fan, HM; Liu, ZM; He, JQ				Kan, Lijuan; Smith, Aubrie; Chen, Miao; Ledford, Benjamin T.; Fan, Huimin; Liu, Zhongmin; He, Jia-Qiang			Rho-Associated Kinase Inhibitor (Y-27632) Attenuates Doxorubicin-Induced Apoptosis of Human Cardiac Stem Cells	PLOS ONE			English	Article							IN-VITRO; MIGRATION; CARDIOMYOPATHY; ACTIN; HEART; BCL-2; PROLIFERATION; INVOLVEMENT; EXPRESSION; PATHWAYS	Background Recent clinical trials using c-kit(+) human cardiac stem cells (CSCs) demonstrated promising results in increasing cardiac function and improving quality of life. However, CSC efficiency is low, likely due to limited cell survival and engraftment after transplantation. The Rho-associated protein kinase (ROCK) inhibitor, Y-27632, significantly increased cell survival rate, adhesion, and migration in numerous types of cells, including stem cells, suggesting a common feature of the ROCK-mediated apoptotic pathway that may also exist in human CSCs. In this study, we examine the hypothesis that pretreatment of human CSCs with Y-27632 protects cells from Doxorubicin (Dox) induced apoptosis. Methods and Results c-kit(+) CSCs were cultured in CSC medium for 3-5 days followed by 48hr treatment with 0 to 10 mu M Y-27632 alone, 0 to 1.0 mu M Dox alone, or Y-27632 followed by Dox (48hrs). Cell viability, toxicity, proliferation, morphology, migration, Caspase-3 activity, expression levels of apoptotic-related key proteins and c-kit(+) were examined. Results showed that 48hr treatment with Y-27632 alone did not result in great changes in c-kit(+) expression, proliferation, Caspase-3 activity, or apoptosis; however cell viability was significantly increased and cell migration was promoted. These effects likely involve the ROCK/Actin pathways. In contrast, 48hr treatment with Dox alone dramatically increased Caspase-3 activity, resulting in cell death. Although Y-27632 alone did not affect the expression levels of apoptotic-related key factors (p-Akt, Akt, Bcl-2, Bcl-xl, Bax, cleaved Caspase-3, and Caspase-3) under basal conditions, it significantly inhibited the Dox-induced increase in cleaved Caspase-3 and reduced cell death under Dox treatment. Conclusions We conclude that preconditioning human CSCs with Y-27632 significantly reduces Dox-induced cell death and possibly involves the cleaved Caspase-3 and ROCK/Actin pathways. The beneficial effects of Y-27632 may be applied to stem cell-based therapy to increase cell survival rates after transplantation or to act as a cardiac protective agent for Dox-treated cancer patients.	[Kan, Lijuan; Smith, Aubrie; Chen, Miao; Ledford, Benjamin T.; He, Jia-Qiang] Virginia Polytech Inst & State Univ, Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA; [Fan, Huimin; Liu, Zhongmin] Tongji Univ, Shanghai East Hosp, Res Inst Heart Failure, Shanghai 200092, Peoples R China	Virginia Polytechnic Institute & State University; Tongji University	He, JQ (corresponding author), Virginia Polytech Inst & State Univ, Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA.	jiahe@vt.edu			PI's startup fund; Institute for Critical Technology and Applied Science (ICTAS) at Virginia Polytechnic Institute and State Universit [JFC2014_JIAHE958451025]	PI's startup fund; Institute for Critical Technology and Applied Science (ICTAS) at Virginia Polytechnic Institute and State Universit	This work was supported by the PI's startup fund and a grant from the Institute for Critical Technology and Applied Science (ICTAS) at Virginia Polytechnic Institute and State University (#JFC2014_JIAHE958451025). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanchoin L, 2014, PHYSIOL REV, V94, P235, DOI 10.1152/physrev.00018.2013; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Bollini S, 2011, J MOL CELL CARDIOL, V50, P296, DOI 10.1016/j.yjmcc.2010.07.006; Braam SR, 2010, ANN NY ACAD SCI, V1188, P52, DOI 10.1111/j.1749-6632.2009.05083.x; Bueno C, 2010, STEM CELL REV REP, V6, P215, DOI 10.1007/s12015-010-9118-5; Chang J, 2006, P NATL ACAD SCI USA, V103, P14495, DOI 10.1073/pnas.0601911103; D'Amario D, 2011, CIRC RES, V108, P1467, DOI 10.1161/CIRCRESAHA.111.240648; De Angelis A, 2010, CIRCULATION, V121, P276, DOI 10.1161/CIRCULATIONAHA.109.895771; Don CW, 2013, J CELL MOL MED, V17, P1355, DOI 10.1111/jcmm.12147; Eding JEC, 2015, CIRC RES, V116, P80, DOI 10.1161/CIRCRESAHA.116.304872; Fisher SA, 2015, CIRC RES, V116, P1361, DOI 10.1161/CIRCRESAHA.116.304386; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Gauthaman K, 2010, STEM CELL REV REP, V6, P86, DOI [10.1007/s12015-010-9166-x, 10.1007/s12015-009-9107-8]; Grzanka D, 2013, ACTA HISTOCHEM, V115, P775, DOI 10.1016/j.acthis.2013.04.002; He JQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027719; Heng BC, 2009, TISSUE CELL, V41, P376, DOI 10.1016/j.tice.2009.01.004; Hong KU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096725; Hosoda T, 2009, P NATL ACAD SCI USA, V106, P17169, DOI 10.1073/pnas.0903089106; Huigsloot M, 2002, J BIOL CHEM, V277, P35869, DOI 10.1074/jbc.M200378200; Kajstura J, 2012, CIRC RES, V111, P894, DOI 10.1161/CIRCRESAHA.112.273649; Kaushal V, 2004, ENDOTHELIUM-J ENDOTH, V11, P253, DOI 10.1080/10623320490904124; Keith MCL, 2015, CIRC RES, V116, P1216, DOI 10.1161/CIRCRESAHA.116.305557; Kroening S, 2010, J CELL PHYSIOL, V223, P703, DOI 10.1002/jcp.22079; Lee ER, 2006, BBA-MOL CELL RES, V1763, P958, DOI 10.1016/j.bbamcr.2006.06.006; Magdalena J, 2003, J CELL SCI, V116, P743, DOI 10.1242/jcs.00288; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Monti M, 2013, PHARMACOL RES, V76, P171, DOI 10.1016/j.phrs.2013.08.003; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Okumura N, 2009, INVEST OPHTH VIS SCI, V50, P3680, DOI 10.1167/iovs.08-2634; Olson MF, 2008, CURR OPIN CELL BIOL, V20, P242, DOI 10.1016/j.ceb.2008.01.002; Piegari E, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0334-4; Piltti J, 2015, PROTEOMICS, V15, P2953, DOI 10.1002/pmic.201400417; Pipparelli A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062095; Sano J, 2005, RES VET SCI, V79, P197, DOI 10.1016/j.rvsc.2005.03.001; Shi JJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.10; Shum MSY, 2011, FASEB J, V25, P4423, DOI 10.1096/fj.11-185447; Somlyo AV, 2000, BIOCHEM BIOPH RES CO, V269, P652, DOI 10.1006/bbrc.2000.2343; Surma M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090758; Surma M, 2011, FUTUR CARDIOL, V7, P657, DOI [10.2217/fca.11.51, 10.2217/FCA.11.51]; Tacar O, 2013, J PHARM PHARMACOL, V65, P157, DOI 10.1111/j.2042-7158.2012.01567.x; Tu YP, 1996, BLOOD, V88, P1805, DOI 10.1182/blood.V88.5.1805.bloodjournal8851805; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Vichalkovski A, 2005, CELL SIGNAL, V17, P447, DOI 10.1016/j.cellsig.2004.09.010; Wang N, 2011, FOOD CHEM TOXICOL, V49, P2975, DOI 10.1016/j.fct.2011.06.080; Yin J, 2008, AM J PHYSIOL-CELL PH, V295, pC378, DOI 10.1152/ajpcell.90624.2007; Yu ZY, 2012, NEUROCHEM INT, V61, P1114, DOI 10.1016/j.neuint.2012.08.003; Zhang XJ, 2011, CELL MOL BIOL LETT, V16, P279, DOI 10.2478/s11658-011-0006-z	47	18	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0144513	10.1371/journal.pone.0144513	http://dx.doi.org/10.1371/journal.pone.0144513			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YV	26645568	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903100027
J	Chen, XD; Winckler, B; Lu, M; Cheng, HW; Yuan, ZY; Yang, YJ; Jin, L; Ye, WM				Chen, Xingdong; Winckler, Bjorn; Lu, Ming; Cheng, Hongwei; Yuan, Ziyu; Yang, Yajun; Jin, Li; Ye, Weimin			Oral Microbiota and Risk for Esophageal Squamous Cell Carcinoma in a High-Risk Area of China	PLOS ONE			English	Article							STREPTOCOCCUS-ANGINOSUS; TOOTH LOSS; CANCER; INFECTION; HYGIENE; HEALTH; ASSOCIATION; DYSPLASIA; SEQUENCES; DNA	Poor oral health has been linked with an increased risk of esophageal squamous cell carcinoma (ESCC). We investigated whether alteration of oral microbiota is associated with ESCC risk. Fasting saliva samples were collected from 87 incident and histopathologicallly diagnosed ESCC cases, 63 subjects with dysplasia and 85 healthy controls. All subjects were also interviewed with a questionnaire. V3-V4 region of 16S rRNA was amplified and sequenced by 454-pyrosequencing platform. Carriage of each genus was compared by means of multivariate-adjusted odds ratios derived from logistic regression model. Relative abundance was compared using Metastats method. Beta diversity was estimated using Unifrac and weighted Unifrac distances. Principal coordinate analysis (PCoA) was applied to ordinate dissimilarity matrices. Multinomial logistic regression was used to compare the coordinates between different groups. ESCC subjects had an overall decreased microbial diversity compared to control and dysplasia subjects (P<0.001). Decreased carriage of genera Lautropia, Bulleidia, Catonella, Corynebacterium, Moryella, Peptococcus and Cardio-bacterium were found in ESCC subjects compared to non-ESCC subjects. Multinomial logistic regression analyses on PCoA coordinates also revealed that ESCC subjects had significantly different levels for several coordinates compared to non-ESCC subjects. In conclusion, we observed a correlation between altered salivary bacterial microbiota and ESCC risk. The results of our study on the saliva microbiome are of particular interest as it reflects the shift in microbial communities. Further studies are warranted to verify this finding, and if being verified, to explore the underlying mechanisms.	[Chen, Xingdong; Winckler, Bjorn; Ye, Weimin] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Chen, Xingdong; Yuan, Ziyu; Yang, Yajun; Jin, Li] Fudan Univ, Minist Educ, Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Chen, Xingdong; Yuan, Ziyu; Yang, Yajun; Jin, Li] Fudan Univ, State Key Lab Genet Engn, Collaborat Innovat Ctr Genet & Dev, Sch Life Sci, Shanghai 200433, Peoples R China; [Chen, Xingdong; Lu, Ming; Yuan, Ziyu; Yang, Yajun; Jin, Li; Ye, Weimin] Fudan Taizhou Inst Hlth Sci, Taizhou, Peoples R China; [Lu, Ming] Shandong Univ, Qilu Hosp, Clin Epidemiol Unit, Jinan 250100, Peoples R China; [Cheng, Hongwei] Taixing Peoples Hosp, Taixing, Peoples R China	Karolinska Institutet; Fudan University; Fudan University; Shandong University	Lu, M (corresponding author), Fudan Taizhou Inst Hlth Sci, Taizhou, Peoples R China.	lvming@sdu.edu.cn	Jin, Li/M-5063-2019; Jin, Li/C-1468-2009	Jin, Li/0000-0002-4546-2415; ye, weimin/0000-0002-6859-4648	Natural Science Foundation of China [81072358, 81273151]; Science and Technology Committee of Shandong Province [2012GSF11857]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Committee of Shandong Province	This work was supported by a grant from Natural Science Foundation of China (81072358, 81273151), and a grant from Science and Technology Committee of Shandong Province (2012GSF11857). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2001, CANCER CAUSE CONTROL, V12, P847, DOI 10.1023/A:1012290009545; Abnet CC, 2008, CANCER EPIDEM BIOMAR, V17, P3062, DOI 10.1158/1055-9965.EPI-08-0558; Ahn J, 2013, JNCI-J NATL CANCER I, V105, P1907, DOI 10.1093/jnci/djt300; Ahn J, 2012, CANCER CAUSE CONTROL, V23, P399, DOI 10.1007/s10552-011-9892-7; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Contreras M, 2010, MICROBIOL-SGM, V156, P3282, DOI 10.1099/mic.0.043174-0; Dar NA, 2013, BRIT J CANCER, V109, P1367, DOI 10.1038/bjc.2013.437; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Guha N, 2007, AM J EPIDEMIOL, V166, P1159, DOI 10.1093/aje/kwm193; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Herlemann DPR, 2011, ISME J, V5, P1571, DOI 10.1038/ismej.2011.41; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Mager DL, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-27; Mariotti E, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-120; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Morita E, 2003, CANCER SCI, V94, P492, DOI 10.1111/j.1349-7006.2003.tb01471.x; Nair J, 1996, CRIT REV TOXICOL, V26, P149, DOI 10.3109/10408449609017928; Narikiyo M, 2004, CANCER SCI, V95, P569, DOI 10.1111/j.1349-7006.2004.tb02488.x; Nasrollahzadeh D, 2012, BRIT J CANCER, V107, P888, DOI 10.1038/bjc.2012.332; Nyren O, 2002, TXB CANC EPIDEMIOLOG, P137; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pushalkar S, 2011, FEMS IMMUNOL MED MIC, V61, P269, DOI 10.1111/j.1574-695X.2010.00773.x; Salaspuro MP, 2003, CRIT REV CL LAB SCI, V40, P183, DOI 10.1080/713609333; Sasaki H, 1998, CANCER RES, V58, P2991; Sato F, 2011, HEAD NECK-J SCI SPEC, V33, P1628, DOI 10.1002/hed.21649; Schwabe RF, 2013, NAT REV CANCER, V13, P800, DOI 10.1038/nrc3610; Sepehr A, 2005, ANTICANCER RES, V25, P543; Socransky SS, 2005, PERIODONTOL 2000, V38, P135, DOI 10.1111/j.1600-0757.2005.00107.x; Urbanek C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-233; von Rosenvinge EC, 2013, ISME J, V7, P1354, DOI 10.1038/ismej.2013.33; Wang XF, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-223; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Yang H, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-132; Yu GQ, 2014, CANCER EPIDEM BIOMAR, V23, P735, DOI 10.1158/1055-9965.EPI-13-0855; Zhuang M, 2012, CHINA PLOS ONE, V7, DOI [10.1371/journal.pone.0048341, DOI 10.1371/JOURNAL.PONE.0048341]	39	97	106	5	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0143603	10.1371/journal.pone.0143603	http://dx.doi.org/10.1371/journal.pone.0143603			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641451	gold, Green Published, Green Submitted			2022-12-27	WOS:000366902700023
J	Ge, PF; Dong, CX; Ren, XL; Weiderpass, E; Zhang, CJ; Fan, HQ; Zhang, J; Zhang, YR; Xi, J				Ge, Pengfei; Dong, Caixia; Ren, Xiaolan; Weiderpass, Elisabete; Zhang, Chouji; Fan, Haoqiang; Zhang, Jing; Zhang, Yongrui; Xi, Jinen			The High Prevalence of Low HDL-Cholesterol Levels and Dyslipidemia in Rural Populations in Northwestern China	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; HIGH-DENSITY-LIPOPROTEIN; CARDIOVASCULAR-DISEASE; ALCOHOL-CONSUMPTION; RISK-FACTOR; MORTALITY; ADULTS	Background Dyslipidemia is a major health problem in China and an important modifiable cardiovascular disease (CVD) risk factor. This study aimed to describe the prevalence of dyslipidemia and low high density lipoprotein cholesterol (HDL-cholesterol) and associated risk factors among adults in rural northwest China. Methods In a cross-sectional analyses involving 2,980 adults aged >18 years, information on the demographics, cigarette smoking, alcohol consumption, education, and medical history was collected via face-to-face interviews. Blood samples were collected to determine total cholesterol (TC), low-density lipoprotein cholesterol (LDL-cholesterol), and HDL-cholesterol, and triglycerides (TG) levels. Results The prevalence of high TC, high LDL-cholesterol, low HDL-cholesterol, and high TG were 1.0%, 0.6%, 60.9%, and 13.7%, respectively. TC, LDL-cholesterol, and TG increased with age in females. Elevated TC was more common in females than in males. The prevalence of low HDL-cholesterol was 67.6% in males and 55.4% in females. Current smokers, those with less education, those who were overweight or obese, and those with large waist circumference were more likely to have low HDL-cholesterol (p<0.05). Multivariable regression showed that male gender showed an association with low HDL-cholesterol (OR 2.10, 95% CI 1.68-2.61), age >= 60 years (OR 0.80, 95% CI 0.64-0.99), BMI (BMI = 24-27.9, OR 1.27, 95% CI 1.04-1.54, p = 0.02 and BMI >= 28, OR 1.56, 95% CI 1.10-2.20, p = 0.01) and enlarged waist circumference (OR 2.10, 95% CI 1.51-2.92). Non-alcohol drinker was associated with low HDL-cholesterol levels (OR 0.72, 95% CI 0.53-0.99, p = 0.04). Conclusions This study found that the prevalence of low HDL-cholesterol was 67.6% and 55.4% for males and females. Male gender, non-alcohol drinker, BMI and central obesity were important risk factors for low HDL-cholesterol in Chinese adults.	[Ge, Pengfei; Dong, Caixia; Ren, Xiaolan; Zhang, Chouji; Fan, Haoqiang; Zhang, Jing; Zhang, Yongrui; Xi, Jinen] Gansu Ctr Dis Control & Prevent, Inst Noncommunicable Chron Dis, Lanzhou 730000, Gansu, Peoples R China; [Weiderpass, Elisabete] Univ Tromso, Dept Community Med, Fac Hlth Sci, Tromso, Norway; [Weiderpass, Elisabete] Canc Registry Norway, Dept Res, Oslo, Norway; [Weiderpass, Elisabete] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Weiderpass, Elisabete] Samfundet Folkhalsan, Helsinki, Finland	UiT The Arctic University of Tromso; University of Oslo; Karolinska Institutet; Samfundet Folkhalsan	Dong, CX (corresponding author), Gansu Ctr Dis Control & Prevent, Inst Noncommunicable Chron Dis, 230 Donggang Western Rd, Lanzhou 730000, Gansu, Peoples R China.	dongcaixia2008@163.com	Weiderpass, Elisabete/M-4029-2016; Weiderpass, Elisabete/AAP-2747-2021	Weiderpass, Elisabete/0000-0003-2237-0128; Weiderpass, Elisabete/0000-0003-2237-0128	Chinese government	Chinese government	Financial and technical support was provided by the Chinese government and the Chinese Center for Disease Control and Prevention in facilitating this survey.; We gratefully acknowledge the financial and technical support provided by the Chinese government and the Chinese Center for Disease Control and Prevention in facilitating this survey. We also thank the field team from the Centers for Disease Control and Prevention in the surveillance areas for their contributions to data collection. We also thank the local community health doctors and nurses for providing fieldwork assistants. We thank all of the individuals who participated in the present survey.	Alwaili K, 2010, EXPERT REV CARDIOVAS, V8, P413, DOI [10.1586/erc.10.4, 10.1586/ERC.10.4]; [Anonymous], 2007, ZHONGHUA XIN XUE GUA, V35, P390, DOI DOI 10.3760/J.ISSN:0253-3758.2007.05.003; Ascaso Juan F, 2004, Am J Cardiovasc Drugs, V4, P299, DOI 10.2165/00129784-200404050-00003; Assmann G, 1996, ATHEROSCLEROSIS, V124, pS11, DOI 10.1016/0021-9150(96)05852-2; Assmann G, 1996, AM J CARDIOL, V77, P1179, DOI 10.1016/S0002-9149(96)00159-2; Barter P, 2007, NEW ENGL J MED, V357, P1301, DOI 10.1056/NEJMoa064278; Bruckert E, 2005, CURR MED RES OPIN, V21, P1927, DOI 10.1185/030079905X74871; Cai L, 2012, J ATHEROSCLER THROMB, V19, P159, DOI 10.5551/jat.10116; Chalmers J, 1999, J HYPERTENS, V17, P151; Choi Sun-Ja, 2011, Osong Public Health Res Perspect, V2, P94, DOI 10.1016/j.phrp.2011.07.006; deGoma EM, 2008, J AM COLL CARDIOL, V51, P49, DOI 10.1016/j.jacc.2007.07.086; Elisaf M., 2000, IDRUGS, V3, P156; Gao Ya, 2012, Zhonghua Xin Xue Guan Bing Za Zhi, V40, P432; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Jia W P, 2002, Obes Rev, V3, P157; Li Jian-hong, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P607; Li Jian-hong, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P414; Lin Y, 2010, VASC HEALTH RISK MAN, V6, P73; Liu Y, 2011, J LIPID RES, V52, P354, DOI 10.1194/jlr.P007476; Moran A, 2010, CIRC-CARDIOVASC QUAL, V3, P243, DOI 10.1161/CIRCOUTCOMES.109.910711; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Natarajan P, 2010, J AM COLL CARDIOL, V55, P1283, DOI 10.1016/j.jacc.2010.01.008; Peasey A, 2005, ALCOHOL ALCOHOLISM, V40, P431, DOI 10.1093/alcalc/agh161; Reddy KS, 1998, CIRCULATION, V97, P596; Rodgers A, 1998, LANCET, V352, P1801; Rutherford JN, 2010, ASIA PAC J CLIN NUTR, V19, P57; Stamler J, 2000, JAMA-J AM MED ASSOC, V284, P311, DOI 10.1001/jama.284.3.311; Toth PP, 2009, POL ARCH MED WEWN, V119, P667, DOI 10.20452/pamw.801; Wang B, 2012, ATHEROSCLEROSIS, V223, P512, DOI 10.1016/j.atherosclerosis.2012.06.009; WHO publishes definitive atlas on global heart disease and stroke epidemic, 2004, INDIAN J MED SCI, V58, P405; Wu JY, 2010, PREV MED, V51, P412, DOI 10.1016/j.ypmed.2010.08.013; Wu ZS, 2001, CIRCULATION, V103, P462; Yang ZJ, 2012, EUR HEART J, V33, P213, DOI 10.1093/eurheartj/ehr205; Yoon YS, 2004, AM J CLIN NUTR, V80, P217; Zhao WH, 2007, BIOMED ENVIRON SCI, V20, P329; 赵文华, 2012, [中华预防医学杂志, Chinese Journal of Preventive Medicine], V46, P477	37	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144104	10.1371/journal.pone.0144104	http://dx.doi.org/10.1371/journal.pone.0144104			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26640891	Green Published, gold, Green Submitted			2022-12-27	WOS:000366902700056
J	Sinishaw, MA; Gebregergs, GB; Shiferaw, MB				Sinishaw, Mulusew Alemneh; Gebregergs, Gebremedhin Berhe; Shiferaw, Melashu Balew			Distribution and Availability of Essential Tuberculosis Diagnostic Items in Amhara Region, Ethiopia	PLOS ONE			English	Article								Adequate supplies of tuberculosis laboratory reagents and consumables are necessary for tuberculosis diagnosis and monitoring of treatment response. This study assessed the distribution and stock levels of laboratory commodities used in tuberculosis control in health centers of Amhara region, Ethiopia. A cross-sectional study was conducted in 82 health centers, among 801, providing sputum microscopy services. Stock levels were calculated, and distribution of reagents and consumables assessed. Thirty three (40.2%) health centers were under stocked for at least one of the key items for tuberculosis diagnosis at the time of visit. Fifteen (18.3%) health centers had no stocks of at least one of the key items (methylene blue (11%), carbol fuchsin (11%), acid alcohol (8.5%) and sputum cups (3.7%)). Of the 82 health centers, 77 (93.9%) did not fulfill the criteria for effective distribution of tuberculosis laboratory reagents and consumables. There were many health centers that had no or only low stocks of key tuberculosis laboratory reagents and consumables as a result of ineffective distribution system. It is necessary to strengthen supply chain management to ensure uninterrupted TB diagnostic service.	[Sinishaw, Mulusew Alemneh; Shiferaw, Melashu Balew] Bahir Dar Reg Hlth Res Lab Ctr, Bahir Dar, Ethiopia; [Gebregergs, Gebremedhin Berhe] Bahir Dar Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Bahir Dar, Ethiopia	Bahir Dar University	Sinishaw, MA (corresponding author), Bahir Dar Reg Hlth Res Lab Ctr, Bahir Dar, Ethiopia.	mulusewalemneh@yahoo.com	Shiferaw, Melashu/GPT-3320-2022; Sinishaw, Mulusew Alemneh/AAN-8447-2021	Sinishaw, Mulusew Alemneh/0000-0002-5737-7496; Shiferaw, Melashu Balew/0000-0002-5066-0758	Global Health Bureau, Office of Health, Infectious Disease and Nutrition (HIDN), United States Agency for International Development [AID-OAA-A-10-00020]; American people through the United States Agency for International Development (USAID)	Global Health Bureau, Office of Health, Infectious Disease and Nutrition (HIDN), United States Agency for International Development; American people through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	The Global Health Bureau, Office of Health, Infectious Disease and Nutrition (HIDN), United States Agency for International Development, financially supported this study through TB CARE I under the terms of Agreement No. AID-OAA-A-10-00020. This study was made possible by the generous support of the American people through the United States Agency for International Development (USAID). The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government.	Amhara National Regional State Health Bureau, 2013, REG HLTH BUR ANN REP; Amhara National Regional State Health Bureau, 2012, REG HLTH BUR ANN REP; Arney L, 2014, GLOBAL HLTH SCI PRAC, V2; Butao D, 2009, 1 USAID DELIVER PROJ; Desale A, 2013, PAN AFR MED J, V15, DOI 10.11604/pamj.2013.15.46.1969; Ethiopian Federal Ministry of Health, 2014, WHY TB EV NAT TB CON; Ethiopian Health & Nutrition Research Institute and Federal Ministry of Health of Ethiopia, 2009, GUID QUAL ASS SMEAR; Global HIV/AIDS Initiative Nigeria, 2011, GHAIN LAB END PROJ M; Harries AD, 2009, INT J TUBERC LUNG D, V13, P1194; Kagoma C, 2011, ASSESSMENT ANG UNPUB; Nigatu A, 2009, IMPACT ETHIOPIAN NAT; PROJECT Program Medicine Integration UD, 2012, TURN POL PRACT TIGR, P1; Taylor J., 2001, PHARM J, V267, P128; Ugandan Ministry of Health Health, COMM MAN LOG SYST PE; World Health Organization, 2006, STRAT APPR STRENGTH; World Health Organization, 2011, GUID SPEC MAN TB LAB	16	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0141032	10.1371/journal.pone.0141032	http://dx.doi.org/10.1371/journal.pone.0141032			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641097	Green Published, Green Submitted, gold			2022-12-27	WOS:000366902700003
J	Sun, Y; Gu, XZ; Wang, ZJ; Huang, YM; Wei, YY; Zhang, MM; Tu, K; Pan, LQ				Sun, Ye; Gu, Xinzhe; Wang, Zhenjie; Huang, Yangmin; Wei, Yingying; Zhang, Miaomiao; Tu, Kang; Pan, Leiqing			Growth Simulation and Discrimination of Botrytis cinerea, Rhizopus stolonifer and Colletotrichum acutatum Using Hyperspectral Reflectance Imaging	PLOS ONE			English	Article							CARP CTENOPHARYNGODON-IDELLA; LISTERIA-MONOCYTOGENES; PREDICTIVE MICROBIOLOGY; SCATTERING; PATHOGENS	This research aimed to develop a rapid and nondestructive method to model the growth and discrimination of spoilage fungi, like Botrytis cinerea, Rhizopus stolonifer and Colletotrichum acutatum, based on hyperspectral imaging system (HIS). A hyperspectral imaging system was used to measure the spectral response of fungi inoculated on potato dextrose agar plates and stored at 28 degrees C and 85% RH. The fungi were analyzed every 12 h over two days during growth, and optimal simulation models were built based on HIS parameters. The results showed that the coefficients of determination (R-2) of simulation models for testing datasets were 0.7223 to 0.9914, and the sum square error (SSE) and root mean square error (RMSE) were in a range of 2.03-53.40x10(-4) and 0.011-0.756, respectively. The correlation coefficients between the HIS parameters and colony forming units of fungi were high from 0.887 to 0.957. In addition, fungi species was discriminated by partial least squares discrimination analysis (PLSDA), with the classification accuracy of 97.5% for the test dataset at 36 h. The application of this method in real food has been addressed through the analysis of Botrytis cinerea, Rhizopus stolonifer and Colletotrichum acutatum inoculated in peaches, demonstrating that the HIS technique was effective for simulation of fungal infection in real food. This paper supplied a new technique and useful information for further study into modeling the growth of fungi and detecting fruit spoilage caused by fungi based on HIS.	[Sun, Ye; Gu, Xinzhe; Wang, Zhenjie; Huang, Yangmin; Wei, Yingying; Zhang, Miaomiao; Tu, Kang; Pan, Leiqing] Nanjing Agr Univ, Coll Food Sci & Technol, Nanjing 210095, Jiangsu, Peoples R China	Nanjing Agricultural University	Pan, LQ (corresponding author), Nanjing Agr Univ, Coll Food Sci & Technol, 1 Weigang Rd, Nanjing 210095, Jiangsu, Peoples R China.	pan_leiqing@njau.edu.cn	Tu, Kangsheng/N-1544-2019	Tu, Kangsheng/0000-0002-0032-1459; Wei, Yingying/0000-0003-2177-2301	Chinese National Foundation of Natural Science [31101282]; Special Fund for Agro-scientific Research in the Public Interest [201303088]; National Key Technology RD Program [2015BAD19B03]; Grain Industry Public Welfare Scientific Research Special Fund [201313002-01]	Chinese National Foundation of Natural Science(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; National Key Technology RD Program(National Key Technology R&D Program); Grain Industry Public Welfare Scientific Research Special Fund	The research was financially supported by the Chinese National Foundation of Natural Science (31101282), Special Fund for Agro-scientific Research in the Public Interest (201303088), National Key Technology R&D Program (2015BAD19B03) and Grain Industry Public Welfare Scientific Research Special Fund (201313002-01). The authors acknowledge all of the support received.	[Anonymous], 2010, 20104789 GB; Bae E, 2007, APPL OPTICS, V46, P3639, DOI 10.1364/AO.46.003639; Bae E, 2011, J BIOPHOTONICS, V4, P236, DOI 10.1002/jbio.201000051; Banada PP, 2007, BIOSENS BIOELECTRON, V22, P1664, DOI 10.1016/j.bios.2006.07.028; Banada PP, 2009, BIOSENS BIOELECTRON, V24, P1685, DOI 10.1016/j.bios.2008.08.053; Baranyi J, 2014, INT J FOOD MICROBIOL, V170, P78, DOI 10.1016/j.ijfoodmicro.2013.10.018; Bautista-Banos S., 2014, POSTHARVEST DECAY, P1; Bhunia AK, 2014, FUTURE MICROBIOL, V9, P935, DOI [10.2217/FMB.14.61, 10.2217/fmb.14.61]; Cen HY, 2013, POSTHARVEST BIOL TEC, V85, P30, DOI 10.1016/j.postharvbio.2013.04.014; Cheng JH, 2015, LWT-FOOD SCI TECHNOL, V62, P1060, DOI 10.1016/j.lwt.2015.01.021; Cheng JH, 2014, INNOV FOOD SCI EMERG, V21, P179, DOI 10.1016/j.ifset.2013.10.013; Cheng JH, 2014, FOOD RES INT, V56, P190, DOI 10.1016/j.foodres.2013.12.009; Damm U, 2012, STUD MYCOL, P37, DOI 10.3114/sim0010; Del Fiore A, 2010, INT J FOOD MICROBIOL, V144, P64, DOI 10.1016/j.ijfoodmicro.2010.08.001; Delwiche SR, 2000, PROC SPIE, V4203, P13, DOI 10.1117/12.411752; Dowell FE, 2002, CEREAL CHEM, V79, P222, DOI 10.1094/CCHEM.2002.79.2.222; El Ghaouth A, 2003, APPLIED MYCOLOGY AND BIOTECHNOLOGY, VOL 2, P219; Enos-Berlage JL, 2000, J BACTERIOL, V182, P5513, DOI 10.1128/JB.182.19.5513-5520.2000; Fernandez-Ibanez V, 2009, FOOD CHEM, V113, P629, DOI 10.1016/j.foodchem.2008.07.049; Gomez-Sanchis J, 2004, 2004 CIGR INT C BEIJ, P11; Gougouli M, 2010, INT J FOOD MICROBIOL, V140, P254, DOI 10.1016/j.ijfoodmicro.2010.03.021; Hahm BK, 2006, J APPL MICROBIOL, V100, P1017, DOI 10.1111/j.1365-2672.2006.02814.x; Haibo Yao, 2008, Sensing and Instrumentation for Food Quality and Safety, V2, P215, DOI 10.1007/s11694-008-9055-z; He HJ, 2013, INNOV FOOD SCI EMERG, V18, P237, DOI 10.1016/j.ifset.2013.02.009; Howard DL, 2006, J PHYS CHEM A, V110, P10245, DOI 10.1021/jp063631+; Iqbal A, 2013, J FOOD ENG, V117, P42, DOI 10.1016/j.jfoodeng.2013.02.001; Jackson R.S., 2014, BOTRYTIS ENCYCL FOOD, VSecond, P288, DOI [10.1016/B978-0-12-384730-0.00042-2, DOI 10.1016/B978-0-12-384730-0.00042-2]; Jasson V, 2010, FOOD MICROBIOL, V27, P710, DOI 10.1016/j.fm.2010.04.008; Jin P, 2009, STUDY REGULATION MEC, P5; KRISHNAN PS, 1954, APPL MICROBIOL, V2, P303, DOI 10.1128/AEM.2.6.303-308.1954; Lathrop AA, 2008, J APPL MICROBIOL, V104, P627, DOI 10.1111/j.1365-2672.2007.03574.x; Li JB, 2011, COMPUT ELECTRON AGR, V78, P38, DOI 10.1016/j.compag.2011.05.010; McDonald K, 1999, INT J FOOD MICROBIOL, V52, P1, DOI 10.1016/S0168-1605(99)00126-9; McMeekin TA, 2002, INT J FOOD MICROBIOL, V73, P395, DOI 10.1016/S0168-1605(01)00663-8; Mollazade K, 2012, FOOD BIOPROCESS TECH, V5, P1465, DOI 10.1007/s11947-012-0821-x; Monk IR, 2004, APPL ENVIRON MICROB, V70, P6686, DOI 10.1128/AEM.70.11.6686-6694.2004; Polder G, 2003, J NEAR INFRARED SPEC, V11, P193, DOI 10.1255/jnirs.366; Qin JW, 2013, J FOOD ENG, V118, P157, DOI 10.1016/j.jfoodeng.2013.04.001; Qing T.S.F., 2000, CHIN B BOT, V17, P211; Siripatrawan U, 2015, INT J FOOD MICROBIOL, V199, P93, DOI 10.1016/j.ijfoodmicro.2015.01.001; Teena MA, 2014, J STORED PROD RES, V59, P306, DOI 10.1016/j.jspr.2014.09.005; [韦莹莹 Wei Yingying], 2012, [南京农业大学学报, Journal of Nanjing Agricultural University], V35, P183; WHITING RC, 1994, FOOD TECHNOL-CHICAGO, V48, P113; WHITING RC, 1993, FOOD MICROBIOL, V10, P175; Zhang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088659; Zou XB, 2010, CHEMOMETR INTELL LAB, V104, P265, DOI 10.1016/j.chemolab.2010.08.019	46	19	19	8	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0143400	10.1371/journal.pone.0143400	http://dx.doi.org/10.1371/journal.pone.0143400			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642054	Green Published, gold, Green Submitted			2022-12-27	WOS:000366902700017
J	Theobald, DM; Harrison-Atlas, D; Monahan, WB; Albano, CM				Theobald, David M.; Harrison-Atlas, Dylan; Monahan, William B.; Albano, Christine M.			Ecologically-Relevant Maps of Landforms and Physiographic Diversity for Climate Adaptation Planning	PLOS ONE			English	Article							TOPOGRAPHIC POSITION; SPECIES-DIVERSITY; LAND FACETS; CONSERVATION; BIODIVERSITY; LANDSCAPE; MANAGEMENT; DIVERSIFICATION; HETEROGENEITY; ASSESSMENTS	Key to understanding the implications of climate and land use change on biodiversity and natural resources is to incorporate the physiographic platform on which changes in ecological systems unfold. Here, we advance a detailed classification and high-resolution map of physiography, built by combining landforms and lithology (soil parent material) at multiple spatial scales. We used only relatively static abiotic variables (i.e., excluded climatic and biotic factors) to prevent confounding current ecological patterns and processes with enduring landscape features, and to make the physiographic classification more interpretable for climate adaptation planning. We generated novel spatial databases for 15 landform and 269 physiographic types across the conterminous United States of America. We examined their potential use by natural resource managers by placing them within a contemporary climate change adaptation framework, and found our physiographic databases could play key roles in four of seven general adaptation strategies. We also calculated correlations with common empirical measures of biodiversity to examine the degree to which the physiographic setting explains various aspects of current biodiversity patterns. Additionally, we evaluated the relationship between landform diversity and measures of climate change to explore how changes may unfold across a geophysical template. We found landform types are particularly sensitive to spatial scale, and so we recommend using high-resolution datasets when possible, as well as generating metrics using multiple neighborhood sizes to both minimize and characterize potential unknown biases. We illustrate how our work can inform current strategies for climate change adaptation. The analytical framework and classification of landforms and parent material are easily extendable to other geographies and may be used to promote climate change adaptation in other settings.	[Theobald, David M.; Albano, Christine M.] Conservat Sci Partners, Truckee, CA 96161 USA; [Theobald, David M.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Theobald, David M.; Harrison-Atlas, Dylan] Colorado State Univ, Grad Degree Program Ecol, Ft Collins, CO 80523 USA; [Monahan, William B.] Natl Pk Serv, Inventory & Monitoring Div, Ft Collins, CO USA; [Albano, Christine M.] Univ Calif Davis, John Muir Inst Environm, Davis, CA 95616 USA	Colorado State University; Colorado State University; United States Department of the Interior; University of California System; University of California Davis	Theobald, DM (corresponding author), Conservat Sci Partners, Truckee, CA 96161 USA.	davet@csp-inc.org			NASA Applied Sciences program [10-BIOCLIM10-0034]	NASA Applied Sciences program(National Aeronautics & Space Administration (NASA))	This work was supported by the NASA Applied Sciences program (http://www.nasa.gov/applied-sciences/) through award number 10-BIOCLIM10-0034. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Conservation Science Partners provided support in the form of salaries for authors (DMT, DH-A, CMA), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ackerly DD, 2010, DIVERS DISTRIB, V16, P476, DOI 10.1111/j.1472-4642.2010.00654.x; Albano CM, 2015, LANDSCAPE ECOL, V30, P1023, DOI 10.1007/s10980-015-0167-7; Anderson MG, 2014, CONSERV BIOL, V28, P959, DOI 10.1111/cobi.12272; Anderson MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011554; [Anonymous], 2011, SCANNING CONSERVATIO; Ashcroft MB, 2012, INT J CLIMATOL, V32, P2134, DOI 10.1002/joc.2428; Bates RL, 1995, GLOSSARY GEOLOGY; Beier P, 2010, CONSERV BIOL, V24, P701, DOI 10.1111/j.1523-1739.2009.01422.x; Brierley G, 2006, AREA, V38, P165, DOI 10.1111/j.1475-4762.2006.00671.x; Clement JoelP., 2014, STRATEGY IMPROVING M; Cowling RM, 2001, P NATL ACAD SCI USA, V98, P5452, DOI 10.1073/pnas.101093498; Davis EB, 2008, MOL ECOL, V17, P120, DOI 10.1111/j.1365-294X.2007.03469.x; Davis FW, 1990, LANDSC ECOL, V4; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; De Reu J, 2013, GEOMORPHOLOGY, V186, P39, DOI 10.1016/j.geomorph.2012.12.015; Deng YX, 2009, COMPUT GEOSCI-UK, V35, P327, DOI 10.1016/j.cageo.2008.08.005; Dickson BG, 2007, J ZOOL, V271, P270, DOI 10.1111/j.1469-7998.2006.00215.x; Dikau R., 1990, Proceedings of the 4th International Symposium on Spatial Data Handling, P230; Dobrowski SZ, 2013, GLOBAL CHANGE BIOL, V19, P241, DOI 10.1111/gcb.12026; Dobrowski SZ, 2010, GLOB CHANG BIOL; Dufour A, 2006, ECOGRAPHY, V29, P573, DOI 10.1111/j.0906-7590.2006.04605.x; FLINT LE, 2012, ECOL PROCESS, V1, pNIL6, DOI DOI 10.1186/2192-1709-1-2; Game ET, 2011, GLOBAL CHANGE BIOL, V17, P3150, DOI 10.1111/j.1365-2486.2011.02457.x; Geiger R., 2003, CLIMATE NEAR GROUND; Gesch D, 2002, PHOTOGRAMM ENG REM S, V68, P5; Gray M., 2004, GEODIVERSITY; Groves CR, 2012, BIODIVERS CONSERV, V21, P1651, DOI 10.1007/s10531-012-0269-3; Guisan A, 1999, PLANT ECOL, V143, P107, DOI 10.1023/A:1009841519580; Hammond EH, 1954, ANN ASSOC AM GEOGR, V44, P33; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hjort J, 2015, CONSERV BIOL, V29, P630, DOI 10.1111/cobi.12510; Holden ZA, 2011, FOREST ECOL MANAG, V262, P2133, DOI 10.1016/j.foreco.2011.08.002; HUNTER ML, 1988, CONSERV BIOL, V2, P375, DOI 10.1111/j.1523-1739.1988.tb00202.x; Huston M. A., 1994, BIOL DIVERSITY; Iverson LR, 1997, LANDSCAPE ECOL, V12, P331, DOI 10.1023/A:1007989813501; Jenkins CN, 2013, P NATL ACAD SCI USA, V110, pE2602, DOI 10.1073/pnas.1302251110; Jennings MD, 2000, LANDSCAPE ECOL, V15, P5, DOI 10.1023/A:1008184408300; Kadmon R, 2007, AM NAT, V170, P443, DOI 10.1086/519853; Keppel G, 2012, GLOBAL ECOL BIOGEOGR, V21, P393, DOI 10.1111/j.1466-8238.2011.00686.x; Klausmeyer KR, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00044.1; Klingseisen B, 2008, ENVIRON MODELL SOFTW, V23, P109, DOI 10.1016/j.envsoft.2007.05.007; Kruckeberg A. R., 2004, GEOLOGY PLANT LIFE E; Lawler JJ, 2015, CONSERV BIOL, V29, P618, DOI 10.1111/cobi.12505; Lawson CR, 2014, ECOGRAPHY, V37, P732, DOI 10.1111/ecog.00535; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Mawdsley JR, 2009, CONSERV BIOL, V23, P1080, DOI 10.1111/j.1523-1739.2009.01264.x; McCune B, 2002, J VEG SCI, V13, P603, DOI 10.1111/j.1654-1103.2002.tb02087.x; Moritz C, 2002, SYST BIOL, V51, P238, DOI 10.1080/10635150252899752; National Fish Wildlife and Plants Climate Adaptation Partnership (NFWPCAP). National Fish Wildlife and Plants Climate Adaptation Strategy, 2011, NAT FISH WILDL PLANT; PEET RK, 1981, VEGETATIO, V45, P3; Peterson A. T., 2011, ECOLOGICAL NICHES GE; Phillips JD, 2006, HYDROL EARTH SYST SC, V3, P365, DOI DOI 10.5194/HESSD-3-365-2006; Pierce KB, 2005, LANDSCAPE ECOL, V20, P137, DOI 10.1007/s10980-004-1296-6; Potter KA, 2013, GLOBAL CHANGE BIOL, V19, P2932, DOI [10.1111/, 10.1111/gcb.12257]; Potts AJ, 2013, DIVERS DISTRIB, V19, P1418, DOI 10.1111/ddi.12113; Pressey RL, 2000, BIOL CONSERV, V96, P55, DOI 10.1016/S0006-3207(00)00050-1; Pressey RL, 2007, TRENDS ECOL EVOL, V22, P583, DOI 10.1016/j.tree.2007.10.001; R Core Team, 2014, R LANG ENV STAT COMP; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rouget M, 2006, CONSERV BIOL, V20, P549, DOI 10.1111/j.1523-1739.2006.00297.x; Ruhe R.V., 1968, P 9 C INT SOIL SCI S, V4, P551; Sayre R., 2014, NEW MAP GLOBAL ECOLO; Sayre R., 2009, 1768 USGS; Schloss CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028788; Schmitz OJ, 2015, NAT AREA J, V35, P190, DOI 10.3375/043.035.0120; Secretary of the Interior, 2009, 3289 SECR INT; Seneviratne SI, 2010, EARTH-SCI REV, V99, P125, DOI 10.1016/j.earscirev.2010.02.004; Soller D. R., 2009, US GEOLOGICAL SURVEY, V425; Stein B.A., 2014, CLIMATE SMART CONSER; Stein BA, 2013, FRONT ECOL ENVIRON, V11, P502, DOI 10.1890/120277; Theobald DM, 2013, LANDSCAPE ECOL, V28, P1859, DOI 10.1007/s10980-013-9941-6; Theobald DM, 2010, LANDSCAPE ECOL, V25, P999, DOI 10.1007/s10980-010-9484-z; Theobald DM, 2000, LANDSCAPE ECOL, V15, P35, DOI 10.1023/A:1008165311026; US Department of Agriculture Natural Resources Conservation Service (NRCS), 2015, NAT SOIL SURV HD 629; US Forest Service (USFS), 2010, FOR SERV GLOB CHANG; US Geological Survey Gap Analysis Program (USGS-GAP), 2010, NAT GAP LAND COV VER; Vellend M, 2005, ECOL LETT, V8, P767, DOI 10.1111/j.1461-0248.2005.00775.x; Wessels KJ, 1999, BIOL CONSERV, V89, P21, DOI 10.1016/S0006-3207(98)00133-5; WHITTAKER RH, 1956, ECOL MONOGR, V26, P1, DOI 10.2307/1943577; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037	82	83	84	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0143619	10.1371/journal.pone.0143619	http://dx.doi.org/10.1371/journal.pone.0143619			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641818	Green Published, gold, Green Submitted			2022-12-27	WOS:000366902700025
J	Angel, LP; Wells, MR; Rodriguez-Malagon, MA; Tew, E; Speakman, JR; Arnould, JPY				Angel, Lauren P.; Wells, Melanie R.; Rodriguez-Malagon, Marlenne A.; Tew, Emma; Speakman, John R.; Arnould, John P. Y.			Sexual Size Dimorphism and Body Condition in the Australasian Gannet	PLOS ONE			English	Article							BLUE-FOOTED BOOBY; DISCRIMINANT FUNCTION-ANALYSIS; PENGUINS EUDYPTULA-MINOR; BLACK-LEGGED KITTIWAKES; PORT PHILLIP BAY; FORAGING BEHAVIOR; MORUS-SERRATOR; BREEDING SUCCESS; WANDERING ALBATROSSES; MONOMORPHIC SEABIRD	Sexual size dimorphism is widespread throughout seabird taxa and several drivers leading to its evolution have been hypothesised. While the Australasian Gannet (Morus serrator) has previously been considered nominally monomorphic, recent studies have documented sexual segregation in diet and foraging areas, traits often associated with size dimorphism. The present study investigated the sex differences in body mass and structural size of this species at two colonies (Pope's Eye, PE; Point Danger, PD) in northern Bass Strait, southeastern Australia. Females were found to be 3.1% and 7.3% heavier (2.74 +/- 0.03, n = 92; 2.67 +/- 0.03 kg, n = 43) than males (2.66 +/- 0.03, n = 92; 2.48 +/- 0.03 kg, n = 43) at PE and PD, respectively. Females were also larger in wing ulna length (0.8% both colonies) but smaller in bill depth (PE: 2.2%; PD: 1.7%) than males. Despite this dimorphism, a discriminant function provided only mild accuracy in determining sex. A similar degree of dimorphism was also found within breeding pairs, however assortative mating was not apparent at either colony (R-2 < 0.04). Using hydrogen isotope dilution, a body condition index was developed from morphometrics to estimate total body fat (TBF) stores, where TBF(%) = 24.43+1.94*(body mass/wing ulna length) -0.58* tarsus length (r(2) = 0.84, n = 15). This index was used to estimate body composition in all sampled individuals. There was no significant difference in TBF(%) between the sexes for any stage of breeding or in any year of the study at either colony suggesting that, despite a greater body mass, females were not in a better condition than males. While the driving mechanism for sexual dimorphism in this species is currently unknown, studies of other Sulids indicate segregation in foraging behaviour, habitat and diet may be a contributing factor.	[Angel, Lauren P.; Wells, Melanie R.; Rodriguez-Malagon, Marlenne A.; Tew, Emma; Arnould, John P. Y.] Deakin Univ, Sch Life & Environm Sci, Burwood, Vic, Australia; [Speakman, John R.] Univ Aberdeen, Inst Environm & Biol Sci, Aberdeen, Scotland	Deakin University; University of Aberdeen	Angel, LP (corresponding author), Deakin Univ, Sch Life & Environm Sci, Burwood, Vic, Australia.	langel@deakin.edu.au		Wells, Melanie/0000-0003-2817-8743; Angel, Lauren/0000-0002-8696-3945	Holsworth Wildlife Research Endowment	Holsworth Wildlife Research Endowment	The research was financially supported by the Holsworth Wildlife Research Endowment.	Castillo-Guerrero JA, 2011, J ORNITHOL, V152, P269, DOI 10.1007/s10336-010-0575-z; AMAT JA, 1993, COLON WATERBIRD, V16, P213, DOI 10.2307/1521441; Arnould JPY, 2004, EMU, V104, P261, DOI 10.1071/MU04035; Barbraud C, 1998, J AVIAN BIOL, V29, P161, DOI 10.2307/3677194; Barker S., 2012, GEOGRAPHIC VARIATION; Bijleveld AI, 2009, BEHAV ECOL, V20, P736, DOI 10.1093/beheco/arp054; Bosch M, 1996, J FIELD ORNITHOL, V67, P534; Bunce A, 2001, ICES J MAR SCI, V58, P904, DOI 10.1006/jmsc.2001.1083; Chastel O, 1995, AUK, V112, P964, DOI 10.2307/4089027; CHOUDHURY S, 1992, ANIM BEHAV, V44, P171, DOI 10.1016/S0003-3472(05)80768-7; Cleasby IR, 2015, MAR ECOL PROG SER, V518, P1, DOI 10.3354/meps11112; Coulson J. C., 2009, Ringing & Migration, V24, P233; CROXALL JP, 1995, OIKOS, V73, P399, DOI 10.2307/3545964; Daniel C, 2007, AUST J ZOOL, V55, P377, DOI 10.1071/ZO07073; Dechaume-Moncharmont FX, 2011, AUK, V128, P78, DOI 10.1525/auk.2011.10129; Einoder Luke D., 2008, Marine Ornithology, V36, P167; Elliott KH, 2008, J AVIAN BIOL, V39, P619, DOI 10.1111/j.1600-048X.2008.04316.x; Erikstad KE, 1998, ECOLOGY, V79, P1781; EVANS DR, 1993, J FIELD ORNITHOL, V64, P472; Ewing AD, 2005, EMU, V105, P137, DOI 10.1071/MU03061; Fairbairn DJ, 1997, ANNU REV ECOL SYST, V28, P659, DOI 10.1146/annurev.ecolsys.28.1.659; FAIRBAIRN J, 1993, OIKOS, V68, P139, DOI 10.2307/3545319; FLINT EN, 1984, AUK, V101, P288, DOI 10.1093/auk/101.2.288; Forero MG, 2002, MAR ECOL PROG SER, V234, P289, DOI 10.3354/meps234289; Forero MG, 2001, CAN J ZOOL, V79, P1414, DOI 10.1139/cjz-79-8-1414; GALES R, 1989, PHYSIOL ZOOL, V62, P147, DOI 10.1086/physzool.62.1.30160003; GILARDI JD, 1992, COLON WATERBIRD, V15, P148, DOI 10.2307/1521367; Golet GH, 1999, OECOLOGIA, V120, P530, DOI 10.1007/s004420050887; Gonzalez-Solis J, 2005, SEXUAL SEGREGATION V, P1; Green Jonathan A., 2010, Endangered Species Research, V10, P269, DOI 10.3354/esr00223; GUERRA M, 1995, BEHAVIOUR, V132, P479, DOI 10.1163/156853995X00162; Guggenheimer S, 2012, SEPARATION SEXES STA; HALLIDAY D, 1977, BIOMED MASS SPECTROM, V4, P82, DOI 10.1002/bms.1200040205; HEDRICK AV, 1989, TRENDS ECOL EVOL, V4, P136, DOI 10.1016/0169-5347(89)90212-7; Hennicke JC, 2014, MAR ECOL PROG SER, V499, P259, DOI 10.3354/meps10664; Hobday A. J, 2014, DEV ADAPTATION OPTIO; Hobday AJ, 2015, APPLIED STUDIES IN CLIMATE ADAPTATION, P77; Hull Cindy L., 1996, Marine Ornithology, V24, P23; Ismar SMH, 2010, THESIS; Ismar SMH, 2014, WILSON J ORNITHOL, V126, P417, DOI 10.1676/13-203.1; Kato A, 2008, AUK, V125, P588, DOI 10.1525/auk.2008.06273; Labocha MK, 2012, J ORNITHOL, V153, P1, DOI 10.1007/s10336-011-0706-1; Layton HN, 2000, COMP BIOCHEM PHYS A, V126, P295, DOI 10.1016/S1095-6433(00)00212-9; Lewis S, 2006, OECOLOGIA, V147, P606, DOI 10.1007/s00442-005-0321-z; Lewis S, 2005, IBIS, V147, P408, DOI 10.1111/j.1474-919x.2005.00428.x; Lewis S, 2002, P ROY SOC B-BIOL SCI, V269, P1687, DOI 10.1098/rspb.2002.2083; Lormee H, 2005, IBIS, V147, P307, DOI 10.1111/j.1474-919x.2005.00404.x; Lormee H, 2003, IBIS, V145, P212, DOI 10.1046/j.1474-919X.2003.00106.x; Lough JM, 2011, MAR FRESHWATER RES, V62, P984, DOI 10.1071/MF10272; LOVICH JE, 1992, GROWTH DEVELOP AGING, V56, P269; Mata AJ, 2006, PHYSIOL BIOCHEM ZOOL, V79, P202, DOI 10.1086/498354; MONAGHAN P, 1989, J ANIM ECOL, V58, P261, DOI 10.2307/4999; Moseley C, 2012, J EXP MAR BIOL ECOL, V422, P29, DOI 10.1016/j.jembe.2012.04.002; Mullers RHE, 2009, ARDEA, V97, P89, DOI 10.5253/078.097.0111; Navarro J, 2009, ZOOLOGY, V112, P128, DOI 10.1016/j.zool.2008.05.001; NELSON J.B., 1978, SULIDAE GANNETS BOOB; NELSON JB, 1966, IBIS, V108, P584, DOI 10.1111/j.1474-919X.1966.tb07210.x; O'Dwyer TW, 2007, AUST J ZOOL, V55, P155, DOI 10.1071/ZO07005; Patterson SA, 2011, MOL PHYLOGENET EVOL, V58, P181, DOI 10.1016/j.ympev.2010.11.021; Pyk TM, 2013, J ORNITHOL, V154, P299, DOI 10.1007/s10336-012-0894-3; Renner M, 1998, COLON WATERBIRD, V21, P444, DOI 10.2307/1521659; Renner M, 1999, EMU, V99, P74, DOI 10.1071/MU99009C; Rishworth GM, 2014, AFR ZOOL, V49, P107, DOI 10.3377/004.049.0115; RISING JD, 1989, AUK, V106, P666; Ropert-Coudert Y, 2005, OSTRICH, V76, P212, DOI 10.2989/00306520509485495; Ruckstuhl KE, 2005, SEXUAL SEGREGATION V, P1; Schamber JL, 2009, J AVIAN BIOL, V40, P49, DOI 10.1111/j.1600-048X.2008.04462.x; Schulte-Hostedde AI, 2001, CAN J ZOOL, V79, P1021, DOI 10.1139/cjz-79-6-1021; Schulte-Hostedde AI, 2005, ECOLOGY, V86, P155, DOI 10.1890/04-0232; Schultner J, 2013, FUNCT ECOL, V27, P45, DOI 10.1111/j.1365-2435.2012.02058.x; Selander RK, 1972, SSATDOM CA; Serrano-Meneses MA, 2006, OIKOS, V113, P385, DOI 10.1111/j.0030-1299.2006.14246.x; Shaffer SA, 2001, FUNCT ECOL, V15, P203, DOI 10.1046/j.1365-2435.2001.00514.x; Shaffer SA, 2001, J ANIM ECOL, V70, P864, DOI 10.1046/j.0021-8790.2001.00548.x; Shaffer SA, 2006, PHYSIOL BIOCHEM ZOOL, V79, P836, DOI 10.1086/504611; SHINE R, 1989, Q REV BIOL, V64, P419, DOI 10.1086/416458; Spear LB, 1997, IBIS, V139, P221, DOI 10.1111/j.1474-919X.1997.tb04620.x; Stauss C, 2012, MAR ECOL PROG SER, V457, P151, DOI 10.3354/meps09734; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Velando A, 2003, J ANIM ECOL, V72, P846, DOI 10.1046/j.1365-2656.2003.00756.x; Viblanc VA, 2012, PHYSIOL BIOCHEM ZOOL, V85, P533, DOI 10.1086/667540; WARHAM J, 1977, NEW ZEAL J ZOOL, V4, P73, DOI 10.1080/03014223.1977.9517938; Weimerskirch H, 2006, OECOLOGIA, V146, P681, DOI 10.1007/s00442-005-0226-x; WEIMERSKIRCH H, 1994, ANIM BEHAV, V47, P472, DOI 10.1006/anbe.1994.1065; Weimerskirch H, 2009, OECOLOGIA, V161, P637, DOI 10.1007/s00442-009-1397-7; WINGHAM EJ, 1984, EMU, V84, P129, DOI 10.1071/MU9840129; Zavalaga CB, 2009, WILSON J ORNITHOL, V121, P739, DOI 10.1676/09-19.1	87	15	15	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0142653	10.1371/journal.pone.0142653	http://dx.doi.org/10.1371/journal.pone.0142653			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26637116	Green Published, gold, Green Submitted			2022-12-27	WOS:000366143800001
J	Konigs, M; Weeda, WD; van Heurn, LWE; Vermeulen, J; Goslings, JC; Luitse, JSK; Poll-The, BT; Beelen, A; van der Wees, M; Kemps, RJJK; Catsman-Berrevoets, CE; Oosterlaan, J				Konigs, Marsh; Weeda, Wouter D.; van Heurn, L. W. Ernest; Vermeulen, Jeroen; Goslings, J. Carel; Luitse, Jan S. K.; Poll-The, Bwee Tien; Beelen, Anita; van der Wees, Marleen; Kemps, Rachel J. J. K.; Catsman-Berrevoets, Coriene E.; Oosterlaan, Jaap			Impaired Visual Integration in Children with Traumatic Brain Injury: An Observational Study	PLOS ONE			English	Article							DIFFUSION-MODEL ANALYSIS	Background Axonal injury after traumatic brain injury (TBI) may cause impaired sensory integration. We aim to determine the effects of childhood TBI on visual integration in relation to general neurocognitive functioning. Methods We compared children aged 6-13 diagnosed with TBI (n = 103; M = 1.7 years post-injury) to children with traumatic control (TC) injury (n = 44). Three TBI severity groups were distinguished: mild TBI without risk factors for complicated TBI (mild(RF-)TBI, n = 22), mild TBI with >= 1 risk factor (mild(RF+) TBI, n = 46) or moderate/severe TBI (n = 35). An experimental paradigm measured speed and accuracy of goal-directed behavior depending on: (1) visual identification; (2) visual localization; or (3) both, measuring visual integration. Group-differences on reaction time (RT) or accuracy were tracked down to task strategy, visual processing efficiency and extra-decisional processes (e.g. response execution) using diffusion model analysis. General neurocognitive functioning was measured by a Wechsler Intelligence Scale short form. Results The TBI group had poorer accuracy of visual identification and visual integration than the TC group (Ps <= .03; ds <= -0.40). Analyses differentiating TBI severity revealed that visual identification accuracy was impaired in the moderate/severe TBI group (P = .05, d = -0.50) and that visual integration accuracy was impaired in the mild(RF+) TBI group and moderate/severe TBI group (Ps < .02, ds <= -0.56). Diffusion model analyses tracked impaired visual integration accuracy down to lower visual integration efficiency in the mild(RF+) TBI group and moderate/severe TBI group (Ps < .001, ds <= -0.73). Importantly, intelligence impairments observed in the TBI group (P = .009, d = -0.48) were statistically explained by visual integration efficiency (P = .002). Conclusions Children with mild(RF+) TBI or moderate/severe TBI have impaired visual integration efficiency, which may contribute to poorer general neurocognitive functioning.	[Konigs, Marsh; Weeda, Wouter D.; Oosterlaan, Jaap] Vrije Univ Amsterdam, Dept Clin Neuropsychol, Amsterdam, Netherlands; [Weeda, Wouter D.] Vrije Univ Amsterdam, Dept Methods, Amsterdam, Netherlands; [Weeda, Wouter D.] Leiden Univ, Dept Methodol & Stat, Inst Psychol, Leiden, Netherlands; [van Heurn, L. W. Ernest] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Pediat Surg Ctr Amsterdam, NL-1105 AZ Amsterdam, Netherlands; [van Heurn, L. W. Ernest] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; [Vermeulen, Jeroen] Vrije Univ Amsterdam, Med Ctr, Dept Pediat Neurol, Amsterdam, Netherlands; [Vermeulen, Jeroen] Maastricht Univ, Med Ctr, Dept Pediat Neurol, Maastricht, Netherlands; [Goslings, J. Carel] Univ Amsterdam, Acad Med Ctr, Trauma Unit, NL-1105 AZ Amsterdam, Netherlands; [Luitse, Jan S. K.] Univ Amsterdam, Acad Med Ctr, Dept Emergency Med, NL-1105 AZ Amsterdam, Netherlands; [Poll-The, Bwee Tien] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Pediat Neurol, NL-1105 AZ Amsterdam, Netherlands; [Beelen, Anita] Merem Rehabil Ctr De Trappenberg, Huizen, Netherlands; [Beelen, Anita] Univ Amsterdam, Acad Med Ctr, Dept Rehabil, NL-1105 AZ Amsterdam, Netherlands; [van der Wees, Marleen] Blixembosch, Libra Rehabil Med & Audiol, Eindhoven, Netherlands; [Kemps, Rachel J. J. K.] Libra Rehabil Med & Audiol Leijpark, Tilburg, Netherlands; [Catsman-Berrevoets, Coriene E.] Erasmus MC, Dept Pediat Neurol, Rotterdam, Netherlands; [Oosterlaan, Jaap] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, NL-1105 AZ Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Leiden University; Leiden University - Excl LUMC; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Maastricht University; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Konigs, M (corresponding author), Vrije Univ Amsterdam, Dept Clin Neuropsychol, Amsterdam, Netherlands.	m.konigs@vu.nl		Weeda, W. D./0000-0001-8619-2645; Vermeulen, R. Jeroen/0000-0002-3503-3625; Poll-The, Bwee Tien/0000-0002-8118-5419	Netherlands Organization for Scientific Research (NWO) [022.003.010]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Netherlands Organization for Scientific Research (NWO, http://www.nwo.nl/) grant number 022.003.010, granted to Marsh Konigs MSc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwis DS, 2013, CLIN EXP PHARMACOL P, V40, P473, DOI 10.1111/1440-1681.12100; American College of Surgeons, 2004, ADV TRAUM LIF SUPP P, V7th; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Damoiseaux JS, 2009, BRAIN STRUCT FUNCT, V213, P525, DOI 10.1007/s00429-009-0208-6; Deary IJ, 2001, TRENDS COGN SCI, V5, P164, DOI 10.1016/S1364-6613(00)01623-5; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Ginstfeldt T, 2010, BRAIN INJURY, V24, P1123, DOI 10.3109/02699052.2010.506853; Kaufman AS, 1996, J CLIN CHILD PSYCHOL, V25, P97, DOI 10.1207/s15374424jccp2501_11; Konigs M, 2015, EUR J NEUROL; Kurylo DD, 2014, EXP BRAIN RES, V232, P2899, DOI 10.1007/s00221-014-3970-5; Max J, 1998, CHILD ADOLESC PSYCHI, V37, P932; Park HJ, 2013, SCIENCE, V342, P579, DOI 10.1126/science.1238411; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Raja Beharelle A, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00164; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Roberts RM, 2014, DEV NEUROPSYCHOL, V39, P600, DOI 10.1080/87565641.2014.973958; Schmitz F, 2012, J EXP PSYCHOL HUMAN, V38, P222, DOI 10.1037/a0026003; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Statistics Netherlands, 2006, ED CAT STAND; Tabachnick B. G.., 2012, USING MULTIVARIATE S; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Voss A, 2007, BEHAV RES METHODS, V39, P767, DOI 10.3758/BF03192967; Voss A, 2013, EXP PSYCHOL, V60, P385, DOI 10.1027/1618-3169/a000218; Wagenmakers EJ, 2009, EUR J COGN PSYCHOL, V21, P641, DOI 10.1080/09541440802205067; Weeda WD, 2014, J EXP CHILD PSYCHOL, V126, P178, DOI 10.1016/j.jecp.2014.05.001; Winslade W., 1999, CONFRONTING TRAUMATI; World Medical Association, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI DOI 10.1001/JAMA.2013.281053; YOUNG MP, 1992, NATURE, V358, P152, DOI 10.1038/358152a0; Zeguers MHT, 2011, DEVELOPMENTAL SCI, V14, P1340, DOI 10.1111/j.1467-7687.2011.01091.x	33	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144395	10.1371/journal.pone.0144395	http://dx.doi.org/10.1371/journal.pone.0144395			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY1CH	26637182	Green Published, Green Submitted, gold			2022-12-27	WOS:000366143800086
J	Liu, FW; Liu, FC; Wang, YR; Tsai, HI; Yu, HP				Liu, Fu-Wei; Liu, Fu-Chao; Wang, Yu-Ren; Tsai, Hsin-I; Yu, Huang-Ping			Aloin Protects Skin Fibroblasts from Heat Stress-Induced Oxidative Stress Damage by Regulating the Oxidative Defense System	PLOS ONE			English	Article							ANTIOXIDANT; VERA; HYPERTHERMIA; GLUTATHIONE; MITOCHONDRIA; ALOESIN; ENZYMES; HSP70; CELLS; GEL	Oxidative stress is commonly involved in the pathogenesis of skin damage induced by environmental factors, such as heat stress. Skin fibroblasts are responsible for the connective tissue regeneration and the skin recovery from injury. Aloin, a bioactive compound in Aloe vera, has been reported to have various pharmacological activities, such as anti-inflammatory effects. The aim of this study was to investigate the protective effect of aloin against heat stress-mediated oxidative stress in human skin fibroblast Hs68 cells. Hs68 cells were first incubated at 43 degrees C for 30 min to mimic heat stress. The study was further examined if aloin has any effect on heat stress-induced oxidative stress. We found that aloin protected Hs68 cells against heat stress-induced damage, as assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide and lactate dehydrogenase assay. Aloin protected Hs68 cells by regulating reactive oxygen species production and increasing the levels of glutathione, cytosolic and mitochondrial superoxide dismutase. Aloin also prevented the elevation of thiobarbituric acid reactive substances and the reduction of 8-OH-dG induced by heat stress. These results indicated that aloin protected human skin fibroblasts from heat stress-induced oxidative stress damage by regulating the oxidative defense system.	[Liu, Fu-Wei] Taichung Vet Gen Hosp, Dept Phys Med & Rehabil, Puli Branch, Nantou, Taiwan; [Liu, Fu-Chao; Tsai, Hsin-I; Yu, Huang-Ping] Chang Gung Mem Hosp, Dept Anesthesiol, Taoyuan, Taiwan; [Liu, Fu-Chao; Wang, Yu-Ren; Tsai, Hsin-I; Yu, Huang-Ping] Chang Gung Univ, Coll Med, Taoyuan, Taiwan	Taichung Veterans General Hospital; Chang Gung Memorial Hospital; Chang Gung University	Yu, HP (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.	yubirmingham@yahoo.com	Liu, Fu-Chao/AAB-3780-2021	Liu, F-C/0000-0003-1712-4053	National Science Council [NSC102-2314-B-182A-051-MY3, NSC103-2314-B-182-046-MY2]; Chang Gung Memorial Hospital [CMRPG3B1053, CMRPG3E1551, CMRPG3E1541]	National Science Council(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was partially supported by grants from the National Science Council (NSC102-2314-B-182A-051-MY3) and Chang Gung Memorial Hospital (CMRPG3B1053 and CMRPG3E1551) to Huang-Ping Yu. Support was also provided by the National Science Council (NSC103-2314-B-182-046-MY2) and Chang Gung Memorial Hospital (CMRPG3E1541) to Fu-Chao Liu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was partially supported by grants from the National Science Council (NSC1022314- B-182A-051-MY3) and Chang Gung Memorial Hospital (CMRPG3B1053 and CMRPG3E1551) to Huang-Ping Yu. Support was also provided by the National Science Council (NSC103-2314-B-182-046-MY2) and Chang Gung Memorial Hospital (CMRPG3E1541) to Fu-Chao Liu.	Beckham JT, 2010, LASER SURG MED, V42, P752, DOI 10.1002/lsm.20983; Bergmeyer HU., 1974, METHODS ENZYMATIC AN, P574, DOI [10.1016/B978-0-12-091302-2.50010-4, DOI 10.1016/B978-0-12-091302-2.50010-4]; Brenneisen P, 1997, FREE RADICAL BIO MED, V22, P515, DOI 10.1016/S0891-5849(96)00404-2; Calabrese V, 2002, J NEUROSCI RES, V68, P65, DOI 10.1002/jnr.10177; Cole L, 2007, INT J PHARM, V333, P10, DOI 10.1016/j.ijpharm.2006.09.047; Dinh HKB, 2001, PHYSIOL GENOMICS, V7, P3, DOI 10.1152/physiolgenomics.2001.7.1.3; Eberlein-Konig B, 1998, J AM ACAD DERMATOL, V38, P45, DOI 10.1016/S0190-9622(98)70537-7; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fox LT, 2015, J PHARM PHARMACOL, V67, P96, DOI 10.1111/jphp.12311; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; HALLIWELL B, 1981, FEBS LETT, V128, P347, DOI 10.1016/0014-5793(81)80114-7; Harlev E, 2012, PLANTA MED, V78, P843, DOI 10.1055/s-0031-1298453; Hayes JD, 1999, FREE RADICAL RES, V31, P273, DOI 10.1080/10715769900300851; Hegazy SK, 2012, WORLD J GASTROENTERO, V18, P2026, DOI 10.3748/wjg.v18.i17.2026; Hu Y, 2003, J AGR FOOD CHEM, V51, P7788, DOI 10.1021/jf034255i; JOHNSON LV, 1980, P NATL ACAD SCI-BIOL, V77, P990, DOI 10.1073/pnas.77.2.990; Kohl E, 2011, J EUR ACAD DERMATOL, V25, P873, DOI 10.1111/j.1468-3083.2010.03963.x; Kumar S, 2010, J ASIAN NAT PROD RES, V12, P360, DOI 10.1080/10286021003775327; LIN PS, 1991, RADIAT RES, V126, P43, DOI 10.2307/3578169; Malyshev IY, 2000, PHYSIOL RES, V49, P99; Mates JM, 2000, TOXICOLOGY, V153, P83, DOI 10.1016/S0300-483X(00)00306-1; MICHIELS C, 1994, FREE RADICAL BIO MED, V17, P235, DOI 10.1016/0891-5849(94)90079-5; Monika Mahajan, 2013, American Journal of Biochemistry and Molecular Biology, V3, P81; Murray JI, 2004, MOL BIOL CELL, V15, P2361, DOI 10.1091/mbc.E03-11-0799; Niciforovic A, 2007, RUSS J PHYS CHEM A+, V81, P1463, DOI 10.1134/S0036024407090221; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Park G, 2012, SKIN PHARMACOL PHYS, V25, P93, DOI 10.1159/000335257; Park MY, 2011, LIFE SCI, V88, P486, DOI 10.1016/j.lfs.2011.01.010; SANO M, 1986, Journal of Free Radicals in Biology and Medicine, V2, P41, DOI 10.1016/0748-5514(86)90122-4; Schrauwen P, 2010, BBA-MOL CELL BIOL L, V1801, P266, DOI 10.1016/j.bbalip.2009.09.011; Sharma P., 2012, AFR J BIOTECHNOL, V11, P184, DOI DOI 10.5897/AJB11.2185; Sinha K, 2013, ARCH TOXICOL, V87, P1157, DOI 10.1007/s00204-013-1034-4; Sorrell JM, 2007, CELL TISSUE RES, V327, P499, DOI 10.1007/s00441-006-0317-y; Stadtman ER, 1998, DRUG METAB REV, V30, P225, DOI 10.3109/03602539808996310; Strober Warren, 2015, Curr Protoc Immunol, V111, DOI 10.1002/0471142735.ima03bs111; Tabuchi Y, 2013, INT J HYPERTHER, V29, P38, DOI 10.3109/02656736.2012.753163; Tabuchi Y, 2012, INT J MOL MED, V29, P380, DOI 10.3892/ijmm.2011.862; Walrand S, 2003, CLIN CHIM ACTA, V331, P103, DOI 10.1016/S0009-8981(03)00086-X; Wamer WG, 2003, FREE RADICAL BIO MED, V34, P233, DOI 10.1016/S0891-5849(02)01242-X; Yagi A, 2002, PLANTA MED, V68, P957, DOI 10.1055/s-2002-35666; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001	41	27	27	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143528	10.1371/journal.pone.0143528	http://dx.doi.org/10.1371/journal.pone.0143528			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26637174	gold, Green Published, Green Submitted			2022-12-27	WOS:000366143800016
J	Nam, HS; Kwon, I; Lee, BH; Kim, H; Kim, J; An, S; Lee, OH; Lee, PH; Kim, HO; Namgoong, H; Kim, YD; Heo, JH				Nam, Hyo Suk; Kwon, Il; Lee, Bo Hyung; Kim, Haejin; Kim, Jayoung; An, Sunho; Lee, Ok-Hee; Lee, Phil Hyu; Kim, Hyun Ok; Namgoong, Hyun; Kim, Young Dae; Heo, Ji Hoe			Effects of Mesenchymal Stem Cell Treatment on the Expression of Matrix Metalloproteinases and Angiogenesis during Ischemic Stroke Recovery	PLOS ONE			English	Article							MARROW STROMAL CELLS; FOCAL CEREBRAL-ISCHEMIA; BLOOD-BRAIN-BARRIER; BONE-MARROW; DOPAMINERGIC-NEURONS; THERAPEUTIC BENEFIT; FUNCTIONAL RECOVERY; ARTERY OCCLUSION; IN-VIVO; RATS	Background The efficacy of mesenchymal stem cell (MSC) transplantation in ischemic stroke might depend on the timing of administration. We investigated the optimal time point of MSC transplantation. After MSC treatment, we also investigated the expression of matrix metalloproteinases (MMPs), which play a role in vascular and tissue remodeling. Methods Human bone marrow-derived MSCs (2 x 10(6), passage 5) were administrated intravenously after permanent middle cerebral artery occlusion (MCAO) was induced in male Sprague-Dawley rats. First, we determined the time point of MSC transplantation that led to maximal neurological recovery at 1 h, 1 day, and 3 days after MCAO. Next, we measured activity of MMP-2 and MMP-9, neurological recovery, infarction volume, and vascular density after transplanting MSCs at the time that led to maximal neurological recovery. Results Among the MSC-transplanted rats, those of the MSC 1-hour group showed maximal recovery in the rotarod test (P = 0.023) and the Longa score (P = 0.018). MMP-2 activity at 1 day after MCAO in the MSC 1-hour group was significantly higher than that in the control group (P = 0.002), but MMP-9 activity was not distinct. The MSC 1-hour group also showed smaller infarction volume and higher vascular density than did the control group. Conclusions In a permanent model of rodent MCAO, very early transplantation of human MSCs (1 h after MCAO) produced greater neurological recovery and decreased infraction volume. The elevation of MMP-2 activity and the increase in vascular density after MSC treatment suggest that MSCs might help promote angiogenesis and lead to neurological improvement during the recovery phase after ischemic stroke.	[Nam, Hyo Suk; Kwon, Il; Lee, Bo Hyung; Kim, Haejin; Kim, Jayoung; An, Sunho; Lee, Ok-Hee; Lee, Phil Hyu; Kim, Young Dae; Heo, Ji Hoe] Yonsei Univ, Coll Med, Severance Hosp, Dept Neurol, Seoul, South Korea; [Nam, Hyo Suk; Kwon, Il; Lee, Bo Hyung; Kim, Haejin; Kim, Jayoung; An, Sunho; Lee, Ok-Hee; Kim, Young Dae; Heo, Ji Hoe] Yonsei Univ Hlth Syst, Severance Integrat Res Inst Cerebral & Cardiovasc, Seoul, South Korea; [Kim, Hyun Ok] Yonsei Univ, Coll Med, Severance Hosp, Yonsei Cell Therapy Ctr,Dept Lab Med, Seoul, South Korea; [Namgoong, Hyun] Univ Calif Los Angeles, Microbiol Immunol & Mol Genet, Los Angeles, CA USA	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; University of California System; University of California Los Angeles	Heo, JH (corresponding author), Yonsei Univ, Coll Med, Severance Hosp, Dept Neurol, Seoul, South Korea.	jhheo@yuhs.ac		Lee, Phil Hyu/0000-0001-9931-8462; NAM, HYO SUK/0000-0002-4415-3995; Kim, Hyun Ok/0000-0002-4964-1963; Kwon, Il/0000-0001-9449-5646; Heo, Ji Hoe/0000-0001-9898-3321; Kim, Young Dae/0000-0001-5750-2616	Korea Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea [HI08C2149]; Korea Government Ministry of Education, Science and Technology [2009-0069165]; Korea Research Foundation Grant - Korean Government [KRF-2007-331-E00126]; Yonsei University College of Medicine [6-2011-0095]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2014R1A1A1005913]	Korea Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea; Korea Government Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Korea Research Foundation Grant - Korean Government(National Research Foundation of KoreaKorean Government); Yonsei University College of Medicine(General Electric); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning(National Research Foundation of Korea)	This study was supported by a grant from the Korea Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea (HI08C2149) (JHH), a grant from the Korea Government Ministry of Education, Science and Technology under Grant (2009-0069165) (HSN), a Korea Research Foundation Grant funded by the Korean Government (KRF-2007-331-E00126) (HSN), a faculty research grant from Yonsei University College of Medicine for 2011 (6-2011-0095) (HSN), and Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2014R1A1A1005913) (IK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barichello T, 2014, EXP BIOL MED, V239, P225, DOI 10.1177/1535370213508354; Beck H, 2000, AM J PATHOL, V157, P1473, DOI 10.1016/S0002-9440(10)64786-4; Beck H, 2009, ACTA NEUROPATHOL, V117, P481, DOI 10.1007/s00401-009-0483-6; Borlongan CV, 2011, LEUKEMIA, V25, P1674, DOI 10.1038/leu.2011.167; Borlongan CV, 2004, BRAIN RES, V1010, P108, DOI 10.1016/j.brainres.2004.02.072; Bronckaers A, 2014, PHARMACOL THERAPEUT, V143, P181, DOI 10.1016/j.pharmthera.2014.02.013; Brumm AJ, 2012, NAT MED, V18, P1609, DOI 10.1038/nm.2990; Carmichael ST, 2012, ARCH NEUROL-CHICAGO, V69, P161, DOI 10.1001/archneurol.2011.1175; Chen JL, 2000, NEUROPHARMACOLOGY, V39, P711, DOI 10.1016/S0028-3908(00)00006-X; Chen JL, 2003, J NEUROSCI RES, V73, P778, DOI 10.1002/jnr.10691; Chen JL, 2003, CIRC RES, V92, P692, DOI 10.1161/01.RES.0000063425.51108.8D; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Choi SA, 2007, CURR NEUROVASC RES, V4, P89, DOI 10.2174/156720207780637252; Clark AW, 1997, NEUROSCI LETT, V238, P53, DOI 10.1016/S0304-3940(97)00859-8; Cui X, 2007, STEM CELLS, V25, P2777, DOI 10.1634/stemcells.2007-0169; Ding YC, 2009, DIABETES, V58, P1797, DOI 10.2337/db09-0317; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Eckert MA, 2013, J CEREBR BLOOD F MET, V33, P1322, DOI 10.1038/jcbfm.2013.91; Frielingsdorf H, 2004, P NATL ACAD SCI USA, V101, P10177, DOI 10.1073/pnas.0401229101; Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/res.90.3.251; Heo JH, 1999, J CEREBR BLOOD F MET, V19, P624, DOI 10.1097/00004647-199906000-00005; Iihoshi S, 2004, BRAIN RES, V1007, P1, DOI 10.1016/j.brainres.2003.09.084; Kaya D, 2005, J CEREBR BLOOD F MET, V25, P1111, DOI 10.1038/sj.jcbfm.9600109; Kim SH, 2008, CURR NEUROVASC RES, V5, P28; Kim SJ, 2013, J STROKE, V15, P27, DOI 10.5853/jos.2013.15.1.27; Kim YJ, 2009, GLIA, V57, P13, DOI 10.1002/glia.20731; KRUPINSKI J, 1994, STROKE, V25, P1794, DOI 10.1161/01.STR.25.9.1794; Kwon I, 2009, J NEUROSCI RES, V87, P668, DOI 10.1002/jnr.21877; Li L, 2007, BRAIN RES, V1132, P185, DOI 10.1016/j.brainres.2006.10.098; Li WY, 2008, CELL TRANSPLANT, V17, P1045, DOI 10.3727/096368908786991551; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Li Y, 2000, J CEREBR BLOOD F MET, V20, P1311, DOI 10.1097/00004647-200009000-00006; Li Y, 2001, NEUROLOGY, V56, P1666, DOI 10.1212/WNL.56.12.1666; Lin TN, 2000, J CEREBR BLOOD F MET, V20, P387, DOI 10.1097/00004647-200002000-00021; Liu H, 2006, BRAIN, V129, P2734, DOI 10.1093/brain/awl207; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Lucivero V, 2007, NEUROL SCI, V28, P165, DOI 10.1007/s10072-007-0814-0; Rosenberg GA, 1996, J CEREBR BLOOD F MET, V16, P360, DOI 10.1097/00004647-199605000-00002; Savitz SI, 2011, STROKE, V42, P825, DOI 10.1161/STROKEAHA.110.601914; Shen LH, 2007, J CEREBR BLOOD F MET, V27, P6, DOI 10.1038/sj.jcbfm.9600311; Silletti S, 2001, P NATL ACAD SCI USA, V98, P119, DOI 10.1073/pnas.011343298; Vu Q, 2014, NEUROLOGY, V82, P1277, DOI 10.1212/WNL.0000000000000278; Yanev P, 2012, STROKE, V43, P3436, DOI 10.1161/STROKEAHA.111.642686; Yang Y, 2011, STROKE, V42, P3323, DOI 10.1161/STROKEAHA.110.608257; Yavagal DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093735; Zacharek A, 2007, J CEREBR BLOOD F MET, V27, P1684, DOI 10.1038/sj.jcbfm.9600475; Zhang J, 2004, BRAIN RES, V1030, P19, DOI 10.1016/j.brainres.2004.09.061; Zhang J, 2013, EXPERT OPIN BIOL TH, V13, P1229, DOI 10.1517/14712598.2013.804507; Zhao BQ, 2006, NAT MED, V12, P441, DOI 10.1038/nm1387; Zhao MZ, 2006, J CEREBR BLOOD F MET, V26, P1176, DOI 10.1038/sj.jcbfm.9600273	50	32	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144218	10.1371/journal.pone.0144218	http://dx.doi.org/10.1371/journal.pone.0144218			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26637168	Green Published, gold, Green Submitted			2022-12-27	WOS:000366143800058
J	Ren, LJ; Cai, JJ; Liang, J; Li, WP; Sun, ZH				Ren, Lijie; Cai, Jingjing; Liang, Jie; Li, Weiping; Sun, Zhonghua			Impact of Cardiovascular Risk Factors on Carotid Intima-Media Thickness and Degree of Severity: A Cross-Sectional Study	PLOS ONE			English	Article							YOUNG-ADULTS; DEPRESSIVE SYMPTOMS; ARTERY; ATHEROSCLEROSIS; STROKE; PROGRESSION; HYPERTENSION; PLAQUE; ASSOCIATION; POPULATION	Objective Age, hypertension, dyslipidemia and diabetes are common cardiovascular risk factors (CVRFs) that contribute to the development of atherosclerosis in cardiovascular system including carotid artery disease. However, the impact of these risk factors on the increased carotid intima-media thickness (cIMT) and degree of carotid severity remains to be further clarified. This study aims to evaluate the relationship between CVRFs and degree of carotid severity and cIMT in high-risk subjects. Methods Four thousand and three hundred ninety-four subjects with one or more risk factors were retrospectively reviewed in this study. Patients were divided into different groups based on age, the type and quantity of CVRFs. cIMT and degree of carotid artery stenosis were measured and analyzed based on carotid ultrasound imaging with findings compared to the CVRFs to determine the correlation between these variables. Results Aging was significantly associated with degree of severity (P < 0.05) and cIMT was significantly increased with age (P < 0.05). Individual CVRF analysis shows that hypertension was more related to the degree of severity than dyslipidemia and diabetes with corresponding abnormal cIMT rates being 79.39%, 72.98% and 32.37%, respectively. The prevalence of carotid atherosclerosis were 20.06%, 22.88% and 28.63%, respectively corresponding to patients with zero, one and more than one chronic diseases. The percentage of abnormal cIMT in hypertensive patient group with dyslipidemia is significantly higher than the other groups (P< 0.05). Conclusions This study shows a direct correlation between the degree of carotid severity and cIMT and cardiovascular risk factors, especially with age and hypertension. Carotid atherosclerosis is closely related to the number of cardiovascular risk factors.	[Ren, Lijie; Cai, Jingjing] Anhui Med Univ, Clin Med Coll, Peoples Hosp 2, Dept Shenzhen, Shenzhen, Guangdong, Peoples R China; [Ren, Lijie; Cai, Jingjing; Liang, Jie] Shenzhen Second Peoples Hosp, Dept Neurol, Shenzhen, Guangdong, Peoples R China; [Liang, Jie] Guangzhou Med Univ, Clin Med Coll, Peoples Hosp 2, Dept Shenzhen, Shenzhen, Guangdong, Peoples R China; [Li, Weiping] Shenzhen Second Peoples Hosp, Dept Neurosurg, Shenzhen, Guangdong, Peoples R China; [Sun, Zhonghua] Curtin Univ, Dept Med Radiat Sci, Perth, WA 6845, Australia	Anhui Medical University; Second People's Hospital of Shenzhen; Guangzhou Medical University; Second People's Hospital of Shenzhen; Curtin University	Li, WP (corresponding author), Shenzhen Second Peoples Hosp, Dept Neurosurg, Shenzhen, Guangdong, Peoples R China.	liweiping60@yahoo.com.cn	Sun, Zhonghua/B-3125-2010; 黎, 伟/GXM-4040-2022; li, wj/HGD-7322-2022; Sun, Zhonghua/N-1648-2019	Sun, Zhonghua/0000-0002-7538-4761; Sun, Zhonghua/0000-0002-7538-4761	Shenzhen Development and Reform Commission [2012110]; Shenzhen-based chronic disease tracking and monitoring and control of public service platform cloud platform [20120830145119425]; Guangdong Province Science and Technology Project [2013B021800102]; Shenzhen Knowledge Innovation Program [20130322131035]; Shenzhen-based research project [JCYJ20140414170821262]	Shenzhen Development and Reform Commission; Shenzhen-based chronic disease tracking and monitoring and control of public service platform cloud platform; Guangdong Province Science and Technology Project; Shenzhen Knowledge Innovation Program; Shenzhen-based research project	This work was supported in part by Shenzhen Development and Reform Commission project "Shenzhen stroke screening and prevention public service platform" (2012110), the Shenzhen-based chronic disease tracking and monitoring and control of public service platform cloud platform (20120830145119425), Guangdong Province Science and Technology Project (2013B021800102), Shenzhen Knowledge Innovation Program (20130322131035) and Shenzhen-based research project (JCYJ20140414170821262).; This work was supported in part by Shenzhen Development and Reform Commission project "Shenzhen stroke screening and prevention public service platform" (2012110), the Shenzhen-based chronic disease tracking and monitoring and control of public service platform cloud platform (20120830145119425), Guangdong Province Science and Technology Project (2013B021800102), Shenzhen Knowledge Innovation Program (20130322131035) and Shenzhen-based research project (JCYJ20140414170821262).	Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Bots ML, 2012, J AM COLL CARDIOL, V60, P1599, DOI 10.1016/j.jacc.2011.12.061; CHEN ZM, 1991, BRIT MED J, V303, P276, DOI 10.1136/bmj.303.6797.276; Chirinos DA, 2015, J BEHAV MED, V38, P284, DOI 10.1007/s10865-014-9599-9; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Conner W T, 1998, Evid Based Cardiovasc Med, V2, P71, DOI 10.1016/S1361-2611(98)80064-X; Herder M, 2012, STROKE, V43, P1818, DOI 10.1161/STROKEAHA.111.646596; Kabir AA, 2009, AM J MED, V122, DOI 10.1016/j.amjmed.2009.07.016; KANNEL WB, 1988, AM J CARDIOL, V62, P1109, DOI 10.1016/0002-9149(88)90558-9; Koskinen J, 2009, CIRCULATION, V120, P229, DOI 10.1161/CIRCULATIONAHA.108.845065; Lee HY, 2010, CIRC J, V74, P2257, DOI 10.1253/circj.CJ-10-0910; Liang YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085927; Liapis CD, 2001, STROKE, V32, P2782, DOI 10.1161/hs1201.099797; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Lorenz MW, 2006, STROKE, V37, P87, DOI 10.1161/01.STR.0000196964.24024.ea; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Mancia G, 2001, J HYPERTENS, V19, P1981, DOI 10.1097/00004872-200111000-00008; Meschia JF, 2014, STROKE, V45, P3754, DOI 10.1161/STR.0000000000000046; Mostaza JM, 2015, ATHEROSCLEROSIS, V242, P377, DOI 10.1016/j.atherosclerosis.2015.07.028; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Naqvi TZ, 2014, JACC-CARDIOVASC IMAG, V7, P1025, DOI 10.1016/j.jcmg.2013.11.014; Niu LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067809; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Pall D, 2003, CEREBROVASC DIS, V15, P167, DOI 10.1159/000068834; Pan A, 2011, JAMA-J AM MED ASSOC, V306, P1241, DOI 10.1001/jama.2011.1282; Paul TK, 2005, AM J CARDIOL, V95, P469, DOI 10.1016/j.amjcard.2004.10.013; Polak JF, 2011, STROKE, V42, P3017, DOI 10.1161/STROKEAHA.111.625186; Rothwell PM, 2000, LANCET, V355, P19, DOI 10.1016/S0140-6736(99)04470-0; Rundek T, 2013, STROKE, V44, P2101, DOI 10.1161/STROKEAHA.111.000745; Santos IS, 2015, ATHEROSCLEROSIS, V240, P529, DOI 10.1016/j.atherosclerosis.2015.04.800; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Sun ZJ, 2015, HYPERTENSION, V65, P252, DOI 10.1161/HYPERTENSIONAHA.114.03617; Sztajzel R, 2005, SWISS MED WKLY, V135, P635; Talelli P, 2007, J CLIN NEUROSCI, V14, P1067, DOI 10.1016/j.jocn.2006.06.019; Tattersall MC, 2014, STROKE, V45, P3257, DOI 10.1161/STROKEAHA.114.005669; Touboul PJ, 2012, CEREBROVASC DIS, V34, P290, DOI 10.1159/000343145; Tsivgoulis G, 2006, STROKE, V37, P1913, DOI 10.1161/01.STR.0000226399.13528.0a; Urbina EM, 2009, CIRCULATION, V119, P2913, DOI 10.1161/CIRCULATIONAHA.108.830380; Urbina EM, 2002, AM J CARDIOL, V90, P953, DOI 10.1016/S0002-9149(02)02660-7; van der Meer IM, 2003, STROKE, V34, P2374, DOI 10.1161/01.STR.0000088643.07108.19; van Rooy MJ, 2014, CURR MED CHEM, V21, P2121; WALDSTEIN SR, 1991, PSYCHOL BULL, V110, P451, DOI 10.1037/0033-2909.110.3.451; Weingartner O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013467; Yang YP, 2015, MED SCI MONITOR, V21, P2467, DOI 10.12659/MSM.894693; Yuan C, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/179686; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488; Zhang FL, 2014, INT J CLIN EXP MED, V7, P5412	51	30	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144182	10.1371/journal.pone.0144182	http://dx.doi.org/10.1371/journal.pone.0144182			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636669	Green Published, gold, Green Submitted			2022-12-27	WOS:000366143800054
J	Yin, P; Xu, JQ; He, SS; Liu, FH; Yin, J; Wan, CR; Mei, C; Yin, YL; Xu, XL; Xia, ZF				Yin, Peng; Xu, Jianqin; He, Shasha; Liu, Fenghua; Yin, Jie; Wan, Changrong; Mei, Chen; Yin, Yulong; Xu, Xiaolong; Xia, Zhaofei			Endoplasmic Reticulum Stress in Heat- and Shake-Induced Injury in the Rat Small Intestine	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; OXIDATIVE STRESS; ER-STRESS; MONITORING AUTOPHAGY; TRIGGERS AUTOPHAGY; ANTIOXIDANT SYSTEM; SIGNALING PATHWAYS; INDUCED APOPTOSIS; GENE-EXPRESSION; DISEASE	We investigated the mechanisms underlying damage to rat small intestine in heat- and shake-induced stress. Eighteen Sprague-Dawley rats were randomly divided into a control group and a 3-day stressed group treated 2 h daily for 3 days on a rotary platform at 35 degrees C and 60 r/min. Hematoxylin and eosin-stained paraffin sections of the jejunum following stress revealed shedding of the villus tip epithelial cells and lamina propria exposure. Apoptosis increased at the villus tip and extended to the basement membrane. Photomicro-graphs revealed that the microvilli were shorter and sparser; the nuclear envelope invaginated and gaps in the karyolemma increased; and the endoplasmic reticulum (ER) swelled significantly. Gene microarray analysis assessed 93 differentially expressed genes associated with apoptosis, ER stress, and autophagy. Relevant genes were compiled from the Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) data-bases. Forty-one genes were involved in the regulation of apoptosis, fifteen were related to autophagy, and eleven responded to ER stress. According to KEGG, the apoptosis pathways, mitogen-activated protein kinase(MAPK) signaling pathway, the mammalian target of rapamycin (mTOR) signaling pathway, and regulation of autophagy were involved. Caspase-3 (Casp3), caspase12 (Casp12), and microtubule-associate proteins 1 light chain 3 (LC3) increased significantly at the villus tip while mTOR decreased; phosphorylated-AKT (P-AKT) decreased. ER stress was involved and induced autophagy and apoptosis in rat intestinal damage following heat and shake stress. Bioinformatic analysis will help determine the underlying mechanisms in stress-induced damage in the small intestine.	[Yin, Peng; Xu, Jianqin; He, Shasha; Wan, Changrong; Xu, Xiaolong; Xia, Zhaofei] China Agr Univ, Coll Vet Med, BUA TCVM Teaching & Researching Team, Beijing, Peoples R China; [Liu, Fenghua; Mei, Chen] Beijing Agr Univ, Coll Anim Sci & Technol, Beijing 100094, Peoples R China; [Yin, Jie; Yin, Yulong] Chinese Acad Sci, Inst Subtrop Agr, Key Lab Agroecol Proc Subtrop Reg, Changsha 410125, Hunan, Peoples R China	Beijing University of Agriculture; China Agricultural University; Beijing University of Agriculture; Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS	Xia, ZF (corresponding author), China Agr Univ, Coll Vet Med, BUA TCVM Teaching & Researching Team, Beijing, Peoples R China.	liufenghua1209@126.com; yinyulong@isa.ac.cn; zhaofeixiacau@126.com		Xia, zhaofei/0000-0002-7567-1007; xu, xiaolong/0000-0003-3333-0906	National Natural Science Foundation of China [31572584, 31272478]; National Twelve-Five Technological Supported Plan of China [2011BAD34B01]; PHR (IHLB); Research Fund for the Doctoral Program of Higher Education of China and Ministry of Agriculture, Public Service Sectors Agriculture Research Projects [201003060-9/10]; Chinese Academy of Science STS Project [KFJ-EW-STS-063]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Twelve-Five Technological Supported Plan of China; PHR (IHLB); Research Fund for the Doctoral Program of Higher Education of China and Ministry of Agriculture, Public Service Sectors Agriculture Research Projects; Chinese Academy of Science STS Project	This work was supported by grants from National Natural Science Foundation of China (No. 31572584 and No. 31272478), National Twelve-Five Technological Supported Plan of China (No. 2011BAD34B01), PHR (IHLB), Research Fund for the Doctoral Program of Higher Education of China and Ministry of Agriculture, Public Service Sectors Agriculture Research Projects (No. 201003060-9/10), and The Chinese Academy of Science STS Project (KFJ-EW-STS-063). The authors are thankful for the help from the members of CAU-BUA TCVM teaching & research team. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chalhoub N, 2009, GENE DEV, V23, P1619, DOI 10.1101/gad.1799609; CUERVO AM, 1995, AM J PHYSIOL-CELL PH, V269, pC1200, DOI 10.1152/ajpcell.1995.269.5.C1200; Essick EE, 2010, OXID MED CELL LONGEV, V3, P168, DOI 10.4161/oxim.3.3.12106; Hall DM, 2001, AM J PHYSIOL-HEART C, V280, pH509, DOI 10.1152/ajpheart.2001.280.2.H509; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; HB, 1994, HOSP PRACT OFF ED, V29, P8; Ishida Y, 2009, MOL BIOL CELL, V20, P2744, DOI 10.1091/mbc.E08-11-1092; Kadowaki Motoni, 2006, Molecular Aspects of Medicine, V27, P426, DOI 10.1016/j.mam.2006.08.010; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kiffin R, 2006, ANTIOXID REDOX SIGN, V8, P152, DOI 10.1089/ars.2006.8.152; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; KREGEL KC, 1988, J APPL PHYSIOL, V64, P2582, DOI 10.1152/jappl.1988.64.6.2582; Li JZ, 2006, J BIOL CHEM, V281, P7260, DOI 10.1074/jbc.M509868200; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Lin WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039120; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Meddings JB, 2000, GASTROENTEROLOGY, V119, P1019, DOI 10.1053/gast.2000.18152; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Moriwaki Y, 1993, Nihon Geka Gakkai Zasshi, V94, P1017; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Novosad VL, 2013, AM J PHYSIOL-GASTR L, V305, pG418, DOI 10.1152/ajpgi.00166.2013; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Qin L, 2010, AUTOPHAGY, V6, P239, DOI 10.4161/auto.6.2.11062; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Shu B., 2013, THESIS; Soderholm JD, 2001, AM J PHYSIOL-GASTR L, V280, pG7, DOI 10.1152/ajpgi.2001.280.1.G7; Sui XB, 2014, CANCER LETT, V344, P174, DOI 10.1016/j.canlet.2013.11.019; Szegezdi E, 2003, ANN NY ACAD SCI, V1010, P186, DOI 10.1196/annals.1299.032; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wan CR, 2014, RES VET SCI, V96, P355, DOI 10.1016/j.rvsc.2014.01.008; Wiseman H, 1996, BIOCHEM J, V313, P17, DOI 10.1042/bj3130017; Wu HH, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-19; Yan XH, 2012, AUTOPHAGY, V8, P213, DOI 10.4161/auto.8.2.18563; Yin J, 2014, J ANIM SCI, V92, P612, DOI 10.2527/jas.2013-6986; Yin J, 2013, FREE RADICAL RES, V47, P1027, DOI 10.3109/10715762.2013.848277; Yin J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122893; Yin J, 2015, RSC ADV, V5, P15479, DOI 10.1039/c4ra13557a; Yin J, 2014, AMINO ACIDS, V46, P883, DOI 10.1007/s00726-013-1643-5; Yin J, 2013, J FOOD AGRIC ENVIRON, V11, P132; Yin Peng, 2013, BIOTECHNOLOGY INDIAN, V8, P1561; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200; Yu J, 2013, STRESS, V16, P99, DOI 10.3109/10253890.2012.680526; Yu J, 2010, INT J HYPERTHER, V26, P538, DOI 10.3109/02656736.2010.481276; Yu J, 2010, COMP BIOCHEM PHYS A, V156, P119, DOI 10.1016/j.cbpa.2010.01.008; Zhang KZ, 2010, INT J CLIN EXP MED, V3, P33; Zou CG, 2009, ENDOCRINOLOGY, V150, P277, DOI 10.1210/en.2008-0794	55	9	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143922	10.1371/journal.pone.0143922	http://dx.doi.org/10.1371/journal.pone.0143922			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636675	gold, Green Published, Green Submitted			2022-12-27	WOS:000366143800033
J	Basset, Y; Cizek, L; Cuenoud, P; Didham, RK; Novotny, V; Odegaard, F; Roslin, T; Tishechkin, AK; Schmidl, J; Winchester, NN; Roubik, DW; Aberlenc, HP; Bail, J; Barrios, H; Bridle, JR; Castano-Meneses, G; Corbara, B; Curletti, G; da Rocha, WD; De Bakker, D; Delabie, JHC; Dejean, A; Fagan, LL; Floren, A; Kitching, RL; Medianero, E; de Oliveira, EG; Orivel, J; Pollet, M; Rapp, M; Ribeiro, SP; Roisin, Y; Schmidt, JB; Sorensen, L; Lewinsohn, TM; Leponce, M				Basset, Yves; Cizek, Lukas; Cuenoud, Philippe; Didham, Raphael K.; Novotny, Vojtech; Odegaard, Frode; Roslin, Tomas; Tishechkin, Alexey K.; Schmidl, Juergen; Winchester, Neville N.; Roubik, David W.; Aberlenc, Henri-Pierre; Bail, Johannes; Barrios, Hector; Bridle, Jonathan R.; Castano-Meneses, Gabriela; Corbara, Bruno; Curletti, Gianfranco; da Rocha, Wesley Duarte; De Bakker, Domir; Delabie, Jacques H. C.; Dejean, Alain; Fagan, Laura L.; Floren, Andreas; Kitching, Roger L.; Medianero, Enrique; de Oliveira, Evandro Gama; Orivel, Jerome; Pollet, Marc; Rapp, Mathieu; Ribeiro, Servio P.; Roisin, Yves; Schmidt, Jesper B.; Sorensen, Line; Lewinsohn, Thomas M.; Leponce, Maurice			Arthropod Distribution in a Tropical Rainforest: Tackling a Four Dimensional Puzzle	PLOS ONE			English	Article							BETA-DIVERSITY; SPECIES RICHNESS; HERBIVOROUS INSECTS; ASSEMBLAGES; TREES; SPECIALIZATION; BIODIVERSITY; SIMILARITY; TURNOVER; STRATEGY	Quantifying the spatio-temporal distribution of arthropods in tropical rainforests represents a first step towards scrutinizing the global distribution of biodiversity on Earth. To date most studies have focused on narrow taxonomic groups or lack a design that allows partitioning of the components of diversity. Here, we consider an exceptionally large dataset (113,952 individuals representing 5,858 species), obtained from the San Lorenzo forest in Panama, where the phylogenetic breadth of arthropod taxa was surveyed using 14 protocols targeting the soil, litter, understory, lower and upper canopy habitats, replicated across seasons in 2003 and 2004. This dataset is used to explore the relative influence of horizontal, vertical and seasonal drivers of arthropod distribution in this forest. We considered arthropod abundance, observed and estimated species richness, additive decomposition of species richness, multiplicative partitioning of species diversity, variation in species composition, species turnover and guild structure as components of diversity. At the scale of our study (2km of distance, 40m in height and 400 days), the effects related to the vertical and seasonal dimensions were most important. Most adult arthropods were collected from the soil/litter or the upper canopy and species richness was highest in the canopy. We compared the distribution of arthropods and trees within our study system. Effects related to the seasonal dimension were stronger for arthropods than for trees. We conclude that: (1) models of beta diversity developed for tropical trees are unlikely to be applicable to tropical arthropods; (2) it is imperative that estimates of global biodiversity derived from mass collecting of arthropods in tropical rainforests embrace the strong vertical and seasonal partitioning observed here; and (3) given the high species turnover observed between seasons, global climate change may have severe consequences for rainforest arthropods.	[Basset, Yves; Roubik, David W.] STRI Res, Smithsonian Trop Res Inst, Panama City 080814, Panama; [Basset, Yves; Cizek, Lukas; Novotny, Vojtech] Univ South Bohemia, Biol Faculy, Ceske Budejovice 37005, Czech Republic; [Basset, Yves; Barrios, Hector; Medianero, Enrique] Univ Panama, Panama City 080814, Panama; [Cizek, Lukas; Novotny, Vojtech] Acad Sci Czech Republic, Inst Entomol, Ctr Biol, Ceske Budejovice 37005, Czech Republic; [Cuenoud, Philippe] Museum Hist Nat Ville Geneve, Dept Arthropodes & Entomol 1, CH-1208 Geneva, Switzerland; [Didham, Raphael K.] Univ Western Australia, Sch Anim Biol, Perth, WA 6009, Australia; [Didham, Raphael K.] CSIRO Land & Water, Perth, WA 6009, Australia; [Odegaard, Frode] Norwegian Inst Nat Res, N-7485 Trondheim, Norway; [Roslin, Tomas] Swedish Univ Agr Sci, Dept Ecol, SE-75007 Uppsala, Sweden; [Tishechkin, Alexey K.] Natl Museum Nat Hist, Dept Entomol, Washington, DC 20013 USA; [Schmidl, Juergen] Univ Erlangen Nurnberg, Dept Biol, D-91058 Erlangen, Germany; [Winchester, Neville N.] Univ Victoria, Dept Biol, Victoria, BC V8W 2Y2, Canada; [Aberlenc, Henri-Pierre] Cirad, Ctr Biol Gest Populat, F-34988 Montferrier Sur Lez, France; [Bridle, Jonathan R.] Univ Bristol, Sch Biol Sci, Bristol BS8 1TH, Avon, England; [Castano-Meneses, Gabriela] Univ Nacl Autonoma Mexico, Fac Ciencias, Queretaro 76230, Mexico; [Corbara, Bruno] Univ Clermont Ferrand 2, Photochim Mol & Macromol Lab, CNRS, UMR 6023, F-63177 Clermont Ferrand, France; [Corbara, Bruno] Univ Blaise Pascal, F-63000 Clermont Ferrand, France; [Curletti, Gianfranco] Museo Civ Storia Nat, I-10022 Carmagnola, Italy; [da Rocha, Wesley Duarte] Univ Fed Minas Gerais, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil; [De Bakker, Domir] Operat Directorate Nat Environm, Inst Royal Sci Nat Belgique, B-1000 Brussels, Belgium; [Delabie, Jacques H. C.] Convenio UESC CEPLAC, Ctr Pesquisas Cacau, BR-45600000 Itabuna, Brazil; [Delabie, Jacques H. C.] Univ Estadual Santa Cruz, BR-45662900 Ilheus, Brazil; [Dejean, Alain] Univ Toulouse 3, UMR EcoFoG, F-31062 Toulouse, France; [Fagan, Laura L.] Western Australia Dept Agr & Food Biosecur & Regu, Perth, WA 6151, Australia; [Floren, Andreas] Univ Wurzburg, Dept Anim Ecol & Trop Biol, D-97070 Wurzburg, Germany; [Kitching, Roger L.] Griffith Univ, Sch Environm, Nathan, Qld 4111, Australia; [de Oliveira, Evandro Gama] Ctr Univ Una, Ciencias Biol, BR-30180100 Belo Horizonte, MG, Brazil; [Orivel, Jerome] CNRS, UMR EcoFoG, F-97379 Kourou, France; [Pollet, Marc] Res Inst Nat & Forest, Res Grp Species Divers, B-1070 Brussels, Belgium; [Ribeiro, Servio P.] Univ Fed Ouro Preto, Inst Ciencias Exatas & Biol, BR-35400000 Ouro Preto, MG, Brazil; [Roisin, Yves] Univ Libre Bruxelles, Evolutionary Biol & Ecol, B-1050 Brussels, Belgium; [Lewinsohn, Thomas M.] Univ Estadual Campinas, Dept Biol Anim, BR-13083870 Campinas, SP, Brazil	Smithsonian Institution; Smithsonian Tropical Research Institute; University of South Bohemia Ceske Budejovice; Universidad de Panama; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of Western Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Norwegian Institute Nature Research; Swedish University of Agricultural Sciences; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Erlangen Nuremberg; University of Victoria; CIRAD; Institut de Recherche pour le Developpement (IRD); University of Bristol; Universidad Nacional Autonoma de Mexico; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Universidade Federal de Minas Gerais; Universidade Estadual de Santa Cruz; AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Wurzburg; Griffith University; Centro Universitario UNA; AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; Research Institute for Nature & Forest; Universidade Federal de Ouro Preto; Universite Libre de Bruxelles; Universidade Estadual de Campinas	Basset, Y (corresponding author), STRI Res, Smithsonian Trop Res Inst, Panama City 080814, Panama.	bassety@si.edu	Novotny, Vojtech/G-9434-2014; Basset, Yves F/B-6642-2014; Didham, Raphael K/B-5953-2011; Lewinsohn, Thomas M/D-5880-2012; Ribeiro, Sérvio/G-1887-2012; Roslin, Tomas/E-8648-2016; Cizek, Lukas/G-7905-2014; Cizek, Lukas/K-7111-2015; Ribeiro, Sérvio Pontes/AAG-1146-2020	Novotny, Vojtech/0000-0001-7918-8023; Basset, Yves F/0000-0002-1942-5717; Lewinsohn, Thomas M/0000-0001-5950-5343; Ribeiro, Sérvio/0000-0002-0191-8759; Roslin, Tomas/0000-0002-2957-4791; Cizek, Lukas/0000-0002-6447-2002; Cizek, Lukas/0000-0002-6447-2002; Ribeiro, Sérvio Pontes/0000-0002-0191-8759; Dejean, Alain/0000-0002-3561-2248; Roisin, Yves/0000-0001-6635-3552; Orivel, Jerome/0000-0002-5636-3228; Delabie, Jacques Hubert Charles/0000-0002-2695-1061; Bridle, Jonathan/0000-0002-5999-0307; CORBARA, Bruno/0000-0003-4232-8234	SolVin-Solvay SA; STRI; United Nations Environment Programme; Smithsonian Institution (Walcott Fund); European Science Foundation; Global Canopy Programme; Czech Science foundation GACR grant [14-36098G]; European Social Fund; Czech Ministry of Education [CZ.1.07/2.3.00/20.0064]; U.S. National Science Fundation [DEB-0841885]; Australian Research Council [FT100100040]; CNPq; "Investissement d'Avenir'' grant [ANR-10-LABX-25-01]; Norwegian Research Council; Grant Agency of the Czech Republic [14-36098G]	SolVin-Solvay SA(Solvay SA); STRI(Smithsonian InstitutionSmithsonian Tropical Research Institute); United Nations Environment Programme; Smithsonian Institution (Walcott Fund)(Smithsonian InstitutionSmithsonian National Museum of Natural History); European Science Foundation(European Science Foundation (ESF)European Commission); Global Canopy Programme; Czech Science foundation GACR grant; European Social Fund(European Social Fund (ESF)); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); U.S. National Science Fundation; Australian Research Council(Australian Research Council); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); "Investissement d'Avenir'' grant(French National Research Agency (ANR)); Norwegian Research Council(Research Council of NorwayEuropean Commission); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	Core funding was provided from SolVin-Solvay SA, STRI, the United Nations Environment Programme, the Smithsonian Institution (Walcott Fund), the European Science Foundation, and the Global Canopy Programme. YB and HB are members of the Sistema Nacional de Investigacion of the SENACYT in Panama, and acknowledge the help of the Smithsonian Tropical Research Institute and Maestria Centroamericana de Entomologia, Universidad de Panama, during the preparation of the IBISCA-Panama project. YB was supported by Czech Science foundation GACR grant 14-36098G, European Social Fund and Czech Ministry of Education CZ.1.07/2.3.00/20.0064 and U.S. National Science Fundation DEB-0841885. RLK acknowledges the Queensland Government for provision of a visiting fellowship under its Queensland/Smithsonian Institution Scheme. RKD was supported by an Australian Research Council Future Fellowship FT100100040. SPR was supported by CNPq. JO was supported by a "Investissement d'Avenir'' grant managed by the Agence Nationale de la Recherche (CEBA, ref. ANR-10-LABX-25-01). FO's research was funded by the Norwegian Research Council. VN was supported by the Grant Agency of the Czech Republic (14-36098G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Barton PS, 2013, GLOBAL ECOL BIOGEOGR, V22, P639, DOI 10.1111/geb.12031; BASSET Y, 2003, ARTHROPODS TROPICAL; Basset Yves, 2007, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Entomologie, V77, P39; Basset Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136623; Basset Y, 2012, SCIENCE, V338, P1481, DOI 10.1126/science.1226727; Beck J, 2007, J ANIM ECOL, V76, P230, DOI 10.1111/j.1365-2656.2006.01189.x; BIGGER M, 1976, NATURE, V259, P207, DOI 10.1038/259207a0; Blackburn TM, 2002, GLOBAL ECOL BIOGEOGR, V11, P185, DOI 10.1046/j.1466-822X.2002.00290.x; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Colwell R.K., 2006, ESTIMATES STAT ESTIM; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Crist TO, 2003, AM NAT, V162, P734, DOI 10.1086/378901; Dauby G, 2012, ECOGRAPHY, V35, P661, DOI 10.1111/j.1600-0587.2011.06860.x; DeVries PJ, 1999, BIOL J LINN SOC, V68, P333, DOI 10.1111/j.1095-8312.1999.tb01175.x; Didham RK, 1998, ECOL MONOGR, V68, P295, DOI 10.1890/0012-9615(1998)068[0295:BSRTTF]2.0.CO;2; Didham RK, 2003, ARTHROPODS OF TROPICAL FORESTS, P28; Didham RK, 1996, TRENDS ECOL EVOL, V11, P255, DOI 10.1016/0169-5347(96)20047-3; Feener DH, 1998, OECOLOGIA, V116, P191, DOI 10.1007/s004420050579; Fine PVA, 2004, SCIENCE, V305, P663, DOI 10.1126/science.1098982; Gomes-Westphalen JS, 2012, REV BIOL TROP, V60, P1025; Grimbacher PS, 2009, BIOTROPICA, V41, P328, DOI 10.1111/j.1744-7429.2008.00477.x; Grotan V, 2014, ECOGRAPHY, V37, P509, DOI 10.1111/ecog.00635; Hamilton AJ, 2013, OECOLOGIA, V171, P357, DOI 10.1007/s00442-012-2434-5; Holt Robert D., 1993, P77; Hubbell SP, 1999, SCIENCE, V283, P554, DOI 10.1126/science.283.5401.554; Hubbell Stephen P., 2001, V32, pi; Jost L, 2010, DIVERS DISTRIB, V16, P65, DOI 10.1111/j.1472-4642.2009.00626.x; Kitching RL, 2013, ECOGRAPHY, V36, P675, DOI 10.1111/j.1600-0587.2012.00023.x; Lande R, 1996, OIKOS, V76, P5, DOI 10.2307/3545743; Legendre P, 2013, ECOL LETT, V16, P951, DOI 10.1111/ele.12141; Leibold MA, 2006, ECOLOGY, V87, P1399, DOI 10.1890/0012-9658(2006)87[1399:COTNAN]2.0.CO;2; Marcon E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090289; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; Novotny V, 2007, NATURE, V448, P692, DOI 10.1038/nature06021; Odegaard F, 2004, ECOL ENTOMOL, V29, P76, DOI 10.1111/j.0307-6946.2004.00580.x; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Pokon R, 2005, J TROP ECOL, V21, P595, DOI 10.1017/S0266467405002567; Ricklefs Robert E., 1993, P350; Roberge JM, 2004, CONSERV BIOL, V18, P76, DOI 10.1111/j.1523-1739.2004.00450.x; Singer MC, 2010, PHILOS T R SOC B, V365, P3161, DOI 10.1098/rstb.2010.0144; Soininen J, 2010, BIOSCIENCE, V60, P433, DOI 10.1525/bio.2010.60.6.7; Soininen J, 2007, ECOGRAPHY, V30, P3, DOI 10.1111/j.2006.0906-7590.04817.x; Speight MR, 2003, ARTHROPODS OF TROPICAL FORESTS, P380; STEVENS GC, 1992, AM NAT, V140, P893, DOI 10.1086/285447; Stork N.E., 1997, CANOPY ARTHROPODS; Stork NE, 2014, J BIOGEOGR, V41, P421, DOI 10.1111/jbi.12223; Stork NE, 2013, INSECT CONSERV DIVER, V6, P67, DOI 10.1111/j.1752-4598.2012.00188.x; Weaver P. L., 2004, SAN LORENZO PROTECTE; Wolda H., 1987, P69; WOLDA H, 1989, OECOLOGIA, V80, P437, DOI 10.1007/BF00380064	52	69	78	2	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144110	10.1371/journal.pone.0144110	http://dx.doi.org/10.1371/journal.pone.0144110			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633187	Green Published, gold, Green Accepted			2022-12-27	WOS:000366040000058
J	Cheng, W; Liu, FF; Wang, Z; Zhang, Y; Zhao, YX; Zhang, QY; Jiang, F				Cheng, Wen; Liu, Fangfang; Wang, Zhe; Zhang, Yun; Zhao, Yu-Xia; Zhang, Qunye; Jiang, Fan			Soluble TRAIL Concentration in Serum Is Elevated in People with Hypercholesterolemia	PLOS ONE			English	Article							APOPTOSIS-INDUCING-LIGAND; VASCULAR INFLAMMATION; HEALTHY-ADULTS; OSTEOPROTEGERIN; ATHEROSCLEROSIS; ASSOCIATIONS; INVOLVEMENT; ARTHRITIS; MARKER; CELLS	Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a multi-functional cytokine, which is involved in the pathophysiological processes of cardiovascular and metabolic diseases. Previously, we demonstrated that TRAIL stimulated lipid uptake and foam cell formation in macrophages in vitro. Several clinical studies have suggested that the serum concentration of TRAIL may be increased in humans with elevated blood cholesterol; however, the current data appear to be inconclusive in this regard. In the present study, we examined the relationships between the serum TRAIL concentration and cholesterol levels in 352 generally healthy subjects undergoing the routine annual health check. We showed that there were significant correlations between TRAIL concentration and levels of total and low-density lipoprotein cholesterols. The level of TRAIL was significantly elevated in subjects with hypercholesterolemia, although this relationship might be also associated with changes of other metabolic factors. Moreover, we showed that the level of blood cholesterol was significantly higher in subjects in the upper quartile of serum TRAIL. In conclusion, our data demonstrate that the serum TRAIL concentration is elevated in people with hypercholesterolemia.	[Cheng, Wen; Liu, Fangfang; Zhang, Yun; Zhang, Qunye; Jiang, Fan] Shandong Univ, Qilu Hosp, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250012, Shandong, Peoples R China; [Wang, Zhe] Shandong Univ, Shandong Prov Hosp, Dept Endocrinol, Jinan 250012, Shandong, Peoples R China; [Zhao, Yu-Xia] Qilu Hosp, Dept Tradit Chinese Med, Jinan 250012, Shandong, Peoples R China; [Jiang, Fan] Shandong Univ, Sch Med, Dept Pathophysiol, Jinan 250012, Shandong, Peoples R China	Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University; Shandong University	Zhao, YX (corresponding author), Qilu Hosp, Dept Tradit Chinese Med, 107 Wen Hua Xi Rd, Jinan 250012, Shandong, Peoples R China.	yxzhao@sdu.edu.cn; fjiang@sdu.edu.cn	Jiang, Fan/B-7753-2013	Jiang, Fan/0000-0001-9466-2192	National 973 Basic Research Program of China [2012CB518603]; National Natural Science Foundation of China [91539102]; State Program of National Natural Science Foundation of China for Innovative Research Group [81021001]	National 973 Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Program of National Natural Science Foundation of China for Innovative Research Group(National Natural Science Foundation of China (NSFC))	This work was partially supported by the following research grants: the National 973 Basic Research Program of China (2012CB518603); National Natural Science Foundation of China (91539102); State Program of National Natural Science Foundation of China for Innovative Research Group (81021001).; The authors thank Xiao-Wei Wang for technical assistance in sample collection and processing. This work was partially supported by the following research grants: the National 973 Basic Research Program of China (2012CB518603); National Natural Science Foundation of China (91539102); State Program of National Natural Science Foundation of China for Innovative Research Group (81021001).	Ashley DT, 2011, METABOLISM, V60, P994, DOI 10.1016/j.metabol.2010.10.001; Azab NA, 2012, CLIN RHEUMATOL, V31, P1359, DOI 10.1007/s10067-012-2023-3; Bernardi S, 2012, CURR DRUG TARGETS, V13, P1215, DOI 10.2174/138945012802002357; Bisgin A, 2012, DIABETES RES CLIN PR, V96, pE84, DOI 10.1016/j.diabres.2012.02.028; Brombo G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058225; Castellino G, 2010, RHEUMATOLOGY, V49, P1173, DOI 10.1093/rheumatology/keq064; Chaemsaithong P, 2013, J MATERN-FETAL NEO M, V26, P1568, DOI 10.3109/14767058.2013.783811; Cheng W, 2014, VASC PHARMACOL, V63, P135, DOI 10.1016/j.vph.2014.10.004; Choi JW, 2006, CLIN CHIM ACTA, V365, P113, DOI 10.1016/j.cca.2005.08.004; Choi JW, 2005, ANN HEMATOL, V84, P728, DOI 10.1007/s00277-005-1077-6; Choi JW, 2004, ANN CLIN LAB SCI, V34, P400; Corazza N, 2009, ANN NY ACAD SCI, V1171, P50, DOI 10.1111/j.1749-6632.2009.04905.x; Davenport C, 2012, EUR J CLIN INVEST, V42, P1173, DOI 10.1111/j.1365-2362.2012.02703.x; Deftereos S, 2012, HEART, V98, P214, DOI 10.1136/heartjnl-2011-300339; Di Bartolo BA, 2011, DIABETOLOGIA, V54, P3157, DOI 10.1007/s00125-011-2308-0; Genc S, 2009, NEUROL SCI, V30, P263, DOI 10.1007/s10072-009-0047-5; Guicciardi ME, 2009, FASEB J, V23, P1625, DOI 10.1096/fj.08-111005; Harith HH, 2013, TRENDS ENDOCRIN MET, V24, P578, DOI 10.1016/j.tem.2013.07.001; Hofbauer LC, 2006, RHEUMATOLOGY, V45, P1218, DOI 10.1093/rheumatology/kel108; Holven KB, 2014, ATHEROSCLEROSIS, V233, P561, DOI 10.1016/j.atherosclerosis.2014.01.022; Kang S, 2010, ENDOCRINOLOGY, V151, P5638, DOI 10.1210/en.2009-0478; Kawano N, 2011, DIABETES RES CLIN PR, V91, P316, DOI 10.1016/j.diabres.2010.11.034; Lamhamedi-Cherradi SE, 2003, DIABETES, V52, P2274, DOI 10.2337/diabetes.52.9.2274; Liabeuf S, 2010, NEPHROL DIAL TRANSPL, V25, P2596, DOI 10.1093/ndt/gfq042; Liu FF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087059; Lub-de Hooge MN, 2004, SHOCK, V22, P186, DOI 10.1097/01.shk.0000132486.82177.ec; Lub-de Hooge MN, 2005, ANN RHEUM DIS, V64, P854, DOI 10.1136/ard.2004.029058; Mariani SM, 1998, EUR J IMMUNOL, V28, P973, DOI 10.1002/(SICI)1521-4141(199803)28:03<973::AID-IMMU973>3.0.CO;2-T; Michowitz Y, 2005, J AM COLL CARDIOL, V45, P1018, DOI 10.1016/j.jacc.2004.12.065; Mori K, 2010, THROMB RES, V125, P322, DOI 10.1016/j.thromres.2009.11.024; Neve A, 2014, CLIN EXP MED, V14, P115, DOI 10.1007/s10238-012-0226-1; O'Sullivan EP, 2010, DIABETES-METAB RES, V26, P496, DOI 10.1002/dmrr.1109; Perik PJ, 2006, ACTA ONCOL, V45, P175, DOI 10.1080/02841860500482225; Schaefer U, 2007, FRONT BIOSCI, V12, P3813, DOI 10.2741/2354; Secchiero P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004442; Tecchio C, 2004, BLOOD, V103, P3837, DOI 10.1182/blood-2003-08-2806; Tornese G, 2014, ACTA DIABETOL, V51, P239, DOI 10.1007/s00592-013-0507-5; Yalcin AD, 2012, MED SCI MONITOR, V18, pPI11, DOI 10.12659/MSM.882504; Yan XH, 2009, IMMUNOGENETICS, V61, P551, DOI 10.1007/s00251-009-0389-4	39	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144015	10.1371/journal.pone.0144015	http://dx.doi.org/10.1371/journal.pone.0144015			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633016	gold, Green Published, Green Submitted			2022-12-27	WOS:000366040000043
J	Fujiwara, Y; Kobayashi, S; Nagano, H; Kanai, M; Hatano, E; Toyoda, M; Ajiki, T; Takashima, Y; Yoshimura, K; Hamada, A; Minami, H; Ioka, T				Fujiwara, Yutaka; Kobayashi, Shogo; Nagano, Hiroaki; Kanai, Masashi; Hatano, Etsuo; Toyoda, Masanori; Ajiki, Tetsuo; Takashima, Yuki; Yoshimura, Kenichi; Hamada, Akinobu; Minami, Hironobu; Ioka, Tatsuya			Pharmacokinetic Study of Adjuvant Gemcitabine Therapy for Biliary Tract Cancer following Major Hepatectomy (KHBO1101)	PLOS ONE			English	Article							CHEMOTHERAPY IMPROVES SURVIVAL; PHASE-II; HILAR CHOLANGIOCARCINOMA; NUCLEOSIDE TRANSPORTERS; LIVER-REGENERATION; CARCINOMA; CISPLATIN; MULTICENTER; RESECTION; PLASMA	Background Biliary tract cancer (BTC) patients who have undergone surgical resection with major hepatectomy cannot tolerate the standard gemcitabine regimen (1,000 mg/m(2) on days 1, 8, and 15 every 4 weeks) due to severe toxicities such as myelosuppression. Our dose-finding study of adjuvant gemcitabine therapy for biliary tract cancer following major hepatectomy determined that the recommended dose is 1,000 mg/m(2) on days 1 and 15 every 4 weeks. Here, we evaluate the pharmacokinetics and pharmacodynamics of gemcitabine in these subjects. Methods We evaluated BTC patients scheduled to undergo surgical resection with major hepatectomy followed by gemcitabine therapy. A pharmacokinetic evaluation of gemcitabine and its main metabolite, 2',2'-difluorodeoxyuridine (dFdU), was conducted at the initial administration of gemcitabine, which was given by intravenous infusion over 30 min at a dose of 800-1,000 mg/m(2). Physical examination and adverse events were monitored for 12 weeks. Results Thirteen patients were enrolled from August 2011 to January 2013, with 12 ultimately completing the pharmacokinetic study. Eight patients had hilar cholangiocarcinoma, three had intrahepatic cholangiocarcinoma, and one had superficial spreading type cholangiocarcinoma. The median interval from surgery to first administration of gemcitabine was 65.5 days (range, 43-83 days). We observed the following toxicities: neutropenia (n = 11, 91.7%), leukopenia (n = 10, 83.3%), thrombocytopenia (n = 6, 50.0%), and infection (n = 5, 41.7%). Grade 3 or 4 neutropenia was observed in 25% (n = 3) of patients. There were differences in clearance of gemcitabine and dFdU between our subjects and the subjects who had not undergone hepatectomy. Conclusion Major hepatectomy did not affect the pharmacokinetics of gemcitabine or dFdU.	[Fujiwara, Yutaka; Toyoda, Masanori; Minami, Hironobu] Kobe Univ, Grad Sch Med, Div Med Oncol & Hematol, Kobe, Hyogo 657, Japan; [Fujiwara, Yutaka] Natl Canc Ctr, Dept Expt Therapeut, Exploratory Oncol Res & Clin Trial Ctr, Tokyo, Japan; [Kobayashi, Shogo; Nagano, Hiroaki] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Suita, Osaka, Japan; [Kanai, Masashi] Kyoto Univ Hosp, Outpatient Oncol Unit, Kyoto 606, Japan; [Hatano, Etsuo] Kyoto Univ Hosp, Grad Sch Med, Dept Surg, Kyoto 606, Japan; [Ajiki, Tetsuo] Kobe Univ, Grad Sch Med, Dept Surg, Div Hepatobiliary Pancreat Surg, Kobe, Hyogo 657, Japan; [Takashima, Yuki; Hamada, Akinobu] Natl Canc Ctr, Res Inst, Dept Clin Pharmacol, Fundamental Innovat Oncol Core, Tokyo 104, Japan; [Yoshimura, Kenichi] Kanazawa Univ, Innovat Clin Res Ctr, Kanazawa, Ishikawa, Japan; [Ioka, Tatsuya] Osaka Med Ctr Canc & Cardiovasc Dis, Hepatobiliary & Pancreat Oncol, Osaka, Japan	Kobe University; National Cancer Center - Japan; Osaka University; Kyoto University; Kyoto University; Kobe University; National Cancer Center - Japan; Kanazawa University; Osaka Medical Center for Cancer & Cardiovascular Diseases	Fujiwara, Y (corresponding author), Kobe Univ, Grad Sch Med, Div Med Oncol & Hematol, Kobe, Hyogo 657, Japan.	yutakafu@ncc.go.jp	Hatano, Etsuro/AAX-2407-2020; Fujiwara, Yutaka/ABB-4863-2020	Hatano, Etsuro/0000-0003-3407-1918; Fujiwara, Yutaka/0000-0001-6981-0800; Minami, Hironobu/0000-0001-8630-9145	Eli Lilly; Taiho; Yakult	Eli Lilly(Eli Lilly); Taiho; Yakult	The authors have the following interests: Y. Fujiwara has received research funding from Eli Lilly. M. Kanai has received research funding from Taiho. E. Hatano has received research funding from Eli Lilly. T. Ioka has received research funding from Taiho and Yakult and has honoraria from Eli Lilly, Taiho, and Yakult. The research funding from Eli Lilly, Taiho and Yakult does not relate to this study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials as detailed online in the guide for authors.	ABBRUZZESE JL, 1991, J CLIN ONCOL, V9, P491, DOI 10.1200/JCO.1991.9.3.491; Andre T, 2004, ANN ONCOL, V15, P1339, DOI 10.1093/annonc/mdh351; Baldwin SA, 1999, MOL MED TODAY, V5, P216, DOI 10.1016/S1357-4310(99)01459-8; Bapiro TE, 2011, CANCER CHEMOTH PHARM, V68, P1243, DOI 10.1007/s00280-011-1613-0; BISMUTH H, 1992, ANN SURG, V215, P31, DOI 10.1097/00000658-199201000-00005; Ducreux M, 2005, EUR J CANCER, V41, P398, DOI 10.1016/j.ejca.2004.10.026; Ebrahem Q, 2012, ONCOTARGET, V3, P1137, DOI 10.18632/oncotarget.597; Eckel F, 2007, BRIT J CANCER, V96, P896, DOI 10.1038/sj.bjc.6603648; Furuse J, 2008, J HEPATO-BILIARY-PAN, V15, P463, DOI 10.1007/s00534-008-1358-2; Furuse J, 2008, CANCER CHEMOTH PHARM, V62, P849, DOI 10.1007/s00280-007-0673-7; Gallardo JO, 2001, ANN ONCOL, V12, P1403, DOI 10.1023/A:1012543223020; Goto T, 2009, BRIT J SURG, V96, P4; Hata S, 2004, LIVER TRANSPLANT, V10, P65, DOI 10.1002/lt.20006; Hatano E, 2009, J JAPAN SURG SOC; Japan EL, 2013, COMMUNICATION, P10; Jarnagin WR, 2001, ANN SURG, V234, P507, DOI 10.1097/00000658-200110000-00010; Kobayashi S, 2014, CANCER CHEMOTH PHARM, V74, P699, DOI 10.1007/s00280-014-2543-4; Kume M, 2009, 47 ANN M JAP SOC CLI; Leonard GD, 2005, EXPERT OPIN PHARMACO, V6, P211, DOI 10.1517/14656566.6.2.211; Mackey JR, 1998, CANCER RES, V58, P4349; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Murakami Y, 2009, ANN SURG, V250, P950, DOI 10.1097/SLA.0b013e3181b0fc8b; Murakami Y, 2009, J GASTROINTEST SURG, V13, P1470, DOI 10.1007/s11605-009-0900-0; Nagakawa Takukazu, 2002, J Hepatobiliary Pancreat Surg, V9, P569, DOI 10.1007/s005340200076; Nakagami M, 1998, TRANSPLANT P, V30, P195, DOI 10.1016/S0041-1345(97)01229-3; Oh SH, 2007, GASTROENTEROLOGY, V132, P1077, DOI 10.1053/j.gastro.2007.01.001; Okusaka T, 2010, BRIT J CANCER, V103, P469, DOI 10.1038/sj.bjc.6605779; Rao S, 2005, BRIT J CANCER, V92, P1650, DOI 10.1038/sj.bjc.6602576; Sugiyama E, 2007, J CLIN ONCOL, V25, P32, DOI 10.1200/JCO.2006.06.7405; Takahara T, 2012, CANCER CHEMOTH PHARM, V69, P1127, DOI 10.1007/s00280-011-1805-7; Thongprasert S, 2005, ANN ONCOL, V16, P279, DOI 10.1093/annonc/mdi046; Tsavaris N, 2004, INVEST NEW DRUG, V22, P193, DOI 10.1023/B:DRUG.0000011797.09549.53; Valle J, 2010, NEW ENGL J MED, V362, P1273, DOI 10.1056/NEJMoa0908721; Xu Y, 2004, J CHROMATOGR B, V802, P263, DOI 10.1016/j.jchromb.2003.11.038	34	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143072	10.1371/journal.pone.0143072	http://dx.doi.org/10.1371/journal.pone.0143072			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633034	Green Published, Green Submitted, gold			2022-12-27	WOS:000366040000008
J	Davis, WT; Drymon, JM; Powers, SP				Davis, William T.; Drymon, J. Marcus; Powers, Sean P.			Spatial and Dietary Overlap Creates Potential for Competition between Red Snapper (Lutjanus campechanus) and Vermilion snapper (Rhomboplites aurorubens)	PLOS ONE			English	Article							REEF; FISHERIES; MANAGEMENT; PERFORMANCE; MORTALITY; ECOLOGY; HABITAT; GROWTH; AGE	Understanding the complex nature of direct and indirect species interactions is a critical precursor to successful resource management. In the northern Gulf of Mexico fisheries ecosystem, red snapper (Lutjanus campechanus) and vermilion snapper (Rhomboplites aurorubens) are two commercially harvested species within a larger reef fish complex. These two species share similar habitats and diets; however, little is known about how these species partition habitat and dietary resources. In this study we examined the extent of spatial and dietary overlap between red snapper and vermilion snapper, and experimentally compared their feeding behavior. Field data from multiple gear types demonstrates that red snapper and vermilion snapper frequently cohabited reefs in the northern Gulf of Mexico, and Pianka's niche overlap indices suggest significantly overlapping diets. Experimental manipulations show that red snapper are the dominant forager of the two species, as red snapper foraging alone ate more shrimp per fish than vermilion snapper in both the single species (p = 0.003) and mixed species (p = 0.02) treatments. In addition, red snapper ate significantly more shrimp per fish in the mixed species treatment than in the single species treatment (p = 0.04). Vermilion snapper shrimp consumption per fish did not differ significantly between mixed and single species treatments. Cumulatively, our results suggest that spatial and dietary overlap could lead to competition between red and vermilion snapper in the study area; however, conclusively determining the existence of such competition would require further research.	[Davis, William T.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Drymon, J. Marcus; Powers, Sean P.] Univ S Alabama, Dept Marine Sci, Mobile, AL 36688 USA; [Drymon, J. Marcus; Powers, Sean P.] Dauphin Isl Sea Lab, Ctr Ecosyst Based Fishery Management, Dauphin Isl, AL 36528 USA	Princeton University; University of South Alabama; Dauphin Island Sea Lab	Drymon, JM (corresponding author), Univ S Alabama, Dept Marine Sci, LSCB Room 25, Mobile, AL 36688 USA.	mdrymon@disl.org		Powers, Sean/0000-0002-4770-9944	National Oceanic and Atmospheric Administration (NOAA) Fisheries Marine Fisheries Initiative (MARFIN) program [NOAA-NMFS-SE-2010-2001772]	National Oceanic and Atmospheric Administration (NOAA) Fisheries Marine Fisheries Initiative (MARFIN) program	This work was funded through a grant from the National Oceanic and Atmospheric Administration (NOAA) Fisheries Marine Fisheries Initiative (MARFIN) program (grant number NOAA-NMFS-SE-2010-2001772) to SPP. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaumariage D. S., 1966, FLA STATE BOARD CONS; Botsford LW, 1997, SCIENCE, V277, P509, DOI 10.1126/science.277.5325.509; Chipps Steven R., 2007, P473; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; Coleman FC, 2000, FISHERIES, V25, P14, DOI 10.1577/1548-8446(2000)025<0014:LRF>2.0.CO;2; Connell JH, 1975, ECOLOGY EVOLUTION CO, V460, P490; Dance MA, 2011, B MAR SCI, V87, P301, DOI 10.5343/bms.2010.1040; FABLE WA, 1980, CONTRIB MAR SCI, V23, P115; Fodrie FJ, 2008, ECOLOGY, V89, P3268, DOI 10.1890/07-1679.1; Geers T. M., 2014, DEEP SEA RES 2; Gotelli N. J., 2015, ECOSIMR NULL MODEL A, DOI 10.5281/zenodo.16522; Gregalis KC, 2012, T AM FISH SOC, V141, P1453, DOI 10.1080/00028487.2012.703154; GRIMES CB, 1982, B MAR SCI, V32, P277; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; Hixon MA, 2006, ECOLOGY OF MARINE FISHES: CALIFORNIA AND ADJACENT WATERS, P449; Johnson MW, 2010, T AM FISH SOC, V139, P1136, DOI 10.1577/T09-179.1; Lindberg WJ, 2006, ECOL APPL, V16, P731, DOI 10.1890/1051-0761(2006)016[0731:DHSAPB]2.0.CO;2; Link JS, 2002, FISHERIES, V27, P18; McCawley JR, 2007, POPULATION ECOLOGY F, P77; NMFS, 2013, EC PROGR; Pianka E.R., 1976, P114; Saari CR, 2014, FISH B-NOAA, V112, P261, DOI 10.7755/FB.112.4.3; Sabo JL, 1997, CAN J FISH AQUAT SCI, V54, P2609, DOI 10.1139/cjfas-54-11-2609; SALE PF, 1977, AM NAT, V111, P337, DOI 10.1086/283164; Schobernd ZH, 2014, CAN J FISH AQUAT SCI, V71, P464, DOI 10.1139/cjfas-2013-0086; Sih A, 1998, TRENDS ECOL EVOL, V13, P350, DOI 10.1016/S0169-5347(98)01437-2; Simons JD, 2013, B MAR SCI, V89, P135, DOI 10.5343/bms.2011.1130; Simonsen KA, 2015, ENVIRON BIOL FISH, V98, P811, DOI 10.1007/s10641-014-0317-9; Stoner AW, 2008, CAN J FISH AQUAT SCI, V65, P1230, DOI 10.1139/F08-032; Szedlmayer ST, 2004, FISH B-NOAA, V102, P366; Tarnecki JH, 2015, MAR COAST FISH, V7, P135, DOI 10.1080/19425120.2015.1020402; Topping DT, 2011, FISH RES, V112, P77, DOI 10.1016/j.fishres.2011.08.013; Travis J, 2014, P NATL ACAD SCI USA, V111, P581, DOI 10.1073/pnas.1305853111; Waters JR, 1996, EC SUMMARY COMMERCIA, P63; Wells RJD, 2008, MAR ECOL PROG SER, V361, P213, DOI 10.3354/meps07425; Wells RJD, 2007, AM FISH S S, V60, P39	36	10	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144051	10.1371/journal.pone.0144051	http://dx.doi.org/10.1371/journal.pone.0144051			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630481	Green Submitted, Green Published, gold			2022-12-27	WOS:000365926300149
J	Mishra, S; Jakkala, K; Srinivasan, R; Arumugam, M; Ranjeri, R; Gupta, P; Rajeswari, H; Ajitkumar, P				Mishra, Saurabh; Jakkala, Kishor; Srinivasan, Ramanujam; Arumugam, Muthu; Ranjeri, Raghavendra; Gupta, Prabuddha; Rajeswari, Haryadi; Ajitkumar, Parthasarathi			NDK Interacts with FtsZ and Converts GDP to GTP to Trigger FtsZ Polymerisation - A Novel Role for NDK	PLOS ONE			English	Article							NUCLEOSIDE-DIPHOSPHATE KINASE; DIVISION PROTEIN FTSZ; MYCOBACTERIUM-TUBERCULOSIS FTSZ; MICROTUBULE ASSEMBLY INVITRO; BETA-GAMMA DIMERS; ESCHERICHIA-COLI; CELL-DIVISION; BACILLUS-SUBTILIS; PSEUDOMONAS-AERUGINOSA; NUCLEOTIDE-BINDING	Introduction Nucleoside diphosphate kinase (NDK), conserved across bacteria to humans, synthesises NTP from NDP and ATP. The eukaryotic homologue, the NDPK, uses ATP to phosphorylate the tubulin-bound GDP to GTP for tubulin polymerisation. The bacterial cytokinetic protein FtsZ, which is the tubulin homologue, also uses GTP for polymerisation. Therefore, we examined whether NDK can interact with FtsZ to convert FtsZ-bound GDP and/or free GDP to GTP to trigger FtsZ polymerisation. Methods Recombinant and native NDK and FtsZ proteins of Mycobacterium smegmatis and Mycobacterium tuberculosis were used as the experimental samples. FtsZ polymersation was monitored using 90 degrees light scattering and FtsZ polymer pelleting assays. The gamma 32P-GTP synthesised by NDK from GDP and gamma 32P-ATP was detected using thin layer chromatography and quantitated using phosphorimager. The FtsZ bound P-32-GTP was quantitated using phosphorimager, after UV-crosslinking, followed by SDS-PAGE. The NDK-FtsZ interaction was determined using Ni2+-NTA-pulldown assay and co-immunoprecipitation of the recombinant and native proteins in vitro and ex vivo, respectively. Results NDK triggered instantaneous polymerisation of GDP-precharged recombinant FtsZ in the presence of ATP, similar to the polymerisation of recombinant FtsZ (not GDP-precharged) upon the direct addition of GTP. Similarly, NDK triggered polymerisation of recombinant FtsZ (not GDP-precharged) in the presence of free GDP and ATP as well. Mutant NDK, partially deficient in GTP synthesis from ATP and GDP, triggered low level of polymerisation of MsFtsZ, but not of MtFtsZ. As characteristic of NDK's NTP substrate non-specificity, it used CTP, TTP, and UTP also to convert GDP to GTP, to trigger FtsZ polymerisation. The NDK of one mycobacterial species could trigger the polymerisation of the FtsZ of another mycobacterial species. Both the recombinant and the native NDK and FtsZ showed interaction with each other in vitro and ex vivo, alluding to the possibility of direct phosphorylation of FtsZ-bound GDP by NDK. Conclusion Irrespective of the bacterial species, NDK interacts with FtsZ in vitro and ex vivo and, through the synthesis of GTP from FtsZ-bound GDP and/or free GDP, and ATP (CTP/TTP/UTP), triggers FtsZ polymerisation. The possible biological context of this novel activity of NDK is presented.	[Mishra, Saurabh; Jakkala, Kishor; Srinivasan, Ramanujam; Arumugam, Muthu; Ranjeri, Raghavendra; Gupta, Prabuddha; Rajeswari, Haryadi; Ajitkumar, Parthasarathi] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Ajitkumar, P (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	ajitkpartha@gmail.com	Muthu, Arumugam/AGO-2371-2022; Muthu, Arumugam/G-3336-2018; MISHRA, SAURABH/N-5686-2017; Srinivasan, Ramanujam/AAY-7779-2021	Muthu, Arumugam/0000-0003-4697-6925; Muthu, Arumugam/0000-0003-4697-6925; MISHRA, SAURABH/0000-0003-1590-884X; Srinivasan, Ramanujam/0000-0001-8071-6110; Gupta, Prabuddha/0000-0003-1009-2781	Indian Council of Medical Research, Government of India [63/72/2001-BMS]; DBT Programme Support - Pathogen Biology; UGC-CAS; DST-FIST; CSIR SRF; DBT-RA; DBT	Indian Council of Medical Research, Government of India(Indian Council of Medical Research (ICMR)); DBT Programme Support - Pathogen Biology; UGC-CAS(University Grants Commission, IndiaChinese Academy of Sciences); DST-FIST(Department of Science & Technology (India)); CSIR SRF(Council of Scientific & Industrial Research (CSIR) - India); DBT-RA; DBT(Department of Biotechnology (DBT) India)	Funded by Research grant (63/72/2001-BMS) from the Indian Council of Medical Research, Government of India, to PA; DBT-funded Centre of Excellence in Tuberculosis Research, to PA; DBT Programme Support - Pathogen Biology - to Biological Sciences Division, Indian Institute of Science; UGC-CAS, and DST-FIST support to the MCB Dep't., Indian Institute of Science; CSIR SRF to SM; DBT-RA to RR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admiraal SJ, 1999, BIOCHEMISTRY-US, V38, P4701, DOI 10.1021/bi9827565; Anderson DE, 2004, J BACTERIOL, V186, P5775, DOI 10.1128/JB.186.17.5775-5781.2004; Arumugam M., 2009, THESIS; Arumugam M, 2013, ACTA BIOCHIM POL, V60, P199; Arumugam Muthu, 2012, Open Biochem J, V6, P71, DOI 10.2174/1874091X01206010071; BERG P, 1953, NATURE, V172, P1008, DOI 10.1038/1721008a0; Bernard MA, 2000, J BIOENERG BIOMEMBR, V32, P259, DOI 10.1023/A:1005537013120; Bilitou A, 2009, MOL CELL BIOCHEM, V329, P17, DOI 10.1007/s11010-009-0121-6; Boissan M, 2014, SCIENCE, V344, P1510, DOI 10.1126/science.1253768; BOMINAAR AA, 1993, EMBO J, V12, P2275, DOI 10.1002/j.1460-2075.1993.tb05881.x; BRAMHILL D, 1994, P NATL ACAD SCI USA, V91, P5813, DOI 10.1073/pnas.91.13.5813; BURNS RG, 1981, EUR J BIOCHEM, V117, P515; CASHEL M, 1969, J CHROMATOGR, V40, P103, DOI 10.1016/S0021-9673(01)96624-5; Chen Y, 2007, J BIOL CHEM, V282, P27736, DOI 10.1074/jbc.M703788200; Chen YD, 2005, J BIOL CHEM, V280, P22549, DOI 10.1074/jbc.M500895200; Chen YX, 2002, PROTEINS, V47, P556, DOI 10.1002/prot.10113; Cuello F, 2003, J BIOL CHEM, V278, P7220, DOI 10.1074/jbc.M210304200; DEBOER P, 1992, NATURE, V359, P254, DOI 10.1038/359254a0; Dziadek J, 2002, MICROBIOL-SGM, V148, P961, DOI 10.1099/00221287-148-4-961; Erickson HP, 1996, J CELL BIOL, V135, P5, DOI 10.1083/jcb.135.1.5; Feucht A, 2005, MICROBIOL-SGM, V151, P2053, DOI 10.1099/mic.0.27899-0; FREESE E, 1979, J GEN MICROBIOL, V115, P193, DOI 10.1099/00221287-115-1-193; Gandhi VV, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002078; GASKIN F, 1974, J MOL BIOL, V89, P737, DOI 10.1016/0022-2836(74)90048-5; Georgescauld F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057867; Gupta P, 2009, THESIS; Gupta P, 2008, BIOCHEM BIOPH RES CO, V368, P445, DOI 10.1016/j.bbrc.2008.01.115; Gupta P, 2010, ACTA BIOCH BIOPH SIN, V42, P58, DOI 10.1093/abbs/gmp105; Haeusser DP, 2004, MOL MICROBIOL, V52, P801, DOI 10.1111/j.1365-2958.2004.04016.x; Huecas S, 2004, FEBS LETT, V569, P43, DOI 10.1016/j.febslet.2004.05.048; Huecas S, 2003, J BIOL CHEM, V278, P46146, DOI 10.1074/jbc.M307128200; Huecas S, 2007, J BIOL CHEM, V282, P37515, DOI 10.1074/jbc.M706399200; HUITOREL P, 1984, EUR J BIOCHEM, V144, P233, DOI 10.1111/j.1432-1033.1984.tb08455.x; JACOBS M, 1979, EUR J BIOCHEM, V99, P613, DOI 10.1111/j.1432-1033.1979.tb13294.x; Janin J, 2000, J BIOENERG BIOMEMBR, V32, P215, DOI 10.1023/A:1005528811303; KADRMAS EF, 1991, BIOCHIM BIOPHYS ACTA, V1074, P339, DOI 10.1016/0304-4165(91)90083-S; Kapatral V, 2000, J BACTERIOL, V182, P1333, DOI 10.1128/JB.182.5.1333-1339.2000; KIKKAWA S, 1990, J BIOL CHEM, V265, P21536; Kim YJ, 2014, INFECT IMMUN, V82, P3252, DOI 10.1128/IAI.02007-14; KIMURA N, 1990, BIOCHEM BIOPH RES CO, V168, P99, DOI 10.1016/0006-291X(90)91680-Q; Kirkpatrick CL, 2011, CURR OPIN MICROBIOL, V14, P691, DOI 10.1016/j.mib.2011.09.011; KOWLURU A, 1994, BIOCHEMISTRY-US, V33, P12495, DOI 10.1021/bi00207a017; KREBS HA, 1953, BIOCHIM BIOPHYS ACTA, V12, P172, DOI 10.1016/0006-3002(53)90136-X; Krishnan KS, 2001, NEURON, V30, P197, DOI 10.1016/S0896-6273(01)00273-2; Kumar K, 2010, FUTURE MED CHEM, V2, P1305, DOI [10.4155/fmc.10.220, 10.4155/FMC.10.220]; Lacombe ML, 2000, J BIOENERG BIOMEMBR, V32, P247, DOI 10.1023/A:1005584929050; LECROISEY A, 1995, BIOCHEMISTRY-US, V34, P12445, DOI 10.1021/bi00038a043; Leung AKW, 2004, J MOL BIOL, V342, P953, DOI 10.1016/j.jmb.2004.07.061; LOPEZ JM, 1979, BIOCHIM BIOPHYS ACTA, V587, P238, DOI 10.1016/0304-4165(79)90357-X; Lu CL, 1998, CELL MOTIL CYTOSKEL, V40, P71, DOI 10.1002/(SICI)1097-0169(1998)40:1<71::AID-CM7>3.3.CO;2-Z; LU Q, 1995, J MOL BIOL, V254, P337, DOI 10.1006/jmbi.1995.0620; Mingorance J, 2001, MOL MICROBIOL, V41, P83, DOI 10.1046/j.1365-2958.2001.02498.x; MITANI T, 1977, BIOCHEM BIOPH RES CO, V77, P1118, DOI 10.1016/S0006-291X(77)80094-6; Mohammadi T, 2009, BIOCHEMISTRY-US, V48, P11056, DOI 10.1021/bi901461p; MORERA S, 1995, BIOCHEMISTRY-US, V34, P11062, DOI 10.1021/bi00035a011; Mukherjee A, 1999, J BACTERIOL, V181, P823, DOI 10.1128/JB.181.3.823-832.1999; MUKHERJEE A, 1994, J BACTERIOL, V176, P2754, DOI 10.1128/JB.176.9.2754-2758.1994; MUKHERJEE A, 1993, P NATL ACAD SCI USA, V90, P1053, DOI 10.1073/pnas.90.3.1053; Mukherjee A, 1998, EMBO J, V17, P462, DOI 10.1093/emboj/17.2.462; Mukhopadhyay S, 1997, J BIOL CHEM, V272, P17815, DOI 10.1074/jbc.272.28.17815; Neidhardt FC, 1990, PHYSL BACTERIAL CELL; Neuhard J, 1987, ESCHERICHIA COLI SAL, P445; NICKERSON JA, 1984, J BIOL CHEM, V259, P1297; Nogales E, 1998, NAT STRUCT BIOL, V5, P451, DOI 10.1038/nsb0698-451; OHTSUKI K, 1986, BIOCHIM BIOPHYS ACTA, V882, P322, DOI 10.1016/0304-4165(86)90254-0; Oliva MA, 2003, J BIOL CHEM, V278, P33562, DOI 10.1074/jbc.M303798200; Parks R.E., 1973, ENZYMES, V8, P307, DOI [10.1016/S1874-6047(08)60069-4, DOI 10.1016/S1874-6047(08)60069-4]; PENNINGROTH SM, 1977, J MOL BIOL, V115, P643, DOI 10.1016/0022-2836(77)90108-5; PLA J, 1991, MOL MICROBIOL, V5, P1681, DOI 10.1111/j.1365-2958.1991.tb01915.x; Raman K, 2009, MOL BIOSYST, V5, P1740, DOI [10.1039/B905817F, 10.1039/b905817f]; RAY NB, 1992, CURR TOP CELL REGUL, V33, P343; RAYCHAUDHURI D, 1992, NATURE, V359, P251, DOI 10.1038/359251a0; Rueda S, 2003, J BACTERIOL, V185, P3344, DOI 10.1128/JB.185.11.3344-3351.2003; Schaertl S, 1998, J BIOL CHEM, V273, P5662, DOI 10.1074/jbc.273.10.5662; Shankar S, 1997, MOL MICROBIOL, V24, P477, DOI 10.1046/j.1365-2958.1997.3491724.x; Small E, 2003, MICROBIOL-SGM, V149, P2235, DOI 10.1099/mic.0.26126-0; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Snider NT, 2015, N-S ARCH PHARMACOL, V388, P189, DOI 10.1007/s00210-014-1046-5; Stricker J, 2002, P NATL ACAD SCI USA, V99, P3171, DOI 10.1073/pnas.052595099; Sun J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003499; Sun J, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008769, 10.1371/journal.pone.0011351]; TEPPER AD, 1994, J BIOL CHEM, V269, P32175; Tiwari S, 2004, J BIOL CHEM, V279, P43595, DOI 10.1074/jbc.M401704200; Vaughan S, 2004, J MOL EVOL, V58, P19, DOI 10.1007/s00239-003-2523-5; White EL, 2000, J BACTERIOL, V182, P4028, DOI 10.1128/JB.182.14.4028-4034.2000; Wieland T, 2007, N-S ARCH PHARMACOL, V374, P373, DOI 10.1007/s00210-006-0126-6; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Zhu JH, 1999, P NATL ACAD SCI USA, V96, P14911, DOI 10.1073/pnas.96.26.14911	88	2	2	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143677	10.1371/journal.pone.0143677	http://dx.doi.org/10.1371/journal.pone.0143677			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630542	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000365926300080
J	Russell-Smith, J; Yates, CP; Edwards, AC; Whitehead, PJ; Murphy, BP; Lawes, MJ				Russell-Smith, Jeremy; Yates, Cameron P.; Edwards, Andrew C.; Whitehead, Peter J.; Murphy, Brett P.; Lawes, Michael J.			Deriving Multiple Benefits from Carbon Market-Based Savanna Fire Management: An Australian Example	PLOS ONE			English	Article							MONSOONAL NORTHERN AUSTRALIA; KAKADU NATIONAL-PARK; CALLITRIS-INTRATROPICA CUPRESSACEAE; TROPICAL SAVANNAS; SMALL MAMMALS; SENSITIVE VEGETATION; FREQUENCY MATTERS; SANDSTONE HEATH; LAND-MANAGEMENT; ARNHEM PLATEAU	Carbon markets afford potentially useful opportunities for supporting socially and environmentally sustainable land management programs but, to date, have been little applied in globally significant fire-prone savanna settings. While fire is intrinsic to regulating the composition, structure and dynamics of savanna systems, in north Australian savannas frequent and extensive late dry season wildfires incur significant environmental, production and social impacts. Here we assess the potential of market-based savanna burning greenhouse gas emissions abatement and allied carbon biosequestration projects to deliver compatible environmental and broader socio-economic benefits in a highly biodiverse north Australian setting. Drawing on extensive regional ecological knowledge of fire regime effects on fire-vulnerable taxa and communities, we compare three fire regime metrics (seasonal fire frequency, proportion of long-unburnt vegetation, fire patch-size distribution) over a 15-year period for three national parks with an indigenously (Aboriginal) owned and managed market-based emissions abatement enterprise. Our assessment indicates improved fire management outcomes under the emissions abatement program, and mostly little change or declining outcomes on the parks. We attribute improved outcomes and putative biodiversity benefits under the abatement program to enhanced strategic management made possible by the market-based mitigation arrangement. For these same sites we estimate quanta of carbon credits that could be delivered under realistic enhanced fire management practice, using currently available and developing accredited Australian savanna burning accounting methods. We conclude that, in appropriate situations, market-based savanna burning activities can provide transformative climate change mitigation, ecosystem health, and community benefits in northern Australia, and, despite significant challenges, potentially in other fire-prone savanna settings.	[Russell-Smith, Jeremy; Yates, Cameron P.; Edwards, Andrew C.; Whitehead, Peter J.] Charles Darwin Univ, Darwin Ctr Bushfires Res, Darwin, NT 0909, Australia; [Russell-Smith, Jeremy; Whitehead, Peter J.] North Australian Indigenous Land & Sea Management, Darwin, NT, Australia; [Russell-Smith, Jeremy; Yates, Cameron P.; Edwards, Andrew C.] Australian Natl Univ, Long Term Ecol Res Network, Canberra, ACT, Australia; [Murphy, Brett P.; Lawes, Michael J.] Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia	Charles Darwin University; Australian National University; Charles Darwin University	Russell-Smith, J (corresponding author), Charles Darwin Univ, Darwin Ctr Bushfires Res, Darwin, NT 0909, Australia.	jeremy.russell-smith@cdu.edu.au	Murphy, Brett Patrick/A-3991-2011; Lawes, Michael J/N-2132-2013	Murphy, Brett Patrick/0000-0002-8230-3069; Lawes, Michael J/0000-0002-2381-6147; Russell-Smith, Jeremy/0000-0003-1489-2866	Long-term Ecological Research Network, Australian National University, Canberra; Department of Environment, Government of Australia, Canberra	Long-term Ecological Research Network, Australian National University, Canberra; Department of Environment, Government of Australia, Canberra	This work was supported by the Long-term Ecological Research Network, Australian National University, Canberra, toJR-S, and by the Department of Environment (and predecessor agencies), Government of Australia, Canberra, to JR-S, CPY, ACE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen AN, 2012, AUSTRAL ECOL, V37, P658, DOI 10.1111/j.1442-9993.2011.02334.x; Barlow J, 2012, BIOL CONSERV, V154, P1, DOI 10.1016/j.biocon.2012.03.034; Barrow PH, 2008, ROLE FIRE ECOLOGY LE; Beringer J, 2015, GLOBAL CHANGE BIOL, V21, P62, DOI 10.1111/gcb.12686; Bond W. J., 1996, FIRE PLANTS, DOI DOI 10.2307/2404797; Bowman DMJS, 1998, NEW PHYTOL, V140, P385, DOI [10.1046/j.1469-8137.1998.00289.x, 10.1111/j.1469-8137.1998.00289.x]; BOWMAN DMJS, 1993, J BIOGEOGR, V20, P373, DOI 10.2307/2845586; Brazill-Boast J, 2011, EMU, V111, P304, DOI 10.1071/MU10064; Bureau of Meteorology (BoM), 2014, STAT CLIM 2014; Bustamante M, 2014, GLOBAL CHANGE BIOL, V20, P3270, DOI 10.1111/gcb.12591; CoA (Commonwealth of Australia), 2015, CARB CRED CARB FARM; CoA (Commonwealth of Australia), 2015, EM RED FUND; CoA (Commonwealth of Australia), 2012, CARB FARM RED GREENH; CoA (Commonwealth of Australia), 2012, NAT PROT AMH PLAT SA; Cochrane MA, 1999, SCIENCE, V284, P1832, DOI 10.1126/science.284.5421.1832; Cook G. D., 2009, Culture, ecology and economy of fire management in North Australian savannas: rekindling the Wurrk tradition, P313; Cook GD, 2015, CARBON ACCOUNTING AND SAVANNA FIRE MANAGEMENT, P321; Djoeroemana S, 2007, INTEGRATED RURAL DEV; Dyer R., 2001, SAVANNA BURNING UNDE; Edwards A, 2015, INT J WILDLAND FIRE; Edwards AC, 2015, CARBON ACCOUNTING AND SAVANNA FIRE MANAGEMENT, P169; Edwards AC, 2009, INT J WILDLAND FIRE, V18, P127, DOI 10.1071/WF08008; Fahey TJ, 2010, FRONT ECOL ENVIRON, V8, P245, DOI 10.1890/080169; FAO, 2007, 151 FAO UN; Firth RSC, 2010, BIOL CONSERV, V143, P1193, DOI 10.1016/j.biocon.2010.02.027; Fisher R, 2015, CARBON ACCOUNTING AND SAVANNA FIRE MANAGEMENT, P57; Fox J, 2009, HUM ECOL, V37, P305, DOI 10.1007/s10745-009-9240-7; Franklin DC, 1999, BIOL CONSERV, V90, P53, DOI 10.1016/S0006-3207(99)00010-5; Fraser F, 2003, ECOLOGICAL MANAGEMEN, V4; Fui LH, 2012, WORLD FORESTS, V12, P357, DOI 10.1007/978-94-007-2144-9_10; Garde M, 2009, MANAGING FIRE REGIME, P86; Gardner TA, 2012, BIOL CONSERV, V154, P61, DOI 10.1016/j.biocon.2011.11.018; George M., 2014, RESPECT CENTRAL ROLE; Grace J, 2006, J BIOGEOGR, V33, P387, DOI 10.1111/j.1365-2699.2005.01448.x; Griffiths AD, 2015, BIOL CONSERV, V186, P337, DOI 10.1016/j.biocon.2015.03.021; Hoffmann WA, 2012, ECOL LETT, V15, P759, DOI 10.1111/j.1461-0248.2012.01789.x; Johnston FH, 2002, MED J AUSTRALIA, V176, P535, DOI 10.5694/j.1326-5377.2002.tb04551.x; Kerins S., 2012, PEOPLE COUNTRY VITAL, P26; Lawes MJ, 2011, OECOLOGIA, V166, P229, DOI 10.1007/s00442-010-1829-4; Lawes MJ, 2015, INT J WILDLAND FIRE, V24, P712, DOI 10.1071/WF14163; Lawrence D, 2000, KAKADU MAKING NATL P; Le Quere C, 2013, EARTH SYST SCI DATA, V5, P165, DOI 10.5194/essd-5-165-2013; Legge S, 2008, WILDLIFE RES, V35, P33, DOI 10.1071/WR07016; Lehmann CER, 2014, SCIENCE, V343, P548, DOI 10.1126/science.1247355; Lowe L, 1995, J ORTHOPTERA RES; Lyster R, 2011, ENVIRON SCI POLICY, V14, P118, DOI 10.1016/j.envsci.2010.11.008; McLean I, 2014, BCOM0348 MEAT LIV AU; Mertz O, 2009, HUM ECOL, V37, P281, DOI 10.1007/s10745-009-9249-y; Meyer CP, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD017671; Muradian R, 2010, ECOL ECON, V69, P1202, DOI 10.1016/j.ecolecon.2009.11.006; Murphy B.P., 2009, MANAGING FIRE REGIME; Murphy BP, 2015, J APPL ECOL, V52, P980, DOI 10.1111/1365-2664.12455; Murphy BP, 2010, GLOBAL CHANGE BIOL, V16, P331, DOI 10.1111/j.1365-2486.2009.01933.x; NLAWT (Northern Australia Land and Water Taskforce), 2009, SUST DEV NO AUSTR; Oliveira SLJ, 2015, FIRE ECOLOGY, V11; Pardon LG, 2003, J ANIM ECOL, V72, P106, DOI 10.1046/j.1365-2656.2003.00686.x; Pfeifer M, 2013, ENVIRON CONSERV, V40, P241, DOI 10.1017/S0376892912000379; Price O, 2003, INT J WILDLAND FIRE, V12, P227, DOI 10.1071/WF03040; Price OF, 2012, INT J WILDLAND FIRE, V21, P297, DOI 10.1071/WF10079; Prior LD, 2007, ECOL RES, V22, P228, DOI 10.1007/s11284-006-0011-2; Radford IJ, 2012, AUSTRAL ECOL, V37, P926, DOI 10.1111/j.1442-9993.2011.02352.x; Rands MRW, 2010, SCIENCE, V329, P1298, DOI 10.1126/science.1189138; Reside AE, 2012, DIVERS DISTRIB, V18, P213, DOI 10.1111/j.1472-4642.2011.00818.x; Ritchie D, 2009, CULTURE ECOLOGY EC S; Russell-Smith J, 1998, J APPL ECOL, V35, P829, DOI 10.1111/j.1365-2664.1998.tb00002.x; Russell-Smith J, 2003, INT J WILDLAND FIRE, V12, P283, DOI 10.1071/WF03015; Russell-Smith J, 2002, BIOL CONSERV, V104, P91, DOI 10.1016/S0006-3207(01)00157-4; Russell-Smith J, 2013, CLIMATIC CHANGE, V121, P1; Russell-Smith J, 2014, BIODIVERSITY ENV CHA, P335; Russell-Smith J, 2009, INT J WILDLAND FIRE, V18, P1, DOI 10.1071/WF08009; Russell-Smith J, 2007, INT J WILDLAND FIRE, V16, P361, DOI 10.1071/WF07018; Russell-Smith J, 2006, INT J WILDLAND FIRE, V15, P551, DOI 10.1071/WF05112; Russell-Smith J, 2006, INT J WILDLAND FIRE, V15, P541, DOI 10.1071/WF05111; Russell-Smith J, 2006, AUST J BOT, V54, P479, DOI 10.1071/BT05133; Russell-Smith J, 2013, FRONT ECOL ENVIRON, V11, pE55, DOI 10.1890/120251; Russell-Smith J, 2012, J BIOGEOGR, V39, P1303, DOI 10.1111/j.1365-2699.2012.02679.x; Russell-Smith J, 2010, ECOL APPL, V20, P1615, DOI 10.1890/09-1553.1; RUSSELLSMITH J, 1992, BIOL CONSERV, V59, P51, DOI 10.1016/0006-3207(92)90713-W; RussellSmith J, 1997, J APPL ECOL, V34, P748, DOI 10.2307/2404920; Sankaran M., 2013, ENCY BIODIVERSITY, P58, DOI DOI 10.1016/B978-0-12-384719-5.00355-5; Setterfield SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059144; Setterfield SA, 2010, DIVERS DISTRIB, V16, P854, DOI 10.1111/j.1472-4642.2010.00688.x; Skroblin A, 2013, EMU, V113, P309, DOI 10.1071/MU12075; SoE, 2011, AUSTR STAT ENV 2011; Standard) VVC, 2015, VM0029 METH AV FOR D; Tacconi L, 2003, 38 CIFOR; Townsend SA, 2000, J HYDROL, V229, P118, DOI 10.1016/S0022-1694(00)00165-7; UN, 1997, REP C PART ITS 21 SE; UNFCCC (United Nations Framework Convention on Climate Change), 2005, FCCCKPCMP20058; van der Werf GR, 2010, ATMOS CHEM PHYS, V10, P11707, DOI 10.5194/acp-10-11707-2010; van Vliet N, 2012, GLOBAL ENV CHANGE, V22; Walsh D, 2014, RANGELAND J, V36, P313, DOI 10.1071/RJ13122; Williams M.A.J., 1991, MONSOONAL AUSTR LAND, P5; Williams Richard J., 2002, P281; Williams RJ, 1999, AUST J ECOL, V24, P50, DOI 10.1046/j.1442-9993.1999.00946.x; Williams RJ, 1998, INT J WILDLAND FIRE, V8, P227, DOI 10.1071/WF9980227; Woinarski J, 2007, NATURE OF NORTHERN AUSTRALIA: NATURAL VALUES, ECOLOGICAL PROCESSES AND FUTURE PROSPECTS, P1; Woinarski JCZ, 2013, EMU, V113, P319, DOI 10.1071/MU12109; Woinarski JCZ, 2010, WILDLIFE RES, V37, P116, DOI 10.1071/WR09125; Woinarski J. C. Z., 2014, STRATEGY CONSERVATIO; Woinarski JCZ, 2005, WILDLIFE RES, V32, P377, DOI 10.1071/WR03008; Woinarski JCZ, 2001, AUSTRAL ECOL, V26, P360, DOI 10.1046/j.1442-9993.2001.01121.x; Woinarski JCZ, 1992, CONSERVATION STATUS; Woinarski JCZ, 2011, CONSERV LETT, V4, P192, DOI 10.1111/j.1755-263X.2011.00164.x; Yates CP, 2008, INT J WILDLAND FIRE, V17, P768, DOI 10.1071/WF07150; Yibarbuk D, 2001, J BIOGEOGR, V28, P325, DOI 10.1046/j.1365-2699.2001.00555.x; Ziembicki Mark R., 2015, Therya, V6, P169, DOI 10.12933/therya-15-236	107	49	49	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143426	10.1371/journal.pone.0143426	http://dx.doi.org/10.1371/journal.pone.0143426			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630453	Green Published, gold			2022-12-27	WOS:000365926300049
J	Mochizuki, H; Shapiro, SG; Breen, M				Mochizuki, Hiroyuki; Shapiro, Susan G.; Breen, Matthew			Detection of BRAF Mutation in Urine DNA as a Molecular Diagnostic for Canine Urothelial and Prostatic Carcinoma	PLOS ONE			English	Article							TRANSITIONAL-CELL CARCINOMA; DIGITAL PCR; KRAS MUTATIONS; RAPID RESPONSE; CANCER; VEMURAFENIB; BLADDER; DOGS; LEUKEMIA; DISEASE	Urothelial carcinoma (UC) of the lower urinary tract and prostatic carcinoma (PC) are aggressive genitourinary cancers in dogs, characterized by invasion to surrounding tissues and high metastatic potential. Current diagnosis of canine UC and PC requires histopathological examination of a biopsy. Such specimens require specialized medical equipment and are invasive procedures, limiting the availability of diagnosis by histopathology for many canine patients. Access to a non-invasive means to confirm diagnosis is currently an unmet need. Recently, the canine BRAF V595E mutation was detected in similar to 80% of canine UCs and PCs. In this study, we developed a droplet digital PCR (ddPCR) assay for detection of the canine BRAF V595E mutation in canine urogenital tumors. The assay was evaluated in DNA samples prepared from biopsy specimens of UC (n = 48) and PC (n = 27), as well and non-neoplastic bladder epithelium (n = 38). In addition the assay was assessed for use with DNA isolated from free catch urine samples derived from canine patients with UC (n = 23), PC (n = 3), as well as from dogs with cystitis and healthy controls (n = 37). In all cases the sensitivity to detect the mutant allele was compared with conventional Sanger sequencing. ddPCR had superior sensitivity for detection of the V595E mutation: 75% of UC, 85% of PC, and 0% of control samples were mutation positive, respectively, and the V595E mutation was detected at a level as low as just 1 in 10,000 alleles (similar to 0.01%). Furthermore, the ddPCR assay identified the mutation in free catch urine samples from 83% of canine UC and PC patients, demonstrating its utility as a non-invasive means of diagnosis. We have shown that ddPCR is a sensitive molecular technique with the potential to facilitate accurate and non-invasive means of canine UC and PC diagnosis.	[Mochizuki, Hiroyuki; Shapiro, Susan G.; Breen, Matthew] N Carolina State Univ, Coll Vet Med, Dept Mol Biomed Sci, Raleigh, NC 27695 USA; [Breen, Matthew] N Carolina State Univ, Comparat Med Inst, Raleigh, NC 27695 USA; [Breen, Matthew] N Carolina State Univ, Ctr Human Hlth & Environm, Raleigh, NC 27695 USA; [Breen, Matthew] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Chapel Hill	Breen, M (corresponding author), N Carolina State Univ, Coll Vet Med, Dept Mol Biomed Sci, 4700 Hillsborough St, Raleigh, NC 27695 USA.	Matthew_Breen@ncsu.edu	Mochizuki, Hiroyuki/L-9510-2015	Mochizuki, Hiroyuki/0000-0002-1520-0393; Breen, Matthew/0000-0002-8901-4155	NCSU Cancer Genomics Funds; NATIONAL CENTER FOR RESEARCH RESOURCES [T35RR025837] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T35OD011070] Funding Source: NIH RePORTER	NCSU Cancer Genomics Funds; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funded by the NCSU Cancer Genomics Funds (MB).; The authors would like to thank Dr. T. Rosol for providing Leo cell line. We thank the NCSU Clinical Studies Core for assistance with case recruitment. This study was funded by the NCSU Cancer Genomics Fund (MB).	BELL FW, 1991, J AM VET MED ASSOC, V199, P1623; Cao YP, 2015, WATER RES, V70, P337, DOI 10.1016/j.watres.2014.12.008; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Cornell KK, 2000, PROSTATE, V45, P173; Decker B, 2015, MOL CANC RES; Follows GA, 2013, BRIT J HAEMATOL, V161, P150, DOI 10.1111/bjh.12201; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Haroche J, 2013, BLOOD, V121, P1495, DOI 10.1182/blood-2012-07-446286; Higuchi T, 2013, JAVMA-J AM VET MED A, V242, P499, DOI 10.2460/javma.242.4.499; Holderfield M, 2014, NAT REV CANCER, V14, P455, DOI 10.1038/nrc3760; Huggett Jim F, 2008, BMC Res Notes, V1, P70, DOI 10.1186/1756-0500-1-70; Knapp DW, 2014, ILAR J, V55, P100, DOI 10.1093/ilar/ilu018; Knapp DW, 2000, UROL ONCOL, V5, P47, DOI 10.1016/S1078-1439(99)00006-X; Lamy PJ, 2015, J MOL DIAGN; Lo YMD, 2007, P NATL ACAD SCI USA, V104, P13116, DOI 10.1073/pnas.0705765104; Mochizuki H, PLOS ONE IN PRESS; Mochizuki H, 2015, PCR VET PATHOL, DOI [10.1177/0300985815614975, DOI 10.1177/0300985815614975]; Mochizuki Hiroyuki, 2015, Vet Sci, V2, P231, DOI 10.3390/vetsci2030231; Munoz J, 2013, J CLIN ONCOL, V31, pE351, DOI 10.1200/JCO.2012.45.7739; Nyland TG, 2002, VET RADIOL ULTRASOUN, V43, P50, DOI 10.1111/j.1740-8261.2002.tb00443.x; Powe JR, 2004, VET CLIN PATH, V33, P150, DOI 10.1111/j.1939-165X.2004.tb00365.x; Shapiro SG, 2015, CHROMOSOME RES, V23, P311, DOI 10.1007/s10577-015-9471-y; Smith J, 2008, THERIOGENOLOGY, V70, P375, DOI 10.1016/j.theriogenology.2008.04.039; Taly V, 2013, CLIN CHEM, V59, P1722, DOI 10.1373/clinchem.2013.206359; Thudi NK, 2011, PROSTATE, V71, P1251, DOI 10.1002/pros.21341; Toye B, 1998, J CLIN MICROBIOL, V36, P2356, DOI 10.1128/JCM.36.8.2356-2358.1998; Tsiatis AC, 2010, J MOL DIAGN, V12, P425, DOI 10.2353/jmoldx.2010.090188; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Yung TKF, 2009, CLIN CANCER RES, V15, P2076, DOI 10.1158/1078-0432.CCR-08-2622; Zinkl J, 2007, DIAGNOSTIC CYTOLOGY, P350	30	53	53	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144170	10.1371/journal.pone.0144170	http://dx.doi.org/10.1371/journal.pone.0144170			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26649430	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903300038
J	Xing, GS; Wang, S; Sun, YM; Yuan, Z; Zhao, XM; Zhou, CW				Xing, Gu-sheng; Wang, Shuang; Sun, Yue-Min; Yuan, Zheng; Zhao, Xin-Ming; Zhou, Chun-wu			Small Bowel Stromal Tumors: Different Clinicopathologic and Computed Tomography Features in Various Anatomic Sites	PLOS ONE			English	Article							RECURRENCE; PATHOLOGY; LOCATION; RISK; GIST; CT	Gastrointestinal stromal tumors (GISTs) can present with different clinical and immunohistochemical characteristics according to different anatomic sites. The aim of this study was to compare clinicopathologic and computed tomography (CT) features of small bowel stromal tumors located in the duodenum, jejunum, and ileum. In total, 197 patients (109 male, 88 female) with small bowel GISTs were retrospectively reviewed. All tumors had definite anatomic sites in the small bowel tract with surgical confirmation. The clinicopathologic variables included age, sex, onset of symptoms, and tumor risk category. CT variables included tumor size, degree enhancement, enhancement pattern (region of necrosis), adjacent tissue involvement, lymphadenopathy, and distant metastasis. We assessed any possible differences according to different GIST site of origin. Based on tumor size and mitotic count, the risk categories in different anatomic sites did not differ significantly between duodenal and jejunal GISTs. However, high risk ileum GISTs accounted for 66.0% of ileal cases, which was higher than duodenum cases (36.8%, P = 0.002) and jejunum cases (43.9%, P = 0.004). The mean size of GISTs in the ileum was 9.77 cm, which was significantly larger than in the duodenum (7.41 cm, P = 0.043), and in the jejunum (8.14 cm, P = 0.027). On CT images, enhancement degree appeared to gradually increase from the duodenum to the ileum in the portal phase, and the enhancement pattern presented a tendency for heterogeneity. In Conclusions, the clinicopathologic and CT features of small bowel GISTs can differ according to different primary anatomic sites.	[Xing, Gu-sheng; Wang, Shuang; Zhao, Xin-Ming; Zhou, Chun-wu] Peking Union Med Coll, Canc Hosp & Inst, Dept Diagnost Imaging, Beijing 100021, Peoples R China; [Xing, Gu-sheng; Wang, Shuang; Sun, Yue-Min; Yuan, Zheng; Zhao, Xin-Ming; Zhou, Chun-wu] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Sun, Yue-Min] Peking Union Med Coll, Canc Hosp & Inst, Dept Abdominal Surg Oncol, Beijing 100021, Peoples R China; [Yuan, Zheng] Peking Union Med Coll, Canc Hosp & Inst, Dept Pathol, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Zhou, CW (corresponding author), Peking Union Med Coll, Canc Hosp & Inst, Dept Diagnost Imaging, Beijing 100021, Peoples R China.	chunwuzhoucams@163.com						Burkill GJC, 2003, RADIOLOGY, V226, P527, DOI 10.1148/radiol.2262011880; Casali PG, 2014, ANN ONCOL, V25, P21, DOI 10.1093/annonc/mdu255; Caterino S, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-13; Crosby JA, 2001, ANN SURG ONCOL, V8, P50, DOI 10.1007/s10434-001-0050-4; De Vogelaere K, 2014, ACTA CHIR BELG, V114, P167, DOI 10.1080/00015458.2014.11681003; DeMatteo RP, 2008, CANCER-AM CANCER SOC, V112, P608, DOI 10.1002/cncr.23199; DeMatteo RP, 2002, ANN SURG ONCOL, V9, P831, DOI 10.1007/BF02557518; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Han IW, 2015, WORLD J SURG, V39, P1026, DOI 10.1007/s00268-014-2810-x; Hersh Marla R, 2005, Cancer Control, V12, P111; HONG X, 2006, GASTROINTESTINAL STR, V26, P481, DOI DOI 10.1148/RG.262055097; Horton KM, 2004, J COMPUT ASSIST TOMO, V28, P811, DOI 10.1097/00004728-200411000-00014; Horton KM, 2004, J COMPUT ASSIST TOMO, V28, P106, DOI 10.1097/00004728-200401000-00019; Joensuu H, 2008, HUM PATHOL, V39, P1411, DOI 10.1016/j.humpath.2008.06.025; Joensuu H, 2012, LANCET ONCOL, V13, P265, DOI 10.1016/S1470-2045(11)70299-6; Levy AD, 2003, RADIOGRAPHICS, V23, P283, DOI 10.1148/rg.232025146; Lupescu IG, 2007, J GASTROINTEST LIVER, V16, P147; Miettinen M, 2006, AM J SURG PATHOL, V30, P477, DOI 10.1097/00000478-200604000-00008; Miettinen M, 2006, SEMIN DIAGN PATHOL, V23, P70, DOI 10.1053/j.semdp.2006.09.001; Miettinen M, 2011, J SURG ONCOL, V104, P865, DOI 10.1002/jso.21945; Miki Y, 2010, J CLIN GASTROENTEROL, V44, P97, DOI 10.1097/MCG.0b013e3181b8e754; Pickhardt PJ, 2003, RADIOGRAPHICS, V23, P645, DOI 10.1148/rg.233025134; Sandrasegaran K, 2005, EUR RADIOL, V15, P1407, DOI 10.1007/s00330-005-2647-7; Ulusan S, 2008, BRIT J RADIOL, V81, P618, DOI 10.1259/bjr/90134736; Werewka-Maczuga A, 2011, POL J RADIOL, V76, P38; Wong RJ, 2013, DIGEST DIS SCI, V58, P3112, DOI 10.1007/s10620-013-2678-x; Xie Yi-bin, 2012, Zhonghua Yi Xue Za Zhi, V92, P1694; Yang WL, 2009, J SURG ONCOL, V100, P606, DOI 10.1002/jso.21378; Yu QX, 2014, WORLD J GASTROENTERO, V20, P11800, DOI 10.3748/wjg.v20.i33.11800	29	15	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0144277	10.1371/journal.pone.0144277	http://dx.doi.org/10.1371/journal.pone.0144277			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YV	26646242	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903100016
J	Gonzalez-Recio, O; Daetwyler, HD; MacLeod, IM; Pryce, JE; Bowman, PJ; Hayes, BJ; Goddard, ME				Gonzalez-Recio, Oscar; Daetwyler, Hans D.; MacLeod, Iona M.; Pryce, Jennie E.; Bowman, Phil J.; Hayes, Ben J.; Goddard, Michael E.			Rare Variants in Transcript and Potential Regulatory Regions Explain a Small Percentage of the Missing Heritability of Complex Traits in Cattle	PLOS ONE			English	Article							HOLSTEIN-FRIESIAN CATTLE; DAIRY-CATTLE; GENOMIC PREDICTIONS; SEQUENCE DATA; BREEDING VALUES; COMMON SNPS; ACCURACY; IMPUTATION; RELIABILITY; PERSISTENCE	The proportion of genetic variation in complex traits explained by rare variants is a key question for genomic prediction, and for identifying the basis of "missing heritability"-the proportion of additive genetic variation not captured by common variants on SNP arrays. Sequence variants in transcript and regulatory regions from 429 sequenced animals were used to impute high density SNP genotypes of 3311 Holstein sires to sequence. There were 675,062 common variants (MAF>0.05), 102,549 uncommon variants (0.01<MAF<0.05), and 83,856 rare variants (MAF<0.01). We describe a novel method for estimating the proportion of the rare variants that are sequencing errors using parent-progeny duos. We then used mixed model methodology to estimate the proportion of variance captured by these different classes of variants for fat, milk and protein yields, as well as for fertility. Common sequence variants captured 83%, 77%, 76% and 84% of the total genetic variance for fat, milk, and protein yields and fertility, respectively. This was between 2 and 5% more variance than that captured from 600k SNPs on a high density chip, although the difference was not significant. Rare variants captured 3%, 0%, 1% and 14% of the genetic variance for fat, milk and protein yields, and fertility respectively, whereas pedigree explained the remaining amount of genetic variance (none for fertility). The proportion of variation explained by rare variants is likely to be under-estimated due to reduced accuracies of imputation for this class of variants. Using common sequence variants slightly improved accuracy of genomic predictions for fat and milk yield, compared to high density SNP array genotypes. However, including rare variants from transcript regions did not increase the accuracy of genomic predictions. These results suggest that rare variants recover a small percentage of the missing heritability for complex traits, however very large reference sets will be required to exploit this to improve the accuracy of genomic predictions. Our results do suggest the contribution of rare variants to genetic variation may be greater for fitness traits.	[Gonzalez-Recio, Oscar; Daetwyler, Hans D.; MacLeod, Iona M.; Pryce, Jennie E.; Bowman, Phil J.; Hayes, Ben J.; Goddard, Michael E.] Biosci Res Div, Dept Econ Dev Jobs Transport & Resources, Bundoora, Vic 3083, Australia; [Gonzalez-Recio, Oscar; Daetwyler, Hans D.; MacLeod, Iona M.; Pryce, Jennie E.; Bowman, Phil J.; Hayes, Ben J.] Dairy Futures Cooperat Res Ctr, Bundoora, Vic 3083, Australia; [Daetwyler, Hans D.; Pryce, Jennie E.; Hayes, Ben J.] La Trobe Univ, Sch Appl Syst Biol, Bundoora, Vic 3086, Australia; [MacLeod, Iona M.; Goddard, Michael E.] Univ Melbourne, Fac Vet & Agr Sci, Parkville, Vic 3010, Australia	La Trobe University; University of Melbourne	Gonzalez-Recio, O (corresponding author), Biosci Res Div, Dept Econ Dev Jobs Transport & Resources, Bundoora, Vic 3083, Australia.	ogrecio@gmail.com	Daetwyler, Hans D/H-9775-2019; Hayes, Ben J/L-3308-2016; Pryce, Jennie E/AAC-2490-2019; Gonzalez-Recio, Oscar/C-8553-2016	Hayes, Ben J/0000-0002-5606-3970; Pryce, Jennie/0000-0002-1397-1282; Goddard, Michael/0000-0001-9917-7946; Gonzalez-Recio, Oscar/0000-0002-9106-4063; Daetwyler, Hans D/0000-0002-3018-3640	Biosciences Research Division, Department of Environment, Land, Water and Planning, Bundoora (Melbourne, Australia); Dairy Futures Cooperative Research Centre (Melbourne, Australia)	Biosciences Research Division, Department of Environment, Land, Water and Planning, Bundoora (Melbourne, Australia); Dairy Futures Cooperative Research Centre (Melbourne, Australia)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This work was funded by Biosciences Research Division, Department of Environment, Land, Water and Planning, Bundoora (Melbourne, Australia) and Dairy Futures Cooperative Research Centre (Melbourne, Australia). The 1000 bull genomes project provided sequences used in this study. The funders provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	An SS, 2013, GENET EPIDEMIOL, V37, P13, DOI 10.1002/gepi.21685; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Clark SA, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-18; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Daetwyler HD, 2014, NAT GENET, V46, P858, DOI 10.1038/ng.3034; Daetwyler HD, 2010, GENETICS, V185, P1021, DOI 10.1534/genetics.110.116855; de los Campos G, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005048; Druet T, 2014, HEREDITY, V112, P39, DOI 10.1038/hdy.2013.13; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Erbe M, 2012, J DAIRY SCI, V95, P4114, DOI 10.3168/jds.2011-5019; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Gilmour AR, 2009, ASREML USER GUIDE RE; Grant JR, 2011, BIOINFORMATICS, V27, P2300, DOI 10.1093/bioinformatics/btr372; Guenther CA, 2014, NAT GENET, V46, P748, DOI 10.1038/ng.2991; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Haile-Mariam M, 2013, J ANIM BREED GENET, V130, P20, DOI 10.1111/j.1439-0388.2013.01001.x; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Jensen J, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-44; Koufariotis L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-436; Lee SH, 2012, NAT GENET, V44, P247, DOI 10.1038/ng.1108; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu DJ, 2012, AM J HUM GENET, V91, P585, DOI 10.1016/j.ajhg.2012.08.008; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; de Maturana EL, 2014, HUM GENET, V133, P1235, DOI 10.1007/s00439-014-1461-1; Lund MS, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-43; MacLeod IM, 2014, GENETICS, V198, P1671, DOI 10.1534/genetics.114.168344; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meacham F, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-451; Meuwissen THE, 2001, GENETICS, V157, P1819; Meuwissen T, 2010, GENETICS, V185, P623, DOI 10.1534/genetics.110.116590; Ober U, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002685; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Roman-Ponce SI, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-36; Saunders EJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004129; Solberg TR, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-53; van Binsbergen R, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-41; VanRaden PM, 2013, J DAIRY SCI, V96, P668, DOI 10.3168/jds.2012-5702; VanRaden PM, 2009, J DAIRY SCI, V92, P16, DOI 10.3168/jds.2008-1514; VanRaden PM, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-7; VANRADEN PM, 1991, J DAIRY SCI, V74, P2737, DOI 10.3168/jds.S0022-0302(91)78453-1; Wiggans GR, 2011, J DAIRY SCI, V94, P3202, DOI 10.3168/jds.2010-3866; Wolc A, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-23; Wray NR, 2005, TWIN RES HUM GENET, V8, P87; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zuk O, 2014, PNAS, V17, pE455; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	51	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0143945	10.1371/journal.pone.0143945	http://dx.doi.org/10.1371/journal.pone.0143945			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642058	gold, Green Published			2022-12-27	WOS:000366902700035
J	Misra, BB; de Armas, E; Tong, ZH; Chen, SX				Misra, Biswapriya B.; de Armas, Evaldo; Tong, Zhaohui; Chen, Sixue			Metabolomic Responses of Guard Cells and Mesophyll Cells to Bicarbonate	PLOS ONE			English	Article							ATMOSPHERIC CARBON-DIOXIDE; INDUCED STOMATAL CLOSURE; INTEGRATED METHOD; PROTEIN-KINASE; CROP YIELD; RISING CO2; PLANTS; PHOTOSYNTHESIS; ARABIDOPSIS; MECHANISMS	Anthropogenic CO2 presently at 400 ppm is expected to reach 550 ppm in 2050, an increment expected to affect plant growth and productivity. Paired stomatal guard cells (GCs) are the gate-way for water, CO2, and pathogen, while mesophyll cells (MCs) represent the bulk cell-type of green leaves mainly for photosynthesis. We used the two different cell types, i.e., GCs and MCs from canola (Brassica napus) to profile metabolomic changes upon increased CO2 through supplementation with bicarbonate (HCO3-). Two metabolomics platforms enabled quantification of 268 metabolites in a time-course study to reveal short-term responses. The HCO3- responsive metabolomes of the cell types differed in their responsiveness. The MCs demonstrated increased amino acids, phenylpropanoids, redox metabolites, auxins and cytokinins, all of which were decreased in GCs in response to HCO3-. In addition, the GCs showed differential increases of primary C-metabolites, N-metabolites (e.g., purines and amino acids), and defense-responsive pathways (e.g., alkaloids, phenolics, and flavonoids) as compared to the MCs, indicating differential C/N homeostasis in the cell-types. The metabolomics results provide insights into plant responses and crop productivity under future climatic changes where elevated CO2 conditions are to take center-stage.	[Misra, Biswapriya B.; Chen, Sixue] Univ Florida, Dept Biol, Genet Inst, Plant Mol & Cellular Biol Program, Gainesville, FL 32610 USA; [de Armas, Evaldo] Thermo Fisher Sci, Training Inst, W Palm Beach, FL 33407 USA; [Tong, Zhaohui] Univ Florida, Dept Agr & Biol Engn, Gainesville, FL 32611 USA; [Chen, Sixue] Univ Florida, Interdisciplinary Ctr Biotechnol Res, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; Thermo Fisher Scientific; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Chen, SX (corresponding author), Univ Florida, Dept Biol, Genet Inst, Plant Mol & Cellular Biol Program, Gainesville, FL 32610 USA.	schen@ufl.edu	Tong, Zhaohui/HGC-0747-2022; CHEN, SI/GZL-4800-2022; Misra, Biswapriya B./D-2055-2012	Misra, Biswapriya B./0000-0003-2589-6539	National Science Foundation [MCB-1158000]; U.S. National Science Foundation grant [MCB-1158000]; Div Of Molecular and Cellular Bioscience [1158000] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); U.S. National Science Foundation grant(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by National Science Foundation grant MCB-1158000 to SC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Fei Wang in the Tong lab is thanked for technical assistance with GC-MS analysis. This work was supported by the U.S. National Science Foundation grant MCB-1158000 to SC.	Agati G, 2012, PLANT SCI, V196, P67, DOI 10.1016/j.plantsci.2012.07.014; Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Ainsworth EA, 2008, NEW PHYTOL, V179, P5, DOI 10.1111/j.1469-8137.2008.02500.x; Ainsworth EA, 2007, PLANT CELL ENVIRON, V30, P258, DOI 10.1111/j.1365-3040.2007.01641.x; Araujo WL, 2011, PLANT SIGNAL BEHAV, V6, P1305, DOI 10.4161/psb.6.9.16425; Assmann SM, 1999, PLANT CELL ENVIRON, V22, P629, DOI 10.1046/j.1365-3040.1999.00408.x; Azoulay-Shemer T, 2015, PLANT J, V83, P567, DOI 10.1111/tpj.12916; Baba M, 2011, PLANT CELL PHYSIOL, V52, P1302, DOI 10.1093/pcp/pcr078; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Bauwe H, 2010, TRENDS PLANT SCI, V15, P330, DOI 10.1016/j.tplants.2010.03.006; Beardall J, 1998, CAN J BOT, V76, P1010, DOI 10.1139/b98-079; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Chen SX, 2000, J BIOL CHEM, V275, P22955, DOI 10.1074/jbc.M002768200; Chen W, 2013, MOL PLANT, V6, P1769, DOI 10.1093/mp/sst080; Chen Z, 2004, PLANT CELL, V16, P1143, DOI 10.1105/tpc.021584; Chollet R, 1996, ANNU REV PLANT PHYS, V47, P273, DOI 10.1146/annurev.arplant.47.1.273; Daloso DM, 2015, PLANT CELL ENVIRON, V38, P2353, DOI 10.1111/pce.12555; Dubovskaya LV, 2011, NEW PHYTOL, V191, P57, DOI 10.1111/j.1469-8137.2011.03661.x; During H., 2015, VITIS J GRAPEVINE RE, V42, P65; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Evans JR, 1996, PLANT PHYSIOL, V110, P339, DOI 10.1104/pp.110.2.339; Fang W, 2012, PLANT CELL, V24, P1876, DOI 10.1105/tpc.112.097949; Fiehn O, 2008, PLANT J, V53, P691, DOI 10.1111/j.1365-313X.2007.03387.x; Forde BG, 2007, J EXP BOT, V58, P2339, DOI 10.1093/jxb/erm121; Foyer CH, 2009, ANNU REV PLANT BIOL, V60, P455, DOI 10.1146/annurev.arplant.043008.091948; Fukayama H, 2011, FIELD CROP RES, V121, P195, DOI 10.1016/j.fcr.2010.11.018; Geissler N, 2010, PLANTA, V231, P583, DOI 10.1007/s00425-009-1064-6; Gillespie KM, 2012, PLANT CELL ENVIRON, V35, P169, DOI 10.1111/j.1365-3040.2011.02427.x; Grapov D., 2014, DEVIUMWEB VERSION 0, DOI [10.5281/zenodo.12879, DOI 10.5281/ZENODO.12879]; HAMPP R, 1982, PLANT PHYSIOL, V70, P1582, DOI 10.1104/pp.70.6.1582; HARRIS PJ, 1980, J SCI FOOD AGR, V31, P959, DOI 10.1002/jsfa.2740310914; Haworth M, 2015, AM J BOT, V102, P677, DOI 10.3732/ajb.1400508; Hu HH, 2015, PLANT PHYSIOL, V169, P1168, DOI 10.1104/pp.15.00646; Hu HH, 2010, NAT CELL BIOL, V12, P87, DOI 10.1038/ncb2009; Hutzler P, 1998, J EXP BOT, V49, P953, DOI 10.1093/jexbot/49.323.953; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Jin XF, 2013, PLANT CELL, V25, P4789, DOI 10.1105/tpc.113.119800; Joudoi T, 2013, PLANT CELL, V25, P558, DOI 10.1105/tpc.112.105049; Kafer C, 2004, FRONT BIOSCI-LANDMRK, V9, P1611; Kamennaya NA, 2015, METAB ENG, V29, P76, DOI 10.1016/j.ymben.2015.03.002; Kaplan F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043583; Kolla VA, 2007, PLANTA, V225, P1421, DOI 10.1007/s00425-006-0450-6; Kolla VA, 2007, PHYSIOL PLANTARUM, V130, P91, DOI 10.1111/j.1399-3054.2007.00887.x; Kopka J, 2005, BIOINFORMATICS, V21, P1635, DOI 10.1093/bioinformatics/bti236; Kuehn H., 2008, CURR PROTOC BIOINFOR, V22, P7; Lammertyn J, 2001, J EXP BOT, V52, P1769, DOI 10.1093/jexbot/52.362.1769; Levine LH, 2008, ADV SPACE RES, V42, P1917, DOI 10.1016/j.asr.2008.07.014; Li PH, 2008, PLANT CELL ENVIRON, V31, P1673, DOI 10.1111/j.1365-3040.2008.01874.x; Li X, 2013, SCI REP-UK, V3, DOI 10.1038/srep03433; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Long SP, 2004, ANNU REV PLANT BIOL, V55, P591, DOI 10.1146/annurev.arplant.55.031903.141610; Long SP, 2006, SCIENCE, V312, P1918, DOI 10.1126/science.1114722; Matros A, 2006, PLANT CELL ENVIRON, V29, P126, DOI 10.1111/j.1365-3040.2005.01406.x; Matrosova A, 2015, NEW PHYTOL, V208, P1126, DOI 10.1111/nph.13566; Medeiros DB, 2015, PLANT CELL ENVIRON, V38, P1457, DOI 10.1111/pce.12517; Misra BB, 2015, METABOLOMICS, V11, P1478, DOI 10.1007/s11306-015-0825-4; Misra BB, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00334; Misra BB, 2014, TRENDS PLANT SCI, V19, P637, DOI 10.1016/j.tplants.2014.05.005; Miyagi A, 2011, METABOLOMICS, V7, P524, DOI 10.1007/s11306-010-0272-1; Mott KA, 2009, PLANT CELL ENVIRON, V32, P1479, DOI 10.1111/j.1365-3040.2009.02022.x; MRINALINI T, 1982, NEW PHYTOL, V91, P413, DOI 10.1111/j.1469-8137.1982.tb03320.x; Papadimitropoulos MEP, 2015, COMBINED STRESSES PL, P49; Perez-Lopez U, 2009, PHYSIOL PLANTARUM, V135, P29, DOI 10.1111/j.1399-3054.2008.01174.x; Price GD, 2011, PLANT PHYSIOL, V155, P20, DOI 10.1104/pp.110.164681; Prior SA, 2004, ENCY PLANT CROP SCI, P648; Qiu QS, 2008, PHOTOSYNTH RES, V97, P155, DOI 10.1007/s11120-008-9310-5; Ramanan R, 2012, ALGAE-SEOUL, V27, P295, DOI 10.4490/algae.2012.27.4.295; Renberg L, 2010, PLANT PHYSIOL, V154, P187, DOI 10.1104/pp.110.157651; Runion GB, 2010, NEW FOREST, V39, P275, DOI 10.1007/s11056-009-9170-7; Scheible WR, 1997, PLANT CELL, V9, P783, DOI 10.1105/tpc.9.5.783; Shinde S, 2015, J EXP BOT, V66, P4001, DOI 10.1093/jxb/erv197; Sokal R. R., 1995, BIOMETRY PRINCIPLES, P337; Stasolla C, 2003, J PLANT PHYSIOL, V160, P1271, DOI 10.1078/0176-1617-01169; Stein SE, 1999, J AM SOC MASS SPECTR, V10, P770, DOI 10.1016/S1044-0305(99)00047-1; Sun YC, 2015, GLOBAL CHANGE BIOL, V21, P2739, DOI 10.1111/gcb.12858; Tallis MJ, 2010, NEW PHYTOL, V186, P415, DOI 10.1111/j.1469-8137.2010.03184.x; Tian W, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7057; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; Wang SY, 2003, J AGR FOOD CHEM, V51, P4315, DOI 10.1021/jf021172d; Watkins JM, 2014, PLANT PHYSIOL, V164, P1707, DOI 10.1104/pp.113.233528; Wei AL, 2015, ECOTOX ENVIRON SAFE, V114, P198, DOI 10.1016/j.ecoenv.2015.01.024; Wei AL, 2013, ECOTOX ENVIRON SAFE, V98, P41, DOI 10.1016/j.ecoenv.2013.09.029; Wu Y, 1997, SCIENCE, V278, P2126, DOI 10.1126/science.278.5346.2126; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Xue SW, 2011, EMBO J, V30, P1645, DOI 10.1038/emboj.2011.68; Yamano T, 2015, P NATL ACAD SCI USA, P01659; Yi HL, 2012, ECOTOX ENVIRON SAFE, V78, P281, DOI 10.1016/j.ecoenv.2011.11.035; Zhang S, 2015, J EXP BOT, V66, P1951, DOI 10.1093/jxb/eru538; Ziska L, 2008, CLIMATIC CHANGE, V91, P395, DOI 10.1007/s10584-008-9418-9; Ziska LH, 2005, GLOBAL CHANGE BIOL, V11, P1798, DOI 10.1111/j.1365-2486.2005.001029.x; Zrenner R, 2006, ANNU REV PLANT BIOL, V57, P805, DOI 10.1146/annurev.arplant.57.032905.105421	92	25	26	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144206	10.1371/journal.pone.0144206	http://dx.doi.org/10.1371/journal.pone.0144206			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641455	gold, Green Published, Green Submitted			2022-12-27	WOS:000366902700077
J	Ghimire, S; Castelino, RL; Lioufas, NM; Peterson, GM; Zaidi, STR				Ghimire, Saurav; Castelino, Ronald L.; Lioufas, Nicole M.; Peterson, Gregory M.; Zaidi, Syed Tabish R.			Nonadherence to Medication Therapy in Haemodialysis Patients: A Systematic Review	PLOS ONE			English	Article							STAGE RENAL-DISEASE; QUALITY-OF-LIFE; PHOSPHATE-BINDING MEDICATION; CHRONIC KIDNEY-DISEASE; REGIMEN COMPLEXITY; PHOSPHORUS CONTROL; DIALYSIS PATIENTS; ADULT PATIENTS; ADHERENCE; PREVALENCE	Background End-stage kidney disease (ESKD) patients are often prescribed multiple medications. Together with a demanding weekly schedule of dialysis sessions, increased number of medicines and associated regimen complexity pre-dispose them at high risk of medication nonadherence. This review summarizes existing literature on nonadherence and identifies factors associated with nonadherence to medication therapy in patients undergoing haemodialysis. Methods A comprehensive search of PubMed, Embase, CINAHL, PsycInfo, and Cochrane Database of Systematic Reviews covering the period from 1970 through November 2014 was performed following a predefined inclusion and exclusion criteria. Reference lists from relevant materials were reviewed. Data on study characteristics, measures of nonadherence, prevalence rates and factors associated with nonadherence were collected. The Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines was followed in conducting this systematic review. Results Of 920 relevant publications, 44 were included. The prevalence of medication nonadherence varied from 12.5% to 98.6%, with widespread heterogeneity in measures and definitions employed. Most common patient-related factors significantly associated with nonadherence were younger age, non-Caucasian ethnicity, illness interfering family life, being a smoker, and living single and being divorced or widowed. Similarly, disease-related factors include longevity of haemodialysis, recurrent hospitalization, depressive symptoms and having concomitant illness like diabetes and hypertension. Medication-related factors such as daily tablet count, total pill burden, number of phosphate binders prescribed and complexity of medication regimen were also associated with poor adherence. Conclusions A number of patient-, disease-, and medication-related factors are associated with medication nonadherence in haemodialysis patients. Clinicians should be aware of such factors so that adherence to medications can be optimised in haemodialysis patients. Future research should be directed towards well-designed prospective longitudinal studies developing standard definitions and validating available measurement tools, while focusing on the role of additional factors such as psychosocial and behavioural factors in predicting nonadherence to medications.	[Ghimire, Saurav; Castelino, Ronald L.; Peterson, Gregory M.; Zaidi, Syed Tabish R.] Univ Tasmania, Unit Medicat Outcomes Res & Educ, Sch Med, Pharm,Fac Hlth, Hobart, Tas, Australia; [Lioufas, Nicole M.] Royal Hobart Hosp, Dept Nephrol, Hobart, Tas, Australia	University of Tasmania; Royal Hobart Hospital	Zaidi, STR (corresponding author), Univ Tasmania, Unit Medicat Outcomes Res & Educ, Sch Med, Pharm,Fac Hlth, Hobart, Tas, Australia.	tabish.razizaidi@utas.edu.au	Ghimire, Saurav/P-6043-2014; Zaidi, Syed Tabish R./J-7336-2014	Ghimire, Saurav/0000-0002-2538-9433; Zaidi, Syed Tabish R./0000-0002-2031-1055; Peterson, Gregory/0000-0002-6764-3882				Alkatheri AM, 2014, SAUDI J KIDNEY DIS T, V25, P762, DOI 10.4103/1319-2442.134990; Armijo-Olivo S, 2012, J EVAL CLIN PRACT, V18, P12, DOI 10.1111/j.1365-2753.2010.01516.x; Asher DR, 2012, HEMODIAL INT, V16, P387, DOI 10.1111/j.1542-4758.2012.00688.x; BAME SI, 1993, SOC SCI MED, V37, P1035, DOI 10.1016/0277-9536(93)90438-A; Betts D K, 1988, ANNA J, V15, P96; BLANCHARD R, 1990, CLIN NEPHROL, V34, P173; Browne T, 2010, AM J KIDNEY DIS, V56, P547, DOI 10.1053/j.ajkd.2010.03.002; Burnier M, 2015, NEPHROL DIAL TRANSPL, V30, P39, DOI 10.1093/ndt/gfu015; Caraballo Nazario G L, 2001, P R Health Sci J, V20, P383; Cardone KE, 2011, HEMODIAL INT, V15, P234, DOI 10.1111/j.1542-4758.2011.00539.x; Cavanaugh KL, 2010, J AM SOC NEPHROL, V21, P1979, DOI 10.1681/ASN.2009111163; Chan Yoke Mun, 2012, PLoS One, V7, pe41362, DOI [10.1371/journal.pone.0038079, 10.1371/journal.pone.0041362]; Chater AM, 2014, PSYCHOL HEALTH, V29, P1407, DOI 10.1080/08870446.2014.942663; Chiu YW, 2009, CLIN J AM SOC NEPHRO, V4, P1089, DOI 10.2215/CJN.00290109; Clark S, 2014, SEMIN DIALYSIS, V27, P42, DOI 10.1111/sdi.12159; CLEARY DJ, 1995, AM J HEALTH-SYST PH, V52, P1895, DOI 10.1093/ajhp/52.17.1895; Correr CJ, 2011, INT J CLIN PHARM-NET, V33, P273, DOI 10.1007/s11096-011-9493-2; Cukor D, 2009, KIDNEY INT, V75, P1223, DOI 10.1038/ki.2009.51; CUMMINGS KM, 1982, MED CARE, V20, P567, DOI 10.1097/00005650-198206000-00003; Curtin R B, 1997, Geriatr Nephrol Urol, V7, P35, DOI 10.1023/A:1008267104024; Curtin R B, 1999, ANNA J, V26, P307; de Jager DJ, 2009, JAMA-J AM MED ASSOC, V302, P1782, DOI 10.1001/jama.2009.1488; Denhaerynd K, 2007, AM J CRIT CARE, V16, P222; Arenas MD, 2013, NEFROLOGIA, V33, P196, DOI 10.3265/Nefrologia.pre2012.Oct.11726; Arenas MD, 2010, J NEPHROL, V23, P525; Elliott RA, 2013, INT J CLIN PHARM-NET, V35, P217, DOI 10.1007/s11096-012-9730-3; FLANDERS WD, 1992, AM J EPIDEMIOL, V135, P926, DOI 10.1093/oxfordjournals.aje.a116388; Gago C, 2000, J RENAL CARE, V26, P4; Garcia AO, 2008, ENFERM NEFROL, V11, P23; Garcia-Llana H, 2013, PSICOTHEMA, V25, P79, DOI 10.7334/psicothema2012.96; George J, 2004, ANN PHARMACOTHER, V38, P1369, DOI 10.1345/aph.1D479; Gincherman Y, 2010, HEMODIAL INT, V14, P68, DOI 10.1111/j.1542-4758.2009.00397.x; Griva K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089001; Hamer RA, 2006, BMJ-BRIT MED J, V332, P563, DOI 10.1136/bmj.332.7541.563; Hirth RA, 2008, HEALTH AFFAIR, V27, P89, DOI 10.1377/hlthaff.27.1.89; Holley Jean L, 2006, Adv Perit Dial, V22, P162; Horne R, 2001, INT J PHARM PRAC, V9, P169, DOI DOI 10.1111/J.2042-7174.2001.TB01045.X; Horne R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080633; Ingersoll KS, 2008, J BEHAV MED, V31, P213, DOI 10.1007/s10865-007-9147-y; Kammerer Jean, 2007, Nephrol Nurs J, V34, P479; Kane S, 2008, DIGEST DIS SCI, V53, P1020, DOI 10.1007/s10620-007-9968-0; KAPLAN B, 1994, ANN PHARMACOTHER, V28, P316, DOI 10.1177/106002809402800303; Karamanidou C, 2008, BMC NEPHROL, V9, DOI 10.1186/1471-2369-9-2; Kardas P, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00091; Kaveh K, 2001, AM J KIDNEY DIS, V37, P244, DOI 10.1053/ajkd.2001.21286; Krass I, 2015, DIABETIC MED, V32, P725, DOI 10.1111/dme.12651; Lavsa SM, 2011, J AM PHARM ASSOC, V51, P90, DOI 10.1331/JAPhA.2011.09154; Lee Andrew, 2011, J Med Econ, V14, P798, DOI 10.3111/13696998.2011.627404; Lee A, 2008, NEPHROL DIAL TRANSPL, V23, P3953, DOI 10.1093/ndt/gfn365; Leggat JE, 1998, AM J KIDNEY DIS, V32, P139, DOI 10.1053/ajkd.1998.v32.pm9669435; Lehane E, 2007, INT J NURS STUD, V44, P1468, DOI 10.1016/j.ijnurstu.2006.07.010; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; Lin Chiu-Chu, 1997, Kaohsiung Journal of Medical Sciences, V13, P243; Lindberg M, 2007, SCAND J UROL NEPHROL, V41, P546, DOI 10.1080/00365590701421363; Loghmain-Adham M, 2003, AM J MANAG CARE, V9, P155; Lysaght MJ, 2002, J AM SOC NEPHROL, V13, pS37; Manley HJ, 2005, AM J KIDNEY DIS, V46, P669, DOI 10.1053/j.ajkd.2005.07.001; Manley HJ, 2004, NEPHROL DIAL TRANSPL, V19, P1842, DOI 10.1093/ndt/gfh280; Mason NA, 2011, CURR OPIN NEPHROL HY, V20, P492, DOI 10.1097/MNH.0b013e328349c261; Mohammed Ismail A, 2008, Ther Clin Risk Manag, V4, P887; Morgan L, 2000, Nephrol Nurs J, V27, P299; MORRIS LS, 1992, J CLIN PHARM THER, V17, P283, DOI 10.1111/j.1365-2710.1992.tb01306.x; Neri L, 2011, AM J NEPHROL, V34, P71, DOI 10.1159/000328391; Nieves Cazorla S, 2013, ENFERM NEFROL, V16, P41; O'Connor SM, 2008, J PSYCHOSOM RES, V65, P191, DOI 10.1016/j.jpsychores.2008.02.008; Ossareh S, 2014, IRAN J KIDNEY DIS, V8, P467; Park Haesuk, 2014, J Manag Care Spec Pharm, V20, P862; Porter A, 2013, AM J NEPHROL, V37, P568, DOI 10.1159/000351185; Rahman M, 2004, AM J HEALTH-SYST PH, V61, P1473, DOI 10.1093/ajhp/61.14.1473; Richard CJ, 2006, NEPHROL NURS J, V33, P387; Saounatsou M, 1999, EDTNA ERCA J, V25, P32; Saran R, 2003, KIDNEY INT, V64, P254, DOI 10.1046/j.1523-1755.2003.00064.x; Schmid H, 2009, EUR J MED RES, V14, P185, DOI 10.1186/2047-783X-14-5-185; Sendt KV, 2015, PSYCHIAT RES, V225, P14, DOI 10.1016/j.psychres.2014.11.002; Sgnaolin Vanessa, 2012, J Bras Nefrol, V34, P109; Martins MTS, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-208; Sulowicz W, 2006, KIDNEY INT, V70, pS36, DOI 10.1038/sj.ki.5001975; Theofilou P, 2013, INT J BEHAV MED, V20, P311, DOI 10.1007/s12529-012-9231-8; Thorneloe RJ, 2013, BRIT J DERMATOL, V168, P20, DOI 10.1111/bjd.12039; Tijerina MS, 2006, SOC WORK HEALTH CARE, V43, P57, DOI 10.1300/J010v43n01_04; Velligan DI, 2009, J CLIN PSYCHIAT, V70, P6; Weed-Collins M, 1989, ANNA J, V16, P278; WENEROWICZ WJ, 1978, J DIALYSIS, V2, P495, DOI 10.3109/08860227809080102; Wileman V, 2015, BRIT J HEALTH PSYCH, V20, P563, DOI 10.1111/bjhp.12116; Wileman V, 2011, NEPHRON CLIN PRACT, V119, pC205, DOI 10.1159/000329106	85	114	122	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144119	10.1371/journal.pone.0144119	http://dx.doi.org/10.1371/journal.pone.0144119			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636968	Green Submitted, gold, Green Published			2022-12-27	WOS:000366143800042
J	Hager, C; Keubler, LM; Biernot, S; Dietrich, J; Buchheister, S; Buettner, M; Bleich, A				Haeger, Christine; Keubler, Lydia M.; Biernot, Svenja; Dietrich, Jana; Buchheister, Stephanie; Buettner, Manuela; Bleich, Andre			Time to Integrate to Nest Test Evaluation in a Mouse DSS-Colitis Model	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; LABORATORY MICE; INTESTINAL INFLAMMATION; INDICATOR; RODENTS; PAIN; CD14; QTL; IBD	Severity assessment in laboratory animals is an important issue regarding the implementation of the 3R concept into biomedical research and pivotal in current EU regulations. In mouse models of inflammatory bowel disease severity assessment is usually undertaken by clinical scoring, especially by monitoring reduction of body weight. This requires daily observance and handling of each mouse, which is time consuming, stressful for the animal and necessitates an experienced observer. The time to integrate to nest test (TINT) is an easily applicable test detecting disturbed welfare by measuring the time interval mice need to integrate nesting material to an existing nest. Here, TINT was utilized to assess severity in a mouse DSS-colitis model. TINT results depended on the group size of mice maintained per cage with most consistent time intervals measured when co-housing 4 to 5 mice. Colitis was induced with 1% or 1.5% DSS in group-housed WT and Cd14-deficient mice. Higher clinical scores and loss of body weight were detected in 1.5% compared to 1% DSS treated mice. TINT time intervals showed no dose dependent differences. However, increased clinical scores, body weight reductions, and increased TINT time intervals were detected in Cd14(-/-) compared to WT mice revealing mouse strain related differences. Therefore, TINT is an easily applicable method for severity assessment in a mouse colitis model detecting CD14 related differences, but not dose dependent differences. As TINT revealed most consistent results in group-housed mice, we recommend utilization as an additional method substituting clinical monitoring of the individual mouse.	[Bleich, Andre] Hannover Med Sch, Inst Lab Anim Sci, Hannover, Germany; Hannover Med Sch, Cent Anim Facil, Hannover, Germany	Hannover Medical School; Hannover Medical School	Bleich, A (corresponding author), Hannover Med Sch, Inst Lab Anim Sci, Hannover, Germany.	bleich.andre@mh-hannover.de		Dietrich, Jana/0000-0001-7211-3168				Bleich A, 2004, MAMM GENOME, V15, P865, DOI 10.1007/s00335-004-2392-2; Bleich EM, 2010, INT J EXP PATHOL, V91, P281, DOI 10.1111/j.1365-2613.2009.00701.x; Campos AC, 2013, REV BRAS PSIQUIATR, V35, pS101, DOI 10.1590/1516-4446-2013-1139; COOPER HS, 1993, LAB INVEST, V69, P238; de Buhr MF, 2006, PHYSIOL GENOMICS, V25, P426, DOI 10.1152/physiolgenomics.00022.2005; de Buhr MF, 2009, INFLAMM BOWEL DIS, V15, P1824, DOI 10.1002/ibd.21030; Deacon RMJ, 2006, NAT PROTOC, V1, P2828, DOI 10.1038/nprot.2006.171; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; Deacon RMJ, 2006, NAT PROTOC, V1, P118, DOI 10.1038/nprot.2006.19; Dieleman LA, 1997, SCAND J GASTROENTERO, V32, P99; Erben U, 2014, INT J CLIN EXP PATHO, V7, P4557; Gaskill BN, 2013, JOVE-J VIS EXP, DOI 10.3791/51012; Gaskill BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032799; Gaudio E, 1999, DIGEST DIS SCI, V44, P1458, DOI 10.1023/A:1026620322859; Huet O, 2013, SHOCK, V39, P488, DOI 10.1097/SHK.0b013e3182939831; Jirkof P, 2013, LAB ANIM-UK, V47, P274, DOI 10.1177/0023677213493409; Jirkof P, 2013, LAB ANIM-UK, V47, P153, DOI 10.1177/0023677213475603; Jirkof P, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00165; Jurjus Abdo R., 2004, Journal of Pharmacological and Toxicological Methods, V50, P81, DOI 10.1016/j.vascn.2003.12.002; Mahler M, 2014, LAB ANIM-UK, V48, P178, DOI 10.1177/0023677213516312; MOOLENBEEK C, 1981, LAB ANIM, V15, P57, DOI 10.1258/002367781780958577; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Pritchett-Corning KR, 2014, J AM ASSOC LAB ANIM, V53, P633; Randhawa PK, 2014, KOREAN J PHYSIOL PHA, V18, P279, DOI 10.4196/kjpp.2014.18.4.279; Rock ML, 2014, J AM ASSOC LAB ANIM, V53, P24; Wirtz S, 2007, ADV DRUG DELIVER REV, V59, P1073, DOI 10.1016/j.addr.2007.07.003; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yan YT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006073	30	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143824	10.1371/journal.pone.0143824	http://dx.doi.org/10.1371/journal.pone.0143824			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26637175	Green Submitted, Green Published, gold			2022-12-27	WOS:000366143800030
J	Landry, M; Comeau, AM; Derome, N; Cusson, M; Levesque, RC				Landry, Mathieu; Comeau, Andre M.; Derome, Nicolas; Cusson, Michel; Levesque, Roger C.			Composition of the Spruce Budworm (Choristoneura fumiferana) Midgut Microbiota as Affected by Rearing Conditions	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; GYPSY-MOTH; GUT; DIGESTION; BACTERIA; COMMUNITY; INSECTS	The eastern spruce budworm (Choristoneura fumiferana) is one of the most destructive forest insect pests in Canada. Little is known about its intestinal microbiota, which could play a role in digestion, immune protection, communication and/or development. The present study was designed to provide a first characterization of the effects of rearing conditions on the taxonomic diversity and structure of the C. fumiferana midgut microbiota, using a culture-independent approach. Three diets and insect sources were examined: larvae from a laboratory colony reared on a synthetic diet and field-collected larvae reared on balsam fir or black spruce foliage. Bacterial DNA from the larval midguts was extracted to amplify and sequence the V6-V8 region of the 16S rRNA gene, using the Roche 454 GS-FLX technology. Our results showed a dominance of Proteobacteria, mainly Pseudomonas spp., in the spruce budworm midgut, irrespective of treatment group. Taxonomic diversity of the midgut microbiota was greater for larvae reared on synthetic diet than for those collected and reared on host plants, a difference that is likely accounted for by several factors. A greater proportion of bacteria from the phylum Bacteroidetes in insects fed artificial diet constituted the main difference between this group and those reared on foliage; within the phylum Proteobacteria, the presence of the genus Bradyrhizobium was also unique to insects reared on artificial diet. Strikingly, a Bray-Curtis analysis showed important differences in microbial diversity among the treatment groups, pointing to the importance of diet and environment in defining the spruce budworm midgut microbiota.	[Landry, Mathieu; Derome, Nicolas; Levesque, Roger C.] Univ Laval, IBIS, Quebec City, PQ, Canada; [Landry, Mathieu; Levesque, Roger C.] Univ Laval, Fac Med, Quebec City, PQ G1K 7P4, Canada; [Comeau, Andre M.] Dalhousie Univ, Dept Pharmacol, CGEB IMR, Halifax, NS B3H 4H7, Canada; [Derome, Nicolas] Univ Laval, Fac Sci & Genie, Quebec City, PQ G1K 7P4, Canada; [Cusson, Michel] Nat Resources Canada, Laurentian Forest Ctr, Quebec City, PQ, Canada	Laval University; Laval University; Dalhousie University; Laval University; Natural Resources Canada	Levesque, RC (corresponding author), Univ Laval, IBIS, Quebec City, PQ, Canada.	rclevesq@ibis.ulaval.ca	Cusson, Michel/AAG-9036-2019; Levesque, Roger C./ABD-8407-2021	Levesque, Roger/0000-0001-8315-5937	NSERC Discovery grant [171350-2012]; Genome Quebec	NSERC Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Genome Quebec	This research was funded by grants to R. C. Levesque, M. Cusson (NSERC Discovery grant #171350-2012 and in part by Genome Quebec).; We express our gratitude to members of the next generation sequencing platform and bioinformatics platform at the Institut de biologie integrative et des systemes (IBIS), Universite Laval, and to Catherine Beliveau for technical assistance with the PCR work. We thank Dr. D. Pureswaran (Natural Resources Canada, Quebec City) for providing the field-collected larvae. This research was funded by grants to R. C. Levesque, M. Cusson (NSERC Discovery grant #171350-2012 and in part by Genome Quebec).	Altschul SF, J MOL BIOL, V990, P403; Anand AAP, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.10701; Backhed F, 2012, CELL HOST MICROBE, V12, P611, DOI 10.1016/j.chom.2012.10.012; BREZNAK JA, 1994, ANNU REV ENTOMOL, V39, P453, DOI 10.1146/annurev.en.39.010194.002321; Broderick NA, 2004, APPL ENVIRON MICROB, V70, P293, DOI 10.1128/AEM.70.1.293-300.2004; Buchon N, 2013, NAT REV MICROBIOL, V11, P615, DOI 10.1038/nrmicro3074; Calderon-Cortes N, 2012, ANNU REV ECOL EVOL S, V43, P45, DOI 10.1146/annurev-ecolsys-110411-160312; Comeau AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027492; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Dobson AJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7312; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Engel P, 2013, FEMS MICROBIOL REV, V37, P699, DOI 10.1111/1574-6976.12025; Hui XA, 2006, CAN J MICROBIOL, V52, P1085, DOI 10.1139/W06-064; Kikuchi Y, 2012, P NATL ACAD SCI USA, V109, P8618, DOI 10.1073/pnas.1200231109; Kudo T, 1998, EXTREMOPHILES, V2, P155, DOI 10.1007/s007920050055; Machado VE, 2014, J VECTOR DIS, V51, P137; MCMORRAN A, 1965, CAN ENTOMOL, V97, P58, DOI 10.4039/Ent9758-1; Pang Anthony S D, 2010, Open Microbiol J, V4, P26, DOI 10.2174/1874285801004010026; Priya NG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030768; Quezada-Garcia R, 2014, CAN ENTOMOL, V146, P219, DOI 10.4039/tce.2013.72; Schloss PD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008230; Thomas F, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00093; van Frankenhuyzen K, 2010, J INVERTEBR PATHOL, V103, P124, DOI 10.1016/j.jip.2009.12.008	23	17	17	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144077	10.1371/journal.pone.0144077	http://dx.doi.org/10.1371/journal.pone.0144077			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636571	Green Published, Green Submitted, gold			2022-12-27	WOS:000366143800039
J	Ross, AI; Schenk, T; Hesse, C				Ross, Alasdair Iain; Schenk, Thomas; Hesse, Constanze			The Effect of Gaze Position on Reaching Movements in an Obstacle Avoidance Task	PLOS ONE			English	Article							EYE-HAND COORDINATION; AUTOMATIC AVOIDANCE; PERIPHERAL-VISION; REFERENCE FRAMES; VISUAL FEEDBACK; ARM MOVEMENTS; HEAD; LOCALIZATION; TARGET; MEMORY	Numerous studies have addressed the issue of where people look when they perform hand movements. Yet, very little is known about how visuomotor performance is affected by fixation location. Previous studies investigating the accuracy of actions performed in visual periphery have revealed inconsistent results. While movements performed under full visual-feedback (closed-loop) seem to remain surprisingly accurate, open-loop as well as memory-guided movements usually show a distinct bias (i.e. overestimation of target eccentricity) when executed in periphery. In this study, we aimed to investigate whether gaze position affects movements that are performed under full-vision but cannot be corrected based on a direct comparison between the hand and target position. To do so, we employed a classical visuomotor reaching task in which participants were required to move their hand through a gap between two obstacles into a target area. Participants performed the task in four gaze conditions: free-viewing (no restrictions on gaze), central fixation, or fixation on one of the two obstacles. Our findings show that obstacle avoidance behaviour is moderated by fixation position. Specifically, participants tended to select movement paths that veered away from the obstacle fixated indicating that perceptual errors persist in closed-loop vision conditions if they cannot be corrected effectively based on visual feedback. Moreover, measuring the eye-movement in a free-viewing task (Experiment 2), we confirmed that naturally participants' prefer to move their eyes and hand to the same spatial location.	[Ross, Alasdair Iain; Hesse, Constanze] Univ Aberdeen, Sch Psychol, Aberdeen, Scotland; [Schenk, Thomas] Univ Munich, Clin Neuropsychol, Munich, Germany	University of Aberdeen; University of Munich	Hesse, C (corresponding author), Univ Aberdeen, Sch Psychol, Aberdeen, Scotland.	c.hesse@abdn.ac.uk	Hesse, Constanze/H-2941-2016; S, T/GXF-0648-2022; S, T/GRY-0013-2022	Hesse, Constanze/0000-0002-4395-0781; 				BALLARD DH, 1995, J COGNITIVE NEUROSCI, V7, P66, DOI 10.1162/jocn.1995.7.1.66; BALLARD DH, 1992, PHILOS T R SOC B, V337, P331, DOI 10.1098/rstb.1992.0111; BARD C, 1985, CAN J PSYCHOL, V39, P151, DOI 10.1037/h0080120; Beurze SM, 2006, J NEUROPHYSIOL, V96, P352, DOI 10.1152/jn.01362.2005; BIGUER B, 1984, EXP BRAIN RES, V55, P462; BIGUER B, 1982, EXP BRAIN RES, V46, P301; Binsted G, 2001, HUM MOVEMENT SCI, V20, P563, DOI 10.1016/S0167-9457(01)00068-9; BOCK O, 1993, BEHAV BRAIN RES, V56, P77, DOI 10.1016/0166-4328(93)90023-J; BOCK O, 1986, EXP BRAIN RES, V64, P476, DOI 10.1007/BF00340484; Brown LE, 2005, EXP BRAIN RES, V165, P97, DOI 10.1007/s00221-005-2285-y; Cavina-Pratesi C, 2013, J VISION, V13, DOI 10.1167/13.5.15; Chapman CS, 2008, EXP BRAIN RES, V191, P83, DOI 10.1007/s00221-008-1499-1; de Grave DDJ, 2008, J VISION, V8, DOI 10.1167/8.7.5; de Haan AM, 2014, ACTA PSYCHOL, V150, P94, DOI 10.1016/j.actpsy.2014.04.007; DEAN J, 1994, EXP BRAIN RES, V97, P497; Dessing JC, 2012, J VISION, V12, DOI 10.1167/12.11.17; Elliott D, 1999, HUM MOVEMENT SCI, V18, P121, DOI 10.1016/S0167-9457(99)00004-4; Franz VH, 2010, THE OPTOTRAK TOOLBOX, V15, P2010; Goodale M. A., 1997, PARIETAL LOBE CONTRI, P447; Hayhoe M, 2005, TRENDS COGN SCI, V9, P188, DOI 10.1016/j.tics.2005.02.009; Hayhoe M, 2000, VIS COGN, V7, P43, DOI 10.1080/135062800394676; Hayhoe MM, 2003, J VISION, V3, P49, DOI 10.1167/3.1.6; Henriques DYP, 1998, J NEUROSCI, V18, P1583; Henriques DYP, 2000, EXP BRAIN RES, V132, P179, DOI 10.1007/s002210000340; Johansson RS, 2001, J NEUROSCI, V21, P6917, DOI 10.1523/JNEUROSCI.21-17-06917.2001; Land MF, 1997, PHILOS T ROY SOC B, V352, P1231, DOI 10.1098/rstb.1997.0105; Land MF, 2001, VISION RES, V41, P3559, DOI 10.1016/S0042-6989(01)00102-X; Marigold DS, 2007, EXP BRAIN RES, V176, P32, DOI 10.1007/s00221-006-0598-0; McGuire LMM, 2009, NAT NEUROSCI, V12, P1056, DOI 10.1038/nn.2357; McIntosh RD, 2004, NEUROPSYCHOLOGIA, V42, P1107, DOI 10.1016/j.neuropsychologia.2003.11.023; McIntosh RD, 2004, P ROY SOC B-BIOL SCI, V271, P15, DOI 10.1098/rspb.2003.2545; Menger R, 2015, PSYCHONOMIC B REV, P1; Menger R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059294; Menger R, 2012, ACTA PSYCHOL, V141, P1, DOI 10.1016/j.actpsy.2012.06.006; Mitra AR, 2010, NEUROPSYCHOLOGIA, V48, P1742, DOI 10.1016/j.neuropsychologia.2010.02.023; Neggers SFW, 2000, J NEUROPHYSIOL, V83, P639, DOI 10.1152/jn.2000.83.2.639; Neggers SFW, 2001, J NEUROPHYSIOL, V86, P961, DOI 10.1152/jn.2001.86.2.961; Nielsen KE, 1999, NEUROPSYCHOLOGIA, V37, P267, DOI 10.1016/S0028-3932(98)00080-3; Patla AE, 1997, NEUROREPORT, V8, P3661, DOI 10.1097/00001756-199712010-00002; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Rice NJ, 2006, EXP BRAIN RES, V174, P176, DOI 10.1007/s00221-006-0435-5; Ross AI, 2014, ACTA PSYCHOL, V151, P74, DOI 10.1016/j.actpsy.2014.05.019; Saunders JA, 2004, J NEUROSCI, V24, P3223, DOI 10.1523/JNEUROSCI.4319-03.2004; Saunders JA, 2003, EXP BRAIN RES, V152, P341, DOI 10.1007/s00221-003-1525-2; Schindler I, 2004, NAT NEUROSCI, V7, P779, DOI 10.1038/nn1273; Schlicht EJ, 2007, EXP BRAIN RES, V182, P47, DOI 10.1007/s00221-007-0970-8; Selen LPJ, 2011, VISION RES, V51, P898, DOI 10.1016/j.visres.2011.01.004; ULLMAN S, 1984, COGNITION, V18, P97, DOI 10.1016/0010-0277(84)90023-4; VERCHER JL, 1994, EXP BRAIN RES, V99, P507	50	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144193	10.1371/journal.pone.0144193	http://dx.doi.org/10.1371/journal.pone.0144193			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636966	Green Published, Green Submitted, gold			2022-12-27	WOS:000366143800056
J	Tolios, A; Teupser, D; Holdt, LM				Tolios, Alexander; Teupser, Daniel; Holdt, Lesca M.			Preanalytical Conditions and DNA Isolation Methods Affect Telomere Length Quantification in Whole Blood	PLOS ONE			English	Article							CIGARETTE-SMOKING; CANCER; MUTATIONS; DISEASE; TISSUE	Telomeres are located at chromosome ends and their length (TL) has been associated with aging and human diseases such as cancer. Whole blood DNA is frequently used for TL measurements but the influence of preanalytical conditions and DNA isolation methods on TL quantification has not been thoroughly investigated. To evaluate potential preanalytical as well as methodological bias on TL, anonymized leftover EDTA-whole blood samples were pooled according to leukocyte counts and were incubated with and without actinomycin D to induce apoptosis as a prototype of sample degradation. DNA was isolated from fresh blood pools and after freezing at -80 degrees C. Commercially available kits using beads (Invitrogen), spin columns (Qiagen, Macherey-Nagel and 5prime) or precipitation (Stratec/ Invisorb) and a published isopropanol precipitation protocol (IPP) were used for DNA isolation. TL was assessed by qPCR, and normalized to the single copy reference gene 36B4 using two established single-plex and a new multiplex protocol. We show that the method of DNA isolation significantly affected TL (e.g. 1.86-fold longer TL when comparing IPP vs. Invitrogen). Sample degradation led to an average TL decrease of 22% when using all except for one DNA isolation method (5prime). Preanalytical storage conditions did not affect TL with exception of samples that were isolated with the 5prime kit, where a 27% increase in TL was observed after freezing. Finally, performance of the multiplex qPCR protocol was comparable to the single-plex assays, but showed superior time-and cost-effectiveness and required >80% less DNA. Findings of the current study highlight the need for standardization of whole blood processing and DNA isolation in clinical study settings to avoid preanalytical bias of TL quantification and show that multiplex assays may improve TL/SCG measurements.	[Tolios, Alexander; Teupser, Daniel; Holdt, Lesca M.] Univ Munich, Inst Lab Med, Munich, Germany	University of Munich	Holdt, LM (corresponding author), Univ Munich, Inst Lab Med, Munich, Germany.	lesca.holdt@med.uni-muenchen.de			Invitrogen; Qiagen; Marcherey-Nagel; 5prime; Stratec	Invitrogen; Qiagen; Marcherey-Nagel; 5prime; Stratec	The authors thank the companies (Invitrogen, Qiagen, Marcherey-Nagel, 5prime, Stratec) for their support and kind supply of reagents used in this study.	Anchordoquy TJ, 2007, CELL PRESERV TECHNOL, V5, P180, DOI 10.1089/cpt.2007.0511; Armanios M, 2013, J CLIN INVEST, V123, P996, DOI 10.1172/JCI66370; Armanios M, 2012, MUTAT RES-FUND MOL M, V730, P1, DOI 10.1016/j.mrfmmm.2011.11.005; Armanios M, 2012, MUTAT RES-FUND MOL M, V730, P52, DOI 10.1016/j.mrfmmm.2011.10.013; Armanios M, 2009, AM J HUM GENET, V85, P823, DOI 10.1016/j.ajhg.2009.10.028; Aubert G, 2012, MUTAT RES-FUND MOL M, V730, P59, DOI 10.1016/j.mrfmmm.2011.04.003; Aviv A, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr634; Baird DM, 2003, NAT GENET, V33, P203, DOI 10.1038/ng1084; Calado RT, 2009, P NATL ACAD SCI USA, V106, P1187, DOI 10.1073/pnas.0807057106; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chang S, 2003, GENE DEV, V17, P88, DOI 10.1101/gad.1029903; Codd V, 2013, NAT GENET, V45, P422, DOI 10.1038/ng.2528; Cunningham JM, 2013, CANCER EPIDEM BIOMAR, V22, P2047, DOI 10.1158/1055-9965.EPI-13-0409; Eisenberg DTA, 2015, AM J HUM BIOL, V27, P570, DOI 10.1002/ajhb.22690; Gertler R, 2008, CANCER-AM CANCER SOC, V112, P2173, DOI 10.1002/cncr.23419; Ghatak Souvik, 2013, J Biomol Tech, V24, P224, DOI 10.7171/jbt.13-2404-001; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Kirwan M, 2009, HUM MUTAT, V30, P1567, DOI 10.1002/humu.21115; Koppelstaetter C, 2005, MECH AGEING DEV, V126, P1331, DOI 10.1016/j.mad.2005.08.003; Krstajic D, 2015, INT J EPIDEMIOL, V44, P1738, DOI 10.1093/ije/dyv167; Lin KW, 2005, J CELL MOL MED, V9, P977, DOI 10.1111/j.1582-4934.2005.tb00395.x; Lin SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060815; Martens UM, 1998, NAT GENET, V18, P76, DOI 10.1038/ng0198-018; Martin-Ruiz CM, 2015, INT J EPIDEMIOL, V44, P1739, DOI 10.1093/ije/dyv170; Martin-Ruiz CM, 2015, INT J EPIDEMIOL, V44, P1686, DOI 10.1093/ije/dyv169; Martin-Ruiz CM, 2015, INT J EPIDEMIOL, V44, P1673, DOI 10.1093/ije/dyu191; McGrath M, 2007, CANCER EPIDEM BIOMAR, V16, P815, DOI 10.1158/1055-9965.EPI-06-0961; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; Mu YC, 2012, MED ONCOL, V29, P893, DOI 10.1007/s12032-011-9866-3; Nagami Kazuyuki, 2002, J Toxicol Sci, V27, P191, DOI 10.2131/jts.27.191; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poon SSS, 2001, METHOD CELL BIOL, V64, P69; Rajatileka S, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-105; SOUTHERN EM, 1979, ANAL BIOCHEM, V100, P319, DOI 10.1016/0003-2697(79)90235-5; Svenson U, 2008, CANCER RES, V68, P3618, DOI 10.1158/0008-5472.CAN-07-6497; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Valls-Bautista C, 2015, J SURG ONCOL, V111, P899, DOI 10.1002/jso.23894; Vera E, 2012, AGING-US, V4, P379, DOI 10.18632/aging.100462; Verhulst S, 2015, INT J EPIDEMIOL, V44, P1683, DOI 10.1093/ije/dyv166; Whyte MKB, 1997, J LEUKOCYTE BIOL, V62, P195, DOI 10.1002/jlb.62.2.195; Yamaguchi H, 2003, BLOOD, V102, P916, DOI 10.1182/blood-2003-01-0335; Zanet DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057787; Zhang B, 2012, ONCOGENE, V31, P1, DOI 10.1038/onc.2011.214	47	24	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143889	10.1371/journal.pone.0143889	http://dx.doi.org/10.1371/journal.pone.0143889			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636575	gold, Green Submitted, Green Published			2022-12-27	WOS:000366143800032
J	Chae, YN; Kim, TH; Kim, MK; Shin, CY; Jung, IH; Sohn, YS; Son, MH				Chae, Yu-Na; Kim, Tae-Hyoung; Kim, Mi-Kyung; Shin, Chang-Yell; Jung, Il-Hoon; Sohn, Yong Sung; Son, Moon-Ho			Beneficial Effects of Evogliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, on Adiposity with Increased Ppargc1a in White Adipose Tissue in Obese Mice	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; ENDOPLASMIC-RETICULUM STRESS; GLP-1 ANALOG LIRAGLUTIDE; ENERGY-EXPENDITURE; INSULIN-RESISTANCE; FOOD-INTAKE; GLYCEMIC CONTROL; IV INHIBITOR; SITAGLIPTIN; METABOLISM	Although dipeptidyl peptidase 4 (DPP4) is an adipokine known to positively correlate with adiposity, the effects of pharmacological DPP4 inhibition on body composition have not been fully understood. This study was aimed to assess the effects of DPP4 inhibitors on adiposity for the first time in the established obese mice model. The weight loss effects of multiple DPP4 inhibitors were compared after a 4 week treatment in diet-induced obese mice. In addition, a 2 week study was performed to explore and compare the acute effects of evogliptin, a novel DPP4 inhibitor, and exenatide, a glucagon-like peptide-1 (GLP-1) analogue, on whole body composition, energy consumption, various plasma adipokines and gene expression in white adipose tissue (WAT). After the 4 week treatment, weight loss and blood glucose reductions were consistently observed with multiple DPP4 inhibitors. Moreover, after 2-week treatment, evogliptin dose-dependently reduced whole body fat mass while increasing the proportion of smaller adipocytes. However, insulin sensitivity or plasma lipid levels were not significantly altered. In addition to increased active GLP-1 levels by plasma DPP4 inhibition, evogliptin also enhanced basal metabolic rate without reduction in caloric intake, in contrast to exenatide; this finding suggested evogliptin's effects may be mediated by pathways other than via GLP-1. Evogliptin treatment also differentially increased Ppargc1a expression, a key metabolic regulator, in WAT, but not in skeletal muscle and brown adipose tissue. The increased expression of the downstream mitochondrial gene, Cox4i1, was also suggestive of the potential metabolic alteration in WAT by DPP4 inhibitors. We are the first to demonstrate that pharmacological DPP4 inhibition by evogliptin directly causes fat loss in established obese mice. In contradistinction to exenatide, the fat-loss effect of DPP4 inhibitor is partly attributed to enhanced energy expenditure along with metabolic changes in WAT. These results provide insight into the regulation of energy storage in WAT caused by DPP4 inhibition.	[Chae, Yu-Na; Kim, Tae-Hyoung; Kim, Mi-Kyung; Shin, Chang-Yell; Jung, Il-Hoon; Sohn, Yong Sung; Son, Moon-Ho] Dong A ST Co Ltd, Res Inst, Yongin 446905, Gyeonggi Do, South Korea		Son, MH (corresponding author), Dong A ST Co Ltd, Res Inst, Yongin 446905, Gyeonggi Do, South Korea.	ssonmh@donga.co.kr			Dong-A ST Co., Ltd.	Dong-A ST Co., Ltd.	This research was funded by Dong-A ST Co., Ltd. The funder provided support in the form of salaries for all authors [YNC, THK, MKK, CYS, IHJ, YSS, and MHS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abernathy RP, 1996, AM J CLIN NUTR, V63, P448; Amori RE, 2007, JAMA-J AM MED ASSOC, V298, P194, DOI 10.1001/jama.298.2.194; Baggio LL, 2004, GASTROENTEROLOGY, V127, P546, DOI 10.1053/j.gastro.2004.04.063; Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Bergman AJ, 2006, CLIN THER, V28, P55, DOI 10.1016/j.clinthera.2006.01.015; Bogacka I, 2005, DIABETES, V54, P1392, DOI 10.2337/diabetes.54.5.1392; Boschmann M, 2009, J CLIN ENDOCR METAB, V94, P846, DOI 10.1210/jc.2008-1400; Bradley DP, 2012, APPL PHYSIOL NUTR ME, V37, P893, DOI [10.1139/H2012-068, 10.1139/h2012-068]; Cahn A, 2013, EXPERT OPIN EMERG DR, V18, P245, DOI 10.1517/14728214.2013.807796; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; Cannavino J, 2014, J PHYSIOL-LONDON, V592, P4575, DOI 10.1113/jphysiol.2014.275545; Ceddia RB, 2005, INT J OBESITY, V29, P1175, DOI 10.1038/sj.ijo.0803025; Challa TD, 2012, J BIOL CHEM, V287, P6421, DOI 10.1074/jbc.M111.310342; Cho JM, 2011, DIABETES RES CLIN PR, V91, P72, DOI 10.1016/j.diabres.2010.10.012; Conarello SL, 2003, P NATL ACAD SCI USA, V100, P6825, DOI 10.1073/pnas.0631828100; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Dobrian AD, 2011, AM J PHYSIOL-ENDOC M, V300, pE410, DOI 10.1152/ajpendo.00463.2010; Elfers CT, 2012, HORM RES PAEDIAT, V78, P47, DOI 10.1159/000338464; Even PC, 2012, AM J PHYSIOL-REG I, V303, pR459, DOI 10.1152/ajpregu.00137.2012; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Flint A, 2013, DIABETES OBES METAB, V15, P958, DOI 10.1111/dom.12108; Flint A, 2000, INT J OBESITY, V24, P288, DOI 10.1038/sj.ijo.0801126; Flock G, 2007, DIABETES, V56, P3006, DOI 10.2337/db07-0697; Fukuda-Tsuru S, 2014, EUR J PHARMACOL, V723, P207, DOI 10.1016/j.ejphar.2013.11.030; Gaidhu MP, 2010, AM J PHYSIOL-CELL PH, V298, pC961, DOI 10.1152/ajpcell.00547.2009; Gaidhu MP, 2009, J LIPID RES, V50, P704, DOI 10.1194/jlr.M800480-JLR200; Goldsmith F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126177; Guillet C, 2012, OBES REV, V13, P51, DOI 10.1111/j.1467-789X.2012.01037.x; Hamamoto S, 2013, DIABETES OBES METAB, V15, P153, DOI 10.1111/dom.12005; Horowitz M, 2012, DIABETES RES CLIN PR, V97, P258, DOI 10.1016/j.diabres.2012.02.016; Kern M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038744; Kim HJ, 2011, BIOORG MED CHEM LETT, V21, P3809, DOI 10.1016/j.bmcl.2011.04.029; Kim MK, 2012, LIFE SCI, V90, P21, DOI 10.1016/j.lfs.2011.10.007; Kirino Y, 2011, AM J PHYSIOL-ENDOC M, V300, pE372, DOI 10.1152/ajpendo.00319.2010; Kirno Y, 2009, BIOL PHARM BULL, V32, P463, DOI 10.1248/bpb.32.463; Kos K, 2009, DIABETES OBES METAB, V11, P285, DOI 10.1111/j.1463-1326.2008.00909.x; Lamers D, 2011, DIABETES, V60, P1917, DOI 10.2337/db10-1707; Lamont BJ, 2008, DIABETES, V57, P190, DOI 10.2337/db07-1202; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Mack CM, 2006, INT J OBESITY, V30, P1332, DOI 10.1038/sj.ijo.0803284; Mu J, 2009, EUR J PHARMACOL, V623, P148, DOI 10.1016/j.ejphar.2009.09.027; Ostenson CG, 2013, DIABETES METAB SYNDR, V6, P171, DOI 10.2147/DMSO.S41827; Pannacciulli N, 2006, AM J CLIN NUTR, V84, P556, DOI 10.1093/ajcn/84.3.556; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Rosmaninho-Salgado J, 2012, PEPTIDES, V37, P49, DOI 10.1016/j.peptides.2012.06.014; Sawada T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014006; Scheen AJ, 2012, EXPERT OPIN PHARMACO, V13, P81, DOI 10.1517/14656566.2012.642866; Skurk T, 2007, J CLIN ENDOCR METAB, V92, P1023, DOI 10.1210/jc.2006-1055; Son MH, 2010, INT J OBESITY, V34, P547, DOI 10.1038/ijo.2009.253; Souza-Mello V, 2010, CLIN SCI, V119, P239, DOI 10.1042/CS20100061; Talsania T, 2005, ENDOCRINOLOGY, V146, P3748, DOI 10.1210/en.2005-0473; Thomas L, 2009, J PHARMACOL EXP THER, V328, P556, DOI 10.1124/jpet.108.143966; Vendrell J, 2011, ENDOCRINOLOGY, V152, P4072, DOI 10.1210/en.2011-1070; Verhoef SPM, 2013, OBES RES CLIN PRACT, V7, pE8, DOI 10.1016/j.orcp.2012.03.001; Vyas AK, 2012, CARDIOVASC ENDOCRINO, V1, P74, DOI 10.1097/XCE.0b013e32835bfb24; Wendel AA, 2009, LIPIDS, V44, P975, DOI 10.1007/s11745-009-3348-9; Wu YJ, 2015, METABOLISM, V64, P226, DOI 10.1016/j.metabol.2014.08.006; Yo K, 2013, AM J PHYSIOL-ENDOC M, V304, pE331, DOI 10.1152/ajpendo.00098.2012; Zambrowicz B, 2013, CLIN THER, V35, P273, DOI 10.1016/j.clinthera.2013.01.010	60	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144064	10.1371/journal.pone.0144064	http://dx.doi.org/10.1371/journal.pone.0144064			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633898	Green Submitted, Green Published, gold			2022-12-27	WOS:000366040000048
J	Chaudhuri, D; Ghate, NB; Panja, S; Das, A; Mandal, N				Chaudhuri, Dipankar; Ghate, Nikhil Baban; Panja, Sourav; Das, Abhishek; Mandal, Nripendranath			Wild Edible Fruit of Prunus nepalensis Ser. (Steud), a Potential Source of Antioxidants, Ameliorates Iron Overload-Induced Hepatotoxicity and Liver Fibrosis in Mice	PLOS ONE			English	Article							HEPATOPROTECTIVE ACTIVITY; SUPEROXIDE; EXTRACTS; FERRITIN; ASSAY; ACID; L.; HYDROXYPROLINE; LEAVES; RATS	The antioxidant and restoration potentials of hepatic injury by Prunus nepalensis Ser. (Steud), a wild fruit plant from the Northeastern region of India, were investigated. The fruit extract (PNME) exhibited excellent antioxidant and reducing properties and also scavenged the 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical (IC50 = 30.92 +/- 0.40 mu g/ml). PNME demonstrated promising scavenging potency, as assessed by the scavenging of different reactive oxygen and nitrogen species. Moreover, the extract revealed an exceptional iron chelation capacity with an IC50 of 25.64 +/- 0.60 mu g/ml. The extract induced significant improvement of hepatic injury and liver fibrosis against iron overload induced hepatotoxicity in mice in a dose-dependent manner, and this effect was supported by different histopathological studies. The phytochemical constitutions and their identification by HPLC confirmed the presence of purpurin, tannic acid, methyl gallate, reserpine, gallic acid, ascorbic acid, catechin and rutin. The identified compounds were investigated for their individual radical scavenging and iron chelation activity; some compounds exhibited excellent radical scavenging and iron chelation properties, but most were toxic towards normal cells (WI-38). On the other hand, crude PNME was found to be completely nontoxic to normal cells, suggesting its feasibility as a safe oral drug. The above study suggests that different phytochemicals in PNME contributed to its free radical scavenging and iron chelation activity; however, further studies are required to determine the pathway in which PNME acts to treat iron-overload diseases.	[Chaudhuri, Dipankar; Ghate, Nikhil Baban; Panja, Sourav; Das, Abhishek; Mandal, Nripendranath] Bose Inst, Div Mol Med, Kolkata 700054, W Bengal, India	Department of Science & Technology (India); Bose Institute	Mandal, N (corresponding author), Bose Inst, Div Mol Med, P 1-12,CIT Rd, Kolkata 700054, W Bengal, India.	mandaln@rediffmail.com	Chudhuri, Dipankar/AAU-6215-2021; Mandal, Nripendranath/ABC-3918-2020; Ghate, Nikhil/T-4153-2017; PANJA, SOURAV/AAA-7163-2022; Panja, Sourav/AFO-5798-2022	Mandal, Nripendranath/0000-0002-8733-3566; Ghate, Nikhil/0000-0002-4447-3737; Panja, Sourav/0000-0001-8540-5266; Chaudhuri, Dipankar/0000-0001-7991-0469				Adikwu E., 2013, Pharmacology and Pharmacy, V4, P84; Afdhal NH, 2004, AM J GASTROENTEROL, V99, P1160, DOI 10.1111/j.1572-0241.2004.30110.x; Agrahar-Murugkar D, 2005, ECOL FOOD NUTR, V44, P207, DOI 10.1080/03670240590953025; Anusha M, 2011, INDIAN J PHARMACOL, V43, P563, DOI 10.4103/0253-7613.84973; Arabshahi-Delouee S, 2007, FOOD CHEM, V102, P1233, DOI 10.1016/j.foodchem.2006.07.013; Arthur MJP, 1996, J GASTROEN HEPATOL, V11, P1124, DOI 10.1111/j.1440-1746.1996.tb01840.x; ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; BARRY M, 1971, LANCET, V1, P100; Begum S, 2012, NAT PROD RES, V26, P2084, DOI 10.1080/14786419.2011.625502; BERGMAN I, 1963, ANAL CHEM, V35, P1961, DOI 10.1021/ac60205a053; BONAVENTURA J, 1972, ARCH BIOCHEM BIOPHYS, V150, P606, DOI 10.1016/0003-9861(72)90080-X; Bothwell T.H., 1979, IRON METABOLISM MAN; Buege J A, 1978, Methods Enzymol, V52, P302; Chatha SAS, 2006, GRASAS ACEITES, V57, P328; Chaudhuri D, 2012, ASIAN J PHARM CLIN R, V5, P193, DOI DOI 10.1186/0717-6287-47-24; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Ercal Nuran, 2001, Current Topics in Medicinal Chemistry, V1, P529, DOI 10.2174/1568026013394831; Galleano Monica, 2004, Molecular Aspects of Medicine, V25, P141, DOI 10.1016/j.mam.2004.02.015; Ghate NB., 2013, INT J PHARM BIO SCI, V4, P373; Ghate NB, 2014, CYTOTECHNOLOGY, V66, P209, DOI 10.1007/s10616-013-9553-7; Ghate NB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082293; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Harborne J.B., 1995, PHYTOCHEMICAL DICT H; HARRISON PM, 1977, SEMIN HEMATOL, V14, P55; Hassan S, 2009, TOXICOL LETT, P189; Hazra B, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-63; HERSHKO C, 1994, IRON METABOLISM HLTH, P391; HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868; Hynes MJ, 2002, J INORG BIOCHEM, V90, P18, DOI 10.1016/S0162-0134(02)00383-5; Janbaz KH, 2002, FITOTERAPIA, V73, P557, DOI 10.1016/S0367-326X(02)00217-4; KAKKAR P, 1984, INDIAN J BIOCHEM BIO, V21, P130; Khatri A, 2009, J ETHNOPHARMACOL, V122, P1, DOI 10.1016/j.jep.2008.10.043; KIVIRIKKO KI, 1967, ANAL BIOCHEM, V19, P249, DOI 10.1016/0003-2697(67)90160-1; Kochevar IE, 2000, METHOD ENZYMOL, V319, P20; Kokate C.K., 2003, TXB PHARMACOGNOSY, V1st ed., P330; Koncic MZ, 2011, MOLECULES, V16, P6232, DOI 10.3390/molecules16086232; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lushchak VI, 2011, COMP BIOCHEM PHYS C, V153, P175, DOI 10.1016/j.cbpc.2010.10.004; OBRIEN RT, 1974, ANN NY ACAD SCI, V232, P221, DOI 10.1111/j.1749-6632.1974.tb20588.x; Ramm GA, 2005, SEMIN LIVER DIS, V25, P433, DOI 10.1055/s-2005-923315; Reddy ACP, 1996, TOXICOLOGY, V107, P39, DOI 10.1016/0300-483X(95)03199-P; REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357; RICEEVANS CA, 1995, FREE RADICAL RES, V22, P375, DOI 10.3109/10715769509145649; ROTHMAN RJ, 1992, MOL PHARMACOL, V42, P703; Ryan T. P., 1992, REV TOXICOL, V22, P119; Sabir SM, 2012, FOOD CHEM, V131, P741, DOI 10.1016/j.foodchem.2011.09.026; Saukkonen JJ, 2006, AM J RESP CRIT CARE, V174, P935, DOI 10.1164/rccm.200510-1666ST; Sayre Lawrence M, 2005, Ann Ist Super Sanita, V41, P143; Stief TW, 2003, MED HYPOTHESES, V60, P567, DOI 10.1016/S0306-9877(03)00026-4; Sudha G., 2011, INT J CURR PHARM RES, V3, P137; Tam TF, 2003, CURR MED CHEM, V10, P983, DOI 10.2174/0929867033457593; Tapan S., 2011, INT J PHARM PHARM SC, V3, P233; Taylor BS, 1997, ARCH SURG-CHICAGO, V132, P1177; Toyokuni S, 1996, FREE RADICAL BIO MED, V20, P553, DOI 10.1016/0891-5849(95)02111-6; VILE GF, 1995, FREE RADICAL BIO MED, V18, P721, DOI 10.1016/0891-5849(94)00192-M; Visioli F, 1998, BIOCHEM BIOPH RES CO, V247, P60, DOI 10.1006/bbrc.1998.8735; YATES WR, 1987, DRUG ALCOHOL DEPEN, V20, P155, DOI 10.1016/0376-8716(87)90065-2; Yildirim A, 2001, J AGR FOOD CHEM, V49, P4083, DOI 10.1021/jf0103572; Zhou J., 2011, ENCY TRADITIONAL CHI	61	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144280	10.1371/journal.pone.0144280	http://dx.doi.org/10.1371/journal.pone.0144280			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633891	Green Submitted, Green Published, gold			2022-12-27	WOS:000366040000076
J	El-Sayed, ASA; Yassin, MA; Ali, GS				El-Sayed, Ashraf S. A.; Yassin, Marwa A.; Ali, Gul Shad			Transcriptional and Proteomic Profiling of Aspergillus flavipes in Response to Sulfur Starvation	PLOS ONE			English	Article							L-METHIONINASE PRODUCTION; CYSTATHIONINE GAMMA-LYASE; SACCHAROMYCES-CEREVISIAE; SULFATE TRANSPORT; AMINO-ACIDS; MOLECULAR CHARACTERIZATION; INHIBITORY-ACTIVITY; CYSTEINE SYNTHASE; NEUROSPORA-CRASSA; FILAMENTOUS FUNGI	Aspergillus flavipes has received considerable interest due to its potential to produce therapeutic enzymes involved in sulfur amino acid metabolism. In natural habitats, A. flavipes survives under sulfur limitations by mobilizing endogenous and exogenous sulfur to operate diverse cellular processes. Sulfur limitation affects virulence and pathogenicity, and modulates proteome of sulfur assimilating enzymes of several fungi. However, there are no previous reports aimed at exploring effects of sulfur limitation on the regulation of A. flavipes sulfur metabolism enzymes at the transcriptional, post-transcriptional and proteomic levels. In this report, we show that sulfur limitation affects morphological and physiological responses of A. flavipes. Transcription and enzymatic activities of several key sulfur metabolism genes, ATP-sulfurylase, sulfite reductase, methionine permease, cysteine synthase, cystathionine beta- and gamma-lyase, glutathione reductase and glutathione peroxidase were increased under sulfur starvation conditions. A 50 kDa protein band was strongly induced by sulfur starvation, and the proteomic analyses of this protein band using LC-MS/MS revealed similarity to many proteins involved in the sulfur metabolism pathway.	[El-Sayed, Ashraf S. A.; Yassin, Marwa A.] Zagazig Univ, Dept Bot & Microbiol, Fac Sci, Zagazig 44519, Egypt; [El-Sayed, Ashraf S. A.; Ali, Gul Shad] Univ Florida, Dept Plant Pathol, Mid Florida Res & Educ Ctr, Apopka, FL 32703 USA	Egyptian Knowledge Bank (EKB); Zagazig University; State University System of Florida; University of Florida	El-Sayed, ASA (corresponding author), Zagazig Univ, Dept Bot & Microbiol, Fac Sci, Zagazig 44519, Egypt.	Ashrafzu@ufl.edu; gsali@ufl.edu			Florida Agriculture Experiment Station, Institute of Food and Agricultural Sciences at the University of Florida	Florida Agriculture Experiment Station, Institute of Food and Agricultural Sciences at the University of Florida	This work was supported by funds to G.S.A. from the Florida Agriculture Experiment Station, Institute of Food and Agricultural Sciences at the University of Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by funds to G.S.A. from the Florida Agriculture Experiment Station, Institute of Food and Agricultural Sciences at the University of Florida.	Amich J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003573; Anderson M.E., 1985, J METH ENZYMOL, V113, P548, DOI DOI 10.1016/S0076-6879(85)13073-9; Bai ZQ, 2014, FITOTERAPIA, V95, P194, DOI 10.1016/j.fitote.2014.03.021; BARROW CJ, 1994, J NAT PROD, V57, P471, DOI 10.1021/np50106a005; Brzywczy J, 2002, YEAST, V19, P29, DOI 10.1002/yea.798; Brzywczy J, 2007, RES MICROBIOL, V158, P428, DOI 10.1016/j.resmic.2007.03.002; Brzywczy J, 2011, FUNGAL GENET BIOL, V48, P104, DOI 10.1016/j.fgb.2010.10.002; Carmel-Harel O, 2000, ANNU REV MICROBIOL, V54, P439, DOI 10.1146/annurev.micro.54.1.439; Ferreira MED, 2006, MOL GENET GENOMICS, V276, P450, DOI 10.1007/s00438-006-0154-4; Desai PR, 2011, J BIOL CHEM, V286, P41183, DOI 10.1074/jbc.M111.272377; DEVITO PC, 1964, J BACTERIOL, V88, P1341, DOI 10.1128/JB.88.5.1341-1348.1964; El-Sayed AS, 2015, ACTA BIOL HUNG, V66, P119, DOI 10.1556/ABiol.66.2015.1.10; El-Sayed AS, 2013, J MICROBIOL BIOTECHN, V23, P499, DOI 10.4014/jmb.1208.08070; El-Sayed AS, 2012, ENZYME MICROB TECH, V51, P200, DOI 10.1016/j.enzmictec.2012.06.004; El-Sayed AS, 2010, APPL MICROBIOL BIOT, V86, P445, DOI 10.1007/s00253-009-2303-2; El-Sayed ASA, 2014, ENZYME MICROB TECH, V54, P59, DOI 10.1016/j.enzmictec.2013.10.004; El-Sayed ASA, 2011, J MICROBIOL, V49, P130, DOI 10.1007/s12275-011-0259-2; El-Sayed ASA, 2009, J BASIC MICROB, V49, P331, DOI 10.1002/jobm.200800318; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; ELSKENS MT, 1991, J GEN MICROBIOL, V137, P637, DOI 10.1099/00221287-137-3-637; Esbelin J, 2013, PHOTOCHEM PHOTOBIOL, V89, P758, DOI 10.1111/php.12037; Fauchon M, 2002, MOL CELL, V9, P713, DOI 10.1016/S1097-2765(02)00500-2; GAITONDE MK, 1967, BIOCHEM J, V104, P627, DOI 10.1042/bj1040627; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; HALLENBECK PC, 1989, J BACTERIOL, V171, P3008, DOI 10.1128/jb.171.6.3008-3015.1989; Hansen J, 2000, MOL GEN GENET, V263, P535, DOI 10.1007/s004380051199; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hebert A, 2013, APPL ENVIRON MICROB, V79, P1200, DOI 10.1128/AEM.03259-12; Irmler S, 2008, APPL ENVIRON MICROB, V74, P99, DOI 10.1128/AEM.00745-07; Jiang T, 2004, J ASIAN NAT PROD RES, V6, P249, DOI 10.1080/1028602031000147384; KETTER JS, 1988, MOL CELL BIOL, V8, P1504, DOI 10.1128/MCB.8.4.1504; Khalaf SA, 2009, CURR MICROBIOL, V58, P219, DOI 10.1007/s00284-008-9311-9; Kumar C, 2011, EMBO J, V30, P2044, DOI 10.1038/emboj.2011.105; Kwon YJ, 2012, J NAT PROD, V75, P271, DOI 10.1021/np200720v; LAEMMLI UK, 1970, J MOL BIOL, V47, P69, DOI 10.1016/0022-2836(70)90402-X; Lafaye A, 2005, J BIOL CHEM, V280, P24723, DOI 10.1074/JBC.M502285200; Laxman S, 2013, CELL, V154, P416, DOI 10.1016/j.cell.2013.06.043; Lima PD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002855; MARESCA B, 1978, J BACTERIOL, V135, P987, DOI 10.1128/JB.135.3.987-992.1978; Marzluf GA, 1997, ANNU REV MICROBIOL, V51, P73, DOI 10.1146/annurev.micro.51.1.73; NATORFF R, 1993, MOL GEN GENET, V238, P185, DOI 10.1007/BF00279546; Natorff R, 2003, MOL MICROBIOL, V49, P1081, DOI 10.1046/j.1365-2958.2003.03617.x; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Nosanchuk JD, 2003, CELL MICROBIOL, V5, P203, DOI 10.1046/j.1462-5814.2003.00268.x; Parente AFA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022810; Pilsyk S, 2007, FUNGAL GENET BIOL, V44, P715, DOI 10.1016/j.fgb.2006.11.007; Pilsyk S, 2009, ACTA BIOCHIM POL, V56, P375; Piotrowska M, 2000, MOL GEN GENET, V264, P276, DOI 10.1007/s004380000319; Raper KB, 1965, GENUS ASPERGILLUS GE; Reveal Brad S, 2012, BMC Res Notes, V5, P339, DOI 10.1186/1756-0500-5-339; Rochfort S, 2005, J ANTIBIOT, V58, P279, DOI 10.1038/ja.2005.34; Sato I, 2009, J BIOL CHEM, V284, P8042, DOI 10.1074/jbc.M807771200; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; SIEGEL LM, 1965, ANAL BIOCHEM, V11, P126, DOI 10.1016/0003-2697(65)90051-5; Singaravelan N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002993; Stalder D, 2013, P NATL ACAD SCI USA, V110, P19995, DOI 10.1073/pnas.1320029110; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; THOMAS D, 1995, MOL CELL BIOL, V15, P6526; Trotter EW, 2003, EMBO REP, V4, P184, DOI 10.1038/sj.embor.embor729; van de Kamp M, 1999, J BACTERIOL, V181, P7228, DOI 10.1128/JB.181.23.7228-7234.1999; Vido K, 2001, J BIOL CHEM, V276, P8469, DOI 10.1074/jbc.M008708200; Warrilow AGS, 2000, J EXP BOT, V51, P985, DOI 10.1093/jexbot/51.347.985; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhou GX, 2004, J NAT PROD, V67, P328, DOI 10.1021/np030353m	64	20	23	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144304	10.1371/journal.pone.0144304	http://dx.doi.org/10.1371/journal.pone.0144304			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633307	Green Submitted, Green Published, gold			2022-12-27	WOS:000366040000080
J	Jancuchova-Laskova, J; Landova, E; Frynta, D				Jancuchova-Laskova, Jitka; Landova, Eva; Frynta, Daniel			Experimental Crossing of Two Distinct Species of Leopard Geckos, Eublepharis angramainyu and E. macularius: Viability, Fertility and Phenotypic Variation of the Hybrids	PLOS ONE			English	Article							DEPENDENT SEX DETERMINATION; HETERONOTIA-BINOEI GEKKONIDAE; PRINCIPAL-COMPONENTS-ANALYSIS; DRAGON LIZARDS AGAMIDAE; POSTZYGOTIC ISOLATION; IRANIAN PLATEAU; BODY SHAPE; INTERSPECIFIC HYBRIDIZATION; OUTBREEDING DEPRESSION; NATURAL HYBRIDIZATION	Hybridization between distinct species of animals and subsequent genetic introgression plays a considerable role in the speciation process and the emergence of adaptive characters. Fitness of between-species hybrids usually sharply decreases with the divergence time of the concerned species and the divergence depth, which still allows for a successful crossing differs among principal clades of vertebrates. Recently, a review of hybridization events among distinct lizard species revealed that lizards belong to vertebrates with a highly developed ability to hybridize. In spite of this, reliable reports of experimental hybridizations between genetically fairly divergent species are only exceptional. Here, we show the results of the crossing of two distinct allopatric species of eyelid geckos possessing temperature sex determination and lacking sex chromosomes: Eublepharis macularius distributed in Pakistan/Afghanistan area and E. angramainyu, which inhabits Mesopotamia and adjacent areas. We demonstrated that F-1 hybrids were viable and fertile, and the introgression of E. angramainyu genes into the E. macularius genome can be enabled via a backcrossing. The examined hybrids (except those of the F-2 generation) displayed neither malformations nor a reduced survival. Analyses of morphometric and coloration traits confirmed phenotypic distinctness of both parental species and their F-1 hybrids. These findings contrast with long-term geographic and an evolutionary separation of the studied species. Thus, the occurrence of fertile hybrids of comparably divergent species, such as E. angramainyu and E. macularius, may also be expected in other taxa of squamates. This would violate the current estimates of species diversity in lizards.	[Jancuchova-Laskova, Jitka; Landova, Eva; Frynta, Daniel] Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic	Charles University Prague	Frynta, D (corresponding author), Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic.	frynta@centrum.cz	Lásková, Jitka Jančúchová/V-1899-2019; Frynta, Daniel/L-7350-2016; Landova, Eva/R-8759-2017	Frynta, Daniel/0000-0002-1375-7972; Landova, Eva/0000-0001-8365-8710	Grant Agency of the Academy of Sciences of the Czech Republic [IAA 601410803]; Specific Academic Research Projects Competition [SVV-2015-260208]	Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic); Specific Academic Research Projects Competition	This study was supported by the Grant Agency of the Academy of Sciences of the Czech Republic project no. IAA 601410803 and by the Specific Academic Research Projects Competition project no. SVV-2015-260208. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson S.C., 1999, LIZARDS IRAN SOC STU; Sanchez-Guillen RA, 2012, EVOLUTION, V66, P690, DOI 10.1111/j.1558-5646.2011.01469.x; [Anonymous], 2005, EYELASH GECKOS CARE; ARNOLD ML, 1992, ANNU REV ECOL SYST, V23, P237, DOI 10.1146/annurev.es.23.110192.001321; Arnold SJ, 1996, EVOLUTION, V50, P1024, DOI 10.1111/j.1558-5646.1996.tb02343.x; Arntzen JW, 2014, BIOL J LINN SOC, V113, P604, DOI 10.1111/bij.12358; Arrieta RS, 2013, BIOL J LINN SOC, V110, P528, DOI 10.1111/bij.12153; AUTUMN K, 1995, J HERPETOL, V29, P157, DOI 10.2307/1564552; Baranwal VK, 2012, J EXP BOT, V63, P6309, DOI 10.1093/jxb/ers291; Barton NH, 2001, MOL ECOL, V10, P551, DOI 10.1046/j.1365-294x.2001.01216.x; BAUR B, 1984, Salamandra, V20, P70; Berry OF, 2006, CONSERV GENET, V7, P427, DOI 10.1007/s10592-005-9054-0; Bolnick DI, 2008, GENETICS, V178, P1037, DOI 10.1534/genetics.107.081364; Bolnick DI, 2005, EVOLUTION, V59, P1754, DOI 10.1111/j.0014-3820.2005.tb01824.x; Booth W, 2012, BIOL LETTERS, V8, P983, DOI 10.1098/rsbl.2012.0666; Bragg WK, 2000, BIOL J LINN SOC, V69, P319, DOI 10.1006/bijl.1999.0359; BRANCH B., 1984, J HERPETOL ASS AFRIC, V30, P1; Breuil M, 2000, W INDIAN IGUANA SPEC, V3, P11; Brochu CA, 2000, COPEIA, P657, DOI 10.1643/0045-8511(2000)000[0657:PRADTO]2.0.CO;2; BULL JJ, 1980, Q REV BIOL, V55, P3, DOI 10.1086/411613; BULL JJ, 1987, CAN J ZOOL, V65, P1421, DOI 10.1139/z87-224; BULL JJ, 1988, J EVOLUTION BIOL, V2, P177; Burke JM, 2001, ANNU REV GENET, V35, P31, DOI 10.1146/annurev.genet.35.102401.085719; Buskirk James R., 2005, Salamandra, V41, P21; CAPULA M, 1993, BIOCHEM SYST ECOL, V21, P373, DOI 10.1016/0305-1978(93)90028-P; Capula M, 2002, AMPHIBIA-REPTILIA, V23, P313, DOI 10.1163/15685380260449199; CUELLAR O, 1972, J GENET, V61, P14, DOI 10.1007/BF02984098; Darevsky Ilya S., 1993, Herpetozoa, V6, P3; DAREVSKY IS, 1984, J HERPETOL, V18, P277, DOI 10.2307/1564081; Darwin C, 1859, ORIGIN SPECIES MEANS; Devitt TJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-245; Dobson AP, 1996, CONSERVATION BIODIVE; Dobzhansky T, 1936, GENETICS, V21, P113; Dobzhansky T., 1937; Dowling TE, 1997, ANNU REV ECOL SYST, V28, P593, DOI 10.1146/annurev.ecolsys.28.1.593; Edmands S, 1999, EVOLUTION, V53, P1757, DOI 10.1111/j.1558-5646.1999.tb04560.x; Edmands S, 2007, MOL ECOL, V16, P463, DOI 10.1111/j.1365-294X.2006.03148.x; Fitzpatrick BM, 2007, P NATL ACAD SCI USA, V104, P15793, DOI 10.1073/pnas.0704791104; Fitzpatrick BM, 2004, EVOLUTION, V58, P1865; FLORES D, 1994, PHYSIOL BEHAV, V55, P1067, DOI 10.1016/0031-9384(94)90389-1; Frankham R, 1995, ANNU REV GENET, V29, P305, DOI 10.1146/annurev.ge.29.120195.001513; Frankham R, 2012, BIOL CONSERV, V153, P25, DOI 10.1016/j.biocon.2012.04.034; Frankham R, 2011, CONSERV BIOL, V25, P465, DOI 10.1111/j.1523-1739.2011.01662.x; Frydlova P, 2011, AMPHIBIA-REPTILIA, V32, P27, DOI 10.1163/017353710X532184; Frynta Daniel, 1997, Acta Societatis Zoologicae Bohemicae, V61, P3; Fuller RC, 2008, EVOLUTION, V62, P3056, DOI 10.1111/j.1558-5646.2008.00518.x; Galan Pedro, 2002, Boletin de la Asociacion Herpetologica Espanola, V13, P28; Garland Theodore Jr., 1994, P240; Georges A, 2002, ZOOL J LINN SOC-LOND, V134, P401, DOI 10.1046/j.1096-3642.2002.00007.x; Glover KA, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-74; Godinho R, 2005, AMPHIBIA-REPTILIA, V26, P271, DOI 10.1163/156853805774408667; Grabe Julian, 2014, Biawak, V8, P79; Grant BR, 2008, PHILOS T R SOC B, V363, P2821, DOI 10.1098/rstb.2008.0051; Grant BR, 1996, ECOLOGY, V77, P500, DOI 10.2307/2265625; GRANT PR, 1992, SCIENCE, V256, P193, DOI 10.1126/science.256.5054.193; Grant PR, 2004, EVOLUTION, V58, P1588; Gutsche Alexander, 2004, Salamandra, V40, P201; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Hedrick PW, 2013, MOL ECOL, V22, P4606, DOI 10.1111/mec.12415; Herrel A, 2001, BIOL J LINN SOC, V74, P305, DOI 10.1006/bijl.2001.0579; Herrington SJ, 2008, T AM FISH SOC, V137, P158, DOI 10.1577/T07-044.1; Hiadlovska Z, 2013, BIOL J LINN SOC, V108, P225, DOI 10.1111/j.1095-8312.2012.01997.x; Hoser R., 1988, Litteratura Serpentium English Edition, V8, P134; Huang V, 2012, PHYSIOL BEHAV, V107, P121, DOI 10.1016/j.physbeh.2012.06.014; Huxley J, 1940, NEW SYSTEMATICS, P185; Jancuchova-Laskova J, 2015, CURR ZOOL, V61, P155; KARL SA, 1995, J HERED, V86, P262, DOI 10.1093/oxfordjournals.jhered.a111579; Kearney M, 2005, PHYSIOL BIOCHEM ZOOL, V78, P316, DOI 10.1086/430033; Kearney M, 2004, AM NAT, V164, P803, DOI 10.1086/425986; Kinney ME, 2013, ZOO BIOL, V32, P172, DOI 10.1002/zoo.21050; Kohler J, 2012, SALAMANDRA, V48, P1; Kratochvil L, 2003, CAN J ZOOL, V81, P1112, DOI 10.1139/Z03-078; Kratochvil L, 2002, BIOL J LINN SOC, V76, P303, DOI 10.1046/j.1095-8312.2002.00064.x; Kratochvil L, 2006, BIOL J LINN SOC, V88, P527, DOI 10.1111/j.1095-8312.2006.00627.x; LaDage LD, 2006, BEHAVIOUR, V143, P1033, DOI 10.1163/156853906778623644; Lampert KP, 2008, SEX DEV, V2, P290, DOI 10.1159/000195678; LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403; Landova E, 2013, BEHAV ECOL SOCIOBIOL, V67, P1113, DOI 10.1007/s00265-013-1536-3; LeClere JB, 2012, J HERPETOL, V46, P257, DOI 10.1670/10-260; Lijtmaer DA, 2003, EVOLUTION, V57, P1411, DOI 10.1111/j.0014-3820.2003.tb00348.x; Lopez-Fernandez H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001294; Lourenco JM, 2013, J EVOLUTION BIOL, V26, P38, DOI 10.1111/jeb.12031; Lucker H, 2002, ELAPHE, V10, P49; LYNCH M, 1991, EVOLUTION, V45, P622, DOI [10.1111/j.1558-5646.1991.tb04333.x, 10.2307/2409915]; Macey JR, 1998, MOL PHYLOGENET EVOL, V10, P118, DOI 10.1006/mpev.1997.0478; Macey JR, 2000, MOL PHYLOGENET EVOL, V14, P479, DOI 10.1006/mpev.1999.0722; Machado T, 2014, MOL PHYLOGENET EVOL, V71, P1, DOI 10.1016/j.ympev.2013.10.003; Macholan M, 2007, EVOLUTION, V61, P746, DOI 10.1111/j.1558-5646.2007.00065.x; Mallet J, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-28; Matute DR, 2010, SCIENCE, V329, P1518, DOI 10.1126/science.1193440; Miralles L, 2014, J SEA RES, V86, P69, DOI 10.1016/j.seares.2013.11.009; MORITZ C, 1987, EVOLUTION, V41, P1252, DOI 10.1111/j.1558-5646.1987.tb02464.x; MORITZ C, 1983, SCIENCE, V220, P735, DOI 10.1126/science.220.4598.735; Mouthereau F, 2012, TECTONOPHYSICS, V532, P27, DOI 10.1016/j.tecto.2012.01.022; Mouthereau F, 2011, GEOL MAG, V148, P726, DOI 10.1017/S0016756811000306; Muller HJ, 1942, BIOL S, V6, P71; Naro-Maciel E, 2008, MOL PHYLOGENET EVOL, V49, P659, DOI 10.1016/j.ympev.2008.08.004; Neaves WB, 2011, TRENDS GENET, V27, P81, DOI 10.1016/j.tig.2010.12.002; Nichols P, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2272; Olave M, 2011, MOL PHYLOGENET EVOL, V61, P381, DOI 10.1016/j.ympev.2011.07.006; Olsson M, 1996, J EVOLUTION BIOL, V9, P229, DOI 10.1046/j.1420-9101.1996.9020229.x; ORR HA, 1989, GENETICS, V121, P527; Peek Ron, 2009, Lacerta, V67, P251; Placyk JS, 2012, CONSERV GENET, V13, P649, DOI 10.1007/s10592-012-0315-4; Pokorna M, 2010, CHROMOSOME RES, V18, P809, DOI 10.1007/s10577-010-9154-7; Pokorna M, 2009, ZOOL J LINN SOC-LOND, V156, P168, DOI 10.1111/j.1096-3642.2008.00481.x; POLET G, 2002, P 16 WORK M IUCN SSC, P86; Pouyani ER, 2010, ZOOL J LINN SOC-LOND, V158, P641, DOI 10.1111/j.1096-3642.2009.00553.x; PRAGER EM, 1975, P NATL ACAD SCI USA, V72, P200, DOI 10.1073/pnas.72.1.200; Presgraves DC, 2010, AM NAT, V176, pS45, DOI 10.1086/657058; Price TD, 2002, EVOLUTION, V56, P2083; Rassmann K, 1997, J ZOOL, V242, P729, DOI 10.1111/j.1469-7998.1997.tb05822.x; Reifova R, 2011, J ORNITHOL, V152, P1063, DOI 10.1007/s10336-011-0700-7; Rhen T, 2000, GEN COMP ENDOCR, V118, P322, DOI 10.1006/gcen.2000.7477; Rieseberg LH, 1999, HEREDITY, V83, P363, DOI 10.1038/sj.hdy.6886170; Robbins TR, 2014, J HERED, V105, P226, DOI 10.1093/jhered/est093; Robbins TR, 2010, J ANIM ECOL, V79, P137, DOI 10.1111/j.1365-2656.2009.01594.x; Rykena S, 1996, ISRAEL J ZOOL, V42, P171; RYKENA S, 1978, Salamandra, V14, P147; Rykena S., 1991, Mitteilungen aus dem Zoologischen Museum in Berlin, V67, P55; Rykena S, 2002, MERTENSIELLA, V13, P78; Sasa MM, 1998, EVOLUTION, V52, P1811, DOI 10.1111/j.1558-5646.1998.tb02258.x; Schilde Maik, 2004, Asiatic Herpetological Research, V10, P120; Schumer M, 2014, ELIFE, V3, DOI 10.7554/eLife.02535; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Shine R, 2004, CAN J ZOOL, V82, P1091, DOI 10.1139/Z04-086; Smid J, 2012, ACTA HERPETOL, V7, P139; Smit JHW, 2013, TECTONOPHYSICS, V602, P176, DOI 10.1016/j.tecto.2012.10.032; Smith SA, 2005, EVOLUTION, V59, P2433; SOMERS KM, 1989, SYST ZOOL, V38, P169, DOI 10.2307/2992386; SOMERS KM, 1986, SYST ZOOL, V35, P359, DOI 10.2307/2413387; Starostova Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064715; Starostova Z, 2009, AM NAT, V174, pE100, DOI 10.1086/603610; Stelkens R, 2009, EVOLUTION, V63, P884, DOI 10.1111/j.1558-5646.2008.00599.x; Strasburg JL, 2005, MOL ECOL, V14, P2755, DOI 10.1111/j.1365-294X.2005.02627.X; Amaral AT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085814; Thompson GG, 2005, AMPHIBIA-REPTILIA, V26, P73, DOI 10.1163/1568538053693369; Thompson GG, 2005, AMPHIBIA-REPTILIA, V26, P65, DOI 10.1163/1568538053693323; Thompson GG, 2005, AMPHIBIA-REPTILIA, V26, P55, DOI 10.1163/1568538053693332; Trobisch Dietmar, 2005, Eidechse, V16, P25; True JR, 1996, GENETICS, V142, P819; Turelli M, 2000, GENETICS, V154, P1663; TURELLI M, 1995, GENETICS, V140, P389; Turelli M, 2007, GENETICS, V176, P1059, DOI 10.1534/genetics.106.065979; UZZELL T, 1975, COPEIA, P204; Van der Sluijs I, 2008, J EVOLUTION BIOL, V21, P480, DOI 10.1111/j.1420-9101.2007.01495.x; VIETS BE, 1993, J EXP ZOOL, V265, P679, DOI 10.1002/jez.1402650610; Vines TH, 2003, EVOLUTION, V57, P1876; Vitt LJ, 1997, P NATL ACAD SCI USA, V94, P3828, DOI 10.1073/pnas.94.8.3828; Wagner E., 1980, Q REV BIOL, V55, P21; Watts PC, 2006, NATURE, V444, P1021, DOI 10.1038/4441021a; WILSON AC, 1974, P NATL ACAD SCI USA, V71, P2843, DOI 10.1073/pnas.71.7.2843; WRIGHT JW, 1968, COPEIA, P128; Zhang PJ, 2014, AQUAT MAMM, V40, P5, DOI 10.1578/AM.40.1.2014.5; Zinenko O. I., 2003, Vestnik Zoologii, V37, P101; Zinenko Oleksander, 2004, Mertensiella, V15, P17	157	8	8	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143630	10.1371/journal.pone.0143630	http://dx.doi.org/10.1371/journal.pone.0143630			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633648	Green Published, gold, Green Submitted			2022-12-27	WOS:000366040000018
J	Wang, JT; Chang, SC; Chang, FY; Fung, CP; Chuang, YC; Chen, YS; Shiau, YR; Tan, MC; Wang, HY; Lai, JF; Huang, IW; Lauderdale, TLY				Wang, Jann-Tay; Chang, Shan-Chwen; Chang, Feng-Yee; Fung, Chang-Phone; Chuang, Yin-Ching; Chen, Yao-Shen; Shiau, Yih-Ru; Tan, Mei-Chen; Wang, Hui-Ying; Lai, Jui-Fen; Huang, I-Wen; Lauderdale, Tsai-Ling Yang			Antimicrobial Non-Susceptibility of Escherichia coli from Outpatients and Patients Visiting Emergency Rooms in Taiwan	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASE; MEDIATED QUINOLONE RESISTANCE; URINARY-TRACT-INFECTIONS; CTX-M; RISK-FACTORS; KLEBSIELLA-PNEUMONIAE; MULTIPLEX PCR; TRENDS SMART; ENTEROBACTERIACEAE; AMPC	Longitudinal nationwide surveillance data on antimicrobial non-susceptibility and prevalence of extended-spectrum beta-lactamases (ESBLs) as well as AmpC beta-lactamases producers among Escherichia coli from different sources in the community settings are limited. Such data may impact treatment practice. The present study investigated E. coli from outpatients and patients visiting emergency rooms collected by the Taiwan Surveillance of Antimicrobial Resistance (TSAR) program. A total of 3481 E. coli isolates were studied, including 2153 (61.9%) from urine and 1125 (32.3%) from blood samples. These isolates were collected biennially between 2002 and 2012 from a total of 28 hospitals located in different geographic regions of Taiwan. Minimum inhibitory concentrations (MIC) were determined using methods recommended by the Clinical Laboratory Standards Institute (CLSI). The prevalence and factors associated with the presence of ESBL and AmpC beta-lactamase-producers were determined. Significant increases in non-susceptibility to most beta-lactams and ciprofloxacin occurred during the study period. By 2012, non-susceptibility to cefotaxime and ciprofloxacin reached 21.1% and 26.9%, respectively. The prevalence of ESBL- and AmpC-producers also increased from 4.0% and 5.3%, respectively, in 2002-2004, to 10.7% for both in 2010-2012 (P < 0.001). The predominant ESBL and AmpC beta-lactamase genes were CTX-M and CMY-types, respectively. Non-susceptibility of urine isolates to nitrofurantoin remained at around 8% and to fosfomycin was low (0.7%) but to cefazolin (based on the 2014 CLSI urine criteria) increased from 11.5% in 2002-2004 to 23.9% in 2010-2012 (P < 0.001). Non-susceptibility of isolates from different specimen types was generally similar, but isolates from elderly patients were significantly more resistant to most antimicrobial agents and associated with the presence of ESBL-and AmpC-beta-lactamases. An additional concern is that decreased ciprofloxacin susceptibility (MIC 0.12-1 mg/L) was as high as 25% in isolates from all age groups, including those from pediatric patients. Our data indicated that there is a need to re-evaluate appropriate treatment selection for community-acquired infections in Taiwan. Identification of community reservoirs of multidrug-resistant E. coli is also warranted.	[Wang, Jann-Tay; Chang, Shan-Chwen] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Wang, Jann-Tay; Shiau, Yih-Ru; Tan, Mei-Chen; Wang, Hui-Ying; Lai, Jui-Fen; Huang, I-Wen; Lauderdale, Tsai-Ling Yang] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan, Taiwan; [Chang, Shan-Chwen] Natl Taiwan Univ, Grad Inst Clin Pharm, Coll Med, Taipei 10764, Taiwan; [Chang, Feng-Yee] Triserv Gen Hosp, Div Infect Dis & Trop Med, Taipei, Taiwan; [Chang, Feng-Yee] Natl Def Med Ctr, Dept Internal Med, Taipei, Taiwan; [Fung, Chang-Phone] Taipei Vet Gen Hosp, Div Infect Dis, Dept Med, Taipei, Taiwan; [Chuang, Yin-Ching] Chi Mei Med Ctr, Dept Internal Med, Tainan, Taiwan; [Chen, Yao-Shen] Kaohsiung Vet Gen Hosp, Dept Med, Kaohsiung, Taiwan; [Chen, Yao-Shen] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan	National Taiwan University; National Taiwan University Hospital; National Health Research Institutes - Taiwan; National Taiwan University; Tri-Service General Hospital; National Defense Medical Center; Taipei Veterans General Hospital; Chi Mei Hospital; Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University	Lauderdale, TLY (corresponding author), Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan, Taiwan.	lauderdale@nhri.org.tw	wang, hui/GRS-4730-2022	WANG, JANN-TAY/0000-0002-0924-3469; CHANG, SHAN-CHWEN/0000-0001-6505-4139	National Health Research Institutes [IV-101-PP-01, IV-102-PP-01]	National Health Research Institutes(National Health Research Institutes, JapanNational Health Research Institutes - Taiwan)	This project was supported by an intramural grant from the National Health Research Institutes (IV-101-PP-01 and IV-102-PP-01).	Allocati N, 2013, INT J ENV RES PUB HE, V10, P6235, DOI 10.3390/ijerph10126235; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Balode A, 2013, INT J ANTIMICROB AG, V41, P527, DOI 10.1016/j.ijantimicag.2013.02.022; Ben-Ami R, 2009, CLIN INFECT DIS, V49, P682, DOI 10.1086/604713; Bouchillon Sam, 2012, Open Microbiol J, V6, P74; Bouchillon SK, 2013, CLIN THER, V35, P872, DOI 10.1016/j.clinthera.2013.03.022; Brolund Alma, 2014, Infection Ecology & Epidemiology, V4, P24555, DOI 10.3402/iee.v4.24555; Carbonnel A, 2013, J ANTIMICROB CHEMOTH, V68, P954, DOI 10.1093/jac/dks464; Clinical and Laboratory Standards Institute (CLSI), 2014, M100S24 CLSI S; D'Andrea MM, 2013, INT J MED MICROBIOL, V303, P305, DOI 10.1016/j.ijmm.2013.02.008; Dudley MN, 2013, CLIN INFECT DIS, V56, P1301, DOI 10.1093/cid/cit017; EDBERG SC, 1983, J CLIN MICROBIOL, V18, P1287, DOI 10.1128/JCM.18.6.1287-1291.1983; Foxman B, 2010, NAT REV UROL, V7, P653, DOI 10.1038/nrurol.2010.190; Hanson ND, 2008, ANTIMICROB AGENTS CH, V52, P3814, DOI 10.1128/AAC.00877-08; Harbarth S, 2003, AM J MED, V115, P529, DOI 10.1016/j.amjmed.2003.07.005; Hawkey PM, 2009, J ANTIMICROB CHEMOTH, V64, P3, DOI 10.1093/jac/dkp256; Hawser SP, 2010, INT J ANTIMICROB AG, V36, P293, DOI 10.1016/j.ijantimicag.2010.05.012; Hooton TM, 2012, NEW ENGL J MED, V366, P1028, DOI 10.1056/NEJMcp1104429; Ironmonger D, 2015, J ANTIMICROB CHEMOTH, V70, P1744, DOI 10.1093/jac/dkv043; Kahlmeter G, 2012, INT J ANTIMICROB AG, V39, P45, DOI 10.1016/j.ijantimicag.2011.09.013; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Karlowsky JA, 2013, ANTIMICROB AGENTS CH, V57, P5600, DOI 10.1128/AAC.01485-13; Kuo SC, 2014, EMERG INFECT DIS, V20, P1386, DOI 10.3201/eid2008.140341; Labreche MJ, 2012, AM J HEALTH-SYST PH, V69, P1863, DOI 10.2146/ajhp110464; Lee CH, 2015, J MICROBIOL IMMUNOL, V48, P269, DOI 10.1016/j.jmii.2013.08.010; McDonald LC, 2001, ANTIMICROB AGENTS CH, V45, P3084, DOI 10.1128/AAC.45.11.3084-3091.2001; Monstein HJ, 2007, APMIS, V115, P1400, DOI 10.1111/j.1600-0463.2007.00722.x; O'Brien TF, 2011, CLIN MICROBIOL REV, V24, P281, DOI 10.1128/CMR.00021-10; Oteo J, 2010, CURR OPIN INFECT DIS, V23, P320, DOI 10.1097/QCO.0b013e3283398dc1; Pascual V, 2015, J ANTIMICROB CHEMOTH, V70, P899, DOI 10.1093/jac/dku468; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Piddock LJV, 1999, DRUGS, V58, P11, DOI 10.2165/00003495-199958002-00003; Pitout JDD, 2013, CURR PHARM DESIGN, V19, P257, DOI 10.2174/138161213804070348; Poirel L, 2006, ANTIMICROB AGENTS CH, V50, P1525, DOI 10.1128/AAC.50.4.1525-1527.2006; Poulou A, 2014, J CLIN MICROBIOL, V52, P1483, DOI 10.1128/JCM.03361-13; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Rooney PJ, 2009, J ANTIMICROB CHEMOTH, V64, P635, DOI 10.1093/jac/dkp220; Rossolini GM, 2008, CLIN MICROBIOL INFEC, V14, P33, DOI 10.1111/j.1469-0691.2007.01867.x; Sanchez GV, 2014, J ANTIMICROB CHEMOTH, V69, P3259, DOI 10.1093/jac/dku282; Sheng WH, 2013, ANTIMICROB AGENTS CH, V57, P2981, DOI 10.1128/AAC.00971-12; Solomkin JS, 2010, CLIN INFECT DIS, V50, P133, DOI 10.1086/649554; Strahilevitz J, 2009, CLIN MICROBIOL REV, V22, P664, DOI 10.1128/CMR.00016-09; Tan TY, 2011, DIAGN MICR INFEC DIS, V70, P423, DOI 10.1016/j.diagmicrobio.2011.03.008; Tansarli GS, 2014, J ANTIMICROB CHEMOTH, V69, P1177, DOI 10.1093/jac/dkt500; Theuretzbacher U, 2015, J ANTIMICROB CHEMOTH, V70, P2177, DOI 10.1093/jac/dkv157; Valles J, 2003, CHEST, V123, P1615, DOI 10.1378/chest.123.5.1615; Wang JT, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-486; World Health Organization, 2013, TECHN CONS STRAT GLO; Zhang J, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0659-0	49	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144103	10.1371/journal.pone.0144103	http://dx.doi.org/10.1371/journal.pone.0144103			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26632819	gold, Green Published, Green Submitted			2022-12-27	WOS:000366040000056
J	Bonasera, SJ; Schenk, AK; Luxenberg, EJ; Wang, XD; Basbaum, A; Tecott, LH				Bonasera, Stephen J.; Schenk, A. Katrin; Luxenberg, Evan J.; Wang, Xidao; Basbaum, Allan; Tecott, Laurence H.			Mice Lacking Serotonin 2C Receptors Have increased Affective Responses to Aversive Stimuli	PLOS ONE			English	Article							FEAR-POTENTIATED STARTLE; VENTRAL TEGMENTAL AREA; PAIN-RELATED BEHAVIOR; ACOUSTIC STARTLE; SHOCK SENSITIZATION; NEUROPATHIC PAIN; 5-HT RECEPTORS; ULTRASONIC VOCALIZATION; 5-HT2A/2C RECEPTORS; MESSENGER-RNAS	Although central serotonergic systems are known to influence responses to noxious stimuli, mechanisms underlying serotonergic modulation of pain responses are unclear. We proposed that serotonin 2C receptors (5-HT(2C)Rs), which are expressed within brain regions implicated in sensory and affective responses to pain, contribute to the serotonergic modulation of pain responses. In mice constitutively lacking 5-HT(2C)Rs (2CKO mice) we found normal baseline sensory responses to noxious thermal, mechanical and chemical stimuli. In contrast, 2CKO mice exhibited a selective enhancement of affect-related ultrasonic after-discharge vocalizations in response to footshock. Enhanced affect-related responses to noxious stimuli were also exhibited by 2CKO mice in a fear-sensitized startle assay. The extent to which a brief series of unconditioned footshocks produced enhancement of acoustic startle responses was markedly increased in 2CKO mice. As mesolimbic dopamine pathways influence affective responses to noxious stimuli, and these pathways are disinhibited in 2CKO mice, we examined the sensitivity of footshock-induced enhancement of startle to dopamine receptor blockade. Systemic administration of the dopamine D-2/D-3 receptor antagonist raclopride selectively reduced footshock-induced enhancement of startle without influencing baseline acoustic startle responses. We propose that 5-HT(2C)Rs regulate affective behavioral responses to unconditioned aversive stimuli through mechanisms involving the disinhibition of ascending dopaminergic pathways.	[Bonasera, Stephen J.; Luxenberg, Evan J.] Univ Calif San Francisco, Dept Med, Div Geriatr, San Francisco, CA USA; [Schenk, A. Katrin; Tecott, Laurence H.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Wang, Xidao; Basbaum, Allan] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bonasera, SJ (corresponding author), Univ Nebraska Med Ctr, Dept Internal Med, Div Geriatr, Omaha, NE 68198 USA.	sbonasera@unmc.edu		Bonasera, Stephen/0000-0001-6808-2821	National Institutes of Health (NIH) [MH065983]; Brookdale National Fellowship Program; NIH [AG026043, NS014627, DA29204, DA11177]; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH065983] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS014627, R37NS014627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG026043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011177, R01DA029204] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brookdale National Fellowship Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from National Institutes of Health (NIH) MH065983 and the Brookdale National Fellowship Program (SJB), NIH AG026043 (SJB, AKS), NIH NS014627, DA29204 (AB, XW), and NIH DA11177 (LHT).	Abdallah L, 2009, J NEUROSCI, V29, P8156, DOI 10.1523/JNEUROSCI.3905-08.2009; Alex KD, 2007, PHARMACOL THERAPEUT, V113, P296, DOI 10.1016/j.pharmthera.2006.08.004; Basura GJ, 2000, SYNAPSE, V38, P216, DOI 10.1002/1098-2396(200011)38:2<216::AID-SYN12>3.0.CO;2-5; Berg KA, 2008, NEUROPHARMACOLOGY, V55, P969, DOI 10.1016/j.neuropharm.2008.06.014; Borszcz GS, 2003, NEUROBIOL LEARN MEM, V79, P212, DOI 10.1016/S1074-7427(03)00002-9; BORSZCZ GS, 1994, PHARMACOL BIOCHEM BE, V49, P827, DOI 10.1016/0091-3057(94)90230-5; BORSZCZ GS, 1993, BEHAV NEUROSCI, V107, P678; Braz JM, 2010, PAIN, V150, P290, DOI 10.1016/j.pain.2010.05.005; Brennan TJ, 1997, NAT GENET, V16, P387, DOI 10.1038/ng0897-387; Cao YQ, 1998, NATURE, V392, P390, DOI 10.1038/32897; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; DAVIS M, 1989, BEHAV NEUROSCI, V103, P495, DOI 10.1037/0735-7044.103.3.495; DEUTCH AY, 1985, BRAIN RES, V333, P143, DOI 10.1016/0006-8993(85)90134-9; Di Giovanni G, 2011, RECEPT SER, P215, DOI 10.1007/978-1-60761-941-3_11; Di Matteo V, 2008, PROG BRAIN RES, V172, P7, DOI 10.1016/S0079-6123(08)00902-3; Drago A, 2009, AM J MED GENET B, V150B, P601, DOI 10.1002/ajmg.b.30864; Falls WA, 2002, CURRENT PROTOCOLS NE; Filip M, 2009, PHARMACOL REP, V61, P761, DOI 10.1016/S1734-1140(09)70132-X; Freitas RL, 2008, EXP NEUROL, V213, P410, DOI 10.1016/j.expneurol.2008.07.003; Gifkins A, 2002, BEHAV NEUROSCI, V116, P785, DOI 10.1037//0735-7044.116.5.785; Girard P, 2006, PHARMACOL RES, V54, P195, DOI 10.1016/j.phrs.2006.04.008; Gobert A, 2000, SYNAPSE, V36, P205, DOI 10.1002/(SICI)1098-2396(20000601)36:3<205::AID-SYN5>3.0.CO;2-D; Greba Q, 2001, BRAIN RES, V899, P218, DOI 10.1016/S0006-8993(01)02243-0; Greba Q, 2000, BEHAV NEUROSCI, V114, P262, DOI 10.1037//0735-7044.114.2.262; Grillon C, 2004, BEHAV NEUROSCI, V118, P916, DOI 10.1037/0735-7044.118.5.916; Guarraci FA, 2000, BEHAV NEUROSCI, V114, P647, DOI 10.1037/0735-7044.114.3.647; Guo JD, 2009, NEUROSCIENCE, V164, P1776, DOI 10.1016/j.neuroscience.2009.09.028; Han JS, 2005, J NEUROSCI METH, V141, P261, DOI 10.1016/j.jneumeth.2004.07.005; Harte SE, 2011, NEUROSCIENCE, V172, P460, DOI 10.1016/j.neuroscience.2010.10.055; Honda M, 2006, NEUROPHARMACOLOGY, V51, P866, DOI 10.1016/j.neuropharm.2006.05.031; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; Hoyer D, 2002, PHARMACOL BIOCHEM BE, V71, P533, DOI 10.1016/S0091-3057(01)00746-8; Hutson PH, 2000, NEUROPHARMACOLOGY, V39, P2318, DOI 10.1016/S0028-3908(00)00089-7; Jeong CY, 2004, EUR J PHARMACOL, V502, P205, DOI 10.1016/j.ejphar.2004.08.048; Johansen JP, 2001, P NATL ACAD SCI USA, V98, P8077, DOI 10.1073/pnas.141218998; JOURDAN D, 1995, PAIN, V63, P237, DOI 10.1016/0304-3959(95)00049-X; Kjorsvik A, 2001, BRAIN RES, V910, P179, DOI 10.1016/S0006-8993(01)02652-X; Kurihara T, 2003, PHARMACOL BIOCHEM BE, V74, P841, DOI 10.1016/S0091-3057(03)00014-5; LAPPALAINEN J, 1995, GENOMICS, V27, P274, DOI 10.1006/geno.1995.1042; Lerer B, 2001, MOL PSYCHIATR, V6, P579, DOI 10.1038/sj.mp.4000883; LEVINE JD, 1984, BRAIN RES, V296, P121, DOI 10.1016/0006-8993(84)90517-1; Liu FY, 2010, BRAIN RES, V1330, P45, DOI 10.1016/j.brainres.2010.03.010; Liu RC, 2003, J ACOUST SOC AM, V114, P3412, DOI 10.1121/1.1623787; Liu S, 2007, NEUROSCIENCE, V146, P1677, DOI 10.1016/j.neuroscience.2007.02.064; Mickey BJ, 2012, J NEUROSCI, V32, P9344, DOI 10.1523/JNEUROSCI.1260-12.2012; Millan MJ, 2003, PROG NEUROBIOL, V70, P83, DOI 10.1016/s0301-0082(03)00087-X; Nakae A, 2008, EUR J NEUROSCI, V27, P2373, DOI 10.1111/j.1460-9568.2008.06205.x; Nakai K, 2010, EUR J PAIN, V14, P999, DOI 10.1016/j.ejpain.2010.04.008; Obata H, 2004, PAIN, V108, P163, DOI 10.1016/j.pain.2003.12.019; OEI TPS, 1980, NEUROSCI BIOBEHAV R, V4, P161, DOI 10.1016/0149-7634(80)90014-7; Okada M, 2004, MOL PSYCHIATR, V9, P55, DOI 10.1038/sj.mp.4001357; Ormazabal MJ, 1999, BRAIN RES, V845, P130, DOI 10.1016/S0006-8993(99)01839-9; Pennanen L, 2013, NEUROPSYCHOPHARMACOL, V38, P957, DOI 10.1038/npp.2012.258; Pezze MA, 2004, PROG NEUROBIOL, V74, P301, DOI 10.1016/j.pneurobio.2004.09.004; Pompeiano M., 1994, MOL BRAIN RES, V23, P163; Richardson R, 2000, BEHAV BRAIN RES, V110, P109, DOI 10.1016/S0166-4328(99)00189-8; Rocha BA, 2002, J NEUROSCI, V22, P10039; Scott DJ, 2006, J NEUROSCI, V26, P10789, DOI 10.1523/JNEUROSCI.2577-06.2006; Spuz CA, 2012, J PAIN, V13, P328, DOI 10.1016/j.jpain.2011.12.007; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; THIERRY AM, 1976, NATURE, V263, P242, DOI 10.1038/263242a0; Van Nobelen M, 2006, NEUROSCIENCE, V137, P707, DOI 10.1016/j.neuroscience.2005.08.061; Wei H, 2008, PHARMACOL RES, V57, P469, DOI 10.1016/j.phrs.2008.05.007; Williams WO, 2008, J AM ASSOC LAB ANIM, V47, P8; Wohr M, 2005, NEUROBIOL LEARN MEM, V84, P228, DOI 10.1016/j.nlm.2005.07.004; WRIGHT DE, 1995, J COMP NEUROL, V351, P357, DOI 10.1002/cne.903510304; Zeitz KP, 2004, NEUROSCIENCE, V128, P889, DOI 10.1016/j.neuroscience.2004.07.029	67	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0142906	10.1371/journal.pone.0142906	http://dx.doi.org/10.1371/journal.pone.0142906			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630489	gold, Green Published			2022-12-27	WOS:000365926300019
J	Fisher, R; Stark, C; Ridd, P; Jones, R				Fisher, Rebecca; Stark, Clair; Ridd, Peter; Jones, Ross			Spatial Patterns in Water Quality Changes during Dredging in Tropical Environments	PLOS ONE			English	Article							GREAT-BARRIER-REEF; CORAL-REEFS; SEDIMENT DISPERSION; PHYSICAL IMPACTS; COASTAL WATERS; POWER ANALYSIS; TURBIDITY; SEA; VARIABILITY; DISTURBANCE	Dredging poses a potential risk to tropical ecosystems, especially in turbidity-sensitive environments such as coral reefs, filter feeding communities and seagrasses. There is little detailed observational time-series data on the spatial effects of dredging on turbidity and light and defining likely footprints is a fundamental task for impact prediction, the EIA process, and for designing monitoring projects when dredging is underway. It is also important for public perception of risks associated with dredging. Using an extensive collection of in situ water quality data (73 sites) from three recent large scale capital dredging programs in Australia, and which included extensive pre-dredging baseline data, we describe relationships with distance from dredging for a range of water quality metrics. Using a criterion to define a zone of potential impact of where the water quality value exceeds the 80th percentile of the baseline value for turbidity-based metrics or the 20th percentile for the light based metrics, effects were observed predominantly up to three km from dredging, but in one instance up to nearly 20 km. This upper (similar to 20 km) limit was unusual and caused by a local oceanographic feature of consistent unidirectional flow during the project. Water quality loggers were located along the principal axis of this flow (from 200 m to 30 km) and provided the opportunity to develop a matrix of exposure based on running means calculated across multiple time periods (from hours to one month) and distance from the dredging, and summarized across a broad range of percentile values. This information can be used to more formally develop water quality thresholds for benthic organisms, such as corals, filter-feeders (e.g. sponges) and seagrasses in future laboratory-and field-based studies using environmentally realistic and relevant exposure scenarios, that may be used to further refine distance based analyses of impact, potentially further reducing the size of the dredging footprint.	[Fisher, Rebecca; Jones, Ross] Australian Inst Marine Sci, Perth, WA, Australia; [Fisher, Rebecca; Stark, Clair; Ridd, Peter; Jones, Ross] Western Australian Marine Sci Inst, Perth, WA, Australia; [Fisher, Rebecca; Jones, Ross] Univ Western Australia, Oceans Inst, Perth, WA 6009, Australia; [Stark, Clair; Ridd, Peter] James Cook Univ, Sch Engn & Phys Sci, Townsville, Qld 4811, Australia	Australian Institute of Marine Science; University of Western Australia; James Cook University	Fisher, R (corresponding author), Australian Inst Marine Sci, Perth, WA, Australia.	r.fisher@aims.gov.au	Fisher, Rebecca/C-5459-2011; Jones, Ross/N-4651-2013; Stark, Clair/O-2189-2017	Fisher, Rebecca/0000-0001-5148-6731; Jones, Ross/0000-0003-1661-4149; Stark, Clair/0000-0003-3598-724X	Western Australian Marine Science Institution as part of the WAMSI Dredging Science Node	Western Australian Marine Science Institution as part of the WAMSI Dredging Science Node	This project was funded by the Western Australian Marine Science Institution as part of the WAMSI Dredging Science Node, and made possible through investment from Chevron Australia, Woodside Energy Limited, BHP Billiton as environmental offsets and by co-investment from the WAMSI Joint Venture partners. This research was also enabled by data provided by Woodside Energy Ltd, Rio Tinto Iron Ore and Chevron. The commercial investors and data providers had no role in the data analysis, data interpretation, the decision to publish or in the preparation of the manuscript.	ANDREW NL, 1987, OCEANOGR MAR BIOL, V25, P39; [Anonymous], 2012, AD ILL VERS CS6 COMP; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 1988, NONLINEAR REGRESSION, DOI DOI 10.1002/9780470316757; Anthony K.R.N., 2000, P 9 INT COR REEF S, V1, P239; Anthony KRN, 2000, J EXP MAR BIOL ECOL, V252, P221, DOI 10.1016/S0022-0981(00)00237-9; ANZECC/ARMCANZ, 2001, AUSTR NZ GUID FRESH; Bak RPM, 1978, MARINE POLLUTION B, V9, P14; Bates DM, 1992, STAT MODELS S; Bivand, 2015, PACKAGE RGDAL BINDIN; Block WA, 2001, RESTOR ECOL, V9, P293, DOI 10.1046/j.1526-100x.2001.009003293.x; Bray R.N., 2008, ENV ASPECTS DREDGING; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carroll SS, 2000, CONSERV BIOL, V14, P1893, DOI 10.1111/j.1523-1739.2000.99432.x; Cavanaugh J., 1997, STAT PROBABILITY LET, V31, P201; CEDA, 2015, ENV MON PROC; Chapman M. G., 1998, Journal of Aquatic Ecosystem Stress and Recovery, V6, P235, DOI 10.1023/A:1009987403481; Clarke A, 2000, J ANIM ECOL, V69, P799, DOI 10.1046/j.1365-2656.2000.00440.x; Cole RG, 2001, ENVIRON MONIT ASSESS, V69, P85, DOI 10.1023/A:1010756729485; Cryer JD, 2008, TIME SERIES ANAL APP, P249, DOI DOI 10.1007/978-0-387-75959-3_11; Cutroneo L, 2012, J SOIL SEDIMENT, V12, P797, DOI 10.1007/s11368-012-0486-0; Doorn-Groen S., 2007, TERRA AQUA, V108, P3; Duclos PA, 2013, J COASTAL RES, V29, P25, DOI 10.2112/JCOASTRES-D-12-00148.1; EPA, 2011, ENV ASS GUID MAR DRE, P36; Erftemeijer PLA, 2006, MAR POLLUT BULL, V52, P1553, DOI 10.1016/j.marpolbul.2006.09.006; Erftemeijer PLA, 2012, MAR POLLUT BULL, V64, P1737, DOI 10.1016/j.marpolbul.2012.05.008; ESRI, 2013, ARCGIS DESKT V10 2; Evans RD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051668; Fairweather P.G., 1991, MARINE FRESHWATER RE, V42, P555, DOI DOI 10.1071/MF9910555; Foster T., 2010, 108 PIANC ENV COMM; Fox D, 2001, UNDERSTANDING NEW AN; Fredette TJ, 2004, MAR POLLUT BULL, V49, P93, DOI 10.1016/j.marpolbul.2004.01.014; GBRMPA, 2012, US HYDR NUM MOD DRED; Geosciences Australia, 2004, GEOD COAST 100K 2004; GERRODETTE T, 1987, ECOLOGY, V68, P1364, DOI 10.2307/1939220; Green R., 1979, SAMPLING DESIGN STAT; Hanley JR, 2011, APPEA J, P273; Hanley N, 1993, COST BENEFIT ANAL EN, V499; Harris CA, 2014, ENVIRON SCI TECHNOL, V48, P3100, DOI 10.1021/es4047507; Hitchcock DR, 2004, J COASTAL RES, V20, P101, DOI 10.2112/1551-5036(2004)20[101:PIOMAD]2.0.CO;2; Johnston JSA, 1981, ENVIRON MANAGE, V5, P427; Jones R, 2015, MAR POLLUT BULL, V100, P13, DOI 10.1016/j.marpolbul.2015.08.021; Jones R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137112; Kirk J. T. O., 1984, PERSPECTIVES SO HEMI; Kirk J.T.O., 1994, LIGHT PHOTOSYNTHESIS; Kleypas JA, 1999, AM ZOOL, V39, P146; Koskela R. W., 2002, 10 PAC C MAR SCI TEC; Larcombe P, 2001, SEDIMENTOLOGY, V48, P811, DOI 10.1046/j.1365-3091.2001.00396.x; LARCOMBE P, 1995, CORAL REEFS, V14, P163, DOI 10.1007/BF00367235; Macdonald RK, 2013, MAR POLLUT BULL, V74, P82, DOI 10.1016/j.marpolbul.2013.07.026; McArthur C, 2002, P 3 SPEC C DREDG DRE, P1; McCook L.J., 2015, SYNTHESIS CURRENT KN; MILLARD SP, 1986, ESTUAR COAST SHELF S, V22, P637, DOI 10.1016/0272-7714(86)90018-1; Morton J, 1977, US FISH WILDLIFE SER, V94, P1; Mulligan M, 2009, FREIGHT LOG COUNC WA; Murrell P, 2014, GRIDBASE INTEGRATION; Newell RC, 1998, OCEANOGR MAR BIOL<D>, V36, P127; NICHOLS M, 1990, ENVIRON GEOL WATER S, V15, P31, DOI 10.1007/BF01704879; Orpin AR, 2012, CONT SHELF RES, V47, P55, DOI 10.1016/j.csr.2012.06.013; Orpin AR, 2004, MAR POLLUT BULL, V49, P602, DOI 10.1016/j.marpolbul.2004.03.020; OSENBERG CW, 1994, ECOL APPL, V4, P16, DOI 10.2307/1942111; ROGERS CS, 1990, MAR ECOL PROG SER, V62, P185, DOI 10.3354/meps062185; Ruffin KK, 1998, ESTUAR COAST SHELF S, V47, P579, DOI 10.1006/ecss.1998.0366; Spearman J, 2015, MAR POLLUT BULL, V94, P260, DOI 10.1016/j.marpolbul.2015.01.025; Stoddart J, 2004, CORALS DAMPIER HARBO, P9; Thrush SF, 2002, ANNU REV ECOL SYST, V33, P449, DOI 10.1146/annurev.ecolsys.33.010802.150515; Trimarchi S, 2007, ECOPORTS MONOGRAPH S, V24; Tuszynski Jarek, 2013, CATOOLS TOOLS MOVING; Underwood A.J., 1994, ECOLOGICAL APPL, V4, P4, DOI DOI 10.2307/1942110; VANDERVEER HW, 1985, NETH J SEA RES, V19, P183, DOI 10.1016/0077-7579(85)90022-5; VBKO, 2003, PROT FIELD MEAS SED; Wolanski E, 1992, WATER ENVIRON RES, V1992, P910; Wood S., 2013, GAMM4 GEN ADDITIVE M; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zeileis A, 2005, J STAT SOFTW, V14, P1, DOI [10.18637/jss.v014.i06, DOI 10.18637/JSS.V014.I06]	75	43	43	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143309	10.1371/journal.pone.0143309	http://dx.doi.org/10.1371/journal.pone.0143309			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630575	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000365926300040
J	Suzuki, R; Kikuchi, S; Harada, T; Mimura, N; Minami, J; Ohguchi, H; Yoshida, Y; Sagawa, M; Gorgun, G; Cirstea, D; Cottini, F; Jakubikova, J; Tai, YT; Chauhan, D; Richardson, PG; Munshi, N; Ando, K; Utsugi, T; Hideshima, T; Anderson, KC				Suzuki, Rikio; Kikuchi, Shohei; Harada, Takeshi; Mimura, Naoya; Minami, Jiro; Ohguchi, Hiroto; Yoshida, Yasuhiro; Sagawa, Morihiko; Gorgun, Gullu; Cirstea, Diana; Cottini, Francesca; Jakubikova, Jana; Tai, Yu-Tzu; Chauhan, Dharminder; Richardson, Paul G.; Munshi, Nikhil; Ando, Kiyoshi; Utsugi, Teruhiro; Hideshima, Teru; Anderson, Kenneth C.			Combination of a Selective HSP90 alpha/beta Inhibitor and a RAS-RAF-MEK-ERK Signaling Pathway Inhibitor Triggers Synergistic Cytotoxicity in Multiple Myeloma Cells	PLOS ONE			English	Article							PROTEIN 90 INHIBITOR; PHASE-I; ANTITUMOR-ACTIVITY; BRAF INHIBITION; HSP90 INHIBITOR; CANCER; RESISTANCE; KINASE; APOPTOSIS; MUTATION	Heat shock protein (HSP) 90 inhibitors have shown significant anti-tumor activities in preclinical settings in both solid and hematological tumors. We previously reported that the novel, orally available HSP90 alpha/beta inhibitor TAS-116 shows significant anti-MM activities. In this study, we further examined the combination effect of TAS-116 with a RAS-RAF-MEK-ERK signaling pathway inhibitor in RAS-or BRAF-mutated MM cell lines. TAS-116 monotherapy significantly inhibited growth of RAS-mutated MM cell lines and was associated with decreased expression of downstream target proteins of the RAS-RAF-MEK-ERK signaling pathway. Moreover, TAS-116 showed synergistic growth inhibitory effects with the farnesyltransferase inhibitor tipifarnib, the BRAF inhibitor dabrafenib, and the MEK inhibitor selumetinib. Importantly, treatment with these inhibitors paradoxically enhanced p-C-Raf, p-MEK, and p-ERK activity, which was abrogated by TAS-116. TAS-116 also enhanced dabrafenib-induced MM cytotoxicity associated with mitochondrial damage-induced apoptosis, even in the BRAF-mutated U266 MM cell line. This enhanced apoptosis in RAS-mutated MM triggered by combination treatment was observed even in the presence of bone marrow stromal cells. Taken together, our results provide the rationale for novel combination treatment with HSP90 alpha/beta inhibitor and RAS-RAF-MEK-ERK signaling pathway inhibitors to improve outcomes in patients with in RAS-or BRAF-mutated MM.	[Suzuki, Rikio; Kikuchi, Shohei; Harada, Takeshi; Mimura, Naoya; Minami, Jiro; Ohguchi, Hiroto; Yoshida, Yasuhiro; Sagawa, Morihiko; Gorgun, Gullu; Cirstea, Diana; Cottini, Francesca; Jakubikova, Jana; Tai, Yu-Tzu; Chauhan, Dharminder; Richardson, Paul G.; Hideshima, Teru; Anderson, Kenneth C.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Jerome Lipper Multiple Myeloma Ctr,Dept Med Oncol, Boston, MA 02115 USA; [Suzuki, Rikio; Ando, Kiyoshi] Tokai Univ, Sch Med, Dept Hematol Oncol, Isehara, Kanagawa 25911, Japan; [Utsugi, Teruhiro] Taiho Pharmaceut Co Ltd, Tsukuba Res Ctr, Tsukuba, Ibaraki, Japan; [Munshi, Nikhil] Harvard Univ, Sch Med, Dana Farber Canc Inst, VA Boston Healthcare Syst,Jerome Lipper Multiple, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Tokai University; Taiho Pharmaceutical; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Boston Healthcare System	Anderson, KC (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Jerome Lipper Multiple Myeloma Ctr,Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.	kenneth_anderson@dfci.harvard.edu	Munshi, Nikhil/ABE-2338-2021; Kikuchi, Shohei/AAF-6775-2020; Suzuki, Rikio/AAJ-6675-2021; Jakubikova, Jana/ABE-5761-2020	Kikuchi, Shohei/0000-0002-0961-6253; Jakubikova, Jana/0000-0003-2593-569X; Cottini, Francesca/0000-0001-8676-7840	National Institutes of Health [P50-100707, PO1-CA078378, PO1-155258, RO1-CA050947, RO1-178264, IO1-BX001584]; SENSHIN Medical Research Foundation; NATIONAL CANCER INSTITUTE [P50CA100707, R01CA178264, P01CA078378, R01CA050947] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001584] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported by the National Institutes of Health Grants (http://grants.nih.gov/grants/oer.htm) P50-100707, PO1-CA078378, and PO1-155258 (K.C.A., N.M.); RO1-CA050947 (K.C.A.) and RO1-178264 (T.H., K.C.A.); IO1-BX001584 (N.M.); and SENSHIN Medical Research Foundation (http://www.mt-pharma.co.jp/zaidan/) (R.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquaviva J, 2012, MOL CANCER THER, V11, P2633, DOI 10.1158/1535-7163.MCT-12-0615; Andrulis M, 2013, CANCER DISCOV, V3, P862, DOI 10.1158/2159-8290.CD-13-0014; Banerji U, 2005, J CLIN ONCOL, V23, P4152, DOI 10.1200/JCO.2005.00.612; Barrott JJ, 2013, FEBS J, V280, P1381, DOI 10.1111/febs.12147; Chng WJ, 2008, LEUKEMIA, V22, P2280, DOI 10.1038/leu.2008.142; Chng WJ, 2011, LEUKEMIA, V25, P1026, DOI 10.1038/leu.2011.53; Cirstea D, 2010, MOL CANCER THER, V9, P963, DOI 10.1158/1535-7163.MCT-09-0763; Ding HS, 2014, HAEMATOLOGICA, V99, P60, DOI 10.3324/haematol.2013.087734; Garcia-Carbonero R, 2013, LANCET ONCOL, V14, pE358, DOI 10.1016/S1470-2045(13)70169-4; Gollob JA, 2006, SEMIN ONCOL, V33, P392, DOI 10.1053/j.seminoncol.2006.04.002; Grem JL, 2005, J CLIN ONCOL, V23, P1885, DOI 10.1200/JCO.2005.12.085; Hata AN, 2014, CANCER RES, V74, P3146, DOI 10.1158/0008-5472.CAN-13-3728; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hideshima T, 2006, CLIN CANCER RES, V12, P5887, DOI 10.1158/1078-0432.CCR-05-2501; Hideshima T, 2006, BLOOD, V107, P4053, DOI 10.1182/blood-2005-08-3434; Hideshima T, 2011, INT J HEMATOL, V94, P344, DOI 10.1007/s12185-011-0917-5; Hoang B, 2006, BLOOD, V107, P4484, DOI 10.1182/blood-2005-09-3926; Johnson DB, 2014, J CLIN ONCOL, V32, P3697, DOI 10.1200/JCO.2014.57.3535; Khong T, 2011, MOL CANCER THER, V10, P1909, DOI 10.1158/1535-7163.MCT-11-0174; Kumar SK, 2008, BLOOD, V111, P2516, DOI 10.1182/blood-2007-10-116129; Leow CCY, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.1; Lin L, 2015, NAT GENET; Lito P, 2013, NAT MED, V19, P1401, DOI 10.1038/nm.3392; Lohr JG, 2014, CANCER CELL, V25, P91, DOI 10.1016/j.ccr.2013.12.015; Long GV, 2014, NEW ENGL J MED, V371, P1877, DOI 10.1056/NEJMoa1406037; Martz CA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.aaa1877; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Mirza AM, 2004, MOL CELL BIOL, V24, P10868, DOI 10.1128/MCB.24.24.10868-10881.2004; Mitsiades CS, 2006, BLOOD, V107, P1092, DOI 10.1182/blood-2005-03-1158; Montagut C, 2009, CANCER LETT, V283, P125, DOI 10.1016/j.canlet.2009.01.022; Mulligan G, 2014, BLOOD, V123, P632, DOI 10.1182/blood-2013-05-504340; Nakadate Y, 2014, INT J CANCER, V134, P2146, DOI 10.1002/ijc.28550; Nakashima T, 2010, CLIN CANCER RES, V16, P2792, DOI 10.1158/1078-0432.CCR-09-3112; Ohkubo S, 2015, MOL CANCER THER, V14, P14, DOI 10.1158/1535-7163.MCT-14-0219; Okawa Y, 2009, BLOOD, V113, P846, DOI 10.1182/blood-2008-04-151928; Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442; Peeters M, 2013, J CLIN ONCOL, V31, P759, DOI 10.1200/JCO.2012.45.1492; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Raab MS, 2009, LANCET, V374, P324, DOI 10.1016/S0140-6736(09)60221-X; Rajan A, 2011, CLIN CANCER RES, V17, P6831, DOI 10.1158/1078-0432.CCR-11-0821; Scaltriti M, 2012, CLIN CANCER RES, V18, P4508, DOI 10.1158/1078-0432.CCR-11-2138; Sharman JP, 2014, CL LYMPH MYELOM LEUK, V14, pE161, DOI 10.1016/j.clml.2014.06.004; Shi HB, 2014, CANCER DISCOV, V4, P80, DOI 10.1158/2159-8290.CD-13-0642; Spagnolo F, 2014, ONCOTARGET, V5, P10206, DOI 10.18632/oncotarget.2602; Suzuki R, 2015, LEUKEMIA, V29, P510, DOI 10.1038/leu.2014.300; Suzuki T, 2002, GENE DEV, V16, P1356, DOI 10.1101/gad.962802; Tai YT, 2007, BLOOD, V110, P1656, DOI 10.1182/blood-2007-03-081240; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Yasui H, 2006, BRIT J HAEMATOL, V132, P385, DOI 10.1111/j.1365-2141.2005.05860.x; Yasui H, 2005, CANCER RES, V65, P7478, DOI 10.1158/0008-5472.CAN-05-0850; Zhang L, 2014, ONCOTARGET, V5, P1132, DOI 10.18632/oncotarget.1584; Zhao YJ, 2014, NAT REV CLIN ONCOL, V11, P385, DOI 10.1038/nrclinonc.2014.83	53	19	20	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143847	10.1371/journal.pone.0143847	http://dx.doi.org/10.1371/journal.pone.0143847			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630652	Green Published, gold, Green Submitted			2022-12-27	WOS:000365926300111
J	Frey, WD; Kim, J				Frey, Wesley D.; Kim, Joomyeong			Tissue-Specific Contributions of Paternally Expressed Gene 3 in Lactation and Maternal Care of Mus musculus	PLOS ONE			English	Article							IMPRINTED GENE; PEG3; BEHAVIOR; MICE; APEG3	Paternally Expressed Gene 3 (Peg3) is an imprinted gene that controls milk letdown and maternal-caring behaviors. In this study, a conditional knockout allele has been developed in Mus musculus to further characterize these known functions of Peg3 in a tissue-specific manner. The mutant line was first crossed with a germline Cre. The progeny of this cross displayed growth retardation phenotypes. This is consistent with those seen in the previous mutant lines of Peg3, confirming the usefulness of the new mutant allele. The mutant line was subsequently crossed individually with MMTV-and Nkx2.1-Cre lines to test Peg3's roles in the mammary gland and hypothalamus, respectively. According to the results, the milk letdown process was impaired in the nursing females with the Peg3 mutation in the mammary gland, but not in the hypothalamus. This suggests that Peg3's roles in the milk letdown process are more critical in the mammary gland than in the hypothalamus. In contrast, one of the maternal-caring behaviors, nest-building, was interrupted in the females with the mutation in both MMTV-and Nkx2.1-driven lines. Overall, this is the first study to introduce a conditional knockout allele of Peg3 and to further dissect its contribution to mammalian reproduction in a tissue-specific manner.	[Frey, Wesley D.; Kim, Joomyeong] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Kim, J (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	jkim@lsu.edu		Frey, Wesley/0000-0003-0392-5714	National Institutes of Health [R01-GM066225, R01-GM097074]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066225, R01GM097074] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by National Institutes of Health (J.K. R01-GM066225 and R01-GM097074).; We would like to thank Dr. Hana Kim, Corey Bretz, Arundhati Bakshi and Terri Cain for their careful reading and discussion of the manuscript. We would also like to thank HK for helping with mouse illustrations, Austin Wong for helping with mammary gland isolations, TC for assisting in tissue isolation and CB for helping to make the bedding analysis more comprehendible. This research was supported by National Institutes of Health (J.K. R01-GM066225 and R01-GM097074).	Angoa-Perez M, 2013, JOVE-J VIS EXP, DOI 10.3791/50978; Champagne FA, 2009, BEHAV NEUROSCI, V123, P469, DOI 10.1037/a0015060; Chiavegatto S, 2012, BRAIN BEHAV, V2, P365, DOI 10.1002/brb3.58; Choo JH, 2008, GENE, V409, P28, DOI 10.1016/j.gene.2007.10.036; Curley JP, 2004, P ROY SOC B-BIOL SCI, V271, P1303, DOI 10.1098/rspb.2004.2725; Frey WD, 2014, GENE, V540, P251, DOI 10.1016/j.gene.2014.02.056; Kim J, 1997, GENOME RES, V7, P532, DOI 10.1101/gr.7.5.532; Kim J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083359; Kim J, 2012, HUM MOL GENET, V21, P2677, DOI 10.1093/hmg/dds092; Kohda T, 2001, GENES CELLS, V6, P237, DOI 10.1046/j.1365-2443.2001.00412.x; Kuroiwa Y, 1996, NAT GENET, V12, P186, DOI 10.1038/ng0296-186; Li LL, 1999, SCIENCE, V284, P330, DOI 10.1126/science.284.5412.330; Macbeth AH, 2010, BEHAV NEUROSCI, V124, P677, DOI 10.1037/a0020799; Neville MC, 2001, PEDIATR CLIN N AM, V48, P13, DOI 10.1016/S0031-3955(05)70283-2; Plante I, 2011, JOVE-J VIS EXP, DOI 10.3791/2828; Rich ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098839; Thiaville MM, 2013, GENE, V512, P314, DOI 10.1016/j.gene.2012.10.005; Wagner KU, 2001, TRANSGENIC RES, V10, P545, DOI 10.1023/A:1013063514007; Xu Q, 2008, J COMP NEUROL, V506, P16, DOI 10.1002/cne.21529; Yoshida M, 2009, J NEUROSCI, V29, P2259, DOI 10.1523/JNEUROSCI.5593-08.2009; Yuan TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019233	21	16	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144459	10.1371/journal.pone.0144459	http://dx.doi.org/10.1371/journal.pone.0144459			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26640945	Green Published, Green Submitted, gold			2022-12-27	WOS:000366902700128
J	Marti, C; Grosgurin, O; Harbarth, S; Combescure, C; Abbas, M; Rutschmann, O; Perrier, A; Garin, N				Marti, Christophe; Grosgurin, Olivier; Harbarth, Stephan; Combescure, Christophe; Abbas, Mohamed; Rutschmann, Olivier; Perrier, Arnaud; Garin, Nicolas			Adjunctive Corticotherapy for Community Acquired Pneumonia: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							INFLAMMATORY MARKERS; SEVERE SEPSIS; DOUBLE-BLIND; CORTICOSTEROIDS; HYDROCORTISONE; MORTALITY; MANAGEMENT; EFFICACY; ADULTS; DEXAMETHASONE	Background Community-acquired pneumonia (CAP) induces lung and systemic inflammation, leading to high morbidity and mortality. We systematically reviewed the risks and benefits of adjunctive corticotherapy in the management of patients with CAP. Methods We systematically searched Pubmed, Embase and the Cochrane Library for randomized controlled trials comparing adjunctive corticotherapy and antimicrobial therapy with antimicrobial therapy alone in patients with CAP. The primary outcome was 30-day mortality. Secondary outcomes were length of hospital stay, time to clinical stability and severe complications. Results 14 trials (2077 patients) were included. The reported 30-day mortality was 7.9% (80/1018) among patients treated with adjunctive corticotherapy versus 8.3% (85/1028) among patients treated with antimicrobial therapy alone (RR 0.84; 95%CI 0.55 to 1.29). Adjunctive corticotherapy was associated with a reduction of severe complications (RR 0.36; 95%CI 0.23 to 0.56), a shorter length of stay (9.0 days; 95%CI 7.6 to 10.7 vs 10.6 days; 95%CI 7.4 to 15.3) and a shorter time to clinical stability (3.3 days; 95%CI 2.8 to 4.1 vs 4.3 days; 95%CI 3.6 to 5.1). The risk of hyperglycemia was higher among patients treated with adjunctive corticotherapy (RR 1.59; 95%CI 1.06 to 2.38), whereas the risk of gastro-intestinal bleeding was similar (RR 0.83; 95%CI 0.35 to 1.93). In the subgroup analysis based on CAP severity, a survival benefit was found among patients with severe CAP (RR 0.47; 95%CI 0.23 to 0.96). Conclusion Adjunctive corticotherapy is associated with a reduction of length of stay, time to clinical stability, and severe complications among patients with CAP, but the effect on mortality remains uncertain.	[Marti, Christophe; Grosgurin, Olivier; Perrier, Arnaud; Garin, Nicolas] Univ Hosp Geneva, Dept Internal Med Rehabil & Geriatr, Div Gen Internal Med, Geneva, Switzerland; [Marti, Christophe; Grosgurin, Olivier; Harbarth, Stephan; Combescure, Christophe; Abbas, Mohamed; Rutschmann, Olivier; Perrier, Arnaud; Garin, Nicolas] Geneva Fac Med, Geneva, Switzerland; [Harbarth, Stephan; Abbas, Mohamed] Univ Hosp Geneva, Div Infect Dis, Dept Med Specialties, Geneva, Switzerland; [Combescure, Christophe] Univ Hosp Geneva, Dept Hlth & Community Med, Geneva, Switzerland; [Rutschmann, Olivier] Univ Hosp Geneva, Div Emergency Med, Geneva, Switzerland; [Garin, Nicolas] Hop Riviera Chablais, Div Internal Med, Monthey, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Geneva	Marti, C (corresponding author), Univ Hosp Geneva, Dept Internal Med Rehabil & Geriatr, Div Gen Internal Med, Geneva, Switzerland.	christophe.marti@hcuge.ch	grosgurin, olivier/AAT-5605-2021; Abbas, Mohamed/M-1724-2019	Abbas, Mohamed/0000-0002-7265-1887				Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Annane D, 2009, JAMA-J AM MED ASSOC, V301, P2362, DOI 10.1001/jama.2009.815; AUSTRIAN R, 1964, ANN INTERN MED, V60, P759, DOI 10.7326/0003-4819-60-5-759; Bassler D, 2010, JAMA-J AM MED ASSOC, V303, P1180, DOI 10.1001/jama.2010.310; Blum CA, 2015, LANCET, V385, P1511, DOI 10.1016/S0140-6736(14)62447-8; Cheng M, 2014, RESP CARE, V59, P557, DOI 10.4187/respcare.02758; Confalonieri M, 2005, AM J RESP CRIT CARE, V171, P242, DOI 10.1164/rccm.200406-808OC; Confalonieri M, 2013, CURR INFECT DIS REP, V15, P158, DOI 10.1007/s11908-013-0322-8; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; El-Ghamrawy AH., 2006, EGYPT J CHEST DIS TU, V55, P91; Ewig S, 2009, THORAX, V64, P1062, DOI 10.1136/thx.2008.109785; Fernandez-Serrano S, 2011, CRIT CARE, V15, DOI 10.1186/cc10103; Gans J. de, 2002, New England Journal of Medicine, V347, P1549, DOI 10.1056/NEJMoa021334; Group CS, 1963, JAMA-J AM MED ASSOC, V183, P462, DOI DOI 10.1001/JAMA.1963.63700060029012; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2008, STAT MED, V27, P6072, DOI 10.1002/sim.3427; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kellum JA, 2007, ARCH INTERN MED, V167, P1655, DOI 10.1001/archinte.167.15.1655; KLASTERSKY J, 1971, NEW ENGL J MED, V284, P1248, DOI 10.1056/NEJM197106032842206; Laterre PF, 2005, CRIT CARE MED, V33, P952, DOI 10.1097/01.CCM.0000162381.24074.D7; Lim WS, 2009, THORAX, V64, P1, DOI 10.1136/thx.2009.121434; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; MANTEL N, 1959, J NATL CANCER I, V22, P719; MARIK P, 1993, CHEST, V104, P389, DOI 10.1378/chest.104.2.389; MCHARDY VU, 1972, BRIT MED J, V4, P569, DOI 10.1136/bmj.4.5840.569; Meijvis SCA, 2011, LANCET, V377, P2023, DOI 10.1016/S0140-6736(11)60607-7; Mikami K, 2007, LUNG, V185, P249, DOI 10.1007/s00408-007-9020-3; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Nafae RM, 2013, EGYPT J CHEST DIS TU, V62, P439, DOI 10.1016/j.ejcdt.2013.03.009; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nie W, 2011, RESPIROLOGY, V16, P54; Niederman MS, 2001, MED CLIN N AM, V85, P1493, DOI 10.1016/S0025-7125(05)70392-8; Sabry NA, 2011, PHARM PHARM, V2, P73, DOI DOI 10.4236/PP.2011.22009; Siemieniuk RAC, 2015, ANN INTERN MED, V163, P519, DOI 10.7326/M15-0715; Snijders D, 2010, AM J RESP CRIT CARE, V181, P975, DOI 10.1164/rccm.200905-0808OC; Steinberg KP, 2006, NEW ENGL J MED, V354, P1671; Tagami T, 2015, EUR RESPIR J, V45, P463, DOI 10.1183/09031936.00081514; Tian L, 2009, BIOSTATISTICS, V10, P275, DOI 10.1093/biostatistics/kxn034; Torres A, 2015, JAMA-J AM MED ASSOC, V313, P677, DOI 10.1001/jama.2015.88; WAGNER HN, 1956, B JOHNS HOPKINS HOSP, V98, P197; Walden AP, 2014, CRIT CARE, V18, DOI 10.1186/cc13812; Wan X, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-135; Yende S, 2008, AM J RESP CRIT CARE, V177, P1242, DOI 10.1164/rccm.200712-1777OC; Zhang Y, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0764-5	44	32	33	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144032	10.1371/journal.pone.0144032	http://dx.doi.org/10.1371/journal.pone.0144032			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641253	Green Published, gold, Green Submitted			2022-12-27	WOS:000366902700049
J	Murata, J; Matsumoto, E; Morimoto, K; Koyama, T; Satake, H				Murata, Jun; Matsumoto, Erika; Morimoto, Kinuyo; Koyama, Tomotsugu; Satake, Honoo			Generation of Triple-Transgenic Forsythia Cell Cultures as a Platform for the Efficient, Stable, and Sustainable Production of Lignans	PLOS ONE			English	Article							PINORESINOL LARICIRESINOL REDUCTASE; GENE-EXPRESSION; ARYLTETRALIN LIGNANS; DOWN-REGULATION; LINUM-ALBUM; BIOSYNTHESIS; ARABIDOPSIS; SESAMIN; PLANTS; GROWTH	Sesamin is a furofuran lignan biosynthesized from the precursor lignan pinoresinol specifically in sesame seeds. This lignan is shown to exhibit anti-hypertensive activity, protect the liver from damages by ethanol and lipid oxidation, and reduce lung tumor growth. Despite rapidly elevating demand, plant sources of lignans are frequently limited because of the high cost of locating and collecting plants. Indeed, the acquisition of sesamin exclusively depends on the conventional extraction of particular Sesamum seeds. In this study, we have created the efficient, stable and sustainable sesamin production system using triple-transgenic Forsythia koreana cell suspension cultures, U18i-CPi-Fk. These transgenic cell cultures were generated by stably introducing an RNAi sequence against the pinoresinol-glucosylating enzyme, UGT71A18, into existing CPi-Fk cells, which had been created by introducing Sesamum indicum sesamin synthase (CYP81Q1) and an RNA interference (RNAi) sequence against pinoresinol/lariciresinol reductase (PLR) into F. koreanna cells. Compared to its transgenic prototype, U18i-CPi-Fk displayed 5-fold higher production of pinoresinol aglycone and 1.4-fold higher production of sesamin, respectively, while the wildtype cannot produce sesamin due to a lack of any intrinsic sesamin synthase. Moreover, red LED irradiation of U18i-CPi-Fk specifically resulted in 3.0-fold greater production in both pinoresinol aglycone and sesamin than production of these lignans under the dark condition, whereas pinoresinol production was decreased in the wildtype under red LED. Moreover, we developed a procedure for sodium alginate-based long-term storage of U18i-CPiFk in liquid nitrogen. Production of sesamin in U18i-CPi-Fk re-thawed after six-month cryopreservation was equivalent to that of non-cryopreserved U18i-CPi-Fk. These data warrant on-demand production of sesamin anytime and anywhere. Collectively, the present study provides evidence that U18i-CP-Fk is an unprecedented platform for efficient, stable, and sustainable production of sesamin, and shows that a transgenic and specific light-regulated Forsythia cell-based metabolic engineering is a promising strategy for the acquisition of rare and beneficial lignans.	[Murata, Jun; Matsumoto, Erika; Morimoto, Kinuyo; Koyama, Tomotsugu; Satake, Honoo] Suntory Fdn Life Sci, Bioorgan Res Inst, Kyoto 6190284, Japan	Suntory Holdings Ltd	Satake, H (corresponding author), Suntory Fdn Life Sci, Bioorgan Res Inst, Kyoto 6190284, Japan.	satake@sunbor.or.jp	Murata, Jun/AAN-9101-2020; Koyama, Tomotsugu/AAM-2243-2020	Murata, Jun/0000-0001-7867-330X; 	Plant Factory project of the Ministry of Economy, Trade and Industry, Japan	Plant Factory project of the Ministry of Economy, Trade and Industry, Japan	This work is supported by the Plant Factory project of the Ministry of Economy, Trade and Industry, Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RS, 2004, NAT BIOTECHNOL, V22, P1559, DOI 10.1038/nbt1033; Ayella AK, 2007, MOL NUTR FOOD RES, V51, P1518, DOI 10.1002/mnfr.200700233; Babst BA, 2014, J EXP BOT, V65, P4191, DOI 10.1093/jxb/eru192; Babu PR, 2013, GENE, V513, P156, DOI 10.1016/j.gene.2012.10.040; Badejo AA, 2009, PLANT CELL PHYSIOL, V50, P423, DOI 10.1093/pcp/pcn206; Bahabadi S. E., 2014, Journal of Medicinal Plants, V13, P46; Bahabadi SE, 2012, J PLANT PHYSIOL, V169, P487, DOI 10.1016/j.jplph.2011.12.006; Bahabadi SE, 2011, PLANT BIOTECHNOL REP, V5, P367, DOI 10.1007/s11816-011-0190-3; Barvkar VT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-175; Bayindir U, 2008, PLANT J, V55, P810, DOI 10.1111/j.1365-313X.2008.03558.x; Bharti AK, 1997, PHOTOCHEM PHOTOBIOL, V65, P765, DOI 10.1111/j.1751-1097.1997.tb01923.x; Bhattacharyya D, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-748; Bowles D, 2005, CURR OPIN PLANT BIOL, V8, P254, DOI 10.1016/j.pbi.2005.03.007; Butelli E, 2008, NAT BIOTECHNOL, V26, P1301, DOI 10.1038/nbt.1506; Cutillo F, 2003, J AGR FOOD CHEM, V51, P6165, DOI 10.1021/jf034644c; Davin Laurence B., 2003, Phytochemistry Reviews, V2, P257, DOI 10.1023/B:PHYT.0000046175.83729.b5; Davin LB, 2008, NAT PROD REP, V25, P1015, DOI 10.1039/b510386j; Dima O, 2015, PLANT CELL, V27, P695, DOI 10.1105/tpc.114.134643; Farhi M, 2011, NAT BIOTECHNOL, V29, P1072, DOI 10.1038/nbt.2054; Griesser M, 2008, PLANT PHYSIOL, V146, P1528, DOI 10.1104/pp.107.114280; Hano C, 2006, PLANTA, V223, P975, DOI 10.1007/s00425-005-0156-1; Harmatha Juraj, 2003, Phytochemistry Reviews, V2, P321, DOI 10.1023/B:PHYT.0000045494.98645.a3; Hata N, 2013, PLANT BIOTECHNOL-NAR, V30, P1, DOI 10.5511/plantbiotechnology.12.1021a; Hata N, 2012, ENVIRON EXP BOT, V75, P212, DOI 10.1016/j.envexpbot.2011.07.004; Hemmati S, 2007, FEBS LETT, V581, P603, DOI 10.1016/j.febslet.2007.01.018; Kim HJ, 2009, PLANT CELL PHYSIOL, V50, P2200, DOI 10.1093/pcp/pcp156; Kim IA, 2010, J PLANT BIOL, V53, P233, DOI 10.1007/s12374-010-9110-2; Lao JM, 2014, PLANT J, V79, P517, DOI 10.1111/tpj.12577; Lee CH, 2009, PLANT CELL PHYSIOL, V50, P1075, DOI 10.1093/pcp/pcp060; Leonard E, 2009, NAT CHEM BIOL, V5, P292, DOI 10.1038/nchembio.160; Malik S, 2014, PHYTOCHEM REV, V13, P893, DOI 10.1007/s11101-014-9345-5; Marques JV, 2014, MOL BIOSYST, V10, P2838, DOI 10.1039/c4mb00403e; Marques JV, 2013, J BIOL CHEM, V288, P466, DOI 10.1074/jbc.M112.400689; Miki D, 2004, PLANT CELL PHYSIOL, V45, P490, DOI 10.1093/pcp/pch048; Montefiori M, 2011, PLANT J, V65, P106, DOI 10.1111/j.1365-313X.2010.04409.x; Morimoto K, 2013, BIOL PHARM BULL, V36, P1519, DOI 10.1248/bpb.b13-00437; Morimoto K, 2011, PLANT BIOTECHNOL-NAR, V28, P331, DOI 10.5511/plantbiotechnology.11.0420a; Nakai M, 2003, J AGR FOOD CHEM, V51, P1666, DOI 10.1021/jf0258961; Nakano D, 2002, BIOL PHARM BULL, V25, P1247, DOI 10.1248/bpb.25.1247; Niino T, 2005, PLANT BIOTECHNOL-NAR, V22, P105, DOI [10.5511/plantbiotechnology.22.105, DOI 10.5511/PLANTBIOTECHNOLOGY.22.105]; Ogawa Y, 2012, PLANT CELL PHYSIOL, V53, P943, DOI 10.1093/pcp/pcs038; Ogita S, 2003, NATURE, V423, P823, DOI 10.1038/423823a; Oliva A, 2002, PESTIC BIOCHEM PHYS, V72, P45, DOI 10.1006/pest.2002.2582; Ono E, 2006, P NATL ACAD SCI USA, V103, P10116, DOI 10.1073/pnas.0603865103; Ono E, 2010, PLANT BIOTECHNOL-NAR, V27, P317, DOI 10.5511/plantbiotechnology.27.317; Paddon CJ, 2013, NATURE, V496, P528, DOI 10.1038/nature12051; Ramakrishna A, 2011, PLANT SIGNAL BEHAV, V6, P1720, DOI 10.4161/psb.6.11.17613; Renouard S, 2014, J PLANT PHYSIOL, V171, P1372, DOI 10.1016/j.jplph.2014.06.005; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Sarasan V, 2006, IN VITRO CELL DEV-PL, V42, P206; Satake H, 2015, METABOLITES, V5, P270, DOI 10.3390/metabo5020270; Satake H, 2013, J AGR FOOD CHEM, V61, P11721, DOI 10.1021/jf4007104; Sirato-Yasumoto S, 2001, J AGR FOOD CHEM, V49, P2647, DOI 10.1021/jf001362t; Sugimoto K, 2014, P NATL ACAD SCI USA, V111, P7144, DOI 10.1073/pnas.1320660111; Suzuki S, 2007, J WOOD SCI, V53, P273, DOI 10.1007/s10086-007-0892-x; Tanaka Y, 2008, PLANT J, V54, P733, DOI 10.1111/j.1365-313X.2008.03447.x; Truan JS, 2012, NUTR CANCER, V64, P65, DOI 10.1080/01635581.2012.630165; Umezawa Toshiaki, 2003, Phytochemistry Reviews, V2, P371, DOI 10.1023/B:PHYT.0000045487.02836.32; vonLintig J, 1997, PLANT J, V12, P625, DOI 10.1046/j.1365-313X.1997.00625.x; Wang LH, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0225-3; Wang LH, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r39; Wang ZW, 2012, PLANT J, V72, P461, DOI 10.1111/j.1365-313X.2012.05093.x; Westfall PJ, 2012, P NATL ACAD SCI USA, V109, P111, DOI 10.1073/pnas.1110740109; Winzer T, 2015, SCIENCE, V349, P309, DOI 10.1126/science.aab1852; Wu K, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-35; Yazaki K., 1999, PLANT BIOTECHNOL-NAR, V16, P335, DOI DOI 10.5511/PLANTBI0TECHN0L0GY.16.335; Yousefzadi M, 2012, PLANT PHYSIOL BIOCH, V56, P41, DOI 10.1016/j.plaphy.2012.04.010; Yousefzadi M, 2010, BIOTECHNOL LETT, V32, P1739, DOI 10.1007/s10529-010-0343-4	68	16	17	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144519	10.1371/journal.pone.0144519	http://dx.doi.org/10.1371/journal.pone.0144519			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641084	gold, Green Published, Green Submitted			2022-12-27	WOS:000366902700138
J	Stafford, RE; Coughlin, G; Lutton, NJ; Hodges, PW				Stafford, Ryan E.; Coughlin, Geoff; Lutton, Nicholas J.; Hodges, Paul W.			Validity of Estimation of Pelvic Floor Muscle Activity from Transperineal Ultrasound Imaging in Men	PLOS ONE			English	Article							RADICAL PROSTATECTOMY; URINARY-INCONTINENCE; CONTRACTIONS; EXERCISES; SYMPTOMS; DYNAMICS; LENGTH	Purpose To investigate the relationship between displacement of pelvic floor landmarks observed with transperineal ultrasound imaging and electromyography of the muscles hypothesised to cause the displacements. Materials and Methods Three healthy men participated in this study, which included ultrasound imaging of the midurethra, urethra-vesical junction, ano-rectal junction and bulb of the penis. Fine-wire electromyography electrodes were inserted into the puborectalis and bulbocavernosus muscles and a transurethral catheter electrode recorded striated urethral sphincter electromyography. A nasogastric sensor recorded intra-abdominal pressure. Tasks included submaximal and maximal voluntary contractions, and Valsalva. The relationship between each of the parameters measured from ultrasound images and electromyography or intra-abdominal pressure amplitudes was described with nonlinear regression. Results Strong, non-linear relationships were calculated for each predicted landmark/muscle pair for submaximal contractions (R-2-0.87-0.95). The relationships between mid-urethral displacement and striated urethral sphincter electromyography, and bulb of the penis displacement and bulbocavernosus electromyography were strong during maximal contractions (R-2-0.74-0.88). Increased intra-abdominal pressure prevented shortening of puborectalis, which resulted in weak relationships between electromyography and anorectal and urethra-vesical junction displacement during all tasks. Conclusions Displacement of landmarks in transperineal ultrasound imaging provides meaningful measures of activation of individual pelvic floor muscles in men during voluntary contractions. This method may aid assessment of muscle function or feedback for training.	[Stafford, Ryan E.; Hodges, Paul W.] Univ Queensland, Ctr Clin Res Excellence Spinal Pain Injury & Hlth, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia; [Coughlin, Geoff] Royal Brisbane & Womens Hosp, Dept Urol, Brisbane, Qld, Australia; [Lutton, Nicholas J.] Princess Alexandra Hosp, Dept Colorectal Surg, Brisbane, Qld 4102, Australia	University of Queensland; Royal Brisbane & Women's Hospital	Hodges, PW (corresponding author), Univ Queensland, Ctr Clin Res Excellence Spinal Pain Injury & Hlth, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia.	p.hodges@uq.edu.au	Hodges, Paul W/B-6578-2008; Stafford, Ryan/F-3970-2010	Hodges, Paul W/0000-0002-1206-9107; Stafford, Ryan/0000-0002-5444-477X	Australian Research Council Linkage Project [LP100100400]; National Health and Medical Research Council (NHMRC) of Australia	Australian Research Council Linkage Project(Australian Research Council); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by an Australian Research Council Linkage Project grant LP100100400 - http://www.arc.gov.au/ to PH. Paul Hodges is funded by a Senior Principal Research Fellowship from the National Health and Medical Research Council (NHMRC) of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campbell SE, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001843.pub4; Davis SN, 2011, J SEX MED, V8, P3173, DOI 10.1111/j.1743-6109.2011.02452.x; Dietz HP, 2010, AM J OBSTET GYNECOL, V202, P321, DOI 10.1016/j.ajog.2009.08.018; Dietz HP, 2001, INT UROGYNECOL J PEL, V12, P166, DOI 10.1007/s001920170059; Dorey G, 2009, PHYSIOTHERAPY, V95, P199, DOI 10.1016/j.physio.2009.03.003; Floratos DL, 2002, BJU INT, V89, P714, DOI 10.1046/j.1464-410X.2002.02721.x; Geraerts I, 2013, BJU INT, V112, P936, DOI 10.1111/bju.12258; Glazener C, 2011, LANCET, V378, P328, DOI 10.1016/S0140-6736(11)60751-4; GORDON AM, 1966, J PHYSIOL-LONDON, V184, P170, DOI 10.1113/jphysiol.1966.sp007909; Herbert RD, 2002, J PHYSIOL-LONDON, V539, P637, DOI 10.1113/jphysiol.2001.012756; Hodges PW, 2003, MUSCLE NERVE, V27, P682, DOI 10.1002/mus.10375; Jones RCL, 2010, EUR UROL, V57, P1101, DOI 10.1016/j.eururo.2009.06.011; Junginger B, 2010, INT UROGYNECOL J, V21, P69, DOI 10.1007/s00192-009-0981-z; Koppenhaver SL, 2009, AUST J PHYSIOTHER, V55, P153, DOI 10.1016/S0004-9514(09)70076-5; Nahon I, 2011, NEUROUROL URODYNAM, V30, P1329, DOI 10.1002/nau.21069; Peng QY, 2007, ULTRASOUND MED BIOL, V33, P342, DOI 10.1016/j.ultrasmedbio.2006.08.020; Peschers UM, 2001, NEUROUROL URODYNAM, V20, P269, DOI 10.1002/nau.1004; Sladden MJ, 2000, AUST NZ J SURG, V70, P322, DOI 10.1046/j.1440-1622.2000.01738.x; Stafford RE, NEUROUROL URODYN; Stafford RE, 2014, J APPL PHYSIOL, V116, P953, DOI 10.1152/japplphysiol.01225.2013; Stafford RE, 2013, UROLOGY, V81, P685, DOI 10.1016/j.urology.2012.11.034; Stafford RE, 2012, J UROLOGY, V188, P1224, DOI 10.1016/j.juro.2012.06.028; Stafford RE, 2010, J UROLOGY, V183, P378, DOI 10.1016/j.juro.2009.08.105; WILKIE DR, 1949, J PHYSIOL-LONDON, V110, P249, DOI 10.1113/jphysiol.1949.sp004437	24	31	33	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144342	10.1371/journal.pone.0144342	http://dx.doi.org/10.1371/journal.pone.0144342			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642347	Green Submitted, Green Published, gold			2022-12-27	WOS:000366902700100
J	Utne-Palm, AC; Eduard, K; Jensen, KH; Mayer, I; Jakobsen, PJ				Utne-Palm, A. C.; Eduard, K.; Jensen, K. H.; Mayer, I.; Jakobsen, P. J.			Size Dependent Male Reproductive Tactic in the Two-Spotted Goby (Gobiusculus flavescens)	PLOS ONE			English	Article							MALE MATING TACTICS; SEXUAL SELECTION; SPERM COMPETITION; FISH; INVESTMENT; TELEOSTEI; BEHAVIOR; GOBIES; RATIO; DIMORPHISM	Male investment in testes and sperm duct gland in the polygamous nest breeding two-spotted goby Gobiusculus flavescens (Fabricius) was investigated in relation to time in reproductive season and individual physical parameters. This small teleost fish is most likely the most abundant species found along the rocky shores of the North East Atlantic. The two-spotted goby has a single reproductive season, during which nest-caring males can raise several clutches of offspring. According to the literature the males are on average larger than the females. Here we report for the first time a population showing a reversal of this trend, with males on average being smaller than females, a difference likely caused by a large proportion of small males. Early in the breeding season these small males have typical sneaker characters, with relatively large testes and small seminal duct glands compared to the larger dominant territorial males. The presence of these two alternative male reproductive tactics is confirmed by histological studies, which shows the presence of sperm in the sperm duct glands (SDG) of smaller males, but not in the SDG of intermediate and larger males. To our knowledge, males with typical sneaker characters have not been reported in earlier studied populations of two-spotted goby. Interestingly we found that testes investment declined significantly over the course of the breeding season, and that this reduction was significantly more pronounced in small compared to the large males. Further, a significant increase in seminal duct gland (SDG) mass was observed for the smaller males over the breeding season. We propose that this indicates a possible shift in mating tactic by smaller males from a parasitic to a nest-holding tactic over the course of the breeding season. Thus, the observed size dependent plasticity in investment in SDG over time suggests that the reproductive tactic of G. flavescens is conditional, and possibly influenced by mate availability and male-male competition.	[Utne-Palm, A. C.] Inst Marine Res, N-5024 Bergen, Norway; [Eduard, K.; Jensen, K. H.; Jakobsen, P. J.] Univ Bergen, Dept Biol, Bergen, Norway; [Mayer, I.] Norwegian Univ Life Sci, Oslo, Norway; [Eduard, K.] Oslo Univ Hosp, N-0450 Oslo, Norway	Institute of Marine Research - Norway; University of Bergen; Norwegian University of Life Sciences; University of Oslo	Utne-Palm, AC (corresponding author), Inst Marine Res, POB 1870, N-5024 Bergen, Norway.	annecu@imr.no			University of Bergen	University of Bergen	This study was funded by the University of Bergen through the contributing work of a Master student.	Amundsen T, 2001, P NATL ACAD SCI USA, V98, P13155, DOI 10.1073/pnas.211439298; Andersson Malte, 1994; CARROLL SP, 1995, BEHAV ECOL, V6, P46, DOI 10.1093/beheco/6.1.46; COSTELLO MJ, 1992, ENVIRON BIOL FISH, V33, P239, DOI 10.1007/BF00005868; CRESPI BJ, 1988, AM MIDL NAT, V119, P83, DOI 10.2307/2426056; Eggert C, 2003, CAN J ZOOL, V81, P46, DOI 10.1139/Z02-224; EMERSON LS, 1990, J FISH BIOL, V36, P721, DOI 10.1111/j.1095-8649.1990.tb04326.x; FISHELSON L, 1991, JPN J ICHTHYOL, V38, P17, DOI 10.1007/BF02910104; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Forsgren E, 1996, EVOLUTION, V50, P646, DOI 10.1111/j.1558-5646.1996.tb03875.x; Forsgren E, 2004, NATURE, V429, P551, DOI 10.1038/nature02562; FOSSA JH, 1991, ICES MAR SC, V192, P147; Garcia CM, 1998, J FISH BIOL, V53, P104, DOI 10.1111/j.1095-8649.1998.tb01021.x; GORDON JCD, 1983, OPHELIA, V22, P173, DOI 10.1080/00785326.1983.10426593; GRIER HJ, 1981, AM ZOOL, V21, P345; Grier HJ, 1993, SERTOLI CELLS, P703; Gross MR, 1996, TRENDS ECOL EVOL, V11, P92, DOI 10.1016/0169-5347(96)81050-0; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Immler S, 2004, J EXP ZOOL PART A, V301A, P177, DOI 10.1002/jez.a.20019; KODRICBROWN A, 1988, ANIM BEHAV, V36, P1136, DOI 10.1016/S0003-3472(88)80073-3; Kokita T, 1998, J ETHOL, V16, P81, DOI 10.1007/BF02769286; Kvarnemo C, 2010, J FISH BIOL, V76, P1609, DOI 10.1111/j.1095-8649.2010.02587.x; Lengkeek W, 2008, CAN J ZOOL, V86, P1173, DOI 10.1139/Z08-103; Lindstrom K, 2001, AM NAT, V158, P64, DOI 10.1086/320867; LUCAS JR, 1995, AM NAT, V146, P365, DOI 10.1086/285805; MAGNHAGEN C, 1992, ANIM BEHAV, V44, P182, DOI 10.1016/S0003-3472(05)80772-9; MAGNHAGEN C, 1989, J FISH BIOL, V35, P755, DOI 10.1111/j.1095-8649.1989.tb03027.x; Magnhagen C, 1998, J FISH BIOL, V53, P130, DOI 10.1111/j.1095-8649.1998.tb00115.x; MARCONATO A, 1993, BEHAV ECOL SOCIOBIOL, V32, P229; Marconato A, 1996, ENVIRON BIOL FISH, V46, P321, DOI 10.1007/BF00005009; Mazzoldi C, 2000, MAR BIOL, V137, P1041, DOI 10.1007/s002270000417; Mills SC, 2003, BEHAV ECOL SOCIOBIOL, V54, P98, DOI 10.1007/s00265-003-0616-1; Mobley KB, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-6; Myhre LC, 2012, AM NAT, V179, P741, DOI 10.1086/665651; Nakashima Y, 1996, ENVIRON BIOL FISH, V46, P281, DOI 10.1007/BF00005004; PARKER GA, 1990, P ROY SOC B-BIOL SCI, V242, P127, DOI 10.1098/rspb.1990.0115; Pearse A.G.E., 1985, HISTOCHEMISTRY THEOR, Vfourth; Pelabon C, 2005, MAR BIOL, V148, P189, DOI 10.1007/s00227-005-0056-8; Pelabon C, 2003, BEHAV ECOL, V14, P787, DOI 10.1093/beheco/arg074; Pinheiro J, 2001, MIXED EFFECTS MODELS; Pujolar JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046711; RADWAN J, 1993, BEHAV ECOL SOCIOBIOL, V33, P201, DOI 10.1007/BF00216601; Rasotto MB, 2002, J FISH BIOL, V61, P173, DOI 10.1006/jfbi.2002.2029; Scaggiante M, 1999, J EXP ZOOL, V283, P81, DOI 10.1002/(SICI)1097-010X(19990101)283:1<81::AID-JEZ9>3.0.CO;2-9; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Skolbekken R, 2001, J EXP MAR BIOL ECOL, V261, P137, DOI 10.1016/S0022-0981(01)00249-0; Taborsky M, 2001, J HERED, V92, P100, DOI 10.1093/jhered/92.2.100; Taborsky M, 1997, BEHAV ECOL SOCIOBIOL, V41, P361, DOI 10.1007/s002650050396; TABORSKY M, 1994, ADV STUD BEHAV, V23, P1, DOI 10.1016/S0065-3454(08)60351-4; Tomkins JL, 2002, ANIM BEHAV, V63, P1009, DOI 10.1006/anbe.2001.1994; Tomkins JL, 2007, TRENDS ECOL EVOL, V22, P522, DOI 10.1016/j.tree.2007.09.002; Wacker S, 2014, J EVOLUTION BIOL, V27, P466, DOI 10.1111/jeb.12314; Wacker S, 2014, MOL ECOL, V23, P3587, DOI 10.1111/mec.12826; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134; Young KA, 2005, P ROY SOC B-BIOL SCI, V272, P167, DOI 10.1098/rspb.2004.2931; Zuur AF, 2009, USE R, pVII	56	11	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0143487	10.1371/journal.pone.0143487	http://dx.doi.org/10.1371/journal.pone.0143487			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642324	gold, Green Published, Green Submitted			2022-12-27	WOS:000366902700019
J	Guo, LY; Qu, J; Zheng, C; Cao, Y; Zhang, T; Lu, HB; Hu, JZ				Guo, Liyun; Qu, Jin; Zheng, Cheng; Cao, Yong; Zhang, Tao; Lu, Hongbin; Hu, Jianzhong			Preparation and Characterization of a Novel Decellularized Fibrocartilage "Book" Scaffold for Use in Tissue Engineering	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX SCAFFOLDS; MESENCHYMAL STEM-CELLS; BONE INTERFACE; BIOLOGICAL SCAFFOLD; TENDON; MODEL; JOINT	At the tendon-to-bone insertion, there is a unique transitional structure: tendon, non-calcified fibrocartilage, calcified fibrocartilage, and bone. The reconstruction of this special graded structure after defects or damage is an important but challenging task in orthopedics. In particular, reconstruction of the fibrocartilage zone has yet to be successfully achieved. In this study, the development of a novel book-shape scaffold derived from the extracellular matrix of fibrocartilage was reported. Specifically, fibrocartilage from the pubic symphysis was obtained from rabbits and sliced into the shape of a book (dimensions: 10 mm x 3 mm x 1 mm) with 10 layers, each layer (akin to a page of a book) with a thickness of 100-mu m. These fibrocartilage "book" scaffolds were decellularized using sequentially 3 freeze-thaw cycles, 0.1% Triton X-100 with 1.5 M KCl, 0.25% trypsin, and a nuclease. Histology and DNA quantification analysis confirmed substantial removal of cells from the fibrocartilage scaffolds. Furthermore, the quantities of DNA, collagen, and glycosaminoglycan in the fibrocartilage were markedly reduced following decellularization. Scanning electron microscopy confirmed that the intrinsic ultrastructure of the fibrocartilage tissue was well preserved. Therefore, the results of this study suggest that the novel "book" fibrocartilage scaffold could have potential applications in tissue engineering.	[Guo, Liyun; Qu, Jin; Zheng, Cheng; Zhang, Tao; Lu, Hongbin] Cent S Univ, Xiangya Hosp, Res Ctr Sports Med, Dept Sports Med, Changsha 410008, Hunan, Peoples R China; [Guo, Liyun] Changzhi Med Coll, Peace Hosp, Dept Rehabil Med, Changzhi 046000, Shanxi, Peoples R China; [Zheng, Cheng] Hosp Wuhan Sports Univ, Dept Orthopaed, Wuhan 430079, Hubei, Peoples R China; [Cao, Yong; Hu, Jianzhong] Cent S Univ, Xiangya Hosp, Dept Spine Surg, Changsha 410008, Hunan, Peoples R China	Central South University; Changzhi Medical College; Wuhan Sports University; Central South University	Lu, HB (corresponding author), Cent S Univ, Xiangya Hosp, Res Ctr Sports Med, Dept Sports Med, Changsha 410008, Hunan, Peoples R China.	hongbinlu@hotmail.com; jianzhonghu@hotmail.com	Zheng, Cheng/AIA-7877-2022	Zheng, Cheng/0000-0003-1726-0258	National Natural Science Foundation of China [81171699, 84172072]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by The National Natural Science Foundation of China (NO. 81171699 and NO. 84172072).	Aubin H, 2013, TISSUE ENG PART C-ME, V19, P970, DOI [10.1089/ten.tec.2012.0712, 10.1089/ten.TEC.2012.0712]; Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013; Becker I, 2010, J ANAT, V217, P475, DOI 10.1111/j.1469-7580.2010.01300.x; Bedi A, 2012, J SHOULDER ELB SURG, V21, P218, DOI 10.1016/j.jse.2011.09.020; Chang CH, 2014, J BIOMED MATER RES A, V102, P2248, DOI 10.1002/jbm.a.34897; Chen K, 2013, J TISSUE ENG REGEN M; Cheng CW, 2014, BIOTECHNOL ADV, V32, P462, DOI 10.1016/j.biotechadv.2013.12.012; Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057; Elder BD, 2009, BIOMATERIALS, V30, P3749, DOI 10.1016/j.biomaterials.2009.03.050; Gao JZ, 1996, J ANAT, V188, P367; Genin GM, 2009, BIOPHYS J, V97, P976, DOI 10.1016/j.bpj.2009.05.043; Gilbert TW, 2012, J CELL BIOCHEM, V113, P2217, DOI 10.1002/jcb.24130; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; Gong YY, 2011, BIOMATERIALS, V32, P2265, DOI 10.1016/j.biomaterials.2010.11.078; Hjorthaug GA, 2015, J ORTHOP RES, V33, P216, DOI 10.1002/jor.22756; Liao JH, 2010, BIOMATERIALS, V31, P8911, DOI 10.1016/j.biomaterials.2010.07.110; Lu HX, 2012, J BIOMED MATER RES A, V100A, P2507, DOI 10.1002/jbm.a.34150; Lu HX, 2011, BIOMATERIALS, V32, P9658, DOI 10.1016/j.biomaterials.2011.08.091; Lumpkins SB, 2008, ACTA BIOMATER, V4, P808, DOI 10.1016/j.actbio.2008.01.016; Qu J, 2013, J ORTHOP RES, V31, P1713, DOI 10.1002/jor.22412; Stapleton TW, 2008, TISSUE ENG PT A, V14, P505, DOI 10.1089/tea.2007.0233; Sutherland AJ, 2015, ADV HEALTHC MATER, V4, DOI 10.1002/adhm.201400165; Wang INE, 2007, J ORTHOP RES, V25, P1609, DOI 10.1002/jor.20475; Weeks Kenneth D 3rd, 2014, Instr Course Lect, V63, P443; Xu Y, 2015, J BIOMED MATER RES B, V103, P670, DOI 10.1002/jbm.b.33231; Xue JX, 2013, BIOMATERIALS, V34, P2624, DOI 10.1016/j.biomaterials.2012.12.011; Yang Q, 2008, BIOMATERIALS, V29, P2378, DOI 10.1016/j.biomaterials.2008.01.037; Zang MQ, 2013, PLAST RECONSTR SURG, V132, p549E, DOI 10.1097/PRS.0b013e3182a013fc; Zheng XF, 2011, J MATER SCI-MATER M, V22, P693, DOI 10.1007/s10856-011-4248-0	29	15	15	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144240	10.1371/journal.pone.0144240	http://dx.doi.org/10.1371/journal.pone.0144240			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636672	Green Published, gold, Green Submitted			2022-12-27	WOS:000366143800061
J	Kosicka, K; Siemiatkowska, A; Krzyscin, M; Breborowicz, GH; Resztak, M; Majchrzak-Celinska, A; Chuchracki, M; Glowka, FK				Kosicka, Katarzyna; Siemiatkowska, Anna; Krzyscin, Mariola; Breborowicz, Grzegorz H.; Resztak, Matylda; Majchrzak-Celinska, Aleksandra; Chuchracki, Marek; Glowka, Franciszek K.			Glucocorticoid Metabolism in Hypertensive Disorders of Pregnancy: Analysis of Plasma and Urinary Cortisol and Cortisone	PLOS ONE			English	Article							11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-2; CORTICOTROPIN-RELEASING HORMONE; BIRTH-WEIGHT; PREECLAMPSIA; EXPRESSION; IMPACT; RATIO; SERUM	Objectives The aim of the study was to analyze the plasma and urinary cortisol (F) and cortisone (E) levels in normotensive and hypertensive pregnant women. The parameters known to reflect the function of 11 beta-hydroxysteroid dehydrogenase type 2 (11 beta-HSD2) were calculated to verify the changes in glucocorticoid balance over the course of gestational hypertension (GH) and pre-eclampsia (PE). Materials and Methods This retrospective case-control study included women in the third trimester of pregnancy, diagnosed with: GH (n = 29), PE (n = 26), or chronic hypertension (CH; n = 22). Normotensive women in their third trimester of pregnancy were also included (controls; n = 43). The plasma and urinary F and E levels were measured with the HPLC-FLD method. The 11 beta-HSD2 function was estimated by calculating the following ratios: plasma F/E and urinary free F to urinary free E (UFF/UFE). A statistical analysis was performed based on case-control structure. Results and Discussion PE was characterized by lower plasma F levels (639.0 nmol/L), UFF/Cr levels (3.80 mu g/mmol) and F/E ratio (3.46) compared with that of the controls (811.7 nmol/L, 6.28 mu g/mmol and 5.19, respectively) with marked abnormalities observed in the changes of F/E and UFF/UFE ratios with advancing gestation. GH patients showed significant disparities in the urinary steroid profile with lower UFF/UFE ratio (0.330 vs. 0.401) compared with the normotensive controls and abnormal changes in the UFF/UFE throughout pregnancy. The observed tendency towards lower F/E and UFF/UFE ratios in PE and GH patients may reflect more intensive F metabolism over the course of those disorders. In the normal pregnancy group, the plasma F/E and UFF/UFE ratios tended to present inverse correlations with advancing gestation. This trend was much less marked in PE and GH patients, suggesting that the abnormalities in 11 beta-HSD2 functions progressed with the GA. The birth weights of neonates born from pre-eclamptic pregnancies were lower than those from uncomplicated pregnancies, although only when the babies were born prematurely. Children born at term to normotensive mothers or mothers suffering from PE had comparable birth weights.	[Kosicka, Katarzyna; Siemiatkowska, Anna; Resztak, Matylda; Glowka, Franciszek K.] Poznan Univ Med Sci, Dept Phys Pharm & Pharmacokinet, Poznan, Poland; [Krzyscin, Mariola; Breborowicz, Grzegorz H.; Chuchracki, Marek] Poznan Univ Med Sci, Dept Perinatol & Gynecol, Poznan, Poland; [Majchrzak-Celinska, Aleksandra] Poznan Univ Med Sci, Dept Pharmaceut Biochem, Poznan, Poland	Poznan University of Medical Sciences; Poznan University of Medical Sciences; Poznan University of Medical Sciences	Kosicka, K (corresponding author), Poznan Univ Med Sci, Dept Phys Pharm & Pharmacokinet, Poznan, Poland.	kasiakosicka@ump.edu.pl	Siemiątkowska, Anna/L-2295-2019; Kosicka-Noworzyń, Katarzyna/B-3077-2019; Majchrzak-Celińska, Aleksandra/AAA-9149-2021	Siemiątkowska, Anna/0000-0003-3568-4716; Kosicka-Noworzyń, Katarzyna/0000-0003-3551-4784; Majchrzak-Celinska, Aleksandra/0000-0002-2872-8875; Krzyscin, Mariola/0000-0002-4027-7122; Glowka, Franciszek/0000-0002-6611-5789	National Science Center (Narodowe Centrum Nauki) in Poland [2012/05/B/NZ7/02532]	National Science Center (Narodowe Centrum Nauki) in Poland	The study was funded by National Science Center (Narodowe Centrum Nauki) in Poland - grant number 2012/05/B/NZ7/02532 received by FKG [http://ncn.gov.pl/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananth CV, 2010, EPIDEMIOLOGY, V21, P118, DOI 10.1097/EDE.0b013e3181c297af; Aufdenblatten M, 2009, PEDIATR RES, V65, P198, DOI 10.1203/PDR.0b013e31818d6c24; Brus R, 1999, ARCH INTERN MED, V159, P1903, DOI 10.1001/archinte.159.16.1903; Causevic M, 2007, MOL ASPECTS MED, V28, P220, DOI 10.1016/j.mam.2007.04.003; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0; Dy J, 2008, PLACENTA, V29, P193, DOI 10.1016/j.placenta.2007.10.010; Ferrari P, 2010, BBA-MOL BASIS DIS, V1802, P1178, DOI 10.1016/j.bbadis.2009.10.017; FURUHASHI N, 1986, TOHOKU J EXP MED, V149, P21, DOI 10.1620/tjem.149.21; Gadzinowski Janusz, 2003, Ginekol Pol, V74, P186; Glowka FK, 2010, J CHROMATOGR B, V878, P283, DOI 10.1016/j.jchromb.2009.11.016; Harris A, 2011, HORM BEHAV, V59, P279, DOI 10.1016/j.yhbeh.2010.06.007; Heilmann P, 1999, EXP CLIN ENDOCR DIAB, V107, P370, DOI 10.1055/s-0029-1212128; Heilmann P, 2001, J CLIN ENDOCR METAB, V86, P5222, DOI 10.1210/jc.86.11.5222; Ho JT, 2007, CLIN ENDOCRINOL, V66, P869, DOI 10.1111/j.1365-2265.2007.02826.x; Hutcheon JA, 2011, BEST PRACT RES CL OB, V25, P391, DOI 10.1016/j.bpobgyn.2011.01.006; Jung C, 2011, J CLIN ENDOCR METAB, V96, P1533, DOI 10.1210/jc.2010-2395; LAATIKAINEN T, 1991, EUR J OBSTET GYN R B, V39, P19, DOI 10.1016/0028-2243(91)90136-9; Martinerie L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031949; Mastorakos G, 2003, ANN NY ACAD SCI, V997, P136, DOI 10.1196/annals.1290.016; McCalla CO, 1998, STEROIDS, V63, P511, DOI 10.1016/S0039-128X(98)00056-7; MEULENBERG PMM, 1990, CLIN CHEM, V36, P70; Morineau G, 2006, J AM SOC NEPHROL, V17, P3176, DOI 10.1681/ASN.2006060570; Odegard RA, 2000, OBSTET GYNECOL, V96, P950, DOI 10.1016/S0029-7844(00)01040-1; Odermatt A, 2008, BIOCHEM PHARMACOL, V76, P1184, DOI 10.1016/j.bcp.2008.07.019; Reynolds RM, 2013, PSYCHONEUROENDOCRINO, V38, P1, DOI 10.1016/j.psyneuen.2012.08.012; Rogerson FM, 1997, MOL CELL ENDOCRINOL, V128, P103, DOI 10.1016/S0303-7207(97)04027-6; Schoof E, 2001, J CLIN ENDOCR METAB, V86, P1313, DOI 10.1210/jc.86.3.1313; Shams M, 1998, HUM REPROD, V13, P799, DOI 10.1093/humrep/13.4.799; Shimodaira M, 2013, GYNECOL ENDOCRINOL, V29, P657, DOI 10.3109/09513590.2013.788623; Struwe E, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.02.012; WALKER BR, 1995, HYPERTENSION, V25, P626, DOI 10.1161/01.HYP.25.4.626; WARREN WB, 1995, AM J OBSTET GYNECOL, V172, P661, DOI 10.1016/0002-9378(95)90589-8; World Health Organization, 2011, WHO REC PREV TREATM; Xiong X, 2002, AM J EPIDEMIOL, V155, P203, DOI 10.1093/aje/155.3.203; Young BC, 2010, ANNU REV PATHOL-MECH, V5, P173, DOI 10.1146/annurev-pathol-121808-102149	35	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144343	10.1371/journal.pone.0144343	http://dx.doi.org/10.1371/journal.pone.0144343			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26637176	Green Submitted, Green Published, gold			2022-12-27	WOS:000366143800079
J	He, WM; He, HM; Zhu, MY				He, Wenming; He, Hongming; Zhu, Mingyong			Calcium Nodules as a Proxy for Quaternary Paleoclimate Change on China's Loess Plateau	PLOS ONE			English	Article							CARBONATE NODULES; PALEOSOLS; SOILS; CLASSIFICATION	Different proxies have been used to investigate Quaternary paleoclimate change. Here, we used weathering of calcium nodules in paleosols on China's Loess Plateau as a proxy for Quaternary paleoclimate changes to provide an alternative indicator of these changes. Paleosol and carbonate nodules were collected from Luochuan and Lantian counties in Shaanxi Province, China. We found that this approach allowed quantitative reconstruction of temperature, rainfall, soil mineral composition, and the effects of weathering and leaching. The changes in carbonate content in the loess and paleosol sequences were controlled by alternating dry and wet climatic conditions. Nodule formation conditions were directly affected by the leaching and migration of elements. The loess and paleosol sequences developed calcium nodules, and their formation was closely related to the rainfall and leaching characteristics of the paleoclimate. The paleoclimate and soil minerals affected the vegetation types and directly influenced changes in the soil. During formation of the calcium nodules, the surface vegetation evolved slowly, and the number of species and quantity of vegetation both decreased.	[He, Wenming] Jiaying Univ, Sch Chem & Environm, Meizhou, Guangdong, Peoples R China; [He, Wenming; He, Hongming; Zhu, Mingyong] Northwest Agr & Forestry Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shaanxi, Peoples R China; [He, Wenming; He, Hongming; Zhu, Mingyong] Chinese Acad Sci, Inst Soil & Water Conservat, Yangling, Shaanxi, Peoples R China; [He, Wenming; He, Hongming; Zhu, Mingyong] Minist Water Resources, Yangling, Shaanxi, Peoples R China; [Zhu, Mingyong] Minnan Normal Univ, Dept Hist & Sociol, Zhangzhou, Fujian, Peoples R China	Jiaying University; Northwest A&F University - China; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Ministry of Water Resources; MinNan Normal University	He, HM (corresponding author), Northwest Agr & Forestry Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shaanxi, Peoples R China.	hongming.he@yahoo.com	He, Hongming/A-4161-2010	Mingyong, Zhu/0000-0001-6849-1692	Hundred-Talents Project of the Chinese Academy of Sciences [2011009]; National Natural Science Foundation of China [501100001809, 41072137]; Innovation Frontier Project of the Institute of Soil and Water Conservation of the Chinese Academy of Sciences [10502]; Key Research Program of the Chinese Academy of Sciences [KZZD-EW-04]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB03020300]; State Key Laboratory of Soil Erosion and Dryland Farming on the Loess Plateau [10501-192, K318009902-1402]	Hundred-Talents Project of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Frontier Project of the Institute of Soil and Water Conservation of the Chinese Academy of Sciences; Key Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); State Key Laboratory of Soil Erosion and Dryland Farming on the Loess Plateau	We are grateful for research grants from the Hundred-Talents Project of the Chinese Academy of Sciences (2011009, Hongming He), the National Natural Science Foundation of China (Grant No. 501100001809 and No. 41072137), the Innovation Frontier Project of the Institute of Soil and Water Conservation of the Chinese Academy of Sciences (10502), the Key Research Program of the Chinese Academy of Sciences (Grant No. KZZD-EW-04), the Strategic Priority Research Program of the Chinese Academy of Sciences (Grant No. XDB03020300), and the State Key Laboratory of Soil Erosion and Dryland Farming on the Loess Plateau (10501-192, K318009902-1402).	Ballestrero T, 2006, PRACTICAL HDB GROUND, P207; EMILIANI C, 1955, J GEOL, V63, P538, DOI 10.1086/626295; Gallet S, 1996, CHEM GEOL, V133, P67, DOI 10.1016/S0009-2541(96)00070-8; Guo ZT, 2002, NATURE, V416, P159, DOI 10.1038/416159a; Han JM, 1997, QUATERN INT, V37, P37, DOI 10.1016/1040-6182(96)00005-5; Kraus MJ, 2007, PALAEOGEOGR PALAEOCL, V245, P444, DOI 10.1016/j.palaeo.2006.09.011; Lee H, 2014, GEOARCHAEOLOGY, V29, P326, DOI 10.1002/gea.21478; [刘恋 Liu Lian], 2011, [第四纪研究, Quaternary Sciences], V31, P506; Liu LA, 2010, CHINESE SCI BULL, V55, P2926, DOI 10.1007/s11434-010-4073-8; Liu T, 2004, LOESS ENV; Lu H. Y., 1999, ACTA SEDIMENT SIN, V17, P226, DOI [10.3969/j.issn.1000-0550.1999.02.011, DOI 10.3969/J.ISSN.1000-0550.1999.02.011]; Lu Y, 2006, ARID LAND GEOGRAPHY, V28, P450; MACK GH, 1993, GEOL SOC AM BULL, V105, P129, DOI 10.1130/0016-7606(1993)105&lt;0129:COP&gt;2.3.CO;2; MAGARITZ M, 1981, GEODERMA, V25, P157, DOI 10.1016/0016-7061(81)90033-1; MAYNARD JB, 1992, J GEOL, V100, P279, DOI 10.1086/629632; Nettleton WD, 2000, CATENA, V41, P61, DOI 10.1016/S0341-8162(00)00109-0; [欧阳椿陶 OUYANG Chuntao], 2007, [地理学报, Acta Geographica Sinica], V62, P518; RETALLACK GJ, 1993, GEOL SOC AM BULL, V105, P1635, DOI 10.1130/0016-7606(1993)105<1635:COPDAR>2.3.CO;2; Retallack GJ, 2010, GEOLOGY, V38, P403, DOI 10.1130/G30514.1; Shackleton N. J., 1973, Quaternary Research, V3, P39, DOI 10.1016/0033-5894(73)90052-5; Sheldon ND, 2002, J GEOL, V110, P687, DOI 10.1086/342865; Shuang GS, 2005, J SOIL WATER CONSERV, V19, P109; Strahler A.N., 1957, EOS T AM GEOPHYS UN, V38, P913, DOI [DOI 10.1029/TR038I006P00913, 10.1029/TR038i006p00913]; Wanas HA, 2006, SEDIMENT GEOL, V183, P243, DOI 10.1016/j.sedgeo.2005.09.013; Wen Q.Z., 1989, GEOCHEMISTRY CHINESE	25	12	13	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143928	10.1371/journal.pone.0143928	http://dx.doi.org/10.1371/journal.pone.0143928			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633304	Green Submitted, Green Published, gold			2022-12-27	WOS:000366040000031
J	Srinivasan, P; Thrower, EC; Loganathan, G; Balamurugan, AN; Subramanian, VS; Gorelick, FS; Said, HM				Srinivasan, Padmanabhan; Thrower, Edwin C.; Loganathan, Gopalakrishnan; Balamurugan, A. N.; Subramanian, Veedamali S.; Gorelick, Fred S.; Said, Hamid M.			Chronic Nicotine Exposure In Vivo and In Vitro Inhibits Vitamin B1 (Thiamin) Uptake by Pancreatic Acinar Cells	PLOS ONE			English	Article							CHRONIC ALCOHOL EXPOSURE; DIFFERENTIAL EXPRESSION; SMOKING; DEFICIENCY; TOBACCO; PRESERVATION; INFLAMMATION; SECRETION; INSULIN; GLUCOSE	Thiamin (vitamin B1), a member of the water-soluble family of vitamins, is essential for normal cellular functions; its deficiency results in oxidative stress and mitochondrial dysfunction. Pancreatic acinar cells (PAC) obtain thiamin from the circulation using a specific carrier-mediated process mediated by both thiamin transporters -1 and -2 (THTR-1 and THTR-2; encoded by the SLC19A2 and SLC19A3 genes, respectively). The aim of the current study was to examine the effect of chronic exposure of mouse PAC in vivo and human PAC in vitro to nicotine (a major component of cigarette smoke that has been implicated in pancreatic diseases) on thiamin uptake and to delineate the mechanism involved. The results showed that chronic exposure of mice to nicotine significantly inhibits thiamin uptake in murine PAC, and that this inhibition is associated with a marked decrease in expression of THTR-1 and THTR-2 at the protein, mRNA and hnRNAs level. Furthermore, expression of the important thiamin-metabolizing enzyme, thiamin pyrophosphokinase (TPKase), was significantly reduced in PAC of mice exposed to nicotine. Similarly, chronic exposure of cultured human PAC to nicotine (0.5 mu M, 48 h) significantly inhibited thiamin uptake, which was also associated with a decrease in expression of THTR-1 and THTR-2 proteins and mRNAs. This study demonstrates that chronic exposure of PAC to nicotine impairs the physiology and the molecular biology of the thiamin uptake process. Furthermore, the study suggests that the effect is, in part, mediated through transcriptional mechanism(s) affecting the SLC19A2 and SLC19A3 genes.	[Srinivasan, Padmanabhan; Subramanian, Veedamali S.; Said, Hamid M.] VA Med Ctr, Dept Med Res, Long Beach, CA 90822 USA; [Srinivasan, Padmanabhan; Subramanian, Veedamali S.; Said, Hamid M.] Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA; [Srinivasan, Padmanabhan; Subramanian, Veedamali S.; Said, Hamid M.] Univ Calif Irvine, Dept Physiol Biophys, Irvine, CA USA; [Loganathan, Gopalakrishnan; Balamurugan, A. N.] Univ Louisville, Dept Surg, Clin Islet Cell Lab, Cardiovasc Innovat Inst, Louisville, KY 40292 USA; [Thrower, Edwin C.] Yale Univ, Sch Med, Dept Internal Med, Sect Digest Dis, New Haven, CT 06510 USA; [Gorelick, Fred S.] Yale Univ, Dept Internal Med, Sect Digest Dis, New Haven, CT USA; [Gorelick, Fred S.] Vet Affairs Healthcare Syst, West Haven, CT USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of Louisville; Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Said, HM (corresponding author), VA Med Ctr, Dept Med Res, Long Beach, CA 90822 USA.	hmsaid@uci.edu			National Institutes of Health [AA018071, DK56061]; Department of Veterans Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK056061, R01DK056061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018071] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by grants from the National Institutes of Health (AA018071 and DK56061) and the Department of Veterans Affairs.	Alexandre M, 2011, PANCREATOLOGY, V11, P469, DOI 10.1159/000332196; Andriulli A, 2010, PANCREAS, V39, P1205, DOI 10.1097/MPA.0b013e3181df27c0; Askari MDF, 2005, J CANCER RES CLIN, V131, P639, DOI 10.1007/s00432-005-0002-7; Balamurugan AN, 2012, TRANSPLANTATION, V93, P693, DOI 10.1097/TP.0b013e318247281b; Balamurugan AN, 2010, TRANSPLANTATION, V89, P954, DOI 10.1097/TP.0b013e3181d21e9a; BETTENDORFF L, 1995, J NEUROCHEM, V64, P2013; Bruin JE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003371; Buisson B, 2002, TRENDS PHARMACOL SCI, V23, P130, DOI 10.1016/S0165-6147(00)01979-9; Calingasan NY, 1999, J NEUROPATH EXP NEUR, V58, P946, DOI 10.1097/00005072-199909000-00005; Chowdhury P, 2002, EXP BIOL MED, V227, P445, DOI 10.1177/153537020222700708; Chowdhury P, 2008, LANGENBECK ARCH SURG, V393, P547, DOI 10.1007/s00423-007-0267-1; Chowdhury P, 2013, TOB INDUC DIS, V11, DOI 10.1186/1617-9625-11-1; Di YP, 2012, J BIOL CHEM, V287, P27948, DOI 10.1074/jbc.M111.334375; DOI R, 1995, PANCREAS, V10, P154, DOI 10.1097/00006676-199503000-00008; Gangolf M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013616; JAMIESON NV, 1989, TRANSPLANT P, V21, P1292; Jianyu-Hao, 2009, INHAL TOXICOL, V21, P1007, DOI 10.1080/08958370802665937; LATIF ZA, 1988, TRANSPLANTATION, V45, P827; Lindkvist B, 2008, PANCREAS, V37, P288, DOI 10.1097/MPA.0b013e31816a7744; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowenfels AB, 1999, GASTROENTEROL CLIN N, V28, P673, DOI 10.1016/S0889-8553(05)70080-7; Malfertheiner P, 2006, AM J GASTROENTEROL, V101, P160, DOI 10.1111/j.1572-0241.2006.00402.x; McGilligan VE, 2007, FOOD CHEM TOXICOL, V45, P1593, DOI 10.1016/j.fct.2007.02.021; Mee L, 2009, AM J PHYSIOL-GASTR L, V297, pG197, DOI 10.1152/ajpgi.00092.2009; Nabokina SM, 2004, AM J PHYSIOL-GASTR L, V287, pG822, DOI 10.1152/ajpgi.00234.2004; Papas KK, 2009, CURR OPIN ORGAN TRAN, V14, P674, DOI 10.1097/MOT.0b013e328332a489; Portari GV, 2008, BASIC CLIN PHARMACOL, V103, P482, DOI 10.1111/j.1742-7843.2008.00311.x; PRASANNAN KG, 1977, EXPERIENTIA, V33, P169, DOI 10.1007/BF02124046; Prokopczyk B, 2002, CHEM RES TOXICOL, V15, P677, DOI 10.1021/tx0101088; RATHANASWAMI P, 1991, BIOCHEM INT, V24, P1057; RATHANASWAMI P, 1991, BIOCHEM INT, V25, P577; Reidling JC, 2002, BBA-BIOMEMBRANES, V1561, P180, DOI 10.1016/S0005-2736(02)00341-3; RICORDI C, 1988, DIABETES, V37, P413, DOI 10.2337/diabetes.37.4.413; Shugrue CA, 2012, AM J PHYSIOL-GASTR L, V303, pG723, DOI 10.1152/ajpgi.00082.2012; Singh L, 2008, DIGEST DIS SCI, V53, P2569, DOI 10.1007/s10620-007-0162-1; SINGH M, 1982, AM J CLIN NUTR, V36, P500, DOI 10.1093/ajcn/36.3.500; Slattery ML, 2003, CANCER EPIDEM BIOMAR, V12, P882; Srinivasan P, 2015, AM J PHYSIOL-GASTR L, V309, pG750, DOI 10.1152/ajpgi.00226.2015; Srinivasan P, 2014, AM J PHYSIOL-GASTR L, V307, pG941, DOI 10.1152/ajpgi.00278.2014; Srinivasan P, 2014, AM J PHYSIOL-GASTR L, V306, pG631, DOI 10.1152/ajpgi.00420.2013; Srinivasan P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078853; Subramanian VS, 2012, AM J PHYSIOL-GASTR L, V302, pG572, DOI 10.1152/ajpgi.00484.2011; Subramanya SB, 2011, AM J PHYSIOL-GASTR L, V301, pG896, DOI 10.1152/ajpgi.00308.2011; Thrower E, 2015, CANCERS, V7, P723, DOI 10.3390/cancers7020723; TODO S, 1989, JAMA-J AM MED ASSOC, V261, P711, DOI 10.1001/jama.261.5.711; Ulrich CM, 2001, CANCER EPIDEM BIOMAR, V10, P875; Wang F, 1998, J BIOL CHEM, V273, P28721, DOI 10.1074/jbc.273.44.28721; WETSCHER GJ, 1995, FREE RADICAL BIO MED, V18, P877, DOI 10.1016/0891-5849(94)00221-5; Wittel UA, 2006, AM J GASTROENTEROL, V101, P148, DOI 10.1111/j.1572-0241.2006.00405.x; Wittel UA, 2006, PANCREAS, V33, P364, DOI 10.1097/01.mpa.0000240601.80570.31; Word B, 2013, INT J TOXICOL, V32, P23, DOI 10.1177/1091581812465902; Xu H, 2007, EUR RESPIR J, V30, P633, DOI 10.1183/09031936.00014107; Zhang H, 2003, RESPIROLOGY, V8, P17, DOI 10.1046/j.1440-1843.2003.00433.x	53	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143575	10.1371/journal.pone.0143575	http://dx.doi.org/10.1371/journal.pone.0143575			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633299	Green Published, gold			2022-12-27	WOS:000366040000017
J	Saenroth, D; Meyer, A; Salewsky, B; Kroh, M; Norman, K; Steinhagen-Thiessen, E; Demuth, I				Saenroth, Denise; Meyer, Antje; Salewsky, Bastian; Kroh, Martin; Norman, Kristina; Steinhagen-Thiessen, Elisabeth; Demuth, Ilja			Sports and Exercise at Different Ages and Leukocyte Telomere Length in Later Life - Data from the Berlin Aging Study II (BASE-II)	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; ASSOCIATION; SHELTERIN; HEALTHY; MIDLIFE; COMPLEX; ADULTS; TIME	Physical activity and sports have repeatedly been reported to be associated with telomere length. We studied the association of different types of sports across different stages of life on relative leukocyte telomere length (rLTL) in advanced age. 815 participants (397 men) from the Berlin Aging Study II aged over 61 years were included in the analysis. rLTL was measured by real time PCR and physical activity was determined retrospectively by questionnaire, assessing type and duration of sports in the past as well as currently. Five separate multiple linear regression models adjusted for various control variables were performed. 67.3% of participants exercised currently, whereas 19.4% performed sports only between the age of 20 and 30. rLTL was higher in subjects who stated to exercise currently (N = 456), and in subjects who engaged in endurance (N = 138) or intensive activity sports (N = 32). Current physical activity was positively associated with rLTL in the risk factor adjusted regression model (beta = 0.26, p < 0.001) and practicing sports for a minimum of 10 years preceding the assessment had a significant effect on rLTL (beta = 0.39, p = 0.011). The highest impact was seen for intensive activity sports (beta = 0.79, p < 0.001) and physical activity since at least 42 years (beta = 0.47, p = 0.001). However, physical activity only between 20 and 30 years of age did not affect rLTL in old age when compared to no sports at all (beta = -0.16, p = 0.21). Physical activity is clearly associated with longer rLTL. The effect is seen with longer periods of physical activity (at least 10 years), with intensive sports activities having the greatest impact on rLTL. Our data suggest that regular physical activity for at least 10 years is necessary to achieve a sustained effect on rLTL.	[Saenroth, Denise; Kroh, Martin] German Inst Econ Res DIW Berlin, Res Infrastruct Socioecon Panel SOEP, Berlin, Germany; [Kroh, Martin] Humboldt Univ HUB, Berlin, Germany; [Meyer, Antje; Salewsky, Bastian; Norman, Kristina; Steinhagen-Thiessen, Elisabeth; Demuth, Ilja] Charite, Berlin Aging Study 2, Res Grp Geriatr, D-13353 Berlin, Germany; [Demuth, Ilja] Charite, Inst Med & Human Genet, D-13353 Berlin, Germany	DIW Berlin - Deutsches Institut fur Wirtschaftsforschung; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Demuth, I (corresponding author), Charite, Berlin Aging Study 2, Res Grp Geriatr, D-13353 Berlin, Germany.	ilja.demuth@charite.de	Demuth, Ilja/ABD-5352-2021	Demuth, Ilja/0000-0002-4340-2523; Meyer, Antje/0000-0003-1675-4512; Kroh, Martin/0000-0002-4889-8425; Norman, Kristina/0000-0003-2029-9102	German Federal Ministry of Education and Research [16SV5536K, 16SV5537]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This study was supported by the German Federal Ministry of Education and Research (http://www.bmbf.de/en/index.php) under grant numbers 16SV5536K and 16SV5537. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertram L, 2014, INT J EPIDEMIOL, V43, P703, DOI 10.1093/ije/dyt018; Bockenhoff A, 2013, SOEPPAPERS, V568; Bojesen SE, 2013, J INTERN MED, V274, P399, DOI 10.1111/joim.12083; Borghini A, 2015, MUTAGENESIS, V30, P711, DOI 10.1093/mutage/gev038; Buxton JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099133; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cherkas LF, 2008, ARCH INTERN MED, V168, P154, DOI 10.1001/archinternmed.2007.39; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Denham J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069377; Diotti R, 2011, NUCLEUS-PHILA, V2, P119, DOI 10.4161/nucl.2.2.15135; Gardner M, 2014, EXP GERONTOL, V51, P15, DOI 10.1016/j.exger.2013.12.004; Gerstorf D, 2015, PSYCHOL AGING, V30, P301, DOI 10.1037/pag0000016; Huzen J, 2014, J INTERN MED, V275, P155, DOI 10.1111/joim.12149; LaRocca TJ, 2010, MECH AGEING DEV, V131, P165, DOI 10.1016/j.mad.2009.12.009; Lee M, 2011, AM J HUM BIOL, V23, P100, DOI 10.1002/ajhb.21109; Ludlow AT, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/601368; Mathur S, 2013, J INVEST MED, V61, P613, DOI [10.231/JIM.0b013e3182814cc2, 10.2310/JIM.0b013e3182814cc2]; Meyer A, 2015, GERONTOLOGY IN PRESS; Muezzinler A, 2014, OBES REV, V15, P192, DOI 10.1111/obr.12126; Muezzinler A, 2013, AGEING RES REV, V12, P509, DOI 10.1016/j.arr.2013.01.003; Needham BL, 2013, SOC SCI MED, V85, P1, DOI 10.1016/j.socscimed.2013.02.023; Ornish D, 2013, LANCET ONCOL, V14, P1112, DOI 10.1016/S1470-2045(13)70366-8; Osthus IBO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052769; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rae DE, 2010, EUR J APPL PHYSIOL, V109, P323, DOI 10.1007/s00421-010-1353-6; Rode L, 2013, THORAX, V68, P429, DOI 10.1136/thoraxjnl-2012-202544; Savela S, 2013, EXP GERONTOL, V48, P81, DOI 10.1016/j.exger.2012.02.003; Seitz H, 2008, EMPFEHLUNGEN WISSENS; Shen Q, 2012, J CLIN ENDOCR METAB, V97, P1371, DOI 10.1210/jc.2011-1562; Strandberg TE, 2012, EUR J EPIDEMIOL, V27, P815, DOI 10.1007/s10654-012-9728-0; Sun Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038374; Weischer M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004191; Willeit P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112483; Zee RYL, 2010, TRANSL RES, V155, P166, DOI 10.1016/j.trsl.2009.09.012	35	26	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0142131	10.1371/journal.pone.0142131	http://dx.doi.org/10.1371/journal.pone.0142131			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630493	Green Published, Green Submitted, gold			2022-12-27	WOS:000365926300009
J	Andrews, TD; Felzer, BS				Andrews, Travis D.; Felzer, Benjamin S.			Very-Heavy Precipitation in the Greater New York City Region and Widespread Drought Alleviation Tied to Western US Agriculture	PLOS ONE			English	Article							ATMOSPHERIC RESPONSE; GLOBAL IRRIGATION; CLIMATE; WATER; SIMULATIONS; IMPACTS; LAND	Observed intensification of precipitation extremes, responsible for extensive societal impacts, are widely attributed to anthropogenic sources, which may include indirect effects of agricultural irrigation. However quantifying the effects of irrigation on far-downstream climate remains a challenge. We use three paired Community Earth System Model simulations to assess mechanisms of irrigation-induced precipitation trends and extremes in the conterminous US and the effect on the terrestrial carbon sink. Results suggest precipitation enhancement in the central US reduced drought conditions and increased regional carbon uptake, while further downstream, the heaviest precipitation events were more frequent and intense. Specifically, moisture advection from irrigation in the western U.S. and recycling of enhanced local convective precipitation produced very-heavy storm events that were 11% more intense and occurred 23% more frequently in the densely populated greater New York City region.	[Andrews, Travis D.; Felzer, Benjamin S.] Lehigh Univ, Earth & Environm Sci, Bethlehem, PA 18015 USA	Lehigh University	Andrews, TD (corresponding author), Lehigh Univ, Earth & Environm Sci, Bethlehem, PA 18015 USA.	tda210@alum.lehigh.edu	Felzer, Benjamin S/AAB-3456-2021	Felzer, Benjamin S/0000-0002-3990-3739	NSF Macrosystems [1137306]; National Science Foundation (NSF); NSF Macrosystems Biology [1137306]	NSF Macrosystems; National Science Foundation (NSF)(National Science Foundation (NSF)); NSF Macrosystems Biology(National Science Foundation (NSF))	BSF supported by NSF Macrosystems 1137306.; We acknowledge the immense CESM development efforts provided by NCAR staff that made these analyses possible. All analysis R code and summarized datasets are publicly accessible via Github (github.com/wanderswest/IRRIG). Thanks to Zav Kothavala for assistance with experiments. We would like to acknowledge high-performance computing support from Yellowstone (ark:/85065/d7wd3xhc) provided by NCAR's Computational and Information Systems Laboratory, sponsored by the National Science Foundation (NSF). This material is based upon work supported by the NSF Macrosystems Biology under Grant Number 1137306 (program solicitation NSF 10-555).	Alter RE, 2015, J HYDROMETEOROLOGY; [Anonymous], 2009, ESTIMATED USE WATER; [Anonymous], 2009, CLIMATE CHANGE IMPAC, DOI DOI 10.1111/j.1365-2664.2010.01827.x; Bacmeister JT, 2014, J CLIMATE, V27, P3073, DOI 10.1175/JCLI-D-13-00387.1; Boucher O, 2004, CLIM DYNAM, V22, P597, DOI 10.1007/s00382-004-0402-4; Change IPoC, 2014, CLIM CHANG 2013 PHYS; Coumou D, 2012, NAT CLIM CHANGE, V2, P491, DOI 10.1038/NCLIMATE1452; Dai A, 2006, J CLIMATE, V19, P4605, DOI 10.1175/JCLI3884.1; DeAngelis A, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD013892; Frumhoff PC, 2007, CONFRONTING CLIMATE; Giorgi F, 2002, J CLIMATE, V15, P1141, DOI 10.1175/1520-0442(2002)015<1141:COAURA>2.0.CO;2; Harding KJ, 2012, J HYDROMETEOROL, V13, P1687, DOI 10.1175/JHM-D-11-099.1; Harding KJ, 2012, J HYDROMETEOROL, V13, P1667, DOI 10.1175/JHM-D-11-098.1; Houze RA, 1997, B AM METEOROL SOC, V78, P2179, DOI 10.1175/1520-0477(1997)078<2179:SPIROC>2.0.CO;2; Huber DB, 2014, CLIMATE, V2, P103, DOI 10.3390/cli2020103; Hurrell JW, 2013, 2011 COMMUNITY EARTH; Konzmann M, 2013, HYDROLOG SCI J, V58, P88, DOI 10.1080/02626667.2013.746495; Kooperman GJ, 2014, J ADV MODEL EARTH SY, V6, P859, DOI 10.1002/2014MS000306; Kopparla P, 2013, GEOPHYS RES LETT, V40, P5803, DOI 10.1002/2013GL057866; Kueppers LM, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028679; Lawrence DM, 2012, J CLIMATE, V25, P2240, DOI 10.1175/JCLI-D-11-00103.1; Lee E., 2011, INT J GEOSCI, V2, P420, DOI [10.4236/ijg.2011.24046, DOI 10.4236/IJG.2011.24046]; Levis S, 2011, TECHNICAL DESCRIPTIO; Lo MH, 2013, GEOPHYS RES LETT, V40, P301, DOI 10.1002/grl.50108; McDonald RI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065589; McGuire VL, 2009, CHANGES WATER LEVELS; Neale R. B., 2010, NCARTN486STR; Oleson K.W., 2010, TECHNICAL DESCRIPTIO; Perlman H, 2014, IRRIGATION WATER USE; Puma M, 2010, J GEOPHYS RES-ATMOS, P115; Qian Y, 2013, J HYDROMETEOROL, V14, P700, DOI 10.1175/JHM-D-12-0134.1; Sacks WJ, 2009, CLIM DYNAM, V33, P159, DOI 10.1007/s00382-008-0445-z; Schneiderman E, 2014, CURRENT FUTURE TREND; Segal M, 1998, J APPL METEOROL, V37, P325, DOI 10.1175/1520-0450-37.3.325; Shiklomanov IA, 2000, WATER INT, V25, P11, DOI 10.1080/02508060008686794; Siebert S, 2015, HYDROL EARTH SYST SC, V19, P1521, DOI 10.5194/hess-19-1521-2015; Sorooshian S., 2011, J GEOPHYS RES ATMOSP, V116; Steward DR, 2013, P NATL ACAD SCI USA, V110, pE3477, DOI 10.1073/pnas.1220351110; Team RC, 2012, R LANG ENV STAT COMP; Wen LJ, 2012, HYDROL PROCESS, V26, P445, DOI 10.1002/hyp.8142	40	0	0	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144416	10.1371/journal.pone.0144416	http://dx.doi.org/10.1371/journal.pone.0144416			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642049	Green Submitted, Green Published, gold			2022-12-27	WOS:000366902700116
J	Bastos, TF; Canesqui, AM; Barros, MBD				Bastos, Tassia Fraga; Canesqui, Ana Maria; de Azevedo Barros, Marilisa Berti			"Healthy Men" and High Mortality: Contributions from a Population-Based Study for the Gender Paradox Discussion	PLOS ONE			English	Article							SEX-DIFFERENCES; PHYSICAL INACTIVITY; ALCOHOL; LEISURE; INEQUALITIES; CONSUMPTION; PREVALENCE	Background Inequalities between men and women in morbidity and mortality show a contrast, which has been called gender paradox. Most studies evaluating this paradox were conducted in high-income countries and, until now, few investigations have been performed in Brazil. This study aims to estimate the magnitude of inequalities between adult men and women in several dimensions: demographic and socioeconomic, health behaviors, morbidity, use of health services and mortality. Methods The data were obtained from population-based household survey carried out in Campinas (Campinas Health Survey 2008/09) corresponding to 957 people, and data from the Mortality Information System (MIS) between 2009 and 2011. Prevalences and prevalence ratios were analyzed in order to verify the differences between men and women regarding socioeconomic and demographic variables, health behaviors, morbidities and consultations in the last two weeks. Mortality rates and the ratio between coefficients considering the underlying causes of death were calculated. Results Women had a greater disadvantage in socioeconomic indicators, chronic diseases diagnosed by a health professional and referred health problems as well as make more use of health services, while men presented higher frequency of most unhealthy behaviors and excessive mortality for all causes investigated. Conclusions The findings contribute to the discussion of gender paradox and demonstrate the need to employ health actions that consider the differences between men and women in the various health dimensions analyzed. The premature male mortality from preventable causes was outstanding, making clear the need for more effective prevention and health promotion directed to this segment of the population.	[Bastos, Tassia Fraga; Canesqui, Ana Maria; de Azevedo Barros, Marilisa Berti] Univ Estadual Campinas, Sch Med Sci, Dept Publ Hlth, Campinas, SP, Brazil	Universidade Estadual de Campinas	Bastos, TF (corresponding author), Univ Estadual Campinas, Sch Med Sci, Dept Publ Hlth, Campinas, SP, Brazil.	tassiafraga@yahoo.com.br			Sao Paulo Research Foundation (FAPESP) [12/07970-2]; National Council of Technological and Scientific Development (CNPq) [409747/2006-8]; Ministry of Health and the Secretary of Health of Campinas (Partnership UNICAMP/Funcamp/SMS) [4300]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministry of Health and the Secretary of Health of Campinas (Partnership UNICAMP/Funcamp/SMS)	The Sao Paulo Research Foundation (FAPESP) funded the PhD scholarship of TFB (Grant number: 12/07970-2; URLs: http://www.bv.fapesp.br/28630). The National Council of Technological and Scientific Development (CNPq) funded the research (Grant number: 409747/2006-8) and funds the productivity scholarship granted to MBAB. Financial support for the survey from the Ministry of Health and the Secretary of Health of Campinas (Partnership UNICAMP/Funcamp/SMS no 4300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, ISA CAMPINAS 2008 20; Azevedo MR, 2007, INT J PUBLIC HEALTH, V52, P8, DOI 10.1007/s00038-006-5062-1; Barros MBA, 2008, B MORTALIDADE, V42; Brasil. Ministerio da Saude, 2013, VIG BRAS 2012 VIG FA; Campinas. Municipal Department of Health, 2014, MORT INF SYST TABNET; Canesqui AM, 2005, ANTROPOLOGIA NUTR DI, P23; Case A, 2005, DEMOGRAPHY, V42, P189, DOI 10.1353/dem.2005.0011; Courtenay W. H., 2002, International Journal of Men's Health, V1, P281, DOI 10.3149/jmh.0103.281; Crimmins EM, 2011, EUR J PUBLIC HEALTH, V21, P81, DOI 10.1093/eurpub/ckq022; DANIEL J.M.P., 2005, ANTROPOLOGIA NUTR DI, P57; Barros MBD, 2007, REV SAUDE PUBL, V41, P502, DOI 10.1590/S0034-89102006005000032; Barros MBD, 2011, CIENC SAUDE COLETIVA, V16, P3755, DOI 10.1590/S1413-81232011001000012; Del Duca GF, 2013, PUBLIC HEALTH, V127, P530, DOI 10.1016/j.puhe.2013.02.013; Ferreira LN, 2011, CAD SAUDE PUBLICA, V27, P1473, DOI 10.1590/S0102-311X2011000800003; Freitas I. C., 2006, CAD SAUDE PUBLICA, V27, P2021; Giovino GA, 2012, LANCET, V380, P668, DOI 10.1016/S0140-6736(12)61085-X; Gomes R, 2011, CIENC SAUDE COLETIVA, V16, P983, DOI 10.1590/S1413-81232011000700030; IBGE. Instituto Brasileiro de Geografia e Estatistica, 2010, DEM CENS 2010 POP MU; Jaime PC, 2009, REV SAUDE PUBL, V43, P57, DOI 10.1590/S0034-89102009000900008; Laurenti Ruy, 2005, Ciênc. saúde coletiva, V10, P35, DOI 10.1590/S1413-81232005000100010; Lindahl-Jacobsen R, 2013, ANN EPIDEMIOL, V23, P161, DOI 10.1016/j.annepidem.2013.02.001; Malta DC, 2015, CIENC SAUDE COLETIVA, V20, P631, DOI 10.1590/1413-81232015203.15232014; McCartney G, 2011, TOB CONTROL, V20, P166, DOI 10.1136/tc.2010.037929; NATHANSON CA, 1975, SOC SCI MED, V9, P57, DOI 10.1016/0037-7856(75)90094-3; Oksuzyan A, 2014, EUR J EPIDEMIOL, V29, P243, DOI 10.1007/s10654-014-9893-4; Oksuzyan A, 2008, AGING CLIN EXP RES, V20, P91; Oksuzyan A, 2010, EUR J EPIDEMIOL, V25, P471, DOI 10.1007/s10654-010-9460-6; Perelman J, 2012, CAD SAUDE PUBLICA, V28, P2339, DOI 10.1590/S0102-311X2012001400012; Pinheiro Rejane Sobrino, 2002, Ciênc. saúde coletiva, V7, P687; Read JG, 2010, ANNU REV SOCIOL, V36, P371, DOI 10.1146/annurev.soc.012809.102535; Redonnet B, 2012, DRUG ALCOHOL DEPEN, V121, P231, DOI 10.1016/j.drugalcdep.2011.09.002; SARTI C.A., 2001, SAUDE SOC, V10, P3; Stevens A, 2012, CIENC SAUDE COLETIVA, V17, P2627, DOI 10.1590/S1413-81232012001000012; Van Tuyckom C, 2013, EUR J PUBLIC HEALTH, V23, P452, DOI 10.1093/eurpub/cks009; VERBRUGGE LM, 1989, J HEALTH SOC BEHAV, V30, P282, DOI 10.2307/2136961; Wang H, 2010, LANCET, V380, p2071 , DOI DOI 10.1016/S0140-6736(12)61719-X; White A, 2006, MED J AUSTRALIA, V185, P454, DOI 10.5694/j.1326-5377.2006.tb00647.x; World Health Organization, 2011, NONCOMMUNICABLE DIS; Zanchetta Luane Margarete, 2010, Rev. bras. epidemiol., V13, P387, DOI 10.1590/S1415-790X2010000300003	39	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144520	10.1371/journal.pone.0144520	http://dx.doi.org/10.1371/journal.pone.0144520			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1YS	26641245	Green Published, gold, Green Submitted			2022-12-27	WOS:000366902700139
J	Bertholet, N; Cunningham, JA; Faouzi, M; Gaume, J; Gmel, G; Burnand, B; Daeppen, JB				Bertholet, Nicolas; Cunningham, John A.; Faouzi, Mohamed; Gaume, Jacques; Gmel, Gerhard; Burnand, Bernard; Daeppen, Jean-Bernard			Internet-Based Brief Intervention to Prevent Unhealthy Alcohol Use among Young Men: A Randomized Controlled Trial	PLOS ONE			English	Article							IDENTIFICATION TEST AUDIT; PERSONALIZED-FEEDBACK; COLLEGE DRINKING; GLOBAL BURDEN; CONSUMPTION; DRINKERS; STUDENTS; DISEASE; ONLINE	Introduction Alcohol use is one of the leading modifiable morbidity and mortality risk factors among young adults. Study Design 2 parallel-group randomized controlled trial with follow-up at 1 and 6 months. Setting/Participants Internet based study in a general population sample of young men with low-risk drinking, recruited between June 2012 and February 2013. Intervention: Internet-based brief alcohol primary prevention intervention (IBI). The IBI aims at preventing an increase in alcohol use: it consists of normative feedback, feedback on consequences, calorific value alcohol, computed blood alcohol concentration, indication that the reported alcohol use is associated with no or limited risks for health. Intervention group participants received the IBI. Control group (CG) participants completed only an assessment. Main Outcome Measures Alcohol use (number of drinks per week), binge drinking prevalence. Analyses were conducted in 2014-2015. Results Of 4365 men invited to participate, 1633 did so; 896 reported low-risk drinking and were randomized (IBI: n = 451; CG: n = 445). At baseline, 1 and 6 months, the mean (SD) number of drinks/week was 2.4(2.2), 2.3(2.6), 2.5(3.0) for IBI, and 2.4(2.3), 2.8(3.7), 2.7(3.9) for CG. Binge drinking, absent at baseline, was reported by 14.4% (IBI) and 19.0% (CG) at 1 month and by 13.3% (IBI) and 13.0% (CG) at 6 months. At 1 month, beneficial intervention effects were observed on the number of drinks/week (p = 0.05). No significant differences were observed at 6 months. Conclusion We found protective short term effects of a primary prevention IBI.	[Bertholet, Nicolas; Faouzi, Mohamed; Gaume, Jacques; Gmel, Gerhard; Daeppen, Jean-Bernard] Univ Lausanne Hosp, Dept Community Med & Hlth, Alcohol Treatment Ctr, Lausanne, Switzerland; [Cunningham, John A.] Australian Natl Univ, Natl Inst Mental Hlth Res, Canberra, ACT, Australia; [Cunningham, John A.] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Burnand, Bernard] Univ Lausanne Hosp, Dept Community Med & Hlth, Inst Social & Prevent Med, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Australian National University; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Bertholet, N (corresponding author), Univ Lausanne Hosp, Dept Community Med & Hlth, Alcohol Treatment Ctr, Lausanne, Switzerland.	Nicolas.Bertholet@chuv.ch	Gachoud, Céline/K-1104-2018; Bertholet, Nicolas/AAX-2061-2020	Bertholet, Nicolas/0000-0001-5064-6377; Gmel, Gerhard/0000-0001-9403-9405; Gaume, Jacques/0000-0002-9149-0994; Daeppen, Jean-Bernard/0000-0001-7059-1393; Cunningham, John/0000-0002-0668-5982	Swiss National Science Foundation [33CSCO-122679, 325130_135538]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	C-SURF and the internet trial were funded by the Swiss National Science Foundation (33CSCO-122679, PI:GG and 325130_135538, PI. NB), the internet trial being a large nested project of C-SURF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Swiss National Science Foundation: www.snf.ch/en.	Abel T, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13901; Bertholet N, 2015, ADDICTION; Bewick BM, 2008, PREV MED, V47, P17, DOI 10.1016/j.ypmed.2008.01.005; Cunningham JA, 2009, ADDICTION, V104, P2023, DOI 10.1111/j.1360-0443.2009.02726.x; Cunningham JA, 2012, J MED INTERNET RES, V14, P24, DOI 10.2196/jmir.2090; D'Amico EJ, 2012, PREV SCI, V13, P415, DOI 10.1007/s11121-011-0269-7; Foster S, 2015, ADDICTION; Gache P, 2005, ALCOHOL CLIN EXP RES, V29, P2001, DOI 10.1097/01.alc.0000187034.58955.64; Gmel G, 2008, ALCOHOL ALCOHOLISM, V43, P692, DOI 10.1093/alcalc/agn070; Larimer ME, 2007, J CONSULT CLIN PSYCH, V75, P285, DOI 10.1037/0022-006X.75.2.285; Murphy JG, 2007, ADDICT BEHAV, V32, P2573, DOI 10.1016/j.addbeh.2007.05.015; Neighbors C, 2012, J CONSULT CLIN PSYCH, V80, P850, DOI 10.1037/a0029480; OFS, 2004, ENQ SUISS SANT 2002; Palfai TP, 2014, J PRIM PREV, V35, P75, DOI 10.1007/s10935-013-0337-9; Prince MA, 2014, PSYCHOL ADDICT BEHAV, V28, P538, DOI 10.1037/a0036402; Rehm J, 2003, EUR ADDICT RES, V9, P157, DOI 10.1159/000072222; Rehm J, 2007, INT J PUBLIC HEALTH, V52, P383, DOI 10.1007/s00038-007-7010-0; Rehm J, 2006, DRUG ALCOHOL REV, V25, P503, DOI 10.1080/09595230600944453; Riper H, 2009, AM J PREV MED, V36, P247, DOI 10.1016/j.amepre.2008.10.016; Saitz R, 2007, ALCOHOL ALCOHOLISM, V42, P28, DOI [10.1093/alcalc/ag1092, 10.1093/alcalc/agl092]; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Walton M.A., 2013, ADDICTION; WECHSLER H, 1994, JAMA-J AM MED ASSOC, V272, P1672, DOI 10.1001/jama.272.21.1672; Werch CE, 2002, J STUD ALCOHOL, V63, P581, DOI 10.15288/jsa.2002.63.581; White A, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1479	25	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144146	10.1371/journal.pone.0144146	http://dx.doi.org/10.1371/journal.pone.0144146			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1YS	26642329	Green Published, Green Submitted, gold			2022-12-27	WOS:000366902700064
J	Liu, XW; Cai, H; Sheng, WQ; Yu, L; Long, ZW; Shi, YQ; Wang, YN				Liu, Xiaowen; Cai, Hong; Sheng, Weiqi; Yu, Lin; Long, Ziwen; Shi, Yingqiang; Wang, Yanong			Clinicopathological Characteristics and Survival Outcomes of Primary Signet Ring Cell Carcinoma in the Stomach: Retrospective Analysis of Single Center Database	PLOS ONE			English	Article							PROGNOSTIC-SIGNIFICANCE; GASTRIC-CARCINOMA	Purpose To investigate the clinicopathological features and prognosis of signet ring cell carcinoma of the stomach (SRC). Methods A total of 1464 gastric cancer patients who underwent curative gastrectomy from 2000 to 2008 at a single center were evaluated. Signet ring cell carcinoma (SRC) was defined as the presence of at least 50% signet ring cells in the pathologic specimen. The clinicopatho-logical parameters and prognosis of SRC were analyzed by comparing with non-signet ring cell carcinoma (NSRC). Results Of 1464 patients, 138 patients (9.4%) were classified as SRC. There were significant differences in gender, age, tumor location, TNM stage, p21 expression, and p53 expression between SRC and NSRC. The 5-year survival rates of SRC and NSRC were 36.2% and 49.5%, respectively. The prognosis of SRC was poorer than that of NSRC (P < 0.001). Multivariate analysis showed that SRC histology was an independent factor for poor prognosis (P < 0.001). Conclusion Patients with SRC tend to present with a more advanced stage and poorer prognosis than patients with other types of gastric carcinoma.	[Liu, Xiaowen; Cai, Hong; Long, Ziwen; Shi, Yingqiang; Wang, Yanong] Fudan Univ, Shanghai Canc Ctr, Dept Gastr Canc & Soft Tissue Sarcoma, Shanghai 200032, Peoples R China; [Liu, Xiaowen; Cai, Hong; Sheng, Weiqi; Yu, Lin; Long, Ziwen; Shi, Yingqiang; Wang, Yanong] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China; [Sheng, Weiqi; Yu, Lin] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200032, Peoples R China	Fudan University; Fudan University; Fudan University	Wang, YN (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Gastr Canc & Soft Tissue Sarcoma, Shanghai 200032, Peoples R China.	wangyn1111@hotmail.com			Shanghai Committee of Science and Technology Funds [14ZR1407800, 124119a4302]; National Natural Science Foundation of China [81502027]	Shanghai Committee of Science and Technology Funds(Shanghai Science & Technology Committee); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research is supported by grants from the Shanghai Committee of Science and Technology Funds (Contract grant numbers: 14ZR1407800, 124119a4302), and the National Natural Science Foundation of China (81502027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	ANTONIOLI DA, 1982, CANCER, V50, P775, DOI 10.1002/1097-0142(19820815)50:4<775::AID-CNCR2820500425>3.0.CO;2-W; Chu PG, 2004, AM J CLIN PATHOL, V121, P884, DOI 10.1309/A09ERYMFR64NERDW; Hamilton SR, 2010, WHO CLASSIFICATION T, P134; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Jiang CG, 2011, J SURG ONCOL, V103, P700, DOI 10.1002/jso.21878; Kim DY, 2004, ANZ J SURG, V74, P1060, DOI 10.1111/j.1445-1433.2004.03268.x; KIM JP, 1994, SURG ONCOL, V3, P221, DOI 10.1016/0960-7404(94)90037-X; Kwon KJ, 2014, GASTRIC CANCER, V17, P43, DOI 10.1007/s10120-013-0234-1; Lee JH, 2010, BRIT J SURG, V97, P732, DOI 10.1002/bjs.6941; Li C, 2007, ONCOLOGY-BASEL, V72, P64, DOI 10.1159/000111096; Liu XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029670; MAEHARA Y, 1992, CANCER, V69, P1645, DOI 10.1002/1097-0142(19920401)69:7<1645::AID-CNCR2820690702>3.0.CO;2-X; Matsuyama S, 2002, J CANCER RES CLIN, V128, P319, DOI 10.1007/s00432-002-0336-3; Otsuji E, 1998, J SURG ONCOL, V67, P216, DOI 10.1002/(SICI)1096-9098(199804)67:4<216::AID-JSO2>3.0.CO;2-B; Piessen G, 2009, ANN SURG, V250, P878, DOI 10.1097/SLA.0b013e3181b21c7b; Shibata A, 2006, CANC EPIDEMIOLOGY PR, P707; Taghavi S, 2012, J CLIN ONCOL, V30, P3493, DOI 10.1200/JCO.2012.42.6635; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Yarnamichi N, 2007, CANCER RES, V67, P10727, DOI 10.1158/0008-5472.CAN-07-2601; Zhang M, 2010, J GASTROINTEST SURG, V14, P601, DOI 10.1007/s11605-009-1127-9	20	43	46	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144420	10.1371/journal.pone.0144420	http://dx.doi.org/10.1371/journal.pone.0144420			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642199	gold, Green Submitted, Green Published			2022-12-27	WOS:000366902700117
J	Posluszny, A; Liguz-Lecznar, M; Turzynska, D; Zakrzewska, R; Bielecki, M; Kossut, M				Posluszny, Anna; Liguz-Lecznar, Monika; Turzynska, Danuta; Zakrzewska, Renata; Bielecki, Maksymilian; Kossut, Malgorzata			Learning-Dependent Plasticity of the Barrel Cortex Is Impaired by Restricting GABA-Ergic Transmission	PLOS ONE			English	Article							INHIBITORY SYNAPTIC-TRANSMISSION; OCULAR DOMINANCE PLASTICITY; LONG-TERM POTENTIATION; CORTICAL PLASTICITY; INDUCED ENHANCEMENT; ADULT MICE; 3-MERCAPTOPROPIONIC ACID; CEREBELLAR CORTEX; DENDRITIC SPINES; NMDA RECEPTORS	Experience-induced plastic changes in the cerebral cortex are accompanied by alterations in excitatory and inhibitory transmission. Increased excitatory drive, necessary for plasticity, precedes the occurrence of plastic change, while decreased inhibitory signaling often facilitates plasticity. However, an increase of inhibitory interactions was noted in some instances of experience-dependent changes. We previously reported an increase in the number of inhibitory markers in the barrel cortex of mice after fear conditioning engaging vibrissae, observed concurrently with enlargement of the cortical representational area of the row of vibrissae receiving conditioned stimulus (CS). We also observed that an increase of GABA level accompanied the conditioning. Here, to find whether unaltered GABAergic signaling is necessary for learning-dependent rewiring in the murine barrel cortex, we locally decreased GABA production in the barrel cortex or reduced transmission through GABAA receptors (GABAARs) at the time of the conditioning. Injections of 3-mercaptopropionic acid (3-MPA), an inhibitor of glutamic acid decarboxylase (GAD), into the barrel cortex prevented learning-induced enlargement of the conditioned vibrissae representation. A similar effect was observed after injection of gabazine, an antagonist of GABAARs. At the behavioral level, consistent conditioned response (cessation of head movements in response to CS) was impaired. These results show that appropriate functioning of the GABAergic system is required for both manifestation of functional cortical representation plasticity and for the development of a conditioned response.	[Posluszny, Anna; Liguz-Lecznar, Monika; Zakrzewska, Renata; Kossut, Malgorzata] M Nencki Inst Expt Biol, Dept Mol & Cellular Neurobiol, PL-02093 Warsaw, Poland; [Bielecki, Maksymilian; Kossut, Malgorzata] SWPS Univ Social Sci & Humanities, Dept Psychol, Warsaw, Poland; [Turzynska, Danuta] Inst Psychiat & Neurol, Dept Neurochem, Warsaw, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; SWPS University of Social Sciences & Humanities; Institute of Psychiatry & Neurology	Kossut, M (corresponding author), M Nencki Inst Expt Biol, Dept Mol & Cellular Neurobiol, PL-02093 Warsaw, Poland.	m.kossut@nencki.gov.pl	Bielecki, Maksymilian/AAI-6699-2020; Liguz-Lecznar, Monika/R-2834-2016; Liguz-Lecznar, Monika/K-6850-2019	Bielecki, Maksymilian/0000-0002-2881-4976; Liguz-Lecznar, Monika/0000-0002-2113-7407; Liguz-Lecznar, Monika/0000-0002-2113-7407; Turzynska, Danuta/0000-0001-5183-1435; Kossut, Malgorzata/0000-0001-7808-1101; Posluszny, Anna/0000-0003-1571-1393; Zakrzewska, Renata/0000-0002-7882-9463	Ministry of Science and Education [N N301 248639]	Ministry of Science and Education	The research was supported by grant no N N301 248639 of Ministry of Science and Education to MK.	Bekisz M, 2010, EUR J NEUROSCI, V32, P1715, DOI 10.1111/j.1460-9568.2010.07453.x; Bieszczad KM, 2010, NEUROBIOL LEARN MEM, V94, P127, DOI 10.1016/j.nlm.2010.04.009; Brosh I, 2009, LEARN MEMORY, V16, P413, DOI 10.1101/lm.1430809; Chiu CQ, 2013, SCIENCE, V340, P759, DOI 10.1126/science.1234274; Cybulska-Klosowicz A, 2013, NEUROSCIENCE, V254, P18, DOI 10.1016/j.neuroscience.2013.09.020; Cybulska-Klosowicz A, 2009, BEHAV BRAIN RES, V204, P102, DOI 10.1016/j.bbr.2009.05.024; Duguid I, 2012, J NEUROSCI, V32, P11132, DOI 10.1523/JNEUROSCI.0460-12.2012; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; Engel D, 2001, J PHYSIOL-LONDON, V535, P473, DOI 10.1111/j.1469-7793.2001.00473.x; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Fu Y, 2014, CELL, V156, P1139, DOI 10.1016/j.cell.2014.01.050; Galvez R, 2006, J NEUROSCI, V26, P6062, DOI 10.1523/JNEUROSCI.5582-05.2006; Gandolfi D, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00064; Gentet LJ, 2010, NEURON, V65, P422, DOI 10.1016/j.neuron.2010.01.006; Gierdalski M, 2001, CEREB CORTEX, V11, P806, DOI 10.1093/cercor/11.9.806; Griffen TC, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00091; Grunze HCR, 1996, J NEUROSCI, V16, P2034; Harauzov A, 2010, J NEUROSCI, V30, P361, DOI 10.1523/JNEUROSCI.2233-09.2010; Holmgren CD, 2001, J NEUROSCI, V21, P8270; Jablonska B, 1999, CEREB CORTEX, V9, P222, DOI 10.1093/cercor/9.3.222; Jasinska M, 2010, J NEUROSCI, V30, P1176, DOI 10.1523/JNEUROSCI.2970-09.2010; Jerome D, 2012, EUR J NEUROSCI, V36, P3134, DOI 10.1111/j.1460-9568.2012.08210.x; JULIANO SL, 1989, J NEUROSCI, V9, P1; KARLSSON A, 1974, BIOCHEM PHARMACOL, V23, P3053, DOI 10.1016/0006-2952(74)90281-0; Kilgard MP, 2007, HEARING RES, V229, P171, DOI 10.1016/j.heares.2007.01.005; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Komatsu Y, 2000, J NEUROSCI, V20, P7539; Kossut M, 1998, EXP BRAIN RES, V123, P110, DOI 10.1007/s002210050551; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Liguz-Lecznar M, 2015, BRAIN STRUCT FUNCT, V220, P1681, DOI 10.1007/s00429-014-0752-6; Liguz-Lecznar M, 2011, NEUROBIOL AGING, V32, P1896, DOI 10.1016/j.neurobiolaging.2009.11.009; LOSCHER W, 1985, J NEUROCHEM, V45, P879, DOI 10.1111/j.1471-4159.1985.tb04076.x; Lovett-Barron M, 2014, CURR OPIN NEUROBIOL, V26, P27, DOI 10.1016/j.conb.2013.11.002; Ma DS, 1999, ANAL BIOCHEM, V276, P124, DOI 10.1006/abio.1999.4352; McKay BM, 2013, J NEUROSCI, V33, P5499, DOI 10.1523/JNEUROSCI.4068-12.2013; Petrini EM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4921; Pi HJ, 2013, NATURE, V503, P521, DOI 10.1038/nature12676; Poorthuis RB, 2014, J PHYSIOL-LONDON, V592, P4155, DOI 10.1113/jphysiol.2014.273862; Saar D, 2012, J NEUROPHYSIOL, V107, P1222, DOI 10.1152/jn.00356.2011; Scelfo B, 2008, P NATL ACAD SCI USA, V105, P769, DOI 10.1073/pnas.0706342105; SILLITO AM, 1986, NATURE, V320, P109, DOI 10.1038/320109a0; Siucinska E, 1996, CEREB CORTEX, V6, P506, DOI 10.1093/cercor/6.3.506; Siucinska E, 1999, BRAIN RES, V843, P62, DOI 10.1016/S0006-8993(99)01881-8; Siucinska E, 2006, BRAIN RES, V1106, P52, DOI 10.1016/j.brainres.2006.05.061; SPRINCE H, 1969, ANN NY ACAD SCI, V166, P323, DOI 10.1111/j.1749-6632.1969.tb46402.x; STROMINGER RN, 1987, J NEUROSCI METH, V22, P113, DOI 10.1016/0165-0270(87)90004-5; Thiele A, 2012, J NEUROSCI, V32, P16602, DOI 10.1523/JNEUROSCI.0554-12.2012; Tokarski K, 2007, EUR J NEUROSCI, V26, P134, DOI 10.1111/j.1460-9568.2007.05629.x; Urban-Ciecko J, 2010, J NEUROPHYSIOL, V104, P746, DOI 10.1152/jn.00988.2009; van Versendaal D, 2012, NEURON, V74, P374, DOI 10.1016/j.neuron.2012.03.015; WANG XQ, 1995, NATURE, V378, P71, DOI 10.1038/378071a0; WELKER E, 1989, EXP BRAIN RES, V78, P659, DOI 10.1007/BF00230256; WIGSTROM H, 1985, ACTA PHYSIOL SCAND, V125, P159, DOI 10.1111/j.1748-1716.1985.tb07703.x; Wolff SBE, 2014, NATURE, V509, P453, DOI 10.1038/nature13258	56	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144415	10.1371/journal.pone.0144415	http://dx.doi.org/10.1371/journal.pone.0144415			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641862	Green Published, gold, Green Submitted			2022-12-27	WOS:000366902700115
J	Rudolph, A; Teske, M; Illner, S; Kiefel, V; Sternberg, K; Grabow, N; Wree, A; Hovakimyan, M				Rudolph, Andreas; Teske, Michael; Illner, Sabine; Kiefel, Volker; Sternberg, Katrin; Grabow, Niels; Wree, Andreas; Hovakimyan, Marina			Surface Modification of Biodegradable Polymers towards Better Biocompatibility and Lower Thrombogenicity	PLOS ONE			English	Article							DRUG-ELUTING STENTS; CORONARY-ARTERY-DISEASE; BARE-METAL STENTS; POLY-(L-LACTIC ACID); ENDOTHELIALIZATION; HEMOCOMPATIBILITY; RESTENOSIS; THROMBOSIS; POLY(L-LACTIDE); IMMOBILIZATION	Purpose Drug-eluting stents (DES) based on permanent polymeric coating matrices have been introduced to overcome the in stent restenosis associated with bare metal stents (BMS). A further step was the development of DES with biodegradable polymeric coatings to address the risk of thrombosis associated with first-generation DES. In this study we evaluate the biocompatibility of biodegradable polymer materials for their potential use as coating matrices for DES or as materials for fully bioabsorbable vascular stents. Materials and Methods Five different polymers, poly(L-lactide) PLLA, poly(D, L-lactide) PDLLA, poly(L-lactide-co-glycolide) P(LLA-co-GA), poly(D, L-lactide-co-glycolide) P(DLLA-co-GA) and poly(L-lactideco-e-caprolactone), P(LLA-co-CL) were examined in vitro without and with surface modification. The surface modification of polymers was performed by means of wet-chemical (NaOH and ethylenediamine (EDA)) and plasma-chemical (O-2 and NH3) processes. The biocompatibility studies were performed on three different cell types: immortalized mouse fibroblasts (cell line L929), human coronary artery endothelial cells (HCAEC) and human umbilical vein endothelial cells (HUVEC). The biocompatibility was examined quantitatively using in vitro cytotoxicity assay. Cells were investigated immunocytochemically for expression of specific markers, and morphology was visualized using confocal laser scanning (CLSM) and scanning electron (SEM) microscopy. Additionally, polymer surfaces were examined for their thrombogenicity using an established hemocompatibility test. Results Both endothelial cell types exhibited poor viability and adhesion on all five unmodified polymer surfaces. The biocompatibility of the polymers could be influenced positively by surface modifications. In particular, a reproducible effect was observed for NH3-plasma treatment, which enhanced the cell viability, adhesion and morphology on all five polymeric surfaces. Conclusion Surface modification of polymers can provide a useful approach to enhance their biocompatibility. For clinical application, attempts should be made to stabilize the plasma modification and use it for coupling of biomolecules to accelerate the re-endothelialization of stent surfaces in vivo.	[Rudolph, Andreas; Teske, Michael; Illner, Sabine; Sternberg, Katrin; Grabow, Niels; Hovakimyan, Marina] Univ Rostock, Med Ctr, Inst Biomed Engn, D-18119 Rostock, Germany; [Kiefel, Volker] Univ Rostock, Med Ctr, Dept Transfus Med, D-18057 Rostock, Germany; [Wree, Andreas] Univ Rostock, Med Ctr, Inst Anat, D-18057 Rostock, Germany	University of Rostock; University of Rostock; University of Rostock	Hovakimyan, M (corresponding author), Univ Rostock, Med Ctr, Inst Biomed Engn, Friedrich Barnewitz Str 4, D-18119 Rostock, Germany.	marina.hovakimyan@uni-rostock.de			BMBF; German Federal Ministry of Education and Research [FKZ: 03IS2081]	BMBF(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This study was financially supported by BMBF, the German Federal Ministry of Education and Research within the coordinated research project REMEDIS, "Hohere Lebensqualitat durch neuartige Mikroimplantate", (FKZ: 03IS2081). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was financially supported by BMBF, the German Federal Ministry of Education and Research within the coordinated research project REMEDIS, "Hohere Lebensqualitat durch neuartige Mikroimplantate", (FKZ: 03IS2081).	Bavry AA, 2007, CIRCULATION, V116, P696, DOI 10.1161/CIRCULATIONAHA.107.719484; Bavry AA, 2006, AM J MED, V119, P1056, DOI 10.1016/j.amjmed.2006.01.023; Bax DV, 2014, BIOMATERIALS, V35, P6797, DOI 10.1016/j.biomaterials.2014.04.082; Bedair T.M., 2014, BIOMATERIALS BIOMEDI, V1, P121, DOI 10.12989/bme.2014.1.3.121; Bonow R., 2012, BRAUNWALDS HEART DIS, DOI DOI 10.1093/eurheartj/ehw249; Byrne RA, 2009, JACC-CARDIOVASC INTE, V2, P291, DOI 10.1016/j.jcin.2008.11.015; Camenzind E, 2007, CIRCULATION, V115, P1440, DOI 10.1161/CIRCULATIONAHA.106.666800; Chaabane C, 2013, CARDIOVASC RES, V99, P353, DOI 10.1093/cvr/cvt115; Chong DST, 2015, EUR J VASC ENDOVASC, V49, P335, DOI 10.1016/j.ejvs.2014.12.008; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Dangas GD, 2010, J AM COLL CARDIOL, V56, P1897, DOI 10.1016/j.jacc.2010.07.028; Duraiswamy N, 2009, J BIOMATER APPL, V23, P367, DOI 10.1177/0885328208093854; Garcia-Garcia JM, 2012, J BIOMED MATER RES A, V100A, P7, DOI 10.1002/jbm.a.33215; Hirotsu T, 2002, POLYM ENG SCI, V42, P299, DOI 10.1002/pen.10949; Holmvang L, 2013, JACC-CARDIOVASC INTE, V6, P548, DOI 10.1016/j.jcin.2012.12.129; Hyuck Joon Kwon, 2014, Polymers, V6, P755, DOI 10.3390/polym6030755; Iijima R, 2013, INT J CARDIOL, V168, P2588, DOI 10.1016/j.ijcard.2013.03.046; Ino JM, 2013, J BIOMED MATER RES B, V101, P1549, DOI 10.1002/jbm.b.32977; Inoue M, 2013, J BIOMED MATER RES A, V101, P2049, DOI 10.1002/jbm.a.34488; Iqbal J, 2013, BRIT MED BULL, V106, P193, DOI 10.1093/bmb/ldt009; Jeewandara TM, 2014, MATERIALS, V7, P769, DOI 10.3390/ma7020769; Khorasani MT, 2008, RADIAT PHYS CHEM, V77, P280, DOI 10.1016/j.radphyschem.2007.05.013; Laslett LJ, 2012, J AM COLL CARDIOL, V60, pS1, DOI 10.1016/j.jacc.2012.11.002; Lemos PA, 2003, CIRCULATION, V107, P3003, DOI 10.1161/01.CIR.0000078025.19258.28; Leon MB, 2009, JACC-CARDIOVASC INTE, V2, P504, DOI 10.1016/j.jcin.2009.04.004; Luscher TF, 2007, CIRCULATION, V115, P1051, DOI 10.1161/CIRCULATIONAHA.106.675934; Martin DM, 2011, MED ENG PHYS, V33, P148, DOI 10.1016/j.medengphy.2010.10.009; Mitra AK, 2006, J CLIN PATHOL, V59, P232, DOI 10.1136/jcp.2005.025742; Morent R, 2008, NUCL INSTRUM METH B, V266, P3081, DOI 10.1016/j.nimb.2008.03.166; Morent R, 2011, PLASMA PROCESS POLYM, V8, P171, DOI 10.1002/ppap.201000153; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Nguyen KT, 2003, BIOMATERIALS, V24, P5191, DOI 10.1016/S0142-9612(03)00451-4; Niemela KO, 2008, EUR HEART J, V29, P1930, DOI 10.1093/eurheartj/ehn304; Nordmann AJ, 2006, EUR HEART J, V27, P2784, DOI 10.1093/eurheartj/ehl282; Ormiston JA, 2008, LANCET, V371, P899, DOI 10.1016/S0140-6736(08)60415-8; Petersen S, 2014, J BIOMED MATER RES B, V102, P345, DOI 10.1002/jbm.b.33012; Pfisterer M, 2006, J AM COLL CARDIOL, V48, P2584, DOI 10.1016/j.jacc.2006.10.026; Scislowska-Czarnecka A, 2015, J BIOMED MATER RES A, V103, P3965, DOI 10.1002/jbm.a.35509; Sharma K, 2013, GLOB HEART, V8, P105, DOI 10.1016/j.gheart.2013.02.001; Siow KS, 2006, PLASMA PROCESS POLYM, V3, P392, DOI 10.1002/ppap.200600021; Smith SC, 2012, J AM COLL CARDIOL, V60, P2343, DOI 10.1016/j.jacc.2012.08.962; Solouk A, 2015, MAT SCI ENG C-MATER, V46, P400, DOI 10.1016/j.msec.2014.10.065; Stone GW, 2009, NEW ENGL J MED, V360, P1946, DOI 10.1056/NEJMoa0810116; Storm T, 2014, J MATER SCI-MATER M, V25, P2003, DOI 10.1007/s10856-014-5226-0; Tezcaner A, 2003, BIOMATERIALS, V24, P4573, DOI 10.1016/S0142-9612(03)00302-8; Wang LP, 2014, ARQ BRAS CARDIOL, V102, P529, DOI 10.5935/abc.20140070; Whyte EM, 2001, AM J PSYCHIAT, V158, P2074, DOI 10.1176/appi.ajp.158.12.2074; Wong ND, 2014, NAT REV CARDIOL, V11, P276, DOI 10.1038/nrcardio.2014.26; Xu H, 2011, TISSUE ENG PT A, V17, P865, DOI [10.1089/ten.tea.2010.0129, 10.1089/ten.TEA.2010.0129]; Yahagi K, 2015, ATHEROSCLEROSIS, V239, P260, DOI 10.1016/j.atherosclerosis.2015.01.017; Yang J, 2003, POLYM INT, V52, P1892, DOI 10.1002/pi.1272; Yoneda S, 2013, CORONARY ARTERY DIS, V24, P368, DOI 10.1097/MCA.0b013e32836222ec	52	25	30	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0142075	10.1371/journal.pone.0142075	http://dx.doi.org/10.1371/journal.pone.0142075			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641662	Green Published, Green Submitted, gold			2022-12-27	WOS:000366902700006
J	So, SHW; Tang, V; Leung, PWL				So, Suzanne Ho-wai; Tang, Venus; Leung, Patrick Wing-leung			Dimensions of Delusions and Attribution Biases along the Continuum of Psychosis	PLOS ONE			English	Article							PERSECUTORY DELUSIONS; RELEVANT DIMENSIONS; GENERAL-POPULATION; HIGH-RISK; STYLE; EXPERIENCES; INDIVIDUALS; DEPRESSION; IDEATION; PARANOIA	This study compared delusional dimensions and attribution biases along the continuum of psychosis. Participants completed questionnaires on delusion-like beliefs and attributions. Although patients with first-episode psychosis (N = 70) endorsed fewer delusion-like beliefs than non-clinical individuals with psychotic-like experiences (N = 12), they scored highest on delusional conviction, distress and preoccupation, followed by non-clinical individuals with psychotic-like experiences, and then healthy controls (N = 642). Self-serving bias was found in patients and non-clinical individuals with psychotic-like experiences, but not in healthy controls. Personalizing bias for negative events was not significantly different across the three groups. When compared with healthy controls, non-clinical individuals with psychotic-like experiences had an exaggerated self-serving bias, but were not more marked in personalizing bias. Self-serving bias and personalizing bias were both associated with delusional dimensions. However, the association between self-serving bias and number of delusion-like beliefs was stronger among patients than non-clinical participants. Future research could investigate the extent to which self-serving bias, in combination with an appraisal of delusional ideation as convincing, distress, and preoccupying, contributes to the development of clinical delusions.	[So, Suzanne Ho-wai; Leung, Patrick Wing-leung] Chinese Univ Hong Kong, Dept Psychol, Hong Kong, Hong Kong, Peoples R China; [Tang, Venus] Prince Wales Hosp, Dept Clin Psychol, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital	So, SHW (corresponding author), Chinese Univ Hong Kong, Dept Psychol, Hong Kong, Hong Kong, Peoples R China.	shwso@psy.cuhk.edu.hk		Tang, Venus/0000-0001-8113-8092; So, Suzanne/0000-0001-8918-7139	Croucher Foundation Startup Fund	Croucher Foundation Startup Fund	SS is supported by the Croucher Foundation Startup Fund, but there was no specific funding for this project. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CA, 1999, PERS SOC PSYCHOL B, V25, P482, DOI 10.1177/0146167299025004007; [Anonymous], 2000, DIAGNOSTIC STAT MANU, V4th; Bentall RP, 2009, ARCH GEN PSYCHIAT, V66, P236, DOI 10.1001/archgenpsychiatry.2009.1; Blackwood NJ, 2001, AM J PSYCHIAT, V158, P527, DOI 10.1176/appi.ajp.158.4.527; Boonstra N, 2009, EARLY INTERV PSYCHIA, V3, P289, DOI 10.1111/j.1751-7893.2009.00147.x; Diez-Alegria C, 2006, BRIT J CLIN PSYCHOL, V45, P531, DOI 10.1348/014466505X86681; Fear C, 1996, BRIT J PSYCHIAT, V168, P61, DOI 10.1192/bjp.168.1.61; Freeman D, 2001, PSYCHOL MED, V31, P1293, DOI 10.1017/S003329170100455X; Freeman D, 2014, SOC PSYCH PSYCH EPID, V49, P1045, DOI 10.1007/s00127-013-0803-y; Garety PA, 2013, BRIT J PSYCHIAT, V203, P327, DOI 10.1192/bjp.bp.113.126953; Garety PA, 2005, J ABNORM PSYCHOL, V114, P373, DOI 10.1037/0021-843X.114.3.373; Green C, 2006, BRIT J CLIN PSYCHOL, V45, P561, DOI 10.1348/014466506X98768; Harris ST, 2014, AGGRESS VIOLENT BEH, V19, P235, DOI 10.1016/j.avb.2014.04.009; Heine SJ, 2007, PERS SOC PSYCHOL REV, V11, P4, DOI 10.1177/1088868306294587; IBM Corp, 2010, IBM SPSS STAT WINDOW; Janssen I, 2006, PSYCHOL MED, V36, P771, DOI 10.1017/S0033291706007422; Johns LC, 2001, CLIN PSYCHOL REV, V21, P1125, DOI 10.1016/S0272-7358(01)00103-9; Jolley S, 2006, BEHAV RES THER, V44, P1597, DOI 10.1016/j.brat.2005.12.002; Kelleher I, 2011, PSYCHOL MED, V41, P1, DOI 10.1017/S0033291710001005; Kinderman P, 1996, PERS INDIV DIFFER, V20, P261, DOI 10.1016/0191-8869(95)00186-7; Langdon R, 2013, BRIT J CLIN PSYCHOL, V52, P408, DOI 10.1111/bjc.12026; Lincoln TM, 2007, SCHIZOPHR RES, V93, P211, DOI 10.1016/j.schres.2007.02.013; Linscott RJ, 2013, PSYCHOL MED, V43, P1133, DOI 10.1017/S0033291712001626; LYON HM, 1994, BRIT J PSYCHIAT, V164, P637, DOI 10.1192/bjp.164.5.637; McGrath JJ, 2015, JAMA PSYCHIAT, V72, P697, DOI 10.1001/jamapsychiatry.2015.0575; McKay R, 2005, PSYCHIAT RES, V136, P233, DOI 10.1016/j.psychres.2005.06.004; Mehl S, 2014, SCHIZOPHRENIA BULL, V40, P1338, DOI 10.1093/schbul/sbu040; Mezulis AH, 2004, PSYCHOL BULL, V130, P711, DOI 10.1037/0033-2909.130.5.711; Moritz S, 2014, CLIN PSYCHOL REV, V34, P358, DOI 10.1016/j.cpr.2014.04.004; Mossaheb N, 2012, SCHIZOPHR RES, V141, P210, DOI 10.1016/j.schres.2012.08.008; Peters E, 2004, SCHIZOPHRENIA BULL, V30, P1005, DOI 10.1093/oxfordjournals.schbul.a007116; Peters E, 1999, BRIT J CLIN PSYCHOL, V38, P83, DOI 10.1348/014466599162683; Sisti D, 2012, COMPR PSYCHIAT, V53, P1039, DOI 10.1016/j.comppsych.2012.02.005; Stefanis NC, 2002, PSYCHOL MED, V32, P347, DOI 10.1017/S0033291701005141; Taylor HE, 2014, BEHAV COGN PSYCHOTH, V42, P718, DOI 10.1017/S1352465813000593; van Os J, 2001, ARCH GEN PSYCHIAT, V58, P663, DOI 10.1001/archpsyc.58.7.663; van Os J, 2000, SCHIZOPHR RES, V41, P8, DOI 10.1016/S0920-9964(00)90323-2; van Os J, 2009, PSYCHOL MED, V39, P179, DOI 10.1017/S0033291708003814	38	28	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144558	10.1371/journal.pone.0144558	http://dx.doi.org/10.1371/journal.pone.0144558			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1YS	26640897	gold, Green Published			2022-12-27	WOS:000366902700146
J	Berry, RH; Qu, J; John, SWM; Howell, GR; Jakobs, TC				Berry, Ryan H.; Qu, Juan; John, Simon W. M.; Howell, Gareth R.; Jakobs, Tatjana C.			Synapse Loss and Dendrite Remodeling in a Mouse Model of Glaucoma	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; CLASSICAL COMPLEMENT CASCADE; DBA/2J MICE; OPTIC-NERVE; POSTSYNAPTIC DENSITIES; QUANTITATIVE-ANALYSIS; AMPA RECEPTORS; PROTEINS; PSD-95; DEGENERATION	It has been hypothesized that synaptic pruning precedes retinal ganglion cell degeneration in glaucoma, causing early dysfunction to retinal ganglion cells. To begin to assess this, we studied the excitatory synaptic inputs to individual ganglion cells in normal mouse retinas and in retinas with ganglion cell degeneration from glaucoma (DBA/2J), or following an optic nerve crush. Excitatory synapses were labeled by AAV2-mediated transfection of ganglion cells with PSD-95-GFP. After both insults the linear density of synaptic inputs to ganglion cells decreased. In parallel, the dendritic arbors lost complexity. We did not observe any cells that had lost dendritic synaptic input while preserving a normal or near-normal morphology. Within the temporal limits of these observations, dendritic remodeling and synapse pruning thus appear to occur near-simultaneously.	[Berry, Ryan H.; Qu, Juan; Jakobs, Tatjana C.] Harvard Univ, Sch Med, Dept Ophthalmol, Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA; [John, Simon W. M.; Howell, Gareth R.] Jackson Lab, Bar Harbor, ME 04609 USA; [John, Simon W. M.] Howard Hughes Med Inst, Jackson Lab, Bar Harbor, ME USA; [John, Simon W. M.] Tufts Univ, Sch Med, Dept Ophthalmol, Boston, MA 02111 USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Jackson Laboratory; Howard Hughes Medical Institute; Jackson Laboratory; Tufts University	Howell, GR (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	Gareth.Howell@jax.org; Tatjana_Jakobs@meei.harvard.edu		Jakobs, Tatjana/0000-0002-8104-9206	National Eye Institute [EY019703, EY021525, EY14104]; Research to Prevent Blindness; Massachusetts Lions Eye Research Fund; NATIONAL EYE INSTITUTE [R01EY019703, R01EY021525, P30EY014104, R01EY022092] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Massachusetts Lions Eye Research Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	National Eye Institute (http://www.nei.nih.gov/) grant EY019703 (TJ); National Eye Institute grant EY021525 (GH); National Eye Institute core grant EY14104 (MEEI); Grants from Research to Prevent Blindness (http://www.rpbusa.org/rpb/) and the Massachusetts Lions Eye Research Fund (http://www.masslionseyeresearch.org/). SJ is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MG, 2002, NAT GENET, V30, P81, DOI 10.1038/ng794; Arnold DB, 1999, NEURON, V23, P149, DOI 10.1016/S0896-6273(00)80761-8; Badea TC, 2004, J COMP NEUROL, V480, P331, DOI 10.1002/cne.20304; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chen YP, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086159, 10.1371/journal.pone.0109012, 10.1371/journal.pone.0094614]; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Coombs J, 2006, NEUROSCIENCE, V140, P123, DOI 10.1016/j.neuroscience.2006.02.079; Dakoji S, 2003, NEUROPHARMACOLOGY, V45, P849, DOI 10.1016/S0028-3908(03)00267-3; Danias J, 2003, INVEST OPHTH VIS SCI, V44, P5151, DOI 10.1167/iovs.02-1101; Della Santina L, 2013, J NEUROSCI, V33, P17444, DOI 10.1523/JNEUROSCI.5461-12.2013; Ebihara T, 2003, J NEUROSCI, V23, P2170; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; El-Danaf RN, 2015, J NEUROSCI, V35, P2329, DOI 10.1523/JNEUROSCI.1419-14.2015; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Famiglietti EV, 2005, J COMP NEUROL, V484, P357, DOI 10.1002/cne.20433; Feng L, 2013, INVEST OPHTH VIS SCI, V54, P1106, DOI 10.1167/iovs.12-10791; Gray NW, 2006, PLOS BIOL, V4, P2065, DOI 10.1371/journal.pbio.0040370; Howell GR, 2007, J CELL BIOL, V179, P1523, DOI 10.1083/jcb.200706181; Howell GR, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-45; Howell GR, 2011, J CLIN INVEST, V121, P1429, DOI 10.1172/JCI44646; Inoue A, 2003, CURR OPIN NEUROBIOL, V13, P332, DOI 10.1016/S0959-4388(03)00077-1; Jakobs TC, 2008, J COMP NEUROL, V510, P221, DOI 10.1002/cne.21795; Jakobs TC, 2005, J CELL BIOL, V171, P313, DOI 10.1083/jcb.200506099; Jeon CJ, 2002, J COMP NEUROL, V449, P195, DOI 10.1002/cne.10288; Kalesnykas G, 2012, INVEST OPHTH VIS SCI, V53, P3847, DOI 10.1167/iovs.12-9712; Kettenmann H, 2013, NEURON, V77, P10, DOI 10.1016/j.neuron.2012.12.023; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Koizumi A, 2011, J COMP NEUROL, V519, P341, DOI 10.1002/cne.22522; Kong JH, 2005, J COMP NEUROL, V489, P293, DOI 10.1002/cne.20631; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Libby RT, 2005, VISUAL NEUROSCI, V22, P637, DOI 10.1017/S0952523805225130; Lin B, 2004, NEURON, V43, P475, DOI 10.1016/j.neuron.2004.08.002; Lye-Barthel M, 2013, INVEST OPHTH VIS SCI, V54, P909, DOI 10.1167/iovs.12-10109; Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717; Morgan JL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-8; Nehring RB, 2000, J NEUROSCI, V20, P156, DOI 10.1523/JNEUROSCI.20-01-00156.2000; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; Percival KA, 2009, J COMP NEUROL, V517, P655, DOI 10.1002/cne.22183; Perry VH, 2010, ASN NEURO, V2, P281, DOI 10.1042/AN20100024; Qu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067094; Quigley HA, 1999, PROG RETIN EYE RES, V18, P39, DOI 10.1016/S1350-9462(98)00014-7; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Rosen AM, 2010, ADV EXP MED BIOL, V703, P75, DOI 10.1007/978-1-4419-5635-4_6; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Schlamp CL, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-66; Stasi K, 2006, INVEST OPHTH VIS SCI, V47, P1024, DOI 10.1167/iovs.05-0830; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Sumbul U, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4512; Sumioka A, 2010, NEURON, V66, P755, DOI 10.1016/j.neuron.2010.04.035; Sun D, 2010, J NEUROSCI, V30, P14008, DOI 10.1523/JNEUROSCI.3605-10.2010; Sun WZ, 2002, J COMP NEUROL, V451, P115, DOI 10.1002/cne.10323; WASSLE H, 1981, PROC R SOC SER B-BIO, V212, P157, DOI 10.1098/rspb.1981.0032; WONG ROL, 1992, EUR J NEUROSCI, V4, P1387, DOI 10.1111/j.1460-9568.1992.tb00164.x	56	30	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144341	10.1371/journal.pone.0144341	http://dx.doi.org/10.1371/journal.pone.0144341			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26637126	Green Published, gold, Green Submitted			2022-12-27	WOS:000366143800078
J	Girardello, R; Tasselli, S; Baranzini, N; Valvassori, R; de Eguileor, M; Grimaldi, A				Girardello, Rossana; Tasselli, Stefano; Baranzini, Nicolo; Valvassori, Roberto; de Eguileor, Magda; Grimaldi, Annalisa			Effects of Carbon Nanotube Environmental Dispersion on an Aquatic Invertebrate, Hirudo medicinalis	PLOS ONE			English	Article							AROMATIC-HYDROCARBONS; SILVER NANOPARTICLES; IMMUNE-RESPONSE; ACUTE TOXICITY; GENOTOXICITY; COMPLEX; METALS; GROWTH	The recent widespread applications of nanomaterials, because of their properties, opens new scenarios that affect their dispersal in the environment. In particular multiwall carbon nanotubes (MWCNTs), despite their qualities, seem to be harmful for animals and humans. To evaluate possible toxic effects caused by carbon nanotube environmental dispersion, with regard to aquatic compartment, we proposed as experimental model a freshwater invertebrate: Hirudo medicinalis. In the present study we analyse acute and chronic immune responses over a short (1, 3, 6 and 12 hours) and long time (from 1 to 5 weeks) exposure to MWCNTs by optical, electron and immunohistochemical approaches. In the exposed leeches angiogenesis and fibroplasia accompanied by massive cellular migration occur. Immunocytochemical characterization using specific markers shows that in these inflammatory processes the monocyte-macrophages (CD45(+), CD68(+)) are the most involved cells. These immunocompetent cells are characterized by sequence of events starting from the expression of pro-inflammatory cytokines (in particular IL-18), and amyloidogenensis. Our combined experimental approaches, basing on high sensitive inflammatory response can highlight adverse effects of nanomaterials on aquatic organisms and could be useful to assess the MWCNTs impact on aquatic, terrestrial animal and human health.	[Girardello, Rossana; Tasselli, Stefano; Baranzini, Nicolo; Valvassori, Roberto; de Eguileor, Magda; Grimaldi, Annalisa] Univ Insubria, Dept Biotechnol & Life Sci, Varese, Italy	University of Insubria	Grimaldi, A (corresponding author), Univ Insubria, Dept Biotechnol & Life Sci, Varese, Italy.	annalisa.grimaldi@uninsubria.it	Baranzini, Nicoló/AAK-9531-2021; Baranzini, Nicolò/AFW-4561-2022; Tasselli, Stefano/B-8017-2018	Tasselli, Stefano/0000-0002-0787-5710; Baranzini, Nicolo/0000-0001-6996-4797; Girardello, Rossana/0000-0001-8605-6037	MIUR (Ministero dell'Universita' e della Ricerca) PRIN; CARIPLO foundation [CUPJ31J11004830003]	MIUR (Ministero dell'Universita' e della Ricerca) PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); CARIPLO foundation(Fondazione Cariplo)	This work was supported by the MIUR (Ministero dell'Universita' e della Ricerca) PRIN (program of scientific research of major national interest) 2010-2011 to MdeE and by CARIPLO foundation 2012 (Grant number CUPJ31J11004830003, URL http://www.fondazionecariplo.it) to VR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albini A, 2015, INT J NANOTECHNOL, V10, P1; Alboni S, 2011, BRAIN BEHAV IMMUN, V25, P483, DOI 10.1016/j.bbi.2010.11.011; Alboni S, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-9; Ali D, 2014, CHEMOSPHERE, V104, P134, DOI 10.1016/j.chemosphere.2013.10.081; Alloy MM, 2011, ECOTOX ENVIRON SAFE, V74, P1839, DOI 10.1016/j.ecoenv.2011.06.020; Banni M, 2009, CHEMOSPHERE, V77, P902, DOI 10.1016/j.chemosphere.2009.08.041; Baun A, 2008, ECOTOXICOLOGY, V17, P387, DOI 10.1007/s10646-008-0208-y; Benedetti M, 2007, AQUAT TOXICOL, V85, P167, DOI 10.1016/j.aquatox.2007.08.009; Bouraoui Z, 2009, ECOTOX ENVIRON SAFE, V72, P1893, DOI 10.1016/j.ecoenv.2009.05.011; Chang XF, 2009, J HAZARD MATER, V166, P728, DOI 10.1016/j.jhazmat.2008.11.126; Cornelis G, 2010, ENVIRON CHEM, V7, P298, DOI 10.1071/EN10013; Coutris C, 2012, NANOTOXICOLOGY, V6, P186, DOI 10.3109/17435390.2011.569094; de Eguileor M, 2000, TISSUE CELL, V32, P40; de Eguileor M, 1999, J INVERTEBR PATHOL, V74, P14, DOI 10.1006/jipa.1999.4850; de Eguileor M, 2000, TISSUE CELL, V32, P437; de Eguileor M, 2003, CURR PHARM DESIGN, V9, P133, DOI 10.2174/1381612033392198; Demir ER, 2011, NANOTOXICOLOGY, V5, P417, DOI 10.3109/17435390.2010.529176; Di Giorgio ML, 2011, MUTAT RES-GEN TOX EN, V722, P20, DOI 10.1016/j.mrgentox.2011.02.008; Dondero F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-195; Du J, 2013, ENVIRON TOXICOL PHAR, V36, P451, DOI 10.1016/j.etap.2013.05.007; Edgington AJ, 2010, ENVIRON TOXICOL CHEM, V29, P2511, DOI 10.1002/etc.309; Falabella P, 2012, INSECT BIOCHEM MOLEC, V42, P203, DOI 10.1016/j.ibmb.2011.11.011; Fleeger JW, 2007, ENVIRON TOXICOL CHEM, V26, P1677, DOI 10.1897/06-397R.1; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Funahashi S, 2015, J CLIN BIOCHEM NUTR, V56, P111, DOI 10.3164/jcbn.14-92; Girardello R., 2015, J NANOMEDICINE NANOT, V6, P323, DOI DOI 10.4172/2157-7439.1000323; GORCHEV HG, 1984, WHO CHRON, V38, P104; Grimaldi A., 2004, ISJ, V1, P38; Grimaldi A, 2006, CURR PHARM DESIGN, V12, P3033, DOI 10.2174/138161206777947443; Grimaldi A, 2012, ISJ-INVERT SURVIV J, V9, P153; Grimaldi A, 2012, CELL TISSUE RES, V350, P491, DOI 10.1007/s00441-012-1503-8; Hayashi Y, 2012, ENVIRON SCI TECHNOL, V46, P4166, DOI 10.1021/es3000905; Kawata K, 2009, ENVIRON SCI TECHNOL, V43, P6046, DOI 10.1021/es900754q; Kennedy AJ, 2009, ENVIRON TOXICOL CHEM, V28, P1930, DOI 10.1897/09-024.1; Lam CW, 2006, CRIT REV TOXICOL, V36, P189, DOI 10.1080/10408440600570233; Ma-Hock L, 2009, TOXICOL SCI, V112, P468, DOI 10.1093/toxsci/kfp146; Macagno ER, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-407; Maria VL, 2011, COMP BIOCHEM PHYS C, V154, P56, DOI 10.1016/j.cbpc.2011.02.004; MOORE RD, 1960, J ULTRA MOL STRUCT R, V4, P113, DOI 10.1016/S0022-5320(60)90047-2; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; Park MVDZ, 2011, BIOMATERIALS, V32, P9810, DOI 10.1016/j.biomaterials.2011.08.085; Petersen EJ, 2011, ENVIRON SCI TECHNOL, V45, P9837, DOI 10.1021/es201579y; Pulskamp K, 2007, TOXICOL LETT, V168, P58, DOI 10.1016/j.toxlet.2006.11.001; Roberts AP, 2007, ENVIRON SCI TECHNOL, V41, P3025, DOI 10.1021/es062572a; Schorn T, 2015, CELL TISSUE RES, V359, P853, DOI 10.1007/s00441-014-2058-7; Shoults-Wilson WA, 2011, ECOTOXICOLOGY, V20, P385, DOI 10.1007/s10646-010-0590-0; Shoults-Wilson WA, 2011, NANOTOXICOLOGY, V5, P432, DOI 10.3109/17435390.2010.537382; Simate GS, 2012, ENVIRON INT, V39, P38, DOI 10.1016/j.envint.2011.09.006; Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221; Tettamanti G, 2006, CURR MED CHEM, V13, P2737, DOI 10.2174/092986706778521986; Tettamanti G, 2005, BIOL CELL, V97, P557, DOI 10.1042/BC20040085; Tettamanti G, 2004, BIOL CELL, V96, P443, DOI 10.1016/j.biolcel.2004.04.008; Tettamanti G, 2003, TISSUE CELL, V35, P199, DOI 10.1016/S0040-8166(03)00027-2; TROWBRIDGE IS, 1994, ANNU REV IMMUNOL, V12, P85, DOI 10.1146/annurev.iy.12.040194.000505; Zhang LJ, 2014, ECOTOX ENVIRON SAFE, V103, P29, DOI 10.1016/j.ecoenv.2014.01.041	55	13	13	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144361	10.1371/journal.pone.0144361	http://dx.doi.org/10.1371/journal.pone.0144361			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636582	gold, Green Submitted, Green Published			2022-12-27	WOS:000366143800081
J	Nogueira, M; Brandini, FP; Codina, JCU				Nogueira Junior, Miodeli; Brandini, Frederico Pereira; Ugaz Codina, Juan Carlos			Diel Vertical Dynamics of Gelatinous Zooplankton (Cnidaria, Ctenophora and Thaliacea) in a Subtropical Stratified Ecosystem (South Brazilian Bight)	PLOS ONE			English	Article							NORTHWESTERN MEDITERRANEAN-SEA; GEGENBAURI ULJANIN TUNICATA; VILLEFRANCHE-SUR-MER; BLACK-SEA; DOLIOLUM-DENTICULATUM; PLANKTONIC CNIDARIANS; MESOPELAGIC COMMUNITY; MIGRATION PATTERNS; NORTHEAST ATLANTIC; ADRIATIC SEA	The diel vertical dynamics of gelatinous zooplankton in physically stratified conditions over the 100-m isobath (similar to 110 km offshore) in the South Brazilian Bight (26 degrees 45'S; 47 degrees 33'W) and the relationship to hydrography and food availability were analyzed by sampling every six hours over two consecutive days. Zooplankton samples were taken in three depth strata, following the vertical structure of the water column, with cold waters between 17 and 13.1 degrees C, influenced by the South Atlantic Central Water (SACW) in the lower layer (>70m); warm (>20 degrees C) Tropical Water in the upper 40 m; and an intermediate thermocline with a deep chlorophyll-a maximum layer (0.3-0.6 mg m(-3)). Two distinct general patterns were observed, emphasizing the role of (i) physical and (ii) biological processes: (i) a strong influence of the vertical stratification, with most zooplankton absent or little abundant in the lower layer. The influence of the cold SACW on the bottom layer apparently restricted the vertical occupation of most species, which typically inhabit epipelagic warm waters. Even among migratory species, only a few (Aglaura hemistoma, Abylopsis tetragona eudoxids, Beroe sp., Thalia democratica, Salpa fusiformis) crossed the thermocline and reached the bottom layer. (ii) A general tendency of partial migrations, with variable intensity depending on the different species and developmental stages; populations tended to be more widely distributed through the water column during daylight, and to become more aggregated in the upper layer during the night, which can be explained based on the idea of the "hungersatiation hypothesis", maximizing feeding and minimizing the chances of being predated.	[Nogueira Junior, Miodeli] Univ Fed Paraiba, Dept Sistemat & Ecol, BR-58059900 Joao Pessoa, Paraiba, Brazil; [Brandini, Frederico Pereira] Univ Sao Paulo, Inst Oceanog, Dept Oceanog Biol, Sao Paulo, Brazil; [Ugaz Codina, Juan Carlos] Univ Fed Paraiba, Dept Zool, Programa Pos Grad Zool, Curitiba, Parana, Brazil	Universidade Federal da Paraiba; Universidade de Sao Paulo; Universidade Federal da Paraiba	Nogueira, M (corresponding author), Univ Fed Paraiba, Dept Sistemat & Ecol, BR-58059900 Joao Pessoa, Paraiba, Brazil.	miodeli@gmail.com	Brandini, Frederico/C-9402-2012; Júnior, Miodeli Nogueira/M-2211-2013	Júnior, Miodeli Nogueira/0000-0001-5409-8312	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [474165/2004-3, 140945/2007-5]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/21290-1, 2011/09880-8]; USA National Science Foundation through the InterAmerican Institute of Global Change Research [GEO-0452325, CRN 2076]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); USA National Science Foundation through the InterAmerican Institute of Global Change Research	This study was undertaken as part of the PROPELL project (Dinamica das interacoes fisicobiologicas no sistema pelagico da plataforma continental Sudeste do Brasil), supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq.;www.cnpq.br, project no 474165/2004-3). This investigation also received funds from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; http://www.fapesp.br/, project no 2011/21290-1). MNJ had a scholarship from CNPq (PhD grant no 140945/2007-5) and from FAPESP (post-doctoral grant no 2011/09880-8 and JCUC from the USA National Science Foundation (http://www.nsf.gov/, Grant GEO-0452325) through the InterAmerican Institute of Global Change Research (http://www.iai.int/, grant CRN 2076). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves N, 2015, ARCH MICROBIOL, V197, P165, DOI 10.1007/s00203-014-1035-6; Amaral W.J.A., 1997, Atlantica, V19, P51; Andersen V., 1998, P125; ANDERSEN V, 1992, J PLANKTON RES, V14, P1155, DOI 10.1093/plankt/14.8.1155; Andersen V, 2001, J PLANKTON RES, V23, P243, DOI 10.1093/plankt/23.3.243; Andersen V, 1998, OCEANOL ACTA, V21, P655, DOI 10.1016/S0399-1784(98)90007-X; ANDERSEN V, 1994, J PLANKTON RES, V16, P337, DOI 10.1093/plankt/16.4.337; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MI, AUSTRAL ECOL, V26, P32; ANDERSON PAV, 1985, B MAR SCI, V37, P460; ANDERSON PAV, 1977, SCIENCE, V197, P186, DOI 10.1126/science.17918; Apablaza P, 2006, INVEST MAR, V34, P83; ARKETT SA, 1985, BIOL BULL-US, V169, P297, DOI 10.2307/1541483; Baumgartner MF, 2011, MAR ECOL PROG SER, V423, P167, DOI 10.3354/meps08931; BERNER LD, 1961, LIMNOL OCEANOGR, V6, P205, DOI 10.4319/lo.1961.6.2.0205; Bigelow E. B., 1937, Report on the Danish Oceanographical Expeditions 1908-10 to the Mediterranean, V2, P1; Boero F, 2008, MAR ECOL PROG SER, V356, P299, DOI 10.3354/meps07368; Boltovskoy D, 2002, OCEANOL ACTA, V25, P271, DOI 10.1016/S0399-1784(02)01199-4; Boltovskoy D., 1999, S ATLANTIC ZOOPLANKT; Brandini FP, 2014, CONT SHELF RES, V89, P61, DOI 10.1016/j.csr.2013.08.002; Chae J, 2008, J ENVIRON BIOL, V29, P585; Cohen JH, 2009, OCEANOGR MAR BIOL, V47, P77; Cottier FR, 2006, LIMNOL OCEANOGR, V51, P2586, DOI 10.4319/lo.2006.51.6.2586; Daniel R., 1977, SPECIAL PUBLICATION, P124; de Castro B. M, 2006, AMBIENTE OCEANOGRAFI, P11; Esnal Graciela B., 1999, P1409; Falkenhaug T, 1996, MAR ECOL PROG SER, V140, P59, DOI 10.3354/meps140059; Frank TM, 1997, J PLANKTON RES, V19, P1975, DOI 10.1093/plankt/19.12.1975; Gibbons MJ, 1997, J MAR BIOL ASSOC UK, V77, P493, DOI 10.1017/S0025315400071824; Gibson DM, 2002, J PLANKTON RES, V24, P703, DOI 10.1093/plankt/24.7.703; Gibson DM, 2000, J PLANKTON RES, V22, P1485, DOI 10.1093/plankt/22.8.1485; Guerrero E, 2013, MAR ECOL-EVOL PERSP, V34, P71, DOI 10.1111/maec.12027; Haraldsson M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086595; HARBISON GR, 1979, LIMNOL OCEANOGR, V24, P1081, DOI 10.4319/lo.1979.24.6.1081; HARDY AC, 1947, J MAR BIOL ASSOC UK, V26, P467, DOI 10.1017/S0025315400013722; Hays GC, 2003, HYDROBIOLOGIA, V503, P163, DOI 10.1023/B:HYDR.0000008476.23617.b0; Hays GC, 2001, LIMNOL OCEANOGR, V46, P2050, DOI 10.4319/lo.2001.46.8.2050; HIROTA J, 1974, FISH B-NOAA, V72, P295; Huber AMR, 2011, LIMNOL OCEANOGR, V56, P695, DOI 10.4319/lo.2011.56.2.0695; HUNTLEY M, 1982, MAR BIOL, V71, P23, DOI 10.1007/BF00396989; JOHANNESSEN OM, 1968, CONTRIBUTIONS I OCEA, V10, P1; Kaartvedt S, 2011, LIMNOL OCEANOGR, V56, P2189, DOI 10.4319/lo.2011.56.6.2189; Larson RJ, 1986, STUD FAUNA CURACAO C, V213, P191; LAVAL P, 1992, MAR ECOL PROG SER, V79, P235; Legendre P., 2012, NUMERICAL ECOLOGY; Leps J, 2003, MULTIVARIATE ANAL EC; Liu SH, 2003, J PLANKTON RES, V25, P1069, DOI 10.1093/plankt/25.9.1069; Lopes RM, 2007, AN ACAD BRAS CIENC, V79, P369, DOI 10.1590/S0001-37652007000300002; Lucic D, 2011, ACTA ADRIAT, V52, P159; Lucic D, 2009, MAR ECOL-EVOL PERSP, V30, P16, DOI 10.1111/j.1439-0485.2008.00264.x; Macias D, 2010, MAR ECOL PROG SER, V408, P79, DOI 10.3354/meps08566; Martin VJ, 2002, CAN J ZOOL, V80, P1703, DOI 10.1139/Z02-136; Matsuura Y., 1985, CULTURA, V38, P1439, DOI DOI 10.1590/S0102-261X2009000100007; Menard F, 1997, OCEANOL ACTA, V20, P733; MILLS CE, 1983, J PLANKTON RES, V5, P619, DOI 10.1093/plankt/5.5.619; MOORE HILARY B., 1953, BULL MARINE SCI GULF AND CARIBBEAN, V2, P559; Moreira G.S., 1973, PUBLICATIONS SETO MA, V20, P537; MUSAEVA E I, 1971, Okeanologiya, V11, P1098; Musaeva E.I., 1976, Trudy Instituta Okeanologii Akademii Nauk SSSR, V105, P171; Mutlu E, 1999, MAR BIOL, V135, P603, DOI 10.1007/s002270050661; Mutlu E, 1999, MAR BIOL, V135, P589, DOI 10.1007/s002270050660; Nagata RM, 2014, J MAR BIOL ASSOC UK, V94, P1387, DOI 10.1017/S0025315414000617; Neumann-Leitao S, 2008, J PLANKTON RES, V30, P795, DOI 10.1093/plankt/fbn040; Nogueira M, 2014, CONT SHELF RES, V89, P93, DOI 10.1016/j.csr.2014.02.022; Oliveira OMP, 2010, 3 INT JELL BLOOMS S, P85; PAFFENHOFER GA, 1995, CONT SHELF RES, V15, P255, DOI 10.1016/0278-4343(94)E0004-6; PAGES F, 1992, S AFR J ZOOL, V27, P50, DOI 10.1080/02541858.1992.11448262; PAGES F, 1994, POLAR BIOL, V14, P243; PAGES F, 1991, HYDROBIOLOGIA, V216, P355, DOI 10.1007/BF00026486; PALMA S, 1985, INVEST PESQ, V49, P261; PALMA S, 2004, INVEST MAR, V32, P47; Patriti G., 1964, Recueil des Travaux de la Station Marine de l'Endoume, VNo. 51, P185; Pearre S, 2003, BIOL REV, V78, P1, DOI 10.1017/S146479310200595X; PEARRE S JR, 1979, Journal of Plankton Research, V1, P29, DOI 10.1093/plankt/1.1.29; Pernica P., 2013, LIMNOL OCEANOGR FLUI, V3, P279, DOI DOI 10.1215/21573689-2409149; Pierrot-Bults A.C., 2003, Zoologische Verhandelingen (Leiden), V345, P297; PUGH PR, 1984, PROG OCEANOGR, V13, P461, DOI 10.1016/0079-6611(84)90016-8; PUGH PR, 1974, J MAR BIOL ASSOC UK, V54, P25, DOI 10.1017/S0025315400022086; Purcell JE, 2001, HYDROBIOLOGIA, V451, P145, DOI 10.1023/A:1011826618539; Ralston DK, 2007, J PLANKTON RES, V29, P803, DOI 10.1093/plankt/fbm061; Rinke K, 2007, FRESHWATER BIOL, V52, P137, DOI 10.1111/j.1365-2427.2006.01687.x; ROE HSJ, 1984, PROG OCEANOGR, V13, P425, DOI 10.1016/0079-6611(84)90015-6; Russell F. S., 1925, Journal of the Marine Biological Association Plymouth NS, V13, P769; Sainmont J, 2013, THEOR ECOL-NETH, V6, P241, DOI 10.1007/s12080-012-0174-0; Saltzman J, 1997, DEEP-SEA RES PT I, V44, P931, DOI 10.1016/S0967-0637(97)00006-X; Sardou J, 1996, OCEANOL ACTA, V19, P645; Schlitzer R., 2012, OCEAN DATA VIEW; Sekino T, 1999, EVOL ECOL, V13, P267, DOI 10.1023/A:1006797101565; Tamaki A, 2010, ESTUAR COAST SHELF S, V86, P125, DOI 10.1016/j.ecss.2009.11.005; Tew KS, 2005, MAR ECOL PROG SER, V292, P181, DOI 10.3354/meps292181; TSUDA A, 1992, DEEP-SEA RES, V39, pS219, DOI 10.1016/S0198-0149(11)80013-0; UYE S, 1990, MAR BIOL, V104, P389, DOI 10.1007/BF01314341; Vannucci M., 1963, S Bol Inst oceanogr S Paulo, V13, P143; Vereshchaka AL, 2002, OCEANOLOGY+, V42, P811; Vinogradov M. E., 1970, VERTICAL DISTRIBUTIO; VINOGRADOV ME, 1985, MAR BIOL, V89, P95, DOI 10.1007/BF00392881; WIEBE PH, 1979, MAR BIOL, V53, P249, DOI 10.1007/BF00952433; Zar JH., 2010, BIOSTAT ANAL, V5th	98	19	20	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144161	10.1371/journal.pone.0144161	http://dx.doi.org/10.1371/journal.pone.0144161			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26637179	gold, Green Submitted, Green Published			2022-12-27	WOS:000366143800051
J	Reiter, SF; Veiby, G; Bjork, MH; Engelsen, BA; Daltveit, AK; Gilhus, NE				Reiter, Simone Frizell; Veiby, Gyri; Bjork, Marte Helene; Engelsen, Bernt A.; Daltveit, Anne-Kjersti; Gilhus, Nils Erik			Psychiatric Comorbidity, Social Aspects and Quality of Life in a Population-Based Cohort of Expecting Fathers with Epilepsy	PLOS ONE			English	Article							ANTIEPILEPTIC DRUGS; DEPRESSIVE SYMPTOMS; PATERNAL DEPRESSION; MAJOR DEPRESSION; NORWEGIAN MOTHER; MENTAL-HEALTH; CHILD COHORT; PREGNANCY; WOMEN; SATISFACTION	Objectives To investigate psychiatric disorders, adverse social aspects and quality of life in men with epilepsy during partner's pregnancy. Method We used data from the Norwegian Mother and Child Cohort Study, including 76,335 men with pregnant partners. Men with epilepsy were compared to men without epilepsy, and to men with non-neurological chronic diseases. Results Expecting fathers in 658 pregnancies (mean age 31.8 years) reported a history of epilepsy, 36.9% using antiepileptic drugs (AEDs) at the onset of pregnancy. Symptoms of anxiety or depression were increased in epilepsy (7.0% and 3.9%, respectively) vs. non-epilepsy (4.6% and 2.5%, respectively, p = 0.004 and 0.023), and so were new onset symptoms of depression (2.0% vs. 1.0%, p < 0.031) and anxiety (4.3% vs. 2.3%, p = 0.023). Low self-esteem (2.5%) and low satisfaction with life (1.7%) were more frequent among fathers with epilepsy compared to fathers without epilepsy (1.3% and 0.7%, respectively, p = 0.01 and 0.010). Adverse social aspects and life events were associated with epilepsy vs. both reference groups. Self-reported diagnoses of ADHD (2.2%) and bipolar disorder (1.8%) were more common in epilepsy vs. non-epilepsy (0.4% and 0.3%, respectively, p = 0.002 and 0.003) and non-neurological chronic disorders (0.5% and 0.5%, respectively, p = 0.004 and 0.018). A screening tool for ADHD symptoms revealed a higher rate compared to selfreported ADHD (9.5% vs. 2.2%, p < 0.001). Conclusion Expecting fathers with epilepsy are at high risk of depression and anxiety, adverse socioeconomic aspects, low self-esteem, and low satisfaction with life. Focus on mental health in fathers with epilepsy during and after pregnancy is important. The use of screening tools can be particularly useful to identify those at risk.	[Reiter, Simone Frizell; Veiby, Gyri; Bjork, Marte Helene; Engelsen, Bernt A.; Gilhus, Nils Erik] Univ Bergen, Dept Clin Med, Bergen, Norway; [Veiby, Gyri; Bjork, Marte Helene; Engelsen, Bernt A.; Gilhus, Nils Erik] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway; [Daltveit, Anne-Kjersti] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Daltveit, Anne-Kjersti] Norwegian Inst Publ Hlth, Div Epidemiol, Med Birth Registry Norway, Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Norwegian Institute of Public Health (NIPH)	Reiter, SF (corresponding author), Univ Bergen, Dept Clin Med, Bergen, Norway.	simone.reiter@uib.no	Bjørk, Marte Helene/N-3569-2016	Bjørk, Marte Helene/0000-0002-5745-1094	GSK; UCB Pharma; Lundbeck	GSK(GlaxoSmithKline); UCB Pharma(UCB Pharma SA); Lundbeck(Lundbeck Corporation)	G. Veiby and M.H. Bjork have received congress travel support from GSK and UCB Pharma and lecture fee from GSK. B.A. Engelsen has received congress travel support from GSK and lecture fee from Lundbeck. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, CONC DEF; [Anonymous], 2013, STAT YB NORWAY 2013; Baxendale S, 2007, EPILEPSY BEHAV, V11, P192, DOI 10.1016/j.yebeh.2007.04.019; Bjork M. H., 2014, Norsk Epidemiologi, V24, P79; Bjork MH, 2015, EPILEPSIA, V56, P28, DOI 10.1111/epi.12884; Croy CD, 2005, J AM ACAD CHILD PSY, V44, P1230, DOI 10.1097/01.chi.0000181044.06337.6f; D'Souza WJ, 2012, ACTA NEUROL SCAND, V125, P96, DOI 10.1111/j.1600-0404.2011.01499.x; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Elliott JO, 2011, EPILEPSY BEHAV, V20, P533, DOI 10.1016/j.yebeh.2011.01.013; Ettinger AB, 2005, NEUROLOGY, V65, P535, DOI 10.1212/01.wnl.0000172917.70752.05; Ettinger AB, 2015, EPILEPSIA, V56, P218, DOI 10.1111/epi.12897; Fenwick J, 2012, SEX REPROD HEALTHC, V3, P3, DOI 10.1016/j.srhc.2011.11.001; Field T, 2006, INFANT BEHAV DEV, V29, P579, DOI 10.1016/j.infbeh.2006.07.010; Figueiredo B, 2011, J AFFECT DISORDERS, V132, P146, DOI 10.1016/j.jad.2011.02.007; Gawlik S, 2014, ARCH WOMEN MENT HLTH, V17, P49, DOI 10.1007/s00737-013-0377-4; Gere MK, 2013, DEPRESS ANXIETY, V30, P31, DOI 10.1002/da.22010; Hermann BP, 2000, EPILEPSIA, V41, pS31, DOI 10.1111/j.1528-1157.2000.tb01522.x; Kanner AM, 2012, EPILEPSY BEHAV, V24, P156, DOI 10.1016/j.yebeh.2012.01.007; Kaufman KR, 2011, EPILEPSY BEHAV, V21, P1, DOI 10.1016/j.yebeh.2011.03.011; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P863; Kessler RC, 2007, INT J METH PSYCH RES, V16, P52, DOI 10.1002/mpr.208; Konda K, 2009, EPILEPSY BEHAV, V16, P120, DOI 10.1016/j.yebeh.2009.07.010; Kvalevaag AL, 2013, PEDIATRICS, V131, pE463, DOI 10.1542/peds.2012-0804; Landmark CJ, 2011, EPILEPSY RES, V95, P51, DOI 10.1016/j.eplepsyres.2011.02.012; Magnus P, 2006, INT J EPIDEMIOL, V35, P1146, DOI 10.1093/ije/dyl170; Matthey S, 2000, J AFFECT DISORDERS, V60, P75, DOI 10.1016/S0165-0327(99)00159-7; Micallef S, 2010, EPILEPSIA, V51, P2066, DOI 10.1111/j.1528-1167.2010.02664.x; Ngugi AK, 2010, EPILEPSIA, V51, P883, DOI 10.1111/j.1528-1167.2009.02481.x; Nilsen RM, 2009, PAEDIATR PERINAT EP, V23, P597, DOI 10.1111/j.1365-3016.2009.01062.x; Nohr EA, 2006, EPIDEMIOLOGY, V17, P413, DOI 10.1097/01.ede.0000220549.14177.60; Rai D, 2012, EPILEPSIA, V53, P1095, DOI 10.1111/j.1528-1167.2012.03500.x; Ramchandani P, 2005, LANCET, V365, P2201, DOI 10.1016/S0140-6736(05)66778-5; Reiter SF, 2013, EPILEPSY BEHAV, V29, P379, DOI 10.1016/j.yebeh.2013.08.016; Rodenburg R, 2013, EPILEPSY BEHAV, V27, P497, DOI 10.1016/j.yebeh.2013.01.026; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Schmitz B, 2005, EPILEPSIA, V46, P45, DOI 10.1111/j.1528-1167.2005.463009.x; Schytt E, 2011, SEX REPROD HEALTHC, V2, P57, DOI 10.1016/j.srhc.2010.12.003; Shackleton DP, 2003, NEUROLOGY, V61, P64, DOI 10.1212/01.WNL.0000073543.63457.0A; Sherman EMS, 2007, EPILEPSIA, V48, P1083, DOI 10.1111/j.1528-1167.2007.01028.x; Swinkels WAM, 2005, EPILEPSY BEHAV, V7, P37, DOI 10.1016/j.yebeh.2005.04.012; Talge NM, 2007, J CHILD PSYCHOL PSYC, V48, P245, DOI 10.1111/j.1469-7610.2006.01714.x; Tambs K., 2004, UBEVISST SJELELIV BE, P217; Veiby G, 2014, J NEUROL, V261, P579, DOI 10.1007/s00415-013-7239-x; Whatley AD, 2010, HEALTH EDUC RES, V25, P575, DOI 10.1093/her/cyq001; WINOKUR A, 1984, BRIT J PSYCHIAT, V144, P395, DOI 10.1192/bjp.144.4.395	45	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144159	10.1371/journal.pone.0144159	http://dx.doi.org/10.1371/journal.pone.0144159			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY1CH	26637130	Green Published, Green Submitted, gold			2022-12-27	WOS:000366143800050
J	Anstoetz, M; Rose, TJ; Clark, MW; Yee, LH; Raymond, CA; Vancov, T				Anstoetz, Manuela; Rose, Terry J.; Clark, Malcolm W.; Yee, Lachlan H.; Raymond, Carolyn A.; Vancov, Tony			Novel Applications for Oxalate-Phosphate-Amine Metal-Organic-Frameworks (OPA-MOFs): Can an Iron-Based OPA-MOF Be Used as Slow-Release Fertilizer?	PLOS ONE			English	Article							ENHANCED EFFICIENCY FERTILIZERS; AMMONIA VOLATILIZATION; PHOSPHORUS; NITROGEN; SOIL; MAIZE; ACCUMULATION; MOBILIZATION; AGRICULTURE; RHIZOSPHERE	A porous iron-based oxalate-phosphate-amine metal-organic framework material (OPA-MOF) was investigated as a microbially-induced slow-release nitrogen (N) and phosphorus (P) fertilizer. Seedling growth, grain yields, nutrient uptake of wheat plants, and soil dynamics in incubated soil, were investigated using OPA-MOF vs standard P (triple-superphosphate) and N (urea) fertilizers in an acidic Ferralsol at two application rates (equivalent 120 and 40 kg N ha(-1)). While urea hydrolysis in the OPA-MOF treatment was rapid, conversion of ammonium to nitrate was significantly inhibited compared to urea treatment. Reduced wheat growth in OPA-MOF treatments was not caused by N-deficiency, but by limited P-bioavailability. Two likely reasons were slow P-mobilisation from the OPA-MOF or rapid P-binding in the acid soil. P-uptake and yield in OPA-MOF treatments were significantly higher than in nil-P controls, but significantly lower than in conventionally-fertilised plants. OPA-MOF showed potential as enhanced efficiency N fertilizer. However, as P-bioavailability was insufficient to meet plant demands, further work should determine if P-availability may be enhanced in alkaline soils, or whether central ions other than Fe, forming the inorganic metal-P framework in the MOF, may act as a more effective P-source in acid soils.	[Anstoetz, Manuela; Clark, Malcolm W.; Yee, Lachlan H.] So Cross Univ, Sch Environm Sci & Engn, Lismore, NSW 2480, Australia; [Clark, Malcolm W.; Yee, Lachlan H.] So Cross Univ, Sch Environm Sci & Engn, Marine Ecol Res Ctr, Lismore, NSW 2480, Australia; [Rose, Terry J.; Raymond, Carolyn A.; Vancov, Tony] So Cross Univ, Southern Cross Plant Sci, Lismore, NSW 2480, Australia; [Vancov, Tony] Wollongbar Primary Ind Inst, NSW Dept Primary Ind, Wollongbar, NSW 2477, Australia	Southern Cross University; Southern Cross University; Southern Cross University; NSW Department of Primary Industries	Anstoetz, M (corresponding author), So Cross Univ, Sch Environm Sci & Engn, Lismore, NSW 2480, Australia.	manuela.anstoetz@scu.edu.au	Vancov, Tony/Q-4142-2019; Vancov, Tony/A-6408-2010; Yee, Lachlan H./B-6856-2008; Raymond, Carolyn A/P-4764-2017; Clark, M W/Q-4875-2017	Vancov, Tony/0000-0001-5227-7405; Yee, Lachlan H./0000-0002-7258-2076; Raymond, Carolyn A/0000-0003-2887-9267; Rose, Terry/0000-0001-5386-6818; Anstoetz, Manuela/0000-0002-0580-5786	Grains Research and Development Corporation Grant [51426]; Australian Postgraduate Award - Australian Government Department of Education and Training	Grains Research and Development Corporation Grant(Grains R&D Corp); Australian Postgraduate Award - Australian Government Department of Education and Training	This work was supported by Grains Research and Development Corporation Grant Project No 51426 (http://www.grdc.com.au/). MA was funded by an Australian Postgraduate Award (3.5 years), a scholarship for living support granted by the Australian Government Department of Education and Training (https://education.gov.au/australian-postgraduate-awards). The funders had a role in the decision to publish (publishing results was part of the grant agreement); the funders had no role in data collection and analysis, or preparation of the manuscript.	Abu-Shandi K, 2003, CRYSTENGCOMM, P180, DOI 10.1039/b303498d; Ahmed OH, 2010, INT J PHYS SCI, V5, P2198; Ahmed OH, 2008, ACTA AGR SCAND B-S P, V58, P182, DOI 10.1080/09064710701478271; Alef K, 1995, METHODS APPL SOIL MI; Barroso CB, 2006, BRAZ J MICROBIOL, V37, P434, DOI 10.1590/S1517-83822006000400006; Bovill WD, 2013, CROP PASTURE SCI, V64, P179, DOI 10.1071/CP13135; Brady N.C, 2000, NATURE PROPERTIES SO; Cailleau G, 2004, NATURWISSENSCHAFTEN, V91, P191, DOI 10.1007/s00114-004-0512-1; Certini G, 2000, J PLANT NUTR SOIL SC, V163, P173, DOI 10.1002/(SICI)1522-2624(200004)163:2<173::AID-JPLN173>3.0.CO;2-H; Chalk PM, 2015, NUTR CYCLING AGROECO; Chang WJ, 2001, J SOLID STATE CHEM, V157, P233, DOI 10.1006/jssc.2000.9081; Chen D, 2008, AUST J SOIL RES, V46, P289, DOI 10.1071/SR07197; Chen DL, 2010, SOIL BIOL BIOCHEM, V42, P660, DOI 10.1016/j.soilbio.2009.12.014; Choudhury A, 1999, J MATER CHEM, V9, P3113, DOI 10.1039/a906663b; Choudhury A, 2000, CHEM-EUR J, V6, P1168, DOI 10.1002/(SICI)1521-3765(20000403)6:7<1168::AID-CHEM1168>3.3.CO;2-J; Clemente-Leon M, 2008, INORG CHEM, V47, P9111, DOI 10.1021/ic801165b; de Magalhaes JV, 1998, J PLANT NUTR, V21, P1753, DOI 10.1080/01904169809365520; Echigo T, 2010, CAN MINERAL, V48, P1329, DOI 10.3749/canmin.48.5.1329; Ehlers K, 2010, SOIL BIOL BIOCHEM, V42, P558, DOI 10.1016/j.soilbio.2009.11.025; Farha OK, 2010, ACCOUNTS CHEM RES, V43, P1166, DOI 10.1021/ar1000617; He ZL, 1999, SOIL SCI, V164, P750, DOI 10.1097/00010694-199910000-00006; Husson O, 2013, PLANT SOIL, V362, P389, DOI 10.1007/s11104-012-1429-7; International V, 2014, GENSTAT WINDOWS; Jiang YC, 2003, CHEM MATER, V15, P1633, DOI 10.1021/cm021701t; JONES DL, 1994, PLANT SOIL, V166, P247, DOI 10.1007/BF00008338; Lucassen ECHET, 2004, BIOGEOCHEMISTRY, V67, P249, DOI 10.1023/B:BIOG.0000015342.40992.cb; Mandal S, 2007, CHEM-EUR J, V13, P968, DOI 10.1002/chem.200601026; Maspoch D, 2007, CHEM SOC REV, V36, P770, DOI 10.1039/b501600m; MOODY PW, 1994, AUST J SOIL RES, V32, P1015, DOI 10.1071/SR9941015; Neeraj S, 2001, J CHEM SOC DALTON, P289, DOI 10.1039/b007980o; Rao S. N. S., 1999, SOIL MICROBIOLOGY; Raun WR, 1999, AGRON J, V91, P357, DOI 10.2134/agronj1999.00021962009100030001x; Rayment G.E., 2011, SOIL CHEM METHODS AU; Reuter DJ., 1997, PLANT ANAL INTERPRET, P241, DOI 10.1071/9780643101265; Rochester I, 2015, CROP PASTURE SCI, V66, P689, DOI 10.1071/CP14301; ROMER W, 1986, PLANT SOIL, V91, P221, DOI 10.1007/BF02181789; Rose TJ, 2007, J PLANT NUTR SOIL SC, V170, P404, DOI 10.1002/jpln.200625163; Rose TJ, 2010, PLANT SOIL, V326, P159, DOI 10.1007/s11104-009-9990-4; Rose TJ, 2013, MATCHING SOIL NUTR S; Scharer M, 2009, EUR J SOIL SCI, V60, P386, DOI 10.1111/j.1365-2389.2009.01135.x; Smieja-Krol B, 2014, ENVIRON SCI POLLUT R, V21, P7227, DOI 10.1007/s11356-014-2700-7; Strom L, 2002, SOIL BIOL BIOCHEM, V34, P703, DOI 10.1016/S0038-0717(01)00235-8; Stumm W, 1995, AQUATIC CHEM CHEM EQ, V3rd, DOI [DOI 10.1094/ASBCMOA-BEER-13, 10.1094/asbcmoa-beer-13]; Timilsena YP, 2015, J SCI FOOD AGR, V95, P1131, DOI 10.1002/jsfa.6812; Van Zwieten L, 2015, PLANT SOIL, V395, P7, DOI 10.1007/s11104-015-2427-3; Vandamme E, 2014, NUTR CYCL AGROECOSYS, V98, P187, DOI 10.1007/s10705-014-9605-1; Vu DT, 2008, PLANT SOIL, V304, P21, DOI 10.1007/s11104-007-9516-x; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zerulla W, 2001, BIOL FERT SOILS, V34, P79, DOI 10.1007/s003740100380	49	32	34	8	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144169	10.1371/journal.pone.0144169	http://dx.doi.org/10.1371/journal.pone.0144169			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633174	Green Published, Green Submitted, gold			2022-12-27	WOS:000366040000065
J	Bejarano-Castillo, M; Campo, J; Roa-Fuentes, LL				Bejarano-Castillo, Marylin; Campo, Julio; Roa-Fuentes, Lilia L.			Effects of Increased Nitrogen Availability on C and N Cycles in Tropical Forests: A Meta-Analysis	PLOS ONE			English	Article							NET PRIMARY PRODUCTIVITY; NUTRIENT LIMITATION; ADDITIONS; CLIMATE; LOSSES; GROWTH; CONSEQUENCES; PHOSPHORUS; ALLOCATION; DEPOSITION	Atmospheric N deposition is predicted to increase four times over its current status in tropical forests by 2030. Our ability to understand the effects of N enrichment on C and N cycles is being challenged by the large heterogeneity of the tropical forest biome. The specific response will depend on the forest's nutrient status; however, few studies of N addition appear to incorporate the nutrient status in tropical forests, possibly due to difficulties in explaining how this status is maintained. We used a meta-analysis to explore the consequences of the N enrichment on C and N cycles in tropical montane and lowland forests. We tracked changes in aboveground and belowground plant C and N and in mineral soil in response to N addition. We found an increasing trend of plant biomass in montane forests, but not in lowland forests, as well as a greater increase in NO emission in montane forest compared with lowland forest. The N2O and NO emission increase in both forest; however, the N2O increase in lowland forest was significantly even at first time N addition. The NO emission increase showed be greater at first term compared with long term N addition. Moreover, the increase in total soil N, ammonium, microbial N, and dissolved N concentration under N enrichment indicates a rich N status of lowland forests. The available evidence of N addition experiments shows that the lowland forest is richer in N than montane forests. Finally, the greater increase in N leaching and N gas emission highlights the importance of study the N deposition effect on the global climate change.	[Bejarano-Castillo, Marylin] Pronatura Sur, San Cristobal Las Casas 29250, Mexico; [Campo, Julio] Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City 04510, DF, Mexico; [Roa-Fuentes, Lilia L.] Ctr Cambio Global & Sustentabilidad Sureste AC, Villahermosa, Mexico	Universidad Nacional Autonoma de Mexico	Roa-Fuentes, LL (corresponding author), Ctr Cambio Global & Sustentabilidad Sureste AC, Villahermosa, Mexico.	lilia.roa@ccgss.org		Roa-Fuentes, Lilia/0000-0002-0989-4261				Bai E, 2012, BIOGEOSCIENCES, V9, P3287, DOI 10.5194/bg-9-3287-2012; Brookshire ENJ, 2012, NAT GEOSCI, V5, P123, DOI 10.1038/NGEO1372; Campo J, 2004, ECOSYSTEMS, V7, P311, DOI 10.1007/s10021-003-0249-2; Chapin FS., 2011, PRINCIPLES TERRESTRI, V2nd ed.; Chapin III., 2002, PRINCIPLES TERRESTRI, DOI [10.1007/978-1-4419-9504-9, DOI 10.1007/978-1-4419-9504-9]; Cleveland CC, 2011, ECOL LETT, V14, P939, DOI 10.1111/j.1461-0248.2011.01658.x; Cusack DF, 2010, GLOBAL CHANGE BIOL, V16, P2555, DOI 10.1111/j.1365-2486.2009.02131.x; Finzi AC, 2011, FRONT ECOL ENVIRON, V9, P61, DOI 10.1890/100001; FOG K, 1988, BIOL REV, V63, P433, DOI 10.1111/j.1469-185X.1988.tb00725.x; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Hartung J., 2011, STAT METAANALYSIS AP; Hedges LV, 1999, ECOLOGY, V80, P1150, DOI 10.2307/177062; Hedin LO, 2009, ANNU REV ECOL EVOL S, V40, P613, DOI 10.1146/annurev.ecolsys.37.091305.110246; Houlton BZ, 2015, SOIL-GERMANY, V1, P381, DOI 10.5194/soil-1-381-2015; Houlton BZ, 2006, P NATL ACAD SCI USA, V103, P8745, DOI 10.1073/pnas.0510185103; Kaye JP, 1997, TRENDS ECOL EVOL, V12, P139, DOI 10.1016/S0169-5347(97)01001-X; Knorr W, 2005, NATURE, V433, P298, DOI 10.1038/nature03226; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Lohse KA, 2005, ECOL APPL, V15, P1629, DOI 10.1890/03-5421; Lu M, 2011, NEW PHYTOL, V189, P1040, DOI 10.1111/j.1469-8137.2010.03563.x; Marklein AR, 2012, NEW PHYTOL, V193, P696, DOI 10.1111/j.1469-8137.2011.03967.x; Matson P, 2002, AMBIO, V31, P113, DOI 10.1639/0044-7447(2002)031[0113:TGONDC]2.0.CO;2; Rosenberg MS, 2000, METAWIN STAT SOFTWAR; Sinsabaugh RL, 2002, BIOGEOCHEMISTRY, V60, P1, DOI 10.1023/A:1016541114786; Sullivan BW, 2014, P NATL ACAD SCI USA, V111, P8101, DOI 10.1073/pnas.1320646111; Tanner EVJ, 1998, ECOLOGY, V79, P10, DOI 10.1890/0012-9658(1998)079[0010:EIONLO]2.0.CO;2; Templer PH, 2008, ECOLOGY, V89, P3030, DOI 10.1890/07-1631.1; Thornton PE, 2009, BIOGEOSCIENCES, V6, P2099, DOI 10.5194/bg-6-2099-2009; Townsend AR, 2011, FRONT ECOL ENVIRON, V9, P9, DOI 10.1890/100047; Treseder KK, 2008, ECOL LETT, V11, P1111, DOI 10.1111/j.1461-0248.2008.01230.x; Vitousek P, 1989, GLOBAL BIOGEOCHEM CY, V3, P375, DOI 10.1029/GB003i004p00375; Vitousek PM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0119; VITOUSEK PM, 1993, BIOGEOCHEMISTRY, V23, P197, DOI 10.1007/BF00023752; Vitousek PM, 2012, ECOLOGICAL APPL, V20, P5; Wania R, 2012, GMD, V5, P67; Wright SJ, 2011, ECOLOGY, V92, P1616, DOI 10.1890/10-1558.1; Zaehle S, 2011, CURR OPIN ENV SUST, V3, P1	38	18	18	7	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144253	10.1371/journal.pone.0144253	http://dx.doi.org/10.1371/journal.pone.0144253			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633681	Green Submitted, Green Published, gold			2022-12-27	WOS:000366040000074
J	Benedict, KM; Gow, SP; McAllister, TA; Booker, CW; Hannon, SJ; Checkley, SL; Noyes, NR; Morley, PS				Benedict, Katharine M.; Gow, Sheryl P.; McAllister, Tim A.; Booker, Calvin W.; Hannon, Sherry J.; Checkley, Sylvia L.; Noyes, Noelle R.; Morley, Paul S.			Antimicrobial Resistance in Escherichia coli Recovered from Feedlot Cattle and Associations with Antimicrobial Use	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; WESTERN CANADA; HUMAN HEALTH; MANNHEIMIA-HAEMOLYTICA; UNDIFFERENTIATED FEVER; ANIMAL ORIGIN; FOOD ANIMALS; BACTERIA; CALVES; SUSCEPTIBILITY	The objectives of this study were to estimate the prevalence of antimicrobial resistance (AMR) and to investigate the associations between exposures to antimicrobial drugs (AMDs) and AMR in fecal non-type specific Escherichia coli (NTSEC) recovered from a large population of feedlot cattle. Two-stage random sampling was used to select individually identified cattle for enrollment, which were sampled at arrival and then a second time later in the feeding period. Advanced regression techniques were used to estimate resistance prevalences, and to investigate associations between AMD exposures in enrolled cattle and penmates and AMR identified in NTSEC recovered from the second sample set. Resistance was most commonly detected to tetracycline, streptomycin, and sulfisoxazole, and was rarely identified for critically important AMDs. All cattle were exposed to AMDs in feed, and 45% were treated parenterally. While resistance prevalence generally increased during the feeding period, most AMD exposures were not significantly associated with AMR outcomes. Exposures of enrolled cattle to tetracycline were associated with increased resistance to tetracycline and trimethoprim sulfa, while beta-lactam exposures were associated with decreased likelihood of detecting streptomycin resistance. Pen-level AMD exposure measures were not associated with resistance outcomes. These findings suggest that tetracycline treatment of feedlot cattle can be associated with modest increases in risk for recovery of resistant NTSEC, but the numerous treatments with an advanced macrolide (tulathromycin) were not associated with detectable increases in resistance in NTSEC. All cattle were exposed to in-feed treatments of tetracycline and this could limit the ability to identify the full impact of these exposures, but these exposures varied for enrolled cattle varied, providing an opportunity to evaluate a dose response. While AMD exposures were not associated with detectably increased risks for resistance to critically important AMDs, rare resistance outcomes and infrequent exposure to other important AMDs (e.g., cephalosporins) limited our ability to rigorously investigate questions regarding factors that can influence resistance to these important AMDs.	[Benedict, Katharine M.; Noyes, Noelle R.; Morley, Paul S.] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Clin Sci, Ft Collins, CO 80523 USA; [Gow, Sheryl P.] Univ Saskatchewan, Lab Foodborne Zoonoses, Publ Hlth Agcy Canada, Saskatoon, SK, Canada; [McAllister, Tim A.] Univ Lethbridge, Lethbridge Res Ctr, Lethbridge, AB T1K 3M4, Canada; [Booker, Calvin W.; Hannon, Sherry J.] Feedlot Hlth Management Serv Ltd, Okotoks, AB, Canada; [Checkley, Sylvia L.] Univ Calgary, Fac Vet Med, Calgary, AB, Canada	Colorado State University; Public Health Agency of Canada; University of Saskatchewan; University of Lethbridge; University of Calgary	Morley, PS (corresponding author), Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Clin Sci, Ft Collins, CO 80523 USA.	paul.morley@colostate.edu	Morley, Paul/T-1721-2019; Morley, Paul S/C-9960-2009; McAllister, Tim A./R-9201-2017	Morley, Paul S/0000-0001-8138-2714; McAllister, Tim A./0000-0002-8266-6513; Checkley, Sylvia/0000-0002-9118-2721; Noyes, Noelle/0000-0001-6149-1008	Advancing Canadian Agriculture and Agri-Food (ACAAF) Program; Alberta Beef Producers [0007- 038RDB]; Canadian Cattlemen's Association, Beef Cattle Research Council [BCRC 6.41]; Public Health Agency of Canada; Colorado State University	Advancing Canadian Agriculture and Agri-Food (ACAAF) Program(Agriculture & Agri Food Canada); Alberta Beef Producers; Canadian Cattlemen's Association, Beef Cattle Research Council; Public Health Agency of Canada; Colorado State University	This research was supported by grants from the Advancing Canadian Agriculture and Agri-Food (ACAAF) Program, http://www.agr.gc.ca/eng/?id=1251739303866, 2006-2011; from the Alberta Beef Producers, http://www.albertabeef.org/, 2006-2008 (Project Number 0007- 038RDB); and from the Canadian Cattlemen's Association, Beef Cattle Research Council, http://www.beefresearch.ca/, 2006-2008 (Project Number BCRC 6.41). The Public Health Agency of Canada (http://www.phac-aspc.gc.ca/lfz-llczoa/) provided additional funding for broth microdilution susceptibility testing and to support data analysis and report preparation. Publication costs were provided by the Colorado State University Libraries Open Access Research and Scholarship Fund. Dr. Gow is employed by the Public Health Agency of Canada and was involved in this research as part of her duties assigned by that government agency. She was substantively involved in the study design, conduct, analysis, and reporting of this research. Drs. Booker and Hannon are affiliated with the commercial company Feedlot Health Management Services, Ltd. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. They were substantively involved in the study design, conduct, analysis, and reporting of this research.	Aarestrup FM, 2005, BASIC CLIN PHARMACOL, V96, P271, DOI 10.1111/j.1742-7843.2005.pto960401.x; Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Akwar HT, 2008, CAN J VET RES, V72, P202; Alexander TW, 2008, VET MICROBIOL, V130, P165, DOI 10.1016/j.vetmic.2008.01.001; Angulo FJ, 2004, J VET MED B, V51, P374, DOI 10.1111/j.1439-0450.2004.00789.x; Barbosa TM, 2000, DRUG RESIST UPDATE, V3, P303, DOI 10.1054/drup.2000.0167; Barton MD, 1998, AUST VET J, V76, P177, DOI 10.1111/j.1751-0813.1998.tb10124.x; Benedict KM, 2014, EPIDEMIOL INFECT, V142, P2314, DOI 10.1017/S0950268813003300; Benedict KM, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-216; Berge AC, 2010, JAVMA-J AM VET MED A, V236, P1338, DOI 10.2460/javma.236.12.1338; Booker CW, 2007, VET THER, V8, P183; Booker CW, 1999, CAN VET J, V40, P40; Bywater R, 2006, VET MICROBIOL, V118, P158, DOI 10.1016/j.vetmic.2006.09.005; Caprioli A, 2000, INT J ANTIMICROB AG, V14, P295, DOI 10.1016/S0924-8579(00)00140-0; CAREY V, 1993, BIOMETRIKA, V80, P517, DOI 10.2307/2337173; Checkley SL, 2008, CAN J VET RES, V72, P101; Checkley SL, 2010, CAN VET J, V51, P853; Clinical and Laboratory Standards Institute, 2014, M100S24 CLIN LAB STA; Clinical and Laboratory Standards Institute, 2013, VET01A4 CLIN LAB STA; Clinical and Laboratory Standards Institute (CLSI), 2010, M45A2 CLSI; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Lowrance TC, 2007, AM J VET RES, V68, P501, DOI 10.2460/ajvr.68.5.501; McDermott PF, 2002, ANIM BIOTECHNOL, V13, P71, DOI 10.1081/ABIO-120005771; McGeer AJ, 1998, CAN MED ASSOC J, V159, P1119; Morley PS, 2011, FOODBORNE PATHOG DIS, V8, P87, DOI 10.1089/fpd.2010.0632; National Research Council Subcommittee on Beef Cattle Nutrition, 2000, NUTR REQ BEEF CATTL, Vxiv; Noyes N, 2015, EPIDEMIOL I IN PRESS; Noyes NR, 2014, J VET INTER IN PRESS; Phillips I, 2004, J ANTIMICROB CHEMOTH, V53, P28, DOI 10.1093/jac/dkg483; Platt TM, 2008, AM J VET RES, V69, P988, DOI 10.2460/ajvr.69.8.988; Rao S, 2010, FOODBORNE PATHOG DIS, V7, P449, DOI 10.1089/fpd.2009.0400; Schunicht OC, 2002, CAN VET J, V43, P940; Schunicht OC, 2002, CAN VET J, V43, P355; Simjee S, 2008, J ANTIMICROB CHEMOTH, V61, P228, DOI 10.1093/jac/dkm423; Singer RS, 2014, CURR OPIN MICROBIOL, V19, P1, DOI 10.1016/j.mib.2014.05.014; Thibodeau A, 2008, CAN J VET RES, V72, P129; Wagner BA, 2003, AM J VET RES, V64, P1570, DOI 10.2460/ajvr.2003.64.1570; Witte W, 2000, INT J ANTIMICROB AG, V14, P321, DOI 10.1016/S0924-8579(00)00144-8	38	31	32	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143995	10.1371/journal.pone.0143995	http://dx.doi.org/10.1371/journal.pone.0143995			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633649	Green Published, gold, Green Submitted			2022-12-27	WOS:000366040000039
J	De, P; Amin, AG; Valli, E; Perkins, MD; McNeil, M; Chatterjee, D				De, Prithwiraj; Amin, Anita G.; Valli, Eloise; Perkins, Mark D.; McNeil, Michael; Chatterjee, Delphi			Estimation of D-Arabinose by Gas Chromatography/Mass Spectrometry as Surrogate for Mycobacterial Lipoarabinomannan in Human Urine	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; CELL-WALL; DIAGNOSIS; MTB/RIF; LAM; DNA	Globally, tuberculosis is slowly declining each year and it is estimated that 37 million lives were saved between 2000 and 2013 through effective diagnosis and treatment. Currently, diagnosis relies on demonstration of the bacteria, Mycobacterium tuberculosis (Mtb), in clinical specimens by serial sputum microscopy, culture and molecular testing. Commercial immunoassay lateral flow kits developed to detect Mtb lipoglycan lipoarabinomannan (LAM) in urine as a marker of active TB exhibit poor sensitivity, especially in immunocompetent individuals, perhaps due to low abundance of the analyte. Our present study was designed to develop methods to validate the presence of LAM in a quantitative fashion in human urine samples obtained from culture-confirmed TB patients. Herein we describe, a consolidated approach for isolating LAM from the urine and quantifying D-arabinose as a proxy for LAM, using Gas Chromatography/Mass Spectrometry. 298 urine samples obtained from a repository were rigorously analyzed and shown to contain varying amounts of LAM-equivalent ranging between similar to 10-40 ng/mL. To further substantiate that D-arabinose detected in the samples originated from LAM, tuberculostearic acid, the unique 10-methyloctadecanoic acid present at the phosphatidylinositol end of LAM was also analyzed in a set of samples and found to be present confirming that the D-arabinose was indeed derived from LAM. Among the 144 samples from culture-negative TB suspects, 30 showed presence of D-arabinose suggesting another source of the analyte, such as disseminated TB or from non-tuberculosis mycobacterium. Our work validates that LAM is present in the urine samples of culture-positive patients in small but readily detectable amounts. The study further substantiates LAM in urine as a powerful biomarker for active tuberculosis.	[De, Prithwiraj; Amin, Anita G.; McNeil, Michael; Chatterjee, Delphi] Colorado State Univ, Dept Microbiol Immunol & Pathol, Mycobacteria Res Labs, Ft Collins, CO 80523 USA; [Valli, Eloise; Perkins, Mark D.] FIND, CH-1202 Geneva, Switzerland	Colorado State University; Foundation For Innovative New Diagnostics	Chatterjee, D (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Mycobacteria Res Labs, 1682 Campus Delivery, Ft Collins, CO 80523 USA.	Delphi.Chatterjee@colostate.edu	McNeil, Michael/G-3325-2019; De, Prithwiraj/S-1199-2019	De, Prithwiraj/0000-0003-4499-2147; Valli, Eloise/0000-0002-1499-3176	Bill and Melinda Gates Foundation [OPP1039621]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Bill and Melinda Gates Foundation funded the OPP1039621 under which the study was undertaken. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhamidi S, 2012, ANAL BIOCHEM, V421, P240, DOI 10.1016/j.ab.2011.10.046; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Cannas A, 2008, INT J TUBERC LUNG D, V12, P146; CHATTERJEE D, 1992, J BIOL CHEM, V267, P6234; Finley-Jones HJ, 2008, J ANAL ATOM SPECTROM, V23, P1214, DOI 10.1039/b804048f; Gardiner JL, 2015, J EXP MED, V212, P1759, DOI 10.1084/jem.20151468; HALL CL, 1979, ANNU REV MED, V30, P199, DOI 10.1146/annurev.me.30.020179.001215; Hamasur B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123457; HUNTER SW, 1990, J BIOL CHEM, V265, P9272; HUNTER SW, 1986, J BIOL CHEM, V261, P2345; Kang PB, 2005, J EXP MED, V202, P987, DOI 10.1084/jem.20051239; LARSSON L, 1987, J CLIN MICROBIOL, V25, P893, DOI 10.1128/JCM.25.5.893-896.1987; Lawn SD, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-103; Lawn SD, 2012, CLIN INFECT DIS, V54, P1071, DOI 10.1093/cid/cir1039; LEOPOLD K, 1993, ANAL BIOCHEM, V208, P57, DOI 10.1006/abio.1993.1008; Lindqvist L, 1997, J CHROMATOGR A, V767, P325, DOI 10.1016/S0021-9673(96)01062-X; Peter JG, 2012, INT J TUBERC LUNG D, V16, P1108, DOI 10.5588/ijtld.11.0614; Peter JG, 2012, LANCET INFECT DIS, V12, P825, DOI 10.1016/S1473-3099(12)70220-7; Petrone L, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/589471; Petrone L, 2014, J INFECTION, V68, P591, DOI 10.1016/j.jinf.2014.02.008; Petrucci R, 2015, J CLIN MICROBIOL, V53, P336, DOI 10.1128/JCM.02548-14; Ruiz-Matute AI, 2011, J CHROMATOGR B, V879, P1226, DOI 10.1016/j.jchromb.2010.11.013; Shah M, 2010, J CLIN MICROBIOL, V48, P2972, DOI 10.1128/JCM.00363-10; Sharma A, 2006, CLIN VACCINE IMMUNOL, V13, P1143, DOI 10.1128/CVI.00127-06; Small PM, 2010, NEW ENGL J MED, V363, P1070, DOI 10.1056/NEJMe1008496; Strohmeier GR, 1999, MICROBES INFECT, V1, P709, DOI 10.1016/S1286-4579(99)80072-0; Treumann A, 2002, J MOL BIOL, V316, P89, DOI 10.1006/jmbi.2001.5317; Van Rie A, 2010, EXPERT REV MOL DIAGN, V10, P937, DOI [10.1586/erm.10.67, 10.1586/ERM.10.67]; Wallis RS, 2013, LANCET INFECT DIS, V13, P362, DOI 10.1016/S1473-3099(13)70034-3; Wood R, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-47; World Health Organization, 2014, GLOB TUB REP	33	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144088	10.1371/journal.pone.0144088	http://dx.doi.org/10.1371/journal.pone.0144088			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633829	gold, Green Submitted, Green Published			2022-12-27	WOS:000366040000054
J	Lee, JS; Jeong, SW; Cho, SW; Juhn, JP; Kim, KW				Lee, Jun-Seok; Jeong, Seo-Won; Cho, Sung-Wook; Juhn, Joon-Pyo; Kim, Ki-Won			Relationship between Initial Telomere Length, Initial Telomerase Activity, Age, and Replicative Capacity of Nucleus Pulposus Chondrocytes in Human Intervertebral Discs: What Is a Predictor of Replicative Potential?	PLOS ONE			English	Article							DONOR AGE; LIFE-SPAN; IN-VITRO; CELLS; DEGENERATION; SENESCENCE; MODEL; TRANSPLANTATION; EXPRESSION; ORIGIN	There is evidence that telomere length (TL), telomerase activity (TA), and age are related to the replicative potential of human nucleus pulposus chondrocytes (NPCs). However, it has not yet been established if any of these factors can serve as predictors of the replicative potential of NPCs. To establish predictors of the replicative potential of NPCs, we evaluated potential relationships between replicative capacity of NPCs, initial TL (telomere length at the first passage), initial TA (telomerase activity at the first passage), and age. Nucleus pulposus specimens were obtained from 14 patients of various ages undergoing discectomy. NPCs were serially cultivated until the end of their replicative lifespans. Relationships among cumulative population doubling level (PDL), initial TL, initial TA, and age were analyzed. Initial TA was negatively correlated with age (r = -0.674, P = 0.008). However, no correlation between initial TL and age was observed. Cumulative PDL was also negatively correlated with age (r = -0.585, P = 0.028). Although the cumulative PDL appeared to increase with initial TL or initial TA, this trend was not statistically significant. In conclusion, age is the sole predictor of the replicative potential of human NPCs, and replicative potential decreases with age. Initial TL and initial TA are not predictors of replicative potential, and can serve only as reference values.	[Lee, Jun-Seok; Cho, Sung-Wook; Juhn, Joon-Pyo; Kim, Ki-Won] Catholic Univ Korea, Yeouido St Marys Hosp, Dept Orthoped Surg, Coll Med, Seoul, South Korea; [Lee, Jun-Seok; Jeong, Seo-Won; Kim, Ki-Won] Catholic Univ Korea, Med Res Inst, Yeouido St Marys Hosp, Dept Orthoped Res, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea	Lee, JS (corresponding author), Catholic Univ Korea, Yeouido St Marys Hosp, Dept Orthoped Surg, Coll Med, Seoul, South Korea.	junband@naver.com			Catholic Medical Research Foundation	Catholic Medical Research Foundation	This work was supported by the Catholic Medical Research Foundation: JSL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported in part by the Catholic Medical Research Foundation.	ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; ALLSOPP RC, 1995, EXP CELL RES, V219, P130, DOI 10.1006/excr.1995.1213; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Bojesen SE, 2013, J INTERN MED, V274, P399, DOI 10.1111/joim.12083; Chan SRWL, 2004, PHILOS T R SOC B, V359, P109, DOI 10.1098/rstb.2003.1370; Cheung KMC, 2009, SPINE, V34, P934, DOI 10.1097/BRS.0b013e3181a01b3f; Chung SA, 2007, SPINE, V32, P1188, DOI 10.1097/BRS.0b013e31805471a3; Cristofalo VJ, 1998, P NATL ACAD SCI USA, V95, P10614, DOI 10.1073/pnas.95.18.10614; Del Bufalo D, 2005, CELL DEATH DIFFER, V12, P1429, DOI 10.1038/sj.cdd.4401670; Demerath EW, 2004, HUM BIOL, V76, P127, DOI 10.1353/hub.2004.0018; Deyo RA, 2001, NEW ENGL J MED, V344, P363, DOI 10.1056/NEJM200102013440508; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Freemont AJ, 1997, LANCET, V350, P178, DOI 10.1016/S0140-6736(97)02135-1; Gruber HE, 2002, SPINE, V27, P1626, DOI 10.1097/00007632-200208010-00007; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hegewald AA, 2011, J TISSUE ENG REGEN M, V5, P275, DOI 10.1002/term.312; Hiyama A, 2008, J ORTHOP RES, V26, P589, DOI 10.1002/jor.20584; Imai Y, 2007, SPINE, V32, P1303, DOI 10.1097/BRS.0b013e3180593238; Jeong SW, 2014, SPINE J, V14, P499, DOI 10.1016/j.spinee.2013.06.099; Kang HJ, 2004, J NEUROSCI, V24, P1280, DOI 10.1523/JNEUROSCI.4082-03.2004; Karavassilis Maria E, 2013, Longev Healthspan, V2, P3, DOI 10.1186/2046-2395-2-3; Kim KW, 2008, ASIAN SPINE J, V2, P1, DOI 10.4184/asj.2008.2.1.1; Kim KW, 2009, SPINE J, V9, P658, DOI 10.1016/j.spinee.2009.04.018; Kim KW, 2005, SPINE, V30, P1373, DOI 10.1097/01.brs.0000166155.48168.0e; Kim KW, 2003, SPINE, V28, P982, DOI 10.1097/00007632-200305150-00005; Ksiazek K, 2007, EXP GERONTOL, V42, P840, DOI 10.1016/j.exger.2007.04.012; Le Maitre CL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2198; Masuda K, 2005, SPINE, V30, P5, DOI 10.1097/01.brs.0000148152.04401.20; Masuda K, 2004, SPINE, V29, P2757, DOI 10.1097/01.brs.0000146048.14946.af; Mauth C, 2009, EUR CELLS MATER, V18, P27, DOI 10.22203/eCM.v018a03; Meisel HJ, 2007, BIOMOL ENG, V24, P5, DOI 10.1016/j.bioeng.2006.07.002; Mern DS, 2014, J TISSUE ENG REGEN M, V8, P925, DOI 10.1002/term.1583; Murillo-Ortiz B, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-99; Okuma M, 2000, J ORTHOPAED RES, V18, P988, DOI 10.1002/jor.1100180620; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Parsch D, 2002, ARTHRITIS RHEUM, V46, P2911, DOI 10.1002/art.10626; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Rodrigues-Pinto R, 2014, EUR SPINE J, V23, P1803, DOI 10.1007/s00586-014-3305-z; Saretzki G, 2002, ANN NY ACAD SCI, V959, P24, DOI 10.1111/j.1749-6632.2002.tb02079.x; SLAGBOOM PE, 1994, AM J HUM GENET, V55, P876; Sobajima S, 2008, SPINE J, V8, P888, DOI 10.1016/j.spinee.2007.09.011; Verdun RE, 2007, NATURE, V447, P924, DOI 10.1038/nature05976; WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0; Wu JH, 2014, J ORTHOP RES, V32, P159, DOI 10.1002/jor.22474; Wu JH, 2011, TISSUE ENG PT A, V17, P2407, DOI [10.1089/ten.tea.2011.0132, 10.1089/ten.TEA.2011.0132]; Xu Z, 2013, GENETICS, V194, P847, DOI 10.1534/genetics.113.152322; Yang LQ, 2001, MECH AGEING DEV, V122, P1685, DOI 10.1016/S0047-6374(01)00280-9; Yang XL, 2009, EUR SPINE J, V18, P1564, DOI 10.1007/s00586-009-1092-8	50	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144177	10.1371/journal.pone.0144177	http://dx.doi.org/10.1371/journal.pone.0144177			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633809	Green Submitted, Green Published, gold			2022-12-27	WOS:000366040000068
J	Millares, L; Perez-Brocal, V; Ferrari, R; Gallego, M; Pomares, X; Garcia-Nunez, M; Monton, C; Capilla, S; Monso, E; Moya, A				Millares, Laura; Perez-Brocal, Vicente; Ferrari, Rafaela; Gallego, Miguel; Pomares, Xavier; Garcia-Nunez, Marian; Monton, Concepcion; Capilla, Silvia; Monso, Eduard; Moya, Andres			Functional Metagenomics of the Bronchial Microbiome in COPD	PLOS ONE			English	Article							LUNG-CANCER; COMMUNITY; EXACERBATIONS; PATHOGENESIS; DYNAMICS; RESOURCE; DATABASE; THERAPY; NUMBER; RISK	The course of chronic obstructive pulmonary disease (COPD) is frequently aggravated by exacerbations, and changes in the composition and activity of the microbiome may be implicated in their appearance. The aim of this study was to analyse the composition and the gene content of the microbial community in bronchial secretions of COPD patients in both stability and exacerbation. Taxonomic data were obtained by 16S rRNA gene amplification and pyrosequencing, and metabolic information through shotgun metagenomics, using the Metagenomics RAST server (MG-RAST), and the PICRUSt (Phylogenetic Investigation of Communities by Reconstruction of Unobserved States) programme, which predict metagenomes from 16S data. Eight severe COPD patients provided good quality sputum samples, and no significant differences in the relative abundance of any phyla and genera were found between stability and exacerbation. Bacterial biodiversity (Chao1 and Shannon indexes) did not show statistical differences and beta-diversity analysis (Bray-Curtis dissimilarity index) showed a similar microbial composition in the two clinical situations. Four functional categories showed statistically significant differences with MG-RAST at KEGG level 2: in exacerbation, Cell growth and Death and Transport and Catabolism decreased in abundance [1.6 (0.2-2.3) vs 3.6 (3.3-6.9), p = 0.012; and 1.8 (0-3.3) vs 3.6 (1.8-5.1), p = 0.025 respectively], while Cancer and Carbohydrate Metabolism increased [0.8 (0-1.5) vs 0 (0-0.5), p = 0.043; and 7 (6.4-9) vs 5.9 (6.3-6.1), p = 0.012 respectively]. In conclusion, the bronchial microbiome as a whole is not significantly modified when exacerbation symptoms appear in severe COPD patients, but its functional metabolic capabilities show significant changes in several pathways.	[Millares, Laura; Garcia-Nunez, Marian] Fundacio Parc Tauli, Sabadell, Spain; [Millares, Laura; Pomares, Xavier; Garcia-Nunez, Marian; Monton, Concepcion; Monso, Eduard] CIBERES, CIBER Enfermedades Resp, Bunyola, Spain; [Millares, Laura; Garcia-Nunez, Marian; Monso, Eduard] Univ Autonoma Barcelona, Esfera UAB, E-08193 Barcelona, Spain; [Millares, Laura; Garcia-Nunez, Marian] Fundacio Insitut Invest Germans Trias & Pujol, Badalona, Spain; [Perez-Brocal, Vicente; Ferrari, Rafaela; Moya, Andres] Fdn Fomento Invest Sanitaria & Biomed Comunidad V, Genom & Hlth Area, Valencia, Spain; [Perez-Brocal, Vicente; Ferrari, Rafaela; Moya, Andres] CIBERESP, Barcelona, Spain; [Perez-Brocal, Vicente; Ferrari, Rafaela; Moya, Andres] Univ Valencia, ICBiBE, Evolutionary Genet Unit, Valencia, Spain; [Gallego, Miguel; Pomares, Xavier; Monton, Concepcion; Monso, Eduard] Hosp Univ Parc Tauli, Dept Resp Med, Sabadell, Spain; [Capilla, Silvia] Hosp Univ Parc Tauli, Dept Microbiol, Sabadell, Spain	Autonomous University of Barcelona; Parc Tauli Hospital Universitari; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Valencia; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Autonomous University of Barcelona; Parc Tauli Hospital Universitari	Millares, L (corresponding author), Fundacio Parc Tauli, Sabadell, Spain.	lmillares@tauli.cat	Garcia, Marian/GXN-2696-2022; FERRARI, RAFAELA/ABB-7060-2020; Moya, Andrés/A-8190-2008; Garcia, Marian/F-9170-2013; Perez Brocal, Vicente/K-3627-2014	FERRARI, RAFAELA/0000-0002-5243-2695; Moya, Andrés/0000-0002-2867-1119; Garcia, Marian/0000-0002-5158-3758; Perez Brocal, Vicente/0000-0002-1927-9676; Capilla, Silvia/0000-0002-7274-2973; Pomares, Xavier/0000-0002-2783-414X	Sociedad Catalana de Neumologia; Fundacio Catalana de Neumologia; Fundacio Parc Tauli; Marato de TV3; Sociedad Espanola de Neumologia y Cirugia Toracica; Fundacion Menarini; Ministerio de Economia y Competitividad (Spain) [SAF2012-31187]; Generalitat Valenciana (Spain) [Prometeo/2009/092]; Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (CIBERES)	Sociedad Catalana de Neumologia; Fundacio Catalana de Neumologia; Fundacio Parc Tauli; Marato de TV3; Sociedad Espanola de Neumologia y Cirugia Toracica; Fundacion Menarini(Menarini Group); Ministerio de Economia y Competitividad (Spain)(Spanish Government); Generalitat Valenciana (Spain)(Center for Forestry Research & Experimentation (CIEF)); Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (CIBERES)	This work was supported by Sociedad Catalana de Neumologia (http://www.socapnet.org); Fundacio Catalana de Neumologia (http://www.ccfundacions.cat/fundacions/fundacio-catalana-de-pneumologia-fucap); Fundacio Parc Tauli (https://www.tauli.cat/tauli/cat/fpt/fpt.htm); Marato de TV3 (http://www.tv3.cat/marato/es/); Sociedad Espanola de Neumologia y Cirugia Toracica (http://www.separ.es/); Fundacion Menarini (http://www.menarini.es/); Ministerio de Economia y Competitividad (Spain) (http://www.idi.mineco.gob.es/) [SAF2012-31187]; Generalitat Valenciana (Spain) [Prometeo/2009/092] and Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (CIBERES) (http://www.ciberisciii.es/). CIBERES is an initiative of the Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1987, Am Rev Respir Dis, V136, P1285; ANTHONISEN NR, 1987, ANN INTERN MED, V106, P196, DOI 10.7326/0003-4819-106-2-196; Barreiro E, 2013, FREE RADICAL BIO MED, V65, P859, DOI 10.1016/j.freeradbiomed.2013.08.006; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Carr R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105776; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Chaffin DO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041329; CHAO A, 1984, SCAND J STAT, V11, P265; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Davenport M, 2014, INFLAMM BOWEL DIS, V20, P723, DOI 10.1097/MIB.0000000000000011; de Torres JP, 2007, CHEST, V132, P1932, DOI 10.1378/chest.07-1490; Decramer M, 2012, LANCET, V379, P1341, DOI 10.1016/S0140-6736(11)60968-9; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fodor AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045001; Gallego M, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-103; Garcia-Nunez M, 2014, J CLIN MICROBIOL, V52, P4217, DOI 10.1128/JCM.01967-14; Glass Elizabeth M, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5368; Greenblum S, 2015, CELL, V160, P583, DOI 10.1016/j.cell.2014.12.038; Huang YJ, 2014, J CLIN MICROBIOL, V52, P2813, DOI 10.1128/JCM.00035-14; Huang YJ, 2010, OMICS, V14, P9, DOI 10.1089/omi.2009.0100; Iwai S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095726; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Meyer F, 2012, GENOME BIOL, V13, DOI 10.1186/gb4042; Millares L, 2014, EUR J CLIN MICROBIOL, V33, P1101, DOI 10.1007/s10096-013-2044-0; Niu BF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-187; Pomares X, 2011, INT J CHRONIC OBSTR, V6, P449, DOI 10.2147/COPD.S23655; Pragman AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047305; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Rangelov K, 2014, CLIN CHEST MED, V35, P87, DOI 10.1016/j.ccm.2013.09.012; Rodriguez-Roisin R, 2000, CHEST, V117, p398S, DOI 10.1378/chest.117.5_suppl_2.398S; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schroedl C, 2012, CURR OPIN PULM MED, V18, P131, DOI 10.1097/MCP.0b013e32834f2080; Seidl K, 2006, ANTIMICROB AGENTS CH, V50, P1183, DOI 10.1128/AAC.50.4.1183-1194.2006; Seidl K, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-95; Sethi S, 2008, NEW ENGL J MED, V359, P2355, DOI 10.1056/NEJMra0800353; Shannon CE, 1997, M D COMPUT, V14, P306; Shelburne SA, 2008, TRENDS MICROBIOL, V16, P318, DOI 10.1016/j.tim.2008.04.002; Shelburne SA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000817; Tunney MM, 2013, AM J RESP CRIT CARE, V187, P1118, DOI 10.1164/rccm.201210-1937OC; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; van der Gast CJ, 2011, ISME J, V5, P780, DOI 10.1038/ismej.2010.175; Wei X, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-175; Zhao JC, 2012, P NATL ACAD SCI USA, V109, P5809, DOI 10.1073/pnas.1120577109	48	33	38	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144448	10.1371/journal.pone.0144448	http://dx.doi.org/10.1371/journal.pone.0144448			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26632844	Green Published, gold, Green Submitted			2022-12-27	WOS:000366040000084
J	Xie, JD; Huang, Y; Chen, DT; Pan, JH; Bi, BT; Feng, KY; Huang, W; Zeng, WA				Xie, Jing-Dun; Huang, Yang; Chen, Dong-Tai; Pan, Jia-Hao; Bi, Bing-Tian; Feng, Kun-Yao; Huang, Wan; Zeng, Wei-An			Fentanyl Enhances Hepatotoxicity of Paclitaxel via Inhibition of CYP3A4 and ABCB1 Transport Activity in Mice	PLOS ONE			English	Article							REVERSES MULTIDRUG-RESISTANCE; P-GLYCOPROTEIN; DRUG-INTERACTIONS; IN-VITRO; CLINICAL-IMPLICATIONS; OVEREXPRESSING CELLS; CYTOCHROME-P450 3A; PHARMACOKINETICS; BINDING; VIVO	Fentanyl, a potent opioid analgesic that is used to treat cancer pain, is commonly administered with paclitaxel in advanced tumors. However, the effect of fentanyl on the hepatotoxicity of paclitaxel and its potential mechanism of action is not well studied. The purpose of this study was to investigate the effect of fentanyl on the hepatotoxicity of paclitaxel and its potential mechanisms of action. Pharmacokinetic parameters of paclitaxel were tested using reversed phase high-performance liquid chromatography (RP-HPLC). Aspartate transaminase (AST), alanine aminotransferase (ALT), and mouse liver histopathology were examined. Moreover, the cytotoxicity of anti-carcinogens was examined using 1-(4, 5-dimethylthiazol-2-yl)-3,5-diphenylformazan (MTT), and the intracellular accumulation of doxorubicin and rhodamine 123 was detected by flow cytometry. Furthermore, the expression of ABCB1 and the activity of ABCB1 ATPase and CYP3A4 were also examined. In this study, the co-administration of fentanyl and paclitaxel prolonged the half-life (t(1/2)) of paclitaxel from 1.455 hours to 2.344 hours and decreased the clearance (CL) from 10.997 ml/h to 7.014 ml/h in mice. Fentanyl significantly increased the levels of ALT in mice to 88.2 U/L, which is more than 2-fold higher than the level detected in the control group, and it increased the histological damage in mouse livers. Furthermore, fentanyl enhanced the cytotoxicity of anti-carcinogens that are ABCB1 substrates and increased the accumulation of doxorubicin and rhodamine 123. Additionally, fentanyl stimulated ABCB1 ATPase activity and inhibited CYP3A4 activity in the liver microsomes of mice. Our study indicates that the obvious hepatotoxicity during this co-administration was due to the inhibition of CYP3A4 activity and ABCB1 transport activity. These findings suggested that the accumulation-induced hepatotoxicity of paclitaxel when it is combined with fentanyl should be avoided.	[Xie, Jing-Dun; Huang, Yang; Chen, Dong-Tai; Pan, Jia-Hao; Huang, Wan; Zeng, Wei-An] Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Dept Anesthesiol,Canc Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Bi, Bing-Tian; Feng, Kun-Yao] Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Dept Clin Trial Ctr,Canc Ctr, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University	Zeng, WA (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Dept Anesthesiol,Canc Ctr, Guangzhou 510275, Guangdong, Peoples R China.	zengwa@mail.sysu.edu.cn			Natural Science Foundation of China [81271246]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Grant (No. 81271246) from the Natural Science Foundation of China (http://www.nsfc.gov.cn/).	Al-Farsi A, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00157; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; Andersen Anders, 2006, BMC Clin Pharmacol, V6, P2, DOI 10.1186/1472-6904-6-2; Brozik A, 2011, EXPERT OPIN DRUG MET, V7, P623, DOI 10.1517/17425255.2011.562892; Bujedo Borja Mugabure, 2012, J Opioid Manag, V8, P177, DOI 10.5055/jom.2012.0114; Dagenais C, 2004, BIOCHEM PHARMACOL, V67, P269, DOI 10.1016/j.bcp.2003.08.027; Dai CL, 2009, BIOCHEM PHARMACOL, V78, P355, DOI 10.1016/j.bcp.2009.04.023; Dreher MR, 2006, JNCI-J NATL CANCER I, V98, P335, DOI 10.1093/jnci/djj070; Englund G, 2014, DRUG METAB DISPOS, V42, P441, DOI 10.1124/dmd.113.054932; Fromm MF, 2004, TRENDS PHARMACOL SCI, V25, P423, DOI 10.1016/j.tips.2004.06.002; Fu LW, 2004, CANCER CHEMOTH PHARM, V53, P349, DOI 10.1007/s00280-003-0742-5; Goh IXW, 2013, SINGAP MED J, V54, P131, DOI 10.11622/smedj.2013044; Henthorn TK, 1999, J PHARMACOL EXP THER, V289, P1084; Honjo Y, 2001, CANCER RES, V61, P6635; Hsu PW, 2013, J AGR FOOD CHEM, V61, P4464, DOI 10.1021/jf3052384; King S, 2011, PALLIATIVE MED, V25, P525, DOI 10.1177/0269216311406313; KLEIN HO, 1982, CIRCULATION, V65, P998, DOI 10.1161/01.CIR.65.5.998; Lee CK, 2011, BIOPHARM DRUG DISPOS, V32, P245, DOI 10.1002/bdd.754; Lin JH, 2003, CLIN PHARMACOKINET, V42, P59, DOI 10.2165/00003088-200342010-00003; Lin JH, 1998, CLIN PHARMACOKINET, V35, P361, DOI 10.2165/00003088-199835050-00003; Ling SY, 2014, BRIT J CLIN PHARMACO, V77, P1039, DOI 10.1111/bcp.12309; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mercer SL, 2011, CURR TOP MED CHEM, V11, P1157; Miller AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060685; MORDEL A, 1993, CLIN PHARMACOL THER, V53, P457, DOI 10.1038/clpt.1993.51; Park BK, 2005, ANNU REV PHARMACOL, V45, P177, DOI 10.1146/annurev.pharmtox.45.120403.100058; Pawar M, 2007, EUR J PHARMACOL, V563, P92, DOI 10.1016/j.ejphar.2007.01.059; Perez-Tomas R, 2006, CURR MED CHEM, V13, P1859, DOI 10.2174/092986706777585077; Rabindran SK, 2000, CANCER RES, V60, P47; Shi S, 2010, INT J PHARMACEUT, V383, P264, DOI 10.1016/j.ijpharm.2009.09.025; Tang R, 2004, LEUKEMIA, V18, P1246, DOI 10.1038/sj.leu.2403390; Thummel KE, 1998, ANNU REV PHARMACOL, V38, P389, DOI 10.1146/annurev.pharmtox.38.1.389; Yamazaki M, 2001, J PHARMACOL EXP THER, V296, P723; Yang XN, 2008, J ETHNOPHARMACOL, V117, P408, DOI 10.1016/j.jep.2008.02.021; Zanger UM, 2013, PHARMACOL THERAPEUT, V138, P103, DOI 10.1016/j.pharmthera.2012.12.007; Zhang JY, 2007, CANCER BIOL THER, V6, P1413; Zhao F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113478; Zhao XQ, 2012, MOL PHARMACOL, V82, P47, DOI 10.1124/mol.111.076299; Zhou WJ, 2012, BRIT J PHARMACOL, V166, P1669, DOI 10.1111/j.1476-5381.2012.01849.x	39	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143701	10.1371/journal.pone.0143701	http://dx.doi.org/10.1371/journal.pone.0143701			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633878	Green Submitted, gold, Green Published			2022-12-27	WOS:000366040000020
J	Li, PS; Thomas, DC; Saunders, RMK				Li, Pui-Sze; Thomas, Daniel C.; Saunders, Richard M. K.			Phylogenetic Reconstruction, Morphological Diversification and Generic Delimitation of Disepalum (Annonaceae)	PLOS ONE			English	Article							GENUS GONIOTHALAMUS ANNONACEAE; ASIMINA-TRILOBA ANNONACEAE; CHLOROPLAST DNA REGIONS; POLLEN-TUBE GROWTH; HISTORICAL BIOGEOGRAPHY; MOLECULAR PHYLOGENETICS; SPORODERM DEVELOPMENT; DEVELOPMENTAL EVENTS; DIPTEROCARP FOREST; BASAL ANGIOSPERMS	Taxonomic delimitation of Disepalum (Annonaceae) is contentious, with some researchers favoring a narrow circumscription following segregation of the genus Enicosanthellum. We reconstruct the phylogeny of Disepalum and related taxa based on four chloroplast and two nuclear DNA regions as a framework for clarifying taxonomic delimitation and assessing evolutionary transitions in key morphological characters. Maximum parsimony, maximum likelihood and Bayesian methods resulted in a consistent, well-resolved and strongly supported topology. Disepalum s.l. is monophyletic and strongly supported, with Disepalum s. str. and Enicosanthellum retrieved as sister groups. Although this topology is consistent with both taxonomic delimitations, the distribution of morphological synapomorphies provides greater support for the inclusion of Enicosanthellum within Disepalum s.l. We propose a novel infrageneric classification with two subgenera. Subgen. Disepalum (= Disepalum s. str.) is supported by numerous synapomorphies, including the reduction of the calyx to two sepals and connation of petals. Subgen. Enicosanthellum lacks obvious morphological synapomorphies, but possesses several diagnostic characters (symplesiomorphies), including a trimerous calyx and free petals in two whorls. We evaluate changes in petal morphology in relation to hypotheses of the genetic control of floral development and suggest that the compression of two petal whorls into one and the associated fusion of contiguous petals may be associated with the loss of the pollination chamber, which in turn may be associated with a shift in primary pollinator. We also suggest that the formation of pollen octads may be selectively advantageous when pollinator visits are infrequent, although this would only be applicable if multiple ovules could be fertilized by each octad; since the flowers are apocarpous, this would require an extragynoecial compitum to enable intercarpellary growth of pollen tubes. We furthermore infer that the monocarp fruit stalks are likely to have evolved independently from those in other Annonaceae genera and may facilitate effective dispersal by providing a color contrast within the fruit.	[Li, Pui-Sze; Thomas, Daniel C.; Saunders, Richard M. K.] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Saunders, RMK (corresponding author), Univ Hong Kong, Sch Biol Sci, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	saunders@hku.hk	Saunders, Richard M. K./A-7436-2008	Saunders, Richard M. K./0000-0002-8104-7761; Thomas, Daniel Caspar/0000-0002-1307-6042	Hong Kong Research Grants Council [HKU777211]; RMKS; DCT	Hong Kong Research Grants Council(Hong Kong Research Grants Council); RMKS; DCT	This research was funded by a grant from the Hong Kong Research Grants Council (HKU777211; http://www.ugc.edu.hk/eng/rgc/index.htm), awarded to RMKS and DCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1981, J ECONOMETRICS, V16, P3, DOI 10.1016/0304-4076(81)90071-3; Ban N.T., 1975, BOT ZH MOSCOW LENING, V60, P808; Barker FK, 2002, SYST BIOL, V51, P625, DOI 10.1080/10635150290102302; BOWMAN JL, 1991, DEVELOPMENT, V112, P1; Brewer PB, 2004, DEVELOPMENT, V131, P4035, DOI 10.1242/dev.01279; Chatrou LW, 2012, BOT J LINN SOC, V169, P5, DOI 10.1111/j.1095-8339.2012.01235.x; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Couvreur TLP, 2008, MOL PHYLOGENET EVOL, V47, P302, DOI 10.1016/j.ympev.2008.01.018; Couvreur TLP, 2011, J BIOGEOGR, V38, P664, DOI 10.1111/j.1365-2699.2010.02434.x; Couvreur TLP, 2009, SYSTEMATIC BOT MONOG, V87, P1; Cunningham CW, 1997, MOL BIOL EVOL, V14, P733, DOI 10.1093/oxfordjournals.molbev.a025813; Diels L, 1930, NOTIZBLATT BOT GARTE, V10, P886; DNYANSAGAR V. R., 1954, LLOYDIA [CINCINNATI], V17, P263; Doyle J. J., 1987, PHYTOCHEM B, P11; Doyle JA, 2012, BOT J LINN SOC, V169, P190, DOI 10.1111/j.1095-8339.2012.01241.x; Drummond A.J., 2010, GENEIOUS VERSION 5 4; ELMER ADE, 1913, LEAFL PHILIPP BOT, V5, P1705; Endress PK, 2007, CURR OPIN PLANT BIOL, V10, P52, DOI 10.1016/j.pbi.2006.11.007; Endress PK, 2009, AM J BOT, V96, P22, DOI 10.3732/ajb.0800047; ENDRESS PK, 1982, TAXON, V31, P48, DOI 10.2307/1220588; Erkens RHJ, 2008, BLUMEA, V53, P407, DOI 10.3767/000651908X608052; Erkens RHJ, 2014, TAXON, V63, P1244, DOI 10.12705/636.34; Erkens RHJ, 2009, J BIOGEOGR, V36, P2338, DOI 10.1111/j.1365-2699.2009.02162.x; Farris JS, 1995, CLADISTICS, V10, P315, DOI [DOI 10.1111/J.1096-0031.1994.TB00181.X, DOI 10.1111/J.1096-0031.1996.TB00196.X]; Favaro R, 2003, PLANT CELL, V15, P2603, DOI 10.1105/tpc.015123; Fero M, 2014, SYST BOT, V39, P17, DOI 10.1600/036364414X678071; Fries RE, 1959, NATURL PFLANZ, P1; GABARAYEVA NI, 1992, GRANA, V31, P213, DOI 10.1080/00173139209432033; GABARAYEVA NI, 1993, GRANA, V32, P210, DOI 10.1080/00173139309429984; GUINET P, 1990, REV PALAEOBOT PALYNO, V64, P109, DOI 10.1016/0034-6667(90)90124-2; Harder LD, 2008, INT J PLANT SCI, V169, P59, DOI 10.1086/523364; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hooker JD, 1860, T LINN SOC, V23; Hotta M, 1989, OCCAS PAPERS KAGOSHI, P16; JOHNSON DM, 1989, BRITTONIA, V41, P356, DOI 10.2307/2807547; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kim S, 2005, PLANT J, V43, P724, DOI 10.1111/j.1365-313X.2005.02487.x; King G., 1892, NAT HIST, V61, P1; KRAL ROBERT, 1960, BRITTONIA, V12, P233, DOI 10.2307/2805119; Lee MSY, 2001, MOL BIOL EVOL, V18, P676, DOI 10.1093/oxfordjournals.molbev.a003848; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; LOOCKERMAN DJ, 1996, SAMPLING GREEN WORLD, P205; Lora J, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-129; Lyew J, 2007, AM J BOT, V94, P1170, DOI 10.3732/ajb.94.7.1170; MAAS PJM, 1988, P K NED AKAD C BIOL, V91, P243; Maddison WP, 2011, MESQUITE MODULAR SYS; Meade A, 2014, BAYESTRAITS VERSION; Merrill E.D., 1926, U CALIF PUBL BOT, V13, P131; Miller M.A., 2010, P GAT COMP ENV WORKS; Momose K, 2005, ECOL STU AN, V174, P104; Momose K, 1998, BIOTROPICA, V30, P444, DOI 10.1111/j.1744-7429.1998.tb00078.x; Nagamitsu T, 1997, AM J BOT, V84, P208, DOI 10.2307/2446082; Neubig KM, 2010, AM J BOT, V97, pE52, DOI 10.3732/ajb.1000128; Nylander JAA., 2004, MRMODELTEST 2 2; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; OLMSTEAD RG, 1994, SYST BIOL, V43, P467, DOI 10.2307/2413546; PACINI E, 1985, PLANT SYST EVOL, V149, P155, DOI 10.1007/BF00983304; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Pelaz S, 2000, NATURE, V405, P200, DOI 10.1038/35012103; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rambaut A., 2009, TRACER VERSION 1 5; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Richardson JE, 2004, PHILOS T R SOC B, V359, P1495, DOI 10.1098/rstb.2004.1537; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roubik D., 2005, POLLINATION ECOLOGY; Saunders RMK, 2012, BOT J LINN SOC, V169, P222, DOI 10.1111/j.1095-8339.2011.01208.x; Saunders RMK, 2010, BIOL REV, V85, P571, DOI 10.1111/j.1469-185X.2009.00116.x; Savolainen V, 1995, PL SYST EVOL, V197, P712; Scheunert A, 2014, MOL PHYLOGENET EVOL, V70, P296, DOI 10.1016/j.ympev.2013.09.023; Schmidt V, 2004, OIKOS, V106, P551, DOI 10.1111/j.0030-1299.2004.12769.x; Silberbauer-Gottsberger I, 2003, TAXON, V52, P701, DOI 10.2307/3647345; Sinclair J., 1955, Gardens' Bulletin, V14, P149; Soltis PS, 2009, ANNU REV PLANT BIOL, V60, P561, DOI 10.1146/annurev.arplant.043008.092039; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Su YCF, 2008, MOL PHYLOGENET EVOL, V48, P188, DOI 10.1016/j.ympev.2008.03.028; Sullivan J, 1996, SYST BIOL, V45, P375, DOI 10.2307/2413571; Swofford D., 2003, PHYLOGENETIC ANAL US; Tang C, 2014, THESIS; Tang CC, 2015, MOL PHYLOGENET EVOL, V92, P124, DOI 10.1016/j.ympev.2015.06.016; Tang CC, 2015, DATA BRIEF, V4, P410, DOI 10.1016/j.dib.2015.06.021; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Thomas DC, 2015, PERSPECT PLANT ECOL, V17, P1, DOI 10.1016/j.ppees.2014.11.001; Thomas DC, 2012, TAXON, V61, P559, DOI 10.1002/tax.613006; TOBE H, 1986, AM J BOT, V73, P475, DOI 10.2307/2444251; Tsou CH, 2007, PLANT SYST EVOL, V263, P13, DOI 10.1007/s00606-006-0471-4; Tsou CH, 2003, AM J BOT, V90, P832, DOI 10.3732/ajb.90.6.832; Tsou CH, 2002, AM J BOT, V89, P734, DOI 10.3732/ajb.89.5.734; Turner IM, 2008, NORD J BOT, V26, P329, DOI 10.1111/j.1756-1051.2008.00359.x; van Heusden ECH, 1992, BLUMEA, P1, DOI DOI 10.1111/J.1756-1051.1993.TB00089.X; van SAK., 1992, BIBLIOTHECA BOT, V142, P1; Vandenbussche M, 2009, PLANT CELL, V21, P2269, DOI 10.1105/tpc.109.065862; WAHA M, 1987, Pollen et Spores, V29, P31; WALKER J. W., 1971, Contributions, Grey Herbarium, Harvard University.; Wang XF, 2012, NEW PHYTOL, V193, P253, DOI 10.1111/j.1469-8137.2011.03912.x; WHEELWRIGHT NT, 1985, AM NAT, V126, P777, DOI 10.1086/284453; Xue B, 2012, TAXON, V61, P1021, DOI 10.1002/tax.615009; Yang ZH, 1997, MOL BIOL EVOL, V14, P717, DOI 10.1093/oxfordjournals.molbev.a025811	101	10	10	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143481	10.1371/journal.pone.0143481	http://dx.doi.org/10.1371/journal.pone.0143481			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630651	gold, Green Published, Green Submitted			2022-12-27	WOS:000365926300051
J	Michaels-Igbokwe, C; Terris-Prestholt, F; Lagarde, M; Chipeta, E; Cairns, J				Michaels-Igbokwe, Christine; Terris-Prestholt, Fern; Lagarde, Mylene; Chipeta, Effie; Cairns, John		Integra Initiative	Young People's Preferences for Family Planning Service Providers in Rural Malawi: A Discrete Choice Experiment	PLOS ONE			English	Article							REPRODUCTIVE HEALTH-SERVICES; ADOLESCENTS; BARRIERS; NURSES; NEEDS; CARE	Objective To quantify the impact of service provider characteristics on young people's choice of family planning (FP) service provider in rural Malawi in order to identify strategies for increasing access and uptake of FP among youth. Methods and Findings A discrete choice experiment was developed to assess the relative impact of service characteristics on preferences for FP service providers among young people (aged 15-24). Four alternative providers were included (government facility, private facility, outreach and community based distribution of FP) and described by six attributes (the distance between participants' home and the service delivery point, frequency of service delivery, waiting time at the facility, service providers' attitude, availability of FP commodities and price). A random parameters logit model was used to estimate preferences for service providers and the likely uptake of services following the expansion of outreach and community based distribution (CBDA) services. In the choice experiment young people were twice as likely to choose a friendly provider (government service odds ratio [OR] = 2.45, p<0.01; private service OR = 1.99, p<0.01; CBDA OR = 1.88, p<0.01) and more than two to three times more likely to choose a provider with an adequate supply of FP commodities (government service OR = 2.48, p<0.01; private service OR = 2.33, p<0.01; CBDA = 3.85, p<0.01). Uptake of community based services was greater than facility based services across a variety of simulated service scenarios indicating that such services may be an effective means of expanding access for youth in rural areas and an important tool for increasing service uptake among youth. Conclusions Ensuring that services are acceptable to young people may require additional training for service providers in order to ensure that all providers are friendly and non-judgemental when dealing with younger clients and to ensure that supplies are consistently available.	[Michaels-Igbokwe, Christine; Terris-Prestholt, Fern; Lagarde, Mylene] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, Dept Global Hlth & Dev, London WC1, England; [Lagarde, Mylene; Cairns, John] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, Dept Hlth Serv Res & Policy, London WC1, England; [Chipeta, Effie] Univ Malawi, Coll Med, Blantyre, Malawi	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Malawi	Michaels-Igbokwe, C (corresponding author), London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, Dept Global Hlth & Dev, London WC1, England.	christine.michaels-igbokwe@lshtm.ac.uk	Cairns, John/AAD-1168-2020; Lagarde, Mylene/GVS-9289-2022	Terris-Prestholt, Fern/0000-0003-1693-5196; Michaels-Igbokwe, Christine/0000-0003-0469-7055; Mayhew, Susannah/0000-0002-2433-3809	Bill and Melinda Gates Foundation; Family Planning Association of Malawi	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Family Planning Association of Malawi	This work was funded by The Bill and Melinda Gates Foundation and administered by the International Planned Parenthood Foundation. FTP and CMI were grant recipients. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to the Family Planning Association of Malawi for their support in conducting this study. Special thanks to Mathias Chatuluka for administrative and technical support and to Fredrick Chelewani and Michael Maunjiri for helping to coordinate fieldwork. We would also like to acknowledge the Centre for Reproductive Health at the College of Medicine, University of Malawi and thank staff for assistance with coordinating and implementing field work. Many thanks to the field workers who conducted the interviews and the participants for sharing their views.	Abdul-Rahman Lutuf, 2011, Afr J Reprod Health, V15, P45; African Union, 2006, PLAN ACT SEX REPR HL; Alli F, 2013, J COMMUN HEALTH, V38, P150, DOI 10.1007/s10900-012-9595-3; Amuyunzu-Nyamongo M., 2006, QUALITATIVE EVIDENCE; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Biddlecom Ann E, 2007, Afr J Reprod Health, V11, P99, DOI 10.2307/25549734; Blaauw D, 2010, B WORLD HEALTH ORGAN, V88, P350, DOI 10.2471/BLT.09.072918; ChoiceMetrics, 2011, NGEN 1 1 US MAN REF; ChoiceMetrics Pty Ltd, 2010, NGEN 1 1; de Bekker-Grob EW, 2012, HEALTH ECON, V21, P145, DOI 10.1002/hec.1697; Erulkar Annabel S, 2005, Afr J Reprod Health, V9, P51; Fiebig DG, 2011, HEALTH ECON, V20, P35, DOI 10.1002/hec.1686; Flaherty A, 2005, TROP DOCT, V35, P4, DOI 10.1258/0049475053001813; Frehiwot Berhane, 2005, Ethiopian Journal of Health Development, V19, P29; Hensher D., 2005, APPL CHOICE ANAL PRI, DOI 10.1017/CBO9780511610356; Kesterton AJ, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-25; Lagarde M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023588; Mathews C, 2009, J ADOLESCENT HEALTH, V44, P188, DOI 10.1016/j.jadohealth.2008.05.009; Michaels C, 2012, 19 INT AIDS C JUL 22; Michaels-Igbokwe C, 2013, HLTH EC STUD GROUP S; Michaels-Igbokwe C, 2015, HEALTH ECON REV, V5, DOI 10.1186/s13561-015-0046-6; Michaels-Igbokwe C, 2014, SOC SCI MED, V105, P93, DOI 10.1016/j.socscimed.2014.01.016; National Statistical Office, 2011, DHS MAL FIN REP 2010; Southern Africa HIV and AIDS Information Dissemination Service, SUCC STOR UN ACC COM; Speizer Ilene S, 2004, Afr J Reprod Health, V8, P38, DOI 10.2307/3583392; Speizer IS, 2003, J ADOLESCENT HLTH, V33; Tylee A, 2007, LANCET, V369, P1565, DOI 10.1016/S0140-6736(07)60371-7; United Nations Population Fund, 2012, STAT WORLD POP 2012; Wood K, 2006, REPROD HEALTH MATTER, V14, P109, DOI 10.1016/S0968-8080(06)27231-8; World Health Organization (WHO), 2011, WHO GUIDELINES ON PR; Zuurmond MA, 2012, STUD FAMILY PLANN, V43, P239, DOI 10.1111/j.1728-4465.2012.00324.x	31	21	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143287	10.1371/journal.pone.0143287	http://dx.doi.org/10.1371/journal.pone.0143287			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX8BI	26630492	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000365926300039
J	Wu, ML; Lan, SR; Cai, BP; Chen, SP; Chen, H; Zhou, SL				Wu, Miaoli; Lan, Siren; Cai, Bangping; Chen, Shipin; Chen, Hui; Zhou, Shiliang			The Complete Chloroplast Genome of Guadua angustifolia and Comparative Analyses of Neotropical-Paleotropical Bamboos	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; PLASTID GENOMES; GRASSES POACEAE; RELATIVE RATES; WOODY BAMBOOS; LIFE-HISTORY; EVOLUTION; BAMBUSOIDEAE; SEQUENCE; BIOGEOGRAPHY	To elucidate chloroplast genome evolution within neotropical-paleotropical bamboos, we fully characterized the chloroplast genome of the woody bamboo Guadua angustifolia. This genome is 135,331 bp long and comprises of an 82,839-bp large single-copy (LSC) region, a 12,898-bp small single-copy (SSC) region, and a pair of 19,797-bp inverted repeats (IRs). Comparative analyses revealed marked conservation of gene content and sequence evolutionary rates between neotropical and paleotropical woody bamboos. The neotropical herbaceous bamboo Cryptochloa strictiflora differs from woody bamboos in IR/SSC boundaries in that it exhibits slightly contracted IRs and a faster substitution rate. The G. angustifolia chloroplast genome is similar in size to that of neotropical herbaceous bamboos but is similar to 3 kb smaller than that of paleotropical woody bamboos. Dissimilarities in genome size are correlated with differences in the lengths of intergenic spacers, which are caused by large-fragment insertion and deletion. Phylogenomic analyses of 62 taxa yielded a tree topology identical to that found in preceding studies. Divergence time estimation suggested that most bamboo genera diverged after the Miocene and that speciation events of extant species occurred during or after the Pliocene.	[Wu, Miaoli; Lan, Siren; Chen, Shipin; Chen, Hui] Fujian Agr & Forestry Univ, Coll Forestry, Fuzhou 350002, Fujian, Peoples R China; [Cai, Bangping] Xiamen Bot Garden, Xiamen 361000, Fujian, Peoples R China; [Zhou, Shiliang] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing 100093, Peoples R China	Fujian Agriculture & Forestry University; Chinese Academy of Sciences; Institute of Botany, CAS	Chen, H (corresponding author), Fujian Agr & Forestry Univ, Coll Forestry, Fuzhou 350002, Fujian, Peoples R China.	zjchchenh@163.com; slzhou@ibcas.ac.cn			Forestry Discipline Construction Fund of Fujian Agriculture and Forestry University	Forestry Discipline Construction Fund of Fujian Agriculture and Forestry University	This work was supported by a grant from the Forestry Discipline Construction Fund of Fujian Agriculture and Forestry University.	Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bortiri Esteban, 2008, BMC Res Notes, V1, P61, DOI 10.1186/1756-0500-1-61; Bouchenak-Khelladi Y, 2008, MOL PHYLOGENET EVOL, V47, P488, DOI 10.1016/j.ympev.2008.01.035; Bouchenak-Khelladi Y, 2010, BOT J LINN SOC, V162, P543, DOI 10.1111/j.1095-8339.2010.01041.x; Brea M, 2007, ANN BOT-LONDON, V100, P711, DOI 10.1093/aob/mcm175; Bremer K, 2002, EVOLUTION, V56, P1374, DOI 10.1111/j.0014-3820.2002.tb01451.x; Bromham L, 2000, J MOL EVOL, V50, P296, DOI 10.1007/s002399910034; Burke SV, 2014, AM J BOT, V101, P886, DOI 10.3732/ajb.1400063; Burke SV, 2012, AM J BOT, V99, P1951, DOI 10.3732/ajb.1200365; Burleigh JG, 2011, SYST BIOL, V60, P117, DOI 10.1093/sysbio/syq072; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Chumley TW, 2006, MOL BIOL EVOL, V23, P2175, DOI 10.1093/molbev/msl089; Conant GC, 2008, BIOINFORMATICS, V24, P861, DOI 10.1093/bioinformatics/btm598; Das M, 2008, ADV BOT RES, V47, P225, DOI 10.1016/S0065-2296(08)00005-0; Davis JI, 2010, AM J BOT, V97, P874, DOI 10.3732/ajb.0900228; Delannoy E, 2011, MOL BIOL EVOL, V28, P2077, DOI 10.1093/molbev/msr028; Dong WP, 2013, GENOME BIOL EVOL, V5, P989, DOI 10.1093/gbe/evt063; Doyle J. J., 1987, PHYTOCHEM B, P11; DOYLE JJ, 1992, P NATL ACAD SCI USA, V89, P7722, DOI 10.1073/pnas.89.16.7722; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Gaut BS, 1997, MOL BIOL EVOL, V14, P769, DOI 10.1093/oxfordjournals.molbev.a025817; GAUT BS, 1993, MOL PHYLOGENET EVOL, V2, P89, DOI 10.1006/mpev.1993.1009; Gould SB, 2008, ANNU REV PLANT BIOL, V59, P491, DOI 10.1146/annurev.arplant.59.032607.092915; Guisinger MM, 2010, J MOL EVOL, V70, P149, DOI 10.1007/s00239-009-9317-3; Guisinger MM, 2008, P NATL ACAD SCI USA, V105, P18424, DOI 10.1073/pnas.0806759105; Jansen RK, 2012, GENOMICS CHLOROPLAST, P103, DOI [DOI 10.1007/978-94-007-2920-9_5, 10.1007/978-94-007-2920-9_5]; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Judziewicz EJ, 1999, AM BAMBOOS; Kelchner SA, 2013, MOL PHYLOGENET EVOL, V67, P404, DOI 10.1016/j.ympev.2013.02.005; Kumar S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-131; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Ma PF, 2015, SCI REP-UK, V5, DOI 10.1038/srep11608; Martin GE, 2014, ANN BOT-LONDON, V113, P1197, DOI 10.1093/aob/mcu050; McInerney JO, 2006, TRENDS ECOL EVOL, V21, P230, DOI 10.1016/j.tree.2006.03.008; Miller M.A., 2010, P GAT COMP ENV WORKS; MORTON BR, 1994, MOL BIOL EVOL, V11, P231; OHTA T, 1995, J MOL EVOL, V40, P56, DOI 10.1007/BF00166595; Olivier J, 2009, REV PALAEOBOT PALYNO, V153, P1, DOI 10.1016/j.revpalbo.2008.06.001; Parks M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-84; Posada D, 2005, MODELTEST 3 7; Rambaut A., 1996, SEQUENCE ALIGNMENT E; Raubeson LA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-174; Ruiz-Sanchez E, 2011, B SOC BOT MEX, V88, P67; Schelkunov MI, 2015, GENOME BIOL EVOL, V7, P1179, DOI 10.1093/gbe/evv019; Smith DR, 2014, NEW PHYTOL, V202, P736, DOI 10.1111/nph.12704; Smith SA, 2008, SCIENCE, V322, P86, DOI 10.1126/science.1163197; Smith SA, 2009, P ROY SOC B-BIOL SCI, V276, P4345, DOI 10.1098/rspb.2009.1176; SODERSTROM TR, 1979, BIOTROPICA, V11, P161, DOI 10.2307/2388036; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Sungkaew S, 2009, J PLANT RES, V122, P95, DOI 10.1007/s10265-008-0192-6; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang L, 2010, MOL PHYLOGENET EVOL, V54, P266, DOI 10.1016/j.ympev.2009.08.007; Triplett JK, 2014, NEW PHYTOL, V204, P66, DOI 10.1111/nph.12988; Vicentini A, 2008, GLOBAL CHANGE BIOL, V14, P2963, DOI 10.1111/j.1365-2486.2008.01688.x; Wang L, 2013, REV PALAEOBOT PALYNO, V197, P253, DOI 10.1016/j.revpalbo.2013.06.004; Wicke S, 2013, PLANT CELL, V25, P3711, DOI 10.1105/tpc.113.113373; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; Wickett NJ, 2011, AM J BOT, V98, P1263, DOI 10.3732/ajb.1100010; Wolf PG, 2010, GENOME, V53, P731, DOI [10.1139/G10-061, 10.1139/g10-061]; Worobiec E, 2009, REV PALAEOBOT PALYNO, V157, P211, DOI 10.1016/j.revpalbo.2009.05.002; Wu CS, 2014, PLANT BIOTECHNOL J, V12, P344, DOI 10.1111/pbi.12141; Wu CS, 2009, MOL PHYLOGENET EVOL, V52, P115, DOI 10.1016/j.ympev.2008.12.026; Wu FH, 2009, TREE PHYSIOL, V29, P847, DOI 10.1093/treephys/tpp015; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Wysocki WP, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0321-5; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yi X, 2013, GENOME BIOL EVOL, V5, P688, DOI 10.1093/gbe/evt042; Zhang YJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021342, 10.1371/journal.pone.0020596]	69	15	20	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143792	10.1371/journal.pone.0143792	http://dx.doi.org/10.1371/journal.pone.0143792			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630488	gold, Green Submitted, Green Published			2022-12-27	WOS:000365926300099
J	Zhu, XF; Sun, Q; Zou, HD; Xu, X; Zhang, X				Zhu, Xiaofeng; Sun, Qian; Zou, Haidong; Xu, Xun; Zhang, Xi			Disparities between Ophthalmologists and Patients in Estimating Quality of Life Associated with Diabetic Retinopathy	PLOS ONE			English	Article							VISION IMPAIRMENT QUESTIONNAIRE; TIME TRADE-OFF; UTILITY VALUES; IMPACT; EYE; PERCEPTIONS; PREVALENCE	Background This study aimed to evaluate and compare the utility values associated with diabetic retinopathy (DR) in a sample of Chinese patients and ophthalmologists. Methods Utility values were evaluated by both the time trade-off (TTO) and rating scale (RS) methods for 109 eligible patients with DR and 2 experienced ophthalmologists. Patients were stratified by Snellen best-corrected visual acuity (BCVA) in the better-seeing eye. The correlations between the utility values and general vision-related health status measures were analyzed. These utility values were compared with data from two other studies. Results The mean utility values elicited from the patients themselves with the TTO (0.81; SD 0.10) and RS (0.81; SD 0.11) methods were both statistically lower than the mean utility values assessed by ophthalmologists. Significant predictors of patients' TTO and RS utility values were both LogMAR BCVA in the affected eye and average weighted LogMAR BCVA. DR grade and duration of visual dysfunction were also variables that significantly predicted patients' TTO utility values. For ophthalmologists, patients' LogMAR BCVA in the affected eye and in the better eye were the variables that significantly predicted both the TTO and RS utility values. Patients' education level was also a variable that significantly predicted RS utility values. Moreover, both diabetic macular edema and employment status were significant predictors of TTO and RS utility values, whether from patients or ophthalmologists. There was no difference in mean TTO utility values compared to our American and Canadian patients. Conclusions DR caused a substantial decrease in Chinese patients' utility values, and ophthalmologists substantially underestimated its effect on patient quality of life.	[Zhu, Xiaofeng; Sun, Qian; Zou, Haidong; Xu, Xun; Zhang, Xi] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Ophthalmol, Shanghai, Peoples R China	Shanghai Jiao Tong University	Zou, HD (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Ophthalmol, Shanghai, Peoples R China.	zouhaidong@hotmail.com		Zou, Haidong/0000-0002-6831-7560	Shanghai Health Bureau; Hong Kong K.C. Wong Education foundation	Shanghai Health Bureau; Hong Kong K.C. Wong Education foundation	This study was supported by a grant from Shanghai Health Bureau and a grant from Hong Kong K.C. Wong Education foundation.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; BAKKER C, 1995, J RHEUMATOL, V22, P1197; Brose LS, 2010, VALUE HEALTH, V13, P119, DOI 10.1111/j.1524-4733.2009.00589.x; Brown G C, 2001, Trans Am Ophthalmol Soc, V99, P199; Brown GC, 2000, ARCH OPHTHALMOL-CHIC, V118, P47; Brown GC, 1998, INT OPHTHALMOL, V22, P307, DOI 10.1023/A:1006311910304; Brown GC, 2000, CAN J OPHTHALMOL, V35, P127, DOI 10.1016/S0008-4182(00)80005-8; Brown MM, 1999, AM J OPHTHALMOL, V128, P324, DOI 10.1016/S0002-9394(99)00146-4; Brown MM, 2004, BRIT J OPHTHALMOL, V88, P979, DOI 10.1136/bjo.2003.040030; Brown MM, 2003, OPHTHALMOLOGY, V110, P1076, DOI 10.1016/S0161-6420(03)00254-9; Brown MM, 2002, ARCH OPHTHALMOL-CHIC, V120, P481; Brown MM, 2001, BRIT J OPHTHALMOL, V85, P327, DOI 10.1136/bjo.85.3.327; Coyne KS, 2004, FAM PRACT, V21, P447, DOI 10.1093/fampra/cmh417; Cunningham SJ, 2000, EUR J ORTHODONT, V22, P335, DOI 10.1093/ejo/22.3.335; Eong KGA, 2012, EYE, V26, P379, DOI 10.1038/eye.2011.218; Fenwick EK, 2011, BRIT J OPHTHALMOL, V95, P774, DOI 10.1136/bjo.2010.191312; FROBERG DG, 1989, J CLIN EPIDEMIOL, V42, P459, DOI 10.1016/0895-4356(89)90136-4; Gonder JR, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/939315; HOLLADAY JT, 1991, AM J OPHTHALMOL, V111, P372, DOI 10.1016/S0002-9394(14)72328-1; Hollands H, 2001, CAN J OPHTHALMOL, V36, P202, DOI 10.1016/S0008-4182(01)80041-7; Keeffe JE, 1998, AUST NZ J OPHTHALMOL, V26, pS16, DOI 10.1111/j.1442-9071.1998.tb01360.x; Lamoureux EL, 2007, INVEST OPHTH VIS SCI, V48, P1001, DOI 10.1167/iovs.06-0361; Lamoureux EL, 2006, INVEST OPHTH VIS SCI, V47, P4732, DOI 10.1167/iovs.06-0220; Liem YS, 2008, VALUE HEALTH, V11, P733, DOI 10.1111/j.1524-4733.2007.00308.x; Mangione CM, 1998, ARCH OPHTHALMOL-CHIC, V116, P227; Mangione CM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1050, DOI 10.1001/archopht.119.7.1050; Peng JJ, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-250; Resnikoff S, 2002, B WORLD HEALTH ORGAN, V82, P844; Scanlon PH, 2006, DIABETIC MED, V23, P60, DOI 10.1111/j.1464-5491.2005.01736.x; Scott IU, 1998, OPHTHALMOLOGY, V105, P795, DOI 10.1016/S0161-6420(98)95017-5; Shah VA, 2004, OPHTHAL EPIDEMIOL, V11, P43, DOI 10.1076/opep.11.1.43.26436; Sharma S, 2003, BRIT J OPHTHALMOL, V87, P259, DOI 10.1136/bjo.87.3.259; Sharma S, 2002, BRIT J OPHTHALMOL, V86, P493, DOI 10.1136/bjo.86.5.493; Sharma S, 2001, CURR OPIN OPHTHALMOL, V12, P230, DOI 10.1097/00055735-200106000-00016; STEINBERG EP, 1994, ARCH OPHTHALMOL-CHIC, V112, P630, DOI 10.1001/archopht.1994.01090170074026; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; Tung TH, 2008, J EPIDEMIOL, V18, P225, DOI 10.2188/jea.JE2007439; Wang N, 2008, OPHTHALMOLOGICA, V222, P32, DOI 10.1159/000109276; Weih LM, 2002, INVEST OPHTH VIS SCI, V43, P927; Woodcock A, 2004, PATIENT EDUC COUNS, V53, P365, DOI 10.1016/j.pec.2003.10.007; Xie XW, 2008, GRAEF ARCH CLIN EXP, V246, P1519, DOI 10.1007/s00417-008-0884-6; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Zou HD, 2011, OPHTHALMOLOGY, V118, P601, DOI 10.1016/j.ophtha.2010.10.046	43	3	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143678	10.1371/journal.pone.0143678	http://dx.doi.org/10.1371/journal.pone.0143678			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630653	Green Submitted, Green Published, gold			2022-12-27	WOS:000365926300081
J	Huber, R; Panterodt, T; Welz, B; Christmann, M; Friesenhagen, J; Westphal, A; Pietsch, D; Brand, K				Huber, Rene; Panterodt, Thomas; Welz, Bastian; Christmann, Martin; Friesenhagen, Judith; Westphal, Andreas; Pietsch, Daniel; Brand, Korbinian			C/EBP beta-LAP*/LAP Expression Is Mediated by RSK/eIF4B-Dependent Signalling and Boosted by Increased Protein Stability in Models of Monocytic Differentiation	PLOS ONE			English	Article							TRANSLATION INITIATION; GENE-EXPRESSION; TRANSCRIPTION FACTORS; S6 PHOSPHORYLATION; CALPAIN SYSTEM; MESSENGER-RNAS; CELLS; PROTEASOME; ALPHA; CANCER	The transcription factor C/EBP beta plays a key role in monocytic differentiation and inflammation. Its small isoform LIP is associated with proliferation at early premonocytic developmental stages and regulated via mTOR-dependent signalling. During later stages of (pre) monocytic differentiation there is a considerable increase in the large C/EBP beta isoforms LAP*/LAP which inhibit proliferation thus supporting terminal differentiation. Here, we showed in different models of monocytic differentiation that this dramatic increase in the LAP*/LAP protein and LAP/LIP ratio was accompanied by an only modest/retarded mRNA increase suggesting an important role for (post) translational mechanisms. We found that LAP*/LAP formation was induced via MEK/RSK-dependent cascades, whereas mTOR/S6K1 were not involved. Remarkably, LAP*/LAP expression was dependent on phosphorylated eIF4B, an acceleratory protein of RNA helicase eIF4A. PKR inhibition reduced the expression of eIF4B and C/EBP beta in an eIF2 alpha-independent manner. Furthermore, under our conditions a marked stabilisation of LAP*/LAP protein occurred, accompanied by reduced chymotrypsin-like proteasome/calpain activities and increased calpastatin levels. Our study elucidates new signalling pathways inducing LAP*/LAP expression and indicates new alternative PKR functions in monocytes. The switch from mTOR- to RSK-mediated signalling to orchestrate eIF4B-dependent LAP*/LAP translation, accompanied by increased protein stability but only small mRNA changes, may be a prototypical example for the regulation of protein expression during selected processes of differentiation/proliferation.	[Huber, Rene; Panterodt, Thomas; Welz, Bastian; Christmann, Martin; Friesenhagen, Judith; Westphal, Andreas; Pietsch, Daniel; Brand, Korbinian] Hannover Med Sch, Inst Clin Chem, D-30625 Hannover, Germany	Hannover Medical School	Brand, K (corresponding author), Hannover Med Sch, Inst Clin Chem, D-30625 Hannover, Germany.	brand.korbinian@mh-hannover.de	Christmann, Martin/AFT-2159-2022	Christmann, Martin/0000-0003-2646-5538; Huber, Rene/0000-0002-1041-9935	German Research Foundation [SFB 566/B17]; Deutsche Vereinte Gesellschaft fur Klinische Chemie und Laboratoriumsmedizin (DGKL; Stiftung fur Pathobiochemie und Molekulare Diagnostik) [2012/14, 2014/15]	German Research Foundation(German Research Foundation (DFG)); Deutsche Vereinte Gesellschaft fur Klinische Chemie und Laboratoriumsmedizin (DGKL; Stiftung fur Pathobiochemie und Molekulare Diagnostik)	This work was supported by the German Research Foundation (grant SFB 566/B17 to KB; www.dfg.de) and the Deutsche Vereinte Gesellschaft fur Klinische Chemie und Laboratoriumsmedizin (DGKL; Stiftung fur Pathobiochemie und Molekulare Diagnostik; grant 2012/14 to KB and DP, grant 2014/15 to MC; www.dgkl.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken CE, 2012, NAT STRUCT MOL BIOL, V19, P568, DOI 10.1038/nsmb.2303; Ali A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3667; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Atwood AA, 2010, ONCOGENE, V29, P6004, DOI 10.1038/onc.2010.336; Baer M, 2000, J BIOL CHEM, V275, P26582, DOI 10.1074/jbc.M004268200; Bergalet J, 2011, MOL CANCER RES, V9, P485, DOI 10.1158/1541-7786.MCR-10-0351; BRAND K, 1993, J CLIN INVEST, V91, P2031, DOI 10.1172/JCI116425; Calkhoven CF, 2000, GENE DEV, V14, P1920; Chung SS, 2010, MOL CELL BIOL, V30, P2135, DOI 10.1128/MCB.00852-09; Csibi A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008994; Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6; Galicia-Vazquez G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087237; Gorgoni B, 2002, J IMMUNOL, V168, P4055, DOI 10.4049/jimmunol.168.8.4055; Grolleau A, 2000, J CLIN INVEST, V106, P1561, DOI 10.1172/JCI9352; Gunther J, 2014, J IMMUNOL, V192, P3143, DOI 10.4049/jimmunol.1301610; Gutsch R, 2011, J BIOL CHEM, V286, P22716, DOI 10.1074/jbc.M110.152538; Haas SC, 2010, BRIT J HAEMATOL, V148, P777, DOI 10.1111/j.1365-2141.2009.08012.x; Hagner PR, 2011, ONCOGENE, V30, P1531, DOI 10.1038/onc.2010.533; Hattori T, 2003, ONCOGENE, V22, P1273, DOI 10.1038/sj.onc.1206204; Huber R, 2012, CELL SIGNAL, V24, P1287, DOI 10.1016/j.cellsig.2012.02.007; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Kish-Trier E, 2013, ANNU REV BIOPHYS, V42, P29, DOI 10.1146/annurev-biophys-083012-130417; Konstantinova IM, 2008, INT REV CEL MOL BIO, V267, P59, DOI 10.1016/S1937-6448(08)00602-3; Kuang PP, 2005, AM J PHYSIOL-CELL PH, V289, pC766, DOI 10.1152/ajpcell.00525.2004; Kunjappu MJ, 2014, BBA-MOL CELL RES, V1843, P2, DOI 10.1016/j.bbamcr.2013.03.008; Lechner S, 2013, DIFFERENTIATION, V85, P20, DOI 10.1016/j.diff.2012.11.001; Li XR, 2009, J MOL BIOL, V391, P729, DOI 10.1016/j.jmb.2009.06.055; Li Y, 2008, J BIOL CHEM, V283, P22443, DOI 10.1074/jbc.M801046200; Liu Y, 2013, MOL CELL BIOL, V33, P4606, DOI 10.1128/MCB.00723-13; Liu YC, 2004, ANNU REV IMMUNOL, V22, P81, DOI 10.1146/annurev.immunol.22.012703.104813; Parsyan A, 2011, NAT REV MOL CELL BIO, V12, P235, DOI 10.1038/nrm3083; Pham TH, 2007, J BIOL CHEM, V282, P21924, DOI 10.1074/jbc.M611618200; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Rodrigo-Brenni MC, 2012, DEV CELL, V23, P896, DOI 10.1016/j.devcel.2012.10.012; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Ruvinsky I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005618; Santos DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033468; SEARS RC, 1994, MOL CELL BIOL, V14, P4855, DOI 10.1128/MCB.14.7.4855; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Stirewalt DL, 2003, NAT REV CANCER, V3, P650, DOI 10.1038/nrc1169; Storr SJ, 2011, NAT REV CANCER, V11, P364, DOI 10.1038/nrc3050; Taylor SS, 2005, CELL, V122, P823, DOI 10.1016/j.cell.2005.09.007; Timchenko LT, 2002, MOL CELL BIOL, V22, P7242, DOI 10.1128/MCB.22.20.7242-7257.2002; Timchenko NA, 2005, J BIOL CHEM, V280, P20549, DOI 10.1074/jbc.M409563200; Um JW, 2010, J BIOL CHEM, V285, P36434, DOI 10.1074/jbc.M110.133777; Wang XN, 2006, J CELL PHYSIOL, V209, P253, DOI 10.1002/jcp.20731; Wei W, 2006, J CELL PHYSIOL, V208, P386, DOI 10.1002/jcp.20684; Welm AL, 1999, MOL CELL BIOL, V19, P1695; Wethmar K, 2010, BIOESSAYS, V32, P885, DOI 10.1002/bies.201000037; Yajima Y, 2002, BIOL CHEM, V383, P757, DOI 10.1515/BC.2002.079; Yajima Y, 2006, ENDOCRINOLOGY, V147, P4811, DOI 10.1210/en.2005-1647; Zhang YY, 2012, BIOCHEM BIOPH RES CO, V419, P550, DOI 10.1016/j.bbrc.2012.02.058; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025; Zwergal A, 2006, J IMMUNOL, V177, P665, DOI 10.4049/jimmunol.177.1.665	55	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0144338	10.1371/journal.pone.0144338	http://dx.doi.org/10.1371/journal.pone.0144338			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YV	26646662	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903100019
J	Liu, YM; Li, Y; Bin Wei, W; Xu, XL; Jonas, JB				Liu, Yue Ming; Li, Yang; Bin Wei, Wen; Xu, Xiaolin; Jonas, Jost B.			Clinical Characteristics of 582 Patients with Uveal Melanoma in China	PLOS ONE			English	Article							YOUNG-PATIENTS; RISK-FACTORS; CELL-TYPE; SURVIVAL; PROGNOSIS; MELANOGENESIS; METASTASIS; RADIATION; EUROPE; SIZE	Objective To assess clinical characteristics, treatment and survival of patients with uveal melanoma in China. Methods The retrospective study included all patients with malignant uveal melanoma who were consecutively examined in the study period from January 2005 and June 2015 in the Beijing Tongren hospital. Results The mean age of the 582 patients (295(50.7%) women) was 44.6 +/- 12.6 years (range: 5-77 years). The tumors were located most often in the superior temporal region (in 117(21.5%) patients) and least common in the inferior region (in 31(5.7%) patients). In 548(94.2%) patients, the tumors were located in the choroid, in 33(5.7%) patients in the ciliary body, and in one (0.2%) patient in the iris. Treatment included episcleral brachytherapy (415(71.3%) patients), local tumor resection (48(8.2%) patients) and primary enucleation (119(20.4%) patients). In 53 individuals out of the 415 patients with primary brachytherapy, episcleral brachytherapy was followed by enucleation, due to an increasing tumor size or due to uncontrolled neovascular glaucoma. Median follow-up time was of 30 months (range: 1-124 months; mean: 34.8 +/- 24.4 months). Overall survival rate at 5 and 10 years was of 92.7% and 85.1%. Younger age (P = 0.017), tumor location in the nasal meridian(P = 0.004), smaller tumor size (P<0.001), hemispheric tumor shape (P = 0.025), histological tumor cell type (spindle-cell type versus epitheloid cell type;P = 0.014), and type of treatment (episcleral brachytherapy versus local tumor resection and versus primary enucleation; P<0.001) were significantly associated with the overall survival in univariate analysis, while in multivariate analysis only smaller tumor size was significantly (P<0.001; RR: 4.75; 95% confidence interval: 2.11,10.7) associated with better overall survival. Conclusions In this study on clinical characteristics of uveal melanoma of a larger group of patients from China, the onset age was considerably younger and survival rate better than in studies from Western countries. Tumor size was the most significant factor for survival.	[Liu, Yue Ming; Li, Yang; Bin Wei, Wen] Capital Med Univ, Beijing Ophthalmol & Visual Sci Key Lab, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing, Peoples R China; [Xu, Xiaolin; Jonas, Jost B.] Capital Med Univ, Beijing Ophthalmol & Visual Sci Key Lab, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Heidelberg, Germany	Capital Medical University; Capital Medical University; Ruprecht Karls University Heidelberg	Bin Wei, W (corresponding author), Capital Med Univ, Beijing Ophthalmol & Visual Sci Key Lab, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing, Peoples R China.	weiwenbintr@163.com			Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support [ZYLX201307]; National Natural Science Foundation of China [81272981]; Beijing Natural Science Foundation [7151003, 7112031]; Advanced Health Care Professionals Development Project of Beijing Municipal Health Bureau [2014-2-003]	Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Advanced Health Care Professionals Development Project of Beijing Municipal Health Bureau	Supported by Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support, code: ZYLX201307; National Natural Science Foundation of China, NO. 81272981; Beijing Natural Science Foundation, NO. 7151003, 7112031; Advanced Health Care Professionals Development Project of Beijing Municipal Health Bureau (No. 2014-2-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert DM, 1998, AM J OPHTHALMOL, V125, P779; Apt L, 1962, INT OPHTHALMOL CLIN, V2, P403, DOI DOI 10.1097/00004397-196206000-00008; BARR CC, 1981, ARCH OPHTHALMOL-CHIC, V99, P2133; Bergman L, 2003, INVEST OPHTH VIS SCI, V44, P3282, DOI 10.1167/iovs.03-0081; Biswas Jyotirmay, 2004, Indian Journal of Ophthalmology, V52, P41; Brozyna AA, 2008, INT J CANCER, V123, P1448, DOI 10.1002/ijc.23664; Brozyna AA, 2013, HUM PATHOL, V44, P2071, DOI 10.1016/j.humpath.2013.02.022; Burr JM, 2007, OPHTHAL EPIDEMIOL, V14, P3, DOI 10.1080/09286580600977281; Callender G., 1931, T AM ACAD OPHTHALMOL, V36, P131; Collaborative Ocular Melanoma Grp, 2006, ARCH OPHTHALMOL-CHIC, V124, P1684; Collaborative Ocular Melanoma Study (COMS), 1995, GROUP COMS MAN PROC; Coupland SE, 2008, OPHTHALMOLOGY, V115, P1778, DOI 10.1016/j.ophtha.2008.04.025; Damato B, OPHTHALMOLOGY, V114, P1925; Ewens KG, 2014, INVEST OPHTH VIS SCI, V55, P5160, DOI 10.1167/iovs.14-14550; Frenkel S, 2009, ISR MED ASSOC J, V11, P280; Gill HS, 2012, CAN J OPHTHALMOL, V47, P246, DOI 10.1016/j.jcjo.2012.03.038; Graell X., 2007, Arch Soc Esp Oftalmol, V82, P343; Hawkins BS, 2004, AM J OPHTHALMOL, V138, P936, DOI DOI 10.1016/J.AJ0.2004.07.006; Kaliki S, 2013, EUR J OPHTHALMOL, V23, P208, DOI 10.5301/ejo.5000200; Kujala E, 2003, INVEST OPHTH VIS SCI, V44, P4651, DOI 10.1167/iovs.03-0538; Lake SL, 2013, AM J PATHOL, V182, P678, DOI 10.1016/j.ajpath.2012.11.036; MCLEAN IW, 1982, HUM PATHOL, V13, P123; MCLEAN IW, 1983, AM J OPHTHALMOL, V96, P502, DOI 10.1016/S0002-9394(14)77914-0; Paul EV, 1962, INT OPHTHALMOL CLIN, V2, P387, DOI [10.1097/00004397-196206000-00007, DOI 10.1097/00004397-196206000-00007]; Pogrzebielski A, 2006, GRAEF ARCH CLIN EXP, V244, P1646, DOI 10.1007/s00417-006-0347-x; Rietschel P, 2005, J CLIN ONCOL, V23, P8076, DOI 10.1200/JCO.2005.02.6534; Schoenfield L, 2014, ADV ANAT PATHOL, V21, P138, DOI 10.1097/PAP.0000000000000010; SEDDON JM, 1987, ARCH OPHTHALMOL-CHIC, V105, P801, DOI 10.1001/archopht.1987.01060060087039; Shields CL, 2015, EYE, V29, P1027, DOI 10.1038/eye.2015.51; Shields CL, 2012, RETINA-J RET VIT DIS, V32, P1363, DOI 10.1097/IAE.0b013e31824d09a8; Shields CL, 2011, OPHTHALMOLOGY, V118, P396, DOI 10.1016/j.ophtha.2010.05.023; Shields CL, 2009, ARCH OPHTHALMOL-CHIC, V127, P989, DOI 10.1001/archophthalmol.2009.208; Singh AD, 2003, OPHTHALMOLOGY, V110, P962, DOI 10.1016/S0161-6420(03)00077-0; Singh AD, 2011, OPHTHALMOLOGY, V118, P1881, DOI 10.1016/j.ophtha.2011.01.040; Slominski A, 2009, INT J CANCER, V124, P1470, DOI 10.1002/ijc.24005; Vicente N, 2013, Arch Soc Esp Oftalmol, V88, P433, DOI 10.1016/j.oftal.2013.06.003; Virgili G, 2008, ARCH OPHTHALMOL-CHIC, V126, P1413, DOI 10.1001/archopht.126.10.1413; Virgili G, 2007, OPHTHALMOLOGY, V114, P2309, DOI 10.1016/j.ophtha.2007.01.032; Zloto O, 2013, INVEST OPHTH VIS SCI, V54, P652, DOI 10.1167/iovs.12-10365	39	14	20	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0144562	10.1371/journal.pone.0144562	http://dx.doi.org/10.1371/journal.pone.0144562			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YV	26645696	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903100028
J	Rohani, M; Noohi, N; Talebi, M; Katouli, M; Pourshafie, MR				Rohani, Mahdi; Noohi, Nasrin; Talebi, Malihe; Katouli, Mohammad; Pourshafie, Mohammad R.			Highly Heterogeneous Probiotic Lactobacillus Species in Healthy Iranians with Low Functional Activities	PLOS ONE			English	Article							GUT MICROBIOTA; STRAINS; IDENTIFICATION; RESISTANCE; BACTERIA; COLITIS; DNA	Background Lactic acid bacteria (LAB) have been considered as potentially probiotic organisms due to their potential human health properties. This study aimed to evaluate both in vitro and in vivo, the potential probiotic properties of Lactobacillus species isolated from fecal samples of healthy humans in Iran. Methods and Results A total of 470 LAB were initially isolated from 53 healthy individual and characterized to species level. Of these, 88 (86%) were Lactobacillus species. Biochemical and genetic fingerprinting with Phene-Plate system (PhP-LB) and RAPD-PCR showed that the isolates were highly diverse consisted of 67(76.1%) and 75 (85.2%) single types (STs) and a diversity indices of 0.994 and 0.997, respectively. These strains were tested for production of adhesion to Caco-2 cells, antibacterial activity, production of B12, anti-proliferative effect and interleukin-8 induction on gut epithelial cell lines and antibiotic resistance against 9 commonly used antibiotics. Strains showing the characteristics consistent with probiotic strains, were further tested for their anti-inflammatory effect in mouse colitis model. Only one L. brevis; one L. rhamnosus and two L. plantarum were shown to have significant probiotic properties. These strains showed shortening the length of colon compared to dextran sulfate sodium and disease activity index (DAI) was also significantly reduced in mouse. Conclusion Low number of LAB with potential probiotic activity as well as high diversity of lactobacilli species was evident in Iranian population. It also suggest that specific strains of L. plantarum, L. brevis and L. rhamnosus with anti-inflammatory effect in mouse model of colitis could be used as a potential probiotic candidate in inflammatory bowel disease to decrease the disease activity index.	[Rohani, Mahdi; Noohi, Nasrin; Pourshafie, Mohammad R.] Pasteur Inst Iran, Dept Microbiol, Tehran, Iran; [Talebi, Malihe] Iran Univ Med Sci, Dept Microbiol, Sch Med, Tehran, Iran; [Katouli, Mohammad] Univ Sunshine Coast, Genecol Res Ctr, Fac Sci Hlth Educ & Engn, Maroochydore, Qld, Australia	Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Iran University of Medical Sciences; University of the Sunshine Coast	Pourshafie, MR (corresponding author), Pasteur Inst Iran, Dept Microbiol, Tehran, Iran.	pour@pasteur.ac.ir	Rohani, Mahdi/ABG-3890-2021; Rohani, Mahdi/K-9489-2017; Pourshafie, Mohammad R/GQH-4798-2022	Rohani, Mahdi/0000-0001-8956-5072; Rohani, Mahdi/0000-0001-8956-5072; 	research committee of the Pasteur Institute of Iran [B8802]; Iran National Science Foundation [90007454]	research committee of the Pasteur Institute of Iran; Iran National Science Foundation(Iran National Science Foundation (INSF))	This work was supported by the research committee of the Pasteur Institute of Iran (PhD. Grant no.: B8802) and, in part, by a grant (No. 90007454) from Iran National Science Foundation.; Our special thanks go to the research committee of the Pasteur Institute of Iran (PhD. Grant no.: B8802) for the financial assistance and in part by a grant (No. 90007454) from Iran National Science Foundation.	Aquilina G, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2740; Benson J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057998; Cano Roca CL, 2014, THESIS; Cary VA, 2010, J CLIN NURS, V19, P904, DOI 10.1111/j.1365-2702.2009.03123.x; Castillo NA, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-177; Clinical and Laboratory Standards Institute, 2009, M100S19 CLSI; Davoodabadi A, 2015, JUNDISHAPUR J MICROB, V8, DOI 10.5812/jjm.22295; Davoodabadi A, 2015, ANAEROBE, V34, P53, DOI 10.1016/j.anaerobe.2015.04.014; Dixit G., 2013, EURASIA J BIOSCI, DOI [DOI 10.5053/ejobios.2013.7.0.1, 10.5053/ejobios.2013.7.0.1]; Fernandez MF, 2003, J APPL MICROBIOL, V94, P449, DOI 10.1046/j.1365-2672.2003.01850.x; Gareau MG, 2010, NAT REV GASTRO HEPAT, V7, P503, DOI 10.1038/nrgastro.2010.117; Grimoud J, 2010, INT J FOOD MICROBIOL, V144, P42, DOI 10.1016/j.ijfoodmicro.2010.09.007; Haghi F, 2014, J MED MICROBIOL, V63, P427, DOI 10.1099/jmm.0.064600-0; Hamamoto N, 1999, CLIN EXP IMMUNOL, V117, P462; Hemarajata P, 2013, THER ADV GASTROENTER, V6, P39, DOI 10.1177/1756283X12459294; Jacobsen CN, 1999, APPL ENVIRON MICROB, V65, P4949; Kim JJ, 2012, JOVE-J VIS EXP, DOI 10.3791/3678; Klare I, 2007, J ANTIMICROB CHEMOTH, V59, P900, DOI 10.1093/jac/dkm035; Kwon HS, 2004, FEMS MICROBIOL LETT, V239, P267, DOI 10.1016/j.femsle.2004.08.049; Lee B, 2009, J MICROBIOL BIOTECHN, V19, P616, DOI 10.4014/jmb.0808.479; Lee DK, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-310; Lee HS, 2009, INFLAMMATION, V32, P27, DOI 10.1007/s10753-008-9099-6; Lievin-Le Moal V, 2014, CLIN MICROBIOL REV, V27, P167, DOI 10.1128/CMR.00080-13; McLean E, 2008, FOOD NUTR BULL, V29, pS38, DOI 10.1177/15648265080292S107; McOrist AL, 2002, J MICROBIOL METH, V50, P131, DOI 10.1016/S0167-7012(02)00018-0; Reid G, 1999, APPL ENVIRON MICROB, V65, P3763; Shahrokhi N, 2011, J INFECT DEV COUNTR, V5, P248; Shanahan F, 2004, INFLAMM BOWEL DIS, V10, pS16, DOI 10.1097/00054725-200402001-00004; Shen XJ, 2010, GUT MICROBES, V1, P138, DOI 10.4161/gmic.1.3.12360; Sobhani I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016393; Tharmaraj N., 2009, International Food Research Journal, V16, P261; Tilsala-Timisjarvi A, 1998, APPL ENVIRON MICROB, V64, P4816; Tuomola E, 2001, AM J CLIN NUTR, V73, p393S, DOI 10.1093/ajcn/73.2.393s; Veerappan Ganesh R, 2012, Curr Gastroenterol Rep, V14, P324, DOI 10.1007/s11894-012-0265-5	34	30	30	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0144467	10.1371/journal.pone.0144467	http://dx.doi.org/10.1371/journal.pone.0144467			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YV	26645292	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903100025
J	Wobus, C; Prucha, R; Albert, D; Woll, C; Loinaz, M; Jones, R				Wobus, Cameron; Prucha, Robert; Albert, David; Woll, Christine; Loinaz, Maria; Jones, Russell			Hydrologic Alterations from Climate Change Inform Assessment of Ecological Risk to Pacific Salmon in Bristol Bay, Alaska	PLOS ONE			English	Article							SOCKEYE-SALMON; CHINOOK SALMON; CHUM SALMON; TEMPERATURE; COHO; COLUMBIA; IMPACTS; FLOW; MAGNITUDE; MIGRATION	We developed an integrated hydrologic model of the upper Nushagak and Kvichak watersheds in the Bristol Bay region of southwestern Alaska, a region under substantial development pressure from large-scale copper mining. We incorporated climate change scenarios into this model to evaluate how hydrologic regimes and stream temperatures might change in a future climate, and to summarize indicators of hydrologic alteration that are relevant to salmon habitat ecology and life history. Model simulations project substantial changes in mean winter flow, peak flow dates, and water temperature by 2100. In particular, we find that annual hydrographs will no longer be dominated by a single spring thaw event, but will instead be characterized by numerous high flow events throughout the winter. Stream temperatures increase in all future scenarios, although these temperature increases are moderated relative to air temperatures by cool baseflow inputs during the summer months. Projected changes to flow and stream temperature could influence salmon through alterations in the suitability of spawning gravels, changes in the duration of incubation, increased growth during juvenile stages, and increased exposure to chronic and acute temperature stress. These climate-modulated changes represent a shifting baseline in salmon habitat quality and quantity in the future, and an important consideration to adequately assess the types and magnitude of risks associated with proposed large-scale mining in the region.	[Wobus, Cameron; Jones, Russell] Abt Associates Inc, Boulder, CO 80302 USA; [Prucha, Robert] Integrated Hydro Syst, Golden, CO USA; [Albert, David; Woll, Christine] Nature Conservancy, Juneau, AK USA; [Loinaz, Maria] ADA Engn Inc, Tampa, FL USA	ABT Associates; Nature Conservancy	Wobus, C (corresponding author), Abt Associates Inc, Boulder, CO 80302 USA.	cwobus@stratusconsulting.com	Wöll, Christof/D-5563-2011	Wöll, Christof/0000-0003-1078-3304; Wobus, Cameron/0000-0002-9654-1738	Moore Foundation; Abt Associates; Integrated Hydro Systems; A.D.A. Engineering, Inc.	Moore Foundation(Gordon and Betty Moore Foundation); Abt Associates; Integrated Hydro Systems; A.D.A. Engineering, Inc.	This work was funded by a grant from the Moore Foundation to The Nature Conservancy, through an award to CW at Abt Associates. Abt Associates, Integrated Hydro Systems and A.D.A. Engineering, Inc., provided support in the form of salaries for authors CW, RJ, RP, and ML but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alaska Department of Fish and Game, 2014, AN WAT CAT; Alaska Department of Natural Resources, 2013, INT ACC STAET AL LAN; Armstrong JB, 2013, ECOSYSTEMS, V16, P1429, DOI 10.1007/s10021-013-9693-9; Beechie T, 2013, RIVER RES APPL, V29, P939, DOI 10.1002/rra.2590; Bukovsky MS, 2007, J HYDROMETEOROL, V8, P837, DOI 10.1175/JHM595.1; Chen YD, 1998, J ENVIRON ENG, V124, P304, DOI 10.1061/(ASCE)0733-9372(1998)124:4(304); Dittmer K, 2013, CLIMATIC CHANGE, V120, P627, DOI 10.1007/s10584-013-0745-0; Ghaffari H, 2011, 1056140100REPR000100; Goniea TM, 2006, T AM FISH SOC, V135, P408, DOI 10.1577/T04-113.1; Goode JR, 2013, HYDROL PROCESS, V27, P750, DOI 10.1002/hyp.9728; Graham DN, 2006, WATERSHED MODELS, P245; Hill M.C., 1998, METHODS GUIDELINES E, DOI DOI 10.1061/40517(2000)18; HOLTBY LB, 1988, CAN J FISH AQUAT SCI, V45, P502, DOI 10.1139/f88-060; Homer C, 2004, PHOTOGRAMM ENG REM S, V70, P829, DOI 10.14358/PERS.70.7.829; Jeffries KM, 2014, EVOL APPL, V7, P286, DOI 10.1111/eva.12119; Keefer ML, 2008, T AM FISH SOC, V137, P1120, DOI 10.1577/T07-008.1; Knight Piesold & Co. and HDR Alaska, 2008, PREP ENV SOC DAT REP; Kurylyk BL, 2014, WATER RESOUR RES, V50, P3253, DOI 10.1002/2013WR014588; Leppi JC, 2014, GLOBAL CHANGE BIOL, V20, P1808, DOI 10.1111/gcb.12492; Loinaz MC, 2013, J HYDROL, V495, P238, DOI 10.1016/j.jhydrol.2013.04.039; Manciocco A, 2014, CHEMOSPHERE, V100, P1, DOI 10.1016/j.chemosphere.2013.12.072; Mantua N, 2010, CLIMATIC CHANGE, V102, P187, DOI 10.1007/s10584-010-9845-2; Martins EG, 2012, REV FISH BIOL FISHER, V22, P887, DOI 10.1007/s11160-012-9271-9; Mesinger F, 2006, B AM METEOROL SOC, V87, P343, DOI 10.1175/BAMS-87-3-343; Montgomery DR, 1996, CAN J FISH AQUAT SCI, V53, P1061, DOI 10.1139/cjfas-53-5-1061; Moss Richard, 2008, NEW SCENARIOS ANAL E; Munoz NJ, 2015, NAT CLIM CHANGE, V5, P163, DOI 10.1038/NCLIMATE2473; Natural Resources Conservation Service, 2011, DIG GEN SOIL MAP US; Nislow KH, 2012, FISHERIES MANAG ECOL, V19, P451, DOI 10.1111/j.1365-2400.2011.00810.x; Perschbacher PW, 2005, AQUACULTURE, V243, P225, DOI 10.1016/j.aquaculture.2004.10.006; Piper R.G., 1982, FISH HATCHERY MANAGE, V1st ed.; Quinn Thomas P., 2005, P1; Richter A, 2005, REV FISH SCI, V13, P23, DOI 10.1080/10641260590885861; Richter BD, 1996, CONSERV BIOL, V10, P1163, DOI 10.1046/j.1523-1739.1996.10041163.x; Ruggerone GT, 2010, MAR COAST FISH, V2, P306, DOI 10.1577/C09-054.1; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Schlumberger Water Services, 2011, PEBBL PROJ ENV BAS D; Serreze MC, 2011, GLOBAL PLANET CHANGE, V77, P85, DOI 10.1016/j.gloplacha.2011.03.004; Shanley CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104799; U.S. EPA, 2014, ASS POT MIN IMP SALM; Walsh JE, 2008, J CLIMATE, V21, P6156, DOI 10.1175/2008JCLI2163.1; Wobus C, 2012, REVIEW IN PRESS	42	13	13	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0143905	10.1371/journal.pone.0143905	http://dx.doi.org/10.1371/journal.pone.0143905			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YV	26645380	gold, Green Published, Green Submitted			2022-12-27	WOS:000366903100010
J	Li, LL; Wang, J; Xu, GH; Li, M; Xie, J				Li, Lili; Wang, Jing; Xu, Guanghua; Li, Min; Xie, Jun			The Study of Object-Oriented Motor Imagery Based on EEG Suppression	PLOS ONE			English	Article							GRANGER CAUSALITY; EFFECTIVE CONNECTIVITY; PHYSICAL PRACTICE; FUNCTIONAL MRI; MU-RHYTHM; PERFORMANCE; MOVEMENT; AREAS; SYNCHRONIZATION; TOOLBOX	Motor imagery is a conventional method for brain computer interface and motor learning. To avoid the great individual difference of the motor imagery ability, object-oriented motor imagery was applied, and the effects were studied. Kinesthetic motor imagery and visual observation were administered to 15 healthy volunteers. The EEG during cue-based simple imagery (SI), object-oriented motor imagery (OI), non-object-oriented motor imagery (NI) and visual observation (VO) was recorded. Study results showed that OI and NI presented significant contralateral suppression in mu rhythm (p < 0.05). Besides, OI exhibited significant contralateral suppression in beta rhythm (p < 0.05). While no significant mu or beta contralateral suppression could be found during VO or SI (p > 0.05). Compared with NI, OI showed significant difference (p < 0.05) in mu rhythm and weak significant difference (p = 0.0612) in beta rhythm over the contralateral hemisphere. The ability of motor imagery can be reflected by the suppression degree of mu and beta frequencies which are the motor related rhythms. Thus, greater enhancement of activation in mirror neuron system is involved in response to object-oriented motor imagery. The object-oriented motor imagery is favorable for improvement of motor imagery ability.	[Li, Lili; Wang, Jing; Xu, Guanghua; Li, Min; Xie, Jun] Xi An Jiao Tong Univ, Sch Mech Engn, Xian, Shaanxi, Peoples R China; [Xu, Guanghua] Xi An Jiao Tong Univ, State Key Lab Mfg Syst Engn, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Xu, GH (corresponding author), Xi An Jiao Tong Univ, Sch Mech Engn, Xian, Shaanxi, Peoples R China.	ghxu@mail.xjtu.edu.cn	Li, Min/W-2652-2017	Li, Min/0000-0002-2959-9147	National Natural Science Foundation of China [51175412]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/ approval no. : 51175412). The funder played a role in study design and decision to publish.	Allami N, 2008, EXP BRAIN RES, V184, P105, DOI 10.1007/s00221-007-1086-x; Allami N, 2014, NEUROPSYCHOLOGIA, V55, P6, DOI 10.1016/j.neuropsychologia.2013.12.017; Babiloni C, 2003, HUM BRAIN MAPP, V20, P148, DOI 10.1002/hbm.10135; Battaglia C, 2014, HUM MOVEMENT SCI, V38, P225, DOI 10.1016/j.humov.2014.10.001; Bhattacharyya S, 2014, MED BIOL ENG COMPUT, V52, P1007, DOI 10.1007/s11517-014-1204-4; Boord P, 2010, MED BIOL ENG COMPUT, V48, P343, DOI 10.1007/s11517-010-0579-0; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Callow N, 2013, FRONT HUM NEUROSCI, V7; Chen HF, 2009, NEUROIMAGE, V47, P1844, DOI 10.1016/j.neuroimage.2009.06.026; Chiviacowsky S, 2013, J INTELL DISABIL RES, V57, P627, DOI 10.1111/j.1365-2788.2012.01569.x; Cui RQ, 2000, EXP BRAIN RES, V134, P49, DOI 10.1007/s002210000449; Di Rienzo F, 2015, EXP BRAIN RES, V233, P291, DOI 10.1007/s00221-014-4114-7; Gao Q, 2011, NEUROIMAGE, V54, P1280, DOI 10.1016/j.neuroimage.2010.08.071; Guye M, 2003, NEUROIMAGE, V19, P1349, DOI 10.1016/S1053-8119(03)00165-4; Iacoboni M, 2009, ANNU REV PSYCHOL, V60, P653, DOI 10.1146/annurev.psych.60.110707.163604; Jurcak V, 2007, NEUROIMAGE, V34, P1600, DOI 10.1016/j.neuroimage.2006.09.024; Li LL, 2013, J VIBROENG, V15, P961; Miller LE, 2013, COGNITION, V128, P140, DOI 10.1016/j.cognition.2013.03.013; Muthukumaraswamy SD, 2004, COGNITIVE BRAIN RES, V19, P195, DOI 10.1016/j.cogbrainres.2003.12.001; Nedungadi AG, 2009, J COMPUT NEUROSCI, V27, P55, DOI 10.1007/s10827-008-0126-2; Neuper C, 2001, CLIN NEUROPHYSIOL, V112, P2084, DOI 10.1016/S1388-2457(01)00661-7; Park CH, 2015, NEUROREHAB NEURAL RE, V29, P247, DOI 10.1177/1545968314543308; Park H, 2013, PLOS ONE, V8; Perry A, 2011, NEUROIMAGE, V58, P895, DOI 10.1016/j.neuroimage.2011.06.060; Pfurtscheller G, 2000, CLIN NEUROPHYSIOL, V111, P1873, DOI 10.1016/S1388-2457(00)00428-4; PFURTSCHELLER G, 1994, NEUROSCI LETT, V174, P93, DOI 10.1016/0304-3940(94)90127-9; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pfurtscheller G, 1997, NEUROSCI LETT, V239, P65, DOI 10.1016/S0304-3940(97)00889-6; Qin Y, 2010, CLIN NEUROPHYSIOL, V121, P1981, DOI 10.1016/j.clinph.2010.03.056; Seth AK, 2010, J NEUROSCI METH, V186, P262, DOI 10.1016/j.jneumeth.2009.11.020; Sharma N, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00564; Shi TW, 2015, EXPERT SYST APPL, V42, P4196, DOI 10.1016/j.eswa.2015.01.031; Shtyrov Y, 2004, EUR J NEUROSCI, V19, P1083, DOI 10.1111/j.0953-816X.2004.03126.x; Tamura Y, 2005, EUR J NEUROSCI, V21, P2555, DOI 10.1111/j.1460-9568.2005.04096.x; Vuckovic A, 2013, CLIN NEUROPHYSIOL, V124, P1586, DOI 10.1016/j.clinph.2013.02.016; Wang Z, 2014, NEUROSCIENCE, V275, P102, DOI 10.1016/j.neuroscience.2014.06.004; Yao DZ, 2001, PHYSIOL MEAS, V22, P693, DOI 10.1088/0967-3334/22/4/305; Zangrando F, 2015, CASE REP MED, V2015, DOI 10.1155/2015/670385	38	16	18	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144256	10.1371/journal.pone.0144256	http://dx.doi.org/10.1371/journal.pone.0144256			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641241	Green Published, gold, Green Submitted			2022-12-27	WOS:000366902700085
J	Ma, L; Zhu, FG; Li, ZW; Zhang, JF; Li, X; Dong, JL; Wang, T				Ma, Lei; Zhu, Fugui; Li, Zhenwei; Zhang, Jianfu; Li, Xin; Dong, Jiangli; Wang, Tao			TALEN-Based Mutagenesis of Lipoxygenase LOX3 Enhances the Storage Tolerance of Rice (Oryza sativa) Seeds	PLOS ONE			English	Article							GENE; LONGEVITY; SYSTEM; ARABIDOPSIS; GERMINATION; RESISTANCE; VIABILITY; QUALITY; ACID; NUCLEASES	The deterioration of rice grain reduces the quality of rice, resulting in serious economic losses for farmers. Lipoxygenases (LOXs) catalyze the dioxygenation of polyunsaturated fatty acids with at least one cis, cis-1,4-pentadiene to form hydroperoxide, which is a major factor influencing seed longevity and viability. Recently, genome editing, an essential tool employed in reverse genetics, has been used experimentally to investigate basic plant biology or to modify crop plants for the improvement of important agricultural traits. In this study, we performed targeted mutagenesis in rice using transcription activator-like effector nucleases (TALENs) to improve seed storability. A modified ligation-independent cloning method (LIC) was employed to allow for the quick and efficient directional insertion of TALEN monomer modules into destination vectors used in plants. We demonstrated the feasibility and flexibility of the technology by developing a set of modular vectors for genome editing. After construction and validation, the TALEN pairs were used to create stable transgenic rice lines via Agrobacterium-mediated transformation. One heterozygous mutant (4%) was recovered from 25 transgenic NPTII-resistant lines, and the mutation was transmitted to the next generation. Further molecular and protein level experiments verified LOX3 deficiency and demonstrated the improvement of seed storability. Our work provides a flexible genome editing tool for improving important agronomic traits, as well as direct evidence that Lox3 has only a limited impact on seed longevity.	[Ma, Lei; Zhu, Fugui; Li, Zhenwei; Li, Xin; Dong, Jiangli; Wang, Tao] China Agr Univ, State Key Lab Agrobiotechnol, Coll Biol Sci, Beijing 100094, Peoples R China; [Ma, Lei] Inst Cotton Res CAAS, State Key Lab Cotton Biol, Anyang, Peoples R China; [Zhang, Jianfu] Fujian Acad Agr Sci, Rice Res Inst, Fuzhou, Peoples R China	China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Fujian Academy of Agricultural Sciences	Wang, T (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Coll Biol Sci, Beijing 100094, Peoples R China.	wangt@cau.edu.cn			National Major Projects of Cultivated Transgenic New Crop Varieties Foundation of China [2009ZX08001-01513, 2011ZX08009-002]; State Key Laboratory of Agrobiotechnology [2013SKLAB06-14]	National Major Projects of Cultivated Transgenic New Crop Varieties Foundation of China; State Key Laboratory of Agrobiotechnology	The National Major Projects of Cultivated Transgenic New Crop Varieties Foundation of China (2009ZX08001-01513, 2011ZX08009-002) received by T. Wand State Key Laboratory of Agrobiotechnology (2013SKLAB06-14) received by TW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Addgene.org for providing plasmids and their initial constructors, we also thank Prof. Liying Zhang at Ministry of Agriculture Feed Industry Center for the supply of method of measuring the contents of linoleic acids. This work is supported by The National Major Projects of Cultivated Transgenic New Crop Varieties Foundation of China (2009ZX08001-01513, 2011ZX08009-002) and State Key Laboratory of Agrobiotechnology (2013SKLAB06-14).	Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Carranco R, 2010, P NATL ACAD SCI USA, V107, P21908, DOI 10.1073/pnas.1014856107; Cermak T, 2011, NUCLEIC ACIDS RES, V39, P7879, DOI 10.1093/nar/gkr739; Chatelain E, 2013, P NATL ACAD SCI USA, V110, P3633, DOI 10.1073/pnas.1220589110; Chen HH, 2012, J EXP BOT, V63, P4107, DOI 10.1093/jxb/ers093; Chen KL, 2014, METHODS, V69, P2, DOI 10.1016/j.ymeth.2014.02.013; Devaiah SP, 2007, PLANT J, V50, P950, DOI 10.1111/j.1365-313X.2007.03103.x; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Gayen D, 2014, PLANT CELL TISS ORG, V118, P229, DOI 10.1007/s11240-014-0476-6; Halpin C, 2001, PLANT MOL BIOL, V47, P295, DOI 10.1023/A:1010604120234; Haun W, 2014, PLANT BIOTECHNOL J, V12, P934, DOI 10.1111/pbi.12201; Huang JX, 2014, TRANSGENIC RES, V23, P643, DOI 10.1007/s11248-014-9803-2; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Li T, 2014, METHODS, V69, P9, DOI 10.1016/j.ymeth.2014.03.019; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Long QZ, 2013, J PLANT BIOL, V56, P232, DOI 10.1007/s12374-013-0085-7; Ma AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065259; Miller M, 2002, TRANSGENIC RES, V11, P381, DOI 10.1023/A:1016390621482; Miura K, 2002, THEOR APPL GENET, V104, P981, DOI 10.1007/s00122-002-0872-x; Mizuno K, 2003, PLANT CELL PHYSIOL, V44, P1168, DOI 10.1093/pcp/pcg142; Oge L, 2008, PLANT CELL, V20, P3022, DOI 10.1105/tpc.108.058479; Prieto-Dapena P, 2006, PLANT PHYSIOL, V142, P1102, DOI 10.1104/pp.106.087817; Sattler SE, 2004, PLANT CELL, V16, P1419, DOI 10.1105/tpc.021360; Schmid-Burgk JL, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks236; Seo YS, 2011, J EXP BOT, V62, P5683, DOI 10.1093/jxb/err250; Shan QW, 2015, PLANT BIOTECHNOL J, V13, P791, DOI 10.1111/pbi.12312; Shirasawa K, 2008, BREEDING SCI, V58, P169, DOI 10.1270/jsbbs.58.169; Song M, 2007, NUCL INSTRUM METH B, V265, P495, DOI 10.1016/j.nimb.2007.09.035; Sun ZJ, 2013, J INTEGR PLANT BIOL, V55, P1092, DOI 10.1111/jipb.12091; Suzuki Y, 1999, J AGR FOOD CHEM, V47, P1119, DOI 10.1021/jf980967a; Umate P, 2011, PLANT SIGNAL BEHAV, V6, P335, DOI 10.4161/psb.6.3.13546; Wang R, 2008, PLANT MOL BIOL, V66, P401, DOI 10.1007/s11103-007-9278-0; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Xu H., 2014, PROC IEEE INT FUNCT, P1, DOI DOI 10.1111/PBI.12277; Yin JD, 2008, POULTRY SCI, V87, P284, DOI 10.3382/ps.2007-00220; Zhang Y, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-30; Zhang Y, 2013, PLANT PHYSIOL, V161, P20, DOI 10.1104/pp.112.205179; Zhou GX, 2014, PHYSIOL PLANTARUM, V152, P59, DOI 10.1111/ppl.12148	38	48	56	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0143877	10.1371/journal.pone.0143877	http://dx.doi.org/10.1371/journal.pone.0143877			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641666	Green Published, Green Submitted, gold			2022-12-27	WOS:000366902700033
J	Marin-Navarro, J; Roupain, N; Talens-Perales, D; Polaina, J				Marin-Navarro, Julia; Roupain, Nicole; Talens-Perales, David; Polaina, Julio			Identification and Structural Analysis of Amino Acid Substitutions that Increase the Stability and Activity of Aspergillus niger Glucose Oxidase	PLOS ONE			English	Article							DIRECTED EVOLUTION; BETA-GLUCOSIDASE; SACCHAROMYCES-CEREVISIAE; HISTIDINE-HISTIDINE; ANGSTROM RESOLUTION; SEQUENCE; PURIFICATION; RESISTANCE; POLYMYXA; GENE	Glucose oxidase is one of the most conspicuous commercial enzymes due to its many different applications in diverse industries such as food, chemical, energy and textile. Among these applications, the most remarkable is the manufacture of glucose biosensors and in particular sensor strips used to measure glucose levels in serum. The generation of ameliorated versions of glucose oxidase is therefore a significant biotechnological objective. We have used a strategy that combined random and rational approaches to isolate uncharacterized mutations of Aspergillus niger glucose oxidase with improved properties. As a result, we have identified two changes that increase significantly the enzyme's thermal stability. One (T554M) generates a sulfur-pi interaction and the other (Q90R/Y509E) introduces a new salt bridge near the interphase of the dimeric protein structure. An additional double substitution (Q124R/L569E) has no significant effect on stability but causes a twofold increase of the enzyme's specific activity. Our results disclose structural motifs of the protein which are critical for its stability. The combination of mutations in the Q90R/Y509E/T554M triple mutant yielded a version of A. niger glucose oxidase with higher stability than those previously described.	[Marin-Navarro, Julia; Roupain, Nicole; Talens-Perales, David; Polaina, Julio] CSIC, Inst Agroquim & Tecnol Alimentos, E-46010 Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA)	Polaina, J (corresponding author), CSIC, Inst Agroquim & Tecnol Alimentos, Jaime Roig 11, E-46010 Valencia, Spain.	jpolaina@iata.csic.es	, Marín-Navarro/F-7630-2016; Talens-Perales, David/E-8558-2017; Polaina, Julio/H-4498-2012; Talens-Perales, David/AAE-9116-2020	, Marín-Navarro/0000-0001-7893-3423; Talens-Perales, David/0000-0002-8693-4239; Polaina, Julio/0000-0001-9912-0640	Spain's "Secretaria de Estado de Investigacion, Desarrollo e Innovacion" [BIO2013-48779-C4-3-R]; European Union within the Project Leangreenfood; Ministerio de Economia y Competitividad; Spain's 'Secretaria de Estado de Investigacion, Desarrollo e Innovacion' [BIO2013-48779-C4-3-R]	Spain's "Secretaria de Estado de Investigacion, Desarrollo e Innovacion"; European Union within the Project Leangreenfood; Ministerio de Economia y Competitividad(Spanish Government); Spain's 'Secretaria de Estado de Investigacion, Desarrollo e Innovacion'	This work was funded by grant BIO2013-48779-C4-3-R from Spain's "Secretaria de Estado de Investigacion, Desarrollo e Innovacion". NR was supported by a Marie Curie ITN fellowship from the European Union within the Project Leangreenfood. DTP was supported by a FPU fellowship from "Ministerio de Economia y Competitividad".; This work was funded by grant BIO2013-48779-C4-3-R, from Spain's 'Secretaria de Estado de Investigacion, Desarrollo e Innovacion'. N R was supported by a Marie Curie ITN fellowship from the European Union within the Project Leangreenfood. D T-P was supported by a FPU fellowship from 'Ministerio de Economia y Competitividad'.	ERHART E, 1983, J BACTERIOL, V156, P625, DOI 10.1128/JB.156.2.625-635.1983; Gonzalez-Blasco G, 2000, J BIOL CHEM, V275, P13708, DOI 10.1074/jbc.275.18.13708; Gutierrez EA, 2013, BIOSENS BIOELECTRON, V50, P84, DOI 10.1016/j.bios.2013.06.029; Haghani K, 2012, INT J BIOL MACROMOL, V50, P1040, DOI 10.1016/j.ijbiomac.2011.12.009; HECHT HJ, 1993, J MOL BIOL, V229, P153, DOI 10.1006/jmbi.1993.1015; Heyda J, 2010, J PHYS CHEM B, V114, P8744, DOI 10.1021/jp101031v; Holland JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037924; Kommoju PR, 2011, BIOCHEMISTRY-US, V50, P5521, DOI 10.1021/bi200388g; KRIECHBAUM M, 1989, FEBS LETT, V255, P63, DOI 10.1016/0014-5793(89)81061-0; Lafraya A, 2011, APPL ENVIRON MICROB, V77, P6148, DOI 10.1128/AEM.05032-11; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Marin-Navarro J, 2011, APPL MICROBIOL BIOT, V89, P121, DOI 10.1007/s00253-010-2845-3; Mohammadi M, 2014, APPL BIOCHEM BIOTECH, V172, P157, DOI 10.1007/s12010-013-0404-y; Ostafe R, 2014, CHEM BIOL, V21, P414, DOI 10.1016/j.chembiol.2014.01.010; Sanz-Aparicio J, 1998, PROTEINS, V33, P567, DOI 10.1002/(SICI)1097-0134(19981201)33:4<567::AID-PROT9>3.0.CO;2-U; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SWOBODA BEP, 1965, J BIOL CHEM, V240, P2209; TSUGE H, 1975, J BIOCHEM, V78, P835, DOI 10.1093/oxfordjournals.jbchem.a130974; Valley CC, 2012, J BIOL CHEM, V287, P34979, DOI 10.1074/jbc.M112.374504; Wohlfahrt G, 1999, ACTA CRYSTALLOGR D, V55, P969, DOI 10.1107/S0907444999003431; Wohlfahrt G, 2004, MOL CELL BIOCHEM, V260, P69, DOI 10.1023/B:MCBI.0000026056.75937.98; Wong CM, 2008, APPL MICROBIOL BIOT, V78, P927, DOI 10.1007/s00253-008-1407-4; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhu Ziwei, 2007, Biotechnology Journal, V2, P241, DOI 10.1002/biot.200600185; Zhu ZW, 2006, BIOSENS BIOELECTRON, V21, P2046, DOI 10.1016/j.bios.2005.11.018; Zubillaga RA, 2006, PROTEIN PEPTIDE LETT, V13, P113, DOI 10.2174/092986606775101698	26	17	22	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144289	10.1371/journal.pone.0144289	http://dx.doi.org/10.1371/journal.pone.0144289			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642312	Green Published, Green Submitted, gold			2022-12-27	WOS:000366902700091
J	Oh, E; Choi, YL; Kwon, MJ; Kim, RN; Kim, YJ; Song, JY; Jung, KS; Shin, YK				Oh, Ensel; Choi, Yoon-La; Kwon, Mi Jeong; Kim, Ryong Nam; Kim, Yu Jin; Song, Ji-Young; Jung, Kyung Soo; Shin, Young Kee			Comparison of Accuracy of Whole-Exome Sequencing with Formalin-Fixed Paraffin-Embedded and Fresh Frozen Tissue Samples	PLOS ONE			English	Article							FFPE TUMOR-TISSUES; BREAST-CANCER; COPY-NUMBER; SPECIMENS; MUTATIONS	Formalin fixing with paraffin embedding (FFPE) has been a standard sample preparation method for decades, and archival FFPE samples are still very useful resources. Nonetheless, the use of FFPE samples in cancer genome analysis using next-generation sequencing, which is a powerful technique for the identification of genomic alterations at the nucleotide level, has been challenging due to poor DNA quality and artificial sequence alterations. In this study, we performed whole-exome sequencing of matched frozen samples and FFPE samples of tissues from 4 cancer patients and compared the next-generation sequencing data obtained from these samples. The major differences between data obtained from the 2 types of sample were the shorter insert size and artificial base alterations in the FFPE samples. A high proportion of short inserts in the FFPE samples resulted in overlapping paired reads, which could lead to overestimation of certain variants; >20% of the inserts in the FFPE samples were double sequenced. A large number of soft clipped reads was found in the sequencing data of the FFPE samples, and about 30% of total bases were soft clipped. The artificial base alterations, C>T and G>A, were observed in FFPE samples only, and the alteration rate ranged from 200 to 1,200 per 1M bases when sequencing errors were removed. Although high-confidence mutation calls in the FFPE samples were compatible to that in the frozen samples, caution should be exercised in terms of the artifacts, especially for low-confidence calls. Despite the clearly observed artifacts, archival FFPE samples can be a good resource for discovery or validation of biomarkers in cancer research based on whole-exome sequencing.	[Oh, Ensel; Choi, Yoon-La; Kim, Yu Jin; Song, Ji-Young; Jung, Kyung Soo] Samsung Med Ctr, Samsung Biomed Res Inst, Lab Canc Genom & Mol Pathol, Seoul, South Korea; [Oh, Ensel; Choi, Yoon-La; Kim, Yu Jin; Song, Ji-Young] Samsung Med Ctr, Inst Refractory Canc Res, Seoul, South Korea; [Choi, Yoon-La] Sungkyunkwan Univ, Coll Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea; [Choi, Yoon-La; Jung, Kyung Soo] Sungkyunkwan Univ, Sch Med, Samsung Adv Inst Hlth Sci & Technol, Seoul, South Korea; [Kwon, Mi Jeong] Kyungpook Natl Univ, Coll Pharm, Daegu, South Korea; [Kwon, Mi Jeong] Kyungpook Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Daegu, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Kyungpook National University; Kyungpook National University	Shin, YK (corresponding author), Seoul Natl Univ, Coll Pharm, Dept Pharm, Seoul, South Korea.	ykeeshin@snu.ac.kr	Shin, Young Kee/C-8929-2011	Shin, Young Kee/0000-0003-0896-718X; Kwon, Mi Jeong/0000-0002-7599-878X	Korea Healthcare Technology R&D project, Ministry for Health & Welfare Affairs, Republic of Korea [A092255]; National Research Foundation of Korea (NRF) grant for the Global Core Research Center (GCRC) - Ministry of Science, ICT & Future Planning (MSIP) [2011-0030001]	Korea Healthcare Technology R&D project, Ministry for Health & Welfare Affairs, Republic of Korea; National Research Foundation of Korea (NRF) grant for the Global Core Research Center (GCRC) - Ministry of Science, ICT & Future Planning (MSIP)	This work was supported by: grant of the Korea Healthcare Technology R&D project, Ministry for Health & Welfare Affairs, Republic of Korea (A092255); National Research Foundation of Korea (NRF) grant for the Global Core Research Center (GCRC) funded by the Ministry of Science, ICT & Future Planning (MSIP) (No. 2011-0030001). All the funding was received by YKS.	Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Choi YL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-507; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Espinosa E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005911; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Kerick M, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-68; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Schweiger MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005548; Spencer DH, 2013, J MOL DIAGN, V15, P623, DOI 10.1016/j.jmoldx.2013.05.004; Srinivasan M, 2002, AM J PATHOL, V161, P1961, DOI 10.1016/S0002-9440(10)64472-0; Van Allen EM, 2014, NAT MED, V20, P682, DOI 10.1038/nm.3559; Williams C, 1999, AM J PATHOL, V155, P1467, DOI 10.1016/S0002-9440(10)65461-2; Wood HM, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq510; Yost SE, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks299	15	61	61	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144162	10.1371/journal.pone.0144162	http://dx.doi.org/10.1371/journal.pone.0144162			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641479	Green Published, gold, Green Submitted			2022-12-27	WOS:000366902700068
J	Cramer, CK; Yoon, SW; Reinsvold, M; Joo, KM; Norris, H; Hood, RC; Adamson, JD; Klein, RC; Kirsch, DG; Oldham, M				Cramer, C. K.; Yoon, S. W.; Reinsvold, M.; Joo, K. M.; Norris, H.; Hood, R. C.; Adamson, J. D.; Klein, R. C.; Kirsch, D. G.; Oldham, M.			Treatment Planning and Delivery of Whole Brain Irradiation with Hippocampal Avoidance in Rats	PLOS ONE			English	Article							RADIOTHERAPY; METASTASES; RADIATION; ACCURACY; MEMORY	Background Despite the clinical benefit of whole brain radiotherapy (WBRT), patients and physicians are concerned by the long-term impact on cognitive functioning. Many studies investigating the molecular and cellular impact of WBRT have used rodent models. However, there has not been a rodent protocol comparable to the recently reported Radiation Therapy Oncology Group (RTOG) protocol for WBRT with hippocampal avoidance (HA) which is intended to spare cognitive function. The aim of this study was to develop a hippocampal-sparing WBRT protocol in Wistar rats. Methods The technical and clinical challenges encountered in hippocampal sparing during rat WBRT are substantial. Three key challenges were identified: hippocampal localization, treatment planning, and treatment localization. Hippocampal localization was achieved with sophisticated imaging techniques requiring deformable registration of a rat MRI atlas with a high resolution MRI followed by fusion via rigid registration to a CBCT. Treatment planning employed a Monte Carlo dose calculation in SmART-Plan and creation of 0.5cm thick lead blocks custom-shaped to match DRR projections. Treatment localization necessitated the on-board image-guidance capability of the XRAD C225Cx micro-CT/micro-irradiator (Precision X-Ray). Treatment was accomplished with opposed lateral fields with 225 KVp X-rays at a current of 13mA filtered through 0.3mm of copper using a 40x40mm square collimator and the lead blocks. A single fraction of 4Gy was delivered (2Gy per lateral field) with a 41 second beam on time per field at a dose rate of 304.5 cGy/min. Dosimetric verification of hippocampal sparing was performed using radiochromic film. In vivo verification of HA was performed after delivery of a single 4Gy fraction either with or without HA using gamma-H2Ax staining of tissue sections from the brain to quantify the amount of DNA damage in rats treated with HA, WBRT, or sham-irradiated (negative controls). Results The mean dose delivered to radiochromic film beneath the hippocampal block was 0.52Gy compared to 3.93Gy without the block, indicating an 87% reduction in the dose delivered to the hippocampus. This difference was consistent with doses predicted by Monte Carlo dose calculation. The Dose Volume Histogram (DVH) generated via Monte Carlo simulation showed an underdose of the target volume (brain minus hippocampus) with 50% of the target volume receiving 100% of the prescription isodose as a result of the lateral blocking techniques sparing some midline thalamic and subcortical tissue. Staining of brain sections with anti-phospho-Histone H2A.X (reflecting double-strand DNA breaks) demonstrated that this treatment protocol limited radiation dose to the hippocampus in vivo. The mean signal intensity from gamma-H2Ax staining in the cortex was not significantly different from the signal intensity in the cortex of rats treated with WBRT (5.40 v. 5.75, P = 0.32). In contrast, the signal intensity in the hippocampus of rats treated with HA was significantly lower than rats treated with WBRT (4.55 v. 6.93, P = 0.012). Conclusion Despite the challenges of planning conformal treatments for small volumes in rodents, our dosimetric and in vivo data show that WBRT with HA is feasible in rats. This study provides a useful platform for further application and refinement of the technique.	[Cramer, C. K.; Yoon, S. W.; Reinsvold, M.; Joo, K. M.; Norris, H.; Adamson, J. D.; Klein, R. C.; Kirsch, D. G.; Oldham, M.] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC 27708 USA; [Klein, R. C.] Durham VA, Dept Psychiat, Durham, NC USA; [Kirsch, D. G.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA; [Joo, K. M.] Sungkyunkwan Univ, Sch Med, Dept Anat & Cell Biol, Seoul, South Korea; [Klein, R. C.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA	Duke University; Duke University; Sungkyunkwan University (SKKU); Duke University	Cramer, CK (corresponding author), Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC 27708 USA.	Christina.Cramer@duke.edu	Adamson, Justus/AAM-5335-2021	Adamson, Justus/0000-0002-7868-5631; Yoon, Suk Whan "Paul"/0000-0002-0313-8131	NIAID [K02AI093866]; Radiation Oncology departmental support; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K02AI093866] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Radiation Oncology departmental support; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was partially supported by K02AI093866 from the NIAID (awarded to DGK). The remainder of the research was funded by Radiation Oncology departmental support (start up funds) awarded to DGK.	Bache ST, 2015, MED PHYS, V42, P846, DOI 10.1118/1.4905489; Barlind A, 2010, EXP BRAIN RES, V201, P781, DOI 10.1007/s00221-009-2095-8; Chang EL, 2009, LANCET ONCOL, V10, P1037, DOI 10.1016/S1470-2045(09)70263-3; Gondi V, 2014, J CLIN ONCOL, V32, P3810, DOI 10.1200/JCO.2014.57.2909; Johnson GA, 2012, NEUROIMAGE, V62, P1848, DOI 10.1016/j.neuroimage.2012.05.041; Li J, 2007, J CLIN ONCOL, V25, P1260, DOI 10.1200/JCO.2006.09.2536; Linninger AA, 2008, IEEE T BIOMEDICAL EN, V55; Marsh JC, 2010, INT J RADIAT ONCOL, V76, P504, DOI 10.1016/j.ijrobp.2009.02.038; Meyers CA, 2004, J CLIN ONCOL, V22, P157, DOI 10.1200/JCO.2004.05.128; Monje ML, 2007, ANN NEUROL, V62, P515, DOI 10.1002/ana.21214; Newton J, 2011, MED PHYS, V38, P6754, DOI 10.1118/1.3663675; Parihar VK, 2014, TRANSL CANCER RES, V3, P124, DOI 10.3978/j.issn.2218-676X.2013.06.02; Parihar VK, 2013, P NATL ACAD SCI USA, V110, P12822, DOI 10.1073/pnas.1307301110; Patchell RA, 1998, JAMA-J AM MED ASSOC, V280, P1485, DOI 10.1001/jama.280.17.1485; Rankine LJ, 2013, PHYS MED BIOL, V58, P7791, DOI 10.1088/0031-9155/58/21/7791; Welzel G, 2008, INT J RADIAT ONCOL, V72, P1311, DOI 10.1016/j.ijrobp.2008.03.009; Wolf OT, 2002, BRAIN RES PROTOC, V10, P41	17	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143208	10.1371/journal.pone.0143208	http://dx.doi.org/10.1371/journal.pone.0143208			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636762	gold, Green Published, Green Submitted			2022-12-27	WOS:000366143800006
J	Dong, XJ; Tsuji, J; Labadorf, A; Roussos, P; Chen, JF; Myers, RH; Akbarian, S; Weng, ZP				Dong, Xianjun; Tsuji, Junko; Labadorf, Adam; Roussos, Panos; Chen, Jiang-Fan; Myers, Richard H.; Akbarian, Schahram; Weng, Zhiping			The Role of H3K4me3 in Transcriptional Regulation Is Altered in Huntington's Disease	PLOS ONE			English	Article							GENE-EXPRESSION; HUMAN GENOME; EPIGENETIC DYSREGULATION; HISTONE MODIFICATIONS; TRINUCLEOTIDE REPEAT; PREFRONTAL CORTEX; CELL IDENTITY; EPH RECEPTORS; CHROMATIN; ENHANCERS	Huntington's disease (HD) is an autosomal-dominant neurodegenerative disorder resulting from expansion of CAG repeats in the Huntingtin (HTT) gene. Previous studies have shown mutant HTT can alter expression of genes associated with dysregulated epigenetic modifications. One of the most widely studied chromatin modifications is trimethylated lysine 4 of histone 3 (H3K4me3). Here, we conducted the first comprehensive study of H3K4me3 ChIP-sequencing in neuronal chromatin from the prefrontal cortex of six HD cases and six non-neurologic controls, and its association with gene expression measured by RNA-sequencing. We detected 2,830 differentially enriched H3K4me3 peaks between HD and controls, with 55% of them down-regulated in HD. Although H3K4me3 signals are expected to be associated with mRNA levels, we found an unexpected discordance between altered H3K4me3 peaks and mRNA levels. Gene ontology (GO) term enrichment analysis of the genes with differential H3K4me3 peaks, revealed statistically significantly enriched GO terms only in the genes with down-regulated signals in HD. The most frequently implicated biological process terms are organ morphogenesis and positive regulation of gene expression. More than 9,000 H3K4me3 peaks were located not near any recognized transcription start sites and approximately 36% of these "distal" peaks co-localized to known enhancer sites. Six transcription factors and chromatin remodelers are differentially enriched in HD H3K4me3 distal peaks, including EZH2 and SUZ12, two core subunits of the polycomb repressive complex 2 (PRC2). Moreover, PRC2 repressive state was significantly depleted in HD-enriched peaks, suggesting the epigenetic role of PRC2 inhibition associated with up-regulated H3K4me3 in Huntington's disease. In summary, our study provides new insights into transcriptional dysregulation of Huntington's disease by analyzing the differentiation of H3K4me3 enrichment.	[Dong, Xianjun; Tsuji, Junko; Weng, Zhiping] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01003 USA; [Labadorf, Adam; Chen, Jiang-Fan; Myers, Richard H.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Labadorf, Adam; Myers, Richard H.] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Roussos, Panos; Akbarian, Schahram] Mt Sinai Sch Med, Dept Psychiat, Friedman Brain Inst, New York, NY USA; [Roussos, Panos] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA; [Myers, Richard H.] Boston Univ, Sch Med, Genome Sci Inst, Boston, MA 02118 USA	University of Massachusetts System; University of Massachusetts Worcester; Boston University; Boston University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Boston University	Weng, ZP (corresponding author), Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01003 USA.	zhiping.weng@umassmed.edu	Dong, Xianjun/N-3867-2014	Dong, Xianjun/0000-0002-8052-9320; Chen, Jiang-Fan/0000-0002-0446-3956; Tsuji, Junko/0000-0003-0139-3750; Labadorf, Adam/0000-0002-0753-8992	Jerry McDonald HD Research Fund and Public Health Service, National Institutes of Health grants, National Institute of Neurological disorders and stroke [R01 NS073947]; National Institute of Mental Health [R01 MH106056]; NSF-EArly-concept Grants for Exploratory Research (EAGER) [PHY-1444389]; National Institutes of Health (NIH/NIA) [R01AG050986]; Veterans Affairs [BX002395]; PHS [HHSN-271-2013-00030C]; Division Of Physics [1444389] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH096890, R01MH106056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073947] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG050986] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002395] Funding Source: NIH RePORTER	Jerry McDonald HD Research Fund and Public Health Service, National Institutes of Health grants, National Institute of Neurological disorders and stroke; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NSF-EArly-concept Grants for Exploratory Research (EAGER); National Institutes of Health (NIH/NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs); PHS(United States Department of Health & Human ServicesUnited States Public Health Service); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the Jerry McDonald HD Research Fund and Public Health Service, National Institutes of Health grants, National Institute of Neurological disorders and stroke (R01 NS073947; Epigenetic Markers in Huntington's disease Brain) National Institute of Mental Health (R01 MH106056; Higher Order Chromatin and Genetic Risk for Schizophrenia). The authors would like to acknowledge the Harvard Brain Tissue Resource Center McLean Hospital, Belmont, Massachusetts for providing the HD tissue. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Anshul Kundaje of Stanford University and the NIH Roadmap Epigenomics Consortium (nihroadmap.nih.gov/epigenomics/) for providing chromatin state data. We thank Iris Cheung for conducting ChIP-seq assays and the UMASS flow cytometry and sequencing cores for help with the experiments. This work was supported by the Jerry McDonald HD Research Fund and Public Health Service, National Institutes of Health grants, National Institute of Neurological disorders and stroke (R01 NS073947; Epigenetic Markers in Huntington's disease Brain) National Institute of Mental Health (R01 MH106056; Higher Order Chromatin and Genetic Risk for Schizophrenia), NSF-EArly-concept Grants for Exploratory Research (EAGER) (PHY-1444389), National Institutes of Health (NIH/NIA R01AG050986, Roussos) and the Veterans Affairs (Merit grant BX002395, Roussos). We would like to acknowledge the Harvard Brain Tissue Resource Center McLean Hospital (Belmont, Massachusetts), which is supported in part by PHS contract, HHSN-271-2013-00030C for providing the HD tissue. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Bai G, 2015, HUM MOL GENET, V24, P1441, DOI 10.1093/hmg/ddu561; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Benayoun BA, 2014, CELL, V158, P673, DOI 10.1016/j.cell.2014.06.027; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bharadwaj R, 2014, NEURON, V84, P997, DOI 10.1016/j.neuron.2014.10.032; Bharadwaj R, 2013, J NEUROSCI, V33, P11839, DOI 10.1523/JNEUROSCI.1252-13.2013; Biagioli M, 2015, HUM MOL GENET, V24, P2442, DOI 10.1093/hmg/ddv006; Cattaneo E, 2005, NAT REV NEUROSCI, V6, P919, DOI 10.1038/nrn1806; Cha JHJ, 2007, PROG NEUROBIOL, V83, P228, DOI 10.1016/j.pneurobio.2007.03.004; Cha JHJ, 2000, TRENDS NEUROSCI, V23, P387, DOI 10.1016/S0166-2236(00)01609-X; Cheung I, 2010, P NATL ACAD SCI USA, V107, P8824, DOI 10.1073/pnas.1001702107; Clouaire T, 2012, GENE DEV, V26, P1714, DOI 10.1101/gad.194209.112; Connor C, 2010, EPIGENETICS-US, V5, P392, DOI 10.4161/epi.5.5.11874; Dong XJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r53; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hadzi TC, 2012, NEUROLOGY, V79, P1708, DOI 10.1212/WNL.0b013e31826e9a5d; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Heidari N, 2014, GENOME RES, V24, P1905, DOI 10.1101/gr.176586.114; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hodges A, 2006, HUM MOL GENET, V15, P965, DOI 10.1093/hmg/ddl013; Hoss AG, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0083-3; Hoss AG, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004188; Huntington G., 1872, MED SURG REP, V26, P320; Jiang Y, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-42; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim TH, 2005, GENOME RES, V15, P830, DOI 10.1101/gr.3430605; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Koch CM, 2007, GENOME RES, V17, P691, DOI 10.1101/gr.5704207; Kvon EZ, 2012, GENE DEV, V26, P908, DOI 10.1101/gad.188052.112; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Lee J, 2013, NEUROTHERAPEUTICS, V10, P664, DOI 10.1007/s13311-013-0206-5; Lee J, 2013, ACTA NEUROPATHOL, V125, P727, DOI 10.1007/s00401-013-1103-z; Li C, 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-8-RESEARCH0032; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; McFarland KN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041423; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Milavetz BI, 2002, VIROLOGY, V294, P170, DOI 10.1006/viro.2001.1308; MYERS RH, 1993, NAT GENET, V5, P168, DOI 10.1038/ng1093-168; Myers Richard H, 2004, NeuroRx, V1, P255, DOI 10.1007/BF03206609; Ng CW, 2013, P NATL ACAD SCI USA, V110, P2354, DOI 10.1073/pnas.1221292110; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Okitsu CY, 2010, MOL CELL BIOL, V30, P2933, DOI 10.1128/MCB.01478-09; Pekowska A, 2011, EMBO J, V30, P4198, DOI 10.1038/emboj.2011.295; Pena PV, 2008, J MOL BIOL, V380, P303, DOI 10.1016/j.jmb.2008.04.061; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Qiu ZH, 2006, J BIOL CHEM, V281, P16672, DOI 10.1074/jbc.M511648200; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ravache M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014311; Roadmap Epigenomics Consortium, 2015, Nature, V518, P317, DOI 10.1038/nature14248; Rosas HD, 2014, NEUROLOGY, V82, P850, DOI 10.1212/WNL.0000000000000187; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Ryu H, 2006, P NATL ACAD SCI USA, V103, P19176, DOI 10.1073/pnas.0606373103; Sadri-Vakili G, 2007, HUM MOL GENET, V16, P1293, DOI 10.1093/hmg/ddm078; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Sato S, 2008, NAT NEUROSCI, V11, P923, DOI 10.1038/nn.2160; Schmitges FW, 2011, MOL CELL, V42, P330, DOI 10.1016/j.molcel.2011.03.025; Seong IS, 2010, HUM MOL GENET, V19, P573, DOI 10.1093/hmg/ddp524; Shulha HP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003433; Shulha HP, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001427; Shulha HP, 2012, ARCH GEN PSYCHIAT, V69, P314, DOI 10.1001/archgenpsychiatry.2011.151; SOTREL A, 1991, NEUROLOGY, V41, P1117, DOI 10.1212/WNL.41.7.1117; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Trushina E, 2004, MOL CELL BIOL, V24, P8195, DOI 10.1128/MCB.24.18.8195-8209.2004; Unland R, 2014, J NEURO-ONCOL, V116, P237, DOI 10.1007/s11060-013-1313-1; Valor LM, 2013, J NEUROSCI, V33, P10471, DOI 10.1523/JNEUROSCI.0670-13.2013; Vashishtha M, 2013, P NATL ACAD SCI USA, V110, pE3027, DOI 10.1073/pnas.1311323110; Villar-Menendez I, 2013, NEUROMOL MED, V15, P295, DOI 10.1007/s12017-013-8219-0; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Wang J, 2012, NUCL ACIDS RES; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang JD, 2009, BIOINFORMATICS, V25, P1470, DOI 10.1093/bioinformatics/btp167; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219; Zuccato C, 2007, J NEUROSCI, V27, P6972, DOI 10.1523/JNEUROSCI.4278-06.2007	88	28	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144398	10.1371/journal.pone.0144398	http://dx.doi.org/10.1371/journal.pone.0144398			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636336	Green Published, Green Submitted, gold			2022-12-27	WOS:000366143800087
J	Gokulakrishnan, P; Ganeshkumar, P				Gokulakrishnan, P.; Ganeshkumar, P.			Road Accident Prevention with Instant Emergency Warning Message Dissemination in Vehicular Ad-Hoc Network	PLOS ONE			English	Article							FUEL CONSUMPTION; VEHICLES; TIME; COMMUNICATION; MODEL	A Road Accident Prevention (RAP) scheme based on Vehicular Backbone Network (VBN) structure is proposed in this paper for Vehicular Ad-hoc Network (VANET). The RAP scheme attempts to prevent vehicles from highway road traffic accidents and thereby reduces death and injury rates. Once the possibility of an emergency situation (i.e. an accident) is predicted in advance, instantly RAP initiates a highway road traffic accident prevention scheme. The RAP scheme constitutes the following activities: (i) the Road Side Unit (RSU) constructs a Prediction Report (PR) based on the status of the vehicles and traffic in the highway roads, (ii) the RSU generates an Emergency Warning Message (EWM) based on an abnormal PR, (iii) the RSU forms a VBN structure and (iv) the RSU disseminates the EWM to the vehicles that holds the high Risk Factor (RF) and travels in High Risk Zone (HRZ). These vehicles might reside either within the RSU's coverage area or outside RSU's coverage area (reached using VBN structure). The RAP scheme improves the performance of EWM dissemination in terms of increase in notification and decrease in end-to-end delay. The RAP scheme also reduces infrastructure cost (number of RSUs) by formulating and deploying the VBN structure. The RAP scheme with VBN structure improves notification by 19 percent and end-to-end delay by 14.38 percent for a vehicle density of 160 vehicles. It is also proved from the simulation experiment that the performance of RAP scheme is promising in 4-lane highway roads.	[Gokulakrishnan, P.] PSNA Coll Engn & Technol, Dept Comp Sci & Engn, Dindigul 624622, Tamil Nadu, India; [Ganeshkumar, P.] PSNA Coll Engn & Technol, Dept Informat Technol, Dindigul 624622, Tamil Nadu, India	PSNA College of Engineering & Technology; PSNA College of Engineering & Technology	Gokulakrishnan, P (corresponding author), PSNA Coll Engn & Technol, Dept Comp Sci & Engn, Dindigul 624622, Tamil Nadu, India.	gokulakrishnan_77@yahoo.com						Ahmed Rana E., 2011, Journal of Advances in Information Technology, V2, P128, DOI 10.4304/jait.2.2.128-132; Ambhaikar Asha, 2012, INT J SCI ENG RES, V3, P1; [Anonymous], ACC DEATHS SUIC IND; [Anonymous], WORLD BANK REP; [Anonymous], 2013, SUPP DEC ACT; Blaszczyszyn Barlomiej, 2009, 2009 European Wireless Conference (EW 2009), P32, DOI 10.1109/EW.2009.5358011; Busson A, 2011, IEEE T VEH TECHNOL, V60, P4487, DOI 10.1109/TVT.2011.2169819; Chitra M., 2013, INT J MOBILE NETWORK, V3, P47, DOI [10.5121/ijmnct.2013.3306, DOI 10.5121/IJMNCT.2013.3306]; Choi JI, 2014, EURASIP J WIREL COMM, DOI 10.1186/1687-1499-2014-133; Cuomo F, 2014, AD HOC NETW, V21, P42, DOI 10.1016/j.adhoc.2014.04.008; Daraghmi YA, 2013, IEEE NETWORK, V27, P74, DOI 10.1109/MNET.2013.6678930; Dawood HS, 2013, INT J DISTRIB SENS N, DOI 10.1155/2013/232916; Fan X, 2014, 16 INT C ADV COMM TE, P103, DOI [10.1109/ICACT.2014.6778930, DOI 10.1109/ICACT.2014.6778930]; Ganan Carlos, 2012, Multiple Access Communications. 5th International Workshop, MACOM 2012. Proceedings, P49, DOI 10.1007/978-3-642-34976-8_5; Ganeshkumar P, 2015, SCI WORLD J, V2015; Gerharz M, 2002, C LOCAL COMPUT NETW, P30, DOI 10.1109/LCN.2002.1181761; Gupta AK, 2014, INT J MOD PHYS C, V25, DOI 10.1142/S0129183114500454; Hassanabadi B, 2014, IEEE T WIREL COMMUN, V13, P1284, DOI 10.1109/TWC.2014.010214.122008; Ngo HP, 2012, KSII T INTERNET INF, V6, P3081, DOI 10.3837/tiis.2012.12.003; Hoque F, 2014, SCI WORLD J, DOI 10.1155/2014/480435; Huang JW, 2014, SCI WORLD J, DOI 10.1155/2014/584164; Javed MA, 2014, EURASIP J WIREL COMM, DOI 10.1186/1687-1499-2014-179; Jeni P. R. Jasmine, 2014, Journal of Computer Science, V10, P1561, DOI 10.3844/jcssp.2014.1561.1568; Ju HJ, 2007, IEEE T WIREL COMMUN, V6, P4285, DOI 10.1109/TWC.2007.05692; Kao JC, 2011, COVERAGE ENHANCEMENT; Khattak AJ, 2011, PRIMARY SECONDARY IN; Liu JL, 2013, IEEE T EMERG TOP COM, V1, P57, DOI 10.1109/TETC.2013.2273445; Lu SN, 2010, J APPL SCI ENG, V13, P395; Ma XM, 2011, IEEE T VEH TECHNOL, V60, P3933, DOI 10.1109/TVT.2011.2165975; Martinez FJ, 2010, IEEE INTEL TRANSP SY, V2, P6, DOI 10.1109/MITS.2010.938166; Mathew TV, MULTILANE HIGHWAYS L; Meshram S. S., 2014, IOSR J COMPUTER SCI, P5; Naito K, 2013, ROAD SIDE UNIT COVER; Nakamura M., 2010, P 7 IEEE CCNC LAS VE, P1; Ota K, 2015, IEEE T EMERG TOP COM, V3, P34, DOI 10.1109/TETC.2014.2371245; Palma Veronica, 2013, Journal of Telecommunications and Information Technology, V1, P41; Paridel K., 2012, MOBILITY INT C MOBIL, P151; Redhu P, 2015, COMMUN NONLINEAR SCI, V27, P263, DOI 10.1016/j.cnsns.2015.03.015; Rubin Izhak, 2014, 2014 13th Annual Mediterranean Ad Hoc Networking Workshop (MED-HOC-NET), P95, DOI 10.1109/MedHocNet.2014.6849110; Rubin I, 2014, J COMMUNICATIONS, V9, P616, DOI DOI 10.12720/JCM.9.8.616-626; Rubin I., 2013, INF THEOR APPL WORKS, P1, DOI [10. 1109/ ITA. 2013. 6502973, DOI 10.1109/ITA.2013.6502973]; Salvo P., 2012, 2012 9th Annual Conference on Wireless On-demand Network Systems and Services (WONS), P47, DOI 10.1109/WONS.2012.6152235; Samara G., 2011, Journal of Applied Sciences, V11, P2606, DOI 10.3923/jas.2011.2606.2612; Sou SI, 2011, IEEE T VEH TECHNOL, V60, P3586, DOI 10.1109/TVT.2011.2165739; Sousanis J., 2011, WARDS AUTO, V15; Suthaputchakun C, 2014, IEEE T VEH TECHNOL, V63, P2926, DOI 10.1109/TVT.2013.2293020; Sze-Yao Ni, 1999, MobiCom'99. Proceedings of Fifth Annual ACM/IEEE International Conference on Mobile Computing and Networking, P151; Tang A, 2010, ACCIDENT ANAL PREV, V42, P182, DOI 10.1016/j.aap.2009.07.019; Tang TQ, 2008, PHYSICA A, V387, P6845, DOI 10.1016/j.physa.2008.08.036; Tang TQ, 2008, INT J MOD PHYS C, V19, P1367, DOI 10.1142/S0129183108012947; Tang TQ, 2015, PHYSICA A, V419, P293, DOI 10.1016/j.physa.2014.10.051; Tang TQ, 2014, INT J MOD PHYS C, V25, DOI 10.1142/S0129183114500077; Tang TQ, 2009, CHINESE PHYS B, V18, P975, DOI 10.1088/1674-1056/18/3/022; Tang TQ, 2013, SCI CHINA TECHNOL SC, V56, P1307, DOI 10.1007/s11431-013-5182-9; Vasanthi V., 2011, Journal of Theoretical and Applied Information Technology, V33, P7; Voelcker J., 1 2 BILLION VEHICLES; Wu C, 2013, PROC 20 ANN NETW DIS, P1, DOI 10.1109/VTCFall.2013.6692152; Wu CX, 2011, TRANSPORT RES D-TR E, V16, P515, DOI 10.1016/j.trd.2011.06.002; Yao Y, 2013, IEEE T VEH TECHNOL, V62, P4198, DOI 10.1109/TVT.2013.2284594; Zhuang YY, 2011, IEEE J SEL AREA COMM, V29, P187, DOI 10.1109/JSAC.2011.110118	60	15	16	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143383	10.1371/journal.pone.0143383	http://dx.doi.org/10.1371/journal.pone.0143383			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636576	Green Published, gold			2022-12-27	WOS:000366143800011
J	Mazaki-Tovi, S; Vaisbuch, E; Tarca, AL; Kusanovic, JP; Than, NG; Chaiworapongsa, T; Dong, Z; Hassan, SS; Romero, R				Mazaki-Tovi, Shali; Vaisbuch, Edi; Tarca, Adi L.; Kusanovic, Juan Pedro; Than, Nandor Gabor; Chaiworapongsa, Tinnakorn; Dong, Zhong; Hassan, Sonia S.; Romero, Roberto			Characterization of Visceral and Subcutaneous Adipose Tissue Transcriptome and Biological Pathways in Pregnant and Non-Pregnant Women: Evidence for Pregnancy-Related Regional-Specific Differences in Adipose Tissue	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; MATERNAL SERUM ADIPONECTIN; MESSENGER-RNA EXPRESSION; C-REACTIVE PROTEIN; GESTATIONAL DIABETES-MELLITUS; COLONY-ENHANCING FACTOR; GLUCOSE-TRANSPORTER EXPRESSION; PLASMA VISFATIN CONCENTRATIONS; RETINOL-BINDING PROTEIN-4; HORMONE-SENSITIVE LIPASE	Objective The purpose of this study was to compare the transcriptome of visceral and subcutaneous adipose tissues between pregnant and non-pregnant women. Study Design The transcriptome of paired visceral and abdominal subcutaneous adipose tissues from pregnant women at term and matched non-pregnant women (n = 11) was profiled with the Affymetrix Human Exon 1.0 ST array. Differential expression of selected genes was validated with the use of quantitative reverse transcription-polymerase chain reaction. Results Six hundred forty-four transcripts from 633 known genes were differentially expressed (false discovery rate (FDR) <0.1; fold-change >1.5), while 42 exons from 36 genes showed differential usage (difference in FIRMA scores >2 and FDR<0.1) between the visceral and subcutaneous fat of pregnant women. Fifty-six known genes were differentially expressed between pregnant and non-pregnant subcutaneous fat and three genes in the visceral fat. Enriched biological processes in the subcutaneous adipose tissue of pregnant women were mostly related to inflammation. Conclusion The transcriptome of visceral and subcutaneous fat depots reveals pregnancy-related gene expression and splicing differences in both visceral and subcutaneous adipose tissue. Furthermore, for the first time, alternative splicing in adipose tissue has been associated with regional differences and human parturition.	[Mazaki-Tovi, Shali] Chaim Sheba Med Ctr, Dept Obstet & Gynecol, IL-52621 Tel Hashomer, Israel; [Mazaki-Tovi, Shali] Tel Aviv Univ, IL-69978 Tel Aviv, Israel; [Vaisbuch, Edi] Kaplan Med Ctr, Dept Obstet & Gynecol, Rehovot, Israel; [Tarca, Adi L.; Kusanovic, Juan Pedro; Than, Nandor Gabor; Chaiworapongsa, Tinnakorn; Dong, Zhong; Hassan, Sonia S.; Romero, Roberto] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Perinatol Res Branch, NIH, Dept Hlth & Human Serv, Bethesda, MD USA; [Tarca, Adi L.; Kusanovic, Juan Pedro; Than, Nandor Gabor; Chaiworapongsa, Tinnakorn; Dong, Zhong; Hassan, Sonia S.; Romero, Roberto] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Perinatol Res Branch, NIH, Dept Hlth & Human Serv, Detroit, MI USA; [Tarca, Adi L.] Wayne State Univ, Dept Comp Sci, Detroit, MI 48202 USA; [Tarca, Adi L.] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI USA; [Kusanovic, Juan Pedro] Pontificia Univ Catolica Chile, Sch Med, Dept Obstet & Gynecol, Santiago, Chile; [Kusanovic, Juan Pedro] Hosp Dr Sotero del Rio, Ctr Res & Innovat Maternal Fetal Med CIMAF, Dept Obstet & Gynecol, Santiago, Chile; [Than, Nandor Gabor] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Budapest, Hungary; [Than, Nandor Gabor] Semmelweis Univ, Dept Pathol & Expt Canc Res 1, H-1085 Budapest, Hungary; [Chaiworapongsa, Tinnakorn; Hassan, Sonia S.; Romero, Roberto] Wayne State Univ, Sch Med, Dept Obstet & Gynecol, Detroit, MI 48201 USA	Chaim Sheba Medical Center; Tel Aviv University; Hebrew University of Jerusalem; Kaplan Medical Center; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Wayne State University; Wayne State University; Pontificia Universidad Catolica de Chile; Universidad de Chile; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Semmelweis University; Wayne State University	Mazaki-Tovi, S (corresponding author), Chaim Sheba Med Ctr, Dept Obstet & Gynecol, IL-52621 Tel Hashomer, Israel.	shalimazaki@gmail.com; romeror@mail.nih.gov	Than, Nandor G/N-1442-2016; Kusanovic, Juan Pedro/R-8616-2019; Kusanovic, Juan Pedro/AAM-5782-2020; Romero, Roberto/A-5268-2019	Kusanovic, Juan Pedro/0000-0003-0640-2070; Romero, Roberto/0000-0002-4448-5121	Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, U.S. Department of Health and Human Services; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD002400] Funding Source: NIH RePORTER	Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, U.S. Department of Health and Human Services; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This project has been funded in whole or in part by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, U.S. Department of Health and Human Services.	Acosta O, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.08.009; Ahmadzia HK, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.06.041; Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X; Alvarez-Llamas G, 2007, MOL CELL PROTEOMICS, V6, P589, DOI 10.1074/mcp.M600265-MCP200; Alvehus M, 2010, OBESITY, V18, P879, DOI 10.1038/oby.2010.22; Apostoli AJ, 2012, PPAR RES, V2012, DOI 10.1155/2012/504918; Atzmon G, 2002, HORM METAB RES, V34, P622, DOI 10.1055/s-2002-38250; Auguet T, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-60; Avram AS, 2005, J AM ACAD DERMATOL, V53, P671, DOI 10.1016/j.jaad.2005.05.015; Avram MM, 2007, J AM ACAD DERMATOL, V56, P472, DOI 10.1016/j.jaad.2006.06.022; Avram MM, 2005, J AM ACAD DERMATOL, V53, P663, DOI 10.1016/j.jaad.2005.05.014; Bahado-Singh RO, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.03.056; Barker G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042943; Barth S, 2010, OBESITY FACTS, V3, P245, DOI 10.1159/000319508; Bashan N, 2007, ENDOCRINOLOGY, V148, P2955, DOI 10.1210/en.2006-1369; Bashiri A, 2014, MOL GENET GENOMICS, V289, P695, DOI 10.1007/s00438-014-0841-5; Batista CMDS, 2007, DIABETES, V56, P1655, DOI 10.2337/db06-1506; BECK P, 1969, DIABETES, V18, P146, DOI 10.2337/diab.18.3.146; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berndt J, 2005, DIABETES, V54, P2911, DOI 10.2337/diabetes.54.10.2911; Bethin KE, 2003, MOL ENDOCRINOL, V17, P1454, DOI 10.1210/me.2003-0007; Bigelow CA, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.11.004; Blaudeau TE, 2006, INT J OBESITY, V30, P1119, DOI 10.1038/sj.ijo.0803252; Bluher M, 2009, J CLIN ENDOCR METAB, V94, P2507, DOI 10.1210/jc.2009-0002; Bokarewa M, 2005, J IMMUNOL, V174, P5789, DOI 10.4049/jimmunol.174.9.5789; Brandt B, 2015, J PERINAT MED, V43, P325, DOI 10.1515/jpm-2014-0215; Briana DD, 2008, NEONATOLOGY, V93, P153, DOI 10.1159/000108412; Briana DD, 2011, METABOLISM, V60, P486, DOI 10.1016/j.metabol.2010.04.014; Briana DD, 2010, ANN NY ACAD SCI, V1205, P82, DOI 10.1111/j.1749-6632.2010.05650.x; Briana DD, 2009, REPROD SCI, V16, P921, DOI 10.1177/1933719109336614; BUCHANAN TA, 1990, AM J OBSTET GYNECOL, V162, P1008, DOI 10.1016/0002-9378(90)91306-W; Bujold E, 2008, J MATERN-FETAL NEO M, V21, P697, DOI 10.1080/14767050802053289; Bukowski R, 2006, PLOS MED, V3, P918, DOI 10.1371/journal.pmed.0030169; Catalano PM, 2006, DIABETOLOGIA, V49, P1677, DOI 10.1007/s00125-006-0264-x; Catov JM, 2007, AM J OBSTET GYNECOL, V196, P558, DOI 10.1016/j.ajog.2007.01.032; Ceyhan ST, 2015, AM J OBSTET GYNECOL, V212, P120, DOI 10.1016/j.ajog.2014.09.033; Chan EC, 2002, J CLIN ENDOCR METAB, V87, P2435, DOI 10.1210/jc.87.6.2435; Chan TF, 2007, REPROD SCI, V14, P169, DOI 10.1177/1933719106298407; Chan TF, 2006, J SOC GYNECOL INVEST, V13, P364, DOI 10.1016/j.jsgi.2006.04.007; CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798; Chen D, 2007, CLIN ENDOCRINOL, V67, P208, DOI 10.1111/j.1365-2265.2007.02862.x; Chen DQ, 2005, CLIN SCI, V108, P81, DOI 10.1042/CS20040225; Cho CKJ, 2007, MOL CELL PROTEOMICS, V6, P1406, DOI 10.1074/mcp.M700090-MCP200; Clark TA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r64; Cobo T, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.12.036; Colomiere M, 2010, J MOL ENDOCRINOL, V44, P213, DOI 10.1677/JME-09-0091; Copland JA, 2003, RECENT PROG HORM RES, V58, P25, DOI 10.1210/rp.58.1.25; Cortelazzi D, 2007, CLIN ENDOCRINOL, V66, P447, DOI 10.1111/j.1365-2265.2007.02761.x; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; D'Anna R, 2006, BJOG-INT J OBSTET GY, V113, P1264, DOI 10.1111/j.1471-0528.2006.01078.x; D'Anna R, 2005, OBSTET GYNECOL, V106, P340, DOI 10.1097/01.AOG.0000168441.79050.03; Daly N, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.03.022; Dandona P, 1998, J CLIN ENDOCR METAB, V83, P2907, DOI 10.1210/jc.83.8.2907; Darling AM, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.05.032; Davies B, 2004, MOL CELL BIOL, V24, P8642, DOI 10.1128/MCB.24.19.8642-8648.2004; Davies B, 2007, MOL REPROD DEV, V74, P539, DOI 10.1002/mrd.20636; Davies B, 2010, ADV EXP MED BIOL, V706, P179; de Castro J, 2011, ENDOCRINOLOGY, V152, P4094, DOI 10.1210/en.2011-0068; DESOYE G, 1987, J CLIN ENDOCR METAB, V64, P704, DOI 10.1210/jcem-64-4-704; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Dicker A, 2009, HORM METAB RES, V41, P350, DOI 10.1055/s-0028-1112135; Diet nutrition and the prevention of chronic diseases, 2003, WHO TECH REP SER, V916, pi; Dolinkova M, 2008, MOL CELL ENDOCRINOL, V291, P63, DOI 10.1016/j.mce.2008.05.001; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Drolet R, 2009, OBESITY, V17, P424, DOI 10.1038/oby.2008.555; Dusserre E, 2000, BBA-MOL BASIS DIS, V1500, P88, DOI 10.1016/S0925-4439(99)00091-5; Edlow AG, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.03.023; Einstein FH, 2005, DIABETES, V54, P672, DOI 10.2337/diabetes.54.3.672; Einstein FH, 2008, AM J PHYSIOL-ENDOC M, V294, pE451, DOI 10.1152/ajpendo.00570.2007; Engfeldt P, 1988, Horm Metab Res Suppl, V19, P26; Esplin MS, 2005, AM J OBSTET GYNECOL, V193, P404, DOI 10.1016/j.ajog.2004.12.021; Fain JN, 2008, INT J OBESITY, V32, P810, DOI 10.1038/sj.ijo.0803790; Farren M, 2014, J PERINAT MED; Fasshauer M, 2007, CLIN ENDOCRINOL, V66, P434, DOI 10.1111/j.1365-2265.2007.02751.x; Fasshauer M, 2008, CLIN ENDOCRINOL, V69, P69, DOI 10.1111/j.1365-2265.2007.03147.x; Fasshauer M, 2008, EUR J ENDOCRINOL, V158, P197, DOI 10.1530/EJE-07-0454; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; FRIED SK, 1987, INT J OBESITY, V11, P129; Gainsford T, 1996, P NATL ACAD SCI USA, V93, P14564, DOI 10.1073/pnas.93.25.14564; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; Gealekman O, 2011, CIRCULATION, V123, P186, DOI 10.1161/CIRCULATIONAHA.110.970145; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghartey J, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2015.03.052; Giusti V, 2004, J CLIN ENDOCR METAB, V89, P1379, DOI 10.1210/jc.2003-031507; Gottwald U, 2006, MOL CELL ENDOCRINOL, V250, P49, DOI 10.1016/j.mce.2005.12.024; Gravett MG, 2004, JAMA-J AM MED ASSOC, V292, P462, DOI 10.1001/jama.292.4.462; Guan HY, 2005, AM J PHYSIOL-ENDOC M, V288, pE663, DOI 10.1152/ajpendo.00461.2004; Gunderson EP, 2008, OBESITY, V16, P1078, DOI 10.1038/oby.2008.40; Haddad R, 2006, AM J OBSTET GYNECOL, V195, P394, DOI 10.1016/j.ajog.2005.08.057; Haider DG, 2007, DIABETES CARE, V30, P1889, DOI 10.2337/dc07-0013; Hancke K, 2015, J PERINAT MED, V43, P141, DOI 10.1515/jpm-2014-0069; Harman-Boehm I, 2007, J CLIN ENDOCR METAB, V92, P2240, DOI 10.1210/jc.2006-1811; Harper LM, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.04.028; Hassan SS, 2006, AM J OBSTET GYNECOL, V195, P778, DOI 10.1016/j.ajog.2006.06.021; Hassan SS, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.076; Hassan SS, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.08.016; Hassan SS, 2009, J MATERN-FETAL NEO M, V22, P1183, DOI 10.3109/14767050903353216; Hassan SS, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.07.008; Haugen F, 2006, AM J PHYSIOL-ENDOC M, V290, pE326, DOI 10.1152/ajpendo.00020.2005; Haugen F, 2007, ENDOCRINOLOGY, V148, P5478, DOI 10.1210/en.2007-0370; Havelock OC, 2005, BIOL REPROD, V72, P707, DOI 10.1095/biolreprod.104.032979; Hendler I, 2005, AM J OBSTET GYNECOL, V193, P979, DOI 10.1016/j.ajog.2005.06.041; Hermann M, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.08.002; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hojbjerre L, 2011, J APPL PHYSIOL, V111, P1863, DOI 10.1152/japplphysiol.00960.2011; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Howard JK, 1999, J CLIN INVEST, V104, P1051, DOI 10.1172/JCI6762; Hube F, 1996, HORM METAB RES, V28, P690, DOI 10.1055/s-2007-979879; Huber A, 2005, OBSTET GYNECOL, V105, P91, DOI 10.1097/01.AOG.0000146636.61611.e3; Hutley L, 2005, AM J MED SCI, V330, P280, DOI 10.1097/00000441-200512000-00005; Hytten F, 1991, CLIN PHYSL OBSTET; Ibrahim MM, 2010, OBES REV, V11, P11, DOI 10.1111/j.1467-789X.2009.00623.x; Insenser M, 2012, MOL CELL ENDOCRINOL, V363, P10, DOI 10.1016/j.mce.2012.07.001; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jia SH, 2004, J CLIN INVEST, V113, P1318, DOI [10.1172/JCI19930, 10.1172/JCI200419930]; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kajantie E, 2004, J CLIN ENDOCR METAB, V89, P4031, DOI 10.1210/jc.2004-0018; Kajantie E, 2005, J SOC GYNECOL INVEST, V12, P433, DOI 10.1016/j.jsgi.2005.04.006; KALKHOFF RK, 1970, J CLIN ENDOCR METAB, V31, P24, DOI 10.1210/jcem-31-1-24; Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104; Karachaliou M, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.12.038; Karatas A, 2014, AM J OBSTET GYNECOL, V210, P282, DOI 10.1016/j.ajog.2013.09.035; KERN PA, 1995, J CLIN INVEST, V95, P2111, DOI 10.1172/JCI117899; Kessous R, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.05.050; Kevane B, 2014, J PERINAT MED, V42, P417, DOI 10.1515/jpm-2013-0207; Khatri P, 2002, GENOMICS, V79, P266, DOI 10.1006/geno.2002.6698; Khoury MJ, 2006, AM J OBSTET GYNECOL, V195, P1503, DOI 10.1016/j.ajog.2006.10.883; Kinalski M, 2005, HORM METAB RES, V37, P450, DOI 10.1055/s-2005-870238; Kinoshita T, 2006, GYNECOL OBSTET INVES, V61, P115, DOI 10.1159/000089456; Kirchhoff C, 2006, MOL CELL ENDOCRINOL, V250, P43, DOI 10.1016/j.mce.2005.12.023; Kirchhoff C, 1998, ANDROLOGIA, V30, P225; Kirchhoff C, 2008, REPRODUCTION, V136, P235, DOI 10.1530/REP-08-0078; Kleiblova P, 2010, MOL CELL ENDOCRINOL, V314, P150, DOI 10.1016/j.mce.2009.08.002; Kloting N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004699; KNOPP RH, 1986, BIOL NEONATE, V50, P297, DOI 10.1159/000242614; Koenig W, 1999, CIRCULATION, V99, P237, DOI 10.1161/01.CIR.99.2.237; Kolialexi A, 2008, MASS SPECTROM REV, V27, P624, DOI 10.1002/mas.20181; Krzyzanowska K, 2008, DIABETOLOGIA, V51, P1115, DOI 10.1007/s00125-008-1009-9; Krzyzanowska K, 2006, CLIN SCI, V110, P605, DOI 10.1042/CS20050363; Kurokawa K, 2010, NEUROSCI LETT, V484, P128, DOI 10.1016/j.neulet.2010.08.031; Kusanovic Juan Pedro, 2008, J Matern Fetal Neonatal Med, V21, P902, DOI 10.1080/14767050802320357; Kuzmicki M, 2011, DIABETES RES CLIN PR, V94, pE43, DOI 10.1016/j.diabres.2011.07.033; Kuzmicki M, 2011, GYNECOL ENDOCRINOL, V27, P1065, DOI 10.3109/09513590.2011.579651; Kuzmicki M, 2009, GYNECOL ENDOCRINOL, V25, P258, DOI 10.1080/09513590802653825; Langin D, 1996, P NUTR SOC, V55, P93, DOI 10.1079/PNS19960013; Lappas M, 2005, ENDOCRINOLOGY, V146, P3334, DOI 10.1210/en.2005-0406; Lappas M, 2010, J ENDOCRINOL, V204, P75, DOI 10.1677/JOE-09-0321; Lareau LF, 2007, NATURE, V446, P926, DOI 10.1038/nature05676; Lassance L, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2015.02.026; Lee MJ, 2011, AM J PHYSIOL-ENDOC M, V300, pE571, DOI 10.1152/ajpendo.00231.2010; Lee YS, 2009, ANN ACAD MED SINGAP, V38, P45; Lefebvre AM, 1998, DIABETES, V47, P98, DOI 10.2337/diabetes.47.1.98; Leng J, 2015, CHINA PLOS ONE, V10, DOI [10.1371/journal.pone.0121029, DOI 10.1371/JOURNAL.PONE.0121029]; Leng JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129536; Lesseur C, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.06.037; Lewandowski KC, 2007, DIABETOLOGIA, V50, P1033, DOI 10.1007/s00125-007-0610-7; Lewandowski K, 2010, GINEKOL POL, V81, P907; Lewandowski KC, 2008, GYNECOL ENDOCRINOL, V24, P300, DOI 10.1080/09513590802141052; Li N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082310; Liao W, 2007, AM J PHYSIOL-ENDOC M, V293, pE219, DOI 10.1152/ajpendo.00695.2006; Lihn AS, 2004, MOL CELL ENDOCRINOL, V219, P9, DOI 10.1016/j.mce.2004.03.002; Linder K, 2004, J LIPID RES, V45, P148, DOI 10.1194/jlr.M300256-JLR200; Liu YH, 2012, HYPERTENS PREGNANCY, V31, P40, DOI 10.3109/10641955.2010.525273; LIVINGSTON JN, 1984, DIABETOLOGIA, V27, P447, DOI 10.1007/BF00273909; Lord GM, 1998, NATURE, V394, P897, DOI 10.1038/29795; Lu DH, 2006, INT J GYNECOL OBSTET, V95, P121, DOI 10.1016/j.ijgo.2006.06.015; Lundgren CH, 1996, CIRCULATION, V93, P106, DOI 10.1161/01.CIR.93.1.106; Ma LJ, 2004, DIABETES, V53, P336, DOI 10.2337/diabetes.53.2.336; Ma Y, 2010, DIABETES RES CLIN PR, V90, P60, DOI 10.1016/j.diabres.2010.06.010; Macaulay S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097871; Mackeen AD, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.12.020; Madsen-Bouterse SA, 2010, AM J REPROD IMMUNOL, V63, P73, DOI 10.1111/j.1600-0897.2009.00791.x; Manuck TA, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2015.02.010; Marette A, 1997, DIABETOLOGIA, V40, P590, DOI 10.1007/s001250050720; Marrs CC, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2014.01.018; MASUZAKI H, 1995, DIABETES, V44, P855, DOI 10.2337/diabetes.44.7.855; Matarese G, 2005, J IMMUNOL, V174, P3137, DOI 10.4049/jimmunol.174.6.3137; Mathur SK, 2011, J OBES, V2011, DOI 10.1155/2011/587495; Matsuki T, 2003, J EXP MED, V198, P877, DOI 10.1084/jem.20030299; Mazaki-Tovi S, 2007, J PERINATOL, V27, P77, DOI 10.1038/sj.jp.7211639; Mazaki-Tovi S, 2008, J MATERN-FETAL NEO M, V21, P796, DOI 10.1080/14767050802266881; Mazaki-Tovi S, 2008, J PERINAT MED; Mazaki-Tovi S, 2008, J PERINAT MED, V36, P485, DOI 10.1515/JPM.2008.084; Mazaki-Tovi Shali, 2005, Curr Diab Rep, V5, P278, DOI 10.1007/s11892-005-0023-2; Mazaki-Tovi S, 2010, J PERINAT MED, V38, P281, DOI [10.1515/JPM.2010.045, 10.1515/jpm.2010.045]; Mazaki-Tovi S, 2010, J PERINAT MED, V38, P9, DOI 10.1515/jpm.2009.134; Mazaki-Tovi S, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.08.008; Mazaki-Tovi S, 2011, J PEDIATR ENDOCR MET, V24, P411, DOI 10.1515/JPEM.2011.181; Mazaki-Tovi S, 2011, GYNECOL ENDOCRINOL, V27, P725, DOI 10.3109/09513590.2010.500426; Mazaki-Tovi S, 2010, J MATERN-FETAL NEO M, V23, P1119, DOI 10.3109/14767050903572190; Mazaki-Tovi S, 2010, J MATERN-FETAL NEO M, V23, P857, DOI 10.3109/14767050903301017; Mazaki-Tovi S, 2010, AM J REPROD IMMUNOL, V63, P358, DOI 10.1111/j.1600-0897.2010.00809.x; Mazaki-Tovi S, 2010, J PERINAT MED, V38, P147, DOI [10.1515/JPM.2010.044, 10.1515/jpm.2010.044]; Mazaki-Tovi S, 2010, J MATERN-FETAL NEO M, V23, P120, DOI 10.3109/14767050903026481; Mazaki-Tovi S, 2010, AM J REPROD IMMUNOL, V63, P252, DOI 10.1111/j.1600-0897.2009.00804.x; Mazaki-Tovi S, 2009, J PERINAT MED, V37, P637, DOI 10.1515/JPM.2009.101; Mazaki-Tovi S, 2009, J PERINAT MED, V37, P623, DOI 10.1515/JPM.2009.128; Mazaki-Tovi S, 2009, J MATERN-FETAL NEO M, V22, P887, DOI 10.1080/14767050902994655; Mazaki-Tovi S, 2009, J MATERN-FETAL NEO M, V22, P693, DOI 10.1080/14767050902994788; Mazaki-Tovi S, 2009, J PERINAT MED, V37, P218, DOI 10.1515/JPM.2009.053; Mazaki-Tovi S, 2009, J PERINAT MED, V37, P349, DOI 10.1515/JPM.2009.085; Mazaki-Tovi S, 2009, J PERINAT MED, V37, P206, DOI 10.1515/JPM.2009.054; Mazurek T, 2003, CIRCULATION, V108, P2460, DOI 10.1161/01.CIR.0000099542.57313.C5; Mei-Dan E, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.10.020; Mendall MA, 1996, BRIT MED J, V312, P1061; Michaels JEA, 2007, J PROTEOME RES, V6, P1277, DOI 10.1021/pr060543t; Michels KB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025254; Miranda M, 2010, J CLIN ENDOCR METAB, V95, P3470, DOI 10.1210/jc.2009-2655; Mittal P, 2010, J PERINAT MED, V38, P617, DOI [10.1515/JPM.2010.097, 10.1515/jpm.2010.097]; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Moller-Levet CS, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000571; Montague CT, 1998, DIABETES, V47, P1384, DOI 10.2337/diabetes.47.9.1384; Morgan SA, 2008, PEPTIDES, V29, P1382, DOI 10.1016/j.peptides.2008.04.010; Mowa CN, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-64; Mutch DM, 2009, AM J CLIN NUTR, V89, P51, DOI 10.3945/ajcn.2008.26802; Naccasha N, 2001, AM J OBSTET GYNECOL, V185, P1118, DOI 10.1067/mob.2001.117682; Naruse K, 2005, J REPROD IMMUNOL, V65, P65, DOI 10.1016/j.jri.2004.09.004; Netea MG, 2006, NAT MED, V12, P650, DOI 10.1038/nm1415; Nhan-Chang CL, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.02.045; Ni JZ, 2007, GENE DEV, V21, P708, DOI 10.1101/gad.1525507; Nien JK, 2007, J PERINAT MED, V35, P522, DOI 10.1515/JPM.2007.123; Nien JK, 2007, J PERINAT MED, V35, P513, DOI 10.1515/JPM.2007.122; Nien JK, 2007, J PERINAT MED, V35, P503, DOI 10.1515/JPM.2007.121; Nohr EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008444; O'Brien M, 2008, REPROD SCI, V15, P382, DOI 10.1177/1933719108316179; Obermann H, 2003, MOL REPROD DEV, V64, P13, DOI 10.1002/mrd.10220; Ognjanovic S, 2002, AM J OBSTET GYNECOL, V187, P1051, DOI 10.1067/mob.2002.126295; Okamoto Y, 2008, CIRC RES, V102, P218, DOI 10.1161/CIRCRESAHA.107.164988; OKUNO S, 1995, HORM METAB RES, V27, P231, DOI 10.1055/s-2007-979946; Orcy RB, 2008, GYNECOL OBSTET INVES, V66, P231, DOI 10.1159/000147169; Osterhoff C, 1997, DNA CELL BIOL, V16, P379, DOI 10.1089/dna.1997.16.379; Oteng-Ntim E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053749; Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473; Pacora P, 2002, J Matern Fetal Neonatal Med, V11, P18, DOI 10.1080/713605445; Park JS, 2008, REPROD SCI, V15, P457, DOI 10.1177/1933719108316909; Park SJ, 2006, PROTEOMICS, V6, P349, DOI 10.1002/pmic.200500084; Parry S, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.06.035; PHELPS RL, 1981, AM J OBSTET GYNECOL, V140, P730, DOI 10.1016/0002-9378(81)90731-6; PIPE NGJ, 1979, BRIT J OBSTET GYNAEC, V86, P929, DOI 10.1111/j.1471-0528.1979.tb11240.x; POLDERMAN KH, 1994, J CLIN ENDOCR METAB, V79, P265, DOI 10.1210/jc.79.1.265; Poole AT, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.06.004; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Purdom E, 2008, BIOINFORMATICS, V24, P1707, DOI 10.1093/bioinformatics/btn284; Ramsay JE, 2003, HYPERTENSION, V42, P891, DOI 10.1161/01.HYP.0000095981.92542.F6; Ranheim T, 2004, ACTA OBSTET GYN SCAN, V83, P341, DOI 10.1111/j.0001-6349.2004.00413.x; Read CP, 2007, REPRODUCTION, V134, P327, DOI 10.1530/REP-07-0032; REBUFFESCRIVE M, 1985, J CLIN INVEST, V75, P1973, DOI 10.1172/JCI111914; Redline RW, 2006, SEMIN FETAL NEONAT M, V11, P296, DOI 10.1016/j.siny.2006.02.011; Rehrer CW, 2012, OBESITY, V20, P2168, DOI 10.1038/oby.2012.117; Resi V, 2012, AM J PHYSIOL-ENDOC M, V303, pE832, DOI 10.1152/ajpendo.00002.2012; Reynisdottir S, 1997, J CLIN ENDOCR METAB, V82, P4162, DOI 10.1210/jc.82.12.4162; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P118, DOI 10.1111/j.1471-0528.2006.01150.x; Romero R, 2009, J MATERN-FETAL NEO M; Romero R, 2008, J MATERN-FETAL NEO M, V21, P367, DOI 10.1080/14767050802045848; Romero R, 2006, AM J OBSTET GYNECOL, V195, P360, DOI 10.1016/j.ajog.2006.06.077; Romero R, 2010, J MATERN-FETAL NEO M, V23, P1344, DOI 10.3109/14767058.2010.482618; Rosa-e-Silva JC, 2015, AM J OBSTET GYNECOL, V212, P407, DOI 10.1016/j.ajog.2014.11.038; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Ruetschi U, 2005, J PROTEOME RES, V4, P2236, DOI 10.1021/pr050139e; RYAN EA, 1985, DIABETES, V34, P380, DOI 10.2337/diabetes.34.4.380; RYAN EA, 1988, J CLIN ENDOCR METAB, V67, P341, DOI 10.1210/jcem-67-2-341; Ryden M, 2001, INT J OBESITY, V25, P811, DOI 10.1038/sj.ijo.0801625; Saghizadeh M, 1996, J CLIN INVEST, V97, P1111, DOI 10.1172/JCI118504; Saijo S, 2005, BIOCHEM BIOPH RES CO, V334, P1180, DOI 10.1016/j.bbrc.2005.07.016; Samaras K, 2010, OBESITY, V18, P884, DOI 10.1038/oby.2009.443; Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100; Schaffler A, 2005, BBA-GENE STRUCT EXPR, V1732, P96, DOI 10.1016/j.bbaexp.2005.11.005; Schupp M, 2009, J BIOL CHEM, V284, P9458, DOI 10.1074/jbc.M809498200; Seol HJ, 2011, J PERINAT MED, V39, P287, DOI [10.1515/JPM.2011.016, 10.1515/jpm.2011.016]; Silswal N, 2005, BIOCHEM BIOPH RES CO, V334, P1092, DOI 10.1016/j.bbrc.2005.06.202; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; SOHLSTROM A, 1995, AM J CLIN NUTR, V61, P287, DOI 10.1093/ajcn/61.2.287; Soto E, 2010, J MATERN-FETAL NEO M, V23, P1085, DOI 10.3109/14767051003649870; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Stepan H, 2011, REGUL PEPTIDES, V168, P69, DOI 10.1016/j.regpep.2011.03.005; Subramaniam A, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.06.045; Sugerman HJ, 2014, AM J OBSTET GYNECOL, V210, P375, DOI 10.1016/j.ajog.2013.10.014; Suwaki N, 2006, AM J OBSTET GYNECOL, V195, P1687, DOI 10.1016/j.ajog.2006.04.003; Sween LK, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.07.055; Szamatowicz J, 2009, GINEKOL POL, V80, P14; Tan BK, 2010, TRENDS CARDIOVAS MED, V20, P143, DOI 10.1016/j.tcm.2010.12.002; Tchernof A, 2006, DIABETES, V55, P1353, DOI 10.2337/db05-1439; Telejko B, 2010, EXP CLIN ENDOCR DIAB, V118, P87, DOI 10.1055/s-0029-1238313; Telejko B, 2010, DIABETES RES CLIN PR, V87, P176, DOI 10.1016/j.diabres.2009.10.018; Telejko B, 2009, DIABETES RES CLIN PR, V84, P68, DOI 10.1016/j.diabres.2008.12.017; Thorsen K, 2008, MOL CELL PROTEOMICS, V7, P1214, DOI 10.1074/mcp.M700590-MCP200; Tian ZG, 2002, BIOCHEM BIOPH RES CO, V298, P297, DOI 10.1016/S0006-291X(02)02462-2; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Vaisbuch E, 2009, J MATERN-FETAL NEO M; Vaisbuch E, 2010, J PERINAT MED, V38, P359, DOI 10.1515/jpm.2010.066; Vaisbuch E, 2010, J PERINAT MED, V38, P129, DOI [10.1515/JPM.2009.140, 10.1515/jpm.2009.140]; Van Harmelen V, 1998, DIABETES, V47, P913, DOI 10.2337/diabetes.47.6.913; van Harmelen V, 2002, DIABETES, V51, P2029, DOI 10.2337/diabetes.51.7.2029; Venables JP, 2006, BIOESSAYS, V28, P378, DOI 10.1002/bies.20390; Verma S, 2003, CIRCULATION, V108, P736, DOI 10.1161/01.CIR.0000084503.91330.49; Vidal H, 2001, ANN MED, V33, P547, DOI 10.3109/07853890108995965; Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131; Vohl MC, 2004, OBES RES, V12, P1217, DOI 10.1038/oby.2004.153; Von Eyben FE, 2004, ANN NY ACAD SCI, V1030, P508, DOI 10.1196/annals.1329.063; Vozarova B, 2001, OBES RES, V9, P414, DOI 10.1038/oby.2001.54; Vuadens F, 2003, PROTEOMICS, V3, P1521, DOI 10.1002/pmic.200300455; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Walker GE, 2008, OBESITY, V16, P1983, DOI 10.1038/oby.2008.326; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Wang H, 2001, MOL HUM REPROD, V7, P293, DOI 10.1093/molehr/7.3.293; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; WHITE RT, 1992, J BIOL CHEM, V267, P9210; Wolf AM, 2004, BIOCHEM BIOPH RES CO, V323, P630, DOI 10.1016/j.bbrc.2004.08.145; Worda C, 2004, AM J OBSTET GYNECOL, V191, P2120, DOI 10.1016/j.ajog.2004.04.038; Wronska A, 2012, ACTA PHYSIOL, V205, P194, DOI 10.1111/j.1748-1716.2012.02409.x; Yamaguchi N, 2005, FEBS LETT, V579, P6821, DOI 10.1016/j.febslet.2005.11.019; Yang RZ, 2006, PLOS MED, V3, P884, DOI 10.1371/journal.pmed.0030287; Yang RZ, 2006, AM J PHYSIOL-ENDOC M, V290, pE1253, DOI 10.1152/ajpendo.00572.2004; Yao RF, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2014.01.044; Yokota T, 2003, J IMMUNOL, V171, P5091, DOI 10.4049/jimmunol.171.10.5091; Yokota T, 2000, BLOOD, V96, P1723, DOI 10.1182/blood.V96.5.1723; Yu ZB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061627; Zera CA, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.03.020; Zha JM, 2009, ENDOCR J, V56, P935, DOI 10.1507/endocrj.K09E-091; Zhang JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064542; Zhang LY, 2011, J MOL ENDOCRINOL, V47, P157, DOI 10.1530/JME-11-0030; Zhang W, 2009, HUM GENET, V125, P81, DOI 10.1007/s00439-008-0601-x; Zhang YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038603; Zhao T, 2005, CELL IMMUNOL, V238, P19, DOI 10.1016/j.cellimm.2005.12.002; Zhou Yongming, 2006, J Huazhong Univ Sci Technolog Med Sci, V26, P288	331	10	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143779	10.1371/journal.pone.0143779	http://dx.doi.org/10.1371/journal.pone.0143779			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636677	Green Published, Green Submitted, gold			2022-12-27	WOS:000366143800026
J	Wang, SW; Yu, J; Suvira, M; Setlow, P; Li, YQ				Wang, Shiwei; Yu, Jing; Suvira, Milomir; Setlow, Peter; Li, Yong-qing			Uptake of and Resistance to the Antibiotic Berberine by Individual Dormant, Germinating and Outgrowing Bacillus Spores as Monitored by Laser Tweezers Raman Spectroscopy	PLOS ONE			English	Article							ESCHERICHIA-COLI; SUBTILIS; ACID; DNA	Berberine, an alkaloid originally extracted from the plant Coptis chinensis and other herb plants, has been used as a pharmacological substance for many years. The therapeutic effect of berberine has been attributed to its interaction with nucleic acids and blocking cell division. However, levels of berberine entering individual microbial cells minimal for growth inhibition and its effects on bacterial spores have not been determined. In this work the kinetics and levels of berberine accumulation by individual dormant and germinated spores were measured by laser tweezers Raman spectroscopy and differential interference and fluorescence microscopy, and effects of berberine on spore germination and outgrowth and spore and growing cell viability were determined. The major conclusions from this work are that: (1) colony formation from B. subtilis spores was blocked similar to 99% by 25 mu g/mL berberine plus 20 mu g/mL INF55 (a multidrug resistance pump inhibitor); (2) 200 mu g/mL berberine had no effect on B. subtilis spore germination with L-valine, but spore outgrowth was completely blocked; (3) berberine levels accumulated in single spores germinating with >= 25 mu g/mL berberine were > 10 mg/mL; (4) fluorescence microscopy showed that germinated spores accumulated high-levels of berberine primarily in the spore core, while dormant spores accumulated very low berberine levels primarily in spore coats; and (5) during germination, uptake of berberine began at the time of commitment (T-1) and reached a maximum after the completion of CaDPA release (T-release) and spore cortex lysis (T-lysis).	[Wang, Shiwei; Yu, Jing; Li, Yong-qing] E Carolina Univ, Dept Phys, Greenville, NC 27858 USA; [Suvira, Milomir; Setlow, Peter] UConn Hlth, Dept Mol Biol & Biophys, Farmington, CT 06030 USA	University of North Carolina; East Carolina University	Li, YQ (corresponding author), E Carolina Univ, Dept Phys, Greenville, NC 27858 USA.	liy@ecu.edu		Suvira, Milomir/0000-0003-2086-1388	Army Research Office [W911NF-12-2-0024, W911F-09-1-0286]; Department of Defense Multi-disciplinary University Research Initiative through the U.S. Army Research Laboratory	Army Research Office; Department of Defense Multi-disciplinary University Research Initiative through the U.S. Army Research Laboratory	This work was supported by a grant from the Army Research Office under contract number W911NF-12-2-0024 and by a Department of Defense Multi-disciplinary University Research Initiative through the U.S. Army Research Laboratory and the U.S. Army Research Office under contract number W911F-09-1-0286 (PS/YQL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a grant from the Army Research Office under contract number W911NF-12-2-0024 and by a Department of Defense Multi-disciplinary University Research Initiative through the U.S. Army Research Laboratory and the U.S. Army Research Office under contract number W911F-09-1-0286 (PS/YQL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We are grateful to Barbara Setlow for assistance with one experiment.	AMIN AH, 1969, CAN J MICROBIOL, V15, P1067, DOI 10.1139/m69-190; Ball AR, 2006, ACS CHEM BIOL, V1, P594, DOI 10.1021/cb600238x; Boberek JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013745; DAVIDSON MW, 1977, NUCLEIC ACIDS RES, V4, P2697, DOI 10.1093/nar/4.8.2697; Domadia PN, 2008, BIOCHEMISTRY-US, V47, P3225, DOI 10.1021/bi7018546; Kong LB, 2011, NAT PROTOC, V6, P625, DOI 10.1038/nprot.2011.307; Kong LB, 2010, ANAL CHEM, V82, P8717, DOI 10.1021/ac1022327; Kong WJ, 2012, APPL MICROBIOL BIOT, V96, P503, DOI 10.1007/s00253-012-4302-y; Li XZ, 2004, DRUGS, V64, P159, DOI 10.2165/00003495-200464020-00004; Mao LY, 2011, CURR MICROBIOL, V63, P198, DOI 10.1007/s00284-011-9967-4; Nicholson WL., 1990, MOL BIOL METHODS BAC, P391, DOI DOI 10.1111/J.1751-1097.1991.TB02087.X; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Olguin-Araneda V, 2015, RES MICROBIOL, V166, P236, DOI 10.1016/j.resmic.2014.07.017; Setlow B, 1996, J BACTERIOL, V178, P3486, DOI 10.1128/jb.178.12.3486-3495.1996; Setlow P, 2003, CURR OPIN MICROBIOL, V6, P550, DOI 10.1016/j.mib.2003.10.001; Setlow P, 2013, J APPL MICROBIOL, V115, P1251, DOI 10.1111/jam.12343; Setlow P, 2012, FOOD MICROBIOLOGY FU, V4th, P45; Setlow P, 2014, J BACTERIOL, V196, P1297, DOI 10.1128/JB.01455-13; Sinai L, 2015, MOL CELL, V57, P695, DOI 10.1016/j.molcel.2014.12.019; Taylor CT, 1999, EUR J PHARMACOL, V368, P111, DOI 10.1016/S0014-2999(99)00023-0; Tomkiewicz D, 2010, ANTIMICROB AGENTS CH, V54, P3219, DOI 10.1128/AAC.01715-09; Wang SW, 2015, J BACTERIOL, V197, P1095, DOI 10.1128/JB.02490-14; Wang ST, 2006, J MOL BIOL, V358, P16, DOI 10.1016/j.jmb.2006.01.059; Yi XA, 2010, J BACTERIOL, V192, P3424, DOI 10.1128/JB.00326-10; Zhang PF, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3494567; Zuo F, 2006, DRUG METAB DISPOS, V34, P2064, DOI 10.1124/dmd.106.011361	26	6	6	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144183	10.1371/journal.pone.0144183	http://dx.doi.org/10.1371/journal.pone.0144183			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636757	Green Published, gold, Green Submitted			2022-12-27	WOS:000366143800055
J	Agmo, A; Snoeren, EMS				Agmo, Anders; Snoeren, Eelke M. S.			Silent or Vocalizing Rats Copulate in a Similar Manner	PLOS ONE			English	Article							50-KHZ ULTRASONIC VOCALIZATIONS; RATTUS-NORVEGICUS; SEXUAL-BEHAVIOR; FEMALE RATS; PLAYFUL INTERACTIONS; INCENTIVE VALUE; CALLS; COMMUNICATION; DEVOCALIZATION; EXPERIENCE	Both male and female rats produce 50 kHz ultrasonic vocalizations (USVs) in the presence of a sexual partner and during copulation. Previous studies showed that USVs have no incentive value for rats. In this study, we evaluated the role of USVs in behavior during copulation. Three groups of rats were used: sham males paired with sham females, devocalized females paired with sham males, and sham females paired with devocalized males. During the copulation test, the USVs emitted by the sham rat were recorded and the sexual behavior of both the male and the female were observed. The results revealed that devocalized and sham females showed similar patterns of sexual behavior and no difference was found in the copulatory behavior of devocalized and sham males. Also the behavior of the partner of a sham rat was comparable to the partner of a devocalized rat. In addition, almost no changes in USVs emission were found in the 5 seconds before and/or after a copulatory behavior. It can be concluded that USVs play no important role in rat copulatory behavior at least in sexually naive rats.	[Agmo, Anders; Snoeren, Eelke M. S.] Univ Tromso, Dept Psychol, Tromso, Norway	UiT The Arctic University of Tromso	Snoeren, EMS (corresponding author), Univ Tromso, Dept Psychol, Tromso, Norway.	eelke.snoeren@uit.no		Snoeren, Eelke/0000-0001-9652-1668; Agmo, Anders/0000-0002-7087-0429				BARFIELD RJ, 1979, AM ZOOL, V19, P469; BARFIELD RJ, 1986, ANN NY ACAD SCI, V474, P33, DOI 10.1111/j.1749-6632.1986.tb27996.x; BELL RW, 1974, DEV PSYCHOBIOL, V7, P39, DOI 10.1002/dev.420070107; Bialy M, 2000, BEHAV NEUROSCI, V114, P983, DOI 10.1037//0735-7044.114.5.983; BLUMBERG MS, 1992, J COMP PSYCHOL, V106, P360, DOI 10.1037/0735-7036.106.4.360; Brudzynski SM, 2005, BEHAV GENET, V35, P85, DOI 10.1007/s10519-004-0858-3; Burgdorf J, 2008, J COMP PSYCHOL, V122, P357, DOI 10.1037/a0012889; Cruz-Casallas PE, 2000, PSYCHOBIOLOGY, V28, P406; GEYER LA, 1978, J COMP PHYSIOL PSYCH, V92, P457, DOI 10.1037/h0077478; Hegoburu C, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00025; Himmler BT, 2014, BEHAV PROCESS, V106, P60, DOI 10.1016/j.beproc.2014.04.014; Kisko TM, 2015, BEHAV PROCESS, V113, P113, DOI 10.1016/j.beproc.2015.01.016; Kisko TM, 2015, BEHAV PROCESS, V111, P25, DOI 10.1016/j.beproc.2014.11.011; Knutson B, 1998, J COMP PSYCHOL, V112, P65, DOI 10.1037/0735-7036.112.1.65; McGinnis MY, 2003, PHYSIOL BEHAV, V80, P81, DOI 10.1016/S0031-9384(03)00227-0; Riede T, 2013, J EXP ZOOL PART A, V319A, P213, DOI 10.1002/jez.1785; Riede T, 2011, J NEUROPHYSIOL, V106, P2580, DOI 10.1152/jn.00478.2011; ROBERTS LH, 1972, J ZOOL, V168, P439; Snoeren EMS, 2014, J COMP PSYCHOL, V128, P367, DOI 10.1037/a0036541; Snoeren EMS, 2014, J COMP PSYCHOL, V128, P40, DOI 10.1037/a0033204; Snoeren EMS, 2013, BEHAV NEUROSCI, V127, P439, DOI 10.1037/a0032027; THOMAS DA, 1982, J COMP PHYSIOL PSYCH, V96, P807, DOI 10.1037/h0077919; THOMAS DA, 1981, J COMP PHYSIOL PSYCH, V95, P630, DOI 10.1037/h0077803; THOR DH, 1977, PHYSIOL BEHAV, V19, P411, DOI 10.1016/0031-9384(77)90287-6; WHITE NR, 1990, J COMP PSYCHOL, V104, P255, DOI 10.1037/0735-7036.104.3.255; WHITE NR, 1987, J COMP PSYCHOL, V101, P73, DOI 10.1037/0735-7036.101.1.73; WHITE NR, 1990, J COMP PSYCHOL, V104, P140, DOI 10.1037/0735-7036.104.2.140; WHITE NR, 1989, PHYSIOL BEHAV, V45, P229, DOI 10.1016/0031-9384(89)90123-6; WHITE NR, 1990, J COMP PSYCHOL, V104, P147, DOI 10.1037/0735-7036.104.2.147; Willadsen M, 2014, J COMP PSYCHOL, V128, P56, DOI 10.1037/a0034778; Wohr M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001365; Wohr M, 2013, CELL TISSUE RES, V354, P81, DOI 10.1007/s00441-013-1607-9; Wright JM, 2010, PSYCHOPHARMACOLOGY, V211, P1, DOI 10.1007/s00213-010-1859-y	33	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144164	10.1371/journal.pone.0144164	http://dx.doi.org/10.1371/journal.pone.0144164			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633013	Green Published, gold			2022-12-27	WOS:000366040000064
J	Crockett, T; Wright, N; Thornquist, S; Ariel, M; Wessel, R				Crockett, Thomas; Wright, Nathaniel; Thornquist, Stephen; Ariel, Michael; Wessel, Ralf			Turtle Dorsal Cortex Pyramidal Neurons Comprise Two Distinct Cell Types with Indistinguishable Visual Responses	PLOS ONE			English	Article							SUBTYPE-SPECIFIC GENES; SPINY STELLATE; IN-VIVO; INTERNEURONS; LAYER; CLASSIFICATION; PROJECTIONS; EXCITATION; MORPHOLOGY; DIVERSITY	A detailed inventory of the constituent pieces in cerebral cortex is considered essential to understand the principles underlying cortical signal processing. Specifically, the search for pyramidal neuron subtypes is partly motivated by the hypothesis that a subtype-specific division of labor could create a rich substrate for computation. On the other hand, the extreme integration of individual neurons into the collective cortical circuit promotes the hypothesis that cellular individuality represents a smaller computational role within the context of the larger network. These competing hypotheses raise the important question to what extent the computational function of a neuron is determined by its individual type or by its circuit connections. We created electrophysiological profiles from pyramidal neurons within the sole cellular layer of turtle visual cortex by measuring responses to current injection using whole-cell recordings. A blind clustering algorithm applied to these data revealed the presence of two principle types of pyramidal neurons. Brief diffuse light flashes triggered membrane potential fluctuations in those same cortical neurons. The apparently network driven variability of the visual responses concealed the existence of subtypes. In conclusion, our results support the notion that the importance of diverse intrinsic physiological properties is minimized when neurons are embedded in a synaptic recurrent network.	[Crockett, Thomas; Wright, Nathaniel; Thornquist, Stephen; Wessel, Ralf] Washington Univ, Dept Phys, St Louis, MO 63130 USA; [Ariel, Michael] St Louis Univ, Sch Med, Dept Physiol & Pharmacol, St Louis, MO USA	Washington University (WUSTL); Saint Louis University	Crockett, T (corresponding author), Washington Univ, Dept Phys, St Louis, MO 63130 USA.	thomas.crockett@wustl.edu			National Science Foundation CRCNS grant [1308159]; Whitehall Foundation [20121221]; NSF CRCNS grant [1308159]; Direct For Computer & Info Scie & Enginr [1308159] Funding Source: National Science Foundation	National Science Foundation CRCNS grant; Whitehall Foundation; NSF CRCNS grant(National Science Foundation (NSF)NSF - Office of the Director (OD)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was funded by National Science Foundation CRCNS grant (#1308159, RW) and by the Whitehall Foundation, grant number (#20121221, RW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Mahmood Hosseini for his help in developing the computational model. This research was supported by a Whitehall Foundation grant #20121221 and a NSF CRCNS grant #1308159 to R. Wessel.	Andjelic S, 2009, J NEUROPHYSIOL, V101, P641, DOI 10.1152/jn.91094.2008; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; ARMSTRONGJAMES M, 1992, J NEUROPHYSIOL, V68, P1345, DOI 10.1152/jn.1992.68.4.1345; BARANYI A, 1993, J NEUROPHYSIOL, V69, P1865, DOI 10.1152/jn.1993.69.6.1865; Battaglia D, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00013; Bekkers JM, 2013, TRENDS NEUROSCI, V36, P429, DOI 10.1016/j.tins.2013.04.005; Brecht M, 2002, J PHYSIOL-LONDON, V543, P49, DOI 10.1113/jphysiol.2002.018465; Brumback A, 2014, NEUROLOGY S7, V82, pS329; Brunel N, 2003, J NEUROPHYSIOL, V90, P415, DOI 10.1152/jn.01095.2002; CALVIN WH, 1976, J NEUROPHYSIOL, V39, P420, DOI 10.1152/jn.1976.39.2.420; Cauli B, 1997, J NEUROSCI, V17, P3894; Cauli B, 2000, P NATL ACAD SCI USA, V97, P6144, DOI 10.1073/pnas.97.11.6144; Christophe E, 2005, J NEUROPHYSIOL, V94, P3357, DOI 10.1152/jn.00076.2005; Colombe JB, 2004, J COMP NEUROL, V471, P333, DOI 10.1002/cne.20037; CONNORS BW, 1986, J NEUROSCI, V6, P164; de Kock CPJ, 2007, J PHYSIOL-LONDON, V581, P139, DOI 10.1113/jphysiol.2006.124321; Desan P.H., 1984, THESIS; Dugas-Ford J, 2012, P NATL ACAD SCI USA, V109, P16974, DOI 10.1073/pnas.1204773109; Fournier J, 2015, CURR OPIN NEUROBIOL, V31, P119, DOI 10.1016/j.conb.2014.09.006; Gallopin T, 2006, CEREB CORTEX, V16, P1440, DOI 10.1093/cercor/bhj081; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; Graves AR, 2012, NEURON, V76, P776, DOI 10.1016/j.neuron.2012.09.036; Groh A, 2010, CEREB CORTEX, V20, P826, DOI 10.1093/cercor/bhp152; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; HELLER SB, 1987, ANAT EMBRYOL, V175, P505, DOI 10.1007/BF00309685; Helmstaedter M, 2009, CEREB CORTEX, V19, P938, DOI 10.1093/cercor/bhn138; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Johnson DMG, 2000, J NEUROSCI, V20, P6974, DOI 10.1523/JNEUROSCI.20-18-06974.2000; Johnston D., 2004, SYNAPTIC ORG BRAIN, V5th, P455; Karagiannis A, 2009, J NEUROSCI, V29, P3642, DOI 10.1523/JNEUROSCI.0058-09.2009; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; KRIEGSTEIN AR, 1987, J NEUROSCI, V7, P2488; Krimer LS, 2005, J NEUROPHYSIOL, V94, P3009, DOI 10.1152/jn.00156.2005; Larkum ME, 2008, J NEUROPHYSIOL, V99, P683, DOI 10.1152/jn.01076.2007; Lee AT, 2014, NEURON, V81, P61, DOI 10.1016/j.neuron.2013.10.031; Mancilla JG, 1998, VISUAL NEUROSCI, V15, P979, DOI 10.1017/S0952523898155190; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Martinez LM, 2005, NAT NEUROSCI, V8, P372, DOI 10.1038/nn1404; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Molyneaux BJ, 2015, NEURON, V85, P275, DOI 10.1016/j.neuron.2014.12.024; Molyneaux BJ, 2009, J NEUROSCI, V29, P12343, DOI 10.1523/JNEUROSCI.6108-08.2009; Moore CI, 2010, CELL, V142, P184, DOI 10.1016/j.cell.2010.07.005; MULLIGAN KA, 1990, J COMP NEUROL, V296, P531, DOI 10.1002/cne.902960403; Neville K.R., 2004, SYNAPTIC ORG BRAIN, P415, DOI DOI 10.1093/ACPR0F:0S0/9780195159561.003.0010; Nowak LG, 2003, J NEUROPHYSIOL, V89, P1541, DOI 10.1152/jn.00580.2002; Porter JT, 2001, J NEUROSCI, V21, P2699, DOI 10.1523/JNEUROSCI.21-08-02699.2001; REINER A, 2000, EVOLUTIONARY DEV BIO, P83; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Sachidhanandam S, 2013, NAT NEUROSCI, V16, P1671, DOI 10.1038/nn.3532; Saha D, 2011, J COMP PHYSIOL A, V197, P153, DOI 10.1007/s00359-010-0596-3; Schubert D, 2001, J NEUROSCI, V21, P3580, DOI 10.1523/JNEUROSCI.21-10-03580.2001; Sekerli M, 2004, IEEE T BIO-MED ENG, V51, P1665, DOI 10.1109/TBME.2004.827531; Senseman DM, 1996, VISUAL NEUROSCI, V13, P963, DOI 10.1017/S0952523800009196; SHEN JM, 1986, J NEUROPHYSIOL, V56, P1626, DOI 10.1152/jn.1986.56.6.1626; Shepherd GM, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00030; Shew WL, 2015, NAT PHYS, V11, P659, DOI 10.1038/NPHYS3370; SMITH LM, 1980, J COMP NEUROL, V190, P445, DOI 10.1002/cne.901900304; Soltesz I., 2006, DIVERSITY NEURONAL M; Sosulina L, 2006, MOL CELL NEUROSCI, V33, P57, DOI 10.1016/j.mcn.2006.06.005; Staiger JF, 2004, CEREB CORTEX, V14, P690, DOI 10.1093/cercor/bhh029; Striedter G.F., 2005, PRINCIPLES BRAIN EVO; Suzuki N, 2006, J NEUROSCI, V26, P11938, DOI 10.1523/JNEUROSCI.3473-06.2006; Suzuki N, 2011, J NEUROSCI, V31, P2156, DOI 10.1523/JNEUROSCI.5430-10.2011; Swanson L. W., 2003, BRAIN ARCHITECTURE U; TAKAHASHI K, 1965, J NEUROPHYSIOL, V28, P908, DOI 10.1152/jn.1965.28.5.908; Thorndike R. L., 1953, PSYCHOMETRIKA, V18, P267, DOI [10.1007/BF02289263, DOI 10.1007/BF02289263]; Ulinski P., 2007, P195; ULINSKI PS, 1986, J COMP NEUROL, V254, P529, DOI 10.1002/cne.902540406; Wang Y, 2006, NAT NEUROSCI, V9, P534, DOI 10.1038/nn1670; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967	71	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144012	10.1371/journal.pone.0144012	http://dx.doi.org/10.1371/journal.pone.0144012			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633877	Green Submitted, Green Published, gold			2022-12-27	WOS:000366040000041
J	Lake, RJ; Devleesschauwer, B; Nasinyama, G; Havelaar, AH; Kuchenmuller, T; Haagsma, JA; Jensen, HH; Jessani, N; de Noordhout, CM; Angulo, FJ; Ehiri, JE; Molla, L; Agaba, F; Aungkulanon, S; Kumagai, Y; Speybroeck, N				Lake, Robin J.; Devleesschauwer, Brecht; Nasinyama, George; Havelaar, Arie H.; Kuchenmueller, Tanja; Haagsma, Juanita A.; Jensen, Helen H.; Jessani, Nasreen; de Noordhout, Charline Maertens; Angulo, Frederick J.; Ehiri, John E.; Molla, Lindita; Agaba, Friday; Aungkulanon, Suchunya; Kumagai, Yuko; Speybroeck, Niko			National Studies as a Component of the World Health Organization Initiative to Estimate the Global and Regional Burden of Foodborne Disease	PLOS ONE			English	Article							ALBANIA	Background The World Health Organization (WHO) initiative to estimate the global burden of foodborne diseases established the Foodborne Diseases Burden Epidemiology Reference Group (FERG) in 2007. In addition to global and regional estimates, the initiative sought to promote actions at a national level. This involved capacity building through national foodborne disease burden studies, and encouragement of the use of burden information in setting evidence-informed policies. To address these objectives a FERG Country Studies Task Force was established and has developed a suite of tools and resources to facilitate national burden of foodborne disease studies. This paper describes the process and lessons learned during the conduct of pilot country studies under the WHO FERG initiative. Findings Pilot country studies were initiated in Albania, Japan and Thailand in 2011 and in Uganda in 2012. A brief description of each study is provided. The major scientific issue is a lack of data, particularly in relation to disease etiology, and attribution of disease burden to foodborne transmission. Situation analysis, knowledge translation, and risk communication to achieve evidence-informed policies require specialist expertise and resources. Conclusions The FERG global and regional burden estimates will greatly enhance the ability of individual countries to fill data gaps and generate national estimates to support efforts to reduce the burden of foodborne disease.	[Lake, Robin J.] Inst Environm Sci & Res, Christchurch, New Zealand; [Devleesschauwer, Brecht] Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, Merelbeke, Belgium; [Devleesschauwer, Brecht] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Devleesschauwer, Brecht; de Noordhout, Charline Maertens; Speybroeck, Niko] Catholic Univ Louvain, Fac Publ Hlth, Inst Hlth & Soc, B-1200 Brussels, Belgium; [Devleesschauwer, Brecht; Havelaar, Arie H.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Nasinyama, George] Makerere Univ, Kampala, Uganda; [Kuchenmueller, Tanja] WHO Reg Off Europe, Div Informat Evidence Res & Innovat, Copenhagen, Denmark; [Haagsma, Juanita A.] Erasmus Univ, Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [Jensen, Helen H.] Iowa State Univ, Ames, IA USA; [Jessani, Nasreen] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Angulo, Frederick J.] Ctr Dis Control & Prevent, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA USA; [Ehiri, John E.] Univ Arizona, Mel & Enid Zuckerman Coll Publ Hlth, Tucson, AZ USA; [Molla, Lindita] Inst Publ Hlth, Hlth & Environm Dept, Food Safety & Nutr Sect, Tirana, Albania; [Agaba, Friday] Minist Hlth, Natl Drug Author, Kampala, Uganda; [Aungkulanon, Suchunya] Minist Publ Hlth, Int Hlth Policy Program, Bangkok, Thailand; [Kumagai, Yuko] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Med Sci, Tokyo, Japan	Institute of Environmental Science & Research (ESR) - New Zealand; Ghent University; Institute of Tropical Medicine (ITM); Universite Catholique Louvain; State University System of Florida; University of Florida; Makerere University; World Health Organization; Erasmus University Rotterdam; Erasmus MC; Iowa State University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Centers for Disease Control & Prevention - USA; University of Arizona; Ministry of Public Health - Thailand; University of Tokyo	Lake, RJ (corresponding author), Inst Environm Sci & Res, Christchurch, New Zealand.	rob.lake@esr.cri.nz	Havelaar, Arie H./P-8495-2014; NASINYAMA, GEORGE/GVS-7396-2022; Nasinyama, George/AAN-3148-2020; Jessani, Nasreen/AAB-5518-2020; Devleesschauwer, Brecht/G-9895-2018	Havelaar, Arie H./0000-0002-6456-5460; Jessani, Nasreen/0000-0002-1160-3099; Devleesschauwer, Brecht/0000-0002-2867-6892; Jensen, Helen/0000-0001-6878-1729; Speybroeck, Niko/0000-0003-3322-3502	World Health Organization (WHO)	World Health Organization (WHO)(World Health Organization)	This study was commissioned and paid for by the World Health Organization (WHO). Copyright in the original work on which this article is based belongs to WHO. The authors have been given permission to publish this article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, apart from Tanja Kuchenmuller who is an employee of WHO and participated in the country studies described in the article, and the writing.	Agaba F., 2015, FERG WHO IN EST GLOB; [Anonymous], 2008, WHO IN EST GLOB BURD; [Anonymous], 2001, NATL BURDEN DIS STUD; Bennett G., 2011, KNOWLEDGE TRANSLATIO; Codex Alimentarius Commission, 632007 CACGL; Devleesschauwer B, 2013, J Nepal Health Res Counc, V11, P221; Etienne Carissa F, 2013, J Health Popul Nutr, V31, P1; Fabiana A, 2007, J MED VIROL, V79, P1844, DOI 10.1002/jmv.21001; Haagsma JA, 2013, INT J FOOD MICROBIOL, V166, P34, DOI 10.1016/j.ijfoodmicro.2013.05.029; Havelaar AH, 2008, FOODBORNE PATHOG DIS, V5, P649, DOI 10.1089/fpd.2008.0115; Institute for Health Metrics and Evaluation, 2013, COUNTR PROF; Kangethe E., 2011, SITUATION ANAL IMPRO; Kumagai Y, 2015, B WORLD HEALTH ORGAN, V93, P540, DOI 10.2471/BLT.14.148056; Pariyo GW, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-39; Polinder S, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-21; Sejdini A, 2011, ANN TROP MED PARASIT, V105, P241, DOI 10.1179/136485911X12987676649584; Tangcharoensathien V, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001726; UNICEF, 2013, ALB CHILDR ALB HLTH; Valenciano M, 2004, EURO SURVEILL, V9; [No title captured]	20	12	12	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0140319	10.1371/journal.pone.0140319	http://dx.doi.org/10.1371/journal.pone.0140319			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633010	Green Published, gold, Green Submitted			2022-12-27	WOS:000366040000001
J	Saunders, B; He, FFH; Inzlicht, M				Saunders, Blair; He, Frank F. H.; Inzlicht, Michael			No Evidence That Gratitude Enhances Neural Performance Monitoring or Conflict-Driven Control	PLOS ONE			English	Article							COGNITIVE CONTROL; BRAIN ACTIVITY; ERROR; MISTAKES; MODEL; TASK	It has recently been suggested that gratitude can benefit self-regulation by reducing impulsivity during economic decision making. We tested if comparable benefits of gratitude are observed for neural performance monitoring and conflict-driven self-control. In a pre-post design, 61 participants were randomly assigned to either a gratitude or happiness condition, and then performed a pre-induction flanker task. Subsequently, participants recalled an autobiographical event where they had felt grateful or happy, followed by a post-induction flanker task. Despite closely following existing protocols, participants in the gratitude condition did not report elevated gratefulness compared to the happy group. In regard to self-control, we found no association between gratitude-operationalized by experimental condition or as a continuous predictor-and any control metric, including flanker interference, post-error adjustments, or neural monitoring (the error-related negativity, ERN). Thus, while gratitude might increase economic patience, such benefits may not generalize to conflict-driven control processes.	[Saunders, Blair; He, Frank F. H.; Inzlicht, Michael] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Inzlicht, Michael] Univ Toronto, Rotman Sch Management, Toronto, ON, Canada	University of Toronto; University of Toronto	Saunders, B (corresponding author), Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada.	blairsaunders01@gmail.com			Ontario Ministry of Research and Innovation; Canada's Natural Sciences and Engineering Research Council	Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Canada's Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was made possible by grants from the Ontario Ministry of Research and Innovation and from Canada's Natural Sciences and Engineering Research Council to Michael Inzlicht.	AINSLIE G, 1975, PSYCHOL BULL, V82, P463, DOI 10.1037/h0076860; Bartlett MY, 2006, PSYCHOL SCI, V17, P319, DOI 10.1111/j.1467-9280.2006.01705.x; Baumeister RF, 2007, CURR DIR PSYCHOL SCI, V16, P351, DOI 10.1111/j.1467-8721.2007.00534.x; Botvinick MM, 2007, COGN AFFECT BEHAV NE, V7, P356, DOI 10.3758/CABN.7.4.356; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Braver TS, 2012, TRENDS COGN SCI, V16, P106, DOI 10.1016/j.tics.2011.12.010; Compton RJ, 2008, PSYCHOL SCI, V19, P702, DOI 10.1111/j.1467-9280.2008.02145.x; Cumming G, 2014, PSYCHOL SCI, V25, P7, DOI 10.1177/0956797613504966; De Bruijn ERA, 2012, Q J EXP PSYCHOL, V65, P317, DOI 10.1080/17470218.2010.545133; DeSteno D, 2014, THE NEW YORK TIME; DeSteno D, 2014, PACIFIC STANDARD; DeSteno D, 2014, PSYCHOL SCI, V25, P1262, DOI 10.1177/0956797614529979; Edwards LJ, 2008, STAT MED, V27, P6137, DOI 10.1002/sim.3429; Emmons R.A., 2004, PSYCHOL GRATITUDE, DOI [10.1093/acprof:oso/9780195150100.001.0001, DOI 10.1093/ACPROF:OSO/9780195150100.001.0001]; Enticott PG, 2006, PERS INDIV DIFFER, V41, P285, DOI 10.1016/j.paid.2006.01.011; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Falkenstein M., 1990, PSYCHOPHYSIOLOGICAL, V1, P192; Franken IHA, 2007, BIOL PSYCHOL, V75, P45, DOI 10.1016/j.biopsycho.2006.11.003; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Hajcak G, 2012, CURR DIR PSYCHOL SCI, V21, P101, DOI 10.1177/0963721412436809; Hirsh JB, 2010, PSYCHOPHYSIOLOGY, V47, P192, DOI 10.1111/j.1469-8986.2009.00877.x; Hobson NM, 2014, EMOTION, V14, P1014, DOI 10.1037/a0038028; Inzlicht M, 2015, TRENDS COGN SCI, V19, P126, DOI 10.1016/j.tics.2015.01.004; Legault L, 2013, J PERS SOC PSYCHOL, V105, P123, DOI 10.1037/a0030426; Levenson R. W., 1994, NATURE EMOTION FUNDA, V1, P123, DOI DOI 10.4324/9780203075630-22; Luck S.J., 2005, INTRO EVENT RELATED; MISCHEL W, 1989, SCIENCE, V244, P933, DOI 10.1126/science.2658056; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Olvet DM, 2009, PSYCHOPHYSIOLOGY, V46, P957, DOI 10.1111/j.1469-8986.2009.00848.x; Olvet DM, 2008, CLIN PSYCHOL REV, V28, P1343, DOI 10.1016/j.cpr.2008.07.003; Picton L, 2012, NEUROPSYCHOLOGIA, V50, P777, DOI 10.1016/j.neuropsychologia.2012.01.011; RABBITT P, 1977, Q J EXP PSYCHOL, V29, P727, DOI 10.1080/14640747708400645; RABBITT P, 1981, Q J EXP PSYCHOL-A, V33, P223, DOI 10.1080/14640748108400790; Saunders B, COGNITIVE A IN PRESS; Saunders B, 2015, PSYCHOPHYSIOLOGY, V52, P1205, DOI 10.1111/psyp.12454; Saunders B, 2012, PSYCHON B REV, V19, P1210, DOI 10.3758/s13423-012-0314-y; van Steenbergen H, 2010, PSYCHOL SCI, V21, P1629, DOI 10.1177/0956797610385951	38	2	2	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143312	10.1371/journal.pone.0143312	http://dx.doi.org/10.1371/journal.pone.0143312			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX9QI	26633830	Green Submitted, Green Published, gold			2022-12-27	WOS:000366040000012
J	Spracklen, BD; Kalamandeen, M; Galbraith, D; Gloor, E; Spracklen, DV				Spracklen, B. D.; Kalamandeen, M.; Galbraith, D.; Gloor, E.; Spracklen, D. V.			A Global Analysis of Deforestation in Moist Tropical Forest Protected Areas	PLOS ONE			English	Article							CLIMATE-CHANGE; PERFORMANCE; LOCATION; PARKS	Protected areas (PAs) have been established to conserve tropical forests, but their effectiveness at reducing deforestation is uncertain. To explore this issue, we combined high resolution data of global forest loss over the period 2000-2012 with data on PAs. For each PA we quantified forest loss within the PA, in buffer zones 1, 5, 10 and 15 km outside the PA boundary as well as a 1 km buffer within the PA boundary. We analysed 3376 tropical and subtropical moist forest PAs in 56 countries over 4 continents. We found that 73% of PAs experienced substantial deforestation pressure, with >0.1% a(-1) forest loss in the outer 1 km buffer. Forest loss within PAs was greatest in Asia (0.25% a(-1)) compared to Africa (0.1% a(-1)), the Neotropics (0.1% a(-1)) and Australasia (Australia and Papua New Guinea; 0.03% a(-1)). We defined performance (P) of a PA as the ratio of forest loss in the inner 1 km buffer compared to the loss that would have occurred in the absence of the PA, calculated as the loss in the outer 1 km buffer corrected for any difference in deforestation pressure between the two buffers. To remove the potential bias due to terrain, we analysed a subset of PAs (n = 1804) where slope and elevation in inner and outer 1 km buffers were similar (within 1 degrees and 100 m, respectively). We found 41% of PAs in this subset reduced forest loss in the inner buffer by at least 25% compared to the expected inner buffer forest loss (P<0.75). Median performance (<(P)over tilde>) of subset reserves was 0.87, meaning a reduction in forest loss within the PA of 13%. We found PAs were most effective in Australasia ((P) over tilde = 0.16), moderately successful in the Neotropics ((P) over tilde = 0.72) and Africa ((P) over tilde = 0.83), but ineffective in Asia ((P) over tilde = 1). We found many countries have PAs that give little or no protection to forest loss, particularly in parts of Asia, west Africa and central America. Across the tropics, the median effectiveness of PAs at the national level improved with gross domestic product per capita. Whilst tropical and subtropical moist forest PAs do reduce forest loss, widely varying performance suggests substantial opportunities for improved protection, particularly in Asia.	[Spracklen, B. D.; Spracklen, D. V.] Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England; [Kalamandeen, M.; Galbraith, D.; Gloor, E.] Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England; [Spracklen, B. D.] Rowans, Thomastown AB54 6AJ, Huntly, Scotland	University of Leeds; University of Leeds	Spracklen, BD (corresponding author), Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England.	b10spracklen@gmail.com	Galbraith, David/AAE-8162-2019; Spracklen, Dominick/AAA-6257-2019; Spracklen, Dominick V/B-4890-2014	Galbraith, David/0000-0002-5555-4823; Kalamandeen, Michelle/0000-0001-5385-7444	United Bank of Carbon (UBoC); Natural Environment Research Council [NE/G015015/1]; NERC [NE/F005806/1, NE/K01644X/1] Funding Source: UKRI; Natural Environment Research Council [NE/F005806/1, NE/K01644X/1] Funding Source: researchfish	United Bank of Carbon (UBoC); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The authors acknowledge the United Bank of Carbon (UBoC) and a Natural Environment Research Council grant (NE/G015015/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeney JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005014; Andam KS, 2008, P NATL ACAD SCI USA, V105, P16089, DOI 10.1073/pnas.0800437105; Barber CP, 2012, BIOL CONSERV, V149, P6, DOI 10.1016/j.biocon.2011.08.024; Beresford AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065370; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Clark NE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065298; Curran LM, 2004, SCIENCE, V303, P1000, DOI 10.1126/science.1091714; DeFries R, 2005, ECOL APPL, V15, P19, DOI 10.1890/03-5258; FAO, 2010, GLOBAL FOREST RESOUR; Farr T.G., 2000, EOS T AM GEOPHYS UN, V81, P583, DOI [DOI 10.1029/EO081I048P00583, 10.1029/EO081i048p00583]; Gaveau DLA, 2007, BIOL CONSERV, V134, P495, DOI 10.1016/j.biocon.2006.08.035; Gaveau DLA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069887; Gaveau DLA, 2009, J BIOGEOGR, V36, P2165, DOI 10.1111/j.1365-2699.2009.02147.x; Geldmann J, 2013, BIOL CONSERV, V161, P230, DOI 10.1016/j.biocon.2013.02.018; Green JMH, 2013, BIOL CONSERV, V164, P62, DOI 10.1016/j.biocon.2013.04.016; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Huang CQ, 2007, REMOTE SENS ENVIRON, V106, P460, DOI 10.1016/j.rse.2006.09.016; Jenkins CN, 2009, BIOL CONSERV, V142, P2166, DOI 10.1016/j.biocon.2009.04.016; Joppa L, 2010, ANN NY ACAD SCI, V1185, P135, DOI 10.1111/j.1749-6632.2009.05162.x; Joppa LN, 2008, P NATL ACAD SCI USA, V105, P6673, DOI 10.1073/pnas.0802471105; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004279; Joppa LN, 2011, P ROY SOC B-BIOL SCI, V278, P1633, DOI 10.1098/rspb.2010.1713; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008273; Laurance WF, 2012, NATURE, V489, P290, DOI 10.1038/nature11318; Leverington F, 2010, ENVIRON MANAGE, V46, P685, DOI 10.1007/s00267-010-9564-5; Liu JG, 2001, SCIENCE, V292, P98, DOI 10.1126/science.1058104; NELSON A, 2009, PROTECTED AREA EFFEC; Nepstad D, 2006, CONSERV BIOL, V20, P65, DOI 10.1111/j.1523-1739.2006.00351.x; Porter-Bolland L, 2012, FOREST ECOL MANAG, V268, P6, DOI 10.1016/j.foreco.2011.05.034; Reuter HI, 2007, INT J GEOGR INF SCI, V21, P983, DOI 10.1080/13658810601169899; Scharlemann JPW, 2010, ORYX, V44, P352, DOI 10.1017/S0030605310000542; Soares B, 2010, P NATL ACAD SCI USA, V107, P10821, DOI 10.1073/pnas.0913048107; Watson JEM, 2014, NATURE, V515, P67, DOI 10.1038/nature13947; Wittemyer G, 2008, SCIENCE, V321, P123, DOI 10.1126/science.1158900; WorldBank, 2015, WORLDWIDE GOVERNANCE; Wright SJ, 2007, ECOL APPL, V17, P1259, DOI 10.1890/06-1330.1	37	79	81	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143886	10.1371/journal.pone.0143886	http://dx.doi.org/10.1371/journal.pone.0143886			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26632842	Green Published, gold			2022-12-27	WOS:000366040000028
J	Anegawa, E; Kotorii, N; Ishimaru, Y; Okuro, M; Sakai, N; Nishino, S				Anegawa, Emiko; Kotorii, Nozomu; Ishimaru, Yuji; Okuro, Masashi; Sakai, Noriaki; Nishino, Seiji			Chronic Powder Diet After Weaning Induces Sleep, Behavioral, Neuroanatomical, and Neurophysiological Changes in Mice	PLOS ONE			English	Article							AGED SAMP8 MICE; SOFT-DIET; MAST-CELLS; BRAIN HISTAMINE; SPATIAL MEMORY; DENTATE GYRUS; MOLAR TEETH; MASTICATORY FUNCTION; DAYTIME SLEEPINESS; COGNITIVE FUNCTION	The purpose of this study is to clarify the effects of chronic powder diet feeding on sleep patterns and other physiological/anatomical changes in mice. C57BL/6 male mice were divided into two groups from weaning: a group fed with solid food (SD) and a group fed with powder food (PD), and sleep and physiological and anatomical changes were compared between the groups. PD exhibited less cranial bone structure development and a significant weight gain. Furthermore, these PD mice showed reduced number of neurogenesis in the hippocampus. Sleep analysis showed that PD induced attenuated diurnal sleep/wake rhythm, characterized by increased sleep during active period and decreased sleep during rest period. With food deprivation (FD), PD showed less enhancement of wake/locomotor activity compared to SD, indicating reduced food-seeking behavior during FD. These results suggest that powder feeding in mice results in a cluster of detrimental symptoms caused by abnormal energy metabolism and anatomical/neurological changes.	[Anegawa, Emiko; Kotorii, Nozomu; Ishimaru, Yuji; Okuro, Masashi; Sakai, Noriaki; Nishino, Seiji] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Sleep & Circadian Neurobiol Lab,Sleep Res Ctr, Palo Alto, CA 94304 USA; [Anegawa, Emiko] Kurume Univ, Sch Med, Dept Oral & Maxillofacial Surg, Kurume, Fukuoka 830, Japan; [Anegawa, Emiko] Yokohama City Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Yokohama, Kanagawa 232, Japan	Stanford University; Kurume University; Yokohama City University	Nishino, S (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Sleep & Circadian Neurobiol Lab,Sleep Res Ctr, Palo Alto, CA 94304 USA.	nishino@stanfrod.edu			Mishima Kaiun Foundation	Mishima Kaiun Foundation	EA received a research grant from Mishima Kaiun Foundation. http://www.mishima-kaiun.or.jp/assist/gakujutu.html. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anaclet C, 2009, J NEUROSCI, V29, P14423, DOI 10.1523/JNEUROSCI.2604-09.2009; Aoki H, 2005, GERONTOLOGY, V51, P369, DOI 10.1159/000088700; Bauer KW, 2009, PREV MED, V48, P284, DOI 10.1016/j.ypmed.2008.12.021; BEECHER RM, 1981, ANGLE ORTHOD, V51, P61; Borsini F, 2002, PSYCHOPHARMACOLOGY, V163, P121, DOI 10.1007/s00213-002-1155-6; Carroll MC, 2004, MOL IMMUNOL, V41, P141, DOI 10.1016/j.molimm.2004.03.017; Cassady BA, 2009, AM J CLIN NUTR, V89, P794, DOI 10.3945/ajcn.2008.26669; Chikahisa S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078434; CORRUCCINI RS, 1982, SCIENCE, V218, P74, DOI 10.1126/science.7123221; Enomoto A, 2010, EUR J ORTHODONT, V32, P66, DOI 10.1093/ejo/cjp060; FUJISE T, 1993, BRAIN RES BULL, V32, P555, DOI 10.1016/0361-9230(93)90307-W; Fujise T, 1998, P SOC EXP BIOL MED, V217, P228; GALLI SJ, 1987, AM J PATHOL, V127, P191; Gooney M, 2002, BEHAV NEUROSCI, V116, P455, DOI 10.1037//0735-7044.116.3.455; Goto S, 2015, ANGLE ORTHOD, V85, P969, DOI 10.2319/102214-765.1; Gould E, 1999, BIOL PSYCHIAT, V46, P1472, DOI 10.1016/S0006-3223(99)00247-4; Guan Z, 2008, SLEEP, V31, P627, DOI 10.1093/sleep/31.5.627; Hamada Y, 2014, OBESITY, V22, pE62, DOI 10.1002/oby.20715; Hashimoto K, 2011, ARCH ORAL BIOL, V56, P1610, DOI 10.1016/j.archoralbio.2011.06.015; Hichijo N, 2014, J ORAL REHABIL, V41, P581, DOI 10.1111/joor.12171; Ho YJ, 2002, BEHAV BRAIN RES, V136, P1, DOI 10.1016/S0166-4328(02)00089-X; Ishizuka T, 2010, BRAIN RES, V1313, P97, DOI 10.1016/j.brainres.2009.11.058; Jenkins JB, 2006, PHYSIOL BEHAV, V87, P255, DOI 10.1016/j.physbeh.2005.10.010; JOHNSON D, 1992, NEUROCHEM RES, V17, P939, DOI 10.1007/BF00993271; Karnani MM, 2011, NEURON, V72, P616, DOI 10.1016/j.neuron.2011.08.027; Kato T, 1997, BEHAV BRAIN RES, V83, P239, DOI 10.1016/S0166-4328(97)86078-0; KATSAROS C, 1994, EUR J ORTHODONT, V16, P353, DOI 10.1093/ejo/16.5.353; KILIARIDIS S, 1985, EUR J ORTHODONT, V7, P273, DOI 10.1093/ejo/7.4.273; Kubo K, 2005, BRAIN RES, V1057, P191, DOI 10.1016/j.brainres.2005.07.038; KUSHIDA CA, 1985, ELECTROEN CLIN NEURO, V61, P61, DOI 10.1016/0013-4694(85)91073-9; Kushida S, 2008, NEUROSCI LETT, V439, P208, DOI 10.1016/j.neulet.2008.05.017; Li J, 2011, AM J CLIN NUTR, V94, P709, DOI 10.3945/ajcn.111.015164; MAEYAMA K, 1983, J NEUROCHEM, V41, P128, DOI 10.1111/j.1471-4159.1983.tb11823.x; Mitome M, 2005, NEUROREPORT, V16, P249, DOI 10.1097/00001756-200502280-00009; Miura H, 2003, J ORAL REHABIL, V30, P808, DOI 10.1046/j.1365-2842.2003.01124.x; Miura H, 2000, J ORAL REHABIL, V27, P731, DOI 10.1046/j.1365-2842.2000.00590.x; Ogawa A, 2003, NEUROSCIENCE, V120, P1081, DOI 10.1016/S0306-4522(03)00214-8; Oka K, 2003, J DENT RES, V82, P491, DOI 10.1177/154405910308200617; Onozuka M, 2002, BEHAV BRAIN RES, V131, P125, DOI 10.1016/S0166-4328(01)00378-3; Onozuka M, 2002, BEHAV BRAIN RES, V133, P197, DOI 10.1016/S0166-4328(02)00006-2; Onozuka M, 1999, BRAIN RES, V826, P148, DOI 10.1016/S0006-8993(99)01255-X; Onozuka M, 2000, BEHAV BRAIN RES, V108, P145, DOI 10.1016/S0166-4328(99)00145-X; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Proffit W R, 1998, Int J Adult Orthodon Orthognath Surg, V13, P97; Ranawana V, 2010, NUTR RES, V30, P382, DOI 10.1016/j.nutres.2010.06.002; Ranawana V, 2010, NUTR RES, V30, P246, DOI 10.1016/j.nutres.2010.02.004; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Remond D, 2007, AM J CLIN NUTR, V85, P1286, DOI 10.1093/ajcn/85.5.1286; Resta O, 2003, J INTERN MED, V253, P536, DOI 10.1046/j.1365-2796.2003.01133.x; Sakata T, 2003, EXP BIOL MED, V228, P1106, DOI 10.1177/153537020322801002; Sakurai T, 2010, ANN NY ACAD SCI, V1200, P149, DOI 10.1111/j.1749-6632.2010.05513.x; Scherder E, 2008, J ORAL REHABIL, V35, P324, DOI 10.1111/j.1365-2842.2007.01842.x; Shan L, 2015, NAT REV NEUROL, V11, P401, DOI 10.1038/nrneurol.2015.99; Silver R, 1996, TRENDS NEUROSCI, V19, P25, DOI 10.1016/0166-2236(96)81863-7; Stephens R, 2004, APPETITE, V43, P211, DOI 10.1016/j.appet.2004.07.006; Takigami K, 2002, J SHIGA U MED SCI, V17, P29; Vgontzas AN, 1998, ARCH INTERN MED, V158, P1333, DOI 10.1001/archinte.158.12.1333; Watanabe K, 2002, BEHAV BRAIN RES, V128, P19, DOI 10.1016/S0166-4328(01)00268-6; Watanabe K, 2001, EXP GERONTOL, V36, P283, DOI 10.1016/S0531-5565(00)00216-3; Wilkinson L, 2002, APPETITE, V38, P235, DOI 10.1006/appe.2002.0473; Yamamoto T, 2001, BRAIN RES, V902, P255, DOI 10.1016/S0006-8993(01)02410-6; Yamanaka A, 2003, NEURON, V38, P701, DOI 10.1016/S0896-6273(03)00331-3; Yanagisawa Y, 1985, Shoni Shikagaku Zasshi, V23, P962; Zhu Y, 2015, INT J FOOD SCI NUTR, V66, P135, DOI 10.3109/09637486.2014.979317	64	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143909	10.1371/journal.pone.0143909	http://dx.doi.org/10.1371/journal.pone.0143909			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630494	gold, Green Published			2022-12-27	WOS:000365926300119
J	Viprey, M; Caillet, P; Canat, G; Jaglal, S; Haesebaert, J; Chapurlat, R; Schott, AM				Viprey, Marie; Caillet, Pascal; Canat, Guillaume; Jaglal, Susan; Haesebaert, Julie; Chapurlat, Roland; Schott, Anne-Marie			Low Osteoporosis Treatment Initiation Rate in Women after Distal Forearm or Proximal Humerus Fracture: A Healthcare Database Nested Cohort Study	PLOS ONE			English	Article							HIP FRACTURE; FOLLOW-UP; FRAGILITY FRACTURE; RADIAL FRACTURE; WRIST FRACTURES; POPULATION; TRAUMA; EPIDEMIOLOGY; PREVALENCE; GUIDELINES	Treatment initiation rates following fragility fractures have often been reported to be low and in recent years numerous programs have been implemented worldwide to increase them. This study aimed at describing osteoporosis (OP) treatment initiation in a representative sample of women who were hospitalized for a distal forearm fracture (DFF) or proximal humerus fracture (PHF) in 2009-2011 in France. The data source was a nationwide sample of 600,000 individuals, extracted from the French National Insurance Healthcare System database. All women aged 50 years and older who were hospitalized for a DFF or PHF between 2009 and 2011 and who had not received any OP treatment in the preceding 12 months were included in a retrospective cohort study. OP treatments initiated during the year following the fracture were analyzed. From 2009 to 2011, 729 women were hospitalized for a DFF or a PHF and 284 were on OP treatment at the time of the fracture occurrence. Among the 445 women who had no prevalent OP treatment, 131 (29.4%) received supplementation treatment only (vitamin D and/or calcium) and 42 (9.4%) received a pharmacologic OP treatment in the year following their fracture. Pharmacological OP treatments included bisphosphonates (n = 21), strontium ranelate (n = 14), hormone replacement therapy (n = 4), or raloxifene (n = 3). General practitioners prescribed 75% of initial OP treatments. Despite the guidelines published in 2006 and the numerous initiatives to promote post-fracture OP treatment, OP treatment initiation rate in women who were hospitalized for a fragility fracture remained low in 2009-2011 in France.	[Viprey, Marie; Caillet, Pascal; Canat, Guillaume; Haesebaert, Julie; Schott, Anne-Marie] Hosp Civils Lyon, Pole Informat Med, Evaluat, Rech, Lyon, France; [Viprey, Marie; Caillet, Pascal; Chapurlat, Roland; Schott, Anne-Marie] Univ Lyon 1, Fac Med Lyon Est, F-69365 Lyon, France; [Caillet, Pascal] Ctr Hosp Univ Amiens, Dept Epidemiol Hyg Hosp & Sante Publ, Amiens, France; [Caillet, Pascal; Chapurlat, Roland; Schott, Anne-Marie] INSERM, U1033, F-69008 Lyon, France; [Canat, Guillaume] Ctr Hosp Univ Reunion, Grp Hosp Sud Reunion, Dept Informat Med, St Pierre, France; [Jaglal, Susan] Univ Toronto, Dept Phys Therapy, Toronto Rehabil Inst, UHN Chair, Toronto, ON, Canada; [Chapurlat, Roland] Hosp Civils Lyon, Grp Hosp Edouard Herriot, Serv Rhumatol & Pathol Osseuse, Lyon, France	CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Reunion; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute; CHU Lyon	Viprey, M (corresponding author), Hosp Civils Lyon, Pole Informat Med, Evaluat, Rech, Lyon, France.	marie.viprey@chu-lyon.fr	HAESEBAERT, JULIE/E-7141-2017; Caillet, Pascal/K-5299-2019; CHAPURLAT, ROLAND/AAU-1165-2021; Haesebaert, Julie/AAN-1702-2020; Schott, Anne-Marie/V-7580-2018; Viprey, Marie/AAH-2856-2020	HAESEBAERT, JULIE/0000-0001-9109-5604; Caillet, Pascal/0000-0001-5667-7887; Haesebaert, Julie/0000-0001-9109-5604; Schott, Anne-Marie/0000-0003-3337-4474; Viprey, Marie/0000-0002-3281-1970; Jaglal, Susan/0000-0002-2930-1443				Andrade SE, 2003, ARCH INTERN MED, V163, P2052, DOI 10.1001/archinte.163.17.2052; Bahari S, 2007, INJURY, V38, P759, DOI 10.1016/j.injury.2006.11.007; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Boudou L, 2011, OSTEOPOROSIS INT, V22, P2099, DOI 10.1007/s00198-011-1638-6; Briot K, 2012, JOINT BONE SPINE, V79, P304, DOI 10.1016/j.jbspin.2012.02.014; Cadarette SM, 2005, J RHEUMATOL, V32, P550; Canoui-Poitrine F, 2010, BONE, V47, P790, DOI 10.1016/j.bone.2010.06.026; Cuddihy MT, 1999, OSTEOPOROSIS INT, V9, P469, DOI 10.1007/s001980050172; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; De Roquefeuille L, 2009, PRATIQUES ORG SOINS, P40; Diez-Perez A, 2011, BONE, V49, P493, DOI 10.1016/j.bone.2011.05.007; Eisman J, 2004, J BONE MINER RES, V19, P1969, DOI 10.1359/JBMR.040905; Elliot-Gibson V, 2004, OSTEOPOROSIS INT, V15, P767, DOI 10.1007/s00198-004-1675-5; Freedman KB, 2000, J BONE JOINT SURG AM, V82A, P1063, DOI 10.2106/00004623-200008000-00001; GAY JDL, 1974, CAN MED ASSOC J, V111, P156; Hajcsar EE, 2000, CAN MED ASSOC J, V163, P819; Haute Autorite de Sante, 2006, PREV DIAGN TRAIT OST; Huot L, 2008, OSTEOPOROSIS INT, V19, P1047, DOI 10.1007/s00198-008-0587-1; Jaglal SB, 2005, J BONE MINER RES, V20, P898, DOI 10.1359/JBMR.041231; Juby AG, 2002, OSTEOPOROSIS INT, V13, P205, DOI 10.1007/s001980200015; Khan SA, 2001, ARCH INTERN MED, V161, P1309, DOI 10.1001/archinte.161.10.1309; Latry P, 2010, EUR J CLIN PHARMACOL, V66, P743, DOI 10.1007/s00228-010-0819-0; Leslie WD, 2012, OSTEOPOROSIS INT, V23, P1623, DOI 10.1007/s00198-011-1630-1; MALLMIN H, 1993, CALCIFIED TISSUE INT, V52, P269, DOI 10.1007/BF00296650; MALLMIN H, 1994, OSTEOPOROSIS INT, V4, P357, DOI 10.1007/BF01622198; Maravic M, 2014, ORTHOP TRAUMATOL-SUR, V100, P931, DOI 10.1016/j.otsr.2014.09.017; Maravic M, 2010, ORTHOP TRAUMATOL-SUR, V96, P662, DOI 10.1016/j.otsr.2010.04.012; Martin-Latry K, 2010, PHARMACOEPIDEM DR S, V19, P256, DOI 10.1002/pds.1912; Noize P, 2009, PHARMACOEPIDEM DR S, V18, P310, DOI 10.1002/pds.1717; PECK WA, 1993, AM J MED, V94, P646; Prior JC, 2015, BONE, V71, P237, DOI 10.1016/j.bone.2014.10.026; Reymondier A, 2013, OSTEOPOROSIS INT, V24, P559, DOI 10.1007/s00198-012-1999-5; Roux A, 2012, ORTHOP TRAUMATOL-SUR, V98, P715, DOI 10.1016/j.otsr.2012.05.013; Sale JEM, 2011, OSTEOPOROSIS INT, V22, P2067, DOI 10.1007/s00198-011-1544-y; Solomon DH, 2004, AM J MED, V117, P919, DOI 10.1016/j.amjmed.2004.06.040; Talbot JC, 2007, INJURY, V38, P1236, DOI 10.1016/j.injury.2007.03.004	36	14	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143842	10.1371/journal.pone.0143842	http://dx.doi.org/10.1371/journal.pone.0143842			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630534	Green Published, Green Submitted, gold			2022-12-27	WOS:000365926300110
J	Johansson, KA; Memirie, ST; Pecenka, C; Jamison, DT; Verguet, S				Johansson, Kjell Arne; Memirie, Solomon Tessema; Pecenka, Clint; Jamison, Dean T.; Verguet, Stephane			Health Gains and Financial Protection from Pneumococcal Vaccination and Pneumonia Treatment in Ethiopia: Results from an Extended Cost-Effectiveness Analysis	PLOS ONE			English	Article							CHILDHOOD PNEUMONIA; CONJUGATE VACCINE; ROTAVIRUS VACCINATION; SEVERE MORBIDITY; NATIONAL CAUSES; PUBLIC-FINANCE; MORTALITY; DISEASE; CHILDREN; BENEFITS	Background Pneumonia and pneumococcal disease cause a large disease burden in resource-constrained settings. We pursue an extended cost-effectiveness analysis (ECEA) of two fully publicly financed interventions in Ethiopia: pneumococcal vaccination for newborns and pneumonia treatment for under-five children in Ethiopia. Methods We apply ECEA methods and estimate the program impact on: (1) government program costs; (2) pneumonia and pneumococcal deaths averted; (3) household expenses related to pneumonia/pneumococcal disease treatment averted; (4) prevention of household medical impoverishment measured by an imputed money-metric value of financial risk protection; and (5) distributional consequences across the wealth strata of the country population. Available epidemiological and cost data from Ethiopia are applied and the two interventions are assessed separately at various incremental coverage levels. Results Scaling-up pneumococcal vaccines at around 40% coverage would cost about $11.5 million and avert about 2090 child deaths annually, while a 10% increase of pneumonia treatment to all children under 5 years of age would cost about $13.9 million and avert 2610 deaths annually. Health benefits of the two interventions publicly financed would be concentrated among the bottom income quintile, where 30-40% of all deaths averted would be expected to occur in the poorest quintile. In sum, the two interventions would eliminate a total of $2.4 million of private household expenditures annually, where the richest quintile benefits from around 30% of the total private expenditures averted. The financial risk protection benefits would be largely concentrated among the bottom income quintile. The results are most sensitive to variations in vaccine price, population size, number of deaths due to pneumonia, efficacy of interventions and out-of-pocket copayment share. Conclusions Vaccine and treatment interventions for children, as shown with the illustrative examples of pneumococcal vaccine and pneumonia treatment, can bring large health and financial benefits to households in Ethiopia, most particularly among the poorest socio-economic groups.	[Johansson, Kjell Arne; Memirie, Solomon Tessema] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Pecenka, Clint] PATH, Seattle, WA USA; [Jamison, Dean T.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Verguet, Stephane] Harvard Univ, TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA	University of Bergen; University of Washington; University of Washington Seattle; Harvard University; Harvard T.H. Chan School of Public Health	Johansson, KA (corresponding author), Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway.	kjell.johansson@igs.uib.no	Johansson, Kjell Arne/ABE-3628-2020; Memirie, Solomon T/AAH-3342-2020	Johansson, Kjell Arne/0000-0001-8912-8710; 	NORAD; Norwegian Research Council, through the Priority Setting in Global Health [218694]; Bill & Melinda Gates Foundation through the Disease Control Priorities Network (DCPN)	NORAD(CGIAR); Norwegian Research Council, through the Priority Setting in Global Health; Bill & Melinda Gates Foundation through the Disease Control Priorities Network (DCPN)	This work received funding from NORAD and the Norwegian Research Council, through the Priority Setting in Global Health - 2020 grant (grant number 218694) to the University of Bergen and the Bill & Melinda Gates Foundation through the Disease Control Priorities Network (DCPN) grant to the University of Washington. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advisors DGD, 2013, ADV MARKET COMMITMEN; Ayieko P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067324; Beutels P, 2007, VACCINE, V25, P1355, DOI 10.1016/j.vaccine.2006.10.034; Bhutta ZA, 2013, LANCET, V381, P1417, DOI 10.1016/S0140-6736(13)60648-0; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Brock Dan W, 2003, Cost Eff Resour Alloc, V1, P4, DOI 10.1186/1478-7547-1-4; Brock DW, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P259; Central Statistical Agency [Ethiopia] and ORC Macro [USA], 2011, ETH DEM HLTH SURV; Chola Lumbwe, 2009, Cost Eff Resour Alloc, V7, P16, DOI 10.1186/1478-7547-7-16; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Daniels N, 2008, JUST HLTH; Griffiths UK, 2009, VACCINE, V27, P1426, DOI 10.1016/j.vaccine.2008.12.037; HENRICHSEN J, 1995, J CLIN MICROBIOL, V33, P2759, DOI 10.1128/JCM.33.10.2759-2762.1995; Hsu HE, 2009, NEW ENGL J MED, V360, P244, DOI 10.1056/NEJMoa0800836; Institute for Health Metrics and Evaluation, 2014, GLOB BURD DIS STUD 2; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Jamison DT, 2013, GLOBAL HLTH 2035 WOR, P1; Johansson KA, 2011, AM J BIOETHICS, V11, P32, DOI 10.1080/15265161.2011.627287; Johnson HL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000348; Johri M, 2012, INT J TECHNOL ASSESS, V28, P125, DOI 10.1017/S0266462312000050; Kim SY, 2008, PHARMACOECONOMICS, V26, P191, DOI 10.2165/00019053-200826030-00004; Kim SY, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-260; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; McClellan M, 2006, J PUBLIC ECON, V90, P257, DOI 10.1016/j.jpubeco.2005.05.008; Ministry of Health [Ethiopia], 2010, HLTH SECT DEV PROGR; Mkandawire T, 2005, 23 SOC POL DEV PROGR; Norheim OF, 2010, GINI IMPACT ANAL MEA; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Rheingans R, 2012, VACCINE, V30, pA15, DOI 10.1016/j.vaccine.2012.01.018; Rudan I, 2004, B WORLD HEALTH ORGAN, V82, P895; Rudan I, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.03.010401; SALEM ABZ, 1974, ECONOMETRICA, V42, P1115, DOI 10.2307/1914221; Stack ML, 2011, HEALTH AFFAIR, V30, P1021, DOI 10.1377/hlthaff.2011.0382; The World Bank Group Africa Region Human Development Ministry of Health Ethiopia, 2005, COUNTR STAT REP HLTH, VII; Theodoratou E, 2010, INT J EPIDEMIOL, V39, P155, DOI 10.1093/ije/dyq032; Theodoratou E, 2010, INT J EPIDEMIOL, V39, P172, DOI 10.1093/ije/dyq033; UN Interagency Group for Child Mortality Estimates, 2013, LEV TRENDS CHILD MOR; UN-United Nations, 2012, WORLD POP PROSP 2012; United Nations Department of Economic and Social Affairs Population Division, 2013, WORLD FERT DAT 2012; United Nations Development Programme (UNDP), 2014, HUM DEV REP 2013 RIS; Verguet Stephane, 2015, Lancet Glob Health, V3, pe288, DOI 10.1016/S2214-109X(14)70346-8; Verguet S, 2015, LANCET GLOB HEALTH, V3, pE206, DOI 10.1016/S2214-109X(15)70095-1; Verguet S, 2015, HEALTH ECON, V24, P318, DOI 10.1002/hec.3019; Verguet S, 2013, VACCINE, V31, P4902, DOI 10.1016/j.vaccine.2013.07.014; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Wikler D., 2007, ETHICS PREVENTION PU, P78; World Bank, 2014, WORLD DEV IND 2014; World Health Organization, 2014, REV WHO CLASS TREATM; World Health Organization (WHO), 2014, MAK FAIR CHOIC PATH	52	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0142691	10.1371/journal.pone.0142691	http://dx.doi.org/10.1371/journal.pone.0142691			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1YX	26650078	gold, Green Published, Green Submitted			2022-12-27	WOS:000366903300006
J	Reyes-Aviles, E; Kostadinova, L; Rusterholtz, A; Cruz-Lebron, A; Falck-Ytter, Y; Anthony, DD				Reyes-Aviles, Elane; Kostadinova, Lenche; Rusterholtz, Anne; Cruz-Lebron, Angelica; Falck-Ytter, Yngve; Anthony, Donald D.			Presence of Rheumatoid Factor during Chronic HCV Infection Is Associated with Expansion of Mature Activated Memory B-Cells that Are Hypo-Responsive to B-Cell Receptor Stimulation and Persist during the Early Stage of IFN Free Therapy	PLOS ONE			English	Article							C VIRUS-INFECTION; CHRONIC HEPATITIS-C; MARGINAL ZONE-LIKE; IN-VITRO; NAIVE; CRYOGLOBULINEMIA; SUBSETS; EXPRESSION; CONTAIN; IGM	Approximately half of those with chronic hepatitis C virus (HCV) infection have circulating rheumatoid factor (RF), and a portion of these individuals develop cryoglobulinemic vasculitis. B cell phenotype/function in relation to RF in serum has been unclear. We examined B cell subset distribution, activation state (CD86), cell cycle state (Ki67), and ex-vivo response to BCR, TLR9 and TLR7/8 stimulation, in chronic HCV-infected donors with or without RF, and uninfected donors. Mature-activated B-cells of HCV-infected donors had lower CD86 expression compared to uninfected donors, and in the presence of RF they also showed reduced CD86 expression in response to BCR and TLR9 stimulation. Additionally, mature activated memory B cells of HCV RF+ donors less commonly expressed Ki67(+) than HCV RF-donors, and did not proliferate as well in response to BCR stimulation. Proportions of mature-activated B cells were enhanced, while naive B-cells were lower in the peripheral blood of HCV-RF+ compared to RF- and uninfected donors. None of these parameters normalize by week 8 of IFN free direct acting antiviral (DAA) therapy in HCV RF+ donors, while in RF-donors, mature activated B cell proportions did normalize. These data indicate that while chronic HCV infection alone results in a lower state of activation in mature activated memory B cells, the presence of RF in serum is associated with a more pronounced state of unresponsiveness and an overrepresentation of these B cells in the blood. This phenotype persists at least during the early time window after removal of HCV from the host.	[Reyes-Aviles, Elane; Anthony, Donald D.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Kostadinova, Lenche; Cruz-Lebron, Angelica; Anthony, Donald D.] Case Western Reserve Univ, Univ Hosp Cleveland, Dept Med, Div Infect Dis, Cleveland, OH 44106 USA; [Kostadinova, Lenche; Cruz-Lebron, Angelica; Anthony, Donald D.] Case Western Reserve Univ, Univ Hosp Cleveland, Dept Med, Div Rheumat Dis, Cleveland, OH 44106 USA; [Rusterholtz, Anne; Anthony, Donald D.] Case Western Reserve Univ, Dept Med, VA Med Ctr, Cleveland, OH 44106 USA; [Falck-Ytter, Yngve] Case Western Reserve Univ, Vet Adm Med Ctr, Div Gastroenterol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Anthony, DD (corresponding author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.	dda3@case.edu	Yngve Falck-Ytter, AGAF/AAC-5362-2019; Falck-Ytter, Yngve/GZH-0993-2022; Cruz-Lebron, Angelica/AAD-6893-2022	Yngve Falck-Ytter, AGAF/0000-0002-4688-3211; Cruz Lebron, Angelica/0000-0002-7419-7382	NIH [R01 DK068361, R21 AI100809-01]; VA Merit [110BX001894-01, T32-AR007505-25, T32AI089474]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI089474, R21AI100809] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007505] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068361] Funding Source: NIH RePORTER; Veterans Affairs [I01CX001104, I01BX001894] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by NIH R01 DK068361, R21 AI100809-01, VA Merit 110BX001894-01, T32-AR007505-25 and T32AI089474. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2011, J CLIN IMMUNOL, V31, P472, DOI [10.1007/s10875-010-9456-8, 10.1007/s10875-010-9507-1]; Ali A, 2005, CLEV CLIN J MED, V72, P1005, DOI 10.3949/ccjm.72.11.1005; Antonescu C, 1998, BLOOD, V92, P3486, DOI 10.1182/blood.V92.9.3486; Avalos AM, 2010, AUTOIMMUNITY, V43, P76, DOI 10.3109/08916930903374618; Bauer M, 1999, IMMUNOLOGY, V97, P699, DOI 10.1046/j.1365-2567.1999.00811.x; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Cacoub P, 2015, AM J MED, V128, P950, DOI 10.1016/j.amjmed.2015.02.017; Cambier JC, 2007, NAT REV IMMUNOL, V7, P633, DOI 10.1038/nri2133; Chak E, 2011, LIVER INT, V31, P1090, DOI 10.1111/j.1478-3231.2011.02494.x; Charles ED, 2008, BLOOD, V111, P1344, DOI 10.1182/blood-2007-07-101717; Charles ED, 2011, BLOOD, V117, P5425, DOI 10.1182/blood-2010-10-312942; Charles ED, 2009, KIDNEY INT, V76, P818, DOI 10.1038/ki.2009.247; Dore MP, 2007, DIGEST DIS SCI, V52, P897, DOI 10.1007/s10620-006-9510-9; Flynn R, 2015, BLOOD, V125, P4085, DOI 10.1182/blood-2014-08-595470; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Ho J, 2006, P NATL ACAD SCI USA, V103, P19436, DOI 10.1073/pnas.0609515103; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Isnardi I, 2010, BLOOD, V115, P5026, DOI 10.1182/blood-2009-09-243071; Jiang W, 2007, EUR J IMMUNOL, V37, P2205, DOI 10.1002/eji.200636984; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; LENSCHOW DJ, 1994, J IMMUNOL, V153, P1990; MANTOVANI L, 1993, J IMMUNOL, V151, P473; Merrell KT, 2006, IMMUNITY, V25, P953, DOI 10.1016/j.immuni.2006.10.017; Moir S, 2004, J EXP MED, V200, P587, DOI 10.1084/jem.20032236; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Mongini PKA, 2002, CELL IMMUNOL, V216, P50, DOI 10.1016/S0008-8749(02)00512-9; Ni JH, 2003, J IMMUNOL, V170, P3429, DOI 10.4049/jimmunol.170.6.3429; Oliviero B, 2015, J VIRAL HEPATITIS, V22, P391, DOI 10.1111/jvh.12336; Oliviero B, 2011, J HEPATOL, V55, P53, DOI 10.1016/j.jhep.2010.10.016; Poeck H, 2004, BLOOD, V103, P3058, DOI 10.1182/blood-2003-08-2972; Quah BJC, 2007, NAT PROTOC, V2, P2049, DOI 10.1038/nprot.2007.296; Racanelli V, 2006, J VIROL, V80, P3923, DOI 10.1128/JVI.80.8.3923-3934.2006; Rosa D, 2005, P NATL ACAD SCI USA, V102, P18544, DOI 10.1073/pnas.0509402102; Santer DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068308; Sebastiani G, 2014, WORLD J GASTROENTERO, V20, P11033, DOI 10.3748/wjg.v20.i32.11033; Shihabi ZK, 2006, ANN CLIN LAB SCI, V36, P395; Snyder N, 2006, J CLIN GASTROENTEROL, V40, P535, DOI 10.1097/00004836-200607000-00013; Sugalski JM, 2010, J IMMUNOL, V185, P3019, DOI 10.4049/jimmunol.1000879; Suryani S, 2010, BLOOD, V115, P519, DOI 10.1182/blood-2009-07-234799; Terrier B, 2011, J IMMUNOL, V187, P6550, DOI 10.4049/jimmunol.1102022; Vigani AG, 2011, J VIRAL HEPATITIS, V18, pe91, DOI 10.1111/j.1365-2893.2010.01385.x; Visentini M, 2012, EUR J IMMUNOL, V42, P1468, DOI 10.1002/eji.201142313; Wald O, 2007, CYTOKINE, V39, P50, DOI 10.1016/j.cyto.2007.05.013; Weller S, 2004, BLOOD, V104, P3647, DOI 10.1182/blood-2004-01-0346; Zignego AL, 2008, AUTOIMMUN REV, V8, P107, DOI 10.1016/j.autrev.2008.07.012	46	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144629	10.1371/journal.pone.0144629	http://dx.doi.org/10.1371/journal.pone.0144629			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26649443	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903300062
J	Newman, L; Rowley, J; Vander Hoorn, S; Wijesooriya, NS; Unemo, M; Low, N; Stevens, G; Gottlieb, S; Kiarie, J; Temmerman, M				Newman, Lori; Rowley, Jane; Vander Hoorn, Stephen; Wijesooriya, Nalinka Saman; Unemo, Magnus; Low, Nicola; Stevens, Gretchen; Gottlieb, Sami; Kiarie, James; Temmerman, Marleen			Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting	PLOS ONE			English	Article							DISEASE; STI	Background Quantifying sexually transmitted infection (STI) prevalence and incidence is important for planning interventions and advocating for resources. The World Health Organization (WHO) periodically estimates global and regional prevalence and incidence of four curable STIs: chlamydia, gonorrhoea, trichomoniasis and syphilis. Methods and Findings WHO's 2012 estimates were based upon literature reviews of prevalence data from 2005 through 2012 among general populations for genitourinary infection with chlamydia, gonorrhoea, and trichomoniasis, and nationally reported data on syphilis seroprevalence among antenatal care attendees. Data were standardized for laboratory test type, geography, age, and high risk subpopulations, and combined using a Bayesian meta-analytic approach. Regional incidence estimates were generated from prevalence estimates by adjusting for average duration of infection. In 2012, among women aged 15-49 years, the estimated global prevalence of chlamydia was 4.2%(95% uncertainty interval (UI): 3.7-4.7%), gonorrhoea 0.8%(0.6-1.0%), trichomoniasis 5.0%(4.0-6.4%), and syphilis 0.5%(0.4-0.6%); among men, estimated chlamydia prevalence was 2.7% (2.0-3.6%), gonorrhoea 0.6%(0.40.9%), trichomoniasis 0.6%(0.4-0.8%), and syphilis 0.48% (0.3-0.7%). These figures correspond to an estimated 131 million new cases of chlamydia (100-166 million), 78 million of gonorrhoea (53-110 million), 143 million of trichomoniasis (98-202 million), and 6 million of syphilis (4-8 million). Prevalence and incidence estimates varied by region and sex. Conclusions Estimates of the global prevalence and incidence of chlamydia, gonorrhoea, trichomoniasis, and syphilis in adult women and men remain high, with nearly one million new infections with curable STI each day. The estimates highlight the urgent need for the public health community to ensure that well-recognized effective interventions for STI prevention, screening, diagnosis, and treatment are made more widely available. Improved estimation methods are needed to allow use of more varied data and generation of estimates at the national level.	[Newman, Lori; Gottlieb, Sami; Kiarie, James; Temmerman, Marleen] World Hlth Org, Dept Reprod Hlth & Res, Geneva, Switzerland; [Rowley, Jane; Vander Hoorn, Stephen; Wijesooriya, Nalinka Saman] WHO, Dept Reprod Hlth & Res, Geneva, Switzerland; [Vander Hoorn, Stephen] Univ Melbourne, Ctr Stat Consulting, Melbourne, Vic, Australia; [Unemo, Magnus] WHO, Orebro Univ Hosp, Dept Lab Med, Collaborating Ctr Gonorrhoea & Other STIs, Orebro, Sweden; [Unemo, Magnus] Univ Orebro, SE-70182 Orebro, Sweden; [Low, Nicola] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Stevens, Gretchen] WHO, Dept Hlth Stat & Informat Syst, Geneva, Switzerland	World Health Organization; World Health Organization; University of Melbourne; Orebro University; World Health Organization; Orebro University; University of Bern; World Health Organization	Newman, L (corresponding author), World Hlth Org, Dept Reprod Hlth & Res, Geneva, Switzerland.	lorinewman424@gmail.com	Unemo, Magnus/ABD-6653-2021	kiarie, james/0000-0003-4180-7858	UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction	UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction	This work was funded by UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction.	Amin A, 2013, SEX TRANSM INFECT, V89, pA8, DOI 10.1136/sextrans-2013-051184.0022; [Anonymous], 2011, PREVALENCE INCIDENCE; [Anonymous], 2014, GLOB UPD HLTH SECT R; [Anonymous], 2012, GLOB INC PREV SEL SE; Berry SM, 2010, CH CRC BIOSTAT SER, P1, DOI 10.1201/EBK1439825488; Carne CA, 2013, INT J STD AIDS, V24, P273, DOI 10.1177/0956462412472306; Geelen TH, 2013, SEX TRANSM INFECT, V89, P532, DOI 10.1136/sextrans-2012-051010; Gerbase AC, 1998, SEX TRANSM INFECT, V74, pS12; Ham D Cal, 2015, Int J Gynaecol Obstet, V130 Suppl 1, pS10, DOI 10.1016/j.ijgo.2015.04.012; Holmes KK, 2008, SEXUALLY TRANSMITTED, V4th; Horton R, 2012, LANCET, V380, P2053, DOI 10.1016/S0140-6736(12)62133-3; Marcone V, 2012, EURO SURVEILL, V17; R Core Team, 2012, R FDN STAT COMP; Redmond SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115753; Satterwhite CL, 2013, SEX TRANSM DIS, V40, P187, DOI 10.1097/OLQ.0b013e318286bb53; Shipitsyna E, 2013, J EUR ACAD DERMATOL, V27, pe75, DOI 10.1111/j.1468-3083.2012.04512.x; The World Bank, COUNTR LEND GROUPS; Thomas A., 2006, R NEWS, V6, P12, DOI DOI 10.1159/000323281; Torrone E, 2014, MMWR-MORBID MORTAL W, V63, P834; UN, WORLD POP PROSP 2012; Van der Bij AK, 2007, SEX TRANSM DIS, V34, P461, DOI 10.1097/01.olq.0000251230.62493.f3; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; WHO World Health Organisation STD Statistics, 2001, GLOB PREV INC SEL CU; Workowski KA, 2015, MMWR RECOMM REP, V64, P1, DOI 10.15585/mmwr.rr7004a1; World Health Organization, MON REP HLTH SECT RE; World Health Organization, 2014, REP GLOB SEX TRANSM; World Health Organization, 2013, GLOB HLTH EST PROP W; Young-Xu YN, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-58	28	924	972	3	154	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0143304	10.1371/journal.pone.0143304	http://dx.doi.org/10.1371/journal.pone.0143304			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YV	26646541	gold, Green Published			2022-12-27	WOS:000366903100002
J	Bahadori, L; Chakrabarti, MH; Manan, NSA; Hashim, MA; Mjalli, FS; AlNashef, IM; Brandon, N				Bahadori, Laleh; Chakrabarti, Mohammed Harun; Manan, Ninie Suhana Abdul; Hashim, Mohd Ali; Mjalli, Farouq Sabri; AlNashef, Inas Muen; Brandon, Nigel			The Effect of Temperature on Kinetics and Diffusion Coefficients of Metallocene Derivatives in Polyol-Based Deep Eutectic Solvents	PLOS ONE			English	Article							IONIC LIQUIDS; QUATERNARY AMMONIUM; CHOLINE-CHLORIDE; CYCLIC VOLTAMMETRY; PHYSICOCHEMICAL PROPERTIES; ELECTRICAL-CONDUCTIVITY; COBALTOCENIUM CATION; AQUEOUS MIXTURES; REDOX COUPLES; FERROCENE	The temperature dependence of the density, dynamic viscosity and ionic conductivity of several deep eutectic solvents (DESs) containing ammonium-based salts and hydrogen bond donvnors (polyol type) are investigated. The temperature-dependent electrolyte viscosity as a function of molar conductivity is correlated by means of Walden's rule. The oxidation of ferrocene (Fc/Fc(+)) and reduction of cobaltocenium (Cc(+)/Cc) at different temperatures are studied by cyclic voltammetry and potential-step chronoamperometry in DESs. For most DESs, chronoamperometric transients are demonstrated to fit an Arrhenius-type relation to give activation energies for the diffusion of redox couples at different temperatures. The temperature dependence of the measured conductivities of DES1 and DES2 are better correlated with the Vogel-Tamman-Fulcher equation. The kinetics of the Fc/Fc(+) and Cc(+)/Cc electrochemical systems have been investigated over a temperature range from 298 to 338 K. The heterogeneous electron transfer rate constant is then calculated at different temperatures by means of a logarithmic analysis. The glycerol-based DES (DES5) appears suitable for further testing in electrochemical energy storage devices.	[Bahadori, Laleh; Hashim, Mohd Ali] Univ Malaya, Dept Chem Engn, Fac Engn, Kuala Lumpur 50603, Malaysia; [Chakrabarti, Mohammed Harun; Brandon, Nigel] Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London SW7 2AZ, England; [Manan, Ninie Suhana Abdul] Univ Malaya, Dept Chem, Fac Sci, Kuala Lumpur 50603, Malaysia; [Mjalli, Farouq Sabri] Sultan Qaboos Univ, Petr & Chem Engn Dept, Muscat 123, Oman; [AlNashef, Inas Muen] Masdar Inst Sci & Technol, Dept Chem & Environm Engn, Abu Dhabi, U Arab Emirates	Universiti Malaya; Imperial College London; Universiti Malaya; Sultan Qaboos University; Khalifa University of Science & Technology	Chakrabarti, MH (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London SW7 2AZ, England.	mohammedharun77@yahoo.com	Nashef, Enas/AAA-1995-2022; Manan, Ninie Suhana Abdul/F-6067-2011; HASHIM, MOHD ALI/B-9065-2010	Manan, Ninie Suhana Abdul/0000-0001-9660-4383; HASHIM, MOHD ALI/0000-0002-0570-6788; Bahadori, Laleh/0000-0002-5677-5142; Mjalli, Farouq S./0000-0001-6584-8983; AlNashef, Inas/0000-0003-4654-2932; Chakrabarti, Barun/0000-0002-0172-986X; Brandon, Nicholas/0000-0002-3917-0096	University of Malaya; High Impact Research Grant in Malaysia (Ministry of Higher Education) [UM.C/HIR/MOHE/ENG/18]; Ministry of Higher Education [UM.C/HIR/MOHE/ENG/18]; EPSRC [EP/L014289/1, EP/K002252/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/K002252/1, EP/L014289/1] Funding Source: researchfish	University of Malaya(Universiti Malaya); High Impact Research Grant in Malaysia (Ministry of Higher Education); Ministry of Higher Education(Science and Technology Development Fund (STDF)Ministry of Higher Education & Scientific Research (MHESR)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The University of Malaya and the Ministry of Higher Education funded this work by means of research grant UM.C/HIR/MOHE/ENG/18. The funder's website is http://hir.um.edu.my/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful for the financial support from the High Impact Research Grant (UM.C/HIR/MOHE/ENG/18) in Malaysia (Ministry of Higher Education).	Abbott AP, 2008, T I MET FINISH, V86, P234, DOI 10.1179/174591908X327581; Abbott AP, 2007, GREEN CHEM, V9, P868, DOI 10.1039/b702833d; Abbott AP, 2006, J CHEM ENG DATA, V51, P1280, DOI 10.1021/je060038c; Abbott AP, 2012, PHYS CHEM CHEM PHYS, V14, P2443, DOI 10.1039/c2cp23712a; Abbott AP, 2005, GREEN CHEM, V7, P705, DOI 10.1039/b511691k; Abbott AP, 2004, J AM CHEM SOC, V126, P9142, DOI 10.1021/ja048266j; Abbott AP, 2003, CHEM COMMUN, P70, DOI 10.1039/b210714g; Abbott AR, 2006, CHEMPHYSCHEM, V7, P803, DOI 10.1002/cphc.200500489; Bahadori L, 2013, ELECTROCHIM ACTA, V113, P205, DOI 10.1016/j.electacta.2013.09.102; Bahadori L, 2013, PHYS CHEM CHEM PHYS, V15, P1707, DOI 10.1039/c2cp43077k; Bandres I, 2011, J PHYS CHEM B, V115, P12499, DOI 10.1021/jp203433u; Barrosse-Antle LE, 2009, J PHYS CHEM B, V113, P2805, DOI 10.1021/jp810926u; Bockris J., 1998, MODERN ELECTROCHEMIS; Bonhote P, 1996, INORG CHEM, V35, P1168, DOI 10.1021/ic951325x; Carriazo D, 2012, CHEM SOC REV, V41, P4996, DOI 10.1039/c2cs15353j; Chakrabarti MH, 2015, CHEM ENG J, V274, P213, DOI 10.1016/j.cej.2015.03.083; Chakrabarti MH, 2013, INT J ELECTROCHEM SC, V8, P9652; Chakrabarti MH, 2013, J SOLUTION CHEM, V42, P2329, DOI 10.1007/s10953-013-0111-x; Ciocirlan O, 2010, REV CHIM-BUCHAREST, V61, P721; Serrano MC, 2012, CHEM COMMUN, V48, P579, DOI 10.1039/c1cc15284j; CROOKS RM, 1988, J ELECTROANAL CHEM, V243, P117, DOI 10.1016/0022-0728(88)85033-2; Dai YT, 2013, ANAL CHIM ACTA, V766, P61, DOI 10.1016/j.aca.2012.12.019; de Maria PD, 2011, CURR OPIN CHEM BIOL, V15, P220, DOI 10.1016/j.cbpa.2010.11.008; Gorke J, 2010, BIOTECHNOL BIOPROC E, V15, P40, DOI 10.1007/s12257-009-3079-z; Guo YL, 2010, J ELECTROANAL CHEM, V639, P109, DOI 10.1016/j.jelechem.2009.11.030; Hayamizu K, 2008, J PHYS CHEM B, V112, P1189, DOI 10.1021/jp077714h; Hayyan M, 2010, FUEL PROCESS TECHNOL, V91, P116, DOI 10.1016/j.fuproc.2009.09.002; Hu SQ, 2009, GREEN CHEM, V11, P873, DOI 10.1039/b822328a; Hultgren VM, 2002, ANAL CHEM, V74, P3151, DOI 10.1021/ac015729k; Ilgen F, 2009, GREEN CHEM, V11, P848, DOI 10.1039/b816551c; Kareem MA, 2010, J CHEM ENG DATA, V55, P4632, DOI 10.1021/je100104v; KEITA B, 1988, J ELECTROCHEM SOC, V135, P87, DOI 10.1149/1.2095596; Kim DY, 2013, ELECTROCHIM ACTA, V94, P49, DOI 10.1016/j.electacta.2013.01.140; Leron RB, 2012, FLUID PHASE EQUILIBR, V335, P32, DOI 10.1016/j.fluid.2012.08.016; Leron RB, 2012, J TAIWAN INST CHEM E, V43, P551, DOI 10.1016/j.jtice.2012.01.007; Lindberg D, 2010, J BIOTECHNOL, V147, P169, DOI 10.1016/j.jbiotec.2010.04.011; MacFarlane DR, 2009, PHYS CHEM CHEM PHYS, V11, P4962, DOI 10.1039/b900201d; Mamlouk M, 2014, J POWER SOURCES, V245, P915, DOI 10.1016/j.jpowsour.2013.07.050; Matsumiya M, 2006, ELECTROCHIM ACTA, V51, P1178, DOI 10.1016/j.electacta.2005.06.006; Maugeri Z, 2012, RSC ADV, V2, P421, DOI 10.1039/c1ra00630d; NICHOLSON RS, 1965, ANAL CHEM, V37, P1351, DOI 10.1021/ac60230a016; Ong SP, 2011, CHEM MATER, V23, P2979, DOI 10.1021/cm200679y; Pan Y, 2013, J ELECTROCHEMICAL SO, V159, pF125; Rogers EI, 2008, J PHYS CHEM C, V112, P2729, DOI 10.1021/jp710134e; Russ C, 2012, GREEN CHEM, V14, P2969, DOI 10.1039/c2gc36005e; Shahbaz K, 2012, THERMOCHIM ACTA, V527, P59, DOI 10.1016/j.tca.2011.10.010; Shahbaz K., 2010, Journal of Applied Sciences, V10, P3349, DOI 10.3923/jas.2010.3349.3354; Shiddiky MJA, 2009, J AM CHEM SOC, V131, P7976, DOI 10.1021/ja8092295; SHOUP D, 1982, J ELECTROANAL CHEM, V140, P237, DOI 10.1016/0022-0728(82)85171-1; Smith EL, 2014, CHEM REV, V114, P11060, DOI 10.1021/cr300162p; STOJANOVIC RS, 1993, ANAL CHEM, V65, P56, DOI 10.1021/ac00049a012; Sukardi SK, 2008, ELECTROCHEM COMMUN, V10, P250, DOI 10.1016/j.elecom.2007.11.022; Tang BK, 2013, MONATSH CHEM, V144, P1427, DOI 10.1007/s00706-013-1050-3; Taylor AW, 2011, PHYS CHEM CHEM PHYS, V13, P10147, DOI 10.1039/c1cp20373h; Torriero AAJ, 2012, ELECTROCHIM ACTA, V82, P60, DOI 10.1016/j.electacta.2012.01.115; Torriero AAJ, 2009, J PHYS CHEM B, V113, P11222, DOI 10.1021/jp9046769; Tsierkezos NG, 2007, J SOLUTION CHEM, V36, P289, DOI 10.1007/s10953-006-9119-9; Vila J, 2006, FLUID PHASE EQUILIBR, V242, P141, DOI 10.1016/j.fluid.2006.01.022; Vila J, 2007, PORT ELECTROCHIM ACT, V25, P163, DOI 10.4152/pea.200701163; Waligora L, 2009, ELECTROCHIM ACTA, V54, P1414, DOI 10.1016/j.electacta.2008.09.023; Wang YJ, 2010, J ELECTROANAL CHEM, V648, P15, DOI 10.1016/j.jelechem.2010.07.006; Weaver JEF, 2011, J PHYS CHEM C, V115, P19379, DOI 10.1021/jp206927w; Zhang J, 2003, ANAL CHEM, V75, P2694, DOI 10.1021/ac026329f; Zhang QH, 2012, CHEM SOC REV, V41, P7108, DOI 10.1039/c2cs35178a; Zhang ZH, 2012, GREEN CHEM, V14, P1502, DOI 10.1039/c2gc35258c; Zhao C, 2008, J PHYS CHEM B, V112, P6923, DOI 10.1021/jp711804j; Zhao H, 2013, J CHEM TECHNOL BIOT, V88, P3, DOI 10.1002/jctb.3935	67	25	25	3	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144235	10.1371/journal.pone.0144235	http://dx.doi.org/10.1371/journal.pone.0144235			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642045	gold, Green Published, Green Submitted			2022-12-27	WOS:000366902700080
J	Hagmann-von Arx, P; Manicolo, O; Perkinson-Gloor, N; Weber, P; Grob, A; Lemola, S				Hagmann-von Arx, Priska; Manicolo, Olivia; Perkinson-Gloor, Nadine; Weber, Peter; Grob, Alexander; Lemola, Sakari			Gait in Very Preterm School-Aged Children in Dual-Task Paradigms	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; EXECUTIVE FUNCTION; MOTOR DEVELOPMENT; INDEPENDENT WALKING; AEROBIC CAPACITY; CONCURRENT TASK; SELF-WORTH; ATTENTION; BORN; COORDINATION	Objective The control of gait requires executive and attentional functions. As preterm children show executive and attentional deficits compared to full-term children, performing concurrent tasks that impose additional cognitive load may lead to poorer walking performance in preterm compared to full-term children. Knowledge regarding gait in preterm children after early childhood is scarce. We examined straight walking and if it is more affected in very preterm than in full-term children in dual-task paradigms. Study design Twenty preterm children with very low birth-weight (<= 1500 g), 24 preterm children with birth-weight > 1500 g, and 44 full-term children, born between 2001 and 2006, were investigated. Gait was assessed using an electronic walkway system (GAITRite) while walking without a concurrent task (single-task) and while performing one concurrent (dual-task) or two concurrent (triple-task) tasks. Spatio-temporal gait parameters (gait velocity, cadence, stride length, single support time, double support time), normalized gait parameters (normalized velocity, normalized cadence, normalized stride length) and gait variability parameters (stride velocity variability, stride length variability) were analyzed. Results In dual- and triple-task conditions children showed decreased gait velocity, cadence, stride length, as well as increased single support time, double support time and gait variability compared to single-task walking. Further, results showed systematic decreases in stride velocity variability from preterm children with very low birth weight (<= 1500 g) to preterm children with birth weight > 1500 g to full-term children. There were no significant interactions between walking conditions and prematurity status. Conclusions Dual and triple tasking affects gait of preterm and full-term children, confirming previous results that walking requires executive and attentional functions. Birth-weight dependent systematic changes in stride velocity variability indicate poorer walking performance in preterm children who were less mature at birth.	[Hagmann-von Arx, Priska; Manicolo, Olivia; Perkinson-Gloor, Nadine; Grob, Alexander; Lemola, Sakari] Univ Basel, Dept Psychol, Basel, Switzerland; [Weber, Peter] Univ Childrens Hosp Basel, Div Neuropediat & Dev Med, Basel, Switzerland	University of Basel; University of Basel	Hagmann-von Arx, P (corresponding author), Univ Basel, Dept Psychol, Basel, Switzerland.	priska.hagmann@unibas.ch	Lemola, Sakari/A-2659-2008; Grob, Alexander/AAU-5842-2021	Lemola, Sakari/0000-0002-1314-6194; 	Swiss National Science Foundation [143962]; Research Fund of the University of Basel	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Research Fund of the University of Basel	This research was financially supported by the Swiss National Science Foundation (Project: Sleep, cognitive, and socio-emotional development in preterm children during middle and late childhood Grant number: 143962), and the Research Fund of the University of Basel. SL, PH, PW, AG received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnoudse-Moens CSH, 2009, PEDIATRICS, V124, P717, DOI 10.1542/peds.2008-2816; Abbruzzese LD, 2014, GAIT POSTURE, V40, P658, DOI 10.1016/j.gaitpost.2014.07.017; Adolph KE, 2003, CHILD DEV, V74, P475, DOI 10.1111/1467-8624.7402011; Al-Yahya E, 2011, NEUROSCI BIOBEHAV R, V35, P715, DOI 10.1016/j.neubiorev.2010.08.008; Anderson PJ, 2011, DEV NEUROPSYCHOL, V36, P57, DOI 10.1080/87565641.2011.540538; Anderson V, 2002, CHILD NEUROPSYCHOL, V8, P69, DOI 10.1076/chin.8.2.69.8725; Bejerot S, 2013, AGGRESSIVE BEHAV, V39, P453, DOI 10.1002/ab.21489; Bejerot S, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-68; Belmonti V, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00880; Belmonti V, 2013, EXP BRAIN RES, V227, P131, DOI 10.1007/s00221-013-3495-3; Beurskens R, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/131608; Bloem BR, 2001, EXP BRAIN RES, V137, P478, DOI 10.1007/s002210000672; Bouffard M, 1996, ADAPT PHYS ACT Q, V13, P61, DOI 10.1123/apaq.13.1.61; CANTELL MH, 1994, ADAPT PHYS ACT Q, V11, P115, DOI 10.1123/apaq.11.2.115; Cherng RJ, 2007, GAIT POSTURE, V26, P231, DOI 10.1016/j.gaitpost.2006.09.004; Cherng RJ, 2009, GAIT POSTURE, V29, P204, DOI 10.1016/j.gaitpost.2008.08.003; Chester VL, 2006, CLIN BIOMECH, V21, P726, DOI 10.1016/j.clinbiomech.2006.02.007; Clemm H, 2012, PEDIATRICS, V129, pE97, DOI 10.1542/peds.2011-0326; de Kieviet JF, 2009, JAMA-J AM MED ASSOC, V302, P2235, DOI 10.1001/jama.2009.1708; Dubost V, 2006, HUM MOVEMENT SCI, V25, P372, DOI 10.1016/j.humov.2006.03.004; EBERSBACH G, 1995, PERCEPT MOTOR SKILL, V81, P107, DOI 10.2466/pms.1995.81.1.107; Erikson C, 2003, ACTA PAEDIATR, V92, P197; Finn K, 2002, J PEDIATR-US, V140, P81, DOI 10.1067/mpd.2002.120693; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goyen TA, 2009, ARCH DIS CHILD, V94, P298, DOI 10.1136/adc.2007.134692; Gozzo Y, 2009, NEUROIMAGE, V48, P458, DOI 10.1016/j.neuroimage.2009.06.046; Grob A., 2009, INTELLIGENCE DEV SCA; Hagmann-von Arx P, 2014, NEUROPSYCHOBIOLOGY, V70, P244, DOI 10.1159/000369026; Hagmann-von Arx P, 2012, Z KINDER JUG-PSYCH, V40, P41, DOI 10.1024/1422-4917/a000148; Hausdorff JM, 2007, HUM MOVEMENT SCI, V26, P555, DOI 10.1016/j.humov.2007.05.003; Hausdorff JM, 1999, J APPL PHYSIOL, V86, P1040, DOI 10.1152/jappl.1999.86.3.1040; Hausdorff JM, 2005, EXP BRAIN RES, V164, P541, DOI 10.1007/s00221-005-2280-3; Hausdorff JM, 2005, J NEUROENG REHABIL, V2, P19, DOI [DOI 10.1186/1743-0003-2-19, 10.1186/1743-0003-2-19]; HOF AL, 1996, GAIT POSTURE, V4, P222; Huang H J, 2001, Pediatr Phys Ther, V13, P133, DOI 10.1097/00001577-200110000-00005; Huang Hsiang-Ju, 2003, Pediatr Phys Ther, V15, P105, DOI 10.1097/01.PEP.0000067886.96352.6B; Jaekel J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065219; Jeng SF, 1997, MED SCI SPORT EXER, V29, P370, DOI 10.1097/00005768-199703000-00012; Jeng SF, 2008, GAIT POSTURE, V27, P340, DOI 10.1016/j.gaitpost.2007.04.012; Kajantie E, 2010, J PEDIATR-US, V157, P610, DOI 10.1016/j.jpeds.2010.04.002; Katz-Leurer M, 2011, BRAIN INJURY, V25, P581, DOI 10.3109/02699052.2011.572943; Kressig RW, 2006, AGING CLIN EXP RES, V18, P174, DOI 10.1007/BF03327437; Leitner Y, 2007, J NEUROL, V254, P1330, DOI 10.1007/s00415-006-0522-3; Lemola S, 2015, EUR PSYCHOL, V20, P128, DOI 10.1027/1016-9040/a000207; Lindenberger U, 2000, PSYCHOL AGING, V15, P417, DOI 10.1037//0882-7974.15.3.417; Lythgo N, 2009, GAIT POSTURE, V30, P502, DOI 10.1016/j.gaitpost.2009.07.119; Gabriel MAM, 2009, ACTA PAEDIATR, V98, P1815, DOI 10.1111/j.1651-2227.2009.01475.x; Marlow N, 2007, PEDIATRICS, V120, P793, DOI 10.1542/peds.2007-0440; Muhaidat J, 2013, PHYSIOTHER THEOR PR, V29, P351, DOI 10.3109/09593985.2012.752056; Mulder H, 2009, DEV NEUROPSYCHOL, V34, P393, DOI 10.1080/87565640902964524; Nuysink J, 2013, EARLY HUM DEV, V89, P693, DOI 10.1016/j.earlhumdev.2013.04.016; Odberg MD, 2011, ACTA PAEDIATR, V100, P284, DOI 10.1111/j.1651-2227.2010.02096.x; Petermann F., 2008, MOVEMENT ASSESSMENT, V2nd ed.; Petermann F., 2011, WECHSLER INTELLIGENC; Piek J., 2000, DEV MED CHILD NEUROL, V37, P976, DOI DOI 10.1080/713671115; Piek JP, 2006, HUM MOVEMENT SCI, V25, P65, DOI 10.1016/j.humov.2005.10.011; Piek JP, 2005, BRIT J EDUC PSYCHOL, V75, P453, DOI 10.1348/000709904X24573; Rinehart NJ, 2006, DEV MED CHILD NEUROL, V48, P819, DOI 10.1017/S0012162206001769; Ritter BC, 2013, EUR J PEDIATR, V172, P473, DOI 10.1007/s00431-012-1906-2; Rogers M, 2005, PEDIATRICS, V116, pE58, DOI 10.1542/peds.2004-1603; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Saigal S, 2007, PEDIATRICS, V119, pE562, DOI 10.1542/peds.2006-2328; Schoemaker MM, 2004, ADAPT PHYS ACT Q, V11, P130; Sheridan PL, 2003, J AM GERIATR SOC, V51, P1633, DOI 10.1046/j.1532-5415.2003.51516.x; Skinner RA, 2001, HUM MOVEMENT SCI, V20, P73, DOI 10.1016/S0167-9457(01)00029-X; Spittle A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005495.pub3; Stansfield BW, 2003, GAIT POSTURE, V17, P81, DOI 10.1016/S0966-6362(02)00062-0; Storvold GV, 2013, EARLY HUM DEV, V89, P655, DOI 10.1016/j.earlhumdev.2013.04.010; Thorpe DE, 2005, ARCH PHYS MED REHAB, V86, P2342, DOI 10.1016/j.apmr.2005.07.301; Tombu M, 2003, J EXP PSYCHOL HUMAN, V29, P3, DOI 10.1037/0096-1523.29.1.3; Yang YR, 2007, GAIT POSTURE, V25, P185, DOI 10.1016/j.gaitpost.2006.03.007; Yogev G, 2005, EUR J NEUROSCI, V22, P1248, DOI 10.1111/j.1460-9568.2005.04298.x; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720; Yogev-Seligmann G, 2012, MOVEMENT DISORD, V27, P765, DOI 10.1002/mds.24963; Zwicker JG, 2012, EUR J PAEDIATR NEURO, V16, P573, DOI 10.1016/j.ejpn.2012.05.005	75	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144363	10.1371/journal.pone.0144363	http://dx.doi.org/10.1371/journal.pone.0144363			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1YS	26641492	Green Published, Green Submitted, gold			2022-12-27	WOS:000366902700104
J	Kumar, S; Jain, KK; Bhardwaj, KN; Chakraborty, S; Kuhad, RC				Kumar, Sandeep; Jain, Kavish Kumar; Bhardwaj, Kailash N.; Chakraborty, Subhojit; Kuhad, Ramesh Chander			Multiple Genes in a Single Host: Cost-Effective Production of Bacterial Laccase (cotA), Pectate Lyase (pel), and Endoxylanase (xyl) by Simultaneous Expression and Cloning in Single Vector in E. coli	PLOS ONE			English	Article							BACILLUS-SUBTILIS; ESCHERICHIA-COLI; PICHIA-PASTORIS; HYDROLYSIS; OVEREXPRESSION; FERMENTATION; SUBSTRATE; XYLANASE; ETHANOL; SYSTEM	This study attempted to reduce the enzyme production cost for exploiting lignocellulosic materials by expression of multiple genes in a single host. Genes for bacterial laccase (CotA), pectate lyase (Pel) and endoxylanase (Xyl), which hold significance in lignocellulose degradation, were cloned in pETDuet-1 vector containing two independent cloning sites (MCS). CotA and xyl genes were cloned in MCS1 and MCS 2, respectively. Pel gene was cloned by inserting complete cassette (T-7 promoter, ribosome binding site, pel gene, His tag and complete gene ORF) preceded by cotA open reading frame in the MCS1. IPTG induction of CPXpDuet-1 construct in E. coli BL21(DE3) resulted in expression of all three heterologous proteins of similar to 65 kDa (CotA), similar to 45 kDa (Pel) and similar to 25 kDa (Xyl), confirmed by SDS-PAGE and western blotting. Significant portions of the enzymes were also found in culture supernatant (similar to 16, similar to 720 and similar to 370 IU/ml activities of CotA, Pel and Xyl, respectively). Culture media optimization resulted in 2, 3 and 7 fold increased secretion of recombinant CotA, Pel and Xyl, respectively. Bioreactor level optimization of the recombinant cocktail expression resulted in production of 19 g/L dry cell biomass at OD600nm 74 from 1 L induced culture after 15 h of cultivation, from which 9, 627 and 1090 IU/ml secretory enzyme activities of CotA, Xyl and Pel were obtained, respectively. The cocktail was also found to increase the saccharification of orange peel in comparison to the xylanase alone. Thus, simultaneous expression as well as extra cellular secretion of these enzymes as cocktail can reduce the enzyme production cost which increases their applicability specially for exploiting lignocellulosic materials for their conversion to value added products like alcohol and animal feed.	[Kumar, Sandeep; Jain, Kavish Kumar; Chakraborty, Subhojit; Kuhad, Ramesh Chander] Univ Delhi South Campus, Dept Microbiol, Lignocellulose Biotechnol Lab, New Delhi 110021, India; [Bhardwaj, Kailash N.] Uttarakhand State Council Sci & Technol UCOST, Dehra Dun 248007, Uttarakhand, India; [Kuhad, Ramesh Chander] Cent Univ Haryana, Pali 123029, Haryana, India	University of Delhi; Central University of Haryana	Kuhad, RC (corresponding author), Univ Delhi South Campus, Dept Microbiol, Lignocellulose Biotechnol Lab, Benito Juarez Rd, New Delhi 110021, India.	kuhad85@gmail.com	Kuhad, Ramesh Chander/T-7753-2019	Kuhad, Ramesh Chander/0000-0002-4120-948X; Jain, Kavish Kumar/0000-0002-6609-1756	University of Delhi Research; PURSE Grant; Indian Medical Council of Research (ICMR); Council of Scientific and Industrial Research (CSIR); University of Delhi South Campus; DU/DST PURSE grant; Indian Council of Medical Research (ICMR), New Delhi	University of Delhi Research; PURSE Grant; Indian Medical Council of Research (ICMR); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); University of Delhi South Campus; DU/DST PURSE grant; Indian Council of Medical Research (ICMR), New Delhi(Indian Council of Medical Research (ICMR))	The work has been sponsored by a University of Delhi Research and PURSE Grant to RCK (www.du.ac.in). SK received a research fellowship from the Indian Medical Council of Research (ICMR) (http://icmr.nic.in/). KKJ received a research fellowship from the Council of Scientific and Industrial Research (CSIR) (www.csirhrdg.res.in). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The financial assistance from University of Delhi South Campus and DU/DST PURSE grant is highly acknowledged. Also the fellowship grants from Indian Council of Medical Research (ICMR), New Delhi to SK and from Council of Scientific and industrial research (CSIR) to KKJ is gratefully acknowledged. We wish to thank Mayura Dutta, for her sincere effort in copy editing of the manuscript. The authors are grateful to Prof. J. P. Khurana, Department of Plant Molecular Biology, University of Delhi South Campus, New Delhi, for editing our manuscript. The authors also wish to thank Ms Urvashi Kuhad, Research Fellow, Department of Modern Indian Languages and Comparative Literature, University of Delhi, Delhi for language editing. We would also like to thank Dr. Rishi Gupta (DST Fast Track Young Scientist), Dr. Arvind and Dr. Rishikesh, Research Associates, Lignocellulose Biotechnology Laboratory, University of Delhi South Campus, New Delhi for their constructive suggestions during the preparation of the manuscript.	ALBERSHEIM P, 1962, ARCH BIOCHEM BIOPHYS, V97, P107, DOI 10.1016/0003-9861(62)90050-4; Broedel SE, 2007, ACES SIGNAL SEQUENCE; Busso D, 2011, J STRUCT BIOL, V175, P159, DOI 10.1016/j.jsb.2011.03.004; Carneiro S, 2013, J BIOTECHNOL, V164, P396, DOI 10.1016/j.jbiotec.2012.08.026; Durao P, 2008, J BIOL INORG CHEM, V13, P183, DOI 10.1007/s00775-007-0312-0; Dzivenu OK, 2004, PROTEIN EXPRES PURIF, V38, P1, DOI 10.1016/j.pep.2004.07.016; Ferrer M, 2003, NAT BIOTECHNOL, V21, P1266, DOI 10.1038/nbt1103-1266; Fonseca-Maldonado R, 2014, PROCESS BIOCHEM, V49, P1152, DOI 10.1016/j.procbio.2014.03.027; Gupta R, 2009, BIORESOURCE TECHNOL, V100, P1214, DOI 10.1016/j.biortech.2008.08.033; Jalal A, 2009, J BIOSCI BIOENG, V107, P360, DOI 10.1016/j.jbiosc.2008.12.005; Kapoor M, 2007, J APPL MICROBIOL, V103, P305, DOI 10.1111/j.1365-2672.2006.03251.x; Khamseh AAG, 2012, PROCESS BIOCHEM, V47, P1588, DOI 10.1016/j.procbio.2011.10.018; Khasa YP, 2011, YEAST, V28, P213, DOI 10.1002/yea.1832; Kuhad RC, 2011, RENEW SUST ENERG REV, V15, P4950, DOI 10.1016/j.rser.2011.07.058; Liu M, 2012, BIOCHEM ENG J, V68, P1, DOI 10.1016/j.bej.2012.07.003; MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Oberoi HS, 2010, J AGR FOOD CHEM, V58, P3422, DOI 10.1021/jf903163t; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Reiss R, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-9; SAIER MH, 2006, MICROBE, V1, P414; Schlapschy M, 2006, PROTEIN ENG DES SEL, V19, P385, DOI 10.1093/protein/gzl018; Shokri A, 2002, APPL MICROBIOL BIOT, V58, P386, DOI 10.1007/s00253-001-0889-0; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Sorensen HP, 2005, J BIOTECHNOL, V115, P113, DOI 10.1016/j.jbiotec.2004.08.004; Sweeney MD, 2012, CATALYSTS, V2, P244, DOI 10.3390/catal2020244; Tripathi, 2009, IND BIOTECHNOLOGY, V5, P179, DOI DOI 10.1089/IND.2009.3.179; Ukkonen K, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-73; Ylitervo P, 2008, PRODUCTION ETHANOL B; Yu NY, 2010, BIOINFORMATICS, V13; Zhang CJ, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-26	31	9	10	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144379	10.1371/journal.pone.0144379	http://dx.doi.org/10.1371/journal.pone.0144379			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642207	gold, Green Submitted, Green Published			2022-12-27	WOS:000366902700108
J	Manzur, JP; Fita, A; Prohens, J; Rodriguez-Burruezo, A				Pablo Manzur, Juan; Fita, Ana; Prohens, Jaime; Rodriguez-Burruezo, Adrian			Successful Wide Hybridization and Introgression Breeding in a Diverse Set of Common Peppers (Capsicum annuum) Using Different Cultivated Aji (C-baccatum) Accessions as Donor Parents	PLOS ONE			English	Article							LYCOPERSICON-ESCULENTUM; INTERSPECIFIC HYBRIDS; WILD RELATIVES; PERUVIANUM; RESISTANCE; GENETICS; CROSSES; GROWTH; L.	Capsicum baccatum, commonly known as aji, has been reported as a source of variation for many different traits to improve common pepper (C. annuum), one of the most important vegetables in the world. However, strong interspecific hybridization barriers exist between them. A comparative study of two wide hybridization approaches for introgressing C. baccatum genes into C. annuum was performed: i) genetic bridge (GB) using C. chinense and C. frutescens as bridge species; and, ii) direct cross between C. annuum and C. baccatum combined with in vitro embryo rescue (ER). A diverse and representative collection of 18 accessions from four cultivated species of Capsicum was used, including C. annuum (12), C. baccatum (3), C. chinense (2), and C. frutescens (1). More than 5000 crosses were made and over 1000 embryos were rescued in the present study. C. chinense performed as a good bridge species between C. annuum and C. baccatum, with the best results being obtained with the cross combination [C. baccatum (female) x C. chinense (male)] (female) x C. annuum (male), while C. frutescens gave poor results as bridge species due to strong prezygotic and postzygotic barriers. Virus-like-syndrome or dwarfism was observed in F-1 hybrids when both C. chinense and C. frutescens were used as female parents. Regarding the ER strategy, the best response was found in C. annuum (female) x C. baccatum (male) crosses. First backcrosses to C. annuum (BC(1)s) were obtained according to the crossing scheme [C. annuum (female) x C. baccatum (male)] (female) x C. annuum (male) using ER. Advantages and disadvantages of each strategy are discussed in relation to their application to breeding programmes. These results provide breeders with useful practical information for the regular utilization of the C. baccatum gene pool in C. annuum breeding.	[Pablo Manzur, Juan] Inst Invest Agr CRI La Platina, Santiago, Chile; [Fita, Ana; Prohens, Jaime; Rodriguez-Burruezo, Adrian] Univ Politecn Valencia, Inst Conservac & Mejora Agrodiversidad Valenciana, E-46022 Valencia, Spain	Universitat Politecnica de Valencia	Fita, A (corresponding author), Univ Politecn Valencia, Inst Conservac & Mejora Agrodiversidad Valenciana, Camino Vera S-N, E-46022 Valencia, Spain.	anfifer@upvnet.upv.es	Prohens, Jaime/H-2228-2015; Fita, ANA/K-4250-2017; Burruezo, Adrian Rodriguez/AAB-1498-2019; Prohens, Jaime/ABF-1229-2021	Prohens, Jaime/0000-0003-1181-9065; Prohens, Jaime/0000-0003-1181-9065; FITA, ANA/0000-0002-8637-5852; Rodriguez-Burruezo, Adrian/0000-0002-4530-8071	Universitat Politecnica de Valencia [2011-S2-4264]	Universitat Politecnica de Valencia	Juan P. Manzur thanks Universitat Politecnica de Valencia for a research predoctoral grant (2011-S2-4264, programa para la formacion de personal investigador). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Juan P. Manzur thanks Universitat Politecnica de Valencia for a research predoctoral grant (2011-S2-4264, programa para la formacion de personal investigador). Authors are grateful to Centro Inv. Agr. Mabegondo, S. Larregla from NEIKER, P.W. Bosland from NMSU and the Consejos Reguladores of IGP Pimiento Asado del Bierzo, DOP Pimenton de Murcia, and IGP Piquillo de Lodosa for providing us with seeds from Arnoia, Guindilla de Ibarra, Numex, Bierzo, Bola and Piquillo, respectively.	BARBANO PP, 1984, J AM SOC HORTIC SCI, V109, P95; Bento CS, 2013, GENET MOL RES, V12, P1074, DOI 10.4238/2013.April.10.3; Bosland P. W., 2012, Peppers: vegetable and spice capsicums, DOI 10.1079/9781845938253.0000; Chen LZ, 1996, PLANT BREEDING, V115, P251, DOI 10.1111/j.1439-0523.1996.tb00912.x; Monteiro CED, 2011, CROP BREED APPL BIOT, V11, P241, DOI 10.1590/S1984-70332011000300006; de Souza VL, 2003, PLANT PATHOL, V52, P613, DOI 10.1046/j.1365-3059.2003.00920.x; do Rego ER, 2009, EUPHYTICA, V168, P275, DOI 10.1007/s10681-009-9947-y; EGAWA Y, 1986, JPN J BREED, V36, P16; Eggink PM, 2014, THEOR APPL GENET, V127, P373, DOI 10.1007/s00122-013-2225-3; GONZALEZSALAN MM, 1991, EUPHYTICA, V59, P49; Hajjar R, 2007, EUPHYTICA, V156, P1, DOI 10.1007/s10681-007-9363-0; Hirsch CN, 2013, G3-GENES GENOM GENET, V3, P1003, DOI 10.1534/g3.113.005595; Honnay O, 2012, FRONT ECOL ENVIRON, V10, P121, DOI 10.1890/12.WB.007; INAI S, 1993, THEOR APPL GENET, V87, P416, DOI 10.1007/BF00215086; Kamvorn W, 2014, SCI HORTIC-AMSTERDAM, V179, P9, DOI 10.1016/j.scienta.2014.09.003; Kim SangHoon, 2008, Journal of Crop Science and Biotechnology, V11, P13; Kollmannsberger H, 2011, J SCI FOOD AGR, V91, P1598, DOI 10.1002/jsfa.4354; Lafon-Placette C, 2015, CURR OPIN PLANT BIOL, V23, P39, DOI 10.1016/j.pbi.2014.10.006; Lin T, 2014, NAT GENET, V46, P1220, DOI 10.1038/ng.3117; Mahasuk P, 2009, PHYTOPATHOLOGY, V99, P1100, DOI 10.1094/PHYTO-99-9-1100; Maheshwari S, 2011, ANNU REV GENET, V45, P331, DOI 10.1146/annurev-genet-110410-132514; Manzur JP, 2013, SCI HORTIC-AMSTERDAM, V161, P181, DOI 10.1016/j.scienta.2013.06.036; Manzur JP, 2013, SCI AGR, V71, P488; Matsunaga H., 1995, Capsicum & Eggplant Newsletter, P60; Md. Amzad Hossain, 2003, Japanese Journal of Tropical Agriculture, V47, P9; Minamiyama Y, 2006, MOL BREEDING, V18, P157, DOI 10.1007/s11032-006-9024-3; Mongkolporn O, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES - VEGETABLES, P43, DOI 10.1007/978-3-642-20450-0_4; MUHYI R, 1995, HORTSCIENCE, V30, P341, DOI 10.21273/HORTSCI.30.2.341; Nowack MK, 2010, BIOCHEM SOC T, V38, P604, DOI 10.1042/BST0380604; Nuez F, 2003, CULTIVO PIMIENTOS CH; Orr HA, 1996, GENETICS, V144, P1331; PICKERSGILL B, 1971, EVOLUTION, V25, P683, DOI 10.1111/j.1558-5646.1971.tb01926.x; PICKERSGILL B, 1988, BIOL ZBL, V107, P381; Pickersgill B, 1997, EUPHYTICA, V96, P129, DOI 10.1023/A:1002913228101; RAO NB, 1992, EUPHYTICA, V59, P135, DOI 10.1007/BF00041265; Rodriguez-Riano T, 2000, SEX PLANT REPROD, V12, P241, DOI 10.1007/s004970050008; Shen XL, 2011, METHODS MOL BIOL, V710, P75, DOI 10.1007/978-1-61737-988-8_7; Shivanna KR, 2015, PLANT BIOL BIOTECHNO, V2, P347, DOI [10.1007/978-81-322-2283-5_17, DOI 10.1007/978-81-322-2283-5_17]; Soler S, 2015, ANN APPL BIOL, V167, P343, DOI 10.1111/aab.12229; Yang DC, 2001, THESIS; YAZAWA S, 1989, J JPN SOC HORTIC SCI, V58, P609, DOI 10.2503/jjshs.58.609; Yoon Jae Bok, 2005, Journal of the Korean Society for Horticultural Science, V46, P5; Yoon Jae Bok, 2004, Journal of the Korean Society for Horticultural Science, V45, P324; Yoon JB, 2006, BREEDING SCI, V56, P31, DOI 10.1270/jsbbs.56.31; ZIJLSTRA S, 1991, HORTSCIENCE, V26, P585, DOI 10.21273/HORTSCI.26.5.585	45	24	26	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144142	10.1371/journal.pone.0144142	http://dx.doi.org/10.1371/journal.pone.0144142			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642059	Green Published, gold, Green Submitted			2022-12-27	WOS:000366902700062
J	Wai, KM; Shibanuma, A; Oo, NN; Fillman, TJ; Saw, YM; Jimba, M				Wai, Kyi Mar; Shibanuma, Akira; Oo, Nwe Nwe; Fillman, Toki Jennifer; Saw, Yu Mon; Jimba, Masamine			Are Husbands Involving in Their Spouses' Utilization of Maternal Care Services?: A Cross-Sectional Study in Yangon, Myanmar	PLOS ONE			English	Article							MALE INVOLVEMENT; BIRTH PREPAREDNESS; ANTENATAL CARE; COMPLICATION READINESS; REPRODUCTIVE-HEALTH; POSTNATAL CARE; PREGNANCY; WOMEN; DETERMINANTS; MORTALITY	Introduction Husbands can play a crucial role in pregnancy and childbirth, especially in patriarchal societies of developing countries. In Myanmar, despite the critical influence of husbands on the health of mothers and newborns, their roles in maternal health have not been well explored. Therefore, the aim of this study was to identify the factors associated with husbands' involvement in maternal health in Myanmar. This study also examined the associations between husbands' involvement and their spouses' utilization of maternal care services during antenatal, delivery and postnatal periods. Methods A community-based, cross sectional study was conducted with 426 husbands in Thingangyun Township, Yangon, Myanmar. Participants were husbands aged 18 years or older who had at least one child within two years at the time of interview. Face to face interviews were conducted using a pretested structured questionnaire. Factors associated with the characteristics of husband's involvement as well as their spouses' utilization of maternal care services were analyzed by multivariable logistic regression models. Results Of 426 husbands, 64.8% accompanied their spouses for an antenatal visit more than once while 51.6% accompanied them for a postnatal visit. Husbands were major financial supporters for both antenatal (95.8%) and postnatal care (68.5%). Overall, 69.7% were involved in decision making about the place of delivery. Regarding birth preparedness, the majority of husbands prepared for skilled birth attendance (91.1%), delivery place (83.6%), and money saving (81.7%) before their spouses gave birth. In contrast, fewer planned for a potential blood donor (15.5%) and a safe delivery kit (21.1%). In the context of maternal health, predictors of husband's involvement were parity, educational level, type of marriage, decision making level in family, exposure to maternal health education and perception of risk during pregnancy and childbirth. Increased utilization of maternal health services was found among spouses of husbands who accompanied them to antenatal visits (AOR 5.82, 95% CI, 3.34-10.15) and those who had a well birth plan (AOR 2.42, 95% CI, 1.34-4.39 for antenatal visit and AOR 2.88, 95% CI, 1.52-5.47 for postnatal visit). Conclusion The majority of husbands supported their spouses' maternal care services use financially; however, they were less involved in birth preparedness and postnatal care. Exposure to maternal health education and their maternal health knowledge were main predictors of their involvement. Women were more likely to use maternal care services when their husbands company them for ANC visits and had a well-birth plan in advance.	[Wai, Kyi Mar; Fillman, Toki Jennifer] Univ Tokyo, Grad Sch Med, Dept Human Ecol, Tokyo, Japan; [Wai, Kyi Mar; Shibanuma, Akira; Jimba, Masamine] Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Tokyo, Japan; [Oo, Nwe Nwe] Dept Med Res Lower Myanmar, Yangon, Myanmar; [Saw, Yu Mon] Nagoya Univ, Grad Sch Med, Women Leaders Program Promote Well Being Asia, Nagoya, Aichi 4648601, Japan	University of Tokyo; University of Tokyo; Nagoya University	Jimba, M (corresponding author), Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Tokyo, Japan.	mjimba@m.u-tokyo.ac.jp	Jimba, Masamine/AAF-5630-2020; Saw, Yu Mon/M-7946-2019; Shibanuma, Akira/C-7652-2016	Shibanuma, Akira/0000-0003-2058-1722; Wai, Kyi Mar/0000-0001-8755-277X; Saw, Yu Mon/0000-0002-5038-0043	Asian Development Bank Japan Scholarship Program's research grant	Asian Development Bank Japan Scholarship Program's research grant	The data collection of this study was supported by Asian Development Bank Japan Scholarship Program's research grant (http://www.adb.org/site/careers/japan-scholarship-program/main).	Acuin CS, 2011, LANCET, V377, P516, DOI 10.1016/S0140-6736(10)62049-1; Agarwal S, 2010, J HEALTH POPUL NUTR, V28, P383; Agha S, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-31; Ampt F, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0561-9; Barnes-Josiah D, 1998, SOC SCI MED, V46, P981, DOI 10.1016/S0277-9536(97)10018-1; Bhatta DN, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-14; Carter M, 2002, SOC SCI MED, V55, P437, DOI 10.1016/S0277-9536(01)00175-7; Chakraborty N, 2002, HEALTH SOC CARE COMM, V10, P492, DOI 10.1046/j.1365-2524.2002.00389.x; Chattopadhyay A, 2012, J BIOSOC SCI, V44, P129, DOI 10.1017/S0021932011000502; Del Barco R. E., 2004, MONITORING BIRTH PRE; Ditekemena J, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-32; Dudgeon MR, 2004, SOC SCI MED, V59, P1379, DOI 10.1016/j.socscimed.2003.11.035; Farquhar C, 2004, JAIDS-J ACQ IMM DEF, V37, P1620, DOI 10.1097/00126334-200412150-00016; Graft-Johnson J, 2006, CONTINUUM CARE MATER; Gyimah SO, 2006, SOC SCI MED, V62, P2930, DOI 10.1016/j.socscimed.2005.11.034; Iliyasu Zubairu, 2010, Afr J Reprod Health, V14, P21; Islam MR, 2011, RURAL REMOTE HEALTH, V11; Jennings L, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-297; Kabakyenga JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035747; Kakaire O, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-12; Kaso M, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-55; Kaye DK, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-54; Kululanga Lucy I, 2012, Afr J Reprod Health, V16, P145; Kwambai TK, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-134; Liu N, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-274; Mangeni J, 2014, E AFR MED J, V89, P372; Ministry of Health Myanmar, 2009, 5 YEAR STRAT PLAN RE; Ministry of Information Myanmar, 2008, CONST REP UN MYANM; Mullany BC, 2006, SOC SCI MED, V62, P2798, DOI 10.1016/j.socscimed.2005.11.013; Mullany BC, 2005, SOC SCI MED, V61, P1993, DOI 10.1016/j.socscimed.2005.04.006; Mullany BC, 2007, HEALTH EDUC RES, V22, P166, DOI 10.1093/her/cyl060; Mumtaz Z, 2007, SOCIOL HEALTH ILL, V29, P1, DOI 10.1111/j.1467-9566.2007.00519.x; Olayemi O, 2009, J BIOSOC SCI, V41, P493, DOI 10.1017/S0021932009003356; Redshaw M, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-70; Requejo J, 2014, INT J EPIDEMIOL, V43, P586, DOI 10.1093/ije/dyu034; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Saw YM, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-78; Sein KK, 2013, MIDWIFERY, V29, P1257, DOI 10.1016/j.midw.2012.11.012; Sein KK, 2012, MATERN CHILD HLTH J, V16, P1021, DOI 10.1007/s10995-011-0815-8; Sen BK, 2001, LEGAL ISSUE BURMA, V9, P28; Shen C, 1999, SOC SCI MED, V49, P197, DOI 10.1016/S0277-9536(99)00112-4; Story WT, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-28; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Theuring S, 2009, AIDS BEHAV, V13, pS92, DOI 10.1007/s10461-009-9543-0; Tweheyo R, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-53; UNFPA, 2006, MAT NEON HLTH E S E; UNFPA [United Nations Population Fund], 2010, REP SIT AN POP DEV R; UNICEF World Health Organization, 2012, COUNTD 2015 BUILD FU; United Nations Country Team in Myanmar, 2011, ACH MILL DEV GOALS M; Wendy Holmes JD, 2013, ENGAGING MEN REPROD; WHO, 2013, MAT DEATH SURV RESP; WHO UNICEF, 2013, TRENDS MAT MORT 1990; World Health Organization, 2009, WOMEN AND HEALTH: TODAY'S EVIDENCE TOMORROW'S AGENDA, P1; Yanagisawa S, 2006, TROP MED INT HEALTH, V11, P238, DOI 10.1111/j.1365-3156.2005.01547.x	54	37	37	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144135	10.1371/journal.pone.0144135	http://dx.doi.org/10.1371/journal.pone.0144135			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1YS	26641891	gold, Green Published			2022-12-27	WOS:000366902700061
J	Cuomo, RE; Garland, CF; Gorham, ED; Mohr, SB				Cuomo, Raphael E.; Garland, Cedric F.; Gorham, Edward D.; Mohr, Sharif B.			Low Cloud Cover-Adjusted Ultraviolet B Irradiance Is Associated with High Incidence Rates of Leukemia: Study of 172 Countries	PLOS ONE			English	Article							VITAMIN-D; 1,25-DIHYDROXYVITAMIN D-3; CANCER-RISK; EXPRESSION; SURVIVAL; CELLS	There are 52,380 cases of leukemia and 24,090 deaths from it in the US annually. Its causes are unknown and no preventive strategies have been implemented. We hypothesized that leukemia is due mainly to vitamin D deficiency, which is due mainly to low solar ultraviolet B (UVB) irradiance. To test this hypothesis, we estimated age-standardized cloud-cover-adjusted winter UVB irradiance using cloud cover data from the International Satellite Cloud Climatology Project, latitudes of population centroids, and standard astronomical calculations. Incidence rates for 172 countries, available from the International Agency for Cancer Research, were plotted according to cloud-adjusted UVB irradiance. We used multiple regression to account for national differences in elevation and average life expectancy. Leukemia incidence rates were inversely associated with cloud-adjusted UVB irradiance in males (rho <= 0.01) and females (rho <= 0.01) in both hemispheres. There were few departures from the trend line, which was parabolic when plotted with the equator at the center of the display, northern hemisphere countries on the right side and southern hemisphere countries on the left. The bivariate association displayed by the polynomial trend line indicated that populations at higher latitudes had at least two times the risk of leukemia compared to equatorial populations. The association persisted in males (rho <= 0.05) and females (rho <= 0.01) after controlling for elevation and life expectancy. Incidence rates of leukemia were inversely associated with solar UVB irradiance. It is plausible that the association is due to vitamin D deficiency. This would be consistent with laboratory studies and a previous epidemiological study. Consideration should be given to prudent use of vitamin D for prevention of leukemia.	[Cuomo, Raphael E.] Univ Calif San Diego, Dept Family Med & Publ Hlth, Div Global Hlth, La Jolla, CA 92093 USA; [Cuomo, Raphael E.] San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA; [Garland, Cedric F.; Gorham, Edward D.; Mohr, Sharif B.] Univ Calif San Diego, Dept Family Med & Publ Hlth, Div Epidemiol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; California State University System; San Diego State University; University of California System; University of California San Diego	Cuomo, RE (corresponding author), Univ Calif San Diego, Dept Family Med & Publ Hlth, Div Global Hlth, La Jolla, CA 92093 USA.	raphael.e.cuomo@gmail.com		Cuomo, Raphael/0000-0002-8179-0619				Abe E, 1981, P NATL ACAD SCI US, V78; Cancer Research UK, 2014, LEUK ALL SUBT COMB K; Cuomo RE, 2013, DERM-ENDOCRINOL, V5, DOI 10.4161/derm.23773; Fong WF, 2005, INT J BIOCHEM CELL B, V37, P427, DOI 10.1016/j.biocel.2004.05.021; Giovannucci E, 2006, JNCI-J NATL CANCER I, V98, P451, DOI 10.1093/jnci/djj101; Grigalavicius M, 2013, DERM-ENDOCRINOL, V5, DOI 10.4161/derm.22941; Heaney RP, 2003, AM J CLIN NUTR, V77, P204, DOI 10.1093/ajcn/77.1.204; HONMA Y, 1983, P NATL ACAD SCI-BIOL, V80, P201, DOI 10.1073/pnas.80.1.201; International Agency for Research on Cancer, 2012, GLOBOCAN 2012 DAT; Jenab M., 2010, BMJ, V350, pb5500; Lappe JM, 2007, AM J CLIN NUTR, V85, P1586, DOI 10.1093/ajcn/85.6.1586; Lee HJ, 2014, CANCER-AM CANCER SOC, V120, P521, DOI 10.1002/cncr.28368; Lin XY, 2000, MOL CELL BIOL, V20, P7259, DOI 10.1128/MCB.20.19.7259-7272.2000; Liu FM, 2010, MOL CELL BIOL, V30, P1971, DOI 10.1128/MCB.01247-09; Lopes N, 2012, ANTICANCER RES, V32, P249; MACLAUGHLIN J, 1985, J CLIN INVEST, V76, P1536, DOI 10.1172/JCI112134; Mohr SB, 2008, BREAST J, V14, P255, DOI 10.1111/j.1524-4741.2008.00571.x; Mohr SB, 2011, AM J PREV MED, V41, P68, DOI 10.1016/j.amepre.2011.04.003; *NAT AER SPAC ADM, SOL RAD EARTH SYST; *NAT AER SPAC ADM, INT SAT CLOUD CLIM P; National Cancer Institute, 2014, LEUKEMIA; Naz A, 2013, PAK J MED SCI, V29, P10, DOI 10.12669/pjms.291.2764; Parkin DM, 2006, NAT REV CANCER, V6, P603, DOI 10.1038/nrc1948; Portland State University, COUNTR GEOGR DAT; Sekeres M., 2014, ACUTE MYELOID LEUKEM; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Vieth R, 2012, SCAND J CLIN LAB INV, V72, P144, DOI 10.3109/00365513.2012.682893; Wang X, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-5; Wang XF, 2009, IMECE 2008: PROCEEDINGS OF THE ASME INTERNATIONAL MECHANICAL ENGINEERING CONGRESS AND EXPOSITION, VOL 5, P25; Wang XN, 1997, P SOC EXP BIOL MED, V215, P399, DOI 10.3181/00379727-215-44150; World Health Organization, WHO GLOB INF; Xie Y, 2003, CANCER-AM CANCER SOC, V97, P2229, DOI 10.1002/cncr.11316	32	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144308	10.1371/journal.pone.0144308	http://dx.doi.org/10.1371/journal.pone.0144308			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26637119	Green Published, gold, Green Submitted			2022-12-27	WOS:000366143800071
J	Mettrop, IS; Cusell, C; Kooijman, AM; Lamers, LPM				Mettrop, Ivan S.; Cusell, Casper; Kooijman, Annemieke M.; Lamers, Leon P. M.			Short-Term Summer Inundation as a Measure to Counteract Acidification in Rich Fens	PLOS ONE			English	Article							WATER-LEVEL FLUCTUATION; MOBILIZATION; BRYOPHYTES; SEDIMENTS; DYNAMICS; AMMONIUM; IMPACTS; NITRATE; CLIMATE; PEAT	In regions with intensive agriculture, water level fluctuation in wetlands has generally become constricted within narrow limits. Water authorities are, however, considering the re-establishment of fluctuating water levels as a management tool in biodiverse, base-rich fens ('rich fens'). This includes temporary inundation with surface water from ditches, which may play an important role in counteracting acidification in order to conserve and restore biodiversity. Inundation may result in an increased acid neutralizing capacity (ANC) for two reasons: infiltration of base-rich inundation water into peat soils, and microbial alkalinity generation under anaerobic conditions. The main objectives of this study were to test whether short-term (2 weeks) summer inundation is more effective than short-term winter inundation to restore the ANC in the upper 10 cm of non-floating peat soils, and to explain potential differences. Large-scale field experiments were conducted for five years in baserich fens and Sphagnum-dominated poor fens. Winter inundation did not result in increased porewater ANC, because infiltration was inhibited in the waterlogged peat and evapotranspiration rates were relatively low. Also, low temperatures limit microbial alkalinity generation. In summer, however, when temperature and evapotranspiration rates are higher, inundation resulted in increased porewater Ca and HCO3- concentrations, but only in areas with characteristic rich fen bryophytes. This increase was not only due to stronger infiltration into the soil, but also to higher microbial alkalinity generation under anaerobic conditions. In contrast, porewater ANC did not increase in Sphagnum-plots as a result of the ability of Sphagnum spp. to acidify their environment. In both rich and poor fens, flooding-induced P-mobilization remained sufficiently low to safeguard P-limited vegetation. NO3- and NH4+ dynamics showed no considerable changes either. In conclusion, short-term summer inundation with base-rich and nutrient-poor surface water is considered beneficial in the management of non-floating rich fens, and much more effective than winter inundation.	[Mettrop, Ivan S.; Cusell, Casper; Kooijman, Annemieke M.] Univ Amsterdam, IBED, NL-1090 GE Amsterdam, Netherlands; [Mettrop, Ivan S.; Cusell, Casper; Lamers, Leon P. M.] Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Aquat Ecol & Environm Biol, NL-6525 Nijmegen, Netherlands	University of Amsterdam; Radboud University Nijmegen	Mettrop, IS (corresponding author), Univ Amsterdam, IBED, POB 94248, NL-1090 GE Amsterdam, Netherlands.	I.Mettrop@uva.nl	Lamers, Leon P.M./A-8718-2012; Kooijman, Annemieke/S-5762-2016	Lamers, Leon P.M./0000-0003-3769-2154; Mettrop, Ivan/0000-0001-7143-9086	Kennisnetwerk Ontwikkeling en Beheer Natuurkwaliteit (O+BN) of the Dutch Ministry of Economic Affairs, Agriculture and Innovation; Water Management Authority Reest Wieden; Province of Overijssel; Natuurmonumenten	Kennisnetwerk Ontwikkeling en Beheer Natuurkwaliteit (O+BN) of the Dutch Ministry of Economic Affairs, Agriculture and Innovation; Water Management Authority Reest Wieden; Province of Overijssel; Natuurmonumenten	This research was funded by Kennisnetwerk Ontwikkeling en Beheer Natuurkwaliteit (O+BN) of the Dutch Ministry of Economic Affairs, Agriculture and Innovation, the Water Management Authority Reest & Wieden, the Province of Overijssel, and Natuurmonumenten.	BAKER LA, 1986, WATER AIR SOIL POLL, V31, P89, DOI 10.1007/BF00630822; Bronstert A, 2003, RISK ANAL, V23, P545, DOI 10.1111/1539-6924.00335; CARACO NF, 1989, NATURE, V341, P316, DOI 10.1038/341316a0; Clapham AR, 1940, J ECOL, V28, P71, DOI 10.2307/2256163; Clymo R.S., 1963, ANN BOT, V27, P71; Cusell C., 2013, 2013OBN171LZ MIN EC; Cusell C, 2015, ECOL ENG, V77, P127, DOI 10.1016/j.ecoleng.2015.01.025; Cusell C, 2013, J APPL ECOL, V50, P998, DOI 10.1111/1365-2664.12096; Gorham E., 1987, Effects of atmospheric pollutants on forests, wetlands and agricultural ecosystems NATO ASI Series G: Ecological Sciences, Vol. 16., P493; Kooijman AM, 2006, APPL VEG SCI, V9, P205, DOI 10.1658/1402-2001(2006)9[205:HARIFW]2.0.CO;2; Kooijman A. M., 2012, Lindbergia, V35, P42; KOOIJMAN AM, 1992, BIOL CONSERV, V59, P139, DOI 10.1016/0006-3207(92)90573-6; KOOIJMAN AM, 1994, AQUAT BOT, V48, P133, DOI 10.1016/0304-3770(94)90080-9; Kundzewicz ZW, 2006, CLIM RES, V31, P51, DOI 10.3354/cr031051; Lamers LPM, 2015, BIOL REV, V90, P182, DOI 10.1111/brv.12102; Lamers LPM, 1998, ENVIRON SCI TECHNOL, V32, P199, DOI 10.1021/es970362f; Lamers LPM, 1998, WATER AIR SOIL POLL, V105, P95, DOI 10.1023/A:1005083526455; LINDSAY W. L., 1960, SOIL SCI SOC AMER PROC, V24, P177; Mettrop IS, 2015, ECOL ENG, V85, P226, DOI 10.1016/j.ecoleng.2015.09.077; Mettrop IS, 2014, SOIL BIOL BIOCHEM, V68, P317, DOI 10.1016/j.soilbio.2013.10.023; PATRICK WH, 1974, SCIENCE, V186, P53, DOI 10.1126/science.186.4158.53; Paulissen MPCP, 2004, NEW PHYTOL, V164, P451, DOI 10.1111/j.1469-8137.2004.01196.x; Ponnamperuma F. N., 1984, Flooding and plant growth, P9; Roden EE, 1997, ARCH HYDROBIOL, V139, P347; SMOLDERS A, 1993, AQUAT BOT, V46, P247, DOI 10.1016/0304-3770(93)90005-H; Stumm W., 1996, AQUATIC CHEM CHEM EQ, V3rd ed., DOI [10.5860/choice.33-6312, DOI 10.5860/CHOICE.33-6312]; Van Wirdum G., 1992, FENS BOGS NETHERLAND, P323; vanDiggelen R, 1996, J VEG SCI, V7, P809, DOI 10.2307/3236459; Venterink HO, 2002, PLANT SOIL, V243, P119, DOI 10.1023/A:1019993510737; Verhoeven JTA, 2011, APPL VEG SCI, V14, P149, DOI 10.1111/j.1654-109X.2010.01113.x; Vorenhout M, 2011, INT J ENVIRON AN CH, V91, P801, DOI 10.1080/03067319.2010.535123; Wheeler BD, 2000, J ECOL, V88, P187, DOI 10.1046/j.1365-2745.2000.00455.x; Whitworth KL, 2014, ALKALINITY CAPTURE M; Zak D, 2010, ECOL APPL, V20, P1336, DOI 10.1890/08-2053.1	34	3	3	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144006	10.1371/journal.pone.0144006	http://dx.doi.org/10.1371/journal.pone.0144006			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26637121	Green Published, Green Submitted, gold			2022-12-27	WOS:000366143800036
J	Smetanova, M; Bolfikova, BC; Randi, E; Caniglia, R; Fabbri, E; Galaverni, M; Kutal, M; Hulva, P				Smetanova, Milena; Bolfikova, Barbora Cerna; Randi, Ettore; Caniglia, Romolo; Fabbri, Elena; Galaverni, Marco; Kutal, Miroslav; Hulva, Pavel			From Wolves to Dogs, and Back: Genetic Composition of the Czechoslovakian Wolfdog	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; RE-IMPLEMENTATION; N-E; SOFTWARE; CONSERVATION; PROGRAM; ADAPTATION; INFERENCE; REVEALS; HISTORY	The Czechoslovakian Wolfdog is a unique dog breed that originated from hybridization between German Shepherds and wild Carpathian wolves in the 1950s as a military experiment. This breed was used for guarding the Czechoslovakian borders during the cold war and is currently kept by civilian breeders all round the world. The aim of our study was to characterize, for the first time, the genetic composition of this breed in relation to its known source populations. We sequenced the hypervariable part of the mtDNA control region and genotyped the Amelogenin gene, four sex-linked microsatellites and 39 autosomal microsatellites in 79 Czechoslovakian Wolfdogs, 20 German Shepherds and 28 Carpathian wolves. We performed a range of population genetic analyses based on both empirical and simulated data. Only two mtDNA and two Y-linked haplotypes were found in Czechoslovakian Wolfdogs. Both mtDNA haplotypes were of domestic origin, while only one of the Y-haplotypes was shared with German Shepherds and the other was unique to Czechoslovakian Wolfdogs. The observed inbreeding coefficient was low despite the small effective population size of the breed, possibly due to heterozygote advantages determined by introgression of wolf alleles. Moreover, Czechoslovakian Wolfdog genotypes were distinct from both parental populations, indicating the role of founder effect, drift and/or genetic hitchhiking. The results revealed the peculiar genetic composition of the Czechoslovakian Wolfdog, showing a limited introgression of wolf alleles within a higher proportion of the dog genome, consistent with the reiterated backcrossing used in the pedigree. Artificial selection aiming to keep wolf-like phenotypes but dog-like behavior resulted in a distinctive genetic composition of Czechoslovakian Wolfdogs, which provides a unique example to study the interactions between dog and wolf genomes.	[Smetanova, Milena; Bolfikova, Barbora Cerna] Czech Univ Life Sci Prague, Fac Trop AgriSci, Prague, Czech Republic; [Randi, Ettore; Caniglia, Romolo; Fabbri, Elena; Galaverni, Marco] ISPRA, Lab Genet, Ozzano Dell Emilia, BO, Italy; [Randi, Ettore] Aalborg Univ, Dept 18, Sect Environm Engn, Aalborg, Denmark; [Kutal, Miroslav] Mendel Univ Brno, Fac Forestry & Wood Technol, Inst Forest Ecol, Brno, Czech Republic; [Kutal, Miroslav] Friends Earth Czech Republ, Olomouc Branch, Olomouc, Czech Republic; [Hulva, Pavel] Charles Univ Prague, Dept Zool, Prague, Czech Republic; [Hulva, Pavel] Univ Ostrava, Dept Biol & Ecol, CZ-70103 Ostrava, Czech Republic	Czech University of Life Sciences Prague; Italian Institute for Environmental Protection & Research (ISPRA); Aalborg University; Mendel University in Brno; Charles University Prague; University of Ostrava	Bolfikova, BC (corresponding author), Czech Univ Life Sci Prague, Fac Trop AgriSci, Prague, Czech Republic.	bolfikova@ftz.czu.cz	Kutal, Miroslav/B-9612-2014; Bolfikova, Barbora Cerna/I-6620-2019	Kutal, Miroslav/0000-0003-3857-5419; Bolfikova, Barbora Cerna/0000-0001-8059-4889; CANIGLIA, Romolo/0000-0002-3641-9490; Galaverni, Marco/0000-0002-2648-1506	Internal Grant Agency of Czech University of Life Sciences Prague [IGA 20155014]; Ministry of Finance of the Czech Republic, Norway [EHP-CZ02-OV-1-022-2015]; Charles University in Prague [260208/2015]	Internal Grant Agency of Czech University of Life Sciences Prague; Ministry of Finance of the Czech Republic, Norway; Charles University in Prague	The study was funded by: Internal Grant Agency of Czech University of Life Sciences Prague (IGA 20155014) for BCB and MS; Ministry of Finance of the Czech Republic, Norway Grants (EHP-CZ02-OV-1-022-2015) for MK, PH and BCB; Charles University in Prague (SVV 260208/2015) for PH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf FW, 2001, TRENDS ECOL EVOL, V16, P613, DOI 10.1016/S0169-5347(01)02290-X; Anderson TM, 2009, SCIENCE, V323, P1339, DOI 10.1126/science.1165448; Axelsson E, 2013, NATURE, V495, P360, DOI 10.1038/nature11837; Barton NH, 2000, PHILOS T R SOC B, V355, P1553, DOI 10.1098/rstb.2000.0716; Belkihr K, 2004, 5000 CNRS UMR; BELYAEV DK, 1979, J HERED, V70, P301, DOI 10.1093/oxfordjournals.jhered.a109263; Bigi D, 2015, ANIMAL FIRSTVIEW, P1; Caniglia R, 2014, J MAMMAL, V95, P41, DOI 10.1644/13-MAMM-A-039; Cieslak M, 2011, BIOL REV, V86, P885, DOI 10.1111/j.1469-185X.2011.00177.x; Cilova D, 2011, J VET BEHAV, V6, P60; Clarke B.C., 1996, Royal Society Philosophical Transactions Biological Sciences, V351, P723; De Lavigne G, 2015, FREE RANGING DOGS ST, P447; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Freedman A. H., 2014, PLOS GENET, V10; Glemin S, 2003, EVOLUTION, V57, P2678; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hartl K, 2002, CESKOSLOVENSY VLCAK, P1; Hoban S, 2014, MOL ECOL, V23, P2383, DOI 10.1111/mec.12741; Hundertmark KJ, 2010, CONSERV GENET, V11, P139, DOI 10.1007/s10592-009-0013-z; Huson HJ, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-71; Kuo CH, 2003, MOL ECOL NOTES, V3, P669, DOI 10.1046/j.1471-8286.2003.00532.x; Leroy G, 2009, ANIM GENET, V40, P333, DOI 10.1111/j.1365-2052.2008.01843.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Miklosi A, 2003, CURR BIOL, V13, P763, DOI 10.1016/S0960-9822(03)00263-X; Nagasawa M, 2015, OBSTET GYNECOL SURV, V70, P450, DOI 10.1097/01.ogx.0000469196.99143.92; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pritchard JK, 2000, GENETICS, V155, P945; Randi E, 2014, PLOS ONE, V9, P13; Rieseberg LH, 1999, HEREDITY, V83, P363, DOI 10.1038/sj.hdy.6886170; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Skoglund P, 2015, CURR BIOL, V25, P1515, DOI 10.1016/j.cub.2015.04.019; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vila C, 1999, MOL ECOL, V8, P2089, DOI 10.1046/j.1365-294x.1999.00825.x; Voorbij AMWY, 2014, J VET INTERN MED, V28, P1770, DOI 10.1111/jvim.12448; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waples RS, 2010, EVOL APPL, V3, P244, DOI 10.1111/j.1752-4571.2009.00104.x; Wilbe M, 2010, NAT GENET, V42, P250, DOI 10.1038/ng.525; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356; Zeng R, 2014, J VET INTERN MED, V28, P515, DOI 10.1111/jvim.12317	45	14	14	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143807	10.1371/journal.pone.0143807	http://dx.doi.org/10.1371/journal.pone.0143807			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636975	Green Published, Green Submitted, gold			2022-12-27	WOS:000366143800028
J	Bai, T; Wang, L; Wang, DW; Yuan, XB; Bai, W; Yang, Q; Yang, X				Bai, Tao; Wang, Li; Wang, Dongwen; Yuan, Xiaobin; Bai, Wei; Yang, Qin; Yang, Xian			Clinicopathologica Epidemiological Characteristics and Change Tendencies of Renal Cell Carcinoma in Shanxi Province of China from 2005 to 2014	PLOS ONE			English	Article							KIDNEY CANCER; UNITED-STATES; MORTALITY; TRENDS; RISK; EUROPE; METAANALYSIS; DISEASE	Objectives RCC is the most common solid renal malignancy in adults worldwide. To provide the insight of clinicopathologica epidemiological characteristics and change tendencies of renal cell carcinoma (RCC), 2154 cases were collected from Shanxi Province of China, including diagnose time, age, gender, tumor size, Fuhrman grade, tumor stage, tumor location, local advance or distant metastasis and first symptom from 2005 to 2014. This retrospectively investigation, as its general objective, was to analyze the clinicopathologica epidemiological characteristics and the change tendencies of RCC. Methods Between 2005 and 2014, 2154 patients who were diagnosed with RCC in three large tertiary hospitals at Shanxi Province were included. The patients' demographic features, pathological diagnoses and metastatic statuses were analyzed. Statistics methods include the chi- squared test, analysis of variance, Spearman's correlation analysis, Logistic regression and ARIMA modeling. Results Of the 2154 included patients, the constituent ratio of female /male was 63.1% and 36.9%, with the median age of 57 years old. Fuhrman grade distributions differed significantly between males and females (p = 0.024). Also, a significant difference in tumor size was found by different clinical stages (p < 0.001), with a linear correlation (p < 0.001). Moreover, Spearman's analysis indicated tumor grade has a negative correlation with female (p = 0.009) and a positive correlation with tumor size (p = 0.000). It was found that the tumor diameter is bigger in the left side (p = 0.022). Furthermore, the metastasis rate was higher in the bigger tumor (p < 0.001) and the left-sided tumors (p = 0.027). Logistic regression also showed that tumor size is a risk factor for metastasis (OR = 1.724). The risk of local advance or distant metastasis in the left kidney was 1.6-fold greater than that of the right kidney. From 2005 to 2014 the number of RCC cases gradually increased (mainly for pathological grade II and III, but grade I and IV), while the average tumor size decreased, showing the severity increase mildly. Base on the results of a time series analysis-prediction the average RCC size would continue to decrease from the first quarter of 2015 to the fourth quarter of 2016. Conclusions The cases of RCC increased from 2005 to 2014 with clear cell type as the main pathological type in this population. The characteristics in the constituent ratios of the RCC vary depending on gender, pathological grade, tumor size, and location, which may be the important factors impacting treatment and prognosis.	[Bai, Tao; Wang, Dongwen; Yuan, Xiaobin] Shanxi Med Univ, Dept Urol, Hosp 1, Taiyuan, Shanxi, Peoples R China; [Wang, Li] Shanxi Med Univ, Sch Publ Hlth, Taiyuan, Shanxi, Peoples R China; [Bai, Wei] Shanxi Canc Hosp, Dept Pathol, Taiyuan, Shanxi, Peoples R China; [Yang, Qin] Shanxi Prov Peoples Hosp, Dept Pathol, Taiyuan, Shanxi, Peoples R China; [Yang, Xian] Shanxi Med Univ, Dept Pathol, Hosp 1, Taiyuan, Shanxi, Peoples R China	Shanxi Medical University; Shanxi Medical University; Shanxi People's Hospital; Shanxi Medical University	Wang, DW (corresponding author), Shanxi Med Univ, Dept Urol, Hosp 1, Taiyuan, Shanxi, Peoples R China.	wangdongwen1973@126.com			Natural Science Foundation of Shanxi Province [2014011038-4]; Medical Research Foundation of WU Jieping [320.6750.13122]; Youth Innovation Research Fund of the First Hospital of Shanxi Medical University [YC1429]	Natural Science Foundation of Shanxi Province(Natural Science Foundation of Shanxi Province); Medical Research Foundation of WU Jieping; Youth Innovation Research Fund of the First Hospital of Shanxi Medical University	This work was supported by the Natural Science Foundation of Shanxi Province (No. 2014011038-4), Medical Research Foundation of WU Jieping (No. 320.6750.13122) and the Youth Innovation Research Fund of the First Hospital of Shanxi Medical University (YC1429). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron M, 2008, EUR UROL, V54, P133, DOI 10.1016/j.eururo.2007.12.001; Bosetti C, 2011, EUR UROL, V60, P1, DOI 10.1016/j.eururo.2011.03.047; Capitanio U, 2015, LANCET; China Ccogftdatousdi, 2014, CHINA CCOGFTDATOUSDI, P4; De P, 2014, CANCER CAUSE CONTROL, V25, P1271, DOI 10.1007/s10552-014-0427-x; Ferlay J, 2014, GLOBOCAN 2012 CANC I; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; Gandaglia G, 2014, CUAJ-CAN UROL ASSOC, V8, P247, DOI 10.5489/cuaj.1760; Gu L, 2002, J PRACTICAL ONCOLOGY, V15, P1; Guha N, 2012, LANCET ONCOL, V13, P1192, DOI 10.1016/S1470-2045(12)70485-0; Hofmann JN, 2015, EPIDEMIOLOGY, V26, P59, DOI 10.1097/EDE.0000000000000205; Hsu CC, 2007, AM J EPIDEMIOL, V166, P62, DOI 10.1093/aje/kwm043; Hunt JD, 2005, INT J CANCER, V114, P101, DOI 10.1002/ijc.20618; Ingimarsson JP, 2014, BMC UROL, V14, DOI 10.1186/1471-2490-14-72; Lee JE, 2009, CANCER EPIDEM BIOMAR, V18, P1730, DOI 10.1158/1055-9965.EPI-09-0045; Levi F, 2008, BJU INT, V101, P949, DOI 10.1111/j.1464-410X.2008.07451.x; [李鸣 LI Ming], 2010, [中华泌尿外科杂志, Chinese Journal of Urology], V31, P77; Lipworth L, 2014, BJU INT, DOI [10.1111/bju.12950.25307281, DOI 10.1111/BJU.12950.25307281]; Ljungberg B, 2010, EUR UROL, V58, P398, DOI 10.1016/j.eururo.2010.06.032; [马建辉 MA Jian-hui], 2009, [中华泌尿外科杂志, Chinese Journal of Urology], V30, P511; Mindrup SR, 2005, BJU INT, V95, P31, DOI 10.1111/j.1464-410X.2005.05243.x; Nguyen MM, 2006, J UROLOGY, V176, P2397, DOI 10.1016/j.juro.2006.07.144; Pantuck AJ, 2001, J UROLOGY, V166, P1611, DOI 10.1016/S0022-5347(05)65640-6; Rabjerg M, 2014, APMIS, V122, P708, DOI 10.1111/apm.12282; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Sauter G, 2004, PATHOLOGY GENETICS T; Weikert S, 2008, AM J EPIDEMIOL, V167, P438, DOI 10.1093/aje/kwm321; Weikert S, 2010, WORLD J UROL, V28, P247, DOI 10.1007/s00345-010-0555-1; Wu Jieping, 1991, PRACTICAL UROLOGICAL, P230; Zastrow S, 2014, UROL INT, V92, P462, DOI 10.1159/000356325; Zhao Z., 2013, CLIN ANAL 1068 CASES; Znaor A, 2015, EUR UROL, V67, P519, DOI 10.1016/j.eururo.2014.10.002; 张斯良, 2006, [中华放射肿瘤学杂志, Chinese Journal of Radiation Oncology], V15, P430	33	7	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144246	10.1371/journal.pone.0144246	http://dx.doi.org/10.1371/journal.pone.0144246			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633179	Green Submitted, Green Published, gold			2022-12-27	WOS:000366040000072
J	Hekmatdoost, A; Vahid, F; Yari, Z; Sadeghi, M; Eini-Zinab, H; Lakpour, N; Arefi, S				Hekmatdoost, Azita; Vahid, Farhad; Yari, Zahra; Sadeghi, Mohammadreza; Eini-Zinab, Hassan; Lakpour, Niknam; Arefi, Soheila			Methyltetrahydrofolate vs Folic Acid Supplementation in Idiopathic Recurrent Miscarriage with Respect to Methylenetetrahydrofolate Reductase C677T and A1298C Polymorphisms: A Randomized Controlled Trial	PLOS ONE			English	Article							ADVERSE PREGNANCY OUTCOMES; PLASMA TOTAL HOMOCYSTEINE; FOLATE CONCENTRATIONS; SPONTANEOUS-ABORTION; RISK; WOMEN; ASSOCIATION; 5-METHYLTETRAHYDROFOLATE; AUTOANTIBODIES; DEFECTS	Purpose To determine whether 5-methylenetetrahydrofolate (MTHF) is more effective than folic acid supplementation in treatment of recurrent abortion in different MTHFR gene C677T and A1298C polymorphisms. Methods A randomized, double blind, placebo-controlled trial conducted April 2011-September 2014 in recurrent abortion clinics in Tehran, Iran. The participants were women with three or more idiopathic recurrent abortion, aged 20 to 45 years. Two hundred and twenty eligible women who consented to participate were randomly assigned to receive either folic acid or 5-MTHF according to the stratified blocked randomization by age and the number of previous abortions. Participants took daily 1 mg 5-methylentetrahydrofolate or 1 mg folic acid from at least 8 weeks before conception to the 20th week of the pregnancy. The primary outcome was ongoing pregnancy rate at 20th week of pregnancy, and the secondary outcomes were serum folate and homocysteine at the baseline, after 8 weeks, and at the gestational age of 4, 8, 12, and 20 weeks, MTHFR gene C677T and A1298C polymorphisms. Results There was no significant difference in abortion rate between two groups. Serum folate increased significantly in both groups over time; these changes were significantly higher in the group receiving 5-MTHF than the group receiving folic acid (value = 2.39, p< 00.1) and the result was the same by considering the time (value = 1.24, p< 0.01). Plasma tHcys decreased significantly in both groups over time; however these changes were not significantly different between the groups (value = 0.01, p = 0.47). Conclusion The results do not support any beneficial effect of 5-MTHF vs. folate supplementation in women with recurrent abortion with any MTHFR C677T and/or A1298C polymorphism.	[Hekmatdoost, Azita] Shahid Beheshti Univ Med Sci, Res Inst, Natl Nutr & Food Technol, Dept Clin Nutr & Dietet,Fac Nutr & Food Technol, Tehran, Iran; [Vahid, Farhad; Yari, Zahra] Shahid Beheshti Univ Med Sci, Students Res Comm, Fac Nutr & Food Technol, Natl Nutr & Food Technol Res Inst, Tehran, Iran; [Sadeghi, Mohammadreza; Lakpour, Niknam] ACECR, Avicenna Res Inst, Reprod Biotechnol Res Ctr, Dept Androl & Embryol, Tehran, Iran; [Eini-Zinab, Hassan] Shahid Beheshti Univ Med Sci, Res Inst, Natl Nutr & Food Technol, Dept Community Nutr,Fac Nutr & Food Technol, Tehran, Iran; [Arefi, Soheila] ACECR, Avicenna Res Inst, Reprod Biotechnol Res Ctr, Dept Endocrinol, Tehran, Iran	Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Academic Center for Education, Culture & Research (ACECR); Shahid Beheshti University Medical Sciences; Academic Center for Education, Culture & Research (ACECR)	Hekmatdoost, A (corresponding author), Shahid Beheshti Univ Med Sci, Res Inst, Natl Nutr & Food Technol, Dept Clin Nutr & Dietet,Fac Nutr & Food Technol, Tehran, Iran.	a_hekmat2000@yahoo.com; soheilaarefi@yahoo.com	Eini-Zinab, Hassan/R-8992-2016; Hekmatdoost, Azita/AGM-6497-2022; Yari, Zahra/P-6594-2019; Vahid, Farhad/L-7547-2018	Eini-Zinab, Hassan/0000-0002-6895-034X; Hekmatdoost, Azita/0000-0002-1944-0052; Yari, Zahra/0000-0003-2796-2413; Vahid, Farhad/0000-0002-7380-3790; Sadeghi, Mohamad Reza/0000-0003-0401-3493	NNFTRI (National Nutrition and Food Technology Research Institute) [1157]; ACECR (Academic Center for Education, Culture and Research) [322]	NNFTRI (National Nutrition and Food Technology Research Institute); ACECR (Academic Center for Education, Culture and Research)	This work was supported by NNFTRI (National Nutrition and Food Technology Research Institute (grant No: 1157), and ACECR (Academic Center for Education, Culture and Research) (grant No: 322).	Bergen NE, 2012, BJOG-INT J OBSTET GY, V119, P739, DOI 10.1111/j.1471-0528.2012.03321.x; Brouwer IA, 1999, AM J CLIN NUTR, V69, P99; Byrne J, 2011, IRISH J MED SCI, V180, P59, DOI 10.1007/s11845-010-0629-5; Cao YL, 2013, GENE, V514, P105, DOI 10.1016/j.gene.2012.10.091; Charles DHM, 2005, PAEDIATR PERINAT EP, V19, P112, DOI 10.1111/j.1365-3016.2005.00633.x; Chiaffarino F, 2010, Minerva Ginecol, V62, P293; Creus M, 2013, CLIN CHEM LAB MED, V51, P693, DOI 10.1515/cclm-2012-0452; Fohr IP, 2002, AM J CLIN NUTR, V75, P275, DOI 10.1093/ajcn/75.2.275; Furness D, 2013, MATERN CHILD NUTR, V9, P155, DOI 10.1111/j.1740-8709.2011.00364.x; George L, 2002, JAMA-J AM MED ASSOC, V288, P1867, DOI 10.1001/jama.288.15.1867; Gindler J, 2001, LANCET, V358, P796, DOI 10.1016/S0140-6736(01)05969-4; Kim MW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097273; Kirke PN, 2004, BRIT MED J, V328, P1535, DOI 10.1136/bmj.38036.646030.EE; Lamers Y, 2004, AM J CLIN NUTR, V79, P473; Lamers Y, 2006, AM J CLIN NUTR, V84, P156, DOI 10.1093/ajcn/84.1.156; Molloy AM, 2009, NEW ENGL J MED, V361, P152, DOI 10.1056/NEJMoa0803783; Nair RR, 2013, FERTIL STERIL, V99, P1311, DOI 10.1016/j.fertnstert.2012.12.027; Nelen WLDM, 2000, OBSTET GYNECOL, V95, P519, DOI 10.1016/S0029-7844(99)00610-9; Nelen WLDM, 1998, J NUTR, V128, P1336, DOI 10.1093/jn/128.8.1336; Obeid R, 2013, J PERINAT MED, V41, P469, DOI 10.1515/jpm-2012-0256; Prinz-Langenohl R, 2009, BRIT J PHARMACOL, V158, P2014, DOI 10.1111/j.1476-5381.2009.00492.x; Quere I, 2001, FERTIL STERIL, V75, P823, DOI 10.1016/S0015-0282(01)01678-8; Ray JG, 1999, PLACENTA, V20, P519, DOI 10.1053/plac.1999.0417; Ren AG, 2006, FERTIL STERIL, V86, P1716, DOI 10.1016/j.fertnstert.2006.05.052; Ronnenberg AG, 2002, OBSTET GYNECOL, V100, P107, DOI 10.1016/S0029-7844(02)01978-6; Rothenberg SP, 2004, NEW ENGL J MED, V350, P134, DOI 10.1056/NEJMoa031145; Scholl TO, 2000, AM J CLIN NUTR, V71, p1295S, DOI 10.1093/ajcn/71.5.1295s; Shi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128646; STEEGERSTHEUNISSEN RPM, 1992, LANCET, V339, P1122, DOI 10.1016/0140-6736(92)90725-I; Tempfer CB, 2006, FERTIL STERIL, V86, P145, DOI 10.1016/j.fertnstert.2005.12.035; Vollset SE, 2000, AM J CLIN NUTR, V71, P962; WOUTERS MGAJ, 1993, FERTIL STERIL, V60, P820; Wu XM, 2012, GENET TEST MOL BIOMA, V16, P806, DOI 10.1089/gtmb.2011.0318; Yamada T, 2013, ARCH GYNECOL OBSTET, V287, P9, DOI 10.1007/s00404-012-2501-5; Zetterberg H, 2003, HUM REPROD, V18, P1948, DOI 10.1093/humrep/deg375; Zhang Xueyan, 2011, Environmental Health and Preventive Medicine, V16, P273, DOI 10.1007/s12199-010-0196-4	36	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143569	10.1371/journal.pone.0143569	http://dx.doi.org/10.1371/journal.pone.0143569			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630680	Green Published, Green Submitted, gold			2022-12-27	WOS:000365926300061
J	Taporoski, TP; Negrao, AB; Horimoto, ARVR; Duarte, NE; Alvim, RO; de Oliveira, CM; Krieger, JE; von Schantz, M; Vallada, H; Pereira, AC				Taporoski, Tamara P.; Negrao, Andre B.; Horimoto, Andrea R. V. R.; Duarte, Nubia E.; Alvim, Rafael O.; de Oliveira, Camila M.; Krieger, Jose E.; von Schantz, Malcolm; Vallada, Homero; Pereira, Alexandre C.			Shared Genetic Factors of Anxiety and Depression Symptoms in a Brazilian Family-Based Cohort, the Baependi Heart Study	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; LARGE NONCLINICAL SAMPLE; HOSPITAL ANXIETY; MAJOR DEPRESSION; MOOD DISORDERS; NORMATIVE DATA; CO-MORBIDITY; SCALE HADS; EPIDEMIOLOGY; HERITABILITY	To investigate the phenotypic and genetic overlap between anxiety and depression symptoms in an admixed population from extended family pedigrees. Participants (n = 1,375) were recruited from a cohort of 93 families (mean age +/- SD 42 +/- 16.3, 57% female) in the rural town of Baependi, Brazil. The Hospital Anxiety and Depression Scale (HADS) was used to assess depression and anxiety symptoms. Heritability estimates were obtained by an adjusted variance component model. Bivariate analyses were performed to obtain the partition of the covariance of anxiety and depression into genetic and environmental components, and to calculate the genetic contribution modulating both sets of symptoms. Anxiety and depression scores were 7.49 +/- 4.01 and 5.70 +/- 3.82, respectively. Mean scores were affected by age and were significantly higher in women. Heritability for depression and anxiety, corrected for age and sex, were 0.30 and 0.32, respectively. Significant genetic correlations (p(g) = 0.81) were found between anxiety and depression scores; thus, nearly 66% of the total genetic variance in one set of symptoms was shared with the other set. Our results provided strong evidence for a genetic overlap between anxiety and depression symptoms, which has relevance for our understanding of the biological basis of these constructs and could be exploited in genome-wide association studies.	[Taporoski, Tamara P.; Negrao, Andre B.; Vallada, Homero] Univ Sao Paulo, Sch Med, Dept & Inst Psychiat LIM 23, Sao Paulo, SP, Brazil; [Taporoski, Tamara P.; Negrao, Andre B.; Horimoto, Andrea R. V. R.; Duarte, Nubia E.; Alvim, Rafael O.; de Oliveira, Camila M.; Krieger, Jose E.; von Schantz, Malcolm; Pereira, Alexandre C.] Univ Sao Paulo, Sch Med, Inst Heart, Lab Genet & Mol Cardiol, Sao Paulo, SP, Brazil; [Alvim, Rafael O.; de Oliveira, Camila M.] Univ Fed Juiz de Fora, Dept Physiol, Juiz De Fora, MG, Brazil; [von Schantz, Malcolm] Univ Surrey, Fac Hlth & Med Sci, Dept Biochem & Physiol, Guildford GU2 5XH, Surrey, England	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Juiz de Fora; University of Surrey	Negrao, AB (corresponding author), Univ Sao Paulo, Sch Med, Dept & Inst Psychiat LIM 23, Sao Paulo, SP, Brazil.	abnegrao@usp.br	Vallada, Homero/D-1333-2014; Alvim, Rafael/ABA-7823-2021; NegrÃo, AndrÃ© Brooking/C-9526-2014; Pereira, Alexandre/HHN-1038-2022; von Schantz, Malcolm/C-5962-2014	Vallada, Homero/0000-0001-5123-8295; Alvim, Rafael/0000-0003-3150-4239; NegrÃo, AndrÃ© Brooking/0000-0002-8133-6723; von Schantz, Malcolm/0000-0002-9911-9436	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/17368-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [400791/2014-5]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Programa de Excelencia (CAPES-PROEX) [1322/08]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Programa de Excelencia (CAPES-PROEX)	This study was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, 2013/17368-0, to ACP), from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, 400791/2014-5), Special Visiting Scientist grant to HV on behalf of MvS, and from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Programa de Excelencia (CAPES-PROEX, to TPT and 1322/08 to ABN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Almasy L., 2010, COLD SPRING HARB PRO, V2010, DOI 10. 1101/pdb. top77; Bjelland I, 2008, SOC SCI MED, V66, P1334, DOI 10.1016/j.socscimed.2007.12.019; Boomsma D I, 2000, Twin Res, V3, P323, DOI 10.1375/136905200320565300; Botega NJ, 1995, REV SAUDE PUBL, V29, P355, DOI 10.1590/S0034-89101995000500004; Cerda M, 2010, J AFFECT DISORDERS, V126, P14, DOI 10.1016/j.jad.2009.11.006; Crawford JR, 2001, BRIT J CLIN PSYCHOL, V40, P429, DOI 10.1348/014466501163904; Crawford JR, 2003, BRIT J CLIN PSYCHOL, V42, P111, DOI 10.1348/014466503321903544; Czajkowski N, 2010, J AFFECT DISORDERS, V125, P355, DOI 10.1016/j.jad.2010.01.006; de Andrade M, 1999, GENET EPIDEMIOL, V17, P64, DOI 10.1002/(SICI)1098-2272(1999)17:1<64::AID-GEPI5>3.0.CO;2-M; de Oliveira CM, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-32; Docherty AR, 2015, BEHAV GENET, V45, P461, DOI 10.1007/s10519-015-9720-z; Flint J, 2014, NEURON, V81, P484, DOI [10.1016/j.neuron.2014.02.033, 10.1016/j.neuron.2014.01.027]; Hinz A, 2011, J PSYCHOSOM RES, V71, P74, DOI 10.1016/j.jpsychores.2011.01.005; KENDLER KS, 1987, ARCH GEN PSYCHIAT, V44, P451; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Kessler RC, 2007, J CLIN PSYCHIAT, V68, P10; LANGE K, 1983, AM J MED GENET, V14, P513, DOI 10.1002/ajmg.1320140315; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Lopez-Leon S, 2010, J AFFECT DISORDERS, V122, P247, DOI 10.1016/j.jad.2009.07.008; Lorant V, 2003, AM J EPIDEMIOL, V157, P98, DOI 10.1093/aje/kwf182; Mathew AR, 2011, PSYCHOL MED, V41, P2023, DOI 10.1017/S0033291711000407; McGrath LM, 2012, DEV PSYCHOPATHOL, V24, P1179, DOI 10.1017/S0954579412000636; Melchior Maria, 2010, Depress Anxiety, V27, P1095, DOI 10.1002/da.20761; Middeldorp CM, 2005, PSYCHOL MED, V35, P611, DOI 10.1017/S003329170400412X; Olvera RL, 2011, AM J MED GENET B, V156B, P561, DOI 10.1002/ajmg.b.31196; Smoller JW, 2009, DEPRESS ANXIETY, V26, P965, DOI 10.1002/da.20623; Soares GLF, 2009, CLINICS, V64, P209, DOI 10.1590/S1807-59322009000300011; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; TAMBS K, 1991, J AFFECT DISORDERS, V21, P117, DOI 10.1016/0165-0327(91)90058-Z; Thompson EA, 2013, GENETICS, V194, P301, DOI 10.1534/genetics.112.148825; von Schantz M, 2015, SCI REP-UK, V5, DOI [10.1038/srep09214, 10.1016/j.sleep.2015.02.105]; Yun YH, 2007, J CLIN EPIDEMIOL, V60, P1164, DOI 10.1016/j.jclinepi.2006.12.014; Zbozinek TD, 2012, DEPRESS ANXIETY, V29, P1065, DOI 10.1002/da.22026; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	35	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144255	10.1371/journal.pone.0144255	http://dx.doi.org/10.1371/journal.pone.0144255			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1YX	26650098	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000366903300042
J	Newaz, K; Sriram, K; Bera, D				Newaz, Khalique; Sriram, K.; Bera, Debajyoti			Identification of Major Signaling Pathways in Prion Disease Progression Using Network Analysis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; PROTEIN; MODELS; GENES; METABOLISM; BRAINS; CELLS; PRP	Prion diseases are transmissible neurodegenerative diseases that arise due to conformational change of normal, cellular prion protein (PrPC) to protease-resistant isofrom (rPrP(Sc)). Deposition of misfolded Prp(Sc) proteins leads to an alteration of many signaling pathways that includes immunological and apoptotic pathways. As a result, this culminates in the dysfunction and death of neuronal cells. Earlier works on transcriptomic studies have revealed some affected pathways, but it is not clear which is (are) the prime network pathway(s) that change during the disease progression and how these pathways are involved in crosstalks with each other from the time of incubation to clinical death. We perform network analysis on large-scale transcriptomic data of differentially expressed genes obtained from whole brain in six different mouse strain-prion strain combination models to determine the pathways involved in prion diseases, and to understand the role of crosstalks in disease propagation. We employ a notion of differential network centrality measures on protein interaction networks to identify the potential biological pathways involved. We also propose a crosstalk ranking method based on dynamic protein interaction networks to identify the core network elements involved in crosstalk with different pathways. We identify 148 DEGs (differentially expressed genes) potentially related to the prion disease progression. Functional association of the identified genes implicates a strong involvement of immunological pathways. We extract a bow-tie structure that is potentially dysregulated in prion disease. We also propose an ODE model for the bow-tie network. Predictions related to diseased condition suggests the downregulation of the core signaling elements (PI3Ks and AKTs) of the bow-tie network. In this work, we show using transcriptomic data that the neuronal dysfunction in prion disease is strongly related to the immunological pathways. We conclude that these immunological pathways occupy influential positions in the PFNs (protein functional networks) that are related to prion disease. Importantly, this functional network involvement is prevalent in all the five different mouse strain-prion strain combinations that we studied. We also conclude that the dysregulation of the core elements of the bow-tie structure, which belongs to PI3K-Akt signaling pathway, leads to dysregulation of the downstream components corresponding to other biological pathways.	[Newaz, Khalique; Bera, Debajyoti] IIIT Delhi, Dept Comp Sci, New Delhi, India; [Sriram, K.] IIIT Delhi, Ctr Computat Biol, New Delhi, India	Indraprastha Institute of Information Technology Delhi; Indraprastha Institute of Information Technology Delhi	Bera, D (corresponding author), IIIT Delhi, Dept Comp Sci, New Delhi, India.	dbera@iiitd.ac.in	Newaz, Khalique/AAT-6018-2020; Bera, Debajyoti/W-9963-2019	Newaz, Khalique/0000-0002-1192-8360; 				Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 2003, SCI AM, V288, P60, DOI 10.1038/scientificamerican0503-60; Booth S, 2004, J GEN VIROL, V85, P3459, DOI 10.1099/vir.0.80110-0; Brown DR, 2001, MICROSC RES TECHNIQ, V54, P71, DOI 10.1002/jemt.1122; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Burwinkel M, 2004, INT J DEV NEUROSCI, V22, P497, DOI 10.1016/j.ijdevneu.2004.07.017; Chaves M, 2004, J PHYS CHEM B, V108, P15311, DOI 10.1021/jp048935f; Colby DW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a006833; Csete M, 2004, TRENDS BIOTECHNOL, V22, P446, DOI 10.1016/j.tibtech.2004.07.007; Didonna A, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-29; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Faisal F. E., 2014, BIOINFORMATICS; Fernandez-Borges N., 2013, INT J CELL BIOL, V2013, DOI [10.1155/2013/583498, DOI 10.1155/2013/583498]; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gehlenborg N, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap011; Ghosh S, 2012, DRUG DISCOV TODAY, V17, P600, DOI 10.1016/j.drudis.2012.01.018; Gomez-Nicola D, 2013, J NEUROSCI, V33, P2481, DOI 10.1523/JNEUROSCI.4440-12.2013; Hegde SR, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000237; Heinrich R, 2002, MOL CELL, V9, P957, DOI 10.1016/S1097-2765(02)00528-2; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hwang D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.10; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kitano H, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100039; Koschutzki D, 2008, GENE REGUL SYST BIO, V2, P193, DOI 10.4137/GRSB.S702; Kovacs GG, 2008, AM J PATHOL, V172, P555, DOI 10.2353/ajpath.2008.070442; Koyasu S, 2003, NAT IMMUNOL, V4, P313, DOI 10.1038/ni0403-313; Milenkovic T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023016; Nakamura Y, 2002, BIOL PHARM BULL, V25, P945, DOI 10.1248/bpb.25.945; Panickar KS, 2005, GLIA, V50, P287, DOI 10.1002/glia.20181; Perry VH, 2002, CURR OPIN NEUROL, V15, P349, DOI 10.1097/00019052-200206000-00020; Prusiner SB, 2012, SCIENCE, V336, P1511, DOI 10.1126/science.1222951; Przytycka TM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-48; Rajarathinam Thanigaimani, 2006, Genomics Proteomics & Bioinformatics, V4, P80, DOI 10.1016/S1672-0229(06)60020-X; Riemer C, 2004, BIOCHEM BIOPH RES CO, V323, P556, DOI 10.1016/j.bbrc.2004.08.124; Samelson LE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a011510; Scardoni G, 2009, BIOINFORMATICS, V25, P2857, DOI 10.1093/bioinformatics/btp517; Schultz J, 2004, AM J PATHOL, V165, P671, DOI 10.1016/S0002-9440(10)63331-7; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Simon D, 2014, NEUROPATH APPL NEURO, V40, P311, DOI 10.1111/nan.12066; Skinner PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-114; Sorensen G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-114; Soto C, 2011, TRENDS MOL MED, V17, P14, DOI 10.1016/j.molmed.2010.09.001; Stein KC, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004328; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Wang M, 2005, J NEUROCHEM, V95, P630, DOI 10.1111/j.1471-4159.2005.03408.x; Williams A, 1997, EXP NEUROL, V144, P433, DOI 10.1006/exnr.1997.6424; Wojtera M, 2005, FOLIA NEUROPATHOL, V43, P311; Xiang W, 2004, J VIROL, V78, P11051, DOI 10.1128/JVI.78.20.11051-11060.2004; Xiang W, 2007, J NEUROCHEM, V102, P834, DOI 10.1111/j.1471-4159.2007.04566.x; Yang SK, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-19; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059	56	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0144389	10.1371/journal.pone.0144389	http://dx.doi.org/10.1371/journal.pone.0144389			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YV	26646948	gold, Green Submitted, Green Published			2022-12-27	WOS:000366903100022
J	Ceci, M; Pio, G; Kuzmanovski, V; Dzeroski, S				Ceci, Michelangelo; Pio, Gianvito; Kuzmanovski, Vladimir; Dzeroski, Saso			Semi-Supervised Multi-View Learning for Gene Network Reconstruction	PLOS ONE			English	Article							LARGE-SCALE ORGANIZATION; REGULATORY NETWORKS; EXPRESSION DATA; CLASSIFICATION; DISCOVERY; INFERENCE; VIEW	The task of gene regulatory network reconstruction from high-throughput data is receiving increasing attention in recent years. As a consequence, many inference methods for solving this task have been proposed in the literature. It has been recently observed, however, that no single inference method performs optimally across all datasets. It has also been shown that the integration of predictions from multiple inference methods is more robust and shows high performance across diverse datasets. Inspired by this research, in this paper, we propose a machine learning solution which learns to combine predictions from multiple inference methods. While this approach adds additional complexity to the inference process, we expect it would also carry substantial benefits. These would come from the automatic adaptation to patterns on the outputs of individual inference methods, so that it is possible to identify regulatory interactions more reliably when these patterns occur. This article demonstrates the benefits (in terms of accuracy of the reconstructed networks) of the proposed method, which exploits an iterative, semi-supervised ensemble-based algorithm. The algorithm learns to combine the interactions predicted by many different inference methods in the multi-view learning setting. The empirical evaluation of the proposed algorithm on a prokaryotic model organism (E. coli) and on a eukaryotic model organism (S. cerevisiae) clearly shows improved performance over the state of the art methods. The results indicate that gene regulatory network reconstruction for the real datasets is more difficult for S. cerevisiae than for E. coli. The software, all the datasets used in the experiments and all the results are available for download at the following link: http://figshare.com/articles/ Semi_supervised_Multi_View_Learning_for_Gene_Network_Reconstruction/1604827.	[Ceci, Michelangelo; Pio, Gianvito] Univ Bari Aldo Moro, Dept Comp Sci, I-70125 Bari, Italy; [Kuzmanovski, Vladimir; Dzeroski, Saso] Jozef Stefan Inst, Dept Knowledge Technol, Ljubljana 1000, Slovenia; [Kuzmanovski, Vladimir; Dzeroski, Saso] Jozef Stefan Int Postgrad Sch, Ljubljana 1000, Slovenia	Universita degli Studi di Bari Aldo Moro; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Pio, G (corresponding author), Univ Bari Aldo Moro, Dept Comp Sci, Via Orabona 4, I-70125 Bari, Italy.	gianvito.pio@uniba.it; vladimir.kuzmanovski@ijs.si	Kuzmanovski, Vladimir/Z-3137-2019; Dzeroski, Saso/ABH-2758-2021; Pio, Gianvito/AAH-9841-2019	Kuzmanovski, Vladimir/0000-0001-7355-1581; Dzeroski, Saso/0000-0003-2363-712X; Pio, Gianvito/0000-0003-2520-3616; Ceci, Michelangelo/0000-0002-6690-7583	Slovenian Research Agency [P2-0103]; European Commission [ICT-2013-612944 MAESTRA, ICT-2013- 604102 HBP]; European Social Fund [CCI2007-SI051PO001]	Slovenian Research Agency(Slovenian Research Agency - Slovenia); European Commission(European CommissionEuropean Commission Joint Research Centre); European Social Fund(European Social Fund (ESF))	The authors acknowledge the financial support of the Slovenian Research Agency via the grant P2-0103, and the European Commission via the grants ICT-2013-612944 MAESTRA and ICT-2013- 604102 HBP, as well as the grant CCI2007SI051PO001 through the European Social Fund for co-financing postgraduate studies in the context of the Operational Programme for Human Resources Development for the period 2007-2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank Sabrina Hempel and Jurgen Kurths for providing the datasets used in the experimental evaluation. We acknowledge the financial support of the Slovenian Research Agency, via the grant P2-0103, and the European Commission via the grants ICT-2013-612944 MAESTRA and ICT-2013-604102 HBP, as well as the grant CCI2007-SI051PO001 through the European Social Fund for co-financing postgraduate studies in the context of the Operational Programme for Human Resources Development for the period 2007-2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Atias N, 2012, COMMUN ACM, V55, P88, DOI 10.1145/2160718.2160738; Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger MF, 2009, NAT PROTOC, V4, P393, DOI 10.1038/nprot.2008.195; Blum A., 1998, Proceedings of the Eleventh Annual Conference on Computational Learning Theory, P92, DOI 10.1145/279943.279962; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boyd Kendrick, 2013, Machine Learning and Knowledge Discovery in Databases. European Conference, ECML PKDD 2013. Proceedings: LNCS 8190, P451, DOI 10.1007/978-3-642-40994-3_29; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Bulyk ML, 2005, NAT BIOTECHNOL, V23, P942, DOI 10.1038/nbt0805-942; Butte AJ, 2000, P NATL ACAD SCI USA, V97, P12182, DOI 10.1073/pnas.220392197; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; Efron B, 1994, INTRO BOOTSTRAP; Elkan C., 2008, PROC ACM SIGKDD INT, P213, DOI DOI 10.1145/1401890.1401920; Emmert-Streib Frank, 2012, Frontiers in Genetics, V3, P8, DOI [10.3389/fgene.2012.00313, 10.3389/fgene.2012.00008]; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Guo HY, 2008, KNOWL INF SYST, V17, P287, DOI 10.1007/s10115-008-0127-5; Hase T, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003361; Haury AC, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-145; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Hempel S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-292; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Li D, 2006, PROTEOMICS, V6, P456, DOI 10.1002/pmic.200500228; Lu LY, 2011, PHYSICA A, V390, P1150, DOI 10.1016/j.physa.2010.11.027; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Markowetz F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S5; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Penfold CA, 2011, INTERFACE FOCUS, V1, P857, DOI 10.1098/rsfs.2011.0053; Pio G, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S1-S4; Provost F, 2001, MACH LEARN, V42, P203, DOI 10.1023/A:1007601015854; Sales-Pardo M, 2007, P NATL ACAD SCI USA, V104, P15224, DOI 10.1073/pnas.0703740104; Smith VA., 2002, BIOINFORMATICS, V18, pS216; Stojanova D, 2012, DATA MIN KNOWL DISC, V25, P378, DOI 10.1007/s10618-012-0278-6; Van den Bulcke T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-43; Vapnik V., 1998, STAT LEARNING THEORY, V3, DOI DOI 10.1007/978-1-4419-1428-6_5864; Vilalta R, 2002, ARTIF INTELL REV, V18, P77, DOI 10.1023/A:1019956318069; Whalen S, 2013, IEEE DATA MINING, P807, DOI 10.1109/ICDM.2013.21	39	31	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144031	10.1371/journal.pone.0144031	http://dx.doi.org/10.1371/journal.pone.0144031			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641091	Green Submitted, gold, Green Published			2022-12-27	WOS:000366902700048
J	de Lucio, A; Martinez-Ruiz, R; Merino, FJ; Bailo, B; Aguilera, M; Fuentes, I; Carmena, D				de Lucio, Aida; Martinez-Ruiz, Rocio; Merino, Francisco J.; Bailo, Begona; Aguilera, Maria; Fuentes, Isabel; Carmena, David			Molecular Genotyping of Giardia duodenalis Isolates from Symptomatic Individuals Attending Two Major Public Hospitals in Madrid, Spain	PLOS ONE			English	Article							DAY-CARE-CENTERS; REFRACTORY GIARDIASIS; CRYPTOSPORIDIUM SPP.; PARASITIC INFECTIONS; HELICOBACTER-PYLORI; CHILDREN; LAMBLIA; IDENTIFICATION; TRANSMISSION; EPIDEMIOLOGY	Background The flagellate protozoan Giardia duodenalis is an enteric parasite causing human giardiasis, a major gastrointestinal disease of global distribution affecting both developing and industrialised countries. In Spain, sporadic cases of giardiasis have been regularly identified, particularly in pediatric and immigrant populations. However, there is limited information on the genetic variability of circulating G. duodenalis isolates in the country. Methods In this longitudinal molecular epidemiological study we report the diversity and frequency of the G. duodenalis assemblages and sub-assemblages identified in 199 stool samples collected from 184 individual with symptoms compatible with giardiasis presenting to two major public hospitals in Madrid for the period December 2013-January 2015. G. duodenalis cysts were initially detected by conventional microscopy and/or immunochomatography on stool samples. Confirmation of the infection was performed by direct immunofluorescence and real-time PCR methods. G. duodenalis assemblages and sub-assemblages were determined by multi-locus genotyping of the glutamate dehydrogenase (GDH) and beta-giardin (BG) genes of the parasite. Sociodemographic and clinical features of patients infected with G. duodenalis were also analysed. Principal findings Of 188 confirmed positive samples from 178 giardiasis cases a total of 124 G. duodenalis isolates were successfully typed at the GDH and/or the BG loci, revealing the presence of sub-assemblages BIV (62.1%), AII (15.3%), BIII (4.0%), AI (0.8%), and AIII (0.8%). Additionally, 6.5% of the isolates were only characterised at the assemblage level, being all of them assigned to assemblage B. Discordant genotype results AII/AIII or BIII/BIV were also observed in 10.5% of DNA isolates. A large number of multi-locus genotypes were identified in G. duodenalis assemblage B, but not assemblage A, isolates at both the GDH and BG loci, confirming the high degree of genetic variability observed in other molecular surveys. BIV was the most prevalent genetic variant of G. duodenalis found in individuals with symptomatic giardiasis in the population under study. Conclusions Human giardiasis is an ongoing public health problem in Spain affecting primarily young children under four years of age but also individuals of all age groups. Our typing and sub-typing results demonstrate that assemblage B is the most prevalent G. duodenalis assemblage circulating in patients with clinical giardiasis in Central Spain. Our analyses also revealed a large genetic variability in assemblage B (but not assemblage A) isolates of the parasite, corroborating the information obtained in similar studies in other geographical regions. We believe that molecular data presented here provide epidemiological evidence at the population level in support of the existence of genetic exchange within assemblages of G. duodenalis.	[de Lucio, Aida; Bailo, Begona; Aguilera, Maria; Fuentes, Isabel; Carmena, David] Carlos III Hlth Inst, Natl Ctr Microbiol, Parasitol Serv, Madrid, Spain; [Martinez-Ruiz, Rocio] Univ Hosp Puerta Hierro Majadahonda, Microbiol & Clin Parasitol Serv, Madrid, Spain; [Merino, Francisco J.] Univ Hosp Severo Ochoa, Microbiol Serv, Madrid, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Hospital Puerta de Hierro-Majadahonda; Severo Ochoa University Hospital	Carmena, D (corresponding author), Carlos III Hlth Inst, Natl Ctr Microbiol, Parasitol Serv, Madrid, Spain.	dacarmena@isciii.es	Carmena, David/S-4049-2019	Carmena, David/0000-0002-4015-8553; Merino Fernandez, Francisco Jesus/0000-0001-9180-2479	Carlos III Health Institute, Ministry of Economy and Competitiveness, Spain [CP12/03081, PI13/01106]; FIS Carlos III Health Institute, Ministry of Economy and Competitiveness, Spain [CP12/03081, PI13/01106]	Carlos III Health Institute, Ministry of Economy and Competitiveness, Spain; FIS Carlos III Health Institute, Ministry of Economy and Competitiveness, Spain	This work was supported by research projects CP12/03081, Carlos III Health Institute, Ministry of Economy and Competitiveness, Spain (DC), research project PI13/01106, Carlos III Health Institute, Ministry of Economy and Competitiveness, Spain (IF).; This project was funded by research projects CP12/03081 and PI13/01106, FIS Carlos III Health Institute, Ministry of Economy and Competitiveness, Spain.	Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; Adam RD, 2013, GENOME BIOL EVOL, V5, P2498, DOI 10.1093/gbe/evt197; Almeida AA, 2006, J EUKARYOT MICROBIOL, V53, pS177, DOI 10.1111/j.1550-7408.2006.00222.x; Alonso-Sanz M, 1995, Enferm Infecc Microbiol Clin, V13, P90; Andersson JO, 2012, TRENDS PARASITOL, V28, P46, DOI 10.1016/j.pt.2011.11.002; Ankarklev J, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-65; Ankarklev J, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001780; Aydin AF, 2004, DIAGN MICR INFEC DIS, V50, P147, DOI 10.1016/j.diagmicrobio.2004.06.001; Baldursson S, 2011, WATER RES, V45, P6603, DOI 10.1016/j.watres.2011.10.013; Ballweber LR, 2010, TRENDS PARASITOL, V26, P180, DOI 10.1016/j.pt.2010.02.005; Barry MA, 2013, PEDIATR CLIN N AM, V60, P471, DOI 10.1016/j.pcl.2012.12.011; Berkman DS, 2002, LANCET, V359, P564, DOI 10.1016/S0140-6736(02)07744-9; Cardona GA, 2011, SCI TOTAL ENVIRON, V412, P101, DOI 10.1016/j.scitotenv.2011.09.076; Carmena D., 2012, WORLD J CLIN INFECT, V2, P1, DOI DOI 10.5495/WJCID.V2.I1.1; Cobo F, 2016, J IMMIGR MINOR HEALT, V18, P8, DOI 10.1007/s10903-014-0141-5; Cooper MA, 2007, CURR BIOL, V17, P1984, DOI 10.1016/j.cub.2007.10.020; Cooper MA, 2010, J INFECT DIS, V202, P1713, DOI 10.1086/657142; Dado D, 2012, PARASITOL RES, V111, P2419, DOI 10.1007/s00436-012-3100-x; Eldash Hanaa H, 2013, J Egypt Soc Parasitol, V43, P509; Elghareeb Azza S, 2015, Trop Parasitol, V5, P36, DOI 10.4103/2229-5070.149919; European Centre for Disease Prevention and Control, 2014, ANN EP REP 2014 FOOD; Farthing MJG, 1996, GASTROENTEROL CLIN N, V25, P493, DOI 10.1016/S0889-8553(05)70260-0; Feng YY, 2011, CLIN MICROBIOL REV, V24, P110, DOI 10.1128/CMR.00033-10; Flecha MJ, 2015, TROP MED INT HEALTH, V20, P1213, DOI 10.1111/tmi.12535; Fletcher SM, 2012, CLIN MICROBIOL REV, V25, P420, DOI 10.1128/CMR.05038-11; Garcia LS, 2003, J CLIN MICROBIOL, V41, P209, DOI 10.1128/JCM.41.1.209-212.2003; Gautret P, 2012, EURO SURVEILL, V17; Goni P, 2012, EUR J CLIN MICROBIOL, V31, P2077, DOI 10.1007/s10096-012-1544-7; Goni P, 2010, ENFERM INFEC MICR CL, V28, P710, DOI 10.1016/j.eimc.2010.04.010; Gonzalez-Moreno O, 2011, PARASITOL RES, V108, P87, DOI 10.1007/s00436-010-2044-2; Gutierrez JM, 2013, TRAVEL MED INFECT DI, V11, P126, DOI 10.1016/j.tmaid.2012.10.004; Haque R, 2009, CLIN INFECT DIS, V48, P1191, DOI 10.1086/597580; Homan WL, 2001, INT J PARASITOL, V31, P822, DOI 10.1016/S0020-7519(01)00183-7; Ignatius R, 2014, CLIN MICROBIOL INFEC, V20, pO783, DOI 10.1111/1469-0691.12596; Jerlstrom-Hultqvist J, 2010, GUT MICROBES, V1, P379, DOI 10.4161/gmic.1.6.13608; Gutierrez-Cisneros MJ, 2011, ENFERM INFEC MICR CL, V29, P201, DOI 10.1016/j.eimc.2010.09.005; Julio C, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-22; Kosuwin R, 2010, GENE, V449, P1, DOI 10.1016/j.gene.2009.09.010; Krumkamp R, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003568; Lalle M, 2005, INT J PARASITOL, V35, P207, DOI 10.1016/j.ijpara.2004.10.022; Lebbad M, 2008, ACTA TROP, V106, P44, DOI 10.1016/j.actatropica.2008.01.004; Lopez-Velez R, 2003, AM J TROP MED HYG, V69, P115, DOI 10.4269/ajtmh.2003.69.115; Manser M, 2014, CLIN MICROBIOL INFEC, V20, pO65, DOI 10.1111/1469-0691.12297; Manzardo Christian, 2008, Travel Med Infect Dis, V6, P4, DOI 10.1016/j.tmaid.2007.11.002; Mateo M, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000075; Minetti C, 2015, J CLIN MICROBIOL, V53, P3133, DOI 10.1128/JCM.00715-15; Morch K, 2008, J INFECTION, V56, P268, DOI 10.1016/j.jinf.2008.01.013; Nabarro LEB, 2015, CLIN MICROBIOL INFEC, V21, P791, DOI 10.1016/j.cmi.2015.04.019; NASH TE, 1985, J INFECT DIS, V152, P64, DOI 10.1093/infdis/152.1.64; Nguyen TKT, 2012, EUR J CLIN MICROBIOL, V31, P623, DOI 10.1007/s10096-011-1332-9; Oberhelman RA, 2001, PEDIATR INFECT DIS J, V20, P792, DOI 10.1097/00006454-200108000-00014; Poxleitner MK, 2008, SCIENCE, V319, P1530, DOI 10.1126/science.1153752; Read C, 2002, INT J PARASITOL, V32, P229, DOI 10.1016/S0020-7519(01)00340-X; Read CM, 2004, INFECT GENET EVOL, V4, P125, DOI 10.1016/j.meegid.2004.02.001; Requena-Mendez A, 2014, CLIN MICROBIOL INFEC, V20, pO135, DOI 10.1111/1469-0691.12327; Robertson LJ, 2013, GIARDIA FOODBORNE PA, P13; RodriguezHernandez J, 1996, EUR J EPIDEMIOL, V12, P291, DOI 10.1007/BF00145419; Ryan U, 2013, INT J PARASITOL, V43, P943, DOI 10.1016/j.ijpara.2013.06.001; Sahagun J, 2008, EUR J CLIN MICROBIOL, V27, P81, DOI 10.1007/s10096-007-0404-3; Soriano JM, 2011, TROP BIOMED, V28, P557; Sprong H, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000558; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Teodorovic S, 2007, EUKARYOT CELL, V6, P1421, DOI 10.1128/EC.00138-07; Verweij JJ, 2003, MOL CELL PROBE, V17, P223, DOI 10.1016/S0890-8508(03)00057-4; Wang L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002437; Yadav P, 2014, INDIAN J MED MICROBI, V32, P378, DOI 10.4103/0255-0857.142236; Zeyrek Dost, 2008, Turkiye Parazitoloji Dergisi, V32, P4	67	39	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0143981	10.1371/journal.pone.0143981	http://dx.doi.org/10.1371/journal.pone.0143981			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641082	Green Published, Green Submitted, gold			2022-12-27	WOS:000366902700039
J	Kelly, VJ; Winkler, T; Venegas, JG; Kone, M; Hamilos, DL; Afshar, R; Cho, JL; Luster, AD; Medoff, BD; Harris, RS				Kelly, Vanessa J.; Winkler, Tilo; Venegas, Jose G.; Kone, Mamary; Hamilos, Daniel L.; Afshar, Roshi; Cho, Josalyn L.; Luster, Andrew D.; Medoff, Benjamin D.; Harris, R. Scott			Allergic Non-Asthmatic Adults Have Regional Pulmonary Responses to Segmental Allergen Challenge	PLOS ONE			English	Article							BRAIN TRANSFER CONSTANTS; BLOOD-FLOW DISTRIBUTION; TIME UPTAKE DATA; GRAPHICAL EVALUATION; VENTILATION DEFECTS; AIRWAY RESPONSE; F-18-FDG UPTAKE; ATOPIC ASTHMA; GAS-EXCHANGE; INFLAMMATION	Background Allergic non-asthmatic (ANA) adults experience upper airway symptoms of allergic disease such as rhinorrhea, congestion and sneezing without symptoms of asthma. The aim of this study was to utilize PET-CT functional imaging to determine whether allergen challenge elicits a pulmonary response in ANA subjects or whether their allergic disease is truly isolated to the upper airways. Methods In 6 ANA subjects, bronchoalveolar lavages (BAL) were performed at baseline and 24h after instillation of an allergen and a diluent in separate lung lobes. After instillation (10h), functional imaging was performed to quantify and compare regional perfusion, ventilation, fractional gas content (Fgas), and glucose uptake rate (Ki) between the baseline, diluent and allergen lobes. BAL cell counts were also compared. Results In ANA subjects, compared to the baseline and diluent lobes, perfusion and ventilation were significantly lower in the allergen lobe (median [inter-quartile range], baseline vs. diluent vs. allergen: Mean-normalized perfusion; 0.87 [0.85-0.97] vs. 0.90 [0.86-0.98] vs. 0.59 [0.55-0.67]; p<0.05. Mean-normalized ventilation 0.89 [0.88-0.98] vs. 0.95 [0.89-1.02] vs. 0.63 [0.52-0.67], p< 0.05). In contrast, no significant differences were found in Fgas between baseline, diluent and allergen lobes or in Ki. Total cell counts, eosinophil and neutrophil cell counts (cells/ml BAL) were significantly greater in the allergen lobe compared to the baseline lobe (all P<0.05). Conclusions Despite having no clinical symptoms of a lower airway allergic response (cough and wheeze) allergic non-asthmatic subjects have a pulmonary response to allergen exposure which manifests as reduced ventilation and perfusion.	[Kelly, Vanessa J.; Kone, Mamary; Hamilos, Daniel L.; Afshar, Roshi; Cho, Josalyn L.; Luster, Andrew D.; Medoff, Benjamin D.; Harris, R. Scott] Massachusetts Gen Hosp, Dept Med, Div Pulm, Boston, MA 02114 USA; [Kelly, Vanessa J.; Kone, Mamary; Hamilos, Daniel L.; Afshar, Roshi; Cho, Josalyn L.; Luster, Andrew D.; Medoff, Benjamin D.; Harris, R. Scott] Massachusetts Gen Hosp, Dept Med, Div Crit Care & Rheumatol, Boston, MA 02114 USA; [Kelly, Vanessa J.; Kone, Mamary; Hamilos, Daniel L.; Afshar, Roshi; Cho, Josalyn L.; Luster, Andrew D.; Medoff, Benjamin D.; Harris, R. Scott] Massachusetts Gen Hosp, Dept Med, Div Allergy, Boston, MA 02114 USA; [Kelly, Vanessa J.; Kone, Mamary; Hamilos, Daniel L.; Afshar, Roshi; Cho, Josalyn L.; Luster, Andrew D.; Medoff, Benjamin D.; Harris, R. Scott] Massachusetts Gen Hosp, Dept Med, Div Immunol, Boston, MA 02114 USA; [Kelly, Vanessa J.; Winkler, Tilo; Venegas, Jose G.; Kone, Mamary; Hamilos, Daniel L.; Afshar, Roshi; Cho, Josalyn L.; Luster, Andrew D.; Medoff, Benjamin D.; Harris, R. Scott] Harvard Univ, Sch Med, Boston, MA USA; [Winkler, Tilo; Venegas, Jose G.] Massachusetts Gen Hosp, Dept Anaesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Afshar, Roshi; Cho, Josalyn L.; Luster, Andrew D.; Medoff, Benjamin D.] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Harris, RS (corresponding author), Massachusetts Gen Hosp, Dept Med, Div Pulm, Boston, MA 02114 USA.	rsharris@mgh.harvard.edu	Luster, Andrew/ABE-6504-2020; Winkler, Tilo/B-5337-2009; Cho, Josalyn/ABF-8931-2021	Luster, Andrew/0000-0001-9679-7912; Winkler, Tilo/0000-0002-7276-5550; Cho, Josalyn/0000-0002-0367-4495; Medoff, Benjamin/0000-0002-2558-0449	National Institutes of Health [HL088297, AI040618, AI095261, HL086717]; American Heart Association [12POST11820025]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088297, R01HL086717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI095261, R01AI040618, R37AI040618] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health: BDM HL088297, ADL AI040618 and AI095261, RSH HL086717; and American Heart Association, VJK 12POST11820025.	Bergeron C, 2010, CAN RESPIR J, V17, pE85, DOI 10.1155/2010/318029; Boulay ME, 2002, CLIN EXP ALLERGY, V32, P1441, DOI 10.1046/j.1365-2745.2002.01508.x; Campana L, 2009, J APPL PHYSIOL, V106, P1293, DOI 10.1152/japplphysiol.91428.2008; CARROLL N, 1993, AM REV RESPIR DIS, V147, P405, DOI 10.1164/ajrccm/147.2.405; Crapo RO, 2000, AM J RESP CRIT CARE, V161, P309; FICK RB, 1987, J APPL PHYSIOL, V63, P1147, DOI 10.1152/jappl.1987.63.3.1147; Harris RS, 2006, AM J RESP CRIT CARE, V174, P245, DOI 10.1164/rccm.200510-1634OC; Harris RS, 2011, J NUCL MED, V52, P1713, DOI 10.2967/jnumed.110.086355; Hopkins SR, 2007, J APPL PHYSIOL, V103, P240, DOI 10.1152/japplphysiol.01289.2006; Kelly EAB, 2003, J ALLERGY CLIN IMMUN, V111, P79, DOI 10.1067/mai.2003.28; KNUDSON RJ, 1983, AM REV RESPIR DIS, V127, P725; LAM S, 1991, J ALLERGY CLIN IMMUN, V87, P842, DOI 10.1016/0091-6749(91)90131-7; Lilly CM, 2001, AM J RESP CRIT CARE, V163, P1669, DOI 10.1164/ajrccm.163.7.9812044; Lommatzsch M, 2006, J ALLERGY CLIN IMMUN, V118, P91, DOI 10.1016/j.jaci.2006.02.034; Lopuhaa CE, 2002, CLIN EXP ALLERGY, V32, P1720, DOI 10.1046/j.1365-2222.2002.01542.x; MARSHALL BE, 1994, INTENS CARE MED, V20, P291, DOI 10.1007/BF01708968; MARSHALL BE, 1994, INTENS CARE MED, V20, P379, DOI 10.1007/BF01720916; Meerschaert J, 1999, AM J RESP CRIT CARE, V159, P619, DOI 10.1164/ajrccm.159.2.9806053; Melo MFV, 2003, J NUCL MED, V44, P1982; Musch G, 2002, J APPL PHYSIOL, V93, P1841, DOI 10.1152/japplphysiol.00223.2002; Oettgen HC, 2012, ALLERGY; PATLAK CS, 1985, J CEREBR BLOOD F MET, V5, P584, DOI 10.1038/jcbfm.1985.87; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; Schroeder T, 2007, J NUCL MED, V48, P1889, DOI 10.2967/jnumed.107.041079; SHAVER JR, 1995, AM J RESP CRIT CARE, V152, P1189, DOI 10.1164/ajrccm.152.4.7551369; Tgavalekos NT, 2007, EUR RESPIR J, V29, P1174, DOI 10.1183/09031936.00113606; Tgavalekos NT, 2005, J APPL PHYSIOL, V99, P2388, DOI 10.1152/japplphysiol.00391.2005; Thomas SY, 2007, J IMMUNOL, V179, P1901, DOI 10.4049/jimmunol.179.3.1901; Venegas JG, 2005, NATURE, V434, P777, DOI 10.1038/nature03490; WENZEL SE, 1988, AM REV RESPIR DIS, V137, P1002, DOI 10.1164/ajrccm/137.5.1002; West JB, 2012, RESP PHYSL ESSENTIAL, Vviii	31	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0143976	10.1371/journal.pone.0143976	http://dx.doi.org/10.1371/journal.pone.0143976			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26640951	Green Published, gold, Green Submitted			2022-12-27	WOS:000366902700038
J	Kiyohara, N; Yamamoto, M; Sugimoto, T				Kiyohara, Nobuaki; Yamamoto, Masahiro; Sugimoto, Toshitsugu			Discordance between Prevalent Vertebral Fracture and Vertebral Strength Estimated by the Finite Element Method Based on Quantitative Computed Tomography in Patients with Type 2 Diabetes Mellitus	PLOS ONE			English	Article							POSTMENOPAUSAL WOMEN; COMPRESSIVE STRENGTH; BONE QUALITY; RISK; PREDICTION; LOAD; BMD	Background Bone fragility is increased in patients with type 2 diabetes mellitus (T2DM), but a useful method to estimate bone fragility in T2DM patients is lacking because bone mineral density alone is not sufficient to assess the risk of fracture. This study investigated the association between prevalent vertebral fractures (VFs) and the vertebral strength index estimated by the quantitative computed tomography-based nonlinear finite element method (QCT-based nonlinear FEM) using multi-detector computed tomography (MDCT) for clinical practice use. Research Design and Methods A cross-sectional observational study was conducted on 54 postmenopausal women and 92 men over 50 years of age, all of whom had T2DM. The vertebral strength index was compared in patients with and without VFs confirmed by spinal radiographs. A standard FEM procedure was performed with the application of known parameters for the bone material properties obtained from nondiabetic subjects. Results A total of 20 women (37.0%) and 39 men (42.4%) with VFs were identified. The vertebral strength index was significantly higher in the men than in the women (P<0.01). Multiple regression analysis demonstrated that the vertebral strength index was significantly and positively correlated with the spinal bone mineral density (BMD) and inversely associated with age in both genders. There were no significant differences in the parameters, including the vertebral strength index, between patients with and without VFs. Logistic regression analysis adjusted for age, spine BMD, BMI, HbA1c, and duration of T2DM did not indicate a significant relationship between the vertebral strength index and the presence of VFs. Conclusion The vertebral strength index calculated by QCT-based nonlinear FEM using material property parameters obtained from nondiabetic subjects, whose risk of fracture is lower than that of T2DM patients, was not significantly associated with bone fragility in patients with T2DM. This discordance may indirectly suggest that patients with T2DM have deteriorated bone material compared with nondiabetic subjects, a potential cause of bone fragility in T2DM patients.	[Kiyohara, Nobuaki; Yamamoto, Masahiro; Sugimoto, Toshitsugu] Shimane Univ, Fac Med, Internal Med 1, Izumo, Shimane, Japan	Shimane University	Yamamoto, M (corresponding author), Shimane Univ, Fac Med, Internal Med 1, Izumo, Shimane, Japan.	masa-ya@med.shimae-u.ac.jp			Japan Society for the Promotion of Science [15K19286, 25460900]; Grants-in-Aid for Scientific Research [25460900] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aids for Young Scientists (B) Grant No. 15K19286 (to NK) from Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/index.html) and Grants-in-Aids for Scientific Research (C) Grant No. 25460900 (to MY) from Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buckley JM, 2007, BONE, V40, P767, DOI 10.1016/j.bone.2006.10.025; Crawford RP, 2003, BONE, V33, P744, DOI 10.1016/S8756-3282(03)00210-2; Dall'Ara E, 2012, OSTEOPOROSIS INT, V23, P563, DOI 10.1007/s00198-011-1568-3; Farr JN, 2014, J BONE MINER RES, V29, P787, DOI 10.1002/jbmr.2106; GENANT HK, 1993, J BONE MINER RES, V8, P1137, DOI 10.1002/jbmr.5650080915; Imai K, 2009, OSTEOPOROSIS INT, V20, P801, DOI 10.1007/s00198-008-0750-8; Imai K, 2006, SPINE, V31, P1789, DOI 10.1097/01.brs.0000225993.57349.df; Janghorbani M, 2007, AM J EPIDEMIOL, V166, P495, DOI 10.1093/aje/kwm106; Keyak JH, 1998, J BIOMECH, V31, P125, DOI 10.1016/S0021-9290(97)00123-1; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Martin H, 1998, BIOMED TECH, V43, P82, DOI 10.1515/bmte.1998.43.4.82; Saito M, 2006, OSTEOPOROSIS INT, V17, P1514, DOI 10.1007/s00198-006-0155-5; Schwartz AV, 2011, JAMA-J AM MED ASSOC, V305, P2184, DOI 10.1001/jama.2011.715; Silva MJ, 1998, J ORTHOPAED RES, V16, P300, DOI 10.1002/jor.1100160305; Vestergaard P, 2007, OSTEOPOROSIS INT, V18, P427, DOI 10.1007/s00198-006-0253-4; Wang X, 2012, J BONE MINER RES, V27, P808, DOI 10.1002/jbmr.1539; Yamamoto M, 2008, J CLIN ENDOCR METAB, V93, P1013, DOI 10.1210/jc.2007-1270; Yamamoto M, 2009, J BONE MINER RES, V24, P702, DOI 10.1359/JBMR.081207	18	6	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144496	10.1371/journal.pone.0144496	http://dx.doi.org/10.1371/journal.pone.0144496			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642210	gold, Green Published, Green Submitted			2022-12-27	WOS:000366902700135
J	Miyashita, A; Fukushima, S; Nakahara, S; Yamashita, J; Tokuzumi, A; Aoi, J; Ichihara, A; Kanemaru, H; Jinnin, M; Ihn, H				Miyashita, Azusa; Fukushima, Satoshi; Nakahara, Satoshi; Yamashita, Junji; Tokuzumi, Aki; Aoi, Jun; Ichihara, Asako; Kanemaru, Hisashi; Jinnin, Masatoshi; Ihn, Hironobu			Investigation of FOXM1 as a Potential New Target for Melanoma	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXM1; DOWN-REGULATION; INDUCE APOPTOSIS; EXPRESSION; CELLS; CARCINOGENESIS; SUPPRESSION; INHIBITION; IPILIMUMAB; REGULATOR	Recent studies have shown that immunotherapies and molecular targeted therapies are effective for advanced melanoma. Non-antigen-specific immunotherapies such as immuno-checkpoint blockades have been shown to be effective in the treatment of advanced melanoma. However, the response rates remain low. To improve their efficacy, they should be combined with antigen-specific immunotherapy. Elevated expression of the transcription factor, Forkhead box M1 (FOXM1), has been reported in various human cancers, and it has been shown to have potential as a target for immunotherapy. The purpose of this study was to investigate the FOXM1 expression in human melanoma samples and cell lines, to evaluate the relationship between the FOXM1 expression and the clinical features of melanoma patients and to investigate the association between the FOXM1 and MAPK and PI3K/AKT pathways in melanoma cell lines. We conducted the quantitative reverse transcription PCR (qRT-PCR) and Western blotting analyses of melanoma cell lines, and investigated melanoma and nevus tissue samples by qRT-PCR and immunohistochemistry. We performed MEK siRNA and PI3K/AKT inhibitor studies and FOXM1 siRNA studies in melanoma cell lines. We found that FOXM1 was expressed in all of the melanoma cell lines, and was expressed in 49% of primary melanomas, 67% of metastatic melanomas and 10% of nevi by performing immunohistochemical staining. Metastatic melanoma samples exhibited significantly higher mRNA levels of FOXM1 (p = 0.004). Primary melanomas thicker than 2 mm were also more likely to express FOXM1. Patients whose primary melanoma expressed FOXM1 had a significantly poorer overall survival compared to patients without FOXM1 expression (p = 0.024). Downregulation of FOXM1 by siRNA significantly inhibited the proliferation of melanoma cells, and blockade of the MAPK and PI3K/AKT pathways decreased the FOXM1 expression in melanoma cell lines. In conclusion, FOXM1 is considered to be a new therapeutic target for melanoma.	[Miyashita, Azusa; Fukushima, Satoshi; Nakahara, Satoshi; Yamashita, Junji; Tokuzumi, Aki; Aoi, Jun; Ichihara, Asako; Kanemaru, Hisashi; Jinnin, Masatoshi; Ihn, Hironobu] Kumamoto Univ, Fac Life Sci, Dept Dermatol & Plast Surg, Kumamoto, Japan	Kumamoto University	Fukushima, S (corresponding author), Kumamoto Univ, Fac Life Sci, Dept Dermatol & Plast Surg, 1-1-1 Honjo, Kumamoto, Japan.	satoshi.fukushima.tb@gmail.com	Kanemaru, Hisashi/AAC-3258-2022	Kanemaru, Hisashi/0000-0003-3725-6213; Fukushima, Satoshi/0000-0002-0622-7682	JSPS [23791280, 25870545, 15K09772, 15K19694]; National Cancer Center Research and Development Fund [23-A-22]; scholarship for the Graduate School of Medical Sciences, Kumamoto University, Japan; Grants-in-Aid for Scientific Research [15K19694] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Cancer Center Research and Development Fund(National Cancer Center - Japan); scholarship for the Graduate School of Medical Sciences, Kumamoto University, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a JSPS Grant-in-Aid for Young Scientists (B) 23791280, 25870545, 15K09772 and 15K19694, the National Cancer Center Research and Development Fund (23-A-22) and the scholarship for the Graduate School of Medical Sciences, Kumamoto University, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a JSPS Grant-in-Aid for Young Scientists (B) 23791280, 25870545, 15K09772 and 15K19694, the National Cancer Center Research and Development Fund (23-A-22) and the scholarship for the Graduate School of Medical Sciences, Kumamoto University, Japan.	Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Bektas N, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-42; Bhat UG, 2008, CELL CYCLE, V7, P1851, DOI 10.4161/cc.7.12.6032; Bhat UG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005592; Bonet C, 2012, J BIOL CHEM, V287, P29887, DOI 10.1074/jbc.M112.371682; Cantwell-Dorris ER, 2011, MOL CANCER THER, V10, P385, DOI 10.1158/1535-7163.MCT-10-0799; Chen B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042598; Feng YM, 2013, MOL CANCER RES, V11, P834, DOI 10.1158/1541-7786.MCR-13-0007; Fukushima S, 2009, J IMMUNOTHER, V32, P219, DOI 10.1097/CJI.0b013e318194b63b; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Huynh KM, 2011, J CELL PHYSIOL, V226, P194, DOI 10.1002/jcp.22326; JANITZ M, 1994, MOL REPROD DEV, V38, P231, DOI 10.1002/mrd.1080380215; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kageshita T, 1999, AM J PATHOL, V154, P745, DOI 10.1016/S0002-9440(10)65321-7; Ma RYM, 2005, J CELL SCI, V118, P795, DOI 10.1242/jcs.01657; Major ML, 2004, MOL CELL BIOL, V24, P2649, DOI 10.1128/MCB.24.7.2649-2661.2004; McArthur GA, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00161; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Park HJ, 2009, EMBO J, V28, P2908, DOI 10.1038/emboj.2009.239; Priller M, 2011, CLIN CANCER RES, V17, P6791, DOI 10.1158/1078-0432.CCR-11-1214; Raychaudhuri P, 2011, CANCER RES, V71, P4329, DOI 10.1158/0008-5472.CAN-11-0640; Schadendorf D, 2015, J CLIN ONCOL, V33, P1889, DOI 10.1200/JCO.2014.56.2736; Slipicevic A, 2005, AM J CLIN PATHOL, V124, P528, DOI 10.1309/YT58WWMTA6YR1PRV; Teh MT, 2002, CANCER RES, V62, P4773; Teh MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034329; Valsecchi ME, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Wang M, 2011, ONCOTARGET, V2, P1218; Wang XH, 2002, P NATL ACAD SCI USA, V99, P16881, DOI 10.1073/pnas.252570299; Wang ZW, 2007, CANCER RES, V67, P8293, DOI 10.1158/0008-5472.CAN-07-1265; Wang ZW, 2011, J CELL BIOCHEM, V112, P78, DOI 10.1002/jcb.22770; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059; Yamashita J, 2012, ACTA DERM-VENEREOL, V92, P593, DOI 10.2340/00015555-1416; Ye HG, 1997, MOL CELL BIOL, V17, P1626, DOI 10.1128/MCB.17.3.1626; Yokomine K, 2010, INT J CANCER, V126, P2153, DOI 10.1002/ijc.24836	34	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144241	10.1371/journal.pone.0144241	http://dx.doi.org/10.1371/journal.pone.0144241			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26640950	gold, Green Submitted, Green Published			2022-12-27	WOS:000366902700083
J	Poujol, F; Monneret, G; Pachot, A; Textoris, J; Venet, F				Poujol, Fanny; Monneret, Guillaume; Pachot, Alexandre; Textoris, Julien; Venet, Fabienne			Altered T Lymphocyte Proliferation upon Lipopolysaccharide Challenge Ex Vivo	PLOS ONE			English	Article							OKT3 MONOCLONAL-ANTIBODY; CRITICALLY-ILL PATIENTS; SEVERE SEPSIS; CELL-PROLIFERATION; SEPTIC SHOCK; COSTIMULATORY RECEPTOR; ENDOTOXIN TOLERANCE; ANTI-PD-1 ANTIBODY; IMPROVES SURVIVAL; IN-VIVO	Context Sepsis is characterized by the development of adaptive immune cell alterations, which intensity and duration are associated with increased risk of health-care associated infections and mortality. However, pathophysiological mechanisms leading to such lymphocyte dysfunctions are not completely understood, although both intrinsic lymphocyte alterations and antigen-presenting cells (APCs) dysfunctions are most likely involved. Study The aim of the current study was to evaluate whether lipopolysaccharide (LPS, mimicking initial Gram negative bacterial challenge) could directly impact lymphocyte function after sepsis. Therefore, we explored ex-vivo the effect of LPS priming on human T lymphocyte proliferation induced by different stimuli. Results We showed that LPS priming of PBMCs reduced T cell proliferative response and altered IFN gamma secretion after stimulation with OKT3 but not with phytohaemagglutinin or anti-CD2/CD3/CD28-coated beads stimulations. Interestingly only LPS priming of monocytes led to decreased T cell proliferative response as opposed to LPS priming of lymphocytes. Importantly, LPS priming was associated with reduced expression of HLA-DR, CD86 and CD64 on monocytes but not with the modification of CD3, CTLA4, PD-1 and CD28 expressions on lymphocytes. Finally, IFN gamma stimulation restored monocytes accessory functions and T cell proliferative response to OKT3. Conclusion We conclude that LPS priming does not directly impact lymphocyte functions but reduces APC's capacity to activate T cells. This recapitulates ex vivo indirect mechanisms participating in sepsis-induced lymphocyte alterations and suggests that monocyte-targeting immunoadjuvant therapies in sepsis may also help to improve adaptive immune dysfunctions. Direct mechanisms impacting lymphocytes being also at play during sepsis, the respective parts of direct versus indirect sepsis-induced lymphocyte alterations remain to be evaluated in clinic.	[Poujol, Fanny; Monneret, Guillaume; Pachot, Alexandre; Textoris, Julien; Venet, Fabienne] Hop Edouard Herriot, Hosp Civils Lyon BioMerieux, Joint Res Unit, BioMerieux, Lyon, France; [Monneret, Guillaume; Venet, Fabienne] Hop Edouard Herriot, Hosp Civils Lyon, Immunol Lab, Lyon, France; [Textoris, Julien] Hop Edouard Herriot, Hosp Civils Lyon, Anesthesiol & Intens Care Dept, Lyon, France	bioMerieux; CHU Lyon; CHU Lyon; CHU Lyon	Venet, F (corresponding author), Hop Edouard Herriot, Hosp Civils Lyon BioMerieux, Joint Res Unit, BioMerieux, Lyon, France.	fabienne.venet@chu-lyon.fr	Textoris, Julien/H-3317-2019	Textoris, Julien/0000-0002-3821-9337; Venet, Fabienne/0000-0003-0462-4235	bioMerieux; Hospices Civils de Lyon	bioMerieux; Hospices Civils de Lyon	This work was supported by funds from bioMerieux (FP, AP, JT) and the Hospices Civils de Lyon to GM and FV. FP, AP, and JT are bioMerieux employees. This commercial affiliation only provided support in the form of salaries for authors (FP, JT, AP), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Allantaz-Frager F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068218; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; BISMUTH G, 1985, J IMMUNOL, V134, P1415; Boomer JS, 2012, CRIT CARE, V16, DOI 10.1186/cc11404; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Brahmamdam P, 2010, J LEUKOCYTE BIOL, V88, P233, DOI 10.1189/jlb.0110037; Bryn T, 2008, INT IMMUNOL, V20, P235, DOI 10.1093/intimm/dxm134; Caramalho I, 2003, J EXP MED, V197, P403, DOI 10.1084/jem.20021633; Caron G, 2005, J IMMUNOL, V175, P1551, DOI 10.4049/jimmunol.175.3.1551; Chang KC, 2013, CRIT CARE, V17, DOI 10.1186/cc12711; CHANG TW, 1982, J IMMUNOL, V128, P585; Chien EJ, 2000, J CELL BIOCHEM, V76, P404, DOI 10.1002/(SICI)1097-4644(20000301)76:3<404::AID-JCB8>3.0.CO;2-E; Cole MS, 1997, J IMMUNOL, V159, P3613; Cottalorda A, 2006, EUR J IMMUNOL, V36, P1684, DOI 10.1002/eji.200636181; Deutschman CS, 2014, IMMUNITY, V40, P464, DOI 10.1016/j.immuni.2014.04.001; Docke WD, 1997, NAT MED, V3, P678, DOI 10.1038/nm0697-678; Dominguez-Villar M, 2015, NAT IMMUNOL, V16, P118, DOI 10.1038/ni.3036; Drewry AM, 2014, SHOCK, V42, P383, DOI 10.1097/SHK.0000000000000234; Fontaine M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100909; Gelman AE, 2004, J IMMUNOL, V172, P6065, DOI 10.4049/jimmunol.172.10.6065; Gomez HG, 2014, CRIT CARE MED, V42, P771, DOI 10.1097/CCM.0000000000000100; Guignant C, 2011, CRIT CARE, V15, DOI 10.1186/cc10112; Heininger A, 2011, CRIT CARE, V15, DOI 10.1186/cc10069; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Inoue S, 2014, CRIT CARE, V18, DOI 10.1186/cc13941; KAWAKAMI K, 1989, J IMMUNOL, V142, P1818; Komai-Koma M, 2004, P NATL ACAD SCI USA, V101, P3029, DOI 10.1073/pnas.0400171101; Lahn M, 1998, J IMMUNOL, V160, P5221; Leentjens J, 2012, AM J RESP CRIT CARE, V186, P838, DOI 10.1164/rccm.201204-0645OC; LOHRMANN HP, 1974, J EXP MED, V139, P1553, DOI 10.1084/jem.139.6.1553; Lukaszewicz AC, 2009, CRIT CARE MED, V37, P2746, DOI 10.1097/CCM.0b013e3181ab858a; Manjuck J, 2000, J LAB CLIN MED, V135, P153, DOI 10.1067/mlc.2000.104306; MANZO C, 1990, CELL IMMUNOL, V125, P79, DOI 10.1016/0008-8749(90)90064-X; MATTERN T, 1994, J IMMUNOL, V153, P2996; Mattern T, 1998, J IMMUNOL, V160, P3412; Maxwell JR, 2002, J IMMUNOL, V168, P4372, DOI 10.4049/jimmunol.168.9.4372; McAleer JP, 2007, J IMMUNOL, V179, P6524, DOI 10.4049/jimmunol.179.10.6524; MILLER K, 1983, IMMUNOBIOLOGY, V165, P132, DOI 10.1016/S0171-2985(83)80055-2; Monneret G, 2011, MED MYCOL, V49, pS17, DOI 10.3109/13693786.2010.509744; Muszynski JA, 2014, CRIT CARE, V18, DOI 10.1186/cc13980; Nakagawa Y, 2003, J INFECT DIS, V188, P1284, DOI 10.1086/379036; Porichis F, 2011, BLOOD, V118, P965, DOI 10.1182/blood-2010-12-328070; Poujol F, 2014, J IMMUNOL METHODS, V415, P71, DOI 10.1016/j.jim.2014.10.006; Reynolds JM, 2013, TRENDS IMMUNOL, V34, P511, DOI 10.1016/j.it.2013.06.003; Roger PM, 2009, EUR J CLIN MICROBIOL, V28, P575, DOI 10.1007/s10096-008-0673-5; SCHWAB R, 1985, J IMMUNOL, V135, P1714; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tough DF, 1997, J EXP MED, V185, P2089, DOI 10.1084/jem.185.12.2089; Turrel-Davin F, 2011, CRIT CARE, V15, DOI 10.1186/cc10513; Ulmer AJ, 2000, TOXICOLOGY, V152, P37, DOI 10.1016/S0300-483X(00)00290-0; Venet F, 2013, CURR OPIN IMMUNOL, V25, P477, DOI 10.1016/j.coi.2013.05.006; Venet F, 2012, J IMMUNOL, V189, P5073, DOI 10.4049/jimmunol.1202062; Venet F, 2009, INTENS CARE MED, V35, P678, DOI 10.1007/s00134-008-1337-8; VOGEL SN, 1983, J IMMUNOL, V130, P1774; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wolk K, 2000, BLOOD, V96, P218, DOI 10.1182/blood.V96.1.218.013k04_218_223; Yaqub S, 2003, MED SCI MONITOR, V9, pBR120; Zanin-Zhorov A, 2007, J IMMUNOL, V179, P41, DOI 10.4049/jimmunol.179.1.41	58	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144375	10.1371/journal.pone.0144375	http://dx.doi.org/10.1371/journal.pone.0144375			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642057	Green Published, gold, Green Submitted			2022-12-27	WOS:000366902700107
J	Zhou, ZM; Ding, XH; Yang, Q; Hu, J; Shang, XJ; Huang, XJ; Ge, L; Zhou, TF				Zhou, Zhiming; Ding, Xianhui; Yang, Qian; Hu, Jia; Shang, Xianjin; Huang, Xianjun; Ge, Liang; Zhou, Taofeng			Association between Single-Nucleotide Polymorphisms of the Tyrosine Kinase Receptor B (Tr kappa B) and Post-Stroke Depression in China	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; N-ACETYLSEROTONIN; GLOBAL BURDEN; STROKE; MECHANISMS; NTRK2; BDNF; RISK	Background Polymorphisms of the brain-derived neurotrophic factor (BDNF) have been investigated as candidate genes for post-stroke depression (PSD), and its receptor, neurotrophic tyrosine kinase receptor B (TrkB), has been associated with depression. However, no further data have yet reported the association between PSD and polymorphisms in TrkB. This study aims to investigate whether a relationship exists between TrkB polymorphisms and PSD. Methods A total of 312 depression patients (PSD patients) and 472 non-depression patient controls (NPSD patients) were recruited. All patients were evaluated using the Hamilton Rating Scale for Depression (HAMD) to determine depression severity, and PSD patients were diagnosed in accordance with DSM-V criteria. Three single-nucleotide polymorphisms (SNPs), namely, rs1187323, rs1212171, and rs1778929, in the TrkB gene were genotyped by high-resolution melt analysis. Results The SNP rs1778929 was significantly more associated with incident PSD in participants with the TT genotype than in those with CC (OR 0.482, 95% CI: 0.313-0.744). In terms of rs1187323, stroke was significantly more associated with incident depression in participants with the AC genotype than in those with AA (OR 0.500, 95% CI: 0.368-0.680). The minor allele (T) of rs1778929 (P = 0.024, OR = 0.725, 95% CI = 0.590-0.890) and the minor allele (C) of rs1187323 (P = 0.000, OR = 0.598, 95% CI = 0.466-0.767) were found to be significantly associated with PSD. Neither genotype nor allele frequencies of rs1212171 showed statistically significant differences between PSD and NPSD patients. Conclusions The results suggest that rs1778929 and rs1187323 in the TrkB gene are significantly associated with post-stroke depression in the Chinese population. Further studies are necessary to confirm our findings.	[Zhou, Zhiming; Ding, Xianhui; Yang, Qian; Hu, Jia; Shang, Xianjin; Huang, Xianjun; Ge, Liang; Zhou, Taofeng] Yijishan Hosp, Wannan Med Coll, Dept Neurol, Wuhu, Anhui, Peoples R China	Wannan Medical College	Zhou, ZM (corresponding author), Yijishan Hosp, Wannan Med Coll, Dept Neurol, Wuhu, Anhui, Peoples R China.	neuro_depar@hotmail.com			National Natural Science Foundation of China [81171110]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (Grant No. 81171110, awarded to Dr. Zhiming Zhou).	Avdoshina V, 2013, JAIDS-J ACQ IMM DEF, V64, P138, DOI 10.1097/QAI.0b013e3182a468e9; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Cozza A, 2008, J ALZHEIMERS DIS, V15, P61; Dong C, 2009, MOL PSYCHIATR, V14, P1105, DOI 10.1038/mp.2009.92; Duman RS, 2012, TRENDS NEUROSCI, V35, P47, DOI 10.1016/j.tins.2011.11.004; Feng C, 2014, SCI WORLD J, DOI 10.1155/2014/521349; Gazal M, 2012, NEUROCHEM RES, V37, P583, DOI 10.1007/s11064-011-0647-3; Hackett ML, 2005, STROKE, V36, P2296, DOI 10.1161/01.STR.0000183622.75135.a4; Jang SW, 2010, P NATL ACAD SCI USA, V107, P3876, DOI 10.1073/pnas.0912531107; Kohli MA, 2010, ARCH GEN PSYCHIAT, V67, P348, DOI 10.1001/archgenpsychiatry.2009.201; Li J, 2014, J AFFECT DISORDERS, V168, P373, DOI 10.1016/j.jad.2014.07.011; Lin E, 2009, REJUV RES, V12, P387, DOI 10.1089/rej.2009.0871; Loubinoux I, 2012, J CELL MOL MED, V16, P1961, DOI 10.1111/j.1582-4934.2012.01555.x; Mukherjee D, 2011, WORLD NEUROSURG, V76, pS85, DOI 10.1016/j.wneu.2011.07.023; O'Donnell M, 2009, LANCET NEUROL, V8, P306, DOI 10.1016/S1474-4422(09)70024-9; Oxenkrug G, 2012, AGING DIS, V3, P330; Paolucci S, 2005, ACTA PSYCHIAT SCAND, V112, P272, DOI 10.1111/j.1600-0447.2005.00590.x; Paolucci Stefano, 2008, Neuropsychiatr Dis Treat, V4, P145; Taylor WD, 2007, AM J GERIAT PSYCHIAT, V15, P850, DOI 10.1097/JGP.0b013e318050c9d5; Verhagen M, 2010, MOL PSYCHIATR, V15, P260, DOI 10.1038/mp.2008.109; Yang LL, 2011, INT J GERIATR PSYCH, V26, P495, DOI 10.1002/gps.2552; Zhou ZM, 2011, CLIN CHEM LAB MED, V49, P185, DOI 10.1515/CCLM.2011.039	22	15	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144301	10.1371/journal.pone.0144301	http://dx.doi.org/10.1371/journal.pone.0144301			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641254	Green Published, Green Submitted, gold			2022-12-27	WOS:000366902700094
J	Donnell-Fink, LA; Klara, K; Collins, JE; Yang, HY; Goczalk, MG; Katz, JN; Losina, E				Donnell-Fink, Laurel A.; Klara, Kristina; Collins, Jamie E.; Yang, Heidi Y.; Goczalk, Melissa G.; Katz, Jeffrey N.; Losina, Elena			Effectiveness of Knee Injury and Anterior Cruciate Ligament Tear Prevention Programs: A Meta-Analysis	PLOS ONE			English	Article							TRAINING-PROGRAM; WARM-UP; PROSPECTIVE INTERVENTION; HANDBALL PLAYERS; SOCCER INJURIES; FEMALE SOCCER; BASKETBALL; FOOTBALL; BALANCE	Objective Individuals frequently involved in jumping, pivoting or cutting are at increased risk of knee injury, including anterior cruciate ligament (ACL) tears. We sought to use meta-analytic techniques to establish whether neuromuscular and proprioceptive training is efficacious in preventing knee and ACL injury and to identify factors related to greater efficacy of such programs. Methods We performed a systematic literature search of studies published in English between 1996 and 2014. Intervention efficacy was ascertained from incidence rate ratios (IRRs) weighted by their precision (1/variance) using a random effects model. Separate analyses were performed for knee and ACL injury. We examined whether year of publication, study quality, or specific components of the intervention were associated with efficacy of the intervention in a meta-regression analysis. Results Twenty-four studies met the inclusion criteria and were used in the meta-analysis. The mean study sample was 1,093 subjects. Twenty studies reported data on knee injury in general terms and 16 on ACL injury. Maximum Jadad score was 3 (on a 0-5 scale). The summary incidence rate ratio was estimated at 0.731 (95% CI: 0.614, 0.871) for knee injury and 0.493 (95% CI: 0.285, 0.854) for ACL injury, indicating a protective effect of intervention. Meta-regression analysis did not identify specific intervention components associated with greater efficacy but established that later year of publication was associated with more conservative estimates of intervention efficacy. Conclusion The current meta-analysis provides evidence that neuromuscular and proprioceptive training reduces knee injury in general and ACL injury in particular. Later publication date was associated with higher quality studies and more conservative efficacy estimates. As study quality was generally low, these data suggest that higher quality studies should be implemented to confirm the preventive efficacy of such programs.	[Donnell-Fink, Laurel A.; Klara, Kristina; Collins, Jamie E.; Yang, Heidi Y.; Goczalk, Melissa G.; Katz, Jeffrey N.; Losina, Elena] Brigham & Womens Hosp, Orthopaed & Arthrit Ctr Outcomes Res, Dept Orthoped Surg, Boston, MA 02115 USA; [Collins, Jamie E.; Katz, Jeffrey N.; Losina, Elena] Harvard Univ, Sch Med, Boston, MA USA; [Katz, Jeffrey N.] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Losina, Elena] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Boston University	Losina, E (corresponding author), Brigham & Womens Hosp, Orthopaed & Arthrit Ctr Outcomes Res, Dept Orthoped Surg, 75 Francis St, Boston, MA 02115 USA.	elosina@partners.org		Losina, ELENA/0000-0002-3424-0892	National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01 AR064320, K24 AR057827, P60 AR047782]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR057827, P60AR047782, R01AR064320] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was supported by National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases: R01 AR064320 (EL), K24 AR057827 (EL), P60 AR047782 (JNK, EL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARENDT E, 1995, AM J SPORT MED, V23, P694, DOI 10.1177/036354659502300611; Boden BP, 2000, PHYSICIAN SPORTSMED, V28, P53, DOI 10.3810/psm.2000.04.841; Caraffa A, 1996, Knee Surg Sports Traumatol Arthrosc, V4, P19, DOI 10.1007/BF01565992; Chappell JD, 2008, AM J SPORT MED, V36, P1081, DOI 10.1177/0363546508314425; Cimino F, AM FAM PHYS, V82, P917; Darrow CJ, 2009, AM J SPORT MED, V37, P1798, DOI 10.1177/0363546509333015; Donner A, 2002, STAT MED, V21, P2971, DOI 10.1002/sim.1301; Emery CA, 2010, BRIT J SPORT MED, V44, P555, DOI 10.1136/bjsm.2010.074377; Fithian DC, 2002, ORTHOP CLIN N AM, V33, P621, DOI 10.1016/S0030-5898(02)00015-9; Gilchrist J, 2008, AM J SPORT MED, V36, P1476, DOI 10.1177/0363546508318188; Goodall RL, 2013, INT J INJ CONTROL SA, V20, P271, DOI 10.1080/17457300.2012.717085; Grimm NL, 2015, AM J SPORT MED, V43, P2049, DOI 10.1177/0363546514556737; Grooms DR, 2013, J ATHL TRAINING, V48, P782, DOI 10.4085/1062-6050-48.4.08; Heidt RS, 2000, AM J SPORT MED, V28, P659, DOI 10.1177/03635465000280050601; Hewett TE, 1999, AM J SPORT MED, V27, P699, DOI 10.1177/03635465990270060301; Hewett TE, 2006, AM J SPORT MED, V34, P490, DOI 10.1177/0363546505282619; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Junge A, 2002, AM J SPORT MED, V30, P652, DOI 10.1177/03635465020300050401; Kiani A, 2010, ARCH INTERN MED, V170, P43, DOI 10.1001/archinternmed.2009.289; LaBella CR, 2011, ARCH PEDIAT ADOL MED, V165, P1033, DOI 10.1001/archpediatrics.2011.168; Lohmander LS, 2007, AM J SPORT MED, V35, P1756, DOI 10.1177/0363546507307396; Longo UG, 2012, AM J SPORT MED, V40, P996, DOI 10.1177/0363546512438761; Louw QA, 2008, BRIT J SPORT MED, V42, DOI 10.1136/bjsm.2007.035360; MacLeod TD, 2014, J ORTHOP SPORT PHYS, V44, P76, DOI 10.2519/jospt.2014.4876; Malliou P, 2004, PERCEPT MOTOR SKILL, V99, P149, DOI 10.2466/PMS.99.5.149-154; Mandelbaum BR, 2005, AM J SPORT MED, V33, P1003, DOI 10.1177/0363546504272261; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Myklebust G, 2003, CLIN J SPORT MED, V13, P71, DOI 10.1097/00042752-200303000-00002; NCAA, 2013, EST PROB COMP ATHL H; Olsen OE, 2005, BRIT MED J, V330, P449, DOI 10.1136/bmj.38330.632801.8F; Pasanen K, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a295; Petersen W, 2005, ARCH ORTHOP TRAUM SU, V125, P614, DOI 10.1007/s00402-005-0793-7; Pfeiffer RP, 2006, J BONE JOINT SURG AM, V88A, P1769, DOI 10.2106/JBJS.E.00616; Renstrom P, 2008, BRIT J SPORT MED, V42, P394, DOI 10.1136/bjsm.2008.048934; Sadoghi P, 2012, J BONE JOINT SURG AM, V94A, P769, DOI 10.2106/JBJS.K.00467; Soderman K, 2000, KNEE SURG SPORT TR A, V8, P356, DOI 10.1007/s001670000147; Soligard T, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2469; Steffen K, 2008, SCAND J MED SCI SPOR, V18, P605, DOI 10.1111/j.1600-0838.2007.00703.x; van Beijsterveldt AMC, 2012, BRIT J SPORT MED, V46, P1114, DOI 10.1136/bjsports-2012-091277; van Houwelingen HC, 2002, STAT MED, V21, P589, DOI 10.1002/sim.1040; Walden M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3042; Wedderkopp N, 1999, SCAND J MED SCI SPOR, V9, P41; Whitehead A., 2002, METAANALYSIS CONTROL; Yoo JH, 2010, KNEE SURG SPORT TR A, V18, P824, DOI 10.1007/s00167-009-0901-2	45	58	59	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144063	10.1371/journal.pone.0144063	http://dx.doi.org/10.1371/journal.pone.0144063			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26637173	Green Published, gold, Green Submitted			2022-12-27	WOS:000366143800037
J	Ghislain, M; Bastard, JP; Meyer, L; Capeau, J; Fellahi, S; Gerard, L; May, T; Simon, A; Vigouroux, C; Goujard, C				Ghislain, Mathilde; Bastard, Jean-Philippe; Meyer, Laurence; Capeau, Jacqueline; Fellahi, Soraya; Gerard, Laurence; May, Thierry; Simon, Anne; Vigouroux, Corinne; Goujard, Cecile		ANRS-COPANA Cohort Study Grp	Late Antiretroviral Therapy (ART) Initiation Is Associated with Long-Term Persistence of Systemic Inflammation and Metabolic Abnormalities	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; DIABETES-MELLITUS; INSULIN SENSITIVITY; MICROBIAL TRANSLOCATION; IMMUNE ACTIVATION; MARKERS; COAGULATION; PREVALENCE; RISK; DYSLIPIDEMIA	Objectives HIV-induced immunodeficiency is associated with metabolic abnormalities and systemic inflammation. We investigated the effect of antiretroviral therapy (ART) on restoration of insulin sensitivity, markers of immune activation and inflammation. Methods Immunological, metabolic and inflammatory status was assessed at antiretroviral therapy initiation and three years later in 208 patients from the ANRS-COPANA cohort. Patients were compared according to their pre-ART CD4(+) cell count (group 1: <= 200/mm(3), n = 66 vs. group 2: >200/mm(3), n = 142). Results Median CD4(+) cell count increased in both groups after 3 years of successful ART but remained significantly lower in group 1 than in group 2 (404 vs 572 cells/mm(3)). Triglyceride and insulin levels were higher or tended to be higher in group 1 than in group 2 at ART initiation (median: 1.32 vs 0.97 mmol/l, p = 0.04 and 7.6 vs 6.8 IU, p = 0.09, respectively) and remained higher after three years of ART (1.42 vs 1.16 mmol/L, p = 0.0009 and 8.9 vs 7.2 IU, p = 0.01). After adjustment for individual characteristics and antiretroviral therapy regimens (protease inhibitor (PI), zidovudine), insulin levels remained significantly higher in patients with low baseline CD4(+) cell count. Baseline IL-6, sCD14 and sTNFR2 levels were higher in group 1 than in group 2. Most biomarkers of immune activation/inflammation declined during ART, but IL-6 and hsCRP levels remained higher in patients with low baseline CD4(+) cell count than in the other patients (median are respectively 1.4 vs 1.1 pg/ml, p = 0.03 and 2.1 vs 1.3 mg/ml, p = 0.07). Conclusion After three years of successful ART, low pretreatment CD4(+) T cell count remained associated with elevated insulin, triglyceride, IL-6 and hsCRP levels. These persistent metabolic and inflammatory abnormalities could contribute to an increased risk of cardiovascular and metabolic disease.	[Ghislain, Mathilde; Meyer, Laurence; Goujard, Cecile] CESP, Inserm UMRS1018, Epidemiol HIV & STI, Le Kremlin Bicetre, France; [Bastard, Jean-Philippe; Capeau, Jacqueline; Fellahi, Soraya] Tenon Hosp, AP HP, Dept Biochem & Hormonol, Paris, France; [Bastard, Jean-Philippe; Capeau, Jacqueline; Fellahi, Soraya; Vigouroux, Corinne] Ctr Rech St Antoine, Inserm UMRS 938, Paris, France; [Bastard, Jean-Philippe; Capeau, Jacqueline; Fellahi, Soraya; Vigouroux, Corinne] UPMC, Univ Paris 04, ICAN, Paris, France; [Meyer, Laurence; Goujard, Cecile] Univ Paris Sud, F-94275 Le Kremlin Bicetre, France; [Meyer, Laurence] Bicetre Hosp, AP HP, Dept Publ Hlth, Le Kremlin Bicetre, France; [Gerard, Laurence] Hop St Louis, AP HP, Dept Clin Immunopathol, Paris, France; [May, Thierry] Teaching Hosp Nancy, Brabois Hosp, Dept Infect & Trop Dis, Vandoeuvre Les Nancy, France; [Simon, Anne] Hop La Pitie Salpetriere, AP HP, Dept Internal Med & Clin Immunol, Paris, France; [Vigouroux, Corinne] Hop St Antoine, AP HP, Common Lab Biol & Mol Genet, Paris, France; [Goujard, Cecile] Bicetre Hosp, AP HP, Dept Internal Med, Le Kremlin Bicetre, France; [ANRS-COPANA Cohort Study Grp] Inserm ANRS, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de Nancy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)	Ghislain, M (corresponding author), CESP, Inserm UMRS1018, Epidemiol HIV & STI, Le Kremlin Bicetre, France.	mathilde.ghislain@inserm.fr	Gallien, Sébastien/F-9930-2015; Bergmann, Jean-Francois/L-6044-2017; Matheron, Sophie/D-7420-2017	Gallien, Sébastien/0000-0002-8033-0936; ABEL, Sylvie/0000-0002-3351-0547; Kansau, Imad/0000-0002-1893-6822; Cabie, Andre/0000-0003-0117-3061; Bergmann, Jean-Francois/0000-0001-6861-9748; Matheron, Sophie/0000-0001-7879-6553	ANRS (Agence Nationale de Recherches sur le SIDA et les Hepatites Virales), Paris, France	ANRS (Agence Nationale de Recherches sur le SIDA et les Hepatites Virales), Paris, France(ANRS)	The Inserm-ANRS C09 COPANA Cohort Study is supported by ANRS (Agence Nationale de Recherches sur le SIDA et les Hepatites Virales), Paris, France [http://www.anrs.fr/].	Armah KA, 2012, CLIN INFECT DIS, V55, P126, DOI 10.1093/cid/cis406; Baker JV, 2011, JAIDS-J ACQ IMM DEF, V56, P36, DOI 10.1097/QAI.0b013e3181f7f61a; Bastard JP, 2015, J ANTIMICROB CHEMOTH, V70, P1816, DOI 10.1093/jac/dkv036; Beltran LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090541; Borges AH, 2015, J INFECT DIS, V212, P585, DOI 10.1093/infdis/jiv123; Boufassa F, 2012, ANTIVIR THER, V17, P91, DOI 10.3851/IMP1916; Brown TT, 2010, DIABETES CARE, V33, P2244, DOI 10.2337/dc10-0633; Brown TT, 2005, ARCH INTERN MED, V165, P1179, DOI 10.1001/archinte.165.10.1179; Burdo TH, 2011, J INFECT DIS, V204, P1227, DOI 10.1093/infdis/jir520; Capeau J, 2012, AIDS, V26, P303, DOI 10.1097/QAD.0b013e32834e8776; De Wit S, 2008, DIABETES CARE, V31, P1224, DOI 10.2337/dc07-2013; Dooko CBA, 2014, JAIDS-J ACQ IMM DEF, V67, P538, DOI 10.1097/QAI.0000000000000354; Duprez DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044454; El-Sadr W, 2005, HIV MED, V6, P114, DOI 10.1111/j.1468-1293.2005.00273.x; Finucane FM, 2009, DIABETOLOGIA, V52, P2345, DOI 10.1007/s00125-009-1508-3; French MA, 2009, J INFECT DIS, V200, P1212, DOI 10.1086/605890; Galli L, 2012, EUR J EPIDEMIOL, V27, P657, DOI 10.1007/s10654-012-9707-5; Hattab S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-122; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Krishnan S, 2012, JAIDS-J ACQ IMM DEF, V61, P381, DOI 10.1097/QAI.0b013e3182690e3c; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Ledergerber B, 2007, CLIN INFECT DIS, V45, P111, DOI 10.1086/518619; Lee GA, 2007, AIDS, V21, P2183, DOI 10.1097/QAD.0b013e32826fbc54; McComsey GA, 2012, AIDS, V26, P1371, DOI 10.1097/QAD.0b013e328354f4fb; Mulligan K, 2000, J ACQ IMMUN DEF SYND, V23, P35, DOI 10.1097/00042560-200001010-00005; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; Noor MA, 2001, AIDS, V15, pF11, DOI 10.1097/00002030-200105040-00001; Nordell AD, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000844; Paik IJ, 2011, BEST PRACT RES CL EN, V25, P469, DOI 10.1016/j.beem.2011.04.003; Pedersen KK, 2013, JAIDS-J ACQ IMM DEF, V64, P425, DOI 10.1097/QAI.0b013e31829f919d; Petoumenos K, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17426; Rasmussen LD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044575; Riddler SA, 2003, JAMA-J AM MED ASSOC, V289, P2978, DOI 10.1001/jama.289.22.2978; Samaras K, 2009, JAIDS-J ACQ IMM DEF, V50, P499, DOI 10.1097/QAI.0b013e31819c291b; Sandler NG, 2012, NAT REV MICROBIOL, V10, P655, DOI 10.1038/nrmicro2848; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Shikuma CM, 1999, AIDS, V13, P1359, DOI 10.1097/00002030-199907300-00013; Tenorio AR, 2014, J INFECT DIS, V210, P1248, DOI 10.1093/infdis/jiu254; Tien PC, 2010, JAIDS-J ACQ IMM DEF, V55, P316, DOI 10.1097/QAI.0b013e3181e66216; van Vonderen MGA, 2010, JAIDS-J ACQ IMM DEF, V53, P186, DOI 10.1097/QAI.0b013e3181c190f4; Vigouroux C, 2003, AIDS, V17, P1503, DOI 10.1097/00002030-200307040-00011; Visnegarwala F, 2005, J INFECTION, V50, P331, DOI 10.1016/j.jinf.2004.06.001; Zanni MV, 2012, CLIN ENDOCRINOL, V77, P385, DOI 10.1111/j.1365-2265.2011.04284.x	43	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144317	10.1371/journal.pone.0144317	http://dx.doi.org/10.1371/journal.pone.0144317			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636578	Green Published, gold			2022-12-27	WOS:000366143800074
J	Song, J; Chen, S; Liu, XT; Duan, HT; Kong, JH; Li, ZD				Song, Jian; Chen, Song; Liu, Xiaoting; Duan, Hongtao; Kong, Jiahui; Li, Zedong			Relationship between C-Reactive Protein Level and Diabetic Retinopathy: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; BODY-MASS INDEX; MICROVASCULAR COMPLICATIONS; INFLAMMATORY MARKERS; RISK-FACTORS; TNF-ALPHA; MELLITUS; INTERLEUKIN-6; HOMOCYSTEINE; PATHOGENESIS	Objectives To date, the relationship between C-reactive protein (CRP) level and diabetic retinopathy (DR) remains controversial. Therefore, a systematic review and meta-analysis was used to reveal the potential relationship between CRP level and DR. Methods A systematic search of PubMed, Embase. com, and Web of Science was performed to identify all comparative studies that compared the CRP level of two groups (case group and control group). We defined that diabetic patients without retinopathy and / or matched healthy persons constituted the control group, and patients with DR were the case group. Results Two cross sectional studies and twenty case control studies including a total of 3679 participants were identified. After pooling the data from all 22 studies, obvious heterogeneity existed between the studies, so a subgroup analysis and sensitivity analysis were performed. Removing the sensitivity studies, the blood CRP levels in the case group were observed to be higher than those in the control group [SMD = 0.22, 95% confidence interval (CI), 0.11-0.34], and the blood CRP levels in the proliferative diabetic retinopathy (PDR) group were also higher than those in the non-proliferative diabetic retinopathy (NPDR) group [SMD = 0.50, 95% CI, 0.30-0.70]. Conclusions The results from this current meta-analysis indicate that the CRP level might be used as a biomarker to determine the severity of DR.	[Song, Jian; Chen, Song; Duan, Hongtao; Kong, Jiahui; Li, Zedong] Tianjin Med Univ, Clin Coll Ophthalmol, Tianjin, Peoples R China; [Chen, Song] Tianjin Eye Hosp, Tianjin, Peoples R China; [Chen, Song] Tianjin Key Lab Ophthalmol & Visual Sci, Tianjin, Peoples R China; [Chen, Song] Tianjin Eye Inst, Tianjin, Peoples R China; [Liu, Xiaoting] Xinxiang Med Univ, Dept Publ Hlth, Xinxiang, Peoples R China	Tianjin Medical University; Tianjin Medical University; Xinxiang Medical University	Chen, S (corresponding author), Tianjin Med Univ, Clin Coll Ophthalmol, Tianjin, Peoples R China.	chensong20@hotmail.com						Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Blum A, 2012, EUR CYTOKINE NETW, V23, P158, DOI 10.1684/ecn.2012.0321; Boscia F, 2010, DRUGS, V70, P2171, DOI 10.2165/11538130-000000000-00000; Budak YU, 2013, INT J DIABETES DEV C, V33, P40, DOI 10.1007/s13410-012-0103-1; Cai XL, 2006, CHINESE MED J-PEKING, V119, P822, DOI 10.1097/00029330-200605020-00005; Chen YS, 2010, GUOJI YANKE ZAZHI, V10, P2107; Chistiakov DA, 2011, DIABETES METAB SYND, V5, P165, DOI 10.1016/j.dsx.2012.02.025; Du JH, 2014, INT J OPHTHALMOL-CHI, V7, P968, DOI 10.3980/j.issn.2222-3959.2014.06.10; Fletcher EL, 2011, PROG MOL BIOL TRANSL, V100, P211, DOI 10.1016/B978-0-12-384878-9.00006-6; Genest J, 2010, CAN J CARDIOL, V26, p41A, DOI 10.1016/S0828-282X(10)71061-8; Gerl VB, 2002, INVEST OPHTH VIS SCI, V43, P1104; Gholamhossein Yaghoobi, 2014, Korean J Ophthalmol, V28, P373, DOI 10.3341/kjo.2014.28.5.373; Gustavsson C, 2008, J DIABETES COMPLICAT, V22, P309, DOI 10.1016/j.jdiacomp.2007.03.001; Heng LZ, 2013, DIABETIC MED, V30, P640, DOI 10.1111/dme.12089; Huang EJ, 2006, CLIN CHIM ACTA, V366, P293, DOI 10.1016/j.cca.2005.10.025; Izuora KE, 2005, DIABETES CARE, V28, P714, DOI 10.2337/diacare.28.3.714; Jia Zhao-tong, 2009, Zhonghua Yan Ke Za Zhi, V45, P805; Kang ES, 2005, DIABETES RES CLIN PR, V69, P151, DOI 10.1016/j.diabres.2004.11.014; Kulkarni RP, 2013, INT J PHARM BIO SCI, V4, pB1306; Kushner I, 2010, ARTHRIT CARE RES, V62, P442, DOI 10.1002/acr.20052; Lim LS, 2010, INVEST OPHTH VIS SCI, V51, P4458, DOI 10.1167/iovs.09-4939; Mastej K, 2008, ACTA DIABETOL, V45, P183, DOI 10.1007/s00592-008-0040-0; Mysliwiec M, 2008, DIABETES RES CLIN PR, V79, P141, DOI 10.1016/j.diabres.2007.07.011; Mysliwska J, 2012, CYTOKINE, V60, P309, DOI 10.1016/j.cyto.2012.03.010; NAYAK BS, 2006, J INFLAMM-LOND, V3, P1; Nowak M, 2010, CLIN EXP MED, V10, P185, DOI 10.1007/s10238-009-0084-7; Rangasamy S, 2012, MIDDLE EAST AFR J OP, V19, P52, DOI 10.4103/0974-9233.92116; Schram MT, 2005, DIABETOLOGIA, V48, P370, DOI 10.1007/s00125-004-1628-8; Sen D, 2015, DIABETES METAB SYND, V9, P28, DOI 10.1016/j.dsx.2014.05.004; Sharma RK, 2009, MOL VIS, V15, P60; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; Tomic M, 2013, MEDIAT INFLAMM, V2013, P1; Tsunoda K, 2005, J DIABETES COMPLICAT, V19, P123, DOI 10.1016/j.jdiacomp.2004.08.001; Wang XL, 2010, INT J OPHTHAL, V10, P1699; Wu L, 2013, WORLD J DIABETES, V4, P290, DOI 10.4239/wjd.v4.i6.290; Yang HS, 2014, INVEST OPHTH VIS SCI, V55, P5989, DOI 10.1167/iovs.14-14864; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909; Zhou YD, 2014, INT J CLIN EXP MED, V7, P4544; Zorena K, 2007, MEDIAT INFLAMM, V2007, P92; Zorena Katarzyna, 2007, Central European Journal of Immunology, V32, P124	40	34	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144406	10.1371/journal.pone.0144406	http://dx.doi.org/10.1371/journal.pone.0144406			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636823	Green Published, Green Submitted, gold			2022-12-27	WOS:000366143800090
J	Szulcek, R; van Bezu, J; Boonstra, J; van Loon, JJWA; Amerongen, GPV				Szulcek, Robert; van Bezu, Jan; Boonstra, Johannes; van Loon, Jack J. W. A.; Amerongen, Geerten P. van Nieuw			Transient Intervals of Hyper-Gravity Enhance Endothelial Barrier Integrity: Impact of Mechanical and Gravitational Forces Measured Electrically	PLOS ONE			English	Article							CELL RESPONSE; SHEAR-STRESS; MICROGRAVITY; GROWTH; CYTOSKELETON; IMPEDANCE; JUNCTIONS	Background Endothelial cells (EC) guard vascular functions by forming a dynamic barrier throughout the vascular system that sensitively adapts to 'classical' biomechanical forces, such as fluid shear stress and hydrostatic pressure. Alterations in gravitational forces might similarly affect EC integrity, but remain insufficiently studied. Methods In an unique approach, we utilized Electric Cell-substrate Impedance Sensing (ECIS) in the gravity-simulators at the European Space Agency (ESA) to study dynamic responses of human EC to simulated micro-and hyper-gravity as well as to classical forces. Results Short intervals of micro-or hyper-gravity evoked distinct endothelial responses. Stimulated micro-gravity led to decreased endothelial barrier integrity, whereas hyper-gravity caused sustained barrier enhancement by rapid improvement of cell-cell integrity, evidenced by a significant junctional accumulation of VE-cadherin (p = 0.011), significant enforcement of peripheral F-actin (p = 0.008) and accompanied by a slower enhancement of cell-matrix interactions. The hyper-gravity triggered EC responses were force dependent and nitricoxide (NO) mediated showing a maximal resistance increase of 29.2 +/- 4.8 ohms at 2g and 60.9 +/- 6.2 ohms at 4g vs. baseline values that was significantly suppressed by NO blockage (p = 0.011). Conclusion In conclusion, short-term application of hyper-gravity caused a sustained improvement of endothelial barrier integrity, whereas simulated micro-gravity weakened the endothelium. In clear contrast, classical forces of shear stress and hydrostatic pressure induced either short-lived or no changes to the EC barrier. Here, ECIS has proven a powerful tool to characterize subtle and distinct EC gravity-responses due to its high temporal resolution, wherefore ECIS has a great potential for the study of gravity-responses such as in real space flights providing quantitative assessment of a variety of cell biological characteristics of any adherent growing cell type in an automated and continuous fashion.	[Szulcek, Robert; van Bezu, Jan; Amerongen, Geerten P. van Nieuw] Vrije Univ Amsterdam, Med Ctr, Inst Cardiovasc Res ICaR VU, Dept Physiol, Amsterdam, Netherlands; [Szulcek, Robert] Vrije Univ Amsterdam, Med Ctr, Inst Cardiovasc Res ICaR VU, Dept Pulmonol, Amsterdam, Netherlands; [Boonstra, Johannes] Univ Utrecht, Fac Sci, Dept Cellular Architecture & Dynam, Utrecht, Netherlands; [van Loon, Jack J. W. A.] European Space Agcy, Estec, DESC, TEC MMG Lab, NL-2200 AG Noordwijk, Netherlands; [van Loon, Jack J. W. A.] Vrije Univ Amsterdam, Med Ctr, Dept Oral & Maxillofacial Surg Oral Pathol, Amsterdam, Netherlands; [van Loon, Jack J. W. A.] Acad Ctr Dent ACTA, Dept Oral Cell Biol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Utrecht University; European Space Agency; Vrije Universiteit Amsterdam; Academic Center for Dentistry Amsterdam; Vrije Universiteit Amsterdam	Szulcek, R (corresponding author), Vrije Univ Amsterdam, Med Ctr, Inst Cardiovasc Res ICaR VU, Dept Physiol, Amsterdam, Netherlands.	r.szulcek@vumc.nl	Szulcek, Robert/D-7229-2013	Szulcek, Robert/0000-0003-0450-7338; van Loon, Jack/0000-0001-9051-6016	Dutch Lung Foundation; Netherlands CardioVascular Research Initiative [2012-08]; Dutch Heart Foundation; Dutch Federation of University Medical Centers; Netherlands Organization for Health Research and Development; Royal Netherlands Academy of Sciences; Netherlands Heart Foundation [2011T072]; Netherlands Space Office (NSO) NWO [MG-057]	Dutch Lung Foundation; Netherlands CardioVascular Research Initiative; Dutch Heart Foundation(Netherlands Heart Foundation); Dutch Federation of University Medical Centers; Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Royal Netherlands Academy of Sciences; Netherlands Heart Foundation(Netherlands Heart Foundation); Netherlands Space Office (NSO) NWO	We acknowledge the support from the Dutch Lung Foundation, Netherlands CardioVascular Research Initiative under grant number 2012-08 awarded to the Phaedra consortium (www.phaedraresearch.nl), the Dutch Heart Foundation, Dutch Federation of University Medical Centers, The Netherlands Organization for Health Research and Development and the Royal Netherlands Academy of Sciences. GPvNA was supported by The Netherlands Heart Foundation grant 2011T072. JJWAvL was supported by Netherlands Space Office (NSO) NWO grant MG-057. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado-Azevedo J, 2014, CELL TISSUE RES, V355, P557, DOI 10.1007/s00441-014-1828-6; Antonutto G, 2003, EUR J APPL PHYSIOL, V90, P283, DOI 10.1007/s00421-003-0884-5; Biolo G, 2003, CURR OPIN CLIN NUTR, V6, P31, DOI 10.1097/00075197-200301000-00006; Brennan LM, 2012, TOXICOL IN VITRO, V26, P736, DOI 10.1016/j.tiv.2012.03.010; Carlsson SIM, 2003, BBA-MOL CELL RES, V1642, P173, DOI 10.1016/j.bbamcr.2003.08.003; Chien S, 2007, AM J PHYSIOL-HEART C, V292, pH1209, DOI 10.1152/ajpheart.01047.2006; Cunningham KS, 2005, LAB INVEST, V85, P9, DOI 10.1038/labinvest.3700215; Curtis TM, 2009, LAB CHIP, V9, P2176, DOI [10.1039/b901314h, 10.1039/b901314b]; Davidson JM, 1999, FASEB J, V13, P325, DOI 10.1096/fasebj.13.2.325; DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Dejana E, 2013, J CELL SCI, V126, P2545, DOI 10.1242/jcs.124529; DePaola N, 2001, ANN BIOMED ENG, V29, P648, DOI 10.1114/1.1385811; Farahani RM, 2008, INT WOUND J, V5, P552, DOI 10.1111/j.1742-481X.2008.00438.x; Fomina G A, 2009, Aviakosm Ekolog Med, V43, P11; GIAEVER I, 1991, P NATL ACAD SCI USA, V88, P7896, DOI 10.1073/pnas.88.17.7896; Goldenberg NM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002011; Grenon SM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01494; Gulino-Debrac D, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.24180; Herranz R, 2013, ASTROBIOLOGY, V13, P1, DOI 10.1089/ast.2012.0876; Infanger M, 2006, APOPTOSIS, V11, P749, DOI 10.1007/s10495-006-5697-7; Infanger M, 2007, J CELL BIOCHEM, V101, P1439, DOI 10.1002/jcb.21261; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Koyama T, 2009, PFLUG ARCH EUR J PHY, V457, P711, DOI 10.1007/s00424-008-0544-z; Leach CS, 1996, J APPL PHYSIOL, V81, P105, DOI 10.1152/jappl.1996.81.1.105; Lo CM, 1999, EXP CELL RES, V250, P576, DOI 10.1006/excr.1999.4538; Mariotti M, 2008, J CELL BIOCHEM, V104, P129, DOI 10.1002/jcb.21605; POLLARD EC, 1965, J THEOR BIOL, V8, P113, DOI 10.1016/0022-5193(65)90097-4; Spisni E, 2003, J CELL PHYSIOL, V197, P198, DOI 10.1002/jcp.10344; Szulcek R, 2014, JOVE-J VIS EXP, DOI 10.3791/51300; Szulcek R, 2013, CARDIOVASC RES, V99, P471, DOI 10.1093/cvr/cvt075; Todd P, 1989, ASGSB Bull, V2, P95; Todd P, 1977, BIOPROCESSING SPACE, P103; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; van Loon JJWA, 2007, ADV SPACE RES, V39, P1161, DOI 10.1016/j.asr.2007.02.016; van Loon JJWA, 2003, J BIOMECH ENG-T ASME, V125, P342, DOI 10.1115/1.1574521; Vanloon J, 2008, P LIF SPAC LIF EARTH, P663; Versari S, 2007, BBA-MOL CELL RES, V1773, P1645, DOI 10.1016/j.bbamcr.2007.05.014; Versari S, 2013, FASEB J, V27, P4466, DOI 10.1096/fj.13-229195; Voelkel NF, 2012, EUR RESPIR J, V40, P1555, DOI 10.1183/09031936.00046612; Vorselen D, 2014, FASEB J, V28, P536, DOI 10.1096/fj.13-236356; Yoshikawa N, 1997, CELL CALCIUM, V22, P189, DOI 10.1016/S0143-4160(97)90012-9; Zhang Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/413708	44	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144269	10.1371/journal.pone.0144269	http://dx.doi.org/10.1371/journal.pone.0144269			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26637177	Green Submitted, Green Published, gold			2022-12-27	WOS:000366143800065
J	Conrad, MO; Gadhoke, B; Scheidt, RA; Schmit, BD				Conrad, Megan O.; Gadhoke, Bani; Scheidt, Robert A.; Schmit, Brian D.			Effect of Tendon Vibration on Hemiparetic Arm Stability in Unstable Workspaces	PLOS ONE			English	Article							SOMATOSENSORY STIMULATION; MUSCLE VIBRATION; MOTOR CONTROL; PROPRIOCEPTIVE CONTRIBUTIONS; REACHING MOVEMENTS; IMPEDANCE CONTROL; FINAL POSITION; SENSORY LOSS; STROKE; ADAPTATION	Sensory stimulation of wrist musculature can enhance stability in the proximal arm and may be a useful therapy aimed at improving arm control post-stroke. Specifically, our prior research indicates tendon vibration can enhance stability during point-to-point arm movements and in tracking tasks. The goal of the present study was to investigate the influence of forearm tendon vibration on endpoint stability, measured at the hand, immediately following forward arm movements in an unstable environment. Both proximal and distal workspaces were tested. Ten hemiparetic stroke subjects and 5 healthy controls made forward arm movements while grasping the handle of a two-joint robotic arm. At the end of each movement, the robot applied destabilizing forces. During some trials, 70 Hz vibration was applied to the forearm flexor muscle tendons. 70 Hz was used as the stimulus frequency as it lies within the range of optimal frequencies that activate the muscle spindles at the highest response rate. Endpoint position, velocity, muscle activity and grip force data were compared before, during and after vibration. Stability at the endpoint was quantified as the magnitude of oscillation about the target position, calculated from the power of the tangential velocity data. Prior to vibration, subjects produced unstable, oscillating hand movements about the target location due to the applied force field. Stability increased during vibration, as evidenced by decreased oscillation in hand tangential velocity.	[Conrad, Megan O.] Oakland Univ, Dept Ind & Syst Engn, Rochester, MI 48063 USA; [Gadhoke, Bani; Scheidt, Robert A.; Schmit, Brian D.] Marquette Univ, Dept Biomed Engn, Milwaukee, WI 53233 USA	Oakland University; Marquette University	Conrad, MO (corresponding author), Oakland Univ, Dept Ind & Syst Engn, Rochester, MI 48063 USA.	conrad@oakland.edu	Scheidt, Robert A/F-5047-2010	Scheidt, Robert A/0000-0002-2024-5051; Conrad, Megan/0000-0002-8180-9789	NIH [R01-NS052509]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052509] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded through a NIH Research Grant R01-NS052509 to BDS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander CM, 2003, EXP BRAIN RES, V148, P277, DOI 10.1007/s00221-002-1256-9; Bernier P, 1998, J NEUROPHYSIOL, V98, P1815; Burdet E, 2004, P ANN INT IEEE EMBS, V26, P4491; Burdet E, 2001, NATURE, V414, P446, DOI 10.1038/35106566; Canning CG, 1999, ARCH PHYS MED REHAB, V80, P66, DOI 10.1016/S0003-9993(99)90309-X; CAREY LM, 1993, ARCH PHYS MED REHAB, V74, P602, DOI 10.1016/0003-9993(93)90158-7; CAVALLARI P, 1989, EXP BRAIN RES, V78, P465; Celnik P, 2007, ARCH PHYS MED REHAB, V88, P1369, DOI 10.1016/j.apmr.2007.08.001; Conforto AB, 2007, J NEUROL, V254, P333, DOI 10.1007/s00415-006-0364-z; Connell LA, 2008, CLIN REHABIL, V22, P758, DOI 10.1177/0269215508090674; Conrad MO, 2011, J NEUROPHYSIOL, V106, P1480, DOI 10.1152/jn.00404.2010; Conrad MO, 2011, NEUROREHAB NEURAL RE, V25, P61, DOI 10.1177/1545968310378507; Conrad Megan O, 2009, Biomed Sci Instrum, V45, P286; CORDO P, 1995, J NEUROPHYSIOL, V74, P1675, DOI 10.1152/jn.1995.74.4.1675; Dechaumont-Palacin S, 2008, NEUROREHAB NEURAL RE, V22, P154, DOI 10.1177/1545968307307118; DEWALD JPA, 1995, BRAIN, V118, P495, DOI 10.1093/brain/118.2.495; Franklin DW, 2004, J NEUROPHYSIOL, V92, P3097, DOI 10.1152/jn.00364.2004; Franklin DW, 2003, J NEUROPHYSIOL, V90, P3270, DOI 10.1152/jn.01112.2002; Franklin DW, 2003, EXP BRAIN RES, V152, P211, DOI 10.1007/s00221-003-1540-3; Franklin DW, 2003, EXP BRAIN RES, V151, P145, DOI 10.1007/s00221-003-1443-3; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; GHEZ C, 1995, J NEUROPHYSIOL, V73, P361, DOI 10.1152/jn.1995.73.1.361; GORDON J, 1995, J NEUROPHYSIOL, V73, P347, DOI 10.1152/jn.1995.73.1.347; GRACIES JM, 1991, J PHYSIOL-LONDON, V434, P151, DOI 10.1113/jphysiol.1991.sp018463; Graziano MSA, 1999, P NATL ACAD SCI USA, V96, P10418, DOI 10.1073/pnas.96.18.10418; HAGBARTH K. E., 1966, BRAIN RES, V2, P201, DOI 10.1016/0006-8993(66)90029-1; Hasan Z, 2005, J MOTOR BEHAV, V37, P484, DOI 10.3200/JMBR.37.6.484-493; Hay L, 1996, EXP BRAIN RES, V108, P129; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Judkins T, 2014, J NEUROPHYSIOL, V111, P868, DOI 10.1152/jn.00314.2012; Kaelin-Lang A, 2002, J PHYSIOL-LONDON, V540, P623, DOI 10.1113/jphysiol.2001.012801; Kamper DG, 2001, ANN BIOMED ENG, V29, P1122, DOI 10.1114/1.1424918; KATZ RT, 1989, ARCH PHYS MED REHAB, V70, P144; Kossev A, 1999, MUSCLE NERVE, V22, P946, DOI 10.1002/(SICI)1097-4598(199907)22:7<946::AID-MUS22>3.0.CO;2-O; LACQUANITI F, 1993, J NEUROPHYSIOL, V69, P1443, DOI 10.1152/jn.1993.69.5.1443; McCrea PH, 2005, J NEUROPHYSIOL, V94, P2999, DOI 10.1152/jn.00732.2004; MILNER TE, 1993, EXP BRAIN RES, V94, P522; Milner TE, 1998, EXP BRAIN RES, V122, P309, DOI 10.1007/s002210050519; Naito E, 1999, J NEUROSCI, V19, P6134, DOI 10.1523/JNEUROSCI.19-14-06134.1999; Osu R, 2003, J NEUROPHYSIOL, V90, P3255, DOI 10.1152/jn.00073.2003; Perreault EJ, 2001, EXP BRAIN RES, V141, P312, DOI 10.1007/s002210100880; Priplata AA, 2006, ANN NEUROL, V59, P4, DOI 10.1002/ana.20670; Priplata AA, 2003, LANCET, V362, P1123, DOI 10.1016/S0140-6736(03)14470-4; Radovanovic S, 2002, EXP BRAIN RES, V143, P276, DOI 10.1007/s00221-001-0994-4; Ridding MC, 2000, EXP BRAIN RES, V131, P135, DOI 10.1007/s002219900269; ROLL JP, 1989, EXP BRAIN RES, V76, P213; Romaiguere P, 2003, COGNITIVE BRAIN RES, V16, P74, DOI 10.1016/S0926-6410(02)00221-5; ROTHWELL JC, 1982, BRAIN, V105, P515, DOI 10.1093/brain/105.3.515; SAINBURG RL, 1993, J NEUROPHYSIOL, V70, P2136, DOI 10.1152/jn.1993.70.5.2136; SANES JN, 1985, HUM NEUROBIOL, V4, P101; Sangani SG, 2007, MUSCLE NERVE, V36, P694, DOI 10.1002/mus.20852; Sarlegna FR, 2007, EXP BRAIN RES, V176, P267, DOI 10.1007/s00221-006-0613-5; Scheidt RA, 2001, J NEUROPHYSIOL, V86, P971, DOI 10.1152/jn.2001.86.2.971; Scheidt RA, 2007, J NEUROPHYSIOL, V98, P3600, DOI 10.1152/jn.00121.2007; Scheidt RA, 2007, J NEUROPHYSIOL, V97, P2824, DOI 10.1152/jn.00870.2006; Scheidt RA, 2010, EXP BRAIN RES, V204, P239, DOI 10.1007/s00221-010-2308-1; Siggelkow S, 1999, MUSCLE NERVE, V22, P1544, DOI 10.1002/(SICI)1097-4598(199911)22:11<1544::AID-MUS9>3.3.CO;2-#; Smania N, 2003, ARCH PHYS MED REHAB, V84, P1692, DOI 10.1053/S0003-9993(03)00277-6; Smith L, 2005, J REHABIL RES DEV, V42, P787, DOI 10.1682/JRRD.2005.02.0041; Sober SJ, 2005, NAT NEUROSCI, V8, P490, DOI 10.1038/nn1427; Sober SJ, 2003, J NEUROSCI, V23, P6982, DOI 10.1523/JNEUROSCI.23-18-06982.2003; Srungboonmee KA, 2011, MARQUETTE U PUBILCAT; Sullivan JE, 2008, TOP STROKE REHABIL, V15, P200, DOI 10.1310/tsr1503-200; Trumbower RD, 2008, IEEE ENG MED BIO, P3558, DOI 10.1109/IEMBS.2008.4649974; Tyson SF, 2008, NEUROREHAB NEURAL RE, V22, P166, DOI 10.1177/1545968307305523; Westlake KP, 2005, PHYS THER, V27, P872; Wu CW, 2006, ARCH PHYS MED REHAB, V87, P351, DOI 10.1016/j.apmr.2005.11.019; Wu CWH, 2005, NEUROIMAGE, V27, P872, DOI 10.1016/j.neuroimage.2005.05.055	68	8	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144377	10.1371/journal.pone.0144377	http://dx.doi.org/10.1371/journal.pone.0144377			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633892	Green Published, Green Submitted, gold			2022-12-27	WOS:000366040000083
J	Dai, XX; Zhang, MQ; Lu, YJ; Miao, YL; Zhou, CY; Sun, SC; Xiong, B				Dai, Xiaoxin; Zhang, Mianqun; Lu, Yajuan; Miao, Yilong; Zhou, Changyin; Sun, Shaochen; Xiong, Bo			Melamine Impairs Female Fertility via Suppressing Protein Level of Juno in Mouse Eggs	PLOS ONE			English	Article							ZONA-PELLUCIDA; MAMMALIAN FERTILIZATION; MOLECULAR-BASIS; ASTACIN FAMILY; FETUIN-B; SPERM; FUSION; OOCYTE; IZUMO; MICE	Melamine is an organic nitrogenous compound widely used as an industrial chemical, and it has been recently reported by us that melamine has a toxic effect on the female reproductive system in mice, and renders females subfertile; the molecular basis, however, has not been adequately assessed. In the present study, we explore the underlying mechanism regarding how melamine compromises fertility in the mouse. The data showed that melamine exposure significantly impaired the fertilization capability of the egg during in vitro fertilization. To further figure out the cause, we analyzed ovastacin localization and protein level, the sperm binding ability of zona pellucida, and ZP2 cleavage status in unfertilized eggs from melamine fed mice, and no obvious differences were found between control and treatment groups. However, the protein level of Juno on the egg plasma membrane in the high-dose feeding group indeed significantly decreased compared to the control group. Thus, these data suggest that melamine compromises female fertility via suppressing Juno protein level on the egg membrane.	[Dai, Xiaoxin; Zhang, Mianqun; Lu, Yajuan; Miao, Yilong; Zhou, Changyin; Sun, Shaochen; Xiong, Bo] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing 20095, Jiangsu, Peoples R China	Nanjing Agricultural University	Xiong, B (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing 20095, Jiangsu, Peoples R China.	xiongbo@njau.edu.cn			Natural Science Foundation of Jiangsu Province [BK20150677]; National Natural Science Foundation [31571545]	Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was funded by BK20150677 (www.jstd.gov.cn), Natural Science Foundation of Jiangsu Province, to BX; and 31571545 (www.nsfc.gov.cn), National Natural Science Foundation, to BX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfieri JA, 2003, J CELL SCI, V116, P2149, DOI 10.1242/jcs.00430; Avella MA, 2013, MOL HUM REPROD, V19, P279, DOI 10.1093/molehr/gat004; Bianchi E, 2014, CELL CYCLE, V13, P2019, DOI 10.4161/cc.29461; Bianchi E, 2014, NATURE, V508, P483, DOI 10.1038/nature13203; BLEIL JD, 1981, DEV BIOL, V86, P189, DOI 10.1016/0012-1606(81)90329-8; BOCK M, 1957, BRIT J PHARM CHEMOTH, V12, P1; BOND JS, 1995, PROTEIN SCI, V4, P1247, DOI 10.1002/pro.5560040701; Burkart AD, 2012, J CELL BIOL, V197, P37, DOI 10.1083/jcb.201112094; Clark GF, 2011, REPRODUCTION, V142, P377, DOI 10.1530/REP-11-0118; Cook HA, 2005, ELECTROPHORESIS, V26, P1576, DOI 10.1002/elps.200410058; Coonrod SA, 1999, DEV BIOL, V207, P334, DOI 10.1006/dbio.1998.9161; Dietzel E, 2013, DEV CELL, V25, P106, DOI 10.1016/j.devcel.2013.03.001; Duan X, 2015, HUM REPROD, V30, P1643, DOI 10.1093/humrep/dev091; DUMERMUTH E, 1991, J BIOL CHEM, V266, P21381; Gupta SK, 2012, CELL TISSUE RES, V349, P665, DOI 10.1007/s00441-011-1319-y; Hau AKC, 2009, J AM SOC NEPHROL, V20, P245, DOI 10.1681/ASN.2008101065; Ingelfinger JR, 2008, NEW ENGL J MED, V359, P2745, DOI 10.1056/NEJMp0808410; Inoue N, 2005, NATURE, V434, P234, DOI 10.1038/nature03362; Ohnami N, 2012, BIOL OPEN, V1, P640, DOI 10.1242/bio.20121420; Skinner CG, 2010, J MED TOXICOL, V6, P50, DOI 10.1007/s13181-010-0038-1; Stocker W, 2014, BIOL CHEM, V395, P1195, DOI 10.1515/hsz-2014-0189; Wassarman PA, 2004, EUR J OBSTET GYN R B, V115, pS57, DOI 10.1016/j.ejogrb.2004.01.025; Wassarman PM, 1999, CELL, V96, P175, DOI 10.1016/S0092-8674(00)80558-9; Wassarman PM, 2001, NAT CELL BIOL, V3, pE59, DOI 10.1038/35055178	24	6	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144248	10.1371/journal.pone.0144248	http://dx.doi.org/10.1371/journal.pone.0144248			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633308	Green Submitted, gold, Green Published			2022-12-27	WOS:000366040000073
J	de Souza, DA; Borges, AC; Santana, AC; Oliver, C; Jamur, MC				de Souza Junior, Devandir Antonio; Borges, Antonio Carlos; Santana, Ana Carolina; Oliver, Constance; Jamur, Maria Celia			Mast Cell Proteases 6 and 7 Stimulate Angiogenesis by Inducing Endothelial Cells to Release Angiogenic Factors	PLOS ONE			English	Article							IN-VITRO; TRYPTASE; EXPRESSION; GROWTH; PROLIFERATION; INHIBITION; INVOLVEMENT; MECHANISMS; MIGRATION; SURVIVAL	Mast cell proteases are thought to be involved with tumor progression and neo-vascularization. However, their exact role is still unclear. The present study was undertaken to further elucidate the function of specific subtypes of recombinant mouse mast cell proteases (rmMCP-6 and 7) in neo-vascularization. SVEC4-10 cells were cultured on Geltrex (R) with either rmMCP-6 or 7 and tube formation was analyzed by fluorescence microscopy and scanning electron microscopy. Additionally, the capacity of these proteases to induce the release of angiogenic factors and pro and anti-angiogenic proteins was analyzed. Both rmMCP-6 and 7 were able to stimulate tube formation. Scanning electron microscopy showed that incubation with the proteases induced SVEC4-10 cells to invade the gel matrix. However, the expression and activity of metalloproteases were not altered by incubation with the mast cell proteases. Furthermore, rmMCP-6 and rmMCP-7 were able to induce the differential release of angiogenic factors from the SVEC4-10 cells. rmMCP-7 was more efficient in stimulating tube formation and release of angiogenic factors than rmMCP-6. These results suggest that the subtypes of proteases released by mast cells may influence endothelial cells during in vivo neo-vascularization.	[de Souza Junior, Devandir Antonio; Borges, Antonio Carlos; Santana, Ana Carolina; Oliver, Constance; Jamur, Maria Celia] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Cell & Mol Biol & Pathogen Bioagents, Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo	Jamur, MC (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Cell & Mol Biol & Pathogen Bioagents, Ribeirao Preto, SP, Brazil.	mjamur@fmrp.usp.br	Jamur, Maria Celia/L-5520-2016	Jamur, Maria Celia/0000-0001-7065-8543; Borges, Antonio Carlos/0000-0003-0023-6403	FAPESP (Fundacao de Amparo e Pesquisa do Estado de Sao Paulo); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [150022/2012-3]; FAEPA (Fundacao de Apoio ao Ensino, Pesquisa e Assistencia);  [11/10363-8];  [09/54013-0]	FAPESP (Fundacao de Amparo e Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAEPA (Fundacao de Apoio ao Ensino, Pesquisa e Assistencia); ; 	Funding was provided by FAPESP (Fundacao de Amparo e Pesquisa do Estado de Sao Paulo, http://www.fapesp.br/); Post Doctoral Fellowship 11/10363-8 to DASJ and Equipment Grant 09/54013-0 to MCJ; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, http://www.cnpq.br) Fellowship to MCJ and ACB Post Doctoral Fellowship 150022/2012-3, FAEPA (Fundacao de Apoio ao Ensino, Pesquisa e Assistencia, http://www.faepa.br) Grant to MCJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi A, 2003, CANCER RES, V63, P8890; Akers IA, 2000, AM J PHYSIOL-LUNG C, V278, pL193, DOI 10.1152/ajplung.2000.278.1.L193; Ammendola M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/154702; Askou AL, 2015, MOL THER-METH CLIN D, V2, DOI 10.1038/mtm.2014.64; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Bernard A, 2009, J BIOL CHEM, V284, P10480, DOI 10.1074/jbc.M809259200; Blair RJ, 1997, J CLIN INVEST, V99, P2691, DOI 10.1172/JCI119458; Blanco R, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a006569; Bles N, 2010, BLOOD, V116, P3219, DOI 10.1182/blood-2010-01-265611; Bodnar RJ, 2006, CIRC RES, V98, P617, DOI 10.1161/01.RES.0000209968.66606.10; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Cates AM, 2015, RHEUMATOLOGY, V54, P1114, DOI 10.1093/rheumatology/keu431; Ch'ng S, 2006, MODERN PATHOL, V19, P149, DOI 10.1038/modpathol.3800474; Checchin D, 2006, INVEST OPHTH VIS SCI, V47, P3595, DOI 10.1167/iovs.05-1522; Compton SJ, 1998, J IMMUNOL, V161, P1939; Conway EM, 2001, CARDIOVASC RES, V49, P507, DOI 10.1016/S0008-6363(00)00281-9; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; Crivellato E, 2008, CANCER LETT, V269, P1, DOI 10.1016/j.canlet.2008.03.031; Cui Y, 2014, J IMMUNOL, V193, P4783, DOI 10.4049/jimmunol.1302947; Dace DS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003381; de Souza DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040790; de Souza DA, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/142359; Dhanabal M, 1999, J BIOL CHEM, V274, P11721, DOI 10.1074/jbc.274.17.11721; Distler JHW, 2003, Q J NUCL MED, V47, P149; Dyduch G, 2012, POL J PATHOL, V63, P1; Fantin A, 2010, BLOOD, V116, P829, DOI 10.1182/blood-2009-12-257832; Fu YN, 2011, J HISTOCHEM CYTOCHEM, V59, P463, DOI 10.1369/0022155411401748; Gao XW, 2008, ACTA BIOCH BIOPH SIN, V40, P619, DOI 10.1111/j.1745-7270.2008.00442.x; Gellhaus A, 2006, MOL HUM REPROD, V12, P389, DOI 10.1093/molehr/gal044; Gillis P, 1999, J CELL SCI, V112, P2049; Granata R, 2004, FASEB J, V18, P1456, DOI 10.1096/fj.04-1618fje; GRUBER BL, 1989, J CLIN INVEST, V84, P1657, DOI 10.1172/JCI114344; Grzeszkiewicz TM, 2002, ENDOCRINOLOGY, V143, P1441, DOI 10.1210/en.143.4.1441; Gurish MF, 2012, IMMUNITY, V37, P25, DOI 10.1016/j.immuni.2012.07.003; Hallgren J, 2014, EUR J IMMUNOL, V44, P33, DOI 10.1002/eji.201344262; Huang CF, 1997, J BIOL CHEM, V272, P31885, DOI 10.1074/jbc.272.50.31885; Huang CF, 1998, J IMMUNOL, V160, P1910; Jamur Maria Celia, 2011, Front Biosci (Schol Ed), V3, P1390; Jamur MC, 2005, BLOOD, V105, P4282, DOI 10.1182/blood-2004-02-0756; Kato M, 2003, BIOCHEM BIOPH RES CO, V301, P1109, DOI 10.1016/S0006-291X(03)00093-7; Khoo CP, 2011, TISSUE ENG PART C-ME, V17, P895, DOI [10.1089/ten.tec.2011.0150, 10.1089/ten.TEC.2011.0150]; Kijowski J, 2001, STEM CELLS, V19, P453, DOI 10.1634/stemcells.19-5-453; Krishnaswamy Guha, 2006, Methods Mol Biol, V315, P13; Kuhnert F, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-20; Kumar S, 2012, AM J PATHOL, V181, P1056, DOI 10.1016/j.ajpath.2012.05.022; Kume T, 2009, VASC CELL, V1, DOI 10.1186/2040-2384-1-8; Lawler J, 2002, J CELL MOL MED, V6, P1, DOI 10.1111/j.1582-4934.2002.tb00307.x; Leber TM, 1997, ANAL BIOCHEM, V249, P24, DOI 10.1006/abio.1997.2170; Lee WS, 2015, AM J CANCER RES, V5, P101; Lieu C, 2011, CLIN CANCER RES, V17, P6130, DOI 10.1158/1078-0432.CCR-11-0659; Lin CG, 2003, J BIOL CHEM, V278, P24200, DOI 10.1074/jbc.M302028200; Liu B, 2007, ONCOGENE, V26, P1811, DOI 10.1038/sj.onc.1209977; Liu MG, 2014, MOL MED REP, V10, P2177, DOI 10.3892/mmr.2014.2457; Lu C, 2005, CHINESE MED J-PEKING, V118, P1900; Lundequist A, 2011, CELL MOL LIFE SCI, V68, P965, DOI 10.1007/s00018-010-0587-0; Ma J, 2007, BLOOD, V109, P987, DOI 10.1182/blood-2006-07-036400; Maciel Thiago T, 2015, F1000Prime Rep, V7, P09, DOI 10.12703/P7-09; Magalhaes MAO, 2011, J CELL BIOL, V195, P903, DOI 10.1083/jcb.201103045; Maity G, 2014, SCI REP-UK, V4, DOI 10.1038/srep04995; Mangia A, 2011, HISTOPATHOLOGY, V58, P1096, DOI 10.1111/j.1365-2559.2011.03842.x; da Silva EZM, 2014, J HISTOCHEM CYTOCHEM, V62, P698, DOI 10.1369/0022155414545334; Marichal T, 2013, CANCER IMMUNOL RES, V1, P269, DOI 10.1158/2326-6066.CIR-13-0119; Marinaccio C, 2014, LEUKEMIA RES, V38, P1374, DOI 10.1016/j.leukres.2014.09.007; McNeil HP, 2008, ARTHRITIS RHEUM-US, V58, P2338, DOI 10.1002/art.23639; Marchini-Alves CMM, 2012, J HISTOCHEM CYTOCHEM, V60, P386, DOI 10.1369/0022155412438886; Nakatsu MN, 2003, LAB INVEST, V83, P1873, DOI 10.1097/01.LAB.0000107160.81875.33; Neufeld G, 2001, Surg Oncol Clin N Am, V10, P339; Neufeld G, 2006, CANCER METAST REV, V25, P373, DOI 10.1007/s10555-006-9011-5; Niu JL, 2013, J PHARMACOL EXP THER, V347, P288, DOI 10.1124/jpet.113.207316; Olivera Ana, 2014, Methods Mol Biol, V1192, P3, DOI 10.1007/978-1-4939-1173-8_1; Pappa CA, 2015, CANCER INVEST, V33, P137, DOI 10.3109/07357907.2015.1008639; Pastorello EA, 2014, INT ARCH ALLERGY IMM, V164, P97, DOI 10.1159/000360164; Pejler G, 2007, ADV IMMUNOL, V95, P167, DOI 10.1016/S0065-2776(07)95006-3; Petit I, 2007, TRENDS IMMUNOL, V28, P299, DOI 10.1016/j.it.2007.05.007; Reber LL, 2015, MUCOSAL IMMUNOL, V8, P444, DOI 10.1038/mi.2014.131; Ribatti D, 2004, CLIN EXP ALLERGY, V34, P1660, DOI 10.1111/j.1365-2222.2004.02104.x; Ribatti D, 2015, EXP CELL RES, V332, P157, DOI 10.1016/j.yexcr.2014.11.014; Ribatti D, 2012, BBA-MOL BASIS DIS, V1822, P2, DOI 10.1016/j.bbadis.2010.11.010; Ribatti D, 2011, INT J DEV BIOL, V55, P99, DOI 10.1387/ijdb.103138dr; Rymo SF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015846; SCHWARTZ LB, 1987, AM REV RESPIR DIS, V135, P1186; Shin K, 2009, J IMMUNOL, V182, P647, DOI 10.4049/jimmunol.182.1.647; Singer J, 2014, ALLERGY, V69, P137, DOI 10.1111/all.12276; Skovseth DK, 2005, BLOOD, V105, P1044, DOI 10.1182/blood-2004-03-1164; Subramanian M, 2014, J CELL BIOCHEM, V115, P1974, DOI 10.1002/jcb.24869; Szukiewicz D, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/437576; Tahir A, 2013, J CANCER RES THER, V9, P387, DOI 10.4103/0973-1482.119311; Ullah E, 2013, J CANCER RES THER, V9, P701, DOI 10.4103/0973-1482.126487; Wedemeyer J, 2000, BRIT MED BULL, V56, P936, DOI 10.1258/0007142001903616; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Yang XH, 2012, J BIOL CHEM, V287, P6490, DOI 10.1074/jbc.M111.254631; Zhi XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060960	92	13	13	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144081	10.1371/journal.pone.0144081	http://dx.doi.org/10.1371/journal.pone.0144081			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633538	gold, Green Published, Green Submitted			2022-12-27	WOS:000366040000052
J	Feiss, M; Min, JY; Sultana, S; Patel, P; Sippy, J				Feiss, Michael; Min, Jea Young; Sultana, Sawsan; Patel, Priyal; Sippy, Jean			DNA Packaging Specificity of Bacteriophage N15 with an Excursion into the Genetics of a Cohesive End Mismatch	PLOS ONE			English	Article							INTEGRATION HOST FACTOR; TERMINASE BINDING-SITE; LAMBDA-DNA; ESCHERICHIA-COLI; VIRAL-DNA; PHAGE-LAMBDA; TAILED-BACTERIOPHAGES; NUCLEOPROTEIN COMPLEX; ANGSTROM RESOLUTION; PORTAL PROTEIN	During DNA replication by the lambda-like bacteriophages, immature concatemeric DNA is produced by rolling circle replication. The concatemers are processed into mature chromosomes with cohesive ends, and packaged into prohead shells, during virion assembly. Cohesive ends are generated by the viral enzyme terminase, which introduces staggered nicks at cos, an approx. 200 bp-long sequence containing subsites cosQ, cosN and cosB. Interactions of cos subsites of immature concatemeric DNA with terminase orchestrate DNA processing and packaging. To initiate DNA packaging, terminase interacts with cosB and nicks cosN. The cohesive ends of N15 DNA differ from those of lambda at 2/12 positions. Genetic experiments show that phages with chromosomes containing mismatched cohesive ends are functional. In at least some infections, the cohesive end mismatch persists through cyclization and replication, so that progeny phages of both allelic types are produced in the infected cell. N15 possesses an asymmetric packaging specificity: N15 DNA is not packaged by phages lambda or 21, but surprisingly, N15-specific terminase packages lambda DNA. Implications for genetic interactions among lambda-like bacteriophages are discussed.	[Feiss, Michael; Min, Jea Young; Sultana, Sawsan; Patel, Priyal; Sippy, Jean] Univ Iowa, Carver Coll Med, Dept Microbiol, Iowa City, IA 52242 USA	University of Iowa	Sippy, J (corresponding author), Univ Iowa, Carver Coll Med, Dept Microbiol, Iowa City, IA 52242 USA.	jean-sippy@uiowa.edu			National Science Foundation [MCB-0717620, MCB-1158495]; National Institutes of Health, United States awards [5R01GM088186, 5R01GM051611]; University of Iowa Department of Microbiology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088186, R01GM051611] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health, United States awards(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Iowa Department of Microbiology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by funding from National Science Foundation awards MCB-0717620 and MCB-1158495, the National Institutes of Health, United States awards 5R01GM088186 and 5R01GM051611 (www.nih.gov/), and the University of Iowa Department of Microbiology.; MF and JS dedicate this work to the late Erich W. Six, for decades our lively colleague and friend. Erich always liked a good phage yarn. This project was supported by funding from National Science Foundation awards MCB-0717620 and MCB-1158495, National Institutes of Health, United States awards 5R01GM088186 and 5R01GM051611 (www.nih.gov/), and the University of Iowa Department of Microbiology.	Agirrezabala X, 2005, J MOL BIOL, V347, P895, DOI 10.1016/j.jmb.2005.02.005; Al-Zahrani AS, 2009, J BIOL CHEM, V284, P24490, DOI 10.1074/jbc.M109.025007; Arber W., 1983, LAMBDA, P433; Baker ML, 2005, J VIROL, V79, P14967, DOI 10.1128/JVI.79.23.14967-14970.2005; BEAR SE, 1984, J VIROL, V52, P966, DOI 10.1128/JVI.52.3.966-972.1984; BECKER A, 1977, VIROLOGY, V78, P291, DOI 10.1016/0042-6822(77)90100-3; BECKER A, 1990, J BACTERIOL, V172, P2819, DOI 10.1128/jb.172.6.2819-2824.1990; Benini S, 2013, ACTA CRYSTALLOGR F, V69, P376, DOI 10.1107/S1744309113004399; Black LW, 2015, VIROLOGY; Buttner CR, 2012, P NATL ACAD SCI USA, V109, P811, DOI 10.1073/pnas.1110270109; Casjens SR, 2008, RES MICROBIOL, V159, P340, DOI 10.1016/j.resmic.2008.04.005; Casjens SR, 2011, NAT REV MICROBIOL, V9, P647, DOI 10.1038/nrmicro2632; Casjens SR, 2005, J BACTERIOL, V187, P1091, DOI 10.1128/JB.187.3.1091-1104.2005; Catalano C.E., 2005, VIRAL GENOME PACKAGI; CATALANO CE, 1995, MOL MICROBIOL, V16, P1075, DOI 10.1111/j.1365-2958.1995.tb02333.x; CHAI SH, 1995, J MOL BIOL, V252, P386, DOI 10.1006/jmbi.1995.0505; CUE D, 1993, P NATL ACAD SCI USA, V90, P9290, DOI 10.1073/pnas.90.20.9290; Cue D, 2001, J MOL BIOL, V311, P233, DOI 10.1006/jmbi.2001.4840; CUE D, 1992, J MOL BIOL, V228, P58, DOI 10.1016/0022-2836(92)90491-2; CUE D, 1992, J MOL BIOL, V228, P72, DOI 10.1016/0022-2836(92)90492-3; CUE D, 1993, J MOL BIOL, V234, P594, DOI 10.1006/jmbi.1993.1614; de Beer T, 2002, MOL CELL, V9, P981, DOI 10.1016/S1097-2765(02)00537-3; Dhar A, 2005, J MOL BIOL, V347, P71, DOI 10.1016/j.jmb.2004.12.041; DOKLAND T, 1993, J MOL BIOL, V233, P682, DOI 10.1006/jmbi.1993.1545; FEISS M, 1979, VIROLOGY, V92, P190, DOI 10.1016/0042-6822(79)90224-1; FEISS M, 1985, J MOL BIOL, V186, P759, DOI 10.1016/0022-2836(85)90395-X; Feiss M, 1981, BACTERIOPHAGE ASSEMB, P213; Feiss M, 2015, VIROLOGY, V482, P260, DOI 10.1016/j.virol.2015.03.027; Feiss M, 2010, GENETICS, V184, P43, DOI 10.1534/genetics.109.108548; FRACKMAN S, 1984, J MOL BIOL, V180, P283, DOI 10.1016/S0022-2836(84)80005-4; FRACKMAN S, 1985, J MOL BIOL, V183, P225, DOI 10.1016/0022-2836(85)90215-3; Furth M., 1983, LAMBDA 2, P145; Gao S, 2011, J BIOL CHEM, V286, P3944, DOI 10.1074/jbc.M110.196907; GRANSTON AE, 1988, MOL GEN GENET, V212, P149, DOI 10.1007/BF00322458; Hang JQ, 2001, BIOCHEMISTRY-US, V40, P13370, DOI 10.1021/bi011126r; Hendrix RW, 2000, TRENDS MICROBIOL, V8, P504, DOI 10.1016/S0966-842X(00)01863-1; HIGGINS RR, 1988, CELL, V54, P765, DOI 10.1016/S0092-8674(88)91021-5; HIGGINS RR, 1994, EMBO J, V13, P6152, DOI 10.1002/j.1460-2075.1994.tb06962.x; HIGGINS RR, 1994, EMBO J, V13, P6162, DOI 10.1002/j.1460-2075.1994.tb06963.x; Kosturko L., 1989, NUCLEIC ACIDS RES, V17, P329; Lander GC, 2008, STRUCTURE, V16, P1399, DOI 10.1016/j.str.2008.05.016; Leavitt JC, 2013, VIROLOGY, V440, P117, DOI 10.1016/j.virol.2013.02.023; Lebedev AA, 2007, EMBO J, V26, P1984, DOI 10.1038/sj.emboj.7601643; Little JW, 2010, CURR BIOL, V20, pR724, DOI 10.1016/j.cub.2010.06.028; Maluf NK, 2006, MOL MICROBIOL, V61, P1, DOI 10.1111/j.1365-2958.2006.05214.x; Maluf NK, 2006, BIOCHEMISTRY-US, V45, P15259, DOI 10.1021/bi0615036; MILLER G, 1988, MOL GEN GENET, V212, P157, DOI 10.1007/BF00322459; MURRAY K, 1975, NATURE, V254, P262, DOI 10.1038/254262a0; Nemecek D, 2007, J MOL BIOL, V374, P817, DOI 10.1016/j.jmb.2007.08.070; Newcomb WW, 1999, J VIROL, V73, P4239, DOI 10.1128/JVI.73.5.4239-4250.1999; Oliveira L, 2013, VIRUS RES, V173, P247, DOI 10.1016/j.virusres.2013.01.021; Ortega ME, 2006, BIOCHEMISTRY-US, V45, P5180, DOI 10.1021/bi052284b; PAL SK, 1988, J BACTERIOL, V172, P2819; Przech AJ, 2003, J VIROL, V77, P9613, DOI 10.1128/JVI.77.17.9613-9621.2003; Rao VB, 2008, ANN REV GENETICS ANN, P647; Rice PA, 1996, CELL, V87, P1295, DOI 10.1016/S0092-8674(00)81824-3; Rixon FJ, 2014, CURR OPIN VIROL, V5, P105, DOI 10.1016/j.coviro.2014.02.003; Roy A, 2012, STRUCTURE, V20, P1403, DOI 10.1016/j.str.2012.05.014; Simpson AA, 2000, NATURE, V408, P745, DOI 10.1038/35047129; Sippy J, 2015, VIROLOGY, V476, P115, DOI 10.1016/j.virol.2014.11.028; STERNBERG N, 1983, J BACTERIOL, V153, P800, DOI 10.1128/JB.153.2.800-812.1983; Sun S, 2012, P NATL ACAD SCI USA, V109, P817, DOI 10.1073/pnas.1110224109; Trus BL, 2004, J VIROL, V78, P12668, DOI 10.1128/JVI.78.22.12668-12671.2004; Wieczorek DJ, 2001, GENETICS, V158, P495; Wu H, 2002, MOL MICROBIOL, V45, P1631, DOI 10.1046/j.1365-2958.2002.03114.x; WU WF, 1988, GENETICS, V119, P477; XIN W, 1993, J MOL BIOL, V230, P492, DOI 10.1006/jmbi.1993.1166; XU SY, 1991, J MOL BIOL, V220, P281, DOI 10.1016/0022-2836(91)90013-V; Yang G, 2003, VIROLOGY, V305, P276, DOI 10.1006/viro.2002.1602; Yang Q, 1997, BIOCHEMISTRY-US, V36, P2744, DOI 10.1021/bi9622682; Zhao HY, 2012, J MOL BIOL, V423, P413, DOI 10.1016/j.jmb.2012.07.016	71	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0141934	10.1371/journal.pone.0141934	http://dx.doi.org/10.1371/journal.pone.0141934			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633301	Green Submitted, gold, Green Published			2022-12-27	WOS:000366040000003
J	Gutierrez, S; Descamps, B; Vanhove, C				Gutierrez, Shandra; Descamps, Benedicte; Vanhove, Christian			MRI-Only Based Radiotherapy Treatment Planning for the Rat Brain on a Small Animal Radiation Research Platform (SARRP)	PLOS ONE			English	Article							DOSE CALCULATIONS; SIMULATION	Computed tomography (CT) is the standard imaging modality in radiation therapy treatment planning (RTP). However, magnetic resonance (MR) imaging provides superior soft tissue contrast, increasing the precision of target volume selection. We present MR-only based RTP for a rat brain on a small animal radiation research platform (SARRP) using probabilistic voxel classification with multiple MR sequences. Six rat heads were imaged, each with one CT and five MR sequences. The MR sequences were: T1-weighted, T2-weighted, zero-echo time (ZTE), and two ultra-short echo time sequences with 20 mu s (UTE1) and 2 ms (UTE2) echo times. CT data were manually segmented into air, soft tissue, and bone to obtain the RTP reference. Bias field corrected MR images were automatically segmented into the same tissue classes using a fuzzy c-means segmentation algorithm with multiple images as input. Similarities between segmented CT and automatic segmented MR (ASMR) images were evaluated using Dice coefficient. Three ASMR images with high similarity index were used for further RTP. Three beam arrangements were investigated. Dose distributions were compared by analysing dose volume histograms. The highest Dice coefficients were obtained for the ZTE-UTE2 combination and for the T1-UTE1-T2 combination when ZTE was unavailable. Both combinations, along with UTE1-UTE2, often used to generate ASMR images, were used for further RTP. Using 1 beam, MR based RTP underestimated the dose to be delivered to the target (range: 1.4%-7.6%). When more complex beam configurations were used, the calculated dose using the ZTE-UTE2 combination was the most accurate, with 0.7% deviation from CT, compared to 0.8% for T1-UTE1-T2 and 1.7% for UTE1-UTE2. The presented MR-only based workflow for RTP on a SARRP enables both accurate organ delineation and dose calculations using multiple MR sequences. This method can be useful in longitudinal studies where CT's cumulative radiation dose might contribute to the total dose.	[Gutierrez, Shandra; Descamps, Benedicte; Vanhove, Christian] Univ Ghent, iMinds Med IT Dept, Med Image & Signal Proc Grp, B-9000 Ghent, Belgium	Ghent University; IMEC	Gutierrez, S (corresponding author), Univ Ghent, iMinds Med IT Dept, Med Image & Signal Proc Grp, B-9000 Ghent, Belgium.	shandra.gutierrezdiaz@ugent.be	Vanhove, Christian/I-2095-2019	Vanhove, Christian/0000-0002-3988-5980	Ghent University; GROUP-ID consortium of Ghent University; iMinds	Ghent University(Ghent University); GROUP-ID consortium of Ghent University; iMinds	This work is funded by iMinds and Ghent University. CV is supported by the GROUP-ID consortium of Ghent University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird EGA, 2002, BRIT J RADIOL, V75, P937, DOI 10.1259/bjr.75.900.750937; Bazalova M, 2011, MED PHYS, V38, P3039, DOI 10.1118/1.3589138; Bezdek J.C., 1981, PATTERN RECOGN, DOI 10.1007/978-1-4757-0450-1; Bolcaen J, 2014, J NEUROONC; Cherry SR, 2004, PHYS MED BIOL, V49, pR13, DOI 10.1088/0031-9155/49/3/R01; Eilertsen K, 2008, ACTA ONCOL, V47, P1294, DOI 10.1080/02841860802256426; Figueroa SD, 2008, MED PHYS, V35, P3866, DOI 10.1118/1.2959847; Fiorentino A, 2013, CLIN TRANSL ONCOL, V15, P754, DOI 10.1007/s12094-012-0992-y; Hsu SH, 2013, PHYS MED BIOL, V58, P8419, DOI 10.1088/0031-9155/58/23/8419; Johanson A, 2013, ACTA ONCOL, V52, P1369, DOI 10.3109/0284186X.2013.819119; Johansson A, 2011, MED PHYS, V38, P2708, DOI 10.1118/1.3578928; Keereman V, 2010, J NUCL MED, V51, P812, DOI 10.2967/jnumed.109.065425; Li CM, 2009, LECT NOTES COMPUT SC, V5636, P288; Shukla Divya, 2005, J Cancer Res Ther, V1, P235; Siewerdsen JH, 2004, MED PHYS, V31, P3506, DOI 10.1118/1.1819789; Sorensen T., 1948, BIOL SKAR, V5, P1; Vanhoof SJ, 2013, DEV VALIDATION TREAT, P361; Verhaegen F, 2014, Z MED PHYS, V24, P323, DOI 10.1016/j.zemedi.2014.02.004; Verhaegen F, 2011, PHYS MED BIOL, V56, pR55, DOI 10.1088/0031-9155/56/12/R01	19	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143821	10.1371/journal.pone.0143821	http://dx.doi.org/10.1371/journal.pone.0143821			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633302	gold, Green Published, Green Submitted			2022-12-27	WOS:000366040000024
J	Nelveg-Kristensen, KE; Madsen, MB; Torp-Pedersen, C; Kober, L; Egfjord, M; Rasmussen, HB; Hansen, PR				Nelveg-Kristensen, Karl Emil; Madsen, Majbritt Busk; Torp-Pedersen, Christian; Kober, Lars; Egfjord, Martin; Rasmussen, Henrik Berg; Hansen, Peter Riis			Pharmacogenetic Risk Stratification in Angiotensin-Converting Enzyme Inhibitor-Treated Patients with Congestive Heart Failure: A Retrospective Cohort Study	PLOS ONE			English	Article							LEFT-VENTRICULAR DYSFUNCTION; DELETION POLYMORPHISM; BLOOD-PRESSURE; MORTALITY; SURVIVAL; ASSOCIATION; GENE; DETERMINANTS; MANAGEMENT; RECEPTORS	Background Evidence for pharmacogenetic risk stratification of angiotensin-converting enzyme inhibitor (ACEI) treatment is limited. Therefore, in a cohort of ACEI-treated patients with congestive heart failure (CHF), we investigated the predictive value of two pharmacogenetic scores that previously were found to predict ACEI efficacy in patients with ischemic heart disease and hypertension, respectively. Score A combined single nucleotide polymorphisms (SNPs) of the angiotensin II receptor type 1 gene (rs275651 and rs5182) and the bradykinin receptor B1 gene (rs12050217). Score B combined SNPs of the angiotensin-converting enzyme gene (rs4343) and ABO blood group genes (rs495828 and rs8176746). Methods Danish patients with CHF enrolled in the previously reported Echocardiography and Heart Outcome Study were included. Subjects were genotyped and categorized according to pharmacogenetic scores A and B of <= 1, 2 and >= 3 each, and followed for up to 10 years. Difference in cumulative incidences of cardiovascular death and all-cause death were assessed by the cumulative incidence estimator. Survival was modeled by Cox proportional hazard analyses. Results We included 667 patients, of whom 80% were treated with ACEIs. Differences in cumulative incidences of cardiovascular death (P = 0.346 and P = 0.486) and all-cause death (P = 0.515 and P = 0.486) were not significant for score A and B, respectively. There was no difference in risk of cardiovascular death or all-cause death between subjects with score A <= 1 vs. 2 (HR 1.03 [95% CI 0.79-1.34] and HR 1.11 [95% CI 0.88-1.42]), score A <= 1 vs. >= 3 (HR 0.80 [95% CI 0.59-1.08] and HR 0.91 [95% CI 0.70-1.20]), score B <= 1 vs. 2 ( HR 1.02 [95% CI 0.78-1.32] and HR 0.98 [95% CI 0.77-1.24]), and score B <= 1 vs. >= 3 ( HR 1.03 [95% CI 0.75-1.41] and HR 1.05 [95% CI 0.79-1.40]), respectively. Conclusions We found no association between either of the analyzed pharmacogenetic scores and fatal outcomes in ACEI-treated patients with CHF.	[Nelveg-Kristensen, Karl Emil; Hansen, Peter Riis] Gentofte Univ Hosp, Dept Cardiol, Hellerup, Denmark; [Madsen, Majbritt Busk; Rasmussen, Henrik Berg] Copenhagen Univ Hosp, Inst Biol Psychiat, Mental Hlth Ctr Sct Hans, iPSYCH, Roskilde, Denmark; [Torp-Pedersen, Christian] Aalborg Univ, Inst Hlth Sci & Technol, Aalborg, Denmark; [Kober, Lars] Copenhagen Univ Hosp, Ctr Heart, Rigshosp, Copenhagen, Denmark; [Egfjord, Martin] Copenhagen Univ Hosp, Dept Nephrol, Rigshosp, Copenhagen, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); University of Copenhagen; Aalborg University; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Nelveg-Kristensen, KE (corresponding author), Gentofte Univ Hosp, Dept Cardiol, Hellerup, Denmark.	karl.emil.kristensen@regionh.dk	Hansen, Peter Riis/AAR-7659-2020	Kober, Lars/0000-0002-6635-1466; Hansen, Peter Riis/0000-0002-9056-535X; Busk Madsen, Majbritt/0000-0003-2123-8483	Danish Council for Strategic Research, Programme Commission on Individuals, Disease and Society [10092792/DSF]; Lundbeck Foundation [R155-2014-1724] Funding Source: researchfish	Danish Council for Strategic Research, Programme Commission on Individuals, Disease and Society; Lundbeck Foundation(Lundbeckfonden)	The present study is part of the Individualized Drug Therapy Based on Pharmacogenetics: Focus on Carboxylesterase 1 (INDICES) project, which was funded by grant 10092792/DSF from the Danish Council for Strategic Research, Programme Commission on Individuals, Disease and Society URL:http://ufm.dk/en/research-and-innovation/councils-and-commissions/former-councils-and-commissions/the-danish-council-for-strategic-research The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALEN OO, 1978, SCAND J STAT, V5, P141; Andersson B, 1996, J AM COLL CARDIOL, V28, P162, DOI 10.1016/0735-1097(96)00098-8; Arnett DK, 2005, CIRCULATION, V111, P3374, DOI 10.1161/CIRCULATIONAHA.104.504639; BALL SG, 1993, LANCET, V342, P821; Barki-Harrington L, 2003, CIRCULATION, V108, P1611, DOI 10.1161/01.CIR.0000092166.30360.78; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bart BA, 1997, J AM COLL CARDIOL, V30, P1002, DOI 10.1016/S0735-1097(97)00235-0; Batenburg WW, 2006, J HYPERTENS, V24, P1355, DOI 10.1097/01.hjh.0000234116.17778.63; Braunwald E, 2013, JACC-HEART FAIL, V1, P1, DOI 10.1016/j.jchf.2012.10.002; Brown NJ, 1998, CIRCULATION, V97, P1411, DOI 10.1161/01.CIR.97.14.1411; Brugts JJ, 2010, EUR HEART J, V31, P1854, DOI 10.1093/eurheartj/ehq169; Chung CM, 2010, PHARMACOGENOMICS J, V10, P537, DOI 10.1038/tpj.2009.70; Chung CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056119; Deng MC, 1997, INT J CARDIOL, V61, P261, DOI 10.1016/S0167-5273(97)00163-0; Elliott WJ, 1996, CLIN PHARMACOL THER, V60, P582, DOI 10.1016/S0009-9236(96)90155-1; Feldman RD, 2014, ANN REV PHARM TOXICO; Furberg CD, 2001, J AM COLL CARDIOL, V37, P1456, DOI 10.1016/S0735-1097(01)01161-5; Gislason GH, 2007, CIRCULATION, V116, P737, DOI 10.1161/CIRCULATIONAHA.106.669101; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Holmes MV, 2011, JAMA-J AM MED ASSOC, V306, P2704, DOI 10.1001/jama.2011.1880; Hunt SA, 2009, J AM COLL CARDIOL, V53, pE1, DOI 10.1016/j.jacc.2008.11.013; Jhund PS, 2009, CIRCULATION, V119, P515, DOI 10.1161/CIRCULATIONAHA.108.812172; Joseph PG, 2014, CLIN CARDIOL, V37, P48, DOI 10.1002/clc.22200; KOBER L, 1995, NEW ENGL J MED, V333, P1670, DOI 10.1056/NEJM199512213332503; Mas S, 2011, PHARMACOGENET GENOM, V21, P531, DOI 10.1097/FPC.0b013e328348c6db; McNamara DM, 2004, J AM COLL CARDIOL, V44, P2019, DOI 10.1016/j.jacc.2004.08.048; Ng ACC, 2008, INT J CARDIOL, V129, P198, DOI 10.1016/j.ijcard.2007.07.014; OSBORN JL, 1981, J PHARMACOL EXP THER, V216, P265; Petersen M, 2012, PHARMACOGENET GENOM, V22, P709, DOI 10.1097/FPC.0b013e3283540286; Petersen M, 2011, BRIT J CLIN PHARMACO, V71, P556, DOI 10.1111/j.1365-2125.2010.03868.x; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; Rogg H, 1996, EUR HEART J, V17, P1112; Schelleman H, 2004, DRUGS, V64, P1801, DOI 10.2165/00003495-200464160-00006; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P541, DOI 10.1007/s10654-014-9930-3; Shah Apurva D, 2005, Clin Cardiol, V28, P551; Silva ACSE, 2013, BRIT J PHARMACOL, V169, P477, DOI 10.1111/bph.12159; STEVENSON LW, 1990, AM J CARDIOL, V66, P1348, DOI 10.1016/0002-9149(90)91166-4; Talameh Jasmine A, 2012, Curr Heart Fail Rep, V9, P23, DOI 10.1007/s11897-011-0076-2; Torp-Pedersen C, 2008, EUR J HEART FAIL, V10, P89, DOI 10.1016/j.ejheart.2007.10.012; Webb AJS, 2010, LANCET, V375, P906, DOI 10.1016/S0140-6736(10)60235-8; Zhuo JL, 2011, PEPTIDES, V32, P1551, DOI 10.1016/j.peptides.2011.05.012	42	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144195	10.1371/journal.pone.0144195	http://dx.doi.org/10.1371/journal.pone.0144195			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633885	gold, Green Published, Green Submitted			2022-12-27	WOS:000366040000069
J	Li, Y; Jia, ZX; Niu, WQ; Wang, JW; Zhang, MZ				Li, Yuan; Jia, Zongxia; Niu, Wenquan; Wang, Jingwei; Zhang, Mingzhi			Effect of Post-Infiltration Soil Aeration at Different Growth Stages on Growth and Fruit Quality of Drip-Irrigated Potted Tomato Plants (Solanum lycopersicum)	PLOS ONE			English	Article							PROLONGED ROOT HYPOXIA; OXYGEN DEFICIENCY; PHYSIOLOGICAL-RESPONSES; WATER; YIELD; ETHYLENE; VEGETABLES; SYSTEMS	Soil hydraulic principles suggest that post-infiltration hypoxic conditions would be induced in the plant root-zone for drip-irrigated tomato production in small pots filled with natural soil. No previous study specifically examined the response of tomato plants (Solanum lycopersicum) at different growth stages to low soil aeration under these conditions. A 2 x 6 factorial experiment was conducted to quantify effects of no post-infiltration soil aeration versus aeration during 5 different periods (namely 27-33, 34-57, 58-85, 86-99, and 27-99 days after sowing), on growth and fruit quality of potted single tomato plants that were sub-surface trickle-irrigated every 2 days at 2 levels. Soil was aerated by injecting 2.5 liters of air into each pot through the drip tubing immediately after irrigation. Results showed that post-infiltration aeration, especially during the fruit setting (34-57 DAS) and enlargement (58-85 DAS) growth stages, can positively influence the yield, root dry weight and activity, and the nutritional (soluble solids and vitamin C content), taste (titratable acidity), and market quality (shape and firmness) of the tomato fruits. Interactions between irrigation level and post-infiltration aeration on some of these fruit quality parameters indicated a need for further study on the dynamic interplay of air and water in the root zone of the plants under the conditions of this experiment.	[Li, Yuan; Jia, Zongxia; Niu, Wenquan; Wang, Jingwei] Northwest A&F Univ, Inst Soil & Water Conservat, Yangling 712100, Shaanxi, Peoples R China; [Li, Yuan; Niu, Wenquan; Wang, Jingwei] Chinese Acad Sci, Inst Soil & Water Conservat, Yangling 712100, Shaanxi, Peoples R China; [Li, Yuan; Niu, Wenquan; Wang, Jingwei] Minist Water Resources, Yangling 712100, Shaanxi, Peoples R China; [Li, Yuan; Niu, Wenquan; Wang, Jingwei; Zhang, Mingzhi] Northwest A&F Univ, Coll Water Resources & Architectural Engn, Yangling 712100, Shaanxi, Peoples R China; [Li, Yuan; Niu, Wenquan; Wang, Jingwei; Zhang, Mingzhi] Northwest A&F Univ, Inst Water Saving Agr Arid Areas China, Yangling 712100, Shaanxi, Peoples R China; [Jia, Zongxia] Dezhou Prospecting & Designing Inst Water Conserv, Dezhou 253000, Shandong, Peoples R China	Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Northwest A&F University - China; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Ministry of Water Resources; Northwest A&F University - China; Northwest A&F University - China	Niu, WQ (corresponding author), Northwest A&F Univ, Inst Soil & Water Conservat, Yangling 712100, Shaanxi, Peoples R China.	nwq@vip.sina.com		li, yuan/0000-0001-6884-1699	China 863 Plan [2011AA100507]; National 111 Project of China [B12007]	China 863 Plan(National High Technology Research and Development Program of China); National 111 Project of China(Ministry of Education, China - 111 Project)	This work is supported jointly by China 863 Plan (2011AA100507) and the National 111 Project of China (No. B12007).	AHRENS MJ, 1990, PHYSIOL PLANTARUM, V78, P8, DOI 10.1111/j.1399-3054.1990.tb08707.x; Aldrich HT, 2010, J SCI FOOD AGR, V90, P2548, DOI 10.1002/jsfa.4116; Ashraf M. A., 2012, African Journal of Agricultural Research, V7, P1976; Bhattarai SP, 2008, IRRIGATION SCI, V26, P439, DOI 10.1007/s00271-008-0112-5; Bhattarai S.P., 2008, AQUAPONICS J, V49, P29; Bhattarai SP, 2005, ADV AGRON, V88, P313, DOI 10.1016/s0065-2113(05)88008-3; Bhattarai SP, 2006, SCI HORTIC-AMSTERDAM, V108, P278, DOI 10.1016/j.scienta.2006.02.011; Blom CWPM, 1996, TRENDS ECOL EVOL, V11, P290, DOI 10.1016/0169-5347(96)10034-3; BRADFORD KJ, 1981, HORTSCIENCE, V16, P25; BRADFORD KJ, 1982, PLANT PHYSIOL, V70, P1508, DOI 10.1104/pp.70.5.1508; BRADFORD KJ, 1983, PLANT PHYSIOL, V73, P475, DOI 10.1104/pp.73.2.475; BRYCE JH, 1982, SOIL SCI, V134, P111, DOI 10.1097/00010694-198208000-00005; Chang J, 2013, FRONT ECOL ENVIRON, V11, P43, DOI 10.1890/100223; Chen JL, 2014, AGR WATER MANAGE, V146, P131, DOI 10.1016/j.agwat.2014.07.026; Chen JL, 2013, AGR WATER MANAGE, V129, P152, DOI 10.1016/j.agwat.2013.07.011; Chen JinPing, 2004, Acta Botanica Boreali-Occidentalia Sinica, V24, P1589; Costa J. M., 2005, Tomatoes, P1, DOI 10.1079/9780851993966.0001; Cussler E.L., 1997, DIFFUSION MASS TRANS; DAVIES JN, 1981, CRC CR REV FOOD SCI, V15, P205, DOI 10.1080/10408398109527317; Dresboll DB, 2012, PLANT SOIL, V357, P161, DOI 10.1007/s11104-012-1135-5; Drew MC, 1997, ANNU REV PLANT PHYS, V48, P223, DOI 10.1146/annurev.arplant.48.1.223; Ezin Vincent, 2010, Braz. J. Plant Physiol., V22, P131, DOI 10.1590/S1677-04202010000200007; Gao J.F, 2006, EXPT TECHNIQUES PLAN, P203; Gould WA, 1992, TOMATO PRODUCTION PR; HALL C. B., 1964, PROC AMER SOC HORT SCI, V84, P507; Hanson B., 2007, Irrigation and Drainage Systems, V21, P109, DOI 10.1007/s10795-007-9023-5; Harmanto, 2005, AGR WATER MANAGE, V71, P225, DOI 10.1016/j.agwat.2004.09.003; Heuvelink E., 2005, CROP PRODUCTION SCI; Horchani F, 2008, J AGRON CROP SCI, V194, P297, DOI 10.1111/j.1439-037X.2008.00313.x; Horchani F, 2009, J AGRON CROP SCI, V195, P313, DOI 10.1111/j.1439-037X.2009.00363.x; Horchani F, 2011, PLANT SIGNAL BEHAV, V6, P1, DOI 10.4161/psb.6.1.13880; Hui Y.H., 2010, HDB FRUIT VEGETABLE; JACKSON MB, 1994, AGRON J, V86, P775, DOI 10.2134/agronj1994.00021962008600050006x; Jongen W.M, 2002, FRUIT VEGETABLE PROC, P1; KARLEN DL, 1983, COMMUN SOIL SCI PLAN, V14, P699, DOI 10.1080/00103628309367401; Klaring HP, 2009, SCI HORTIC-AMSTERDAM, V122, P17, DOI 10.1016/j.scienta.2009.03.029; Kozlowski TT, EFFECTS FLOODING GRO, P47; Lee SK, 2000, POSTHARVEST BIOL TEC, V20, P207, DOI 10.1016/S0925-5214(00)00133-2; Maboko M. M., 2008, South African Journal of Plant and Soil, V25, P178; Marrero T. R., 1972, J PHYS CHEM A, V1, P113, DOI DOI 10.1063/1.3253094); Mbonihankuye C, 2013, ACTA HORTIC, V1007, P535; MEEK BD, 1983, SOIL SCI SOC AM J, V47, P631, DOI 10.2136/sssaj1983.03615995004700040004x; Morard P, 2000, J PLANT NUTR, V23, P1063, DOI 10.1080/01904160009382082; Nahar K., 2012, Bangladesh Journal of Agricultural Research, V37, P355, DOI 10.3329/bjar.v37i2.11240; Narolia Rajeev Kumar, 2012, Agricultural Science Digest, V32, P281; Niu WQ, 2012, CLEAN-SOIL AIR WATER, V40, P1364, DOI 10.1002/clen.201100417; PAULSON KN, 1974, J FOOD SCI, V39, P354, DOI 10.1111/j.1365-2621.1974.tb02893.x; Pieper JR, 2009, J SCI FOOD AGR, V89, P177, DOI 10.1002/jsfa.3437; Rao R, 2003, HORTTECHNOLOGY, V13, P610, DOI 10.21273/HORTTECH.13.4.0610; RAWLS WJ, 1982, T ASAE, V25, P1316; Shao GC, 2014, SCI WORLD J, DOI 10.1155/2014/457937; SOJKA RE, 1980, SOIL SCI, V130, P350, DOI 10.1097/00010694-198012000-00010; SOJKA RE, 1992, SOIL SCI, V154, P269, DOI 10.1097/00010694-199210000-00003; Su NH, 2005, J HYDROL, V313, P158, DOI 10.1016/j.jhydrol.2005.02.025; Walter S, 2004, ACTA HORTIC, P499, DOI 10.17660/ActaHortic.2004.659.66; Wang JF, 2008, PLANT SOIL, V302, P45, DOI 10.1007/s11104-007-9453-8; WATADA AE, 1976, J FOOD SCI, V41, P856, DOI [10.1111/j.1365-2621.1976.tb00738.x, 10.1111/j.1365-2621.1976.tb00738_41_4.x]; Weaver E, 1927, ROOT DEV VEGETABLE C, P180; Wen GaiJuan, 2013, Journal of Northwest A & F University - Natural Science Edition, V41, P113; Zhao SJ, 1998, GUIDANCE PHYS EXPT P, P56	60	15	17	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143322	10.1371/journal.pone.0143322	http://dx.doi.org/10.1371/journal.pone.0143322			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630675	Green Submitted, gold, Green Published			2022-12-27	WOS:000365926300041
J	Lin, DM; Ma, J; Xue, YY; Wang, ZQ				Lin, Duomao; Ma, Jun; Xue, Yanyan; Wang, Zhaoqi			Penehyclidine Hydrochloride Preconditioning Provides Cardioprotection in a Rat Model of Myocardial Ischemia/Reperfusion Injury	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; NECROSIS-FACTOR-ALPHA; KAPPA-B PATHWAY; INFARCTION; MICE; INVOLVEMENT; INHIBITION; ACTIVATION; EXPRESSION; RECEPTORS	To investigate the impacts and related mechanisms of penehyclidine hydrochloride (PHC) on ischemia/reperfusion (I/R)-induced myocardial injury. A rat model of myocardial I/R injury was established by the ligation of left anterior descending coronary artery for 30 min followed by 3 h perfusion. Before I/R, the rats were pretreated with or without PHC. Cardiac function was measured by echocardiography. The activities/levels of myocardial enzymes, oxidants and antioxidant enzymes were detected. Evans blue/TTC double staining was performed to assess infarct size. Cardiomyocyte apoptosis was evaluated by TUNEL assay. The release of inflammatory cytokines and inflammatory mediators was detected by ELISA. Western blot was performed to analyze the expression of COX-2, I kappa B, p-I kappa B and NF-kappa B. Meanwhile, the rats were given a single injection of H-PHC before I/R. The effects of PHC on myocardial infarct and cardiac function were investigated after 7 days post-reperfusion. We found that PHC remarkably improved cardiac function, alleviated myocardial injury by decreasing myocardial enzyme levels and attenuated oxidative stress in a dose-dependent manner. Additionally, PHC preconditioning significantly reduced infarct size and the apoptotic rate of cardiomyocytes. Administration of PHC significantly decreased serum TNF-alpha, IL-1 beta, IL-6 and PGE(2) levels and myocardium COX-2 level. Meanwhile, the expression levels of p-I kappa B and NF-kappa B were downregulated, while I kappa B expression was upregulated. H-PHC also exerted long-term cardioprotection in a rat model of I/R injury by decreasing infarct size and improving cardiac function. These results suggest that PHC can efficiently protect the rats against I/R-induced myocardial injury.	[Lin, Duomao; Ma, Jun; Xue, Yanyan; Wang, Zhaoqi] Capital Med Univ, Beijing Anzhen Hosp, Ctr Anesthesiol, Beijing 100029, Peoples R China	Capital Medical University	Ma, J (corresponding author), Capital Med Univ, Beijing Anzhen Hosp, Ctr Anesthesiol, Beijing 100029, Peoples R China.	majun7689@163.com			National Nature Science Foundation of China [81471902]; Beijing Health System High-Level Health Technical Talents Cultivation Fund [2013-2-004]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Health System High-Level Health Technical Talents Cultivation Fund	The work was supported by the National Nature Science Foundation of China (Grant Number 81471902) (URL: www.nsfc.gov.cn) and Beijing Health System High-Level Health Technical Talents Cultivation Fund (Grant Number 2013-2-004) (URL: www.bjwsrc.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravinthan A, 2015, J GINSENG RES, V39, P206, DOI 10.1016/j.jgr.2014.12.001; Cai DS, 2010, EUR J ANAESTH, V27, P824, DOI 10.1097/EJA.0b013e32833b650f; Chen KC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/873010; Chen ZC, 2013, EXP THER MED, V5, P1089, DOI 10.3892/etm.2013.942; Chien SJ, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0583-x; Di Paola R, 2009, INTENS CARE MED, V35, P687, DOI 10.1007/s00134-008-1334-y; Du XJ, 2014, MOL BIOL REP, V41, P3853, DOI 10.1007/s11033-014-3252-0; FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657; Han XY, 2005, BIOORG MED CHEM LETT, V15, P1979, DOI 10.1016/j.bmcl.2005.02.071; Huang CS, 2014, J SURG RES, V188, P260, DOI 10.1016/j.jss.2013.12.011; Li DY, 1999, AM HEART J, V137, P1145, DOI 10.1016/S0002-8703(99)70375-3; Li XR, 2014, J THORAC DIS, V6, P1271, DOI 10.3978/j.issn.2072-1439.2014.07.22; Liu FC, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/568634; Lonborg J, 2012, EUR HEART J, V33, P1491, DOI 10.1093/eurheartj/ehr309; Lysiak JJ, 2005, J ANDROL, V26, P129; Ma TF, 2013, SYNAPSE, V67, P865, DOI 10.1002/syn.21693; Maekawa N, 2002, J AM COLL CARDIOL, V39, P1229, DOI 10.1016/S0735-1097(02)01738-2; Moghadam AR, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0773-6; Niessen HWM, 2003, CARDIOVASC RES, V60, P68, DOI 10.1016/S0008-6363(03)00324-9; Peng FL, 2014, GENET MOL RES, V13, P7503, DOI 10.4238/2014.September.12.17; Salio M, 2008, CIRCULATION, V117, P1055, DOI 10.1161/CIRCULATIONAHA.107.749234; Shen WF, 2009, PHARMACOL RES, V60, P296, DOI 10.1016/j.phrs.2009.04.007; Sima N, 2011, MED HYPOTHESES, V76, P607, DOI 10.1016/j.mehy.2011.01.013; Song CL, 2014, INT J MOL SCI, V15, P17442, DOI 10.3390/ijms151017442; Souza DG, 2005, MEM I OSWALDO CRUZ, V100, P59, DOI 10.1590/S0074-02762005000900011; Vakeva AP, 1998, CIRCULATION, V97, P2259, DOI 10.1161/01.CIR.97.22.2259; Wang B, 2006, TOXICOL LETT, V161, P115, DOI 10.1016/j.toxlet.2005.08.007; Wang J, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/970156; Wang LS, 2015, INT J CLIN EXP PATHO, V8, P4830; Wang MJ, 2009, P NATL ACAD SCI USA, V106, P17499, DOI 10.1073/pnas.0908924106; Wang PN, 2015, EXP THER MED, V9, P603, DOI 10.3892/etm.2014.2087; Wang XM, 2015, CELL PHYSIOL BIOCHEM, V35, P676, DOI 10.1159/000369728; Wang YA, 2005, LIFE SCI, V78, P210, DOI 10.1016/j.lfs.2005.04.071; Wang Y, 2013, NEUROL RES, V35, P1022, DOI 10.1179/1743132813Y.0000000247; Wang Y, 2011, INT J NEUROSCI, V121, P442, DOI 10.3109/00207454.2011.570611; Wang YP, 2014, J SURG RES, V186, P390, DOI 10.1016/j.jss.2013.07.041; Xia A, 2014, EVID-BASED COMPL ALT, V2014, DOI [10. 1155/ 2014/ 573745, DOI 10.1155/2014/573745, 10.1155/2014/573745]; Xiao HT, 2012, DRUG DES DEV THER, V6, P317, DOI 10.2147/DDDT.S36555; Yu CC, 2013, NEURAL REGEN RES, V8, P622, DOI 10.3969/j.issn.1673-5374.2013.07.006; Zeng M, 2013, BIOCHEM BIOPH RES CO, V436, P180, DOI 10.1016/j.bbrc.2013.05.070; Zengyong Q, 2011, INT J MOL SCI, V12, P1991; Zhan J, 2007, SHOCK, V28, P727, DOI 10.1097/shk.0b013e31805565b1; Zhang J, 2014, INT J CLIN EXP MED, V7, P4107; Zhang Y, 2011, WORLD J GASTROENTERO, V17, P254, DOI 10.3748/wjg.v17.i2.254; Zhu J, 2014, ARCH MED SCI, V10, P855, DOI 10.5114/aoms.2014.46206	45	21	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0138051	10.1371/journal.pone.0138051	http://dx.doi.org/10.1371/journal.pone.0138051			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26632817	gold, Green Published, Green Submitted			2022-12-27	WOS:000365926300002
J	Trani, JF; Babulal, GM; Bakhshi, P				Trani, Jean-Francois; Babulal, Ganesh Muneshwar; Bakhshi, Parul			Development and Validation of the 34-Item Disability Screening Questionnaire (DSQ-34) for Use in Low and Middle Income Countries Epidemiological and Development Surveys	PLOS ONE			English	Article							HEALTH; STIGMA; REHABILITATION; PREVALENCE; POVERTY; PEOPLE; ADULTS; IMPACT	Background Although 80% of persons with disabilities live in low and middle-income countries, there is still a lack of comprehensive, cross-culturally validated tools to identify persons facing activity limitations and functioning difficulties in these settings. In absence of such a tool, disability estimates vary considerably according to the methodology used, and policies are based on unreliable estimates. Methods and Findings The Disability Screening Questionnaire composed of 27 items (DSQ-27) was initially designed by a group of international experts in survey development and disability in Afghanistan for a national survey. Items were selected based on major domains of activity limitations and functioning difficulties linked to an impairment as defined by the International Classification of Functioning, Disability and Health. Face, content and construct validity, as well as sensitivity and specificity were examined. Based on the results obtained, the tool was subsequently refined and expanded to 34 items, tested and validated in Darfur, Sudan. Internal consistency for the total DSQ-34 using a raw and standardized Cronbach's Alpha and within each domain using a standardized Cronbach's Alpha was examined in the Asian context (India and Nepal). Exploratory factor analysis (EFA) using principal axis factoring (PAF) evaluated the lowest number of factors to account for the common variance among the questions in the screen. Test-retest reliability was determined by calculating intraclass correlation (ICC) and inter-rater reliability by calculating the kappa statistic; results were checked using Bland-Altman plots. The DSQ-34 was further tested for standard error of measurement (SEM) and for the minimum detectable change (MDC). Good internal consistency was indicated by Cronbach's Alpha of 0.83/0.82 for India and 0.76/0.78 for Nepal. We confirmed our assumption for EFA using the Kaiser-Meyer-Olkin measure of sampling well above the accepted cutoff of 0.40 for India (0.82) and Nepal (0.82). The criteria for Bartlett's test of sphericity were also met for both India (< .001) and Nepal (< .001). Estimates of reliability from the two countries reached acceptable levels of ICC of 0.75 (p< 0.001) for India of 0.77 for Nepal (p< 0.001) and good strength of agreement for weighted kappa (respectively 0.77 and 0.79). The SEM/MDC was 0.80/2.22 for India and 0.96/2.66 for Nepal indicating a smaller amount of measurement error in the screen. Conclusions In Nepal and India, the DSQ-34 shows strong psychometric properties that indicate that it effectively discriminates between persons with and without disabilities. This instrument can be used in association with other instruments for the purpose of comparing health outcomes of persons with and without disabilities in LMICs.	[Trani, Jean-Francois] Washington Univ, Brown Sch, St Louis, MO 63130 USA; [Trani, Jean-Francois] Washington Univ, Inst Publ Hlth, St Louis, MO USA; [Babulal, Ganesh Muneshwar] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Bakhshi, Parul] Washington Univ, Sch Med, Program Occupat Therapy, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Trani, JF (corresponding author), Washington Univ, Brown Sch, St Louis, MO 63130 USA.	jtrani@wustl.edu	Trani, Jean-Francois/M-1946-2014		Economic and Social Research Council [ES/M005011/1] Funding Source: researchfish; ESRC [ES/M005011/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Alonso J, 2008, ACTA PSYCHIAT SCAND, V118, P305, DOI 10.1111/j.1600-0447.2008.01241.x; Altman B., 2001, EXPLORING THEORIES E, V2, P77; ALTMAN DG, 1983, J ROY STAT SOC D-STA, V32, P307, DOI 10.2307/2987937; [Anonymous], 2006, CONV RIGHTS PERS DIS; Bakhshi P., 2006, CONDUCTING SURVEYS D; Bhalla D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046296; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; DeMaio TJ., 1996, ANSWERING QUESTIONS, P177; Dubois JL, 2009, ALTER, V3, P192, DOI 10.1016/j.alter.2009.04.003; Eide AH, 2008, DISABIL REHABIL, V30, P819, DOI 10.1080/09638280701390998; Filmer D, 2008, WORLD BANK ECON REV, V22, P141, DOI 10.1093/wber/lhm021; Goujon N, 2014, DISABIL REHABIL, V36, P804, DOI 10.3109/09638288.2013.821178; Groce N, 2011, THIRD WORLD Q, V32, P1493, DOI 10.1080/01436597.2011.604520; Henson RK, 2006, EDUC PSYCHOL MEAS, V66, P393, DOI 10.1177/0013164405282485; Hosseinpoor AR, 2013, AM J PUBLIC HEALTH, V103, P1278, DOI 10.2105/AJPH.2012.301115; Huq NL, 2013, DISABILITY CBR INCLU, V24, P37, DOI DOI 10.5463/DCID.V24I3.174; Kassah AK, 1998, DISABIL REHABIL, V20, P66, DOI 10.3109/09638289809166056; Lim KS, 2014, NEUROL ASIA, V19, P1; Lim YJ, 2009, EPILEPSY RES, V87, P107, DOI 10.1016/j.eplepsyres.2009.08.014; Link BG, 2001, PSYCHIATR SERV, V52, P1621, DOI 10.1176/appi.ps.52.12.1621; Madans JH, 2013, DISABIL REHABIL, V35, P1070, DOI 10.3109/09638288.2012.720353; Madans JH, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S4-S4; Marella M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-900; Mitra S., 2006, J DISABIL POLICY STU, V16, P236, DOI DOI 10.1177/10442073060160040501; Mitra S, 2014, DISABIL REHABIL, V36, P940, DOI 10.3109/09638288.2013.825333; Mitra S, 2013, WORLD DEV, V41, P1, DOI 10.1016/j.worlddev.2012.05.024; Mizunoya S, 2013, WORLD DEV, V42, P28, DOI 10.1016/j.worlddev.2012.05.037; Mont D, 2007, SP DISCUSSION PAPER; Mont D, 2007, LANCET, V369, P1658, DOI 10.1016/S0140-6736(07)60752-1; Parnes P, 2009, DISABIL REHABIL, V31, P1170, DOI 10.1080/09638280902773778; Sabariego C, 2015, INT J ENV RES PUB HE, V12, P10329, DOI 10.3390/ijerph120910329; Savitz DA, 2003, INTERPRETING EPIDEMI; Sen AK, 1982, CHOICE WELFARE MEASU, P353; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Tourangeau R., 2000, PSYCHOL SURVEY RESPO; Trani JF, 2011, ALTER, V5, P143, DOI 10.1016/j.alter.2011.04.001; Trani JF, 2011, SOC SCI MED, V73, P1477, DOI 10.1016/j.socscimed.2011.08.040; Trani JF, 2010, SOC SCI MED, V70, P1745, DOI 10.1016/j.socscimed.2010.02.007; Trani JF, 2008, ALTER, V2, P44, DOI 10.1016/j.alter.2007.10.003; Velema JP, 2008, LEPROSY REV, V79, P65; WHO, 2011, WORLD REPORT ON DISABILITY, P1; Williams B., 2012, AUST J MED SCI, V8, P223; World Health Organization, 2014, WHO MDS SURV MAN WHO	43	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143610	10.1371/journal.pone.0143610	http://dx.doi.org/10.1371/journal.pone.0143610			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX8BI	26630668	Green Published, gold			2022-12-27	WOS:000365926300071
J	Kim, JH; Kim, KH; Kim, HJ; Lee, J; Myung, SC				Kim, Jung Hoon; Kim, Kyeoung-Hwa; Kim, Hae Jong; Lee, Jaehyouk; Myung, Soon Chul			Expression of Beta-Defensin 131 Promotes an Innate Immune Response in Human Prostate Epithelial Cells	PLOS ONE			English	Article							LIPOTEICHOIC ACID; ANTIMICROBIAL PEPTIDES; HUMAN BETA-DEFENSIN-2; CYTOKINE PRODUCTION; PERIPHERAL-BLOOD; GENE-EXPRESSION; WALL COMPONENTS; RECEPTOR 2; IN-VITRO; KAPPA-B	Previously, using the Illumina HumanHT-12 microarray we found that beta-defensin 131 (DEFB131), an antimicrobial peptide, is upregulated in the human prostate epithelial cell line RWPE-1 upon stimulation with lipoteichoic acid (LTA; a gram-positive bacterial component), than that in the untreated RWPE-1 cells. In the current study, we aimed to investigate the role of DEFB131 in RWPE-1 cells during bacterial infection. We examined the intracellular signaling pathways and nuclear responses in RWPE-1 cells that contribute to DEFB131 gene induction upon stimulation with LTA. Chromatin immunoprecipitation was performed to determine whether NF-kappa B directly binds to the DEFB131 promoter after LTA stimulation in RWPE-1 cells. We found that DEFB131 expression was induced by LTA stimulation through TLR2 and p38MAPK/NF-kappa B activation, which was evident in the phosphorylation of both p38MAPK and I kappa B alpha. We also found that SB203580 and Bay11-7082, inhibitors of p38MAPK and NF-kappa B, respectively, suppressed LTA-induced DEFB131 expression. The chromatin immunoprecipitation assay showed that NF-kappa B directly binds to the DEFB131 promoter, suggesting that NF-kappa B is a direct regulator, and is necessary for LTA-induced DEFB131 expression in RWPE-1 cells. Interestingly, with DEFB131 overexpression in RWPE-1 cells, the accumulation of mRNA and protein secretion of cytokines (IL-1 alpha, IL-1 beta, IL-6, and IL-12 alpha) and chemokines (CCL20, CCL22, and CXCL8) were significantly enhanced. In addition, DEFB131-transfected RWPE-1 cells markedly induced chemotactic activity in THP-1 monocytes. We concluded that DEFB131 induces cytokine and chemokine upregulation through the TLR2/NF-kappa B signaling pathway in RWPE-1 cells during bacterial infection and promotes an innate immune response.	[Kim, Jung Hoon] KEPCO Med Ctr, Dept Urol, Seoul, South Korea; [Kim, Kyeoung-Hwa; Kim, Hae Jong; Lee, Jaehyouk] Chung Ang Univ, Coll Med, Res Inst Translat Syst Biom, Seoul 156756, South Korea; [Myung, Soon Chul] Chung Ang Univ, Coll Med, Dept Urol, Seoul 156756, South Korea	Chung Ang University; Chung Ang University Hospital; Chung Ang University; Chung Ang University Hospital	Myung, SC (corresponding author), Chung Ang Univ, Coll Med, Dept Urol, Seoul 156756, South Korea.	uromyung@cau.ac.kr	Kim, Jung Hoon/HHM-2687-2022	Kim, Jung Hoon/0000-0002-0947-876X	National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2013R1A1A2011824]	National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2013R1A1A2011824). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education (NRF-2013R1A1A2011824).	Baroni A, 2006, ARCH DERMATOL RES, V297, P280, DOI 10.1007/s00403-005-0594-4; Boniotto M, 2006, ANTIMICROB AGENTS CH, V50, P1433, DOI 10.1128/AAC.50.4.1433-1441.2006; Bunk S, 2010, J IMMUNOL, V185, P3708, DOI 10.4049/jimmunol.0901660; Charalambous C, 2005, CANCER RES, V65, P10347, DOI 10.1158/0008-5472.CAN-05-0949; COHENKAMINSKY S, 1991, CELL IMMUNOL, V138, P79, DOI 10.1016/0008-8749(91)90134-W; DEBLAKERHOHE DF, 1995, CELL IMMUNOL, V165, P33, DOI 10.1006/cimm.1995.1184; Eskan MA, 2008, INFECT IMMUN, V76, P2080, DOI 10.1128/IAI.01428-07; Ganz T, 2003, INTEGR COMP BIOL, V43, P300, DOI 10.1093/icb/43.2.300; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Gao JJ, 2001, INFECT IMMUN, V69, P751, DOI 10.1128/IAI.69.2.751-757.2001; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Hertz CJ, 2003, J IMMUNOL, V171, P6820, DOI 10.4049/jimmunol.171.12.6820; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jia HP, 2001, GENE, V263, P211; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Kao CY, 2003, AM J RESP CELL MOL, V29, P71, DOI 10.1165/rcmb.2002-0205OC; Kim HJ, 2011, BJU INT, V107, P144, DOI 10.1111/j.1464-410X.2010.09469.x; Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976; Manna SK, 2005, J BIOL CHEM, V280, P7010, DOI 10.1074/jbc.M410994200; Menzies BE, 2006, INFECT IMMUN, V74, P6847, DOI 10.1128/IAI.00389-06; Motzkus D, 2006, FASEB J, V20, P1701, DOI 10.1096/fj.05-4970fje; Mukaida N, 2000, INT J HEMATOL, V72, P391; Nakao Y, 2005, J IMMUNOL, V174, P1566, DOI 10.4049/jimmunol.174.3.1566; Nilsen NJ, 2008, J LEUKOCYTE BIOL, V84, P280, DOI 10.1189/jlb.0907656; Niyonsaba F, 2010, J IMMUNOL, V184, P3526, DOI 10.4049/jimmunol.0900712; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; POWRIE F, 1993, EUR J IMMUNOL, V23, P3043, DOI 10.1002/eji.1830231147; Schutte BC, 2002, P NATL ACAD SCI USA, V99, P2129, DOI 10.1073/pnas.042692699; STADNYK AW, 1994, FASEB J, V8, P1041, DOI 10.1096/fasebj.8.13.7926369; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Underhill DM, 1999, P NATL ACAD SCI USA, V96, P14459, DOI 10.1073/pnas.96.25.14459; Wang KS, 2000, BLOOD, V95, P3183, DOI 10.1182/blood.V95.10.3183.010k36_3183_3190; Wehkamp J, 2004, INFECT IMMUN, V72, P5750, DOI 10.1128/IAI.72.10.5750-5758.2004; WHICHER JT, 1990, CLIN CHEM, V36, P1269; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yoshimura A, 1999, J IMMUNOL, V163, P1	40	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144776	10.1371/journal.pone.0144776	http://dx.doi.org/10.1371/journal.pone.0144776			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26649771	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903300076
J	De Pretto, L; Acreman, S; Ashfold, MJ; Mohankumar, SK; Campos-Arceiz, A				De Pretto, Laura; Acreman, Stephen; Ashfold, Matthew J.; Mohankumar, Suresh K.; Campos-Arceiz, Ahimsa			The Link between Knowledge, Attitudes and Practices in Relation to Atmospheric Haze Pollution in Peninsular Malaysia	PLOS ONE			English	Article							AIR-POLLUTION; TRANSBOUNDARY HAZE; SOUTHEAST-ASIA; HEALTH; CHINA; BEHAVIOR; IMPACT; POLICY; FIRES	Transboundary haze episodes caused by seasonal forest fires have become a recurrent phenomenon in Southeast Asia, with serious environmental, economic, and public health implications. Here we present a cross-sectional survey conducted among people in Kuala Lumpur and surrounds to assess the links between knowledge, attitudes, and practices in relation to the transboundary haze episodes. Of 305 respondents, 125 were amateur athletes participating in a duathlon event and the remainder were surveyed in an inner-city shopping mall. Across the whole sample, people who possessed more factual information about the haze phenomenon showed significantly higher levels of concern. Duathletes were more knowledgeable than non-duathletes and also more concerned about the negative effects of haze, especially on health. For all people who regularly practice outdoor sports (including people interviewed at the shopping mall), higher levels of knowledge and concerned attitudes translated into a greater likelihood of engaging in protective practices, such as cancelling their outdoor training sessions, while those with greater knowledge were more likely to check the relevant air pollution index on a daily basis. Our results indicate that the provision of accurate and timely information about air quality to residents will translate into beneficial practices, at least among particularly exposed individuals, such as amateur athletes who regularly practice outdoor sports.	[De Pretto, Laura; Acreman, Stephen; Ashfold, Matthew J.; Mohankumar, Suresh K.; Campos-Arceiz, Ahimsa] Univ Nottingham Malaysia Campus, Mindset Interdisciplinary Ctr Trop Environm Studi, Semenyih, Selangor, Malaysia; [De Pretto, Laura] Univ Nottingham Malaysia Campus, Dept Appl Psychol, Semenyih, Selangor, Malaysia; [Acreman, Stephen] Univ Nottingham Malaysia Campus, Sch Polit Hist & Int Relat, Semenyih, Selangor, Malaysia; [Ashfold, Matthew J.] Univ Nottingham Malaysia Campus, Sch Biosci, Semenyih, Selangor, Malaysia; [Mohankumar, Suresh K.] Univ Nottingham Malaysia Campus, Dept Biomed Sci, Semenyih, Selangor, Malaysia; [Campos-Arceiz, Ahimsa] Univ Nottingham Malaysia Campus, Sch Geog, Semenyih, Selangor, Malaysia	University of Nottingham Malaysia; University of Nottingham Malaysia; University of Nottingham Malaysia; University of Nottingham Malaysia; University of Nottingham Malaysia; University of Nottingham Malaysia	De Pretto, L (corresponding author), Univ Nottingham Malaysia Campus, Mindset Interdisciplinary Ctr Trop Environm Studi, Jalan Broga, Semenyih, Selangor, Malaysia.	Laura.DePretto@nottingham.edu.my	Ashfold, Matthew/K-3909-2019; Mohankumar, Suresh Kumar/G-5201-2011; Campos-Arceiz, Ahimsa/HCH-6042-2022; Campos-Arceiz, Ahimsa/O-8120-2014	Ashfold, Matthew/0000-0002-2191-1554; Mohankumar, Suresh Kumar/0000-0001-8862-2979; De Pretto, Laura/0000-0002-7175-3240; Campos-Arceiz, Ahimsa/0000-0002-4657-4216	University of Nottingham in Malaysia's Faculty of Science	University of Nottingham in Malaysia's Faculty of Science	This study was funded with the individual research budget provided by the University of Nottingham in Malaysia's Faculty of Science to ACA. The funder had no role in the study design, data collection and analysis, decisions to publish, or preparation of the manuscript.	Ajzen I, 2002, J APPL SOC PSYCHOL, V32, P665, DOI 10.1111/j.1559-1816.2002.tb00236.x; [Anonymous], 2004, NAJ ITS SECR TRUTH I; [Anonymous], 2014, JAKARTA POST; [Anonymous], 1999, DEC KEEP AIR QUAL FA; [Anonymous], 2015, ASEAN SECRETARI 0120; [Anonymous], 2000, INT HERALD TRIBUNE; Bickerstaff K, 2001, GLOBAL ENVIRON CHANG, V11, P133, DOI 10.1016/S0959-3780(00)00063-7; Chen YY, 2013, P NATL ACAD SCI USA, V110, P12936, DOI 10.1073/pnas.1300018110; Crawley MJ, 2013, R BOOK, P557; Diener E, 2009, SOC INDIC RES SER, V39, P1, DOI 10.1007/978-90-481-2354-4_1; Forsyth T, 2014, GLOBAL ENVIRON CHANG, V25, P76, DOI 10.1016/j.gloenvcha.2014.01.013; Fransson N, 1999, J ENVIRON PSYCHOL, V19, P369, DOI 10.1006/jevp.1999.0141; Glover D., 1999, INDONESIAS FIRES HAZ; Haron S.A., 2005, INT J CONSUM STUD, V29, P426, DOI [10.1111/j.1470-6431.2005.00460.x, DOI 10.1111/J.1470-6431.2005.00460.X]; Ho RC, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-81; Launiala A, 2009, ANTHR MATTERS; Li FZ, 2015, J EPIDEMIOL COMMUN H, V69, P201, DOI 10.1136/jech-2014-203892; MacKerron G, 2009, ECOL ECON, V68, P1441, DOI 10.1016/j.ecolecon.2008.10.004; MALONEY MP, 1975, AM PSYCHOL, V30, P787, DOI 10.1037/h0084394; MANDERSON L, 1992, SOC SCI MED, V35, P839, DOI 10.1016/0277-9536(92)90098-B; Marlier ME, 2013, NAT CLIM CHANGE, V3, P131, DOI [10.1038/NCLIMATE1658, 10.1038/nclimate1658]; Mayer J., 2006, Journal of Environment & Development, V15, P202, DOI 10.1177/1070496506288369; Medicins du monde, 2011, KAP SURV MOD; Murdiyarso D, 2004, AGR ECOSYST ENVIRON, V104, P47, DOI 10.1016/j.agee.2004.01.005; Sudarmadi S., 2001, ENVIRON DEV SUSTAIN, V3, P169, DOI DOI 10.1023/A:1011633729185; Thirusanku J, 2014, ASIAN SOCIAL SCI, P10; Tolvanen M, 2012, ACTA ODONTOL SCAND, V70, P169, DOI 10.3109/00016357.2011.600722; Varkkey H, 2013, INT ENVIRON AGREEM-P, V14, P65; Varkkey H, 2013, ENVIRON HAZARDS-UK, V12, P200, DOI 10.1080/17477891.2012.759524; Wang R, 2015, INT J ENV RES PUB HE, V12, P1834, DOI 10.3390/ijerph120201834; Xiao ZM, 2011, AEROSOL AIR QUAL RES, V11, P873, DOI 10.4209/aaqr.2011.04.0052	31	33	34	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0143655	10.1371/journal.pone.0143655	http://dx.doi.org/10.1371/journal.pone.0143655			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1YV	26646896	Green Submitted, Green Published, gold			2022-12-27	WOS:000366903100005
J	Tsou, YA; Lin, CD; Chen, HC; Hsu, HY; Wu, LT; Chiang-Ni, C; Chen, CJ; Wu, TF; Kao, MC; Chen, YA; Peng, MT; Tsai, MH; Chen, CM; Lai, CH				Tsou, Yung-An; Lin, Chia-Der; Chen, Hui-Chen; Hsu, Hui-Ying; Wu, Lii-Tzu; Chiang-Ni, Chuan; Chen, Chih-Jung; Wu, Tsu-Fang; Kao, Min-Chuan; Chen, Yu-An; Peng, Ming-Te; Tsai, Ming-Hsui; Chen, Chuan-Mu; Lai, Chih-Ho			Interleukin-13 Inhibits Lipopolysaccharide-Induced BPIFA1 Expression in Nasal Epithelial Cells	PLOS ONE			English	Article							CHRONIC RHINOSINUSITIS; PSEUDOMONAS INFECTION; HOST-DEFENSE; SPLUNC1; AIRWAY; PROTEIN; PLUNC; NASOPHARYNX; CONTRIBUTES; SURFACTANT	Short palate, lung, and nasal epithelium clone 1 (SPLUNC1) protein is expressed in human nasopharyngeal and respiratory epithelium and has demonstrated antimicrobial activity. SPLUNC1 is now referred to as bactericidal/permeability-increasing fold containing family A, member 1 (BPIFA1). Reduced BPIFA1 expression is associated with bacterial colonization in patients with chronic rhinosinusitis with nasal polyps (CRSwNP). Interleukin 13 (IL-13), predominately secreted by T helper 2 (TH2) cells, has been found to contribute to airway allergies and suppress BPIFA1 expression in nasal epithelial cells. However, the molecular mechanism of IL-13 perturbation of bacterial infection and BPIFA1 expression in host airways remains unclear. In this study, we found that lipopolysaccharide (LPS)-induced BPIFA1 expression in nasal epithelial cells was mediated through the JNK/c-Jun signaling pathway and AP-1 activation. We further demonstrated that IL-13 downregulated the LPS-induced activation of phosphorylated JNK and c-Jun, followed by attenuation of BPIFA1 expression. Moreover, the immunohistochemical analysis showed that IL-13 prominently suppressed BPIFA1 expression in eosinophilic CRSwNP patients with bacterial infection. Taken together, these results suggest that IL-13 plays a critical role in attenuation of bacteria-induced BPIFA1 expression that may result in eosinophilic CRSwNP.	[Tsou, Yung-An; Lin, Chia-Der; Hsu, Hui-Ying; Tsai, Ming-Hsui] China Med Univ & Hosp, Dept Otolaryngol Head & Neck Surg, Taichung, Taiwan; [Tsou, Yung-An; Chen, Chuan-Mu] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Lin, Chia-Der; Chen, Hui-Chen; Hsu, Hui-Ying; Wu, Lii-Tzu; Chen, Yu-An; Peng, Ming-Te; Lai, Chih-Ho] China Med Univ & Hosp, Sch Med, Grad Inst Basic Med Sci, Taichung, Taiwan; [Chiang-Ni, Chuan; Chen, Chih-Jung; Kao, Min-Chuan; Lai, Chih-Ho] Chang Gung Univ, Grad Inst Biomed Sci, Dept Microbiol & Immunol, Taoyuan, Taiwan; [Chen, Chih-Jung] Chang Gung Childrens Hosp, Dept Paediat, Div Paediat Infect Dis, Taoyuan, Taiwan; [Chen, Chih-Jung] Chang Gung Mem Hosp, Taoyuan, Taiwan; [Wu, Tsu-Fang] Hung Kuang Univ, Dept Appl Cosmetol, Taichung, Taiwan; [Lai, Chih-Ho] Asia Univ, Dept Nursing, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; National Chung Hsing University; China Medical University Taiwan; China Medical University Hospital - Taiwan; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Hungkuang University; Asia University Taiwan	Lin, CD (corresponding author), China Med Univ & Hosp, Dept Otolaryngol Head & Neck Surg, Taichung, Taiwan.	d6355@mail.cmuh.org.tw; chchen1@dragon.nchu.edu.tw; chlai@mail.cgu.edu.tw	Chen, Hui-Chen/L-8149-2013; Chiang-Ni, Chuan/ABD-9765-2021; Chen, Chuan-Mu/K-7049-2013	Chen, Hui-Chen/0000-0001-9751-5729; Chiang-Ni, Chuan/0000-0002-0753-035X; Chen, Chuan-Mu/0000-0003-2461-9150	Ministry of Science and Technology [103-2633-B-182-001, 104-2320-B-182-040, 104-2314-B-039-040]; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW104-TDU-B-212-113002]; China Medical University and Hospital [CMU102-ASIA-21, 103-S-15, 103-S-18, DMR103-025]; Chang Gung Memorial Hospital [CMRPD3E0511-3]; Tomorrow Medicine Foundation [TMF104-01]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University and Hospital(China Medical University); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Tomorrow Medicine Foundation	This work was supported by research grants from the Ministry of Science and Technology (103-2633-B-182-001, 104-2320-B-182-040, 104-2314-B-039-040); Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW104-TDU-B-212-113002); China Medical University and Hospital (CMU102-ASIA-21, 103-S-15, 103-S-18, and DMR103-025); Chang Gung Memorial Hospital (CMRPD3E0511-3), and the Tomorrow Medicine Foundation (TMF104-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachert C, 2008, CURR OPIN ALLERGY CL, V8, P34, DOI 10.1097/ACI.0b013e3282f4178f; Bartlett J, 2011, BIOCHEM SOC T, V39, P1012, DOI 10.1042/BST0391012; Bassiouni A, 2012, LARYNGOSCOPE, V122, P460, DOI 10.1002/lary.22461; Bingle CD, 2004, INT J BIOCHEM CELL B, V36, P2144, DOI 10.1016/j.biocel.2004.05.002; Bingle CD, 2011, BIOCHEM SOC T, V39, P977, DOI 10.1042/BST0390977; Chen HX, 2015, BIOMEDICINE-TAIWAN, V5, P39, DOI 10.7603/s40681-015-0006-9; Coticchia J, 2007, ARCH OTOLARYNGOL, V133, P110, DOI 10.1001/archotol.133.2.110; Di YP, 2003, J BIOL CHEM, V278, P1165, DOI 10.1074/jbc.M210523200; Di YP, 2007, BIOCHEM SOC T, V39, P1051; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Fong YC, 2008, J BONE MINER RES, V23, P961, DOI 10.1359/JBMR.080206; Gakhar L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009098; Garcia-Caballero A, 2009, P NATL ACAD SCI USA, V106, P11412, DOI 10.1073/pnas.0903609106; Guillot L, 2004, J BIOL CHEM, V279, P2712, DOI 10.1074/jbc.M305790200; Hsu J, 2011, AM J RHINOL ALLERGY, V25, P285, DOI 10.2500/ajra.2011.25.3680; Huang CC, 2012, J LARYNGOL OTOL, V126, P470, DOI 10.1017/S0022215112000497; HUANG TS, 1991, P NATL ACAD SCI USA, V88, P5292, DOI 10.1073/pnas.88.12.5292; Hunsaker DH, 2008, CURR OPIN OTOLARYNGO, V16, P237, DOI 10.1097/MOO.0b013e3282fdc6d5; Kern RC, 2008, AM J RHINOL, V22, P549, DOI 10.2500/ajr.2008.22.3228; LeClair EE, 2003, BIOCHEM SOC T, V31, P801, DOI 10.1042/BST0310801; Lin CD, 2014, NANOMEDICINE-UK, V9, P1327, DOI [10.2217/NNM.14.48, 10.2217/nnm.14.48]; Lin CD, 2012, EUR ARCH OTO-RHINO-L, V269, P503, DOI 10.1007/s00405-011-1704-x; Lin CD, 2011, INFECT IMMUN, V79, P3563, DOI 10.1128/IAI.05175-11; Lin CD, 2011, LAB INVEST, V91, P1092, DOI 10.1038/labinvest.2011.69; Liu Y, 2013, AM J PATHOL, V182, P1519, DOI 10.1016/j.ajpath.2013.01.050; Liu YY, 2013, J IMMUNOL, V191, P4259, DOI 10.4049/jimmunol.1202340; Lu DY, 2012, INFECT IMMUN, V80, P1823, DOI 10.1128/IAI.05856-11; Lukinskiene L, 2011, J IMMUNOL, V187, P382, DOI 10.4049/jimmunol.1001769; McGillivary G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013224; Meltzer Eli O, 2004, J Allergy Clin Immunol, V114, P155, DOI 10.1016/j.jaci.2004.09.029; Park S, 1999, B KOR CHEM SOC, V20, P925; Sayeed S, 2013, INFECT IMMUN, V81, P285, DOI 10.1128/IAI.00500-12; Seshadri S, 2012, ALLERGY, V67, P920, DOI 10.1111/j.1398-9995.2012.02848.x; Singhal D, 2011, LARYNGOSCOPE, V121, P1578, DOI 10.1002/lary.21805; SMITH LF, 1993, OTOLARYNG HEAD NECK, V108, P688, DOI 10.1177/019459989310800610; Tsou YA, 2014, EUR ARCH OTO-RHINO-L, V271, P299, DOI 10.1007/s00405-013-2535-8; Tsou YA, 2013, LARYNGOSCOPE, V123, P845, DOI 10.1002/lary.23871; Wei Y, 2014, J ALLERGY CLIN IMMUN, V133, P420, DOI 10.1016/j.jaci.2013.09.052; Yeh TH, 2010, AMJ RHINOL ALLERGY, V24, P17, DOI 10.2500/ajra.2010.24.3381; You H, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.26845	40	6	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2015	10	12							e0143484	10.1371/journal.pone.0143484	http://dx.doi.org/10.1371/journal.pone.0143484			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YV	26646664	Green Submitted, Green Published, gold			2022-12-27	WOS:000366903100003
J	Booiman, T; Loukachov, VV; van Dort, KA; van 't Wout, AB; Kootstra, NA				Booiman, Thijs; Loukachov, Vladimir V.; van Dort, Karel A.; van 't Wout, Angelique B.; Kootstra, Neeltje A.			DYRK1A Controls HIV-1 Replication at a Transcriptional Level in an NFAT Dependent Manner	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; FUSION INHIBITOR T-20; CD4(+) T-CELLS; SODIUM-BUTYRATE; GENE-EXPRESSION; IN-VITRO; HISTONE DEACETYLATION; TYPE-1; ACTIVATION; INFECTION	Background Transcription of the HIV-1 provirus is regulated by both viral and host proteins and is very important in the context of viral latency. In latently infected cells, viral gene expression is inhibited as a result of the sequestration of host transcription factors and epigenetic modifications. Results In our present study we analyzed the effect of host factor dual specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) on HIV-1 replication. We show that DYRK1A controls HIV-1 replication by regulating provirus transcription. Downregulation or inhibition of DYRK1A increased LTR-driven transcription and viral replication in cell lines and primary PBMC. Furthermore, inhibition of DYRK1A resulted in reactivation of latent HIV-1 provirus to a similar extent as two commonly used broad-spectrum HDAC inhibitors. We observed that DYRK1A regulates HIV-1 transcription via the Nuclear Factor of Activated T-cells (NFAT) by promoting its translocation from the nucleus to the cytoplasm. Therefore, inhibition of DYRK1A results in increased nuclear levels of NFAT and increased NFAT binding to the viral LTR and thus increasing viral transcription. Conclusions Our data indicate that host factor DYRK1A plays a role in the regulation of viral transcription and latency. Therefore, DYRK1A might be an attractive candidate for therapeutic strategies targeting the viral reservoir.	[Kootstra, Neeltje A.] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Sanquin Res,Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun CINIMA, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Kootstra, NA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Sanquin Res,Landsteiner Lab, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	n.a.kootstra@amc.uva.nl		van 't Wout, Angelique/0000-0003-3705-2392; Kootstra, Neeltje A./0000-0001-9429-7754	Landsteiner Foundation for Blood Transfusion Research [0526]	Landsteiner Foundation for Blood Transfusion Research	This study was funded by the Landsteiner Foundation for Blood Transfusion Research (0526).	Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Archin NM, 2009, AIDS RES HUM RETROV, V25, P207, DOI 10.1089/aid.2008.0191; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Bates DL, 2008, STRUCTURE, V16, P684, DOI 10.1016/j.str.2008.01.020; Borner K, 2010, BIOTECHNOL J, V5, P39, DOI 10.1002/biot.200900226; BOFFA LC, 1978, J BIOL CHEM, V253, P3364; Bol SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017190; Bosque A, 2009, BLOOD, V113, P58, DOI 10.1182/blood-2008-07-168393; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Bullen CK, 2014, NAT MED, V20, P425, DOI 10.1038/nm.3489; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; CANDIDO EPM, 1978, CELL, V14, P105, DOI 10.1016/0092-8674(78)90305-7; Cillo AR, 2014, P NATL ACAD SCI USA, V111, P7078, DOI 10.1073/pnas.1402873111; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Cron RQ, 2000, CLIN IMMUNOL, V94, P179, DOI 10.1006/clim.1999.4831; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Dierssen M, 2006, THESCIENTIFICWORLDJO, V6, P1911, DOI 10.1100/tsw.2006.319; Doehle BP, 2005, VIROLOGY, V339, P281, DOI 10.1016/j.virol.2005.06.005; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Fotaki V, 2002, MOL CELL BIOL, V22, P6636, DOI 10.1128/MCB.22.18.6636-6647.2002; GOLUB EI, 1991, AIDS, V5, P663, DOI 10.1097/00002030-199106000-00004; Goujon C, 2013, NATURE, V502, P559, DOI 10.1038/nature12542; GRIFFIN GE, 1989, NATURE, V339, P70, DOI 10.1038/339070a0; Guo XM, 2010, J BIOL CHEM, V285, P13223, DOI 10.1074/jbc.M110.102574; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Hammerle B, 2002, DEV BIOL, V246, P259, DOI 10.1006/dbio.2002.0675; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Jeeninga RE, 2000, J VIROL, V74, P3740, DOI 10.1128/JVI.74.8.3740-3751.2000; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Jordan A, 2001, EMBO J, V20, P1726, DOI 10.1093/emboj/20.7.1726; Kane M, 2013, NATURE, V502, P563, DOI 10.1038/nature12653; Kinoshita S, 1997, IMMUNITY, V6, P235, DOI 10.1016/S1074-7613(00)80326-X; Kok KH, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-78; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Kwon HS, 2008, CELL HOST MICROBE, V3, P158, DOI 10.1016/j.chom.2008.02.002; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Liu ZL, 2013, CELL HOST MICROBE, V14, P398, DOI 10.1016/j.chom.2013.08.015; Mao JH, 2002, J BIOL CHEM, V277, P35156, DOI 10.1074/jbc.M206743200; de Lagran MM, 2012, CEREB CORTEX, V22, P2867, DOI 10.1093/cercor/bhr362; Matsuo R, 2001, J IMMUNOL METHODS, V247, P141, DOI 10.1016/S0022-1759(00)00313-6; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Nguyen DG, 2006, J VIROL, V80, P130, DOI 10.1128/JVI.80.1.130-137.2006; Novis CL, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-119; Ogawa Y, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1090; Pagans S, 2005, PLOS BIOL, V3, P210, DOI 10.1371/journal.pbio.0030041; Park J, 2007, MOL CELL NEUROSCI, V36, P270, DOI 10.1016/j.mcn.2007.07.007; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Platt EJ, 2009, J VIROL, V83, P8289, DOI 10.1128/JVI.00709-09; Pozo N, 2013, J CLIN INVEST, V123, P2475, DOI 10.1172/JCI63623; Rachidi M, 2008, EUR J PAEDIATR NEURO, V12, P168, DOI 10.1016/j.ejpn.2007.08.010; Rato S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009276; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Sayah DM, 2004, NATURE, V430, P569, DOI 10.1038/nature02777; SEALY L, 1978, CELL, V14, P115, DOI 10.1016/0092-8674(78)90306-9; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Stroud JC, 2009, J MOL BIOL, V393, P98, DOI 10.1016/j.jmb.2009.08.023; Takeuchi Y, 2008, J VIROL, V82, P12585, DOI 10.1128/JVI.01726-08; van de Klundert MA, 2015, J VIRAL HEPAT; van't Wout AB, 2008, NAT PROTOC, V3, P363, DOI 10.1038/nprot.2008.3; VanLint C, 1996, EMBO J, V15, P1112, DOI 10.1002/j.1460-2075.1996.tb00449.x; Wei DG, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004071; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Woods YL, 2001, BIOCHEM J, V355, P597, DOI 10.1042/bj3550597; Yang EJ, 2001, J BIOL CHEM, V276, P39819, DOI 10.1074/jbc.M104091200; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yeung ML, 2009, J BIOL CHEM, V284, P19463, DOI 10.1074/jbc.M109.010033; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	74	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144229	10.1371/journal.pone.0144229	http://dx.doi.org/10.1371/journal.pone.0144229			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641855	gold, Green Published, Green Submitted			2022-12-27	WOS:000366902700079
J	Shi, JD; Zhang, J; Li, SJ; Sun, J; Teng, YM; Wu, MN; Li, JF; Li, YH; Hu, NZ; Wang, HX; Hu, YZ				Shi, Jiandong; Zhang, Jing; Li, Sijin; Sun, Jing; Teng, Yumei; Wu, Meini; Li, Jianfan; Li, Yanhan; Hu, Ningzhu; Wang, Haixuan; Hu, Yunzhang			Epitope-Based Vaccine Target Screening against Highly Pathogenic MERS-CoV: An In Silico Approach Applied to Emerging Infectious Diseases	PLOS ONE			English	Article							EAST RESPIRATORY SYNDROME; RECEPTOR-BINDING DOMAIN; T-CELL EPITOPES; MIDDLE-EAST; SYNDROME CORONAVIRUS; NUCLEOCAPSID PROTEIN; PEPTIDE BINDING; SPIKE PROTEIN; PREDICTION; IMMUNOGENICITY	Middle East respiratory syndrome coronavirus (MERS-CoV) with pandemic potential is a major worldwide threat to public health. However, vaccine development for this pathogen lags behind as immunity associated with protection is currently largely unknown. In this study, an immunoinformatics-driven genome-wide screening strategy of vaccine targets was performed to thoroughly screen the vital and effective dominant immunogens against MERS-CoV. Conservancy and population coverage analysis of the epitopes were done by the Immune Epitope Database. The results showed that the nucleocapsid (N) protein of MERS-CoV might be a better protective immunogen with high conservancy and potential eliciting both neutralizing antibodies and T-cell responses compared with spike (S) protein. Further, the B-cell, helper T-cell and cytotoxic T lymphocyte (CTL) epitopes were screened and mapped to the N protein. A total of 15 linear and 10 conformal B-cell epitopes that may induce protective neutralizing antibodies were obtained. Additionally, a total of 71 peptides with 9-mer core sequence were identified as helper T-cell epitopes, and 34 peptides were identified as CTL epitopes. Based on the maximum HLA binding alleles, top 10 helper T-cell epitopes and CTL epitopes that may elicit protective cellular immune responses against MERS-CoV were selected as MERS vaccine candidates. Population coverage analysis showed that the putative helper T-cell epitopes and CTL epitopes could cover the vast majority of the population in 15 geographic regions considered where vaccine would be employed. The B-and T-cell stimulation potentials of the screened epitopes is to be further validated for their efficient use as vaccines against MERS-CoV. Collectively, this study provides novel vaccine target candidates and may prompt further development of vaccines against MERS-CoV and other emerging infectious diseases.	[Shi, Jiandong; Zhang, Jing; Li, Sijin; Sun, Jing; Teng, Yumei; Wu, Meini; Li, Jianfan; Li, Yanhan; Hu, Ningzhu; Wang, Haixuan; Hu, Yunzhang] Chinese Acad Med Sci, Inst Med Biol, Kunming, Peoples R China; [Shi, Jiandong; Zhang, Jing; Li, Sijin; Sun, Jing; Teng, Yumei; Wu, Meini; Li, Jianfan; Li, Yanhan; Hu, Ningzhu; Wang, Haixuan; Hu, Yunzhang] Peking Union Med Coll, Kunming, Peoples R China; [Shi, Jiandong; Li, Sijin; Sun, Jing; Teng, Yumei; Wu, Meini; Li, Jianfan; Li, Yanhan; Hu, Ningzhu; Wang, Haixuan; Hu, Yunzhang] Chinese Acad Med Sci, Inst Med Biol, Yunnan Prov Key Lab Arbo Infect Dis Control Res P, Kunming, Peoples R China; [Zhang, Jing] Shijiazhuang Obstet & Gynecol Hosp, Prenatal Diag Ctr, Shijiazhuang, Hebei, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS	Hu, YZ (corresponding author), Chinese Acad Med Sci, Inst Med Biol, Kunming, Peoples R China.	huyunzhangym@126.com			Applied and Fundamental Research program of Yunnan Province [2013FA025, 2013BC011]	Applied and Fundamental Research program of Yunnan Province	This research was supported by grant from the Applied and Fundamental Research program of Yunnan Province (Grant No. 2013FA025 and 2013BC011), which were received by Yunzhang Hu and Ningzhu Hu. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almazan F, 2013, MBIO, V4, DOI 10.1128/mBio.00650-13; Bermingham A, 2012, EUROSURVEILLANCE, V17, P6; Briese T, 2014, MBIO, V5, DOI 10.1128/mBio.01146-14; Bui HH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-361; Bui HH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-153; Calis JJA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003266; Coleman CM, 2014, J VIROL, V88, P5209, DOI 10.1128/JVI.03488-13; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Doytchinova IA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-4; Du LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081587; Du LY, 2013, J VIROL, V87, P9939, DOI 10.1128/JVI.01048-13; Dutta NK, 2008, IMMUNOL LETT, V118, P65, DOI 10.1016/j.imlet.2008.03.003; EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985; Esser MT, 2003, VACCINE, V21, P419, DOI 10.1016/S0264-410X(02)00407-3; Firbas C, 2006, VACCINE, V24, P4343, DOI 10.1016/j.vaccine.2006.03.009; Gao X, 2015, J INFECTION, V71, P599, DOI 10.1016/j.jinf.2015.07.002; Guo XJ, 2015, IMMUNOLOGY, V145, P476, DOI 10.1111/imm.12462; Gupta V, 2006, VIROLOGY, V347, P127, DOI 10.1016/j.virol.2005.11.042; Han ZX, 2013, VIRUS RES, V171, P54, DOI 10.1016/j.virusres.2012.10.028; He LL, 2015, SCI REP-UK, V5, DOI 10.1038/srep12501; Hoof I, 2009, IMMUNOGENETICS, V61, P1, DOI 10.1007/s00251-008-0341-z; Hu H, 2009, BIOTECHNOL LETT, V31, P1685, DOI 10.1007/s10529-009-0061-y; Ithete NL, 2013, EMERG INFECT DIS, V19, P1697, DOI 10.3201/eid1910.130946; Kallberg M, 2014, METHODS MOL BIOL, V1137, P17, DOI 10.1007/978-1-4939-0366-5_2; Karosiene E, 2013, IMMUNOGENETICS, V65, P711, DOI 10.1007/s00251-013-0720-y; Kim E, 2014, VACCINE, V32, P5975, DOI 10.1016/j.vaccine.2014.08.058; Kim Y, 2012, NUCLEIC ACIDS RES, V40, pW525, DOI 10.1093/nar/gks438; KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q; Le TM, 2007, FEBS J, V274, P4211, DOI 10.1111/j.1742-4658.2007.05947.x; Liu DQ, 2012, APPL MICROBIOL BIOT, V93, P2437, DOI 10.1007/s00253-011-3734-0; Liu SJ, 2006, VACCINE, V24, P3100, DOI 10.1016/j.vaccine.2006.01.058; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Ma CL, 2006, CELL MOL IMMUNOL, V3, P459; Mackay IM, 2015, VIRUS RES, V202, P60, DOI 10.1016/j.virusres.2015.01.021; Maenaka K, 1999, CURR OPIN STRUC BIOL, V9, P745, DOI 10.1016/S0959-440X(99)00039-1; Mou H, 2013, J VIROL, V87, P9379, DOI 10.1128/JVI.01277-13; Muh HC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005861; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Nielsen M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000796; Peters B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-132; Purcell AW, 2007, NAT REV DRUG DISCOV, V6, P404, DOI 10.1038/nrd2224; Sidney John, 2008, Immunome Res, V4, P2, DOI 10.1186/1745-7580-4-2; Sominskaya I, 2010, CLIN VACCINE IMMUNOL, V17, P1027, DOI 10.1128/CVI.00468-09; Song F, 2013, J VIROL, V87, P11950, DOI 10.1128/JVI.01672-13; Stanekova Z, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-351; STERN LJ, 1994, STRUCTURE, V2, P245, DOI 10.1016/S0969-2126(00)00026-5; Tang J, 2015, HUM VACC IMMUNOTHER, V11, P1244, DOI 10.1080/21645515.2015.1021527; Terry FE, 2015, EXPERT REV VACCINES, V14, P21, DOI 10.1586/14760584.2015.955478; VIHINEN M, 1994, PROTEINS, V19, P141, DOI 10.1002/prot.340190207; Volz A, 2015, J VIROL, V89, P8651, DOI 10.1128/JVI.00614-15; Wang LS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8712; Wang NS, 2013, CELL RES, V23, P986, DOI 10.1038/cr.2013.92; Wilkins MR, 1999, METH MOL B, V112, P531; Wilson JA, 2001, J VIROL, V75, P2660, DOI 10.1128/JVI.75.6.2660-2664.2001; World Health Organization (WHO), 2019, MIDDLE E RESP SYNDRO; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhang LM, 2012, BRIEF BIOINFORM, V13, P350, DOI 10.1093/bib/bbr060; Zhang NR, 2014, EXPERT REV VACCINES, V13, P761, DOI 10.1586/14760584.2014.912134; Zhao JC, 2007, J VIROL, V81, P6079, DOI 10.1128/JVI.02568-06; Zheng NY, 2009, VACCINE, V27, P5001, DOI 10.1016/j.vaccine.2009.05.073; Zhou MH, 2006, J IMMUNOL, V177, P2138, DOI 10.4049/jimmunol.177.4.2138; Zumla A, 2015, LANCET, V386, P995, DOI 10.1016/S0140-6736(15)60454-8	62	31	35	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144475	10.1371/journal.pone.0144475	http://dx.doi.org/10.1371/journal.pone.0144475			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641892	Green Published, Green Submitted, gold			2022-12-27	WOS:000366902700133
J	Yoshikawa, K; Aikawa, S; Kojima, Y; Toya, Y; Furusawa, C; Kondo, A; Shimizu, H				Yoshikawa, Katsunori; Aikawa, Shimpei; Kojima, Yuta; Toya, Yoshihiro; Furusawa, Chikara; Kondo, Akihiko; Shimizu, Hiroshi			Construction of a Genome-Scale Metabolic Model of Arthrospira platensis NIES-39 and Metabolic Design for Cyanobacterial Bioproduction	PLOS ONE			English	Article							TRICARBOXYLIC-ACID CYCLE; SPIRULINA-PLATENSIS; ESCHERICHIA-COLI; CARBON-DIOXIDE; GREEN-ALGA; ETHANOL; RECONSTRUCTION; BIOSYNTHESIS; NETWORK; GENES	Arthrospira (Spirulina) platensis is a promising feedstock and host strain for bioproduction because of its high accumulation of glycogen and superior characteristics for industrial production. Metabolic simulation using a genome-scale metabolic model and flux balance analysis is a powerful method that can be used to design metabolic engineering strategies for the improvement of target molecule production. In this study, we constructed a genome-scale metabolic model of A. platensis NIES-39 including 746 metabolic reactions and 673 metabolites, and developed novel strategies to improve the production of valuable metabolites, such as glycogen and ethanol. The simulation results obtained using the metabolic model showed high consistency with experimental results for growth rates under several trophic conditions and growth capabilities on various organic substrates. The metabolic model was further applied to design a metabolic network to improve the autotrophic production of glycogen and ethanol. Decreased flux of reactions related to the TCA cycle and phosphoenolpyruvate reaction were found to improve glycogen production. Furthermore, in silico knockout simulation indicated that deletion of genes related to the respiratory chain, such as NAD(P)H dehydrogenase and cytochrome-c oxidase, could enhance ethanol production by using ammonium as a nitrogen source.	[Yoshikawa, Katsunori; Kojima, Yuta; Toya, Yoshihiro; Furusawa, Chikara; Shimizu, Hiroshi] Osaka Univ, Grad Sch Informat Sci & Technol, Dept Bioinformat Engn, Suita, Osaka 5650871, Japan; [Yoshikawa, Katsunori; Aikawa, Shimpei; Kojima, Yuta; Furusawa, Chikara; Kondo, Akihiko; Shimizu, Hiroshi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Chiyoda Ku, Tokyo 1020075, Japan; [Aikawa, Shimpei; Kondo, Akihiko] Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Nada Ku, Kobe, Hyogo 6578501, Japan; [Furusawa, Chikara] RIKEN, Quantitat Biol Ctr, Suita, Osaka 5650874, Japan	Osaka University; Japan Science & Technology Agency (JST); Kobe University; RIKEN	Shimizu, H (corresponding author), Osaka Univ, Grad Sch Informat Sci & Technol, Dept Bioinformat Engn, 1-5 Yamadaoka, Suita, Osaka 5650871, Japan.	shimizu@ist.osaka-u.ac.jp	Furusawa, Chikara/N-6103-2015; Shimizu, Hiroshi/C-3688-2017; Kondo, Akihiko/A-2130-2015; Furusawa, Chikara/ABB-6516-2021	Furusawa, Chikara/0000-0003-3554-4975; Shimizu, Hiroshi/0000-0002-8986-0861; Furusawa, Chikara/0000-0003-3554-4975; Toya, Yoshihiro/0000-0001-9670-6961; Aikawa, Shimpei/0000-0001-9202-0225	Core Research for Evolutional Science and Technology, Japan Science and Technology Agency, JAPAN	Core Research for Evolutional Science and Technology, Japan Science and Technology Agency, JAPAN(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This work was supported by Core Research for Evolutional Science and Technology, Japan Science and Technology Agency, JAPAN.	Aikawa S, 2013, ENERG ENVIRON SCI, V6, P1844, DOI 10.1039/c3ee40305j; Aikawa S, 2012, BIORESOURCE TECHNOL, V108, P211, DOI 10.1016/j.biortech.2012.01.004; Angermayr SA, 2009, CURR OPIN BIOTECH, V20, P257, DOI 10.1016/j.copbio.2009.05.011; Aoyama K, 1997, J FERMENT BIOENG, V83, P17, DOI 10.1016/S0922-338X(97)87320-5; Atsumi S, 2009, NAT BIOTECHNOL, V27, P1177, DOI 10.1038/nbt.1586; Cogne G, 2003, BIOTECHNOL BIOENG, V84, P667, DOI 10.1002/bit.10808; Deng MD, 1999, APPL ENVIRON MICROB, V65, P523; ERNST A, 1984, ARCH MICROBIOL, V140, P120, DOI 10.1007/BF00454913; Feist AM, 2008, NAT BIOTECHNOL, V26, P659, DOI 10.1038/nbt1401; Feist AM, 2009, NAT REV MICROBIOL, V7, P129, DOI 10.1038/nrmicro1949; Fujisawa T, 2010, DNA RES, V17, P85, DOI 10.1093/dnares/dsq004; Gao ZX, 2012, ENERG ENVIRON SCI, V5, P9857, DOI 10.1039/c2ee22675h; Hasunuma T, 2013, J EXP BOT, V64, P2943, DOI 10.1093/jxb/ert134; Joseph A, 2013, BIOSCI BIOTECH BIOCH, V77, P966, DOI 10.1271/bbb.120921; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Klanchui A, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-71; Knoop H, 2010, PLANT PHYSIOL, V154, P410, DOI 10.1104/pp.110.157198; Lee KH, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100196; Liu XY, 2011, P NATL ACAD SCI USA, V108, P6899, DOI 10.1073/pnas.1103014108; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; MARQUEZ FJ, 1993, J FERMENT BIOENG, V76, P408, DOI 10.1016/0922-338X(93)90034-6; Meechai A, 2004, BIOTECHNOL BIOPROC E, V9, P506, DOI 10.1007/BF02933494; MIKI W, 1986, B JPN SOC SCI FISH, V52, P1225; Montagud A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-156; Nakamura Y, 1998, NUCLEIC ACIDS RES, V26, P63, DOI 10.1093/nar/26.1.63; Nogales J, 2012, P NATL ACAD SCI USA, V109, P2678, DOI 10.1073/pnas.1117907109; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Ohira Y, 2009, KAGAKU KOGAKU RONBUN, V35, P553, DOI 10.1252/kakoronbunshu.35.553; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Osanai T, 2014, ENVIRON MICROBIOL, V16, P512, DOI 10.1111/1462-2920.12170; Park JH, 2011, BIOTECHNOL BIOENG, V108, P934, DOI 10.1002/bit.22995; PEARCE J, 1969, J GEN MICROBIOL, V55, P371, DOI 10.1099/00221287-55-3-371; Pulz O, 2004, APPL MICROBIOL BIOT, V65, P635, DOI 10.1007/s00253-004-1647-x; QUOC KP, 1993, BIOCHIM BIOPHYS ACTA, V1168, P94, DOI 10.1016/0005-2760(93)90271-A; Schilling CH, 1999, BIOTECHNOL PROGR, V15, P296, DOI 10.1021/bp990048k; Segre D., 2012, PLOS COMPUT BIOL, V8; Shastri AA, 2005, BIOTECHNOL PROGR, V21, P1617, DOI 10.1021/bp050246d; SMITH AJ, 1967, J BACTERIOL, V94, P972, DOI 10.1128/JB.94.4.972-983.1967; Sydney EB, 2010, BIORESOURCE TECHNOL, V101, P5892, DOI 10.1016/j.biortech.2010.02.088; Tokuyama K, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-64; Ueno Y, 1998, J FERMENT BIOENG, V86, P38, DOI 10.1016/S0922-338X(98)80031-7; Vazquez-Bermudez MF, 2000, J BACTERIOL, V182, P211, DOI 10.1128/JB.182.1.211-215.2000; VINCENZINI M, 1990, J BACTERIOL, V172, P2791, DOI 10.1128/jb.172.5.2791-2792.1990; Vonshak A., 2002, SPIRULINA PLATENSIS; Vu TT, 2013, BIOTECHNOL J, V8, P619, DOI 10.1002/biot.201200315; Yoshikawa K, 2011, APPL MICROBIOL BIOT, V92, P347, DOI 10.1007/s00253-011-3559-x; Zhang SY, 2011, SCIENCE, V334, P1551, DOI 10.1126/science.1210858	47	17	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144430	10.1371/journal.pone.0144430	http://dx.doi.org/10.1371/journal.pone.0144430			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26640947	Green Published, gold, Green Submitted			2022-12-27	WOS:000366902700119
J	Younge, JO; Wery, MF; Gotink, RA; Utens, EMWJ; Michels, M; Rizopoulos, D; van Rossum, EFC; Hunink, MGM; Roos-Hesselink, JW				Younge, John O.; Wery, Machteld F.; Gotink, Rinske A.; Utens, Elisabeth M. W. J.; Michels, Michelle; Rizopoulos, Dimitris; van Rossum, Elisabeth F. C.; Hunink, M. G. Myriam; Roos-Hesselink, Jolien W.			Web-Based Mindfulness Intervention in Heart Disease: A Randomized Controlled Trial	PLOS ONE			English	Article							HEALTH SURVEY SF-36; MIND-BODY MEDICINE; QUALITY-OF-LIFE; MULTIDIMENSIONAL SCALE; ENDOTHELIAL FUNCTION; PROGNOSTIC VALUE; STRESS; MEDITATION; ADULTS; METAANALYSIS	Background Evidence is accumulating that mindfulness training has favorable effects on psychological outcomes, but studies on physiological outcomes are limited. Patients with heart disease have a high incidence of physiological and psychological problems and may benefit from mindfulness training. Our aim was to determine the beneficial physiological and psychological effects of online mindfulness training in patients with heart disease. Methods The study was a pragmatic randomized controlled single-blind trial. Between June 2012 and April 2014 we randomized 324 patients (mean age 43.2 years, 53.7% male) with heart disease in a 2: 1 ratio (n = 215 versus n = 109) to a 12-week onlinemindfulness training in addition to usual care (UC) compared to UC alone. The primary outcome was exercise capacity measured with the 6 minute walk test (6MWT). Secondary outcomes were other physiological parameters (heart rate, blood pressure, respiratory rate, and NT-proBNP), subjective health status (SF-36), perceived stress (PSS), psychological well-being (HADS), social support (PSSS12) and a composite endpoint (all-cause mortality, heart failure, symptomatic arrhythmia, cardiac surgery, and percutaneous cardiac intervention). Linear mixed models were used to evaluate differences between groups on the repeated outcome measures. Results Compared to UC, mindfulness showed a borderline significant improved 6MWT (effect size, meters: 13.2, 95% CI: -0.02; 26.4, p = 0.050). There was also a significant lower heart rate in favor of the mindfulness group (effect size, beats per minute: -2.8, 95% CI: -5.4;-0.2, p = 0.033). No significant differences were seen on other outcomes. Conclusions Mindfulness training showed positive effects on the physiological parameters exercise capacity and heart rate and it might therefore be a useful adjunct to current clinical therapy in patients with heart disease.	[Younge, John O.; Michels, Michelle; Roos-Hesselink, Jolien W.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Cardiol, Rotterdam, Netherlands; [Younge, John O.; Wery, Machteld F.; Gotink, Rinske A.; Hunink, M. G. Myriam] Univ Med Ctr Rotterdam, Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Gotink, Rinske A.] Univ Med Ctr, Erasmus MC Rotterdam, Dept Psychiat, Sect Med Psychol & Psychotherapy, Rotterdam, Netherlands; [Utens, Elisabeth M. W. J.] Univ Med Ctr, Erasmus MC Rotterdam, Dept Adolescent Psychiat Psychol, Rotterdam, Netherlands; [Gotink, Rinske A.; Hunink, M. G. Myriam] Univ Med Ctr Rotterdam, Erasmus MC, Dept Radiol, Rotterdam, Netherlands; [Rizopoulos, Dimitris] Univ Med Ctr Rotterdam, Erasmus MC, Dept Biostat, Rotterdam, Netherlands; [van Rossum, Elisabeth F. C.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Hunink, M. G. Myriam] Harvard Univ, TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Harvard University; Harvard T.H. Chan School of Public Health	Roos-Hesselink, JW (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Cardiol, Rotterdam, Netherlands.	j.roos@erasmusmc.nl	Michels, Michelle/C-1687-2014; van Rossum, Elisabeth/AAP-9388-2020	Michels, Michelle/0000-0001-6432-0431; Gotink, Rinske/0000-0002-4760-3226	Erasmus MC	Erasmus MC	JOY, RAG, MGMH, and JWR received an internal grant from the Erasmus MC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3; Abbott RA, 2014, J PSYCHOSOM RES, V76, P341, DOI 10.1016/j.jpsychores.2014.02.012; Baer RA, 2003, CLIN PSYCHOL-SCI PR, V10, P125, DOI 10.1093/clipsy/bpg015; BENSON H, 1974, PSYCHIATRY, V37, P37, DOI 10.1080/00332747.1974.11023785; BENSON H, 1983, TRENDS NEUROSCI, V6, P281, DOI 10.1016/0166-2236(83)90120-0; Bishop SR, 2004, CLIN PSYCHOL-SCI PR, V11, P230, DOI 10.1093/clipsy/bph077; Clark AM, 2005, ANN INTERN MED, V143, P659, DOI 10.7326/0003-4819-143-9-200511010-00010; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Cohen S., 1988, SOCIAL PSYCHOL HLTH; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Crawford JR, 2001, BRIT J CLIN PSYCHOL, V40, P429, DOI 10.1348/014466501163904; Custodis F, 2011, STROKE, V42, P1742, DOI 10.1161/STROKEAHA.110.598607; De Bruaene AV, 2013, INT J CARDIOL, V168, P1386, DOI 10.1016/j.ijcard.2012.12.021; Diaz A, 2005, EUR HEART J, V26, P967, DOI 10.1093/eurheartj/ehi190; Diller GP, 2005, CIRCULATION, V112, P828, DOI 10.1161/CIRCULATIONAHA.104.529800; Dimopoulos K, 2006, CIRCULATION, V113, P2796, DOI 10.1161/CIRCULATIONAHA.105.594218; Ditto B, 2006, ANN BEHAV MED, V32, P227, DOI 10.1207/s15324796abm3203_9; Dod HS, 2010, AM J CARDIOL, V105, P362, DOI 10.1016/j.amjcard.2009.09.038; Emani S, 2010, CIRC-HEART FAIL, V3, P715, DOI 10.1161/CIRCHEARTFAILURE.110.951509; Germano G, 2012, EUR HEART J, V33, P137; Gluck TM, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-175; Goyal M, 2014, JAMA INTERN MED, V174, P357, DOI 10.1001/jamainternmed.2013.13018; Greeson JM, 2009, J EVID-BASED INTEGR, V14, P10, DOI 10.1177/1533210108329862; Gullestad L, 2005, J AM COLL CARDIOL, V45, P252, DOI 10.1016/j.jacc.2004.10.032; Heran BS, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001800.pub2, 10.1002/14651858.CD001800.pub3]; HJALMARSON A, 1990, AM J CARDIOL, V65, P547, DOI 10.1016/0002-9149(90)91029-6; Hofmann SG, 2010, J CONSULT CLIN PSYCH, V78, P169, DOI 10.1037/a0018555; Inuzuka R, 2012, CIRCULATION, V125, P250, DOI 10.1161/CIRCULATIONAHA.111.058719; KABATZINN J, 1982, GEN HOSP PSYCHIAT, V4, P33, DOI 10.1016/0163-8343(82)90026-3; Kempny A, 2013, INT J CARDIOL, V168, P4784, DOI 10.1016/j.ijcard.2013.07.227; Kind P, 1998, BMJ-BRIT MED J, V316, P736, DOI 10.1136/bmj.316.7133.736; Krusche A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000803; Lane DA, 2002, HEART, V88, P71, DOI 10.1136/heart.88.1.71; Maex E., 2006, MINDFULNESS MAALSTRO; Manzano L, 2011, EUR J HEART FAIL, V13, P528, DOI 10.1093/eurjhf/hfr030; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; Moons P, 2006, EUR J CARDIOV PREV R, V13, P407, DOI 10.1097/00149831-200606000-00017; Morledge TJ, 2013, ANN BEHAV MED, V46, P137, DOI 10.1007/s12160-013-9490-x; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nyklicek I, 2014, J BEHAV MED, V37, P135, DOI 10.1007/s10865-012-9475-4; Olivo EL, 2009, PSYCHOL HEALTH MED, V14, P513, DOI 10.1080/13548500902890087; Ospina Maria B, 2007, Evid Rep Technol Assess (Full Rep), P1; Parswani Manish J, 2013, Int J Yoga, V6, P111, DOI 10.4103/0973-6131.113405; Pedersen SS, 2009, PSYCHOSOMATICS, V50, P461, DOI 10.1176/appi.psy.50.5.461; Richardson S, 2012, AM J CARDIOL, V110, P1711, DOI 10.1016/j.amjcard.2012.08.004; Robert-McComb JJ, 2004, J ALTERN COMPLEM MED, V10, P819; Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0; Rostagno C, 2003, EUR J HEART FAIL, V5, P247, DOI 10.1016/S1388-9842(02)00244-1; Segal Z. V., 2002, MINDFULNESS BASED CO; Spatola CAM, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-22; Tacon AM, 2003, FAM COMMUNITY HEALTH, V26, P25, DOI 10.1097/00003727-200301000-00004; Taylor AG, 2010, EXPLORE-NY, V6, P29, DOI 10.1016/j.explore.2009.10.004; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Younge JO, 2015, EUR J PREV CARDIOL, V22, P1385, DOI 10.1177/2047487314549927; Zeidan F, 2010, J ALTERN COMPLEM MED, V16, P867, DOI 10.1089/acm.2009.0321; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2	57	33	34	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0143843	10.1371/journal.pone.0143843	http://dx.doi.org/10.1371/journal.pone.0143843			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1YS	26641099	Green Published, gold, Green Submitted			2022-12-27	WOS:000366902700030
J	Zhu, ZX; Cai, WH; Wang, T; Ye, HB; Zhu, YT; Chi, LS; Duan, YM; Sun, CC; Xuan, YH; Jin, LT				Zhu, Zhong Xin; Cai, Wan Hui; Wang, Tao; Ye, Hong Bo; Zhu, Yu Ting; Chi, Li Sha; Duan, Yuan Meng; Sun, Cong Cong; Xuan, Yuan Hu; Jin, Li Tai			bFGF-Regulating MAPKs Are Involved in High Glucose-Mediated ROS Production and Delay of Vascular Endothelial Cell Migration	PLOS ONE			English	Article							DIABETES-MELLITUS; GROWTH-FACTOR; SKIN REGENERATION; FIBROBLAST; ANGIOGENESIS; DYSFUNCTION; DEATH; RATS; JNK	High blood sugar is a symptom of diabetes mellitus (DM). Vascular endothelial cells (VECs) directly contact the blood and are damaged when blood sugar levels are high. However, the molecular mechanism underlying this process remains elusive. To analyze the effects of DM on migration, we simulated DM by applying high glucose (HG) to the human VEC. HG delayed cell migration and induced phosphorylation of MAPKs (JNK and ERK). By contrast, in presence of bFGF, cell migration was promoted and MAPK phosphorylation levels were reduced. Furthermore, treatment with JNK and ERK inhibitors rescued HG-mediated delay of cell migration. Molecular and cell biological studies demonstrated that HG increased ROS production, whereas treatment with bFGF or JNK/ERK inhibitors blocked HG-induced ROS accumulation. Addition of MnTMPyP, a ROS scavenger, reduced HG-induced ROS production and accelerated cell migration, suggesting that the influence of HG on bFGF-MAPK signaling causes accumulation of ROS, which in turn regulate cell migration. This is the first study to elucidate the molecular mechanism of HG-mediated VEC migration; these findings could facilitate the development of novel therapies for DM.	[Zhu, Zhong Xin; Cai, Wan Hui; Wang, Tao; Zhu, Yu Ting; Chi, Li Sha; Duan, Yuan Meng; Sun, Cong Cong; Xuan, Yuan Hu; Jin, Li Tai] Wenzhou Med Univ, Sch Pharmaceut Sci, Key Lab Biotechnol Pharmaceut Engn, Wenzhou 325000, Peoples R China; [Ye, Hong Bo] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Wenzhou Medical University; Stanford University	Xuan, YH (corresponding author), Wenzhou Med Univ, Sch Pharmaceut Sci, Key Lab Biotechnol Pharmaceut Engn, Wenzhou 325000, Peoples R China.	yhxuan@wzmc.edu.cn; jin_litai@126.com		, Yuanhu/0000-0002-4704-8090	National Nature Science Foundation of China [81371753, 81573069, 81201245]; Zhejiang Key Health Science and Technology [WKJ-ZJ-1415]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Key Health Science and Technology	This work was supported by grants from the National Nature Science Foundation of China (No. 81371753, No. 81573069, and No. 81201245), Zhejiang Key Health Science and Technology Project (WKJ-ZJ-1415).	Abaci A, 1999, CIRCULATION, V99, P2239, DOI 10.1161/01.CIR.99.17.2239; ARNOLD F, 1991, PHARMACOL THERAPEUT, V52, P407, DOI 10.1016/0163-7258(91)90034-J; Barr RK, 2001, INT J BIOCHEM CELL B, V33, P1047, DOI 10.1016/S1357-2725(01)00093-0; Bikfalvi A, 1997, ENDOCR REV, V18, P26, DOI 10.1210/er.18.1.26; Brahmbhatt AA, 2003, J BIOL CHEM, V278, P13016, DOI 10.1074/jbc.M211873200; Cai L, 2006, J AM COLL CARDIOL, V48, P1688, DOI 10.1016/j.jacc.2006.07.022; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Currie CJ, 1998, DIABETES CARE, V21, P42, DOI 10.2337/diacare.21.1.42; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hauck CR, 2001, CANCER RES, V61, P7079; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Kanazawa S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012228; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Lamers ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022865; Lan CCE, 2008, BRIT J DERMATOL, V159, P1103, DOI 10.1111/j.1365-2133.2008.08789.x; LANGENSTROER P, 1992, AM J PHYSIOL, V263, pH257, DOI 10.1152/ajpheart.1992.263.1.H257; Lee H, 2000, AM J PHYSIOL-CELL PH, V278, pC612, DOI 10.1152/ajpcell.2000.278.3.C612; Lerman OZ, 2003, AM J PATHOL, V162, P303, DOI 10.1016/S0002-9440(10)63821-7; LORENZI M, 1985, DIABETES, V34, P621, DOI 10.2337/diabetes.34.7.621; LORENZI M, 1991, DIABETES, V40, P653, DOI 10.2337/diabetes.40.6.653; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; ONO H, 1988, THROMB HAEMOSTASIS, V60, P174; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sheetz MJ, 2002, JAMA-J AM MED ASSOC, V288, P2579, DOI 10.1001/jama.288.20.2579; Shenouda SM, 2011, CIRCULATION, V124, P444, DOI 10.1161/CIRCULATIONAHA.110.014506; Shi HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059966; TESFAMARIAM B, 1992, AM J PHYSIOL, V263, pH321, DOI 10.1152/ajpheart.1992.263.2.H321; Uyen HD, 2002, J CELL SCI, V115, P3073; Waltenberger J, 2001, CARDIOVASC RES, V49, P554, DOI 10.1016/S0008-6363(00)00228-5; Xuan YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108182; Yang Y, 2011, BIOMATERIALS, V32, P4243, DOI 10.1016/j.biomaterials.2011.02.042; Yu HY, 2014, INJURY, V45, P1054, DOI 10.1016/j.injury.2014.03.003	32	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144495	10.1371/journal.pone.0144495	http://dx.doi.org/10.1371/journal.pone.0144495			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26642060	Green Published, gold, Green Submitted			2022-12-27	WOS:000366902700134
J	Egan, AM; Sweeney, T; Hayes, M; O'Doherty, JV				Egan, Aine M.; Sweeney, Torres; Hayes, Maria; O'Doherty, John V.			Prawn Shell Chitosan Has Anti-Obesogenic Properties, Influencing Both Nutrient Digestibility and Microbial Populations in a Pig Model	PLOS ONE			English	Article							GUT MICROBIOTA; BODY-WEIGHT; GASTROINTESTINAL-TRACT; SMALL-INTESTINE; FOOD-INTAKE; OBESITY; LEPTIN; LACTOBACILLUS; INSULIN; DIETARY	The potential of natural products to prevent obesity have been investigated, with evidence to suggest that chitosan has anti-obesity effects. The current experiment investigated the anti-obesity potential of prawn shell derived chitosan on a range of variables relevant to obesity in a pig model. The two dietary treatment groups included in this 63 day study were: T1) basal diet and T2) basal diet plus 1000 ppm chitosan (n = 20 gilts per group (70 +/- 0.90 kg). The parameter categories which were assessed included: performance, nutrient digestibility, serum leptin concentrations, nutrient transporter and digestive enzyme gene expression and gut microbial populations. Pigs offered chitosan had reduced feed intake and final body weight (P<0.001), lower ileal digestibility of dry matter (DM), gross energy (GE) (P<0.05) and reduced coefficient of apparent total tract digestibility (CATTD) of gross energy and nitrogen (P<0.05) when compared to the basal group. Fatty acid binding protein 2 (FABP2) gene expression was down-regulated in pigs offered chitosan (P = 0.05) relative to the basal diet. Serum leptin concentrations increased (P<0.05) in animals offered the chitosan diet compared to pigs offered the basal diet. Fatness traits, back-fat depth (mm), fat content (kg), were significantly reduced while lean meat (%) was increased (P<0.05) in chitosan supplemented pigs. Pigs offered chitosan had decreased numbers of Firmicutes in the colon (P < 0.05), and Lactobacillus spp. in both the caecum (P < 0.05) and colon (P <0.001). Bifidobacteria populations were increased in the caecum of animals offered the chitosan diet (P < 0.05). In conclusion, these findings suggest that prawn shell chitosan has potent anti-obesity/body weight control effects which are mediated through multiple biological systems in vivo.	[Egan, Aine M.; O'Doherty, John V.] Univ Coll Dublin, Sch Agr & Food Sci, Dublin 4, Ireland; [Sweeney, Torres] Univ Coll Dublin, Sch Vet Med, Dublin 4, Ireland; [Hayes, Maria] TEAGASC, Food Res Ctr, Dublin 15, Ireland	University College Dublin; University College Dublin; Teagasc	O'Doherty, JV (corresponding author), Univ Coll Dublin, Sch Agr & Food Sci, Dublin 4, Ireland.	john.vodoherty@ucd.ie	O'Doherty, John/AAS-7261-2021	O'Doherty, John/0000-0002-0906-4065; Sweeney, Torres/0000-0003-2639-395X	Marine Institute [MFFRI/07/01]; Department of Agriculture, Food and the Marine	Marine Institute; Department of Agriculture, Food and the Marine	This study was supported financially (Grant-Aid Agreement No. MFFRI/07/01) under the Sea Change Strategy with the support of the Marine Institute and the Department of Agriculture, Food and the Marine, funded under the National Development Plan 2007-2013.	[Anonymous], 2012, NUTR REQ SWIN; Armougom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007125; Baskin DG, 1999, BRAIN RES, V848, P114, DOI 10.1016/S0006-8993(99)01974-5; BRADY LS, 1990, NEUROENDOCRINOLOGY, V52, P441, DOI 10.1159/000125626; CAMPBELL RG, 1988, J ANIM SCI, V66, P676; Cardinelli CS, 2015, OBES SURG, V25, P346, DOI 10.1007/s11695-014-1525-2; CLOSE WH, 1994, PRINCIPLES OF PIG SCIENCE, P123; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; de Wit NJW, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-14; DiBaise JK, 2012, AM J GASTROENTEROL S, V1, P22, DOI [10.1038/ajgsup.2012.5, DOI 10.1038/AJGSUP.2012.5]; Dyer CJ, 1999, DOMEST ANIM ENDOCRIN, V16, P145, DOI 10.1016/S0739-7240(99)00011-9; Gajda AM, 2015, PROSTAG LEUKOTR ESS, V93, P9, DOI 10.1016/j.plefa.2014.10.001; Han LK, 1999, INT J OBESITY, V23, P174, DOI 10.1038/sj.ijo.0800806; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Heim G, 2014, THE BRITISH JOURNAL, P1; Houseknecht KL, 2003, NUTR RES REV, V16, P83, DOI 10.1079/NRR200256; Klok MD, 2007, OBES REV, V8, P21, DOI 10.1111/j.1467-789X.2006.00270.x; Kumar SG, 2009, PROTEOMICS, V9, P2149, DOI 10.1002/pmic.200800571; Lee C, 2006, J BIOTECHNOL, V123, P273, DOI 10.1016/j.jbiotec.2005.11.014; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Macfarlane S, 2003, P NUTR SOC, V62, P67, DOI 10.1079/PNS2002207; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; MCCARTHY JF, 1977, CAN J ANIM SCI, V57, P131, DOI 10.4141/cjas77-015; Million M, 2012, MICROB PATHOGENESIS, V53, P100, DOI 10.1016/j.micpath.2012.05.007; Mott CR, 2008, POULTRY SCI, V87, P2215, DOI 10.3382/ps.2008-00101; MUZZARELLI RAA, 1985, CARBOHYD POLYM, V5, P461, DOI 10.1016/0144-8617(85)90005-0; O'Connell JM, 2006, ANIM FEED SCI TECH, V127, P73, DOI 10.1016/j.anifeedsci.2005.09.002; O'Shea CJ, 2012, J ANIM SCI, V90, P3848, DOI 10.2527/jas.2011-4461; O'Shea CJ, 2011, J ANIM SCI, V89, P1366, DOI 10.2527/jas.2010-2922; Santacruz A, 2009, OBESITY, V17, P1906, DOI 10.1038/oby.2009.112; SAS Institute Inc, 2004, SAS US GUID; Sclafani A, 2012, AM J PHYSIOL-REG I, V302, pR1119, DOI 10.1152/ajpregu.00038.2012; Shen J, 2013, MOL ASPECTS MED, V34, P39, DOI 10.1016/j.mam.2012.11.001; Shiraishi T, 2000, PHYSIOL BEHAV, V71, P251, DOI 10.1016/S0031-9384(00)00341-3; Sumiyoshi M, 2006, J PHARM PHARMACOL, V58, P201, DOI 10.1211/jpp.58.2.0007; Sweeney T, 2012, BRIT J NUTR, V108, P1226, DOI 10.1017/S0007114511006751; Tran G., 2004, TABLE COMPOSITION NU, V1st ed.; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Varley PF, 2011, LIVEST SCI, V135, P282, DOI 10.1016/j.livsci.2010.07.025; Walsh AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053828; Woods SC, 2008, J CLIN ENDOCR METAB, V93, pS37, DOI 10.1210/jc.2008-1630	43	24	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144127	10.1371/journal.pone.0144127	http://dx.doi.org/10.1371/journal.pone.0144127			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636332	Green Submitted, Green Published, gold			2022-12-27	WOS:000366143800045
J	Richard, P; Shin, P; Beeson, T; Burke, LS; Wood, SF; Rosenbaum, S				Richard, Patrick; Shin, Peter; Beeson, Tishra; Burke, Laura S.; Wood, Susan F.; Rosenbaum, Sara			Quality and Cost of Diabetes Mellitus Care in Community Health Centers in the United States	PLOS ONE			English	Article							RETRANSFORMATION; MODELS; ADO	Objective To examine variations in the quality and cost of care provided to patients with diabetes mellitus by Community Health Centers (CHCs) compared to other primary care settings. Research Design and Methods We used data from the 2005- 2008 Medical Expenditure Panel Survey (N = 2,108). We used two dependent variables: quality of care and ambulatory care expenditures. Our primary independent variable was whether the respondent received care in a Community Health Centers (CHCs) or not. We estimated logistic regression models to determine the probability of quality of care, and used generalized linear models with log link and gamma distribution to predict expenditures for CHC users compared to non- users of CHCs, conditional on patients with positive expenditures. Results Results showed that variations of quality between CHC users and non- CHC users were not statistically significant. Patients with diabetes mellitus who used CHCs saved payers and individuals approximately $ 1,656 in ambulatory care costs compared to non- users of CHCs. Conclusions These findings suggest an opportunity for policymakers to control costs for diabetes mellitus patients without having a negative impact on quality of care.	[Richard, Patrick; Burke, Laura S.] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biometr, Bethesda, MD 20814 USA; [Shin, Peter; Beeson, Tishra; Wood, Susan F.; Rosenbaum, Sara] George Washington Univ, Milken Inst Sch Publ Hlth, Dept Hlth Policy & Management, Washington, DC USA; [Beeson, Tishra] Cent Washington Univ, Ellensburg, WA USA	Uniformed Services University of the Health Sciences - USA; George Washington University; Central Washington University	Richard, P (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biometr, Bethesda, MD 20814 USA.	patrick.richard@usuhs.edu						Aday L A, 1974, Health Serv Res, V9, P208; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Beal A, 2010, J HEALTH CARE POOR U, V21, P591, DOI 10.1353/hpu.0.0305; Buntin MB, 2004, J HEALTH ECON, V23, P525, DOI 10.1016/j.jhealeco.2003.10.005; Cameron A.C., 2008, MICROECONOMETRICS US; Chin MH, 2000, AM J PUBLIC HEALTH, V90, P431, DOI 10.2105/AJPH.90.3.431; Chin MH, 2001, DIABETES CARE, V24, P268, DOI 10.2337/diacare.24.2.268; Deb P, 2006, MODELING HLTH CARE C; DEFRIESE GH, 1975, MILBANK FUND Q, V53, P117, DOI 10.2307/3349523; Frick Kevin, 2007, Prog Community Health Partnersh, V1, P75, DOI 10.1353/cpr.0.0003; Jacobs J, 2009, DIABETIC MED, V8, pS23; Ku L, USING PRIMARY CARE B; Manning WG, 2001, J HEALTH ECON, V20, P461, DOI 10.1016/S0167-6296(01)00086-8; Manning WG, 1998, J HEALTH ECON, V17, P283, DOI 10.1016/S0167-6296(98)00025-3; McRae T, 2006, EVALUATION COST EFFE; Mullahy J, 1998, J HEALTH ECON, V17, P247, DOI 10.1016/S0167-6296(98)00030-7; Petersen M, 2008, DIABETES CARE, V31, P1271, DOI 10.2337/dc08-9017; Porterfield DS, 2002, DIABETES CARE, V25, P319, DOI 10.2337/diacare.25.2.319; Richard P, 2011, PREV CHRONIC DIS, V8; Shi LY, 2003, SOUTH MED J, V96, P787, DOI 10.1097/01.SMJ.0000066811.53167.2E; Streeter S, 2009, EFFECT COMMUNITY HLT; Ulmer C, 2000, J Ambul Care Manage, V23, P23	22	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144075	10.1371/journal.pone.0144075	http://dx.doi.org/10.1371/journal.pone.0144075			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY1CH	26636324	Green Submitted, Green Published, gold			2022-12-27	WOS:000366143800038
J	Vega, D; Vila-Ballo, A; Soto, A; Amengual, J; Ribas, J; Torrubia, R; Rodriguez-Fornells, A; Marco-Pallares, J				Vega, Daniel; Vila-Ballo, Adria; Soto, Angel; Amengual, Julia; Ribas, Joan; Torrubia, Rafael; Rodriguez-Fornells, Antoni; Marco-Pallares, Josep			Preserved Error-Monitoring in Borderline Personality Disorder Patients with and without Non-Suicidal Self-Injury Behaviors	PLOS ONE			English	Article							EMOTION DYSREGULATION; ERP COMPONENTS; POTENTIALS; MARKERS; VERSION; SYSTEM; MODEL; TASK	Background The presence of non-suicidal self-injury acts in Borderline Personality Disorder (BPD) is very prevalent. These behaviors are a public health concern and have become a poorly understood phenomenon in the community. It has been proposed that the commission of non-suicidal self-injury might be related to a failure in the brain network regulating executive functions. Previous studies have shown that BPD patients present an impairment in their capacity to monitor actions and conflicts associated with the performance of certain actions, which suppose an important aspect of cognitive control. Method We used Event Related Potentials to examine the behavioral and electrophysiological indexes associated with the error monitoring in two BPD outpatients groups (17 patients each) differentiated according to the presence or absence of non-suicidal self-injury behaviors. We also examined 17 age-and intelligence-matched healthy control participants. Results The three groups did not show significant differences in event-related potentials associated with errors (Error-Related Negativity and Pe) nor in theta power increase following errors. Conclusions This is the first study investigating the behavioral and electrophysiological error monitoring indexes in BPD patients characterized by their history of non-suicidal self-injury behaviors. Our results show that error monitoring is preserved in BPD patients and suggest that non-suicidal self-injury acts are not related to a dysfunction in the cognitive control mechanisms.	[Vega, Daniel; Soto, Angel; Ribas, Joan] Consorci Sanitari Anoia, Dept Psychiat & Mental Hlth, Barcelona, Spain; [Vega, Daniel; Torrubia, Rafael] Univ Autonoma Barcelona, Dept Psiquiatria & Med Legal, Unitat Psicol Med, E-08193 Barcelona, Spain; [Vega, Daniel; Torrubia, Rafael] Univ Autonoma Barcelona, Inst Neurociencies, E-08193 Barcelona, Spain; [Vega, Daniel; Vila-Ballo, Adria; Amengual, Julia; Rodriguez-Fornells, Antoni; Marco-Pallares, Josep] IDIBELL, Bellvitge Biomed Res Inst, Cognit & Brain Plast Grp, Barcelona, Spain; [Rodriguez-Fornells, Antoni; Marco-Pallares, Josep] Univ Barcelona, Dept Basic Psychol, Barcelona, Spain; [Rodriguez-Fornells, Antoni] Catalan Inst Res & Adv Studies ICREA, Barcelona, Spain; [Marco-Pallares, Josep] Univ Barcelona, IR3C, Inst Recerca Cervell Cognicio & Conducta, Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; University of Barcelona; ICREA; University of Barcelona	Marco-Pallares, J (corresponding author), IDIBELL, Bellvitge Biomed Res Inst, Cognit & Brain Plast Grp, Barcelona, Spain.	josepmarco@gmail.com	Marco-Pallares, Josep/C-1256-2008; vega, daniel/AAB-7859-2019; Marco-Pallares, Josep/GNH-1787-2022; Vilà-Balló, Adrià/AAB-2206-2021; Vega, Daniel/G-1995-2016; Torrubia, Rafael/C-4815-2009; Vila-Ballo, Adria/A-8357-2018; Rodriguez Fornells, Antoni/L-5878-2014	Marco-Pallares, Josep/0000-0001-9175-1480; Marco-Pallares, Josep/0000-0001-9175-1480; Amengual, Julian/0000-0002-8613-6325; Torrubia, Rafael/0000-0002-6826-6572; Vila-Ballo, Adria/0000-0001-7593-6012; Vega, Daniel/0000-0002-5621-8987; Rodriguez Fornells, Antoni/0000-0002-3249-6931	Fundacio La Marato de TV3 [2009-092410]; Spanish Ministry of Science [PSI2012-37472, PSI2011-29219]; Catalan Government [SGR 93]; Ramon y Cajal Grant [RYC-2007-01614]; IDIBELL grant [06/IDB-001]; Spanish grants from the MINECO [PSI2012-37472, PSI2011-29219]; Catalan Government (Generalitat de Catalunya) [SGR 93]; ICREA Funding Source: Custom	Fundacio La Marato de TV3; Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Catalan Government; Ramon y Cajal Grant(Spanish Government); IDIBELL grant; Spanish grants from the MINECO; Catalan Government (Generalitat de Catalunya)(Generalitat de Catalunya); ICREA(ICREA)	This research was funded by the "Fundacio La Marato de TV3" (2009-092410; www.tv3.cat/marato), Spanish Ministry of Science (www.idi.mineco.gob.es) to JMP (PSI2012-37472) and ARF (PSI2011-29219) and Catalan Government to ARF (2009 SGR 93; www10.gencat.cat). JMP was supported by the Ramon y Cajal Grant (RYC-2007-01614; www.idi.mineco.gob.es) and AVB by a predoctoral IDIBELL grant (06/IDB-001; www.idibell.cat). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project has been supported by grants from Fundacio La Marato de TV3 (2009-092410), Spanish grants from the MINECO (PSI2011-29219 to A.R.F and PSI2012-37472 to J.M.P.) and the Catalan Government (Generalitat de Catalunya, 2009 SGR 93).	Almeida JRC, 2009, PSYCHIAT RES-NEUROIM, V171, P54, DOI 10.1016/j.pscychresns.2008.02.001; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Band GPH, 1999, ACTA PSYCHOL, V101, P179, DOI 10.1016/S0001-6918(99)00005-0; Band GPH, 2003, ACTA PSYCHOL, V112, P105, DOI 10.1016/S0001-6918(02)00079-3; Barrachina J, 2004, ACTAS ESP PSIQUIATRI, V32, P293; Bernat EM, 2011, J ABNORM PSYCHOL, V120, P352, DOI 10.1037/a0022124; Bohus M, 2009, PSYCHOPATHOLOGY, V42, P32, DOI 10.1159/000173701; Bolla KI, 2004, CEREB CORTEX, V14, P1226, DOI 10.1093/cercor/bhh083; Carpenter RW, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-012-0335-2; Chapman AL, 2006, BEHAV RES THER, V44, P371, DOI 10.1016/j.brat.2005.03.005; Crowell SE, 2009, PSYCHOL BULL, V135, P495, DOI 10.1037/a0015616; Davis JM, 2004, J CLIN PSYCHOPHARM, V24, P192, DOI 10.1097/01.jcp.0000117422.05703.ae; de Bruijn ERA, 2006, BRAIN RES, V1105, P122, DOI 10.1016/j.brainres.2006.01.006; de Bruijn ERA, 2006, J PSYCHIATR RES, V40, P428, DOI 10.1016/j.jpsychires.2005.09.004; de Bruijn ERA, 2004, PSYCHOPHARMACOLOGY, V177, P151, DOI 10.1007/s00213-004-1915-6; Dougherty DM, 2009, PSYCHIAT RES, V169, P22, DOI 10.1016/j.psychres.2008.06.011; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Falkenstein M, 2000, BIOL PSYCHOL, V51, P87, DOI 10.1016/S0301-0511(99)00031-9; Falkenstein M., 1990, PSYCHOPHYSIOLOGICAL, P192; Fikke LT, 2011, PSYCHOL MED, V41, P601, DOI 10.1017/S0033291710001030; First M. B., 1997, STRUCTURED CLIN INTE; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Glenn CR, 2011, ASSESSMENT, V18, P375, DOI 10.1177/1073191111411669; Glenn CR, 2009, J PERS DISORD, V23, P20, DOI 10.1521/pedi.2009.23.1.20; Hagenhoff M, 2013, PSYCHIAT RES, V210, P224, DOI 10.1016/j.psychres.2013.05.016; HERPERTZ S, 1995, ACTA PSYCHIAT SCAND, V91, P57, DOI 10.1111/j.1600-0447.1995.tb09743.x; Herpertz S, 1997, J PSYCHIAT RES, V31, P451, DOI 10.1016/S0022-3956(97)00004-6; Holroyd CB, 1998, NEUROSCI LETT, V242, P65, DOI 10.1016/S0304-3940(98)00035-4; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Holtmann J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00054; Janis IB, 2009, PSYCHIAT RES, V169, P261, DOI 10.1016/j.psychres.2008.06.041; JENNINGS JR, 1976, PSYCHOPHYSIOLOGY, V13, P277; Jollant F, 2005, AM J PSYCHIAT, V162, P304, DOI 10.1176/appi.ajp.162.2.304; Joyce CA, 2004, PSYCHOPHYSIOLOGY, V41, P313, DOI 10.1111/j.1469-8986.2003.00141.x; King-Casas B, 2008, SCIENCE, V321, P806, DOI 10.1126/science.1156902; Klonsky ED, 2011, PSYCHOL MED, V41, P1981, DOI 10.1017/S0033291710002497; Klonsky ED, 2007, CLIN PSYCHOL REV, V27, P226, DOI 10.1016/j.cpr.2006.08.002; Klonsky ED, 2009, J PSYCHOPATHOL BEHAV, V31, P215, DOI 10.1007/s10862-008-9107-z; Kramer UM, 2007, J NEUROSCI, V27, P14190, DOI 10.1523/JNEUROSCI.4229-07.2007; Krause-Utz A, 2013, J NERV MENT DIS, V201, P116, DOI 10.1097/NMD.0b013e31827f6462; Lampe K, 2007, PSYCHOL MED, V37, P1717, DOI 10.1017/S0033291707000517; LeGris J, 2012, PSYCHIAT RES, V196, P101, DOI 10.1016/j.psychres.2011.10.008; Lenzenweger MF, 2007, BIOL PSYCHIAT, V62, P553, DOI 10.1016/j.biopsych.2006.09.019; Linehan M. M., 1987, J PERS DISORD, V1, P328, DOI DOI 10.1521/PEDI.1987.1.4.328; LINEHAN MM, 1993, ARCH GEN PSYCHIAT, V50, P971; LINEHAN MM, 1991, ARCH GEN PSYCHIAT, V48, P1060; Mak ADP, 2013, CURR OPIN PSYCHIATR, V26, P90, DOI 10.1097/YCO.0b013e32835b57a9; Manoach DS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00350; Moran TP, 2012, INT J PSYCHOPHYSIOL, V85, P188, DOI 10.1016/j.ijpsycho.2012.05.005; Nieuwenhuis S, 2001, PSYCHOPHYSIOLOGY, V38, P752, DOI 10.1017/S0048577201001111; Nock MK, 2010, ANNU REV CLIN PSYCHO, V6, P339, DOI 10.1146/annurev.clinpsy.121208.131258; Nock MK, 2004, J CONSULT CLIN PSYCH, V72, P885, DOI 10.1037/0022-006X.72.5.885; Olvet DM, 2008, CLIN PSYCHOL REV, V28, P1343, DOI 10.1016/j.cpr.2008.07.003; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Perez V, 2007, ACTAS ESP PSIQUIATRI, V35, P229; Perez-Prieto F, 2008, ADAPTACION ESPANOLA; Rodriguez-Fornells A, 2002, J NEUROSCI, V22, P9990; Ruchsow M, 2006, BIOL PSYCHOL, V72, P133, DOI 10.1016/j.biopsycho.2005.08.006; Sackeim Harold A., 2001, Journal of Clinical Psychiatry, V62, P10; Schuermann B, 2011, PSYCHOL MED, V41, P1917, DOI 10.1017/S003329171000262X; Silbersweig D, 2007, AM J PSYCHIAT, V164, P1832, DOI 10.1176/appi.ajp.2007.06010126; Soler J, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-139; TallonBaudry C, 1997, J NEUROSCI, V17, P722; Ullsperger M, 2006, INT J PSYCHOPHYSIOL, V59, P59, DOI 10.1016/j.ijpsycho.2005.06.010; Vederman AC, 2012, CORTEX, V48, P1027, DOI 10.1016/j.cortex.2011.03.017; Vega D, 2013, BIOL PSYCHOL, V94, P388, DOI 10.1016/j.biopsycho.2013.08.002; Vila-Ballo A, 2014, BIOL PSYCHOL, V102, P141, DOI 10.1016/j.biopsycho.2014.07.021; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI 10.1037/0033-295x.111.4.931; Zanarini MC, 2008, ACTA PSYCHIAT SCAND, V117, P177, DOI 10.1111/j.1600-0447.2008.01155.x; Zanarini MC, 2013, J PERS DISORD, V27, P783, DOI 10.1521/pedi_2013_27_115	73	13	13	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143994	10.1371/journal.pone.0143994	http://dx.doi.org/10.1371/journal.pone.0143994			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY1CH	26636971	Green Published, gold			2022-12-27	WOS:000366143800035
J	Frandsen, SK; Gibot, L; Madi, M; Gehl, J; Rols, MP				Frandsen, Stine Krog; Gibot, Laure; Madi, Moinecha; Gehl, Julie; Rols, Marie-Pierre			Calcium Electroporation: Evidence for Differential Effects in Normal and Malignant Cell Lines, Evaluated in a 3D Spheroid Model	PLOS ONE			English	Article							STANDARD OPERATING PROCEDURES; IRREVERSIBLE ELECTROPORATION; BLADDER-CANCER; CUTANEOUS METASTASES; ELECTROCHEMOTHERAPY; SKIN; ELECTROPERMEABILIZATION; MECHANISMS; BLEOMYCIN; ABLATION	Background Calcium electroporation describes the use of high voltage electric pulses to introduce supraphysiological calcium concentrations into cells. This promising method is currently in clinical trial as an anti-cancer treatment. One very important issue is the relation between tumor cell kill efficacy-and normal cell sensitivity. Methods Using a 3D spheroid cell culture model we have tested the effect of calcium electroporation and electrochemotherapy using bleomycin on three different human cancer cell lines: a colorectal adenocarcinoma (HT29), a bladder transitional cell carcinoma (SW780), and a breast adenocarcinoma (MDA-MB231), as well as on primary normal human dermal fibroblasts (HDF-n). Results The results showed a clear reduction in spheroid size in all three cancer cell spheroids three days after treatment with respectively calcium electroporation (p<0.0001) or electrochemotherapy using bleomycin (p<0.0001). Strikingly, the size of normal fibroblast spheroids was neither affected after calcium electroporation nor electrochemotherapy using bleomycin, indicating that calcium electroporation, like electrochemotherapy, will have limited adverse effects on the surrounding normal tissue when treating with calcium electroporation. The intracellular ATP level, which has previously been shown to be depleted after calcium electroporation, was measured in the spheroids after treatment. The results showed a dramatic decrease in the intracellular ATP level (p<0.01) in all four spheroid types-malignant as well as normal. Conclusion In conclusion, calcium electroporation seems to be more effective in inducing cell death in cancer cell spheroids than in a normal fibroblast spheroid, even though intracellular ATP level is depleted in all spheroid types after treatment. These results may indicate an important therapeutic window for this therapy; although further studies are needed in vivo and in patients to investigate the effect of calcium electroporation on surrounding normal tissue when treating tumors.	[Frandsen, Stine Krog; Gehl, Julie] Univ Copenhagen, Herlev Hosp, Dept Oncol, Ctr Expt Drug & Gene Electrotransfer, DK-2730 Herlev, Denmark; [Gibot, Laure; Madi, Moinecha; Rols, Marie-Pierre] CNRS, Inst Pharmacol & Biol Struct, Toulouse, France; [Gibot, Laure; Madi, Moinecha; Rols, Marie-Pierre] Univ Toulouse, UPS, Inst Pharmacol & Biol Struct, Toulouse, France	University of Copenhagen; Herlev & Gentofte Hospital; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Gehl, J (corresponding author), Univ Copenhagen, Herlev Hosp, Dept Oncol, Ctr Expt Drug & Gene Electrotransfer, DK-2730 Herlev, Denmark.	Karen.Julie.Gehl@regionh.dk; Marie-Pierre.Rols@ipbs.fr	Gibot, Laure/AAD-8507-2020; ROLS, Marie-Pierre/GLV-6546-2022; rols, marie-pierre/AAU-8093-2021	Gibot, Laure/0000-0001-7255-4123; Frandsen, Stine/0000-0002-3133-5351; rols, marie-pierre/0000-0003-3100-6272; Gehl, Julie/0000-0003-3829-0210	University of Copenhagen [ECOST-STSM-TD1104-14339, TD1104]; ANR Astrid PIERGEN [ANR-12-ASTR-0039-01]; Department de Mayotte; Acta Oncologica Foundation	University of Copenhagen; ANR Astrid PIERGEN(French National Research Agency (ANR)); Department de Mayotte; Acta Oncologica Foundation	SKF-grant, University of Copenhagen, The experimental work was performed during the Short-Term Scientific Mission (Grant ECOST-STSM-TD1104-14339) under the networking efforts of COST Action TD1104; LG-grant, ANR Astrid PIERGEN, ANR-12-ASTR-0039-01; MM-grant, Department de Mayotte; JG-research fellow of the Royal Swedish Academy of Science supported by the Acta Oncologica Foundation; MPR-ANR Astrid PIERGEN, ANR-12-ASTR-0039-01. Research was conducted in the scope of the EBAM European Associated Laboratory. This report is the result of networking efforts of COST Action TD1104 (http://www.electroporation.net). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerholm-Larsen B, 2011, CANCER RES, V71, P3753, DOI 10.1158/0008-5472.CAN-11-0451; Aung CS, 2007, BIOCHEM BIOPH RES CO, V355, P932, DOI 10.1016/j.bbrc.2007.02.050; Berchtold MW, 2014, BBA-MOL CELL RES, V1843, P398, DOI 10.1016/j.bbamcr.2013.10.021; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Canatella PJ, 2004, BIOPHYS J, V86, P3260, DOI 10.1016/S0006-3495(04)74374-X; Carafoli E, 2001, CRIT REV BIOCHEM MOL, V36, P107, DOI 10.1080/20014091074183; Dubois C, 2014, CANCER CELL, V26, P19, DOI 10.1016/j.ccr.2014.04.025; Edhemovic I, 2014, J SURG ONCOL, V110, P320, DOI 10.1002/jso.23625; Frandsen SK, 2014, BBA-GEN SUBJECTS, V1840, P1204, DOI 10.1016/j.bbagen.2013.12.003; Frandsen SK, 2012, CANCER RES, V72, P1336, DOI 10.1158/0008-5472.CAN-11-3782; Fyfe AJ, 2010, J ROY COLL PHYS EDIN, V40, P213, DOI 10.4997/JRCPE.2010.306; Gibot L, 2013, J MEMBRANE BIOL, V246, P745, DOI 10.1007/s00232-013-9535-x; Gibot L, 2013, J CONTROL RELEASE, V167, P138, DOI 10.1016/j.jconrel.2013.01.021; Haynes MD, 2005, INT J MOL MED, V16, P3; Heller R, 2002, TECHNOL CANCER RES T, V1, P385, DOI 10.1177/153303460200100509; Herbsleb M, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-31; Jiang CL, 2015, IEEE T BIO-MED ENG, V62, P4, DOI 10.1109/TBME.2014.2367543; Kee ST, 2011, CLINICAL ASPECTS OF ELECTROPORATION, P1, DOI 10.1007/978-1-4419-8363-3; Marty M, 2006, EJC SUPPL, V4, P3, DOI 10.1016/j.ejcsup.2006.08.002; Matthiessen LW, 2012, ACTA ONCOL, V51, P713, DOI 10.3109/0284186X.2012.685524; Matthiessen LW, 2011, ACTA ONCOL, V50, P621, DOI 10.3109/0284186X.2011.573626; Mellgren RL, 2009, BBA-MOL CELL RES, V1793, P1886, DOI 10.1016/j.bbamcr.2009.09.013; Miklavcic D, 2012, MED BIOL ENG COMPUT, V50, P1213, DOI 10.1007/s11517-012-0991-8; Mir LM, 2006, EJC SUPPL, V4, P14, DOI 10.1016/j.ejcsup.2006.08.003; Neal RE, 2014, PROSTATE, V74, P458, DOI 10.1002/pros.22760; Neal RE, 2011, J CLIN ONCOL, V29, pE372, DOI 10.1200/JCO.2010.33.0902; NICE, 2013, EL MET SKIN TUM NONS; ORLOWSKI S, 1988, BIOCHEM PHARMACOL, V37, P4727, DOI 10.1016/0006-2952(88)90344-9; Papp B, 2012, BIOMOLECULES, V2, P165, DOI 10.3390/biom2010165; Scheffer HJ, 2014, J VASC INTERV RADIOL, V25, P997, DOI 10.1016/j.jvir.2014.01.028; Spratt DE, 2014, J CLIN ONCOL, V32, P3144, DOI 10.1200/JCO.2014.55.4634; Stratigos A, 2015, EUR J CANCER, V51, P1989, DOI 10.1016/j.ejca.2015.06.110; Thompson GL, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.5.055005; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vasquez JL, 2012, BIOELECTROCHEMISTRY, V88, P127, DOI 10.1016/j.bioelechem.2012.08.001; Vasquez JL, 2015, J UROLOGY, V193, P1009, DOI 10.1016/j.juro.2014.09.039; Yarmush ML, 2014, ANNU REV BIOMED ENG, V16, P295, DOI 10.1146/annurev-bioeng-071813-104622; Zhivotovsky B, 2011, CELL CALCIUM, V50, P211, DOI 10.1016/j.ceca.2011.03.003	38	59	59	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144028	10.1371/journal.pone.0144028	http://dx.doi.org/10.1371/journal.pone.0144028			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633834	gold, Green Published, Green Submitted			2022-12-27	WOS:000366040000047
J	Chen, Z; Gallie, DR				Chen, Zhong; Gallie, Daniel R.			Ethylene Regulates Energy- Dependent Non-Photochemical Quenching in Arabidopsis through Repression of the Xanthophyll Cycle	PLOS ONE			English	Article							VIOLAXANTHIN DE-EPOXIDASE; PHOTOSYSTEM-II ANTENNA; LIGHT-HARVESTING COMPLEXES; INDUCED STOMATAL CLOSURE; FOLIAR GAS-EXCHANGE; CHLOROPHYLL FLUORESCENCE; RESPONSE PATHWAY; SINGLET OXYGEN; ENDOPLASMIC-RETICULUM; PHOTOOXIDATIVE STRESS	Energy-dependent (qE) non-photochemical quenching (NPQ) thermally dissipates excess absorbed light energy as a protective mechanism to prevent the over reduction of photosystem II and the generation of reactive oxygen species (ROS). The xanthophyll cycle, induced when the level of absorbed light energy exceeds the capacity of photochemistry, contributes to qE. In this work, we show that ethylene regulates the xanthophyll cycle in Arabidopsis. Analysis of eto1-1, exhibiting increased ethylene production, and ctr1-3, exhibiting constitutive ethylene response, revealed defects in NPQ resulting from impaired de-epoxidation of violaxanthin by violaxanthin de-epoxidase (VDE) encoded by NPQ1. Elevated ethylene signaling reduced the level of active VDE through decreased NPQ1 promoter activity and impaired VDE activation resulting from a lower transthylakoid membrane pH gradient. Increasing the concentration of CO2 partially corrected the ethylene-mediated defects in NPQ and photosynthesis, indicating that changes in ethylene signaling affect stromal CO2 solubility. Increasing VDE expression in eto1-1 and ctr1-3 restored light-activated de-epoxidation and qE, reduced superoxide production and reduced photoinhibition. Restoring VDE activity significantly reversed the small growth phenotype of eto1-1 and ctr1-3 without altering ethylene production or ethylene responses. Our results demonstrate that ethylene increases ROS production and photosensitivity in response to high light and the associated reduced plant stature is partially reversed by increasing VDE activity.	[Chen, Zhong; Gallie, Daniel R.] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA	University of California System; University of California Riverside	Gallie, DR (corresponding author), Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.	drgallie@citrus.ucr.edu			AgroFresh, Inc; University of California Agricultural Experiment Station	AgroFresh, Inc; University of California Agricultural Experiment Station(University of California System)	This work was supported by AgroFresh, Inc and the University of California Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeles F, 1992, ETHYLENE PLANT BIOL; Achnine L, 1999, PHYSIOL PLANTARUM, V106, P246, DOI 10.1034/j.1399-3054.1999.106215.x; Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; [Anonymous], 1901, BOT CENTRALBL BEIH; Arnoux P, 2009, PLANT CELL, V21, P2036, DOI 10.1105/tpc.109.068007; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Asada K., 1987, PHOTOINHIBITION, P227; BARENYI B, 1985, PLANTA, V163, P218, DOI 10.1007/BF00393510; Betterle N, 2009, J BIOL CHEM, V284, P15255, DOI 10.1074/jbc.M808625200; Bleecker AB, 2000, ANNU REV CELL DEV BI, V16, P1, DOI 10.1146/annurev.cellbio.16.1.1; Bohm F, 1997, J AM CHEM SOC, V119, P621, DOI 10.1021/ja962512c; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRATT CE, 1995, PHOTOSYNTH RES, V45, P169, DOI 10.1007/BF00032588; BRIANTAIS JM, 1979, BIOCHIM BIOPHYS ACTA, V548, P128, DOI 10.1016/0005-2728(79)90193-2; Bugos RC, 1999, PLANT PHYSIOL, V121, P207, DOI 10.1104/pp.121.1.207; Chang C, 1999, CURR OPIN PLANT BIOL, V2, P352, DOI 10.1016/S1369-5266(99)00004-7; Chang C, 2001, BIOESSAYS, V23, P619, DOI 10.1002/bies.1087; Chao QM, 1997, CELL, V89, P1133, DOI 10.1016/S0092-8674(00)80300-1; Chaves MM, 2002, ANN BOT-LONDON, V89, P907, DOI 10.1093/aob/mcf105; Chen JF, 2010, PLANT MOL BIOL, V74, P405, DOI 10.1007/s11103-010-9686-4; Chen YF, 2002, J BIOL CHEM, V277, P19861, DOI 10.1074/jbc.M201286200; Chen Z, 2012, PLANT PHYSIOL BIOCH, V58, P66, DOI 10.1016/j.plaphy.2012.06.010; Clark KL, 1998, P NATL ACAD SCI USA, V95, P5401, DOI 10.1073/pnas.95.9.5401; Conklin PL, 2000, GENETICS, V154, P847; Corbin DR, 2001, PLANT PHYSIOL, V126, P1116, DOI 10.1104/pp.126.3.1116; D'Haese D, 2004, J THEOR BIOL, V227, P175, DOI 10.1016/j.jtbi.2003.10.011; Dall'Osto L, 2005, PLANT CELL, V17, P1217, DOI 10.1105/tpc.104.030601; Dall'Osto L, 2007, PLANT CELL, V19, P1048, DOI 10.1105/tpc.106.049114; Dall'Osto L, 2010, MOL PLANT, V3, P576, DOI 10.1093/mp/ssp117; DEMMIGADAMS B, 1990, BIOCHIM BIOPHYS ACTA, V1020, P1, DOI 10.1016/0005-2728(90)90088-L; DemmigAdams B, 1996, FASEB J, V10, P403, DOI 10.1096/fasebj.10.4.8647339; Desikan R, 2005, PLANT PHYSIOL, V137, P831, DOI 10.1104/pp.104.056994; Desikan R, 2006, PLANT J, V47, P907, DOI 10.1111/j.1365-313X.2006.02842.x; Eskling M, 1997, PHYSIOL PLANTARUM, V100, P806, DOI 10.1034/j.1399-3054.1997.1000407.x; FELDMAN LJ, 1984, ANNU REV PLANT PHYS, V35, P223, DOI 10.1146/annurev.arplant.35.1.223; Finazzi G, 2004, P NATL ACAD SCI USA, V101, P12375, DOI 10.1073/pnas.0404798101; Flexas J, 2002, ANN BOT-LONDON, V89, P183, DOI 10.1093/aob/mcf027; FOYER CH, 2005, ADV PHOTOSYNTHESIS R, V19, P241; Frahry G, 2001, PLANTA, V212, P175, DOI 10.1007/s004250000376; Frank H. A., 1993, CAROTENOIDS PHOTOSYN, P252, DOI [10.1007/978-94-011-2124-8_8, DOI 10.1007/978-94-011-2124-8_8]; GENTY B, 1990, PLANT PHYSIOL BIOCH, V28, P1; GILMORE AM, 1991, J CHROMATOGR, V543, P137, DOI 10.1016/S0021-9673(01)95762-0; Golan T, 2006, PLANT CELL ENVIRON, V29, P879, DOI 10.1111/j.1365-3040.2005.01467.x; Grouneva I, 2006, PHYSIOL PLANTARUM, V126, P205, DOI 10.1111/j.1399-3054.2006.00613.x; GUNDERSON CA, 1991, PLANT PHYSIOL, V95, P337, DOI 10.1104/pp.95.1.337; GUZMAN P, 1990, PLANT CELL, V2, P513, DOI 10.1105/tpc.2.6.513; HAGER A, 1969, PLANTA, V89, P224, DOI 10.1007/BF00385028; HAGER A, 1994, PLANTA, V192, P581, DOI 10.1007/BF00203597; HARAUX F, 1980, BIOCHIM BIOPHYS ACTA, V592, P153, DOI 10.1016/0005-2728(80)90122-X; Havaux M, 1999, P NATL ACAD SCI USA, V96, P8762, DOI 10.1073/pnas.96.15.8762; Havaux M, 2005, PLANT CELL, V17, P3451, DOI 10.1105/tpc.105.037036; Havaux M, 2000, PLANT PHYSIOL, V124, P273, DOI 10.1104/pp.124.1.273; Havaux M, 2007, PLANT PHYSIOL, V145, P1506, DOI 10.1104/pp.107.108480; HIDEG E, 1994, BBA-BIOENERGETICS, V1186, P143, DOI 10.1016/0005-2728(94)90173-2; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Holt NE, 2004, BIOCHEMISTRY-US, V43, P8281, DOI 10.1021/bi0494020; HOPE AB, 1985, AUST J PLANT PHYSIOL, V12, P9, DOI 10.1071/PP9850009; HORTON P, 1983, BIOCHIM BIOPHYS ACTA, V724, P404, DOI 10.1016/0005-2728(83)90100-7; Horton P, 2005, FEBS LETT, V579, P4201, DOI 10.1016/j.febslet.2005.07.003; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; HORTON P, 1994, PLANT PHYSIOL, V106, P415, DOI 10.1104/pp.106.2.415; Hua J, 1998, CELL, V94, P261, DOI 10.1016/S0092-8674(00)81425-7; Hyodo H., 1991, PLANT HORMONE ETHYLE; Jahns P, 2002, FEBS LETT, V519, P99, DOI 10.1016/S0014-5793(02)02719-9; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Ji YS, 2013, MOL PLANT, V6, P11, DOI 10.1093/mp/sss150; Johnson MP, 2011, PLANT CELL, V23, P1468, DOI 10.1105/tpc.110.081646; Johnson MP, 2009, PLANT PHYSIOL, V149, P1061, DOI 10.1104/pp.108.129957; Kalituho L, 2007, PLANTA, V225, P423, DOI 10.1007/s00425-006-0356-3; KAYS SJ, 1980, NATURE, V285, P51, DOI 10.1038/285051a0; Kereiche S, 2010, FEBS LETT, V584, P759, DOI 10.1016/j.febslet.2009.12.031; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Kiss AZ, 2008, J BIOL CHEM, V283, P3972, DOI 10.1074/jbc.M707410200; Klee HJ, 2004, PLANT PHYSIOL, V135, P660, DOI 10.1104/pp.104.040998; KRAUSE GH, 1973, BIOCHIM BIOPHYS ACTA, V292, P715, DOI 10.1016/0005-2728(73)90019-4; Krieger-Liszkay A, 2005, J EXP BOT, V56, P337, DOI 10.1093/jxb/erh237; Kulheim C, 2002, SCIENCE, V297, P91, DOI 10.1126/science.1072359; KYLE DJ, 1984, P NATL ACAD SCI-BIOL, V81, P4070, DOI 10.1073/pnas.81.13.4070; KYLE DJ, 1987, TOPICS PHOTOSYNTHESI, V9, P197; LEVITT LK, 1987, PLANT PHYSIOL, V85, P318, DOI 10.1104/pp.85.2.318; Li XP, 2004, J BIOL CHEM, V279, P22866, DOI 10.1074/jbc.M402461200; Li XP, 2002, P NATL ACAD SCI USA, V99, P15222, DOI 10.1073/pnas.232447699; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Li ZR, 2009, PLANT CELL, V21, P1798, DOI 10.1105/tpc.109.066571; Li ZH, 2013, PLANT CELL, V25, P3311, DOI 10.1105/tpc.113.113340; LIM BP, 1992, BIOCHIM BIOPHYS ACTA, V1126, P178; Lin ZF, 2009, J EXP BOT, V60, P3311, DOI 10.1093/jxb/erp204; Lokstein H, 2002, BBA-BIOENERGETICS, V1553, P309, DOI 10.1016/S0005-2728(02)00184-6; MADHAVAN S, 1983, PLANT CELL PHYSIOL, V24, P569; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Melis A, 1999, TRENDS PLANT SCI, V4, P130, DOI 10.1016/S1360-1385(99)01387-4; Merritt F, 2001, PLANT CELL PHYSIOL, V42, P223, DOI 10.1093/pcp/pce030; MISHRA NP, 1993, J PHOTOCH PHOTOBIO B, V19, P19, DOI 10.1016/1011-1344(93)80088-Q; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Morgan PW, 1997, PHYSIOL PLANTARUM, V100, P620, DOI 10.1034/j.1399-3054.1997.1000325.x; Muller-Moule P, 2004, PLANT PHYSIOL, V134, P1163, DOI 10.1104/pp.103.032375; Munekage Y, 2001, PLANT J, V28, P351, DOI 10.1046/j.1365-313X.2001.01178.x; Nilkens M, 2010, BBA-BIOENERGETICS, V1797, P466, DOI 10.1016/j.bbabio.2010.01.001; Niyogi KK, 1997, P NATL ACAD SCI USA, V94, P14162, DOI 10.1073/pnas.94.25.14162; Niyogi KK, 1998, PLANT CELL, V10, P1121, DOI 10.1105/tpc.10.7.1121; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Niyogi KK, 2001, PHOTOSYNTH RES, V67, P139, DOI 10.1023/A:1010661102365; OJA V, 1986, BIOCHIM BIOPHYS ACTA, V849, P355, DOI 10.1016/0005-2728(86)90147-7; Osmond CB, 1994, PHOTOINHIBITION PHOT, P1; PALLAGHY CK, 1972, PLANT PHYSIOL, V49, P275, DOI 10.1104/pp.49.2.275; PALLAS JE, 1982, PLANT PHYSIOL, V70, P598, DOI 10.1104/pp.70.2.598; PALOZZA P, 1992, ARCH BIOCHEM BIOPHYS, V297, P184, DOI 10.1016/0003-9861(92)90658-J; Pogson BJ, 1998, P NATL ACAD SCI USA, V95, P13324, DOI 10.1073/pnas.95.22.13324; Pogson BJ, 2000, PHILOS T ROY SOC B, V355, P1395, DOI 10.1098/rstb.2000.0701; PRASIL O, 1992, PHOTOSYSTEMS STRUCTU, P295, DOI DOI 10.1016/B978-0-444-89440-3.50017-5; Reddy AR, 2004, J PLANT PHYSIOL, V161, P1189, DOI 10.1016/j.jplph.2004.01.013; ROBERTS CS, 1995, PLANT MOL BIOL, V29, P303, DOI 10.1007/BF00043654; Rossel JB, 2007, PLANT CELL, V19, P4091, DOI 10.1105/tpc.106.045898; ROTTENBERG H, 1993, BIOCHIM BIOPHYS ACTA, V1183, P161, DOI 10.1016/0005-2728(93)90014-7; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Savidge B, 2002, PLANT PHYSIOL, V129, P321, DOI 10.1104/pp.010747; SCHULDINER S, 1972, EUR J BIOCHEM, V25, P64, DOI 10.1111/j.1432-1033.1972.tb01667.x; SEREK M, 1995, PHYSIOL PLANTARUM, V94, P229, DOI 10.1111/j.1399-3054.1995.tb05305.x; Sewelam N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070289; SHARMA PK, 1992, PHYSIOL PLANTARUM, V86, P623, DOI 10.1111/j.1399-3054.1992.tb02179.x; SIEFERMANN D, 1975, ARCH BIOCHEM BIOPHYS, V171, P70, DOI 10.1016/0003-9861(75)90008-9; Sielewiesiuk J., 1997, CELL MOL BIOL LETT, V2, P59; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Stepanova Anna N, 2005, Sci STKE, V2005, pcm4, DOI 10.1126/stke.2762005cm4; STROTMANN H, 1990, EUR J BIOCHEM, V193, P879, DOI 10.1111/j.1432-1033.1990.tb19412.x; Sutherland MW, 1997, FREE RADICAL RES, V27, P283, DOI 10.3109/10715769709065766; Takahashi S, 2008, TRENDS PLANT SCI, V13, P178, DOI 10.1016/j.tplants.2008.01.005; Takahashi S, 2009, PLANT PHYSIOL, V149, P1560, DOI 10.1104/pp.108.134122; Tanaka Y, 2005, PLANT PHYSIOL, V138, P2337, DOI 10.1104/pp.105.063503; TAYLOR GE, 1986, PLANT PHYSIOL, V82, P653, DOI 10.1104/pp.82.3.653; THOLEN D, 2004, PLANT PHYSIOL, V134, P1803, DOI DOI 10.1104/pp.103.034389; Tholen D, 2008, PLANT SIGNAL BEHAV, V3, P108, DOI 10.4161/psb.3.2.4968; vanWijk KJ, 1996, J BIOL CHEM, V271, P9627, DOI 10.1074/jbc.271.16.9627; Vogel JP, 1998, P NATL ACAD SCI USA, V95, P4766, DOI 10.1073/pnas.95.8.4766; Wagner D, 2004, SCIENCE, V306, P1183, DOI 10.1126/science.1103178; WALTERS RG, 1994, EUR J BIOCHEM, V226, P1063, DOI 10.1111/j.1432-1033.1994.01063.x; WALTERS RG, 1991, PHOTOSYNTH RES, V27, P121, DOI 10.1007/BF00033251; Wang KLC, 2004, NATURE, V428, P945, DOI 10.1038/nature02516; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Wang PC, 2013, PLANT PHYSIOL, V161, P1392, DOI 10.1104/pp.112.210724; WOODROW L, 1988, J EXP BOT, V39, P667, DOI 10.1093/jxb/39.6.667; WRAIGHT CA, 1970, EUR J BIOCHEM, V17, P319, DOI 10.1111/j.1432-1033.1970.tb01169.x; Wrona M, 2004, FREE RADICAL BIO MED, V36, P1094, DOI 10.1016/j.freeradbiomed.2004.02.005; Yamamoto HY, 1999, ADV PHOTOSYNTH, V8, P293; YANG SF, 1984, ANNU REV PLANT PHYS, V35, P155, DOI 10.1146/annurev.pp.35.060184.001103; Young TE, 2004, PLANT J, V40, P813, DOI 10.1111/j.1365-313X.2004.02255.x; Zhao Q, 2011, MOL PLANT, V4, P626, DOI 10.1093/mp/ssr042; Zhong SW, 2010, PLANT SIGNAL BEHAV, V5, P739, DOI 10.4161/psb.5.6.11698; Zhong SW, 2009, P NATL ACAD SCI USA, V106, P21431, DOI 10.1073/pnas.0907670106	150	12	13	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144209	10.1371/journal.pone.0144209	http://dx.doi.org/10.1371/journal.pone.0144209			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630486	Green Submitted, Green Published, gold			2022-12-27	WOS:000365926300169
J	Oda, Y; Ueda, F; Utsuyama, M; Kamei, A; Kakinuma, C; Abe, K; Hirokawa, K				Oda, Yuriko; Ueda, Fumitaka; Utsuyama, Masanori; Kamei, Asuka; Kakinuma, Chihaya; Abe, Keiko; Hirokawa, Katsuiku			Improvement in Human Immune Function with Changes in Intestinal Microbiota by Salacia reticulata Extract Ingestion: A Randomized Placebo-Controlled Trial	PLOS ONE			English	Article							ALPHA-GLUCOSIDASE; DOUBLE-BLIND; DENDRITIC CELLS; INFECTION	Plants belonging to the genus Salacia in the Hippocrateaceae family are known to inhibit sugar absorption. In a previous study, administration of Salacia reticulata extract in rats altered the intestinal microbiota and increased expression of immune-relevant genes in small intestinal epithelial cells. This study aimed to investigate the effect of S. reticulata extract in human subjects by examining the gene expression profiles of blood cells, immunological indices, and intestinal microbiota. The results revealed an improvement in T-cell proliferation activity and some other immunological indices. In addition, the intestinal microbiota changed, with an increase in Bifidobacterium and a decrease in Clostridium bacteria. The expression levels of many immune-relevant genes were altered in blood cells. We concluded that S. reticulata extract ingestion in humans improved immune functions and changed the intestinal microbiota.	[Oda, Yuriko; Ueda, Fumitaka; Kakinuma, Chihaya] FUJIFILM Corp, Res & Dev Management Headquarters, Pharmaceut & Healthcare Res Labs, Ebina, Kanagawa, Japan; [Utsuyama, Masanori; Hirokawa, Katsuiku] Inst Hlth & Life Sci, Tokyo, Japan; [Utsuyama, Masanori; Hirokawa, Katsuiku] Tokyo Med & Dent Univ, Dept Comprehens Pathol, Tokyo, Japan; [Kamei, Asuka; Abe, Keiko] Kanagawa Acad Sci & Technol, Kawasaki, Kanagawa, Japan; [Abe, Keiko] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo, Japan	Fujifilm Corporation; Tokyo Medical & Dental University (TMDU); Kanagawa Academy Science & Technology; University of Tokyo	Oda, Y (corresponding author), FUJIFILM Corp, Res & Dev Management Headquarters, Pharmaceut & Healthcare Res Labs, Ebina, Kanagawa, Japan.	yuriko.oda@fujifilm.com	Kamei, Asuka/GXH-4934-2022	jin teng, long/0000-0002-1948-9331	Fujifilm Corporation; Council for Science, Technology and Innovation (CSTI)	Fujifilm Corporation; Council for Science, Technology and Innovation (CSTI)	Fujifilm Corporation funded this study and provided support in the form of salaries for authors YO, FU, and CK but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Council for Science, Technology and Innovation (CSTI), Cross-ministerial Strategic Innovation Promotion Program (SIP), and "Technologies for creating next-generation agriculture, forestry, and fisheries."	Arunakumara K. K. I. U., 2010, Tropical Agricultural Research and Extension, V13, P41; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Chen ZX, 2007, BIOINFORMATICS, V23, P321, DOI 10.1093/bioinformatics/btl609; de Vrese M, 2005, CLIN NUTR, V24, P481, DOI 10.1016/j.clnu.2005.02.006; Flammang AM, 2007, FOOD CHEM TOXICOL, V45, P1954, DOI 10.1016/j.fct.2007.04.013; Fujimoto K, 2011, J IMMUNOL, V186, P6287, DOI 10.4049/jimmunol.1004036; Hirokawa K, 2014, US Patent, Patent No. [2014; 8815524, 20148815524]; Hirokawa K., 2009, HDB IMMUNOSENESCENCE, P1547, DOI [10.1007/978-1-40209062-2_73, DOI 10.1007/978-1-40209062-2_73]; Hirokawa K, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-19; Hirokawa K, 2009, MECH AGEING DEV, V130, P86, DOI 10.1016/j.mad.2008.05.001; Hirose Y, 2013, J NUTR SCI, V2, DOI 10.1017/jns.2013.35; Hopkins MJ, 2001, GUT, V48, P198, DOI 10.1136/gut.48.2.198; Im R, 2008, BIOSCI BIOTECH BIOCH, V72, P3075, DOI 10.1271/bbb.70745; Kajimoto O., 2000, Nippon Eiyo Shokuryo Gakkaishi = Journal of the Japanese Society of Nutrition and Food Science, V53, P199; Kobayashi M., 2010, JPN PHARMACOL THER, V38, P545; Kukkonen K, 2007, J ALLERGY CLIN IMMUN, V119, P192, DOI 10.1016/j.jaci.2006.09.009; Lehne G, 2006, CLIN EXP IMMUNOL, V143, P65, DOI 10.1111/j.1365-2249.2005.02962.x; Makino S, 2010, BRIT J NUTR, V104, P998, DOI 10.1017/S000711451000173X; Matsuura T, 2004, YAKUGAKU ZASSHI, V124, P217, DOI 10.1248/yakushi.124.217; Mitsuoka Tomotari, 2014, Biosci Microbiota Food Health, V33, P117, DOI [10.12938/bmfh.33.117, 10.12938/bmfh.2014-003]; Muraoka O, 2011, J NAT MED-TOKYO, V65, P142, DOI 10.1007/s11418-010-0474-x; Muraoka O, 2010, J PHARMACEUT BIOMED, V52, P770, DOI 10.1016/j.jpba.2010.02.025; Nagashima K., 2006, Bioscience and Microflora, V25, P99; Nakamura S, 2010, BIOORG MED CHEM LETT, V20, P4420, DOI 10.1016/j.bmcl.2010.06.059; Oda Y, 2011, BIOFACTORS, V37, P31, DOI 10.1002/biof.132; Ozaki S, 2008, J JPN SOC FOOD SCI, V55, P481, DOI 10.3136/nskkk.55.481; Shivaprasad HN, 2013, J MED FOOD, V16, P564, DOI 10.1089/jmf.2013.2751; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Underwood MA, 2009, J PEDIATR GASTR NUTR, V48, P216, DOI 10.1097/MPG.0b013e31818de195; Williams JA, 2007, AM J CLIN NUTR, V86, P124, DOI 10.1093/ajcn/86.1.124; Yoshikawa M, 2002, BIOORGAN MED CHEM, V10, P1547, DOI 10.1016/S0968-0896(01)00422-9; Yoshikawa M, 2001, YAKUGAKU ZASSHI, V121, P371, DOI 10.1248/yakushi.121.371; Yoshikawa M, 1997, TETRAHEDRON LETT, V38, P8367, DOI 10.1016/S0040-4039(97)10270-2	33	5	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0142909	10.1371/journal.pone.0142909	http://dx.doi.org/10.1371/journal.pone.0142909			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630568	Green Published, gold, Green Submitted			2022-12-27	WOS:000365926300020
J	Sun, LM; Liao, K; Wang, DY				Sun, Lingmei; Liao, Kai; Wang, Dayong			Effects of Magnolol and Honokiol on Adhesion, Yeast-Hyphal Transition, and Formation of Biofilm by Candida albicans	PLOS ONE			English	Article							RETIGERIC ACID B; NATURAL-PRODUCTS; DRUG DISCOVERY; RESISTANCE; VIRULENCE; THERAPY	Background The first step in infection by Candida albicans is adhesion to host cells or implanted medical devices and this followed by hyphal growth and biofilm formation. Yeast-to-hyphal transition has long been identified as a key factor in fungal virulence. Following biofilm formation, C. albicans is usually less sensitive or insensitive to antifungals. Therefore, development of new antifungals with inhibitory action on adhesion, yeast-hyphal transition and biofilm formation by C. albicans is very necessary. Methods The effects of magnolol and honokiol on hypha growth were investigated using different induction media. Their inhibitory effects were determined using the 2,3-bis(2-methoxy-4-nitro-5- sulfophenyl)-2H-tetrazolium-5-carboxanilide assay, and biofilm thickness and viability were observed by a confocal scanning laser microscope. Mammalian cells were used in adhesion assays. Genes related to hyphae development and cell adhesions were analyzed by real-time reverse transcription-polymerase chain reaction. The exogenous cyclic adenosine monophosphate was used to determine the mechanisms of action of magnolol and honokiol. Caenorhabditis elegans was used as an in vivo model to estimate the antifungal activities of magnolol and honokiol. Results and conclusions Magnolol and honokiol inhibited adhesion, the transition from yeast to hypha, and biofilm formation by C. albicans through the Ras1-cAMP-Efg1 pathway. Moreover, magnolol and honokiol prolonged the survival of nematodes infected by C. albicans. Magnolol and honokiol have potential inhibitory effects against biofilm formation by C. albicans. General Significance This study provides useful information towards the development of new strategies to reduce the incidence of C. albicans biofilm-associated infection.	[Sun, Lingmei] Southeast Univ, Sch Med, Dept Pharmacol, Nanjing, Jiangsu, Peoples R China; [Liao, Kai] Southeast Univ, Sch Med, Dept Pathol & Pathophysiol, Nanjing, Jiangsu, Peoples R China; [Wang, Dayong] Southeast Univ, Sch Med, Minist Educ, Key Lab Dev Genes & Human Dis, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China; Southeast University - China	Sun, LM (corresponding author), Southeast Univ, Sch Med, Dept Pharmacol, Nanjing, Jiangsu, Peoples R China.	sunlingmei@seu.edu.cn; dayongw@seu.edu.cn	孙, 琳/HGE-6966-2022; shen, chen/AAC-2458-2020		National Natural Science Foundation of China [81302814]; Jiangsu Province Natural Science Foundation [BK20130640, BK20140624]; Doctoral Fund of Ministry of Education of China [20120092120068]; China Postdoctoral Science Foundation [2012M511182]; Fundamental Research Funds of Southeast University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Fundamental Research Funds of Southeast University	This work was supported by grants from the National Natural Science Foundation of China (No. 81302814), Jiangsu Province Natural Science Foundation (No. BK20130640 and BK20140624), Doctoral Fund of Ministry of Education of China (No. 20120092120068), China Postdoctoral Science Foundation (No. 2012M511182), and Fundamental Research Funds of Southeast University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrantes PMDS, 2014, DIAGN MICR INFEC DIS, V79, P222, DOI 10.1016/j.diagmicrobio.2013.09.016; Ahariz M, 2010, MED DEVICES-EVID RES, V3, P33; Alexander BD, 1997, DRUGS, V54, P657, DOI 10.2165/00003495-199754050-00002; Bang KH, 2000, ARCH PHARM RES, V23, P46, DOI 10.1007/BF02976465; Bauer A, 2014, NAT PROD REP, V31, P35, DOI 10.1039/c3np70058e; Biswas S, 2007, MICROBIOL MOL BIOL R, V71, P348, DOI 10.1128/MMBR.00009-06; Blankenship JR, 2006, CURR OPIN MICROBIOL, V9, P588, DOI 10.1016/j.mib.2006.10.003; Breger J, 2007, PLOS PATHOG, V3, P168, DOI 10.1371/journal.ppat.0030018; Chang WQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041624; Chen G, 2014, EUR J PHARM SCI, V65, P21, DOI 10.1016/j.ejps.2014.09.001; Clinical and Laboratory Standards Institute, 2008, M27A3 CLIN LAB STAND; Cragg GM, 1997, J NAT PROD, V60, P52, DOI 10.1021/np9604893; de Freitas MM, 2011, IMPLANT DENT, V20, pE14, DOI 10.1097/ID.0b013e31820fb99e; Jacobo-Salcedo MD, 2011, NAT PROD COMMUN, V6, P1121; Fazly A, 2013, P NATL ACAD SCI USA, V110, P13594, DOI 10.1073/pnas.1305982110; Feldman M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093225; Ferreira AV, 2013, MYCOPATHOLOGIA, V175, P265, DOI 10.1007/s11046-013-9638-z; Finkel JS, 2011, NAT REV MICROBIOL, V9, P109, DOI 10.1038/nrmicro2475; FONZI WA, 1993, GENETICS, V134, P717; Harvey A, 2010, IDRUGS, V13, P70; Hogan DA, 2009, FUTURE MICROBIOL, V4, P1263, DOI 10.2217/FMB.09.106; Inigo M, 2012, INT J ARTIF ORGANS, V35, P780, DOI 10.5301/ijao.5000170; Jin J, 2010, LETT APPL MICROBIOL, V51, P351, DOI 10.1111/j.1472-765X.2010.02900.x; Larsen B, 2006, YEAST, V23, P795, DOI 10.1002/yea.1394; Lopez-Ribot JL, 2005, CURR BIOL, V15, pR453, DOI 10.1016/j.cub.2005.06.020; Miller LG, 2001, CLIN INFECT DIS, V32, P1110, DOI 10.1086/319613; Newman DJ, 2003, J NAT PROD, V66, P1022, DOI 10.1021/np030096l; Nobile CJ, 2006, EUKARYOT CELL, V5, P1604, DOI 10.1128/EC.00194-06; Nobile CJ, 2006, PLOS PATHOG, V2, P636, DOI 10.1371/journal.ppat.0020063; Pappas PG, 2003, CLIN INFECT DIS, V37, P634, DOI 10.1086/376906; Perumal P, 2007, ANTIMICROB AGENTS CH, V51, P2454, DOI 10.1128/AAC.01237-06; Ruhnke M, 2014, CLIN MICROBIOL INFEC, V20, P11, DOI 10.1111/1469-0691.12622; Staab JF, 1999, SCIENCE, V283, P1535, DOI 10.1126/science.283.5407.1535; Sun LM, 2010, J APPL MICROBIOL, V108, P341, DOI 10.1111/j.1365-2672.2009.04429.x; Sun LM, 2009, ANTIMICROB AGENTS CH, V53, P1586, DOI 10.1128/AAC.00940-08; Tobudic S, 2013, MYCOSES, V56, P623, DOI 10.1111/myc.12079; Toenjes KA, 2005, ANTIMICROB AGENTS CH, V49, P963, DOI 10.1128/AAC.49.3.963-972.2005; Wu XZ, 2009, BBA-GEN SUBJECTS, V1790, P770, DOI 10.1016/j.bbagen.2009.05.002	38	107	117	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0117695	10.1371/journal.pone.0117695	http://dx.doi.org/10.1371/journal.pone.0117695			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	26640948	Green Published, gold, Green Submitted			2022-12-27	WOS:000350683900036
J	Sun, L; Tian, JL; Yin, QQ; Xiao, J; Li, JQ; Guo, YJ; Feng, GS; Peng, XX; Qi, H; Xu, F; Jiao, WW; Shen, C; Shen, AD				Sun, Lin; Tian, Jian-ling; Yin, Qing-qin; Xiao, Jing; Li, Jie-qiong; Guo, Ya-jie; Feng, Guo-shuang; Peng, Xiao-xia; Qi, Hui; Xu, Fang; Jiao, Wei-wei; Shen, Chen; Shen, A-dong			Performance of the Interferon Gamma Release Assays in Tuberculosis Disease in Children Five Years Old or Less	PLOS ONE			English	Article							PEDIATRIC TUBERCULOSIS; SKIN-TEST; INFECTION; DIAGNOSIS; AGE	Interferon Gamma Release Assays (IGRAs) were developed for the indirect or immunologic diagnosis of tuberculosis infection; however, they have also been used to assist in difficult to diagnose cases of tuberculosis disease in adults, and to a lesser extent, in children, especially in those under 5 years old. We evaluated the utility of using an IGRA in pediatric tuberculosis in younger children in a hospital setting. The diagnostic accuracy of T-SPOT. TB and TST was assessed in 117 children with active tuberculosis and 413 children with respiratory tract infection. Sensitivity and specificity were calculated for the tests used individually and together. Concordance was also calculated. Sensitivity of T-SPOT. TB (82.9%) was higher than TST (78.6% using a 5mm cut-off), especially in children confirmed to have TB. T-SPOT. TB was more specific than TST using a 5mm cut-off (96.1% vs. 70.9%). Combining T-SPOT. TB and TST results improved the sensitivity to 96.6%. In conclusion, the results of the current study indicate that T-SPOT. TB has good sensitivity and specificity, supporting its use among patients of this age. A combination of IGRA and TST would be useful additions to assist in the diagnosis of childhood TB.	[Sun, Lin; Tian, Jian-ling; Yin, Qing-qin; Xiao, Jing; Li, Jie-qiong; Guo, Ya-jie; Qi, Hui; Xu, Fang; Jiao, Wei-wei; Shen, Chen; Shen, A-dong] Capital Med Univ, Key Lab Major Dis Children & Natl Key Discipline, Beijing Key Lab Pediat Resp Infect Dis,Beijing Ch, Beijing Pediat Res Inst,Minist Educ,Natl Clin Res, Beijing, Peoples R China; [Feng, Guo-shuang; Peng, Xiao-xia] Capital Med Univ, Beijing Childrens Hosp, Ctr Clin Epidemiol & Evidence Based Med, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Shen, AD (corresponding author), Capital Med Univ, Key Lab Major Dis Children & Natl Key Discipline, Beijing Key Lab Pediat Resp Infect Dis,Beijing Ch, Beijing Pediat Res Inst,Minist Educ,Natl Clin Res, Beijing, Peoples R China.	shenad16@hotmail.com	孙, 琳/HGE-6966-2022; shen, chen/AAC-2458-2020		National Science and Technology Major Project of China [2013ZX10003003-004]; National Natural Science Foundation of China [81200064]; Collaborative Innovation Center of Infectious Diseases [PXM2014_014226_000011]	National Science and Technology Major Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Collaborative Innovation Center of Infectious Diseases	This work was supported by National Science and Technology Major Project of China (2013ZX10003003-004), National Natural Science Foundation of China (no. 81200064) and Collaborative Innovation Center of Infectious Diseases (no. PXM2014_014226_000011).	Blandinieres A, 2013, J INFECTION, V67, P391, DOI 10.1016/j.jinf.2013.06.011; Carvalho ACC, 2013, INFECTION, V41, P827, DOI 10.1007/s15010-013-0450-y; Committee On Infectious Diseases AAOP, 2009, RED BOOK REP COMM IN; Critselis E, 2012, J PEDIATR-US, V161, P632, DOI 10.1016/j.jpeds.2012.04.007; Cruz AT, 2010, PEDIATR REV, V31, P13, DOI 10.1542/pir.31-1-13; Dogra S, 2007, J INFECTION, V54, P267, DOI 10.1016/j.jinf.2006.04.007; Haimi-Cohen Y, 2001, CLIN INFECT DIS, V33, P1786, DOI 10.1086/323984; Haustein T, 2009, PEDIATR INFECT DIS J, V28, P669, DOI 10.1097/INF.0b013e3181a16394; Newton SM, 2008, LANCET INFECT DIS, V8, P498, DOI 10.1016/S1473-3099(08)70182-8; Nicol MP, 2009, PEDIATRICS, V123, P38, DOI 10.1542/peds.2008-0611; PAVIC I, 2011, PEDIATR INFECT DIS J, V30, P866, DOI DOI 10.1097/INF.0B013E318220C52A; PrabhuDas M, 2011, NAT IMMUNOL, V12, P189, DOI 10.1038/ni0311-189; Roy RB, 2012, AM J RESP CRIT CARE, V186, P378, DOI 10.1164/rccm.201201-0026OC; Schopfer K, 2014, EUR J PEDIATR, V173, P331, DOI 10.1007/s00431-013-2161-x; Sollai S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-S1-S6; Sun L, 2010, CHINESE MED J-PEKING, V123, P2786, DOI 10.3760/cma.j.issn.0366-6999.2010.20.007; Thomas TA, 2010, PEDIATRICS, V126, pE1522, DOI 10.1542/peds.2010-0885; Tuberculosis NTSG, 2002, REP 4 NAT EP SAMPL S, V2, P3; World Health Organization, 2014, GLOB TUB REP; Wu XR, 2012, PEDIATRICS, V130, pE1433, DOI 10.1542/peds.2011-3742; Zar HJ, 2010, EXPERT REV ANTI-INFE, V8, P277, DOI [10.1586/eri.10.9, 10.1586/ERI.10.9]	21	107	117	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0143820	10.1371/journal.pone.0143820	http://dx.doi.org/10.1371/journal.pone.0143820			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26640948	gold, Green Published, Green Submitted			2022-12-27	WOS:000366902700029
